PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Chu, AHY; Ng, SHX; Paknezhad, M; Gauterin, A; Koh, D; Brown, MS; Muller-Riemenschneider, F				Chu, Anne H. Y.; Ng, Sheryl H. X.; Paknezhad, Mahsa; Gauterin, Alvaro; Koh, David; Brown, Michael S.; Muller-Riemenschneider, Falk			Comparison of wrist-worn Fitbit Flex and waist-worn ActiGraph for measuring steps in free-living adults	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; ACTIVITY MONITORS; SEDENTARY BEHAVIOR; ACTIVITY TRACKERS; WEARABLE DEVICES; ACCELEROMETER; RELIABILITY; VALIDATION; CONSUMER; HEALTH	Introduction Accelerometers are commonly used to assess physical activity. Consumer activity trackers have become increasingly popular today, such as the Fitbit. This study aimed to compare the average number of steps per day using the wrist-worn Fitbit Flex and waist-worn Acti-Graph (wGT3X-BT) in free-living conditions. Methods 104 adult participants (n = 35 males; n = 69 females) were asked to wear a Fitbit Flex and an ActiGraph concurrently for 7 days. Daily step counts were used to classify inactive (< 10,000 steps) and active (>= 10,000 steps) days, which is one of the commonly used physical activity guidelines to maintain health. Proportion of agreement between physical activity categorizations from ActiGraph and Fitbit Flex was assessed. Statistical analyses included Spearman's rho, intraclass correlation (ICC), median absolute percentage error (MAPE), Kappa statistics, and Bland-Altman plots. Analyses were performed among all participants, by each step-defined daily physical activity category and gender. Results The median average steps/day recorded by Fitbit Flex and ActiGraph were 10193 and 8812, respectively. Strong positive correlations and agreement were found for all participants, both genders, as well as daily physical activity categories (Spearman's rho: 0.76-0.91; ICC: 0.73-0.87). The MAPE was: 15.5% (95% confidence interval [CI]: 5.8-28.1%) for overall steps, 16.9% (6.8-30.3%) vs. 15.1% (4.5-27.3%) in males and females, and 20.4% (8.7-35.9%) vs. 9.6% (1.0-18.4%) during inactive days and active days. Bland-Altman plot indicated a median overestimation of 1300 steps/day by the Fitbit Flex in all participants. Fitbit Flex and ActiGraph respectively classified 51.5% and 37.5% of the days as active (Kappa: 0.66). Conclusions There were high correlations and agreement in steps between Fitbit Flex and ActiGraph. However, findings suggested discrepancies in steps between devices. This imposed a challenge that needs to be considered when using Fibit Flex in research and health promotion programs.	[Chu, Anne H. Y.; Ng, Sheryl H. X.; Koh, David; Muller-Riemenschneider, Falk] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore, Singapore; [Paknezhad, Mahsa; Gauterin, Alvaro] Natl Univ Singapore, Sch Comp, Dept Comp Sci, Singapore, Singapore; [Koh, David] Univ Brunei Darussalam, PAPRSB Inst Hlth Sci, Jalan Tungku Link, Gadong, Brunei; [Brown, Michael S.] York Univ, Lassonde Sch Engn, Dept Elect Engn & Comp Sci, Toronto, ON, Canada; [Muller-Riemenschneider, Falk] Charite, Med Ctr Berlin, Inst Social Med Epidemiol & Hlth Econ, Berlin, Germany	National University of Singapore; National University of Singapore; University Brunei Darussalam; York University - Canada; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Chu, AHY (corresponding author), Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore, Singapore.	anne.chu@u.nus.edu		Muller-Riemenschneider, Falk/0000-0003-1402-7477; Koh, David/0000-0001-6803-7879; Ng, Sheryl/0000-0001-5046-2666	National University of Singapore [WBS: R-608-000-117-646]	National University of Singapore(National University of Singapore)	This research was supported by a grant WBS: R-608-000-117-646 from the National University of Singapore.	Aadland E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134606; Abel T, 2001, SOZ PRAVENTIV MED, V46, P268, DOI 10.1007/BF01593182; [Anonymous], 2015, SMART WEARABLES STAT; Barreira TV, 2013, J PHYS ACT HEALTH, V10, P263, DOI 10.1123/jpah.10.2.263; Bravata DM, 2007, JAMA-J AM MED ASSOC, V298, P2296, DOI 10.1001/jama.298.19.2296; Calabro MA, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/s12966-014-0119-7; Case MA, 2015, JAMA-J AM MED ASSOC, V313, P625, DOI 10.1001/jama.2014.17841; Choi L, 2011, MED SCI SPORT EXER, V43, P357, DOI 10.1249/MSS.0b013e3181ed61a3; Chu AHY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136944; Diaz KM, 2015, INT J CARDIOL, V185, P138, DOI 10.1016/j.ijcard.2015.03.038; Dierker KE, 2014, MED SCI SPORT EXER, V46, P792, DOI 10.1249/01.mss.0000495877.54448.6c; Dominick GM, 2016, JMIR MHEALTH UHEALTH, V4, DOI 10.2196/mhealth.6281; Dontje Manon L., 2015, Journal of Medical Engineering & Technology, V39, P286, DOI 10.3109/03091902.2015.1050125; Evenson KR, 2015, INT J BEHAV NUTR PHY, V12, DOI 10.1186/s12966-015-0314-1; Fanning J, 2012, J MED INTERNET RES, V14, P159, DOI 10.2196/jmir.2171; Fleiss J. L., 1981, STAT METHODS RATES P, V2, P22; Freedson P, 2012, MED SCI SPORT EXER, V44, pS1, DOI 10.1249/MSS.0b013e3182399b7e; Hardman A. E., 2009, PHYS ACTIVITY HLTH E; Hildebrand M, 2014, MED SCI SPORT EXER, V46, P1816, DOI 10.1249/MSS.0000000000000289; John D, 2012, MED SCI SPORT EXER, V44, pS86, DOI 10.1249/MSS.0b013e3182399f5e; Kooiman TJM, 2015, BMC SPORTS SCI MED R, V7, DOI 10.1186/s13102-015-0018-5; Lee IM, 2014, BRIT J SPORT MED, V48, P197, DOI 10.1136/bjsports-2013-093154; Lee JA, 2015, J SPORT SCI, V33, P991, DOI 10.1080/02640414.2014.981848; Marquez DX, 2006, ANN BEHAV MED, V31, P138, DOI 10.1207/s15324796abm3102_5; Nelson MB, 2016, MED SCI SPORTS EXERC; Ranck J., 2012, WEARABLE COMPUTING M; Rosenberger ME, 2016, MED SCI SPORT EXER, V48, P457, DOI 10.1249/MSS.0000000000000778; Rosenberger ME, 2013, MED SCI SPORT EXER, V45, P964, DOI 10.1249/MSS.0b013e31827f0d9c; Sasaki JE, 2011, J SCI MED SPORT, V14, P411, DOI 10.1016/j.jsams.2011.04.003; Schneider Margaret, 2016, BMC Res Notes, V9, P448; Shephard RJ, 2016, SPRINGER SER EPIDEMI, P1, DOI 10.1007/978-3-319-29577-0; Storm FA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118723; Sushames A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161224; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; Troiano RP, 2014, BRIT J SPORT MED, V48, DOI 10.1136/bjsports-2014-093546; Tudor-Locke C, 2004, SPORTS MED, V34, P1, DOI 10.2165/00007256-200434010-00001; Tudor-Locke C, 2015, INT J BEHAV NUTR PHY, V12, DOI 10.1186/s12966-015-0172-x; Tudor-Locke C, 2015, MED SCI SPORT EXER, V47, P839, DOI 10.1249/MSS.0000000000000476; Tudor-Locke C, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-79; Tudor-Locke C, 2010, CURR CARDIOVASC RISK, V4, DOI 10.1007/s12170-010-0109-5; Tudor-Locke C, 2008, J PHYS ACT HEALTH, V5, P633, DOI 10.1123/jpah.5.5.633; Tudor-Locke C, 2009, MED SCI SPORT EXER, V41, P1384, DOI 10.1249/MSS.0b013e318199885c; Welk G., 2002, PHYSICAL ACTIVITY AS	43	66	67	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0172535	10.1371/journal.pone.0172535	http://dx.doi.org/10.1371/journal.pone.0172535			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5VB	28234953	Green Published, Green Submitted, gold			2022-12-27	WOS:000394688200089
J	Kato, T; Yorifuji, T; Yamakawa, M; Inoue, S; Doi, H; Eboshida, A; Kawachi, I				Kato, Tsuguhiko; Yorifuji, Takashi; Yamakawa, Michiyo; Inoue, Sachiko; Doi, Hiroyuki; Eboshida, Akira; Kawachi, Ichiro			Association of maternal age with child health: A Japanese longitudinal study	PLOS ONE			English	Article							POPULATION; BIRTH; OUTCOMES; COHORT; LIFE	Average maternal age at birth has been rising steadily in Western and some Asian countries. Older maternal age has been associated with adverse pregnancy and birth outcomes; however, studies on the relationship between maternal age and young children's health remain scarce. Therefore, we sought to investigate the association of maternal age with child health outcomes in the Japanese population. We analyzed data from two birth cohorts of the nationwide Japanese Longitudinal Survey of Babies in 21 st Century (n(2001) = 47,715 and n(2010) = 38,554). We estimated risks of unintentional injuries and hospital admissions at 18 and 66 months according to maternal age, controlling for the following potential confounders: parental education; maternal parity, smoking status, and employment status; household income; paternal age, and sex of the child. We also included the following as potential mediators: preterm births and birthweight. We observed a decreasing trend in the risks of children's unintentional injuries and hospital admissions at 18 months according to maternal age in both cohorts. In the 2001 cohort, compared to mothers <25 years, odds ratios of hospital admission at 18 months were 0.97 [95% CI: 0.86, 1.09], 0.92 [0.81, 1.05], 0.76 [0.65, 0.90], and 0.71 [0.51, 0.98] for mothers aged 25.0-29.9, 30.0-34.9, 35.0-39.9, and >40.0 years, respectively, controlling for confounders. Our findings were in line with previous findings from population-based studies conducted in the United Kingdom and Canada suggesting that older maternal age may be beneficial for early child health.	[Kato, Tsuguhiko] Natl Ctr Child Hlth & Dev, Dept Social Med, Tokyo, Japan; [Yorifuji, Takashi] Okayama Univ, Grad Sch Environm & Life Sci, Dept Human Ecol, Okayama, Japan; [Yamakawa, Michiyo] Okayama Univ, Ctr Reg Res, Okayama, Japan; [Inoue, Sachiko] Okayama Prefectural Univ, Grad Sch Hlth & Welf Sci, Dept Nursing, Okayama, Japan; [Doi, Hiroyuki] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Epidemiol, Okayama, Japan; [Eboshida, Akira] Hiroshima Univ, Inst Biomed Sci, Dept Publ Hlth & Hlth Policy, Hiroshima, Japan; [Kawachi, Ichiro] Harvard TH Chan Sch Publ Hlth, Dept Social & Behav Sci, Boston, MA USA	National Center for Child Health & Development - Japan; Okayama University; Okayama University; Okayama Prefectural University; Okayama University; Hiroshima University; Harvard University; Harvard T.H. Chan School of Public Health	Kato, T (corresponding author), Natl Ctr Child Hlth & Dev, Dept Social Med, Tokyo, Japan.	kato-tg@ncchd.go.jp		Kato, Tsuguhiko/0000-0002-6009-7962	Japan Society for the Promotion of Science [KAKENHI] [26870404, 16K16631]; Grants-in-Aid for Scientific Research [26870404] Funding Source: KAKEN	Japan Society for the Promotion of Science [KAKENHI](Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Japan Society for the Promotion of Science [KAKENHI], (26870404), awarded to TK, and the Japan Society for the Promotion of Science [KAKENHI], (16K16631), also awarded to TK; https://kaken.nii.ac.jp/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benzies K, 2006, JOGNN-J OBST GYN NEO, V35, P625, DOI 10.1111/J.1552-6909.2006.00079.x; Boyle EM, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e896; Carolan M, 2003, JOGNN-J OBST GYN NEO, V32, P19, DOI 10.1177/0884217502239797; Carolan M, 2011, MIDWIFERY, V27, P793, DOI 10.1016/j.midw.2010.07.006; Delnord M, 2015, CURR OPIN OBSTET GYN, V27, P133, DOI 10.1097/GCO.0000000000000156; Fujiwara T, 2013, AM J EPIDEMIOL, V177, P1042, DOI 10.1093/aje/kws355; Garner Rochelle, 2008, Genus, V64, P63; Gender Equality Bureau Cabinet Office, 1999, GEND EQ WORKPL HOM C; Geronimus Arline T., 1992, Ethnicity and Disease, V2, P207; Health Labour and Welfare Statistic Association, 2014, J HLTH WELFARE STAT; Heffner LJ, 2004, NEW ENGL J MED, V351, P1927, DOI 10.1056/NEJMp048087; Hsieh TT, 2010, EUR J OBSTET GYN R B, V148, P21, DOI 10.1016/j.ejogrb.2009.08.022; Japan Society of Obstetrics and Gynecology, 2013, TERMINOLOGY FOR OBST; Kato T, 2013, J PEDIATR-US, V163, P1578, DOI 10.1016/j.jpeds.2013.07.004; Lim Jae Woo, 2011, Korean J Pediatr, V54, P429, DOI 10.3345/kjp.2011.54.11.429; Mills T. A., 2014, OBSTET GYNAECOL REPR, V24, P85, DOI DOI 10.1016/J.OGRM.2014.01.004; Ministry of Health Labour and Welfare, LONG SURV BAB 21 CEN; Nelson Antonia M, 2004, J Pediatr Health Care, V18, P284, DOI 10.1016/S0891-5245(04)00089-6; OECD, 2020, OECD FAM DAT, DOI 10.1787/efd30a09-en; Office for National Statistics, 2013, BIRTHS ENGL WAL 2012; Pillas D, 2014, PEDIATR RES, V76, P418, DOI 10.1038/pr.2014.122; Power C, 2013, ANNU REV PUBL HEALTH, V34, P7, DOI 10.1146/annurev-publhealth-031912-114423; Raymo JM, 2015, ANNU REV SOCIOL, V41, P471, DOI 10.1146/annurev-soc-073014-112428; Rothman KJ., 2012, EPIDEMIOLOGY INTRO; Schmidt L, 2012, HUM REPROD UPDATE, V18, P29, DOI 10.1093/humupd/dmr040; Stein Z, 2000, BMJ-BRIT MED J, V320, P1681, DOI 10.1136/bmj.320.7251.1681; Sutcliffe AG, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e5116; World Health Organization, 2017, PRET BIRTH GEN WHO; Yamakawa M, 2013, JAMA PEDIATR, V167, P919, DOI 10.1001/jamapediatrics.2013.2230	29	12	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0172544	10.1371/journal.pone.0172544	http://dx.doi.org/10.1371/journal.pone.0172544			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5VB	28234951	Green Published, gold, Green Submitted			2022-12-27	WOS:000394688200091
J	Abraham, M; Alramadhan, S; Iniguez, C; Duijts, L; Jaddoe, VWV; Den Dekker, HT; Crozier, S; Godfrey, KM; Hindmarsh, P; Vik, T; Jacobsen, GW; Hanke, W; Sobala, W; Devereux, G; Turner, S				Abraham, Miriam; Alramadhan, Salem; Iniguez, Carmen; Duijts, Liesbeth; Jaddoe, Vincent W. V.; Den Dekker, Herman T.; Crozier, Sarah; Godfrey, Keith M.; Hindmarsh, Peter; Vik, Torstein; Jacobsen, Geir W.; Hanke, Wojciech; Sobala, Wojciech; Devereux, Graham; Turner, Steve			A systematic review of maternal smoking during pregnancy and fetal measurements with meta-analysis	PLOS ONE			English	Review							CIGARETTE-SMOKING; GROWTH; IMPACT; EXPOSURE; TRIMESTER; BIOMETRY; OUTCOMES; VOLUME; WOMEN; SIZE	Background Maternal smoking during pregnancy is linked to reduced birth weight but the gestation at onset of this relationship is not certain. We present a systematic review of the literature describing associations between maternal smoking during pregnancy and ultrasound measurements of fetal size, together with an accompanying meta-analysis. Methods Studies were selected from electronic databases (OVID, EMBASE and Google Scholar) that examined associations between maternal smoking or smoke exposure and antenatal fetal ultrasound measurements. Outcome measures were first, second or third trimester fetal measurements. Results There were 284 abstracts identified, 16 papers were included in the review and the metaanalysis included data from eight populations. Maternal smoking was associated with reduced second trimester head size (mean reduction 0.09 standard deviation (SD) [95% CI 0.01, 0.16]) and femur length (0.06 [0.01, 0.10]) and reduced third trimester head size (0.18 SD [0.13, 0.23]), femur length (0.27 SD [0.21, 0.32]) and estimated fetal weight (0.18 SD [0.11, 0.24]). Higher maternal cigarette consumption was associated with a lower z score for head size in the second (mean difference 0.09 SD [0, 0.19]) and third (0.15 SD [0.03, 0.26]) trimesters compared to lower consumption. Fetal measurements were not reduced for those whose mothers quit before or after becoming pregnant compared to mothers who had never smoked. Conclusions Maternal smoking during pregnancy is associated with reduced fetal measurements after the first trimester, particularly reduced head size and femur length. These effects may be attenuated if mothers quit or reduce cigarette consumption during pregnancy.	[Abraham, Miriam; Alramadhan, Salem; Devereux, Graham; Turner, Steve] Univ Aberdeen, Child Hlth, Aberdeen, Scotland; [Iniguez, Carmen] Univ Valencia, Univ Jaume 1, FISABIO, Epidemiol & Environm Hlth Joint Res Unit, Valencia, Spain; [Iniguez, Carmen] Spanish Consortium Res Epidemiol & Publ Hlth CIBE, Valencia, Spain; [Duijts, Liesbeth; Jaddoe, Vincent W. V.; Den Dekker, Herman T.] Univ Med Ctr Rotterdam, Dept Epidemiol, Dept Paediat, Erasmus MC,Generat R Study, Rotterdam, Netherlands; [Crozier, Sarah; Godfrey, Keith M.] Univ Southampton, MRC Lifecourse Epidemiol Unit, Southampton, Hants, England; [Crozier, Sarah; Godfrey, Keith M.] Univ Southampton, NIHR Southampton Biomed Res Ctr, Southampton, Hants, England; [Crozier, Sarah; Godfrey, Keith M.] Univ Hosp Southampton NHS Fdn Trust, Southampton, Hants, England; [Hindmarsh, Peter] UCL, London, England; [Vik, Torstein; Jacobsen, Geir W.] Norwegian Univ Sci & Technol, Fac Med, Trondheim, Norway; [Hanke, Wojciech; Sobala, Wojciech] Nofer Inst Occupat Med, Dept Environm Epidemiol, Lodz, Poland	University of Aberdeen; Universitat Jaume I; University of Valencia; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Erasmus University Rotterdam; Erasmus MC; University of Southampton; University of Southampton; University of Southampton; University Hospital Southampton NHS Foundation Trust; University of London; University College London; Norwegian University of Science & Technology (NTNU); Nofer Institute of Occupational Medicine	Turner, S (corresponding author), Univ Aberdeen, Child Hlth, Aberdeen, Scotland.	s.w.turner@abdn.ac.uk	Iñiguez, Carmen/AAA-5866-2019	Iñiguez, Carmen/0000-0003-3471-4928; Iniguez, Carmen/0000-0002-5156-0732; Hanke, Wojciech/0000-0001-7162-2569	European Cooperation in Science and Technology; National Institute for Health Research through the NIHR Southampton Biomedical Research Centre; European Union [289346, 613977]; MRC [MR/K007017/1, MC_UU_12011/4, MR/M501633/2, MC_UP_A620_1017] Funding Source: UKRI; British Heart Foundation [PG/14/33/30827, RG/15/17/31749] Funding Source: researchfish; Medical Research Council [MR/M501633/2, MC_PC_13040, MR/M501633/1, MC_UP_A620_1017, MC_UU_12011/4, MR/K007017/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0515-10042] Funding Source: researchfish	European Cooperation in Science and Technology(European Cooperation in Science and Technology (COST)); National Institute for Health Research through the NIHR Southampton Biomedical Research Centre; European Union(European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	The study was supported by the European Cooperation in Science and Technology, who provided funds for publication. KMG is supported by the National Institute for Health Research through the NIHR Southampton Biomedical Research Centre and by the European Union's Seventh Framework Programme (FP7/2007-2013), projects Early Nutrition and ODIN under grant agreement numbers 289346 and 613977.	Alkandari F, 2015, J EPIDEMIOL COMMUN H, V69, P41, DOI 10.1136/jech-2014-204091; AlMakoshi A, 2015, PEDIAT ALLERG IMM-UK, V26, P811, DOI 10.1111/pai.12380; Anblagan D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067223; Bergsjo P, 2007, ACTA OBSTET GYN SCAN, V86, P156, DOI 10.1080/00016340600984696; Bernstein IM, 2000, AM J OBSTET GYNECOL, V183, P883, DOI 10.1067/mob.2000.109103; Cochrane Library, COCHRANE HANDBOOK FO; Guxens M, 2012, INT J EPIDEMIOL, V41, P930, DOI 10.1093/ije/dyr054; HADLOCK FP, 1984, RADIOLOGY, V150, P535, DOI 10.1148/radiology.150.2.6691115; Hanke W, 2004, INT ARCH OCC ENV HEA, V77, P47, DOI 10.1007/s00420-003-0475-0; Heil SH, 2008, ADDICTION, V103, P1009, DOI 10.1111/j.1360-0443.2008.02237.x; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; Iniguez C, 2013, AM J EPIDEMIOL, V178, P1067, DOI 10.1093/aje/kwt085; Iniguez C, 2012, J EPIDEMIOL COMMUN H, V66, P563, DOI 10.1136/jech.2010.116756; Jaddoe VWV, 2007, AM J EPIDEMIOL, V165, P1207, DOI 10.1093/aje/kwm014; JEANTY P, 1987, J ULTRAS MED, V6, P13, DOI 10.7863/jum.1987.6.1.13; Kfir M, 2009, ULTRASOUND OBST GYN, V33, P683, DOI 10.1002/uog.6379; Klebanoff MA, 1998, AM J EPIDEMIOL, V148, P259; Lampl M, 2003, AM J HUM BIOL, V15, P533, DOI 10.1002/ajhb.10140; Leonardi-Bee J, 2008, ARCH DIS CHILD-FETAL, V93, pF351, DOI 10.1136/adc.2007.133553; Lindell G, 2012, ULTRASOUND OBST GYN, V40, P680, DOI 10.1002/uog.11125; Mook-Kanamori DO, 2010, JAMA-J AM MED ASSOC, V303, P527, DOI 10.1001/jama.2010.78; National Institute for Health and Care Excellence, STOP SMOK PREGN FOLL; NEWNHAM JP, 1990, EARLY HUM DEV, V24, P23, DOI 10.1016/0378-3782(90)90003-2; Physicians R. C.O., 2010, PASS SMOK CHILDR; Prabhu N, 2010, THORAX, V65, P235, DOI 10.1136/thx.2009.123232; Pringle PJ, 2005, J CLIN ENDOCR METAB, V90, P2556, DOI 10.1210/jc.2004-1674; Roza SJ, 2007, EUR J NEUROSCI, V25, P611, DOI 10.1111/j.1460-9568.2007.05393.x; Schmid M, 2011, PRENATAL DIAG, V31, P491, DOI 10.1002/pd.2725; Sterne JAC, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4002; Taal HR, 2011, PEDIATR NEPHROL, V26, P1275, DOI 10.1007/s00467-011-1848-3; Vielwerth SE, 2007, EARLY HUM DEV, V83, P491, DOI 10.1016/j.earlhumdev.2006.09.010; Vik T, 1996, EARLY HUM DEV, V45, P245, DOI 10.1016/0378-3782(96)01735-5; Whisner CM, 2015, INT J OBESITY, V39, P565, DOI 10.1038/ijo.2014.202; Zaren B, 2000, PAEDIATR PERINAT EP, V14, P118, DOI 10.1046/j.1365-3016.2000.00247.x	34	115	118	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2017	12	2							e0170946	10.1371/journal.pone.0170946	http://dx.doi.org/10.1371/journal.pone.0170946			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5SX	28231292	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000394682400006
J	Bertella, MA; Pires, FR; Rego, HHA; Silva, JN; Vodenska, I; Stanley, HE				Bertella, Mario A.; Pires, Felipe R.; Rego, Henio H. A.; Silva, Jonathas N.; Vodenska, Irena; Stanley, H. Eugene			Confidence and self-attribution bias in an artificial stock market	PLOS ONE			English	Article							TIME-SERIES; UNIT-ROOT; HYPOTHESIS	Using an agent-based model we examine the dynamics of stock price fluctuations and their rates of return in an artificial financial market composed of fundamentalist and chartist agents with and without confidence. We find that chartist agents who are confident generate higher price and rate of return volatilities than those who are not. We also find that kurtosis and skewness are lower in our simulation study of agents who are not confident. We show that the stock price and confidence index-both generated by our model D are cointegrated and that stock price affects confidence index but confidence index does not affect stock price. We next compare the results of our model with the S&P 500 index and its respective stock market confidence index using cointegration and Granger tests. As in our model, we find that stock prices drive their respective confidence indices, but that the opposite relationship, i.e., the assumption that confidence indices drive stock prices, is not significant.	[Bertella, Mario A.; Silva, Jonathas N.] Sao Paulo State Univ, UNESP, Dept Econ, Sao Paulo, Brazil; [Pires, Felipe R.] Sao Paulo Metropolitan Co, Sao Paulo, Brazil; [Rego, Henio H. A.] Fed Inst Educ Sci & Technol, Maranhao, Brazil; [Vodenska, Irena] Boston Univ, Metropolitan Coll, Boston, MA 02215 USA; [Stanley, H. Eugene] Boston Univ, Ctr Polymer Studies, Boston, MA 02215 USA; [Stanley, H. Eugene] Boston Univ, Dept Phys, 590 Commonwealth Ave, Boston, MA 02215 USA	Universidade Estadual Paulista; Boston University; Boston University; Boston University	Silva, JN (corresponding author), Sao Paulo State Univ, UNESP, Dept Econ, Sao Paulo, Brazil.	jonathas.water@gmail.com	Vodenska, Irena/AAR-7025-2021; Bertella, Mario A./AAW-7716-2020	Bertella, Mario A./0000-0003-3237-0455; Stanley, H./0000-0003-2800-4495; Silva, Jonathas/0000-0001-6283-3831	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2014/19534-8]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior [1267846]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by grant number: 2014/19534-8, URL: http://www.fapesp.br/, Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, MAB; and grant number: 1267846, URL: http://www.capes.gov.br/, Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, JNS.	[Anonymous], 2001, MARKET MODELS GUIDE; Arthur WB, 1997, EC EVOLVING COMPLEX; Barberis N, 2005, ADV BEHAV FINANCE, V2; BELTRATTI A, 1993, COM ADAP SY, P494; Bertella MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083488; BLACK F, 1986, J FINANC, V41, P529, DOI 10.2307/2328481; Brock WA, 1998, J ECON DYN CONTROL, V22, P1235, DOI 10.1016/S0165-1889(98)00011-6; DAY RH, 1990, J ECON BEHAV ORGAN, V14, P299, DOI 10.1016/0167-2681(90)90061-H; DICKEY DA, 1979, J AM STAT ASSOC, V74, P427, DOI 10.2307/2286348; Engle RF, 2001, ESSAYS ECONOMETRICS, P145; FAMA EF, 1970, J FINANC, V25, P383, DOI 10.2307/2325486; Farmer JD, 2005, P NATL ACAD SCI USA, V102, P2254, DOI 10.1073/pnas.0409157102; Farmer JD, 2002, J ECON BEHAV ORGAN, V49, P149, DOI 10.1016/S0167-2681(02)00065-3; JENSEN MC, 1978, J FINANC ECON, V6, P95, DOI 10.1016/0304-405X(78)90025-9; JOHANSEN S, 1991, ECONOMETRICA, V59, P1551, DOI 10.2307/2938278; Kahneman D, 1998, J PORTFOLIO MANAGE, V24, P52, DOI 10.3905/jpm.1998.409643; KWIATKOWSKI D, 1992, J ECONOMETRICS, V54, P159, DOI 10.1016/0304-4076(92)90104-Y; LeBaron B, 1999, J ECON DYN CONTROL, V23, P1487, DOI 10.1016/S0165-1889(98)00081-5; Lebaron B, 2006, HANDB ECON, V13, P1187; Levy H., 2000, MICROSCOPIC SIMULATI; LJUNG GM, 1978, BIOMETRIKA, V65, P297, DOI 10.2307/2335207; Lovric M, 2011, EPS2011229FA; MacKinnon J., 1991, LONG RUN EC RELATION; Odean T, 1999, AM ECON REV, V89, P1279, DOI 10.1257/aer.89.5.1279; PHILLIPS PCB, 1988, BIOMETRIKA, V75, P335, DOI 10.1093/biomet/75.2.335; Shleifer A., 2000, INEFFICIENT MARKETS; Takahashi H., 2003, JASSS-J ARTIF SOC S, V6, P3; TVERSKY A, 1986, J BUS, V59, pS251, DOI 10.1086/296365; Xu HC, 2014, ABSTR APPL ANAL, DOI 10.1155/2014/328498; Zhou WX, 2011, PLOS ONE, V6, P1	30	4	4	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2017	12	2							e0172258	10.1371/journal.pone.0172258	http://dx.doi.org/10.1371/journal.pone.0172258			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL5SX	28231255	gold, Green Published, Green Submitted			2022-12-27	WOS:000394682400031
J	Kollmann, M; Aldrian, L; Scheuchenegger, A; Mautner, E; Herzog, SA; Urlesberger, B; Raggam, RB; Lang, U; Obermayer-Pietsch, B; Klaritsch, P				Kollmann, Martina; Aldrian, Lisa; Scheuchenegger, Anna; Mautner, Eva; Herzog, Sereina A.; Urlesberger, Berndt; Raggam, Reinhard B.; Lang, Uwe; Obermayer-Pietsch, Barbara; Klaritsch, Philipp			Early skin-to-skin contact after cesarean section: A randomized clinical pilot study	PLOS ONE			English	Article							OXYGEN-SATURATION; PSYCHOLOGICAL STRESS; SALIVARY CORTISOL; ALPHA-AMYLASE; TERM INFANTS; DELIVERY; MOTHER; CARE; FETAL; BIRTH	Objective Early bonding by skin-to-skin contact (SSC) has been demonstrated to be beneficial for mothers and newborns following vaginal delivery. The aim of this study was to investigate the impact of intraoperative bonding (early SSC) after cesarean section on neonatal adaptation, maternal pain and stress response. Study design This prospective, randomized-controlled pilot study was performed at a single academic tertiary hospital (Department of Obstetrics and Gynecology, Medical University of Graz, Austria) between September 2013 and January 2014. Women were randomly assigned to intraoperative ("early") SCC (n = 17) versus postoperative ("late") SCC (n = 18). Main variables investigated were neonatal transition (Apgar score, arterial oxygen saturation, heart rate and temperature), maternal pain perception and both maternal and neonatal stress response by measuring the stress biomarkers salivary free cortisol and salivary alpha amylase. Results There was no evidence for differences in parameters reflecting neonatal transition or stress response between the 'Early SSC Group' and the 'Late SSC Group'. Maternal salivary cortisol and alpha-amylase levels as well as maternal wellbeing and pain did not differ between the groups. However, the rise of maternal salivary alpha-amylase directly after delivery was higher in the 'Early SSC Group' compared to the 'Late SSC Group' (p = 0.004). Conclusions This study did not reveal significant risks for the newborn in terms of neonatal transition when early SSC is applied in the operating room. Maternal condition and stress marker levels did not differ either, although the rise of maternal salivary alpha-amylase directly after delivery was higher in the 'Early SSC Group' compared to the 'Late SSC Group', which may indicate a stressor sign due to intensive activation of the sympathetic-adreno-medullary-system. This needs to be further evaluated in a larger prospective randomized trial.	[Kollmann, Martina; Aldrian, Lisa; Mautner, Eva; Lang, Uwe; Klaritsch, Philipp] Med Univ Graz, Div Obstet & Maternal Fetal Med, Dept Obstet & Gynecol, Graz, Austria; [Scheuchenegger, Anna; Urlesberger, Berndt] Med Univ Graz, Div Neonatol, Dept Pediat & Adolescence Med, Graz, Austria; [Herzog, Sereina A.] Med Univ Graz, Inst Med Informat Stat & Documentat IMI, Graz, Austria; [Raggam, Reinhard B.] Med Univ Graz, Clin Inst Med & Chem Lab Diagnost, Graz, Austria; [Raggam, Reinhard B.] Med Univ Graz, Div Angiol, Dept Internal Med, Graz, Austria; [Obermayer-Pietsch, Barbara] Med Univ Graz, Div Endocrinol & Metab, Dept Internal Med, Graz, Austria	Medical University of Graz; Medical University of Graz; Medical University of Graz; Medical University of Graz; Medical University of Graz; Medical University of Graz	Klaritsch, P (corresponding author), Med Univ Graz, Div Obstet & Maternal Fetal Med, Dept Obstet & Gynecol, Graz, Austria.	philipp.klaritsch@medunigraz.at	Herzog, Sereina A/K-8865-2017; Klaritsch, Philipp/Q-5870-2016	Herzog, Sereina A/0000-0002-5373-5866; Klaritsch, Philipp/0000-0002-7359-4853; Urlesberger, Berndt/0000-0003-0648-5785				[Anonymous], 2016, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003519.PUB3; Beiranvand S, 2014, INT J PEDIAT, V2014, DOI 10.1155/2014/846486; Bigert C, 2005, INT J HYG ENVIR HEAL, V208, P227, DOI 10.1016/j.ijheh.2005.01.014; Chatterton RT, 1997, J CLIN ENDOCR METAB, V82, P2503, DOI 10.1210/jc.82.8.2503; Crenshaw JT, 2012, BREASTFEED MED, V7, P69, DOI 10.1089/bfm.2011.0040; Dawson JA, 2007, ARCH DIS CHILD-FETAL, V92, pF4, DOI 10.1136/adc.2006.102749; Dawson JA, 2010, ARCH DIS CHILD-FETAL, V95, pF177, DOI 10.1136/adc.2009.169102; Dawson JA, 2010, PEDIATRICS, V125, pE1340, DOI 10.1542/peds.2009-1510; Einarsson S, 2008, ACTA VET SCAND, V50, DOI 10.1186/1751-0147-50-48; Garcia-Blanco A, 2016, J CHROMATOGR B, V1022, P249, DOI 10.1016/j.jchromb.2016.04.035; Gouchon S, 2010, NURS RES, V59, P78, DOI 10.1097/NNR.0b013e3181d1a8bc; GUNNAR MR, 1985, CHILD DEV, V56, P824, DOI 10.1111/j.1467-8624.1985.tb00155.x; Hellhammer DH, 2009, PSYCHONEUROENDOCRINO, V34, P163, DOI 10.1016/j.psyneuen.2008.10.026; Hewitt V, 2005, INT J EVID-BASED HEA, V3, P169, DOI 10.1111/j.1479-6988.2005.00025.x; Horn EP, 2014, ANESTH ANALG, V118, P997, DOI 10.1213/ANE.0000000000000160; Hui CK, 2006, ANAESTHESIA, V61, P29, DOI 10.1111/j.1365-2044.2005.04466.x; Hung KJ, 2011, MCN-AM J MATERN-CHIL, V36, P318, DOI 10.1097/NMC.0b013e3182266314; Kamlin COF, 2006, J PEDIATR-US, V148, P585, DOI 10.1016/j.jpeds.2005.12.050; KIRSCHBAUM C, 1994, PSYCHONEUROENDOCRINO, V19, P313, DOI 10.1016/0306-4530(94)90013-2; KLAUS MH, 1972, NEW ENGL J MED, V286, P460, DOI 10.1056/NEJM197203022860904; Lewis John G, 2006, Clin Biochem Rev, V27, P139; Gabriel MAM, 2010, ACTA PAEDIATR, V99, P1630, DOI 10.1111/j.1651-2227.2009.01597.x; Maruyama Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039375; Mercer JS, 2007, J MIDWIFERY WOM HEAL, V52, P262, DOI 10.1016/j.jmwh.2007.01.005; Nater UM, 2006, PSYCHONEUROENDOCRINO, V31, P49, DOI 10.1016/j.psyneuen.2005.05.010; Nater UM, 2007, PSYCHONEUROENDOCRINO, V32, P392, DOI 10.1016/j.psyneuen.2007.02.007; Nolan A, 2009, JOGNN-J OBST GYN NEO, V38, P430, DOI 10.1111/j.1552-6909.2009.01039.x; Organization PAH, 2013, SURV INT DEL CAR PRA; Puig G, 2007, EARLY TO SKIN CONTAC; Rabi Y, 2006, J PEDIATR-US, V148, P590, DOI 10.1016/j.jpeds.2005.12.047; Reif P, 2015, CLIN CHEM LAB MED; Reif P, 2014, CLIN CHEM LAB MED, V52, P825, DOI 10.1515/cclm-2013-0732; Saito T, 1998, REGION ANESTH PAIN M, V23, P418, DOI 10.1016/S1098-7339(98)90017-7; Srivastava Smita, 2014, Indian J Public Health, V58, P22, DOI 10.4103/0019-557X.128160; Stevens J, 2014, MATERN CHILD NUTR, V10, P456, DOI 10.1111/mcn.12128; Takai N, 2004, ARCH ORAL BIOL, V49, P963, DOI 10.1016/j.archoralbio.2004.06.007; Tappauf C, 2013, AM J OBSTET GYNECOL, V209, DOI 10.1016/j.ajog.2013.05.057; Urlesberger B, 2011, J PEDIATR-US, V159, P404, DOI 10.1016/j.jpeds.2011.02.030; Velandia M, 2012, ACTA PAEDIATR, V101, P360, DOI 10.1111/j.1651-2227.2011.02523.x; Velandia M, 2010, BIRTH-ISS PERINAT C, V37, P192, DOI 10.1111/j.1523-536X.2010.00406.x; Wagner J, 2010, INT J HYG ENVIR HEAL, V213, P153, DOI 10.1016/j.ijheh.2009.08.004; Walters MW, 2007, MCN-AM J MATERN-CHIL, V32, P375, DOI 10.1097/01.NMC.0000298134.39785.6c; Yuksel B, 2016, J MATERN-FETAL NEO M, V29, P2691, DOI 10.3109/14767058.2015.1101447	43	15	16	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2017	12	2							e0168783	10.1371/journal.pone.0168783	http://dx.doi.org/10.1371/journal.pone.0168783			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5SX	28231274	Green Published, Green Submitted, gold			2022-12-27	WOS:000394682400001
J	Srikanok, S; Parker, DM; Parker, AL; Lee, T; Min, AM; Ontuwong, P; Tan, SO; Sirinonthachai, S; McGready, R				Srikanok, Somjet; Parker, Daniel M.; Parker, Amber L.; Lee, Tracey; Min, Aung Myat; Ontuwong, Pranee; Tan, Saw Oo; Sirinonthachai, Supachai; McGready, Rose			Empirical lessons regarding contraception in a protracted refugee setting: A descriptive study from Maela camp on the Thai-Myanmar border 1996-2015	PLOS ONE			English	Article							REPRODUCTIVE HEALTH; INFANT-MORTALITY; CHILD HEALTH; PREGNANCY; MALARIA; KAREN; FERTILITY; SERVICES; ECOLOGY; WOMEN	Conflict settings and refugee camps can be chaotic places, with large and rapid population movements, exacerbated public health problems, and ad hoc health services. Reproductive health care that includes family planning is of heightened importance in such settings, however, funding and resources tend to be constrained and geared towards acute health services such as trauma management and infectious disease containment. Here we report on the complexities and challenges of providing family planning in a post-emergency refugee setting, using the example of the largest refugee camp on the Thai-Myanmar border, in existence now for over 30 years. Data from 2009 demonstrates an upward trend in uptake of all contraceptives, especially long acting reversible contraception (LARC) and permanent methods (e.g.sterilization) over time. Increased uptake occurred during periods of time when there were boosts in funding or when barriers to access were alleviated. For example a surgeon fluent in local languages is correlated with increased uptake of tubal ligation in females. These data indicate that funding directed toward contraceptives in this refugee setting led to increases in contraceptives use. However, contraceptive uptake estimates depend on the baseline population which is difficult to measure in this setting. As far as we are aware, this is the longest reported review of family planning services for a refugee camp setting to date. The lessons learned from this setting may be valuable given the current global refugee crisis.	[Srikanok, Somjet; Ontuwong, Pranee; Sirinonthachai, Supachai] Planned Parenthood Assoc Thailand, Bangkok, Thailand; [Parker, Daniel M.; Parker, Amber L.; Lee, Tracey; Min, Aung Myat; Tan, Saw Oo; McGready, Rose] Mahidol Univ, Fac Trop Med, Shoklo Malaria Res Unit, Mahidol Oxford Trop Med Res Unit, Mae Sot, Thailand; [McGready, Rose] Univ Oxford, Nuffield Dept Med, Ctr Trop Med & Global Hlth, Old Rd Campus, Oxford, England	Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University; University of Oxford	Parker, DM (corresponding author), Mahidol Univ, Fac Trop Med, Shoklo Malaria Res Unit, Mahidol Oxford Trop Med Res Unit, Mae Sot, Thailand.	daniel@shoklo-unit.com	McGready, Rose/A-3290-2014; Parker, Daniel M./B-5471-2013	McGready, Rose/0000-0003-1621-3257; Parker, Daniel M./0000-0002-5352-7338; Parker, Amber/0000-0002-6248-3904	UNHCR; International Planned Parenthood Federation East and South East Asia and Oceania Region (IPPF ESEAOR); Malariadokters (The Netherlands); Wellcome Trust [WT-106698]	UNHCR; International Planned Parenthood Federation East and South East Asia and Oceania Region (IPPF ESEAOR); Malariadokters (The Netherlands)(Netherlands Government); Wellcome Trust(Wellcome TrustEuropean Commission)	We are grateful for the support received by PPAT under the patronage of H.R.H the Princess Mother, from UNHCR in 2008, and International Planned Parenthood Federation East and South East Asia and Oceania Region (IPPF ESEAOR) in 2009, and Malariadokters (The Netherlands) in 2011. We are grateful to the organizations that have supported supplies of contraceptives to SMRU including Thailand Department of Public Health, Family Planning Australia, and other private donors. SMRU is part of the Wellcome Trust Mahidol University Oxford Tropical Medicine Research Program funded by the Wellcome Trust (WT-106698). The funding bodies had no role in the design, collection, analysis or interpretation of data, nor in the writing or submission of the manuscript for publication.r We are grateful to the women and men from Maela camp who attended SMRU or PPAT over the years and who participated in family planning, antenatal and birth services. We are grateful for the support received by PPAT under the patronage of H.R.H the Princess Mother, from UNHCR in 2008, and International Planned Parenthood Federation East and South East Asia and Oceania Region (IPPF ESEAOR) in 2009, and Malariadokters (The Netherlands) in 2011 and Stichting Vluchteling in 2015. We are grateful to the organizations that have supported supplies of contraceptives to SMRU including Thailand Department of Public Health, Family Planning Australia, and other private donors. SMRU is part of the Wellcome Trust Mahidol University Oxford Tropical Medicine Research Program funded by the Wellcome Trust (WT 106698). The funding bodies had no role in the design, collection, analysis or interpretation of data, nor in the writing or submission of the manuscript for publication.	Adelman, 2009, CHILDHOOD INTERGENER; BARKER DJP, 1990, BRIT MED J, V301, P1111, DOI 10.1136/bmj.301.6761.1111; Black BO, 2014, OBSTET GYNAECOL, V16, P153, DOI 10.1111/tog.12114; BOSS LP, 1994, JAMA-J AM MED ASSOC, V272, P371, DOI 10.1001/jama.272.5.371; CALDWELL JC, 1976, POPUL DEV REV, V2, P321, DOI 10.2307/1971615; Carrara VI, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-45; Casey SE, 2015, CONFL HEALTH, V9, DOI 10.1186/1752-1505-9-S1-S3; CLEVELAND WS, 1988, J AM STAT ASSOC, V83, P596, DOI 10.2307/2289282; Coale A J, 1984, Pak Dev Rev, V23, P531; Corak Miles, 2006, IZA DISCUSSION PAPER; Cottrell MP, 2015, REFUG SURV Q, V34, P20, DOI 10.1093/rsq/hdv015; Curry DW, 2015, GLOB HEALTH, V3, P14, DOI 10.9745/GHSP-D-14-00164; Curtin S. C., 2013, NCHS DATA BRIEF; Dixon-Mueller R, 2007, AM J PUBLIC HEALTH, V97, P45, DOI 10.2105/AJPH.2005.068056; Gedeon J, 2015, CONFL HEALTH, V9, DOI 10.1186/s13031-015-0034-9; GUHA-SAPIR D, 1991, World Health Statistics Quarterly, V44, P171; Hegde S, 2012, ASIA-PAC J PUBLIC HE, V24, P989, DOI 10.1177/1010539511409024; Helweg-Larsen K, 1994, Ugeskr Laeger, V156, P1475; Hobstetter Margaret, 2015, Int J Gynaecol Obstet, V130 Suppl 3, pE37, DOI 10.1016/j.ijgo.2015.05.008; Hunter P, 2016, EMBO REP, V17, P492, DOI 10.15252/embr.201642171; Hynes M, 2002, JAMA-J AM MED ASSOC, V288, P595, DOI 10.1001/jama.288.5.595; Kobori E, 2007, AIDS BEHAV, V11, P611, DOI 10.1007/s10461-006-9167-6; Krause SK, 2000, INT FAM PLAN PERSPEC, V26, P181, DOI 10.2307/2648256; Lee T, 2000, REPROD HLTH REFUGEES, P23; Luxemburger C, 2003, T ROY SOC TROP MED H, V97, P251, DOI 10.1016/S0035-9203(03)90134-9; Luxemburger C, 2001, AM J EPIDEMIOL, V154, P459, DOI 10.1093/aje/154.5.459; MBAGO MCY, 1994, J BIOSOC SCI, V26, P451, DOI 10.1017/S0021932000021593; McGready R, 2015, F1000RESEARCH, V3, P123, DOI 10.12688/f1000research.4190.2; McGready R, 2012, PLOS ONE, V7; Moss WJ, 2006, B WORLD HEALTH ORGAN, V84, P58, DOI 10.2471/BLT.04.019570; Tran NT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137412; NOSTEN F, 1991, T ROY SOC TROP MED H, V85, P424, DOI 10.1016/0035-9203(91)90205-D; O'Hare BAM, 2007, J ROY SOC MED, V100, P564, DOI 10.1258/jrsm.100.12.564; Parker DM, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0921-y; Parker DM, 2014, DEMOGR RES, V30, P1129, DOI 10.4054/DemRes.2014.30.39; Patel P, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000090; Peters DH, 2008, ANN NY ACAD SCI, V1136, P161, DOI 10.1196/annals.1425.011; Plewes K, 2008, INT J STD AIDS, V19, P833, DOI 10.1258/ijsa.2008.008034; Radelet S, 1998, BROOKINGS PAP ECO AC, P1; Raheel H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048760; Rochat RW, 2011, AM J EPIDEMIOL, V174, pS80, DOI 10.1093/aje/kwr304; Salisbury P, 2016, BMC REPROD HEAL; Schreck L, 2000, INT FAM PLAN PERSPEC, V26, P162, DOI 10.2307/2648253; Short RV, 2001, REPROD FERT DEVELOP, V13, P405, DOI 10.1071/RD01107; TBC, 2015, REF IDP CAMP POP; TBC, 2004, WORLDS 20 YEARS BORD; UNCHR, 2016, OV UNHCRS OP AS PAC; UNHCR Women's Refugee Commission, 2011, WOM REF COMM REF FAM; van Min M., 2009, FORCED MIGRATION REV, P68; Ventura SJ, 1999, NATL VITAL STAT REPO; Weerasuriya Chathika K, 2012, Confl Health, V6, P5, DOI 10.1186/1752-1505-6-5; World Health Organization, 2014, MAT MORT; World Health Organization, 2015, FAM PLANN CONTR	53	9	9	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2017	12	2							e0172007	10.1371/journal.pone.0172007	http://dx.doi.org/10.1371/journal.pone.0172007			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL5SX	28231251	Green Published, gold			2022-12-27	WOS:000394682400025
J	Wang, SQ; Fan, WL; Wan, B; Tu, MQ; Jin, F; Liu, F; Xu, HB; Han, P				Wang, Siqi; Fan, Wenliang; Wan, Bing; Tu, Mengqi; Jin, Feng; Liu, Fang; Xu, Haibo; Han, Ping			Characterization of long noncoding RNA and messenger RNA signatures in melanoma tumorigenesis and metastasis	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; TUMOR-SUPPRESSOR GENE; EXPRESSION PROFILES; PROSTATE-CANCER; POOR-PROGNOSIS; PROGRESSION; IDENTIFICATION; MASPIN; PROLIFERATION; SPRY4-IT1	The incidence of melanoma, the most aggressive and life-threatening form of skin cancer, has significantly risen over recent decades. Therefore, it is essential to identify the mechanisms that underlie melanoma tumorigenesis and metastasis and to explore novel and effective melanoma treatment strategies. Accumulating evidence s uggests that aberrantly expressed long noncoding RNAs (lncRNAs) have vital functions in multiple cancers. However, lncRNA functions in melanoma tumorigenesis and metastasis remain unclear. In this study, we investigated lncRNA and messenger RNA (mRNA) expression profiles in primary melanomas, metastatic melanomas and normal skin samples from the Gene Expression Omnibus database. We used GSE15605 as the training set (n = 74) and GSE7553 as the validation set (n = 58). In three comparisons (primary melanoma versus normal skin, metastatic melanoma versus normal skin, and metastatic melanoma versus primary melanoma), 178, 295 and 48 lncRNAs and 847, 1758, and 295 mRNAs were aberrantly expressed, respectively. We performed Gene Ontology and Kyoto Encyclopedia of Genes and Genomes pathway analyses to examine the differentially expressed mRNAs, and potential core lncRNAs were predicted by lncRNA-mRNA co-expression networks. Based on our results, 15 lncRNAs and 144 mRNAs were significantly associated with melanoma tumorigenesis and metastasis. A subsequent analysis suggested a critical role for a five-lncRNA signature during melanoma tumorigenesis and metastasis. Low expression of U47924.27 was significantly associated with decreased survival of patients with melanoma. To the best of our knowledge, this study is the first to explore the expression patterns of lncRNAs and mRNAs during melanoma tumorigenesis and metastasis by re-annotating microarray data from the Gene Expression Omnibus (GEO) microarray dataset. These findings reveal potential roles for lncRNAs during melanoma tumorigenesis and metastasis and provide a rich candidate reservoir for future studies.	[Wang, Siqi; Fan, Wenliang; Wan, Bing; Tu, Mengqi; Jin, Feng; Liu, Fang; Han, Ping] Huazhong Univ Sci & Technol, Union Hosp, Dept Radiol, Tongji Med Coll, Wuhan, Peoples R China; [Jin, Feng] Inner Mongolia Med Univ, Affiliated Hosp 1, Dept Radiol, Hohhot, Peoples R China; [Xu, Haibo] Wuhan Univ, Zhongnan Hosp, Dept Radiol, Wuhan, Peoples R China	Huazhong University of Science & Technology; Inner Mongolia Medical University; Wuhan University	Han, P (corresponding author), Huazhong Univ Sci & Technol, Union Hosp, Dept Radiol, Tongji Med Coll, Wuhan, Peoples R China.; Xu, HB (corresponding author), Wuhan Univ, Zhongnan Hosp, Dept Radiol, Wuhan, Peoples R China.	xuhaibo1120@hotmail.com; cjr.hanping@vip.163.com		Fan, Wenliang/0000-0001-8949-6775	National Natural Science Foundation of China [81372369, 81371661, 81101042]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was financially supported by the National Natural Science Foundation of China (81372369 to HX; 81371661 to PH; and 81101042 to FL) (http://www.nsfc.gov.cn/). As funders, HX, PH, and FL have role in study design and preparation of the manuscript.	Agrawal U, 2016, UROL ONCOL-SEMIN ORI, V34, DOI 10.1016/j.urolonc.2016.04.013; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bhan A, 2014, CHEMMEDCHEM, V9, P1932, DOI 10.1002/cmdc.201300534; Bieging KT, 2014, NAT REV CANCER, V14, P359, DOI 10.1038/nrc3711; BROWN CJ, 1991, NATURE, V349, P38, DOI 10.1038/349038a0; BROWN CJ, 1992, CELL, V71, P527, DOI 10.1016/0092-8674(92)90520-M; Brozyna AA, 2013, HUM PATHOL, V44, P2071, DOI 10.1016/j.humpath.2013.02.022; Cabianca DS, 2012, CELL, V149, DOI 10.1016/j.cell.2012.03.035; Cancer Genome Atlas Research Network, 2013, Nat Genet, V45, P1113, DOI 10.1038/ng.2764; Chen L, 2016, ONCOTARGETS THER, V9, P4075, DOI 10.2147/OTT.S98203; Cheng ZP, 2015, ONCOTARGET, V6, P25381, DOI 10.18632/oncotarget.4541; Conley SJ, 2016, ONCOGENE, V35, P4225, DOI 10.1038/onc.2015.487; Dinger ME, 2008, GENOME RES, V18, P1433, DOI 10.1101/gr.078378.108; Dowling P, 2016, ONCOL LETT, V12, P3296, DOI 10.3892/ol.2016.5101; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fatica A, 2014, NAT REV GENET, V15, P7, DOI 10.1038/nrg3606; Flockhart RJ, 2012, GENOME RES, V22, P1006, DOI 10.1101/gr.140061.112; Guan YS, 2016, ANTI-CANCER DRUG, V27, P811, DOI 10.1097/CAD.0000000000000397; Guo X, 2010, ONCOGENE, V29, P3908, DOI 10.1038/onc.2010.143; Gupta M, 2015, ARCH DERMATOL RES, V307, P767, DOI 10.1007/s00403-015-1571-1; Nguyen HH, 2012, HUM MOL GENET, V21, P2076, DOI 10.1093/hmg/dds025; Hung T, 2011, NAT GENET, V43, P621, DOI 10.1038/ng.848; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jiang XC, 2016, J NEUROSURG, V124, P129, DOI [10.3171/2014.12.JNS1426, 10.3171/2014.12.JNS1426.test]; Jin L, 2012, CELL RES, V22, P1356, DOI 10.1038/cr.2012.90; Joerger AC, 2016, ANNU REV BIOCHEM, V85, P375, DOI 10.1146/annurev-biochem-060815-014710; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; Khaitan D, 2011, CANCER RES, V71, P3852, DOI 10.1158/0008-5472.CAN-10-4460; Kim NH, 2010, PIGM CELL MELANOMA R, V23, P84, DOI 10.1111/j.1755-148X.2009.00659.x; Lessard L, 2015, J INVEST DERMATOL, V135, P2464, DOI 10.1038/jid.2015.200; Leucci E, 2016, PIGM CELL MELANOMA R, V29, P619, DOI 10.1111/pcmr.12537; Leucci E, 2016, NATURE, V531, P518, DOI 10.1038/nature17161; Li J, 2015, CANCER RES, V75, P3728, DOI 10.1158/0008-5472.CAN-15-0273; Liu H, 2010, J HUAZHONG U SCI-MED, V30, P61, DOI 10.1007/s11596-011-0111-7; Liu Z, 2011, CELL DEATH DIFFER, V18, P1174, DOI 10.1038/cdd.2010.187; Liu ZQ, 2014, ARCH GYNECOL OBSTET, V289, P373, DOI 10.1007/s00404-013-2988-4; Machtens S, 2001, INT J CANCER, V95, P337, DOI 10.1002/1097-0215(20010920)95:5<337::AID-IJC1059>3.0.CO;2-1; Mazar J, 2014, ONCOTARGET, V5, P8959, DOI 10.18632/oncotarget.1863; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Michiels S, 2005, LANCET, V365, P488, DOI 10.1016/S0140-6736(05)17866-0; Miksicek RJ, 2002, CANCER RES, V62, P2736; Montes M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7967; Myrthue A, 2008, CLIN CANCER RES, V14, P3562, DOI 10.1158/1078-0432.CCR-07-4649; National Cancer Institute, 2016, SURV EP END RES; Pan J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092815; Pangeni RP, 2015, CLIN EPIGENETICS, V7, DOI 10.1186/s13148-015-0089-x; Pasmant E, 2007, CANCER RES, V67, P3963, DOI 10.1158/0008-5472.CAN-06-2004; Peng W, 2016, BIOMED PHARMACOTHER, V83, P450, DOI 10.1016/j.biopha.2016.06.056; Poliseno L, 2011, J INVEST DERMATOL, V131, P2497, DOI 10.1038/jid.2011.232; Pulukuri SM, 2009, ONCOGENE, V28, P2829, DOI 10.1038/onc.2009.134; Qiu MT, 2016, ONCOTARGET, V7, P16012, DOI 10.18632/oncotarget.7559; Rabjerg M, 2016, APMIS, V124, P372, DOI 10.1111/apm.12519; Raskin L, 2013, J INVEST DERMATOL, V133, P2585, DOI 10.1038/jid.2013.197; Riker AI, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-13; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Sarkar D, 2015, EPIGENETICS-US, V10, P103, DOI 10.1080/15592294.2014.1003746; Schmidt K, 2016, CELL REP, V15, P2025, DOI 10.1016/j.celrep.2016.04.018; Shepelev MV, 2013, CANCER GENET-NY, V206, P393, DOI 10.1016/j.cancergen.2013.10.006; Shimada Y, 2005, ONCOLOGY-BASEL, V68, P285, DOI 10.1159/000086961; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Tang LH, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/251098; Terai G, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-015-2307-5; Tian YJ, 2014, MELANOMA RES, V24, P335, DOI 10.1097/CMR.0000000000000080; Valladares-Ayerbes M, 2009, J CANCER RES CLIN, V135, P1185, DOI 10.1007/s00432-009-0559-7; Wan DC, 2014, COLD SPRING HARB PER, P4; Wang LH, 2007, VIRCHOWS ARCH, V451, P959, DOI 10.1007/s00428-007-0485-5; Wang MC, 2004, WORLD J GASTROENTERO, V10, P634, DOI 10.3748/wjg.v10.i5.634; Wu CF, 2013, J GENET GENOMICS, V40, P179, DOI 10.1016/j.jgg.2013.03.001; Xie M, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0595-9; Xu Y, 2016, DIS ESOPHAGUS; Yang XJ, 2016, GENE, V592, P172, DOI 10.1016/j.gene.2016.08.002; Yu H, 2015, J THORAC ONCOL, V10, P645, DOI 10.1097/JTO.0000000000000470; Zhang H, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-37; Zhang XQ, 2012, NEUROBIOL DIS, V48, P1, DOI 10.1016/j.nbd.2012.06.004; Zhang ZY, 2016, ONCOTARGET, V7, P22639, DOI 10.18632/oncotarget.8141; ZOU ZQ, 1994, SCIENCE, V263, P526, DOI 10.1126/science.8290962	76	26	28	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2017	12	2							e0172498	10.1371/journal.pone.0172498	http://dx.doi.org/10.1371/journal.pone.0172498			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5SK	28225791	gold, Green Submitted, Green Published			2022-12-27	WOS:000394680900046
J	Li, SC; Li, DY; Zhao, XL; Wang, Y; Yin, HD; Zhou, LY; Zhong, CL; Zhu, Q				Li, Sichen; Li, Diyan; Zhao, Xiaoling; Wang, Yan; Yin, Huadong; Zhou, Lanyun; Zhong, Chengling; Zhu, Qing			A non-synonymous SNP with the allele frequency correlated with the altitude may contribute to the hypoxia adaptation of Tibetan chicken	PLOS ONE			English	Article							PULMONARY-HYPERTENSION; INDUCIBLE FACTORS; REVEALS ADAPTATION; GENOME; BLOOD; CONVERGENCE; SELECTION; SEQUENCE; GAIN; HIF	The hypoxia adaptation to high altitudes is of considerable interest in the biological sciences. As a breed with adaptability to highland environments, the Tibetan chicken (Gallus gallus domestics), provides a biological model to search for genetic differences between high and lowland chickens. To address mechanisms of hypoxia adaptability at high altitudes for the Tibetan chicken, we focused on the Endothelial PAS domain protein 1 (EPAS1), a key regulatory factor in hypoxia responses. Detected were polymorphisms of EPAS1 exons in 157 Tibetan chickens from 8 populations and 139 lowland chickens from 7 breeds. We then designed 15 pairs of primers to amplify exon sequences by Sanger sequencing methods. Six single nucleotide polymorphisms (SNPs) were detected, including 2 missense mutations (SNP3 rs316126786 and SNP5 rs740389732) and 4 synonymous mutations (SNP1 rs315040213, SNP4 rs739281102, SNP6 rs739010166, and SNP2 rs14330062). There were negative correlations between altitude and mutant allele frequencies for both SNP6 (rs739010166, r = 0.758, p<0.001) and SNP3 (rs316126786, r = 0.844, P<0.001). We also aligned the EPAS1 protein with ortholog proteins from diverse vertebrates and focused that SNP3 (Y333C) was a conserved site among species. Also, SNP3 (Y333C) occurred in a well-defined protein domain Per-AhR-Arnt-Sim (PAS domain). These results imply that SNP3 (Y333C) is the most likely casual mutation for the high-altitude adaption in Tibetan chicken. These variations of EPAS1 provide new insights into the gene's function.	[Li, Sichen; Li, Diyan; Zhao, Xiaoling; Wang, Yan; Yin, Huadong; Zhou, Lanyun; Zhong, Chengling; Zhu, Qing] Sichuan Agr Univ, Farm Anim Genet Resources Explorat & Innovat Key, Chengdu, Sichuan, Peoples R China	Sichuan Agricultural University	Zhu, Q (corresponding author), Sichuan Agr Univ, Farm Anim Genet Resources Explorat & Innovat Key, Chengdu, Sichuan, Peoples R China.	zhuqingsicau@163.com		Li, Diyan/0000-0001-7490-3550	National Natural Science Foundation of China [31402070]; China Agriculture Research System [CARS-41]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Agriculture Research System	The work was supported by National Natural Science Foundation of China (Grant No: 31402070) and the China Agriculture Research System (CARS-41).	Bao HG, 2007, POULTRY SCI, V86, P2210, DOI 10.1093/ps/86.10.2210; BAUMANN R, 1983, AM J PHYSIOL, V244, pR733, DOI 10.1152/ajpregu.1983.244.5.R733; Beall CM, 2010, P NATL ACAD SCI USA, V107, P11459, DOI 10.1073/pnas.1002443107; Bigham A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001116; Bouckaert R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003537; Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088; Dzialowski EM, 2002, COMP BIOCHEM PHYS A, V131, P713, DOI 10.1016/S1095-6433(02)00009-0; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Ge RL, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2860; Golding GB, 1998, MOL BIOL EVOL, V15, P355, DOI 10.1093/oxfordjournals.molbev.a025932; Gou X, 2014, GENOME RES, V24, P1308, DOI 10.1101/gr.171876.113; Hickey MM, 2006, CURR TOP DEV BIOL, V76, P217, DOI 10.1016/S0070-2153(06)76007-0; KAMITOMO M, 1993, AM J OBSTET GYNECOL, V169, P701, DOI 10.1016/0002-9378(93)90646-Z; LARKIN MA, 2007, BIOINFORMATICS, V23, P2947, DOI DOI 10.1093/BI0INF0RMATICS/BTM404; Lee FS, 2011, ANNU REV PATHOL-MECH, V6, P165, DOI 10.1146/annurev-pathol-011110-130321; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lorenzo FR, 2014, NAT GENET, V46, P951, DOI 10.1038/ng.3067; Maxwell PH, 2005, EXP PHYSIOL, V90, P791, DOI 10.1113/expphysiol.2005.030924; MULLENBACH R, 1989, TRENDS GENET, V5, P391; Natarajan C, 2016, SCIENCE, V354, P336, DOI 10.1126/science.aaf9070; Newman JH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7863; Patel SA, 2008, CELL DEATH DIFFER, V15, P628, DOI 10.1038/cdd.2008.17; Percy MJ, 2008, NEW ENGL J MED, V358, P162, DOI 10.1056/NEJMoa073123; Prabhakar NR, 2012, PHYSIOL REV, V92, P967, DOI 10.1152/physrev.00030.2011; Priyatno D., 2014, SPSS 22 PENGOLAH DAT; Qing GL, 2009, CURR OPIN GENET DEV, V19, P60, DOI 10.1016/j.gde.2008.12.001; Qiu Q, 2012, NAT GENET, V44, P946, DOI 10.1038/ng.2343; Quirouette R, 2004, AIR PRESSURE AND THE; RODGERS JL, 1988, AM STAT, V42, P59, DOI 10.2307/2685263; Semenza GL, 2012, CELL, V148, P399, DOI 10.1016/j.cell.2012.01.021; Shimoda LA, 2011, AM J RESP CRIT CARE, V183, P152, DOI 10.1164/rccm.201009-1393PP; Singh VK, 1998, BIOTECHNIQUES, V24, P318, DOI 10.2144/98242pf02; Song L, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2378-y; Storz JF, 2007, PLOS GENET, V3, P448, DOI 10.1371/journal.pgen.0030045; Sun J, 2013, GENE, V529, P131, DOI 10.1016/j.gene.2013.06.075; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tan QL, 2013, J BIOL CHEM, V288, P17134, DOI 10.1074/jbc.M112.444059; van Patot MCT, 2011, HIGH ALT MED BIOL, V12, P157, DOI 10.1089/ham.2010.1099; Wang GD, 2014, GENOME BIOL EVOL, V6, P2122, DOI 10.1093/gbe/evu162; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wideman RF, 2002, POULTRY SCI, V81, P1203, DOI 10.1093/ps/81.8.1203; Wideman RF, 2001, WORLD POULTRY SCI J, V57, P289, DOI 10.1079/WPS20010021; Yates A, 2016, NUCLEIC ACIDS RES, V44, pD710, DOI 10.1093/nar/gkv1157; Yi X, 2010, SCIENCE, V329, P75, DOI 10.1126/science.1190371; Zhang H, 2007, POULTRY SCI, V86, P1384, DOI 10.1093/ps/86.7.1384; Zhang H, 2004, JOURNAL OF CHINA AGR, V10, P109; Zhang Hao, 2006, Journal of China Agricultural University, V11, P35; Zhang Q, 2016, GENOME BIOL EVOL, V8, P765, DOI 10.1093/gbe/evw032; Zhang WP, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004466; Zhao M, 2009, P NATL ACAD SCI USA, V106, P21230, DOI 10.1073/pnas.0907844106; Zhao XL, 2016, MITOCHONDRIAL DNA A, V27, P3280, DOI 10.3109/19401736.2015.1015006	52	4	4	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2017	12	2							e0172211	10.1371/journal.pone.0172211	http://dx.doi.org/10.1371/journal.pone.0172211			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5QV	28222154	Green Submitted, gold, Green Published			2022-12-27	WOS:000394676800041
J	Vaughan, JA; Turell, MJ				Vaughan, Jefferson A.; Turell, Michael J.			Brugia malayi microfilariae transport alphaviruses across the mosquito midgut	PLOS ONE			English	Article							EQUINE ENCEPHALITIS-VIRUS; HEPARAN-SULFATE BINDING; AEDES-AEGYPTI; PAHANGI MICROFILARIAE; ENCEPHALOMYELITIS VIRUS; INCREASED DISSEMINATION; EXSHEATHMENT; VECTOR; TRANSMISSION; CULICIDAE	Concurrent ingestion of microfilariae (MF) and arboviruses by mosquitoes can enhance mosquito transmission of virus compared to when virus is ingested alone. Within hours of being ingested, MF penetrate the mosquito midgut and introduce virus into mosquito hemocoel, creating a disseminated viral infection much sooner than normal. How virus is actually introduced is not known. In this report, we present experimental evidence that suggests that certain alphaviruses may adhere or otherwise associate with sheathed Brugia malayi MF in the blood of a dually-infected host and that the virus is carried into the mosquito hemocoel by the MF during their penetration of the mosquito midgut. The mechanism of MF enhancement may be more complex than simple leakage of viremic blood into the hemocoel during MF penetration. The affinity of arboviruses to adhere to or otherwise associate with MF may depend on the specific combination of the virus and MF involved in a dual host infection. This in turn may determine the relative importance that MF enhancement has within an arbovirus transmission system.	[Vaughan, Jefferson A.; Turell, Michael J.] US Army Med Res Inst Infect Dis, Div Virol, Ft Detrick, MD 21702 USA; [Vaughan, Jefferson A.] Univ North Dakota, Dept Biol, Grand Forks, ND 58201 USA; [Turell, Michael J.] 7217 Ridge Rd, Frederick, MD USA	United States Army Medical Research Institute of Infectious Diseases; United States Department of Defense; United States Army; University of North Dakota Grand Forks	Vaughan, JA (corresponding author), US Army Med Res Inst Infect Dis, Div Virol, Ft Detrick, MD 21702 USA.; Vaughan, JA (corresponding author), Univ North Dakota, Dept Biol, Grand Forks, ND 58201 USA.	Jefferson.vaughan@email.und.edu	Turell, Michael/ABE-1826-2020	Turell, Michael/0000-0003-1902-7740; Vaughan, Jefferson/0000-0002-7067-0654	National Research Council; NIAID grant [R21AI105662]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI105662] Funding Source: NIH RePORTER	National Research Council; NIAID grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	All experimental work was conducted while JAV was a research associated funded by the National Research Council. Additional data analysis was supported by NIAID grant R21AI105662 (JAV). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGUDELOSILVA F, 1985, J INVERTEBR PATHOL, V45, P117, DOI 10.1016/0022-2011(85)90058-8; ASH LR, 1964, J PARASITOL, V50, P119, DOI 10.2307/3276044; BAIN O, 1972, Annales de Parasitologie Humaine et Comparee, V47, P399; CHAMBERLAIN R, 1961, ANNU REV ENTOMOL, V6, P371, DOI 10.1146/annurev.en.06.010161.002103; CHEN CC, 1988, ANN TROP MED PARASIT, V82, P201, DOI 10.1080/00034983.1988.11812229; CHRISTENSEN BM, 1984, T AM MICROSC SOC, V103, P423, DOI 10.2307/3226478; CHRISTENSEN BM, 1987, J INVERTEBR PATHOL, V49, P14, DOI 10.1016/0022-2011(87)90120-0; DAVIS NL, 1989, VIROLOGY, V171, P189, DOI 10.1016/0042-6822(89)90526-6; de Thoisy B, 2001, AM J PRIMATOL, V54, P1, DOI 10.1002/ajp.1008; Gardner CL, 2013, J VIROL, V87, P8582, DOI 10.1128/JVI.00937-13; Gardner CL, 2011, P NATL ACAD SCI USA, V108, P16026, DOI 10.1073/pnas.1110617108; GARGAN TP, 1983, AM J TROP MED HYG, V32, P1154, DOI 10.4269/ajtmh.1983.32.1154; GRANATH WO, 1980, POULTRY SCI, V59, P996, DOI 10.3382/ps.0590996; HARDY JL, 1983, ANNU REV ENTOMOL, V28, P229, DOI 10.1146/annurev.en.28.010183.001305; Highby Paul R., 1943, JOUR PARASITOL, V29, P253, DOI 10.2307/3272756; Highby PR, 1943, J PARASITOL, V29, P243; Intakhan N, 2014, PARASITOL RES, V113, P4141, DOI 10.1007/s00436-014-4086-3; Jariyapan N, 2013, PARASITOL RES, V112, P2431, DOI 10.1007/s00436-013-3404-5; KRAMER LD, 1981, AM J TROP MED HYG, V30, P190, DOI 10.4269/ajtmh.1981.30.190; Laaksonen S, 2009, PARASITOL RES, V104, P257, DOI 10.1007/s00436-008-1184-0; Laurence B. R., 1961, Journal of Helminthology, V35, P285, DOI 10.1017/S0022149X00004661; MELLOR PS, 1980, ANN TROP MED PARASIT, V74, P463, DOI 10.1080/00034983.1980.11687368; MITCHELL CJ, 1992, SCIENCE, V257, P526, DOI 10.1126/science.1321985; OWEN RR, 1977, T ROY SOC TROP MED H, V71, P110; OWEN RR, 1978, ANN TROP MED PARASIT, V72, P567, DOI 10.1080/00034983.1978.11719362; Paredes A, 2001, J VIROL, V75, P9532, DOI 10.1128/JVI.75.19.9532-9537.2001; PERRONE JB, 1986, J PARASITOL, V72, P723, DOI 10.2307/3281463; RAMACHANDRAN C. P., 1966, J MED ENTOMOL, V3, P239, DOI 10.1093/jmedent/3.3-4.239; ROBINSON EJ, 1955, J PARASITOL, V41, P209, DOI 10.2307/3273794; ROSEN L, 1974, AM J TROP MED HYG, V23, P1153, DOI 10.4269/ajtmh.1974.23.1153; SOUSA OE, 1974, AM J TROP MED HYG, V23, P862, DOI 10.4269/ajtmh.1974.23.862; STABLER RM, 1961, J PARASITOL, V47, P413, DOI 10.2307/3275367; TURELL MJ, 1987, AM J TROP MED HYG, V37, P197, DOI 10.4269/ajtmh.1987.37.197; TURELL MJ, 1984, SCIENCE, V225, P1039, DOI 10.1126/science.6474165; Vaughan JA, 1996, AM J TROP MED HYG, V54, P105, DOI 10.4269/ajtmh.1996.54.105; Vaughan JA, 1999, J MED ENTOMOL, V36, P758, DOI 10.1093/jmedent/36.6.758; Vaughan JA, 2012, J MED ENTOMOL, V49, P1430, DOI 10.1603/ME12103; Vaughan JA, 2009, AM J TROP MED HYG, V80, P44, DOI 10.4269/ajtmh.2009.80.44; WEAVER SC, 1993, J MED ENTOMOL, V30, P391, DOI 10.1093/jmedent/30.2.391; WEINMANN C J, 1973, Journal of Wildlife Diseases, V9, P213; ZYTOON EM, 1993, AM J TROP MED HYG, V49, P201, DOI 10.4269/ajtmh.1993.49.201	41	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2017	12	2							e0172309	10.1371/journal.pone.0172309	http://dx.doi.org/10.1371/journal.pone.0172309			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5QV	28222120	Green Published, Green Submitted, gold			2022-12-27	WOS:000394676800049
J	Vluggen, C; Soetaert, K; Groenen, G; Wanlin, M; Spitaels, M; de Onate, WA; Fauville-Dufaux, M; Saegerman, C; Mathys, V				Vluggen, Christelle; Soetaert, Karine; Groenen, Guido; Wanlin, Maryse; Spitaels, Martine; de Onate, Wouter Arrazola; Fauville-Dufaux, Maryse; Saegerman, Claude; Mathys, Vanessa			Molecular epidemiology of Mycobacterium tuberculosis complex in Brussels, 2010-2013	PLOS ONE			English	Article							MIRU-VNTRPLUS; IDENTIFICATION; SURVEILLANCE; NETHERLANDS	The tuberculosis (TB) incidence rate in Brussels-Capital Region is 3-fold higher than in Belgium as a whole. Eight years after the realization of initial prospective population-based molecular epidemiology investigations in this Region, a similar study over the period 2010-2013 was conducted. TB strains isolated from 945 patients were submitted to genotyping by standardized 24-locus-MIRU-VNTR typing and spoligotyping. The phylogenetic analysis showed that the LAM (16.7%) and Haarlem (15.7%) branches are the two most prevalent TB lineages circulating in Brussels. Analysis of the MDR subgroup showed an association with Beijing strains (39.9%) and patients native of Eastern Europe (40.7%). Genotyping detected 113 clusters involving 321 patients, giving a recent transmission index of 22.9%. Molecular-guided epidemiological investigations and routine surveillance activities revealed family transmission or social contact for patients distributed over 34 clusters. Most of the patients were foreign-born (75.7%). However, cluster analysis revealed only limited transnational transmission. Comparison with the previous study shows a stable epidemiological situation except for the mean age difference between Belgian-born and foreign-born patients which has disappeared. This study confirms that molecular epidemiology has become an important determinant for TB control programs. However, sufficient financial means need to be available to perform all required epidemiological investigations.	[Vluggen, Christelle; Soetaert, Karine; Fauville-Dufaux, Maryse; Mathys, Vanessa] Sci Inst Publ Hlth WIV ISP, Operat Direct Communicable & Infect Dis, Bacterial Dis Serv, Brussels, Belgium; [Groenen, Guido; Wanlin, Maryse; Spitaels, Martine; de Onate, Wouter Arrazola] Belgian Lung & TB Assoc, Brussels, Belgium; [Saegerman, Claude] Fundamental & Appl Res Anim & Hlth FARAH Ctr, Res Unit Epidemiol & Risk Anal Appl Vet Sci UREAR, Liege, Belgium		Mathys, V (corresponding author), Sci Inst Publ Hlth WIV ISP, Operat Direct Communicable & Infect Dis, Bacterial Dis Serv, Brussels, Belgium.	vmathys@wiv-isp.be		Saegerman, Claude/0000-0001-9087-7436	European Community [FP7-223681]; Belgian Ministry of Social Affairs through Health Insurance System	European Community(European Commission); Belgian Ministry of Social Affairs through Health Insurance System	The study was supported by the European Community Seventh Framework Programme (FP7/2007-2013), Grant FP7-223681 Tuberculosis Pan European Network (TB PAN-NET). The National Reference Center is partially supported by the Belgian Ministry of Social Affairs through a fund within the Health Insurance System. C.V. was a fellow of the RP/PJ WIV-ISP (TYPTUB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allix C, 2004, CLIN INFECT DIS, V39, P783, DOI 10.1086/423383; Allix-Beguec C, 2008, EUR RESPIR J, V31, P1077, DOI 10.1183/09031936.00053307; Allix-Beguec C., 2007, MARQUEURS GE NE TIQU; Allix-Beguec C, 2008, J CLIN MICROBIOL, V46, P2692, DOI 10.1128/JCM.00540-08; Allix-Beguec C, 2008, J CLIN MICROBIOL, V46, P1398, DOI 10.1128/JCM.02089-07; Barnes PF, 2003, NEW ENGL J MED, V349, P1149, DOI 10.1056/NEJMra021964; Borgdorff MW, 2013, CLIN MICROBIOL INFEC, V19, P889, DOI 10.1111/1469-0691.12253; Cardoso OM, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0018256, DOI 10.1371/JOURNAL.PONE.0018256]; de Beer J, 2014, EURO SURVEILL, V19; de Beer JL, 2013, J CLIN MICROBIOL, V51, P1193, DOI 10.1128/JCM.03061-12; de Colombani P, 2015, PUBLIC HEALTH ACTION, V5, P194, DOI 10.5588/pha.15.0026; Diel R, 2014, EUR RESPIR J, V43, P554, DOI 10.1183/09031936.00079413; FARES, 2016, REG TUB 2015; Frothingham R, 1998, MICROBIOL-UK, V144, P1189, DOI 10.1099/00221287-144-5-1189; Groenen G., 2015, EENDRACHTSTRAAT, V56; Heinze G, 2002, STAT MED, V21, P2409, DOI 10.1002/sim.1047; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Lambregts-van Weezenbeek CSB, 2003, INT J TUBERC LUNG D, V7, pS463; Martiniello M, 2013, REV EUROPE ENNE MIGR, V29, P7; Moss AR, 2000, AM J RESP CRIT CARE, V162, P460, DOI 10.1164/ajrccm.162.2.9910055; Sandgren A, 2014, EUR RESPIR J, V43, P1159, DOI 10.1183/09031936.00117213; SMALL PM, 1993, J CLIN MICROBIOL, V31, P1677, DOI 10.1128/JCM.31.7.1677-1682.1993; Stoffels K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063128; Supply P, 2000, MOL MICROBIOL, V36, P762, DOI 10.1046/j.1365-2958.2000.01905.x; Supply P, 1997, MOL MICROBIOL, V26, P991, DOI 10.1046/j.1365-2958.1997.6361999.x; Supply P, 2006, J CLIN MICROBIOL, V44, P4498, DOI 10.1128/JCM.01392-06; van Soolingen D, 2001, J INTERN MED, V249, P1, DOI 10.1046/j.1365-2796.2001.00772.x; Weniger T, 2010, NUCLEIC ACIDS RES, V38, pW326, DOI 10.1093/nar/gkq351; World Health Organisation, 2015, WHOHTMTB201613	29	11	12	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2017	12	2							e0172554	10.1371/journal.pone.0172554	http://dx.doi.org/10.1371/journal.pone.0172554			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5QV	28222189	Green Submitted, Green Published, gold			2022-12-27	WOS:000394676800066
J	Wang, ZQ; Ma, YN; Liu, F; Chen, LJ; Gao, RT; Zhang, W				Wang, Zhiqiang; Ma, Younan; Liu, Fan; Chen, Linjie; Gao, Ruitong; Zhang, Wei			Autoantibodies against mono-and trimethylated lysine display similar but also distinctive characteristics	PLOS ONE			English	Article							ZONE B-CELLS; SYSTEMIC-LUPUS-ERYTHEMATOSUS; NEUTROPHIL EXTRACELLULAR TRAPS; MARGINAL ZONE; IGM ANTIBODIES; NATURAL IGM; ACTIVATION; NEPHRITIS; ANTIGEN; MICE	Autoantibodies can be either harmful or beneficial to the body. The beneficial autoantibodies play important roles in immunosurveillance, clearance of body waste and maintenance of immune homeostasis. Despite their importance, however, people's knowledge on the protective autoantibodies is still very limited. In the current study, we examined two autoantibodies that recognized epitopes with only one amino acid. One was against mono-methylated lysine (Kme) and the other was against tri-methylated lysine (Kme3). We found that the antibodies were highly specific and not polyreactive. They did not cross-react each other. Although antiKme antibodies were IgM only, a large proportion of the anti-Kme3 antibodies were switched to the IgG isotype. Mass spectrometric analysis showed that both of the antibodies were mainly derived from IGHV 3-7 and/or IGHV3-74 germ line genes with conserved CDR2. De novo sequencing showed that there was a mutation at either of the SS positions on the CDR1 region, which changed one of the serine residues to a basic amino acid, i. e., arginine or lysine. We also found that neither of the antibodies was expressed at birth, and their earliest appearance was approximately 5 months after birth. All healthy human beings expressed the antibodies when they reached age two and maintained the expression thereafter throughout their life. Patients with systemic lupus erythematosus had lower levels of the IgM isotype antibodies. Serum levels of the two IgM antibodies were closely correlated, implying that they were produced by cells from the same B cell subset. We also found that both anti-Kme and antiKme3 antibodies could bind and might take part in the clearance of neutrophil extracellular traps released from activated cells. In conclusion, although anti-Kme and anti-Kme3 antibodies share many similarities in their origins, they are different antibodies and have different characteristics.	[Wang, Zhiqiang; Ma, Younan; Zhang, Wei] Chinese Acad Med Sci, Inst Basic Med Sci, Sch Basic Med, Dept Immunol,Peking Union Med Coll, Beijing, Peoples R China; [Liu, Fan] Univ Utrecht, Bijvoet Ctr Biomol Res, Biomol Mass Spectrometry & Prote, Utrecht, Netherlands; [Liu, Fan] Univ Utrecht, Utrecht Inst Pharmaceut Sci, Utrecht, Netherlands; [Liu, Fan] Netherlands Prote Ctr, Utrecht, Netherlands; [Chen, Linjie] Bengbu Med Coll, Dept Rheumatol & Immunoloy, Affiliated Hosp 1, Bengbu, Peoples R China; [Gao, Ruitong] Chinese Acad Med Sci, Dept Nephrol, Peking Union Med Coll Hosp, Peking Union Med Coll, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Utrecht University; Utrecht University; Bengbu Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking Union Medical College Hospital	Zhang, W (corresponding author), Chinese Acad Med Sci, Inst Basic Med Sci, Sch Basic Med, Dept Immunol,Peking Union Med Coll, Beijing, Peoples R China.	zw83423@hotmail.com			National Natural Science Foundation of China [30972717]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by a grant (no. 30972717) from the National Natural Science Foundation of China (http://www.nsfc.gov.cn) for WZ. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano H, 2003, J IMMUNOL, V170, P2293, DOI 10.4049/jimmunol.170.5.2293; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Cerutti A, 2013, NAT REV IMMUNOL, V13, P118, DOI 10.1038/nri3383; Choi YS, 2012, EUR J IMMUNOL, V42, P120, DOI 10.1002/eji.201141890; Denny MR, 2010, J IMMUNOL, V184, P3284, DOI 10.4049/jimmunol.0902199; Ehrenstein MR, 2010, NAT REV IMMUNOL, V10, P778, DOI 10.1038/nri2849; Elkon K, 2008, NAT CLIN PRACT RHEUM, V4, P491, DOI 10.1038/ncprheum0895; Guo S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068520; Hakkim A, 2010, P NATL ACAD SCI USA, V107, P9813, DOI 10.1073/pnas.0909927107; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; HOOIJKAAS H, 1984, EUR J IMMUNOL, V14, P1127, DOI 10.1002/eji.1830141212; Jiang CC, 2007, J IMMUNOL, V178, P7422, DOI 10.4049/jimmunol.178.11.7422; Kohm AP, 2003, TRENDS MICROBIOL, V11, P101, DOI 10.1016/S0966-842X(03)00006-4; Liu CL, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3707; Lopes-Carvalho T, 2005, CURR OPIN IMMUNOL, V17, P244, DOI 10.1016/j.coi.2005.04.009; Lutz HU, 2009, TRENDS IMMUNOL, V30, P43, DOI 10.1016/j.it.2008.10.002; Martin F, 2001, IMMUNITY, V14, P617, DOI 10.1016/S1074-7613(01)00129-7; Mauerer K, 2005, BRIT J HAEMATOL, V129, P499, DOI 10.1111/j.1365-2141.2005.05480.x; Notkins AL, 2004, TRENDS IMMUNOL, V25, P174, DOI 10.1016/j.it.2004.02.004; Peng YF, 2005, MOL IMMUNOL, V42, P781, DOI 10.1016/j.molimm.2004.07.045; SCHULTZ CL, 1991, CURR OPIN IMMUNOL, V3, P350, DOI 10.1016/0952-7915(91)90037-2; SENALDI G, 1988, ARTHRITIS RHEUM, V31, P1213, DOI 10.1002/art.1780310929; Sherer Y, 2004, SEMIN ARTHRITIS RHEU, V34, P501, DOI 10.1016/j.semarthrit.2004.07.002; Tachibana M, 2001, J BIOL CHEM, V276, P25309, DOI 10.1074/jbc.M101914200; Tangye SG, 2003, J IMMUNOL, V170, P686, DOI 10.4049/jimmunol.170.2.686; TEW JG, 1980, IMMUNOL REV, V53, P175; Tiller T, 2008, J IMMUNOL METHODS, V329, P112, DOI 10.1016/j.jim.2007.09.017; Varettoni M, 2013, LEUKEMIA LYMPHOMA, V54, P2485, DOI 10.3109/10428194.2013.779689; Vas J, 2012, ARTHRITIS RHEUM-US, V64, P3388, DOI 10.1002/art.34537; Weill JC, 2009, ANNU REV IMMUNOL, V27, P267, DOI 10.1146/annurev.immunol.021908.132607; Weller S, 2004, BLOOD, V104, P3647, DOI 10.1182/blood-2004-01-0346; Witte T, 2008, CLIN REV ALLERG IMMU, V34, P345, DOI 10.1007/s12016-007-8046-x; Zhang X, 2012, ACTA BIOCH BIOPH SIN, V44, P14, DOI 10.1093/abbs/gmr100; Zhen QL, 2005, J CLIN INVEST, V115, P3428, DOI 10.1172/JCI23587	34	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2017	12	2							e72166	10.1371/journal.pone.0172166	http://dx.doi.org/10.1371/journal.pone.0172166			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5QV	28222195	Green Published, gold, Green Submitted			2022-12-27	WOS:000394676800037
J	Hu, ZH; Wu, Q; Dalal, J; Vasani, N; Lopez, HO; Sederoff, HW; Qu, RD				Hu, Zhaohui; Wu, Qian; Dalal, Jyoti; Vasani, Naresh; Lopez, Harry O.; Sederoff, Heike W.; Qu, Rongda			Accumulation of medium-chain, saturated fatty acyl moieties in seed oils of transgenic Camelina sativa	PLOS ONE			English	Article							CARRIER-PROTEIN THIOESTERASES; MICROSOMAL PREPARATIONS; ARABIDOPSIS-THALIANA; ACID ACCUMULATION; BIOSYNTHESIS; PLANTS; PHOSPHATIDYLCHOLINE; TRANSFORMATION; EXPRESSION; ENDOSPERM	With its high seed oil content, the mustard family plant Camelina sativa has gained attention as a potential biofuel source. As a bioenergy crop, camelina has many advantages. It grows on marginal land with low demand for water and fertilizer, has a relatively short life cycle, and is stress tolerant. As most other crop seed oils, camelina seed triacylglycerols ( TAGs) consist of mostly long, unsaturated fatty acyl moieties, which is not desirable for biofuel processing. In our efforts to produce shorter, saturated chain fatty acyl moieties in camelina seed oil for conversion to jet fuel, a 12:0-acyl-carrier thioesterase gene, UcFATB1, from California bay ( Umbellularia californica Nutt.) was expressed in camelina seeds. Up to 40% of short chain laurate ( C12:0) and myristate ( C14:0) were present in TAGs of the seed oil of the transgenics. The total oil content and germination rate of the transgenic seeds were not affected. Analysis of positions of these two fatty acyl moieties in TAGs indicated that they were present at the sn-1 and sn-3 positions, but not sn-2, on the TAGs. Suppression of the camelina KASII genes by RNAi constructs led to higher accumulation of palmitate ( C16:0), from 7.5% up to 28.5%, and further reduction of longer, unsaturated fatty acids in seed TAGs. Co-transformation of camelina with both constructs resulted in enhanced accumulation of all three medium-chain, saturated fatty acids in camelina seed oils. Our results show that a California bay gene can be successfully used to modify the oil composition in camelina seed and present a new biological alternative for jet fuel production.	[Hu, Zhaohui; Wu, Qian; Dalal, Jyoti; Vasani, Naresh; Lopez, Harry O.; Qu, Rongda] North Carolina State Univ, Dept Crop & Soil Sci, Raleigh, NC 27695 USA; [Sederoff, Heike W.] North Carolina State Univ, Dept Plant & Microbial Biol, Raleigh, NC USA	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University	Qu, RD (corresponding author), North Carolina State Univ, Dept Crop & Soil Sci, Raleigh, NC 27695 USA.	rqu@ncsu.edu	Vasani, Naresh B/K-9082-2019; Sederoff, Heike/AAE-1505-2021	Sederoff, Heike/0000-0002-0960-9678; Vasani, Naresh/0000-0003-4814-3310				BAFOR M, 1990, BIOCHEM J, V272, P31, DOI 10.1042/bj2720031; BAFOR M, 1991, BIOCHEM J, V280, P507, DOI 10.1042/bj2800507; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bouchy C, 2009, OIL GAS SCI TECHNOL, V64, P91, DOI 10.2516/ogst/2008047; Cahoon EB, 2006, PHYTOCHEMISTRY, V67, P1166, DOI 10.1016/j.phytochem.2006.04.013; Dalal J, 2015, PLASMID, V81, P55, DOI 10.1016/j.plasmid.2015.06.003; Dehesh K, 1998, PLANT J, V15, P383, DOI 10.1046/j.1365-313X.1998.00218.x; Gibellini F, 2010, IUBMB LIFE, V62, P414, DOI 10.1002/iub.337; Hu ZH, 2012, PLANT PHYSIOL, V158, P1944, DOI 10.1104/pp.111.192153; Nguyen HT, 2015, PLANT BIOTECHNOL J, V13, P38, DOI 10.1111/pbi.12233; Kang JL, 2011, PLANT PHYSIOL BIOCH, V49, P223, DOI 10.1016/j.plaphy.2010.12.004; Kim HJ, 2015, J EXP BOT, V66, P4251, DOI 10.1093/jxb/erv225; Knutzon DS, 1999, PLANT PHYSIOL, V120, P739, DOI 10.1104/pp.120.3.739; LAURENT P, 1992, PLANT PHYSIOL, V99, P1711, DOI 10.1104/pp.99.4.1711; Li YH, 2006, PHYTOCHEMISTRY, V67, P904, DOI 10.1016/j.phytochem.2006.02.015; Lu CF, 2008, PLANT CELL REP, V27, P273, DOI 10.1007/s00299-007-0454-0; Lu CF, 2011, CURR OPIN BIOTECH, V22, P252, DOI 10.1016/j.copbio.2010.11.006; Mansour MP, 2014, NUTRIENTS, V6, P776, DOI 10.3390/nu6020776; Nguyen HT, 2013, PLANT BIOTECHNOL J, V11, P759, DOI 10.1111/pbi.12068; OKULEY J, 1994, PLANT CELL, V6, P147, DOI 10.1105/tpc.6.1.147; Pidkowich MS, 2007, P NATL ACAD SCI USA, V104, P4742, DOI 10.1073/pnas.0611141104; Pilgeram A.L., 2007, ISSUES NEW CROPS NEW; Poirier Y, 2000, THEOR APPL GENET, V100, P487, DOI 10.1007/s001220050063; Putnam D. H., 1993, New crops., P314; SHIMAKATA T, 1982, P NATL ACAD SCI-BIOL, V79, P5808, DOI 10.1073/pnas.79.19.5808; Smith MA, 2003, PLANTA, V217, P507, DOI 10.1007/s00425-003-1015-6; Voelker TA, 1997, PLANT PHYSIOL, V114, P669, DOI 10.1104/pp.114.2.669; VOELKER TA, 1992, SCIENCE, V257, P72, DOI 10.1126/science.1621095; Voelker TA, 1996, PLANT J, V9, P229, DOI 10.1046/j.1365-313X.1996.09020229.x; Xu YN, 1999, FETT-LIPID, V101, P104	30	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2017	12	2							e0172296	10.1371/journal.pone.0172296	http://dx.doi.org/10.1371/journal.pone.0172296			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BI	28212406	Green Published, gold, Green Submitted			2022-12-27	WOS:000394424700031
J	Jang, J; Kim, H; Kang, S				Jang, Jaewon; Kim, Heetae; Kang, Sungho			A low-cost DAC BIST structure using a resistor loop	PLOS ONE			English	Article							ADCS	This paper proposes a new DAC BIST ( digital-to-analog converter built-in self-test) structure using a resistor loop known as a DDEM ADC ( deterministic dynamic element matching analog-to-digital converter). Methods for both switch reduction and switch effect reduction are proposed for solving problems related to area overhead and accuracy of the conventional DAC BIST. The proposed BIST modifies the length of each resistor in the resistor loop via a merging operation and reduces the number of switches and resistors. In addition, the effect of switches is mitigated using the proposed switch effect reduction method. The accuracy of the proposed BIST is demonstrated by the reduction in the switch effect. The experimental results show that the proposed BIST reduces resource usages and the mismatch error caused by the switches.	[Jang, Jaewon; Kim, Heetae; Kang, Sungho] Yonsei Univ, Dept Elect & Elect Engn, 50 Yonsei Ro, Seoul 134, South Korea	Yonsei University	Kang, S (corresponding author), Yonsei Univ, Dept Elect & Elect Engn, 50 Yonsei Ro, Seoul 134, South Korea.	shkang@yonsei.ac.kr		Kang, Sungho/0000-0002-7093-2095				Abacherli R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150207; Balestrieri E, 2007, MEASUREMENT, V40, P500, DOI 10.1016/j.measurement.2006.11.014; Hong Phuc Ninh, 2011, 2011 International Symposium on Radio-Frequency Integration Technology (RFIT), P109, DOI 10.1109/RFIT.2011.6141779; Jang J, 2011, CIRC SYST MWSCAS 201, P1; Kook S, 2013, IEEE T VLSI SYST, V21, P454, DOI 10.1109/TVLSI.2012.2190433; Kothadia R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061076; Lin C.-B., 2012, EVID-BASED COMPL ALT, V2012, P1, DOI DOI 10.1155/2012/967182; Sall E, 2006, 24TH NORCHIP CONFERENCE, PROCEEDINGS, P159, DOI 10.1109/NORCHP.2006.329268; Semiconductor M., 2005, LTD 0 35 MICRON 3 3; Xing HQ, 2008, INT CONF ELECTRO INF, P117, DOI 10.1109/EIT.2008.4554278; Xing Hanqing, 2007, IEEE INT TEST C OCT, P1; Zaki T, 2012, IEEE J SOLID-ST CIRC, V47, P292, DOI 10.1109/JSSC.2011.2170639; Zhu Hongyu, 2012, Proceedings 2012 IEEE Symposium on Electrical & Electronics Engineering (EEESYM 2012), P109, DOI 10.1109/EEESym.2012.6258600	13	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2017	12	2							e0172331	10.1371/journal.pone.0172331	http://dx.doi.org/10.1371/journal.pone.0172331			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BI	28212421	gold, Green Published, Green Submitted			2022-12-27	WOS:000394424700032
J	Zeriouh, W; Nani, A; Belarbi, M; Dumont, A; de Rosny, C; Aboura, I; Ghanemi, FZ; Murtaza, B; Patoli, D; Thomas, C; Apetoh, L; Rebe, C; Delmas, D; Khan, NA; Ghiringhelli, F; Rialland, M; Hichami, A				Zeriouh, Wafa; Nani, Abdelhafid; Belarbi, Meriem; Dumont, Adelie; de Rosny, Charlotte; Aboura, Ikram; Ghanemi, Fatima Zahra; Murtaza, Babar; Patoli, Danish; Thomas, Charles; Apetoh, Lionel; Rebe, Cedric; Delmas, Dominique; Khan, Naim Akhtar; Ghiringhelli, Francois; Rialland, Mickael; Hichami, Aziz			Phenolic extract from oleaster (Olea europaea var. Sylvestris) leaves reduces colon cancer growth and induces caspase-dependent apoptosis in colon cancer cells via the mitochondrial apoptotic pathway	PLOS ONE			English	Article							OLIVE LEAF EXTRACT; COLORECTAL-CANCER; CARCINOMA CELLS; CYTOCHROME-C; CALCIUM; P53; POLYPHENOLS; ACTIVATION; DISEASE; PROTEIN	Dietary polyphenols, derived from natural products, have received a great interest for their chemopreventive properties against cancer. In this study, we investigated the effects of phenolic extract of the oleaster leaves ( PEOL) on tumor growth in mouse model and on cell death in colon cancer cell lines. We assessed the effect of oleaster leaf infusion on HCT116 ( human colon cancer cell line) xenograft growth in athymic nude mice. We observed that oleaster leaf polyphenol-rich infusion limited HCT116 tumor growth in vivo. Investigations of PEOL on two human CRC cell lines showed that PEOL induced apoptosis in HCT116 and HCT8 cells. We demonstrated an activation of caspase-3, -7 and -9 by PEOL and that pretreatment with the pan-caspase inhibitor, N-benzyloxycarbonyl-Val-Ala-Asp-fluoromethylketone ( z-VAD-fmk), prevented PEOL-induced cell death. We observed an involvement of the mitochondrial pathway in PEOL-induced apoptosis evidenced by reactive oxygen species ( ROS) production, a decrease of mitochondrial membrane potential, and cytochrome c release. Increase in intracellular Ca2+ concentration induced by PEOL represents the early event involved in mitochondrial dysfunction, ROS-induced endoplasmic reticulum ( ER) stress and apoptosis induced by PEOL, as ruthenium red, an inhibitor of mitochondrial calcium uptake inhibited apoptotic effect of PEOL, BAPTA/AM inhibited PEOL-induced ROS generation and finally, N-acetyl-L-cysteine reversed ER stress and apoptotic effect of PEOL. These results demonstrate that polyphenols from oleaster leaves might have a strong potential as chemopreventive agent in colorectal cancer.	[Zeriouh, Wafa; Nani, Abdelhafid; Belarbi, Meriem; Aboura, Ikram; Ghanemi, Fatima Zahra] Aboubekr Belkaid Univ, Lab Nat Prod, Tilimsen, Algeria; [Nani, Abdelhafid] African Univ Ahmed Draia, Dept Nat & Life Sci, Adrar, Algeria; [Nani, Abdelhafid; Dumont, Adelie; de Rosny, Charlotte; Aboura, Ikram; Ghanemi, Fatima Zahra; Murtaza, Babar; Patoli, Danish; Thomas, Charles; Apetoh, Lionel; Rebe, Cedric; Delmas, Dominique; Khan, Naim Akhtar; Ghiringhelli, Francois; Rialland, Mickael; Hichami, Aziz] Univ Bourgogne Franche Comte, INSERM U1231, Dijon, France; [Rebe, Cedric; Ghiringhelli, Francois] Ctr Georges Francois Leclerc, Dijon, France	Universite Abou Bekr Belkaid; Universite d'Adrar; Institut Agro; AgroSup Dijon; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne; UNICANCER; Centre Georges-Francois Leclerc	Hichami, A (corresponding author), Univ Bourgogne Franche Comte, INSERM U1231, Dijon, France.	aziz.hichami@u-bourgogne.fr	Delmas, Dominique/AAD-9749-2019; Apetoh, Lionel/G-3310-2014; REBE, Cédric/AAD-4316-2019; Thomas, charles/C-7130-2019; Apetoh, Lionel/AIC-2384-2022; Murtaza, Babar/AAR-8200-2021	Delmas, Dominique/0000-0003-3576-0248; Apetoh, Lionel/0000-0002-2774-438X; REBE, Cédric/0000-0001-8831-145X; Thomas, charles/0000-0001-9998-6698; Apetoh, Lionel/0000-0002-2774-438X; Khan, Naim Akhtar/0000-0002-8930-9332; Patoli, Danish/0000-0002-6837-336X; NANI, ABDELHAFID/0000-0002-8665-0447; ghiringhelli, francois/0000-0002-5465-8305; Delmas, Dominique/0000-0002-8911-8499; Rialland, Mickael/0000-0001-9693-9351	Inserm, Labex LipSTIC INSERM	Inserm, Labex LipSTIC INSERM	This study was supported by Inserm, Labex LipSTIC INSERM U866, bilateral Franco-Algerian collaborative project "Tassili."	Abaza L, 2007, BIOSCI BIOTECH BIOCH, V71, P1306, DOI 10.1271/bbb.60716; Aires V, 2004, MOL CELL BIOCHEM, V260, P103, DOI 10.1023/B:MCBI.0000026061.57326.28; Armutcu F, 2011, SPAT DD PER REV J CO, V1, P159; Banerjee A, 2016, ONCOTARGET IMPACT J, V5; Bennani-Kabchi N., 2000, Annales Pharmaceutiques Francaises, V58, P271; Boehning D, 2004, CELL CYCLE, V3, P252; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Castedo M, 2002, J IMMUNOL METHODS, V265, P39, DOI 10.1016/S0022-1759(02)00069-8; Chen CY, 2007, J AGR FOOD CHEM, V55, P948, DOI 10.1021/jf0624594; Corsi L, 2002, FITOTERAPIA, V73, P674, DOI 10.1016/S0367-326X(02)00227-7; Cottet-Rousselle C, 2011, CYTOM PART A, V79A, P405, DOI 10.1002/cyto.a.21061; Dramane G, 2012, J CLIN INVEST, V122, P2267, DOI 10.1172/JCI59953; Fares R, 2011, PLANT FOOD HUM NUTR, V66, P58, DOI 10.1007/s11130-011-0213-9; Giovannini C, 2012, NUTR NEUROSCI, V15, P134, DOI 10.1179/1476830512Y.0000000006; Gottlieb E, 2000, MOL CELL BIOL, V20, P5680, DOI 10.1128/MCB.20.15.5680-5689.2000; Hajiaghaalipour F, 2015, FOOD CHEM, V169, P401, DOI 10.1016/j.foodchem.2014.07.005; Han J, 2009, CYTOTECHNOLOGY, V59, P45, DOI 10.1007/s10616-009-9191-2; Hanene G, 2015, INT J PHARM PHARM SC, V7; Hannachi H, 2013, PAK J PHARM SCI, V26, P503; Jang MS, 1997, SCIENCE, V275, P218, DOI 10.1126/science.275.5297.218; Katiyar Santosh K., 2006, Endocrine Metabolic & Immune Disorders-Drug Targets, V6, P17; Kim ER, 2014, WORLD J GASTROENTERO, V20, P9872, DOI 10.3748/wjg.v20.i29.9872; Kroemer G, 1997, IMMUNOL TODAY, V18, P44, DOI 10.1016/S0167-5699(97)80014-X; Kroemer G, 2000, NAT MED, V6, P513, DOI 10.1038/74994; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; Kruman II, 1999, J NEUROCHEM, V72, P529, DOI 10.1046/j.1471-4159.1999.0720529.x; Lafka TI, 2013, FOODS, V2, P18, DOI 10.3390/foods2010018; Levin B, 2008, CA-CANCER J CLIN, V58, P130, DOI 10.3322/CA.2007.0018; Marchetti C, 2002, HUM REPROD, V17, P1257, DOI 10.1093/humrep/17.5.1257; McGuire S, 2014, ADV NUTR, V5, P456, DOI 10.3945/an.114.006171; Middleton E, 2000, PHARMACOL REV, V52, P673; Mijatovic SA, 2011, INT J CANCER, V128, P1955, DOI 10.1002/ijc.25526; Minville-Walz M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014363; Nakazato T, 2005, HEMATOL J, V90; Nani A, 2015, BMC COMPLEM ALTERN M, V15, DOI 10.1186/s12906-015-0946-3; Nicholson DW, 1999, CELL DEATH DIFFER, V6, P1028, DOI 10.1038/sj.cdd.4400598; Oak MH, 2005, J NUTR BIOCHEM, V16, P1, DOI 10.1016/j.jnutbio.2004.09.004; Obrenovich ME, 2010, REJUV RES, V13, P631, DOI 10.1089/rej.2010.1043; Parkin DM, 1999, CA-CANCER J CLIN, V49, P33, DOI 10.3322/canjclin.49.1.33; Petrosillo G, 2003, FASEB J, V17, P2202, DOI 10.1096/fj.03-0012com; Reyes FJ, 2006, FEBS LETT, V580, P6302, DOI 10.1016/j.febslet.2006.10.038; Rodriguez M.L., 2013, J CARCINOG MUTAGEN, V6; Rodriguez ML, 2013, AFRIQUE SCI, V09, P159; Roy AM, 2005, MOL CANCER THER, V4, P81; Soni MG, 2006, FOOD CHEM TOXICOL, V44, P903, DOI 10.1016/j.fct.2006.01.008; Vasen HFA, 2015, NAT REV GASTRO HEPAT, V12, P88, DOI 10.1038/nrgastro.2014.229; Watson JL, 2010, MOL CARCINOGEN, V49, P13, DOI 10.1002/mc.20571; Zhong Y, 2010, EUR J CANCER, V46, P3365, DOI 10.1016/j.ejca.2010.07.007	48	22	23	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2017	12	2							e0170823	10.1371/journal.pone.0170823	http://dx.doi.org/10.1371/journal.pone.0170823			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BI	28212423	Green Submitted, Green Published, gold			2022-12-27	WOS:000394424700003
J	Zhan, WB; Gedroyc, W; Xu, XY				Zhan, Wenbo; Gedroyc, Wladyslaw; Xu, Xiao Yun			The effect of tumour size on drug transport and uptake in 3-D tumour models reconstructed from magnetic resonance images	PLOS ONE			English	Article							SOLID TUMORS; INTERSTITIAL PRESSURE; NEOPLASTIC TISSUES; BLOOD-FLOW; DELIVERY; MACROMOLECULES; DOXORUBICIN; VASCULATURE; FLUID; ADRIAMYCIN	Drug transport and its uptake by tumour cells are strongly dependent on tumour properties, which vary in different types of solid tumours. By simulating the key physical and biochemical processes, a numerical study has been carried out to investigate the transport of anticancer drugs in 3-D tumour models of different sizes. The therapeutic efficacy for each tumour is evaluated by using a pharmacodynamics model based on the predicted intracellular drug concentration. Simulation results demonstrate that interstitial fluid pressure and interstitial fluid loss vary non-linearly with tumour size. Transvascular drug exchange, driven by the concentration gradient of unbound drug between blood and interstitial fluid, is more efficient in small tumours, owing to the low spatial-mean interstitial fluid pressure and dense microvasculature. However, this has a detrimental effect on therapeutic efficacy over longer periods as a result of enhanced reverse diffusion of drug to the blood circulation after the cessation of drug infusion, causing more rapid loss of drug in small tumours.	[Zhan, Wenbo; Xu, Xiao Yun] Imperial Coll London, Dept Chem Engn, South Kensington Campus, London, England; [Gedroyc, Wladyslaw] Imperial Coll Healthcare NHS Trust, St Marys Hosp, Dept Radiol, London, England	Imperial College London; Imperial College London	Xu, XY (corresponding author), Imperial Coll London, Dept Chem Engn, South Kensington Campus, London, England.	yun.xu@imperial.ac.uk	Zhan, Wenbo/O-7709-2018	Zhan, Wenbo/0000-0003-0268-5042	Engineering and Physical Sciences Research Council [EP/I001700/1] Funding Source: researchfish; EPSRC [EP/I001700/1] Funding Source: UKRI	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		Arap W, 1998, SCIENCE, V279, P377, DOI 10.1126/science.279.5349.377; BAXTER LT, 1989, MICROVASC RES, V37, P77, DOI 10.1016/0026-2862(89)90074-5; BAXTER LT, 1991, MICROVASC RES, V41, P5, DOI 10.1016/0026-2862(91)90003-T; BAXTER LT, 1991, MICROVASC RES, V41, P252, DOI 10.1016/0026-2862(91)90026-8; BAXTER LT, 1990, MICROVASC RES, V40, P246, DOI 10.1016/0026-2862(90)90023-K; Eatock MM, 2000, CANCER TREAT REV, V26, P191, DOI 10.1053/ctrv.1999.0158; Eikenberry S, 2009, THEOR BIOL MED MODEL, V6, DOI 10.1186/1742-4682-6-16; El-Kareh AW, 2000, NEOPLASIA, V2, P325, DOI 10.1038/sj.neo.7900096; Eliaz RE, 2004, CANCER RES, V64, P711, DOI 10.1158/0008-5472.CAN-03-0654; Goh YMF, 2001, PHARM RES-DORDR, V18, P761, DOI 10.1023/A:1011076110317; Goodman LS, 2005, GOODMAN GILMANS PHAR; GRANATH KA, 1967, J CHROMATOGR, V28, P69, DOI 10.1016/S0021-9673(01)85930-6; GREENE RF, 1983, CANCER RES, V43, P3417; HILMAS DE, 1974, CANCER, V33, P103, DOI 10.1002/1097-0142(197401)33:1<103::AID-CNCR2820330116>3.0.CO;2-7; Jain HV, 2008, B MATH BIOL, V70, P89, DOI 10.1007/s11538-007-9242-9; JAIN RK, 1988, CANCER RES, V48, P7022; JAIN RK, 1988, CANCER RES, V48, P2641; JAIN RK, 1987, CANCER RES, V47, P3039; Jang SH, 2003, PHARM RES-DORDR, V20, P1337, DOI 10.1023/A:1025785505977; KERR DJ, 1986, BIOCHEM PHARMACOL, V35, P2817, DOI 10.1016/0006-2952(86)90195-4; LESS JR, 1991, CANCER RES, V51, P265; Lichtenbeld Hera C., 1996, Microcirculation (Philadelphia), V3, P349, DOI 10.3109/10739689609148307; Liu C, 2013, INTEGR BIOL-UK, V5, P555, DOI 10.1039/c2ib20238g; NUGENT LJ, 1984, CANCER RES, V44, P238; Pappenheimer J. R., 1951, AM J PHYSIOL, V167, P2578; ROBERT J, 1982, EUR J CANCER CLIN ON, V18, P739, DOI 10.1016/0277-5379(82)90072-4; Rubin P, 1966, Clin Radiol, V17, P220, DOI 10.1016/S0009-9260(66)80027-2; SALTZMAN WM, 1991, CHEM ENG SCI, V46, P2429, DOI 10.1016/0009-2509(91)80036-X; Schiffelers RM, 2003, J CONTROL RELEASE, V91, P115, DOI 10.1016/S0168-3659(03)00240-2; Sefidgar M, 2014, J BIOL ENG, V8, DOI 10.1186/1754-1611-8-12; Soltani M, 2012, J BIOL ENG, V6, DOI 10.1186/1754-1611-6-4; SWABB EA, 1974, CANCER RES, V34, P2814; Taverna G, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00015; VAUPEL P, 1989, CANCER RES, V49, P6449; WOLF MB, 1987, AM J PHYSIOL, V253, pH194, DOI 10.1152/ajpheart.1987.253.1.H194; WU NZ, 1993, MICROVASC RES, V46, P231, DOI 10.1006/mvre.1993.1049; YUAN F, 1995, CANCER RES, V55, P3752; Zhan WB, 2013, J DRUG DELIV, V2013, DOI 10.1155/2013/172529; Zhao JB, 2007, MICROVASC RES, V73, P224, DOI 10.1016/j.mvr.2006.12.003	39	25	30	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2017	12	2							e0172276	10.1371/journal.pone.0172276	http://dx.doi.org/10.1371/journal.pone.0172276			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BI	28212385	Green Published, gold, Green Submitted			2022-12-27	WOS:000394424700026
J	Kim, CY; Son, BJ; Son, J; Hong, J; Lee, SY				Kim, Chang Yeom; Son, Byeong Jae; Son, Jangyup; Hong, Jongill; Lee, Sang Yeul			Analysis of the causes of recurrence after frontalis suspension using silicone rods for congenital ptosis	PLOS ONE			English	Article							FASCIA LATA; LEVATOR RESECTION; SUTURE MATERIAL; BLEPHAROPTOSIS; SURGERY; REPAIR; MIGRATION; EFFICACY; TARSAL; WOMEN	Background Silicone rod is a commonly used synthetic suspension material in frontalis suspension surgery to correct blepharoptosis. The most challenging problem and a decisive drawback of the use of silicone rod is a considerable rate of ptosis recurrence after surgery. We examined patients with recurred ptosis and assessed the physical and micromorphological properties of implanted silicone rods to determine the causative mechanisms of recurred ptosis after frontalis suspension using silicone rod. Methods This is a prospective observational case series of 22 pediatric patients with recurred ptosis after frontalis suspension using silicone rods for congenital ptosis. Implanted silicone rods were observed and removed during the operation for correction of recurred ptosis. The removed silicone rods were physically and micromorphologically evaluated to determine the cause of recurrence. Results Pretarsal fixation positions migrated upward, whereas suprabrow fixation positions migrated downward during ptosis recurrence. The breaking strength of implanted silicone rods was reduced by approximately 50% during 3 years. Cracks, debris, and loss of homogenous structure with disintegration were observed on scanning electron micrographs of implanted silicone rods in patients with recurred ptosis. Preoperative severe degree of ptosis also contributed to recurred ptosis. Conclusions Recurrence of ptosis after frontalis suspension using silicone rod was associated with physical changes of implanted silicone rods, including positional migration, weakened tensile strength, and micromorphological changes in combination with patients' characteristics.	[Kim, Chang Yeom; Lee, Sang Yeul] Yonsei Univ, Coll Med, Dept Ophthalmol, Inst Vis Res, Seoul, South Korea; [Kim, Chang Yeom] Konyang Univ, Coll Med, Dept Ophthalmol, Kims Eye Hosp,Myung Gok Eye Res Inst, Seoul, South Korea; [Son, Byeong Jae] Kyungpook Natl Univ, Sch Med, Dept Ophthalmol, Daegu, South Korea; [Son, Jangyup; Hong, Jongill] Yonsei Univ, Dept Mat Sci & Engn, Seoul, South Korea; [Son, Jangyup] Univ Illinois, Mech Sci & Engn, Urbana, IL USA; [Lee, Sang Yeul] Lees Eye Clin, Seoul, South Korea	Yonsei University; Yonsei University Health System; Konyang University; Konyang University Hospital; Kyungpook National University; Yonsei University; University of Illinois System; University of Illinois Urbana-Champaign	Kim, CY (corresponding author), Yonsei Univ, Coll Med, Dept Ophthalmol, Inst Vis Res, Seoul, South Korea.; Kim, CY (corresponding author), Konyang Univ, Coll Med, Dept Ophthalmol, Kims Eye Hosp,Myung Gok Eye Res Inst, Seoul, South Korea.	nachay@hanmail.net						ANDERSON RL, 1990, ARCH OPHTHALMOL-CHIC, V108, P1628, DOI 10.1001/archopht.1990.01070130130043; Bansal RK, 2015, J PEDIAT OPHTH STRAB, V52, P93, DOI 10.3928/01913913-20150313-11; Ben Simon GJ, 2005, AM J OPHTHALMOL, V140, P877, DOI 10.1016/j.ajo.2005.05.031; Bernardini Francesco P, 2002, Orbit, V21, P195, DOI 10.1076/orbi.21.3.195.7171; Bernardini FP, 2013, CURR OPIN OPHTHALMOL, V24, P484, DOI 10.1097/ICU.0b013e328363861a; Buttanri IB, 2013, OPHTHAL PLAST RECONS, V29, P98, DOI 10.1097/IOP.0b013e31827a0068; Carter SR, 1996, OPHTHALMOLOGY, V103, P623, DOI 10.1016/S0161-6420(96)30643-X; Chung HW, 2016, CLIN OPHTHALMOL, V10, P1779, DOI 10.2147/OPTH.S113814; CRAWFORD JS, 1977, OPHTHALMIC SURG LAS, V8, P31; EPSTEIN GA, 1984, OPHTHALMIC SURG LAS, V15, P971; GARRIDO L, 1994, MAGNET RESON MED, V31, P328, DOI 10.1002/mrm.1910310314; Hayashi K, 2013, AM J OPHTHALMOL, V155, P654, DOI 10.1016/j.ajo.2012.10.022; Hersh D, 2006, J PEDIAT OPHTH STRAB, V43, P212, DOI 10.3928/01913913-20060701-02; Holmstrom H, 2002, SCAND J PLAST RECONS, V36, P149, DOI 10.1080/028443102753718023; Kook KH, 2004, AM J OPHTHALMOL, V138, P756, DOI 10.1016/j.ajo.2004.06.019; Kwon KA, 2014, MAT SCI ENG C-MATER, V35, P220, DOI 10.1016/j.msec.2013.10.031; Lee MJ, 2009, OPHTHALMOLOGY, V116, P123, DOI 10.1016/j.ophtha.2008.08.049; Liu D, 1999, AM J OPHTHALMOL, V128, P772, DOI 10.1016/S0002-9394(99)00258-5; MAURIELLO JA, 1986, OPHTHALMOLOGY, V93, P466; Morris CL, 2008, J PEDIAT OPHTH STRAB, V45, P280, DOI 10.3928/01913913-20080901-11; Nerad J.A., 2001, OCULOPLASTIC SURG RE, P157; Nucci P, 2016, SEMIN OPHTHALMOL, V31, P215, DOI 10.3109/08820538.2014.936618; Pacella E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160827; PFLEIDERER B, 1995, MAGNET RESON MED, V33, P8, DOI 10.1002/mrm.1910330103; de Figueiredo ARP, 2010, SEMIN OPHTHALMOL, V25, P39, DOI 10.3109/08820538.2010.496695; SPOOR TC, 1990, AM J OPHTHALMOL, V109, P314, DOI 10.1016/S0002-9394(14)74557-X; WAGNER RS, 1984, OPHTHALMOLOGY, V91, P245; Wasserman BN, 2001, ARCH OPHTHALMOL-CHIC, V119, P687, DOI 10.1001/archopht.119.5.687	28	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0171769	10.1371/journal.pone.0171769	http://dx.doi.org/10.1371/journal.pone.0171769			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207846	Green Published, gold, Green Submitted			2022-12-27	WOS:000394424500053
J	Shu, PS; Chan, YM; Huang, SL				Shu, Ping Soon; Chan, Yoke Mun; Huang, Soo Lee			Higher body mass index and lower intake of dairy products predict poor glycaemic control among Type 2 Diabetes patients in Malaysia	PLOS ONE			English	Article							DOSE-RESPONSE METAANALYSIS; VEGETABLE INTAKE; LIFE-STYLE; SITUATIONAL OBSTACLES; MEDICATION ADHERENCE; METABOLIC SYNDROME; NATIONAL-HEALTH; BLOOD-GLUCOSE; PRIMARY-CARE; RISK	This cross-sectional study was designed to determine factors contributing to glyceamic control in order to provide better understanding of diabetes management among Type 2 Diabetes patients. A pre-tested structured questionnaire was used to obtain information on sociodemographic and medical history. As a proxy measure for glycaemic control, glycosylated haemoglobin (HbA1c) was obtained as secondary data from the medical reports. Perceived self-care barrier on diabetes management, diet knowledge and skills, and diet quality were assessed using pretested instruments. With a response rate of 80.3%, 155 subjects were recruited for the study. Mean HbA1c level of the subjects was 9.02 +/- 2.25% with more than 70% not able to achieve acceptable level in accordance to WHO recommendation. Diet quality of the subjects was unsatisfactory especially for vegetables, fruits, fish and legumes as well as from the milk and dairy products group. Higher body mass index (BMI), poorer medication compliance, lower diet knowledge and skill scores and lower intake of milk and dairy products contributed significantly on poor glycaemic control. In conclusion, while perceived self-care barriers and diet quality failed to predict HbA1c, good knowledge and skill ability, together with appropriate BMI and adequate intake of dairy products should be emphasized to optimize glycaemic control among type 2 diabetes patients.	[Shu, Ping Soon; Chan, Yoke Mun; Huang, Soo Lee] Univ Putra Malaysia, Fac Med & Hlth Sci, Dept Nutr & Dietet, Serdang, Malaysia; [Chan, Yoke Mun] Univ Putra Malaysia, Malaysian Res Inst Ageing, Serdang, Malaysia	Universiti Putra Malaysia; Universiti Putra Malaysia	Chan, YM (corresponding author), Univ Putra Malaysia, Fac Med & Hlth Sci, Dept Nutr & Dietet, Serdang, Malaysia.; Chan, YM (corresponding author), Univ Putra Malaysia, Malaysian Res Inst Ageing, Serdang, Malaysia.	cym@upm.edu.my	Chan, Yoke Mun Yoke/L-2965-2015	Chan, Yoke Mun Yoke/0000-0002-3853-736X	Universiti Putra Malaysia (Research University Grant Scheme Initiative 6)	Universiti Putra Malaysia (Research University Grant Scheme Initiative 6)	This study was funded under Universiti Putra Malaysia (Research University Grant Scheme Initiative 6). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to express our sincere appreciation for all assistance given by everybody involved in this study. This study was funded under Universiti Putra Malaysia (Research University Grant Scheme Initiative 6).	Abioye-Kuteyi E A, 2005, Niger J Med, V14, P58; Abraham AM, 2015, INT J DIABETES DEV C, V35, pS137, DOI 10.1007/s13410-014-0266-z; Abu Hassan H, 2013, BMC FAM PRACT, V14, DOI 10.1186/1471-2296-14-164; Adibe O, 2009, INT J DRUG DEV RES, V1, P85; Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; American Diabetes Association (ADA), 2014, IMPR DIET QUAL RED T; [Anonymous], 2010, INT J DIABETES MELLI, DOI DOI 10.1016/J.IJDM.2010.08.001; [Anonymous], 2007, DEV EVALUATION HLTH; [Anonymous], 2011, US GLYC HEM HBA1C DI; Aune D, 2013, AM J CLIN NUTR, V98, P1066, DOI 10.3945/ajcn.113.059030; Azim W., 2010, INT J PATHOL, V8, P59; Bassuk SS, 2008, AM J LIFESTYLE MED, V2, P191, DOI 10.1177/1559827608314095; Bazzano LA, 2008, DIABETES CARE, V31, P1311, DOI 10.2337/dc08-0080; Beghin JC, 2006, FOOD POLICY, V31, P195, DOI 10.1016/j.foodpol.2006.03.001; Blackburn DF, 2013, PATIENT PREFER ADHER, V7, P183, DOI 10.2147/PPA.S30613; Boccuzzi SJ, 2001, DIABETES CARE, V24, P1411, DOI 10.2337/diacare.24.8.1411; Bowler C, 2014, END ABSTR, V34, pP221; Buabeng KO, 2004, J PHARM PHARM SCI, V7, P350; Carter P, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4229; Chang HY, 2005, PREV MED, V40, P344, DOI 10.1016/j.ypmed.2004.06.012; Chen M, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0215-1; Choi S, 2009, WESTERN J NURS RES, V31, P347, DOI 10.1177/0193945908328472; Colagiuri R, 2009, DIABETIC MED, V26, P442, DOI 10.1111/j.1464-5491.2009.02700.x; Cooper AJ, 2012, DIABETES CARE, V35, P1293, DOI 10.2337/dc11-2388; Cramer JA, 2005, DIABETES CARE, V28, P78, DOI 10.2337/diacare.28.1.78; Cramer JA, 2004, DIABETES CARE, V27, P1218, DOI 10.2337/diacare.27.5.1218; Daly JM, 2009, J AM BOARD FAM MED, V22, P280, DOI 10.3122/jabfm.2009.03.080114; Daousi C, 2006, POSTGRAD MED J, V82, P280, DOI 10.1136/pmj.2005.039032; Dinehart ME, 2006, PHYSIOL BEHAV, V87, P304, DOI 10.1016/j.physbeh.2005.10.018; Donnan PT, 2002, DIABETIC MED, V19, P279, DOI 10.1046/j.1464-5491.2002.00689.x; Drewnowski A, 2000, AM J CLIN NUTR, V72, P1424; Egan BM, 2012, ETHNIC DIS, V22, P29; Elwood PC, 2007, J EPIDEMIOL COMMUN H, V61, P695, DOI 10.1136/jech.2006.053157; Elwood PC, 2010, LIPIDS, V45, P925, DOI 10.1007/s11745-010-3412-5; Ericson U, 2015, AM J CLIN NUTR, V101, P1065, DOI 10.3945/ajcn.114.103010; Funnell MM, 2010, DIABETES CARE, V33, pS89, DOI 10.2337/dc10-S089; Gao DF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073965; Gijsbers L, 2016, AM J CLIN NUTR, V103, P1111, DOI 10.3945/ajcn.115.123216; Gonzalez JS, 2013, DIABETES CARE, V36, P831, DOI 10.2337/dc12-0410; Goudswaard AN, 2004, EUR J EPIDEMIOL, V19, P541, DOI 10.1023/B:EJEP.0000032351.42772.e7; Grantham NM, 2013, PUBLIC HEALTH NUTR, V16, P339, DOI 10.1017/S1368980012001310; Gu K, 1999, JAMA-J AM MED ASSOC, V281, P1291, DOI 10.1001/jama.281.14.1291; Harris MI, 2001, DIABETES CARE, V24, P979, DOI 10.2337/diacare.24.6.979; Hjelm K, 2003, J ADV NURS, V41, P424, DOI 10.1046/j.1365-2648.2003.02548.x; Hjelm K, 2010, BMC INT HEALTH HUM R, V10, DOI 10.1186/1472-698X-10-7; Hjelm KG, 2005, J ADV NURS, V50, P47, DOI 10.1111/j.1365-2648.2004.03348.x; Hofe CR, 2014, NUTR RES, V34, P285, DOI 10.1016/j.nutres.2014.02.001; Institute for Public Health, 2011, NAT HLTH MORB SURV N; Institute for Public Health (IPH), 2015, NAT HLTH MORB SURV 2; Institute for Public Health Ministry of Health Malaysia, 2006, NAT HLTH MORB SURV N; Institute of Public Health, 1996, NAT HLTH MORB SURV N; Ismail H, 2011, MED HLTH SCI J, V9, P58; Jansen H, 2013, J INTERN MED, V273, P283, DOI 10.1111/joim.12010; Johnson RJ, 2007, AM J CLIN NUTR, V86, P899; Kholdebarin R, 2008, CAN J OPHTHALMOL, V43, P454, DOI [10.1139/i08-076, 10.3129/i08-076]; King JC, 2005, ARCH INTERN MED, V165, P975, DOI 10.1001/archinte.165.9.975; Krapek K, 2004, ANN PHARMACOTHER, V38, P1357, DOI 10.1345/aph.1D612; Lane JD, 2000, DIABETES CARE, V23, P1321, DOI 10.2337/diacare.23.9.1321; Lang VB, 2015, CROAT MED J, V56, P357, DOI 10.3325/cmj.2015.56.357; Lanting LC, 2008, PATIENT EDUC COUNS, V72, P146, DOI 10.1016/j.pec.2008.03.008; Latifah D, 2010, BARRIERS INITIATING; Lee KL, 2012, KOREAN J FAM MED, V33, P280, DOI 10.4082/kjfm.2012.33.5.280; Lin Yutao, 2004, Wei Sheng Yan Jiu, V33, P737; Liu SM, 2006, DIABETES CARE, V29, P1579, DOI 10.2337/dc06-0256; Liu SM, 2004, DIABETES CARE, V27, P2993, DOI 10.2337/diacare.27.12.2993; Mafauzy M, 2006, Med J Malaysia, V61, P477; Mafauzy M., 2011, MED J MALAYSIA, V66, P175; Maizlish NA, 2004, AM J MED QUAL, V19, P172, DOI 10.1177/106286060401900406; Malik VS, 2011, AM J CLIN NUTR, V94, P854, DOI 10.3945/ajcn.110.009621; Mastura I, 2007, Med J Malaysia, V62, P147; Mastura I, 2011, INT J COLLAB RES INT, V3, P98; Ministry of Agriculture and Agro-Based Industry Malaysia, 2014, AGR FOOD STAT 2013 I; Ministry of Health Malaysia, 2013, NAT DIAB REG, V1; Ministry of Health Malaysia (MOH), 2010, MAL DIET GUID MDG; Monnier L, 2004, DIABETES METAB, V30, P35, DOI 10.1016/S1262-3636(07)70087-3; Montonen J, 2005, AM J EPIDEMIOL, V161, P219, DOI 10.1093/aje/kwi039; Murata G, 2004, J AM DIET ASSOC, V12, P1816; Mursu J, 2014, AM J CLIN NUTR, V99, P328, DOI 10.3945/ajcn.113.069641; Nelson KM, 2002, DIABETES CARE, V25, P1722, DOI 10.2337/diacare.25.10.1722; Nisak MYB, 2010, J AM COLL NUTR, V29, P161, DOI 10.1080/07315724.2010.10719830; Norimah A K Jr, 2008, Malays J Nutr, V14, P25; Nurul Izzah A., 2012, INT FOOD RES J, V19, P1095, DOI [10.1177/1010539512458523, DOI 10.1177/1010539512458523]; O'Connor LM, 2014, DIABETOLOGIA, V57, P909, DOI 10.1007/s00125-014-3176-1; O'Connor PJ, 2008, PREV CHRONIC DIS, V5, P1; Ong WM, 2014, PATIENT PREFER ADHER, V8, P237, DOI 10.2147/PPA.S57567; Pereira MA, 2002, JAMA-J AM MED ASSOC, V287, P2081, DOI 10.1001/jama.287.16.2081; Persell SD, 2004, PREV MED, V39, P746, DOI 10.1016/j.ypmed.2004.02.045; Ramona G, 2011, STUDIA U VASILE GOLD, V21, P313; Rubin RR, 2005, AM J MED, V118, P27, DOI 10.1016/j.amjmed.2005.04.012; Schillinger D, 2006, PUBLIC HEALTH REP, V121, P245, DOI 10.1177/003335490612100305; SCHLUNDT DG, 1994, J AM DIET ASSOC, V94, P874, DOI 10.1016/0002-8223(94)92367-1; SCHLUNDT DG, 1994, DIABETES EDUCATOR, V20, P207, DOI 10.1177/014572179402000305; Simmons D, 2007, DIABETES CARE, V30, P490, DOI 10.2337/dc06-2338; Siram AT, 2010, MT SINAI J MED, V77, P533, DOI 10.1002/msj.20208; Sluijs I, 2012, AM J CLIN NUTR, V96, P382, DOI 10.3945/ajcn.111.021907; Sowattanangoon N, 2009, DIABETES RES CLIN PR, V84, P245, DOI 10.1016/j.diabres.2009.02.011; Stetson B, 2011, DIABETES RES CLIN PR, V91, P321, DOI 10.1016/j.diabres.2010.12.002; Tabesh M, 2013, INT J PREVENTIVE MED, V4, pS63; Takahashi K, 2012, GERIATR GERONTOL INT, V12, P50, DOI 10.1111/j.1447-0594.2011.00812.x; Tan MunChieng, 2013, Health, V5, P1689; Thanopoulou A, 2004, DIABETOLOGIA, V47, P367, DOI 10.1007/s00125-003-1316-0; Tiew KF, 2014, J HEALTH POPUL NUTR, V32, P665; Tong X, 2011, EUR J CLIN NUTR, V65, P1027, DOI 10.1038/ejcn.2011.62; Vallis M, 2003, DIABETES CARE, V26, P1468, DOI 10.2337/diacare.26.5.1468; Van Duyn MS, 2000, J AM DIET ASSOC, V100, P1511, DOI 10.1016/S0002-8223(00)00420-X; Vijen S, 2004, DIABETIC MED, V22, P32; Villegas R, 2008, J NUTR, V138, P574, DOI 10.1093/jn/138.3.574; Virtanen SM, 2000, EUR J CLIN NUTR, V54, P181, DOI 10.1038/sj.ejcn.1600916; Warr S, 2008, O86 ABARE DEP AGR FI; Wedick NM, 2012, AM J CLIN NUTR, V95, P925, DOI 10.3945/ajcn.111.028894; Williams DEM, 1999, J CLIN EPIDEMIOL, V52, P329, DOI 10.1016/S0895-4356(99)00006-2	111	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0172231	10.1371/journal.pone.0172231	http://dx.doi.org/10.1371/journal.pone.0172231			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL5VB	28234927	Green Published, gold, Green Submitted			2022-12-27	WOS:000394688200055
J	Di Pilla, M; Bruno, RM; Stea, F; Massetti, L; Taddei, S; Ghiadoni, L; Modesti, PA				Di Pilla, Marina; Bruno, Rosa Maria; Stea, Francesco; Massetti, Luciano; Taddei, Stefano; Ghiadoni, Lorenzo; Modesti, Pietro Amedeo			Impact of seasonality and air pollutants on carotid-femoral pulse wave velocity and wave reflection in hypertensive patients	PLOS ONE			English	Article							LONG-TERM EXPOSURE; BLOOD-PRESSURE; ARTERIAL STIFFNESS; VITAMIN-D; CARDIOVASCULAR-DISEASE; INDEPENDENT RELATIONSHIP; OUTDOOR TEMPERATURE; VASCULAR FUNCTION; MORTALITY; POLLUTION	Objective The effects of seasonality on blood pressure (BP) and cardiovascular (CV) events are well established, while the influence of seasonality and other environmental factors on arterial stiffness and wave reflection has never been analyzed. This study evaluated whether seasonality (daily number of hours of light) and acute variations in outdoor temperature and air pollutants may affect carotid-femoral pulse wave velocity (PWV) and pressure augmentation. Design and method 731 hypertensive patients (30-88 years, 417 treated) were enrolled in a cross-sectional study during a 5-year period. PWV, central BP, Augmentation Index (AIx) and Augmentation Pressure (AP) were measured in a temperature-controlled (22-24 degrees C) room. Data of the local office of the National Climatic Data Observatory were used to estimate meteorological conditions and air pollutants (PM10, O-3, CO, N2O) exposure on the same day. Results PWV (mean value 8.5 +/- 1.8 m/s) was related to age (r = 0.467, p<0.001), body mass index (r = 0.132, p<0.001), central systolic (r = 0.414, p<0.001) and diastolic BP (r = 0.093, p = 0.013), daylight hours (r = -0.176, p<0.001), mean outdoor temperature (r = -0.082, p = 0.027), O-3 (r = -0.135, p<0.001), CO (r = 0.096, p = 0.012), N2O (r = 0.087, p = 0.022). In multiple linear regression analysis, adjusted for confounders, PWV remained independently associated only with daylight hours (beta = -0.170; 95% CI: -0.273 to -0.067, p = 0.001). No significant correlation was found between pressure augmentation and daylight hours, mean temperature or air pollutants. The relationship was stronger in untreated patients and women. Furthermore, a positive, independent association between O-3 levels and PWV emerged in untreated patients (beta: 0.018; p = 0.029; CI: 0.002 to 0.034) and in women (beta: 0.027; p = 0.004; CI: 0.009 to 0.045). Conclusions PWV showed a marked seasonality in hypertensive patients. Environmental O-3 levels may acutely reduce arterial stiffness in hypertensive women and in untreated patients.	[Di Pilla, Marina; Bruno, Rosa Maria; Taddei, Stefano; Ghiadoni, Lorenzo] Univ Pisa, Dept Clin & Expt Med, Pisa, Italy; [Stea, Francesco] CNR, Inst Clin Physiol, Pisa, Italy; [Massetti, Luciano] CNR, Inst Biometeorol, Florence, Italy; [Modesti, Pietro Amedeo] Univ Florence, Dept Expt & Clin Med, Florence, Italy	University of Pisa; Consiglio Nazionale delle Ricerche (CNR); Istituto di Fisiologia Clinica (IFC-CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto di Biometeorologia (IBIMET-CNR); University of Florence	Di Pilla, M (corresponding author), Univ Pisa, Dept Clin & Expt Med, Pisa, Italy.	m.dipilla.md@gmail.com	Stefanadis, Christodoulos/ABH-2232-2020; Taddei, Stefano/AAB-2828-2019; Bruno, Rosa Maria/C-3594-2015; Massetti, Luciano/AAC-4653-2019; Modesti, Pietro Amedeo/B-2638-2012; Massetti, Luciano/O-3360-2015; Ghiadoni, Lorenzo/AAC-5176-2022	Stefanadis, Christodoulos/0000-0001-5974-6454; Bruno, Rosa Maria/0000-0002-6107-3356; Modesti, Pietro Amedeo/0000-0002-9511-2173; Massetti, Luciano/0000-0002-0941-5347; Ghiadoni, Lorenzo/0000-0002-7399-2720				AirBase, 2015, EUR AIR QUAL DAT; Analitis A, 2008, AM J EPIDEMIOL, V168, P1397, DOI 10.1093/aje/kwn266; Andrukhova O, 2014, MOL ENDOCRINOL, V28, P53, DOI 10.1210/me.2013-1252; Barath S, 2013, TOXICOL SCI, V135, P292, DOI 10.1093/toxsci/kft157; Beelen R, 2008, ENVIRON HEALTH PERSP, V116, P196, DOI 10.1289/ehp.10767; Ben-Shlomo Y, 2014, J AM COLL CARDIOL, V63, P636, DOI 10.1016/j.jacc.2013.09.063; Beveridge LA, 2015, JAMA INTERN MED, V175, P745, DOI 10.1001/jamainternmed.2015.0237; Brook RD, 2002, CIRCULATION, V105, P1534, DOI 10.1161/01.CIR.0000013838.94747.64; Brook RD, 2011, J CLIN HYPERTENS, V13, P881, DOI 10.1111/j.1751-7176.2011.00545.x; Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1; Bruno M, 2015, EUR HEART J, V36, P1152, DOI 10.1093/eurheartj/ehv024; Bruno RM, 2012, DIABETOLOGIA, V55, P1847, DOI 10.1007/s00125-012-2517-1; Bruno RM, 2013, J HYPERTENS, V31, P1456, DOI 10.1097/HJH.0b013e328360f773; Bruno RM, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00284; Carvalho LSF, 2015, ATHEROSCLEROSIS, V241, P729, DOI 10.1016/j.atherosclerosis.2015.06.034; Cheng XS, 2010, EUR J INTERN MED, V21, P164, DOI 10.1016/j.ejim.2010.03.001; Danet S, 1999, CIRCULATION, V100, pE11, DOI 10.1161/01.CIR.100.1.e1; Edwards DG, 2006, J APPL PHYSIOL, V100, P1210, DOI 10.1152/japplphysiol.01154.2005; Fedecostante M, 2012, J HYPERTENS, V30, P1392, DOI 10.1097/HJH.0b013e328354668a; Fortier C, 2017, HYPERTENSION, V69, P96, DOI 10.1161/HYPERTENSIONAHA.116.08409; Gavhed D, 2000, EUR J APPL PHYSIOL, V83, P449, DOI 10.1007/s004210000262; Ghiadoni L, 2009, CURR HYPERTENS REP, V11, P190, DOI 10.1007/s11906-009-0034-5; Giallauria F, 2012, J CLIN ENDOCR METAB, V97, P3717, DOI 10.1210/jc.2012-1584; Hamilton SL, 2008, ANN HUM BIOL, V35, P154, DOI 10.1080/03014460801908058; Kaess BM, 2012, JAMA-J AM MED ASSOC, V308, P875, DOI 10.1001/2012.jama.10503; Keatinge WR, 1997, LANCET, V349, P1341, DOI 10.1016/S0140-6736(96)12338-2; Laden F, 2006, AM J RESP CRIT CARE, V173, P667, DOI 10.1164/rccm.200503-443OC; Lenters V, 2010, EPIDEMIOLOGY, V21, P512, DOI 10.1097/EDE.0b013e3181dec3a7; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Lewington S, 2012, J HYPERTENS, V30, P1383, DOI 10.1097/HJH.0b013e32835465b5; Lundback M, 2009, PART FIBRE TOXICOL, V6, DOI 10.1186/1743-8977-6-7; Mancia G, 2013, J HYPERTENS, V31, P1281, DOI 10.1097/01.hjh.0000431740.32696.cc; Marti-Soler H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113500; Mehta AJ, 2014, AM J EPIDEMIOL, V179, P192, DOI 10.1093/aje/kwt271; Mercer JB, 2003, ENVIRON RES, V92, P8, DOI 10.1016/S0013-9351(02)00009-9; Modesti PA, 2013, HYPERTENSION, V61, P908, DOI 10.1161/HYPERTENSIONAHA.111.00315; Munzel T., 2016, EUR HEART J; Paffett ML, 2015, TOXICOL SCI, V146, P244, DOI 10.1093/toxsci/kfv093; Pope CA, 2002, JAMA-J AM MED ASSOC, V287, P1132, DOI 10.1001/jama.287.9.1132; Roman MJ, 2007, HYPERTENSION, V50, P197, DOI 10.1161/HYPERTENSIONAHA.107.089078; Rostand SG, 1997, HYPERTENSION, V30, P150, DOI 10.1161/01.HYP.30.2.150; Safar ME, 2000, CARDIOVASC RES, V46, P269, DOI 10.1016/S0008-6363(99)00426-5; Selander J, 2009, ENVIRON HEALTH PERSP, V117, P1713, DOI 10.1289/ehp.0900933; Swierblewska E, 2010, J HYPERTENS, V28, P979, DOI 10.1097/HJH.0b013e328336ed9a; Vlachopoulos C, 2010, EUR HEART J, V31, P1865, DOI 10.1093/eurheartj/ehq024; Yang L, 2015, EUR HEART J, V36, P1178, DOI 10.1093/eurheartj/ehv023; Ye XF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151119	47	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2017	12	2							e0172550	10.1371/journal.pone.0172550	http://dx.doi.org/10.1371/journal.pone.0172550			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5SX	28231259	Green Published, gold, Green Submitted			2022-12-27	WOS:000394682400054
J	Velten, J; Margraf, J				Velten, Julia; Margraf, Juergen			Satisfaction guaranteed? How individual, partner, and relationship factors impact sexual satisfaction within partnerships	PLOS ONE			English	Article							ERECTILE FUNCTION IIEF; FUNCTION INDEX FSFI; INTERNATIONAL INDEX; HETEROSEXUAL RELATIONSHIPS; DESIRE DISCREPANCY; MENTAL-HEALTH; WOMEN; LIFE; DYSFUNCTION; PREDICTORS	Within committed relationships, a wide range of factors may challenge or facilitate sexual satisfaction. The aim of this study was to clarify which individual, partner-,and partnership-related aspects of a sexual relationship are crucial for the prediction of sexual satisfaction. The study included data of a representative sample of 964 couples from the general population. The actor-partner interdependence model was used to estimate actor and partner effects. Overall, predictors explained 57% of outcome variance. Actor effects were found for sexual function, sexual distress, frequency of sexual activity, desire discrepancy, sexual initiative, sexual communication, sociosexual orientation, masturbation, and life satisfaction. Gender-specific partner effects were found for sexual function and sexual distress. Neither age, nor relationship duration were significant predictors. To deepen our understanding of sexual satisfaction, it is necessary to take quantitative and qualitative aspects of sexual relationships into account and to consider actor-,partner-, and relationship-related predictors.	[Velten, Julia; Margraf, Juergen] Ruhr Univ Bochum, Mental Hlth Res & Treatment Ctr, Bochum, Germany	Ruhr University Bochum	Velten, J (corresponding author), Ruhr Univ Bochum, Mental Hlth Res & Treatment Ctr, Bochum, Germany.	julia.velten@rub.de	Margraf, Jürgen/A-6873-2008; Velten, Julia/B-2297-2017	Margraf, Jürgen/0000-0001-5207-7016; Velten, Julia/0000-0002-6822-767X	Alexander von Humboldt Professorship	Alexander von Humboldt Professorship(Alexander von Humboldt Foundation)	We gratefully acknowledge funding by the Alexander von Humboldt Professorship awarded to Jurgen Margraf by the Alexander von Humboldt-Foundation	Adler NE, 1999, ANN NY ACAD SCI, V896, P3, DOI 10.1111/j.1749-6632.1999.tb08101.x; Althof SE, 2010, J SEX MED, V7, P203, DOI 10.1111/j.1743-6109.2009.01554.x; American Psychiatric Association, 2013, DIAGN STAT MAN MENT; Arrindell WA, 1999, PERS INDIV DIFFER, V26, P815, DOI 10.1016/S0191-8869(98)00180-9; Berner MM, 2004, GEBURTSH FRAUENHEILK, V64, P293; Brody S, 2009, J SEX MED, V6, P1947, DOI 10.1111/j.1743-6109.2009.01303.x; Byers ES, 2011, CAN PSYCHOL, V52, P20, DOI 10.1037/a0022048; Byers ES, 2005, J SEX RES, V42, P113, DOI 10.1080/00224490509552264; BYERS ES, 1989, J SEX RES, V26, P210, DOI 10.1080/00224498909551507; CALL V, 1995, J MARRIAGE FAM, V57, P639, DOI 10.2307/353919; CATANIA JA, 1989, J SEX RES, V26, P514, DOI 10.1080/00224498909551532; CHOI KH, 1994, AM J PUBLIC HEALTH, V84, P2003, DOI 10.2105/AJPH.84.12.2003; Cohen J.E., 1988, STAT POWER ANAL BEHA; Coleman E., 2002, J PSYCHOL HUMAN SEXU, V14, P5, DOI [10.1300/J056v14n02_02, DOI 10.1300/J056V14N02_02]; Cook WL, 2005, INT J BEHAV DEV, V29, P101, DOI 10.1080/01650250444000405; Davies S, 1999, ARCH SEX BEHAV, V28, P553, DOI 10.1023/A:1018721417683; Sanchez-Fuentes MD, 2014, INT J CLIN HLTH PSYC, V14, P67, DOI 10.1016/S1697-2600(14)70038-9; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Dundon CM, 2010, J SEX MED, V7, P896, DOI 10.1111/j.1743-6109.2009.01557.x; Forbes MK, 2014, J SEX RES, V51, P485, DOI 10.1080/00224499.2013.876607; Fugl-Meyer A.R., 1991, CLIN REHABIL, V5, P25, DOI [DOI 10.1177/026921559100500105, 10.1177/026921559100500105]; Heiman JR, 2011, ARCH SEX BEHAV, V40, P741, DOI 10.1007/s10508-010-9703-3; HURLBERT DF, 1993, J SEX MARITAL THER, V19, P41; Hurlbert DF, 1991, J SEX EDUC THER, V17, P272, DOI DOI 10.1080/01614576.1991.11074029; Kaestle CE, 2011, ARCH SEX BEHAV, V40, P983, DOI 10.1007/s10508-010-9722-0; Kenny D.A., 2015, INTERACTIVE TOOL EST; Kenny D. A., 2006, DYADIC DATA ANAL; Lau JTF, 2006, UROLOGY, V67, P579, DOI 10.1016/j.urology.2005.09.039; Laumann EO, 2005, INT J IMPOT RES, V17, P39, DOI 10.1038/sj.ijir.3901250; Lawrance KA, 1995, PERS RELATIONSHIP, V2, P267, DOI 10.1111/j.1475-6811.1995.tb00092.x; Lee David M, 2016, Arch Sex Behav, V45, P133, DOI 10.1007/s10508-014-0465-1; Lever J., 2006, PSYCHOL MEN MASC, V7, P129, DOI [10.1037/1524-9220.7.3.129, DOI 10.1037/1524-9220.7.3.129]; Mark KP, 2012, J SEX MARITAL THER, V38, P198, DOI 10.1080/0092623X.2011.606877; Meltzer AL, 2010, J FAM PSYCHOL, V24, P156, DOI 10.1037/a0019063; Molarius A, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-302; Pavot W., 2008, J POSIT PSYCHOL, V3, P137, DOI [10.1080/17439760701756946, DOI 10.1080/17439760701756946]; Pavot W, 2009, SOC INDIC RES SER, V39, P101, DOI 10.1007/978-90-481-2354-4_5; Penke L, 2008, J PERS SOC PSYCHOL, V95, P1113, DOI 10.1037/0022-3514.95.5.1113; R Core Team, 2021, R LANGUAGE ENV STAT; Rainer H, 2012, KYKLOS, V65, P581, DOI 10.1111/kykl.12007; Raudenbush S. W., 2002, HIERARCHICAL LINEAR, V1; Rehman US, 2011, J SEX MED, V8, P3108, DOI 10.1111/j.1743-6109.2011.02439.x; Rosen R, 2000, J SEX MARITAL THER, V26, P191, DOI 10.1080/009262300278597; Rosen RC, 2016, ARCH SEX BEHAV, V45, P159, DOI 10.1007/s10508-015-0568-3; Rosen RC, 1997, UROLOGY, V49, P822, DOI 10.1016/S0090-4295(97)00238-0; Rosen RC, 2002, INT J IMPOT RES, V14, P226, DOI 10.1038/sj.ijir.3900857; Safarinejad MR, 2009, J SEX MED, V6, P1645, DOI 10.1111/j.1743-6109.2009.01232.x; Sanchez-Fuentes MM, 2016, ARCH SEX BEHAV; Schmiedeberg C, 2015, ARCH SEX BEHAV, V45, P1; Schnarch D, 2000, PRINCIPLES AND PRACTICE OF SEX THERAPY, THIRD EDITION, P17; Schoenfeld EA, 2016, ARCH SEX BEHAV; SHIN DC, 1978, SOC INDIC RES, V5, P475, DOI 10.1007/BF00352944; SIMPSON JA, 1991, J PERS SOC PSYCHOL, V60, P870, DOI 10.1037/0022-3514.60.6.870; Smith AMA, 2012, INTERN MED J, V42, P641, DOI 10.1111/j.1445-5994.2011.02597.x; STARRELS ME, 1994, SEX ROLES, V31, P473, DOI 10.1007/BF01544202; Stulhofer A, 2014, SEX RELATSH THER, V29, P229, DOI 10.1080/14681994.2013.870335; Theiss JA, 2011, COMMUN RES, V38, P565, DOI 10.1177/0093650211402186; Tuinman MA, 2005, SUPPORT CARE CANCER, V13, P540, DOI 10.1007/s00520-004-0758-3; Wiederman MW, 1999, J SEX RES, V36, P59, DOI 10.1080/00224499909551968; Wiegel M, 2005, J SEX MARITAL THER, V31, P1, DOI 10.1080/00926230590475206; Willoughby BJ, 2014, ARCH SEX BEHAV, V43, P551, DOI 10.1007/s10508-013-0181-2; Wiltink J, 2003, INT J IMPOT RES, V15, P192, DOI 10.1038/sj.ijir.3900997; Yucel D, 2010, SOC SCI RES, V39, P725, DOI 10.1016/j.ssresearch.2009.09.002	63	68	69	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2017	12	2							e72855	10.1371/journal.pone.0172855	http://dx.doi.org/10.1371/journal.pone.0172855			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL5SX	28231314	Green Published, gold, Green Submitted			2022-12-27	WOS:000394682400081
J	Welvaert, M; Al-Ghattas, O; Cameron, M; Caley, P				Welvaert, Marijke; Al-Ghattas, Omar; Cameron, Mark; Caley, Peter			Limits of use of social media for monitoring biosecurity events	PLOS ONE			English	Article								Compared to applications that trigger massive information streams, like earthquakes and human disease epidemics, the data input for agricultural and environmental biosecurity events (ie. the introduction of unwanted exotic pests and pathogens), is expected to be sparse and less frequent. To investigate if Twitter data can be useful for the detection and monitoring of biosecurity events, we adopted a three-step process. First, we confirmed that sightings of two migratory species, the Bogong moth (Agrotis infusa) and the Common Koel (Eudynamys scolopaceus) are reported on Twitter. Second, we developed search queries to extract the relevant tweets for these species. The queries were based on either the taxonomic name, common name or keywords that are frequently used to describe the species (symptomatic or syndromic). Third, we validated the results using ground truth data. Our results indicate that the common name queries provided a reasonable number of tweets that were related to the ground truth data. The taxonomic query resulted in too small datasets, while the symptomatic queries resulted in large datasets, but with highly variable signal-to-noise ratios. No clear relationship was observed between the tweets from the symptomatic queries and the ground truth data. Comparing the results for the two species showed that the level of familiarity with the species plays a major role. The more familiar the species, the more stable and reliable the Twitter data. This clearly presents a problem for using social media to detect the arrival of an exotic organism of biosecurity concern for which public is unfamiliar.	[Welvaert, Marijke; Al-Ghattas, Omar; Cameron, Mark; Caley, Peter] CSIRO, Canberra, ACT, Australia; [Welvaert, Marijke; Caley, Peter] Plant Biosecur Cooperat Res Ctr, Canberra, ACT, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Caley, P (corresponding author), CSIRO, Canberra, ACT, Australia.; Caley, P (corresponding author), Plant Biosecur Cooperat Res Ctr, Canberra, ACT, Australia.	Peter.Caley@csiro.au	Caley, Peter/D-8638-2011; Welvaert, Marijke/GOE-6151-2022; Welvaert, Marijke/K-8486-2013	Caley, Peter/0000-0002-8077-6460; Welvaert, Marijke/0000-0002-0802-8134	the Australian Government's Cooperative Research Centres Program (Plant Biosecurity CRC Project) [1029]	the Australian Government's Cooperative Research Centres Program (Plant Biosecurity CRC Project)	The research in this paper was supported by the Australian Government's Cooperative Research Centres Program (Plant Biosecurity CRC Project 1029). Omar Al-Ghattas received a CSIRO Summer Vacation Scholarship to perform his contribution.; The research in this paper was supported by the Australian Government's Cooperative Research Centres Program (Project CRC 1029, Plant Biosecurity CRC). Omar Al-Ghattas received a CSIRO Summer Vacation Scholarship to perform part of this work. Members of the Canberra Ornithologists Groups assisted with data retrieval. Staff from the ACT Parks and Conservation Service assisted with access to Mount Gingera. Thanks to Ross Sparks, Rieks Van Klinken and Nolan Phillips for their comments on earlier drafts of this paper.	[Anonymous], 2013, CANBERRA TIMES; BARNARD GA, 1959, J ROY STAT SOC B, V21, P239; Birds in Backyards, 2015, E KOEL; Bouchet-Valat M, 2014, SNOWBALLC SNOWBALL S; Broniatowski DA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083672; Cameron M. A., 2012, P 21 INT C WORLD WID, P695, DOI DOI 10.1145/2187980.2188183; Canberra Ornithologists Group, 2015, GARD BIRD SURV; COMMON IFB, 1954, AUST J ZOOL, V2, P223, DOI 10.1071/ZO9540223; Cox L, 2014, LIBERALS ENV SPOKESW; Evershed N, 2013, MOTHS MOVE ANN BOGON; Eysenbach Gunther, 2006, AMIA Annu Symp Proc, P244; Feinerer I, 2008, J STAT SOFTW, V25, P1; Fitzhugh SM, 2016, SOC SCI RES, V59, P137, DOI 10.1016/j.ssresearch.2016.04.023; FLOOD JM, 1996, MOTH HUNTERS AUSTR C; Froud KJ, 2008, PASSIVE SURVEILLANCE, P97; Griffiths E, 2013, PLAGUE BOTH HOUSES S; Jarrad FC, 2011, BIOL INVASIONS, V13, P803, DOI 10.1007/s10530-010-9870-0; Lampos V, 2010, LECT NOTES ARTIF INT, V6323, P599, DOI 10.1007/978-3-642-15939-8_42; Lazer D, 2014, SCIENCE, V345, P148, DOI 10.1126/science.345.6193.148-b; Lazer D, 2014, SCIENCE, V343, P1203, DOI 10.1126/science.1248506; MacIntyre CR, 2016, SOCIAL MEDIA TRACKIN; PAGE ES, 1954, BIOMETRIKA, V41, P100, DOI 10.1093/biomet/41.1-2.100; Power R, 2014, EMERGENCY SITUATION, P218; R Core Team, 2013, R LANG ENV STAT COMP; Robbins M, 2011, J TIME SER ANAL, V32, P498, DOI 10.1111/j.1467-9892.2010.00707.x; Scrucca L., 2004, R NEWS, V4, P11; Sosin Daniel M, 2003, Biosecur Bioterror, V1, P247, DOI 10.1089/153871303771861441; Sutton J.N., 2008, P 5 INT ISCRAM C WAS, P624; Welvaert M, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-3583-5; Westcott B, 2014, BOGONG MOTH NUMBERS	30	6	7	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2017	12	2							e0172457	10.1371/journal.pone.0172457	http://dx.doi.org/10.1371/journal.pone.0172457			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5SX	28231339	Green Published, Green Submitted, gold			2022-12-27	WOS:000394682400045
J	Dumaidi, K; Al-Jawabreh, A				Dumaidi, Kamal; Al-Jawabreh, Amer			Molecular detection and genotyping of enteroviruses from CSF samples of patients with suspected sepsis-like illness and/or aseptic meningitis from 2012 to 2015 in West Bank, Palestine	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; CENTRAL-NERVOUS-SYSTEM; CEREBROSPINAL-FLUID; INFECTIONS; DIAGNOSIS; OUTBREAK; IDENTIFICATION; PLEOCYTOSIS; CHILDREN; INFANTS	Background Human enteroviruses (HEVs) are the most frequently reported cause of aseptic meningitis with or without CSF pleocytosis in childhood. Rapid detection and genotype of HEVs is essential to determine the causative agent and variant causing sepsis-like illness and/or aseptic meningitis. Aim To investigate the molecular epidemiology of enteroviruses (EVs) among patients with sepsis- like illness and/or aseptic meningitis admitted to three major hospitals in West Bank, Palestine from 2012 to 2015. Methods During the study period, 356 CSF samples were collected from patients with sepsis-like illness and/or aseptic meningitis. Two RT-nested PCR assays targeting a partial part of 5' UTR for direct diagnosis and the VP1 region for genotyping by sequence analysis of the viral genome were used. Results HEV RNA was detected in 66 of 356 (18.5%) of CSF samples. Age distribution showed that 64% (42/66) were infants (<1 year), 18% were children between 1 and 5 years old, 12% were children between 5 and 10 years old, and 6% were more than 10 years old. Of the 66 EV cases, 12 were successfully genotyped. Five different EV genotypes were identified. All of them belonged to HEV-B species. The study showed that echovirus 6 genotype accounted for 42% of the sequenced cases. The HEV infections in the present study tended to show slight seasonal pattern with more cases occurring during spring and summer, yet still significant numbers were also reported in fall and winter seasons. Conclusion HEV was isolated from a significant number of children with sepsis-like illness and/or aseptic meningitis. In addition, the molecular method utilized for direct diagnosis and genotyping of HEV from CSF revealed that more than one HEV type circulated in the West Bank, Palestine during the study period.	[Dumaidi, Kamal; Al-Jawabreh, Amer] Arab Amer Univ Jenin, Fac Allied Hlth Sci, Dept Med Lab Sci, Jenin, Palestine; [Al-Jawabreh, Amer] Al Quds Publ Hlth Soc, Jerusalem, Palestine	Arab American University	Dumaidi, K (corresponding author), Arab Amer Univ Jenin, Fac Allied Hlth Sci, Dept Med Lab Sci, Jenin, Palestine.	kamal.dumaidi@aauj.edu	Al-Jawabreh, Amer/I-9960-2019	Al-Jawabreh, Amer/0000-0001-5929-8743; Dumaidi, Kamal/0000-0002-7299-9736				Bahri O, 2005, J MED MICROBIOL, V54, P63, DOI 10.1099/jmm.0.45695-0; Bailly JL, 2002, J MED VIROL, V68, P558, DOI 10.1002/jmv.10235; Brunel D, 2008, J CLIN VIROL, V42, P225, DOI 10.1016/j.jcv.2008.02.008; Casas I, 2001, J MED VIROL, V65, P138, DOI 10.1002/jmv.2013; Chen P, 2013, J MED VIROL, V85, P483, DOI 10.1002/jmv.23478; Dalwai A, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-236; Guney C, 2003, DIAGN MICR INFEC DIS, V47, P557, DOI 10.1016/S0732-8893(03)00148-2; Ishiko H, 2002, J INFECT DIS, V185, P744, DOI 10.1086/339298; Kadambari S, 2014, CLIN MICROBIOL INFEC, V20, P1289, DOI 10.1111/1469-0691.12753; Khetsuriani N., 2006, MMWR SURVEILL SUMM; Kim HJ, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-38; Knowles NJ, 2012, VIRUS TAXONOMY CLASS; Krasota A, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8010010; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Kupila L, 2005, CLIN INFECT DIS, V40, P982, DOI 10.1086/428581; Lee BE, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-68; Markey PG, 2010, EMERG INFECT DIS, V16, P63, DOI 10.3201/eid1601.081519; Melnick J.L, 1996, FIELDS VIROLOGY; Meqdam MM, 2002, J MED VIROL, V66, P224, DOI 10.1002/jmv.2133; Mirand A, 2008, J CLIN MICROBIOL, V46, P87, DOI 10.1128/JCM.01020-07; Nix WA, 2006, J CLIN MICROBIOL, V44, P2698, DOI 10.1128/JCM.00542-06; Nougairede A, 2014, J CLIN VIROL, V61, P118, DOI 10.1016/j.jcv.2014.05.022; Oberste MS, 1999, J CLIN MICROBIOL, V37, P1288, DOI 10.1128/JCM.37.5.1288-1293.1999; Palestinian Ministry of Health, 2015, ANN HLTH REP PAL 200; Papadakis G, 2014, J MED VIROL, V86, P1609, DOI 10.1002/jmv.23885; Rotbart Harley A., 1995, P271; SAWYER MH, 1994, PEDIATR INFECT DIS J, V13, P177, DOI 10.1097/00006454-199403000-00002; Seiden JA, 2010, PEDIATR EMERG CARE, V26, P77, DOI 10.1097/PEC.0b013e3181ce2fad; Shahroodi MJG, 2016, JUNDISHAPUR J MICROB, V9, DOI 10.5812/jjm.19955; Siafakas N, 2011, MOL CELL PROBE, V25, P249, DOI 10.1016/j.mcp.2011.06.001; Tao ZX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089766; Thoelen I, 2003, J MED VIROL, V70, P420, DOI 10.1002/jmv.10412; Trallero G, 2000, EPIDEMIOL INFECT, V124, P497, DOI 10.1017/S0950268899003726; Wolfaardt M, 2014, J CLIN VIROL, V61, P400, DOI 10.1016/j.jcv.2014.08.001; Yun KW, 2012, ARCH DIS CHILD, V97, P874, DOI 10.1136/archdischild-2012-301884	35	14	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2017	12	2							e0172357	10.1371/journal.pone.0172357	http://dx.doi.org/10.1371/journal.pone.0172357			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5SK	28225788	gold, Green Published, Green Submitted			2022-12-27	WOS:000394680900036
J	Laakkonen, EK; Kulmala, J; Aukee, P; Hakonen, H; Kujala, UM; Lowe, DA; Kovanen, V; Tammelin, T; Sipila, S				Laakkonen, Eija K.; Kulmala, Janne; Aukee, Pauliina; Hakonen, Harto; Kujala, Urho M.; Lowe, Dawn A.; Kovanen, Vuokko; Tammelin, Tuija; Sipila, Sarianna			Female reproductive factors are associated with objectively measured physical activity in middle-aged women	PLOS ONE			English	Article							URINARY-INCONTINENCE; SPORTS; ADULTS; VALIDATION; EXERCISE; BEHAVIOR	Physical activity improves health and may delay the onset of several chronic diseases. For women in particular, the rate of these diseases accelerates at middle age; therefore it is important to identify the determinants of health-enhancing physical activity during midlife in this population. In this study, we focused on determinants that are unique to the female sex, such as childbearing and menopause. The main objective was to characterize the level of physical activity and differences between active and inactive middle-aged Finnish women. In addition, we examined the association of physical activity with female reproductive factors at midlife. The study population consisted of 647 women aged 48 to 55 years who participated in our Estrogenic Regulation of Muscle Apoptosis (ERMA) study during the period from 2015 to 2016. Physical activity was measured objectively using hip-worn accelerometers for seven consecutive days. The outcome measures included the amounts of light intensity physical activity and moderate to vigorous intensity physical activity accumulated in bouts of at least 10 minutes (MVPA(10)). MVPA(10) was used to determine whether women were placed in the active (>= 150 min/week) or inactive (<150 min/week) group. Multiple linear regression models were performed with physical activity measures as dependent variables and cumulative reproductive history index, menopausal symptoms, and pelvic floor dysfunction as independent variables. We found that a large portion (61%) of Finnish middle-aged women did not meet the physical activity recommendations of 150 minutes of MVPA(10) per week. In the studied cohort, 78% of women experienced menopausal symptoms, and 54% exhibited pelvic floor dysfunction. Perceived menopausal symptoms were associated with greater light physical activity. Perceived pelvic floor dysfunction was associated with lower MVPA(10). According to the fully adjusted multiple linear regression models, reproductive factors explained 6.0% of the variation of MVPA(10) and 7.5% of the variation of light physical activity. The results increase our knowledge of the factors related to physical activity participation among middle-aged women and indicate that menopausal symptoms and pelvic floor dysfunction should be identified and considered when promoting physical activity for women during midlife. The results emphasize that awareness of female reproductive factors, especially menopausal symptoms and pelvic floor dysfunction, is important for physical activity counseling to effectively help women in performing and sustaining health-enhancing amounts of physical activity. Specifically, the condition of the pelvic floor should be taken into account when identifying the proper activity type and intensity level so that health benefits of physical activity can still be attained without worsening symptoms.	[Laakkonen, Eija K.; Sipila, Sarianna] Univ Jyvaskyla, Fac Sport & Hlth Sci, Gerontol Res Ctr, Jyvaskyla, Finland; [Laakkonen, Eija K.; Lowe, Dawn A.] Univ Minnesota, Sch Med, Div Rehabil Sci, Dept Rehabil Med, Minneapolis, MN 55455 USA; [Laakkonen, Eija K.; Lowe, Dawn A.] Univ Minnesota, Sch Med, Div Phys Therapy, Dept Rehabil Med, Minneapolis, MN 55455 USA; [Kulmala, Janne; Hakonen, Harto; Tammelin, Tuija] LIKES Res Ctr Phys Act & Hlth, Jyvaskyla, Finland; [Aukee, Pauliina] Cent Finland Cent Hosp, Pelv Floor Res & Therapy Unit, Dept Obstet & Gynecol, Jyvaskyla, Finland; [Kujala, Urho M.; Kovanen, Vuokko] Univ Jyvaskyla, Fac Sport & Hlth Sci, Jyvaskyla, Finland	University of Jyvaskyla; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Central Finland Central Hospital; University of Jyvaskyla	Laakkonen, EK (corresponding author), Univ Jyvaskyla, Fac Sport & Hlth Sci, Gerontol Res Ctr, Jyvaskyla, Finland.	eija.pollanen@jyu.fi	Laakkonen, Eija/G-3345-2017; Kujala, Urho/AAP-2547-2020	Laakkonen, Eija/0000-0001-6655-9489; Lowe, Dawn/0000-0002-5784-9289; Kujala, Urho/0000-0002-9262-1992; Sipila, Sarianna/0000-0001-5934-7728	Academy of Finland (VK); Juho Vainio's Foundation (EKL); NATIONAL INSTITUTE ON AGING [R01AG031743] Funding Source: NIH RePORTER	Academy of Finland (VK); Juho Vainio's Foundation (EKL); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was funded by Academy of Finland (VK) and Juho Vainio's Foundation (EKL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauman AE, 2012, LANCET, V380, P258, DOI 10.1016/S0140-6736(12)60735-1; Bennie JA, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2736-3; Blumel JE, 2016, MENOPAUSE, V23, P488, DOI 10.1097/GME.0000000000000575; Bo K, 2004, SPORTS MED, V34, P451; Boyer WR, 2016, PREV CHRONIC DIS, V13, DOI 10.5888/pcd13.160159; Brandao S, 2015, J SPORT MED PHYS FIT, V55, P1272; Brown WJ, 2001, J SCI MED SPORT, V4, P373, DOI 10.1016/S1440-2440(01)80046-3; Buss L, 2006, ACTA OBSTET GYN SCAN, V85, P467, DOI 10.1080/00016340500494887; Cao X, 2015, BMC CARDIOVASC DISOR, V15, DOI 10.1186/s12872-015-0172-4; Da Roza T, 2015, CLIN J SPORT MED, V25, P270, DOI 10.1097/JSM.0000000000000129; Daley A, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006108.pub4; Devore EE, 2013, AM J OBSTET GYNECOL, V209, DOI 10.1016/j.ajog.2013.05.002; Gillen JB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154075; Grindler NM, 2015, MENOPAUSE, V22, P1351, DOI 10.1097/GME.0000000000000536; Hallal PC, 2012, LANCET, V380, P247, DOI 10.1016/S0140-6736(12)60646-1; Harlow SD, 2012, CLIMACTERIC, V15, P105, DOI [10.3109/13697137.2011.650656, 10.1016/j.fertnstert.2012.01.128, 10.1210/jc.2011-3362, 10.1097/gme.0b013e31824d8f40]; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI [10.1249/mss.0b013e3180616b27, 10.1161/CIRCULATIONAHA.107.185649]; Heil DP, 2012, MED SCI SPORT EXER, V44, pS50, DOI 10.1249/MSS.0b013e3182399dcc; Im EO, 2008, JOGNN-J OBST GYN NEO, V37, P203, DOI 10.1111/j.1552-6909.2008.00219.x; Kari JT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135651; Kleinbaum D.G, 1988, APPL REGRESSION ANAL; Lee IM, 2012, LANCET, V380, P219, DOI 10.1016/S0140-6736(12)61031-9; Lee PH, 2013, GAIT POSTURE, V38, P912, DOI 10.1016/j.gaitpost.2013.04.018; Matthews CE, 2016, AM J CLIN NUTR, V104, P1424, DOI 10.3945/ajcn.116.135129; Mesters I, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-647; Moilanen J, 2010, MATURITAS, V67, P368, DOI 10.1016/j.maturitas.2010.08.007; Newman DK, 2013, CURR OPIN OBSTET GYN, V25, P388, DOI 10.1097/GCO.0b013e328364a35d; Nygaard IE, 2016, AM J OBSTET GYNECOL, V214, P164, DOI 10.1016/j.ajog.2015.08.067; Nygaard IE, 2015, AM J OBSTET GYNECOL, V213, DOI 10.1016/j.ajog.2015.01.044; Nygaard IE, 2014, AM J OBSTET GYNECOL, V210, DOI 10.1016/j.ajog.2014.01.035; Pan SY, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-21; Pedersen BK, 2006, SCAND J MED SCI SPOR, V16, P3, DOI 10.1111/j.1600-0838.2006.00520.x; Sasaki JE, 2011, J SCI MED SPORT, V14, P411, DOI 10.1016/j.jsams.2011.04.003; Steindorf K, 2010, PUBLIC HEALTH NUTR, V13, P1905, DOI 10.1017/S1368980010001965; Sussman M, 2015, BMC WOMENS HEALTH, V15, DOI 10.1186/s12905-015-0217-y; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; Wanner M, 2016, INT J OBES LOND; WHO, 2010, GLOB REC PHYS ACT HL, V1st, P15; Woods Nancy Fugate, 2005, Am J Med, V118 Suppl 12B, P14; World Health Organization, 2011, WHO EC PROJECT ON MO	40	18	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2017	12	2							e0172054	10.1371/journal.pone.0172054	http://dx.doi.org/10.1371/journal.pone.0172054			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5SK	28225786	Green Published, gold, Green Submitted			2022-12-27	WOS:000394680900028
J	Lown, M; Fuller, R; Lightowler, H; Fraser, A; Gallagher, A; Stuart, B; Byrne, C; Lewith, G				Lown, Mark; Fuller, Richard; Lightowler, Helen; Fraser, Ann; Gallagher, Andrew; Stuart, Beth; Byrne, Christopher; Lewith, George			Mulberry-extract improves glucose tolerance and decreases insulin concentrations in normoglycaemic adults: Results of a randomised double-blind placebo-controlled study	PLOS ONE			English	Article							POSTPRANDIAL BLOOD-GLUCOSE; LEAF EXTRACT; MORUS-ALBA; 1-DEOXYNOJIRIMYCIN; LEAVES; FOOD; HYPERGLYCEMIA; SUPPRESSES; MEDICINES; HUMANS	Background High sugar and refined carbohydrate intake is associated with weight gain, increased incidence of diabetes and is linked with increased cardiovascular mortality. Reducing the health impact of poor quality carbohydrate intake is a public health priority. Reducose, a proprietary mulberry leaf extract (ME), may reduce blood glucose responses following dietary carbohydrate intake by reducing absorption of glucose from the gut. Methods A double-blind, randomised, repeat measure, phase 2 crossover design was used to study the glycaemic and insulinaemic response to one reference product and three test products at the Functional Food Centre, Oxford Brooks University, UK. Participants; 37 adults aged 19-59 years with a BMI >= 20kg/m(2) and <= 30kg/m(2). The objective was to determine the effect of three doses of mulberry-extract (Reducose) versus placebo on blood glucose and insulin responses when co-administered with 50g maltodextrin in normoglycaemic healthy adults. We also report the gastrointestinal tolerability of the mulberry extract. Results Thirty-seven participants completed the study: The difference in the positive Incremental Area Under the Curve (pIAUC) (glucose (mmol /L x h)) for half, normal and double dose ME compared with placebo was -6.1% (-18.2%, 5.9%; p = 0.316), -14.0% (-26.0%, -2.0%; p = 0.022) and -22.0% (-33.9%, -10.0%; p< 0.001) respectively. The difference in the pIAUC insulin (mIU/L x h)) for half, normal and double dose ME compared with placebo was -9.7% (-25.8%, 6.3%; p = 0.234), -23.8% (-39.9%, -7.8%; p = 0.004) and -24.7% (-40.8%, -8.6%; p = 0.003) respectively. There were no statistically significant differences between any of the 4 groups in the odds of experiencing one or more gastrointestinal symptoms (nausea, abdominal cramping, distension or flatulence). Conclusions Mulberry leaf extract significantly reduces total blood glucose rise after ingestion of maltodextrin over 120 minutes. The pattern of effect demonstrates a classical dose response curve with significant effects over placebo. Importantly, total insulin rises were also significantly suppressed over the same time-period. There were no statistically significant differences between any of the treatment groups (including placebo) in the odds of experiencing one or more gastrointestinal symptoms. Mulberry extract may have multiple modes of action and further studies are necessary to evaluate ME as a potential target for the prevention of type 2 diabetes and the regulation of dysglycaemia.	[Lown, Mark; Fuller, Richard; Stuart, Beth; Lewith, George] Univ Southampton, Fac Med, Primary Care & Populat Sci, Aldermoor Hlth Ctr, Southampton, Hants, England; [Lightowler, Helen; Fraser, Ann] Oxford Brooks Univ, Funct Food Ctr, Oxford, England; [Gallagher, Andrew] Phynova Grp Ltd, Long Hanborough, England; [Byrne, Christopher] Univ Southampton, Fac Med, Nutr & Metab, Southampton, Hants, England; [Byrne, Christopher] Southampton Univ Hosp, Southampton, Hants, England; [Byrne, Christopher] Southampton Univ Hosp, Biomed Res Ctr, Southampton Natl Inst Hlth Res, Southampton, Hants, England	University of Southampton; University of Southampton; University of Southampton; University of Southampton	Lown, M (corresponding author), Univ Southampton, Fac Med, Primary Care & Populat Sci, Aldermoor Hlth Ctr, Southampton, Hants, England.	m.lown@soton.ac.uk	Capel, Helen/AAC-8818-2022	Gallagher, Andrew/0000-0002-5974-4093; Stuart, Beth/0000-0001-5432-7437; Byrne, Christopher D/0000-0001-6322-7753; Lown, Mark/0000-0001-8309-568X	Technology Strategy Board/Innovate UK grant [101726]; Southampton National Institute for Health Research Biomedical Research Centre; National Institute for Health Research [CL-2014-26-004(1)] Funding Source: researchfish	Technology Strategy Board/Innovate UK grant; Southampton National Institute for Health Research Biomedical Research Centre; National Institute for Health Research(National Institute for Health Research (NIHR))	The work has been funded by a Technology Strategy Board/Innovate UK grant (101726). CB is supported in part by the Southampton National Institute for Health Research Biomedical Research Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The work has been funded by a Technology Strategy Board/Innovate UK grant.; CDB is supported in part by the Southampton National Institute for Health Research Biomedical Research Centre.	Andallu B, 2001, CLIN CHIM ACTA, V314, P47, DOI 10.1016/S0009-8981(01)00632-5; BAILEY CJ, 1989, DIABETES CARE, V12, P553, DOI 10.2337/diacare.12.8.553; Banu S, 2015, SAUDI J BIOL SCI, V22, P32, DOI 10.1016/j.sjbs.2014.04.005; Basu S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057873; Bensky D, 1993, CHINESE HERBAL MED M; Brouns F, 2005, NUTR RES REV, V18, P145, DOI 10.1079/NRR2005100; Chau CF, 2006, TRENDS FOOD SCI TECH, V17, P313, DOI 10.1016/j.tifs.2005.12.005; DeFronzo RA, 2011, DIABETES CARE, V34, pS202, DOI 10.2337/dc11-s221; Feinman RD, 2015, NUTRITION, V31, P1, DOI 10.1016/j.nut.2014.06.011; Glube Natalie, 2013, Results Pharma Sci, V3, P1, DOI 10.1016/j.rinphs.2013.08.002; HotherNielsen O, 1996, METABOLISM, V45, P82, DOI 10.1016/S0026-0495(96)90204-8; Kimura T, 2007, J AGR FOOD CHEM, V55, P5869, DOI 10.1021/jf062680g; Kojima Y, 2010, J CLIN BIOCHEM NUTR, V47, P155, DOI 10.3164/jcbn.10-53; Lown M, 2015, TRIALS, V16, DOI 10.1186/s13063-015-0997-2; Ma X, 2009, J ETHNOPHARMACOL, V122, P54, DOI 10.1016/j.jep.2008.11.022; Malhotra A., 2015, BR J SPORTS MED; Miura T, 1998, J NUTR SCI VITAMINOL, V44, P371, DOI 10.3177/jnsv.44.371; Monnier L, 2006, JAMA-J AM MED ASSOC, V295, P1681, DOI 10.1001/jama.295.14.1681; Morenga LT, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.e7492; Mudra M, 2007, DIABETES CARE, V30, P1272, DOI 10.2337/dc06-2120; Nakagawa K, 2007, J AGR FOOD CHEM, V55, P8928, DOI 10.1021/jf071559m; Nakamura M, 2009, NUTR METAB, V6, DOI 10.1186/1743-7075-6-29; Naowaboot J, 2012, AM J CHINESE MED, V40, P163, DOI 10.1142/S0192415X12500139; National Institute for Health and Care Excellence, 2011, NICE GUID PH35 PREV; National Institute for Health and Care Excellence, 2006, NICE GUID CG43 OB GU; National Institute for Health and Care Excellence, 2012, NICE GUID PH 38 PREV; Oku T, 2006, BRIT J NUTR, V95, P933, DOI 10.1079/BJN20061746; Romaguera D, 2013, DIABETOLOGIA, V56, P1520, DOI 10.1007/s00125-013-2899-8; Schwartz S, 2006, DIABETES CARE, V29, P759, DOI 10.2337/diacare.29.04.06.dc05-1967; Srivastava S, 2003, INT J FOOD SCI NUTR, V54, P411, DOI 10.1080/09637480310001622288; THIEBAUD D, 1982, DIABETES, V31, P957, DOI 10.2337/diacare.31.11.957; Velasquez-Mieyer PA, 2003, INT J OBESITY, V27, P219, DOI 10.1038/sj.ijo.802227; Wu T, 2013, FOOD CHEM, V141, P482, DOI 10.1016/j.foodchem.2013.03.046	33	26	27	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2017	12	2							e0172239	10.1371/journal.pone.0172239	http://dx.doi.org/10.1371/journal.pone.0172239			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5SK	28225835	Green Accepted, Green Published, gold			2022-12-27	WOS:000394680900032
J	Mills, MG; Gallagher, EP				Mills, Margaret G.; Gallagher, Evan P.			A targeted gene expression platform allows for rapid analysis of chemical-induced antioxidant mRNA expression in zebrafish larvae	PLOS ONE			English	Article							GLUTATHIONE-S-TRANSFERASE; INDUCED OXIDATIVE STRESS; COHO SALMON; DEVELOPMENTAL TOXICOLOGY; INDUCIBLE EXPRESSION; RESPONSIVE ELEMENT; AQUATIC ORGANISMS; OLFACTORY SYSTEM; FREE-RADICALS; DANIO-RERIO	Chemical-induced oxidative stress and the biochemical pathways that protect against oxidative damage are of particular interest in the field of toxicology. To rapidly identify oxidative stress-responsive gene expression changes in zebrafish, we developed a targeted panel of antioxidant genes using the Affymetrix QuantiGene Plex ( QGP) platform. The genes contained in our panel include eight putative Nrf2 ( Nfe2l2a)-dependent antioxidant genes ( hmox1a, gstp1, gclc, nqo1, prdx1, gpx1a, sod1, sod2), a stress response gene ( hsp70), an inducible DNA damage repair gene ( gadd45bb), and three reference genes ( actb1, gapdh, hprt1). We tested this platform on larval zebrafish exposed to tert-butyl hydroperoxide ( tBHP) and cadmium ( Cd), two model oxidative stressors with different modes of action, and compared our results with those obtained using the more common quantitative PCR ( qPCR) method. Both methods showed that exposure to tBHP and Cd induced expression of prdx1, gstp1, and hmox1a ( 2-to 12-fold increase via QGP), indicative of an activated Nrf2 response in larval zebrafish. Both compounds also elicited a general stress response as reflected by elevation of hsp70 and gadd45bb, with Cd being the more potent inducer. Transient changes were observed in sod2 and gpx1a expression, whereas nqo1, an Nrf2-responsive gene in mammalian cells, was minimally affected by either tBHP or Cd chemical exposures. Developmental expression analysis of the target genes by QGP revealed marked upregulation of sod2 between 0-96hpf, and to a lesser extent, of sod1 and gstp1. Once optimized, QGP analysis of these experiments was accomplished more rapidly, using far less tissue, and at lower total costs than qPCR analysis. In summary, the QGP platform as applied to higher-throughput zebrafish studies provides a reasonable cost-effective alternative to qPCR or more comprehensive transcriptomics approaches to rapidly assess the potential for chemicals to elicit oxidative stress as a mechanism of chemical toxicity.	[Mills, Margaret G.; Gallagher, Evan P.] Univ Washington, Sch Publ Hlth, Dept Environm & Occupat Hlth Sci, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Gallagher, EP (corresponding author), Univ Washington, Sch Publ Hlth, Dept Environm & Occupat Hlth Sci, Seattle, WA 98195 USA.	evang3@uw.edu			U.S. National Science Foundation [CHE-1339637]; U.S. National Institutes of Health [P42-ES004696]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES007033, P42ES004696] Funding Source: NIH RePORTER	U.S. National Science Foundation(National Science Foundation (NSF)); U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Support for this study was provided to EG by the U.S. National Science Foundation [https://www.nsf.gov/] (CHE-1339637, the Molecular Design Research Network) and by the U.S. National Institutes of Health [https://www.nih.gov/] Superfund Research Program (P42-ES004696). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ball JS, 2014, TOXICOL SCI, V139, P210, DOI 10.1093/toxsci/kfu017; BENSON AM, 1980, P NATL ACAD SCI-BIOL, V77, P5216, DOI 10.1073/pnas.77.9.5216; Blechinger SR, 2007, TOXICOL APPL PHARM, V224, P72, DOI 10.1016/j.taap.2007.06.025; Blechinger SR, 2002, ENVIRON HEALTH PERSP, V110, P1041, DOI 10.1289/ehp.021101041; Bustin SA, 2013, NAT METHODS, V10, P1063, DOI 10.1038/nmeth.2697; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Calabrese V, 2010, ANTIOXID REDOX SIGN, V13, P1763, DOI 10.1089/ars.2009.3074; Canning P, 2015, FREE RADICAL BIO MED, V88, P101, DOI 10.1016/j.freeradbiomed.2015.05.034; Corrales J, 2016, CHEM RES TOXICOLOGY; Dell'Orco M, 2016, BBA-GENE REGUL MECH, V1859, P315, DOI 10.1016/j.bbagrm.2015.11.009; Espinoza HM, 2012, AQUAT TOXICOL, V110, P37, DOI 10.1016/j.aquatox.2011.12.012; Fischer BM, 2015, ARCH TOXICOL, P1; Flagella M, 2006, ANAL BIOCHEM, V352, P50, DOI 10.1016/j.ab.2006.02.013; FRILING RS, 1990, P NATL ACAD SCI USA, V87, P6258, DOI 10.1073/pnas.87.16.6258; Gupta SC, 2012, ANTIOXID REDOX SIGN, V16, P1295, DOI 10.1089/ars.2011.4414; Hahn ME, 2015, FREE RADICAL BIO MED, V88, P275, DOI 10.1016/j.freeradbiomed.2015.06.022; Hahn ME, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113158; Hall JS, 2015, J MOL DIAGN, V17, P402, DOI 10.1016/j.jmoldx.2015.03.010; Hayes JD, 2010, ANTIOXID REDOX SIGN, V13, P1713, DOI 10.1089/ars.2010.3221; Hu JJ, 2015, J AM CHEM SOC, V137, P6837, DOI 10.1021/jacs.5b01881; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Itoh K, 2003, GENES CELLS, V8, P379, DOI 10.1046/j.1365-2443.2003.00640.x; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; Jaiswal AK, 2004, FREE RADICAL BIO MED, V36, P1199, DOI 10.1016/j.freeradbiomed.2004.02.074; Johnson DA, 2015, FREE RADICAL BIO MED, V88, P253, DOI 10.1016/j.freeradbiomed.2015.07.147; Kaur P, 2006, REPROD TOXICOL, V22, P479, DOI 10.1016/j.reprotox.2006.03.017; Khedoe PPSJ, 2016, AM J PHYSL LUNG CELL; Kim Hyun Soo, 2015, J Cancer Prev, V20, P232, DOI 10.15430/JCP.2015.20.4.232; Kobayashi M, 2002, GENES CELLS, V7, P807, DOI 10.1046/j.1365-2443.2002.00561.x; Lagana AS, 2016, INT J FERTIL STERIL, V9, P416; Lambert MJ, 2015, GENOME RES, V25, P624, DOI 10.1101/gr.184473.114; Lambert MJ, 2014, GENE, V546, P271, DOI 10.1016/j.gene.2014.05.068; Larsen MK, 2016, MEDICINA-LITHUANIA, V52, P19, DOI 10.1016/j.medici.2016.01.005; Truong L, 2014, TOXICOL SCI, V137, P212, DOI 10.1093/toxsci/kft235; Liu J, 2009, TOXICOL APPL PHARM, V238, P209, DOI 10.1016/j.taap.2009.01.029; Liu J, 2012, DNA REPAIR, V11, P167, DOI 10.1016/j.dnarep.2011.10.016; Liu X, 2016, BBA-MOL CELL RES, V1863, P2093, DOI 10.1016/j.bbamcr.2016.05.009; Lu JG, 2010, MOL GENET GENOMICS, V283, P531, DOI 10.1007/s00438-010-0538-3; Luis A, 2014, FREE RADICAL BIO MED, V77, P217, DOI 10.1016/j.freeradbiomed.2014.09.008; Lunge VR, 2002, J MICROBIOL METH, V51, P361, DOI 10.1016/S0167-7012(02)00113-6; Lushchak VI, 2016, FISH PHYSIOL BIOCHEM, V42, P711, DOI 10.1007/s10695-015-0171-5; McMahon M, 2001, CANCER RES, V61, P3299; Metzger DC, 2013, GEN COMP ENDOCR, V189, P134, DOI 10.1016/j.ygcen.2013.04.022; Meyer JN, 2003, AQUAT TOXICOL, V65, P377, DOI 10.1016/j.aquatox.2003.06.001; Miao L, 2009, FREE RADICAL BIO MED, V47, P344, DOI 10.1016/j.freeradbiomed.2009.05.018; Mimura J, 2015, FREE RADICAL BIO MED, V88, P221, DOI 10.1016/j.freeradbiomed.2015.06.019; Montezano AC, 2015, CAN J CARDIOL, V31, P631, DOI 10.1016/j.cjca.2015.02.008; Motohashi H, 2004, TRENDS MOL MED, V10, P549, DOI 10.1016/j.molmed.2004.09.003; Mukaigasa K, 2012, MOL CELL BIOL, V32, P4455, DOI 10.1128/MCB.00481-12; Naidu SD, 2015, TRENDS PHARMACOL SCI, V36, P6, DOI 10.1016/j.tips.2014.10.011; Osborne NN, 2004, PROG RETIN EYE RES, V23, P91, DOI 10.1016/j.preteyeres.2003.12.001; Padilla S, 2012, REPROD TOXICOL, V33, P174, DOI 10.1016/j.reprotox.2011.10.018; Pascual I, 2010, EXP EYE RES, V90, P420, DOI 10.1016/j.exer.2009.12.003; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Planchart A, 2016, ALTEX; Ramsden R, 2016, REDOX BIOL, V9, P114, DOI 10.1016/j.redox.2016.07.001; Rotman Janneke, 2011, BMC Res Notes, V4, P196, DOI 10.1186/1756-0500-4-196; Rousseau ME, 2015, AQUAT TOXICOL, V167, P157, DOI 10.1016/j.aquatox.2015.08.002; RUSHMORE TH, 1991, J BIOL CHEM, V266, P11632; Sarkar S, 2014, ECOTOX ENVIRON SAFE, V107, P1, DOI 10.1016/j.ecoenv.2014.05.012; SCHWARZ MA, 1994, J BIOL CHEM, V269, P15238; Stewart D, 2003, J BIOL CHEM, V278, P2396, DOI 10.1074/jbc.M209195200; Sun Hong, 2015, Curr Environ Health Rep, V2, P295, DOI 10.1007/s40572-015-0054-z; Suzuki T, 2005, BIOCHEM J, V388, P65, DOI 10.1042/BJ20041860; Tezel G, 2006, PROG RETIN EYE RES, V25, P490, DOI 10.1016/j.preteyeres.2006.07.003; Timme-Laragy AR, 2009, TOXICOL SCI, V109, P217, DOI 10.1093/toxsci/kfp038; Tinkov AA, 2015, BIOMETALS, V28, P231, DOI 10.1007/s10534-015-9823-2; Toyokuni S., 2016, PATHOLOGY INT; Truong L, 2016, REPROD TOXICOL, V65, P139, DOI 10.1016/j.reprotox.2016.05.015; Usenko CY, 2008, TOXICOL APPL PHARM, V229, P44, DOI 10.1016/j.taap.2007.12.030; Valavanidis A, 2006, ECOTOX ENVIRON SAFE, V64, P178, DOI 10.1016/j.ecoenv.2005.03.013; Valko M, 2006, CHEM-BIOL INTERACT, V160, P1, DOI 10.1016/j.cbi.2005.12.009; Valko M, 2016, ARCH TOXICOL, V90, P1, DOI 10.1007/s00204-015-1579-5; Venugopal R, 1996, P NATL ACAD SCI USA, V93, P14960, DOI 10.1073/pnas.93.25.14960; Wadle S, 2016, Biomol Detect Quantif, V7, P1, DOI 10.1016/j.bdq.2015.12.002; Wang L, 2013, TOXICOL APPL PHARM, V266, P177, DOI 10.1016/j.taap.2012.11.010; Wilmes A, 2011, TOXICOL IN VITRO, V25, P613, DOI 10.1016/j.tiv.2010.12.009; WINSTON GW, 1991, AQUAT TOXICOL, V19, P137, DOI 10.1016/0166-445X(91)90033-6; Yan MH, 2013, FREE RADICAL BIO MED, V62, P90, DOI 10.1016/j.freeradbiomed.2012.11.014; Zhang Y, 2011, CHEM BIOL, V18, P1355, DOI 10.1016/j.chembiol.2011.09.008	80	17	17	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2017	12	2							e0171025	10.1371/journal.pone.0171025	http://dx.doi.org/10.1371/journal.pone.0171025			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BI	28212397	Green Submitted, Green Published, gold			2022-12-27	WOS:000394424700005
J	Dagher, D; Ungar, K; Robison, R; Dagher, F				Dagher, Dori; Ungar, Ken; Robison, Richard; Dagher, Fadi			The wide spectrum high biocidal potency of Bioxy formulation when dissolved in water at different concentrations	PLOS ONE			English	Article							BACTERICIDAL ACTIVITY; DISINFECTANTS; SUSCEPTIBILITY; MYCOBACTERIA; RESISTANCE; EFFICACY	Traditional surface disinfectants that have long been applied in medicine, animal husbandry, manufacturing and institutions are inconvenient at best and dangerous at worst. Moreover, some of these substances have adverse environmental impacts: for example, quaternary ammonium compounds ("quats") are reproductive toxicants in both fish and mammals. Halogens are corrosive both to metals and living tissues, are highly reactive, can be readily neutralized by metals, and react with organic matter to form toxic, persistent by-products such as dioxins and furans. Aldehydes may be carcinogenic to both human and animals upon repeated exposures, are corrosive, cross-link living tissues and many synthetic materials, and may lose efficacy when pathogens enzymatically adapt to them. Alcohols are flammable and volatile and can be enzymatically degraded by certain bacterial pathogens. Quats are highly irritating to mucous membranes and over time can induce pathogen resistance, especially if they are not alternated with functionally different disinfectants. In contrast, peracetic acid (PAA), a potent oxidizer, liberates hydrogen peroxide (itself a disinfectant), biodegrades to carbon dioxide, water and oxygen, and is at least as efficacious as contact biocides e.g., halogens and aldehydes. Nevertheless, the standard form of liquid PAA is highly corrosive, is neutralized by metals and organic matter, gives off noxious odours and must be stored in vented containers. For the reasons stated above, Bioxy formulations were developed, a series of powder forms of PAA, which are odourless, stable in storage and safe to transport and handle. They generate up to 10% PAA in situ when dissolved in water. A 0.2% aqueous solution of Bioxy (equivalent to 200 ppm PAA) effected a 6.76 log reduction in Methicillin-resistant Staphylococcus aureus (MRSA) within 2 minutes after application. A 5% aqueous solution of Bioxy achieved a 3.93 log reduction in the bovine tuberculosis bacillus Mycobacterium bovis, within 10 minutes after contact. A 1% solution of Bioxy reduced vancomycin-resistant enterococci (VRE) and Pseudomonas aeruginosa by 6.31 and 7.18 logs, respectively, within 3 minutes after application. A 0.5% solution of Bioxy inactivated porcine epidemic diarrhea virus (PEDV) within 15 minutes of contact, and a 5% solution of Bioxy realized a 5.36 log reduction in the spores of Clostridium difficile within 10 minutes of application. In summary, Bioxy is safe and easy to transport and store, poses negligible human, animal and environmental health risks, shows high levels of pathogen control efficacy and does not induce microbial resistance. Further investigations are recommended to explore its use as an industrial biocide.	[Dagher, Dori; Ungar, Ken; Dagher, Fadi] Bioxy AFD Inc, St Laurent, PQ, Canada; [Dagher, Dori; Ungar, Ken; Dagher, Fadi] Atomes FD Inc, St Laurent, PQ, Canada; [Robison, Richard] Brigham Young Univ, Provo, UT 84602 USA	Brigham Young University	Dagher, F (corresponding author), Bioxy AFD Inc, St Laurent, PQ, Canada.; Dagher, F (corresponding author), Atomes FD Inc, St Laurent, PQ, Canada.	fadi@atomesbio.com		Robison, Richard/0000-0002-4324-5169	Atomes FD Inc.; Bioxy AFD Inc.	Atomes FD Inc.; Bioxy AFD Inc.	This study was funded by Atomes FD Inc. and Bioxy AFD Inc. Dori Dagher, Ken Ungar and Fadi Dagher are affiliated with Atomes FD Inc. and Bioxy AFD Inc. Atomes FD Inc. and Bioxy AFD Inc. provided support in the form of salaries for authors DD, KU and FD, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	[Anonymous], 2000, REP PER AC; [Anonymous], 1998, GLUT SCREEN INF DAT; [Anonymous], 2008, GD DIS 101 BIOS; Carvajal A, 2015, PORCINE HEALTH MANAG, V1, DOI 10.1186/s40813-015-0007-9; De Groote MA, 2014, AM J INFECT CONTROL, V42, P932, DOI 10.1016/j.ajic.2014.05.014; Eleraky NZ, 2002, J AM ANIM HOSP ASSOC, V38, P231, DOI 10.5326/0380231; Estrela Carlos, 2002, Braz. Dent. J., V13, P113, DOI 10.1590/S0103-64402002000200007; Hirose Ryoji, 1994, Journal of Dermatology (Tokyo), V21, P248; Konkel, 2014, ENV HEAL NEWS; Le Dantec C, 2002, APPL ENVIRON MICROB, V68, P1025, DOI 10.1128/AEM.68.3.1025-1032.2002; Leggett MJ, 2015, J ANTIMICROB CHEMOTH, V70, P773, DOI 10.1093/jac/dku445; Liou JW, 2012, ARCH IMMUNOL THER EX, V60, P267, DOI 10.1007/s00005-012-0178-x; MARIS P, 1995, REV SCI TECH OIE, V14, P47, DOI 10.20506/rst.14.1.829; Martinez, 2005, BIOPROCESS INT, V8, P32; Meyers J, 2014, J ANTIMICROB CHEMOTH, V69, P1546, DOI 10.1093/jac/dku006; Nemoto M, 2014, J VET MED SCI, V76, P1061, DOI 10.1292/jvms.14-0018; Pandian SRK, 2010, BRAZ J MICROBIOL, V41, P805, DOI 10.1590/S1517-83822010000300033; Pleskova SN, 2016, MAT SCI ENG C-MATER, V59, P807, DOI 10.1016/j.msec.2015.10.021; Rabenau HF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086128; Rahman S., 2007, HDB FOOD PRESERVATIO, DOI 10.1201/9781420017373; Rutala WA, WD GUIDELINE DISINFE; Ryndock E, 2016, J MED VIROL, V88, P1076, DOI 10.1002/jmv.24421; Tarquinio KM, 2010, INT J NANOMED, V5, P177; Tetraacetylethylenediamine (TAED), 2002, 10543574 TAED CAS; TURKHEIM H J, 1955, J Dent Res, V34, P295, DOI 10.1177/00220345550340021801; Wirtanen G, 2001, EUR FOOD RES TECHNOL, V213, P409, DOI 10.1007/s002170100375; Zhang TY, 2007, CHINESE J CHEM ENG, V15, P320, DOI 10.1016/S1004-9541(07)60087-1; [ZHAO Xuebing 赵雪冰], 2008, [过程工程学报, The Chinese Journal of Process Engineering], V8, P35	28	6	6	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0172224	10.1371/journal.pone.0172224	http://dx.doi.org/10.1371/journal.pone.0172224			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207828	gold, Green Published, Green Submitted			2022-12-27	WOS:000394424500103
J	Shao, CH; Dai, WZ; Li, HL; Tang, WR; Jia, ST; Wu, XM; Luo, Y				Shao, Chihao; Dai, Wenzhu; Li, Haili; Tang, Wenru; Jia, Shuting; Wu, Xiaoming; Luo, Ying			The relationship between RASSF1A gene promoter methylation and the susceptibility and prognosis of melanoma: A meta-analysis and bioinformatics	PLOS ONE			English	Article							TUMOR-SUPPRESSOR GENES; EPIGENETIC INACTIVATION; CPG ISLAND; LUNG; ASSOCIATION; KINASE; BREAST; SERUM; CONTRIBUTE; DNA	Background The function of the tumor suppressor gene RASSF1A in cancer cells has been detailed in many studies. However, due to the methylation of its promoter, the expression of RASSF1A is missing in most cancers. In the literature, we found that the conclusion regarding the relationship between RASSF1A gene promoter methylation and the susceptibility and prognosis of melanoma was not unified. This study adopts the use of a meta-analysis and bioinformatics to explore the relationship between RASSF1A gene promoter methylation and the susceptibility and prognosis of melanoma. Methods Data on melanoma susceptibility were downloaded from the PubMed, Cochrane Library, Web of Science and Google Scholar databases, which were analyzed via a meta-analysis. The effect sizes were estimated by measuring an odds ratio (OR) with a 95% confidence interval (CI). We also used a chi-squared-based Q test to examine the between-study heterogeneity, and used funnel plots to evaluate publication bias. The data on melanoma prognosis, which were analyzed by bioinformatics methods, were downloaded from The Cancer Genome Atlas (TCGA) project. The effect sizes were estimated by measuring the hazard ratios (HRs) with a 95% confidence interval (CI). Results Our meta-analysis included 10 articles. We found that RASSF1A gene promoter methylation was closely related to melanoma susceptibility (OR = 12.67, 95% CI: 6.16 similar to 26.05, z = 6.90, P<0.0001 according to a fixed effects model and OR = 9.25, 95% CI: 4.37 similar to 19.54, z = 5.82, P<0.0001 according to a random effects model). The results of the meta-analysis did not reveal any heterogeneity (tau(2) = 0.00; H =1 [1; 1.55]; I-2 = 0% [0%; 58.6%], P = 0.5158) or publication bias (t = 0.87, P = 0.4073 by Egger's test; Z = 0.45, P = 0.6547 by Begg's test); therefore, we believe that the results of our meta-analysis were more reliable. To explore the relationship between RASSF1A gene methylation, the prognosis of melanoma and the clinical features of this cancer type, we used the melanoma DNA methylation data and clinical data from TCGA project. We found that RASSF1A gene promoter methylation and melanoma prognosis did not demonstrate any relationship (HR was 0.94 (95% CI = [0.69; 1.27], P = 0.694) with disease-free survival and 0.74 (95% CI = [0.53; 1.05], P = 0.106) for overall survival), and no significant difference was observed between RASSF1A gene promoter methylation and the clinical-pathological features of melanoma. Conclusions In conclusion, the meta-analysis of the data in these articles provides strong evidence that the methylation status of the RASSF1A gene promoter was strongly related to melanoma susceptibility. Our bioinformatics analysis revealed no significant difference between RASSF1A gene promoter methylation and the prognosis and clinical-pathological features of melanoma.	[Shao, Chihao; Dai, Wenzhu; Li, Haili; Tang, Wenru; Jia, Shuting; Wu, Xiaoming; Luo, Ying] Kunming Univ Sci & Technol, Lab Mol Genet Aging & Tumor, Fac Med, Kunming, Yunnan, Peoples R China	Kunming University of Science & Technology	Wu, XM; Luo, Y (corresponding author), Kunming Univ Sci & Technol, Lab Mol Genet Aging & Tumor, Fac Med, Kunming, Yunnan, Peoples R China.	xiao_tracy@163.com; luoyingabc@yahoo.com	Luo, Ying/AAQ-7666-2020		area of national natural science fund project China [81460224]; scientific research fund project of Yunnan province education department [KKJA201560039]	area of national natural science fund project China; scientific research fund project of Yunnan province education department	This work was financially supported by the area of national natural science fund project China (No. 81460224) and the scientific research fund project of Yunnan province education department (KKJA201560039).	Agathanggelou A, 2001, ONCOGENE, V20, P1509, DOI 10.1038/sj.onc.1204175; [Anonymous], 2014, WORLD CANC REPORT 20; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Burbee DG, 2001, JNCI-J NATL CANCER I, V93, P691, DOI 10.1093/jnci/93.9.691; Calipel A, 2011, MOL CANCER RES, V9, P1187, DOI 10.1158/1541-7786.MCR-10-0437; Chen WQ, 2016, CA-CANCER J CLIN, V66, P115, DOI 10.3322/caac.21338; Chow C, 2012, ONCOGENE, V31, P1975, DOI 10.1038/onc.2011.372; Dammann R, 2000, NAT GENET, V25, P315, DOI 10.1038/77083; Dammann R, 2001, ONCOGENE, V20, P3563, DOI 10.1038/sj.onc.1204469; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M. DS G, 1997, BMJ OPEN; Furuta J, 2004, CANCER SCI, V95, P962, DOI 10.1111/j.1349-7006.2004.tb03184.x; Ge YZ, 2014, TUMOR BIOL, V35, P3881, DOI 10.1007/s13277-013-1515-3; Hesson LB, 2007, DIS MARKERS, V23, P73, DOI 10.1155/2007/291538; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hoon DSB, 2004, ONCOGENE, V23, P4014, DOI 10.1038/sj.onc.1207505; Jiang Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036780; Koyanagi K, 2006, CANCER RES, V66, P6111, DOI 10.1158/0008-5472.CAN-05-4198; Li YS, 2014, MOL BIOL REP, V41, P3925, DOI 10.1007/s11033-014-3260-0; Liu SH, 2008, PIGM CELL MELANOMA R, V21, P545, DOI 10.1111/j.1755-148X.2008.00484.x; Liu WJ, 2013, ASIAN PAC J CANCER P, V14, P3719, DOI 10.7314/APJCP.2013.14.6.3719; MANTEL N, 1959, J NATL CANCER I, V22, P719; Marini A, 2006, J INVEST DERMATOL, V126, P422, DOI 10.1038/sj.jid.5700073; Mori T, 2005, J CLIN ONCOL, V23, P9351, DOI 10.1200/JCO.2005.02.9876; Pfeifer GP, 2002, BIOL CHEM, V383, P907, DOI 10.1515/BC.2002.097; Reifenberger J, 2004, INT J CANCER, V109, P377, DOI 10.1002/ijc.11722; Romano D, 2010, CANCER RES, V70, P1195, DOI 10.1158/0008-5472.CAN-09-3147; Rong R, 2007, ONCOGENE, V26, P7700, DOI 10.1038/sj.onc.1210575; SHI H, 2013, J APPL MATH, V2013, P1, DOI DOI 10.1371/J0URNAL.P0NE.0076787; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Sproul D, 2011, P NATL ACAD SCI USA, V108, P4364, DOI 10.1073/pnas.1013224108; Spugnardi M, 2003, CANCER RES, V63, P1639; Tanemura A, 2009, CLIN CANCER RES, V15, P1801, DOI 10.1158/1078-0432.CCR-08-1361; Vichalkovski A, 2008, CURR BIOL, V18, P1889, DOI 10.1016/j.cub.2008.10.060; Wang HL, 2014, ANN HUM GENET, V78, P208, DOI 10.1111/ahg.12059; Yu J, 2002, BMC CANCER, V2, DOI 10.1186/1471-2407-2-29	36	9	11	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0171676	10.1371/journal.pone.0171676	http://dx.doi.org/10.1371/journal.pone.0171676			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207831	gold, Green Published, Green Submitted			2022-12-27	WOS:000394424500045
J	Turner, D; Wand, ME; Briers, Y; Lavigne, R; Sutton, JM; Reynolds, DM				Turner, Dann; Wand, Matthew E.; Briers, Yves; Lavigne, Rob; Sutton, J. Mark; Reynolds, Darren M.			Characterisation and genome sequence of the lytic Acinetobacter baumannii bacteriophage vB_AbaS_Loki	PLOS ONE			English	Article							PROGRAMMED TRANSLATIONAL FRAMESHIFT; COLISTIN RESISTANCE; CRYSTAL-STRUCTURE; PROTEIN; PHAGE; INFECTION; CALCIUM; IDENTIFICATION; MECHANISMS; SOFTWARE	Acinetobacter baumannii has emerged as an important nosocomial pathogen in healthcare and community settings. While over 100 of Acinetobacter phages have been described in the literature, relatively few have been sequenced. This work describes the characterisation and genome annotation of a new lytic Acinetobacter siphovirus, vB_AbaS_Loki, isolated from activated sewage sludge. Sequencing revealed that Loki encapsulates a 41,308 bp genome, encoding 51 predicted open reading frames. Loki is most closely related to Acinetobacter phage IME_AB3 and more distantly related to Burkholderia phage KL1, Paracoccus phage vB_PmaS_IMEP1 and Pseudomonas phages vB_Pae_Kakheti25, vB_PaeS_SCH_Ab26 and PA73. Loki is characterised by a narrow host range, among the 40 Acinetobacter isolates tested, productive infection was only observed for the propagating host, A. baumannii ATCC 17978. Plaque formation was found to be dependent upon the presence of Ca2+ ions and adsorption to host cells was abolished upon incubation with a mutant of ATCC 17978 encoding a premature stop codon in lpxA. The complete genome sequence of vB_AbaS_Loki was deposited in the European Nucleotide Archive (ENA) under the accession number LN890663.	[Turner, Dann; Reynolds, Darren M.] Univ West England, Fac Hlth & Appl Sci, Dept Appl Sci, Ctr Res Biosci, Coldharbour Lane, Bristol, Avon, England; [Wand, Matthew E.; Sutton, J. Mark] Publ Hlth England, Natl Infect Serv, Salisbury, Wilts, England; [Briers, Yves] Univ Ghent, Dept Appl Biosci, Lab Appl Biotechnol, Ghent, Belgium; [Briers, Yves; Lavigne, Rob] Katholieke Univ Leuven, Biosyst Dept, Lab Gene Technol, Heverlee, Belgium	University of West England; Public Health England; Ghent University; KU Leuven	Reynolds, DM (corresponding author), Univ West England, Fac Hlth & Appl Sci, Dept Appl Sci, Ctr Res Biosci, Coldharbour Lane, Bristol, Avon, England.	darren.reynolds@uwe.ac.uk	Wand, Matthew/AAJ-1111-2020; Turner, Dann/P-5043-2019	Turner, Dann/0000-0002-0249-4513; Sutton, J. Mark/0000-0002-2288-0446; Wand, Matthew/0000-0002-9277-8869; Reynolds, Darren M/0000-0002-7002-1320	University of the West of England, Bristol; Geconcerteerde Onderzoeks Actie grant 'Phage Biosystems' from KU Leuven	University of the West of England, Bristol; Geconcerteerde Onderzoeks Actie grant 'Phage Biosystems' from KU Leuven	This work was supported by a QR2015 award from the University of the West of England, Bristol to D.T. R.L. is supported by a the Geconcerteerde Onderzoeks Actie grant 'Phage Biosystems' from KU Leuven. R.L. & Y.B. are members of the FWO research community Phagebiotics". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by a QR2015 award from the University of the West of England, Bristol. R.L. is supported by a the Geconcerteerde Onderzoeks Actie grant 'Phage Biosystems' from KU Leuven. R.L. & Y.B. are members of the FWO research community Thagebiotics". The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication. We wish to thank Dr J. Turton (Public Health England) and Dr D. Centron (Universidad de Buenos Airies-Consejo Nacional de Investigaciones Cientificas y Tecnologicas) for the supply and permission to use bacterial strains, and Wessex Water PLC for the provision of sewage and activated sludge samples. We thank Professor H.-W. Ackermann (Universite Laval) for his advice and informative discussions on the bacteriophages of Acinetobacter sp.	Abedon Stephen T, 2011, Bacteriophage, V1, P46, DOI 10.4161/bact.1.1.13980; Ackermann HW, 2012, ARCH VIROL, V157, P1843, DOI 10.1007/s00705-012-1383-y; Ackermann Hans-W., 2009, V501, P113, DOI 10.1007/978-1-60327-164-6_12; Adams MJ, 2015, ARCH VIROL, V160, P1837, DOI 10.1007/s00705-015-2425-z; Adriaenssens EM, 2015, VIROLOGY, V477, P144, DOI 10.1016/j.virol.2014.10.016; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; ANDREWS HJ, 1986, J HOSP INFECT, V7, P169, DOI 10.1016/0195-6701(86)90060-5; Angly F, 2009, ENVIRON MICROBIOL, V11, P2863, DOI 10.1111/j.1462-2920.2009.02021.x; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Besemer J, 1999, NUCLEIC ACIDS RES, V27, P3911, DOI 10.1093/nar/27.19.3911; BJELLQVIST B, 1993, ELECTROPHORESIS, V14, P1023, DOI 10.1002/elps.11501401163; Bollivar DW, 2016, GENOME ANNOUNCEMENTS, V4, DOI 10.1128/genomeA.00051-16; BONHIVERS M, 1995, FEBS LETT, V374, P169, DOI 10.1016/0014-5793(95)01101-J; Briers Y, 2007, MOL MICROBIOL, V65, P1334, DOI 10.1111/j.1365-2958.2007.05870.x; Michael JB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002048; Cai Y, 2012, J ANTIMICROB CHEMOTH, V67, P1607, DOI 10.1093/jac/dks084; Cardarelli L, 2010, J MOL BIOL, V395, P754, DOI 10.1016/j.jmb.2009.10.067; Casjens Sherwood R., 2009, V502, P91, DOI 10.1007/978-1-60327-565-1_7; Casjens SR, 2005, CURR OPIN MICROBIOL, V8, P451, DOI 10.1016/j.mib.2005.06.014; Chagot B, 2012, PROTEINS, V80, P319, DOI 10.1002/prot.23191; Christie GE, 2002, J BACTERIOL, V184, P6522, DOI 10.1128/JB.184.23.6522-6531.2002; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; Dijkshoorn L, 2007, NAT REV MICROBIOL, V5, P939, DOI 10.1038/nrmicro1789; Field D, 2006, NAT BIOTECHNOL, V24, P801, DOI 10.1038/nbt0706-801; Flayhan A, 2014, J VIROL, V88, P820, DOI 10.1128/JVI.02135-13; Fullner KJ, 1997, MOL MICROBIOL, V26, P755, DOI 10.1046/j.1365-2958.1997.6111984.x; Geisinger E, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004691; Grant JR, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-202; Grose JH, 2014, VIROLOGY, V468, P421, DOI 10.1016/j.virol.2014.08.024; Gruber AR, 2008, NUCLEIC ACIDS RES, V36, pW70, DOI 10.1093/nar/gkn188; Hatfull GF, 2015, J VIROL, V89, P8107, DOI 10.1128/JVI.01340-15; Hatfull GF, 2008, CURR OPIN MICROBIOL, V11, P447, DOI 10.1016/j.mib.2008.09.004; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Jeon J, 2015, ARCH VIROL, V160, P3157, DOI 10.1007/s00705-015-2604-y; Jeon J, 2012, J VIROL, V86, P12437, DOI 10.1128/JVI.02132-12; Karumidze N, 2012, APPL MICROBIOL BIOT, V94, P1609, DOI 10.1007/s00253-012-4119-8; Kingsford CL, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r22; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kropinski Andrew M., 2009, V501, P69, DOI 10.1007/978-1-60327-164-6_7; Kutter Elizabeth, 2009, V501, P141, DOI 10.1007/978-1-60327-164-6_14; Kwan T, 2006, J BACTERIOL, V188, P1184, DOI 10.1128/JB.188.3.1184-1187.2006; Labrie SJ, 2010, NAT REV MICROBIOL, V8, P317, DOI 10.1038/nrmicro2315; Laslett D, 2004, NUCLEIC ACIDS RES, V32, P11, DOI 10.1093/nar/gkh152; LEVIN ME, 1993, J MOL BIOL, V234, P124, DOI 10.1006/jmbi.1993.1568; Loessner MJ, 2000, MOL MICROBIOL, V35, P324, DOI 10.1046/j.1365-2958.2000.01720.x; Lynch KH, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-223; Mahony J, 2015, INT J FOOD MICROBIOL, V201, P47, DOI 10.1016/j.ijfoodmicro.2015.02.017; Marchler-Bauer Aron, 2011, Nucleic Acids Res, V39, pD225, DOI 10.1093/nar/gkq1189; Maxwell KL, 2002, J MOL BIOL, V318, P1395, DOI 10.1016/S0022-2836(02)00276-0; Merrill BD, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3018-2; Moffatt JH, 2010, ANTIMICROB AGENTS CH, V54, P4971, DOI 10.1128/AAC.00834-10; Pell LG, 2013, J MOL BIOL, V425, P2436, DOI 10.1016/j.jmb.2013.03.035; Pell LG, 2009, J MOL BIOL, V389, P938, DOI 10.1016/j.jmb.2009.04.072; Perez F, 2007, ANTIMICROB AGENTS CH, V51, P3471, DOI 10.1128/AAC.01464-06; Peters DL, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1848-y; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Poirel L, 2011, IUBMB LIFE, V63, P1061, DOI 10.1002/iub.532; Rakhuba DV, 2010, POL J MICROBIOL, V59, P145, DOI 10.33073/pjm-2010-023; Roucourt B, 2009, ENVIRON MICROBIOL, V11, P2789, DOI 10.1111/j.1462-2920.2009.02029.x; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Sambrook J., 2001, MOL CLONING LAB MANU; Schattner P, 2005, NUCLEIC ACIDS RES, V33, pW686, DOI 10.1093/nar/gki366; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shin H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043392; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; STEENSMA HY, 1979, J GEN VIROL, V42, P305, DOI 10.1099/0022-1317-42-2-305; Turner D, 2016, GENOME ANNOUNCEMENTS, V4, DOI 10.1128/genomeA.01051-16; Van den Bossche A, 2016, ELIFE, V5, DOI 10.7554/eLife.16413; Van den Bossche A, 2014, J PROTEOME RES, V13, P4446, DOI 10.1021/pr500796n; Wagemans J, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01242; Wagemans J, 2014, CELL MICROBIOL, V16, P1822, DOI 10.1111/cmi.12330; Wand ME, 2015, J ANTIMICROB CHEMOTH, V70, P2209, DOI 10.1093/jac/dkv097; Weigele PR, 2007, ENVIRON MICROBIOL, V9, P1675, DOI 10.1111/j.1462-2920.2007.01285.x; Wendt C, 1997, J CLIN MICROBIOL, V35, P1394, DOI 10.1128/JCM.35.6.1394-1397.1997; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Wisplinghoff H, 2007, J HOSP INFECT, V66, P174, DOI 10.1016/j.jhin.2007.02.016; Xu J, 2004, MOL CELL, V16, P11, DOI 10.1016/j.molcel.2004.09.006; Zhang JJ, 2002, J BACTERIOL, V184, P5323, DOI 10.1128/JB.184.19.5323-5329.2002	82	18	17	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0172303	10.1371/journal.pone.0172303	http://dx.doi.org/10.1371/journal.pone.0172303			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207864	gold, Green Submitted, Green Published			2022-12-27	WOS:000394424500117
J	Wilks, M; Phillips, CJC				Wilks, Matti; Phillips, Clive J. C.			Attitudes to in vitro meat: A survey of potential consumers in the United States	PLOS ONE			English	Article							PERCEPTIONS; FOOD	Positivity towards meat consumption remains strong, despite evidence of negative environmental and ethical outcomes. Although awareness of these repercussions is rising, there is still public resistance to removing meat from our diets. One potential method to alleviate these effects is to produce in vitro meat: meat grown in a laboratory that does not carry the same environmental or ethical concerns. However, there is limited research examining public attitudes towards in vitro meat, thus we know little about the capacity for it be accepted by consumers. This study aimed to examine perceptions of in vitro meat and identify potential barriers that might prevent engagement. Through conducting an online survey with US participants, we identified that although most respondents were willing to try in vitro meat, only one third were definitely or probably willing to eat in vitro meat regularly or as a replacement for farmed meat. Men were more receptive to it than women, as were politically liberal respondents compared with conservative ones. Vegetarians and vegans were more likely to perceive benefits compared to farmed meat, but they were less likely to want to try it than meat eaters. The main concerns were an anticipated high price, limited taste and appeal and a concern that the product was unnatural. It is concluded that people in the USA are likely to try in vitro meat, but few believed that it would replace farmed meat in their diet.	[Wilks, Matti] Univ Queensland, Sch Psychol, Early Cognit Dev Ctr, Brisbane, Qld, Australia; [Phillips, Clive J. C.] Univ Queensland, Sch Vet Sci, Ctr Anim Welf & Eth, Gatton, Australia	University of Queensland; University of Queensland	Wilks, M (corresponding author), Univ Queensland, Sch Psychol, Early Cognit Dev Ctr, Brisbane, Qld, Australia.	matti.wilks@uqconnect.edu.au						Alexandratos N., 2012, 1203 ESA FAO, DOI DOI 10.1016/S0264-8377(03)00047-4; [Anonymous], 2010, NATURE, V466, P531, DOI 10.1038/466531a; [Anonymous], 2005, BIOTECHNOLOGY PIOFA; [Anonymous], 2013, SCI ENV; Baron J, 2000, J EXP PSYCHOL-APPL, V6, P183, DOI 10.1037/1076-898X.6.3.183; Bartneck C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121595; Bastian B, 2012, PERS SOC PSYCHOL B, V38, P247, DOI 10.1177/0146167211424291; Berinsky AJ, 2012, POLIT ANAL, V20, P351, DOI 10.1093/pan/mpr057; Bhat ZF, 2015, CRITICAL REV FOOD SC; Bratanova B, 2011, APPETITE, V57, P193, DOI 10.1016/j.appet.2011.04.020; Buckingham D., 2000, MAKING CITIZENS YOUN; Buhrmester M, 2016, AMAZONS MECH TURK NE, P133; Cooney N., 2014, VEGANOMICS SUPRISING; Daniel CR, 2011, PUBLIC HEALTH NUTR, V14, P575, DOI 10.1017/S1368980010002077; Dilworth T, 2015, J AGR ENVIRON ETHIC, V28, P85, DOI 10.1007/s10806-014-9522-y; Frewer LJ, 2013, TRENDS FOOD SCI TECH, V30, P142, DOI 10.1016/j.tifs.2013.01.003; Gaskell G, 1999, SCIENCE, V285, P384, DOI 10.1126/science.285.5426.384; Graham J, 2009, J PERS SOC PSYCHOL, V96, P1029, DOI 10.1037/a0015141; Haidt J., 2007, SOCIAL JUSTICE RES, V20, P98, DOI [DOI 10.1007/S11211-007-0034-Z, 10.1007/s11211-007-0034-z]; Hocquette A, 2015, J INTEGR AGR, V14, P273, DOI 10.1016/S2095-3119(14)60886-8; James C., 2013, GLOBAL STATUS COMMER; Laestadius LI, 2015, PUBLIC HEALTH NUTR, V18, P2457, DOI 10.1017/S1368980015000622; Mahar D, 2014, 2014 INT COMM ASS IC; Post MJ, 2014, ANN NY ACAD SCI, V1328, P29, DOI 10.1111/nyas.12569; Post MJ, 2014, J SCI FOOD AGR, V94, P1039, DOI 10.1002/jsfa.6474; Rollin BE, 2004, ANIMALS AGR FACTORY, P212; Rozin P, 2005, PSYCHOL SCI, V16, P652, DOI 10.1111/j.1467-9280.2005.01589.x; Ruby MB, 2011, APPETITE, V56, P447, DOI 10.1016/j.appet.2011.01.018; Schaefer GO, 2014, J APPL PHILOS, V31, P188, DOI 10.1111/japp.12056; Scott SE, 2016, PERSPECT PSYCHOL SCI, V11, P315, DOI 10.1177/1745691615621275; Thomas MA, 2016, APPETITE, V97, P79, DOI 10.1016/j.appet.2015.11.021; Tucker CA, 2014, APPETITE, V81, P168, DOI 10.1016/j.appet.2014.06.022; USDA, 2016, CHICK COWS PIGS OH M; Verbeke W, 2015, J INTEGR AGR, V14, P285, DOI 10.1016/S2095-3119(14)60884-4; Verbeke W, 2015, MEAT SCI, V102, P49, DOI 10.1016/j.meatsci.2014.11.013; Walker P, 2005, PUBLIC HEALTH NUTR, V8, P348, DOI 10.1079/PHN2005727	37	129	132	5	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0171904	10.1371/journal.pone.0171904	http://dx.doi.org/10.1371/journal.pone.0171904			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL2BG	28207878	Green Published, gold, Green Submitted			2022-12-27	WOS:000394424500059
J	Afanasyeva, MA; Putlyaeva, LV; Demin, DE; Kulakovskiy, IV; Vorontsov, IE; Fridman, MV; Makeev, VJ; Kuprash, DV; Schwartz, AM				Afanasyeva, Marina A.; Putlyaeva, Lidia V.; Demin, Denis E.; Kulakovskiy, Ivan V.; Vorontsov, Ilya E.; Fridman, Marina V.; Makeev, Vsevolod J.; Kuprash, Dmitry V.; Schwartz, Anton M.			The single nucleotide variant rs12722489 determines differential estrogen receptor binding and enhancer properties of an IL2RA intronic region	PLOS ONE			English	Article							MULTIPLE-SCLEROSIS; DENDRITIC CELLS; AUTOIMMUNE-DISEASE; GENE POLYMORPHISMS; SUSCEPTIBILITY; ALPHA; INTERLEUKIN-2-RECEPTOR; EXPRESSION; CHAIN; CONSERVATION	We studied functional effect of rs12722489 single nucleotide polymorphism located in the first intron of human IL2RA gene on transcriptional regulation. This polymorphism is associated with multiple autoimmune conditions (rheumatoid arthritis, multiple sclerosis, Crohn's disease, and ulcerative colitis). Analysis in silico suggested significant difference in the affinity of estrogen receptor (ER) binding site between alternative allelic variants, with stronger predicted affinity for the risk (G) allele. Electrophoretic mobility shift assay showed that purified human ERa bound only G variant of a 32-bp genomic sequence containing rs12722489. Chromatin immunoprecipitation demonstrated that endogenous human ERa interacted with rs12722489 genomic region in vivo and DNA pull-down assay confirmed differential allelic binding of amplified 189-bp genomic fragments containing rs12722489 with endogenous human ERa. In a luciferase reporter assay, a kilobase-long genomic segment containing G but not A allele of rs12722489 demonstrated enhancer properties in MT-2 cell line, an HTLV-1 transformed human cell line with a regulatory T cell phenotype.	[Afanasyeva, Marina A.; Putlyaeva, Lidia V.; Kulakovskiy, Ivan V.; Makeev, Vsevolod J.; Kuprash, Dmitry V.; Schwartz, Anton M.] Russian Acad Sci, Engelhardt Inst Mol Biol, Moscow, Russia; [Demin, Denis E.; Makeev, Vsevolod J.; Kuprash, Dmitry V.] Moscow Inst Phys & Technol, Moscow, Russia; [Kulakovskiy, Ivan V.; Vorontsov, Ilya E.; Fridman, Marina V.; Makeev, Vsevolod J.] Russian Acad Sci, Vavilov Inst Gen Genet, Moscow, Russia; [Kulakovskiy, Ivan V.] Skolkovo Innovat Ctr, Skolkovo Inst Sci & Technol, Moscow, Russia; [Kuprash, Dmitry V.] Lomonosov Moscow State Univ, Fac Biol, Moscow, Russia	Russian Academy of Sciences; Engelhardt Institute of Molecular Biology, RAS; Moscow Institute of Physics & Technology; Russian Academy of Sciences; Vavilov Institute of General Genetics; Skolkovo Institute of Science & Technology; Lomonosov Moscow State University	Afanasyeva, MA (corresponding author), Russian Acad Sci, Engelhardt Inst Mol Biol, Moscow, Russia.	ama@eimb.ru	Schwartz, Anton/HHZ-5795-2022; Putlyaeva, Lidia V./Q-6527-2017; Vorontsov, Ilya E/C-6333-2014; Kuprash, Dmitry/O-4899-2015; Demin, Denis/HHZ-4654-2022; Makeev, Vsevolod/E-8015-2013; Kulakovskiy, Ivan/A-1462-2014	Vorontsov, Ilya E/0000-0001-8888-0804; Kuprash, Dmitry/0000-0002-1488-4148; Demin, Denis/0000-0002-5553-6588; Makeev, Vsevolod/0000-0001-9405-9748; Kulakovskiy, Ivan/0000-0002-6554-8128; Putlyaeva, Lidia/0000-0003-0684-5672; Afanasyeva, Marina/0000-0001-5294-970X	Russian Science Foundation [14-14-01140]	Russian Science Foundation(Russian Science Foundation (RSF))	This work was supported by Russian Science Foundation (http://rscf.ru/en), grant #14-14-01140 to DVK. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainiding G, 2014, J NEUROL SCI, V337, P147, DOI 10.1016/j.jns.2013.11.037; Akkad DA, 2009, J AUTOIMMUN, V32, P110, DOI 10.1016/j.jaut.2009.01.002; Andersson R, 2014, NATURE, V507, P455, DOI 10.1038/nature12787; Brian Jo YH, 2016, DISTANT REGULATORY E; Browning BL, 2008, HUM GENET, V123, P273, DOI 10.1007/s00439-008-0472-1; Bryois J, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004461; Cerosaletti K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083811; Cunningham M, 2011, CLIN REV ALLERG IMMU, V40, P66, DOI 10.1007/s12016-010-8203-5; Degn M, 2015, MULTIPLE SCLEROSIS; Dendrou CA, 2009, NAT GENET, V41, P1011, DOI 10.1038/ng.434; Dendrou CA, 2008, J CLIN IMMUNOL, V28, P685, DOI 10.1007/s10875-008-9237-9; Deplancke B, 2016, CELL, V166, P538, DOI 10.1016/j.cell.2016.07.012; Dermitzakis ET, 2002, MOL BIOL EVOL, V19, P1114, DOI 10.1093/oxfordjournals.molbev.a004169; Dimas AS, 2009, SCIENCE, V325, P1246, DOI 10.1126/science.1174148; Driscoll MD, 1998, J BIOL CHEM, V273, P29321, DOI 10.1074/jbc.273.45.29321; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; DYER RB, 1995, BIOTECHNIQUES, V19, P192; Eicher JD, 2015, NUCLEIC ACIDS RES, V43, pD799, DOI 10.1093/nar/gku1202; Farh KKH, 2015, NATURE, V518, P337, DOI 10.1038/nature13835; Fehrmann RSN, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002197; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; FREUDENTHAL PS, 1990, P NATL ACAD SCI USA, V87, P7698, DOI 10.1073/pnas.87.19.7698; Goris A, 2012, CURR GENOMICS, V13, P646, DOI 10.2174/138920212803759695; Hafler DA, 2007, NEW ENGL J MED, V357, P851, DOI 10.1056/NEJMoa073493; Hamano R, 2015, CELL MOL IMMUNOL, V12, P780, DOI 10.1038/cmi.2014.123; Handel AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010142; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; JUNG LKL, 1984, J EXP MED, V160, P1597, DOI 10.1084/jem.160.5.1597; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Klinge CM, 2001, NUCLEIC ACIDS RES, V29, P2905, DOI 10.1093/nar/29.14.2905; KNIEP EM, 1992, IMMUNOLOGY, V75, P299; Kulakovskiy I, 2013, J BIOINF COMPUT BIOL, V11, DOI 10.1142/S0219720013400040; Kulakovskiy IV, 2016, NUCLEIC ACIDS RES, V44, pD116, DOI 10.1093/nar/gkv1249; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Lin YC, 2015, ANN CLIN TRANSL NEUR, V2, P445, DOI 10.1002/acn3.181; Macintyre G, 2010, BIOINFORMATICS, V26, pi524, DOI 10.1093/bioinformatics/btq378; Maier LM, 2009, J IMMUNOL, V182, P1541, DOI 10.4049/jimmunol.182.3.1541; Malek TR, 2010, IMMUNITY, V33, P153, DOI 10.1016/j.immuni.2010.08.004; Manke T, 2010, HUM MUTAT, V31, P477, DOI 10.1002/humu.21209; Matiello M, 2011, MULT SCLER J, V17, P634, DOI 10.1177/1352458510394703; Mnasria K, 2008, J LEUKOCYTE BIOL, V84, P460, DOI 10.1189/jlb.1007712; NAGATA K, 1989, J VIROL, V63, P3220, DOI 10.1128/JVI.63.8.3220-3226.1989; Patsopoulos NA, 2011, ANN NEUROL, V70, P897, DOI 10.1002/ana.22609; Perry JSA, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004140; POLLARD AM, 1990, J EXP MED, V172, P159, DOI 10.1084/jem.172.1.159; Reid G, 2003, MOL CELL, V11, P695, DOI 10.1016/S1097-2765(03)00090-X; Sawcer S, 2008, LANCET NEUROL, V7, P567, DOI 10.1016/S1474-4422(08)70122-4; Schwartz AM, 2016, BBA-GENE REGUL MECH, V1859, P1259, DOI 10.1016/j.bbagrm.2016.07.004; Smemo S, 2014, NATURE, V507, P371, DOI 10.1038/nature13138; Stygar D, 2006, CLIN ENDOCRINOL, V64, P74, DOI 10.1111/j.1365-2265.2005.02420.x; Takao T, 2005, J ENDOCRINOL, V184, P191, DOI 10.1677/joe.1.05914; Taylor SE, 2010, CANCER LETT, V288, P133, DOI 10.1016/j.canlet.2009.06.017; VALITUTTI S, 1989, IMMUNOLOGY, V67, P44; Vandenbroeck K, 2012, J INTERF CYTOK RES, V32, P139, DOI 10.1089/jir.2011.0103; Vorontsov IE KI, 2015, P INT C BIOINF MOD M; Wang LM, 2011, J INT MED RES, V39, P1625, DOI 10.1177/147323001103900505; Ward LD, 2012, NUCLEIC ACIDS RES, V40, pD930, DOI 10.1093/nar/gkr917; Weber F, 2008, GENES IMMUN, V9, P259, DOI 10.1038/gene.2008.14; Yakimchuk K, 2012, LEUKEMIA LYMPHOMA, V53, P139, DOI 10.3109/10428194.2011.605187; Yeh JH, 2001, MOL CELL BIOL, V21, P4515, DOI 10.1128/MCB.21.14.4515-4527.2001; Yin WX, 2005, ANAL BIOCHEM, V346, P289, DOI 10.1016/j.ab.2005.08.029	61	9	9	4	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0172681	10.1371/journal.pone.0172681	http://dx.doi.org/10.1371/journal.pone.0172681			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5VB	28234966	Green Published, Green Submitted, gold			2022-12-27	WOS:000394688200113
J	Carr, L; Parkinson, DB; Dun, XP				Carr, Lauren; Parkinson, David B.; Dun, Xin-peng			Expression patterns of Slit and Robo family members in adult mouse spinal cord and peripheral nervous system	PLOS ONE			English	Article							SCHWANN-CELL MIGRATION; DORSAL-ROOT GANGLIA; AXON GUIDANCE; RECEPTOR; ANGIOGENESIS; REGENERATION; REGULATOR; PATHWAY; PROTEIN; MICE	The secreted glycoproteins, Slit1-3, are classic axon guidance molecules that act as repulsive cues through their well characterised receptors Robo1-2 to allow precise axon pathfinding and neuronal migration. The expression patterns of Slit1-3 and Robo1-2 have been most characterized in the rodent developing nervous system and the adult brain, but little is known about their expression patterns in the adult rodent peripheral nervous system. Here, we report a detailed expression analysis of Slit1-3 and Robo1-2 in the adult mouse sciatic nerve as well as their expression in the nerve cell bodies within the ventral spinal cord (motor neurons) and dorsal root ganglion (sensory neurons). Our results show that, in the adult mouse peripheral nervous system, Slit1-3 and Robo1-2 are expressed in the cell bodies and axons of both motor and sensory neurons. While Slit1 and Robo2 are only expressed in peripheral axons and their cell bodies, Slit2, Slit3 and Robo1 are also expressed in satellite cells of the dorsal root ganglion, Schwann cells and fibroblasts of peripheral nerves. In addition to these expression patterns, we also demonstrate the expression of Robo1 in blood vessels of the peripheral nerves. Our work gives important new data on the expression patterns of Slit and Robo family members within the peripheral nervous system that may relate both to nerve homeostasis and the reaction of the peripheral nerves to injury.	[Carr, Lauren; Parkinson, David B.; Dun, Xin-peng] Univ Plymouth, Peninsula Sch Med, Plymouth, Devon, England; [Carr, Lauren; Parkinson, David B.; Dun, Xin-peng] Univ Plymouth, Peninsula Sch Dent, Plymouth, Devon, England; [Dun, Xin-peng] Hubei Univ Sci & Technol, Xian Ning City, Hubei, Peoples R China	University of Plymouth; University of Plymouth; Hubei University of Science & Technology	Dun, XP (corresponding author), Univ Plymouth, Peninsula Sch Med, Plymouth, Devon, England.; Dun, XP (corresponding author), Univ Plymouth, Peninsula Sch Dent, Plymouth, Devon, England.; Dun, XP (corresponding author), Hubei Univ Sci & Technol, Xian Ning City, Hubei, Peoples R China.	xin-peng.dun@plymouth.ac.uk		Dun, Xin-peng/0000-0003-2837-4672	National Natural Science Foundation of China [81371353]; UK Medical Research Council [MR/J012785/1]; MRC [MR/J012785/1] Funding Source: UKRI; Medical Research Council [MR/J012785/1] Funding Source: researchfish	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by The National Natural Science Foundation of China (81371353, http://www.nsfc.gov.cn) to Dr. Xin-peng Dun and the UK Medical Research Council (MR/J012785/1, http://www.mrc.ac.uk) to Prof. David B. Parkinson. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerley S, 2003, J CELL BIOL, V161, P489, DOI 10.1083/jcb.200303138; Alajez NM, 2011, CANCER RES, V71, P2381, DOI 10.1158/0008-5472.CAN-10-2754; Andrews W, 2008, DEV BIOL, V313, P648, DOI 10.1016/j.ydbio.2007.10.052; Andrews W, 2006, DEVELOPMENT, V133, P2243, DOI 10.1242/dev.02379; Anselmo MA, 2003, GENE EXPR PATTERNS, V3, P13, DOI 10.1016/S1567-133X(02)00095-9; Black DL, 2008, NEURON, V58, P297, DOI 10.1016/j.neuron.2008.04.019; Blockus H, 2016, DEVELOPMENT, V143, P3037, DOI 10.1242/dev.132829; Bloechlinger S, 2004, EUR J NEUROSCI, V19, P1119, DOI 10.1111/j.1460-9568.2004.03262.x; Brose K, 2000, CURR OPIN NEUROBIOL, V10, P95, DOI 10.1016/S0959-4388(99)00066-5; Cattin AL, 2015, CELL, V162, P1127, DOI 10.1016/j.cell.2015.07.021; Chen ZB, 2012, ANAT REC, V295, P652, DOI 10.1002/ar.22419; Comer JD, 2015, FRONT NEURAL CIRCUIT, V9, DOI 10.3389/fncir.2015.00036; Dascenco D, 2015, CELL, V162, P1140, DOI 10.1016/j.cell.2015.08.003; Evans TA, 2015, ELIFE, V4, DOI 10.7554/eLife.08407; Fish JE, 2011, DEVELOPMENT, V138, P1409, DOI 10.1242/dev.060046; Fujiwara M, 2006, VASC MED, V11, P115, DOI 10.1191/1358863x06vm658ra; Grieshammer U, 2004, DEV CELL, V6, P709, DOI 10.1016/S1534-5807(04)00108-X; Guo SW, 2013, REPROD SCI, V20, P285, DOI 10.1177/1933719112452940; Hammond R, 2005, DEVELOPMENT, V132, P4483, DOI 10.1242/dev.02038; Heermann S, 2013, CELL ADHES MIGR, V7, P18, DOI 10.4161/cam.22123; Huang ZH, 2011, J CELL SCI, V124, P186, DOI 10.1242/jcs.071357; Huminiecki L, 2002, GENOMICS, V79, P547, DOI 10.1006/geno.2002.6745; Ip BK, 2011, CEREB CORTEX, V21, P1395, DOI 10.1093/cercor/bhq219; Isaacman-Beck J, 2015, NEURON, V88, P691, DOI 10.1016/j.neuron.2015.10.004; Jones CA, 2008, NAT MED, V14, P448, DOI 10.1038/nm1742; Jones CA, 2009, NAT CELL BIOL, V11, P1325, DOI 10.1038/ncb1976; Kaus S, 2006, J BIOL CHEM, V281, P11347, DOI 10.1074/jbc.M508853200; Kidd T, 1999, CELL, V96, P785, DOI 10.1016/S0092-8674(00)80589-9; Koch AW, 2011, DEV CELL, V20, P33, DOI 10.1016/j.devcel.2010.12.001; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma L, 2007, J NEUROSCI, V27, P6843, DOI 10.1523/JNEUROSCI.1479-07.2007; Mallon BS, 2002, J NEUROSCI, V22, P876, DOI 10.1523/JNEUROSCI.22-03-00876.2002; Marillat V, 2004, NEURON, V43, P69, DOI 10.1016/j.neuron.2004.06.018; Marillat V, 2002, J COMP NEUROL, V442, P130, DOI 10.1002/cne.10068; Marlow R, 2010, P NATL ACAD SCI USA, V107, P10520, DOI 10.1073/pnas.1001896107; Michalski N, 2013, NEURON, V78, P855, DOI 10.1016/j.neuron.2013.04.006; Mommersteeg MTM, 2013, CIRC RES, V112, P465, DOI 10.1161/CIRCRESAHA.112.277426; Morlot C, 2007, P NATL ACAD SCI USA, V104, P14923, DOI 10.1073/pnas.0705310104; Nascimento RS, 2008, BRAZ J MED BIOL RES, V41, P1011, DOI 10.1590/S0100-879X2008005000051; Niemann A, 2014, BRAIN, V137, P668, DOI 10.1093/brain/awt371; Pina-Oviedo S, 2008, ADV ANAT PATHOL, V15, P147, DOI 10.1097/PAP.0b013e31816f8519; Piper M, 2002, NEUROREPORT, V13, P2375, DOI 10.1097/00001756-200212030-00041; Plump AS, 2002, NEURON, V33, P219, DOI 10.1016/S0896-6273(01)00586-4; Qian L, 2005, CURR BIOL, V15, P2271, DOI 10.1016/j.cub.2005.10.037; Sabatier C, 2004, CELL, V117, P157, DOI 10.1016/S0092-8674(04)00303-4; Sheldon H, 2009, FASEB J, V23, P513, DOI 10.1096/fj.07-098269; Shu TZ, 2003, J NEUROSCI, V23, P8176; Smith-Berdan S, 2015, STEM CELL REP, V4, P255, DOI 10.1016/j.stemcr.2014.12.013; Smith-Berdan S, 2011, CELL STEM CELL, V8, P72, DOI 10.1016/j.stem.2010.11.030; Suchting S, 2006, FASEB J, V19, P121; Sundaresan V, 2004, J COMP NEUROL, V468, P467, DOI 10.1002/cne.10984; Torigoe K, 1996, EXP NEUROL, V137, P301, DOI 10.1006/exnr.1996.0030; Wang KH, 1999, CELL, V96, P771, DOI 10.1016/S0092-8674(00)80588-7; Wang Y, 2013, GLIA, V61, P710, DOI 10.1002/glia.22464; Wayburn B, 2009, DEVELOPMENT, V136, P3607, DOI 10.1242/dev.040329; Yang YHC, 2013, P NATL ACAD SCI USA, V110, P16480, DOI 10.1073/pnas.1214312110; Yi XN, 2006, NEUROSCI RES, V56, P314, DOI 10.1016/j.neures.2006.07.014; Yuan WL, 2003, P NATL ACAD SCI USA, V100, P5217, DOI 10.1073/pnas.0730709100; Yuan WL, 1999, DEV BIOL, V212, P290, DOI 10.1006/dbio.1999.9371; Zelina P, 2014, NEURON, V84, P1258, DOI 10.1016/j.neuron.2014.11.004; Zhang B, 2009, BLOOD, V114, P4300, DOI 10.1182/blood-2008-12-193326; Zhang HY, 2010, J CHEM NEUROANAT, V39, P256, DOI 10.1016/j.jchemneu.2010.02.001; Zhang ZH, 2016, GLIA, V64, P374, DOI 10.1002/glia.22934; Zhuang XD, 2011, BIOCHEM SOC T, V39, P1571, DOI 10.1042/BST20110746; Zhuo L, 1997, DEV BIOL, V187, P36, DOI 10.1006/dbio.1997.8601	65	29	29	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0172736	10.1371/journal.pone.0172736	http://dx.doi.org/10.1371/journal.pone.0172736			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5VB	28234971	gold, Green Published, Green Submitted			2022-12-27	WOS:000394688200123
J	Groszyk, J; Kowalczyk, M; Yanushevska, Y; Stochmal, A; Rakoczy-Trojanowska, M; Orczyk, W				Groszyk, Jolanta; Kowalczyk, Mariusz; Yanushevska, Yuliya; Stochmal, Anna; Rakoczy-Trojanowska, Monika; Orczyk, Waclaw			Identification and VIGS-based characterization of Bx1 ortholog in rye (Secale cereale L.)	PLOS ONE			English	Article							STRIPE-MOSAIC-VIRUS; MOLECULAR CHARACTERIZATION; HYDROXAMIC ACIDS; BENZOXAZINOID BIOSYNTHESIS; CHROMOSOMAL LOCALIZATION; PLANT RESISTANCE; INNATE IMMUNITY; GENE; MAIZE; WHEAT	The first step of the benzoxazinoid (BX) synthesis pathway is catalyzed by an enzyme with indole-3-glycerol phosphate lyase activity encoded by 3 genes, Bx1, TSA and Igl. A gene highly homologous to maize and wheat Bx1 has been identified in rye. The goal of the study was to analyze the gene and to experimentally verify its role in the rye BX biosynthesis pathway as a rye ortholog of the Bx1 gene. Expression of the gene showed peak values 3 days after imbibition (dai) and at 21 dai it was undetectable. Changes of the BX content in leaves were highly correlated with the expression pattern until 21 dai. In plants older than 21 dai despite the undetectable expression of the analyzed gene there was still low accumulation of BXs. Function of the gene was verified by correlating its native expression and virusinduced silencing with BX accumulation. Barley stripe mosaic virus (BSMV)-based vectors were used to induce transcriptional (TGS) and posttranscriptional (PTGS) silencing of the analyzed gene. Both strategies (PTGS and TGS) significantly reduced the transcript level of the analyzed gene, and this was highly correlated with lowered BX content. Inoculation with virus-based vectors specifically induced expression of the analyzed gene, indicating up-regulation by biotic stressors. This is the first report of using the BSMV-based system for functional analysis of rye gene. The findings prove that the analyzed gene is a rye ortholog of the Bx1 gene. Its expression is developmentally regulated and is strongly induced by biotic stress. Stable accumulation of BXs in plants older than 21 dai associated with undetectable expression of ScBx1 indicates that the function of the ScBx1 in the BX biosynthesis is redundant with another gene. We anticipate that the unknown gene is a putative ortholog of the Igl, which still remains to be identified in rye.	[Groszyk, Jolanta; Yanushevska, Yuliya; Orczyk, Waclaw] Natl Res Inst, Plant Breeding & Acclimatizat Inst, Dept Genet Engn, Blonie, Poland; [Kowalczyk, Mariusz; Stochmal, Anna] Inst Soil Sci, Dept Biochem & Crop Qual, Pulawy, Poland; [Kowalczyk, Mariusz; Stochmal, Anna] Plant Cultivat State Res Inst, Pulawy, Poland; [Rakoczy-Trojanowska, Monika] Warsaw Univ Life Sci, Dept Plant Genet Breeding & Biotechnol, Warsaw, Poland	Institute of Plant Breeding & Acclimatization; Institute of Soil Science & Plant Cultivation; Warsaw University of Life Sciences	Orczyk, W (corresponding author), Natl Res Inst, Plant Breeding & Acclimatizat Inst, Dept Genet Engn, Blonie, Poland.	w.orczyk@ihar.edu.pl	Stochmal, Anna/AAR-1759-2021; Kowalczyk, Mariusz/ABD-2910-2020	Kowalczyk, Mariusz/0000-0001-7454-4762; Groszyk, Jolanta/0000-0002-2517-8142; Rakoczy-Trojanowska, Monika/0000-0001-6891-0471; Kloc, Yuliya/0000-0001-6837-2255	National Centre for Research and Development [PBS1/A8/12/2012]; National Science Centre [UMO-2015/19/B/NZ9/00921, NCN UMO-2015/19/B/NZ9/00921]; Plant Breeding and Acclimatization-NRI Statutory Research [1-1-01-4-04]	National Centre for Research and Development(National Centre for Research & Development, Poland); National Science Centre(National Science Centre, Poland); Plant Breeding and Acclimatization-NRI Statutory Research	The research has been financed by The National Centre for Research and Development grant No PBS1/A8/12/2012, National Science Centre UMO-2015/19/B/NZ9/00921 (M.R-T) and Plant Breeding and Acclimatization-NRI Statutory Research Grant No 1-1-01-4-04 (WO). The funders had no role in study design, data collection and analysis, decision to publish,or preparation of the manuscript.; The research has been financed by The National Centre for Research and Development grant No PBS1/A8/12/2012, National Science Centre NCN UMO-2015/19/B/NZ9/00921 (M.R-T) and Plant Breeding and Acclimatization Institute - NRI Statutory Research Grant No 1-1-014-04 (WO).	Ahmad S, 2011, PLANT PHYSIOL, V157, P317, DOI 10.1104/pp.111.180224; Anderson CM, 2001, PLANT MOL BIOL, V47, P197, DOI 10.1023/A:1010691701578; Bakera B, 2015, J APPL GENET, V56, P287, DOI 10.1007/s13353-015-0271-z; Bennypaul HS, 2012, FUNCT INTEGR GENOMIC, V12, P143, DOI 10.1007/s10142-011-0245-0; Bond DM, 2015, P NATL ACAD SCI USA, V112, P917, DOI 10.1073/pnas.1413053112; Brenet F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014524; Bruun-Rasmussen M, 2007, MOL PLANT MICROBE IN, V20, P1323, DOI 10.1094/MPMI-20-11-1323; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Copaja SV, 2006, Z NATURFORSCH C, V61, P670; Delventhal R, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-26; Demircan T, 2010, PLANT CELL TISS ORG, V100, P91, DOI 10.1007/s11240-009-9623-x; Deng SL, 2014, PLANT CELL PHYSIOL, V55, P823, DOI 10.1093/pcp/pcu025; Dutartre L, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-64; Erb M, 2009, PLANT J, V59, P292, DOI 10.1111/j.1365-313X.2009.03868.x; FREY M, 1995, MOL GEN GENET, V246, P100, DOI 10.1007/BF00290138; Frey M, 2003, PHYTOCHEMISTRY, V62, P371, DOI 10.1016/S0031-9422(02)00556-3; Frey M, 1997, SCIENCE, V277, P696, DOI 10.1126/science.277.5326.696; Frey M, 2000, P NATL ACAD SCI USA, V97, P14801, DOI 10.1073/pnas.260499897; Frey M, 2009, PHYTOCHEMISTRY, V70, P1645, DOI 10.1016/j.phytochem.2009.05.012; Gierl A, 2001, PLANTA, V213, P493, DOI 10.1007/s004250100594; Glauser G, 2011, PLANT J, V68, P901, DOI 10.1111/j.1365-313X.2011.04740.x; Grun S, 2005, PHYTOCHEMISTRY, V66, P1264, DOI 10.1016/j.phytochem.2005.01.024; Guo J, 2013, PLANT PHYSIOL BIOCH, V71, P164, DOI 10.1016/j.plaphy.2013.07.009; Holzberg S, 2002, PLANT J, V30, P315, DOI 10.1046/j.1365-313X.2002.01291.x; Hua W, 2008, CAN J PLANT PATHOL, V30, P368; Huffaker A, 2011, PLANT PHYSIOL, V155, P1325, DOI 10.1104/pp.110.166710; Jonczyk R, 2008, PLANT PHYSIOL, V146, P1053, DOI 10.1104/pp.107.111237; Jones L, 1999, PLANT CELL, V11, P2291, DOI 10.1105/tpc.11.12.2291; Jones L, 2001, CURR BIOL, V11, P747, DOI 10.1016/S0960-9822(01)00226-3; Kanazawa A, 2011, PLANT J, V65, P156, DOI 10.1111/j.1365-313X.2010.04401.x; Kawalek A, 2012, CELL MOL BIOL LETT, V17, P107, DOI 10.2478/s11658-011-0041-9; Kettle AJ, 2015, MOL PLANT PATHOL, V16, P946, DOI 10.1111/mpp.12250; Kriechbaumer V, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-44; KUMAGAI MH, 1995, P NATL ACAD SCI USA, V92, P1679, DOI 10.1073/pnas.92.5.1679; La Hovary C., 2011, ALLELOCHEMICALS SECA, P152; Lacomme C, 2011, CURR TOP MICROBIOL I, V375, P89, DOI DOI 10.1007/82_; Lacomme C, 2014, CURR TOP MICROBIOL, V375, P89, DOI 10.1007/82_2011_186; Liang D, 2014, BMC GENET, V15, DOI 10.1186/1471-2156-15-S1-S9; Ma M, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-141; Meihls LN, 2013, PLANT CELL, V25, P2341, DOI 10.1105/tpc.113.112409; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Neal AL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035498; NIEMEYER HM, 1992, REV CHIL HIST NAT, V65, P103; Nomura T, 2005, P NATL ACAD SCI USA, V102, P16490, DOI 10.1073/pnas.0505156102; Nomura T, 2003, PLANTA, V217, P776, DOI 10.1007/s00425-003-1040-5; Nomura T, 2002, MOL GENET GENOMICS, V267, P210, DOI 10.1007/s00438-002-0653-x; Nomura T, 2007, PHYTOCHEMISTRY, V68, P1008, DOI 10.1016/j.phytochem.2007.01.007; Oikawa A, 2004, PHYTOCHEMISTRY, V65, P2995, DOI 10.1016/j.phytochem.2004.09.006; Otagaki S., 2006, PLANT BIOTECHNOL-NAR, V23, P259, DOI [DOI 10.5511/PLANTBIOTECHNOLOGY.23.259, 10.5511/plantbiotechnology.23.259]; Pacak A, 2010, PLANT METHODS, V6, DOI 10.1186/1746-4811-6-26; PETTY ITD, 1989, VIROLOGY, V171, P342, DOI 10.1016/0042-6822(89)90601-6; Pogue G.P. L JA, 1998, TOBAMOVIRUS TRANSIEN; Schullehner K, 2008, PHYTOCHEMISTRY, V69, P2668, DOI 10.1016/j.phytochem.2008.08.023; Schulz M, 2013, J CHEM ECOL, V39, P154, DOI 10.1007/s10886-013-0235-x; Senthil-Kumar M, 2011, TRENDS PLANT SCI, V16, P656, DOI 10.1016/j.tplants.2011.08.006; SMISSMAN EE, 1957, J ORG CHEM, V22, P220, DOI 10.1021/jo01353a036; Sue M, 2011, PLANT PHYSIOL, V157, P985, DOI 10.1104/pp.111.182378; Tanwir F, 2013, FOOD CHEM, V141, P444, DOI 10.1016/j.foodchem.2013.02.109; Teasdale JR, 2012, PLANT ECOL, V213, P1893, DOI 10.1007/s11258-012-0057-x; VIRTANEN AI, 1955, ACTA CHEM SCAND, V9, P1543, DOI 10.3891/acta.chem.scand.09-1543b; Wang ZG, 2013, PLANT PHYSIOL, V162, P885, DOI 10.1104/pp.113.214700; Wijekoon CP, 2012, PLANT J, V69, P1052, DOI 10.1111/j.1365-313X.2011.04855.x; Yang YC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079434	63	14	14	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e71506	10.1371/journal.pone.0171506	http://dx.doi.org/10.1371/journal.pone.0171506			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5VB	28234909	gold, Green Published, Green Submitted			2022-12-27	WOS:000394688200024
J	Amyotte, B; Bowen, AJ; Banks, T; Rajcan, I; Somers, DJ				Amyotte, Beatrice; Bowen, Amy J.; Banks, Travis; Rajcan, Istvan; Somers, Daryl J.			Mapping the sensory perception of apple using descriptive sensory evaluation in a genome wide association study	PLOS ONE			English	Article							SELECTION; FRUIT	Breeding apples is a long-term endeavour and it is imperative that new cultivars are selected to have outstanding consumer appeal. This study has taken the approach of merging sensory science with genome wide association analyses in order to map the human perception of apple flavour and texture onto the apple genome. The goal was to identify genomic associations that could be used in breeding apples for improved fruit quality. A collection of 85 apple cultivars was examined over two years through descriptive sensory evaluation by a trained sensory panel. The trained sensory panel scored randomized sliced samples of each apple cultivar for seventeen taste, flavour and texture attributes using controlled sensory evaluation practices. In addition, the apple collection was subjected to genotyping by sequencing for marker discovery. A genome wide association analysis suggested significant genomic associations for several sensory traits including juiciness, crispness, mealiness and fresh green apple flavour. The findings include previously unreported genomic regions that could be used in apple breeding and suggest that similar sensory association mapping methods could be applied in other plants.	[Amyotte, Beatrice; Bowen, Amy J.; Banks, Travis; Somers, Daryl J.] Vineland Res & Innovat Ctr, Victoria Ave North, Vineland Stn, ON, Canada; [Rajcan, Istvan] Univ Guelph, Dept Plant Agr, Guelph, ON, Canada	University of Guelph	Somers, DJ (corresponding author), Vineland Res & Innovat Ctr, Victoria Ave North, Vineland Stn, ON, Canada.	Daryl.Somers@vinelandresearch.com	Bowen, Amy/V-9820-2019	Bowen, Amy/0000-0002-2677-7104	Ontario Apple Growers, University of Guelph / Ontario Ministry of Agri-Food and Rural Affairs; Agriculture and Agri-Food Canada Growing Forward 2 Agri-Innovations Program	Ontario Apple Growers, University of Guelph / Ontario Ministry of Agri-Food and Rural Affairs; Agriculture and Agri-Food Canada Growing Forward 2 Agri-Innovations Program	This research was carried out at the Vineland Research and Innovation Centre. Funding was privded to DS by the Ontario Apple Growers, University of Guelph / Ontario Ministry of Agri-Food and Rural Affairs partnership program as well as the Agriculture and Agri-Food Canada Growing Forward 2 Agri-Innovations Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai Y, 2012, MOL GENET GENOMICS; Ban Y, 2007, PLANT CELL PHYSL; Bates D, 2015, J STAT SOFTWARE; Baumgartner IO, 2016, TREE GENET GENOMES, V12, DOI 10.1007/s11295-016-0994-y; BEACH SA, 1905, APPLES NEW YORK, V2; Ben Sadok I, 2015, TREE GENET GENOMES, V11, DOI 10.1007/s11295-015-0947-x; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bink MC, 2014, THEOR APPL GENET; Blanpied G.D., 1992, CORNELL COOPERATIVE, V221; Bradbury P.J., 2007, BIOINFORMATICS; Brummell DA, 2006, FUNCT PLANT BIOL, V33, P103, DOI 10.1071/FP05234; CATTELL RB, 1966, MULTIVAR BEHAV RES, V1, P245, DOI 10.1207/s15327906mbr0102_10; Cliff MA, 2015, J SCI FOOD AGR; Corollaro ML, 2013, POSTHARVEST BIOL TEC; Costa F, 2001, J EXP BOT; Costa F, 2008, TREE GENET GENOMES; Costa F, 2005, EUPHYTICA; Dunemann F, 2009, MOL BREED; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Endelman JB, 2012, SHRINKAGE ESTIMATION, V3; Evans K, 2010, HORTTECHNOLOGY, V20, P1026, DOI 10.21273/HORTSCI.20.6.1026; FAO, 2016, FAOSTAT DAT; Gardner KM, 2014, FAST COST EFFECTIVE, V3; Glaubitz JC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090346; Guan Y, 2015, MOL BREED; Hampson CR, 2000, EUPHYTICA; Hancock JF., 2008, TEMPERATE FRUIT CROP; HARKER FR, 1992, HORTSCIENCE, V27, P1291, DOI 10.21273/HORTSCI.27.12.1291; Harker FR, 2006, J FOOD SCI; Harker FR, 2002, POSTHARVEST BIOL TEC; Harker FR, 2008, POSTHARVEST BIOL TEC; Harrell Jr F.E., 2016, PACKAGE HMISC VERSIO; Hoehn E, 2003, POSTHARVEST BIOL TEC; Johnson M, 2012, NUCL ACIDS RES; Jung S, 2013, NUCL ACIDS RES; Kenis K, 2008, TREE GENET GENOMES; Khan MA, 2012, J EXP BOT; King GJ, 2000, THEOR APPL GENET; Kumar S, 2015, MOL BREED; Kumar S, 2014, PLANT GENET RESOUR; Kumar S, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-393; Leforestier D, 2015, EVOL APPL; Liebhard R, 2003, PLANT MOL BIOL; Longhi S, 2012, J EXP BOT; Luby JJ, 2001, HORTSCIENCE, V36, P872, DOI 10.21273/HORTSCI.36.5.872; Maliepaard C, 1998, THEOR APPL GENET; Maliepaard C, 2001, THEOR APPL GENET; Marroni F, 2011, TREE GENET GENOMES; Mehinagic E, 2006, J AGR FOOD CHEM; Merk, 2014, ESTIMATING HERITABIL; Merk HL, 2012, J AM SOC HORTIC SCI, V137, P427, DOI 10.21273/JASHS.137.6.427; Micheletti D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136803; Micheli F., 2001, TRENDS PLANT SCI; Money D, 2015, LINKIMPUTE FAST ACCU, V3; Morgan J, 1993, NEW BOOK APPLES; Murray J. M., 2001, FOOD RES INT; MYLES S, 2009, PLANT CELL; Oraguzie N, 2009, POSTHARVEST BIOL TEC; Purcell S, 2007, AM J HUM GENET; R Core Team, 2013, R LANG ENV STAT COMP; Ru S, 2015, TREE GENET GENOMES, V11, DOI 10.1007/s11295-015-0834-5; Segonne SM, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0375-3; Souleyre E, 2014, PLANT J; Stone H, SENSORY EVALUATION P, V4; Turner S. D., 2014, BIORXIV, DOI DOI 10.1101/005165; Velasco R, 2011, NAT GENET; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Xu K, 2011, MOL BREED; Yang J, 2014, NATURE GENET	69	34	36	12	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2017	12	2							e0171710	10.1371/journal.pone.0171710	http://dx.doi.org/10.1371/journal.pone.0171710			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5SX	28231290	gold, Green Published, Green Submitted			2022-12-27	WOS:000394682400017
J	Carmona-Quiroga, PM; Jacobs, RMJ; Martinez-Ramirez, S; Viles, HA				Carmona-Quiroga, Paula M.; Jacobs, Robert M. J.; Martinez-Ramirez, Sagrario; Viles, Heather A.			Durability of anti-graffiti coatings on stone: natural vs accelerated weathering	PLOS ONE			English	Article							SURFACES; PAINT	Extending the use of novel anti-graffiti coatings to built heritage could be of particular interest providing the treatments are efficient enough in facilitating graffiti removal and long-lasting to maintain their protective properties without interfering with the durability of the substrates. However, studies of the durability of these coatings are scarce and have been mainly carried out under accelerated weathering conditions, the most common practice for assessing the durability of materials but one that does not reproduce accurately natural working conditions. The present study aimed to assess the durability of the anti-graffiti protection afforded by two anti-graffiti treatments (a water dispersion of polyurethane with a perfluoropolyether backbone and a water based crystalline micro wax) on Portland limestone and Woodkirk sandstone after 1 year of outdoor exposure in the South of England with periodic painting and cleaning episodes taking place. A parallel study under artificial weathering conditions in a QUV chamber for 2000 hours was also carried out. Changes to the coatings were assessed by measuring colour, gloss, water-repellency, roughness and microstructure, the latter through micro-Raman and optical microscope observations, periodically during the experiments. The results show that both anti-graffiti treatments deteriorated under both artificial and natural weathering conditions. For the polyurethane based anti-graffiti treatment, artificial ageing produced more deterioration than 1 year of outdoor exposure in the south of England due to loss of adhesion from the stones, whereas for micro wax coating there were no substantial differences between the two types of weathering.	[Carmona-Quiroga, Paula M.; Viles, Heather A.] Univ Oxford, Sch Geog & Environm, Oxford, England; [Jacobs, Robert M. J.] Univ Oxford, Dept Chem, Chem Res Lab, Oxford, England; [Martinez-Ramirez, Sagrario] CSIC, Inst Estruct Mat, Dept Espect Nucl Vibrac & Medios Desordenados, Madrid, Spain	University of Oxford; University of Oxford; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Estructura de la Materia (IEM)	Viles, HA (corresponding author), Univ Oxford, Sch Geog & Environm, Oxford, England.	heather.viles@ouce.ox.ac.uk	Martinez-Ramirez, Sagrario/L-7516-2014; Carmona-Quiroga, Paula/M-4701-2015; Varela, M Teresa Blanco/F-9500-2016	Martinez-Ramirez, Sagrario/0000-0002-6322-535X; Carmona-Quiroga, Paula/0000-0002-9583-7131; Varela, M Teresa Blanco/0000-0003-3306-3289; Viles, Heather/0000-0002-2444-1295	People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme (FP7) under REA [PIEF-GA-2013-622417]	People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme (FP7) under REA	The research leading to these results has received funding from the People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme (FP7/2007-2013) under REA grant agreement PIEF-GA-2013-622417 (CLEANING HERITAGE).	[Anonymous], 2008, D4799D4799M082013E1; [Anonymous], 2013, 164743 ISO EUR COMM; [Anonymous], 1999, 101519 EN; [Anonymous], 2011, 6006825 EN; [Anonymous], 2016, 1936 EN; Berns R. S., 2000, BILLMEYER SALTZMANS, DOI DOI 10.1002/9781119367314; Bochen J, 2015, CONSTR BUILD MATER, V79, P192, DOI 10.1016/j.conbuildmat.2014.12.079; Boostani H, 2016, PROCEDIA ENGINEER, V145, P1541, DOI 10.1016/j.proeng.2016.04.194; Building Research Establishment (BRE), 2000, BRE BRIT STON STON L; Carvalhao M, 2015, J CULT HERIT, V16, P579, DOI 10.1016/j.culher.2014.10.004; Doehne E., 2010, STONE CONSERVATION O, VVolume 158; Dorn R.I, 1998, DEV EARTH SURFACE PR, V6; European Commission, 2012, PV GIS; Gagne L., 2014, THESIS QUEENS U KING; Garcia O, 2010, MATER CONSTRUCC, V60, P69, DOI 10.3989/mc.2010.45507; Garcia O, 2012, J CULT HERIT, V13, P77, DOI 10.1016/j.culher.2011.07.004; Lettieri M, 2014, APPL SURF SCI, V288, P466, DOI 10.1016/j.apsusc.2013.10.056; Licchelli M, 2014, APPL PHYS A-MATER, V116, P1525, DOI 10.1007/s00339-014-8356-9; Licchelli M, 2011, J CULT HERIT, V12, P34, DOI 10.1016/j.culher.2010.07.002; Malaga K, 2013, J MATER CIVIL ENG, V25, P755, DOI 10.1061/(ASCE)MT.1943-5533.0000557; Carmona-Quiroga PM, 2015, ENGINEERING GEOLOGY FOR SOCIETY AND TERRITORY, VOL 8: PRESERVATION OF CULTURAL HERITAGE, P531, DOI 10.1007/978-3-319-09408-3_94; Carmona-Quiroga PM, 2010, J CULT HERIT, V11, P297, DOI 10.1016/j.culher.2009.09.006; Marzolla SJ, 2008, SCI ACTA, V2, P12; Maxova A I, 2006, 7 EUR C SAUVEUR SAF, P831; Mercero O. Garcia, 2008, THESIS; Moura A, 2016, CONSTR BUILD MATER, V107, P157, DOI 10.1016/j.conbuildmat.2015.12.181; Rabea AM, 2012, J APPL POLYM SCI, V124, P3082, DOI 10.1002/app.35344; Rabea AM, 2011, J COAT TECHNOL RES, V8, P497, DOI 10.1007/s11998-011-9324-3; Radice S, 2004, J FLUORINE CHEM, V125, P151, DOI 10.1016/j.jfluchem.2003.07.004; Rivas T, 2012, APPL SURF SCI, V263, P563, DOI 10.1016/j.apsusc.2012.09.110; Rossi S, 2016, J COAT TECHNOL RES, V13, P427, DOI 10.1007/s11998-015-9764-2; Shalini D, 2016, NANORESEARCH APPL, V2, P1; Tarnowski A., 2007, J CANADIAN ASS CONSE, V32, P3; Wewers D, 2005, 49 ULM CONCR PREC CO	34	15	15	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2017	12	2							e0172347	10.1371/journal.pone.0172347	http://dx.doi.org/10.1371/journal.pone.0172347			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5SX	28231301	Green Published, Green Submitted, gold			2022-12-27	WOS:000394682400037
J	Liu, XL; He, LL; Han, JY; Wang, LJ; Li, MG; Jiang, YY; Wang, XB; Yang, ZY				Liu, Xiaoli; He, Lingling; Han, Junyan; Wang, Lijia; Li, Mengge; Jiang, Yuyong; Wang, Xianbo; Yang, Zhiyun			Association of neutrophil-lymphocyte ratio and T lymphocytes with the pathogenesis and progression of HBV-associated primary liver cancer	PLOS ONE			English	Article							RECENT THYMIC EMIGRANTS; HEPATITIS-B; CELLS; SURVIVAL; PREDICTOR; EPIDEMIOLOGY; RECURRENCE; MARKER; MEMORY	Background The neutrophil-lymphocyte ratio (NLR) is a new prognostic predictor for patients with liver cancer. The association of NLR and T lymphocytes with the pathogenesis and progression of liver cancer is poorly understood. Methods Seventy-three patients with hepatitis B virus (HBV)-associated primary liver cancer (HBVPLC), 50 patients with HBV-associated liver cirrhosis (HBV-LC) and 37 patients with chronic HBV infection (CHB) were prospectively enrolled from July 1, 2013 to February 28, 2014 in Beijing Ditan Hospital, Capital Medical University (Beijing, China). The NLR, proportions and concentrations of neutrophils and lymphocytes, concentration of subpopulations of lymphocytes, and the expression of CD31 (index for recent thymic output) and HLA-DR (index for activation of T lymphocytes) of T cells in the peripheral blood samples of the patients were assessed and statistically compared between different groups. Results The NLR was significantly increased from patients with CHB, those with HBV-LC to those with HBV-PLC (P< 0.05), along with significant increase of neutrophils and decrease of lymphocytes in the same way (P< 0.05). The concentrations of T lymphocytes, natural killer cells, B cells, CD4(+) T cells and CD8(+) T cells were decreased from patients with CHB, those with HBV-LC to those with HBV-PLC, and were significantly reduced in patients with HBVPLC compared with those in patients with CHB (P< 0.05). The CD31 and HLA-DR expression of naive CD4(+) and CD8(+) T cells was significantly decreased and increased, respectively in patients with HBV-PLC compared with that in patients with CHB. Conclusions Elevated NLR, resulted from the increase of neutrophils and decrease of lymphocytes, is positively associated with the pathogenesis and progression of HBV-PLC. The reduced thymic output and hyperactivation of T lymphocytes may contribute to the decrease of T lymphocytes, which could be also related to the pathogenesis of HBV-PLC.	[Liu, Xiaoli; He, Lingling; Wang, Lijia; Li, Mengge; Jiang, Yuyong; Wang, Xianbo; Yang, Zhiyun] Capital Med Univ, Beijing Ditan Hosp, Ctr Integrat Med, Beijing, Peoples R China; [Han, Junyan] Capital Med Univ, Beijing Ditan Hosp, Inst Infect Dis, Beijing Key Lab Emerging Infect Dis, Beijing, Peoples R China	Capital Medical University; Capital Medical University	Yang, ZY (corresponding author), Capital Med Univ, Beijing Ditan Hosp, Ctr Integrat Med, Beijing, Peoples R China.	yangzhiyun66@163.com	Liu, Xiaoli/HGE-7614-2022	jiang, yu yong/0000-0002-6082-1180; He, Lingling/0000-0001-8082-8788	Beijing Natural Science Foundation of China [7142081]; Capital Special Health Research and Development [2016-2-2171]; Science and Technology Project of Beijing Municipal Education Commission [SQKM201610025026]; Science and Technology Development Project of Beijing Traditional Chinese Medicine [JJ2016-14]; Beijing Health High-Level Personnel Plan [2013-3-026]	Beijing Natural Science Foundation of China(Beijing Natural Science Foundation); Capital Special Health Research and Development; Science and Technology Project of Beijing Municipal Education Commission; Science and Technology Development Project of Beijing Traditional Chinese Medicine; Beijing Health High-Level Personnel Plan	This work was supported by the Beijing Natural Science Foundation of China (No.7142081), the Capital Special Health Research and Development (No. 2016-2-2171), the Science and Technology Project of Beijing Municipal Education Commission (No. SQKM201610025026), the Science and Technology Development Project of Beijing Traditional Chinese Medicine (No. JJ2016-14), and Beijing Health High-Level Personnel Plan (No. 2013-3-026).	Caligiuri MA, 2008, BLOOD, V112, P461, DOI 10.1182/blood-2007-09-077438; Cao LL, 2016, ONCOTARGET; Chen TM, 2012, J GASTROEN HEPATOL, V27, P553, DOI 10.1111/j.1440-1746.2011.06910.x; Coulie PG, 2014, NAT REV CANCER, V14, P135, DOI 10.1038/nrc3670; Cui Y, 2013, J GASTROEN HEPATOL, V28, P7, DOI 10.1111/jgh.12220; Cummings M, 2015, BRIT J CANCER, V113, P311, DOI 10.1038/bjc.2015.200; D'Emic N, 2016, J GASTROINTEST ONCOL, V7, P269, DOI 10.3978/j.issn.2078-6891.2015.108; Duzlu Mehmet, 2015, Asian Pac J Cancer Prev, V16, P351; El-Serag HB, 2012, GASTROENTEROLOGY, V142, P1264, DOI 10.1053/j.gastro.2011.12.061; Gao FY, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000639; Gomez D, 2008, WORLD J SURG, V32, P1757, DOI 10.1007/s00268-008-9552-6; Guthrie GJK, 2013, CRIT REV ONCOL HEMAT, V88, P218, DOI 10.1016/j.critrevonc.2013.03.010; Janssen EM, 2003, NATURE, V421, P852, DOI 10.1038/nature01441; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kennedy R, 2008, IMMUNOL REV, V222, P129, DOI 10.1111/j.1600-065X.2008.00616.x; Kohler S, 2009, BLOOD, V113, P769, DOI 10.1182/blood-2008-02-139154; Kuss I, 2005, CLIN IMMUNOL, V116, P27, DOI 10.1016/j.clim.2004.12.011; Li Yang-Qiu, 2007, Zhongguo Shi Yan Xue Ye Xue Za Zhi, V15, P1023; Lian L, 2015, CANCER BIOMARK, V15, P899, DOI 10.3233/CBM-150534; Liaw YF, 2006, ANTIVIR THER, V11, P669; Lu SD, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002722; Millrud CR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051120; Milne K, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-33; Na N, 2016, ONCOTARGET; Okamura Y, 2016, BRIT J SURG, V103, P891, DOI 10.1002/bjs.10123; Parkin DM, 2006, INT J CANCER, V118, P3030, DOI 10.1002/ijc.21731; Pratesi C, 2008, CLIN EXP IMMUNOL, V151, P101, DOI 10.1111/j.1365-2249.2007.03516.x; Prins RM, 2003, J NEURO-ONCOL, V64, P45, DOI 10.1023/A:1024929724736; Salman T, 2015, CHEMOTHERAPY, V61, P281, DOI 10.1159/000445045; Shao N, 2015, CLIN TRANSL ONCOL, V17, P772, DOI 10.1007/s12094-015-1289-8; Sharaiha RZ, 2011, ANN SURG ONCOL, V18, P3362, DOI 10.1245/s10434-011-1754-8; Taipale K, 2016, MOL THER; Takahashi Y, 2016, WORLD J SURG, V40, P365, DOI 10.1007/s00268-015-3275-2; Tanaskovic S, 2010, IMMUNOL CELL BIOL, V88, P321, DOI 10.1038/icb.2009.108; Tang L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153981; Vivier E, 2008, NAT IMMUNOL, V9, P503, DOI 10.1038/ni1582; Wang WJ, 2013, ASIAN PAC J CANCER P, V14, P4671, DOI 10.7314/APJCP.2013.14.8.4671; Wong BYW, 2016, HEAD NECK-J SCI SPEC, V38, pE1903, DOI 10.1002/hed.24346; Yeo W, 2007, HEPATOLOGY, V45, P1382, DOI 10.1002/hep.21572; Yin Qing-song, 2013, Zhonghua Xue Ye Xue Za Zhi, V34, P55	40	16	19	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2017	12	2							e0170605	10.1371/journal.pone.0170605	http://dx.doi.org/10.1371/journal.pone.0170605			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5SX	28231294	Green Published, Green Submitted, gold			2022-12-27	WOS:000394682400004
J	Teguete, I; Dolo, A; Sangare, K; Sissoko, A; Rochas, M; Beseme, S; Tounkara, K; Yekta, S; De Groot, AS; Koita, OA				Teguete, Ibrahima; Dolo, Amadou; Sangare, Kotou; Sissoko, Abdoulaye; Rochas, Mali; Beseme, Sarah; Tounkara, Karamoko; Yekta, Shahla; De Groot, Anne S.; Koita, Ousmane A.			Prevalence of HPV 16 and 18 and attitudes toward HPV vaccination trials in patients with cervical cancer in Mali	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS INFECTION; SUB-SAHARAN AFRICA; HIGH-RISK; NEUTRALIZING EPITOPES; CARCINOMA; WOMEN; ANTIBODIES; NEOPLASIA	Background Cervical cancer is one of the most common and lethal cancers in West Africa. Even though vaccines that protect against the most common Human papillomavirus (HPV) strains, 16 and 18, are currently in use in developed countries, the implementation of these vaccines in developing countries has been painfully slow, considering the pre-eminence of HPV-associated cervical cancer among women in those countries. Aim We performed serological and PCR-based assessment of blood and tissue specimens obtained from women undergoing cervical cancer-related surgery at a major urban hospital in Bamako. Since several therapeutic HPV vaccines are currently in clinical trials, we also assessed willingness to participate in HPV cancer vaccine trials. Methods Blood and biopsy samples of 240 women were evaluated for HPV types 16 and 18 by serology and PCR. Knowledge regarding the HPV vaccine and autonomy to decide to vaccinate their own child was assessed with a standardized questionnaire. Results HPV 16 and 18 were identified in 137/166 (82.5%) cervical cancer biopsy samples by PCR. Co-infection with both HPV 16 and 18 was significantly more frequent in women over 50 years of age than in younger women (63.0% vs. 37.0%). 44% of study participants said they would be willing to vaccinate their child with HPV vaccine. Only 39% of women participating in this study reported that they would be able to make an autonomous decision to receive HPV vaccination. Permission from a male spouse or head of household was identified as important for participation by 59% of the women. Conclusion This study provides strong support for the introduction of currently available HPV vaccines in Mali, and also provides key information about conditions for obtaining informed consent for HPV vaccine trials and HPV vaccination in Mali.	[Teguete, Ibrahima; Dolo, Amadou] Hop Gabriel Toure, Bamako, Mali; [Sangare, Kotou; Sissoko, Abdoulaye; Koita, Ousmane A.] USTTB, Lab Appl Mol Biol LBMA, FST, Bamako, Mali; [Rochas, Mali; Beseme, Sarah; Yekta, Shahla; De Groot, Anne S.] GAIA Vaccine Fdn, Providence, RI 02903 USA; [Tounkara, Karamoko] Fdn GAIA, Bamako, Mali; [De Groot, Anne S.] Univ Rhode Isl, Inst Immunol & Informat iCubed, 825 Chalkstone Ave, Providence, RI 02908 USA	University of Science & Technology of Bamako; University of Rhode Island	De Groot, AS (corresponding author), GAIA Vaccine Fdn, Providence, RI 02903 USA.; De Groot, AS (corresponding author), Univ Rhode Isl, Inst Immunol & Informat iCubed, 825 Chalkstone Ave, Providence, RI 02908 USA.	dr.annie.degroot@gmail.com	De Groot, Annie/B-6221-2013	De Groot, Annie/0000-0001-5911-1459; Sangare, Kotou/0000-0002-6750-820X	Investigator-Initiated Studies Program of Merck Sharp & Dohme Corp (MSD); EpiVax, Inc.	Investigator-Initiated Studies Program of Merck Sharp & Dohme Corp (MSD); EpiVax, Inc.	This study was supported in part by a research grant from the Investigator-Initiated Studies Program of Merck Sharp & Dohme Corp (MS&D). The opinions expressed in this paper are those of the authors and do not necessarily represent those of MS&D. MS&D had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript. Donors to GAIA Vaccine Foundation provided additional financial support for field site identification and logistics. EpiVax, Inc. provided funding in the form of salaries for author Anne S. De Groot, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Badawi Hala, 2008, Medscape J Med, V10, P232; Bayo S, 2002, INT J EPIDEMIOL, V31, P202, DOI 10.1093/ije/31.1.202; BOSCH FX, 1995, JNCI-J NATL CANCER I, V87, P796, DOI 10.1093/jnci/87.11.796; Bosch FX, 2002, J CLIN PATHOL, V55, P244, DOI 10.1136/jcp.55.4.244; Bruni L, 2010, J INFECT DIS, V202, P1789, DOI 10.1086/657321; DAS BC, 1992, J GEN VIROL, V73, P2327, DOI 10.1099/0022-1317-73-9-2327; De Groot AS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171631; De Vuyst H, 2013, VACCINE, V31, pF32, DOI 10.1016/j.vaccine.2012.07.092; Denny L, 2014, INT J CANCER, V134, P1389, DOI 10.1002/ijc.28425; Dias D, 2005, CLIN DIAGN LAB IMMUN, V12, P959, DOI 10.1128/CDLI.12.8.959-969.2005; Doorbar J, 2012, VACCINE, V30, pF55, DOI 10.1016/j.vaccine.2012.06.083; Ebot JO, 2015, J HEALTH POPUL NUTR, V33, DOI 10.1186/s41043-015-0028-7; Ferlay J, 2013, GLOBOCAN 2012 V1 0 C; Fountzilas G, 2009, J ONCOL, V2009, DOI 10.1155/2009/305908; Grayson W, 2002, J CLIN PATHOL, V55, P108, DOI 10.1136/jcp.55.2.108; Herrero R, 2000, JNCI-J NATL CANCER I, V92, P464, DOI 10.1093/jnci/92.6.464; HPV Information Centre, HUM PAP REL DIS REP; Jacobs MV, 1997, J CLIN MICROBIOL, V35, P791, DOI 10.1128/JCM.35.3.791-795.1997; Li N, 2011, INT J CANCER, V128, P927, DOI 10.1002/ijc.25396; Melief CJM, 2015, J CLIN INVEST, V125, P3401, DOI 10.1172/JCI80009; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Ndiaye C, 2012, TROP MED INT HEALTH, V17, P1432, DOI 10.1111/tmi.12004; Opalka D, 2003, CLIN DIAGN LAB IMMUN, V10, P108, DOI 10.1128/CDLI.10.1.108-115.2003; Poole DN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056402; Randall TC, 2016, FRONT ONCOL, V6, DOI 10.3389/fonc.2016.00160; Schluterman NH, 2013, BMC WOMENS HEALTH, V13, DOI 10.1186/1472-6874-13-4; SHIMADA M, 1990, JPN J CANCER RES, V81, P1; The World Bank, WORLD DEV IND POV RA; Tracy JK, 2011, TROP MED INT HEALTH, V16, P1432, DOI 10.1111/j.1365-3156.2011.02843.x; Tracy L, 2011, CLIN INFECT DIS, V52, P641, DOI 10.1093/cid/ciq190; Trimble CL, 2015, LANCET; Trottier H, 2008, J INFECT DIS, V197, P1436, DOI 10.1086/587698; Vermandere H, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2219-y; World Cancer Research Fund International, CERV CANC STAT; World Health Organization, 2013, COMPR CERV CANC PREV; Bosch FX, 2008, VACCINE, V26, pK1, DOI 10.1016/j.vaccine.2008.05.064	36	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2017	12	2							e0172661	10.1371/journal.pone.0172661	http://dx.doi.org/10.1371/journal.pone.0172661			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5SX	28231334	Green Published, gold, Green Submitted			2022-12-27	WOS:000394682400067
J	Elmes, J; Skovdal, M; Nhongo, K; Ward, H; Campbell, C; Hallett, TB; Nyamukapa, C; White, PJ; Gregson, S				Elmes, Jocelyn; Skovdal, Morten; Nhongo, Kundai; Ward, Helen; Campbell, Catherine; Hallett, Timothy B.; Nyamukapa, Constance; White, Peter J.; Gregson, Simon			A reconfiguration of the sex trade: How social and structural changes in eastern Zimbabwe left women involved in sex work and transactional sex more vulnerable	PLOS ONE			English	Article							MIDDLE-INCOME COUNTRIES; HIV PREVENTION; BEHAVIOR-CHANGE; CONDOM USE; RISK; OPPORTUNITIES; COMMUNITY; INTERVENTIONS; DETERMINANTS; HIV/AIDS	Understanding the dynamic nature of sex work is important for explaining the course of HIV epidemics. While health and development interventions targeting sex workers may alter the dynamics of the sex trade in particular localities, little has been done to explore how large-scale social and structural changes, such as economic recessions-outside of the bounds of organizational intervention-may reconfigure social norms and attitudes with regards to sex work. Zimbabwe's economic collapse in 2009, following a period (2000-2009) of economic decline, within a declining HIV epidemic, provides a unique opportunity to study community perceptions of the impact of socio-economic upheaval on the sex trade. We conducted focus group discussions with 122 community members in rural eastern Zimbabwe in January-February 2009. Groups were homogeneous by gender and occupation and included female sex workers, married women, and men who frequented bars. The focus groups elicited discussion around changes (comparing contemporaneous circumstances in 2009 to their memories of circumstances in 2000) in the demand for, and supply of, paid sex, and how sex workers and clients adapted to these changes, and with what implications for their health and well-being. Transcripts were thematically analyzed. The analysis revealed how changing economic conditions, combined with an increased awareness and fear of HIV- changing norms and local attitudes toward sex work-had altered the demand for commercial sex. In response, sex work dispersed from the bars into the wider community, requiring female sex workers to employ different tactics to attract clients. Hyperinflation meant that sex workers had to accept new forms of payment, including sex-on-credit and commodities. Further impacting the demand for commercial sex work was a poverty-driven increase in transactional sex. The economic upheaval in Zimbabwe effectively reorganized the market for sex by reducing previously dominant forms of commercial sex, while simultaneously providing new opportunities for women to exchange sex in less formal and more risky transactions. Efforts to measure and respond to the contribution of sex work to HIV transmission need to guard against unduly static definitions and consider the changing socioeconomic context and how this can cause shifts in behavior.	[Elmes, Jocelyn; Ward, Helen; Hallett, Timothy B.; Nyamukapa, Constance; White, Peter J.; Gregson, Simon] Imperial Coll London, Sch Publ Hlth, Dept Infect Dis Epidemiol, London, England; [Skovdal, Morten] Univ Copenhagen, Dept Publ Hlth, Copenhagen, Denmark; [Nhongo, Kundai; Nyamukapa, Constance; Gregson, Simon] Biomed Res & Training Inst, Harare, Zimbabwe; [Campbell, Catherine] London Sch Econ & Polit Sci, Dept Psychol & Behav Sci, London, England; [Hallett, Timothy B.; White, Peter J.] Imperial Coll London, Sch Publ Hlth, MRC Ctr Outbreak Anal & Modelling, London, England; [Hallett, Timothy B.; White, Peter J.] Imperial Coll London, Sch Publ Hlth, Dept Infect Dis Epidemiol, NIHR Hlth Protect Res Unit Modelling Methodol, London, England; [White, Peter J.] Publ Hlth England, Natl Infect Serv, Modelling & Econ Unit, London, England	Imperial College London; University of Copenhagen; Biomedical Research Training Institute; University of London; London School Economics & Political Science; Imperial College London; Imperial College London; Public Health England	Elmes, J (corresponding author), Imperial Coll London, Sch Publ Hlth, Dept Infect Dis Epidemiol, London, England.	jocelyn.elmes@imperial.ac.uk	Skovdal, Morten/AAE-2883-2022; Ward, Helen/A-1836-2009	Skovdal, Morten/0000-0002-2068-1814; Ward, Helen/0000-0001-8238-5036; Gregson, Simon/0000-0003-2707-0714; Nyamukapa, Constance/0000-0001-6779-4069; Elmes, Jocelyn/0000-0003-2097-5465; Hallett, Timothy/0000-0002-9681-0424	Wellcome Trust [090285/Z/09/Z, 084401/Z/07/Z]; Bill and Melinda Gates Foundation [OPP1161471, OPP1331208, OPP 106713]; United Nations Programme on HIV/AIDS [EIP/DFA/PG/ca12/18]; MRC [MR/K010174/1]; UK NIHR Health Protection Research Unit in Modelling Methodology at Imperial College London; Public Health England [HPRU-2012-10080]; World Bank [1078406]; Rush Foundation; Medical Research Council [MR/K010174/1B] Funding Source: researchfish; National Institute for Health Research [HPRU-2012-10080] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); United Nations Programme on HIV/AIDS; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK NIHR Health Protection Research Unit in Modelling Methodology at Imperial College London; Public Health England; World Bank(The World Bank India); Rush Foundation; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	JE thanks the Medical Research Council for PhD funding (grant number http://www.mrc.a.c.uk/index.htm) and the Wellcome Trust for postdoctoral funding (grant number: 090285/Z/09/Z; http://www.wellcome.ac.uk/). SG and HW thank the Wellcome Trust(grant numbers: 084401/Z/07/Z and 090285/Z/09/Z; http://www.welicome.ac.uk/). SG additionally thanks the Bill and Melinda Gates Foundation (Grant numbers: OPP1161471, OPP1331208) and The Joint United Nations Programme on HIV/AIDS (Grant number: EIP/DFA/PG/ca12/18; http://www.unaids.org/en/). PJW thanks the MRC for Centre funding (MR/K010174/1), and the UK NIHR Health Protection Research Unit in Modelling Methodology at Imperial College London in partnership with Public Health England for funding (HPRU-2012-10080). TBH thanks the Bill and Melinda Gates Foundation (Grant number: OPP 106713; http://www.gatesfoundation.org/), The Joint United Nations Programme on HIV/AIDS (Grant number: EIP/DFA/PG/ca12/18; http://www.unaids.org/en), The World Bank (Grant number: 1078406; http.//www.worldbank.org/) and The Rush Foundation (http://www.rushfoundation.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The views expressed are those of the authors and not necessarily those of the Department of Health, MRC, NHS, NIHR, or Public Health England.	[Anonymous], ZIMB NAT HIV AIDS ES; [Anonymous], ZIMB OV INT; Attride-Stirling J, 2001, QUAL RES, V1, P385, DOI DOI 10.1177/146879410100100307; Baral S, 2012, LANCET INFECT DIS, V12, P538, DOI 10.1016/S1473-3099(12)70066-X; Basu I, 2004, JAIDS-J ACQ IMM DEF, V36, P845, DOI 10.1097/00126334-200407010-00012; Blankenship KM, 2006, J URBAN HEALTH, V83, P59, DOI 10.1007/s11524-005-9007-4; Bourdillon M. F. C., 1982, SHONA PEOPLES ETHNOG; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Campbell C, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-354; Cheater AP, 1996, J S AFR STUD, V22, P189, DOI 10.1080/03057079608708486; Cowan FM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077080; Desmond N, 2005, SOC SCI MED, V60, P1739, DOI 10.1016/j.socscimed.2004.08.027; Elmes J, 2014, J INFECT DIS, V210, pS569, DOI 10.1093/infdis/jiu493; Evans C, 2010, GLOB PUBLIC HEALTH, V5, P449, DOI 10.1080/17441690902942472; Evans C, 2008, CULT HEALTH SEX, V10, P27, DOI 10.1080/13691050701561393; Farira D., 2008, BBC NEWS; Fritz K. E., 2002, AIDS BEHAV, V6, P221, DOI DOI 10.1023/A:1019887707474; Gregson S, 2006, SCIENCE, V311, P664, DOI 10.1126/science.1121054; Gregson S., 2010, INT J EPIDEMIOL; Gregson S, 2007, PLOS MED, V4, P545, DOI 10.1371/journal.pmed.0040102; Halperin DT, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000414; Hanke S.H., 2008, ZIMBABWE HYPERINFLAT; Hawken MP, 2002, SEX TRANSM INFECT, V78, P271, DOI 10.1136/sti.78.4.271; Heise L.L., 2011, WHAT WORKS PREVENT P; Hunter M, 2007, SOC SCI MED, V64, P689, DOI 10.1016/j.socscimed.2006.09.015; IMF, 2009, PUBL INF NOT IMF EX; Jana S, 2004, AIDS EDUC PREV, V16, P405, DOI 10.1521/aeap.16.5.405.48734; Jewkes R., 2012, Journal of AIDS and Clinical Research, V3, P158; Jewkes R, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-325; Johnston D, 2015, REV AFR POLIT ECON, V42, P335, DOI 10.1080/03056244.2015.1065603; Kalichman SC, 2007, PREV SCI, V8, P141, DOI 10.1007/s11121-006-0061-2; Kapiga SH, 2002, J ACQ IMMUN DEF SYND, V29, P409, DOI 10.1097/00126334-200204010-00013; Kerrigan D, 2006, AM J PUBLIC HEALTH, V96, P120, DOI 10.2105/AJPH.2004.042200; Kerrigan D, 2015, LANCET, V385, P172, DOI 10.1016/S0140-6736(14)60973-9; KITZINGER J, 1995, BRIT MED J, V311, P299, DOI 10.1136/bmj.311.7000.299; Lugalla J, 2004, SOC SCI MED, V59, P185, DOI 10.1016/j.socscimed.2003.10.033; Maher L, 2011, HARM REDUCT J, V8, DOI 10.1186/1477-7517-8-30; Mishra S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050691; Mojola S., 2014, SITUATING T SEX COMP; Mountain E, 2014, EXPERT REV ANTI-INFE, V12, P1203, DOI 10.1586/14787210.2014.948422; Moyo ON, 2002, FEM ECON, V8, P163, DOI 10.1080/13545700220000175; Muchini B, 2011, AIDS BEHAV, V15, P487, DOI 10.1007/s10461-010-9783-z; Muleya D., 2005, ZIMBABWE INDEPE 0107; Nagot N, 2002, J ACQ IMMUN DEF SYND, V29, P517, DOI 10.1097/00126334-200204150-00013; Ngugi EN, 1996, J INFECT DIS, V174, pS240, DOI 10.1093/infdis/174.Supplement_2.S240; O'Brien S, 2013, CULT HEALTH SEX, V15, P583, DOI 10.1080/13691058.2013.776111; O'Laughlin B, 2015, REV AFR POLIT ECON, V42, P342, DOI 10.1080/03056244.2015.1064368; Oliver DG, 2005, SOC FORCES, V84, P1273, DOI 10.1353/sof.2006.0023; Overs C, 2013, HEALTH HUM RIGHTS, V15, P186; Poundstone KE, 2004, EPIDEMIOL REV, V26, P22, DOI 10.1093/epirev/mxh005; Rhodes T., 2002, INT J DRUG POLICY, V13, P85, DOI [10.1016/S0955-3959(02)00007-5, DOI 10.1016/S0955-3959(02)00007-5]; Robinson J, 2011, AM ECON J-APPL ECON, V3, P35, DOI 10.1257/app.3.1.35; Schur N, 2015, J INT AIDS SOC, V18, DOI 10.7448/IAS.18.1.20063; Shannon K, 2015, LANCET, V385, P55, DOI 10.1016/S0140-6736(14)60931-4; Silbereisen RK, 2011, MAPPING DEMANDS SOCI; Singh K, 2010, AIDS BEHAV, V14, P200, DOI 10.1007/s10461-009-9572-8; STANDING H, 1992, SOC SCI MED, V34, P475, DOI 10.1016/0277-9536(92)90202-2; Strathdee SA, 2013, ANNU REV PUBL HEALTH, V34, P301, DOI 10.1146/annurev-publhealth-031912-114411; Strauss A., 1998, BASICS QUALITATIVE R; van den Borne F., 2003, WORKING PAPER SERIES, V13, P8; Wasserheit JN, 1996, J INFECT DIS, V174, pS201, DOI 10.1093/infdis/174.Supplement_2.S201; WILSON D, 1990, SOC SCI MED, V31, P609, DOI 10.1016/0277-9536(90)90097-C; WILSON D, 1989, AIDS Care, V1, P269, DOI 10.1080/09540128908253032; Wojcicki JM, 2002, CULT MED PSYCHIAT, V26, P339, DOI 10.1023/A:1021291922026; WTO, 2011, TRAD POL REV REP GOV	65	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2017	12	2							e0171916	10.1371/journal.pone.0171916	http://dx.doi.org/10.1371/journal.pone.0171916			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL5SK	28225822	Green Accepted, gold, Green Published			2022-12-27	WOS:000394680900025
J	Howcroft, J; Lemaire, ED; Kofman, J; McIlroy, WE				Howcroft, Jennifer; Lemaire, Edward D.; Kofman, Jonathan; McIlroy, William E.			Elderly fall risk prediction using static posturography	PLOS ONE			English	Article							WII BALANCE BOARD; OLDER-ADULTS; POSTURAL STABILITY; STATISTICAL APPROACH; CLINICAL UTILITY; SPONTANEOUS-SWAY; FORCE PLATFORM; COMMUNITY; GAIT; RELIABILITY	Maintaining and controlling postural balance is important for activities of daily living, with poor postural balance being predictive of future falls. This study investigated eyes open and eyes closed standing posturography with elderly adults to identify differences and determine appropriate outcome measure cut-off scores for prospective faller, single-faller, multi-faller, and non-faller classifications. 100 older adults (75.5 +/- 6.7 years) stood quietly with eyes open and then eyes closed while Wii Balance Board data were collected. Range in anterior-posterior (AP) and medial-lateral (ML) center of pressure (CoP) motion; AP and ML CoP root mean square distance from mean (RMS); and AP, ML, and vector sum magnitude (VSM) CoP velocity were calculated. Romberg Quotients (RQ) were calculated for all parameters. Participants reported six-month fall history and six-month post-assessment fall occurrence. Groups were retrospective fallers (24), prospective all fallers (42), prospective fallers (22 single, 6 multiple), and prospective non-fallers (47). Non-faller RQ AP range and RQ AP RMS differed from prospective all fallers, fallers, and single fallers. Non-faller eyes closed AP velocity, eyes closed VSM velocity, RQ AP velocity, and RQ VSM velocity differed from multi-fallers. RQ calculations were particularly relevant for elderly fall risk assessments. Cut-off scores from Clinical Cut-off Score, ROC curves, and discriminant functions were clinically viable for multi-faller classification and provided better accuracy than singlefaller classification. RQ AP range with cut-off score 1.64 could be used to screen for older people who may fall once. Prospective multi-faller classification with a discriminant function (-1.481 + 0.146 x Eyes Closed AP Velocity-0.114 x Eyes Closed Vector Sum Magnitude Velocity-2.027 x RQ AP Velocity + 2.877 x RQ Vector Sum Magnitude Velocity) and cut-off score 0.541 achieved an accuracy of 84.9% and is viable as a screening tool for older people at risk of multiple falls.	[Howcroft, Jennifer; Kofman, Jonathan] Univ Waterloo, Dept Syst Design Engn, Waterloo, ON, Canada; [Lemaire, Edward D.] Ottawa Hosp, Res Inst, Ctr Rehabil Res & Dev, Ottawa, ON, Canada; [Lemaire, Edward D.] Univ Ottawa, Fac Med, Ottawa, ON, Canada; [McIlroy, William E.] Univ Waterloo, Dept Kinesiol, Waterloo, ON, Canada	University of Waterloo; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Waterloo	Lemaire, ED (corresponding author), Ottawa Hosp, Res Inst, Ctr Rehabil Res & Dev, Ottawa, ON, Canada.; Lemaire, ED (corresponding author), Univ Ottawa, Fac Med, Ottawa, ON, Canada.	elemaire@ohri.ca			Natural Sciences and Engineering Research Council of Canada (NSERC); Ontario Ministry of Training, Colleges and Universities; University of Waterloo	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Ontario Ministry of Training, Colleges and Universities; University of Waterloo	This work was supported by the Natural Sciences and Engineering Research Council of Canada (NSERC); the Ontario Ministry of Training, Colleges and Universities; and the University of Waterloo.	Bauer CM, 2016, Z GERONTOL GERIATR, V49, P232, DOI 10.1007/s00391-015-0885-0; Bigelow KE, 2011, J GERONTOL A-BIOL, V66, P228, DOI 10.1093/gerona/glq202; Brauer SG, 2000, J GERONTOL A-BIOL, V55, pM469, DOI 10.1093/gerona/55.8.M469; Buatois S, 2006, GERONTOLOGY, V52, P345, DOI 10.1159/000094983; Carneiro JAO, 2012, CLINICS, V67, P475, DOI 10.6061/clinics/2012(05)12; Clark RA, 2010, GAIT POSTURE, V31, P307, DOI 10.1016/j.gaitpost.2009.11.012; Clark RA, 2011, GAIT POSTURE, V34, P288, DOI 10.1016/j.gaitpost.2011.04.010; COLLEDGE NR, 1994, GERONTOLOGY, V40, P273, DOI 10.1159/000213596; Era P, 2006, GERONTOLOGY, V52, P204, DOI 10.1159/000093652; Goble DJ, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-12; Haas B M, 2000, Physiother Res Int, V5, P19, DOI 10.1002/pri.181; Howcroft JD, 2015, IFMBE PROC, V51, P966, DOI 10.1007/978-3-319-19387-8_235; Howcroft J, 2013, J NEUROENG REHABIL, V10, DOI 10.1186/1743-0003-10-91; Huurnink A, 2013, J BIOMECH, V46, P1392, DOI 10.1016/j.jbiomech.2013.02.018; JACOBSON NS, 1991, J CONSULT CLIN PSYCH, V59, P12, DOI 10.1037/0022-006X.59.1.12; Kurz I, 2013, J ELECTROMYOGR KINES, V23, P814, DOI 10.1016/j.jelekin.2013.04.001; Kwok BC, 2015, CLIN BIOMECH, V30, P481, DOI 10.1016/j.clinbiomech.2015.03.006; Maja P, 2004, METODOLOSKI ZVEZKI, V1, P143; MAKI BE, 1990, J AM GERIATR SOC, V38, P1, DOI 10.1111/j.1532-5415.1990.tb01588.x; Maki BE, 1997, J AM GERIATR SOC, V45, P313, DOI 10.1111/j.1532-5415.1997.tb00946.x; MAKI BE, 1987, IEEE T BIO-MED ENG, V34, P797, DOI 10.1109/TBME.1987.325922; Maranesi E, 2016, CLIN BIOMECH, V32, P8, DOI 10.1016/j.clinbiomech.2015.12.009; Merlo A, 2012, GAIT POSTURE, V36, P662, DOI 10.1016/j.gaitpost.2012.06.016; Perrin PP, 1997, GERONTOLOGY, V43, P223; Piirtola M, 2006, GERONTOLOGY, V52, P1, DOI 10.1159/000089820; PRESS SJ, 1978, J AM STAT ASSOC, V73, P699, DOI 10.2307/2286261; Prieto TE, 1996, IEEE T BIO-MED ENG, V43, P956, DOI 10.1109/10.532130; Scaglioni-Solano P, 2014, INT J REHABIL RES, V37, P138, DOI 10.1097/MRR.0000000000000046; Schwesig R, 2013, CLIN REHABIL, V27, P183, DOI 10.1177/0269215512452880; Stel VS, 2003, J CLIN EPIDEMIOL, V56, P659, DOI 10.1016/S0895-4356(03)00082-9; Thomas JC, 2008, HDB RES METHODS ABNO, P319; TINETTI ME, 1988, NEW ENGL J MED, V319, P1701, DOI 10.1056/NEJM198812293192604; TOPPER AK, 1993, J AM GERIATR SOC, V41, P479, DOI 10.1111/j.1532-5415.1993.tb01881.x; VANPARYS JAP, 1976, AGRESSOLOGIE, V17, P95; Visser JE, 2008, CLIN NEUROPHYSIOL, V119, P2424, DOI 10.1016/j.clinph.2008.07.220; Weinstein M, 2006, HOME HLTH CARE MAN P, V19, P45, DOI 10.1177/1084822306292232	36	81	83	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2017	12	2							e0172398	10.1371/journal.pone.0172398	http://dx.doi.org/10.1371/journal.pone.0172398			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL5QV	28222191	gold, Green Published			2022-12-27	WOS:000394676800055
J	Jadalannagari, S; Converse, G; McFall, C; Buse, E; Filla, M; Villar, MT; Artigues, A; Mellot, AJ; Wang, JX; Detamore, MS; Hopkins, RA; Aljitawi, OS				Jadalannagari, Sushma; Converse, Gabriel; McFall, Christopher; Buse, Eric; Filla, Michael; Villar, Maria T.; Artigues, Antonio; Mellot, Adam J.; Wang, Jinxi; Detamore, Michael S.; Hopkins, Richard A.; Aljitawi, Omar S.			Decellularized Wharton's Jelly from human umbilical cord as a novel 3D scaffolding material for tissue engineering applications	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; STROMAL CELLS; IN-VITRO; OSTEOBLAST DIFFERENTIATION; OSTEOGENIC DIFFERENTIATION; CLINICAL-APPLICATIONS; EXTRACELLULAR-MATRIX; GROWTH-FACTORS; BONE; IMMUNOFLUORESCENCE	In tissue engineering, an ideal scaffold attracts and supports cells thus providing them with the necessary mechanical support and architecture as they reconstruct new tissue in vitro and in vivo. This manuscript details a novel matrix derived from decellularized Wharton's jelly (WJ) obtained from human umbilical cord for use as a scaffold for tissue engineering application. This decellularized Wharton's jelly matrix (DWJM) contained 0.66 +/- 0.12 mu g/mg sulfated glycosaminoglycans (GAGs), and was abundant in hyaluronic acid, and completely devoid of cells. Mass spectroscopy revealed the presence of collagen types II, VI and XII, fibronectin- I, and lumican I. When seeded onto DWJM, WJ mesenchymal stem cells (WJMSCs), successfully attached to, and penetrated the porous matrix resulting in a slower rate of cell proliferation. Gene expression analysis of WJ and bone marrow (BM) MSCs cultured on DWJM demonstrated decreased expression of proliferation genes with no clear pattern of differentiation. When this matrix was implanted into a murine calvarial defect model with, green fluorescent protein (GFP) labeled osteocytes, the osteocytes were observed to migrate into the matrix as early as 24 hours. They were also identified in the matrix up to 14 days after transplantation. Together with these findings, we conclude that DWJM can be used as a 3D porous, bioactive and biocompatible scaffold for tissue engineering and regenerative medicine applications.	[Jadalannagari, Sushma; Converse, Gabriel; Hopkins, Richard A.; Aljitawi, Omar S.] Univ Kansas, Dept Bioengn, Lawrence, KS 66045 USA; [Jadalannagari, Sushma; Aljitawi, Omar S.] Univ Kansas, Med Ctr, Dept Hematol Oncol, Kansas City, KS 66103 USA; [Converse, Gabriel; McFall, Christopher; Buse, Eric; Hopkins, Richard A.] Childrens Mercy Hosp & Clin, Cardiac Regenerat Surg Res Labs, Kansas City, MO USA; [Filla, Michael] Univ Kansas, Med Ctr, Dept Anat & Cell Biol, Kansas City, KS 66103 USA; [Villar, Maria T.; Artigues, Antonio] Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, Kansas City, KS USA; [Mellot, Adam J.] Univ Kansas, Med Ctr, Dept Plast Surg, Kansas City, KS 66103 USA; [Wang, Jinxi] Univ Kansas, Med Ctr, Dept Orthoped Surg, Kansas City, KS 66103 USA; [Detamore, Michael S.] Univ Kansas, Dept Chem & Petr Engn, Lawrence, KS 66045 USA	University of Kansas; University of Kansas; University of Kansas Medical Center; Children's Mercy Hospital; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; University of Kansas	Aljitawi, OS (corresponding author), Univ Kansas, Dept Bioengn, Lawrence, KS 66045 USA.; Aljitawi, OS (corresponding author), Univ Kansas, Med Ctr, Dept Hematol Oncol, Kansas City, KS 66103 USA.	omar_aljitawi@urmc.rochester.edu	Aljitawi, Omar/R-6053-2019; Hopkins, Richard/AAI-5007-2020		G. Harold and Leila Y. Mathers Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103326] Funding Source: NIH RePORTER	G. Harold and Leila Y. Mathers Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Drs. CD Little and BJ Rongish, Department of Anatomy and Cell Biology, KUMC, for advice and use of their time-lapse instrumentation, supported by the The G. Harold and Leila Y. Mathers Foundation. We would also like to thank Dr. David W Rowe, University of Connecticut Health Center and Dr. Lynda Bonewald, University of Missouri Kansas City, for their generous gift of GFP mice. We also thank Dr. Sonia Rawal, Peggy Keefe, Yinghua Xiao, Barbara Fegley, Dr. Yi Feng, Mingcai Zhang, and Dr. Dandan Li for their help with some of the experiments and Da Zhang for his help with microscopy imaging.	Aljitawi O, 2012, STEM CELLS DEV; Altmann B, 2011, BIOMATERIALS, V32, P8947, DOI 10.1016/j.biomaterials.2011.08.023; Bai J, 2012, J GERIATR CARDIOL, V9, P166, DOI 10.3724/SP.J.1263.2011.12091; Baino F, 2011, J BIOMED MATER RES A, V97A, P514, DOI 10.1002/jbm.a.33072; Barry FP, 2004, INT J BIOCHEM CELL B, V36, P568, DOI 10.1016/j.biocel.2003.11.001; Bastow ER, 2008, CELL MOL LIFE SCI, V65, P395, DOI 10.1007/s00018-007-7360-z; Bobis S, 2006, FOLIA HISTOCHEM CYTO, V44, P215; Bueno EM, 2009, NAT REV RHEUMATOL, V5, P685, DOI 10.1038/nrrheum.2009.228; Burns JS, 2010, TISSUE ENG PT A, V16, P2331, DOI [10.1089/ten.tea.2009.0735, 10.1089/ten.TEA.2009.0735]; Chan BP, 2008, EUR SPINE J, V17, pS467, DOI 10.1007/s00586-008-0745-3; Chan RW, 2009, TISSUE ENG PT A, V15, P3537, DOI [10.1089/ten.tea.2009.0064, 10.1089/ten.TEA.2009.0064]; Clarke SA, 2011, BIOTECHNOL ADV, V29, P610, DOI 10.1016/j.biotechadv.2011.04.003; Conconi MT, 2006, INT J MOL MED, V18, P1089; Crapo PM, 2011, BIOMATERIALS, V32, P3233, DOI 10.1016/j.biomaterials.2011.01.057; Derfoul A, 2007, OSTEOARTHR CARTILAGE, V15, P646, DOI 10.1016/j.joca.2007.01.014; Ducy P, 2000, DEV DYNAM, V219, P461, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1074>3.0.CO;2-C; Feng JQ, 2008, GENESIS, V46, P87, DOI 10.1002/dvg.20370; Foschi F, 2011, J BIOMATER APPL; Foschi F, 2012, J BIOMATER APPL, V26, P1035, DOI 10.1177/0885328210393046; Franc S, 1998, PLACENTA, V19, P95, DOI 10.1016/S0143-4004(98)90104-7; Gloria A, 2010, J APPL BIOMATER BIOM, V8, P57; Goldring MB, 2006, J CELL BIOCHEM, V97, P33, DOI 10.1002/jcb.20652; Hopkins RA, 2005, CARDIAC RECONSTRUCTI; JACKSON RL, 1991, PHYSIOL REV, V71, P481, DOI 10.1152/physrev.1991.71.2.481; James AW, 2009, PLAST RECONSTR SURG, V123, P31, DOI 10.1097/PRS.0b013e3181904c19; Kliemt S, 2013, J PROTEOME RES, V12, P378, DOI 10.1021/pr300640h; LESLEY J, 1993, ADV IMMUNOL, V54, P271, DOI 10.1016/S0065-2776(08)60537-4; Loebel C, 2015, TISSUE ENG PT A, V21, P115, DOI [10.1089/ten.tea.2014.0096, 10.1089/ten.TEA.2014.0096]; Munarin F, 2011, BIOMACROMOLECULES, V12, P568, DOI 10.1021/bm101110x; O'Brien FJ, 2011, MATER TODAY, V14, P88, DOI 10.1016/S1369-7021(11)70058-X; Qian H, 2012, J BIOL CHEM, V287, P25795, DOI 10.1074/jbc.M112.339622; Scaglione S, 2006, BIOTECHNOL BIOENG, V93, P181, DOI 10.1002/bit.20677; Schagemann JC, 2012, J BIOMED MAT RES A, DOI 10.1002/jbm.a.34457; Schieker M, 2004, J ANAT, V204, P133, DOI 10.1111/j.1469-7580.2004.00252.x; Schieker M, 2007, J ANAT, V210, P592, DOI 10.1111/j.1469-7580.2007.00716.x; Sobolewski K, 2005, PLACENTA, V26, P747, DOI 10.1016/j.placenta.2004.10.008; Taipale J, 1997, FASEB J, V11, P51, DOI 10.1096/fasebj.11.1.9034166; Tan W, 2001, TISSUE ENG, V7, P203, DOI 10.1089/107632701300062831; van Susante JLC, 2001, BIOMATERIALS, V22, P2359, DOI 10.1016/S0142-9612(00)00423-3; Wang LM, 2009, J TISSUE ENG REGEN M, V3, P398, DOI 10.1002/term.176; Yamaguchi A, 2000, ENDOCR REV, V21, P393, DOI 10.1210/er.21.4.393; Zhao LM, 2011, VITAM HORM, V87, P127, DOI 10.1016/B978-0-12-386015-6.00042-1; Zhou G, 2006, P NATL ACAD SCI USA, V103, P19004, DOI 10.1073/pnas.0605170103	43	34	37	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2017	12	2							e172098	10.1371/journal.pone.0172098	http://dx.doi.org/10.1371/journal.pone.0172098			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5QV	28222169	Green Submitted, Green Published, gold			2022-12-27	WOS:000394676800031
J	Muradian, ML; Branch, TA; Moffitt, SD; Hulson, PJF				Muradian, Melissa L.; Branch, Trevor A.; Moffitt, Steven D.; Hulson, Peter-John F.			Bayesian stock assessment of Pacific herring in Prince William Sound, Alaska	PLOS ONE			English	Article							VALDEZ OIL-SPILL; CLUPEA-PALLASI; FISHERY; HISTOPATHOLOGY; ABUNDANCE; RECOVERY; IMPACTS; DISEASE; CATCH	The Pacific herring (Clupea pallasii) population in Prince William Sound, Alaska crashed in 1993 and has yet to recover, affecting food web dynamics in the Sound and impacting Alaskan communities. To help researchers design and implement the most effective monitoring, management, and recovery programs, a Bayesian assessment of Prince William Sound herring was developed by reformulating the current model used by the Alaska Department of Fish and Game. The Bayesian model estimated pre-fishery spawning biomass of herring age-3 and older in 2013 to be a median of 19,410 mt (95% credibility interval 12,150-31,740 mt), with a 54% probability that biomass in 2013 was below the management limit used to regulate fisheries in Prince William Sound. The main advantages of the Bayesian model are that it can more objectively weight different datasets and provide estimates of uncertainty for model parameters and outputs, unlike the weighted sum-of-squares used in the original model. In addition, the revised model could be used to manage herring stocks with a decision rule that considers both stock status and the uncertainty in stock status.	[Muradian, Melissa L.] Univ Washington, Quantitat Ecol & Resource Management, Seattle, WA 98195 USA; [Branch, Trevor A.] Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA; [Moffitt, Steven D.] Alaska Dept Fish & Game, Cordova, AK USA; [Hulson, Peter-John F.] NOAA, Alaska Fisheries Sci Ctr, Juneau, AK USA; [Muradian, Melissa L.] Henrys Fork Fdn, Ashton, ID USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Alaska Department of Fish & Game; National Oceanic Atmospheric Admin (NOAA) - USA	Muradian, ML (corresponding author), Univ Washington, Quantitat Ecol & Resource Management, Seattle, WA 98195 USA.; Muradian, ML (corresponding author), Henrys Fork Fdn, Ashton, ID USA.	melissa@henrysfork.org		Branch, Trevor/0000-0003-4308-8930	Exxon Valdez Oil Spill Trustee Council [13120111-Q]; Joint Institute for the Study of the Atmosphere and Ocean (JISAO) under NOAA [NA10OAR4320148, 2448]; Richard C. and Lois M. Worthington Endowed Professor in Fisheries Management	Exxon Valdez Oil Spill Trustee Council(Exxon Mobil Corporation); Joint Institute for the Study of the Atmosphere and Ocean (JISAO) under NOAA; Richard C. and Lois M. Worthington Endowed Professor in Fisheries Management	MLM and TAB were funded by the Exxon Valdez Oil Spill Trustee Council, grant 13120111-Q. Supplementary funding was also received from the Joint Institute for the Study of the Atmosphere and Ocean (JISAO) under NOAA Cooperative Agreement No. NA100AR4320148, Contribution No. 2448. TAB was funded in part by the Richard C. and Lois M. Worthington Endowed Professor in Fisheries Management. The funders encourage publications but did not have any role in design, data, writing, or the decision to submit this particular article for publication. Author contributions: TAB and MLM designed the study, MLM and TAB conducted the analyses and wrote the paper, SDM contributed data and interpreted results, PJFH contributed computer code.	Botz J., 2010, 1055 AL DEP FISH GAM; CHIB S, 1995, AM STAT, V49, P327, DOI 10.2307/2684568; Cury PM, 2011, SCIENCE, V334, P1703, DOI 10.1126/science.1212928; Fournier DA, 2012, OPTIM METHOD SOFTW, V27, P233, DOI 10.1080/10556788.2011.597854; Francis RICC, 2011, CAN J FISH AQUAT SCI, V68, P1124, DOI 10.1139/F2011-025; FRANCIS RIC, 1992, CAN J FISH AQUAT SCI, V49, P922, DOI 10.1139/f92-102; HAEGELE CW, 1985, CAN J FISH AQUAT SCI, V42, P39, DOI 10.1139/f85-261; Hose JE, 1996, CAN J FISH AQUAT SCI, V53, P2355, DOI 10.1139/cjfas-53-10-2355; Hulson PJF, 2008, ICES J MAR SCI, V65, P25, DOI 10.1093/icesjms/fsm162; Hurtado-Ferro F, 2015, ICES J MAR SCI, V72, P99, DOI 10.1093/icesjms/fsu198; Kocan RM, 1996, CAN J FISH AQUAT SCI, V53, P2388, DOI 10.1139/cjfas-53-10-2388; Kurota H, 2010, POPUL ECOL, V52, P359, DOI 10.1007/s10144-010-0201-1; Marty GD, 2010, DIS AQUAT ORGAN, V90, P1, DOI 10.3354/dao02210; Marty GD, 2003, CAN J FISH AQUAT SCI, V60, P1258, DOI [10.1139/f03-109, 10.1139/F03-109]; Marty GD, 1999, CAN J FISH AQUAT SCI, V56, P419, DOI 10.1139/cjfas-56-3-419; MCALLISTER MK, 1994, CAN J FISH AQUAT SCI, V51, P2673, DOI 10.1139/f94-267; McAllister MK, 1997, CAN J FISH AQUAT SCI, V54, P284, DOI 10.1139/cjfas-54-2-284; Mohn R, 1999, ICES J MAR SCI, V56, P473, DOI 10.1006/jmsc.1999.0481; Monson DH, 2000, P NATL ACAD SCI USA, V97, P6562, DOI 10.1073/pnas.120163397; Norcross BL, 1996, CAN J FISH AQUAT SCI, V53, P2376, DOI 10.1139/cjfas-53-10-2376; Pearson WH, 2012, REV FISH BIOL FISHER, V22, P95, DOI 10.1007/s11160-011-9225-7; Peterson CH, 2001, ADV MAR BIOL, V39, P1, DOI 10.1016/S0065-2881(01)39008-9; PIATT JF, 1990, AUK, V107, P387, DOI 10.2307/4087623; Punt AE, 1997, REV FISH BIOL FISHER, V7, P35, DOI 10.1023/A:1018419207494; Quinn Terrance J. II, 2001, VAK-SG-01-04, P363; Reum JCP, 2013, FISH OCEANOGR, V22, P324, DOI 10.1111/fog.12025; Rooper CN, 1999, CAN J FISH AQUAT SCI, V56, P1133, DOI 10.1139/cjfas-56-6-1133; Shertzer KW, 2010, MAR COAST FISH, V2, P451, DOI 10.1577/C10-014.1; Smith ADM, 1999, ICES J MAR SCI, V56, P967, DOI 10.1006/jmsc.1999.0540; Smith ADM, 2011, SCIENCE, V333, P1147, DOI 10.1126/science.1209395; Stewart IJ, 2014, CAN J FISH AQUAT SCI, V71, P581, DOI 10.1139/cjfas-2013-0289; Stokesbury KDE, 1999, ENVIRON BIOL FISH, V56, P409, DOI 10.1023/A:1007557509202; Thomas GL, 2003, AQUAT LIVING RESOUR, V16, P247, DOI 10.1016/S0990-7440(03)00044-5; Thomas GL, 2001, NATURE, V411, P1013, DOI 10.1038/35082745; Thorne RE, 2008, ICES J MAR SCI, V65, P44, DOI 10.1093/icesjms/fsm176; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]	47	19	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2017	12	2							e72153	10.1371/journal.pone.0172153	http://dx.doi.org/10.1371/journal.pone.0172153			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5QV	28222151	Green Published, Green Submitted, gold			2022-12-27	WOS:000394676800036
J	Duan, XL; Wang, K; Su, S; Tian, RZ; Li, YT; Chen, MH				Duan, Xinle; Wang, Kang; Su, Sha; Tian, Ruizheng; Li, Yuting; Chen, Maohua			De novo transcriptome analysis and microsatellite marker development for population genetic study of a serious insect pest, Rhopalosiphum padi (L.) (Hemiptera: Aphididae)	PLOS ONE			English	Article							SIMPLE SEQUENCE REPEATS; PARTHENOGENETIC SITOBION APHIDS; BIRD-CHERRY APHID; EST-SSR MARKERS; ACETYLCHOLINESTERASE GENES; THROUGHPUT DISCOVERY; LIFE-CYCLE; TRANSFERABILITY; AVENAE; WHEAT	The bird cherry-oat aphid, Rhopalosiphum padi (L.), is one of the most abundant aphid pests of cereals and has a global distribution. Next-generation sequencing (NGS) is a rapid and efficient method for developing molecular markers. However, transcriptomic and genomic resources of R. padi have not been investigated. In this study, we used transcriptome information obtained by RNA-Seq to develop polymorphic microsatellites for investigating population genetics in this species. The transcriptome of R. padi was sequenced on an Illumina HiSeq 2000 platform. A total of 114.4 million raw reads with a GC content of 40.03% was generated. The raw reads were cleaned and assembled into 29,467 unigenes with an N50 length of 1,580 bp. Using several public databases, 82.47% of these unigenes were annotated. Of the annotated unigenes, 8,022 were assigned to COG pathways, 9,895 were assigned to GO pathways, and 14,586 were mapped to 257 KEGG pathways. A total of 7,936 potential microsatellites were identified in 5,564 unigenes, 60 of which were selected randomly and amplified using specific primer pairs. Fourteen loci were found to be polymorphic in the four R. padi populations. The transcriptomic data presented herein will facilitate gene discovery, gene analyses, and development of molecular markers for future studies of R. padi and other closely related aphid species.	[Duan, Xinle; Wang, Kang; Su, Sha; Tian, Ruizheng; Li, Yuting; Chen, Maohua] Northwest A&F Univ, Coll Plant Protect, Minist Agr, State Key Lab Crop Stress Biol Arid Areas,Key Lab, Yangling, Peoples R China; [Duan, Xinle] Fujian Agr & Forestry Univ, Coll Bee Sci, Fuzhou, Peoples R China	Ministry of Agriculture & Rural Affairs; Northwest A&F University - China; Fujian Agriculture & Forestry University	Chen, MH (corresponding author), Northwest A&F Univ, Coll Plant Protect, Minist Agr, State Key Lab Crop Stress Biol Arid Areas,Key Lab, Yangling, Peoples R China.	maohua.chen@nwsuaf.edu.cn			National Natural Science Foundation of China [31272036, 31471766]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants of the National Natural Science Foundation of China (No. 31272036 and No. 31471766). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; [Anonymous], 2002, FSTAT VERSION 2 9 3; Archak S, 2007, NUCLEIC ACIDS RES, V35, pD36, DOI 10.1093/nar/gkl778; Artigaud S, 2014, MAR GENOM, V15, P3, DOI 10.1016/j.margen.2014.03.006; Bai XD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011370; BIRD AP, 1986, NATURE, V321, P209, DOI 10.1038/321209a0; Blair MW, 2003, THEOR APPL GENET, V107, P1362, DOI 10.1007/s00122-003-1398-6; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; Carter MJ, 2012, ECOL EVOL, V2, P1414, DOI 10.1002/ece3.247; Castagnone-Sereno P, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-598; Chen EH, 2014, INSECT MOL BIOL, V23, P52, DOI 10.1111/imb.12060; Chen MH, 2007, GENOME, V50, P172, DOI 10.1139/G07-021; Chen MH, 2007, PESTIC BIOCHEM PHYS, V87, P189, DOI 10.1016/j.pestbp.2006.07.009; Chen XM, 2016, GENE, V576, P537, DOI 10.1016/j.gene.2015.11.001; Comeault AA, 2012, MOL ECOL RESOUR, V12, P549, DOI 10.1111/j.1755-0998.2012.03121.x; Cook N, 2011, CONSERV GENET RESOUR, V3, P789, DOI 10.1007/s12686-011-9459-7; Delmotte F, 2002, MOL ECOL, V11, P711, DOI 10.1046/j.1365-294X.2002.01478.x; Deng YW, 2014, BIOSCI BIOTECH BIOCH, V78, P1685, DOI 10.1080/09168451.2014.936351; Duan XL, 2017, J PEST SCI, V90, P103, DOI 10.1007/s10340-016-0752-9; Duan XL, 2015, J PLANT PROTECT, V42, P297; Durand J, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-570; Graveley BR, 2011, NATURE, V471, P473, DOI 10.1038/nature09715; Hou R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021560; Huang DN, 2014, MOL ECOL RESOUR, V14, P569, DOI 10.1111/1755-0998.12197; Karaiskou N, 2008, J HERED, V99, P688, DOI 10.1093/jhered/esn052; Karaoglu H, 2005, MOL BIOL EVOL, V22, P639, DOI [10.1093/molbev/mis057, 10.1093/molbev/msi057]; Karsten M, 2016, MOL ECOL, V25, P3019, DOI 10.1111/mec.13646; Karsten M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054281; Katti MV, 2001, MOL BIOL EVOL, V18, P1161, DOI 10.1093/oxfordjournals.molbev.a003903; Kim TS, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-31; LEATHER SR, 1981, ANN APPL BIOL, V99, P115, DOI 10.1111/j.1744-7348.1981.tb05136.x; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Li YC, 2002, MOL ECOL, V11, P2453, DOI 10.1046/j.1365-294X.2002.01643.x; Liang XQ, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-35; Liu GH, 2016, GENE, V576, P333, DOI 10.1016/j.gene.2015.10.045; Liu MY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046766; Llewellyn KS, 2003, MOL ECOL, V12, P21, DOI 10.1046/j.1365-294X.2003.01703.x; Lu Y, 2009, B ENTOMOL RES, V99, P611, DOI 10.1017/S0007485309006725; Luo Mei, 2014, Acta Entomologica Sinica, V57, P395; Margam VM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021388; MartinezTorres D, 1997, B ENTOMOL RES, V87, P161, DOI 10.1017/S0007485300027309; Meglecz E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040861; Meyer E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-219; Morgante M, 2002, NAT GENET, V30, P194, DOI 10.1038/ng822; Novaes E, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-312; Ollivier M, 2012, GENOME BIOL EVOL, V4, P155, DOI 10.1093/gbe/evr140; OSTRANDER EA, 1992, P NATL ACAD SCI USA, V89, P3419, DOI 10.1073/pnas.89.8.3419; Papura D, 2003, HEREDITY, V90, P397, DOI 10.1038/sj.hdy.6800262; Park SDE, 2001, THESIS; Pascual L, 2012, INSECT BIOCHEM MOLEC, V42, P557, DOI 10.1016/j.ibmb.2012.04.003; PIKE KS, 1985, J ECON ENTOMOL, V78, P676, DOI 10.1093/jee/78.3.676; Rispe C, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2530-8; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Ryman N, 2006, MOL ECOL NOTES, V6, P600, DOI 10.1111/j.1471-8286.2006.01378.x; SCHORDERET DF, 1992, P NATL ACAD SCI USA, V89, P957, DOI 10.1073/pnas.89.3.957; Schuelke M, 2000, NAT BIOTECHNOL, V18, P233, DOI 10.1038/72708; Schwarz D, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-633; Shiel BP, 2015, MAR BIOTECHNOL, V17, P23, DOI 10.1007/s10126-014-9591-y; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; SIMON JC, 1991, B ENTOMOL RES, V81, P315, DOI 10.1017/S0007485300033599; Simon JC, 1996, HEREDITY, V76, P305, DOI 10.1038/hdy.1996.44; Simon JC, 2001, MOL ECOL NOTES, V1, P4, DOI 10.1046/j.1471-8278.2000.00002.x; Sonah H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021298; Sunnucks P, 1996, GENETICS, V144, P747; Tang Yuan-ju, 2007, Zhongguo Yufang Shouyi Xuebao, V29, P629; TATCHELL GM, 1988, ANN APPL BIOL, V112, P1, DOI 10.1111/j.1744-7348.1988.tb02035.x; TAUTZ D, 1984, NUCLEIC ACIDS RES, V12, P4127, DOI 10.1093/nar/12.10.4127; Toth G, 2000, GENOME RES, V10, P967, DOI 10.1101/gr.10.7.967; Uliano-Silva M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102973; Valenzuela I, 2010, ANN ENTOMOL SOC AM, V103, P886, DOI 10.1603/AN09113; Varshney RK, 2005, PLANT SCI, V168, P195, DOI 10.1016/j.plantsci.2004.08.001; Wang BA, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120054; Wang XW, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-400; Wang ZY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-726; WEBER JL, 1990, GENOMICS, V7, P524, DOI 10.1016/0888-7543(90)90195-Z; Wei Dan-dan, 2014, Yingyong Shengtai Xuebao, V25, P1799; Wilson ACC, 1999, MOL ECOL, V8, P1655, DOI 10.1046/j.1365-294x.1999.00751.x; Wilson ACC, 2004, MOL ECOL NOTES, V4, P104, DOI 10.1046/j.1471-8286.2004.00584.x; Yeh F. C., 2000, POPGENE32 MICROSOFT; Yuan Yuan, 2014, Huanjing Kunchong Xuebao, V36, P166; Zane L, 2002, MOL ECOL, V11, P1, DOI 10.1046/j.0962-1083.2001.01418.x; Zhang LL, 2014, MAR BIOTECHNOL, V16, P17, DOI 10.1007/s10126-013-9526-z; Zhang LY, 2005, THEOR APPL GENET, V111, P677, DOI 10.1007/s00122-005-2041-5; Zhang XC, 1985, J PLANT PROTECT, V12, P9; Zheng XF, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-490; Zhou Q, 2016, SCI REP-UK, V6, DOI 10.1038/srep20549; Zhu Jia-Ying, 2013, PLoS ONE, V8, pe54411, DOI 10.1371/journal.pone.0054411	87	22	26	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2017	12	2							e0172513	10.1371/journal.pone.0172513	http://dx.doi.org/10.1371/journal.pone.0172513			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BI	28212394	Green Published, Green Submitted, gold			2022-12-27	WOS:000394424700057
J	Foschi, C; Laghi, L; Parolin, C; Giordani, B; Compri, M; Cevenini, R; Marangoni, A; Vitali, B				Foschi, Claudio; Laghi, Luca; Parolin, Carola; Giordani, Barbara; Compri, Monica; Cevenini, Roberto; Marangoni, Antonella; Vitali, Beatrice			Novel approaches for the taxonomic and metabolic characterization of lactobacilli: Integration of 16S rRNA gene sequencing with MALDI-TOF MS and H-1-NMR	PLOS ONE			English	Article							DESORPTION-IONIZATION-TIME; FLIGHT MASS-SPECTROMETRY; SPECIES IDENTIFICATION; VAGINAL MICROBIOME; CASEI GROUP; HUMAN GUT; PCR; STRAINS; FOOD; PROBIOTICS	Lactobacilli represent a wide range of bacterial species with several implications for the human host. They play a crucial role in maintaining the ecological equilibrium of different biological niches and are essential for fermented food production and probiotic formulation. Despite the consensus about the 'health-promoting' significance of Lactobacillus genus, its genotypic and phenotypic characterization still poses several difficulties. The aim of this study was to assess the integration of different approaches, genotypic (16S rRNA gene sequencing), proteomic (MALDI-TOF MS) and metabolomic (H-1-NMR), for the taxonomic and metabolic characterization of Lactobacillus species. For this purpose we analyzed 40 strains of various origin (intestinal, vaginal, food, probiotics), belonging to different species. The high discriminatory power of MALDI-TOF for species identification was underlined by the excellent agreement with the genotypic analysis. Indeed, MALDI-TOF allowed to correctly identify 39 out of 40 Lactobacillus strains at the species level, with an overall concordance of 97.5%. In the perspective to simplify the MALDI TOF sample preparation, especially for routine practice, we demonstrated the perfect agreement of the colony-picking from agar plates with the protein extraction protocol. H-1-NMR analysis, applied to both culture supernatants and bacterial lysates, identified a panel of metabolites whose variations in concentration were associated with the taxonomy, but also revealed a high intra-species variability that did not allow a species-level identification. Therefore, despite not suitable for mere taxonomic purposes, metabolomics can be useful to correlate particular biological activities with taxonomy and to understand the mechanisms related to the antimicrobial effect shown by some Lactobacillus species.	[Foschi, Claudio; Compri, Monica; Cevenini, Roberto; Marangoni, Antonella] Univ Bologna, Microbiol, DIMES, Bologna, Italy; [Laghi, Luca] Univ Bologna, Dept Agrofood Sci & Technol, Ctr Food, Bologna, Italy; [Parolin, Carola; Giordani, Barbara; Vitali, Beatrice] Univ Bologna, Dept Pharm & Biotechnol, Bologna, Italy	University of Bologna; University of Bologna; University of Bologna	Marangoni, A (corresponding author), Univ Bologna, Microbiol, DIMES, Bologna, Italy.	antonella.marangoni@unibo.it	Giordani, Barbara/AAC-2941-2020; Mattei, Benedetta/F-1504-2015; parolin, carola/C-1144-2013; Foschi, Claudio/A-7299-2016; Laghi, Luca/R-5278-2016	Mattei, Benedetta/0000-0003-2927-6329; parolin, carola/0000-0003-1536-9276; Foschi, Claudio/0000-0001-7253-8799; Laghi, Luca/0000-0003-1593-7376; Marangoni, Antonella/0000-0002-7397-6560	Ministry of Instruction, University and Research (MIUR), Italy [RF02014]	Ministry of Instruction, University and Research (MIUR), Italy(Ministry of Education, Universities and Research (MIUR))	This study was supported by the Ministry of Instruction, University and Research (MIUR), Italy to BV and RC (RF02014). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson AC, 2014, BMC MICROBIOL, V14, DOI 10.1186/s12866-014-0312-5; Angelakis E, 2011, J FOOD SCI, V76, pM568, DOI 10.1111/j.1750-3841.2011.02369.x; Antonio MAD, 1999, J INFECT DIS, V180, P1950, DOI 10.1086/315109; Bauer E, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0121-6; Bernardeau M, 2006, FEMS MICROBIOL REV, V30, P487, DOI 10.1111/j.1574-6976.2006.00020.x; Bizzini A, 2011, J CLIN MICROBIOL, V49, P693, DOI 10.1128/JCM.01463-10; Blaiotta G, 2008, APPL ENVIRON MICROB, V74, P208, DOI 10.1128/AEM.01711-07; Bourdichon F, 2012, INT J FOOD MICROBIOL, V154, P87, DOI 10.1016/j.ijfoodmicro.2011.12.030; Callaway A, 2013, CLIN LAB, V59, P1373, DOI 10.7754/Clin.Lab.2013.121225; Carbonnelle E, 2011, CLIN BIOCHEM, V44, P104, DOI 10.1016/j.clinbiochem.2010.06.017; Chavagnat F, 2002, FEMS MICROBIOL LETT, V217, P177, DOI 10.1111/j.1574-6968.2002.tb11472.x; Croxatto A, 2012, FEMS MICROBIOL REV, V36, P380, DOI 10.1111/j.1574-6976.2011.00298.x; Cruciani F, 2015, ANTIMICROB AGENTS CH, V59, P2825, DOI 10.1128/AAC.00225-15; Cruciani F, 2012, ANTIMICROB AGENTS CH, V56, P4062, DOI 10.1128/AAC.00061-12; Dec M, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-016-0732-5; Dec M, 2014, RES MICROBIOL, V165, P190, DOI 10.1016/j.resmic.2014.02.003; Doan NTL, 2012, LETT APPL MICROBIOL, V55, P265, DOI 10.1111/j.1472-765X.2012.03287.x; Duskova M, 2012, INT J FOOD MICROBIOL, V159, P107, DOI 10.1016/j.ijfoodmicro.2012.07.029; Felis Giovanna E, 2007, Curr Issues Intest Microbiol, V8, P44; Food and Agriculture Organization of the United Nations/World Health Organization FAO/WHO, 2002, GUID EV PROB FOOD, DOI DOI 10.1111/J.1469-0691.2012.03873; Helland MH, 2004, INT J FOOD MICROBIOL, V91, P305, DOI 10.1016/j.ijfoodmicro.2003.07.007; Huang CH, 2014, MOL CELL PROBE, V28, P192, DOI 10.1016/j.mcp.2014.03.003; Kern CC, 2014, FOOD MICROBIOL, V40, P18, DOI 10.1016/j.fm.2013.11.015; Kern CC, 2013, J MICROBIOL METH, V93, P185, DOI 10.1016/j.mimet.2013.03.012; Laghi L, 2014, TRAC-TREND ANAL CHEM, V59, P93, DOI 10.1016/j.trac.2014.04.009; Laghi L, 2014, ANTIMICROB AGENTS CH, V58, P3411, DOI 10.1128/AAC.02469-14; Lee IJ, 2009, J PROTEOME RES, V8, P4104, DOI 10.1021/pr8010759; Macklaim JM, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-12; Massi M, 2004, J APPL MICROBIOL, V96, P777, DOI 10.1111/j.1365-2672.2004.02228.x; Mastromarino P, 2014, INT J MED MICROBIOL, V304, P654, DOI 10.1016/j.ijmm.2014.04.006; Mazzeo MF, 2006, APPL ENVIRON MICROB, V72, P1180, DOI 10.1128/AEM.72.2.1180-1189.2006; Mencacci A, 2013, J CLIN MICROBIOL, V51, P603, DOI 10.1128/JCM.01811-12; Meyer H, 2013, MICROB CELL FACT, V12, DOI 10.1186/1475-2859-12-69; Munson MA, 2004, J CLIN MICROBIOL, V42, P3023, DOI 10.1128/JCM.42.7.3023-3029.2004; Nardini P, 2016, SCI REP-UK, V6, DOI 10.1038/srep29024; O'Callaghan J, 2013, CURR TOP MICROBIOL, V358, P119, DOI 10.1007/82_2011_187; Parolin C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131220; Patel JB, 2001, MOL DIAGN, V6, P313, DOI 10.1054/modi.2001.29158; Patel R, 2015, CLIN INFECT DIS, V60, pS108, DOI 10.1093/cid/civ177; Petrova MI, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00081; Pot B, 2014, LACTIC ACID BACTERIA: BIODIVERSITY AND TAXONOMY, P249; Rettinger A, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-185; Riegel SD, 2016, TRAC TRENDS ANAL CHE; Rossi M, 2016, ENV MICROBIOL REP, V8, P399, DOI 10.1111/1758-2229.12405; Martinez RCR, 2015, BRIT J NUTR, V114, P1993, DOI 10.1017/S0007114515003864; Salvetti E, 2013, SYST APPL MICROBIOL, V36, P291, DOI 10.1016/j.syapm.2013.03.009; Salvetti E, 2012, PROBIOTICS ANTIMICRO, V4, P217, DOI 10.1007/s12602-012-9117-8; Sandrin TR, 2013, MASS SPECTROM REV, V32, P188, DOI 10.1002/mas.21359; Sato H, 2012, SYST APPL MICROBIOL, V35, P447, DOI 10.1016/j.syapm.2012.08.008; Sheu SJ, 2009, J FOOD PROTECT, V72, P93, DOI 10.4315/0362-028X-72.1.93; Smolinska A, 2012, ANAL CHIM ACTA, V750, P82, DOI 10.1016/j.aca.2012.05.049; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tannock GW, 2004, APPL ENVIRON MICROB, V70, P3189, DOI 10.1128/AEM.70.6.3189-3194.2004; Urbanczyk-Wochniak E, 2003, EMBO REP, V4, P989, DOI 10.1038/sj.embor.embor944; Vielfort K, 2008, MICROBES INFECT, V10, P1325, DOI 10.1016/j.micinf.2008.07.032; Vitali B, 2015, EUR J CLIN MICROBIOL, V34, P2367, DOI 10.1007/s10096-015-2490-y; Von Wright A, 2012, LACTIC ACID BACTERIA: MICROBIOLOGICAL AND FUNCTIONAL ASPECTS, 4TH EDITION, P1; Yang JS, 2016, J DAIRY SCI, V99, P5325, DOI 10.3168/jds.2016-10952; Zhang B, 2012, FUTURE MED CHEM, V4, P1273, DOI [10.4155/FMC.12.59, 10.4155/fmc.12.59]; Zhang YF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106185; Zheng JS, 2015, APPL ENVIRON MICROB, V81, P7233, DOI 10.1128/AEM.02116-15	61	31	32	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0172483	10.1371/journal.pone.0172483	http://dx.doi.org/10.1371/journal.pone.0172483			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207855	Green Published, Green Submitted, gold			2022-12-27	WOS:000394424500141
J	Jin, F; Wan, CP; Li, WF; Yao, LL; Zhao, HQ; Zou, Y; Peng, DW; Huang, WF				Jin, Fen; Wan, Chunpeng; Li, Weifang; Yao, Liangliang; Zhao, Hongqian; Zou, Yuan; Peng, Dewei; Huang, Weifeng			Formononetin protects against acetaminophen-induced hepatotoxicity through enhanced NRF2 activity	PLOS ONE			English	Article							RED-CLOVER ISOFLAVONES; MICE; MECHANISMS	To examine the effects of formononetin (FMN) on Acetaminophen (APAP)-induced liver injury in vitro and in vivo. Human non-tumor hepatic cells LO2 were pretreated with either vehicle or FMN (20, 40 mu M), for 6 h, followed by incubation with or without APAP (10 mM) for 24 h. In an in vivo assay, male BALB/c mice were randomly divided into four groups: (1) control group; (2) APAP group; (3) APAP + FMN (50 mg/Kg); (4) APAP + FMN (100 mg/Kg). The mice in the control and APAP groups were pre-treated with vehicle; the other two groups were pretreated daily with FMN (50, 100 mg/Kg) orally for 7 consecutive days. After the final treatment, acute liver injury was induced in all groups, except the control group, by intraperitoneal (i.p.) injection of 300 mg/Kg APAP. In LO2 cells, APAP exposure decreased the cell viability and glutathione (GSH) content, which were both greatly restored by FMN pretreatment. Overdose of APAP increased hepatic malondialdehyde (MDA) content, serum alanine aminotransferase (ALT), and aspartate aminotransferase (AST) activity in experimental mice. Supplementation with 100 mg/Kg FMN significantly reduced APAP-induced elevated levels of MDA (1.97 +/- 0.27 vs 0.55 +/- 0.14 nmol/mg protein, p < 0.001), ALT (955.80 +/- 209.40 vs 46.90 +/- 20.40 IU/L, p < 0.001) and AST (1533.80 +/- 244.80 vs 56.70 +/- 28.80 IU/L, p < 0.001), and hepatic GSH level (5.54 +/- 0.93 vs 8.91 +/- 1.11 mu mol/mg protein, p < 0.001) was significantly increased. These results were further validated by histopathology and TdT-mediated biotin-dUTP nick-endlabeling (TUNEL) staining, pretreatment with 100 mg/Kg FMN significant decreased APAP-induced hepatocellular damage and cell apoptosis (36.55 +/- 3.82 vs 2.58 +/- 1.80%, p < 0.001). Concomitantly, FMN stimulated the expression of Nrf2 and antioxidant gene expression in the presence of APAP. These data provide an experimental basis for the use of FMN in the treatment of patients with APAP-induced hepatotoxicity.	[Jin, Fen; Li, Weifang; Zhao, Hongqian; Zou, Yuan; Peng, Dewei; Huang, Weifeng] China Three Gorges Univ, Coll Med, Yichang, Hubei, Peoples R China; [Wan, Chunpeng] Jiangxi Agr Univ, Coll Agron, Jiangxi Key Lab Postharvest Technol & Nondestruct, Nanchang, Jiangxi, Peoples R China; [Yao, Liangliang] Jiangxi Univ Tradit Chinese Med, Affiliated Hosp, Nanchang, Jiangxi, Peoples R China	China Three Gorges University; Jiangxi Agricultural University; Jiangxi University of Traditional Chinese Medicine	Huang, WF (corresponding author), China Three Gorges Univ, Coll Med, Yichang, Hubei, Peoples R China.; Wan, CP (corresponding author), Jiangxi Agr Univ, Coll Agron, Jiangxi Key Lab Postharvest Technol & Nondestruct, Nanchang, Jiangxi, Peoples R China.	lemonwan@126.com; huangweifeng@ctgu.edu.cn	Wan, Chunpeng/H-1423-2011; Wan, Chunpeng/T-8707-2019	Wan, Chunpeng/0000-0001-6892-016X; Wan, Chunpeng/0000-0001-6892-016X; Yao, Liangliang/0000-0002-8435-5954	National Natural Science Foundation of China [81100281, 31500286]; Medical and Health Research Project from Yichang Science and Technology Bureau [A15301-35]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Medical and Health Research Project from Yichang Science and Technology Bureau	This project was supported by the National Natural Science Foundation of China (No. 81100281; 31500286), Medical and Health Research Project from Yichang Science and Technology Bureau, No. A15301-35.; This project was supported by the National Natural Science Foundation of China (No. 81100281; 31500286), Medical and Health Research Project from Yichang Science and Technology Bureau, No. A15301-35. We would like to thank Dr Fred Bogott from Austin Medical Center at Austin, Minnesota and Dr Chengfu Yuan from China Three Gorges University, for their excellent English editing of the manuscript.	Arora S, 2015, TOXICOL LETT, V239, P1, DOI 10.1016/j.toxlet.2015.08.202; Bessems JGM, 2001, CRIT REV TOXICOL, V31, P55, DOI 10.1080/20014091111677; Britton RS, 1996, SEMIN LIVER DIS, V16, P3, DOI 10.1055/s-2007-1007214; Chan KM, 2001, P NATL ACAD SCI USA, V98, P4611, DOI 10.1073/pnas.081082098; Chen Mei-Yuan, 2010, Zhonghua Nan Ke Xue, V16, P34; Clifton-Bligh PB, 2015, EUR J CLIN NUTR, V69, P134, DOI 10.1038/ejcn.2014.207; Eugenio-Perez D, 2016, PHARM BIOL, P1; Fritz H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081968; Jaeschke H, 2006, TOXICOL SCI, V89, P31, DOI 10.1093/toxsci/kfi336; Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046; Larson Anne M, 2007, Clin Liver Dis, V11, P525, DOI 10.1016/j.cld.2007.06.006; Lee SST, 1996, J BIOL CHEM, V271, P12063, DOI 10.1074/jbc.271.20.12063; Liu XX, 2011, CARCINOGENESIS, V32, P1648, DOI 10.1093/carcin/bgr206; Mohan M, 2013, NAT PROD RES, V27, P2140, DOI 10.1080/14786419.2013.778853; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Ozer J, 2008, TOXICOLOGY, V245, P194, DOI 10.1016/j.tox.2007.11.021; POTTER DW, 1986, MOL PHARMACOL, V30, P33; Qiu LX, 2012, PHYTOTHER RES, V26, P860, DOI 10.1002/ptr.3641; Reisman SA, 2009, TOXICOL SCI, V109, P31, DOI 10.1093/toxsci/kfp047; Reiter E, 2011, GYNECOL ENDOCRINOL, V27, P1037, DOI 10.3109/09513590.2011.588743; VERMEULEN NPE, 1992, DRUG METAB REV, V24, P367, DOI 10.3109/03602539208996298; Ye DW, 2014, HEPATOLOGY, V60, P977, DOI 10.1002/hep.27060; Yoon E, 2016, J CLIN TRANSL HEPATO, V4, P131, DOI 10.14218/JCTH.2015.00052	23	33	34	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0170900	10.1371/journal.pone.0170900	http://dx.doi.org/10.1371/journal.pone.0170900			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5VB	28234915	Green Submitted, gold, Green Published			2022-12-27	WOS:000394688200014
J	Mochizuki, T; Tanizawa, Y; Fujisawa, T; Ohta, T; Nikoh, N; Shimizu, T; Toyoda, A; Fujiyama, A; Kurata, N; Nagasaki, H; Kaminuma, E; Nakamura, Y				Mochizuki, Takako; Tanizawa, Yasuhiro; Fujisawa, Takatomo; Ohta, Tazro; Nikoh, Naruo; Shimizu, Tokurou; Toyoda, Atsushi; Fujiyama, Asao; Kurata, Nori; Nagasaki, Hideki; Kaminuma, Eli; Nakamura, Yasukazu			DNApod: DNA polymorphism annotation database from next-generation sequence read archives	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; COMPLEX TRAITS; REVEALS; RICE; DISCOVERY; RESOURCES; ARCHITECTURE; INFERENCE; SELECTION; CULTIVAR	With the rapid advances in next-generation sequencing (NGS), datasets for DNA polymorphisms among various species and strains have been produced, stored, and distributed. However, reliability varies among these datasets because the experimental and analytical conditions used differ among assays. Furthermore, such datasets have been frequently distributed from the websites of individual sequencing projects. It is desirable to integrate DNA polymorphism data into one database featuring uniform quality control that is distributed from a single platform at a single place. DNA polymorphism annotation database (DNApod; http://tga.nig.ac.jp/dnapod/) is an integrated database that stores genome-wide DNA polymorphism datasets acquired under uniform analytical conditions, and this includes uniformity in the quality of the raw data, the reference genome version, and evaluation algorithms. DNApod genotypic data are re-analyzed whole-genome shotgun datasets extracted from sequence read archives, and DNApod distributes genome-wide DNA polymorphism datasets and known-gene annotations for each DNA polymorphism. This new database was developed for storing genome-wide DNA polymorphism datasets of plants, with crops being the first priority. Here, we describe our analyzed data for 679, 404, and 66 strains of rice, maize, and sorghum, respectively. The analytical methods are available as a DNApod work-flow in an NGS annotation system of the DNA Data Bank of Japan and a virtual machine image. Furthermore, DNApod provides tables of links of identifiers between DNApod genotypic data and public phenotypic data. To advance the sharing of organism knowledge, DNApod offers basic and ubiquitous functions for multiple alignment and phylogenetic tree construction by using orthologous gene information.	[Mochizuki, Takako; Tanizawa, Yasuhiro; Fujisawa, Takatomo; Kaminuma, Eli; Nakamura, Yasukazu] Natl Inst Genet, Genome Informat Lab, Mishima, Shizuoka, Japan; [Ohta, Tazro] Res Org Informat & Syst, Joint Support Ctr Data Sci Res, Database Ctr Life Sci, Mishima, Shizuoka, Japan; [Nikoh, Naruo] Open Univ Japan, Dept Liberal Arts, Chiba, Chiba, Japan; [Shimizu, Tokurou] NARO, Inst Fruit Tree & Tea Sci, Div Citrus Res, Shimizu, Shizuoka, Japan; [Toyoda, Atsushi] Natl Inst Genet, Comparat Genom Lab, Mishima, Shizuoka, Japan; [Toyoda, Atsushi; Fujiyama, Asao] Natl Inst Genet, Adv Genom Ctr, Mishima, Shizuoka, Japan; [Kurata, Nori] Natl Inst Genet, Plant Genet Lab, Mishima, Shizuoka, Japan; [Nagasaki, Hideki] Kazusa DNA Res Inst, Dev Technol Dept, Genome Informat Grp, Kisarazu, Chiba, Japan	Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Research Organization of Information & Systems (ROIS); National Agriculture & Food Research Organization - Japan; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Kazusa DNA Research Institute	Kaminuma, E (corresponding author), Natl Inst Genet, Genome Informat Lab, Mishima, Shizuoka, Japan.	ekaminum@nig.ac.jp	Ohta, Tazro/HGE-5906-2022	Ohta, Tazro/0000-0003-3777-5945; Nakamura, Yasukazu/0000-0002-6782-5715	Transdisciplinary Research Integration Center Project of the Research Organization of Information and Systems; Japanese Ministry of Agriculture, Forestry and Fisheries [NGB1006]; Japan Society for the Promotion of Science (JSPS) [24500366, 24510273]	Transdisciplinary Research Integration Center Project of the Research Organization of Information and Systems; Japanese Ministry of Agriculture, Forestry and Fisheries(Ministry of Agriculture Forestry & Fisheries - Japan); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by the Transdisciplinary Research Integration Center Project of the Research Organization of Information and Systems to T.M., E.K., Y.N., A.F. and N.K.; the Japanese Ministry of Agriculture, Forestry and Fisheries [Genomics for Agricultural Innovation (NGB1006 to E.K. and T.S.)]; the Japan Society for the Promotion of Science (JSPS) [Grant-in-Aid for Scientific Research (C) (No. 24500366 to E.K. and No. 24510273 to H.N.)];. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe A, 2012, NAT BIOTECHNOL, V30, P174, DOI 10.1038/nbt.2095; Akpinar BA, 2015, PLANT BIOTECHNOL J, V13, P740, DOI 10.1111/pbi.12302; Akpinar BA, 2017, FUNCT INTEGR GENOMIC, V17, P97, DOI 10.1007/s10142-016-0536-6; Akpinar BA, 2015, SCI REP-UK, V5, DOI 10.1038/srep10763; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arai-Kichise Y, 2011, PLANT CELL PHYSIOL, V52, P274, DOI 10.1093/pcp/pcr003; Asamizu E, 2014, PLANT CELL PHYSIOL, V55, DOI 10.1093/pcp/pct189; Bernardo R, 2008, CROP SCI, V48, P1649, DOI 10.2135/cropsci2008.03.0131; Blanc G, 2004, PLANT CELL, V16, P1667, DOI 10.1105/tpc.021345; Bolot S, 2009, CURR OPIN PLANT BIOL, V12, P119, DOI 10.1016/j.pbi.2008.10.011; Bolser DM, 2015, PLANT CELL PHYSIOL, V56, DOI 10.1093/pcp/pcu183; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Chia JM, 2012, NAT GENET, V44, P803, DOI 10.1038/ng.2313; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; Crowell S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10527; Curk F, 2014, BMC GENET, V15, DOI 10.1186/s12863-014-0152-1; D'Hont A, 2000, THEOR APPL GENET, V100, P177, DOI 10.1007/s001220050024; Dong Min, 2015, Methods Mol Biol, V1255, P25, DOI 10.1007/978-1-4939-2175-1_3; Fingerman IM, 2013, NUCLEIC ACIDS RES, V41, pD221, DOI 10.1093/nar/gks1171; Huang XH, 2012, NATURE, V490, P497, DOI 10.1038/nature11532; Jannink JL, 2010, BRIEF FUNCT GENOMICS, V9, P166, DOI 10.1093/bfgp/elq001; Jiao YP, 2012, NAT GENET, V44, P812, DOI 10.1038/ng.2312; Kobayashi M, 2014, PLANT CELL PHYSIOL, V55, P445, DOI 10.1093/pcp/pct181; Kodama Y, 2010, ADV EXP MED BIOL, V680, P125, DOI 10.1007/978-1-4419-5913-3_15; Kumar V, 2015, DNA RES, V22, P133, DOI 10.1093/dnares/dsu046; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Lucas SJ, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1080; Mace ES, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3320; Mayer KFX, 2014, SCIENCE, V345, DOI 10.1126/science.1251788; McCouch SR, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10532; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Monaco MK, 2014, NUCLEIC ACIDS RES, V42, pD1193, DOI 10.1093/nar/gkt1110; Morris GP, 2013, P NATL ACAD SCI USA, V110, P453, DOI 10.1073/pnas.1215985110; Nagasaki H, 2013, DNA RES, V20, P383, DOI 10.1093/dnares/dst017; Nakazato T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077910; Obayashi T, 2014, PLANT CELL PHYSIOL, V55, DOI 10.1093/pcp/pct178; Ohyanagi H, 2015, PLANT CELL PHYSIOL, V56, DOI 10.1093/pcp/pcu188; Oki S, 2014, GENES CELLS, V19, P919, DOI 10.1111/gtc.12190; Pace J, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1226-9; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Paterson AH, 2010, ANNU REV PLANT BIOL, V61, P349, DOI 10.1146/annurev-arplant-042809-112235; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Penjor T, 2014, SCI REP-UK, V4, DOI 10.1038/srep04853; Pruitt KD, 2012, NUCLEIC ACIDS RES, V40, pD130, DOI 10.1093/nar/gkr1079; Rellosa MC, 2014, GIGASCIENCE, V3, DOI 10.1186/2047-217X-3-7; Roberts A, 2007, BIOINFORMATICS, V23, pI401, DOI 10.1093/bioinformatics/btm220; Sakai H, 2013, PLANT CELL PHYSIOL, V54, pE6, DOI 10.1093/pcp/pcs183; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Silvester N, 2015, NUCLEIC ACIDS RES, V43, pD23, DOI 10.1093/nar/gku1129; Stephens M, 2005, AM J HUM GENET, V76, P449, DOI 10.1086/428594; Takeya M, 2011, NUCLEIC ACIDS RES, V39, pD1108, DOI 10.1093/nar/gkq916; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Zhao K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1467; Zhao KY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010780	59	2	2	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0172269	10.1371/journal.pone.0172269	http://dx.doi.org/10.1371/journal.pone.0172269			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5VB	28234924	gold, Green Published, Green Submitted			2022-12-27	WOS:000394688200060
J	Yu, XX; Yu, GX; Wang, J				Yu, Xianxue; Yu, Guoxian; Wang, Jun			Clustering cancer gene expression data by projective clustering ensemble	PLOS ONE			English	Article							FUZZY C-MEANS; MICROARRAY DATA; CLASS DISCOVERY; FRAMEWORK; CRITERIA	Gene expression data analysis has paramount implications for gene treatments, cancer diagnosis and other domains. Clustering is an important and promising tool to analyze gene expression data. Gene expression data is often characterized by a large amount of genes but with limited samples, thus various projective clustering techniques and ensemble techniques have been suggested to combat with these challenges. However, it is rather challenging to synergy these two kinds of techniques together to avoid the curse of dimensionality problem and to boost the performance of gene expression data clustering. In this paper, we employ a projective clustering ensemble (PCE) to integrate the advantages of projective clustering and ensemble clustering, and to avoid the dilemma of combining multiple projective clusterings. Our experimental results on publicly available cancer gene expression data show PCE can improve the quality of clustering gene expression data by at least 4.5% (on average) than other related techniques, including dimensionality reduction based single clustering and ensemble approaches. The empirical study demonstrates that, to further boost the performance of clustering cancer gene expression data, it is necessary and promising to synergy projective clustering with ensemble clustering. PCE can serve as an effective alternative technique for clustering gene expression data.	[Yu, Xianxue; Yu, Guoxian; Wang, Jun] Southwest Univ, Coll Comp & Informat Sci, Chongqing, Peoples R China	Southwest University - China	Wang, J (corresponding author), Southwest Univ, Coll Comp & Informat Sci, Chongqing, Peoples R China.	kingjun@swu.edu.cn			National Natural Science Foundation of China [61101234, 61402378]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (61101234), www.nsfc.gov.cn, and National Natural Science Foundation of China (61402378), www.nsfc.gov.cn.	Aggarwal CC, 1999, SIGMOD RECORD, VOL 28, NO 2 - JUNE 1999, P61, DOI 10.1145/304181.304188; Agrawal R, 2005, DATA MIN KNOWL DISC, V11, P5, DOI 10.1007/s10618-005-1396-1; Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Armstrong SA, 2002, NAT GENET, V30, P41, DOI 10.1038/ng765; Avogadri R, 2009, ARTIF INTELL MED, V45, P173, DOI 10.1016/j.artmed.2008.07.014; Barthelemy JP, 1995, DIMACS SERIES DISCRE, V19, P3, DOI DOI 10.1090/DIMACS/019/01; Ben-Dor A, 2001, P 5 ANN INT C COMP M, P31, DOI DOI 10.1145/369133.369167; BEZDEK JC, 1984, COMPUT GEOSCI, V10, P191, DOI 10.1016/0098-3004(84)90020-7; Brazma A, 2000, FEBS LETT, V480, P17, DOI 10.1016/S0014-5793(00)01772-5; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Cheng Y, 2000, Proc Int Conf Intell Syst Mol Biol, V8, P93; Coello CAC, 2004, APPL MULTIOBJECTIVE, V1; D'haeseleer P, 2005, NAT BIOTECHNOL, V23, P1499, DOI 10.1038/nbt1205-1499; de Souto MCP, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-497; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Demsar J, 2006, J MACH LEARN RES, V7, P1; Domeniconi C, 2009, ACM T KNOWL DISCOV D, V2, P1; Domeniconi C, 2007, DATA MIN KNOWL DISC, V14, P63, DOI 10.1007/s10618-006-0060-8; Dudoit S, 2003, BIOINFORMATICS, V19, P1090, DOI 10.1093/bioinformatics/btg038; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fred ALN, 2005, IEEE T PATTERN ANAL, V27, P835, DOI 10.1109/TPAMI.2005.113; Frey BJ, 2007, SCIENCE, V315, P972, DOI 10.1126/science.1136800; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Grotkjaer T, 2006, BIOINFORMATICS, V22, P58, DOI 10.1093/bioinformatics/bti746; Gullo F, 2013, DATA MIN KNOWL DISC, V26, P452, DOI 10.1007/s10618-012-0266-x; Hopp L, 2015, GENES-BASEL, V6, P812, DOI 10.3390/genes6030812; Hoshida Y, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001195; Huang SD, 2015, KNOWL-BASED SYST, V84, P46, DOI 10.1016/j.knosys.2015.03.027; Iam-On N, 2010, IEEE INT C BIOINFORM, P573, DOI 10.1109/BIBM.2010.5706631; Jiang DX, 2004, IEEE T KNOWL DATA EN, V16, P1370, DOI 10.1109/TKDE.2004.68; Kluger Y, 2003, GENOME RES, V13, P703, DOI 10.1101/gr.648603; Kumar V, 2004, NEW DIRECTIONS STAT, P273, DOI DOI 10.1007/978-3-662-08968-2_16; Li Y, 2008, PATTERN RECOGN, V41, P217, DOI 10.1016/j.patcog.2007.06.007; Liu YY, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-37; Lu Y, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-172; MARTINETZ TM, 1993, IEEE T NEURAL NETWOR, V4, P558, DOI 10.1109/72.238311; MILLIGAN GW, 1986, MULTIVAR BEHAV RES, V21, P441, DOI 10.1207/s15327906mbr2104_5; Monti S, 2003, MACH LEARN, V52, P91, DOI 10.1023/A:1023949509487; Mukhopadhyay A, 2013, IEEE T BIO-MED ENG, V60, P35, DOI 10.1109/TBME.2012.2220765; Nepomuceno JA, 2011, BIODATA MIN, V4, DOI 10.1186/1756-0381-4-3; Parsons L., 2004, ACM SIGKDD EXPLORATI, V6, P90, DOI [10.1145/1007730.1007731, DOI 10.1145/1007730.1007731]; Pedrycz W, 2008, FUZZY SET SYST, V159, P2399, DOI 10.1016/j.fss.2007.12.030; RAND WM, 1971, J AM STAT ASSOC, V66, P846, DOI 10.2307/2284239; Shi JB, 2000, IEEE T PATTERN ANAL, V22, P888, DOI 10.1109/34.868688; Smolkin M, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-36; Spirin V, 2003, P NATL ACAD SCI USA, V100, P12123, DOI 10.1073/pnas.2032324100; Strehl A., 2003, Journal of Machine Learning Research, V3, P583, DOI 10.1162/153244303321897735; Studholme C, 1999, PATTERN RECOGN, V32, P71, DOI 10.1016/S0031-3203(98)00091-0; Vesanto J, 2000, IEEE T NEURAL NETWOR, V11, P586, DOI 10.1109/72.846731; Wang Y, 2008, BRIT J CANCER, V98, P1023, DOI 10.1038/sj.bjc.6604207; WILCOXON F, 1946, J ECON ENTOMOL, V39, P269, DOI 10.1093/jee/39.2.269; Xing E P, 2001, Bioinformatics, V17 Suppl 1, pS306; Yeung KY, 2001, BIOINFORMATICS, V17, P977, DOI 10.1093/bioinformatics/17.10.977; Yu ZW, 2007, BIOINFORMATICS, V23, P2888, DOI 10.1093/bioinformatics/btm463; Yu ZW, 2015, IEEE ACM T COMPUT BI, V12, P887, DOI 10.1109/TCBB.2014.2359433; Yu ZW, 2013, IEEE ACM T COMPUT BI, V10, P657, DOI 10.1109/TCBB.2013.59	56	19	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e71429	10.1371/journal.pone.0171429	http://dx.doi.org/10.1371/journal.pone.0171429			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5VB	28234920	Green Published, Green Submitted, gold			2022-12-27	WOS:000394688200022
J	Kasahara, K; Shiina, M; Fukuda, I; Ogata, K; Nakamura, H				Kasahara, Kota; Shiina, Masaaki; Fukuda, Ikuo; Ogata, Kazuhiro; Nakamura, Haruki			Molecular mechanisms of cooperative binding of transcription factors Runx1-CBF beta-Ets1 on the TCRa gene enhancer	PLOS ONE			English	Article							ETS-1 DNA-BINDING; STROMELYSIN-1 PROMOTER; NUCLEIC-ACIDS; DYNAMICS; AUTOINHIBITION; SIMULATIONS; MODULATION; PARAMETERS; COMPLEXES; SEQUENCES	Ets1 is an essential transcription factor (TF) for several important physiological processes, including cell proliferation and differentiation. Its recognition of the enhancer region of the TCRa gene is enhanced by the cooperative binding of the Runx1-CBF beta heterodimer, with the cancelation of phosphorylation-dependent autoinhibition. The detailed mechanism of this interesting cooperativity between Ets1 and the Runx1-CBF beta heterodimer is still largely unclear. Here, we investigated the molecular mechanisms of this cooperativity, by using molecular dynamics simulations. Consequently, we detected high flexibility of the loop region between the HI2 and H1 helices of Ets1. Upon Runx1-CBF beta heterodimer binding, this loop transiently adopts various sub-stable conformations in its interactions with the DNA. In addition, a network analysis suggested an allosteric pathway in the molecular assembly and identified some key residues that coincide with previous experimental studies. Our simulations suggest that the cooperative binding of Ets1 and the Runx1-CBF beta heterodimer alters the DNA conformation and induces sub-stable conformations of the HI2-H1 loop of Ets1. This phenomenon increases the flexibility of the regulatory module, including the HI2 helix, and destabilizes the inhibitory form of this module. Thus, we hypothesize that this effect facilitates Ets1-DNA binding and prevents the phosphorylation-dependent DNA binding autoinhibition.	[Kasahara, Kota] Ritsumeikan Univ, Coll Life Sci, Kusatsu, Shiga, Japan; [Shiina, Masaaki; Ogata, Kazuhiro] Yokohama City Univ, Grad Sch Med, Kanazawa Ku, Yokohama, Kanagawa, Japan; [Fukuda, Ikuo; Nakamura, Haruki] Osaka Univ, Inst Prot Res, Suita, Osaka, Japan	Ritsumeikan University; Yokohama City University; Osaka University	Kasahara, K (corresponding author), Ritsumeikan Univ, Coll Life Sci, Kusatsu, Shiga, Japan.	ktkshr@fc.ritsumei.ac.jp		Kasahara, Kota/0000-0003-0207-6271	HPCI System Research Project [hp130061, hp140032, hp150015]; Cooperative Research Program of Institute for Protein Research, Osaka University [CR-16-05]; Japan Society for the Promotion of Science [24118008, 24118005]; Grants-in-Aid for Scientific Research [16K18526] Funding Source: KAKEN	HPCI System Research Project; Cooperative Research Program of Institute for Protein Research, Osaka University; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Society for the Promotion of Science, https://www.jsps.go.jp/english/index.html, Grant numbers: 24118008 and 24118005. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The MD simulations were performed on the TSUBAME2.5 supercomputer at the Tokyo Institute of Technology, provided through the HPCI System Research Project (Project IDs: hp130061, hp140032, and hp150015). The numerical computations for post-simulation analyses were performed with the supercomputer system provided by the National Institute of Genetics, Research Organization of Information and Systems, Japan. This work was performed in part under the Cooperative Research Program of Institute for Protein Research, Osaka University, CR-16-05.	Arakawa T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076606; Attias H, 1999, UNCERTAINTY IN ARTIFICIAL INTELLIGENCE, PROCEEDINGS, P21; Babayeva ND, 2010, CELL CYCLE, V9, P3054, DOI 10.4161/cc.9.14.12257; Baillat D, 2002, J BIOL CHEM, V277, P29386, DOI 10.1074/jbc.M200088200; Bravo J, 2001, NAT STRUCT BIOL, V8, P371, DOI 10.1038/86264; del Sol A, 2009, STRUCTURE, V17, P1042, DOI 10.1016/j.str.2009.06.008; Desjardins G, 2014, P NATL ACAD SCI USA, V111, P11019, DOI 10.1073/pnas.1401891111; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Fukuda I, 2014, J CHEM PHYS, V140, DOI 10.1063/1.4875693; Fukuda I, 2013, J CHEM PHYS, V139, DOI 10.1063/1.4827055; Fukuda Ikuo, 2012, Biophys Rev, V4, P161, DOI 10.1007/s12551-012-0089-4; Fukuda I, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4739789; Fukuda I, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3582791; Garrett-Sinha LA, 2013, CELL MOL LIFE SCI, V70, P3375, DOI 10.1007/s00018-012-1243-7; Garvie CW, 2002, J BIOL CHEM, V277, P45529, DOI 10.1074/jbc.M206327200; Garvie CW, 2001, MOL CELL, V8, P1267, DOI 10.1016/S1097-2765(01)00410-5; Hollenhorst PC, 2011, ANNU REV BIOCHEM, V80, P437, DOI 10.1146/annurev.biochem.79.081507.103945; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Jonsen MD, 1996, MOL CELL BIOL, V16, P2065; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Joung IS, 2008, J PHYS CHEM B, V112, P9020, DOI 10.1021/jp8001614; Kamberaj H, 2009, BIOPHYS J, V96, P1307, DOI 10.1016/j.bpj.2008.11.019; Karolak A, 2012, BIOPHYS CHEM, V165, P74, DOI 10.1016/j.bpc.2012.03.007; Kasahara K, 2016, BIOINFORMATICS, V32, P2531, DOI 10.1093/bioinformatics/btw129; Kasahara K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112419; Lamber EP, 2008, EMBO J, V27, P2006, DOI 10.1038/emboj.2008.117; Lavery R, 2009, NUCLEIC ACIDS RES, V37, P5917, DOI 10.1093/nar/gkp608; Lis M., 2011, IMMUNOME RES, V7, P1, DOI DOI 10.4172/1745-7580.1000041; Mashimo T, 2013, J CHEM THEORY COMPUT, V9, P5599, DOI 10.1021/ct400342e; MCCAMMON JA, 1984, REP PROG PHYS, V47, P1, DOI 10.1088/0034-4885/47/1/001; Ogata K, 2003, CURR OPIN STRUC BIOL, V13, P40, DOI 10.1016/S0959-440X(03)00012-5; Perez A, 2007, BIOPHYS J, V92, P3817, DOI 10.1529/biophysj.106.097782; PETERSEN JM, 1995, SCIENCE, V269, P1866, DOI 10.1126/science.7569926; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Pufall MA, 2005, SCIENCE, V309, P142, DOI 10.1126/science.1111915; Reddy SY, 2003, P NATL ACAD SCI USA, V100, P15475, DOI 10.1073/pnas.1936251100; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Shaikhibrahim Z, 2012, INT J ONCOL, V40, P1748, DOI 10.3892/ijo.2012.1380; Shiina M, 2015, J MOL BIOL, V427, P1655, DOI 10.1016/j.jmb.2014.07.020; Shiina M, 2014, ACTA CRYSTALLOGR F, V70, P1380, DOI 10.1107/S2053230X14018470; Wang H, 2002, J BIOL CHEM, V277, P2225, DOI 10.1074/jbc.M109430200	41	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2017	12	2							e0172654	10.1371/journal.pone.0172654	http://dx.doi.org/10.1371/journal.pone.0172654			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5SX	28231333	gold, Green Published, Green Submitted			2022-12-27	WOS:000394682400066
J	Liao, S; Ruiz, Y; Gulzar, H; Yelskaya, Z; Taouit, LA; Houssou, M; Jaikaran, T; Schvarts, Y; Kozlitina, K; Basu-Roy, U; Mansukhani, A; Mahajan, SS				Liao, Sally; Ruiz, Yuleisy; Gulzar, Hira; Yelskaya, Zarina; Taouit, Lyes Ait; Houssou, Murielle; Jaikaran, Trisha; Schvarts, Yuriy; Kozlitina, Kristina; Basu-Roy, Upal; Mansukhani, Alka; Mahajan, Shahana S.			Osteosarcoma cell proliferation and survival requires mGluR5 receptor activity and is blocked by Riluzole	PLOS ONE			English	Article							METABOTROPIC GLUTAMATE RECEPTORS; SIGNALING PATHWAYS; PROSTATE-CANCER; MELANOMA-CELLS; KINASE PATHWAY; MOUSE MODEL; PI3 KINASE; BONE; EXPRESSION; GROWTH	Osteosarcomas are malignant tumors of bone, most commonly seen in children and adolescents. Despite advances in modern medicine, the poor survival rate of metastatic osteosarcoma has not improved in two decades. In the present study we have investigated the effect of Riluzole on a human and mouse metastatic osteosarcoma cells. We show that LM7 cells secrete glutamate in the media and that mGluR5 receptors are required for the proliferation of LM7 cells. Riluzole, which is known to inhibit glutamate release, inhibits proliferation, induces apoptosis and prevents migration of LM7 cells. This is also seen with Fenobam, a specific blocker of mGluR5. We also show that Riluzole alters the phosphorylation status of AKT/P70 S6 kinase, ERK1/2 and JNK1/2. Thus Riluzole is an effective drug to inhibit proliferation and survival of osteosarcoma cells and has therapeutic potential for the treatment of osteosarcoma exhibiting autocrine glutamate signaling.	[Liao, Sally; Ruiz, Yuleisy; Gulzar, Hira; Yelskaya, Zarina; Taouit, Lyes Ait; Houssou, Murielle; Jaikaran, Trisha; Schvarts, Yuriy; Kozlitina, Kristina; Mahajan, Shahana S.] CUNY Hunter Coll, Dept Med Lab Sci, New York, NY 10021 USA; [Basu-Roy, Upal; Mansukhani, Alka] NYU, Dept Microbiol, Langone Med Ctr, New York, NY 10016 USA; [Basu-Roy, Upal; Mansukhani, Alka] NYU, Perlmutter Canc Ctr, Langone Med Ctr, New York, NY USA; [Mahajan, Shahana S.] Weill Cornell Med Coll, Brain & Mind Res Inst, New York, NY USA	City University of New York (CUNY) System; Hunter College (CUNY); New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center; Cornell University	Mahajan, SS (corresponding author), CUNY Hunter Coll, Dept Med Lab Sci, New York, NY 10021 USA.; Mahajan, SS (corresponding author), Weill Cornell Med Coll, Brain & Mind Res Inst, New York, NY USA.	smahajan@hunter.cuny.edu		Mansukhani, Alka/0000-0003-1020-3242	PSC CUNY grant [TRADB-43-141]; NATIONAL CANCER INSTITUTE [R21CA186031] Funding Source: NIH RePORTER	PSC CUNY grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by PSC CUNY grant TRADB-43-141 (https://www.rfcuny.org/rfwebsite/research/AwardedPersons.aspx? programID=TRADB&sequence=43&desc=Health% 20Sciences,%20Health%20%26%20Human% 20Services,%20Speech%20%26%20Hearing). The funder had no role in the research, preparation of the manuscript, or the decision to publish.	Akamatsu K, 2009, ANTICANCER RES, V29, P2195; Basu-Roy U, 2010, CELL DEATH DIFFER, V17, P1345, DOI 10.1038/cdd.2010.57; Chenu C, 1998, BONE, V22, P295, DOI 10.1016/S8756-3282(97)00295-0; COURATIER P, 1994, NEUROREPORT, V5, P1012, DOI 10.1097/00001756-199404000-00040; Cowan Robert W, 2012, Front Endocrinol (Lausanne), V3, P89, DOI 10.3389/fendo.2012.00089; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; de Groot J, 2011, GLIA, V59, P1181, DOI 10.1002/glia.21113; DORFMAN HD, 1995, CANCER, V75, P203, DOI 10.1002/1097-0142(19950101)75:1+<203::AID-CNCR2820751308>3.0.CO;2-V; Du J, 2016, EUR J PHARMACOL, V784, P42, DOI 10.1016/j.ejphar.2016.05.009; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; Geller David S, 2010, Clin Adv Hematol Oncol, V8, P705; Genever PG, 2001, FASEB J, V15, P1586, DOI 10.1096/fj.00-0594fje; Gerber U, 2007, CURR OPIN PHARMACOL, V7, P56, DOI 10.1016/j.coph.2006.08.008; Goldberg L, 2006, CANCER RES, V66, P11709, DOI 10.1158/0008-5472.CAN-06-1878; Hinoi E, 2004, EUR J BIOCHEM, V271, P1, DOI 10.1046/j.1432-1033.2003.03907.x; Jia SF, 1999, CLIN EXP METASTAS, V17, P501, DOI 10.1023/A:1006623001465; Julio-Pieper M, 2011, PHARMACOL REV, V63, P35, DOI 10.1124/pr.110.004036; Kalariti N., 2007, Journal of Musculoskeletal & Neuronal Interactions, V7, P113; Kalariti N, 2005, EXPERT OPIN INV DRUG, V14, P1487, DOI 10.1517/13543784.14.12.1487; Kalariti N, 2004, ANTICANCER RES, V24, P3923; Kelly A, 2001, MENT RETARD DEV D R, V7, P287, DOI 10.1002/mrdd.1040; Koochekpour S, 2013, ASIAN J ANDROL, V15, P212, DOI 10.1038/aja.2012.145; Lacomblez L, 1996, NEUROLOGY, V47, pS242, DOI 10.1212/WNL.47.6_Suppl_4.242S; Lacomblez L, 1996, LANCET, V347, P1425, DOI 10.1016/S0140-6736(96)91680-3; Le Liboux A, 1999, J CLIN PHARMACOL, V39, P480; Le MN, 2010, J INVEST DERMATOL, V130, P2240, DOI 10.1038/jid.2010.126; Martino JJ, 2013, ONCOGENE, V32, P4366, DOI 10.1038/onc.2012.471; Namkoong J, 2007, CANCER RES, V67, P2298, DOI 10.1158/0008-5472.CAN-06-3665; Nedergaard M, 2002, NAT REV NEUROSCI, V3, P748, DOI 10.1038/nrn916; Patton AJ, 1998, BONE, V22, P645, DOI 10.1016/S8756-3282(98)00061-1; Peavy RD, 2001, J NEUROSCI, V21, P9619, DOI 10.1523/JNEUROSCI.21-24-09619.2001; Pollock PM, 2003, NAT GENET, V34, P108, DOI 10.1038/ng1148; Rong R, 2003, NAT NEUROSCI, V6, P1153, DOI 10.1038/nn1134; Rosenberg SA, 2015, TRANSL ONCOL, V8, P1, DOI 10.1016/j.tranon.2014.11.001; SCOTLANDI K, 1995, CANCER, V75, P806, DOI 10.1002/1097-0142(19950201)75:3<806::AID-CNCR2820750310>3.0.CO;2-S; Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869; Skerry TM, 2001, TRENDS PHARMACOL SCI, V22, P174, DOI 10.1016/S0165-6147(00)01642-4; Song MS, 2012, NAT REV MOL CELL BIO, V13, P283, DOI 10.1038/nrm3330; Sontheimer H, 2004, MOL NEUROBIOL, V29, P61, DOI 10.1385/MN:29:1:61; Speyer CL, 2016, BREAST CANCER RES TR, V157, P217, DOI 10.1007/s10549-016-3816-x; Speyer CL, 2012, BREAST CANCER RES TR, V132, P565, DOI 10.1007/s10549-011-1624-x; Stepulak A, 2014, J NEURAL TRANSM, V121, P933, DOI 10.1007/s00702-014-1182-6; Stepulak A, 2009, HISTOCHEM CELL BIOL, V132, P435, DOI 10.1007/s00418-009-0613-1; Teh JLF, 2014, PIGM CELL MELANOMA R, V27, DOI 10.1111/pcmr.12237; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Walkley CR, 2008, GENE DEV, V22, P1662, DOI 10.1101/gad.1656808; Wall BA, 2015, PIGM CELL MELANOMA R, V28, DOI 10.1111/pcmr.12327; Wang S, 2016, MOL CLIN ONCOL, V4, P65, DOI 10.3892/mco.2015.661; Whelan JS, 1997, EUR J CANCER, V33, P1611, DOI 10.1016/S0959-8049(97)00251-7; Whelan JS, 1997, EUR J CANCER, V33, P8; Willard SS, 2013, INT J BIOL SCI, V9, P948, DOI 10.7150/ijbs.6426; Willard SS, 2013, INT J BIOL SCI, V9, P728, DOI 10.7150/ijbs.6475; Wu Y, 2014, J CANCER RES CLIN, V140, P419, DOI 10.1007/s00432-013-1581-3; Yang L, 2006, J NEUROSCI, V26, P971, DOI 10.1523/JNEUROSCI.4423-05.2006; Yelskaya Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064588; Yip D, 2009, CLIN CANCER RES, V15, P3896, DOI 10.1158/1078-0432.CCR-08-3303; Yu LJ, 2016, NEUROPHARMACOLOGY; Zhang C, 2015, CELL PHYSIOL BIOCHEM, V35, P419, DOI 10.1159/000369707; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	59	17	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2017	12	2							e0171256	10.1371/journal.pone.0171256	http://dx.doi.org/10.1371/journal.pone.0171256			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5SX	28231291	Green Published, gold			2022-12-27	WOS:000394682400009
J	Springate, DA; Parisi, R; Olier, I; Reeves, D; Kontopantelis, E				Springate, David A.; Parisi, Rosa; Olier, Ivan; Reeves, David; Kontopantelis, Evangelos			rEHR: An R package for manipulating and analysing Electronic Health Record data	PLOS ONE			English	Article							PERFORMANCE	Research with structured Electronic Health Records (EHRs) is expanding as data becomes more accessible; analytic methods advance; and the scientific validity of such studies is increasingly accepted. However, data science methodology to enable the rapid searching/extraction, cleaning and analysis of these large, often complex, datasets is less well developed. In addition, commonly used software is inadequate, resulting in bottlenecks in research workflows and in obstacles to increased transparency and reproducibility of the research. Preparing a research-ready dataset from EHRs is a complex and time consuming task requiring substantial data science skills, even for simple designs. In addition, certain aspects of the workflow are computationally intensive, for example extraction of longitudinal data and matching controls to a large cohort, which may take days or even weeks to run using standard software. The rEHR package simplifies and accelerates the process of extracting ready-for-analysis datasets from EHR databases. It has a simple import function to a database backend that greatly accelerates data access times. A set of generic query functions allow users to extract data efficiently without needing detailed knowledge of SQL queries. Longitudinal data extractions can also be made in a single command, making use of parallel processing. The package also contains functions for cutting data by time-varying covariates, matching controls to cases, unit conversion and construction of clinical code lists. There are also functions to synthesise dummy EHR. The package has been tested with one for the largest primary care EHRs, the Clinical Practice Research Datalink (CPRD), but allows for a common interface to other EHRs. This simplified and accelerated work flow for EHR data extraction results in simpler, cleaner scripts that are more easily debugged, shared and reproduced.	[Springate, David A.; Reeves, David; Kontopantelis, Evangelos] Univ Manchester, NIHR Sch Primary Care Res, Manchester, Lancs, England; [Springate, David A.; Reeves, David] Univ Manchester, Ctr Biostat, Fac Biol Med & Hlth, Manchester, Lancs, England; [Parisi, Rosa] Univ Manchester, Ctr Pharmacoepidemiol & Drug Safety, Fac Biol Med & Hlth, Manchester, Lancs, England; [Olier, Ivan] Manchester Metropolitan Univ, Sch Comp Math & Digital Technol, Informat Res Ctr, Manchester, Lancs, England; [Kontopantelis, Evangelos] Univ Manchester, Farr Inst Hlth Informat Res, Fac Biol Med & Hlth, Manchester, Lancs, England; [Kontopantelis, Evangelos] Vaughan House,Portsmouth St, Manchester M13 9GB, Lancs, England	University of Manchester; University of Manchester; University of Manchester; Manchester Metropolitan University; University of Manchester	Kontopantelis, E (corresponding author), Univ Manchester, NIHR Sch Primary Care Res, Manchester, Lancs, England.; Kontopantelis, E (corresponding author), Univ Manchester, Farr Inst Hlth Informat Res, Fac Biol Med & Hlth, Manchester, Lancs, England.; Kontopantelis, E (corresponding author), Vaughan House,Portsmouth St, Manchester M13 9GB, Lancs, England.	e.kontopantelis@manchester.ac.uk	Kontopantelis, Evangelos/H-2966-2019; Reeves, David/H-6203-2014	Kontopantelis, Evangelos/0000-0001-6450-5815; Parisi, Rosa/0000-0002-0968-9153; Reeves, David/0000-0001-6377-6859; Olier, Ivan/0000-0002-5679-7501	National Institute for Health Research (NIHR) School for Primary Care Research (SPCR) [211]; National Institute for Health Research (NIHR); MRC Health eResearch Centre Grant [MR/K006665/1]; MRC [MR/K006665/1] Funding Source: UKRI	National Institute for Health Research (NIHR) School for Primary Care Research (SPCR)(National Institute for Health Research (NIHR)); National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); MRC Health eResearch Centre Grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was funded by the National Institute for Health Research (NIHR) School for Primary Care Research (SPCR), under the title 'An analytical framework for increasing the efficiency and validity of research using primary care databases' (Project no. 211). This paper presents independent research funded by the National Institute for Health Research (NIHR). The views expressed are those of the authors and not necessarily those of the NHS, the National Institute for Health Research or the Department of Health. In addition, MRC Health eResearch Centre Grant MR/K006665/1 supported the time and facilities of one investigator (EK).	Ainsworth John, 2012, Stud Health Technol Inform, V175, P39; [Anonymous], 2014, R LANG ENV STAT COMP; Bechhofer S, 2013, FUTURE GENER COMP SY, V29, P599, DOI 10.1016/j.future.2011.08.004; Carstensen Bendix, 2014, EPI A PACKAGE FOR ST; Danaei G, 2013, STAT METHODS MED RES, V22, P70, DOI 10.1177/0962280211403603; Dave S, 2009, PHARMACOEPIDEM DR S, V18, P704, DOI [10.1002/pds.1770, DOI 10.1002/PDS.1770]; Doran T, 2006, NEW ENGL J MED, V355, P375, DOI 10.1056/NEJMsa055505; Gelfand JM, 2006, JAMA-J AM MED ASSOC, V296, P1735, DOI 10.1001/jama.296.14.1735; Grothendieck G, 2014, SQLDF PERFORM SQL SE; Herrett E, 2015, INT J EPIDEMIOL, V44, P827, DOI 10.1093/ije/dyv098; James DA, 2013, RSQLITE SQLITE INTER; Kontopantelis E, 2013, J STAT SOFTWARE, V55; Kontopantelis E, 2014, DIABETOLOGIA, P1; Kontopantelis E, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003190; Kontopantelis E, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g330; Olier I, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146715; Overhage JM, 2013, STAT METHODS MED RES, V22, P7, DOI 10.1177/0962280211403598; Parisi R, 2015, J INVEST DERMATOL, V135, P2189, DOI 10.1038/jid.2015.87; Perlis RH, 2012, PSYCHOL MED, V42, P41, DOI 10.1017/S0033291711000997; Reeves D, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-004952; Richardson DB, 2004, OCCUP ENVIRON MED, V61, DOI 10.1136/oem.2004.014472; Springate DA, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-007299; Springate DA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099825; Wickham H, 2014, DEVTOOLS TOOLS MAKE; Wickham H., 2015, R PACKAGE VERSION, V0.4, P156; Zorych I, 2013, STAT METHODS MED RES, V22, P39, DOI 10.1177/0962280211403602	26	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2017	12	2							e0171784	10.1371/journal.pone.0171784	http://dx.doi.org/10.1371/journal.pone.0171784			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5SX	28231289	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000394682400019
J	Ma, QY; Jiao, Y; Ren, YP				Ma, Qiuyun; Jiao, Yan; Ren, Yiping			Linear mixed-effects models to describe length-weight relationships for yellow croaker (Larimichthys Polyactis) along the north coast of China	PLOS ONE			English	Article								In this study, length-weight relationships and relative condition factors were analyzed for Yellow Croaker (Larimichthys polyactis) along the north coast of China. Data covered six regions from north to south: Yellow River Estuary, Coastal Waters of Northern Shandong, Jiaozhou Bay, Coastal Waters of Qingdao, Haizhou Bay, and South Yellow Sea. In total 3,275 individuals were collected during six years (2008, 2011 -2015). One generalized linear model, two simply linear models and nine linear mixed effect models that applied the effects from regions and/or years to coefficient a and/or the exponent b were studied and compared. Among these twelve models, the linear mixed effect model with random effects from both regions and years fit the data best, with lowest Akaike information criterion value and mean absolute error. In this model, the estimated a was 0.0192, with 95% confidence interval 0.0178 similar to 0.0308, and the estimated exponent b was 2.917 with 95% confidence interval 2.731 similar to 2.945. Estimates for a and b with the random effects in intercept and coefficient from Region and Year, ranged from 0.013 to 0.023 and from 2.835 to 3.017, respectively. Both regions and years had effects on parameters a and b, while the effects from years were shown to be much larger than those from regions. Except for Coastal Waters of Northern Shandong, a decreased from north to south. Condition factors relative to reference years of 1960, 1986, 2005, 2007, 2008 similar to 2009 and 2010 revealed that the body shape of Yellow Croaker became thinner in recent years. Furthermore relative condition factors varied among months, years, regions and length. The values of a and relative condition factors decreased, when the environmental pollution became worse, therefore, length-weight relationships could be an indicator for the environment quality. Results from this study provided basic description of current condition of Yellow Croaker along the north coast of China.	[Ma, Qiuyun; Ren, Yiping] Ocean Univ China, Coll Fisheries, Qingdao, Shandong, Peoples R China; [Ma, Qiuyun; Jiao, Yan] Virginia Polytech Inst & State Univ, Dept Fish & Wildlife Conservat, Blacksburg, VA 24061 USA	Ocean University of China; Virginia Polytechnic Institute & State University	Ren, YP (corresponding author), Ocean Univ China, Coll Fisheries, Qingdao, Shandong, Peoples R China.	renyip@ouc.edu.cn		Ren, Yiping/0000-0003-2482-0284; Jiao, Yan/0000-0002-8804-5005	Agriculture of the People's Republic of China [201303050-02]; Ocean University of China [841512002]; China Scholarship Council [201506330034]; Qingdao National Laboratory for Marine Science and Technology [.2015ASKJ02]	Agriculture of the People's Republic of China; Ocean University of China; China Scholarship Council(China Scholarship Council); Qingdao National Laboratory for Marine Science and Technology	1. Agriculture of the People's Republic of China. Grant No. 201303050-02. http://www.moa .gov. cn/ 2. Ocean University of China. Grant No. 841512002. http.//www.ouc.edu.cn/_s8/main.psp 3. China Scholarship Council. Grant No. 201506330034. http://www.csc.edu.cn 4. Qingdao National Laboratory for Marine Science and Technology. Grant No.2015ASKJ02. http:/www.qnlm.ac/index The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ak O, 2009, TURK J FISH AQUAT SC, V9, P125; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Andrade HA, 2002, FISH RES, V55, P307, DOI 10.1016/S0165-7836(01)00305-8; Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Becker Richard A., 2016, ENHANCEMENTS TP MINK; Becker Richard A., 2016, R VERSION RAY BROWNR; Bolognini L, 2013, TURK J FISH AQUAT SC, V13, P555, DOI 10.4194/1303-2712-v13_3_21; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Can MF, 2002, TURK J VET ANIM SCI, V26, P1181; Carlander KD., 1977, HDB FRESHWATER FISHE, V2, P1; Cheng J, 2004, ECOENVIRONMENT BIOCO; Cnaan A, 1997, STAT MED, V16, P2349, DOI 10.1002/(SICI)1097-0258(19971030)16:20<2349::AID-SIM667>3.0.CO;2-E; Froese R, 2006, J APPL ICHTHYOL, V22, P241, DOI 10.1111/j.1439-0426.2006.00805.x; Froese R, 2014, J APPL ICHTHYOL, V30, P78, DOI 10.1111/jai.12299; Guo Xu-peng, 2006, Journal of Fishery Sciences of China, V13, P243; Hile R., 1936, FISH B-NOAA, V48, P211; Hyndman RJ, 2005, INT J FORECASTING, V22, P1; Jin X.S., 1996, J FISH SCI CHINA, V3, P32; Jin XS., 2005, BIOL RESOURCES HABIT; Keys AB, 1928, P NATL ACAD SCI USA, V14, P922, DOI 10.1073/pnas.14.12.922; LECREN ED, 1951, J ANIM ECOL, V20, P201, DOI 10.2307/1540; Li Jian-sheng, 2007, Marine Fisheries, V29, P31; [李忠炉 LI Zhonglu], 2011, [中国水产科学, Journal of Fishery Sciences of China], V18, P602; Lin L.S., 2004, MAR FISH, V26, P18, DOI [10.3969/j.issn.1004-2490.2004.01.004, DOI 10.3969/J.ISSN.1004-2490.2004.01.004]; Lin Long-shan, 2004, Journal of Fishery Sciences of China, V11, P333; [林龙山 Lin Longshan], 2004, [中国海洋大学学报. 自然科学版, Journal of Ocean University of China], V34, P565; Lin X, 1965, COLLECTIONS MARINE F, P84; Liu, 1990, INVESTIGATION ZONING; Liu Chang-Dong, 2015, Zhongguo Haiyang Daxue Xuebao, V45, P36; Liu W., 1999, J SHANGHAI FISH U, V8, P105; Martin W. R., 1949, Publications of the Ontario Fisheries Research Laboratory, VNo. 70, P1; Ministry of Environmental Protection of the People's Republic ofChina, 1997, 30971997 GB MIN ENV; Nakabo T., 2002, FISHES JAPAN PICTORI; Oberg Ann L., 2007, V404, P213, DOI 10.1007/978-1-59745-530-5_11; PETRAKIS G, 1995, FISH RES, V21, P465, DOI 10.1016/0165-7836(94)00294-7; Ren Y, 2001, T OCEANOL LIMNOL, V6482, P41; Schneider JC, 2000, MANUAL FISHERIES SUR; Shan Xiu-juan, 2011, Yuye Kexue Jinzhan, V32, P7; Shui B., 2003, J ZHEJIANG OCEAN U, V29, P80, DOI [10.3969/j.issn.1008-830X.2003.01.004, DOI 10.3969/J.ISSN.1008-830X.2003.01.004]; Shui B, 2000, J ZHEJIANG OCEAN U, V19, P58; State Oceanic Administration People's Republic of of China, 2008, B MAR ENV STAT CHIN, P2011; Wang X, 2013, J APPL ICHTHYOL, V29, P1183, DOI 10.1111/jai.12200; Wilson JR, 2012, PLOS ONE, V7, P1; Xu H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122257; Xu H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104012; Xu Zhao-li, 2010, Yingyong Shengtai Xuebao, V21, P2856; [徐兆礼 XU Zhao-li], 2009, [中国水产科学, Journal of Fishery Sciences of China], V16, P931; Yan L, 2006, MAR FISH, V28, P117; Yan Li-ping, 2014, Marine Fisheries, V36, P481; Yan Li-Ping, 2006, Zhongguo Haiyang Daxue Xuebao, V36, P95; Zhang G, 2010, POPULATION CHARACTER; [张国政 Zhang Guozheng], 2010, [生态学报, Acta Ecologica Sinica], V30, P6854; [张国政 Zhang Guozheng], 2010, [渔业科学进展, Progress in Fishery Sciences], V31, P15	54	14	27	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2017	12	2							e0171811	10.1371/journal.pone.0171811	http://dx.doi.org/10.1371/journal.pone.0171811			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5SK	28225777	Green Published, gold, Green Submitted			2022-12-27	WOS:000394680900021
J	Argyriou, AV; Teeuw, RM; Sarris, A				Argyriou, Athanasios V.; Teeuw, Richard M.; Sarris, Apostolos			GIS-based landform classification of Bronze Age archaeological sites on Crete Island	PLOS ONE			English	Article							TOPOGRAPHIC POSITION; LANDSCAPE	Various physical attributes of the Earth's surface are factors that influence local topography and indirectly influence human behaviour in terms of habitation locations. The determination of geomorphological setting plays an important role in archaeological landscape research. Several landform types can be distinguished by characteristic geomorphic attributes that portray the landscape surrounding a settlement and influence its ability to sustain a population. Geomorphometric landform information, derived from digital elevation models (DEMs), such as the ASTER Global DEM, can provide useful insights into the processes shaping landscapes. This work examines the influence of landform classification on the settlement locations of Bronze Age (Minoan) Crete, focusing on the districts of Phaistos, Kavousi and Vrokastro. The landform classification was based on the topographic position index (TPI) and deviation from mean elevation (DEV) analysis to highlight slope steepness of various landform classes, characterizing the surrounding landscape environment of the settlements locations. The outcomes indicate no interrelationship between the settlement locations and topography during the Early Minoan period, but a significant interrelationship exists during the later Minoan periods with the presence of more organised societies. The landform classification can provide insights into factors favouring human habitation and can contribute to archaeological predictive modelling.	[Argyriou, Athanasios V.; Teeuw, Richard M.] Univ Portsmouth, Ctr Appl Geosci, Sch Earth & Environm Sci, Portsmouth PO1 3QL, Hants, England; [Argyriou, Athanasios V.; Sarris, Apostolos] Fdn Res & Technol FORTH, IMS, Lab Geophys Satellite Remote Sensing & Archaeoenv, Melissinou & Nikiforou Foka 130, Rethimnon, Greece	University of Portsmouth	Argyriou, AV (corresponding author), Univ Portsmouth, Ctr Appl Geosci, Sch Earth & Environm Sci, Portsmouth PO1 3QL, Hants, England.; Argyriou, AV (corresponding author), Fdn Res & Technol FORTH, IMS, Lab Geophys Satellite Remote Sensing & Archaeoenv, Melissinou & Nikiforou Foka 130, Rethimnon, Greece.	argyriou.nasos@gmail.com	Argyriou, Athanasios V./AAB-3865-2021; Teeuw, Richard M/N-7214-2015	Argyriou, Athanasios V./0000-0003-2886-4348; Teeuw, Richard/0000-0003-4014-5362				Agapiou A, 2015, COMPUT ENVIRON URBAN, V54, P230, DOI 10.1016/j.compenvurbsys.2015.09.003; [Anonymous], 2004, GEODIVERSITY VALUING; Argyriou AV, 2016, GEOMORPHOLOGY, V253, P262, DOI 10.1016/j.geomorph.2015.10.018; Bevan Andrew, 2002, J FIELD ARCHAEOL, V29, P123, DOI [DOI 10.1179/jfa.2004.29.1-2.123, 10.2307/3181488, DOI 10.1179/JFA.2004.29.1-2.123]; Blaszczynski JS, 1997, PHOTOGRAMM ENG REM S, V63, P183; Bowner B., 2010, SCI NEWS, V177; CADOGAN G, 1971, BICS, V18, P145; Chaniotis A., 2010, CLASSICS; Christopherson G.L., 2003, ESRI US C P 23 ANN E; Chryssoulaki S., 1999, AEGAEUM, V19, P75; Cunningham T. F., 2003, SIDE BY SIDE SURVEY, P101; De Reu J, 2013, GEOMORPHOLOGY, V186, P39, DOI 10.1016/j.geomorph.2012.12.015; De Reu J, 2011, J ARCHAEOL SCI, V38, P3435, DOI 10.1016/j.jas.2011.08.005; Dragut L, 2006, GEOMORPHOLOGY, V81, P330, DOI 10.1016/j.geomorph.2006.04.013; Fairen-Jimenez S, 2007, J FIELD ARCHAEOL, V32, P283, DOI 10.1179/009346907791071584; Gallant J.C., 2000, TERRAIN ANAL PRINCIP, P51, DOI [10.1016/S0925-8574(00)00178-6, DOI 10.1016/S0925-8574(00)00178-6]; Gesell G., 2004, PREHISTORY MONOGRAPH, V16, P242; Guisan A, 1999, PLANT ECOL, V143, P107, DOI 10.1023/A:1009841519580; Haggis DC, 1996, HESPERIA, V65, P373, DOI 10.2307/148436; Hayden J. B., 2004, U MUSEUM MONOGRAPH, V119, P427; Hayden J. B., 1992, JSTOR, P66; Holmgren K, 2016, QUATERNARY SCI REV, V136, P1, DOI 10.1016/j.quascirev.2015.12.014; Izdebski A, 2016, QUATERNARY SCI REV, V136, P189, DOI 10.1016/j.quascirev.2015.07.022; Jenness J., 2005, TOPOGRAPHIC POSITION; Kvamme K.L., 1992, COMPUTER APPL QUANTI, P127; Llobera M, 2001, J ARCHAEOL SCI, V28, P1005, DOI 10.1006/jasc.2001.0720; MacMillan RA, 2000, FUZZY SET SYST, V113, P81, DOI 10.1016/S0165-0114(99)00014-7; Manning S.W., 1994, DEV DECLINE MEDITERR, V8, P221; McGarigal K., 2002, FRAGSTATS SPATIAL PA; Moody J., 2014, CRETAN LANDSCAPE TIM, P23; MORAN PAP, 1950, BIOMETRIKA, V37, P17, DOI 10.1093/biomet/37.1-2.17; Muller Celka S., 2012, AEGAEUM, V37, P431; Nieto L. M, 2001, BOL GEOL MIN, V112, P3; Nowicki K., 1999, AEGAEUM, V19, P191; NOWICKI K, 1994, AEGEAN ARCHAEOLOGY, V1, P31; Panizza M, 2008, 2 GEOLOGO EMILIA ROM, V29, P35; Patterson JJ, 2008, ARCTIC ANTHROPOL, V45, P114, DOI 10.1353/arc.0.0009; Pike R. J., 1999, BIBLIO GEOMORPHOMETR; Pracilio G, 2006, PLANT SOIL, V288, P113, DOI 10.1007/s11104-006-9098-z; Roughley C, 2001, BRIT ARCHAEOL REP IN, VS931, P211; Speight JG, 1990, AUSTR SOIL LAND SURV, P9; Tagil Sermin, 2008, Journal of Applied Sciences, V8, P910, DOI 10.3923/jas.2008.910.921; Tilley C.Y, 1994, PHENOMENOLOGY LANDSC; Warren R.E., 2000, PRACTICAL APPL GIS A, P3; Watrous L. V., 2004, MONUMENTA ARCHAEOLOG, V23, P668; WATROUS LV, 1993, HESPERIA, V62, P191, DOI 10.2307/148150; Weiss A.D, 2001, ESRI SAN DIEG CA US; WILFORD JN, 2010, NY TIMES	48	13	13	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2017	12	2							e0170727	10.1371/journal.pone.0170727	http://dx.doi.org/10.1371/journal.pone.0170727			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	EL5QV	28222134	Green Published, gold			2022-12-27	WOS:000394676800004
J	Simons, P; Sommerer, T; Zderic, I; Wahl, D; Lenz, M; Skulev, H; Knobe, M; Gueorguiev, B; Richards, RG; Klos, K				Simons, Paul; Sommerer, Theresia; Zderic, Ivan; Wahl, Dieter; Lenz, Mark; Skulev, Hristo; Knobe, Matthias; Gueorguiev, Boyko; Richards, R. Geoff; Klos, Kajetan			Biomechanical investigation of two plating systems for medial column fusion in foot	PLOS ONE			English	Article							TIBIOTALOCALCANEAL ARTHRODESIS; LOCKING PLATE; INTRAMEDULLARY FIXATION; LAPIDUS ARTHRODESIS; COMPRESSION SCREW; CROSSED SCREWS; BLADE; OSTEOSYNTHESIS; FRACTURES; STABILITY	Background Arthrodesis of the medial column (navicular, cuneiform I and metatarsal I) is performed for reasons such as Charcot arthropathy, arthritis, posttraumatic reconstruction or severe pes planus. However, the complication rate is still high and mainly resulting from inadequate fixation. Special plates, designed for medial column arthrodesis, seem to offer potential to reduce the complication rate. The aim of this study was to investigate biomechanically plantar and dorsomedial fusion of the medial column using two new plating systems. Methods Eight matched pairs of human cadaveric lower legs were randomized in two groups and medial column fusion was performed using either plantar or dorsomedial variable-angle locking compression plates. The specimens were biomechanically tested under cyclic progressively increasing axial loading with physiological profile of each cycle. In addition to the machine data, mediolateral x-rays were taken every 250 cycles and motion tracking was performed to determine movements at the arthrodesis site. Statistical analysis of the parameters of interest was performed at a level of significance p = 0.05. Results Displacement of the talo-navicular joint after 1000, 2000 and 4000 cycles was significantly lower for plantar plating (p <= 0.039) while there was significantly less movement in the naviculo-cuneiform I joint for dorsal plating post these cycle numbers (p<0.001). Displacements in all three joints of the medial column, as well as angular and torsional deformations between the navicular and metatarsal I increased significantly for each plating technique between 1000, 2000 and 4000 cycles (p <= 0.021). The two plating systems did not differ significantly with regard to stiffness and cycles to failure (p >= 0.171). Conclusion From biomechanical point of view, although dorsomedial plating showed less movement than plantar plating in the current setup under dynamic loading, there was no significant difference between the two plating systems with regard to stiffness and cycles to failure. Both tested techniques for dorsomedial and plantar plating appear to be applicable for arthrodesis of the medial column of the foot and other considerations, such as access morbidity, associated deformities or surgeon's preference, may also guide the choice of plating pattern. Further clinical studies are necessary before definitive recommendations can be given.	[Simons, Paul; Klos, Kajetan] Catholic Clin Mainz, Dept Foot & Ankle Surg, Mainz, Germany; [Sommerer, Theresia; Zderic, Ivan; Wahl, Dieter; Gueorguiev, Boyko; Richards, R. Geoff] AO Res Inst Davos, Davos, Switzerland; [Lenz, Mark] Univ Hosp Jena, Dept Trauma Hand & Reconstruct Surg, Jena, Germany; [Skulev, Hristo] Tech Univ Varna, Varna, Bulgaria; [Knobe, Matthias] Univ Hosp Aachen, Dept Trauma & Reconstruct Surg, Aachen, Germany	Friedrich Schiller University of Jena; Technical University Varna; RWTH Aachen University; RWTH Aachen University Hospital	Klos, K (corresponding author), Catholic Clin Mainz, Dept Foot & Ankle Surg, Mainz, Germany.	kajetan.klos@freenet.de	Knobe, Matthias/Y-3537-2019; klos, kajetan/AAI-2459-2019; Zderic, Ivan/ABB-7483-2020	Knobe, Matthias/0000-0002-9166-0965; Zderic, Ivan/0000-0003-0484-887X; Skulev, Hristo/0000-0001-6696-7546	DePuy Synthes, Zuchwil, Switzerland	DePuy Synthes, Zuchwil, Switzerland	The study was funded in part and implants were provided by DePuy Synthes, Zuchwil, Switzerland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfahd UA, 2005, J ORTHOP TRAUMA, V19, P703, DOI 10.1097/01.bot.0000184142.90448.e3; Chiodo CP, 2003, J BONE JOINT SURG AM, V85A, P2425, DOI 10.2106/00004623-200312000-00022; Cohen DA, 2005, FOOT ANKLE INT, V26, P984, DOI 10.1177/107110070502601114; Fucs PMDB, 2012, CLIN ORTHOP RELAT R, V470, P1334, DOI 10.1007/s11999-011-2185-3; Eschler A, 2014, INJURY, V45, pS38, DOI 10.1016/j.injury.2013.10.037; Gruber F, 2008, FOOT ANKLE INT, V29, P927, DOI 10.3113/FAI.2008.0927; Gutteck N, 2013, FOOT ANKLE SURG, V19, P218, DOI 10.1016/j.fas.2013.05.002; Klos K, 2013, FOOT ANKLE SURG, V19, P239, DOI 10.1016/j.fas.2013.06.003; Klos K, 2011, FOOT ANKLE INT, V32, P1081, DOI 10.3113/FAI.2011.1081; Klos K, 2010, FOOT ANKLE INT, V31, P158, DOI [10.3113/FAI.2010.0157, 10.3113/FAI.2010.0158]; Klos K, 2009, FOOT ANKLE INT, V30, P1212, DOI 10.3113/FAI.2009.1212; Lenz M, 2015, J ORTHOP RES; Lill H, 2003, ARCH ORTHOP TRAUM SU, V123, P74, DOI 10.1007/s00402-002-0465-9; Marks RM, 1998, FOOT ANKLE INT, V19, P507, DOI 10.1177/107110079801900801; Mittlmeier T, 2008, UNFALLCHIRURG, V111, P218, DOI 10.1007/s00113-008-1431-y; Muckley T, 2008, J BONE JOINT SURG AM, V90A, P620, DOI 10.2106/JBJS.G.00010; O'Neill PJ, 2008, FOOT ANKLE INT, V29, P581, DOI 10.3113/FAI.2008.0581; O'Neill PJ, 2007, FOOT ANKLE INT, V28, P804, DOI 10.3113/FAI.2006.0804; Rausch S, 2014, INT ORTHOP, V38, P1705, DOI 10.1007/s00264-014-2334-x; Ray R G, 1998, J Foot Ankle Surg, V37, P376; Richter M, 2015, FOOT ANKLE SURG, V21, P269, DOI 10.1016/j.fas.2015.02.003; Richter M, 2014, FOOT ANKLE SURG, V20, P14, DOI 10.1016/j.fas.2013.08.003; Ruedi P, 2007, AO PRINCIPLES FRACTU; Stone NC, 2000, CAN J SURG, V43, P449; Windolf M, 2009, CLIN BIOMECH, V24, P53, DOI 10.1016/j.clinbiomech.2008.09.005	25	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2017	12	2							e0172563	10.1371/journal.pone.0172563	http://dx.doi.org/10.1371/journal.pone.0172563			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5QV	28222170	gold, Green Published			2022-12-27	WOS:000394676800068
J	Wang, F; Zhan, RX; Chen, L; Dai, X; Wang, WP; Guo, R; Li, XG; Li, Z; Wang, L; Huang, SP; Shen, J; Li, SR; Cao, C				Wang, Fan; Zhan, Rixing; Chen, Liang; Dai, Xia; Wang, Wenping; Guo, Rui; Li, Xiaoge; Li, Zhe; Wang, Liang; Huang, Shupeng; Shen, Jie; Li, Shirong; Cao, Chuan			RhoA promotes epidermal stem cell proliferation via PKN1-cyclin D1 signaling	PLOS ONE			English	Article							PROTEIN-KINASE; CANCER-CELLS; CARDIAC MYOCYTES; GENE-EXPRESSION; CYCLIN D1; ACTIVATION; MIGRATION; GTPASE; PKN; PHOSPHORYLATION	Objective Epidermal stem cells (ESCs) play a critical role in wound healing, but the mechanism underlying ESC proliferation is not well defined. Here, we explore the effects of RhoA on ESC proliferation and the possible underlying mechanism. Methods Human ESCs were enriched by rapid adhesion to collagen IV. RhoA((+/+))(G14V), RhoA((-/-))(T19N) and pGFP control plasmids were transfected into human ESCs. The effect of RhoA on cell proliferation was detected by cell proliferation and DNA synthesis assays. Induction of PKN1 activity by RhoA was determined by immunoblot analysis, and the effects of PKN1 on RhoA in terms of inducing cell proliferation and cyclin D1 expression were detected using specific siRNA targeting PKN1. The effects of U-46619 (a RhoA agonist) and C3 transferase (a RhoA antagonist) on ESC proliferation were observed in vivo. Results RhoA had a positive effect on ESC proliferation, and PKN1 activity was up-regulated by the active RhoA mutant (G14V) and suppressed by RhoA T19N. Moreover, the ability of RhoA to promote ESC proliferation and DNA synthesis was interrupted by PKN1 siRNA. Additionally, cyclin D1 protein and mRNA expression levels were up-regulated by RhoA G14V, and these effects were inhibited by siRNA-mediated knock-down of PKN1. RhoA also promoted ESC proliferation via PKN in vivo. Conclusion This study shows that the effect of RhoA on ESC proliferation is mediated by activation of the PKN1-cyclin D1 pathway in vitro, suggesting that RhoA may serve as a new therapeutic target for wound healing.	[Wang, Fan; Chen, Liang; Dai, Xia; Wang, Wenping; Guo, Rui; Li, Xiaoge; Li, Zhe; Wang, Liang; Huang, Shupeng; Shen, Jie; Li, Shirong; Cao, Chuan] Third Mil Med Univ, Southwestern Hosp, Dept Plast & Reconstruct Surg, Chongqing, Peoples R China; [Zhan, Rixing] Third Mil Med Univ, Sch Nursing, Chongqing, Peoples R China	Army Medical University; Army Medical University	Li, SR; Cao, C (corresponding author), Third Mil Med Univ, Southwestern Hosp, Dept Plast & Reconstruct Surg, Chongqing, Peoples R China.	lishirongzx@sina.com; Caochuancc@126.com			National Natural Science Foundation of China [81272121]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (no. 81272121). The funders had no roles in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alao JP, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-24; Bickenbach JR, 1998, EXP CELL RES, V244, P184, DOI 10.1006/excr.1998.4163; Chai LL, 2010, INT J MOL MED, V25, P723, DOI 10.3892/ijmm_00000397; Deaton RA, 2005, J BIOL CHEM, V280, P31172, DOI 10.1074/jbc.M504774200; Du DS, 2016, MOL MED REP, V13, P550, DOI 10.3892/mmr.2015.4523; Dvorsky R, 2004, EMBO REP, V5, P1130, DOI 10.1038/sj.embor.7400293; Balana ME, 2015, WORLD J STEM CELLS, V7, P711, DOI 10.4252/wjsc.v7.i4.711; Gampel A, 1999, CURR BIOL, V9, P955, DOI 10.1016/S0960-9822(99)80422-9; Hashimoto T, 2011, CARDIOVASC RES, V91, P711, DOI 10.1093/cvr/cvr108; Horii Y, 2016, FOOD FUNCT, V7, P3176, DOI [10.1039/C6FO00177G, 10.1039/c6fo00177g]; Hu JJ, 2016, ANN BIOMED ENG, V44, P1462, DOI 10.1007/s10439-015-1442-0; Kajimoto K, 2011, AM J PHYSIOL-HEART C, V300, pH191, DOI 10.1152/ajpheart.00232.2010; Kim DS, 2004, CELL MOL LIFE SCI, V61, P2774, DOI 10.1007/s00018-004-4288-4; Kim JY, 2014, MOL CELL, V54, P613, DOI 10.1016/j.molcel.2014.03.043; Kim JY, 2016, MOL ENDOCRINOL; Lachmann S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021732; LaRock DL, 2012, J BIOL CHEM, V287, P29654, DOI 10.1074/jbc.M112.363598; Liu XJ, 2014, BIOSCI BIOTECH BIOCH, V78, P1895, DOI 10.1080/09168451.2014.943650; Mohan RR, 2003, EXP EYE RES, V76, P71, DOI 10.1016/S0014-4835(02)00251-8; Morasso MI, 2005, BIOL CELL, V97, P173; Mukai H, 2003, J BIOCHEM, V133, P17, DOI 10.1093/jb/mvg019; Mukai M, 2003, INT J ONCOL, V22, P1247; Patel M, 2014, CELL ADHES MIGR, V8, P11, DOI 10.4161/cam.28058; Renteria LS, 2013, CELL PROLIFERAT, V46, P563, DOI 10.1111/cpr.12052; Ridley AJ, 2015, CURR OPIN CELL BIOL, V36, P103, DOI 10.1016/j.ceb.2015.08.005; Schmidt A, 2007, EMBO J, V26, P1624, DOI 10.1038/sj.emboj.7601637; Singh NK, 2012, J BIOL CHEM, V287, P36291, DOI 10.1074/jbc.M112.361220; Takagi H, 2010, CIRC RES, V107, P642, DOI 10.1161/CIRCRESAHA.110.217554; Tani H, 2000, P NATL ACAD SCI USA, V97, P10960, DOI 10.1073/pnas.97.20.10960; Hernandez-Hernandez OT, 2013, MINI-REV MED CHEM, V13, P635; Taylor G, 2000, CELL, V102, P451, DOI 10.1016/S0092-8674(00)00050-7; Thauerer B, 2014, CURR NEUROPHARMACOL, V12, P213, DOI 10.2174/1570159X11666131225000518; Tseliou M, 2016, CELL PHYSIOL BIOCHEM, V38, P94, DOI 10.1159/000438612; Vega FM, 2008, FEBS LETT, V582, P2093, DOI 10.1016/j.febslet.2008.04.039; Witzel II, 2010, BIOCHEM SOC T, V38, P217, DOI 10.1042/BST0380217; Zhan R, 2016, SCI REP, P30687, DOI [10.1038/1016/j.jebslet.2008.04.039, DOI 10.1038/1016/J.FEBSLET.2008.04.039]; Zhan RX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121551; Zhang J, 2015, CELL SIGNAL, V27, P1703, DOI 10.1016/j.cellsig.2015.05.009; Zhang WW, 2015, CAN J PHYSIOL PHARM, V93, P129, DOI 10.1139/cjpp-2014-0388	39	14	14	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2017	12	2							e0172613	10.1371/journal.pone.0172613	http://dx.doi.org/10.1371/journal.pone.0172613			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5QV	28222172	Green Published, gold, Green Submitted			2022-12-27	WOS:000394676800073
J	Mazinska, B; Struzycka, I; Hryniewicz, W				Mazinska, Beata; Struzycka, Izabela; Hryniewicz, Waleria			Surveys of public knowledge and attitudes with regard to antibiotics in Poland: Did the European Antibiotic Awareness Day campaigns change attitudes?	PLOS ONE			English	Article							RESPIRATORY-TRACT INFECTIONS; RESISTANCE; BELIEFS; BEHAVIOR; MEDIA	Background Antimicrobial resistance is a global public health problem. Monitoring the level of knowledge regarding antibiotics is a part of the European Union Community strategy against antimicrobial resistance. Objective To assess knowledge by the general public in Poland regarding antibiotics, AMR, and the impact of the European Antibiotic Awareness Day campaigns. Methods The repeated cross-sectional study was developed and carried out among the general public in Poland ( in 5 waves between 2009 and 2011, embracing a total of 5004 respondents). The survey was based on a self-designed questionnaire, and carried out by Millward Brown SMG/KRC, using Computer Assisted Telephone Interviews ( CATI). Results A high percentage of Polish adults had used antibiotics within the 12 months preceding their participation in the study ( 38%). Statistically relevant differences were observed regarding the respondents' gender, age, education and employment status. The majority of the antibiotics used were prescribed by physicians ( 90%). In all five waves, 3% of the respondents purchased an antibiotic without a prescription. Prescriptions were mostly obtained from a general practitioner. The prevailing reasons for taking antibiotics were the common cold, sore throat, cough and flu. Approximately 40% of the respondents expected a prescription for an antibiotic against the flu. The vast majority knew that antibiotics kill bacteria ( 80%) but at the same time 60% of respondents believed antibiotics kill viruses. Physicians, pharmacists, hospital staff and nurses were mentioned as the most trustworthy sources of information. A third of the respondents declared to have come across information on the prudent use of antibiotics in the preceding 12 months. In the fifth wave, nearly half of the participants ( 48%), who had come across information about antibiotics in the preceding 12 months declared that the information resulted in a change in their attitude towards antibiotic use. Conclusion The survey generated information about the knowledge, attitude, and behavior regarding antibiotics among the general population of Poland. Inappropriate antibiotic use is still highly prevalent in Poland, although a positive trend in behavioral change was observed after the educational campaigns. Additional didactic and systematic education campaigns regarding appropriate antibiotic use are needed and the use of the Internet as an education tool should be enhanced.	[Mazinska, Beata; Hryniewicz, Waleria] Natl Med Inst, Dept Epidemiol & Clin Microbiol, Warsaw, Poland; [Struzycka, Izabela] Med Univ Warsaw, Dept Dent Comprehens Care, Warsaw, Poland	National Medicines Institute Lekow (NIL); Medical University of Warsaw	Mazinska, B (corresponding author), Natl Med Inst, Dept Epidemiol & Clin Microbiol, Warsaw, Poland.	sekret@cls.edu.pl		Mazinska, Beata/0000-0002-3744-0128				Andre M, 2010, J ANTIMICROB CHEMOTH, V65, P1292, DOI 10.1093/jac/dkq104; [Anonymous], 2010, TNS OPINION SOCIAL S; Awad AI, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117910; Belongia EA, 2002, PREV MED, V34, P346, DOI 10.1006/pmed.2001.0992; Bosevska G, 2012, MED GLAS, V9, P393; Broniatowski DA, 2015, MED DECIS MAKING, V35, P60, DOI 10.1177/0272989X14553472; Bronzwaer SLAM, 2002, EMERG INFECT DIS, V8, P278, DOI 10.3201/eid0803.010192; Buke C, 2005, J INFECTION, V51, P135, DOI 10.1016/j.jinf.2004.12.001; Cals JWL, 2007, BRIT J GEN PRACT, V57, P942, DOI 10.3399/096016407782605027; Cebotarenco N, 2008, HEALTH EDUC RES, V23, P146, DOI 10.1093/her/cym008; Curry Misty, 2006, N Z Med J, V119, pU1957; Dyar OJ, 2014, J ANTIMICROB CHEMOTH, V69, P2568, DOI 10.1093/jac/dku165; Earnshaw S, 2014, EUROSURVEILLANCE, V19; Eng JV, 2003, EMERG INFECT DIS, V9, P1128; Faber MS, 2010, EUROSURVEILLANCE, P15; Godycki-Cwirko M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109248; Goossens H, 2005, LANCET, V365, P579, DOI 10.1016/S0140-6736(05)17907-0; Goossens H, 2006, EUR J CLIN PHARMACOL, V62, P373, DOI 10.1007/s00228-005-0094-7; Grigoryan L, 2010, CURR DRUG SAF, V5, P329, DOI 10.2174/157488610792246046; Gualano MR, 2015, PHARMACOEPIDEM DR S, V24, P2, DOI 10.1002/pds.3716; Huttner B, 2010, LANCET INFECT DIS, V10, P17, DOI 10.1016/S1473-3099(09)70305-6; Ilhan MN, 2009, PHARMACOEPIDEM DR S, V18, P1150, DOI 10.1002/pds.1829; Lambert MF, 2007, J ANTIMICROB CHEMOTH, V59, P537, DOI 10.1093/jac/dkl511; Laxminarayan R, 2013, LANCET INFECT DIS, V13, P1057, DOI 10.1016/S1473-3099(13)70318-9; Madle G, 2009, J ANTIMICROB CHEMOTH, V63, P221, DOI 10.1093/jac/dkn438; Madle Gemma, 2004, Inform Prim Care, V12, P19; McNulty CAM, 2007, J ANTIMICROB CHEMOTH, V59, P727, DOI 10.1093/jac/dkl558; McNulty CAM, 2010, J ANTIMICROB CHEMOTH, V65, P1526, DOI 10.1093/jac/dkq126; Mira JJ, 2014, PSYCHOL HEALTH MED, V19, P201, DOI 10.1080/13548506.2013.793370; Napolitano F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084177; Oh AL, 2011, J INFECT DEV COUNTR, V5, P338; Panagakou SG, 2011, BMC PEDIATR, V11, DOI 10.1186/1471-2431-11-60; Roca I., 2015, New Microbes and New Infections, V6, P22, DOI 10.1016/j.nmni.2015.02.007; Rossignoli A, 2007, EUR J CLIN PHARMACOL, V63, P1099, DOI 10.1007/s00228-007-0376-3; Sabuncu E, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000084; TNS Opinion & Social, 2013, TNS OPINION SOCIAL S; TNS Opinion & Social, 2016, TNS OPINION SOCIAL S; Vallin M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152160; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; WHO, 2012, EVOLVING THREAT OF ANTIMICROBIAL RESISTANCE: OPTIONS FOR ACTION, P1; Wilson AA, 1999, J GEN INTERN MED, V14, P658, DOI 10.1046/j.1525-1497.1999.08118.x; Wutzke SE, 2007, HEALTH PROMOT INT, V22, P53, DOI 10.1093/heapro/dal034; You JHS, 2008, INFECTION, V36, P153, DOI 10.1007/s15010-007-7214-5	43	51	51	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2017	12	2							e0172146	10.1371/journal.pone.0172146	http://dx.doi.org/10.1371/journal.pone.0172146			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BI	28212400	Green Published, gold, Green Submitted			2022-12-27	WOS:000394424700020
J	Haggblom, A; Lindback, S; Gisslen, M; Flamholc, L; Hejdeman, B; Palmborg, A; Leval, A; Herweijer, E; Valgardsson, S; Svedhem, V				Haggblom, Amanda; Lindback, Stefan; Gisslen, Magnus; Flamholc, Leo; Hejdeman, Bo; Palmborg, Andreas; Leval, Amy; Herweijer, Eva; Valgardsson, Sverrir; Svedhem, Veronica			HIV drug therapy duration; a Swedish real world nationwide cohort study on InfCareHIV 2009-2014	PLOS ONE			English	Article							TREATMENT-EXPERIENCED PATIENTS; TREATMENT-NAIVE; HIV-1-INFECTED PATIENTS; ANTIRETROVIRAL THERAPY; EFAVIRENZ THERAPY; INFECTED PATIENTS; CONTROLLED-TRIAL; ADVERSE EVENTS; DARUNAVIR/RITONAVIR; DISCONTINUATION	Background As HIV infection needs a lifelong treatment, studying drug therapy duration and factors influencing treatment durability is crucial. The Swedish database InfCareHIV includes high quality data from more than 99% of all patients diagnosed with HIV infection in Sweden and provides a unique opportunity to examine outcomes in a nationwide real world cohort. Methods Adult patients who started a new therapy defined as a new 3 rd agent (all antiretrovirals that are not N[t]RTIs) 2009-2014 with more than 100 observations in treatment-naive or treatment-experienced patients were included. Dolutegravir was excluded due to short follow up period. Multivariate Cox proportional hazards models were used to estimate hazard ratios for treatment discontinuation. Results In treatment-naive 2541 patients started 2583 episodes of treatments with a 3 rd agent. Efavirenz was most commonly used (n = 1096) followed by darunavir (n = 504), atazanavir (n = 386), lopinavir (n = 292), rilpivirine (n = 156) and raltegravir (n = 149). In comparison with efavirenz, patients on rilpivirine were least likely to discontinue treatment (adjusted HR 0.33; 95% CI 0.20-0.54, p<0.001), while patients on lopinavir were most likely to discontinue treatment (adjusted HR 2.80; 95% CI 2.30-3.40, p<0.001). Also raltegravir was associated with early treatment discontinuation (adjusted HR 1.47; 95% CI 1.12-1.92, p = 0.005). The adjusted HR for atazanavir and darunavir were not significantly different from efavirenz. In treatment-experienced 2991 patients started 4552 episodes of treatments with a 3 rd agent. Darunavir was most commonly used (n = 1285), followed by atazanavir (n = 806), efavirenz (n = 694), raltegravir (n = 622), rilpivirine (n = 592), lopinavir (n = 291) and etravirine (n = 262). Compared to darunavir all other drugs except for rilpivirine (HR 0.66; 95% CI 0.52-0.83, p<0.001) had higher risk for discontinuation in the multivariate adjusted analyses; atazanavir (HR 1.71; 95% CI 1.48-1.97, p<0.001), efavirenz (HR 1.86; 95% CI 1.59-2.17, p<0.001), raltegravir (HR 1.35; 95% CI 1.15-1.58, p<0.001), lopinavir (HR 3.58; 95% CI 3.02-4.25, p<0.001) and etravirine (HR 1.61; 95% CI 1.31-1.98, p<0.001). Besides the 3rd agent chosen also certain baseline characteristics of patients were independently associated with differences in treatment duration. In naive patients, presence of an AIDS-defining diagnosis and the use of other backbone than TDF/FTC or ABC/3TC increased the risk for early treatment discontinuation. In treatment-experienced patients, detectable plasma viral load at the time of switch or being highly treatment experienced increased the risk for early treatment discontinuation. Conclusions Treatment durability is dependent on several factors among others patient characteristics and ART guidelines. The choice of 3 rd agent has a strong impact and significant differences between different drugs on treatment duration exist.	[Haggblom, Amanda] Cty Council Gavleborg, Dept Infect Dis, Gavle, Sweden; [Haggblom, Amanda; Svedhem, Veronica] Karolinska Inst, Infect Dis Unit, Dept Med Huddinge, S-10401 Stockholm, Sweden; [Lindback, Stefan; Palmborg, Andreas; Leval, Amy; Valgardsson, Sverrir] Janssen Nord, Stockholm, Sweden; [Gisslen, Magnus] Univ Gothenburg, Sahlgrenska Acad, Dept Infect Dis, Gothenburg, Sweden; [Flamholc, Leo] Malmo Univ Hosp, Dept Infect Dis, Malmo, Sweden; [Hejdeman, Bo] Venhalsan Sodersjukhuset, Dept Infect Dis, Stockholm, Sweden; [Herweijer, Eva] Karolinska Inst, Med Epidemiol & Biostat, Stockholm, Sweden; [Svedhem, Veronica] Karolinska Univ Hosp, Dept Infect Dis, Huddinge, Sweden	Karolinska Institutet; University of Gothenburg; Lund University; Skane University Hospital; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Svedhem, V (corresponding author), Karolinska Inst, Infect Dis Unit, Dept Med Huddinge, S-10401 Stockholm, Sweden.; Svedhem, V (corresponding author), Karolinska Univ Hosp, Dept Infect Dis, Huddinge, Sweden.	veronica.svedhem-johansson@karolinska.se	Gisslen, Magnus/D-7454-2015	Gisslen, Magnus/0000-0002-2357-1020	Janssen	Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc)	The author(s) received no specific funding for this work. S Lindback, A Palmborg, A Leval and S Valgardsson are employed by Janssen Nordics. The ten authors of this manuscript have all contributed to the study according to what is stated in the Author Contributions section. Five of the authors are HIV clinicians and affiliated with academia (AH, MG, LF, BH,VS), one was a PhD student at Karolinska Institute at the time of the data analysis and manuscript preparation (EH) and four of the authors are employees at and receive salaries from Janssen (SL, AP, AL, SV). This does not alter our adherence to PLOS ONE policies on sharing data and materials. Janssen has in no other way contributed financially to this study and did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of all authors are articulated in author contribution.	Abgrall S, 2013, AIDS, V27, P803, DOI 10.1097/QAD.0b013e32835cb997; Blanch J, 2001, J ACQ IMMUN DEF SYND, V27, P336, DOI 10.1097/00126334-200108010-00003; Cohen CJ, 2011, LANCET, V378, P229, DOI 10.1016/S0140-6736(11)60983-5; De Meyer S, 2009, AIDS, V23, P1829, DOI 10.1097/QAD.0b013e32832cbcec; Di Biagio A, 2014, J INT AIDS SOC, V17, P203, DOI 10.7448/IAS.17.4.19825; Eriksen J, 2016, INFECTIOUS DIS LOND, P1; Gisslen M, 2017, HIV MED, V18, P305, DOI 10.1111/hiv.12431; Gutierrez F, 2005, CLIN INFECT DIS, V41, P1648, DOI 10.1086/497835; Hofstra LM, 2016, CLIN INFECT DIS, V62, P655, DOI 10.1093/cid/civ963; Josephson F, 2009, SCAND J INFECT DIS, V41, P788, DOI 10.3109/00365540903214322; Kennedy-Martin T, 2015, TRIALS, V16, DOI 10.1186/s13063-015-1023-4; Kowalska JD, 2016, AIDS RES THER, V13, DOI 10.1186/s12981-015-0084-5; Lennox JL, 2014, ANN INTERN MED, V161, P461, DOI 10.7326/M14-1084; Leutscher PDC, 2013, SCAND J INFECT DIS, V45, P645, DOI 10.3109/00365548.2013.773067; Marrone G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156916; Mills AM, 2013, HIV MED, V14, P391, DOI 10.1111/hiv.12012; Mills AM, 2009, AIDS, V23, P1679, DOI 10.1097/QAD.0b013e32832d7350; Molina JM, 2011, LANCET, V378, P238, DOI 10.1016/S0140-6736(11)60936-7; Naver L, 2011, SCAND J INFECT DIS, V43, P411, DOI 10.3109/00365548.2011.567392; Nelson M, 2010, J ANTIMICROB CHEMOTH, V65, P1505, DOI 10.1093/jac/dkq150; Ortego C, 2011, AIDS BEHAV, V15, P1381, DOI 10.1007/s10461-011-9942-x; Perez-Molina Jose A, 2002, HIV Clin Trials, V3, P279, DOI 10.1310/3Q91-YT2D-BUT4-8HN6; Prosperi MCF, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-296; Ray M, 2010, AIDS, V24, P123, DOI 10.1097/QAD.0b013e3283324283; Rockstroh JK, 2013, JAIDS-J ACQ IMM DEF, V63, P77, DOI 10.1097/QAI.0b013e31828ace69; Sheth AN, 2016, JAIDS-J ACQ IMM DEF, V71, P47, DOI 10.1097/QAI.0000000000000813; Spire B, 2004, AIDS CARE, V16, P558, DOI 10.1080/09540120410001716342	27	17	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0171227	10.1371/journal.pone.0171227	http://dx.doi.org/10.1371/journal.pone.0171227			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207816	gold, Green Published, Green Submitted			2022-12-27	WOS:000394424500020
J	Paavola, T; Kuusisto, S; Jauhiainen, M; Kakko, S; Kangas-Kontio, T; Metso, J; Soininen, P; Ala-Korpela, M; Bloigu, R; Hannuksela, ML; Savolainen, MJ; Salonurmi, T				Paavola, Timo; Kuusisto, Sanna; Jauhiainen, Matti; Kakko, Sakari; Kangas-Kontio, Tiia; Metso, Jari; Soininen, Pasi; Ala-Korpela, Mika; Bloigu, Risto; Hannuksela, Minna L.; Savolainen, Markku J.; Salonurmi, Tuire			Impaired HDL2-mediated cholesterol efflux is associated with metabolic syndrome in families with early onset coronary heart disease and low HDL-cholesterol level	PLOS ONE			English	Article							HIGH-DENSITY-LIPOPROTEIN; B TYPE-I; PHOSPHOLIPID CONTENT; INSULIN-RESISTANCE; PARTICLE-SIZE; CAPACITY; PLASMA; IMPACT; CELLS; ABCA1	Objective The potential of high-density lipoproteins (HDL) to facilitate cholesterol removal from arterial foam cells is a key function of HDL. We studied whether cholesterol efflux to serum and HDL subfractions is impaired in subjects with early coronary heart disease (CHD) or metabolic syndrome (MetS) in families where a low HDL-cholesterol level (HDL-C) predisposes to early CHD. Methods HDL subfractions were isolated from plasma by sequential ultracentrifugation. THP-1 macrophages loaded with acetyl-LDL were used in the assay of cholesterol efflux to total HDL, HDL2, HDL3 or serum. Results While cholesterol efflux to serum, total HDL and HDL3 was unchanged, the efflux to HDL2 was 14% lower in subjects with MetS than in subjects without MetS (p<0.001). The efflux to HDL2 was associated with components of MetS such as plasma HDL-C (r = 0.76 in men and r = 0.56 in women, p<0.001 for both). The efflux to HDL2 was reduced in men with early CHD (p<0.01) only in conjunction with their low HDL-C. The phospholipid content of HDL2 particles was a major correlate with the efflux to HDL2 (r = 0.70, p<0.001). A low ratio of HDL2 to total HDL was associated with MetS (p<0.001). Conclusion Our results indicate that impaired efflux to HDL2 is a functional feature of the low HDL-C state and MetS in families where these risk factors predispose to early CHD. The efflux to HDL2 related to the phospholipid content of HDL2 particles but the phospholipid content did not account for the impaired efflux in cardiometabolic disease, where a combination of low level and poor quality of HDL2 was observed.	[Paavola, Timo; Kuusisto, Sanna; Kakko, Sakari; Kangas-Kontio, Tiia; Hannuksela, Minna L.; Savolainen, Markku J.; Salonurmi, Tuire] Univ Oulu, Inst Clin Med, Dept Internal Med, Oulu, Finland; [Paavola, Timo; Kuusisto, Sanna; Kakko, Sakari; Kangas-Kontio, Tiia; Hannuksela, Minna L.; Savolainen, Markku J.; Salonurmi, Tuire] Univ Oulu, Bioctr Oulu, Oulu, Finland; [Paavola, Timo; Kakko, Sakari; Kangas-Kontio, Tiia; Hannuksela, Minna L.; Savolainen, Markku J.; Salonurmi, Tuire] Oulu Univ Hosp, Med Res Ctr, Oulu, Finland; [Jauhiainen, Matti; Metso, Jari] Biomedicum, Natl Inst Hlth & Welf, Genom & Biomarkers Unit, Helsinki, Finland; [Soininen, Pasi; Ala-Korpela, Mika] Univ Oulu, Inst Hlth Sci, Computat Med, Oulu, Finland; [Kuusisto, Sanna; Soininen, Pasi; Ala-Korpela, Mika] Univ Eastern Finland, Sch Pharm, NMR Metabol Lab, Kuopio, Finland; [Ala-Korpela, Mika] Oulu Univ Hosp, Oulu, Finland; [Ala-Korpela, Mika] Univ Bristol, Sch Social & Community Med, Computat Med, Bristol, Avon, England; [Ala-Korpela, Mika] Univ Bristol, MRC, Integrat Epidemiol Unit, Bristol, Avon, England; [Bloigu, Risto] Univ Oulu, Med Informat & Stat Res Grp, Oulu, Finland; [Hannuksela, Minna L.] Univ Oulu, Inst Diagnost, Dept Clin Chem, Oulu, Finland	University of Oulu; University of Oulu; University of Oulu; Finland National Institute for Health & Welfare; University of Helsinki; University of Oulu; University of Eastern Finland; University of Oulu; University of Bristol; University of Bristol; University of Oulu; University of Oulu	Salonurmi, T (corresponding author), Univ Oulu, Inst Clin Med, Dept Internal Med, Oulu, Finland.; Salonurmi, T (corresponding author), Univ Oulu, Bioctr Oulu, Oulu, Finland.; Salonurmi, T (corresponding author), Oulu Univ Hosp, Med Res Ctr, Oulu, Finland.	tuire.salonurmi@oulu.fi	Salonurmi, Tuire/L-3637-2018	Salonurmi, Tuire/0000-0001-5104-5792; Kuusisto, Sanna/0000-0002-4468-7057; Ala-Korpela, Mika/0000-0001-5905-1206	Sigrid Juselius Foundation; Academy of Finland [132629, 257545]; Finnish Cultural Foundation; Finnish Foundation for Cardiovascular Research; Paavo Nurmi Foundation; Foundation of Medical Licentiate Paavo Ilmari Ahvenainen	Sigrid Juselius Foundation(Sigrid Juselius Foundation); Academy of Finland(Academy of Finland); Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Finnish Foundation for Cardiovascular Research; Paavo Nurmi Foundation; Foundation of Medical Licentiate Paavo Ilmari Ahvenainen	This work was funded by Sigrid Juselius Foundation (MJS; http://www.sigridjuselius.fi/foundation), Academy of Finland (Grant #132629 to MJ; http://www.aka.fi/en), Finnish Cultural Foundation (TP; https://skr.fi/en), Finnish Foundation for Cardiovascular Research (MJS, TP; http://www.sydantutkimussaatio.fi/en/foundation), Paavo Nurmi Foundation (TP; http://www.paavonurmensaatio.fi/index_e.htm), Foundation of Medical Licentiate Paavo Ilmari Ahvenainen (TP) and Academy of Finland (Grant #257545 to MJ; http://www.aka.fi/en). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwala AP, 2015, ARTERIOSCL THROM VAS, V35, P1515, DOI 10.1161/ATVBAHA.115.305504; Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; Aron-Wisnewsky J, 2011, J CLIN ENDOCR METAB, V96, P1151, DOI 10.1210/jc.2010-2378; Assanasen C, 2005, J CLIN INVEST, V115, P969, DOI 10.1172/JCI23858; Attia N, 2008, ATHEROSCLEROSIS, V198, P49, DOI 10.1016/j.atherosclerosis.2007.09.023; BANKA CL, 1994, J BIOL CHEM, V269, P10288; BLANCHE PJ, 1981, BIOCHIM BIOPHYS ACTA, V665, P408, DOI 10.1016/0005-2760(81)90253-8; Bonora E, 2000, DIABETES CARE, V23, P57, DOI 10.2337/diacare.23.1.57; BROWN MS, 1975, P NATL ACAD SCI USA, V72, P2925, DOI 10.1073/pnas.72.8.2925; Davis CS, 2002, STAT METHODS ANAL RE, P295; Du XM, 2015, CIRC RES, V116, P1133, DOI 10.1161/CIRCRESAHA.116.305485; Fournier N, 1997, ARTERIOSCL THROM VAS, V17, P2685, DOI 10.1161/01.ATV.17.11.2685; Gelissen IC, 2006, ARTERIOSCL THROM VAS, V26, P534, DOI 10.1161/01.ATV.0000200082.58536.e1; GORDON T, 1977, AM J MED, V62, P707, DOI 10.1016/0002-9343(77)90874-9; Haase CL, 2012, J CLIN ENDOCR METAB, V97, pE248, DOI 10.1210/jc.2011-1846; HAVEL RJ, 1955, J CLIN INVEST, V34, P1345, DOI 10.1172/JCI103182; Jakobsson T, 2009, MOL CELL, V34, P510, DOI 10.1016/j.molcel.2009.05.006; Jian B, 1998, J BIOL CHEM, V273, P5599, DOI 10.1074/jbc.273.10.5599; Jiang ZG, 2016, METABOLISM, V65, P92, DOI 10.1016/j.metabol.2015.10.017; Jones PH, 2003, AM J CARDIOL, V92, P152, DOI 10.1016/S0002-9149(03)00530-7; Kekulawala JR, 2008, ANAL BIOCHEM, V379, P213, DOI 10.1016/j.ab.2008.05.002; Khera AV, 2011, NEW ENGL J MED, V364, P127, DOI 10.1056/NEJMoa1001689; Kontush A., 2012, HIGH DENSITY LIPOPRO; Kumpula LS, 2010, J LIPID RES, V51, P431, DOI 10.1194/jlr.D000760; Larrede S, 2009, ARTERIOSCL THROM VAS, V29, P1930, DOI 10.1161/ATVBAHA.109.194548; Li XM, 2013, ARTERIOSCL THROM VAS, V33, P1696, DOI 10.1161/ATVBAHA.113.301373; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Liinamaa MJ, 1997, ARTERIOSCL THROM VAS, V17, P2940, DOI 10.1161/01.ATV.17.11.2940; Lucero D, 2015, ATHEROSCLEROSIS, V242, P236, DOI 10.1016/j.atherosclerosis.2015.07.019; Makela SM, 2008, ALCOHOL CLIN EXP RES, V32, P991, DOI 10.1111/j.1530-0277.2008.00660.x; McGillicuddy FC, 2009, CIRCULATION, V119, P1135, DOI 10.1161/CIRCULATIONAHA.108.810721; Miyamoto-Sasaki M, 2013, J ATHEROSCLER THROMB, V20, P708; Nakanishi S, 2009, J LIPID RES, V50, P183, DOI 10.1194/jlr.M800196-JLR200; Niemi J, 2009, ANN MED, V41, P451, DOI 10.1080/07853890902893392; Posadas-Sanchez R, 2012, AM J CARDIOL, V109, P636, DOI 10.1016/j.amjcard.2011.10.017; Pussinen PJ, 1997, J LIPID RES, V38, P12; Rader DJ, 2014, LANCET, V384, P618, DOI 10.1016/S0140-6736(14)61217-4; Rohatgi A, 2014, NEW ENGL J MED, V371, P2383, DOI 10.1056/NEJMoa1409065; Shao BH, 2014, CIRC RES, V114, P1733, DOI 10.1161/CIRCRESAHA.114.303454; Shuhei N, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-104; Siggins S, 2003, J LIPID RES, V44, P1698, DOI 10.1194/jlr.M300059-JLR200; Song GJ, 2015, BIOCHEM BIOPH RES CO, V457, P112, DOI 10.1016/j.bbrc.2014.12.028; Sorci-Thomas MG, 2012, ARTERIOSCL THROM VAS, V32, P2561, DOI 10.1161/ATVBAHA.112.300135; Soro-Paavonen A, 2007, J LIPID RES, V48, P1409, DOI 10.1194/jlr.P600012-JLR200; Stahlman M, 2013, BBA-MOL CELL BIOL L, V1831, P1609, DOI 10.1016/j.bbalip.2013.07.009; Superko HR, 2012, J CLIN LIPIDOL, V6, P496, DOI 10.1016/j.jacl.2012.03.001; Tan YW, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0105192, 10.1371/journal.pone.0094264]; Thuahnai ST, 2004, J BIOL CHEM, V279, P12448, DOI 10.1074/jbc.M311718200; Triolo M, 2014, EUR J CLIN INVEST, V44, P240, DOI 10.1111/eci.12226; TSUCHIYA S, 1980, INT J CANCER, V26, P171, DOI 10.1002/ijc.2910260208; van Haperen R, 2000, ARTERIOSCL THROM VAS, V20, P1082, DOI 10.1161/01.ATV.20.4.1082; VERDERY RB, 1989, J LIPID RES, V30, P1085; Voight BF, 2012, LANCET, V380, P572, DOI 10.1016/S0140-6736(12)60312-2; Weibel GL, 2014, ARTERIOSCL THROM VAS, V34, P17, DOI 10.1161/ATVBAHA.113.302437; Yancey PG, 2000, J BIOL CHEM, V275, P36596, DOI 10.1074/jbc.M006924200; Yuhanna IS, 2001, NAT MED, V7, P853, DOI 10.1038/89986	56	13	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0171993	10.1371/journal.pone.0171993	http://dx.doi.org/10.1371/journal.pone.0171993			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207870	Green Published, gold			2022-12-27	WOS:000394424500069
J	Wang, L; Deng, YJ; Duan, D; Sun, SQ; Ge, LT; Zhuo, Y; Yuan, T; Wu, P; Wang, H; Lu, M; Xia, Y				Wang, Lei; Deng, Yujia; Duan, Da; Sun, Shuaiqi; Ge, Lite; Zhuo, Yi; Yuan, Ting; Wu, Pei; Wang, Hao; Lu, Ming; Xia, Ying			Hyperthermia influences fate determination of neural stem cells with lncRNAs alterations in the early differentiation	PLOS ONE			English	Article							LONG NONCODING RNAS; SPECIFICATION; PLURIPOTENCY	Background Temperature is an important parameter in the microenvironment of neural stem cells (NSCs); however, little is known about the precise effects of hyperthermia on fate determination in NSCs or the role of long non-coding (lnc) RNAs in this process. This was addressed in the present study using NSCs cultured at two different temperatures. Methods NSCs were divided into 37NSC and 40NSC groups that were cultured at 37 degrees C or 40 degrees C, respectively, for 72 h. Neuronal or glial cell differentiation was evaluated by flow cytometry and western blotting. LncRNA expression was detected by quantitative real-time PCR. Results The numbers of cells positive for the neuronal marker Tuj-1 and the glial cell marker glial fibrillary acidic protein were higher in the 40NSC than in the 37NSC group. The two groups also showed distinct lncRNA expression profiles. Conclusion Hyperthermia promotes neuronal and glial differentiation in NSCs, which involves specific lncRNAs.	[Wang, Lei; Sun, Shuaiqi; Xia, Ying] Cent S Univ, Xiangya Sch, Affiliated Haikou Hosp, Dept Neurosurg, Haikou, Hsinan, Peoples R China; [Wang, Lei; Deng, Yujia; Duan, Da; Ge, Lite; Zhuo, Yi; Yuan, Ting; Wu, Pei; Wang, Hao; Lu, Ming] Hunan Normal Univ, PLA Hosp 163, Affiliated Hosp 2, Dept Neurosurg, Changsha, Hunan, Peoples R China; [Ge, Lite; Lu, Ming] Hunan Normal Univ, Coll Life Sci, Minist Educ, Key Lab Prot Chem & Dev Biol, Changsha, Hunan, Peoples R China	Central South University; Hunan Normal University; Hunan Normal University	Xia, Y (corresponding author), Cent S Univ, Xiangya Sch, Affiliated Haikou Hosp, Dept Neurosurg, Haikou, Hsinan, Peoples R China.; Lu, M (corresponding author), Hunan Normal Univ, PLA Hosp 163, Affiliated Hosp 2, Dept Neurosurg, Changsha, Hunan, Peoples R China.; Lu, M (corresponding author), Hunan Normal Univ, Coll Life Sci, Minist Educ, Key Lab Prot Chem & Dev Biol, Changsha, Hunan, Peoples R China.	luminscs163@163.com; xiaying008@163.com	Wang, Lei/AAU-4297-2021; Ge, Lite/AAG-2097-2021	Wang, Lei/0000-0002-1069-7644; Lu, Ming/0000-0003-3768-7267	National Natural Science Foundation of China [81360190, 81371358]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This project was supported by grants from the National Natural Science Foundation of China (grant no. 81360190 to YX and grant no. 81371358 to ML). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BANET M, 1986, YALE J BIOL MED, V59, P117; Bernard D, 2010, EMBO J, V29, P3082, DOI 10.1038/emboj.2010.199; Chou CH, 2015, PARKINSONS DIS-US, V2015, DOI 10.1155/2015/571475; Compagnucci C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054271; Duan D, 2011, ACTA NEUROCHIR, V153, P2085, DOI 10.1007/s00701-011-0955-z; Goliaei B, 1998, LEUKEMIA RES, V22, P705, DOI 10.1016/S0145-2126(98)00061-7; Goliaei B, 2004, LEUKEMIA RES, V28, P1323, DOI 10.1016/j.leukres.2004.04.012; Knauss JL, 2013, NEUROSCIENCE, V235, P200, DOI 10.1016/j.neuroscience.2013.01.022; Landsberg L, 2009, METABOLISM, V58, P871, DOI 10.1016/j.metabol.2009.02.017; Lin NW, 2014, MOL CELL, V53, P1005, DOI 10.1016/j.molcel.2014.01.021; Mace TA, 2011, J LEUKOCYTE BIOL, V90, P951, DOI 10.1189/jlb.0511229; Mercer TR, 2008, P NATL ACAD SCI USA, V105, P716, DOI 10.1073/pnas.0706729105; Mercer TR, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-14; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Ng SY, 2012, EMBO J, V31, P522, DOI 10.1038/emboj.2011.459; Plaisance KI, 2000, PHARMACOTHERAPY, V20, P1417, DOI 10.1592/phco.20.19.1417.34865; Roy NS, 2006, NAT MED, V12, P1259, DOI 10.1038/nm1495; Wang L, 2016, REV NEUROSCIENCE, V27, P491, DOI 10.1515/revneuro-2015-0061	18	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0171359	10.1371/journal.pone.0171359	http://dx.doi.org/10.1371/journal.pone.0171359			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5VB	28234910	Green Published, gold, Green Submitted			2022-12-27	WOS:000394688200020
J	Wu, G; Wollen, A; Himley, S; Austin, G; Delarosa, J; Izadnegahdar, R; Ginsburg, AS; Zehrung, D				Wu, Grace; Wollen, Alec; Himley, Stephen; Austin, Glenn; Delarosa, Jaclyn; Izadnegahdar, Rasa; Ginsburg, Amy Sarah; Zehrung, Darin			A model for oxygen conservation associated with titration during pediatric oxygen therapy	PLOS ONE			English	Article							PAPUA-NEW-GUINEA; PULSE OXIMETRY; HOSPITALS; DELIVERY; HYPOXEMIA; CHILDREN; FEASIBILITY; SUPPORT	Background Continuous oxygen treatment is essential for managing children with hypoxemia, but access to oxygen in low-resource countries remains problematic. Given the high burden of pneumonia in these countries and the fact that flow can be gradually reduced as therapy progresses, oxygen conservation through routine titration warrants exploration. Aim To determine the amount of oxygen saved via titration during oxygen therapy for children with hypoxemic pneumonia. Methods Based on published clinical data, we developed a model of oxygen flow rates needed to manage hypoxemia, assuming recommended flow rate at start of therapy, and comparing total oxygen used with routine titration every 3 minutes or once every 24 hours versus no titration. Results Titration every 3 minutes or every 24 hours provided oxygen savings estimated at 11.7% +/- 5.1% and 8.1% +/- 5.1% (average +/- standard error of the mean, n = 3), respectively. For every 100 patients, 44 or 30 kiloliters would be saved D equivalent to 733 or 500 hours at 1 liter per minute. Conclusions Ongoing titration can conserve oxygen, even performed once-daily. While clinical validation is necessary, these findings could provide incentive for the routine use of pulse oximeters for patient management, as well as further development of automated systems.	[Wu, Grace] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA; [Wu, Grace; Wollen, Alec; Himley, Stephen; Austin, Glenn; Delarosa, Jaclyn; Zehrung, Darin] PATH, Seattle, WA USA; [Izadnegahdar, Rasa] Bill & Melinda Gates Fdn, Seattle, WA USA; [Ginsburg, Amy Sarah] Save Children, Fairfield, CT USA	Boston University; Bill & Melinda Gates Foundation; Save the Children	Zehrung, D (corresponding author), PATH, Seattle, WA USA.	dzehrung@path.org		Wollen, Alec/0000-0002-4812-3523	Bill and Melinda Gates Foundation [OPP1107534]	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This work was funded by grant number OPP1107534 from the Bill and Melinda Gates Foundation (http://www.gatesfoundation.org). RI advised the study team and reviewed the manuscript. The specific roles of these authors are articulated in the'author contributions' section.; The authors thank Dr. Ofer Yanay from the Seattle Children's Hospital for his valuable input and the Bill & Melinda Gates Foundation for funding the activities reported in this publication.	Badiu-Tisa I. D., 2013, Notulae Scientia Biologicae, V5, P407; BENARON DA, 1994, ARCH PEDIAT ADOL MED, V148, P294, DOI 10.1001/archpedi.1994.02170030064015; Bradley BD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089872; Choi SJ, 2010, ACTA ANAESTH SCAND, V54, P212, DOI 10.1111/j.1399-6576.2009.02101.x; Claure N, 2013, RESP CARE, V58, P151, DOI 10.4187/respcare.01955; Duke T, 2010, INT J TUBERC LUNG D, V14, P1362; Duke Trevor, 2010, Papua New Guinea Medical Journal, V53, P126; Enarson PM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102955; Finer NN, 1996, PEDIATR PULM, V21, P48, DOI 10.1002/(SICI)1099-0496(199601)21:1<48::AID-PPUL8>3.0.CO;2-M; Floyd J, 2015, NATURE, V528, pS53, DOI 10.1038/nature16043; Frey B, 2003, ARCH DIS CHILD-FETAL, V88, pF84, DOI 10.1136/fn.88.2.F84; Ginsburg AS, 2014, TROP MED INT HEALTH, V19, P537, DOI 10.1111/tmi.12291; Howie SRC, 2009, B WORLD HEALTH ORGAN, V87, P763, DOI 10.2471/BLT.08.058370; Howie SR, 2008, B WORLD HEALTH ORGAN, V86, P52, DOI 10.2471/BLT.07.042994; Jindal S K, 2008, Indian J Chest Dis Allied Sci, V50, P97; Kuti Bankole Peter, 2013, ISRN Pediatr, V2013, P435976, DOI 10.1155/2013/435976; Lee GJ, 2014, RESP CARE, V59, P1191, DOI 10.4187/respcare.02937; Lellouche F, 2013, CAN RESPIR J, V20, P259, DOI 10.1155/2013/376545; Matai S, 2008, ANN TROP PAEDIATR, V28, P71, DOI 10.1179/146532808X270716; Muhe L, 2001, INT J TUBERC LUNG D, V5, P527; Ralston ME, 2013, LANCET, V381, P256, DOI 10.1016/S0140-6736(12)61191-X; Rinderknecht AS, 2015, ACAD EMERG MED, V22, P431, DOI 10.1111/acem.12633; Rojas MX, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005975.pub2; Rosen MA, 2014, BRIT J ANAESTH, V113, P410, DOI 10.1093/bja/aeu096; Saihi K, 2014, CRIT CARE, V18, DOI 10.1186/cc13734; Vo D, 2012, J ANESTH CLIN RES, V3, P1, DOI DOI 10.1007/S00268-012-1629-6; Wandi F, 2006, ANN TROP PAEDIATR, V26, P277, DOI 10.1179/146532806X152791; WEBER MW, 1995, J PEDIATR-US, V127, P378, DOI 10.1016/S0022-3476(95)70067-6; Weinberger B, 2002, TOXICOL APPL PHARM, V181, P60, DOI 10.1006/taap.2002.9387; WHO , 2016, OX THER CHILDR; WHO, 2010, MON BUILD BLOCKS HLT, P43, DOI 10.1016/j.path.2015.02.014; World Health Oraganization, 2011, PULS OX TRAIN MAN; World Health Organization,, 2012, GUID BAS NEWB RES; World Health Organization, 2012, REC MAN COMM CHILDH, P69; World Health Organization, 2003, MAN HLTH FAC HOSP; World Health Organization, 2013, POCK BOOK HOSP CAR C; World Health Organization UNICEF, 2013, END PREV CHILD DEATH; Zapata J, 2014, ACTA PAEDIATR, V103, P928, DOI 10.1111/apa.12684	38	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e71530	10.1371/journal.pone.0171530	http://dx.doi.org/10.1371/journal.pone.0171530			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5VB	28234903	Green Published, Green Submitted, gold			2022-12-27	WOS:000394688200025
J	Yoo, W; Kim, S; Huh, WK; Dilley, S; Coughlin, SS; Partridge, EE; Chung, YM; Dicks, V; Lee, JK; Bae, S				Yoo, Wonsuk; Kim, Sangmi; Huh, Warner K.; Dilley, Sarah; Coughlin, Steven S.; Partridge, Edward E.; Chung, Yunmi; Dicks, Vivian; Lee, Jae-Kwan; Bae, Sejong			Recent trends in racial and regional disparities in cervical cancer incidence and mortality in United States	PLOS ONE			English	Article							FOLLOW-UP; HEALTH; WOMEN; PREVALENCE; AMERICAN; BREAST; CARE; AGE	Background Although black women experienced greater cervical cancer incidence and mortality rate reduction in recent years, they continue to have higher incidence rates than whites. Great variations also exist among geographic regions of the US, with the South having both the highest incidence and mortality rates compared to other regions. The present study explores the question of whether living in the South is associated with greater racial disparity in cervical cancer incidence and mortality by examining race-and region-specific rates and the trend between 2000 and 2012. Methods The Surveillance, Epidemiology, and End Results (SEER) 18 Program data was used. Cervical cancer incidence and mortality rates, annual percent changes, and disparity ratios were calculated using SEER*Stat software and Joinpoint regression for four groups: US14-Non- Hispanic White (NHW), US14-Non-Hispanic Black (NHB), South-NHW, and South-NHB, where South included 4 registries from Georgia and Louisiana and US14 were 14 US registries except the four South registries. Results The average age-adjusted cervical cancer incidence rate was the highest among SouthNHBs (11.1) and mortality rate was the highest among US14-NHBs (5.4). In 2012, the degree of racial disparities between South-NHBs and South-NHWs was greater in terms of mortality rates (NHB: NHW = 1.80: 1.35) than incidence rates (NHB: NHW = 1.45: 1.15). While mortality disparity ratios decreased from 2000-2012 for US14-NHB (APC: -1.9(-2.3,-1.4), mortality disparity ratios for South-NHWs (although lower than NHBs) increased compared to US14-NHW. Incidence rates for NHBs continued to increase with increasing age, whereas rates for NHWs decreased after age 40. Mortality rates for NHBs dramatically increased at age 65 compared to a relatively stable trend for NHWs. The increasing racial disparity with increasing age in terms of cervical cancer incidence rates became more pronounced when corrected for hysterectomy prevalence. Conclusions Black race and South region were associated with higher cervical cancer incidence and mortality. Cervical cancer rates uncorrected for hysterectomy may underestimate regional and racial disparities. Increasing incidence rates for older NHBs compared to NHWs warrant further research to determine whether screening should continue for NHBs over age 65.	[Yoo, Wonsuk; Chung, Yunmi; Dicks, Vivian] Augusta Univ, Inst Publ & Prevent Hlth, Augusta, GA USA; [Kim, Sangmi] Augusta Univ, Georgia Canc Ctr, Augusta, GA USA; [Huh, Warner K.; Dilley, Sarah; Partridge, Edward E.] Univ Alabama Birmingham, Dept Obstet & Gynecol, Birmingham, AL 35294 USA; [Coughlin, Steven S.] Augusta Univ, Dept Clin & Digital Hlth Sci, Augusta, GA USA; [Chung, Yunmi] Emory Univ, Sch Med, Dept Med, Atlanta, GA USA; [Lee, Jae-Kwan] Korea Univ, Guro Hosp, Dept Obstet & Gynecol, Seoul, South Korea; [Bae, Sejong] Univ Alabama Birmingham, Div Prevent Med, Birmingham, AL 35294 USA; [Bae, Sejong] Univ Alabama Birmingham, Ctr Comprehens Canc, Birmingham, AL 35294 USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University; University of Alabama System; University of Alabama Birmingham; University System of Georgia; Augusta University; Emory University; Korea University; Korea University Medicine (KU Medicine); University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Yoo, W (corresponding author), Augusta Univ, Inst Publ & Prevent Hlth, Augusta, GA USA.; Bae, S (corresponding author), Univ Alabama Birmingham, Div Prevent Med, Birmingham, AL 35294 USA.; Bae, S (corresponding author), Univ Alabama Birmingham, Ctr Comprehens Canc, Birmingham, AL 35294 USA.	wyoo153@gmail.com; bsejong@uab.edu	YOO, WONSUK/HHN-9044-2022	LEE, Jae Kwan/0000-0003-3101-6403; YOO, WONSUK/0000-0003-2414-2399; Dilley, Sarah/0000-0003-2974-9202; bae, sejong/0000-0001-9982-3223	National Cancer Institute [P30 CA013148, P50CA098252, 2U54 CA118948]; National Institute on Minority Health and Health Disparities [U54MD008149, U54MD008176]; Atlanta Clinical & Translational Science Institute [UL1TR000454]; NATIONAL CANCER INSTITUTE [P30CA013148, U54CA118948, U54CA118638, P50CA098252, U54CA118623] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007585] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); Atlanta Clinical & Translational Science Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This article was partially supported by the National Cancer Institute (P30 CA013148, P50CA098252, 2U54 CA118948), National Institute on Minority Health and Health Disparities (U54MD008149, U54MD008176), and Atlanta Clinical & Translational Science Institute (UL1TR000454). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This article was partially supported by the National Cancer Institute (P30 CA013148, P50CA098252, 2U54 CA118948), National Institute on Minority Health and Health Disparities (U54MD008149, U54MD008176), and Atlanta Clinical & Translational Science Institute (UL1TR000454). We would like to express our gratitude to anonymous peer reviewers for carefully revising our manuscript and for his/her comments.	Ackerson K, 2007, J AM ACAD NURSE PRAC, V19, P591, DOI 10.1111/j.1745-7599.2007.00268.x; American Cancer Society, 2016, CANC FACTS FIGURES 2; [Anonymous], 2014, DAT INC SEER 18 REGS; [Anonymous], 2015, SEER STAT DAT INC D; Benard VB, 2014, MMWR-MORBID MORTAL W, V63, P1004; Braveman PA, 2010, AM J PUBLIC HEALTH, V100, pS186, DOI 10.2105/AJPH.2009.166082; Bynum SA, 2016, AIDS BEHAV, V20, P2101, DOI 10.1007/s10461-016-1345-6; Centers for Disease Control and Prevention (CDC), 2014, BEH RISK FACT SURV S; Choi SK, 2015, AM J PUBLIC HEALTH, V105, pS706, DOI 10.2105/AJPH.2015.302876; Chu KC, 2007, J NATL MED ASSOC, V99, P1092; Churilla T, 2016, GYNECOL ONCOL, V141, P516, DOI 10.1016/j.ygyno.2016.03.025; Downs LS, 2008, GYNECOL ONCOL, V109, pS22, DOI 10.1016/j.ygyno.2008.01.003; Eggleston KS, 2007, OBSTET GYNECOL, V109, P1332, DOI 10.1097/01.AOG.0000266396.25244.68; Ferlay J S I, 2014, CANC INCIDENCE MORTA; Garfield R DA, 2014, COVERAGE GAP UNINSUR; Grant SR, 2015, CANCER-AM CANCER SOC, V121, P2020, DOI 10.1002/cncr.29120; Ilic M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109379; Jemal A, 2013, JNCI-J NATL CANCER I, V105, P175, DOI 10.1093/jnci/djs491; Kepka D, 2014, AM J PREV MED, V47, P629, DOI 10.1016/j.amepre.2014.07.034; Kim HJ, 2000, STAT MED, V19, P335, DOI 10.1002/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z; Levinson KL, 2011, GYNECOL ONCOL, V122, P324, DOI 10.1016/j.ygyno.2011.04.038; Markowitz LE, 2013, J INFECT DIS, V208, P385, DOI 10.1093/infdis/jit192; Nguyen KH, 2016, AM J PUBLIC HEALTH, V106, P1409, DOI 10.2105/AJPH.2016.303156; Office of Disease Prevention and Health Promotion, 2016, DISP DET RAC ETHN 20; Proctor BD, 2016, INCOME POVERTY US 20; Roman L, 2014, J WOMENS HEALTH, V23, P57, DOI 10.1089/jwh.2013.4397; Rositch AF, 2014, CANCER-AM CANCER SOC, V120, P2032, DOI 10.1002/cncr.28548; Ryerson AB, 2016, CANCER-AM CANCER SOC, V122, P1312, DOI 10.1002/cncr.29936; Saslow D, 2012, CA-CANCER J CLIN, V62, P147, DOI 10.3322/caac.21139; Shavers VL, 2002, JNCI-J NATL CANCER I, V94, P334; Tejeda S, 2013, J WOMENS HEALTH, V22, P507, DOI 10.1089/jwh.2012.3590; Tiwari RC, 2006, STAT METHODS MED RES, V15, P547, DOI 10.1177/0962280206070621; Ward E, 2004, CA-CANCER J CLIN, V54, P78, DOI 10.3322/canjclin.54.2.78; Weragoda J, 2016, CANCER MED-US, V5, P2126, DOI 10.1002/cam4.765; Williams DR, 2002, AM J PUBLIC HEALTH, V92, P588, DOI 10.2105/AJPH.92.4.588; Yoo W, 2016, ANN PUBLIC HLTH RES, V3	36	77	79	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0172548	10.1371/journal.pone.0172548	http://dx.doi.org/10.1371/journal.pone.0172548			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL5VB	28234949	Green Submitted, gold, Green Published			2022-12-27	WOS:000394688200092
J	Liang, YJ; Liu, LJ; Huang, JJ				Liang, Youjia; Liu, Lijun; Huang, Jiejun			Integrating the SD-CLUE-S and InVEST models into assessment of oasis carbon storage in northwestern China	PLOS ONE			English	Article							MULTIPLE ECOSYSTEM SERVICES; HEIHE RIVER-BASIN; LAND-USE CHANGE; BIODIVERSITY; SCENARIOS; IMPACTS; URBAN	Spatio-temporal integrated assessment of land-use change impacts on carbon storage services is a new and important research field in land science and landscape ecology. The objective of this paper is to use an integrated SD-CLUE-S and InVEST model to simulate and predict land-use changes impacts during 2000-2018 on carbon storage at pixel and regional scales in the Zhangye oasis, Northwest China. The SD-CLUE-S model was used to simulate land-use change, and three land-use scenarios (current trend, moderate protection, and strict protection) were defined in collaboration with oasis socioeconomic development and ecological environment conservation by local government. The InVEST model was then used to simulate land-use change impacts on carbon storage at different scales in the oasis. The results showed that: (1) the effects of built-up land expansion were especially notable, with a rapid decrease in cropland during 2009-2018; (2) the strict protection scenario saved the largest amount of carbon storage for the oasis compared with the current trend and moderate protection scenarios. The scientific value of this study has been to show that the proposed modeling method can be used to reflect different land-use patterns and their effects on ecosystem services at multiple scales in the oasis. Furthermore, this research can be used to help government managers encourage stakeholders to contribute funds and strategies to maintain oasis landscape patterns and ecological processes by implementing local plans for potential conservation projects.	[Liang, Youjia; Huang, Jiejun] Wuhan Univ Technol, Sch Resources & Environm Engn, Wuhan, Hubei Province, Peoples R China; [Liu, Lijun] Meteorol Serv Ctr Gansu Prov, Lanzhou, Gansu, Peoples R China	Wuhan University of Technology	Liang, YJ (corresponding author), Wuhan Univ Technol, Sch Resources & Environm Engn, Wuhan, Hubei Province, Peoples R China.	yjliang@whut.edu.cn		Liang, Youjia/0000-0002-1503-3417	National Natural Science Foundation of China [41601184]; Fundamental Research Funds for the Central Universities [WUT: 2016IVA044]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the National Natural Science Foundation of China (41601184) and the Fundamental Research Funds for the Central Universities (WUT: 2016IVA044).	Burkhard B, 2012, ECOL INDIC, V21, P1, DOI 10.1016/j.ecolind.2012.03.008; Cheng GD, 2014, NATL SCI REV, V1, P413, DOI 10.1093/nsr/nwu017; Daily GC, 2009, FRONT ECOL ENVIRON, V7, P21, DOI 10.1890/080025; de Groot RS, 2010, ECOL COMPLEX, V7, P260, DOI 10.1016/j.ecocom.2009.10.006; Ehrlich PR, 2012, NATURE, V486, P68, DOI 10.1038/nature11157; Eigenbrod F, 2011, P ROY SOC B-BIOL SCI, V278, P3201, DOI 10.1098/rspb.2010.2754; Feng Q, 2001, HYDROLOG SCI J, V46, P647, DOI 10.1080/02626660109492862; Fu L, 2014, INT J ENV RES PUB HE, V11, P2698, DOI 10.3390/ijerph110302698; Han J, 2009, LANDSCAPE URBAN PLAN, V91, P133, DOI 10.1016/j.landurbplan.2008.12.002; He CY, 2016, ENVIRON MODELL SOFTW, V75, P44, DOI 10.1016/j.envsoft.2015.09.015; Hilty LM, 2006, ENVIRON MODELL SOFTW, V21, P1618, DOI 10.1016/j.envsoft.2006.05.007; Kok K, 2007, LAND USE POLICY, V24, P517, DOI 10.1016/j.landusepol.2006.04.007; Lawler JJ, 2014, P NATL ACAD SCI USA, V111, P7492, DOI 10.1073/pnas.1405557111; Leh MDK, 2013, AGR ECOSYST ENVIRON, V165, P6, DOI 10.1016/j.agee.2012.12.001; Li F, 2014, INT J ENV RES PUB HE, V11, P2698; Liang Y., 2012, SCI COLD ARID REGION, V4, P320, DOI [DOI 10.3724/SP.J.1226.2012.00320, 10.3724/SP.J.1226.2012.00320]; Liang YJ, 2014, LANDSCAPE ECOL, V29, P1725, DOI 10.1007/s10980-014-0089-9; Nelson E, 2009, FRONT ECOL ENVIRON, V7, P4, DOI 10.1890/080023; Nelson Erik J, 2010, F1000 Biol Rep, V2, P53, DOI 10.3410/B2-53; Pereira HM, 2010, SCIENCE, V330, P1496, DOI 10.1126/science.1196624; Polasky S, 2011, ENVIRON RESOUR ECON, V48, P219, DOI 10.1007/s10640-010-9407-0; Pontius RG, 2008, ANN REGIONAL SCI, V42, P11, DOI 10.1007/s00168-007-0138-2; Ranganathan J., 2008, ECOSYSTEM SERVICES G, P96; Rao NS, 2015, ECOSYST SERV, V11, P95, DOI 10.1016/j.ecoser.2014.11.011; Seppelt R, 2012, ECOL INDIC, V21, P145, DOI 10.1016/j.ecolind.2011.09.003; Shangguan W, 2013, J ADV MODEL EARTH SY, V5, P212, DOI 10.1002/jame.20026; Sohl TL, 2012, APPL GEOGR, V34, P111, DOI 10.1016/j.apgeog.2011.10.019; Sun XT, 2002, SCI TECHNOLOGY REV, V6, P61; Tallis H., 2010, B BR ECOL SOC, V41, P10; Tallis H.T., 2013, INVEST 2 6 0 USERS G; Trisurat Y, 2016, ENVIRON RES, V147, P611, DOI 10.1016/j.envres.2016.02.019; Verburg PH, 2009, LANDSCAPE ECOL, V24, P1167, DOI 10.1007/s10980-009-9355-7; Verburg PH, 1999, ECOL MODEL, V116, P45, DOI 10.1016/S0304-3800(98)00156-2; Verburg PH, 2002, ENVIRON MANAGE, V30, P391, DOI 10.1007/s00267-002-2630-x; Wang SQ, 2002, ENVIRON POLLUT, V116, pS157, DOI 10.1016/S0269-7491(01)00269-X; [张俊华 ZHANG Junhua], 2011, [地理科学, Scientia Geographica Sinica], V31, P982; Zhao WZ, 2010, AGR WATER MANAGE, V97, P215, DOI 10.1016/j.agwat.2009.09.011; ZSB (Zhangye Statistic Bureau), 2000, YB NAT EC SOC DEV ZH, P43; ZSB (Zhangye Statistic Bureau), 2009, YB NAT EC SOC DEV ZH, P34	39	37	43	22	110	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2017	12	2							e0172494	10.1371/journal.pone.0172494	http://dx.doi.org/10.1371/journal.pone.0172494			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL5SX	28231328	Green Submitted, gold, Green Published			2022-12-27	WOS:000394682400050
J	Salih, DA; Pelle, R; Mwacharo, JM; Njahira, MN; Marcellino, WL; Kiara, H; Malak, AK; El Hussein, ARM; Bishop, R; Skilton, RA				Salih, Diaeldin A.; Pelle, Roger; Mwacharo, Joram M.; Njahira, Moses N.; Marcellino, Wani L.; Kiara, Henry; Malak, Agol K.; El Hussein, Abdel Rahim M.; Bishop, Richard; Skilton, Robert A.			Genes encoding two Theileria parva antigens recognized by CD8(+) T-cells exhibit sequence diversity in South Sudanese cattle populations but the majority of alleles are similar to the Muguga component of the live vaccine cocktail	PLOS ONE			English	Article							EAST-COAST FEVER; SPECIFICITY; RESPONSES; SOFTWARE; RATES	East Coast fever (ECF), caused by Theileria parva infection, is a frequently fatal disease of cattle in eastern, central and southern Africa, and an emerging disease in South Sudan. Immunization using the infection and treatment method (ITM) is increasingly being used for control in countries affected by ECF, but not yet in South Sudan. It has been reported that CD8(+) T-cell lymphocytes specific for parasitized cells play a central role in the immunity induced by ITM and a number of T. parva antigens recognized by parasite-specific CD8(+) T-cells have been identified. In this study we determined the sequence diversity among two of these antigens, Tp1 and Tp2, which are under evaluation as candidates for inclusion in a sub-unit vaccine. T. parva samples (n = 81) obtained from cattle in four geographical regions of South Sudan were studied for sequence polymorphism in partial sequences of the Tp1 and Tp2 genes. Eight positions (1.97%) in Tp1 and 78 positions (15.48%) in Tp2 were shown to be polymorphic, giving rise to four and 14 antigen variants in Tp1 and Tp2, respectively. The overall nucleotide diversity in the Tp1 and Tp2 genes was pi = 1.65% and pi = 4.76%, respectively. The parasites were sampled from regions approximately 300 km apart, but there was limited evidence for genetic differentiation between populations. Analyses of the sequences revealed limited numbers of amino acid polymorphisms both overall and in residues within the mapped CD8(+) T-cell epitopes. Although novel epitopes were identified in the samples from South Sudan, a large number of the samples harboured several epitopes in both antigens that were similar to those in the T. parva Muguga reference stock, which is a key component in the widely used live vaccine cocktail.	[Salih, Diaeldin A.; Pelle, Roger; Njahira, Moses N.; Marcellino, Wani L.; Skilton, Robert A.] Biosci Eastern & Cent Africa Int Livestock Res In, Nairobi, Kenya; [Salih, Diaeldin A.; El Hussein, Abdel Rahim M.] Cent Vet Res Lab, Khartoum, Sudan; [Mwacharo, Joram M.] Univ Nottingham, Sch Life Sci, Ctr Genet & Genom, Nottingham, England; [Marcellino, Wani L.; Malak, Agol K.] Minist Anim Resources & Fisheries, Juba, South Sudan; [Kiara, Henry; Bishop, Richard] ILRI, Nairobi, Kenya; [Mwacharo, Joram M.] Int Ctr Agr Res Dry Areas, Addis Ababa, Ethiopia; [Njahira, Moses N.; Skilton, Robert A.] Icipe, Nairobi, Kenya	University of Nottingham; CGIAR; International Livestock Research Institute (ILRI); International Centre of Insect Physiology & Ecology (ICIPE)	Salih, DA; Skilton, RA (corresponding author), Biosci Eastern & Cent Africa Int Livestock Res In, Nairobi, Kenya.; Salih, DA (corresponding author), Cent Vet Res Lab, Khartoum, Sudan.; Skilton, RA (corresponding author), Icipe, Nairobi, Kenya.	Diaeldin2000@hotmail.com; rskilton@icipe.org		Salih, Diaeldin/0000-0002-4278-9754	Africa Biosciences Challenge Fund (ABCF) Fellowship; Australian Agency for International Development (AusAID); Syngenta Foundation for Sustainable Agriculture (SFSA); Bill & Melinda Gates Foundation (BMGF); Swedish Ministry of Foreign Affairs through the Swedish International Development Agency (Sida); International Foundation for Science, Stockholm, Sweden; Organisation of Islamic Conference Standing Committee on Scientific and Technological Cooperation (COMSTECH), Islamabad, Pakistan [3765-2]; Deutsche Forschungsgemeinschaft (DFG) [SE862/2-1]	Africa Biosciences Challenge Fund (ABCF) Fellowship; Australian Agency for International Development (AusAID)(Australian Aid (AusAID)); Syngenta Foundation for Sustainable Agriculture (SFSA)(Syngenta); Bill & Melinda Gates Foundation (BMGF)(Bill & Melinda Gates Foundation); Swedish Ministry of Foreign Affairs through the Swedish International Development Agency (Sida); International Foundation for Science, Stockholm, Sweden(International Foundation for Science); Organisation of Islamic Conference Standing Committee on Scientific and Technological Cooperation (COMSTECH), Islamabad, Pakistan; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	Australian Agency for International Development (AusAID) through a partnership between Australia's Commonwealth Scientific and Industrial Research Organisation (CSIRO) and the Biosciences eastern and central Africa Hub at the International Livestock Research Institute (BecA-ILRI Hub); and by the Syngenta Foundation for Sustainable Agriculture (SFSA); the Bill & Melinda Gates Foundation (BMGF); and the Swedish Ministry of Foreign Affairs through the Swedish International Development Agency (Sida), which made this work possible. DAS was a recipient of an Africa Biosciences Challenge Fund (ABCF) Fellowship (hub.africabiosciences.org). International Foundation for Science, Stockholm, Sweden and the Organisation of Islamic Conference Standing Committee on Scientific and Technological Cooperation (COMSTECH), Islamabad, Pakistan, through a grant (IFS grant 3765-2) to DAS (http://ifs.se/). Deutsche Forschungsgemeinschaft (DFG) project 'Molecular epidemiology network for promotion and support of delivery of live vaccines against Theileria parva and T. annulata infection in Eastern and Northern Africa' (SE862/2-1) (http://theileriainafrica.weebly.com/).; We gratefully acknowledge the financial support provided to the Biosciences eastern and central Africa Hub at the International Livestock Research Institute (BecA-ILRI Hub) by the Australian Agency for International Development (AusAID) through a partnership between Australia's Commonwealth Scientific and Industrial Research Organisation (CSIRO) and the BecA-ILRI Hub; and by the Syngenta Foundation for Sustainable Agriculture (SFSA); the Bill & Melinda Gates Foundation (BMGF); and the Swedish Ministry of Foreign Affairs through the Swedish International Development Agency (SIDA), which made this work possible. DAS was a recipient of an Africa Biosciences Challenge Fund (ABCF) Fellowship. This research was also supported by the International Foundation for Science, Stockholm, Sweden and the Organization of Islamic Conference Standing Committee on Scientific and Technological Cooperation (COMSTECH), Islamabad, Pakistan, through a grant (IFS grant 3765-2) to DAS. This work was supported in part by Deutsche Forschungsgemeinschaft (DFG) project 'Molecular epidemiology network for promotion and support of delivery of live vaccines against Theileria parva and T. annulata infection in Eastern and Northern Africa' (SE862/2-1).	[Anonymous], 1983, AGCPSUD024DEN; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bird CE, 2011, CRUSTISSUES, V10, P39; De Deken R, 2007, VET PARASITOL, V143, P245, DOI 10.1016/j.vetpar.2006.08.018; Di Giulio G, 2009, TRENDS PARASITOL, V25, P85, DOI 10.1016/j.pt.2008.11.007; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fu YX, 1997, GENETICS, V147, P915; George JE, 2004, PARASITOLOGY, V129, pS353, DOI 10.1017/S0031182003004682; Geysen D, 1999, TROP MED INT HEALTH, V4, pA21, DOI 10.1046/j.1365-3156.1999.00447.x; Geysen D, 2013, ONDERSTEPOORT J VET, V80; Graham Simon P, 2007, Immunome Res, V3, P2, DOI 10.1186/1745-7580-3-2; Graham SP, 2008, INFECT IMMUN, V76, P685, DOI 10.1128/IAI.01244-07; Graham SP, 2006, P NATL ACAD SCI USA, V103, P3286, DOI 10.1073/pnas.0511273103; HOOGSTRAAL H., 1956, African Ixodoidea. I. Ticks of the Sudan. (With special reference to Equatoria Province and with preliminary reviews of the genera Boophilus, Margaropus, and Hyalomma.; Julla II, 1994, THESIS, P115; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kivaria FM, 2012, ONDERSTEPOORT J VET, V79, DOI 10.4102/ojvr.v79i1.400; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; MacHugh ND, 2009, EUR J IMMUNOL, V39, P2459, DOI 10.1002/eji.200939227; Malak AK, 2012, PREV VET MED, V104, P216, DOI 10.1016/j.prevetmed.2011.12.001; Marcellino W. L., 2011, International Research Journal of Agricultural Science and Soil Science, V1, P218; Minjauw B, 1998, PREV VET MED, V35, P101, DOI 10.1016/S0167-5877(98)00053-1; Morzaria S. P., 1981, Advances in the Control of Theileriosis. Proceedings of an International Conference held at the International Laboratory for Research on Animal Diseases in Nairobi, 9-13th February, 1981, P83; Odongo DO, 2010, PARASITOL RES, V106, P357, DOI 10.1007/s00436-009-1670-z; Oura CAL, 2005, MOL BIOCHEM PARASIT, V140, P229, DOI 10.1016/j.molbiopara.2004.12.015; Oura CAL, 2003, INT J PARASITOL, V33, P1641, DOI 10.1016/S0020-7519(03)00280-7; Patel EH, 2011, VET PARASITOL, V179, P62, DOI 10.1016/j.vetpar.2011.01.057; Paul REL, 1998, AM J TROP MED HYG, V58, P195, DOI 10.4269/ajtmh.1998.58.195; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Pelle R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019015; RADLEY D E, 1975, Veterinary Parasitology, V1, P51, DOI 10.1016/0304-4017(75)90007-2; Salih DA, 2007, PARASITOL RES, V101, P1035, DOI 10.1007/s00436-007-0583-y; Schneider S, 1999, GENETICS, V152, P1079; SLATKIN M, 1991, GENETICS, V129, P555; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; TARACHA ELN, 1995, INFECT IMMUN, V63, P1258, DOI 10.1128/IAI.63.4.1258-1262.1995; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TIBAYRENC M, 1991, P NATL ACAD SCI USA, V88, P5129, DOI 10.1073/pnas.88.12.5129	39	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2017	12	2							e0171426	10.1371/journal.pone.0171426	http://dx.doi.org/10.1371/journal.pone.0171426			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5SX	28231338	Green Published, gold, Green Submitted			2022-12-27	WOS:000394682400013
J	Zhang, JY; Chen, SC; Chen, YY; Li, SY; Zhang, LL; Shen, YH; Chang, CX; Xiang, YQ; Huang, HF; Xu, CM				Zhang, Jun-Yu; Chen, Song-Chang; Chen, Yi-Yao; Li, Shu-Yuan; Zhang, Lan-Lan; Shen, Ying-Hua; Chang, Chun-Xin; Xiang, Yu-Qian; Huang, He-Feng; Xu, Chen-Ming			Targeted sequencing identifies a novel SH2D1A pathogenic variant in a Chinese family: Carrier screening and prenatal genetic testing	PLOS ONE			English	Article							LINKED LYMPHOPROLIFERATIVE SYNDROME; MESSENGER-RNA DECAY; OF-THE-LITERATURE; ENCODING GENE; DISEASE; MUTATIONS; SAP; INFECTION; SLAM; IMMUNODEFICIENCY	X-linked lymphoproliferative disease type 1 (XLP1) is a rare primary immunodeficiency characterized by a clinical triad consisting of severe EBV-induced hemophagocytic lymphohistiocytosis, B-cell lymphoma, and dysgammaglobulinemia. Mutations in SH2D1A gene have been revealed as the cause of XLP1. In this study, a pregnant woman with recurrence history of birthing immunodeficiency was screened for pathogenic variant because the proband sample was unavailable. We aimed to clarify the genetic diagnosis and provide prenatal testing for the family. Next-generation sequencing (NGS)-based multigene panel was used in carrier screening of the pregnant woman. Variants of immunodeficiency related genes were analyzed and prioritized. Candidate variant was verified by using Sanger sequencing. The possible influence of the identified variant was evaluated through RNA assay. Amniocentesis, karyotyping, and Sanger sequencing were performed for prenatal testing. We identified a novel de novo frameshift SH2D1A pathogenic variant (c.251_ 255delTTTCA) in the pregnant carrier. Peripheral blood RNA assay indicated that the mutant transcript could escape nonsense-mediated mRNA decay (NMD) and might encode a C-terminal truncated protein. Information of the variant led to success prenatal diagnosis of the fetus. In conclusion, our study clarified the genetic diagnosis and altered disease prevention for a pregnant carrier of XLP1.	[Zhang, Jun-Yu; Chen, Song-Chang; Chen, Yi-Yao; Li, Shu-Yuan; Zhang, Lan-Lan; Shen, Ying-Hua; Chang, Chun-Xin; Xiang, Yu-Qian; Huang, He-Feng; Xu, Chen-Ming] Shanghai Jiao Tong Univ, Sch Med, Int Peace Matern & Child Hlth Hosp, Shanghai, Peoples R China; [Zhang, Jun-Yu; Chen, Song-Chang; Chen, Yi-Yao; Li, Shu-Yuan; Zhang, Lan-Lan; Shen, Ying-Hua; Chang, Chun-Xin; Xiang, Yu-Qian; Huang, He-Feng; Xu, Chen-Ming] Shanghai Jiao Tong Univ, Sch Med, Inst Embryofetal Original Adult Dis, Shanghai, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Xu, CM (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Int Peace Matern & Child Hlth Hosp, Shanghai, Peoples R China.; Xu, CM (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Inst Embryofetal Original Adult Dis, Shanghai, Peoples R China.	chenming_xu2006@163.com	Huang, Hefeng/ABF-1117-2020; Huang, Hefeng/AAR-7184-2021; Zhang, Junyu/AAF-6658-2019; Huang, He-Feng/AAN-7985-2020	Zhang, Junyu/0000-0003-0239-6670; Huang, He-Feng/0000-0003-4344-8019	National Natural Science Foundation of China [81401219, 81501276, 81471506, 81501231]; Shanghai Municipal Commission of Science and Technology Program [15411966700, 14411965100, 15411964000, 14DJ1400102]; Shanghai Municipal Commission of Health and Family Planning Program [20154Y0039]; Shanghai Hospital Development Center [SHDC12014131]; Shanghai Jiao Tong University Program [14XJ10083, YG2014M534, 15ZH4011]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Commission of Science and Technology Program; Shanghai Municipal Commission of Health and Family Planning Program; Shanghai Hospital Development Center; Shanghai Jiao Tong University Program	This work is supported by the National Natural Science Foundation of China [NO. 81401219; 81501276; 81471506; 81501231], the Shanghai Municipal Commission of Science and Technology Program [NO. 15411966700; 14411965100; 15411964000; 14DJ1400102], the Shanghai Municipal Commission of Health and Family Planning Program [NO. 20154Y0039], the Research Grant from Shanghai Hospital Development Center [NO. SHDC12014131] and the Shanghai Jiao Tong University Program [NO. 14XJ10083; YG2014M534; 15ZH4011]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; [Anonymous], 2016, OBSTET GYNECOL; Booth C, 2011, BLOOD, V117, P53, DOI 10.1182/blood-2010-06-284935; Coffey AJ, 1998, NAT GENET, V20, P129, DOI 10.1038/2424; den Dunnen JT, 2016, HUM MUTAT, V37, P564, DOI 10.1002/humu.22981; Drury S, 2015, PRENATAL DIAG, V35, P1010, DOI 10.1002/pd.4675; Filipovich AH, 2010, BLOOD, V116, P3398, DOI 10.1182/blood-2010-03-275909; Jin YY, 2016, HUM IMMUNOL, V77, P658, DOI 10.1016/j.humimm.2016.06.005; Khajavi M, 2006, EUR J HUM GENET, V14, P1074, DOI 10.1038/sj.ejhg.5201649; Lankester AC, 2005, BONE MARROW TRANSPL, V36, P99, DOI 10.1038/sj.bmt.1705016; Lek M, 2015, BIORXIV; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu YQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133636; Ma CS, 2011, ANN NY ACAD SCI, V1217, P32, DOI 10.1111/j.1749-6632.2010.05824.x; Maquat LE, 2004, NAT REV MOL CELL BIO, V5, P89, DOI 10.1038/nrm1310; Morra M, 2001, ANNU REV IMMUNOL, V19, P657, DOI 10.1146/annurev.immunol.19.1.657; Nichols KE, 1998, P NATL ACAD SCI USA, V95, P13765, DOI 10.1073/pnas.95.23.13765; Pangalos C, 2016, PEERJ, V4, DOI 10.7717/peerj.1955; PURTILO D T, 1991, Pediatric Pathology, V11, P685; Rehm HL, 2013, GENET MED, V15, P733, DOI 10.1038/gim.2013.92; Rezaei N, 2011, BRIT J HAEMATOL, V152, P13, DOI 10.1111/j.1365-2141.2010.08442.x; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Rigaud S, 2006, NATURE, V444, P110, DOI 10.1038/nature05257; Sayos J, 1998, NATURE, V395, P462, DOI 10.1038/26683; Schmid JP, 2011, BLOOD, V117, P1522, DOI 10.1182/blood-2010-07-298372; Schwartzberg PL, 2009, NAT REV IMMUNOL, V9, P39, DOI 10.1038/nri2456; Scott SA, 2010, HUM MUTAT, V31, P1240, DOI 10.1002/humu.21327; Stenson PD, 2003, HUM MUTAT, V21, P577, DOI 10.1002/humu.10212; Sumegi J, 2000, BLOOD, V96, P3118; Sun J, 2013, SCAND J IMMUNOL, V78, P463, DOI 10.1111/sji.12103; Tangye SG, 2014, J CLIN IMMUNOL, V34, P772, DOI 10.1007/s10875-014-0083-7; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Woon ST, 2008, SCAND J IMMUNOL, V68, P153, DOI 10.1111/j.1365-3083.2008.02128.x; Yang H, 2015, NAT PROTOC, V10, P1556, DOI 10.1038/nprot.2015.105	34	3	3	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2017	12	2							e0172173	10.1371/journal.pone.0172173	http://dx.doi.org/10.1371/journal.pone.0172173			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5SX	28231257	Green Submitted, Green Published, gold			2022-12-27	WOS:000394682400028
J	Deviatkin, AA; Lukashev, AN; Poleshchuk, EM; Dedkov, VG; Tkachev, SE; Sidorov, GN; Karganova, GG; Galkina, IV; Shchelkanov, MY; Shipulin, GA				Deviatkin, Andrei A.; Lukashev, Alexander N.; Poleshchuk, Elena M.; Dedkov, Vladimir G.; Tkachev, Sergey E.; Sidorov, Gennadiy N.; Karganova, Galina G.; Galkina, Irina V.; Shchelkanov, Mikhail Yu.; Shipulin, German A.			The phylodynamics of the rabies virus in the Russian Federation	PLOS ONE			English	Article							BIG-BANG; DIVERSITY; EVOLUTION; ECOLOGY; HISTORY	Near complete rabies virus N gene sequences (1,110 nt) were determined for 82 isolates obtained from different regions of Russia between 2008 and 2016. These sequences were analyzed together with 108 representative GenBank sequences from 1977-2016 using the Bayesian coalescent approach. The timing of the major evolutionary events was estimated. Most of the isolates represented the steppe rabies virus group C, which was found over a vast geographic region from Central Russia to Mongolia and split into three groups (C0-C2) with discrete geographic prevalence. A single strain of the steppe rabies virus lineage was isolated in the far eastern part of Russia (Primorsky Krai), likely as a result of a recent anthropogenic introduction. For the first time the polar rabies virus group A2, previously reported in Alaska, was described in the northern part of European Russia and at the Franz Josef Land. Phylogenetic analysis suggested that all currently circulating rabies virus groups in the Russian Federation were introduced within the few last centuries, with most of the groups spreading in the 20th century. The dating of evolutionary events was highly concordant with the historical epidemiological data.	[Deviatkin, Andrei A.; Dedkov, Vladimir G.; Shipulin, German A.] Cent Res Inst Epidemiol, Fed Budget Inst Sci, Moscow, Russia; [Deviatkin, Andrei A.; Lukashev, Alexander N.; Karganova, Galina G.] Chumakov Inst Poliomyelitis & Viral Encephalitide, Fed Budget Inst, Moscow, Russia; [Deviatkin, Andrei A.; Dedkov, Vladimir G.] Res Inst Occupat Hlth, Moscow, Russia; [Lukashev, Alexander N.] Sechenov First Moscow State Med Univ, Inst Mol Med, Moscow, Russia; [Poleshchuk, Elena M.; Sidorov, Gennadiy N.] Inst Nat Foci Infect, Omsk, Russia; [Tkachev, Sergey E.] ICBFM SB RAS, Novosibirsk, Russia; [Sidorov, Gennadiy N.] Omsk State Pedag Univ, Omsk, Russia; [Galkina, Irina V.; Shchelkanov, Mikhail Yu.] Far Eastern Fed Univ, Vladivostok, Russia; [Shchelkanov, Mikhail Yu.] Russian Acad Sci, Inst Biol & Soil Sci, Far Eastern Branch, Vladivostok, Russia	Chumakov Federal Scientific Center for Research & Development of Immune & Biological Products of Russian Academy of Sciences; Russian Academy of Sciences; Izmerov Research Institute of Occupational Health; Sechenov First Moscow State Medical University; Institute of Chemical Biology & Fundamental Medicine, Siberian Branch of the RAS; Russian Academy of Sciences; Omsk State Pedagogical University; Far Eastern Federal University; Russian Academy of Sciences; Federal Scientific Center of the East Asia Terrestrial Biodiversity, Far Eastern Branch of the Russian Academy of Sciences	Deviatkin, AA (corresponding author), Cent Res Inst Epidemiol, Fed Budget Inst Sci, Moscow, Russia.; Deviatkin, AA (corresponding author), Chumakov Inst Poliomyelitis & Viral Encephalitide, Fed Budget Inst, Moscow, Russia.; Deviatkin, AA (corresponding author), Res Inst Occupat Hlth, Moscow, Russia.	andreideviatkin@gmail.com	Sidorov, Gennadiy/AAX-6529-2021; Shchelkanov, Mikhail Yu./L-6164-2016; Tkachev, Sergey/I-7390-2013; Lukashev, Alexander/G-2777-2013; Dedkov, Vladimir G/M-7010-2018; Karganova, Galina G/D-8601-2014; Poleshchuk, Elena/AAB-1281-2020; Shipulin, German A/J-1167-2014; Deviatkin, Andrei/K-4351-2015	Shchelkanov, Mikhail Yu./0000-0001-8610-7623; Lukashev, Alexander/0000-0001-7365-0352; Dedkov, Vladimir G/0000-0002-5500-0169; Karganova, Galina G/0000-0002-8901-6206; Shipulin, German A/0000-0002-3668-6601; Deviatkin, Andrei/0000-0003-0789-4601; Tkachev, Sergey/0000-0001-7767-380X; Poleshchuk, Elena/0000-0002-8217-5159	Russian Scientific Foundation (RSF) [14-15-00619]; Russian Science Foundation [17-15-00010] Funding Source: Russian Science Foundation	Russian Scientific Foundation (RSF)(Russian Science Foundation (RSF)); Russian Science Foundation(Russian Science Foundation (RSF))	Data analysis was supported by Russian Scientific Foundation (RSF) grant 14-15-00619 (http://grant.rscf.ru/prjcard_int?14-15-00619).	ANDERSON RM, 1981, NATURE, V289, P765, DOI 10.1038/289765a0; Avilov VM, 2004, VET PATHOL, V3, P134; Badrane H, 2001, J VIROL, V75, P8096, DOI 10.1128/JVI.75.17.8096-8104.2001; Berezina ES, 2011, RUSS VET J SMALL DOM, V2, P26; Botvinkin A., 2004, Historical perspective of rabies in Europe and the Mediterranean Basin: a testament to rabies by Dr Arthur A. King, P47; Bouckaert R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003537; Bourhy H, 1999, J GEN VIROL, V80, P2545, DOI 10.1099/0022-1317-80-10-2545; Bourhy H, 2008, J GEN VIROL, V89, P2673, DOI 10.1099/vir.0.2008/003913-0; Chupin S. A., 2013, Voprosy Virusologii, V58, P44; Cleaveland S, 2002, B WORLD HEALTH ORGAN, V80, P304; Dietzschold Bernhard, 2003, Expert Rev Vaccines, V2, P399, DOI 10.1586/14760584.2.3.399; Fooks Anthony R, 2014, Lancet, V384, P1389, DOI 10.1016/S0140-6736(13)62707-5; Hamilton G, 2011, POLAR NOMADS GHOST F; Hanke D, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004779; Jackson AC, 2013, RABIES: SCIENTIFIC BASIS OF THE DISEASE AND ITS MANAGEMENT, 3RD EDITION, P1; Knobel DL, 2005, B WORLD HEALTH ORGAN, V83, P360; Koonin EV, 2008, NAT REV MICROBIOL, V6, P925, DOI 10.1038/nrmicro2030; Koonin EV, 2007, BIOL DIRECT, V2, DOI 10.1186/1745-6150-2-21; Kuzmin IV, 2008, EPIDEMIOL INFECT, V136, P509, DOI 10.1017/S095026880700903X; Kuzmin IV, 2004, J WILDLIFE DIS, V40, P617, DOI 10.7589/0090-3558-40.4.617; Lvov DK, 2015, FRONT MATTER ZOONOTI; Makarov VV, 2009, VET PATHOL, V4, P2; Martin DP, 2015, VIRUS EVOL, V1, DOI 10.1093/ve/vev003; McElhinney LM, 2011, J GEN VIROL, V92, P2171, DOI 10.1099/vir.0.032748-0; Metlin AE, 2007, ARCH VIROL, V152, P1645, DOI 10.1007/s00705-007-1001-6; Mulder Jaap L., 2012, Lutra, V55, P101; Nadin-Davis SA, 2003, EPIDEMIOL INFECT, V131, P777, DOI 10.1017/S095026880300863X; Nadin-Davis SA, 2012, VIRUS RES, V163, P352, DOI 10.1016/j.virusres.2011.10.026; Poleschuk EM, 2012, RUSS VET J SMALL CAT, V6, P8, DOI DOI 10.1038/LABAN0107-8B; Poleshchuk E. M., 2013, Voprosy Virusologii, V58, P9; Poleshchuk EM, 2013, VET PATHOL, V2, P101; Poleshchuk EM, 2013, RUSS J INFECT IMMUN, V3, P164; Rupprecht CE, 2008, DEV BIOLOGICALS, V131, P95; Rupprecht CE, 2015, FUTURE VIROL, V10, P517, DOI 10.2217/FVL.15.26; Saito M, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002144; Shchelkanov M. Yu, 2016, Voprosy Virusologii, V61, P180, DOI 10.18821/0507-4088-2016-61-4-180-186; Shchelkanov MY, 2016, GENOME ANNOUNCEMENTS, V4, DOI 10.1128/genomeA.00642-16; Sidorov G, 2010, RUSS J ZOOL, V88, P26; Sidorov GN, 2002, VET PATHOL, V1, P21; SMITH JM, 1992, J MOL EVOL, V34, P126; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Vitasek J, 2004, VET MED-CZECH, V49, P171, DOI 10.17221/5692-VETMED	42	14	15	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2017	12	2							e0171855	10.1371/journal.pone.0171855	http://dx.doi.org/10.1371/journal.pone.0171855			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5SK	28225771	Green Submitted, Green Published, gold			2022-12-27	WOS:000394680900023
J	Dmello, C; Sawant, S; Alam, H; Gangadaran, P; Mogre, S; Tiwari, R; D'Souza, Z; Narkar, M; Thorat, R; Patil, K; Chaukar, D; Kane, S; Vaidya, M				Dmello, Crismita; Sawant, Sharada; Alam, Hunain; Gangadaran, Prakash; Mogre, Saie; Tiwari, Richa; D'Souza, Zinia; Narkar, Manish; Thorat, Rahul; Patil, Komal; Chaukar, Devendra; Kane, Shubhada; Vaidya, Milind			Vimentin regulates differentiation switch via modulation of keratin 14 levels and their expression together correlates with poor prognosis in oral cancer patients	PLOS ONE			English	Article							INTERMEDIATE FILAMENT PROTEINS; STRATIFIED EPITHELIAL-CELLS; STEM-CELLS; P63; NOTCH; PROLIFERATION; CARCINOMA; LINE; KERATINOCYTES; COMMITMENT	Vimentin is an intermediate filament protein, predominantly expressed in cells of mesenchymal origin, although its aberrant expression is seen in many carcinomas during epithelial mesenchymal transition. In cancer, vimentin expression is associated with the transition from a more differentiated epithelial phenotype to a dedifferentiated state. In view of the perceived role of keratins (Ks) as regulators of differentiation in epithelia, it was important to understand whether vimentin modulates differentiation through the reprogramming of keratins, in transformed cells. To address this, vimentin was stably downregulated in oral cancer derived cells. Further, global keratin profiling was performed after high salt keratin extraction. K5/K14 pair was found to be significantly downregulated, both at protein and mRNA levels upon vimentin downregulation. The previous study from our laboratory has shown a role of the K5/K14 pair in proliferation and differentiation of squamous epithelial cells. Vimentin depleted cells showed an increase in the differentiation state, marked by an increase in the levels of differentiation specific markers K1, involucrin, filaggrin and loricrin while its proliferation status remained unchanged. Rescue experiments with the K5/K14 pair overexpressed in vimentin knockdown background resulted in decreased differentiation state Delta Np63 emerged as one of the indirect targets of vimentin, through which it modulates the expression levels of K5/K14. Further, immunohistochemistry showed a significant correlation between high vimentin-K14 expression and recurrence/poor survival in oral cancer patients. Thus, in conclusion, vimentin regulates the differentiation switch via modulation of K5/K14 expression. Moreover, vimentin-K14 together may prove to be the novel markers for the prognostication of human oral cancer.	[Dmello, Crismita; Sawant, Sharada; Alam, Hunain; Gangadaran, Prakash; Mogre, Saie; Tiwari, Richa; D'Souza, Zinia; Narkar, Manish; Thorat, Rahul; Patil, Komal; Vaidya, Milind] Tata Mem Hosp, Adv Ctr Treatment Res & Educ Canc, Canc Res Inst, Kharghar, Navi Mumbai, India; [Dmello, Crismita; Sawant, Sharada; Tiwari, Richa; Chaukar, Devendra; Kane, Shubhada; Vaidya, Milind] Homi Bhabha Natl Inst, Training Sch Complex, Bombay, Maharashtra, India; [Chaukar, Devendra] Tata Mem Hosp, Surg Oncol Head & Neck Unit, Bombay, Maharashtra, India; [Kane, Shubhada] Tata Mem Hosp, Dept Pathol, Bombay, Maharashtra, India; [Alam, Hunain] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Gangadaran, Prakash] Kyunpook Natl Univ, Sch Med, Dept Nucl Med, N101, Daegu, South Korea	Tata Memorial Centre (TMC); Advance Centre for Treatment, Research & Education in Cancer (ACTREC); Tata Memorial Hospital; Homi Bhabha National Institute; Tata Memorial Centre (TMC); Tata Memorial Hospital; Tata Memorial Centre (TMC); Tata Memorial Hospital; University of Texas System; UTMD Anderson Cancer Center	Vaidya, M (corresponding author), Tata Mem Hosp, Adv Ctr Treatment Res & Educ Canc, Canc Res Inst, Kharghar, Navi Mumbai, India.; Vaidya, M (corresponding author), Homi Bhabha Natl Inst, Training Sch Complex, Bombay, Maharashtra, India.	mvaidya@actrec.gov.in	Gangadaran, Prakash/AAV-3102-2021; Dmello, Crismita/ABE-3901-2022	Gangadaran, Prakash/0000-0002-0658-4604; /0000-0001-9944-3335; Alam, Hunain/0000-0002-6183-3677	Department of Biotechnology [102/IFD/SAN/947]	Department of Biotechnology	Support was provided by the Department of Biotechnology, grant number: 102/IFD/SAN/947 [http://www.dbtindia.nic.in/] to SS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACHTSTAETTER T, 1986, METHOD ENZYMOL, V134, P355; Alam H, 2011, MOL BIOL CELL, V22, P4068, DOI 10.1091/mbc.E10-08-0703; Alam H, 2011, J CELL SCI, V124, P2096, DOI 10.1242/jcs.073585; Blanpain C, 2006, GENE DEV, V20, P3022, DOI 10.1101/gad.1477606; Boraas LC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145084; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Candi E, 2015, CELL DEATH DIFFER, V22, P12, DOI 10.1038/cdd.2014.113; CHANG SE, 1992, INT J CANCER, V52, P896, DOI 10.1002/ijc.2910520612; Chiang CT, 2009, J CELL PHYSIOL, V219, P117, DOI 10.1002/jcp.21656; Ding L, 2009, CELL STEM CELL, V4, P403, DOI 10.1016/j.stem.2009.03.009; Dmello C, 2016, INT J BIOCHEM CELL B, V70, P161, DOI 10.1016/j.biocel.2015.11.015; Dotto GP, 2009, NAT REV CANCER, V9, P587, DOI 10.1038/nrc2675; Eriksson JE, 2009, J CLIN INVEST, V119, P1763, DOI 10.1172/JCI38339; Flores ER, 2007, CELL CYCLE, V6, P300, DOI 10.4161/cc.6.3.3793; FRANKE WW, 1982, DIFFERENTIATION, V23, P43, DOI 10.1111/j.1432-0436.1982.tb01266.x; GIARD DJ, 1973, J NATL CANCER I, V51, P1417, DOI 10.1093/jnci/51.5.1417; Hoffmann A, 2006, ONCOGENE, V25, P6706, DOI 10.1038/sj.onc.1209933; Hsu YC, 2014, NAT MED, V20, P847, DOI 10.1038/nm.3643; Iyer SV, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0053532, 10.1371/journal.pone.0059613]; Jensen Mette Munk, 2008, BMC Med Imaging, V8, P16, DOI 10.1186/1471-2342-8-16; Kidd ME, 2014, AM J RESP CELL MOL, V50, P1, DOI 10.1165/rcmb.2013-0314TR; Lee KB, 2014, CANCER LETT, V353, P124, DOI 10.1016/j.canlet.2014.07.016; Li B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017092; Lian N, 2009, J BIOL CHEM, V284, P30518, DOI 10.1074/jbc.M109.052373; Liu LK, 2010, MODERN PATHOL, V23, P213, DOI 10.1038/modpathol.2009.160; Lu H, 2005, EUR J CELL BIOL, V84, P709, DOI 10.1016/j.ejcb.2005.04.001; Ma SH, 1997, GENE EXPRESSION, V6, P361; Manni I, 2009, FASEB J, V23, P3957, DOI 10.1096/fj.09-131847; Medawar A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003441; Mendez MG, 2010, FASEB J, V24, P1838, DOI 10.1096/fj.09-151639; Mishra R, 2015, OR SURG OR MED OR PA, V120, P497, DOI 10.1016/j.oooo.2015.06.027; MOLL R, 1991, LAB INVEST, V65, P74; Moll R, 2008, HISTOCHEM CELL BIOL, V129, P705, DOI 10.1007/s00418-008-0435-6; Nguyen BC, 2006, GENE DEV, V20, P1028, DOI 10.1101/gad.1406006; Oeckinghaus A, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000034; Otsuki S, 2011, ONCOL REP, V25, P1235, DOI 10.3892/or.2011.1185; Raul U, 2004, INT J CANCER, V111, P662, DOI 10.1002/ijc.20349; Restivo G, 2011, EMBO J, V30, P4571, DOI 10.1038/emboj.2011.325; Romano RA, 2007, J INVEST DERMATOL, V127, P1175, DOI 10.1038/sj.jid.5700652; Romano RA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005623; Satelli A, 2011, CELL MOL LIFE SCI, V68, P3033, DOI 10.1007/s00018-011-0735-1; Sawant SS, 2014, ORAL DIS, V20, P453, DOI 10.1111/odi.12151; Sniezek JC, 2004, LARYNGOSCOPE, V114, P2063, DOI 10.1097/01.mlg.0000149437.35855.4b; SOMMERS CL, 1994, BREAST CANCER RES TR, V31, P325, DOI 10.1007/BF00666165; Su XH, 2013, NAT REV CANCER, V13, P136, DOI 10.1038/nrc3446; TAPSCOTT SJ, 1981, DEV BIOL, V86, P40, DOI 10.1016/0012-1606(81)90313-4; TATAKE RJ, 1990, J CANCER RES CLIN, V116, P179, DOI 10.1007/BF01612674; Tetsu O, 2003, CANCER CELL, V3, P233, DOI 10.1016/S1535-6108(03)00053-9; Thomas PA, 1999, CLIN CANCER RES, V5, P2698; Troy TC, 1999, J CELL PHYSIOL, V180, P409, DOI 10.1002/(SICI)1097-4652(199909)180:3<409::AID-JCP12>3.0.CO;2-V; Truong AB, 2006, GENE DEV, V20, P3185, DOI 10.1101/gad.1463206; Vaidya MM, 2007, J BIOSCIENCES, V32, P629, DOI 10.1007/s12038-007-0062-8; Vuoriluoto K, 2011, ONCOGENE, V30, P1436, DOI 10.1038/onc.2010.509; Watt FM, 2008, CURR OPIN CELL BIOL, V20, P171, DOI 10.1016/j.ceb.2008.01.010; WATT FM, 1983, J INVEST DERMATOL, V81, pS100, DOI 10.1111/1523-1747.ep12540786; Wawersik M, 1997, J BIOL CHEM, V272, P32557, DOI 10.1074/jbc.272.51.32557; Workman P, 2010, BRIT J CANCER, V102, P1555, DOI 10.1038/sj.bjc.6605642; Yao Jeng-Yuan, 2012, Biomed J, V35, P457, DOI 10.4103/2319-4170.104410; Yoh K, 2015, FRONT ENDOCRINOL, V6, DOI 10.3389/fendo.2015.00051; Zeineddine D, 2014, AM J STEM CELLS, V3, P74; Zheng Y, 2008, CANCER BIOL THER, V7, P873, DOI 10.4161/cbt.7.6.5868	61	23	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2017	12	2							e0172559	10.1371/journal.pone.0172559	http://dx.doi.org/10.1371/journal.pone.0172559			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5SK	28225793	Green Published, gold, Green Submitted			2022-12-27	WOS:000394680900053
J	van Hecke, O; Hocking, LJ; Torrance, N; Campbell, A; Padmanabhan, S; Porteous, DJ; McIntosh, AM; Burri, AV; Tanaka, H; Williams, FMK; Smith, BH				van Hecke, Oliver; Hocking, Lynne J.; Torrance, Nicola; Campbell, Archie; Padmanabhan, Sandosh; Porteous, David J.; McIntosh, Andrew M.; Burri, Andrea V.; Tanaka, Haruka; Williams, Frances M. K.; Smith, Blair H.			Chronic pain, depression and cardiovascular disease linked through a shared genetic predisposition: Analysis of a family-based cohort and twin study	PLOS ONE			English	Article							MUSCULOSKELETAL PAIN; GENERAL-POPULATION; REGISTRY TWINSUK; HEART-DISEASE; HEALTH-CARE; STRESS; RISK; ASSOCIATION; LIFE; EPIDEMIOLOGY	Background Depression and chronic pain are the two most important causes of disability (Global Burden of Disease Study 2013). They occur together more frequently than expected and both conditions have been shown to be co-morbid with cardiovascular disease. Although shared socio-demographic risk factors (e.g. gender, deprivation) might explain the co-morbidity of these three conditions, we hypothesised that these three long-term, highly prevalent conditions co-occur and may be due to shared familial risk, and/or genetic factors. Methods and findings We employed three different study designs in two independent cohorts, namely Generation Scotland and TwinsUK, having standardised, validated questionnaire data on the three traits of interest. First, we estimated the prevalence and co-occurrence of chronic pain, depression and angina among 24,024 participants of a population-based cohort of extended families (Generation Scotland: Scottish Family Health Study), adjusting for age, gender, education, smoking status, and deprivation. Secondly, we compared the odds of co-morbidity in sibling-pairs with the odds in unrelated individuals for the three conditions in the same cohort. Lastly, examination of similar traits in a sample of female twins (TwinsUK, n = 2,902), adjusting for age and BMI, allowed independent replication of the findings and exploration of the influence of additive genetic (A) factors and shared (C) and non-shared (E) environmental factors predisposing to co-occurring chronic widespread pain (CWP) and cardiovascular disease (hypertension, angina, stroke, heart attack, elevated cholesterol, angioplasty or bypass surgery). In the Generation Scotland cohort, individuals with depression were more than twice as likely to have chronic pain as those without depression (adjusted OR 2.64 [95% CI 2.34-2.97]); those with angina were four times more likely to have chronic pain (OR 4.19 [3.64-4.82]); those with depression were twice as likely to have angina (OR 2.20 [1.90-2.54]). Similar odds were obtained when the outcomes and predictors were reversed and similar effects seen among sibling pairs; depression in one sibling predicted chronic pain in the other (OR 1.34 [1.05-1.71]), angina predicted chronic pain in the other (OR 2.19 [1.63-2.95]), and depression, angina (OR 1.98 [1.49-2.65]). Individuals with chronic pain and angina showed almost fourfold greater odds of depression compared with those manifesting neither trait (OR 3.78 [2.99-4.78]); angina showed seven-fold increased odds in the presence of chronic pain and depression (OR 7.76 [6.05-9.95]) and chronic pain nine-fold in the presence of depression and angina (OR 9.43 [6.85-12.98]). In TwinsUK, the relationship between CWP and depression has been published (R = 0.34, p< 0.01). Considering the CWP-cardiovascular relationship, the most suitable model to describe the observed data was a combination of A, C and E, with a small but significant genetic predisposition, shared between the two traits (2.2% [95% CI 0.06-0.23]). Conclusion We found an increased co-occurrence of chronic pain, depression and cardiovascular disease in two independent cohorts (general population-based cohort, twins cohort) suggesting a shared genetic contribution. Adjustment for known environmental influences, particularly those relating to socio-economic status (Generation Scotland: age, gender, deprivation, smoking, education; Twins UK: age, BMI) did not explain the relationship observed between chronic pain, depression and cardiovascular disease. Our findings from two independent cohorts challenge the concept of traditional disease boundaries and warrant further investigation of shared biological mechanisms.	[van Hecke, Oliver; Torrance, Nicola; Smith, Blair H.] Univ Dundee, Sch Med, Div Populat Hlth Sci, Dundee, Scotland; [Hocking, Lynne J.] Univ Aberdeen, Inst Med Sci, Aberdeen, Scotland; [Hocking, Lynne J.; Campbell, Archie; Padmanabhan, Sandosh; Porteous, David J.; McIntosh, Andrew M.; Smith, Blair H.] Univ Edinburgh, Generat Scotland, Ctr Genom & Expt Med, Inst Genet & Mol Med, Edinburgh, Midlothian, Scotland; [Padmanabhan, Sandosh] Univ Glasgow, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland; [Porteous, David J.] Univ Edinburgh, Ctr Genom & Mol Med, Inst Genet & Mol Med, Edinburgh, Midlothian, Scotland; [McIntosh, Andrew M.] Univ Edinburgh, Div Psychiat, Edinburgh, Midlothian, Scotland; [Burri, Andrea V.] Univ Zurich, Inst Psychol, Zurich, Switzerland; [Burri, Andrea V.] Auckland Univ Technol, Fac Hlth & Environm Sci, Auckland, New Zealand; [Burri, Andrea V.; Williams, Frances M. K.] Kings Coll London, Dept Twin Res & Genet Epidemiol, London, England; [Tanaka, Haruka] Mie Prefectural Coll Nursing, Tsu, Mie, Japan; [van Hecke, Oliver] Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Oxford, England	University of Dundee; University of Aberdeen; University of Edinburgh; University of Glasgow; University of Edinburgh; University of Edinburgh; University of Zurich; Auckland University of Technology; University of London; King's College London; University of Oxford	Smith, BH (corresponding author), Univ Dundee, Sch Med, Div Populat Hlth Sci, Dundee, Scotland.; Smith, BH (corresponding author), Univ Edinburgh, Generat Scotland, Ctr Genom & Expt Med, Inst Genet & Mol Med, Edinburgh, Midlothian, Scotland.	b.h.smith@dundee.ac.uk	Campbell, Archie/AAZ-1757-2021; Smith, Blair H/G-2834-2012; McIntosh, Andrew M/B-9379-2008; Porteous, David/AAA-3446-2021	Smith, Blair H/0000-0002-5362-9430; McIntosh, Andrew M/0000-0002-0198-4588; Porteous, David/0000-0003-1249-6106; Campbell, Archie/0000-0003-0198-5078; van Hecke, Oliver/0000-0002-6229-5057; Burri, Andrea/0000-0002-4705-3551; Torrance, Nicola/0000-0002-7856-7408; Williams, Frances/0000-0002-2998-2744; Padmanabhan, Sandosh/0000-0003-3869-5808	Arthritis Research UK [20682]; EU FP7 project Pain-omics; Swiss National Science Foundation; Swisslife Jubilaumsstiftung; Chief Scientist Office of the Scottish Government Health Directorates [CZD/16/6]; Scottish Funding Council [HR03006]; Wellcome Trust; European Community's Seventh Framework Programme; National Institute for Health Research (NIHR); St Thomas' NHS Foundation Trust; EU FP7 project Painomics; Medical Research Council [MR/K026992/1] Funding Source: researchfish; Versus Arthritis [20682] Funding Source: researchfish; Chief Scientist Office [CZD/16/6/4] Funding Source: researchfish	Arthritis Research UK(Versus Arthritis); EU FP7 project Pain-omics; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swisslife Jubilaumsstiftung; Chief Scientist Office of the Scottish Government Health Directorates; Scottish Funding Council; Wellcome Trust(Wellcome TrustEuropean Commission); European Community's Seventh Framework Programme(European Commission); National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); St Thomas' NHS Foundation Trust; EU FP7 project Painomics; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Versus Arthritis(Versus Arthritis); Chief Scientist Office	FMKW is supported by Arthritis Research UK grant 20682 and by EU FP7 project Pain-omics. AB reports an Ambizione personal career fellowship by the Swiss National Science Foundation and a project grant from the Swisslife Jubilaumsstiftung. Generation Scotland (www.generatonscotland.org) has received core funding from the Chief Scientist Office of the Scottish Government Health Directorates CZD/16/6 and the Scottish Funding Council HR03006. The sponsor of the study had no role in study design, data collection, data analysis, data interpretation, or writing of the report, or the decision to submit for publication. The corresponding author had full access to all the data in the study and had final responsibility for the decision to submit for publication. TwinsUK (www.twinsuk.ac.uk): the study was funded by the Wellcome Trust; European Community's Seventh Framework Programme (FP7/2007-2013). The study also receives support from the National Institute for Health Research (NIHR)-funded BioResource, Clinical Research Facility and Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust in partnership with King's College London. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrew T, 2001, Twin Res, V4, P464, DOI 10.1375/1369052012803; [Anonymous], 2014, R LANG ENV STAT COMP; Barnett K, 2012, LANCET, V380, P37, DOI 10.1016/S0140-6736(12)60240-2; Breivik H, 2006, EUR J PAIN, V10, P287, DOI 10.1016/j.ejpain.2005.06.009; Bromley C DS, SCOTTISH HLTH SURVEY, V1; Burri A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140289; Burri A, 2015, PAIN, V156, P1458, DOI 10.1097/j.pain.0000000000000182; Charlson FJ, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-250; Colman I, 2014, PSYCHOL MED, V44, P2845, DOI 10.1017/S0033291714000385; de Heer EW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106907; Dominick CH, 2012, PAIN, V153, P293, DOI 10.1016/j.pain.2011.09.018; Dong YR, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-222; Elliott AM, 1999, LANCET, V354, P1248, DOI 10.1016/S0140-6736(99)03057-3; First MB, 2002, STRUCTURED CLIN INTE; Generaal E, 2016, ANN RHEUM DIS, V75, P847, DOI 10.1136/annrheumdis-2014-206741; Generaal E, 2014, PAIN, V155, P1605, DOI 10.1016/j.pain.2014.05.007; Gerrits MMJG, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/1471-244X-14-187; Goldstein BI, 2015, CIRCULATION, V132, P965, DOI 10.1161/CIR.0000000000000229; Goldston K, 2008, CLIN PSYCHOL REV, V28, P288, DOI 10.1016/j.cpr.2007.05.005; Goodson NJ, 2013, PAIN; Hiles SA, 2015, J BEHAV MED; Hocking LJ, 2012, EUR J PAIN, V16, P1053, DOI 10.1002/j.1532-2149.2011.00095.x; Hocking LJ, 2010, PAIN, V149, P143, DOI 10.1016/j.pain.2010.01.023; Holliday KL, 2010, ANN RHEUM DIS, V69, P556, DOI 10.1136/ard.2009.116137; IASP, 1986, PAIN S, V3, pS1; Jones GT, 2009, PAIN, V143, P92, DOI 10.1016/j.pain.2009.02.003; Kessler RC, 2004, INT J METH PSYCH RES, V13, P93, DOI 10.1002/mpr.168; Kroenke K, 2009, JAMA-J AM MED ASSOC, V301, P2099, DOI 10.1001/jama.2009.723; Lawlor DA, 2003, J EPIDEMIOL COMMUN H, V57, P538, DOI 10.1136/jech.57.7.538; Livshits G, 2015, PAIN, V156, P1845, DOI 10.1097/j.pain.0000000000000200; Maccari S, 2014, J NEUROENDOCRINOL, V26, P707, DOI 10.1111/jne.12175; Marco EM, 2014, BEHAV PHARMACOL, V25, P547, DOI 10.1097/FBP.0000000000000068; McLean G, 2014, BRIT J GEN PRACT, V64, pE440, DOI 10.3399/bjgp14X680545; Moayyeri A, 2013, TWIN RES HUM GENET, V16, P144, DOI 10.1017/thg.2012.89; Morgan MAJ, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002171; Neale M. C., 2015, PSYCHOMETRIKA; Oei HHS, 2004, ANN EPIDEMIOL, V14, P431, DOI 10.1016/j.annepidem.2003.09.009; Peters MJ, 2013, ANN RHEUM DIS, V72, P427, DOI 10.1136/annrheumdis-2012-201742; Purves AM, 1998, PAIN CLINIC, V10, P139; Reich CG, 2013, NEUROSCIENCE, V253, P444, DOI 10.1016/j.neuroscience.2013.08.066; Rijsdijk Fruhling V, 2002, Brief Bioinform, V3, P119, DOI 10.1093/bib/3.2.119; ROSE GA, 1962, B WORLD HEALTH ORGAN, V27, P645; Slavich GM, 2014, PSYCHOL BULL, V140, P774, DOI 10.1037/a0035302; Smith BH, 2006, BMC MED GENET, V7, DOI 10.1186/1471-2350-7-74; Smith BH, 2013, INT J EPIDEMIOL, V42, P689, DOI 10.1093/ije/dys084; Smith SB, 2012, ARTHRITIS RHEUM-US, V64, P584, DOI 10.1002/art.33338; Spector TD, 2006, TWIN RES HUM GENET, V9, P899, DOI 10.1375/twin.9.6.899; Staud Roland, 2009, Curr Rheumatol Rep, V11, P433; Stone AL, 2016, PAIN, V157, P2628, DOI 10.1097/j.pain.0000000000000637; Tomasdottir MO, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130591; Torrance N, 2010, EUR J PAIN, V14, P380, DOI 10.1016/j.ejpain.2009.07.006; Van der Kooy K, 2007, INT J GERIATR PSYCH, V22, P613, DOI 10.1002/gps.1723; van Hecke O, 2014, EUR J PAIN, V18, P1223, DOI 10.1002/j.1532-2149.2014.00470.x; van Hecke O, 2013, BRIT J PAIN, V7, P209, DOI 10.1177/2049463713493264; Von Korff M, 2009, PAIN, V143, P76, DOI 10.1016/j.pain.2009.01.034; von Wurmb-Schwark Nicole, 2004, Leg Med (Tokyo), V6, P125, DOI 10.1016/j.legalmed.2003.12.002; VONKORFF M, 1993, PAIN, V55, P251, DOI 10.1016/0304-3959(93)90154-H; VONKORFF M, 1992, PAIN, V50, P133, DOI 10.1016/0304-3959(92)90154-4; Walsh SK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108999; White KP, 1999, J RHEUMATOL, V26, P885; Wolfe F, 2010, J RHEUMATOL, V37, P305, DOI 10.3899/jrheum.090781	61	47	47	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2017	12	2							e0170653	10.1371/journal.pone.0170653	http://dx.doi.org/10.1371/journal.pone.0170653			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL5SK	28225781	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000394680900006
J	Wong, WCW; Zhao, YP; Wong, NS; Parish, WL; Miu, HYH; Yang, LG; Emch, M; Ho, KM; Fong, FY; Tucker, JD				Wong, William Chi Wai; Zhao, Yanping; Wong, Ngai Sze; Parish, William L.; Miu, Heidi Yin Hai; Yang, Li-Gang; Emch, Michael; Ho, King Man; Fong, Francois Yeung; Tucker, Joseph D.			Prevalence and risk factors of chlamydia infection in Hong Kong: A population-based geospatial household survey and testing	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED INFECTIONS; FEMALE SEX WORKERS; TRACHOMATIS INFECTION; YOUNG-ADULTS; EPIDEMIOLOGY; BRITAIN	Background Chlamydia causes infertility and increases risk of HIV infection, and population-based studies provide essential information for effective infection control and prevention. This study examined Chlamydia trachomatis prevalence and risk factors among a representative sample of 18-49-year-old residents in Hong Kong. Methods Census boundary map of 412 constituency areas was used as primary sampling units to construct the sampling frame and, residential buildings and units were randomly selected using geospatial modelling. A questionnaire on sexual practice and health was conducted, and polymerase chain reaction was used to test the urine for genital chlamydial infection. Invitation letters were sent to the selected households and a team of interviewers were sent to recruit one subject per household. Prevalence data was weighted according to the 2011 census and risk factors identified through logistic regression. Results Among 881 participants (response rate of 24.5%), the overall Chlamydia trachomatis prevalence was low at 1.4% (95% CI 0.8-2.5%) but sexually active young (18-26 years) women had relatively high prevalence (5.8%, 95% CI 1.7-18.2%) in Hong Kong. A unique U-shape disease burden was observed with peaks in younger and older (40-49 years) women. Amongst the sexually active women, the risk factors of Chlamydia trachomatis infection were: younger age (aOR = 25.4, 95% CI 2.81-230); living alone (aOR = 8.99, 95% CI 1.46-55.40); and, among all the sexually active participants, males (including the male partners of the female participants) who had travelled out of Hong Kong in the previous 12 months had higher risks of infection (aOR = 5.35; 95% CI 1.25-22.8). A core-peripheral geographical distribution of Chlamydia trachomatis prevalence was also observed. Conclusion Young and older sexually active women in Hong Kong have high prevalence of chlamydia. Routine screening for sexually active women and young men should be considered. Further research on testing feasibility and linkage-to-care are urgently needed to control the infection.	[Wong, William Chi Wai; Zhao, Yanping; Miu, Heidi Yin Hai] Univ Hong Kong, Li Ka Shing Fac Med, Dept Family Med & Primary Care, Hong Kong, Hong Kong, Peoples R China; [Wong, Ngai Sze; Tucker, Joseph D.] Univ North Carolina Project China, Guangzhou, Guangdong, Peoples R China; [Wong, Ngai Sze] Univ North Carolina Chapel Hill, Inst Global Hlth & Infect Dis, Chapel Hill, NC USA; [Parish, William L.] Univ Chicago, Dept Sociol, Chicago, IL 60637 USA; [Yang, Li-Gang] Guangdong Prov Ctr Skin Dis & STI Control, Guangzhou, Guangdong, Peoples R China; [Emch, Michael] Univ North Carolina Chapel Hill, Dept Geog, Chapel Hill, NC USA; [Ho, King Man] Hong Kong Govt, Dept Hlth, Social Hyg Serv, Hong Kong, Hong Kong, Peoples R China; [Fong, Francois Yeung] Hong Kong Sexual Hlth Ctr, Hong Kong, Hong Kong, Peoples R China; [Tucker, Joseph D.] London Sch Hyg & Trop Med, London, England	University of Hong Kong; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of Chicago; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of London; London School of Hygiene & Tropical Medicine	Zhao, YP (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Dept Family Med & Primary Care, Hong Kong, Hong Kong, Peoples R China.	zhaohelen@hku.hk	Zhao, Yanping/CAF-1220-2022; Wong, Ngai Sze/A-3145-2012; Zhao, Yanping/E-7425-2017	Zhao, Yanping/0000-0002-6806-1593; Wong, Ngai Sze/0000-0003-3788-8114; Zhao, Yanping/0000-0002-6806-1593; Tucker, Joseph/0000-0003-2804-1181; Wong, William/0000-0003-2540-4055	Health and Medical Research Fund [13121242]; Food and Health Bureau, Hong Kong S.A.R.; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P2CHD050924] Funding Source: NIH RePORTER; FOGARTY INTERNATIONAL CENTER [D43TW009532] Funding Source: NIH RePORTER	Health and Medical Research Fund; Food and Health Bureau, Hong Kong S.A.R.; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This study was supported by Health and Medical Research Fund (Ref #13121242) (Project title: To Determine Prevalence and Contextual Risk Factors of Sexually Transmitted Infections in Hong Kong), Food and Health Bureau, Hong Kong S.A.R. (URL of the grant: https://rfs1.fhb.gov.hk/app/fundedsearch/projectdetail.xhtml?id=1529). The sponsor has no role throughout the process including the study design, data collection, analysis and interpretation, nor is it involved in the manuscript writing.	Abdullah ASM, 2002, SEX TRANSM INFECT, V78, P180, DOI 10.1136/sti.78.3.180; [Anonymous], 2001, STRAT FRAM PROM SEX; Bozicevic I, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-230; Carcamo CP, 2012, LANCET INFECT DIS, V12, P765, DOI 10.1016/S1473-3099(12)70144-5; CATES W, 1991, AM J OBSTET GYNECOL, V164, P1771, DOI 10.1016/0002-9378(91)90559-A; Census and Statistics Department of the Government of the Hong Kong Special Administrative Region, 2016, HONG KONG FIG HONG K; Cheney LD, 2014, EDWARD BURNE-JONES' MYTHICAL PAINTINGS: THE PYGMALION OF THE PRE-RAPHAELITE PAINTERS, P3; Cohen MS, 1997, LANCET, V349, P1868, DOI 10.1016/S0140-6736(97)02190-9; Datta SD, 2012, SEX TRANSM DIS, V39, P92, DOI 10.1097/OLQ.0b013e31823e2ff7; District Council Election, 2011, SUMM DISTR COUNC CON; Division of STD Prevention of the Centers for Disease Control and Prevention, 2015, SEX TRANSM DIS SURV; European Centre for Disease Prevention and Control (ECDC), 2015, SEX TRANSM INF EUR 2; Family Planning Association of Hong Kong, 2011, REP YOUTH SEX STUD; Farley TA, 2003, PREV MED, V36, P502, DOI 10.1016/S0091-7435(02)00058-0; Fenton KA, 2001, LANCET, V358, P1851, DOI 10.1016/S0140-6736(01)06886-6; Goulet V, 2010, SEX TRANSM INFECT, V86, P263, DOI 10.1136/sti.2009.038752; Ho KM, 2015, COMM DIS WATCH, V12, P107; Honey E, 2002, SEX TRANSM INFECT, V78, P406, DOI 10.1136/sti.78.6.406; Hong Kong Tourism Board, 2012, HONG KONG SIMPL BEST; Hong X., 2014, J DIAGN THER DERMATO, V21, P65, DOI 10.3969/j.issn.1674-8468.2014.01.023; Klavs I, 2004, SEX TRANSM INFECT, V80, P121, DOI 10.1136/sti.2003.005900; LeFevre ML, 2014, ANN INTERN MED, V161, P902, DOI 10.7326/M14-1981; Leung PHM, 2009, SEX TRANSM INFECT, V85, P27, DOI 10.1136/sti.2008.031880; Merlo J, 2006, J EPIDEMIOL COMMUN H, V60, P290, DOI 10.1136/jech.2004.029454; Miller WC, 2004, JAMA-J AM MED ASSOC, V291, P2229, DOI 10.1001/jama.291.18.2229; National Health and Family Planning Commission of the People's Republic of China, 2007, CHIN HLTH FAM PLANN; National Health and Family Planning Commission of the People's Republic of China, 2016, 2015 NAT NOT INF DIS; Newman L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143304; Owusu-Edusei K, 2013, SEX TRANSM DIS, V40, P197, DOI 10.1097/OLQ.0b013e318285c6d2; Parish WL, 2003, JAMA-J AM MED ASSOC, V289, P1265, DOI 10.1001/jama.289.10.1265; Redmond SM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115753; Scottish Executive, 2005, RESP RESP STRAT ACT; Sit A, 2016, HONG KONG STD AIDS U; Sonnenberg P, 2013, LANCET, V382, P1795, DOI 10.1016/S0140-6736(13)61947-9; US Preventive Services Task Force, 2007, ANN INTERN MED, V147, P128, DOI 10.7326/0003-4819-147-2-200707170-00172; van Bergen J, 2005, SEX TRANSM INFECT, V81, P17, DOI 10.1136/sti.2004.010173; Vivancos R, 2010, INT J INFECT DIS, V14, pE842, DOI 10.1016/j.ijid.2010.02.2251; Wong HTH, 2015, SEX TRANSM DIS, V42, P185, DOI 10.1097/OLQ.0000000000000257; Wong P, 2012, HONG KONG STD AIDS U; Wong WCW, 2011, J TRAVEL MED, V18, P1, DOI 10.1111/j.1708-8305.2010.00453.x; World Health Organization, 2015, TOOL STRENGTH STI SU; Zhang JJ, 2012, SEX TRANSM INFECT, V88, P272, DOI 10.1136/sextrans-2011-050163; Zhao YP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140426	43	21	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2017	12	2							e0172561	10.1371/journal.pone.0172561	http://dx.doi.org/10.1371/journal.pone.0172561			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5SK	28225805	Green Submitted, Green Accepted, gold, Green Published			2022-12-27	WOS:000394680900054
J	Harris, ML; Oldmeadow, C; Hure, A; Luu, J; Loxton, D; Attia, J				Harris, Melissa L.; Oldmeadow, Christopher; Hure, Alexis; Luu, Judy; Loxton, Deborah; Attia, John			Stress increases the risk of type 2 diabetes onset in women: A 12-year longitudinal study using causal modelling	PLOS ONE			English	Article							PERCEIVED STRESS; PSYCHOSOCIAL FACTORS; METABOLIC SYNDROME; MELLITUS; EXERCISE; JAPANESE; OBESITY; HEALTH; TRIALS	Background Type 2 diabetes is associated with significant morbidity and mortality. Modifiable risk factors have been found to contribute up to 60% of type 2 diabetes risk. However, type 2 diabetes continues to rise despite implementation of interventions based on traditional risk factors. There is a clear need to identify additional risk factors for chronic disease prevention. The aim of this study was to examine the relationship between perceived stress and type 2 diabetes onset, and partition the estimates into direct and indirect effects. Methods and findings Women born in 1946 -1951 (n = 12,844) completed surveys for the Australian Longitudinal Study on Women's Health in 1998, 2001, 2004, 2007 and 2010. The total causal effect was estimated using logistic regression and marginal structural modelling. Controlled direct effects were estimated through conditioning in the regression model. A graded association was found between perceived stress and all mediators in the multivariate time lag analyses. A significant association was found between hypertension, as well as physical activity and body mass index, and diabetes, but not smoking or diet quality. Moderate/high stress levels were associated with a 2.3-fold increase in the odds of diabetes three years later, for the total estimated effect. Results were only slightly attenuated when the direct and indirect effects of perceived stress on diabetes were partitioned, with the mediators only explaining 10-20% of the excess variation in diabetes. Conclusions Perceived stress is a strong risk factor for type 2 diabetes. The majority of the effect estimate of stress on diabetes risk is not mediated by the traditional risk factors of hypertension,physical activity, smoking, diet quality, and body mass index. This gives a new pathway for diabetes prevention trials and clinical practice.	[Harris, Melissa L.; Hure, Alexis; Loxton, Deborah] Univ Newcastle, Fac Hlth & Med, Res Ctr Generat Hlth & Ageing, Newcastle, NSW, Australia; [Oldmeadow, Christopher; Attia, John] Hunter Med Res Inst, Clin Res Design IT & Stat Support Unit, Newcastle, NSW, Australia; [Oldmeadow, Christopher; Hure, Alexis; Luu, Judy; Attia, John] Univ Newcastle, Sch Med & Publ Hlth, Fac Hlth & Med, Newcastle, NSW, Australia; [Luu, Judy; Attia, John] Hunter New England Hlth, John Hunter Hosp, Div Med, Newcastle, NSW, Australia	University of Newcastle; Hunter Medical Research Institute; University of Newcastle; University of Newcastle; John Hunter Hospital	Hure, A (corresponding author), Univ Newcastle, Fac Hlth & Med, Res Ctr Generat Hlth & Ageing, Newcastle, NSW, Australia.; Hure, A (corresponding author), Univ Newcastle, Sch Med & Publ Hlth, Fac Hlth & Med, Newcastle, NSW, Australia.	Alexis.Hure@newcastle.edu.au	Attia, John R/F-5376-2013	Attia, John R/0000-0001-9800-1308; Harris, Melissa/0000-0002-5733-9684; Oldmeadow, Christopher/0000-0001-6104-1322; Hure, Alexis/0000-0003-2225-0986	Australian Government Department of Health; John Hunter Hospital Charitable Trust	Australian Government Department of Health(Australian GovernmentDepartment of Health & Ageing); John Hunter Hospital Charitable Trust	This work uses data from the Australian Longitudinal Study on Women's Health, which is funded by the Australian Government Department of Health. This analysis was funded by a John Hunter Hospital Charitable Trust Grant received by MLH, JL, DL, and JA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2007, DIABETIC MED, V24, P451, DOI 10.1111/j.1464-5491.2007.02157.x; Barr E, 2006, AUSTR DIABETES OBESI; Beatty LJ, 2012, COMPLEMENT THER MED, V20, P61, DOI 10.1016/j.ctim.2011.09.008; Bell S, 2003, PSYCHOL HEALTH MED, V8, P343, DOI DOI 10.1080/1354850031000135786; Bell S, 2002, PSYCHOL HEALTH MED, V7, P189; Bergmann N, 2014, ENDOCR CONNECT, V3, pR55, DOI 10.1530/EC-14-0031; BJORNTORP P, 1991, J INTERN MED, V230, P195; Black PH, 2006, MED HYPOTHESES, V67, P879, DOI 10.1016/j.mehy.2006.04.008; Blumenthal JA, 1999, ARCH INTERN MED, V159, P2349, DOI 10.1001/archinte.159.19.2349; Brown WJ, 2000, AUST NZ J PUBL HEAL, V24, P520, DOI 10.1111/j.1467-842X.2000.tb00503.x; COHEN S, 1988, CLAR SYMP, P31; Collins CE, 2008, J AM COLL NUTR, V27, P146, DOI 10.1080/07315724.2008.10719686; Cosgrove MP, 2012, OCCUP MED-OXFORD, V62, P167, DOI 10.1093/occmed/kqs002; Dobson AJ, 2015, INT J EPIDEMIOL, V44, DOI 10.1093/ije/dyv110; Ferrannini E, 2004, DIABETES, V53, P160, DOI 10.2337/diabetes.53.1.160; Harris ML, 2013, ANN BEHAV MED, V46, P9, DOI 10.1007/s12160-013-9478-6; HARRIS MI, 1992, DIABETES CARE, V15, P815, DOI 10.2337/diacare.15.7.815; Hawkley LC, 2005, CAN PSYCHOL, V46, P115, DOI 10.1037/h0087015; Ismail K, 2004, LANCET, V363, P1589, DOI 10.1016/S0140-6736(04)16202-8; Jackson JM, 2013, J CLIN EPIDEMIOL, V66, P349, DOI 10.1016/j.jclinepi.2012.01.013; Kahle EB, 1996, INT J SPORTS MED, V17, P1, DOI 10.1055/s-2007-972799; Kato M, 2009, ENDOCR J, V56, P459, DOI 10.1507/endocrj.K09E-003; Kelly SJ, 2015, ANN REV PUBLIC HLTH; Li M, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005497; Magnavita N, 2014, RADIOL MED, V119, P142, DOI 10.1007/s11547-013-0329-0; Murea Mariana, 2012, Rev Diabet Stud, V9, P6, DOI 10.1900/RDS.2012.9.6; Novak M, 2013, DIABETIC MED, V30, pE8, DOI 10.1111/dme.12037; Padgett DA, 2003, TRENDS IMMUNOL, V24, P444, DOI 10.1016/S1471-4906(03)00173-X; Pickup JC, 2004, DIABETES CARE, V27, P813, DOI 10.2337/diacare.27.3.813; Richiardi L, 2013, INT J EPIDEMIOL, V42, P1511, DOI 10.1093/ije/dyt127; Roberts AL, 2015, JAMA PSYCHIAT, V72, P203, DOI 10.1001/jamapsychiatry.2014.2632; Strodl E, 2003, INT J BEHAV MED, V10, P205, DOI 10.1207/S15327558IJBM1003_02; Toshihiro M, 2008, DIABETIC MED, V25, P1211, DOI 10.1111/j.1464-5491.2008.02566.x; Twisk JWR, 2003, APPL LONGITUDINAL DA; Whiting DR, 2011, DIABETES RES CLIN PR, V94, P311, DOI 10.1016/j.diabres.2011.10.029; Willi C, 2007, JAMA-J AM MED ASSOC, V298, P2654, DOI 10.1001/jama.298.22.2654; Williams ED, 2013, ANN BEHAV MED, V46, P62, DOI 10.1007/s12160-013-9473-y	37	42	42	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2017	12	2							e172126	10.1371/journal.pone.0172126	http://dx.doi.org/10.1371/journal.pone.0172126			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL5QV	28222165	Green Submitted, Green Published, gold			2022-12-27	WOS:000394676800032
J	Hotti, H; Gopalacharyulu, P; Seppanen-Laakso, T; Rischer, H				Hotti, Hannu; Gopalacharyulu, Peddinti; Seppanen-Laakso, Tuulikki; Rischer, Heiko			Metabolite profiling of the carnivorous pitcher plants Darlingtonia and Sarracenia	PLOS ONE			English	Article							PURPUREA L.; PHYLOGENETIC-RELATIONSHIPS; POLYKETIDE SYNTHASES; INSECTIVOROUS PLANT; ANTITUMOR-ACTIVITY; TUMOR INHIBITORS; MEDICINAL-PLANT; AMINO-ACIDS; FLAVA; ALKALOIDS	Sarraceniaceae is a New World carnivorous plant family comprising three genera: Darlingtonia, Heliamphora, and Sarracenia. The plants occur in nutrient-poor environments and have developed insectivorous capability in order to supplement their nutrient uptake. Sarracenia flava contains the alkaloid coniine, otherwise only found in Conium maculatum, in which its biosynthesis has been studied, and several Aloe species. Its ecological role and biosynthetic origin in S. flava is speculative. The aim of the current research was to investigate the occurrence of coniine in Sarracenia and Darlingtonia and to identify common constituents of both genera, unique compounds for individual variants and floral scent chemicals. In this comprehensive metabolic profiling study, we looked for compound patterns that are associated with the taxonomy of Sarracenia species. In total, 57 different Sarracenia and D. californica accessions were used for metabolite content screening by gas chromatography-mass spectrometry. The resulting high-dimensional data were studied using a data mining approach. The two genera are characterized by a large number of metabolites and huge chemical diversity between different species. By applying feature selection for clustering and by integrating new biochemical data with existing phylogenetic data, we were able to demonstrate that the chemical composition of the species can be explained by their known classification. Although transcriptome analysis did not reveal a candidate gene for coniine biosynthesis, the use of a sensitive selected ion monitoring method enabled the detection of coniine in eight Sarracenia species, showing that it is more widespread in this genus than previously believed.	[Hotti, Hannu; Seppanen-Laakso, Tuulikki; Rischer, Heiko] VTT Tech Res Ctr Finland Ltd, Espoo, Finland; [Gopalacharyulu, Peddinti] Univ Helsinki, Inst Mol Med Finland FIMM, Helsinki, Finland	VTT Technical Research Center Finland; University of Helsinki	Rischer, H (corresponding author), VTT Tech Res Ctr Finland Ltd, Espoo, Finland.	heiko.rischer@vtt.fi	Rischer, Heiko/ABB-4681-2020; Peddinti, Gopal/G-4872-2016	Rischer, Heiko/0000-0002-8004-4526; Peddinti, Gopal/0000-0002-8767-968X; Hotti, Hannu/0000-0003-4180-4024	Finnish Doctoral Program in Plant Science; Societas pro Fauna et Flora Fennica; Etelasuomalaisten ylioppilaiden saatio; Oskar Oflunds Stiftelse; Otto A. Maim Foundation; VTT; Academy of Finland [138808, 265966]	Finnish Doctoral Program in Plant Science; Societas pro Fauna et Flora Fennica; Etelasuomalaisten ylioppilaiden saatio; Oskar Oflunds Stiftelse; Otto A. Maim Foundation; VTT; Academy of Finland(Academy of Finland)	This work was supported by the Finnish Doctoral Program in Plant Science, Societas pro Fauna et Flora Fennica, Etelasuomalaisten ylioppilaiden saatio, Oskar Oflunds Stiftelse, the Otto A. Maim Foundation (all to HH), VTT and the Academy of Finland (decision number 138808 to HR, and 265966 to PG). VTT provided support in the form of salaries for authors [HH, TS-L, HR], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section. The other funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, R LANG ENV STAT COMP; [Anonymous], [No title captured]; Austin MB, 2003, NAT PROD REP, V20, P79, DOI 10.1039/b100917f; Bayer RJ, 1996, SYST BOT, V21, P121, DOI 10.2307/2419743; BORGKARLSON AK, 1994, PHYTOCHEMISTRY, V35, P111, DOI 10.1016/S0031-9422(00)90518-1; Buchbauer G, 1995, FLAVOUR FRAG J, V10, P221, DOI 10.1002/ffj.2730100316; BURGER BV, 1988, J HIGH RES CHROMATOG, V11, P496, DOI 10.1002/jhrc.1240110613; Butler JL, 2007, FUNCT ECOL, V21, P835, DOI 10.1111/j.1365-2435.2007.01307.x; Cieniak C, 2015, J PHARM PHARM SCI, V18, P484, DOI 10.18433/J35W27; CIPOLLINI DF, 1994, AM MIDL NAT, V131, P374, DOI 10.2307/2426265; Deppe JL, 2000, AM MIDL NAT, V144, P123, DOI 10.1674/0003-0031(2000)144[0123:DVOSAI]2.0.CO;2; Dress WJ, 1997, AM J BOT, V84, P1701, DOI 10.2307/2446468; DRING JV, 1984, PLANTA MED, V50, P442, DOI 10.1055/s-2007-969761; Durak D, 2007, FOLIA BIOL-KRAKOW, V55, P133, DOI 10.3409/173491607781492551; Ellison AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039291; Franzios G, 1997, J AGR FOOD CHEM, V45, P2690, DOI 10.1021/jf960685f; Hakkinen ST, 2005, J EXP BOT, V56, P2611, DOI 10.1093/jxb/eri253; Harris CS, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-245; Hotti H, 2015, FEBS J, V282, P4141, DOI 10.1111/febs.13410; Hu JF, 2009, HELV CHIM ACTA, V92, P273, DOI 10.1002/hlca.200800248; Janssen E, 1995, J CHEM ECOL, V21, P1947, DOI 10.1007/BF02033854; Jurgens A, 2009, FUNCT ECOL, V23, P875, DOI 10.1111/j.1365-2435.2009.01626.x; JUNGHANS H, 1993, PLANT MOL BIOL, V22, P239, DOI 10.1007/BF00014932; Kam TS, 2004, PHYTOCHEMISTRY, V65, P603, DOI 10.1016/j.phytochem.2003.12.014; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Knudsen JT, 2006, BOT REV, V72, P1, DOI 10.1663/0006-8101(2006)72[1:DADOFS]2.0.CO;2; Kreuzwieser J, 2014, J EXP BOT, V65, P755, DOI 10.1093/jxb/ert455; McPherson S., 2011, SARRACENIACEAE N AM; McPherson S., 2011, SARRACENIACEAE S AM; MILES DH, 1975, PHYTOCHEMISTRY, V14, P845; MILES DH, 1974, J PHARM SCI, V63, P613, DOI 10.1002/jps.2600630427; MILES DH, 1976, J AM CHEM SOC, V98, P1569, DOI 10.1021/ja00422a048; MILES DH, 1976, J PHARM SCI, V65, P284, DOI 10.1002/jps.2600650226; MODY NV, 1976, EXPERIENTIA, V32, P829, DOI 10.1007/BF02003710; Muhammad A, 2013, PHYTOCHEMISTRY, V94, P238, DOI 10.1016/j.phytochem.2013.05.015; NASH RJ, 1992, PLANTA MED, V58, P84, DOI 10.1055/s-2006-961396; Newman T, 2000, BIOCHEM SYST ECOL, V28, P193, DOI 10.1016/S0305-1978(99)00051-4; Neyland Ray, 2006, Madrono, V53, P223, DOI 10.3120/0024-9637(2006)53[223:SROSIF]2.0.CO;2; Roberts MF, 1998, ALKALOIDS, P109; Schlauer J, 2005, ACTA BOT GALLICA, V152, P187, DOI 10.1080/12538078.2005.10515469; Sheridan PM, 1998, PLANT SCI, V135, P11, DOI 10.1016/S0168-9452(98)00065-X; Sheridan PM, 2001, HORTSCIENCE, V36, P384, DOI 10.21273/HORTSCI.36.2.384; Srivastava A, 2011, DNA RES, V18, P253, DOI 10.1093/dnares/dsr014; Stephens JD, 2015, MOL PHYLOGENET EVOL, V85, P76, DOI 10.1016/j.ympev.2015.01.015; Syed Z, 2009, P NATL ACAD SCI USA, V106, P18803, DOI 10.1073/pnas.0906932106; WILSON LA, 1992, J AGR FOOD CHEM, V40, P1362, DOI 10.1021/jf00020a015; Witten DM, 2010, J AM STAT ASSOC, V105, P713, DOI 10.1198/jasa.2010.tm09415; [No title captured]	48	12	13	2	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2017	12	2							e0171078	10.1371/journal.pone.0171078	http://dx.doi.org/10.1371/journal.pone.0171078			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5QV	28222171	gold, Green Published, Green Submitted			2022-12-27	WOS:000394676800006
J	Ramirez-Ponce, A; Garfias-Lozano, G; Contreras-Ramos, A				Ramirez-Ponce, Andres; Garfias-Lozano, Gabriela; Contreras-Ramos, Atilano			The nature of allometry in an exaggerated trait: The postocular flange in Platyneuromus Weele (Insecta: Megaloptera)	PLOS ONE			English	Article							SEXUAL SIZE DIMORPHISM; STATIC ALLOMETRY; EVOLUTION; SELECTION; ORNAMENTS; SHAPE; CONSTRAINTS; COLEOPTERA; ORIGIN	The origin and function of exaggerated traits exhibited by a great number of species with sexual dimorphism remain largely unexplored. The usual model considered as the evolutionary mechanism for the development of these structures is sexual selection. The nature of growth of the postocular flange (POF) in three species of the dobsonfly genus Platyneuromus (Megaloptera, Corydalidae, Corydalinae) is analyzed to explore sexual size dimorphism and allometric scaling. Results involve positive allometry of POF in males of two species, and negative allometry in males of one species, in general with a female-biased sexual dimorphism. We suggest an ancestral condition of dual incipient ornamentation in Platyneuromus, with a subsequent departure of size and shape of POF in males, triggered by sexual selection. Different sexual selection intensities may explain the parallel or divergent growth of POF within the scheme of dual ornamentation. Empirical behavioral data as well as a phylogenetic framework are necessary to clarify possible causes of phenotypic development, time of origin, and evolution of the POF.	[Ramirez-Ponce, Andres] UNAM, Inst Biol, Lab Reg Biodiversidad & Cult Tejidos Vegetales, Catedrat CONACYT, Santa Cruz Tlaxcala, Tlaxcala, Mexico; [Garfias-Lozano, Gabriela] Univ Nacl Autonoma Mexico, Fac Ciencias, Biol, Mexico City, DF, Mexico; [Contreras-Ramos, Atilano] Univ Nacl Autonoma Mexico, Inst Biol, Dept Zool, Mexico City, DF, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Contreras-Ramos, A (corresponding author), Univ Nacl Autonoma Mexico, Inst Biol, Dept Zool, Mexico City, DF, Mexico.	acontreras@ib.unam.mx	Contreras-Ramos, Atilano/AAE-5966-2021; Ramírez-Ponce, Andrés/N-8965-2017	Contreras-Ramos, Atilano/0000-0001-8044-1348; Ramírez-Ponce, Andrés/0000-0003-4742-7397	Consejo Nacional de Ciencia y Tecnologia-Mexico, Apoyos Complementarios para el Establecimiento y Consolidacion de Laboratorios Nacionales [CONACYT 2015-2]; Nacional de Biodiversidad, Instituto de Biologia, UNAM [261145]; Programa Catedras CONACYT	Consejo Nacional de Ciencia y Tecnologia-Mexico, Apoyos Complementarios para el Establecimiento y Consolidacion de Laboratorios Nacionales; Nacional de Biodiversidad, Instituto de Biologia, UNAM; Programa Catedras CONACYT	This work received support from Consejo Nacional de Ciencia y Tecnologia-Mexico, Apoyos Complementarios para el Establecimiento y Consolidacion de Laboratorios Nacionales CONACYT 2015-2, Solicitud 261145 Laboratorio Nacional de Biodiversidad, Instituto de Biologia, UNAM, institutional project (conacyt.gob.mx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Cristina Mayorga Martinez for help with access to the National Insect Collection (CNIN), Instituto de Biologia-UNAM, and Susana Guzman Gomez for technical support with stereomicroscope photos. Andres Ramirez thanks Programa Catedras CONACYT for funding for laboratory equipment and general support.	Abouheif E, 1997, AM NAT, V149, P540, DOI 10.1086/286004; Baker RH, 2001, EVOLUTION, V55, P1373; Berglund A, 1996, BIOL J LINN SOC, V58, P385, DOI 10.1111/j.1095-8312.1996.tb01442.x; Berns C. M., 2013, SEXUAL DIMORPHISM, P1, DOI DOI 10.5772/55154; Blanckenhorn WU, 2007, AM NAT, V169, P245, DOI 10.1086/510597; Bonduriansky R, 2003, EVOLUTION, V57, P2450, DOI 10.1111/j.0014-3820.2003.tb01490.x; Bonduriansky R, 2007, EVOLUTION, V61, P838, DOI 10.1111/j.1558-5646.2007.00081.x; Calabuig CP, 2013, ZOOLOGIA-CURITIBA, V30, P424, DOI 10.1590/S1984-46702013000400008; Contreras-Ramos A, 1999, ENTOMOL NEWS, V110, P125; Contreras-Ramos A, 1998, T SAY PUBLICATIONS E; Emlen DJ, 2006, HEREDITY, V97, P179, DOI 10.1038/sj.hdy.6800868; Emlen DJ, 2000, ANNU REV ENTOMOL, V45, P661, DOI 10.1146/annurev.ento.45.1.661; Emlen DJ, 2008, ANNU REV ECOL EVOL S, V39, P387, DOI 10.1146/annurev.ecolsys.39.110707.173502; Fairbairn DJ, 1997, ANNU REV ECOL SYST, V28, P659, DOI 10.1146/annurev.ecolsys.28.1.659; Fairbairn DJ, 2007, SEX SIZE GENDER ROLE; Gates TA, 2016, NAT COMMUN NATURE PU, V7, P1; Gidaszewski NA, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-110; GLORIOSO MJ, 1981, SYST ENTOMOL, V6, P253, DOI 10.1111/j.1365-3113.1981.tb00440.x; GLORIOSO MJ, 1984, P BIOL SOC WASH, V97, P601; GOULD SJ, 1974, EVOLUTION, V28, P191, DOI 10.1111/j.1558-5646.1974.tb00740.x; GOULD SJ, 1966, BIOL REV, V41, P587, DOI 10.1111/j.1469-185X.1966.tb01624.x; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hanley RS, 2001, BIOL J LINN SOC, V72, P451, DOI 10.1111/j.1095-8312.2001.tb01330.x; Hone DWE, 2012, LETHAIA, V45, P139, DOI 10.1111/j.1502-3931.2011.00300.x; Hormiga G, 2000, SYST BIOL, V49, P435, DOI 10.1080/10635159950127330; Huxley J., 1932, PROBLEMS RELATIVE GR; Kawano K, 2000, ANN ENTOMOL SOC AM, V93, P198, DOI 10.1603/0013-8746(2000)093[0198:GAAITS]2.0.CO;2; Kerkhoff AJ, 2009, J THEOR BIOL, V257, P519, DOI 10.1016/j.jtbi.2008.12.026; Klingenberg CP, 2016, DEV GENES EVOL, V226, P113, DOI 10.1007/s00427-016-0539-2; Klingenberg CP, 2011, MOL ECOL RESOUR, V11, P353, DOI 10.1111/j.1755-0998.2010.02924.x; KLINGENBERG CP, 1992, AM NAT, V140, P601, DOI 10.1086/285430; Kodric-Brown A, 2006, P NATL ACAD SCI USA, V103, P8733, DOI 10.1073/pnas.0602994103; Kunte K, 2007, FUNCT ECOL, V21, P982, DOI 10.1111/j.1365-2435.2007.01299.x; Lavine L, 2016, ANNU REV ENTOMOL, V60, P1; Liu XY, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0247; Marlowe MH, 2015, PEERJ, V3, DOI 10.7717/peerj.1123; Mascaro J, 2014, BIOL J LINN SOC, V111, P230, DOI 10.1111/bij.12177; Matsuo Y, 2005, J INSECT BEHAV, V18, P465, DOI 10.1007/s10905-005-5605-y; McCullough EL, 2016, TRENDS ECOL EVOL, V31, P742, DOI 10.1016/j.tree.2016.07.004; Painting CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082467; Pelabon C, 2014, ANN NY ACAD SCI, V1320, P58, DOI 10.1111/nyas.12470; Raia P, 2016, AM NAT, V186, P1; Randau M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072868; Rohlf FJ, 2015, HYSTRIX, V26, P9, DOI 10.4404/hystrix-26.1-11264; Sanger TJ, 2013, EVOLUTION, V67, P2180, DOI 10.1111/evo.12100; Sheets H. D., 2014, COORDGEN8; Shingleton AW, 2007, BIOESSAYS, V29, P536, DOI 10.1002/bies.20584; Stern DL, 1999, DEVELOPMENT, V126, P1091; Tobias JA, 2012, PHILOS T R SOC B, V367, P2274, DOI 10.1098/rstb.2011.0280; Tomkins JL, 2010, AM NAT, V176, P141, DOI 10.1086/653001; Vencl FV, 2004, INTEGR COMP BIOL, V44, P242, DOI 10.1093/icb/44.3.242; Voje KL, 2014, EVOLUTION, V68, P866, DOI 10.1111/evo.12312; Wilkinson Gerald S., 1997, P310, DOI 10.1017/CBO9780511721946.019; Wu H, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0086085, 10.1371/journal.pone.0091856]	54	10	10	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2017	12	2							e0172388	10.1371/journal.pone.0172388	http://dx.doi.org/10.1371/journal.pone.0172388			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BI	28212437	Green Submitted, Green Published, gold			2022-12-27	WOS:000394424700041
J	Springer, DJ; Mohan, R; Heitman, J				Springer, Deborah J.; Mohan, Rajinikanth; Heitman, Joseph			Plants promote mating and dispersal of the human pathogenic fungus Cryptococcus	PLOS ONE			English	Article							CANDIDA-ALBICANS; NEOFORMANS; OUTBREAK; DIVERSITY; COCCIDIOIDOMYCOSIS; FILOBASIDIELLA; BLASTOMYCOSIS; RHIZOSPHERE; POPULATION; INFECTIONS	Infections due to Cryptococcus are a leading cause of fungal infections worldwide and are acquired as a result of environmental exposure to desiccated yeast or spores. The ability of Cryptococcus to grow, mate, and produce infectious propagules in association with plants is important for the maintenance of the genetic diversity and virulence factors important for infection of animals and humans. In the Western United States and Canada, Cryptococcus has been associated with conifers and tree species other than Eucalyptus; however, to date Cryptococcus has only been studied on live Arabidopsis thaliana, Eucalyptus sp., and Terminalia catappa ( almond) seedlings. Previous research has demonstrated the ability of Cryptococcus to colonize live plants, leaves, and vasculature. We investigated the ability of Cryptococcus to grow on live seedlings of the angiosperms, A. thaliana, Eucalyptus camaldulensis, Colophospermum mopane, and the gymnosperms, Pseudotsuga menziesii ( Douglas fir), and Tsuga heterophylla ( Western hemlock). We observed a broad-range ability of Cryptococcus to colonize both traditional infection models as well as newly tested conifer species. Furthermore, C. neoformans, C. deneoformans, C. gattii ( VGI), C. deuterogattii ( VGII) and C. bacillisporus ( VGIII) were able to colonize live plant leaves and needles but also undergo filamentation and mating on agar seeded with plant materials or in saprobic association with dead plant materials. The ability of Cryptococcus to grow and undergo filamentation and reproduction in saprobic association with both angiosperms and gymnosperms highlights an important role of plant debris in the sexual cycle and exposure to infectious propagules. This study highlights the broad importance of plants ( and plant debris) as the ecological niche and reservoirs of infectious propagules of Cryptococcus in the environment.	[Springer, Deborah J.; Heitman, Joseph] Duke Univ, Dept Mol Genet & Microbiol, Durham, NC 27708 USA; [Mohan, Rajinikanth] Hamilton Coll, Dept Biol, Clinton, NY 13323 USA; [Heitman, Joseph] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Heitman, Joseph] Duke Univ, Med Ctr, Dept Pharmacol Canc Biol, Durham, NC USA; [Springer, Deborah J.] Novozymes North Amer INC, Durham, NC 27713 USA	Duke University; Hamilton College; Duke University; Duke University	Springer, DJ; Heitman, J (corresponding author), Duke Univ, Dept Mol Genet & Microbiol, Durham, NC 27708 USA.; Heitman, J (corresponding author), Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA.; Heitman, J (corresponding author), Duke Univ, Med Ctr, Dept Pharmacol Canc Biol, Durham, NC USA.; Springer, DJ (corresponding author), Novozymes North Amer INC, Durham, NC 27713 USA.	dbs@novozymes.com; heitm001@duke.edu	Heitman, Joseph/ABC-6006-2021		NIAID NIH HHS [R01 AI050113, R37 AI039115] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050113, R37AI039115] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Barker BM, 2007, ANN NY ACAD SCI, V1111, P147, DOI 10.1196/annals.1406.040; Bennett JW, 2009, MED MYCOL, V47, pS5, DOI 10.1080/13693780802712515; Botes A, 2009, MICROB ECOL, V57, P757, DOI 10.1007/s00248-008-9452-1; Brown GD, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004404; Byrnes EJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002205; Cairns L, 2000, CLIN INFECT DIS, V30, P61, DOI 10.1086/313602; Chamany S, 2004, PEDIATR INFECT DIS J, V23, P909, DOI 10.1097/01.inf.0000141738.60845.da; COLES FB, 1992, AM J EPIDEMIOL, V136, P475, DOI 10.1093/oxfordjournals.aje.a116521; Durden FM, 1997, SEMIN CUTAN MED SURG, V16, P200, DOI 10.1016/S1085-5629(97)80043-0; ERKE KH, 1976, J BACTERIOL, V128, P445, DOI 10.1128/JB.128.1.445-455.1976; Fanfair RN, 2012, NEW ENGL J MED, V367, P2214, DOI 10.1056/NEJMoa1204781; Ferreira-Paim K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108633; Fisher FS, 2007, ANN NY ACAD SCI, V1111, P47, DOI 10.1196/annals.1406.031; Gomes NCM, 2003, APPL ENVIRON MICROB, V69, P3758, DOI 10.1128/AEM.69.7.3758-3766.2003; Hagen F, 2015, FUNGAL GENET BIOL, V78, P16, DOI 10.1016/j.fgb.2015.02.009; Hebecker B, 2014, EXPERT REV ANTI-INFE, V12, P867, DOI 10.1586/14787210.2014.916210; HOWARD DH, 1984, ZBL BAKT-INT J MED M, V257, P219, DOI 10.1016/S0174-3031(84)80075-X; Huerfano Sandra, 2001, Revista Iberoamericana de Micologia, V18, P131; Johnson LB, 1998, MYCOSES, V41, P277, DOI 10.1111/j.1439-0507.1998.tb00338.x; Khawcharoenporn T, 2007, INFECTION, V35, P51, DOI 10.1007/s15010-007-6142-8; Kidd SE, 2007, EMERG INFECT DIS, V13, P51, DOI 10.3201/eid1301.060823; KLEIN BS, 1986, NEW ENGL J MED, V314, P529, DOI 10.1056/NEJM198602273140901; Kwon-Chung KJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003743; KWONCHUNG KJ, 1975, MYCOLOGIA, V67, P1197, DOI 10.2307/3758842; KWONCHUNG KJ, 1976, MYCOLOGIA, V68, P942, DOI 10.2307/3758813; KWONCHUNG KJ, 1978, INT J SYST BACTERIOL, V28, P616, DOI 10.1099/00207713-28-4-616; Li WJ, 2012, G3-GENES GENOM GENET, V2, P83, DOI 10.1534/g3.111.001255; Lin X, 2007, PLOS GENET, V3, P1975, DOI 10.1371/journal.pgen.0030186; Makandar R, 2010, MOL PLANT MICROBE IN, V23, P861, DOI 10.1094/MPMI-23-7-0861; Nielsen K, 2007, EUKARYOT CELL, V6, P949, DOI 10.1128/EC.00097-07; O'Gorman Celine M., 2011, Fungal Biology Reviews, V25, P151, DOI 10.1016/j.fbr.2011.07.002; Pappagianis D, 1988, Curr Top Med Mycol, V2, P199; Pfaller MA, 2004, J CLIN MICROBIOL, V42, P4419, DOI 10.1128/JCM.42.10.4419-4431.2004; Phadke SS, 2013, EUKARYOT CELL, V12, P1155, DOI 10.1128/EC.00147-13; Powel MS, 2012, J CLIN MICROBIOL, V50, P1125, DOI 10.1128/JCM.05678-11; Ren P, 2006, EUKARYOT CELL, V5, P1065, DOI 10.1128/EC.00009-06; Rhoden SA, 2013, GENET MOL RES, V12, P935, DOI 10.4238/2013.April.2.10; Saul N, 2008, EUKARYOT CELL, V7, P727, DOI 10.1128/EC.00020-08; Shahid M, 2008, GENOME, V51, P272, DOI 10.1139/G08-004; Shinde S M, 2004, Indian Pediatr, V41, P1162; Smith RM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088875; Springer D. J., 2009, BIOMENDICAL SCI, P317; Springer DJ, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004285; Springer DJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010978; Vieira MLA, 2012, CAN J MICROBIOL, V58, P54, DOI [10.1139/w11-105, 10.1139/W11-105]; Warpeha KM, 2013, APPL ENVIRON MICROB, V79, P2979, DOI 10.1128/AEM.03697-12; Xue CY, 2007, CELL HOST MICROBE, V1, P263, DOI 10.1016/j.chom.2007.05.005; Zachow C, 2009, ISME J, V3, P79, DOI 10.1038/ismej.2008.87	48	22	22	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2017	12	2							e0171695	10.1371/journal.pone.0171695	http://dx.doi.org/10.1371/journal.pone.0171695			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BI	28212396	Green Published, Green Submitted, gold			2022-12-27	WOS:000394424700010
J	Breskin, A; Adimora, AA; Westreich, D				Breskin, Alexander; Adimora, Adaora A.; Westreich, Daniel			Women and HIV in the United States	PLOS ONE			English	Article							INFECTION	Background The demographic and geographic characteristics of the HIV epidemic in the US has changed substantially since the disease emerged, with women in the South experiencing a particularly high HIV incidence. In this study, we identified and described counties in the US in which the prevalence of HIV is particularly high in women compared to men. Methods Using data from AIDSVu, a public dataset of HIV cases in the US in 2012, we categorized counties by their decile of the ratio of female to male HIV prevalence. The demographic and socioeconomic characteristics of counties in the highest decile were compared to those of counties in the lower deciles. Results Most of the counties in the highest decile were located in the Deep South. These counties had a lower median income, higher percentage of people in poverty, and lower percentage of people with a high school education. Additionally, people with HIV in these counties were more likely to be non-Hispanic black. Conclusions Counties with the highest ratios of female-to-male HIV prevalence are concentrated in the Southern US, and residents of these counties tend to be of lower socioeconomic status. Identifying and describing these counties is important for developing public health interventions.	[Breskin, Alexander; Adimora, Adaora A.; Westreich, Daniel] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27514 USA; [Adimora, Adaora A.] Univ N Carolina, Dept Med, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Westreich, D (corresponding author), Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27514 USA.	djw@unc.edu	Breskin, Alexander/L-6375-2019	Breskin, Alexander/0000-0001-5568-2510; Westreich, Daniel/0000-0003-3069-1650	National Institutes of Health [U01AI069918, DP2HD084070]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI103390, P30AI050410] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding for this study was provided by the National Institutes of Health grants U01AI069918 (M) and DP2HD084070 (DW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2015, EM U ROLL SCH PUBL H; Anselin L, 2006, GEOGR ANAL, V38, P5, DOI 10.1111/j.0016-7363.2005.00671.x; CDC, 2012, EST HIV INC US 2007, V17; CLAYTON D, 1987, BIOMETRICS, V43, P671, DOI 10.2307/2532003; CRESSIE N, 1992, GEOGR ANAL, V24, P75; CURRAN JW, 1988, SCIENCE, V239, P610, DOI 10.1126/science.3340847; Leyland AH, 2005, STAT METHODS MED RES, V14, P17, DOI 10.1191/0962280205sm387oa; Meditz AL, 2011, J INFECT DIS, V203, P442, DOI 10.1093/infdis/jiq085; Prejean J, 2013, J COMMUN HEALTH, V38, P414, DOI 10.1007/s10900-012-9633-1; Sullivan PS, 2013, MED 20 C; Sutton M, 2010, J RURAL HEALTH, V26, P240, DOI 10.1111/j.1748-0361.2010.00284.x; The World Bank, 2016, MEASURING INEQUALITY; United States Census Bureau, 2013, COUNT CHAR DAT ANN C	13	19	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0172367	10.1371/journal.pone.0172367	http://dx.doi.org/10.1371/journal.pone.0172367			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL2BG	28207818	Green Published, gold, Green Submitted			2022-12-27	WOS:000394424500126
J	Lewitowicz, P; Gluszek, S; Koziel, D; Horecka-Lewitowicz, A; Chrapek, M; Wolak, P; Klusek, J; Nasierowska-Guttmejer, A				Lewitowicz, Piotr; Gluszek, Stanislaw; Koziel, Dorota; Horecka-Lewitowicz, Agata; Chrapek, Magdalena; Wolak, Przemyslaw; Klusek, Justyna; Nasierowska-Guttmejer, Anna			Conventional colon adenomas harbor various disturbances in microsatellite stability and contain micro-serrated foci with microsatellite instability	PLOS ONE			English	Article							COLORECTAL-CANCER; PATHWAY; KRAS; BRAF	Introduction Colorectal cancer belongs to the most frequent occurring malignancies. A prediction of the clinical outcome and appropriate choice of neoadjuvant chemotherapy needs personalized insight to the main driving pathways. Because most CRCs have polyps as progenitor lesions, studying the pathways driving to adenomagenesis is no less important. Goals Our purpose was the evaluation of microsatellite stability status within conventional colon adenomas and also beta-catenin, BRAFV600E and p53 contribution. Material and methods The cohort included 101 cases of typical colon adenomas with high grade epithelial dysplasia according to WHO. An immunohistochemistry method was used for the depiction of the expression of targeted proteins, as also their heterogeneity. Results Generally, we noted a 10% frequency of MSI events where MSI-H reached a 5% share occurred within the left colon and rectal polyps. beta-catenin nuclear overexpression was noted with a 70% frequency and p53 with close to a 24% frequency. In addition, we found a presence of micro-serration foci more often within tubular adenomas, where focal MSI took place more often. Our results indicate that MSI events occur more often than had been theorized earlier. It results in tumour heterogeneity, more complex underlying pathways and finally ontogenetic molecular-diversity of tumours besides similar occurring histopathological features.	[Lewitowicz, Piotr; Nasierowska-Guttmejer, Anna] Jan Kochanowski Univ Humanities & Sci, Fac Med & Hlth Sci, Dept Pathol, Kielce, Poland; [Gluszek, Stanislaw; Koziel, Dorota; Klusek, Justyna] Jan Kochanowski Univ Humanities & Sci, Fac Med & Hlth Sci, Dept Surg & Surg Nursing, Kielce, Poland; [Horecka-Lewitowicz, Agata] Jan Kochanowski Univ Humanities & Sci, Fac Med & Hlth Sci, Dept Publ Hlth, Kielce, Poland; [Chrapek, Magdalena] Jan Kochanowski Univ Humanities & Sci, Fac Math & Nat Sci, Inst Math, Dept Probabil Theory & Stat, Kielce, Poland; [Wolak, Przemyslaw] Jan Kochanowski Univ Humanities & Sci, Fac Med & Hlth Sci, Dept Anat, Kielce, Poland	Jan Kochanowski University; Jan Kochanowski University; Jan Kochanowski University; Jan Kochanowski University; Jan Kochanowski University	Lewitowicz, P (corresponding author), Jan Kochanowski Univ Humanities & Sci, Fac Med & Hlth Sci, Dept Pathol, Kielce, Poland.	lewitowicz@gmail.com	KLUSEK, JUSTYNA/AFL-6606-2022; Wolak, Przemyslaw Karol/ABC-6924-2021; Stanisław, Gluszek/S-3303-2019; KLUSEK, JUSTYNA/AAG-6738-2022; Lewitowicz, Piotr/O-7137-2015	KLUSEK, JUSTYNA/0000-0002-1098-8919; Wolak, Przemyslaw Karol/0000-0003-4450-5011; Stanisław, Gluszek/0000-0001-7752-0459; KLUSEK, JUSTYNA/0000-0002-1098-8919; Horecka-Lewitowicz, Agata/0000-0002-7711-4220; Nasierowska-Guttmejer, Anna/0000-0001-7182-5841; Lewitowicz, Piotr/0000-0002-5443-7975; Koziel, Dorota/0000-0001-8114-1814; Chrapek, Magdalena/0000-0003-2480-6124	Jan Kochanowski University in Kielce, Poland [615 515]	Jan Kochanowski University in Kielce, Poland	The study has been completely financed by the Statute Scientific Found (No. 615 515) of Jan Kochanowski University in Kielce, Poland.; This work has been financially supported by the Statute Scientific Grant (No 615 515) of the Jan Kochanowski University in Kielce, Poland.	Bosman FT, 2014, POL J PATHOL, V65, P257, DOI 10.5114/PJP.2014.48094; Jorissen RN, 2015, BRIT J CANCER, V113, P979, DOI 10.1038/bjc.2015.296; Kolos M, 2015, POL J PATHOL, V66, P109, DOI 10.5114/PJP.2015.53003; Kozlowska M, 2015, MED STUD, V31, P307, DOI 10.5114/ms.2015.56675; Laghi L, 2012, DIGEST DIS, V30, P304, DOI 10.1159/000337003; Lemieux E, 2015, ONCOGENE, V34, P4914, DOI 10.1038/onc.2014.416; Lewitowicz P, 2015, POL J PATHOL, V65, P276; Li L, 2013, HUM PATHOL, V44, P1079, DOI 10.1016/j.humpath.2012.09.013; LYNCH HT, 1988, GASTROENTEROL CLIN N, V17, P679; Markowitz SD, 2009, NEW ENGL J MED, V361, P2449, DOI 10.1056/NEJMra0804588; Muto Y, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-466; Nielsen M, 2011, CRIT REV ONCOL HEMAT, V79, P1, DOI 10.1016/j.critrevonc.2010.05.011; Pino MS, 2011, EXPERT REV GASTROENT, V5, P385, DOI [10.1586/EGH.11.25, 10.1586/egh.11.25]; Rashid M, 2016, J PATHOL, V238, P98, DOI 10.1002/path.4643; Setaffy L, 2015, POL J PATHOL, V66, P203, DOI 10.5114/PJP.2015.54953; Silva AL, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-891; Tian S, 2013, GUT, V62, P540, DOI 10.1136/gutjnl-2012-302423; Wojcik P, 2010, POL J PATHOL, V61, P23; Zaanan A, 2011, CELL ONCOL, V34, P155, DOI 10.1007/s13402-011-0024-x; Zhou J, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003762	20	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0172381	10.1371/journal.pone.0172381	http://dx.doi.org/10.1371/journal.pone.0172381			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5VB	28234922	Green Published, Green Submitted, gold			2022-12-27	WOS:000394688200075
J	Yan, P; Pan, JX; Zhang, WJ; Shi, JF; Chen, XP; Cui, ZL				Yan, Peng; Pan, Junxiao; Zhang, Wenjie; Shi, Junfang; Chen, Xinping; Cui, Zhenling			A high plant density reduces the ability of maize to use soil nitrogen	PLOS ONE			English	Article							GRAIN-YIELD; USE EFFICIENCY; SUMMER MAIZE; DRY-MATTER; MANAGEMENT; HYBRIDS; ACCUMULATION; STRESS; GROWTH	Understanding the physiological changes associated with high grain yield and high N use efficiency (NUE) is important when increasing the plant density and N rate to develop optimal agronomic management. We tested the hypothesis that high plant densities resulting in crowding stress reduce the ability of plants to use the N supply post-silking, thus decreasing the grain yield and NUE. In 2013 and 2014, a field experiment, with five N-application rates and three plant densities (6.0, 7.5, and 9.0 plants m(-2)), was conducted in the North China Plain (NCP). The calculated maximum grain yield and agronomic use efficiency (AEN) at a density of 7.5 plants m(-2) were 12.4 Mg ha(-1) and 39.3 kg kg(-1), respectively, which were significantly higher than the values obtained at densities of 6.0 (11.3 Mg ha(-1) and 30.2 kg kg(-1)) and 9.0 plant m(-2) (11.7 Mg ha(-1) and 27.8 kg kg(-1)). A high plant density of 9.0 plants m(-2) decreased the post-silking N accumulation, leaf N concentration and net photosynthesis, which reduced the post-silking dry matter production, resulting in a low yield and NUE. Although a relatively low grain yield was observed at a density of 9.0 plants m(-2), the optimal N rate increased from 150 to 186 kg N ha(-1) at a density of 7.5 plants m(-2). These results indicate that high plant densities with crowding stress reduce the ability of plants to use soil N during the post-silking period, and high rate of N fertilizer was needed to increase grain yield. We conclude that selecting the appropriate plant density combined with optimal N management could increase grain yields and the NUE in the NCP.	[Yan, Peng; Pan, Junxiao; Zhang, Wenjie; Shi, Junfang; Chen, Xinping; Cui, Zhenling] China Agr Univ, Ctr Resources Environm & Food Secur, Key Lab Plant Soil Interact, Minist Educ, Beijing, Peoples R China; [Yan, Peng] Chinese Acad Agr Sci, Tea Res Inst, Key Lab Tea Biol & Resources Utilizat, Minist Agr, Hangzhou, Zhejiang, Peoples R China	China Agricultural University; Chinese Academy of Agricultural Sciences; Tea Research Institute, CAAS; Ministry of Agriculture & Rural Affairs	Cui, ZL (corresponding author), China Agr Univ, Ctr Resources Environm & Food Secur, Key Lab Plant Soil Interact, Minist Educ, Beijing, Peoples R China.	cuizl@cau.edu.cn						Antonietta M, 2014, FIELD CROP RES, V155, P111, DOI 10.1016/j.fcr.2013.09.016; BEAUCHAMP EG, 1976, AGRON J, V68, P418, DOI 10.2134/agronj1976.00021962006800020055x; Below F.E., 2002, HDB PLANT CROP PHYSL, P385; Borras L, 2004, FIELD CROP RES, V86, P131, DOI 10.1016/j.fcr.2003.08.002; CARLONE MR, 1987, CROP SCI, V27, P465, DOI 10.2135/cropsci1987.0011183X002700030008x; CERRATO ME, 1990, AGRON J, V82, P138, DOI 10.2134/agronj1990.00021962008200010030x; Chen GP, 1995, MAIZE SCI, V3, P26; [陈国平 CHEN Guoping], 2008, [玉米科学, Maize Science], V16, P1; Chen XP, 2011, P NATL ACAD SCI USA, V108, P6399, DOI 10.1073/pnas.1101419108; Ciampitti IA, 2011, FIELD CROP RES, V121, P2, DOI 10.1016/j.fcr.2010.10.009; Cui Z L., 2005, THESIS CHINA AGR U B; Cui ZL, 2008, AGRON J, V100, P517, DOI 10.2134/agronj2007.0194; Ding L, 2005, FIELD CROP RES, V93, P108, DOI 10.1016/j.fcr.2004.09.008; Duvick DN, 2005, ADV AGRON, V86, P83, DOI 10.1016/S0065-2113(05)86002-X; Echarte L., 2000, FIELD CROPS RES, V68, P1, DOI DOI 10.1016/S0378-4290(00)00101-5; Horowitz W., 1970, OFFICIAL METHODS ANA, P17; Jin LB, 2012, FIELD CROP RES, V134, P30, DOI 10.1016/j.fcr.2012.04.008; Lee EA, 2007, CROP SCI, V47, pS202, DOI 10.2135/cropsci2007.04.0010IPBS; Li ChaoHai, 2001, Scientia Agricultura Sinica, V34, P311; Liu JL, 2014, AGRON J, V106, P390, DOI 10.2134/agronj2013.0404; Maddonni GA, 1998, FIELD CROP RES, V56, P257, DOI 10.1016/S0378-4290(97)00094-4; Meng QF, 2013, FIELD CROP RES, V143, P91, DOI 10.1016/j.fcr.2012.09.023; Mueller SM, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00053; RUSSELL WA, 1991, ADV AGRON, V46, P245; SAS Institute, 1998, SAS US GUID STAT; Shiferaw B, 2011, FOOD SECUR, V3, P475, DOI 10.1007/s12571-011-0153-0; Tokatlidis IS, 2011, FIELD CROP RES, V120, P345, DOI 10.1016/j.fcr.2010.11.006; Tokatlidis IS, 2004, FIELD CROP RES, V88, P103, DOI 10.1016/j.fcr.2003.11.013; TOLLENAAR M, 1991, CROP SCI, V31, P119, DOI 10.2135/cropsci1991.0011183X003100010029x; Tollenaar M, 2002, FIELD CROP RES, V75, P161, DOI 10.1016/S0378-4290(02)00024-2; Tollenaar M, 1997, AGRON J, V89, P239, DOI 10.2134/agronj1997.00021962008900020014x; Tollenaar M, 1999, CROP SCI, V39, P1597, DOI 10.2135/cropsci1999.3961597x; Tollenaar M, 2006, AGRON J, V98, P930, DOI 10.2134/agronj2005.0336; Vos J, 2005, FIELD CROP RES, V93, P64, DOI 10.1016/j.fcr.2004.09.013; Worku M, 2007, CROP SCI, V47, P519, DOI 10.2135/cropsci2005.05.0070; Yan P, 2016, J AGR SCI-CAMBRIDGE, V154, P978, DOI 10.1017/S0021859615000854; Yan P, 2014, FIELD CROP RES, V166, P38, DOI 10.1016/j.fcr.2014.06.012; ZHANG JW, 2010, WORKSH HIGH YIELD HI	38	33	39	4	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0172717	10.1371/journal.pone.0172717	http://dx.doi.org/10.1371/journal.pone.0172717			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5VB	28234970	Green Submitted, Green Published, gold			2022-12-27	WOS:000394688200121
J	Chlapek, P; Zitterbart, K; Kren, L; Filipova, L; Sterba, J; Veselska, R				Chlapek, Petr; Zitterbart, Karel; Kren, Leos; Filipova, Lenka; Sterba, Jaroslav; Veselska, Renata			Uniformity under in vitro conditions: Changes in the phenotype of cancer cell lines derived from different medulloblastoma subgroups	PLOS ONE			English	Article							PEDIATRIC MEDULLOBLASTOMA; CHILDHOOD MEDULLOBLASTOMA; GLIOBLASTOMA-MULTIFORME; FILAMIN; MODELS; TUMORS; STRATIFICATION; RESISTANCE; INHIBITION; KINASE	Medulloblastoma comprises four main subgroups (WNT, SHH, Group 3 and Group 4) originally defined by transcriptional profiling. In primary medulloblastoma tissues, these groups are thought to be distinguishable using the immunohistochemical detection of beta-catenin, filamin A, GAB1 and YAP1 protein markers. To investigate the utility of these markers for in vitro studies using medulloblastoma cell lines, immunoblotting and indirect immunofluorescence were employed for the detection of beta-catenin, filamin A, GAB1 and YAP1 in both DAOY and D283 Med reference cell lines and the panel of six medulloblastoma cell lines derived in our laboratory from the primary tumor tissues of known molecular subgroups. Immunohistochemical detection of these markers was performed on formalin-fixed paraffin-embedded tissue of the matching primary tumors. The results revealed substantial divergences between the primary tumor tissues and matching cell lines in the immunoreactivity pattern of medulloblastoma-subgroup-specific protein markers. Regardless of the molecular subgroup of the primary tumor, all six patient-derived medulloblastoma cell lines exhibited a uniform phenotype: immunofluorescence showed the nuclear localization of YAP1, accompanied by strong cytoplasmic positivity for beta-catenin and filamin A, as well as weak positivity for GAB1. The same immunoreactivity pattern was also found in both DAOY and D283 Med reference medulloblastoma cell lines. Therefore, we can conclude that various medulloblastoma cell lines tend to exhibit the same characteristics of protein marker expression under standard in vitro conditions. Such a finding emphasizes the importance of the analyses of primary tumors in clinically oriented medulloblastoma research and the urgent need to develop in vitro models of improved clinical relevance, such as 3D cultures and organotypic slice cultures.	[Chlapek, Petr; Zitterbart, Karel; Filipova, Lenka; Veselska, Renata] Masaryk Univ, Dept Expt Biol, Lab Tumor Biol, Fac Sci, Brno, Czech Republic; [Chlapek, Petr; Sterba, Jaroslav; Veselska, Renata] Masaryk Univ, St Annes Univ Hosp, Int Clin Res Ctr, Brno, Czech Republic; [Chlapek, Petr; Zitterbart, Karel; Kren, Leos; Sterba, Jaroslav; Veselska, Renata] Masaryk Univ, Fac Med, Brno, Czech Republic; [Zitterbart, Karel; Sterba, Jaroslav; Veselska, Renata] Masaryk Univ, Univ Hosp Brno, Dept Pediat Oncol, Brno, Czech Republic; [Kren, Leos] Masaryk Univ, Univ Hosp Brno, Dept Pathol, Brno, Czech Republic	Masaryk University Brno; Masaryk University Brno; St Anne's University Hospital Brno (FNUSA-ICRC); Masaryk University Brno; Masaryk University Brno; University Hospital Brno; Masaryk University Brno; University Hospital Brno	Veselska, R (corresponding author), Masaryk Univ, Dept Expt Biol, Lab Tumor Biol, Fac Sci, Brno, Czech Republic.; Veselska, R (corresponding author), Masaryk Univ, St Annes Univ Hosp, Int Clin Res Ctr, Brno, Czech Republic.; Veselska, R (corresponding author), Masaryk Univ, Fac Med, Brno, Czech Republic.; Veselska, R (corresponding author), Masaryk Univ, Univ Hosp Brno, Dept Pediat Oncol, Brno, Czech Republic.	veselska@sci.muni.cz	Chlapek, Petr/AAD-2657-2022; Veselska, Renata/L-7661-2016; /AAA-2208-2022	/0000-0002-7274-897X; Veselska, Renata/0000-0002-0048-9913; Sterba, Jaroslav/0000-0002-8482-8352	European Regional Development FundProject FNUSA-ICRC [CZ.1.05/1.1.00/02.0123]; National Program of Sustainability IIProject Translational Medicine [LQ1605]	European Regional Development FundProject FNUSA-ICRC; National Program of Sustainability IIProject Translational Medicine	This study was supported by grants from the European Regional Development Fund-Project FNUSA-ICRC (No. CZ.1.05/1.1.00/02.0123) and by the National Program of Sustainability II-Project Translational Medicine LQ1605. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anglesio MS, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0072162, 10.1371/annotation/ffcaf179-872f-470b-8bb6-f06d8ba6d03a]; Baldassarre M, 2012, J CELL SCI, V125, P3858, DOI 10.1242/jcs.104018; Boora GK, 2015, CANCER GENET-NY, V208, P374, DOI 10.1016/j.cancergen.2015.04.002; Dixit D, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.179; Domcke S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3126; Dubuc AM, 2013, ACTA NEUROPATHOL, V125, P373, DOI 10.1007/s00401-012-1070-9; Eberhart CG, 2002, CANCER-AM CANCER SOC, V94, P552, DOI 10.1002/cncr.10189; Ecker J, 2015, ACTA NEUROPATHOL COM, V3, DOI 10.1186/s40478-015-0201-7; Ellison DW, 2011, ACTA NEUROPATHOL, V121, P381, DOI 10.1007/s00401-011-0800-8; Felici A, 2010, J CELL BIOCHEM, V111, P310, DOI 10.1002/jcb.22695; Gazdar AF, 2010, LUNG CANCER, V68, P309, DOI 10.1016/j.lungcan.2009.12.005; Gillet JP, 2011, P NATL ACAD SCI USA, V108, P18708, DOI 10.1073/pnas.1111840108; Goschzik T, 2015, NEUROPATH APPL NEURO, V41, P135, DOI 10.1111/nan.12161; Holliday DL, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2889; Ivanov DP, 2016, J BIOTECHNOL, V236, P10, DOI 10.1016/j.jbiotec.2016.07.028; Jacob F, 2014, J OVARIAN RES, V7, DOI 10.1186/1757-2215-7-60; Jones DTW, 2012, NATURE, V488, P100, DOI 10.1038/nature11284; Kaur K, 2016, BRAIN PATHOL, V26, P334, DOI 10.1111/bpa.12293; Kim H, 2008, EXP CELL RES, V314, P834, DOI 10.1016/j.yexcr.2007.11.022; Kim H, 2011, FEBS LETT, V585, P18, DOI 10.1016/j.febslet.2010.11.033; Kim H, 2010, AM J PHYSIOL-CELL PH, V298, pC221, DOI 10.1152/ajpcell.00323.2009; Kool M, 2012, ACTA NEUROPATHOL, V123, P473, DOI 10.1007/s00401-012-0958-8; Liang LS, 2015, ONCOTARGET, V6, P38881, DOI 10.18632/oncotarget.6195; Lin CY, 2016, NATURE, V530, P57, DOI 10.1038/nature16546; Louis DN, 2016, ACTA NEUROPATHOL, V131, P803, DOI 10.1007/s00401-016-1545-1; Northcott PA, 2012, NAT REV CANCER, V12, P818, DOI 10.1038/nrc3410; Northcott PA, 2012, NATURE, V488, P49, DOI 10.1038/nature11327; Pambid MR, 2014, PEDIATR BLOOD CANCER, V61, P107, DOI 10.1002/pbc.24675; Pilli T, 2009, THYROID, V19, P1333, DOI 10.1089/thy.2009.0195; Pizer BL, 2009, BRIT J NEUROSURG, V23, P364, DOI 10.1080/02688690903121807; Ramaswamy V, 2016, ACTA NEUROPATHOL, V131, P821, DOI 10.1007/s00401-016-1569-6; Rutkowski S, 2005, NEW ENGL J MED, V352, P978, DOI 10.1056/NEJMoa042176; Schwalbe E, 2016, NEURO-ONCOLOGY, V18, P102; Schwalbe EC, 2013, ACTA NEUROPATHOL, V125, P359, DOI 10.1007/s00401-012-1077-2; Shao QQ, 2016, PATHOL ONCOL RES, V22, P245, DOI 10.1007/s12253-015-9980-1; Stossel TP, 2001, NAT REV MOL CELL BIO, V2, P138, DOI 10.1038/35052082; Tilghman RW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012905; Triscott J, 2013, CANCER RES, V73, P6734, DOI 10.1158/0008-5472.CAN-12-4331; van Staveren WCG, 2009, BBA-REV CANCER, V1795, P92, DOI 10.1016/j.bbcan.2008.12.004; Veselska R, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-32; Vogel TW, 2005, CLIN CANCER RES, V11, P3624, DOI 10.1158/1078-0432.CCR-04-2115; Xu JY, 2015, J CELL BIOCHEM, V116, P218, DOI 10.1002/jcb.24976; Yang ZQ, 2012, MOL CELL, V47, P469, DOI 10.1016/j.molcel.2012.06.037	43	1	1	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2017	12	2							e0172552	10.1371/journal.pone.0172552	http://dx.doi.org/10.1371/journal.pone.0172552			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5SX	28231263	Green Published, gold, Green Submitted			2022-12-27	WOS:000394682400055
J	Hollenbach, M; Thonig, A; Pohl, S; Ripoll, C; Michel, M; Zipprich, A				Hollenbach, Marcus; Thonig, Antje; Pohl, Sabine; Ripoll, Cristina; Michel, Maurice; Zipprich, Alexander			Expression of glyoxalase-I is reduced in cirrhotic livers: A possible mechanism in the development of cirrhosis	PLOS ONE			English	Article							ADVANCED GLYCATION ENDPRODUCTS; OXIDATIVE STRESS; END-PRODUCTS; DISEASE; RECEPTOR; CELLS; PATHWAYS; ALCOHOL; LENS	Background High concentrations of methylglyoxal (MGO) cause cytotoxiticy via formation of advanced glycation endproducts (AGEs) and inflammation. MGO is detoxificated enzymatically by glyoxalase-I (Glo-I). The aim of this study was to analyze the role of Glo-I during the development of cirrhosis. Methods In primary hepatocytes, hepatic stellate cells (pHSC) and sinusoidal endothelial cells (pLSEC) from rats with early (CCl4 8wk) and advanced cirrhosis (CCl4 12wk) expression and activity of Glo-I were determined and compared to control. LPS stimulation (24h; 100ng/ml) of HSC was conducted in absence or presence of the partial Glo-I inhibitor ethyl pyruvate (EP) and the specific Glo-I inhibitor BrBzGSHCp(2). MGO, inflammatory and fibrotic markers were measured by ELISA and Western blot. Additional rats were treated with CCl4 +/- EP 40mg/kg b.w. i.p. from wk 8-12 and analyzed with sirius red staining and Western blot. Results Expression of Glo-I was significantly reduced in cirrhosis in whole liver and primary liver cells accompanied by elevated levels of MGO. Activity of Glo-I was reduced in cirrhotic pHSC and pLSEC. LPS induced increases of TNF-alpha, Nrf2, collagen-I, alpha-SMA, NF-kappa B and pERK of HSC were blunted by EP and BrBzGSHCp2. Treatment with EP during development of cirrhosis significantly decreased the amount of fibrosis (12wk CCl4: 33.3 +/- 7.3%; EP wk 8-12: 20.7 +/- 6.2%; p<0.001) as well as levels of alpha-SMA, TGF-beta and NF-kappa B in vivo. Conclusions Our results show the importance of Glo-I as major detoxifying enzyme for MGO in cirrhosis. The reduced expression of Glo-I in cirrhosis demonstrates a possible explanation for increased inflammatory injury and suggests a "vicious circle" in liver disease. Blunting of the Glo-I activity decrease the amount of fibrosis in established cirrhosis and constitutes a novel target for antifibrotic therapy.	[Hollenbach, Marcus; Thonig, Antje; Pohl, Sabine; Ripoll, Cristina; Michel, Maurice; Zipprich, Alexander] Martin Luther Univ Halle Wittenberg, Dept Internal Med 1, Halle, Germany	Martin Luther University Halle Wittenberg	Zipprich, A (corresponding author), Martin Luther Univ Halle Wittenberg, Dept Internal Med 1, Halle, Germany.	alexander.zipprich@medizin.uni-halle.de	Ripoll, Cristina/AAF-6497-2019; Hollenbach, Marcus/ABF-7452-2021	Ripoll, Cristina/0000-0002-9704-4741				Barbezier N, 2014, ANN BIOL CLIN-PARIS, V72, P669, DOI 10.1684/abc.2014.1010; Basta G, 2011, LIVER TRANSPLANT, V17, P633, DOI 10.1002/lt.22306; Beier JI, 2010, BIOL CHEM, V391, P1249, DOI 10.1515/BC.2010.137; CHOMCZYNSKI P, 1995, BIOTECHNIQUES, V19, P942; Cubero FJ, 2009, SEMIN LIVER DIS, V29, P211, DOI 10.1055/s-0029-1214376; Engelbrecht B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065195; Fehrenbach H, 2001, HEPATOLOGY, V34, P943, DOI 10.1053/jhep.2001.28788; FRIEDMAN SL, 1987, ANAL BIOCHEM, V161, P207, DOI 10.1016/0003-2697(87)90673-7; Hanssen NMJ, 2014, EUR HEART J, V35, P1137, DOI 10.1093/eurheartj/eht402; Hollenbach M, 2008, BIOCHEM PHARMACOL, V76, P631, DOI 10.1016/j.bcp.2008.06.006; Laga M, 2007, BIOCHEM PHARMACOL, V74, P579, DOI 10.1016/j.bcp.2007.05.026; Lattouf R, 2014, J HISTOCHEM CYTOCHEM, V62, P751, DOI 10.1369/0022155414545787; Lo TW, 1994, J BIOL CHEM, V269, P32299; Mannervik B., 1980, ENZYMATIC BASIS DETO, VVolume 2, P263; Palsamy P, 2014, FREE RADICAL BIO MED, V72, P134, DOI 10.1016/j.freeradbiomed.2014.04.010; Piperi C, 2015, INT J BIOCHEM CELL B, V60, P197, DOI 10.1016/j.biocel.2015.01.009; Rabbani N, 2015, BIOCHEM BIOPH RES CO, V458, P221, DOI 10.1016/j.bbrc.2015.01.140; Ribaux P, 2002, ENDOCRINOLOGY, V143, P3766, DOI 10.1210/en.2002-220304; Sakamoto H, 2002, J BIOL CHEM, V277, P45770, DOI 10.1074/jbc.M207485200; Salim S, 2011, BRAIN RES, V1404, P63, DOI 10.1016/j.brainres.2011.06.024; Seglen P O, 1976, Methods Cell Biol, V13, P29, DOI 10.1016/S0091-679X(08)61797-5; Seth D, 2011, J GASTROEN HEPATOL, V26, P1089, DOI 10.1111/j.1440-1746.2011.06756.x; Shamsi FA, 2000, EXP EYE RES, V70, P369, DOI 10.1006/exer.1999.0800; Thornalley PJ, 1996, BIOCHEM PHARMACOL, V51, P1365, DOI 10.1016/0006-2952(96)00059-7; THORNALLEY PJ, 1990, BIOCHEM J, V269, P1; Xue MZ, 2012, BIOCHEM J, V443, P213, DOI 10.1042/BJ20111648; Zima T, 2005, ALCOHOL CLIN EXP RES, V29, p110S, DOI 10.1097/01.alc.0000189288.30358.4b; Zipprich A, 2008, J HEPATOL, V49, P739, DOI 10.1016/j.jhep.2008.06.027; Zuin A, 2005, J BIOL CHEM, V280, P36708, DOI 10.1074/jbc.M508400200	29	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2017	12	2							e0171260	10.1371/journal.pone.0171260	http://dx.doi.org/10.1371/journal.pone.0171260			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5SX	28231326	Green Published, gold, Green Submitted			2022-12-27	WOS:000394682400010
J	Ye, ZL; Lu, HL; Su, Q; Guo, WQ; Dai, WR; Li, HQ; Yang, HF; Li, L				Ye, Ziliang; Lu, Haili; Su, Qiang; Guo, Wenqin; Dai, Weiran; Li, Hongqing; Yang, Huafeng; Li, Lang			Effect of high-dose rosuvastatin loading before percutaneous coronary intervention in Chinese patients with acute coronary syndrome: A systematic review and meta-analysis	PLOS ONE			English	Review							STATIN THERAPY; UNSTABLE ANGINA; ATORVASTATIN; INSIGHTS	Background Acute coronary syndrome (ACS) is an important disease threatening human life and health. Many studies have shown that the loading dose of atorvastatin can significantly improve the prognosis of patients with ACS, and reduce the mortality. However, this conclusion is not consistent. Thus, we aimed to evaluate the effect of high-dose rosuvastatin loading before percutaneous coronary intervention (PCI) in Chinese patients with ACS using a meta-analysis based on a systematic review of published articles. Methods We systematically reviewed published studies, evaluating the effect of high-dose rosuvastatin loading before percutaneous coronary intervention in Chinese patients with ACS. The retrieval time is limited from inception to 2 November 2016, and the retrieved databases included PubMed, Embase, the Cochrane Library, Web of Science, CBM, CNKI, the VIP database and the Wang Fang database. Two researchers independently assessed the quality of the included studies and then extracted the data. Stata 11.0 was used for data analysis. Results In total, 11 articles, which included 802 patients, were included in our meta-analysis. Among these patients, 398 patients were in the high-dose group (20 mg/day) and 404 patients were in the conventional dose group (10 mg/day). Meta-analysis results showed that compared with the conventional dose group: 1) The loading dose of rosuvastatin can significantly reduce the hs-CRP level after PCI, including at 24 hours (SMD = -0.65, 95% CI -0.84 similar to -0.47, P = 0.000), 48 hours (SMD = -0.40, 95%CI -0.68 similar to -0.11, P = 0.006), and four weeks (SMD = -1.64, 95%CI -2.01 similar to -1.26, P = 0.000). 2) The loading dose of rosuvastatin can significantly reduce the levels of LDL-C and cTnT, including the level of LDL-C at 30 d after PCI (SMD = -0.89, 95%CI -1.10 similar to -0.69, P = 0.000), and the level of cTnT at 24 h after PCI (SMD = -1.93, 95%CI -2.28 similar to -1.59, P = 0.000), and increase the level of HDL-C at 48 h after PCI (SMD = 0.61, 95%CI 0.34 similar to 0.88, P = 0.000). 3) The loading dose of rosuvastatin can significantly reduce the levels of TG and TC, including the level of TG at 30 d after PCI (SMD = -0.94, 95%CI -1.17 similar to -0.71, P = 0.000), the level of TC at 48 h after PCI (SMD = -0.35, 95%CI -0.68 similar to -0.01, P = 0.043), and the level of TC at 30 d after PCI (SMD = -0.77, 95%CI -0.98 similar to -0.56, P = 0.000). Conclusions Our systematic review and meta-analysis showed that, compared with the conventional dose, the loading dose of rosuvastatin was more beneficial to patients with ACS in China and is suitable for clinical application. Due to the limitations of the quality and quantity of included articles, this conclusion still needs to be confirmed by multicenter clinical trials.	[Ye, Ziliang; Su, Qiang; Guo, Wenqin; Dai, Weiran; Li, Hongqing; Yang, Huafeng; Li, Lang] Guangxi Med Univ, Dept Cardiol, Affiliated Hosp 1, Nanning, Guangxi, Peoples R China; [Lu, Haili] Guangxi Med Univ, Affiliated Dent Hosp, Dept Orthodont, Nanning, Guangxi, Peoples R China	Guangxi Medical University; Guangxi Medical University	Li, L (corresponding author), Guangxi Med Univ, Dept Cardiol, Affiliated Hosp 1, Nanning, Guangxi, Peoples R China.	2108539080@qq.com	Zi, Ye/GWM-3932-2022; LI, LI QING/GRR-8855-2022; li, li/AAT-2097-2020; Guo, Wenqin/GPK-1723-2022; Li, Li/AEM-3636-2022; li, li/GPX-3938-2022; li, li/HII-4157-2022; LI, LI/GVS-5344-2022	Guo, Wenqin/0000-0002-3142-4928				Akinkuolie AO, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.003822; Badimon JJ, 1999, THROMB HAEMOSTASIS, V82, P997; Basra SS, 2014, CARDIOL CLIN, V32, P353, DOI 10.1016/j.ccl.2014.04.010; Benjo AM, 2013, CATHETERIZATION CARD, V85, P53; Braun OO, 2015, THROMB RES, V135, P26, DOI 10.1016/j.thromres.2014.10.016; Canducci F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042283; Cannon CP, 2015, NEW ENGL J MED, V372, P2387, DOI 10.1056/NEJMoa1410489; Cay S, 2010, CARDIOVASC DRUG THER, V24, P41, DOI 10.1007/s10557-010-6224-1; Chen QiYing, 2016, Journal of Tropical Medicine (Guangzhou), V16, P506; Clearfield MB, 2006, TRIALS, V7, DOI 10.1186/1745-6215-7-35; Gao R, 2008, HEART, V94, P554, DOI 10.1136/hrt.2007.119750; Genereux P, 2014, EUROINTERVENTION J E, V11, pA407; Geri G, 2015, CIRC-CARDIOVASC INTE, V8, DOI 10.1161/CIRCINTERVENTIONS.114.002303; Goto S, 2014, CLIN CARDIOL, V37, P178, DOI 10.1002/clc.22233; Grani C, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-007442; Grech ED, 2003, BRIT MED J, V326, P1259, DOI 10.1136/bmj.326.7401.1259; Helbing T, 2010, ARTERIOSCL THROM VAS, V30, P554, DOI 10.1161/ATVBAHA.109.201087; Jiao Yungen, 2014, CHINESE J NEW DRUGS, P608; Kedev S, 2014, EUR HEART J SUPPL, V16, pA33, DOI 10.1093/eurheartj/sut009; Kim LK, 2014, AM J CARDIOL, V114, P1003, DOI 10.1016/j.amjcard.2014.07.013; Li Hua, 2014, MODERN PREVENTIVE ME, V41, P180; Liao Bihong, 2013, COMP EFFICACY DIFFER; Liao Bihong, 2013, COMP EFFECTS DIFFERE; Lim HS, 2014, INT J CARDIOL, V177, P66, DOI 10.1016/j.ijcard.2014.09.010; Link E, 2008, NEW ENGL J MED, V359, P789, DOI 10.1056/NEJMoa0801936; Liu YH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085323; Luo Jun, 2012, EFFECT MECH HIGH DOS; Nallamothu B K, 2011, BOND U COLL CAP PEN, P31; Navarese EP, 2014, AM J CARDIOL, V113, P1753, DOI 10.1016/j.amjcard.2014.02.034; Pandie S, 2015, JACC-CARDIOVASC INTE, V8, P505, DOI 10.1016/j.jcin.2014.11.017; Park Jong-Seon, 2010, Korean Journal of Internal Medicine, V25, P27, DOI 10.3904/kjim.2010.25.1.27; Sahlen A, 2015, EUROPEAN HEART J CAR, V2; Saku K, 2011, CIRC J, V75, P1493, DOI 10.1253/circj.CJ-10-1281; Shehata M, 2015, TEX HEART I J, V42, P528, DOI 10.14503/THIJ-14-4891; Shi Yibao, 2013, J MED U ANHUI, V48, P1118; Sun M., 2014, THESIS QUFU NORMAL U; Torres M, 2007, CLIN GERIATR MED, V23, P307, DOI 10.1016/j.cger.2007.01.007; Tsimikas S, 2009, J AM COLL CARDIOL, V54, P2164, DOI 10.1016/j.jacc.2009.08.014; Vergallo R, 2014, AM HEART J, V167, P59, DOI 10.1016/j.ahj.2013.10.011; Weitz JI, 2014, THROMB HAEMOSTASIS, V112, P924, DOI 10.1160/TH14-03-0265; Wu Haibo, 2013, EFFECT INTENSIVE THE; Xu Chongze, 2013, CHINESE J MED, V20, P9; Yang Yi, 2015, EFFECTS DIFFERENT DO; Yun KH, 2011, INT J CARDIOL, V146, P68, DOI 10.1016/j.ijcard.2010.04.052; Zhou X H, 2008, STAT METHODS DIAGNOS, P396; Zou Yong, 2012, EFFECT ATORVASTATIN	46	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2017	12	2							e0171682	10.1371/journal.pone.0171682	http://dx.doi.org/10.1371/journal.pone.0171682			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5SX	28231287	gold, Green Published, Green Submitted			2022-12-27	WOS:000394682400015
J	Donges, SC; D'Amico, JM; Butler, JE; Taylor, JL				Donges, Siobhan C.; D'Amico, Jessica M.; Butler, Jane E.; Taylor, Janet L.			The effects of cervical transcutaneous spinal direct current stimulation on motor pathways supplying the upper limb in humans	PLOS ONE			English	Article							SOLEUS H-REFLEX; POST-ACTIVATION DEPRESSION; DC STIMULATION; INDUCED PLASTICITY; CORD-INJURY; EVOKED-POTENTIALS; CORTEX; PAIN; MODULATION; EXCITABILITY	Non-invasive, weak direct current stimulation can induce changes in excitability of underlying neural tissue. Many studies have used transcranial direct current stimulation to induce changes in the brain, however more recently a number of studies have used transcutaneous spinal direct current stimulation to induce changes in the spinal cord. This study further characterises the effects following cervical transcutaneous spinal direct current stimulation on motor pathways supplying the upper limb. In Study 1, on two separate days, participants (n = 12, 5 F) received 20 minutes of either real or sham direct current stimulation at 3 mA through electrodes placed in an anterior-posterior configuration over the neck (anode anterior). Biceps brachii, flexor carpi radialis and first dorsal interosseous responses to transcranial magnetic stimulation (motor evoked potentials) and cervicomedullary stimulation (cervicomedullary motor evoked potentials) were measured before and after real or sham stimulation. In Study 2, on two separate days, participants (n = 12, 7 F) received either real or sham direct current stimulation in the same way as for Study 1. Before and after real or sham stimulation, median nerve stimulation elicited M waves and H reflexes in the flexor carpi radialis. H-reflex recruitment curves and homosynaptic depression of the H reflex were assessed. Results show that the effects of real and sham direct current stimulation did not differ for motor evoked potentials or cervicomedullary motor evoked potentials for any muscle, nor for H-reflex recruitment curve parameters or homosynaptic depression. Cervical transcutaneous spinal direct current stimulation with the parameters described here does not modify motor responses to corticospinal stimulation nor does it modify H reflexes of the upper limb. These results are important for the emerging field of transcutaneous spinal direct current stimulation.	[Donges, Siobhan C.; D'Amico, Jessica M.; Butler, Jane E.; Taylor, Janet L.] Neurosci Res Australia, Randwick, NSW, Australia; [Donges, Siobhan C.; Butler, Jane E.; Taylor, Janet L.] Univ New South Wales, Sydney, NSW, Australia	Neuroscience Research Australia; University of New South Wales Sydney	Taylor, JL (corresponding author), Neurosci Res Australia, Barker St, Randwick, NSW, Australia.	j.taylor@neura.edu.au	Butler, Jane E/D-4186-2011; Taylor, Janet/C-9667-2011	Butler, Jane/0000-0002-5834-8152; D'Amico, Jessica/0000-0002-3487-0712; Taylor, Janet/0000-0001-8976-5162	National Health and Medical Research Council of Australia [1055084]; Australian Postgraduate Award; University of New South Wales research excellence scholarship; National Health and Medical Research Council Research Fellowships	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Postgraduate Award(Australian Government); University of New South Wales research excellence scholarship; National Health and Medical Research Council Research Fellowships(National Health and Medical Research Council (NHMRC) of Australia)	This study was supported by a Program Grant (1055084) from the National Health and Medical Research Council of Australia. SCD holds an Australian Postgraduate Award and a University of New South Wales research excellence scholarship. JLT and JEB hold National Health and Medical Research Council Research Fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar J, 2011, J PHYSIOL-LONDON, V589, P4981, DOI 10.1113/jphysiol.2011.214189; Ahmed Z, 2014, PHYSIOL REP, V2, DOI 10.14814/phy2.12157; Ahmed Z, 2014, J NEUROSCI, V34, P1701, DOI 10.1523/JNEUROSCI.4445-13.2014; Ahmed Z, 2013, J NEUROSCI, V33, P14949, DOI 10.1523/JNEUROSCI.2793-13.2013; Ahmed Z, 2013, J NEUROSCI, V33, P4935, DOI 10.1523/JNEUROSCI.4930-12.2013; Ahmed Z, 2012, J APPL PHYSIOL, V112, P1576, DOI 10.1152/japplphysiol.00967.2011; Ahmed Z, 2011, J APPL PHYSIOL, V110, P1414, DOI 10.1152/japplphysiol.01390.2010; Batsikadze G, 2013, J PHYSIOL-LONDON, V591, P1987, DOI 10.1113/jphysiol.2012.249730; Bocci T, 2015, NEUROMODULATION, V18, P686, DOI 10.1111/ner.12298; Bocci T, 2015, J NEUROPHYSIOL, V114, P440, DOI 10.1152/jn.00490.2014; Bolzoni F, 2015, J PHYSIOL-LONDON, V593, P947, DOI 10.1113/jphysiol.2014.285940; Boudreau S, 2007, PAIN, V132, P169, DOI 10.1016/j.pain.2007.07.019; Bunday KL, 2012, CURR BIOL, V22, P2355, DOI 10.1016/j.cub.2012.10.046; Cabral ME, 2015, NEUROREPORT, V26, P618, DOI 10.1097/WNR.0000000000000397; Carroll TJ, 2001, J NEUROSCI METH, V112, P193, DOI 10.1016/S0165-0270(01)00468-X; Christie AD, 2005, J CLIN NEUROPHYSIOL, V22, P204; Cogiamanian F., 2012, FRONT PSYCHIAT, V3; Cogiamanian F, 2011, PAIN, V152, P370, DOI 10.1016/j.pain.2010.10.041; Cogiamanian F, 2008, CLIN NEUROPHYSIOL, V119, P2636, DOI 10.1016/j.clinph.2008.07.249; CREUTZFELDT O, 1962, EXP NEUROL, V5, P436, DOI 10.1016/0014-4886(62)90056-0; CRONE C, 1989, EXP BRAIN RES, V78, P28, DOI 10.1007/bf00230683; D'Amico JM, 2013, J NEUROPHYSIOL, V109, P1485, DOI 10.1152/jn.00822.2012; Fanelli D, 2012, SCIENTOMETRICS, V90, P891, DOI 10.1007/s11192-011-0494-7; Fanelli D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010271; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Fitzpatrick SC, 2016, CLIN NEUROPHYSIOL, V127, P724, DOI 10.1016/j.clinph.2015.03.013; Heide AC, 2014, BRAIN STIMUL, V7, P636, DOI 10.1016/j.brs.2014.06.008; Hubli M, 2013, CLIN NEUROPHYSIOL, V124, P1187, DOI 10.1016/j.clinph.2012.11.021; Hultborn H, 1996, EXP BRAIN RES, V108, P450; Ingham D, 2011, EUR J PAIN, V15, P1028, DOI 10.1016/j.ejpain.2011.04.006; Kabakov AY, 2012, J NEUROPHYSIOL, V107, P1881, DOI 10.1152/jn.00715.2011; Klimstra M, 2008, EXP BRAIN RES, V186, P93, DOI 10.1007/s00221-007-1207-6; Kohn AF, 1997, EXP BRAIN RES, V116, P375, DOI 10.1007/PL00005765; Lamy JC, 2013, J NEUROPHYSIOL, V110, P109, DOI 10.1152/jn.00116.2013; Lamy JC, 2012, J NEUROPHYSIOL, V108, P906, DOI 10.1152/jn.10898.2011; Le Pera D, 2001, CLIN NEUROPHYSIOL, V112, P1633, DOI 10.1016/S1388-2457(01)00631-9; Lim CY, 2011, NEUROREPORT, V22, P819, DOI 10.1097/WNR.0b013e32834b939d; Lundbye-Jensen J, 2008, J APPL PHYSIOL, V105, P139, DOI 10.1152/japplphysiol.00687.2007; Martin PG, 2008, J PHYSIOL-LONDON, V586, P1277, DOI 10.1113/jphysiol.2007.140426; Matosin N, 2014, DIS MODEL MECH, V7, P171, DOI 10.1242/dmm.015123; Mavromatis N, 2016, NEUROSCIENCE, V330, P403, DOI 10.1016/j.neuroscience.2016.06.008; Meyer-Friessem CH, 2015, NEUROSCI LETT, V589, P153, DOI 10.1016/j.neulet.2015.01.029; Nardone R, 2015, NEUROMODULATION, V18, P580, DOI 10.1111/ner.12332; Nierat MC, 2014, J NEUROSCI, V34, P14420, DOI 10.1523/JNEUROSCI.1288-14.2014; Nitsche MA, 2011, RESTOR NEUROL NEUROS, V29, P463, DOI 10.3233/RNN-2011-0618; Parazzini M, 2014, CLIN NEUROPHYSIOL, V125, P2260, DOI 10.1016/j.clinph.2014.02.027; Perrotta A, 2016, CLIN NEUROPHYSIOL, V127, P755, DOI 10.1016/j.clinph.2015.01.031; Priori A, 2014, J PHYSIOL-LONDON, V592, P3345, DOI 10.1113/jphysiol.2013.270280; Song WG, 2015, J NEUROPHYSIOL, V113, P2801, DOI 10.1152/jn.00784.2014; Stagg CJ, 2011, NEUROPSYCHOLOGIA, V49, P800, DOI 10.1016/j.neuropsychologia.2011.02.009; Svensson P, 2003, EUR J PAIN-LONDON, V7, P55, DOI 10.1016/S1090-3801(02)00050-2; Taylor JL, 2009, J NEUROSCI, V29, P11708, DOI 10.1523/JNEUROSCI.2217-09.2009; Taylor JL, 2004, J APPL PHYSIOL, V96, P1496, DOI 10.1152/japplphysiol.01116.2003; Taylor JL, 2002, J PHYSIOL-LONDON, V541, P949, DOI 10.1113/jphysiol.2002.016782; Thirugnanasambandam N, 2011, RESTOR NEUROL NEUROS, V29, P311, DOI 10.3233/RNN-2011-0601; Truini A, 2011, EUR J PAIN, V15, P1023, DOI 10.1016/j.ejpain.2011.04.009; UGAWA Y, 1991, ANN NEUROL, V29, P418, DOI 10.1002/ana.410290413; Valeriani M, 1999, CLIN NEUROPHYSIOL, V110, P1475, DOI 10.1016/S1388-2457(99)00075-9; Winkler T, 2010, CLIN NEUROPHYSIOL, V121, P957, DOI 10.1016/j.clinph.2010.01.014; Zehr EP, 2007, NEUROSCI LETT, V419, P10, DOI 10.1016/j.neulet.2007.03.045; Zehr EP, 1999, EXP BRAIN RES, V124, P474, DOI 10.1007/s002210050643	61	16	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2017	12	2							e0172333	10.1371/journal.pone.0172333	http://dx.doi.org/10.1371/journal.pone.0172333			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5SK	28225813	Green Submitted, Green Published, gold			2022-12-27	WOS:000394680900035
J	Jean, A; Tardy, F; Allatif, O; Grosjean, I; Blanquier, B; Gerlier, D				Jean, Audrey; Tardy, Florence; Allatif, Omran; Grosjean, Isabelle; Blanquier, Bariza; Gerlier, Denis			Assessing mycoplasma contamination of cell cultures by qPCR using a set of universal primer pairs targeting a 1.5 kb fragment of 16S rRNA genes	PLOS ONE			English	Article							TIME PCR EXPERIMENTS; MINIMUM INFORMATION; RAPID DETECTION; PUBLICATION; MIQE; ASSAYS	Mycoplasmas (a generic name for Mollicutes) are a predominant bacterial contaminant of cell culture and cell derived products including viruses. This prokaryote class is characterized by very small size and lack of a cell wall. Consequently, mycoplasmas escape ultrafiltration and visualization under routine microscopic examination, hence the ease with which cells in culture can be contaminated, with routinely more than 10% of cell lines being contaminated. Mycoplasma are a formidable threat both in fundamental research by perverting a whole range of cell properties and functions and in the pharmacological use of cells and cell derived products. Although many methods have been developed, there is still a need for a sensitive, universal assay. Here is reported the development and validation of a quantitative polymerase chain reaction (qPCR) based on the amplification of a 1.5 kb fragment covering the 16S rDNA of the Mollicute class by real-time PCR using universal U1 and U8 degenerate primers. The method includes the addition of a DNA loading probe to each sample to monitor DNA extraction and the absence of PCR inhibitors in the extracted DNA, a positive mycoplasma 16S rDNA traceable reference sample to exclude any accidental contamination of an unknown sample with this reference DNA, an analysis procedure based on the examination of the melting curve and the size of the PCR amplicon, followed by quantification of the number of 16S rDNA copies (with a lower limit of 19 copies) when relevant, and, if useful, the identification of the contaminating prokaryote by sequencing. The method was validated on a collection of mycoplasma strains and by testing over 100 samples of unknown contamination status including stocks of viruses requiring biosafety level 2, 3 or 4 containments. When compared to four established methods, the m16S_qPCR technique exhibits the highest sensitivity in detecting mycoplasma contamination.	[Jean, Audrey; Grosjean, Isabelle; Blanquier, Bariza; Gerlier, Denis] Univ Lyon, SFR BioSci, ENS Lyon, CNRS UMS344,Inserm US8,UCBL, Lyon, France; [Tardy, Florence] Univ Lyon, Agence Natl Secur Sanit Alimentat Environm & Trav, ANSES, VetAgro Sup,UMR Mycoplasmoses Ruminants, Marcy Letoile, France; [Gerlier, Denis] Univ Claude Bernard Lyon 1, Univ Lyon, Ecole Normale Super Lyon,Int Ctr Infectiol Res, CNRS,UMR5308,CIRI,Inserm,U1111, Lyon, France	Ecole Normale Superieure de Lyon (ENS de LYON); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); VetAgro Sup; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Ecole Normale Superieure de Lyon (ENS de LYON); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Gerlier, D (corresponding author), Univ Lyon, SFR BioSci, ENS Lyon, CNRS UMS344,Inserm US8,UCBL, Lyon, France.; Gerlier, D (corresponding author), Univ Claude Bernard Lyon 1, Univ Lyon, Ecole Normale Super Lyon,Int Ctr Infectiol Res, CNRS,UMR5308,CIRI,Inserm,U1111, Lyon, France.	denis.gerlier@inserm.fr	Gerlier, Denis/L-6094-2014	Gerlier, Denis/0000-0001-5539-456X; ALLATIF, Omran/0000-0002-2539-972X; TARDY, Florence/0000-0003-3968-4801	Infrastructure BIOBANQUES [INSERM US013]; IBiSA (AAP) [BB-0033-00072]; Measles virus BioBank [BB-0033-00053]	Infrastructure BIOBANQUES; IBiSA (AAP); Measles virus BioBank	This work was supported by a two-year grant from the Infrastructure BIOBANQUES (INSERM US013) and IBiSA (AAP2013).; This work was supported by a two-year grant from the Infrastructure BIOBANQUES (INSERM US013) and IBiSA (AAP2013) to CelluloNet BioBank, BB-0033-00072 (DG). The authors thank the following people for their commitment in providing virus stocks, cell supernatant or bacteria and planta samples and/or performing tests requiring BSL3 or BSL4 containment: C. PEREIRA, J. BRUNEL, C. MATHIEU (CIRI team "Immunobiology of Viral Infections"), Y. BENITO, L. BERAUD, (CIRI team "Staphylocococcal Pathogenesis"), O. REYNARD, (CIRI team "Molecular Basis of Viral Pathogenicity"), S. ALAIS, (CIRI team "Retroviral Oncogenesis"), H. GRUFFAT, (CIRI team "Oncogenic Herpesviruses"), D. DECIMO (CIRI team "Eukaryotic and Viral Translation") J. HOFFMANN, M. MOROSO, M. MILENKOV, (CIRI team "Emerging Pathogens Laboratory", Fondation Merieux), L. LINES, I. PILA-CASTELLANOS (CIRI team "Cell Biology of Viral Infections"), S. REYNARD (CIRI team "Unit of Biology of Emerging Viral Infections", Institut Pasteur), V. BARATEAU, (CIRI team "Host-Pathogen Interaction during Lentiviral Infection"), E. DECEMBRE (CIRI team "Vesicular trafficking, innate response and viruses"), F. FAURE (CIRI team Innate Immunity in Infectious and Autoimmune Diseases), F. GUIGUEN, Christophe TERZIAN (INRA, UMR 754, RPC team "Infection and Endogenous Retroviruses"), S. MELY, D PANNETIER (Laboratoire P4 Jean Merieux, INSERM, US3), and Nicolas SAUVION (INRA BGPI, Montpellier). The authors also thank R. CATTANEO and P. DEVAUX for providing us with useful plasmid reagent, Xavier FOISSAC for helpful discussions, and acknowledge the support of the Measles virus BioBank BB-0033-00053 facility and the BSL3-ANIRA facility of the SFR BioSciences, INSERM, CNRS, UMS3444/US8. Philip Lawrence is also thanked for English language revision.	ALTMAN DG, 1994, BRIT MED J, V308, P1552, DOI 10.1136/bmj.308.6943.1552; Alves MP, 2007, IMMUNOL LETT, V110, P101, DOI 10.1016/j.imlet.2007.04.006; Baronti C, 2013, J VIROL METHODS, V187, P234, DOI 10.1016/j.jviromet.2012.09.014; BEAMAN KD, 1981, J BACTERIOL, V146, P1055, DOI 10.1128/JB.146.3.1055-1058.1981; Boonyayatra S, 2012, J VET DIAGN INVEST, V24, P7, DOI 10.1177/1040638711425936; Bustin SA, 2010, METHODS, V50, P217, DOI 10.1016/j.ymeth.2009.12.006; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Calcutt MJ, 2015, GENOME ANNOUNC, V3; CAREY TE, 1976, P NATL ACAD SCI USA, V73, P3278, DOI 10.1073/pnas.73.9.3278; COHEN MM, 1967, EXPERIENTIA, V23, P769, DOI 10.1007/BF02154168; DAMASSA AJ, 1994, INT J SYST BACTERIOL, V44, P479, DOI 10.1099/00207713-44-3-479; Devaux P, 2004, J VIROL, V78, P11632, DOI 10.1128/JVI.78.21.11632-11640.2004; Drexler HG, 2002, CYTOTECHNOLOGY, V39, P75, DOI 10.1023/A:1022913015916; DRUM DE, 1972, J NUCL MED, V13, P908; Huang L, 2014, J CLIN MICROBIOL, V52, P1947, DOI 10.1128/JCM.03363-13; Johansson KE, 1998, METH MOL B, V104, P145; Li H, 2014, J CLIN MICROBIOL, V52, P260, DOI 10.1128/JCM.02285-13; Lysnyansky I, 2016, VET J, V207, P180, DOI 10.1016/j.tvjl.2015.10.057; MCBURNEY MW, 1982, DEV BIOL, V89, P503, DOI 10.1016/0012-1606(82)90338-4; Jimena ON, 2009, PREV VET MED, V92, P150, DOI 10.1016/j.prevetmed.2009.08.002; Olarerin-George AO, 2015, NUCLEIC ACIDS RES, V43, P2535, DOI 10.1093/nar/gkv136; Peredeltchouk M, 2011, J APPL MICROBIOL, V110, P54, DOI 10.1111/j.1365-2672.2010.04853.x; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; PUCK TT, 1958, J EXP MED, V108, P945, DOI 10.1084/jem.108.6.945; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Sailing HK, 2016, BIOLOGICALS, V44, P129, DOI 10.1016/j.biologicals.2016.03.003; Sampath Rangarajan, 2010, PDA J Pharm Sci Technol, V64, P458; Taylor SC, 2014, J MOL MICROB BIOTECH, V24, P46, DOI 10.1159/000356189; Tomkowiak M, 2013, GENESIS, V51, P193, DOI 10.1002/dvg.22364; Uphoff CC, 2014, CURR PROTOC MOL BIOL, V106, P28, DOI DOI 10.1002/0471142727.MB2805S106; Wilder CN, 2015, AM PHARM REV, V18; Yasumura Y., 1963, NIHON RINSHO, V21, P1201; Young L, 2010, NAT PROTOC, V5, P929, DOI 10.1038/nprot.2010.43	33	18	20	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2017	12	2							e0172358	10.1371/journal.pone.0172358	http://dx.doi.org/10.1371/journal.pone.0172358			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5SK	28225826	gold, Green Published, Green Submitted			2022-12-27	WOS:000394680900037
J	Liu, J; Saponjian, Y; Mahoney, MM; Staley, KJ; Berdichevsky, Y				Liu, Jing; Saponjian, Yero; Mahoney, Mark M.; Staley, Kevin J.; Berdichevsky, Yevgeny			Epileptogenesis in organotypic hippocampal cultures has limited dependence on culture medium composition	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; METHYL-D-ASPARTATE; EPILEPTIFORM ACTIVITY; CEREBROSPINAL-FLUID; SLICE CULTURES; EXTRACELLULAR FLUID; INTERICTAL SPIKES; CELL-DEATH; IN-VITRO; L-SERINE	Rodent organotypic hippocampal cultures spontaneously develop epileptiform activity after approximately 2 weeks in vitro and are increasingly used as a model of chronic post-traumatic epilepsy. However, organotypic cultures are maintained in an artificial environment (culture medium), which contains electrolytes, glucose, amino acids and other components that are not present at the same concentrations in cerebrospinal fluid (CSF). Therefore, it is possible that epileptogenesis in organotypic cultures is driven by these components. We examined the influence of medium composition on epileptogenesis. Epileptogenesis was evaluated by measurements of lactate and lactate dehydrogenase (LDH) levels (biomarkers of ictal activity and cell death, respectively) in spent culture media, immunohistochemistry and automated 3-D cell counts, and extracellular recordings from CA3 regions. Changes in culture medium components moderately influenced lactate and LDH levels as well as electrographic seizure burden and cell death. However, epileptogenesis occurred in any culture medium that was capable of supporting neural survival. We conclude that medium composition is unlikely to be the cause of epileptogenesis in the organotypic hippocampal culture model of chronic post-traumatic epilepsy.	[Liu, Jing; Berdichevsky, Yevgeny] Lehigh Univ, Dept Elect & Comp Engn, Bethlehem, PA 18015 USA; [Saponjian, Yero; Staley, Kevin J.] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Saponjian, Yero; Staley, Kevin J.] Harvard Med Sch, Boston, MA USA; [Mahoney, Mark M.; Berdichevsky, Yevgeny] Lehigh Univ, Bioengn Program, Bethlehem, PA 18015 USA	Lehigh University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Lehigh University	Berdichevsky, Y (corresponding author), Lehigh Univ, Dept Elect & Comp Engn, Bethlehem, PA 18015 USA.; Berdichevsky, Y (corresponding author), Lehigh Univ, Bioengn Program, Bethlehem, PA 18015 USA.	yeb211@lehigh.edu		Berdichevsky, Yevgeny/0000-0001-7539-601X	National Institute of Neurological Disorders and Stroke [R01NS077908]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034700, R37NS077908] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This project was partially supported by National Institute of Neurological Disorders and Stroke R01NS077908 to K.J.S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMTORP O, 1974, J PHYSIOL-LONDON, V243, P387, DOI 10.1113/jphysiol.1974.sp010759; Ashrafi MR, 2007, PEDIATR NEUROL, V36, P25, DOI 10.1016/j.pediatrneurol.2006.09.001; BARNES D, 1980, ANAL BIOCHEM, V102, P255, DOI 10.1016/0003-2697(80)90151-7; Bausch SB, 2000, J NEUROPHYSIOL, V84, P2918, DOI 10.1152/jn.2000.84.6.2918; Berdichevsky Y, 2013, J NEUROSCI, V33, P9056, DOI 10.1523/JNEUROSCI.3870-12.2013; Berdichevsky Y, 2012, NEUROBIOL DIS, V45, P774, DOI 10.1016/j.nbd.2011.11.001; BONFOCO E, 1995, P NATL ACAD SCI USA, V92, P7162, DOI 10.1073/pnas.92.16.7162; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Cacheaux LP, 2009, J NEUROSCI, V29, P8927, DOI 10.1523/JNEUROSCI.0430-09.2009; Cassar SC, 2010, J NEUROSCI METH, V192, P249, DOI 10.1016/j.jneumeth.2010.07.042; COLTMAN BW, 1995, J COMP NEUROL, V362, P209, DOI 10.1002/cne.903620205; COTTON DB, 1992, AM J OBSTET GYNECOL, V166, P1127, DOI 10.1016/S0002-9378(11)90599-7; Coulter DA, 1996, EPILEPSY RES, V26, P81, DOI 10.1016/S0920-1211(96)00044-7; De Simoni A, 2003, J PHYSIOL-LONDON, V550, P135, DOI 10.1113/jphysiol.2003.039099; DECKER T, 1988, J IMMUNOL METHODS, V115, P61, DOI 10.1016/0022-1759(88)90310-9; DELRIO JA, 1991, NEUROSCIENCE, V43, P335, DOI 10.1016/0306-4522(91)90298-3; Dyhrfjeld-Johnsen J, 2010, J CLIN NEUROPHYSIOL, V27, P418, DOI 10.1097/WNP.0b013e3181fe0709; Dzhala V, 2015, CNS NEUROSCI THER, V21, P173, DOI 10.1111/cns.12369; Fujikawa DG, 2005, EPILEPSY BEHAV, V7, pS3, DOI 10.1016/j.yebeh.2005.08.003; Furuya S, 2000, P NATL ACAD SCI USA, V97, P11528, DOI 10.1073/pnas.200364497; Gahwiler B TS, 1998, CULTURING NERVE CELL; GLOBUS MYT, 1991, J NEUROCHEM, V57, P470, DOI 10.1111/j.1471-4159.1991.tb03775.x; Gutierrez R, 1999, BRAIN RES, V815, P304, DOI 10.1016/S0006-8993(98)01101-9; Hailer NP, 1996, GLIA, V18, P319, DOI 10.1002/(SICI)1098-1136(199612)18:4<319::AID-GLIA6>3.0.CO;2-S; Hajos N, 2009, J NEUROSCI METH, V183, P107, DOI 10.1016/j.jneumeth.2009.06.005; HASHIMOTO A, 1995, NEUROSCIENCE, V66, P635, DOI 10.1016/0306-4522(94)00597-X; Hayashi I, 1976, NATURE; HEIBLIM DI, 1978, ARCH NEUROL-CHICAGO, V35, P765, DOI 10.1001/archneur.1978.00500350069015; Heinemann U, 2014, ADV EXP MED BIOL, V813, P25, DOI 10.1007/978-94-017-8914-1_2; Heinemann U, 2012, GLIA, V60, P1251, DOI 10.1002/glia.22311; Ivens S, 2007, BRAIN, V130, P535, DOI 10.1093/brain/awl317; JOHNSON JW, 1987, NATURE, V325, P529, DOI 10.1038/325529a0; Kawai N, 2012, AMINO ACIDS, V42, P2129, DOI 10.1007/s00726-011-0950-y; Kew JNC, 1998, J NEUROSCI, V18, P1935; Kharatishvili I, 2006, NEUROSCIENCE, V140, P685, DOI 10.1016/j.neuroscience.2006.03.012; Kirchner A, 2003, EPILEPSIA, V44, P1145, DOI 10.1046/j.1528-1157.2003.01603.x; KOROBKIN RK, 1977, BRAIN RES, V119, P181, DOI 10.1016/0006-8993(77)90098-1; KORZENIEWSKI C, 1983, J IMMUNOL METHODS, V64, P313, DOI 10.1016/0022-1759(83)90438-6; Lillis KP, 2015, J NEUROSCI, V35, P9920, DOI 10.1523/JNEUROSCI.4007-14.2015; Loscher W, 2010, PHARMACOL REV, V62, P668, DOI 10.1124/pr.110.003046; MANTHEI RC, 1973, PHYSIOL BEHAV, V10, P517, DOI 10.1016/0031-9384(73)90214-X; MCBAIN CJ, 1989, J NEUROSCI METH, V27, P35, DOI 10.1016/0165-0270(89)90051-4; McNay EC, 2004, J NEUROSCI METH, V132, P35, DOI 10.1016/j.jneumeth.2003.08.014; MILLER LDP, 1994, NEUROSCIENCE, V63, P471, DOI 10.1016/0306-4522(94)90544-4; MODY I, 1987, J NEUROPHYSIOL, V57, P869, DOI 10.1152/jn.1987.57.3.869; Mothet JP, 2015, J NEUROCHEM, V135, P210, DOI 10.1111/jnc.13204; Mothet JP, 2000, P NATL ACAD SCI USA, V97, P4926, DOI 10.1073/pnas.97.9.4926; Naziroglu M, 2008, J MEMBRANE BIOL, V225, P39, DOI 10.1007/s00232-008-9132-6; Papetti L, 2013, BRAIN DEV-JPN, V35, P827, DOI 10.1016/j.braindev.2012.11.010; Park KI, 2015, ENEURO, V2, DOI 10.1523/ENEURO.0027-14.2015; Pitkanen A, 2011, LANCET NEUROL, V10, P173, DOI 10.1016/S1474-4422(10)70310-0; Reiber H, 2001, CLIN CHIM ACTA, V310, P173, DOI 10.1016/S0009-8981(01)00573-3; REID KH, 1988, PROG NEUROBIOL, V31, P1, DOI 10.1016/0301-0082(88)90020-2; RUBIN JJ, 1980, EXP NEUROL, V67, P472, DOI 10.1016/0014-4886(80)90119-3; RUTECKI PA, 1985, J NEUROPHYSIOL, V54, P1363, DOI 10.1152/jn.1985.54.5.1363; Safar MM, 2010, BRAIN RES, V1334, P58, DOI 10.1016/j.brainres.2010.03.076; Santhakumar V, 2001, ANN NEUROL, V50, P708, DOI 10.1002/ana.1230; Seyfert S, 2004, J NEUROL SCI, V219, P31, DOI 10.1016/j.jns.2003.12.002; Somjen GG, 2002, NEUROSCIENTIST, V8, P254, DOI 10.1177/1073858402008003011; Staley KJ, 2001, J NEUROPHYSIOL, V86, P2736, DOI 10.1152/jn.2001.86.6.2736; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Tabatabaie L, 2010, MOL GENET METAB, V99, P256, DOI 10.1016/j.ymgme.2009.10.012; TANAKA M, 1995, NEUROSCI LETT, V199, P37, DOI 10.1016/0304-3940(95)12009-S; TRAUB RD, 1994, J PHYSIOL-LONDON, V478, P379, DOI 10.1113/jphysiol.1994.sp020259; van Vliet EA, 2007, BRAIN, V130, P521, DOI 10.1093/brain/awl318; van Vliet EA, 2014, NEUROSCIENCE, V277, P455, DOI 10.1016/j.neuroscience.2014.07.030; VYKLICKY L, 1990, J PHYSIOL-LONDON, V428, P313, DOI 10.1113/jphysiol.1990.sp018214; WESTERGREN I, 1994, J NEUROCHEM, V62, P159; Yu JY, 2013, EPILEPSY RES TREATME, V2013; ZUCKERMANN EC, 1968, EXP NEUROL, V20, P87, DOI 10.1016/0014-4886(68)90126-X	70	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2017	12	2							e72677	10.1371/journal.pone.0172677	http://dx.doi.org/10.1371/journal.pone.0172677			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5SK	28225808	gold, Green Published, Green Submitted			2022-12-27	WOS:000394680900063
J	Yang, S; Mountrakis, G				Yang, Sheng; Mountrakis, Giorgos			Forest dynamics in the US indicate disproportionate attrition in western forests, rural areas and public lands	PLOS ONE			English	Article							CONTERMINOUS UNITED-STATES; URBAN HEAT-ISLAND; CARBON STORAGE; COVER CHANGE; FRAGMENTED FORESTS; CLIMATE-CHANGE; DEFORESTATION; HABITAT; SEQUESTRATION; DISTURBANCE	Forests are experiencing significant changes; studying geographic patterns in forests is critical in understanding the impact of forest dynamics to biodiversity, soil erosion, water chemistry and climate. Few studies have examined forest geographic pattern changes other than fragmentation; however, other spatial processes of forest dynamics are of equal importance. Here, we study forest attrition, the complete removal of forest patches, that can result in complete habitat loss, severe decline of population sizes and species richness, and shifts of local and regional environmental conditions. We aim to develop a simple yet insightful proximity-based spatial indicator capturing forest attrition that is independent of spatial scale and boundaries with worldwide application potential. Using this proximity indicator, we evaluate forest attrition across ecoregions, land ownership and urbanization stratifications across continental United States of America. Nationally, the total forest cover loss was approximately 90,400 km 2, roughly the size of the state of Maine, constituting a decline of 2.96%. Examining the spatial arrangement of this change the average FAD was 3674m in 1992 and increased by 514m or 14.0% in 2001. Simulations of forest cover loss indicate only a 10m FAD increase suggesting that the observed FAD increase was more than an order of magnitude higher than expected. Furthermore, forest attrition is considerably higher in the western United States, in rural areas and in public lands. Our mathematical model (R-2 = 0.93) supports estimation of attrition for a given forest cover. The FAD metric quantifies forest attrition across spatial scales and geographic boundaries and assesses unambiguously changes over time. The metric is applicable to any landscape and offers a new complementary insight on forest landscape patterns from local to global scales, improving future exploration of drivers and repercussions of forest cover changes and supporting more informative management of forest carbon, changing climate and species biodiversity.	[Yang, Sheng; Mountrakis, Giorgos] SUNY Coll Environm Sci & Forestry, Dept Environm Resources Engn, Syracuse, NY 13210 USA	State University of New York (SUNY) System; State University of New York (SUNY) College of Environmental Science & Forestry	Mountrakis, G (corresponding author), SUNY Coll Environm Sci & Forestry, Dept Environm Resources Engn, Syracuse, NY 13210 USA.	gmountrakis@esf.edu	Mountrakis, Giorgos/I-9612-2014	Mountrakis, Giorgos/0000-0001-5958-8134	National Urban and Community Forestry Advisory Council; U.S. Forest Service; SUNY ESF Graduate Assistantship	National Urban and Community Forestry Advisory Council; U.S. Forest Service(United States Department of Agriculture (USDA)United States Forest Service); SUNY ESF Graduate Assistantship	This work was supported by the National Urban and Community Forestry Advisory Council, U.S. Forest Service and a SUNY ESF Graduate Assistantship. We would like to thank Dr. Colin Beier and Dr. David Nowak for their insights and Dr. Steve Stehman for statistical support.	[Anonymous], 1994, COASTAL WILDERNESS F; [Anonymous], 2006, GLOBAL ECOL BIOGEOGR, V15, P50; Bender DJ, 1998, ECOLOGY, V79, P517, DOI 10.2307/176950; Bernhardt ES, 2003, P NATL ACAD SCI USA, V100, P10304, DOI 10.1073/pnas.1233676100; Brook BW, 2003, NATURE, V424, P420, DOI 10.1038/nature01795; Cadenasso ML, 2001, CONSERV BIOL, V15, P91, DOI 10.1046/j.1523-1739.2001.99309.x; Carpenter SR, 1998, ECOL APPL, V8, P559, DOI 10.1890/1051-0761(1998)008[0559:NPOSWW]2.0.CO;2; Cattarino L, 2014, GLOBAL ECOL BIOGEOGR, V23, P1215, DOI 10.1111/geb.12187; Churkina G, 2010, GLOBAL CHANGE BIOL, V16, P135, DOI 10.1111/j.1365-2486.2009.02002.x; Colwell RK, 2008, SCIENCE, V322, P258, DOI 10.1126/science.1162547; Dean C, 2015, ECOL ENG, V74, P148, DOI 10.1016/j.ecoleng.2014.09.125; Defries RS, 1999, GLOBAL ECOL BIOGEOGR, V8, P367, DOI 10.1046/j.1365-2699.1999.00139.x; Dramstad WE, 2009, NORSK GEOGR TIDSSKR, V63, P246, DOI 10.1080/00291950903368359; Drummond MA, 2010, BIOSCIENCE, V60, P286, DOI 10.1525/bio.2010.60.4.7; Dumortier M, 2002, FOREST ECOL MANAG, V158, P85, DOI 10.1016/S0378-1127(00)00674-5; DZWONKO Z, 1989, OIKOS, V56, P77, DOI 10.2307/3566089; Echeverria C, 2007, GLOBAL ECOL BIOGEOGR, V16, P426, DOI 10.1111/j.1466-8238.2007.00311.x; Escobedo FJ, 2009, LANDSCAPE URBAN PLAN, V90, P102, DOI 10.1016/j.landurbplan.2008.10.021; Fahrig L., 2003, EFFECTS HABITAT FRAG, P487; Fahrig L, 2013, J BIOGEOGR, V40, P1649, DOI 10.1111/jbi.12130; Fischer J, 2007, GLOBAL ECOL BIOGEOGR, V16, P265, DOI 10.1111/j.1466-8238.2007.00287.x; Forman R., 2014, ECOLOGICAL DESIGN PL, P217; Forman RTT, 2000, CONSERV BIOL, V14, P36, DOI 10.1046/j.1523-1739.2000.99088.x; FRAVER S, 1994, CONSERV BIOL, V8, P822, DOI 10.1046/j.1523-1739.1994.08030822.x; Fry JA, 2008, COMPLETION NATL LAND, P1379; Gardner RH, 2007, LANDSCAPE ECOL, V22, P15, DOI 10.1007/s10980-006-9011-4; Gibson L, 2011, NATURE, V478, P378, DOI 10.1038/nature10425; Githiru M, 2007, BIOL CONSERV, V134, P271, DOI 10.1016/j.biocon.2005.11.016; Haddad NM, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500052; HainesYoung R, 1996, PROG PHYS GEOG, V20, P418, DOI 10.1177/030913339602000403; Hansen MC, 2014, REMOTE SENS ENVIRON, V140, P466, DOI 10.1016/j.rse.2013.08.014; Hansen MC, 2008, P NATL ACAD SCI USA, V105, P9439, DOI 10.1073/pnas.0804042105; Hansen MC, 2010, P NATL ACAD SCI USA, V107, P8650, DOI 10.1073/pnas.0912668107; Hanski I, 2000, NATURE, V404, P755, DOI 10.1038/35008063; Hanski I, 2013, P NATL ACAD SCI USA, V110, P12715, DOI 10.1073/pnas.1311491110; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Hargis CD, 1998, LANDSCAPE ECOL, V13, P167, DOI 10.1023/A:1007965018633; Homer C, 2007, PHOTOGRAMM ENG REM S, V73, P337; Houghton RA, 2000, GLOBAL ECOL BIOGEOGR, V9, P125, DOI 10.1046/j.1365-2699.2000.00166.x; Howarth RW, 1996, BIOGEOCHEMISTRY, V35, P75, DOI 10.1007/BF02179825; Jarzyna MA, 2015, GLOBAL CHANGE BIOL, V21, P2942, DOI 10.1111/gcb.12885; Kim DH, 2014, REMOTE SENS ENVIRON, V155, P178, DOI 10.1016/j.rse.2014.08.017; Krieger D., 2001, NEW YORK; Kuemmerle T, 2009, J LAND USE SCI, V4, P73, DOI 10.1080/17474230802645857; Kupfer JA, 2006, GLOBAL ENVIRON CHANG, V16, P73, DOI 10.1016/j.gloenvcha.2005.10.003; Lambin EF, 1999, GLOBAL ECOL BIOGEOGR, V8, P191, DOI 10.1046/j.1365-2699.1999.00123.x; Laurance WF, 2001, ENVIRON CONSERV, V28, P305, DOI 10.1017/S0376892901000339; Li HB, 2004, LANDSCAPE ECOL, V19, P389, DOI 10.1023/B:LAND.0000030441.15628.d6; Li SJ, 2015, ECOL INDIC, V56, P116, DOI 10.1016/j.ecolind.2015.03.031; Li Yue-hui, 2013, Yingyong Shengtai Xuebao, V24, P2056; Liu CF, 2012, URBAN FOR URBAN GREE, V11, P121, DOI 10.1016/j.ufug.2011.03.002; Loiselle BA, 2010, J BIOGEOGR, V37, P1288, DOI 10.1111/j.1365-2699.2010.02285.x; Loughner CP, 2012, J APPL METEOROL CLIM, V51, P1775, DOI 10.1175/JAMC-D-11-0228.1; Lovejoy T.E., 1986, EDGE OTHER EFFECTS I; Magnani F, 2007, NATURE, V447, P848, DOI 10.1038/nature05847; Manning AD, 2006, BIOL CONSERV, V132, P311, DOI 10.1016/j.biocon.2006.04.023; Masek JG, 2008, REMOTE SENS ENVIRON, V112, P2914, DOI 10.1016/j.rse.2008.02.010; Masek JG, 2013, ECOSYSTEMS, V16, P1087, DOI 10.1007/s10021-013-9669-9; MATLACK GR, 1993, ENVIRON MANAGE, V17, P829, DOI 10.1007/BF02393903; McLauchlan KK, 2007, P NATL ACAD SCI USA, V104, P7466, DOI 10.1073/pnas.0701779104; McPherson EG, 2013, LANDSCAPE URBAN PLAN, V120, P70, DOI 10.1016/j.landurbplan.2013.08.005; Moskowitz K, 1998, EC CASE AGAINST LOGG; Murphy DJ, 2011, INT J CLIMATOL, V31, P1222, DOI 10.1002/joc.2145; Nepstad D, 2001, FOREST ECOL MANAG, V154, P395, DOI 10.1016/S0378-1127(01)00511-4; Nepstad DC, 1999, NATURE, V398, P505, DOI 10.1038/19066; Olander LP, 2008, ENVIRON RES LETT, P3; Omernik JM, 2014, ENVIRON MANAGE, V54, P1249, DOI 10.1007/s00267-014-0364-1; Pe'er G, 2013, PLOS ONE, P8; PETERKEN GF, 1984, J ECOL, V72, P155, DOI 10.2307/2260011; Prugh LR, 2008, P NATL ACAD SCI USA, V105, P20770, DOI 10.1073/pnas.0806080105; Reed RA, 1996, CONSERV BIOL, V10, P1098, DOI 10.1046/j.1523-1739.1996.10041098.x; Riitters K, 2000, CONSERV ECOL, V4, DOI 10.5751/ES-00209-040203; Riitters KH, 2002, ECOSYSTEMS, V5, P815, DOI 10.1007/s10021-002-0209-2; Riitters K, 2016, LANDSCAPE ECOL, V31, P137, DOI 10.1007/s10980-015-0270-9; Riitters KH, 2012, FOREST ECOL MANAG, V263, P85, DOI 10.1016/j.foreco.2011.09.022; RIPPLE WJ, 1991, BIOL CONSERV, V57, P73, DOI 10.1016/0006-3207(91)90108-L; Sasaki N, 2009, CONSERV LETT, V2, P226, DOI 10.1111/j.1755-263X.2009.00067.x; SAUNDERS DA, 1991, CONSERV BIOL, V5, P18, DOI 10.1111/j.1523-1739.1991.tb00384.x; Schaich H, 2013, FOREST ECOL MANAG, V305, P146, DOI 10.1016/j.foreco.2013.05.013; Sexton JO, 2013, INT J DIGIT EARTH, V6, P427, DOI 10.1080/17538947.2013.786146; Sierra R, 2000, APPL GEOGR, V20, P1, DOI 10.1016/S0143-6228(99)00014-4; SKOLE D, 1993, SCIENCE, V260, P1905, DOI 10.1126/science.260.5116.1905; Sleeter BM, 2013, GLOBAL ENVIRON CHANG, V23, P733, DOI 10.1016/j.gloenvcha.2013.03.006; Stark SC, 2015, LANDSC ECOL; Strassburg BBN, 2012, NAT CLIM CHANGE, V2, P350, DOI [10.1038/NCLIMATE1375, 10.1038/nclimate1375]; The Conservation Biology Institute, 2014, PROT NAT VEG COMP AN; Theobald DM, 2011, ECOL APPL, V21, P2445, DOI 10.1890/10-1701.1; Townshend JR, 2012, INT J DIGIT EARTH, V5, P373, DOI 10.1080/17538947.2012.713190; Turner M.G., 2001, LANDSCAPE ECOLOGY TH; TURNER MG, 1989, ANNU REV ECOL SYST, V20, P171, DOI 10.1146/annurev.es.20.110189.001131; Tyukavina A, 2016, GLOBAL ECOL BIOGEOGR, V25, P151, DOI 10.1111/geb.12394; US Bureau of Census, 2000, CENS 2000 TIGER LIN; Valdes A, 2015, GLOBAL ECOL BIOGEOGR, V24, P1094, DOI 10.1111/geb.12345; Vogelmann JE, 2001, PHOTOGRAMM ENG REM S, V67, P650; Watts RD, 2007, SCIENCE, V316, P736, DOI 10.1126/science.1138141; Zheng DL, 2013, URBAN FOR URBAN GREE, V12, P61, DOI 10.1016/j.ufug.2012.10.003; Zheng DL, 2010, ENVIRON MANAGE, V45, P377, DOI 10.1007/s00267-009-9408-3; Zipperer WC, 2012, URBAN ECOSYST, V15, P533, DOI 10.1007/s11252-012-0238-3	98	4	4	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2017	12	2							e0171383	10.1371/journal.pone.0171383	http://dx.doi.org/10.1371/journal.pone.0171383			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL5SK	28225787	Green Published, gold, Green Submitted			2022-12-27	WOS:000394680900012
J	Yuan, HS; Wilks, MQ; El Fakhri, G; Normandin, MD; Kaittanis, C; Josephson, L				Yuan, Hushan; Wilks, Moses Q.; El Fakhri, Georges; Normandin, Marc D.; Kaittanis, Charalambos; Josephson, Lee			Heat-induced-radiolabeling and click chemistry: A powerful combination for generating multifunctional nanomaterials	PLOS ONE			English	Article							INTEGRIN TARGETED DELIVERY; OVARIAN-CANCER; PHYSICOCHEMICAL PROPERTIES; PLASMA PHARMACOKINETICS; NANOPARTICLES; FERUMOXYTOL; LIPOSOMES; PROTAMINE; THERAPY; SAFETY	A key advantage of nanomaterials for biomedical applications is their ability to feature multiple small reporter groups (multimodality), or combinations of reporter groups and therapeutic agents (multifunctionality), while being targeted to cell surface receptors. Here a facile combination of techniques for the syntheses of multimodal, targeted nanoparticles (NPs) is presented, whereby heat-induced-radiolabeling (HIR) labels NPs with radiometals and socalled click chemistry is used to attach bioactive groups to the NP surface. Click-reactive alkyne or azide groups were first attached to the nonradioactive clinical Feraheme (FH) NPs. Resulting "Alkyne-FH " and "Azide-FH " intermediates, like the parent NP, tolerated (89) Zr labeling by the HIR method previously described. Subsequently, biomolecules were quickly conjugated to the radioactive NPs by either copper-catalyzed or copper-free click reactions with high efficiency. Synthesis of the Alkyne-FH or Azide-FH intermediates, followed by HIR and then by click reactions for biomolecule attachment, provides a simple and potentially general path for the synthesis of multimodal, multifunctional, and targeted NPs for biomedical applications.	[Yuan, Hushan; Wilks, Moses Q.; El Fakhri, Georges; Normandin, Marc D.; Kaittanis, Charalambos; Josephson, Lee] Harvard Med Sch, Massachusetts Gen Hosp, Gordon Ctr Med Imaging, 149,13th St, Charlestown, MA 02129 USA	Harvard University; Massachusetts General Hospital	Yuan, HS (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Gordon Ctr Med Imaging, 149,13th St, Charlestown, MA 02129 USA.	HYUAN@mgh.harvard.edu	Normandin, Marc D/C-6728-2015	Normandin, Marc D/0000-0003-1645-523X	NIH [R01 EB017699, T32EB013180, R01MH100350]; Prostate Cancer Foundation; Alex's Lemonade Stand Foundation; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB017699, T32EB013180] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH100350] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Prostate Cancer Foundation; Alex's Lemonade Stand Foundation; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Support was provided by the NIH R01 EB017699 (LJ), the Prostate Cancer Foundation (CK), Alex's Lemonade Stand Foundation (CK), NIH T32EB013180, NIH R01MH100350 (MN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcantara D, 2012, ANGEW CHEM INT EDIT, V51, P6904, DOI 10.1002/anie.201201661; Aljammaz I, 2014, ANTICANCER RES, V34, P6547; Auerbach M, 2013, AM J HEMATOL, V88, P944, DOI 10.1002/ajh.23534; Balakrishnan VS, 2009, EUR J CLIN INVEST, V39, P489, DOI 10.1111/j.1365-2362.2009.02130.x; Barz M, 2010, BIOMACROMOLECULES, V11, P2274, DOI 10.1021/bm100338x; Bashir M. R., 2014, J MAGNETIC RESONANCE; Boros E, 2015, CHEM SCI, V6, P225, DOI 10.1039/c4sc02778g; Bunschoten A, 2012, CHEMBIOCHEM, V13, P1039, DOI 10.1002/cbic.201200034; Chen K, 2011, THERANOSTICS, V1, P189, DOI 10.7150/thno/v01p0189; Chen S, 2011, J NANOSCI NANOTECHNO, V11, P3058, DOI 10.1166/jnn.2011.4164; Cho HS, 2013, ACS NANO, V7, P2032, DOI 10.1021/nn305962n; Corbin IR, 2013, NANOMEDICINE-UK, V8, P875, DOI [10.2217/nnm.12.137, 10.2217/NNM.12.137]; Futterer S, 2013, J PHARMACEUT BIOMED, V86, P151, DOI 10.1016/j.jpba.2013.08.005; Futaki S, 2006, BIOPOLYMERS, V84, P241, DOI 10.1002/bip.20421; Gaertner FC, 2012, EUR J NUCL MED MOL I, V39, P126, DOI 10.1007/s00259-011-2028-1; Goel S, 2014, SMALL, V10, P3825, DOI 10.1002/smll.201401048; Guo YY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058290; Guo YY, 2012, J AM CHEM SOC, V134, P19338, DOI 10.1021/ja309085b; Haubner R, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/871609; Jahn MR, 2011, EUR J PHARM BIOPHARM, V78, P480, DOI 10.1016/j.ejpb.2011.03.016; Josephson L, 1999, BIOCONJUGATE CHEM, V10, P186, DOI 10.1021/bc980125h; JUNG CW, 1995, MAGN RESON IMAGING, V13, P675, DOI 10.1016/0730-725X(95)00023-A; Kircher MF, 2003, CANCER RES, V63, P6838; Landry R, 2005, AM J NEPHROL, V25, P400, DOI 10.1159/000087212; Lee DE, 2012, CHEM SOC REV, V41, P2656, DOI 10.1039/c2cs15261d; Lewis J., 2003, U.S. Patent, Patent No. [6,599,498B1, 6599498]; Liu SL, 2014, CHEM COMMUN, V50, P7371, DOI 10.1039/c4cc01411a; Liu ZF, 2011, THERANOSTICS, V1, P201, DOI 10.7150/thno/v01p0201; Lu J, 2009, BIOCONJUGATE CHEM, V20, P87, DOI 10.1021/bc8003167; Mansoori G Ali, 2010, Cancers (Basel), V2, P1911, DOI 10.3390/cancers2041911; Marumo S, 1993, US Patent, V5, Patent No. [5 , 204,457, 5204457]; Maruno S, 2000, US Patent, Patent No. [6,165,378, 6165378]; Meyers MO, 2000, SOUTHERN MED J, V93, P809; Montet X, 2006, J MED CHEM, V49, P6087, DOI 10.1021/jm060515m; Muller C, 2014, J NUCL MED, V55, P1658, DOI 10.2967/jnumed.114.141614; Mulder WJM, 2006, NANO LETT, V6, P1, DOI 10.1021/nl051935m; Niu G, 2011, THERANOSTICS, V1, P30, DOI 10.7150/thno/v01p0030; Normandin MD, 2015, ANGEW CHEM INT EDIT, V54, P13002, DOI 10.1002/anie.201505525; Novak-Hofer I, 2002, EUR J NUCL MED MOL I, V29, P821, DOI 10.1007/s00259-001-0724-y; Pai AB, 2010, CLIN PHARMACOL THER, V88, P237, DOI 10.1038/clpt.2010.80; Plock N, 2015, CLIN PHARMACOKINET, V54, P385, DOI 10.1007/s40262-014-0203-9; Reynolds F, 2005, BIOCONJUGATE CHEM, V16, P1240, DOI 10.1021/bc0501451; Rothbard JB, 2000, NAT MED, V6, P1253, DOI 10.1038/81359; Sapsford KE, 2013, CHEM REV, V113, P1904, DOI 10.1021/cr300143v; Schiller B, 2014, CLIN THER, V36, P70, DOI 10.1016/j.clinthera.2013.09.028; Setua S, 2010, BIOMATERIALS, V31, P714, DOI 10.1016/j.biomaterials.2009.09.090; Siegel BA, 2003, J NUCL MED, V44, P700; Torchilin VP, 2005, NAT REV DRUG DISCOV, V4, P145, DOI 10.1038/nrd1632; Tung CH, 2002, CHEMBIOCHEM, V3, P784, DOI 10.1002/1439-7633(20020802)3:8<784::AID-CBIC784>3.0.CO;2-X; Turk MJ, 2004, CANCER LETT, V213, P165, DOI 10.1016/j.canlet.2003.12.028; van Dam GM, 2011, NAT MED, V17, P1315, DOI 10.1038/nm.2472; Zhang Y, 2011, THERANOSTICS, V1, P135, DOI 10.7150/thno/v01p0135	52	7	7	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2017	12	2							e72722	10.1371/journal.pone.0172722	http://dx.doi.org/10.1371/journal.pone.0172722			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5SK	28225818	Green Published, gold			2022-12-27	WOS:000394680900065
J	Chevalier, NR; Fleury, V; Dufour, S; Proux-Gillardeaux, V; Asnacios, A				Chevalier, N. R.; Fleury, V.; Dufour, S.; Proux-Gillardeaux, V.; Asnacios, A.			Emergence and development of gut motility in the chicken embryo	PLOS ONE			English	Article							ENTERIC NERVOUS-SYSTEM; INTESTINAL MOTILITY; INTERSTITIAL-CELLS; NEURONS; DIFFERENTIATION; PATTERNS; NETWORK; ORIGIN; LARVAE; TRACT	The gastrointestinal tract transports the food bolus by peristalsis. Gut motility starts at an early age in the developing embryo, well before it is required for nutrition of the organism. We present a comprehensive kinematic study of the emergence and physiological development of gut motility in all regions of the lower digestive tract of the chicken embryo from embryonic days E5 through E9. We characterized motility emergence time, propagation patterns, speed, frequency and amplitude of peristalsis waves. We found that the emergence of an uninterrupted circular ring of smooth muscle correlated with the appearance of propagative contractile waves, at E6 in the hindgut and midgut, and at E9 in the caecal appendix. We show that peristalsis at these stages is critically dependent on calcium and is not mediated by neurons as gut motility is insensitive to tetrodotoxin and takes place in the hindgut in the absence of neurons. We further demonstrate that motility also matures in ex-vivo organ culture. We compare our results to existing literature on zebrafish, mouse and human motility development, and discuss their chronological relationship with other major developmental events occurring in the chicken embryonic gut at these stages. Our work sets a baseline for further investigations of motility development in this important animal model.	[Chevalier, N. R.; Fleury, V.; Asnacios, A.] Univ Paris Diderot, Lab Mat & Syst Complexes, CNRS, UMR 7057,Sorbonne Paris Cite, Paris, France; [Dufour, S.] INSERM, U955, Equipe 6, F-75654 Paris 13, France; [Dufour, S.] Univ Paris Est, Fac Med, Creteil, France; [Proux-Gillardeaux, V.] Inst Jacques Monod, CNRS, UMR 7592, Membrane Traff Hlth & Dis Lab, Paris, France; [Proux-Gillardeaux, V.] Univ Paris 07, INSERM, U950, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Chevalier, NR (corresponding author), Univ Paris Diderot, Lab Mat & Syst Complexes, CNRS, UMR 7057,Sorbonne Paris Cite, Paris, France.	nicolas.chevalier@univ-paris-diderot.fr	DUFOUR, Sylvie/G-2253-2019	Dufour, Sylvie/0000-0002-6663-0676	Agence Nationale de la Recherche (ANR) through "Initiatives d'Excellence" Idex" [ANR-11-IDEX-0005-02]; Agence Nationale de la Recherche (ANR) through "Labex Who Am I?" [ANR-11-LABX-0071]	Agence Nationale de la Recherche (ANR) through "Initiatives d'Excellence" Idex"(French National Research Agency (ANR)); Agence Nationale de la Recherche (ANR) through "Labex Who Am I?"(French National Research Agency (ANR))	This research was funded by Agence Nationale de la Recherche (ANR) through "Initiatives d'Excellence" Idex (ANR-11-IDEX-0005-02), and "Labex Who Am I?" (ANR-11-LABX-0071) Collaborative Project (VPG, AA, NRC) and Postdoctoral Fellowship Grants (NRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alim K, 2013, P NATL ACAD SCI USA, V110, P13306, DOI 10.1073/pnas.1305049110; ALLAN IJ, 1980, AM J ANAT, V157, P137, DOI 10.1002/aja.1001570203; Anderson ADG, 2004, GUT, V53, P241, DOI 10.1136/gut.2003.024620; ATTARDI G, 1955, EXPERIENTIA, V11, P37, DOI 10.1007/BF02165889; Burns AJ, 1998, DEVELOPMENT, V125, P4335; Carey E, 1920, J GEN PHYSIOL, P357; Crisp SJ, 2011, J NEUROSCI, V31, P10445, DOI 10.1523/JNEUROSCI.0346-11.2011; Dongaonkar RM, 2012, AM J PHYSIOL-REG I, V302, pR1436, DOI 10.1152/ajpregu.00635.2011; Faure S, 2015, DEVELOPMENT, V142, P331, DOI 10.1242/dev.118422; Fu M, 2004, ANAT EMBRYOL, V208, P33, DOI 10.1007/s00429-003-0371-0; Goldstein AM, 2008, PEDIATR RES, V64, P326, DOI 10.1203/PDR.0b013e31818535e8; Harrison R, 1902, AM J ANAT, V11; Hearn CJ, 1999, DEV DYNAM, V214, P239, DOI 10.1002/(SICI)1097-0177(199903)214:3<239::AID-AJA7>3.0.CO;2-O; Holmberg A, 2003, J FISH BIOL, V63, P318, DOI 10.1046/j.1095-8649.2003.00149.x; Holmberg A, 2007, J EXP BIOL, V210, P1084, DOI 10.1242/jeb.000935; KORT AA, 1985, CIRC RES, V57, P844, DOI 10.1161/01.RES.57.6.844; Kunz G, 1997, ADV EXP MED BIOL, V424, P267; Lecoin L, 1996, DEVELOPMENT, V122, P725; Nagy N, 2006, DEV BIOL, V293, P203, DOI 10.1016/j.ydbio.2006.01.032; Roberts RR, 2010, J PHYSIOL-LONDON, V588, P1153, DOI 10.1113/jphysiol.2009.185421; Rugiero F, 2003, J NEUROSCI, V23, P2715; Shimizu H, 2004, J COMP PHYSIOL A, V190, P623, DOI 10.1007/s00359-004-0518-3; Thomason RT, 2012, DEV DYNAM, V241, P1678, DOI 10.1002/dvdy.23855; Willmer E, 1966, CELLS TISSUES CULTUR	24	23	24	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2017	12	2							e0172511	10.1371/journal.pone.0172511	http://dx.doi.org/10.1371/journal.pone.0172511			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5QV	28222167	gold, Green Submitted, Green Published			2022-12-27	WOS:000394676800061
J	Barasch, N; Gong, X; Kwei, KA; Varma, S; Biscocho, J; Qu, KB; Xiao, N; Lipsick, JS; Pelham, RJ; West, RB; Pollack, JR				Barasch, Nicholas; Gong, Xue; Kwei, Kevin A.; Varma, Sushama; Biscocho, Jewison; Qu, Kunbin; Xiao, Nan; Lipsick, Joseph S.; Pelham, Robert J.; West, Robert B.; Pollack, Jonathan R.			Recurrent rearrangements of the Myb/SANT-like DNA-binding domain containing 3 gene (MSANTD3) in salivary gland acinic cell carcinoma	PLOS ONE			English	Article							HUMAN CANCER; FUSION TRANSCRIPTS; CRYSTAL-STRUCTURE; BREAST-CANCER; SANT DOMAIN; EXPRESSION; IDENTIFICATION; TRANSLOCATION; MUTATIONS; RECEPTOR	Pathogenic gene fusions have been identified in several histologic types of salivary gland neoplasia, but not previously in acinic cell carcinoma ( AcCC). To discover novel gene fusions, we performed whole-transcriptome sequencing surveys of three AcCC archival cases. In one specimen we identified a novel HTN3-MSANTD3 gene fusion, and in another a novel PRB3-ZNF217 gene fusion. The structure of both fusions was consistent with the promoter of the 5' partner ( HTN3 or PRB3), both highly expressed salivary gland genes, driving overexpression of full-length MSANTD3 or ZNF217. By fluorescence in situ hybridization of an expanded AcCC case series, we observed MSANTD3 rearrangements altogether in 3 of 20 evaluable cases ( 15%), but found no additional ZNF217 rearrangements. MSANTD3 encodes a previously uncharacterized Myb/SANT domain-containing protein. Immunohistochemical staining demonstrated diffuse nuclear MSANTD3 expression in 8 of 27 AcCC cases ( 30%), including the three cases with MSANTD3 rearrangement. MSANTD3 displayed heterogeneous expression in normal salivary ductal epithelium, as well as among other histologic types of salivary gland cancer though without evidence of translocation. In a broader survey, MSANTD3 showed variable expression across a wide range of normal and neoplastic human tissue specimens. In preliminary functional studies, engineered MSANTD3 overexpression in rodent salivary gland epithelial cells did not enhance cell proliferation, but led to significant upregulation of gene sets involved in protein synthesis. Our findings newly identify MSANTD3 rearrangement as a recurrent event in salivary gland AcCC, providing new insight into disease pathogenesis, and identifying a putative novel human oncogene.	[Barasch, Nicholas; Gong, Xue; Varma, Sushama; Biscocho, Jewison; Lipsick, Joseph S.; West, Robert B.; Pollack, Jonathan R.] Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA; [Kwei, Kevin A.; Qu, Kunbin; Pelham, Robert J.] Genom Hlth, Redwood City, CA USA; [Xiao, Nan] Univ Pacific, Arthur A Dugoni Sch Dent, San Francisco, CA USA; [Kwei, Kevin A.] Pharmacyclics, Sunnyvale, CA USA; [Qu, Kunbin] OncoMed Pharmaceut, Redwood City, CA USA; [Pelham, Robert J.] Amgen Inc, San Francisco, CA USA	Stanford University; Genomic Health; University of the Pacific; Pharmacyclics; Amgen	West, RB; Pollack, JR (corresponding author), Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA.	rbwest@stanford.edu; pollack1@stanford.edu		Xiao, Nan/0000-0001-7264-3046; West, Robert/0000-0002-8330-8283	Stanford University Department of Pathology; NIH/NCI [R01 CA128836]; Genomic Health; NATIONAL CANCER INSTITUTE [R01CA128836] Funding Source: NIH RePORTER	Stanford University Department of Pathology; NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Genomic Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The Stanford authors (NB, XG, SV, JB, JSL, RBW, JRP) were funded by the Stanford University Department of Pathology, and by the NIH/NCI (R01 CA128836 to JSL); those funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The Genomic Health authors (KAK, KQ, RJP) were funded by Genomic Health, whose interest had been in developing robust methods for RNAseq analysis of FFPE specimens; Genomic Health (the funders) had no other role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the 'author contributions' section.	Aasland R, 1996, TRENDS BIOCHEM SCI, V21, P87, DOI 10.1016/S0968-0004(96)30009-1; Amemiya CT, 2013, NATURE, V496, P311, DOI 10.1038/nature12027; Asmann YW, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr362; AZEN E, 1993, INFECT IMMUN, V61, P4434, DOI 10.1128/IAI.61.10.4434-4439.1993; Bader AG, 2005, NAT REV CANCER, V5, P921, DOI 10.1038/nrc1753; Bell D, 2012, CURR ONCOL REP, V14, P166, DOI 10.1007/s11912-012-0220-5; Boyer LA, 2004, NAT REV MOL CELL BIO, V5, P158, DOI 10.1038/nrm1314; Brayer KJ, 2015, CANC DISCOV; Brenner JC, 2009, BBA-REV CANCER, V1796, P201, DOI 10.1016/j.bbcan.2009.04.005; Choi YL, 2010, CANCER RES, V70, P2296, DOI 10.1158/0008-5472.CAN-09-3141; Cohen PA, 2015, ONCOTARGET; Collins C, 1998, P NATL ACAD SCI USA, V95, P8703, DOI 10.1073/pnas.95.15.8703; Diez-Villanueva A, 2015, EPIGENET CHROMATIN, V8, DOI 10.1186/s13072-015-0014-8; Ellis GLA., 2008, AFIP ATLAS TUMOR PAT, P301; GODWIN JT, 1954, AM J PATHOL, V30, P465; Grune T, 2003, MOL CELL, V12, P449, DOI 10.1016/S1097-2765(03)00273-9; Hall DA, 2008, DIAGN CYTOPATHOL, V36, P380, DOI 10.1002/dc.20852; Hallberg B, 2013, NAT REV CANCER, V13, P685, DOI 10.1038/nrc3580; Hoffman HT, 1999, HEAD NECK-J SCI SPEC, V21, P297, DOI 10.1002/(SICI)1097-0347(199907)21:4<297::AID-HED2>3.0.CO;2-R; Iyer MK, 2011, BIOINFORMATICS, V27, P2903, DOI 10.1093/bioinformatics/btr467; Kim D, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r72; Klijn C, 2015, NAT BIOTECHNOL, V33, P306, DOI 10.1038/nbt.3080; Kononen J, 1998, NAT MED, V4, P844, DOI 10.1038/nm0798-844; Kurzrock R, 2003, ANN INTERN MED, V138, P819, DOI 10.7326/0003-4819-138-10-200305200-00010; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Marchler-Bauer A, 2015, NUCLEIC ACIDS RES, V43, pD222, DOI 10.1093/nar/gku1221; Marinelli RJ, 2008, NUCLEIC ACIDS RES, V36, pD871, DOI 10.1093/nar/gkm861; McPherson A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001138; Mitani Y, 2015, CLIN CANC RES; Mitelman F, 2007, NAT REV CANCER, V7, P233, DOI 10.1038/nrc2091; Nguyen TDT, 2005, AM J SURG PATHOL, V29, P617, DOI 10.1097/01.pas.0000157940.80538.ec; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Quissell D O, 1997, In Vitro Cell Dev Biol Anim, V33, P164; Ramsay RG, 2008, NAT REV CANCER, V8, P523, DOI 10.1038/nrc2439; Razin SV, 2012, BIOCHEMISTRY-MOSCOW+, V77, P217, DOI 10.1134/S0006297912030017; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Ruggero D, 2003, NAT REV CANCER, V3, P179, DOI 10.1038/nrc1015; SCHULER GD, 1991, PROTEINS, V9, P180, DOI 10.1002/prot.340090304; Sharma A, 2011, J BIOL CHEM, V286, P42099, DOI 10.1074/jbc.C111.294462; Stenman G, 2013, HEAD NECK PATHOL, V7, pS12, DOI 10.1007/s12105-013-0462-z; Stenner M, 2009, EUR ARCH OTO-RHINO-L, V266, P333, DOI 10.1007/s00405-008-0882-7; Subramanian A, 2007, BIOINFORMATICS, V23, P3251, DOI 10.1093/bioinformatics/btm369; Sweeney RT, 2014, NAT GENET, V46, P722, DOI 10.1038/ng.2986; van Riggelen J, 2010, NAT REV CANCER, V10, P301, DOI 10.1038/nrc2819; VANDERSPEK JC, 1990, ARCH ORAL BIOL, V35, P137, DOI 10.1016/0003-9969(90)90175-A; Vasquez MM, 2009, EXP BIOL MED, V234, P522, DOI 10.3181/0806-RM-209; Weimann M, 2013, NAT METHODS, V10, P339, DOI [10.1038/NMETH.2397, 10.1038/nmeth.2397]; Weinreb I, 2013, ADV ANAT PATHOL, V20, P367, DOI 10.1097/PAP.0b013e3182a92cc3; West RB, 2011, AM J SURG PATHOL, V35, P92, DOI 10.1097/PAS.0b013e3182002777; Yamada K, 2011, NATURE, V472, P448, DOI 10.1038/nature09947	50	25	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2017	12	2							e0171265	10.1371/journal.pone.0171265	http://dx.doi.org/10.1371/journal.pone.0171265			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BI	28212443	Green Published, gold, Green Submitted			2022-12-27	WOS:000394424700006
J	Lu, XF; Wang, YF; Liu, CY; Wang, YG				Lu, Xiaofang; Wang, Yuefen; Liu, Chunyan; Wang, Yangang			Depressive disorder and gastrointestinal dysfunction after myocardial infarct are associated with abnormal tryptophan-5-hydroxytryptamine metabolism in rats	PLOS ONE			English	Article							INDOLEAMINE 2,3-DIOXYGENASE EXPRESSION; GUT-BRAIN AXIS; SEROTONIN SYNTHESIS; MAJOR DEPRESSION; KYNURENINE; TRYPTOPHAN; MODEL; BOWEL; VULNERABILITY; METAANALYSIS	In this study, we investigated the relationship between tryptophan-5-hydroxytryptamine metabolism, depressive disorder, and gastrointestinal dysfunction in rats after myocardial infarction. Our goal was to elucidate the physiopathologic bases of somatic/psychiatric depression symptoms after myocardial infarction. A myocardial infarction model was established by permanent occlusion of the left anterior descending coronary artery. Depression-like behavior was evaluated using the sucrose preference test, open field test, and forced swim test. Gastric retention and intestinal transit were detected using the carbon powder labeling method. Immunohistochemical staining was used to detect indoleamine 2,3-dioxygenase expression in the hippocampus and ileum. High-performance liquid chromatography with fluorescence and ultraviolet detection determined the levels of 5-hydroxytryptamine, its precursor tryptophan, and its metabolite 5-hydroxyindoleacetic acid in the hippocampus, distal ileum, and peripheral blood. All data were analyzed using one-way analyses of variance. Three weeks after arterial occlusion, rats in the model group began to exhibit depression-like symptoms. For example, the rate of sucrose consumption was reduced, the total and central distance traveled in the open field test were reduced, and immobility time was increased, while swimming, struggling and latency to immobility were decreased in the forced swim test. Moreover, the gastric retention rate and gastrointestinal transit rate were increased in the model group. Expression of indoleamine 2,3-dioxygenase was increased in the hippocampus and ileum, whereas 5-hydroxytryptamine metabolism was decreased, resulting in lower 5-hydroxytryptamine and 5-hydroxyindoleacetic acid levels in the hippocampus and higher levels in the ileum. Depressive disorder and gastrointestinal dysfunction after myocardial infarction involve abnormal tryptophan-5-hydroxytryptamine metabolism, which may explain the somatic, cognitive, and psychiatric symptoms of depression commonly observed after myocardial infarction. Peripheral 5-hydroxytryptamine is an important substance in the gut-brain axis, and its abnormal metabolism is a critical finding after myocardial infarct.	[Lu, Xiaofang] Capital Med Univ, Beijing Hosp Tradit Chinese Med, Ctr Digest Dis, Beijing, Peoples R China; [Wang, Yuefen] Capital Med Univ, Beijing Hosp Tradit Chinese Med, Dept Nephropathy, Beijing, Peoples R China; [Liu, Chunyan] Hebei Med Univ, Hosp 3, Dept Rheumatol, Shijiazhuang, Hebei, Peoples R China; [Wang, Yangang] Hebei Prov Hosp Tradit Chinese Med, Dept Gastroenterol, Shijiazhuang, Hebei, Peoples R China	Capital Medical University; Capital Medical University; Hebei Medical University	Lu, XF (corresponding author), Capital Med Univ, Beijing Hosp Tradit Chinese Med, Ctr Digest Dis, Beijing, Peoples R China.; Wang, YG (corresponding author), Hebei Prov Hosp Tradit Chinese Med, Dept Gastroenterol, Shijiazhuang, Hebei, Peoples R China.	hbydlu@163.com; piwei001@163.com						Al-Ebrahim F, 2012, CAN J GASTROENTEROL, V26, P151, DOI 10.1155/2012/841792; Arnold SA, 2012, NEUROPHARMACOLOGY, V63, P1238, DOI 10.1016/j.neuropharm.2012.07.047; Arseneault-Breard J, 2012, BRIT J NUTR, V107, P1793, DOI 10.1017/S0007114511005137; Badawy AAB, 2013, J PSYCHOPHARMACOL, V27, P878, DOI 10.1177/0269881113499209; Basova N A, 2003, Ross Fiziol Zh Im I M Sechenova, V89, P1010; CAMPBELL AW, 2015, ALTERN THER HEALT S3, V21, P8; Castilla-Ortega E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085348; Chen S, 2013, PLOS ONE, V27; Cryan JF, 2011, NEUROGASTROENT MOTIL, V23, P187, DOI 10.1111/j.1365-2982.2010.01664.x; Dale E, 2015, CNS SPECTRUMS, V8, P1; Dennis RL, 2012, POULTRY SCI, V91, P817, DOI 10.3382/ps.2011-01779; Fallarino F, 2002, INT IMMUNOL, V14, P65, DOI 10.1093/intimm/14.1.65; GAL EM, 1980, NEUROCHEM RES, V5, P223, DOI 10.1007/BF00964611; Georgin-Lavialle S, 2016, ALLERGY, V71, P416, DOI 10.1111/all.12802; Gershon Michael D, 2012, Trans Am Clin Climatol Assoc, V123, P268; Gold AB, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-17; Grandjean J., 2016, NEUROIMAGE; Holzer P, 2012, NEUROPEPTIDES, V46, P261, DOI 10.1016/j.npep.2012.08.005; Hu XY, 2007, EUR J CARDIO-THORAC, V31, P438, DOI 10.1016/j.ejcts.2006.11.057; Keszthelyi D, 2013, J PSYCHOSOM RES, V74, P501, DOI 10.1016/j.jpsychores.2013.01.008; Knapton AD, 2010, METHOD FIND EXP CLIN, V32, P489, DOI 10.1358/mf.2010.32.7.1507854; Lapin IP, 2003, ADV EXP MED BIOL, V527, P121; LAPIN IP, 1969, LANCET, V1, P132; Larsson MBO, 2012, GASTROENTEROLOGY, V142, P463, DOI 10.1053/j.gastro.2011.11.022; Lesurtel M, 2008, CELL MOL LIFE SCI, V65, P940, DOI 10.1007/s00018-007-7377-3; Liu HN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024928; Ma XC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056053; Mazarei G, 2013, EXP NEUROL, V249, P144, DOI 10.1016/j.expneurol.2013.08.007; Meijer A, 2011, GEN HOSP PSYCHIAT, V33, P203, DOI 10.1016/j.genhosppsych.2011.02.007; Mohamed BM, 2013, NEUROPSYCH DIS TREAT, V9, DOI 10.2147/NDT.S41020; Muller N, 2008, EUR ARCH PSY CLIN N, V258, P97, DOI 10.1007/s00406-008-2012-3; Nakamura R, 2002, CARDIOVASC RES, V56, P373, DOI 10.1016/S0008-6363(02)00594-1; Nishizawa S, 1997, P NATL ACAD SCI USA, V94, P5308, DOI 10.1073/pnas.94.10.5308; O'Malley D, 2010, STRESS, V13, P114, DOI 10.3109/10253890903067418; Overstreet DH, 2012, METHODS MOL BIOL, V829, P125, DOI 10.1007/978-1-61779-458-2_7; Oxenkrug G, 2013, CURR DRUG TARGETS, V14, P514, DOI 10.2174/1389450111314050002; Oxenkrug GF, 2007, ANN NY ACAD SCI, V1122, P35, DOI 10.1196/annals.1403.003; RAPPORT MM, 1948, J BIOL CHEM, V176, P1243; Rogoz Z, 2012, PHARMACOL REP, V64, P1391, DOI 10.1016/S1734-1140(12)70936-2; Shi Rong-xing, 2015, Zhen Ci Yan Jiu, V40, P444; Sui Zhi-Yan, 2012, Clin Psychopharmacol Neurosci, V10, P155, DOI 10.9758/cpn.2012.10.3.155; Tang Yamei, 2012, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V37, P790, DOI 10.3969/j.issn.1672-7347.2012.08.006; Teramoto Y, 1998, JPN J PHYSIOL, V48, P333, DOI 10.2170/jjphysiol.48.333; Trueblood NA, 2001, CIRC RES, V88, P1080, DOI 10.1161/hh1001.090842; Wang Y-H, 2013, WCJD, V21, P1226, DOI DOI 10.11569/WCJD.V21.I13.1226; Wang YM, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-32; Wann BP, 2007, J PSYCHIATR NEUROSCI, V32, P11; Won E., 2015, CURR NEUROPHARMACOL, P1; Wood JD, 2010, CURR OPIN GASTROEN, V26, P102, DOI 10.1097/MOG.0b013e328334df4f; Wu Q, 2016, MEDICINE, V95, P1, DOI 10.1097/MD.0000000000002815; [张仲林 ZHANG Zhong-lin], 2009, [时珍国医国药, Lishizhen Medicine and Materia Medica Research], V20, P3151; Zhou LP, 2012, EUR J GASTROEN HEPAT, V24, P695, DOI 10.1097/MEG.0b013e328351c1c2	52	6	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2017	12	2							e0172339	10.1371/journal.pone.0172339	http://dx.doi.org/10.1371/journal.pone.0172339			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BI	28212441	gold, Green Submitted, Green Published			2022-12-27	WOS:000394424700034
J	Grune, F; Kazmaier, S; Hoeks, SE; Stolker, RJ; Coburn, M; Weyland, A				Grune, Frank; Kazmaier, Stephan; Hoeks, Sanne Elisabeth; Stolker, Robert Jan; Coburn, Marc; Weyland, Andreas			Argon does not affect cerebral circulation or metabolism in male humans	PLOS ONE			English	Article							BLOOD-FLOW VELOCITY; TRANSCRANIAL DOPPLER SONOGRAPHY; INERT-GAS NARCOSIS; XENON ANESTHESIA; STABLE XENON; ORGANOPROTECTIVE PROPERTIES; ORGAN PERFUSION; NOBLE-GAS; PRESSURE; RESISTANCE	Objective Accumulating data have recently underlined argon As neuroprotective potential. However, to the best of our knowledge, no data are available on the cerebrovascular effects of argon (Ar) in humans. We hypothesized that argon inhalation does not affect mean blood flow velocity of the middle cerebral artery (Vmca), cerebral flow index (FI), zero flow pressure (ZFP), effective cerebral perfusion pressure (CPPe), resistance area product (RAP) and the arterio-jugular venous content differences of oxygen (AJVDO(2)), glucose (AJVDG), and lactate (AJVDL) in anesthetized patients. Materials and methods In a secondary analysis of an earlier controlled cross-over trial we compared parameters of the cerebral circulation under 15 minutes exposure to 70%Ar/30%O-2 versus 70%N-2/30%O-2 in 29 male patients under fentanyl-midazolam anaesthesia before coronary surgery. Vmca was measured by transcranial Doppler sonography. ZFP and RAP were estimated by linear regression analysis of pressure-flow velocity relationships of the middle cerebral artery. CPPe was calculated as the difference between mean arterial pressure and ZFP. AJVDO2, AJVDG and AJVDL were calculated as the differences in contents between arterial and jugular-venous blood of oxygen, glucose, and lactate. Statistical analysis was done by t-tests and ANOVA. Results Mechanical ventilation with 70% Ar did not cause any significant changes in mean arterial pressure, Vmca, FI, ZFP, CPPe, RAP, AJVDO2, AJVDG, and AJVDL. Discussion Short-term inhalation of 70% Ar does not affect global cerebral circulation or metabolism in male humans under general anaesthesia.	[Grune, Frank; Hoeks, Sanne Elisabeth; Stolker, Robert Jan] Erasmus Univ, Dept Anaesthesiol, Med Ctr, Rotterdam, Netherlands; [Kazmaier, Stephan] Univ Hosp Gottingen, Ctr Anaesthesiol Crit Care Emergency Med & Pain T, Gottingen, Germany; [Coburn, Marc] Rhein Westfal TH Aachen, Dept Anaesthesiol, Univ Hosp, Aachen, Germany; [Weyland, Andreas] Carl von Ossietzky Univ Oldenburg, Klinikum Oldenburg, Dept Anaesthesiol Crit Care Emergency Med & Pain, Med Campus, Oldenburg, Germany	Erasmus University Rotterdam; Erasmus MC; University of Gottingen; RWTH Aachen University; RWTH Aachen University Hospital; Carl von Ossietzky Universitat Oldenburg; Klinikum Oldenburg	Grune, F (corresponding author), Erasmus Univ, Dept Anaesthesiol, Med Ctr, Rotterdam, Netherlands.	f.grune@erasmusmc.nl; weyland.andreas@klinikum-oldenburg.de	Grüne, Frank/G-4869-2018; Hoeks, Sanne/AAM-3313-2020	Grüne, Frank/0000-0001-5693-3721; 				AASLID R, 1987, STROKE, V18, P771, DOI 10.1161/01.STR.18.4.771; Alderliesten T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113575; Ashina M, 2012, CEPHALALGIA, V32, P428, DOI 10.1177/0333102412438978; Behnke AR, 1939, AM J PHYSIOL, V126, P409, DOI 10.1152/ajplegacy.1939.126.2.409; Brucken A, 2013, BRIT J ANAESTH, V110, P106, DOI 10.1093/bja/aes509; Coburn M, 2012, EUR J ANAESTH, V29, P549, DOI 10.1097/EJA.0b013e328357bfdd; COESA, 1976, NOAAST761562 COESA, P1; Cummings P, 2011, ARCH PEDIAT ADOL MED, V165, P592, DOI 10.1001/archpediatrics.2011.97; Deng J, 2014, PROG NEUROBIOL, V115, P210, DOI 10.1016/j.pneurobio.2014.01.001; EVANS DH, 1988, ULTRASOUND MED BIOL, V14, P103, DOI 10.1016/0301-5629(88)90176-7; Fahlenkamp AV, 2012, EUR J PHARMACOL, V674, P104, DOI 10.1016/j.ejphar.2011.10.045; FOWLER B, 1985, UNDERSEA BIOMED RES, V12, P369; Frietsch T, 2001, ANESTHESIOLOGY, V94, P290, DOI 10.1097/00000542-200102000-00019; Giller CA, 1998, NEUROSURGERY, V42, P1076, DOI 10.1097/00006123-199805000-00077; GILLER CA, 1990, AM J NEURORADIOL, V11, P177; Grune F, 2001, ANASTH INTENSIV NOTF, V36, P538, DOI 10.1055/s-2001-17259; Grune F, 2015, J CEREBR BLOOD F MET, V35, P1470, DOI 10.1038/jcbfm.2015.63; Grune F, 2014, ANESTHESIOLOGY, V120, P335, DOI 10.1097/ALN.0b013e3182a8eb09; GUR D, 1985, STROKE, V16, P871, DOI 10.1161/01.STR.16.5.871; HARTMANN A, 1991, STROKE, V22, P182, DOI 10.1161/01.STR.22.2.182; HARTMANN A, 1987, STROKE, V18, P643, DOI 10.1161/01.STR.18.3.643; Hatab MR, 1997, ULTRASOUND MED BIOL, V23, P1025, DOI 10.1016/S0301-5629(97)00030-6; Hoellig A, 2014, INT J MOL SCI, V15, P18175, DOI 10.3390/ijms151018175; ITOH T, 1993, STROKE, V24, P1192, DOI 10.1161/01.STR.24.8.1192; Laitio RM, 2007, ANESTHESIOLOGY, V106, P1128, DOI 10.1097/01.anes.0000267596.57497.92; Law LSC, 2016, ANESTH ANALG, V122, P678, DOI 10.1213/ANE.0000000000000914; Loetscher PD, 2009, CRIT CARE, V13, DOI 10.1186/cc8214; Lunt MJ, 2004, PHYSIOL MEAS, V25, P467, DOI 10.1088/0967-3334/25/2/006; LUTTROPP HH, 1993, ANAESTHESIA, V48, P1045; Maller K, 2002, ACTA ANAESTH SCAND, V46, P567; McCulloch TJ, 2005, ANESTH ANALG, V100, P1463, DOI 10.1213/01.ANE.0000148623.06596.7E; Mielck F, 1999, ANESTH ANALG, V89, P364, DOI 10.1097/00000539-199908000-00022; Mielck F, 1998, BRIT J ANAESTH, V81, P155, DOI 10.1093/bja/81.2.155; Ogoh S, 2010, EXP PHYSIOL, V95, P678, DOI 10.1113/expphysiol.2010.052340; Pavlov BN, 1999, ADVANCES IN HIGH PRESSURE BIOSCIENCE AND BIOTECHNOLOGY, P561; Rau G, 1969, BASIC RES CARDIOL, V58, P322; Rossaint R, 2003, ANESTHESIOLOGY, V98, P6, DOI 10.1097/00000542-200301000-00005; Rostain JC, 2006, UNDERSEA HYPERBAR M, V33, P197; Sawilowsky S., 2002, J MODERN APPL STAT M, V1, P461, DOI DOI 10.22237/JMASM/1036109940; Schmidt M, 2001, ANAESTHESIA, V56, P1154, DOI 10.1046/j.1365-2044.2001.02322.x; Shulagin IA, 2001, HUM PHYSL, V27, P84; STEPHAN H, 1989, ANAESTHESIA, V44, P310, DOI 10.1111/j.1365-2044.1989.tb11284.x; Stephan H, 1996, ANAESTHESIST, V45, P1030, DOI 10.1007/s001010050336; Tarek R, 2014, AIN SHAMS J ANAESTHE, V7, P444; TAUCHERT M, 1971, Z KREISLAUFFORSCH, V60, P871; Ulbrich F, 2015, NEURAL REGEN RES, V10, P1043, DOI 10.4103/1673-5374.160071; Valdueza JM, 1999, STROKE, V30, P81, DOI 10.1161/01.STR.30.1.81; Varsos GV, 2015, J NEUROSURG, V123, P638, DOI 10.3171/2014.10.JNS14613; Victor A, 2010, DTSCH ARZTEBL INT, V107, P50, DOI [10.3238/arztebl.2009.0050, 10.3238/arztebl.2010.0050]; Weyland A, 1996, ANAESTHESIST, V45, P1037, DOI 10.1007/s001010050337; Weyland A, 2000, J NEUROSURG ANESTH, V12, P210, DOI 10.1097/00008506-200007000-00002; WEYLAND A, 1994, ANESTHESIOLOGY, V81, P1401, DOI 10.1097/00000542-199412000-00015; YAO LP, 1992, STROKE, V23, P69, DOI 10.1161/01.STR.23.1.69; YAO LP, 1992, J NEUROSURG ANESTH, V4, P268, DOI 10.1097/00008506-199210000-00007	55	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0171962	10.1371/journal.pone.0171962	http://dx.doi.org/10.1371/journal.pone.0171962			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207907	gold, Green Published, Green Submitted			2022-12-27	WOS:000394424500064
J	Kuzniar, A; Laffeber, C; Eppink, B; Bezstarosti, K; Dekkers, D; Woelders, H; Zwamborn, APM; Demmers, J; Lebbink, JHG; Kanaar, R				Kuzniar, Arnold; Laffeber, Charlie; Eppink, Berina; Bezstarosti, Karel; Dekkers, Dick; Woelders, Henri; Zwamborn, A. Peter M.; Demmers, Jeroen; Lebbink, Joyce H. G.; Kanaar, Roland			Semi-quantitative proteomics of mammalian cells upon short-term exposure to non-ionizing electromagnetic fields	PLOS ONE			English	Article							DNA-DAMAGE RESPONSE; GENE-EXPRESSION; IN-VITRO; AMINO-ACIDS; METHYLATION; CANCER; TRANSCRIPTION; SENESCENCE; RADIATION; POWERFUL	The potential effects of non-ionizing electromagnetic fields (EMFs), such as those emitted by power-lines (in extremely low frequency range), mobile cellular systems and wireless networking devices (in radio frequency range) on human health have been intensively researched and debated. However, how exposure to these EMFs may lead to biological changes underlying possible health effects is still unclear. To reveal EMF-induced molecular changes, unbiased experiments (without a priori focusing on specific biological processes) with sensitive readouts are required. We present the first proteome-wide semi-quantitative mass spectrometry analysis of human fibroblasts, osteosarcomas and mouse embryonic stem cells exposed to three types of non-ionizing EMFs (ELF 50 Hz, UMTS 2.1 GHz and WiFi 5.8 GHz). We performed controlled in vitro EMF exposures of metabolically labeled mammalian cells followed by reliable statistical analyses of differential protein-and path-way-level regulations using an array of established bioinformatics methods. Our results indicate that less than 1% of the quantitated human or mouse proteome responds to the EMFs by small changes in protein abundance. Further network-based analysis of the differentially regulated proteins did not detect significantly perturbed cellular processes or pathways in human and mouse cells in response to ELF, UMTS or WiFi exposure. In conclusion, our extensive bioinformatics analyses of semi-quantitative mass spectrometry data do not support the notion that the short-time exposures to non-ionizing EMFs have a consistent biologically significant bearing on mammalian cells in culture.	[Kuzniar, Arnold; Laffeber, Charlie; Eppink, Berina; Lebbink, Joyce H. G.; Kanaar, Roland] Erasmus Univ, Med Ctr, Dept Mol Genet, Canc Genom Netherlands, Rotterdam, Netherlands; [Kuzniar, Arnold] Netherlands eSci Ctr, Amsterdam, Netherlands; [Bezstarosti, Karel; Dekkers, Dick; Demmers, Jeroen] Erasmus Univ, Med Ctr, Prote Ctr, Rotterdam, Netherlands; [Woelders, Henri] Wageningen Livestock Res, Wageningen, Netherlands; [Zwamborn, A. Peter M.] TNO, The Hague, Netherlands; [Demmers, Jeroen] Netherlands Prote Ctr, Rotterdam, Netherlands; [Lebbink, Joyce H. G.; Kanaar, Roland] Erasmus Univ, Med Ctr, Dept Radiat Oncol, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Wageningen University & Research; Netherlands Organization Applied Science Research; Erasmus University Rotterdam; Erasmus MC	Kuzniar, A; Kanaar, R (corresponding author), Erasmus Univ, Med Ctr, Dept Mol Genet, Canc Genom Netherlands, Rotterdam, Netherlands.; Kuzniar, A (corresponding author), Netherlands eSci Ctr, Amsterdam, Netherlands.; Kanaar, R (corresponding author), Erasmus Univ, Med Ctr, Dept Radiat Oncol, Rotterdam, Netherlands.	a.kuzniar@esciencecenter.nl; r.kanaar@erasmusmc.nl	Demmers, Jeroen AA/F-4046-2016	Demmers, Jeroen AA/0000-0002-8757-9611; Kuzniar, Arnold/0000-0003-1711-7961	Zon-MW Electromagnetic Fields Health [85800003, 85100004, 85300007]; Netherlands Organization for Scientific Research (NWO); NWO as part of the National Roadmap Large-Scale Research Facilities of The Netherlands [184.032.201]; SURF Foundation	Zon-MW Electromagnetic Fields Health; Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); NWO as part of the National Roadmap Large-Scale Research Facilities of The Netherlands; SURF Foundation	This work was supported by Zon-MW (www.zonmw.nl) subsidy in Electromagnetic Fields & Health [85800003, 85100004, 85300007]; the Netherlands Organization for Scientific Research (NWO, http://www.nwo.nl) Gravitation subsidy Cancer Genomics Netherlands. This work was part of the project Proteins At Work, a program of The Netherlands Proteomics Centre financed by NWO as part of the National Roadmap Large-Scale Research Facilities of The Netherlands [184.032.201], and was carried out on the Dutch national e-infrastructure with the support of SURF Foundation. Funding for open access charge: Zon-MW subsidy in Electromagnetic Fields & Health [85800003].	Amente S, 2013, BBA-GENE REGUL MECH, V1829, P981, DOI 10.1016/j.bbagrm.2013.05.002; Bai WF, 2013, CYTOTHERAPY, V15, P961, DOI 10.1016/j.jcyt.2013.03.001; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Bauer S, 2011, BIOINFORMATICS, V27, P1882, DOI 10.1093/bioinformatics/btr296; Belyaev IY, 2006, BIOELECTROMAGNETICS, V27, P295, DOI 10.1002/bem.20216; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Breitling R, 2004, FEBS LETT, V573, P83, DOI 10.1016/j.febslet.2004.07.055; Cejka P, 2003, EMBO J, V22, P2245, DOI 10.1093/emboj/cdg216; Chauhan V, 2007, PROTEOMICS, V7, P3896, DOI 10.1002/pmic.200700215; Chen GD, 2012, BIOELECTROMAGNETICS, V33, P550, DOI 10.1002/bem.21724; Chen HS, 2015, MOL CELL, V59, P719, DOI 10.1016/j.molcel.2015.07.011; Chen ZJ, 2013, BIOCHEM BIOPH RES CO, V433, P36, DOI 10.1016/j.bbrc.2013.02.071; Colaert N, 2010, PROTEOMICS, V10, P1226, DOI 10.1002/pmic.200900379; Collard JF, 2015, CELL SIGNAL, V27, P889, DOI 10.1016/j.cellsig.2015.02.007; Collard JF, 2013, PROG BIOPHYS MOL BIO, V111, P37, DOI 10.1016/j.pbiomolbio.2012.12.004; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Croft D, 2014, NUCLEIC ACIDS RES, V42, pD472, DOI 10.1093/nar/gkt1102; Dembele D, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-14; Derks KWJ, 2014, DNA REPAIR, V19, P214, DOI 10.1016/j.dnarep.2014.03.008; Focke F, 2010, MUTAT RES-FUND MOL M, V683, P74, DOI 10.1016/j.mrfmmm.2009.10.012; Ford DJ, 2015, CANCER GENET-NY, V208, P178, DOI 10.1016/j.cancergen.2015.01.005; Giglia-Mari G, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a000745; Girgert R, 2008, BIOELECTROMAGNETICS, V29, P169, DOI 10.1002/bem.20387; Graumann J, 2008, MOL CELL PROTEOMICS, V7, P672, DOI 10.1074/mcp.M700460-MCP200; Hamidi T, 2015, EPIGENOMICS-UK, V7, P247, DOI [10.2217/EPI.14.80, 10.2217/epi.14.80]; Harada S, 2001, BIOELECTROMAGNETICS, V22, P260, DOI 10.1002/bem.48; Hauri DD, 2014, AM J EPIDEMIOL, V179, P843, DOI 10.1093/aje/kwt442; Hong FX, 2006, BIOINFORMATICS, V22, P2825, DOI 10.1093/bioinformatics/btl476; Huntley RP, 2015, NUCLEIC ACIDS RES, V43, pD1057, DOI 10.1093/nar/gku1113; Huwiler SG, 2012, BIOELECTROMAGNETICS, V33, P488, DOI 10.1002/bem.21709; Iglewicz B, 1993, DETECT HANDLE OUTLIE, V16; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Jiang H, 2011, CELL, V144, P513, DOI 10.1016/j.cell.2011.01.020; Jiricny J, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012633; Kanavi MR, 2012, INVEST OPHTH VIS SCI, V53, P7881, DOI 10.1167/iovs.12-10248; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kirschenlohr H, 2012, RADIAT RES, V178, P138, DOI 10.1667/RR2859.1; Kuzniar A, 2014, NUCLEIC ACIDS RES, V42, pW100, DOI 10.1093/nar/gku478; Le Quement C, 2012, BIOELECTROMAGNETICS, V33, P147, DOI 10.1002/bem.20693; Leszczynski D, 2014, PROTEOMICS, V14, P481, DOI 10.1002/pmic.201300390; Loughery JEP, 2011, HUM MOL GENET, V20, P3241, DOI 10.1093/hmg/ddr236; Lundberg E, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.106; Margolin AA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007454; McCarthy DJ, 2009, BIOINFORMATICS, V25, P765, DOI 10.1093/bioinformatics/btp053; Merrifield Matt, 2013, Frontiers in Genetics, V4, P40, DOI 10.3389/fgene.2013.00040; Neutzner M, 2012, ESSAYS BIOCHEM, V52, P37, DOI [10.1042/bse0520037, 10.1042/BSE0520037]; Nylund R, 2010, PROTEOME SCI, V8, DOI 10.1186/1477-5956-8-52; Ong SE, 2006, NAT PROTOC, V1, P2650, DOI 10.1038/nprot.2006.427; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; Sap KA, 2015, PROTEOMICS, V15, P725, DOI 10.1002/pmic.201400308; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schuderer J, 2004, BIOELECTROMAGNETICS, V25, P582, DOI 10.1002/bem.20037; Schwammle V, 2013, J PROTEOME RES, V12, P3874, DOI 10.1021/pr400045u; Sever R, 2015, CSH PERSPECT MED, V5, DOI 10.1101/cshperspect.a006098; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Ting L, 2009, MOL CELL PROTEOMICS, V8, P2227, DOI 10.1074/mcp.M800462-MCP200; Tomson BN, 2013, BBA-GENE REGUL MECH, V1829, P116, DOI 10.1016/j.bbagrm.2012.08.011; Vijayalaxmi, 2009, INT J RADIAT BIOL, V85, P196, DOI 10.1080/09553000902748575; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Vizcaino JA, 2013, NUCLEIC ACIDS RES, V41, pD1063, DOI 10.1093/nar/gks1262; Zhang J, 2011, CHEM RES TOXICOL, V24, P2040, DOI 10.1021/tx2003849; Zhang RG, 2005, DEV CELL, V8, P19, DOI 10.1016/j.devcel.2004.10.019	63	12	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0170762	10.1371/journal.pone.0170762	http://dx.doi.org/10.1371/journal.pone.0170762			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5VB	28234898	gold, Green Published, Green Submitted			2022-12-27	WOS:000394688200012
J	Ali, H; Bitar, MS; Al Madhoun, A; Marafie, M; Al-Mulla, F				Ali, Hamad; Bitar, Milad S.; Al Madhoun, Ashraf; Marafie, Makia; Al-Mulla, Fahd			Functionally-focused algorithmic analysis of high resolution microarray-CGH genomic landscapes demonstrates comparable genomic copy number aberrations in MSI and MSS sporadic colorectal cancer	PLOS ONE			English	Article							LIVER METASTASES; GENE-EXPRESSION; MICROSATELLITE INSTABILITY; HYBRIDIZATION ANALYSIS; PATIENT SURVIVAL; SOLID TUMORS; COLON-CANCER; DNA; CHROMOTHRIPSIS; CARCINOMA	Array-based comparative genomic hybridization (aCGH) emerged as a powerful technology for studying copy number variations at higher resolution in many cancers including colorectal cancer. However, the lack of standardized systematic protocols including bioinformatic algorithms to obtain and analyze genomic data resulted in significant variation in the reported copy number aberration (CNA) data. Here, we present genomic aCGH data obtained using highly stringent and functionally relevant statistical algorithms from 116 well-defined microsatellites instable (MSI) and microsatellite stable (MSS) colorectal cancers. We utilized aCGH to characterize genomic CNAs in 116 well-defined sets of colorectal cancer (CRC) cases. We further applied the significance testing for aberrant copy number (STAC) and Genomic Identification of Significant Targets in Cancer (GISTIC) algorithms to identify functionally relevant (nonrandom) chromosomal aberrations in the analyzed colorectal cancer samples. Our results produced high resolution genomic landscapes of both, MSI and MSS sporadic CRC. We found that CNAs in MSI and MSS CRCs are heterogeneous in nature but may be divided into 3 distinct genomic patterns. Moreover, we show that although CNAs in MSI and MSS CRCs differ with respect to their size, number and chromosomal distribution, the functional copy number aberrations obtained from MSI and MSS CRCs were in fact comparable but not identical. These unifying CNAs were verified by MLPA tumor-loss gene panel, which spans 15 different chromosomal locations and contains 50 probes for at least 20 tumor suppressor genes. Consistently, deletion/amplification in these frequently cancer altered genes were identical in MSS and MSI CRCs. Our results suggest that MSI and MSS copy number aberrations driving CRC may be functionally comparable.	[Ali, Hamad] Kuwait Univ, Fac Allied Hlth Sci, Dept Med Lab Sci, Jabriya, Kuwait; [Ali, Hamad; Bitar, Milad S.; Al Madhoun, Ashraf] DDI, Div Res, Immunol Unit, Dasman, Kuwait; [Bitar, Milad S.] Kuwait Univ, Dept Pharmacol & Toxicol, Fac Med, Jabriya, Kuwait; [Marafie, Makia] Kuwait Med Genet Ctr, Kuwait, Kuwait; [Al-Mulla, Fahd] Kuwait Univ, Dept Pathol, Mol Pathol Unit, Fac Med, Jabriya, Kuwait; [Al-Mulla, Fahd] DDI, Div Res, Genom Unit, Dasman, Kuwait	Kuwait University; Kuwait University; Kuwait University	Ali, H (corresponding author), Kuwait Univ, Fac Allied Hlth Sci, Dept Med Lab Sci, Jabriya, Kuwait.; Ali, H (corresponding author), DDI, Div Res, Immunol Unit, Dasman, Kuwait.; Al-Mulla, F (corresponding author), Kuwait Univ, Dept Pathol, Mol Pathol Unit, Fac Med, Jabriya, Kuwait.; Al-Mulla, F (corresponding author), DDI, Div Res, Genom Unit, Dasman, Kuwait.	hamad.ali@hsc.edu.kw; fahd@al-mulla.org	Al-Mulla, Fahd/E-2068-2015; Ali, Hamad/AAA-2192-2021	Al-Mulla, Fahd/0000-0001-5409-3829; Al Madhoun, Ashraf/0000-0001-8593-3878; Yaseen Ali, Hamad/0000-0001-6623-3374	Kuwait Foundation for the Advancement of Sciences KFAS [2011-1302-06]	Kuwait Foundation for the Advancement of Sciences KFAS(Kuwait Foundation for the Advancement of Sciences (KFAS))	This work was supported by grant number 2011-1302-06, given to Prof. Fahd Al-Mulla by the Kuwait Foundation for the Advancement of Sciences KFAS (www.kfas.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by grant number 2011-1302-06, given to Prof. Fahd Al-Mulla by the Kuwait Foundation for the Advancement of Sciences KFAS. We wish to thank Mrs Sindhu Jacob, and Mrs Diana Thomas for their technical assistance.	Al-Mulla F, 2006, MODERN PATHOL, V19, P648, DOI 10.1038/modpathol.3800564; Al-Mulla F, 1999, GENE CHROMOSOME CANC, V24, P306, DOI 10.1002/(SICI)1098-2264(199904)24:4<306::AID-GCC3>3.0.CO;2-5; Al-Mulla F, 2011, METHODS MOL BIOL, V724, P131, DOI 10.1007/978-1-61779-055-3_9; Al-Mulla Fahd, 2007, V382, P77, DOI 10.1007/978-1-59745-304-2_6; Al-Temaimi RA, 2013, J HISTOCHEM CYTOCHEM, V61, P627, DOI 10.1369/0022155413497367; Aragane H, 2001, INT J CANCER, V94, P623, DOI 10.1002/ijc.1522; Ashktorab H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008879; Barrett MT, 2004, P NATL ACAD SCI USA, V101, P17765, DOI 10.1073/pnas.0407979101; Bejjani BA, 2006, J MOL DIAGN, V8, P528, DOI 10.2353/jmoldx.2006.060029; Bentz M, 1998, GENE CHROMOSOME CANC, V21, P172, DOI 10.1002/(SICI)1098-2264(199802)21:2<172::AID-GCC14>3.0.CO;2-T; Bosso M, 2011, METHODS MOL BIOL, V724, P161, DOI 10.1007/978-1-61779-055-3_11; Calon A, 2015, NAT GENET, V47, P320, DOI 10.1038/ng.3225; Camps J, 2006, CARCINOGENESIS, V27, P419, DOI 10.1093/carcin/bgi244; Chin L, 2011, GENE DEV, V25, P534, DOI 10.1101/gad.2017311; Chu CM, 2014, DIS MARKERS, V2014, DOI 10.1155/2014/634123; Diep CB, 2003, GENE CHROMOSOME CANC, V36, P189, DOI 10.1002/gcc.10162; Diskin SJ, 2006, GENOME RES, V16, P1149, DOI 10.1101/gr.5076506; Douglas EJ, 2004, CANCER RES, V64, P4817, DOI 10.1158/0008-5472.CAN-04-0328; Dyrso T, 2011, CANCER GENET-NY, V204, P84, DOI 10.1016/j.cancergencyto.2010.08.019; Fatemi M, 2014, CANCER-AM CANCER SOC, V120, P172, DOI 10.1002/cncr.28316; Jasmine F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031968; Ji XL, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-426; Jones AM, 2005, ONCOGENE, V24, P118, DOI 10.1038/sj.onc.1208194; Jones MJK, 2012, DEV CELL, V23, P908, DOI 10.1016/j.devcel.2012.10.010; Jorissen RN, 2008, CLIN CANCER RES, V14, P8061, DOI 10.1158/1078-0432.CCR-08-1431; Kallioniemi A, 2008, CURR OPIN BIOTECH, V19, P36, DOI 10.1016/j.copbio.2007.11.004; KALLIONIEMI OP, 1994, GENE CHROMOSOME CANC, V10, P231, DOI 10.1002/gcc.2870100403; Kheirelseid EAH, 2013, J GASTROINTEST ONCOL, V4, P144, DOI 10.3978/j.issn.2078-6891.2013.010; Kloosterman WP, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-10-r103; Kloosterman WP, 2011, HUM MOL GENET, V20, P1916, DOI 10.1093/hmg/ddr073; Korn WM, 1999, GENE CHROMOSOME CANC, V25, P82, DOI 10.1002/(SICI)1098-2264(199906)25:2<82::AID-GCC2>3.0.CO;2-6; Lassmann S, 2007, J MOL MED-JMM, V85, P289, DOI 10.1007/s00109-006-0126-5; Lee S, 2006, ONCOL REP, V16, P747; Lockwood WW, 2006, EUR J HUM GENET, V14, P139, DOI 10.1038/sj.ejhg.5201531; Loo LWM, 2013, GENE CHROMOSOME CANC, V52, P450, DOI 10.1002/gcc.22043; Marisa L, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001453; Martin ES, 2007, CANCER RES, V67, P10736, DOI 10.1158/0008-5472.CAN-07-2742; Meacham CE, 2013, NATURE, V501, P328, DOI 10.1038/nature12624; Mermel CH, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r41; Mertens F, 1997, CANCER RES, V57, P2765; Mlecnik B, 2016, IMMUNITY, V44, P698, DOI 10.1016/j.immuni.2016.02.025; Nakao K, 2001, CANCER, V91, P721, DOI 10.1002/1097-0142(20010215)91:4<721::AID-CNCR1057>3.3.CO;2-V; Nosho K, 2010, J PATHOL, V222, P350, DOI 10.1002/path.2774; Pancione M, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-297; Pinkel D, 1998, NAT GENET, V20, P207, DOI 10.1038/2524; Pinkel D, 2005, NAT GENET, V37, pS11, DOI 10.1038/ng1569; Pollack JR, 1999, NAT GENET, V23, P41, DOI 10.1038/12640; Ried T, 1996, GENE CHROMOSOME CANC, V15, P234, DOI 10.1002/(SICI)1098-2264(199604)15:4<234::AID-GCC5>3.0.CO;2-2; Salovaara R, 2002, GUT, V51, P56, DOI 10.1136/gut.51.1.56; Sarli L, 2004, EUR J CANCER, V40, P1581, DOI 10.1016/j.ejca.2004.02.021; Sawai H, 2008, BMC GASTROENTEROL, V8, DOI 10.1186/1471-230X-8-56; Trautmann K, 2006, CLIN CANCER RES, V12, P6379, DOI 10.1158/1078-0432.CCR-06-1248; Wang X, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-95; Zack TI, 2013, NAT GENET, V45, P1134, DOI 10.1038/ng.2760	54	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2017	12	2							e0171690	10.1371/journal.pone.0171690	http://dx.doi.org/10.1371/journal.pone.0171690			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5SX	28231327	Green Submitted, gold, Green Published			2022-12-27	WOS:000394682400016
J	Doi, H; Osawa, I; Adachi, H; Kawada, M				Doi, Hiroyasu; Osawa, Ikuko; Adachi, Hayamitsu; Kawada, Manabu			Vibrio japonicus sp nov., a novel member of the Nereis clade in the genus Vibrio isolated from the coast of Japan	PLOS ONE			English	Article							RECLASSIFICATION; IDENTIFICATION; TAXONOMY	A novel Vibrio strain, JCM 31412 (T), was isolated from seawater collected from the Inland Sea (Setonaikai), Japan, and characterized as a Gram-negative, oxidase-positive, catalase- negative, facultatively anaerobic, motile, ovoid-shaped bacterium with one polar flagellum. Based on 16S rDNA gene identity, strain JCM 31412 (T) showed a close relationship with type strains of Vibrio brasiliensis (LMG 20546 (T), 98.2% identity), V. harveyi (NBRC 15634 (T), 98.2%), V. caribbeanicus (ATCC BAA-2122 (T), 97.8%) and V. proteolyticus (NBRC 13287 (T), 97.8%). The G+ C content of strain JCM 31412 T DNA was 46.8%. Multi-locus sequence analysis (MLSA) of eight loci (ftsZ, gapA, gyrB, mreB, pyrH, recA, rpoA and topA; 5535bp) further clustered strain JCM 31412 (T) in the Nereis clade, genus Vibrio. Phenotypically, strain JCM 31412 (T) differed from the closest related Vibrio species in its utilization of melibiose and raffinose, and its lack of casein and gelatin hydrolysis. It was further differentiated based on its fatty acid composition, specifically properties of C12: 03OH and summed features, which were significantly different from those of V. brasiliensis, V. nigripulchritudo and V. caribbeanicus type strains. Overall, the results of DNA-DNA hybridization, and physiological and biochemical analysis differentiated strain JCM 31412 (T) from other described species of the genus Vibrio. Based on these polyphasic taxonomic findings, it was therefore concluded that JCM 31412 (T) was a novel Vibrio species, for which the name Vibrio japonicus sp. nov. was proposed, with JCM 31412 (T) (= LMG 29636 (T) = ATCC TSD-62 (T)) as the type strain.	[Doi, Hiroyasu; Adachi, Hayamitsu; Kawada, Manabu] Inst Microbial Chem BIKAKEN, Numazu, Shizuoka, Japan; [Osawa, Ikuko; Kawada, Manabu] Inst Microbial Chem BIKAKEN, Shinagawa Ku, Tokyo, Japan		Doi, H (corresponding author), Inst Microbial Chem BIKAKEN, Numazu, Shizuoka, Japan.	doih@bikaken.or.jp		Doi, Hiroyasu/0000-0003-1851-6817; Kawada, Manabu/0000-0001-9348-4240				Al-Saari N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136279; ALSINA M, 1994, J APPL BACTERIOL, V76, P79, DOI 10.1111/j.1365-2672.1994.tb04419.x; BAUMANN P, 1971, J BACTERIOL, V107, P268, DOI 10.1128/JB.107.1.268-294.1971; BAUMANN P, 1980, CURR MICROBIOL, V4, P127, DOI 10.1007/BF02602814; Baumann P, 1984, BERGEYS MANUAL SYSTE, P539; Baumann P, 1984, BERGEYS MANUAL SYSTE, V1, P516; CLSI, 2010, M45A2 CLSI, V30; Colwell RR, 2006, BIOLOGY OF VIBRIOS, P3; Farmer J.J., 2005, BERGEYS MANUAL SYSTE, V2, P494; Gao F, 2016, SYST APPL MICROBIOL, V39, P330, DOI 10.1016/j.syapm.2016.04.002; Gomez-Gil B, 2012, INT J SYST EVOL MICR, V62, P2955, DOI 10.1099/ijs.0.033191-0; Gonzalez-Castillo A, 2015, ANTON LEEUW INT J G, V108, P355, DOI 10.1007/s10482-015-0488-1; Hoffmann M, 2012, INT J SYST EVOL MICR, V62, P1736, DOI 10.1099/ijs.0.032375-0; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Mellado E, 1996, INT J SYST BACTERIOL, V46, P817, DOI 10.1099/00207713-46-3-817; MIDI, 2005, SHERL MICR ID SYST O; Nakagawa Y, 2001, IDENTIFICATION MANUA, P83; Nedashkovskaya OI, 2013, ANTON LEEUW INT J G, V103, P69, DOI 10.1007/s10482-012-9787-y; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sasser M, 1990, USFCC NEWS; Sawabe T, 2007, J BACTERIOL, V189, P7932, DOI 10.1128/JB.00693-07; Sawabe T, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00414; SOROKIN DY, 1992, J GEN MICROBIOL, V138, P2287, DOI 10.1099/00221287-138-11-2287; Stackebrandt E, 2006, MICROBIOLOGY TODAY, V06, P152, DOI DOI 10.1038/MSB.2013.22; Suzuki K, 2001, G C CONTETENT, P28; Suzuki K, 2001, DNA DNA HYBRIDIZATIO, P34; Takemura AE, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00038; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thompson F.L., 2003, INT J SYST EVOL MICR, V53, P252; Thompson FL, 2007, APPL ENVIRON MICROB, V73, P4279, DOI 10.1128/AEM.00020-07; Thompson FL, 2005, APPL ENVIRON MICROB, V71, P5107, DOI 10.1128/AEM.71.9.5107-5115.2005; Thompson FL, 2004, MICROBIOL MOL BIOL R, V68, P403, DOI 10.1128/MMBR.68.3.403-431.2004; Thompson FL, 2003, INT J SYST EVOL MICR, V53, P1615, DOI 10.1099/ijs.0.02660-0; Thompson FL, 2002, INT J SYST EVOL MICR, V52, P2015, DOI 10.1099/00207713-52-6-2015; Urbanczyk H, 2007, INT J SYST EVOL MICR, V57, P2823, DOI 10.1099/ijs.0.65081-0; Wang Y, 2010, INT J SYST EVOL MICR, V60, P2517, DOI 10.1099/ijs.0.016915-0; WAYNE LG, 1987, INT J SYST BACTERIOL, V37, P463, DOI 10.1099/00207713-37-4-463	37	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2017	12	2							e0172164	10.1371/journal.pone.0172164	http://dx.doi.org/10.1371/journal.pone.0172164			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5SX	28231272	gold, Green Published, Green Submitted			2022-12-27	WOS:000394682400027
J	Ismail, AA; Bonner, MR; Hendy, O; Rasoul, GA; Wang, K; Olson, JR; Rohlman, DS				Ismail, Ahmed A.; Bonner, Matthew R.; Hendy, Olfat; Rasoul, Gaafar Abdel; Wang, Kai; Olson, James R.; Rohlman, Diane S.			Comparison of neurological health outcomes between two adolescent cohorts exposed to pesticides in Egypt	PLOS ONE			English	Article							LONG-TERM EXPOSURE; NEUROBEHAVIORAL PERFORMANCE; AGRICULTURAL-WORKERS; FARM-WORKERS; ORGANOPHOSPHATE PESTICIDES; APPLICATORS; SYMPTOMS; CHLORPYRIFOS; INSECTICIDES; RESIDENTS	Pesticide-exposed adolescents may have a higher risk of neurotoxic effects because of their developing brains and bodies. However, only a limited number of studies have addressed this risk among adolescents. The aim of this study was to compare neurological outcomes from two cohorts of Egyptian adolescents working as pesticide applicators. In 2005 and 2009, two cohorts of male adolescents working as pesticide applicators for the cotton crop were recruited from Menoufia Governorate, Egypt. The same application schedule and pesticides were used at both times, including both organophosphorus, and pyrethroid compounds. Participants in both cohorts completed three neurobehavioral tests, health and exposure questionnaires, and medical and neurological screening examinations. In addition, blood samples were collected to measure butyryl cholinesterase (BChE) activity. Pesticide applicators in both cohorts reported more neurological symptoms and signs than non-applicators, particularly among participants in the 2005 cohort (OR ranged from 1.18 to 15.3). Except for one test (Trail Making B), there were no significant differences between either applicators or non-applicators of both cohorts on the neurobehavioral outcome measures (p > 0.05). The 2005 cohort showed greater inhibition of serum BChE activity than the 2009 cohort (p < 0.05). In addition, participants with depressed BChE activity showed more symptoms and signs than others without BChE depression (p < 0.05). Our study is the first to examine the consistency of health outcomes associated with pesticide exposure across two cohorts tested at different times from the same geographical region in rural Egypt. This similar pattern of findings across the two cohorts provides strong evidence of the health impact of exposure of adolescents to pesticides.	[Ismail, Ahmed A.; Rohlman, Diane S.] Univ Iowa, Coll Publ Hlth, Dept Occupat & Environm Hlth, Iowa City, IA 52242 USA; [Ismail, Ahmed A.; Rasoul, Gaafar Abdel] Menoufia Univ, Fac Med, Community Med & Publ Hlth Dept, Shibin Al Kawm, Egypt; [Bonner, Matthew R.; Olson, James R.] SUNY Buffalo, Dept Epidemiol & Environm Hlth, Buffalo, NY USA; [Hendy, Olfat] Menoufia Univ, Natl Liver Inst, Dept Clin Pathol, Shibin Al Kawm, Egypt; [Wang, Kai] Univ Iowa, Coll Publ Hlth, Dept Biostat, Iowa City, IA USA; [Olson, James R.] SUNY Buffalo, Dept Pharmacol & Toxicol, Buffalo, NY USA; [Rohlman, Diane S.] Oregon Hlth & Sci Univ, Oregon Inst Occupat Hlth Sci, Portland, OR 97201 USA	University of Iowa; Egyptian Knowledge Bank (EKB); Menofia University; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Egyptian Knowledge Bank (EKB); Menofia University; University of Iowa; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Oregon Health & Science University	Rohlman, DS (corresponding author), Univ Iowa, Coll Publ Hlth, Dept Occupat & Environm Hlth, Iowa City, IA 52242 USA.; Rohlman, DS (corresponding author), Oregon Hlth & Sci Univ, Oregon Inst Occupat Hlth Sci, Portland, OR 97201 USA.	diane-rohlman@uiowa.edu	Bonner, Matthew/X-7786-2018; Ismail, Ahmed/B-3825-2013; Rohlman, Diane/E-5556-2015	Bonner, Matthew/0000-0002-8695-9014; Ismail, Ahmed/0000-0002-6337-2341; Rohlman, Diane/0000-0002-6697-1577	Fogarty International Center; National Institute of Environmental Health Sciences [R21 ES017223, R01 ES022163]; NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH [U54OH007548] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES022163, R21ES017223, P30ES005605] Funding Source: NIH RePORTER	Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The work was supported by the Fogarty International Center and the National Institute of Environmental Health Sciences (R21 ES017223 and R01 ES022163).	ABDELKHALEK AM, 1994, J CONT PSYCHOL, V3, P29; Abu Mourad T, 2005, INT J OCCUP ENV HEAL, V11, P144; AMES RG, 1989, AM J IND MED, V15, P143, DOI 10.1002/ajim.4700150203; Amr MM, 1999, TOXICOL LETT, V107, P1, DOI 10.1016/S0378-4274(99)00026-0; Bushnell PJ, 2006, TOXICOLOGY ORGANOPHO, P347; Clarke EEK, 1997, OCCUP MED-OXFORD, V47, P301, DOI 10.1093/occmed/47.5.301; Crane AL, 2013, J EXPO SCI ENV EPID, V23, P356, DOI 10.1038/jes.2012.113; Eckerman DA, 2007, NEUROTOXICOL TERATOL, V29, P164, DOI 10.1016/j.ntt.2006.09.028; El-Aswad AF, 2007, J PEST CONT ENV SCI, V15, P63; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; EQM Research I, 2003, ACHE ER CHOL ASS KIT; Eskenazi B, 2010, ENVIRON HEALTH PERSP, V118, P1775, DOI 10.1289/ehp.1002234; Farahat TM, 2003, OCCUP ENVIRON MED, V60, P279, DOI 10.1136/oem.60.4.279; Gomes J, 1998, SCAND J WORK ENV HEA, V24, P213, DOI 10.5271/sjweh.301; Hurst P, 2007, FOOD NUTR BULL, V28, pS364, DOI 10.1177/15648265070282S216; Ismail AA, 2010, INT J OCCUP ENV MED, V1, P124; Ismail AA, 2012, OCCUP ENVIRON MED, V69, P457, DOI 10.1136/oemed-2011-100204; Ismail AA, 2008, 66 ANN M OR AC SCI P; Kalia M, 2008, METABOLISM, V57, pS2, DOI 10.1016/j.metabol.2008.07.009; Kamel F, 2007, HUM EXP TOXICOL, V26, P243, DOI 10.1177/0960327107070582; Kamel F, 2005, ENVIRON HEALTH PERSP, V113, P877, DOI 10.1289/ehp.7645; Kamel F, 2004, ENVIRON HEALTH PERSP, V112, P950, DOI 10.1289/ehp.7135; Kamel F, 2003, ENVIRON HEALTH PERSP, V111, P1765, DOI 10.1289/ehp.6341; Khan K, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004177; KISHI M, 1995, SCAND J WORK ENV HEA, V21, P124, DOI 10.5271/sjweh.19; Ohayo-Mitoko GJA, 1999, ANN OCCUP HYG, V43, P519, DOI 10.1016/S0003-4878(99)00045-9; Parron T, 1996, HUM EXP TOXICOL, V15, P957, DOI 10.1177/096032719601501203; Rasoul GMA, 2008, NEUROTOXICOLOGY, V29, P833, DOI 10.1016/j.neuro.2008.06.009; Rohlman DS, 2007, NEUROTOXICOLOGY, V28, P240, DOI 10.1016/j.neuro.2006.03.021; Rohlman DS, 2014, METAB BRAIN DIS, V29, P845, DOI 10.1007/s11011-014-9565-9; Rohlman DS, 2003, NEUROTOXICOLOGY, V24, P523, DOI 10.1016/S0161-813X(03)00023-8; Roldan-Tapia L, 2005, NEUROTOXICOL TERATOL, V27, P259, DOI 10.1016/j.ntt.2004.12.002; RYAN JJ, 1982, PERCEPT MOTOR SKILL, V55, P1277, DOI 10.2466/pms.1982.55.3f.1277; Smit LAM, 2003, AM J IND MED, V44, P254, DOI 10.1002/ajim.10271; Srivastava AK, 2000, FOOD CHEM TOXICOL, V38, P65, DOI 10.1016/S0278-6915(99)00123-4; Stallones L, 2002, ENVIRON RES, V90, P89, DOI 10.1006/enrs.2002.4398; Stallones L, 2002, ANN EPIDEMIOL, V12, P389, DOI 10.1016/S1047-2797(01)00298-8; Steenland K, 2000, ENVIRON HEALTH PERSP, V108, P293, DOI 10.2307/3454346; WEBER H, 1966, DEUT MED WOCHENSCHR, V91, P1927, DOI 10.1055/s-0028-1111616	39	15	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2017	12	2							e0172696	10.1371/journal.pone.0172696	http://dx.doi.org/10.1371/journal.pone.0172696			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5SX	28231336	Green Published, gold			2022-12-27	WOS:000394682400074
J	Midde, NM; Sinha, N; Lukka, PB; Meibohm, B; Kumar, S				Midde, Narasimha M.; Sinha, Namita; Lukka, Pradeep B.; Meibohm, Bernd; Kumar, Santosh			Alterations in cellular pharmacokinetics and pharmacodynamics of elvitegravir in response to ethanol exposure in HIV-1 infected monocytic (U1) cells	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HIV-INFECTED PATIENTS; BLOOD MONONUCLEAR-CELLS; PROTEASE INHIBITORS; INTEGRASE INHIBITOR; DRUG-INTERACTIONS; ANTIRETROVIRAL DRUGS; TREATMENT-NAIVE; IN-VITRO; ALCOHOL	Ethanol consumption is negatively associated with antiretroviral therapy (ART) adherence and general health in HIV positive individuals. Previously, we demonstrated ethanol-mediated alterations to metabolism of elvitegravir (EVG) in human liver microsomes. In the current study, we investigated ethanol influence on the pharmacokinetic and pharmacodynamic interactions of EVG in HIV infected monocytic (U1) cells. U1 cells were treated with 5 mu M EVG, 2 mu M Cobicistat (COBI), a booster drug, and 20 mM ethanol for up to 24 hours. EVG, HIV p24 levels, alterations in cytochrome P450 (CYP) 3A4, MRP1, and MDR1 protein expressions were measured. Presence of ethanol demonstrated a significant effect on the total exposures of both EVG and EVG in combination with COBI. Ethanol also increased the HIV replication despite the presence of drugs and this elevated HIV replication was reduced in the presence of MRP1 and MDR1 inhibitors. Consequently, a slight increase in EVG concentration was observed in the presence of MRP1 inhibitor but not with MDR1 inhibitor. Furthermore, CYP3A4, MRP1 and MDR1 protein levels were significantly induced in treatment groups which included ethanol compared to those with no treatment. In summary, these findings suggest that Ethanol reduces intra cellular EVG exposure by modifying drug metabolism and transporter protein expression. This study provides valuable evidence for further investigation of ethanol effects on the intracellular concentration of EVG in ex vivo or in vivo studies.	[Midde, Narasimha M.; Sinha, Namita; Lukka, Pradeep B.; Meibohm, Bernd; Kumar, Santosh] Univ Tennessee, Ctr Hlth Sci, Coll Pharm, Pharmaceut Sci, Memphis, TN 38163 USA	University of Tennessee System; University of Tennessee Health Science Center	Kumar, S (corresponding author), Univ Tennessee, Ctr Hlth Sci, Coll Pharm, Pharmaceut Sci, Memphis, TN 38163 USA.	ksantosh@uthsc.edu	Lukka, Pradeep/E-2910-2010	Lukka, Pradeep/0000-0001-8034-7810; Kumar, Santosh/0000-0001-7846-5674; Meibohm, Bernd/0000-0003-3923-3648	National Institute of Health [NIAAA/NIH AA-022063, OD/NIH S10OD016226]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA022063] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD016226] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was supported by National Institute of Health grants to Dr. Santosh Kumar (NIAAA/NIH AA-022063) and Bernd Meibohm (OD/NIH S10OD016226). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by National Institute of Health grants to Dr. Santosh Kumar (NIAAA/NIH AA-022063) and Bernd Meibohm (OD/NIH S10OD016226).	Agudelo M, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01452; Alexaki A, 2008, CURR HIV RES, V6, P388, DOI 10.2174/157016208785861195; [Anonymous], 2016, GUID WHAT START AD A; Avery LB, 2013, AIDS RES HUM RETROV, V29, P1434, DOI [10.1089/aid.2013.0031, 10.1089/AID.2013.0031]; BAGASRA O, 1993, J INFECT DIS, V167, P789, DOI 10.1093/infdis/167.4.789; Bazzoli C, 2010, CLIN PHARMACOKINET, V49, P17, DOI 10.2165/11318110-000000000-00000; Canducci F, 2013, J ANTIMICROB CHEMOTH, V68, P2525, DOI 10.1093/jac/dkt220; Cederbaum AI, 2012, CLIN LIVER DIS, V16, P667, DOI 10.1016/j.cld.2012.08.002; Chan LN, 2014, CLIN PHARMACOKINET, V53, P1115, DOI 10.1007/s40262-014-0190-x; Cory T.J., 2016, PHARM RES; DeJesus E, 2006, JAIDS-J ACQ IMM DEF, V43, P1, DOI 10.1097/01.qai.0000233308.82860.2f; DeJesus E, 2012, LANCET, V379, P2429, DOI 10.1016/S0140-6736(12)60918-0; Egorina EM, 2006, J THROMB HAEMOST, V4, P614, DOI 10.1111/j.1538-7836.2005.01781.x; Feierman DE, 2003, ALCOHOL CLIN EXP RES, V27, P981, DOI 10.1097/01.ALC.0000071738.53337.F4; Fletcher CV, 2014, P NATL ACAD SCI USA, V111, P2307, DOI 10.1073/pnas.1318249111; FOLKS TM, 1987, SCIENCE, V238, P800, DOI 10.1126/science.3313729; Giraud C, 2010, J CLIN PHARMACOL, V50, P226, DOI 10.1177/0091270009343696; Griffin L, 2011, J PHARM SCI-US, V100, P3636, DOI 10.1002/jps.22655; Gruber Valerie A, 2013, J Int Assoc Provid AIDS Care, V12, P375, DOI 10.1177/2325957413495567; Hughes AJ, 2014, NAT METHODS, V11, P749, DOI [10.1038/NMETH.2992, 10.1038/nmeth.2992]; Jin M, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.78; Jin MY, 2011, ALCOHOL CLIN EXP RES, V35, P132, DOI 10.1111/j.1530-0277.2010.01330.x; Josephson F, 2010, J INTERN MED, V268, P530, DOI 10.1111/j.1365-2796.2010.02301.x; Kedzierska K, 2002, CURR MED CHEM, V9, P1893, DOI 10.2174/0929867023368935; Klibanov OM, 2009, CURR OPIN INVEST DR, V10, P190; Kock K, 2007, CLIN PHARMACOKINET, V46, P449; Koh Y, 2011, ANTIMICROB AGENTS CH, V55, P42, DOI 10.1128/AAC.01064-10; KOSTRUBSKY VE, 1995, ARCH BIOCHEM BIOPHYS, V322, P516, DOI 10.1006/abbi.1995.1495; Kumar S, 2011, ALCOHOL CLIN EXP RES, V35, P2121, DOI 10.1111/j.1530-0277.2011.01575.x; Kumar S, 2010, BIOCHEM BIOPH RES CO, V402, P163, DOI 10.1016/j.bbrc.2010.10.014; Lotsch J, 2007, ANTIMICROB AGENTS CH, V51, P3264, DOI 10.1128/AAC.00036-07; Massud I, 2015, J ANTIMICROB CHEMOTH, V70, P1473, DOI 10.1093/jac/dku556; Mastrogiannis DS, 2014, CURR HIV RES, V12, P301, DOI 10.2174/1570162X12666140721124923; McCance-Katz EF, 2013, J ADDICT MED, V7, P264, DOI 10.1097/ADM.0b013e318293655a; McDowell JA, 2000, ANTIMICROB AGENTS CH, V44, P1686, DOI 10.1128/AAC.44.6.1686-1690.2000; Mello AF, 2011, J ANTIMICROB CHEMOTH, V66, P1573, DOI 10.1093/jac/dkr151; Midde NM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149225; Minuesa G, 2008, J PHARMACOL EXP THER, V324, P558, DOI 10.1124/jpet.107.131482; Nagai F, 2002, BIOL PHARM BULL, V25, P383, DOI 10.1248/bpb.25.383; Pal D, 2011, LIFE SCI, V88, P959, DOI 10.1016/j.lfs.2010.09.012; Perno CF, 1998, J INFECT DIS, V178, P413, DOI 10.1086/515642; Rao PSS, 2016, ALCOHOL CLIN EXP RES, V40, P73, DOI 10.1111/acer.12938; Rizk ML, 2012, ANTIMICROB AGENTS CH, V56, P3101, DOI 10.1128/AAC.06417-11; ROBERTS BJ, 1995, BIOCHEM PHARMACOL, V49, P1665, DOI 10.1016/0006-2952(95)00098-K; Schafer JJ, 2010, ANN PHARMACOTHER, V44, P145, DOI 10.1345/aph.1M309; Shimura Kazuya, 2009, Antiviral Chemistry & Chemotherapy, V20, P79, DOI 10.3851/IMP1397; Turriziani O, 2008, J MED VIROL, V80, P766, DOI 10.1002/jmv.21152; Zembruski NCL, 2011, J ANTIMICROB CHEMOTH; Zha WB, 2012, CURR DRUG METAB, V13, P1174, DOI 10.2174/138920012802850119; Zhou F, 2011, DRUG METAB REV, V43, P335, DOI 10.3109/03602532.2011.560607	50	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2017	12	2							e0172628	10.1371/journal.pone.0172628	http://dx.doi.org/10.1371/journal.pone.0172628			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5SX	28231276	Green Published, gold, Green Submitted			2022-12-27	WOS:000394682400062
J	Nishi, A; Christakis, NA; Rand, DG				Nishi, Akihiro; Christakis, Nicholas A.; Rand, David G.			Cooperation, decision time, and culture: Online experiments with American and Indian participants	PLOS ONE			English	Article							SMALL-SCALE SOCIETIES; BEHAVIORAL-EXPERIMENTS; SOCIAL HEURISTICS; RESPONSE-TIMES; PROSOCIALITY; PUNISHMENT; SLOW; RECIPROCITY; EVOLUTION; FAIRNESS	Two separate bodies of work have examined whether culture affects cooperation in economic games and whether cooperative or non-cooperative decisions occur more quickly. Here, we connect this work by exploring the relationship between decision time and cooperation in American versus Indian subjects. We use a series of dynamic social network experiments in which subjects play a repeated public goods game: 80 sessions for a total of 1,462 subjects (1,059 from the United States, 337 from India, and 66 from other countries) making 13,560 decisions. In the first round, where subjects do not know if connecting neighbors are cooperative, American subjects are highly cooperative and decide faster when cooperating than when defecting, whereas a majority of Indian subjects defect and Indians decide faster when defecting than when cooperating. Almost the same is true in later rounds where neighbors were previously cooperative (a cooperative environment) except decision time among Indian subjects. However, when connecting neighbors were previously not cooperative (a non-cooperative environment), a large majority of both American and Indian subjects defect, and defection is faster than cooperation among both sets of subjects. Our results imply the cultural background of subjects in their real life affects the speed of cooperation decision-making differentially in online social environments.	[Nishi, Akihiro] Univ Calif Los Angeles, Dept Epidemiol, Fielding Sch Publ Hlth, Los Angeles, CA USA; [Christakis, Nicholas A.; Rand, David G.] Yale Univ, Yale Inst Network Sci, New Haven, CT USA; [Christakis, Nicholas A.] Yale Univ, Dept Sociol, New Haven, CT USA; [Christakis, Nicholas A.] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT USA; [Christakis, Nicholas A.] Yale Univ, Dept Med, New Haven, CT 06520 USA; [Rand, David G.] Yale Univ, Dept Psychol, New Haven, CT USA; [Rand, David G.] Yale Univ, Dept Econ, New Haven, CT 06520 USA	University of California System; University of California Los Angeles; Yale University; Yale University; Yale University; Yale University; Yale University; Yale University	Nishi, A (corresponding author), Univ Calif Los Angeles, Dept Epidemiol, Fielding Sch Publ Hlth, Los Angeles, CA USA.	akihironishi@ucla.edu		Nishi, Akihiro/0000-0003-1629-5985	 [67919]		This work was supported by grant 67919 (http://www.rwjf.org/en/library/grants/2011/06/using-social-networks-to-understand-and-improve-health.html)	Bear A, 2016, P NATL ACAD SCI US; Blake PR, 2015, NATURE, V528, P258, DOI 10.1038/nature15703; Buhrmester M, 2011, PERSPECT PSYCHOL SCI, V6, P3, DOI 10.1177/1745691610393980; Cappelen A. W., 2014, FAIRNESS IS INTUITIV; Capraro V., 2015, P ROY SOC B; Capraro V., 2016, DELIBERATION FAVORS; Capraro V, 2014, SCI REP-UK, V4, DOI 10.1038/srep06790; Chudek M, 2011, TRENDS COGN SCI, V15, P218, DOI 10.1016/j.tics.2011.03.003; Deary IJ, 2011, BEHAV RES METHODS, V43, P258, DOI 10.3758/s13428-010-0024-1; Ellingsen T., 2012, SSRN ELECT J, P2, DOI [10.2139/ssrn.2179575, DOI 10.2139/SSRN.2179575]; Evans AM, 2017, J EXP SOC PSYCHOL, V68, P50, DOI 10.1016/j.jesp.2016.05.009; Evans AM, 2015, J EXP PSYCHOL GEN, V144, P951, DOI 10.1037/xge0000107; Fehr E, 2008, AM ECON REV, V98, P494, DOI 10.1257/aer.98.2.494; Fiedler S, 2013, ORGAN BEHAV HUM DEC, V120, P272, DOI 10.1016/j.obhdp.2012.07.002; Gachter S, 2010, PHILOS T R SOC B, V365, P2651, DOI 10.1098/rstb.2010.0135; Gachter S, 2009, PHILOS T R SOC B, V364, P791, DOI 10.1098/rstb.2008.0275; Graubard B I, 1996, Stat Methods Med Res, V5, P263, DOI 10.1177/096228029600500304; GRIESINGER DW, 1973, BEHAV SCI, V18, P173, DOI 10.1002/bs.3830180305; Henrich J, 2005, BEHAV BRAIN SCI, V28, P795, DOI 10.1017/S0140525X05000142; Henrich J, 2001, AM ECON REV, V91, P73, DOI 10.1257/aer.91.2.73; Henrich J, 2010, SCIENCE, V327, P1480, DOI 10.1126/science.1182238; Herrmann B, 2008, SCIENCE, V319, P1362, DOI 10.1126/science.1153808; Kiyonari T, 2000, EVOL HUM BEHAV, V21, P411, DOI 10.1016/S1090-5138(00)00055-6; Kosinski RA, 2013, LIT REVEW REACTION T; Krajbich I, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8455; Legatum Institute, 2015, 2015 LEG PROSP IND; LIEBRAND WBG, 1984, EUR J SOC PSYCHOL, V14, P239, DOI 10.1002/ejsp.2420140302; Lohse J., 2014, U HEIDELBERG DEP EC, V566; Lotito G., 2013, J BIOECON, V15, P123, DOI [DOI 10.1007/s10818-012-9141-5, 10.1007/s10818-012-9141-5]; Nielsen UH, 2014, ECON LETT, V122, P136, DOI 10.1016/j.econlet.2013.11.021; Nishi A, 2016, SCI REP-UK, V6, DOI 10.1038/srep29622; Nishi A, 2015, NATURE, V526, P426, DOI 10.1038/nature15392; Peysakhovich A, 2016, MANAGE SCI, V62, P631, DOI 10.1287/mnsc.2015.2168; Piovesan M, 2009, ECON LETT, V105, P193, DOI 10.1016/j.econlet.2009.07.017; Raihani NJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073131; Rand DG, 2016, PSYCHOL SCI, V27, P1192, DOI 10.1177/0956797616654455; Rand DG, 2015, J ECON BEHAV ORGAN, V116, P481, DOI 10.1016/j.jebo.2015.05.013; Rand DG, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00300; Rand DG, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4677; Rand DG, 2013, TRENDS COGN SCI, V17, P413, DOI 10.1016/j.tics.2013.06.003; Rand DG, 2012, NATURE, V489, P427, DOI 10.1038/nature11467; Rubinstein A, 2007, ECON J, V117, P1243, DOI 10.1111/j.1468-0297.2007.02081.x; Stagnaro MN, 2016, GOOD I GOOD NORMS TO; Tomasello M, 2012, CURR ANTHROPOL, V53, P673, DOI 10.1086/668207; TOOBY J, 1990, ETHOL SOCIOBIOL, V11, P375, DOI 10.1016/0162-3095(90)90017-Z; VanLange PAM, 1997, J PERS SOC PSYCHOL, V73, P733, DOI 10.1037/0022-3514.73.4.733; Wansink B, 2009, AM ECON REV, V99, P165, DOI 10.1257/aer.99.2.165; Wu JJ, 2009, P NATL ACAD SCI USA, V106, P17448, DOI 10.1073/pnas.0905918106; YAMAGISHI T, 1988, SOC PSYCHOL QUART, V51, P265, DOI 10.2307/2786924; Zaki J, 2013, CURR DIR PSYCHOL SCI, V22, P466, DOI 10.1177/0963721413492764; Zaki J, 2011, P NATL ACAD SCI USA, V108, P19761, DOI 10.1073/pnas.1112324108	51	16	17	3	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2017	12	2							e0171252	10.1371/journal.pone.0171252	http://dx.doi.org/10.1371/journal.pone.0171252			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL5SX	28231296	Green Published, Green Submitted, gold			2022-12-27	WOS:000394682400008
J	Jung, WM; Lee, YS; Wallraven, C; Chae, Y				Jung, Won-Mo; Lee, Ye-Seul; Wallraven, Christian; Chae, Younbyoung			Bayesian prediction of placebo analgesia in an instrumental learning model	PLOS ONE			English	Article							PERCEIVED CONTROL; PAIN; MECHANISMS; EXPECTATION; UNCERTAINTY; EVENTS; REWARD; BRAIN	Placebo analgesia can be primarily explained by the Pavlovian conditioning paradigm in which a passively applied cue becomes associated with less pain. In contrast, instrumental conditioning employs an active paradigm that might be more similar to clinical settings. In the present study, an instrumental conditioning paradigm involving a modified trust game in a simulated clinical situation was used to induce placebo analgesia. Additionally, Bayesian modeling was applied to predict the placebo responses of individuals based on their choices. Twenty-four participants engaged in a medical trust game in which decisions to receive treatment from either a doctor (more effective with high cost) or a pharmacy (less effective with low cost) were made after receiving a reference pain stimulus. In the conditioning session, the participants received lower levels of pain following both choices, while high pain stimuli were administered in the test session even after making the decision. The choice-dependent pain in the conditioning session was modulated in terms of both intensity and uncertainty. Participants reported significantly less pain when they chose the doctor or the pharmacy for treatment compared to the control trials. The predicted pain ratings based on Bayesian modeling showed significant correlations with the actual reports from participants for both of the choice categories. The instrumental conditioning paradigm allowed for the active choice of optional cues and was able to induce the placebo analgesia effect. Additionally, Bayesian modeling successfully predicted pain ratings in a simulated clinical situation that fits well with placebo analgesia induced by instrumental conditioning.	[Jung, Won-Mo; Lee, Ye-Seul; Chae, Younbyoung] Kyung Hee Univ, Coll Korean Med, Acupuncture & Meridian Sci Res Ctr, Seoul, South Korea; [Wallraven, Christian] Korea Univ, Dept Brain Cognit Engn, Seoul, South Korea	Kyung Hee University; Korea University	Chae, Y (corresponding author), Kyung Hee Univ, Coll Korean Med, Acupuncture & Meridian Sci Res Ctr, Seoul, South Korea.	ybchae@khu.ac.kr	Chae, Younbyoung/AAM-1243-2020	Lee, Ye-Seul/0000-0001-6127-5401; Chae, Younbyoung/0000-0001-6787-2215; Wallraven, Christian/0000-0002-2604-9115	Basic Science Research Program through the National Research Foundation of Korea [2015R1D1A1A01058033]; LG Yonam Foundation for Research Fellowship [2016]	Basic Science Research Program through the National Research Foundation of Korea(National Research Foundation of Korea); LG Yonam Foundation for Research Fellowship	YC was supported by the Basic Science Research Program through the National Research Foundation of Korea (grant number 2015R1D1A1A01058033; nrf.re.kr) and the LG Yonam Foundation for Research Fellowship (grant number 2016; foundation.lg.or.kr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amanzio M, 1999, J NEUROSCI, V19, P484, DOI 10.1523/JNEUROSCI.19-01-00484.1999; Anchisi D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117270; Benedetti F, 2005, J NEUROSCI, V25, P10390, DOI 10.1523/JNEUROSCI.3458-05.2005; Benedetti F, 2003, J NEUROSCI, V23, P4315; Beydoun A, 1996, PAIN, V65, P189, DOI 10.1016/0304-3959(95)00161-1; Buchel C, 2014, NEURON, V81, P1223, DOI 10.1016/j.neuron.2014.02.042; CHAN AW, 1992, J NEUROL NEUROSUR PS, V55, P56, DOI 10.1136/jnnp.55.1.56; Colloca L, 2013, PAIN, V154, P511, DOI 10.1016/j.pain.2013.02.002; Colloca L, 2011, PHILOS T R SOC B, V366, P1859, DOI 10.1098/rstb.2010.0398; Doering BK, 2012, TRENDS PHARMACOL SCI, V33, P165, DOI 10.1016/j.tips.2011.12.001; Friston K, 2016, NEUROSCI BIOBEHAV R, V68, P862, DOI 10.1016/j.neubiorev.2016.06.022; Friston KJ, 2010, NAT REV NEUROSCI, V11, P127, DOI 10.1038/nrn2787; Friston KJ, 2009, PHILOS T R SOC B, V364, P1211, DOI 10.1098/rstb.2008.0300; Garrison J, 2013, NEUROSCI BIOBEHAV R, V37, P1297, DOI 10.1016/j.neubiorev.2013.03.023; Kersten D, 2004, ANNU REV PSYCHOL, V55, P271, DOI 10.1146/annurev.psych.55.090902.142005; Kessner S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109014; Kessner S, 2013, JAMA INTERN MED, V173, P1468, DOI 10.1001/jamainternmed.2013.6705; Knill DC, 2004, TRENDS NEUROSCI, V27, P712, DOI 10.1016/j.tins.2004.10.007; Kong Jian, 2014, Handb Exp Pharmacol, V225, P3, DOI 10.1007/978-3-662-44519-8_1; Lee IS, 2015, SCI REP-UK, V5, DOI 10.1038/srep17140; Meulders A, 2011, PAIN, V152, P2460, DOI 10.1016/j.pain.2011.05.015; Nolan TA, 2012, PAIN, V153, P2009, DOI 10.1016/j.pain.2012.04.026; O'Reilly JX, 2012, EUR J NEUROSCI, V35, P1169, DOI 10.1111/j.1460-9568.2012.08010.x; Pan WX, 2005, J NEUROSCI, V25, P6235, DOI 10.1523/JNEUROSCI.1478-05.2005; Patil A, 2010, J STAT SOFTW, V35, P1; Pellino TA, 1998, J PAIN SYMPTOM MANAG, V15, P110, DOI 10.1016/S0885-3924(97)00255-8; Pessiglione M, 2008, NEURON, V59, P561, DOI 10.1016/j.neuron.2008.07.005; RESCORLA RA, 1988, AM PSYCHOL, V43, P151, DOI 10.1037/0003-066X.43.3.151; Seymour B, 2007, J NEUROSCI, V27, P4826, DOI 10.1523/JNEUROSCI.0400-07.2007; Talmi D, 2008, J NEUROSCI, V28, P360, DOI 10.1523/JNEUROSCI.4028-07.2008; Talmi D, 2009, J NEUROSCI, V29, P14617, DOI 10.1523/JNEUROSCI.2026-09.2009; Tracey I, 2010, NAT MED, V16, P1277, DOI 10.1038/nm.2229; van't Wout M, 2008, COGNITION, V108, P796, DOI 10.1016/j.cognition.2008.07.002; Vlaeyen JWS, 2015, PAIN, V156, pS86, DOI 10.1097/j.pain.0000000000000107; Wager TD, 2004, SCIENCE, V303, P1162, DOI 10.1126/science.1093065; Wardle MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068884; WEISENBERG M, 1985, PAIN, V23, P187, DOI 10.1016/0304-3959(85)90059-4; Wiech K, 2006, J NEUROSCI, V26, P11501, DOI 10.1523/JNEUROSCI.2568-06.2006; Wiech K, 2016, SCIENCE, V354, P584, DOI 10.1126/science.aaf8934; Winston JS, 2014, J NEUROSCI, V34, P14526, DOI 10.1523/JNEUROSCI.1706-14.2014; Yoshida W, 2013, J NEUROSCI, V33, P5638, DOI 10.1523/JNEUROSCI.4984-12.2013; Ziegler EA, 1999, BRAIN, V122, P2245, DOI 10.1093/brain/122.12.2245	42	12	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2017	12	2							e0172609	10.1371/journal.pone.0172609	http://dx.doi.org/10.1371/journal.pone.0172609			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL5SK	28225816	Green Published, gold, Green Submitted			2022-12-27	WOS:000394680900058
J	Menger, J; Magnusson, WE; Anderson, MJ; Schlegel, M; Pe'er, G; Henle, K				Menger, Juliana; Magnusson, William E.; Anderson, Marti J.; Schlegel, Martin; Pe'er, Guy; Henle, Klaus			Environmental characteristics drive variation in Amazonian understorey bird assemblages	PLOS ONE			English	Article							MESOSCALE DISTRIBUTION PATTERNS; NATAL DISPERSAL DISTANCES; TREEFALL GAPS; FLORISTIC COMPOSITION; HABITAT SELECTION; FOREST FRAGMENTS; BETA-DIVERSITY; HETEROGENEITY; LIMITATION; MOVEMENTS	Tropical bird assemblages display patterns of high alpha and beta diversity and, as tropical birds exhibit strong habitat specificity, their spatial distributions are generally assumed to be driven primarily by environmental heterogeneity and interspecific interactions. However, spatial distributions of some Amazonian forest birds are also often restricted by large rivers and other large-scale topographic features, suggesting that dispersal limitation may also play a role in driving species' turnover. In this study, we evaluated the effects of environmental characteristics, topographic and spatial variables on variation in local assemblage structure and diversity of birds in an old-growth forest in central Amazonia. Birds were mist-netted in 72 plots distributed systematically across a 10,000 ha reserve in each of three years. Alpha diversity remained stable through time, but species composition changed. Spatial variation in bird-assemblage structure was significantly related to environmental and topographic variables but not strongly related to spatial variables. At a broad scale, we found bird assemblages to be significantly distinct between two watersheds that are divided by a central ridgeline. We did not detect an effect of the ridgeline per se in driving these patterns, indicating that most birds are able to fly across it, and that differences in assemblage structure between watersheds may be due to unmeasured environmental variables or unique combinations of measured variables. Our study indicates that complex geography and landscape features can act together with environmental variables to drive changes in the diversity and composition of tropical bird assemblages at local scales, but highlights that we still know very little about what makes different parts of tropical forest suitable for different species.	[Menger, Juliana; Pe'er, Guy; Henle, Klaus] UFZ Helmholtz Ctr Environm Res, Dept Conservat Biol, Leipzig, Saxony, Germany; [Menger, Juliana; Schlegel, Martin] Univ Leipzig, Fac Biosci Pharm & Psychol, Leipzig, Saxony, Germany; [Menger, Juliana; Magnusson, William E.] INPA, Coordenacao Pesquisa Biodiversidade, Manaus, Amazonas, Brazil; [Anderson, Marti J.] Massey Univ, NZIAS, Albany Campus, Auckland, New Zealand; [Schlegel, Martin; Pe'er, Guy; Henle, Klaus] German Ctr Integrat Biodivers Res iDiv, Leipzig, Saxony, Germany	Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Leipzig University; Institute Nacional de Pesquisas da Amazonia; Massey University	Menger, J (corresponding author), UFZ Helmholtz Ctr Environm Res, Dept Conservat Biol, Leipzig, Saxony, Germany.; Menger, J (corresponding author), Univ Leipzig, Fac Biosci Pharm & Psychol, Leipzig, Saxony, Germany.; Menger, J (corresponding author), INPA, Coordenacao Pesquisa Biodiversidade, Manaus, Amazonas, Brazil.	j.menger@ufz.de	Henle, Klaus/I-6837-2013; Anderson, Marti J./AAQ-9038-2021	Henle, Klaus/0000-0002-6647-5362; Anderson, Marti J./0000-0002-4018-4049; da Silva Menger, Juliana/0000-0002-6968-8275	Brazilian Science Funding Agency CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior) [12401129]; EU [308454]; Brazilian Program for Biodiversity Research PPBio [457544/2012-0]; National Institute for Amazonian Biodiversity INCT-CENBAM [573721/2008-4]; Brazilian Long-Term Ecological Research Project PELD through the Brazilian National Research Council CNPq [403764/2012-2]	Brazilian Science Funding Agency CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior); EU(European Commission); Brazilian Program for Biodiversity Research PPBio; National Institute for Amazonian Biodiversity INCT-CENBAM; Brazilian Long-Term Ecological Research Project PELD through the Brazilian National Research Council CNPq	The Brazilian Science Funding Agency CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior) awarded stipend to JM (Process 12401129). The EU FP7 project EU BON funded GP (contract 308454). Bird-data collection was financed by the Brazilian Program for Biodiversity Research PPBio (Grant 457544/2012-0), the National Institute for Amazonian Biodiversity INCT-CENBAM (Grant 573721/2008-4) and the Brazilian Long-Term Ecological Research Project PELD (Grant 403764/2012-2) through the Brazilian National Research Council CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson M.J., 2008, PERMANOVA PRIMER GUI; Anderson MJ, 2003, AUST NZ J STAT, V45, P301, DOI 10.1111/1467-842X.00285; Anderson MJ, 2003, ECOLOGY, V84, P511, DOI 10.1890/0012-9658(2003)084[0511:CAOPCA]2.0.CO;2; Anderson MJ, 2003, J STAT COMPUT SIM, V73, P85, DOI 10.1080/00949650215733; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; [Anonymous], 2021, LANG ENV STAT COMP; Banks-Leite Cristina, 2008, Ecotropica (Bonn), V14, P1; Banks-Leite C, 2010, OIKOS, V119, P918, DOI 10.1111/j.1600-0706.2009.18061.x; Bennett PM, 1997, P ROY SOC B-BIOL SCI, V264, P401, DOI 10.1098/rspb.1997.0057; Blake JG, 2001, AUK, V118, P304, DOI 10.1642/0004-8038(2001)118[0304:BAISGA]2.0.CO;2; BORCARD D, 1992, ECOLOGY, V73, P1045, DOI 10.2307/1940179; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; Borges SH, 1999, CONDOR, V101, P529, DOI 10.2307/1370182; Bregman TP, 2015, ECOLOGY, V96, P2692, DOI [10.1890/14-1731.1, 10.1890/14-1731.1.sm]; Brown JH, 2001, OECOLOGIA, V126, P321, DOI 10.1007/s004420000536; Bueno AS, 2012, ECOL APPL, V22, P722, DOI 10.1890/11-0789.1; Burney CW, 2009, AM NAT, V174, P358, DOI 10.1086/603613; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; CEMAVE, 1994, MAN AN AV SILV; Chan EKW, 2008, BIOTROPICA, V40, P623, DOI 10.1111/j.1744-7429.2008.00420.x; CHAUVEL A, 1987, EXPERIENTIA, V43, P234, DOI 10.1007/BF01945546; Cintra R, 2012, INT J ECOLOGY, V2012, P25; Cintra Renato, 2006, Acta Amaz., V36, P209, DOI 10.1590/S0044-59672006000200011; Clarke K., 2015, PRIMER E V7 USER MAN; Clarke KR, 2006, J EXP MAR BIOL ECOL, V330, P55, DOI 10.1016/j.jembe.2005.12.017; Clobert J, 2009, ECOL LETT, V12, P197, DOI 10.1111/j.1461-0248.2008.01267.x; Cohn-Haft Mario, 1997, Ornithological Monographs, V48, P205; Condit R, 2002, SCIENCE, V295, P666, DOI 10.1126/science.1066854; Costa FRC, 2009, J VEG SCI, V20, P69, DOI 10.1111/j.1654-1103.2009.05314.x; Costa FRC, 2005, J ECOL, V93, P863, DOI 10.1111/j.1365-2745.2005.01020.x; Cracraft J, 1985, ORNITHOLOGICAL MONOG, V36, P49, DOI DOI 10.2307/40168278; Da Silva JMC, 2005, CONSERV BIOL, V19, P689, DOI 10.1111/j.1523-1739.2005.00705.x; Dambros C., 2014, DATABASE FIGSHARE; Dawideit BA, 2009, J ANIM ECOL, V78, P388, DOI 10.1111/j.1365-2656.2008.01504.x; de Castilho CV, 2006, FOREST ECOL MANAG, V234, P85, DOI 10.1016/j.foreco.2006.06.024; de Oliveira PY, 2009, PESQUI AGROPECU BRAS, V44, P852, DOI 10.1590/S0100-204X2009000800008; de Toledo JJ, 2012, FOREST ECOL MANAG, V263, P253, DOI 10.1016/j.foreco.2011.09.017; Develey PF, 2001, CONSERV BIOL, V15, P1416, DOI 10.1046/j.1523-1739.2001.00170.x; Duivenvoorden JF, 2002, SCIENCE, V295, P636, DOI 10.1126/science.295.5555.636; Fahrig L, 2007, FUNCT ECOL, V21, P1003, DOI 10.1111/j.1365-2435.2007.01326.x; Fernandes AM, 2012, J BIOGEOGR, V39, P1524, DOI 10.1111/j.1365-2699.2012.02712.x; Fleishman E, 2006, DIVERS DISTRIB, V12, P236, DOI 10.1111/j.1366-9516.2006.00240.x; Francis CD, 2009, CURR BIOL, V19, P1415, DOI 10.1016/j.cub.2009.06.052; Freedman D., 1983, J BUS ECON STAT, V1, P292, DOI [10.2307/1391660, DOI 10.2307/1391660]; Haffer J, 1997, BIODIVERS CONSERV, V6, P451, DOI 10.1023/A:1018320925954; Haffer Juergen, 1992, Boletim do Museu Paraense Emilio Goeldi Serie Zoologia, V8, P217; Hayes FE, 2004, J BIOGEOGR, V31, P1809, DOI 10.1111/j.1365-2699.2004.01139.x; Henle K, 2004, BIODIVERS CONSERV, V13, P207, DOI 10.1023/B:BIOC.0000004319.91643.9e; Higgins MA, 2011, J BIOGEOGR, V38, P2136, DOI 10.1111/j.1365-2699.2011.02585.x; Hubbell Stephen P., 2001, V32, pi; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; Iwata T, 2003, ECOGRAPHY, V26, P325, DOI 10.1034/j.1600-0587.2003.03355.x; Jayapal R, 2009, FOREST ECOL MANAG, V257, P2287, DOI 10.1016/j.foreco.2009.03.010; Jones MM, 2006, J ECOL, V94, P181, DOI 10.1111/j.1365-2745.2005.01071.x; KARR JR, 1983, ECOLOGY, V64, P1481, DOI 10.2307/1937503; Kinupp VF, 2005, J TROP ECOL, V21, P363, DOI 10.1017/S0266467405002440; LACHENBR.PA, 1968, TECHNOMETRICS, V10, P1, DOI 10.2307/1266219; Laurance SGW, 2005, BIOTROPICA, V37, P149, DOI 10.1111/j.1744-7429.2005.04099.x; Laurance SGW, 2004, ECOL APPL, V14, P1344, DOI 10.1890/03-5194; Lee PY, 2005, J BIOGEOGR, V32, P1139, DOI 10.1111/j.1365-2699.2005.01254.x; Lees AC, 2009, OIKOS, V118, P280, DOI 10.1111/j.1600-0706.2008.16842.x; Legendre P, 1999, ECOL MONOGR, V69, P1, DOI 10.1890/0012-9615(1999)069[0001:DBRATM]2.0.CO;2; LEVEY DJ, 1990, J TROP ECOL, V6, P409, DOI 10.1017/S026646740000479X; Luizao RCC, 2004, GLOBAL CHANGE BIOL, V10, P592, DOI 10.1111/j.1529-8817.2003.00757.x; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; MacQueen J., 1967, P 5 BERKELEY S MATH, VVolume 1, P281, DOI DOI 10.1007/S11665-016-2173-6; Magnusson WE, 2013, BIODIVERSITY INTEGRA; Magnusson William E., 2005, Biota Neotrop., V5, P19, DOI 10.1590/S1676-06032005000300002; Marques JP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069294; McArdle BH, 2001, ECOLOGY, V82, P290, DOI 10.1890/0012-9658(2001)082[0290:FMMTCD]2.0.CO;2; Mendonca FP, 2005, COPEIA, P751, DOI 10.1643/0045-8511(2005)005[0751:RBHCAF]2.0.CO;2; Menger J, 2016, PPBIOAMOC 82 4; Menin M, 2008, S AM J HERPETOLOGY, V3; Menin M, 2007, J TROP ECOL, V23, P539, DOI 10.1017/S0266467407004269; Mockford EJ, 2009, P ROY SOC B-BIOL SCI, V276, P2979, DOI 10.1098/rspb.2009.0586; Mokross K, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2599; Moore RP, 2008, ECOL LETT, V11, P960, DOI 10.1111/j.1461-0248.2008.01196.x; Naka Luciano Nicolas, 2006, Revista Brasileira de Ornitologia, V14, P197; Pe'er G, 2006, LANDSCAPE ECOL, V21, P47, DOI 10.1007/s10980-005-1622-7; Pe'er G, 2005, CONSERV BIOL, V19, P1997, DOI 10.1111/j.1523-1739.2005.00227.x; Pe'er G, 2008, ECOL MODEL, V213, P73, DOI 10.1016/j.ecolmodel.2007.11.020; Pearman PB, 2002, ECOL MONOGR, V72, P19, DOI 10.1890/0012-9615(2002)072[0019:TSOCSH]2.0.CO;2; Pianka E.R., 1981, THEORETICAL ECOLOGY, P167; Pomara LY, 2014, J BIOGEOGR, V41, P784, DOI 10.1111/jbi.12247; Pomara LY, 2012, BIOTROPICA, V44, P545, DOI 10.1111/j.1744-7429.2011.00851.x; Potts JR, 2014, ECOL EVOL, V4, P4578, DOI 10.1002/ece3.1306; Ribas CC, 2009, J BIOGEOGR, V36, P1712, DOI 10.1111/j.1365-2699.2009.02131.x; Ribeiro J.E.L. da S., 1999, FLORA RESERVA DUCKE; ROBINSON SK, 1995, J ANIM ECOL, V64, P1, DOI 10.2307/5822; Rodrigues LF, 2014, J TROP ECOL, V30, P565, DOI 10.1017/S0266467414000431; SCHEMSKE DW, 1981, ECOLOGY, V62, P938, DOI 10.2307/1936992; STOUFFER PC, 1995, ECOLOGY, V76, P2429, DOI 10.2307/2265818; Svenning JC, 2006, J TROP ECOL, V22, P575, DOI 10.1017/S0266467406003348; Tabarelli M, 2008, BIOTROPICA, V40, P657, DOI 10.1111/j.1744-7429.2008.00454.x; TUOMISTO H, 1995, SCIENCE, V269, P63, DOI 10.1126/science.269.5220.63; Tuomisto H, 2003, SCIENCE, V299, P241, DOI 10.1126/science.1078037; Vasconcelos HL, 2010, J BIOGEOGR, V37, P432, DOI 10.1111/j.1365-2699.2009.02230.x; Woltmann S, 2012, J AVIAN BIOL, V43, P33, DOI 10.1111/j.1600-048X.2011.05572.x; Wunderle JM, 2005, IBIS, V147, P109, DOI 10.1111/j.1474-919x.2005.00382.x; WUNDERLE JM, 1987, WILSON BULL, V99, P22; Zurita G, 2012, J APPL ECOL, V49, P503, DOI 10.1111/j.1365-2664.2011.02104.x	101	10	10	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2017	12	2							e0171540	10.1371/journal.pone.0171540	http://dx.doi.org/10.1371/journal.pone.0171540			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5SK	28225774	Green Published, gold, Green Submitted			2022-12-27	WOS:000394680900017
J	Sun, MZ; Xu, H; Zeng, XJ; Zhao, X				Sun, Mingzhu; Xu, Hui; Zeng, Xingjuan; Zhao, Xin			Automated numerical simulation of biological pattern formation based on visual feedback simulation framework	PLOS ONE			English	Article							PARAMETER-ESTIMATION; FIELD MODEL; TIME-DELAY; MORPHOGENESIS; DYNAMICS	There are various fantastic biological phenomena in biological pattern formation. Mathematical modeling using reaction-diffusion partial differential equation systems is employed to study the mechanism of pattern formation. However, model parameter selection is both difficult and time consuming. In this paper, a visual feedback simulation framework is proposed to calculate the parameters of a mathematical model automatically based on the basic principle of feedback control. In the simulation framework, the simulation results are visualized, and the image features are extracted as the system feedback. Then, the unknown model parameters are obtained by comparing the image features of the simulation image and the target biological pattern. Considering two typical applications, the visual feedback simulation framework is applied to fulfill pattern formation simulations for vascular mesenchymal cells and lung development. In the simulation framework, the spot, stripe, labyrinthine patterns of vascular mesenchymal cells, the normal branching pattern and the branching pattern lacking side branching for lung branching are obtained in a finite number of iterations. The simulation results indicate that it is easy to achieve the simulation targets, especially when the simulation patterns are sensitive to the model parameters. Moreover, this simulation framework can expand to other types of biological pattern formation.	[Sun, Mingzhu; Xu, Hui; Zeng, Xingjuan; Zhao, Xin] Nankai Univ, Inst Robot & Automat Informat Syst, Tianjin, Peoples R China; [Sun, Mingzhu; Xu, Hui; Zeng, Xingjuan; Zhao, Xin] Tianjin Key Lab Intelligent Robot, Tianjin, Peoples R China	Nankai University	Zhao, X (corresponding author), Nankai Univ, Inst Robot & Automat Informat Syst, Tianjin, Peoples R China.; Zhao, X (corresponding author), Tianjin Key Lab Intelligent Robot, Tianjin, Peoples R China.	zhaoxin@nankai.edu.cn			National Natural Science Foundation of China (NSFC) [61327802, 61273341]; Tianjin Research Program of Application Foundation and Advanced Technology [14JCQNJC04700]; Key Program of Science Foundation of Tianjin [14JCZDJC31800]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Tianjin Research Program of Application Foundation and Advanced Technology; Key Program of Science Foundation of Tianjin	This work was supported by National Natural Science Foundation of China (NSFC; Grant Nos. 61327802, 61273341), Tianjin Research Program of Application Foundation and Advanced Technology (Grant No. 14JCQNJC04700), Key Program of Science Foundation of Tianjin (Grant No. 14JCZDJC31800). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashyraliyev M, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-83; Bianco P, 2014, ANNU REV CELL DEV BI, V30, P677, DOI 10.1146/annurev-cellbio-100913-013132; BRANDTS WAM, 1990, J THEOR BIOL, V146, P37, DOI 10.1016/S0022-5193(05)80043-8; CAPLAN AI, 1991, J ORTHOP RES, V9, P641, DOI 10.1002/jor.1100090504; Chen TH, 2012, CIRC RES, V110, P551, DOI 10.1161/CIRCRESAHA.111.255927; Eldar A, 2002, NATURE, V419, P304, DOI 10.1038/nature01061; Fomekong-Nanfack Y, 2007, BIOINFORMATICS, V23, P3356, DOI 10.1093/bioinformatics/btm433; Garfinkel A, 2004, P NATL ACAD SCI USA, V101, P9247, DOI 10.1073/pnas.0308436101; GIERER A, 1972, KYBERNETIK, V12, P30, DOI 10.1007/BF00289234; Guo YN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102718; Guo YN, 2014, J PHYSIOL-LONDON, V592, P313, DOI 10.1113/jphysiol.2013.261099; INGHAM PW, 1988, NATURE, V335, P25, DOI 10.1038/335025a0; KONDO S, 1995, NATURE, V376, P765, DOI 10.1038/376765a0; Kondo S, 2010, SCIENCE, V329, P1616, DOI 10.1126/science.1179047; Li L, 2016, APPL MATH MODEL, V40, P4765, DOI 10.1016/j.apm.2015.12.003; Li L, 2015, APPL MATH COMPUT, V258, P342, DOI 10.1016/j.amc.2015.02.006; Li L, 2012, NONLINEAR DYNAM, V67, P1737, DOI 10.1007/s11071-011-0101-8; Lu PF, 2008, SCIENCE, V322, P1506, DOI 10.1126/science.1162783; Maini PK, 1997, J CHEM SOC FARADAY T, V93, P3601, DOI 10.1039/a702602a; Maini PK, 2012, INTERFACE FOCUS; MEINHARDT H, 1987, J THEOR BIOL, V126, P63, DOI 10.1016/S0022-5193(87)80101-7; MEINHARDT H, 1976, DIFFERENTIATION, V6, P117, DOI 10.1111/j.1432-0436.1976.tb01478.x; Meinhardt H., 1982, MODELS BIOL PATERN F, P3; Meinhardt H, 2008, CURR TOP DEV BIOL, V81, P1, DOI 10.1016/S0070-2153(07)81001-5; Metzger RJ, 1999, SCIENCE, V284, P1635, DOI 10.1126/science.284.5420.1635; Metzger RJ, 2008, NATURE, V453, P745, DOI 10.1038/nature07005; MURRAY JD, 1991, J THEOR BIOL, V149, P339, DOI 10.1016/S0022-5193(05)80310-8; Murray JD, 2002, MATH BIOL INTRO, P501; Painter KJ, 1999, P NATL ACAD SCI USA, V96, P5549, DOI 10.1073/pnas.96.10.5549; Schiefthaler U, 1999, P NATL ACAD SCI USA, V96, P11664, DOI 10.1073/pnas.96.20.11664; Storn R, 1997, J GLOBAL OPTIM, V11, P341, DOI 10.1023/A:1008202821328; Sun GQ, 2012, NONLINEAR DYNAM, V69, P1097, DOI 10.1007/s11071-012-0330-5; Sun GQ, 2016, PHYS LIFE REV, V19, P43, DOI 10.1016/j.plrev.2016.08.002; Sun GQ, 2016, NONLINEAR DYNAM, V85, P1, DOI 10.1007/s11071-016-2671-y; Sun GQ, 2016, NONLINEAR DYNAM, V83, P811, DOI 10.1007/s11071-015-2369-6; Sun GQ, 2015, SCI REP-UK, V5, DOI 10.1038/srep11246; Sun GQ, 2014, APPL MATH COMPUT, V246, P336, DOI 10.1016/j.amc.2014.08.028; Sun GQ, 2014, COMMUN NONLINEAR SCI, V19, P1507, DOI 10.1016/j.cnsns.2013.09.016; Sun GQ, 2012, APPL MATH COMPUT, V218, P11151, DOI 10.1016/j.amc.2012.04.071; TEVLIN P, 1985, J THEOR BIOL, V115, P495, DOI 10.1016/S0022-5193(85)80137-5; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Yao Y, 2007, J BIOL CHEM, V282, P30131, DOI 10.1074/jbc.M704297200	42	2	2	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2017	12	2							e0172643	10.1371/journal.pone.0172643	http://dx.doi.org/10.1371/journal.pone.0172643			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5SK	28225811	Green Published, Green Submitted, gold			2022-12-27	WOS:000394680900060
J	Sun, P; Cheng, CZ; Lin, YL; Zhu, QF; Lin, JK; Lai, ZX				Sun, Ping; Cheng, Chunzhen; Lin, Yuling; Zhu, Qiufang; Lin, Jinke; Lai, Zhongxiong			Combined small RNA and degradome sequencing reveals complex microRNA regulation of catechin biosynthesis in tea (Camellia sinensis)	PLOS ONE			English	Article							TRANSCRIPTION FACTORS; EXPRESSION; IDENTIFICATION; ACCUMULATION; GENES; TARGETS; SIRNA	MicroRNAs are endogenous non-coding small RNAs playing crucial regulatory roles in plants. Tea, a globally popular non-alcoholic drink, is rich in health-enhancing catechins. In this study, 69 conserved and 47 novel miRNAs targeting 644 genes were identified by high-throughout sequencing. Predicted target genes of miRNAs were mainly involved in plant growth, signal transduction, morphogenesis and defense. To further identify targets of tea miRNAs, degradome sequencing and RNA ligase-mediated rapid amplification of 5' cDNA ends (RLM-RACE) were applied. Using degradome sequencing, 26 genes mainly involved in transcription factor, resistance protein and signal transduction protein synthesis were identified as potential miRNA targets, with 5 genes subsequently verified. Quantitative realtime PCR (qRT-PCR) revealed that the expression patterns of novel-miR1, novel-miR2, csn-miR160a, csn-miR162a, csn-miR394 and csn-miR396a were negatively correlated with catechin content. The expression of six miRNAs (csn-miRNA167a, csn-miR2593e, csn-miR4380a, csn-miR3444b, csn-miR5251 and csn-miR7777-5p. 1) and their target genes involved in catechin biosynthesis were also analyzed by qRT-PCR. Negative and positive correlations were found between these miRNAs and catechin contents, while positive correlations were found between their target genes and catechin content. This result suggests that these miRNAs may negatively regulate catechin biosynthesis by down-regulating their biosynthesis-related target genes. Taken together, our results indicate that miRNAs are crucial regulators in tea, with the results of 5'-RLM-RACE and expression analyses revealing the important role of miRNAs in catechin anabolism. Our findings should facilitate future research to elucidate the function of miRNAs in catechin biosynthesis.	[Sun, Ping; Cheng, Chunzhen; Lin, Yuling; Zhu, Qiufang; Lin, Jinke; Lai, Zhongxiong] Fujian Agr & Forestry Univ, Coll Hort, Fuzhou, Peoples R China; [Lin, Jinke] Fujian Agr & Forestry Univ, Anxi Coll Tea Sci, Fuzhou, Peoples R China	Fujian Agriculture & Forestry University; Fujian Agriculture & Forestry University	Lin, JK; Lai, ZX (corresponding author), Fujian Agr & Forestry Univ, Coll Hort, Fuzhou, Peoples R China.; Lin, JK (corresponding author), Fujian Agr & Forestry Univ, Anxi Coll Tea Sci, Fuzhou, Peoples R China.	ljk213@163.com; laizx01@163.com	Cheng, Chunzhen/HGA-1240-2022	Cheng, Chunzhen/0000-0003-1978-0097	National Natural Science Foundation of China [31170651]; Major Science and Technology project in Fujian Province [2015NZ 0002-1]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major Science and Technology project in Fujian Province	This work was funded by the National Natural Science Foundation of China (project no. 31170651) and Major Science and Technology project in Fujian Province (2015NZ 0002-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addo-Quaye C, 2008, CURR BIOL, V18, P758, DOI 10.1016/j.cub.2008.04.042; Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; Allen E, 2005, NAT GENET, V36, P1282; BELD M, 1989, PLANT MOL BIOL, V13, P491, DOI 10.1007/BF00027309; Chen XM, 2004, SCIENCE, V303, P2022, DOI 10.1126/science.1088060; Chen YM, 2011, J SCI FOOD AGR, V91, P1111, DOI 10.1002/jsfa.4291; Cui LL, 2016, J EXP BOT, V67, P2285, DOI 10.1093/jxb/erw053; Cui LG, 2014, PLANT J, V80, P1108, DOI 10.1111/tpj.12712; Dai J, 2001, Se Pu, V19, P398; Eckardt NA, 2005, PLANT CELL, V17, P1335, DOI 10.1105/tpc.105.033159; Fan K, 2015, PLANT PHYSIOL BIOCH, V97, P350, DOI 10.1016/j.plaphy.2015.10.026; Friedlander MR, 2012, NUCLEIC ACIDS RES, V40, P37, DOI 10.1093/nar/gkr688; Goetz M, 2007, PLANT PHYSIOL, V145, P351, DOI 10.1104/pp.107.104174; Guo HS, 2005, PLANT CELL, V17, P1376, DOI 10.1105/tpc.105.030841; Hao DC, 2012, PHYSIOL PLANTARUM, V146, P388, DOI 10.1111/j.1399-3054.2012.01668.x; Hoffmann L, 2004, PLANT CELL, V16, P1446, DOI 10.1105/tpc.020297; Hongbiao D., 2014, STUDIES QRT PCR EXPR; HU Z-H, 2010, GENETIC, V32, P1018; Jeyaraj A, 2014, PLANT CELL REP, V33, P1053, DOI 10.1007/s00299-014-1589-4; [贾小云 Jia Xiaoyun], 2015, [中国农业科学, Scientia Agricultura Sinica], V48, P2911; Jiang XL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062315; Jin HL, 2000, EMBO J, V19, P6150, DOI 10.1093/emboj/19.22.6150; Kim JH, 2003, PLANT J, V36, P94, DOI 10.1046/j.1365-313X.2003.01862.x; Kim JS, 2012, PLANT CELL, V24, P3393, DOI 10.1105/tpc.112.100933; Kumar R, 2011, MOL GENET GENOMICS, V285, P245, DOI 10.1007/s00438-011-0602-7; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee BH, 2009, PLANT PHYSIOL, V151, P655, DOI 10.1104/pp.109.141838; Lefebvre B, 2010, P NATL ACAD SCI USA, V107, P2343, DOI 10.1073/pnas.0913320107; Li X-P, 2015, GUIHAIA; Lin JinKe, 2005, Acta Agronomica Sinica, V31, P1511; Lin Y, 2015, FRONTIERS PLANT SCI, V6; Lin YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060337; Liu H, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-104; Liu PP, 2007, PLANT J, V52, P133, DOI 10.1111/j.1365-313X.2007.03218.x; Liu XD, 2010, PLANT J, V62, P416, DOI 10.1111/j.1365-313X.2010.04164.x; Ma ChunLei, 2010, Journal of Tea Science, V30, P27; Mamati GE, 2006, J SCI FOOD AGR, V86, P459, DOI 10.1002/jsfa.2368; Punyasiri PAN, 2004, ARCH BIOCHEM BIOPHYS, V431, P22, DOI 10.1016/j.abb.2004.08.003; Rhoades MW, 2002, CELL, V110, P513, DOI 10.1016/S0092-8674(02)00863-2; Singh BN, 2011, BIOCHEM PHARMACOL, V82, P1807, DOI 10.1016/j.bcp.2011.07.093; Singh K, 2009, FUNCT INTEGR GENOMIC, V9, P125, DOI 10.1007/s10142-008-0092-9; Sunkar R, 2005, PLANT CELL, V17, P1397, DOI 10.1105/tpc.105.031682; Sunkar R, 2007, TRENDS PLANT SCI, V12, P301, DOI 10.1016/j.tplants.2007.05.001; Tamagnone L, 1998, PLANT CELL, V10, P135, DOI 10.1105/tpc.10.2.135; Ulmasov T, 1999, PLANT J, V19, P309, DOI 10.1046/j.1365-313X.1999.00538.x; Ulmasov T, 1997, PLANT CELL, V9, P1963, DOI 10.1105/tpc.9.11.1963; Verhoeyen ME, 2002, J EXP BOT, V53, P2099, DOI 10.1093/jxb/erf044; Wang H, 2011, CARCINOGENESIS, V32, P1881, DOI 10.1093/carcin/bgr218; Wang LW, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-154; Xia T, 2013, CHINA AGR SCI; Yang C, 2014, J NANJING FORESTRY U, P155; Yang SJ, 2014, BMC GENOMICS, V15, DOI [10.1186/1471-2164-15-13, 10.1186/1471-2164-15-146]; Yao ShengBo, 2015, Journal of Tea Science, V35, P35; Yao YY, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r96; Zhang XL, 2012, J SCI FOOD AGR, V92, P1533, DOI 10.1002/jsfa.4739; Zhang Y., 2014, EURASIP J ADV SIG PR, V2014, P1, DOI DOI 10.1016/J.ENGGE0.2014.08.024; Zhao L.T, 2015, THESIS; Zhao L, 2013, FUNCT INTEGR GENOMIC, V13, P75, DOI 10.1007/s10142-012-0301-4; Zheng C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125031; Zheng XQ, 2010, AFRICAN J BIOTECHNOL, V7, P3283; Zhizhong Z., 2008, NATL CHUNG HSING U, P1; Zhou M., 2010, FRONT BIOL, V5, P67, DOI [DOI 10.1007/S11515-010-0007-8, 10.1007/s11515-010-0007-8]; Zhu QW, 2013, J ZHEJIANG UNIV-SC B, V14, P916, DOI 10.1631/jzus.B1300006	63	24	25	3	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2017	12	2							e0171173	10.1371/journal.pone.0171173	http://dx.doi.org/10.1371/journal.pone.0171173			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5SK	28225779	Green Published, Green Submitted, gold			2022-12-27	WOS:000394680900010
J	van Arensbergen, J; Dussaud, S; Pardanaud-Glavieux, C; Garcia-Hurtado, J; Sauty, C; Guerci, A; Ferrer, J; Ravassard, P				van Arensbergen, Joris; Dussaud, Sebastien; Pardanaud-Glavieux, Corinne; Garcia-Hurtado, Javier; Sauty, Claire; Guerci, Aline; Ferrer, Jorge; Ravassard, Philippe			A distal intergenic region controls pancreatic endocrine differentiation by acting as a transcriptional enhancer and as a polycomb response element	PLOS ONE			English	Article							GENE-EXPRESSION; PROGENITOR CELLS; BETA-CELLS; GROUP PROTEINS; HISTONE H2A; NEUROGENIN3; CHROMATIN; MICE; UBIQUITINATION; RECRUITMENT	Lineage-selective expression of developmental genes is dependent on the interplay between activating and repressive mechanisms. Gene activation is dependent on cell-specific transcription factors that recognize transcriptional enhancer sequences. Gene repression often depends on the recruitment of Polycomb group (PcG) proteins, although the sequences that underlie the recruitment of PcG proteins, also known as Polycomb response elements (PREs), remain poorly understood in vertebrates. While distal PREs have been identified in mammals, a role for positive-acting enhancers in PcG-mediated repression has not been described. Here we have used a highly efficient procedure based on lentiviral-mediated transgenesis to carry out in vivo fine-mapping of, cis-regulatory sequences that control lineage-specific activation of Neurog3, a master regulator of pancreatic endocrine differentiation. Our findings reveal an enhancer region that is sufficient to drive correct spacio-temporal expression of Neurog3 and demonstrate that this same region serves as a PRE in alternative lineages where Neurog3 is inactive.	[van Arensbergen, Joris; Garcia-Hurtado, Javier; Ferrer, Jorge] IDIBAPS, Genom Programming, Beta Cells Lab, Barcelona, Spain; [van Arensbergen, Joris; Garcia-Hurtado, Javier; Ferrer, Jorge] CIBER Diabet & Enfermedades Metab, Barcelona, Spain; [Dussaud, Sebastien; Pardanaud-Glavieux, Corinne; Sauty, Claire; Guerci, Aline; Ravassard, Philippe] UPMC Univ Paris 06, Sorbonne Univ, INSERM, CNRS,ICM,Hop Pitie Salpetriere, Paris, France; [Ferrer, Jorge] Imperial Coll, Imperial Ctr Translat & Expt Med, Dept Med, London, England; [van Arensbergen, Joris] Netherlands Canc Inst, Div Gene Regulat, Amsterdam, Netherlands; [Dussaud, Sebastien] Univ Paris 06, INSERM, UMRS Biol & Pharmacol Remodelage Cardiovasc 1166, Paris, France; [Guerci, Aline] Agence Natl Rech, Paris, France	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Imperial College London; Netherlands Cancer Institute; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Ravassard, P (corresponding author), IDIBAPS, Genom Programming, Beta Cells Lab, Barcelona, Spain.	j.ferrer@imperial.ac.uk; philippe.ravassard@upmc.fr	Ferrer, Jorge/A-3176-2012	Ferrer, Jorge/0000-0002-5959-5729; COLACE, claire/0000-0002-2977-0282; Dussaud, Sebastien/0000-0002-5365-8338; ravassard, philippe/0000-0002-0393-9262; Garcia-Hurtado, Javier/0000-0001-5271-3107	Ministerio de Economia y Competitividad [SAF2011-27086, BFU2014-54284-R]; Wellcome Trust [101033]; Association de Langue Francaise pour l'Etude du Diabete et des Maladies Metaboligues (ALFEDIAM); JDRF / INSERM grant; MRC [MR/L02036X/1] Funding Source: UKRI; Medical Research Council [MR/L02036X/1] Funding Source: researchfish	Ministerio de Economia y Competitividad(Spanish Government); Wellcome Trust(Wellcome TrustEuropean Commission); Association de Langue Francaise pour l'Etude du Diabete et des Maladies Metaboligues (ALFEDIAM); JDRF / INSERM grant; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Funding from Ministerio de Economia y Competitividad (SAF2011-27086), (BFU2014-54284-R) and a Wellcome Trust Senior Investigator Award (101033) to J.F. P.R. received funding for the Association de Langue Francaise pour l'Etude du Diabete et des Maladies Metaboligues (ALFEDIAM) and a joint JDRF / INSERM grant.; We thank Finn Cilius Nielsen, Rehannah Borup and Susanne Smed (RH Microarray Center, Rigshospitalet, Copenhagen) for array hybridizations, Anouchka L. Skoudy for ES cells, Mark Kalisz, Jose Luis Gomez-Skarmeta and Jacques Mallet for insightful comments and funding from Ministerio de Economia y Competitividad (SAF2011-27086), (BFU2014-54284-R) and a Wellcome Trust Senior Investigator Award (101033) to J.F. P.R. received funding for the Association de Langue Francaise pour l'Etude du Diabete et des Maladies Metaboliques (ALFE-DIAM) and a joint JDRF / INSERM grant.	Apelqvist A, 1999, NATURE, V400, P877, DOI 10.1038/23716; Arda HE, 2013, DEV CELL, V25, P5, DOI 10.1016/j.devcel.2013.03.016; Beucher A, 2012, DEV BIOL, V361, P277, DOI 10.1016/j.ydbio.2011.10.025; Boj SF, 2001, P NATL ACAD SCI USA, V98, P14481, DOI 10.1073/pnas.241349398; Bracken AP, 2006, GENES DEV; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Castaing M, 2005, DIABETOLOGIA, V48, P709, DOI 10.1007/s00125-005-1694-6; Collombat P, 2009, CELL, V138, P449, DOI 10.1016/j.cell.2009.05.035; de Napoles M, 2004, DEV CELL, V7, P663, DOI 10.1016/j.devcel.2004.10.005; Dejardin J, 2005, NATURE, V434, P533, DOI 10.1038/nature03386; Eskeland R, 2010, MOL CELL, V38, P452, DOI 10.1016/j.molcel.2010.02.032; Fujitani Y, 2006, GENE DEV, V20, P253, DOI 10.1101/gad.1360106; Garcia E, 1999, EMBO J, V18, P3404, DOI 10.1093/emboj/18.12.3404; Gerrish K, 2004, MOL ENDOCRINOL, V18, P533, DOI 10.1210/me.2003-0371; Gradwohl G, 2000, P NATL ACAD SCI USA, V97, P1607, DOI 10.1073/pnas.97.4.1607; Haumaitre C, 2005, P NATL ACAD SCI USA, V102, P1490, DOI 10.1073/pnas.0405776102; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Heintzman ND, 2009, CURR OPIN GENET DEV, V19, P541, DOI 10.1016/j.gde.2009.09.006; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Jacquemin P, 2000, MOL CELL BIOL, V20, P4445, DOI 10.1128/MCB.20.12.4445-4454.2000; Ji HK, 2005, BIOINFORMATICS, V21, P3629, DOI 10.1093/bioinformatics/bti593; Ji HK, 2008, NAT BIOTECHNOL, V26, P1293, DOI 10.1038/nbt.1505; Khalfallah O, 2009, STEM CELLS, V27, P1643, DOI 10.1002/stem.88; Kiefer H, 2005, MOL CELL BIOL, V25, P1713, DOI 10.1128/MCB.25.5.1713-1729.2005; Klose RJ, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003717; Ku M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000242; Lee JC, 2001, DIABETES, V50, P928, DOI 10.2337/diabetes.50.5.928; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Lynch MD, 2012, EMBO J, V31, P317, DOI 10.1038/emboj.2011.399; Lynn FC, 2007, P NATL ACAD SCI USA, V104, P10500, DOI 10.1073/pnas.0704054104; Manzanares M, 2002, EMBO J, V21, P365, DOI 10.1093/emboj/21.3.365; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; May D, 2012, NAT GENET, V44, P89, DOI 10.1038/ng.1006; Mendenhall EM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001244; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Morey L, 2010, TRENDS BIOCHEM SCI, V35, P323, DOI 10.1016/j.tibs.2010.02.009; Norrman K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012413; Oliver-Krasinski JM, 2009, J CLIN INVEST, V119, P1888, DOI 10.1172/JCI37028; Ong CT, 2012, EMBO REP, V13, P423, DOI 10.1038/embor.2012.52; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Raum JC, 2010, MOL CELL BIOL, V30, P4234, DOI 10.1128/MCB.01396-09; Ravassard P, 1997, J NEUROSCI RES, V48, P146, DOI 10.1002/(SICI)1097-4547(19970415)48:2<146::AID-JNR7>3.0.CO;2-C; Ravassard P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004731; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Ringrose L, 2007, DEVELOPMENT, V134, P223, DOI 10.1242/dev.02723; Schorderet P, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003951; Schuettengruber B, 2009, DEVELOPMENT, V136, P3531, DOI 10.1242/dev.033902; Schwitzgebel VM, 2000, DEVELOPMENT, V127, P3533; Sing A, 2009, CELL, V138, P885, DOI 10.1016/j.cell.2009.08.020; Skoudy A, 2004, BIOCHEM J, V379, P749, DOI 10.1042/BJ20031784; Solar M, 2009, DEV CELL, V17, P849, DOI 10.1016/j.devcel.2009.11.003; Trocme C, 1998, EUR J NEUROSCI, V10, P508, DOI 10.1046/j.1460-9568.1998.00059.x; van Arensbergen J, 2012, GENES DEV; van Arensbergen J, 2010, GENOME RES, V20, P722, DOI 10.1101/gr.101709.109; Vernimmen D, 2011, GENE DEV, V25, P1583, DOI 10.1101/gad.16985411; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Wang XK, 2001, GENE, V275, P47, DOI 10.1016/S0378-1119(01)00648-5; WHITING J, 1991, GENE DEV, V5, P2048, DOI 10.1101/gad.5.11.2048; Woo CJ, 2010, CELL, V140, P99, DOI 10.1016/j.cell.2009.12.022; Xi HL, 2007, PLOS GENET, V3, P1377, DOI 10.1371/journal.pgen.0030136; Xie R, 2013, CELL STEM CELL; Zahn S, 2004, HYBRIDOMA HYBRIDOM, V23, P385, DOI 10.1089/hyb.2004.23.385; Zentner GE, 2011, GENOME RES, V21, P1273, DOI 10.1101/gr.122382.111	63	6	6	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2017	12	2							e0171508	10.1371/journal.pone.0171508	http://dx.doi.org/10.1371/journal.pone.0171508			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5SK	28225770	Green Published, gold, Green Submitted			2022-12-27	WOS:000394680900015
J	Yu, Y; Xiang, QY; Manos, PS; Soltis, DE; Soltis, PS; Song, BH; Cheng, SF; Liu, X; Wong, GN				Yu, Yan; Xiang, Qiuyun; Manos, Paul S.; Soltis, Douglas E.; Soltis, Pamela S.; Song, Bao-Hua; Cheng, Shifeng; Liu, Xin; Wong, Gane			Whole-genome duplication and molecular evolution in Cornus L. (Cornaceae) - Insights from transcriptome sequences	PLOS ONE			English	Article							NUCLEOTIDE SUBSTITUTION; PHYLOGENETIC ANALYSIS; EARLY DIVERSIFICATION; FLORAL TRANSCRIPTOME; ABSOLUTE RATES; GENES; POLYPLOIDY; PLANTS; INFERENCE; HISTORY	The pattern and rate of genome evolution have profound consequences in organismal evolution. Whole-genome duplication (WGD), or polyploidy, has been recognized as an important evolutionary mechanism of plant diversification. However, in non-model plants the molecular signals of genome duplications have remained largely unexplored. High-throughput transcriptome data from next-generation sequencing have set the stage for novel investigations of genome evolution using new bioinformatic and methodological tools in a phylogenetic framework. Here we compare ten de novo-assembled transcriptomes representing the major lineages of the angiosperm genus Cornus (dogwood) and relevant outgroups using a customized pipeline for analyses. Using three distinct approaches, molecular dating of orthologous genes, analyses of the distribution of synonymous substitutions between paralogous genes, and examination of substitution rates through time, we detected a shared WGD event in the late Cretaceous across all taxa sampled. The inferred doubling event coincides temporally with the paleoclimatic changes associated with the initial divergence of the genus into three major lineages. Analyses also showed an acceleration of rates of molecular evolution after WGD. The highest rates of molecular evolution were observed in the transcriptome of the herbaceous lineage, C. canadensis, a species commonly found at higher latitudes, including the Arctic. Our study demonstrates the value of transcriptome data for understanding genome evolution in closely related species. The results suggest dramatic increase in sea surface temperature in the late Cretaceous may have contributed to the evolution and diversification of flowering plants.	[Yu, Yan; Xiang, Qiuyun] North Carolina State Univ, Dept Plant & Microbial Biol, Raleigh, NC 27695 USA; [Yu, Yan; Manos, Paul S.] Sichuan Univ, Key Lab Bioresources & Ecoenvironm, Minist Educ, Coll Life Sci, Chengdu, Sichuan, Peoples R China; [Yu, Yan] Duke Univ, Dept Biol, 130 Sci Dr, Durham, NC 27708 USA; [Soltis, Douglas E.; Soltis, Pamela S.] Univ Florida, Florida Museum Nat Hist, Gainesville, FL 32611 USA; [Soltis, Douglas E.; Soltis, Pamela S.] Univ Florida, Dept Biol, Gainesville, FL USA; [Song, Bao-Hua] Univ North Carolina Charlotte, Dept Biol Sci, 9201 Univ City Blvd, Charlotte, NC USA; [Cheng, Shifeng; Liu, Xin] BGI Shenzhen, Shenzhen, Peoples R China; [Wong, Gane] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada; [Wong, Gane] Univ Alberta, Dept Med, Edmonton, AB, Canada	University of North Carolina; North Carolina State University; Sichuan University; Duke University; State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of North Carolina; University of North Carolina Charlotte; Beijing Genomics Institute (BGI); University of Alberta; University of Alberta	Yu, Y; Xiang, QY (corresponding author), North Carolina State Univ, Dept Plant & Microbial Biol, Raleigh, NC 27695 USA.; Yu, Y (corresponding author), Sichuan Univ, Key Lab Bioresources & Ecoenvironm, Minist Educ, Coll Life Sci, Chengdu, Sichuan, Peoples R China.; Yu, Y (corresponding author), Duke Univ, Dept Biol, 130 Sci Dr, Durham, NC 27708 USA.	yyu@scu.edu.cn; jenny_xiang@ncsu.edu	Yu, Yan/HCG-9743-2022; WONG, Gane Ka-Shu/G-5784-2013; Soltis, Douglas/L-5957-2015; Yu, Yan/T-3280-2019; Song, Bao-Hua/B-4867-2017	WONG, Gane Ka-Shu/0000-0001-6108-5560; Song, Bao-Hua/0000-0003-3537-7783; Yu, Yan/0000-0001-7177-7552; Liu, Xin/0000-0003-3256-2940	National Science Foundation [IOS-1024629, DEB-1442161, PGR-1444567]; Direct For Biological Sciences [1542841] Funding Source: National Science Foundation; Division Of Integrative Organismal Systems [1444567] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The study benefited from National Science Foundation grants (IOS-1024629, DEB-1442161, PGR-1444567) in the design, data collection, and National Natural Science Foundation of China (31500188) in the analysis.; We thank Xiang Liu and Qing Ma for collecting, shipping, and vouchering RNA materials and Shichao Chen for extracting RNAs. The study benefited from National Science Foundation grants (IOS-1024629, DEB-1442161, PGR-1444567) and National Natural Science Foundation of China (31500188). We are grateful to the anonymous reviewers for critical comments for improving the manuscript.	Akhunov ED, 2013, PLANT PHYSIOL, V161, P252, DOI 10.1104/pp.112.205161; Arrigo N, 2012, CURR OPIN PLANT BIOL, V15, P140, DOI 10.1016/j.pbi.2012.03.010; Atkinson BA, 2016, PEERJ, V4, DOI 10.7717/peerj.2808; Blanc G, 2004, PLANT CELL, V16, P1679, DOI 10.1105/tpc.021410; Byng JW, 2016, BOT J LINN SOC, V181, P1, DOI 10.1111/boj.12385; Chang S. J., 1993, Plant Molecular Biology Reporter, V11, P113, DOI 10.1007/BF02670468; Cui LY, 2006, GENOME RES, V16, P738, DOI 10.1101/gr.4825606; De Storme N, 2012, PLANT PHYSIOL, V160, P1808, DOI 10.1104/pp.112.208611; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edwards J, 2005, NATURE, V435, P164, DOI 10.1038/435164a; EYDE RH, 1988, BOT REV, V54, P233, DOI 10.1007/BF02868985; Fan CZ, 2003, AM J BOT, V90, P1357, DOI 10.3732/ajb.90.9.1357; Fawcett JA, 2011, GENES-BASEL, V2, P191, DOI 10.3390/genes2010191; Fawcett JA, 2009, P NATL ACAD SCI USA, V106, P5737, DOI 10.1073/pnas.0900906106; Freeling M, 2009, ANNU REV PLANT BIOL, V60, P433, DOI 10.1146/annurev.arplant.043008.092122; Gaut B, 2011, ANNU REV ECOL EVOL S, V42, P245, DOI 10.1146/annurev-ecolsys-102710-145119; Gernhard T, 2008, J MATH BIOL, V57, P713, DOI 10.1007/s00285-008-0186-y; GOLDMAN N, 1994, MOL BIOL EVOL, V11, P725; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gross SM, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-563; Hahn MW, 2009, J HERED, V100, P605, DOI 10.1093/jhered/esp047; Jiao YN, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-1-r3; Jiao YN, 2011, NATURE, V473, P97, DOI 10.1038/nature09916; Johnson MTJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050226; Kimura M., 1977, PREPONDERANCE SYNONY; Kurschner WM, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1708; Larget BR, 2010, BIOINFORMATICS, V26, P2910, DOI 10.1093/bioinformatics/btq539; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Liu X, 2013, PLANT CELL REP, V32, P77, DOI 10.1007/s00299-012-1341-x; Logacheva MD, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-30; Lottaz C, 2003, BIOINFORMATICS, V19, pII103, DOI 10.1093/bioinformatics/btg1067; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Lynch M, 2007, ORIGINS GENOME ARCHI; Maere S, 2005, P NATL ACAD SCI USA, V102, P5454, DOI 10.1073/pnas.0501102102; Manchester SR, 2016, FRUIT CORNUS L UNPUB; Manchester SR, 2010, INT J PLANT SCI, V171, P882, DOI 10.1086/655771; Manchester SR, 2009, INT J PLANT SCI, V170, P132, DOI 10.1086/593040; Manzaneda AJ, 2012, NEW PHYTOL, V193, P797, DOI 10.1111/j.1469-8137.2011.03988.x; Matasci N, 2014, GIGASCIENCE, V3, DOI 10.1186/2047-217X-3-17; Mayrose I, 2011, SCIENCE, V333, P1257, DOI 10.1126/science.1207205; McKain MR, 2012, AM J BOT, V99, P397, DOI 10.3732/ajb.1100537; McLachlan G., 1999, J STAT SOFTW, V4, P1, DOI DOI 10.18637/jss.v004.i02; Murat F, 2014, GENOME BIOL EVOL, V6, P12, DOI 10.1093/gbe/evt200; Ness RW, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-298; Paun O, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-113; Pecrix Y, 2011, J EXP BOT, V62, P3587, DOI 10.1093/jxb/err052; Qiu YC, 2014, GENOME BIOL EVOL, V6, P1830, DOI 10.1093/gbe/evu144; Rabier CE, 2014, MOL BIOL EVOL, V31, P750, DOI 10.1093/molbev/mst263; Rambaut A., 2014, TRACER V1 6; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sanderson MJ, 2003, BIOINFORMATICS, V19, P301, DOI 10.1093/bioinformatics/19.2.301; Schranz ME, 2012, CURR OPIN PLANT BIOL, V15, P147, DOI 10.1016/j.pbi.2012.03.011; Seo TK, 2004, MOL BIOL EVOL, V21, P1201, DOI 10.1093/molbev/msh088; SHEATHER SJ, 1991, J ROY STAT SOC B MET, V53, P683; Smith SA, 2008, SCIENCE, V322, P86, DOI 10.1126/science.1163197; Soltis DE, 2014, NEW PHYTOL, V202, P1105, DOI 10.1111/nph.12756; Soltis DE, 2011, AM J BOT, V98, P704, DOI 10.3732/ajb.1000404; Soltis DE, 2009, AM J BOT, V96, P336, DOI 10.3732/ajb.0800079; Soltis P., 2012, POLYPLOIDY GENOME EV; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Stebbins G, 1950, VARIATION EVOLUTION, DOI [10.7312/steb94536, DOI 10.7312/STEB94536]; Tank DC, 2015, NEW PHYTOL, V207, P454, DOI 10.1111/nph.13491; Van de Peer Y, 2009, TRENDS PLANT SCI, V14, P680, DOI 10.1016/j.tplants.2009.09.001; Vanneste K, 2014, GENOME RES, V24, P1334, DOI 10.1101/gr.168997.113; Vanneste K, 2013, MOL BIOL EVOL, V30, P177, DOI 10.1093/molbev/mss214; Venables W.N., 2002, MODERN APPL STAT S, Vfourth, DOI [DOI 10.1007/978-0-387-21706-2, 10.1007/978-0-387-21706-2]; Wang XY, 2009, GENOME RES, V19, P1026, DOI 10.1101/gr.087288.108; Wen J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074394; Wendel JF, 2000, GENOME EVOLUTION POL, P225; Wendel JF, 2015, AM J BOT, V102, P1753, DOI 10.3732/ajb.1500320; Wickett NJ, 2014, P NATL ACAD SCI USA, V111, pE4859, DOI 10.1073/pnas.1323926111; Wolfe KH, 1997, NATURE, V387, P708, DOI 10.1038/42711; Xiang QY, 2008, J SYST EVOL, V46, P349, DOI 10.3724/SP.J.1002.2008.08056; Xiang QY, 2011, MOL PHYLOGENET EVOL, V59, P123, DOI 10.1016/j.ympev.2011.01.016; Xiang QY, 2008, MOL PHYLOGENET EVOL, V49, P327, DOI 10.1016/j.ympev.2008.07.010; Xiang QYJ, 2006, TAXON, V55, P9, DOI 10.2307/25065525; Yang ZH, 2000, MOL BIOL EVOL, V17, P32, DOI 10.1093/oxfordjournals.molbev.a026236; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yule GU, 1925, PHILOS T R SOC LON B, V213, P21, DOI 10.1098/rstb.1925.0002; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412; Zhang J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082674; Zhang R, 2013, P NATL ACAD SCI USA, V110, P5074, DOI 10.1073/pnas.1219690110; Zhang WH, 2008, MOL PHYLOGENET EVOL, V47, P175, DOI 10.1016/j.ympev.2007.12.022	85	16	18	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2017	12	2							e0171361	10.1371/journal.pone.0171361	http://dx.doi.org/10.1371/journal.pone.0171361			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5SK	28225773	Green Published, Green Submitted, gold			2022-12-27	WOS:000394680900011
J	Laffoon, JE; Sonnemann, TF; Shafie, T; Hofman, CL; Brandes, U; Davies, GR				Laffoon, Jason E.; Sonnemann, Till F.; Shafie, Termeh; Hofman, Corinne L.; Brandes, Ulrik; Davies, Gareth R.			Investigating human geographic origins using dual-isotope (Sr-87/Sr-86, delta O-18) assignment approaches	PLOS ONE			English	Article							STRONTIUM ISOTOPES; MIGRATORY BIRDS; STABLE-ISOTOPES; HUMAN HAIR; IDENTIFICATION; PHOSPHATE; HYDROGEN	Substantial progress in the application of multiple isotope analyses has greatly improved the ability to identify nonlocal individuals amongst archaeological populations over the past decades. More recently the development of large scale models of spatial isotopic variation (isoscapes) has contributed to improved geographic assignments of human and animal origins. Persistent challenges remain, however, in the accurate identification of individual geographic origins from skeletal isotope data in studies of human (and animal) migration and provenance. In an attempt to develop and test more standardized and quantitative approaches to geographic assignment of individual origins using isotopic data two methods, combining Sr-87/Sr-86 and delta O-18 isoscapes, are examined for the Circum-Caribbean region: 1) an Interval approach using a defined range of fixed isotopic variation per location; and 2) a Likelihood assignment approach using univariate and bivariate probability density functions. These two methods are tested with enamel isotope data from a modern sample of known origin from Caracas, Venezuela and further explored with two archaeological samples of unknown origin recovered from Cuba and Trinidad. The results emphasize both the potential and limitation of the different approaches. Validation tests on the known origin sample exclude most areas of the Circum-Caribbean region and correctly highlight Caracas as a possible place of origin with both approaches. The positive validation results clearly demonstrate the overall efficacy of a dual-isotope approach to geoprovenance. The accuracy and precision of geographic assignments may be further improved by better understanding of the relationships between environmental and biological isotope variation; continued development and refinement of relevant isoscapes; and the eventual incorporation of a broader array of isotope proxy data.	[Laffoon, Jason E.; Davies, Gareth R.] Vrije Univ, Fac Earth & Life Sci, Amsterdam, Netherlands; [Laffoon, Jason E.; Sonnemann, Till F.; Hofman, Corinne L.] Leiden Univ, Fac Archaeol, Leiden, Netherlands; [Shafie, Termeh; Brandes, Ulrik] Univ Konstanz, Dept Comp & Informat Sci, Constance, Germany	Vrije Universiteit Amsterdam; Leiden University; Leiden University - Excl LUMC; University of Konstanz	Laffoon, JE (corresponding author), Vrije Univ, Fac Earth & Life Sci, Amsterdam, Netherlands.; Laffoon, JE (corresponding author), Leiden Univ, Fac Archaeol, Leiden, Netherlands.	j.e.laffoon@vu.nl	Shafie, Termeh/AAH-7641-2020; Laffoon, Jason E/T-4302-2018	Shafie, Termeh/0000-0002-8419-8477; Laffoon, Jason E/0000-0002-8821-805X; Davies, Gareth Rees/0000-0002-6136-9202	European Research Council under the European Union [319209]	European Research Council under the European Union(European Research Council (ERC))	The research leading to these results is part of the ERC-Synergy project NEXUS1492 which has received funding from the European Research Council https://erc.europa.eu/funding-and-grants under the European Union's Seventh Framework Programme (FP7/2007-2013)/ERC grant agreement no. 319209. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AlQahtani SJ, 2010, AM J PHYS ANTHROPOL, V142, P481, DOI 10.1002/ajpa.21258; [Anonymous], 2013, RCWIP REG CLLUST BAS; Bataille CP, 2012, ECOSPHERE, V3, DOI 10.1890/ES12-00155.1; Beets CJ, 2006, GEOARCHAEOLOGY, V21, P271, DOI 10.1002/gea.20096; Bentley RA, 2006, J ARCHAEOL METHOD TH, V13, P135, DOI 10.1007/s10816-006-9009-x; Boomert A., 2016, INDIGENOUS PEOPLES T; Bowen GJ, 2014, METHODS ECOL EVOL, V5, P201, DOI 10.1111/2041-210X.12147; Brettell R, 2012, J ANAL ATOM SPECTROM, V27, P778, DOI 10.1039/c2ja10335d; Britton K, 2015, AM J PHYS ANTHROPOL, V157, P226, DOI 10.1002/ajpa.22704; Chabot AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043627; Chenery CA, 2012, RAPID COMMUN MASS SP, V26, P309, DOI 10.1002/rcm.5331; Crowley BE, 2017, BIOL REV, V92, P43, DOI 10.1111/brv.12217; Ehleringer JR, 2008, P NATL ACAD SCI USA, V105, P2788, DOI 10.1073/pnas.0712228105; Ehleringer JR, 2010, ISOSCAPES: UNDERSTANDING MOVEMENT, PATTERN, AND PROCESS ON EARTH THROUGH ISOTOPE MAPPING, P357, DOI 10.1007/978-90-481-3354-3_17; Font L, 2015, SCI JUSTICE, V55, P10, DOI 10.1016/j.scijus.2014.02.005; Font L, 2015, SCI JUSTICE, V55, P34, DOI 10.1016/j.scijus.2014.06.011; France CAM, 2014, J ARCHAEOL SCI, V42, P356, DOI 10.1016/j.jas.2013.10.037; Giovas CM, 2016, J ARCHAEOL SCI, V69, P39, DOI 10.1016/j.jas.2016.03.006; Hobson KA, 2012, ECOSPHERE, V3, DOI 10.1890/ES12-00018.1; Hobson KA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007915; HODELL DA, 1991, NATURE, V352, P790, DOI 10.1038/352790a0; IAEA/WMO, 2016, GLOB NETW IS PREC GN; Kamenov GD, 2014, SCI TOTAL ENVIRON, V490, P861, DOI 10.1016/j.scitotenv.2014.05.085; Laffoon, 2012, THESIS; Laffoon JE, 2013, ARCHAEOMETRY, V55, P742, DOI 10.1111/j.1475-4754.2012.00698.x; Laffoon JE, 2016, J ARCHAEOL SCI-REP, V5, P168, DOI 10.1016/j.jasrep.2015.11.020; Laffoon JE, 2012, J ARCHAEOL SCI, V39, P2371, DOI 10.1016/j.jas.2012.02.002; Lehn C, 2015, SCI JUSTICE, V55, P72, DOI 10.1016/j.scijus.2014.10.006; Malaize B, 2011, HOLOCENE, V21, P911, DOI 10.1177/0959683611400198; Meier-Augenstein W, 2008, SCI JUSTICE, V48, P153, DOI 10.1016/j.scijus.2007.10.010; Nieweg DC, 2001, P 19 INT C CAR ARCH, V1, P173; Ossa G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045729; Pestle W. J., 2010, THESIS; Pollard AM, 2011, AM J PHYS ANTHROPOL, V145, P499, DOI 10.1002/ajpa.21524; PRESS WH, NUMERICAL RECIPES C; Royle JA, 2004, ECOL APPL, V14, P1780; Rundel CW, 2013, MOL ECOL, V22, P4163, DOI 10.1111/mec.12393; Schwarcz HP, 2007, FORENSIC MAGAZINE, V4, P28; Sharp ZD, 2003, J ARCHAEOL SCI, V30, P1709, DOI 10.1016/S0305-4403(03)00071-2; Stokes Anne V, 1998, THESIS; Teeth Hillson S., 2005, TEETH; Terzer S, 2013, HYDROL EARTH SYST SC, V17, P4713, DOI 10.5194/hess-17-4713-2013; Thompson AH, 2010, AM J PHYS ANTHROPOL, V141, P440, DOI 10.1002/ajpa.21162; Valcarcel Rojas R., 2016, ARCHAEOLOGY EARLY CO; van Duijvenbode Anne, 2011, COMMUNITIES CONTACT, P225; Van Wilgenburg SL, 2011, ECOL APPL, V21, P1340, DOI 10.1890/09-2047.1; Veen T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098075; West JB, 2010, ISOSCAPES: UNDERSTANDING MOVEMENT, PATTERN, AND PROCESS ON EARTH THROUGH ISOTOPE MAPPING, P1, DOI 10.1007/978-90-481-3354-3; Wunder MB, 2008, ECOL APPL, V18, P549, DOI 10.1890/07-0058.1; Wunder MB, 2010, ISOSCAPES: UNDERSTANDING MOVEMENT, PATTERN, AND PROCESS ON EARTH THROUGH ISOTOPE MAPPING, P251, DOI 10.1007/978-90-481-3354-3_12; YAREMKO JM, 2010, CANADIAN J LATIN AM, V35, P165	51	56	56	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2017	12	2							e0172562	10.1371/journal.pone.0172562	http://dx.doi.org/10.1371/journal.pone.0172562			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL5QV	28222163	Green Published, Green Submitted, gold			2022-12-27	WOS:000394676800067
J	Zeligman, L; Zivotofsky, AZ				Zeligman, Liran; Zivotofsky, Ari Z.			Back to basics: The effects of block vs. interleaved trial administration on pro- and anti-saccade performance	PLOS ONE			English	Article							VOLUNTARY CONTROL; ANTISACCADE TASK; EYE-MOVEMENTS; VISUAL-ATTENTION; INHIBITION; SCHIZOPHRENIA; GENERATION; DEFICITS; ANXIETY; LATENCY	The pro and anti-saccade task (PAT) is a widely used tool in the study of overt and covert attention with promising potential role in neurocognitive and psychiatric assessment. However, specific PAT protocols can vary significantly between labs, potentially resulting in large variations in findings across studies. In light of recent calls towards a standardization of PAT the current study's objective was to systematically and purposely evaluate the effects of block vs. interleaved administration-a fundamental consideration-on PAT measures in a within subject design. Additionally, this study evaluated whether measures of a Posner-type cueing paradigm parallels measures of the PAT paradigm. As hypothesized, results indicate that PAT performance is highly susceptible to administration mode. Interleaved mode resulted in larger error rates not only for anti (blocks: M = 22%; interleaved: M = 42%) but also for pro-saccades (blocks: M = 5%; interleaved: M = 12%). This difference between block and interleaved administration was significantly larger in anti-saccades compared to pro-saccades and cannot be attributed to a 'speed/accuracy tradeoff'. Interleaved mode produced larger pro and anti-saccade differences in error rates while block administration produced larger latency differences. Results question the reflexive nature of pro-saccades, suggesting they are not purely reflexive. These results were further discussed and compared to previous studies that included within subject data of blocks and interleaved trials.	[Zeligman, Liran] Bar Ilan Univ, Dept Psychol, Ramat Gan, Israel; [Zivotofsky, Ari Z.] Bar Ilan Univ, Leslie & Susan Gonda Goldschmied Multidisciplinar, Ramat Gan, Israel	Bar Ilan University; Bar Ilan University	Zivotofsky, AZ (corresponding author), Bar Ilan Univ, Leslie & Susan Gonda Goldschmied Multidisciplinar, Ramat Gan, Israel.	ari.zivotofsky@mail.biu.ac.il						Abel LA, 2007, NEUROBIOL AGING, V28, P627, DOI 10.1016/j.neurobiolaging.2006.02.003; Albares M, 2011, J NEUROPHYSIOL, V106, P809, DOI 10.1152/jn.00206.2011; Alichniewicz KK, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00467; Ansari TL, 2008, COGN AFFECT BEHAV NE, V8, P229, DOI 10.3758/CABN.8.3.229; Antoniades C, 2013, VISION RES, V84, P1, DOI 10.1016/j.visres.2013.02.007; Brewer GA, 2011, PSYCHON B REV, V18, P923, DOI 10.3758/s13423-011-0130-9; Calkins ME, 2004, SCHIZOPHR RES, V71, P167, DOI 10.1016/j.schres.2003.12.005; Chan JL, 2013, EXP BRAIN RES, V227, P301, DOI 10.1007/s00221-013-3452-1; Chen PL, 2016, NEUROBIOL AGING, V41, P53, DOI 10.1016/j.neurobiolaging.2016.02.010; Cherkasova MV, 2002, EXP BRAIN RES, V144, P528, DOI 10.1007/s00221-002-1075-z; Chiau HY, 2011, J NEUROPHYSIOL, V106, P515, DOI 10.1152/jn.00399.2010; Chica AB, 2014, NEUROSCI BIOBEHAV R, V40, P35, DOI 10.1016/j.neubiorev.2014.01.002; Chica AB, 2010, J EXP PSYCHOL HUMAN, V36, P1193, DOI 10.1037/a0019951; Collie A, 2000, J EXP PSYCHOL HUMAN, V26, P1733, DOI 10.1037//0096-1523.26.6.1733; Crawford TJ, 2011, EXP BRAIN RES, V208, P385, DOI 10.1007/s00221-010-2488-8; Damilou A, 2016, PSYCHOPHYSIOLOGY, V53, P796, DOI 10.1111/psyp.12630; Derakshan N, 2009, EXP PSYCHOL, V56, P48, DOI 10.1027/1618-3169.56.1.48; Evdokimidis I, 2002, EXP BRAIN RES, V147, P45, DOI 10.1007/s00221-002-1208-4; Everling S, 1998, NEUROPSYCHOLOGIA, V36, P885, DOI 10.1016/S0028-3932(98)00020-7; Fischer B, 1997, EXP BRAIN RES, V116, P191, DOI 10.1007/PL00005749; Fischer B, 1984, EXPT BRAIN RES, V57; Frischen A, 2007, PSYCHOL BULL, V133, P694, DOI 10.1037/0033-2909.133.4.694; FUKUSHIMA J, 1988, BIOL PSYCHIAT, V23, P670, DOI 10.1016/0006-3223(88)90050-9; GILMORE GC, 1976, MEM COGNITION, V4, P519, DOI 10.3758/BF03213213; HALLETT PE, 1980, VISION RES, V20, P329, DOI 10.1016/0042-6989(80)90019-X; Hutton SB, 2006, PSYCHOPHYSIOLOGY, V43, P302, DOI 10.1111/j.1469-8986.2006.00403.x; Isotalo E, 2005, EXP BRAIN RES, V165, P461, DOI 10.1007/s00221-005-2317-7; KINGSTONE A, 1993, PERCEPT PSYCHOPHYS, V54, P260, DOI 10.3758/BF03211762; Klein C, 2005, DEV BRAIN RES, V160, P113, DOI 10.1016/j.devbrainres.2005.06.011; Koval MJ, 2005, EXP BRAIN RES, V167, P475, DOI 10.1007/s00221-005-0206-8; Kristjansson A, 2007, SCAND J PSYCHOL, V48, P97, DOI 10.1111/j.1467-9450.2007.00537.x; KRUEGER LE, 1970, J EXP PSYCHOL, V83, P391, DOI 10.1037/h0028845; Kuhn G, 2009, ATTEN PERCEPT PSYCHO, V71, P314, DOI 10.3758/APP.71.2.314; Liu CL, 2010, J NEUROPHYSIOL, V103, P1438, DOI 10.1152/jn.00815.2009; Maruff P, 1999, PSYCHOL MED, V29, P1377, DOI 10.1017/S0033291799008843; Matsuo Y, 2015, PLOS ONE, V10; Mitchell JP, 2002, J COGNITIVE NEUROSCI, V14, P95, DOI 10.1162/089892902317205357; Munoz DP, 2004, NAT REV NEUROSCI, V5, P218, DOI 10.1038/nrn1345; O'Driscoll GA, 2005, BIOL PSYCHIAT, V57, P1452, DOI 10.1016/j.biopsych.2005.02.029; Olk B, 2003, NEUROREPORT, V14, P151, DOI 10.1097/00001756-200301200-00028; Pierce JE, 2014, EXP BRAIN RES, V233, P959, DOI 10.1007/s00221-014-4170-z; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; Schall JD, 2003, CURR OPIN NEUROBIOL, V13, P182, DOI 10.1016/S0959-4388(03)00039-4; Smyrnis N, 2008, BRAIN COGNITION, V68, P341, DOI 10.1016/j.bandc.2008.08.022; Stuyven E, 2000, ACTA PSYCHOL, V104, P69, DOI 10.1016/S0001-6918(99)00054-2; Taylor AJG, 2011, EXP BRAIN RES, V213, P27, DOI 10.1007/s00221-011-2770-4; Taylor TL, 2000, J EXP PSYCHOL HUMAN, V26, P1639, DOI 10.1037//0096-1523.26.5.1639; Wang JX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061566; Wardak C, 2012, EUR J NEUROSCI, V36, P3568, DOI 10.1111/j.1460-9568.2012.08264.x	49	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2017	12	2							e0172485	10.1371/journal.pone.0172485	http://dx.doi.org/10.1371/journal.pone.0172485			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL5QV	28222173	gold, Green Submitted, Green Published			2022-12-27	WOS:000394676800060
J	Kaushik, MK; Kaul, SC; Wadhwa, R; Yanagisawa, M; Urade, Y				Kaushik, Mahesh K.; Kaul, Sunil C.; Wadhwa, Renu; Yanagisawa, Masashi; Urade, Yoshihiro			Triethylene glycol, an active component of Ashwagandha (Withania somnifera) leaves, is responsible for sleep induction	PLOS ONE			English	Article							LEAF EXTRACT; OLDER-ADULTS; RATS; MICE	Insomnia is the most common sleep complaint which occurs due to difficulty in falling asleep or maintaining it. Most of currently available drugs for insomnia develop dependency and/or adverse effects. Hence natural therapies could be an alternative choice of treatment for insomnia. The root or whole plant extract of Ashwagandha (Withania somnifera) has been used to induce sleep in Indian system of traditional home medicine, Ayurveda. However, its active somnogenic components remain unidentified. We investigated the effect of various components of Ashwagandha leaf on sleep regulation by oral administration in mice. We found that the alcoholic extract that contained high amount of active withanolides was ineffective to induce sleep in mice. However, the water extract which contain triethylene glycol as a major component induced significant amount of non-rapid eye movement sleep with slight change in rapid eye movement sleep. Commercially available triethylene glycol also increased non-rapid eye movement sleep in mice in a dose-dependent (10-30 mg/mouse) manner. These results clearly demonstrated that triethylene glycol is an active sleep inducing component of Ashwagandha leaves and could potentially be useful for insomnia therapy.	[Kaushik, Mahesh K.; Urade, Yoshihiro] Univ Tsukuba, Dept Mol Sleep, Int Inst Integrat Sleep Med WPI IIIS, 1-1-1 Tennodai, Tsukuba, Ibaraki, Japan; [Kaushik, Mahesh K.; Yanagisawa, Masashi] Univ Tsukuba, Dept Mol Genet, Int Inst Integrat Sleep Med WPI IIIS, 1-1-1 Tennodai, Tsukuba, Ibaraki, Japan; [Kaul, Sunil C.; Wadhwa, Renu] Natl Inst Adv Ind Sci & Technol, Drug Discovery & Assets Innovat Lab, DBT AIST Int Lab Adv Biomed, Higashi 1-1-1, Tsukuba, Ibaraki, Japan	University of Tsukuba; University of Tsukuba; National Institute of Advanced Industrial Science & Technology (AIST)	Kaushik, MK; Urade, Y (corresponding author), Univ Tsukuba, Dept Mol Sleep, Int Inst Integrat Sleep Med WPI IIIS, 1-1-1 Tennodai, Tsukuba, Ibaraki, Japan.; Kaushik, MK (corresponding author), Univ Tsukuba, Dept Mol Genet, Int Inst Integrat Sleep Med WPI IIIS, 1-1-1 Tennodai, Tsukuba, Ibaraki, Japan.	kaushik.m.k.kb@u.tsukuba.ac.jp; yoshihiro.ft@u.tsukuba.ac.jp	Wadhwa, Renu/L-8898-2018; Kaul, Sunil C/L-8671-2018; Kaushik, Mahesh K./AAD-5977-2019	Wadhwa, Renu/0000-0001-8248-5192; Kaul, Sunil C/0000-0002-0046-3916; Kaushik, Mahesh K./0000-0003-4286-1573	"Japan Society for the Promotion of Science", KAKENHI [16H01881]	"Japan Society for the Promotion of Science", KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported financially by grant from "Japan Society for the Promotion of Science", KAKENHI grant number 16H01881 to Yoshihiro Urade.	Akhoon BA, 2016, EXP GERONTOL, V78, P47, DOI 10.1016/j.exger.2016.03.004; Ballantyne B, 2007, J APPL TOXICOL, V27, P291, DOI 10.1002/jat.1220; Borron SW, 1997, VET HUM TOXICOL, V39, P26; Calcaterra NE, 2014, ACS CHEM NEUROSCI, V5, P253, DOI 10.1021/cn5000056; Chandrasekhar K, 2012, Indian J Psychol Med, V34, P255, DOI 10.4103/0253-7176.106022; Cho S, 2014, PSYCHOPHARMACOLOGY, V231, P2825, DOI 10.1007/s00213-014-3445-1; Gautam A, 2013, NEUROBIOL LEARN MEM, V106, P177, DOI 10.1016/j.nlm.2013.08.009; Gooneratne NS, 2008, CLIN GERIATR MED, V24, P121, DOI 10.1016/j.cger.2007.08.002; Gooneratne NS, 2014, CLIN GERIATR MED, V30, P591, DOI 10.1016/j.cger.2014.04.007; Huang ZL, 2001, P NATL ACAD SCI USA, V98, P9965, DOI 10.1073/pnas.181330998; Jacobson LH, 2014, EXPERT REV CLIN PHAR, V7, P711, DOI 10.1586/17512433.2014.966813; Kaur K, 2004, FOOD CHEM TOXICOL, V42, P2015, DOI 10.1016/j.fct.2004.07.015; Kaushik MK, 2014, EXP NEUROL, V253, P82, DOI 10.1016/j.expneurol.2013.12.002; Kohtoh S, 2008, SLEEP BIOL RHYTHMS, V6, P163, DOI 10.1111/j.1479-8425.2008.00355.x; Konar A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027265; Kumar A, 2008, INDIAN J PHARM SCI, V70, P806, DOI 10.4103/0250-474X.49130; Kumar A, 2007, INDIAN J EXP BIOL, V45, P524; Manchanda S, 2016, MOL NEUROBIOL; MCKENNIS H, 1962, TOXICOL APPL PHARM, V4, P411, DOI 10.1016/0041-008X(62)90029-7; Murthy M. R. Ven, 2010, Central Nervous System Agents in Medicinal Chemistry, V10, P238; PATCHEV V, 1991, HOMEOSTASIS HLTH DIS, V33, P97; Rani G, 2005, FOOD CHEM TOXICOL, V43, P95, DOI 10.1016/j.fct.2004.07.021; Reddy M S, 2011, Indian J Psychol Med, V33, P1, DOI 10.4103/0253-7176.85388; Schwartz Thomas L, 2013, Drugs Context, V2013, P212257, DOI 10.7573/dic.212257; Vassiliadis J, 1999, J TOXICOL-CLIN TOXIC, V37, P773, DOI 10.1081/CLT-100102455; Verma SK., 2011, ASIAN J PHARM CLIN R, V4, P1; Wadhwa R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077189; Widodo N, 2008, CANCER LETT, V262, P37, DOI 10.1016/j.canlet.2007.11.037; Widodo N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013536; ZAKUSOV VV, 1977, ARCH INT PHARMACOD T, V229, P313; Zhang DY, 2010, J CLIN PSYCHOPHARM, V30, P694, DOI 10.1097/JCP.0b013e3181fa8526	31	17	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0172508	10.1371/journal.pone.0172508	http://dx.doi.org/10.1371/journal.pone.0172508			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207892	gold, Green Published, Green Submitted			2022-12-27	WOS:000394424500143
J	Kiwanuka, N; Ssetaala, A; Ssekandi, I; Nalutaaya, A; Kitandwe, PK; Ssempiira, J; Bagaya, BS; Balyegisawa, A; Kaleebu, P; Hahn, J; Lindan, C; Sewankambo, NK				Kiwanuka, Noah; Ssetaala, Ali; Ssekandi, Ismail; Nalutaaya, Annet; Kitandwe, Paul Kato; Ssempiira, Julius; Bagaya, Bernard Ssentalo; Balyegisawa, Apolo; Kaleebu, Pontiano; Hahn, Judith; Lindan, Christina; Sewankambo, Nelson Kaulukusi			Population attributable fraction of incident HIV infections associated with alcohol consumption in fishing communities around Lake Victoria, Uganda	PLOS ONE			English	Article							RISKY SEXUAL-BEHAVIOR; UNPROTECTED SEX; RURAL UGANDA; RAKAI; PREVALENCE; INTERVENTION; METAANALYSIS; DISTRICT; VIOLENCE; COST	Background Although the association between alcohol consumption and HIV risk is well documented, few studies have examined the magnitude of new HIV infections that could be prevented by controlling alcohol use. We report the population attributable fraction (PAF) of incident HIV infections due to alcohol consumption among the HIV high-risk population of fishing communities along Lake Victoria, Uganda. Methods In a community-based cohort study, 1607 HIV sero-negative participants aged 18-49 years were enrolled from eight fishing communities along Lake Victoria, Uganda. At follow up 12 months later, 1288 (80.1%) were seen and interviewed. At baseline and follow-up visits, participants completed interviewer-administered questionnaires on alcohol consumption, demographics, and sexual risk behavior, and were tested for HIV infection. HIV incidence and adjusted incident rate ratios (adjusted IRRs) were estimated using Poisson regression models; the crude and adjusted PAFs of incident HIV infections associated with alcohol consumption were calculated using the Greenland and Drescher method for cohort studies. Results Among the 1288 participants seen at follow up, 53.5% reported drinking alcohol of whom 24.4% drank occasionally (2 days a week or less) and 29.1% drank regularly (3-7 days a week). Forty eight incident HIV infections occurred giving an incidence rate of 3.39/100 person years at-risk (pyar) (95% CI, 2.55-4.49). Compared to non-drinkers, the adjusted IRR of HIV was 3.09 (1.13-8.46) among occasional drinkers and 5.34 (2.04-13.97) among regular drinkers. The overall adjusted PAF of incident HIV infections due alcohol was 64.1 (95% CI; 23.5-83.1); ranging from 52.3 (11.9-74.2) among Muslims to 71.2 (32.6-87.7) for participants who reported >= 2 sexual partners in the past 12 months. Conclusion In fishing communities along Lake Victoria, Uganda, 64% of new HIV infections can be attributed to drinking alcohol. Interventions to reduce alcohol consumption should be integrated in HIV/AIDS prevention activities for populations in whom both HIV and alcohol consumption are highly prevalent.	[Kiwanuka, Noah] Makerere Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Kampala, Uganda; [Kiwanuka, Noah; Ssetaala, Ali; Ssekandi, Ismail; Nalutaaya, Annet; Kitandwe, Paul Kato; Ssempiira, Julius; Bagaya, Bernard Ssentalo] Uganda Virus Res Inst, Int AIDS Vaccine Initiat, HIV Vaccine Program, Entebbe, Uganda; [Bagaya, Bernard Ssentalo] Makerere Univ, Sch Biomed Sci, Dept Med Microbiol, Kampala, Uganda; [Balyegisawa, Apolo] Int AIDS Vaccine Initiat, New York, NY USA; [Kaleebu, Pontiano] MRC, Uganda Virus Res Inst, Uganda Res Unit AIDS, Entebbe, Uganda; [Kaleebu, Pontiano] London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London, England; [Hahn, Judith; Lindan, Christina] Univ Calif San Francisco, Sch Med, Dept Med, San Francisco, CA USA; [Sewankambo, Nelson Kaulukusi] Makerere Univ, Sch Med, Clin Epidemiol Unit, Coll Hlth Sci, Kampala, Uganda	Makerere University; International AIDS Vaccine Initiative; Uganda Virus Research Institute; Makerere University; International AIDS Vaccine Initiative; Uganda Virus Research Institute; University of London; London School of Hygiene & Tropical Medicine; University of California System; University of California San Francisco; Makerere University	Kiwanuka, N (corresponding author), Makerere Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Kampala, Uganda.; Kiwanuka, N (corresponding author), Uganda Virus Res Inst, Int AIDS Vaccine Initiat, HIV Vaccine Program, Entebbe, Uganda.	nkiwanuka@gmail.com	Hahn, Judith/J-5813-2014; Ssetaala, Ali/AAB-3832-2020	Hahn, Judith/0000-0002-2697-8264; Ssetaala, Ali/0000-0003-2156-3024; Ssentalo Bagaya, Bernard/0000-0002-3847-2615	Training Health Researchers into Vocational Excellence in East Africa Project (THRIVE); Wellcome Trust [087540/Z/08/Z]; Canada-Africa Prevention Trials Network (CAPTN) [1063357-001]; International AIDS Vaccine Initiative (IAVI) through UVRI-IAVI HIV Vaccine Program; NATIONAL INSTITUTE OF MENTAL HEALTH [R25MH064712] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [K24AA022586] Funding Source: NIH RePORTER	Training Health Researchers into Vocational Excellence in East Africa Project (THRIVE); Wellcome Trust(Wellcome TrustEuropean Commission); Canada-Africa Prevention Trials Network (CAPTN); International AIDS Vaccine Initiative (IAVI) through UVRI-IAVI HIV Vaccine Program; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by Training Health Researchers into Vocational Excellence in East Africa Project (THRIVE), grant number 087540/Z/08/Z funded by the Wellcome Trust, and the Canada-Africa Prevention Trials Network (CAPTN) grant number 1063357-001. We greatly appreciated the support given by the International AIDS Vaccine Initiative (IAVI) through the UVRI-IAVI HIV Vaccine Program in form of clinical research sites where study coordination activities were carried out. We also thank the study participants and the UVRI-IAVI Community Advisory Board. The contents are solely the responsibility of the authors and do not necessarily represent the official views of the supporting offices. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed S, 2001, AIDS, V15, P2171, DOI 10.1097/00002030-200111090-00013; Baliunas D, 2010, INT J PUBLIC HEALTH, V55, P159, DOI 10.1007/s00038-009-0095-x; Brady AR, 1998, STATA TECHNICAL B, P8; Burnhams NH, 2015, SUBST ABUSE TREAT PR, V10, DOI 10.1186/s13011-015-0014-5; Carrasco MA, 2016, AIDS BEHAV, V20, P484, DOI 10.1007/s10461-015-1233-5; Chersich MF, 2014, GLOBALIZATION HEALTH, V10, DOI 10.1186/1744-8603-10-22; Chersich MF, 2009, GLOBALIZATION HEALTH, V5, DOI 10.1186/1744-8603-5-16; Chiva-Blanch G, 2014, NUTR METAB CARDIOVAS; Coldiron ME, 2008, AIDS BEHAV, V12, P594, DOI 10.1007/s10461-007-9304-x; Cooper ML, 2002, J STUD ALCOHOL, P101, DOI 10.15288/jsas.2002.s14.101; Fisher JC, 2007, SEX TRANSM DIS, V34, P856, DOI 10.1097/OLQ.0b013e318067b4fd; Francis JM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140041; Fritz K, 2010, LANCET, V376, P398, DOI 10.1016/S0140-6736(10)60884-7; Fromme K, 1999, J STUD ALCOHOL, V60, P54, DOI 10.15288/jsa.1999.60.54; Geis S, 2011, JAIDS-J ACQ IMM DEF, V56, P453, DOI 10.1097/QAI.0b013e3182118fa3; Glymour MM, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4334; Gray RH, 1999, AIDS, V13, P2113, DOI 10.1097/00002030-199910220-00015; GREENLAND S, 1993, BIOMETRICS, V49, P865, DOI 10.2307/2532206; Guizzetti M, 2014, FRONT PEDIATR, V2, DOI 10.3389/fped.2014.00123; Hahn JA, 2016, ADDICTION, V111, P272, DOI 10.1111/add.13173; Hahn Judith A, 2011, Curr HIV/AIDS Rep, V8, P172, DOI 10.1007/s11904-011-0088-2; Ippolito JA, 2013, ALCOHOL, V47, P589, DOI 10.1016/j.alcohol.2013.09.003; Kessler J, 2015, ALCOHOL CLIN EXP RES, V39, P2179, DOI 10.1111/acer.12890; Kiene SA, 2009, J ADOLESCENT HEALTH, V44, P73, DOI 10.1016/j.jadohealth.2008.05.008; Kiene SM, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-583; Kim AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017535; Kiwanuka N, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-986; Kiwanuka N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094932; Kiwanuka N, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18621; Koenig MA, 2004, SOC SCI MED, V58, P787, DOI 10.1016/S0277-9536(03)00244-2; Kouyoumdjian FG, 2013, AIDS, V27, P1331, DOI 10.1097/QAD.0b013e32835fd851; Loganantharaj N, 2014, AIDS RES HUM RETROV, V30, P783, DOI [10.1089/aid.2014.0065, 10.1089/AID.2014.0065]; Lubega M, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2371-4; Lubega M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132740; MacDonald TK, 2000, HEALTH PSYCHOL, V19, P290, DOI 10.1037/0278-6133.19.3.290; Matzopoulos RG, 2014, SAMJ S AFR MED J, V104, P127, DOI 10.7196/SAMJ.7644; Medley A, 2014, AIDS CARE, P1; Messaoudi I, 2013, VACCINE, V32, P54, DOI 10.1016/j.vaccine.2013.10.076; Messaoudi I, 2014, EXPERT REV VACCINES, V13, P817, DOI 10.1586/14760584.2014.924405; Morojele NK, 2006, SOC SCI MED, V62, P217, DOI 10.1016/j.socscimed.2005.05.031; Nkosi S, 2014, AIDS BEHAV; Opio A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070770; Parcesepe AM, 2016, DRUG ALCOHOL DEPEN, V161, P21, DOI 10.1016/j.drugalcdep.2015.12.037; PERRY MJ, 1994, AIDS, V8, P1321, DOI 10.1097/00002030-199409000-00016; Scott-Sheldon LA, 2014, DRUG ALCOHOL DEPEND; Scott-Sheldon LAJ, 2013, CURR HIV-AIDS REP, V10, P314, DOI 10.1007/s11904-013-0177-5; Seeley J, 2012, SEX TRANSM DIS, V39, P433, DOI 10.1097/OLQ.0b013e318251555d; Shuper PA, 2009, AIDS BEHAV, V13, P1021, DOI 10.1007/s10461-009-9589-z; Stockwell T, 2000, J SUBST ABUSE, V12, P139, DOI 10.1016/S0899-3289(00)00046-8; Teferra S, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2911-6; Theall KP, 2008, J STUD ALCOHOL DRUGS, V69, P454, DOI 10.15288/jsad.2008.69.454; Tumwesigye NM, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1069; Vandepitte J, 2012, J ACQUIR IMMUNE DEFI; Weiser SD, 2006, PLOS MED, V3, P1940, DOI 10.1371/journal.pmed.0030392; Williams PP, 2015, J MIDWIFERY WOM HEAL, V60, P401, DOI 10.1111/jmwh.12328; Woolf-King SE, 2011, ARCH SEX BEHAV, V40, P17, DOI 10.1007/s10508-009-9516-4; Zablotska IB, 2006, AIDS, V20, P1191, DOI 10.1097/01.aids.0000226960.25589.72; Zablotska IB, 2009, AIDS BEHAV, V13, P225, DOI 10.1007/s10461-007-9333-5; ZEGER SL, 1988, BIOMETRICS, V44, P1049, DOI 10.2307/2531734	59	25	25	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0171200	10.1371/journal.pone.0171200	http://dx.doi.org/10.1371/journal.pone.0171200			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL2BG	28207844	gold, Green Published, Green Submitted			2022-12-27	WOS:000394424500018
J	Liskova, P; Dudakova, L; Krepelova, A; Klema, J; Hysi, PG				Liskova, Petra; Dudakova, Lubica; Krepelova, Anna; Klema, Jiri; Hysi, Pirro G.			Replication of SNP associations with keratoconus in a Czech cohort	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; CORNEAL THICKNESS; GENE; POLYMORPHISMS; VARIANTS	Introduction Keratoconus is a relatively frequent disease leading to severe visual impairment. Existing therapies are imperfect and clinical management may benefit from improved understanding of mechanisms leading to this disease. We aim to investigate the replication of 11 single nucleotide polymorphisms (SNPs) with keratoconus. Methods SNPs from loci previously found in association with keratoconus were genotyped in 165 keratoconus cases of Caucasian Czech origin (108 males and 57 females) and 193 population and gender-matched controls. They included rs1536482 (COL5A1), rs4839200 (KCND3), rs757 219 and rs214884 (IMMP2L), rs1328083 and rs1328089 (DAOA), rs2721051 (FOXO1), rs489 4535 (FNDC3B), rs4954218 (MAP3K19, RAB3GAP1), rs9938149 (ZNF469) and rs1324183 (MPDZ). A case-control association analysis was assessed using Fisher's exact tests. Results The strongest association was found for rs1324183 (allelic test OR = 1.58; 95% CI, 1.10 - 2.24, p = 0.01). Statistically significant values were also obtained for rs2721051 (allelic test OR = 1.72; 95% CI, 1.07 - 2.77, p = 0.025) and rs4954218 (allelic test OR = 1.53; 95% CI, 1.01 - 2.34; p = 0.047) which showed an opposite effect direction compared to previously reported one. Conclusion Independent replication of association between two SNPs and keratoconus supports the association of these loci with the risks for the disease development, while the effect of rs4954218 warrants further investigation. Understanding the role of the genetic factors	[Liskova, Petra; Dudakova, Lubica] Charles Univ Prague, Fac Med 1, Inst Inherited Metab Disorders, Prague, Czech Republic; [Liskova, Petra; Dudakova, Lubica] Gen Univ Hosp Prague, Prague, Czech Republic; [Liskova, Petra] Charles Univ Prague, Fac Med 1, Dept Ophthalmol, Prague, Czech Republic; [Krepelova, Anna] Charles Univ Prague, Fac Med 2, Dept Biol & Med Genet, Prague, Czech Republic; [Krepelova, Anna] Univ Hosp Motol, Prague, Czech Republic; [Klema, Jiri] Czech Tech Univ, Dept Comp Sci, Prague, Czech Republic; [Hysi, Pirro G.] Kings Coll London, KCL Dept Ophthalmol, London, England; [Hysi, Pirro G.] UCL, Great Ormond St Inst Child Hlth, London, England	Charles University Prague; General University Hospital Prague; Charles University Prague; Charles University Prague; Motol University Hospital; Czech Technical University Prague; University of London; King's College London; University of London; University College London	Liskova, P (corresponding author), Charles Univ Prague, Fac Med 1, Inst Inherited Metab Disorders, Prague, Czech Republic.; Liskova, P (corresponding author), Gen Univ Hosp Prague, Prague, Czech Republic.; Liskova, P (corresponding author), Charles Univ Prague, Fac Med 1, Dept Ophthalmol, Prague, Czech Republic.	petra.liskova@lf1.cuni.cz	Liskova, Petra/C-9680-2011; Dudakova, Lubica/F-4781-2017; Krepelova, Anna/AAP-8124-2020	Liskova, Petra/0000-0001-7834-8486; Dudakova, Lubica/0000-0003-4718-8955; Hysi, Pirro/0000-0001-5752-2510; Klema, Jiri/0000-0003-1753-9435	Charles University [PRVOUK-P24/LF1/3]; UNCE [204011]; Fight for Sight [1329/30] Funding Source: researchfish	Charles University; UNCE; Fight for Sight	This work was supported by PRVOUK-P24/LF1/3 program of the Charles University (https://www.cuni.cz/). PL and LD were also supported by UNCE 204011 (https://www.cuni.cz/). We would like to thank the National Center for Medical Genetics (LM2015091; http://www.msmt.cz/) for help with study design.; This work was supported by PRVOUK-P24/LF1/3 program of the Charles University. PL and LD were also supported by UNCE 204011. We would like to thank the National Center for Medical Genetics (LM2015091) for help with study design.	Burdon KP, 2013, CLIN EXP OPTOM, V96, P146, DOI 10.1111/cxo.12024; Burdon KP, 2011, INVEST OPHTH VIS SCI, V52, P8514, DOI 10.1167/iovs.11-8261; Davidson AE, 2015, INVEST OPHTH VIS SCI, V56, P578, DOI 10.1167/iovs.14-15792; Dudakova L, 2015, EUR J HUM GENET, V23, P1581, DOI 10.1038/ejhg.2015.28; Founti P, 2015, ANN HUM GENET, V79, P431, DOI 10.1111/ahg.12128; Bae HA, 2013, INVEST OPHTH VIS SCI, V54, P5132, DOI 10.1167/iovs.13-12377; Kanellopoulos AJ, 2013, CLIN OPHTHALMOL, V7, P1539, DOI 10.2147/OPTH.S44741; KARIN M, 1995, J BIOL CHEM, V270, P16483, DOI 10.1074/jbc.270.28.16483; KENNEDY RH, 1986, AM J OPHTHALMOL, V101, P267, DOI 10.1016/0002-9394(86)90817-2; Li XH, 2006, INVEST OPHTH VIS SCI, V47, P3791, DOI 10.1167/iovs.06-0214; Li X, 2013, INVEST OPHTH VIS SCI, V54, P2696, DOI 10.1167/iovs.13-11601; Li XH, 2012, HUM MOL GENET, V21, P421, DOI 10.1093/hmg/ddr460; Lin PI, 2007, AM J HUM GENET, V80, P531, DOI 10.1086/512133; Lu Y, 2013, NAT GENET, V45, P155, DOI 10.1038/ng.2506; Mace M, 2011, INVEST OPHTH VIS SCI, V52, P6181, DOI 10.1167/iovs.10-70981; Sahebjada S, 2013, INVEST OPHTH VIS SCI, V54, P8224, DOI 10.1167/iovs.13-12982; Smith SM, 2015, METHODS MOL BIOL, V1245, P243, DOI 10.1007/978-1-4939-1966-6_18; Tuft SJ, 2012, ACTA OPHTHALMOL, V90, pe482, DOI 10.1111/j.1755-3768.2012.02448.x; Vazirani J, 2013, CLIN OPHTHALMOL, V7, P2019, DOI 10.2147/OPTH.S50119; Whitmarsh AJ, 1996, J MOL MED-JMM, V74, P589, DOI 10.1007/s001090050063	20	15	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0172365	10.1371/journal.pone.0172365	http://dx.doi.org/10.1371/journal.pone.0172365			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207827	Green Published, gold, Green Submitted			2022-12-27	WOS:000394424500125
J	Sham, A; Moustafa, K; Al-Shamisi, S; Alyan, S; Iratni, R; AbuQamar, S				Sham, Arjun; Moustafa, Khaled; Al-Shamisi, Shamma; Alyan, Sofyan; Iratni, Rabah; AbuQamar, Synan			Microarray analysis of Arabidopsis WRKY33 mutants in response to the necrotrophic fungus Botrytis cinerea	PLOS ONE			English	Article							TGA TRANSCRIPTION FACTORS; GENE-EXPRESSION; SALICYLIC-ACID; JASMONIC ACID; 12-OXO-PHYTODIENOIC ACID; PHYTOALEXIN BIOSYNTHESIS; PLANT-RESPONSES; ABIOTIC STRESS; DEFENSE; RESISTANCE	The WRKY33 transcription factor was reported for resistance to the necrotrophic fungus Botrytis cinerea. Using microarray-based analysis, we compared Arabidopsis WRKY33 overexpressing lines and wrky33 mutant that showed altered susceptibility to B. cinerea with their corresponding wild-type plants. In the wild-type, about 1660 genes (7% of the transcriptome) were induced and 1054 genes (5% of the transcriptome) were repressed at least twofold at early stages of inoculation with B. cinerea, confirming previous data of the contribution of these genes in B. cinerea resistance. In Arabidopsis wild-type plant infected with B. cinerea, the expressions of the differentially expressed genes encoding for proteins and metabolites involved in pathogen defense and non-defense responses, seem to be dependent on a functional WRKY33 gene. The expression profile of 12-oxo-phytodienoic acidand phytoprostane A1-treated Arabidopsis plants in response to B. cinerea revealed that cyclopentenones can also modulate WRKY33 regulation upon inoculation with B. cinerea. These results support the role of electrophilic oxylipins in mediating plant responses to B. cinerea infection through the TGA transcription factor. Future directions toward the identification of the molecular components in cyclopentenone signaling will elucidate the novel oxylipin signal transduction pathways in plant defense.	[Sham, Arjun; Al-Shamisi, Shamma; Alyan, Sofyan; Iratni, Rabah; AbuQamar, Synan] United Arab Emirates Univ, Dept Biol, Al Ain, U Arab Emirates; [Moustafa, Khaled] Conservatoire Natl Arts & Metiers, Paris, France	United Arab Emirates University; heSam Universite; Conservatoire National Arts & Metiers (CNAM)	AbuQamar, S (corresponding author), United Arab Emirates Univ, Dept Biol, Al Ain, U Arab Emirates.	sabuqamar@uaeu.ac.ae	Sham, Arjun/K-3691-2019; AbuQamar, Synan/AAV-1229-2021; Sham, Arjun/AAF-2531-2019	AbuQamar, Synan/0000-0002-2129-7689; Sham, Arjun/0000-0003-1762-3709; Moustafa, Khaled/0000-0002-0819-9064	UAEU Program for Advanced Research [31S255]; Khalifa Center for Biotechnology and Genetic Engineering-UAEU [31R081]	UAEU Program for Advanced Research; Khalifa Center for Biotechnology and Genetic Engineering-UAEU	This project was funded by the UAEU Program for Advanced Research (Grant #: 31S255); and the Khalifa Center for Biotechnology and Genetic Engineering-UAEU (Grant #: 31R081) to SAQ.	AbuQamar S, 2008, PLANT CELL, V20, P1964, DOI 10.1105/tpc.108.059477; AbuQamar S, 2006, PLANT J, V48, P28, DOI 10.1111/j.1365-313X.2006.02849.x; AbuQamar S, 2017, CRIT REV BIOTECHNOL, V37, P262, DOI 10.1080/07388551.2016.1271767; Abuqamar S, 2013, MOL PLANT PATHOL, V14, P813, DOI 10.1111/mpp.12049; AbuQamar SF, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01658; Benito EP, 1998, EUR J PLANT PATHOL, V104, P207, DOI 10.1023/A:1008698116106; Berrocal-Lobo M, 2008, TRENDS PLANT SCI, V13, P145, DOI 10.1016/j.tplants.2007.12.004; Bhosale R, 2013, PLANT CELL, V25, P2865, DOI 10.1105/tpc.113.112268; Birkenbihl RP, 2012, PLANT PHYSIOL, V159, P266, DOI 10.1104/pp.111.192641; Block A, 2005, MOL PLANT PATHOL, V6, P79, DOI 10.1111/j.1364-3703.2004.00265.x; Bluhm BH, 2005, MOL PLANT MICROBE IN, V18, P1333, DOI 10.1094/MPMI-18-1333; Bottcher C, 2009, FEBS J, V276, P4693, DOI 10.1111/j.1742-4658.2009.07195.x; Boller T, 2009, ANNU REV PLANT BIOL, V60, P379, DOI 10.1146/annurev.arplant.57.032905.105346; Chassot C, 2007, PLANT J, V49, P972, DOI 10.1111/j.1365-313X.2006.03017.x; Chen H, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-281; Dean R, 2012, MOL PLANT PATHOL, V13, P414, DOI 10.1111/j.1364-3703.2011.00783.x; Dhawan R, 2009, PLANT CELL, V21, P1000, DOI 10.1105/tpc.108.062364; Diaz J, 2002, PLANT PHYSIOL, V129, P1341, DOI 10.1104/pp.001453; Ferrari S, 2003, PLANT CELL, V15, P93, DOI 10.1105/tpc.005165; Ferrari S, 2007, PLANT PHYSIOL, V144, P367, DOI 10.1104/pp.107.095596; Glazebrook J, 2005, ANNU REV PHYTOPATHOL, V43, P205, DOI 10.1146/annurev.phyto.43.040204.135923; Gomez-Gomez L, 2000, MOL CELL, V5, P1003, DOI 10.1016/S1097-2765(00)80265-8; Govrin EM, 2000, CURR BIOL, V10, P751, DOI 10.1016/S0960-9822(00)00560-1; Grun C, 2007, FUNCT PLANT BIOL, V34, P65, DOI 10.1071/FP06205; Hernandez-Blanco C, 2007, PLANT CELL, V19, P890, DOI 10.1105/tpc.106.048058; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Koornneef A, 2008, PLANT PHYSIOL, V146, P839, DOI 10.1104/pp.107.112029; Kunze G, 2004, PLANT CELL, V16, P3496, DOI 10.1105/tpc.104.026765; Kurdyukov S, 2006, PLANT CELL, V18, P321, DOI 10.1105/tpc.105.036079; LAGRIMINI LM, 1987, P NATL ACAD SCI USA, V84, P7542, DOI 10.1073/pnas.84.21.7542; Laluk K, 2011, PLANT CELL, V23, P2831, DOI 10.1105/tpc.111.087122; Laluk K, 2011, PLANT PHYSIOL, V156, P2053, DOI 10.1104/pp.111.177501; LAM E, 1989, P NATL ACAD SCI USA, V86, P7890, DOI 10.1073/pnas.86.20.7890; Lamb C, 1997, ANNU REV PLANT PHYS, V48, P251, DOI 10.1146/annurev.arplant.48.1.251; Liu SA, 2015, ELIFE, V4, DOI 10.7554/eLife.07295; Llorente F, 2008, MOL PLANT, V1, P496, DOI 10.1093/mp/ssn025; Luo HL, 2010, PLANT PHYSIOL, V154, P1766, DOI 10.1104/pp.110.163915; Mao GH, 2011, PLANT CELL, V23, P1639, DOI 10.1105/tpc.111.084996; Mengiste T, 2010, PLANT PATH 21ST, P13, DOI 10.1007/978-1-4020-8930-5_2; Mhamdi A, 2010, PLANT PHYSIOL, V153, P1144, DOI 10.1104/pp.110.153767; Mishina TE, 2007, PLANT J, V50, P500, DOI 10.1111/j.1365-313X.2007.03067.x; Montesano M, 2003, MOL PLANT PATHOL, V4, P73, DOI 10.1046/j.1364-3703.2003.00150.x; Muckenschnabel I, 2002, J EXP BOT, V53, P207, DOI 10.1093/jexbot/53.367.207; Mueller MJ, 2009, PHYTOCHEMISTRY, V70, P1511, DOI 10.1016/j.phytochem.2009.05.018; Mueller MJ, 1997, PHYSIOL PLANTARUM, V100, P653, DOI 10.1034/j.1399-3054.1997.1000329.x; Mueller S, 2008, PLANT CELL, V20, P768, DOI 10.1105/tpc.107.054809; Mulema JMK, 2012, MOL BIOL REP, V39, P4039, DOI 10.1007/s11033-011-1185-4; Mulema JMK, 2011, AFR J BIOTECHNOL, V10, P17551, DOI 10.5897/AJB10.2558; Pan X, 2013, PLOS ONE; Pitzschke A, 2009, CURR OPIN PLANT BIOL, V12, P421, DOI 10.1016/j.pbi.2009.06.008; Prins TW, 2000, FUNGAL PATHOLOGY, P33; Provart NJ., 2003, CURRENT COMPUTER MOL, V2003, P271; Ren DT, 2008, P NATL ACAD SCI USA, V105, P5638, DOI 10.1073/pnas.0711301105; Ribot C, 2008, PLANT PHYSIOL, V147, P696, DOI 10.1104/pp.108.119321; Rushton PJ, 2010, TRENDS PLANT SCI, V15, P247, DOI 10.1016/j.tplants.2010.02.006; SAS Inst, 1999, SAS SYST WIND; Schaller A, 2009, PHYTOCHEMISTRY, V70, P1532, DOI 10.1016/j.phytochem.2009.07.032; Schenk PM, 2003, PLANT PHYSIOL, V132, P999, DOI 10.1104/pp.103.021683; Segarra G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056075; Sham A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125666; Sham A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113718; Smith JE, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-334; Stotz HU, 2013, J EXP BOT, V64, P963, DOI 10.1093/jxb/ers389; Taki N, 2005, PLANT PHYSIOL, V139, P1268, DOI 10.1104/pp.105.067058; Thoma I, 2003, PLANT J, V34, P363, DOI 10.1046/j.1365-313X.2003.01730.x; Thomma BPHJ, 1999, PLANT PHYSIOL, V121, P1093, DOI 10.1104/pp.121.4.1093; van Wees SCM, 2003, PLANT PHYSIOL, V132, P606, DOI 10.1104/pp.103.022186; Windram O, 2012, PLANT CELL, V24, P3530, DOI 10.1105/tpc.112.102046; Wolpert TJ, 2002, ANNU REV PHYTOPATHOL, V40, P251, DOI 10.1146/annurev.phyto.40.011402.114210; Zheng ZY, 2006, PLANT J, V48, P592, DOI 10.1111/j.1365-313X.2006.02901.x; Zhu T, 2000, PLANT PHYSIOL, V124, P1472, DOI 10.1104/pp.124.4.1472; Zipfel C, 2006, CELL, V125, P749, DOI 10.1016/j.cell.2006.03.037	72	27	29	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2								10.1371/journal.pone.0172343	http://dx.doi.org/10.1371/journal.pone.0172343			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207847	Green Published, gold, Green Submitted			2022-12-27	WOS:000394424500123
J	Triphan, SMF; Jobst, BJ; Anjorin, A; Sedlaczek, O; Wolf, U; Terekhov, M; Hoffmann, C; Ley, S; Duber, C; Biederer, J; Kauczor, HU; Jakob, PM; Wielputz, MO				Triphan, Simon M. F.; Jobst, Bertram J.; Anjorin, Angela; Sedlaczek, Oliver; Wolf, Ursula; Terekhov, Maxim; Hoffmann, Christian; Ley, Sebastian; Dueber, Christoph; Biederer, Juergen; Kauczor, Hans-Ulrich; Jakob, Peter M.; Wielpuetz, Mark O.			Reproducibility and comparison of oxygen-enhanced T-1 quantification in COPD and asthma patients	PLOS ONE			English	Article							CLINICAL STAGE CLASSIFICATION; FUNCTIONAL LOSS ASSESSMENT; ENTIRE LUNG PARENCHYMA; RESPIRATORY PHASE; MRI; VENTILATION; DISEASE; CT	T1 maps have been shown to yield useful diagnostic information on lung function in patients with chronic obstructive pulmonary disease (COPD) and asthma, both for native T1 and Delta T1, the relative reduction while breathing pure oxygen. As parameter quantification is particularly interesting for longitudinal studies, the purpose of this work was both to examine the reproducibility of lung T1 mapping and to compare T1 found in COPD and asthma patients using IRSnapShotFLASH embedded in a full MRI protocol. 12 asthma and 12 COPD patients (site 1) and further 15 COPD patients (site 2) were examined on two consecutive days. In each patient, T1 maps were acquired in 8 single breath-hold slices, breathing first room air, then pure oxygen. Maps were partitioned into 12 regions each to calculate average values. In asthma patients, the average T-1,T-RA = 1206ms (room air) was reduced to T-1,T-O2 = 1141ms under oxygen conditions (Delta T1 = 5.3%, p < 5.10(-4)), while in COPD patients both native T-1,T-RA = 1125ms was significantly shorter (p < 10(-3)) and the relative reduction to T-1,T-O2 = 1081ms on average Delta T1 = 4.2%(p < 10(-5)). On the second day, with T-1,T-RA = 1186ms in asthma and T-1,T-RA = 1097ms in COPD, observed values were slightly shorter on average in all patient groups. Delta T1 reduction was the least repeatable parameter and varied from day to day by up to 23% in individual asthma and 30% in COPD patients. While for both patient groups T1 was below the values reported for healthy subjects, the T1 and Delta T1 found in asthmatics lies between that of the COPD group and reported values for healthy subjects, suggesting a higher blood volume fraction and better ventilation. However, it could be demonstrated that lung T1 quantification is subject to notable inter-examination variability, which here can be attributed both to remaining contrast agent from the previous day and the increased dependency of lung T1 on perfusion and thus current lung state.	[Triphan, Simon M. F.; Jobst, Bertram J.; Anjorin, Angela; Sedlaczek, Oliver; Wolf, Ursula; Ley, Sebastian; Biederer, Juergen; Kauczor, Hans-Ulrich; Wielpuetz, Mark O.] Univ Heidelberg Hosp, Dept Diagnost & Intervent Radiol, Heidelberg, Germany; [Triphan, Simon M. F.; Jobst, Bertram J.; Anjorin, Angela; Sedlaczek, Oliver; Wolf, Ursula; Biederer, Juergen; Kauczor, Hans-Ulrich; Wielpuetz, Mark O.] German Lung Res Ctr DZL, Translat Lung Res Ctr Heidelberg TLRC, Heidelberg, Germany; [Triphan, Simon M. F.; Jakob, Peter M.] Julius Maximilians Univ Wurzburg, Dept Expt Phys 5, Wurzburg, Germany; [Wolf, Ursula; Terekhov, Maxim; Hoffmann, Christian; Dueber, Christoph] Johannes Gutenberg Univ Mainz, Dept Radiol, Sch Med, Mainz, Germany; [Jobst, Bertram J.; Wolf, Ursula; Kauczor, Hans-Ulrich; Wielpuetz, Mark O.] Heidelberg Univ, Thoraxklin, Dept Diagnost & Intervent Radiol Nucl Med, Heidelberg, Germany; [Terekhov, Maxim] Univ Hosp Wurzburg, Comprehens Heart Failure Ctr, Wurzburg, Germany; [Biederer, Juergen] Hosp Gross Gerau, Radiol Darmstadt, Dept Radiol, Gross Gerau, Germany; [Ley, Sebastian] Ludwig Maximilians Univ Munchen, Inst Clin Radiol, Munich, Germany	Ruprecht Karls University Heidelberg; University of Wurzburg; Johannes Gutenberg University of Mainz; Ruprecht Karls University Heidelberg; University of Wurzburg; University of Munich	Triphan, SMF (corresponding author), Univ Heidelberg Hosp, Dept Diagnost & Intervent Radiol, Heidelberg, Germany.; Triphan, SMF (corresponding author), German Lung Res Ctr DZL, Translat Lung Res Ctr Heidelberg TLRC, Heidelberg, Germany.; Triphan, SMF (corresponding author), Julius Maximilians Univ Wurzburg, Dept Expt Phys 5, Wurzburg, Germany.	simon.triphan@uni-heidelberg.de	Wielpuetz, Mark/ABE-1790-2020; Kauczor, HU/AAX-6033-2021; Kauczor, Hans-Ulrich/AAU-5955-2021; Wielpütz, Mark Oliver/ADP-0499-2022; Ley, Sebastian/I-3426-2013	Wielpuetz, Mark/0000-0001-6962-037X; Wielpütz, Mark Oliver/0000-0001-6962-037X; Ley, Sebastian/0000-0001-9269-2670	Competence Network on Asthma / COPD (ASCONET) through a grant from the Bundesministerium fur Bildung and Forschung (BMBF) of the federal government of Germany [01G10870]	Competence Network on Asthma / COPD (ASCONET) through a grant from the Bundesministerium fur Bildung and Forschung (BMBF) of the federal government of Germany(Federal Ministry of Education & Research (BMBF))	This work has been supported by the Competence Network on Asthma / COPD (ASCONET) through a grant from the Bundesministerium fur Bildung and Forschung (BMBF) of the federal government of Germany (01G10870, www.bmbf.de/en). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMAN DG, 1983, J ROY STAT SOC D-STA, V32, P307, DOI 10.2307/2987937; Arnold JFT, 2004, MAGN RESON MATER PHY, V16, P246, DOI 10.1007/s10334-004-0034-z; Bauman G, 2016, MAGNETIC RESONANCE M; Biederer J, 2014, SEMIN RESP CRIT CARE, V35, P74, DOI 10.1055/s-0033-1363453; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; DEICHMANN R, 1992, J MAGN RESON, V96, P608, DOI 10.1016/0022-2364(92)90347-A; Edelman RR, 1996, NAT MED, V2, P1236, DOI 10.1038/nm1196-1236; Hopkins SR, 2012, J APPL PHYSIOL, V113, P328, DOI 10.1152/japplphysiol.00320.2012; Incalzi RA, 2010, CHEST, V137, P831, DOI 10.1378/chest.09-1710; Jakob PM, 2004, MAGN RESON MED, V51, P1009, DOI 10.1002/mrm.20051; Jakob PM, 2001, J MAGN RESON IMAGING, V14, P795, DOI 10.1002/jmri.10024; Jobst BJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137282; Jobst BJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121520; Jobst BJ., 2014, INSIGHTS IMAGING, V5, P340; Kreutner J, 2010, ISMRM, V18; Molinari F, 2008, INVEST RADIOL, V43, P427, DOI 10.1097/RLI.0b013e318169012d; Ohno Y, 2001, AM J ROENTGENOL, V177, P185, DOI 10.2214/ajr.177.1.1770185; Ohno Y, 2008, AM J ROENTGENOL, V190, pW93, DOI 10.2214/AJR.07.2511; Ohno Y, 2011, EUR J RADIOL, V77, P85, DOI 10.1016/j.ejrad.2009.06.027; Pintaske J, 2006, INVEST RADIOL, V41, P213, DOI 10.1097/01.rli.0000197668.44926.f7; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Reddel HK, 2009, AM J RESP CRIT CARE, V180, P59, DOI 10.1164/rccm.200801-060ST; Stadler A, 2005, J MAGN RESON IMAGING, V21, P759, DOI 10.1002/jmri.20319; Stadler A, 2008, MAGN RESON MED, V59, P96, DOI 10.1002/mrm.21446; Triphan SMF, 2015, J MAGN RESON IMAGING, V42, P610, DOI 10.1002/jmri.24840; Triphan SMF, 2015, J MAGN RESON IMAGING, V41, P1708, DOI 10.1002/jmri.24692; Triphan SMF, 2015, ESMRMB; Triphan SMF, 2014, ISMRM, P2311; Wielputz MO, 2016, ROFO-FORTSCHR RONTG, V188, P834, DOI 10.1055/s-0042-104936; Wielputz M, 2012, DIAGN INTERV RADIOL, V18, P344, DOI 10.4261/1305-3825.DIR.5365-11.0; Wielputz MO, 2014, AM J RESP CRIT CARE, V189, P956, DOI 10.1164/rccm.201309-1659OC	31	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0172479	10.1371/journal.pone.0172479	http://dx.doi.org/10.1371/journal.pone.0172479			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207845	gold, Green Submitted, Green Published			2022-12-27	WOS:000394424500140
J	Zhang, HH; Wang, YP; Ai, ST; Chen, XJ; Wang, L; Dai, KR				Zhang, Henghui; Wang, Yiping; Ai, Songtao; Chen, Xiaojun; Wang, Liao; Dai, Kerong			Three-dimensional acetabular orientation measurement in a reliable coordinate system among one hundred Chinese	PLOS ONE			English	Article							TOTAL HIP-REPLACEMENT; CUP NAVIGATION; INCLINATION; ANGLE; TILT	Determining three-dimensional (3D) acetabular orientation is important for several orthopaedic scenarios, but the complex geometries of both pelvis and acetabulum make measurements of orientation unreliable. Acetabular orientation may also differ between the sexes or racial groups. We aimed to (1) establish and evaluate a novel method for measuring 3D acetabular orientation, (2) apply this new method to a large population of Chinese subjects, and (3) report relevant characteristics of native acetabular orientation in this population. We obtained computed tomography scans taken for non-orthopaedic indications in 100 Chinese subjects (50 male, 50 female). A novel algorithm tailored to segmentation of the hip joint was used to construct 3D pelvic models from these scans. We developed a surface-based method to establish a reliable 3D pelvic coordinate system and software to semi-automatically measure 3D acetabular orientation. Differences in various acetabular orientations were compared within and between subjects, between male and female subjects, and between our subjects and subjects previously reported by another group. The reported method was reliable (intraclass correlation coefficient >0.999). Acetabular orientations were symmetrical within subjects, but ranged widely between subjects. The sexes differed significantly in acetabular anteversion (average difference, 3.0 E; p < 0.001) and inclination (1.5 E; p < 0.03). Acetabular anteversion and inclination were substantially smaller among our Chinese subjects than previously reported for American subjects. Thus, our method was reliable and sensitive, and we detected sex differences in 3D acetabular orientation. Awareness of differences between the sexes and races is the first step towards better reconstruction of the hip joint for all individuals and could also be applied to other orthopaedic scenarios.	[Zhang, Henghui; Wang, Liao; Dai, Kerong] Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 9, Shanghai Key Lab Orthopaed Implants,Dept Orthopae, Shanghai, Peoples R China; [Wang, Yiping; Chen, Xiaojun] Shanghai Jiao Tong Univ, Inst Biomed Mfg & Life Qual Engn, Sch Mech Engn, State Key Lab Mech Syst & Vibrat, Shanghai, Peoples R China; [Ai, Songtao] Shanghai Jiao Tong Univ, Sch Med, Dept Radiol, Shanghai Peoples Hosp 9, Shanghai, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Wang, L; Dai, KR (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 9, Shanghai Key Lab Orthopaed Implants,Dept Orthopae, Shanghai, Peoples R China.	wang821127@163.com; krdai@163.com	Wang, Yin/HCI-9352-2022; wang, yi/GVT-8516-2022; Wang, Yixuan/GZK-6559-2022; wang, yixuan/GXW-2866-2022; Wang, Yijun/GXW-1763-2022	Chen, Xiaojun/0000-0002-0298-4491	National Natural Science Foundation of China [81201412]; Science and Technology Commission of Shanghai Municipality [16441908700, 15PJD025]; Office of Research Management [YG2016MS11]; Shanghai Municipal Education Commission-Gaofeng Clinical Medicine Grant [20152221]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Office of Research Management; Shanghai Municipal Education Commission-Gaofeng Clinical Medicine Grant	This study was funded by National Natural Science Foundation of China (no. 81201412, to LW), http://www.nsfc.gov.cn/publish/portal1/; Science and Technology Commission of Shanghai Municipality (16441908700, to LW; 15PJD025, to SA), http://www.stcsm.gov.cn/english/; Office of Research Management affiliated to Shanghai Jiao Tong University (YG2016MS11, to LW), http://kejichu.sjtu.edu.cn/; Shanghai Municipal Education Commission-Gaofeng Clinical Medicine Grant (20152221, to SA), http://en.study-shanghai.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDA S, 1990, ACTA RADIOL, V31, P389; Babisch JW, 2008, J BONE JOINT SURG AM, V90A, P357, DOI 10.2106/JBJS.F.00628; Bonett DG, 2002, STAT MED, V21, P1331, DOI 10.1002/sim.1108; Ganz R, 2008, CLIN ORTHOP RELAT R, V466, P264, DOI 10.1007/s11999-007-0060-z; Higgins SW, 2014, J BONE JOINT SURG AM, V96A, P1776, DOI 10.2106/JBJS.L.01141; KLAUE K, 1988, CLIN ORTHOP RELAT R, P15; Lembeck B, 2005, ACTA ORTHOP, V76, P517, DOI 10.1080/17453670510041501; LEWINNEK GE, 1978, J BONE JOINT SURG AM, V60, P217, DOI 10.2106/00004623-197860020-00014; Liu L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146452; Lubovsky O, 2010, INT J COMPUT ASS RAD, V5, P449, DOI 10.1007/s11548-010-0521-9; Maruyama M, 2001, CLIN ORTHOP RELAT R, P52; MURPHY SB, 1990, CLIN ORTHOP RELAT R, P214; MURRAY DW, 1993, J BONE JOINT SURG BR, V75, P228, DOI 10.1302/0301-620X.75B2.8444942; Murtha PE, 2008, J BONE JOINT SURG BR, V90B, P308, DOI 10.1302/0301-620X.90B3.19548; Nagao Y, 2008, J ORTHOP SCI, V13, P62, DOI 10.1007/s00776-007-1188-0; Portney LG, 2000, FDN CLIN RES APPL PR, V2; Puls M, 2011, COMPUT BIOL MED, V41, P285, DOI 10.1016/j.compbiomed.2011.03.004; Tan S, 2008, MED IMAGING; Tannast M, 2005, CLIN ORTHOP RELAT R, P144, DOI 10.1097/01.blo.00001576957.22894.29; Tannast M, 2008, J ORTHOP RES, V26, P1199, DOI 10.1002/jor.20653; Tarwala R, 2011, CURR REV MUSCULOSKE, V4, P151, DOI 10.1007/s12178-011-9086-7; TONNIS D, 1976, CLIN ORTHOP RELAT R, P39; Vandenbussche E, 2008, CLIN ORTHOP RELAT R, V466, P417, DOI 10.1007/s11999-007-0062-x; Vandenbussche E, 2007, ACTA ORTHOP, V78, P327, DOI 10.1080/174536707100013870; YANG Z, 2014, PLOS ONE, V0009	25	10	11	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0172297	10.1371/journal.pone.0172297	http://dx.doi.org/10.1371/journal.pone.0172297			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207829	gold, Green Published, Green Submitted			2022-12-27	WOS:000394424500114
J	Garcia-Martinez, MA; Valenzuela-Gonzalez, JE; Escobar-Sarria, F; Lopez-Barrera, F; Castano-Meneses, G				Garcia-Martinez, Miguel A.; Valenzuela-Gonzalez, Jorge E.; Escobar-Sarria, Federico; Lopez-Barrera, Fabiola; Castano-Meneses, Gabriela			The surrounding landscape influences the diversity of leaf-litter ants in riparian cloud forest remnants	PLOS ONE			English	Article							HYMENOPTERA-FORMICIDAE; HABITAT CHARACTERISTICS; CENTRAL VERACRUZ; CONSERVATION; VEGETATION; BIODIVERSITY; COMMUNITIES; FRAGMENTATION; EXTRAPOLATION; PLANTATIONS	Riparian vegetation is a distinctive and ecologically important element of landscapes worldwide. However, the relative influence of the surrounding landscape on the conservation of the biodiversity of riparian remnants in human-modified tropical landscapes is poorly understood. We studied the surrounding landscape to evaluate its influence on leaf-litter-ant alpha and beta diversity in riparian remnants in the tropical montane cloud forest region of central Veracruz, Mexico. Sampling was carried out in 12 sites with riparian vegetation during both rainy (2011) and dry (2012) seasons. Ten leaf-litter samples were collected along a 100-m transect per site and processed with Berlese-Tullgren funnels and Winkler sacks. Using remotely-sensed and ground-collected data, we characterized the landscape around each site according to nine land cover types and computed metrics of landscape composition and configuration. We collected a total of 8,684 ant individuals belonging to 53 species, 22 genera, 11 tribes, and 7 subfamilies. Species richness and the diversity of Shannon and Simpson increased significantly in remnants immersed in landscapes with a high percentage of riparian land cover and a low percentage of land covers with areas reforested with Pinus, cattle pastures, and human settlements and infrastructure. The composition of ant assemblages was a function of the percentage of riparian land cover in the landscape. This study found evidence that leaf-litter ants, a highly specialized guild of arthropods, are mainly impacted by landscape composition and the configuration of the focal remnant. Maintaining or improving the surrounding landscape quality of riparian vegetation remnants can stimulate the movement of biodiversity among forest and riparian remnants and foster the provision of ecosystem services by these ecosystems. Effective outcomes may be achieved by considering scientific knowledge during the early stages of riparian policy formulation, in addition to integrating riparian management strategies with broader environmental planning instruments.	[Garcia-Martinez, Miguel A.; Valenzuela-Gonzalez, Jorge E.; Escobar-Sarria, Federico; Lopez-Barrera, Fabiola] Inst Ecol AC, Xalapa, Veracruz, Mexico; [Castano-Meneses, Gabriela] Univ Nacl Autonoma Mexico, Fac Ciencias, Unidad Multidisciplinaria Docencia & Invest, Ecol Artropodos Ambientes Extremos, Campus Juriquilla, Queretaro, Mexico	Instituto de Ecologia - Mexico; Universidad Nacional Autonoma de Mexico	Garcia-Martinez, MA (corresponding author), Inst Ecol AC, Xalapa, Veracruz, Mexico.	magarciamartinez@hotmail.com	Valenzuela-González, Jorge/R-4527-2018; Garcia-Martinez, Miguel A./AAA-1752-2022; Escobar, Federico/C-1396-2011; Garcia Martinez, Miguel/J-8497-2016; López-Barrera, Fabiola/Q-6271-2018	Valenzuela-González, Jorge/0000-0003-2106-6693; Garcia-Martinez, Miguel A./0000-0002-0644-4601; Escobar, Federico/0000-0003-0179-7528; Garcia Martinez, Miguel/0000-0002-0644-4601; López-Barrera, Fabiola/0000-0002-6092-6230	Consejo Nacional de Cienciay Tecnologia [CONACyT 250343/373712/347058, Convocatoria 290733]; Doctoral Program of the Instituto de Ecologia A.C. (INECOL); INECOL [902-11-10204]; CONACyT [CB 2008-101542-F]	Consejo Nacional de Cienciay Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Doctoral Program of the Instituto de Ecologia A.C. (INECOL); INECOL; CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	Miguel Angel Garcia Martinez acknowledges the scholarship and financial support provided by the Consejo Nacional de Cienciay Tecnologia (CONACyT 250343/373712/347058, Convocatoria 290733) and the Doctoral Program of the Instituto de Ecologia A.C. (INECOL). Funding was provided by INECOL (project 902-11-10204) and CONACyT (project CB 2008-101542-F). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript; We are grateful for Dora Luz Martinez Tlapa, Gibran Renoy Perez Toledo and Luis N. Quiroz-Robledo for their assistance in the processing of samples and ant identification. For Javier Tolome Romero, Victor Vasquez-Reyes, and Claudia Gallardo Hernandez for technical assistance in the field. For Rosario Landgrave Ramirez for technical assistance in GIS, and to Gonzalo Castillo Campos for advising us in the LUC classification. For Delfino Hernandez Lagunes for technical assistance in the Entomological Collection IEXA-INECOL. For Ehdiblado Presa-Parra for his help in references management. For John Longino and Michael Branstetter for reviewing our identifications of Adelomyrmex and Stenamma specimens. English version of the manuscript was reviewed by Allison Marie Jermain. Miguel Angel Garcia Martinez acknowledges the scholarship and financial support provided by the Consejo Nacional de Ciencia y Tecnologia (CONACyT 250343/373712/347058, Convocatoria 290733) and the Doctoral Program of the Instituto de Ecologia A.C. (INECOL). Funding was provided by INECOL (project 902-11-10204) and CONACyT (project CB 2008-101542-F).	Alonso Leeanne E., 2000, P1; Andersen AN, 2002, J APPL ECOL, V39, P8, DOI 10.1046/j.1365-2664.2002.00704.x; Anderson M.J., 2008, GUIDE SOFTWARE STAT; Barbosa A.M., 2014, MODEVA MODEL EVALUAT; Bennett AF, 2014, J APPL ECOL, V51, P514, DOI 10.1111/1365-2664.12200; Bivand RJ, 2016, SPDEP SPATIAL DEPEND; Branstetter MG, 2013, ZOOKEYS, P1, DOI 10.3897/zookeys.295.4905; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Calcagno V, 2010, J STAT SOFTW, V34, P1; Chao A, 2014, ECOL MONOGR, V84, P45, DOI 10.1890/13-0133.1; Chao A, 2012, ECOLOGY, V93, P2533, DOI 10.1890/11-1952.1; Clarke K., 2005, PRIMER 6 COMPUTER PR; Clarke KR, 2008, J EXP MAR BIOL ECOL, V366, P56, DOI 10.1016/j.jembe.2008.07.009; Corbacho C, 2003, AGR ECOSYST ENVIRON, V95, P495, DOI 10.1016/S0167-8809(02)00218-9; Crist TO, 2009, MYRMECOL NEWS, V12, P3; Cumming G, 2007, J CELL BIOL, V177, P7, DOI 10.1083/jcb.200611141; Dauber J, 2005, GLOBAL ECOL BIOGEOGR, V14, P213, DOI 10.1111/j.1466-822x.2005.00150.x; Dauber J, 2006, CONSERV BIOL, V20, P1150, DOI 10.1111/j.1523-1739.2006.00373.x; De la Mora A, 2013, BIODIVERS CONSERV, V22, P871, DOI 10.1007/s10531-013-0454-z; Debuse VJ, 2007, LANDSCAPE ECOL, V22, P731, DOI 10.1007/s10980-006-9068-0; Didham R. K., 2010, ECOLOGICAL CONSEQUEN; Dormann CF, 2007, ECOGRAPHY, V30, P609, DOI 10.1111/j.2007.0906-7590.05171.x; Fahrig L, 2011, ECOL LETT, V14, P101, DOI 10.1111/j.1461-0248.2010.01559.x; Fernandez D, 2014, ECOL INDIC, V41, P165, DOI 10.1016/j.ecolind.2014.02.008; Galindo-Gonzalez J, 2003, SOUTHWEST NAT, V48, P579, DOI 10.1894/0038-4909(2003)048&lt;0579:FBIITA&gt;2.0.CO;2; Garcia-Martinez MA, 2016, FLA ENTOMOL, V99, P248, DOI 10.1653/024.099.0214; Garcia-Martinez MA, 2015, ENVIRON ENTOMOL, V44, P1488, DOI 10.1093/ee/nvv141; Gollan JR, 2011, ECOL INDIC, V11, P1517, DOI 10.1016/j.ecolind.2009.09.007; Gorley R.N., 2006, USER MANUAL TUTORIAL; Goslee S, 2015, ECODIST DISSIMILARIT; Granados-Sanchez D., 2006, Revista Chapingo. Serie Ciencias Forestales y del Ambiente, V12, P55; Gray CL, 2015, J APPL ECOL, V52, P31, DOI 10.1111/1365-2664.12371; Guenard B, 2011, ENVIRON ENTOMOL, V40, P1523, DOI 10.1603/EN11104; Herrera-Rangel J, 2015, ENVIRON ENTOMOL, V44, P1287, DOI 10.1093/ee/nvv103; HILL MO, 1973, ECOLOGY, V54, P427, DOI 10.2307/1934352; Hsieh T. C., 2016, METHODS ECOLOGY EVOL; Ives CD, 2011, LANDSCAPE URBAN PLAN, V103, P372, DOI 10.1016/j.landurbplan.2011.08.009; Johnson JT, 2014, J INSECT SCI, V14, DOI 10.1093/jisesa/ieu099; Jost L, 2006, OIKOS, V113, P363, DOI 10.1111/j.2006.0030-1299.14714.x; JOST L, 2010, DIVERSITY-BASEL, V2, P207, DOI [DOI 10.3390/d2020207, 10.3390/d2020207]; Lichstein JW, 2007, PLANT ECOL, V188, P117, DOI 10.1007/s11258-006-9126-3; Longino J, 2007, ANTS COSTA RICA; Longino JT, 2012, ZOOTAXA, P1; Longino JT, 2013, ZOOTAXA, V3693, P101, DOI 10.11646/zootaxa.3693.2.1; Lopes JFS, 2012, PSYCHE J ENTOMOLOGY, V2012; LOPEZBARRERA F, 2008, AGROECOSISTEMAS CAFE, P259; Mackay EE., 1989, MEM 2 S NAC INS SOC, P1; MAGURRAN A. E., 2004, MEASURING BIOLOGICAL; Marczak LB, 2010, ECOL APPL, V20, P126, DOI 10.1890/08-2064.1; Martin TG, 2006, BIOL CONSERV, V127, P201, DOI 10.1016/j.biocon.2005.08.014; Milford ER, 1999, SOUTHWEST NAT, V44, P278; Munoz-Villers LE, 2008, INT J REMOTE SENS, V29, P71, DOI 10.1080/01431160701280967; Murgueitio E, 2011, FOREST ECOL MANAG, V261, P1654, DOI 10.1016/j.foreco.2010.09.027; NAIMAN RJ, 1993, ECOL APPL, V3, P209, DOI 10.2307/1941822; PATTON D R, 1975, Wildlife Society Bulletin, V3, P171; Perez-Toledo GR, 2016, ENTOMOLOGIA MEXICANA, V3, P582; Perfecto I, 2002, CONSERV BIOL, V16, P174, DOI 10.1046/j.1523-1739.2002.99536.x; Rempel R. S., 2012, PATCH ANAL PATCH GRI; Richardson JS, 2005, RIPARIAN COMMUTIES A; Ries L, 2004, ANNU REV ECOL EVOL S, V35, P491, DOI 10.1146/annurev.ecolsys.35.112202.130148; Rodriguez-Mendoza C, 2010, BIOL LETTERS, V6, P781, DOI 10.1098/rsbl.2010.0334; Semlitsch RD, 2003, CONSERV BIOL, V17, P1219, DOI 10.1046/j.1523-1739.2003.02177.x; Silva RR, 2010, ECOL MONOGR, V80, P107, DOI 10.1890/08-1298.1; Silvestre R, 2012, PSYCHE J ENTOMOLOGY, V2012; Sobrinho TG, 2003, SOCIOBIOLOGY, V42, P329; Spiesman BJ, 2008, LANDSCAPE ECOL, V23, P313, DOI 10.1007/s10980-007-9186-3; Tagwireyi P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124807; Underwood EC, 2006, BIOL CONSERV, V132, P166, DOI 10.1016/j.biocon.2006.03.022; Williams-Linera G., 2002, Madera y Bosques, V8, P73; Wilson EO, 2005, P NATL ACAD SCI USA, V102, P7411, DOI 10.1073/pnas.0502264102; Wilson MC, 2016, LANDSCAPE ECOL, V31, P219, DOI 10.1007/s10980-015-0312-3; Woodcock P, 2011, PHILOS T R SOC B, V366, P3256, DOI 10.1098/rstb.2011.0031	72	22	22	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0172464	10.1371/journal.pone.0172464	http://dx.doi.org/10.1371/journal.pone.0172464			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5VB	28234948	Green Published, gold, Green Submitted			2022-12-27	WOS:000394688200082
J	Jauffrais, T; Jesus, B; Meleder, V; Geslin, E				Jauffrais, Thierry; Jesus, Bruno; Meleder, Vona; Geslin, Emmanuelle			Functional xanthophyll cycle and pigment content of a kleptoplastic benthic foraminifer: Haynesina germanica	PLOS ONE			English	Article							ELPHIDIUM-EXCAVATUM TERQUEM; LIGHT-INTENSITY; CHLOROPLASTS; RETENTION; PLASTIDS; MICROPHYTOBENTHOS; PHOTOPROTECTION; DENITRIFICATION; GROWTH; PHOTOACCLIMATION	Some shallow water benthic foraminifera are able to retain functional chloroplasts (kleptoplasts) from their food source, i.e. diatoms. Here we assessed the functionality of the kleptoplast xanthophyll cycle (XC,i.e. the main diatom short-term photo-regulation mechanism) and we surveyed Haynesina germanica kleptoplast pigment composition over time and at different light regimes. Six common diatom lipophilic pigments were detected, two chlorophylls (Chl a, Chl c) and four carotenoids (fucoxanthin and by-products, diadinoxanthin, diatoxanthin and beta-carotene), the same pigment profile as the diatom species frequently isolated at the sampling site. The xanthophyll cycle (XC) was functional with kleptoplast diatoxanthin (DT) content increase with concomitant diadinoxanthin (DD) decrease after short term light exposure. DT/(DT+DD) and DT/DD ratios increased significantly in specimens exposed to low light and high light in comparison to specimens maintained in the dark. Specimens placed in very low light after the light treatments reverted to values close to the initial ones, suggesting that H. germanica XC is functional. A functional XC is an indication of H. germanica kleptoplasts capacity for short-term photo-protection from photo-oxidative damages caused by excess of light. Furthermore, the pigment survey suggests that H. germanica preserved some chloroplasts over a longer time than others and that pigment content is influenced by previous light history. Finally, the current study highlighted seasonal differences, with higher pigment contents in winter specimens (27.35 +/- 1.30 ng cell(-1)) and lower in summer specimens (6.08 +/- 1.21 ng cell(-1)), a quantitative and qualitative composition suggesting light acclimation to low or high light availability, according to the season.	[Jauffrais, Thierry; Geslin, Emmanuelle] Univ Angers, UMR CNRS LPG BIAF 6112, Bioindicateurs Actuels & Fossiles, Angers, France; [Jesus, Bruno; Meleder, Vona] Univ Nantes, EA2160, Lab Mer Mol Sante, Nantes, France; [Jesus, Bruno] Campo Grande Univ Lisboa, Fac Sci, BioISI Biosyst & Integrat Sci Inst, Lisbon, Portugal	Universite d'Angers; Nantes Universite; BIOISI; Universidade de Lisboa	Jauffrais, T (corresponding author), Univ Angers, UMR CNRS LPG BIAF 6112, Bioindicateurs Actuels & Fossiles, Angers, France.	thierry.jauffrais@univ-angers.fr	Jesus, Bruno/B-5441-2011; jauffrais, thierry/Q-5089-2018; jauffrais, thierry/H-1872-2012	Jesus, Bruno/0000-0002-2047-3783; jauffrais, thierry/0000-0001-9681-6239; jauffrais, thierry/0000-0001-9681-6239; Meleder, Vona/0000-0002-1874-1929	CNRS; Region Pays de la Loire	CNRS(Centre National de la Recherche Scientifique (CNRS)); Region Pays de la Loire(Region Pays de la Loire)	This study is part of the EC2CO-Lefe project ForChlo, funded by the CNRS (http://www.insu.cnrs.fr/ec2co and http://www.insu.cnrs.fr/lefe). This study is also strongly supported by the Region Pays de la Loire (Post-doc position of the first author, TJ, on COSELMAR and Fresco projects). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study is part of the EC2CO-Lefe project "ForChlo" funded by the CNRS. This study is also strongly supported by the Region Pays de la Loire (Post-doc position of the first author on "COSELMAR" and "Fresco" projects). The authors would also like to thank Sophie Quinchard and Eric Beneteau from the LPG-BIAF for their help at peaking thousands of foraminifera.	Alve E, 2001, J FORAMIN RES, V31, P12, DOI 10.2113/0310012; Barnett A, 2015, ISME J, V9, P32, DOI 10.1038/ismej.2014.105; Bernhard JM, 1999, EARTH-SCI REV, V46, P149, DOI 10.1016/S0012-8252(99)00017-3; Bernhard JM, 2012, ISME J, V6, P951, DOI 10.1038/ismej.2011.171; Bernhard JM, 2010, ENVIRON MICROBIOL, V12, P2107, DOI 10.1111/j.1462-2920.2009.02073.x; Bouchet VMP, 2009, J EXP MAR BIOL ECOL, V371, P20, DOI 10.1016/j.jembe.2008.12.012; Brotas V, 2003, ACTA OECOL, V24, pS109, DOI 10.1016/S1146-609X(03)00013-4; Cartaxana P, 2011, J EXP MAR BIOL ECOL, V405, P120, DOI 10.1016/j.jembe.2011.05.027; CEDHAGEN T, 1991, OPHELIA, V33, P17, DOI 10.1080/00785326.1991.10429739; Cesbron F, 2017, J FORAMINIF IN PRESS; Cesbron F, 2016, ESTUAR COAS IN PRESS; CLARK KB, 1990, VELIGER, V33, P339; Correia MJ, 2002, SYMBIOSIS, V32, P15; Correia MJ, 2002, SYMBIOSIS, V32, P27; Correia MJ, 2000, SYMBIOSIS, V29, P343; Cruz S, 2015, SCI REP-UK, V5, DOI 10.1038/srep07904; Cruz S, 2014, J MOLLUS STUD, V80, P475, DOI 10.1093/mollus/eyu021; de Nooijer LJ, 2008, LIMNOL OCEANOGR-METH, V6, P610, DOI 10.4319/lom.2008.6.610; de Nooijer LJ, 2009, P NATL ACAD SCI USA, V106, P15374, DOI 10.1073/pnas.0904306106; Dimier C, 2009, PROTIST, V160, P397, DOI 10.1016/j.protis.2009.03.001; Dimier C, 2009, LIMNOL OCEANOGR, V54, P823, DOI 10.4319/lo.2009.54.3.0823; Geslin E, 2004, MAR MICROPALEONTOL, V53, P227, DOI 10.1016/j.marmicro.2004.05.010; Gimenez-Casalduero F, 2011, ANIM BIODIV CONSERV, V34, P217; Goldstein S. T., 2004, MICROSC MICROANAL, V10, P1458, DOI DOI 10.1017/S1431927604885891; Goss R, 2010, PHOTOSYNTH RES, V106, P103, DOI 10.1007/s11120-010-9536-x; Grzymski J, 2002, LIMNOL OCEANOGR, V47, P1569, DOI 10.4319/lo.2002.47.6.1569; Hansen PJ, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00785; Heinz P, 2005, MAR BIOL RES, V1, P149, DOI 10.1080/17451000510019114; Jakob T, 2001, J PLANT PHYSIOL, V158, P383, DOI 10.1078/0176-1617-00288; Jauffrais T, 2016, J SEA RES, V118, P52, DOI 10.1016/j.seares.2016.07.001; Jauffrais T, 2016, BIOGEOSCIENCES, V13, P2715, DOI 10.5194/bg-13-2715-2016; Jauffrais T, 2016, MAR BIOL, V163, DOI 10.1007/s00227-016-2888-9; Jauffrais T, 2015, J EXP MAR BIOL ECOL, V469, P83, DOI 10.1016/j.jembe.2015.04.014; Jesus B, 2006, MAR BIOL, V150, P17, DOI 10.1007/s00227-006-0324-2; Jesus B, 2006, MAR ECOL PROG SER, V315, P55, DOI 10.3354/meps315055; Jesus B, 2010, J EXP MAR BIOL ECOL, V395, P98, DOI 10.1016/j.jembe.2010.08.021; KNIGHT R, 1985, MAR ECOL PROG SER, V23, P241, DOI 10.3354/meps023241; KUHL M, 1994, MAR ECOL PROG SER, V105, P139, DOI 10.3354/meps105139; Lavaud J, 2007, LIMNOL OCEANOGR, V52, P1188, DOI 10.4319/lo.2007.52.3.1188; LEE JJ, 1988, SYMBIOSIS, V5, P45; LONG SP, 1994, ANNU REV PLANT PHYS, V45, P633, DOI 10.1146/annurev.pp.45.060194.003221; LOPEZ E, 1979, MAR BIOL, V53, P201, DOI 10.1007/BF00952427; Maoka T, 2011, MAR DRUGS, V9, P278, DOI 10.3390/md9020278; Meleder V, 2003, REMOTE SENS ENVIRON, V88, P386, DOI 10.1016/j.rse.2003.08.009; Meleder V, 2013, J PHOTOCH PHOTOBIO B, V129, P115, DOI 10.1016/j.jphotobiol.2013.10.005; Moodley L, 1998, MAR MICROPALEONTOL, V34, P91, DOI 10.1016/S0377-8398(97)00044-3; Mouget JL, 2008, AQUAT MICROB ECOL, V52, P223, DOI 10.3354/ame01218; Muller P, 2001, PLANT PHYSIOL, V125, P1558, DOI 10.1104/pp.125.4.1558; Perkins RG, 2010, MAR ECOL PROG SER, V416, P93, DOI 10.3354/meps08787; Pillet L, 2011, PROTIST, V162, P394, DOI 10.1016/j.protis.2010.10.001; Pina-Ochoa E, 2010, P NATL ACAD SCI USA, V107, P1148, DOI 10.1073/pnas.0908440107; Risgaard-Petersen N, 2006, NATURE, V443, P93, DOI 10.1038/nature05070; Schmidt C, 2016, SCI REPORTS, V6; Schmidt C, 2011, LIMNOL OCEANOGR, V56, P1587, DOI 10.4319/lo.2011.56.5.1587; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Serodio J, 2012, AQUAT MICROB ECOL, V67, P161, DOI 10.3354/ame01591; Seuront L, 2015, J FORAMIN RES, V45, P390; Thibault de Chanvalon A, 2015, BIOGEOSCIENCES, V12, P6219, DOI 10.5194/bg-12-6219-2015; Tsuchiya M, 2015, J EUKARYOT MICROBIOL, V62, P454, DOI 10.1111/jeu.12200; Van Leeuwe MA, 2008, EUR J PHYCOL, V43, P123, DOI 10.1080/09670260701726119; Ventura P, 2013, J EXP MAR BIOL ECOL, V441, P105, DOI 10.1016/j.jembe.2013.01.022; Vieira S, 2009, MAR BIOL, V156, P1007, DOI 10.1007/s00227-009-1144-y; Wagele H, 2011, MOL BIOL EVOL, V28, P699, DOI 10.1093/molbev/msq239; WEAVER S, 1981, MAR BEHAV PHYSIOL, V7, P297, DOI 10.1080/10236248109386991	64	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2017	12	2							e0172678	10.1371/journal.pone.0172678	http://dx.doi.org/10.1371/journal.pone.0172678			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5SX	28231315	gold, Green Submitted, Green Published			2022-12-27	WOS:000394682400068
J	Li, YH; Zheng, XZ; Ru, GM; Ding, QN; Hahn, RG				Li, Yuhong; Zheng Xiaozhu; Ru Guomei; Ding Qiannan; Hahn, Robert G.			Effects of vasoactive drugs on crystalloid fluid kinetics in septic sheep	PLOS ONE			English	Article							VOLUME KINETICS; INFUSION; MANAGEMENT; SALINE; SHOCK	Purpose Crystalloid fluid and vasoactive drugs are used in the early treatment of sepsis. The purpose of the present study was to examine how these drugs alter plasma volume expansion, peripheral edema, and urinary excretion. Methods Twenty-five anesthetized sheep were made septic by cecal puncture and a short infusion of lipopolysaccharide. After 50 min, a slow infusion of isotonic saline was initiated: the saline either contained no drug, norepinephrine (1 mu g/kg/min), phenylephrine (3 mu g/kg/min), dopamine (50 mu g/kg/min), or esmolol (50 mu g/kg/min). Ten min later, 20 mL/kg Ringer A s lactate solution was given over 30 min. Central hemodynamics, acid-base balance, and the urinary excretion were monitored. Frequent measurements of the blood hemoglobin concentration were used as input in a kinetic analysis, using a mixed effects modeling software. Results The fluid kinetic analysis showed slow distribution and elimination of Ringer A s lactate, although phenylephrine and dopamine accelerated the distribution. Once distributed, the fluid remained in the peripheral tissues and did not equilibrate adequately with the plasma. Overall, stimulation of adrenergic alpha(1)-receptors accelerated, while beta(1)-receptors retarded, the distribution and elimination of fluid. A pharmacodynamic E-max model showed that Ringer A s lactate increased stroke volume by 13 ml/beat. Alpha(1)-receptors, but not beta(1)-receptors, further increased stroke volume, while both raised the mean arterial pressure. Modulation of the beta1-receptors limited the acidosis. Conclusions Stimulation of adrenergic alpha(1)-receptors with vasoactive drugs accelerated, while beta1receptors retarded, the distribution and elimination of fluid. The tendency for peripheral accumulation of fluid was pronounced, in particular when phenylephrine was given.	[Li, Yuhong] Shaoxing Peoples Hosp, Dept Anesthesiol, Shaoxing, Zhejiang, Peoples R China; [Li, Yuhong; Ru Guomei; Ding Qiannan] Shaoxing Peoples Hosp, Res Ctr, Shaoxing, Zhejiang, Peoples R China; [Zheng Xiaozhu] Zhejiang Hosp, Dept Anesthesiol, Hangzhou, Zhejiang, Peoples R China; [Hahn, Robert G.] Sodertalje Hosp, Res Unit, Sodertalje, Sweden		Hahn, RG (corresponding author), Sodertalje Hosp, Res Unit, Sodertalje, Sweden.	r.hahn@telia.com	li, Yu/HCI-9086-2022	Hahn, Robert/0000-0002-1528-3803	Medical Health Science and Technology Project of Zhejiang province [2014KYB277]; Zhejiang Provincial Science Foundation [LY15H030013]	Medical Health Science and Technology Project of Zhejiang province; Zhejiang Provincial Science Foundation	The project was supported by Medical Health Science and Technology Project of Zhejiang province (No 2014KYB277) and Zhejiang Provincial Science Foundation (No LY15H030013).	Beale Richard J, 2004, Crit Care Med, V32, pS455, DOI 10.1097/01.CCM.0000142909.86238.B1; Brauer KI, 2002, ANESTHESIOLOGY, V96, P442, DOI 10.1097/00000542-200202000-00033; Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI [DOI 10.1007/s00134-012-2769-8, 10.1007/s00134-012-2769-8]; Ewaldsson CA, 2006, J SURG RES, V131, P7, DOI 10.1016/j.jss.2005.09.012; Hahn RG, 2016, ACTA ANAESTH SCAND, V60, P569, DOI 10.1111/aas.12686; Hahn RG, 2016, EUR J ANAESTH, V33, P475, DOI 10.1097/EJA.0000000000000436; Hahn RG, 2014, CLINICS, V69, P120, DOI 10.6061/clinics/2014(02)08; Hahn RG, 2010, ANESTHESIOLOGY, V113, P470, DOI 10.1097/ALN.0b013e3181dcd88f; Heeremans EH, 2010, CURR OPIN ANESTHESIO, V23, P479, DOI 10.1097/ACO.0b013e32833a1d2f; Li Y, 2012, BMC MOL BIOL, V13, DOI 10.1186/1471-2199-13-16; Patel GP, 2010, SHOCK, V33, P375, DOI 10.1097/SHK.0b013e3181c6ba6f; Stowe T, 2011, ANESTHETIC PHARM, P648; Svensen C, 1997, ANESTHESIOLOGY, V87, P204, DOI 10.1097/00000542-199708000-00006; [No title captured]	14	13	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2017	12	2							e0172361	10.1371/journal.pone.0172361	http://dx.doi.org/10.1371/journal.pone.0172361			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5SX	28231305	Green Published, gold, Green Submitted			2022-12-27	WOS:000394682400038
J	Perucca, S; Di Palma, A; Piccaluga, PP; Gemelli, C; Zoratti, E; Bassi, G; Giacopuzzi, E; Lojacono, A; Borsani, G; Tagliafico, E; Scupoli, MT; Bernardi, S; Zanaglio, C; Cattina, F; Cancelli, V; Malagola, M; Krampera, M; Marini, M; Almici, C; Ferrari, S; Russo, D				Perucca, Simone; Di Palma, Andrea; Piccaluga, Pier Paolo; Gemelli, Claudia; Zoratti, Elisa; Bassi, Giulio; Giacopuzzi, Edoardo; Lojacono, Andrea; Borsani, Giuseppe; Tagliafico, Enrico; Scupoli, Maria Teresa; Bernardi, Simona; Zanaglio, Camilla; Cattina, Federica; Cancelli, Valeria; Malagola, Michele; Krampera, Mauro; Marini, Mirella; Almici, Camillo; Ferrari, Sergio; Russo, Domenico			Mesenchymal stromal cells (MSCs) induce ex vivo proliferation and erythroid commitment of cord blood haematopoietic stem cells (CB-CD34+cells)	PLOS ONE			English	Article							GENE-EXPRESSION ANALYSIS; PROGENITOR CELLS; EXPANSION; TRANSPLANTATION; NICHE; ID1; TARGET; VEGF; NEOVASCULARIZATION; HOMEOSTASIS	A human bone marrow-derived mesenchymal stromal cell (MSCs) and cord blood-derived CD34+ stem cell co-culture system was set up in order to evaluate the proliferative and differentiative effects induced by MSCs on CD34+ stem cells, and the reciprocal influences on gene expression profiles. After 10 days of co-culture, non-adherent (SN-fraction) and adherent (AD-fraction) CD34+ stem cells were collected and analysed separately. In the presence of MSCs, a significant increase in CD34+ cell number was observed (fold increase = 14.68), mostly in the SN-fraction (fold increase = 13.20). This was combined with a significant increase in CD34+ cell differentiation towards the BFU-E colonies and with a decrease in the CFU-GM. These observations were confirmed by microarray analysis. Through gene set enrichment analysis (GSEA), we noted a significant enrichment in genes involved in heme metabolism (e.g. LAMP2, CLCN3, BMP2K), mitotic spindle formation and proliferation (e.g. PALLD, SOS1, CCNA1) and TGF-beta signalling (e.g. ID1) and a down-modulation of genes participating in myeloid and lymphoid differentiation (e.g. PCGF2) in the co-cultured CD34+ stem cells. On the other hand, a significant enrichment in genes involved in oxygenlevel response (e.g. TNFAIP3, SLC2A3, KLF6) and angiogenesis (e.g. VEGFA, IGF1, ID1) was found in the co-cultured MSCs. Taken together, our results suggest that MSCs can exert a priming effect on CD34+ stem cells, regulating their proliferation and erythroid differentiation. In turn, CD34+ stem cells seem to be able to polarise the BM-niche towards the vascular compartment by modulating molecular pathways related to hypoxia and angiogenesis.	[Perucca, Simone; Di Palma, Andrea; Bernardi, Simona; Zanaglio, Camilla; Cattina, Federica; Cancelli, Valeria; Malagola, Michele; Russo, Domenico] Univ Brescia, Dept Clin & Expt Sci, Unit Blood Dis & Stem Cells Transplantat, Brescia, Italy; [Perucca, Simone; Di Palma, Andrea; Bernardi, Simona; Zanaglio, Camilla; Cattina, Federica; Cancelli, Valeria; Malagola, Michele; Russo, Domenico] ASST Spedali Civili Brescia, Brescia, Italy; [Perucca, Simone; Di Palma, Andrea; Bernardi, Simona; Zanaglio, Camilla] ASST Spedali Civili Brescia, Lab CREA Ctr Ric Ematooncol AIL, Brescia, Italy; [Piccaluga, Pier Paolo] Univ Bologna, S Orsola Malpighi Hosp, Dept Expt Diagnost & Specialty Med DIMES, Sch Med, Bologna, Italy; [Piccaluga, Pier Paolo] Euromediterranean Inst Sci & Technol IEMEST, Sect Genom & Personalized Med, Palermo, Italy; [Gemelli, Claudia] Parco Sci & Tecnol Mat Innovat & Ric Applicata Mi, Modena, Italy; [Zoratti, Elisa; Krampera, Mauro] Univ Verona, Appl Res Canc Network ARC NET, Verona, Italy; [Bassi, Giulio] Univ Verona, Sect Hematol, Dept Med, Stem Cell Res Lab, Verona, Italy; [Giacopuzzi, Edoardo; Borsani, Giuseppe] Univ Brescia, DMTM, Unit Biol & Genet, Brescia, Italy; [Lojacono, Andrea] ASST Spedali Civili Brescia, UO Obstet & Gynecol 1, Brescia, Italy; [Tagliafico, Enrico] Univ Modena & Reggio Emilia, Dipartimento Sci Vita, Ctr Ric Genom, Modena, Italy; [Scupoli, Maria Teresa] Univ Verona, Interdept Lab Med Res LURM, Verona, Italy; [Marini, Mirella; Almici, Camillo] ASST Spedali Civili Brescia, Dept Transfus Med, Lab Stem Cells Manipulat & Cryopreservat, Brescia, Italy; [Ferrari, Sergio] Univ Modena & Reggio Emilia, Dept Life Sci, Modena, Italy	University of Brescia; Hospital Spedali Civili Brescia; Hospital Spedali Civili Brescia; IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna; University of Verona; University of Verona; University of Brescia; Hospital Spedali Civili Brescia; Universita di Modena e Reggio Emilia; University of Verona; Hospital Spedali Civili Brescia; Universita di Modena e Reggio Emilia	Russo, D (corresponding author), Univ Brescia, Dept Clin & Expt Sci, Unit Blood Dis & Stem Cells Transplantat, Brescia, Italy.; Russo, D (corresponding author), ASST Spedali Civili Brescia, Brescia, Italy.	domenico.russo@unibs.it	Bernardi, Simona/AAO-9572-2020; Tagliafico, Enrico/C-9079-2009; SCUPOLI, Maria/AAX-9712-2021; Almici, Camillo/AAA-2141-2019; KRAMPERA, MAURO/K-5596-2018; Piccaluga, Pier Paolo/H-7132-2019	Bernardi, Simona/0000-0002-3494-2624; Tagliafico, Enrico/0000-0003-0981-2542; SCUPOLI, Maria/0000-0002-3352-7859; Almici, Camillo/0000-0002-9438-2569; Piccaluga, Pier Paolo/0000-0002-9432-0595; Giacopuzzi, Edoardo/0000-0002-5692-366X; Malagola, Michele/0000-0003-0907-130X; KRAMPERA, Mauro/0000-0002-7280-2040	PRIN,BCC "Pompiano e Franciacorta"; LIONS Bassa Bresciana	PRIN,BCC "Pompiano e Franciacorta"(Ministry of Education, Universities and Research (MIUR)); LIONS Bassa Bresciana	This study was supported by PRIN_2009, BCC "Pompiano e Franciacorta", LIONS Bassa Bresciana. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by PRIN_2009, BCC "Pompiano e Franciacorta", LIONS Bassa Bresciana. Special thanks are to Studio Moretto Group Srl for English revision (http://www. smglanguaes.com).	Alakel N, 2009, EXP HEMATOL, V37, P504, DOI 10.1016/j.exphem.2008.12.005; Argiropoulos B, 2007, ONCOGENE, V26, P6766, DOI 10.1038/sj.onc.1210760; Babitt JL, 2006, NAT GENET, V38, P531, DOI 10.1038/ng1777; Baltanas FC, 2013, MOL CELL BIOL, V33, P4562, DOI 10.1128/MCB.01026-13; Bianco P, 2014, ANNU REV CELL DEV BI, V30, P677, DOI 10.1146/annurev-cellbio-100913-013132; Boulais PE, 2015, BLOOD, V125, P2621, DOI 10.1182/blood-2014-09-570192; Brunstein CG, 2009, BONE MARROW TRANSPL, V43, P935, DOI 10.1038/bmt.2008.417; Buitenhuis M, 2005, BLOOD, V105, P4272, DOI 10.1182/blood-2004-12-4883; Carmena M, 2015, FRONT CELL DEV BIOL, V3, DOI 10.3389/fcell.2015.00073; Carrancio S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026241; Chotinantakul K, 2012, BONE MARROW RES, DOI 10.1155/2012/270425; Cullis J, 2014, CANCER CELL, V25, P181, DOI 10.1016/j.ccr.2014.01.025; de Lima M, 2012, NEW ENGL J MED, V367, P2305, DOI 10.1056/NEJMoa1207285; Delaby C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042199; Ding L, 2013, NATURE, V495, P231, DOI 10.1038/nature11885; Doulatov S, 2012, CELL STEM CELL, V10, P120, DOI 10.1016/j.stem.2012.01.006; Ehninger A, 2011, J EXP MED, V208, P421, DOI 10.1084/jem.20110132; Fajardo-Orduna GR, 2015, ARCH MED RES, V46, P589, DOI 10.1016/j.arcmed.2015.10.001; Flores-Guzman P, 2009, CYTOTHERAPY, V11, P886, DOI 10.3109/14653240903180076; Frassoni F, 2008, LANCET ONCOL, V9, P831, DOI 10.1016/S1470-2045(08)70180-3; Frenette PS, 2013, ANNU REV IMMUNOL, V31, P285, DOI 10.1146/annurev-immunol-032712-095919; Frisch Benjamin J, 2008, Curr Opin Support Palliat Care, V2, P211, DOI 10.1097/SPC.0b013e32830d5c12; Galotto M, 1999, EXP HEMATOL, V27, P1460, DOI 10.1016/S0301-472X(99)00076-4; Gavriilidis Paschalis, 2015, J Clin Med Res, V7, P742, DOI 10.14740/jocmr2295w; Greenbaum A, 2013, NATURE, V495, P227, DOI 10.1038/nature11926; Hattori K, 2001, J EXP MED, V193, P1005, DOI 10.1084/jem.193.9.1005; Huai J, 2008, P NATL ACAD SCI USA, V105, P5177, DOI 10.1073/pnas.0801413105; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huang GP, 2007, CELL TRANSPLANT, V16, P579, DOI 10.3727/000000007783465073; HUBER KL, 1993, AM J PHYSIOL, V264, pE770, DOI 10.1152/ajpendo.1993.264.5.E770; Kajiume T, 2004, EXP HEMATOL, V32, P571, DOI 10.1016/j.exphem.2004.03.001; Klein C, 2013, TISSUE ENG PT A, V19, P2577, DOI 10.1089/ten.tea.2013.0073; Kunisaki Y, 2013, NATURE, V502, P637, DOI 10.1038/nature12612; Lee D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088417; Lee EY, 2009, WOUND REPAIR REGEN, V17, P540, DOI 10.1111/j.1524-475X.2009.00499.x; Li T, 2011, BONE MARROW RES, DOI 10.1155/2011/353878; Liu LQ, 2013, CELL BIOL INT, V37, P551, DOI 10.1002/cbin.10097; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu JW, 2013, CELL BIOCHEM BIOPHYS, V67, P235, DOI 10.1007/s12013-011-9298-x; Man SM, 2015, CELL, V162, P45, DOI 10.1016/j.cell.2015.06.001; Martin SK, 2015, STEM CELLS, V33, P1359, DOI 10.1002/stem.1931; McNiece I, 2004, CYTOTHERAPY, V6, P311, DOI 10.1080/14653240410004871; Mehrasa R, 2014, INT J MOL CELL MED, V3, P1; Mendelson A, 2014, NAT MED, V20, P833, DOI 10.1038/nm.3647; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Miyazaki M, 2005, J IMMUNOL, V174, P2507, DOI 10.4049/jimmunol.174.5.2507; Navari M, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00728; Nishiyama K, 2005, CIRCULATION, V112, P2840, DOI 10.1161/CIRCULATIONAHA.104.516898; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Papayannopoulou T, 2001, BLOOD, V98, P2403, DOI 10.1182/blood.V98.8.2403; Park JH, 2011, ONCOGENE, V30, P4578, DOI 10.1038/onc.2011.174; Pelagiadis I, 2015, CELL BIOL INT, V39, P1099, DOI 10.1002/cbin.10483; Perry SS, 2007, BLOOD, V110, P2351, DOI 10.1182/blood-2007-01-069914; Piccaluga PP, 2008, HAEMATOL-HEMATOL J, V93, P1033, DOI 10.3324/haematol.12754; Piccaluga PP, 2007, J CLIN INVEST, V117, P823, DOI 10.1172/JCI26833; Piccaluga PP, 2011, BLOOD, V117, P3596, DOI 10.1182/blood-2010-08-301556; Planas-Paz L, 2016, NAT CELL BIOL, V18, P467, DOI 10.1038/ncb3337; Renstrom J, 2010, CHEM-BIOL INTERACT, V184, P7, DOI 10.1016/j.cbi.2009.11.012; Ryu MS, 2008, J NUTR, V138, P2076, DOI 10.3945/jn.108.093575; Shigematsu Satoshi, 1999, Endocrine Journal, V46, pS59, DOI 10.1507/endocrj.46.Suppl_S59; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tang YL, 2004, REGUL PEPTIDES, V117, P3, DOI 10.1016/j.regpep.2003.09.005; Togel F, 2007, AM J PHYSIOL-RENAL, V292, pF1626, DOI 10.1152/ajprenal.00339.2006; Vijayan KV, 2015, BLOOD, V125, P898, DOI 10.1182/blood-2014-12-617589; Wagner WG, 2007, STEM CELLS, V25, P2638, DOI 10.1634/stemcells.2007-0280; Wagner W, 2007, EXP HEMATOL, V35, P314, DOI 10.1016/j.exphem.2006.10.003; Walker NM, 2016, J BIOL CHEM, V291, P6262, DOI 10.1074/jbc.M115.672170; Wang LD, 2011, NAT REV MOL CELL BIO, V12, P643, DOI 10.1038/nrm3184; Watabe T, 2011, J BIOCHEM, V149, P117, DOI 10.1093/jb/mvq146; Wood AD, 2009, BLOOD, V114, P1820, DOI 10.1182/blood-2009-02-206573; Wu KH, 2013, CELL TRANSPLANT, V22, P723, DOI 10.3727/096368912X655217; Yang R, 1999, MOL CELL BIOL, V19, P2400; Zhang CC, 2008, CURR OPIN HEMATOL, V15, P307, DOI 10.1097/MOH.0b013e3283007db5	74	22	22	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2017	12	2							e0172430	10.1371/journal.pone.0172430	http://dx.doi.org/10.1371/journal.pone.0172430			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5SX	28231331	Green Published, gold, Green Submitted			2022-12-27	WOS:000394682400042
J	Santos, S; Jimenez, S; Sampaio, J; Leite, N				Santos, Sara; Jimenez, Sergio; Sampaio, Jaime; Leite, Nuno			Effects of the Skills4Genius sports-based training program in creative behavior	PLOS ONE			English	Article							SMALL-SIDED GAMES; TORRANCE TESTS; VERTICAL JUMP; AGILITY; THINKING; IMPACT; CHILDREN; EXERCISE; SYSTEMS; PEDAGOGY	Team Sports has been suggested as a suitable environment to investigate creative behavior. This study's purpose was two-fold: first, it intended to identify the effects of the Skills4Genius sports-bases training program in thinking, motor, and in-game creative behavior in team sports. Second, it aimed to investigate the relationship between creative thinking and in-game creativity. Forty children from primary school were allocated into control (n = 18, age: 9.2 +/- 0.4) and experimental (n = 22, age: 9.5 +/- 0.7) groups. The experimental group participated in a five-month training program involving either creative thinking, diversification, physical literacy, and nonlinear pedagogy approaches (Skills4Genius). Variables in the study included: a) creative thinking; b) motor performance (vertical jump, speed, and agility); c) in-game individual creative behavior (attempts, fluency, and versatility); and d) in-game collective behavior (positional regularity). The results suggested that the Skills4Genius program fostered creative thinking, agility, and speed performance. Moreover, it stretched the in-game individual creative behavior mainly through the improvement of the attempts and versatility of the player's actions. Lastly, it nurtured a better learning of the tactical principles, whereas the children were more coordinated with their teammates' and opponents' positioning. Additionally, this study presents a positive correlation linking creative thinking and in-game creative performance. These findings highlighted that creativity is facilitated while players become more thinking and game-skilled. Coaches and educators may apply this functional environment to inspire children's disposition to move outside the box and trigger a creative spark in team sports players. Notwithstanding, the sports environment is ideally suited for fostering creative behavior, a higher-order disposition that will go on to differentiate the everyday life of a child.	[Santos, Sara; Sampaio, Jaime; Leite, Nuno] Univ Tras Os Montes & Alto Douro, Res Ctr Sports Sci Hlth Sci & Human Dev, CIDESD, CreativeLab Res Commun, Vila Real, Portugal; [Jimenez, Sergio] Univ Europea Madrid, Fac Ciencias Actividad Fis & Deporte, Madrid, Spain	University of Tras-os-Montes & Alto Douro; European University of Madrid	Santos, S (corresponding author), Univ Tras Os Montes & Alto Douro, Res Ctr Sports Sci Hlth Sci & Human Dev, CIDESD, CreativeLab Res Commun, Vila Real, Portugal.	sarasantos_8@hotmail.com	Leite, Nuno/AAC-7949-2019; Sampaio, Jaime/B-7392-2008; Santos, Sara/N-8806-2018; Jiménez, Sergio L./AAD-2148-2020	Leite, Nuno/0000-0001-5181-6390; Sampaio, Jaime/0000-0003-2335-9991; Santos, Sara/0000-0002-4090-5790; Jiménez, Sergio L./0000-0002-5069-6099	Foundation for Science and Technology (FCT, Portugal); European Social Fund (ESF) [SFRH/BD/91836/2012]; Fundo Europeu de Desenvolvimento Regional (FEDER) [NORTE-01- 0145-FEDER-000026]	Foundation for Science and Technology (FCT, Portugal)(Portuguese Foundation for Science and Technology); European Social Fund (ESF)(European Social Fund (ESF)); Fundo Europeu de Desenvolvimento Regional (FEDER)(European Commission)	This work was supported by the Foundation for Science and Technology (FCT, Portugal) and European Social Fund (ESF), through a Doctoral grant endorsed to the first author (SFRH/BD/91836/2012) under the Human Potential Operating Program (POPH). Project Symbiotic technology for societal efficiency gains: Deus ex Machina (DEM), NORTE-01- 0145-FEDER-000026, co-financed by Fundo Europeu de Desenvolvimento Regional (FEDER) by NORTE 2020. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Foundation for Science and Technology (FCT, Portugal) and European Social Fund (ESF), through a Doctoral grant endorsed to the first author (SFRH/BD/91836/2012) under the Human Potential Operating Program (POPH). Project Symbiotic technology for societal efficiency gains: Deus ex Machina (DEM), NORTE-01-0145-FEDER-000026, co-financed by Fundo Europeu de Desenvolvimento Regional (FEDER) by NORTE 2020.	Alesi M, 2016, PERCEPT MOTOR SKILL, V122, P27, DOI 10.1177/0031512515627527; Alesi M, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01627; Boden M. A., 1996, DIMENSIONS CREATIVIT; Bourbousson J, 2015, EUR J WORK ORGAN PSY, V24, P742, DOI 10.1080/1359432X.2014.1001977; Bowers MT, 2014, CREATIVITY RES J, V26, P314, DOI 10.1080/10400419.2014.929420; Chaouachi A, 2014, J STRENGTH COND RES, V28, P3121, DOI 10.1519/JSC.0000000000000505; Chow J.Y., 2015, NONLINEAR PEDAGOGY S, V1st; Chow JY, 2008, MOTOR CONTROL, V12, P219, DOI 10.1123/mcj.12.3.219; Chow JY, 2013, QUEST, V65, P469, DOI 10.1080/00336297.2013.807746; Colzato LS, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00824; Cote J., 2014, SCI SPORT, V29, pS63, DOI DOI 10.1016/J.SCISPO.2014.08.133; Darren P, 2015, SPORTS MED, P1; Davies D, 2013, THINK SKILLS CREAT, V8, P80, DOI 10.1016/j.tsc.2012.07.004; Davies MJ, 2013, INT J SPORT PHYSIOL, V8, P139, DOI 10.1123/ijspp.8.2.139; Farrow D., 2016, SPORTS MED, V47, P1; Faude O, 2012, J SPORT SCI, V30, P625, DOI 10.1080/02640414.2012.665940; Folgado H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097145; Frank TD, 2008, BIOL CYBERN, V98, P19, DOI 10.1007/s00422-007-0193-x; Furley P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062278; Garaigordobil M, 2006, CREATIVITY RES J, V18, P329, DOI 10.1207/s15326934crj1803_8; Giblin S, 2014, SPORTS MED, V44, P1177, DOI 10.1007/s40279-014-0205-7; Goncalves B., 2016, J STRENGTH COND RES; Griggs G, 2009, EDUC 3-13, V37, P121, DOI 10.1080/03004270802012707; Harbourne RT, 2009, PHYS THER, V89, P284, DOI 10.2522/ptj.20080130.ar; Harvey S, 2014, PHYS EDUC SPORT PEDA, V19, P278, DOI 10.1080/17408989.2012.754005; Henz D, 2016, FRONT BEHAV NEUROSCI, V10, DOI 10.3389/fnbeh.2016.00199; Holmberg PM, 2009, STRENGTH COND J, V31, P73, DOI 10.1519/SSC.0b013e3181b988f1; Hopkins W.G., 2006, SPORTSCIENCE, V10, P46; Hopkins WG, 2009, MED SCI SPORT EXER, V41, P3, DOI 10.1249/MSS.0b013e31818cb278; Hristovski R., 2012, OPEN SPORTS SCI J S, V5, P26, DOI [10.2174/1875399X01205010026, DOI 10.2174/1875399X01205010026]; Hristovski R, 2011, NONLIN DYNAM PSYCHOL, V15, P175; Hunter ST, 2007, CREATIVITY RES J, V19, P69, DOI 10.1080/10400410709336883; Kim KH, 2006, CREATIVITY RES J, V18, P3, DOI 10.1207/s15326934crj1801_2; Kim KH, 2011, CREATIVITY RES J, V23, P285, DOI 10.1080/10400419.2011.627805; Kleinmintz OM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101568; Kreitz C, 2015, PLOS ONE; Lai SK, 2014, SPORTS MED, V44, P67, DOI 10.1007/s40279-013-0099-9; Lee MD, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0096431, 10.1371/journal.pone.0104744]; Liu HY, 2016, J SPORT SCI, V34, P509, DOI 10.1080/02640414.2015.1117121; Lloyd RS, 2011, J STRENGTH COND RES, V25, P1889, DOI 10.1519/JSC.0b013e3181e7faa8; Longmuir PE, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2106-6; Ma HH, 2006, CREATIVITY RES J, V18, P435, DOI 10.1207/s15326934crj1804_3; Markovic G, 2007, BRIT J SPORT MED, V41, P349, DOI 10.1136/bjsm.2007.035113; Memmert D., 2015, TEACHING TACTICAL CR; Memmert D, 2006, HIGH ABIL STUD, V17, P101, DOI 10.1080/13598130600947176; Memmert D, 2011, J SPORT SCI, V29, P93, DOI 10.1080/02640414.2010.528014; Memmert D, 2010, PHYS EDUC SPORT PEDA, V15, P287, DOI 10.1080/17408980903273121; Memmert D, 2010, HIGH ABIL STUD, V21, P3, DOI 10.1080/13598139.2010.488083; Meylan C, 2009, J STRENGTH COND RES, V23, P2605, DOI 10.1519/JSC.0b013e3181b1f330; Moy B, 2016, PHYS EDUC SPORT PEDA, V21, P517, DOI 10.1080/17408989.2015.1072506; O'Donoghue P, 2010, RES METHODS SPORTS P; Runco M. A., 2014, CREATIVITY THEORIES; Runco MA, 2012, CREATIVITY RES J, V24, P92, DOI 10.1080/10400419.2012.650092; Runco MA, 2010, CREATIVITY RES J, V22, P361, DOI 10.1080/10400419.2010.523393; Sampaio J, 2012, INT J SPORTS MED, V33, P395, DOI 10.1055/s-0031-1301320; Santos S, 2017, J SPORT SCI, V35, P1759, DOI 10.1080/02640414.2016.1236206; Santos SDL, 2016, FRONT PSYCHOL, V7, DOI [10.3389/fpsyg.2016.01282, 10.3389/fpsyg.2076.01282]; Sassi RH, 2009, J STRENGTH COND RES, V23, P1644, DOI 10.1519/JSC.0b013e3181b425d2; Schollhorn WI, 2009, HUM MOVEMENT SCI, V28, P319, DOI 10.1016/j.humov.2008.10.005; Schollhorn W, 2012, TOSSJ, V5, P100; Smith W, 2016, SPORT EDUC SOC, V21, P431, DOI 10.1080/13573322.2014.927757; Tan CWK, 2012, PHYS EDUC SPORT PEDA, V17, P331, DOI 10.1080/17408989.2011.582486; Tomporowski PD, 2008, EDUC PSYCHOL REV, V20, P111, DOI 10.1007/s10648-007-9057-0; Yanci J, 2013, J SPORT SCI MED, V12, P601; Young W, 2014, J SPORT SCI, V32, P307, DOI 10.1080/02640414.2013.823230	65	32	34	8	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2017	12	2							e0172520	10.1371/journal.pone.0172520	http://dx.doi.org/10.1371/journal.pone.0172520			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL5SX	28231260	Green Submitted, Green Published, gold			2022-12-27	WOS:000394682400053
J	Wolfe, MK; Gallandat, K; Daniels, K; Desmarais, AM; Scheinman, P; Lantagne, D				Wolfe, Marlene K.; Gallandat, Karin; Daniels, Kyle; Desmarais, Anne Marie; Scheinman, Pamela; Lantagne, Daniele			Handwashing and Ebola virus disease outbreaks: A randomized comparison of soap, hand sanitizer, and 0.05% chlorine solutions on the inactivation and removal of model organisms Phi6 and E-coli from hands and persistence in rinse water	PLOS ONE			English	Article							HEALTH-CARE WORKERS; HYGIENE AGENTS; DRYING METHODS; EFFICACY; DISINFECTION; CONTAMINATION; RISK; TRANSMISSION; MECHANISMS; SURROGATE	To prevent Ebola transmission, frequent handwashing is recommended in Ebola Treatment Units and communities. However, little is known about which handwashing protocol is most efficacious. We evaluated six handwashing protocols (soap and water, alcohol-based hand sanitizer (ABHS), and 0.05% sodium dichloroisocyanurate, high-test hypochlorite, and stabilized and non-stabilized sodium hypochlorite solutions) for 1) efficacy of handwashing on the removal and inactivation of non-pathogenic model organisms and, 2) persistence of organisms in rinse water. Model organisms E. coli and bacteriophage Phi6 were used to evaluate handwashing with and without organic load added to simulate bodily fluids. Hands were inoculated with test organisms, washed, and rinsed using a glove juice method to retrieve remaining organisms. Impact was estimated by comparing the log reduction in organisms after handwashing to the log reduction without handwashing. Rinse water was collected to test for persistence of organisms. Handwashing resulted in a 1.94-3.01 log reduction in E. coli concentration without, and 2.18-3.34 with, soil load; and a 2.44-3.06 log reduction in Phi6 without, and 2.71-3.69 with, soil load. HTH performed most consistently well, with significantly greater log reductions than other handwashing protocols in three models. However, the magnitude of handwashing efficacy differences was small, suggesting protocols are similarly efficacious. Rinse water demonstrated a 0.28-4.77 log reduction in remaining E. coli without, and 0.21-4.49 with, soil load and a 1.26-2.02 log reduction in Phi6 without, and 1.30-2.20 with, soil load. Chlorine resulted in significantly less persistence of E. coli in both conditions and Phi6 without soil load in rinse water (p<0.001). Thus, chlorine-based methods may offer a benefit of reducing persistence in rinse water. We recommend responders use the most practical handwashing method to ensure hand hygiene in Ebola contexts, considering the potential benefit of chlorine-based methods in rinse water persistence.	[Wolfe, Marlene K.; Gallandat, Karin; Daniels, Kyle; Desmarais, Anne Marie; Lantagne, Daniele] Tufts Univ, Dept Civil & Environm Engn, Medford, MA 02155 USA; [Scheinman, Pamela] Brigham & Womens Hosp, Dept Dermatol, 75 Francis St, Boston, MA 02115 USA	Tufts University; Harvard University; Brigham & Women's Hospital	Wolfe, MK (corresponding author), Tufts Univ, Dept Civil & Environm Engn, Medford, MA 02155 USA.	marlene.wolfe@tufts.edu		Gallandat, Karin/0000-0001-6412-1483	United States Agency for International Development; office of Foerign Disaster Assistance [AID-DFDA-A-15-00026]; National Science Foundation [0966093]	United States Agency for International Development(United States Agency for International Development (USAID)); office of Foerign Disaster Assistance; National Science Foundation(National Science Foundation (NSF))	This study was funded by a grant from the United States Agency for International Development, office of Foerign Disaster Assistance (AID-DFDA-A-15-00026). MW was supported by the National Science Foundation (grant 0966093). The funders had no role in data collection and analysis,decision to publish,or preparation of the manuscript. The funders had no input into study design after the grant was awarded.The funders were provided a final version of the manuscript before submission, and had only minor grammatical comments.	ADAMS MARK H., 1959; Allegranzi B, 2009, J HOSP INFECT, V73, P305, DOI 10.1016/j.jhin.2009.04.019; [Anonymous], 2009, E201113 ASTM; [Anonymous], 1998, INF CONTR VIR HAEM T; [Anonymous], 2010, STAND TEST METH DET; [Anonymous], EB EB VIR DIS SIGNS; [Anonymous], EB EB VIR DIS TREAT; ASCULAI SS, 1978, ANTIMICROB AGENTS CH, V13, P686, DOI 10.1128/AAC.13.4.686; Boyce JM, 2002, INFECT CONT HOSP EP, V23, pS3, DOI 10.1086/503164; Casanova LM, 2015, J APPL MICROBIOL, V118, P1210, DOI 10.1111/jam.12777; Casanova LM, 2015, ENVIRON SCI TECH LET, V2, P76, DOI 10.1021/acs.estlett.5b00029; Commissioner O of the. Press Announcements, FDA ISS FIN RUL SAF; Cook BWM, 2015, VIRUSES-BASEL, V7, P1975, DOI 10.3390/v7041975; Curtis V, 2003, LANCET INFECT DIS, V3, P275, DOI 10.1016/S1473-3099(03)00606-6; de Aceituno AF, 2015, J FOOD PROTECT, V78, P2024, DOI 10.4315/0362-028X.JFP-15-102; Dowell SF, 1999, J INFECT DIS, V179, pS87, DOI 10.1086/514284; Edmonds SL, 2013, INFECT CONT HOSP EP, V34, P302, DOI 10.1086/669521; Emmanueal Jorge N Babacar, 2015, ASSESSMENT RECOMMEND; Fauquet CM, 2005, VIRUS TAXONOMY 8 REP; Feldmann H, 2011, LANCET, V377, P849, DOI 10.1016/S0140-6736(10)60667-8; Francesconi P, 2003, EMERG INFECT DIS, V9, P1430, DOI 10.3201/eid0911.030339; Fung ICH, 2006, TROP MED INT HEALTH, V11, P1749, DOI 10.1111/j.1365-3156.2006.01734.x; Gallandat K, SELECTION BIOSAFETY; Gatherer D, 2014, J GEN VIROL, V95, P1619, DOI 10.1099/vir.0.067199-0; Gire SK, 2014, SCIENCE, V345, P1369, DOI 10.1126/science.1259657; Girou E, 2002, BRIT MED J, V325, P362, DOI 10.1136/bmj.325.7360.362; Grayson ML, 2009, CLIN INFECT DIS, V48, P285, DOI 10.1086/595845; Hitomi S, 1998, ZASSHI J JPN ASS INF, V72, P1176; Holton Ronald H, 2009, Tex Dent J, V126, P1175; Hopman J, 2015, ANTIMICROB RESIST IN, V4, P1; Huang CR, 2012, MAYO CLIN PROC, V87, P791, DOI 10.1016/j.mayocp.2012.02.019; Jensen DA, 2015, J FOOD PROTECT, V78, P685, DOI 10.4315/0362-028X.JFP-14-245; Kac G, 2005, J HOSP INFECT, V60, P32, DOI 10.1016/j.jhin.2004.10.014; Kemp GK, 2000, POULTRY SCI, V79, P1857, DOI 10.1093/ps/79.12.1857; Kortepeter MG, 2011, J INFECT DIS, V204, pS810, DOI 10.1093/infdis/jir299; Lages SLS, 2008, J HOSP INFECT, V68, P159, DOI 10.1016/j.jhin.2007.11.018; LARSON E, 1985, INFECT CONT HOSP EP, V6, P14, DOI 10.1017/S0195941700062445; LARSON EL, 1980, J CLIN MICROBIOL, V12, P355, DOI 10.1128/JCM.12.3.355-360.1980; Lee MT, 2016, ENVIRON SCI TECH LET, V3, P210, DOI 10.1021/acs.estlett.6b00105; Liu PB, 2010, APPL ENVIRON MICROB, V76, P394, DOI 10.1128/AEM.01729-09; LOWBURY EJL, 1964, BMJ-BRIT MED J, V2, P230, DOI 10.1136/bmj.2.5403.230; Lowe JJ, 2014, AM J INFECT CONTROL, V42, P1256, DOI 10.1016/j.ajic.2014.10.006; Michaels B., 2002, Food Service Technology, V2, P139, DOI 10.1046/j.1471-5740.2002.00043.x; Miller T, 2013, HEALTHC INFECT, V16, P18; Oughton MT, 2009, INFECT CONT HOSP EP, V30, P939, DOI 10.1086/605322; Paessler S, 2013, ANNU REV PATHOL-MECH, V8, P411, DOI 10.1146/annurev-pathol-020712-164041; PATTYN S, 1977, LANCET, V1, P573; Pittet D, 2001, LANCET, P9; Rabie T, 2006, TROP MED INT HEALTH, V11, P258, DOI 10.1111/j.1365-3156.2006.01568.x; Rossi P, 1994, ADV BIOLOGICAL TRACE; Rotter ML, 1997, HYG MED, V22, P332, DOI DOI 10.1136/BMJ.319.7208.518; Salmon S, 2014, AM J INFECT CONTROL, V42, P178, DOI 10.1016/j.ajic.2013.07.013; Savolainen-Kopra C, 2012, J MED VIROL, V84, P543, DOI 10.1002/jmv.23222; SCHURMANN W, 1983, ANTIVIR RES, V3, P25, DOI 10.1016/0166-3542(83)90012-8; Sickbert-Bennett EE, 2005, AM J INFECT CONTROL, V33, P67, DOI 10.1016/j.ajic.2004.08.005; Sigstam T, 2013, APPL ENVIRON MICROB, V79, P3455, DOI 10.1128/AEM.00663-13; Steinmann J, 2012, J HOSP INFECT, V82, P277, DOI 10.1016/j.jhin.2012.08.005; STEINMANN J, 1995, ZBL HYG UMWELTMED, V196, P425; Sterk E, 2008, MED SANS FIL HAEM FE; Tuladhar E, 2015, J HOSP INFECT, V90, P226, DOI 10.1016/j.jhin.2015.02.019; Tuladhar E, 2012, APPL ENVIRON MICROB, V78, P7769, DOI 10.1128/AEM.02144-12; VENKOBACHAR C, 1977, WATER RES, V11, P727, DOI 10.1016/0043-1354(77)90114-2; Vollenbroich D, 1997, BIOLOGICALS, V25, P289, DOI 10.1006/biol.1997.0099; Weber DJ, 2003, JAMA-J AM MED ASSOC, V289, P1274, DOI 10.1001/jama.289.10.1274; Wells E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152442; WHO, 2015, EB SIT REP; WHO, 2009, GUID HAND HYG HLTH C; WHO, 2009, RECOMMENDED HANDRUB; Wigginton KR, 2012, ENVIRON SCI TECHNOL, V46, P12069, DOI 10.1021/es3029473; Wigginton KR, 2012, CURR OPIN VIROL, V2, P84, DOI 10.1016/j.coviro.2011.11.003; Wolf T, 2015, LANCET, V385, P1428, DOI 10.1016/S0140-6736(14)62384-9; Wolfe MK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167378; WOOLWINE JD, 1995, ANTIMICROB AGENTS CH, V39, P921, DOI 10.1128/AAC.39.4.921; World Health Organisation, 2016, EB SIT REP 30 MARCH; World Health Organization, 2014, PERS PROT EQ CONT FI; Ye YY, 2016, ENVIRON SCI TECHNOL, V50, P5077, DOI 10.1021/acs.est.6b00876	76	29	32	1	98	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2017	12	2							e0172734	10.1371/journal.pone.0172734	http://dx.doi.org/10.1371/journal.pone.0172734			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5SX	28231311	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000394682400078
J	Zhang, Q; Chen, XG; Liu, ZT; Varma, DS; Wan, R; Zhao, SW				Zhang, Qiang; Chen, Xinguang; Liu, Zhitao; Varma, Deepthi S.; Wan, Rong; Zhao, Shiwen			Diet diversity and nutritional status among adults in southwest China	PLOS ONE			English	Article							SECULAR TRENDS; OBESITY; PREVALENCE; METAANALYSIS; TRANSITION; ADIPOSITY; QUALITY; SCORE	Background With rapid urbanization in the past decades, diet diversity continues to increase in China. The present cross-sectional study aims to explore the association between dietary diversity and nutritional status among adults in southwest China. Methods This study used data from 2011-2012 National Nutritional Survey in Yunnan Province, southwest China (N = 1105). Data of three consecutive 24-hour dietary recalls were used to calculate dietary diversity scores (DDS) and nutrient adequacy ratio (NAR). Body mass index and waist circumference were used to determine nutritional status. Surveylogistic procedure of SAS 9.2 software was used to examine the association between DDS and obesity by estimating odds ratio (OR) and 95% confidence intervals (CI). Results The mean DDS was 5.2 (SD 1.1) out of nine points. Being female, younger age, belonging to Han ethnicity, having higher educational level and household income were positively associated with DDS (all P<0.05). As DDS increased, consumption also increased in most food groups except grains and vegetables. People with medium and high DDS (DDS = 5 and DDS >= 6, respectively) ingested more energy than the recommended quantity(NAR = 1.1 and 1.2, respectively). However, the intakes of Calcium and Vitamin A were seriously inadequate even for people with high DDS (NAR <= 0.5). With potential confounders adjusted, people with medium and high DDS were at higher risk of general and central obesity than people with DDS <= 4 (OR = 1.4-1.9, P<0.01). Conclusions Our data indicated that high DDS was associated with excessive energy intake and obesity among adults in southwest China. Although dietary diversity is widely recommended, public health messages should give less emphasis on dietary diversity.	[Zhang, Qiang; Liu, Zhitao; Wan, Rong; Zhao, Shiwen] Yunnan Ctr Dis Control & Prevent, Dept Nutr & Food Hyg, Kunming, Peoples R China; [Zhang, Qiang; Chen, Xinguang; Varma, Deepthi S.] Univ Florida, Dept Epidemiol, Gainesville, FL USA	State University System of Florida; University of Florida	Zhao, SW (corresponding author), Yunnan Ctr Dis Control & Prevent, Dept Nutr & Food Hyg, Kunming, Peoples R China.	zhangqiang_cs@aliyun.com		Varma, Deepthi/0000-0003-1163-0377	Health and Family Planning Commission of Yunnan Province, China [2016NS146]	Health and Family Planning Commission of Yunnan Province, China	The study was in part funded by research grants from Health and Family Planning Commission of Yunnan Province, China (2016NS146). This work was supported by infrastructure and staff of the department of epidemiology, University of Florida, the U.S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors are grateful to the participants for their enthusiastic cooperation, and also to the interviewers from local centers for disease control and prevention for their excellent work. The study was in part funded by research grants from Health and Family Planning Commission of Yunnan Province, China (2016NS146). This work was supported by infrastructure and staff of the department of epidemiology, University of Florida, the U.S.	Ainsworth BE, 2011, MED SCI SPORT EXER, V43, P1575, DOI 10.1249/MSS.0b013e31821ece12; Azadbakht L, 2011, PUBLIC HEALTH NUTR, V14, P62, DOI 10.1017/S1368980010000522; Bezerra IN, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-22; Du P, 2015, ANN EPIDEMIOL, V25, P797, DOI 10.1016/j.annepidem.2015.06.082; Du SF, 2002, PUBLIC HEALTH NUTR, V5, P169, DOI 10.1079/PHN2001290; FerroLuzzi A, 1995, WHO TECH REP SER, V854, P1; Gao Y, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-919; Henjum S, 2015, PUBLIC HEALTH NUTR, V18, P3201, DOI 10.1017/S1368980015000671; Hu FB, 2002, CURR OPIN LIPIDOL, V13, P3, DOI 10.1097/00041433-200202000-00002; Jayawardena R, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-314; Kabahenda MK, 2014, J HUM NUTR DIET, V27, P143, DOI 10.1111/jhn.12056; Kim Joonseok, 2013, Case Rep Med, V2013, P131395, DOI 10.1155/2013/131395; Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508; Korkalo L, 2016, EUR J NUTR; Kourlaba G, 2009, MATURITAS, V62, P1, DOI 10.1016/j.maturitas.2008.11.021; Li Bai-hui, 2009, Zhonghua Liu Xing Bing Xue Za Zhi, V30, P915; Li Xiao-yan, 2012, Zhonghua Yu Fang Yi Xue Za Zhi, V46, P683; Martin-Prevel Y, 2012, J NUTR, V142, P1748, DOI 10.3945/jn.112.159996; Mayega RW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047632; Mi YJ, 2015, AM J PREV MED, V49, P661, DOI 10.1016/j.amepre.2015.05.005; Mirmiran P, 2006, J AM COLL NUTR, V25, P354, DOI 10.1080/07315724.2006.10719546; Narmaki E, 2015, NUTRITION, V31, P722, DOI 10.1016/j.nut.2014.12.012; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Oldewage-Theron W, 2011, NUTRITION, V27, P420, DOI 10.1016/j.nut.2010.05.013; Popkin BM, 2012, NUTR REV, V70, P3, DOI 10.1111/j.1753-4887.2011.00456.x; Popkin BM, 2004, INT J OBESITY, V28, pS2, DOI [10.1038/sj.ijo.0802804, 10.1038/sj.ijo.0802557]; Salehi-Abargouei A, 2016, EUR J CLIN NUTR, V70, P1, DOI 10.1038/ejcn.2015.118; Vadiveloo M, 2015, J NUTR, V145, P555, DOI 10.3945/jn.114.199067; Vandevijvere S, 2010, PUBLIC HEALTH NUTR, V13, P1965, DOI 10.1017/S1368980010001606; Wang W, 2001, Zhonghua Liu Xing Bing Xue Za Zhi, V22, P129; World Health Organization, 1983, GUID COND TOB SMOK S; Xu X, 2014, BLOOD TRANSFUS, P1; Xu XY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121618; Yang Y, 2005, CHINESE FOOD COMPOSI; Zhang B, 2011, CHN J PRE MED, V45, P5; Zhang JG, 2015, BRIT J NUTR, V113, P1978, DOI 10.1017/S0007114515001154; Zhou BF, 2002, BIOMED ENVIRON SCI, V15, P245	37	41	42	6	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2017	12	2							e0172406	10.1371/journal.pone.0172406	http://dx.doi.org/10.1371/journal.pone.0172406			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5SX	28231308	Green Submitted, Green Published, gold			2022-12-27	WOS:000394682400040
J	Zhu, HY; Zhang, L; Wang, YL; Hamal, P; You, XF; Mao, HX; Li, F; Sun, XW				Zhu, Huiyuan; Zhang, Lian; Wang, Yali; Hamal, Preeti; You, Xiaofang; Mao, Haixia; Li, Fei; Sun, Xiwen			Improved image quality and diagnostic potential using ultra-high-resolution computed tomography of the lung with small scan FOV: A prospective study	PLOS ONE			English	Article							PULMONARY NODULES; CT; RECONSTRUCTION; VARIABILITY; PARAMETERS; CANCER	The aim of this study was to assess whether CT imaging using an ultra-high-resolution CT (UHRCT) scan with a small scan field of view (FOV) provides higher image quality and helps to reduce the follow-up period compared with a conventional high-resolution CT (CHRCT) scan. We identified patients with at least one pulmonary nodule at our hospital from July 2015 to November 2015. CHRCT and UHRCT scans were conducted in all enrolled patients. Three experienced radiologists evaluated the image quality using a 5-point score and made diagnoses. The paired images were displayed side by side in a random manner and annotations of scan information were removed. The following parameters including image quality, diagnostic confidence of radiologists, follow-up recommendations and diagnostic accuracy were assessed. A total of 52 patients (62 nodules) were included in this study. UHRCT scan provides a better image quality regarding the margin of nodules and solid internal component compared to that of CHRCT (P < 0.05). Readers have higher diagnostic confidence based on the UHRCT images than of CHRCT images (P< 0.05). The follow-up recommendations were significantly different between UHRCT and CHRCT images (P< 0.05). Compared with the surgical pathological findings, UHRCT had a relative higher diagnostic accuracy than CHRCT (P > 0.05). These findings suggest that the UHRCT prototype scanner provides a better image quality of subsolid nodules compared to CHRCT and contributes significantly to reduce the patients' follow-up period.	[Zhu, Huiyuan; Zhang, Lian; Wang, Yali; Hamal, Preeti; You, Xiaofang; Mao, Haixia; Sun, Xiwen] Tongji Univ, Pulm Hosp, Dept Radiol, Shanghai, Peoples R China; [Zhang, Lian; Li, Fei] Jiading Hosp Tradit Chinese Med, Dept Radiol, Shanghai, Peoples R China	Tongji University	Sun, XW (corresponding author), Tongji Univ, Pulm Hosp, Dept Radiol, Shanghai, Peoples R China.	sunxiwen88@126.com			project of capacity construction of assisting departments of clinic in Shanghai municipal hospital - Shanghai Hospital Development Center [SHDC22015037]	project of capacity construction of assisting departments of clinic in Shanghai municipal hospital - Shanghai Hospital Development Center	This research was supported by project of capacity construction of assisting departments of clinic in Shanghai municipal hospital (Grant: SHDC22015037) sponsored by Shanghai Hospital Development Center (http://www.shdc.org.cn). Author XWS received the funding. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armato SG, 2007, ACAD RADIOL, V14, P1409, DOI 10.1016/j.acra.2007.07.008; Austin J.H., 2013, RADIOLOGY, V266, P62, DOI DOI 10.1148/RADI0L.12120240; Geyer LL, 2016, BRIT J RADIOL, V89, DOI 10.1259/bjr.20160003; Gierada DS, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju284; Goo JM, 2005, RADIOLOGY, V235, P850, DOI 10.1148/radiol.2353040737; Henschke CI, 2002, AM J ROENTGENOL, V178, P1053, DOI 10.2214/ajr.178.5.1781053; Kakinuma R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137165; Lee HJ, 2009, EUR RADIOL, V19, P552, DOI 10.1007/s00330-008-1188-2; Naidich DP, 2013, RADIOLOGY, V266, P304, DOI 10.1148/radiol.12120628; Nakata M, 2002, CHEST, V121, P1464, DOI 10.1378/chest.121.5.1464; Ridge CA, 2016, RADIOLOGY, V278, P888, DOI 10.1148/radiol.2015150714; Sheshadri A, 2015, J COMPUT ASSIST TOMO, V39, P584, DOI 10.1097/RCT.0000000000000238; van Riel SJ, 2015, RADIOLOGY, V277, P863, DOI 10.1148/radiol.2015142700; Wang JC, 2000, BRIT J RADIOL, V73, P930, DOI 10.1259/bjr.73.873.11064644; Wood DE, 2015, J NATL COMPR CANC NE, V13, P23, DOI 10.6004/jnccn.2015.0006; Yanagawa M, 2010, RADIOLOGY, V255, P944, DOI 10.1148/radiol.10091010; Yasaka K, 2016, EUR J RADIOL, V85, P599, DOI 10.1016/j.ejrad.2016.01.001; ZERHOUNI EA, 1982, J COMPUT ASSIST TOMO, V6, P1075, DOI 10.1097/00004728-198212000-00005; Zhang LJ, 2012, RADIOLOGY, V263, P279, DOI 10.1148/radiol.11101372	19	12	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2017	12	2							e0172688	10.1371/journal.pone.0172688	http://dx.doi.org/10.1371/journal.pone.0172688			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5SX	28231320	Green Submitted, gold, Green Published			2022-12-27	WOS:000394682400073
J	Furuta, Y; Tsai, SH; Kinoshita, M; Fujimoto, K; Okumura, R; Umemoto, E; Kurashima, Y; Kiyono, H; Kayama, H; Takeda, K				Furuta, Yoki; Tsai, Shih-Han; Kinoshita, Makoto; Fujimoto, Kosuke; Okumura, Ryu; Umemoto, Eiji; Kurashima, Yosuke; Kiyono, Hiroshi; Kayama, Hisako; Takeda, Kiyoshi			E-NPP3 controls plasmacytoid dendritic cell numbers in the small intestine	PLOS ONE			English	Article							EXTRACELLULAR ATP TRIGGERS; REGULATORY T-CELLS; PURINERGIC RECEPTORS; P2X7 PURINOCEPTORS; IMMUNE SUPPRESSION; HUMAN MACROPHAGES; VIRUS-INFECTION; MESANGIAL CELLS; APOPTOSIS; RELEASE	Extracellular adenosine 5'-triphosphate (ATP) performs multiple functions including activation and induction of apoptosis of many cell types. The ATP-hydrolyzing ectoenzyme ectonucleotide pyrophosphatase/phosphodiesterase 3 (E-NPP3) regulates ATP-dependent chronic allergic responses by mast cells and basophils. However, E-NPP3 is also highly expressed on epithelial cells of the small intestine. In this study, we showed that E-NPP3 controls plasmacytoid dendritic cell (pDC) numbers in the intestine through regulation of intestinal extracellular ATP. In Enpp3(-/-) mice, ATP concentrations were increased in the intestinal lumen. pDC numbers were remarkably decreased in the small intestinal lamina propria and Peyer's patches. Intestinal pDCs of Enpp3(-/-) mice showed enhanced cell death as characterized by increases in annexin V binding and expression of cleaved caspase-3. pDCs were highly sensitive to ATP-induced cell death compared with conventional DCs. ATP-induced cell death was abrogated in P2rx7(-/-) pDCs. Accordingly, the number of intestinal pDCs was restored in Enpp3(-/-) P2rx7(-/-) mice. These findings demonstrate that E-NPP3 regulates ATP concentration and thereby prevents the decrease of pDCs in the small intestine.	[Furuta, Yoki; Tsai, Shih-Han; Kinoshita, Makoto; Fujimoto, Kosuke; Okumura, Ryu; Umemoto, Eiji; Kayama, Hisako; Takeda, Kiyoshi] Osaka Univ, Lab Immune Regulat, Dept Microbiol & Immunol, Grad Sch Med,WPI Immunol Frontier Res Ctr, Suita, Osaka, Japan; [Furuta, Yoki; Tsai, Shih-Han; Kinoshita, Makoto; Fujimoto, Kosuke; Okumura, Ryu; Umemoto, Eiji; Kurashima, Yosuke; Kiyono, Hiroshi; Kayama, Hisako; Takeda, Kiyoshi] Japan Agcy Med Res & Dev, Core Res Evolut Sci & Technol, Tokyo, Japan; [Furuta, Yoki] Kumamoto Univ, Grad Sch Med Sci, Dept Gastroenterol & Hepatol, Kumamoto, Japan; [Kurashima, Yosuke; Kiyono, Hiroshi] Univ Tokyo, Inst Med Sci, Div Mucosal Immunol, Dept Microbiol & Immunol, Tokyo, Japan	Osaka University; Japan Science & Technology Agency (JST); Kumamoto University; University of Tokyo	Takeda, K (corresponding author), Osaka Univ, Lab Immune Regulat, Dept Microbiol & Immunol, Grad Sch Med,WPI Immunol Frontier Res Ctr, Suita, Osaka, Japan.; Takeda, K (corresponding author), Japan Agcy Med Res & Dev, Core Res Evolut Sci & Technol, Tokyo, Japan.	ktakeda@ongene.med.osaka-u.ac.jp	Kiyono, Hiroshi/AAC-6735-2022; Umemoto, Eiji/AAX-6562-2021	Takeda, Kiyoshi/0000-0002-1778-6332	Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Science and Technology Agency [T15K15152, A15H02511]; Japan Agency for Medical Research and Development [15gm011002h0006]; Mochida Memorial Foundation for Medical and Pharmaceutical	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); Mochida Memorial Foundation for Medical and Pharmaceutical	Support was provided by: the Ministry of Education, Culture, Sports, Science and Technology of Japan, Japan Science and Technology Agency (Recipient: Kiyoshi Takeda, T15K15152, A15H02511); Japan Agency for Medical Research and Development (Recipient: Kiyoshi Takeda, 15gm011002h0006); and Mochida Memorial Foundation for Medical and Pharmaceutical (Recipient: Shih-Han Tsai).	Asselin-Paturel C, 2001, NAT IMMUNOL, V2, P1144, DOI 10.1038/ni736; Atarashi K, 2008, NATURE, V455, P808, DOI 10.1038/nature07240; Borsellino G, 2007, BLOOD, V110, P1225, DOI 10.1182/blood-2006-12-064527; Bulanova E, 2010, PURINERG SIGNAL, V6, P3, DOI 10.1007/s11302-009-9173-z; Chang CW, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-80; Chen Y, 2006, SCIENCE, V314, P1792, DOI 10.1126/science.1132559; Colonna M, 2004, NAT IMMUNOL, V5, P1219, DOI 10.1038/ni1141; Contractor N, 2007, J IMMUNOL, V179, P2690, DOI 10.4049/jimmunol.179.5.2690; Coutinho-Silva R, 1999, AM J PHYSIOL-CELL PH, V276, pC1139, DOI 10.1152/ajpcell.1999.276.5.C1139; Deaglio S, 2007, J EXP MED, V204, P1257, DOI 10.1084/jem.20062512; Di Virgilio Francesco, 2005, Purinergic Signal, V1, P205, DOI 10.1007/s11302-005-6312-z; Duan XZ, 2004, J CLIN IMMUNOL, V24, P637, DOI 10.1007/s10875-004-6249-y; Elliott MR, 2009, NATURE, V461, P282, DOI 10.1038/nature08296; Ferrari D, 1997, J IMMUNOL, V159, P1451; Ferrari D, 2000, FASEB J, V14, P2466, DOI 10.1096/fj.00-0031com; Friedman DJ, 2009, P NATL ACAD SCI USA, V106, P16788, DOI 10.1073/pnas.0902869106; Goding JW, 2003, BBA-MOL BASIS DIS, V1638, P1, DOI 10.1016/S0925-4439(03)00058-9; Goubier A, 2008, IMMUNITY, V29, P464, DOI 10.1016/j.immuni.2008.06.017; Graziano F, 2015, P NATL ACAD SCI USA, V112, pE3265, DOI 10.1073/pnas.1500656112; Hadeiba H, 2008, NAT IMMUNOL, V9, P1253, DOI 10.1038/ni.1658; Hood BL, 2015, BIOL REPROD, V92, DOI 10.1095/biolreprod.114.127217; Hui EKW, 2001, VIROLOGY, V290, P329, DOI 10.1006/viro.2001.1181; Idzko M, 2007, NAT MED, V13, P913, DOI 10.1038/nm1617; Jun DJ, 2007, J BIOL CHEM, V282, P37350, DOI 10.1074/jbc.M707915200; Kanto T, 2004, J INFECT DIS, V190, P1919, DOI 10.1086/425425; Kurashima Y, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2023; Kusu T, 2013, J IMMUNOL, V190, P774, DOI 10.4049/jimmunol.1103067; Lee LN, 2009, J IMMUNOL, V182, P7178, DOI 10.4049/jimmunol.0802526; Lepine S, 2006, BBA-MOL CELL BIOL L, V1761, P73, DOI 10.1016/j.bbalip.2005.10.001; Liu YJ, 2005, ANNU REV IMMUNOL, V23, P275, DOI 10.1146/annurev.immunol.23.021704.115633; Luo J, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.343; Mizuno S, 2012, IMMUNOL LETT, V146, P64, DOI 10.1016/j.imlet.2012.05.001; PADEH S, 1991, J IMMUNOL, V146, P1626; Placido R, 2006, CELL IMMUNOL, V244, P10, DOI 10.1016/j.cellimm.2007.02.001; Proietti M, 2014, IMMUNITY, V41, P789, DOI 10.1016/j.immuni.2014.10.010; Reigada D, 2005, AM J PHYSIOL-CELL PH, V289, pC617, DOI 10.1152/ajpcell.00542.2004; Robson Simon C, 2006, Purinergic Signal, V2, P409, DOI 10.1007/s11302-006-9003-5; Schena F, 2013, CELL REP, V3, P1824, DOI 10.1016/j.celrep.2013.05.022; Schenk U, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001270; Schenk U, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1160583; Schetinger MRC, 2007, BIOFACTORS, V31, P77, DOI 10.1002/biof.5520310205; Schulze-Lohoff E, 1998, AM J PHYSIOL-RENAL, V275, pF962, DOI 10.1152/ajprenal.1998.275.6.F962; Seror C, 2011, J EXP MED, V208, P1823, DOI 10.1084/jem.20101805; Solini A, 2007, AM J PHYSIOL-RENAL, V292, pF1537, DOI 10.1152/ajprenal.00440.2006; Stefan C, 2005, TRENDS BIOCHEM SCI, V30, P542, DOI 10.1016/j.tibs.2005.08.005; Stefan Cristiana, 2006, Purinergic Signal, V2, P361, DOI 10.1007/s11302-005-5303-4; Swiecki M, 2011, J EXP MED, V208, P2367, DOI 10.1084/jem.20110654; Takenaka MC, 2016, TRENDS IMMUNOL; Tezuka H, 2011, IMMUNITY, V34, P247, DOI 10.1016/j.immuni.2011.02.002; Trautmann A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.256pe6; Tsai SH, 2016, SEMIN IMMUNOPATHOL; Tsai SH, 2015, IMMUNITY, V42, P279, DOI 10.1016/j.immuni.2015.01.015; Wen LT, 2003, BRIT J PHARMACOL, V140, P1009, DOI 10.1038/sj.bjp.0705523; Wendland M, 2007, P NATL ACAD SCI USA, V104, P6347, DOI 10.1073/pnas.0609180104; Wilkin F, 2001, J IMMUNOL, V166, P7172, DOI 10.4049/jimmunol.166.12.7172; Yegutkin GG, 2008, BBA-MOL CELL RES, V1783, P673, DOI 10.1016/j.bbamcr.2008.01.024; ZHENG LM, 1991, J CELL BIOL, V112, P279, DOI 10.1083/jcb.112.2.279	57	11	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2017	12	2							e0172509	10.1371/journal.pone.0172509	http://dx.doi.org/10.1371/journal.pone.0172509			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5SK	28225814	gold, Green Published, Green Submitted			2022-12-27	WOS:000394680900048
J	Hassan, MS; Awasthi, N; Li, J; Schwarz, MA; Schwarz, RE; von Holzen, U				Hassan, Md Sazzad; Awasthi, Niranjan; Li, Jun; Schwarz, Margaret A.; Schwarz, Roderich E.; von Holzen, Urs			A novel intraperitoneal metastatic xenograft mouse model for survival outcome assessment of esophageal adenocarcinoma	PLOS ONE			English	Article							IN-VITRO; PRECLINICAL MODELS; TUMOR-GROWTH; CELL-DEATH; PHASE-II; CARBOPLATIN; PACLITAXEL; CANCER; EPIDEMIOLOGY; COMBINATION	Esophageal adenocarcinoma (EAC) has become the dominant type of esophageal cancer in United States. The 5-year survival rate of EAC is below 20% and most patients present with locally advanced or widespread metastatic disease, where current treatment is largely ineffective. Therefore, new therapeutic approaches are urgently needed. Improvement of EAC patient outcome requires well-characterized animal models in which to evaluate novel therapeutics. In this study we aimed to establish a peritoneal dissemination xenograft mouse model of EAC that would support survival outcome analyses. To find the best candidate cell line from 7 human EAC cell lines of different origin named ESO26, OE33, ESO51, SK-GT-2, OE19, OACM5.1C and Flo-1 were injected intraperitoneally/subcutaneously into SCID mice. The peritoneal/xenograft tumor formation and mouse survival were compared among different groups. All cell lines injected subcutaneously formed tumors within 3 months at variable rates. All cell lines except OACM5.1C formed intraperitoneal tumors within 3 months at variable rates. Median animal survival with peritoneal dissemination was 108 days for ESO26 cells (5X10(6)), 65 days for OE33 cells (5X10(6)), 88 days for ESO51 cells (5X10(6)), 76 days for SK-GT-2 cells (5X10(6)), 55 days for OE19 cells (5X10(6)), 45 days for OE19 cells (10X10(6)) and 82 days for Flo-1 cells (5X10(6)). Interestingly, only in the OE19 model all mice (7/7 for 5X10(6) and 5/5 for10X10(6)) developed bloody ascites with liver metastasis after intraperitoneal injection. The median survival time of these animals was the shortest (45 days for 10X10(6) cells). In addition, median survival was significantly increased after paclitaxel treatment compared with the control group (57 days versus 45 days, p = 0.0034) along with a significant decrease of the relative subcutaneous tumor volume (p = 0.00011). Thus peritoneal dissemination mouse xenograft model for survival outcome assessment after intraperitoneal injection of OE19 cells will be very useful for the evaluation of cancer therapeutics.	[Hassan, Md Sazzad; Awasthi, Niranjan; Schwarz, Margaret A.; Schwarz, Roderich E.; von Holzen, Urs] Indiana Univ Sch Med, Dept Surg, South Bend, IN 46617 USA; [Hassan, Md Sazzad; Awasthi, Niranjan; Schwarz, Margaret A.; Schwarz, Roderich E.; von Holzen, Urs] Harper Canc Res Inst, South Bend, IN 46617 USA; [Li, Jun] Univ Notre Dame, Dept Appl & Computat Math & Stat, Notre Dame, IN 46556 USA; [Schwarz, Margaret A.] Indiana Univ Sch Med, Dept Pediat, South Bend, IN USA; [Schwarz, Roderich E.; von Holzen, Urs] Goshen Ctr Canc Care, Goshen, IN USA; [von Holzen, Urs] Univ Basel, Basel, Switzerland	Indiana University System; Indiana University South Bend; University of Notre Dame; Indiana University System; Indiana University South Bend; University of Basel	Hassan, MS (corresponding author), Indiana Univ Sch Med, Dept Surg, South Bend, IN 46617 USA.; Hassan, MS (corresponding author), Harper Canc Res Inst, South Bend, IN 46617 USA.	hassansa@iu.edu	Li, Jun/C-3269-2015	Li, Jun/0000-0003-4353-5761; von Holzen, Urs/0000-0003-3746-6237	Indiana University internal funding	Indiana University internal funding	This work was supported by the Indiana University internal funding.	Awasthi N, 2016, ONCOTARGET; Awasthi N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038477; Awasthi N, 2012, J CELL BIOCHEM, V113, P784, DOI 10.1002/jcb.23405; Awasthi N, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-15; Bollschweiler E, 2015, CHINESE J CANCER RES, V27, P221, DOI 10.3978/j.issn.1000-9604.2015.04.04; Chai JY, 2012, WORLD J GASTROENTERO, V18, P6521, DOI 10.3748/wjg.v18.i45.6521; Cools-Lartigue J, 2015, J GASTROINTEST SURG, V19, P964, DOI 10.1007/s11605-014-2701-3; Dodbiba L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121872; Arnal MJD, 2015, WORLD J GASTROENTERO, V21, P7933, DOI 10.3748/wjg.v21.i26.7933; Drenckhan A, 2013, J SURG RES, V182, P250, DOI 10.1016/j.jss.2012.09.035; El-Rayes BF, 2004, ANN ONCOL, V15, P960, DOI 10.1093/annonc/mdh230; Enzinger PC, 2003, NEW ENGL J MED, V349, P2241, DOI 10.1056/NEJMra035010; Ford SJ, 2013, BRIT J PHARMACOL, V168, P1316, DOI 10.1111/bph.12045; Fujihara S, 2015, INT J ONCOL, V46, P2172, DOI 10.3892/ijo.2015.2903; Gros SJ, 2010, MOL CANCER THER, V9, P2037, DOI 10.1158/1535-7163.MCT-10-0209; Harada K, 2014, INT J ONCOL, V45, P2439, DOI 10.3892/ijo.2014.2655; Hasina Rifat, 2013, J Carcinog, V12, P20, DOI 10.4103/1477-3163.120632; Hastie T, 2001, ELEMENTS STAT LEARNI, V1.8, P371; He TY, 2016, SCI REP-UK, V6, DOI 10.1038/srep21483; Kambhampati S, 2013, MOL CANCER THER, V12, P255, DOI 10.1158/1535-7163.MCT-12-0777; Karginova O, 2015, MOL CANCER THER, V14, P920, DOI 10.1158/1535-7163.MCT-14-0474; Kerbel RS, 2003, CANCER BIOL THER, V2, pS134; Kresty LA, 2015, ONCOTARGET, V6, P33438, DOI 10.18632/oncotarget.5586; Lin H, 2002, MODELING SURVIVAL DA, V44, P85; Liu DSH, 2015, GUT, V64, P1506, DOI 10.1136/gutjnl-2015-309770; Mawhinney Mark R, 2012, Cancer Manag Res, V4, P367, DOI 10.2147/CMAR.S27593; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Prithviraj GK, 2015, DIS ESOPHAGUS, V28, P782, DOI 10.1111/dote.12279; Rashid OM, 2013, J THORAC DIS, V5, P385, DOI 10.3978/j.issn.2072-1439.2013.06.17; RCore Team, 2020, R LANG ENV STAT COMP; Rubenstein JH, 2015, GASTROENTEROLOGY, V149, P302, DOI 10.1053/j.gastro.2015.04.053; Rustgi AK, 2014, NEW ENGL J MED, V371, P2499, DOI 10.1056/NEJMra1314530; Sehdev V, 2012, MOL CANCER THER, V11, P763, DOI 10.1158/1535-7163.MCT-11-0623; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Tetreault MP, 2015, CANCER GROWTH METAST, P37, DOI 10.4137/CGM.S21218; Therneau T., 2015, PACKAGE SURVIVAL ANA; Wang H, 2007, J THORAC ONCOL, V2, P153, DOI 10.1097/JTO.0b013e31802bff75; Zamai M, 2003, MOL CANCER THER, V2, P29; Zhang CH, 2013, J SURG RES, V182, P227, DOI 10.1016/j.jss.2012.10.052; Zhang YW, 2013, WORLD J GASTROENTERO, V19, P5598, DOI 10.3748/wjg.v19.i34.5598; Zhao RH, 2012, J THORAC CARDIOV SUR, V144, P1192, DOI 10.1016/j.jtcvs.2012.08.008	41	6	6	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2017	12	2							e0171824	10.1371/journal.pone.0171824	http://dx.doi.org/10.1371/journal.pone.0171824			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5SK	28225784	Green Published, gold, Green Submitted			2022-12-27	WOS:000394680900022
J	Kilada, R; Reiss, CS; Kawaguchi, S; King, RA; Matsuda, T; Ichii, T				Kilada, Raouf; Reiss, Christian S.; Kawaguchi, So; King, Robert A.; Matsuda, Tsuyoshi; Ichii, Taro			Validation of band counts in eyestalks for the determination of age of Antarctic krill, Euphausia superba	PLOS ONE			English	Article							SCOTIA SEA; HOMARUS-AMERICANUS; PENINSULA REGION; CLIMATE-CHANGE; GASTRIC MILL; GROWTH; SHRINKAGE; RECRUITMENT; LIPOFUSCIN; BIOMASS	Using known-age Antarctic krill (Euphausia superba) grown from eggs hatched at two different laboratories, we validate the annual pattern of bands deposited in the eyestalks of krill and determine the absolute age of these animals. Ages two through five years were validated, and these animals ranged from 37.1 to 62.6 mm in total length. The band counts in these individuals were either identical to their absolute ages, or only failed to agree by a few months, which demonstrates the accuracy of this method. Precision and bias were estimated graphically using Chang's index (Coefficient of Variation = 5.03%). High accuracy and precision between readers and low ageing bias indicate that longitudinal sections of eyestalks can be used to age krill in wild samples and to develop age-based stock assessment models for krill. Archival samples preserved in formalin (5%) and stored in ambient conditions were also readable. Ageing preserved krill will provide the opportunity to examine changes in growth among krill populations within the Southern Ocean and to retrospectively examine changes in krill production over the last century to better understand the historical and future impacts of climate change on this critical Southern Ocean species.	[Kilada, Raouf] Univ New Brunswick, St John, NB, Canada; [Kilada, Raouf] Suez Canal Univ, Dept Marine Sci, Ismailia, Egypt; [Reiss, Christian S.] NOAA Fisheries, Antarctic Ecosyst Res Div, La Jolla, CA 92037 USA; [Kawaguchi, So; King, Robert A.] Australian Antarctic Div, Kingston, Tas, Australia; [Kawaguchi, So] Antarctic Climate & Ecosyst Cooperat Res Ctr, Hobart, Tas, Australia; [Matsuda, Tsuyoshi] Port Nagoya Publ Aquarium, Nagoya, Aichi, Japan; [Ichii, Taro] Natl Res Inst Far Seas Fisheries, Yokohama, Kanagawa, Japan	University of New Brunswick; Egyptian Knowledge Bank (EKB); Suez Canal University; National Oceanic Atmospheric Admin (NOAA) - USA; Australian Antarctic Division; Antarctic Climate & Ecosystems Cooperative Research Centre (ACE CRC); Japan Fisheries Research & Education Agency (FRA)	Reiss, CS (corresponding author), NOAA Fisheries, Antarctic Ecosyst Res Div, La Jolla, CA 92037 USA.	Christian.reiss@noaa.gov		Kawaguchi, So/0000-0002-2042-5095; King, Robert/0000-0002-4650-2335	National Oceanic and Atmospheric Administration; Antarctic Wildlife Research Fund	National Oceanic and Atmospheric Administration(National Oceanic Atmospheric Admin (NOAA) - USA); Antarctic Wildlife Research Fund	This work was supported by a contract to RK by the National Oceanic and Atmospheric Administration and a grant by the Antarctic Wildlife Research Fund to RK, CSR and SK. The Port of Nagoya Public Aquarium provided the very valuable known age animals, and support in the form of salary for author TM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson A, 2009, DEEP-SEA RES PT I, V56, P727, DOI 10.1016/j.dsr.2008.12.007; Bluhm BA, 2001, MAR BIOL, V138, P247, DOI 10.1007/s002270000458; Campana SE, 2001, J FISH BIOL, V59, P197, DOI [10.1111/j.1095-8649.2001.tb00127.x, 10.1006/jfbi.2001.1668]; CHANG WYB, 1982, CAN J FISH AQUAT SCI, V39, P1208, DOI 10.1139/f82-158; DE MEESTER F., 2013, OMEGA 6 3 FATTY ACID, P267, DOI DOI 10.1007/978-1-62703-215-5_14; Everson I., 2000, ECOLOGY FISHERIES, P63; Feinberg LR, 2007, MAR ECOL PROG SER, V341, P141, DOI 10.3354/meps341141; Flores H, 2012, MAR ECOL PROG SER, V458, P1, DOI 10.3354/meps09831; Hewitt RP, 2004, DEEP-SEA RES PT II, V51, P1215, DOI 10.1016/j.dsr2.2004.06.011; Hewitt RP, 2004, CCAMLR SCI, V11, P81; Hewitt RP, 2000, FISH RES, V47, P215, DOI 10.1016/S0165-7836(00)00171-5; Hill SL, 2007, CCAMLR SCI, V14, P1; Hill SL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072246; Hirano Y, 2003, MAR FRESHW BEHAV PHY, V36, P249, DOI 10.1080/10236240310001623637; Hirano Y, 2003, MAR FRESHW BEHAV PHY, V36, P259, DOI 10.1080/10236240310001614448; IKEDA T, 1982, J EXP MAR BIOL ECOL, V62, P143, DOI 10.1016/0022-0981(82)90088-0; Kawaguchi S, 2013, NAT CLIM CHANGE, V3, DOI 10.1038/NCLIMATE1937; Kawaguchi S, 2016, ADV POL ECO, P225, DOI 10.1007/978-3-319-29279-3_6; Kawaguchi S, 2010, DEEP-SEA RES PT II, V57, P683, DOI 10.1016/j.dsr2.2009.10.017; Kilada R., 2016, FISH B IN PRESS; Kilada R, 2015, J CRUSTACEAN BIOL, V35, P499, DOI 10.1163/1937240X-00002353; Kilada R, 2012, CAN J FISH AQUAT SCI, V69, P1728, DOI 10.1139/cjfas-2012-0254; Kilada RW, 2009, MAR BIOL, V156, P1029, DOI 10.1007/s00227-009-1146-9; Kodama K, 2006, MAR BIOL, V150, P131, DOI 10.1007/s00227-006-0337-x; Krafft BA, 2016, J CRUSTACEAN BIOL, V36, P267, DOI 10.1163/1937240X-00002428; Leland JC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134966; Marinovic B, 1999, ECOL LETT, V2, P338; Marr J.W.S., 1962, DISCOVERY REP, VXXXII, P33; NICOL S, 1990, BIOSCIENCE, V40, P833, DOI 10.2307/1311486; NICOL S, 1992, MAR ECOL PROG SER, V89, P175, DOI 10.3354/meps089175; Nicol S, 2016, ADV POL ECO, P387, DOI 10.1007/978-3-319-29279-3_11; O'Farrell S, 2015, MAR ECOL PROG SER, V522, P245, DOI 10.3354/meps11134; Piner KR, 2016, FISH RES, V180, P128, DOI 10.1016/j.fishres.2015.05.024; Pinones A, 2016, GEOPHYS RES LETT, V43, P8580, DOI 10.1002/2016GL069656; Quetin LB, 2007, ANTARCT SCI, V19, P253, DOI 10.1017/S0954102007000363; QUETIN LB, 1991, AM ZOOL, V31, P49; Reiss CS, 2008, ICES J MAR SCI, V65, P497, DOI 10.1093/icesjms/fsn033; Reiss CS, 2016, ADV POL ECO, P101, DOI 10.1007/978-3-319-29279-3_3; Reiss CS, 2015, DIRECT AGEING ANTARC; Schofield O, 2010, SCIENCE, V328, P1520, DOI 10.1126/science.1185779; SHAW CT, 2004, ASLO TOS OC RES C HO; Sheehy MRJ, 2008, MAR ECOL PROG SER, V353, P191, DOI 10.3354/meps07229; Sheehy MRJ, 1999, CAN J FISH AQUAT SCI, V56, P1904, DOI 10.1139/cjfas-56-10-1904; Sheridan M, 2016, J EXP MAR BIOL ECOL, V484, P16, DOI 10.1016/j.jembe.2016.08.005; Shin HC, 2002, MAR ECOL PROG SER, V239, P157, DOI 10.3354/meps239157; SIEGEL V, 1987, MAR BIOL, V96, P483, DOI 10.1007/BF00397966; Siegel V, 2003, POLAR BIOL, V26, P672, DOI 10.1007/s00300-003-0537-5; SIEGEL V, 1990, POLAR BIOL, V10, P549; Smetacek V, 2005, NATURE, V437, P362, DOI 10.1038/nature04161; Stammerjohn SE, 2008, DEEP-SEA RES PT II, V55, P2041, DOI 10.1016/j.dsr2.2008.04.026; SUN S, 1995, ANTARCT SCI, V7, P387, DOI 10.1017/S0954102095000538; Tang F, 2015, MAR BIOL, V162, P69, DOI 10.1007/s00227-014-2559-7; Tarling GA, 2016, MAR ECOL PROG SER, V547, P61, DOI 10.3354/meps11634; Vatcher HE, 2015, J MORPHOL, V276, P1358, DOI 10.1002/jmor.20423; Wahle RA, 1996, MAR ECOL PROG SER, V138, P117, DOI 10.3354/meps138117	55	14	18	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2017	12	2							e0171773	10.1371/journal.pone.0171773	http://dx.doi.org/10.1371/journal.pone.0171773			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5SK	28225825	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000394680900020
J	Anderson, NC; Donk, M				Anderson, Nicola C.; Donk, Mieke			Salient object changes influence overt attentional prioritization and object-based targeting in natural scenes	PLOS ONE			English	Article							REAL-WORLD SCENES; EYE-MOVEMENTS; COMPETITIVE INTEGRATION; SELECTION; FIXATION; GUIDANCE; LOCATIONS; CAPTURE; PREDICT; PERCEPTION	A change to an object in natural scenes attracts attention when it occurs during a fixation. However, when a change occurs during a saccade, and is masked by saccadic suppression, it typically does not capture the gaze in a bottom- up manner. In the present work, we investigated how the type and direction of salient changes to objects affect the prioritization and targeting of objects in natural scenes. We asked observers to look around a scene in preparation for a later memory test. After a period of time, an object in the scene was increased or decreased in salience either during a fixation (with a transient signal) or during a saccade (without transient signal), or it was not changed at all. Changes that were made during a fixation attracted the eyes both when the change involved an increase and a decrease in salience. However, changes that were made during a saccade only captured the eyes when the change was an increase in salience, relative to the baseline no-change condition. These results suggest that the prioritization of object changes can be influenced by the underlying salience of the changed object. In addition, object changes that occurred with a transient signal (which is itself a salient signal) resulted in more central object targeting. Taken together, our results suggest that salient signals in a natural scene are an important component in both object prioritization and targeting in natural scene viewing, insofar as they align with object locations.	[Anderson, Nicola C.; Donk, Mieke] Vrije Univ Amsterdam, Dept Cognit Psychol, Amsterdam, Netherlands	Vrije Universiteit Amsterdam	Anderson, NC (corresponding author), Vrije Univ Amsterdam, Dept Cognit Psychol, Amsterdam, Netherlands.	n.c.c.anderson@vu.nl		Donk, Mieke/0000-0001-9310-8210				Altmann GTM, 2004, COGNITION, V93, pB79, DOI 10.1016/j.cognition.2004.02.005; Anderson NC, 2016, PSYCHON B REV; Anderson NC, 2015, J VISION, V15, DOI 10.1167/15.5.9; Brockmole JR, 2008, VIS COGN, V16, P375, DOI 10.1080/13506280701453623; Brockmole JR, 2005, PSYCHON B REV, V12, P1061, DOI 10.3758/BF03206444; Buswell Guy Thomas, 1935, PEOPLE LOOK PICTURES; Cousineau D, 2005, TUTOR QUANT METHODS, V1, P42, DOI 10.20982/tqmp.01.1.p042; Donk M, 2011, PERCEPTION, V40, P63, DOI 10.1068/p6718; EGLY R, 1994, J EXP PSYCHOL GEN, V123, P161, DOI 10.1037/0096-3445.123.2.161; Einhauser W, 2008, J VISION, V8, DOI 10.1167/8.2.2; Einhauser W, 2003, EUR J NEUROSCI, V17, P1089, DOI 10.1046/j.1460-9568.2003.02508.x; Enns JT, 2001, J EXP PSYCHOL HUMAN, V27, P1287, DOI 10.1037/0096-1523.27.6.1287; Evans KK, 2005, J EXP PSYCHOL HUMAN, V31, P1476, DOI 10.1037/0096-1523.31.6.1476; Foulsham T, 2013, Q J EXP PSYCHOL, V66, P1707, DOI 10.1080/17470218.2012.762798; Foulsham T, 2008, J VISION, V8, DOI 10.1167/8.2.6; Franconeri SL, 2005, PSYCHOL SCI, V16, P275, DOI 10.1111/j.0956-7976.2005.01528.x; Godijn R, 2002, J EXP PSYCHOL HUMAN, V28, P1039, DOI 10.1037//0096-1523.28.5.1039; Hayhoe M, 2005, TRENDS COGN SCI, V9, P188, DOI 10.1016/j.tics.2005.02.009; Henderson John M., 2007, P537, DOI 10.1016/B978-008044980-7/50027-6; Henderson JM, 2009, PSYCHON B REV, V16, P850, DOI 10.3758/PBR.16.5.850; Itti L, 1998, IEEE T PATTERN ANAL, V20, P1254, DOI 10.1109/34.730558; Itti L, 2001, NAT REV NEUROSCI, V2, P194, DOI 10.1038/35058500; Itti L, 2000, VISION RES, V40, P1489, DOI 10.1016/S0042-6989(99)00163-7; JONIDES J, 1988, PERCEPT PSYCHOPHYS, V43, P346, DOI 10.3758/BF03208805; Jonikaitis D, 2014, J NEUROSCI, V34, P6687, DOI 10.1523/JNEUROSCI.4453-13.2014; Jonikaitis D, 2013, J NEUROPHYSIOL, V109, P1425, DOI 10.1152/jn.00656.2012; Li FF, 2002, P NATL ACAD SCI USA, V99, P9596, DOI 10.1073/pnas.092277599; Mannan SK, 1996, SPATIAL VISION, V10, P165, DOI 10.1163/156856896X00123; Mathot S, 2012, BEHAV RES METHODS, V44, P314, DOI 10.3758/s13428-011-0168-7; Matsukura M, 2011, VISION RES, V51, P546, DOI 10.1016/j.visres.2011.01.014; Matsukura M, 2009, VIS COGN, V17, P835, DOI 10.1080/13506280902868660; Moore CM, 1998, PSYCHOL SCI, V9, P104, DOI 10.1111/1467-9280.00019; Morey RD, 2008, TUTOR QUANT METHODS, V4, P61, DOI 10.20982/tqmp.04.2.p061; Nuthmann A, 2010, J VISION, V10, DOI 10.1167/10.8.20; OREGAN JK, 1992, J EXP PSYCHOL HUMAN, V18, P185, DOI 10.1037/0096-1523.18.1.185; Pajak M, 2013, J VISION, V13, DOI 10.1167/13.5.2; Parkhurst D, 2002, VISION RES, V42, P107, DOI 10.1016/S0042-6989(01)00250-4; RAYNER K, 1979, PERCEPTION, V8, P21, DOI 10.1068/p080021; Reingold EM, 2001, PSYCHOL SCI, V12, P48, DOI 10.1111/1467-9280.00309; Rothkopf CA, 2007, J VISION, V7, DOI 10.1167/7.14.16; Russell BC, 2008, INT J COMPUT VISION, V77, P157, DOI 10.1007/s11263-007-0090-8; Siebold A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023552; Silvis JD, 2014, ATTEN PERCEPT PSYCHO, V76, P1803, DOI 10.3758/s13414-014-0688-1; Stirk JA, 2007, J VISION, V7, DOI 10.1167/7.10.3; 't Hart BM, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00455; Tatler BW, 2006, VISION RES, V46, P1857, DOI 10.1016/j.visres.2005.12.005; Tatler BW, 2011, J VISION, V11, DOI 10.1167/11.5.5; Tatler BW, 2005, VISION RES, V45, P643, DOI 10.1016/j.visres.2004.09.017; Theeuwes J, 1998, PSYCHOL SCI, V9, P379, DOI 10.1111/1467-9280.00071; Torralba A, 2006, PSYCHOL REV, V113, P766, DOI 10.1037/0033-295X.113.4.766; Trappenberg TP, 2001, J COGNITIVE NEUROSCI, V13, P256, DOI 10.1162/089892901564306; Underwood G, 2006, EUR J COGN PSYCHOL, V18, P321, DOI 10.1080/09541440500236661; Underwood G, 2009, VIS COGN, V17, P812, DOI 10.1080/13506280902771278; van Zoest W, 2004, J EXP PSYCHOL HUMAN, V30, P746, DOI 10.1037/0096-1523.30.4.749; Venables WN., 2002, MODERN APPL STAT S, V4, DOI 10.1007/978-0-387-21706-2; Walther D, 2006, NEURAL NETWORKS, V19, P1395, DOI 10.1016/j.neunet.2006.10.001; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wu CC, 2014, VISION RES, V105, P10, DOI 10.1016/j.visres.2014.08.019; Yang Shun-Nan, 2007, P293, DOI 10.1016/B978-008044980-7/50015-X; Yarbus A. L., 1967, EYE MOVEMENTS PERCEP, DOI [10.1007/978-1-4899-5379-7_8, DOI 10.1007/978-1-4899-5379-7_8]; Zehetleitner M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052595; Zhaoping L, 2008, J VISION, V8, DOI 10.1167/8.5.1	62	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2017	12	2							e72132	10.1371/journal.pone.0172132	http://dx.doi.org/10.1371/journal.pone.0172132			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL5QV	28222190	gold, Green Published, Green Submitted			2022-12-27	WOS:000394676800033
J	Bae, J; Cha, YJ; Lee, H; Lee, B; Baek, S; Choi, S; Jang, D				Bae, Jonghoon; Cha, Young-Jae; Lee, Hyungsuk; Lee, Boyun; Baek, Sojung; Choi, Semin; Jang, Dayk			Social networks and inference about unknown events: A case of the match between Google's AlphaGo and Sedol Lee	PLOS ONE			English	Article							SMALL-WORLD NETWORKS; COMPLEX NETWORKS; COMMUNITY STRUCTURE; PREDICTION MARKETS; KNOWLEDGE TRANSFER; DYNAMICS; TIES; STABILITY; ONLINE; MODEL	This study examines whether the way that a person makes inferences about unknown events is associated with his or her social relations, more precisely, those characterized by ego network density that reflects the structure of a person's immediate social relation. From the analysis of individual predictions over the Go match between AlphaGo and Sedol Lee in March 2016 in Seoul, Korea, this study shows that the low-density group scored higher than the high-density group in the accuracy of the prediction over a future state of a social event, i.e., the outcome of the first game. We corroborated this finding with three replication tests that asked the participants to predict the following: film awards, President Park's impeachment in Korea, and the counterfactual assessment of the US presidential election. Taken together, this study suggests that network density is negatively associated with vision advantage, i.e., the ability to discover and forecast an unknown aspect of a social event.	[Bae, Jonghoon] Seoul Natl Univ, Grad Sch Business, Seoul, South Korea; [Bae, Jonghoon; Cha, Young-Jae; Lee, Hyungsuk; Lee, Boyun; Baek, Sojung; Choi, Semin; Jang, Dayk] Seoul Natl Univ, Transdisciplinary Res Ctr Culture Brain Dynam, Seoul, South Korea; [Cha, Young-Jae; Baek, Sojung; Jang, Dayk] Seoul Natl Univ, Interdisciplinary Program Cognit Sci, Seoul, South Korea; [Lee, Hyungsuk; Lee, Boyun; Jang, Dayk] Seoul Natl Univ, Interdisciplinary Program Hist & Philosophy Sci, Seoul, South Korea; [Choi, Semin] Seoul Natl Univ, Dept Stat, Seoul, South Korea; [Jang, Dayk] Seoul Natl Univ, Coll Liberal Studies, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Jang, D (corresponding author), Seoul Natl Univ, Transdisciplinary Res Ctr Culture Brain Dynam, Seoul, South Korea.; Jang, D (corresponding author), Seoul Natl Univ, Interdisciplinary Program Cognit Sci, Seoul, South Korea.; Jang, D (corresponding author), Seoul Natl Univ, Interdisciplinary Program Hist & Philosophy Sci, Seoul, South Korea.; Jang, D (corresponding author), Seoul Natl Univ, Coll Liberal Studies, Seoul, South Korea.	djang@snu.ac.kr			National Research Foundation of Korea [NRF-2015R1A5A7037676]	National Research Foundation of Korea(National Research Foundation of Korea)	All were supported by National Research Foundation of Korea (#NRF-2015R1A5A7037676), http://www.nrf.re.kr/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn YY, 2010, NATURE, V466, P761, DOI 10.1038/nature09182; Amaral LAN, 2000, P NATL ACAD SCI USA, V97, P11149, DOI 10.1073/pnas.200327197; Aral S, 2011, AM J SOCIOL, V117, P90, DOI 10.1086/661238; Bae J, 2008, STRATEG ORGAN, V6, P227, DOI 10.1177/1476127008093518; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; BERNDT TJ, 1985, DEV PSYCHOL, V21, P1007, DOI 10.1037/0012-1649.21.6.1007; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Burt R.S, 2010, NEIGHBOR NETWORKS; Burt R.S., 1992, STRUCTURAL HOLES; Burt RS, 2007, ACAD MANAGE J, V50, P119, DOI 10.5465/AMJ.2007.24162082; Burt RS, 2013, ANNU REV PSYCHOL, V64, P527, DOI 10.1146/annurev-psych-113011-143828; Burt RS, 2004, AM J SOCIOL, V110, P349, DOI 10.1086/421787; Buskens V, 2010, SOC NETWORKS, V32, P301, DOI 10.1016/j.socnet.2010.05.001; CAMPBELL KE, 1991, SOC NETWORKS, V13, P203, DOI 10.1016/0378-8733(91)90006-F; Carnabuci G, 2015, ACAD MANAGE J, V58, P881, DOI 10.5465/amj.2013.1042; CARROLL JS, 1978, J EXP SOC PSYCHOL, V14, P88, DOI 10.1016/0022-1031(78)90062-8; Castellano C, 2003, EUROPHYS LETT, V63, P153, DOI 10.1209/epl/i2003-00490-0; Castellano C, 2009, REV MOD PHYS, V81, P591, DOI 10.1103/RevModPhys.81.591; Centola D, 2007, AM J SOCIOL, V113, P702, DOI 10.1086/521848; Centola D, 2010, SCIENCE, V329, P1194, DOI 10.1126/science.1185231; COLEMAN JS, 1988, AM J SOCIOL, V94, pS95, DOI 10.1086/228943; Davies MF, 1997, J EXP SOC PSYCHOL, V33, P561, DOI 10.1006/jesp.1997.1336; DAVIS MH, 1983, J PERS SOC PSYCHOL, V44, P113, DOI 10.1037/0022-3514.44.1.113; DiMaggio P, 2012, ANNU REV SOCIOL, V38, P93, DOI 10.1146/annurev.soc.012809.102545; Dunbar RIM, 2015, SOC NETWORKS, V43, P39, DOI 10.1016/j.socnet.2015.04.005; EINHORN HJ, 1981, ANNU REV PSYCHOL, V32, P53, DOI 10.1146/annurev.ps.32.020181.000413; Fang RL, 2015, ORGAN SCI, V26, P1243, DOI 10.1287/orsc.2015.0972; FELD SL, 1981, AM J SOCIOL, V86, P1015, DOI 10.1086/227352; Fiedler K, 2000, PSYCHOL REV, V107, P659, DOI 10.1037//0033-295X.107.4.659; Fleming L, 2007, ADMIN SCI QUART, V52, P443, DOI 10.2189/asqu.52.3.443; Gale D, 2003, GAME ECON BEHAV, V45, P329, DOI 10.1016/S0899-8256(03)00144-1; GIGERENZER G, 1991, PSYCHOL REV, V98, P506, DOI 10.1037/0033-295X.98.4.506; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Goyal S, 2007, J ECON THEORY, V137, P460, DOI 10.1016/j.jet.2007.01.006; GRANOVETTER M, 1978, AM J SOCIOL, V83, P1420, DOI 10.1086/226707; GRANOVETTER MS, 1973, AM J SOCIOL, V78, P1360, DOI 10.1086/225469; Guimera R, 2007, NAT PHYS, V3, P63, DOI 10.1038/nphys489; Hong L, 2004, P NATL ACAD SCI USA, V101, P16385, DOI 10.1073/pnas.0403723101; Jackson MO, 2008, SOCIAL AND ECONOMIC NETWORKS, P1; Javarone MA, 2014, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2014/08/P08013; KAHNEMAN D, 1973, PSYCHOL REV, V80, P237, DOI 10.1037/h0034747; Kinderman P, 1996, PERS INDIV DIFFER, V20, P261, DOI 10.1016/0191-8869(95)00186-7; Kitsak M, 2010, NAT PHYS, V6, P888, DOI [10.1038/nphys1746, 10.1038/NPHYS1746]; Kossinets G, 2009, AM J SOCIOL, V115, P405, DOI 10.1086/599247; KRACKHARDT D, 1990, ADMIN SCI QUART, V35, P342, DOI 10.2307/2393394; Lancichinetti A, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.046110; Larrick R. P., 2011, FRONTIERS SOCIAL PSY; Lopez-Pintado D, 2008, GAME ECON BEHAV, V62, P573, DOI 10.1016/j.geb.2007.08.001; Lorenz J, 2011, P NATL ACAD SCI USA, V108, P9020, DOI 10.1073/pnas.1008636108; Majumder SR, 2009, P NATL ACAD SCI USA, V106, P679, DOI 10.1073/pnas.0805037106; Marsden P.V., 2005, STRUCTURAL ANAL SOCI, P8, DOI DOI 10.1017/CBO9780511811395.002; Mastrandrea R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136497; McKelvie SJ, 1997, J SOC PSYCHOL, V137, P63, DOI 10.1080/00224549709595414; McPherson M, 2001, ANNU REV SOCIOL, V27, P415, DOI 10.1146/annurev.soc.27.1.415; Merluzzi J, 2013, SOC NETWORKS, V35, P331, DOI 10.1016/j.socnet.2013.03.004; Miller JH, 2007, PRINC STUD COMPLEX, P1, DOI 10.1007/1-4020-5602-8_1; Neckerman HJ, 1996, SOC DEV, V5, P131, DOI 10.1111/j.1467-9507.1996.tb00076.x; Nematzadeh A, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.088701; Newman M.E.J., 2010, NETWORKS INTRO; NEZLEK JB, 1993, J PERS SOC PSYCHOL, V65, P930, DOI 10.1037/0022-3514.65.5.930; Obstfeld D, 2005, ADMIN SCI QUART, V50, P100, DOI 10.2189/asqu.2005.50.1.100; PODOLNY JM, 1993, AM J SOCIOL, V98, P829, DOI 10.1086/230091; Podolny JM, 1997, AM SOCIOL REV, V62, P673, DOI 10.2307/2657354; Podolny JM, 2001, AM J SOCIOL, V107, P33, DOI 10.1086/323038; Pollet TV, 2011, J INDIVID DIFFER, V32, P161, DOI 10.1027/1614-0001/a000048; Reagans R, 2003, ADMIN SCI QUART, V48, P240, DOI 10.2307/3556658; Reich SM, 2012, DEV PSYCHOL, V48, P356, DOI 10.1037/a0026980; Salganik MJ, 2006, SCIENCE, V311, P854, DOI 10.1126/science.1121066; Sanfey AG, 2007, SCIENCE, V318, P598, DOI 10.1126/science.1142996; Stovel K, 2012, ANNU REV SOCIOL, V38, P139, DOI 10.1146/annurev-soc-081309-150054; Tortoriello M, 2010, ACAD MANAGE J, V53, P167, DOI 10.5465/AMJ.2010.48037420; Triandis H. C., 2012, HDB THEORIES SOCIAL, V2, P498; Watts DJ, 2004, ANNU REV SOCIOL, V30, P243, DOI 10.1146/annurev.soc.30.020404.104342; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Watts DJ, 2002, P NATL ACAD SCI USA, V99, P5766, DOI 10.1073/pnas.082090499; Weng LL, 2013, SCI REP-UK, V3, DOI 10.1038/srep02522; WHITE HC, 1976, AM J SOCIOL, V81, P730, DOI 10.1086/226141; Wolfers J, 2004, J ECON PERSPECT, V18, P107, DOI 10.1257/0895330041371321	79	4	4	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2017	12	2							e0171472	10.1371/journal.pone.0171472	http://dx.doi.org/10.1371/journal.pone.0171472			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL5QV	28222114	Green Submitted, Green Published, gold			2022-12-27	WOS:000394676800013
J	Fereshtehnejad, SM; Rahmani, A; Shafieesabet, M; Soori, M; Delbari, A; Motamed, MR; Lokk, J				Fereshtehnejad, Seyed-Mohammad; Rahmani, Arash; Shafieesabet, Mahdiyeh; Soori, Mahshid; Delbari, Ahmad; Motamed, Mohammad Reza; Lokk, Johan			Prevalence and associated comorbidities of restless legs syndrome (RLS): Data from a large population-based door-to-door survey on 19176 adults in Tehran, Iran	PLOS ONE			English	Article							PARKINSONS-DISEASE; SCREENING QUESTIONNAIRE; CARDIOVASCULAR-DISEASE; GENERAL-POPULATION; HEART-DISEASE; RISK-FACTORS; HEALTH; EPIDEMIOLOGY; VALIDATION; SLEEP	Background Discrepancies have been reported in the prevalence rate of restless legs syndrome (RLS) among different ethnic groups and geographic populations. Furthermore, there are disagreements on determinant factors and associated comorbidities of RLS. We aimed to estimate prevalence of RLS and investigate its associated comorbid conditions and risk factors in a large population-based door-to-door survey. Methods Following a multistage random sampling from the households lived in 22 urban districts of Tehran, Iran, 19176 participants with >= 30 years of age were recruited. Trained surveyors filled study checklist consisting of baseline characteristics, risk factors and comorbidity profile and the International RLS Study Group (IRLSSG) diagnostic criteria through face-toface interviews. Results In total, 1580 individuals were positively screened for RLS resulting in a standardized prevalence rate of 60.0/1000. There was a gradual increase in RLS prevalence by advancing age, however, sex difference disappeared after adjustment. Parkinsonism [adjusted odds' ratio (adj-OR) = 7.4 (95% CI: 5.3-10.4)], peripheral neuropathy [adj-OR = 3.7 (95% CI: 3.3-4.1)], subjective cognitive impairment (SCI) [adj-OR = 3.1 (95% CI: 2.7-3.4)], acting out dreams [adj-OR = 2.8 (95% CI: 2.5-3.2)], hyposmia [adj-OR = 2.5 (95% CI: 2.2-2.9)], active smoking [adj-OR = 1.5 (95% CI: 1.3-1.9)] and additional number of cardiometabolic diseases associated with higher risk of RLS [adj-OR = 1.6 (95% CI: 1.2-2.3)]. Conclusion Our findings showed that neuro-cognitive co-morbidities such as parkinsonism, peripheral neuropathy, SCI, acting out dreams and hyposmia as well as cardio-metabolic risk factors and diseases were independent determinants of RLS. It is recommended to screen individuals with either these comorbid conditions for RLS or the ones with RLS for the accompanying diseases.	[Fereshtehnejad, Seyed-Mohammad; Delbari, Ahmad; Lokk, Johan] Karolinska Inst, Div Clin Geriatr, Dept Neurobiol Care Sci & Soc NVS, Stockholm, Sweden; [Fereshtehnejad, Seyed-Mohammad] McGill Univ, Montreal Gen Hosp, Dept Neurol & Neurosurg, Fac Med, Montreal, PQ, Canada; [Fereshtehnejad, Seyed-Mohammad; Motamed, Mohammad Reza] Iran Univ Med Sci, Firoozgar Hosp, Firoozgar Clin Res Dev Ctr, Tehran, Iran; [Rahmani, Arash] Iran Univ Med Sci, Med Student Res Comm, Mental Hlth Res Ctr, Tehran Psychiat Inst, Tehran, Iran; [Shafieesabet, Mahdiyeh; Soori, Mahshid] Iran Univ Med Sci, Med Student Res Comm, Fac Med, Tehran, Iran; [Delbari, Ahmad] Iranian Res Ctr Aging, Univ Social Welf & Rehabil, Tehran, Iran; [Motamed, Mohammad Reza] Iran Univ Med Sci, Dept Neurol, Fac Med, Tehran, Iran; [Lokk, Johan] Karolinska Univ Hosp, Dept Geriatr Med, Stockholm, Sweden	Karolinska Institutet; McGill University; Iran University of Medical Sciences; Iran University of Medical Sciences; Iran University of Medical Sciences; Iran University of Medical Sciences; Karolinska Institutet; Karolinska University Hospital	Fereshtehnejad, SM (corresponding author), Karolinska Inst, Div Clin Geriatr, Dept Neurobiol Care Sci & Soc NVS, Stockholm, Sweden.; Fereshtehnejad, SM (corresponding author), McGill Univ, Montreal Gen Hosp, Dept Neurol & Neurosurg, Fac Med, Montreal, PQ, Canada.; Fereshtehnejad, SM (corresponding author), Iran Univ Med Sci, Firoozgar Hosp, Firoozgar Clin Res Dev Ctr, Tehran, Iran.	sm.fereshtehnejad@ki.se	rahmani, arash/AAL-5457-2020; Fereshtehnejad, Seyed-Mohammad/ABF-6020-2020; Delbari, Ahmad/D-8560-2017	rahmani, arash/0000-0002-2948-3478; Fereshtehnejad, Seyed-Mohammad/0000-0001-9255-9351; 				Allen RP, 2003, SLEEP MED, V4, P101, DOI 10.1016/S1389-9457(03)00010-8; Batool-Anwar S, 2016, J CLIN SLEEP MED, V12, P187, DOI 10.5664/jcsm.5482; Bower JH, 2009, NEUROEPIDEMIOLOGY, V32, P313, DOI 10.1159/000209265; Carlos K, 2015, SLEEP MED, V16, P1156, DOI 10.1016/j.sleep.2015.05.022; Chan DKY, 2000, J NEUROL NEUROSUR PS, V69, P117, DOI 10.1136/jnnp.69.1.117; De Vito K, 2014, MOVEMENT DISORD, V29, P1044, DOI 10.1002/mds.25860; DUARTE J, 1995, MOVEMENT DISORD, V10, P643, DOI 10.1002/mds.870100518; Edwards RR, 2011, SLEEP MED, V12, P603, DOI 10.1016/j.sleep.2010.09.018; Fereshtehnejad SM, 2015, NEUROPSYCH DIS TREAT, V11, P321, DOI 10.2147/NDT.S77391; Fereshtehnejad SM, 2014, NEUROEPIDEMIOLOGY, V43, P178, DOI 10.1159/000368167; Fereshtehnejad SM, 2014, ACTA NEUROL SCAND, P1; Fulda S, 2010, MOVEMENT DISORD, V25, P2641, DOI 10.1002/mds.23353; Gao X, 2009, NEUROLOGY, V72, P1255, DOI 10.1212/01.wnl.0000345673.35676.1c; Gupta R, 2016, ACTA NEUROL SCAND, V133, P320, DOI 10.1111/ane.12520; Hening W, 2004, SLEEP MED, V5, P237, DOI 10.1016/j.sleep.2004.03.006; Hening WA, 2009, SLEEP MED, V10, P976, DOI 10.1016/j.sleep.2008.09.015; Hunter CB, 2008, MOVEMENT DISORD, V23, pS361; Innes KE, 2012, SLEEP MED REV, V16, P309, DOI 10.1016/j.smrv.2011.04.001; Koo BB, 2015, SLEEP MED CLIN, V10, P189, DOI 10.1016/j.jsmc.2015.05.004; Li YP, 2013, NEUROLOGY, V81, P52, DOI 10.1212/WNL.0b013e318297eee0; Li YP, 2012, CIRCULATION, V126, P1689, DOI 10.1161/CIRCULATIONAHA.112.112698; McCrink L, 2007, SLEEP MED, V8, P73, DOI 10.1016/j.sleep.2006.03.014; Mckinnon J, 2010, INT J NEUROSCI, V120, P36, DOI 10.3109/00207450903428954; MENEGHINI F, 1992, J CLIN EPIDEMIOL, V45, P319, DOI 10.1016/0895-4356(92)90033-J; Ohayon MM, 2012, SLEEP MED REV, V16, P283, DOI 10.1016/j.smrv.2011.05.002; Ohayon MM, 2002, J PSYCHOSOM RES, V53, P547, DOI 10.1016/S0022-3999(02)00443-9; Rijsman Roselyne M, 2014, Parkinsonism Relat Disord, V20 Suppl 1, pS5, DOI 10.1016/S1353-8020(13)70004-X; Rocca WA, 1998, J CLIN EPIDEMIOL, V51, P517, DOI 10.1016/S0895-4356(98)00017-1; Setthawatcharawanich S, 2011, CLIN NEUROL NEUROSUR, V113, P885, DOI 10.1016/j.clineuro.2011.07.001; Sevillano MD, 2002, MOVEMENT DISORD, V17, P258, DOI 10.1002/mds.10088; Sevim S, 2004, J NEUROL NEUROSUR PS, V75, P226; Sevim S, 2003, NEUROLOGY, V61, P1562, DOI 10.1212/01.WNL.0000096173.91554.B7; Short ME, 2009, J OCCUP ENVIRON MED, V51, P786, DOI 10.1097/JOM.0b013e3181a86671; Szentkiralyi A, 2013, J SLEEP RES, V22, P434, DOI 10.1111/jsr.12040; TANNER CM, 1990, ANN NEUROL, V28, P267; Teodoro T, 2015, PARKINSONISM RELAT D, P21; Trenkwalder C, 2016, NEUROLOGY, V86, P1336, DOI 10.1212/WNL.0000000000002542; Wali SO, 2015, ANN THORAC MED, V10, P193, DOI 10.4103/1817-1737.160839; Walters AS, 2009, SLEEP, V32, P589, DOI 10.1093/sleep/32.5.589; WALTERS AS, 1995, MOVEMENT DISORD, V10, P634, DOI 10.1002/mds.870100517; Winkelman JW, 2008, NEUROLOGY, V70, P35, DOI 10.1212/01.wnl.0000287072.93277.c9; Wong JC, 2014, SLEEP, V37, P369, DOI 10.5665/sleep.3416	42	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2017	12	2							e0172593	10.1371/journal.pone.0172593	http://dx.doi.org/10.1371/journal.pone.0172593			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BI	28212408	Green Published, Green Submitted, gold			2022-12-27	WOS:000394424700062
J	Liu, J; Zeng, XX; Hong, HG; Li, Y; Fu, P				Liu, Jing; Zeng, Xiaoxi; Hong, Hyokyoung G.; Li, Yi; Fu, Ping			The association between body mass index and mortality among Asian peritoneal dialysis patients: A meta-analysis	PLOS ONE			English	Article							CARDIOVASCULAR MORTALITY; SURVIVAL ADVANTAGE; RISK-FACTOR; LONG-TERM; ALL-CAUSE; OBESITY; DISEASE; OUTCOMES; WEIGHT; SIZE	Background Previous studies have revealed that increased body mass index (BMI) is associated with decreased mortality among hemodialysis patients. However, few studies have dealt with the association between BMI and mortality among patients undergoing peritoneal dialysis (PD) and even fewer studies have focused on the Asian PD patients. The reported studies were often non-conclusive and some even yielded contradictory results. This paper, to our best knowledge, registers the first attempt to systematically review the current literature and summarize new results on the association between BMI and mortality among the Asian PD population. Method A systematic literature review was performed in Medline and EMBASE to identify relevant cohort studies on all-cause and cardiovascular disease (CVD) mortality stratified by BMI categories tailored to Asians among the Asian PD population. We meta-analyzed individual results based on a random effect model, strictly complying with Preferred Reporting Items for Systematic Reviews and Meta-analysis. Results The paper reviews seven cohort studies with a total of 3,610 Asian PD patients. Obese group (BMI = 25-29.9 kg/m(2)) was associated with higher risk of all-cause mortality (HR = 1.46, 95% CI [1.07-1.98]; p = 0.02) and CVD mortality (HR = 2.01, 95% CI [1.14-3.54]; p = 0.02), compared to the normal group (BMI = 18.5-22.9 kg/m(2)). The underweight group (BMI< 18.5kg/m(2)) was also associated with an elevated risk of all-cause mortality (HR = 2.11, 95% CI [1.46-3.07]; p< 0.001). No significant associations between BMI with all-cause mortality were found among the overweight group (23-24.9 kg/m(2)) (HR = 1.00, 95% CI [0.76-1.32]; p = 0.9). The association between BMI and CVD mortality risk among the underweight and overweight groups was found nonsignificant (p = 0.5 and 0.6 respectively). Conclusion Obesity is associated with increased mortality in Asian PD patients. The study indicates a "V-shaped" trend in the association between BMI and mortality in these patients.	[Liu, Jing; Zeng, Xiaoxi; Fu, Ping] Sichuan Univ, Kidney Res Inst, Div Nephrol, West China Hosp, Chengdu, Sichuan, Peoples R China; [Zeng, Xiaoxi; Fu, Ping] Sichuan Univ, West China Hosp, West China Biomed Big Data Ctr, Chengdu, Sichuan, Peoples R China; [Hong, Hyokyoung G.] Michigan State Univ, Dept Stat & Probabil, E Lansing, MI 48824 USA; [Li, Yi] Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA	Sichuan University; Sichuan University; Michigan State University; University of Michigan System; University of Michigan	Fu, P (corresponding author), Sichuan Univ, Kidney Res Inst, Div Nephrol, West China Hosp, Chengdu, Sichuan, Peoples R China.; Fu, P (corresponding author), Sichuan Univ, West China Hosp, West China Biomed Big Data Ctr, Chengdu, Sichuan, Peoples R China.	fupinghx@163.com	Hong, Hyokyoung Grace/ABG-6009-2020	Hong, Hyokyoung Grace/0000-0002-4280-6243	Science and Technology Department of Sichuan Province, China [2016HH0069]	Science and Technology Department of Sichuan Province, China	Xiaoxi Zeng is supported by the international cooperation project (2016HH0069) funded by Science and Technology Department of Sichuan Province, China (http://www.scst.gov.cn). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Afshin A, 2014, AM J CLIN NUTR, V100, P278, DOI 10.3945/ajcn.113.076901; Agarwal R, 2010, HYPERTENSION, V56, P893, DOI 10.1161/HYPERTENSIONAHA.110.160747; Ahmadi SF, 2016, PERITON DIALYSIS INT, V36, P315, DOI 10.3747/pdi.2015.00052; Aslam N, 2002, PERITON DIALYSIS INT, V22, P191; Axelsson J, 2005, J RENAL NUTR, V15, P131, DOI 10.1053/j.jrn.2004.09.034; Badve SV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114897; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Calle EE, 1999, NEW ENGL J MED, V341, P1097, DOI 10.1056/NEJM199910073411501; Fernandes NMD, 2013, CLINICS, V68, P51, DOI 10.6061/clinics/2013(01)OA08; de Gonzalez AB, 2010, NEW ENGL J MED, V363, P2211, DOI 10.1056/NEJMoa1000367; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; DerSimonian R, 2015, CONTEMP CLIN TRIALS, V45, P139, DOI 10.1016/j.cct.2015.09.002; Deurenberg-Yap M, 2000, INT J OBESITY, V24, P1011, DOI 10.1038/sj.ijo.0801353; Grosso G, 2015, AM J CLIN NUTR, V101, P783, DOI 10.3945/ajcn.114.099515; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Huang JW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054976; Jee SH, 2006, NEW ENGL J MED, V355, P779, DOI 10.1056/NEJMoa054017; Johansen KL, 2004, AM J CLIN NUTR, V80, P324, DOI 10.1093/ajcn/80.2.324; Johnson DW, 2007, PERITON DIALYSIS INT, V27, pS250; Kalantar-Zadeh K, 2005, AM J CLIN NUTR, V81, P543; Kalantar-Zadeh K, 2007, NAT CLIN PRACT NEPHR, V3, P493, DOI 10.1038/ncpneph0570; Kim YK, 2014, PERITON DIALYSIS INT, V34, P383, DOI 10.3747/pdi.2013.00008; Kiran VR, 2014, PERITON DIALYSIS INT, V34, P390, DOI 10.3747/pdi.2013.00055; Kodama S, 2012, AM J EPIDEMIOL, V176, P959, DOI 10.1093/aje/kws172; Lam MF, 2006, PERITON DIALYSIS INT, V26, P466; LEW EA, 1979, J CHRON DIS, V32, P563, DOI 10.1016/0021-9681(79)90119-X; Li K, 2016, J EPIDEMIOLOGY; Li Y, 2013, PERITON DIALYSIS INT, V33, P411, DOI 10.3747/pdi.2012.00037; MANSON JE, 1995, NEW ENGL J MED, V333, P677, DOI 10.1056/NEJM199509143331101; Mavridis D, 2014, EVID-BASED MENT HEAL, V17, P30, DOI 10.1136/eb-2013-101699; McCusker FX, 1996, KIDNEY INT, V50, pS56; Mcdonald SP, 2003, J AM SOC NEPHROL, V14, P2894, DOI 10.1097/01.ASN.0000091587.55159.5F; McDonald SR, 2004, PERITON DIALYSIS INT, V24, P340; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; NOLPH KD, 1980, ANN INTERN MED, V92, P609, DOI 10.7326/0003-4819-92-5-609; Obi Y, 2015, CURR OPIN CLIN NUTR, V18, P254, DOI 10.1097/MCO.0000000000000171; Okamoto T, 2014, AM J NEPHROL, V39, P122, DOI 10.1159/000358335; Pliakogiannis T, 2007, INT UROL NEPHROL, V39, P281, DOI 10.1007/s11255-006-9142-1; Prasad N, 2014, PERITON DIALYSIS INT, V34, P399, DOI 10.3747/pdi.2013.00056; Psaty Bruce M., 1995, Annals of Epidemiology, V5, P270, DOI 10.1016/1047-2797(94)00092-8; Ramkumar N, 2005, PERITON DIALYSIS INT, V25, P461; Rostom A, 2004, Evid Rep Technol Assess (Summ), P1; Shao C, 2016, SCI REP-UK, V6, DOI 10.1038/srep30394; Snyder JJ, 2003, KIDNEY INT, V64, P1838, DOI 10.1046/j.1523-1755.2003.00287.x; Stenvinkel P, 1999, KIDNEY INT, V55, P1899, DOI 10.1046/j.1523-1755.1999.00422.x; Thamer M, 2000, AM J KIDNEY DIS, V36, P1155, DOI 10.1053/ajkd.2000.19829; Unal A, 2013, J MED SCI, V30; Wang AYM, 2003, J AM SOC NEPHROL, V14, P159, DOI 10.1097/01.ASN.0000038685.95946.83; WANG J, 1994, AM J CLIN NUTR, V60, P23, DOI 10.1093/ajcn/60.1.23; Wen CP, 2009, PUBLIC HEALTH NUTR, V12, P497, DOI 10.1017/S1368980008002802; Wong JS, 1999, KIDNEY INT, V55, P2515, DOI 10.1046/j.1523-1755.1999.00464.x; Xiong L, 2015, HONG KONG J NEPHROLO, V1, pS124; Zhou H, 2011, RENAL FAILURE, V33, P964, DOI 10.3109/0886022X.2011.615968	54	6	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0172369	10.1371/journal.pone.0172369	http://dx.doi.org/10.1371/journal.pone.0172369			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207885	Green Published, gold, Green Submitted			2022-12-27	WOS:000394424500127
J	Southern, WM; Nichenko, AS; Shill, DD; Spencer, CC; Jenkins, NT; McCully, KK; Call, JA				Southern, William M.; Nichenko, Anna S.; Shill, Daniel D.; Spencer, Corey C.; Jenkins, Nathan T.; McCully, Kevin K.; Call, Jarrod A.			Skeletal muscle metabolic adaptations to endurance exercise training are attainable in mice with simvastatin treatment	PLOS ONE			English	Article							STATIN THERAPY; ATORVASTATIN TREATMENT; OXIDATIVE STRESS; AUTOPHAGY; INCREASES; PROTECTS; HEART; IMPROVEMENT; RESPIRATION; EXPRESSION	We tested the hypothesis that a 6-week regimen of simvastatin would attenuate skeletal muscle adaptation to low-intensity exercise. Male C57BLI6J wildtype mice were subjected to 6-weeks of voluntary wheel running or normal cage activities with or without simvastatin treatment (20 mg/kg/d, n = 7-8 per group). Adaptations in in vivo fatigue resistance were determined by a treadmill running test, and by ankle plantarflexor contractile assessment. The tibialis anterior, gastrocnemius, and plantaris muscles were evaluated for exercised induced mitochondrial adaptations (i.e., biogenesis, function, autophagy). There was no difference in weekly wheel running distance between control and simvastatin-treated mice (P = 0.51). Trained mice had greater treadmill running distance (296%, P<0.001), and ankle plantarflexor contractile fatigue resistance (9%, P<0.05) compared to sedentary mice, independent of simvastatin treatment. At the cellular level, trained mice had greater mitochondrial biogenesis (e.g., similar to 2-fold greater PGC1 alpha expression, P<0.05) and mitochondrial content (e.g., 25% greater citrate synthase activity, P<0.05), independent of simvastatin treatment. Mitochondrial autophagy-related protein contents were greater in trained mice (e.g., 40% greater Bnip3, P<0.05), independent of simvastatin treatment. However, Drp1, a marker of mitochondrial fission, was less in simvastatin treated mice, independent of exercise training, and there was a significant interaction between training and statin treatment (P<0.022) for LC3-II protein content, a marker of autophagy flux. These data indicate that whole body and skeletal muscle adaptations to endurance exercise training are attainable with simvastatin treatment, but simvastatin may have side effects on muscle mitochondrial maintenance via autophagy, which could have long-term implications on muscle health.	[Southern, William M.; Nichenko, Anna S.; Shill, Daniel D.; Spencer, Corey C.; Jenkins, Nathan T.; McCully, Kevin K.; Call, Jarrod A.] Univ Georgia, Dept Kinesiol, Athens, GA 30602 USA; [Call, Jarrod A.] Univ Georgia, Regenerat Biosci Ctr, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Call, JA (corresponding author), Univ Georgia, Dept Kinesiol, Athens, GA 30602 USA.; Call, JA (corresponding author), Univ Georgia, Regenerat Biosci Ctr, Athens, GA 30602 USA.	call@uga.edu	McCully, Kevin K./P-5141-2015	McCully, Kevin K./0000-0001-9850-487X; Call, Jarrod/0000-0002-1094-4940				Ashfield TA, 2010, AGE AGEING, V39, P185, DOI 10.1093/ageing/afp203; Ballard KD, 2013, ATHEROSCLEROSIS, V230, P121, DOI 10.1016/j.atherosclerosis.2013.07.001; Baltgalvis KA, 2012, MED SCI SPORT EXER, V44, P1671, DOI 10.1249/MSS.0b013e31825703f0; Baltgalvis KA, 2009, MUSCLE NERVE, V40, P443, DOI 10.1002/mus.21327; Bea F, 2003, ATHEROSCLEROSIS, V167, P187, DOI 10.1016/S0021-9150(02)00387-8; Bea F, 2002, ARTERIOSCL THROM VAS, V22, P1832, DOI 10.1161/01.ATV.0000036081.01231.16; Bjorkhem-Bergman L, 2011, BRIT J CLIN PHARMACO, V72, P164, DOI 10.1111/j.1365-2125.2011.03907.x; Bonifacio A, 2015, BBA-MOL CELL RES, V1853, P1841, DOI 10.1016/j.bbamcr.2015.04.010; Bouitbir J, 2012, MUSCLE NERVE, V46, P367, DOI 10.1002/mus.23309; Bouitbir J, 2011, J APPL PHYSIOL, V111, P1477, DOI 10.1152/japplphysiol.00107.2011; Bruckert E, 2005, CARDIOVASC DRUG THER, V19, P403, DOI 10.1007/s10557-005-5686-z; Call JA, 2015, CIRC-HEART FAIL, V8, P188, DOI 10.1161/CIRCHEARTFAILURE.114.001540; Call JA, 2011, J APPL PHYSIOL, V111, P200, DOI 10.1152/japplphysiol.00248.2011; Call JA, 2010, MUSCLE NERVE, V42, P871, DOI 10.1002/mus.21764; Choudhury RP, 2004, J VASC RES, V41, P75, DOI 10.1159/000076436; Davis ME, 2015, J SHOULDER ELB SURG, V24, P280, DOI 10.1016/j.jse.2014.06.048; Fox J. G., 2007, MOUSE BIOMEDICAL RES, V3; Ganga HV, 2014, AM HEART J, V168, P6, DOI 10.1016/j.ahj.2014.03.019; Garcia-Cazarin ML, 2011, JOVE-J VIS EXP, DOI 10.3791/2452; Goodman CA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128398; Gorassini M, 2000, J NEUROPHYSIOL, V83, P2002, DOI 10.1152/jn.2000.83.4.2002; Gu Q, 2014, NCHS DATA BRIEF, P1; Hanai JI, 2007, J CLIN INVEST, V117, P3940, DOI 10.1172/JCI32741; Hood DA, 2001, J APPL PHYSIOL, V90, P1137, DOI 10.1152/jappl.2001.90.3.1137; Ikeda Y, 2015, CIRC RES, V116, P264, DOI 10.1161/CIRCRESAHA.116.303356; Jenkins NT, 2011, J PHYSIOL-LONDON, V589, P5539, DOI 10.1113/jphysiol.2011.215277; Krishnan GM, 2010, CURR OPIN LIPIDOL, V21, P324, DOI 10.1097/MOL.0b013e32833c1edf; Kwak HB, 2012, FREE RADICAL BIO MED, V52, P198, DOI 10.1016/j.freeradbiomed.2011.10.449; Larsen S, 2012, J PHYSIOL-LONDON, V590, P3349, DOI 10.1113/jphysiol.2012.230185; Leung BP, 2003, J IMMUNOL, V170, P1524, DOI 10.4049/jimmunol.170.3.1524; Li P, 2007, AM J PATHOL, V170, P599, DOI 10.2353/ajpath.2007.060505; Lira VA, 2013, FASEB J, V27, P4184, DOI 10.1096/fj.13-228486; Mallinson JE, 2009, J PHYSIOL-LONDON, V587, P219, DOI 10.1113/jphysiol.2008.164699; Mikus CR, 2013, J AM COLL CARDIOL, V62, P709, DOI 10.1016/j.jacc.2013.02.074; Miller RA, 2011, J GERONTOL A-BIOL, V66, P191, DOI 10.1093/gerona/glq178; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI 10.1161/CIR.0000000000000152; Muraki A, 2012, J APPL PHYSIOL, V113, P479, DOI 10.1152/japplphysiol.01362.2011; Nichenko AS, 2016, AM J PHYSIOL-CELL PH, V311, pC190, DOI 10.1152/ajpcell.00066.2016; Okutsu M, 2014, CIRC-HEART FAIL, V7, P519, DOI 10.1161/CIRCHEARTFAILURE.113.000841; Otera H, 2013, BBA-MOL CELL RES, V1833, P1256, DOI 10.1016/j.bbamcr.2013.02.002; Paiva H, 2005, CLIN PHARMACOL THER, V78, P60, DOI 10.1016/j.clpt.2005.03.006; Palmer G, 2004, ARTHRITIS RHEUM-US, V50, P4051, DOI 10.1002/art.20673; Panza GA, 2015, J CLIN LIPIDOL, V9, P351, DOI 10.1016/j.jacl.2015.01.004; Parker BA, 2013, CIRCULATION, V127, P96, DOI 10.1161/CIRCULATIONAHA.112.136101; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Rengo JL, 2016, MUSCLE NERVE, V53, P242, DOI 10.1002/mus.24722; Schick BA, 2007, CLIN PHARMACOL THER, V81, P650, DOI 10.1038/sj.clpt.6100124; Scott D, 2009, QJM-INT J MED, V102, P625, DOI 10.1093/qjmed/hcp093; Shiroma EJ, 2010, CIRCULATION, V122, P743, DOI 10.1161/CIRCULATIONAHA.109.914721; Sirvent P, 2012, TOXICOL APPL PHARM, V259, P263, DOI 10.1016/j.taap.2012.01.008; Skoglund RN, 2004, SIMVASTATIN IMPROVES, V17, P2004; Taylor FC, 2013, JAMA-J AM MED ASSOC, V310, P2451, DOI 10.1001/jama.2013.281348; Tong XK, 2012, J NEUROSCI, V32, P4705, DOI 10.1523/JNEUROSCI.0169-12.2012; Traustadottir T, 2008, AGE, V30, P283, DOI 10.1007/s11357-008-9070-3; Wang YX, 2002, ATHEROSCLEROSIS, V162, P23, DOI 10.1016/S0021-9150(01)00678-5; Whitehead NP, 2016, AUTOPHAGY, V12, P705, DOI 10.1080/15548627.2016.1144005; Whitehead NP, 2015, P NATL ACAD SCI USA, V112, P12864, DOI 10.1073/pnas.1509536112; Wu JS, 2011, MUSCLE NERVE, V43, P76, DOI 10.1002/mus.21847; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X	60	21	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0172551	10.1371/journal.pone.0172551	http://dx.doi.org/10.1371/journal.pone.0172551			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207880	Green Submitted, Green Published, gold			2022-12-27	WOS:000394424500145
J	Gonzalez, AV; Santelices, B				Gonzalez, Alejandra V.; Santelices, Bernabe			Frequency of chimerism in populations of the kelp Lessonia spicata in central Chile	PLOS ONE			English	Article							NORTHERN CHILE; GENETIC-VARIABILITY; COALESCENCE; BERTEROANA; NIGRESCENS; RHODOPHYTA; BENEFITS; GIGARTINALES; LAMINARIALES; MACROALGAE	Chimerism occurs when two genetically distinct conspecific individuals fuse together generating a single entity. Coalescence and chimerism in red seaweeds has been positively related to an increase in body size, and the consequent reduction in susceptibility to mortality factors, thus increasing survival, reproductive potential and tolerance to stress in contrast to genetically homogeneous organisms. In addition, they showed that a particular pattern of post-fusion growth maintains higher genetic diversity and chimerism in the holdfast but homogenous axes. In Chilean kelps (brown seaweeds), intraorganismal genetic heterogeneity (IGH) and holdfast coalescence has been described in previous research, but the extent of chimerism in wild populations and the patterns of distribution of the genetically heterogeneous thallus zone have scarcely been studied. Since kelps are under continuous harvesting, with enormous social, ecological and economic importance, natural chimerism can be considered a priceless in-situ reservoir of natural genetic resources and variability. In this study, we therefore examined the frequency of IGH and chimerism in three harvested populations of Lessonia spicata. We then evaluated whether chimeric wild-type holdfasts show higher genetic diversity than erect axes (stipe and lamina) and explored the impact of this on the traditional estimation of genetic diversity at the population level. We found a high frequency of IGH (60 - 100%) and chimerism (33.3 - 86.7%), varying according to the studied population. We evidenced that chimerism occurs mostly in holdfasts, exhibiting heterogeneous tissues, whereas stipes and lamina were more homogeneous, generating a vertical gradient of allele and genotype abundance as well as divergence, constituting the first time " within- plant " genetic patterns have been reported in kelps. This is very different from the chimeric patterns described in land plants and animals. Finally, we evidenced that IGH affected genetic differentiation among populations, showed lower levels of FST index when we compared holdfast than lamina samples. In the light of this, future studies should evaluate the significance of chimeric holdfasts in their ability to increase kelps resilience, improve restoration and ecosystem service.	[Gonzalez, Alejandra V.] Univ Chile, Fac Ciencias, Dept Ciencias Ecol, Santiago, Chile; [Santelices, Bernabe] Pontificia Univ Catolica Chile, Fac Ciencias Biol, Dept Ecol, Santiago, Chile	Universidad de Chile; Pontificia Universidad Catolica de Chile	Gonzalez, AV (corresponding author), Univ Chile, Fac Ciencias, Dept Ciencias Ecol, Santiago, Chile.	apgonzalez@u.uchile.cl	Gonzalez, Alejandra Paola/AAZ-4259-2020		FONDECYT [1120129]; PAIFAC;  [ENL020/16]	FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); PAIFAC; 	This work received support from FONDECYT 1120129 (BS) and PAIFAC-2015 (AV).; We thank J. Beltran, V. Flores, G. Peralta, L. Carrasco and N. Rojas for their invaluable help in the field, laboratory and data analysis. We thank N. Charlesworth for the grammatical improvements as well as D. Veliz and two anonymous reviewers for their valuable comments and suggestions. We also gratefully acknowledge the financial support provided by FONDECYT 1120129 (BS), PAIFAC-2015-2016 and ENL020/16 (AG).	Anuario SERNAPESCA, 2015, AN EST PESC; Araujo Casares F, 2016, EVOL ECOL; BELKHIR K, 2000, GENETIX 4 01 LOGICIE; Buschmann AH, 2013, REV CHIL HIST NAT, V86, P251, DOI 10.4067/S0716-078X2013000300003; BUSS LW, 1981, SCIENCE, V213, P1012, DOI 10.1126/science.213.4511.1012; Cancino J., 1984, REV CHIL HIST NAT, V57, P23; Coulson TN, 1998, P ROY SOC B-BIOL SCI, V265, P489, DOI 10.1098/rspb.1998.0321; Earl DA, 2011, CONSERV GENET RESOUR, V4, P359, DOI DOI 10.1007/S12686-011-9548-7; Engelhardt KAM, 2014, BIOL CONSERV, V179, P6, DOI 10.1016/j.biocon.2014.08.011; EXCOFFIER L, 1992, GENETICS, V131, P479; Faugeron S, 2009, MOL ECOL RESOUR, V9, P937, DOI 10.1111/j.1755-0998.2009.02523.x; Fenster Charles B., 1994, P34, DOI 10.1017/CBO9780511623325.004; Fernando P, 2001, MOL ECOL NOTES, V1, P325, DOI 10.1046/j.1471-8278 .2001.00083.x; Folse HJ, 2012, EVOLUTION, V66, P1091, DOI 10.1111/j.1558-5646.2011.01500.x; Frankham R, 2015, MOL ECOL, V24, P2610, DOI 10.1111/mec.13139; Frankham R, 1999, ANIM CONSERV, V2, P255, DOI 10.1111/j.1469-1795.1999.tb00071.x; Franklin I.R., 1980, CONSERVATION BIOL EV, P135; Gonzalez AV, 2014, J APPL PHYCOL, V26, P1107, DOI 10.1007/s10811-013-0112-6; Gonzalez A, 2012, J PHYCOL, V48, P1153, DOI 10.1111/j.1529-8817.2012.01200.x; Gonzalez AV, 2015, PHYCOLOGIA, V54, P283, DOI 10.2216/14-105.1; Hartl D.L., 1997, PRINCIPLES POPULATIO, V3rd ed.; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; LACY R C, 1987, Conservation Biology, V1, P143, DOI 10.1111/j.1523-1739.1987.tb00023.x; Lindsay JK, 1997, APPL GEN LINEAR MODE; Maier E, 2012, CORAL REEFS, V31, P505, DOI 10.1007/s00338-011-0857-9; Medina FJ, 2015, J APPL PHYCOL, V27, P1593, DOI 10.1007/s10811-014-0478-0; Mudge K., 2009, Horticultural Reviews, V35, P437; Orostica MH, 2014, MAR ECOL PROG SER, V511, P71, DOI 10.3354/meps10931; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Pineda-Krch M, 2004, J EVOLUTION BIOL, V17, P1167, DOI 10.1111/j.1420-9101.2004.00808.x; Pritchard JK, 2000, GENETICS, V155, P945; Puill-Stephan E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039099; Puill-Stephan E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007751; Puurtinen M, 2004, EVOLUTION, V58, P749, DOI 10.1111/j.0014-3820.2004.tb00408.x; QUELLER DC, 1989, EVOLUTION, V43, P258, DOI 10.2307/2409206; Reynolds LK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038397; Rinkevich B, 1999, SCAND J IMMUNOL, V50, P456; Rodriguez D, 2014, J APPL PHYCOL, V26, P1115, DOI 10.1007/s10811-013-0121-5; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Saccheri I, 1998, NATURE, V392, P491, DOI 10.1038/33136; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Santelices B, 2008, J PHYCOL, V44, P624, DOI 10.1111/j.1529-8817.2008.00528.x; Santelices B, 2004, J EXP MAR BIOL ECOL, V300, P31, DOI 10.1016/j.jembe.2003.12.017; Santelices B, 1999, J PHYCOL, V35, P1127, DOI 10.1046/j.1529-8817.1999.3561127.x; Santelices B, 1999, TRENDS ECOL EVOL, V14, P152, DOI 10.1016/S0169-5347(98)01519-5; Santelices B, 2016, J PHYCOL; Santelices B, 2011, J APPL PHYCOL, V23, P395, DOI 10.1007/s10811-010-9566-y; Santelices B, 2010, J PHYCOL, V46, P685, DOI 10.1111/j.1529-8817.2010.00864.x; Schneider S., 1997, ARLEQUIN VER 1 1 SOF; Schuelke M, 2000, NAT BIOTECHNOL, V18, P233, DOI 10.1038/72708; Schweinsberg M, 2015, MOL ECOL, V24, P2673, DOI 10.1111/mec.13200; Segovia NI, 2015, MAR ECOL-EVOL PERSP, V36, P1107, DOI 10.1111/maec.12206; Sokal R.R., 2012, BIOMETRY; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Vasquez JA, 2014, J APPL PHYCOL, V26, P1081, DOI 10.1007/s10811-013-0173-6; Vasquez JA, 2012, J APPL PHYCOL, V24, P417, DOI 10.1007/s10811-012-9794-4; Vasquez J, 2008, J APPL PHYCOL, V20, P457, DOI 10.1007/s10811-007-9308-y; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Wernberg T, 2005, AQUAT BOT, V82, P168, DOI 10.1016/j.aquabot.2005.04.003; Wright S., 1978, EVOLUTION GENETIC PO	61	9	9	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0169182	10.1371/journal.pone.0169182	http://dx.doi.org/10.1371/journal.pone.0169182			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5VB	28234957	Green Published, Green Submitted, gold			2022-12-27	WOS:000394688200004
J	Yagi, H; Takabayashi, T; Xie, MJ; Kuroda, K; Sato, M				Yagi, Hideshi; Takabayashi, Tetsuji; Xie, Min-Jue; Kuroda, Kazuki; Sato, Makoto			Subcellular distribution of non-muscle myosin IIb is controlled by FILIP through Hsc70	PLOS ONE			English	Article							HEAT-SHOCK-PROTEIN; SYNAPTIC PLASTICITY; SPINE MORPHOLOGY; CEREBRAL-CORTEX; CELL-MIGRATION; STRESS FIBERS; CHAPERONE; HEAT-SHOCK-PROTEIN-70; COMPLEX; MUSCLE	The neuronal spine is a small, actin-rich dendritic or somatic protrusion that serves as the postsynaptic compartment of the excitatory synapse. The morphology of the spine reflects the activity of the synapse and is regulated by the dynamics of the actin cytoskeleton inside, which is controlled by actin binding proteins such as non-muscle myosin. Previously, we demonstrated that the subcellular localization and function of myosin IIb are regulated by its binding partner, filamin-A interacting protein (FILIP). However, how the subcellular distribution of myosin IIb is controlled by FILIP is not yet known. The objective of this study was to identify potential binding partners of FILIP that contribute to its regulation of non-muscle myosin IIb. Pull-down assays detected a 70-kDa protein that was identified by mass spectrometry to be the chaperone protein Hsc70. The binding of Hsc70 to FILIP was controlled by the adenosine triphosphatase (ATPase) activity of Hsc70. Further, FILIP bound to Hsc70 via a domain that was not required for binding non-muscle myosin IIb. Inhibition of ATPase activity of Hsc70 impaired the effect of FILIP on the subcellular distribution of non-muscle myosin IIb. Further, in primary cultured neurons, an inhibitor of Hsc70 impeded the morphological change in spines induced by FILIP. Collectively, these results demonstrate that Hsc70 interacts with FILIP to mediate its effects on non-muscle myosin IIb and to regulate spine morphology.	[Yagi, Hideshi] Hyogo Coll Med, Dept Anat & Cell Biol, Nishinomiya, Hyogo, Japan; [Yagi, Hideshi; Takabayashi, Tetsuji; Xie, Min-Jue; Kuroda, Kazuki; Sato, Makoto] Univ Fukui, Div Cell Biol & Neurosci, Dept Morphol & Physiol Sci, Fac Med Sci, Fukui, Japan; [Xie, Min-Jue; Sato, Makoto] Univ Fukui, Res Ctr Child Mental Dev, Fukui, Japan; [Sato, Makoto] Chiba Univ, Hamamatsu Univ, Kanazawa Univ, Osaka Univ,United Grad Sch Child Dev,Sch Med, Osaka, Japan; [Sato, Makoto] Univ Fukui, Osaka, Japan; [Sato, Makoto] Osaka Univ, Grad Sch Med, Dept Anat & Neurosci, Osaka, Japan	Hyogo College of Medicine; University of Fukui; University of Fukui; Chiba University; Hamamatsu University School of Medicine; Kanazawa University; Osaka University; University of Fukui; Osaka University	Yagi, H (corresponding author), Hyogo Coll Med, Dept Anat & Cell Biol, Nishinomiya, Hyogo, Japan.; Yagi, H; Sato, M (corresponding author), Univ Fukui, Div Cell Biol & Neurosci, Dept Morphol & Physiol Sci, Fac Med Sci, Fukui, Japan.; Sato, M (corresponding author), Univ Fukui, Res Ctr Child Mental Dev, Fukui, Japan.; Sato, M (corresponding author), Chiba Univ, Hamamatsu Univ, Kanazawa Univ, Osaka Univ,United Grad Sch Child Dev,Sch Med, Osaka, Japan.; Sato, M (corresponding author), Univ Fukui, Osaka, Japan.; Sato, M (corresponding author), Osaka Univ, Grad Sch Med, Dept Anat & Neurosci, Osaka, Japan.	h-yagi@hyo-med.ac.jp; makosato@anat2.med.osaka-u.ac.jp		Sato, Makoto/0000-0002-6805-8351; Yagi, Hideshi/0000-0002-8506-8965	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [26430045, 21390052, 25293043]; Uehara Memorial Foundation; Kato Memorial Bioscience Foundation; Takeda Science Foundation; NOVARTIS Foundation (Japan) for the Promotion of Science; Grants-in-Aid for Scientific Research [15K08151] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Uehara Memorial Foundation(Uehara Memorial Foundation); Kato Memorial Bioscience Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF)); NOVARTIS Foundation (Japan) for the Promotion of Science(Novartis); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a Grant-in-Aid for Researchers (Hyogo College of Medicine, 2013), a Grant-in-Aid for Scientific Research (C) (JSPS KAKENHI 26430045)(to H.Y.), a Grant-in-Aid for Scientific Research (B) (JSPS KAKENHI 21390052, 25293043) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan, and by the Uehara Memorial Foundation, Kato Memorial Bioscience Foundation, Takeda Science Foundation and the NOVARTIS Foundation (Japan) for the Promotion of Science (to M.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to Dr. M. Takahashi (Hokkaido Univ.) for providing us with the myosin 2b cDNA; to Dr. T. Iguchi and Dr. Y. Oka (Osaka Univ.), Dr. K. Kobayashi, Dr. H. Yamanaka, Dr. S. Maeda, Dr. K. Tanaka, Dr. S. Ohtani, Dr. Y. Minato and Dr. K. Noguchi (Hyogo College of Med.) for helpful discussions; to H. Yoshikawa, S. Kanae and H. Miyagoshi (Univ. of Fukui) for technical assistance; and to T. Taniguchi (Univ. of Fukui) and M. Hatta (Hyogo College of Med.) for secretarial assistance. This work was supported in part by a Grant-in-Aid for Researchers (Hyogo College of Medicine, 2013), a Grant-in-Aid for Scientific Research (C) (JSPS KAKEN HI 26430045 to H. Y.), and a Grant-in-Aid for Scientific Research (B) (JSPS KAKENHI 213900 52, 25293043) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan, and by the Uehara Memorial Foundation, Kato Memorial Bioscience Foundation Takeda Science Foundation and the Novartis Foundation (Japan) for the Promotion of Science (to M. S.).	Abisambra J, 2013, BIOL PSYCHIAT, V74, P367, DOI 10.1016/j.biopsych.2013.02.027; ALVARES K, 1990, P NATL ACAD SCI USA, V87, P5293, DOI 10.1073/pnas.87.14.5293; Chen S, 2007, J NEUROSCI RES, V85, P402, DOI 10.1002/jnr.21124; ChrzanowskaWodnicka M, 1996, J CELL BIOL, V133, P1403, DOI 10.1083/jcb.133.6.1403; Cramer EM, 1997, BLOOD, V89, P2336, DOI 10.1182/blood.V89.7.2336; Daugaard M, 2007, FEBS LETT, V581, P3702, DOI 10.1016/j.febsiet.2007.05.039; Elliott E, 2007, J BIOL CHEM, V282, P37276, DOI 10.1074/jbc.M706379200; Heissler SM, 2013, CELL MOL LIFE SCI, V70, P1, DOI 10.1007/s00018-012-1002-9; Hodges JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024149; Iguchi T, 2008, J BIOL CHEM, V283, P14469, DOI 10.1074/jbc.M708919200; Kim J, 2008, TRENDS CELL BIOL, V18, P264, DOI 10.1016/j.tcb.2008.03.007; Landsverk ML, 2007, J CELL BIOL, V177, P205, DOI 10.1083/jcb.200607084; LEWIS MJ, 1985, EMBO J, V4, P3137, DOI 10.1002/j.1460-2075.1985.tb04056.x; Liu L, 2008, J BIOL CHEM, V283, P13185, DOI 10.1074/jbc.M800757200; Liu T, 2012, PHARMACOL THERAPEUT, V136, P354, DOI 10.1016/j.pharmthera.2012.08.014; Ma XF, 2010, MOL BIOL CELL, V21, P3952, DOI 10.1091/mbc.E10-04-0293; Machado P, 2011, J NEUROSCI, V31, P3, DOI 10.1523/JNEUROSCI.2533-10.2011; Marchler-Bauer A, 2013, NUCLEIC ACIDS RES, V41, pD348, DOI 10.1093/nar/gks1243; Massey AJ, 2010, CANCER CHEMOTH PHARM, V66, P535, DOI 10.1007/s00280-009-1194-3; Moon IS, 2001, CEREB CORTEX, V11, P238, DOI 10.1093/cercor/11.3.238; Morgan JR, 2001, NEURON, V32, P289, DOI 10.1016/S0896-6273(01)00467-6; Nagano T, 2002, NAT CELL BIOL, V4, P495, DOI 10.1038/ncb808; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; OBrien MC, 1996, J BIOL CHEM, V271, P15874, DOI 10.1074/jbc.271.27.15874; Pellegrin S, 2007, J CELL SCI, V120, P3491, DOI 10.1242/jcs.018473; Pemberton S, 2011, J BIOL CHEM, V286, P34690, DOI 10.1074/jbc.M111.261321; Price MG, 2002, J CELL SCI, V115, P4013, DOI 10.1242/jcs.00108; Rex CS, 2010, NEURON, V67, P603, DOI 10.1016/j.neuron.2010.07.016; Ryu JB, 2006, NEURON, V49, P175, DOI 10.1016/j.neuron.2005.12.017; SCHMID D, 1994, SCIENCE, V263, P971, DOI 10.1126/science.8310296; Sellers JR, 2000, BBA-MOL CELL RES, V1496, P3, DOI 10.1016/S0167-4889(00)00005-7; Sharma M, 2011, NAT CELL BIOL, V13, P30, DOI 10.1038/ncb2131; Srikakulam R, 2004, J CELL SCI, V117, P641, DOI 10.1242/jcs.00899; Syamaladevi DP, 2012, BIOINFORM BIOL INSIG, V6, P11, DOI 10.4137/BBI.S8451; Tobaben S, 2001, NEURON, V31, P987, DOI 10.1016/S0896-6273(01)00427-5; Tojkander S, 2012, J CELL SCI, V125, P1855, DOI 10.1242/jcs.098087; Uma S, 1999, MOL CELL BIOL, V19, P5861; Visegrady B, 2004, FEBS LETT, V565, P163, DOI 10.1016/j.febslet.2004.03.096; Yagi H, 2014, SCI REP-UK, V4, DOI 10.1038/srep06353; Yang Q, 2009, SCIENCE, V323, P124, DOI 10.1126/science.1166088; Zhang M, 2005, INVEST OPHTH VIS SCI, V46, P4130, DOI 10.1167/iovs.05-0164	41	1	1	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0172257	10.1371/journal.pone.0172257	http://dx.doi.org/10.1371/journal.pone.0172257			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5VB	28234934	Green Published, gold, Green Submitted			2022-12-27	WOS:000394688200059
J	Kyparissiadis, A; van Heuven, WJB; Pitchford, NJ; Ledgeway, T				Kyparissiadis, Antonios; van Heuven, Walter J. B.; Pitchford, Nicola J.; Ledgeway, Timothy			GreekLex 2: A comprehensive lexical database with part-of-speech, syllabic, phonological, and stress information	PLOS ONE			English	Article							VISUAL WORD RECOGNITION; READING GREEK; FILM SUBTITLES; FREQUENCY; CONSISTENCY; ASSIGNMENT; TYPICALITY; REGULARITY; ENGLISH; SPANISH	Databases containing lexical properties on any given orthography are crucial for psycholinguistic research. In the last ten years, a number of lexical databases have been developed for Greek. However, these lack important part-of-speech information. Furthermore, the need for alternative procedures for calculating syllabic measurements and stress information, as well as combination of several metrics to investigate linguistic properties of the Greek language are highlighted. To address these issues, we present a new extensive lexical database of Modern Greek (GreekLex 2) with part-of-speech information for each word and accurate syllabification and orthographic information predictive of stress, as well as several measurements of word similarity and phonetic information. The addition of detailed statistical information about Greek part-of-speech, syllabification, and stress neighbourhood allowed novel analyses of stress distribution within different grammatical categories and syllabic lengths to be carried out. Results showed that the statistical preponderance of stress position on the pre-final syllable that is reported for Greek language is dependent upon grammatical category. Additionally, analyses showed that a proportion higher than 90% of the tokens in the database would be stressed correctly solely by relying on stress neighbourhood information. The database and the scripts for orthographic and phonological syllabification as well as phonetic transcription are available at http://www.psychology.nottingham. ac.uk/greeklex/.	[Kyparissiadis, Antonios; van Heuven, Walter J. B.; Pitchford, Nicola J.; Ledgeway, Timothy] Univ Nottingham, Sch Psychol, Nottingham, England	University of Nottingham	Kyparissiadis, A (corresponding author), Univ Nottingham, Sch Psychol, Nottingham, England.	Antonios.Kyparissiadis@nottingham.ac.uk	van Heuven, Walter J B/K-9034-2013	van Heuven, Walter J B/0000-0003-3183-4449; Ledgeway, Timothy/0000-0002-2000-2420	School of Psychology and the Vice-Chancellor's Scholarship for Research Excellence, University of Nottingham	School of Psychology and the Vice-Chancellor's Scholarship for Research Excellence, University of Nottingham	This research was funded by the School of Psychology and the Vice-Chancellor's Scholarship for Research Excellence, University of Nottingham. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arciuli J, 2006, Q J EXP PSYCHOL, V59, P920, DOI 10.1080/02724980443000782; Arciuli J, 2003, LANG SPEECH, V46, P353, DOI 10.1177/00238309030460040101; Arciuli J, 2010, J MEM LANG, V63, P180, DOI 10.1016/j.jml.2010.03.005; Baayen RH, 2006, J MEM LANG, V55, P290, DOI 10.1016/j.jml.2006.03.008; Baayen R. H., 1993, CELEX LEXICAL DATABA; Babiniotis G, 2008, ORTHOGRATIKO LEXIKO; Botinis A, 2011, FONITIKI TIS ELLINIK; BROWN P, 1994, J EXP PSYCHOL HUMAN, V20, P537, DOI 10.1037/0096-1523.20.3.537; Brysbaert M, 2012, BEHAV RES METHODS, V44, P991, DOI 10.3758/s13428-012-0190-4; Brysbaert M, 2009, BEHAV RES METHODS, V41, P977, DOI 10.3758/BRM.41.4.977; Burani C, 2004, BRAIN LANG, V90, P318, DOI 10.1016/S0093-934X(03)00444-9; Cai Q, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010729; CARREIRAS M, 1993, J MEM LANG, V32, P766, DOI 10.1006/jmla.1993.1038; Chaida A, 2012, P 5 ISEL C EXP LING, P41; Chalamandaris A, 2005, INT 2005 EUR 9 EUR C; COLOMBO L, 1992, J EXP PSYCHOL HUMAN, V18, P987, DOI 10.1037/0096-1523.18.4.987; Coltheart M., 1977, ATTENTION PERFORM, P535, DOI DOI 10.1006/BRLN.2001.2475; Conrad M, 2004, LANG COGNITIVE PROC, V19, P369, DOI 10.1080/01690960344000224; Conrad M, 2008, LANG COGNITIVE PROC, V23, P296, DOI 10.1080/01690960701571570; Dimitropoulou M, 2010, FRONT PSYCHOL, V1, DOI 10.3389/fpsyg.2010.00218; Gakis P, 2012, LIT LINGUIST COMPUT, V27, P155, DOI 10.1093/llc/fqs002; Gimenes M, 2016, BEHAV RES METHODS, V48, P963, DOI 10.3758/s13428-015-0621-0; Grimani A, J READ RES IN PRESS; Hatzigeorgiu N., 2001, J QUANT LINGUIST, V8, P175, DOI [10.1076/jqul.8.3.175.4096, DOI 10.1076/JQUL.8.3.175.4096]; Hatzigeorgiu N., 2000, P LREC; Hofmann MJ, 2007, BEHAV RES METHODS, V39, P620, DOI 10.3758/BF03193034; Jouravlev O, 2014, LANG COGN NEUROSCI, V29, P605, DOI 10.1080/01690965.2013.813562; Keuleers E, 2010, BEHAV RES METHODS, V42, P643, DOI 10.3758/BRM.42.3.643; Ktori M, 2008, BEHAV RES METHODS, V40, P773, DOI 10.3758/BRM.40.3.773; Mathey S., 2002, CURRENT PSYCHOL LETT, V8, P107; MIKROS G, 2005, J QUANT LINGUIST, V12, P167, DOI DOI 10.1080/09296170500172478; Monaghan P, LINGUISTIC IN PRESS; New B, 2007, APPL PSYCHOLINGUIST, V28, P661, DOI 10.1017/S014271640707035X; Protopapas A, 2006, READ WRIT, V19, P171, DOI 10.1007/s11145-005-4023-z; Protopapas A, 2007, APPL PSYCHOLINGUIST, V28, P695, DOI 10.1017/S0142716407070373; Protopapas A, 2006, J RES READ, V29, P418, DOI 10.1111/j.1467-9817.2006.00316.x; Protopapas A, 2012, LANG RESOUR EVAL, V46, P449, DOI 10.1007/s10579-010-9130-z; Protopapas A, 2009, BEHAV RES METHODS, V41, P991, DOI 10.3758/BRM.41.4.991; Rastle K, 2000, J MEM LANG, V42, P342, DOI 10.1006/jmla.1999.2687; Schiller NO, 2004, BRAIN LANG, V90, P231, DOI 10.1016/S0093-934X(03)00436-X; Selkirk Elisabeth, 1984, PHONOLOGY SYNTAX REL; Triantafyllidis M, 1998, LEXICO TIS KINIS NEO; Triantafyllidis M, 1941, NEOELLINIKI GRAMMATI; Tzakosta M, 2011, STUDIES MODERN GREEK, P95; Tzakosta M, 2010, EL P 4 INT C MOD GRE, P213; van Heuven WJB, 2014, Q J EXP PSYCHOL, V67, P1176, DOI 10.1080/17470218.2013.850521; Yang J, 2011, J NEUROLINGUIST, V24, P674, DOI 10.1016/j.jneuroling.2011.07.002; Yarkoni T, 2008, PSYCHON B REV, V15, P971, DOI 10.3758/PBR.15.5.971	49	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2017	12	2							e0172493	10.1371/journal.pone.0172493	http://dx.doi.org/10.1371/journal.pone.0172493			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL5SX	28231303	Green Published, gold, Green Submitted			2022-12-27	WOS:000394682400049
J	Kirchner, J; Sawicki, LM; Suntharalingam, S; Grueneisen, J; Ruhlmann, V; Aktas, B; Deuschl, C; Herrmann, K; Antoch, G; Forsting, M; Umutlu, L				Kirchner, Julian; Sawicki, Lino Morris; Suntharalingam, Saravanabavaan; Grueneisen, Johannes; Ruhlmann, Verena; Aktas, Bahriye; Deuschl, Cornelius; Herrmann, Ken; Antoch, Gerald; Forsting, Michael; Umutlu, Lale			Whole-body staging of female patients with recurrent pelvic malignancies: Ultra-fast F-18-FDG PET/MRI compared to F-18-FDG PET/CT and CT	PLOS ONE			English	Article							PET/CONTRAST-ENHANCED CT; CANCER; ONCOLOGY; PERFORMANCE; EXPERIENCE; PROTOCOLS; DIAGNOSIS; MRI	Objectives To evaluate the diagnostic feasibility of an ultra-fast 18 F-FDG PET/MRI protocol, including T2-w and contrast-enhanced T1-w imaging as well as metabolic assessment (PET) in comparison to 18 F-FDG PET/CT and CT for whole-body staging of female patients with suspected recurrence of pelvic malignancies. Methods 43 female patients with suspected tumor recurrence were included in this study. Suspicion was based on clinical follow-up and abnormal findings on imaging follow-up. All patients underwent a PET/CT and a subsequent PET/MRI examination. Two readers were asked to evaluate ultra-fast PET/MRI, PET/CT as well as CT datasets of PET/CT separately for suspect lesions regarding lesion count, lesion localization and lesion characterization. Statistical analyses were performed both, on a per-patient and a per-lesion basis. Results Tumor relapse was present in 38 of the 43 patients. Based on CT readings 25/38 tumor relapses were correctly identified. PET/CT enabled correct identification of 37/38 patients, PET/MRI correctly identified 36 of the 38 patients with recurrent cancer. On a lesion-based analysis PET/MRI enabled the correct detection of more lesions, comprising a lesion-based sensitivity, specificity, positive predictive value, negative predictive value and diagnostic accuracy of 50%, 58%, 76%, 31%, and 53% for CT, 97%, 83%, 93%, 94%, and 92% for PET/CT and 98%, 83%, 94%, 94%, and 94% for PET/MRI, respectively. Mean scan duration of ultra-fast PET/MRI, PET/CT and whole-body CT amounted to 18.5 +/- 1 minutes, 18.2 +/- 1 minutes and 3.5 minutes, respectively. Conclusion Ultra-fast PET/MRI provides equivalent diagnostic performance and examination time when compared to PET/CT and superior diagnostic performance to CT in restaging female patients suspected to have recurrent pelvic cancer.	[Kirchner, Julian; Sawicki, Lino Morris; Antoch, Gerald] Univ Dusseldorf, Fac Med, Dept Diagnost & Intervent Radiol, Dusseldorf, Germany; [Suntharalingam, Saravanabavaan; Grueneisen, Johannes; Deuschl, Cornelius; Forsting, Michael; Umutlu, Lale] Univ Duisburg Essen, Univ Hosp Essen, Dept Diagnost & Intervent Radiol & Neuroradiol, Essen, Germany; [Ruhlmann, Verena; Herrmann, Ken] Univ Duisburg Essen, Univ Hosp Essen, Dept Nucl Med, Essen, Germany; [Aktas, Bahriye] Univ Duisburg Essen, Univ Hosp Essen, Dept Gynecol & Obstet, Essen, Germany	Heinrich Heine University Dusseldorf; University of Duisburg Essen; University of Duisburg Essen; University of Duisburg Essen	Kirchner, J (corresponding author), Univ Dusseldorf, Fac Med, Dept Diagnost & Intervent Radiol, Dusseldorf, Germany.	Julian.Kirchner@med.uni-duesseldorf.de	Aktas, Bahriye/AAW-1201-2021; Herrmann, Ken/GOH-1465-2022	Aktas, Bahriye/0000-0002-5474-051X; 				Andersson M, 2014, EJNMMI PHYS, V1, DOI 10.1186/2197-7364-1-9; Antoch G, 2003, JAMA-J AM MED ASSOC, V290, P3199, DOI 10.1001/jama.290.24.3199; Beiderwellen K, 2015, EUR J NUCL MED MOL I, V42, P56, DOI 10.1007/s00259-014-2902-8; Beiderwellen K, 2013, EUR J RADIOL, V82, pE669, DOI 10.1016/j.ejrad.2013.07.027; Beyer T, 2000, J NUCL MED, V41, P1369; Brix G, 2014, NUKLEARMED-NUCL MED, V53, P217, DOI 10.3413/Nukmed-0663-14-04; Buchbender C, 2013, EUR J RADIOL, V82, P877, DOI 10.1016/j.ejrad.2013.01.019; Caobelli F, 2016, EUR J NUCL MED MOL I, V43, P404, DOI 10.1007/s00259-015-3184-5; Christner JA, 2010, AM J ROENTGENOL, V194, P881, DOI 10.2214/AJR.09.3462; Czernin J, 2007, J NUCL MED, V48, p78S; Drzezga A, 2012, J NUCL MED, V53, P845, DOI 10.2967/jnumed.111.098608; Grueneisen J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157880; Grueneisen J, 2015, EUR J RADIOL, V84, P2097, DOI 10.1016/j.ejrad.2015.08.010; Grueneisen J, 2014, INVEST RADIOL, V49, P808, DOI 10.1097/RLI.0000000000000086; Gu P, 2009, EUR J RADIOL, V71, P164, DOI 10.1016/j.ejrad.2008.02.019; Hartung-Knemeyer V, 2013, INVEST RADIOL, V48, P290, DOI 10.1097/RLI.0b013e3182823695; Heusch P, 2015, EUR J NUCL MED MOL I, V42, P42, DOI 10.1007/s00259-014-2885-5; Kershah S, 2013, MOL IMAGING BIOL, V15, P776, DOI 10.1007/s11307-013-0629-8; Kim SK, 2009, EUR J CANCER, V45, P2103, DOI 10.1016/j.ejca.2009.04.006; Kitajima K, 2008, EUR J NUCL MED MOL I, V35, P1439, DOI 10.1007/s00259-008-0776-3; Kitajima K, 2009, EUR J NUCL MED MOL I, V36, P362, DOI 10.1007/s00259-008-0956-1; Kohan AA, 2013, EUR RADIOL, V23, P3161, DOI 10.1007/s00330-013-2914-y; Law WP, 2016, CLIN NUCL MED; Pinker K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155333; Sawicki LM, 2016, EUR J RADIOL, V85, P459, DOI 10.1016/j.ejrad.2015.12.010; Spicks C, 2016, J NUCL MED, V57, P420, DOI 10.2967/jnumed.115.158808; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262	27	21	21	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2017	12	2							e0172553	10.1371/journal.pone.0172553	http://dx.doi.org/10.1371/journal.pone.0172553			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5SK	28225831	Green Published, gold, Green Submitted			2022-12-27	WOS:000394680900052
J	Konde, MK; Baker, DP; Traore, FA; Sow, MS; Camara, A; Barry, AA; Mara, D; Barry, A; Cone, M; Kaba, I; Richard, AA; Beavogui, AH; Gunther, S; Pintilie, M; Fish, EN				Konde, Mandy Kader; Baker, Darren P.; Traore, Fode Amara; Sow, Mamadou Saliou; Camara, Alioune; Barry, Alpha Amadou; Mara, Doussou; Barry, Abdoulaye; Cone, Moussa; Kaba, Ibrahima; Richard, Amento Ablam; Beavogui, Abdoul Habib; Guenther, Stephan; Pintilie, Melania; Fish, Eleanor N.		European Mobile Lab Consortium	Interferon beta-1a for the treatment of Ebola virus disease: A historically controlled, single-arm proof-of-concept trial	PLOS ONE			English	Article								To date there are no approved antiviral drugs for the treatment of Ebola virus disease (EVD). Based on our in vitro evidence of antiviral activity of interferon (IFN)-beta activity against Ebola virus, we conducted a single arm clinical study in Guinea to evaluate the safety and therapeutic efficacy of IFN beta-1a treatment for EVD. Nine individuals infected with Ebola virus were treated with IFN beta-1a and compared retrospectively with a matched cohort of 21 infected patients receiving standardized supportive care only during the same time period at the same treatment unit. Cognizant of the limitations of having treated only 9 individuals with EVD, the data collected are cautiously considered. When compared to supportive care only, IFN beta-1a treatment seemed to facilitate viral clearance from the blood and appeared associated with earlier resolution of disease symptoms. Survival, calculated from the date of consent for those in the trial and date of admission from those in the control cohort, to the date of death, was 19% for those receiving supportive care only, compared to 67% for those receiving supportive care plus IFN beta-1a. Given the differences in baseline blood viremia between the control cohort and the IFN-treated cohort, an additional 17 controls were included for a subset analysis, from other treatment units in Guinea, matched with the IFN-treated patients based on age and baseline blood viremia. Subset analyses using this expanded control cohort suggests that patients without IFN beta-1a treatment were similar to 1.5-1.9 fold more likely to die than those treated. Viewed altogether the results suggest a rationale for further clinical evaluation of IFN beta-1a.	[Konde, Mandy Kader] Sustainable Hlth Fdn FOSAD, Conakry, Guinea; [Konde, Mandy Kader; Camara, Alioune; Barry, Alpha Amadou; Mara, Doussou; Barry, Abdoulaye; Cone, Moussa; Richard, Amento Ablam; Beavogui, Abdoul Habib] Ctr Excellence Training Res & Prior Dis CEFORPAG, Conakry, Guinea; [Baker, Darren P.] Sanofi Genzyme, Cambridge, MA USA; [Traore, Fode Amara; Sow, Mamadou Saliou; Kaba, Ibrahima] Natl Donka Hosp, Infect Dis Ward, Conakry, Guinea; [Guenther, Stephan] Bernhard Nocht Inst Trop Med, Hamburg, Germany; [Pintilie, Melania] Univ Hlth Network, Dept Biostat, Toronto, ON, Canada; [Fish, Eleanor N.] Univ Hlth Network, Toronto Gen Res Inst, Toronto, ON, Canada; [Fish, Eleanor N.] Univ Toronto, Dept Immunol, Toronto, ON, Canada	Sanofi-Aventis; Genzyme Corporation; Bernhard Nocht Institut fur Tropenmedizin; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto	Fish, EN (corresponding author), Univ Hlth Network, Toronto Gen Res Inst, Toronto, ON, Canada.; Fish, EN (corresponding author), Univ Toronto, Dept Immunol, Toronto, ON, Canada.	en.fish@utoronto.ca		ABLAM, Amento/0000-0002-7539-5321; Gunther, Stephan/0000-0002-6562-0230; Cabeza-Cabrerizo, Mar/0000-0001-9061-058X; Camara, Alioune/0000-0001-5874-4641	Canadian Institutes of Health Research (Institute of Infection & Immunity) grant; European Mobile Laboratory (EMLab); Global Outbreak Alert and Response Network (GOARN); European Union's Horizon 2020 research and innovation program [666100]; Directorate-General for International Cooperation and Development [IFS/2011/272-372]	Canadian Institutes of Health Research (Institute of Infection & Immunity) grant; European Mobile Laboratory (EMLab); Global Outbreak Alert and Response Network (GOARN); European Union's Horizon 2020 research and innovation program; Directorate-General for International Cooperation and Development	This study was supported by a Canadian Institutes of Health Research (Institute of Infection & Immunity) grant to ENF. The funder provided support in the form of salaries for authors [MKK, FAT, MSS, AC, AAB, IK, DM, AB, AAR], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. In addition support was provided by The European Mobile Laboratory (EMLab), a technical partner of the WHO Emerging and Dangerous Pathogens Laboratory Network (EDPLN), and the Global Outbreak Alert and Response Network (GOARN). The work of EMLab was carried out in the context of the projects EVIDENT (Ebola virus disease: correlates of protection, determinants of outcome, and clinical management) that received funding from the European Union's Horizon 2020 research and innovation program under grant agreements no. 666100, and in the context of service contract IFS/2011/272-372 funded by Directorate-General for International Cooperation and Development. Both Agreement no. 666100 and IFS/2011/272-372 funding support had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Audet J, 2015, VIRAL IMMUNOL, V28, P10, DOI 10.1089/vim.2014.0066; Bah EI, 2015, NEW ENGL J MED, V372, P40, DOI 10.1056/NEJMoa1411249; Cardenas WB, 2006, J VIROL, V80, P5168, DOI 10.1128/JVI.02199-05; de La Vega MA, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005221; Faye O, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001908; Feldmann H, 2011, LANCET, V377, P849, DOI 10.1016/S0140-6736(10)60667-8; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.1093/biomet/75.4.800; Hutchinson KL, 2007, J INFECT DIS, V196, pS357, DOI 10.1086/520611; Jahrling PB, 1999, J INFECT DIS, V179, pS224, DOI 10.1086/514310; Martinez MJ, 2015, INFECT DIS THER, V4, P365, DOI 10.1007/s40121-015-0079-5; McCarthy SDS, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004364; Qiu X, 2013, SCI TRANSL MED, V5, P1; Richardson J.S., 2011, J BIOTERROR BIODEF, V007; Sissoko D, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1001967; Smith LM, 2013, J INFECT DIS, V208, P310, DOI 10.1093/infdis/jis921; Wang BX, 2012, TRENDS IMMUNOL, V33, P190, DOI 10.1016/j.it.2012.01.004; World Health Organization, CLIN MAN PAT VIR HAE; Yen B, 2014, J VIROL, V88, P12500, DOI 10.1128/JVI.02163-14	18	31	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2017	12	2							e0169255	10.1371/journal.pone.0169255	http://dx.doi.org/10.1371/journal.pone.0169255			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5SK	28225767	Green Submitted, gold, Green Published			2022-12-27	WOS:000394680900001
J	Yang, XX; Wang, QS; Liang, BB; Wu, FL; Li, H; Liu, HB; Sheng, CY; Ma, QX; Yang, CJ; Xie, J; Li, P; Jia, LL; Wang, LG; Du, XY; Qiu, SF; Song, HB				Yang, Xiaoxia; Wang, Qiongshu; Liang, Beibei; Wu, Fuli; Li, Hao; Liu, Hongbo; Sheng, Chunyu; Ma, Qiuxia; Yang, Chaojie; Xie, Jing; Li, Peng; Jia, Leili; Wang, Ligui; Du, Xinying; Qiu, Shaofu; Song, Hongbin			An outbreak of acute respiratory disease caused by a virus associated RNA II gene mutation strain of human adenovirus 7 in China, 2015	PLOS ONE			English	Article							IDENTIFICATION; PNEUMONIA; CHILDREN; ILLNESS; VARIANT	Human adenovirus 7 (HAdV-7) strains are a major cause of acute respiratory disease (ARD) among adults and children, associated with fatal pneumonia. An ARD outbreak caused by HAdV-7 that involved 739 college students was reported in this article. To better understand the underlying cause of this large-scale epidemic, virus strains were isolated from infected patients and sequence variations of the whole genome sequence were detected. Evolutionary trees and alignment results indicated that the major capsid protein genes hexon and fibre were strongly conserved among serotype 7 strains in China at that time. Instead, the HAdV-7 strains presented three thymine deletions in the virus associated RNA (VA RNA) II terminal region. We also found that the mutation might lead to increased mRNA expression of an adjacent gene, L1 52/55K, and thus promoted faster growth. These findings suggest that sequence variation of VA RNA II gene was a potential cause of such a severe HAdV-7 infection and this gene should be a new-emerging factor to be monitored for better understanding of HAdV-7 infection.	[Yang, Xiaoxia; Liang, Beibei; Wu, Fuli; Li, Hao; Liu, Hongbo; Sheng, Chunyu; Ma, Qiuxia; Yang, Chaojie; Xie, Jing; Li, Peng; Jia, Leili; Wang, Ligui; Du, Xinying; Qiu, Shaofu; Song, Hongbin] Acad Mil Med Sci, Inst Dis Control & Prevent, Beijing, Peoples R China; [Wang, Qiongshu] Guangzhou Mil Command, Wuhan Gen Hosp, Deprtment Infect Control, Guangzhou, Guangdong, Peoples R China	Academy of Military Medical Sciences - China; Southern Theater Command General Hospital	Qiu, SF; Song, HB (corresponding author), Acad Mil Med Sci, Inst Dis Control & Prevent, Beijing, Peoples R China.	qiushf0613@hotmail.com; hongbinsong@263.net	Qiu, Shaofu/CAJ-0602-2022	Yang, Xiaoxia/0000-0002-0470-641X	Mega projects of Science and Technology Research [2012ZX10004215, AWS15J006]; National Nature Science Foundation of China [81373053, 81371854]; Beijing Science and Technology Nova program [xx2013061]	Mega projects of Science and Technology Research; National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Science and Technology Nova program	This work was supported by the Mega projects of Science and Technology Research (nos. 2012ZX10004215 and AWS15J006) that received by HBS, who participated in study design and decision to publish. And the National Nature Science Foundation of China (nos. 81373053 and 81371854), and the Beijing Science and Technology Nova program (no. xx2013061) received by SFQ, who participated in study design and decision to publish.	ALPERT G, 1986, AM J INFECT CONTROL, V14, P188, DOI 10.1016/0196-6553(86)90100-8; BOGENHAGEN DF, 1981, CELL, V24, P261, DOI 10.1016/0092-8674(81)90522-5; Calder JAM, 2004, EMERG INFECT DIS, V10, P149, DOI 10.3201/eid1001.020605; Cassir N., 2014, Eurosurveillance, V19, P20914, DOI 10.2807/1560-7917.ES2014.19.39.20914; CHEN M, 2011, PLOS GENET, V7, P64689, DOI DOI 10.1371/JOURNAL.PONE.0121375; Cui XY, 2015, J CLIN MICROBIOL, V53, P746, DOI 10.1128/JCM.02517-14; Dean DE, 2002, EMERG INFECT DIS, V8, P269; Demian PN, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-50; Echavarria M, 2003, J CLIN MICROBIOL, V41, P810, DOI 10.1128/JCM.41.2.810-812.2003; Hage E, 2014, J INFECTION, V69, P490, DOI 10.1016/j.jinf.2014.06.015; HASSON TB, 1992, J VIROL, V66, P6133, DOI 10.1128/JVI.66.10.6133-6142.1992; Hiroi S, 2013, JPN J INFECT DIS, V66, P436, DOI 10.7883/yoken.66.436; Lessa FC, 2009, J INFECT DIS, V200, P1759, DOI 10.1086/647987; Lin YC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127377; Liu HT, 2000, J VIROL, V74, P11681, DOI 10.1128/JVI.74.24.11681-11689.2000; Ma YL, 1996, J VIROL, V70, P5083, DOI 10.1128/JVI.70.8.5083-5099.1996; Moyo SJ, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0666-1; NEVINS JR, 1979, J VIROL, V32, P727, DOI 10.1128/JVI.32.3.727-733.1979; Perez-Romero P, 2006, J VIROL, V80, P1965, DOI 10.1128/JVI.80.4.1965-1971.2006; Qiu SF, 2015, SCI REP-UK, V5, DOI 10.1038/srep13617; Seto D, 2011, J VIROL, V85, P5701, DOI 10.1128/JVI.00354-11; Sriwanna P, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-193; Sun B, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0456-6; Tang LY, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-23; THIMMAPPAYA B, 1982, CELL, V31, P543, DOI 10.1016/0092-8674(82)90310-5; Tsou TP, 2012, EMERG INFECT DIS, V18, P1825, DOI 10.3201/eid1811.120629; Washington C, 2010, J CLIN MICROBIOL, V48, P2217, DOI 10.1128/JCM.00029-10; William S., 2007, ADENOVIRUSES, P2405; Yamamoto D, 2014, JPN J INFECT DIS, V67, P105, DOI 10.7883/yoken.67.105; Yu ZW, 2016, SCI REP-UK, V6, DOI 10.1038/srep37216; Yusof MA, 2012, EMERG INFECT DIS, V18, P852, DOI 10.3201/eid1805.110865; Zhao SH, 2014, SCI REP-UK, V4, DOI 10.1038/srep07365	32	14	14	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2017	12	2							e0172519	10.1371/journal.pone.0172519	http://dx.doi.org/10.1371/journal.pone.0172519			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5SK	28225804	Green Published, gold, Green Submitted			2022-12-27	WOS:000394680900049
J	Ma, J; Shui, SF; Han, XW; Guo, D; Li, TF; Yan, L				Ma, Ji; Shui, Shaofeng; Han, Xinwei; Guo, Dong; Li, Tengfei; Yan, Lei			microRNA-200a silencing protects neural stem cells against cerebral ischemia/reperfusion injury	PLOS ONE			English	Article							CANCER PROGRESSION; MIR-200 FAMILY; C-MYC; DIFFERENTIATION; ACTIVATION; PATHWAY; PROLIFERATION; INFARCTION; RENEWAL; NOTCH	Neural stem cells (NSCs) play major roles in neurological recovery after cerebral infarction (CI). This study was trying to investigate whether miR-200a, a vital regulator in cell proliferation, migration and apoptosis, also has a role in oxygen-glucose deprivation/reperfusion (OGD/R) injured NSCs. In this study, primary NSCs were subjected to OGD/R conditions to mimic an in vitro CI model. Before OGD/R induction, NSCs were transfected with vector or shRNA against miR-200a to overexpress or suppress miR-200a expression. The changes in cell viability, apoptosis, migration, the expression of c-Myc, and the phosphorylation of STAT1, STAT3 and MAPK were respectively assessed. Inhibitors of STAT1/3 and MAPK, i. e., Nifuroxazide and BIRB 796, were used to administrate miR-200a-silenced NSCs, and the expressions of above mentioned proteins were detected. After OGD/R exposure, miR200a was up-regulated in NSCs (P < 0.001)- miR-200a silencing alleviated OGD/R-induced the decrease of cell viability and migration (P < 0.01); meanwhile, alleviated OGD/R-induced apoptosis via reducing Bax/Bcl-2 ratio and down-regulating p53 and cytochrome c (P < 0.01 or P < 0.001). c-Myc, p-STAT1, p-STAT3, p-MAPK were all negatively regulated by miR200a (P < 0.01 or P < 0.001); more important, the increase of c-Myc induced by miR-200a silencing was abolished by Nifuroxazide or BIRB 796 (P < 0.01 or P < 0.001). These data indicate miR-200a silencing protects NSCs from OGD/R-induced injury, possibly via regulating the STATs/c-Myc and MAPK/c-Myc signalings.	[Ma, Ji; Shui, Shaofeng; Han, Xinwei; Guo, Dong; Li, Tengfei; Yan, Lei] Zhengzhou Univ, Dept Intervent Radiol, Affiliated Hosp 1, Zhengzhou, Peoples R China	Zhengzhou University	Han, XW (corresponding author), Zhengzhou Univ, Dept Intervent Radiol, Affiliated Hosp 1, Zhengzhou, Peoples R China.	hanxinwei666@126.com	han, wei/ABG-2691-2021					Ahmed S, 2009, J CELL BIOCHEM, V106, P1, DOI 10.1002/jcb.21972; Aparicio-Siegmund S, 2014, ONCOTARGET, V5, P2131, DOI 10.18632/oncotarget.1852; Becker LE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048474; Dharap A, 2009, J CEREBR BLOOD F MET, V29, P675, DOI 10.1038/jcbfm.2008.157; Dirnagl U, 2008, NEUROPHARMACOLOGY, V55, P334, DOI 10.1016/j.neuropharm.2008.02.017; Esteller M, 2011, NAT REV GENET, V12, P861, DOI 10.1038/nrg3074; Han JY, 2016, TRIALS, V17, DOI 10.1186/s13063-016-1611-y; Hoffman B, 2008, ONCOGENE, V27, P6462, DOI 10.1038/onc.2008.312; Irving EA, 2002, J CEREBR BLOOD F MET, V22, P631, DOI 10.1097/00004647-200206000-00001; Koh SH, 2015, J CLIN NEUROL, V11, P297, DOI 10.3988/jcn.2015.11.4.297; Lee ST, 2010, STROKE, V41, P1646, DOI 10.1161/STROKEAHA.110.579649; Lee WD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165460; Lin HW, 2011, ANTIOXID REDOX SIGN, V14, P1853, DOI 10.1089/ars.2010.3467; Muralidhar GG, 2015, INT J MOL SCI, V16, P16833, DOI 10.3390/ijms160816833; Narayanan G, 2016, JOVE-J VIS EXP, V65, P875; Onteddu SR, 2015, J NEUROL SCI, V359, P418, DOI 10.1016/j.jns.2015.10.005; Pandi G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058039; Perera D, 2016, SCI REP-UK, V6, DOI 10.1038/srep29741; Peter ME, 2009, CELL CYCLE, V8, P843, DOI 10.4161/cc.8.6.7907; Praskova M, 2002, ARCH DERMATOL RES, V294, P198, DOI 10.1007/s00403-002-0312-4; Roese-Koerner B, 2016, STEM CELL REP, V7, P207, DOI 10.1016/j.stemcr.2016.06.008; Subramaniam KS, 2016, AM J CANCER RES, V6, P200; Suliman MA, 2016, INT J MOL MED, V38, P776, DOI 10.3892/ijmm.2016.2689; Vita M, 2006, SEMIN CANCER BIOL, V16, P318, DOI 10.1016/j.semcancer.2006.07.015; Wardlaw JM, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000213.pub3; Wolfer A, 2011, CANCER RES, V71, P2034, DOI 10.1158/0008-5472.CAN-10-3776; Zhang XJ, 2010, J HEMATOL ONCOL, V3, DOI 10.1186/1756-8722-3-46; Zhao C, 2010, P NATL ACAD SCI USA, V107, P1876, DOI 10.1073/pnas.0908750107; Zheng HW, 2008, NATURE, V455, P1129, DOI 10.1038/nature07443	29	15	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2017	12	2							e72178	10.1371/journal.pone.0172178	http://dx.doi.org/10.1371/journal.pone.0172178			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5QV	28222148	Green Published, gold, Green Submitted			2022-12-27	WOS:000394676800039
J	Sumioka, R; Nakata, M; Okahashi, N; Li, YX; Wada, S; Yamaguchi, M; Sumitomo, T; Hayashi, M; Kawabata, S				Sumioka, Ryuichi; Nakata, Masanobu; Okahashi, Nobuo; Li, Yixuan; Wada, Satoshi; Yamaguchi, Masaya; Sumitomo, Tomoko; Hayashi, Mikako; Kawabata, Shigetada			Streptococcus sanguinis induces neutrophil cell death by production of hydrogen peroxide	PLOS ONE			English	Article							VIRIDANS STREPTOCOCCI; PYRUVATE OXIDASE; EXTRACELLULAR TRAPS; VIRULENCE; ENDOCARDITIS; PNEUMONIAE; PLATELETS; GORDONII; GENE; SPXB	Streptococcus is the dominant bacterial genus in the human oral cavity and a leading cause of infective endocarditis. Streptococcus sanguinis belongs to the mitis group of streptococci and produces hydrogen peroxide (H2O2) by the action of SpxB, a pyruvate oxidase. In this study, we investigated the involvement of SpxB in survival of S. sanguinis in human blood and whether bacterial H2O2 exhibits cytotoxicity against human neutrophils. Results of a bactericidal test with human whole blood revealed that the spxB mutation in S. sanguinis is detrimental to its survival in blood. When S. sanguinis strains were exposed to isolated neutrophils, the bacterial survival rate was significantly decreased by spxB deletion. Furthermore, human neutrophils exposed to the S. sanguinis wild-type strain, in contrast to those exposed to an spxB mutant strain, underwent cell death with chromatin de-condensation and release of web-like extracellular DNA, reflecting induction of neutrophil extracellular traps (NETs). Since reactive oxygen species-mediated NET induction requires citrullination of arginine residues in histone proteins and subsequent chromatin de-condensation, we examined citrullination levels of histone in infected neutrophils. It is important to note that the citrullinated histone H3 was readily detected in neutrophils infected with the wild-type strain, as compared to infection with the spxB mutant strain. Moreover, decomposition of streptococcal H2O2 with catalase reduced NET induction. These results suggest that H2O2 produced by S. sanguinis provokes cell death of neutrophils and NET formation, thus potentially affecting bacterial survival in the bloodstream.	[Sumioka, Ryuichi; Nakata, Masanobu; Li, Yixuan; Wada, Satoshi; Yamaguchi, Masaya; Sumitomo, Tomoko; Kawabata, Shigetada] Osaka Univ, Grad Sch Dent, Dept Oral & Mol Microbiol, Suita, Osaka, Japan; [Sumioka, Ryuichi; Hayashi, Mikako] Osaka Univ, Grad Sch Dent, Dept Restorat Dent & Endodontol, Suita, Osaka, Japan; [Okahashi, Nobuo] Osaka Univ, Grad Sch Dent, Ctr Frontier Oral Sci, Suita, Osaka, Japan	Osaka University; Osaka University; Osaka University	Nakata, M (corresponding author), Osaka Univ, Grad Sch Dent, Dept Oral & Mol Microbiol, Suita, Osaka, Japan.	nakata@dent.osaka-u.ac.jp	okahashi, nobuo/A-4032-2010; Yamaguchi, Masaya/I-8156-2019	okahashi, nobuo/0000-0002-8045-7021; Yamaguchi, Masaya/0000-0001-6218-7112; Nakata, Masanobu/0000-0003-1686-5415	Japan Society for the Promotion of Science [JP15H05012, JP26463112, JP26462779]; Grants-in-Aid for Scientific Research [16K15787, 26462780, 15H05012, 26463112] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by KAKENHI Grants-in-Aid for Scientific Research (B) (#JP15H05012), (C) (#JP26463112), and (C) (#JP26462779) awarded to SK, NO, and MN, respectively, from the Japan Society for the Promotion of Science (https://www.jsps.go.ip/english/).	Al-Salih G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045695; Augustin P, 2013, INFECT IMMUN, V81, P1721, DOI 10.1128/IAI.00775-12; Battig P, 2008, J BACTERIOL, V190, P1184, DOI 10.1128/JB.01517-07; Bardoel BW, 2014, CELL HOST MICROBE, V15, P526, DOI 10.1016/j.chom.2014.04.011; Barton CD, 2015, J INFECTION, V71, pS27, DOI 10.1016/j.jinf.2015.04.026; Bejarano I, 2007, MOL CELL BIOCHEM, V296, P77, DOI 10.1007/s11010-006-9301-9; Belanger AE, 2004, J BACTERIOL, V186, P8164, DOI 10.1128/JB.186.24.8164-8171.2004; Benisty R, 2010, BBA-MOL CELL BIOL L, V1801, P1098, DOI 10.1016/j.bbalip.2010.06.004; Benito N, 2009, ANN INTERN MED, V150, P586, DOI 10.7326/0003-4819-150-9-200905050-00004; Bhatt V, 2004, ANN CLIN LAB SCI, V34, P131; Blanchette-Cain K, 2013, MBIO, V4, DOI 10.1128/mBio.00745-13; BOCHUD PY, 1994, AM J MED, V97, P256, DOI 10.1016/0002-9343(94)90009-4; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Brinkmann V, 2012, J CELL BIOL, V198, P773, DOI 10.1083/jcb.201203170; Carvalho SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068277; Chandra J, 2000, FREE RADICAL BIO MED, V29, P323, DOI 10.1016/S0891-5849(00)00302-6; Chen L, 2011, MICROBIOL-SGM, V157, P13, DOI 10.1099/mic.0.039669-0; Dacheux D, 1999, INFECT IMMUN, V67, P6164, DOI 10.1128/IAI.67.11.6164-6167.1999; DOUGLAS CWI, 1993, J MED MICROBIOL, V39, P179, DOI 10.1099/00222615-39-3-179; FARMER ED, 1954, J GEN MICROBIOL, V11, P131, DOI 10.1099/00221287-11-2-131; Feldman C, 2002, RESP MED, V96, P580, DOI 10.1053/rmed.2002.1316; Ford I, 1997, PLATELETS, V8, P285; Fuchs TA, 2010, P NATL ACAD SCI USA, V107, P15880, DOI 10.1073/pnas.1005743107; Giorgio Marco, 2007, Nat Rev Mol Cell Biol, V8, P722, DOI 10.1038/nrm2240; HERZBERG MC, 1983, INFECT IMMUN, V39, P1457, DOI 10.1128/IAI.39.3.1457-1469.1983; Hoffmann O, 2006, INFECT IMMUN, V74, P5058, DOI 10.1128/IAI.01932-05; Jung CJ, 2015, CIRCULATION, V131, P571, DOI 10.1161/CIRCULATIONAHA.114.011432; KAWAMURA Y, 1995, INT J SYST BACTERIOL, V45, P406, DOI 10.1099/00207713-45-2-406; KILIAN M, 1989, INT J SYST BACTERIOL, V39, P471, DOI 10.1099/00207713-39-4-471; Kreth J, 2008, J BACTERIOL, V190, P4632, DOI 10.1128/JB.00276-08; Kreth J, 2009, J BACTERIOL, V191, P6281, DOI 10.1128/JB.00906-09; Kuramitsu HK, 2007, MICROBIOL MOL BIOL R, V71, P653, DOI 10.1128/MMBR.00024-07; LANCEFIELD RC, 1957, J EXP MED, V106, P525, DOI 10.1084/jem.106.4.525; Lee SY, 2006, INFECT IMMUN, V74, P3148, DOI 10.1128/IAI.00087-06; LeMessurier KS, 2006, MICROBIOL-SGM, V152, P305, DOI 10.1099/mic.0.28438-0; Liu XH, 2011, P NATL ACAD SCI USA, V108, P2668, DOI 10.1073/pnas.1018391108; Mahdi LK, 2008, INFECT IMMUN, V76, P646, DOI 10.1128/IAI.01161-07; Mocsai A, 2013, J EXP MED, V210, P1283, DOI 10.1084/jem.20122220; Morita C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103125; Okahashi N, 2016, INFECT IMMUN, V84, P2042, DOI 10.1128/IAI.00134-16; Okahashi N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088136; Okahashi N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062563; Okahashi N, 2011, FEMS MICROBIOL LETT, V323, P164, DOI 10.1111/j.1574-6968.2011.02375.x; Okahashi N, 2011, MICROB PATHOGENESIS, V50, P148, DOI 10.1016/j.micpath.2011.01.005; Okahashi N, 2010, BIOCHEM BIOPH RES CO, V391, P1192, DOI 10.1016/j.bbrc.2009.12.029; Orihuela CJ, 2004, J INFECT DIS, V190, P1661, DOI 10.1086/424596; Pelletier M, 2012, SEMIN IMMUNOL, V24, P384, DOI 10.1016/j.smim.2013.01.002; Pericone CD, 2003, J BACTERIOL, V185, P6815, DOI 10.1128/JB.185.23.6815-6825.2003; Plummer C, 2005, BRIT J HAEMATOL, V129, P101, DOI 10.1111/j.1365-2141.2005.05421.x; Prendergast BD, 2006, HEART, V92, P879, DOI 10.1136/hrt.2005.067256; Que YA, 2011, NAT REV CARDIOL, V8, P322, DOI 10.1038/nrcardio.2011.43; Quinn J, 2002, MOL BIOL CELL, V13, P805, DOI 10.1091/mbc.01-06-0288; Rai P, 2015, P NATL ACAD SCI USA, V112, pE3421, DOI 10.1073/pnas.1424144112; Regev-Yochay G, 2007, J BACTERIOL, V189, P6532, DOI 10.1128/JB.00813-07; Roberts GJ, 2006, HEART, V92, P1274, DOI 10.1136/hrt.2004.046581; Rosan B, 2000, MICROBES INFECT, V2, P1599, DOI 10.1016/S1286-4579(00)01316-2; Saito M, 2007, MICROBIOL IMMUNOL, V51, P889, DOI 10.1111/j.1348-0421.2007.tb03971.x; Sass LA, 2016, J PEDIAT INF DIS SOC, V5, P85, DOI 10.1093/jpids/piu087; Spellerberg B, 1996, MOL MICROBIOL, V19, P803, DOI 10.1046/j.1365-2958.1996.425954.x; Stacy A, 2014, P NATL ACAD SCI USA, V111, P7819, DOI 10.1073/pnas.1400586111; SUNDQVIST G, 1988, ORAL MICROBIOL IMMUN, V3, P103, DOI 10.1111/j.1399-302X.1988.tb00093.x; Syk A, 2014, J INFECT DIS, V210, P4, DOI 10.1093/infdis/jiu038; Thornhill MH, 2016, BRIT DENT J, V220, P51, DOI 10.1038/sj.bdj.2016.49; Wang YM, 2009, J CELL BIOL, V184, P205, DOI 10.1083/jcb.200806072; WHITE JC, 1946, J BACTERIOL, V51, P717, DOI 10.1128/JB.51.6.717-722.1946; Wray D, 2008, BRIT DENT J, V204, P555, DOI 10.1038/sj.bdj.2008.404; Xiao J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002623; Xu YH, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0086685, 10.1371/journal.pone.0087863]	68	20	20	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2017	12	2							e0172223	10.1371/journal.pone.0172223	http://dx.doi.org/10.1371/journal.pone.0172223			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5QV	28222125	Green Published, gold, Green Submitted			2022-12-27	WOS:000394676800043
J	Rothe, H; Brandenburg, V; Haun, M; Kollerits, B; Kronenberg, F; Ketteler, M; Wanner, C				Rothe, Hansjoerg; Brandenburg, Vincent; Haun, Margot; Kollerits, Barbara; Kronenberg, Florian; Ketteler, Markus; Wanner, Christoph			Ecto-5 ' -Nucleotidase CD73 (NT5E), vitamin D receptor and FGF23 gene polymorphisms may play a role in the development of calcific uremic arteriolopathy in dialysis patients - Data from the German Calciphylaxis Registry	PLOS ONE			English	Article							VASCULAR CALCIFICATION; MALIGNANT-MELANOMA; PREDICTORS; DEFICIENCY; MORTALITY; DISEASE; MODEL	Introduction Calciphylaxis/calcific uremic arteriolopathy affects mainly end-stage kidney disease patients but is also associated with malignant disorders such as myeloma, melanoma and breast cancer. Genetic risk factors of calciphylaxis have never been studied before. Methods We investigated 10 target genes using a tagging SNP approach: the genes encoding CD73/ecto-5'-nucleotidase (purinergic pathway), Matrix Gla protein, Fetuin A, Bone Gla protein, VKORC1 (all related to intrinsic calcification inhibition), calcium-sensing receptor, FGF23, Klotho, vitamin D receptor, stanniocalcin 1 (all related to CKD-MBD). 144 dialysis patients from the German calciphylaxis registry were compared with 370 dialysis patients without history of CUA. Genotyping was performed using iPLEX Gold MassARRAY(Sequenom, San Diego, USA), KASP genotyping chemistry (LGC, Teddington, Middlesex, UK) or sequencing. Statistical analysis comprised logistic regression analysis with adjustment for age and sex. Results 165 SNPs were finally analyzed and 6 SNPs were associated with higher probability for calciphylaxis (OR> 1) in our cohort. Nine SNPs of three genes (CD73, FGF23 and Vitamin D receptor) reached nominal significance (p<0.05), but did not reach statistical significance after correction for multiple testing. Of the CD73 gene, rs4431401 (OR = 1.71, 95% CI 1.08-2.17, p = 0.023) and rs9444348 (OR = 1.48, 95% CI 1.11-1.97, p = 0.008) were associated with a higher probability for CUA. Of the FGF23 and VDR genes, rs7310492, rs11063118, rs13312747 and rs17882106 were associated with a higher probability for CUA. Conclusion Polymorphisms in the genes encoding CD73, vitamin D receptor and FGF23 may play a role in calciphylaxis development. Although our study is the largest genetic study on calciphylaxis, it is limited by the low sample sizes. It therefore requires replication in other cohorts if available.	[Rothe, Hansjoerg; Ketteler, Markus] Klinikum Coburg, Coburg, Germany; [Rothe, Hansjoerg; Wanner, Christoph] Julius Maximilians Univ Wurzburg, Div Nephrol, Dept Med, Wurzburg, Germany; [Brandenburg, Vincent] Rhein Westfal TH Aachen, Dept Cardiol, Aachen, Germany; [Haun, Margot; Kollerits, Barbara; Kronenberg, Florian] Med Univ Innsbruck, Div Genet Epidemiol, Innsbruck, Austria	Klinikum Coburg; University of Wurzburg; RWTH Aachen University; Medical University of Innsbruck	Rothe, H (corresponding author), Klinikum Coburg, Coburg, Germany.; Rothe, H (corresponding author), Julius Maximilians Univ Wurzburg, Div Nephrol, Dept Med, Wurzburg, Germany.	hansjoerg.rothe@hs-coburg.de	Kronenberg, Florian/B-1736-2008	Kronenberg, Florian/0000-0003-2229-1120; Rothe, Hansjorg/0000-0003-1163-6576	AMGEN	AMGEN(Amgen)	This work was supported by AMGEN, grant name: CASPAC. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank AMGEN for supporting the German calciphylaxis registry and this study in particular.	Akhtar E, 2015, ACG CASE REP J, V9, P209; Albright RA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10006; Armstrong RA, 2014, OPHTHAL PHYSL OPT, V34, P502, DOI 10.1111/opo.12131; Bae GH, 2015, AM J MED, V128, pE19, DOI 10.1016/j.amjmed.2015.05.049; Barnes MR, 2006, BRIEF BIOINFORM, V7, P211, DOI 10.1093/bib/bbl021; Barth Syndrome, 1993, GENEREVIEWS; Bosler DS, 2007, AM J DERMATOPATH, V29, P400, DOI 10.1097/DAD.0b013e3180ddb535; Brandenburg VM, 2011, HAUTARZT, V62, P452, DOI 10.1007/s00105-011-2169-y; Brandenburg VM, 2014, PEDIATR NEPHROL, V29, P2289, DOI 10.1007/s00467-013-2746-7; Brandenburg VM, 2012, NEPHROL DIAL TRANSPL, V27, P1314, DOI 10.1093/ndt/gfs015; Brandonlnirp C CI, 2016, NEPHROL DIAL TRANSPL; Csakany B, 2009, ACTA OPHTHALMOL, V87, P575, DOI 10.1111/j.1755-3768.2008.01231.x; ESCOVITZ W, 1950, Ann West Med Surg, V4, P339; Evenepoel P, 2014, SEMIN NEPHROL, V34, P151, DOI 10.1016/j.semnephrol.2014.02.007; Falaleeva M, 2016, P NATL ACAD SCI USA, V113, pE1625, DOI 10.1073/pnas.1519292113; Gao ZW, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/460654; Hur DJ, 2005, AM J MED GENET A, V135A, P36, DOI 10.1002/ajmg.a.30680; Ichigozaki Y, 2016, EXP DERMATOL, V25, P67, DOI 10.1111/exd.12868; Idelevich A, 2011, ARTERIOSCL THROM VAS, V31, pE55, DOI 10.1161/ATVBAHA.111.230904; Kerk N, 2012, J DTSCH DERMATOL GES, V10, P518, DOI 10.1111/j.1610-0387.2012.07947.x; Ketteler M, 2003, LANCET, V361, P827, DOI 10.1016/S0140-6736(03)12710-9; Ketteler M, 2011, NAT REV NEPHROL, V7, P509, DOI 10.1038/nrneph.2011.91; Kim HJ, 2014, BJU INT, V114, P303, DOI 10.1111/bju.12396; Kottgen A, 2010, NAT GENET, V42, P376, DOI 10.1038/ng.568; Koopmann TT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097380; Kress M, 2013, FRONT MOL NEUROSCI, V6, DOI 10.3389/fnmol.2013.00033; KUDEJKO J, 1968, GERONTOLOGY, V14, P35, DOI 10.1159/000211640; Kutlu NO, 2003, PEDIATR HEMAT ONCOL, V20, P141, DOI 10.1080/0880010390158621; Lanzer P, 2014, EUR HEART J, V35, P1515, DOI 10.1093/eurheartj/ehu163; Li QL, 2014, CELL CYCLE, V13, P2609, DOI 10.4161/15384101.2014.943567; Lloyd WR, 2015, J BIOMED OPT, V20, DOI 10.1117/1.JBO.20.8.080501; Markello TC, 2011, MOL GENET METAB, V103, P44, DOI 10.1016/j.ymgme.2011.01.018; Minelli C, 2005, INT J EPIDEMIOL, V34, P1319, DOI 10.1093/ije/dyi169; Moe SM, 2003, PEDIATR NEPHROL, V18, P969, DOI 10.1007/s00467-003-1276-0; Nigwekar SU, 2008, CLIN J AM SOC NEPHRO, V3, P1139, DOI 10.2215/CJN.00530108; Petit-Jentreau L, 2015, INFECT IMMUN, V83, P3666, DOI 10.1128/IAI.00418-15; Raymond CB, 2008, AM J HEALTH-SYST PH, V65, P1419, DOI 10.2146/ajhp070546; SELYE H, 1970, CLIN ORTHOP RELAT R, P28; Sowa NA, 2010, J NEUROSCI, V30, P2235, DOI 10.1523/JNEUROSCI.5324-09.2010; St Hilaire C, 2011, NEW ENGL J MED, V364, P432, DOI [10.1056/NEJMoa0912923, 10.1056/NEJMc1102515]; Sullivan Emily, 2011, Br J Haematol, V155, P136, DOI 10.1111/j.1365-2141.2011.08751.x; TWERSKY J, 1975, RADIOLOGY, V116, P627, DOI 10.1148/116.3.627; Vossen LM, 2015, NUTRIENTS, V7, P8905, DOI 10.3390/nu7115443; Wheat D, 1998, CLIN NUCL MED, V23, P824, DOI 10.1097/00003072-199812000-00007	44	14	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2017	12	2							e0172407	10.1371/journal.pone.0172407	http://dx.doi.org/10.1371/journal.pone.0172407			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BI	28212442	Green Published, Green Submitted, gold			2022-12-27	WOS:000394424700044
J	Gonzalez-Juarbe, N; Shen, HQ; Bergman, MA; Orihuela, CJ; Dube, PH				Gonzalez-Juarbe, Norberto; Shen, Haiqian; Bergman, Molly A.; Orihuela, Carlos J.; Dube, Peter H.			YopE specific CD8(+) T cells provide protection against systemic and mucosal Yersinia pseudotuberculosis infection	PLOS ONE			English	Article							III SECRETION SYSTEM; LISTERIA-MONOCYTOGENES; PNEUMONIC PLAGUE; EFFECTOR YOPE; PESTIS; EPITOPE; ANTIGEN; PROTEIN; ENTEROCOLITICA; DETERMINANTS	Prior studies indicated that CD8(+) T cells responding to a surrogate single antigen expressed by Y. pseudotuberculosis, ovalbumin, were insufficient to protect against yersiniosis. Herein we tested the hypothesis that CD8(+) T cells reactive to the natural Yersinia antigen YopE would be more effective at providing mucosal protection. We first confirmed that immunization with the attenuated ksgA-strain of Y. pseudotuberculosis generated YopE-specific CD8(+) T cells. These T cells were protective against challenge with virulent Listeria monocytogenes expressing secreted YopE. Mice immunized with an attenuated L. monocytogenes YopE(+) strain generated large numbers of functional YopE(-) specific CD8(+) T cells, and initially controlled a systemic challenge with virulent Y. pseudotuberculosis, yet eventually succumbed to yersiniosis. Mice vaccinated with a YopE peptide and cholera toxin vaccine generated robust T cell responses, providing protection to 60% of the mice challenged mucosally but failed to show complete protection against systemic infection with virulent Y. pseudotuberculosis. These studies demonstrate that vaccination with recombinant YopE vaccines can generate YopE-specific CD8(+) T cells, that can provide significant mucosal protection but these cells are insufficient to provide sterilizing immunity against systemic Y. pseudotuberculosis infection. Our studies have implications for Yersinia vaccine development studies.	[Gonzalez-Juarbe, Norberto; Orihuela, Carlos J.] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA; [Shen, Haiqian; Bergman, Molly A.; Dube, Peter H.] Univ Texas Hlth Sci Ctr San Antonio, Dept Microbiol & Immunol, San Antonio, TX 78229 USA	University of Alabama System; University of Alabama Birmingham; University of Texas System; University of Texas Health San Antonio	Dube, PH (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Microbiol & Immunol, San Antonio, TX 78229 USA.	dube@uthscsa.edu			National Institute of Allergy and Infectious Disease, National Institutes of Health [AI085116, AI114800, AI067716, AI070412]; Cancer Prevention and Research Institute of Texas [RP160152]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI114800, T32AI007051] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM088010] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Disease, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Cancer Prevention and Research Institute of Texas; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institute of Allergy and Infectious Disease, National Institutes of Health, grant numbers AI085116 awarded to Molly Bergman, AI114800 awarded to Carlos Orihuela, AI067716 and AI070412 awarded to Peter Dube (https://www.niaid.nih.gov/); and Cancer Prevention and Research Institute of Texas, grant number RP160152 awarded to Peter Dube (www.cprit.texas.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achtman M, 2004, P NATL ACAD SCI USA, V101, P17837, DOI 10.1073/pnas.0408026101; Angelakopoulos H, 2002, INFECT IMMUN, V70, P3592, DOI 10.1128/IAI.70.7.3592-3601.2002; Ari TB, 2010, AM J TROP MED HYG, V83, P624, DOI 10.4269/ajtmh.2010.09-0775; Arlen PA, 2008, INFECT IMMUN, V76, P3640, DOI 10.1128/IAI.00050-08; BENGURION R, 1981, PLASMID, V5, P183, DOI 10.1016/0147-619X(81)90019-6; Bergman MA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000573; BOLIN I, 1982, INFECT IMMUN, V37, P506; Boyer JL, 2010, HUM GENE THER, V21, P891, DOI 10.1089/hum.2009.148; Bubeck SS, 2007, CLIN VACCINE IMMUNOL, V14, P1235, DOI 10.1128/CVI.00137-07; Cornelis GR, 1997, MOL MICROBIOL, V23, P861, DOI 10.1046/j.1365-2958.1997.2731623.x; Davis KJ, 1996, ARCH PATHOL LAB MED, V120, P156; Dewoody R, 2011, MOL MICROBIOL, V79, P1445, DOI 10.1111/j.1365-2958.2011.07534.x; Embry A, 2011, VACCINE, V29, P5331, DOI 10.1016/j.vaccine.2011.05.088; Galan JE, 1999, SCIENCE, V284, P1322, DOI 10.1126/science.284.5418.1322; Holmstrom A, 1997, MOL MICROBIOL, V24, P73, DOI 10.1046/j.1365-2958.1997.3211681.x; HOLMSTROM A, 1995, INFECT IMMUN, V63, P2269; Janeway CA., 2001, MAJOR HISTOCOMPATIBI; Lauer P, 2002, J BACTERIOL, V184, P4177, DOI 10.1128/JB.184.15.4177-4186.2002; Lauer P, 2008, INFECT IMMUN, V76, P3742, DOI 10.1128/IAI.00390-08; Lin JS, 2011, J IMMUNOL, V187, P897, DOI 10.4049/jimmunol.1100174; Long C, 2010, EMERG INFECT DIS, V16, P566, DOI 10.3201/eid1603.091106; Mecsas J, 2001, INFECT IMMUN, V69, P2779, DOI 10.1128/IAI.67.5.2779-2787.2001; Medina JL, 2012, AM J RESP CELL MOL, V46, P815, DOI 10.1165/rcmb.2011-0135OC; Quenee LE, 2011, VACCINE, V29, P6572, DOI 10.1016/j.vaccine.2011.06.119; Shen H, 2016, INFECT GENET EVOL, V43, P289, DOI 10.1016/j.meegid.2016.06.008; Smiley ST, 2008, EXPERT REV VACCINES, V7, P209, DOI 10.1586/14760584.7.2.209; Swietnicki W, 2004, J BIOL CHEM, V279, P38693, DOI 10.1074/jbc.M405217200; Szaba FM, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004142; Tscharke DC, 2015, NAT REV IMMUNOL, V15, P705, DOI 10.1038/nri3905; VISELTEAR AJ, 1974, YALE J BIOL MED, V47, P40; von Pawel-Rammingen U, 2000, MOL MICROBIOL, V36, P737, DOI 10.1046/j.1365-2958.2000.01898.x; Wang SX, 2011, VACCINE, V29, P6802, DOI 10.1016/j.vaccine.2010.12.062; Williamson ED, 2013, CLIN EXP IMMUNOL, V172, P1, DOI 10.1111/cei.12044; Zhang Y, 2014, INFECT IMMUN, V82, P3033, DOI 10.1128/IAI.01687-14; Zhang Y, 2012, INFECT IMMUN, V80, P206, DOI 10.1128/IAI.05971-11; Zhong YM, 2010, INFECT IMMUN, V78, P3716, DOI 10.1128/IAI.00203-10	36	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0172314	10.1371/journal.pone.0172314	http://dx.doi.org/10.1371/journal.pone.0172314			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207901	Green Published, Green Submitted, gold			2022-12-27	WOS:000394424500120
J	de Opakua, AI; Merino, N; Villate, M; Cordeiro, TN; Ormaza, G; Sanchez-Carbayo, M; Diercks, T; Bernado, P; Blanco, FJ				Ibanez de Opakua, Alain; Merino, Nekane; Villate, Maider; Cordeiro, Tiago N.; Ormaza, Georgina; Sanchez-Carbayo, Marta; Diercks, Tammo; Bernado, Pau; Blanco, Francisco J.			The metastasis suppressor KISS1 is an intrinsically disordered protein slightly more extended than a random coil	PLOS ONE			English	Article							NATIVELY UNFOLDED PROTEINS; SMALL-ANGLE SCATTERING; NMR CHEMICAL-SHIFTS; COUPLED RECEPTOR; BLADDER-CANCER; CONFORMATIONAL SELECTION; DIPOLAR COUPLINGS; CELLS; GENE; EXPRESSION	The metastasis suppressor KISS1 is reported to be involved in the progression of several solid neoplasias, making it a promising molecular target for controlling their metastasis. The KISS1 sequence contains an N-terminal secretion signal and several dibasic sequences that are proposed to be the proteolytic cleavage sites. We present the first structural characterization of KISS1 by circular dichroism, multi-angle light scattering, small angle X-Ray scattering and NMR spectroscopy. An analysis of the KISS1 backbone NMR chemical shifts does not reveal any preferential conformation and deviation from a random coil ensemble. The backbone N-15 transverse relaxation times indicate a mildly reduced mobility for two regions that are rich in bulky residues. The small angle X-ray scattering curve of KISS1 is likewise consistent with a predominantly random coil ensemble, although an ensemble optimization analysis indicates some preference for more extended conformations possibly due to positive charge repulsion between the abundant basic residues. Our results support the hypothesis that KISS1 mostly samples a random coil conformational space, which is consistent with its high susceptibility to proteolysis and the generation of Kisspeptin fragments.	[Ibanez de Opakua, Alain; Merino, Nekane; Villate, Maider; Ormaza, Georgina; Diercks, Tammo; Blanco, Francisco J.] CIC bioGUNE, Derio, Spain; [Cordeiro, Tiago N.; Bernado, Pau] Univ Montpellier I, CNRS UMR 5048, INSERM U1054, Ctr Biochim Struct, Montpellier, France; [Cordeiro, Tiago N.; Bernado, Pau] Univ Montpellier 2, CNRS UMR 5048, INSERM U1054, Ctr Biochim Struct, Montpellier, France; [Sanchez-Carbayo, Marta] Univ Basque Country, Lucio Lascaray Res Ctr, Vitoria, Spain; [Sanchez-Carbayo, Marta; Blanco, Francisco J.] Basque Fdn Sci, Ikerbasque, Bilbao, Spain; [Cordeiro, Tiago N.] Univ Copenhagen, Niels Bohr Inst, Copenhagen, Denmark	CIC bioGUNE; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; University of Basque Country; Basque Foundation for Science; University of Copenhagen; Niels Bohr Institute	Blanco, FJ (corresponding author), CIC bioGUNE, Derio, Spain.; Blanco, FJ (corresponding author), Basque Fdn Sci, Ikerbasque, Bilbao, Spain.	fblanco@cicbiogune.es	Blanco, Francisco J/D-4401-2009; Cordeiro, Tiago N/E-9842-2012; Diercks, Tammo/G-1167-2011; Merino, Nekane/L-8203-2014; Diercks, Tammo/AAT-3731-2021; Ibáñez de Opakua, Alain/H-5081-2018	Blanco, Francisco J/0000-0003-2545-4319; Cordeiro, Tiago N/0000-0003-2663-3220; Diercks, Tammo/0000-0002-5200-0905; Merino, Nekane/0000-0003-0721-4813; Diercks, Tammo/0000-0002-5200-0905; Ibáñez de Opakua, Alain/0000-0003-1700-9354; Bernado, Pau/0000-0001-7395-5922	Ministerio de Economia y Competitividad [CTQ2014-56966-R]; Agence National de Recherche SR1N-HD ANR Chaires d'Excellence; French Infrastructure for Integrated Structural Biology (FRISBI) [ANR-10-INSB-05-01]; ATIP-Avenir	Ministerio de Economia y Competitividad(Spanish Government); Agence National de Recherche SR1N-HD ANR Chaires d'Excellence(French National Research Agency (ANR)); French Infrastructure for Integrated Structural Biology (FRISBI); ATIP-Avenir	Support was provided by: Ministerio de Economia y Competitividad [http://www.mineco.gob.es/portal/site/mineco/] CTQ2014-56966-R to FJB; Agence National de Recherche [http://www.agence-nationale-recherche.fr/] SR1N-HD ANR Chaires d'Excellence to PB; ATIP-Avenir [http://www.aviesan.fr/en/aviesan/home/atip-averur-prograrp] to PB; The French Infrastructure for Integrated Structural Biology (FRISBI - ANR-10-INSB-05-01) to PB.	Beck BH, 2010, EUR J CANCER, V46, P1283, DOI 10.1016/j.ejca.2010.02.023; Bernado A P, 2012, ROYAL SOC CHEM, V8, P151, DOI [10.1039/c1mb05275f, DOI 10.1039/C1MB05275F]; Bernado P, 2005, P NATL ACAD SCI USA, V102, P17002, DOI 10.1073/pnas.0506202102; Bernado P, 2007, J AM CHEM SOC, V129, P5656, DOI 10.1021/ja069124n; Bernado P, 2009, BIOPHYS J, V97, P2839, DOI 10.1016/j.bpj.2009.08.044; Brill LM, 2004, ANAL CHEM, V76, P2763, DOI 10.1021/ac035352d; Cebrian V, 2011, AM J PATHOL, V179, P540, DOI 10.1016/j.ajpath.2011.05.009; Cho MK, 2007, J AM CHEM SOC, V129, P3032, DOI 10.1021/ja067482k; Click TH, 2010, INT J MOL SCI, V11, P5293, DOI 10.3390/ijms11125292; De Biasio A, 2014, BIOPHYS J, V106, P865, DOI 10.1016/j.bpj.2013.12.046; Dosztanyi Z, 2009, BIOINFORMATICS, V25, P2745, DOI 10.1093/bioinformatics/btp518; Dyson HJ, 2004, CHEM REV, V104, P3607, DOI 10.1021/cr030403s; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Eyal E, 2004, J COMPUT CHEM, V25, P712, DOI 10.1002/jcc.10420; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Ganguly D, 2012, MOL BIOSYST, V8, P198, DOI 10.1039/c1mb05156c; Goddar T. D., 2008, SPARKY NMR ASSIGNMEN; Guinier A., 1939, ANN PHYS-LEIPZIG, DOI DOI 10.1051/ANPHYS/193911120161; Hammes GG, 2009, P NATL ACAD SCI USA, V106, P13737, DOI 10.1073/pnas.0907195106; Harihar S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084958; Iakoucheva LM, 2002, J MOL BIOL, V323, P573, DOI 10.1016/S0022-2836(02)00969-5; Ishida T, 2008, BIOINFORMATICS, V24, P1344, DOI 10.1093/bioinformatics/btn195; Jung YS, 2004, ANGEW CHEM INT EDIT, V43, P3479, DOI 10.1002/anie.200353588; Kjaergaard M, 2011, J BIOMOL NMR, V50, P157, DOI 10.1007/s10858-011-9508-2; Kjaergaard M, 2011, J BIOMOL NMR, V49, P139, DOI 10.1007/s10858-011-9472-x; Knott M, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002605; Kotani M, 2001, J BIOL CHEM, V276, P34631, DOI 10.1074/jbc.M104847200; Lee JH, 1996, JNCI-J NATL CANCER I, V88, P1731, DOI 10.1093/jnci/88.23.1731; Liu JG, 2006, BIOCHEMISTRY-US, V45, P6873, DOI 10.1021/bi0602718; Marley J, 2001, J BIOMOL NMR, V20, P71, DOI 10.1023/A:1011254402785; Marsh JA, 2012, PROTEINS, V80, P556, DOI 10.1002/prot.23220; Milton NGN, 2012, ACS CHEM NEUROSCI, V3, P706, DOI 10.1021/cn300045d; Mittag T, 2007, CURR OPIN STRUC BIOL, V17, P3, DOI 10.1016/j.sbi.2007.01.009; Muir AI, 2001, J BIOL CHEM, V276, P28969, DOI 10.1074/jbc.M102743200; Nash KT, 2007, JNCI-J NATL CANCER I, V99, P309, DOI 10.1093/jnci/djk053; Nash KT, 2006, FRONT BIOSCI-LANDMRK, V11, P647, DOI 10.2741/1824; Navarro VM, 2012, NAT REV ENDOCRINOL, V8, P40, DOI 10.1038/nrendo.2011.147; Ohtaki T, 2001, NATURE, V411, P613, DOI 10.1038/35079135; Orsini MJ, 2007, J MED CHEM, V50, P462, DOI 10.1021/jm0609824; Ozenne V, 2012, BIOINFORMATICS, V28, P1463, DOI 10.1093/bioinformatics/bts172; Pernot P, 2013, J SYNCHROTRON RADIAT, V20, P660, DOI 10.1107/S0909049513010431; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Rambo RP, 2013, NATURE, V496, P477, DOI 10.1038/nature12070; Ruppen I, 2010, MOL CELL PROTEOMICS, V9, P2276, DOI 10.1074/mcp.M900255-MCP200; Sanchez-Carbayo M, 2003, AM J PATHOL, V162, P609, DOI 10.1016/S0002-9440(10)63854-0; Schubert M, 2002, J BIOMOL NMR, V24, P149, DOI 10.1023/A:1020997118364; Schwarzinger S, 2001, J AM CHEM SOC, V123, P2970, DOI 10.1021/ja003760i; Sharma D, 2000, J BIOMOL NMR, V18, P165, DOI 10.1023/A:1008398416292; Shin R, 2009, CLIN EXP METASTAS, V26, P527, DOI 10.1007/s10585-009-9252-0; Sibille N, 2012, BIOCHEM SOC T, V40, P955, DOI 10.1042/BST20120149; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Tamiola K, 2010, J AM CHEM SOC, V132, P18000, DOI 10.1021/ja105656t; Tena-Sempere M, 2008, NAT MED, V14, P1196, DOI 10.1038/nm1108-1196; Tompa P, 2008, TRENDS BIOCHEM SCI, V33, P2, DOI 10.1016/j.tibs.2007.10.003; Topaloglu AK, 2012, NEW ENGL J MED, V366, P629, DOI 10.1056/NEJMoa1111184; Uversky Vladimir N, 2012, Methods Mol Biol, V896, P179, DOI 10.1007/978-1-4614-3704-8_11; Uversky VN, 2000, PROTEINS, V41, P415, DOI 10.1002/1097-0134(20001115)41:3<415::AID-PROT130>3.3.CO;2-Z; Uversky VN, 2002, PROTEIN SCI, V11, P739, DOI 10.1110/ps.4210102; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; WELCH DR, 1994, ONCOGENE, V9, P255; WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777; Wright PE, 2009, CURR OPIN STRUC BIOL, V19, P31, DOI 10.1016/j.sbi.2008.12.003	63	3	3	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0172507	10.1371/journal.pone.0172507	http://dx.doi.org/10.1371/journal.pone.0172507			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207895	Green Submitted, Green Published, gold			2022-12-27	WOS:000394424500142
J	Li, JC; Wang, XB; Song, WW; Huang, XY; Zhou, J; Zeng, HY; Sun, S; Jia, HC; Li, WB; Zhou, XN; Li, SZ; Chen, PY; Wu, CX; Guo, Y; Han, TF; Qiu, LJ				Li, Jicun; Wang, Xiaobo; Song, Wenwen; Huang, Xinyang; Zhou, Jing; Zeng, Haiyan; Sun, Shi; Jia, Hongchang; Li, Wenbin; Zhou, Xinan; Li, Suzhen; Chen, Pengyin; Wu, Cunxiang; Guo, Yong; Han, Tianfu; Qiu, Lijuan			Genetic variation of maturity groups and four E genes in the Chinese soybean mini core collection	PLOS ONE			English	Article							MAP-BASED CLONING; AGRONOMIC TRAITS; RESISTANCE; CLASSIFICATION; DIVERSITY; SELECTION; TIME	The mini core collection (MCC) has been established by streamlining core collection (CC) chosen from China National Genebank including 23,587 soybean (Glycine max) accessions by morphological traits and simple sequence repeat (SSR) markers. Few studies have been focused on the maturity that has been considered as one of the most critical traits for the determination of the adaptation-growing region of the soybean. In the current study, two hundred and ninty-nine accessions of MCC planted for two years at four locations namely in Heihe, Harbin, Jining and Wuhan cities in China were used to assess the variation of maturity in MCC and identify the integrated effect of 4 E loci on flowering and maturity time in soybean. Forty-two North American varieties served as references of maturity groups (MG). Each accession in MCC was classified by comparing with the MG references in the days from VE (emergence) and physiological maturity (R7). The results showed that MCC covered a large range of MGs from MG000 to MGIX/X. Original locations and sowing types were revealed as the major affecting factors for maturity groups of the MCC accessions. The ratio of the reproductive period to the vegetative period (R/V) varied among MCC accessions. Genotyping of 4 maturity genes (i.e. E1, E2, E3 and E4) in 228 accessions indicated that recessive alleles e1, e2, e3 and e4 promoted earlier flowering and shortened the maturity time with different effects, while the dominate alleles were always detected in accessions with longer maturity. The allelic combinations determined the diversification of soybean maturity groups and adaptation to different regions. Our results indicated that the maturity of Chinese soybean MCC showed genetic diversities in phenotype and genotype, which provided information for further MG classification, geographic adaptation analysis of Chinese soybean cultivars, as well as developing new soybean varieties with adaptation to specific regions.	[Li, Jicun; Wang, Xiaobo; Song, Wenwen; Zeng, Haiyan; Sun, Shi; Wu, Cunxiang; Guo, Yong; Han, Tianfu; Qiu, Lijuan] Chinese Acad Agr Sci, MOA Key Lab Soybean Biol Beijing, Inst Crop Sci, Beijing, Peoples R China; [Li, Jicun; Huang, Xinyang; Zhou, Jing; Li, Suzhen] Jining Acad Agr Sci, Jining, Shandong, Peoples R China; [Wang, Xiaobo] Anhui Agr Univ, Sch Agron, Hefei, Peoples R China; [Jia, Hongchang] Heilongjiang Acad Agr Sci, Heihe Branch, Heihe, Peoples R China; [Li, Wenbin] Northeast Agr Univ, Coll Agron, Harbin, Peoples R China; [Zhou, Xinan] Chinese Acad Agr Sci, Oil Crops Res Inst, Wuhan, Peoples R China; [Chen, Pengyin] Univ Arkansas, Dept Crop Soil & Environm Sci, Fayetteville, AR 72701 USA	Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Anhui Agricultural University; Heilongjiang Academy of Agricultural Sciences; Northeast Agricultural University - China; Chinese Academy of Agricultural Sciences; Oil Crops Research Institute, CAAS; University of Arkansas System; University of Arkansas Fayetteville	Wu, CX; Guo, Y; Han, TF; Qiu, LJ (corresponding author), Chinese Acad Agr Sci, MOA Key Lab Soybean Biol Beijing, Inst Crop Sci, Beijing, Peoples R China.	wucunxiang@caas.cn; guoyong@caas.cn; hantianfu@caas.cn; qiulijuan@caas.cn	wang, xiaobo/T-7023-2019		Chinese Academy of Agricultural Sciences (CAAS); China Agriculture Research System (CARS) [CARS-04]	Chinese Academy of Agricultural Sciences (CAAS); China Agriculture Research System (CARS)	This study was supported by the Chinese Academy of Agricultural Sciences (CAAS) Innovation Project to LQ and TH, and China Agriculture Research System (CARS) to TH (CARS-04).; This study was supported by the Chinese Academy of Agricultural Sciences (CAAS) Innovation Project to LQ and TH, and China Agriculture Research System (CARS) to TH (CARS-04). We thank Professor Randall L. Nelson (Pathology and Genetics Research Unit and Department of Crop Sciences, Soybean/Maize Germplasm, Agricultural Research Service, United States Department of Agriculture, University of Illinois, Urbana, Illinois, United States of America) for providing the US soybean germplasm.	Alliprandini LF, 2009, CROP SCI, V49, P801, DOI 10.2135/cropsci2008.07.0390; [Anonymous], ACTA AGRONOMICA SINI; Baigorri HE, 2002, AN 2 C BRAS SOJ MERC, P84; BERNARD RL, 1971, CROP SCI, V11, P242, DOI 10.2135/cropsci1971.0011183X001100020022x; Bonato ER, 1999, GENET MOL BIOL, V22, P229, DOI 10.1590/S1415-47571999000200016; Brown A. H. D., 1995, P3; Buzzell R. I., 1980, SOYBEAN GENETICS NEW, V7, P26, DOI DOI 10.1093/JHERED/ESP113; BUZZELL RI, 1971, CAN J GENET CYTOL, V13, P703, DOI 10.1139/g71-100; Chang RZ, 1989, CHINA SEED IND, P4; Chang RZ, 1992, SOYBEAN SCI, V11, P127; [陈珊宇 CHEN Shan-yu], 2009, [中国油料作物学报, Chinese Journal of Oil Crop Sciences], V31, P513; Cober ER, 2010, CROP SCI, V50, P524, DOI 10.2135/cropsci2009.04.0174; Cober ER, 1996, CROP SCI, V36, P601, DOI 10.2135/cropsci1996.0011183X003600030013x; Cui YH, 2003, J PLANT GENET RESOUR, V27, P286; Curtis DF, 2000, CROP SCI, V40, P1624, DOI 10.2135/cropsci2000.4061624x; Dong YS, 2004, THEOR APPL GENET, V108, P931, DOI 10.1007/s00122-003-1503-x; Doyle J. J., 1987, PHYTOCHEM B, P11; Ellis PR, 1998, EUPHYTICA, V103, P149, DOI 10.1023/A:1018342101069; FEHR W. R., 1977, STAGES SOYBEAN DEV; FRANKEL OH, 1984, CURRENT PLANT GENETI; Gabriel Stacey, 2009, Curr Protoc Hum Genet, VChapter 2, DOI 10.1002/0471142905.hg0212s60; Gai J., 2001, ACTA AGRONOMICA SINI, V27, P286; Gai JY, 1999, REV CHINA AGR SCI TE, V1, P26; Guo Y, 2013, THEOR APPL GENET, V126, P1445, DOI 10.1007/s00122-013-2063-3; Han TianFu, 1998, Acta Agronomica Sinica, V24, P550; Hao G., 1992, Acta Agronomica Sinica, V18, P275; Hartwig EE, 1970, CROP SCI, V12, P47; Hill JL, 2005, USDA TECHNICAL B, V1914; Holbrook CC, 2000, CROP SCI, V40, P1172, DOI 10.2135/cropsci2000.4041172x; Jiang BJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106042; Jiang HongWei, 2009, Acta Agronomica Sinica, V35, P1268, DOI 10.3724/SP.J.1006.2009.01268; Khan NA, 2008, THEOR APPL GENET, V117, P479, DOI 10.1007/s00122-008-0792-5; Liu B, 2008, GENETICS, V180, P995, DOI 10.1534/genetics.108.092742; [刘亚男 LIU Ya-nan], 2009, [植物遗传资源学报, Journal of Plant Genetic Resources], V10, P211; Malvar RA, 2004, J ECON ENTOMOL, V97, P628, DOI 10.1603/0022-0493-97.2.628; Mansur LM, 1996, CROP SCI, V36, P1327, DOI 10.2135/cropsci1996.0011183X003600050042x; MCBLAIN BA, 1987, J HERED, V78, P160, DOI 10.1093/oxfordjournals.jhered.a110349; Poehlman J.M., 1987, BREEDING FIELD CROPS, P421, DOI [10.1007/978-94-015-7271-2_17, DOI 10.1007/978-94-015-7271-2_17]; Qiu LJ, 2013, PLANT MOL BIOL, V83, P41, DOI 10.1007/s11103-013-0076-6; Qiu LiJuan, 2009, Acta Agronomica Sinica, V35, P571, DOI 10.3724/SP.J.1006.2009.00571; Qiu PengCheng, 2011, Acta Agronomica Sinica, V37, P477, DOI 10.3724/SP.J.1006.2011.00477; RAY JD, 1995, CROP SCI, V35, P1001, DOI 10.2135/cropsci1995.0011183X003500040012x; Ren Q. X., 1987, Scientia Agricultura Sinica, V20, P23; Scott W.O., 1970, MODERN SOYBEAN PRODU; Song XiE, 2010, Scientia Agricultura Sinica, V43, P2209; Takahashi R, 1999, CROP SCI, V39, P1657, DOI 10.2135/cropsci1999.3961657x; Tardivel A, 2014, PLANT GENOME-US, V7, DOI 10.3835/plantgenome2013.10.0034; Tian ZX, 2010, P NATL ACAD SCI USA, V107, P8563, DOI 10.1073/pnas.1000088107; Tsubokura Y, 2014, ANN BOT-LONDON, V113, P429, DOI 10.1093/aob/mct269; Wang GX, 1981, SCI AGR SIN, V14, P21; Wang JL, 1956, J AGR SCI, V7, P169; [王林林 WANG Linlin], 2008, [植物遗传资源学报, Journal of Plant Genetic Resources], V9, P68; Wang LX, 2006, EUPHYTICA, V151, P215, DOI 10.1007/s10681-006-9142-3; Wang Ying, 2008, Acta Agronomica Sinica, V34, P1160, DOI 10.3724/SP.J.1006.2008.01160; Wang Y, 2015, EUPHYTICA, V201, P275, DOI 10.1007/s10681-014-1209-y; Wang YS, 2006, GENET RESOUR CROP EV, V53, P803, DOI 10.1007/s10722-004-5731-y; Watanabe S, 2011, GENETICS, V188, P395, DOI 10.1534/genetics.110.125062; Watanabe S, 2009, GENETICS, V182, P1251, DOI 10.1534/genetics.108.098772; Wu CX, 2013, ACTA AGRON SIN, V38, P1977; Xia ZJ, 2012, P NATL ACAD SCI USA, V109, pE2155, DOI 10.1073/pnas.1117982109; Zhang L, 2007, CROP MANAGE	61	17	24	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0172106	10.1371/journal.pone.0172106	http://dx.doi.org/10.1371/journal.pone.0172106			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207889	Green Published, gold, Green Submitted			2022-12-27	WOS:000394424500084
J	Lin, LX; Yuan, F; Zhang, HH; Liao, NN; Luo, JW; Sun, YL				Lin, Long-Xiang; Yuan, Fang; Zhang, Hui-Hui; Liao, Ni-Na; Luo, Jing-Wan; Sun, Yu-Long			Evaluation of surgical anti-adhesion products to reduce postsurgical intra-abdominal adhesion formation in a rat model	PLOS ONE			English	Article							POSTOPERATIVE ADHESIONS; PERITONEAL ADHESIONS; PREVENTION; SURGERY; BARRIER; GEL	.Background Adhesions frequently occur after abdominal surgery. Many anti-adhesion products have been used in clinic. However, the evidences are short for surgeons to reasonably choose the suitable anti-adhesion produces in clinical practice. This study provided such evidence by comparing the efficiency of five products to prevent abdominal adhesion formation in a rat model. Methods Fifty-six Sprague-Dawley rats were randomly divided into seven groups: sham-operation group, adhesion group, and five product groups (n = 8). The abdomens of rats were opened. The injuries were created on abdominal wall and cecum in the adhesion and product groups. The wounds on abdominal wall and cecum of rats in the adhesion group were not treated before the abdomens were closed. The wounds on abdominal wall and cecum of rats in the product groups were covered with anti-adhesion product: polylactic acid (PLA) film, Seprafilm((R)) , medical polyethylene glycol berberine liquid (PEG), medical sodium hyaluronate gel (HA), or medical chitosan (Chitosan). Fourteen days after surgery, the adhesions were evaluated by incidence, severity, adhesion area on abdominal wall and adhesion breaking strength. Results The application of PLA film and Seprafilm((R)) significantly reduced the incidence, severity, adhesion area and breaking strength of cecum-abdomen adhesion (P< 0.05). HA, PEG and Chitosan failed to significantly reduce the cecum-abdomen adhesion (P> 0.05). The statistical significances in the incidence and severity of abdomen-adipose adhesion between adhesion group and the product groups were not achieved. However, Seprafilm r was more effective to reduce abdomen-adipose adhesion than PLA film. Furthermore, it was found that the products tested in this study did not effectively reduce cecum-adipose adhesion. The application of PEG could result in abdomen-small intestine adhesion. Conclusion Based on the results of this study, the preference order of anti-adhesion products used to reduce postsurgical intra-abdominal adhesion formation is Seprafilm > PLA >> HA > Chitosan > PEG	[Lin, Long-Xiang; Yuan, Fang; Zhang, Hui-Hui; Liao, Ni-Na; Luo, Jing-Wan; Sun, Yu-Long] Chinese Acad Sci, Shenzhen Inst Adv Technol, Shenzhen, Guangdong, Peoples R China	Chinese Academy of Sciences; Shenzhen Institute of Advanced Technology, CAS	Sun, YL (corresponding author), Chinese Acad Sci, Shenzhen Inst Adv Technol, Shenzhen, Guangdong, Peoples R China.	yl.sun@siat.ac.cn	Zhang, Hui/HHN-8494-2022; zhang, hui/GXH-6098-2022		"Hundred Talents Program" of Chinese Academy of Sciences,Shenzhen Research Programs [JCYJ20140417113430613, KQCX2015033117354153]	"Hundred Talents Program" of Chinese Academy of Sciences,Shenzhen Research Programs	"Hundred Talents Program" of Chinese Academy of Sciences, Yu-Long Sun; Shenzhen Research Programs (JCYJ20140417113430613 and KQCX2015033117354153) Yu-Long Sun, http://www.szsti.gov.cn/.. The funder participate in the study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Alponat A, 1997, AM SURGEON, V63, P818; Arung W, 2012, J LAPAROENDOSC ADV S, V22, P651, DOI 10.1089/lap.2012.0102; Arung W, 2011, WORLD J GASTROENTERO, V17, P4545, DOI 10.3748/wjg.v17.i41.4545; ELLIS H, 1982, BRIT J SURG, V69, P241, DOI 10.1002/bjs.1800690502; Ersoy E, 2009, J GASTROINTEST SURG, V13, P282, DOI 10.1007/s11605-008-0678-5; HARRIS ES, 1995, SURGERY, V117, P663, DOI 10.1016/S0039-6060(95)80010-7; Liu Mei-Mei, 2012, Zhonghua Fu Chan Ke Za Zhi, V47, P255; Ma F, 2012, CHINA MED ENG, V20, P68; Mais V, 2006, HUM REPROD, V21, P1248, DOI 10.1093/humrep/dei488; MENZIES D, 1990, ANN ROY COLL SURG, V72, P60; Mettler L, 2008, HUM REPROD, V23, P1093, DOI 10.1093/humrep/den080; Mettler L, 2003, J AM ASSOC GYN LAP, V10, P339, DOI 10.1016/S1074-3804(05)60258-7; Ouaissi M, 2012, J VISC SURG, V149, pE104, DOI 10.1016/j.jviscsurg.2011.11.006; Sun YL, 2004, J ORTHOP RES, V22, P984, DOI 10.1016/j.orthres.2004.02.005; van Goor H, 2007, COLORECTAL DIS, V9, P25, DOI 10.1111/j.1463-1318.2007.01358.x; Vlahos A, 2001, AM SURGEON, V67, P15; Ward BC, 2011, J SURG RES, V165, P91, DOI 10.1016/j.jss.2009.09.015; Yuan F, 2016, J BIOMED MATER RES A, V104, P1175, DOI 10.1002/jbm.a.35653	18	31	32	4	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0172088	10.1371/journal.pone.0172088	http://dx.doi.org/10.1371/journal.pone.0172088			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207824	Green Published, Green Submitted, gold			2022-12-27	WOS:000394424500081
J	Lopez-Montalvo, E; Roldan, C; Badal, E; Murcia-Mascaros, S; Villaverde, V				Lopez-Montalvo, Esther; Roldan, Clodoaldo; Badal, Ernestina; Murcia-Mascaros, Sonia; Villaverde, Valentin			Identification of plant cells in black pigments of prehistoric Spanish Levantine rock art by means of a multi-analytical approach. A new method for social identity materialization using charne operatoire	PLOS ONE			English	Article							RAMAN-SPECTROSCOPY; OPEN-AIR; IN-SITU; PAINTINGS; CAVE	We present a new multi-analytical approach to the characterization of black pigments in Spanish Levantine rock art. This new protocol seeks to identify the raw materials that were used, as well as reconstruct the different technical gestures and decision-making processes involved in the obtaining of these black pigments. For the first of these goals, the pictorial matter of the black figurative motifs documented at the Les Dogues rock art shelter (Ares del Maestre, Castellon, Spain) was characterized through the combination of physicochemical and archeobotanical analyses. During the first stage of our research protocol, in situ and nondestructive analyses were carried out by means of portable Energy Dispersive X-Ray Fluorescence spectrometry (EDXRF); during the second stage, samples were analyzed by Optical Microscopy (OM), Raman spectroscopy, and Scanning Electron Microscopy coupled with Energy Dispersive X-ray spectroscopy (SEM-EDX). Two major conclusions have been drawn from these analyses: first, charred plant matter has been identified as a main component of these prehistoric black pigments; and second, angiosperm and conifer charcoal was a primary raw material for pigment production, identified by means of the archaeobotanical study of plant cells. For the second goal, black charcoal pigments were replicated in the laboratory by using different raw materials and binders and by reproducing two main chafnes operatoires. The comparative study of the structure and preservation of plant tissues of both prehistoric and experimental pigments by means of SEM-EDX underlines both a complex preparation process and the use of likely pigment recipes, mixing raw material with fatty or oily binders. Finally, the formal and stylistic analysis of the motifs portrayed at Les Dogues allowed us to explore the relationship between identified stylistic phases and black charcoal pigment use, raising new archaeological questions concerning the acquisition of know-how and the transfer of traditionally learned chafnes operatoires in Spanish Levantine rock art.	[Lopez-Montalvo, Esther] Univ Toulouse 2 Jean Jaures, French Natl Ctr Sci Res CNRS, UMR TRACES 5608, 5 Allees Antonio Machado, Toulouse, France; [Roldan, Clodoaldo; Murcia-Mascaros, Sonia] Univ Valencia ICMUV, Inst Mat Sci, C Catedrat Jose Beltran 2, Paterna Valencia, Spain; [Badal, Ernestina; Villaverde, Valentin] Univ Valencia Spain, Dept Prehist & Archaeol, Ave Blasco Ibanez 28, Valencia, Spain	Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; University of Valencia	Lopez-Montalvo, E (corresponding author), Univ Toulouse 2 Jean Jaures, French Natl Ctr Sci Res CNRS, UMR TRACES 5608, 5 Allees Antonio Machado, Toulouse, France.	esther.lopez-montalvo@univ-tlse2.fr	Roldán, Clodoaldo/K-5095-2014; Murcia-Mascarós, Sonia/L-1183-2014; Villaverde, Valentin/L-2153-2015; Badal Garcia, Ernestina/K-9462-2014	Roldán, Clodoaldo/0000-0001-5988-1189; Murcia-Mascarós, Sonia/0000-0001-5224-8938; Villaverde, Valentin/0000-0002-2876-0306; Badal Garcia, Ernestina/0000-0002-8296-1870; Lopez-Montalvo, Esther/0000-0002-3112-1329	European Union's 7th Framework Programme for Research and Technological Development [628428]	European Union's 7th Framework Programme for Research and Technological Development	This research has been funded by the European Union's 7th Framework Programme for Research and Technological Development (2007-2013)- Marie Curie Actions; Research Project "NEOSOCWESTMED" (no 628428), ELM. "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."	[Anonymous], 2009, COVA CENDRES MORAIRA; [Anonymous], [No title captured]; [Anonymous], [No title captured]; Antolin F., 2010, ACT 30 RENC INT ARCH, P317; Arias P, 2011, ANTHROPOLOGIE, V115, P425, DOI 10.1016/j.anthro.2011.05.005; Badal E., 2012, SAGVNTUM EXTRA, V13, P13; Ballester L, 2010, ABRIGO CIERVOS NEGRO, P127; Bernardez R Montes, 1991, ANALES PREHISTORIA A, V7-8, P69; Ferme LC, 2014, HOLOCENE, V24, P266, DOI 10.1177/0959683613517400; Castro K, 2005, ANAL BIOANAL CHEM, V382, P248, DOI 10.1007/s00216-005-3072-0; Chalmin E., 2003, THESIS; Chalmin E, PICTURALES GROTTE DE; Clottes J., 1990, B SOC PREHISTORIQUE, V87, P170, DOI DOI 10.3406/BSPF.1990.10434; CLOTTES J, 1994, COMPLUTUM, V5, P221; Coccato A, 2015, J RAMAN SPECTROSC, V46, P1003, DOI 10.1002/jrs.4715; Cole N, 1992, ROCK ART RES, V9, P27; Conti C, 2012, J RAMAN SPECTROSC, V43, P1604, DOI 10.1002/jrs.4072; Couraud C, 1979, LASCAUX INCONNU XLLE, P153; Cresswell R., 1994, PREHISTORY BALLISTIC, P273; Behrmann RD, 2009, ANTHROPOLOGIE, V113, P559, DOI 10.1016/j.anthro.2009.09.012; del Hoyo J, 2015, REMOTE SENS SPATIAL, P53, DOI I; Domingo I., 2006, ARCH PREHISTORIA LEV, V26, P161; Garcia O., 2004, ARCH PREHISTORIA LEV, V25, P61; Gay M, 2015, J ANAL ATOM SPECTROM, V30, P767, DOI 10.1039/c4ja00396a; Gismero A Hernanz, 2012, PROBLEMA LEVANTINO, P345; Gosselain O.P, 2011, OXFORD HDB ARCHAEOLO, P246; Guineau B, 2001, ARCHAEOMETRY, V43, P211, DOI 10.1111/1475-4754.00015; Hernanz A, 2007, J OPTOELECTRON ADV M, V9, P512; Hernanz A, 2014, J RAMAN SPECTROSC, V45, P1236, DOI 10.1002/jrs.4535; Hernanz A, 2010, J RAMAN SPECTROSC, V41, P1394, DOI 10.1002/jrs.2582; Jeffra CD, 2015, ARCHAEOL ANTHROP SCI, V7, P141, DOI 10.1007/s12520-014-0177-4; Lemonnier P., 1976, TECHNIQUE CULTURE, V1, P100; Lewis-Williams J. D, 1994, COMPLUTUM, V5, P277; Lopez Montalvo E., 2007, ANALISIS INTERNO ART; Lopez-Montalvo E, 2015, ANTIQUITY, V89, P309, DOI 10.15184/aqy.2014.12; Lopez-Montalvo E, 2014, J ARCHAEOL SCI, V52, P535, DOI 10.1016/j.jas.2014.09.017; LopezMontalvo E, 2011, ARMEMENT IMAGE GUERR, P19; Marti B., 2002, SARGA ARTE RUPESTRE, P147; Marti B, 2013, U OVETENSIS MAGISTER, P467; Navarro Gascon J.V., 2003, ARTE PREHISTORICO IN, P161; Olivares M, 2013, J ARCHAEOL SCI, V40, P1354, DOI 10.1016/j.jas.2012.10.008; PEPE C, 1991, CR ACAD SCI II, V312, P929; Pitarch A, 2014, ANAL METHODS-UK, V6, P6641, DOI 10.1039/c4ay00539b; Ripolles J B Porcar, 1953, ARCH PREHISTORIA LEV, V4, P75; Rodriguez-Ariza M O., 2011, MENGA J ANDALUSIAN P, V2, P220; Roldan C, 2014, P 10 C IB ARQ 2013 1, P128; Roldan C, LOS ABRIGOS; Roldan C, 2010, X-RAY SPECTROM, V39, P243, DOI 10.1002/xrs.1254; Roux V., 2005, POTTERY MANUFACTURIN, V1349, P201; Sole VA, 2007, SPECTROCHIM ACTA B, V62, P63, DOI 10.1016/j.sab.2006.12.002; Tomasini EP, 2012, J RAMAN SPECTROSC, V43, P1671, DOI 10.1002/jrs.4159; Villaverde V., 2002, COVA DELS CAVALLS BA, V1, P135	52	20	20	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0172225	10.1371/journal.pone.0172225	http://dx.doi.org/10.1371/journal.pone.0172225			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	EL2BG	28207835	gold, Green Published, Green Submitted			2022-12-27	WOS:000394424500104
J	Mi, K; Ou, X; Guo, LL; Ye, J; Wu, JY; Yi, S; Niu, XL; Sun, XQ; Li, HJ; Sun, MS				Mi, Kai; Ou, Xia; Guo, Lili; Ye, Jing; Wu, Jinyuan; Yi, Shan; Niu, Xianglian; Sun, Xiaoqin; Li, Hongjun; Sun, Maosheng			Comparative analysis of the immunogenicity of monovalent and multivalent rotavirus immunogens	PLOS ONE			English	Article							VACCINE	The strategies for developing rotavirus (RV) vaccines have always been controversial. At present, both the monovalent RV vaccine and the multivalent RV vaccine have displayed excellent safety and efficacy against RV infection and shown cross-reactive immunity, which laid the question whether the multivalent RV vaccine could be replaced by the monovalent RV vaccine. In this study, we focused on comparing the immunogenicity (serum neutralization activity and protection against homotypic and heterotypic RVs' challenge) of individual standard RV strains (monovalent RV immunogens) and different combinations of them (multivalent RV immunogens). In result, RV immunogens showed general immunogenicity and heterotypic reaction but the multivalent RV immunogens exhibited greater serum neutralization activity and stronger heterotypic reaction than the monovalent RV immunogens (P<0.05). As to the protection, the multivalent RV immunogens also revealed more rapid and stronger protection against homotypic and heterotypic RVs' challenge than the monovalent RV immunogens. The results demonstrated that both the monovalent and multivalent RV immunogens exhibited high immunogenicity, but the monovalent RV immunogens could not provide enough neutralization antibodies to protect MA104 cells against the infection with heterotypic RV strains and timely protection against homotypic and heterotypic RVs, so the multivalent RV vaccine could not be replaced by the monovalent RV vaccine.	[Mi, Kai; Guo, Lili; Ye, Jing; Wu, Jinyuan; Yi, Shan; Niu, Xianglian; Sun, Xiaoqin; Li, Hongjun; Sun, Maosheng] Chinese Acad Med Sci, Inst Med Biol, Yunnan Key Lab Vaccine Res & Dev Severe Infect Di, Kunming, Yunnan Province, Peoples R China; [Mi, Kai; Guo, Lili; Ye, Jing; Wu, Jinyuan; Yi, Shan; Niu, Xianglian; Sun, Xiaoqin; Li, Hongjun; Sun, Maosheng] Peking Union Med Coll, Kunming, Yunnan Province, Peoples R China; [Mi, Kai; Ou, Xia] Kunming Med Univ, Sch Basic Med, Kunming, Yunnan Province, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medical Biology - CAMS; Yunnan Key Laboratory of Vaccine Research & Development on Severe Infectious Diseases; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Kunming Medical University	Li, HJ; Sun, MS (corresponding author), Chinese Acad Med Sci, Inst Med Biol, Yunnan Key Lab Vaccine Res & Dev Severe Infect Di, Kunming, Yunnan Province, Peoples R China.; Li, HJ; Sun, MS (corresponding author), Peking Union Med Coll, Kunming, Yunnan Province, Peoples R China.	lihj6912@hotmail.com; maoshs@imbcams.com.cn			State Project For Essential Drug Research and Development, the National Twelfth Five-Year Plan [2014ZX09102041004]; National High Technology Research and Development Program (863 Program) of China [2012AA02A404]; Yunnan Research Program of Application Foundation and Advanced Technology, self-raised funds [2013FZ140]; PUMC Youth Fund; Fundamental Research Funds for the Central Universities [33320140082]; Science and Technology Plan Project of Yunnan Province-Key New Product Development [2014BC008]	State Project For Essential Drug Research and Development, the National Twelfth Five-Year Plan; National High Technology Research and Development Program (863 Program) of China(National High Technology Research and Development Program of China); Yunnan Research Program of Application Foundation and Advanced Technology, self-raised funds; PUMC Youth Fund; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Science and Technology Plan Project of Yunnan Province-Key New Product Development	This study was supported by the State Project For Essential Drug Research and Development, the National Twelfth Five-Year Plan (project number: 2014ZX09102041004) (receiver: MS, role: study design and decision to publish); the National High Technology Research and Development Program (863 Program) of China (project number: 2012AA02A404) (receiver: MS, role: study design and decision to publish); the Yunnan Research Program of Application Foundation and Advanced Technology, self-raised funds (project number: 2013FZ140) (receiver: JW, role: data collection and analysis); the PUMC Youth Fund and the Fundamental Research Funds for the Central Universities (project number: 33320140082) (receiver: YZ, role: the funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript); and Science and Technology Plan Project of Yunnan Province-Key New Product Development (project number: 2014BC008) (receiver: HL, role: study design and decision to publish).	Andrew DS, 2012, BMC INFECT DIS, V12, P213, DOI [10.1186/1471-2334-12-213, DOI 10.1186/1471-2334-12-213]; Bar-Zen N, 2015, LANCET INFECT DIS, V15, P422, DOI 10.1016/S1473-3099(14)71060-6; Bhandari N, 2014, VACCINE, V32, pA110, DOI 10.1016/j.vaccine.2014.04.079; Bresee J, 2004, EMERG INFECT DIS, V10, P988, DOI 10.3201/eid1006.030519; Chandran A, 2010, BIOL-TARGETS THER, V4, P213; Danchin M, 2013, VACCINE, V31, P2610, DOI 10.1016/j.vaccine.2013.04.008; Anh DD, 2012, VACCINE, V30, pA114, DOI 10.1016/j.vaccine.2011.07.118; Dennehy PH, 2008, CLIN MICROBIOL REV, V21, P198, DOI 10.1128/CMR.00029-07; [高芳銮 GAO Fangluan], 2008, [激光生物学报, Acta Laser Biology Sinica], V17, P486; Gorrell RJ, 1999, J MED VIROL, V57, P204, DOI 10.1002/(SICI)1096-9071(199902)57:2&lt;204::AID-JMV20&gt;3.0.CO;2-Y; Helder IN, 2011, NAT IMMUNOL, V12, P786; Jiang V, 2010, HUM VACCINES, V6, P532, DOI 10.4161/hv.6.7.11278; Lanata CF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072788; Li S, 2014, NAT IMMUNOL, V15, P195, DOI 10.1038/ni.2789; Mameli C, 2012, HUM VACC IMMUNOTHER, V8, P1022, DOI 10.4161/hv.20295; Matthijnssens J, 2008, ARCH VIROL, V153, P1621, DOI 10.1007/s00705-008-0155-1; Osamu N, 2007, CURRENT OPINION INFE, V20, P501, DOI [10.1097/QCO.0b013e3282a56ba0, DOI 10.1097/QCO.0B013E3282A56BA0]; Patton JT, 2012, DISCOV MED, V13, P85; Schwartz JL, 2012, MILBANK Q, V90, P278, DOI 10.1111/j.1468-0009.2012.00664.x; Tom P., 2014, NATURE, V507, pS10; Velasquez DE, 2014, INFECT GENET EVOL, V28, P561, DOI 10.1016/j.meegid.2014.10.008; Vesikari T, 2006, NEW ENGL J MED, V354, P23, DOI 10.1056/NEJMoa052664; Vesikari T, 2012, CLIN MICROBIOL INFEC, V18, P57, DOI 10.1111/j.1469-0691.2012.03981.x; [谢澎 Xie Peng], 2012, [中国新药杂志, Chinese Journal New Drugs], V21, P1107; Yang Xing, 2012, Chinese Journal of Biologicals, V25, P754; Yen C, 2011, HUM VACCINES, V7, P1282, DOI 10.4161/hv.7.12.18321; Yu C, 2013, CHINA FOREIGN MED TR, V28, P18; [章笑安 ZHANG Xiao-an], 2010, [中国全科医学, Chinese General Practice], V13, P1009	28	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0172156	10.1371/journal.pone.0172156	http://dx.doi.org/10.1371/journal.pone.0172156			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207817	gold, Green Published, Green Submitted			2022-12-27	WOS:000394424500091
J	Balaguera-Reina, SA; Espinosa-Blanco, AS; Morales-Betancourt, MA; Seijas, AE; Lasso, CA; Antelo, R; Densmore, LD				Balaguera-Reina, Sergio A.; Espinosa-Blanco, Ariel S.; Morales-Betancourt, Monica A.; Seijas, Andres E.; Lasso, Carlos A.; Antelo, Rafael; Densmore, Llewellyn D., III			Conservation status and regional habitat priorities for the Orinoco crocodile: Past, present, and future	PLOS ONE			English	Article							SPECIES GEOGRAPHIC DISTRIBUTIONS; COJEDES RIVER SYSTEM; CROCODYLUS-INTERMEDIUS; VENEZUELA; POPULATION; MODELS	Conservation of large predator species has historically been a challenge because they often overlap in resource utilization with humans; furthermore, there is a general lack of in-depth knowledge of their ecology and natural history. We assessed the conservation status of the Orinoco crocodile (Crocodylus intermedius), defining regional habitat priorities/crocodile conservation units (RHP/CCU) and regional research priorities (RRP) for this species. We also estimated a species distribution model (SDM) to define current suitable areas where the species might inhabit and/or that might be successfully colonized. The SDM area obtained with a suitable habitat probability >= 0.5 was 23,621 km(2). Out of 2,562 km(2) are included within protected areas in both Colombia (1,643 km 2) and Venezuela (919 km(2)), which represents only 10.8% of C. intermedius' potential range. Areas such as Laguna de Chiguichigue (flood plain lagoon) exhibited an increase in population abundance. In contrast, localities such as the Cojedes and Manapire Rivers reported a significant reduction in relative abundance values. In Colombia, disparity in previous survey methods prevented accurate estimation of population trends. Only one study in this country described an increase over a 13 years span in the Ele, Lipa, and Cravo Norte River populations based on nest surveys. We defined 34 critical areas (16 in Colombia, 17 in Venezuela, and one covering both countries) where we need to preserve/research/monitor and/or generate management actions, 10 RHP/CCU (six from Venezuela and four from Colombia) and 24 RRP (11 from Venezuela, 12 from Colombia, and one in both countries). Cano Guaritico (Creek) and the Capanaparo River in Venezuela and the Ele, Lipa, Cravo Norte River System and the Guayabero River in Colombia were defined as areas with the most optimal conditions for long-term preservation and maintenance of C. intermedius populations. We conclude that the conservation status of this species is still critical, which implies the necessity to increase efforts to recover the species, especially in Colombia, to guarantee its survival as a structural and functional component of the ecosystems it inhabits.	[Balaguera-Reina, Sergio A.; Densmore, Llewellyn D., III] Texas Tech Univ, Dept Biol Sci, Lubbock, TX 79409 USA; [Espinosa-Blanco, Ariel S.] IVIC, Ctr Ecol, Lab Ecol & Genet Poblaciones, Caracas, Venezuela; [Espinosa-Blanco, Ariel S.] UPTC, Grp Estudios Ornitolo & Fauna Silvestre GEO, Tunja, Colombia; [Morales-Betancourt, Monica A.; Lasso, Carlos A.] Inst Invest Recursos Biol Alexander Von Humboldt, Bogota, DC, Colombia; [Seijas, Andres E.] Univ Nacl Expt Los Llanos Occident Ezequiel Zamor, Guanare, Venezuela; [Antelo, Rafael] Fdn Palmarito Casanare, Bogota, Colombia; [Antelo, Rafael] CSIC, Museo Nacl Ciencias Nat, Dept Biodiversidad & Biol Evolut, Madrid, Spain	Texas Tech University System; Texas Tech University; Venezuelan Institute Science Research; Universidad Pedagogica y Tecnologica de Colombia (UPTC); Alliance; International Center for Tropical Agriculture - CIAT; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN)	Balaguera-Reina, SA (corresponding author), Texas Tech Univ, Dept Biol Sci, Lubbock, TX 79409 USA.	sergio.balaguera-reina@ttu.edu	Balaguera-Reina, Sergio A./I-9102-2019	Balaguera-Reina, Sergio A./0000-0002-5153-0031				Anderson RP, 2010, J BIOGEOGR, V37, P1378, DOI 10.1111/j.1365-2699.2010.02290.x; Antelo R, 2016, MEM 12 C INT MAN FAU, P41; Antelo R, 2016, CAIMAN LLANERO CROCO; Antelo R., 2015, CROCODILE SPEC GR NE, V34, P18; Antelo R., 2008, THESIS U AUTONOMA MA; Antelo R, 2010, HERPETOL J, V20, P51; Arcila N., 2009, THESIS; Ardila-Robayo MC, 2002, MEMORIAS TALLER CONS; Arteaga A., 1995, C P 3 C LAT ZOOL MER; Arteaga A, 1996, TECHNICAL REPORT; Avila-Manjon P., 2008, THESIS; Ayarzaguena J, 1990, CROCODILE SPECIALIST, V9, P16; Babarro R, 2014, BOL ACAD C, V74, P75; Balaguera-Reina Sergio A., 2015, Mesoamerican Herpetology, V2, P566; Balaguera-Reina SA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157152; Barahona-Buitrago Sandra Liliana, 2000, Revista de la Academia Colombiana de Ciencias Exactas Fisicas y Naturales, V23, P445; Boria RA, 2014, ECOL MODEL, V275, P73, DOI 10.1016/j.ecolmodel.2013.12.012; Brown JL, 2014, METHODS ECOL EVOL; Broxton PD, 2014, J APPL METEOROL CLIM, V53, P1593, DOI 10.1175/JAMC-D-13-0270.1; Broxton PD, 2014, J APPL METEOROL CLIM; Castro A, 2012, CROCODILES, P65; Chabreck R.H., 1966, P SEAST ASS GAME FIS, V20, P105; Chavez C., 2000, TECHNICAL REPORT; Chavez CA, 2002, TECHNICAL REPORT; CSG (Crocodile Specialist Group), 1996, IUCN RED LIST THREAT; Espinosa-Blanco Ariel S., 2012, Ecotropicos (Caracas), V25, P22; Espinosa-Blanco AS, 2010, THESIS; ESRI (Environmental Systems Research Institute), 2015, ARC GIS VERS 10 4 ES; Fernando Anzola Luis, 2015, Herpetological Bulletin, P10; FRANZ R, 1985, BIOL CONSERV, V32, P137, DOI 10.1016/0006-3207(85)90082-5; Garavito F., 2003, THESIS; Grupo de Especialistas en Cocodrilos en Venezuela, 2007, ESTR NAC CONS CAIM O, P85; Heap M.J., 2014, OPEN J ECOL, V4, P1089, DOI [DOI 10.4236/oje.2014.417089, 10.4236/oje.2014.417089]; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hitchcock CB, 1948, B SOC VENEZ CI NAT, V12; Huber O., 2010, LIBRO ROJO ECOSISTEM, P29; IDEAM IGAC IAvH INVEMAR SINCHI IIAP, 2007, EC CONT COST MAR COL; IUCN UNEP-WCMC, UNEP WCMC WORLD DAT; Jimenez-Oraa M., 2002, THESIS; Lasso C.A., 2010, BIODIVERSIDAD CUENCA; Lehner B., 2008, EOS T AM GEOPHYS UN, P93, DOI [DOI 10.1029/2008EO100001, 10.1029/2008EO100001]; Llobet A., 2002, THESIS; Llobet A, 2002, P 16 WORK M CROC SPE; Lugo-Rugeles M., 1998, THESIS; Lugo-Rugeles M., 1997, PROGRAMA CONSERVACIO; Medem F., 1981, CROCODYLIA AM CROCOD; Ministerio de Medio Ambiente Instituto de Investigacion de Recursos Biologicos Alexander Von Humboldt Universidad Nacional de Colombia, 1998, PROGR NAC CONS CAIM; Morales-Betancourt MA, 2013, SERIE EDITORIAL RECU; Morales-Betancourt MA, 2014, THESIS; Morales-Betancourt MA, 2015, LIBRO ROJO REPTILES, P186; Morales-Betancourt Monica A., 2014, Biota Colombiana, V15, P124; Moreno A. Zamora, 2012, THESIS; Moreno-Arias RA., 2016, CROCODILE SPEC GR NE, V35, P14; Munoz MD, 2000, J HERPETOL, V34, P397; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Rios M., 2004, FAUNA ACUATICA ORINO, P229; Seijas A. E, 2010, CROCODILES STATUS SU, P59; Seijas A. E, 2015, LIBRO ROJO FAUNA VEN; Seijas A.E., 1998, THESIS; Seijas AE, 2000, BIOL CONSERV, V94, P353, DOI 10.1016/S0006-3207(99)00184-6; Seijas AE, 1992, CROCODILES, P79; Seijas AE, 2010, S INV MAN FAUN SILV, P149; Seijas AE, 2009, REVISION SISTEMATICA, V58, P8; Seijas AE, 2010, CIENCIA CONSERVACION, P201; Seijas AE, 1994, BIOLLANIA, V10, P42; Seijas AE, 2016, HERPETOL J, V26, P263; Thorbjarnarson J, 2006, BIOL CONSERV, V128, P25, DOI 10.1016/j.biocon.2005.09.013; THORBJARNARSON JB, 1992, BIOL CONSERV, V62, P179, DOI 10.1016/0006-3207(92)91046-U; Thorbjarnarson JB, 1987, CROCODYLUS INTERMEDI; Thorbjarnarson JB, 1993, ZOOCRIA CROCODYLIA, P320; Trabucco A, 2009, CGIAR CONSORT SPATIA; Treves A, 2003, CONSERV BIOL, V17, P1491, DOI 10.1111/j.1523-1739.2003.00059.x; Velasco A. Plan de accion para la conservacion del caiman del Orinoco (Crocodylus intermedius), 2003, TECHNICAL REPORT	74	5	5	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0172439	10.1371/journal.pone.0172439	http://dx.doi.org/10.1371/journal.pone.0172439			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5VB	28234956	Green Published, gold, Green Submitted			2022-12-27	WOS:000394688200079
J	Izadi, M; Abd Rahman, MS; Ab-Kadir, MZA; Gomes, C; Jasni, J; Hajikhani, M				Izadi, Mahdi; Abd Rahman, Muhammad Syahmi; Ab-Kadir, Mohd Zainal Abidin; Gomes, Chandima; Jasni, Jasronita; Hajikhani, Maryam			The influence of lightning induced voltage on the distribution power line polymer insulators	PLOS ONE			English	Article							WIRES	Protection of medium voltage (MV) overhead lines against the indirect effects of lightning is an important issue in Malaysia and other tropical countries. Protection of these lines against the indirect effects of lightning is a major concern and can be improved by several ways. The choice of insulator to be used for instance, between the glass, ceramic or polymer, can help to improve the line performance from the perspective of increasing the breakdown strength. In this paper, the electrical performance of a 10 kV polymer insulator under different conditions for impulse, weather and insulator angle with respect to a cross-arm were studied (both experimental and modelling) and the results were discussed accordingly. Results show that the weather and insulator angle (with respect to the cross-arm) are surprisingly influenced the values of breakdown voltage and leakage current for both negative and positive impulses. Therefore, in order to select a proper protection system for MV lines against lightning induced voltage, consideration of the local information concerning the weather and also the insulator angles with respect to the cross-arm are very useful for line stability and performance.	[Izadi, Mahdi; Abd Rahman, Muhammad Syahmi; Ab-Kadir, Mohd Zainal Abidin; Gomes, Chandima; Jasni, Jasronita; Hajikhani, Maryam] Univ Putra Malaysia, Fac Engn, Ctr Electromagnet & Lightning Protect Res CELP, Serdang, Malaysia; [Izadi, Mahdi] Islamic Azad Univ, Dept Elect Engn, Firoozkooh Branch, Firoozkooh, Iran	Universiti Putra Malaysia; Islamic Azad University	Izadi, M (corresponding author), Univ Putra Malaysia, Fac Engn, Ctr Electromagnet & Lightning Protect Res CELP, Serdang, Malaysia.; Izadi, M (corresponding author), Islamic Azad Univ, Dept Elect Engn, Firoozkooh Branch, Firoozkooh, Iran.	aryaphase@yahoo.com	Jasni, Jasronita/AAD-8703-2020; Gomes, Chandima/G-4899-2010; Izadi/AAN-5413-2021; Kadir, Zainal/B-6629-2009; Gomes, Chandima/S-1662-2019	Jasni, Jasronita/0000-0002-9617-8609; Gomes, Chandima/0000-0001-5018-8054; Kadir, Zainal/0000-0001-7263-2953; Gomes, Chandima/0000-0001-5018-8054; Izadi, Mahdi/0000-0002-8348-4404	Universiti Putra Malaysia	Universiti Putra Malaysia	This work was supported by Universiti Putra Malaysia.	Abd Rahman M, 2014, 2014 IEEE INT C POW; Abidin NZ, 2012, 2012 IEEE INT POW EN; Ahmadi-Joneidi I, 2013, IEEE T DIELECT EL IN, V20, P212, DOI 10.1109/TDEI.2013.6451360; Bojovschi A, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3551544; Cai L, 2012, IEEE T POWER DELIVER, V27, P2350, DOI 10.1109/TPWRD.2012.2204441; Engelbrecht C, 2013, ARTIFICIAL POLLUTION; Farzaneh M., 2009, INSULATORS ICING POL; Ghosh S, 2013, INSULATION COORDINAT; Ishii M, 1999, IEEE T ELECTROMAGN C, V41, P39, DOI 10.1109/15.748135; Izadi M, 2013, IEEE C IST TURK; Izadi M, 2014, 2014 INT C LIGHTN PR; Izadi M, 2014, MATH PROBL ENG, V2014, DOI 10.1155/2014/925463; Izadi M, 2014, J ELECTR ENG TECHNOL, V9, P1694, DOI 10.5370/JEET.2014.9.5.1694; Izadi M, 2012, ELECTR POW COMPO SYS, V40, P414, DOI 10.1080/15325008.2011.639130; Looms J, 1988, INSULATORS HIGH VOLT; Nucci C, 1995, RETURN STROKE CURR 1; Paolone M, 2004, IEEE T POWER DELIVER, V19, P423, DOI 10.1109/TPWRD.2003.820196; Rachidi F, 1996, IEEE T ELECTROMAGN C, V38, P250, DOI 10.1109/15.536054; Rachidi F, 1999, IEEE T POWER DELIVER, V14, P294, DOI 10.1109/61.736741; Rachidi F, 2012, IEEE T ELECTROMAGN C, V54, P898, DOI 10.1109/TEMC.2011.2181519; Rameli N, 2013, JURNAL TEKNOLOGI, V64; Rawi IM, 2014, 2014 INT C LIGHTN PR; Rizzo R, 2012, PRZ ELEKTROTECHNICZN, V88, P305; Su N, 2012, INSULATORS SURG ARRE, V5, P013; Tavlet M, 1999, FIFTH EUROPEAN CONFERENCE ON RADIATION AND ITS EFFECTS ON COMPONENTS AND SYSTEMS, P210; Tripathi R, 2013, EL INS C EIC 2013 IE; Vazquez I. Ramirez, 2009, STUDY NANOFILLED SIL; YOKOYAMA S, 1986, IEEE T POWER DELIVER, V1, P129, DOI 10.1109/TPWRD.1986.4307943; Yutthagowith P, 2009, IEEE T ELECTROMAGN C, V51, P975, DOI 10.1109/TEMC.2009.2029702	29	5	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0172118	10.1371/journal.pone.0172118	http://dx.doi.org/10.1371/journal.pone.0172118			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5VB	28234930	Green Published, gold, Green Submitted			2022-12-27	WOS:000394688200048
J	Galappaththige, SK; Gray, RA; Roth, BJ				Galappaththige, Suran K.; Gray, Richard A.; Roth, Bradley J.			Cardiac strength-interval curves calculated using a bidomain tissue with a parsimonious ionic current	PLOS ONE			English	Article							ELEVATED EXTRACELLULAR POTASSIUM; ANODE-BREAK STIMULATION; ELECTRICAL-STIMULATION; INTRACELLULAR CALCIUM; MECHANISM; MODEL; SIMULATIONS; ELECTRODES; HEART	The strength-interval curve plays a major role in understanding how cardiac tissue responds to an electrical stimulus. This complex behavior has been studied previously using the bidomain formulation incorporating the Beeler-Reuter and Luo-Rudy dynamic ionic current models. The complexity of these models renders the interpretation and extrapolation of simulation results problematic. Here we utilize a recently developed parsimonious ionic current model with only two currents-a sodium current that activates rapidly upon depolarization I-Na and a time-independent inwardly rectifying repolarization current I-K-which reproduces many experimentally measured action potential waveforms. Bidomain tissue simulations with this ionic current model reproduce the distinctive dip in the anodal (but not cathodal) strength-interval curve. Studying model variants elucidates the necessary and sufficient physiological conditions to predict the polarity dependent dip: a voltage and time dependent I-Na, a nonlinear rectifying repolarization current, and bidomain tissue with unequal anisotropy ratios.	[Galappaththige, Suran K.; Roth, Bradley J.] Oakland Univ, Dept Phys, Rochester, MI 48309 USA; [Gray, Richard A.] US FDA, Ctr Devices & Radiol Hlth, Silver Spring, MD USA	Oakland University; US Food & Drug Administration (FDA)	Roth, BJ (corresponding author), Oakland Univ, Dept Phys, Rochester, MI 48309 USA.	roth@oakland.edu	Roth, Bradley J/A-4920-2008; Galappaththige, Suran/AAE-1623-2021; GRAY, RICHARD/F-3916-2015	Roth, Bradley J/0000-0003-4321-9806; Galappaththige, Suran/0000-0001-5268-1838; GRAY, RICHARD/0000-0003-2798-6378	National Institutes of Health [R01HL118392]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL118392] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Support was provided by the National Institutes of Health, grant R01HL118392. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported in part by a grant from the National Institutes of Health (R01HL118392).	BEELER GW, 1977, J PHYSIOL-LONDON, V268, P177, DOI 10.1113/jphysiol.1977.sp011853; DEKKER E, 1970, CIRC RES, V27, P811, DOI 10.1161/01.RES.27.5.811; Fenton F.H., 2008, SCHOLARPEDIA, V3, P1868, DOI [10.4249/scholarpedia.1868, DOI 10.4249/SCHOLARPEDIA.1868]; Galappaththige S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127837; Gray RA, 2001, J CARDIOVASC ELECTR, V12, P1129, DOI 10.1046/j.1540-8167.2001.01129.x; Gray RA, PLOS COMPUT IN PRESS; HENRIQUEZ CS, 1993, CRIT REV BIOMED ENG, V21, P1; Joung BY, 2011, CIRC J, V75, P834, DOI 10.1253/circj.CJ-10-1014; Kandel SM, 2014, CIRC J, V78, P1127, DOI 10.1253/circj.CJ-13-1261; Kandel SM, 2013, COMPUT MATH METHOD M, V2013, DOI 10.1155/2013/134163; LUO CH, 1994, CIRC RES, V74, P1071, DOI 10.1161/01.RES.74.6.1071; Nygren A, 2000, ANN BIOMED ENG, V28, P951, DOI 10.1114/1.1308489; Press W. H., 2003, NUMERICAL RECIPES FO, V77; Ranjan R, 1999, CIRC RES, V84, P153, DOI 10.1161/01.RES.84.2.153; Ranjan R, 1998, BIOPHYS J, V74, P1850, DOI 10.1016/S0006-3495(98)77895-6; Roth BJ, 2003, J CARDIOVASC ELECTR, V14, P1351, DOI 10.1046/j.1540-8167.2003.03167.x; Roth BJ, 1996, J CARDIOVASC ELECTR, V7, P722, DOI 10.1111/j.1540-8167.1996.tb00580.x; ROTH BJ, 1995, IEEE T BIO-MED ENG, V42, P1174, DOI 10.1109/10.476124; Roth BJ, 2002, CHAOS, V12, P973, DOI 10.1063/1.1496855; SEPULVEDA NG, 1989, BIOPHYS J, V55, P987, DOI 10.1016/S0006-3495(89)82897-8; Shotwell MS, 2016, J AGR BIOL ENVIR ST, V21, P261, DOI 10.1007/s13253-016-0244-7; Sidorov VY, 2003, BIOPHYS J, V84, P3470, DOI 10.1016/S0006-3495(03)70067-8; Trayanova N, 1998, J ELECTROCARDIOL, V31, P23, DOI 10.1016/S0022-0736(98)90274-6; Wikswo JP, 1995, BIOPHYS J, V69, P2195, DOI 10.1016/S0006-3495(95)80115-3	24	4	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2017	12	2							e0171144	10.1371/journal.pone.0171144	http://dx.doi.org/10.1371/journal.pone.0171144			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5QV	28222136	gold, Green Published, Green Submitted			2022-12-27	WOS:000394676800009
J	Myhr, A; Lillefjell, M; Espnes, GA; Halvorsen, T				Myhr, Arnhild; Lillefjell, Monica; Espnes, Geir Arild; Halvorsen, Thomas			Do family and neighbourhood matter in secondary school completion? A multilevel study of determinants and their interactions in a life-course perspective	PLOS ONE			English	Article							INCOME INEQUALITY; HEALTH INEQUALITIES; SOCIOECONOMIC-STATUS; DISABILITY PENSION; FOLLOW-UP; MORTALITY; EDUCATION; CHILD; ASSOCIATION; DEPRIVATION	Background Completion of secondary education is important for individuals' future health and health behaviour. The fundamental purpose of this study is to investigate the variation and clustering of school completion in families and neighbourhoods. Secondly, we aim to examine the impact of individuals' family structure and neighbourhood of residence and examine to what extent parental education level moderates these associations. Methods Longitudinal register data for 30% of the entire Norwegian population aged 21-27 years in 2010 (N = 107,003) was extracted from Statistic Norway A s event database. Three-level logistic regression models, which incorporated individual, family, and neighbourhood contextual factors, were applied to estimate the family and neighbourhood general contextual effects and detect possible educational differences in the impact of family structure and urban place of residence in school completion. Results Completion rates were significantly higher within families with higher education level (79% in tertiary educated families vs. 61% and 48% in secondary and primary educated families respectively) and were strongly correlated within families (ICC = 39.6) and neighbourhoods (ICC = 5.7). Several structural factors at the family level negatively associated with school completion (e.g., family disruption, large family size, and young maternal age) were more prevalent and displayed more negative impact among primary educated individuals. Urban residence was associated with school completion, but only among the tertiary educated. Conclusions Investment in the resources in the individuals' immediate surroundings, including family and neighbourhood, may address a substantial portion of the social inequalities in the completion of upper secondary education. The high intra-familial correlation in school completion suggests that public health policies and future research should acknowledge family environments in order to improve secondary education completion rates among young people within lower educated families.	[Myhr, Arnhild; Lillefjell, Monica] Norwegian Univ Sci & Technol, Dept Neuromed & Movement Sci, NTNU Ctr Hlth Promot Res, Fac Med & Hlth Sci, Trondheim, Norway; [Espnes, Geir Arild] Norwegian Univ Sci & Technol, Dept Publ Hlth & Nursing, NTNU Ctr Hlth Promot Res, Fac Med & Hlth Sci, Trondheim, Norway; [Halvorsen, Thomas] SINTEF Technol & Soc, Dept Hlth Res, Trondheim, Norway	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); SINTEF	Myhr, A (corresponding author), Norwegian Univ Sci & Technol, Dept Neuromed & Movement Sci, NTNU Ctr Hlth Promot Res, Fac Med & Hlth Sci, Trondheim, Norway.	arnhilrm@stud.ntnu.no			Research Council of Norway; Frisknett AS [208173]	Research Council of Norway(Research Council of Norway); Frisknett AS	ARM is financed by the the Research Council of Norway and Frisknett AS (The Industrial PhD Scheme, grant number 208173). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth JW, 2002, SOC FORCES, V81, P117, DOI 10.1353/sof.2002.0038; Amato PR, 2001, J FAM PSYCHOL, V15, P355, DOI 10.1037/0893-3200.15.3.355; ASTONE NM, 1991, AM SOCIOL REV, V56, P309, DOI 10.2307/2096106; Backman O, 2010, EUROPEAN SOCIOLOGICA; Berkman LF., 2014, SOCIAL EPIDEMIOLOGY, V2nd ed.; Bertolini P, 2008, POVERTY SOCIAL EXCLU, P197; Bjorklund A, 2007, BE J ECON ANAL POLI, V7; Blane D., 2006, SOCIAL DETERMINANTS, P54; Bradley RH, 2002, ANNU REV PSYCHOL, V53, P371, DOI 10.1146/annurev.psych.53.100901.135233; Braveman Paula, 2009, Pediatrics, V124 Suppl 3, pS163, DOI 10.1542/peds.2009-1100D; Browne W., 2009, MCMC ESTIMATION MLWI; Browne WJ, 2005, J ROY STAT SOC A STA, V168, P599, DOI 10.1111/j.1467-985X.2004.00365.x; Bruusgaard D, 2010, SCAND J PUBLIC HEALT, V38, P686, DOI 10.1177/1403494810378916; Case A, 2005, J HEALTH ECON, V24, P365, DOI 10.1016/j.jhealeco.2004.09.008; Caspi A, 1998, AM SOCIOL REV, V63, P424, DOI 10.2307/2657557; De Ridder KAA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074954; De Ridder KAA, 2012, J EPIDEMIOL COMMUN H, V66, P995, DOI 10.1136/jech-2011-200047; Downey DB, 2001, AM PSYCHOL, V56, P497, DOI 10.1037//0003-066X.56.6-7.497; DOWNEY DB, 1995, AM SOCIOL REV, V60, P746, DOI 10.2307/2096320; Dundas R, 2014, AM J EPIDEMIOL; ELDER GH, 1994, SOC PSYCHOL QUART, V57, P4; Elder GH, 1998, CHILD DEV, V69, P1, DOI 10.2307/1132065; ELDER GH, 1979, INT J BEHAV DEV, V2, P1, DOI 10.1177/016502547900200101; ELDER GH, 2003, EMERGENCE DEV LIFE C; Evans GW, 2002, ANNU REV PUBL HEALTH, V23, P303, DOI 10.1146/annurev.publhealth.23.112001.112349; Goldstein H, 1995, MULTILEVEL STAT MODE, DOI 10.1002/9780470973394; Hales S, 1999, LANCET, V354, P2047, DOI 10.1016/S0140-6736(99)03763-0; Hauser R, 2000, MERITOCRACY INEQUALI; Kawachi I, 1997, AM J PUBLIC HEALTH, V87, P1491, DOI 10.2105/AJPH.87.9.1491; Knol MJ, 2011, EUR J EPIDEMIOL, V26, P433, DOI 10.1007/s10654-011-9554-9; Krokstad S, 2004, SOC SCI MED, V58, P1837, DOI 10.1016/S0277-9536(03)00409-X; Krokstad S, 2002, INT J EPIDEMIOL, V31, P1183, DOI 10.1093/ije/31.6.1183; L. Sosial reproduksjon i yrkesfagene, 2011, TIDSKRIFT SAMFUNNSFO, V52, P151; Leinonen T, 2012, SCAND J PUBLIC HEALT, V40, P157, DOI 10.1177/1403494811435492; Leventhal T, 2000, PSYCHOL BULL, V126, P309, DOI 10.1037/0033-2909.126.2.309; Lunn D., 2012, BUGS BOOK PRACTICAL; Lynch JW, 2000, BMJ-BRIT MED J, V320, P1200, DOI 10.1136/bmj.320.7243.1200; Mackenbach JP, 1997, LANCET, V349, P1655, DOI 10.1016/S0140-6736(96)07226-1; Marmot M, 2012, PUBLIC HEALTH, V126, pS4, DOI 10.1016/j.puhe.2012.05.014; Marmot M, 2001, BMJ-BRIT MED J, V322, P1233, DOI 10.1136/bmj.322.7296.1233; Marmot MG, 2003, PERSPECT BIOL MED, V46, pS9, DOI 10.1353/pbm.2003.0056; MARMOT MG, 1991, LANCET, V337, P1387, DOI 10.1016/0140-6736(91)93068-K; MARMOT MG, 1984, LANCET, V1, P1003; Marmot MG, 1997, LANCET, V350, P235, DOI 10.1016/S0140-6736(97)04244-X; Marmot MG., 2006, SOCIAL DETERMINANTS; MERCY JA, 1982, AM SOCIOL REV, V47, P532, DOI 10.2307/2095197; Merlo J, 2009, J EPIDEMIOL COMMUN H, V63, P1043, DOI 10.1136/jech.2009.088310; Merlo J, 2005, J EPIDEMIOL COMMUN H, V59, P443, DOI 10.1136/jech.2004.023473; Merlo J, 2012, SOC SCI MED, V75, P1477, DOI 10.1016/j.socscimed.2012.06.004; Najman JM, 2004, SOC SCI MED, V58, P1147, DOI 10.1016/S0277-9536(03)00286-7; Nieuwenhuis J, 2015, SOC SCI RES, V50, P100, DOI 10.1016/j.ssresearch.2014.11.011; Nilsen SM, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-998; Norman P, 2005, SOC SCI MED, V60, P2755, DOI 10.1016/j.socscimed.2004.11.008; Oakes JM, 2004, SOC SCI MED, V58, P1929, DOI 10.1016/j.socscimed.2003.08.004; OECD, 2014, ED GLANC 2014; Okechukwu C., 2014, SOCIAL EPIDEMIOLOGY, P365; Olausson PO, 2001, FAM PLANN PERSPECT, V33, P70, DOI 10.2307/2673752; Poulton R, 2002, LANCET, V360, P1640, DOI 10.1016/S0140-6736(02)11602-3; Power C, 1997, LANCET, V350, P1584, DOI 10.1016/S0140-6736(97)07474-6; Rabe-Hesketh S., 2012, MULTILEVEL LONGITUDI; Rasbash J, 2010, J R STAT SOC A STAT, V173, P657, DOI 10.1111/j.1467-985X.2010.00642.x; Snijders T A. B., 2012, MULTILEVEL ANAL INTR; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; SSB, 2016, POP AR URB SETTL 201; Stafford M, 2003, INT J EPIDEMIOL, V32, P357, DOI 10.1093/ije/dyg084; Stafford M., 2006, SOCIAL DETERMINANTS, P297; Steelman LC, 2002, ANNU REV SOCIOL, V28, P243, DOI 10.1146/annurev.soc.28.111301.093304; Storen LA, 2009, EUROPEAN SOCIOLOGICA; Subramanian SV, 2004, EPIDEMIOL REV, V26, P78, DOI 10.1093/epirev/mxh003; Uhlenberg P., 2003, HDB LIFE COURSE, P123; van Rossum CTM, 2000, J EPIDEMIOL COMMUN H, V54, P178, DOI 10.1136/jech.54.3.178; Wadsworth MEJ, 1997, SOC SCI MED, V44, P859, DOI 10.1016/S0277-9536(96)00187-6; Welch A, 2007, RURALITY INEQUALITY, P602; Wilkinson RG, 2006, SOC SCI MED, V62, P1768, DOI 10.1016/j.socscimed.2005.08.036; Wilkinson RG, 1999, INT J HEALTH SERV, V29, P525, DOI 10.2190/3QXP-4N6T-N0QG-ECXP; Wilkinson RG, 1999, ANN NY ACAD SCI, V896, P48, DOI 10.1111/j.1749-6632.1999.tb08104.x; Wilkinson RG, 1997, BRIT MED J, V314, P591, DOI 10.1136/bmj.314.7080.591; Wilkinson Richard G., 2006, SOC DETERMINANTS HLT, V2, P341; Winkleby M, 2006, AM J PUBLIC HEALTH, V96, P2145, DOI 10.2105/AJPH.2004.060970	79	5	5	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2017	12	2							e0172281	10.1371/journal.pone.0172281	http://dx.doi.org/10.1371/journal.pone.0172281			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL5QV	28222115	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000394676800046
J	Reside, AE; VanDerWal, J; Moilanen, A; Graham, EM				Reside, April E.; VanDerWal, Jeremy; Moilanen, Atte; Graham, Erin M.			Examining current or future trade-offs for biodiversity conservation in north-eastern Australia	PLOS ONE			English	Article							CLIMATE-CHANGE; SPECIES DISTRIBUTIONS; PROTECTED AREAS; BIRDS; UNCERTAINTY; ABUNDANCE; DIVERSITY; INCREASE; HABITAT; NICHE	With the high rate of ecosystem change already occurring and predicted to occur in the coming decades, long-term conservation has to account not only for current biodiversity but also for the biodiversity patterns anticipated for the future. The trade-offs between prioritising future biodiversity at the expense of current priorities must be understood to guide current conservation planning, but have been largely unexplored. To fill this gap, we compared the performance of four conservation planning solutions involving 662 vertebrate species in the Wet Tropics Natural Resource Management Cluster Region in north-eastern Australia. Input species data for the four planning solutions were: 1) current distributions; 2) projected distributions for 2055; 3) projected distributions for 2085; and 4) current, 2055 and 2085 projected distributions, and the connectivity between each of the three time periods for each species. The four planning solutions were remarkably similar (up to 85% overlap), suggesting that modelling for either current or future scenarios is sufficient for conversation planning for this region, with little obvious trade-off. Our analyses also revealed that overall, species with small ranges occurring across steep elevation gradients and at higher elevations were more likely to be better represented in all solutions. Given that species with these characteristics are of high conservation significance, our results provide confidence that conservation planning focused on either current, near-or distant-future biodiversity will account for these species.	[Reside, April E.] James Cook Univ, Coll Sci & Engn, Ctr Trop Environm & Sustainabil Sci, Townsville, Qld, Australia; [Reside, April E.; VanDerWal, Jeremy] James Cook Univ, Coll Sci & Engn, Ctr Trop Biodivers & Climate Change, Townsville, Qld, Australia; [VanDerWal, Jeremy; Graham, Erin M.] James Cook Univ, ERes Ctr, Townsville, Qld, Australia; [Moilanen, Atte] Univ Helsinki, Dept Biosci, Viikinkaari 1, Helsinki, Finland; [Reside, April E.] Univ Queensland, Ctr Biodivers & Conservat Sci, Sch Biol Sci, St Lucia, Qld, Australia	James Cook University; James Cook University; James Cook University; University of Helsinki; University of Queensland	Reside, AE (corresponding author), James Cook Univ, Coll Sci & Engn, Ctr Trop Environm & Sustainabil Sci, Townsville, Qld, Australia.; Reside, AE (corresponding author), James Cook Univ, Coll Sci & Engn, Ctr Trop Biodivers & Climate Change, Townsville, Qld, Australia.; Reside, AE (corresponding author), Univ Queensland, Ctr Biodivers & Conservat Sci, Sch Biol Sci, St Lucia, Qld, Australia.	april.reside@gmail.com	Moilanen, Atte/A-5005-2011; Reside, April/H-4940-2011	Reside, April/0000-0002-0760-9527	Australian Government's Regional NRM planning for climate change program; ERC-StG project GEDA [260393]; Academy of Finland Center of Excellence programme	Australian Government's Regional NRM planning for climate change program(Australian Government); ERC-StG project GEDA; Academy of Finland Center of Excellence programme(Academy of Finland)	A.E.R. was supported by the Australian Government's Regional NRM planning for climate change program. http://www.environment.gov.au/cleanenergyfuture/regional-fund/. A.M. was supported by the ERC-StG project GEDA (grant #260393), https://erc.europa.eu/projects-and-results/erc-funded-projects/geda, and the Academy of Finland Center of Excellence programme, http://www.aka.fi/en/research-and-science-policy/centres-of-excellence/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerly DD, 2010, DIVERS DISTRIB, V16, P476, DOI 10.1111/j.1472-4642.2010.00654.x; Alvarez-Romero JG, 2014, CONSERV LETT, V7, P425; Anderson AS, 2012, GLOBAL CHANGE BIOL, V18, P2126, DOI 10.1111/j.1365-2486.2012.02683.x; [Anonymous], 2010, COMPLETE GUIDE REPTI; Araujo MB, 2007, TRENDS ECOL EVOL, V22, P42, DOI 10.1016/j.tree.2006.09.010; Bateman BL, 2013, DIVERS DISTRIB, V19, P1224, DOI 10.1111/ddi.12107; Bateman BL, 2012, DIVERS DISTRIB, V18, P861, DOI 10.1111/j.1472-4642.2012.00922.x; Carroll C, 2010, GLOBAL CHANGE BIOL, V16, P891, DOI 10.1111/j.1365-2486.2009.01965.x; Carvalho SB, 2011, BIOL CONSERV, V144, P2020, DOI 10.1016/j.biocon.2011.04.024; Churchill S, 2008, AUSTR BATS, V2nd; Coetzee BWT, 2009, GLOBAL ECOL BIOGEOGR, V18, P701, DOI 10.1111/j.1466-8238.2009.00485.x; COVACEVICH J, 1982, BIOL CONSERV, V22, P283, DOI 10.1016/0006-3207(82)90023-4; D'Amen M, 2011, BIOL CONSERV, V144, P989, DOI 10.1016/j.biocon.2010.11.004; Di Marco M, 2016, J APPL ECOLOGY; Di Minin E., 2014, QUICK INTRO ZONATION; Di Minin E, 2016, SCI REP-UK, V6, DOI 10.1038/srep23814; Diniz JAF, 2009, ECOGRAPHY, V32, P897, DOI 10.1111/j.1600-0587.2009.06196.x; Elith J, 2008, J ANIM ECOL, V77, P802, DOI 10.1111/j.1365-2656.2008.01390.x; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Environment Australia, 2000, REV INT BIOG REG AUS; Ferro VG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107792; Fowler HJ, 2007, INT J CLIMATOL, V27, P1543, DOI 10.1002/joc.1616; Friedman JH, 2003, STAT MED, V22, P1365, DOI 10.1002/sim.1501; Grant I, 2008, METEOROLOGICAL REMOT; Hannah L, 2007, FRONT ECOL ENVIRON, V5, P131, DOI 10.1890/1540-9295(2007)5[131:PANIAC]2.0.CO;2; Heller NE, 2015, ECOSPHERE, V6, DOI 10.1890/ES14-00313.1; Heller NE, 2009, BIOL CONSERV, V142, P14, DOI 10.1016/j.biocon.2008.10.006; Jones D.A., 2007, CLIMATE DATA AUSTR W; Kujala H, 2013, CONSERV LETT, V6, P73, DOI 10.1111/j.1755-263X.2012.00299.x; Kujala H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053315; Lehtomaki J, 2013, ENVIRON MODELL SOFTW, V47, P128, DOI 10.1016/j.envsoft.2013.05.001; MACKEY BG, 2001, NATURAL HERITAGE SIG; Mair L, 2014, NAT CLIM CHANGE, V4, P127, DOI [10.1038/nclimate2086, 10.1038/NCLIMATE2086]; Makino A, 2014, DIVERS DISTRIB, V20, P859, DOI 10.1111/ddi.12184; Marchetto KM, 2010, ECOLOGY, V91, P2485, DOI 10.1890/09-1069.1; Meir E, 2004, ECOL LETT, V7, P615, DOI 10.1111/j.1461-0248.2004.00624.x; Menkhorst, 2001, FIELD GUIDE MAMMALS, V110; Moilanen A, 2005, P ROY SOC B-BIOL SCI, V272, P1885, DOI 10.1098/rspb.2005.3164; Moilanen A, 2009, SPATIAL CONSERVATION; Moilanen A., 2014, SPATIAL CONSERVATION; Moilanen A, 2006, CONSERV BIOL, V20, P1688, DOI 10.1111/j.1523-1739.2006.00560.x; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Pressey RL, 2007, TRENDS ECOL EVOL, V22, P583, DOI 10.1016/j.tree.2007.10.001; R Core Team, 2014, LANG ENV STAT COMP; Reside A. E., 2013, CLIMATE CHANGE REFUG; Reside AE, 2016, AUSTRAL ECOL, V41, P106, DOI 10.1111/aec.12304; Reside AE, 2014, AUSTRAL ECOL, V39, P887, DOI 10.1111/aec.12146; Reside AE, 2012, ECOL EVOL, V2, P705, DOI 10.1002/ece3.197; Reside AE, 2011, ECOL MODEL, V222, P3444, DOI 10.1016/j.ecolmodel.2011.06.015; Reside AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013569; Reside AE, 2017, BIOL CONSERV, V207, P9, DOI 10.1016/j.biocon.2017.01.004; Ridgeway G., 2006, GEN BOOSTED REGRESSI; Rogelj J, 2012, NAT CLIM CHANGE, V2, P248, DOI [10.1038/NCLIMATE1385, 10.1038/nclimate1385]; Sarkar S, 2006, ANNU REV ENV RESOUR, V31, P123, DOI 10.1146/annurev.energy.31.042606.085844; Seneviratne SI, 2014, NAT CLIM CHANGE, V4, P161, DOI 10.1038/nclimate2145; Shoo L, 2013, CLIMATIC CHANGE, P1; Shoo LP, 2005, BIOL CONSERV, V125, P335, DOI 10.1016/j.biocon.2005.04.003; Struebig MJ, 2015, CURR BIOL, V25, P1; Sutcliffe PR, 2013, ECOGRAPHY, V36, P001; Thomas CD, 2015, BIOL J LINN SOC, V115, P718, DOI 10.1111/bij.12510; Thomas CD, 2013, ECOL LETT, V16, P39, DOI 10.1111/ele.12054; Thomas CD, 2012, P NATL ACAD SCI USA, V109, P14063, DOI 10.1073/pnas.1210251109; Thuiller W, 2014, ECOGRAPHY, V37, P1254, DOI 10.1111/ecog.00670; Tingley MW, 2009, P NATL ACAD SCI USA, V106, P19637, DOI 10.1073/pnas.0901562106; Tyler M.J., 2009, FIELD GUIDE FROGS AU; Vanderduys E. P., 2012, Australian Zoologist, V36, P59; Vanderduys Eric, 2012, P1; Vanderwal J, 2011, PACKAGE CLIMATES MET; VanDerWal J, 2013, NAT CLIM CHANGE, V3, P239, DOI [10.1038/nclimate1688, 10.1038/NCLIMATE1688]; VanDerWal J, 2009, AM NAT, V174, P282, DOI 10.1086/600087; VanDerWal J, 2009, ECOL MODEL, V220, P589, DOI 10.1016/j.ecolmodel.2008.11.010; Warren R, 2013, NAT CLIM CHANGE, V3, P678, DOI [10.1038/nclimate1887, 10.1038/NCLIMATE1887]; Williams S. E., 1996, Pacific Conservation Biology, V2, P327; Williams S.E., 2006, VERTEBRATES WET TROP; Williams SE, 2003, P ROY SOC B-BIOL SCI, V270, P1887, DOI 10.1098/rspb.2003.2464; Wintle BA, 2011, NAT CLIM CHANGE, V1, P355, DOI 10.1038/NCLIMATE1227	77	8	8	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2017	12	2							e0172230	10.1371/journal.pone.0172230	http://dx.doi.org/10.1371/journal.pone.0172230			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5QV	28222199	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000394676800044
J	Hoshino, E; Mogi, K				Hoshino, Eiichi; Mogi, Ken			Multiple processes in two-dimensional visual statistical learning	PLOS ONE			English	Article							UNSUPERVISED CATEGORIZATION; KNOWLEDGE; INFANTS; MEMORY; RECOGNITION; INFORMATION; COMPLEXITY; SEQUENCES; OBJECTS; HUMANS	Knowledge about the arrangement of visual elements is an important aspect of perception. This study investigates whether humans learn rules of two-dimensional abstract patterns ( exemplars) generated from Reber's artificial grammar. The key question is whether the subjects can implicitly learn them without explicit instructions, and, if so, how they use the acquired knowledge to judge new patterns ( probes) in relation to their finite experience of the exemplars. The analysis was conducted using dissimilarities among patterns, which are defined with n-gram probabilities and the Levenshtein distance. The results show that subjects are able to learn rules of two-dimensional visual patterns ( exemplars) and make categorical judgment of probes based on knowledge of exemplar-based representation. Our analysis revealed that subjects' judgments of probes were related to the degree of dissimilarities between the probes and exemplars. The result suggests the coexistence of configural and element-based processing in exemplar-based representations. Exemplar-based representation was preferred to prototypical representation through tasks requiring discrimination, recognition and working memory. Relations of the studied judgment processes to the neural basis are discussed. We conclude that knowledge of a finite experience of two-dimensional visual patterns would be crystalized in different levels of relations among visual elements.	[Hoshino, Eiichi] Tokyo Inst Technol, Dept Computat Intelligence & Syst Sci, Midori Ku, Nagatsuta Cho, Yokohama, Kanagawa, Japan; [Hoshino, Eiichi; Mogi, Ken] Sony Comp Sci Labs, Shinagawa Ku, Tokyo, Japan	Tokyo Institute of Technology	Mogi, K (corresponding author), Sony Comp Sci Labs, Shinagawa Ku, Tokyo, Japan.	kenmogi@qualia-manifesto.com						Alvarez GA, 2004, PSYCHOL SCI, V15, P106, DOI 10.1111/j.0963-7214.2004.01502006.x; Ashby EG, 2005, ANNU REV PSYCHOL, V56, P149, DOI 10.1146/annurev.psych.56.091103.070217; Barsalou LW, 1998, COGNITIVE PSYCHOL, V36, P203, DOI 10.1006/cogp.1998.0687; BIEDERMA.I, 1972, SCIENCE, V177, P77, DOI 10.1126/science.177.4043.77; Briscoe E, 2011, COGNITION, V118, P2, DOI 10.1016/j.cognition.2010.10.004; Chomsky N, 1980, RULES REPRESENTATION; Chomsky Noam., 1965, ASPECTS THEORY SYNTA; Colreavy E, 2008, MEM COGNITION, V36, P762, DOI 10.3758/MC.36.4.762; Conway CM, 2009, EUR J COGN PSYCHOL, V21, P561, DOI 10.1080/09541440802097951; COSMIDES L, 1994, AM ECON REV, V84, P327; DEGRAEF P, 1990, PSYCHOL RES-PSYCH FO, V52, P317, DOI 10.1007/BF00868064; Fiser J, 2005, J EXP PSYCHOL GEN, V134, P521, DOI 10.1037/0096-3445.134.4.521; Fiser J, 2002, J EXP PSYCHOL LEARN, V28, P458, DOI 10.1037//0278-7393.28.3.458; Fiser J, 2001, PSYCHOL SCI, V12, P499, DOI 10.1111/1467-9280.00392; FRIEDMAN A, 1979, J EXP PSYCHOL GEN, V108, P316, DOI 10.1037/0096-3445.108.3.316; Garoff RJ, 2005, NEUROPSYCHOLOGIA, V43, P847, DOI 10.1016/j.neuropsychologia.2004.09.014; Gauthier I, 2000, NAT NEUROSCI, V3, P191, DOI 10.1038/72140; Gigerenzer G, 1996, PSYCHOL REV, V103, P650, DOI 10.1037/0033-295X.103.4.650; Gomez RL, 1999, COGNITION, V70, P109, DOI 10.1016/S0010-0277(99)00003-7; Hahn U, 2010, COGNITION, V114, P1, DOI 10.1016/j.cognition.2009.08.011; Kirkham NZ, 2002, COGNITION, V83, pB35, DOI 10.1016/S0010-0277(02)00004-5; Lake BM, 2015, SCIENCE, V350, P1332, DOI 10.1126/science.aab3050; Levenshtein VI, 1966, SOV PHYS DOKL, V10, P707; Mack ML, 2013, CURR BIOL, V23, P2023, DOI 10.1016/j.cub.2013.08.035; Marcus GF, 1999, SCIENCE, V283, P77, DOI 10.1126/science.283.5398.77; McMenamin BW, 2015, BRAIN COGNITION, V93, P54, DOI 10.1016/j.bandc.2014.11.007; Oliva Aude, 2005, P251, DOI 10.1016/B978-012375731-9/50045-8; PAGE EB, 1963, J AM STAT ASSOC, V58, P216, DOI 10.2307/2282965; Pothos EM, 2011, Q J EXP PSYCHOL, V64, P1692, DOI 10.1080/17470218.2011.554990; REBER AS, 1967, J VERB LEARN VERB BE, V6, P855, DOI 10.1016/S0022-5371(67)80149-X; REBER AS, 1989, J EXP PSYCHOL GEN, V118, P219, DOI 10.1037/0096-3445.118.3.219; REED SK, 1972, COGNITIVE PSYCHOL, V3, P382, DOI 10.1016/0010-0285(72)90014-X; RENTSCHLER I, 1994, VISION RES, V34, P963, DOI 10.1016/0042-6989(94)90045-0; ROSCH E, 1975, COGNITIVE PSYCHOL, V7, P573, DOI 10.1016/0010-0285(75)90024-9; Ross Brian H., 1999, P205; Saffran JR, 1996, SCIENCE, V274, P1926, DOI 10.1126/science.274.5294.1926; Saffran JR, 1999, COGNITION, V70, P27, DOI 10.1016/S0010-0277(98)00075-4; Saksida LM, 2007, CEREB CORTEX, V17, P108, DOI 10.1093/cercor/bhj128; Selby-Bigge L.A., 1896, TREATISE HUMAN NATUR; Smith JD, 2014, PSYCHON B REV, V21, P312, DOI 10.3758/s13423-013-0506-0; Stobbe N, 2012, PHILOS T R SOC B, V367, P1995, DOI 10.1098/rstb.2012.0096; Storms G, 2000, J MEM LANG, V42, P51, DOI 10.1006/jmla.1999.2669; Turk-Browne NB, 2009, J COGNITIVE NEUROSCI, V21, P1934, DOI 10.1162/jocn.2009.21131; Tyier LK, 2013, J COGNITIVE NEUROSCI, V25, P1723, DOI [10.1162/jocn_a_00419, DOI 10.1162/JOCN_A_00419]; Tyler LK, 2013, J COGNITIVE NEUROSCI, V25, P1723, DOI 10.1162/jocn_a_00419; Weisberg J, 2007, CEREB CORTEX, V17, P513, DOI 10.1093/cercor/bhj176; Westphal-Fitch G, 2012, PHILOS T R SOC B, V367, P2007, DOI 10.1098/rstb.2012.0098; Wilson B, 2015, EUR J NEUROSCI, V41, P568, DOI 10.1111/ejn.12834; Wright P, 2015, NEUROPSYCHOLOGIA, V76, P192, DOI 10.1016/j.neuropsychologia.2015.01.041	49	0	0	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2017	12	2							e0172290	10.1371/journal.pone.0172290	http://dx.doi.org/10.1371/journal.pone.0172290			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL2BI	28212388	Green Published, Green Submitted, gold			2022-12-27	WOS:000394424700030
J	Mansouri, M; Gregory, SD; Salamonsen, RF; Lovell, NH; Stevens, MC; Pauls, JP; Akmeliawati, R; Lim, E				Mansouri, Mahdi; Gregory, Shaun D.; Salamonsen, Robert F.; Lovell, Nigel H.; Stevens, Michael C.; Pauls, Jo P.; Akmeliawati, Rini; Lim, Einly			Preload-based Starling-like control of rotary blood pumps: An in-vitro evaluation	PLOS ONE			English	Article							VENTRICULAR ASSIST DEVICES; HEART-FAILURE; EXERCISE; FLOW; SPEED	Due to a shortage of donor hearts, rotary left ventricular assist devices (LVADs) are used to provide mechanical circulatory support. To address the preload insensitivity of the constant speed controller (CSC) used in conventional LVADs, we developed a preload-based Starling-like controller (SLC). The SLC emulates the Starling law of the heart to maintain mean pump flow ((Q) over bar (P)) with respect to mean left ventricular end diastolic pressure (PLVEDm) as the feedback signal. The SLC and CSC were compared using a mock circulation loop to assess their capacity to increase cardiac output during mild exercise while avoiding ventricular suction (marked by a negative PLVEDm) and maintaining circulatory stability during blood loss and severe reductions in left ventricular contractility (LVC). The root mean squared hemodynamic deviation (RMSHD) metric was used to assess the clinical acceptability of each controller based on pre-defined hemodynamic limits. We also compared the in-silico results from our previously published paper with our in-vitro outcomes. In the exercise simulation, the SLC increased (Q) over bar (P) by 37%, compared to only 17% with the CSC. During blood loss, the SLC maintained a better safety margin against left ventricular suction with PLVEDm of 2.7 mmHg compared to -0.1 mmHg for CSC. A transition to reduced LVC resulted in decreased mean arterial pressure (MAP) and (Q) over bar (P) with CSC, whilst the SLC maintained MAP and (Q) over bar (P). The results were associated with a much lower RMSHD value with SLC (70.3%) compared to CSC (225.5%), demonstrating improved capacity of the SLC to compensate for the varying cardiac demand during profound circulatory changes. In-vitro and in-silico results demonstrated similar trends to the simulated changes in patient state however the magnitude of hemodynamic changes were different, thus justifying the progression to in-vitro evaluation.	[Mansouri, Mahdi; Lim, Einly] Univ Malaya, Dept Biomed Engn, Kuala Lumpur, Malaysia; [Mansouri, Mahdi; Gregory, Shaun D.; Stevens, Michael C.; Pauls, Jo P.] Prince Charles Hosp, Crit Care Res Grp, Innovat Cardiovasc Engn & Technol Lab, Brisbane, Qld, Australia; [Gregory, Shaun D.; Pauls, Jo P.] Univ Queensland, Sch Med, Brisbane, Qld, Australia; [Gregory, Shaun D.; Pauls, Jo P.] Griffith Univ, Sch Engn, Brisbane, Qld, Australia; [Salamonsen, Robert F.] Alfred Hosp, Dept Intens Care, Prahran, Vic, Australia; [Salamonsen, Robert F.] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic, Australia; [Lovell, Nigel H.; Stevens, Michael C.] UNSW, Grad Sch Biomed Engn, Sydney, NSW, Australia; [Stevens, Michael C.] Univ Sydney, Sch Med, Camperdown, NSW, Australia; [Akmeliawati, Rini] Int Islamic Univ Malaysia, Dept Mechatron Engn, Kuala Lumpur, Malaysia	Universiti Malaya; Prince Charles Hospital; University of Queensland; Griffith University; Florey Institute of Neuroscience & Mental Health; Monash University; University of New South Wales Sydney; University of Sydney; International Islamic University Malaysia	Lim, E (corresponding author), Univ Malaya, Dept Biomed Engn, Kuala Lumpur, Malaysia.	einly_lim@um.edu.my	Pauls, Jo/G-3180-2017; Lovell, Nigel H/AGF-6679-2022; LIM, EINLY/B-8861-2010; Akmeliawati, Rini/T-4776-2018	Pauls, Jo/0000-0002-4994-5967; Lovell, Nigel H/0000-0003-1637-1079; LIM, EINLY/0000-0003-2037-4213; Gregory, Shaun/0000-0002-5448-1917; Stevens, Michael/0000-0003-3583-688X; Akmeliawati, Rini/0000-0003-0660-2312; Mansouri, Majdi/0000-0001-6390-4304	Ministry of Higher Education, Malaysia [UM.C/HIR/MOHE/ENG/50]; Australian Research Council Linkages scheme Universiti Malaya [RP028-14HTM]	Ministry of Higher Education, Malaysia(Ministry of Education, Malaysia); Australian Research Council Linkages scheme Universiti Malaya(Australian Research Council)	Funded by Ministry of Higher Education, Malaysia (MY) (UM.C/HIR/MOHE/ENG/50) The Australian Research Council Linkages scheme Universiti Malaya (RP028-14HTM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AlOmari AHH, 2013, PHYSIOL MEAS, V34, pR1, DOI 10.1088/0967-3334/34/1/R1; Bakouri MA, 2014, ARTIF ORGANS, V38, P587, DOI 10.1111/aor.12223; Bullister E, 2002, ARTIF ORGANS, V26, P931, DOI 10.1046/j.1525-1594.2002.07126.x; Bullister E, 2001, ARTIF ORGANS, V25, P376, DOI 10.1046/j.1525-1594.2001.025005376.x; Gaddum NR, 2014, ARTIF ORGANS, V38, pE46, DOI 10.1111/aor.12221; Gregory SD, 2011, ENG MED BIOL SCI EMB; GROSSMAN W, 1972, CIRC RES, V31, P83, DOI 10.1161/01.RES.31.1.83; Guyton AC, 1965, AM J MED SCI, V219, P122; Guyton AC, 1963, CIRCULATORY PHYSL CA, P237; Haddad F, 2008, CIRCULATION, V117, P1717, DOI 10.1161/CIRCULATIONAHA.107.653584; Jacquet L, 2011, ARTIF ORGANS, V35, P682, DOI 10.1111/j.1525-1594.2011.01227.x; Lim E, 2015, ARTIF ORGANS, V39, pE24, DOI 10.1111/aor.12370; Mancini D, 1998, CIRCULATION, V98, P1178, DOI 10.1161/01.CIR.98.12.1178; Mansouri M, 2016, PHYSL CONTROL IMPLAN; Mansouri M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121413; Salamonsen RF, 2013, ARTIF ORGANS, V37, P695, DOI 10.1111/aor.12070; Salamonsen RF, 2011, ARTIF ORGANS, V35, pE47, DOI 10.1111/j.1525-1594.2010.01168.x; Salamonsen RF, 2015, ARTIF ORGANS, V39, P681, DOI 10.1111/aor.12550; Salamonsen RF, 2012, ARTIF ORGANS, V36, P787, DOI 10.1111/j.1525-1594.2012.01457.x; Schima H, 2006, J HEART LUNG TRANSPL, V25, P167, DOI 10.1016/j.healun.2005.09.008; Starling EH, 1927, J PHYSIOL-LONDON, V52, P243; Stevens MC, 2011, ENG MED BIOL SOC EMB; Stevens MC, 2014, AUTOMATIC CONTROL DU; Timms DL, 2011, ARTIF ORGANS, V35, P384, DOI 10.1111/j.1525-1594.2010.01088.x; Zinober AS, 1990, DETERMINISTIC NONLIN	25	8	10	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2017	12	2							e0172393	10.1371/journal.pone.0172393	http://dx.doi.org/10.1371/journal.pone.0172393			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BI	28212401	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000394424700042
J	Kabir, A; Maitrot, MRL				Kabir, Ashraful; Maitrot, Mathilde Rose Louise			Factors influencing feeding practices of extreme poor infants and young children in families of working mothers in Dhaka slums: A qualitative study	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; NUTRITIONAL-STATUS; WOMENS WORK; MATERNAL EMPLOYMENT; BANGLADESH; CARE; DIFFERENTIALS; MALNUTRITION; NONWORKING	Background Nutritional status differs between infants and young children living in slum and non-slum conditions - infants and young children living in City Corporation slums are likely to have worse nutritional status compared to those from non-slums. Furthermore, families in slums tend to engage female labor in cash-earning activities as a survival strategy; hence, a higher percentage of mothers stay at work. However, little is known about feeding practices for infants and young children in families with working mothers in slums. This study aims to understand the factors that determine feeding practices for infants and young children living in families with working mothers in Dhaka slums. Methods This study adopted a qualitative approach. Sixteen In-depth Interviews, five Key Informant Interviews, and Focused Group Discussions were conducted with family members, community leaders, and program staff. Method triangulation and thematic analyses were conducted. Results Feeding practices for infants and young children in families with working mothers are broadly determined by mothers' occupation, basis civic facilities, and limited family buying capacity. Although mothers have good nutritional knowledge, they negotiate between work and feeding their infants and young children. Household composition, access to cooking facilities, and poverty level were also found to be significant determining factors. Conclusion The results suggest a trade-off between mothers' work and childcare. The absence of alternative care support in homes and/or work places along with societal factors outweighs full benefits of project interventions. Improving alternative childcare support could reduce the burden of feeding practice experienced by working mothers and may improve nutritional outcomes.	[Kabir, Ashraful] Dushtha Shasthya Kendra, Dhaka, Bangladesh; [Maitrot, Mathilde Rose Louise] Univ Bath, Dept Social & Policy Sci, Bath, Avon, England	University of Bath	Kabir, A (corresponding author), Dushtha Shasthya Kendra, Dhaka, Bangladesh.	ashraful262@yahoo.com		Maitrot, Mathilde/0000-0001-9365-6380	UK Department for International Development (DFID); Swiss Agency for Development and Cooperation (SDC); Government of Bangladesh (GOB); ESRC [ES/P010016/1] Funding Source: UKRI	UK Department for International Development (DFID); Swiss Agency for Development and Cooperation (SDC); Government of Bangladesh (GOB); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	The authors would like to thank the UK Department for International Development (DFID), the Swiss Agency for Development and Cooperation (SDC) and the Government of Bangladesh (GOB) for their support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank the UK Department for International Development (DFID), the Swiss Agency for Development and Cooperation (SDC) and the Government of Bangladesh (GOB) for their support. They are also grateful to the community and project staff who participated in this study.	Afsana K, 2014, ASIA PAC J CLIN NUTR, V23, P377, DOI 10.6133/apjcn.2014.23.3.22; Afsar R., 2000, RURAL URBAN MIGRATIO; Ahmed T, 2014, FOOD NUTR BULL, V35, pS14, DOI 10.1177/15648265140352S103; Banks N., 2013, ENVIRON URBAN; BHUIYA A, 1986, J TROP PEDIATRICS, V32, P17, DOI 10.1093/tropej/32.1.17; Deolalikar A B, 1996, J Int Dev, V8, P375, DOI 10.1002/(SICI)1099-1328(199605)8:3&lt;375::AID-JID395&gt;3.0.CO;2-9; Fakir AMS, 2015, HEALTH ECON REV, V5, DOI 10.1186/s13561-015-0059-1; FANTA II, 2010, IND ASS INF YOUNG 3; Fotso JC, 2007, HEALTH PLACE, V13, P205, DOI 10.1016/j.healthplace.2006.01.004; Goudet SM, 2011, AM J PUBLIC HEALTH, V101, P1225, DOI 10.2105/AJPH.2010.300090; Guest G, 2006, FIELD METHOD, V18, P59, DOI 10.1177/1525822X05279903; Henry B P, 2000, HLTH BANGLADESH LESS; Kamau-Thuita F, 2002, East Afr Med J, V79, P524; Lamontagne JF, 1998, SOC SCI MED, V46, P403, DOI 10.1016/S0277-9536(97)00184-6; LESLIE J, 1988, WORLD DEV, V16, P1341, DOI 10.1016/0305-750X(88)90209-4; Mascie-Taylor N, 2015, CHANGE MONITORING ST; Mittal A., 2007, Indian Journal of Community Medicine, V32, P264; Moser A, 2012, PUBLIC HEALTH NUTR, V15, P1256, DOI 10.1017/S1368980011003375; Mostafa Kamal S M, 2011, Malays J Nutr, V17, P105; Nair M, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004434; Nakahara S, 2006, AM J HUM BIOL, V18, P169, DOI 10.1002/ajhb.20481; National Institute of Population Research and Training (NIPORT) Mitra and Associates and ICF International, 2016, BANGL DEM HLTH SURV; NIPORT MEASURE UNC and ICDDRb, 2014, BANGL URB HLTH SURV; Pierre-Louis JN, 2007, FOOD NUTR BULL, V28, P67, DOI 10.1177/156482650702800108; POPKIN BM, 1980, ECOL FOOD NUTR, V9, P1, DOI 10.1080/03670244.1980.9990579; Pryer JA, 2006, EUR J CLIN NUTR, V60, P815, DOI 10.1038/sj.ejcn.1602385; Rathnayake Ishara M., 2005, Food and Nutrition Bulletin, V26, P222; Roshita A, 2013, ECOL FOOD NUTR, V52, P344, DOI 10.1080/03670244.2012.707438; Salway S, 2003, WORLD DEV, V31, P881, DOI 10.1016/S0305-750X(03)00016-0; Ukwuani FA, 2003, SOC SCI MED, V56, P2109, DOI 10.1016/S0277-9536(02)00205-8; World B., 2007, BANGLADESH DEV SERIE; Yeleswarapu BK, 2012, J CLIN DIAGN RES, V6, P1718, DOI 10.7860/JCDR/2012/4395.2629	32	23	23	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0172119	10.1371/journal.pone.0172119	http://dx.doi.org/10.1371/journal.pone.0172119			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL2BG	28207894	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000394424500088
J	Salas, IH; Callaerts-Vegh, Z; Arranz, AM; Guix, FX; D'Hooge, R; Esteban, JA; De Strooper, B; Dotti, CG				Salas, Isabel H.; Callaerts-Vegh, Zsuzsanna; Arranz, Amaia M.; Guix, Francesc X.; D'Hooge, Rudi; Esteban, Jose A.; De Strooper, Bart; Dotti, Carlos G.			Tetraspanin 6: A novel regulator of hippocampal synaptic transmission and long term plasticity	PLOS ONE			English	Article							AMPA RECEPTORS; TRAFFICKING; EPILEPSY; POTENTIATION; DENSITY; MICE; ORGANIZATION; MICRODOMAINS; DISORDER; FEMALES	Tetraspanins (Tspan) are transmembrane proteins with important scaffold and signalling functions. Deletions of Tetraspanin 6 (Tspan6) gene, a member of the tetraspanin family, have been reported in patients with Epilepsy Female-restricted with Mental Retardation (EFMR). Interestingly, mutations in Tspan7, highly homologous to Tspan6, are associated with X-linked intellectual disability, suggesting that these two proteins are important for cognition. Considering recent evidences showing that Tspan7 plays a key role in synapse development and AMPAR trafficking, we initiated the study of Tspan6 in synaptic function using a Tspan6 knock out mouse model. Here we report that hippocampal field recordings from Tspan6 knock out mice show an enhanced basal synaptic transmission and impaired long term potentiation (LTP). A normal paired-pulse facilitation response suggests that Tspan6 affects the properties of the postsynaptic rather than the presynaptic terminal. However, no changes in spine morphology or postsynaptic markers could be detected in Tspan6 KO mice compared with wild types. In addition, Tspan6 KO mice show normal locomotor behaviour and no defects in hippocampus-dependent memory tests.	[Salas, Isabel H.; Arranz, Amaia M.; Guix, Francesc X.; De Strooper, Bart] VIB, VIB Ctr Biol Dis, Leuven, Belgium; [Salas, Isabel H.; Arranz, Amaia M.; Guix, Francesc X.; De Strooper, Bart] Katholieke Univ Leuven, Ctr Human Genet, Gasthuisberg O&N4, Leuven, Belgium; [Salas, Isabel H.; Arranz, Amaia M.; Guix, Francesc X.; De Strooper, Bart] Katholieke Univ Leuven, LIND, Gasthuisberg O&N4, Leuven, Belgium; [Callaerts-Vegh, Zsuzsanna; D'Hooge, Rudi] Katholieke Univ Leuven, Lab Biol Psychol, Leuven, Belgium; [Esteban, Jose A.; Dotti, Carlos G.] UAM, CSIC, Ctr Biol Mol Severo Ochoa, Madrid, Spain	Flanders Institute for Biotechnology (VIB); KU Leuven; KU Leuven; KU Leuven; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM)	De Strooper, B (corresponding author), VIB, VIB Ctr Biol Dis, Leuven, Belgium.; De Strooper, B (corresponding author), Katholieke Univ Leuven, Ctr Human Genet, Gasthuisberg O&N4, Leuven, Belgium.; De Strooper, B (corresponding author), Katholieke Univ Leuven, LIND, Gasthuisberg O&N4, Leuven, Belgium.; Dotti, CG (corresponding author), UAM, CSIC, Ctr Biol Mol Severo Ochoa, Madrid, Spain.	bart.DeStrooper@cme.vib-kuleuven.be; cdotti@cbm.csic.es	Arranz, Amaia M/C-3776-2017; Arranz, Amaia/ACV-3437-2022; de+Strooper, Bart/Z-1638-2019; Guix, Francesc/AAA-7462-2020	Arranz, Amaia M/0000-0002-8314-7870; 	Fund for Scientific Research Flanders (FWO) grant; KU Leuven; Flemish Institute for Biotechnology (VIB); IUAP [P7/16]; Spanish Ministry of Science [SAF2010-14906]; Innovation Ingenio-Consolider [CSD2010-00045]; Spanish Ministry of Economy and Competitiveness [SAF2013-45392]; MRC [MC_PC_17116] Funding Source: UKRI; Medical Research Council [MC_PC_17116] Funding Source: researchfish	Fund for Scientific Research Flanders (FWO) grant(FWO); KU Leuven(KU Leuven); Flemish Institute for Biotechnology (VIB); IUAP; Spanish Ministry of Science(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Innovation Ingenio-Consolider; Spanish Ministry of Economy and Competitiveness(Spanish Government); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was financially supported by Fund for Scientific Research Flanders (FWO) grant, KU Leuven, Flemish Institute for Biotechnology (VIB), IUAP (P7/16). Bart De Strooper is the Arthur Bax and Anna Vanluffelen chair for Alzheimer disease. This paper was also supported by Spanish Ministry of Science (SAF2010-14906), Innovation Ingenio-Consolider (CSD2010-00045) and Spanish Ministry of Economy and Competitiveness (SAF2013-45392) grants to Carlos G. Dotti.	Baj G, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00018; Balschun D, 2010, CEREB CORTEX, V20, P684, DOI 10.1093/cercor/bhp133; Banke TG, 2000, J NEUROSCI, V20, P89, DOI 10.1523/JNEUROSCI.20-01-00089.2000; Bassani S, 2012, NEURON, V73, P1143, DOI 10.1016/j.neuron.2012.01.021; Berditchevski F, 2007, TRAFFIC, V8, P89, DOI 10.1111/j.1600-0854.2006.00515.x; Callaerts-Vegh Z, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00179; Charrin S, 2014, J CELL SCI, V127, P3641, DOI 10.1242/jcs.154906; Citri A, 2008, NEUROPSYCHOPHARMACOL, V33, P18, DOI 10.1038/sj.npp.1301559; De Rubeis S, 2013, NEURON, V79, P1169, DOI 10.1016/j.neuron.2013.06.039; de Wit J, 2013, NEURON, V79, P696, DOI 10.1016/j.neuron.2013.06.049; Depienne C, 2011, HUM MUTAT, V32, pE1959, DOI 10.1002/humu.21373; Derkach V, 1999, P NATL ACAD SCI USA, V96, P3269, DOI 10.1073/pnas.96.6.3269; Fukata Y, 2013, J CELL BIOL, V202, P145, DOI 10.1083/jcb.201302071; Goddyn H, 2006, BEHAV BRAIN RES, V173, P138, DOI 10.1016/j.bbr.2006.06.016; Hemler ME, 2005, NAT REV MOL CELL BIO, V6, P801, DOI 10.1038/nrm1736; Huang SF, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-306; Hung AY, 2002, J BIOL CHEM, V277, P5699, DOI 10.1074/jbc.R100065200; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Kato AS, 2010, NEURON, V68, P1082, DOI 10.1016/j.neuron.2010.11.026; Kristensen AS, 2011, NAT NEUROSCI, V14, P727, DOI 10.1038/nn.2804; Laude AJ, 2004, MOL MEMBR BIOL, V21, P193, DOI 10.1080/09687680410001700517; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MacGillavry HD, 2013, NEURON, V78, P615, DOI 10.1016/j.neuron.2013.03.009; Marini C, 2010, NEUROLOGY, V75, P646, DOI 10.1212/WNL.0b013e3181ed9e67; NAGY A, 1984, J NEUROCHEM, V43, P1114, DOI 10.1111/j.1471-4159.1984.tb12851.x; Nair D, 2013, J NEUROSCI, V33, P13204, DOI 10.1523/JNEUROSCI.2381-12.2013; Neves G, 2008, NAT REV NEUROSCI, V9, P65, DOI 10.1038/nrn2303; Paradee W, 1999, NEUROSCIENCE, V94, P185, DOI 10.1016/S0306-4522(99)00285-7; Perez-Cruz C, 2011, J NEUROSCI, V31, P3926, DOI 10.1523/JNEUROSCI.6142-10.2011; Phillips GR, 2001, NEURON, V32, P63, DOI 10.1016/S0896-6273(01)00450-0; Plant K, 2006, NAT NEUROSCI, V9, P602, DOI 10.1038/nn1678; Reisel D, 2002, NAT NEUROSCI, V5, P868, DOI 10.1038/nn910; Ribeiro LF, 2014, P NATL ACAD SCI USA, V111, pE149, DOI 10.1073/pnas.1313798111; Ryan SG, 1997, NAT GENET, V17, P92, DOI 10.1038/ng0997-92; Savas JN, 2015, NEURON, V87, P764, DOI 10.1016/j.neuron.2015.08.007; Scheffer IE, 2008, BRAIN, V131, P918, DOI 10.1093/brain/awm338; Schwenk J, 2012, NEURON, V74, P621, DOI 10.1016/j.neuron.2012.03.034; Sheng M, 2001, P NATL ACAD SCI USA, V98, P7058, DOI 10.1073/pnas.111146298; Stein V, 2003, J NEUROSCI, V23, P5503; Straub C, 2012, CURR OPIN NEUROBIOL, V22, P488, DOI 10.1016/j.conb.2011.09.005; Tang AH, 2016, NATURE, V536, P210, DOI 10.1038/nature19058; Vincent AK, 2012, CLIN GENET, V82, P540, DOI 10.1111/j.1399-0004.2011.01812.x; Wegiel J, 2010, ACTA NEUROPATHOL, V119, P755, DOI 10.1007/s00401-010-0655-4; Wu K, 2003, NEUROSCIENCE, V116, P599, DOI 10.1016/S0306-4522(02)00567-5; Xu X, 2014, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00097; Zamanillo D, 1999, SCIENCE, V284, P1805, DOI 10.1126/science.284.5421.1805; Zhong L, 2009, EMBO J, V28, P3027, DOI 10.1038/emboj.2009.236; Zoghbi HY, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a009886; Zuidscherwoude M, 2015, SCI REP-UK, V5, DOI 10.1038/srep12201	49	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0171968	10.1371/journal.pone.0171968	http://dx.doi.org/10.1371/journal.pone.0171968			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207852	Green Published, Green Submitted, gold			2022-12-27	WOS:000394424500065
J	Karuppaiya, P; Yan, XX; Liao, W; Wu, J; Chen, F; Tang, L				Karuppaiya, Palaniyandi; Yan, Xiao-Xue; Liao, Wang; Wu, Jun; Chen, Fang; Tang, Lin			Identification and validation of superior reference gene for gene expression normalization via RT-qPCR in staminate and pistillate flowers of Jatropha curcas - A biodiesel plant	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; RELIABLE REFERENCE GENES; APPROPRIATE REFERENCE GENES; TRANSCRIPTION-PCR DATA; HOUSEKEEPING GENES; COPY NUMBER; QRT-PCR; SELECTION; L.; BIOFUEL	Physic nut (Jatropha curcas L) seed oil is a natural resource for the alternative production of fossil fuel. Seed oil production is mainly depended on seed yield, which was restricted by the low ratio of staminate flowers to pistillate flowers. Further, the mechanism of physic nut flower sex differentiation has not been fully understood yet. Quantitative Real Time-Poly-merase Chain Reaction is a reliable and widely used technique to quantify the gene expression pattern in biological samples. However, for accuracy of qRT-PCR, appropriate reference gene is highly desirable to quantify the target gene level. Hence, the present study was aimed to identify the stable reference genes in staminate and pistillate flowers of J. curcas. In this study, 10 candidate reference genes were selected and evaluated for their expression stability in staminate and pistillate flowers, and their stability was validated by five different algorithms (Delta Ct, BestKeeper, NormFinder, GeNorm and RefFinder). Resulting, TUB and EF found to be the two most stably expressed reference for staminate flower; while GAPDH1 and EF found to be the most stably expressed reference gene for pistillate flowers. Finally, RT-qPCR assays of target gene AGAMOUS using the identified most stable reference genes confirmed the reliability of selected reference genes in different stages of flower development. AGAMOUS gene expression levels at different stages were further proved by gene copy number analysis. Therefore, the present study provides guidance for selecting appropriate reference genes for analyzing the expression pattern of floral developmental genes in staminate and pistillate flowers of J. curcas.	[Karuppaiya, Palaniyandi; Liao, Wang; Chen, Fang; Tang, Lin] Sichuan Univ, Dept Bot, Key Lab Bioresources & Ecoenvironm, Minist Educ, Chengdu, Peoples R China; [Yan, Xiao-Xue; Wu, Jun] Sichuan Univ, Coll Life Sci, Chengdu, Peoples R China	Sichuan University; Sichuan University	Chen, F (corresponding author), Sichuan Univ, Dept Bot, Key Lab Bioresources & Ecoenvironm, Minist Educ, Chengdu, Peoples R China.; Wu, J (corresponding author), Sichuan Univ, Coll Life Sci, Chengdu, Peoples R China.	zhongsnh2018@126.com; fangchenscu@163.com	Palaniyandi, Karuppaiya/S-8106-2017	Palaniyandi, Karuppaiya/0000-0002-5178-8040	National Natural Science Foundation of China [31270359]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the National Natural Science Foundation of China (Grand Number: 31270359). Fund received by JW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achten WMJ, 2008, BIOMASS BIOENERG, V32, P1063, DOI 10.1016/j.biombioe.2008.03.003; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Carels N., 2013, JATROPHA CHALLENGES, P263, DOI [10.1007/978-1-4614-4915-7_14, DOI 10.1007/978-1-4614-4915-7_14]; Dheda K, 2005, ANAL BIOCHEM, V344, P141, DOI 10.1016/j.ab.2005.05.022; Exposito-Rodriguez M, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-131; Fairless D, 2007, NATURE, V449, P652, DOI 10.1038/449652a; FeiWu L, 2010, AGRI SCI TECH HUNAN, V11, P86; Gao JH, 2012, MOL BIOL REP, V39, P3443, DOI 10.1007/s11033-011-1116-4; Gimeno J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091474; Guenin S, 2009, J EXP BOT, V60, P487, DOI 10.1093/jxb/ern305; Gutierrez L, 2008, PLANT BIOTECHNOL J, V6, P609, DOI 10.1111/j.1467-7652.2008.00346.x; Hao XY, 2014, INT J MOL SCI, V15, P22155, DOI 10.3390/ijms151222155; Huang LK, 2014, BIOENERG RES, V7, P1201, DOI 10.1007/s12155-014-9457-1; Kozera B, 2013, J APPL GENET, V54, P391, DOI 10.1007/s13353-013-0173-x; Kumar A, 2008, IND CROP PROD, V28, P1, DOI 10.1016/j.indcrop.2008.01.001; Lee C, 2006, J BIOTECHNOL, V123, P273, DOI 10.1016/j.jbiotec.2005.11.014; Li FeiWu, 2010, Agricultural Science & Technology - Hunan, V11, P55; Ma R, 2016, FRONT PLANT SCI, V7, DOI [10.3359/fpls.2016.00536, 10.3389/fpls.2016.00536]; Ma SS, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003840; Mahoney DJ, 2004, PHYSIOL GENOMICS, V18, P226, DOI 10.1152/physiolgenomics.00067.2004; Martinez-Herrera J, 2006, FOOD CHEM, V96, P80, DOI 10.1016/j.foodchem.2005.01.059; MIZUKAMI Y, 1992, CELL, V71, P119, DOI 10.1016/0092-8674(92)90271-D; Openshaw K, 2000, BIOMASS BIOENERG, V19, P1, DOI 10.1016/S0961-9534(00)00019-2; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Plaxton WC, 1996, ANNU REV PLANT PHYS, V47, P185, DOI 10.1146/annurev.arplant.47.1.185; Reid KE, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-27; Silver N, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-33; Sood A, 2015, PLANT PHYSIOL BIOCH, V94, P253, DOI 10.1016/j.plaphy.2015.06.015; Tong ZG, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-71; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wan HJ, 2010, ANAL BIOCHEM, V399, P257, DOI 10.1016/j.ab.2009.12.008; Wang HL, 2014, PHYSIOL PLANTARUM, V152, P529, DOI 10.1111/ppl.12206; Wang MZ, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0290-7; Wang Z, 2014, MOL GENET GENOMICS, V289, P1023, DOI 10.1007/s00438-014-0853-1; Wu J, 2011, AFR J AGR RES, V6, P275; Xiao L, 2014, FRONT PLANT SCI, V5, DOI [10.3389/fpls.2014.00388, 10.3389/fpls.2014.00788]; Xu G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145613; Xue BT, 2014, INT J MOL SCI, V15, P8846, DOI 10.3390/ijms15058846; Yang C.X, 2015, SCI REP, V5; Yang Q, 2014, MOL BIOL REP, V41, P2325, DOI 10.1007/s11033-014-3086-9; Zhang L, 2013, INT J MOL SCI, V14, P24338, DOI 10.3390/ijms141224338; Zhu JY, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054411, 10.1371/journal.pone.0053196]	42	15	19	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0172460	10.1371/journal.pone.0172460	http://dx.doi.org/10.1371/journal.pone.0172460			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5VB	28234941	Green Published, gold, Green Submitted			2022-12-27	WOS:000394688200081
J	Poorebrahim, M; Sadeghi, S; Rahimi, H; Karimipoor, M; Azadmanesh, K; Mazlomi, MA; Teimoori-Toolabi, L				Poorebrahim, Mansour; Sadeghi, Solmaz; Rahimi, Hamzeh; Karimipoor, Morteza; Azadmanesh, Kayhan; Mazlomi, Mohammad Ali; Teimoori-Toolabi, Ladan			Rational design of DKK3 structure-based small peptides as antagonists of Wnt signaling pathway and in silico evaluation of their efficiency	PLOS ONE			English	Article							WEB SERVER; MOLECULAR-DYNAMICS; PROTEIN; INHIBITION; BINDING; IDENTIFICATION; PREDICTION; STABILITY; DRIVEN; CANCER	Dysregulated Wnt signaling pathway is highly associated with the pathogenesis of several human cancers. Dickkopf proteins (DKKs) are thought to inhibit Wnt signaling pathway through binding to lipoprotein receptor-related protein (LRP) 5/6. In this study, based on the 3-dimensional (3D) structure of DKK3 Cys-rich domain 2 (CRD2), we have designed and developed several peptide inhibitors of Wnt signaling pathway. Modeller 9.15 package was used to predict 3D structure of CRD2 based on the Homology modeling (HM) protocol. After refinement and minimization with GalaxyRefine and NOMAD-REF servers, the quality of selected models was evaluated utilizing VADAR, SAVES and ProSA servers. Molecular docking studies as well as literature-based information revealed two distinct boxes located at CRD2 which are actively involved in the DKK3-LRP5/6 interaction. A peptide library was constructed conducting the backrub sequence tolerance scanning protocol in Rosetta3.5 according to the DKK3-LRP5/6 binding sites. Seven tolerated peptides were chosen and their binding affinity and stability were improved by some logical amino acid substitutions. Molecular dynamics (MD) simulations of peptide-LRP5/6 complexes were carried out using GROMACS package. After evaluation of binding free energies, stability, electrostatic potential and some physicochemical properties utilizing computational approaches, three peptides (PEP-I1, PEP-I3 and PEP-II2) demonstrated desirable features. However, all seven improved peptides could sufficiently block the Wnt-binding site of LRP6 in silico. In conclusion, we have designed and improved several small peptides based on the LRP6-binding site of CRD2 of DKK3. These peptides are highly capable of binding to LRP6 in silico, and may prevent the formation of active Wnt-LRP6-Fz complex.	[Poorebrahim, Mansour; Sadeghi, Solmaz; Mazlomi, Mohammad Ali; Teimoori-Toolabi, Ladan] Univ Tehran Med Sci, Sch Adv Technol Med, Dept Med Biotechnol, Tehran, Iran; [Poorebrahim, Mansour; Sadeghi, Solmaz; Rahimi, Hamzeh; Karimipoor, Morteza; Teimoori-Toolabi, Ladan] Pasteur Inst Iran, Dept Mol Med, Tehran, Iran; [Azadmanesh, Kayhan] Pasteur Inst Iran, Dept Virol, Tehran, Iran	Tehran University of Medical Sciences; Le Reseau International des Instituts Pasteur (RIIP); Pasteur Institute of Iran; Le Reseau International des Instituts Pasteur (RIIP); Pasteur Institute of Iran	Teimoori-Toolabi, L (corresponding author), Univ Tehran Med Sci, Sch Adv Technol Med, Dept Med Biotechnol, Tehran, Iran.; Teimoori-Toolabi, L (corresponding author), Pasteur Inst Iran, Dept Mol Med, Tehran, Iran.	lteimoori@pasteur.ac.ir	Azadmanesh, kayhan/W-2445-2017; Rahimi, Hamzeh/I-6044-2018; Poorebrahim, Mansour/AAP-4133-2021; Karimipoor, Morteza/ABG-4882-2021; Teimoori-Toolabi, Ladan/J-5547-2018	Azadmanesh, kayhan/0000-0002-7165-9043; Karimipoor, Morteza/0000-0002-2406-5963; Teimoori-Toolabi, Ladan/0000-0002-6588-9774; mazlomi, mohammadali/0000-0001-5370-3111; rahimi, Hamzeh/0000-0001-9425-2353; Sadeghi, Solmaz/0000-0001-5861-2606; Poorebrahim, Mansour/0000-0003-0956-3507	Tehran University of Medical Sciences [93-04-87-27327]; Pasteur Institute of Iran	Tehran University of Medical Sciences(Tehran University of Medical Sciences); Pasteur Institute of Iran	This study has been supported by Tehran University of Medical Sciences (Grant Number: 93-04-87-27327) and Pasteur Institute of Iran.	Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001; Ahn VE, 2011, DEV CELL, V21, P862, DOI 10.1016/j.devcel.2011.09.003; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bao J, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003028; Chen S, 2011, DEV CELL, V21, P848, DOI 10.1016/j.devcel.2011.09.007; Cheng ZH, 2011, NAT STRUCT MOL BIOL, V18, P1204, DOI 10.1038/nsmb.2139; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Comeau SR, 2004, BIOINFORMATICS, V20, P45, DOI 10.1093/bioinformatics/btg371; Conchillo-Sole O, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-65; Cruciat CM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a015081; De Vries SJ, 2010, NAT PROTOC, V5, P883, DOI 10.1038/nprot.2010.32; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Fosgerau K, 2015, DRUG DISCOV TODAY, V20, P122, DOI 10.1016/j.drudis.2014.10.003; Fujii Y, 2014, ACTA MED OKAYAMA, V68, P63; GURUPRASAD K, 1990, PROTEIN ENG, V4, P155, DOI 10.1093/protein/4.2.155; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Heo L, 2013, NUCLEIC ACIDS RES, V41, pW384, DOI 10.1093/nar/gkt458; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Huo SH, 2002, J MED CHEM, V45, P1412, DOI 10.1021/jm010338j; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Jo S, 2008, NUCLEIC ACIDS RES, V36, pW270, DOI 10.1093/nar/gkn314; kafshdouziamin M, 2016, INT J PEPT RES THER, P1; Kastritis PL, 2014, J MOL BIOL, V426, P2632, DOI 10.1016/j.jmb.2014.04.017; Kawano Y, 2003, J CELL SCI, V116, P2627, DOI 10.1242/jcs.00623; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lauck F, 2010, NUCLEIC ACIDS RES, V38, pW569, DOI 10.1093/nar/gkq369; Lear S, 2016, J COMPUT AID MOL DES, V30, P271, DOI 10.1007/s10822-016-9902-7; Lin C, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0056499, 10.1371/journal.pone.0080883, 10.1371/journal.pone.0065734, 10.1371/journal.pone.0070187]; Lobanov MY, 2008, MOL BIOL+, V42, P623, DOI 10.1134/S0026893308040195; Lumb KJ, 1998, BIOCHEMISTRY-US, V37, P13042, DOI 10.1021/bi9850468; Mao BY, 2002, NATURE, V417, P664, DOI 10.1038/nature756; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; Maryam I, 2016, RECENT PAT ANTI-CANC, V11, P1; Maupetit J., 2009, NUCLEIC ACIDS RES; McGuffin LJ, 2013, NUCLEIC ACIDS RES, V41, pW368, DOI 10.1093/nar/gkt294; Mohammadpour H, 2016, J THEORETICAL BIOL; Monhemi H, 2014, PHYS CHEM CHEM PHYS, V16, P14882, DOI 10.1039/c4cp00503a; Myant K, 2014, WNT SIGNALING IN DEVELOPMENT AND DISEASE: MOLECULAR MECHANISMS AND BIOLOGICAL FUNCTIONS, P359; Padhi AK, 2013, SCI REP-UK, V3, DOI 10.1038/srep01225; Polakis P, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008052; Pushie MJ, 2010, J PHYS CHEM B, V114, P3266, DOI 10.1021/jp908731f; Sheinerman FB, 2000, CURR OPIN STRUC BIOL, V10, P153, DOI 10.1016/S0959-440X(00)00065-8; Simmerling C, 2002, J AM CHEM SOC, V124, P11258, DOI 10.1021/ja0273851; Vangone A., 2015, CONTACTS BASED PREDI; Veeck J, 2012, BBA-REV CANCER, V1825, P18, DOI 10.1016/j.bbcan.2011.09.003; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; Willard L, 2003, NUCLEIC ACIDS RES, V31, P3316, DOI 10.1093/nar/gkg565; Xiao L, 1999, J MOL BIOL, V289, P1435, DOI 10.1006/jmbi.1999.2810; Xu D, 2011, BIOPHYS J, V101, P2525, DOI 10.1016/j.bpj.2011.10.024; You L, 2004, ONCOGENE, V23, P6170, DOI 10.1038/sj.onc.1207844; Zhang YL, 2016, AMINO ACIDS, V48, P1509, DOI 10.1007/s00726-016-2211-6; Zhang YN, 2009, NAT CHEM BIOL, V5, P217, DOI 10.1038/nchembio.152; Zhang ZM, 2011, BIOINFORMATICS, V27, P2083, DOI 10.1093/bioinformatics/btr331	53	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0172217	10.1371/journal.pone.0172217	http://dx.doi.org/10.1371/journal.pone.0172217			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5VB	28234935	Green Submitted, Green Published, gold			2022-12-27	WOS:000394688200053
J	Sandoe, P; Kondrup, SV; Bennett, PC; Forkman, B; Meyer, I; Proschowsky, HF; Serpell, JA; Lund, TB				Sandoe, P.; Kondrup, S. V.; Bennett, P. C.; Forkman, B.; Meyer, I.; Proschowsky, H. F.; Serpell, J. A.; Lund, T. B.			Why do people buy dogs with potential welfare problems related to extreme conformation and inherited disease? A representative study of Danish owners of four small dog breeds	PLOS ONE			English	Article							KING-CHARLES SPANIELS; CESAREAN-SECTION; PET CONSUMPTION; DARK SIDE; ATTACHMENT; SCALE; EPIDEMIOLOGY; PREFERENCES; POPULATION; ATTITUDES	A number of dog breeds suffer from welfare problems due to extreme phenotypes and high levels of inherited diseases but the popularity of such breeds is not declining. Using a survey of owners of two popular breeds with extreme physical features (French Bulldog and Chihuahua), one with a high load of inherited diseases not directly related to conformation (Cavalier King Charles Spaniel), and one representing the same size range but without extreme conformation and with the same level of disease as the overall dog population (Cairn Terrier), we investigated this seeming paradox. We examined planning and motivational factors behind acquisition of the dogs, and whether levels of experienced health and behavior problems were associated with the quality of the owner-dog relationship and the intention to reprocure a dog of the same breed. Owners of each of the four breeds (750/breed) were randomly drawn from a nationwide Danish dog registry and invited to participate. Of these, 911 responded, giving a final sample of 846. There were clear differences between owners of the four breeds with respect to degree of planning prior to purchase, with owners of Chihuahuas exhibiting less. Motivations behind choice of dog were also different. Health and other breed attributes were more important to owners of Cairn Terriers, whereas the dog's personality was reported to be more important for owners of French Bulldogs and Cavalier King Charles Spaniels but less important for Chihuahua owners. Higher levels of health and behavior problems were positively associated with a closer owner-dog relationship for owners of Cavalier King Charles Spaniels and Chihuahuas but, for owners of French Bulldogs, high levels of problems were negatively associated with an intention to procure the same breed again. In light of these findings, it appears less paradoxical that people continue to buy dogs with welfare problems.	[Sandoe, P.; Kondrup, S. V.; Lund, T. B.] Univ Copenhagen, Dept Food & Resource Econ, Copenhagen C, Denmark; [Sandoe, P.; Forkman, B.; Meyer, I.] Univ Copenhagen, Dept Large Anim Sci, Copenhagen C, Denmark; [Bennett, P. C.] La Trobe Univ, Dept Psychol & Counseling, Bendigo, Vic, Australia; [Proschowsky, H. F.] Danish Kennel Club, Solrod Strand, Denmark; [Serpell, J. A.] Univ Penn, Sch Vet Med, Dept Clin Studies, Philadelphia, PA 19104 USA	University of Copenhagen; University of Copenhagen; La Trobe University; University of Pennsylvania	Sandoe, P (corresponding author), Univ Copenhagen, Dept Food & Resource Econ, Copenhagen C, Denmark.; Sandoe, P (corresponding author), Univ Copenhagen, Dept Large Anim Sci, Copenhagen C, Denmark.	pes@sund.ku.dk	Kondrup, Sara Vincentzen/O-5749-2015; Bennett, Pauleen/C-2138-2016; Lund, Thomas/E-4584-2015; Sandoe, Peter/E-8758-2015	Kondrup, Sara Vincentzen/0000-0003-2285-6187; Bennett, Pauleen/0000-0001-5864-4464; Lund, Thomas/0000-0001-5282-1562; Sandoe, Peter/0000-0003-0397-3273; Forkman, Bjorn/0000-0002-0153-6240	Danish Centre for Animal Welfare; University of Copenhagen	Danish Centre for Animal Welfare; University of Copenhagen	The results presented in this paper derive from a project funded by the Danish Centre for Animal Welfare, https://www.foedevarestyrelsen.dk/english/Animal/AnimalWelfare/DCAW/Projects/Pages/default.aspx (no grant number). The funding was given to the University of Copenhagen and was used to hire Iben Meyer as a post.doc., to cover the costs of one months salary to Thomas Boker Lund and to pay for costs in relation to data collection. The Department of Food and Resource Economics, University of Copenhagen, resources for manpower (salaries to the part of Thomas Boker Lunds time that was not covered by the grant and salaries relating to the working time put into the project by Sara Vincentzen Kondrup and Peter Sandoe) and help from staff in printing and posting the questionnaires. No individuals employed or contracted by the funders played any role in: study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahuvia A, 2008, J BUS RES, V61, P497, DOI 10.1016/j.jbusres.2007.01.028; Alam MR, 2007, VET COMP ORTHOPAED, V20, P59; Archer J, 1997, EVOL HUM BEHAV, V18, P237, DOI 10.1016/S0162-3095(99)80001-4; Archer J, 2011, ETHOLOGY, V117, P217, DOI 10.1111/j.1439-0310.2010.01863.x; Asher L, 2009, VET J, V182, P402, DOI 10.1016/j.tvjl.2009.08.033; Bagley DK, 2005, ANTHROZOOS, V18, P28, DOI 10.2752/089279305785594333; Bateson P., 2010, INDEPENDENT INQUIRY; Bergstrom A, 2006, VET SURG, V35, P786, DOI 10.1111/j.1532-950X.2006.00223.x; Beverland MB, 2008, J BUS RES, V61, P490, DOI 10.1016/j.jbusres.2006.08.009; Bradshaw JWS, 1999, RES VET SCI, V66, P73, DOI 10.1053/rvsc.1998.0246; Collins LM, 2010, ANIM WELFARE, V19, P67; Cromer L. D., 2013, Human-Animal Interaction Bulletin, V1, P34; Daly B, 2006, ANTHROZOOS, V19, P113, DOI 10.2752/089279306785593801; Danmarks Statistik, DEGR URB DEGURBA; Dansk Kennel Klub, 2015, ARL REG STAMB; Dotson MJ, 2008, J BUS RES, V61, P457, DOI 10.1016/j.jbusres.2007.07.019; Duffy DL, 2008, APPL ANIM BEHAV SCI, V114, P441, DOI 10.1016/j.applanim.2008.04.006; Egenvall A, 1998, PREV VET MED, V36, P51, DOI 10.1016/S0167-5877(98)00073-7; El-Alayli A, 2006, BASIC APPL SOC PSYCH, V28, P131, DOI 10.1207/s15324834basp2802_3; Evans KM, 2010, J SMALL ANIM PRACT, V51, P113, DOI 10.1111/j.1748-5827.2009.00902.x; Federation Cynologique Internationale (AISBL), 2010, 218 AISBL FCI; Fox M, 1981, S HUM COMP AN BOND L; GAUDET DA, 1985, J AM ANIM HOSP ASSOC, V21, P813; Ghirlanda S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074770; Greenebaum J, 2004, SOC ANIM, V12, P117, DOI 10.1163/1568530041446544; Hair J, 2007, MULTIVAR DATA ANAL, P89; Hecht J, 2015, ANTHROZOOS, V28, P153, DOI 10.2752/089279315X14129350722217; Hens K, 2009, J AGR ENVIRON ETHIC, V22, P3, DOI 10.1007/s10806-008-9120-y; Herzog H, 2006, SOC ANIM, V14, P383, DOI 10.1163/156853006778882448; Hoffman Christy L, 2013, Hum Anim Interact Bull, V1, P20; JOHNSON TP, 1992, ANTHROZOOS, V5, P160, DOI 10.2752/089279392787011395; Julius H., 2013, ATTACHMENT PETS AN I; Kurdek LA, 2008, J SOC PERS RELAT, V25, P247, DOI 10.1177/0265407507087958; LaFond E, 2002, J AM ANIM HOSP ASSOC, V38, P467, DOI 10.5326/0380467; Leppanen M, 2000, PREV VET MED, V43, P145, DOI 10.1016/S0167-5877(99)00098-7; Marinelli L, 2007, APPL ANIM BEHAV SCI, V108, P143, DOI 10.1016/j.applanim.2006.11.018; Meyer I, 2014, J VET BEHAV, V9, P143, DOI 10.1016/j.jveb.2014.03.002; Mosteller J, 2008, J BUS RES, V61, P512, DOI 10.1016/j.jbusres.2007.07.004; Nagasawa M, 2009, HORM BEHAV, V55, P434, DOI 10.1016/j.yhbeh.2008.12.002; Nicholas FW, 2010, VET J, V183, P8, DOI 10.1016/j.tvjl.2009.11.008; Packer RMA, 2012, ANIM WELFARE, V21, P81, DOI 10.7120/096272812X13345905673809; Packer RMA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137496; PADGETT GA, 1986, AM J MED GENET, V25, P9, DOI 10.1002/ajmg.1320250103; Payne C, 2005, J ETHOL, V23, P15, DOI 10.1007/s10164-004-0122-6; Pedersen HD, 1999, VET REC, V144, P315; PETERSENJONES SM, 1991, J SMALL ANIM PRACT, V32, P19, DOI 10.1111/j.1748-5827.1991.tb00851.x; PORESKY RH, 1987, PSYCHOL REP, V60, P743, DOI 10.2466/pr0.1987.60.3.743; Redmalm D, 2014, INT J CULTURAL STUD, V17, P93, DOI 10.1177/1367877912464539; Rehn T, 2014, APPL ANIM BEHAV SCI, V150, P65, DOI 10.1016/j.applanim.2013.10.008; Retsinformation, 2015, BEK ERHV HAND MED OP; Rockett B, 2014, SOC ANIM, V22, P415, DOI 10.1163/15685306-12341322; Roy MM, 2005, PSYCHOL SCI, V16, P743, DOI 10.1111/j.1467-9280.2005.01605.x; Roy MM, 2004, PSYCHOL SCI, V15, P361, DOI 10.1111/j.0956-7976.2004.00684.x; Rusbridge C, 2003, VET REC, V153, P107, DOI 10.1136/vr.153.4.107; Sandoe P, 2014, DYREVELFAERD DANMARK, P36; Sandoe P., 2016, COMPANION ANIMAL ETH, P103; Schlensker E, 2013, EUR J COMP ANIM PRAC, V23, P119; Serpell JA, 1996, APPL ANIM BEHAV SCI, V47, P49, DOI 10.1016/0168-1591(95)01010-6; Smith S., 2016, MOST POPULAR DOG BRE; Stammbach KB, 1999, ANTHROZOOS, V12, P162, DOI 10.2752/089279399787000237; Statistiska Centralbyran, HUND KATT ANDR SALLS; Stern-Bertholtz W, 2003, J SMALL ANIM PRACT, V44, P253, DOI 10.1111/j.1748-5827.2003.tb00151.x; Summers JF, 2010, VET J, V183, P39, DOI 10.1016/j.tvjl.2009.11.002; TEMPLER DI, 1981, PSYCHOL REC, V31, P343, DOI 10.1007/BF03394747; Tesfom G, 2012, INT REV PUBLIC NONPR, V10, P103; The Kennel Club, BREED REG STAT 10 YE; The Kennel Club, TOP 20 BREEDS REG OR; Turcsan B, 2011, APPL ANIM BEHAV SCI, V132, P61, DOI 10.1016/j.applanim.2011.03.006; Veevers J.E., 1985, MARRIAGE FAM REV, V8, P11, DOI [10.1300/J002v08n03_03, DOI 10.1300/J002V08N03_03]; Wilson C. C., 1987, Anthrozoos, V1, P76, DOI 10.2752/089279388787058650	70	32	32	3	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0172091	10.1371/journal.pone.0172091	http://dx.doi.org/10.1371/journal.pone.0172091			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL5VB	28234931	Green Published, Green Submitted, gold			2022-12-27	WOS:000394688200046
J	Sothmann, T; Gauer, T; Werner, R				Sothmann, Thilo; Gauer, Tobias; Werner, Rene			4D dose simulation in volumetric arc therapy: Accuracy and affecting parameters	PLOS ONE			English	Article							STEREOTACTIC BODY RADIOTHERAPY; RADIATION-THERAPY; DOSIMETRIC IMPACT; MOTION; DELIVERY; SBRT; BEAMS	Radiotherapy of lung and liver lesions has changed from normofractioned 3D-CRT to stereotactic treatment in a single or few fractions, often employing volumetric arc therapy (VMAT)-based techniques. Potential unintended interference of respiratory target motion and dynamically changing beam parameters during VMAT dose delivery motivates establishing 4D quality assurance (4D QA) procedures to assess appropriateness of generated VMAT treatment plans when taking into account patient-specific motion characteristics. Current approaches are motion phantom-based 4D QA and image-based 4D VMAT dose simulation. Whereas phantom-based 4D QA is usually restricted to a small number of measurements, the computational approaches allow simulating many motion scenarios. However, 4D VMAT dose simulation depends on various input parameters, influencing estimated doses along with mitigating simulation reliability. Thus, aiming at routine use of simulation-based 4D VMAT QA, the impact of such parameters as well as the overall accuracy of the 4D VMAT dose simulation has to be studied in detail-which is the topic of the present work. In detail, we introduce the principles of 4D VMAT dose simulation, identify influencing parameters and assess their impact on 4D dose simulation accuracy by comparison of simulated motion-affected dose distributions to corresponding dosimetric motion phantom measurements. Exploiting an ITV-based treatment planning approach, VMAT treatment plans were generated for a motion phantom and different motion scenarios (sinusoidal motion of different period/direction; regular/irregular motion). 4D VMAT dose simulation results and dose measurements were compared by local 3% / 3 mm gamma-evaluation, with the measured dose distributions serving as ground truth. Overall gamma-passing rates of simulations and dynamic measurements ranged from 97% to 100% (mean across all motion scenarios: 98% +/- 1%); corresponding values for comparison of different day repeat measurements were between 98% and 100%. Parameters of major influence on 4D VMAT dose simulation accuracy were the degree of temporal discretization of the dose delivery process (the higher, the better) and correct alignment of the assumed breathing phases at the beginning of the dose measurements and simulations. Given the high gamma-passing rates between simulated motion-affected doses and dynamic measurements, we consider the simulations to provide a reliable basis for assessment of VMAT motion effects that-in the sense of 4D QA of VMAT treatment plans-allows to verify target coverage in hypofractioned VMAT-based radiotherapy of moving targets. Remaining differences between measurements and simulations motivate, however, further detailed studies.	[Sothmann, Thilo; Werner, Rene] Univ Med Ctr Hamburg Eppendorf, Dept Computat Neurosci, Hamburg, Germany; [Gauer, Tobias] Univ Med Ctr Hamburg Eppendorf, Dept Radiotherapy & Radiooncol, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf	Sothmann, T (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Computat Neurosci, Hamburg, Germany.	t.sothmann@uke.de	Werner, Rene/B-4989-2017	Werner, Rene/0000-0002-2296-3305; Sentker, Thilo/0000-0001-6663-0003	Forschungsforderungsfond of the Medical Faculty of the University of Hamburg	Forschungsforderungsfond of the Medical Faculty of the University of Hamburg	This work was supported by Forschungsforderungsfond of the Medical Faculty of the University of Hamburg (to RW; URL: https://www.uke.de/english/research/funding-opportunities/faculty-of-medicine/index.html).	Bortfeld T, 2002, PHYS MED BIOL, V47, P2203, DOI 10.1088/0031-9155/47/13/302; Dogan N, 2003, INT J RADIAT ONCOL, V57, P1480, DOI 10.1016/S0360-3016(03)01569-4; Ehrbar S, 3 DIMENSIONAL VERSUS; Gauer T, 2016, RADIOTHER ONCOL, V119, pS826, DOI 10.1016/S0167-8140(16)33014-6; Goodman KA, 2010, INT J RADIAT ONCOL, V78, P486, DOI 10.1016/j.ijrobp.2009.08.020; Grohmann C, 2015, Z MED PHYS, V25, P156, DOI 10.1016/j.zemedi.2014.09.003; Guckenberger M, 2009, RADIOTHER ONCOL, V93, P259, DOI 10.1016/j.radonc.2009.08.015; Katz AW, 2007, INT J RADIAT ONCOL, V67, P793, DOI 10.1016/j.ijrobp.2006.10.025; Keall PJ, 2006, MED PHYS, V33, P3874, DOI 10.1118/1.2349696; Korreman SS, 2012, PHYS MED BIOL, V57, pR161, DOI 10.1088/0031-9155/57/23/R161; Li X, 2013, J APPL CLIN MED PHYS, V14, P195, DOI 10.1120/jacmp.v14i6.4370; Low DA, 1998, MED PHYS, V25, P656, DOI 10.1118/1.598248; Markovic M, 2014, MED PHYS, V41, DOI 10.1118/1.4870439; McGrath SD, 2010, RADIOTHER ONCOL, V95, P153, DOI 10.1016/j.radonc.2009.12.039; Milz S, 2014, PHYS MED BIOL, V59, P6401, DOI 10.1088/0022-3727/59/21/6401; Murphy K, 2011, IEEE T MED IMAGING, V30, P1901, DOI 10.1109/TMI.2011.2158349; Ong CL, 2013, INT J RADIAT ONCOL, V86, P743, DOI 10.1016/j.ijrobp.2013.03.038; Ong C, 2011, INT J RADIAT ONCOL, V79, P305, DOI 10.1016/j.ijrobp.2010.02.059; Palma DA, 2010, CANCER TREAT REV, V36, P393, DOI 10.1016/j.ctrv.2010.01.004; Poppe B, 2013, MED PHYS, V40, DOI 10.1118/1.4816298; Poulsen PR, 2012, MED PHYS, V39, P6237, DOI 10.1118/1.4754297; Rao M, 2012, INT J RADIAT ONCOL, V83, pE251, DOI 10.1016/j.ijrobp.2011.12.001; Riley C, 2014, MED PHYS, V41, DOI 10.1118/1.4855956; Simeonova AO, 2012, TRANSL LUNG CANCER R, V1, P45, DOI 10.3978/j.issn.2218-6751.10.01; Sothmann T, 2016, PHYS MED BIOL, V61, P1677, DOI 10.1088/0031-9155/61/4/1677; Stambaugh C, 2013, MED PHYS, V40, DOI 10.1118/1.4818255; Teoh M, 2011, BRIT J RADIOL, V84, P967, DOI 10.1259/bjr/22373346; Tsuruta Y, 2014, MED PHYS, V41, P189, DOI 10.1118/1.4890592; Werner R, 2014, PHYS MED BIOL, V59, P4247, DOI 10.1088/0031-9155/59/15/4247; Werner R, 2012, Z MED PHYS, V22, P109, DOI 10.1016/j.zemedi.2011.08.001; Zhang GG, 2011, RADIAT ONCOL, V6, DOI 10.1186/1748-717X-6-152; Zou W, 2014, RADIAT ONCOL, V9, DOI 10.1186/s13014-014-0225-3	32	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2017	12	2							e0172810	10.1371/journal.pone.0172810	http://dx.doi.org/10.1371/journal.pone.0172810			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5SX	28231337	Green Published, Green Submitted, gold			2022-12-27	WOS:000394682400080
J	Swami, V; Barron, D; Weis, L; Voracek, M; Stieger, S; Furnham, A				Swami, Viren; Barron, David; Weis, Laura; Voracek, Martin; Stieger, Stefan; Furnham, Adrian			An examination of the factorial and convergent validity of four measures of conspiracist ideation, with recommendations for researchers	PLOS ONE			English	Article							EXPLORATORY FACTOR-ANALYSIS; CONFIRMATORY FACTOR-ANALYSIS; CUTOFF CRITERIA; BELIEF; ASSOCIATIONS; WORLD	A number scales have been developed to measure conspiracist ideation, but little attention has been paid to the factorial validity of these scales. We reassessed the psychometric properties of four widely-used scales, namely the Belief in Conspiracy Theories Inventory (BCTI), the Conspiracy Mentality Questionnaire (CMQ), the Generic Conspiracist Beliefs Scale (GCBS), and the One-Item Conspiracy Measure (OICM). Eight-hundred-and-three U.S. adults completed all measures, along with measures of endorsement of 9/11 and antivaccination conspiracy theories. Through both exploratory and confirmatory factor analysis, we found that only the BCTI had acceptable factorial validity. We failed to confirm the factor structures of the CMQ and the GBCS, suggesting these measures had poor factorial validity. Indices of convergent validity were acceptable for the BCTI, but weaker for the other measures. Based on these findings, we provide suggestions for the future refinement in the measurement of conspiracist ideation.	[Swami, Viren] Anglia Ruskin Univ, Dept Psychol, Cambridge, Cambs, England; [Swami, Viren] HELP Univ Coll, Dept Psychol, Kuala Lumpur, Malaysia; [Barron, David] Univ Westminster, Dept Psychol, London, England; [Weis, Laura; Furnham, Adrian] UCL, Dept Clin Educ & Hlth Psychol, London, England; [Voracek, Martin] Univ Vienna, Sch Psychol, Dept Basic Psychol Res & Res Methods, Vienna, Austria; [Stieger, Stefan] Univ Konstanz, Dept Psychol, Res Methods Assessment & iSci, Constance, Germany	Anglia Ruskin University; Help University; University of Westminster; University of London; University College London; University of Vienna; University of Konstanz	Swami, V (corresponding author), Anglia Ruskin Univ, Dept Psychol, Cambridge, Cambs, England.; Swami, V (corresponding author), HELP Univ Coll, Dept Psychol, Kuala Lumpur, Malaysia.	viren.swami@anglia.ac.uk	Stieger, Stefan/G-2572-2012; Furnham, Adrian/ABB-2072-2020; Voracek, Martin/S-5865-2016	Stieger, Stefan/0000-0002-7784-6624; Voracek, Martin/0000-0001-6109-6155				Abalakina-Paap M, 1999, POLIT PSYCHOL, V20, P637, DOI 10.1111/0162-895X.00160; American Educational Research Association American Psychological Association Na- tional Council on Measurement in Education, 2014, STAND ED PSYCH TEST; [Anonymous], 2014, IBM SPSS AMOSTM 23 U; Barron D, 2014, PERS INDIV DIFFER, V82, P136; Brotherton R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124125; Brotherton R, 2015, PERS INDIV DIFFER, V80, P1, DOI 10.1016/j.paid.2015.02.011; Brotherton R, 2014, APPL COGNITIVE PSYCH, V28, P238, DOI 10.1002/acp.2995; Brotherton R, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00279; Brown T.A., 2006, CONFIRMATORY FACTOR, V1st; Bruder M., 2013, FRONT PSYCHOL, V4, P279; Buhrmester M, 2011, PERSPECT PSYCHOL SCI, V6, P3, DOI 10.1177/1745691610393980; Cichocka A, 2016, SOC PSYCHOL PERS SCI, V7, P157, DOI 10.1177/1948550615616170; Clark LA, 1995, PSYCHOL ASSESSMENT, V7, P309, DOI 10.1037/1040-3590.7.3.309; Comrey AL., 1992, 1 COURSE FACTOR ANAL, V2nd ed., DOI DOI 10.4324/9781315827506; Dagnall N, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00206; Darwin H, 2011, PERS INDIV DIFFER, V50, P1289, DOI 10.1016/j.paid.2011.02.027; Dieguez S, 2015, PSYCHOL SCI, V26, P1762, DOI 10.1177/0956797615598740; Douglas KM, 2016, THINK REASONING, V22, P57, DOI 10.1080/13546783.2015.1051586; Douglas KM, 2011, BRIT J SOC PSYCHOL, V50, P544, DOI 10.1111/j.2044-8309.2010.02018.x; Fabrigar LR, 1999, PSYCHOL METHODS, V4, P272, DOI 10.1037/1082-989X.4.3.272; Goertzel T, 1994, POLITICAL PSYCHOL, V15, P31; Hayton JC, 2004, ORGAN RES METHODS, V7, P191, DOI 10.1177/1094428104263675; Heene M, 2011, PSYCHOL METHODS, V16, P319, DOI 10.1037/a0024917; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Imhoff R, 2014, EUR J PERSONALITY, V28, P25, DOI 10.1002/per.1930; Jolley D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089177; Kline R.B., 2011, PRINCIPLES PRACTICE; Kline R.B., 2019, APPL QUANTITATIVE AN, P171; Lance CE, 2006, ORGAN RES METHODS, V9, P202, DOI 10.1177/1094428105284919; Lantian A, 2016, INT REV SOC PSYCHOL, V29, P1, DOI 10.5334/irsp.8; Leman PJ, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00378; Lipsey M. W., 2001, PRACTICAL METAANALYS, V49; Lobato E, 2014, APPL COGNITIVE PSYCH, V28, P617, DOI 10.1002/acp.3042; Marsh HW, 2011, J EDUC PSYCHOL, V103, P701, DOI 10.1037/a0024122; Moulding R, 2016, PERS INDIV DIFFER, V98, P345, DOI 10.1016/j.paid.2016.04.060; Nunnally J., 1978, PSYCHOMETRIC THEORY; Parent MC, 2013, COUNS PSYCHOL, V41, P568, DOI 10.1177/0011000012445176; Patil VH, 2008, J BUS RES, P61162; Patil VH, 2010, AM J HEALTH PROMOT, V24, P178, DOI 10.4278/ajhp.08033131; Pedhazur EJ, 1991, MEASUREMENT DESIGN A; Pennycook G, 2015, JUDGM DECIS MAK, V10, P549; Schreiber JB, 2006, J EDUC RES, V99, P323, DOI 10.3200/JOER.99.6.323-338; Sijtsma K, 2009, PSYCHOMETRIKA, V74, P107, DOI 10.1007/s11336-008-9101-0; Stieger S, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00297; Stojanov A, 2015, PSIHOLOGIJA, V48, P251, DOI 10.2298/PSI1503251S; Swami V, 2016, PERS INDIV DIFFER, V99, P72, DOI 10.1016/j.paid.2016.04.084; Swami V, 2016, PSYCHIAT RES, V236, P86, DOI 10.1016/j.psychres.2015.12.027; Swami V, 2014, COGNITION, V133, P572, DOI 10.1016/j.cognition.2014.08.006; Swami V, 2013, APPL COGNITIVE PSYCH, V27, P71, DOI 10.1002/acp.2873; Swami V, 2012, J GEN PSYCHOL, V139, P244, DOI 10.1080/00221309.2012.697932; Swami V, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00280; Swami V, 2012, PERS INDIV DIFFER, V53, P443, DOI 10.1016/j.paid.2012.04.015; Swami V, 2011, BRIT J PSYCHOL, V102, P443, DOI 10.1111/j.2044-8295.2010.02004.x; Swami V, 2010, APPL COGNITIVE PSYCH, V24, P749, DOI 10.1002/acp.1583; Swami Viren, 2014, POWER POLITICS PARAN, P218, DOI DOI 10.1017/CBO9781139565417.016; Tabachnik B.G., 2014, DISCRIMINANT ANAL US, Vsixth; van der Tempel J, 2015, PERS INDIV DIFFER, V82, P136, DOI 10.1016/j.paid.2015.03.010; Van Prooijen JW, 2015, APPL COGNITIVE PSYCH, V29, P753, DOI 10.1002/acp.3161; van Prooijen JW, 2015, SOC PSYCHOL PERS SCI, V6, P570, DOI 10.1177/1948550614567356; Wood MJ, 2012, SOC PSYCHOL PERS SCI, V3, P767, DOI 10.1177/1948550611434786; Wood MJ, POLITICAL P IN PRESS	61	74	76	3	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2017	12	2							e0172617	10.1371/journal.pone.0172617	http://dx.doi.org/10.1371/journal.pone.0172617			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL5SX	28231266	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000394682400061
J	Deb, A; Johnson, WA; Kline, AP; Scott, BJ; Meador, LR; Srinivas, D; Martin-Garcia, JM; Dorner, K; Borges, CR; Misra, R; Hogue, BG; Fromme, P; Mor, TS				Deb, Arpan; Johnson, William A.; Kline, Alexander P.; Scott, Boston J.; Meador, Lydia R.; Srinivas, Dustin; Martin-Garcia, Jose M.; Dorner, Katerina; Borges, Chad R.; Misra, Rajeev; Hogue, Brenda G.; Fromme, Petra; Mor, Tsafrir S.			Bacterial expression, correct membrane targeting and functional folding of the HIV-1 membrane protein Vpu using a periplasmic signal peptide	PLOS ONE			English	Article							TRANSCYTOSIS-BLOCKING ABS; ESCHERICHIA-COLI; CODON USAGE; AFFINITY-CHROMATOGRAPHY; NICOTIANA-BENTHAMIANA; TRANSMEMBRANE DOMAIN; CYTOPLASMIC DOMAIN; RESPECTIVE CODONS; TRANSLATION RATE; TRANSFER-RNAS	Viral protein U (Vpu) is a type-III integral membrane protein encoded by Human Immunodeficiency Virus-1 (HIV-1). It is expressed in infected host cells and plays several roles in viral progeny escape from infected cells, including down-regulation of CD4 receptors. But key structure/ function questions remain regarding the mechanisms by which the Vpu protein contributes to HIV-1 pathogenesis. Here we describe expression of Vpu in bacteria, its purification and characterization. We report the successful expression of PelB-Vpu in Escherichia coli using the leader peptide pectate lyase B (PelB) from Erwinia carotovora. The protein was detergent extractable and could be isolated in a very pure form. We demonstrate that the PelB signal peptide successfully targets Vpu to the cell membranes and inserts it as a type I membrane protein. PelB-Vpu was biophysically characterized by circular dichroism and dynamic light scattering experiments and was shown to be an excellent candidate for elucidating structural models.	[Deb, Arpan; Johnson, William A.; Kline, Alexander P.; Scott, Boston J.; Meador, Lydia R.; Srinivas, Dustin; Misra, Rajeev; Hogue, Brenda G.; Mor, Tsafrir S.] Arizona State Univ, Sch Life Sci, Tempe, AZ USA; [Deb, Arpan; Johnson, William A.; Kline, Alexander P.; Scott, Boston J.; Meador, Lydia R.; Srinivas, Dustin; Hogue, Brenda G.; Mor, Tsafrir S.] Arizona State Univ, Biodesign Ctr Immunotherapy Vaccines & Virotherap, Biodesign Inst, Tempe, AZ USA; [Johnson, William A.; Martin-Garcia, Jose M.; Dorner, Katerina; Borges, Chad R.; Fromme, Petra] Arizona State Univ, Sch Mol Sci, Tempe, AZ USA; [Martin-Garcia, Jose M.; Hogue, Brenda G.; Fromme, Petra] Arizona State Univ, Biodesign Ctr Appl Struct Discovery, Biodesign Inst, Tempe, AZ USA; [Borges, Chad R.] Arizona State Univ, Biodesign Ctr Personal Diagnost, Biodesign Inst, Tempe, AZ USA; [Deb, Arpan] Univ Montana, Dept Chem & Biochem, Missoula, MT 59812 USA; [Meador, Lydia R.] Univ Arizona, Coll Med Phoenix, Dept Basic Med Sci, Phoenix, AZ USA; [Srinivas, Dustin] Cedars Sinai Med Ctr, Dept Biomed Sci, Los Angeles, CA 90048 USA; [Dorner, Katerina] European XFEL GmbH, Schenefeld, Germany	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; University of Montana System; University of Montana; University of Arizona; Cedars Sinai Medical Center; European XFEL	Mor, TS (corresponding author), Arizona State Univ, Sch Life Sci, Tempe, AZ USA.	tsafrir.mor@asu.edu	Garcia, Jose Manuel Martin/V-2043-2018; MARTIN GARCIA, JOSE MANUEL/AAB-6838-2020; MARTIN GARCIA, JOSE MANUEL/GQA-3160-2022; Deb, Arpan/C-2898-2017	Garcia, Jose Manuel Martin/0000-0002-4558-3858; MARTIN GARCIA, JOSE MANUEL/0000-0002-4558-3858; MARTIN GARCIA, JOSE MANUEL/0000-0002-4558-3858; Hogue, Brenda/0000-0002-4545-9208; Deb, Arpan/0000-0002-2989-3661; Fromme, Petra/0000-0003-0953-4909	Center for Membrane Proteins in Infectious Diseases (MPID) - PSI:Biology program within the National Institute of General Medical Sciences' Protein Structure Initiative (National Institutes of Health grant) [U54GM094599]	Center for Membrane Proteins in Infectious Diseases (MPID) - PSI:Biology program within the National Institute of General Medical Sciences' Protein Structure Initiative (National Institutes of Health grant)	This work was supported by the Center for Membrane Proteins in Infectious Diseases (MPID), which was funded by the PSI:Biology program within the National Institute of General Medical Sciences' Protein Structure Initiative (National Institutes of Health grant number U54GM094599) awarded to BGH, TSM and PF.	ALEXANDER DM, 1992, PROTEIN EXPRES PURIF, V3, P204, DOI 10.1016/1046-5928(92)90016-P; Arvola M, 1996, J BIOL CHEM, V271, P15527, DOI 10.1074/jbc.271.26.15527; Berks BC, 2000, MOL MICROBIOL, V35, P260, DOI 10.1046/j.1365-2958.2000.01719.x; Bolduan S, 2013, VIROLOGY, V440, P190, DOI 10.1016/j.virol.2013.02.021; COHEN EA, 1988, NATURE, V334, P532, DOI 10.1038/334532a0; Combet C, 2000, TRENDS BIOCHEM SCI, V25, P147, DOI 10.1016/S0968-0004(99)01540-6; Fecker LE, 1996, PLANT MOL BIOL, V32, P979, DOI 10.1007/BF00020494; Geyer BC, 2010, P NATL ACAD SCI USA, V107, P20251, DOI 10.1073/pnas.1009021107; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; HARTL FU, 1990, CELL, V63, P269, DOI 10.1016/0092-8674(90)90160-G; Herrero L, 2013, BIOCHEMISTRY-US, V52, P171, DOI 10.1021/bi3011175; Hilf RJC, 2008, NATURE, V452, P375, DOI 10.1038/nature06717; Hout DR, 2005, VIROLOGY, V339, P56, DOI 10.1016/j.virol.2005.04.038; IKEMURA T, 1982, J MOL BIOL, V158, P573, DOI 10.1016/0022-2836(82)90250-9; IKEMURA T, 1981, J MOL BIOL, V146, P1, DOI 10.1016/0022-2836(81)90363-6; IWASAKI Y, 1995, J FERMENT BIOENG, V79, P417, DOI 10.1016/0922-338X(95)91254-3; JANSSEN JJM, 1995, J BIOL CHEM, V270, P11222, DOI 10.1074/jbc.270.19.11222; Jumpertz T, 2011, ANAL BIOCHEM, V408, P64, DOI 10.1016/j.ab.2010.09.011; Kanaya S, 2001, J MOL EVOL, V53, P290, DOI 10.1007/s002390010219; Kefala Georgia, 2007, Journal of Structural and Functional Genomics, V8, P167, DOI 10.1007/s10969-007-9033-4; Kessans SA, 2013, PLANT BIOTECHNOL J, V11, P681, DOI 10.1111/pbi.12058; Kueck T, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002609; KUHELJ R, 1995, EUR J BIOCHEM, V229, P533, DOI 10.1111/j.1432-1033.1995.0533k.x; Lavner Y, 2005, GENE, V345, P127, DOI 10.1016/j.gene.2004.11.035; Lee HH, 2014, IUCRJ, V1, P305, DOI 10.1107/S2052252514014900; LEI SP, 1987, J BACTERIOL, V169, P4379, DOI 10.1128/jb.169.9.4379-4383.1987; LENBURG ME, 1993, J VIROL, V67, P7238, DOI 10.1128/JVI.67.12.7238-7245.1993; Lindner Peter, 1992, Methods (Orlando), V4, P41, DOI 10.1016/1046-2023(92)90055-D; LOO TW, 1995, J BIOL CHEM, V270, P21449, DOI 10.1074/jbc.270.37.21449; Luo JY, 2009, PROTEIN SCI, V18, P1735, DOI 10.1002/pro.189; Ma C, 2002, PROTEIN SCI, V11, P546, DOI 10.1110/ps.37302; Magadan JG, 2012, J VIROL, V86, P757, DOI 10.1128/JVI.05933-11; Magadan JG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000869; Margottin F, 1996, VIROLOGY, V223, P381, DOI 10.1006/viro.1996.0491; Marin Monica, 2008, Biotechnology Journal, V3, P1047, DOI 10.1002/biot.200800089; Matoba N, 2004, P NATL ACAD SCI USA, V101, P13584, DOI 10.1073/pnas.0405297101; Matoba N, 2008, CURR HIV RES, V6, P218, DOI 10.2174/157016208784324994; National Center for Biotechnology Information, 2016, PUBCHEM COMP DAT; Nguyen KL, 2004, VIROLOGY, V319, P163, DOI 10.1016/j.virol.2003.11.021; Patra AK, 2000, PROTEIN EXPRES PURIF, V18, P182, DOI 10.1006/prep.1999.1179; PETERS D, 1995, EUR J BIOCHEM, V228, P798, DOI 10.1111/j.1432-1033.1995.tb20325.x; POWER BE, 1992, GENE, V113, P95, DOI 10.1016/0378-1119(92)90674-E; Prive GG, 2007, METHODS, V41, P388, DOI 10.1016/j.ymeth.2007.01.007; PURVIS IJ, 1987, J MOL BIOL, V193, P413, DOI 10.1016/0022-2836(87)90230-0; Quax TEF, 2015, MOL CELL, V59, P149, DOI 10.1016/j.molcel.2015.05.035; ROBINSON M, 1984, NUCLEIC ACIDS RES, V12, P6663, DOI 10.1093/nar/12.17.6663; SCHUBERT U, 1992, EUR J BIOCHEM, V204, P875, DOI 10.1111/j.1432-1033.1992.tb16707.x; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; SORENSEN MA, 1989, J MOL BIOL, V207, P365, DOI 10.1016/0022-2836(89)90260-X; Steiner D, 2006, NAT BIOTECHNOL, V24, P823, DOI 10.1038/nbt1218; STREBEL K, 1988, SCIENCE, V241, P1221, DOI 10.1126/science.3261888; Strop P, 2005, PROTEIN SCI, V14, P2207, DOI 10.1110/ps.051543805; Thie H, 2008, NEW BIOTECHNOL, V25, P49, DOI 10.1016/j.nbt.2008.01.001; Tiganos E, 1997, J VIROL, V71, P4452, DOI 10.1128/JVI.71.6.4452-4460.1997; Urrutia AO, 2003, GENOME RES, V13, P2260, DOI 10.1101/gr.641103; VANAKEN T, 1986, METHOD ENZYMOL, V125, P27; WAEBER U, 1993, FEBS LETT, V324, P109, DOI 10.1016/0014-5793(93)81542-8; Walsh NP, 2003, CELL, V113, P61, DOI 10.1016/S0092-8674(03)00203-4; Wittlich M, 2009, FEBS J, V276, P6560, DOI 10.1111/j.1742-4658.2009.07363.x	59	6	7	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2017	12	2							e0172529	10.1371/journal.pone.0172529	http://dx.doi.org/10.1371/journal.pone.0172529			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5SK	28225803	gold, Green Submitted, Green Published			2022-12-27	WOS:000394680900051
J	Schmidt, SAJ; Ording, AG; Horvath-Puho, E; Sorensen, HT; Henderson, VW				Schmidt, Sigrun A. J.; Ording, Anne G.; Horvath-Puho, Erzsebet; Sorensen, Henrik T.; Henderson, Victor W.			Non-melanoma skin cancer and risk of Alzheimer's disease and all-cause dementia	PLOS ONE			English	Article							ASSOCIATION	Cancer patients may be at decreased risk of Alzheimer's disease. This hypothesis is best developed for non-melanoma skin cancer (NMSC), but supportive epidemiological data are sparse. We therefore conducted a nationwide cohort study of the association between NMSC and Alzheimer's disease (main outcome) and all-cause dementia. Using Danish medical databases, we identified adults diagnosed with NMSC between 1 January 1980 and 30 November 2013 (n = 216,221) and a comparison cohort of five individuals matched to each NMSC patient by sex and birth year (n = 1,081,097). We followed individuals from the time of diagnosis, or corresponding date for matched comparators, until a dementia diagnosis, death, emigration, or 30 November 2013, whichever came first. We used stratified Cox regression adjusted for comorbidities to compute hazard ratios (HRs) associating NMSC with dementia. We computed cumulative risks of dementia, treating death as a competing risk. NMSC was associated with a HR of 0.95 (95% confidence interval [CI]: 0.92-0.98) for Alzheimer's disease and 0.92 (95% CI: 0.90-0.94) for all-cause dementia. HRs were similar for basal cell and squamous cell carcinoma, the two most common forms of NMSC. Estimates of risk reduction were more pronounced in the beginning of follow-up, reaching null after 5-10 years. At the end of follow-up (34 years), cumulative risk of Alzheimer's disease was 4.6% (95% CI: 4.4%-4.8%) among patients with NMSC vs. 4.7% (95% CI: 4.6%-4.9%) in the comparison cohort. In conclusion, NMSC was associated with 2%-10% reductions in relative risks of Alzheimer's disease and all-cause dementia. However, these small inverse associations may have been caused by ascertainment bias due to decreased awareness of NMSC tumors in persons with undiagnosed early cognitive impairment or by confounding from a more neuroprotective lifestyle among persons with NMSC.	[Schmidt, Sigrun A. J.; Ording, Anne G.; Horvath-Puho, Erzsebet; Sorensen, Henrik T.; Henderson, Victor W.] Aarhus Univ Hosp, Dept Clin Epidemiol, Aarhus, Denmark; [Sorensen, Henrik T.; Henderson, Victor W.] Stanford Univ, Dept Hlth Res & Policy Epidemiol, Stanford, CA 94305 USA; [Henderson, Victor W.] Stanford Univ, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA	Aarhus University; Stanford University; Stanford University	Schmidt, SAJ (corresponding author), Aarhus Univ Hosp, Dept Clin Epidemiol, Aarhus, Denmark.	saj@clin.au.dk	Henderson, V/AAW-4744-2021; Sorensen, Henrik Toft/Z-6181-2019	Sorensen, Henrik Toft/0000-0003-4299-7040; Schmidt, Sigrun/0000-0001-5527-0698; Horvath-Puho, Erzsebet/0000-0002-3594-2212	Lundbeck Foundation; Novo Nordisk Foundation; Danish Cancer Society; Aarhus University Research Foundation; National Institutes of Health [P50AG047366]; Lundbeck Foundation [R155-2014-2647] Funding Source: researchfish; Novo Nordisk Fonden [NNF14SA0015794] Funding Source: researchfish; NATIONAL INSTITUTE ON AGING [P50AG047366] Funding Source: NIH RePORTER	Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Danish Cancer Society(Danish Cancer Society); Aarhus University Research Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Fonden(Novo Nordisk Foundation); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The study was supported by the Program for Clinical Research Infrastructure (PROCRIN) established by the Lundbeck Foundation and the Novo Nordisk Foundation (http://regioner.dk/sundhed/forskning-og-innovation/forskningsinfrastruktur), the Danish Cancer Society (https://www.cancer.dk), and the Aarhus University Research Foundation (http://auff.au.dk). VWH's effort was supported by National Institutes of Health grant P50AG047366. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annweiler C, 2015, J INTERN MED, V277, P45, DOI 10.1111/joim.12279; Asgari MM, 2010, INT J ENV RES PUB HE, V7, P427, DOI 10.3390/ijerph7020427; Bahmanyar S, 2009, NEUROLOGY, V72, P1170, DOI 10.1212/01.wnl.0000345366.10455.62; Behrens MI, 2009, CURR ALZHEIMER RES, V6, P196, DOI 10.2174/156720509788486608; Behrens MI, 2008, NEURODEGENER DIS, P111; Brandt B, 2004, DANISH NATL BOARD HL, P1; English DR, 1997, CANCER CAUSE CONTROL, V8, P271, DOI 10.1023/A:1018440801577; Frentz G, 1996, Ugeskr Laeger, V158, P7202; Frentz G, 1999, BRIT J DERMATOL, V140, P237; Ganguli M, 2015, CANC DEMENTIA ITS CO; Gjerstorff ML, 2011, SCAND J PUBLIC HEALT, V39, P42, DOI 10.1177/1403494810393562; Jensen AO, 2008, BRIT J DERMATOL, V159, P419, DOI 10.1111/j.1365-2133.2008.08698.x; Jensen AO, 2008, J INVEST DERMATOL, V128, P926, DOI 10.1038/sj.jid.5701094; Jensen AO, 2007, CANCER DETECT PREV, V31, P352, DOI 10.1016/j.cdp.2007.04.011; Kubo JT, 2014, CANCER CAUSE CONTROL, V25, P1, DOI 10.1007/s10552-013-0280-3; Ma LL, 2014, J ALZHEIMERS DIS, V42, P565, DOI 10.3233/JAD-140168; Madan V, 2010, LANCET, V375, P673, DOI 10.1016/S0140-6736(09)61196-X; Nudelman KNH, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00423; Phung TKT, 2007, DEMENT GERIATR COGN, V24, P220, DOI 10.1159/000107084; Phung TKT, 2010, DEMENT GERIATR COGN, V29, P146, DOI 10.1159/000269933; Poulsen S, 2011, HVORDAN HAR 2010 SUN; Prince MJA, 2014, DEMENTIA RISK REDUCT; Robinson L, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h3029; Roe CM, 2010, NEUROLOGY, V74, P106, DOI 10.1212/WNL.0b013e3181c91873; Salem LC, DEMENT GERIATR COGN; Saracci R, 2007, INT J EPIDEMIOL, V36, P244, DOI 10.1093/ije/dyl263; Schmidt M, 2015, CLIN EPIDEMIOL, V7, P449, DOI 10.2147/CLEP.S91125; Schmidt M, 2014, EUR J EPIDEMIOL, V29, P541, DOI 10.1007/s10654-014-9930-3; Steding-Jessen M, 2010, CANCER EPIDEMIOL, V34, P689, DOI 10.1016/j.canep.2010.06.011; White RS, 2013, NEUROLOGY, V80, P1966, DOI 10.1212/WNL.0b013e3182941990	30	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2017	12	2							e0171527	10.1371/journal.pone.0171527	http://dx.doi.org/10.1371/journal.pone.0171527			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5SK	28225789	gold, Green Submitted, Green Published			2022-12-27	WOS:000394680900016
J	Kavka, M; Polle, A				Kavka, Mareike; Polle, Andrea			Dissecting nutrient-related co-expression networks in phosphate starved poplars	PLOS ONE			English	Article							TRANSCRIPTION FACTOR PHR1; STARVATION RESPONSE 1; ARABIDOPSIS-THALIANA; PHOSPHORUS ACQUISITION; IRON DEFICIENCIES; ROOT-SYSTEM; CROSS-TALK; GENE; EXPRESSION; AVAILABILITY	Phosphorus (P) is an essential plant nutrient, but its availability is often limited in soil. Here, we studied changes in the transcriptome and in nutrient element concentrations in leaves and roots of poplars (Populus x canescens) in response to P deficiency. P starvation resulted in decreased concentrations of S and major cations (K, Mg, Ca), in increased concentrations of N, Zn and Al, while C, Fe and Mn were only little affected. In roots and leaves >4,000 and >9,000 genes were differently expressed upon P starvation. These genes clustered in eleven co-expression modules of which seven were correlated with distinct elements in the plant tissues. One module (4.7% of all differentially expressed genes) was strongly correlated with changes in the P concentration in the plant. In this module the GO term "response to P starvation was enriched with phosphoenolpyruvate carboxylase kinases, phosphatases and pyrophosphatases as well as regulatory domains such as SPX, but no phosphate transporters. The P-related module was also enriched in genes of the functional category "galactolipid synthesis". Galactolipids substitute phospholipids in membranes under P limitation. Two modules, one correlated with C and N and the other with bio-mass, S and Mg, were connected with the P-related module by co-expression. In these modules GO terms indicating "DNA modification" and "cell division" as well as "defense" and "RNA modification" and "signaling" were enriched; they contained phosphate transporters. Bark storage proteins were among the most strongly upregulated genes in the growth-related module suggesting that N, which could not be used for growth, accumulated in typical storage compounds. In conclusion, weighted gene coexpression network analysis revealed a hierarchical structure of gene clusters, which separated phosphate starvation responses correlated with P tissue concentrations from other gene modules, which most likely represented transcriptional adjustments related to down-stream nutritional changes and stress.	[Kavka, Mareike; Polle, Andrea] Georg August Univ Gottingen, Forstbot & Baumphysiol, Gottingen, Germany; [Kavka, Mareike; Polle, Andrea] Georg August Univ Gottingen, Lab Radio Isotope, Gottingen, Germany	University of Gottingen; University of Gottingen	Polle, A (corresponding author), Georg August Univ Gottingen, Forstbot & Baumphysiol, Gottingen, Germany.; Polle, A (corresponding author), Georg August Univ Gottingen, Lab Radio Isotope, Gottingen, Germany.	apolle@gwdg.de		Polle, Andrea/0000-0001-8697-6394; Kavka, Mareike/0000-0003-0124-1167	Georg-August University of Gottingen; Deutsche Forschungsgemeinschaft (DFG) [SPP 1685, Po362/22-2]; University of Gottingen	Georg-August University of Gottingen; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); University of Gottingen	The Georg-August University of Gottingen (http://www.uni-goettingen.de/de/1.html) funded the PhD position of MJK. The Deutsche Forschungsgemeinschaft (DFG, http://www.dfg.de/foerderung/programme/listen/projektdetails/index.jsp?id=220238996), Priority Program SPP 1685 "Ecosystem Nutrition" provided financial support for this research Project under grant number Po362/22-2. The publication fund of the University of Gottingen and the Deutsche Forschungsgemeinschaft supported open access publication of this article. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson MX, 2003, FEBS LETT, V537, P128, DOI 10.1016/S0014-5793(03)00109-1; Baker A, 2015, J EXP BOT, V66, P3523, DOI 10.1093/jxb/erv210; Bauer S, 2008, BIOINFORMATICS, V24, P1650, DOI 10.1093/bioinformatics/btn250; BIELESKI RL, 1973, ANNU REV PLANT PHYS, V24, P225, DOI 10.1146/annurev.pp.24.060173.001301; Bournier M, 2013, J BIOL CHEM, V288, P22670, DOI 10.1074/jbc.M113.482281; Burg J van den, 1985, RAPP RIJKSINST VOOR; Bustos R, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001102; Chiou TJ, 2011, ANNU REV PLANT BIOL, V62, P185, DOI 10.1146/annurev-arplant-042110-103849; COLEMAN GD, 1991, PLANT PHYSIOL, V96, P686, DOI 10.1104/pp.96.3.686; Dai XY, 2016, J EXP BOT, V67, P947, DOI 10.1093/jxb/erv515; del Pozo JC, 1999, PLANT J, V19, P579, DOI 10.1046/j.1365-313X.1999.00562.x; Desai S, 2014, MYCORRHIZA, V24, P369, DOI 10.1007/s00572-013-0548-1; Ducic T, 2007, FUNCT PLANT BIOL, V34, P31, DOI 10.1071/FP06157; Gan HH, 2016, TREE PHYSIOL, V36, P22, DOI 10.1093/treephys/tpv093; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gruber BD, 2013, PLANT PHYSIOL, V163, P161, DOI 10.1104/pp.113.218453; Hammond JP, 2008, J EXP BOT, V59, P93, DOI 10.1093/jxb/erm221; Hartel H, 2000, BIOCHEM SOC T, V28, P729, DOI 10.1042/BST0280729; Heberle H, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0611-3; HEINRICHS H, 1986, Z PFLANZ BODENKUNDE, V149, P350, DOI 10.1002/jpln.19861490313; Hewitt EJ, 1974, PLANT MINERAL NUTR L; Hirsch J, 2006, BIOCHIMIE, V88, P1767, DOI 10.1016/j.biochi.2006.05.007; Holford ICR, 1997, AUST J SOIL RES, V35, P227, DOI 10.1071/S96047; Janz D, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-150; Kauffmann A, 2009, BIOINFORMATICS, V25, P2092, DOI 10.1093/bioinformatics/btp354; Kavka M, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0892-3; Kellermeier F, 2014, PLANT CELL, V26, P1480, DOI 10.1105/tpc.113.122101; Khan GA, 2014, J EXP BOT, V65, P871, DOI 10.1093/jxb/ert444; Kobayashi K, 2006, PLANT J, V47, P238, DOI 10.1111/j.1365-313X.2006.02778.x; Lan P, 2015, ANNU PLANT REV, V48, P65, DOI 10.1002/9781118958841.ch3; Lan P, 2012, MOL CELL PROTEOMICS, V11, P1156, DOI 10.1074/mcp.M112.020461; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Loth-Pereda V, 2011, PLANT PHYSIOL, V156, P2141, DOI 10.1104/pp.111.180646; Misson J, 2005, P NATL ACAD SCI USA, V102, P11934, DOI 10.1073/pnas.0505266102; Morcuende R, 2007, PLANT CELL ENVIRON, V30, P85, DOI 10.1111/j.1365-3040.2006.01608.x; Mudge SR, 2002, PLANT J, V31, P341, DOI 10.1046/j.1365-313X.2002.01356.x; Nussaume L, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00083; Puga MI, 2014, P NATL ACAD SCI USA, V111, P14947, DOI 10.1073/pnas.1404654111; R Development Core Team, 2012, R LANG ENV STAT COMP; Rai V, 2015, PLANT CELL PHYSIOL, V56, P1107, DOI 10.1093/pcp/pcv035; Remy E, 2012, NEW PHYTOL, V195, P356, DOI 10.1111/j.1469-8137.2012.04167.x; Rennenberg H, 2010, PLANT BIOLOGY, V12, P275, DOI 10.1111/j.1438-8677.2009.00309.x; Rouached H, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-19; Saenchai C, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00396; Schachtman DP, 1998, PLANT PHYSIOL, V116, P447, DOI 10.1104/pp.116.2.447; Scheible WR, 2015, ANNU PLANT REV, V48, P25, DOI 10.1002/9781118958841.ch2; Schwender H., 2011, SIGGENES MULTIPLE TE; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Tsai C. J., 2011, Genetics, genomics and breeding of poplar, P112; Valentinuzzi F, 2015, J EXP BOT, V66, P6483, DOI 10.1093/jxb/erv364; Vance CP, 2003, NEW PHYTOL, V157, P423, DOI 10.1046/j.1469-8137.2003.00695.x; Vert G, 2002, PLANT CELL, V14, P1223, DOI 10.1105/tpc.001388; von Wiren N, 1999, PLANT PHYSIOL, V119, P1107, DOI 10.1104/pp.119.3.1107; Wang XF, 2014, PLANT CELL ENVIRON, V37, P1159, DOI 10.1111/pce.12224; Wang YH, 2002, PLANT PHYSIOL, V130, P1361, DOI 10.1104/pp.008854; Wang ZY, 2014, P NATL ACAD SCI USA, V111, P14953, DOI 10.1073/pnas.1404680111; Ward JT, 2008, PLANT PHYSIOL, V147, P1181, DOI 10.1104/pp.108.118562; Wasaki J, 2003, PLANT CELL ENVIRON, V26, P1515, DOI 10.1046/j.1365-3040.2003.01074.x; White PJ, 2010, ANN BOT-LONDON, V105, P1073, DOI 10.1093/aob/mcq085; Wildhagen H, 2010, TREE PHYSIOL, V30, P1096, DOI 10.1093/treephys/tpq018; Woo J, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-62; Wu P, 2003, PLANT PHYSIOL, V132, P1260, DOI 10.1104/pp.103.021022; Zhang CX, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01398; Zheng LQ, 2009, PLANT PHYSIOL, V151, P262, DOI 10.1104/pp.109.141051; Zhu BL, 2001, PLANT PHYSIOL, V126, P342, DOI 10.1104/pp.126.1.342	67	14	15	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2017	12	2							e0171958	10.1371/journal.pone.0171958	http://dx.doi.org/10.1371/journal.pone.0171958			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5QV	28222153	Green Published, gold			2022-12-27	WOS:000394676800023
J	Kesztyus, D; Lauer, R; Kesztyus, T; Kilian, R; Steinacker, JM				Kesztyues, Dorothea; Lauer, Romy; Kesztyues, Tibor; Kilian, Reinhold; Steinacker, Juergen M.		Join Hlth Boat Study Grp	Costs and effects of a state-wide health promotion program in primary schools in Germany - The Baden-Wurttemberg Study: A cluster-randomized, controlled trial	PLOS ONE			English	Article							BODY-MASS INDEX; CHILDHOOD OVERWEIGHT; ECONOMIC-EVALUATION; WAIST CIRCUMFERENCE; VISCERAL FAT; OBESITY; CHILDREN; PREVALENCE; ADOLESCENTS; PREVENTION	Aim To evaluate the cost-effectiveness of the state-wide implementation of the health promotion program "Join the Healthy Boat" in primary schools in Germany. Methods Cluster-randomized intervention trial with wait-list control group. Anthropometric data of 1733 participating children (7.1 +/- 0.6 years) were taken by trained staff before and after a one year intervention period in the academic year 2010/11. Parents provided information about the health status, and the health behaviour of their children and themselves, parental anthropometrics, and socio-economic background variables. Incidence of abdominal obesity, defined as waist-to-height ratio (WHtR) >= 0.5, was determined. Generalized linear models were applied to account for the clustering of data within schools, and to adjust for baseline-values. Losses to follow-up and missing data were analysed. From a societal perspective, the overall costs, costs per pupil, and incremental cost-effectiveness ratio (ICER) to identify the costs per case of averted abdominal obesity were calculated. Results The final regression model for the incidence of abdominal obesity shows lower odds for the intervention group after an adjustment for grade, gender, baseline WHtR, and breakfast habits (odds ratio = 0.48, 95% CI [0.25; 0.94]). The intervention costs per child/year were (sic)25.04. The costs per incidental case of averted abdominal obesity varied between (sic)1515 and (sic)1993, depending on the different dimensions of the target group. Conclusion This study demonstrates the positive effects of state-wide, school-based health promotion on incidental abdominal obesity, at affordable costs and with proven cost-effectiveness. These results should support allocative decisions of policymakers. An early start to the prevention of abdominal obesity is of particular importance because of its close relationship to non-communicable diseases.	[Kesztyues, Dorothea; Lauer, Romy; Steinacker, Juergen M.] Univ Ulm, Dept Internal Med 2, Sect Sports & Rehabil Med, Ulm, Germany; [Kesztyues, Dorothea] Univ Ulm, Inst Gen Med, Ulm, Germany; [Kesztyues, Tibor] Ulm Univ Appl Sci, Dept Comp Sci, Ulm, Germany; [Kilian, Reinhold] Univ Ulm, Dept Psychiat 2, Sect Hlth Econ & Hlth Serv Res, Gunzburg, Japan	Ulm University; Ulm University; Ulm University; Ulm University	Kesztyus, D (corresponding author), Univ Ulm, Dept Internal Med 2, Sect Sports & Rehabil Med, Ulm, Germany.; Kesztyus, D (corresponding author), Univ Ulm, Inst Gen Med, Ulm, Germany.	dorothea.kesztyues@uni-ulm.de	Steinacker, Juergen M. M/E-6876-2015	Steinacker, Juergen M. M/0000-0001-8901-9450	German network 'Health Services Research Baden-Wurttemberg' of the Ministry of Science, Research and Arts; Ministry of Employment and Social Order, Family, Women and Senior Citizens, Baden-Wurttemberg, Germany [VfD_13_003405]; Baden-Wurttemberg Stiftung, State of Baden-Wurttemberg, Germany [BWS_1.479.00_2009]	German network 'Health Services Research Baden-Wurttemberg' of the Ministry of Science, Research and Arts; Ministry of Employment and Social Order, Family, Women and Senior Citizens, Baden-Wurttemberg, Germany; Baden-Wurttemberg Stiftung, State of Baden-Wurttemberg, Germany	This work was supported by: 1. German network 'Health Services Research Baden-Wurttemberg' of the Ministry of Science, Research and Arts in collaboration with the Ministry of Employment and Social Order, Family, Women and Senior Citizens, Baden-Wurttemberg, Germany, recipient: Dr. Dorothea Kesztyus (VfD_13_003405, http://www.versorgungsforschung-bw.de/nwakad3.shtml); 2. Baden-Wurttemberg Stiftung, State of Baden-Wurttemberg, Germany, recipient: Prof. Dr. Jurgen M Steinacker (BWS_1.479.00_2009, http://www.bwstiftung.de/startseite/).	Alexander KE, 2009, OBESITY, V17, P1528, DOI 10.1038/oby.2009.127; [Anonymous], 2015, LANCET LONDON ENGLAN, DOI [DOI 10.1016/S0140-6736(14)61746-3, 10.1016/S0140-6736(14)61746-3]; Bandura A, 2001, ANNU REV PSYCHOL, V52, P1, DOI 10.1146/annurev.psych.52.1.1; Bartholomew LK, 2006, PLANNING HLTH PROMOT; Bloom DE, 2011, GLOBAL EC BURDEN NON; Bronfenbrenner U., 2012, HDB BILDUNGSUND ERZI, P167, DOI [10.1007/978-3-531-18944-4_11, DOI 10.1007/978-3-531-18944-4_11]; Byford S, 1998, BRIT MED J, V316, P1529, DOI 10.1136/bmj.316.7143.1529; Cali AMG, 2008, J CLIN ENDOCR METAB, V93, pS31, DOI 10.1210/jc.2008-1363; Cawley J., 2013, NBER REPORTER 2013 4, P1; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; Dreyhaupt J, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-157; Edwards RT, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1001; Ekelund U, 2011, AM J CLIN NUTR, V93, P826, DOI 10.3945/ajcn.110.006593; Finelli C, 2013, AGEING RES REV, V12, P996, DOI 10.1016/j.arr.2013.05.007; Froschl B, 2009, PRAVENTION ADIPOSITA; Garnett SP, 2011, OBES REV, V12, P887, DOI 10.1111/j.1467-789X.2011.00899.x; Griffiths C, 2013, PUBLIC HEALTH, V127, P1090, DOI 10.1016/j.puhe.2013.09.020; Janssen I, 2004, AM J CLIN NUTR, V79, P379; Javed A, 2014, PEDIAT OBES, P1; John J, 2012, NUTRITION, V28, P829, DOI 10.1016/j.nut.2011.11.016; John J, 2010, NESTLE NUTR WORKS SE, V66, P111, DOI 10.1159/000318952; Kesztyus D, 2014, HEALTH ECON REV, V4, DOI 10.1186/s13561-014-0020-8; Kesztyus D, 2013, EUR J HEALTH ECON, V14, P185, DOI 10.1007/s10198-011-0358-3; Knoll KP., 2008, ADIPOSITAS, V02, P204, DOI [10.1055/s-0037-1618649, DOI 10.1055/S-0037-1618649]; Korber K, 2014, INT J ENV RES PUB HE, V11, P10606, DOI 10.3390/ijerph111010606; Krauth C, 2013, GESUNDHEITSWESEN, V75, P742, DOI 10.1055/s-0033-1355365; Krech R, 2010, HEALTH PROMOT INT, V25, P258, DOI 10.1093/heapro/daq034; Kromeyer-Hauschild K, 2001, MONATSSCHR KINDERH, V149, P807, DOI 10.1007/s001120170107; Langford R, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008958.pub2; Marfell-Jones M, 2006, INT STANDARDS ANTHRO; McAuley KA, 2010, OBESITY, V18, P131, DOI 10.1038/oby.2009.148; McCarthy HD, 2006, INT J OBESITY, V30, P988, DOI 10.1038/sj.ijo.0803226; Moss A, 2007, BUNDESGESUNDHEITSBLA, V50, P1424, DOI 10.1007/s00103-007-0370-z; Martinez PM, 2011, GAC SANIT, V25, P198, DOI 10.1016/j.gaceta.2010.11.003; OECD, 2011, 2011 PPP BENCHM RES; Olds T, 2011, INT J PEDIATR OBES, V6, P342, DOI 10.3109/17477166.2011.605895; Raftery J, 2000, BRIT MED J, V320, P1597, DOI 10.1136/bmj.320.7249.1597; Richelsen B, 2013, CURR OPIN CLIN NUTR, V16, P478, DOI 10.1097/MCO.0b013e328361c53e; Rowland K, 2009, J FAM PRACTICE, V58, P431; Scaglione R, 2010, INTERN EMERG MED, V5, P111, DOI 10.1007/s11739-009-0332-6; Singh AS, 2008, OBES REV, V9, P474, DOI 10.1111/j.1467-789X.2008.00475.x; Steinmann S., 1999, ZUMA NACHRICHTEN, V23, P7; Trasande L, 2009, OBESITY, V17, P1749, DOI 10.1038/oby.2009.67; Ungar WJ, 2011, PHARMACOECONOMICS, V29, P641, DOI 10.2165/11591570-000000000-00000; Wang LY, 2008, J SCHOOL HEALTH, V78, P619, DOI 10.1111/j.1746-1561.2008.00357.x; Waters E, 2011, COCHRANE COLLABORATI, V12, P1; World Health Organization, 2003, OB OV GLOB STRAT DIE	47	12	12	4	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2017	12	2							e0172332	10.1371/journal.pone.0172332	http://dx.doi.org/10.1371/journal.pone.0172332			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL5QV	28222101	Green Published, gold, Green Submitted			2022-12-27	WOS:000394676800051
J	Seemann, R; Jirku, A; Wagner, F; Wutzl, A				Seemann, Rudolf; Jirku, Alexander; Wagner, Florian; Wutzl, Arno			What do sales data tell us about implant survival?	PLOS ONE			English	Article							DENTAL IMPLANTS; FAILURE RATES; BONE; IMPACT; METAANALYSIS; MM	Objective The aim of this study was to evaluate the influence of implant diameter, length and shape on a surrogate parameter of implant survival; i.e. the implant return rate in a big data analysis. Materials and methods A retrospective study was conducted and the factors influencing the success rates of 69,377 sold implants over a seven-year period were evaluated. The osseointegration program of a reseller provides reliable data of a single country. Implant loss rates were investigated using logistic regression models and regressed by implant type, diameter, and length. Results The return rate of 69,377 sold implants was 2.78% and comparable to implant loss rates in previous published prospective studies as its surrogate parameter. A total of 80% of implant returns had occurred within 157 days, and an additional 15% within 750.25 days. Diameters of 3.8 to 5.0mm showed the lowest return rates with its bottom in the 4.3mm implant whilst 6.0mm implants had significantly higher return rates. In comparison to the most sold implant length ( 13mm) shorter implants showed significantly higher early return rates. Conclusions The study provides evidence that in cases of standard indications and sufficient bone, the use of screw typed dental implants with 3.8 or 4.3 diameter and 11 or 13 mm length shows the lowest implant return rates. Other implants may be selected only in specific indications.	[Seemann, Rudolf; Wagner, Florian; Wutzl, Arno] Med Univ Vienna, Univ Clin Cranio Maxillofacial & Oral Surg, Vienna, Austria; [Jirku, Alexander] Alexas AG, Mauren, Liechtenstein	Medical University of Vienna	Seemann, R (corresponding author), Med Univ Vienna, Univ Clin Cranio Maxillofacial & Oral Surg, Vienna, Austria.	rudolf.seemann@meduniwien.ac.at		Seemann, Rudolf/0000-0003-4234-4090				Albrektsson T, 2012, CLIN ORAL IMPLAN RES, V23, P63, DOI 10.1111/j.1600-0501.2012.02557.x; Alsaadi G, 2008, J CLIN PERIODONTOL, V35, P51, DOI 10.1111/j.1600-051X.2007.01165.x; Atieh MA, 2010, J PERIODONTOL, V81, P1350, DOI 10.1902/jop.2010.100232; French D, 2015, CLIN ORAL IMPLAN RES, V26, P1345, DOI 10.1111/clr.12463; Haas R, 1996, Int J Oral Maxillofac Implants, V11, P581; Herrmann I, 2005, INT J ORAL MAX IMPL, V20, P220; Jemt T, 2016, CLIN IMPLANT DENT R, V18, P861, DOI 10.1111/cid.12379; Jung RE, 2012, CLIN ORAL IMPLAN RES, V23, P2, DOI 10.1111/j.1600-0501.2012.02547.x; Kinsel RP, 2007, INT J ORAL MAX IMPL, V22, P823; Koodaryan R, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/4987526; Lee CT, 2016, CLIN ORAL IMPLAN RES, V27, P1251, DOI 10.1111/clr.12730; Lee SA, 2014, INT J ORAL MAX IMPL, V29, P1085, DOI 10.11607/jomi.3504; Moraschini V, 2016, INT J ORAL MAX SURG, V45, P205, DOI 10.1016/j.ijom.2015.08.996; Nickenig HJ, 2009, CLIN ORAL IMPLAN RES, V20, P550, DOI 10.1111/j.1600-0501.2008.01684.x; Pjetursson BE, 2014, INT J ORAL MAX IMPL, V29, P308, DOI 10.11607/jomi.2014suppl.g5.2; Pommer B, 2011, J CLIN PERIODONTOL, V38, P856, DOI 10.1111/j.1600-051X.2011.01750.x; Romeo E, 2012, CLIN ORAL IMPLAN RES, V23, P39, DOI 10.1111/j.1600-0501.2012.02551.x; Sakka S, 2012, J INVESTIG CLIN DENT, V3, DOI 10.1111/j.2041-1626.2012.00162.x; Sesma N, 2012, INT J ORAL MAX IMPL, V27, P1243; Shalabi MM, 2006, J DENT RES, V85, P496, DOI 10.1177/154405910608500603; Sohrabi K, 2012, CLIN ORAL IMPLAN RES, V23, P515, DOI 10.1111/j.1600-0501.2011.02410.x; Strietzel FP, 2015, CLIN ORAL IMPLAN RES, V26, P342, DOI 10.1111/clr.12339; Sun HL, 2011, INT J ORAL MAX IMPL, V26, P816; World Health Organization, 2016, TOB FACT SHEET	24	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2017	12	2							e0171128	10.1371/journal.pone.0171128	http://dx.doi.org/10.1371/journal.pone.0171128			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5QV	28222128	Green Published, Green Submitted, gold			2022-12-27	WOS:000394676800008
J	Turcsan, B; Miklosi, A; Kubinyi, E				Turcsan, Borbala; Miklosi, Adam; Kubinyi, Eniko			Owner perceived differences between mixed-breed and purebred dogs	PLOS ONE			English	Article							SHELTER DOGS; RISK-FACTORS; PET DOGS; BEHAVIOR; TEMPERAMENT; PREVALENCE; FAMILIARIS; MORTALITY; RESPONSES; TRAITS	Studies about the behaviours of mixed-breed dogs are rare, although mixed-breeds represent the majority of the world's dog population. We have conducted two surveys to investigate the behavioural, demographic, and dog keeping differences between purebred and mixed-breed companion dogs. Questionnaire data were collected on a large sample of dogs living in Germany (N = 7,700 purebred dogs representing more than 200 breeds, and N = 7,691 mixedbreeds). We found that according to their owners, mixed-breeds were (1) less calm, (2) less sociable toward other dogs, and (3) showed more problematic behaviour than purebreds (p < 0.001 for all). Mixed-breeds and purebreds were similar in trainability and boldness scores. However, twelve out of 20 demographic and dog keeping factors differed between purebred and mixed-breed dogs, and two factors showed considerable (>10%) differences: neutering was more frequent among mixed-breeds, and they were acquired at older ages than purebreds (p < 0.001 for both), which could result in the observed behaviour differences. After controlling for the distribution of the demographic and dog keeping factors, we found that mixedbreeds were (1) more trainable than purebreds, (2) less calm, and (3) showed more problematic behaviour than purebreds (p < 0.001 for all). We discuss that these differences at least partly might be due to selective forces. Our results suggest that instead of being the "average" dogs, mixed-breeds represent a special group with characteristic behavioural traits.	[Turcsan, Borbala; Miklosi, Adam; Kubinyi, Eniko] Eotvos Lorand Univ, Dept Ethol, Budapest, Hungary; [Turcsan, Borbala] Hungarian Acad Sci, Res Ctr Nat Sci, Inst Cognit Neurosci & Psychol, Budapest, Hungary; [Miklosi, Adam] MTA ELTE Comparat Ethol Res Grp, Budapest, Hungary	Eotvos Lorand University; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences; MTA-ELTE Comparative Ethology Research Group	Turcsan, B (corresponding author), Eotvos Lorand Univ, Dept Ethol, Budapest, Hungary.; Turcsan, B (corresponding author), Hungarian Acad Sci, Res Ctr Nat Sci, Inst Cognit Neurosci & Psychol, Budapest, Hungary.	borbala.turcsan@gmail.com	Kubinyi, Eniko/B-5824-2013; Turcsán, Borbála/I-7983-2018	Kubinyi, Eniko/0000-0002-4468-9845; Turcsán, Borbála/0000-0002-0197-5243	European Research Council (ERC) under the European Union [680040]; Hungarian Scientific Research Fund [K84036, K112138]; Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences; MTA-ELTE Comparative Ethological Research Group [MTA 01 031]	European Research Council (ERC) under the European Union(European Research Council (ERC)); Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences(Hungarian Academy of Sciences); MTA-ELTE Comparative Ethological Research Group	This project has received funding from the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme (Grant Agreement No. 680040), the Hungarian Scientific Research Fund (K84036, K112138), the Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences, and the MTA-ELTE Comparative Ethological Research Group (MTA 01 031). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akey JM, 2010, P NATL ACAD SCI USA, V107, P1160, DOI 10.1073/pnas.0909918107; American Pet Products Association (APPA), 2009, 2010 NAT PET OWN SUR; [Anonymous], PET OWN AUSTR 2013; [Anonymous], 2012, GESCH ZUM JAHR 2012; AVMA, 2012, US PET OWN DEM SOURC; Barrera G, 2010, J VET BEHAV, V5, P339, DOI 10.1016/j.jveb.2010.08.012; Bennett PC, 2007, APPL ANIM BEHAV SCI, V102, P65, DOI 10.1016/j.applanim.2006.03.009; Birkenheuer AJ, 2004, THESIS; Blackwell EJ, 2013, APPL ANIM BEHAV SCI, V145, P15, DOI 10.1016/j.applanim.2012.12.004; Coppinger Roger, 2002, DOGS NEW UNDERSTANDI; De Palma C, 2005, BEHAVIOUR, V142, P1307, DOI 10.1163/156853905774539337; Diverio S, 2014, J VET BEHAV, V9, P151, DOI 10.1016/j.jveb.2014.02.007; Egenvall A, 2000, VET REC, V146, P519, DOI 10.1136/vr.146.18.519; Gacsi M, 2009, BEHAV BRAIN FUNCT, V5, DOI 10.1186/1744-9081-5-31; Harvey ND, 2016, J VET BEHAV IN PRESS; Hennessy MB, 1997, PHYSIOL BEHAV, V62, P485, DOI 10.1016/S0031-9384(97)80328-9; Howell TJ, 2015, VET MED-RES REP, V6, P143, DOI 10.2147/VMRR.S62081; Hsu YY, 2010, APPL ANIM BEHAV SCI, V123, P108, DOI 10.1016/j.applanim.2010.01.013; Kubinyi E, 2015, ACTA BIOL HUNG, V66, P27, DOI 10.1556/ABiol.66.2015.1.3; Kubinyi E, 2009, BEHAV PROCESS, V81, P392, DOI 10.1016/j.beproc.2009.04.004; Leroy G, 2011, VET J, V189, P177, DOI 10.1016/j.tvjl.2011.06.016; Ley J, 2008, APPL ANIM BEHAV SCI, V110, P305, DOI 10.1016/j.applanim.2007.04.016; Ley JM, 2009, APPL ANIM BEHAV SCI, V116, P220, DOI 10.1016/j.applanim.2008.09.009; Luescher AU, 2009, APPL ANIM BEHAV SCI, V117, P63, DOI 10.1016/j.applanim.2008.11.001; McGreevy PD, 2008, APPL ANIM BEHAV SCI, V109, P320, DOI 10.1016/j.applanim.2007.04.001; Mehrkam LR, 2014, APPL ANIM BEHAV SCI, V155, P12, DOI 10.1016/j.applanim.2014.03.005; Mellanby RJ, 2013, VET J, V196, P92, DOI 10.1016/j.tvjl.2012.08.009; Nakagawa S, 2007, BIOL REV, V82, P591, DOI 10.1111/j.1469-185X.2007.00027.x; Ottenheimer-Carrier L, 2016, J VET BEHAV IN PRESS; Patronek GJ, 1995, ANTHROZOOS, V8, P199, DOI 10.2752/089279395787156590; Patronek GJ, 1997, J GERONTOL A-BIOL, V52, pB171, DOI 10.1093/gerona/52A.3.B171; People's Dispensary for Sick Animals (PDSA), 2013, AN WELLB REP 2013 ST; Pierce CA, 2004, EDUC PSYCHOL MEAS, V64, P916, DOI 10.1177/0013164404264848; Proschowsky HF, 2003, PREV VET MED, V58, P63, DOI 10.1016/S0167-5877(03)00010-2; Salvin HE, 2012, J VET BEHAV, V7, P61, DOI 10.1016/j.jveb.2011.06.002; Schneider LA, 2013, J VET BEHAV, V8, P124, DOI 10.1016/j.jveb.2012.06.004; Temesi A, 2014, APPL ANIM BEHAV SCI, V161, P121, DOI 10.1016/j.applanim.2014.09.009; Tuber DS, 1999, PSYCHOL SCI, V10, P379, DOI 10.1111/1467-9280.00173; Turcsan B, 2011, APPL ANIM BEHAV SCI, V132, P61, DOI 10.1016/j.applanim.2011.03.006; Wells DL, 2000, APPL ANIM BEHAV SCI, V69, P55, DOI 10.1016/S0168-1591(00)00118-0	40	16	16	3	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2017	12	2							e0172720	10.1371/journal.pone.0172720	http://dx.doi.org/10.1371/journal.pone.0172720			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL5QV	28222103	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000394676800079
J	Dawson, MRW; Gupta, M				Dawson, Michael R. W.; Gupta, Maya			Probability matching in perceptrons: Effects of conditional dependence and linear nonseparability	PLOS ONE			English	Article							BINARY VARIABLES; JUDGMENT; CONTINGENCY; INFORMATION; NETWORKS; MODEL	Probability matching occurs when the behavior of an agent matches the likelihood of occurrence of events in the agent's environment. For instance, when artificial neural networks match probability, the activity in their output unit equals the past probability of reward in the presence of a stimulus. Our previous research demonstrated that simple artificial neural networks (perceptrons, which consist of a set of input units directly connected to a single output unit) learn to match probability when presented different cues in isolation. The current paper extends this research by showing that perceptrons can match probabilities when presented simultaneous cues, with each cue signaling different reward likelihoods. In our first simulation, we presented up to four different cues simultaneously; the likelihood of reward signaled by the presence of one cue was independent of the likelihood of reward signaled by other cues. Perceptrons learned to match reward probabilities by treating each cue as an independent source of information about the likelihood of reward. In a second simulation, we violated the independence between cues by making some reward probabilities depend upon cue interactions. We did so by basing reward probabilities on a logical combination (AND or XOR) of two of the four possible cues. We also varied the size of the reward associated with the logical combination. We discovered that this latter manipulation was a much better predictor of perceptron performance than was the logical structure of the interaction between cues. This indicates that when perceptrons learn to match probabilities, they do so by assuming that each signal of a reward is independent of any other; the best predictor of perceptron performance is a quantitative measure of the independence of these input signals, and not the logical structure of the problem being learned.	[Dawson, Michael R. W.; Gupta, Maya] Univ Alberta, Dept Psychol, Edmonton, AB, Canada	University of Alberta	Dawson, MRW (corresponding author), Univ Alberta, Dept Psychol, Edmonton, AB, Canada.	mdawson@ualberta.ca	Dawson, Michael RW/R-2573-2018	Dawson, Michael RW/0000-0002-9152-199X				Agresti A, 2002, CATEGORICAL DATA ANA, Vxv; ALLAN LG, 1983, LEARN MOTIV, V14, P381, DOI 10.1016/0023-9690(83)90024-3; ALLAN LG, 1980, CAN J PSYCHOL, V34, P1, DOI 10.1037/h0081013; ALLAN LG, 1980, B PSYCHONOMIC SOC, V15, P147; Arbib M., 1969, IEEE T INFORM THEORY, V15, P738; Bishop C. M., 2006, PATTERN RECOGNITION, Vxx; Bishop CM, 1995, NEURAL NETWORKS PATT, Vxvii; CHENG PW, 1990, J PERS SOC PSYCHOL, V58, P545, DOI 10.1037/0022-3514.58.4.545; Cheng PW, 1997, PSYCHOL REV, V104, P367, DOI 10.1037/0033-295X.104.2.367; Cheng PW, 1995, COMP APPROACHES COGN, P271; Costa RP, 2013, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00075; Costa RP, 2015, ELIFE, V4, DOI 10.7554/eLife.09457; Dawson M., 2013, MIND BODY WORLD FDN; Dawson M. R. W., 1998, UNDERSTANDING COGNIT; Dawson M. R. W., 2008, COMP COGNITION BEHAV, V3, P1, DOI DOI 10.3819/CCBR.2008.30008; Dawson MRW, 2008, J EXP PSYCHOL-ANIM L, V34, P415, DOI 10.1037/0097-7403.34.3.415; Dawson MRW, 2005, CONNECTIONISM: A HANDS-ON APPROACH, P1; Dawson MRW, 2010, COGNITION, V114, P207, DOI 10.1016/j.cognition.2009.09.006; Dawson MRW, 2009, IEEE T NEURAL NETWOR, V20, P1368, DOI 10.1109/TNN.2009.2025588; Dawson MRW, 2012, IEEE T NEUR IN PRESS; Dawson MRW., 2004, MINDS AND MACHINES C; De Houwer J, 2002, Q J EXP PSYCHOL-B, V55, P289, DOI 10.1080/02724990244000034; Dupuis B, 2013, J EXPT PSYCHOL ANIMA; GLUCK MA, 1988, J EXP PSYCHOL GEN, V117, P227, DOI 10.1037/0096-3445.117.3.227; Hastie T., 2009, ELEMENTS STAT LEARNI, Vxxii; Hosmer DW., 2000, APPL LOGISTIC REGRES, V12; JENKINS HM, 1965, PSYCHOL MONOGR, V79, P1, DOI 10.1037/h0093874; RESCORLA RA, 1968, J COMP PHYSIOL PSYCH, V66, P1, DOI 10.1037/h0025984; RESCORLA RA, 1967, PSYCHOL REV, V74, P71, DOI 10.1037/h0024109; ROSENBLATT F, 1958, PSYCHOL REV, V65, P386, DOI 10.1037/h0042519; Rosenblatt F., 1962, PRINCIPLES NEURODYNA, DOI 10.21236/AD0256582; Rozanov YA, 1977, PROBABILITY THEORY C, Vix; Rudas T, 1998, ODDS RATIOS ANAL CON, Vvi; Schumacher M, 1996, COMPUT STAT DATA AN, V21, P661, DOI 10.1016/0167-9473(95)00032-1; Shanks DR., 1995, PSYCHOL  ASS LEARNIN; Sutton R.S., 2015, REINFORCEMENT LEARNI, V2nd ed.; SUTTON RS, 1981, PSYCHOL REV, V88, P135, DOI 10.1037/0033-295X.88.2.135; WARD WC, 1965, CAN J PSYCHOLOGY, V19, P231, DOI 10.1037/h0082908	38	2	2	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2017	12	2							e0172431	10.1371/journal.pone.0172431	http://dx.doi.org/10.1371/journal.pone.0172431			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL2BI	28212422	Green Published, gold, Green Submitted			2022-12-27	WOS:000394424700050
J	Limbrick, DD; Baksh, B; Morgan, CD; Habiyaremye, G; McAllister, JP; Inder, TE; Mercer, D; Holtzman, DM; Strahle, J; Wallendorf, MJ; Morales, DM				Limbrick, David D., Jr.; Baksh, Brandon; Morgan, Clinton D.; Habiyaremye, Gakwaya; McAllister, James P., II; Inder, Terrie E.; Mercer, Deanna; Holtzman, David M.; Strahle, Jennifer; Wallendorf, Michael J.; Morales, Diego M.			Cerebrospinal fluid biomarkers of infantile congenital hydrocephalus	PLOS ONE			English	Article							NORMAL-PRESSURE HYDROCEPHALUS; AMYLOID PRECURSOR PROTEIN; KAOLIN-INDUCED HYDROCEPHALUS; WHITE-MATTER DAMAGE; CELL JUNCTION PATHOLOGY; TRAUMATIC BRAIN-INJURY; NEURAL STEM-CELLS; ALZHEIMERS-DISEASE; POSTHEMORRHAGIC HYDROCEPHALUS; NEUROLOGICAL DISEASES	Introduction Hydrocephalus is a complex neurological disorder with a pervasive impact on the central nervous system. Previous work has demonstrated derangements in the biochemical profile of cerebrospinal fluid ( CSF) in hydrocephalus, particularly in infants and children, in whom neurodevelopment is progressing in parallel with concomitant neurological injury. The objective of this study was to examine the CSF of children with congenital hydrocephalus ( CHC) to gain insight into the pathophysiology of hydrocephalus and identify candidate biomarkers of CHC with potential diagnostic and therapeutic value. Methods CSF levels of amyloid precursor protein ( APP) and derivative isoforms ( sAPP alpha, sAPP beta, A beta(42)), tau, phosphorylated tau ( pTau), L1CAM, NCAM-1, aquaporin 4 ( AQP4), and total protein ( TP) were measured by ELISA in 20 children with CHC. Two comparative groups were included: age-matched controls and children with other neurological diseases. Demographic parameters, ventricular frontal-occipital horn ratio, associated brain malformations, genetic alterations, and surgical treatments were recorded. Logistic regression analysis and receiver operating characteristic curves were used to examine the association of each CSF protein with CHC. Results CSF levels of APP, sAPP alpha, sAPP beta, A beta(42), tau, pTau, L1CAM, and NCAM-1 but not AQP4 or TP were increased in untreated CHC. CSF TP and normalized L1CAM levels were associated with FOR in CHC subjects, while normalized CSF tau levels were associated with FOR in control subjects. Predictive ability for CHC was strongest for sAPPa, especially in subjects <= 12 months of age ( p<0.0001 and AUC = 0.99), followed by normalized sAPP beta ( p = 0.0001, AUC = 0.95), tau, APP, and L1CAM. Among subjects <= 12 months, a normalized CSF sAPP alpha cut-point of 0.41 provided the best prediction of CHC ( odds ratio = 528, sensitivity = 0.94, specificity = 0.97); these infants were 32 times more likely to have CHC. Conclusions CSF proteins such as sAPPa and related proteins hold promise as biomarkers of CHC in infants and young children, and provide insight into the pathophysiology of CHC during this critical period in neurodevelopment.	[Limbrick, David D., Jr.; Baksh, Brandon; Habiyaremye, Gakwaya; McAllister, James P., II; Mercer, Deanna; Strahle, Jennifer; Morales, Diego M.] Washington Univ, Sch Med, Dept Neurol Surg, St Louis, MO USA; [Limbrick, David D., Jr.; Strahle, Jennifer] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; [Morgan, Clinton D.] Barrow Neurol Inst, Phoenix, AZ 85013 USA; [Inder, Terrie E.] Harvard Med Sch, Brigham & Womens Hosp, Dept Pediat, Boston, MA USA; [Holtzman, David M.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Wallendorf, Michael J.] Washington Univ, Sch Med, Dept Biostat, St Louis, MO USA	Washington University (WUSTL); Washington University (WUSTL); Barrow Neurological Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Washington University (WUSTL); Washington University (WUSTL)	Morales, DM (corresponding author), Washington Univ, Sch Med, Dept Neurol Surg, St Louis, MO USA.	moralesd@wudosis.wustl.edu	McAllister, James P./N-9657-2019	Morgan, Clinton/0000-0002-7511-0488; Morales, Diego/0000-0001-6672-9046	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T34GM083914] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K23NS075151] Funding Source: NIH RePORTER; NIGMS NIH HHS [T34 GM083914] Funding Source: Medline; NINDS NIH HHS [K23 NS075151] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Agren-Wilsson A, 2007, ACTA NEUROL SCAND, V116, P333, DOI 10.1111/j.1600-0404.2007.00890.x; Aojula A, 2016, FLUIDS BARRIERS CNS, V13, DOI 10.1186/s12987-016-0033-2; Blennow K, 2016, MOVEMENT DISORD, V31, P836, DOI 10.1002/mds.26656; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Dawkins E, 2014, J NEUROCHEM, V129, P756, DOI 10.1111/jnc.12675; Del Bigio MR, 2012, J NEUROPATH EXP NEUR, V71, P274, DOI 10.1097/NEN.0b013e31824c1b44; Del Bigio MR, 2010, DEV DISABIL RES REV, V16, P16, DOI 10.1002/ddrr.94; DELBIGIO MR, 1989, NEUROSURGERY, V25, P416, DOI 10.1227/00006123-198909000-00016; Di Curzio DL, 2013, EXP NEUROL, V248, P112, DOI 10.1016/j.expneurol.2013.06.004; Douglas MR, 2009, J NEUROL NEUROSUR PS, V80, P545, DOI 10.1136/jnnp.2008.155671; Eskandari R, 2004, J NEUROSURG, V101, P196, DOI 10.3171/ped.2004.101.2.0196; Eskandari R, 2011, CHILD NERV SYST, V27, P2067, DOI 10.1007/s00381-011-1552-4; GONZALEZDARDER J, 1984, J NEUROSURG, V61, P918, DOI 10.3171/jns.1984.61.5.0918; Gopal SC, 2008, CHILD NERV SYST, V24, P713, DOI 10.1007/s00381-007-0546-8; Gopal SC, 2007, PEDIATR SURG INT, V23, P571, DOI 10.1007/s00383-006-1689-5; Heep A, 2006, CHILD NERV SYST, V22, P1249, DOI 10.1007/s00381-006-0102-y; Herukka SK, 2015, J ALZHEIMERS DIS, V46, P261, DOI 10.3233/JAD-142862; Huang H, 2016, NEUROCHEM RES, V41, P1713, DOI 10.1007/s11064-016-1887-z; Iliff JJ, 2015, LANCET NEUROL, V14, P977, DOI 10.1016/S1474-4422(15)00221-5; Iliff JJ, 2014, J NEUROSCI, V34, P16180, DOI 10.1523/JNEUROSCI.3020-14.2014; Iliff JJ, 2013, STROKE, V44, pS93, DOI 10.1161/STROKEAHA.112.678698; Iliff JJ, 2013, J CLIN INVEST, V123, P1299, DOI 10.1172/JCI67677; Iliff JJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003748; Jeppsson A, 2013, NEUROLOGY, V80, P1385, DOI 10.1212/WNL.0b013e31828c2fda; Jimenez AJ, 2014, TISSUE BARRIERS, V2, DOI 10.4161/tisb.28426; Jingami N, 2015, J ALZHEIMERS DIS, V45, P109, DOI 10.3233/JAD-142622; Kahle KT, 2016, LANCET, V387, P788, DOI 10.1016/S0140-6736(15)60694-8; Kamenetz F, 2003, NEURON, V37, P925, DOI 10.1016/S0896-6273(03)00124-7; Kang K, 2014, J CLIN NEUROSCI, V21, P1398, DOI 10.1016/j.jocn.2013.11.039; Klarica M, 2013, NEUROSCIENCE, V248, P278, DOI 10.1016/j.neuroscience.2013.06.022; Kondziella D, 2002, BRAIN RES, V927, P35, DOI 10.1016/S0006-8993(01)03320-0; KOO EH, 1990, P NATL ACAD SCI USA, V87, P1561, DOI 10.1073/pnas.87.4.1561; Kress BT, 2014, ANN NEUROL, V76, P845, DOI 10.1002/ana.24271; Krishnamurthy S, 2012, FLUIDS BARRIERS CNS, V9, DOI 10.1186/2045-8118-9-13; Krishnamurthy S, 2009, FLUIDS BARRIERS CNS, V6, DOI 10.1186/1743-8454-6-16; Kudo T, 2000, PSYCHIAT CLIN NEUROS, V54, P199, DOI 10.1046/j.1440-1819.2000.00658.x; Lee L, 2013, J NEUROSCI RES, V91, P1117, DOI 10.1002/jnr.23238; Leinonen Ville, 2011, Int J Alzheimers Dis, V2011, P312526, DOI 10.4061/2011/312526; Lewczuk P, 2004, J MOL NEUROSCI, V23, P115, DOI 10.1385/JMN:23:1-2:115; Li XF, 2007, NEUROSCI LETT, V413, P141, DOI 10.1016/j.neulet.2006.11.039; Lim TS, 2014, BMC NEUROL, V14, DOI 10.1186/1471-2377-14-66; McAllister JP, 2015, J NEUROSURG, V123, P1427, DOI 10.3171/2014.12.JNS132352; McAllister JP, 2012, SEMIN FETAL NEONAT M, V17, P285, DOI 10.1016/j.siny.2012.06.004; Merhar S, 2012, NEONATOLOGY, V101, P1, DOI 10.1159/000323498; Miyajima M, 2013, EUR J NEUROL, V20, P236, DOI 10.1111/j.1468-1331.2012.03781.x; Guerra MM, 2015, J NEUROPATH EXP NEUR, V74, P653, DOI 10.1097/NEN.0000000000000203; Morales DM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115045; Morales DM, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.011973; Morales DM SS, NEUROSURGER IN PRESS; Murlidharan G, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.88034; Nakajima M, 2015, J NEUROL SCI, V357, P88, DOI 10.1016/j.jns.2015.07.001; Nakajima Madoka, 2010, Rinsho Shinkeigaku, V50, P973; Narita K, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00039; Naureen I, 2013, FLUIDS BARRIERS CNS, V10, DOI 10.1186/2045-8118-10-34; O'Hayon BB, 1998, PEDIATR NEUROSURG, V29, P245, DOI 10.1159/000028730; Ohata S, 2016, TRENDS NEUROSCI; Ohata S, 2014, NEURON, V83, P558, DOI 10.1016/j.neuron.2014.06.022; Petraglia Anthony L, 2014, Surg Neurol Int, V5, P184, DOI 10.4103/2152-7806.147566; Priller C, 2006, J NEUROSCI, V26, P7212, DOI 10.1523/JNEUROSCI.1450-06.2006; Pyykko OT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091974; Ray B, 2011, J PSYCHIATR RES, V45, P539, DOI 10.1016/j.jpsychires.2010.07.011; Reiber H, 1998, MULT SCLER, V4, P99, DOI 10.1177/135245859800400302; Reiber H, 2003, RESTOR NEUROL NEUROS, V21, P79; REIBER H, 1994, J NEUROL SCI, V122, P189, DOI 10.1016/0022-510X(94)90298-4; Reiber H, 2001, CLIN CHIM ACTA, V310, P173, DOI 10.1016/S0009-8981(01)00573-3; Rodriguez EM, 2012, BIOL RES, V45, P231, DOI 10.4067/S0716-97602012000300005; Savman K, 2002, ACTA PAEDIATR, V91, P1357; Schirinzi T, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00086; Schmitz T, 2007, PEDIATR RES, V61, P722, DOI 10.1203/pdr.0b013e31805341f1; Schmitz T, 2011, J PERINAT MED, V39, P83, DOI [10.1515/JPM.2010.125, 10.1515/jpm.2010.125]; Schob S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160680; Sendrowski K, 2004, Rocz Akad Med Bialymst, V49 Suppl 1, P236; Sival Deborah A, 2008, Cerebrospinal Fluid Res, V5, P21, DOI 10.1186/1743-8454-5-21; Sussmuth SD, 2001, NEUROSCI LETT, V300, P95, DOI 10.1016/S0304-3940(01)01556-7; Tarnaris A, 2011, J NEUROSURG, V115, P145, DOI 10.3171/2011.2.JNS101316; Tarnaris A, 2009, BIOMARK MED, V3, P787, DOI 10.2217/BMM.09.37; Tullberg M, 2007, EUR J NEUROL, V14, P248, DOI 10.1111/j.1468-1331.2006.01553.x; Tullberg M, 2008, CEREBROSPINAL FLUID, V5, P9, DOI DOI 10.1186/1743-8454-5-9; van der Kant R, 2015, DEV CELL, V32, P502, DOI 10.1016/j.devcel.2015.01.022; Waybright T, 2010, J PROTEOMICS, V73, P1156, DOI 10.1016/j.jprot.2010.02.004; Zhang SL, 2013, INT J NEUROSCI, V123, P392, DOI 10.3109/00207454.2012.762363	81	13	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2017	12	2							e0172353	10.1371/journal.pone.0172353	http://dx.doi.org/10.1371/journal.pone.0172353			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BI	28212403	Green Published, Green Submitted, gold			2022-12-27	WOS:000394424700037
J	Mitchell, NJ; Hsu, HH; Chandyo, RK; Shrestha, B; Bodhidatta, L; Tu, YK; Gong, YY; Egner, PA; Ulak, M; Groopman, JD; Wu, F				Mitchell, Nicole J.; Hsu, Hui-Husan; Chandyo, Ram Krishna; Shrestha, Binob; Bodhidatta, Ladaporn; Tu, Yu-Kang; Gong, Yun-Yun; Egner, Patricia A.; Ulak, Manjeswori; Groopman, John D.; Wu, Felicia			Aflatoxin exposure during the first 36 months of life was not associated with impaired growth in Nepalese children: An extension of the MAL-ED study	PLOS ONE			English	Article							YOUNG-CHILDREN; ALBUMIN ADDUCTS; BIRTH COHORT; BENIN; UNDERNUTRITION; TOGO; DIARRHEA; DEATHS	Exposure to aflatoxin, a mycotoxin common in many foods, has been associated with child growth impairment in sub-Saharan Africa. To improve our understanding of growth impairment in relation to aflatoxin and other risk factors, we assessed biospecimens collected in Nepalese children at 15, 24, and 36 months of age for aflatoxin exposure. Children ( N = 85) enrolled in the Bhaktapur, Nepal MAL-ED study encompassed the cohort analysed in this study. Exposure was assessed through a plasma biomarker of aflatoxin exposure: the AFB1-lysine adduct. The aflatoxin exposures in the study participants were compared to anthropometrics at each time period ( length-for-age [ LAZ], weight-for-age [ WAZ], and weight-for-length [ WLZ] z-scores), growth trajectories over time, age, and breastfeeding status. Results demonstrated chronic aflatoxin exposure in this cohort of children, with a geometric mean of 3.62 pg AFB1-lysine/mg albumin. However, the chronic aflatoxin exposure in this cohort was not significantly associated with anthropometric z-scores, growth trajectories, age, or feeding status, based on the available time points to assess aflatoxin exposure. Low mean levels of aflatoxin exposure and infrequent occurrence of stunting, wasting, or underweight z-score values in this cohort are possible contributing factors to a lack of evidence for an association. Further research is needed to examine whether a threshold dose of aflatoxin exists that could induce child growth impairment.	[Mitchell, Nicole J.; Wu, Felicia] Michigan State Univ, Dept Food Sci & Human Nutr, E Lansing, MI 48824 USA; [Hsu, Hui-Husan; Tu, Yu-Kang] Natl Taiwan Univ, Inst Epidemiol & Prevent Med, Coll Publ Hlth, Taipei, Taiwan; [Chandyo, Ram Krishna] Univ Bergen, Ctr Intervent Sci Maternal & Child Hlth, Ctr Int Hlth, Bergen, Norway; [Chandyo, Ram Krishna; Ulak, Manjeswori] Tribhuvan Univ, Inst Med, Dept Child Hlth, Kathmandu, Nepal; [Shrestha, Binob] Walter Reed Armed Forces Res Inst Med Sci, Res Unit, Kathmandu, Nepal; [Bodhidatta, Ladaporn] Armed Forces Res Inst Med Sci, Dept Enter Dis, Bangkok, Thailand; [Gong, Yun-Yun] Queens Univ Belfast, Inst Global Food Secur, Sch Biol Sci, Belfast, Antrim, North Ireland; [Egner, Patricia A.; Groopman, John D.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Environm Hlth Sci, Baltimore, MD USA	Michigan State University; National Taiwan University; University of Bergen; Tribhuvan University; Institute of Medicine (IoM) - Nepal; Walter Reed Army Institute of Research (WRAIR); Armed Forces Research Institute of Medical Science (AFRIMS); United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Armed Forces Research Institute of Medical Science (AFRIMS); Queens University Belfast; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Wu, F (corresponding author), Michigan State Univ, Dept Food Sci & Human Nutr, E Lansing, MI 48824 USA.	fwu@msu.edu	Gong, Yun Yun/C-8412-2018; Gong, Yun Yun/L-7094-2016; /X-4205-2019	Gong, Yun Yun/0000-0003-4927-5526; Gong, Yun Yun/0000-0003-4927-5526; /0000-0003-4690-2133; Tu, Yu-Kang/0000-0002-2461-474X				Acosta AM, 2014, CLIN INFECT DIS, V59, pS193, DOI 10.1093/cid/ciu653; Applegate TJ, 2009, POULTRY SCI, V88, P1235, DOI 10.3382/ps.2008-00494; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Bodine AB, 1983, SO COOPERATIVE SERIE, V279; CAST, 2003, MYCOTOXINS RISKS PLA; Caulfield LE, 2014, CLIN INFECT DIS, V59, pS248, DOI 10.1093/cid/ciu421; Caulfield LE, 2004, AM J CLIN NUTR, V80, P193; Central Bureau of Statistics & UNICEF Nepal, 2015, MULT IND CLUST SURV; Dewey KG, 2008, MATERN CHILD NUTR, V4, P24, DOI 10.1111/j.1740-8709.2007.00124.x; Egal S, 2005, INT J FOOD MICROBIOL, V104, P215, DOI 10.1016/j.ijfoodmicro.2005.03.004; Ghosh A, 2009, ANN HUM BIOL, V36, P38, DOI 10.1080/03014460802555650; Gong YY, 2004, ENVIRON HEALTH PERSP, V112, P1334, DOI 10.1289/ehp.6954; Gong YY, 2003, INT J EPIDEMIOL, V32, P556, DOI 10.1093/ije/dyg109; Gong YY, 2002, BRIT MED J, V325, P20, DOI 10.1136/bmj.325.7354.20; Grantham-McGregor Sally M., 1999, Food and Nutrition Bulletin, V20, P53; Groopman JD, 2014, FOOD CHEM TOXICOL, V74, P184, DOI 10.1016/j.fct.2014.09.016; Houpt E, 2014, CLIN INFECT DIS, V59, pS225, DOI 10.1093/cid/ciu413; Jones G, 2003, LANCET, V362, P65, DOI 10.1016/S0140-6736(03)13811-1; Khlangwiset P, 2011, CRIT REV TOXICOL, V41, P740, DOI 10.3109/10408444.2011.575766; Kline RB., 2015, METHODOLOGY SOCIAL S, V4th ed; Koirala P, 2005, Indian J Med Sci, V59, P331; Martorell R, 2010, J NUTR, V140, P348, DOI 10.3945/jn.109.112300; Mccoy LF, 2008, CANCER EPIDEM BIOMAR, V17, P1653, DOI 10.1158/1055-9965.EPI-07-2780; Ministry of Health and Population (MOHP) [Nepal] New ERA & ICF International Inc, 2012, NEP DEM HLTH SURV 20; Mitchell N.J., 2016, J EXPO SCI ENV EPIDE; Mitchell NJ, 2016, FOOD ADDIT CONTAM A, V33, P540, DOI 10.1080/19440049.2016.1138545; OKUMURA H, 1993, CARCINOGENESIS, V14, P1233, DOI 10.1093/carcin/14.6.1233; Partanen HA, 2010, TOXICOL SCI, V113, P216, DOI 10.1093/toxsci/kfp257; Patil CL, 2015, J HEALTH POPUL NUTR, V34, DOI 10.1186/s41043-015-0004-2; Platts-Mills JA, 2015, LANCET GLOB HEALTH, V3, pE564, DOI 10.1016/S2214-109X(15)00151-5; Psaki S, 2012, POPUL HEALTH METR, V10, DOI 10.1186/1478-7954-10-24; Psaki SR, 2014, POPUL HEALTH METR, V12, DOI 10.1186/1478-7954-12-8; Richard SA, 2014, CLIN INFECT DIS, V59, pS255, DOI 10.1093/cid/ciu436; Scholl PF, 2006, CANCER EPIDEM BIOMAR, V15, P823, DOI 10.1158/1055-9965.EPI-05-0890; Shirima CP, 2015, ENVIRON HEALTH PERSP, V123, P173, DOI 10.1289/ehp.1408097; Shrestha PS, 2014, CLIN INFECT DIS, V59, pS300, DOI 10.1093/cid/ciu459; Smith LE, 2011, ADV NUTR, V3, P1; Turner PC, 2007, INT J EPIDEMIOL, V36, P1119, DOI 10.1093/ije/dym122; Wild CP, 2010, CARCINOGENESIS, V31, P71, DOI 10.1093/carcin/bgp264; World Health Organization, 1997, WHO GLOB DAT CHILD G; Wu F, 2011, WORLD MYCOTOXIN J, V4, P79, DOI 10.3920/WMJ2010.1246; Yunus AW, 2011, POULTRY SCI, V90, P1683, DOI 10.3382/ps.2011-01448	42	33	33	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2017	12	2							e0172124	10.1371/journal.pone.0172124	http://dx.doi.org/10.1371/journal.pone.0172124			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BI	28212415	Green Published, gold			2022-12-27	WOS:000394424700018
J	Nakano, M; Arai, Y; Kotera, I; Okabe, K; Kamei, Y; Nagai, T				Nakano, Masahiro; Arai, Yoshiyuki; Kotera, Ippei; Okabe, Kohki; Kamei, Yasuhiro; Nagai, Takeharu			Genetically encoded ratiometric fluorescent thermometer with wide range and rapid response	PLOS ONE			English	Article							SINGLE-CELL THERMOMETRY; 10(5) GAP ISSUE; INTRACELLULAR TEMPERATURE; POLYMERIC THERMOMETER; LIVING CELLS; IN-VIVO; PROTEIN; THERMOSENSORS; MITOCHONDRIA; VARIANTS	Temperature is a fundamental physical parameter that plays an important role in biological reactions and events. Although thermometers developed previously have been used to investigate several important phenomena, such as heterogeneous temperature distribution in a single living cell and heat generation in mitochondria, the development of a thermometer with a sensitivity over a wide temperature range and rapid response is still desired to quantify temperature change in not only homeotherms but also poikilotherms from the cellular level to in vivo. To overcome the weaknesses of the conventional thermometers, such as a limitation of applicable species and a low temporal resolution, owing to the narrow temperature range of sensitivity and the thermometry method, respectively, we developed a genetically encoded ratiometric fluorescent temperature indicator, gTEMP, by using two fluorescent proteins with different temperature sensitivities. Our thermometric method enabled a fast tracking of the temperature change with a time resolution of 50 ms. We used this method to observe the spatiotemporal temperature change between the cytoplasm and nucleus in cells, and quantified thermogenesis from the mitochondria matrix in a single living cell after stimulation with carbonyl cyanide 4-(trifluoromethoxy)phenylhydrazone, which was an uncoupler of oxidative phosphorylation. Moreover, exploiting the wide temperature range of sensitivity from 5 degrees C to 50 degrees C of gTEMP, we monitored the temperature in a living medaka embryo for 15 hours and showed the feasibility of in vivo thermometry in various living species.	[Nakano, Masahiro; Arai, Yoshiyuki; Nagai, Takeharu] Osaka Univ, Inst Sci & Ind Res, Ibaraki, Osaka, Japan; [Kotera, Ippei] Hokkaido Univ, Res Inst Elect Sci, Sapporo, Hokkaido, Japan; [Okabe, Kohki] Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo, Japan; [Okabe, Kohki] JST, PRESTO, Kawaguchi, Saitama, Japan; [Kamei, Yasuhiro] Natl Inst Basic Biol, Okazaki, Aichi, Japan	Osaka University; Hokkaido University; University of Tokyo; Japan Science & Technology Agency (JST); National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB)	Nagai, T (corresponding author), Osaka Univ, Inst Sci & Ind Res, Ibaraki, Osaka, Japan.	ng1@sanken.osaka-u.ac.jp	Kamei, Yasuhiro/AAD-9281-2019	Kamei, Yasuhiro/0000-0001-6382-1365; Nagai, Takeharu/0000-0003-2650-9895				Arai S, 2015, CHEM COMMUN, V51, P8044, DOI 10.1039/c5cc01088h; Baffou G, 2015, NAT METHODS, V12, P803, DOI 10.1038/nmeth.3552; Baffou G, 2014, NAT METHODS, V11, P899, DOI 10.1038/nmeth.3073; Cranfill PJ, 2016, NAT METHODS, V13, P557, DOI [10.1038/nmeth.3891, 10.1038/NMETH.3891]; Donner JS, 2012, NANO LETT, V12, P2107, DOI 10.1021/nl300389y; Gota C, 2009, J AM CHEM SOC, V131, P2766, DOI 10.1021/ja807714j; Hayashi T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117677; Kamei Y, 2009, NAT METHODS, V6, P79, DOI [10.1038/NMETH.1278, 10.1038/nmeth.1278]; Kinoshita M., 2009, MEDAKA BIOL MANAGEME; Kitano T, 2012, MOL REPROD DEV, V79, P719, DOI 10.1002/mrd.22080; Kiyonaka S, 2015, NAT METHODS, V12, P801, DOI 10.1038/nmeth.3548; Kiyonaka S, 2013, NAT METHODS, V10, P1232, DOI [10.1038/NMETH.2690, 10.1038/nmeth.2690]; Kucsko G, 2013, NATURE, V500, P54, DOI 10.1038/nature12373; Kummer AD, 2002, CHEMBIOCHEM, V3, P659, DOI 10.1002/1439-7633(20020703)3:7<659::AID-CBIC659>3.0.CO;2-U; Morimoto RI, 1998, NAT BIOTECHNOL, V16, P833, DOI 10.1038/nbt0998-833; NAKAMURA T, 1978, J BIOCHEM-TOKYO, V84, P39, DOI 10.1093/oxfordjournals.jbchem.a132117; Okabe K, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1714; Suzuki M, 2015, NAT METHODS, V12, P802, DOI 10.1038/nmeth.3551; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; Tanimoto R, 2016, SCI REP-UK, V6, DOI 10.1038/srep22071; Tiwari DK, 2015, NAT METHODS, V12, P515, DOI 10.1038/nmeth.3362; Tomosugi W, 2009, NAT METHODS, V6, P351, DOI [10.1038/NMETH.1317, 10.1038/nmeth.1317]; Uchiyama S, 2015, ANALYST, V140, P4498, DOI 10.1039/c5an00420a; Yang JM, 2011, ACS NANO, V5, P5067, DOI 10.1021/nn201142f; Yatsu R, 2015, SCI REP-UK, V5, DOI 10.1038/srep18581; Zapata-Hommer O, 2003, BMC BIOTECHNOL, V3, DOI 10.1186/1472-6750-3-5	26	61	62	2	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2017	12	2							e0172344	10.1371/journal.pone.0172344	http://dx.doi.org/10.1371/journal.pone.0172344			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BI	28212432	Green Published, gold, Green Submitted			2022-12-27	WOS:000394424700035
J	Zong, F; Wang, LF				Zong, Fan; Wang, Lifang			Evaluation of university scientific research ability based on the output of sci-tech papers: A D-AHP approach	PLOS ONE			English	Article							RESEARCH PERFORMANCE; D NUMBERS; PREFERENCE; IMPACT	University scientific research ability is an important indicator to express the strength of universities. In this paper, the evaluation of university scientific research ability is investigated based on the output of sci-tech papers. Four university alliances from North America, UK, Australia, and China, are selected as the case study of the university scientific research evaluation. Data coming from Thomson Reuters InCites are collected to support the evaluation. The work has contributed new framework to the issue of university scientific research ability evaluation. At first, we have established a hierarchical structure to show the factors that impact the evaluation of university scientific research ability. Then, a new MCDM method called D-AHP model is used to implement the evaluation and ranking of different university alliances, in which a data-driven approach is proposed to automatically generate the D numbers preference relations. Next, a sensitivity analysis has been given to show the impact of weights of factors and sub-factors on the evaluation result. At last, the results obtained by using different methods are compared and discussed to verify the effectiveness and reasonability of this study, and some suggestions are given to promote China's scientific research ability.	[Zong, Fan] Northwestern Polytech Univ, Div Human Resources, Xian 710072, Shaanxi, Peoples R China; [Wang, Lifang] Northwestern Polytech Univ, Sch Management, Xian 710072, Shaanxi, Peoples R China	Northwestern Polytechnical University; Northwestern Polytechnical University	Zong, F (corresponding author), Northwestern Polytech Univ, Div Human Resources, Xian 710072, Shaanxi, Peoples R China.	zongfan@nwpu.edu.cn						[Anonymous], 2005, HIGHER ED EUROPE; BRANS JP, 1986, EUR J OPER RES, V24, P228, DOI 10.1016/0377-2217(86)90044-5; Chen K, 2007, WORLD DEV, V35, P1056, DOI 10.1016/j.worlddev.2006.05.013; Choi S, 2010, ASIA PAC EDUC REV, V11, P169, DOI 10.1007/s12564-010-9076-2; Cooper WW, 2004, INT SER OPER RES MAN, P1; DEMPSTER AP, 1967, ANN MATH STAT, V38, P325, DOI 10.1214/aoms/1177698950; Deng XY, 2016, IEEE T CYBERNETICS, V46, P2070, DOI 10.1109/TCYB.2015.2462352; Deng XY, 2015, KNOWL-BASED SYST, V73, P61, DOI 10.1016/j.knosys.2014.09.007; Deng XY, 2014, EXPERT SYST APPL, V41, P635, DOI 10.1016/j.eswa.2013.07.088; Deng XY, 2014, EXPERT SYST APPL, V41, P156, DOI 10.1016/j.eswa.2013.07.018; Deng Y., 2012, J INF COMPUT SCI, V9, P2421; Dymova L, 2013, EXPERT SYST APPL, V40, P4841, DOI 10.1016/j.eswa.2013.02.022; Fan GC, 2016, EXPERT SYST APPL, V44, P289, DOI 10.1016/j.eswa.2015.09.006; Feng Y. J., 2004, International Transactions in Operational Research, V11, P181, DOI 10.1111/j.1475-3995.2004.00450.x; Geuna A, 2003, MINERVA, V41, P277, DOI 10.1023/B:MINE.0000005155.70870.bd; Herrera-Viedma E, 2004, EUR J OPER RES, V154, P98, DOI 10.1016/S0377-2217(02)00725-7; Hicks D, 2009, HIGH EDUC, V57, P393, DOI 10.1007/s10734-008-9154-0; Hwang C-L., 1981, MULTIPLE ATTRIBUTE D, V186, P58, DOI [DOI 10.1007/978-3-642-48318-9, 10.1007/978-3-642-48318-9]; Ishizaka A., 2013, MULTICRITERIA DECISI, V1st, P1, DOI [10.1002/9781118644898, DOI 10.1002/9781118644898]; JAFFE AB, 1989, AM ECON REV, V79, P957; Jin BH, 2004, HANDBOOK OF QUANTITATIVE SCIENCE AND TECHNOLOGY RESEARCH: THE USE OF PUBLICATION AND PATENT STATISTICS IN STUDIES OF S&T SYSTEMS, P497; Kahraman C, 2008, SPRINGER SER OPTIM A, V16, P1, DOI 10.1007/978-0-387-76813-7; Li F, 2012, SCIENTOMETRICS, V90, P531, DOI 10.1007/s11192-011-0544-1; Li MZ, 2016, ENG APPL ARTIF INTEL, V47, P61, DOI 10.1016/j.engappai.2015.06.004; Liang LM, 2001, RES EVALUAT, V10, P105, DOI 10.3152/147154401781777042; Liu HC, 2014, EXPERT SYST APPL, V41, P4670, DOI 10.1016/j.eswa.2014.01.031; Lixu Li, 2004, Asia Pacific Education Review, V5, P14; Moed HF, 2002, SCIENTOMETRICS, V53, P281, DOI 10.1023/A:1014812810602; Moed HF, 2006, CITATION ANAL RES EV, V9; Qi W, 2011, CHINESE EDUC SOC, V44, P41, DOI [10.2753/CED1061-1932440504, DOI 10.2753/CED1061-1932440504]; Saaty T. L., 2004, Journal of Systems Science and Systems Engineering, V13, P1, DOI 10.1007/s11518-006-0151-5; Saaty TL, 2003, EUR J OPER RES, V145, P85, DOI 10.1016/S0377-2217(02)00227-8; Shafer G., 1976, MATH THEORY EVIDENCE; SMETS P, 1994, ARTIF INTELL, V66, P191, DOI 10.1016/0004-3702(94)90026-4; TANINO T, 1984, FUZZY SET SYST, V12, P117, DOI 10.1016/0165-0114(84)90032-0; Triantaphyllou E., 2013, MULTICRITERIA DECISI, V44; Xu ZS, 2007, INT J GEN SYST, V36, P179, DOI 10.1080/03081070600913726; Yager RR, 2015, KNOWL-BASED SYST, V80, P58, DOI 10.1016/j.knosys.2014.12.031; Yager RR, 2015, INFORM SCIENCES, V303, P83, DOI 10.1016/j.ins.2014.12.047; Yang K.J., 2009, TQM MAGAZINE, V21, P220, DOI DOI 10.1108/17542730910953004; Ying C., 2011, CHINESE EDUC SOC, V44, P19, DOI [10.2753/CED1061-1932440502, DOI 10.2753/CED1061-1932440502]; YU PL, 1973, MANAGE SCI B-APPL, V19, P936, DOI 10.1287/mnsc.19.8.936; Zhang H, 2013, RES POLICY, V42, P765, DOI 10.1016/j.respol.2012.10.003	43	11	11	4	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2017	12	2							e0171437	10.1371/journal.pone.0171437	http://dx.doi.org/10.1371/journal.pone.0171437			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL2BI	28212446	Green Published, gold, Green Submitted			2022-12-27	WOS:000394424700007
J	Kala, A; Kamra, DN; Kumar, A; Agarwal, N; Chaudhary, LC; Joshi, CG				Kala, Anju; Kamra, D. N.; Kumar, Avinash; Agarwal, Neeta; Chaudhary, L. C.; Joshi, C. G.			Impact of levels of total digestible nutrients on microbiome, enzyme profile and degradation of feeds in buffalo rumen	PLOS ONE			English	Article							REAL-TIME PCR; CELLULOLYTIC BACTERIA; COLORIMETRIC DETERMINATION; CATTLE; DIVERSITY; ACID; DIET; FERMENTATION; POPULATIONS; ADAPTATION	The present study was aimed at understanding a shift in rumen microbiome of buffaloes fed various levels of total digestible nutrients. To understand the process, the metagenomics of rumen microbes, in vivo and in vitro rumen fermentation studies were carried out. Three rumen fistulated adult male Murrah buffaloes were fed three isonitrogenous diets varying in total digestible nutrients (70, 85 and 100% of TDN requirement) in 3X3 switch over design. On dry matter basis, wheat straw/roughage content were 81, 63 and 51% and that of maize grain was 8, 16 and 21% in three diets respectively. After 20 d of feeding, rumen liquor and rumen contents were sampled just before (0h) and 4h post feeding. Ruminococcus flavefaciens and R. albus (estimated with real time PCR) were higher in high roughage diets. The predominant phyla in all the three groups were Bacteroidetes, Firmicutes followed by Proteobacteria, Actinobacteria and Fibrobacteres. A core group of more than fifty rumen bacteria was present in all the animals with very little variations due to level of TDN. The most predominant bacterial genera reported in order of decreasing abundance were: Prevotella, Bacteroides, Clostridium, Ruminococcus, Eubacterium, Parabacteroides, Fibrobacter, Butyrivibrio etc. The higher diversity of the enyzmes families GH 23, GH 28, GH 39, GH 97, GH 106, and GH 127 (the enzymes active in fibre and starch degradation) were significantly higher on 100% TDN diet while CE 14 (required for the hydrolysis of bond between carbohydrate and lignin) was higher on low TDN (70%) diet, indicating ester bond cleavage was better in animals fed high roughage (wheat straw) diet.	[Kala, Anju; Kamra, D. N.; Kumar, Avinash; Agarwal, Neeta; Chaudhary, L. C.] Indian Vet Res Inst, Ctr Adv Fac Training Anim Nutr, ICAR Natl Professorial Chair, Izatnagar, Uttar Pradesh, India; [Joshi, C. G.] Anand Agr Univ, Coll Vet Sci, Dept Biotechnol, Anand, Gujarat, India	Indian Council of Agricultural Research (ICAR); ICAR - Indian Veterinary Research Institute; Anand Agricultural University	Kala, A (corresponding author), Indian Vet Res Inst, Ctr Adv Fac Training Anim Nutr, ICAR Natl Professorial Chair, Izatnagar, Uttar Pradesh, India.	anjukalavet2002@gmail.com	Joshi, Chaitanya G/AAK-1842-2020	Joshi, Chaitanya G/0000-0003-4680-2861	Indian Council of Agricultural Research, Ministry of agriculture, India [27(17)/2011-HRD]	Indian Council of Agricultural Research, Ministry of agriculture, India	This work was funded by a grant recieved from Indian Council of Agricultural Research, Ministry of agriculture, India via F.No. 27(17)/2011-HRD dated 24/12/2012 to DNK.	Agarwal N, 2000, J APPL ANIM RES, V18, P73, DOI 10.1080/09712119.2000.9706325; Agarwal N, 2008, ASIAN AUSTRAL J ANIM, V21, P818, DOI 10.5713/ajas.2008.70336; Atis I, 2012, INT J AGRIC BIOL, V14, P879; Barker SB, 1941, J BIOL CHEM, V138, P535; Brulc JM, 2009, P NATL ACAD SCI USA, V106, P1948, DOI 10.1073/pnas.0806191105; Callaway TR, 2010, J ANIM SCI, V88, P3977, DOI 10.2527/jas.2010-2900; CARPITA NC, 1993, PLANT J, V3, P1, DOI 10.1111/j.1365-313X.1993.tb00007.x; COTTYN BG, 1968, J AGR FOOD CHEM, V16, P105, DOI 10.1021/jf60155a002; Dai X, 2015, APPL ENVIRON MICROB, V81, P1375, DOI 10.1128/AEM.03682-14; Dai X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040430; Jesus Raphael Barbetta de, 2015, Acta Sci., Anim. Sci., V37, P251, DOI 10.4025/actascianimsci.v37i3.26535; Denman SE, 2007, FEMS MICROBIOL ECOL, V62, P313, DOI 10.1111/j.1574-6941.2007.00394.x; Denman SE, 2006, FEMS MICROBIOL ECOL, V58, P572, DOI 10.1111/j.1574-6941.2006.00190.x; Durso LM, 2010, APPL ENVIRON MICROB, V76, P4858, DOI 10.1128/AEM.00207-10; Fernando SC, 2010, APPL ENVIRON MICROB, V76, P7482, DOI 10.1128/AEM.00388-10; Flint HJ, 2008, NAT REV MICROBIOL, V6, P121, DOI 10.1038/nrmicro1817; Harper D, 2001, PAST PALAEONTOLOGICA; Hristov AN, 1999, CAN J ANIM SCI, V79, P73, DOI 10.4141/A98-056; HUGGINS C, 1947, J BIOL CHEM, V170, P467; ICAR, 2013, NUTRIENT REQUIREMENT; Jami E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085423; Jami E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033306; Kamra DN, 2005, CURR SCI INDIA, V89, P124; Kamra DN, 2013, INT TRAINING COURSE, P48; Koike S, 2001, FEMS MICROBIOL LETT, V204, P361, DOI 10.1111/j.1574-6968.2001.tb10911.x; Li M, 2009, J APPL MICROBIOL, V107, P1924, DOI 10.1111/j.1365-2672.2009.04376.x; Li YD, 2014, ANN MICROBIOL, V64, P1385, DOI 10.1007/s13213-013-0783-x; Lim S, 2013, ASIAN AUSTRAL J ANIM, V26, P1144, DOI 10.5713/ajas.2013.13219; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mao SY, 2015, SCI REP-UK, V5, DOI 10.1038/srep16116; Menke K.H, 1988, ANIM RES DEV, V28, P7, DOI DOI 10.1016/S0301-6226(01)00298-6.PALMQUIST; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Miron J, 2001, J DAIRY SCI, V84, P1294, DOI 10.3168/jds.S0022-0302(01)70159-2; Ritalahti KM, 2006, APPL ENVIRON MICROB, V72, P2765, DOI 10.1128/AEM.72.4.2765-2774.2006; SHEWALE JG, 1978, CAN J MICROBIOL, V24, P1204, DOI 10.1139/m78-195; Singh KM, 2011, MOL BIOL REP; Stevenson DM, 2007, APPL MICROBIOL BIOT, V75, P165, DOI 10.1007/s00253-006-0802-y; Sun YZ, 2010, ANIMAL, V4, P210, DOI 10.1017/S175173110999111X; Tapio I, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151220; Van Soest P. J., 1988, LAB MANUAL ANIMAL SC, V612; Wallace RJ, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2032-0; Wanapat M, 2009, CURR MICROBIOL, V58, P294, DOI 10.1007/s00284-008-9322-6; WEATHERBURN MW, 1967, ANAL CHEM, V39, P971, DOI 10.1021/ac60252a045; Zhao LP, 2015, ASIAN AUSTRAL J ANIM, V28, P1433, DOI 10.5713/ajas.15.0091	44	29	29	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0172051	10.1371/journal.pone.0172051	http://dx.doi.org/10.1371/journal.pone.0172051			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207851	Green Published, Green Submitted, gold			2022-12-27	WOS:000394424500078
J	La Manna, MP; Orlando, V; Dieli, F; Di Carlo, P; Cascio, A; Cuzzi, G; Palmieri, F; Goletti, D; Caccamo, N				La Manna, Marco Pio; Orlando, Valentina; Dieli, Francesco; Di Carlo, Paola; Cascio, Antonio; Cuzzi, Gilda; Palmieri, Fabrizio; Goletti, Delia; Caccamo, Nadia			Quantitative and qualitative profiles of circulating monocytes may help identifying tuberculosis infection and disease stages	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELLS; MYCOBACTERIUM-TUBERCULOSIS; IFN-GAMMA; RATIO; HETEROGENEITY; MACROPHAGES; EXPRESSION; LYMPHOCYTES; DIAGNOSIS; BIOMARKER	Tuberculosis (TB) is one of the most important cause of morbidity and death among infectious diseases, and continuous efforts are needed to improve diagnostic tools and therapy. Previous published studies showed that the absolute cells number of monocytes or lymphocytes in peripheral blood or yet the ratio of monocytes to lymphocytes displayed the ability to predict the risk of active TB. In the present study we evaluated the ratio of monocytes to lymphocytes variation and we also analyzed the ex-vivo expression of CD64 on monocytes as tools to identify biomarkers for discriminating TB stages. Significant differences were found when the average ratio of monocytes to lymphocytes of active TB patients was compared with latent TB infection (LTBI) subjects, cured TB and healthy donors (HD). By the receiver operator characteristics (ROC) curve analysis the cut-off value of 0.285, allowed the discrimination of active TB from HD, with a sensitivity of 91.04% and a specificity of 93.55% (95% of confidence interval: 0.92-0.99). The ROC curve analysis comparing TB patients and LTBI groups, led to a sensitivity and the specificity of the assay of 85.07% and 85.71%, respectively (95% of confidence interval: 0.85 to 0.96). The upregulation of CD64 expression on circulating monocytes in active TB patients could represent an additional biomarker for diagnosis of active TB. In conclusion, we found that the ML ratio or monocyte absolute count or phenotypic measures show predictive value for active TB.	[La Manna, Marco Pio; Orlando, Valentina; Dieli, Francesco; Caccamo, Nadia] Azienda Univ Osped Policlin P Giaccone, Cent Lab Adv Diag & Biomed Res CLADIBIOR, Palermo, Italy; [Dieli, Francesco; Caccamo, Nadia] Univ Palermo, Dipartimento Biopatol & Biotecnol Med, Palermo, Italy; [Di Carlo, Paola; Cascio, Antonio] Univ Palermo, Dept Sci Hlth Promot & Mother Child Care G DAless, Palermo, Italy; [Cuzzi, Gilda; Palmieri, Fabrizio; Goletti, Delia] Natl Inst Infect Dis L Spallanzani, Translat Res Unit, Rome, Italy	University of Palermo; University of Palermo; IRCCS Lazzaro Spallanzani	Caccamo, N (corresponding author), Azienda Univ Osped Policlin P Giaccone, Cent Lab Adv Diag & Biomed Res CLADIBIOR, Palermo, Italy.; Caccamo, N (corresponding author), Univ Palermo, Dipartimento Biopatol & Biotecnol Med, Palermo, Italy.	nadia.caccamo@unipa.it	Palmieri, Fabrizio/B-5420-2017; Caccamo, Nadia/J-6808-2018; Di Carlo, Paola/I-2123-2019; goletti, delia/AAM-6577-2020; Cascio, Antonio/K-5453-2016; Di Carlo, Paola/S-2456-2017; La Manna, Marco Pio/AAN-8117-2020	Palmieri, Fabrizio/0000-0001-8184-6291; Di Carlo, Paola/0000-0003-4418-5855; Cascio, Antonio/0000-0002-1992-1796; Di Carlo, Paola/0000-0003-4418-5855; Dieli, Francesco/0000-0002-6685-352X; Goletti, Delia/0000-0001-8360-4376; CACCAMO, Nadia Rosalia/0000-0002-1018-5710; LA MANNA, Marco Pio/0000-0002-3327-9541	Italian Ministry of Health: "Ricerca Corrente, Linea 4"; European Union [HEALTH-F3-2009-241642]; EC FP7 NEWTBVAC [HEALTH.F3.2009 241745]; TBVAC [H2020-PHC-643381]; EMITB [H2020-PHC-643558]	Italian Ministry of Health: "Ricerca Corrente, Linea 4"; European Union(European Commission); EC FP7 NEWTBVAC; TBVAC; EMITB	The study was supported by grants from the Italian Ministry of Health: "Ricerca Corrente, Linea 4" and a grant from the European Union: HEALTH-F3-2009-241642 and EC FP7 NEWTBVAC (contract no. HEALTH.F3.2009 241745), TBVAC2020 (contract number H2020-PHC-643381) and EMITB (contract number H2020-PHC-643558).	Agarwal A, 2016, TROP DOCT, V46, P73, DOI 10.1177/0049475515609244; Baldridge MT, 2010, NATURE, V465, P793, DOI 10.1038/nature09135; Benoit M, 2008, J IMMUNOL, V181, P3733, DOI 10.4049/jimmunol.181.6.3733; Benoit M, 2008, EUR J IMMUNOL, V38, P1065, DOI 10.1002/eji.200738067; Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247; Cavaillon JM, 2006, CRIT CARE, V10, DOI 10.1186/cc5055; Chacon-Salinas R, 2005, CLIN EXP IMMUNOL, V140, P443, DOI 10.1111/j.1365-2249.2005.02797.x; Das B, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004912; Delogu G, 2016, SCAND J IMMUNOL, V84, P344, DOI 10.1111/sji.12493; Delogu G, 2014, J RHEUMATOL, V41, P11, DOI 10.3899/jrheum.140097; Dowdy DW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004057; Goletti D, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-11; Goletti D, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-5; Goletti D, 2016, INFECT DIS REP, V8, P24, DOI 10.4081/idr.2016.6568; Goletti D, 2014, J RHEUMATOL, V41, P24, DOI 10.3899/jrheum.140099; Guggino G, 2015, IMMUNOL LETT, V166, P87, DOI 10.1016/j.imlet.2015.05.019; Jouanguy E, 1999, CURR OPIN IMMUNOL, V11, P346, DOI 10.1016/S0952-7915(99)80055-7; Kabeer BSA, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-135; Kikuchi-Taura A, 2015, LUPUS, V24, P1076, DOI 10.1177/0961203315579093; Kiszewski AE, 2006, CLIN EXP IMMUNOL, V143, P445, DOI 10.1111/j.1365-2249.2006.03020.x; Klimchenko O, 2011, BLOOD, V117, P3065, DOI 10.1182/blood-2010-07-295246; Lastrucci C, 2015, CELL RES, V25, P1333, DOI 10.1038/cr.2015.123; Mege JL, 2011, CURR OPIN INFECT DIS, V24, P230, DOI 10.1097/QCO.0b013e328344b73e; Muller-Sieburg CE, 2002, BLOOD, V100, P1302, DOI 10.1182/blood.V100.4.1302.h81602001302_1302_1309; Muller-Sieburg CE, 2012, BLOOD, V119, P3900, DOI 10.1182/blood-2011-12-376749; Murphy JT, 2006, PHYSIOL GENOMICS, V28, P67, DOI 10.1152/physiolgenomics.00098.2006; Naranbhai V, J ACQUIR IMMUNE DEFI, P573; Naranbhai V, 2015, EBIOMEDICINE, V2, P1619, DOI 10.1016/j.ebiom.2015.09.027; Naranbhai V, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0120-7; Naranbhai V, 2014, J INFECT DIS, V209, P500, DOI 10.1093/infdis/jit494; Noel W, 2004, TRENDS PARASITOL, V20, P126, DOI 10.1016/j.pt.2004.01.004; Ohta S, 2012, J CELL SCI, V125, P3210, DOI 10.1242/jcs.102210; Organization WH, 2016, GLOBAL TUBERCULOSIS; Pai M, 2007, AM J RESP CRIT CARE, V175, P529, DOI 10.1164/rccm.200701-024ED; Pang WW, 2011, P NATL ACAD SCI USA, V108, P20012, DOI 10.1073/pnas.1116110108; Pathak SK, 2007, NAT IMMUNOL, V8, P610, DOI 10.1038/ni1468; Petruccioli E, 2016, DIAGN MICROBIOL INFE, V86; Petruccioli E, 2016, ERJ, V48; Schroeder T, 2010, CELL STEM CELL, V6, P203, DOI 10.1016/j.stem.2010.02.006; Sester M, 2012, EUR RESPIR J, V39, P793, DOI 10.1183/09031936.50114810; Sester M, 2011, EUR RESPIR J, V37, P100, DOI 10.1183/09031936.00114810; Shaughnessy LM, 2007, FRONT BIOSCI-LANDMRK, V12, P2683, DOI 10.2741/2364; VANDEWINKEL JGJ, 1993, IMMUNOL TODAY, V14, P215, DOI 10.1016/0167-5699(93)90166-I; Yang JY, 2014, BIOMARK RES, V2, DOI 10.1186/2050-7771-2-1; Yazdanbakhsh Karina, 2013, Semin Hematol, V50 Suppl 1, pS63, DOI 10.1053/j.seminhematol.2013.03.011	45	57	60	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0171358	10.1371/journal.pone.0171358	http://dx.doi.org/10.1371/journal.pone.0171358			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28208160	Green Published, gold			2022-12-27	WOS:000394424500026
J	Shelake, RM; Ito, Y; Masumoto, J; Morita, EH; Hayashi, H				Shelake, Rahul Mahadev; Ito, Yuki; Masumoto, Junya; Morita, Eugene Hayato; Hayashi, Hidenori			A novel mechanism of "metal gel -shift" by histidine-rich Ni2+-binding Hpn protein from Helicobacter pylori strain SS1	PLOS ONE			English	Article							X-RAY-FLUORESCENCE; SODIUM DODECYL-SULFATE; SDS-PAGE MIGRATION; MASS-SPECTROMETRY; ESCHERICHIA-COLI; BIOCHEMICAL-CHARACTERIZATION; BINDING PROTEINS; ZINC-BINDING; ICP-MS; ELECTROPHORESIS	Sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) is a universally used method for determining approximate molecular weight (MW) in protein research. Migration of protein that does not correlate with formula MW, termed "gel shifting" appears to be common for histidine-rich proteins but not yet studied in detail. We investigated "gel shifting" in Ni2+-binding histidine-rich Hpn protein cloned from Helicobacter pylori strain SS1. Our data demonstrate two important factors determining "gel shifting" of Hpn, polyacrylamide-gel concentration and metal binding. Higher polyacrylamide-gel concentrations resulted in faster Hpn migration. Irrespective of polyacrylamide-gel concentration, preserved Hpn-Ni2+ complex migrated faster (3-4 kDa) than apo-Hpn, phenomenon termed "metal gel-shift" demonstrating an intimate link between Ni2+ binding and "gel shifting". To examine this discrepancy, eluted samples from corresponding spots on SDS-gel were analyzed by matrix-assisted laser desorption/ionization-time-of-flight mass spectrometry (MALDI-TOFMS). The MW of all samples was the same (6945.66 +/- 0.34 Da) and identical to formula MW with or without added mass of Ni2+. MALDI-TOF-MS of Ni2+-treated Hpn revealed that monomer bound up to six Ni2+ ions non-cooperatively, and equilibrium between protein metal species was reliant on Ni2+ availability. This corroborates with gradually increased heterogeneity of apo-Hpn band followed by compact "metal-gel shift" band on SDS-PAGE. In view of presented data metal-binding and "metal-gel shift" models are discussed.	[Shelake, Rahul Mahadev; Ito, Yuki; Masumoto, Junya; Hayashi, Hidenori] Ehime Univ, Proteosci Ctr, Matsuyama, Ehime, Japan; [Morita, Eugene Hayato] Ehime Univ, Lab Mol Cell Physiol, Fac Agr, Matsuyama, Ehime, Japan; [Morita, Eugene Hayato] Josai Univ, Dept Chem, Fac Sci, Saitama, Japan	Ehime University; Ehime University; Josai University	Hayashi, H (corresponding author), Ehime Univ, Proteosci Ctr, Matsuyama, Ehime, Japan.	hayashi.hidenori.mj@ehime-u.ac.jp	Shelake, Rahul Mahadev/H-8349-2019	Shelake, Rahul Mahadev/0000-0003-0691-560X				Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Akiyama H, 1998, DNA Res, V5, P327, DOI 10.1093/dnares/5.6.327; Atwood CS, 2000, J NEUROCHEM, V75, P1219, DOI 10.1046/j.1471-4159.2000.0751219.x; Binet MRB, 2003, ANAL BIOCHEM, V318, P30, DOI 10.1016/S0003-2697(03)00190-8; Brayman TG, 1996, J BACTERIOL, V178, P5410, DOI 10.1128/jb.178.18.5410-5416.1996; Bullis BL, 2002, EUR J BIOCHEM, V269, P4887, DOI 10.1046/j.1432-1033.2002.03202.x; Chan KH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030547; Chen F, 2007, MASS SPECTROM REV, V26, P223; Chen SH, 2014, J AM CHEM SOC, V136, P9499, DOI 10.1021/ja5047878; Chiera NM, 2013, METALLOMICS, V5, P214, DOI 10.1039/c3mt20166j; Cun SJ, 2008, J BIOL CHEM, V283, P15142, DOI 10.1074/jbc.M800591200; DAMIANI E, 1991, BIOCHEM J, V277, P825, DOI 10.1042/bj2770825; de Reuse H, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00094; Erickson HP, 2009, BIOL PROCED ONLINE, V11, P32, DOI 10.1007/s12575-009-9008-x; Finney L, 2010, ACS CHEM BIOL, V5, P577, DOI 10.1021/cb1000263; FU CL, 1995, P NATL ACAD SCI USA, V92, P2333, DOI 10.1073/pnas.92.6.2333; Gao YX, 2003, ANAL CHIM ACTA, V485, P131, DOI 10.1016/S0003-2670(03)00347-7; Ge RG, 2006, BIOCHEM J, V393, P285, DOI 10.1042/BJ20051160; Ge RG, 2006, J AM CHEM SOC, V128, P11330, DOI 10.1021/ja062589t; GILBERT JV, 1995, INFECT IMMUN, V63, P2682, DOI 10.1128/IAI.63.7.2682-2688.1995; Hayward LJ, 2002, J BIOL CHEM, V277, P15923, DOI 10.1074/jbc.M112087200; Hottenrott S, 1997, J BIOL CHEM, V272, P15697, DOI 10.1074/jbc.272.25.15697; Jeon WB, 2001, J BIOL CHEM, V276, P38602, DOI 10.1074/jbc.M104945200; Jin Y, 2005, ELECTROPHORESIS, V26, P1019, DOI 10.1002/elps.200410187; Kaluarachchi H, 2009, J AM CHEM SOC, V131, P18489, DOI 10.1021/ja9081765; Karch CM, 2010, ARCH BIOCHEM BIOPHYS, V503, P175, DOI 10.1016/j.abb.2010.07.027; Kleinschmidt JH, 1999, PROTEIN SCI, V8, P2065, DOI 10.1110/ps.8.10.2065; Kohler C, 2000, FEBS LETT, V471, P133, DOI 10.1016/S0014-5793(00)01383-1; Kolodziejski PJ, 2003, P NATL ACAD SCI USA, V100, P14263, DOI 10.1073/pnas.2435290100; Laemmli UK, 1970, NATURE, P680; Lee A, 1997, GASTROENTEROLOGY, V112, P1386, DOI 10.1016/S0016-5085(97)70155-0; Li JX, 1998, PLANT PHYSIOL, V116, P785, DOI 10.1104/pp.116.2.785; Liao SM, 2013, CHEM CENT J, V7, DOI 10.1186/1752-153X-7-44; Mena ML, 2011, J CHROMATOGR A, V1218, P1281, DOI 10.1016/j.chroma.2010.12.115; Mahadev SR, 2013, PROTEIN J, V32, P626, DOI 10.1007/s10930-013-9525-y; Mobley HLT, 1999, HELICOBACTER, V4, P162, DOI 10.1046/j.1523-5378.1999.99286.x; Nowakowski AB, 2014, METALLOMICS, V6, P1068, DOI 10.1039/c4mt00033a; Otzen D, 2011, BBA-PROTEINS PROTEOM, V1814, P562, DOI 10.1016/j.bbapap.2011.03.003; PANAYOTATOS N, 1993, J BIOL CHEM, V268, P19000; Pinato O, 2013, J INORG BIOCHEM, V122, P27, DOI 10.1016/j.jinorgbio.2013.01.007; PITTRIVE.R, 1968, BIOCHEM J, V109, P825, DOI 10.1042/bj1090825; Raab A, 2009, ELECTROPHORESIS, V30, P303, DOI 10.1002/elps.200800264; Rath A, 2013, P NATL ACAD SCI USA, V110, P15668, DOI 10.1073/pnas.1311305110; Rath A, 2009, P NATL ACAD SCI USA, V106, P1760, DOI 10.1073/pnas.0813167106; REY L, 1994, J BACTERIOL, V176, P6066, DOI 10.1128/jb.176.19.6066-6073.1994; Rom S, 2006, BIOCHIMIE, V88, P621, DOI 10.1016/j.biochi.2005.11.008; Romeis T, 2011, CALCIUM DEPENDENT PR, V4, DOI [10.1093/mp/ssq064, DOI 10.1093/MP/SSQ064]; Rowinska-Zyrek M, 2011, DALTON T, V40, P5604, DOI 10.1039/c1dt10187k; Saha S, 2009, J BIOL CHEM, V284, P27135, DOI 10.1074/jbc.M109.020032; Schlosser G, 2003, RAPID COMMUN MASS SP, V17, P2741, DOI 10.1002/rcm.1239; Seshadri S, 2007, J BACTERIOL, V189, P4120, DOI 10.1128/JB.01245-06; Shi R, 2010, BIOCHEMISTRY-US, V49, P7080, DOI 10.1021/bi100372h; Shi YH, 2012, PROTEIN SCI, V21, P1197, DOI 10.1002/pro.2107; Solis C, 1998, NUCL INSTRUM METH B, V136, P928, DOI 10.1016/S0168-583X(97)00896-3; Strupat K, 2005, METHOD ENZYMOL, V405, P1, DOI 10.1016/S0076-6879(05)05001-9; Sussulini A, 2011, METALLOMICS, V3, P1271, DOI 10.1039/c1mt00116g; Sutherland DEK, 2008, BIOCHEM BIOPH RES CO, V372, P840, DOI 10.1016/j.bbrc.2008.05.142; Szajli E, 2008, MOL CELL PROTEOMICS, V7, P2410, DOI 10.1074/mcp.M800108-MCP200; Tham SJ, 2010, BIOSCI BIOTECH BIOCH, V74, P727, DOI 10.1271/bbb.90773; Tulumello DV, 2011, BIOCHEMISTRY-US, V50, P3928, DOI 10.1021/bi200238g; Verbi FM, 2005, J BIOCHEM BIOPH METH, V62, P97, DOI 10.1016/j.jbbm.2004.09.008; Vinella D, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005312; Watanabe Y, 2005, J IMMUNOL METHODS, V300, P115, DOI 10.1016/j.jim.2005.02.014; Wegner SV, 2011, CHEM SCI, V2, P451, DOI 10.1039/c0sc00411a; Weseloh G, 2004, J RADIOANAL NUCL CH, V259, P473, DOI 10.1023/B:JRNC.0000020921.66046.1c; Witkowska D, 2012, CHEM-EUR J, V18, P11088, DOI 10.1002/chem.201200780; Yamauchi S, 2012, EXTREMOPHILES, V16, P871, DOI 10.1007/s00792-012-0483-7; Yoon GM, 1999, PLANT MOL BIOL, V39, P991, DOI 10.1023/A:1006170512542	68	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0172182	10.1371/journal.pone.0172182	http://dx.doi.org/10.1371/journal.pone.0172182			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207866	Green Submitted, Green Published, gold			2022-12-27	WOS:000394424500095
J	Wimmer, MC; Robinson, EJ; Doherty, MJ				Wimmer, Marina C.; Robinson, Elizabeth J.; Doherty, Martin J.			Are developments in mental scanning and mental rotation related?	PLOS ONE			English	Article							VISUOSPATIAL WORKING-MEMORY; INDIVIDUAL-DIFFERENCES; SPATIAL MEMORY; SEX DIFFERENCE; IMAGERY; INFORMATION; ABILITIES; TRANSFORMATIONS; CAPACITY; PATTERNS	The development and relation of mental scanning and mental rotation were examined in 4-, 6-, 8-, 10-year old children and adults (N = 102). Based on previous findings from adults and ageing populations, the key question was whether they develop as a set of related abilities and become increasingly differentiated or are unrelated abilities per se. Findings revealed that both mental scanning and rotation abilities develop between 4- and 6 years of age. Specifically, 4-year-olds showed no difference in accuracy of mental scanning and no scanning trials whereas all older children and adults made more errors in scanning trials. Additionally, the minority of 4-year-olds showed a linear increase in response time with increasing rotation angle difference of two stimuli in contrast to all older participants. Despite similar developmental trajectories, mental scanning and rotation performances were unrelated. Thus, adding to research findings from adults, mental scanning and rotation appear to develop as a set of unrelated abilities from the outset. Different underlying abilities such as visual working memory and spatial coding versus representing past and future events are discussed.	[Wimmer, Marina C.] Univ Plymouth, Sch Psychol, Cognit Ctr, Plymouth, Devon, England; [Robinson, Elizabeth J.] Univ Warwick, Dept Psychol, Coventry, W Midlands, England; [Doherty, Martin J.] Univ East Anglia, Sch Psychol, Norwich, Norfolk, England	University of Plymouth; University of Warwick; University of East Anglia	Wimmer, MC (corresponding author), Univ Plymouth, Sch Psychol, Cognit Ctr, Plymouth, Devon, England.	marina.wimmer@plymouth.ac.uk			Economic and Social Research Council, UK [RES-000-22-4158]; Economic and Social Research Council [ES/I003479/1, ES/I003479/2] Funding Source: researchfish; ESRC [ES/I003479/2] Funding Source: UKRI	Economic and Social Research Council, UK(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This research was supported by a grant from the Economic and Social Research Council, UK (RES-000-22-4158). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez GA, 2004, PSYCHOL SCI, V15, P106, DOI 10.1111/j.0963-7214.2004.01502006.x; Borst G, 2008, MEM COGNITION, V36, P849, DOI 10.3758/MC.36.4.849; Borst G, 2010, Q J EXP PSYCHOL, V63, P2031, DOI 10.1080/17470211003802459; BRANDIMONTE MA, 1992, MEM COGNITION, V20, P449, DOI 10.3758/BF03210929; Bullens J, 2010, DEVELOPMENTAL SCI, V13, P170, DOI 10.1111/j.1467-7687.2009.00870.x; Denis M, 1999, CAH PSYCHOL COGN, V18, P409; DROR IE, 1994, PSYCHOL AGING, V9, P90, DOI 10.1037/0882-7974.9.1.90; Estes D, 1998, CHILD DEV, V69, P1345, DOI 10.2307/1132270; FINKE RA, 1983, J EXP PSYCHOL LEARN, V9, P398, DOI 10.1037/0278-7393.9.3.398; Frick A, 2014, TRENDS COGN SCI, V18, P536, DOI 10.1016/j.tics.2014.05.011; Frick A, 2012, COGNITIVE DEV, V27, P270, DOI 10.1016/j.cogdev.2012.05.004; Frick A, 2009, J COGN DEV, V10, P18, DOI 10.1080/15248370902966719; GEORGOPOULOS AP, 1995, NEUROPSYCHOLOGIA, V33, P1531, DOI 10.1016/0028-3932(95)00079-I; Hamilton CJ, 2003, EUR J COGN PSYCHOL, V15, P43, DOI 10.1080/09541440303597; Kail R, 1997, J EXP CHILD PSYCHOL, V64, P67, DOI 10.1006/jecp.1996.2337; KAIL R, 1980, J EXP CHILD PSYCHOL, V29, P102, DOI 10.1016/0022-0965(80)90094-6; Kosslyn S. M., 2006, SENSORIUM EMBODIED E; KOSSLYN SM, 1984, COGNITION, V18, P195, DOI 10.1016/0010-0277(84)90025-8; KOSSLYN SM, 1990, CHILD DEV, V61, P995, DOI 10.1111/j.1467-8624.1990.tb02837.x; Kosslyn SM, 2003, TRENDS COGN SCI, V7, P109, DOI 10.1016/S1364-6613(03)00025-1; KOSSLYN SM, 1978, J EXP PSYCHOL HUMAN, V4, P47, DOI 10.1037/0096-1523.4.1.47; Logie RH, 1997, EUR J COGN PSYCHOL, V9, P241, DOI 10.1080/713752559; Maras KL, 2014, RES AUTISM SPECT DIS, V8, P1416, DOI 10.1016/j.rasd.2014.07.003; MARMOR GS, 1975, COGNITIVE PSYCHOL, V7, P548, DOI 10.1016/0010-0285(75)90022-5; Mohring W, 2014, DEV PSYCHOL, V50, P1614, DOI 10.1037/a0035905; MORTON N, 1995, COGN NEUROPSYCHOL, V12, P767, DOI 10.1080/02643299508251401; Perner J, 2010, CONSCIOUS COGN, V19, P802, DOI 10.1016/j.concog.2010.06.022; Peruch P, 2011, NEUROPSYCHOLOGIA, V49, P3136, DOI 10.1016/j.neuropsychologia.2011.07.026; PINKER S, 1980, J EXP PSYCHOL GEN, V109, P354, DOI 10.1037/0096-3445.109.3.354; Plumert J., 2007, EMERGING SPATIAL MIN; Pylyshyn ZW, 2002, BEHAV BRAIN SCI, V25, P157, DOI 10.1017/S0140525X02000043; Quinn PC, 2008, PSYCHOL SCI, V19, P1067, DOI 10.1111/j.1467-9280.2008.02201.x; Riggs KJ, 2006, J EXP CHILD PSYCHOL, V95, P18, DOI 10.1016/j.jecp.2006.03.009; SHEPARD RN, 1971, SCIENCE, V171, P701, DOI 10.1126/science.171.3972.701; Shepard RN., 1982, J HIST BEHAV SCI, V19, P301, DOI 10.2307/1422825; Tagaris GA, 1998, BRAIN RES REV, V26, P106, DOI 10.1016/S0165-0173(97)00060-X; Walker P, 2008, MEMORY, V16, P626, DOI 10.1080/09658210802135369; WILSON JTL, 1987, BRIT J DEV PSYCHOL, V5, P249, DOI 10.1111/j.2044-835X.1987.tb01060.x; Wimmer MC, 2016, COGNITION, V154, P49, DOI 10.1016/j.cognition.2016.05.017; Wimmer MC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142566; Wimmer MC, 2016, EUROPEAN J DEV PSYCH, P1	42	5	5	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0171762	10.1371/journal.pone.0171762	http://dx.doi.org/10.1371/journal.pone.0171762			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL2BG	28207810	Green Published, gold, Green Accepted			2022-12-27	WOS:000394424500052
J	Li, LF; Lee, CS; Lin, CW; Chen, NH; Chuang, LP; Hung, CY; Liu, YY				Li, Li-Fu; Lee, Chung-Shu; Lin, Chang-Wei; Chen, Ning-Hung; Chuang, Li-Pang; Hung, Chen-Yiu; Liu, Yung-Yang			Trichostatin A attenuates ventilation-augmented epithelial-mesenchymal transition in mice with bleomycin-induced acute lung injury by suppressing the Akt pathway	PLOS ONE			English	Article							RESPIRATORY-DISTRESS-SYNDROME; HISTONE DEACETYLASE INHIBITION; IDIOPATHIC PULMONARY-FIBROSIS; CONTROLLED ANIMAL-EXPERIMENT; MECHANICAL VENTILATION; MYOFIBROBLASTIC DIFFERENTIATION; EXTRACELLULAR-MATRIX; GENE-EXPRESSION; CELLS; CORTICOSTEROIDS	Background Mechanical ventilation (MV) used in patients with acute respiratory distress syndrome (ARDS) can cause diffuse lung inflammation, an effect termed ventilator-induced lung injury, which may produce profound pulmonary fibrogenesis. Histone deacetylases (HDACs) and serine/threonine kinase/protein kinase B (Akt) are crucial in modulating the epithelial-mesenchymal transition (EMT) during the reparative phase of ARDS; however, the mechanisms regulating the interactions among MV, EMT, HDACs, and Akt remain unclear. We hypothesized that trichostatin A (TSA), a HDAC inhibitor, can reduce MV-augmented bleomycin-induced EMT by inhibiting the HDAC4 and Akt pathways. Methods Five days after bleomycin treatment to mimic acute lung injury (ALI), wild-type or Akt-deficient C57BL/6 mice were exposed to low-tidal-volume (low-VT, 6 mL/kg) or high-VT (30 mL/ kg) MV with room air for 5 h after receiving 2 mg/kg TSA. Nonventilated mice were examined as controls. Results Following bleomycin exposure in wild-type mice, high-VT MV induced substantial increases in microvascular leaks; matrix metalloproteinase-9 (MMP-9) and plasminogen activator inhibitor- 1 proteins; free radical production; Masson's trichrome staining; fibronectin, MMP-9, and collagen 1a1 gene expression; EMT (identified by increased localized staining of a-smooth muscle actin and decreased staining of E-cadherin); total HDAC activity; and HDAC4 and Akt activation (P < 0.05). In Akt-deficient mice, the MV-augmented lung inflammation, profibrotic mediators, EMT profiles, Akt activation, and pathological fibrotic scores were reduced and pharmacologic inhibition of HDAC4 expression was triggered by TSA (P < 0.05). Conclusions Our data indicate that TSA treatment attenuates high-VT MV-augmented EMT after bleomycin- induced ALI, in part by inhibiting the HDAC4 and Akt pathways.	[Li, Li-Fu; Lee, Chung-Shu; Lin, Chang-Wei; Chen, Ning-Hung; Chuang, Li-Pang; Hung, Chen-Yiu] Chang Gung Mem Hosp, Dept Internal Med, Div Pulm & Crit Care Med, Taoyuan, Taiwan; [Li, Li-Fu; Lee, Chung-Shu; Lin, Chang-Wei; Chen, Ning-Hung; Chuang, Li-Pang; Hung, Chen-Yiu] Chang Gung Univ, Taoyuan, Taiwan; [Li, Li-Fu; Chen, Ning-Hung] Chang Gung Mem Hosp, Dept Resp Therapy, Taoyuan, Taiwan; [Liu, Yung-Yang] Taipei Vet Gen Hosp, Chest Dept, Taipei, Taiwan; [Liu, Yung-Yang] Natl Yang Ming Univ, Sch Med, Inst Clin Med, Taipei, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University	Liu, YY (corresponding author), Taipei Vet Gen Hosp, Chest Dept, Taipei, Taiwan.; Liu, YY (corresponding author), Natl Yang Ming Univ, Sch Med, Inst Clin Med, Taipei, Taiwan.	yyliu1103@gmail.com	Chuang, Li-Pang/L-8929-2019	Chuang, Li-Pang/0000-0001-5466-8995	Ministry of Science and Technology [105-2314-B-182A-091-MY2]; Chang Gung Medical Research Project [CMRPG3E1712]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Chang Gung Medical Research Project	This research was supported by the Ministry of Science and Technology (https://www.most.gov.tw) (105-2314-B-182A-091-MY2; to LFL) and Chang Gung Medical Research Project (https://www.cgmh.org.tw) (CMRPG3E1712; to CSL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backs J, 2008, MOL CELL BIOL, V28, P3437, DOI 10.1128/MCB.01611-07; Barnes PJ, 2005, EUR RESPIR J, V25, P552, DOI 10.1183/09031936.05.00117504; Blanchard F, 2005, DRUG DISCOV TODAY, V10, P197, DOI 10.1016/S1359-6446(04)03309-4; Burnham EL, 2014, EUR RESPIR J, V43, P276, DOI 10.1183/09031936.00196412; Cabrera-Benitez NE, 2014, ANESTHESIOLOGY, V121, P189, DOI 10.1097/ALN.0000000000000264; Cabrera-Benitez NE, 2012, CRIT CARE MED, V40, P510, DOI 10.1097/CCM.0b013e31822f09d7; Cetinkaya M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126028; Chen X, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.416; Cho H, 2001, J BIOL CHEM, V276, P38349, DOI 10.1074/jbc.C100462200; Craig VJ, 2015, AM J RESP CELL MOL, V53, P585, DOI 10.1165/rcmb.2015-0020TR; Davies ER, 2012, AM J RESP CELL MOL, V46, P687, DOI 10.1165/rcmb.2011-0040OC; Ding L, 2012, THERIOGENOLOGY, V78, P784, DOI 10.1016/j.theriogenology.2012.03.026; Fischle W, 2002, MOL CELL, V9, P45, DOI 10.1016/S1097-2765(01)00429-4; Ghosh AK, 2007, BIOCHEM BIOPH RES CO, V354, P420, DOI 10.1016/j.bbrc.2006.12.204; Glenisson W, 2007, BBA-MOL CELL RES, V1773, P1572, DOI 10.1016/j.bbamcr.2007.05.016; Gregoretti IV, 2004, J MOL BIOL, V338, P17, DOI 10.1016/j.jmb.2004.02.006; Guo WC, 2009, AM J PHYSIOL-LUNG C, V297, pL864, DOI 10.1152/ajplung.00128.2009; Heise RL, 2011, J BIOL CHEM, V286, P17435, DOI 10.1074/jbc.M110.137273; Huber LC, 2007, ARTHRITIS RHEUM, V56, P2755, DOI 10.1002/art.22759; Ichikado K, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000545; Jin GY, 2012, EUR J RADIOL, V81, P1901, DOI 10.1016/j.ejrad.2010.12.061; Kaimori A, 2010, HEPATOLOGY, V52, P1033, DOI 10.1002/hep.23765; Korfei M, 2015, THORAX, V70, P1022, DOI 10.1136/thoraxjnl-2014-206411; Li LF, 2014, LAB INVEST, V94, P1017, DOI 10.1038/labinvest.2014.75; Li LF, 2013, CHEST, V143, P1252, DOI 10.1378/chest.12-2058; Li LF, 2008, CRIT CARE, V12, DOI 10.1186/cc6983; Li LF, 2007, CRIT CARE, V11, DOI 10.1186/cc6101; Lien SC, 2006, CELL SIGNAL, V18, P1270, DOI 10.1016/j.cellsig.2005.10.013; Linnerth-Petrik NM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094595; Liu RM, 2008, ANTIOXID REDOX SIGN, V10, P303, DOI 10.1089/ars.2007.1903; Mani SK, 2015, AM J PHYSIOL-HEART C, V308, pH1391, DOI 10.1152/ajpheart.00390.2014; Marshall RP, 2000, AM J RESP CRIT CARE, V162, P1783, DOI 10.1164/ajrccm.162.5.2001061; Niki T, 1999, HEPATOLOGY, V29, P858, DOI 10.1002/hep.510290328; Ota C, 2015, EXP LUNG RES, V41, P422, DOI 10.3109/01902148.2015.1060275; Pang MY, 2010, J PHARMACOL EXP THER, V335, P266, DOI 10.1124/jpet.110.168385; Park IH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162058; Pelosi P, 2008, INTENS CARE MED, V34, P631, DOI 10.1007/s00134-007-0964-9; Peter JV, 2008, BMJ-BRIT MED J, V336, P1006, DOI 10.1136/bmj.39537.939039.BE; Rahman I, 2004, BIOCHEM PHARMACOL, V68, P1255, DOI 10.1016/j.bcp.2004.05.042; Rombouts K, 2001, ACTA GASTRO-ENT BELG, V64, P239; Ruan SY, 2014, CRIT CARE, V18, DOI 10.1186/cc13819; Sanders YY, 2014, EUR RESPIR J, V43, P1448, DOI 10.1183/09031936.00095113; Steinberg KP, 2006, NEW ENGL J MED, V354, P1671; Sweet MJ, 2012, IMMUNOL CELL BIOL, V90, P14, DOI 10.1038/icb.2011.88; Takebe M, 2014, J SURG RES, V187, P559, DOI 10.1016/j.jss.2013.10.050; Tan ZX, 2016, TOXICOL LETT, V240, P161, DOI 10.1016/j.toxlet.2015.10.022; Villar J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023914; Vittal R, 2005, AM J PATHOL, V166, P367, DOI 10.1016/S0002-9440(10)62260-2; Wang Z, 2009, EUR RESPIR J, V34, P145, DOI 10.1183/09031936.00084808; Ye Q, 2014, SARCOIDOSIS VASC DIF, V31, P219; Yoshikawa M, 2007, J AM SOC NEPHROL, V18, P58, DOI 10.1681/ASN.2005111187; Zhang R, 2015, AM J RESP CRIT CARE, V192, P315, DOI 10.1164/rccm.201412-2326OC; Zhang Y, 2014, AM J PHYSIOL-LUNG C, V307, pL173, DOI 10.1152/ajplung.00083.2014	53	13	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0172571	10.1371/journal.pone.0172571	http://dx.doi.org/10.1371/journal.pone.0172571			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5VB	28234968	Green Submitted, Green Published, gold			2022-12-27	WOS:000394688200095
J	Fan, MF; Zeng, ZG; Zio, E; Kang, R; Chen, Y				Fan, Mengfei; Zeng, Zhiguo; Zio, Enrico; Kang, Rui; Chen, Ying			A stochastic hybrid systems based framework for modeling dependent failure processes	PLOS ONE			English	Article							RISK-ASSESSMENT; RELIABILITY ASSESSMENT; DYNAMIC RELIABILITY; DEGRADATION; MAINTENANCE; SHOCKS; UNCERTAINTY; SUBJECT; PHYSICS; MODES	In this paper, we develop a framework to model and analyze systems that are subject to dependent, competing degradation processes and random shocks. The degradation processes are described by stochastic differential equations, whereas transitions between the system discrete states are triggered by random shocks. The modeling is, then, based on Stochastic Hybrid Systems (SHS), whose state space is comprised of a continuous state determined by stochastic differential equations and a discrete state driven by stochastic transitions and reset maps. A set of differential equations are derived to characterize the conditional moments of the state variables. System reliability and its lower bounds are estimated from these conditional moments, using the First Order Second Moment (FOSM) method and Markov inequality, respectively. The developed framework is applied to model three dependent failure processes from literature and a comparison is made to Monte Carlo simulations. The results demonstrate that the developed framework is able to yield an accurate estimation of reliability with less computational costs compared to traditional Monte Carlo-based methods.	[Fan, Mengfei; Kang, Rui; Chen, Ying] Beihang Univ, Sch Reliabil & Syst Engn, Beijing, Peoples R China; [Zeng, Zhiguo; Zio, Enrico] Univ Paris Saclay, Chair Syst Sci & Energy Challenge, Fdn Elect France EDF, Cent Supelec, Chatenay Malabry, France; [Zio, Enrico] Politecn Milan, Dept Energy, Milan, Italy	Beihang University; Electricite de France (EDF); UDICE-French Research Universities; Universite Paris Saclay; Polytechnic University of Milan	Zeng, ZG (corresponding author), Univ Paris Saclay, Chair Syst Sci & Energy Challenge, Fdn Elect France EDF, Cent Supelec, Chatenay Malabry, France.	zhiguo.zeng@centralesupelec.fr	, Zhiguo/I-8525-2019	, Zhiguo/0000-0003-4937-4380; Fan, Mengfei/0000-0002-7713-7625	National Natural Science Foundation of China [61573043, 71671009]; China Scholarship Council [201606020082]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Scholarship Council(China Scholarship Council)	RK and ZZ received funding from the National Natural Science Foundation of China (https://isisn.nsfc.gov.cn/egrantweb/) under grant number 61573043 and 71671009, respectively. MF received funding from the China Scholarship Council (http://www.csc.edu.cn/), No. 201606020082. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abate A, 2008, AUTOMATICA, V44, P2724, DOI 10.1016/j.automatica.2008.03.027; Bagdonavicius V, 2004, LIFETIME DATA ANAL, V10, P65, DOI 10.1023/B:LIDA.0000019256.59372.63; Bjerga T, 2014, RELIAB ENG SYST SAFE, V125, P46, DOI 10.1016/j.ress.2014.01.014; Castro IT, 2011, MATH COMPUT MODEL, V54, P598, DOI 10.1016/j.mcm.2011.03.003; Cha JH, 2011, J APPL PROBAB, V48, P258, DOI 10.1239/jap/1300198148; Chiacchio F, 2016, RELIAB ENG SYST SAFE, V149, P1, DOI 10.1016/j.ress.2015.12.007; Dhople SV, 2014, RELIAB ENG SYST SAFE, V123, P158, DOI 10.1016/j.ress.2013.10.011; Fan JJ, 2000, J APPL PROBAB, V37, P521, DOI 10.1017/S0021900200015709; Fan M., 2015, P 25 EUR SAF REL C E, P4407; Guo CM, 2013, RELIAB ENG SYST SAFE, V111, P183, DOI 10.1016/j.ress.2012.10.015; Hespanha JP, 2006, IEE P-CONTR THEOR AP, V153, P520, DOI 10.1049/ip-cta:20050088; Hespanha JP, 2005, NONLINEAR ANAL-THEOR, V62, P1353, DOI 10.1016/j.na.2005.01.112; Hespanha JP, 2004, LECT NOTES COMPUT SC, V2993, P387; Huynh KT, 2012, EUR J OPER RES, V218, P140, DOI 10.1016/j.ejor.2011.10.025; Huynh KT, 2011, RELIAB ENG SYST SAFE, V96, P497, DOI 10.1016/j.ress.2010.12.018; Jiang L, 2015, IIE TRANS, V47, P460, DOI 10.1080/0740817X.2014.955152; Jiang L, 2012, IEEE T RELIAB, V61, P932, DOI 10.1109/TR.2012.2221016; Jin G, 2013, ENG FAIL ANAL, V28, P222, DOI 10.1016/j.engfailanal.2012.10.027; Kang R, 2016, CHINESE J AERONAUT, V29, P571, DOI 10.1016/j.cja.2016.04.004; Klutke GA, 2002, IEEE T RELIAB, V51, P371, DOI 10.1109/TR.2002.802891; Kuniewski SP, 2009, RELIAB ENG SYST SAFE, V94, P1480, DOI 10.1016/j.ress.2008.11.013; Labeau PE, 2000, RELIAB ENG SYST SAFE, V68, P219, DOI 10.1016/S0951-8320(00)00017-X; Lando D., 1998, REV DERIV RES, V2, P99, DOI DOI 10.1007/BF01531332; Lawless J, 2004, LIFETIME DATA ANAL, V10, P213, DOI 10.1023/B:LIDA.0000036389.14073.dd; LEMOINE AJ, 1985, NAV RES LOG, V32, P497, DOI 10.1002/nav.3800320312; Lin YH, 2015, IEEE T FUZZY SYST, V23, P1428, DOI 10.1109/TFUZZ.2014.2362145; Lin YH, 2015, IEEE T RELIAB, V64, P154, DOI 10.1109/TR.2014.2354874; McPherson J.W, 2013, RELIABILITY PHYS ENG; Nilsen T, 2003, RELIAB ENG SYST SAFE, V79, P309, DOI 10.1016/S0951-8320(02)00239-9; Pan DH, 2016, NEUROCOMPUTING, V185, P64, DOI 10.1016/j.neucom.2015.12.041; Peng H, 2011, IIE TRANS, V43, P12, DOI 10.1080/0740817X.2010.491502; Peng WW, 2015, IEEE T RELIAB, V64, P1367, DOI 10.1109/TR.2015.2443858; Castaneda GAP, 2011, P I MECH ENG O-J RIS, V225, P28, DOI 10.1177/1748006XJRR312; Pishro-Nik H., 2014, INTRO PROBABILITY ST; Pola G, 2003, STOCHASTIC HYBRID MO, P45; Rafiee K, 2014, IIE TRANS, V46, P483, DOI 10.1080/0740817X.2013.812270; SIU N, 1994, RELIAB ENG SYST SAFE, V43, P43, DOI 10.1016/0951-8320(94)90095-7; Teel AR, 2014, AUTOMATICA, V50, P2435, DOI 10.1016/j.automatica.2014.08.006; Wang WB, 2011, MICROELECTRON RELIAB, V51, P285, DOI 10.1016/j.microrel.2010.09.013; Wang YP, 2011, IEEE T RELIAB, V60, P770, DOI 10.1109/TR.2011.2167779; Yang H, 2016, NONLINEAR ANAL-HYBRI, V19, P26, DOI 10.1016/j.nahs.2015.07.004; Ye ZS, 2011, IEEE T RELIAB, V60, P246, DOI 10.1109/TR.2010.2103710; Ye ZS, 2014, TECHNOMETRICS, V56, P302, DOI 10.1080/00401706.2013.830074; Zeng ZG, 2016, CHINESE J AERONAUT, V29, P1294, DOI 10.1016/j.cja.2016.08.014; Zhao YG, 2001, STRUCT SAF, V23, P47, DOI 10.1016/S0167-4730(00)00027-8; Zio E, 2013, MONTE CARLO SIMULATI, DOI [10.1007/978-1-4471-4588-2, DOI 10.1007/978-1-4471-4588-2]	46	7	7	3	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2017	12	2							e0172680	10.1371/journal.pone.0172680	http://dx.doi.org/10.1371/journal.pone.0172680			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5SX	28231313	Green Submitted, gold, Green Published			2022-12-27	WOS:000394682400069
J	Kanmogne, GD; Qiu, F; Ntone, FE; Fonsah, JY; Njamnshi, DM; Kuate, CT; Doh, RF; Kengne, AM; Tagny, CT; Nchindap, E; Kenmogne, L; Mbanya, D; Cherner, M; Heaton, RK; Njamnshi, AK				Kanmogne, Georgette D.; Qiu, Fang; Ntone, Fealicien E.; Fonsah, Julius Y.; Njamnshi, Dora M.; Kuate, Callixte T.; Doh, Roland F.; Kengne, Anne M.; Tagny, Claude T.; Nchindap, Emilienne; Kenmogne, Leopoldine; Mbanya, Dora; Cherner, Mariana; Heaton, Robert K.; Njamnshi, Alfred K.			Depressive symptoms in HIV-infected and seronegative control subjects in Cameroon: Effect of age, education and gender	PLOS ONE			English	Article							INVENTORY-II; LOW-INCOME; BDI-II; PREVALENCE; PEOPLE; HEALTH; ADOLESCENTS; ANXIETY; RISK; UNEMPLOYMENT	Depression is a leading cause of HIV/ AIDS disease burden; it worsens health outcomes and quality of life. Addressing this problem requires accurate quantification of the extra burden of depression to HIV/ AIDS in a given population, and knowledge of the baseline depression prevalence in the general population. There has been no previous study of depression in the general Cameroonian population. The current study attempts to address that important need. We used the Beck Depression Inventory-II to assess the prevalence and severity of depressive symptoms in 270 HIV-infected and seronegative Cameroonians. Univariate analyses showed a trend toward higher depressive symptoms among cases, compared to controls ( p = 0.055), and among older subjects (> 40 years), compared to younger subjects ( <= 40 years) ( p = 0.059). Analysis of depression severity showed that 33.73% of cases had moderate-to-severe depressive symptoms, compared to 19.8% of controls ( p< 0.01). However, multivariable negative binomial regression analyses showed no effect of age, HIV status, CD4 levels, viral loads, ART, or opportunistic infections on the risk of depressive symptoms. Both univariate and multivariable regression analyses showed significantly higher risk of depressive symptoms among females compared to males; this was significant for both female controls and female cases. Female cases had significantly higher CD4 cell counts and lower viral loads, compared to males. Both univariate and multivariable regression analyses showed that lower education ( <= 10 years) was associated with increased risk of depressive symptoms. This study shows a high prevalence of depressive symptoms among seronegative controls and HIV-infected Cameroonians. Integrating care for mental disorders such as depression into primary health care and existing HIV/ AIDS treatmentprograms in Cameroon may improve the wellbeing of the general population and could lower the HIV/AIDS burden.	[Kanmogne, Georgette D.] Univ Nebraska Med Ctr, Coll Med, Dept Pharmacol & Expt Neurosci, Omaha, NE USA; [Qiu, Fang] Univ Nebraska Med Ctr, Coll Publ Hlth, Dept Biostat, Omaha, NE USA; [Ntone, Fealicien E.; Fonsah, Julius Y.; Kuate, Callixte T.; Tagny, Claude T.; Mbanya, Dora; Njamnshi, Alfred K.] Univ Yaounde I, Fac Med & Biomed Sci, Yaounde, Cameroon; [Fonsah, Julius Y.; Doh, Roland F.; Kengne, Anne M.; Njamnshi, Alfred K.] Yaounde Cent Hosp, Dept Neurol, Yaounde, Cameroon; [Njamnshi, Dora M.] Yaounde Cent Hosp, HIV Day Care Serv, Yaounde, Cameroon; [Tagny, Claude T.; Nchindap, Emilienne; Kenmogne, Leopoldine; Mbanya, Dora] Univ Yaounde, Teaching Hosp, Yaounde, Cameroon; [Cherner, Mariana] Univ Calif San Diego, Sch Med, HIV Neurobehav Res Ctr, San Diego, CA 92103 USA; [Heaton, Robert K.] Univ Calif San Diego, Sch Med, Dept Psychiat, San Diego, CA 92103 USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Yaounde I; University of Yaounde I; University of California System; University of California San Diego; University of California System; University of California San Diego	Kanmogne, GD (corresponding author), Univ Nebraska Med Ctr, Coll Med, Dept Pharmacol & Expt Neurosci, Omaha, NE USA.; Kanmogne, GD (corresponding author), Univ Nebraska Med Ctr, Coll Publ Hlth, Dept Biostat, Omaha, NE USA.	gkanmogne@unmc.edu	cherner, mariana/N-4810-2015	cherner, mariana/0000-0002-5479-7401; Kengne, Andre Pascal/0000-0002-5183-131X	National Institute of Health, National Institute of Mental Health [R01 MH094160]; Fogarty International Center; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH062512, R01MH094160] Funding Source: NIH RePORTER	National Institute of Health, National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by grants from the National Institute of Health, National Institute of Mental Health R01 MH094160, and the Fogarty International Center.; This work was supported by grants from the National Institute of Health, National Institute of Mental Health R01 MH094160, and the Fogarty International Center. We would like to thank Dr. Michel K. Mengnjo for critical reading of the manuscript, and all Cameroonian volunteers who participated in this study.	Adewuya AO, 2006, SOC PSYCH PSYCH EPID, V41, P674, DOI 10.1007/s00127-006-0068-9; Al-Maddah Esraa M, 2015, Sultan Qaboos Univ Med J, V15, pe78; Allavena C, 2016, AIDS BEHAV, V20, P339, DOI 10.1007/s10461-015-1160-5; Asangbeh SL, 2016, AIDS CARE, V28, P205, DOI 10.1080/09540121.2015.1074654; Atkinson JH, 2011, J AFFECT DISORDERS, V130, P421, DOI 10.1016/j.jad.2010.10.039; Barroso J, 2001, QUAL HEALTH RES, V11, P491, DOI 10.1177/104973201129119271; Beck A.T., 1996, PSYCHOL ASSESS, V10, DOI [10.1037/t00742-000, DOI 10.1037/T00742-000]; Bragard I, 2013, CANCER RADIOTHER, V17, P731, DOI 10.1016/j.canrad.2013.05.014; Charlson FJ, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-250; Chikezie UE, 2013, NIGER J CLIN PRACT, V16, P238, DOI 10.4103/1119-3077.110148; Corbiere M, 2011, CLIN J PAIN, V27, P62, DOI 10.1097/AJP.0b013e3181eef903; Cubero DI, 2015, J CANC ED; Cunningham S, 2008, J CAN ACAD CHILD ADO, V17, P137; Dal-Bo Marcio Jose, 2015, J Int Assoc Provid AIDS Care, V14, P136, DOI 10.1177/2325957413494829; Dawes S E, 2010, Int J Cult Ment Health, V3, P34; de Menil V, 2012, Ghana Med J, V46, P95; Demir F, 2007, TURK PSIKIYATR DERG, V18, P31; Eller LS, 2014, AIDS CARE, V26, P795, DOI 10.1080/09540121.2013.841842; Ferrari AJ, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001547; Gary FA, 2004, NURS RES, V53, P251, DOI 10.1097/00006199-200407000-00008; Gaynes BN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140001; Gaynes BN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041699; Gureje O, 2006, BRIT J PSYCHIAT, V188, P465, DOI 10.1192/bjp.188.5.465; Hainer BL, 1998, ACAD MED, V73, P1305, DOI 10.1097/00001888-199812000-00023; Hammond ER, 2016, J NEUROVIROL; Hsu J., 1996, MULTIPLE COMP THEORY; Judd FK, 2000, AUST NZ J PSYCHIAT, V34, P1015, DOI 10.1046/j.1440-1614.2000.00837.x; Kagee A, 2014, AIDS CARE, V26, P257, DOI 10.1080/09540121.2013.802278; Kagee A, 2010, AIDS CARE, V22, P159, DOI 10.1080/09540120903111445; Kanmogne GD, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-60; Kim MH, 2015, BMC PSYCHIATRY, V15, DOI 10.1186/s12888-015-0649-9; Kim MH, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18965; Kinyanda E, 2011, SOC PSYCH PSYCH EPID, V46, P35, DOI 10.1007/s00127-009-0164-8; KIRSLING RA, 1989, PSYCHOL REP, V65, P355, DOI 10.2466/pr0.1989.65.2.355; L'akoa RM, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-228; Lahlou-Laforet K, 2015, J AFFECT DISORDERS, V184, P256, DOI 10.1016/j.jad.2015.05.056; Legrand F, 2007, J SPORT EXERCISE PSY, V29, P348, DOI 10.1123/jsep.29.3.348; Marcotte D, 2014, CIENC SAUDE COLETIVA, V19, P785, DOI 10.1590/1413-81232014193.16072013; Mascaro N, 2007, J CLIN PSYCHOL, V63, P541, DOI 10.1002/jclp.20365; Mata DA, 2015, JAMA-J AM MED ASSOC, V314, P2373, DOI 10.1001/jama.2015.15845; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Nduna M, 2013, J CHILD ADOLESC MENT, V25, P43, DOI 10.2989/17280583.2012.731410; Nel A, 2013, AIDS CARE, V25, P948, DOI 10.1080/09540121.2012.748867; Nomoto SH, 2015, AIDS CARE, V27, P979, DOI 10.1080/09540121.2015.1017442; Ovuga E, 2005, SOC PSYCH PSYCH EPID, V40, P439, DOI 10.1007/s00127-005-0915-0; Peltzer K, 2013, GLOBAL HEALTH ACTION, V6, P1, DOI 10.3402/gha.v6i0.18871; Pence BW, 2014, AIDS BEHAV, V18, P1142, DOI 10.1007/s10461-014-0727-x; Pence BW, 2012, J AFFECT DISORDERS, V143, P208, DOI 10.1016/j.jad.2012.05.056; Pratt Laura A, 2014, NCHS Data Brief, P1; Reddy M S, 2010, Indian J Psychol Med, V32, P77, DOI 10.4103/0253-7176.78501; Reddy M S, 2010, Indian J Psychol Med, V32, P1, DOI 10.4103/0253-7176.70510; Reis RK, 2011, REV LAT-AM ENFERM, V19, P874, DOI 10.1590/S0104-11692011000400004; Rodriguez E, 1999, J EPIDEMIOL COMMUN H, V53, P335, DOI 10.1136/jech.53.6.335; Segal DL, 2008, BEHAV MODIF, V32, P3, DOI 10.1177/0145445507303833; Shimizu Sheri M, 2011, World J AIDS, V1, P139; Song JY, 2013, INFECT CHEMOTHER, V45, P211, DOI 10.3947/ic.2013.45.2.211; STEINERT Y, 1991, CAN FAM PHYSICIAN, V37, P2130; Silveira MPT, 2012, REV BRAS PSIQUIATR, V34, P162, DOI 10.1590/S1516-44462012000200008; Thapa SB, 2005, SOC PSYCH PSYCH EPID, V40, P78, DOI 10.1007/s00127-005-0855-8; Thapa SB, 2014, J PSYCHIAT, V17, DOI [10.4172/1994-8220.1000167, DOI 10.4172/1994-8220.1000167]; Tomlinson M, 2009, SAMJ S AFR MED J, V99, P368; UNDP, 2015, HUM DEV REP 2015 CAM; Velasquez-Perez L, 2013, GAC MED MEX, V149, P183; Waldman SV, 2009, ACAD PSYCHIATR, V33, P296, DOI 10.1176/appi.ap.33.4.296; Wang YP, 2013, CLINICS, V68, P1274, DOI 10.6061/clinics/2013(09)15; WHO, 2000, WOM MENT HLTH EV BAS; Whooley MA, 2002, ARCH INTERN MED, V162, P2614, DOI 10.1001/archinte.162.22.2614; World Health Organization, 2016, DEPR FACT SHEET; World Health Organization, 2008, GLOB BURD DIS 2004 U	69	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2017	12	2							e0171956	10.1371/journal.pone.0171956	http://dx.doi.org/10.1371/journal.pone.0171956			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL5SX	28231258	gold, Green Published, Green Submitted			2022-12-27	WOS:000394682400024
J	Wang, H; Xu, L; Fan, ZM; Liang, JF; Yan, ZX; Sun, ZH				Wang, Hui; Xu, Lei; Fan, Zhanming; Liang, Junfu; Yan, Zixu; Sun, Zhonghua			Clinical evaluation of new automatic coronary-specific best cardiac phase selection algorithm for single-beat coronary CT angiography	PLOS ONE			English	Article							COMPUTED TOMOGRAPHIC ANGIOGRAPHY; IMAGE QUALITY; ARTERY-DISEASE; HEART-RATE; RECONSTRUCTION; RADIATION	The aim of this study was to evaluate the workflow efficiency of a new automatic coronary-specific reconstruction technique (Smart Phase, GE Healthcare-SP) for selection of the best cardiac phase with least coronary motion when compared with expert manual selection (MS) of best phase in patients with high heart rate. A total of 46 patients with heart rates above 75 bpm who underwent single beat coronary computed tomography angiography (CCTA) were enrolled in this study. CCTA of all subjects were performed on a 256-detector row CT scanner (Revolution CT, GE Healthcare, Waukesha, Wisconsin, US). With the SP technique, the acquired phase range was automatically searched in 2% phase intervals during the reconstruction process to determine the optimal phase for coronary assessment, while for routine expert MS, reconstructions were performed at 5% intervals and a best phase was manually determined. The reconstruction and review times were recorded to measure the workflow efficiency for each method. Two reviewers subjectively assessed image quality for each coronary artery in the MS and SP reconstruction volumes using a 4-point grading scale. The average HR of the enrolled patients was 91.1 +/- 19.0bpm. A total of 204 vessels were assessed. The subjective image quality using SP was comparable to that of the MS, 1.45 +/- 0.85 vs 1.43 +/- 0.81 respectively (p = 0.88). The average time was 246 seconds for the manual best phase selection, and 98 seconds for the SP selection, resulting in average time saving of 148 seconds (60%) with use of the SP algorithm. The coronary specific automatic cardiac best phase selection technique (Smart Phase) improves clinical workflow in high heart rate patients and provides image quality comparable with manual cardiac best phase selection. Reconstruction of single-beat CCTA exams with SP can benefit the users with less experienced in CCTA image interpretation.	[Wang, Hui; Xu, Lei; Fan, Zhanming; Yan, Zixu] Capital Med Univ, Beijing Anzhen Hosp, Dept Radiol, Beijing, Peoples R China; [Liang, Junfu] Beijing Huairou Hosp, Dept Radiol, Beijing, Peoples R China; [Sun, Zhonghua] Curtin Univ, Dept Med Radiat Sci, Perth, WA, Australia	Capital Medical University; Curtin University	Xu, L (corresponding author), Capital Med Univ, Beijing Anzhen Hosp, Dept Radiol, Beijing, Peoples R China.	leixu2001@hotmail.com	Sun, Zhonghua/B-3125-2010; Sun, Zhonghua/N-1648-2019	Sun, Zhonghua/0000-0002-7538-4761; Sun, Zhonghua/0000-0002-7538-4761; wang, hui/0000-0002-8549-3398	Minstry of Science and Technology in china [2016YFC1300301]; Natural Science Foundation of China [81641069]; Minstry of science Foundation of china [81641069]	Minstry of Science and Technology in china; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Minstry of science Foundation of china	This work was supported by Grant from The Minstry of Science and Technology in china (2016YFC1300301) and Grant from Natural Science Foundation of China (grant 81641069).; We thank Dr.Lin Yang for assistance, Mengge Zhou for comments on statistical analysis. This work was supported by Grant from The Minstry of science Foundation of china (grant 81641069).	Achenbach S, 2012, J CARDIOVASC COMPUT, V6, P91, DOI 10.1016/j.jcct.2011.11.006; Aghayev A, 2016, EXPERT REV MED DEVIC, V13, P545, DOI 10.1080/17434440.2016.1184968; Alfakih K, 2015, EUR HEART J-CARD IMG, V16, P1187, DOI 10.1093/ehjci/jev224; Araoz PA, 2009, INT J CARDIOVAS IMAG, V25, P837, DOI 10.1007/s10554-009-9489-3; Arbab-Zadeh A, 2015, CIRC-CARDIOVASC IMAG, V8, DOI 10.1161/CIRCIMAGING.115.003533; Benz DC, 2016, J COMPUTER ASSISTED; Benz DC, 2016, ACAD RADIOL, V23, P1008, DOI 10.1016/j.acra.2016.03.015; Bowman AW, 2009, POL ARCH MED WEWN, V119, P381, DOI 10.20452/pamw.715; Chang SM, 2011, CURR OPIN CARDIOL, V26, P392, DOI 10.1097/HCO.0b013e32834938c6; Cho YJ, 2010, INT J CARDIOVAS IMAG, V26, P41, DOI 10.1007/s10554-009-9536-0; Fan LJ, 2015, J COMPUT ASSIST TOMO, V39, P202, DOI 10.1097/RCT.0000000000000193; Hamon M, 2007, RADIOLOGY, V245, P720, DOI 10.1148/radiol.2453061899; Lee Susanna I, 2006, J Am Coll Radiol, V3, P560, DOI 10.1016/j.jacr.2006.02.034; Oda S, 2015, ACTA RADIOL, V56, P1308, DOI 10.1177/0284185114555152; Ruzsics B, 2009, EUR RADIOL, V19, P1906, DOI 10.1007/s00330-009-1368-8; Shaw LJ, 2012, J AM COLL CARDIOL, V60, P2103, DOI 10.1016/j.jacc.2012.05.062; Sheta HM, 2016, CLIN IMAG, V40, P217, DOI 10.1016/j.clinimag.2015.10.007; Shuman WP, 2008, RADIOLOGY, V248, P431, DOI 10.1148/radiol.2482072192; Stassi D, 2016, MED PHYS, V43, P324, DOI 10.1118/1.4938265; Wang G, 2016, EXP THER MED, V11, P1937, DOI 10.3892/etm.2016.3150	20	6	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2017	12	2							e0172686	10.1371/journal.pone.0172686	http://dx.doi.org/10.1371/journal.pone.0172686			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5SX	28231322	Green Published, Green Submitted, gold			2022-12-27	WOS:000394682400072
J	Li, L; Sawashita, J; Ding, X; Yang, M; Xu, Z; Miyahara, H; Mori, M; Higuchi, K				Li, Lin; Sawashita, Jinko; Ding, Xin; Yang, Mu; Xu, Zhe; Miyahara, Hiroki; Mori, Masayuki; Higuchi, Keiichi			Caloric restriction reduces the systemic progression of mouse AApoAII amyloidosis	PLOS ONE			English	Article							APOLIPOPROTEIN-A-II; SENESCENCE-ACCELERATED MOUSE; HIGH-DENSITY-LIPOPROTEINS; LIFE-SPAN EXTENSION; STOP-CODON MUTATION; SENILE AMYLOIDOSIS; APOA-II; ALZHEIMERS-DISEASE; INBRED STRAINS; MICE	In mouse senile amyloidosis, apolipoprotein (Apo) A-II is deposited extracellularly in many organs in the form of amyloid fibrils (AApoAII). Reduction of caloric intake, known as caloric restriction (CR), slows the progress of senescence and age-related disorders in mice. In this study, we intravenously injected 1 mu g of isolated AApoAII fibrils into R1. P1-Apoa2c mice to induce experimental amyloidosis and investigated the effects of CR for the next 16 weeks. In the CR group, AApoAII amyloid deposits in the liver, tongue, small intestine and skin were significantly reduced compared to those of the ad libitum feeding group. CR treatment led to obvious reduction in body weight, improvement in glucose metabolism and reduction in the plasma concentration of ApoA-II. Our molecular biological analyses of the liver suggested that CR treatment might improve the symptoms of inflammation, the unfolded protein response induced by amyloid deposits and oxidative stress. Furthermore, we suggest that CR treatment might improve mitochondrial functions via the sirtuin 1-peroxisome proliferator- activated receptor. coactivator 1 alpha (SIRT1-PGC-1 alpha) pathway. We suggest that CR is a promising approach for treating the onset and/or progression of amyloidosis, especially for systemic amyloidosis such as senile AApoAII amyloidosis. Our analysis of CR treatment for amyloidosis should provide useful information for determining the cause of amyloidosis and developing effective preventive treatments.	[Li, Lin; Sawashita, Jinko; Ding, Xin; Yang, Mu; Xu, Zhe; Miyahara, Hiroki; Mori, Masayuki; Higuchi, Keiichi] Shinshu Univ, Grad Sch Med, Inst Pathogenesis & Dis Prevent, Dept Aging Biol, Matsumoto, Nagano, Japan; [Sawashita, Jinko; Higuchi, Keiichi] Shinshu Univ, Dept Biol Sci Intractable Neurol Dis, Inst Biomed Sci, Interdisciplinary Cluster Cutting Edge Res, Matsumoto, Nagano, Japan; [Mori, Masayuki] Shinshu Univ, Dept Adv Med Hlth Promot, Inst Biomed Sci, Interdisciplinary Cluster Cutting Edge Res, Matsumoto, Nagano, Japan	Shinshu University; Shinshu University; Shinshu University	Sawashita, J (corresponding author), Shinshu Univ, Grad Sch Med, Inst Pathogenesis & Dis Prevent, Dept Aging Biol, Matsumoto, Nagano, Japan.; Sawashita, J (corresponding author), Shinshu Univ, Dept Biol Sci Intractable Neurol Dis, Inst Biomed Sci, Interdisciplinary Cluster Cutting Edge Res, Matsumoto, Nagano, Japan.	jinkos@shinshu-u.ac.jp		Sawashita, Jinko/0000-0001-8016-6649	Ministry of Education, Culture, Sports, Science, and Technology of Japan [23390093, 26293084, 24500849, 26670152]; Intractable Disease Division, the Ministry of Health, Labor, and Welfare	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Intractable Disease Division, the Ministry of Health, Labor, and Welfare	This research was supported by Grants-in-Aid for Scientific Research (B) (23390093 and 26293084) (KH), Scientific Research (C) (24500849) (JS), and Challenging Exploratory Research (26670152) (KH) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, and by grants (KH) from the Intractable Disease Division, the Ministry of Health, Labor, and Welfare to the Research Committees for Amyloidosis, Japan.	Alwaili K, 2012, BBA-MOL CELL BIOL L, V1821, P405, DOI 10.1016/j.bbalip.2011.07.013; Anderson RM, 2009, TOXICOL PATHOL, V37, P47, DOI 10.1177/0192623308329476; Baumeier C, 2015, BBA-MOL CELL BIOL L, V1851, P566, DOI 10.1016/j.bbalip.2015.01.013; Benson MD, 2001, GENOMICS, V72, P272, DOI 10.1006/geno.2000.6499; Blanco-Vaca F, 2001, J LIPID RES, V42, P1727; Bonda DJ, 2011, LANCET NEUROL, V10, P275, DOI 10.1016/S1474-4422(11)70013-8; Buxbaum JN, 2012, J MOL BIOL, V421, P142, DOI 10.1016/j.jmb.2012.01.024; Castellani LW, 1997, J CLIN INVEST, V100, P464, DOI 10.1172/JCI119554; Chen X, 2015, SCI REP-UK, V5, DOI 10.1038/srep12115; Chiba T, 1999, AM J PATHOL, V155, P1319, DOI 10.1016/S0002-9440(10)65234-0; Cho MH, 2014, AUTOPHAGY, V10, P1761, DOI 10.4161/auto.29647; Chung KW, 2013, EXP GERONTOL, V48, P1049, DOI 10.1016/j.exger.2012.11.007; Ferreira N, 2016, SCI REP-UK, V6, DOI 10.1038/srep26623; Fontana L, 2004, P NATL ACAD SCI USA, V101, P6659, DOI 10.1073/pnas.0308291101; Fontana L, 2015, CELL, V161, P106, DOI 10.1016/j.cell.2015.02.020; FORTE TM, 1995, J LIPID RES, V36, P148; Fu XY, 2004, FEBS LETT, V563, P179, DOI 10.1016/S0014-5793(04)00295-9; Ge FX, 2007, LAB INVEST, V87, P633, DOI 10.1038/labinvest.3700559; Guarente L, 2013, GENE DEV, V27, P2072, DOI 10.1101/gad.227439.113; Hanzen S, 2016, CELL, V166, P140, DOI 10.1016/j.cell.2016.05.006; HIGUCHI K, 1991, BIOCHEM J, V279, P427, DOI 10.1042/bj2790427; HIGUCHI K, 1995, LAB INVEST, V72, P75; Higuchi K, 1998, LAB INVEST, V78, P1535; HIGUCHI K, 1986, J BIOL CHEM, V261, P2834; HIGUCHI K, 1991, VIRCHOWS ARCH B, V60, P231, DOI 10.1007/BF02899551; Jadiya P, 2011, BIOCHEM BIOPH RES CO, V413, P306, DOI 10.1016/j.bbrc.2011.08.092; Karunadharma PP, 2015, AGING CELL, V14, P547, DOI 10.1111/acel.12317; Kisilevsky R, 2007, AMYLOID, V14, P21, DOI 10.1080/13506120601116419; Kitagawa K, 2003, AMYLOID, V10, P207, DOI 10.3109/13506120309041737; KOHNO A, 1985, J NUTR, V115, P1259, DOI 10.1093/jn/115.10.1259; Korenaga T, 2006, AM J PATHOL, V168, P898, DOI 10.2353/ajpath.2006.050350; Lee HR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134486; Levine B, 2005, CELL, V120, P159, DOI 10.1016/j.cell.2005.01.005; Luchsinger JA, 2002, ARCH NEUROL-CHICAGO, V59, P1258, DOI 10.1001/archneur.59.8.1258; Lundmark K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079104; Luo HM, 2015, LAB INVEST, V95, P320, DOI 10.1038/labinvest.2014.158; Macedo B, 2010, PHARMACOL RES, V62, P514, DOI 10.1016/j.phrs.2010.08.001; Madeo F, 2015, J CLIN INVEST, V125, P85, DOI 10.1172/JCI73946; Maesako M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131199; Mattison JA, 2012, NATURE, V489, P318, DOI 10.1038/nature11432; Mercken EM, 2014, AGING CELL, V13, P193, DOI 10.1111/acel.12151; Merlini G, 2003, NEW ENGL J MED, V349, P583, DOI 10.1056/NEJMra023144; Mihara M, 2004, J RHEUMATOL, V31, P1132; Morten IJ, 2007, J BIOL CHEM, V282, P29691, DOI 10.1074/jbc.M705004200; NAIKI H, 1988, AM J PATHOL, V130, P579; Pasinetti GM, 2008, J NEUROCHEM, V106, P1503, DOI 10.1111/j.1471-4159.2008.05454.x; Paulsson JF, 2006, DIABETOLOGIA, V49, P1237, DOI 10.1007/s00125-006-0206-7; Pomin VH, 2015, EUR J MED CHEM, V92, P353, DOI 10.1016/j.ejmech.2015.01.002; PRAS M, 1969, J EXP MED, V130, P777, DOI 10.1084/jem.130.4.777; Pyo JO, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3300; Qian JZ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000914; Qin WP, 2006, J ALZHEIMERS DIS, V10, P417; Qin WP, 2006, J BIOL CHEM, V281, P21745, DOI 10.1074/jbc.M602909200; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Sauvaget D, 2004, DIABETES, V53, P672, DOI 10.2337/diabetes.53.3.672; Sawashita J, 2015, P NATL ACAD SCI USA, V112, pE836, DOI 10.1073/pnas.1416363112; Schafer MJ, 2015, NEUROBIOL AGING, V36, P1293, DOI 10.1016/j.neurobiolaging.2014.10.043; Selman C, 2006, PHYSIOL GENOMICS, V27, P187, DOI 10.1152/physiolgenomics.00084.2006; Simons JP, 2013, P NATL ACAD SCI USA, V110, P16115, DOI 10.1073/pnas.1306621110; Sipe JD, 2014, AMYLOID, V21, P221, DOI 10.3109/13506129.2014.964858; Standard J, 2014, J NUTR BIOCHEM, V25, P1317, DOI 10.1016/j.jnutbio.2014.07.010; Thompson ACS, 2016, AGING CELL, V15, P118, DOI 10.1111/acel.12414; Tian G, 2014, ANTIOXID REDOX SIGN, V20, P2606, DOI 10.1089/ars.2013.5406; Umezawa M, 2003, J LIPID RES, V44, P762, DOI 10.1194/jlr.M200405-JLR200; Umezawa M, 2009, J GERONTOL A-BIOL, V64, P646, DOI 10.1093/gerona/glp047; van der Heijden RA, 2015, SCI REP-UK, V5, DOI 10.1038/srep16474; Walsh ME, 2014, FREE RADICAL BIO MED, V66, P88, DOI 10.1016/j.freeradbiomed.2013.05.037; Wang YY, 2011, J LIPID RES, V52, P1461, DOI 10.1194/jlr.M013235; Watroba M, 2016, ADV MED SCI-POLAND, V61, P52, DOI 10.1016/j.advms.2015.09.003; Wechalekar AD, 2016, LANCET, V387, P2641, DOI 10.1016/S0140-6736(15)01274-X; Westermark P, 2002, AMYLOID, V9, P197; Xing YM, 2002, J BIOL CHEM, V277, P33164, DOI 10.1074/jbc.M111570200; Xing YM, 2001, LAB INVEST, V81, P493, DOI 10.1038/labinvest.3780257; Yan JM, 2007, AM J PATHOL, V171, P172, DOI 10.2353/ajpath.2007.060576; Yazaki M, 2003, KIDNEY INT, V64, P11, DOI 10.1046/j.1523-1755.2003.00047.x; Zhang HY, 2006, FASEB J, V20, P1012, DOI 10.1096/fj.05-4890fje; Zhao L, 2013, BIOCHEMISTRY-US, V52, P1913, DOI 10.1021/bi301313b	77	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2017	12	2							e0172402	10.1371/journal.pone.0172402	http://dx.doi.org/10.1371/journal.pone.0172402			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5SK	28225824	gold, Green Published, Green Submitted			2022-12-27	WOS:000394680900040
J	Marconi, R; Strolin, S; Bossi, G; Strigari, L				Marconi, Raffaella; Strolin, Silvia; Bossi, Gianluca; Strigari, Lidia			A meta-analysis of the abscopal effect in preclinical models: Is the biologically effective dose a relevant physical trigger?	PLOS ONE			English	Article							RADIATION-INDUCED APOPTOSIS; SQUAMOUS-CELL CARCINOMA; IONIZING-RADIATION; LOCAL RADIOTHERAPY; CATALYTIC SUBUNIT; T-CELLS; BYSTANDER; RADIOSURGERY; EFFICACY; IMMUNOTHERAPY	Background Preclinical in vivo studies using small animals are considered crucial in translational cancer research and clinical implementation of novel treatments. This is of paramount relevance in radiobiology, especially for any technological developments permitted to deliver high doses in single or oligo-fractionated regimens, such as stereotactic ablative radiotherapy (SABR). In this context, clinical success in cancer treatment needs to be guaranteed, sparing normal tissue and preventing the potential spread of disease or local recurrence. In this work we introduce a new dose-response relationship based on relevant publications concerning preclinical models with regard to delivered dose, fractionation schedule and occurrence of biological effects on non-irradiated tissue, abscopal effects. Methods We reviewed relevant publications on murine models and the abscopal effect in radiation cancer research following PRISMA methodology. In particular, through a log-likelihood method, we evaluated whether the occurrence of abscopal effects may be related to the biologically effective dose (BED). To this aim, studies accomplished with different tumor histotypes were considered in our analysis including breast, colon, lung, fibrosarcoma, pancreas, melanoma and head and neck cancer. For all the tumors, the alpha/beta ratio was assumed to be 10 Gy, as generally adopted for neoplastic cells. Results Our results support the hypothesis that the occurrence rate of abscopal effects in preclinical models increases with BED. In particular, the probability of revealing abscopal effects is 50% when a BED of 60 Gy is generated. Conclusion Our study provides evidence that SABR treatments associated with high BEDs could be considered an effective strategy in triggering the abscopal effect, thus shedding light on the promising outcomes revealed in clinical practice.	[Marconi, Raffaella; Strolin, Silvia; Bossi, Gianluca; Strigari, Lidia] Regina Elena Inst Canc Res, Lab Med Phys & Expert Syst, Rome, Italy; [Bossi, Gianluca] Regina Elena Inst Canc Res, Translat Res Area, Rome, Italy	IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena	Marconi, R; Strigari, L (corresponding author), Regina Elena Inst Canc Res, Lab Med Phys & Expert Syst, Rome, Italy.	raffaella.marconi@gmail.com; lidia.strigari@ifo.gov.it	Strolin, Silvia/AAC-3716-2022; Strigari, Lidia/B-9352-2017; Bossi, Gianluca/B-9394-2017; Bossi, Gianluca/ABH-6846-2020; Marconi, Raffaella/K-4050-2016	Strigari, Lidia/0000-0003-4293-2298; Bossi, Gianluca/0000-0002-2947-1063; Bossi, Gianluca/0000-0002-2947-1063; Marconi, Raffaella/0000-0002-5678-6861	TOP IMPLART project [I11J10000420002]; Fondazione Umberto Veronesi Fellowship	TOP IMPLART project; Fondazione Umberto Veronesi Fellowship(Fondazione Umberto Veronesi)	This study was supported by grant from the TOP IMPLART project (I11J10000420002) and Fondazione Umberto Veronesi Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akutsu Y, 2007, INT J ONCOL, V31, P509; Aneja S, 2014, SEMIN RADIAT ONCOL, V24, P35, DOI 10.1016/j.semradonc.2013.08.004; Asur R, 2015, CANCER LETT, V356, P52, DOI 10.1016/j.canlet.2013.10.032; Basu D, 2009, CANCER BIOL THER, V8, P380, DOI 10.4161/cbt.8.4.7739; Belizario J., 2009, OPEN IMMUNOL J, V2, P79, DOI [10.2174/1874226200902010079, DOI 10.2174/1874226200902010079]; Bert C, 2014, PHYS MEDICA, V30, P535, DOI 10.1016/j.ejmp.2014.04.011; Blanquicett C, 2005, CLIN CANCER RES, V11, P8773, DOI 10.1158/1078-0432.CCR-05-0627; Blyth BJ, 2011, RADIAT RES, V176, P139, DOI 10.1667/RR2548.1; Bohnke A, 2004, INT J RADIAT BIOL, V80, P53, DOI 10.1080/09553000310001642902; Brown JM, 2014, INT J RADIAT ONCOL, V88, P254, DOI 10.1016/j.ijrobp.2013.07.022; Bumette B, 2015, SEMIN RADIAT ONCOL, V25, P40, DOI 10.1016/j.semradonc.2014.07.009; Butterworth KT, 2013, CLIN ONCOL-UK, V25, P586, DOI 10.1016/j.clon.2013.06.005; Camphausen K, 2003, CANCER RES, V63, P1990; Chai Y., 2008, ACTA MED NAGASAKI, V53, pS65; Chakravarty PK, 1999, CANCER RES, V59, P6028; Chandra RA, 2015, ONCOIMMUNOLOGY, V28, P4, DOI DOI 10.1080/2162402X; Corvo Renzo, 2015, Recenti Progressi in Medicina, V106, P322, DOI 10.1701/1940.21088; Crittenden M, 2015, SEMIN RADIAT ONCOL, V25, P54, DOI 10.1016/j.semradonc.2014.07.003; Demaria S, 2005, CLIN CANCER RES, V11, P728; Demaria S, 2004, INT J RADIAT ONCOL, V58, P862, DOI 10.1016/j.ijrobp.2003.09.012; Demaria S, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00128; Deng LF, 2014, J CLIN INVEST, V124, P687, DOI 10.1172/JCI67313; Dewan MZ, 2009, CLIN CANCER RES, V15, P5379, DOI 10.1158/1078-0432.CCR-09-0265; Formenti SC, 2009, LANCET ONCOL, V10, P718, DOI 10.1016/S1470-2045(09)70082-8; Fowler JF, 2010, BRIT J RADIOL, V83, P554, DOI 10.1259/bjr/31372149; FOWLER JF, 1989, BRIT J RADIOL, V62, P679, DOI 10.1259/0007-1285-62-740-679; Golden EB, 2015, LANCET ONCOL, V16, P795, DOI 10.1016/S1470-2045(15)00054-6; Golden EB, 2014, ONCOIMMUNOLOGY, V3, DOI 10.4161/onci.28133; Hellevik T, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00001; IKEHARA S, 1984, P NATL ACAD SCI-BIOL, V81, P886, DOI 10.1073/pnas.81.3.886; Kanegasaki S, 2014, CANCER RES, V74, P5070, DOI 10.1158/0008-5472.CAN-14-0551; Kataoka Takahiro, 2006, Physiological Chemistry and Physics and Medical NMR, V38, P21; Kaur P, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00191; Lee YJ, 2009, BLOOD, V114, P589, DOI 10.1182/blood-2009-02-206870; Lindsay KJ, 2007, BRIT J RADIOL, V80, pS2, DOI 10.1259/bjr/60507340; Lorimore SA, 2013, RADIAT RES, V179, P406, DOI 10.1667/RR3158.2; Lynch DH, 1997, NAT MED, V3, P625, DOI 10.1038/nm0697-625; McGarry CK, 2012, PHYS MED BIOL, V57, P6635, DOI 10.1088/0031-9155/57/20/6635; Metheetrairut C, 2013, CURR OPIN GENET DEV, V23, P12, DOI 10.1016/j.gde.2013.01.002; MOLE RH, 1953, BRIT J RADIOL, V26, P234, DOI 10.1259/0007-1285-26-305-234; Mori N, 2001, ONCOGENE, V20, P3609, DOI 10.1038/sj.onc.1204497; Ohba K, 1998, GUT, V43, P575, DOI 10.1136/gut.43.4.575; Park HJ, 2012, RADIAT RES, V177, P311, DOI 10.1667/RR2773.1; Prise KM, 2009, NAT REV CANCER, V9, P351, DOI 10.1038/nrc2603; Rastogi S, 2013, RADIAT RES, V179, P135, DOI 10.1667/RR2969.1; Reynders K, 2015, CANCER TREAT REV, V41, P503, DOI 10.1016/j.ctrv.2015.03.011; Rodgers BE, 2001, ENVIRON TOXICOL CHEM, V20, P2830, DOI 10.1002/etc.5620201223; Shiraishi K, 2008, CLIN CANCER RES, V14, P1159, DOI 10.1158/1078-0432.CCR-07-4485; Siva S, 2015, CANCER LETT, V356, P82, DOI 10.1016/j.canlet.2013.09.018; Sologuren I, 2014, TRANSL CANCER RES, V3, P18, DOI 10.3978/j.issn.2218-676X.2014.02.05; Song CW, 2013, INT J RADIAT ONCOL, V87, P18, DOI 10.1016/j.ijrobp.2013.03.013; Sperduto PW, 2015, INT J RADIAT ONCOL, V91, P11, DOI 10.1016/j.ijrobp.2014.08.355; Staffurth J, 2010, CLIN ONCOL-UK, V22, P643, DOI 10.1016/j.clon.2010.06.013; Strigari L, 2008, PHYS MED BIOL, V53, P5257, DOI 10.1088/0031-9155/53/19/001; Strigari L, 2016, CRIT REV ONCOL HEMAT, V102, P101, DOI 10.1016/j.critrevonc.2016.04.004; Strigari L, 2015, INT J RADIAT BIOL, V91, P294, DOI 10.3109/09553002.2014.997514; Teitz-Tennenbaum S, 2003, CANCER RES, V63, P8466; Wallace M, 2001, ONCOGENE, V20, P3597, DOI 10.1038/sj.onc.1204496; Yasuda K, 2011, CANCER SCI, V102, P1257, DOI 10.1111/j.1349-7006.2011.01940.x; Yu YJ, 2001, CANCER RES, V61, P1820	60	63	67	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2017	12	2							e0171559	10.1371/journal.pone.0171559	http://dx.doi.org/10.1371/journal.pone.0171559			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5QV	28222111	Green Submitted, gold, Green Published			2022-12-27	WOS:000394676800014
J	Tejada, MA; Hashem, N; Calloe, K; Klaerke, DA				Tejada, Maria A.; Hashem, Nadia; Calloe, Kirstine; Klaerke, Dan A.			Heteromeric Slick/Slack K+ channels show graded sensitivity to cell volume changes	PLOS ONE			English	Article							ACTIVATED POTASSIUM CHANNELS; SLACK; SLICK; MODULATION; PHYSIOLOGY; ISCHEMIA; ATP; NA+	Slick and Slack high-conductance K+ channels are found in the CNS, kidneys, pancreas, among other organs, where they play an important role in cell excitability as well as in ion transport processes. They are both activated by Na+ and Cl- but show a differential regulation by cell volume changes. Slick has been shown to be regulated by cell volume changes, whereas Slack is insensitive. alpha-subunits of these channels form homomeric as well as heteromeric channels. It is the aim of this work to explore whether the subunit composition of the Slick/Slack heteromeric channel affects the response to osmotic challenges. In order to provide with the adequate water permeability to the cell membrane of Xenopus laevis oocytes, mRNA of aquaporin 1 was co-expressed with homomeric or heteromeric Slick and Slack alpha-subunits. Oocytes were superfused with hypotonic or hypertonic buffers and changes in currents were measured by two-electrode voltage clamp. This work presents the first heteromeric K+ channel with a characteristic graded sensitivity to small and fast changes in cell volume. Our results show that the cell volume sensitivity of Slick/Slack heteromeric channels is dependent on the number of volume sensitive Slick alpha-subunits in the tetrameric channels, giving rise to graded cell volume sensitivity. Regulation of the subunit composition of a channel may constitute a novel mechanism to determine volume sensitivity of cells.	[Tejada, Maria A.; Hashem, Nadia; Calloe, Kirstine; Klaerke, Dan A.] Univ Copenhagen, Fac Hlth & Med Sci, Dept Physiol, IKVH, Frederiksberg C, Denmark	University of Copenhagen	Klaerke, DA (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Dept Physiol, IKVH, Frederiksberg C, Denmark.	dk@sund.ku.dk	Calloe, Kirstine/H-8643-2016	Calloe, Kirstine/0000-0002-1777-7938	Lund beck Foundation [R9-A1131]; Innovation Fund Denmark [5184000488]	Lund beck Foundation(Lundbeckfonden); Innovation Fund Denmark	This work was supported by grants from the Lund beck Foundation (grant ref. R9-A1131) and the Innovation Fund Denmark (grant ref. 5184000488). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Bhattacharjee A, 2005, TRENDS NEUROSCI, V28, P422, DOI 10.1016/j.tins.2005.06.003; Bhattacharjee A, 2003, J NEUROSCI, V23, P11681; Bhattacharjee A, 2002, J COMP NEUROL, V454, P241, DOI 10.1002/cne.10439; Brattacharjee A, 2005, J COMP NEUROL, V484, P80, DOI 10.1002/cne.20462; Brown MR, 2008, J PHYSIOL-LONDON, V586, P5161, DOI 10.1113/jphysiol.2008.160861; Budelli G, 2009, NAT NEUROSCI, V12, P745, DOI 10.1038/nn.2313; Chen HJ, 2009, J NEUROSCI, V29, P5654, DOI 10.1523/JNEUROSCI.5978-08.2009; COETZEE WA, 1992, CARDIOVASC DRUG THER, V6, P201, DOI 10.1007/BF00051140; Grunnet M, 2003, J PHYSIOL-LONDON, V549, P419, DOI 10.1113/jphysiol.2003.038455; Grunnet M, 2002, PFLUG ARCH EUR J PHY, V444, P167, DOI 10.1007/s00424-002-0782-4; Hage TA, 2012, J NEUROSCI, V32, P2714, DOI 10.1523/JNEUROSCI.5088-11.2012; Hayashi M, 2012, AM J PHYSIOL-CELL PH, V303, pC151, DOI 10.1152/ajpcell.00089.2012; Hoffmann EK, 2009, PHYSIOL REV, V89, P193, DOI 10.1152/physrev.00037.2007; Hougaard C, 2004, BBA-BIOMEMBRANES, V1660, P1, DOI 10.1016/j.bbamem.2003.11.015; Joiner WJ, 1998, NAT NEUROSCI, V1, P462, DOI 10.1038/2176; Nour-Eldin HH, 2010, METHODS MOL BIOL, V643, P185, DOI 10.1007/978-1-60761-723-5_13; Rizzi S, 2016, J COMP NEUROL, V524, P2093, DOI 10.1002/cne.23934; Santi CM, 2006, J NEUROSCI, V26, P5059, DOI 10.1523/JNEUROSCI.3372-05.2006; Soe R, 2009, NEUROSCI LETT, V457, P80, DOI 10.1016/j.neulet.2009.04.010; Tano JY, 2014, AM J PHYSIOL-HEART C, V307, pH811, DOI 10.1152/ajpheart.00319.2014; Tejada MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110833; Tejada MD, 2012, BIOCHEM BIOPH RES CO, V424, P208, DOI 10.1016/j.bbrc.2012.06.038; Voss FK, 2014, SCIENCE, V344, P634, DOI 10.1126/science.1252826; Yuan A, 2003, NEURON, V37, P765, DOI 10.1016/S0896-6273(03)00096-5	24	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2017	12	2							e0169914	10.1371/journal.pone.0169914	http://dx.doi.org/10.1371/journal.pone.0169914			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5QV	28222129	Green Published, gold, Green Submitted			2022-12-27	WOS:000394676800003
J	Hayes, HL; Peterson, BS; Haldeman, JM; Newgard, CB; Hohmeier, HE; Stephens, SB				Hayes, Heather L.; Peterson, Brett S.; Haldeman, Jonathan M.; Newgard, Christopher B.; Hohmeier, Hans E.; Stephens, Samuel B.			Delayed apoptosis allows islet beta-cells to implement an autophagic mechanism to promote cell survival	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; STIMULATED INSULIN-SECRETION; CYTOCHROME-C; ENDOGENOUS XIAP; PROLIFERATION; MITOPHAGY; DEATH; MASS; CARDIOMYOCYTES; RESISTANCE	Increased beta-cell death coupled with the inability to replicate existing beta-cells drives the decline in beta-cell mass observed in the progression of both major forms of diabetes. Understanding endogenous mechanisms of islet cell survival could have considerable value for the development of novel strategies to limit beta-cell loss and thereby promote beta-cell recovery. Insulinoma cells have provided useful insight into beta-cell death pathways but observations made in cell lines sometimes fail to translate to primary islets. Here, we report dramatic differences in the temporal regulation and engagement of the apoptotic program in primary rodent islets relative to the INS-1 derived 832/13 cell line. As expected, 832/13 cells rapidly induced cell stress markers in response to ER stress or DNA damage and were fully committed to apoptosis, resulting in >80% cell death within 24 h. In contrast, primary rat islets were largely refractory to cell death in response to ER stress and DNA damage, despite rapid induction of stress markers, such as XBP-1(s), CHOP, and PUMA. Gene expression profiling revealed a general suppression of pro-apoptotic machinery, such as Apaf-1 and caspase 3, and sustained levels of pro-survival factors, such as cIAP-1, cIAP-2, and XIAP, in rat islets. Furthermore, we observed sustained induction of autophagy following chronic ER stress and found that inhibition of autophagy rendered islet beta-cells highly vulnerable to ER stress-induced cell death. We propose that islet beta-cells dampen the apoptotic response to delay the onset of cell death, providing a temporal window in which autophagy can be activated to limit cellular damage and promote survival.	[Hayes, Heather L.; Peterson, Brett S.; Haldeman, Jonathan M.; Newgard, Christopher B.; Hohmeier, Hans E.; Stephens, Samuel B.] Duke Univ, Med Ctr, Sarah W Stedman Nutr & Metab Ctr, Durham, NC 27708 USA; [Peterson, Brett S.; Haldeman, Jonathan M.; Newgard, Christopher B.; Hohmeier, Hans E.; Stephens, Samuel B.] Duke Univ, Med Ctr, Duke Mol Physiol Inst, Durham, NC 27708 USA; [Peterson, Brett S.; Haldeman, Jonathan M.; Newgard, Christopher B.; Stephens, Samuel B.] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27708 USA; [Newgard, Christopher B.; Hohmeier, Hans E.] Duke Univ, Med Ctr, Dept Med, Div Endocrinol, Durham, NC USA; [Hayes, Heather L.] ZenBio Inc, Res Triangle Pk, NC USA; [Stephens, Samuel B.] Univ Iowa, Dept Internal Med, Fraternal Order Eagles Diabet Ctr, Iowa City, IA 52242 USA	Duke University; Duke University; Duke University; Duke University; University of Iowa	Stephens, SB (corresponding author), Duke Univ, Med Ctr, Sarah W Stedman Nutr & Metab Ctr, Durham, NC 27708 USA.; Stephens, SB (corresponding author), Duke Univ, Med Ctr, Duke Mol Physiol Inst, Durham, NC 27708 USA.; Stephens, SB (corresponding author), Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27708 USA.; Stephens, SB (corresponding author), Univ Iowa, Dept Internal Med, Fraternal Order Eagles Diabet Ctr, Iowa City, IA 52242 USA.	samuel-b-stephens@uiowa.edu		Stephens, Samuel/0000-0003-1152-2691; Haldeman, Jonathan/0000-0002-8270-7039	National Institutes of Health [DK099294]; American Heart Association [09POST2250151]; Juvenile Diabetes Research Foundation [17-2011-214, 17-2011-15]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007105, T32GM007184] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health K01 award (DK099294) and American Heart Association (09POST2250151) post-doctoral fellowship to SBS and a Juvenile Diabetes Research Foundation awards (17-2011-214) to HEH and (17-2011-15) to CBN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachar-Wikstrom E, 2013, DIABETES, V62, P1227, DOI 10.2337/db12-1474; Bartolome A, 2012, AUTOPHAGY, V8, P1757, DOI 10.4161/auto.21994; Butler AE, 2003, DIABETES, V52, P2304, DOI 10.2337/diabetes.52.9.2304; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; COMENS PG, 1987, DIABETES, V36, P963, DOI 10.2337/diabetes.36.8.963; Deshmukh M, 2000, J CELL BIOL, V150, P131, DOI 10.1083/jcb.150.1.131; Ebato C, 2008, CELL METAB, V8, P325, DOI 10.1016/j.cmet.2008.08.009; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; Hoshino A, 2014, P NATL ACAD SCI USA, V111, P3116, DOI 10.1073/pnas.1318951111; Hoyer-Hansen M, 2007, CELL DEATH DIFFER, V14, P1576, DOI 10.1038/sj.cdd.4402200; Jensen MV, 2013, J BIOL CHEM, V288, P23128, DOI 10.1074/jbc.M113.491654; Jung HS, 2008, CELL METAB, V8, P318, DOI 10.1016/j.cmet.2008.08.013; Kouroku Y, 2007, CELL DEATH DIFFER, V14, P230, DOI 10.1038/sj.cdd.4401984; Kushner JA, 2013, J CLIN INVEST, V123, P990, DOI 10.1172/JCI64095; Lavine JA, 2010, MOL ENDOCRINOL, V24, P464, DOI 10.1210/me.2009-0384; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Martino L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036188; Martinou I, 1999, J CELL BIOL, V144, P883, DOI 10.1083/jcb.144.5.883; Masini M, 2009, DIABETOLOGIA, V52, P1083, DOI 10.1007/s00125-009-1347-2; MILBURN JL, 1995, J BIOL CHEM, V270, P1295, DOI 10.1074/jbc.270.3.1295; Muoio DM, 2008, NAT REV MOL CELL BIO, V9, P193, DOI 10.1038/nrm2327; NABER SP, 1980, DIABETOLOGIA, V19, P439, DOI 10.1007/BF00281823; Ogata M, 2006, MOL CELL BIOL, V26, P9220, DOI 10.1128/MCB.01453-06; ORCI L, 1984, J CELL BIOL, V98, P222, DOI 10.1083/jcb.98.1.222; Potts MB, 2005, J CELL BIOL, V171, P925, DOI 10.1083/jcb.200504082; Potts PR, 2003, J CELL BIOL, V163, P789, DOI 10.1083/jcb.200307130; Quan W, 2012, DIABETOLOGIA, V55, P392, DOI 10.1007/s00125-011-2350-y; Quan W, 2012, EXP MOL MED, V44, P81, DOI 10.3858/emm.2012.44.2.030; Rankin MM, 2009, DIABETES, V58, P1365, DOI 10.2337/db08-1198; Rivera JF, 2014, J CLIN INVEST, V124, P3489, DOI 10.1172/JCI71981; Sanchis D, 2003, CELL DEATH DIFFER, V10, P977, DOI 10.1038/sj.cdd.4401267; Schisler JC, 2008, MOL CELL BIOL, V28, P3465, DOI 10.1128/MCB.01791-07; Seiler CY, 2014, NUCLEIC ACIDS RES, V42, pD1253, DOI 10.1093/nar/gkt1060; Shigihara N, 2014, J CLIN INVEST, V124, P3634, DOI 10.1172/JCI69866; Soleimanpour SA, 2015, DIABETES, V64, P3475, DOI 10.2337/db15-0376; Soleimanpour SA, 2014, CELL, V157, P1577, DOI 10.1016/j.cell.2014.05.016; Stephens SB, 2012, CELL METAB, V16, P33, DOI 10.1016/j.cmet.2012.05.011; Talchai C, 2012, CELL, V150, P1223, DOI 10.1016/j.cell.2012.07.029; Tschen SI, 2009, DIABETES, V58, P1312, DOI 10.2337/db08-1651; Walpita D, 2012, J BIOMOL SCREEN, V17, P509, DOI 10.1177/1087057111430253; Wright KM, 2007, J CELL BIOL, V179, P825, DOI 10.1083/jcb.200708086; Wright KM, 2006, CELL CYCLE, V5, P1616, DOI 10.4161/cc.5.15.3129; Wright KM, 2004, J CELL BIOL, V167, P303, DOI 10.1083/jcb.200406073; Yang YHC, 2013, J CELL SCI, V126, P4286, DOI 10.1242/jcs.133017	44	23	23	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2017	12	2							e0172567	10.1371/journal.pone.0172567	http://dx.doi.org/10.1371/journal.pone.0172567			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BI	28212395	Green Submitted, Green Published, gold			2022-12-27	WOS:000394424700060
J	Jannas-Vela, S; Roke, K; Boville, S; Mutch, DM; Spriet, LL				Jannas-Vela, Sebastian; Roke, Kaitlin; Boville, Stephanie; Mutch, David M.; Spriet, Lawrence L.			Lack of effects of fish oil supplementation for 12 weeks on resting metabolic rate and substrate oxidation in healthy young men: A randomized controlled trial	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; SKELETAL-MUSCLE METABOLISM; 24-H ENERGY-EXPENDITURE; INDIRECT CALORIMETRY; SEASONAL-VARIATION; VARIABILITY; ADULTS; EFFICIENCY; HUMANS	Fish oil (FO) has been shown to have beneficial effects in the body via incorporation into the membranes of many tissues. It has been proposed that omega-3 fatty acids in FO may increase whole body resting metabolic rate (RMR) and fatty acid (FA) oxidation in human subjects, but the results to date are equivocal. The purpose of this study was to investigate the effects of a 12 week FO supplementation period on RMR and substrate oxidation, in comparison to an olive oil (OO) control group, in young healthy males (n = 26; 22.8 +/- 2.6 yr). Subjects were matched for age, RMR, physical activity, VO2max and body mass, and were randomly separated into a group supplemented with either OO (3 g/d) or FO containing 2 g/d eicosapentaenoic acid (EPA) and 1 g/d docosahexaenoic acid (DHA). Participants visited the lab for RMR and substrate oxidation measurements after an overnight fast (10-12 hr) at weeks 0, 6 and 12. Fasted blood samples were taken at baseline and after 12 weeks of supplementation. There were significant increases in the EPA (413%) and DHA (59%) levels in red blood cells after FO supplementation, with no change of these fatty acids in the OO group. RMR and substrate oxidation did not change after supplementation with OO or FO after 6 and 12 weeks. Since there was no effect of supplementation on metabolic measures, we pooled the two treatment groups to determine whether there was a seasonal effect on RMR and substrate oxidation. During the winter season, there was an increase in FA oxidation (36%) with a concomitant decrease (34%) in carbohydrate (CHO) oxidation (p < 0.01), with no change in RMR. These measures were unaffected during the summer season. In conclusion, FO supplementation had no effect on RMR and substrate oxidation in healthy young males. Resting FA oxidation was increased and CHO oxidation reduced over a 12 week period in the winter, with no change in RMR.	[Jannas-Vela, Sebastian; Roke, Kaitlin; Boville, Stephanie; Mutch, David M.; Spriet, Lawrence L.] Univ Guelph, Dept Human Hlth & Nutr Sci, Guelph, ON, Canada	University of Guelph	Jannas-Vela, S (corresponding author), Univ Guelph, Dept Human Hlth & Nutr Sci, Guelph, ON, Canada.	sjannas@uoguelph.ca		Mutch, David/0000-0002-0908-7259	Natural Sciences and Engineering Research Council of Canada (NSERC) [03996, 371564]	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by Natural Sciences and Engineering Research Council of Canada (NSERC) (LLS - #03996 and DMM - #371564). Study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Aas V, 2006, J LIPID RES, V47, P366, DOI 10.1194/jlr.M500300-JLR200; Andersson A, 2002, AM J CLIN NUTR, V76, P1222, DOI 10.1093/ajcn/76.6.1222; Bader N, 2007, BR J NUTR, V94, P843; Baillie RA, 1999, PROSTAGLANDINS LEUKO, P351; Bortolotti M, 2007, CLIN NUTR, V26, P225, DOI 10.1016/j.clnu.2006.11.006; Calder P. C., 2015, BIOCHIM BIOPHYS ACTA, V1851, P469, DOI [10.1016/j.bbalip.2014.08.01025149823, DOI 10.1016/J.BBALIP.2014.08.010]; Calder PC, 2011, EUR J PHARMACOL, V668, pS50, DOI 10.1016/j.ejphar.2011.05.085; Clausen T, 2003, PHYSIOL REV, V83, P1269, DOI 10.1152/physrev.00011.2003; Couet C, 1997, INT J OBESITY, V21, P637, DOI 10.1038/sj.ijo.0800451; Donahoo WT, 2004, CURR OPIN CLIN NUTR, V7, P599, DOI 10.1097/00075197-200411000-00003; Fajardo VA, 2015, CHEM PHYS LIPIDS, V187, P56, DOI 10.1016/j.chemphyslip.2015.03.001; Gasic S, 1997, HORM METAB RES, V29, P12, DOI 10.1055/s-2007-978972; Geerling JJ, 2014, J LIPID RES, V55, P180, DOI 10.1194/jlr.R045013; Gerling CJ, 2014, APPL PHYSIOL NUTR ME, V39, P1083, DOI 10.1139/apnm-2014-0049; Haugen HA, 2003, AM J CLIN NUTR, V78, P1141, DOI 10.1093/ajcn/78.6.1141; Herbst E a F, 2014, J PHYSL, V00, P1; Hulbert AJ, 2007, LIPIDS, V42, P811, DOI 10.1007/s11745-007-3058-0; Jansky P, 2002, J THERM BIOL, V27, P269, DOI 10.1016/S0306-4565(01)00089-4; Jeromson S, 2015, MAR DRUGS, V13, P6977, DOI 10.3390/md13116977; Lalia AZ, 2015, DIABETES CARE, P1; Lanza IR, 2013, AM J PHYSIOL-ENDOC M, V304, pE1391, DOI 10.1152/ajpendo.00584.2012; Leonard WR, 2014, AM J HUM BIOL, V26, P437, DOI 10.1002/ajhb.22524; Logan SL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144828; McGlory C, 2014, PROSTAG LEUKOTR ESS, V90, P199, DOI 10.1016/j.plefa.2014.03.001; Merino DM, 2011, MOL GENET METAB, V103, P171, DOI 10.1016/j.ymgme.2011.02.012; MURGATROYD PR, 1987, BRIT J NUTR, V58, P347, DOI 10.1079/BJN19870104; Nagahuedi S, 2009, J EXP BIOL, V212, P1106, DOI 10.1242/jeb.027888; Nishimura T, 2015, J PHYSIOL ANTHROPOL, V34, DOI 10.1186/s40101-015-0051-9; Noreen EE, 2010, J INT SOC SPORT NUTR, V7, DOI 10.1186/1550-2783-7-31; PERONNET F, 1991, CAN J SPORT SCI, V16, P23; Plasqui G, 2003, AM J PHYSIOL-ENDOC M, V285, pE338, DOI 10.1152/ajpendo.00488.2002; Plourde M, 2007, APPL PHYSIOL NUTR ME, V32, P619, DOI 10.1139/H07-034; Power GW, 1997, J NUTR, V127, P2142, DOI 10.1093/jn/127.11.2142; Roffey DM, 2006, JPEN-PARENTER ENTER, V30, P426, DOI 10.1177/0148607106030005426; RUMPLER WV, 1990, AM J CLIN NUTR, V51, P147, DOI 10.1093/ajcn/51.2.147; Shaikh SR, 2015, CURR TOP MEMBR, V75, P209, DOI 10.1016/bs.ctm.2015.03.003; Smith GI, 2011, CLIN SCI, V121, P267, DOI 10.1042/CS20100597; Tosi F, 2014, ADV EXP MED BIOL, V824, P61, DOI 10.1007/978-3-319-07320-0_7; WARWICK PM, 1990, BRIT J NUTR, V63, P481, DOI 10.1079/BJN19900135; White MD, 1996, J APPL PHYSIOL, V80, P133, DOI 10.1152/jappl.1996.80.1.133; ZURLO F, 1990, J CLIN INVEST, V86, P1423, DOI 10.1172/JCI114857	41	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2017	12	2							e0172576	10.1371/journal.pone.0172576	http://dx.doi.org/10.1371/journal.pone.0172576			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BI	28212390	Green Published, gold, Green Submitted			2022-12-27	WOS:000394424700061
J	Ayton, DR; Barker, AL; Morello, RT; Brand, CA; Talevski, J; Landgren, FS; Melhem, MM; Bian, E; Brauer, SG; Hill, KD; Livingston, PM; Botti, M				Ayton, Darshini R.; Barker, Anna L.; Morello, Renata T.; Brand, Caroline A.; Talevski, Jason; Landgren, Fiona S.; Melhem, Mayer M.; Bian, Evelyn; Brauer, Sandra G.; Hill, Keith D.; Livingston, Patricia M.; Botti, Mari			Barriers and enablers to the implementation of the 6-PACK falls prevention program: A pre-implementation study in hospitals participating in a cluster randomised controlled trial	PLOS ONE			English	Article							ACUTE-CARE HOSPITALS; INJURIES; SINGAPORE; PROTOCOL	Evidence for effective falls prevention interventions in acute wards is limited. One reason for this may be suboptimal program implementation. This study aimed to identify perceived barriers and enablers of the implementation of the 6-PACK falls prevention program to inform the implementation in a randomised controlled trial. Strategies to optimise successful implementation of 6-PACK were also sought. A mixed-methods approach was applied in 24 acute wards from 6 Australian hospitals. Participants were nurses working on participating wards and senior hospital staff including Nurse Unit Managers; senior physicians; Directors of Nursing; and senior personnel involved in quality and safety or falls prevention. Information on barriers and enablers of 6-PACK implementation was obtained through surveys, focus groups and interviews. Questions reflected the COM-B framework that includes three behaviour change constructs of: capability, opportunity and motivation. Focus group and interview data were analysed thematically, and survey data descriptively. The survey response rate was 60% (420/702), and 12 focus groups (n = 96 nurses) and 24 interviews with senior staff were conducted. Capability barriers included beliefs that falls could not be prevented; and limited knowledge on falls prevention in patients with complex care needs (e.g. cognitive impairment). Capability enablers included education and training, particularly face to face case study based approaches. Lack of resources was identified as an opportunity barrier. Leadership, champions and using data to drive practice change were recognised as opportunity enablers. Motivation barriers included complacency and lack of ownership in falls prevention efforts. Motivation enablers included senior staff articulating clear goals and a commitment to falls prevention; and use of reminders, audits and feedback. The information gained from this study suggests that regular practical face-to-face education and training for nurses; provision of equipment; audit, reminders and feedback; leadership and champions; and the provision of falls data is key to successful falls prevention program implementation in acute hospitals.	[Ayton, Darshini R.; Barker, Anna L.; Morello, Renata T.; Brand, Caroline A.; Talevski, Jason; Melhem, Mayer M.; Bian, Evelyn] Monash Univ, Sch Publ Hlth & Prevent Med, Dept Epidemiol & Prevent Med, Melbourne, Vic, Australia; [Landgren, Fiona S.] Project Hlth, Cremorne, Vic, Australia; [Brauer, Sandra G.] Univ Queensland, Sch Hlth & Rehabil Sci, Div Physiotherapy, Brisbane, Qld, Australia; [Hill, Keith D.] Curtin Univ, Sch Physiotherapy & Exercise Sci, Bentley, WA, Australia; [Livingston, Patricia M.] Deakin Univ, Epworth Deakin Ctr Clin Nursing Res, Geelong, Vic 3217, Australia; [Botti, Mari] Deakin Univ, Sch Nursing & Midwifery, Burwood, Vic, Australia	Monash University; University of Queensland; Curtin University; Deakin University; Deakin University	Ayton, DR (corresponding author), Monash Univ, Sch Publ Hlth & Prevent Med, Dept Epidemiol & Prevent Med, Melbourne, Vic, Australia.	darshini.ayton@monash.edu; anna.barker@monash.edu	Hill, Keith D/L-6398-2017; Morello, Renata/AAC-6300-2019	Hill, Keith D/0000-0002-2191-0308; Talevski, Jason/0000-0001-9180-8758; Barker, Anna/0000-0001-6607-975X	National Health and Medical Research Council (NHMRC), Australia [APP1007627]; NHMRC [APP1067236, APP1055604]	National Health and Medical Research Council (NHMRC), Australia(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by a grant from the National Health and Medical Research Council (NHMRC), Australia (APP1007627). ABs salary was funded by a Fellowship from the NHMRC (APP1067236). RMs salary was supported by a scholarship from the NHMRC (APP1055604).	Alexander KE, 2014, IMPLEMENT SCI, V9, DOI 10.1186/1748-5908-9-60; Anderson JE, 2013, INT J QUAL HEALTH C, V25, P141, DOI 10.1093/intqhc/mzs081; Barker A, 2009, QUAL SAF HEALTH CARE, V18, P467, DOI 10.1136/qshc.2007.025676; Barker AL, 2016, INJ PREV; Barker A, 2011, INJURY PREV, V17, P1, DOI 10.1136/injuryprev-2011-040074; Barker A, 2011, J ADV NURS, V67, P450, DOI 10.1111/j.1365-2648.2010.05503.x; Barker AL, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.h6781; Belcher JVR, 2005, J NURS ADMIN, V35, P382; Cameron ID, 2010, COCHRANE DATABASE SY, V12; Damschroder LJ, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-50; Fereday J, 2006, INT J QUAL METH, V5, P7; Grimshaw Jeremy, 2004, J Contin Educ Health Prof, V24 Suppl 1, pS31, DOI 10.1002/chp.1340240506; Handley MA, 2016, IMPLEMENT SCI, V11, DOI 10.1186/s13012-016-0426-2; Ireland S, 2013, WORLDV EVID-BASED NU, V10, P95, DOI 10.1111/j.1741-6787.2012.00258.x; Jones TL, 2015, INT J NURS STUD, V52, P1121, DOI 10.1016/j.ijnurstu.2015.02.012; Koh SLS, 2009, SINGAP MED J, V50, P425; Koh SSL, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-105; Lee DC, 2013, WILL TELL ME THERE I; Michie S, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-42; Moore JE, 2014, IMPLEMENT SCI, V9, DOI 10.1186/s13012-014-0160-6; Morello R, 2012, INJURY PREV, V18, DOI 10.1136/injuryprev-2011-040302; National Patient Safety Agency, 2010, SLIPS TRIPS FALLS DA; O'Cathain A, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4587; Oliver D, 2010, CLIN GERIATR MED, V26, P645, DOI 10.1016/j.cger.2010.06.005; Royal College of Physicians, 2015, NAT AUD INP FALLS AU; Saldana J, 2013, CODING MANUAL QUALIT; Tzeng HM, 2011, NURS FORUM, V46, P137, DOI 10.1111/j.1744-6198.2011.00222.x	27	17	18	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0171932	10.1371/journal.pone.0171932	http://dx.doi.org/10.1371/journal.pone.0171932			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL2BG	28207841	Green Published, Green Submitted, gold			2022-12-27	WOS:000394424500062
J	Ostermeir, K; Zacharias, M				Ostermeir, Katja; Zacharias, Martin			Accelerated flexible protein-ligand docking using Hamiltonian replica exchange with a repulsive biasing potential	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; DRUG DISCOVERY; COMPUTATIONAL DOCKING; BINDING; FLEXIBILITY; DESIGN; TARGET; MACROMOLECULES; CHALLENGES; ACCURACY	A molecular dynamics replica exchange based method has been developed that allows rapid identification of putative ligand binding sites on the surface of biomolecules. The approach employs a set of ambiguity restraints in replica simulations between receptor and ligand that allow close contacts in the reference replica but promotes transient dissociation in higher replicas. This avoids long-lived trapping of the ligand or partner proteins at nonspecific, sticky, sites on the receptor molecule and results in accelerated exploration of the possible binding regions. In contrast to common docking methods that require knowledge of the binding site, exclude solvent and often keep parts of receptor and ligand rigid the approach allows for full flexibility of binding partners. Application to peptide-protein, protein-protein and a drug-receptor system indicate rapid sampling of near-native binding regions even in case of starting far away from the native binding site outperforming continuous MD simulations. An application on a DNA minor groove binding ligand in complex with DNA demonstrates that it can also be used in explicit solvent simulations.	[Ostermeir, Katja; Zacharias, Martin] Tech Univ Munich, Phys Dept T38, Garching, Germany	Technical University of Munich	Zacharias, M (corresponding author), Tech Univ Munich, Phys Dept T38, Garching, Germany.	martin.zacharias@ph.tum.de			Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This study was supported by the Deutsche Forschungsgemeinschaft.	Alonso H, 2006, MED RES REV, V26, P531, DOI 10.1002/med.20067; Beier C, 2010, EXPERT OPIN DRUG DIS, V5, P347, DOI 10.1517/17460441003713462; Bracher A, 2011, ACTA CRYSTALLOGR D, V67, P549, DOI 10.1107/S0907444911013862; Buch I, 2011, P NATL ACAD SCI USA, V108, P10184, DOI 10.1073/pnas.1103547108; Carlson HA, 2002, CURR OPIN CHEM BIOL, V6, P447, DOI 10.1016/S1367-5931(02)00341-1; Case DA, 2014, AMBER 14; Cheng TJ, 2012, AAPS J, V14, P133, DOI 10.1208/s12248-012-9322-0; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Dror RO, 2011, P NATL ACAD SCI USA, V108, P13118, DOI 10.1073/pnas.1104614108; Gervasio FL, 2005, J AM CHEM SOC, V127, P2600, DOI 10.1021/ja0445950; Harvey MJ, 2012, DRUG DISCOV TODAY, V17, P1059, DOI 10.1016/j.drudis.2012.03.017; Hopkins CW, 2015, J CHEM THEORY COMPUT, V11, P1864, DOI 10.1021/ct5010406; Kim YC, 2008, P NATL ACAD SCI USA, V105, P12855, DOI 10.1073/pnas.0802460105; Luitz M, 2015, J PHYS-CONDENS MAT, V27, DOI 10.1088/0953-8984/27/32/323101; Luitz MP, 2014, J CHEM INF MODEL, V54, P1669, DOI 10.1021/ci500296f; Maier JA, 2015, J CHEM THEORY COMPUT, V11, P3696, DOI 10.1021/acs.jctc.5b00255; May A, 2008, CURR COMPUT-AID DRUG, V4, P143, DOI 10.2174/157340908784533265; Miller DW, 1997, PROTEIN SCI, V6, P2166; NILGES M, 1995, J MOL BIOL, V245, P645, DOI 10.1006/jmbi.1994.0053; Onufriev A, 2000, J PHYS CHEM B, V104, P3712, DOI 10.1021/jp994072s; Ostermeir K, 2013, BBA-PROTEINS PROTEOM, V1834, P847, DOI 10.1016/j.bbapap.2012.12.016; PASTOR RW, 1988, MOL PHYS, V65, P1409, DOI 10.1080/00268978800101881; Perez A, 2007, BIOPHYS J, V92, P3817, DOI 10.1529/biophysj.106.097782; Schindler CEM, 2015, PROTEINS, V83, P248, DOI 10.1002/prot.24728; Shan YB, 2011, J AM CHEM SOC, V133, P9181, DOI 10.1021/ja202726y; Soderhjelm P, 2012, P NATL ACAD SCI USA, V109, P5170, DOI 10.1073/pnas.1201940109; Sugita Y, 1999, CHEM PHYS LETT, V314, P141, DOI 10.1016/S0009-2614(99)01123-9; Swift RV, 2015, MOL MODELING PROTEIN, V11, P445; Totrov M, 2008, CURR OPIN STRUC BIOL, V18, P178, DOI 10.1016/j.sbi.2008.01.004; WANG HJ, 1991, J COMPUT CHEM, V12, P868, DOI 10.1002/jcc.540120712; Wang K, 2013, J COMPUT AID MOL DES, V27, P989, DOI 10.1007/s10822-013-9689-8; Wong CF, 2015, EXPERT OPIN DRUG DIS, V10, P1189, DOI 10.1517/17460441.2015.1078308; Yuriev E, 2011, J MOL RECOGNIT, V24, P149, DOI 10.1002/jmr.1077; Zacharias M, 2004, PROTEINS, V54, P759, DOI 10.1002/prot.10637	34	12	12	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0172072	10.1371/journal.pone.0172072	http://dx.doi.org/10.1371/journal.pone.0172072			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207811	Green Published, Green Submitted, gold			2022-12-27	WOS:000394424500079
J	Tsuchiya, N; Doai, M; Usuda, K; Uramoto, H; Tonami, H				Tsuchiya, Naoko; Doai, Mariko; Usuda, Katsuo; Uramoto, Hidetaka; Tonami, Hisao			Non-small cell lung cancer: Whole-lesion histogram analysis of the apparent diffusion coefficient for assessment of tumor grade, lymphovascular invasion and pleural invasion	PLOS ONE			English	Article							AGGRESSIVENESS; LIVER	Purpose Investigating the diagnostic accuracy of histogram analyses of apparent diffusion coefficient (ADC) values for determining non-small cell lung cancer (NSCLC) tumor grades, lymphovascular invasion, and pleural invasion. Materials and methods We studied 60 surgically diagnosed NSCLC patients. Diffusion-weighted imaging (DWI) was performed in the axial plane using a navigator-triggered single-shot, echo-planar imaging sequence with prospective acquisition correction. The ADC maps were generated, and we placed a volume-of-interest on the tumor to construct the whole-lesion histogram. Using the histogram, we calculated the mean, 5th, 10th, 25th, 50th, 75th, 90th, and 95th percentiles of ADC, skewness, and kurtosis. Histogram parameters were correlated with tumor grade, lymphovascular invasion, and pleural invasion. We performed a receiver operating characteristics (ROC) analysis to assess the diagnostic performance of histogram parameters for distinguishing different pathologic features. Results The ADC mean, 10th, 25th, 50th, 75th, 90th, and 95th percentiles showed significant differences among the tumor grades. The ADC mean, 25th, 50th, 75th, 90th, and 95th percentiles were significant histogram parameters between high-and low-grade tumors. The ROC analysis between high-and low-grade tumors showed that the 95th percentile ADC achieved the highest area under curve (AUC) at 0.74. Lymphovascular invasion was associated with the ADC mean, 50th, 75th, 90th, and 95th percentiles, skewness, and kurtosis. Kurtosis achieved the highest AUC at 0.809. Pleural invasion was only associated with skewness, with the AUC of 0.648. Conclusions ADC histogram analyses on the basis of the entire tumor volume are able to stratify NSCLCs' tumor grade, lymphovascular invasion and pleural invasion.	[Tsuchiya, Naoko; Doai, Mariko; Tonami, Hisao] Kanazawa Med Univ, Dept Radiol, Uchinada, Ishikawa, Japan; [Usuda, Katsuo; Uramoto, Hidetaka] Kanazawa Med Univ, Dept Thorac Surg, Uchinada, Ishikawa, Japan	Kanazawa Medical University; Kanazawa Medical University	Tonami, H (corresponding author), Kanazawa Med Univ, Dept Radiol, Uchinada, Ishikawa, Japan.	tonami@kanazawa-med.ac.jp						Asbach P, 2008, J COMPUT ASSIST TOMO, V32, P372, DOI 10.1097/RCT.0b013e3180dc930c; Bernardin L, 2014, EUR RADIOL, V24, P502, DOI 10.1007/s00330-013-3048-y; Bonekamp S, 2012, J MAGN RESON IMAGING, V35, P257, DOI 10.1002/jmri.22786; Coolen J, 2014, EUR RADIOL, V24, P531, DOI 10.1007/s00330-013-3053-1; Donati OF, 2014, RADIOLOGY, V271, P143, DOI 10.1148/radiol.13130973; Guan Y, 2016, J COMPUT ASSIST TOMO, V40, P212, DOI 10.1097/RCT.0000000000000349; Guo JF, 2011, ANN NUCL MED, V25, P29, DOI 10.1007/s12149-010-0427-1; Higashi K, 2005, J NUCL MED, V46, P267; Just N, 2014, BRIT J CANCER, V111, P2215; Kartalis N, 2012, EUR RADIOL, V22, P2186, DOI 10.1007/s00330-012-2469-3; Koyama H, 2014, BRIT J RADIOL, V87, DOI 10.1259/bjr.20130307; Koyama H, 2015, EUR J RADIOL, V84, P509, DOI 10.1016/j.ejrad.2014.11.024; Lee J, 2014, NMR BIOMED, V27, P1046, DOI 10.1002/nbm.3153; Lin YN, 2015, AM J ROENTGENOL, V204, P1125, DOI 10.2214/AJR.14.13350; Liu HD, 2015, J MAGN RESON IMAGING, V42, P595, DOI 10.1002/jmri.24823; Liu L, 2015, SHOCK VIB, V2015, DOI 10.1155/2015/907310; Nomori H, 2015, J THORAC CARDIOV SUR, V149, P991, DOI 10.1016/j.jtcvs.2015.01.019; Nougaret S, 2015, RADIOLOGY, V276, P797, DOI 10.1148/radiol.15141212; Razek AAKA, 2012, CANCER IMAGING, V12, P452, DOI 10.1102/1470-7330.2012.0041; Rosenkrantz AB, 2015, ABDOM IMAGING, V40, P327, DOI 10.1007/s00261-014-0213-y; Tanaka R, 2013, CLIN IMAG, V37, P876, DOI 10.1016/j.clinimag.2013.06.001; Taouli B, 2009, J MAGN RESON IMAGING, V30, P561, DOI 10.1002/jmri.21876; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Xue HD, 2014, ARCH GYNECOL OBSTET, V290, P341, DOI 10.1007/s00404-014-3221-9; Yu JX, 2014, ADV COND MATTER PHYS, V2014, DOI 10.1155/2014/364627	25	28	35	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0172433	10.1371/journal.pone.0172433	http://dx.doi.org/10.1371/journal.pone.0172433			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207858	gold, Green Published, Green Submitted			2022-12-27	WOS:000394424500135
J	Vega-Cabrera, LA; Guerrero, A; Rodriguez-Mejia, JL; Tabche, ML; Wood, CD; Gutierrez-Rios, RM; Merino, E; Pardo-Lopez, L				Adriana Vega-Cabrera, Luz; Guerrero, Adan; Luis Rodriguez-Mejia, Jose; Luisa Tabche, Maria; Wood, Christopher D.; Gutierrez-Rios, Rosa-Maria; Merino, Enrique; Pardo-Lopez, Liliana			Analysis of Spo0M function in Bacillus subtilis	PLOS ONE			English	Article							PENICILLIN-BINDING PROTEINS; FACTOR-SIGMA-H; CELL-DIVISION; Z-RING; TRANSFORMATION SYSTEM; RNA-POLYMERASE; SPORULATION; GENE; FTSZ; CONSTRUCTION	Spo0M has been previously reported as a regulator of sporulation in Bacillus subtilis; however, little is known about the mechanisms through which it participates in sporulation, and there is no information to date that relates this protein to other processes in the bacterium. In this work we present evidence from proteomic, protein-protein interaction, morphological, subcellular localization microscopy and bioinformatics studies which indicate that Spo0M function is not necessarily restricted to sporulation, and point towards its involvement in other stages of the vegetative life cycle. In the current study, we provide evidence that Spo0M interacts with cytoskeletal proteins involved in cell division, which suggest a function additional to that previously described in sporulation. Spo0M expression is not restricted to the transition phase or sporulation; rather, its expression begins during the early stages of growth and Spo0M localization in B. subtilis depends on the bacterial life cycle and could be related to an additional proposed function. This is supported by our discovery of homologs in a broad distribution of bacterial genera, even in non-sporulating species. Our work paves the way for re-evaluation of the role of Spo0M in bacterial cell.	[Adriana Vega-Cabrera, Luz; Luis Rodriguez-Mejia, Jose; Luisa Tabche, Maria; Gutierrez-Rios, Rosa-Maria; Merino, Enrique; Pardo-Lopez, Liliana] Univ Nacl Autonoma Mexico, Inst Biotecnol, Cuernavaca, Morelos, Mexico; [Guerrero, Adan; Wood, Christopher D.] Univ Autonoma Estado Morelos, Lab Nacl Microscopia Avanzada, Ave Univ 2001, Cuernavaca, Morelos, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Autonoma del Estado de Morelos	Pardo-Lopez, L (corresponding author), Univ Nacl Autonoma Mexico, Inst Biotecnol, Cuernavaca, Morelos, Mexico.	liliana@ibt.unam.mx	Guerrero, Adán/I-4892-2013; Wood, Christopher D/H-5606-2012; Cardenas, Adan Oswaldo Guerrero/AAQ-9036-2021	Guerrero, Adán/0000-0002-4389-5516; Wood, Christopher D/0000-0001-7175-7121; Cardenas, Adan Oswaldo Guerrero/0000-0002-4389-5516; Merino, Enrique/0000-0002-0374-0640; Pardo Lopez, Liliana/0000-0002-8927-1733; Vega-Cabrera, Luz Adriana/0000-0002-0323-4537	CONACyT [176381]; DGAPA [IN 204016]	CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); DGAPA	This work was supported partially by CONACyT 176381 and DGAPA IN 204016. Luz Adriana Vega-Cabrera was supported by a CONACyT and DGAPA scholarship.	Adams DW, 2009, NAT REV MICROBIOL, V7, P642, DOI 10.1038/nrmicro2198; Al-Hinai MA, 2015, MICROBIOL MOL BIOL R, V79, P19, DOI 10.1128/MMBR.00025-14; ANAGNOSTOPOULOS C, 1961, J BACTERIOL, V81, P741, DOI 10.1128/JB.81.5.741-746.1961; Arrieta-Ortiz ML, 2015, MOL SYST BIOL, V11, DOI 10.15252/msb.20156236; BEALL B, 1992, J BACTERIOL, V174, P2398, DOI 10.1128/JB.174.7.2398-2403.1992; BERTANI G, 1951, J BACTERIOL, V62, P293, DOI 10.1128/JB.62.3.293-300.1951; Britton RA, 2002, J BACTERIOL, V184, P4881, DOI 10.1128/JB.184.17.4881-4890.2002; BURKHOLDER PR, 1947, AM J BOT, V34, P345, DOI 10.2307/2437147; Camacho A, 1999, J MOL BIOL, V286, P683, DOI 10.1006/jmbi.1998.2526; CARTER HL, 1988, J BACTERIOL, V170, P1617, DOI 10.1128/jb.170.4.1617-1621.1988; Castanie-Cornet MP, 2014, BBA-MOL CELL RES, V1843, P1442, DOI 10.1016/j.bbamcr.2013.11.007; Ciccarelli FD, 2006, SCIENCE, V311, P1283, DOI 10.1126/science.1123061; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Crozat E, 2014, J MOL MICROB BIOTECH, V24, P396, DOI 10.1159/000369213; de Hoon MJL, 2010, CURR BIOL, V20, pR735, DOI 10.1016/j.cub.2010.06.031; Dempwolff F, 2012, J BACTERIOL, V194, P4652, DOI 10.1128/JB.00910-12; Driks A, 2016, ASMSCIENCE, V4; Duman R, 2013, P NATL ACAD SCI USA, V110, pE4601, DOI 10.1073/pnas.1313978110; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; ERICKSON HP, 1995, CELL, V80, P367, DOI 10.1016/0092-8674(95)90486-7; Errington J, 2003, NAT REV MICROBIOL, V1, P117, DOI 10.1038/nrmicro750; Eswaramoorthy P, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004526; Eswaramoorthy P, 2011, MBIO, V2, DOI 10.1128/mBio.00257-11; Felsenstein J., 2004, PHYLIP PHYLOGENY INF; Feucht A, 2005, MICROBIOL-SGM, V151, P2053, DOI 10.1099/mic.0.27899-0; Fiche JB, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001557; Foulquier E, 2011, MOL MICROBIOL, V80, P309, DOI 10.1111/j.1365-2958.2011.07587.x; Garti-Levi S, 2008, MOL MICROBIOL, V69, P1018, DOI 10.1111/j.1365-2958.2008.06340.x; Girard G, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.130073; Graumann PL, 2007, ANNU REV MICROBIOL, V61, P589, DOI 10.1146/annurev.micro.61.080706.093236; Gueiros FJ, 2002, GENE DEV, V16, P2544, DOI 10.1101/gad.1014102; Gustafsson N, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12471; GUTHRIE B, 1990, J BACTERIOL, V172, P5555, DOI 10.1128/jb.172.10.5555-5562.1990; Han WD, 1998, GENE, V217, P31, DOI 10.1016/S0378-1119(98)00378-3; HEALY J, 1991, MOL MICROBIOL, V5, P477, DOI 10.1111/j.1365-2958.1991.tb02131.x; Hue BTN, 2012, RES MICROBIOL, V163, P114, DOI 10.1016/j.resmic.2011.10.011; Kanamaru K, 2002, J BACTERIOL, V184, P43, DOI 10.1128/JB.184.1.43-50.2002; Kanehisa M, 2016, NUCLEIC ACIDS RES, V44, pD457, DOI 10.1093/nar/gkv1070; Kawai Y, 2006, MICROBIOL-SGM, V152, P1129, DOI 10.1099/mic.0.28497-0; King N, 1999, GENE DEV, V13, P1156, DOI 10.1101/gad.13.9.1156; Kotschwar M, 2004, CURR MICROBIOL, V49, P180, DOI 10.1007/s00284-004-4319-2; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Land AD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102616; Le ATT, 2009, MICROBIOL-SGM, V155, P1122, DOI 10.1099/mic.0.024182-0; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Lutkenhaus J, 2012, CYTOSKELETON, V69, P778, DOI 10.1002/cm.21054; Martinez-Guerrero CE, 2008, NUCL ACIDS RES, V36; Matsuno K, 1999, J BACTERIOL, V181, P3392, DOI 10.1128/JB.181.11.3392-3401.1999; McKenney PT, 2012, MOL MICROBIOL, V83, P245, DOI 10.1111/j.1365-2958.2011.07936.x; Mielich-Suss B, 2013, MBIO, V4, DOI 10.1128/mBio.00719-13; Msadek T, 1998, MOL MICROBIOL, V27, P899, DOI 10.1046/j.1365-2958.1998.00735.x; MULLIGAN ME, 1984, NUCLEIC ACIDS RES, V12, P789, DOI 10.1093/nar/12.1Part2.789; Nicholson WL., 1990, MOL BIOL METHODS BAC, P391, DOI DOI 10.1111/J.1751-1097.1991.TB02087.X; Ohnishi Y, 2002, FEMS MICROBIOL LETT, V216, P1, DOI 10.1111/j.1574-6968.2002.tb11406.x; Ortiz C, 2015, FEMS MICROBIOL REV, P1; Patrick S, 1992, DNA SEQUENCE, V224, P967; Pichoff S, 2005, MOL MICROBIOL, V55, P1722, DOI 10.1111/j.1365-2958.2005.04522.x; Piggot PJ, 2004, CURR OPIN MICROBIOL, V7, P579, DOI 10.1016/j.mib.2004.10.001; Pompeo F, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00568; PRICE VA, 1989, J BACTERIOL, V171, P5933, DOI 10.1128/jb.171.11.5933-5939.1989; ROSENBLUH A, 1981, J BACTERIOL, V148, P341, DOI 10.1128/JB.148.1.341-351.1981; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Scheffers DJ, 2004, MOL MICROBIOL, V51, P749, DOI 10.1046/j.1365-2958.2003.03854.x; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Searle BC, 2010, PROTEOMICS, V10, P1265, DOI 10.1002/pmic.200900437; Sharp MD, 2003, J BACTERIOL, V185, P2005, DOI 10.1128/JB.185.6.2005-2008.2003; Sinai L, 2015, MOL CELL, V57, P695, DOI 10.1016/j.molcel.2014.12.019; Stothard P, 2005, NUCL ACIDS RES, V33; Sugimoto S, 2008, MICROBIOL-SGM, V154, P1876, DOI 10.1099/mic.0.2008/017376-0; Szwedziak P, 2013, CURR OPIN MICROBIOL, V16, P745, DOI 10.1016/j.mib.2013.09.003; Taboada B, 2012, NUCLEIC ACIDS RES, V40, pD627, DOI 10.1093/nar/gkr1020; Turgay K, 2001, MOL MICROBIOL, V42, P717, DOI 10.1046/j.1365-2958.2001.02623.x; Wach A, 1996, YEAST, V12, P259, DOI 10.1002/(SICI)1097-0061(19960315)12:3<259::AID-YEA901>3.0.CO;2-C; Wehrl W, 2000, J BACTERIOL, V182, P3870, DOI 10.1128/JB.182.13.3870-3873.2000; Wei YP, 2003, J BACTERIOL, V185, P4717, DOI 10.1128/JB.185.16.4717-4726.2003; WILSON GA, 1968, J BACTERIOL, V95, P1439, DOI 10.1128/JB.95.4.1439-1449.1968; Yepes A, 2012, MOL MICROBIOL, V86, P457, DOI 10.1111/j.1365-2958.2012.08205.x; YOUNGMAN P, 1984, PLASMID, V12, P1, DOI 10.1016/0147-619X(84)90061-1; Zhang J, 1997, J MOL EVOL, V44; Zhang XZ, 2011, MICROB BIOTECHNOL, V4, P98, DOI 10.1111/j.1751-7915.2010.00230.x; ZUBER P, 1987, J BACTERIOL, V169, P2223, DOI 10.1128/jb.169.5.2223-2230.1987; Zweers JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048471	83	8	8	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0172737	10.1371/journal.pone.0172737	http://dx.doi.org/10.1371/journal.pone.0172737			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5VB	28234965	gold, Green Published, Green Submitted			2022-12-27	WOS:000394688200124
J	Chandler, JR; Haeussler, S; Hamilton, EH; Feller, M; Bradfield, G; Simard, SW				Chandler, Julia R.; Haeussler, Sybille; Hamilton, Evelyn H.; Feller, Michael; Bradfield, Gary; Simard, Suzanne W.			Twenty years of ecosystem response after clearcutting and slashburning in conifer forests of central British Columbia, Canada	PLOS ONE			English	Article							PLANT FUNCTIONAL TYPES; CLIMATE-CHANGE; SUB-BOREAL; FIRE-PRONE; DISTURBANCE; UNDERSTORY; VEGETATION; GRADIENTS; TRAITS; CLASSIFICATION	Forests are being clearcut over extensive areas of western North America, but plant community response to harvesting and slashburning under varying climatic conditions in central British Columbia, Canada is still largely unknown. Evaluation of resilience is hampered by the short history of logging, lack of long-term experiments and methodological limitations. To test the effect of clearcut logging, prescribed burning and reforestation on forest resilience, we recorded vascular plant cover repeatedly after treatment between 1981 and 2008 in 16 permanent research installations in three biogeoclimatic zones: Engelmann Spruce-Subalpine Fir, Interior Cedar-Hemlock and Sub-Boreal Spruce. We created a plant-trait dataset for the 181 recorded species to define plant functional types representing groups of plants that behave in similar ways and/or produce similar ecological outcomes. These plant functional types, along with taxonomic analysis of diagnostic and indicator species, were then used to evaluate plant community response to disturbance. Twenty years post-treatment, species diversity increased in all zones and plant abundance was greatest in the Interior Cedar-Hemlock. Cover of understory plant functional types associated with mature conifer forests increased in all zones, constituting a significant proportion (> 40%) of the vegetation community by year 20. Response patterns varied by zone and with time. Understory species diagnostic of mature forests were present in all zones by year 20, but we identified indicator species sensitive to slashburning or requiring more time for recovery, including white-flowered rhododendron (Rhododendron albiflorum) and devil's club (Oplopanax horridus). Overall, loss of compositional or functional diversity following harvest and site remediation was not detected, suggesting that montane and subalpine forests in British Columbia are resilient to this treatment. However, because these forests can be slow to recover from disturbance, the post-disturbance assessment window of this study may not have been long enough to detect diminishment of ecosystem resilience.	[Chandler, Julia R.; Feller, Michael; Simard, Suzanne W.] Univ British Columbia, Dept Forest & Conservat Sci, Vancouver, BC, Canada; [Haeussler, Sybille] Univ Northern British Columbia, Ecosyst Sci & Management, Prince George, BC, Canada; [Hamilton, Evelyn H.] Royal Rd Univ, Ctr Livelihoods & Ecol, Victoria, BC, Canada; [Bradfield, Gary] Univ British Columbia, Dept Bot, Vancouver, BC, Canada	University of British Columbia; University of Northern British Columbia; University of British Columbia	Chandler, JR (corresponding author), Univ British Columbia, Dept Forest & Conservat Sci, Vancouver, BC, Canada.	juliarchandler@gmail.com			Forest Investment Account - Forest Science Program (FIA-FSP) [Y081033, Y092033, Y103033]	Forest Investment Account - Forest Science Program (FIA-FSP)	Funding for this research was provided by the Forest Investment Account - Forest Science Program (FIA-FSP); Project Y081033, https://www.for.gov.bc.ca/hfd/library/FIA/HTML/FIA2008MR401.htm; Project Y092033 https://www.for.gov.bc.ca/hfd/library/FIA/HTML/FIA2009MR321.htm; Project Y103033, https://www.for.gov.bc.ca/hfd/library/FIA/HTML/FIA2010MR302.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abella SR, 2015, GLOBAL CHANGE BIOL, V21, P789, DOI 10.1111/gcb.12722; Abella SR, 2015, FOREST ECOL MANAG, V335, P281, DOI 10.1016/j.foreco.2014.09.009; [Anonymous], 1990, GUIDE SITE IDENTIFIC; Aubin I, 2007, ECOSCIENCE, V14, P259, DOI 10.2980/1195-6860(2007)14[259:HRANHF]2.0.CO;2; Aubin I, 2014, FOREST ECOL MANAG, V320, P129, DOI 10.1016/j.foreco.2014.02.001; Bartels SF, 2016, FOREST ECOL MANAG, V361, P194, DOI 10.1016/j.foreco.2015.11.015; BCWS, 2010, WILDL FIR MAN STRAT; Blair DP, 2016, ECOL APPL; Boiffin J, 2015, J VEG SCI, V26, P360, DOI 10.1111/jvs.12245; BRAY JR, 1957, ECOL MONOGR, V27, P326, DOI 10.2307/1942268; British Columbia Ministry of Forests and Range and British Columbia Ministry of Environment, FIELD MAN DESCR TERR, V25; Chapin FS, 2003, ANN BOT-LONDON, V91, P455, DOI 10.1093/aob/mcg041; Clarke PJ, 2013, NEW PHYTOL, V197, P19, DOI 10.1111/nph.12001; Clarke PJ, 2015, AM NAT, V185, P747, DOI 10.1086/681160; Coates KD, 2003, FOREST ECOL MANAG, V186, P297, DOI 10.1016/S0378-1127(03)00301-3; Coates KD, 2002, FOREST ECOL MANAG, V155, P387, DOI 10.1016/S0378-1127(01)00574-6; Conover WJ, 1979, TECHNICAL REPORT; Dale VH, 2001, BIOSCIENCE, V51, P723, DOI 10.1641/0006-3568(2001)051[0723:CCAFD]2.0.CO;2; De Caceres M., 2016, R PACKAGE VERSION 1; De Caceres M, 2009, ECOLOGY, V90, P3566, DOI 10.1890/08-1823.1; Diaz S, 1997, J VEG SCI, V8, P463, DOI 10.2307/3237198; Dufrene M, 1997, ECOL MONOGR, V67, P345, DOI 10.1890/0012-9615(1997)067[0345:SAAIST]2.0.CO;2; Duguid MC, 2013, FOREST ECOL MANAG, V303, P81, DOI 10.1016/j.foreco.2013.04.009; DYRNESS CT, 1973, ECOLOGY, V54, P57, DOI 10.2307/1934374; Feller M, 1993, 251 FRDA; Friedman M, 1940, ANN MATH STAT, V11, P86, DOI 10.1214/aoms/1177731944; Grimm V, 1997, OECOLOGIA, V109, P323, DOI 10.1007/s004420050090; Haeussler S, 2002, SILVA FENN, V36, P307, DOI 10.14214/sf.565; Haeussler S, 2011, ENVIRON REV, V19, P254, DOI [10.1139/A11-008, 10.1139/a11-008]; HALPERN CB, 1989, ECOLOGY, V70, P704, DOI 10.2307/1940221; Hamann A, 2005, AGR FOREST METEOROL, V128, P211, DOI 10.1016/j.agrformet.2004.10.004; Hamilton EH, 2006, 33 B C MIN FOR RANG; Hamilton EH, 2006, 28 B C MIN FOR RANG; Hamilton EH, 2003, 23 OTT CREEK SIT; Hamilton EH, 2007, 41 B C MIN FOR RANG; Hamilton EH, 2006, 37 B C MIN FOR RANG; Hamilton EH, 2006, 26 B C MIN FOR RANG; Hamilton EH, 2008, CAN J FOREST RES, V38, P304, DOI 10.1139/X07-098; Hammill K, 2016, PLANT ECOL, V217, P725, DOI 10.1007/s11258-016-0578-9; Hart SA, 2006, CRIT REV PLANT SCI, V25, P381, DOI 10.1080/07352680600819286; Hawkes B, 1990, REGENERATING BRIT CO; Holling C.S., 1973, Annual Rev Ecol Syst, V4, P1, DOI 10.1146/annurev.es.04.110173.000245; Hooper DU, 2002, BIODIVERSITY AND ECOSYSTEM FUNCTIONING: SYNTHESIS AND PERSPECTIVES, P195; Johnson LM, 2006, J ETHNOBIOL, V2, P1; Johnstone JF, 2016, FRONT ECOL ENVIRON, V14, P369, DOI 10.1002/fee.1311; Keeley JE, 2016, PLANT ECOL, V217, P743, DOI 10.1007/s11258-015-0551-z; Kimmins J.P., 2010, FORECASTING FOREST F; Kleyer M, 1999, J VEG SCI, V10, P697, DOI 10.2307/3237084; Klinka K., 1989, INDICATOR PLANTS COA; Kranabetter JM, 2007, CAN J SOIL SCI, V87, P93, DOI 10.4141/S06-012; Kranabetter JM, 1998, 15 B C MIN FOR RANG; Kreyling J, 2008, BIODIVERS CONSERV, V17, P2339, DOI 10.1007/s10531-008-9385-5; KRUSKAL WH, 1952, J AM STAT ASSOC, V47, P583, DOI 10.1080/01621459.1952.10483441; Kurz WA, 1999, ECOL APPL, V9, P526, DOI 10.1890/1051-0761(1999)009[0526:AYRAOC]2.0.CO;2; MACADAM AM, 1987, CAN J FOREST RES, V17, P1577, DOI 10.1139/x87-242; Meidinger D, 2005, FORESTRY HDB BRIT CO; Meidinger D., 1991, ECOSYSTEMS BRIT COLU; Michels KK, 2016, CALIFORNIA MADRONO, V63, P258; Min B.C., 2012, LANDS NAT RES OPER F; Murtagh F, 2014, J CLASSIF, V31, P274, DOI 10.1007/s00357-014-9161-z; Nemenyi P. B., 1963, THESIS; Oksanen J, 2016, COMMUNITY ECOLOGY PA; Ondei S, 2016, PLANT ECOL, V217, P711, DOI 10.1007/s11258-015-0531-3; Paula S., 2009, ECOLOGY, V90, P1420, DOI DOI 10.1890/08-1309.1; Pausas JG, 2014, NEW PHYTOL, V204, P55, DOI 10.1111/nph.12921; Pohlert T, 2016, R PACKAGE VERSION 4; POJAR J, 1987, FOREST ECOL MANAG, V22, P119, DOI 10.1016/0378-1127(87)90100-9; Romme WH, 2016, ECOL MONOGR; Team RDC, 2016, R LANG ENV STAT COMP; Trowbridge R, 1987, B C FRDA HDB, V001; TURNER NJ, 1982, J ETHNOBIOL, V2, P17; Vose J, 2012, PNWGTR870 USFS; Vyse A, 1973, BCX84 CAN FOR SERV; Wang T, 2006, INT J CLIMATOL, V26, P383, DOI 10.1002/joc.1247; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967	75	5	5	3	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0172667	10.1371/journal.pone.0172667	http://dx.doi.org/10.1371/journal.pone.0172667			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5VB	28234960	gold, Green Published, Green Submitted			2022-12-27	WOS:000394688200108
J	Marmolejo, JA; Velasco, J; Selley, HJ				Marmolejo, J. A.; Velasco, Jonaas; Selley, Hector J.			An adaptive random search for short term generation scheduling with network constraints	PLOS ONE			English	Article							UNIT COMMITMENT PROBLEM; GENETIC ALGORITHM; TABU SEARCH; DECOMPOSITION	This paper presents an adaptive random search approach to address a short term generation scheduling with network constraints, which determines the startup and shutdown schedules of thermal units over a given planning horizon. In this model, we consider the transmission network through capacity limits and line losses. The mathematical model is stated in the form of a Mixed Integer Non Linear Problem with binary variables. The proposed heuristic is a population-based method that generates a set of new potential solutions via a random search strategy. The random search is based on the Markov Chain Monte Carlo method. The main key of the proposed method is that the noise level of the random search is adaptively controlled in order to exploring and exploiting the entire search space. In order to improve the solutions, we consider coupling a local search into random search process. Several test systems are presented to evaluate the performance of the proposed heuristic. We use a commercial optimizer to compare the quality of the solutions provided by the proposed method. The solution of the proposed algorithm showed a significant reduction in computational effort with respect to the full-scale outer approximation commercial solver. Numerical results show the potential and robustness of our approach.	[Marmolejo, J. A.; Selley, Hector J.] Anahuac Univ, Fac Engn, Mexico City, DF, Mexico; [Velasco, Jonaas] Ctr Res Math, CONACYT, Aguascalientes, Mexico	Universidad Anahuac	Marmolejo, JA (corresponding author), Anahuac Univ, Fac Engn, Mexico City, DF, Mexico.	jose.marmolejo@anahuac.mx	Marmolejo-Saucedo, José-Antonio/N-7498-2018; Velasco, Jonas/B-3160-2017	Marmolejo-Saucedo, José-Antonio/0000-0002-8539-9828; Velasco, Jonas/0000-0001-5347-0805; Selley Rojas, Hector Julian/0000-0003-0836-4733				Alguacil N, 2000, IEEE T POWER SYST, V15, P196, DOI 10.1109/59.852121; Brooke A., 1998, GAMS USERS GUIDE; FERREIRA LAFM, 1993, 1993 IEEE INTERNATIONAL SYMPOSIUM ON CIRCUITS AND SYSTEMS : PROCEEDINGS, VOLS 1-4 ( ISCAS 93 ), P2204, DOI 10.1109/ISCAS.1993.394197; GAMS Development Corporation DC Washington, 1994, GAMS SOLV MAN CON CP; Institute IT, 2016, IEEE 118 BUS SYST; Institute IT, 2016, IEEE 24 BUS SYSTEM; Juste KA, 1999, IEEE T POWER SYST, V14, P1452, DOI 10.1109/59.801925; Kazarlis SA, 1996, IEEE T POWER SYST, V11, P83, DOI 10.1109/59.485989; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; Mantawy AH, 1998, IEE P-GENER TRANSM D, V145, P56, DOI 10.1049/ip-gtd:19981681; Mantawy AH, 1998, IEEE T POWER SYST, V13, P197, DOI 10.1109/59.651636; Marmolejo J, 2015, MATH PROBLEMS ENG; Marmolejo JA, 2011, J COMPUT SYS SC INT+, V50, P793, DOI 10.1134/S1064230711050145; NELDER JA, 1965, COMPUT J, V7, P308, DOI 10.1093/comjnl/7.4.308; Rajan CCA, 2004, IEEE T POWER SYST, V19, P577, DOI 10.1109/TPWRS.2003.821472; RUZIC S, 1991, IEEE T POWER SYST, V6, P269, DOI 10.1109/59.131072; Saneifard S, 1997, IEEE T POWER SYST, V12, P988, DOI 10.1109/59.589804; SASAKI H, 1992, IEEE T POWER SYST, V7, P974, DOI 10.1109/59.207310; Swarup KS, 2002, IEEE T POWER SYST, V17, P87, DOI 10.1109/59.982197; Tang KS, 1996, IEEE SIGNAL PROC MAG, V13, P22, DOI 10.1109/79.543973; TIERNEY L, 1994, ANN STAT, V22, P1701, DOI 10.1214/aos/1176325750; Tseng C., 1996, POWER SYSTEM GENERAT; Valenzuela J, 2002, J HEURISTICS, V8, P173, DOI 10.1023/A:1017960507177; Velasco J, 2014, COMPUT SIST, V18, P243, DOI 10.13053/CyS-18-2-2014-030; VIRMANI S, 1989, IEEE T POWER SYST, V4, P1373, DOI 10.1109/59.41687; Wood A. J., 1996, POWER GENERATION OPE; Zhang L, 2016, J POWER SOURCES, V314, P28, DOI 10.1016/j.jpowsour.2016.01.066; Zhang L, 2015, J POWER SOURCES, V274, P899, DOI 10.1016/j.jpowsour.2014.10.170; Zhang L, 2013, IEEE IND ELEC, P7331, DOI 10.1109/IECON.2013.6700352; Zhao B, 2006, INT J ELEC POWER, V28, P482, DOI 10.1016/j.ijepes.2006.02.011; ZHUANG F, 1990, IEEE T POWER SYST, V5, P311, DOI 10.1109/59.49122	31	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0172459	10.1371/journal.pone.0172459	http://dx.doi.org/10.1371/journal.pone.0172459			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5VB	28234954	Green Published, Green Submitted, gold			2022-12-27	WOS:000394688200080
J	Parczewski, M; Leszczyszyn-Pynka, M; Witak-Jedra, M; Szetela, B; Gasiorowski, J; Knysz, B; Bociaga-Jasik, M; Skwara, P; Grzeszczuk, A; Jankowska, M; Baralkiewicz, G; Mozer-Lisewska, I; Lojewski, W; Koziel, K; Grabczewska, E; Jablonowska, E; Urbanska, A				Parczewski, Milosz; Leszczyszyn-Pynka, Magdalena; Witak-Jedra, Magdalena; Szetela, Bartosz; Gasiorowski, Jacek; Knysz, Brygida; Bociaga-Jasik, Monika; Skwara, Pawel; Grzeszczuk, Anna; Jankowska, Maria; Baralkiewicz, Grazyna; Mozer-Lisewska, Iwona; Lojewski, Wladyslaw; Koziel, Katarzyna; Grabczewska, Edyta; Jablonowska, Elzbieta; Urbanska, Anna			Expanding HIV-1 subtype B transmission networks among men who have sex with men in Poland	PLOS ONE			English	Article							TRANSMITTED DRUG-RESISTANCE; NAIVE PATIENTS; INFECTIONS; EPIDEMIC; REVEALS; PREVENTION; PATTERNS; EUROPE; SPREAD	Introduction Reconstruction of HIV transmission links allows to trace the spread and dynamics of infection and guide epidemiological interventions. The aim of this study was to characterize transmission networks among subtype B infected patients from Poland. Material and methods Maximum likelihood phylogenenetic trees were inferred from 966 HIV-1 subtype B protease/reverse transcriptase sequences from patients followed up in nine Polish HIV centers. Monophyletic clusters were identified using 3% within-cluster distance and 0.9 bootstrap values. Interregional links for the clusters were investigated and time from infection to onward transmission estimated using Bayesian dated MCMC phylogeny. Results Three hundred twenty one (33.2%) sequences formed 109 clusters, including ten clusters of >= 5 sequences (n = 81, 8.4%). Transmission networks were more common among MSM (234 sequences, 68.6%) compared to other infection routes (injection drug use: 28 (8.2%) and heterosexual transmissions: 59 (17.3%) cases, respectively [OR:3.5 (95% CI:2.6-4.6), p<0.001]. Frequency of clustering increased from 26.92% in 2009 to 50.6% in 2014 [OR:1.18 (95% CI:1.06-1.31), p = 0.0026; slope +2.8%/year] with median time to onward transmission within clusters of 1.38 (IQR:0.59-2.52) years. In multivariate models clustering was associated with both MSM transmission route [OR:2.24 (95%CI:1.38-3.65), p<0.001] and asymptomatic stage of HIV infection [OR:1.93 (95% CI:1.4-2.64), p<0.0001]. Additionally, interregional networks were linked to MSM transmissions [OR:4.7 (95% CI:2.55-8.96), p<0.001]. Conclusions Reconstruction of the HIV-1 subtype B transmission patterns reveals increasing degree of clustering and existence of interregional networks among Polish MSM. Dated phylogeny confirms the association between onward transmission and recent infections. High transmission dynamics among Polish MSM emphasizes the necessity for active testing and early treatment in this group.	[Parczewski, Milosz; Leszczyszyn-Pynka, Magdalena; Witak-Jedra, Magdalena; Urbanska, Anna] Pomeranian Med Univ, Dept Infect Trop Dis & Immune Deficiency, Szczecin, Poland; [Szetela, Bartosz; Gasiorowski, Jacek; Knysz, Brygida] Wroclaw Med Univ, Dept Infect Dis Hepatol & Acquired Immune Deficie, Wroclaw, Poland; [Bociaga-Jasik, Monika; Skwara, Pawel] Jagiellonian Univ, Coll Med, Dept Infect Dis, Krakow, Poland; [Grzeszczuk, Anna] Med Univ Bialystok, Dept Infect Dis & Hepatol, Bialystok, Poland; [Jankowska, Maria] Med Univ Gdansk, Dept Infect Dis, Gdansk, Poland; [Baralkiewicz, Grazyna] J Strus Hosp, Dept Infect Dis, Poznan, Poland; [Mozer-Lisewska, Iwona] Poznan Univ Med Sci, Dept Infect Dis, Poznan, Poland; [Lojewski, Wladyslaw; Koziel, Katarzyna] Reg Hosp Zielona Gora, Dept Infect Dis, Zielona Gora, Poland; [Grabczewska, Edyta] Nicolaus Copernicus Univ, Dept Infect Dis & Hepatol, Coll Med Bydgoszcz, Bydgoszcz, Poland; [Jablonowska, Elzbieta] Med Univ Lodz, Dept Infect Dis & Hepatol, Lodz, Poland	Pomeranian Medical University; Wroclaw Medical University; Jagiellonian University; Collegium Medicum Jagiellonian University; Medical University of Bialystok; Fahrenheit Universities; Medical University Gdansk; Poznan University of Medical Sciences; Nicolaus Copernicus University; Medical University Lodz	Parczewski, M (corresponding author), Pomeranian Med Univ, Dept Infect Trop Dis & Immune Deficiency, Szczecin, Poland.	mparczewski@yahoo.co.uk	Szetela, Bartosz/AGD-4078-2022; Parczewski, Milosz/I-1869-2014; Grzeszczuk, Anna/R-7844-2018	Parczewski, Milosz/0000-0003-1869-1084; Grzeszczuk, Anna/0000-0002-6420-5545; Szetela, Bartosz/0000-0001-7178-9801; Knysz, Brygida/0000-0003-2605-1079; Jablonowska, Elzbieta/0000-0002-7282-1225	internal funds of Pomeranian Medical University, Szczecin, Poland; Polish Scientific AIDS Society funds; Pomeranian Medical University	internal funds of Pomeranian Medical University, Szczecin, Poland; Polish Scientific AIDS Society funds; Pomeranian Medical University	The study was funded partially by the internal funds of Pomeranian Medical University, Szczecin, Poland, and partially by the Polish Scientific AIDS Society funds. MP, MLP, MWJ and UA received the salary from Pomeranian Medical University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldous JL, 2012, CLIN INFECT DIS, V55, P1135, DOI 10.1093/cid/cis612; [Anonymous], 2013, UNAIDS REP GLOB AIDS; Beyrer C, 2013, AIDS, V27, P2665, DOI 10.1097/01.aids.0000432449.30239.fe; Bezemer D, 2010, AIDS, V24, P271, DOI 10.1097/QAD.0b013e328333ddee; Brenner BG, 2007, J INFECT DIS, V195, P951, DOI 10.1086/512088; Brenner BG, 2013, JAIDS-J ACQ IMM DEF, V63, pS248, DOI 10.1097/QAI.0b013e3182986f96; Brenner BG, 2011, J INFECT DIS, V204, P1115, DOI 10.1093/infdis/jir468; Brenner BG, 2008, AIDS, V22, P2509, DOI 10.1097/QAD.0b013e3283121c90; Brown AJL, 2011, J INFECT DIS, V204, P1463, DOI 10.1093/infdis/jir550; Buonaguro Luigi, 2008, Infect Agent Cancer, V3, P13, DOI 10.1186/1750-9378-3-13; Centers for Disease Control and Prevention, 1993, JAMA-J AM MED ASSOC, V269, P460; Chalmet K, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-262; Chan PA, 2015, JAIDS-J ACQ IMM DEF, V70, P428, DOI 10.1097/QAI.0000000000000786; Chan PA, 2014, INFECT GENET EVOL, V28, P358, DOI 10.1016/j.meegid.2014.03.027; Cuevas M, 2009, EUROPEAN COMMUNICABL, V14; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Frange P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031695; Frentz D, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-36; Grabowski MK, 2014, CURR OPIN HIV AIDS, V9, P126, DOI 10.1097/COH.0000000000000040; Grossman Z, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135061; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hill A, 2015, AIDS, V29, P2523, DOI 10.1097/QAD.0000000000000864; Hue S, 2005, P NATL ACAD SCI USA, V102, P4425, DOI 10.1073/pnas.0407534102; Hull MW, 2012, CURR OPIN HIV AIDS, V7, P579, DOI 10.1097/COH.0b013e3283590617; Kaye M, 2008, JAIDS-J ACQ IMM DEF, V49, P9, DOI 10.1097/QAI.0b013e318180c8af; Leitner T, 1996, P NATL ACAD SCI USA, V93, P10864, DOI 10.1073/pnas.93.20.10864; Lewis F, 2008, PLOS MED, V5, P392, DOI 10.1371/journal.pmed.0050050; Little SJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098443; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Niedzwiedzka-Stadnik M, 2015, PRZEGLAD EPIDEMIOLOG, V69; Niedzwiedzka-Stadnik Marta, 2015, Przegl Epidemiol, V69, P267; Niedzwiedzka-Stadnik Marta, 2014, Przegl Epidemiol, V68, P283; Paraskevis D, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-49; Parczewski M, 2015, J ANTIMICROB CHEMOTH, V70, P233, DOI 10.1093/jac/dku372; Parczewski M, 2014, J INT AIDS SOC, V17, P160, DOI 10.7448/IAS.17.4.19753; Parczewski M, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18929; Parczewski M, 2010, J MED VIROL, V82, P1306, DOI 10.1002/jmv.21797; Pennings PS, 2014, J INFECT DIS, V209, P180, DOI 10.1093/infdis/jit525; Ragonnet-Cronin M, 2013, JAIDS-J ACQ IMM DEF, V64, P443, DOI 10.1097/QAI.0b013e3182a4b991; Roehr B, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h3832; Rosinska M, 2013, EUROSURVEILLANCE, V18, P13, DOI 10.2807/1560-7917.ES2013.18.48.20642; Rosinska M, 2015, AIDS CARE, P1; Rosinska M, 2015, EPIDEMIOL INFECT, P1; Rosinska M, 2016, AIDS CARE, V28, P423, DOI 10.1080/09540121.2015.1100702; RosinskaM, 2006, EUROPEAN COMMUNICABL; Smith DA, 2009, AIDS, V23, P225, DOI 10.1097/QAD.0b013e32831d2a81; Smolen-Dzirba J, 2012, J MED VIROL, V84, P1857, DOI 10.1002/jmv.23395; Stanczak GP, 2010, J MED VIROL, V82, P1291, DOI 10.1002/jmv.21782; Vega Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125699; Vermund SH, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007195; Volz EM, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002552; Wertheim JO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027775; Yebra G, 2013, INFECT GENET EVOL, V14, P232, DOI 10.1016/j.meegid.2012.12.006; Yeghiazarian L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070578	55	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0172473	10.1371/journal.pone.0172473	http://dx.doi.org/10.1371/journal.pone.0172473			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5VB	28234955	Green Published, Green Submitted, gold			2022-12-27	WOS:000394688200084
J	Gustine, D; Barboza, P; Adams, L; Griffith, B; Cameron, R; Whitten, K				Gustine, David; Barboza, Perry; Adams, Layne; Griffith, Brad; Cameron, Raymond; Whitten, Kenneth			Advancing the match-mismatch framework for large herbivores in the Arctic: Evaluating the evidence for a trophic mismatch in caribou	PLOS ONE			English	Article							CLIMATE-CHANGE; RED DEER; PHENOLOGY; GROWTH; REPRODUCTION; VEGETATION; REINDEER; HETEROGENEITY; PARTURITION; SYNCHRONY	Climate- induced shifts in plant phenology may adversely affect animals that cannot or do not shift the timing of their reproductive cycle. The realized effect of potential trophic " mismatches " between a consumer and its food varies with the degree to which species rely on dietary income and stored capital. Large Arctic herbivores rely heavily on maternal capital to reproduce and give birth near the onset of the growing season but are they vulnerable to trophic mismatch? We evaluated the long-term changes in the temperatures and characteristics of the growing seasons ( 1970 - 2013), and compared growing conditions and dynamics of forage quality for caribou at peak parturition, peak lactation, and peak forage biomass, and plant senescence between two distinct time periods over 36 years ( 1977 and 2011 - 13). Despite advanced thaw dates ( 7- 12 days earlier), increased growing season lengths ( 15 - 21 days longer), and consistent parturition dates, we found no decline in forage quality and therefore no evidence within this dataset for a trophic mismatch at peak parturition or peak lactation from 1977 to 2011 - 13. In Arctic ungulates that use stored capital for reproduction, reproductive demands are largely met by body stores deposited in the previous summer and autumn, which reduces potential adverse effects of any mismatch between food availability and timing of parturition. Climate- induced effects on forages growing in the summer and autumn ranges, however, do correspond with the demands of female caribou and their offspring to gain mass for the next reproductive cycle and winter. Therefore, we suggest the window of time to examine the match-mismatch framework in Arctic ungulates is not at parturition but in late summer-autumn, where the multiplier effects of small changes in forage quality are amplified by forage abundance, peak forage intake, and resultant mass gains in mother-offspring pairs.	[Gustine, David; Adams, Layne] US Geol Survey, Alaska Sci Ctr, Anchorage, AK USA; [Barboza, Perry] Texas A&M Univ, Wildlife & Fisheries Sci, College Stn, TX USA; [Griffith, Brad] Univ Alaska Fairbanks, Alaska Cooperat Fish & Wildlife Res Unit, US Geol Survey, Fairbanks, AK USA; [Cameron, Raymond; Whitten, Kenneth] Alaska Dept Fish & Game, Fairbanks, AK USA	United States Department of the Interior; United States Geological Survey; Texas A&M University System; Texas A&M University College Station; United States Department of the Interior; United States Geological Survey; University of Alaska System; University of Alaska Fairbanks; Alaska Department of Fish & Game	Gustine, D (corresponding author), US Geol Survey, Alaska Sci Ctr, Anchorage, AK USA.	dave_gustine@nps.gov		Gustine, Dave/0000-0003-1087-1937	U.S. Geological Survey's (USGS) Changing Arctic Ecosystem Initiative; Wildlife Program of the USGS Ecosystem Mission Area	U.S. Geological Survey's (USGS) Changing Arctic Ecosystem Initiative; Wildlife Program of the USGS Ecosystem Mission Area	This work was part of the U.S. Geological Survey's (USGS) Changing Arctic Ecosystem Initiative and was supported by funding from the Wildlife Program of the USGS Ecosystem Mission Area.; Use of any trade names in this manuscript does not imply endorsement by the U.S. government. We thank S. Aguilar, S. Arthur, G. Balogh, K. Iles, J. Lawlor, P. Martin, K. Oster, L. Parrett, G. Roffler, R. Ruffner, R. Hart, B. Streever, L. VanSomeren, E. Wald, J. Welch, R. Wilson, and N. Wolf for their varied contributions. This work was part of the U.S. Geological Survey's (USGS) Changing Arctic Ecosystem Initiative and was supported by funding from the Wildlife Program of the USGS Ecosystem Mission Area. Manuscript was improved by comments from C. Cuyler, T. Fondell, K. Joly, J. Pearce, and R. Wilson. We dedicate this work to our colleague R. Cameron, who passed away 15 November 2014.	Adams LG, 1998, J MAMMAL, V79, P287, DOI 10.2307/1382865; [Anonymous], 2012, OPEN ATMOSPHERIC SCI, DOI [10.2174/1874282301206010111, DOI 10.2174/1874282301206010111]; Barboza P. S., 2009, INT WILDL NUTR, P350, DOI 10. 1007/978-3-540-87885-8; Barboza PS, 2008, PHYSIOL BIOCHEM ZOOL, V81, P835, DOI 10.1086/590414; Bieniek PA, 2014, J CLIMATE, V27, P2800, DOI 10.1175/JCLI-D-13-00342.1; Caikoski J, 2011, UNITS 25A 25B 25D 26; Cameron R.D., 2002, ARCTIC REFUGE COASTA, P38; CAMERON RD, 1993, CAN J ZOOL, V71, P480, DOI 10.1139/z93-069; CAMERON RD, 1994, J WILDLIFE MANAGE, V58, P674, DOI 10.2307/3809681; Chan-McLeod AC, 1999, CAN J ZOOL, V77, P1901, DOI 10.1139/cjz-77-12-1901; CHAPIN FS, 1985, ECOLOGY, V66, P564, DOI 10.2307/1940405; Clausen KK, 2013, OECOLOGIA, V173, P1101, DOI 10.1007/s00442-013-2681-0; CRETE M, 1993, CAN J ZOOL, V71, P2291, DOI 10.1139/z93-321; Cuyler C, 2012, CARIBOU MUSKOXEN HAR; Cuyler C, 2011, STATUS 2 W GREENLAND; Cuyler C, 2007, STATUS 2 W GREENLAND; Dau J, 2011, UNITS 21D 22A E 23 2; DRENT RH, 1980, ARDEA, V68, P225; Durant JM, 2005, ECOL LETT, V8, P952, DOI 10.1111/j.1461-0248.2005.00798.x; Durant JM, 2007, CLIM RES, V33, P271, DOI 10.3354/cr033271; Edwards M, 2004, NATURE, V430, P881, DOI 10.1038/nature02808; Elmendorf SC, 2012, ECOL LETT, V15, P164, DOI 10.1111/j.1461-0248.2011.01716.x; Euskirchen ES, 2014, GLOBAL CHANGE BIOL, V20, P963, DOI 10.1111/gcb.12392; Festa-Bianchet M, 2011, CAN J ZOOL, V89, P419, DOI [10.1139/z11-025, 10.1139/Z11-025]; Finstad G. L., 2008, THESIS; Gallant AL, 1995, GEOLOGICAL SURVEY PR; Gauthier G, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0482; Gustine DD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100588; Gustine DD, 2010, PHYSIOL BIOCHEM ZOOL, V83, P687, DOI 10.1086/652729; Haanes H, 2005, ANIM GENET, V36, P454, DOI 10.1111/j.1365-2052.2005.01343.x; Hobbs N. T., 2010, DYNAMICS LARGE HERBI, P141; Hurley MA, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0196; Johnstone Jill, 2002, Rangifer, V22, P83; Jorgenson J.C., 2002, USGSBRDBSR20020001, P46; Jorgenson MT, 2013, ARCTIC LANDSCAPE CON; Kerby J., 2013, PHENOLOGY INTEGRATIV, P467, DOI [10.1007/978-94-007-6925-0_25, DOI 10.1007/978-94-007-6925-0_25]; Kerby J.T., 2012, TRAIT MEDIATED INDIR, P508, DOI DOI 10.1017/CBO9780511736551.032; Kerby J, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0484; Klaassen M, 2006, ARDEA, V94, P371; KLEIN D R, 1990, Rangifer, P123; Kuropat, 1984, FORAGING BEHAV CARIB; Lenart EA, 2011, UNITS 26B 26C CENTRA; Lepage D, 1998, OECOLOGIA, V114, P226, DOI 10.1007/s004420050440; Loe LE, 2005, J ANIM ECOL, V74, P579, DOI 10.1111/j.1365-2656.2005.00987.x; Marell A, 2006, BASIC APPL ECOL, V7, P13, DOI 10.1016/j.baae.2005.04.005; Marell A, 2006, ARCT ANTARCT ALP RES, V38, P413, DOI 10.1657/1523-0430(2006)38[413:SHAHFH]2.0.CO;2; McCabe, 2002, ARCTIC REFUGE COASTA, P8; McKinnon L, 2013, SCI REP, P3; Moen Jon, 2006, Conservation Biology Series (Cambridge), V11, P50; Myneni RB, 1997, NATURE, V386, P698, DOI 10.1038/386698a0; Oberbauer SF, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0481; Oftedal OT, 2000, P NUTR SOC, V59, P99, DOI 10.1017/S0029665100000124; Ogutu JO, 2013, WILDLIFE RES, V40, P698, DOI 10.1071/WR13117; PARKER KL, 1990, CAN J ZOOL, V68, P106, DOI 10.1139/z90-015; Parrett LS, 2011, TESHEKPUK CARIBOU HE; Pearson RG, 2013, NAT CLIM CHANGE, V3, P673, DOI [10.1038/NCLIMATE1858, 10.1038/nclimate1858]; Pettorelli N, 2005, P ROY SOC B-BIOL SCI, V272, P2357, DOI 10.1098/rspb.2005.3218; Plard F, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001828; Post E, 2003, TASK VEG SC, V39, P437; Post E, 2008, PHILOS T R SOC B, V363, P2369, DOI 10.1098/rstb.2007.2207; REIMERS E, 1983, ARCTIC ALPINE RES, V15, P107, DOI 10.2307/1550986; Robeson SM, 2002, CLIMATIC CHANGE, V52, P219, DOI 10.1023/A:1013088011223; Russell DE, 1993, RANGIFER, V8, P1, DOI DOI 10.7557/2.13.5.1057; Servello Frederick A., 2005, P554; Sinclair ARE, 2013, ECOLOGY, V94, P1123, DOI 10.1890/12-0428.1; Smith NV, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2003JD004472; Taillon J, 2013, ECOLOGY, V94, P1815, DOI 10.1890/12-1424.1; Taillon J, 2012, BIOL CONSERV, V147, P163, DOI 10.1016/j.biocon.2011.12.027; Tews J, 2007, ECOL MODEL, V207, P85, DOI 10.1016/j.ecolmodel.2007.04.011; Thackeray SJ, 2010, GLOBAL CHANGE BIOL, V16, P3304, DOI 10.1111/j.1365-2486.2010.02165.x; THOMPSON DC, 1981, AM MIDL NAT, V105, P70, DOI 10.2307/2425011; TRUDELL J, 1981, J APPL ECOL, V18, P63, DOI 10.2307/2402479; Tveraa T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056450; van der Wal R, 2014, ECOLOGY; VanSomeren LL, 2014, MONITORING ENERGY NI; Veiberg V., 2016, OIKOS; Visser ME, 2005, P ROY SOC B-BIOL SCI, V272, P2561, DOI 10.1098/rspb.2005.3356; Westergaard-Nielsen A, 2016, ECOSYSTEMS; White R.G., 1984, Symposia of the Zoological Society of London, P215; WHITE RG, 1983, OIKOS, V40, P377, DOI 10.2307/3544310; Whitten K.R., 1980, Proceedings of the International Reindeer/Caribou Symposium, V2, P159; Zar JH, 1999, BIOSTATISTICAL ANAL; Zhou LM, 2001, J GEOPHYS RES-ATMOS, V106, P20069, DOI 10.1029/2000JD000115	83	38	40	3	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2017	12	2							e0171807	10.1371/journal.pone.0171807	http://dx.doi.org/10.1371/journal.pone.0171807			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5SX	28231256	Green Submitted, Green Published, gold			2022-12-27	WOS:000394682400021
J	Ma, JS; Wang, L; Yang, YJ; Qiao, ZX; Fang, DY; Qiu, XH; Yang, XX; Zhu, XZ; He, JC; Pan, H; Ban, B; Zhao, Y; Sui, H				Ma, Jingsong; Wang, Lin; Yang, Yanjie; Qiao, Zhengxue; Fang, Deyu; Qiu, Xiaohui; Yang, Xiuxian; Zhu, Xiongzhao; He, Jincai; Pan, Hui; Ban, Bo; Zhao, Yan; Sui, Hong			GNB3 and CREB1 gene polymorphisms combined with negative life events increase susceptibility to major depression in a Chinese Han population	PLOS ONE			English	Article							CHILDHOOD MALTREATMENT; MOOD DISORDERS; SUBUNIT GENE; G-PROTEINS; ASSOCIATION; METAANALYSIS; EXPRESSION; CHILDREN; ETIOLOGY; BINDING	Background Major depression (MD) is caused by a combination of genetic and environmental factors. In this study we investigated the interaction of variations in the G-protein beta 3 subunit (GNB3) and cAMP response element binding protein 1 (CREB1) genes with negative life events in the pathogenesis of MD. One GNB3 polymorphism (rs5443) and four CREB1 polymorphisms (rs2253206, rs2551941, rs6740584, rs11904814) were investigated based on known associations with MD. Methods 512 patients with MD and 513 control subjects were genotyped. The frequency and severity of negative life events were measured by the Life Events Scale (LES). Gene-environment interactions (GxE) were assessed using the generalized multifactor dimensionality reduction (GMDR) method. Results Differences in GNB3 rs5443 allele frequencies and genotype distributions were observed between MD patients and controls. Significant GxE interactions were detected between negative life events and genotypic variation of all five single nucleotide polymorphisms (SNPs). Individuals carrying the T- allele of rs5443 (CC), A(-) allele of rs2253206 (GG), T- allele of rs2551941 (AA), C- allele of rs6740584 (TT) or G(-) allele of rs11904814 (TT) conferred susceptibility to MD in subjects only exposed to high-negative life events. However, individuals with the T+ allele of rs5443 (CT, TT) were susceptible to MD when exposed to low negative life events. Conclusions Interactions between GNB3, CREB1 and negative life events were revealed. Further evidence is provided about the role of the environment in genetic vulnerability to MD.	[Ma, Jingsong; Wang, Lin; Yang, Yanjie; Qiao, Zhengxue; Qiu, Xiaohui; Yang, Xiuxian; Sui, Hong] Harbin Med Univ, Dept Psychol, Inst Publ Hlth, Harbin, Peoples R China; [Fang, Deyu] Northwestern Univ, Feinberg Sch Med, Evanston, IL USA; [Zhu, Xiongzhao] Cent S Univ, Xiangya Hosp 2, Inst Med Psychol, Changsha, Hunan, Peoples R China; [He, Jincai] Wenzhou Med Univ, Affiliated Hosp 1, Wenzhou, Peoples R China; [Pan, Hui] Beijing Union Med Coll Hosp, Beijing, Peoples R China; [Ban, Bo] Jining Med Univ, Affiliated Hosptial, Jining, Peoples R China; [Zhao, Yan] Harbin Med Univ, Affiliated Hosptial 2, Harbin, Peoples R China	Harbin Medical University; Northwestern University; Feinberg School of Medicine; Central South University; Wenzhou Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Jining Medical University; Harbin Medical University	Yang, YJ; Qiao, ZX (corresponding author), Harbin Med Univ, Dept Psychol, Inst Publ Hlth, Harbin, Peoples R China.	yanjie1965@163.com; qiaozhengxue_0@163.com			National Natural Science Foundation of China [81473054, 81302484]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the National Natural Science Foundation of China (81473054) to Prof. Yanjie Yang, the National Natural Science Foundation of China (81302484) to Zhengxue Qiao.	Association AP DSM-IV APA on, 2000, DIAGN STAT MAN MENT; BIRNBAUMER L, 1990, BIOCHIM BIOPHYS ACTA, V1031, P163, DOI 10.1016/0304-4157(90)90007-Y; Blendy JA, 2006, BIOL PSYCHIAT, V59, P1144, DOI 10.1016/j.biopsych.2005.11.003; Brown GW, 2014, DEPRESS ANXIETY, V31, P326, DOI 10.1002/da.22221; Chen GL, 2008, HUM GENET, V122, P645, DOI 10.1007/s00439-007-0443-y; Collip D, 2013, BRIT J PSYCHIAT, V202, P261, DOI 10.1192/bjp.bp.112.115972; Collishaw S, 2007, CHILD ABUSE NEGLECT, V31, P211, DOI 10.1016/j.chiabu.2007.02.004; Desen Yang YZ, 1999, LIFE EVENT SCALE LES; Golan M, 2011, INT J NEUROPSYCHOPH, V14, P1289, DOI 10.1017/S1461145710001550; Hamm HE, 1998, J BIOL CHEM, V273, P669, DOI 10.1074/jbc.273.2.669; Hettema JM, 2009, AM J MED GENET B, V150B, P1128, DOI 10.1002/ajmg.b.30935; Hosang GM, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-7; Kim JM, 2007, BIOL PSYCHIAT, V62, P423, DOI 10.1016/j.biopsych.2006.11.020; Kraaij V, 2002, J GERONTOL B-PSYCHOL, V57, pP87, DOI 10.1093/geronb/57.1.P87; Kunugi H, 2002, J NEURAL TRANSM, V109, P213, DOI 10.1007/s007020200018; Lee HJ, 2004, PHARMACOGENOMICS J, V4, P29, DOI 10.1038/sj.tpj.6500217; Lemonde S, 2004, INT J NEUROPSYCHOPH, V7, P501, DOI 10.1017/S1461145704004699; Li M, 2014, MOL PSYCHIATR, V19, P452, DOI 10.1038/mp.2013.37; MANJI HK, 1992, AM J PSYCHIAT, V149, P746; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; McCrory Eamon, 2011, Front Psychiatry, V2, P48, DOI 10.3389/fpsyt.2011.00048; NESTLER EJ, 1989, J NEUROCHEM, V53, P1644, DOI 10.1111/j.1471-4159.1989.tb08564.x; Niciu MJ, 2013, CNS SPECTRUMS, V18, P231, DOI 10.1017/S1092852913000059; Nugent NR, 2011, PSYCHOPHARMACOLOGY, V214, P175, DOI 10.1007/s00213-010-2151-x; OZAWA H, 1991, JPN J PSYCHIAT NEUR, V45, P137; Peter Z, 2000, NEUROREPORT, V11, P1893; Rice F, 2003, J CHILD PSYCHOL PSYC, V44, P977, DOI 10.1111/1469-7610.00182; Risch N.J., 1994, GENETIC APPROACHES M; Sanders AR, 2004, INT REV PSYCHIATR, V16, P284, DOI 10.1080/09540260400014393; Sands WA, 2008, CELL SIGNAL, V20, P460, DOI 10.1016/j.cellsig.2007.10.005; Schumacher MA, 2000, J BIOL CHEM, V275, P35242, DOI 10.1074/jbc.M007293200; Sullivan PF, 2000, AM J PSYCHIAT, V157, P1552, DOI 10.1176/appi.ajp.157.10.1552; TAYLOR AK, 1990, GENOMICS, V7, P416, DOI 10.1016/0888-7543(90)90176-U; Tottenham N, 2012, J ADOLESCENT HEALTH, V51, pS29, DOI 10.1016/j.jadohealth.2012.04.004; Uher R, 2014, FRONT PSYCHIATRY, V5, DOI 10.3389/fpsyt.2014.00048; Utge S, 2010, AM J MED GENET B, V153B, P468, DOI 10.1002/ajmg.b.31002; Wallace TL, 2004, BIOL PSYCHIAT, V56, P151, DOI 10.1016/j.biopsych.2004.04.010; Wang P, 2015, INT J CLIN EXP PATHO, V8, P906; Zhang H, 2014, MATH PROBL ENG, V2014, DOI [10.1155/2014/183580, 10.1007/978-3-319-07200-5_1]; Zubenko GS, 2003, MOL PSYCHIATR, V8, P611, DOI 10.1038/sj.mp.4001354	41	12	14	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2017	12	2							e0170994	10.1371/journal.pone.0170994	http://dx.doi.org/10.1371/journal.pone.0170994			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5SK	28225778	Green Published, gold, Green Submitted			2022-12-27	WOS:000394680900007
J	Dalgic, OO; Ozaltin, OY; Ciccotelli, WA; Erenay, FS				Dalgic, Ozden O.; Ozaltin, Osman Y.; Ciccotelli, William A.; Erenay, Fatih S.			Deriving effective vaccine allocation strategies for pandemic influenza: Comparison of an agent-based simulation and a compartmental model	PLOS ONE			English	Article							SEASONAL INFLUENZA; DYNAMIC MITIGATION; PRIORITIZATION; INFECTION; HETEROGENEITY; EFFICACY; DISEASE; IMPACT; VIRUS	Individuals are prioritized based on their risk profiles when allocating limited vaccine stocks during an influenza pandemic. Computationally expensive but realistic agent-based simulations and fast but stylized compartmental models are typically used to derive effective vaccine allocation strategies. A detailed comparison of these two approaches, however, is often omitted. We derive age-specific vaccine allocation strategies to mitigate a pandemic influenza outbreak in Seattle by applying derivative-free optimization to an agent-based simulation and also to a compartmental model. We compare the strategies derived by these two approaches under various infection aggressiveness and vaccine coverage scenarios. We observe that both approaches primarily vaccinate school children, however they may allocate the remaining vaccines in different ways. The vaccine allocation strategies derived by using the agent-based simulation are associated with up to 70% decrease in total cost and 34% reduction in the number of infections compared to the strategies derived by using the compartmental model. Nevertheless, the latter approach may still be competitive for very low and/or very high infection aggressiveness. Our results provide insights about potential differences between the vaccine allocation strategies derived by using agent-based simulations and those derived by using compartmental models.	[Dalgic, Ozden O.; Erenay, Fatih S.] Univ Waterloo, Dept Management Sci, Waterloo, ON, Canada; [Ozaltin, Osman Y.] North Carolina State Univ, Edward P Fitts Dept Ind & Syst Engn, Raleigh, NC 27695 USA; [Ciccotelli, William A.] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada; [Ciccotelli, William A.] Grand River Hosp, Kitchener, ON, Canada	University of Waterloo; University of North Carolina; North Carolina State University; McMaster University	Ozaltin, OY (corresponding author), North Carolina State Univ, Edward P Fitts Dept Ind & Syst Engn, Raleigh, NC 27695 USA.	oyozalti@ncsu.edu	Dalgic, Ozden Onur/M-6881-2019	Ozaltin, Osman/0000-0002-0093-5645; Erenay, Fatih Safa/0000-0002-3408-0366	Natural Sciences and Engineering Research Council of Canada [DG 113788, DG 113790]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by the Natural Sciences and Engineering Research Council of Canada (DG 113788 and DG 113790). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramson M.A., 2009, THE NOMAD PROJECT; ANDERSON R., 1991, INFECT DIS; [Anonymous], [No title captured], DOI DOI 10.1080/19488300.2014.880093; Araz OM, 2012, HEALTH CARE MANAG SC, V15, P175, DOI 10.1007/s10729-012-9199-6; Arias E, 2014, NAT VITAL STAT REP, V63, P1; Atkinson K. A., 1989, AN INTRODUCTION TO N; Audet C, 2009, NOMAD USER GUIDE; Bansal S, 2007, J R SOC INTERFACE, V4, P879, DOI 10.1098/rsif.2007.1100; Basta Nicole E, 2009, Am J Epidemiol, V170, P679, DOI 10.1093/aje/kwp237; Basta NE, 2008, AM J EPIDEMIOL, V168, P1343, DOI 10.1093/aje/kwn259; Carrat F, 2008, AM J EPIDEMIOL, V167, P775, DOI 10.1093/aje/kwm375; CDC, 2016, VACCINE EFFECTIVENES; CDC, 2014, LEADING CAUSES OF DE; Chao DL, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000656; Chhatwal J, 2015, PHARMACOECONOMICS, V33, P423, DOI 10.1007/s40273-015-0254-2; Cowling BJ, 2010, CLIN INFECT DIS, V51, P1370, DOI 10.1086/657311; Das TK, 2008, IIE TRANS, V40, P893, DOI 10.1080/07408170802165856; Dasbach EJ, 2006, EPIDEMIOL REV, V28, P88, DOI 10.1093/epirev/mxj006; Dhamodharan A, 2012, HEALTH CARE MANAG SC, V15, P188, DOI 10.1007/s10729-012-9200-4; Eames KTD, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002425; Feng WH, 2013, J SIMUL, V7, P109, DOI 10.1057/jos.2012.21; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Germann TC, 2006, P NATL ACAD SCI USA, V103, P5935, DOI 10.1073/pnas.0601266103; Heffernan JM, 2005, J R SOC INTERFACE, V2, P281, DOI 10.1098/rsif.2005.0042; Hethcote HW, 2000, SIAM REV, V42, P599, DOI 10.1137/S0036144500371907; Hladish T, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-76; Huang GP, 2009, ANN OPER RES, V168, P41, DOI 10.1007/s10479-008-0373-7; Lazer D, 2014, SCIENCE, V343, P1203, DOI 10.1126/science.1248506; Le Digabel S, 2011, ACM T MATH SOFTWARE, V37, DOI 10.1145/1916461.1916468; Lee BY, 2010, VACCINE, V28, P4875, DOI 10.1016/j.vaccine.2010.05.002; Lloyd AL, 1996, J THEOR BIOL, V179, P1, DOI 10.1006/jtbi.1996.0042; Matrajt L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013767; Medlock Jan, 2009, PLoS Curr, V1, pRRN1134; Medlock J, 2009, SCIENCE, V325, P1705, DOI 10.1126/science.1175570; Merler S, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-117; Molinari NAM, 2007, VACCINE, V25, P5086, DOI 10.1016/j.vaccine.2007.03.046; MOLLISON D, 1994, J R STAT SOC A STAT, V157, P115, DOI 10.2307/2983509; Mylius SD, 2008, VACCINE, V26, P3742, DOI 10.1016/j.vaccine.2008.04.043; Nichol KL, 2006, J INFECT DIS, V194, pS111, DOI 10.1086/507544; PARVIN JD, 1986, J VIROL, V59, P377, DOI 10.1128/JVI.59.2.377-383.1986; Pastor-Satorras R, 2015, REV MOD PHYS, V87, P925, DOI 10.1103/RevModPhys.87.925; Patel R, 2005, J THEOR BIOL, V234, P201, DOI 10.1016/j.jtbi.2004.11.032; Rahmandad H, 2008, MANAGE SCI, V54, P998, DOI 10.1287/mnsc.1070.0787; Struchiner CJ, 2010, DESIGN AND ANALYSIS; Talbot HK, 2013, CLIN INFECT DIS, V56, P1774, DOI 10.1093/cid/cit124; Taubenberger JK, 2006, EMERG INFECT DIS, V12, P15, DOI 10.3201/eid1209.05-0979; Thompson M. G., 2010, Morbidity and Mortality Weekly Report, V59, P1057; United States Census Bureau, 2014, POPULATION ESTIMATES; Uribe-Sanchez A, 2011, OR SPECTRUM, V33, P751, DOI 10.1007/s00291-011-0249-0; World Health Organization, 2009, PANDEMIC INFLUENZA V; Zaric GS, 2001, MATH BIOSCI, V171, P33, DOI 10.1016/S0025-5564(01)00050-5	52	11	12	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2017	12	2							e0172261	10.1371/journal.pone.0172261	http://dx.doi.org/10.1371/journal.pone.0172261			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5QV	28222123	Green Submitted, gold, Green Published			2022-12-27	WOS:000394676800045
J	Munoz-Prieto, A; Tvarijonaviciute, A; Escribano, D; Martinez-Subiela, S; Ceron, JJ				Munoz-Prieto, Alberto; Tvarijonaviciute, Asta; Escribano, Damian; Martinez-Subiela, Silvia; Ceron, Jose J.			Use of heterologous immunoassays for quantification of serum proteins: The case of canine C-reactive protein	PLOS ONE			English	Article							ACUTE-PHASE PROTEINS; LINKED-IMMUNOSORBENT-ASSAY; DOGS; VALIDATION; CRP	The use of heterologous immunoassays containing antibodies raised against a different biological species for quantification of serum proteins is studied and discussed, taking as example the case of the use of a commercially available heterologous assay containing antibodies against human C-reactive protein (hCRP) for quantification of CRP in serum of dogs. This assay was adapted and validated for measurements of canine CRP (cCRP) and compared with three different homologous assays containing species-specific canine antibodies, which are currently commercially available for cCRP determination. Serum samples from healthy and diseased dogs (n = 44) were used. Analytical evaluation included precision, accuracy, limit of detection and lower limit of quantification for all assays. In the case of the heterologous assay also cross-reactivity of the antibody of the heterologous assay with cCRP was evaluated by a Western-Blot analysis giving a positive result. The heterologous assay showed similar results than the homologous assays in all the tests of the analytical evaluation that indicated that the assay was precise and accurate. Method comparison showed a high correlation between all assays (r >= 0.9). The Bland-Altman test revealed that the heterologous assay showed a proportional error when compared with the homologous automated assays and a random error when compared with the point-of-care assay. All four CRP assays were able to detect higher CRP values in dogs with inflammatory conditions compared with healthy dogs. It is concluded that heterologous immunoassays could be used for quantification of serum proteins in different species, provided that the antibody has cross-reactivity with the protein to be measured and the assay give satisfactory results in the analytical validation tests. In addition, use of species-specific calibrators and an appropriate batch validation are recommended in these cases.	[Munoz-Prieto, Alberto; Tvarijonaviciute, Asta; Escribano, Damian; Martinez-Subiela, Silvia; Ceron, Jose J.] Univ Murcia, Interdisciplinary Lab Clin Anal, Interlab UMU, Reg Campus Int Excellence Campus Mare Nostrum, Murcia, Spain	University of Murcia	Martinez-Subiela, S (corresponding author), Univ Murcia, Interdisciplinary Lab Clin Anal, Interlab UMU, Reg Campus Int Excellence Campus Mare Nostrum, Murcia, Spain.	silviams@um.es	Tvarijonaviciute, Asta/U-4303-2017; Martinez-Subiela, Silvia/H-5719-2015; Tortosa, Damian Escribano/L-6138-2017; Tortosa, Damian Escribano/AAG-1780-2019; Ceron, Jose J/H-9043-2015; Muñoz, Alberto/GSE-1110-2022	Tvarijonaviciute, Asta/0000-0002-5323-5001; Martinez-Subiela, Silvia/0000-0002-1524-1558; Tortosa, Damian Escribano/0000-0001-9439-6779; Tortosa, Damian Escribano/0000-0001-9439-6779; Ceron, Jose J/0000-0002-8654-1793; Muñoz, Alberto/0000-0001-6865-8712	Ministerio de Economia y Competitividad of Spain; University of Murcia	Ministerio de Economia y Competitividad of Spain(Spanish Government); University of Murcia	This work was supported by The Ministerio de Economia y Competitividad of Spain funded AT through a postdoctoral grant (Juan de la Cierva) and The University of Murcia funded AMP through a predoctoral grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreasson U, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00179; Bathen-Noethen A, 2008, J VET INTERN MED, V22, P1149, DOI 10.1111/j.1939-1676.2008.0164.x; BAUMANN H, 1994, IMMUNOL TODAY, V15, P74, DOI 10.1016/0167-5699(94)90137-6; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CASPI D, 1984, IMMUNOLOGY, V53, P307; Ceron JJ, 2008, VET J, V177, P6, DOI 10.1016/j.tvjl.2007.12.001; Eckersall PD, 2010, VET J, V185, P23, DOI 10.1016/j.tvjl.2010.04.009; ECKERSALL PD, 1989, VET REC, V124, P490, DOI 10.1136/vr.124.18.490; Escribano D, 2012, RES VET SCI, V93, P682, DOI 10.1016/j.rvsc.2011.09.018; Fransson BA, 2007, AM J VET RES, V68, P1281, DOI 10.2460/ajvr.68.12.1281; Gentilini F, 2005, 15 ECVIM CA C GLASG; Hillstrom A, 2014, VET CLIN PATH, V43, P235, DOI 10.1111/vcp.12150; Jasensky AK, 2015, VET CLIN PATH, V44, P205, DOI 10.1111/vcp.12264; Jensen AL, 2006, VET CLIN PATH, V35, P276, DOI 10.1111/j.1939-165X.2006.tb00131.x; Kjelgaard-Hansen M, 2003, VET CLIN PATH, V32, P81, DOI 10.1111/j.1939-165X.2003.tb00319.x; Kjelgaard-Hansen M, 2003, J VET MED A, V50, P164, DOI 10.1046/j.1439-0442.2003.00509.x; Kjelgaard-Hansen M, 2006, ACTA VET SCAND, V48, DOI 10.1186/1751-0147-48-9; Kjelgaard-Hansen M, 2010, VET CLIN PATH, V39, P402, DOI 10.1111/j.1939-165X.2010.00276.x; Klenner S, 2010, J VET DIAGN INVEST, V22, P544, DOI 10.1177/104063871002200408; Martinez-Subiela S, 2002, VET REC, V150, P241, DOI 10.1136/vr.150.8.241; Matijatko V, 2007, VET PARASITOL, V144, P242, DOI 10.1016/j.vetpar.2006.10.004; Mischke R, 2007, VET J, V174, P188, DOI 10.1016/j.tvjl.2006.05.018; Mylonakis ME, 2011, J VET INTERN MED, V25, P811, DOI 10.1111/j.1939-1676.2011.0728.x; Nielsen L, 2008, J VET INTERN MED, P214, DOI 10.1111/vcp.12264; Otabe K, 1998, VET RES COMMUN, V22, P77, DOI 10.1023/A:1006071211779; Parra MD, 2006, VET RES COMMUN, V30, P113, DOI 10.1007/s11259-006-3201-z; Tagata K, 1996, VET RES COMMUN, V20, P21, DOI 10.1007/BF00346573; YAMAMOTO S, 1992, VET IMMUNOL IMMUNOP, V30, P329, DOI 10.1016/0165-2427(92)90103-W	29	24	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2017	12	2							e72188	10.1371/journal.pone.0172188	http://dx.doi.org/10.1371/journal.pone.0172188			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5QV	28222144	Green Submitted, gold, Green Published			2022-12-27	WOS:000394676800040
J	Noll, M; Silveira, EA; de Avelar, IS				Noll, Matias; Silveira, Erika Aparecida; de Avelar, Ivan Silveira			Evaluation of factors associated with severe and frequent back pain in high school athletes	PLOS ONE			English	Article							ADOLESCENT ATHLETE; RISK-FACTORS; PREVALENCE; POSTURE; ALIGNMENT; STRENGTH; SPINE; REPRODUCIBILITY; VALIDATION; BACKPACKS	Several studies have shown that half of all young athletes experience back pain (BP). However, high intensity and frequency of BP may be harmful, and the factors associated with BP severity have not been investigated in detail. Here, we investigated the factors associated with a high intensity and high frequency of BP in high school athletes. We included 251 athletes (173 boys and 78 girls [14-20 years old]) in this cross-sectional study. The dependent variables were a high frequency and high intensity of BP, and the independent variables were demographic, socioeconomic, psychosocial, hereditary, anthropometric, behavioural, and postural factors and the level of exercise. The effect measure is presented as prevalence ratio (PR) with 95% confidence interval (CI). Of 251 athletes, 104 reported BP; thus, only these athletes were included in the present analysis. Results of multivariable analysis showed an association between high BP intensity and time spent using a computer (PR: 1.15, CI: 1.01-1.33), posture while writing (PR: 1.41, CI: 1.27-1.58), and posture while using a computer (PR: 1.39, CI: 1.26-1.54). Multivariable analysis also revealed an association of high BP frequency with studying in bed (PR: 1.19, CI: 1.01-1.40) and the method of carrying a backpack (PR: 1.19, CI: 1.01-1.40). In conclusion, we found that behavioural and postural factors are associated with a high intensity and frequency of BP. To the best of our knowledge, this study is the first to compare different intensities and frequencies of BP, and our results may help physicians and coaches to better understand BP in high school athletes.	[Noll, Matias; Silveira, Erika Aparecida; de Avelar, Ivan Silveira] Univ Fed Goias, Postgrad Program Hlth Sci, Fac Med, Jatai, Go, Brazil; [Noll, Matias] Inst Fed Goiano, Rio Verde, Go, Brazil	Universidade Federal de Goias; Instituto Federal Goiano	Noll, M; Silveira, EA (corresponding author), Univ Fed Goias, Postgrad Program Hlth Sci, Fac Med, Jatai, Go, Brazil.; Noll, M (corresponding author), Inst Fed Goiano, Rio Verde, Go, Brazil.	matiasnoll@yahoo.com.br; erikasil@terra.com.br	noll, matias/E-6993-2013; noll, matias/AAT-6582-2020; Silveira, Erika Aparecida/O-7585-2018	noll, matias/0000-0002-1482-0718; noll, matias/0000-0002-1482-0718; Silveira, Erika Aparecida/0000-0002-8839-4520	FAPEG; Instituto Federal Goiano	FAPEG(Fundacao de Amparo a Pesquisa do Estado do Goias (FAPEG)); Instituto Federal Goiano	Support was provided by Scholarship - FAPEG [www.fapeg.go.gov.br]; Instituto Federal Goiano. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams Michael A, 2004, Acupunct Med, V22, P178; Altmann D.B., 1999, PRACTICAL STAT MED R; Auvinen JP, 2010, EUR SPINE J, V19, P641, DOI 10.1007/s00586-009-1215-2; Azeredo CM, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011571; Bailey CA, 2015, J STRENGTH COND RES, V29, P3188, DOI 10.1519/JSC.0000000000000983; Barros Aluisio J D, 2003, BMC Med Res Methodol, V3, P21, DOI 10.1186/1471-2288-3-21; Boonstra AM, 2014, PAIN, V155, P2545, DOI 10.1016/j.pain.2014.09.014; Brazil. IBGE, 2014, NAT HLTH SURV 2013 H; Choi BKL, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006555.pub2; Dankaerts W, 2006, SPINE, V31, P698, DOI 10.1097/01.brs.0000202532.76925.d2; De Luigi AJ, 2014, PHYS MED REH CLIN N, V25, P763, DOI 10.1016/j.pmr.2014.06.004; Dizdarevic I, 2015, PHYSICIAN SPORTSMED, V43, P421, DOI 10.1080/00913847.2015.1093668; Fess E. E., 1992, GRIP STRENGTH; Garcia-Pinillos F, 2015, J STRENGTH COND RES, V29, P11, DOI 10.1519/JSC.0000000000000591; Gupta N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121159; Hakala PT, 2006, EUR J PUBLIC HEALTH, V16, P536, DOI 10.1093/eurpub/ckl025; Haus BM, 2012, CLIN SPORT MED, V31, P423, DOI 10.1016/j.csm.2012.03.011; Hawker GA, 2011, ARTHRIT CARE RES, V63, pS240, DOI 10.1002/acr.20543; Kanosue K., 2015, SPORTS INJURIES PREV; Korovessis P, 2005, SPINE, V30, P247, DOI 10.1097/01.brs.0000150505.59690.1b; Legault EP, 2015, BMC MUSCULOSKEL DIS, V16, DOI 10.1186/s12891-015-0681-4; Leilnahari K, 2011, BIOMED ENG ONLINE, V10, DOI 10.1186/1475-925X-10-103; Lis AM, 2007, EUR SPINE J, V16, P283, DOI 10.1007/s00586-006-0143-7; Marigold DS, 2006, GAIT POSTURE, V23, P249, DOI 10.1016/j.gaitpost.2005.03.001; Meziat N, 2015, EUR SPINE J, V24, P425, DOI 10.1007/s00586-014-3571-9; Mortazavi J, 2015, ASIAN J SPORTS MED, V6, DOI [10.5812/asjsm.6(2)2015.24718, DOI 10.5812/ASJSM.6(2)2015.24718]; Mueller S, 2016, BMC SPORTS SCI MED R, V8, DOI 10.1186/s13102-016-0064-7; Muller J, 2016, SCAND J MED SCI SPOR; Muslim K, 2015, ERGONOMICS, V0139, P1; Negrini S, 2007, SCOLIOSIS SPINAL DIS, V2, DOI 10.1186/1748-7161-2-8; Neuschwander TB, 2010, SPINE, V35, P83, DOI 10.1097/BRS.0b013e3181b21a5d; Noll M, 2013, J HUM GROWTH DEV, V23, P129; Noll M, 2016, PEDIATR PHYS THER, V28, P435, DOI 10.1097/PEP.0000000000000292; Noll M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150542; Noll M, 2013, INT J PUBLIC HEALTH, V58, P565, DOI 10.1007/s00038-012-0434-1; Noormohammadpour P, 2016, EUR SPINE J, V25, P1196, DOI 10.1007/s00586-015-4034-7; O'Sullivan K, 2012, MANUAL THER, V17, P432, DOI 10.1016/j.math.2012.04.007; O'Sullivan PB, 2011, PHYS THER, V91, P470, DOI 10.2522/ptj.20100160; Puentedura EJ, 2012, PHYS THER SPORT, V13, P123, DOI 10.1016/j.ptsp.2011.12.001; Rivinoja AE, 2011, AM J EPIDEMIOL, V173, P890, DOI 10.1093/aje/kwq459; Roberts HC, 2011, AGE AGEING, V40, P423, DOI 10.1093/ageing/afr051; Roffey DM, 2010, SPINE J, V10, P89, DOI 10.1016/j.spinee.2009.09.003; Rossi M, 2016, BMC MUSCULOSKEL DIS, V17, DOI 10.1186/s12891-016-1114-8; Schmidt CP, 2014, INT J SPORTS MED, V35, P684, DOI 10.1055/s-0033-1358731; Schulz SS, 2016, EUR SPINE J, V25, P1204, DOI 10.1007/s00586-015-4210-9; Sedrez Juliana Adami, 2015, Rev. paul. pediatr., V33, P72, DOI 10.1016/j.rpped.2014.11.012; Smith A, 2008, SPINE, V33, P2101, DOI 10.1097/BRS.0b013e31817ec3b0; Standaert CJ, 2008, PHYS MED REH CLIN N, V19, P287, DOI 10.1016/j.pmr.2008.01.002; Tavares LF, 2014, CAD SAUDE PUBLICA, V30, P2679, DOI 10.1590/0102-311X00016814; Trigueiro MJ, 2013, EUR J PUBLIC HEALTH, V23, P499, DOI 10.1093/eurpub/cks105; Triki M, 2015, LIBYAN J MED, V10, DOI 10.3402/ljm.v10.26802; Um K, 2003, SPORT MED, V33, P869; van Hilst J, 2015, J BACK MUSCULOSKELET, V28, P67, DOI 10.3233/BMR-140491; Wilke HJ, 1999, SPINE, V24, P755, DOI 10.1097/00007632-199904150-00005; Wirth B, 2015, BMC PEDIATR, V15, DOI 10.1186/s12887-015-0344-5; Womersley L, 2006, J MANIP PHYSIOL THER, V29, P213, DOI 10.1016/j.jmpt.2006.01.002; World Health Organization, 2007, WHO 2007 GROWTH REF	57	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2017	12	2							e0171978	10.1371/journal.pone.0171978	http://dx.doi.org/10.1371/journal.pone.0171978			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL5QV	28222141	gold, Green Published, Green Submitted			2022-12-27	WOS:000394676800025
J	Arsic, N; Ho-Pun-Cheung, A; Evelyne, C; Assenat, E; Jarlier, M; Anguille, C; Colard, M; Pezet, M; Roux, P; Gadea, G				Arsic, Nikola; Ho-Pun-Cheung, Alexandre; Evelyne, Crapez; Assenat, Eric; Jarlier, Marta; Anguille, Christelle; Colard, Manon; Pezet, Mikael; Roux, Pierre; Gadea, Gilles			The p53 isoform delta133p53 beta regulates cancer cell apoptosis in a RhoB-dependent manner	PLOS ONE			English	Article							P53-DEPENDENT APOPTOSIS; GERANYLGERANYLATED RHOB; TUMOR-GROWTH; ACTIVATION; TRANSCRIPTION; SUPPRESSION; EXPRESSION; PROGNOSIS; GAIN; EGFR	The TP53 gene plays essential roles in cancer. Conventionally, wild type ( WT) p53 is thought to prevent cancer development and metastasis formation, while mutant p53 has transforming abilities. However, clinical studies failed to establish p53 mutation status as an unequivocal predictive or prognostic factor of cancer progression. The recent discovery of p53 isoforms that can differentially regulate cell cycle arrest and apoptosis suggests that their expression, rather than p53 mutations, could be a more clinically relevant biomarker in patients with cancer. In this study, we show that the p53 isoform delta133p53 beta is involved in regulating the apoptotic response in colorectal cancer cell lines. We first demonstrate delta133p53 beta association with the small GTPase RhoB, a well-described anti-apoptotic protein. We then show that, by inhibiting RhoB activity, delta133p53 beta protects cells from camptothecin-induced apoptosis. Moreover, we found that high delta133p53 mRNA expression levels are correlated with higher risk of recurrence in a series of patients with locally advanced rectal cancer ( n = 36). Our findings describe how a WT TP53 isoform can act as an oncogene and add a new layer to the already complex p53 signaling network.	[Arsic, Nikola; Anguille, Christelle; Colard, Manon; Pezet, Mikael; Roux, Pierre] CNRS, Ctr Rech Biol Cellulaire Montpellier, Montpellier, France; [Arsic, Nikola; Anguille, Christelle; Colard, Manon; Pezet, Mikael; Roux, Pierre] Univ Montpellier, Montpellier, France; [Ho-Pun-Cheung, Alexandre; Evelyne, Crapez] Inst Canc Montpellier, Translat Res Unit, Montpellier, France; [Assenat, Eric] Inst Canc Montpellier, Dept Gastroenterol, Montpellier, France; [Jarlier, Marta] Inst Canc Montpellier, Dept Biostat, Montpellier, France; [Roux, Pierre] INSERM, Montpellier, France; [Gadea, Gilles] Univ Reunion, CNRS Unite Mixte Rech 9192, INSERM Unite 1187,IRD Unite Mixte Rech 249,Platef, Unite Mixte Proc Infect Milieu Insulaire Trop 134, St Clotilde, Reunion, France	Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Universite de Montpellier; UNICANCER; Universite de Montpellier; Institut Regional du Cancer Montpellier / Val d'Aurelle (ICM); UNICANCER; Universite de Montpellier; Institut Regional du Cancer Montpellier / Val d'Aurelle (ICM); UNICANCER; Universite de Montpellier; Institut Regional du Cancer Montpellier / Val d'Aurelle (ICM); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; University of La Reunion	Gadea, G (corresponding author), Univ Reunion, CNRS Unite Mixte Rech 9192, INSERM Unite 1187,IRD Unite Mixte Rech 249,Platef, Unite Mixte Proc Infect Milieu Insulaire Trop 134, St Clotilde, Reunion, France.	gilles.gadea@inserm.fr	Gilles, Gadea/M-9966-2015	Gilles, Gadea/0000-0001-6325-4866; Crapez, evelyne/0000-0002-8261-3470				Arsic N, 2015, STEM CELL REP, V4, P531, DOI 10.1016/j.stemcr.2015.02.001; Bourdon JC, 2005, GENE DEV, V19, P2122, DOI 10.1101/gad.1339905; Bourdon JC, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2811; Brosh R, 2009, NAT REV CANCER, V9, P701, DOI 10.1038/nrc2693; Chen J, 2009, GENE DEV, V23, P278, DOI 10.1101/gad.1761609; Chen Z, 2000, J BIOL CHEM, V275, P17974, DOI 10.1074/jbc.C000145200; De Roock W, 2009, MOL DIAGN THER, V13, P103, DOI 10.2165/01250444-200913020-00004; Delarue FL, 2001, ONCOGENE, V20, P6531, DOI 10.1038/sj.onc.1204801; Du W, 1999, CANCER RES, V59, P5492; Du W, 1999, MOL CELL BIOL, V19, P1831; Fuchs C, 2006, CANCER TREAT REV, V32, P491, DOI 10.1016/j.ctrv.2006.07.001; Gadea G, 2004, J CELL SCI, V117, P6355, DOI 10.1242/jcs.01566; Gadea G, 2002, EMBO J, V21, P2373, DOI 10.1093/emboj/21.10.2373; Gadea G, 2007, J CELL BIOL, V178, P23, DOI 10.1083/jcb.200701120; Gadea G, 2016, ELIFE, V5, DOI [10.7554/elife.14734, 10.7554/eLife.14734]; Gerard JP, 2006, J CLIN ONCOL, V24, P4620, DOI 10.1200/JCO.2006.06.7629; Gong L, 2015, CELL RES, V25, P351, DOI 10.1038/cr.2015.22; Gottlieb TM, 1998, SEMIN CANCER BIOL, V8, P359, DOI 10.1006/scbi.1998.0098; Ho-Pun-Cheung A, 2011, INT J CANCER, V128, P2938, DOI 10.1002/ijc.25639; Ho-Pun-Cheung A, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-31; Huang M, 2006, HISTOL HISTOPATHOL, V21, P213, DOI 10.14670/HH-21.213; Jiang K, 2004, ONCOGENE, V23, P1136, DOI 10.1038/sj.onc.1207236; Khoury MP, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000927; Liu AX, 2001, MOL CELL BIOL, V21, P6906, DOI 10.1128/MCB.21.20.6906-6912.2001; Liu AX, 2000, FEBS LETT, V481, P205, DOI 10.1016/S0014-5793(00)02003-2; Liu AX, 2000, MOL CELL BIOL, V20, P6105, DOI 10.1128/MCB.20.16.6105-6113.2000; Mamouni K, 2014, MOL CELLULAR BIOL; Marcel V, 2011, CARCINOGENESIS, V32, P271, DOI 10.1093/carcin/bgq253; Mukhopadhyay UK, 2009, MOL CELL BIOL, V29, P3088, DOI 10.1128/MCB.01816-08; Ory S, 2000, J CELL SCI, V113, P1177; Petitjean A, 2007, ONCOGENE, V26, P2157, DOI 10.1038/sj.onc.1210302; Polyak K, 1997, NATURE, V389, P300, DOI 10.1038/38525; Schuler M, 2000, J BIOL CHEM, V275, P7337, DOI 10.1074/jbc.275.10.7337; Soengas MS, 1999, SCIENCE, V284, P156, DOI 10.1126/science.284.5411.156; Soussi T, 2007, ONCOGENE, V26, P2145, DOI 10.1038/sj.onc.1210280; Suzuki Keiko, 2010, BMC Res Notes, V3, P294, DOI 10.1186/1756-0500-3-294; SYMONDS H, 1994, CELL, V78, P703, DOI 10.1016/0092-8674(94)90534-7; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037	38	21	21	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2017	12	2							e0172125	10.1371/journal.pone.0172125	http://dx.doi.org/10.1371/journal.pone.0172125			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BI	28212429	Green Published, gold, Green Submitted			2022-12-27	WOS:000394424700019
J	Bogusz, AM; Kovach, AE; Le, LP; Feng, D; Baxter, RHG; Sohani, AR				Bogusz, Agata M.; Kovach, Alexandra E.; Le, Long P.; Feng, Derek; Baxter, Richard H. G.; Sohani, Aliyah R.			Diffuse large B-cell lymphoma with concurrent high MYC and BCL2 expression shows evidence of active B-cell receptor signaling by quantitative immunofluorescence	PLOS ONE			English	Article							RITUXIMAB PLUS CYCLOPHOSPHAMIDE; PARAFFIN-EMBEDDED TISSUE; GENE-EXPRESSION; MIR-17-SIMILAR-TO-92 FAMILY; POOR-PROGNOSIS; C-MYC; INHIBITION; SUBTYPES; SURVIVAL; FEATURES	B-cell receptor ( BCR)-mediated signaling plays an important role in the pathogenesis of a subset of diffuse large B-cell lymphoma ( DLBCL), and novel agents targeting this pathway are now in clinical use. We have previously identified a signature of active BCR signaling on formalin-fixed paraffin-embedded specimens using quantitative immunofluorescence, allowing for identification of patients who might benefit from anti-BCR therapies. We sought to characterize the clinicopathologic significance of active BCR signaling in DLBCL by correlating measures of signaling intensity with clinical features and various tumor cell characteristics. High MYC and concurrent high MYC and BCL2 double-expression was positively correlated with individual markers of active BCR signaling and cases with MYC/BCL2 double-expression showed overall greater BCR activation compared to cases lacking double-expression. Our findings suggest that the BCR signaling pathway may be more active in MYC/BCL2 double-expressor DLBCL and may represent a rational therapeutic target in this aggressive DLBCL subgroup.	[Bogusz, Agata M.] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Kovach, Alexandra E.] Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, Nashville, TN USA; [Le, Long P.; Sohani, Aliyah R.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Feng, Derek] Yale Univ, Dept Stat, New Haven, CT USA; [Baxter, Richard H. G.] Yale Univ, Dept Chem, New Haven, CT USA; [Baxter, Richard H. G.] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT USA	University of Pennsylvania; Vanderbilt University; Harvard University; Massachusetts General Hospital; Yale University; Yale University; Yale University	Bogusz, AM (corresponding author), Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.	Agata.Bogusz@uphs.upenn.edu	Baxter, Richard/F-3027-2013; Kovach, Alexandra/AAP-7332-2020; Kovach, Alexandra Elizabeth/ABC-4382-2021	Baxter, Richard/0000-0001-5140-1726; Kovach, Alexandra Elizabeth/0000-0002-6742-6749	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001863] Funding Source: NIH RePORTER; NCATS NIH HHS [UL1 TR001863] Funding Source: Medline	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))		Advani RH, 2013, J CLIN ONCOL, V31, P88, DOI 10.1200/JCO.2012.42.7906; Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Armitage JO, 1998, J CLIN ONCOL, V16, P2780, DOI 10.1200/JCO.1998.16.8.2780; Aukema SM, 2011, BLOOD, V117, P2319, DOI 10.1182/blood-2010-09-297879; Barrans S, 2010, J CLIN ONCOL, V28, P3360, DOI 10.1200/JCO.2009.26.3947; Bogusz AM, 2012, CLIN CANCER RES, V18, P6122, DOI 10.1158/1078-0432.CCR-12-0397; Bomben R, 2012, LEUKEMIA, V26, P1584, DOI 10.1038/leu.2012.44; Chen LF, 2008, BLOOD, V111, P2230, DOI 10.1182/blood-2007-07-100115; Dang CV, 2012, CELL, V149, P22, DOI 10.1016/j.cell.2012.03.003; Eilers M, 2008, GENE DEV, V22, P2755, DOI 10.1101/gad.1712408; Flinn IW, 2016, EUR J CANCER, V54, P11, DOI 10.1016/j.ejca.2015.10.005; Friedberg JW, 2010, BLOOD, V115, P2578, DOI 10.1182/blood-2009-08-236471; Green TM, 2012, J CLIN ONCOL, V30, P3460, DOI 10.1200/JCO.2011.41.4342; Hans CP, 2004, BLOOD, V103, P275, DOI 10.1182/blood-2003-05-1545; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Horn H, 2013, BLOOD, V121, P2253, DOI 10.1182/blood-2012-06-435842; Hu SM, 2013, BLOOD, V121, P4021, DOI 10.1182/blood-2012-10-460063; Jardin F, 2014, DISCOV MED, V18, P51; Johnson NA, 2012, J CLIN ONCOL, V30, P3452, DOI 10.1200/JCO.2011.41.0985; Klapper W, 2008, LEUKEMIA, V22, P2226, DOI 10.1038/leu.2008.230; Kohrer S, 2016, LEUKEMIA, V30, P1246, DOI 10.1038/leu.2016.9; Kononen J, 1998, NAT MED, V4, P844, DOI 10.1038/nm0798-844; Lenz G, 2008, NEW ENGL J MED, V359, P2313, DOI 10.1056/NEJMoa0802885; Lenz G, 2015, CANCERS, V7, P811, DOI 10.3390/cancers7020812; Li SY, 2015, MODERN PATHOL, V28, P208, DOI 10.1038/modpathol.2014.95; Lin CY, 2012, CELL, V151, P56, DOI 10.1016/j.cell.2012.08.026; Monti S, 2005, BLOOD, V105, P1851, DOI 10.1182/blood-2004-07-2947; Nie ZQ, 2012, CELL, V151, P68, DOI 10.1016/j.cell.2012.08.033; Ota A, 2004, CANCER RES, V64, P3087, DOI 10.1158/0008-5472.CAN-03-3773; Pasqualucci L, 2015, SEMIN HEMATOL, V52, P67, DOI 10.1053/j.seminhematol.2015.01.005; Pasqualucci L, 2013, CURR OPIN HEMATOL, V20, P336, DOI 10.1097/MOH.0b013e3283623d7f; Pedersen MO, 2012, EUR J HAEMATOL, V89, P63, DOI 10.1111/j.1600-0609.2012.01787.x; Perry AM, 2014, BRIT J HAEMATOL, V165, P382, DOI 10.1111/bjh.12763; Psathas JN, 2013, BLOOD, V122, P4220, DOI 10.1182/blood-2012-12-473090; Rosenwald A, 2002, NEW ENGL J MED, V346, P1937, DOI 10.1056/NEJMoa012914; Savage KJ, 2009, BLOOD, V114, P3533, DOI 10.1182/blood-2009-05-220095; Scott DW, 2015, J CLIN ONCOL, V33, P2848, DOI 10.1200/JCO.2014.60.2383; Scott DW, 2014, BLOOD, V123, P1214, DOI 10.1182/blood-2013-11-536433; Snuderl M, 2010, AM J SURG PATHOL, V34, P327, DOI 10.1097/PAS.0b013e3181cd3aeb; Stasik CJ, 2010, HAEMATOL-HEMATOL J, V95, P597, DOI 10.3324/haematol.2009.012864; Stein H, 2008, WHO CLASSIFICATION T, V4th, P233; Testoni M, 2011, BRIT J HAEMATOL, V155, P274, DOI 10.1111/j.1365-2141.2011.08675.x; Ventura A, 2008, CELL, V132, P875, DOI 10.1016/j.cell.2008.02.019; Wang WG, 2015, AM J SURG PATHOL, V39, P902, DOI 10.1097/PAS.0000000000000396; Wang WG, 2015, MODERN PATHOL, V28, p385A; Weremowicz S, 2007, CURR PROTOC HUM GENE; Wilson WH, 2015, NAT MED, V21, P922, DOI 10.1038/nm.3884; Young RM, 2015, SEMIN HEMATOL, V52, P77, DOI 10.1053/j.seminhematol.2015.01.008	48	13	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2017	12	2							e0172364	10.1371/journal.pone.0172364	http://dx.doi.org/10.1371/journal.pone.0172364			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BI	28212447	gold, Green Published, Green Submitted			2022-12-27	WOS:000394424700038
J	Kashiwadani, H; Kanmura, Y; Kuwaki, T				Kashiwadani, Hideki; Kanmura, Yuichi; Kuwaki, Tomoyuki			Application of calibrated forceps for assessing mechanical nociception with high time resolution in mice	PLOS ONE			English	Article							REMIFENTANIL GI87084B; INDUCED HYPERALGESIA; OPIOID REMIFENTANIL; ANALGESIC ACTIVITY; RESTRAINT STRESS; FORMALIN TEST; PAIN; PHARMACOKINETICS; STIMULATION; SENSITIVITY	In order to investigate the basic physiological mechanisms of pain and the anti-nociceptive effects of analgesics, development of pain assays in mice is critical due to the advances of genetic manipulation techniques. The von Frey hairs/Semmes-Weinstein monofilaments test (von Frey test) has long been applied to examine mechanical nociception in mice. Though the von Frey test is a well-established and standardized method, it is inappropriate to assess a rapid change in the nociceptive threshold because voluntary resting/sleeping states are necessary to examine the response. In this study, we assessed the effectiveness of calibrated forceps to determine the mechanical nociceptive threshold in mice. Repeated daily measurements of the threshold over 5 days indicated that the device obtained stable and reliable values. Furthermore, repeated measurements with 5 minute intervals revealed that the device detected the rapid change of the threshold induced by remifentanil, a short-acting mu-receptor agonist. These results indicate that the calibrated forceps are well-suited for measuring the mechanical nociceptive threshold in mice, and are useful in assessing the effects of short-acting analgesics on mechanical nociception.	[Kashiwadani, Hideki; Kuwaki, Tomoyuki] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Physiol, Kagoshima, Japan; [Kanmura, Yuichi] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Anesthesiol, Kagoshima, Japan	Kagoshima University; Kagoshima University	Kashiwadani, H (corresponding author), Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Physiol, Kagoshima, Japan.	danny@m3.kufm.kagoshima-u.ac.jp	Kashiwadani, Hideki/R-3404-2019; Kuwaki, Tomoyuki/B-3247-2019	Kuwaki, Tomoyuki/0000-0003-4226-3610	Cosmetology Research Foundation [J-13-12]; JSPS KAKENHI [16H05130]	Cosmetology Research Foundation; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by a grant from the Cosmetology Research Foundation (#J-13-12, http://www.cosmetology.or.jp/index.html)(HK) and JSPS KAKENHI 16H05130 (http://www.jsps.go.jp/english/index.html) (TK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anseloni VCZ, 2003, J NEUROSCI METH, V131, P93, DOI 10.1016/S0165-0270(03)00241-3; Back SK, 2002, NEUROSCI LETT, V322, P153, DOI 10.1016/S0304-3940(02)00067-8; Barrot M, 2012, NEUROSCIENCE, V211, P39, DOI 10.1016/j.neuroscience.2011.12.041; Bevans T, 2016, ANESTH ANALG; Bradman MJG, 2015, J NEUROSCI METH, V255, P92, DOI 10.1016/j.jneumeth.2015.08.010; Buerkle H, 1996, ANESTHESIOLOGY, V84, P94, DOI 10.1097/00000542-199601000-00012; Butler RK, 2009, PROG NEUROBIOL, V88, P184, DOI 10.1016/j.pneurobio.2009.04.003; CALCAGNETTI DJ, 1992, BRAIN RES, V592, P305, DOI 10.1016/0006-8993(92)91689-C; Callahan BL, 2008, J PAIN, V9, P174, DOI 10.1016/j.jpain.2007.10.011; Costa A, 2005, NEUROSCI LETT, V383, P7, DOI 10.1016/j.neulet.2005.03.026; Cui JG, 1999, EUR J PAIN, V3, P365, DOI 10.1016/S1090-3801(99)90018-6; D'amour FE, 1941, J PHARMACOL EXP THER, V72, P74; DUBUISSON D, 1977, PAIN, V4, P161, DOI 10.1016/0304-3959(77)90130-0; EGAN TD, 1993, ANESTHESIOLOGY, V79, P881, DOI 10.1097/00000542-199311000-00004; GLASS PSA, 1993, ANESTH ANALG, V77, P1031; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Hutchinson MR, 2012, J NEUROSCI, V32, P11187, DOI 10.1523/JNEUROSCI.0684-12.2012; Kieffer BL, 2002, PROG NEUROBIOL, V66, P285, DOI 10.1016/S0301-0082(02)00008-4; Latremoliere A, 2015, NEURON, V86, P1393, DOI 10.1016/j.neuron.2015.05.033; Luis-Delgado OE, 2006, J PAIN, V7, P32, DOI 10.1016/j.jpain.2005.07.011; Mogil JS, 2010, PAIN, V151, P12, DOI 10.1016/j.pain.2010.07.015; OCALLAGHAN JP, 1975, J PHARMACOL EXP THER, V192, P497; RANDALL LO, 1957, ARCH INT PHARMACOD T, V111, P409; Scherrer G, 2009, CELL, V137, P1148, DOI 10.1016/j.cell.2009.04.019; Skyba DA, 2005, J PAIN, V6, P41, DOI 10.1016/j.jpain.2004.10.002; Sluka KA, 2013, J APPL PHYSIOL, V114, P725, DOI 10.1152/japplphysiol.01317.2012; Sluka KA, 2010, PAIN, V148, P188, DOI 10.1016/j.pain.2009.07.001; Sung B, 2000, NEUROSCI LETT, V291, P163, DOI 10.1016/S0304-3940(00)01394-X; TAIWO YO, 1989, BRAIN RES, V487, P148, DOI 10.1016/0006-8993(89)90950-5; TJOLSEN A, 1992, PAIN, V51, P5, DOI 10.1016/0304-3959(92)90003-T; Woolfe G, 1944, J PHARMACOL EXP THER, V80, P300	31	4	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2017	12	2							e0172461	10.1371/journal.pone.0172461	http://dx.doi.org/10.1371/journal.pone.0172461			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BI	28212389	Green Published, gold, Green Submitted			2022-12-27	WOS:000394424700053
J	Gleitz, HFE; O'Leary, C; Holley, RJ; Bigger, BW				Gleitz, Helene F. E.; O'Leary, Claire; Holley, Rebecca J.; Bigger, Brian W.			Identification of age-dependent motor and neuropsychological behavioural abnormalities in a mouse model of Mucopolysaccharidosis Type II	PLOS ONE			English	Article							ENZYME-REPLACEMENT THERAPY; BONE-MARROW-TRANSPLANTATION; HUNTER-SYNDROME; HURLER-SYNDROME; MPS-II; MICE; DISEASE; CHILDREN; DEFICITS; DEFECTS	Severe mucopolysaccharidosis type II (MPS II) is a progressive lysosomal storage disease caused by mutations in the IDS gene, leading to a deficiency in the iduronate-2-sulfatase enzyme that is involved in heparan sulphate and dermatan sulphate catabolism. In constitutive form, MPS II is a multi-system disease characterised by progressive neurocognitive decline, severe skeletal abnormalities and hepatosplenomegaly. Although enzyme replacement therapy has been approved for treatment of peripheral organs, no therapy effectively treats the cognitive symptoms of the disease and novel therapies are in development to remediate this. Therapeutic efficacy and subsequent validation can be assessed using a variety of outcome measures that are translatable to clinical practice, such as behavioural measures. We sought to consolidate current knowledge of the cognitive, skeletal and motor abnormalities present in the MPS II mouse model by performing time course behavioural examinations of working memory, anxiety, activity levels, sociability and coordination and balance, up to 8 months of age. Cognitive decline associated with alterations in spatial working memory is detectable at 8 months of age in MPS II mice using spontaneous alternation, together with an altered response to novel environments and anxiolytic behaviour in the open-field. Coordination and balance on the accelerating rotarod were also significantly worse at 8 months, and may be associated with skeletal changes seen in MPS II mice. We demonstrate that the progressive nature of MPS II disease is also seen in the mouse model, and that cognitive and motor differences are detectable at 8 months of age using spontaneous alternation, the accelerating rotarod and the open-field tests. This study establishes neurological, motor and skeletal measures for use in pre-clinical studies to develop therapeutic approaches in MPS II.	[Gleitz, Helene F. E.; O'Leary, Claire; Holley, Rebecca J.; Bigger, Brian W.] Univ Manchester, Stem Cell & Neurotherapies, Div Cell Matrix Biol & Regenerat Med, Fac Biol Med & Hlth, Manchester, Lancs, England	University of Manchester	Bigger, BW (corresponding author), Univ Manchester, Stem Cell & Neurotherapies, Div Cell Matrix Biol & Regenerat Med, Fac Biol Med & Hlth, Manchester, Lancs, England.	brian.bigger@manchester.ac.uk	Gleitz, Helene/AAX-5620-2020; Bigger, Brian/I-3553-2012	Gleitz, Helene/0000-0001-6138-8916; Bigger, Brian/0000-0002-9708-1112; O'Leary, Claire/0000-0001-8616-7466	Isaac Foundation; Newlife Foundation for Disabled Children; National Mucopolysaccharidosis Society	Isaac Foundation; Newlife Foundation for Disabled Children; National Mucopolysaccharidosis Society	This study was funded by grants awarded by the Isaac Foundation (https://www.theisaacfoundation.com/, awarded to BWB), the Newlife Foundation for Disabled Children (http://www.newlifecharity.co.uk/, awarded to BWB) and the National Mucopolysaccharidosis Society (http://mpssociety.org/, awarded to BWB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldenhoven M, 2015, BLOOD, V125, P2164, DOI 10.1182/blood-2014-11-608075; Arguello PA, 2006, NEURON, V52, P179, DOI 10.1016/j.neuron.2006.09.023; Baehner F, 2005, J INHERIT METAB DIS, V28, P1011, DOI 10.1007/s10545-005-0112-z; Boelens JJ, 2013, BLOOD, V121, P3981, DOI 10.1182/blood-2012-09-455238; Brooks DA, 2003, TRENDS MOL MED, V9, P450, DOI 10.1016/j.molmed.2003.08.004; Canal MM, 2010, BEHAV BRAIN RES, V209, P212, DOI 10.1016/j.bbr.2010.01.045; Cardone M, 2006, HUM MOL GENET, V15, P1225, DOI 10.1093/hmg/ddl038; Carter RJ, 1999, J NEUROSCI, V19, P3248; Cross EM, 2013, J INHERIT METAB DIS, V36, P189, DOI 10.1007/s10545-012-9572-0; Eng C, 2007, MOL GENET METAB, V92, pS18, DOI 10.1016/j.ymgme.2007.08.034; FERRER I, 1988, NEUROPATH APPL NEURO, V14, P315, DOI 10.1111/j.1365-2990.1988.tb00891.x; Garcia AR, 2007, J INHERIT METAB DIS, V30, P924, DOI 10.1007/s10545-007-0641-8; Guffon N, 2009, J PEDIATR-US, V154, P733, DOI 10.1016/j.jpeds.2008.11.041; Guo ZR, 2016, NEUROSCI LETT, V616, P152, DOI 10.1016/j.neulet.2016.01.048; Higuchi T, 2012, MOL GENET METAB, V107, P122, DOI 10.1016/j.ymgme.2012.05.005; Hinderer C, 2016, HUM GENE THER; Holt JB, 2011, PEDIATRICS, V127, pE1258, DOI 10.1542/peds.2010-1274; Jiang LN, 2015, NEUROBIOL DIS, V76, P137, DOI 10.1016/j.nbd.2015.02.006; Kakkis ED, 2001, MOL GENET METAB, V72, P199, DOI 10.1006/mgme.2000.3140; Langford-Smith A, 2011, GENES BRAIN BEHAV, V10, P673, DOI 10.1111/j.1601-183X.2011.00706.x; Langford-Smith A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025717; Martins C, 2015, BRAIN, V138, P336, DOI 10.1093/brain/awu355; McFadyen MP, 2003, GENES BRAIN BEHAV, V2, P214, DOI 10.1034/j.1601-183X.2003.00028.x; Meikle PJ, 1999, JAMA-J AM MED ASSOC, V281, P249, DOI 10.1001/jama.281.3.249; Motas S, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.86696; Muenzer J, 2002, ACTA PAEDIATR, V91, P98, DOI 10.1080/080352502762458012; Muenzer J, 2006, GENET MED, V8, P465, DOI 10.1097/01.gim.0000232477.37660.fb; Muenzer J, 2011, RHEUMATOLOGY, V50, pV4, DOI 10.1093/rheumatology/ker394; Muenzer J, 2011, GENET MED, V13, P95, DOI 10.1097/GIM.0b013e3181fea459; Mumford RA, 2015, J NEURODEV DISORD, V7, DOI 10.1186/s11689-015-9126-5; Neufeld EF, LYSOSOMAL DISORDERS2, P3421; O'Leary C, 2014, NEUROSCIENCE, V277, P294, DOI 10.1016/j.neuroscience.2014.06.028; O'Tuathaigh CMP, 2007, NEUROSCIENCE, V147, P18, DOI 10.1016/j.neuroscience.2007.03.051; Polito VA, 2010, HUM MOL GENET, V19, P4871, DOI 10.1093/hmg/ddq420; Poorthuis BJHM, 1999, HUM GENET, V105, P151, DOI 10.1007/s004390051078; Reolon GK, 2009, CELL MOL NEUROBIOL, V29, P443, DOI 10.1007/s10571-008-9335-5; Shapiro EG, 2015, MOL GENET METAB, V114, P594, DOI 10.1016/j.ymgme.2015.02.008; SIMON P, 1994, BEHAV BRAIN RES, V61, P59, DOI 10.1016/0166-4328(94)90008-6; Vellodi A, 1999, J INHERIT METAB DIS, V22, P638, DOI 10.1023/A:1005525931994; Wakabayashi T, 2015, HUM GENE THER; Wall PM, 2002, PSYCHOPHARMACOLOGY, V160, P233, DOI 10.1007/s00213-001-0979-9; Wietrzych M, 2005, LEARN MEMORY, V12, P318, DOI 10.1101/lm.89805; Wraith JE, 2008, EUR J PEDIATR, V167, P267, DOI 10.1007/s00431-007-0635-4; Wynn RF, 2009, J PEDIATR-US, V154, P609, DOI 10.1016/j.jpeds.2008.11.005; YOUNG ID, 1981, CHILD CARE HLTH DEV, V7, P201, DOI 10.1111/j.1365-2214.1981.tb00838.x	45	15	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0172435	10.1371/journal.pone.0172435	http://dx.doi.org/10.1371/journal.pone.0172435			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207863	Green Submitted, gold, Green Published			2022-12-27	WOS:000394424500136
J	Klonner, G; Fischer, S; Essl, F; Dullinger, S				Klonner, Gunther; Fischer, Stefan; Essl, Franz; Dullinger, Stefan			A Source Area Approach Demonstrates Moderate Predictive Ability but Pronounced Variability of Invasive Species Traits (vol 11, e0155547, 2016)	PLOS ONE			English	Correction													Essl, Franz/ABE-7064-2020	Essl, Franz/0000-0001-8253-2112	 [I 1443-B25]; Austrian Science Fund (FWF) [I 1443] Funding Source: researchfish	; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	In the Funding section, the grant number from the funder FWF (Austrian Science Fund) is listed incorrectly. The correct grant number is: I 1443-B25.	Klonner G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155547	1	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0172656	10.1371/journal.pone.0172656	http://dx.doi.org/10.1371/journal.pone.0172656			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207904	gold, Green Submitted, Green Published			2022-12-27	WOS:000394424500152
J	Wan, HB; Wu, S; Yang, YM; Zhu, J; Zhang, AD; Liang, Y				Wan, Huaibin; Wu, Shuang; Yang, Yanmin; Zhu, Jun; Zhang, Aidong; Liang, Yan			Plasma fibrin D-dimer and the risk of left atrial thrombus: A systematic review and meta-analysis	PLOS ONE			English	Article							SPONTANEOUS ECHO-CONTRAST; C-REACTIVE PROTEIN; BLOOD-FLOW VELOCITY; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; PULMONARY-EMBOLISM; THROMBOEMBOLIC RISK; MITRAL-STENOSIS; WELLS RULE; FIBRILLATION; EXCLUSION	Background Plasma fibrin d-dimer has been taken as a marker for thrombus. The aim of this study was to evaluate the relationship between d-dimer (DD) levels and left atrial spontaneous echo contrast (SEC)/left atrial thrombus (LAT). Methods We identified clinical studies by systematic search of MEDLINE and EMBASE databases up to Feb 2016. All observational studies that considered DD as a study factor and trans-esophageal echocardiography (TEE) identified SEC/LAT as an outcome were included. Two reviewers independently selected the studies and extracted the data. Results Of the 21 included studies, 16 studies (2652 patients) have compared the mean DD differences between patients with and without an evidence of the presence of SEC/LAT, 9 studies (1667 patients) have estimated the diagnostic value of DD in the presence of LAT, and 11 studies (1856 patients) have available information to calculate a ratio of the presence of LAT among individuals in the top and the bottom third of DD levels. The pooled standardized mean difference (SMD) of DD between patients with and without left atrial SEC and/or LAT was 1.29 [95% CI: 0.51, 2.08], with SMDs of 0.42 [95% CI: 0.08, 0.77] and 2.34 [95% CI: 1.01, 3.68] in SEC/LAT and LAT subgroups, respectively. The combined risk ratio of the presence of LAT among individuals between the top of the distribution of DD levels and that in the bottom third was 3.84 [95% CI: 2.35, 6.28], associating with a mean difference of 0.78 ug/ml (1.10 vs 0.32 ug/ml). The pooled sensitivity, specificity and positive likelihood ratio of DD for LAT were 0.75 [95% CI: 0.65, 0.83], 0.81 [95% CI: 0.59, 0.93] and 4.0 [95% CI: 1.7, 9.9], respectively. Conclusions High plasma fibrin DD was associated with left atrial SEC/LAT, particularly among patients with LAT. DD levels have moderate sensitivity and specificity for diagnosing LAT.	[Wan, Huaibin; Zhang, Aidong] Jinan Univ, Affiliated Hosp 1, Dept Cardiol, Guangzhou, Guangdong, Peoples R China; [Wu, Shuang; Yang, Yanmin; Zhu, Jun; Liang, Yan] Chinese Acad Med Sci, Natl Ctr Cardiovasc Dis, Fuwai Hosp, Emergency & Intens Care Ctr, Beijing, Peoples R China; [Wu, Shuang; Yang, Yanmin; Zhu, Jun; Liang, Yan] Peking Union Med Coll, Beijing, Peoples R China	Jinan University; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Wan, HB (corresponding author), Jinan Univ, Affiliated Hosp 1, Dept Cardiol, Guangzhou, Guangdong, Peoples R China.	docvanhb@outlook.com	WAN, HUAIBIN/ABF-6827-2020					Abu-Mahfouz M, 2012, CARDIOL J, V19, P267, DOI 10.5603/CJ.2012.0048; [Anonymous], 2016, NEWCASTLE OTTAWA SCA; Bernhardt P, 2005, J AM COLL CARDIOL, V45, P1807, DOI 10.1016/j.jacc.2004.11.071; BLACK IW, 1993, J AM COLL CARDIOL, V21, P451, DOI 10.1016/0735-1097(93)90688-W; Christersson C, 2014, J THROMB HAEMOST, V12, P1401, DOI 10.1111/jth.12638; Cianfrocca C, 2010, INT J CARDIOL, V142, P22, DOI 10.1016/j.ijcard.2008.12.052; Danesh J, 1998, JAMA-J AM MED ASSOC, V279, P1477, DOI 10.1001/jama.279.18.1477; DANIEL WG, 1988, J AM COLL CARDIOL, V11, P1204, DOI 10.1016/0735-1097(88)90283-5; Dempfle CE, 2001, THROMB HAEMOSTASIS, V86, P1204; Eggebrecht H, 2004, J AM COLL CARDIOL, V44, P804, DOI 10.1016/j.jacc.2004.04.053; FATKIN D, 1994, J AM COLL CARDIOL, V23, P961, DOI 10.1016/0735-1097(94)90644-0; Fukuda S, 2011, J CARDIOL, V58, P266, DOI 10.1016/j.jjcc.2011.06.009; Geersing GJ, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1340; Geersing GJ, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e6564; Habara S, 2007, EUR HEART J, V28, P2217, DOI 10.1093/eurheartj/ehm356; Heppell RM, 1997, HEART, V77, P407, DOI 10.1136/hrt.77.5.407; Hozo Stela Pudar, 2005, BMC Med Res Methodol, V5, P13, DOI 10.1186/1471-2288-5-13; Huang B, 2015, AM J CARDIOL, V115, P1595, DOI 10.1016/j.amjcard.2015.02.067; Igarashi Y, 1998, AM HEART J, V136, P965, DOI 10.1016/S0002-8703(98)70151-6; Jin Yan-yan, 2011, Zhonghua Nei Ke Za Zhi, V50, P836; Kadle N, 2013, J INVEST MED, V61, P487; Kirchhof P, 2016, EUR HEART J, V2016; Kleinegris MCF, 2013, THROMB HAEMOSTASIS, V110, P233, DOI 10.1160/TH13-01-0032; Kotoulas C, 2010, INTERACT CARDIOV TH, V11, P382, DOI 10.1510/icvts.2010.233338A; Kurakula N, 2016, ECHOCARDIOGR-J CARD, V33, P264, DOI 10.1111/echo.13026; LEUNG DYC, 1994, J AM COLL CARDIOL, V24, P755, DOI 10.1016/0735-1097(94)90025-6; Lip GYH, 1996, AM HEART J, V131, P724, DOI 10.1016/S0002-8703(96)90278-1; Nakajima K, 2000, Nihon Ronen Igakkai Zasshi, V37, P903; Naresh K, 2014, INDIAN HEART J, V66, pS136; Numa S, 2014, CIRC J, V78, P1600, DOI 10.1253/circj.CJ-13-1385; Rajappa M, 2013, AFR HEALTH SCI, V13, P584, DOI 10.4314/ahs.v13i3.9; Rathbun SW, 2004, CHEST, V125, P851, DOI 10.1378/chest.125.3.851; Righini M, 2014, JAMA-J AM MED ASSOC, V311, P1117, DOI 10.1001/jama.2014.2135; Sakai Makoto, 1994, Japanese Journal of Geriatrics, V31, P447; Sato Mika, 2006, J Stroke Cerebrovasc Dis, V15, P1, DOI 10.1016/j.jstrokecerebrovasdis.2005.09.005; Schouten HJ, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2492; SOHARA H, 1994, JPN CIRC J, V58, P821, DOI 10.1253/jcj.58.821; Somloi M, 2003, AM J CARDIOL, V92, P85, DOI 10.1016/S0002-9149(03)00476-4; Stein PD, 2004, ANN INTERN MED, V140, P589, DOI 10.7326/0003-4819-140-8-200404200-00005; Sugiura S, 2012, J INTERV CARD ELECTR, V34, P59, DOI 10.1007/s10840-011-9633-6; Topaloglu S, 2007, ANGIOLOGY, V58, P85, DOI 10.1177/0003319706297917; Turchetti V, 2001, CLIN HEMORHEOL MICRO, V25, P119; Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009; Wu N, 2015, CAN J CARDIOL, V31, P278, DOI 10.1016/j.cjca.2014.12.002; Yamamura O, 2001, ANGIOLOGY, V52, P749, DOI 10.1177/000331970105201104; Yoshida N, 2016, J MED ULTRASON, V43, P175, DOI 10.1007/s10396-015-0688-3	46	13	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0172272	10.1371/journal.pone.0172272	http://dx.doi.org/10.1371/journal.pone.0172272			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207839	Green Published, gold, Green Submitted			2022-12-27	WOS:000394424500112
J	Yang, SJ; Liu, DP; Liu, HB; Zhang, JY; Duan, ZQ				Yang, Shujuan; Liu, Danping; Liu, Hongbo; Zhang, Juying; Duan, Zhanqi			Relationship of work-family conflict, self-reported social support and job satisfaction to burnout syndrome among medical workers in southwest China: A cross-sectional study	PLOS ONE			English	Article							TURNOVER INTENTION; CARE WORKERS; STRESS; PHYSICIANS; NURSES; RISK	Background Burnout is a psychosomatic syndrome widely observed in Chinese medical workers due to the increasing cost of medical treatment, excessive workload, and excessive prescribing behavior. No studies have evaluated the interrelationship among occupational burnout, work-family conflict, social support, and job satisfaction in medical workers. The aim of this study was to evaluate these relationships among medical workers in southwest China. Methods This cross-sectional study was conducted between March 2013 and December 2013, and was based on the fifth National Health Service Survey (NHSS). A total of 1382 medical workers were enrolled in the study. Pearson correlation analysis and general linear model univariate analysis were used to evaluate the relationship of work-family conflict, self reported social support, and job satisfaction with burnout syndrome in medical workers. Results We observed that five dimensions of job satisfaction and self-reported social support were negatively associated with burnout syndrome, whereas three dimensions of work-family conflict showed a positive correlation. In a four-stage general linear model analysis, we found that demographic factors accounted for 5.4% of individual variance in burnout syndrome (F = 4.720, P<0.001, R-2 = 0.054), and that work-family conflict, self-reported social support, and job satisfaction accounted for 2.6% (F = 5.93, P<0.001, R-2 = 0.080), 5.7% (F = 9.532, P<0.001, R-2 = 0.137) and 17.8% (F = 21.608, P<0.001, R-2 = 0.315) of the variance, respectively. In the fourth stage of analysis, female gender and a lower technical title correlated to a higher level of burnout syndrome, and medical workers without administrative duties had more serious burnout syndrome than those with administrative duties. Conclusions In conclusion, the present study suggests that work-family conflict and self-reported social support slightly affect the level of burnout syndrome, and that job satisfaction is a much stronger influence on burnout syndrome in medical workers of southwest China.	[Yang, Shujuan; Liu, Danping] Sichuan Univ, West China Sch Publ Hlth, Dept Hlth Related Social & Behav Sci, Chengdu, Sichuan, Peoples R China; [Liu, Hongbo] Chinese Med Univ, Sch Publ Hlth, Dept Hlth Stat, Shenyang, Liaoning, Peoples R China; [Zhang, Juying] Sichuan Univ, West China Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Chengdu, Sichuan, Peoples R China; [Duan, Zhanqi] Ctr Hlth Informat Sichuan Prov, Chengdu, Sichuan, Peoples R China	Sichuan University; China Medical University; Sichuan University	Liu, DP (corresponding author), Sichuan Univ, West China Sch Publ Hlth, Dept Hlth Related Social & Behav Sci, Chengdu, Sichuan, Peoples R China.	liudanping03@163.com			fifth National Health Service Survey from Health and Family Planning Commission of Sichuan province [14QTZX005]	fifth National Health Service Survey from Health and Family Planning Commission of Sichuan province	This research was supported by grant funding from the special funding of the fifth National Health Service Survey from Health and Family Planning Commission of Sichuan province (14QTZX005) Prof. Juying Zhang, Ph.D Danping Liu.	Beschoner P, 2016, BUNDESGESUNDHEITSBLA, V59, P1343, DOI 10.1007/s00103-016-2431-7; BLUEDORN AC, 1982, HUM RELAT, V35, P135, DOI 10.1177/001872678203500204; Bonenberger M, 2014, HUM RESOUR HEALTH, V12, DOI 10.1186/1478-4491-12-43; Boujut E, 2016, J AUTISM DEV DISORD, V46, P2874, DOI 10.1007/s10803-016-2833-2; Chen Yu-Meng, 2016, Hu Li Za Zhi, V63, P87, DOI 10.6224/JN.63.1.87; China NHaFPCotPsRo, 2014, CHIN HLTH STAT YB 20; COHEN S, 1985, PSYCHOL BULL, V98, P310, DOI 10.1037/0033-2909.98.2.310; Conway N, 2009, INT REV IND ORGAN PS, V24, P71; Dall'Ora C, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008331; Silva DDD, 2015, REV ESC ENFERM USP, V49, P1023, DOI 10.1590/S0080-623420150000600020; DIMATTEO MR, 1993, HEALTH PSYCHOL, V12, P93, DOI 10.1037/0278-6133.12.2.93; Fogarty L, 2014, HUM RESOUR HEALTH, V12, DOI 10.1186/1478-4491-12-11; Folkman S, 2008, ANXIETY STRESS COPIN, V21, P3, DOI 10.1080/10615800701740457; FREUDENBERGER HJ, 1974, J SOC ISSUES, V30, P159, DOI 10.1111/j.1540-4560.1974.tb00706.x; Galletta M, 2016, RES NURS HEALTH, V39, P375, DOI 10.1002/nur.21733; GREENHAUS JH, 1985, ACAD MANAGE REV, V10, P76, DOI 10.5465/AMR.1985.4277352; He AJ, 2016, HEALTH ECON POLICY L, V11, P359, DOI 10.1017/S1744133116000128; Johnstone B, 2016, J GENET COUNS, V25, P731, DOI 10.1007/s10897-016-9968-3; [康勇军 Kang Yongjun], 2011, [中国临床心理学杂志, Chinese Journal of Clinical Psychology], V19, P234; Kramer T, 2016, INT J QUAL HLTH CARE; KRAUT AI, 1975, ORGAN BEHAV HUM PERF, V13, P233, DOI 10.1016/0030-5073(75)90047-1; Lu Y, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011388; Martini Mara, 2012, G Ital Med Lav Ergon, V34, pA41; Maslach C, 2001, ANNU REV PSYCHOL, V52, P397, DOI 10.1146/annurev.psych.52.1.397; Masum AKM, 2016, PEERJ, V4, DOI 10.7717/peerj.1896; Michael R Frone, 2003, HDB OCCUPATIONAL HLT, P143; Park Sun-A, 2015, Asian Pac J Cancer Prev, V16, P5463; PORTER LW, 1973, PSYCHOL BULL, V80, P151, DOI 10.1037/h0034829; Price JL, 2000, DEV CAUSAL MODEL VOL; Pu J, 2016, PSYCHOL HEALTH MED, P1; Qiao ZX, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2890-7; Richa N, 2016, ENCEPHALE, V42, P144, DOI 10.1016/j.encep.2015.12.016; Rouxel G, 2016, INT J NURS STUD, V62, P81, DOI 10.1016/j.ijnurstu.2016.07.010; Rzeszutek M, 2014, PSYCHOTHERAPY, V51, P574, DOI 10.1037/a0036020; Schaufeli W.B., 1996, MASLACH BURNOUT INVE, P19; Shanafelt TD, 2009, ANN SURG, V250, P463, DOI 10.1097/SLA.0b013e3181ac4dfd; Valente Mdo S, 2016, ANN OCCUP HYG, V60, P567, DOI [10.1093/annhyg/mew013, DOI 10.1093/ANNHYG/MEW013]; Xiao YB, 2014, EMERG MED AUSTRALAS, V26, P538, DOI 10.1111/1742-6723.12315; Ying GY, 2011, W CHINA MED J, V26, P735; Zhang S, 2015, J OPHTHALMOL, V2015, DOI 10.1155/2015/275435; Zhang YM, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-235; Zhou JW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157013; Zhou WJ, 2015, NURS HEALTH SCI, V17, P444, DOI 10.1111/nhs.12213	43	20	23	1	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0171679	10.1371/journal.pone.0171679	http://dx.doi.org/10.1371/journal.pone.0171679			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL2BG	28207821	Green Published, gold, Green Submitted			2022-12-27	WOS:000394424500046
J	Lee, J; Kim, HH; Ro, SM; Yang, JH				Lee, Jieun; Kim, Hyun Ho; Ro, Sang Mi; Yang, Ji Hyun			Capecitabine and cisplatin (XP) combination systemic chemotherapy in heavily pre-treated HER2 negative metastatic breast cancer	PLOS ONE			English	Article							PLATINUM-BASED CHEMOTHERAPY; CARCINOMA PATIENTS; PLUS CAPECITABINE; PHASE-II; ANTHRACYCLINE; TAXANE; MORTALITY; RESISTANT; DOUBLET	Purpose/Objective(s) After taxane and anthracycline failure, no standard chemotherapy regimen is established in metastatic breast cancer (MBC). Capecitabine and cisplatin (XP) combination shows promising results in gastrointestinal cancer, but there are relatively scarce data in MBC. We reviewed the clinical outcome of XP regimen in anthracycline and taxane resistant, heavily pretreated MBC patients. Materials/Methods Between Jan. 2010 to Feb. 2016, 48 HER2 negative MBC patients who failed anthracycline and taxane based chemotherapy were enrolled. In 43.8% of patients, more than 4 regimens were administrated before XP. Thirty- four patients (70.8%) were hormone receptor (HR) positive MBC. Patients were treated with XP (capecitabine [ 2000mg/m (2) per oral; day 1 -14] plus cisplatin [ 60mg/m (2) IV; day 1], every 3 weeks) regimen. Results Median progression-free survival (PFS) in total population was 4.33 months (range 1.1 similar to 33.57 months). HR positive patients showed trends for superior PFS compared to triple negative breast cancer (TNBC), without statistical significance (6.53 vs. 3.83 months, P = 0.168). In HR positive group, patients receiving 3 or less lines of chemotherapy showed superior PFS compared to others (10.1 vs. 3.0 months, P = 0.039). In multivariate analysis, HR positive patients receiving 3 or less lines of regimens still showed superior PFS (HR = 2.624, 95% CI; 1.071 similar to 6.43, P = 0.032). Most common toxicity was grade 3 - 4 neutropenia, without treatment-related deaths. Conclusions XP combination regimen showed clinical benefit with tolerable toxicity in heavily pretreated patients, including HR positive patients. After anthracycline and taxane failure, early administration of XP regimen in selected patients may have improve clinical outcome in breast cancer.	[Lee, Jieun; Kim, Hyun Ho; Ro, Sang Mi; Yang, Ji Hyun] Catholic Univ Korea, Coll Med, Dept Internal Med, Div Med Oncol, Seoul, South Korea; [Lee, Jieun] Catholic Univ Korea, Canc Res Inst, Seoul, South Korea	Catholic University of Korea; Catholic University of Korea	Lee, J (corresponding author), Catholic Univ Korea, Coll Med, Dept Internal Med, Div Med Oncol, Seoul, South Korea.; Lee, J (corresponding author), Catholic Univ Korea, Canc Res Inst, Seoul, South Korea.	befamiliar@catholic.ac.kr						Andreopoulou E, 2013, CURR BREAST CANCER R, V5, P42, DOI 10.1007/s12609-012-0097-1; Andres Raquel, 2005, Clin Breast Cancer, V6, P158; Cardoso F, 2012, ANN ONCOL, V23, P11, DOI 10.1093/annonc/mds232; Crown JP, 2001, SEMIN ONCOL, V28, P28, DOI 10.1053/sonc.2001.22814; Decatris MP, 2004, CANCER TREAT REV, V30, P53, DOI 10.1016/S0305-7372(03)00139-7; Donadio M, 2005, ONCOLOGY-BASEL, V69, P408, DOI 10.1159/000089995; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Ghosn M, 2006, ANTICANCER RES, V26, P2451; Jung KW, 2015, CANCER RES TREAT, V47, P142, DOI 10.4143/crt.2015.066; Li Q, 2015, CANCER BIOL THER, V16, P1746, DOI 10.1080/15384047.2015.1095400; Massacesi C, 2006, ONCOLOGY-BASEL, V70, P294, DOI 10.1159/000096250; Moreno-Aspitia A, 2009, MAYO CLIN PROC, V84, P533, DOI 10.1016/S0025-6196(11)60585-5; National Comprehensive Cancer Network, 2021, NCCN CLIN PRACTICE G; Oksuzoglu B, 2008, CHEMOTHERAPY, V54, P352, DOI 10.1159/000151630; Ozdemir N, 2013, J BUON, V18, P831; Ozkan M, 2012, NEOPLASMA, V59, P38, DOI 10.4149/neo_2012_005; Silver DP, 2010, J CLIN ONCOL, V28, P1145, DOI 10.1200/JCO.2009.22.4725; Sirohi B, 2008, ANN ONCOL, V19, P1847, DOI 10.1093/annonc/mdn395; SPAETH D, 1993, B CANCER, V80, P351; Staudacher L, 2011, ANN ONCOL, V22, P848, DOI 10.1093/annonc/mdq461; Thomas ES, 2007, J CLIN ONCOL, V25, P5210, DOI 10.1200/JCO.2007.12.6557	21	3	3	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e71605	10.1371/journal.pone.0171605	http://dx.doi.org/10.1371/journal.pone.0171605			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5VB	28234911	Green Published, Green Submitted, gold			2022-12-27	WOS:000394688200027
J	Blanco-Kelly, F; Palomares, M; Vallespin, E; Villaverde, C; Martin-Arenas, R; Velez-Monsalve, C; Lorda-Sanchez, I; Nevado, J; Trujillo-Tiebas, MJ; Lapunzina, P; Ayuso, C; Corton, M				Blanco-Kelly, Fiona; Palomares, Maria; Vallespin, Elena; Villaverde, Cristina; Martin-Arenas, Ruben; Velez-Monsalve, Camilo; Lorda-Sanchez, Isabel; Nevado, Julian; Jose Trujillo-Tiebas, Maria; Lapunzina, Pablo; Ayuso, Carmen; Corton, Marta			Improving molecular diagnosis of aniridia and WAGR syndrome using customized targeted array-based CGH	PLOS ONE			English	Article							PAX6 GENE; WILMS-TUMOR; CHROMOSOMAL MICROARRAY; FAMILIAL ANIRIDIA; DELETIONS; REARRANGEMENTS; IMBALANCES; PHENOTYPE; GLAUCOMA	Chromosomal deletions at 11p13 are a frequent cause of congenital Aniridia, a rare panocular genetic disease, and of WAGR syndrome, accounting up to 30% of cases. First-tier genetic testing for newborn with aniridia, to detect 11p13 rearrangements, includes Multiplex Ligation-dependent Probe Amplification (MLPA) and karyotyping. However, neither of these approaches allow obtaining a complete picture of the high complexity of chromosomal deletions and breakpoints in aniridia. Here, we report the development and validation of a customized targeted array-based comparative genomic hybridization, so called WAGR-array, for comprehensive high-resolution analysis of CNV in the WAGR locus. Our approach increased the detection rate in a Spanish cohort of 38 patients with aniridia, WAGR syndrome and other related ocular malformations, allowing to characterize four undiagnosed aniridia cases, and to confirm MLPA findings in four additional patients. For all patients, breakpoints were accurately established and a contiguous deletion syndrome, involving a large number of genes, was identified in three patients. Moreover, we identified novel micro-deletions affecting 3' PAX6 regulatory regions in three families with isolated aniridia. This tool represents a good strategy for the genetic diagnosis of aniridia and associated syndromes, allowing for a more accurate CNVs detection, as well as a better delineation of breakpoints. Our results underline the clinical importance of performing exhaustive and accurate analysis of chromosomal rearrangements for patients with aniridia, especially new-borns and those without defects in PAX6 after diagnostic screening.	[Blanco-Kelly, Fiona; Villaverde, Cristina; Velez-Monsalve, Camilo; Lorda-Sanchez, Isabel; Jose Trujillo-Tiebas, Maria; Ayuso, Carmen; Corton, Marta] Univ Autonoma Madrid, Dept Genet & Genom, Inst Invest Sanitaria, Fdn Jimenez Diaz Univ Hosp, Madrid, Spain; [Blanco-Kelly, Fiona; Palomares, Maria; Vallespin, Elena; Villaverde, Cristina; Martin-Arenas, Ruben; Velez-Monsalve, Camilo; Lorda-Sanchez, Isabel; Nevado, Julian; Jose Trujillo-Tiebas, Maria; Lapunzina, Pablo; Ayuso, Carmen; Corton, Marta] ISCIII, Ctr Biomed Network Res Rare Dis CIBERER, Madrid, Spain; [Palomares, Maria; Vallespin, Elena; Martin-Arenas, Ruben; Lapunzina, Pablo] Univ Autonoma Madrid, IdiPAZ, Hosp Univ La Paz, Inst Med & Mol Genet INGEMM, Madrid, Spain	Autonomous University of Madrid; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Instituto de Salud Carlos III; Autonomous University of Madrid; Hospital Universitario La Paz	Ayuso, C; Corton, M (corresponding author), Univ Autonoma Madrid, Dept Genet & Genom, Inst Invest Sanitaria, Fdn Jimenez Diaz Univ Hosp, Madrid, Spain.; Ayuso, C; Corton, M (corresponding author), ISCIII, Ctr Biomed Network Res Rare Dis CIBERER, Madrid, Spain.	cayuso@fjd.es; mcorton@fjd.es	Vallespin, Elena/E-5277-2018; nevado, julian/ADX-5844-2022; Lapunzina, Pablo/L-7075-2014	Vallespin, Elena/0000-0002-8080-8629; nevado, julian/0000-0001-5611-2659; Blanco-Kelly, Fiona/0000-0003-0052-5651; Martin Arenas, Ruben/0000-0003-4022-1783; Lapunzina, Pablo/0000-0002-6324-4825; Ayuso, Carmen/0000-0002-9242-7065; Corton, Marta/0000-0003-0087-1626; Palomares-Bralo, Maria/0000-0002-2727-7654	Spanish Centre for Biomedical Network Research on Rare Diseases (CIBERER) [06/07/0036, INTRA/07/704.1]; Institute de Salud Carlos Ill (Spanish Ministry of Health)/FEDER [CP12/03256]; RETICS [RD09/0076/00101, RD12/0034/0010]; Ministry of Economy and Competitiveness/FEDER (MINECO) [SAF2013-46943-R]; Catedra de Patrocinio HU-FJD-UAM "Medicina Genomica"; Fundacion Mutua Madrilena; Miguel Servet Program from Institute de Salud Carlos Ill (Spanish Ministry of Health) [CP12/03256]	Spanish Centre for Biomedical Network Research on Rare Diseases (CIBERER); Institute de Salud Carlos Ill (Spanish Ministry of Health)/FEDER; RETICS; Ministry of Economy and Competitiveness/FEDER (MINECO); Catedra de Patrocinio HU-FJD-UAM "Medicina Genomica"; Fundacion Mutua Madrilena(Instituto de Salud Carlos III); Miguel Servet Program from Institute de Salud Carlos Ill (Spanish Ministry of Health)	This work was supported by several grants from the Spanish Centre for Biomedical Network Research on Rare Diseases (CIBERER) (06/07/0036 and INTRA/07/704.1), Institute de Salud Carlos Ill (Spanish Ministry of Health)/FEDER (CP12/03256), RETICS (RD09/0076/00101 and RD12/0034/0010), Ministry of Economy and Competitiveness/FEDER (MINECO, SAF2013-46943-R), and the Catedra de Patrocinio HU-FJD-UAM "Medicina Genomica" and Fundacion Mutua Madrilena. MC is sponsored by the Miguel Servet Program (CP12/03256) from Institute de Salud Carlos Ill (Spanish Ministry of Health). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansari M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153757; Aradhya S, 2012, GENET MED, V14, P594, DOI 10.1038/gim.2011.65; Askree SH, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-116; Balikova I, 2011, AM J OPHTHALMOL, V151, P1087, DOI 10.1016/j.ajo.2010.11.025; Bayrakli F, 2009, J CLIN NEUROSCI, V16, P1610, DOI 10.1016/j.jocn.2009.03.022; Blanco-Kelly F, 2013, Arch Soc Esp Oftalmol, V88, P145, DOI 10.1016/j.oftal.2012.07.006; Breslow NE, 2005, J UROLOGY, V174, P1972, DOI 10.1097/01.ju.0000176800.00994.3a; Busch M, 2013, AM J MED GENET A, V161A, P958, DOI 10.1002/ajmg.a.35818; Cheng F, 2011, MOL VIS, V17, P448; Clericuzio C, 2011, EUR J HUM GENET, V19, DOI 10.1038/ejhg.2010.220; Crolla JA, 2002, AM J HUM GENET, V71, P1138, DOI 10.1086/344396; Crolla JA, 1997, J MED GENET, V34, P207, DOI 10.1136/jmg.34.3.207; D'Elia AV, 2007, MOL VIS, V13, P1245; del Gaudio D, 2008, HUM MUTAT, V29, P1100, DOI 10.1002/humu.20841; Delahaye A, 2012, EXPERT REV MOL DIAGN, V12, P425, DOI [10.1586/ERM.12.41, 10.1586/erm.12.41]; FANTES J, 1995, HUM MOL GENET, V4, P415, DOI 10.1093/hmg/4.3.415; Gramer E, 2012, EUR J OPHTHALMOL, V22, P104, DOI 10.5301/EJO.2011.8318; Guo HQ, 2013, IEEE T VIS COMPUT GR, V19, P2733, DOI 10.1109/TVCG.2013.144; Hingorani M, 1993, ANIRIDIA; Hingorani M, 2012, EUR J HUM GENET, V20, P1011, DOI 10.1038/ejhg.2012.100; Ito YA, 2009, INVEST OPHTH VIS SCI, V50, P3573, DOI 10.1167/iovs.08-3032; Khan AO, 2008, OPHTHALMIC GENET, V29, P67, DOI 10.1080/13816810801908152; Kleinjan DA, 2006, DEV BIOL, V299, P563, DOI 10.1016/j.ydbio.2006.08.060; Lauderdale J, 2000, P NATL ACAD SCI USA, V97, P13755, DOI 10.1073/pnas.240398797; Miller DT, 2010, AM J HUM GENET, V86, P749, DOI 10.1016/j.ajhg.2010.04.006; MILLER RW, 1964, NEW ENGL J MED, V270, P922, DOI 10.1056/NEJM196404302701802; Morice-Picard F, 2014, PIGM CELL MELANOMA R, V27, DOI 10.1111/pcmr.12173; Quemener S, 2010, HUM MUTAT, V31, P421, DOI 10.1002/humu.21196; Raca G, 2011, GENET MED, V13, P437, DOI 10.1097/GIM.0b013e318204cfd2; Redeker EJW, 2008, MOL VIS, V14, P836; Richardson R, 2016, EUR J HUM GENET, V24, DOI 10.1038/ejhg.2016.73; Robinson DO, 2008, AM J MED GENET A, V146A, P558, DOI 10.1002/ajmg.a.32209; Sadagopan KA, 2015, AM J MED GENET A, V167, P524, DOI 10.1002/ajmg.a.36890; Shaham O, 2012, PROG RETIN EYE RES; Vallespin E, 2013, AM J MED GENET A, V161, P1950, DOI 10.1002/ajmg.a.35960; Van Cauwenbergh C, 2016, GENET MED; van Heyningen V, 2007, J MED GENET, V44, P787, DOI 10.1136/jmg.2007.051318; Vasson A, 2013, EUR J HUM GENET, V21, P977, DOI 10.1038/ejhg.2012.279; Vermeesch JR, 2012, HUM MUTAT, V33, P906, DOI 10.1002/humu.22076; Wang Jisi, 2012, MONOGRAPH SERIES, V4, P13, DOI DOI 10.1016/J.YMGME.2012.03.005; Wawrocka A, 2012, OPHTHALMIC GENET, V33, P44, DOI 10.3109/13816810.2011.615076; Xu S, 2008, CYTOGENET GENOME RES, V122, P181, DOI 10.1159/000172086	42	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2017	12	2							e0172363	10.1371/journal.pone.0172363	http://dx.doi.org/10.1371/journal.pone.0172363			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5SX	28231309	Green Published, gold, Green Submitted			2022-12-27	WOS:000394682400039
J	Philips, JG; Naim, F; Lorenc, MT; Dudley, KJ; Hellens, RP; Waterhouse, PM				Philips, Joshua G.; Naim, Fatima; Lorenc, Michal T.; Dudley, Kevin J.; Hellens, Roger P.; Waterhouse, Peter M.			The widely used Nicotiana benthamiana 16c line has an unusual T-DNA integration pattern including a transposon sequence	PLOS ONE			English	Article							ENDOGENE-RESEMBLING TRANSGENE; SILENCING SUPPRESSOR; RNA; GENOME; DEGRADATION; INITIATION; BACTERIA; ELEMENTS; PROTEIN; TN5393	Nicotiana benthamiana is employed around the world for many types of research and one transgenic line has been used more extensively than any other. This line, 16c, expresses the Aequorea victoria green fluorescent protein (GFP), highly and constitutively, and has been a major resource for visualising the mobility and actions of small RNAs. Insights into the mechanisms studied at a molecular level in N. benthamiana 16c are likely to be deeper and more accurate with a greater knowledge of the GFP gene integration site. Therefore, using next generation sequencing, genome mapping and local alignment, we identified the location and characteristics of the integrated T-DNA. As suggested from previous molecular hybridisation and inheritance data, the transgenic line contains a single GFP-expressing locus. However, the GFP coding sequence differs from that originally reported. Furthermore, a 3.2 kb portion of a transposon, appears to have co-integrated with the T-DNA. The location of the integration mapped to a region of the genome represented by Nbv0.5scaffold4905 in the www.benthgenome.com assembly, and with less integrity to Niben101Scf03641 in the www.solgenomics.net assembly. The transposon is not endogenous to laboratory strains of N. benthamiana or Agrobacterium tumefaciens strain GV3101 (MP90), which was reportedly used in the generation of line 16c. However, it is present in the popular LBA4404 strain. The integrated transposon sequence includes its 5' terminal repeat and a transposase gene, and is immediately adjacent to the GFP gene. This unexpected genetic arrangement may contribute to the characteristics that have made the 16c line such a popular research tool and alerts researchers, taking transgenic plants to commercial release, to be aware of this genomic hitchhiker.	[Philips, Joshua G.; Naim, Fatima; Lorenc, Michal T.; Hellens, Roger P.; Waterhouse, Peter M.] Queensland Univ Technol, Ctr Trop Crops & Biocommod, Brisbane, Qld, Australia; [Dudley, Kevin J.] Queensland Univ Technol, Inst Future Environm, Cent Analyt Res Facil, Brisbane, Qld, Australia; [Hellens, Roger P.; Waterhouse, Peter M.] Queensland Univ Technol, Inst Future Environm, Brisbane, Qld, Australia	Queensland University of Technology (QUT); Queensland University of Technology (QUT); Queensland University of Technology (QUT)	Waterhouse, PM (corresponding author), Queensland Univ Technol, Ctr Trop Crops & Biocommod, Brisbane, Qld, Australia.; Waterhouse, PM (corresponding author), Queensland Univ Technol, Inst Future Environm, Brisbane, Qld, Australia.	Peter.Waterhouse@qut.edu.au	Philips, Joshua G./R-7781-2016	Philips, Joshua G./0000-0001-7022-2897; Waterhouse, Peter/0000-0002-2812-3753; Naim, Fatima/0000-0001-8451-1104; Lorenc, Michal/0000-0002-7421-121X; Dudley, Kevin/0000-0001-5762-1068	ARC Laureate Fellowship [FL160100155]	ARC Laureate Fellowship(Australian Research Council)	This work was supported by an ARC Laureate Fellowship (FL160100155).	Bally J, 2015, NATURE PLANTS, P1; Baumberger N, 2007, CURR BIOL, V17, P1609, DOI 10.1016/j.cub.2007.08.039; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bombarely A, 2012, MOL PLANT MICROBE IN, V25, P1523, DOI 10.1094/MPMI-06-12-0148-TA; CHIOU CS, 1993, J BACTERIOL, V175, P732, DOI 10.1128/JB.175.3.732-740.1993; Dadami E, 2014, RNA BIOL, V11, P934, DOI 10.4161/rna.29623; Dadami E, 2013, FEBS LETT, V587, P706, DOI 10.1016/j.febslet.2013.01.045; Fusaro AF, 2012, VIROLOGY, V426, P178, DOI 10.1016/j.virol.2012.01.026; Goodin MM, 2008, MOL PLANT MICROBE IN, V21, P1015, DOI 10.1094/MPMI-21-8-1015; Haseloff J, 2005, USES GREEN FLUORESCE, P259; Henkel CV, 2014, GENOME ANNOUNCEMENTS, V2; JEFFERSON RA, 1987, EMBO J, V6, P3901; Kim SR, 2012, MOL CELLS, V33, P583, DOI 10.1007/s10059-012-0010-9; L'abee-Lund TM, 2000, APPL ENVIRON MICROB, V66, P5533, DOI 10.1128/AEM.66.12.5533-5535.2000; Li JF, 2013, NAT BIOTECHNOL, V31, P688, DOI 10.1038/nbt.2654; Naim F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052717; Nakasugi K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059534; Nekrasov V, 2013, NAT BIOTECHNOL, V31, P691, DOI 10.1038/nbt.2655; Nuthikattu S, 2013, PLANT PHYSIOL, V162, P116, DOI 10.1104/pp.113.216481; Ruiz MT, 1998, PLANT CELL, V10, P937, DOI 10.1105/tpc.10.6.937; Slotkin RK, 2007, NAT REV GENET, V8, P272, DOI 10.1038/nrg2072; SUNDIN GW, 1995, CAN J MICROBIOL, V41, P792, DOI 10.1139/m95-109; Takeda A, 2002, FEBS LETT, V532, P75, DOI 10.1016/S0014-5793(02)03632-3; WANG K, 1987, SCIENCE, V235, P587, DOI 10.1126/science.235.4788.587	24	13	14	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2017	12	2							e0171311	10.1371/journal.pone.0171311	http://dx.doi.org/10.1371/journal.pone.0171311			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5SX	28231340	Green Published, gold, Green Submitted			2022-12-27	WOS:000394682400011
J	Stahnke, T; Kowtharapu, BS; Stachs, O; Schmitz, KP; Wurm, J; Wree, A; Guthoff, RF; Hovakimyan, M				Stahnke, Thomas; Kowtharapu, Bhavani S.; Stachs, Oliver; Schmitz, Klaus-Peter; Wurm, Johannes; Wree, Andreas; Guthoff, Rudolf Friedrich; Hovakimyan, Marina			Suppression of TGF-beta pathway by pirfenidone decreases extracellular matrix deposition in ocular fibroblasts in vitro	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; FOLLOW-UP; FIBROSIS; MECHANISMS; THERAPY; TRABECULECTOMY; PROLIFERATION; ACTIVATION; EXPRESSION; SURGERY	In glaucoma surgery, fibrotic processes occur, leading to impairment of liquid outflow. Activated fibroblasts are responsible for postoperative scarring. The transforming growth factor-beta (TGF-beta) pathway plays a key role in fibroblast function, differentiation and proliferation. The aim of this study was the characterization of the fibrotic potential of two subtypes of primary human ocular fibroblasts and the attempt to inhibit fibrotic processes specifically, without impairing cell viability. For fibrosis inhibition we focused on the small molecule pirfenidone, which has been shown to prevent pulmonary fibrosis by the decrease of the expression of TGF-beta 1, TGF-beta 2 and TGF-beta 3 cytokines. For in vitro examinations, isolated human primary fibroblasts from Tenon capsule and human intraconal orbital fat tissues were used. These fibroblast subpopulations were analyzed in terms of the expression of matrix components responsible for postoperative scarring. We concentrated on the expression of collagen I, III, VI and fibronectin. Additionally, we analyzed the expression of alpha-smooth muscle actin, which serves as a marker for fibrosis and indicates transformation of fibroblasts into myofibroblasts. Gene expression was analyzed by rtPCR and synthesized proteins were examined by immunofluorescence and Western blot methods. Proliferation of fibroblasts under different culture conditions was assessed using BrdU assay. TGF-beta 1 induced a significant increase of cell proliferation in both cell types. Also the expression of some fibrotic markers was elevated. In contrast, pirfenidone decreased cell proliferation and matrix synthesis in both fibroblast subpopulations. Pirfenidone slightly attenuated TGF-beta 1 induced expression of fibronectin and a-smooth muscle actin in fibroblast cultures, without impairing cell viability. To summarize, manipulation of the TGF-beta signaling pathway by pirfenidone represents a specific antifibrotic approach with no toxic side effects in two human orbital fibroblast subtypes. We presume that pirfenidone is a promising candidate for the treatment of fibrosis following glaucoma surgery.	[Stahnke, Thomas; Kowtharapu, Bhavani S.; Stachs, Oliver; Guthoff, Rudolf Friedrich] Univ Rostock, Med Ctr, Dept Ophthalmol, Rostock, Germany; [Schmitz, Klaus-Peter; Hovakimyan, Marina] Univ Rostock, Med Ctr, Inst Biomed Engn, Rostock, Germany; [Wurm, Johannes; Wree, Andreas] Univ Rostock, Med Ctr, Dept Anat, Rostock, Germany	University of Rostock; University of Rostock; University of Rostock	Stahnke, T (corresponding author), Univ Rostock, Med Ctr, Dept Ophthalmol, Rostock, Germany.	thomas.stahnke@med.uni-rostock.de	Wurm, Johannes/AAA-8249-2019; Kowtharapu, Bhavani S./AAQ-7603-2020	Kowtharapu, Bhavani S./0000-0002-2336-5729	Bundesministerium fur Bildungund Forschung (BMBF) [FKZ: 03IS2081]	Bundesministerium fur Bildungund Forschung (BMBF)(Federal Ministry of Education & Research (BMBF))	The work was financially supported by Bundesministerium fur Bildungund Forschung (BMBF) with in the REMEDIS project "Hohere Lebensqualitat durch neuartige Mikroimplantate" (FKZ: 03IS2081). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Mrs. C. Leyh and Mrs. J. Weiss-Muller for skillful technical assistance. The work was financially supported by Bundesministerium fur Bildung und Forschung (BMBF) within the REMEDIS project "Hohere Lebensqualitat durch neuartige Mikroimplantate" (FKZ: 03IS2081).	Annes JP, 2003, J CELL SCI, V116, P217, DOI 10.1242/jcs.00229; Astrom S, 2007, ACTA OPHTHALMOL SCAN, V85, P832, DOI 10.1111/j.1600-0420.2007.00980.x; Baudouin C, 2010, PROG RETIN EYE RES, V29, P312, DOI 10.1016/j.preteyeres.2010.03.001; Bettin P, 2013, OPHTHALMIC RES, V50, P197, DOI 10.1159/000348736; Bornstein P, 2001, J CLIN INVEST, V107, P929, DOI 10.1172/JCI12749; Burghardt I, 2007, BIOCHEM BIOPH RES CO, V354, P542, DOI 10.1016/j.bbrc.2007.01.012; Coleman AL, 2012, INVEST OPHTH VIS SCI, V53, P2491, DOI 10.1167/iovs.12-9483l; Cordeiro MF, 2003, GENE THER, V10, P59, DOI 10.1038/sj.gt.3301865; Di Sario A, 2002, J HEPATOL, V37, P584, DOI 10.1016/S0168-8278(02)00245-3; FECHTNER RD, 1994, SURV OPHTHALMOL, V39, P23, DOI 10.1016/S0039-6257(05)80042-6; Gassmann M, 2009, ELECTROPHORESIS, V30, P1845, DOI 10.1002/elps.200800720; Gedde SJ, 2013, CURR OPIN OPHTHALMOL, V24, P87, DOI 10.1097/ICU.0b013e32835cf0f5; Gedde SJ, 2012, AM J OPHTHALMOL, V153, P789, DOI 10.1016/j.ajo.2011.10.026; Grizzi F, 2009, CLIN EXP PHARMACOL P, V36, P961, DOI 10.1111/j.1440-1681.2009.05262.x; Hewitson TD, 2001, J NEPHROL, V14, P453; Hilberg O, 2012, CLIN RESPIR J, V6, P131, DOI 10.1111/j.1752-699X.2012.00302.x; Hollo G, 2012, DEV OPHTHALMOL, V50, P79, DOI 10.1159/000334790; Hong CH, 2005, SURV OPHTHALMOL, V50, P48, DOI 10.1016/j.survophthal.2004.10.006; Howard EW, 2012, EXP CELL RES, V318, P1542, DOI 10.1016/j.yexcr.2012.03.007; Kass MA, 2002, ARCH OPHTHALMOL-CHIC, V120, P701; Kim H.T., 2010, INT C 2 COMP ENG TEC, V6, pV6, DOI DOI 10.1371/J0URNAL.PPAT.1000992; Lin XC, 2009, INVEST OPHTH VIS SCI, V50, P3763, DOI 10.1167/iovs.08-2815; Mahale A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122409; Min J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035627; NEUHOFF V, 1979, H-S Z PHYSIOL CHEM, V360, P1657, DOI 10.1515/bchm2.1979.360.2.1657; Nordstrom BL, 2005, AM J OPHTHALMOL, V140, P598, DOI 10.1016/j.ajo.2005.04.051; Olali C, 2011, CLIN EXP OPHTHALMOL, V39, P658, DOI 10.1111/j.1442-9071.2011.02519.x; Palmberg P, 2001, ARCH OPHTHALMOL-CHIC, V119, P897; Pfeiffer N, 2013, CELL TISSUE RES, V353, P245, DOI 10.1007/s00441-013-1671-1; Pohjolainen V, 2012, ATHEROSCLEROSIS, V220, P66, DOI 10.1016/j.atherosclerosis.2011.10.003; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Quigley HA, 2005, OPHTHALMOLOGY, V112, P1642, DOI 10.1016/j.ophtha.2005.05.024; Quigley HA, 2011, LANCET, V377, P1367, DOI 10.1016/S0140-6736(10)61423-7; Sassoli C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063896; Schwartz Kenneth, 2004, Curr Opin Ophthalmol, V15, P119, DOI 10.1097/00055735-200404000-00011; Shi Q, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028134; Spitzer MS, 2012, CURR EYE RES, V37, P463, DOI 10.3109/02713683.2012.658593; Stahnke T, 2012, EXP EYE RES, V100, P88, DOI 10.1016/j.exer.2012.04.015; Takakuta K, 2010, EUR J PHARMACOL, V629, P118, DOI 10.1016/j.ejphar.2009.12.011; Tian Xin-lun, 2006, Chinese Medical Sciences Journal, V21, P145; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Zeisberg M, 2013, AM J PHYSIOL-CELL PH, V304, pC216, DOI 10.1152/ajpcell.00328.2012; Zhong H, 2011, INVEST OPHTH VIS SCI, V52, P3136, DOI 10.1167/iovs.10-6240	43	56	61	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2017	12	2							e0172592	10.1371/journal.pone.0172592	http://dx.doi.org/10.1371/journal.pone.0172592			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5SX	28231275	gold, Green Published, Green Submitted			2022-12-27	WOS:000394682400059
J	Duque-Sosa, P; Martinez-Urbistondo, D; Echarri, G; Callejas, R; Iribarren, MJ; Rabago, G; Monedero, P				Duque-Sosa, Paula; Martinez-Urbistondo, Diego; Echarri, Gemma; Callejas, Raquel; Josefa Iribarren, Maria; Rabago, Gregorio; Monedero, Pablo		Spanish Grp Renal Dysfunction Card	Perioperative hemoglobin area under the curve is an independent predictor of renal failure after cardiac surgery. Results from a Spanish multicenter retrospective cohort study	PLOS ONE			English	Article							ACUTE KIDNEY INJURY; BLOOD-CELL TRANSFUSION; PREOPERATIVE ANEMIA; ADVERSE OUTCOMES; SERUM CREATININE; RISK-FACTORS; MORTALITY; METAANALYSIS; ASSOCIATION; DYSFUNCTION	Perioperative anemia is an important risk factor for cardiac surgery-associated acute kidney injury (CSA-AKI). Nonetheless, the severity of the anemia and the time in the perioperative period in which the hemoglobin level should be considered as a risk factor is conflicting. The present study introduces the concept of perioperative hemoglobin area under the curve (pHb-AUC) as a surrogate marker of the evolution of perioperative hemoglobin concentration. Through a retrospective analysis of prospectively collected data, we assessed this new variable as a risk factor for the development of acute kidney injury after cardiac surgery in 966 adult patients who underwent cardiac surgery with cardiopulmonary bypass, at twenty-three academic hospitals in Spain. Exclusion criteria were patients on renal replacement therapy, who needed a reoperation because of bleeding and/or with missing perioperative hemoglobin or creatinine values. Using a multivariate regression analysis, we found that a pHb-AUC < 19 g/dL was an independent risk factor for CSA-AKI even after adjustment for intraoperative red blood cell transfusion (OR 1.41, p < 0.05). It was also associated with mortality (OR 2.48, p < 0.01) and prolonged hospital length of stay (4.67 +/- 0.99 days, p < 0.001).	[Duque-Sosa, Paula; Echarri, Gemma; Callejas, Raquel; Monedero, Pablo] Clin Univ Navarra, Dept Anesthesia & Crit Care, Pamplona, Navarra, Spain; [Martinez-Urbistondo, Diego] Clin Univ Navarra, Div Intermediate Care, Dept Internal Med, Pamplona, Navarra, Spain; [Martinez-Urbistondo, Diego] Clin Univ Navarra, Hospitalists Unit, Pamplona, Navarra, Spain; [Rabago, Gregorio] Clin Univ Navarra, Dept Cardiovasc Surg, Pamplona, Navarra, Spain	University of Navarra; University of Navarra; University of Navarra; University of Navarra	Duque-Sosa, P (corresponding author), Clin Univ Navarra, Dept Anesthesia & Crit Care, Pamplona, Navarra, Spain.	pduque@unav.es	Tamayo, Eduardo/AAO-9127-2020; Rabago, Gregorio/I-2427-2017; Badenes, Rafael/K-6628-2019; Monedero, Pablo/A-1696-2008; Callejas, Raquel/AAC-4726-2022; Garcia-Fernandez, Nuria/X-2498-2019	Tamayo, Eduardo/0000-0001-8900-0944; Rabago, Gregorio/0000-0003-1936-6881; Badenes, Rafael/0000-0001-7017-0150; Monedero, Pablo/0000-0002-1596-5644; Callejas, Raquel/0000-0001-7841-1190; Echarri, Gemma/0000-0002-6282-1264; Garcia-Fernandez, Nuria/0000-0003-1082-0806; PUIG, JAUME/0000-0001-8272-3859; Martinez-Urbistondo, Diego/0000-0002-0530-7349				Brown JR, 2006, CIRCULATION, V114, pI409, DOI 10.1161/CIRCULATIONAHA.105.000596; Chertow GM, 1998, AM J MED, V104, P343, DOI 10.1016/S0002-9343(98)00058-8; Chertow GM, 2005, J AM SOC NEPHROL, V16, P3365, DOI 10.1681/ASN.2004090740; Chertow GM, 1997, CIRCULATION, V95, P878; Coleman MD, 2011, CURR OPIN ANESTHESIO, V24, P70, DOI 10.1097/ACO.0b013e3283422ebc; Eckardt KU, 2012, KIDNEY INT SUPPL, V2, P7, DOI 10.1038/kisup.2012.8; Fowler AJ, 2015, BRIT J SURG, V102, P1314, DOI 10.1002/bjs.9861; Hobson CE, 2009, CIRCULATION, V119, P2444, DOI 10.1161/CIRCULATIONAHA.108.800011; Karkouti K, 2008, CIRCULATION, V117, P478, DOI 10.1161/CIRCULATIONAHA.107.718353; Karkouti K, 2008, TRANSFUSION, V48, P666, DOI 10.1111/j.1537-2995.2007.01590.x; Karkouti K, 2015, CAN J ANESTH, V62, P377, DOI 10.1007/s12630-014-0302-y; Karkouti K, 2012, ANESTHESIOLOGY, V117, P1175, DOI 10.1097/ALN.0b013e318271604e; Karkouti K, 2012, ANESTHESIOLOGY, V116, P613, DOI 10.1097/ALN.0b013e3182475e39; Karkouti K, 2011, ANESTHESIOLOGY, V115, P523, DOI 10.1097/ALN.0b013e318229a7e8; Karkouti K, 2009, CIRCULATION, V119, P495, DOI 10.1161/CIRCULATIONAHA.108.786913; Kolli H, 2010, RENAL FAILURE, V32, P1066, DOI 10.3109/0886022X.2010.510616; Loor G, 2013, J THORAC CARDIOV SUR, V146, P1480, DOI 10.1016/j.jtcvs.2013.06.033; Mangano CM, 1998, ANN INTERN MED, V128, P194, DOI 10.7326/0003-4819-128-3-199802010-00005; Mehta RH, 2006, CIRCULATION, V114, P2208, DOI 10.1161/CIRCULATIONAHA.106.635573; Moulton MJ, 1996, J THORAC CARDIOV SUR, V111, P1037, DOI 10.1016/S0022-5223(96)70380-X; Nashef SAM, 1999, EUR J CARDIO-THORAC, V16, P9, DOI 10.1016/S1010-7940(99)00134-7; Parida S, 2013, J ANESTH, V27, P433, DOI 10.1007/s00540-012-1523-2; Pickering JW, 2015, AM J KIDNEY DIS, V65, P283, DOI 10.1053/j.ajkd.2014.09.008; Praught ML, 2005, CURR OPIN NEPHROL HY, V14, P265, DOI 10.1097/01.mnh.0000165894.90748.72; Ranucci M, 2014, MINERVA ANESTESIOL, V80, P885; Rosner MH, 2006, CLIN J AM SOC NEPHRO, V1, P19, DOI 10.2215/CJN.00240605; Shander A, 2011, BRIT J ANAESTH, V107, P41, DOI 10.1093/bja/aer350; Thakar CV, 2005, KIDNEY INT, V67, P1112, DOI 10.1111/j.1523-1755.2005.00177.x; Thakar CV, 2005, J AM SOC NEPHROL, V16, P162, DOI 10.1681/ASN.2004040331; Wijeysundera DN, 2007, JAMA-J AM MED ASSOC, V297, P1801, DOI 10.1001/jama.297.16.1801; World Health Organization, 2016, IR DEF AN ASS PREV C; ZANARDO G, 1994, J THORAC CARDIOV SUR, V107, P1489, DOI 10.1016/S0022-5223(94)70429-5	32	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2017	12	2							e0172021	10.1371/journal.pone.0172021	http://dx.doi.org/10.1371/journal.pone.0172021			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5SK	28225801	Green Submitted, gold, Green Published			2022-12-27	WOS:000394680900027
J	Visser, MS; Amarakoon, S; Missotten, T; Timman, R; Busschbach, JJ				Visser, Martijn S.; Amarakoon, Sankha; Missotten, Tom; Timman, Reinier; Busschbach, Jan J.			SF-6D utility values for the better- and worse-seeing eye for health states based on the Snellen equivalent in patients with age-related macular degeneration	PLOS ONE			English	Article							QUALITY-OF-LIFE; VISUAL FUNCTION QUESTIONNAIRE; VISION-RELATED FUNCTION; RANDOMIZED CLINICAL-TRIAL; RANIBIZUMAB TREATMENT; EQ-5D; RESPONSIVENESS; POPULATION; ACUITY	Objective Economic evaluations in wet age-related macular degeneration (ARMD) is hampered as often utility values for solely one eye are used, mostly the better-seeing eye (BSE). Moreover, frequently chosen methods rely on patient values and/or disease specific measures, while economic evaluations prefer generic quality of life (QoL) measures based on societal preferences. The generic QoL utility instrument EQ-5D has shown to be insensitive for differences in visual acuity. The aim of this study was therefore to provide societal utility values, using the generic SF-6D, for health states acknowledging both BSE and worse-seeing eye (WSE). Methods SF-6D utility values of 191 ARMD patients (>= 65 years) with 153 follow-up measures at 1 year were used to fill health states defined by the combination of BSE and WSE using Snellen equivalents; no visual loss (>= 20/40), mild-moderate (<20/40 -> 20/200) and severe (<= 20/200). Results QoL utilities were estimated for the SF-6D, ranging from 0.740 for ARMD patients without visual loss to 0.684 for patients with a combination of mild-moderate visual loss in their BSE and severe visual loss in their WSE. Conclusion Societal utility values are provided for ARMD patients using the generic QoL instrument SF-6D for visual acuity health states based on both BSE and WSE. The range of the values is smaller than previous elicited utilities with the disease-specific VisQoL. Besides, the utility values are placed on a more realistic position on the utility scale, and SF-6D utility values avoid the problem associated with the interpretation of disease-specific utility values.	[Visser, Martijn S.; Amarakoon, Sankha; Missotten, Tom] Rotterdam Ophthalm Inst, Rotterdam, Netherlands; [Visser, Martijn S.; Timman, Reinier; Busschbach, Jan J.] Erasmus MC, Dept Psychiat, Sect Med Psychol & Psychotherapy, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC	Visser, MS (corresponding author), Rotterdam Ophthalm Inst, Rotterdam, Netherlands.	m.s.visser@erasmusmc.nl	Busschbach, Jan/P-1584-2019	Busschbach, Jan/0000-0002-8602-0381	Foundation for scientific research of the Rotterdam Eye Hospital (SWOO-Flieringa); Stichting voor Ooglijders Rotterdam; Theia foundation [2010157]; CZ foundation [AFVV09-168]	Foundation for scientific research of the Rotterdam Eye Hospital (SWOO-Flieringa); Stichting voor Ooglijders Rotterdam; Theia foundation; CZ foundation	This work was financially supported by the Foundation for scientific research of the Rotterdam Eye Hospital (SWOO-Flieringa); the Stichting voor Ooglijders Rotterdam; the Theia foundation (grant number: 2010157) and the CZ foundation (grant number: AFVV09-168). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bozzani FM, 2012, BMC OPHTHALMOL, V12, DOI 10.1186/1471-2415-12-43; Brazier J, 2002, J HEALTH ECON, V21, P271, DOI 10.1016/S0167-6296(01)00130-8; Brazier J, 2004, HEALTH ECON, V13, P873, DOI 10.1002/hec.866; Brazier J, 2012, EUR J HEALTH ECON, V13, P575, DOI 10.1007/s10198-011-0352-9; Brazier J, 2010, HEALTH ECON, V19, P125, DOI 10.1002/hec.1580; Bressler Neil M, 2004, JAMA, V291, P1900, DOI 10.1001/jama.291.15.1900; Bressler NM, 2010, OPHTHALMOLOGY, V117, P747, DOI 10.1016/j.ophtha.2009.09.002; Bressler NM, 2009, ARCH OPHTHALMOL-CHIC, V127, P13, DOI 10.1001/archophthalmol.2008.562; Brown G C, 1999, Trans Am Ophthalmol Soc, V97, P473; Chang TS, 2007, ARCH OPHTHALMOL-CHIC, V125, P1460, DOI 10.1001/archopht.125.11.1460; Drummond MF, 2015, METHODS FOR THE ECON; Falkenstein IA, 2008, OPHTHALMOLOGY, V115, P319, DOI 10.1016/j.ophtha.2007.05.028; Finger RP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081042; Fryback DG, 1997, MED DECIS MAKING, V17, P276, DOI 10.1177/0272989X9701700303; Klaver CCW, 1998, ARCH OPHTHALMOL-CHIC, V116, P653, DOI 10.1001/archopht.116.5.653; Lindblad AS, 2005, ARCH OPHTHALMOL-CHIC, V123, P1207; Longworth L, 2014, HEALTH TECHNOL ASSES, V18, P1, DOI 10.3310/hta18090; Luo N, 2005, MED CARE, V43, P1078, DOI 10.1097/01.mlr.0000182493.57090.c1; Lushchyk T, 2013, ACTA OPHTHALMOL, V91, pe456, DOI 10.1111/aos.12119; Mangione CM, 2001, ARCH OPHTHALMOL-CHIC, V119, P1050, DOI 10.1001/archopht.119.7.1050; Miskala PH, 2004, AM J OPHTHALMOL, V137, P961, DOI 10.1016/j.ajo.2003.11.018; Miskala PH, 2003, ARCH OPHTHALMOL-CHIC, V121, P531; Richardson J, 2012, OPHTHAL EPIDEMIOL, V19, P172, DOI 10.3109/09286586.2012.674613; Sahel JA, 2007, ARCH OPHTHALMOL-CHIC, V125, P945, DOI 10.1001/archopht.125.7.945; Stolk EA, 2003, QUAL LIFE RES, V12, P363, DOI 10.1023/A:1023453405252; Tosh J, 2012, VALUE HEALTH, V15, P118, DOI 10.1016/j.jval.2011.08.002; Visser MS, 2016, HIGH INJECTION FREQU; Ware Jr JE, 1993, SF 36 HEALTH SURVEY; 1991, OPHTHALMOLOGY S, V98, P741, DOI DOI 10.1001/ARCHOPHT.125.7.945	30	3	3	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2017	12	2							e0169816	10.1371/journal.pone.0169816	http://dx.doi.org/10.1371/journal.pone.0169816			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL5SK	28225799	Green Published, gold, Green Submitted			2022-12-27	WOS:000394680900003
J	Gouaref, I; Detaille, D; Wiernsperger, N; Khan, NA; Leverve, X; Koceir, EA				Gouaref, Ines; Detaille, Dominique; Wiernsperger, Nicolas; Khan, Naim Akhtar; Leverve, Xavier; Koceir, Elhadj-Ahmed			The desert gerbil Psammomys obesus as a model for metformin-sensitive nutritional type 2 diabetes to protect hepatocellular metabolic damage: Impact of mitochondrial redox state	PLOS ONE			English	Article							BETA-CELL FUNCTION; FATTY-ACID; GLUCOSE-6-PHOSPHATE HYDROLYSIS; GLUCOSE-PRODUCTION; GUT MICROBIOTA; BODY-WEIGHT; FOOD-INTAKE; RATS; GLUCONEOGENESIS; INSULIN	Introduction While metformin (MET) is the most widely prescribed antidiabetic drug worldwide, its beneficial effects in Psammomys obesus (P. obesus), a rodent model that mimics most of the metabolic features of human diabetes, have not been explored thoroughly. Here, we sought to investigate whether MET might improve insulin sensitivity, glucose homeostasis, lipid profile as well as cellular redox and energy balance in P. obesus maintained on a high energy diet (HED). Materials and methods P. obesus gerbils were randomly assigned to receive either a natural diet (ND) consisting of halophytic plants (control group) or a HED (diabetic group) for a period of 24 weeks. MET (50 mg/kg per os) was administered in both animal groups after 12 weeks of feeding, i.e., the time required for the manifestation of insulin resistance in P. obesus fed a HED. Parallel in vitro experiments were conducted on isolated hepatocytes that were shortly incubated (30 min) with MET and energetic substrates (lactate + pyruvate or alanine, in the presence of octanoate). Results In vivo, MET lowered glycemia, glycosylated haemoglobin, circulating insulin and fatty acid levels in diabetic P. obesus. It also largely reversed HED-induced hepatic lipid alterations. In vitro, MET increased glycolysis but decreased both gluconeogenesis and ketogenesis in the presence of glucogenic precursors and medium-chain fatty acid. Importantly, these changes were associated with an increase in cytosolic and mitochondrial redox states along with a decline in respiration capacity. Conclusions MET prevents the progression of insulin resistance in diabetes-prone P. obesus, possibly through a tight control of gluconeogenesis and fatty acid beta-oxidation depending upon mitochondrial function. While the latter is increasingly becoming a therapeutic issue in diabetes, the gut microbiota is another promising target that would need to be considered as well.	[Gouaref, Ines; Koceir, Elhadj-Ahmed] Univ Sci & Technol Houari Boumediene, Bioenerget & Intermediary Metab Team, Lab Biol & Organism Physiol, Inst Biol Sci, BP 32, Algiers, Algeria; [Detaille, Dominique] Univ Bordeaux, Rhythmol & Heart Modeling Inst, Bordeaux, France; [Wiernsperger, Nicolas] INSERM, U1060, CarMeN Lab, Villeurbanne, France; [Khan, Naim Akhtar] UBFC, Physiol Nutr & Toxicol, INSERM, U1236, Dijon, France; [Leverve, Xavier] Univ Grenoble Alpes, LBFA, INSERM, U1055, Grenoble, France	University Science & Technology Houari Boumediene; UDICE-French Research Universities; Universite de Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut Agro; AgroSup Dijon; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Koceir, EA (corresponding author), Univ Sci & Technol Houari Boumediene, Bioenerget & Intermediary Metab Team, Lab Biol & Organism Physiol, Inst Biol Sci, BP 32, Algiers, Algeria.	e.koceir@gmail.com		Khan, Naim Akhtar/0000-0002-8930-9332; KOCEIR, Elhadj-Ahmed/0000-0003-1345-2535	German Federal Ministry of Education and Research (BMBF) [01EZ0816, 01EZ0818, 13EZ0817]; Deutsche Herzstiftung e.V. [S/05/12]	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Deutsche Herzstiftung e.V.	This work was financially supported by a grant from the German Federal Ministry of Education and Research (BMBF; grant-ID 01EZ0816, 01EZ0818 and 13EZ0817), and in part by the Deutsche Herzstiftung e.V. (S/05/12, Y-X, Ye). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARGAUD D, 1993, EUR J BIOCHEM, V213, P1341, DOI 10.1111/j.1432-1033.1993.tb17886.x; Arora T, 2016, J INTERN MED, V280, P339, DOI 10.1111/joim.12508; Atek-Mebarki F, 2015, BIOCHIMIE, V109, P60, DOI 10.1016/j.biochi.2014.12.004; Bailey CJ, 2008, DIABETOLOGIA, V51, P1552, DOI 10.1007/s00125-008-1053-5; Bergmeyer HU, 1974, METHODS ENZYMATIC AN; BERRY MN, 1969, J CELL BIOL, V43, P506, DOI 10.1083/jcb.43.3.506; Boucaud-Maitre D, 2016, DIABETIC MED, V33, P1536, DOI 10.1111/dme.13098; Bouderba S, 2014, J DIABETES, V6, P184, DOI 10.1111/1753-0407.12083; Bouderba S, 2012, EXP DIABETES RES, DOI 10.1155/2012/430176; BRANDES R, 1986, COMP BIOCHEM PHYS B, V83, P837, DOI 10.1016/0305-0491(86)90156-2; Buse JB, 2016, DIABETES CARE, V39, P198, DOI 10.2337/dc15-0488; CANO N, 1995, KIDNEY INT, V47, P1522, DOI 10.1038/ki.1995.215; Cao J, 2014, J BIOL CHEM, V289, P20435, DOI 10.1074/jbc.M114.567271; CHAN TM, 1976, ANAL BIOCHEM, V71, P96, DOI 10.1016/0003-2697(76)90014-2; Collier GR, 1997, OBES RES, V5, P455, DOI 10.1002/j.1550-8528.1997.tb00670.x; DALY M, 1975, J MAMMAL, V56, P509, DOI 10.2307/1379378; DELPRATO S, 1995, DIABETES METAB REV, V11, pS33; Duca FA, 2015, NAT MED, V21, P506, DOI 10.1038/nm.3787; El-Mir MY, 2000, J BIOL CHEM, V275, P223, DOI 10.1074/jbc.275.1.223; FELIG P, 1975, ANNU REV BIOCHEM, V44, P933, DOI 10.1146/annurev.bi.44.070175.004441; Ferrannini E, 2014, METABOLISM, V63, P1217, DOI 10.1016/j.metabol.2014.05.012; Finlayson A, 2015, WORLD J GASTRO ENDOS, V7, P1103, DOI [10.4253/wjge.v7.i13.1103, 10.4291/wjgp.v6.i4.110]; Foretz M, 2014, CELL METAB, V20, P953, DOI 10.1016/j.cmet.2014.09.018; FRENKEL G, 1972, LIFE SCI, V11, P209, DOI 10.1016/0024-3205(72)90006-9; Fulgencio JP, 2001, BIOCHEM PHARMACOL, V62, P439, DOI 10.1016/S0006-2952(01)00679-7; Fullerton MD, 2013, NAT MED, V19, P1649, DOI 10.1038/nm.3372; Geerling JJ, 2014, DIABETES, V63, P880, DOI 10.2337/db13-0194; Glueck CJ, 2001, METABOLISM, V50, P856, DOI 10.1053/meta.2001.24192; Graham GG, 2011, CLIN PHARMACOKINET, V50, P81, DOI 10.2165/11534750-000000000-00000; GROEN AK, 1982, EUR J BIOCHEM, V122, P87, DOI 10.1111/j.1432-1033.1982.tb05851.x; Hamilton MK, 2015, AM J PHYSIOL-GASTR L, V308, pG840, DOI 10.1152/ajpgi.00029.2015; Hansen AMK, 2011, DIABETOLOGIA, V54, P1379, DOI 10.1007/s00125-011-2080-1; Harmel E, 2014, ENDOCRINOLOGY, V155, P873, DOI 10.1210/en.2013-1750; He L, 2015, CELL METAB, V21, P159, DOI 10.1016/j.cmet.2015.01.003; Ichai C, 2001, J BIOL CHEM, V276, P28126, DOI 10.1074/jbc.M010186200; Inzucchi SE, 2012, DIABETOLOGIA, V55, P1577, DOI 10.1007/s00125-012-2534-0; Kaiser Nurit, 2012, Methods Mol Biol, V933, P89, DOI 10.1007/978-1-62703-068-7_7; Khalkhal A, 2010, CR BIOL, V335, P271; KHAN NA, 1994, J ENDOCRINOL, V142, P245, DOI 10.1677/joe.0.1420245; King H, 1998, DIABETES CARE, V21, P1414, DOI 10.2337/diacare.21.9.1414; Koceir EA, 2003, DIABETES METAB, V29, P363, DOI 10.1016/S1262-3636(07)70047-2; Kuznetsova TA, 2013, MICROB ECOL, V66, P940, DOI 10.1007/s00248-013-0263-7; Lee H, 2014, APPL ENVIRON MICROB, V80, P5935, DOI 10.1128/AEM.01357-14; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Lv WS, 2012, BRAIN RES, V1444, P11, DOI 10.1016/j.brainres.2012.01.028; Madiraju AK, 2014, NATURE, V510, P542, DOI 10.1038/nature13270; Mannucci E, 2001, DIABETES CARE, V24, P489, DOI 10.2337/diacare.24.3.489; MARQUIE G, 1984, DIABETES, V33, P438, DOI 10.2337/diabetes.33.5.438; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Miller RA, 2010, J CLIN INVEST, V120, P2267, DOI 10.1172/JCI43661; Nocito L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122818; Owen MR, 2000, BIOCHEM J, V348, P607, DOI 10.1042/0264-6021:3480607; Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; Quadri I, 2016, MICROBIOL RES, V186, P119, DOI 10.1016/j.micres.2016.04.003; Radziuk J, 1997, DIABETES, V46, P1406, DOI 10.2337/diabetes.46.9.1406; Rapin JR, 2008, METFORMIN MECH INSIG, P131; Sahraoui A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148117; Salpeter SR, 2008, AM J MED, V121, P149, DOI 10.1016/j.amjmed.2007.09.016; SCHAFER H, 1990, COMP BIOCHEM PHYS A, V95, P209, DOI 10.1016/0300-9629(90)90200-C; Shafrir E, 2001, Int J Exp Diabetes Res, V2, P299, DOI 10.1155/EDR.2001.299; Shafrir Eleazar, 1998, Journal of Basic and Clinical Physiology and Pharmacology, V9, P347; SHIBKO S, 1967, ANAL BIOCHEM, V19, P514, DOI 10.1016/0003-2697(67)90242-4; Shin NR, 2014, GUT, V63, P727, DOI 10.1136/gutjnl-2012-303839; SISTARE FD, 1985, J BIOL CHEM, V260, P2748; Song YM, 2015, AUTOPHAGY, V11, P46, DOI 10.4161/15548627.2014.984271; Spolding B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092656; WILCOCK C, 1994, XENOBIOTICA, V24, P49, DOI 10.3109/00498259409043220; Yasuda N, 2004, J PHARMACOL EXP THER, V310, P614, DOI 10.1124/jpet.103.064964; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505	69	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2017	12	2							e0172053	10.1371/journal.pone.0172053	http://dx.doi.org/10.1371/journal.pone.0172053			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5QV	28222147	Green Published, Green Submitted, gold			2022-12-27	WOS:000394676800029
J	Gupta, RS; Nanda, A; Khadka, B				Gupta, Radhey S.; Nanda, Anish; Khadka, Bijendra			Novel molecular, structural and evolutionary characteristics of the phosphoketolases from bifidobacteria and Coriobacteriales	PLOS ONE			English	Article							GUT MICROBIOTA; PROTEIN; GENE; METABOLISM; PATHWAY; EXPRESSION; PREDICTION; SIGNATURES; SEQUENCES; BACTERIAL	Members from the order Bifidobacteriales, which include many species exhibiting health promoting effects, differ from all other organisms in using a unique pathway for carbohydrate metabolism, known as the "bifid shunt", which utilizes the enzyme phosphoketolase ( PK) to carry out the phosphorolysis of both fructose-6-phosphate ( F6P) and xylulose-5-phosphate ( X5P). In contrast to bifidobacteria, the PKs found in other organisms ( referred to XPK) are able to metabolize primarily X5P and show very little activity towards F6P. Presently, very little is known about the molecular or biochemical basis of the differences in the two forms of PKs. Comparative analyses of PK sequences from different organisms reported here have identified multiple high-specific sequence features in the forms of conserved signature inserts and deletions ( CSIs) in the PK sequences that clearly distinguish the X5P/F6P phosphoketolases ( XFPK) of bifidobacteria from the XPK homologs found in most other organisms. Interestingly, most of the molecular signatures that are specific for the XFPK from bifidobacteria are also shared by the PK homologs from the Coriobacteriales order of Actinobacteria. Similarly to the Bifidobacteriales, the order Coriobacteriales is also made up of commensal organisms, that are saccharolytic and able to metabolize wide variety of carbohydrates, producing lactate and other metabolites. Phylogenetic studies provide evidence that the XFPK from bifidobacteria are specifically related to those found in the Coriobacteriales and suggest that the gene for PK ( XFPK) was horizontally transferred between these two groups. A number of the identified CSIs in the XFPK sequence, which serve to distinguish the XFPK homologs from XPK homologs, are located at the subunit interface in the structure of the XFPK dimer protein. The results of protein modelling and subunit docking studies indicate that these CSIs are involved in the formation/ stabilization of the protein dimer. The significance of these observations regarding the differences in the activities of the XFPK and XPK homologs are discussed. Additionally, this work also discusses the significance of the XFPK-like homologs, similar to those found in bifidobacteria, in the order Coriobacteriales.	[Gupta, Radhey S.; Nanda, Anish; Khadka, Bijendra] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON, Canada	McMaster University	Gupta, RS (corresponding author), McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON, Canada.	gupta@mcmaster.ca		Khadka, Bijendra/0000-0001-5137-860X				Akiva E, 2008, P NATL ACAD SCI USA, V105, P13292, DOI 10.1073/pnas.0801207105; Biavati B, 2000, ANN MICROBIOL, V50, P117; Biavati B., 2012, BERGEYS MANUAL SYSTE, V5, P171, DOI DOI 10.1007/978-0-387-68233-4; Biavati B, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 3, THIRD EDITION, P322, DOI 10.1007/0-387-30743-5_17; Bottacini F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044229; BOWIE JU, 1991, SCIENCE, V253, P164, DOI 10.1126/science.1853201; Buchan DWA, 2013, NUCLEIC ACIDS RES, V41, pW349, DOI 10.1093/nar/gkt381; Burge G, 2015, J MICROBIOL, V53, P702, DOI 10.1007/s12275-015-5056-x; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Cherkasov A, 2006, PROTEINS, V62, P371, DOI 10.1002/prot.20631; Clavel T., 2014, PROKARYOTES ACTINOBA, P201, DOI DOI 10.1007/978-3-642-30138-4_343; COLOVOS C, 1993, PROTEIN SCI, V2, P1511, DOI 10.1002/pro.5560020916; Comeau SR, 2004, BIOINFORMATICS, V20, P45, DOI 10.1093/bioinformatics/btg371; Cronin M, 2011, INT J FOOD MICROBIOL, V149, P4, DOI 10.1016/j.ijfoodmicro.2011.01.019; den Besten G, 2013, J LIPID RES, V54, P2325, DOI 10.1194/jlr.R036012; DEVRIES W, 1967, BIOCHIM BIOPHYS ACTA, V136, P415, DOI 10.1016/0304-4165(67)90001-3; Duhovny D, 2002, LECT NOTES COMPUT SC, V2452, P185; Eswar N, 2007, CURR PROTOC BIOINFOR; Fleige C, 2011, APPL MICROBIOL BIOT, V91, P769, DOI 10.1007/s00253-011-3284-5; Gao BL, 2012, MICROBIOL MOL BIOL R, V76, P66, DOI 10.1128/MMBR.05011-11; Glenn K, 2015, J BACTERIOL, V197, P1157, DOI 10.1128/JB.02380-14; Glenn K, 2014, EUKARYOT CELL, V13, P657, DOI 10.1128/EC.00055-14; Graf Daniela, 2015, Microbial Ecology in Health and Disease, V26, P26164, DOI 10.3402/mehd.v26.26164; GRILL JP, 1995, CURR MICROBIOL, V31, P49, DOI 10.1007/BF00294634; Gupta RS, 2016, FEMS MICROBIOL REV, V40, P520, DOI 10.1093/femsre/fuw011; Gupta RS, 2014, METHOD MICROBIOL, V41, P153, DOI 10.1016/bs.mim.2014.05.003; Gupta RS, 2013, INT J SYST EVOL MICR, V63, P3379, DOI 10.1099/ijs.0.048371-0; Itzhaki Z, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-12-r125; Jeanmougin F, 1998, TRENDS BIOCHEM SCI, V23, P403, DOI 10.1016/S0968-0004(98)01285-7; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Kinross JM, 2011, GENOME MED, V3, DOI 10.1186/gm228; Kozakov D, 2006, PROTEINS, V65, P392, DOI 10.1002/prot.21117; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; Maslowski KM, 2009, NATURE, V461, P1282, DOI 10.1038/nature08530; Meile L, 2001, J BACTERIOL, V183, P2929, DOI 10.1128/JB.183.9.2929-2936.2001; Milani C, 2016, APPL ENVIRON MICROB, V82, P980, DOI 10.1128/AEM.03500-15; Nicholson JK, 2012, SCIENCE, V336, P1262, DOI 10.1126/science.1223813; Orban JI, 2000, J MICROBIOL METH, V40, P221, DOI 10.1016/S0167-7012(00)00133-0; Palframan Richard J, 2003, Curr Issues Intest Microbiol, V4, P71; Petrareanu G, 2014, APPL MICROBIOL BIOT, V98, P7855, DOI 10.1007/s00253-014-5723-6; Pierce BG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024657; Pokusaeva K, 2011, GENES NUTR, V6, P285, DOI 10.1007/s12263-010-0206-6; Posthuma CC, 2002, APPL ENVIRON MICROB, V68, P831, DOI 10.1128/AEM.68.2.831-837.2002; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Ruiz L, 2016, J PROTEOMICS, V147, P28, DOI 10.1016/j.jprot.2016.03.023; Sanchez B, 2017, MOL NUTR FOOD RES, V61, DOI 10.1002/mnfr.201600240; Sanchez B, 2010, J MOL MICROB BIOTECH, V18, P37, DOI 10.1159/000274310; Scardovi V., 1965, ANN MICROBIOL ENZ, V15, P19; Segata N, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3304; Serino M, 2012, GUT, V61, P543, DOI 10.1136/gutjnl-2011-301012; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Singh B, 2009, MOL GENET GENOMICS, V281, P361, DOI 10.1007/s00438-008-0417-3; Suzuki R, 2010, J BIOL CHEM, V285, P34279, DOI 10.1074/jbc.M110.156281; Takahashi K, 2010, FEBS LETT, V584, P3855, DOI 10.1016/j.febslet.2010.07.043; Thorasin T, 2015, MICROBIOL-SGM, V161, P565, DOI 10.1099/mic.0.000016; Turroni F, 2011, INT J FOOD MICROBIOL, V149, P37, DOI 10.1016/j.ijfoodmicro.2010.12.010; Turroni F, 2010, P NATL ACAD SCI USA, V107, P19514, DOI 10.1073/pnas.1011100107; Ventura M, 2014, J SCI FOOD AGR, V94, P163, DOI 10.1002/jsfa.6356; Vlkova E, 2005, J MICROBIOL METH, V60, P365, DOI 10.1016/j.mimet.2004.10.012; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; Xiong W, 2016, NAT PLANTS, V2, DOI [10.1038/NPLANTS.2015.187, 10.1038/nplants.2015.187]; Yevenes A, 2008, BIOORG CHEM, V36, P121, DOI 10.1016/j.bioorg.2008.03.002; Yin XH, 2005, FEMS MICROBIOL LETT, V246, P251, DOI 10.1016/j.femsle.2005.04.013; Zhang G, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00978; Zhi XY, 2009, INT J SYST EVOL MICR, V59, P589, DOI 10.1099/ijs.0.65780-0	68	30	31	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2017	12	2							e0172176	10.1371/journal.pone.0172176	http://dx.doi.org/10.1371/journal.pone.0172176			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BI	28212383	Green Published, gold, Green Submitted			2022-12-27	WOS:000394424700021
J	Hao, WR; Gong, SH; Wu, SN; Xu, JC; Go, MR; Friedman, A; Zhu, D				Hao, Wenrui; Gong, Shihua; Wu, Shuonan; Xu, Jinchao; Go, Michael R.; Friedman, Avner; Zhu, Dai			A mathematical model of aortic aneurysm formation	PLOS ONE			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; MATRIX METALLOPROTEINASES; INTERLEUKIN-6 IL-6; IFN-GAMMA; T-CELLS; TRANSCRIPTION; ADVENTITIA; EXPRESSION; MACROPHAGES; RUPTURE	Abdominal aortic aneurysm ( AAA) is a localized enlargement of the abdominal aorta, such that the diameter exceeds 3 cm. The natural history of AAA is progressive growth leading to rupture, an event that carries up to 90% risk of mortality. Hence there is a need to predict the growth of the diameter of the aorta based on the diameter of a patient's aneurysm at initial screening and aided by non-invasive biomarkers. IL-6 is overexpressed in AAA and was suggested as a prognostic marker for the risk in AAA. The present paper develops a mathematical model which relates the growth of the abdominal aorta to the serum concentration of IL-6. Given the initial diameter of the aorta and the serum concentration of IL-6, the model predicts the growth of the diameter at subsequent times. Such a prediction can provide guidance to how closely the patient's abdominal aorta should be monitored. The mathematical model is represented by a system of partial differential equations taking place in the aortic wall, where the media is assumed to have the constituency of an hyperelastic material.	[Hao, Wenrui; Wu, Shuonan; Xu, Jinchao] Penn State Univ, Dept Math, State Coll, PA 16801 USA; [Gong, Shihua] Peking Univ, Beijing Int Ctr Math Res, Beijing, Peoples R China; [Go, Michael R.] Ohio State Univ, Div Vasc Dis & Surg, Wexner Med Ctr, Columbus, OH 43210 USA; [Friedman, Avner] Ohio State Univ, Dept Math, 231 W 18th Ave, Columbus, OH 43210 USA; [Zhu, Dai] Yunnan Cocreat Sci Comp & Datamining Ctr, Kunming, Peoples R China	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Peking University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Hao, WR (corresponding author), Penn State Univ, Dept Math, State Coll, PA 16801 USA.	wxh64@psu.edu		HAO, WENRUI/0000-0002-6925-7424	Mathematical Biosciences Institute; National Science Foundation [0931642]	Mathematical Biosciences Institute; National Science Foundation(National Science Foundation (NSF))	WH was a postdoctoral researcher at Mathematical Biosciences Institute at the time of the study and received financial support from the institution. WH and AF received funding from the National Science Foundation under Grant 0931642. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Hussien H, 2010, J VASC SURG, V51, P1479, DOI 10.1016/j.jvs.2010.01.057; Annabi B, 2002, J VASC SURG, V35, P539, DOI 10.1067/mva.2002.121124; Baer M, 1998, MOL CELL BIOL, V18, P5678, DOI 10.1128/MCB.18.10.5678; Bush RL, 2006, J AM COLL SURGEONS, V202, P577, DOI 10.1016/j.jamcollsurg.2006.01.005; Elmore JR, 1998, ANN VASC SURG, V12, P221, DOI 10.1007/s100169900144; Filardo G, 2012, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001835.pub3, 10.1002/14651858.CD001835.pub4]; Friedman A, 2015, B MATH BIOL, V77, P758, DOI 10.1007/s11538-014-0010-3; Galle C, 2005, CLIN EXP IMMUNOL, V142, P519, DOI 10.1111/j.1365-2249.2005.02938.x; Golledge J, 2008, CIRCULATION, V118, P2382, DOI 10.1161/CIRCULATIONAHA.108.802074; Grytsan A, 2015, J BIOMECH ENG-T ASME, V137, DOI 10.1115/1.4029279; Hao WR, 2014, P NATL ACAD SCI USA, V111, P16065, DOI 10.1073/pnas.1417789111; Hao WR, 2014, P NATL ACAD SCI USA, V111, P14193, DOI 10.1073/pnas.1413970111; Hasan D, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-222; Jones KG, 2001, CIRCULATION, V103, P2260; Kim Y, 2010, B MATH BIOL, V72, P1029, DOI 10.1007/s11538-009-9481-z; KOCH AE, 1993, AM J PATHOL, V142, P1423; Loppnow H, 1998, BLOOD, V91, P134, DOI 10.1182/blood.V91.1.134.134_134_141; LU ZY, 1995, BLOOD, V86, P3123; Maiellaro K, 2007, CARDIOVASC RES, V75, P640, DOI 10.1016/j.cardiores.2007.06.023; Majesky MW, 2011, ARTERIOSCL THROM VAS, V31, P1530, DOI 10.1161/ATVBAHA.110.221549; MCGREGOR JC, 1976, ANN ROY COLL SURG, V58, P388; Middleton RK, 2009, EUR J VASC ENDOVASC, V37, P46, DOI 10.1016/j.ejvs.2008.09.013; Moris D, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/925840; Nicholls SC, 1998, J VASC SURG, V28, P884, DOI 10.1016/S0741-5214(98)70065-5; Parameswaran N, 2010, CRIT REV EUKAR GENE, V20, P87, DOI 10.1615/CritRevEukarGeneExpr.v20.i2.10; Patel MI, 1996, J VASC SURG, V24, P82, DOI 10.1016/S0741-5214(96)70148-9; Raghavan ML, 2000, J BIOMECH, V33, P475, DOI 10.1016/S0021-9290(99)00201-8; Rahim SS, 2005, IMMUNOLOGY, V114, P313, DOI 10.1111/j.1365-2567.2005.02107.x; Schmid H, 2013, COMPUT METHOD BIOMEC, V16, P33, DOI 10.1080/10255842.2011.603309; Sule AA, 2010, INT J ANGIOL, V19, pE138, DOI 10.1055/s-0031-1278384; Takagi H, 2014, ANN VASC SURG, V28, P1913, DOI 10.1016/j.avsg.2014.06.058; Teixeira LK, 2005, J IMMUNOL, V175, P5931, DOI 10.4049/jimmunol.175.9.5931; Tian XH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108105; Tieu BC, 2009, J CLIN INVEST, V119, P3637, DOI 10.1172/JCI38308; Veith Frank J, 2003, Semin Vasc Surg, V16, P171, DOI 10.1016/S0895-7967(03)00003-6; Volk T, 2000, MOL CELL BIOCHEM, V206, P105, DOI 10.1023/A:1007059616914; Volokh KY, 2011, J MECH BEHAV BIOMED, V4, P1582, DOI 10.1016/j.jmbbm.2011.01.002; Vorp DA, 2005, ARTERIOSCL THROM VAS, V25, P1558, DOI 10.1161/01.ATV.0000174129.77391.55; Wang DHJ, 2002, J VASC SURG, V36, P598, DOI 10.1067/mva.2002.126087; Wang Q, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-907; Wang QS, 2010, CELL RES, V20, P701, DOI 10.1038/cr.2010.52; Watton PN, 2004, BIOMECH MODEL MECHAN, V3, P98, DOI 10.1007/s10237-004-0052-9; Xiong WF, 2009, J IMMUNOL, V183, P2741, DOI 10.4049/jimmunol.0803164; Xiong WF, 2004, J IMMUNOL, V172, P2607, DOI 10.4049/jimmunol.172.4.2607; Xu H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089269; Yokoyama U, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036724; Zelaya JE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101353; 1998, LANCET, V352, P1649, DOI DOI 10.1016/S0140-6736(98)10137-X	48	20	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2017	12	2							e0170807	10.1371/journal.pone.0170807	http://dx.doi.org/10.1371/journal.pone.0170807			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BI	28212412	gold, Green Published, Green Submitted			2022-12-27	WOS:000394424700002
J	Xu, G; Xue, YF; Ozkurt, ZG; Slimani, N; Hu, ZZ; Wang, XD; Xia, KW; Ma, T; Zhou, QF; Demirci, H				Xu, Guan; Xue, Yafang; Ozkurt, Zeynep Gursel; Slimani, Naziha; Hu, Zizhong; Wang, Xueding; Xia, Kewen; Ma, Teng; Zhou, Qifa; Demirci, Hakan			Photoacoustic imaging features of intraocular tumors: Retinoblastoma and uveal melanoma	PLOS ONE			English	Article							ULTRASONIC SPECTRUM ANALYSIS; OPHTHALMOSCOPY; ANGIOGRAPHY; TOMOGRAPHY; SYSTEM	The purpose of this study is to examine the capability of photoacoustic (PA) imaging (PAI) in assessing the unique molecular and architectural features in ocular tumors. A real-time PA and ultrasonography (US) parallel imaging system based on a research US platform was developed to examine retinoblastoma in mice in vivo and human retinoblastoma and uveal melanoma ex vivo. PA signals were generated by optical illumination at 720, 750, 800, 850, 900 and 950 nm delivered through a fiber optical bundle. The optical absorption spectra of the tumors were derived from the PA images. The optical absorption spectrum of each tumor was quantified by fitting to a polynomial model. The microscopic architectures of the tumors were quantified by frequency domain analysis of the PA signals. Both the optical spectral and architectural features agree with the histological findings of the tumors. The mouse and human retinoblastoma showed comparable total optical absorption spectra at a correlation of 0.95 (p<0.005). The quantitative PAI features of human retinoblastoma and uveal melanoma have shown statistically significant difference in two tailed t-tests (p<0.05). Fully compatible with the concurrent procedures, PAI could be a potential tool complementary to other diagnostic modalities for characterizing intraocular tumors.	[Xu, Guan; Wang, Xueding] Univ Michigan, Dept Radiol, Sch Med, Ann Arbor, MI 48109 USA; [Xue, Yafang; Wang, Xueding] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA; [Ozkurt, Zeynep Gursel; Slimani, Naziha; Demirci, Hakan] Univ Michigan, Kellogg Eye Ctr, Ann Arbor, MI 48109 USA; [Hu, Zizhong] Nanjing Med Univ, Dept Ophthalmol, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China; [Xia, Kewen] Hebei Univ Technol, Sch Elect & Informat Engn, Tianjin, Peoples R China; [Ma, Teng; Zhou, Qifa] Univ Southern Calif, Dept Biomed Engn, NIH Ultrason Transducer Resource Ctr, Los Angeles, CA USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Nanjing Medical University; Hebei University of Technology; University of Southern California	Demirci, H (corresponding author), Univ Michigan, Kellogg Eye Ctr, Ann Arbor, MI 48109 USA.	hdemirci@med.umich.edu	Ma, Teng/F-7990-2017	hu, zizhong/0000-0001-6289-1804; Xu, Guan/0000-0002-5942-7987; Demirci, Hakan/0000-0003-1593-1476	BI/EYE challenge award by Biointerface Institute in University of Michigan; National Institute of Health [R01AR060350, R01CA186769]; Natural Science Foundation of Hebei Province (China) [E2016202341]; NATIONAL CANCER INSTITUTE [R01CA186769] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR060350] Funding Source: NIH RePORTER	BI/EYE challenge award by Biointerface Institute in University of Michigan; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Natural Science Foundation of Hebei Province (China)(Natural Science Foundation of Hebei Province); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This research was supported by the BI/EYE challenge award by Biointerface Institute in University of Michigan (http://www.biointerfaces.umich.edu/) and generous support from Mr. and Mrs. Witham. This research was also supported in part by National Institute of Health under grant numbers R01AR060350 and R01CA186769. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Financial Disclosure: This research was supported by the BI/EYE challenge award by Biointerface Institute in University of Michigan (http://www.biointerfaces.umich.edu/) and generous support from Mr. and Mrs. Witham. This research was also supported in part by National Institute of Health under grant numbers R01AR060350 and R01CA186769 (https://www.nih.gov/), and Natural Science Foundation of Hebei Province (China, http://www.hensf.gov.cn/) under grant number E2016202341. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CHAR DH, 1980, AM J OPHTHALMOL, V89, P223, DOI 10.1016/0002-9394(80)90115-4; Chitnis PV, 2014, J ACOUST SOC AM, V135, P2372, DOI DOI 10.1121/1.4877828; Coleman D, 1972, T AM ACAD OPHTHALMOL, V77, pOP677; de la Zerda A, 2010, OPT LETT, V35, P270, DOI 10.1364/OL.35.000270; Drexler W, 2001, NAT MED, V7, P502, DOI 10.1038/86589; EDWARDS WC, 1969, AM J OPHTHALMOL, V68, P797, DOI 10.1016/0002-9394(69)94571-1; Hu S, 2010, OPT LETT, V35, P1, DOI 10.1364/OL.35.000001; Hu Z, 2015, INT J OPTHALMOL EYE, V3, P126, DOI DOI 10.19070/2332-290X-1500027; Hysi E, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.12.125006; Imamura Y, 2009, RETINA-J RET VIT DIS, V29, P1469, DOI 10.1097/IAE.0b013e3181be0a83; Jacques SL, 2013, PHYS MED BIOL, V58, pR37, DOI 10.1088/0031-9155/58/11/R37; Jiao SL, 2010, OPT EXPRESS, V18, P3967, DOI 10.1364/OE.18.003967; Kivela T, 2009, BRIT J OPHTHALMOL, V93, P1129, DOI 10.1136/bjo.2008.150292; Li M-L, 2010, GOOGLE PATENTS; Lizzi FL, 2003, PATTERN RECOGN LETT, V24, P637, DOI 10.1016/S0167-8655(02)00172-1; Lizzi FL, 1997, INT J IMAG SYST TECH, V8, P3, DOI 10.1002/(SICI)1098-1098(1997)8:1<3::AID-IMA2>3.0.CO;2-E; Oelze ML, 2004, IEEE T MED IMAGING, V23, P764, DOI 10.1109/TMI.2004.826953; POLEDNAK AP, 1995, CANCER, V75, P330, DOI 10.1002/1097-0142(19950101)75:1+<330::AID-CNCR2820751315>3.0.CO;2-5; REGILLO CD, 1994, OPHTHALMOLOGY, V101, P280; Shields Carol L, 2005, Curr Opin Ophthalmol, V16, P141, DOI 10.1097/01.icu.0000158258.01681.40; SILVERMAN RH, 1995, OPHTHALMOLOGY, V102, P837, DOI 10.1016/S0161-6420(95)30948-7; SILVERMAN RH, 1993, RETINA-J RET VIT DIS, V13, P69, DOI 10.1097/00006982-199313010-00015; Silverman RH, 2010, FINE RESOLUTION PHOT; Silverman RH, 2010, ULTRASOUND MED BIOL, V36, P733, DOI 10.1016/j.ultrasmedbio.2010.02.006; Song W, 2013, J BIOPHOTONICS, V6, P505, DOI 10.1002/jbio.201200061; Vannas A, 1969, Acta Ophthalmol Suppl, V105, P1; Wang L. V., 2009, NATURE PHOTONICS, V3, P503, DOI DOI 10.1038/NPH0T0N.2009.157; Wang LHV, 2012, SCIENCE, V335, P1458, DOI 10.1126/science.1216210; Wang XD, 2003, NAT BIOTECHNOL, V21, P803, DOI 10.1038/nbt839; Xie ZX, 2013, ULTRASOUND MED BIOL, V39, P2176, DOI 10.1016/j.ultrasmedbio.2013.05.018; Xu G, 2016, CHARACTERIZING INTRA; Xu G, 2016, SCI REP-UK, V6, DOI 10.1038/srep16937; Xu G, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4768703; Xu MH, 2006, REV SCI INSTRUM, V77, DOI 10.1063/1.2195024; Xu MH, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.016706; Yuan J, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.8.086001	36	16	16	5	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2017	12	2							e0170752	10.1371/journal.pone.0170752	http://dx.doi.org/10.1371/journal.pone.0170752			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5SX	28231293	Green Published, gold, Green Submitted			2022-12-27	WOS:000394682400005
J	Scott, S; Kendall, L; Gomez, P; Howie, SRC; Zaman, SMA; Ceesay, S; D'Alessandro, U; Jasseh, M				Scott, Susana; Kendall, Lindsay; Gomez, Pierre; Howie, Stephen R. C.; Zaman, Syed M. A.; Ceesay, Samba; D'Alessandro, Umberto; Jasseh, Momodou			Effect of maternal death on child survival in rural West Africa: 25 years of prospective surveillance data in The Gambia	PLOS ONE			English	Article							DEVELOPING-COUNTRIES; MORTALITY; MOTHERS; INFANT; HEALTH; HIV; INTERVENTIONS; PREGNANCY; TANZANIA; DISEASE	Background The death of a mother is a tragedy in itself but it can also have devastating effects for the survival of her children. We aim to explore the impact of a mother's death on child survival in rural Gambia, West Africa. Methods We used 25 years of prospective surveillance data from the Farafenni Health and Demographic surveillance system (FHDSS). Mortality rates per 1,000 child-years up to ten years of age were estimated and Kaplan-Meier survival curves plotted by maternal vital status. Cox proportional hazard models were used to examine factors associated with child survival. Findings Between 1 st April 1989 and 31 st December 2014, a total of 2, 221 (7.8%) deaths occurred during 152,906 child-years of follow up. Overall mortality rate was 14.53 per 1,000 childyears (95% CI: 13.93 - 15.14). Amongst those whose mother died, the rate was 25.89 (95% CI: 17.99 - 37.25) compared to 14.44 (95% CI: 13.84 - 15.06) per 1,000 child-years for those whose mother did not die. Children were 4.66 (95% CI: 3.15 - 6.89) times more likely to die if their mother died compared to those with a surviving mother. Infants whose mothers died during delivery or shortly after were up to 7 times more likely to die within the first month of life compared to those whose mothers survived. Maternal vital status was significantly associated with the risk of dying within the first 2 years of life (p-value < 0.05), while this was no longer observed for children over 2 years of age (P = 0.872). Other factors associated with an increased risk of dying were living in more rural areas, and birth spacing and year of birth. Conclusions Mother's survival is strongly associated with child survival. Our findings highlight the importance of the continuum of care for both the mother and child not only throughout pregnancy, and childbirth but beyond 6 weeks post-partum.	[Scott, Susana; Kendall, Lindsay; Gomez, Pierre; Howie, Stephen R. C.; Zaman, Syed M. A.; D'Alessandro, Umberto; Jasseh, Momodou] MRC, Gambia Unit, Fajara, Gambia; [Scott, Susana; Zaman, Syed M. A.; D'Alessandro, Umberto] London Sch Hyg & Trop Med, London, England; [Howie, Stephen R. C.] Univ Auckland, Dept Paediat, Auckland, New Zealand; [Howie, Stephen R. C.] Univ Otago, Ctr Int Hlth, Dunedin, New Zealand; [Ceesay, Samba] Minist Hlth & Social Welf, Banjul, Gambia	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; University of Auckland; University of Otago	Scott, S (corresponding author), MRC, Gambia Unit, Fajara, Gambia.; Scott, S (corresponding author), London Sch Hyg & Trop Med, London, England.	Susana.Scott@lshtm.ac.uk	Jasseh, Momodou/AAB-6071-2022; D'Alessandro, Umberto/D-3457-2015	Kendall, Lindsay/0000-0003-2812-0154; D'Alessandro, Umberto/0000-0001-6341-5009	UK Medical Research Council (MRC); MRC [MC_UP_A900_1119, MC_UP_A900_1123, MC_UP_A900_1116] Funding Source: UKRI; Medical Research Council [MC_UP_A900_1123, MC_UP_A900_1119, MC_UP_A900_1116] Funding Source: researchfish	UK Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was funded by the UK Medical Research Council (MRC). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becher H, 2004, B WORLD HEALTH ORGAN, V82, P265; Bhutta ZA, 2005, PEDIATRICS, V115, P519, DOI 10.1542/peds.2004-1441; Bhutta ZA, 2014, LANCET, V384, P347, DOI 10.1016/S0140-6736(14)60792-3; Bustreo F, 2013, LANCET GLOB HEALTH, V1, pE176, DOI 10.1016/S2214-109X(13)70059-7; Clark SJ, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001409; Cutts FT, 2005, LANCET, V365, P1139, DOI 10.1016/S0140-6736(05)71876-6; de Bernis L, 2003, BRIT MED BULL, V67, P39, DOI 10.1093/bmb/ldg017; Finlay JE, 2015, MATERN CHILD HLTH J, V19, P2393, DOI 10.1007/s10995-015-1758-2; Jasseh M., 2015, INT J EPIDEMIOLOGY; Jasseh M, 2014, GLOBAL HEALTH ACTION, V7, P1, DOI 10.3402/gha.v7.25598; Jasseh M, 2011, TROP MED INT HEALTH, V16, P1314, DOI 10.1111/j.1365-3156.2011.02809.x; Kassebaum NJ, 2014, LANCET, V384, P980, DOI 10.1016/S0140-6736(14)60696-6; Kotloff KL, 2013, LANCET, V382, P209, DOI 10.1016/S0140-6736(13)60844-2; Lassi ZS, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-S1-S5; Lawn JE, 2014, LANCET, V384, P189, DOI 10.1016/S0140-6736(14)60496-7; Mason E, 2014, LANCET, V384, P455, DOI 10.1016/S0140-6736(14)60750-9; Moucheraud C, 2015, REPROD HEALTH, V12, DOI 10.1186/1742-4755-12-S1-S4; Muenchhoff M, 2014, J INFECT DIS, V209, pS120, DOI 10.1093/infdis/jiu232; Newell ML, 2004, LANCET, V364, P1236, DOI 10.1016/S0140-6736(04)17140-7; Ronsmans C, 2010, LANCET, V375, P2024, DOI 10.1016/S0140-6736(10)60704-0; Scott S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107280; Sear R, 2002, DEMOGRAPHY, V39, P43, DOI 10.1353/dem.2002.0010; Storeng KT, 2012, B WORLD HEALTH ORGAN, V90, P418, DOI 10.2471/BLT.11.094011; Streatfield PK, 2014, GLOBAL HEALTH ACTION, V7, DOI 10.3402/gha.v7.25368; Taha TET, 1996, AIDS, V10, P111, DOI 10.1097/00002030-199601000-00021; The Gambia Bureau of Statistics (GBOS) and ICF International, 2014, GAMB DEM HLTH SURV 2, DOI [10.3402/oha.v7.25598, DOI 10.3402/GHA.V7.25598]; The Partnership for Maternal Newborn & Child Health, 2011, PARTN MAT NEWB CHILD; World Health Organization Department of Maternal N, 2013, WHO REC POSTN CAR MO; World Health Organization (WHO), 2011, WHO GUIDELINES PREVE; Zaba B, 2005, EPIDEMIOLOGY, V16, P275, DOI 10.1097/01.ede.0000155507.47884.43	30	15	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2017	12	2							e0172286	10.1371/journal.pone.0172286	http://dx.doi.org/10.1371/journal.pone.0172286			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5SK	28225798	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000394680900033
J	Li, YZ; Qin, L; Zhao, JJ; Muhammad, T; Cao, HH; Li, HL; Zhang, Y; Liang, Y				Li, Yunzhou; Qin, Lei; Zhao, Jingjing; Muhammad, Tayeb; Cao, Hehe; Li, Hailiang; Zhang, Yan; Liang, Yan			SlMAPK3 enhances tolerance to tomato yellow leaf curl virus (TYLCV) by regulating salicylic acid and jasmonic acid signaling in tomato (Solanum lycopersicum)	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; RESISTANCE GENE TY-2; ABSCISIC-ACID; MAP KINASE; PLANT-RESISTANCE; OXIDATIVE STRESS; MPK4 ACTIVATION; CELL-DEATH; DEFENSE; INFECTION	Several recent studies have reported on the role of mitogen-activated protein kinase (MAPK3) in plant immune responses. However, little is known about how MAPK3 functions in tomato (Solanum lycopersicum L.) infected with tomato yellow leaf curl virus (TYLCV). There is also uncertainty about the connection between plant MAPK3 and the salicylic acid (SA) and jasmonic acid (JA) defense-signaling pathways. The results of this study indicated that SlMAPK3 participates in the antiviral response against TYLCV. Tomato seedlings were inoculated with TYLCV to investigate the possible roles of SlMAPK1, SlMAPK2, and SlMAPK3 against this virus. Inoculation with TYLCV strongly induced the expression and the activity of all three genes. Silencing of SlMAPK1, SlMAPK2, and SlMAPK3 reduced tolerance to TYLCV, increased leaf H2O2 concentrations, and attenuated expression of defense-related genes after TYLCV infection, especially in SlMAPK3-silenced plants. Exogenous SA and methyl jasmonic acid (MeJA) both significantly induced SlMAPK3 expression in tomato leaves. Over-expression of SlMAPK3 increased the transcript levels of SA/JA-mediated defense-related genes (PR1, PR1b/SlLapA, SlPI-I, and SlPI-II) and enhanced tolerance to TYLCV. After TYLCV inoculation, the leaves of SlMAPK3 over-expressed plants compared with wild type plants showed less H2O2 accumulation and greater superoxide dismutase (SOD), peroxidase (POD), catalase (CAT), and ascorbate peroxidase (APX) activity. Overall, the results suggested that SlMAPK3 participates in the antiviral response of tomato to TYLCV, and that this process may be through either the SA or JA defense-signaling pathways.	[Li, Yunzhou; Qin, Lei; Zhao, Jingjing; Muhammad, Tayeb; Zhang, Yan; Liang, Yan] Northwest A&F Univ, Coll Hort, Yangling, Shaanxi, Peoples R China; [Cao, Hehe] Northwest A&F Univ, Coll Plant Protect, Yangling, Shaanxi, Peoples R China; [Li, Hailiang] Northwest A&F Univ, Coll Nat Resources & Environm, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China; Northwest A&F University - China; Northwest A&F University - China	Zhang, Y; Liang, Y (corresponding author), Northwest A&F Univ, Coll Hort, Yangling, Shaanxi, Peoples R China.	zhangyan2014@nwsuaf.edu.cn; liangyan@nwsuaf.edu.cn			Science and Technology Innovation Project of Shaanxi Province [2015KTTSNY03-01]; National Science AMP; Technology Projects of China [2013BAD01B00]	Science and Technology Innovation Project of Shaanxi Province; National Science AMP; Technology Projects of China	This work was supported by the Science and Technology Innovation Project of Shaanxi Province (2015KTTSNY03-01) and National Science & Technology Projects of China (2013BAD01B00). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal GK, 2003, PLANT PHYSIOL BIOCH, V41, P355, DOI 10.1016/S0981-9428(03)00030-5; Alamillo JM, 2006, PLANT J, V48, P217, DOI 10.1111/j.1365-313X.2006.02861.x; Alazem M, 2015, MOL PLANT PATHOL, V16, P529, DOI 10.1111/mpp.12204; Anfoka G, 2016, SCI REP-UK, V6, DOI 10.1038/srep25284; Asai T, 2002, NATURE, V415, P977, DOI 10.1038/415977a; Baebler S, 2014, J EXP BOT, V65, P1095, DOI 10.1093/jxb/ert447; Bai M, 2012, GENE, V501, P52, DOI 10.1016/j.gene.2012.02.009; Beckers GJM, 2009, PLANT CELL, V21, P944, DOI 10.1105/tpc.108.062158; Borges AA, 2015, FRONT PLANT SCI, P1; Butterbach P, 2014, P NATL ACAD SCI USA, V111, P12942, DOI 10.1073/pnas.1400894111; Campos L, 2014, PLANT PHYSIOL BIOCH, V77, P35, DOI 10.1016/j.plaphy.2014.01.016; Caro M, 2015, MOL BREEDING, V35, DOI 10.1007/s11032-015-0329-y; Carr JP, 2010, ADV VIRUS RES, V76, P57, DOI 10.1016/S0065-3527(10)76003-6; Chan ED, 2001, AM J RESP CELL MOL, V24, P627, DOI 10.1165/ajrcmb.24.5.4280; Conrath U, 2002, TRENDS PLANT SCI, V7, P210, DOI 10.1016/S1360-1385(02)02244-6; Conrath U, 2006, MOL PLANT MICROBE IN, V19, P1062, DOI 10.1094/MPMI-19-1062; Maxwell Douglas P., 2007, P409, DOI 10.1007/978-1-4020-4769-5_24; Das SK, 2016, INT REV HYDROBIOL, V101, P3, DOI 10.1002/iroh.201401744; Devadas SK, 2002, PLANT PHYSIOL, V128, P1234, DOI 10.1104/pp.010941; Durrant WE, 2004, ANNU REV PHYTOPATHOL, V42, P185, DOI 10.1146/annurev.phyto.42.040803.140421; Eybishtz A, 2010, PLANTA, V231, P537, DOI 10.1007/s00425-009-1072-6; Faoro F, 2015, PLANT SCI, V234, P1, DOI 10.1016/j.plantsci.2015.01.011; Fauquet CM, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-64; Frei dit Frey N, 2014, GENOME BIOL; FULTON TM, 1995, PLANT MOL BIOL REP, V13, P207, DOI 10.1007/BF02670897; Galletti R, 2011, PLANT PHYSIOL, V157, P804, DOI 10.1104/pp.111.174003; Goellner K, 2008, EUR J PLANT PATHOL, V121, P233, DOI 10.1007/s10658-007-9251-4; Gorovits R, 2007, MOL PLANT MICROBE IN, V20, P1376, DOI 10.1094/MPMI-20-11-1376; Gorovits R, 2014, PEST MANAG SCI, V70, P1632, DOI 10.1002/ps.3737; Gorovits R, 2013, VIRUS RES, V171, P33, DOI 10.1016/j.virusres.2012.09.017; Griffiths PD, 2001, J AM SOC HORTIC SCI, V126, P462, DOI 10.21273/JASHS.126.4.462; Gutierrez L, 2008, PLANT BIOTECHNOL J, V6, P609, DOI 10.1111/j.1467-7652.2008.00346.x; HERSKOWITZ I, 1995, CELL, V80, P187, DOI 10.1016/0092-8674(95)90402-6; Hettenhausen C, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0326-z; Huang L, 2012, PLANT BIOLOGY, V14, P905, DOI 10.1111/j.1438-8677.2012.00582.x; Hunter LJR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066530; Hutton SF, 2012, HORTSCIENCE, V47, P324, DOI 10.21273/HORTSCI.47.3.324; Ichimura K, 2002, TRENDS PLANT SCI, V7, P301, DOI 10.1016/S1360-1385(02)02302-6; Ichimura K, 2006, J BIOL CHEM, V281, P36969, DOI 10.1074/jbc.M605319200; Incarbone M, 2013, TRENDS PLANT SCI, V18, P382, DOI 10.1016/j.tplants.2013.04.001; Ji Y, 2007, MOL BREEDING, V20, P271, DOI 10.1007/s11032-007-9089-7; Ji YF, 2009, J AM SOC HORTIC SCI, V134, P281, DOI 10.21273/JASHS.134.2.281; Ji YF, 2009, HORTSCIENCE, V44, P614, DOI 10.21273/HORTSCI.44.3.614; Jiang MY, 2001, PLANT CELL PHYSIOL, V42, P1265, DOI 10.1093/pcp/pce162; Kadotani N, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0748-x; Kandoth PK, 2007, P NATL ACAD SCI USA, V104, P12205, DOI 10.1073/pnas.0700344104; Kil EJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep19013; Kohler A, 2002, PLANT PHYSIOL, V128, P1046, DOI 10.1104/pp.010744; Kumar KRR, 2009, MOL GENET GENOMICS, V282, P65, DOI 10.1007/s00438-009-0446-6; Lee HY, 2016, J PINEAL RES, V60, P327, DOI 10.1111/jpi.12314; Lee WS, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0705-8; LEON J, 1995, PLANT PHYSIOL, V108, P1673, DOI 10.1104/pp.108.4.1673; Lewsey M, 2009, MOL PLANT MICROBE IN, V22, P642, DOI 10.1094/MPMI-22-6-0642; Li C, 2014, BIOCHEM BIOPH RES CO, V443, P357, DOI 10.1016/j.bbrc.2013.11.061; Li C, 2013, INT J MOL SCI, V14, P21983, DOI 10.3390/ijms141121983; Li GJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002767; Liu YL, 2002, PLANT J, V31, P777, DOI 10.1046/j.1365-313X.2002.01394.x; Lu H, 2016, FRONT PLANT SCI, P1; Mayrose M, 2004, J BIOL CHEM, V279, P14819, DOI 10.1074/jbc.M313388200; Meldau S, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-213; Melvin P, 2015, PLANT MOL BIOL, V87, P287, DOI 10.1007/s11103-014-0276-8; Meng XZ, 2013, PLANT CELL, V25, P1126, DOI 10.1105/tpc.112.109074; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; Moriones E, 2000, VIRUS RES, V71, P123, DOI 10.1016/S0168-1702(00)00193-3; Niu DD, 2016, BIOCHEM BIOPH RES CO, V469, P120, DOI 10.1016/j.bbrc.2015.11.081; Oliveira MDM, 2016, PHYTOCHEM LETT, V15, P152, DOI 10.1016/j.phytol.2015.12.011; Palukaitis P, 2008, J PLANT PATHOL, V90, P153; Parrella G, 2016, PLANT DIS, V100, P539, DOI 10.1094/PDIS-07-15-0742-PDN; Perez-Salamo I, 2014, PLANT PHYSIOL, V165, P319, DOI 10.1104/pp.114.237891; Pitzschke A, 2014, MOL PLANT, V7, P722, DOI 10.1093/mp/sst157; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; Qiu JL, 2008, PLANT PHYSIOL, V148, P212, DOI 10.1104/pp.108.120006; Reuveni M, 2015, PHYSIOL MOL PLANT P, V92, P51, DOI 10.1016/j.pmpp.2015.08.001; Sade D, 2014, PLANT PHYSIOL, V165, P1684, DOI 10.1104/pp.114.243402; Seo S, 1999, PLANT CELL, V11, P289, DOI 10.1105/tpc.11.2.289; Seo S, 2007, PLANT J, V49, P899, DOI 10.1111/j.1365-313X.2006.03003.x; Shang J, 2011, PLANTA, V233, P299, DOI 10.1007/s00425-010-1308-5; Sinisterra XH, 2005, J GEN VIROL, V86, P1525, DOI 10.1099/vir.0.80665-0; Sohrab Sayed Sartaj, 2016, VirusDisease, V27, P19, DOI 10.1007/s13337-015-0292-6; Suarez-Rodriguez MC, 2007, PLANT PHYSIOL, V143, P661, DOI 10.1104/pp.106.091389; Tsuda K, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1004015; Van Wezel R, 2002, MOL PLANT PATHOL, V3, P461, DOI 10.1046/j.1364-3703.2002.00141.x; Verlaan MG, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003399; Verlaan MG, 2011, PLANT J, V68, P1093, DOI 10.1111/j.1365-313X.2011.04762.x; Vlot AC, 2009, ANNU REV PHYTOPATHOL, V47, P177, DOI 10.1146/annurev.phyto.050908.135202; Wang AG, 1990, PLANT PHYSL COMMUNIC, V6; Wang Q, 2013, PLANT CELL REP, V32, P1075, DOI 10.1007/s00299-013-1389-2; Wojtaszek P, 1997, BIOCHEM J, V322, P681, DOI 10.1042/bj3220681; Wu JQ, 2007, PLANT CELL, V19, P1096, DOI 10.1105/tpc.106.049353; Xu J, 2014, PLANT J, V77, P222, DOI 10.1111/tpj.12382; Yang XH, 2014, MOL BREEDING, V34, P749, DOI 10.1007/s11032-014-0072-9; Ye LX, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00953; Yi SY, 2015, PLANT PATHOLOGY J, V31, P192, DOI 10.5423/PPJ.NT.10.2014.0112; Yu L, 2015, PLANT CELL TISS ORG, V121, P21, DOI 10.1007/s11240-014-0675-1; ZAMIR D, 1994, THEOR APPL GENET, V88, P141, DOI 10.1007/BF00225889; Zhang H, 2009, VIRUS GENES, V39, P249, DOI 10.1007/s11262-009-0384-8; Zhang SQ, 1998, P NATL ACAD SCI USA, V95, P7433, DOI 10.1073/pnas.95.13.7433; Zhang SQ, 1997, PLANT CELL, V9, P809, DOI 10.1105/tpc.9.5.809; Zhao JingJing, 2016, Journal of Agricultural Biotechnology, V24, P1017; Zhao PP, 2013, RUSS J PLANT PHYSL+, V60, P672, DOI 10.1134/S1021443713050166; Zong XJ, 2009, PLANTA, V229, P485, DOI 10.1007/s00425-008-0848-4	101	42	51	5	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2017	12	2							e0172466	10.1371/journal.pone.0172466	http://dx.doi.org/10.1371/journal.pone.0172466			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5QV	28222174	Green Submitted, Green Published, gold			2022-12-27	WOS:000394676800058
J	Hwang, JI; Lee, SE; Kim, JE				Hwang, Jeong-In; Lee, Sung-Eun; Kim, Jang-Eok			Comparison of theoretical and experimental values for plant uptake of pesticide from soil	PLOS ONE			English	Article							FRUIT-TREE MODEL; ORGANIC POLLUTANTS; SYSTEMIC FUNGICIDE; CHLORPYRIFOS; TRANSLOCATION; DISSIPATION; FIELD; DEGRADATION; HERBICIDES; MOBILITY	Pesticides that persist in soils may be taken up by the roots of plants. One way to assess plant uptake is to theoretically predict the extent of plant uptake using a mathematical model. In this study, a model was developed to predict plant uptake of pesticide residues in soils using various parameters, such as pesticide mobility within soil, plant transpiration stream, root-soil transfer rate, plant growth, and pesticide dissipation in either soils or plants. The accuracy of the model was evaluated by comparing the modeled concentrations with measured uptake concentrations of chlorpyrifos ( CP) in lettuce, grown on treated soils with concentrations of approximately 10 and 20 mg kg(-1) CP. Measured concentrations of CP in lettuce at 21, 30, and 40 d after planting were between the 5th and 95th percentiles of model variation. A high correlation coefficient of >0.97 between modeled and measured concentrations was found. Coefficients of variation of mean factors to residual errors were between 25.3 and 48.2%. Overall, modeling results matched the experimental results well. Therefore, this plant uptake model could be used as an assessment tool to predict the extent of plant uptake of pesticide residues in soils.	[Hwang, Jeong-In; Lee, Sung-Eun; Kim, Jang-Eok] Kyungpook Natl Univ, Sch Appl Biosci, Daegu, South Korea	Kyungpook National University	Kim, JE (corresponding author), Kyungpook Natl Univ, Sch Appl Biosci, Daegu, South Korea.	jekim@knu.ac.kr	Hwang, Jeong-In/D-8504-2017	Hwang, Jeong-In/0000-0002-3929-0688				BRIGGS GG, 1982, PESTIC SCI, V13, P495, DOI 10.1002/ps.2780130506; Carter LJ, 2014, J AGR FOOD CHEM, V62, P816, DOI 10.1021/jf404282y; Charles R., 2004, THESIS; Chen ZX, 2015, CHEMOSPHERE, V131, P192, DOI 10.1016/j.chemosphere.2015.03.045; Environment Agency (EA), 2008, SC050021SR3 EA; Fang H, 2006, J ENVIRON SCI-CHINA, V18, P760; Fantke P, 2013, ENVIRON SCI TECHNOL, V47, P3548, DOI 10.1021/es303525x; Felizeter S, 2012, ENVIRON SCI TECHNOL, V46, P11735, DOI 10.1021/es302398u; GILES CH, 1960, J CHEM SOC, P3973, DOI 10.1039/jr9600003973; Hwang JI, 2015, ENVIRON GEOCHEM HLTH, V37, P1017, DOI 10.1007/s10653-015-9721-0; *IUPAC, PEST PROP DAT; Juraske R, 2012, CHEMOSPHERE, V89, P850, DOI 10.1016/j.chemosphere.2012.05.007; Juraske R, 2011, ENVIRON SCI TECHNOL, V45, P651, DOI 10.1021/es102907v; Juraske R, 2009, J HAZARD MATER, V165, P683, DOI 10.1016/j.jhazmat.2008.10.043; 황정인, 2014, [THE KOREAN JOURNAL OF PESTICIDE SCIENCE, 농약과학회지], V18, P61, DOI 10.7585/kjps.2014.18.2.61; KLEIER DA, 1988, PLANT PHYSIOL, V86, P803, DOI 10.1104/pp.86.3.803; Kwon CH, 2015, J KOREAN SOC APPL BI, V58, P821, DOI 10.1007/s13765-015-0111-1; 전상오, 2014, [THE KOREAN JOURNAL OF PESTICIDE SCIENCE, 농약과학회지], V18, P314, DOI 10.7585/kjps.2014.18.4.314; Legind CN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047002; Macbean C, PESTICIDE MANUAL; Marin A, 2003, J AGR FOOD CHEM, V51, P4708, DOI 10.1021/jf021222e; Mckone TE, 2007, ENVIRON TOXICOL CHEM, V26, P2494, DOI 10.1897/06-269.1; Min ZW, 2009, J KOREAN SOC APPL BI, V52, P681, DOI 10.3839/jksabc.2009.113; Ministry of Food and Drug Safety (MFDS), 2015, PEST RES DAT; Moore MT, 2002, CHEMOSPHERE, V46, P827, DOI 10.1016/S0045-6535(01)00189-8; Namiki S, 2013, SOIL SCI PLANT NUTR, V59, P669, DOI 10.1080/00380768.2013.813833; National Institute of Public Health and Environmental Protection (RIVM), 2001, 711701021 RIVM; PATERSON S, 1994, ENVIRON SCI TECHNOL, V28, P2259, DOI 10.1021/es00062a009; Rein A, 2011, SAR QSAR ENVIRON RES, V22, P191, DOI 10.1080/1062936X.2010.548829; Riccio R, 2006, FOOD ADDIT CONTAM A, V23, P683, DOI 10.1080/02652030600627248; SABLJIC A, 1995, CHEMOSPHERE, V31, P4489, DOI 10.1016/0045-6535(95)00327-5; SHONE MGT, 1974, J EXP BOT, V25, P401, DOI 10.1093/jxb/25.2.401; SHONE MGT, 1974, J EXP BOT, V25, P390, DOI 10.1093/jxb/25.2.390; Singh BK, 2003, APPL ENVIRON MICROB, V69, P5198, DOI 10.1128/AEM.69.9.5198-5206.2003; Singh DP, 2011, ENVIRON SCI POLLUT R, V18, P1351, DOI 10.1007/s11356-011-0472-x; Trapp S, 2007, SAR QSAR ENVIRON RES, V18, P367, DOI 10.1080/10629360701303693; Trapp S, 2003, SAR QSAR ENVIRON RES, V14, P17, DOI 10.1080/1062936021000058755; Trapp S, 2000, PEST MANAG SCI, V56, P767, DOI 10.1002/1526-4998(200009)56:9<767::AID-PS198>3.0.CO;2-Q; Trapp S, 2013, ENVIRON SCI POLLUT R, V20, P4018, DOI 10.1007/s11356-012-1337-7; United States Environmental Protection Agency (U.S. EPA), 1992, 822R93011B US EPA	40	19	19	7	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2017	12	2							e0172254	10.1371/journal.pone.0172254	http://dx.doi.org/10.1371/journal.pone.0172254			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BI	28212386	Green Submitted, Green Published, gold			2022-12-27	WOS:000394424700025
J	Ramis, R; Tamayo-Uria, I; Gomez-Barroso, D; Lopez-Abente, G; Morales-Piga, A; Romaguera, E; Aragones, N; Garcia-Perez, J				Ramis, Rebeca; Tamayo-Uria, Ibon; Gomez-Barroso, Diana; Lopez-Abente, Gonzalo; Morales-Piga, Antonio; Pardo Romaguera, Elena; Aragones, Nuria; Garcia-Perez, Javier			Risk factors for central nervous system tumors in children: New findings from a case-control study	PLOS ONE			English	Article							CHILDHOOD BRAIN-TUMORS; RESIDENTIAL PROXIMITY; GREAT-BRITAIN; AIR-POLLUTION; EPIDEMIOLOGY-CONSORTIUM; CANCER INCIDENCE; WATER SOURCE; URBAN SITES; LEUKEMIA; EXPOSURE	Background Central nervous system tumors ( CNS) are the most frequent solid tumor in children. Causes of CNS tumors are mainly unknown and only 5% of the cases can be explained by genetic predisposition. We studied the effects of environmental exposure on the incidence of CNS tumors in children by subtype, according to exposure to industrial and/or urban environment, exposure to crops and according to socio-economic status of the child. Methods We carried out a population-based case-control study of CNS tumors in Spain, covering 714 incident cases collected from the Spanish Registry of Childhood Tumors ( period 1996-2011) and 4284 controls, individually matched by year of birth, sex, and autonomous region of residence. We built a covariate to approximate the exposure to industrial and/or urban environment and a covariate for the exposure to crops ( GCI) using the coordinates of the home addresses of the children. We used the 2001 Census to obtain information about socio-economic status ( SES). We fitted logistic regression models to estimate odds ratios ( ORs) and 95% confidence intervals ( 95% CIs). Results The results for all CNS tumors showed an excess risk ( OR = 1.37; 95%CI = 1.09-1.73) for SES, i.e., children living in the least deprived areas had 37% more risk of CNS tumor than children living in the most deprived areas. For GCI, an increase of 10% in crop surface in the 1-km buffer around the residence implied an increase of 22% in the OR ( OR = 1.22; 95%CI = 1.15-1.29). Children living in the intersection of industrial and urban areas could have a greater risk of CNS tumors than children who live outside these areas ( OR = 1.20; 95%CI = 0.82-1.77). Living in urban areas ( OR = 0.90; 95%CI = 0.65-1.24) or industrial areas ( OR = 0.96; 95%CI = 0.81-1.77) did not seem to increase the risk for all CNS tumors together. By subtype, Astrocytomas, Intracranial and intraspinal embryonal tumors, and other gliomas showed similar results. Conclusion Our results suggest that higher socioeconomic status and exposure to crops could increase the risk of CNS tumors in children.	[Ramis, Rebeca; Lopez-Abente, Gonzalo; Aragones, Nuria; Garcia-Perez, Javier] Carlos III Inst Hlth, Canc & Environm Epidemiol Unit, Natl Ctr Epidemiol, Madrid, Spain; [Ramis, Rebeca; Gomez-Barroso, Diana; Lopez-Abente, Gonzalo; Aragones, Nuria; Garcia-Perez, Javier] Consortium Biomed Res Epidemiol & Publ Hlth, CIBERESP, Madrid, Spain; [Tamayo-Uria, Ibon] Ctr Res Environm Epidemiol CREAL, Barcelona, Spain; [Tamayo-Uria, Ibon] UPF, Barcelona, Spain; [Gomez-Barroso, Diana] Carlos III Inst Hlth, Natl Ctr Epidemiol, Madrid, Spain; [Morales-Piga, Antonio] Carlos III Inst Hlth, Rare Dis Res Inst IIER, Madrid, Spain; [Morales-Piga, Antonio] Consortium Biomed Res Rare Dis CIBERER, Madrid, Spain; [Pardo Romaguera, Elena] Univ Valencia, Spanish Registry Childhood Tumors RETI SEHOP, Valencia, Spain	Instituto de Salud Carlos III; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Pompeu Fabra University; Pompeu Fabra University; Instituto de Salud Carlos III; Instituto de Salud Carlos III; Instituto de Investigacion de Enfermedades Raras (IIER); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; University of Valencia	Ramis, R (corresponding author), Carlos III Inst Hlth, Canc & Environm Epidemiol Unit, Natl Ctr Epidemiol, Madrid, Spain.; Ramis, R (corresponding author), Consortium Biomed Res Epidemiol & Publ Hlth, CIBERESP, Madrid, Spain.	rramis@isciii.es	Tamayo-Uria, Ibon/H-5283-2019; Lopez-Abente, Gonzalo/E-5221-2010; Ramis, Rebeca/E-1743-2015; Aragones, Nuria/O-5962-2015; García-Pérez, Javier/F-4566-2016; Gomez-Barroso, Diana/Q-5417-2018	Tamayo-Uria, Ibon/0000-0002-8183-7106; Lopez-Abente, Gonzalo/0000-0003-2423-8075; Ramis, Rebeca/0000-0001-6154-9142; Aragones, Nuria/0000-0003-0983-2156; García-Pérez, Javier/0000-0003-0300-1810; Gomez-Barroso, Diana/0000-0001-7388-1767				Badaloni C, 2013, OCCUP ENVIRON MED, V70, P876, DOI 10.1136/oemed-2013-101604; Bauchet L, 2009, J NEURO-ONCOL, V92, P87, DOI 10.1007/s11060-008-9740-0; Bondy ML, 2008, CANCER-AM CANCER SOC, V113, P1953, DOI 10.1002/cncr.23741; Brender JD, 2011, AM J PUBLIC HEALTH, V101, pS37, DOI 10.2105/AJPH.2011.300183; Chen M, 2015, PEDIATRICS; Choi HS, 2006, ENVIRON HEALTH PERSP, V114, P1113, DOI 10.1289/ehp.9145; Danysh HE, 2015, PEDIATR BLOOD CANCER, V62, P1572, DOI 10.1002/pbc.25549; de Vocht F, 2013, OCCUP ENVIRON MED, V70, P349, DOI 10.1136/oemed-2012-100954; Garcia-Perez J, 2016, ENVIRON INT, V92-93, P269, DOI 10.1016/j.envint.2016.04.023; Garcia-Perez J, 2016, ENVIRON RES, V147, P405, DOI 10.1016/j.envres.2016.02.036; Garcia-Perez J, 2015, ENVIRON RES, V140, P542, DOI 10.1016/j.envres.2015.05.014; Gomez-Barroso D, INTJHEALTH IN PRESS; Grill J, 2013, HAND CLINIC, V112, P931, DOI 10.1016/B978-0-444-52910-7.00015-5; Hajat Anjum, 2015, Curr Environ Health Rep, V2, P440, DOI 10.1007/s40572-015-0069-5; Infante-Rivard C, 2007, J TOXICOL ENV HEAL B, V10, P81, DOI 10.1080/10937400601034589; Jarup L, 2002, BRIT J CANCER, V86, P1732, DOI 10.1038/sj.bjc.6600311; Johnson KJ, 2014, CANCER EPIDEM BIOMAR, V23, P2716, DOI 10.1158/1055-9965.EPI-14-0207; Keegan TJ, 2013, BRIT J CANCER, V108, P1907, DOI 10.1038/bjc.2013.171; Knox EG, 1997, J EPIDEMIOL COMMUN H, V51, P151, DOI 10.1136/jech.51.2.151; Kollerud RD, 2015, SCAND J PUBLIC HEALT, V43, P736, DOI 10.1177/1403494815590499; Liu CC, 2008, J TOXICOL ENV HEAL A, V71, P310, DOI 10.1080/15287390701738491; Lopez-Abente G, 2003, OCCUP ENVIRON MED, V60, P504, DOI 10.1136/oem.60.7.504; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; McKinney PA, 2005, BIOELECTROMAGNETICS, pS60, DOI 10.1002/bem.20149; McNally RJQ, 2004, EUR J CANCER, V40, P2766, DOI 10.1016/j.ejca.2004.08.020; Mueller BA, 2004, INT J EPIDEMIOL, V33, P1209, DOI 10.1093/ije/dyh215; Mueller BA, 2001, ENVIRON HEALTH PERSP, V109, P551, DOI 10.2307/3455026; Ortega-Garcia JA, 2016, AN PEDIATR, V84, P154, DOI 10.1016/j.anpedi.2015.04.021; Pedersen C, 2014, CANCER CAUSE CONTROL, V25, P171, DOI 10.1007/s10552-013-0319-5; Peris-Bonet R, 2010, ANN ONCOL, V21, piii103, DOI 10.1093/annonc/mdq092; Peris-Bonet R, CANC INFANTIL ESPANA; Pollan M, 1999, J NEUROL SCI, V163, P127, DOI 10.1016/S0022-510X(99)00010-6; Ramis R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127273; Reynolds P, 2004, EPIDEMIOLOGY, V15, P6, DOI 10.1097/01.ede.0000101749.28283.de; Reynolds P, 2005, EPIDEMIOLOGY, V16, P93, DOI 10.1097/01.ede.0000147119.32704.5c; Reynolds P, 2002, CANCER CAUSE CONTROL, V13, P665, DOI 10.1023/A:1019579430978; Sadetzki S, 2014, FRONT PUBLIC HLTH, P2; Schuz J, 2011, CANCER EPIDEMIOL, V35, P37, DOI 10.1016/j.canep.2010.08.001; Selvin S, 2004, INT J HYG ENVIR HEAL, V207, P555, DOI 10.1078/1438-4639-00327; Steliarova-Foucher E, 2005, CANCER-AM CANCER SOC, V103, P1457, DOI 10.1002/cncr.20910; Vinson F, 2011, OCCUP ENVIRON MED, V68, P694, DOI 10.1136/oemed-2011-100082; Zahm SH, 1998, ENVIRON HEALTH PERSP, V106, P893, DOI 10.2307/3434207	42	15	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2017	12	2							e0171881	10.1371/journal.pone.0171881	http://dx.doi.org/10.1371/journal.pone.0171881			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BI	28212424	Green Published, gold, Green Submitted			2022-12-27	WOS:000394424700013
J	Zhai, L; Wang, CC; Chen, YF; Zhou, SX; Li, LS				Zhai, Lei; Wang, Chenchen; Chen, Yuanfan; Zhou, Shixin; Li, Lingsong			Rbm46 regulates mouse embryonic stem cell differentiation by targeting beta-Catenin mRNA for degradation	PLOS ONE			English	Article							SELF-RENEWAL; ES CELLS; PLURIPOTENCY; EXPRESSION; NANOG; WNT; CIRCUITRY; NETWORKS; PATHWAY; OCT-3/4	Embryonic stem cells (ESCs) are pluripotent cells and have the capability for differentiation into any of the three embryonic germ layers. The Wnt/beta-Catenin pathway has been shown to play an essential role in ESC differentiation regulation. Activation of beta-Catenin by post-translational modification has been extensively studied. However, mechanism(s) of posttranscriptional regulation of beta-Catenin are not well defined. In this study, we report an RNA recognition motif-containing protein (RNA binding motif protein 46, RBM46) which regulates the degradation of beta-Catenin mRNA. Our results show that Rbm46 is distributed primarily in the cytoplasm of mouse ESCs (mESCs) and is elevated during the process of ESC differentiation. In addition, overexpression of Rbm46 results in differentiation of mESCs into trophectoderm, while knock-down of Rbm46 leads to mESC differentiation into endoderm. beta-Catenin, a key effector in the Wnt pathway which has been reported to play a significant role in the regulation of ESC differentiation, is post-transcriptionally regulated by Rbm46. Our study reveals Rbm46 plays a novel role in the regulation of ESC differentiation.	[Zhai, Lei; Wang, Chenchen; Chen, Yuanfan; Zhou, Shixin; Li, Lingsong] Peking Univ, Sch Basic Med Sci, Dept Cell Biol, Hlth Sci Ctr, Beijing, Peoples R China; [Zhai, Lei; Wang, Chenchen; Chen, Yuanfan; Zhou, Shixin; Li, Lingsong] Peking Univ, Hlth Sci Ctr, China Natl Ctr Int Res, Stem Cell Res Ctr, Beijing, Peoples R China; [Li, Lingsong] Univ Chinese Acad Sci, Shanghai Adv Res Inst, SARI Ctr Stem Cell & Nanomed, Shanghai, Peoples R China	Peking University; Peking University; Chinese Academy of Sciences; Shanghai Advanced Research Institute, CAS; University of Chinese Academy of Sciences, CAS	Zhai, L; Li, LS (corresponding author), Peking Univ, Sch Basic Med Sci, Dept Cell Biol, Hlth Sci Ctr, Beijing, Peoples R China.; Zhai, L; Li, LS (corresponding author), Peking Univ, Hlth Sci Ctr, China Natl Ctr Int Res, Stem Cell Res Ctr, Beijing, Peoples R China.; Li, LS (corresponding author), Univ Chinese Acad Sci, Shanghai Adv Res Inst, SARI Ctr Stem Cell & Nanomed, Shanghai, Peoples R China.	laceyzhai@126.com; lingsongli88@126.com	Zhai, Lei/AAJ-1301-2020	Zhai, Lei/0000-0002-3886-2154	International S&T Cooperation Program [2011DFA31040]; 863 Program from the Ministry of Science and Technology of China [2011AA020106]; New Drug Innovation of China [2011ZX09102-010-02]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDA01040000]; Shanghai Bureau of Science and Technology [12DZ1910900]	International S&T Cooperation Program; 863 Program from the Ministry of Science and Technology of China(National High Technology Research and Development Program of China); New Drug Innovation of China; Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); Shanghai Bureau of Science and Technology	This work was supported by the International S&T Cooperation Program (grant no. 2011DFA31040) and the 863 Program (grant no. 2011AA020106) from the Ministry of Science and Technology of China, the New Drug Innovation of China (grant no. 2011ZX09102-010-02), a grant from Strategic Priority Research Program of the Chinese Academy of Sciences (grant no. XDA01040000), and a special grant from Shanghai Bureau of Science and Technology (grant no. 12DZ1910900). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Ying Jin for providing the E14Tg2a mouse ESC lines and the pPyCAGIP vector; Linheng Li, and Sheng Ding for their comments. We also thank Li Wang for supporting teratoma formation experiment, Yinan Liu and Xiaoyan Zhang for performing FACS. This work was supported by the International S&T Cooperation Program (grant no. 2011DFA31040) and the 863 Program (grant no. 2011AA020106) from the Ministry of Science and Technology of China, the New Drug Innovation of China (grant no. 2011ZX09102-010-02), a grant from Strategic Priority Research Program of the Chinese Academy of Sciences (grant no. XDA01040000), and a special grant from Shanghai Bureau of Science and Technology (grant no. 12DZ1910900).	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Beck ARP, 1998, P NATL ACAD SCI USA, V95, P2331, DOI 10.1073/pnas.95.5.2331; Boiani M, 2005, NAT REV MOL CELL BIO, V6, P872, DOI 10.1038/nrm1744; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Chen CY, 2015, STEM CELLS, V33, P3468, DOI 10.1002/stem.2201; Dalton S, 2013, CURR OPIN CELL BIOL, V25, P241, DOI 10.1016/j.ceb.2012.09.005; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Ezzeddine N, 2007, MOL CELL BIOL, V27, P7791, DOI 10.1128/MCB.01254-07; Glauche I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011238; Hao J, 2006, DEV BIOL, V290, P81, DOI 10.1016/j.ydbio.2005.11.011; Hochedlinger K, 2005, CELL, V121, P465, DOI 10.1016/j.cell.2005.02.018; Jiang JM, 2008, NAT CELL BIOL, V10, P353, DOI 10.1038/ncb1698; Kashyap V, 2009, STEM CELLS DEV, V18, P1093, DOI 10.1089/scd.2009.0113; Kwon SC, 2013, NAT STRUCT MOL BIOL, V20, P1122, DOI 10.1038/nsmb.2638; Lee Min-Ho, 2006, WormBook, P1; Li J, 2012, MOL CELL BIOCHEM, V362, P233, DOI 10.1007/s11010-011-1148-z; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Merrill BJ, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a007971; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Miyabayashi T, 2007, P NATL ACAD SCI USA, V104, P5668, DOI 10.1073/pnas.0701331104; Narva E, 2012, STEM CELLS, V30, P452, DOI 10.1002/stem.1013; Nelakanti R.V, 2015, CURR PROTOC STEM CEL, V32; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Ogawa K, 2006, BIOCHEM BIOPH RES CO, V343, P159, DOI 10.1016/j.bbrc.2006.02.127; Okano H, 2005, EXP CELL RES, V306, P349, DOI 10.1016/j.yexcr.2005.02.021; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Sakakibara S, 2002, P NATL ACAD SCI USA, V99, P15194, DOI 10.1073/pnas.232087499; Sakakibara S, 1996, DEV BIOL, V176, P230, DOI 10.1006/dbio.1996.0130; Shamblott MJ, 1998, P NATL ACAD SCI USA, V95, P13726, DOI 10.1073/pnas.95.23.13726; Singla DK, 2006, BIOCHEM BIOPH RES CO, V345, P789, DOI 10.1016/j.bbrc.2006.04.125; Takao Y, 2007, BIOCHEM BIOPH RES CO, V353, P699, DOI 10.1016/j.bbrc.2006.12.072; Yang YJ, 2011, MOL BIOL REP, V38, P2043, DOI 10.1007/s11033-010-0328-3; Ye J, 2014, CELL STEM CELL, V15, P271, DOI 10.1016/j.stem.2014.08.010; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968	35	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2017	12	2							e0172420	10.1371/journal.pone.0172420	http://dx.doi.org/10.1371/journal.pone.0172420			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BI	28212427	Green Submitted, Green Published, gold			2022-12-27	WOS:000394424700046
J	Amodeo, MR; Vazquez, MB; Zalba, SM				Raul Amodeo, Martin; Belen Vazquez, Maria; Martin Zalba, Sergio			Generalist dispersers promote germination of an alien fleshy-fruited tree invading natural grasslands	PLOS ONE			English	Article							CUTTING ANT NESTS; SEED DISPERSAL; PRUNUS-MAHALEB; PLANT INVASIONS; AVIAN FRUGIVORES; BIRDS; POPULATION; PATTERNS; PASSAGE; MANAGEMENT	Plants with animal-dispersed fruits seem to overcome the barriers that limit their spread into new habitats more easily than other invasive plants and, at the same time, they pose special difficulties for containment, control or eradication. The effects of animals on plant propagules can be very diverse, with positive, neutral or negative consequences for germination and recruitment. Moreover, the environmental conditions where the seeds are deposited and where the post-dispersal processes take place can be crucial for their fate. Prunus mahaleb is a fleshy-fruited tree invading natural grasslands in the Argentine Pampas. In this study, we analyzed the importance of pulp removal, endocarp scarification and the effects of vectors on its germination response, by means of germination experiments both in the laboratory and under semi-natural conditions. Our laboratory results demonstrated that endocarp scarification enhances germination and suggests that vestiges of pulp on the stones have inhibitory effects. Frugivores exert a variety of effects on germination responses and this variation can be explained by their differing influence on pulp removal and endocarp scarification. Most frugivores produced a positive effect on germination under laboratory conditions, in comparison to intact fruits and hand-peeled stones. We observed different degrees of pulp removal from the surface of the stones by the dispersers which was directly correlated to the germination response. On the other hand, all the treatments showed high germination responses under semi-natural conditions suggesting that post-dispersal processes, like seed burial, and the exposure to natural conditions might exert a positive effect on germination response, attenuating the plant's dependence on the dispersers' gut treatment. Our results highlight the need to consider the whole seed dispersal process and the value of combining laboratory and field tests.	[Raul Amodeo, Martin; Martin Zalba, Sergio] Univ Nacl Sur, CONICET, Dept Biol Bioquim & Farm, GEKKO Grp Estudios Conservac & Manejo, Bahia Blanca, Buenos Aires, Argentina; [Belen Vazquez, Maria] Consejo Nacl Invest Cient & Tecn, Ctr Cient Tecnol Bahia Blanca, CERZOS Ctr Recursos Renovables Zona Semiarida, Bahia Blanca, Buenos Aires, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of the South; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Amodeo, MR (corresponding author), Univ Nacl Sur, CONICET, Dept Biol Bioquim & Farm, GEKKO Grp Estudios Conservac & Manejo, Bahia Blanca, Buenos Aires, Argentina.	martin.amodeo@uns.edu.ar		Vazquez, Maria Belen/0000-0001-8748-3348; Amodeo, Martin/0000-0002-6773-5701; Zalba, Sergio/0000-0003-4940-6872	National Scientific and Technical Research Council from Argentina [11220120100413C0]; Universidad Nacional del Sur, Argentina	National Scientific and Technical Research Council from Argentina; Universidad Nacional del Sur, Argentina	This work was supported by the National Scientific and Technical Research Council from Argentina (grant number: 11220120100413C0, CONICET, http://www.conicet.gov.ar/) and Universidad Nacional del Sur, Argentina (http II www.uns.edu.ar/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Absi KM, 2010, SEED SCI TECHNOL, V38, P332, DOI 10.15258/sst.2010.38.2.06; Amodeo M. r., 2014, THESIS U NAC BAH BLA; Amodeo MR, 2015, BIOL INVASIONS PATTE, P121; [Anonymous], 2014, R LANG ENV STAT COMP; Auguie B, 2012, GRIDEXTRA FUNCTIONS; BARNEA A, 1991, FUNCT ECOL, V5, P394, DOI 10.2307/2389811; Baskin C.C, 2001, SEEDS ECOLOGY BIOGEO; Baskin JM, 2004, SEED SCI RES, V14, P1, DOI 10.1079/SSR2003150; Bass DA, 2006, EUPHYTICA, V148, P97, DOI 10.1007/s10681-006-5944-6; Bertonatti C, 2000, SITUACIO AMBIENTAL A; Bilenca D. N., 2004, AREAS VALIOSAS PASTI; Brouillet L, 2010, VASCAN DATABASE VASC; Buckley YM, 2006, J APPL ECOL, V43, P848, DOI 10.1111/j.1365-2664.2006.01210.x; CENET, 2008, PMEP PEST MAN ED; Cipollini ML, 1997, AM NAT, V150, P346, DOI 10.1086/286069; Comita LS, 2014, J ECOL, V102, P845, DOI 10.1111/1365-2745.12232; de Villalobos AE, 2010, ACTA OECOL, V36, P514, DOI 10.1016/j.actao.2010.07.004; Farji-Brener AG, 2000, STUD NEOTROP FAUNA E, V35, P131, DOI 10.1076/0165-0521(200008)35:2;1-9;FT131; Farji-Brener AG, 2000, J VEG SCI, V11, P453, DOI 10.2307/3236638; Farji-Brener AG, 2008, P ROY SOC B-BIOL SCI, V275, P1431, DOI 10.1098/rspb.2008.0154; Finch-Savage WE, 2012, SEED SCI RES, V22, P243, DOI 10.1017/S0960258512000165; Garcia C, 2007, MOL ECOL, V16, P1947, DOI 10.1111/j.1365-294X.2006.03126.x; Gercekcioglu R, 2012, TURK J AGRIC FOR, V23, P145; Ghayyad M., 2010, American-Eurasian Journal of Agricultural and Environmental Science, V9, P163; Gosper CR, 2005, DIVERS DISTRIB, V11, P549, DOI 10.1111/j.1366-9516.2005.00195.x; Grell MN, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-928; Grisez T. J., 2008, WOODY PLANT SEED MAN, V727, P875; Heidari M., 2008, American-Eurasian Journal of Agricultural and Environmental Science, V3, P114; Heleno RH, 2013, BIOL INVASIONS, V15, P1143, DOI 10.1007/s10530-012-0357-z; HERRERA CM, 1984, ECOL MONOGR, V54, P1, DOI 10.2307/1942454; HERRERA CM, 1981, ECOL MONOGR, V51, P203, DOI 10.2307/2937263; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Iliev N., 2012, FORESTRY IDEAS, V18, P28; Jeschke JM, 2013, AMBIO, V42, P541, DOI 10.1007/s13280-013-0387-5; Jordaan LA, 2012, S AFR J BOT, V80, P13, DOI 10.1016/j.sajb.2012.01.007; Jordaan LA, 2012, BIOTROPICA, V44, P738, DOI 10.1111/j.1744-7429.2012.00875.x; Jordaan LA, 2011, BIOL INVASIONS, V13, P1917, DOI 10.1007/s10530-011-0013-z; Jordano P, 2000, ECOL MONOGR, V70, P591, DOI 10.1890/0012-9615(2000)070[0591:SDETQC]2.0.CO;2; JORDANO P, 1995, ECOLOGY, V76, P2627, DOI 10.2307/2265833; KREFTING LW, 1949, ECOL MONOGR, V19, P271, DOI 10.2307/1943538; Long M, 1997, ACTUALIZACIO CONOCIM; Meyer GA, 1998, AM MIDL NAT, V140, P129, DOI 10.1674/0003-0031(1998)140[0129:IOSPBF]2.0.CO;2; Munoz MC, 2013, INVASIVE PLANT ECOLOGY, P121; MURRAY KG, 1994, ECOLOGY, V75, P989, DOI 10.2307/1939422; Peng CYJ, 2002, J EDUC RES, V96, P3, DOI 10.1080/00220670209598786; Pipinis E, 2012, NOT BOT HORTI AGROBO, V40, P183; Prada MA, 2008, MANUAL PROPAGACIO AR; Amodeo MR, 2013, PLANT ECOL, V214, P1299, DOI 10.1007/s11258-013-0252-4; Richardson DM, 2006, PROG PHYS GEOG, V30, P409, DOI 10.1191/0309133306pp490pr; Richardson DM, 2014, BIOL INVASIONS, V16, P473, DOI 10.1007/s10530-013-0606-9; Richardson DM, 2000, BIOL REV, V75, P65, DOI 10.1017/S0006323199005435; Robertson AW, 2006, FUNCT ECOL, V20, P58, DOI 10.1111/j.1365-2435.2005.01057.x; Rodriguez-Perez J, 2005, FUNCT ECOL, V19, P699, DOI 10.1111/j.0269-8463.2005.00971.x; Samuels IA, 2005, FUNCT ECOL, V19, P365, DOI 10.1111/j.1365-2435.2005.00973.x; Saul WC, 2015, ECOL LETT, V18, P236, DOI 10.1111/ele.12408; Schupp EW, 2010, NEW PHYTOL, V188, P333, DOI 10.1111/j.1469-8137.2010.03402.x; Sebert-Cuvillier E, 2010, BIOL INVASIONS, V12, P1183, DOI 10.1007/s10530-009-9539-8; SWEARINGEN J, 2008, WEEDUS DATABASE PLAN; Thabethe V, 2015, BIOL INVASIONS, V17, P3029, DOI 10.1007/s10530-015-0932-1; Traveset A., 2007, Seed dispersal: theory and its application in a changing world, P78, DOI 10.1079/9781845931650.0078; Traveset A, 1998, ECOL EVOL SYST, V1, P151, DOI DOI 10.1078/1433-8319-00057; Traveset A, 2011, FIFTY YEARS OF INVASION ECOLOGY: THE LEGACY OF CHARLES ELTON, P143; Traveset Anna, 2002, P339, DOI 10.1079/9780851995250.0339; Vivian-Smith GE, 2010, INVAS PLANT SCI MANA, V3, P93, DOI 10.1614/IPSM-D-09-00011.1; Webb CJ, 1988, FLORA NZ, V4; Yagihashi T, 1999, ECOL RES, V14, P71, DOI 10.1046/j.1440-1703.1999.141278.x; Yagihashi T., 2000, J FOREST RES-JPN, V5, P213, DOI [10.1007/BF02762405, DOI 10.1007/BF02762405]; Zalba SM, 2015, WEED RES, V55, P546, DOI 10.1111/wre.12171; Zalba SM, 2002, BIOL INVASIONS, V4, P55, DOI DOI 10.1023/A:1020532609792	69	12	14	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0172423	10.1371/journal.pone.0172423	http://dx.doi.org/10.1371/journal.pone.0172423			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207815	Green Submitted, Green Published, gold			2022-12-27	WOS:000394424500133
J	Xu, LY; Munir, K; Kanabkaew, C; Le Coeur, S				Xu, Luyi; Munir, Kerim; Kanabkaew, Cheeraya; Le Coeur, Sophie			Factors influencing antiretroviral treatment suboptimal adherence among perinatally HIV-infected adolescents in Thailand	PLOS ONE			English	Article							DIAGNOSIS DISCLOSURE; MEDICATION ADHERENCE; POSITIVE CHILDREN; THERAPY; OUTCOMES; YOUTH; PREDICTORS; CHALLENGES; BARRIERS; HIV/AIDS	Background Existing studies have suggested decreased adherence and rebound in mortality in perinatally HIV-infected adolescents receiving antiretroviral therapy (ART) as compared to adults and young children. Methods We used both quantitative and qualitative approaches to identify factors influencing adherence among perinatally infected adolescents in Thailand. We analyzed data from 568 pairs of perinatally infected adolescents (aged 12-19) and their primary caregivers in the Teens Living With Antiretrovirals (TEEWA) study, a cross-sectional survey conducted in 2010-2012. We also conducted 12 in-depth interviews in 2014 with infected adolescents or their primary caregivers to elicit experiences of living with long-term ART. Results From the quantitative analysis, a total of 275 (48.4%) adolescents had evidence of suboptimal adherence based on this composite outcome: adolescents self-reported missing doses in the past 7 days, caregiver rating of overall adherence as suboptimal, or latest HIV-RNA viral load >= 1000 copies/ml. In multivariate logistic regression analysis, younger age, having grandparents or extended family members as the primary caregiver, caregiver-assessed poor intellectual ability, having a boy/girlfriend, frequent online chatting, self-reported unhappiness and easiness in asking doctors questions were significantly associated with suboptimal adherence. From the in-depth interviews, tensed relationships with caregivers, forgetfulness due to busy schedules, and fear of disclosing HIV status to others, especially boy/girlfriends, were important contributors to suboptimal adherence. Social and emotional support and counseling from peer group was consistently reported as a strong adherence-promoting factor. Conclusion Our findings highlight unique barriers of ART adherence among the perinatally infected adolescents. Future interventions should be targeted at helping adolescents to improve interpersonal relationships and build adaptive skills in recognizing and addressing challenging situations related to ART taking.	[Xu, Luyi; Munir, Kerim] Harvard Med Sch, Boston, MA 02115 USA; [Munir, Kerim] Boston Childrens Hosp, Div Dev Med, Dev Med Ctr, Boston, MA USA; [Kanabkaew, Cheeraya; Le Coeur, Sophie] Inst Rech Dev IRD 174 PHPT, Chiang Mai, Thailand; [Kanabkaew, Cheeraya; Le Coeur, Sophie] Chiang Mai Univ, Fac Associated Med Sci, Chiang Mai, Thailand; [Le Coeur, Sophie] INED, Paris, France; [Le Coeur, Sophie] Harvard TH Chan Sch Publ Hlth, Boston, MA USA	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Chiang Mai University; Harvard University; Harvard T.H. Chan School of Public Health	Xu, LY (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.	luyi_xu@hms.harvard.edu	Munir, Kerim/D-6910-2015	Munir, Kerim/0000-0002-2404-1806	Sidaction [AI22-1/01855]; Oxfam Great Britain, Thailand [THAA51]; Scholars in Medicine, Harvard Medical School, Boston, USA; Thai Studies Fund, Harvard University Asia Center, Boston, USA; NIMH / Fogarty International Center, National Institutes of Health NCD-LIFESPAN Global Mental Health/Developmental Disorders Research Program [D43TW009680]; FOGARTY INTERNATIONAL CENTER [D43TW009680] Funding Source: NIH RePORTER	Sidaction; Oxfam Great Britain, Thailand; Scholars in Medicine, Harvard Medical School, Boston, USA; Thai Studies Fund, Harvard University Asia Center, Boston, USA; NIMH / Fogarty International Center, National Institutes of Health NCD-LIFESPAN Global Mental Health/Developmental Disorders Research Program; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This work was supported by Sidaction, grant AI22-1/01855, (https://www.sidaction.org/) - receiver: SL; Oxfam Great Britain, Thailand, grant THAA51, (http://www.oxfam.org.uk/) -receiver: Marc Lallemant; Scholars in Medicine, Harvard Medical School, Boston, USA, (http://hms.harvard.edu/departments/medical-education/student-services/scholars-medicine-sim) -receiver: LX; Thai Studies Fund, Harvard University Asia Center, Boston, USA, (http://asiacenter.harvard.edu/grants/students/southeastasia) -receiver: LX. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. NIMH / Fogarty International Center, National Institutes of Health NCD-LIFESPAN Global Mental Health/Developmental Disorders Research Program, grant D43TW009680, (www.fic.nih.gov) -receiver: KM The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agwu AL, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18579; Bernays S, 2014, LANCET, V383, P1355, DOI 10.1016/S0140-6736(13)62328-4; Boon-yasidhi V, 2016, INT J STD AIDS, V27, P288, DOI 10.1177/0956462415579590; Boon-Yasidhi V, 2013, AIDS CARE, V25, P756, DOI 10.1080/09540121.2012.749331; Boussari O, 2015, BMC MED RES METHODOL, V15, DOI 10.1186/1471-2288-15-10; Chandler CN AE, 2013, LOST TRANSITIONS CUR, DOI [10.1007/s10461-012-0364-1, DOI 10.1007/S10461-012-0364-1]; Chandwani S, 2012, J ADOLESCENT HEALTH, V51, P242, DOI 10.1016/j.jadohealth.2011.12.013; Cluver Lucie D, 2015, AIDS, V29 Suppl 1, pS57, DOI 10.1097/QAD.0000000000000695; Denison JA, 2015, J INT AIDS SOC, V18, DOI 10.7448/IAS.18.1.19358; Evans SD, 2015, AIDS PATIENT CARE ST, V29, P43, DOI 10.1089/apc.2014.0058; Falagas ME, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-13; FESTINGER L, 1962, SCI AM, V207, P93, DOI 10.1038/scientificamerican1062-93; Fetzer BC, 2011, AIDS PATIENT CARE ST, V25, P611, DOI 10.1089/apc.2011.0083; Hudelson C, 2015, AIDS CARE, V27, P805, DOI 10.1080/09540121.2015.1011073; Kanabkaew C, 2012, C AM PUBL HLTH ASS S; Kang E, 2015, INT J STD AIDS, V26, P534, DOI 10.1177/0956462414545524; Katz IT, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.3.18640; Kawuma R, 2014, AJAR-AFR J AIDS RES, V13, P189, DOI 10.2989/16085906.2014.927778; Konstantopoulos C, 2015, OPEN FORUM INFECT DI, V2, DOI 10.1093/ofid/ofu119; Li JZ, 2014, AIDS, V28, P181, DOI 10.1097/QAD.0000000000000123; Louthrenoo O, 2013, J INT ASS PROVIDERS; Lowenthal ED, 2014, LANCET INFECT DIS; Lowenthal ED, 2015, JAMA PEDIATR, V169, P498, DOI 10.1001/jamapediatrics.2014.3785; MacDonell K, 2013, AIDS BEHAV, V17, P86, DOI 10.1007/s10461-012-0364-1; Manosuthi W, 2015, AIDS RES THER, V12, DOI 10.1186/s12981-015-0053-z; Mavhu W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070254; Mellins CA, 2004, PEDIATR INFECT DIS J, V23, P1035, DOI 10.1097/01.inf.0000143646.15240.ac; Mellins CA, 2011, AIDS PATIENT CARE ST, V25, P413, DOI 10.1089/apc.2011.0025; Mofenson LM, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18650; Mupambireyi Z, 2014, CHILD YOUTH SERV REV, V45, P106, DOI 10.1016/j.childyouth.2014.03.026; Murphy DA, 2003, ARCH PEDIAT ADOL MED, V157, P249, DOI 10.1001/archpedi.157.3.249; Mutwa PR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060073; Naar-King S, 2013, J PEDIATR PSYCHOL, V38, P664, DOI 10.1093/jpepsy/jst017; Nachega JB, 2009, JAIDS-J ACQ IMM DEF, V51, P65, DOI 10.1097/QAI.0b013e318199072e; Nyogea D, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0753-y; Petersen I, 2010, AIDS CARE, V22, P970, DOI 10.1080/09540121003623693; Reisner Sari L, 2009, Top HIV Med, V17, P14; Rongkavilit Chokechai, 2007, J Adolesc Health, V40, DOI 10.1016/j.jadohealth.2006.11.004; Simoni JM, 2007, PEDIATRICS, V119, pE1371, DOI 10.1542/peds.2006-1232; Sirikum C, 2014, AIDS CARE, V26, P1144, DOI 10.1080/09540121.2014.894614; Sohn AH, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18555; Tulloch O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099061; UNAIDS, 2015, 2014 HIV AIDS EST; UNICEF, 2015, AD RAD AS PAC AIDS R; Vreeman RC, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18466; White YRG, 2008, W INDIAN MED J, V57, P231; Williams PL, 2006, PEDIATRICS, V118, pE1745, DOI 10.1542/peds.2006-0493	47	25	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0172392	10.1371/journal.pone.0172392	http://dx.doi.org/10.1371/journal.pone.0172392			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL2BG	28207891	Green Published, Green Submitted, gold			2022-12-27	WOS:000394424500130
J	Mwadzingeni, L; Shimelis, H; Rees, DJG; Tsilo, TJ				Mwadzingeni, Learnmore; Shimelis, Hussein; Rees, D. Jasper G.; Tsilo, Toi J.			Genome-wide association analysis of agronomic traits in wheat under drought-stressed and non-stressed conditions	PLOS ONE			English	Article							TRITICUM-AESTIVUM L.; SPRING WHEAT; BREAD WHEAT; GRAIN-YIELD; DIVERSITY ARRAYS; CROP PRODUCTION; KERNEL SIZE; POPULATION; TOLERANCE; COMPONENTS	This study determined the population structure and genome-wide marker-trait association of agronomic traits of wheat for drought-tolerance breeding. Ninety-three diverse bread wheat genotypes were genotyped using the Diversity Arrays Technology sequencing (DArTseq) protocol. The number of days-to-heading (DTH), number of days-to-maturity (DTM), plant height (PHT), spike length (SPL), number of kernels per spike (KPS), thousand kernel weight (TKW) and grain yield (GYLD), assessed under drought-stressed and non-stressed conditions, were considered for the study. Population structure analysis and genome-wide association mapping were undertaken based on 16,383 silico DArTs loci with < 10% missing data. The population evaluated was grouped into nine distinct genetic structures. Inter-chromosomal linkage disequilibrium showed the existence of linkage decay as physical distance increased. A total of 62 significant (P < 0.001) marker-trait associations (MTAs) were detected explaining more than 20% of the phenotypic variation observed under both drought-stressed and non-stressed conditions. Significant (P < 0.001) MTA event(s) were observed for DTH, PHT, SPL, SPS, and KPS; under both stressed and non-stressed conditions, while additional significant (P < 0.05) associations were observed for TKW, DTM and GYLD under non-stressed condition. The MTAs reported in this population could be useful to initiate marker-assisted selection (MAS) and targeted trait introgression of wheat under drought-stressed and non-stressed conditions, and for fine mapping and cloning of the underlying genes and QTL.	[Mwadzingeni, Learnmore; Shimelis, Hussein] Univ KwaZulu Natal, Sch Agr Earth & Environm Sci, Pietermaritzburg, South Africa; [Mwadzingeni, Learnmore; Tsilo, Toi J.] ARC, SGI, Bethlehem, South Africa; [Rees, D. Jasper G.] Agr Res Council, Biotechnol Platform, Pretoria, South Africa	University of Kwazulu Natal; Agricultural Research Council of South Africa; Agricultural Research Council of South Africa	Tsilo, TJ (corresponding author), ARC, SGI, Bethlehem, South Africa.	tsilot@arc.agric.za	Tsilo, Toi/AAI-7559-2021; Shimelis, Hussein/N-5073-2013; Tsilo, Toi J/G-5088-2011; Rees, David Jasper Gilbert/AAZ-8073-2020	Shimelis, Hussein/0000-0003-2793-8392; Tsilo, Toi J/0000-0001-6987-8573; Rees, David Jasper Gilbert/0000-0003-3321-1325	National Research Foundation of South Africa	National Research Foundation of South Africa(National Research Foundation - South Africa)	National Research Foundation of South Africa is sincerely thanked for financial support of the study.	Abdolshahi R, 2015, FIELD CROP RES, V174, P20, DOI 10.1016/j.fcr.2015.01.009; Akbari M, 2006, THEOR APPL GENET, V113, P1409, DOI 10.1007/s00122-006-0365-4; Alexander LM, 2012, CROP SCI, V52, P253, DOI 10.2135/cropsci2011.05.0267; Allard R.W., 1999, PRINCIPLES PLANT BRE; Asseng S, 2015, NAT CLIM CHANGE, V5, P143, DOI [10.1038/nclimate2470, 10.1038/NCLIMATE2470]; Baird SJE, 2015, MOL ECOL RESOUR, V15, P1017, DOI 10.1111/1755-0998.12424; Baloch M. J., 2013, Pakistan Journal of Agriculture, Agricultural Engineering, Veterinary Sciences, V29, P96; Berkman PJ, 2012, AM J BOT, V99, P365, DOI 10.3732/ajb.1100309; Blum A, 2011, PLANT BREEDING FOR WATER-LIMITED ENVIRONMENTS, P1, DOI 10.1007/978-1-4419-7491-4; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Breseghello F, 2006, GENETICS, V172, P1165, DOI 10.1534/genetics.105.044586; Crossa J, 2007, GENETICS, V177, P1889, DOI 10.1534/genetics.107.078659; Czyczylo-Mysza I, 2011, PLANT GENET RESOUR-C, V9, P291, DOI 10.1017/S1479262111000207; Dai AG, 2013, NAT CLIM CHANGE, V3, P52, DOI [10.1038/nclimate1633, 10.1038/NCLIMATE1633]; DArT, 2014, EXTR PROT DART; Dholakia BB, 2003, PLANT BREEDING, V122, P392, DOI 10.1046/j.1439-0523.2003.00896.x; Edae EA, 2014, THEOR APPL GENET, V127, P791, DOI 10.1007/s00122-013-2257-8; Gouy M, 2015, EUPHYTICA, V202, P269, DOI 10.1007/s10681-014-1294-y; Jaccoud D, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.4.e25; Kashif M., 2004, INT J AGRIC BIOL, V6, P138; Kuchel H, 2007, THEOR APPL GENET, V115, P1029, DOI 10.1007/s00122-007-0629-7; Laido G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095211; Langridge P, 2015, CURR OPIN BIOTECH, V32, P130, DOI 10.1016/j.copbio.2014.11.027; Le Gouis J, 2012, THEOR APPL GENET, V124, P597, DOI 10.1007/s00122-011-1732-3; Lobell DB, 2011, SCIENCE, V333, P616, DOI [10.1126/science.1204531, 10.1126/science.1206376]; Mathews KL, 2008, THEOR APPL GENET, V117, P1077, DOI 10.1007/s00122-008-0846-8; Matschegewski C, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00720; Mobley AR, 2013, J NUTR, V143, p1527S, DOI 10.3945/jn.113.175737; Mwadzingeni L, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01276; Mwadzingeni L, 2016, J INTEGR AGR, V15, P935, DOI 10.1016/S2095-3119(15)61102-9; Nakamura S, 2015, MOL BREEDING, V35, DOI 10.1007/s11032-015-0358-6; Neumann K, 2011, MOL BREEDING, V27, P37, DOI 10.1007/s11032-010-9411-7; Peleg Z, 2009, PLANT CELL ENVIRON, V32, P758, DOI 10.1111/j.1365-3040.2009.01956.x; Pritchard JK, 2010, DOCUMENTATION STRUCT; Quarrie SA, 2005, THEOR APPL GENET, V110, P865, DOI 10.1007/s00122-004-1902-7; Raman H, 2011, DNA RES; Segura V, 2012, NAT GENET, V44, P825, DOI 10.1038/ng.2314; Snedecor G.W., 1989, AMES IOWA STATE U PR; Sonah H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054603; Spindel J, 2013, THEOR APPL GENET, V126, P2699, DOI 10.1007/s00122-013-2166-x; Sukumaran S, 2015, THEOR APPL GENET, V128, P353, DOI 10.1007/s00122-014-2435-3; Pinto RS, 2010, THEOR APPL GENET, V121, P1001, DOI 10.1007/s00122-010-1351-4; Tadesse W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141339; Tester M, 2010, SCIENCE, V327, P818, DOI 10.1126/science.1183700; Tsilo TJ, 2010, THEOR APPL GENET, V121, P717, DOI 10.1007/s00122-010-1343-4; Tuberosa R, 2006, TRENDS PLANT SCI, V11, P405, DOI 10.1016/j.tplants.2006.06.003; Wang BW, 2014, INT J MOL SCI, V15, P16949, DOI 10.3390/ijms150916949; Wang SC, 2014, PLANT BIOTECHNOL J, V12, P787, DOI 10.1111/pbi.12183; Xu Y, MOL PLANT BREEDING; Yagdi K, 2009, PAK J BOT, V41, P753	50	78	81	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e71692	10.1371/journal.pone.0171692	http://dx.doi.org/10.1371/journal.pone.0171692			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5VB	28234945	Green Published, gold, Green Submitted			2022-12-27	WOS:000394688200030
J	Tan, CH; Low, KA; Kong, T; Fletcher, MA; Zimmerman, B; Maclin, EL; Chiarelli, AM; Gratton, G; Fabiani, M				Tan, Chin Hong; Low, Kathy A.; Kong, Tania; Fletcher, Mark A.; Zimmerman, Benjamin; Maclin, Edward L.; Chiarelli, Antonio M.; Gratton, Gabriele; Fabiani, Monica			Mapping cerebral pulse pressure and arterial compliance over the adult lifespan with optical imaging	PLOS ONE			English	Article							WHITE-MATTER INTEGRITY; WAVE VELOCITY; CARDIORESPIRATORY FITNESS; WORKING-MEMORY; BLOOD-PRESSURE; COGNITIVE IMPAIRMENT; PHYSICAL-ACTIVITY; CARDIOVASCULAR MORTALITY; INTELLECTUAL IMPAIRMENT; ALZHEIMERS-DISEASE	Cerebrovascular health is important for maintaining a high level of cognitive performance, not only in old age, but also throughout the lifespan. Recently, it was first demonstrated that diffuse optical imaging measures of pulse amplitude and arterial compliance can provide estimates of cerebral arterial health throughout the cortex, and were associated with age, estimated cardiorespiratory fitness (eCRF), neuroanatomy and cognitive function in older adults (aged 55-87). The current study replicates and extends the original findings using a broader age range (a new adult sample aged 18-75),longer recording periods (360 s), and a more extensive optical montage (1536 channels). These methodological improvements represent a 5-fold increase in recording time and a 4-fold increase in coverage compared to the initial study. Results show that reliability for both pulse amplitude and compliance measures across recording blocks was very high (r(45) = .99 and .75, respectively). Pulse amplitude and pulse pressure were shown to correlate with age across the broader age range. We also found correlations between arterial health and both cortical and subcortical gray matter volumes. Additionally, we replicated the correlations between arterial compliance and age, eCRF, global brain atrophy, and cognitive flexibility. New regional analyses revealed that higher performance on the operation span (OSPAN) working memory task was associated with greater localized arterial compliance in frontoparietal cortex, but not with global arterial compliance. Further, greater arterial compliance in frontoparietal regions was associated with younger age and higher eCRF. These associations were not present in the visual cortex. The current study not only replicates the initial one in a sample including a much wider age range, but also provides new evidence showing that frontoparietal regions may be especially vulnerable to vascular degeneration during brain aging, with potential functional consequences in cognition.	[Tan, Chin Hong; Kong, Tania; Gratton, Gabriele; Fabiani, Monica] Univ Illinois, Dept Psychol, Urbana, IL 61801 USA; [Tan, Chin Hong; Low, Kathy A.; Kong, Tania; Fletcher, Mark A.; Zimmerman, Benjamin; Maclin, Edward L.; Chiarelli, Antonio M.; Gratton, Gabriele; Fabiani, Monica] Univ Illinois, Beckman Inst, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Fabiani, M (corresponding author), Univ Illinois, Dept Psychol, Urbana, IL 61801 USA.; Fabiani, M (corresponding author), Univ Illinois, Beckman Inst, Urbana, IL 61801 USA.	mfabiani@illinois.edu	Tan, Chin Hong/AAF-7515-2019; Maclin, Edward L/C-9157-2013; Tan, Chin Hong/J-3038-2018; Zimmerman, Ben/AAD-7465-2020; chiarelli, antonio m/L-4365-2017	Tan, Chin Hong/0000-0002-0980-9936; Maclin, Edward L/0000-0003-0771-1422; Tan, Chin Hong/0000-0002-0980-9936; Zimmerman, Ben/0000-0003-2570-8198; chiarelli, antonio m/0000-0002-5347-8417; Fabiani, Monica/0000-0002-7579-2773; Gratton, Gabriele/0000-0003-3634-7463; Kong, Tania/0000-0003-1000-3881	National Institute on Aging grant [1RC1AG035927]; National Institute of Mental Health [R56MH097973]; National Center for Research Resources [S10RR029294]; NIA [1RC1AG035927]; NIMH [R56MH097973]; NCRR [S10RR029294]	National Institute on Aging grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by the National Institute on Aging grant 1RC1AG035927 to M. Fabiani (https://www.nia.niltgov/); National Institute of Mental Health grant R56MH097973 to GG (https://www.nimh.nih.gov/index.shtml) and by the National Center for Research Resources (http://sdminutes.cit.nih.gov/about/almanac/organization/ NCRR.htm) grant S10RR029294 to GG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by NIA grant 1RC1AG035927 to M. Fabiani; NIMH grant R56MH097973 to G. Gratton, and NCRR S10RR029294 to G. Gratton. This work was also presented in partial fulfillment of the Ph.D. requirements of the first author. Correspondence should be addressed to: Monica Fabiani, University of Illinois, Beckman Institute, 405 N. Mathews Ave., Urbana, IL 61801. E-mail: mfabiani@illinois.edu	Al Hazzouri AZ, 2013, STROKE, V44, P388, DOI 10.1161/STROKEAHA.112.673533; Alian AA, 2014, MONITORING TECHNOLOG, P165, DOI DOI 10.1007/978-1-4614-8557-5_19; Alosco ML, 2013, BRAIN BEHAV, V3, P626, DOI 10.1002/brb3.171; Alsop DC, 2000, ANN NEUROL, V47, P93, DOI 10.1002/1531-8249(200001)47:1<93::AID-ANA15>3.0.CO;2-8; Altamura M, 2007, PSYCHIAT RES-NEUROIM, V154, P103, DOI 10.1016/j.pscychresns.2006.08.002; Beauchet O, 2013, J HYPERTENS, V31, P1502, DOI 10.1097/HJH.0b013e32836184b5; Beck A.T., 1996, PSYCHOL ASSESS, V10, DOI [10.1037/t00742-000, DOI 10.1037/T00742-000]; Benton AL., 1983, MULTILINGUAL APHASIA; Chao LL, 2010, ALZ DIS ASSOC DIS, V24, P19, DOI 10.1097/WAD.0b013e3181b4f736; Chiarelli AM, 2016, J BIOMED OPT, V21, DOI 10.1117/1.JBO.21.3.036008; Chiarelli AM, 2015, J BIOMED OPT, V20, DOI 10.1117/1.JBO.20.1.016009; Colcombe SJ, 2003, J GERONTOL A-BIOL, V58, P176; CORRIGAN JD, 1987, J CLIN PSYCHOL, V43, P402, DOI 10.1002/1097-4679(198707)43:4<402::AID-JCLP2270430411>3.0.CO;2-E; Cruickshank JK, 2009, HYPERTENSION, V53, P602, DOI 10.1161/HYPERTENSIONAHA.108.128033; Cruickshank K, 2002, CIRCULATION, V106, P2085, DOI 10.1161/01.CIR.0000033824.02722.F7; D'Esposito M, 2000, EXP BRAIN RES, V133, P3, DOI 10.1007/s002210000395; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Dupuy O, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00066; Ebihara A, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.10.106001; Edwards NM, 2012, METABOLISM, V61, P869, DOI 10.1016/j.metabol.2011.10.016; Elias MF, 2009, HYPERTENSION, V53, P668, DOI 10.1161/HYPERTENSIONAHA.108.126342; Erickson KI, 2014, NEUROBIOL AGING, V35, pS20, DOI 10.1016/j.neurobiolaging.2014.03.034; Fabiani M., 2015, ATTENTION PERFORM, P131, DOI DOI 10.1016/B978-0-12-801371-7.00011-9; Fabiani M, 2014, PSYCHOPHYSIOLOGY, V51, P1072, DOI 10.1111/psyp.12288; Fabiani M, 2012, PSYCHOPHYSIOLOGY, V49, P283, DOI 10.1111/j.1469-8986.2011.01331.x; Fabricius M, 1997, J CEREBR BLOOD F MET, V17, P1326, DOI 10.1097/00004647-199712000-00008; Fernhall B, 2008, J APPL PHYSIOL, V105, P325, DOI 10.1152/japplphysiol.00001.2008; Ferreira I, 2005, ARCH INTERN MED, V165, P42, DOI 10.1001/archinte.165.1.42; Fischl B, 2001, IEEE T MED IMAGING, V20, P70, DOI 10.1109/42.906426; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Fletcher M.A., 2016, FRONTIERS AGING NEUR, V10; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Gordon BA, 2008, PSYCHOPHYSIOLOGY, V45, P825, DOI 10.1111/j.1469-8986.2008.00676.x; Gratton G, 2000, PSYCHOPHYSIOLOGY, V37, pS44; Hamilton PK, 2007, CLIN SCI, V113, P157, DOI 10.1042/CS20070080; Han X, 2006, NEUROIMAGE, V32, P180, DOI 10.1016/j.neuroimage.2006.02.051; Hawkins M, 2014, VASC MED, V19, P257, DOI 10.1177/1358863X14536630; Hayes AF., 2017, MEDIATION MODERATION, V2nd edn; Heaton, 1981, WISCONSIN CARD SORTI; Hughes TM, 2015, NEURODEGENER DIS MAN, V5, P121, DOI [10.2217/NMT.14.53, 10.2217/nmt.14.53]; Joas E, 2012, HYPERTENSION, V59, P796, DOI 10.1161/HYPERTENSIONAHA.111.182204; Jurca R, 2005, AM J PREV MED, V29, P185, DOI 10.1016/j.amepre.2005.06.004; Kalaria RN, 2013, NAT REV NEUROL, V9, P487, DOI 10.1038/nrneurol.2013.164; Kalaria RN, 2012, J NEUROL SCI, V322, P141, DOI 10.1016/j.jns.2012.07.032; Kaufman A. S., 2004, KAUFMANN BRIEF INTEL, VSecond; Keage HAD, 2012, DEMENT GER COGN D EX, V2, P258, DOI 10.1159/000339234; Lancaster JL, 1997, HUM BRAIN MAPP, V5, P238, DOI 10.1002/(SICI)1097-0193(1997)5:4<238::AID-HBM6>3.0.CO;2-4; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; Laurent S, 2006, CURR HYPERTENS REP, V8, P179, DOI 10.1007/s11906-006-0047-2; MacCallum RC, 2002, PSYCHOL METHODS, V7, P19, DOI 10.1037//1082-989X.7.1.19; Mailey EL, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-59; Maillard P, 2012, LANCET NEUROL, V11, P1039, DOI 10.1016/S1474-4422(12)70241-7; Marchais S J, 1993, Drugs, V46 Suppl 2, P82; MAYEUX R, 1981, NEUROLOGY, V31, P645, DOI 10.1212/WNL.31.6.645; McAuley Edward, 2011, Ment Health Phys Act, V4, P5, DOI 10.1016/j.mhpa.2011.01.001; Meaume S, 2001, ARTERIOSCL THROM VAS, V21, P2046, DOI 10.1161/hq1201.100226; Nilsson PM, 2008, J HYPERTENS, V26, P1049, DOI 10.1097/HJH.0b013e3282f82c3e; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Petersen ET, 2006, BRIT J RADIOL, V79, P688, DOI 10.1259/bjr/67705974; Pizzi OL, 2013, ARQ BRAS CARDIOL, V100, P60, DOI 10.1590/S0066-782X2012005000116; Rabkin SW, 2012, J ALZHEIMERS DIS, V32, P541, DOI 10.3233/JAD-2012-120757; Raven J., 2004, MANUAL RAVENS PROGR; Raz N, 1997, CEREB CORTEX, V7, P268, DOI 10.1093/cercor/7.3.268; Raz N, 2005, CEREB CORTEX, V15, P1676, DOI 10.1093/cercor/bhi044; Resnick SM, 2003, J NEUROSCI, V23, P3295; Rocha VZ, 2009, NAT REV CARDIOL, V6, P399, DOI 10.1038/nrcardio.2009.55; Saji N, 2015, PULSE, V3, P182, DOI 10.1159/000443614; Schneider-Garces NJ, 2010, J COGNITIVE NEUROSCI, V22, P655, DOI 10.1162/jocn.2009.21230; Scuteri A, 2014, J ALZHEIMERS DIS, V42, pS401, DOI 10.3233/JAD-141416; Scuteri A, 2013, EXP GERONTOL, V48, P64, DOI 10.1016/j.exger.2012.02.009; Scuteri A, 2012, LANCET NEUROL, V11, P1015, DOI 10.1016/S1474-4422(12)70265-X; Scuteri A, 2010, EUR HEART J, V31, P602, DOI 10.1093/eurheartj/ehp491; Shipley WC, 1940, J PSYCHOL, V9, P371, DOI 10.1080/00223980.1940.9917704; Singer J, 2014, AGEING RES REV, V15, P16, DOI 10.1016/j.arr.2014.02.002; Sonoyama Kazuhiko, 2007, Ther Adv Cardiovasc Dis, V1, P129, DOI 10.1177/1753944707086358; Stamatakis E, 2013, EUR HEART J, V34, P750, DOI 10.1093/eurheartj/ehs097; Sutton-Tyrrell K, 2005, CIRCULATION, V111, P3384, DOI 10.1161/CIRCULATIONAHA.104.483628; Tan CH, 2016, BIOL PSYCHOL, V118, P184, DOI 10.1016/j.biopsycho.2016.05.008; Themelis G, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2710250; Tien Allen Y., 1996, Kaohsiung Journal of Medical Sciences, V12, P479; Toledo JB, 2013, BRAIN, V136, P2697, DOI 10.1093/brain/awt188; Unsworth N, 2005, BEHAV RES METHODS, V37, P498, DOI 10.3758/BF03192720; Unverzagt FW, 2011, NEUROLOGY, V77, P1729, DOI 10.1212/WNL.0b013e318236ef23; Van Bortel LM, 1998, J HUM HYPERTENS, V12, P583, DOI 10.1038/sj.jhh.1000669; Veltman DJ, 2003, NEUROIMAGE, V18, P247, DOI 10.1016/S1053-8119(02)00049-6; Viticchi G, 2014, J ALZHEIMERS DIS, V41, P401, DOI 10.3233/JAD-132480; Waldstein SR, 2008, HYPERTENSION, V51, P99, DOI 10.1161/HYPERTENSIONAHA.107.093674; Wechsler D, 2009, WECHSLER MEMORY SCAL; Whalen C, 2008, HUM BRAIN MAPP, V29, P1288, DOI 10.1002/hbm.20465; Wiinberg N, 2000, Stud Health Technol Inform, V71, P99; Wolf U, 2000, OSA TRENDS OPT PHOTO, V38, P427; Xekardaki A, 2015, RADIOLOGY, V274, P490, DOI 10.1148/radiol.14140680; Zarahn E, 2007, NEUROBIOL AGING, V28, P784, DOI 10.1016/j.neurobiolaging.2006.03.002; Zhu N, 2015, NEUROLOGY, V84, P2347, DOI 10.1212/WNL.0000000000001658; Zimmerman B, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00059; Zlokovic BV, 2011, NAT REV NEUROSCI, V12, P723, DOI 10.1038/nrn3114	98	29	29	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0171305	10.1371/journal.pone.0171305	http://dx.doi.org/10.1371/journal.pone.0171305			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL5VB	28234912	Green Published, gold, Green Submitted			2022-12-27	WOS:000394688200018
J	Bernabe-Garcia, A; Armero-Barranco, D; Liarte, S; Ruzafa-Martinez, M; Ramos-Morcillo, AJ; Nicolas, FJ				Bernabe-Garcia, Angel; Armero-Barranco, David; Liarte, Sergio; Ruzafa-Martinez, Maria; Ramos-Morcillo, Antonio Jesus; Jose Nicolas, Francisco			Oleanolic acid induces migration in Mv1Lu and MDA-MB-231 epithelial cells involving EGF receptor and MAP kinases activation	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; CANCER-CELLS; INHIBITS PROLIFERATION; HEALING ACTIVITY; GELATINASE-B; TGF-BETA; C-JUN; EXPRESSION; PAXILLIN; PHOSPHORYLATION	During wound healing, skin function is restored by the action of several cell types that undergo differentiation, migration, proliferation and/or apoptosis. These dynamics are tightly regulated by the evolution of the extra cellular matrix (ECM) contents along the process. Pharmacologically active flavonoids have shown to exhibit useful physiological properties interesting in pathological states. Among them, oleanolic acid (OA), a pentacyclic triterpene, shows promising properties over wound healing, as increased cell migration in vitro and improved wound resolution in vivo. In this paper, we pursued to disclose the molecular mechanisms underlying those effects, by using an in vitro scratch assay in two epithelial cell lines of different linage: non-malignant mink lung epithelial cells, Mv1Lu; and human breast cancer cells, MDA-MB-231. In every case, we observed that OA clearly enhanced cell migration for in vitro scratch closure. This correlated with the stimulation of molecular pathways related to mitogen-activated protein (MAP) kinases, as ERK1,2 and Jun N-terminal kinase (JNK) 1,2 activation and c-Jun phosphorylation. Moreover, MDA-MB-231 cells treated with OA displayed an altered gene expression profile affecting transcription factor genes (c-JUN) as well as proteins involved in migration and ECM dynamics (PAI1), in line with the development of an epithelial to mesenchymal transition (EMT) status. Strikingly, upon OA treatment, we observed changes in the epidermal growth factor receptor (EGFR) subcellular localization, while interfering with its signalling completely prevented migration effects. This data provides a physiological framework supporting the notion that lipophilic plant extracts used in traditional medicine, might modulate wound healing processes in vivo through its OA contents. The molecular implications of these observations are discussed.	[Bernabe-Garcia, Angel; Liarte, Sergio; Jose Nicolas, Francisco] Hosp Clin Univ Virgen de la Arrixaca, Lab Oncol Mol & TGF, Inst Murciano Invest Biosanitarias Arrixaca, Murcia, Spain; [Armero-Barranco, David; Ruzafa-Martinez, Maria; Ramos-Morcillo, Antonio Jesus] Univ Murcia, Fac Enfermeria, Dept Enfermeria, Murcia, Spain	Hospital Clinico Universitario Virgen de la Arrixaca; University of Murcia	Nicolas, FJ (corresponding author), Hosp Clin Univ Virgen de la Arrixaca, Lab Oncol Mol & TGF, Inst Murciano Invest Biosanitarias Arrixaca, Murcia, Spain.	franciscoj.nicolas2@carm.es	Bernabé-García, Ángel/AAB-2934-2020; Liarte, Sergio/M-2660-2015; Nicolás, Francisco José/H-9422-2019; Ruzafa-Martinez, Maria/AAB-5248-2019; Ramos-Morcillo, Antonio Jesus/J-2195-2016	Bernabé-García, Ángel/0000-0002-2266-5949; Liarte, Sergio/0000-0003-1004-4982; Nicolás, Francisco José/0000-0002-3969-1430; Ruzafa-Martinez, Maria/0000-0001-6570-738X; Ramos-Morcillo, Antonio Jesus/0000-0002-3490-3326				Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; Alcaraz A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135324; BARNUN S, 1983, BIOCHIM BIOPHYS ACTA, V741, P123, DOI 10.1016/0167-4781(83)90018-0; Barrientos S, 2008, WOUND REPAIR REGEN, V16, P585, DOI 10.1111/j.1524-475X.2008.00410.x; Bishayee A, 1999, MOL BIOL CELL, V10, P525, DOI 10.1091/mbc.10.3.525; Bos M, 1997, CLIN CANCER RES, V3, P2099; BREUSS JM, 1995, J CELL SCI, V108, P2241; Buisson AC, 1996, J CELL PHYSIOL, V166, P413, DOI 10.1002/(SICI)1097-4652(199602)166:2<413::AID-JCP20>3.0.CO;2-A; Cho M, 2014, PHYTOMEDICINE, V21, P560, DOI 10.1016/j.phymed.2013.10.006; Czekay Ralf-Peter, 2011, Int J Cell Biol, V2011, P562481, DOI 10.1155/2011/562481; DECKER SJ, 1988, J RECEPTOR RES, V8, P853, DOI 10.3109/10799898809049030; DEMETRIOU M, 1995, J CELL BIOL, V130, P383, DOI 10.1083/jcb.130.2.383; DIMILLA PA, 1993, J CELL BIOL, V122, P729, DOI 10.1083/jcb.122.3.729; Fitsialos G, 2007, J BIOL CHEM, V282, P15090, DOI 10.1074/jbc.M606094200; Geh E, 2011, P NATL ACAD SCI; Guo GC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072079; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Henriksen L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058148; Herbst RS, 2004, INT J RADIAT ONCOL, V59, P21, DOI 10.1016/j.ijrobp.2003.11.041; HILL CS, 1995, CELL, V80, P199, DOI 10.1016/0092-8674(95)90403-4; Huang C, 2003, NATURE, V424, P219, DOI 10.1038/nature01745; Hudson LG, 2009, J DERMATOL SCI, V56, P19, DOI 10.1016/j.jdermsci.2009.06.009; Insausti CL, 2010, WOUND REPAIR REGEN, V18, P368, DOI 10.1111/j.1524-475X.2010.00604.x; Ishibe S, 2003, MOL CELL, V12, P1275, DOI 10.1016/S1097-2765(03)00406-4; Javelaud D, 2003, J BIOL CHEM, V278, P24624, DOI 10.1074/jbc.M301942200; Kasote D., 2015, EVIDENCE BASED VALID, P149; Klemke RL, 1997, J CELL BIOL, V137, P481, DOI 10.1083/jcb.137.2.481; Kobayashi T, 2014, AM J PHYSIOL-LUNG C, V306, pL1006, DOI 10.1152/ajplung.00015.2014; Kojic N, 2010, FASEB J, V24, P1604, DOI 10.1096/fj.09-145367; Kuonen R, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/718105; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Lee YJ, 2006, CARCINOGENESIS, V27, P446, DOI 10.1093/carcin/bgi254; Li GC, 2003, DEV CELL, V4, P865, DOI 10.1016/S1534-5807(03)00159-X; Manach C, 2004, AM J CLIN NUTR, V79, P727, DOI 10.1093/ajcn/79.5.727; Martinez-Mora C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042271; McInroy L, 2007, BIOCHEM BIOPH RES CO, V360, P109, DOI 10.1016/j.bbrc.2007.06.036; Metelmann HR, 2012, J CRANIO MAXILL SURG, V40, pE150, DOI 10.1016/j.jcms.2011.07.020; Mohan R, 2002, J BIOL CHEM, V277, P2065, DOI 10.1074/jbc.M107611200; Moura-Letts G, 2006, J NAT PROD, V69, P978, DOI 10.1021/np0601152; Bui NT, 2014, PHYTOMEDICINE, V21, P570, DOI 10.1016/j.phymed.2013.10.010; Nicolas FJ, 2003, ONCOGENE, V22, P3698, DOI 10.1038/sj.onc.1206420; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Peplow PV, 2013, CYTOKINE, V62, P1, DOI 10.1016/j.cyto.2013.02.015; Pollier J, 2012, PHYTOCHEMISTRY, V77, P10, DOI 10.1016/j.phytochem.2011.12.022; Pontillo CA, 2011, TOXICOL SCI, V120, P284, DOI 10.1093/toxsci/kfq390; Ponugoti B, 2013, J CELL BIOL, V203, P327, DOI 10.1083/jcb.201305074; Prasad S, 2012, CLIN CANCER RES, V18, P4942, DOI 10.1158/1078-0432.CCR-11-2805; Rahimi N, 1998, J BIOL CHEM, V273, P33714, DOI 10.1074/jbc.273.50.33714; Raja, 2007, Front Biosci, V12, P2849; Rodriguez Luis G., 2004, V294, P23; Samarakoon R, 2009, CELL SIGNAL, V21, P986, DOI 10.1016/j.cellsig.2009.02.007; Sanchez M, 2006, LIFE SCI, V79, P1349, DOI 10.1016/j.lfs.2006.03.044; Savagner P, 2005, J CELL PHYSIOL, V202, P858, DOI 10.1002/jcp.20188; Schafer M, 2007, ANNU REV CELL DEV BI, V23, P69, DOI 10.1146/annurev.cellbio.23.090506.123609; SCHREIER T, 1993, RES EXP MED, V193, P195, DOI 10.1007/BF02576227; Shan JZ, 2009, J ZHEJIANG UNIV-SC B, V10, P668, DOI 10.1631/jzus.B0920149; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Shaulian E, 2010, CELL SIGNAL, V22, P894, DOI 10.1016/j.cellsig.2009.12.008; Sophors P, 2016, BIOCHEM BIOPH RES CO, V472, P332, DOI 10.1016/j.bbrc.2016.02.106; Stupack DG, 2000, IMMUNOL RES, V21, P83, DOI 10.1385/IR:21:2-3:83; SUNADA H, 1986, P NATL ACAD SCI USA, V83, P3825, DOI 10.1073/pnas.83.11.3825; Tapia C, 2006, AM J SURG PATHOL, V30, P83, DOI 10.1097/01.pas.0000183572.94140.43; Turner CE, 2000, NAT CELL BIOL, V2, pE231, DOI 10.1038/35046659; Vleugel MM, 2006, HUM PATHOL, V37, P668, DOI 10.1016/j.humpath.2006.01.022; Werner S, 2003, PHYSIOL REV, V83, P835, DOI 10.1152/physrev.2003.83.3.835; Wojciak-Kosior M, 2011, FOLIA HISTOCHEM CYTO, V49, P664, DOI 10.5603/FHC.2011.0050; Zhang N, 2010, CANCER SCI, V101, P2375, DOI 10.1111/j.1349-7006.2010.01680.x; Zou YL, 2003, J BIOL CHEM, V278, P49573, DOI 10.1074/jbc.M307556200	68	11	11	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2017	12	2							e0172574	10.1371/journal.pone.0172574	http://dx.doi.org/10.1371/journal.pone.0172574			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5SX	28231262	Green Published, Green Submitted, gold			2022-12-27	WOS:000394682400056
J	Keister, LA; Aronson, B				Keister, Lisa A.; Aronson, Brian			Immigrants in the one percent: The national origin of top wealth owners	PLOS ONE			English	Article							MULTIPLE IMPUTATION; INCOME INEQUALITY; UNITED-STATES; ASSIMILATION; DISPARITIES; ALRIGHT; RACE; US	Background Economic inequality in the United States is extreme, but little is known about the national origin of affluent households. Households in the top one percent by total wealth own vastly disproportionate quantities of household assets and have correspondingly high levels of economic, social, and political influence. The overrepresentation of white natives (i. e., those born in the U. S.) among high-wealth households is well-documented, but changing migration dynamics suggest that a growing portion of top households may be immigrants. Methods Because no single survey dataset contains top wealth holders and data about country of origin, this paper uses two publicly-available data sets: the Survey of Consumer Finances (SCF) and the Survey of Income and Program Participation (SIPP). Multiple imputation is used to impute country of birth from the SIPP into the SCF. Descriptive statistics are used to demonstrate reliability of the method, to estimate the prevalence of immigrants among top wealth holders, and to document patterns of asset ownership among affluent immigrants. Results Significant numbers of top wealth holders who are usually classified as white natives may be immigrants. Many top wealth holders appear to be European and Canadian immigrants, and increasing numbers of top wealth holders are likely from Asia and Latin America as well. Results suggest that of those in the top one percent of wealth holders, approximately 3% are European and Canadian immigrants,.5% are from Mexico or Cuban, and 1.7% are from Asia (especially Hong Kong, Taiwan, Mainland China, and India). Ownership of key assets varies considerably across affluent immigrant groups. Conclusion Although the percentage of top wealth holders who are immigrants is relatively small, these percentages represent large numbers of households with considerable resources and corresponding social and political influence. Evidence that the propensity to allocate wealth to real and financial assets varies across immigrant groups suggests that wealth ownership is	[Keister, Lisa A.; Aronson, Brian] Duke Univ, Dept Sociol, Durham, NC 27706 USA	Duke University	Keister, LA (corresponding author), Duke Univ, Dept Sociol, Durham, NC 27706 USA.	Lkeister@soc.duke.edu	Aronson, Brian/W-4402-2019	Aronson, Brian/0000-0001-5304-1971	National Science Foundation [SES-1322738]	National Science Foundation(National Science Foundation (NSF))	Keister received a grant from the National Science Foundation (SES-1322738) that supported this research. She used the grant to partially pay Aronson's salary. The National Science Foundation had no role in the study design or any other part of the research.; Keister acknowledges a grant from the National Science Foundation (SES-1322738) that supported this research. We are grateful for comments from Jody Agius Vallejo and Richard Benton.	Alba R, 2014, ETHNIC RACIAL STUD, V37, P446, DOI 10.1080/01419870.2013.786111; Alba R, 2011, SOC FORCES, V89, P763; Alba Richard, 2003, REMAKING AM MAINSTRE; Amuedo-Dorantes C, 2002, SOUTH ECON J, V69, P48, DOI 10.2307/1061556; Amuedo-Dorantes C, 2006, J POPUL ECON, V19, P227, DOI 10.1007/s00148-006-0079-6; [Anonymous], 2013, CAPITAL 21 CENTURY; Atkinson AB, 2011, J ECON LIT, V49, P3, DOI 10.1257/jel.49.1.3; Auten G, 2013, AM ECON REV, V103, P168, DOI 10.1257/aer.103.3.168; Bean Frank D., 2003, AM NEWCOMERS DYNAMIC; Bendixen and Associates, 2005, REM CUB US; Benedetto Gary, 2013, CREATION USE SIPP SY; Bernaards CA, 2007, STAT MED, V26, P1368, DOI 10.1002/sim.2619; Brenner PS, 2011, J SCI STUD RELIG, V50, P103, DOI 10.1111/j.1468-5906.2010.01554.x; Bricker J, 2012, CHANGES US FAMILY FI; Bricker Jesse, 2014, FEDERAL RESERVE BULL, V100, P1; Chenier RC, 2014, WORKING PAPER; Clark WAV, 2001, WORKING PAPER; Cobb-Clark DA, 2006, J HUM RESOUR, V41, P841; Collins C, 2015, BILLINAIRE BONANZA; Congressional Budget Office, 2006, IMM POL US; Dondero M, 2016, POPULATION RES POLIC; Dunn A., 2011, FORBES; Eckstein S., 2006, INT J SOCIOL FAM, V32, P141; Eckstein Susan, 2009, IMMIGRANT DIVIDE CUB; Feliciano C, 2005, INT MIGR REV, V39, P841, DOI 10.1111/j.1747-7379.2005.tb00291.x; Feliciano C, 2006, UNEQUAL ORIGINS IMMI; Frank RH, 2000, E ECON J, V26, P253; Gelman A, 1998, J AM STAT ASSOC, V93, P846, DOI 10.2307/2669819; Glick JE, 1997, J MARRIAGE FAM, V59, P177, DOI 10.2307/353671; Grieco E. M., 2012, SIZE PLACE BIRTH GEO; Haller W, 2011, SOC FORCES, V89, P733, DOI 10.1353/sof.2011.0003; Hao L., 2007, COLOR LINES COUNTRY; Jasso G, 2000, DEMOGRAPHY, V37, P127, DOI 10.2307/2648101; Jimenez TR, 2013, AM SOCIOL REV, V78, P849, DOI 10.1177/0003122413497012; Johnson B, 2005, CONSIDER SOURCE DIFF; Kaufman, 2006, RES SOCIAL STRATIFIC, V24, P131, DOI [DOI 10.1016/J.RSSM.2005.06.001, 10.1016/j.rssm.2005.06.001]; Keister LA, 2015, BUSINESS EC J; Keister LA, 2014, SOC FORCES, V89, P763; Keister LA, 2015, BUSINESS EC J, V6; Keister LA, 2014, ANNU REV SOCIOL, V40, P347, DOI 10.1146/annurev-soc-070513-075314; Kennickell A.B., 2009, FEDERAL RESERVE BOAR; Kennickell AB, 1999, REV INCOME WEALTH, P193; Kennickell AB, 2011, LOOK EDITING IMPUTAT; Kennickell AB, 2007, ROLE OVER SAMPLING W; Kennickell Arthur B., 2008, IRVING FISHER COMMIT, V28, P403; Kopczuk W., HDB PUBLIC EC, V52013, P329; Kuznets S., 1953, SHARES UPPER INCOME; Lee J., 2015, ASIAN AM ACHIEVEMENT; Lloyd KM, 2006, J MARRIAGE FAM, V68, P993, DOI 10.1111/j.1741-3737.2006.00309.x; Motel S, 2012, 10 LARGEST HISPANIC; Ortmeyer D. L., 2012, J DEV AREAS, V46, P185; Page BI, 2013, PERSPECT POLIT, V11, P51, DOI 10.1017/S153759271200360X; Park J, 2014, INT MIGRATION REV; Parrado EA, 2011, DEMOGRAPHY, V48, P1059, DOI 10.1007/s13524-011-0045-0; Passel J., 2011, MANY HISPANICS COMP; Perlmann J., 2005, ITALIANS THEN MEXICA; Pew Hispanic Center, 2003, BILL MOT LAT IMM REM; Pew Hispanic Center, 2011, STAT PORTR HISP US 2; Pew Research Center, 2012, RIS AS AM; Pfeffer FT, 2013, ANN AM ACAD POLIT SS, V650, P98, DOI 10.1177/0002716213497452; Piketty T, 2003, Q J ECON, V118, P1, DOI 10.1162/00335530360535135; Portes A, 2013, MIGRATION STUDIES; Portes Alejandro., 2014, IMMIGRANT AM PORTRAI; Poulsen J, 2008, DISCRIMINANT FUNCTIO; Rubin D. B., 2004, MULTIPLE IMPUTATION; Rumbaut R.G., 2006, IMMIGRANT AM PORTRAI; Shapiro T, 2016, RACE SOC PROBL, V8, P1, DOI 10.1007/s12552-016-9168-7; Shapiro Thomas M., 2004, HIDDEN COST BEING AF; Sharlet J., 2011, ROLLING STONE; Stigletz J., 2011, VANITY FAIR; Tabachnick B. G., 2001, USING MULTIVARIATE S; Taylor Paul, 2011, PEW RES CTR SOCIAL D; Todosijevic Bojan, 2012, B SOCIOL METHODOLOGY, V113, P20; U. S. Census, 2012, US CENS CENS BUR REP; Valdez Zulema, 2011, NEW ENTREPRENEURS RA; Vallejo Jody Agius, 2012, BARRIOS BURBS MAKING; van Buuren S, 2007, STAT METHODS MED RES, V16, P219, DOI 10.1177/0962280206074463; Volscho TW, 2012, AM SOCIOL REV, V77, P679, DOI 10.1177/0003122412458508; Wadwa V, 2007, AM NEW IMMIGRANT ENT; Walters NP, 2011, NEWLY ARRIVED FOREIG; Whatley M, 2012, INDIAN IMMIGRANTS US; Wolff EN, 2011, GREAT RECESSION, P127; Zavodny M, 2003, POPUL RES POLICY REV, V22, P201, DOI 10.1023/A:1026025024501; Zweigenhaft R.L., 2014, NEW CEOS WOMEN AFRIC	84	6	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2017	12	2							e72876	10.1371/journal.pone.0172876	http://dx.doi.org/10.1371/journal.pone.0172876			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL5SX	28231335	Green Submitted, gold, Green Published			2022-12-27	WOS:000394682400082
J	Vedam, S; Stoll, K; Martin, K; Rubashkin, N; Partridge, S; Thordarson, D; Jolicoeur, G				Vedam, Saraswathi; Stoll, Kathrin; Martin, Kelsey; Rubashkin, Nicholas; Partridge, Sarah; Thordarson, Dana; Jolicoeur, Ganga		Changing Childbirth BC Steering	The Mother's Autonomy in Decision Making (MADM) scale: Patient-led development and psychometric testing of a new instrument to evaluate experience of maternity care	PLOS ONE			English	Article							CHILDBIRTH; DELIVERY; HEALTH; LABOR	Shared decision making (SDM) is core to person-centered care and is associated with improved health outcomes. Despite this, there are no validated scales measuring women's agency and ability to lead decision making during maternity care. Objective To develop and validate a new instrument that assesses women's autonomy and role in decision making during maternity care. Design Through a community-based participatory research process, service users designed, content validated, and administered a cross-sectional quantitative survey, including 31 items on the experience of decision-making. Setting and participants Pregnancy experiences (n = 2514) were reported by 1672 women who saw a single type of primary maternity care provider in British Columbia. They described care by a midwife, family physician or obstetrician during 1, 2 or 3 maternity care cycles. We conducted psychometric testing in three separate samples. Main outcome measures We assessed reliability, item-to-total correlations, and the factor structure of the The Mothers' Autonomy in Decision Making (MADM) scale. We report MADM scores by care provider type, length of prenatal appointments, preferences for role in decision-making, and satisfaction with experience of decision-making. Results The MADM scale measures a single construct: autonomy in decision-making during maternity care. Cronbach alphas for the scale exceeded 0.90 for all samples and all provider groups. All item-to-total correlations were replicable across three samples and exceeded 0.7. Eigenvalue and scree plots exhibited a clear 90-degree angle, and factor analysis generated a one factor scale. MADM median scores were highest among women who were cared for by midwives, and 10 or more points lower for those who saw physicians. Increased time for prenatal appointments was associated with higher scale scores, and there were significant differences between providers with respect to average time spent in prenatal appointments. Midwifery care was associated with higher MADM scores, even during short prenatal appointments (<15 minutes). Among women who preferred to lead decisions around their care (90.8%), and who were dissatisfied with their experience of decision making, MADM scores were very low (median 14). Women with physician carers were consistently more likely to report dissatisfaction with their involvement in decision making. Discussion The Mothers Autonomy in Decision Making (MADM) scale is a reliable instrument for assessment of the experience of decision making during maternity care. This new scale was developed and content validated by community members representing various populations of childbearing women in BC including women from vulnerable populations. MADM measures women's ability to lead decision making, whether they are given enough time to consider their options, and whether their choices are respected. Women who experienced midwifery care reported greater autonomy than women under physician care, when engaging in decision-making around maternity care options. Differences in models of care, professional education, regulatory standards, and compensation for prenatal visits between midwives and physicians likely affect the time available for these discussions and prioritization of a shared decision making process. Conclusion The MADM scale reflects person-driven priorities, and reliably assesses interactions with maternity providers related to a person's ability to lead decision-making over the course of maternity care.	[Vedam, Saraswathi; Stoll, Kathrin; Martin, Kelsey; Thordarson, Dana] Univ British Columbia Vancouver, Div Midwifery, Birth Pl Res Lab, Vancouver, BC, Canada; [Stoll, Kathrin] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC, Canada; [Rubashkin, Nicholas] Univ Calif San Francisco, Dept Obstet & Gynecol, San Francisco, CA 94143 USA; [Partridge, Sarah] Univ British Columbia, Dept Family Practice, Residency Program, Vancouver, BC, Canada; [Jolicoeur, Ganga] Midwives Assoc British Columbia, Vancouver, BC, Canada	University of British Columbia; University of British Columbia; University of California System; University of California San Francisco; University of British Columbia	Vedam, S (corresponding author), Univ British Columbia Vancouver, Div Midwifery, Birth Pl Res Lab, Vancouver, BC, Canada.	vedam@midwifery.ubc.ca		Vedam, Saraswathi/0000-0001-6396-3638	Vancouver Foundation (NPO) [UNR12-0701]	Vancouver Foundation (NPO)	Vancouver Foundation (NPO) https://www.vancouverfoundation.ca/ This work was partially supported by operating grant #UNR12-0701 for the provincial community based participatory Changing Childbirth in BC study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2001, CROSSING QUALITY CHA; [Anonymous], 2014, INTR HLTH WOM BAB CL; [Anonymous], J CLIN EPIDEMIOLOGY, V51, P399; [Anonymous], 2015, STATEMENT POLICY GLO; Baker SR, 2005, FEM PSYCHOL, V15, P315, DOI 10.1177/0959-353505054718; Barry MJ, 2012, NEW ENGL J MED, V366, P780, DOI 10.1056/NEJMp1109283; Caron-Flinterman JF, 2005, SOC SCI MED, V60, P2575, DOI 10.1016/j.socscimed.2004.11.023; Cheyney M, 2014, BIRTH-ISS PERINAT C, V41, P1, DOI 10.1111/birt.12099; CMA, 2007, GUID PHYS INT IND, P1; Coxon K, 2014, DISCOURSES RISK BLAM; Duncan E, 1996, COCHRANE DATABASE SY; Edwards A, 2001, Health Expect, V4, P151, DOI 10.1046/j.1369-6513.2001.00116.x; GITHENS PB, 1993, BIRTH-ISS PERINAT C, V20, P136, DOI 10.1111/j.1523-536X.1993.tb00438.x; Grzybowski S, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-147; Hack TF, 2006, PSYCHO-ONCOL, V15, P9, DOI 10.1002/pon.907; Hall WA, 2012, QUAL HEALTH RES, V22, P575, DOI 10.1177/1049732311424292; Harris SJ, 2012, CAN MED ASSOC J, V184, P1885, DOI 10.1503/cmaj.111753; Heaman MI, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-188; Hodnett ED, 2002, AM J OBSTET GYNECOL, V186, pS160, DOI 10.1067/mob.2002.121141; Kriston L, 2010, PATIENT EDUC COUNS, V80, P94, DOI 10.1016/j.pec.2009.09.034; Kukla R, 2009, BIOETHICS, V23, P1, DOI 10.1111/j.1467-8519.2008.00677.x; Lalonde A, 2015, INT J GYNECOL OBSTET, V128, P95, DOI 10.1016/j.ijgo.2014.10.013; Lawrence HC, 2012, AM J OBSTET GYNECOL, V207, P147, DOI 10.1016/j.ajog.2012.07.018; Legare F, 2012, PATIENT, V5, P1, DOI 10.2165/11592180-000000000-00000; Legare F, 2008, PATIENT EDUC COUNS, V73, P526, DOI 10.1016/j.pec.2008.07.018; Lewin SA, 2001, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003267; Lyerly Anne., 2013, GOOD BIRTH FINDING P; O'Connor AM, 2009, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001431.pub2, 10.1002/14651858.CD001431.pub3, 10.1002/14651858.CD001431.pub4]; Regan Mary, 2013, J Clin Ethics, V24, P239; Reis V, 2012, RESPECTFUL MATERNITY; ROBERTS AR, 2004, EVIDENCE BASED PRACT; Sandall J., 2015, COCHRANE DB SYST REV, V9, P1, DOI DOI 10.1002/14651858.CD004667.PUB4; Shay LA, 2015, MED DECIS MAKING, V35, P114, DOI 10.1177/0272989X14551638; ten Hoope-Bender P, 2014, LANCET, V384, P1226, DOI 10.1016/S0140-6736(14)60930-2; Wendland CL, 2007, MED ANTHROPOL Q, V21, P218, DOI 10.1525/MAQ.2007.21.2.218	35	59	59	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2017	12	2							e0171804	10.1371/journal.pone.0171804	http://dx.doi.org/10.1371/journal.pone.0171804			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL5SX	28231285	Green Submitted, gold, Green Published			2022-12-27	WOS:000394682400020
J	Betancur, LA; Naranjo-Gaybor, SJ; Vinchira-Villarraga, DM; Moreno-Sarmiento, NC; Maldonado, LA; Suarez-Moreno, ZR; Acosta-Gonzalez, A; Padilla-Gonzalez, GF; Puyana, M; Castellanos, L; Ramos, FA				Betancur, Luz A.; Naranjo-Gaybor, Sandra J.; Vinchira-Villarraga, Diana M.; Moreno-Sarmiento, Nubia C.; Maldonado, Luis A.; Suarez-Moreno, Zulma R.; Acosta-Gonzalez, Alejandro; Padilla-Gonzalez, Gillermo F.; Puyana, Monica; Castellanos, Leonardo; Ramos, Freddy A.			Marine Actinobacteria as a source of compounds for phytopathogen control: An integrative metabolic-profiling/bioactivity and taxonomical approach	PLOS ONE			English	Article							QUORUM SENSING INHIBITORS; SP NOV.; PSEUDOMONAS-AERUGINOSA; ANTIMICROBIAL ACTIVITY; VIRULENCE FACTORS; NATURAL-PRODUCTS; PLANT-GROWTH; STREPTOMYCES; DEREPLICATION; IDENTIFICATION	Marine bacteria are considered as promising sources for the discovery of novel biologically active compounds. In this study, samples of sediment, invertebrate and algae were collected from the Providencia and Santa Catalina coral reef (Colombian Caribbean Sea) with the aim of isolating Actinobateria-like strain able to produce antimicrobial and quorum quenching compounds against pathogens. Several approaches were used to select actino-bacterial isolates, obtaining 203 strains from all samples. According to their 16S rRNA gene sequencing, a total of 24 strains was classified within Actinobacteria represented by three genera: Streptomyces, Micromonospora, and Gordonia. In order to assess their metabolic profiles, the actinobacterial strains were grown in liquid cultures, and LC-MS-based analyses from ethyl acetate fractions were performed. Based on taxonomical classification, screening information of activity against phytopathogenic strains and quorum quenching activity, as well as metabolic profiling, six out of the 24 isolates were selected for follow-up with chemical isolation and structure identification analyses of putative metabolites involved in antimicrobial activities.	[Betancur, Luz A.; Naranjo-Gaybor, Sandra J.; Vinchira-Villarraga, Diana M.; Moreno-Sarmiento, Nubia C.; Castellanos, Leonardo; Ramos, Freddy A.] Univ Nacl Colombia, Sede Bogota, Dept Quim, Edificio Quim 427, Bogota, Colombia; [Betancur, Luz A.] Univ Caldas, Dept Quim, Manizales, Caldas, Colombia; [Naranjo-Gaybor, Sandra J.] Univ Fuerzas Armadas, Sangolqui, Ecuador; [Maldonado, Luis A.] Univ Autonoma Metropolitana Rectoria, Secretaria Gen, Mexico City, DF, Mexico; [Suarez-Moreno, Zulma R.] Empresa Colombiana Prod Vet VECOL SA, Invest & Desarrollo, Bogota, Colombia; [Acosta-Gonzalez, Alejandro] Univ Sabana, Fac Ingn, Chia, Cundinamarca, Colombia; [Padilla-Gonzalez, Gillermo F.] Univ Sao Paulo, Fac Ciencias Farmaceut Ribeirao Preto, Ribeirao Preto, SP, Brazil; [Puyana, Monica] Univ Jorge Tadeo Lozano, Dept Ciencias Biol & Ambientales, Programa Biol Marina, Bogota, Colombia	Universidad Nacional de Colombia; Universidad de Caldas; Universidad de La Sabana; Universidade de Sao Paulo; Universidad de Bogota Jorge Tadeo Lozano	Ramos, FA (corresponding author), Univ Nacl Colombia, Sede Bogota, Dept Quim, Edificio Quim 427, Bogota, Colombia.	faramosr@unal.edu.co	Padilla-Gonzalez, Guillermo/G-2636-2012; Hernández, Leonardo Castellanos/AAV-5967-2020; Acosta-Gonzalez, Alejandro/AAF-2470-2020; Ramos, Freddy A/AAV-5022-2020	Padilla-Gonzalez, Guillermo/0000-0002-8300-6891; Hernández, Leonardo Castellanos/0000-0001-5248-800X; Acosta-Gonzalez, Alejandro/0000-0002-4573-6113; Suarez-Moreno, Zulma/0000-0001-7100-3442; Ramos, Freddy A/0000-0002-9271-7193	Programa Doctoral Becas Colciencias [567]; SENESCYT Ecuador [2012-2]; "Es Tiempo de volver" postdoctoral fellowship from Colciencias; La Sabana University (Bogota A, Colombia); MALDI-TOF analysis at Pontificia Javeriana University (Bogota A, Colombia); COLCIENCIAS [1101-659-44402.CT.537/14]; IFS [F/5023-2]; Universidad Nacional de Colombia-DIB [23604]	Programa Doctoral Becas Colciencias; SENESCYT Ecuador; "Es Tiempo de volver" postdoctoral fellowship from Colciencias; La Sabana University (Bogota A, Colombia); MALDI-TOF analysis at Pontificia Javeriana University (Bogota A, Colombia); COLCIENCIAS(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); IFS(International Foundation for Science); Universidad Nacional de Colombia-DIB	L.A.B thanks the Programa Doctoral Becas Colciencias (567) for the granted scholarship (2012) and Universidad de Caldas for the leave of absence for doctoral studies. S.J.N thanks SENESCYT Ecuador for the granted scholarship (2012-2) and ESPE for the leave of absence for doctoral studies. A.A.G. is recipient of an "Es Tiempo de volver 2015-2016" postdoctoral fellowship from Colciencias and La Sabana University (Bogota A, Colombia). We thank Dr. Claudia Parra for supported the MALDI-TOF analysis at Pontificia Javeriana University (Bogota A, Colombia). Strains of Burkholderia spp and Colletotrichum gloeosporioides 26B were kindly provided by the Biotechnology Institute of the Universidad Nacional de Colombia. The strain of Fusarium oxysporum was kindly provided by Prof. Harold Ardila, Departamento de Quimica, Universidad Nacional de Colombia. Chromobacterium violaceum ATCC31532 was kindly provided by Prof. Catalina Arevalo Ferro, Departamento de Biologia, Universidad Nacional de Colombia. The ANLA and the Ministerio de Ambiente y Desarrollo Sostenible granted permission to collect samples and perform this research (Permission No 4 of 10/02/2010, Anexo 2, Contrato de Acceso a Recurso Genetico No 108). Financial support from COLCIENCIAS (grant Cod. 1101-659-44402. CT.537/14), IFS (Grant F/5023-2), and Universidad Nacional de Colombia-DIB (grant/Hermes 23604). The funder VECOL S.A. provided support in the form of salaries for authors (Z.R.S.), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section." This does not alter our adherence to PLOS ONE policies on sharing data and materials.	Abdelmohsen UR, 2014, MAR DRUGS, V12, P1220, DOI 10.3390/md12031220; Abdelmohsen UR, 2014, NAT PROD REP, V31, P381, DOI 10.1039/c3np70111e; Aktar Md Wasim, 2009, Interdiscip Toxicol, V2, P1, DOI 10.2478/v10102-009-0001-7; Andersen AS, 2010, MICROBIOL-SGM, V156, P400, DOI 10.1099/mic.0.032730-0; ARDILA HAROLD, 2005, Acta biol.Colomb., V10, P61; Augustine SK, 2005, J BIOSCIENCES, V30, P201, DOI 10.1007/BF02703700; AZEGAMI K, 1987, INT J SYST BACTERIOL, V37, P144, DOI 10.1099/00207713-37-2-144; Balouiri M, 2016, J PHARM ANAL, V6, P71, DOI 10.1016/j.jpha.2015.11.005; Barka EA, 2016, MICROBIOL MOL BIOL R, V80, P1, DOI 10.1128/MMBR.00019-15; Barnard AML, 2007, PHILOS T R SOC B, V362, P1165, DOI 10.1098/rstb.2007.2042; Blunt JW, 2016, NAT PROD REP, V33, P382, DOI 10.1039/c5np00156k; Blunt JW, 2011, NAT PROD REP, V28, P196, DOI 10.1039/c005001f; Bobzin SC, 2000, J IND MICROBIOL BIOT, V25, P342, DOI 10.1038/sj.jim.7000057; Brooks MS, 2012, JOURNAL OF MICROBIAL, V2012; CaLS I, 2011, PERFORMANCE STANDARD; Castillo-Juarez I, 2013, ARCH MED RES, V44, P488, DOI 10.1016/j.arcmed.2013.10.004; Cha JH, 2013, INT J SYST EVOL MICR, V63, P327, DOI 10.1099/ijs.0.039289-0; Chagas-Paula DA, 2015, METABOLITES, V5, P404, DOI 10.3390/metabo5030404; CHEN CL, 2015, PLOS ONE, V10, P1, DOI DOI 10.1371/JOUMAL.PONE.0138528; Cheng K, 2015, APPL ENVIRON MICROB, V81, P966, DOI 10.1128/AEM.02925-14; Christner M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101924; CONDER GA, 1992, J ANTIBIOT, V45, P977, DOI 10.7164/antibiotics.45.977; Devescovi G, 2007, APPL ENVIRON MICROB, V73, P4950, DOI 10.1128/AEM.00105-07; Dong YH, 2000, P NATL ACAD SCI USA, V97, P3526, DOI 10.1073/pnas.060023897; EDEN PA, 1991, INT J SYST BACTERIOL, V41, P324, DOI 10.1099/00207713-41-2-324; Espinoza LE, 2013, ONLINE JOURNAL OF BI, V13, P18; Forner D, 2013, ANAL CHIM ACTA, V805, P70, DOI 10.1016/j.aca.2013.10.029; GILPIN ML, 1989, J ANTIBIOT, V42, P627, DOI 10.7164/antibiotics.42.627; Gomathi A, 2016, BRAZ ARCH BIOL TECHN, V59, DOI 10.1590/1678-4324-2016160055; Goodfellow M, 2012, ACTINOBACTERIA PHYL; GRAFE U, 1982, J ANTIBIOT, V35, P1722, DOI 10.7164/antibiotics.35.1722; Grandclement C, 2016, FEMS MICROBIOL REV, V40, P86, DOI 10.1093/femsre/fuv038; Gulve R.M., 2012, INT MULTIDISCIPLINAR, V2, P16; Handelsman J, 1998, CHEM BIOL, V5, pR245, DOI 10.1016/S1074-5521(98)90108-9; Helman Y, 2015, MOL PLANT PATHOL, V16, P316, DOI 10.1111/mpp.12180; Hou Y, 2012, ANAL CHEM, V84, P4277, DOI 10.1021/ac202623g; IMAI S, 1990, J ANTIBIOT, V43, P1606, DOI 10.7164/antibiotics.43.1606; IMOTO M, 1990, J NAT PROD, V53, P825, DOI 10.1021/np50070a008; Ito T, 2014, J ANTIBIOT, V67, P353, DOI 10.1038/ja.2014.12; Jackisch-Matsuura AB, 2014, BRAZ ARCH BIOL TECHN, V57, P138, DOI 10.1590/S1516-89132014000100019; Jensen PR, 2007, APPL ENVIRON MICROB, V73, P1146, DOI 10.1128/AEM.01891-06; Kalia VC, 2013, BIOTECHNOL ADV, V31, P224, DOI 10.1016/j.biotechadv.2012.10.004; Kang JE, 2016, MICROBIOL RES, V184, P32, DOI 10.1016/j.micres.2015.12.005; Kanini GS, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/387230; Kanoh K, 2005, J ANTIBIOT, V58, P289, DOI 10.1038/ja.2005.36; Kaur T, 2014, J BASIC MICROB, V54, P1175, DOI 10.1002/jobm.201300086; Kim AL, 2014, J MICROBIOL BIOTECHN, V24, P1574, DOI 10.4014/jmb.1407.07009; Kim J, 2004, MOL MICROBIOL, V54, P921, DOI 10.1111/j.1365-2958.2004.04338.x; Kim SK, 2013, MARINE MICROBIOLOGY: BIOACTIVE COMPOUNDS AND BIOTECHNOLOGICAL APPLICATIONS, P1, DOI 10.1002/9783527665259; Li T, 2013, MAR DRUGS, V11, P466, DOI 10.3390/md11020466; Li WJ, 2014, ANTON LEEUW INT J G, V106, P1119, DOI 10.1007/s10482-014-0281-6; Ma G BZ, 2009, CROPS, V5, P3; Macagnan D, 2006, PHYTOPARASITICA, V34, P122, DOI 10.1007/BF02981312; Macintyre L, 2014, MAR DRUGS, V12, P3416, DOI 10.3390/md12063416; Maldonado LA, 2009, ANTON LEEUW INT J G, V95, P111, DOI 10.1007/s10482-008-9294-3; Manivasagan P, 2013, MICROBIOL RES, V168, P311, DOI 10.1016/j.micres.2013.02.002; Marroquin NG, REVISTA COLOMBIANA D, V18, P95; McLean RJC, 2004, J MICROBIOL METH, V58, P351, DOI 10.1016/j.mimet.2004.04.016; Munoz R, 2011, SYST APPL MICROBIOL, V34, P169, DOI 10.1016/j.syapm.2011.03.001; Naik DN, 2013, LETT APPL MICROBIOL, V56, P197, DOI 10.1111/lam.12034; Newman DJ, 2016, PHARMACOL THERAPEUT, V162, P1, DOI 10.1016/j.pharmthera.2015.12.002; Newman DJ, 2012, J NAT PROD, V75, P311, DOI 10.1021/np200906s; O'Callaghan M, 2016, APPL MICROBIOL BIOT, V100, P5729, DOI 10.1007/s00253-016-7590-9; OKUYAMA A, 1971, BIOCHEM BIOPH RES CO, V43, P196, DOI 10.1016/S0006-291X(71)80106-7; Pluskal T, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-395; Prakash D, 2014, J MICROBIOL METH, V99, P54, DOI 10.1016/j.mimet.2014.02.005; Prevost K, 2006, BIOCONTROL, V51, P533, DOI 10.1007/s10526-005-4240-z; Pruesse E, 2012, BIOINFORMATICS, V28, P1823, DOI 10.1093/bioinformatics/bts252; Qin S, 2009, APPL ENVIRON MICROB, V75, P6176, DOI 10.1128/AEM.01034-09; Quintana ET, 2013, ANTON LEEUW INT J G, V104, P63, DOI 10.1007/s10482-013-9926-0; Rai MK, 2011, ENVIRON EXP BOT, V71, P89, DOI 10.1016/j.envexpbot.2010.10.021; Rateb ME, 2011, J NAT PROD, V74, P1965, DOI 10.1021/np200470u; Rezanka T, 2004, EUR J ORG CHEM, V2004, P4239, DOI 10.1002/ejoc.200400276; Ritacco FV, 2003, J IND MICROBIOL BIOT, V30, P472, DOI 10.1007/s10295-003-0038-0; Rong XY, 2013, SYST APPL MICROBIOL, V36, P401, DOI 10.1016/j.syapm.2013.03.010; SAKUDA S, 1993, J CHEM SOC PERK T 1, P2309, DOI 10.1039/p19930002309; Santos-Gandelman JF, 2014, CURR PHARM BIOTECHNO, V15, P143, DOI 10.2174/1389201015666140711115033; Saroj SD, 2013, ANTIMICROB AGENTS CH, V57, P1926, DOI 10.1128/AAC.02161-12; Schneemann I, 2011, MAR DRUGS, V9, P772, DOI 10.3390/md9050772; Seipke RF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116457; Shepherd Micah D, 2010, Curr Protoc Microbiol, VChapter 10, DOI 10.1002/9780471729259.mc10e01s18; SHIGIHARA Y, 1988, J ANTIBIOT, V41, P1260, DOI 10.7164/antibiotics.41.1260; SHIRLING E B, 1968, International Journal of Systematic Bacteriology, V18, P279; Solanki R, 2008, INDIAN J MICROBIOL, V48, P410, DOI 10.1007/s12088-008-0052-z; Solis R, 2006, FEMS MICROBIOL LETT, V259, P106, DOI 10.1111/j.1574-6968.2006.00254.x; Sousa CD, 2008, SCI AGR, V65, P50, DOI 10.1590/S0103-90162008000100007; STANECK JL, 1974, APPL MICROBIOL, V28, P226, DOI 10.1128/AEM.28.2.226-231.1974; Sui JL, 2011, INT J SYST EVOL MICR, V61, P1632, DOI 10.1099/ijs.0.023515-0; Tang YQ, 2000, J ANTIBIOT, V53, P934, DOI 10.7164/antibiotics.53.934; Tawfike AF, 2013, METHODS MOL BIOL, V1055, P227, DOI 10.1007/978-1-62703-577-4_17; Teasdale ME, 2011, MAR BIOTECHNOL, V13, P722, DOI 10.1007/s10126-010-9334-7; Tello E, 2012, J NAT PROD, V75, P1637, DOI 10.1021/np300313k; van den Berg RA, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-142; Viegelmann C, 2014, MAR DRUGS, V12, P3323, DOI 10.3390/md12063323; Waksman SA, 1953, STREPTOMYCIN BACKGRO; Westram R, 2011, HDB MOL MICROBIAL EC, P399, DOI DOI 10.1002/9781118010518.CH46; Yarza P, 2014, NAT REV MICROBIOL, V12, P635, DOI 10.1038/nrmicro3330; Ye X W, 1987, Wei Sheng Wu Xue Bao, V27, P156; Yoshii A, 2012, APPL ENVIRON MICROB, V78, P5555, DOI 10.1128/AEM.01155-12; Zhou XF, 2016, J ANTIBIOT, V69, P582, DOI 10.1038/ja.2016.71	100	36	36	6	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2017	12	2							e0170148	10.1371/journal.pone.0170148	http://dx.doi.org/10.1371/journal.pone.0170148			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5SK	28225766	Green Submitted, gold, Green Published			2022-12-27	WOS:000394680900005
J	Chang, CC; Lin, YF; Chiu, CH; Liao, YM; Ho, MH; Lin, YK; Chou, KR; Liu, MF				Chang, Chia-Chi; Lin, Yu-Fang; Chiu, Chia-Hui; Liao, Yuan-Mei; Ho, Mu-Hsing; Lin, Yen-Kuang; Chou, Kuei-Ru; Liu, Megan F.			Prevalence and factors associated with food intake difficulties among residents with dementia	PLOS ONE			English	Article							NURSING-HOME PATIENTS; FEEDING DIFFICULTY; OLDER-ADULTS; WEIGHT-LOSS; MALNUTRITION; SUBTYPES; INDEX	Background Few studies have examined the prevalence of food intake difficulties and their associated factors among residents with dementia in long-term care facilities in Taiwan. The purpose of the study was to identify the best cutoff point for the Chinese Feeding Difficulty Index (Ch-FDI), which evaluates the prevalence of food intake difficulties and recognizes factors associated with eating behaviors in residents with dementia. Methods and findings A cross-sectional design was adopted. In total, 213 residents with dementia in long-term care facilities in Taiwan were recruited and participated in this study. The prevalence rate of food intake difficulties as measured by the Chinese Feeding Difficulty Index (Ch-FDI) was 44.6%. Factors associated with food intake difficulties during lunch were the duration of institutionalization (beta = 0.176), the level of activities of daily living-feeding (ADL-Q1) (beta = -0.235), and the length of the eating time (beta = 0.416). Associated factors during dinner were the illuminance level (beta = -0.204), sound volume level (beta = 0.187), ADL-Q1 (beta = -0.177), and eating time (beta = 0.395). Conclusions Food intake difficulties may potentially be associated with multiple factors including physical function and the dining environment according to the 45% prevalence rate among dementia residents in long-term care facilities.	[Chang, Chia-Chi; Ho, Mu-Hsing; Liu, Megan F.] Taipei Med Univ, Coll Nursing, Sch Gerontol Hlth Management, Taipei, Taiwan; [Lin, Yu-Fang; Liao, Yuan-Mei; Ho, Mu-Hsing; Lin, Yen-Kuang; Chou, Kuei-Ru] Taipei Med Univ, Sch Nursing, Coll Nursing, Taipei, Taiwan; [Chiu, Chia-Hui] Taipei Med Univ, Ctr Gen Educ, Taipei, Taiwan; [Lin, Yen-Kuang] Taipei Med Univ, Biostat Res Ctr, Taipei, Taiwan	Taipei Medical University; Taipei Medical University; Taipei Medical University; Taipei Medical University	Liu, MF (corresponding author), Taipei Med Univ, Coll Nursing, Sch Gerontol Hlth Management, Taipei, Taiwan.	fangliu@tmu.edu.tw		chou, kueiru/0000-0002-4882-3503; Ho, Mu-Hsing/0000-0002-9443-4082; Chang, Chia-Chi/0000-0002-5257-0238	National Health Research Institutes grant in Taiwan [NHRI-EX99-9921PC, NHRI-EX100-9921PC]	National Health Research Institutes grant in Taiwan	This manuscript was supported by the National Health Research Institutes grant (NHRI-EX99-9921PC; NHRI-EX100-9921PC) in Taiwan. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This manuscript was supported by National Health Research Institutes, Taiwan grants (NHRI-EX99-9921PC and NHRI-EX100-9921PC).	Amella EJ, 2004, NURS CLIN N AM, V39, P607, DOI 10.1016/j.cnur.2004.02.014; Bell CL, 2013, J AM MED DIR ASSOC, V14, P94, DOI 10.1016/j.jamda.2012.10.012; Cegelka A, 2014, J AM GERIATR SOC, V62, P1590, DOI 10.1111/jgs.12924; Chang CC, 2012, J NUTR HEALTH AGING, V16, P258, DOI 10.1007/s12603-011-0158-6; Chang CC, 2008, J NURS SCHOLARSHIP, V40, P235, DOI 10.1111/j.1547-5069.2008.00231.x; Chang CC, 2008, J CLIN NURS, V17, P2266, DOI 10.1111/j.1365-2702.2007.02275.x; Chang CC, 2011, AM J NURS, V111, P36, DOI 10.1097/01.NAJ.0000396553.01996.5e; Chen TF, 2007, NEUROEPIDEMIOLOGY, V28, P142, DOI 10.1159/000102142; Cohen J.E., 1988, STAT POWER ANAL BEHA; Collin C, 1988, Int Disabil Stud, V10, P61; Durnbaugh T, 1996, GERIATR NURS, V17, P63, DOI 10.1016/S0197-4572(96)80170-4; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; GILMORE GC, 1994, J GERONTOL, V49, pP52, DOI 10.1093/geronj/49.2.P52; Guo NW, 1988, J REHABIL MED, V16, pE59; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Jansen S, 2015, NUTR DIET, V72, P36, DOI 10.1111/1747-0080.12144; Kayser-Jones J., 1977, J GERONTOL NURS, V23, P14; Khachiyants N, 2011, PSYCHIAT INVEST, V8, P275, DOI 10.4306/pi.2011.8.4.275; Lin LC, 2010, J CLIN NURS, V19, P53, DOI 10.1111/j.1365-2702.2009.02962.x; LIU HC, 1995, J AM GERIATR SOC, V43, P144, DOI 10.1111/j.1532-5415.1995.tb06379.x; Liu HC, 1998, ALZ DIS ASSOC DIS, V12, P127, DOI 10.1097/00002093-199809000-00002; Liu ML, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134804; Liu W, 2014, INT J NURS STUD, V51, P14, DOI 10.1016/j.ijnurstu.2012.12.021; Ministry of Health and Welfare, 2012, EST STAND SEN CIT WE; Ministry of Health and Welfare, 2012, EV REW ENF SEN CIT S; Mitchell SL, 2015, NEW ENGL J MED, V372, P2533, DOI [10.1056/NEJMcp1412652, 10.1056/NEJMc1509349]; Nyunt MSZ, 2009, AGING MENT HEALTH, V13, P376, DOI 10.1080/13607860902861027; Sampson EL, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007209.pub2; SHAH S, 1989, J CLIN EPIDEMIOL, V42, P703, DOI 10.1016/0895-4356(89)90065-6; Slaughter SE, 2011, CLIN NUTR, V30, P172, DOI 10.1016/j.clnu.2010.09.001; Snowden MB, 2015, AM J GERIAT PSYCHIAT, V23, P897, DOI 10.1016/j.jagp.2014.09.002; Stone L., 2014, END LIFE J, V4; Taiwan Dementia Society, 2011, MMSE MAN 2011; Tamura BK, 2013, J AM MED DIR ASSOC, V14, P649, DOI 10.1016/j.jamda.2013.02.022; Volicer L., 1987, J APPLIED GERONTOLOG, V6, P83, DOI DOI 10.1177/073346488700600107; Volkert D, 2015, CLIN NUTR, V34, P1052, DOI 10.1016/j.clnu.2015.09.004; Watson Roger, 2003, Nurs Older People, V14, P23; Watson Roger, 2002, Nurs Older People, V14, P21; Yeh SCJ, 2003, BMC HEALTH SERV RES, V3, DOI 10.1186/1472-6963-3-9; YESAVAGE JA, 1983, J PSYCHIATR RES, V17, P37, DOI 10.1016/0022-3956(82)90033-4; YOUDEN WJ, 1950, BIOMETRICS, V6, P172, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3	41	13	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2017	12	2							e0171770	10.1371/journal.pone.0171770	http://dx.doi.org/10.1371/journal.pone.0171770			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL5SK	28225776	Green Published, Green Submitted, gold			2022-12-27	WOS:000394680900019
J	Kouyoumdjian, FG; Pivnick, L; McIsaac, KE; Wilton, AS; Lofters, A; Hwang, SW				Kouyoumdjian, Fiona G.; Pivnick, Lucie; McIsaac, Kathryn E.; Wilton, Andrew S.; Lofters, Aisha; Hwang, Stephen W.			Cancer prevalence, incidence and mortality in people who experience incarceration in Ontario, Canada: A population-based retrospective cohort study	PLOS ONE			English	Article							CERVICAL-CANCER; HEALTH-CARE; HUMAN-PAPILLOMAVIRUS; STATE PRISON; MALE INMATES; RISK-FACTORS; ALL-CAUSE; EPIDEMIOLOGY; PREDICTORS; INFECTION	Introduction Evidence suggests that many risk factors for cancer are overrepresented in people who experience incarceration, and data on cancer epidemiology are limited for this population. We aimed to describe cancer prevalence, incidence and mortality in adults admitted to provincial custody in Ontario, Canada in 2000. Methods We linked data on 48,166 adults admitted to provincial custody in Ontario in 2000 with Ontario Cancer Registry data to 2012. We calculated cancer prevalence in the 10 years prior to admission to custody in 2000, incidence between 2000 and 2012 and mortality between 2000 and 2011. Standardized for age, we calculated incidence and mortality ratios by sex compared to the general population of Ontario. Results The 10-year cancer prevalence was 0.4% in men and 0.6% in women at admission to provincial custody in 2000. Between 2000 and 2012, 2.6% of men and 2.8% of women were diagnosed with new cancer. The standardized incidence ratio for cancer was 1.0 (95% CI 0.9-1.0) for men and 0.9 (95% CI 0.7-1.0) for women compared to the general population, and was significantly increased for cervical, head and neck, liver and lung cancers. The standardized mortality ratio was 1.6 (95% CI 1.4-1.7) in men and 1.4 (95% CI 1.0-1.9) in women, and was significantly increased for head and neck, liver, and lung cancers. Conclusions There is an excess burden of cancer in people who experience incarceration. Cancer prevention should include people who experience incarceration, and the period of incarceration may offer an opportunity for intervention.	[Kouyoumdjian, Fiona G.; McIsaac, Kathryn E.; Lofters, Aisha; Hwang, Stephen W.] St Michaels Hosp, Ctr Urban Hlth Solut, Toronto, ON, Canada; [Kouyoumdjian, Fiona G.] McMaster Univ, Dept Family Med, Hamilton, ON, Canada; [Pivnick, Lucie] McMaster Univ, Fac Med, Hamilton, ON, Canada; [McIsaac, Kathryn E.] Nova Scotia Hlth Author, Res Serv, Halifax, NS, Canada; [Wilton, Andrew S.; Lofters, Aisha; Hwang, Stephen W.] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Lofters, Aisha] St Michaels Hosp, Dept Family & Community Med, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; McMaster University; McMaster University; University of Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto	Kouyoumdjian, FG (corresponding author), St Michaels Hosp, Ctr Urban Hlth Solut, Toronto, ON, Canada.	kouyoumdjiaf@smh.ca	Hwang, Stephen W./GVR-7773-2022		University of Toronto Postgraduate Research Award	University of Toronto Postgraduate Research Award	This study was funded by a 2013 University of Toronto Postgraduate Research Award to FK. This funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Lessa PRA, 2012, REV LAT-AM ENFERM, V20, P354, DOI 10.1590/S0104-11692012000200019; AUDETLAPOINTE P, 1971, CAN MED ASSOC J, V104, P509; Bai JR, 2015, J CORRECT HEALTH CAR, V21, P255, DOI 10.1177/1078345815587510; Baillargen J, 2009, PUBLIC HEALTH REP, V124, P120, DOI 10.1177/003335490912400115; Bell A, 2004, CORRECTIONAL SERVIC; Binswanger IA, 2009, J EPIDEMIOL COMMUN H, V63, P912, DOI 10.1136/jech.2009.090662; Binswanger IA, 2005, AM J PUBLIC HEALTH, V95, P1781, DOI 10.2105/AJPH.2004.052498; Binswanger IA, 2007, NEW ENGL J MED, V356, P157, DOI 10.1056/NEJMsa064115; Binswanger IA, 2013, ANN INTERN MED, V159, P592, DOI 10.7326/0003-4819-159-9-201311050-00005; Brochu S, 1999, J SUBST ABUSE TREAT, V16, P173, DOI 10.1016/S0740-5472(98)00042-7; Butler T, 2004, AUST NZ J PUBL HEAL, V28, P344, DOI 10.1111/j.1467-842X.2004.tb00442.x; Calzavara L, 2007, CAN MED ASSOC J, V177, P257, DOI 10.1503/cmaj.060416; Canadian Cancer Society's Advisory Committee on Cancer Statistics, 2015, CAN CANC STAT 2015; Canadian Institutes of Health Research NSaERCoC Social Sciences and Humanities Research Council of Canada, 2014, TRI COUNC POL STAT E; Cancer Care Ontario, 2012, ONTARIO CANCER REGIS; Chaudhari A, 2013, ASIAN PAC J CANCER P, V14, P859, DOI 10.7314/APJCP.2013.14.2.859; Chong N., 1998, INT AGENCY RES CANC; Clarke JG, 2013, JAMA INTERN MED, V173, P789, DOI 10.1001/jamainternmed.2013.197; Correctional Service Canada, 2016, HUM IMM VIR HIV AGE; Correctional Service Canada, 2012, CORR SERV CAN; Correctional Services Canada, 2016, INF DIS SURV 2014 HE; Davies EA, 2010, J PUBLIC HEALTH-UK, V32, P526, DOI 10.1093/pubmed/fdq009; de Sanjose S, 2000, MED CLIN-BARCELONA, V115, P81, DOI 10.1016/S0025-7753(00)71472-2; Fazel S, 2011, LANCET, V377, P956, DOI 10.1016/S0140-6736(10)61053-7; Ford P M, 1995, Can Commun Dis Rep, V21, P132; Gann Peter H, 2002, Rev Urol, V4 Suppl 5, pS3; Gonzalez C, 2008, EPIDEMIOL INFECT, V136, P215, DOI 10.1017/S0950268807008382; Haggar Fatima A, 2009, Clin Colon Rectal Surg, V22, P191, DOI 10.1055/s-0029-1242458; Harzke AJ, 2009, PREV MED, V48, P588, DOI 10.1016/j.ypmed.2009.03.011; International Agency for Research on Cancer, 2016, IARC MON EV CARC RIS; Johnson CM, 2013, CANCER CAUSE CONTROL, V24, P1207, DOI 10.1007/s10552-013-0201-5; Kouyoumdjian F, 2016, CAN FAM PHYSICIAN, V62, P215; Kouyoumdjian Fiona G, 2016, CMAJ Open, V4, pE153, DOI 10.9778/cmajo.20150098; Kouyoumdjian FG, 2011, CAN J PUBLIC HEALTH, V102, P220, DOI 10.1007/BF03404901; Lasnier B, 2011, CAN J PUBLIC HEALTH, V102, P249, DOI 10.1007/BF03404042; Martin RE, 2004, CAN J PUBLIC HEALTH, V95, P285, DOI 10.1007/BF03405133; Martin RE, 1998, CAN J PUBLIC HEALTH, V89, P382, DOI 10.1007/BF03404079; Martin RE, 2000, CAN MED ASSOC J, V162, P657; Maruschak Laura M., 2006, MED PROBLEMS JAIL IN; Mathew P, 2005, CANCER-AM CANCER SOC, V104, P2197, DOI 10.1002/cncr.21468; McPherson K, 2000, BMJ-BRIT MED J, V321, P624, DOI 10.1136/bmj.321.7261.624; MOGHISSI KS, 1968, AM J OBSTET GYNECOL, V100, P607, DOI 10.1016/S0002-9378(15)33386-X; Nijhawan AE, 2010, J WOMENS HEALTH, V19, P17, DOI 10.1089/jwh.2009.1469; Nishri D., 2011, ONTARIO CANC REGISTR; PEREYRA AJ, 1961, OBSTET GYNECOL, V17, P154; Plugge E, 2004, J MED SCREEN, V11, P48, DOI 10.1258/096914104772950763; Robinson D., 1996, SUMMARY FINDINGS 199; Rosen DL, 2012, J HEALTH CARE POOR U, V23, P254, DOI 10.1353/hpu.2012.0033; Rosen DL, 2011, ANN EPIDEMIOL, V21, P719, DOI 10.1016/j.annepidem.2011.04.007; Rosen DL, 2008, AM J PUBLIC HEALTH, V98, P2278, DOI 10.2105/AJPH.2007.121855; Smith A, 2013, TIME OUT 3 PROFILE B; Spaulding AC, 2011, AM J EPIDEMIOL, V173, P479, DOI 10.1093/aje/kwq422; Statistics Canada, 2016, CANSIM 2016; Statistics Canada, 2014, YOUTH CORR SER AV CO; Statistics Canada, 2014, CANSIM TABL 251 0006; Statistics Canada, 2014, CANSIM TABL 251 2005; Stavrou E, 2011, CANCER EPIDEMIOL, V35, pE75, DOI 10.1016/j.canep.2011.02.005; Szklo M., 2007, EPIDEMIOLOGY BASICS; Walmsley R., 2016, WORLD PRISON POPULAT, V11th; World Health Organization, 2013, INT CLASSIFICATION D; Zlotorzynska M, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009778	61	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2017	12	2							e0171131	10.1371/journal.pone.0171131	http://dx.doi.org/10.1371/journal.pone.0171131			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL5SK	28225780	Green Published, Green Submitted, gold			2022-12-27	WOS:000394680900009
J	Senthil, S; Choudhari, NS; Vaddavalli, PK; Murthy, S; Reddy, JC; Garudadri, CS				Senthil, Sirisha; Choudhari, Nikhil S.; Vaddavalli, Pravin K.; Murthy, Somasheila; Reddy, Jagadesh C.; Garudadri, Chandra S.			Etiology and Management of Raised Intraocular Pressure following Posterior Chamber Phakic Intraocular Lens Implantation in Myopic Eyes (vol 11, e0165469, 2016)	PLOS ONE			English	Correction													Choudhari, Nikhil/AAD-7157-2019; Reddy, Jagadesh/ABI-1936-2020	Reddy, Jagadesh/0000-0001-9836-0597				Senthil S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165469	1	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2017	12	2							e0172929	10.1371/journal.pone.0172929	http://dx.doi.org/10.1371/journal.pone.0172929			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5SK	28225821	gold, Green Published, Green Submitted			2022-12-27	WOS:000394680900067
J	Costa, MC; Bessegatto, JA; Alfieri, AA; Weese, JS; Filho, JAB; Oba, A				Costa, Marcio C.; Bessegatto, Jose A.; Alfieri, Amauri A.; Weese, J. Scott; Filho, Joao A. B.; Oba, Alexandre			Different antibiotic growth promoters induce specific changes in the cecal microbiota membership of broiler chicken	PLOS ONE			English	Article							INTESTINAL BACTERIAL COMMUNITY; FECAL MICROBIOTA; POULTRY; PERFORMANCE; DIETS	Antimicrobials are sometimes given to food animals at low doses in order to promote faster growth. However, the mechanisms by which those drugs improve performance are not fully understood. This study aimed to investigate the impact of zinc bacitracin (55g/ton), enramycin (10g/ton); halquinol((R)) (30g/ton); virginiamycin (16,5g/ton) and avilamycin (10g/ton) on the cecal microbiota of broiler chicken, compared to a control group. Six hundred and twenty four chicks (Cobb 500) arriving to an experimental unit were randomly assigned into each treatment with four repetitions per treatment. The cecal content of 16 animals per treatment (n = 96) was used for DNA extraction and sequencing of the V4 region of the 16S rRNA gene using Illumina technology. The use of antimicrobials induced significant changes in membership but not in structure of the cecal microbiota compared to the control group, suggesting a greater impact on the less abundant species of bacteria present in that environment. Halquinol was the only drug that did not affect microbial membership. Firmicutes comprised the major bacterial phylum present in the cecum of all groups. There was no statistical difference in relative abundances of the main phyla between treated animals and the control group (all P> 0.05). Treatment with enramycin was associated with decreased richness and with lower relative abundance of unclassified Firmicutes, Clostridium XI, unclassified Peptostreptococcaceae (all P< 0.001) and greater abundance of Clostridium XIVb (P = 0.004) and Anaerosporobacter spp. (P = 0.015), and treatment with bacitracin with greater relative abundance of Bilophila spp. (P = 0.004). Several bacterial genera were identified as representative of usage of each drug. This study used high throughput sequencing to characterize the impact of several antimicrobials in broiler chicken under controlled conditions and add new insights to the current knowledge on how AGPs affect the cecal microbiota of chicken.	[Costa, Marcio C.; Bessegatto, Jose A.; Alfieri, Amauri A.] Univ Estadual Londrina, Dept Vet Prevent Med, Londrina, Parana, Brazil; [Weese, J. Scott] Univ Guelph, Dept Pathobiol, Ontario Vet Coll, Guelph, ON, Canada; [Filho, Joao A. B.; Oba, Alexandre] Univ Estadual Londrina, Dept Anim Sci, Londrina, Parana, Brazil; [Costa, Marcio C.] Univ Montreal, Dept Vet Biomed, St Hyacinthe, PQ, Canada	Universidade Estadual de Londrina; University of Guelph; Universidade Estadual de Londrina; Universite de Montreal	Costa, MC (corresponding author), Univ Estadual Londrina, Dept Vet Prevent Med, Londrina, Parana, Brazil.; Costa, MC (corresponding author), Univ Montreal, Dept Vet Biomed, St Hyacinthe, PQ, Canada.	costamc@gmail.com		Costa, Marcio/0000-0001-5067-7501	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Brasil	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Brasil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was funded by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Brasil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Castanon JIR, 2007, POULTRY SCI, V86, P2466, DOI 10.3382/ps.2007-00249; Cole JR, 2014, NUCLEIC ACIDS RES, V42, pD633, DOI 10.1093/nar/gkt1244; Costa MC, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0335-7; Costa MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041484; Cox LM, 2014, CELL, V158, P705, DOI 10.1016/j.cell.2014.05.052; Danzeisen JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027949; Dufrene M, 1997, ECOL MONOGR, V67, P345, DOI 10.1890/0012-9615(1997)067[0345:SAAIST]2.0.CO;2; Dumonceaux TJ, 2006, APPL ENVIRON MICROB, V72, P2815, DOI 10.1128/AEM.72.4.2815-2823.2006; Fasina YO, 2015, POULT SCI; Gong JH, 2007, FEMS MICROBIOL ECOL, V59, P147, DOI 10.1111/j.1574-6941.2006.00193.x; Han GG, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-2604-8; Jami E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085423; Klindworth A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks808; Kozich JJ, 2013, APPL ENVIRON MICROB, V79, P5112, DOI 10.1128/AEM.01043-13; Latorre JD, 2016, FRONT VET SCI, V3, DOI 10.3389/fvets.2016.00095; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Lu J, 2008, ANIMAL, V2, P669, DOI 10.1017/S1751731108001894; Mancabelli L, 2016, ENVIRON MICROBIOL, P683, DOI [10.3382/ps.2012-02822, DOI 10.3382/PS.2012-02822]; Maron DF, 2013, GLOBALIZATION HEALTH, V9, DOI 10.1186/1744-8603-9-48; Miller Mark, 2015, MLO Med Lab Obs, V47, P28; Neumann AP, 2015, J APPL MICROBIOLOGY; Patterson JA, 2003, POULTRY SCI, V82, P627, DOI 10.1093/ps/82.4.627; Pedroso AA, 2006, POULTRY SCI, V85, P747, DOI 10.1093/ps/85.4.747; Polansky O, 2016, APPL ENVIRON MICROB, V82, P1569, DOI 10.1128/AEM.03473-15; Pourabedin M, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0079-4; Reed S, 2015, NUTRIENTS, V7, P9768, DOI 10.3390/nu7125497; Rehman HU, 2007, ARCH ANIM NUTR, V61, P319, DOI 10.1080/17450390701556817; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Sergeant MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091941; Singh KM, 2012, MOL BIOL REP, V39, P10595, DOI 10.1007/s11033-012-1947-7; Stanley D, 2012, APPL MICROBIOL BIOT, V96, P1361, DOI 10.1007/s00253-011-3847-5; STUTZ MW, 1984, POULTRY SCI, V63, P2036, DOI 10.3382/ps.0632036; Torok VA, 2011, APPL ENVIRON MICROB, V77, P5868, DOI 10.1128/AEM.00165-11; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Videnska P, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-30; Wei S, 2013, POULTRY SCI, V92, P671, DOI 10.3382/ps.2012-02822; Wise MG, 2007, J APPL MICROBIOL, V102, P1138, DOI 10.1111/j.1365-2672.2006.03153.x; Yegani M, 2008, POULTRY SCI, V87, P2052, DOI 10.3382/ps.2008-00091	38	77	82	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2017	12	2							e0171642	10.1371/journal.pone.0171642	http://dx.doi.org/10.1371/journal.pone.0171642			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5QV	28222110	Green Submitted, Green Published, gold			2022-12-27	WOS:000394676800016
J	Gayle, AA; Shimaoka, M				Gayle, Alberto Alexander; Shimaoka, Motomu			Evaluating the lexico-grammatical differences in the writing of native and non-native speakers of English in peer-reviewed medical journals in the field of pediatric oncology: Creation of the genuine index scoring system	PLOS ONE			English	Article							LOGISTIC-REGRESSION; BIOMEDICAL-RESEARCH; LANGUAGE; CLASSIFICATION; MACHINE	Introduction The predominance of English in scientific research has created hurdles for "non-native speakers" of English. Here we present a novel application of native language identification ( NLI) for the assessment of medical-scientific writing. For this purpose, we created a novel classification system whereby scoring would be based solely on text features found to be distinctive among native English speakers ( NS) within a given context. We dubbed this the "Genuine Index" ( GI). Methodology This methodology was validated using a small set of journals in the field of pediatric oncology. Our dataset consisted of 5,907 abstracts, representing work from 77 countries. A support vector machine ( SVM) was used to generate our model and for scoring. Results Accuracy, precision, and recall of the classification model were 93.3%, 93.7%, and 99.4%, respectively. Class specific F-scores were 96.5% for NS and 39.8% for our benchmark class, Japan. Overall kappa was calculated to be 37.2%. We found significant differences between countries with respect to the GI score. Significant correlation was found between GI scores and two validated objective measures of writing proficiency and readability. Two sets of key terms and phrases differentiating NS and non-native writing were identified. Conclusions Our GI model was able to detect, with a high degree of reliability, subtle differences between the terms and phrasing used by native and non-native speakers in peer reviewed journals, in the field of pediatric oncology. In addition, L1 language transfer was found to be very likely to survive revision, especially in non-Western countries such as Japan. These findings show that even when the language used is technically correct, there may still be some phrasing or usage that impact quality.	[Gayle, Alberto Alexander] Mie Univ, Sch Med, Ctr Med & Nursing Educ, Tsu, Mie, Japan; [Gayle, Alberto Alexander] Mie Univ, Grad Sch Med, Dept Immunol, Tsu, Mie, Japan; [Shimaoka, Motomu] Mie Univ, Grad Sch Med, Dept Mol Pathobiol & Cell Adhes Biol, Tsu, Mie, Japan; [Shimaoka, Motomu] Mie Univ, Grad Sch Med, Ctr Disaster Med Res & Educ, Tsu, Mie, Japan	Mie University; Mie University; Mie University; Mie University	Shimaoka, M (corresponding author), Mie Univ, Grad Sch Med, Dept Mol Pathobiol & Cell Adhes Biol, Tsu, Mie, Japan.; Shimaoka, M (corresponding author), Mie Univ, Grad Sch Med, Ctr Disaster Med Res & Educ, Tsu, Mie, Japan.	shimaoka@doc.medic.mie-u.ac.jp		Gayle, Alberto Alexander/0000-0002-9805-8440				Abilhoa WD, 2014, APPL MATH COMPUT, V240, P308, DOI 10.1016/j.amc.2014.04.090; Alberts B, 2014, P NATL ACAD SCI USA, V111, P5773, DOI 10.1073/pnas.1404402111; Salazar DA, 2012, REV COLOMB ESTAD, V35, P223; Ariza MA Alcaraz, 2012, ENGLISH HLTH SCI NOT; Asadi H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088225; Bellazzi R, 2008, INT J MED INFORM, V77, P81, DOI 10.1016/j.ijmedinf.2006.11.006; Ben-Hur A, 2010, METHODS MOL BIOL, V609, P223, DOI 10.1007/978-1-60327-241-4_13; Bergsma S., 2012, PROC 2012 C N AM CHA, P327; Bian J, 2014, J BIOMED INFORM, V52, P130, DOI 10.1016/j.jbi.2014.01.015; Brooke J, 2013, 20 YEARS LEARNER COR, P37; Brooke J, 2012, ROBUST LEXICALIZED N; Brooke J, 2012, LREC 2012 - EIGHTH INTERNATIONAL CONFERENCE ON LANGUAGE RESOURCES AND EVALUATION, P779; Burrough-Boenisch J, 2005, ENGL SPECIF PURP, V24, P25, DOI 10.1016/j.esp.2003.09.004; Burrough-Boenisch J, 2003, J SECOND LANG WRIT, V12, P223, DOI 10.1016/S1060-3743(03)00037-7; Butler D, 2000, NATURE, V405, P500, DOI 10.1038/35014778; Charlton BG, 2007, MED HYPOTHESES, V69, P1163, DOI 10.1016/j.mehy.2007.07.007; COLEMAN M, 1975, J APPL PSYCHOL, V60, P283, DOI 10.1037/h0076540; Daudaravicius V., LANGUAGE EDITING DAT; Diciolla M, COMPUT BIOL MED; Druss BG, 2005, J MED LIBR ASSOC, V93, P499; Gayle A, GI SCORE PUBMED DATA; Gebre B.G., 2013, P 8 WORKSHOP INNOVAT, P216; Ghasemi A, 2012, INT J ENDOCRINOL MET, V10, P486, DOI 10.5812/ijem.3505; Gholami Javad, 2015, J Tehran Heart Cent, V10, P58; Gledhill C. J., 2000, COLLOCATIONS SCI WRI; Guru DS, 2015, PROCEDIA COMPUT SCI, V45, P13, DOI 10.1016/j.procs.2015.03.074; Guyon I, 2002, MACH LEARN, V46, P389, DOI 10.1023/A:1012487302797; Ho RCM, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-74; Hygge S, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01390; Ionescu Radu Tudor, 2014, P 2014 C EMP METH NA, P1363, DOI DOI 10.3115/V1/D14-1142; Ionescu RT, 2016, COMPUT LINGUIST; Jarvis S, 2013, MAXIMIZING CLASSIFIC; Kachru Y, 2009, GLOBAL ENGLISHES IN ASIAN CONTEXTS: CURRENT AND FUTURE DEBATES, P111; Koopman B, 2015, INT J MED INFORM, V84, P956, DOI 10.1016/j.ijmedinf.2015.08.004; Koppel M, 2005, P 11 ACM SIGKDD INT, P624, DOI DOI 10.1145/1081870.1081947; Lawson C, 2015, GLOBAL MOBILITY RES, P67; Liew WT, 2014, COMPUT IND, V65, P393, DOI 10.1016/j.compind.2014.01.004; Lin HT, 2007, MACH LEARN, V68, P267, DOI 10.1007/s10994-007-5018-6; Luo J, 2013, PLOS ONE, V8; Malmasi Shervin, 2015, P 10 WORKSH INN US N, P49; Man JP, 2004, EUR J EPIDEMIOL, V19, P811; Martin-Barragan B, 2014, EUR J OPER RES, V232, P146, DOI 10.1016/j.ejor.2012.08.017; Massung S, 2015, NAT LANG ENG, P1; Meneghini R, 2007, EMBO REP, V8, P112, DOI 10.1038/sj.embor.7400906; Muller A., INT J NURS STUD; Perez-Llantada C, 2014, J ENGL ACAD PURP, V14, P84, DOI 10.1016/j.jeap.2014.01.002; Platt J.C, 1999, ADV LARGE MARGIN CLA, P61; PORTER MF, 1980, PROGRAM-AUTOM LIBR, V14, P130, DOI 10.1108/eb046814; Rezaeian M, 2015, EPIDEMIOL HEALTH, V37, DOI 10.4178/epih/e2015021; Rumsey M, 2016, INT J NURS STUD, V54, P95, DOI 10.1016/j.ijnurstu.2015.06.001; Sedding J., 2004, P 3 WORKSH ROB METH, P104, DOI [DOI 10.3115/1621445.1621458, 10.3115/1220355.1220356]; Severance SJ., 2015, P BIONLP, V15, P127, DOI [10.18653/v1/W15-3815, DOI 10.18653/V1/W15-3815]; Statnikov A., 2006, SIGN, V1, P474; STOSSEL TP, 1990, NEW ENGL J MED, V322, P739, DOI 10.1056/NEJM199003153221106; Swanson B., 2014, EACL 2014, P169; Tarone E., 2012, ENCY APPL LINGUISTIC; Tetreault J., 2012, P COLING MUMB IND, P2585; Tetreault J., 2013, P 8 WORKSH INN US NL, P48; van Gelderen A, 2011, LANG LEARN, V61, P281, DOI 10.1111/j.1467-9922.2010.00612.x; Vasconcelos SMR, 2007, BRAZ J MED BIOL RES, V40, P743, DOI 10.1590/S0100-879X2007000600001; Verplancke T, 2008, BMC MED INFORM DECIS, V8, DOI 10.1186/1472-6947-8-56; Wang H, 2010, P 16 ACM SIGKDD INT, P783, DOI DOI 10.1145/1835804.1835903; Weiss S.M., 2010, TEXT MINING PREDICTI, DOI [10.1007/978-0-387-34555-0, DOI 10.1007/978-0-387-34555-0]; White R., 1997, CROSS CULT CAP C; Yank V, 1999, ANN INTERN MED, V130, P661, DOI 10.7326/0003-4819-130-8-199904200-00013; Zawacki TM, 2014, PERSPECT WRIT, V183	66	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2017	12	2							e0172338	10.1371/journal.pone.0172338	http://dx.doi.org/10.1371/journal.pone.0172338			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL2BI	28212419	gold, Green Published, Green Submitted			2022-12-27	WOS:000394424700033
J	Hajiluian, G; Farhangi, MA; Jahangiry, L				Hajiluian, Ghazaleh; Farhangi, Mahdieh Abbasalizad; Jahangiry, Leila			Mediterranean dietary pattern and VEGF+405 G/C gene polymorphisms in patients with metabolic syndrome: An aspect of gene-nutrient interaction	PLOS ONE			English	Article							SERUM TRIGLYCERIDE RESPONSES; CORONARY-ARTERY-DISEASE; LIFE-STYLE MODIFICATION; RISK-FACTORS; IRANIAN ADULTS; FAT; CHOLESTEROL; PLASMA; FRUIT; MEN	Aims To evaluate the relationship between Mediterranean dietary pattern, anthropometric and metabolic biomarkers and vascular endothelial growth factor ( VEGF) +405 G/C gene polymorphism in patient with metabolic syndrome ( Mets). Materials and methods In this study 150 patients with Mets and 50 healthy subjects were enrolled. Dietary intakes were evaluated with a semi-quantitative food-frequency questionnaire ( FFQ) and Mediterranean dietary quality index ( Med-DQI) was assessed. Anthropometric assessments and blood pressure measurement were performed. Biochemical assays including fasting serum glucose ( FSG), matrix metalloproteinase-3 ( MMP-3), liver enzymes and lipid profiles were also assessed. Polymorphism of +405 G/C VEGF gene was determined utilizing polymerase chain reaction-restriction fragments length polymorphism ( PCR-RFLP) method. Results Serum high density lipoprotein-cholesterol ( HDL-C) was significantly lower and low density lipoprotein cholesterol ( LDL-C), triglyceride ( TG), total cholesterol ( TC) concentrations and FSG were significantly higher in metabolic syndrome patients compared with control group ( P < 0.05). Metabolic syndrome group with high consumption of "cholesterol" had significantly upper serum TG; also high consumption of "fish" and "vegetables-fruits" was associated with a significantly lower serum LDL concentrations. In metabolic syndrome patients with CC genotype, mean score of "saturated fatty acid" subgroup was significantly higher compared with other genotypes; whereas, in healthy individuals, mean score of "fruit-vegetable" subgroup in individuals of CC and GG genotype was significantly higher ( P<0.05). Conclusion Our findings indicated a significant relationship between Mediterranean dietary quality index and both anthropometric and metabolic risk factors. We also indicated a higher "saturated fatty acid" intake in CC genotype among metabolic syndrome patients.	[Hajiluian, Ghazaleh] Tabriz Univ Med Sci, Student Res Comm, Nutr Res Ctr, Fac Nutr, Tabriz, Iran; [Farhangi, Mahdieh Abbasalizad] Tabriz Univ Med Sci, Nutr Res Ctr, Drug Appl Res Ctr, Dept Community Nutr, Tabriz, Iran; [Jahangiry, Leila] Tabriz Univ Med Sci, Hlth Educ & Hlth Promot Dept, Sch Publ Hlth, Tabriz, Iran	Tabriz University of Medical Science; Tabriz University of Medical Science; Tabriz University of Medical Science	Farhangi, MA (corresponding author), Tabriz Univ Med Sci, Nutr Res Ctr, Drug Appl Res Ctr, Dept Community Nutr, Tabriz, Iran.	abbasalizad_m@yahoo.com	, ../J-9427-2017; Jahangiry, Leila/F-9880-2017; Farhangi, Mahdieh Abbasalizad/AAC-6758-2019	, ../0000-0002-0491-5764; Jahangiry, Leila/0000-0002-0491-5764; 				Aggarwal A, 2014, J CARDIOVASC THORAC, V6, P169, DOI 10.15171/jcvtr.2014.006; Aggarwal A, 2014, J CARDIOVASC THORAC, V6, P15, DOI 10.5681/jcvtr.2014.003; Azizi F, 2003, DIABETES RES CLIN PR, V61, P29, DOI 10.1016/S0168-8227(03)00066-4; Azizi F, 2010, ARCH IRAN MED, V13, P243; Barylski M, 2009, ANGIOLOGY, V60, P87, DOI 10.1177/0003319708327165; Brown L, 1999, AM J CLIN NUTR, V69, P30; Carr DB, 2004, DIABETES, V53, P2087, DOI 10.2337/diabetes.53.8.2087; Carter P, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4229; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; COHEN JC, 1988, AM J CLIN NUTR, V47, P825, DOI 10.1093/ajcn/47.5.825; Delavar MA, 2009, ASIA PAC J CLIN NUTR, V18, P285; Esfahani FH, 2010, J EPIDEMIOL, V20, P150, DOI 10.2188/jea.JE20090083; Esposito K, 2007, MOL NUTR FOOD RES, V51, P1268, DOI 10.1002/mnfr.200600297; Esteghamati A, 2009, DIABETIC MED, V26, P745, DOI 10.1111/j.1464-5491.2009.02756.x; Farhangi MA, ORCP 2015; Farhangi MA, 2015, INT J DIABETES DEV C, P1; Farzi A, 2014, ASS VASCULAR ENDOTHE, V8, P122; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Georgoulis M, 2015, J HUM NUTR DIET, V28, P409, DOI 10.1111/jhn.12323; Gerber M, 2001, J NUTR, V131, p3051S, DOI 10.1093/jn/131.11.3051S; Gerber MJ, 2000, J AM DIET ASSOC, V100, P1164, DOI 10.1016/S0002-8223(00)00340-0; Grundy SM, 2004, CIRCULATION, V109, P433, DOI 10.1161/01.CIR.0000111245.75752.C6; He K, 2004, INT J OBESITY, V28, P1569, DOI 10.1038/sj.ijo.0802795; Jacobs B, 2004, J NUTR, V134, P1400, DOI 10.1093/jn/134.6.1400; Jahangiry L, 2014, BMC PUBLIC HEALTH, V14, P1; Loktionov A, 2003, J NUTR BIOCHEM, V14, P426, DOI 10.1016/S0955-2863(03)00032-9; Mirmiran P, 2009, METABOLISM, V58, P460, DOI 10.1016/j.metabol.2008.11.002; Mohseni T, 2016, CURR TOP NUTRACEUT R, V14, P49; Moradzadegan A, 2015, J RENIN-ANGIO-ALDO S, V16, P672, DOI 10.1177/1470320313497819; Nunez-Cordoba JM, 2009, AM J EPIDEMIOL, V169, P339, DOI 10.1093/aje/kwn335; PHILLIPSON BE, 1985, NEW ENGL J MED, V312, P1210, DOI 10.1056/NEJM198505093121902; Reaven G, 2002, CIRCULATION, V106, P286, DOI 10.1161/01.CIR.0000019884.36724.D9; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595; Romaguera D, 2009, J NUTR, V139, P1728, DOI 10.3945/jn.109.108902; Takahashi MM, 2010, ARCH LATINOAM NUTR, V60, P148; Tur JA, 2005, BRIT J NUTR, V93, P369, DOI 10.1079/BJN20041363; Tzima N, 2007, LIPIDS HEALTH DIS, V6, DOI 10.1186/1476-511X-6-22; Williams DEM, 2000, BRIT J NUTR, V83, P257, DOI 10.1017/S0007114500000337; Yamaoka K, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-138; Yolanda BL, 2006, J NUTR BIOCH, V17, P1, DOI DOI 10.1016/J.JNUTBI0.2005.08.002; Zabetian A, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-138	41	7	7	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2017	12	2							e0171637	10.1371/journal.pone.0171637	http://dx.doi.org/10.1371/journal.pone.0171637			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BI	28212431	Green Published, gold, Green Submitted			2022-12-27	WOS:000394424700009
J	Qiao, WQ; Pan, LL; Kou, CG; Li, K; Yang, M				Qiao, Weiqiang; Pan, Linlin; Kou, Changgui; Li, Ke; Yang, Ming			Prognostic and clinicopathological value of poly (adenosine diphosphate-ribose) polymerase expression in breast cancer: A meta-analysis	PLOS ONE			English	Article							PATHOLOGICAL COMPLETE RESPONSE; NEOADJUVANT THERAPY; CHEMOTHERAPY; PARP-1; GEMCITABINE; CARBOPLATIN; INHIBITORS; INIPARIB	Background Previous studies have shown that the poly (adenosine diphosphate-ribose) polymerase (PARP) level is a promising indicator of breast cancer. However, its prognostic value remains controversial. The present meta-analysis evaluated the prognostic value of PARP expression in breast cancer. Materials and methods Eligible studies were retrieved from the PubMed, Web of Science, Embase, and Cochrane Library databases through July 20, 2016. Studies investigating PARP expression as well as reporting survival data in breast cancer were included. Two independent reviewers carried out all literature searches. The pooled relative risk (RR) and hazard ratio (HR) with 95% confidence interval (95% CI) were applied to assess the association between PARP expression and the clinicopathological features and survival outcome in breast cancer. Results A total of 3506 patients from eight eligible studies were included. We found that higher PARP expression indicated a worse clinical outcome in early stage breast cancer, with a HR of 3.08 (95% CI, 1.14-8.29, P = 0.03) for disease-free survival and a HR of 1.82 (95% CI, 1.20-2.76; P = 0.005) for overall survival. Moreover, increased PARP expression was significantly associated with higher nuclear grade (RR, 1.51; 95% CI, 1.12-2.04; P = 0.008) in breast cancer. A similar correlation was detected in triple-negative breast cancer (TNBC; RR, 1.81; 95% CI, 1.04-3.17; P = 0.04). Conclusions Our findings indicated that elevated PARP expression correlated with worse prognosis in early stage breast cancer. Furthermore, high PARP expression was associated with higher nuclear grade and TNBC.	[Qiao, Weiqiang; Pan, Linlin; Yang, Ming] Jilin Univ, Hosp 1, Dept Breast Surg, Changchun, Peoples R China; [Kou, Changgui] Jilin Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Changchun, Peoples R China; [Li, Ke] Jilin Univ, Hosp 1, Dept Emergency, Changchun, Peoples R China	Jilin University; Jilin University; Jilin University	Yang, M (corresponding author), Jilin Univ, Hosp 1, Dept Breast Surg, Changchun, Peoples R China.	yangming196701@163.com		Pan, Linlin/0000-0002-5909-0309; Qiao, Weiqiang/0000-0003-4178-4617	Science and Technology Development Project of Jilin Province [20150312033ZG]	Science and Technology Development Project of Jilin Province	This work was supported by the Science and Technology Development Project of Jilin Province: NO. 20150312033ZG (http://www.jlkjxm.com/). The funders had no role in the study design, data collection and analysis, decision to publish,or preparation of the manuscript.	Aiad HA, 2015, APPL IMMUNOHISTO M M, V23, P571, DOI 10.1097/PAI.0000000000000124; Ame JC, 2004, BIOESSAYS, V26, P882, DOI 10.1002/bies.20085; Bao ZQ, 2016, ONCOTARGET, V7, P7629, DOI 10.18632/oncotarget.5367; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Berruti A, 2014, J CLIN ONCOL, V32, P3883, DOI 10.1200/JCO.2014.55.2836; Broglio KR, 2016, JAMA ONCOL, V2, P751, DOI 10.1001/jamaoncol.2015.6113; Cleator S, 2007, LANCET ONCOL, V8, P235, DOI 10.1016/S1470-2045(07)70074-8; Comen EA, 2010, CANCER J, V16, P48, DOI 10.1097/PPO.0b013e3181cf01eb; Cortazar P, 2014, LANCET, V384, P164, DOI 10.1016/S0140-6736(13)62422-8; DerSimonian R, 2015, CONTEMP CLIN TRIALS, V45, P139, DOI 10.1016/j.cct.2015.09.002; Donizy P, 2014, ONCOL REP, V31, P1777, DOI 10.3892/or.2014.3024; Foulkes WD, 2010, NEW ENGL J MED, V363, P1938, DOI 10.1056/NEJMra1001389; Gilabert M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104302; Goldhirsch A, 2013, ANN ONCOL, V24, P2206, DOI 10.1093/annonc/mdt303; Goncalves A, 2011, BREAST CANCER RES TR, V127, P273, DOI 10.1007/s10549-010-1199-y; Gralow JR, 2008, J CLIN ONCOL, V26, P814, DOI 10.1200/JCO.2007.15.3510; Green AR, 2015, BREAST CANCER RES TR, V149, P353, DOI 10.1007/s10549-014-3230-1; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Kong XN, 2011, EUR J CANCER, V47, P2084, DOI 10.1016/j.ejca.2011.06.014; Lee YCG, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005269; Legrand AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055883; Mazzotta A, 2016, TUMOR BIOL, V37, P6143, DOI 10.1007/s13277-015-4465-0; Metzger O, 2012, J CLIN ONCOL, V30, P1879, DOI 10.1200/JCO.2011.38.2010; O'Shaughnessy J, 2014, J CLIN ONCOL, V32, P3840, DOI 10.1200/JCO.2014.55.2984; O'Shaughnessy J, 2011, NEW ENGL J MED, V364, P205, DOI 10.1056/NEJMoa1011418; Rojo F, 2012, ANN ONCOL, V23, P1156, DOI 10.1093/annonc/mdr361; Rouleau M, 2010, NAT REV CANCER, V10, P293, DOI 10.1038/nrc2812; Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z; Telli ML, 2015, J CLIN ONCOL, V33, P1895, DOI 10.1200/JCO.2014.57.0085; Tian MY, 2015, ONCOL LETT, V9, P2825, DOI 10.3892/ol.2015.3072; Tierney JF, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-16; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; von Minckwitz G, 2011, J CLIN ONCOL, V29, P2150, DOI 10.1200/JCO.2010.31.9079; Zhai LL, 2015, PATHOL RES PRACT, V211, P130, DOI 10.1016/j.prp.2014.11.004	34	7	7	4	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2017	12	2							e0172413	10.1371/journal.pone.0172413	http://dx.doi.org/10.1371/journal.pone.0172413			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BI	28212434	gold, Green Published, Green Submitted			2022-12-27	WOS:000394424700045
J	Boeck, JM; Spencer, JV				Boeck, Jordan M.; Spencer, Juliet V.			Effect of human cytomegalovirus (HCMV) US27 on CXCR4 receptor internalization measured by fluorogen-activating protein (FAP) biosensors	PLOS ONE			English	Article							REFLECTION FLUORESCENCE MICROSCOPY; THROUGHPUT FLOW-CYTOMETRY; ENVELOPED VIRUS-PARTICLES; CELL-SURFACE PROTEINS; CHEMOKINE RECEPTOR; COUPLED RECEPTOR; CONGENITAL CYTOMEGALOVIRUS; VACCINE DEVELOPMENT; INFECTED-CELLS; WHIM-SYNDROME	Human cytomegalovirus (HCMV) is a widespread pathogen and a member of the Herpesviridae family. HCMV has a large genome that encodes many genes that are non-essential for virus replication but instead play roles in manipulation of the host immune environment. One of these is the US27 gene, which encodes a protein with homology to the chemokine receptor family of G protein-coupled receptors (GPCRs). The US27 protein has no known chemokine ligands but can modulate the signaling activity of host receptor CXCR4. We investigated the mechanism for enhanced CXCR4 signaling in the presence of US27 using a novel biosensor system comprised of fluorogen activating proteins (FAPs). FAP-tagged CXCR4 and US27 were used to explore receptor internalization and recovery dynamics, and the results demonstrate that significantly more CXCR4 internalization was observed in the presence of US27 compared to CXCR4 alone upon stimulation with CXCL12. While ligand-induced endocytosis rates were higher, steady state internalization of CXCR4 was not affected by US27. Additionally, US27 underwent rapid endocytosis at a rate that was independent of either CXCR4 expression or CXCL12 stimulation. These results demonstrate that one mechanism by which US27 can enhance CXCR4 signaling is to alter receptor internalization dynamics, which could ultimately have the effect of promoting virus dissemination by increasing trafficking of HCMV-infected cells to tissues where CXCL12 is highly expressed.	[Boeck, Jordan M.; Spencer, Juliet V.] Univ San Francisco, Dept Biol, San Francisco, CA 94117 USA	University of San Francisco	Spencer, JV (corresponding author), Univ San Francisco, Dept Biol, San Francisco, CA 94117 USA.	jspencer@usfca.edu			NIH [AI111232]; USF Faculty Development funds; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R15AI111232] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USF Faculty Development funds; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by NIH grant AI111232 and USF Faculty Development funds (to JVS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arav-Boger R, 2006, J INFECT DIS, V193, P788, DOI 10.1086/500508; Arnolds KL, 2013, VIROLOGY, V439, P122, DOI 10.1016/j.virol.2013.02.006; Arvin AM, 2004, CLIN INFECT DIS, V39, P233, DOI 10.1086/421999; Axelrod D, 2001, TRAFFIC, V2, P764, DOI 10.1034/j.1600-0854.2001.21104.x; Balabanian K, 2005, BLOOD, V105, P2449, DOI 10.1182/blood-2004-06-2289; Beisser PS, 1999, J VIROL, V73, P7218, DOI 10.1128/JVI.73.9.7218-7230.1999; Bodaghi B, 1998, J EXP MED, V188, P855, DOI 10.1084/jem.188.5.855; Bradley AJ, 2008, J MED VIROL, V80, P1615, DOI 10.1002/jmv.21241; Busillo JM, 2007, BBA-BIOMEMBRANES, V1768, P952, DOI 10.1016/j.bbamem.2006.11.002; Cannon MJ, 2010, REV MED VIROL, V20, P202, DOI 10.1002/rmv.655; Cardin RD, 2009, J VIROL, V83, P7590, DOI 10.1128/JVI.00386-09; CHEE MS, 1990, CURR TOP MICROBIOL, V154, P125; CHEE MS, 1990, NATURE, V344, P774, DOI 10.1038/344774a0; Chow KYC, 2010, CELL HOST MICROBE, V8, P523, DOI 10.1016/j.chom.2010.11.006; Cojoc Monica, 2013, Onco Targets Ther, V6, P1347, DOI 10.2147/OTT.S36109; Deere JD, 2014, VIRUSES-BASEL, V6, P1483, DOI 10.3390/v6041483; Dunn W, 2003, P NATL ACAD SCI USA, V100, P14223, DOI 10.1073/pnas.2334032100; Farrell HE, 2011, J VIROL, V85, P6091, DOI 10.1128/JVI.02113-10; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; Fisher GW, 2014, J BIOMOL SCREEN, V19, P1220, DOI 10.1177/1087057114534299; Fisher GW, 2010, J BIOMOL SCREEN, V15, P703, DOI 10.1177/1087057110370892; Fraile-Ramos A, 2002, TRAFFIC, V3, P218, DOI 10.1034/j.1600-0854.2002.030307.x; Fraile-Ramos A, 2001, MOL BIOL CELL, V12, P1737, DOI 10.1091/mbc.12.6.1737; Frascaroli G, 2006, J VIROL, V80, P7578, DOI 10.1128/JVI.02421-05; Frascaroli G, 2009, J IMMUNOL, V182, P477, DOI 10.4049/jimmunol.182.1.477; GAO JL, 1994, J BIOL CHEM, V269, P28539; Goodrum F, 2012, CELL MICROBIOL, V14, P644, DOI 10.1111/j.1462-5822.2012.01774.x; Griffiths PD, 2012, LANCET INFECT DIS, V12, P790, DOI 10.1016/S1473-3099(12)70197-4; Gruijthuijsen YK, 2002, J VIROL, V76, P1328, DOI 10.1128/JVI.76.3.1328-1338.2002; Gulino AV, 2003, CURR OPIN ALLERGY CL, V3, P443, DOI 10.1097/01.all.0000104449.09202.d8; HANSHAW JB, 1971, J INFECT DIS, V123, P555, DOI 10.1093/infdis/123.5.555; Heo JH, 2008, VIROLOGY, V378, P86, DOI 10.1016/j.virol.2008.05.002; Hernandez PA, 2003, NAT GENET, V34, P70, DOI 10.1038/ng1149; Holleran J, 2010, CYTOM PART A, V77A, P776, DOI 10.1002/cyto.a.20925; Houlihan CF, 2012, AIDS, V26, P2211, DOI 10.1097/QAD.0b013e328358d908; Kledal TN, 1998, FEBS LETT, V441, P209, DOI 10.1016/S0014-5793(98)01551-8; KUHN DE, 1995, BIOCHEM BIOPH RES CO, V211, P325, DOI 10.1006/bbrc.1995.1814; Manicklal S, 2013, CLIN MICROBIOL REV, V26, P86, DOI 10.1128/CMR.00062-12; Margulies BJ, 2007, VIRUS RES, V123, P57, DOI 10.1016/j.virusres.2006.08.003; Margulies BJ, 1996, VIROLOGY, V225, P111, DOI 10.1006/viro.1996.0579; McSharry BP, 2012, VIRUSES-BASEL, V4, P2448, DOI 10.3390/v4112448; Millis BA, 2012, METHODS MOL BIOL, V823, P295, DOI 10.1007/978-1-60327-216-2_19; Murphy E, 2003, P NATL ACAD SCI USA, V100, P14976, DOI 10.1073/pnas.2136652100; O'Connor CM, 2011, J VIROL, V85, P3700, DOI 10.1128/JVI.02442-10; Oliveira SA, 2001, P NATL ACAD SCI USA, V98, P3237, DOI 10.1073/pnas.051629898; Penfold MET, 1999, P NATL ACAD SCI USA, V96, P9839, DOI 10.1073/pnas.96.17.9839; Reinhardt B, 2014, CARDIOVASC RES, V104, P315, DOI 10.1093/cvr/cvu204; Saunders MJ, 2012, METHODS, V57, P308, DOI 10.1016/j.ymeth.2012.02.003; Sinclair J, 2006, J GEN VIROL, V87, P1763, DOI 10.1099/vir.0.81891-0; Sinzger C, 2008, CURR TOP MICROBIOL, V325, P63; Smith MS, 2004, J VIROL, V78, P4444, DOI 10.1128/JVI.78.9.4444-4453.2004; Spector SA, 1999, J VIROL, V73, P7027, DOI 10.1128/JVI.73.8.7027-7030.1999; Stapleton LK, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-42; Szent-Gyorgyi C, 2008, NAT BIOTECHNOL, V26, P235, DOI 10.1038/nbt1368; Tachibana K, 1998, NATURE, V393, P591, DOI 10.1038/31261; Tadagaki K, 2012, BLOOD, V119, P4908, DOI 10.1182/blood-2011-08-372516; Teicher BA, 2010, CLIN CANCER RES, V16, P2927, DOI 10.1158/1078-0432.CCR-09-2329; Tschische P, 2011, BIOCHEM PHARMACOL, V82, P610, DOI 10.1016/j.bcp.2011.06.009; Varani S, 2005, J LEUKOCYTE BIOL, V77, P219, DOI 10.1189/jlb.0504301; Varnum SM, 2004, J VIROL, V78, P10960, DOI 10.1128/JVI.78.20.10960-10966.2004; Waldhoer M, 2002, J VIROL, V76, P8161, DOI 10.1128/JVI.76.16.8161-8168.2002; Warner JA, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-255; Wu Y, 2013, CYTOM PART A, V83A, P220, DOI 10.1002/cyto.a.22242; Wu Y, 2012, MOL PHARMACOL, V82, P645, DOI 10.1124/mol.112.079897	64	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0172042	10.1371/journal.pone.0172042	http://dx.doi.org/10.1371/journal.pone.0172042			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207860	Green Published, gold, Green Submitted			2022-12-27	WOS:000394424500077
J	Daniels, MN; Maynard, S; Porter, I; Kincaid, H; Jain, D; Aslam, N				Daniels, Michael N.; Maynard, Sharon; Porter, Ivan; Kincaid, Hope; Jain, Deepika; Aslam, Nabeel			Career interest and perceptions of nephrology: A repeated cross-sectional survey of internal medicine residents	PLOS ONE			English	Article							FELLOWS	Background Interest in nephrology careers among internal medicine residents in the United States is declining. Our objective was to assess the impact of the presence of a nephrology fellowship training program on perceptions and career interest in nephrology among internal medicine residents. A secondary objective was to identify commonly endorsed negative perceptions of nephrology among internal medicine residents. Methods This was a repeated cross-sectional survey of internal medicine residents before (Group 1) and 3 years after (Group 2) the establishment of nephrology fellowship programs at two institutions. The primary outcome was the percentage of residents indicating nephrology as a career interest in Group 1 vs. Group 2. Secondary outcomes included the frequency that residents agreed with negative statements about nephrology. Results 131 (80.9%) of 162 residents completed the survey. 19 (14.8%) residents indicated interest in a nephrology career, with 8 (6.3%) indicating nephrology as their first choice. There was no difference in career interest in nephrology between residents who were exposed to nephrology fellows during residency training (Group 2) and residents who were not (Group 1). The most commonly endorsed negative perceptions of nephrology were: nephrology fellows have long hours/burdensome call (36 [28.1%] of residents agreed or strongly agreed), practicing nephrologists must take frequent/difficult call (35 [27.6%] agreed or strongly agreed), and nephrology has few opportunities for procedures (35 [27.3%] agreed or strongly agreed). More residents in Group 2 agreed that nephrology is poorly paid (8.9% in Group 1 vs. 20.8% in Group 2, P = 0.04), whereas more residents in Group 1 agreed that nephrologists must take frequent/difficult call (40.0% in Group 1 vs. 18.1% in Group 2, P = 0.02). Conclusions The initiation of a nephrology fellowship program was not associated with an increase in internal medicine residents' interest in nephrology careers. Residents endorsed several negative perceptions of nephrology, which may affect career choice.	[Daniels, Michael N.; Maynard, Sharon; Jain, Deepika] Lehigh Valley Hlth Network, Dept Med, Allentown, PA USA; [Porter, Ivan; Aslam, Nabeel] Mayo Clin, Coll Med, Dept Med, Jacksonville, FL 32224 USA; [Kincaid, Hope] Lehigh Valley Hlth Network, Network Off Res & Innovat, Allentown, PA USA	Lehigh Valley Health Network; Mayo Clinic; Lehigh Valley Health Network	Aslam, N (corresponding author), Mayo Clin, Coll Med, Dept Med, Jacksonville, FL 32224 USA.	aslam.nabeel@mayo.edu	Barretti, Pasqual/K-4156-2012	Barretti, Pasqual/0000-0003-4979-4836				Adams ND, 2012, CLIN J AM SOC NEPHRO, V7, P1382, DOI 10.2215/CJN.07600712; Areephanthu CJ, 2015, CTS-CLIN TRANSL SCI, V8, P479, DOI 10.1111/cts.12289; Cohn DE, 2008, INT J GYNECOL CANCER, V18, P199, DOI 10.1111/j.1525-1438.2007.00986.x; Hoenig MP, 2015, AM J KIDNEY DIS, V66, P28, DOI 10.1053/j.ajkd.2015.03.027; Horn L, 2008, BMC MED EDUC, V8, DOI 10.1186/1472-6920-8-37; Jhaveri KD, 2013, ADV CHRONIC KIDNEY D, V20, P336, DOI 10.1053/j.ackd.2013.03.006; Jhaveri KD, 2013, AM J KIDNEY DIS, V61, P540, DOI 10.1053/j.ajkd.2012.10.025; Lane CA, 2008, NEPHROLOGY, V13, P116, DOI 10.1111/j.1440-1797.2007.00887.x; Lorin S, 2005, CHEST, V127, P630, DOI 10.1378/chest.127.2.630; Parker MG, 2013, ADV CHRONIC KIDNEY D, V20, P326, DOI 10.1053/j.ackd.2013.03.004; Parker MG, 2011, CLIN J AM SOC NEPHRO, V6, P1501, DOI 10.2215/CJN.01290211; Shah HH, 2012, CLIN J AM SOC NEPHRO, V7, P1513, DOI 10.2215/CJN.01620212; The American Medical Group Association's, 2014, MED GROUP COMP FIN S; The New England Journal of Medicine, 2014, NEW ENGLAND J MED	14	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0172167	10.1371/journal.pone.0172167	http://dx.doi.org/10.1371/journal.pone.0172167			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207893	Green Submitted, gold, Green Published			2022-12-27	WOS:000394424500092
J	Hulo, C; Masson, P; de Castro, E; Auchincloss, AH; Foulger, R; Poux, S; Lomax, J; Bougueleret, L; Xenarios, I; Le Mercier, P				Hulo, Chantal; Masson, Patrick; de Castro, Edouard; Auchincloss, Andrea H.; Foulger, Rebecca; Poux, Sylvain; Lomax, Jane; Bougueleret, Lydie; Xenarios, Ioannis; Le Mercier, Philippe			The ins and outs of eukaryotic viruses: Knowledge base and ontology of a viral infection	PLOS ONE			English	Article							STRANDED-RNA VIRUSES; DNA-REPLICATION; TRANSLATIONAL TERMINATION; GENE ONTOLOGY; ENTRY; INFLUENZA; CELLS; TRANSCRIPTION; MICROTUBULES; TRAFFICKING	Viruses are genetically diverse, infect a wide range of tissues and host cells and follow unique processes for replicating themselves. All these processes were investigated and indexed in ViralZone knowledge base. To facilitate standardizing data, a simple ontology of viral life cycle terms was developed to provide a common vocabulary for annotating data sets. New terminology was developed to address unique viral replication cycle processes, and existing terminology was modified and adapted. The virus life-cycle is classically described by schematic pictures. Using this ontology, it can be represented by a combination of successive terms: "entry", "latency", "transcription", "replication" and "exit". Each of these parts is broken down into discrete steps. For example Zika virus "entry" is broken down in successive steps: "Attachment", "Apoptotic mimicry", "Viral endocytosis/macropinocytosis", "Fusion with host endosomal membrane", "Viral factory". To demonstrate the utility of a standard ontology for virus biology, this work was completed by annotating virus data in the ViralZone, UniProtKB and Gene Ontology databases.	[Hulo, Chantal; Masson, Patrick; de Castro, Edouard; Auchincloss, Andrea H.; Poux, Sylvain; Bougueleret, Lydie; Xenarios, Ioannis; Le Mercier, Philippe] Univ Geneva, Sch Med, CMU, SIB Swiss Inst Bioinformat, Geneva, Switzerland; [Foulger, Rebecca; Lomax, Jane] European Bioinformat Inst EMBL EBI, European Mol Biol Lab, Wellcome Trust Genome Campus, Hinxton, England	Swiss Institute of Bioinformatics; University of Geneva; European Molecular Biology Laboratory (EMBL); Wellcome Trust Sanger Institute	Le Mercier, P (corresponding author), Univ Geneva, Sch Med, CMU, SIB Swiss Inst Bioinformat, Geneva, Switzerland.	philippe.lemercier@isb-sib.ch	Lomax, Jane/H-2788-2019; Xenarios, Ioannis/ABD-5045-2021	Lomax, Jane/0000-0001-8865-4321; Xenarios, Ioannis/0000-0002-3413-6841; de Castro, Edouard/0000-0001-5436-7383; Le Mercier, Philippe/0000-0001-8528-090X; Foulger, Rebecca/0000-0001-8682-8754; Poux, Sylvain/0000-0001-7299-6685; Masson, Patrick/0000-0001-7646-0052	Swiss Federal Government through the State Secretariat for Education, Research and Innovation SERI; National Institute of General Medical Sciences (NIGMS) [U41HG007822]; Swiss National Science Foundation (SNSF) [IZLSZ3_148802]; National Institutes of Health (NIH); National Human Genome Research Institute (NHGRI)	Swiss Federal Government through the State Secretariat for Education, Research and Innovation SERI; National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	The Swiss-Prot group is part of the SIB Swiss Institute of Bioinformatics and of the UniProt Consortium. Swiss-Prot group activities are supported by the Swiss Federal Government through the State Secretariat for Education, Research and Innovation SERI, the National Institutes of Health (NIH), National Human Genome Research Institute (NHGRI) and National Institute of General Medical Sciences (NIGMS) grant U41HG007822 and the Swiss National Science Foundation (SNSF) grant IZLSZ3_148802.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; BALTIMORE D, 1971, BACTERIOL REV, V35, P235, DOI 10.1128/MMBR.35.3.235-241.1971; Balvay L, 2009, BBA-GENE REGUL MECH, V1789, P542, DOI 10.1016/j.bbagrm.2009.07.005; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Boehmer PE, 1997, ANNU REV BIOCHEM, V66, P347, DOI 10.1146/annurev.biochem.66.1.347; Brandes N, 2016, BIOL DIRECT, V11, DOI 10.1186/s13062-016-0128-3; CALLAHAN L, 1994, AIDS RES HUM RETROV, V10, P231, DOI 10.1089/aid.1994.10.231; Cheung AK, 2012, VIRUS RES, V164, P46, DOI 10.1016/j.virusres.2011.10.012; Coenen A, 1997, GENET RES, V69, P1, DOI 10.1017/S001667239600256X; Cros JF, 2003, VIRUS RES, V95, P3, DOI 10.1016/S0168-1702(03)00159-X; de Felipe Pablo, 2004, Genet Vaccines Ther, V2, P13, DOI 10.1186/1479-0556-2-13; Decroly E, 2012, NAT REV MICROBIOL, V10, P51, DOI 10.1038/nrmicro2675; Farabaugh PJ, 1996, MICROBIOL REV, V60, P103, DOI 10.1128/MMBR.60.1.103-134.1996; Fodor E, 2013, ACTA VIROL, V57, P113, DOI 10.4149/av_2013_02_113; Foulger RE, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0481-x; Ghazal P, 2000, IMMUNOL RES, V21, P219, DOI 10.1385/IR:21:2-3:219; Goff SP, 2004, CELL CYCLE, V3, P123; Grove J, 2011, J CELL BIOL, V195, P1071, DOI 10.1083/jcb.201108131; Hausmann S, 1999, J VIROL, V73, P5568, DOI 10.1128/JVI.73.7.5568-5576.1999; Helenius A, 2013, CURR OPIN VIROL, V3, P1, DOI 10.1016/j.coviro.2013.01.003; Hogle JM, 2002, ANNU REV MICROBIOL, V56, P677, DOI 10.1146/annurev.micro.56.012302.160757; Howard AR, 2012, J VIROL, V86, P5905, DOI 10.1128/JVI.06997-11; Hu Wei-Shau, 2012, Cold Spring Harb Perspect Med, V2, DOI 10.1101/cshperspect.a006882; Huang J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164787; Hulo C, 2011, NUCLEIC ACIDS RES, V39, pD576, DOI 10.1093/nar/gkq901; Johnson DC, 2011, NAT REV MICROBIOL, V9, P382, DOI 10.1038/nrmicro2559; Kadaja M, 2009, VIROLOGY, V384, P360, DOI 10.1016/j.virol.2008.11.032; Kobiler O, 2012, NUCLEUS-PHILA, V3, P526, DOI 10.4161/nucl.21979; Kolakofsky D, 2005, J GEN VIROL, V86, P1869, DOI 10.1099/vir.0.80986-0; Koonin EV, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-29; Kozak M, 1999, GENE, V234, P187, DOI 10.1016/S0378-1119(99)00210-3; Leopold PL, 2006, TRAFFIC, V7, P516, DOI 10.1111/j.1600-0854.2006.00408.x; Liu H, 2003, CURR TOP MICROBIOL, V272, P131; Masson P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108075; Mattei S, 2016, CURR OPIN VIROL, V18, P27, DOI 10.1016/j.coviro.2016.02.008; McDonald B, 2009, J CELL SCI, V122, P2167, DOI 10.1242/jcs.028308; Mercer J, 2010, ANN NY ACAD SCI, V1209, P49, DOI 10.1111/j.1749-6632.2010.05772.x; Mercer J, 2010, ANNU REV BIOCHEM, V79, P803, DOI 10.1146/annurev-biochem-060208-104626; Mettenleiter TC, 2006, CURR OPIN MICROBIOL, V9, P423, DOI 10.1016/j.mib.2006.06.013; Mhamdi M, 2007, HEPATOLOGY, V46, P95, DOI 10.1002/hep.21666; Moss B., 2013, COLD SPRING HARB PER, V5; Netherton CL, 2011, CURR OPIN VIROL, V1, P381, DOI 10.1016/j.coviro.2011.09.008; Niehl A, 2011, PROTOPLASMA, V248, P75, DOI 10.1007/s00709-010-0246-1; Onfelt Bjorn, 2005, Sci STKE, V2005, ppe55, DOI 10.1126/stke.3132005pe55; Ortin J, 2015, VIROLOGY, V479, P532, DOI 10.1016/j.virol.2015.03.018; Powell ML, 2008, BIOCHEM SOC T, V36, P717, DOI 10.1042/BST0360717; Raghava S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002116; Rossman JS, 2010, CELL, V142, P902, DOI 10.1016/j.cell.2010.08.029; Schudt G., 2015, J INFECT DIS; Schudt G, 2013, P NATL ACAD SCI USA, V110, P14402, DOI 10.1073/pnas.1307681110; Shulla A, 2016, CURR OPIN MICROBIOL, V32, P82, DOI 10.1016/j.mib.2016.05.003; Stanley MA, 2012, CLIN MICROBIOL REV, V25, P215, DOI 10.1128/CMR.05028-11; Sureau C, 2016, J HEPATOL, V64, pS102, DOI 10.1016/j.jhep.2016.02.013; The Gene Ontology: enhancements for, 2011, NUCLEIC ACIDS RES, V40, pD559, DOI [10.1093/nar/gkr1028, DOI 10.1093/NAR/GKR1028]; Trask SD, 2012, NAT REV MICROBIOL, V10, P165, DOI 10.1038/nrmicro2673; Ward BM, 2011, VIROLOGY, V411, P244, DOI 10.1016/j.virol.2010.12.024; Weissenhorn W, 2007, FEBS LETT, V581, P2150, DOI 10.1016/j.febslet.2007.01.093; White JM, 2016, TRAFFIC, V17, P593, DOI 10.1111/tra.12389	58	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0171746	10.1371/journal.pone.0171746	http://dx.doi.org/10.1371/journal.pone.0171746			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207819	Green Submitted, Green Published, gold			2022-12-27	WOS:000394424500050
J	Lin, SF; Lin, JD; Hsueh, C; Chou, TC; Wong, RJ				Lin, Shu-Fu; Lin, Jen-Der; Hsueh, Chuen; Chou, Ting-Chao; Wong, Richard J.			A cyclin-dependent kinase inhibitor, dinaciclib in preclinical treatment models of thyroid cancer	PLOS ONE			English	Article							AURORA-A KINASE; CELL-LINES; SCH 727965; DRUG DISCOVERY; CARCINOMA; SURVIVIN; TRIAL; CDK5	Background We explored the therapeutic effects of dinaciclib, a cyclin-dependent kinase (CDK) inhibitor, in the treatment of thyroid cancer. Materials and methods Seven cell lines originating from three pathologic types of thyroid cancer (papillary, follicular and anaplastic) were studied. The cytotoxicity of dinaciclib was measured using a lactate dehydrogenase assay. The expression of proteins associated with cell cycle and apoptosis was assessed using Western blot analysis and immunofluorescence microscopy. Cell cycle distribution was measured by flow cytometry and immunofluorescence microscopy. Apoptosis and caspase-3 activity were measured by flow cytometry and fluorometric assay. Mice bearing flank anaplastic thyroid cancer (ATC) were treated with intraperitoneal injections of dinaciclib. Results Dinaciclib inhibited thyroid cancer cell proliferation in a dose-dependent manner. Dinaciclib had a low median-effect dose (<= 16.0 nM) to inhibit cell proliferation in seven thyroid cancer cell lines. Dinaciclib decreased CDK1, cyclin B1, and Aurora A expression, induced cell cycle arrest in the G2/M phase, and induced accumulation of prophase mitotic cells. Dinaciclib decreased Mcl-1, Bcl-x(L) and survivin expression, activated caspase-3 and induced apoptosis. In vivo, the growth of ATC xenograft tumors was retarded in a dose-dependent fashion with daily dinaciclib treatment. Higher-dose dinaciclib (50 mg/kg) caused slight, but significant weight loss, which was absent with lower-dose dinaciclib (40 mg/kg) treatment. Conclusions Dinaciclib inhibited thyroid cancer proliferation both in vitro and in vivo. These findings support dinaciclib as a potential drug for further studies in clinical trials for the treatment of patients with refractory thyroid cancer.	[Lin, Shu-Fu; Lin, Jen-Der] Chang Gung Univ, Chang Gung Mem Hosp, Dept Internal Med, Taoyuan, Taiwan; [Hsueh, Chuen] Chang Gung Univ, Chang Gung Mem Hosp, Dept Pathol, Taoyuan, Taiwan; [Chou, Ting-Chao] Mem Sloan Kettering Canc Ctr, Lab Preclin Pharmacol Core, 1275 York Ave, New York, NY 10021 USA; [Wong, Richard J.] Mem Sloan Kettering Canc Ctr, Dept Surg, 1275 York Ave, New York, NY 10021 USA; [Chou, Ting-Chao] PD Sci Inc, Paramus, NY USA	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Lin, SF (corresponding author), Chang Gung Univ, Chang Gung Mem Hosp, Dept Internal Med, Taoyuan, Taiwan.	mmg@cgmh.org.tw	Chou, Ting-Chao/B-4111-2009; Chou, Ting-Chao/AAA-7881-2020	Chou, Ting-Chao/0000-0002-3340-1594; Chou, Ting-Chao/0000-0002-3340-1594; Lin, Shu-Fu/0000-0001-8877-9685; Hsueh, Chuen/0000-0001-7860-5964	Chang Gung Memorial Hospital and Chang Gung University [CMRPG3E0351, CMRPG3E0352, CMRPG3E0353]; Ministry of Science and Technology of Taiwan [NSC 102-2314-B-182A-011-MY3]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	Chang Gung Memorial Hospital and Chang Gung University; Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Chang Gung Memorial Hospital and Chang Gung University (CMRPG3E0351, CMRPG3E0352 and CMRPG3E0353) and partly by the Ministry of Science and Technology of Taiwan (NSC 102-2314-B-182A-011-MY3) [https://www.cgmh.org.tw/]; [https://www.most.gov.tw/].	Ain KB, 2000, THYROID, V10, P587, DOI 10.1089/thy.2000.10.587; Altieri DC, 2008, NAT REV CANCER, V8, P61, DOI 10.1038/nrc2293; Altieri DC, 2013, CANCER LETT, V332, P225, DOI 10.1016/j.canlet.2012.03.005; Asghar U, 2015, NAT REV DRUG DISCOV, V14, P130, DOI 10.1038/nrd4504; Booher RN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108371; Brose MS, 2014, LANCET, V384, P319, DOI 10.1016/S0140-6736(14)60421-9; Bywater MJ, 2013, NAT REV CANCER, V13, P299, DOI 10.1038/nrc3496; Chen XX, 2015, ONCOTARGET, V6, P14926, DOI 10.18632/oncotarget.3717; Chou T.-W., 2005, MICROSTRUCTURAL DESI; Chou TC, 2010, CANCER RES, V70, P440, DOI 10.1158/0008-5472.CAN-09-1947; Cowley DO, 2009, MOL CELL BIOL, V29, P1059, DOI 10.1128/MCB.01062-08; Crudden G, 2005, TUMOR BIOL, V26, P142, DOI 10.1159/000086485; Feldmann G, 2011, CANCER BIOL THER, V12, P598, DOI 10.4161/cbt.12.7.16475; Fu W, 2011, MOL CANCER THER, V10, P1018, DOI 10.1158/1535-7163.MCT-11-0167; Galluzzi L, 2012, CELL DEATH DIFFER, V19, P107, DOI 10.1038/cdd.2011.96; Gojo I, 2013, CANCER CHEMOTH PHARM, V72, P897, DOI 10.1007/s00280-013-2249-z; Haugen BR, 2016, THYROID, V26, P1, DOI 10.1089/thy.2015.0020; ITO T, 1994, INT J ONCOL, V4, P583; Juin P, 2013, NAT REV CANCER, V13, P455, DOI 10.1038/nrc3538; Kawauchi T, 2014, DEV GROWTH DIFFER, V56, P335, DOI 10.1111/dgd.12138; Kumar SK, 2015, BLOOD, V125, P443, DOI 10.1182/blood-2014-05-573741; Lin SP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049605; Lindqvist A, 2007, PLOS BIOL, V5, P1127, DOI 10.1371/journal.pbio.0050123; Malumbres M, 2001, NAT REV CANCER, V1, P222, DOI 10.1038/35106065; Malumbres M, 2011, PHYSIOL REV, V91, P973, DOI 10.1152/physrev.00025.2010; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; Marumoto T, 2002, GENES CELLS, V7, P1173, DOI 10.1046/j.1365-2443.2002.00592.x; Merrick KA, 2012, CELL CYCLE, V11, P2600, DOI 10.4161/cc.20758; Nair Anroop B, 2016, J Basic Clin Pharm, V7, P27, DOI 10.4103/0976-0105.177703; Ortega S, 2002, BBA-REV CANCER, V1602, P73, DOI 10.1016/S0304-419X(02)00037-9; Parry D, 2010, MOL CANCER THER, V9, P2344, DOI 10.1158/1535-7163.MCT-10-0324; Pilli T, 2009, THYROID, V19, P1333, DOI 10.1089/thy.2009.0195; Pozo K, 2013, CANCER CELL, V24, P499, DOI 10.1016/j.ccr.2013.08.027; Schlumberger M, 2015, NEW ENGL J MED, V372, P621, DOI 10.1056/NEJMoa1406470; Schweppe RE, 2008, J CLIN ENDOCR METAB, V93, P4331, DOI 10.1210/jc.2008-1102; Smallridge RC, 2012, THYROID, V22, P1104, DOI 10.1089/thy.2012.0302; Xing MZ, 2013, NAT REV CANCER, V13, P184, DOI 10.1038/nrc3431	37	33	33	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0172315	10.1371/journal.pone.0172315	http://dx.doi.org/10.1371/journal.pone.0172315			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207834	gold, Green Submitted, Green Published			2022-12-27	WOS:000394424500121
J	Regenthal, P; Hansen, JS; Andre, I; Lindkvist-Petersson, K				Regenthal, Paulina; Hansen, Jesper S.; Andre, Ingemar; Lindkvist-Petersson, Karin			Thermal stability and structural changes in bacterial toxins responsible for food poisoning	PLOS ONE			English	Article							MHC CLASS-II; STAPHYLOCOCCAL-ENTEROTOXIN H; CRYSTAL-STRUCTURE; OUTBREAK	The staphylococcal enterotoxins (SEs) are secreted by the bacteria Staphylococcus aureus and are the most common causative agent in staphylococcal food poisoning. The staphylococcal enterotoxin A (SEA) has been associated with large staphylococcal food poisoning outbreaks, but newer identified SEs, like staphylococcal enterotoxin H (SEH) has recently been shown to be present at similar levels as SEA in food poisoning outbreaks. Thus, we set out to investigate the thermo-stability of the three-dimensional structures of SEA, SEH and staphylococcal enterotoxin E (SEE), since heat inactivation is a common method to inactivate toxins during food processing. Interestingly, the investigated toxins behaved distinctly different upon heating. SEA and SEE were more stable at slightly acidic pH values, while SEH adopted an extremely stable structure at neutral pH, with almost no effects on secondary structural elements upon heating to 95 degrees C, and with reversible formation of tertiary structure upon subsequent cooling to room temperature. Taken together, the data suggests that the family of staphylococcal enterotoxins have different ability to withstand heat, and thus the exact profile of heat inactivation for all SEs causing food poisoning needs to be considered to improve food safety.	[Regenthal, Paulina; Hansen, Jesper S.; Lindkvist-Petersson, Karin] Lund Univ, Dept Expt Med Sci, BMC, Lund, Sweden; [Andre, Ingemar] Lund Univ, Dept Biochem & Struct Biol, Lund, Sweden	Lund University; Lund University	Lindkvist-Petersson, K (corresponding author), Lund Univ, Dept Expt Med Sci, BMC, Lund, Sweden.	Karin.Lindkvist@med.lu.se		Lindkvist, Karin/0000-0002-5209-3160; Hansen, Jesper Soendergaard/0000-0003-1638-1285	Swedish Research Council [2011-2891, 2015-04203]; Cancerfoundation [2010/1171, 2014/575]; Novo Nordisk Foundation [9807]; AFA Forsakring; Olle Engkvist Byggmastare foundation; VINNOVA; Crafoord foundation [20160579]; Diabetesfonden [DIA2015-035]; Karin Lindkvist-Petersson; Novo Nordisk Fonden [NNF14OC0009807, NNF15OC0015906] Funding Source: researchfish	Swedish Research Council(Swedish Research CouncilEuropean Commission); Cancerfoundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); AFA Forsakring; Olle Engkvist Byggmastare foundation; VINNOVA(Vinnova); Crafoord foundation; Diabetesfonden; Karin Lindkvist-Petersson; Novo Nordisk Fonden(Novo Nordisk Foundation)	This project was funded by the Swedish Research Council (2011-2891), the Cancerfoundation (2010/1171 and 2014/575), the Novo Nordisk Foundation (9807), AFA Forsakring, the Olle Engkvist Byggmastare foundation, VINNOVA, the Crafoord foundation (20160579) and Diabetesfonden (DIA2015-035), all received by Karin Lindkvist-Petersson, and the Swedish Research Council (2015-04203) received by Ingmar Andre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argudin MA, 2010, TOXINS, V2, P1751, DOI 10.3390/toxins2071751; Brouillard JNP, 2007, J MOL BIOL, V367, P925, DOI 10.1016/j.jmb.2007.01.024; Cavallin A, 2000, J BIOL CHEM, V275, P1665, DOI 10.1074/jbc.275.3.1665; Hakansson M, 2000, J MOL BIOL, V302, P527, DOI 10.1006/jmbi.2000.4093; HUMBER JY, 1975, APPL MICROBIOL, V30, P755, DOI 10.1128/AEM.30.5.755-758.1975; Ikeda T, 2005, APPL ENVIRON MICROB, V71, P2793, DOI 10.1128/AEM.71.5.2793-2795.2005; Jorgensen HJ, 2005, FEMS MICROBIOL LETT, V252, P267, DOI 10.1016/j.femsle.2005.09.005; Krakauer T, 2013, VIRULENCE, V4, P759, DOI 10.4161/viru.23905; Micsonai A, 2015, P NATL ACAD SCI USA, V112, pE3095, DOI 10.1073/pnas.1500851112; Nilsson H, 1999, J IMMUNOL, V163, P6686; Petersson K, 2002, STRUCTURE, V10, P1619, DOI 10.1016/S0969-2126(02)00895-X; Petersson K, 2001, EMBO J, V20, P3306, DOI 10.1093/emboj/20.13.3306; Pinchuk IV, 2010, TOXINS, V2, P2177, DOI 10.3390/toxins2082177; Plasencia I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014674; Rene-Trouillefou M, 2010, BBA-PROTEINS PROTEOM, V1804, P1322, DOI 10.1016/j.bbapap.2010.01.014; Reshetnyak YK, 2001, BIOPHYS J, V81, P1710, DOI 10.1016/S0006-3495(01)75824-9; Rodstrom KEJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131988; SCHAD EM, 1995, EMBO J, V14, P3292, DOI 10.1002/j.1460-2075.1995.tb07336.x; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sospedra I, 2013, FOOD RES INT, V54, P1052, DOI 10.1016/j.foodres.2013.03.002; SWAMINATHAN S, 1992, NATURE, V359, P801, DOI 10.1038/359801a0; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673	22	9	11	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0172445	10.1371/journal.pone.0172445	http://dx.doi.org/10.1371/journal.pone.0172445			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207867	gold, Green Published, Green Submitted			2022-12-27	WOS:000394424500138
J	Lv, FL; Xue, S; Wang, GL; Zhang, C				Lv, Fenglian; Xue, Sha; Wang, Guoliang; Zhang, Chao			Nitrogen addition shifts the microbial community in the rhizosphere of Pinus tabuliformis in Northwestern China	PLOS ONE			English	Article							PLANT; DEPOSITION; ECOSYSTEMS; BIOMASS; MANAGEMENT; RESPONSES; SEEDLINGS; PATTERNS; RATIOS; GROWTH	Atmospheric nitrogen (N) deposition profoundly alters the soil microbial communities and will thus affect nutrient cycles. The effects of N availability on microbial community, however, are not clear. We used PLFA analysis to evaluate the effects of a gradient of N addition (0, 2.8, 5.6, 11.2, and 22.4 g N m(-2) y(-1)) for three years on the rhizospheric microbial community of Pinus tabuliformis seedlings. The main factors influencing the community were quantified using structural equation modelling and redundancy analysis. At the microbial-community level, N addition increased the total phospholipid fatty acids content by increasing the dissolved organic carbon (DOC) and root biomass. Increases in soil microbial biomass carbon and N, however, was attributed to the increased DOC, N content and decreased pH. At the microbial-groups level, Fungal, arbuscular mycorrhizal fungal (AMF), gram-positive bacterial (GP) abundances and the GP:GN ratio first increased and then decreased with N addition. Nitrogen addition increased the abundances of bacteria, fungi, and actinomycetes mainly by increasing the DOC content and decreasing root biomass. Additionally, the decrease of pH and ammonium N caused by N addition increased the fungal abundances and reduced actinomycete abundances, respectively. Nitrogen addition shifted the rhizospheric microbial community mainly by altering the DOC content and root biomass. The current rate of N deposition (2.5 g N m(-2) y(-1)) benefits plant growth and increases the abundances of fungi, arbuscular mycorrhizal fungi, GP, actinomycetes and the GP:GN ratio.	[Lv, Fenglian; Xue, Sha] Northwest A&F Univ, Coll Nat Resources & Environm, State Key Lab Soil Eros & Dryland Farming Loess P, Yangling, Shaanxi, Peoples R China; [Xue, Sha; Wang, Guoliang; Zhang, Chao] Northwest A&F Univ, Inst Soil & Water Conservat, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China; Chinese Academy of Sciences; Institute of Soil & Water Conservation (ISWC), CAS; Northwest A&F University - China	Wang, GL (corresponding author), Northwest A&F Univ, Inst Soil & Water Conservat, Yangling, Shaanxi, Peoples R China.	glwang@nwsuaf.edu.cn		Wang, Guoliang/0000-0003-4880-0333	project of National Natural Science Foundation of China [41371508, 41371510]; Key Technologies RD Program [2015BAC01B03]; key project of natural science foundation research of Shaanxi Province [2013JZ006]	project of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Technologies RD Program(National Key Technology R&D Program); key project of natural science foundation research of Shaanxi Province	This work was supported by the project of National Natural Science Foundation of China (41371508 and 41371510), the Key Technologies R&D Program (2015BAC01B03), and the key project of natural science foundation research of Shaanxi Province (2013JZ006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aber J, 1998, BIOSCIENCE, V48, P921, DOI 10.2307/1313296; Bardgett R.D., 2010, ABOVEGROUND BELOWGRO; Bardgett RD, 1996, BIOL FERT SOILS, V22, P261, DOI 10.1007/BF00382522; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Blue JD, 2011, OECOLOGIA, V167, P771, DOI 10.1007/s00442-011-2028-7; Chapin FS., 2011, PRINCIPLES TERRESTRI, V2nd ed.; Clark CM, 2008, NATURE, V451, P712, DOI 10.1038/nature06503; Cookson WR, 2007, SOIL BIOL BIOCHEM, V39, P744, DOI 10.1016/j.soilbio.2006.09.022; Currey PM, 2011, SOIL BIOL BIOCHEM, V43, P495, DOI 10.1016/j.soilbio.2010.11.003; de Vries FT, 2006, SOIL BIOL BIOCHEM, V38, P2092, DOI 10.1016/j.soilbio.2006.01.008; Feng YZ, 2014, SOIL BIOL BIOCHEM, V74, P193, DOI 10.1016/j.soilbio.2014.03.014; Galloway JN, 2008, SCIENCE, V320, P889, DOI 10.1126/science.1136674; Garcia C, 2005, GEODERMA, V124, P193, DOI 10.1016/j.geoderma.2004.04.013; Grace J.B., 2006, STRUCT EQ MOD NAT; Guo JH, 2010, SCIENCE, V327, P1008, DOI 10.1126/science.1182570; Hamer U, 2009, PLANT SOIL, V316, P57, DOI 10.1007/s11104-008-9758-2; Hogberg P, 2006, GLOBAL CHANGE BIOL, V12, P489, DOI 10.1111/j.1365-2486.2006.01102.x; Hu YL, 2010, PLANT SOIL, V333, P81, DOI 10.1007/s11104-010-0321-6; Jassey VEJ, 2013, GLOBAL CHANGE BIOL, V19, P811, DOI 10.1111/gcb.12075; Jiang LL, 2011, PLANT SOIL, V346, P331, DOI 10.1007/s11104-011-0822-y; LeBauer DS, 2008, ECOLOGY, V89, P371, DOI 10.1890/06-2057.1; Li E., 2014, THESIS; Liang C, 2011, BIOGEOCHEMISTRY, V106, P303, DOI 10.1007/s10533-010-9525-3; Liu LL, 2010, ECOL LETT, V13, P819, DOI 10.1111/j.1461-0248.2010.01482.x; Liu XJ, 2013, NATURE, V494, P459, DOI 10.1038/nature11917; Marschner P, 2005, APPL SOIL ECOL, V28, P23, DOI 10.1016/j.apsoil.2004.06.007; Nilsson LO, 2007, OECOLOGIA, V153, P375, DOI 10.1007/s00442-007-0735-x; Philippot L, 2013, ISME J, V7, P1609, DOI 10.1038/ismej.2013.34; Phoenix GK, 2012, GLOBAL CHANGE BIOL, V18, P1197, DOI 10.1111/j.1365-2486.2011.02590.x; Ramirez KS, 2012, GLOBAL CHANGE BIOL, V18, P1918, DOI 10.1111/j.1365-2486.2012.02639.x; Reed SC, 2010, OECOLOGIA, V164, P521, DOI 10.1007/s00442-010-1649-6; Rousk J, 2009, APPL ENVIRON MICROB, V75, P1589, DOI 10.1128/AEM.02775-08; Saetre P, 2000, SOIL BIOL BIOCHEM, V32, P909, DOI 10.1016/S0038-0717(99)00215-1; Schlesinger WH, 2021, BIOGEOCHEMISTRY, V154, P427, DOI 10.1007/s10533-020-00704-4; Siguenza C, 2006, APPL SOIL ECOL, V32, P13, DOI 10.1016/j.apsoil.2005.02.015; Siira-Pietikainen A, 2003, BIOL FERT SOILS, V37, P163, DOI 10.1007/s00374-002-0571-4; Stark S, 2012, EUR J SOIL SCI, V63, P65, DOI 10.1111/j.1365-2389.2011.01411.x; Sul WJ, 2013, SOIL BIOL BIOCHEM, V65, P33, DOI 10.1016/j.soilbio.2013.05.007; Treseder KK, 2008, ECOL LETT, V11, P1111, DOI 10.1111/j.1461-0248.2008.01230.x; Vitousek PM, 1997, ECOL APPL, V7, P737, DOI 10.2307/2269431; WALLANDER H, 1995, PLANT SOIL, V168, P243, DOI 10.1007/BF00029334; Wang GL, 2014, FOREST ECOL MANAG, V334, P114, DOI 10.1016/j.foreco.2014.09.004; Wedin DA, 1996, SCIENCE, V274, P1720, DOI 10.1126/science.274.5293.1720; Wei CZ, 2013, GLOBAL CHANGE BIOL, V19, P3688, DOI 10.1111/gcb.12348; WHEELER GN, 1991, P NATL ACAD SCI USA, V88, P4796, DOI 10.1073/pnas.88.11.4796; Zhong YQ, 2015, SOIL BIOL BIOCHEM, V91, P151, DOI 10.1016/j.soilbio.2015.08.030	46	17	19	8	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0172382	10.1371/journal.pone.0172382	http://dx.doi.org/10.1371/journal.pone.0172382			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5VB	28234932	Green Published, gold			2022-12-27	WOS:000394688200076
J	Schanzenbach, CI; Kirchner, B; Ulbrich, SE; Pfaffl, MW				Schanzenbach, Corina I.; Kirchner, Benedikt; Ulbrich, Susanne E.; Pfaffl, Michael W.			Can milk cell or skim milk miRNAs be used as biomarkers for early pregnancy detection in cattle?	PLOS ONE			English	Article							MICRORNA-17-92 CLUSTER; EXPRESSION PROFILES; BOVINE; IDENTIFICATION; LACTATION; PLASMA; MODEL	The most critical phase of pregnancy is the first three weeks following insemination. During this period about 50% of high yielding lactating cows suffer embryonic loss prior to implantation, which poses a high economic burden on dairy farmers. Early diagnosis of pregnancy in cattle is therefore essential for monitoring breeding outcome and efficient production intervals. Regulated microRNAs (miRNAs) that reach easily accessible body fluids via a 'liquid biopsy' could be a new class of pregnancy predicting biomarkers. As milk is obtained regularly twice daily and non-invasively from the animal, it represents an ideal sample material. Our aim was to establish a pregnancy test system based on the discovery of small RNA biomarkers derived from the bovine milk cellular fraction and skim milk of cows. Milk samples were taken on days 4, 12 and 18 of cyclic cows and after artificial insemination, respectively, of the same animals (n = 6). miRNAs were analysed using small RNA sequencing (small RNA Seq). The miRNA profiles of milk cells and skim milk displayed similar profiles despite the presence of immune cell related miRNAs in milk cells. Trends in regulation of miRNAs between the oestrous cycle and pregnancy were found in miR-cluster 25 similar to 106b and its paralog cluster 17 similar to 92, miR-125 family, miR-200 family, miR-29 family, miR-15a, miR-21, miR26b, miR-100, miR-140, 193a-5p, miR-221, miR-223, miR-320a, miR-652, miR-2898 and let-7i. A separation of cyclic and pregnant animals was achieved in a principal component analysis. Bta-miRs-29b, -221, -125b and -200b were successfully technically validated using quantitative real-time PCR, however biological validation failed. Therefore we cannot recommend the diagnostic use of these miRNAs in milk as biomarkers for detection of bovine pregnancy for now.	[Schanzenbach, Corina I.; Kirchner, Benedikt; Pfaffl, Michael W.] Tech Univ Munich, Dept Anim Sci, Anim Physiol & Immunol, Wissensch Zentrum Weihenstephan, Freising Weihenstephan, Germany; [Schanzenbach, Corina I.; Ulbrich, Susanne E.] Swiss Fed Inst Technol, Inst Agr Sci, Dept Environm Syst Sci, Anim Physiol, Zurich, Switzerland	Technical University of Munich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Schanzenbach, CI (corresponding author), Tech Univ Munich, Dept Anim Sci, Anim Physiol & Immunol, Wissensch Zentrum Weihenstephan, Freising Weihenstephan, Germany.; Schanzenbach, CI (corresponding author), Swiss Fed Inst Technol, Inst Agr Sci, Dept Environm Syst Sci, Anim Physiol, Zurich, Switzerland.	corina.schanzenbach@usys.ethz.ch	Pfaffl, Michael/G-6622-2013; Schanzenbach, Corina/H-3721-2018; Ulbrich, Susanne E/D-1815-2014	Pfaffl, Michael/0000-0002-3192-1019; Schanzenbach, Corina/0000-0002-0214-9277; Kirchner, Benedikt/0000-0003-3878-0148; Ulbrich, Susanne E/0000-0003-0355-3869	"Bayerisches Staatsministerium fur Ernahrung Landwirtschaftund Forsten" (Munchen, Germany)	"Bayerisches Staatsministerium fur Ernahrung Landwirtschaftund Forsten" (Munchen, Germany)	This work was supported by the "Bayerisches Staatsministerium fur Ernahrung Landwirtschaftund Forsten" (Munchen, Germany). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpini G, 2011, J HEPATOL, V55, P1339, DOI 10.1016/j.jhep.2011.04.015; Alsaweed M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152610; Alsaweed M, 2016, SCI REP-UK, V6, DOI 10.1038/srep20680; Alsaweed M, 2015, J CELL BIOCHEM, V116, P2397, DOI 10.1002/jcb.25207; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Balhara AK, 2013, SCI WORLD J, DOI 10.1155/2013/958540; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bidarimath M, 2014, CELL MOL IMMUNOL, V11, P538, DOI 10.1038/cmi.2014.45; Boutinaud M, 2002, REPROD NUTR DEV, V42, P133, DOI 10.1051/rnd:2002013; Burns DA, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0086855, 10.1371/journal.pone.0090913]; Buschmann D, 2016, NUCL ACIDS RES; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chegini Nasser, 2010, Animal Reproduction, V7, P117; Chen T, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-100; Chen X, 2010, CELL RES, V20, P1128, DOI 10.1038/cr.2010.80; Cheng L, 2014, KIDNEY INT, V86, P433, DOI 10.1038/ki.2013.502; Cochrane DR, 2012, MOL CELL ENDOCRINOL, V357, P50, DOI 10.1016/j.mce.2011.09.022; Doebele C, 2010, BLOOD, V115, P4944, DOI 10.1182/blood-2010-01-264812; Faruq O, 2015, FRONT MED, V2, DOI 10.3389/fmed.2015.00051; Gallo A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030679; Gu Y, 2013, AM J PHYSIOL-ENDOC M, V304, pE836, DOI 10.1152/ajpendo.00660.2012; Guo L, 2013, MOL BIOL REP, V40, P3147, DOI 10.1007/s11033-012-2388-z; Guo L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021072; Hale BJ, 2014, MOL REPROD DEV, V81, P148, DOI 10.1002/mrd.22272; Hata T, 2010, BIOCHEM BIOPH RES CO, V396, P528, DOI 10.1016/j.bbrc.2010.04.135; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Hulsen T, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-488; Ioannidis J, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2529-1; Kim Young-Kook, 2015, Chonnam Med J, V51, P51, DOI 10.4068/cmj.2015.51.2.51; Kong Y, 2011, GENOMICS, V98, P152, DOI 10.1016/j.ygeno.2011.05.009; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Krawczynski K, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2172-2; Kropp J, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00091; Kumar P, 2013, MOL CELL BIOL, V33, P1782, DOI 10.1128/MCB.01228-12; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Le Guillou S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091938; Lessey BA, 2010, BIOL REPROD, V82, P653, DOI 10.1095/biolreprod.110.083667; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li PF, 2013, CLIN SCI, V124, P27, DOI 10.1042/CS20120121; Li TT, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-186; Li Z, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-731; Lonergan P, 2014, ANIMAL, V8, P64, DOI 10.1017/S1751731114000470; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Luo SS, 2009, BIOL REPROD, V81, P717, DOI 10.1095/biolreprod.108.075481; Maalouf SW, 2014, MOL CELL ENDOCRINOL, V398, P78, DOI 10.1016/j.mce.2014.10.005; Manaster I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033395; Mendell JT, 2008, CELL, V133, P217, DOI 10.1016/j.cell.2008.04.001; Mouillet JF, 2010, FASEB J, V24, P2030, DOI 10.1096/fj.09-149724; Nakamura K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158278; Paape MJ, 1997, J ANIM SCI, V75, P556; PAAPE MJ, 1975, AM J VET RES, V36, P1737; Petrov AI, 2015, NUCLEIC ACIDS RES, V43, pD123, DOI 10.1093/nar/gku991; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ponsuksili S, 2014, DIFFERENTIAL EXPRESS; PRAKASH BS, 1987, J STEROID BIOCHEM, V28, P623, DOI 10.1016/0022-4731(87)90389-X; Qian K, 2009, ENDOCRINOLOGY, V150, P4734, DOI 10.1210/en.2008-1629; Salilew-Wondim D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106795; Santos JEP, 2004, ANIM REPROD SCI, V82-3, P513, DOI 10.1016/j.anireprosci.2004.04.015; Sha AG, 2011, FERTIL STERIL, V96, P150, DOI 10.1016/j.fertnstert.2011.04.072; Simons M, 2009, CURR OPIN CELL BIOL, V21, P575, DOI 10.1016/j.ceb.2009.03.007; Sohel MMH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078505; Sonkoly E, 2008, SEMIN CANCER BIOL, V18, P131, DOI 10.1016/j.semcancer.2008.01.005; Spencer Thomas E, 2004, Reprod Biol Endocrinol, V2, P49, DOI 10.1186/1477-7827-2-49; Spornraft M, 2015, BIOTECHNOL LETT, V37, P1165, DOI 10.1007/s10529-015-1788-2; Spornraft M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107259; Su LJ, 2010, REPROD FERT DEVELOP, V22, P1175, DOI 10.1071/RD10046; Tesfaye D, 2009, MOL REPROD DEV, V76, P665, DOI 10.1002/mrd.21005; Treguer K, 2012, J VASC RES, V49, P447, DOI 10.1159/000339429; Turchinovich A., 2013, Frontiers in Genetics, V4, P119, DOI 10.3389/fgene.2013.00119; Undi Ram Babu, 2013, Adv Hematol, V2013, P695754, DOI 10.1155/2013/695754; Wessels JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072264; Zhang J, 2015, GENOM PROTEOM BIOINF, V13, P17, DOI 10.1016/j.gpb.2015.02.001	72	22	24	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0172220	10.1371/journal.pone.0172220	http://dx.doi.org/10.1371/journal.pone.0172220			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5VB	28234939	Green Published, gold, Green Submitted			2022-12-27	WOS:000394688200054
J	Cuco, AP; Abrantes, N; Goncalves, F; Wolinska, J; Castro, BB				Cuco, Ana P.; Abrantes, Nelson; Goncalves, Fernando; Wolinska, Justyna; Castro, Bruno B.			Interplay between fungicides and parasites: Tebuconazole, but not copper, suppresses infection in a Daphnia-Metschnikowia experimental model	PLOS ONE			English	Article							FRESH-WATER ZOOPLANKTON; MULTIPLE STRESSORS; PESTICIDE EXPOSURE; TOXICITY; TEMPERATURE; DISEASE; SURFACE; UNCERTAINTY; IMPACTS; STREAMS	Natural populations are commonly exposed to complex stress scenarios, including anthropogenic contamination and their biological enemies (e.g., parasites). The study of the pollutant-parasite interplay is especially important, given the need for adequate regulations to promote improved ecosystem protection. In this study, a host-parasite model system (Daphnia spp. and the microparasitic yeast Metschnikowia bicuspidata) was used to explore the reciprocal effects of contamination by common agrochemical fungicides (copper sulphate and tebuconazole) and parasite challenge. We conducted 21-day life history experiments with two host clones exposed to copper (0.00, 25.0, 28.8 and 33.1 mu g L-1) or tebuconazole (0.00, 154, 192 and 240 mu g L-1), in the absence or presence of the parasite. For each contaminant, the experimental design consisted of 2 Daphnia clones x 4 contaminant concentrations x 2 parasite treatments x 20 replicates = 320 experimental units. Copper and tebuconazole decreased Daphnia survival or reproduction, respectively, whilst the parasite strongly reduced host survival. Most importantly, while copper and parasite effects were mostly independent, tebuconazole suppressed infection. In a follow-up experiment, we tested the effect of a lower range of tebuconazole concentrations (0.00, 6.25, 12.5, 25.0, 50.0 and 100 mu g L-1) crossed with increasing parasite challenge (2 Daphnia clones x 6 contaminant concentrations x 2 parasite levels x 20 replicates = 480 experimental units). Suppression of infection was confirmed at environmentally relevant concentrations (> 6.25 mu g L-1), irrespective of the numbers of parasite challenge. The ecological consequences of such a suppression of infection include interferences in host population dynamics and diversity, as well as community structure and energy flow across the food web, which could upscale to ecosystem level given the important role of parasites.	[Cuco, Ana P.; Goncalves, Fernando] Univ Aveiro, Dept Biol, Aveiro, Portugal; [Cuco, Ana P.; Abrantes, Nelson; Goncalves, Fernando; Castro, Bruno B.] Univ Aveiro, Ctr Environm & Marine Studies CESAM, Aveiro, Portugal; [Abrantes, Nelson] Univ Aveiro, Dept Environm & Planning, Aveiro, Portugal; [Wolinska, Justyna] Leibniz Inst Freshwater Ecol & Inland Fisheries I, Dept Ecosyst Res, Berlin, Germany; [Wolinska, Justyna] Free Univ Berlin, Inst Biol, Dept Biol, Chem,Pharm, Berlin, Germany; [Castro, Bruno B.] Univ Minho, Dept Biol, Ctr Mol & Environm Biol CBMA, Braga, Portugal	Universidade de Aveiro; Universidade de Aveiro; Universidade de Aveiro; Leibniz Institut fur Gewasserokologie und Binnenfischerei (IGB); Free University of Berlin; Universidade do Minho	Castro, BB (corresponding author), Univ Aveiro, Ctr Environm & Marine Studies CESAM, Aveiro, Portugal.; Castro, BB (corresponding author), Univ Minho, Dept Biol, Ctr Mol & Environm Biol CBMA, Braga, Portugal.	brunocastro@bio.uminho.pt	Wolinska, Justyna/N-6455-2014; Abrantes, Nelson/C-5331-2009; Gonçalves, Fernando J. M./B-8000-2008; Castro, Bruno Branco/B-7552-2008	Abrantes, Nelson/0000-0003-0241-2896; Gonçalves, Fernando J. M./0000-0002-9326-187X; Castro, Bruno Branco/0000-0002-7130-6061; Cuco, Ana Patricia/0000-0002-8640-1248	national funds through the Portuguese Science Foundation (FCT I.P.) [UID/AMB/50017/2013, UID/BIA/04050/2013, POCI-01-0145-FEDER-007569]; European Regional Development Fund (ERDF) through COMPETE; FCT [SFRH/BD/81661/2011, IF/01198/2014]; FEDER through COMPETE [PTDC/AAC-AMB/112438/2009]; Fundação para a Ciência e a Tecnologia [PTDC/AAC-AMB/112438/2009] Funding Source: FCT	national funds through the Portuguese Science Foundation (FCT I.P.); European Regional Development Fund (ERDF) through COMPETE; FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); FEDER through COMPETE; Fundação para a Ciência e a Tecnologia	This work was supported by the strategic programs UID/AMB/50017/2013 (CESAM) and UID/BIA/04050/2013 (CBMA, POCI-01-0145-FEDER-007569), funded by national funds through the Portuguese Science Foundation (FCT I.P. - http://www.fct.pt/) and by the European Regional Development Fund (ERDF) through COMPETE2020 (http://www.poci-compete2020.pt/). APC and NA are recipients of, respectively, a PhD grant (SFRH/BD/81661/2011) and a researcher contract (IF/01198/2014) from FCT. This work is also part of the project VITAQUA (PTDC/AAC-AMB/112438/2009), which was funded by FEDER through COMPETE and by national funding from FCT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agha R, 2016, SCI REP-UK, V6, DOI 10.1038/srep35039; Alvarez-Perez S., 2015, FEMS YEAST RES, V16, P1, DOI DOI 10.1093/FEMSYR/F0V115; [Anonymous], 2014, R LANG ENV STAT COMP; Auld SKJR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039564; Berenzen N, 2005, CHEMOSPHERE, V58, P683, DOI 10.1016/j.chemosphere.2004.05.009; Bereswill R, 2012, AGR ECOSYST ENVIRON, V146, P81, DOI 10.1016/j.agee.2011.10.010; Blanar CA, 2010, B ENVIRON CONTAM TOX, V84, P692, DOI 10.1007/s00128-010-0024-y; Buser CC, 2012, FRESHWATER BIOL, V57, P1865, DOI 10.1111/j.1365-2427.2012.02846.x; Buser CC, 2012, AQUAT ECOL, V46, P261, DOI 10.1007/s10452-012-9397-9; Cerejeira MJ, 2003, WATER RES, V37, P1055, DOI 10.1016/S0043-1354(01)00462-6; Civitello DJ, 2012, P ROY SOC B-BIOL SCI, V279, P3146, DOI 10.1098/rspb.2012.0684; Coors A, 2008, OIKOS, V117, P1840, DOI 10.1111/j.1600-0706.2008.17028.x; Coors A, 2008, J APPL ECOL, V45, P1820, DOI 10.1111/j.1365-2664.2008.01566.x; Cuco AP, 2016, ECOTOXICOLOGY, V25, P1376, DOI 10.1007/s10646-016-1689-8; Dallas T, 2014, ECOL EVOL, V4, P243, DOI 10.1002/ece3.925; Dean R, 2012, MOL PLANT PATHOL, V13, P414, DOI 10.1111/j.1364-3703.2011.00783.x; Devez A, 2005, SCI TOTAL ENVIRON, V348, P82, DOI 10.1016/j.scitotenv.2005.01.004; Dijksterhuis J, 2011, WATER AIR SOIL POLL, V222, P421, DOI 10.1007/s11270-011-0836-3; Ebert D, 2000, OECOLOGIA, V122, P200, DOI 10.1007/PL00008847; Ebert D., 2005, ECOLOGY EPIDEMIOLOGY; Fick J, 2010, REGUL TOXICOL PHARM, V58, P516, DOI 10.1016/j.yrtph.2010.08.025; Gleason FH, 2015, FUNGAL BIOL REV, V29, P20, DOI 10.1016/j.fbr.2015.03.002; Gozlan RE, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00062; Hall SR, 2007, ECOL LETT, V10, P207, DOI 10.1111/j.1461-0248.2007.01011.x; Hall SR, 2011, OECOLOGIA, V166, P833, DOI 10.1007/s00442-011-1905-4; Hanazato T, 2001, ENVIRON POLLUT, V112, P1, DOI 10.1016/S0269-7491(00)00110-X; Hanlon SM, 2015, ENVIRON SCI POLLUT R, V22, P12929, DOI 10.1007/s11356-015-4566-8; Hanlon SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043573; Herrero-Hernandez E, 2013, J HYDROL, V486, P234, DOI 10.1016/j.jhydrol.2013.01.025; Heugens EHW, 2003, ENVIRON SCI TECHNOL, V37, P2145, DOI 10.1021/es0264347; Heugens EHW, 2001, CRIT REV TOXICOL, V31, P247, DOI 10.1080/20014091111695; Hildebrandt A, 2008, WATER RES, V42, P3315, DOI 10.1016/j.watres.2008.04.009; Holmstrup M, 2010, SCI TOTAL ENVIRON, V408, P3746, DOI 10.1016/j.scitotenv.2009.10.067; Jansen M, 2011, EVOLUTION, V65, P2681, DOI 10.1111/j.1558-5646.2011.01331.x; Jephcott TG, 2016, FUNGAL ECOL, V19, P47, DOI 10.1016/j.funeco.2015.03.007; Johnson PTJ, 2007, P NATL ACAD SCI USA, V104, P15781, DOI 10.1073/pnas.0707763104; Jokela J, 2009, AM NAT, V174, pS43, DOI 10.1086/599080; Kahle M, 2008, ENVIRON SCI TECHNOL, V42, P7193, DOI 10.1021/es8009309; Kegley SE, 2014, PESTICIDE ACTION NET; Kelly DW, 2010, J APPL ECOL, V47, P498, DOI 10.1111/j.1365-2664.2010.01791.x; Komarek M, 2010, ENVIRON INT, V36, P138, DOI 10.1016/j.envint.2009.10.005; Lafferty KD, 1999, LIMNOL OCEANOGR, V44, P925, DOI 10.4319/lo.1999.44.3_part_2.0925; Lafferty KD, 2008, ECOL LETT, V11, P533, DOI 10.1111/j.1461-0248.2008.01174.x; Lewis KA, 2016, HUM ECOL RISK ASSESS, V7039; Lohr JN, 2010, PARASITOLOGY, V137, P1493, DOI 10.1017/S0031182010000296; Loureiro C, 2015, CHEMOSPHERE, V139, P126, DOI 10.1016/j.chemosphere.2015.05.081; Loureiro C, 2011, ECOTOXICOLOGY, V20, P139, DOI 10.1007/s10646-010-0565-1; Manavathu EK, 1998, ANTIMICROB AGENTS CH, V42, P3018, DOI 10.1128/AAC.42.11.3018; Marcogliese DJ, 2011, TRENDS PARASITOL, V27, P123, DOI 10.1016/j.pt.2010.11.002; MEYER JS, 1986, ECOLOGY, V67, P1156, DOI 10.2307/1938671; Ochoa-Acuna HG, 2009, ECOTOXICOLOGY, V18, P440, DOI 10.1007/s10646-009-0298-1; OECD, TEST 211 DAPHN MAGN; Pereira JL, 2007, SCI TOTAL ENVIRON, V386, P9, DOI 10.1016/j.scitotenv.2007.07.040; Stampfli NC, 2011, AQUAT TOXICOL, V104, P116, DOI 10.1016/j.aquatox.2011.04.004; Wolinska J, 2008, TRENDS PARASITOL, V24, P121, DOI 10.1016/j.pt.2007.11.010; Wolinska J, 2009, EVOLUTION, V63, P1893, DOI 10.1111/j.1558-5646.2009.00663.x; Wolinska J, 2009, TRENDS PARASITOL, V25, P236, DOI 10.1016/j.pt.2009.02.004; Yin MB, 2011, EVOLUTION, V65, P1482, DOI 10.1111/j.1558-5646.2011.01240.x; Zubrod JP, 2014, AQUAT TOXICOL, V150, P133, DOI 10.1016/j.aquatox.2014.03.002; Zubrod JP, 2010, ECOTOX ENVIRON SAFE, V73, P1674, DOI 10.1016/j.ecoenv.2010.07.046	60	10	10	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2017	12	2							e0172589	10.1371/journal.pone.0172589	http://dx.doi.org/10.1371/journal.pone.0172589			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5SX	28231278	Green Published, Green Submitted, gold			2022-12-27	WOS:000394682400058
J	Levavasseur, E; Biacabe, AG; Comoy, E; Culeux, A; Grznarova, K; Privat, N; Simoneau, S; Flan, B; Sazdovitch, V; Seilhean, D; Baron, T; Haik, S				Levavasseur, Etienne; Biacabe, Anne-Gaelle; Comoy, Emmanuel; Culeux, Audrey; Grznarova, Katarina; Privat, Nicolas; Simoneau, Steve; Flan, Benoit; Sazdovitch, Veronique; Seilhean, Danielle; Baron, Thierry; Haik, Stephane			Detection and partial discrimination of atypical and classical bovine spongiform encephalopathies in cattle and primates using real-time quaking-induced conversion assay	PLOS ONE			English	Article							CREUTZFELDT-JAKOB-DISEASE; HUMAN PRION PROTEIN; TRANSMISSIBLE MINK ENCEPHALOPATHY; PRP TRANSGENIC MICE; CEREBROSPINAL-FLUID; INTERSPECIES TRANSMISSION; BSE TRANSMISSION; STRAIN; SCRAPIE; SHEEP	The transmission of classical bovine spongiform encephalopathy (C-BSE) through contaminated meat product consumption is responsible for variant Creutzfeldt-Jakob disease (vCJD) in humans. More recent and atypical forms of BSE (L-BSE and H-BSE) have been identified in cattle since the C-BSE epidemic. Their low incidence and advanced age of onset are compatible with a sporadic origin, as are most cases of Creutzfeldt-Jakob disease (CJD) in humans. Transmissions studies in primates and transgenic mice expressing a human prion protein (PrP) indicated that atypical forms of BSE may be associated with a higher zoonotic potential than classical BSE, and require particular attention for public health. Recently, methods designed to amplify misfolded forms of PrP have emerged as promising tools to detect prion strains and to study their diversity. Here, we validated realtime quaking-induced conversion assay for the discrimination of atypical and classical BSE strains using a large series of bovine samples encompassing all the atypical BSE cases detected by the French Centre of Reference during 10 years of exhaustive active surveillance. We obtained a 100% sensitivity and specificity for atypical BSE detection. In addition, the assay was able to discriminate atypical and classical BSE in non-human primates, and also sporadic CJD and vCJD in humans. The RT-QuIC assay appears as a practical means for a reliable detection of atypical BSE strains in a homologous or heterologous PrP context.	[Levavasseur, Etienne; Culeux, Audrey; Grznarova, Katarina; Privat, Nicolas; Haik, Stephane] UPMC Univ Paris VI, Sorbonne Univ, CNRS, INSERM,U1127,UMR 7225,UMR S 1127,Inst Cerveau & M, Paris, France; [Biacabe, Anne-Gaelle; Baron, Thierry] Agence Natl Securite Sanitaire Alimentat Environm, Unite Malad Neurogenerat, Lyon, France; [Comoy, Emmanuel] CEA, Inst Malad Emergentes & Therapies Nouvelles IMETI, SEPIA, Fontenay Aux Roses, France; [Simoneau, Steve; Flan, Benoit] LFB Biomedicaments, Les Ulis, France; [Sazdovitch, Veronique; Seilhean, Danielle] Hop La Pitie Salpetriere, AP HP, Neuropathol, Paris, France; [Haik, Stephane] Hop La Pitie Salpetriere, AP HP, Cellule Natl Reference MCJ, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; CEA; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Haik, S (corresponding author), UPMC Univ Paris VI, Sorbonne Univ, CNRS, INSERM,U1127,UMR 7225,UMR S 1127,Inst Cerveau & M, Paris, France.; Haik, S (corresponding author), Hop La Pitie Salpetriere, AP HP, Cellule Natl Reference MCJ, Paris, France.	stephane.haik@upmc.fr	Seilhean, Danielle D/O-6899-2018; Haik, Stephane/M-7247-2018	Seilhean, Danielle D/0000-0003-3498-4602; Haik, Stephane/0000-0001-6022-1188	Investissements d'avenir [ANR-10-IAIHU-06]; LFB Biomedicaments; Institut de Veille Sanitaire (InVS)	Investissements d'avenir(French National Research Agency (ANR)); LFB Biomedicaments; Institut de Veille Sanitaire (InVS)	This work was funded by "Investissements d'avenir" ANR-10-IAIHU-06; LFB Biomedicaments; Institut de Veille Sanitaire (InVS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atarashi R, 2008, NAT METHODS, V5, P211, DOI 10.1038/nmeth0308-211; Atarashi R, 2011, PRION, V5, P150, DOI 10.4161/pri.5.3.16893; Atarashi R, 2011, NAT MED, V17, P175, DOI 10.1038/nm.2294; Baron T, 2007, EMERG INFECT DIS, V13, P1887, DOI 10.3201/eid1312.070635; Bartz JC, 2000, J VIROL, V74, P5542, DOI 10.1128/JVI.74.12.5542-5547.2000; Bencsik A, 2007, J INFECT DIS, V195, P989, DOI 10.1086/512087; Bencsik A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006929; Beringue V, 2008, EMERG INFECT DIS, V14, P1898, DOI 10.3201/eid1412.080941; Beringue V, 2007, J NEUROSCI, V27, P6965, DOI 10.1523/JNEUROSCI.0693-07.2007; Biacabe AG, 2008, EMERG INFECT DIS, V14, P298, DOI 10.3201/eid1402.071141; Brandel JP, 2009, ANN NEUROL, V65, P249, DOI 10.1002/ana.21583; Capobianco R, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030031; Casalone C, 2004, P NATL ACAD SCI USA, V101, P3065, DOI 10.1073/pnas.0305777101; Castilla J, 2003, ARCH VIROL, V148, P677, DOI 10.1007/s00705-002-0958-4; Chabry J, 1998, J BIOL CHEM, V273, P13203, DOI 10.1074/jbc.273.21.13203; Chakroun N, 2010, FASEB J, V24, P3222, DOI 10.1096/fj.09-153924; Cobb NJ, 2007, P NATL ACAD SCI USA, V104, P18946, DOI 10.1073/pnas.0706522104; Comoy EE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003017; Cordier C, 2006, J GEN VIROL, V87, P3763, DOI 10.1099/vir.0.82062-0; Crozet C, 2001, EMBO REP, V2, P952, DOI 10.1093/embo-reports/kve204; Elder AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080203; Govaerts C, 2004, P NATL ACAD SCI USA, V101, P8342, DOI 10.1073/pnas.0402254101; Hill AF, 1997, NATURE, V389, P448, DOI 10.1038/38925; Holscher C, 1998, J VIROL, V72, P1153; Holznagel E, 2013, EMERG INFECT DIS, V19, P712, DOI 10.3201/eid1905.120274; Hosszu LLP, 2010, BIOCHEMISTRY-US, V49, P8729, DOI 10.1021/bi100572j; Jacobs JG, 2007, J CLIN MICROBIOL, V45, P1821, DOI 10.1128/JCM.00160-07; KIMBERLIN RH, 1987, J GEN VIROL, V68, P1875, DOI 10.1099/0022-1317-68-7-1875; Kong QZ, 2008, J VIROL, V82, P3697, DOI 10.1128/JVI.02561-07; Lasmezas CI, 1996, NATURE, V381, P743, DOI 10.1038/381743a0; Lasmezas CI, 2005, LANCET, V365, P781, DOI 10.1016/S0140-6736(05)17985-9; Levavasseur E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002786; Masujin K, 2016, J CLIN MICROBIOLOGY; Matsuura Y, 2013, J COMP PATHOL, V149, P113, DOI 10.1016/j.jcpa.2012.11.231; McGuire LI, 2016, ANN NEUROL, V80, P160, DOI 10.1002/ana.24679; McGuire LI, 2012, ANN NEUROL, V72, P278, DOI 10.1002/ana.23589; Mestre-Frances N, 2012, EMERG INFECT DIS, V18, P142, DOI 10.3201/eid1801.111092; Nicot S, 2014, J INFECT DIS, V209, P950, DOI 10.1093/infdis/jit596; Ono F, 2011, JPN J INFECT DIS, V64, P81; Orru CD, 2015, MBIO, V6, DOI 10.1128/mBio.02451-14; Orru CD, 2015, J CLIN MICROBIOL, V53, P1115, DOI 10.1128/JCM.02906-14; Orru CD, 2014, NEW ENGL J MED, V371, P519, DOI 10.1056/NEJMoa1315200; Orru CD, 2009, PROTEIN ENG DES SEL, V22, P515, DOI 10.1093/protein/gzp031; Peden AH, 2012, J GEN VIROL, V93, P438, DOI 10.1099/vir.0.033365-0; Prusiner SB, 1997, SCIENCE, V278, P245, DOI 10.1126/science.278.5336.245; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Rezaei H, 2000, EUR J BIOCHEM, V267, P2833, DOI 10.1046/j.1432-1033.2000.01347.x; Sano K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054915; Scott MR, 1997, J VIROL, V71, P9032, DOI 10.1128/JVI.71.12.9032-9044.1997; Wadsworth JDF, 2004, SCIENCE, V306, P1793, DOI 10.1126/science.1103932; Wilham JM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001217; Wille H, 2002, P NATL ACAD SCI USA, V99, P3563, DOI 10.1073/pnas.052703499	52	10	10	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2017	12	2							e0172428	10.1371/journal.pone.0172428	http://dx.doi.org/10.1371/journal.pone.0172428			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5SX	28231300	Green Published, Green Submitted, gold			2022-12-27	WOS:000394682400041
J	Sheu, MJ; Hsieh, MJ; Chou, YE; Wang, PH; Yeh, CB; Yang, SF; Lee, HL; Liu, YF				Sheu, Ming-Jen; Hsieh, Ming-Ju; Chou, Ying-Erh; Wang, Po-Hui; Yeh, Chao-Bin; Yang, Shun-Fa; Lee, Hsiang-Lin; Liu, Yu-Fan			Effects of ADAMTS14 genetic polymorphism and cigarette smoking on the clinicopathologic development of hepatocellular carcinoma	PLOS ONE			English	Article							CANCER; DOMAIN; EXPRESSION; PROTEINS; PROLINE; METALLOPROTEINASE; OSTEOARTHRITIS; PREDICTION; MOTIFS; 18Q21	Background ADAMTS14 is a member of the ADAMTS (a disintegrin and metalloproteinase with thrombospondin motifs), which are proteolytic enzymes with a variety of further ancillary domain in the C-terminal region for substrate specificity and enzyme localization via extracellular matrix association. However, whether ADAMTS14 genetic variants play a role in hepatocellular carcinoma (HCC) susceptibility remains unknown. Methodology/Principal findings Four non-synonymous single-nucleotide polymorphisms (nsSNPs) of the ADAMTS14 gene were examined from 680 controls and 340 patients with HCC. Among 141 HCC patients with smoking behaviour, we found significant associations of the rs12774070 (CC+AA vs CC) and rs61573157 (CT+TT vs CC) variants with a clinical stage of HCC (OR: 2.500 and 2.767; 95% CI: 1.148-5.446 and 1.096-6.483; P = 0.019 and 0.026, respectively) and tumour size (OR: 2.387 and 2.659; 95% CI: 1.098-5.188 and 1.055-6.704; P = 0.026 and 0.034, respectively), but not with lymph node metastasis or other clinical statuses. Moreover, an additional integrated in silico analysis proposed that rs12774070 and rs61573157 affected essential post-translation O-glycosylation site within the 3rd thrombospondin type 1 repeat and a novel proline-rich region embedded within the C-terminal extension, respectively. Conclusions Taken together, our results suggest an involvement of ADAMTS14 SNP rs12774070 and rs61573157 in the liver tumorigenesis and implicate the ADAMTS14 gene polymorphism as a predict factor during the progression of HCC.	[Sheu, Ming-Jen] Chi Mei Med Ctr, Dept Gastroenterol & Hepatol, Tainan, Taiwan; [Hsieh, Ming-Ju; Wang, Po-Hui; Yang, Shun-Fa] Chung Shan Med Univ, Inst Med, Taichung, Taiwan; [Hsieh, Ming-Ju] Changhua Christian Hosp, Canc Res Ctr, Changhua, Taiwan; [Hsieh, Ming-Ju] China Med Univ, Grad Inst Biomed Sci, Taichung, Taiwan; [Chou, Ying-Erh; Yeh, Chao-Bin; Lee, Hsiang-Lin] Chung Shan Med Univ, Sch Med, Taichung, Taiwan; [Chou, Ying-Erh; Yang, Shun-Fa] Chung Shan Med Univ Hosp, Dept Med Res, Taichung, Taiwan; [Wang, Po-Hui] Chung Shan Med Univ Hosp, Dept Obstet & Gynecol, Taichung, Taiwan; [Yeh, Chao-Bin] Chung Shan Med Univ Hosp, Dept Emergency Med, Taichung, Taiwan; [Lee, Hsiang-Lin] Chung Shan Med Univ Hosp, Dept Surg, Taichung, Taiwan; [Liu, Yu-Fan] Chung Shan Med Univ, Dept Biomed Sci, Coll Med Sci & Technol, Taichung, Taiwan; [Liu, Yu-Fan] Chung Shan Med Univ Hosp, Div Allergy, Dept Pediat, Taichung, Taiwan	Chi Mei Hospital; Chung Shan Medical University; Changhua Christian Hospital; China Medical University Taiwan; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital	Liu, YF (corresponding author), Chung Shan Med Univ, Dept Biomed Sci, Coll Med Sci & Technol, Taichung, Taiwan.; Liu, YF (corresponding author), Chung Shan Med Univ Hosp, Div Allergy, Dept Pediat, Taichung, Taiwan.	yfliu@csmu.edu.tw	Yang, Shun-Fa/AAN-1519-2020; Hsieh, Ming-Ju/GQB-3025-2022	Yang, Shun-Fa/0000-0002-0365-7927; Yeh, Chao-Bin/0000-0002-3978-5576; Hsieh, Ming-Ju/0000-0001-9726-3234	Ministry of Science and Technology, Taiwan [NSC-102-2320-B-040-012-MY2]; Chung Shan Medical University Hospital and Chi-Mei Foundation	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); Chung Shan Medical University Hospital and Chi-Mei Foundation	The authors would like to thank a research grant from the Ministry of Science and Technology, Taiwan, under Contract No. NSC-102-2320-B-040-012-MY2. Additionally, this study was supported by Chung Shan Medical University Hospital and Chi-Mei Foundation. Medical Center (CSMU-CMMC-105-05), Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei AA, 2013, J MOL BIOL, V425, P2100, DOI 10.1016/j.jmb.2013.03.018; Altamirano J, 2010, GUT, V59, P1159, DOI 10.1136/gut.2008.162453; Apte SS, 2009, J BIOL CHEM, V284, P31493, DOI 10.1074/jbc.R109.052340; Baert-Desurmont S, 2016, EUR J HUM GENET, V24, P99, DOI 10.1038/ejhg.2015.72; Bolz H, 2001, BBA-GENE STRUCT EXPR, V1522, P221, DOI 10.1016/S0167-4781(01)00329-3; Bosch FX, 2004, GASTROENTEROLOGY, V127, pS5, DOI 10.1053/j.gastro.2004.09.011; Breuza L, 2016, DATABASE-OXFORD, DOI 10.1093/database/bav120; Bruni R, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-394; Cal S, 2015, MATRIX BIOL, V44-46, P77, DOI 10.1016/j.matbio.2015.01.013; Cheng HL, 2016, ONCOTARGET, V7, P69384, DOI 10.18632/oncotarget.12082; Chou K.C., 2011, NATUR SCI, V3, P862, DOI [10.4236/ns.2011.310111, DOI 10.4236/NS.2011.310111]; Colige A, 2002, J BIOL CHEM, V277, P5756, DOI 10.1074/jbc.M105601200; Dornan D, 2003, MOL CELL BIOL, V23, P8846, DOI 10.1128/MCB.23.23.8846-8861.2003; Drew K, 2011, GENOME RES, V21, P1981, DOI 10.1101/gr.121475.111; Farazi PA, 2006, NAT REV CANCER, V6, P674, DOI 10.1038/nrc1934; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Kay BK, 2000, FASEB J, V14, P231, DOI 10.1096/fasebj.14.2.231; Kelwick R, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0676-3; Kim DE, 2005, PROTEINS, V61, P193, DOI 10.1002/prot.20737; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lee NV, 2006, EMBO J, V25, P5270, DOI 10.1038/sj.emboj.7601400; Lewis TE, 2015, NUCLEIC ACIDS RES, V43, pD382, DOI 10.1093/nar/gku973; Nardi JB, 1999, INSECT BIOCHEM MOLEC, V29, P883, DOI 10.1016/S0965-1748(99)00064-8; Opitz R, 2015, P NATL ACAD SCI USA, V112, P5011, DOI 10.1073/pnas.1422054112; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Poonpet T, 2013, GENET MOL RES, V12, P5301, DOI 10.4238/2013.November.7.5; Porter S, 2004, CLIN CANCER RES, V10, P2429, DOI 10.1158/1078-0432.CCR-0398-3; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Reisser S, 2014, BIOPHYS J, V106, P2385, DOI 10.1016/j.bpj.2014.04.020; Rodriguez-Lopez J, 2009, OSTEOARTHR CARTILAGE, V17, P321, DOI 10.1016/j.joca.2008.07.012; Salah Z, 2012, FRONT BIOSCI-LANDMRK, V17, P331, DOI 10.2741/3930; Sheng S, 1996, P NATL ACAD SCI USA, V93, P11669, DOI 10.1073/pnas.93.21.11669; Shiiba M, 2010, ONCOL REP, V24, P241, DOI 10.3892/or_00000852; Silverstein RL, 2002, J CELL BIOL, V159, P203, DOI 10.1083/jcb.200209138; Su SC, 2017, J PINEAL RES, V62, DOI 10.1111/jpi.12370; Su SC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159585; Tan KM, 2002, J CELL BIOL, V159, P373, DOI 10.1083/jcb.200206062; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Tsai WL, 2010, ONCOGENE, V29, P2309, DOI 10.1038/onc.2010.36; Vauthey JN, 2002, J CLIN ONCOL, V20, P1527, DOI 10.1200/JCO.20.6.1527; Wang LW, 2009, J BIOL CHEM, V284, P30004, DOI 10.1074/jbc.M109.038059; Wang LY, 2003, CANCER CAUSE CONTROL, V14, P241, DOI 10.1023/A:1023636619477; Yang SF, 2016, SCI REP-UK, V6, DOI 10.1038/srep26605; Zavras AI, 2011, ANN SURG ONCOL, V18, P1478, DOI 10.1245/s10434-010-1431-3; Zhang B, 2014, NAT GENET, V46, P533, DOI 10.1038/ng.2985; Zhang H, 2011, BRIEF BIOINFORM, V12, P672, DOI 10.1093/bib/bbq088; Zhu K, 2013, BIOMARK RES, V1, DOI 10.1186/2050-7771-1-10	47	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2017	12	2							e0172506	10.1371/journal.pone.0172506	http://dx.doi.org/10.1371/journal.pone.0172506			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5SX	28231306	Green Published, gold, Green Submitted			2022-12-27	WOS:000394682400051
J	Dias, CC; Rodrigues, PP; Fernandes, S; Portela, F; Ministro, P; Martins, D; Sousa, P; Lago, P; Rosa, I; Correia, L; Santos, PM; Magro, F				Dias, Claudia Camila; Rodrigues, Pedro Pereira; Fernandes, Samuel; Portela, Francisco; Ministro, Paula; Martins, Diana; Sousa, Paula; Lago, Paula; Rosa, Isadora; Correia, Luis; Santos, Paula Moura; Magro, Fernando			The risk of disabling, surgery and reoperation in Crohn's disease - A decision tree-based approach to prognosis	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; INTESTINAL RESECTION; METAANALYSIS; PREDICTORS; MANAGEMENT	Introduction Crohn's disease (CD) is a chronic inflammatory bowel disease known to carry a high risk of disabling and many times requiring surgical interventions. This article describes a decision-tree based approach that defines the CD patients' risk or undergoing disabling events, surgical interventions and reoperations, based on clinical and demographic variables. Materials and methods This multicentric study involved 1547 CD patients retrospectively enrolled and divided into two cohorts: a derivation one (80%) and a validation one (20%). Decision trees were built upon applying the CHAIRT algorithm for the selection of variables. Results Three-level decision trees were built for the risk of disabling and reoperation, whereas the risk of surgery was described in a two-level one. A receiver operating characteristic (ROC) analysis was performed, and the area under the curves (AUC) Was higher than 70% for all outcomes. The defined risk cut-off values show usefulness for the assessed outcomes: risk levels above 75% for disabling had an odds test positivity of 4.06 [3.50-4.71], whereas risk levels below 34% and 19% excluded surgery and reoperation with an odds test negativity of 0.15 [0.09-0.25] and 0.50 [0.24-1.01], respectively. Overall, patients with B2 or B3 phenotype had a higher proportion of disabling disease and surgery, while patients with later introduction of pharmacological therapeutic (1 months after initial surgery) had a higher proportion of reoperation. Conclusions The decision-tree based approach used in this study, with demographic and clinical variables, has shown to be a valid and useful approach to depict such risks of disabling, surgery and reoperation.	[Dias, Claudia Camila; Rodrigues, Pedro Pereira] Univ Porto, Fac Med, Dept Community Med Informat & Decis Hlth, Oporto, Portugal; [Dias, Claudia Camila; Rodrigues, Pedro Pereira] CINTESIS Ctr Hlth Tecnol & Serv Res, Oporto, Portugal; [Fernandes, Samuel; Correia, Luis; Santos, Paula Moura] Hosp Santa Maria, Ctr Hosp Lisboa Norte, Lisbon, Portugal; [Portela, Francisco] Ctr Hosp & Univ Coimbra, Dept Gastroenterol, Coimbra, Portugal; [Ministro, Paula; Martins, Diana; Sousa, Paula] Ctr Hosp Tondela & Viseu, Dept Gastroenterol, Viseu, Portugal; [Lago, Paula] Ctr Hosp Porto, Dept Gastroenterol, Oporto, Portugal; [Rosa, Isadora] IPO Lisboa, Lisbon, Portugal; [Magro, Fernando] Hosp Sao Joao, Dept Gastroenterol, Oporto, Portugal; [Magro, Fernando] Univ Porto, Fac Med, Inst Pharmacol & Therapeut, Oporto, Portugal; [Magro, Fernando] Univ Porto, MedInUP Ctr Drug Discovery & Innovat Med, Oporto, Portugal	Universidade do Porto; Universidade de Lisboa; Hospital Santa Maria; Universidade de Coimbra; Centro Hospitalar e Universitario de Coimbra (CHUC); Sao Joao Hospital; Universidade do Porto; Universidade do Porto	Magro, F (corresponding author), Hosp Sao Joao, Dept Gastroenterol, Oporto, Portugal.; Magro, F (corresponding author), Univ Porto, Fac Med, Inst Pharmacol & Therapeut, Oporto, Portugal.; Magro, F (corresponding author), Univ Porto, MedInUP Ctr Drug Discovery & Innovat Med, Oporto, Portugal.	fm@med.up.pt	Rodrigues, Pedro Pereira/H-5789-2012; Dias, Claudia Camila/N-7130-2014; Rosa, Isadora/AAU-1590-2020; Sousa, Paula/ABD-8978-2021	Rodrigues, Pedro Pereira/0000-0001-7867-6682; Dias, Claudia Camila/0000-0001-9356-3272; Rosa, Isadora/0000-0002-2953-5987; Sousa, Paula/0000-0002-9009-9635; Magro, Fernando/0000-0003-2634-9668	GEDII - Grupo de Estudo da Doenca Inflamatoria Intestinal; North Portugal Regional Operational Programme (NORTE 2020), under the PORTUGAL [NORTE-01-0145-FEDER-000016]; European Regional Development Fund (ERDF); ERDF - Programa Operacional Competitividade e Internacionalizacao - COMPETE [POCI-01-0145-FEDER-007746]; National Funds through FCT - Fundacao para a Ciencia e a Tecnologia within CINTESIS, RD Unit [UID/IC/4255/2013]	GEDII - Grupo de Estudo da Doenca Inflamatoria Intestinal; North Portugal Regional Operational Programme (NORTE 2020), under the PORTUGAL; European Regional Development Fund (ERDF)(European Commission); ERDF - Programa Operacional Competitividade e Internacionalizacao - COMPETE; National Funds through FCT - Fundacao para a Ciencia e a Tecnologia within CINTESIS, RD Unit	This work was funded by GEDII - Grupo de Estudo da Doenca Inflamatoria Intestinal, for data base maintenance. This work was partially developed under the scope of project NanoStima (NORTE-01-0145-FEDER-000016), which is financed by the North Portugal Regional Operational Programme (NORTE 2020), under the PORTUGAL 2020 Partnership Agreement, and through the European Regional Development Fund (ERDF). This article was supported by ERDF through the operation POCI-01-0145-FEDER-007746 funded by the Programa Operacional Competitividade e Internacionalizacao - COMPETE2020 and by National Funds through FCT - Fundacao para a Ciencia e a Tecnologia within CINTESIS, R&D Unit (reference UID/IC/4255/2013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to acknowledge all investigators at the hospitals who provided data for this study, GEDII-Grupo de Estudo da Doenca InflamatOria Intestinal-for all the support, Sandra Dias for all the help during data collection, and Catarina L. Santos for scientific writing assistance. This work was partially developed under the scope of project NanoStima (NORTE-01-0145-FEDER-000016), which is financed by the North Portugal Regional Operational Programme (NORTE 2020), under the PORTUGAL 2020 Partnership Agreement, and through the European Regional Development Fund (ERDF).	Beaugerie L, 2006, GASTROENTEROLOGY, V130, P650, DOI 10.1053/j.gastro.2005.12.019; Beaugerie L, 2012, WORLD J GASTROENTERO, V18, P3806, DOI 10.3748/wjg.v18.i29.3806; Bernell O, 2000, BRIT J SURG, V87, P1697, DOI 10.1046/j.1365-2168.2000.01589.x; Biggs D., 1991, J APPL STAT, V18, P49, DOI [DOI 10.1080/02664769100000005, 10.1080/02664769100000005]; Breiman L., 1984, CLASSIFICATION REGRE; Carter MJ, 2004, GUT, V53, DOI 10.1136/gut.2004.043372; De Cruz P, 2015, LANCET, V385, P1406, DOI 10.1016/S0140-6736(14)61908-5; Dias CC, 2016, J CROHN COLITIS; Dias CC, 2013, WORLD J GASTROENTERO, V19, P3866, DOI 10.3748/wjg.v19.i24.3866; Dignass A, 2010, J CROHNS COLITIS, V4, P28, DOI 10.1016/j.crohns.2009.12.002; Frolkis AD, 2014, AM J GASTROENTEROL, V109, P1739, DOI 10.1038/ajg.2014.297; Frolkis AD, 2013, GASTROENTEROLOGY, V145, P996, DOI 10.1053/j.gastro.2013.07.041; GEDII Group, 2016, GEDII DAT BAS; Loly C, 2008, SCAND J GASTROENTERO, V43, P948, DOI 10.1080/00365520801957149; Magro F, 2017, INFLAMM BOWEL DIS, V23, P289, DOI 10.1097/MIB.0000000000001007; OLAISON G, 1992, GUT, V33, P331, DOI 10.1136/gut.33.3.331; Silverberg MS, 2005, CAN J GASTROENTEROL, V19, p5A, DOI 10.1155/2005/269076; Yang CH, 2011, J DIGEST DIS, V12, P99, DOI 10.1111/j.1751-2980.2011.00484.x	18	11	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2017	12	2							e0172165	10.1371/journal.pone.0172165	http://dx.doi.org/10.1371/journal.pone.0172165			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5SK	28225800	gold, Green Published, Green Submitted			2022-12-27	WOS:000394680900030
J	Glastras, SJ; Chen, H; Tsang, M; Teh, R; McGrath, RT; Zaky, A; Chen, JS; Wong, MG; Pollock, CA; Saad, S				Glastras, Sarah J.; Chen, Hui; Tsang, Michael; Teh, Rachel; McGrath, Rachel T.; Zaky, Amgad; Chen, Jason; Wong, Muh Geot; Pollock, Carol A.; Saad, Sonia			The renal consequences of maternal obesity in offspring are overwhelmed by postnatal high fat diet	PLOS ONE			English	Article							OXIDATIVE STRESS; KIDNEY-DISEASE; PREMATURE MORTALITY; LIPID-ACCUMULATION; INSULIN-RESISTANCE; FOLLOW-UP; PREGNANCY; INFLAMMATION; METABOLISM; FIBROSIS	Aims/Hypothesis Developmental programming induced by maternal obesity influences the development of chronic disease in offspring. In the present study, we aimed to determine whether maternal obesity exaggerates obesity-related kidney disease. Methods Female C57BL/6 mice were fed high-fat diet (HFD) for six weeks prior to mating, during gestation and lactation. Male offspring were weaned to normal chow or HFD. At postnatal Week 8, HFD-fed offspring were administered one dose streptozotocin (STZ, 100 mg/kg i. p.) or vehicle control. Metabolic parameters and renal functional and structural changes were observed at postnatal Week 32. Results HFD-fed offspring had increased adiposity, glucose intolerance and hyperlipidaemia, associated with increased albuminuria and serum creatinine levels. Their kidneys displayed structural changes with increased levels of fibrotic, inflammatory and oxidative stress markers. STZ administration did not potentiate the renal effects of HFD. Though maternal obesity had a sustained effect on serum creatinine and oxidative stress markers in lean offspring, the renal consequences of maternal obesity were overwhelmed by the powerful effect of diet-induced obesity. Conclusion Maternal obesity portends significant risks for metabolic and renal health in adult offspring. However, diet-induced obesity is an overwhelming and potent stimulus for the development of CKD that is not potentiated by maternal obesity.	[Glastras, Sarah J.; Teh, Rachel; McGrath, Rachel T.; Zaky, Amgad; Wong, Muh Geot; Pollock, Carol A.; Saad, Sonia] Univ Sydney, Kolling Inst, Dept Med, Sydney, NSW, Australia; [Glastras, Sarah J.; McGrath, Rachel T.] Royal North Shore Hosp, Dept Diabet Endocrinol & Metab, St Leonards, NSW, Australia; [Chen, Hui; Tsang, Michael] Univ Technol Sydney, Fac Sci, Sch Life Sci, Sydney, NSW, Australia; [Chen, Jason] Royal North Shore Hosp, Dept Anat Pathol, St Leonards, NSW, Australia	University of Sydney; Kolling Institute of Medical Research; Royal North Shore Hospital; University of Technology Sydney; Royal North Shore Hospital	Glastras, SJ (corresponding author), Univ Sydney, Kolling Inst, Dept Med, Sydney, NSW, Australia.; Glastras, SJ (corresponding author), Royal North Shore Hosp, Dept Diabet Endocrinol & Metab, St Leonards, NSW, Australia.	sarah.glastras@sydney.edu.au	Glastras, Sarah J./AAL-2541-2020; Chen, Hui/D-2005-2014; Chen, Hui/R-6137-2019; Zaky, Amgad/D-8367-2015	Glastras, Sarah J./0000-0002-9317-1348; Chen, Hui/0000-0001-6883-3752; Chen, Hui/0000-0001-6883-3752; Zaky, Amgad/0000-0001-7738-5330; Saad, Sonia/0000-0001-8067-8046; McGrath, Rachel/0000-0003-3453-058X	Diabetes Australia; Diabetes Australia Research Trust [Y15G-POLC]	Diabetes Australia; Diabetes Australia Research Trust	This study was funded by Diabetes Australia; Diabetes Australia Research Trust grant Y15G-POLC awarded to S.J.G., CA.P., and S.S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey Robert A, 2014, BMC Res Notes, V7, P415, DOI 10.1186/1756-0500-7-415; Catalano PM, 2009, DIABETES CARE, V32, P1076, DOI 10.2337/dc08-2077; Decleves AE, 2014, KIDNEY INT, V85, P611, DOI 10.1038/ki.2013.462; Efstratiadis G, 2009, HIPPOKRATIA, V13, P224; Fernandez-Sanchez A, 2011, INT J MOL SCI, V12, P3117, DOI 10.3390/ijms12053117; Filler G, 2008, INT UROL NEPHROL, V40, P483, DOI 10.1007/s11255-007-9328-1; Forbes JM, 2008, DIABETES, V57, P1446, DOI 10.2337/db08-0057; Forsen T, 1997, BRIT MED J, V315, P837, DOI 10.1136/bmj.315.7112.837; Fraser A, 2010, CIRCULATION, V121, P2557, DOI 10.1161/CIRCULATIONAHA.109.906081; Gabbay E, 2015, BMC NEPHROL, V16, DOI 10.1186/s12882-015-0137-y; Gilbert ER, 2011, EXP DIABETES RES, V2011, P12; Glastras SJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep23525; Glastras SJ, 2015, NUTR METAB, V12, DOI 10.1186/s12986-015-0032-3; Glastras SJ, 2016, SCI REPORTS IN PRESS; Hall ME, 2014, INT J NEPHROL RENOV, V7, P75, DOI 10.2147/IJNRD.S39739; Hao J, 2012, BRIT J NUTR, V107, P74, DOI 10.1017/S0007114511002613; Hsu CW, 2014, J AM SOC NEPHROL, V25, P2105, DOI 10.1681/ASN.2013060582; Kume S, 2007, J AM SOC NEPHROL, V18, P2715, DOI 10.1681/ASN.2007010089; Lee KK, 2015, HYPERTENSION, V66, P938, DOI 10.1161/HYPERTENSIONAHA.115.05920; Li M, 2011, EXP DIABETES RES, DOI [10.1155/2011/592408, 10.4061/2011/179819]; Locatelli F, 2003, NEPHROL DIAL TRANSPL, V18, P1272, DOI 10.1093/ndt/gfg074; Malti N, 2014, PLACENTA, V35, P411, DOI 10.1016/j.placenta.2014.03.010; Matsuzawa-Nagata N, 2008, METABOLISM, V57, P1071, DOI 10.1016/j.metabol.2008.03.010; Mount P, 2015, METABOLITES, V5, P720, DOI 10.3390/metabo5040720; PARKER DJP, 1992, J EPIDEMIOL COMMUN H, V46, P8, DOI 10.1136/jech.46.1.8; Reynolds RM, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4539; Shao ML, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092574; Sharma K, 2015, DIABETES, V64, P663, DOI 10.2337/db14-0874; Sharma K, 2014, KIDNEY INT SUPPL, V4, P113, DOI 10.1038/kisup.2014.21; Small DM, 2012, NEPHROLOGY, V17, P311, DOI 10.1111/j.1440-1797.2012.01572.x; Sung CC, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/301982; van der Heijden RA, 2015, SCI REP-UK, V5, DOI 10.1038/srep16474; Wang ZW, 2005, DIABETES, V54, P2328, DOI 10.2337/diabetes.54.8.2328; Wicks SE, 2015, BIOCHIMIE; Wong M, 2014, AM J PHYSIOL-RENAL, V307, pF908, DOI 10.1152/ajprenal.00698.2013	35	22	22	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2017	12	2							e72644	10.1371/journal.pone.0172644	http://dx.doi.org/10.1371/journal.pone.0172644			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5SK	28225809	gold, Green Published, Green Submitted			2022-12-27	WOS:000394680900061
J	Smorodinova, N; Blaha, M; Melenovsky, V; Rozsivalova, K; Pridal, J; Durisova, M; Pirk, J; Kautzner, J; Kucera, T				Smorodinova, Natalia; Blaha, Martin; Melenovsky, Vojtech; Rozsivalova, Karolina; Pridal, Jaromir; Durisova, Maria; Pirk, Jan; Kautzner, Josef; Kucera, Tomas			Analysis of immune cell populations in atrial myocardium of patients with atrial fibrillation or sinus rhythm	PLOS ONE			English	Article							ELECTROPHYSIOLOGICAL CHARACTERISTICS; POSSIBLE INVOLVEMENT; STRUCTURAL-CHANGES; DENDRITIC CELLS; FIBROSIS; MECHANISMS; INFILTRATION; COINCIDES; SUBSTRATE; BIOPSIES	Background Atrial fibrillation (AF) is the most common arrhythmia and despite obvious clinical importance remains its pathogenesis only partially explained. A relation between inflammation and AF has been suggested by findings of increased inflammatory markers in AF patients. Objective The goal of this study was to characterize morphologically and functionally CD45-positive inflammatory cell populations in atrial myocardium of patients with AF as compared to sinus rhythm (SR). Methods We examined 46 subjects (19 with AF, and 27 in SR) undergoing coronary bypass or valve surgery. Peroperative bioptic samples of the left and the right atrial tissue were examined using immunohistochemistry. Results The number of CD3(+) T-lymphocytes and CD68-KP1+ cells were elevated in the left atrial myocardium of patients with AF compared to those in SR. Immune cell infiltration of LA was related to the rhythm, but not to age, body size, LA size, mitral regurgitation grade, type of surgery, systemic markers of inflammation or presence of diabetes or hypertension. Most of CD68-KP1+ cells corresponded to dendritic cell population based on their morphology and immunoreactivity for DC-SIGN. The numbers of mast cells and CD20(+) B-lymphocytes did not differ between AF and SR patients. No foci of inflammation were detected in any sample. Conclusions An immunohistochemical analysis of samples from patients undergoing open heart surgery showed moderate and site-specific increase of inflammatory cells in the atrial myocardium of patients with AF compared to those in SR, with prevailing population of monocyte-macrophage lineage. These cells and their cytokine products may play a role in atrial remodeling and AF persistence.	[Smorodinova, Natalia; Rozsivalova, Karolina; Pridal, Jaromir; Durisova, Maria; Kucera, Tomas] Charles Univ Prague, Fac Med 1, Inst Histol & Embryol, Prague, Czech Republic; [Blaha, Martin; Melenovsky, Vojtech; Kautzner, Josef] Inst Clin & Expt Med, IKEM, Dept Cardiol, Prague, Czech Republic; [Pirk, Jan] Inst Clin & Expt Med, IKEM, Dept Cardiovasc Surg, Prague, Czech Republic	Charles University Prague; Institute for Clinical & Experimental Medicine (IKEM); Institute for Clinical & Experimental Medicine (IKEM)	Kucera, T (corresponding author), Charles Univ Prague, Fac Med 1, Inst Histol & Embryol, Prague, Czech Republic.	tkucer@lf1.cuni.cz	Kučera, Tomáš/C-7532-2017; Smorodinova, Natalia/AAK-6820-2020; Rozsívalová, Karolína/P-2892-2017; Melenovsky, Vojtech/T-9422-2019; Blaha, Martin/G-5015-2015; Smorodinova, Natalia/Q-6111-2017	Kučera, Tomáš/0000-0003-2134-4657; Smorodinova, Natalia/0000-0003-1211-8703; Rozsívalová, Karolína/0000-0002-4903-0548; Melenovsky, Vojtech/0000-0001-8921-7078; Blaha, Martin/0000-0003-3597-6604; Smorodinova, Natalia/0000-0003-1211-8703; Blaha, Martin/0000-0003-4626-3757	Research Program of Charles University [PRVOUK P25/LF1/2]; Ministry of Health for Development of Research Organization [00023001]; EU [CZ.2.16/3.1.00/22126]	Research Program of Charles University; Ministry of Health for Development of Research Organization; EU(European Commission)	This work was supported by the Research Program of Charles University PRVOUK P25/LF1/2 (TK), www.cuni.cz, Ministry of Health for Development of Research Organization 00023001, http://www.mzcr.cz/ (IKEM, institutional support) (JK), and by the EU Operational Program PragueCompetitiveness: project CEVKOON (CZ.2.16/3.1.00/22126), http://www.ikem.cz/cs/centrum-exp-mediciny/cevkoon/a-1676/ (JK, VM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afanasyeva M, 2004, AUTOIMMUN REV, V3, P476, DOI 10.1016/j.autrev.2004.08.009; Aldhoon B, 2013, PHYSIOL RES, V62, P247, DOI 10.33549/physiolres.932409; Aldhoon B, 2010, PHYSIOL RES, V59, P1, DOI 10.33549/physiolres.931651; Allessie M, 2002, CARDIOVASC RES, V54, P230, DOI 10.1016/S0008-6363(02)00258-4; Ausma J, 1997, CIRCULATION, V96, P3157, DOI 10.1161/01.CIR.96.9.3157; Begieneman MPV, 2016, CARDIOVASC PATHOL, V25, P141, DOI 10.1016/j.carpath.2015.12.001; Begieneman MPV, 2015, AM J PATHOL, V185, P2096, DOI 10.1016/j.ajpath.2015.04.018; Boos CJ, 2006, EUR HEART J, V27, P136, DOI 10.1093/eurheartj/ehi645; Burstein B, 2008, J AM COLL CARDIOL, V51, P802, DOI 10.1016/j.jacc.2007.09.064; Caforio ALP, 2013, EUR HEART J, V34, P2636, DOI 10.1093/eurheartj/eht210; Calkins H, 2007, HEART RHYTHM, V4, P816, DOI 10.1016/j.hrthm.2007.04.005; Camm AJ, 2010, EUROPACE, V12, P1360, DOI [10.1093/europace/euq350, 10.1093/eurheartj/ehq278]; Chen MC, 2008, AM J CARDIOL, V102, P861, DOI 10.1016/j.amjcard.2008.05.038; Corradi D, 2004, VIRCHOWS ARCH, V445, P498, DOI 10.1007/s00428-004-1040-2; Corradi D, 2014, HEART RHYTHM, V11, P1250, DOI 10.1016/j.hrthm.2014.02.008; Corradi D, 2014, CARDIOVASC PATHOL, V23, P71, DOI 10.1016/j.carpath.2013.12.001; De Jong AM, 2011, CARDIOVASC RES, V89, P754, DOI 10.1093/cvr/cvq357; de Oliveira IM, 2013, CARDIOVASC PATHOL, V22, P65, DOI 10.1016/j.carpath.2012.06.001; Fabritz L, 2016, NAT REV CARDIOL, V13, P230, DOI 10.1038/nrcardio.2015.194; Frustaci A, 1997, CIRCULATION, V96, P1180, DOI 10.1161/01.CIR.96.4.1180; Guo YT, 2012, J AM COLL CARDIOL, V60, P2263, DOI 10.1016/j.jacc.2012.04.063; Haemers P, 2015, EUR HEART J; Heeringa J, 2006, EUR HEART J, V27, P949, DOI 10.1093/eurheartj/ehi825; Liao CH, 2010, J CLIN INVEST, V120, P242, DOI 10.1172/JCI39942; Maisch B, 2005, HERZ, V30, P535, DOI 10.1007/s00059-005-2730-5; Marty RR, 2006, INT J CARDIOL, V112, P34, DOI 10.1016/j.ijcard.2006.06.022; Nakamura Y, 2003, THROMB RES, V111, P137, DOI 10.1016/S0049-3848(03)00405-5; Nguyen BL, 2009, HEART RHYTHM, V6, P454, DOI 10.1016/j.hrthm.2009.01.010; Pandozi C, 1998, CIRCULATION, V98, P2860, DOI 10.1161/01.CIR.98.25.2860; Pistulli R, 2013, EUR J HEART FAIL, V15, P974, DOI 10.1093/eurjhf/hft054; Platonov PG, 2011, J AM COLL CARDIOL, V58, P2225, DOI 10.1016/j.jacc.2011.05.061; Qu YC, 2009, SCAND CARDIOVASC J, V43, P292, DOI 10.1080/14017430802651803; Rocken C, 2002, CIRCULATION, V106, P2091, DOI 10.1161/01.CIR.0000034511.06350.DF; Rudolph V, 2010, NAT MED, V16, P470, DOI 10.1038/nm.2124; Smorodinova N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129124; van Brakel TJ, 2013, J INTERV CARD ELECTR, V38, P85, DOI 10.1007/s10840-013-9820-8; Verheule S, 2003, CIRCULATION, V107, P2615, DOI 10.1161/01.CIR.0000066915.15187.51; Wakili R, 2011, J CLIN INVEST, V121, P2955, DOI 10.1172/JCI46315; Wu H, 2015, INT J CLIN EXP PATHO, V8, P6859; Yamashita T, 2015, J ARRYTHM, V31, P78, DOI 10.1016/j.joa.2014.07.003; Yamashita T, 2010, CIRC J, V74, P262, DOI 10.1253/circj.CJ-09-0644	41	32	33	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2017	12	2							e72691	10.1371/journal.pone.0172691	http://dx.doi.org/10.1371/journal.pone.0172691			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5SK	28225836	Green Published, Green Submitted, gold			2022-12-27	WOS:000394680900064
J	Ijaz, UZ; Quince, C; Hanske, L; Loman, N; Calus, ST; Bertz, M; Edwards, CA; Gaya, DR; Hansen, R; McGrogan, P; Russell, RK; Gerasimidis, K				Ijaz, Umer Zeeshan; Quince, Christopher; Hanske, Laura; Loman, Nick; Calus, Szymon T.; Bertz, Martin; Edwards, Christine A.; Gaya, Daniel R.; Hansen, Richard; McGrogan, Paraic; Russell, Richard K.; Gerasimidis, Konstantinos			The distinct features of microbial 'dysbiosis' of Crohn's disease do not occur to the same extent in their unaffected, genetically-linked kindred	PLOS ONE			English	Article							ALIGNMENT; TWIN	Background/Aims Studying the gut microbiota in unaffected relatives of people with Crohn's disease (CD) may advance our understanding of the role of bacteria in disease aetiology. Methods Faecal microbiota composition (16S rRNA gene sequencing), genetic functional capacity (shotgun metagenomics) and faecal short chain fatty acids (SCFA) were compared in unaffected adult relatives of CD children (CDR, n = 17) and adult healthy controls, unrelated to CD patients (HUC, n = 14). The microbiota characteristics of 19 CD children were used as a benchmark of CD 'dysbiosis'. Results The CDR microbiota was less diverse (p = 0.044) than that of the HUC group. Local contribution of beta-diversity analysis showed no difference in community structure between the CDR and HUC groups. Twenty one of 1,243 (1.8%) operational taxonomic units discriminated CDR from HUC. The metagenomic functional capacity (p = 0.207) and SCFA concentration or pattern were similar between CDR and HUC (p > 0.05 for all SCFA). None of the KEGG metabolic pathways were different between these two groups. Both of these groups (HUC and CDR) had a higher microbiota a-diversity (CDR, p = 0.026 and HUC, p < 0.001) with a community structure (beta-diversity) distinct from that of children with CD. Conclusions While some alterations were observed, a distinct microbial 'dysbiosis', characteristic of CD patients, was not observed in their unaffected, genetically linked kindred.	[Ijaz, Umer Zeeshan] Univ Glasgow, Sch Engn, Glasgow, Lanark, Scotland; [Quince, Christopher] Univ Warwick, Warwick Med Sch, Warwick, England; [Hanske, Laura; Bertz, Martin; Edwards, Christine A.; Gerasimidis, Konstantinos] Univ Glasgow, Glasgow Royal Infirm, Coll Med Vet & Life Sci, Sch Med Dent & Nursing,Human Nutr, Glasgow, Lanark, Scotland; [Loman, Nick; Calus, Szymon T.] Univ Birmingham, Inst Microbiol & Infect, Birmingham, W Midlands, England; [Gaya, Daniel R.] Glasgow Royal Infirm, Gastroenterol Unit, Glasgow, Lanark, Scotland; [Hansen, Richard; McGrogan, Paraic; Russell, Richard K.] Royal Hosp Children, Dept Paediat Gastroenterol Hepatol & Nutr, Glasgow, Lanark, Scotland	University of Glasgow; University of Warwick; University of Glasgow; University of Birmingham; University of Glasgow	Gerasimidis, K (corresponding author), Univ Glasgow, Glasgow Royal Infirm, Coll Med Vet & Life Sci, Sch Med Dent & Nursing,Human Nutr, Glasgow, Lanark, Scotland.	konstantinos.gerasimidis@glasgow.ac.uk	Loman, Nicholas/Z-1573-2019; Calus, Szymon/L-8419-2019; Edwards, christine/AGQ-4192-2022	Calus, Szymon/0000-0002-0977-1819; Quince, Christopher/0000-0003-1884-8440; Gerasimidis, Konstantinos/0000-0001-9432-2200; Bertz, Martin/0000-0002-6343-1524; Edwards, Christine/0000-0003-0406-918X; Hansen, Richard/0000-0002-3944-6646; Ijaz, Umer Zeeshan/0000-0001-5780-8551; Loman, Nicholas/0000-0002-9843-8988	Greek State Scholarship Foundation; Hellenic Foundation of Gastroenterology; Nutrition and the Barr Endowment Fund; Yorkhill Children's Foundation; Crohn's in Childhood Research Association (CICRA); NERC [IRF NE/L011956/1]; MRC as part of the Cloud Infrastructure for Microbial Genomics (CLIMB) consortium [MR/M50161X/1, MW L015080/1]; NHS Research Scotland career fellowship award; Catherine McEwan Foundation; Yorkhill IBD fund; MRC [MR/L015080/1] Funding Source: UKRI; NERC [NE/L011956/1] Funding Source: UKRI; Medical Research Council [MR/M50161X/1, MR/M501621/1, MR/L015080/1] Funding Source: researchfish; Natural Environment Research Council [NE/L011956/1] Funding Source: researchfish	Greek State Scholarship Foundation(Greek Ministry of Development-GSRT); Hellenic Foundation of Gastroenterology; Nutrition and the Barr Endowment Fund; Yorkhill Children's Foundation; Crohn's in Childhood Research Association (CICRA); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); MRC as part of the Cloud Infrastructure for Microbial Genomics (CLIMB) consortium(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NHS Research Scotland career fellowship award; Catherine McEwan Foundation; Yorkhill IBD fund; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	KG received a postgraduate studentship by the Greek State Scholarship Foundation, the Hellenic Foundation of Gastroenterology, and Nutrition and the Barr Endowment Fund; Part of the running costs were funded by competitive grants from the Yorkhill Children's Foundation and the Crohn's in Childhood Research Association (CICRA). UZI is funded by NERC IRF NE/L011956/1. CQ is funded by an MRC fellowship MR/M50161X/1 as part of the Cloud Infrastructure for Microbial Genomics (CLIMB) consortium - MW L015080/1. RKR, RH and DG are supported by an NHS Research Scotland career fellowship award. The IBD team at the Royal Hospital for Children, Glasgow is supported by the Catherine McEwan Foundation and Yorkhill IBD fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Dicksved J, 2008, ISME J, V2, P716, DOI 10.1038/ismej.2008.37; Falony G, 2016, SCIENCE, V352, P560, DOI 10.1126/science.aad3503; Gerasimidis K, 2014, INFLAMM BOWEL DIS, V20, P861, DOI 10.1097/MIB.0000000000000023; Gevers D, 2014, CELL HOST MICROBE, V15, P382, DOI 10.1016/j.chom.2014.02.005; Halfvarson J, 2003, GASTROENTEROLOGY, V124, P1767, DOI 10.1016/S0016-5085(03)00385-8; Hedin C, 2015, GUT; Hedin CR, 2014, GUT, V63, P1578, DOI 10.1136/gutjnl-2013-306226; Joossens M, 2011, GUT, V60, P631, DOI 10.1136/gut.2010.223263; Joshi NAF, 2015, SLIDING WINDOW ADAPT; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Legendre P, 2013, ECOL LETT, V16, P951, DOI 10.1111/ele.12141; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Masella AP, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-31; McMurdie PJ, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003531; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Meijer K, 2010, CURR OPIN CLIN NUTR, V13, P715, DOI 10.1097/MCO.0b013e32833eebe5; Michielan A, 2013, DIGEST LIVER DIS, V45, P894, DOI 10.1016/j.dld.2013.01.017; Oksanen J., 2019, VEGAN COMMUNITY ECOL; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Quince C, 2015, AM J GASTROENTEROL, V110, P1718, DOI 10.1038/ajg.2015.357; Sartor RB, 2008, GASTROENTEROLOGY, V134, P577, DOI 10.1053/j.gastro.2007.11.059; Segata N, 2012, NAT METHODS, V9, P811, DOI [10.1038/NMETH.2066, 10.1038/nmeth.2066]; Teran-Ventura E, 2014, J CROHNS COLITIS, V8, P1043, DOI 10.1016/j.crohns.2014.02.001; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Watanabe Y, 2012, APPL ENVIRON MICROB, V78, P511, DOI 10.1128/AEM.06035-11; Willing B, 2009, INFLAMM BOWEL DIS, V15, P653, DOI 10.1002/ibd.20783; Ye YZ, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000465	30	22	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2017	12	2							e0172605	10.1371/journal.pone.0172605	http://dx.doi.org/10.1371/journal.pone.0172605			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5QV	28222161	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000394676800072
J	Sandmann, S; de Graaf, AO; van der Reijden, BA; Jansen, JH; Dugas, M				Sandmann, Sarah; de Graaf, Aniek O.; van der Reijden, Bert A.; Jansen, Joop H.; Dugas, Martin			GLM-based optimization of NGS data analysis: A case study of Roche 454, Ion Torrent PGM and Illumina NextSeq sequencing data	PLOS ONE			English	Article							GENOME	Background There are various next-generation sequencing techniques, all of them striving to replace Sanger sequencing as the gold standard. However, false positive calls of single nucleotide variants and especially indels are a widely known problem of basically all sequencing platforms. Methods We considered three common next-generation sequencers-Roche 454, Ion Torrent PGM and Illumina NextSeq- and applied standard as well as optimized variant calling pipelines. Optimization was achieved by combining information of 23 diverse parameters characterizing the reported variants and generating individually calibrated generalized linear models. Models were calibrated using amplicon-based targeted sequencing data (19 genes, 28,775 bp) from seven to 12 myelodysplastic syndrome patients. Evaluation of the optimized pipelines and platforms was performed using sequencing data from three additional myelodysplastic syndrome patients. Results Using standard analysis methods, true mutations were missed and the obtained results contained many artifacts-no matter which platform was considered. Analysis of the parameters characterizing the true and false positive calls revealed significant platform-and variant specific differences. Application of optimized variant calling pipelines considerably improved results. 76% of all false positive single nucleotide variants and 97% of all false positive indels could be filtered out. Positive predictive values could be increased by factors of 1.07 to 1.27 in case of single nucleotide variant calling and by factors of 3.33 to 53.87 in case of indel calling. Application of the optimized variant calling pipelines leads to comparable results for all next-generation sequencing platforms analyzed. However, regarding clinical diagnostics it needs to be considered that even the optimized results still contained false positive as well as false negative calls.	[Sandmann, Sarah; Dugas, Martin] Univ Munster, Inst Med Informat, Munster, Germany; [de Graaf, Aniek O.; van der Reijden, Bert A.; Jansen, Joop H.] RadboudUMC, Hematol Lab, Nijmegen, Netherlands	University of Munster; Radboud University Nijmegen	Sandmann, S (corresponding author), Univ Munster, Inst Med Informat, Munster, Germany.	Sarah.Sandmann@uni-muenster.de	Sandmann, Sarah/X-6727-2019; van der Reijden, Bert A/A-3543-2014; Jansen, J.H./H-8054-2014; de Graaf, Aniek O./G-4745-2016	Sandmann, Sarah/0000-0002-5011-0641; Jansen, J.H./0000-0001-9459-568X; Dugas, Martin/0000-0001-9740-0788	 [BMBF 01KT1401];  [634789]	; 	This work was supported by Grant no. BMBF 01KT1401 (http://www.transcanfp7.eu/abstract/triage-mds.html) and Grant no. 634789 (https://mds-europe.eu/right, http://www.horizont2020.de/).	Bennett S., 2004, PHARMACOGENOMICS, V4; Bragg LM, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003031; Burnham KP, 2002, MODEL SELECTION MULT, V2nd, DOI [DOI 10.1007/B97636, 10.1007/978-1-4757-2917-7, DOI 10.1007/978-1-4757-2917-7]; Chin ELH, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-6; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Ewing AD, 2015, NAT METHODS, V12, P623, DOI [10.1038/NMETH.3407, 10.1038/nmeth.3407]; Gilles A, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-245; Harismendy O, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r32; Hoffmann S, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000502; Hog BB, 2016, PREV VET MED, V130, P137, DOI 10.1016/j.prevetmed.2016.04.002; Homer N, 2010, TMAP TORRENT MAPPING; Janitz M., 2008, GENERATION GENOME SE; Lam HYK, 2012, NAT BIOTECHNOL, V30, P78, DOI 10.1038/nbt.2065; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Liu L, 2012, J BIOMED BIOTECHNOL; Loman NJ, 2012, NAT BIOTECHNOL, V30, P434, DOI 10.1038/nbt.2198; Nakamura K, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr344; Quail MA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-341; R Core Team, 2021, R LANGUAGE ENV STAT; Ross MG, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-5-r51; Rothberg JM, 2011, NATURE, V475, P348, DOI 10.1038/nature10242; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Sato A, 2016, J EPIDEMIOL, V26, P646, DOI 10.2188/jea.JE20150106; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Yeo ZX, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-516; Yeo ZX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045798	27	5	5	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2017	12	2							e0171983	10.1371/journal.pone.0171983	http://dx.doi.org/10.1371/journal.pone.0171983			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5QV	28222155	Green Published, gold, Green Submitted			2022-12-27	WOS:000394676800026
J	Rodriguez-Rodriguez, P; Pablo, ALL; Garcia-Prieto, CF; Somoza, B; Quintana-Villamandos, B; de Diego, JJG; Gutierrez-Arzapalo, PY; Ramiro-Cortijo, D; Gonzalez, MC; Arribas, SM				Rodriguez-Rodriguez, Pilar; Lopez de Pablo, Angel L.; Garcia-Prieto, Concha F.; Somoza, Beatriz; Quintana-Villamandos, Begona; Gomez de Diego, Jose J.; Gutierrez-Arzapalo, Perla Y.; Ramiro-Cortijo, David; Carmen Gonzalez, M.; Arribas, Silvia M.			Long term effects of fetal undernutrition on rat heart. Role of hypertension and oxidative stress	PLOS ONE			English	Article							INTRAUTERINE GROWTH RESTRICTION; LEFT-VENTRICULAR HYPERTROPHY; RENIN-ANGIOTENSIN SYSTEM; LOW-PROTEIN DIET; CATCH-UP GROWTH; CARDIOVASCULAR-DISEASE; BIRTH-WEIGHT; GENDER-DIFFERENCES; BLOOD-PRESSURE; PREGNANCY	Background and aims Fetal undernutrition is a risk factor for heart disease in both genders, despite the protection of women against hypertension development. Using a rat model of maternal undernutrition ( MUN) we aimed to assess possible sex differences in the development of cardiac alterations and the implication of hypertension and cardiac oxidative stress. Methods Male and female offspring from rats fed ad libitum ( control) or with 50% of the normal daily intake during the second half of gestation ( MUN) were used. Heart weight/body weight ratio ( HW/BW), hemodynamic parameters ( anaesthetized rats) and plasma brain natriuretic peptide ( BNP, ELISA) were assessed in 21-day, 6-month and 22-month old rats. Plasma testosterone ( ELISA) and cardiac protein expression of enzymes related to reactive oxygen species synthesis ( p22 phox, xanthine-oxidase) and degradation ( catalase, Cu/Zn-SOD, Mn-SOD, Ec-SOD) were evaluated in 21-day and 6-month old rats ( Western Blot). Heart structure and function was studied at the age of 22 months ( echocardiography). Results At the age of 21 days MUN males exhibited significantly larger HW/BW and cardiac p22 phox expression while females had reduced p22 phox expression, compared to their respective sex-matched controls. At the age of 6-months, MUN males showed significantly larger blood pressure and cardiac xanthine-oxidase expression; MUN females were normotensive and had a lower cardiac expression of antioxidant enzymes, compared to their respective sex-matched controls. At the age of 22 months, both MUN males and females showed larger HW/BW and left ventricular mass and lower ejection fraction compared to sex-matched controls; only MUN males exhibited hypertension and a larger plasma BNP compared to aged male controls. Conclusions 1) During perinatal life females exposed to fetal undernutrition are protected from cardiac alterations, but in ageing they exhibit ventricular hypertrophy and functional loss, like MUN males; 2) cardiac oxidative stress might be implicated in the observed heart alterations in both sexes and 3) the severity of cardiac damage might be greater in males due to hypertension.	[Rodriguez-Rodriguez, Pilar; Lopez de Pablo, Angel L.; Gutierrez-Arzapalo, Perla Y.; Ramiro-Cortijo, David; Carmen Gonzalez, M.; Arribas, Silvia M.] Univ Autonoma Madrid, Fac Med, Dept Fisiol, Madrid, Spain; [Garcia-Prieto, Concha F.; Somoza, Beatriz] Univ CEU San Pablo, Dept Ciencias Expt & Salud, Fac Farm, Madrid, Spain; [Quintana-Villamandos, Begona] Hosp Gen Univ Gregorio Maranon, Dept Anestesiol & Reanimac, Madrid, Spain; [Gomez de Diego, Jose J.] Hosp Clin San Carlos, Dept Cardiol, Madrid, Spain	Autonomous University of Madrid; San Pablo CEU University; General University Gregorio Maranon Hospital; Hospital Clinico San Carlos	Arribas, SM (corresponding author), Univ Autonoma Madrid, Fac Med, Dept Fisiol, Madrid, Spain.	silvia.arribas@uam.es	Ramiro Cortijo, David/V-1217-2019; Somoza, Beatriz/M-1260-2017; Rodríguez-Rodríguez, Pilar/Q-7664-2016; Gonzalez-Garcia, M Carmen/AAE-9533-2019	Ramiro Cortijo, David/0000-0001-7442-1586; Rodríguez-Rodríguez, Pilar/0000-0002-6483-8289; Gonzalez-Garcia, M Carmen/0000-0002-5522-0786; Gutierrez Arzapalo, Perla Yareli/0000-0002-3713-3056; Arribas, Silvia M/0000-0001-7103-6105; Somoza, Beatriz/0000-0003-1232-7791				Alexander BT, 2015, COMPR PHYSIOL, V5, P997, DOI 10.1002/cphy.c140036; [Anonymous], 2014, PHYSIOLOGY, V29, P4, DOI 10.1152/physiol.00064.2013; Balakumar P, 2014, CELL SIGNAL, V26, P2147, DOI 10.1016/j.cellsig.2014.06.011; Barker D J, 1997, Rev Reprod, V2, P105, DOI 10.1530/ror.0.0020105; BARKER DJP, 1986, LANCET, V1, P1077; Battista MC, 2005, J PHYSIOL-LONDON, V565, P197, DOI 10.1113/jphysiol.2004.078139; Byrne JA, 2003, ARCH MAL COEUR VAISS, V96, P214; Condezo-Hoyos L, 2012, J HYPERTENS, V30, P1185, DOI 10.1097/HJH.0b013e328353824b; Corstius HB, 2005, PEDIATR RES, V57, P796, DOI 10.1203/01.PDR.0000157726.65492.CD; Daniels LB, 2007, J AM COLL CARDIOL, V50, P2357, DOI 10.1016/j.jacc.2007.09.021; Dasinger JH, 2016, CLIN SCI, V130, P337, DOI 10.1042/CS20150611; DEVEREUX RB, 1987, HYPERTENSION, V9, P19; Elmes MJ, 2007, BRIT J NUTR, V98, P93, DOI 10.1017/S000711450769182X; Eriksson JG, 1999, BMJ-BRIT MED J, V318, P427, DOI 10.1136/bmj.318.7181.427; Fabiansen C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140472; Fischer M, 2002, CARDIOVASC RES, V53, P672, DOI 10.1016/S0008-6363(01)00479-5; Franco MCP, 2007, LIFE SCI, V80, P709, DOI 10.1016/j.lfs.2006.10.028; Gezmish O, 2010, REPROD SCI, V17, P168, DOI 10.1177/1933719109349536; Gopalakrishnan K, 2016, HYPERTENSION, V67, P630, DOI 10.1161/HYPERTENSIONAHA.115.06946; Gray C, 2014, ENDOCRINOLOGY, V155, P4808, DOI 10.1210/en.2014-1567; Grigore D, 2008, GENDER MED, V5, pS121, DOI 10.1016/j.genm.2008.03.012; Hu XW, 2000, CARDIOVASC RES, V48, P233, DOI 10.1016/S0008-6363(00)00167-X; Huxley VH, 2007, ADV PHYSIOL EDUC, V31, P17, DOI 10.1152/advan.00099.2006; Intapad S, 2013, HYPERTENSION, V61, P828, DOI 10.1161/HYPERTENSIONAHA.111.00645; Jauniaux E, 2000, AM J PATHOL, V157, P2111, DOI 10.1016/S0002-9440(10)64849-3; Lawlor DA, 2004, J EPIDEMIOL COMMUN H, V58, P120, DOI 10.1136/jech.58.2.120; Manikkam M, 2004, ENDOCRINOLOGY, V145, P790, DOI 10.1210/en.2003-0478; Mosca L, 2011, CIRCULATION, V124, P2145, DOI 10.1161/CIRCULATIONAHA.110.968792; OSMOND C, 1993, BRIT MED J, V307, P1519, DOI 10.1136/bmj.307.6918.1519; Ozaki T, 2001, J PHYSIOL-LONDON, V530, P141, DOI 10.1111/j.1469-7793.2001.0141m.x; Painter RC, 2005, REPROD TOXICOL, V20, P345, DOI 10.1016/j.reprotox.2005.04.005; Quintana-Villamandos B, 2013, HYPERTENS RES, V36, P408, DOI 10.1038/hr.2012.191; Reyes-Hernandez CG, 2016, J PHYSL BIOCH, V72, p[1, S64]; RichEdwards JW, 1997, BRIT MED J, V315, P396, DOI 10.1136/bmj.315.7105.396; Rodriguez-Rodriguez P, 2015, J NUTR BIOCHEM, V26, P1650, DOI 10.1016/j.jnutbio.2015.08.004; Rueda-Clausen CF, 2009, CARDIOVASC RES, V81, P713, DOI 10.1093/cvr/cvn341; SAVOLA JM, 1989, ACTA VET SCAND, P39; Sinclair MD, 2003, CAN VET J, V44, P885; Sirker A, 2007, AM J NEPHROL, V27, P649, DOI 10.1159/000109148; Somoza B, 2007, ENDOCRINOLOGY, V148, P924, DOI 10.1210/en.2006-0914; Stacy V, 2009, ANAT REC, V292, P29, DOI 10.1002/ar.20789; Stein CE, 1996, LANCET, V348, P1269, DOI 10.1016/S0140-6736(96)04547-3; Tappia PS, 2013, NUTR METAB CARDIOVAS, V23, P130, DOI 10.1016/j.numecd.2011.03.010; Tarrade A, 2015, J EXP BIOL, V218, P50, DOI 10.1242/jeb.110320; Tarry-Adkins JL, 2013, FASEB J, V27, P379, DOI 10.1096/fj.12-218685; Veskoukis AS, 2009, FREE RADICAL BIO MED, V47, P1371, DOI 10.1016/j.freeradbiomed.2009.07.014; Woods LL, 2005, AM J PHYSIOL-REG I, V289, pR1131, DOI 10.1152/ajpregu.00037.2003; Xu Y, 2006, FASEB J, V20, P1251, DOI 10.1096/fj.05-4917fje	48	31	31	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2017	12	2							e0171544	10.1371/journal.pone.0171544	http://dx.doi.org/10.1371/journal.pone.0171544			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BI	28212445	Green Submitted, Green Published, gold			2022-12-27	WOS:000394424700008
J	Jin, YB; Zhang, GY; Lin, KR; Chen, XP; Cui, JH; Wang, YJ; Luo, W				Jin, Ya-bin; Zhang, Guo-yi; Lin, Kai-Rong; Chen, Xiang-ping; Cui, Jin-Huan; Wang, Yue-jian; Luo, Wei			Changes of plasma cytokines and chemokines expression level in nasopharyngeal carcinoma patients after treatment with definitive intensity-modulated radiotherapy (IMRT)	PLOS ONE			English	Article							PROSTATE-CANCER GROWTH; METASTASIS; CCL2	Background Potential clinical application values of certain cytokines and chemokines that participate in the process of tumor growth, invasion, and metastasis have been reported. However, there still lack of biomarkers for a great many of malignancy. This study identified cytokines or chemokines involved in the occurrence and development of nasopharyngeal carcinoma (NPC), which might be a biomarker for noninvasive early diagnosis. Methods The plasma levels of 19 cytokines and chemokines were detected by the luminex liquid array-based multiplexed immunoassays in 39 NPC patients before and after treatment by definitive intensity-modulated radiotherapy (IMRT). Results Plasma levels of almost all of the 19 cytokines and chemokines in NPC patients were higher than healthy controls, while only IFN-y, IL-1b IL-6, MCP-1, TNF-alpha, FKN, IL-12P70, IL-2, IL-5 and IP-10 showed significant differences. However, expression levels of most of the 19 cytokines and chemokines decreased after therapy, especially IFN-y, IL-10, IL-1b, IL-6, IL-8, MCP-1, TNF-a, VEGF, IL-17A, IL-2, IL-5 and MIP-1 b, have a dramatic decline. Taking together, plasma levels of IFN-y, IL-1b, IL-6, MCP-1, TNF-a, IL-2 and IL-5 are significantly increased in NPC patients and dramatically decreased after treatment, suggesting these cytokines and chemokines might play important roles in the progress of NPC. More interestingly, the expression level of MPC-1 is significantly associated with clinical stage. Conclusion MCP-1 might involve in the genesis and development process of NPC, which might serve as a noninvasive biomarker for early diagnosis.	[Jin, Ya-bin; Lin, Kai-Rong; Chen, Xiang-ping; Cui, Jin-Huan; Luo, Wei] Sun Yat Sen Univ, Foshan Hosp, Clin Res Inst, Foshan, Guangdong, Peoples R China; [Jin, Ya-bin; Zhang, Guo-yi; Lin, Kai-Rong; Chen, Xiang-ping; Cui, Jin-Huan; Wang, Yue-jian; Luo, Wei] Sun Yat Sen Univ, Foshan Hosp, Dept Otolaryngol Head & Neck Surg, Head & Neck Canc Res, Foshan, Guangdong, Peoples R China; [Zhang, Guo-yi] Sun Yat Sen Univ, Foshan Hosp, Ctr Canc, Foshan, Guangdong, Peoples R China; [Wang, Yue-jian] Sun Yat Sen Univ, Foshan Hosp, Otolaryngol Head & Neck Surg, Foshan, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Luo, W (corresponding author), Sun Yat Sen Univ, Foshan Hosp, Clin Res Inst, Foshan, Guangdong, Peoples R China.; Wang, YJ; Luo, W (corresponding author), Sun Yat Sen Univ, Foshan Hosp, Dept Otolaryngol Head & Neck Surg, Head & Neck Canc Res, Foshan, Guangdong, Peoples R China.; Wang, YJ (corresponding author), Sun Yat Sen Univ, Foshan Hosp, Otolaryngol Head & Neck Surg, Foshan, Guangdong, Peoples R China.	wyjian@fsyyy.com; luowei_421@163.com		Wang, Yuejian/0000-0002-7300-8367	National Natural Science Foundation of China [81402255]; Guangdong Province Natural Science Funds for Distinguished Young Scholar [2016A030306050]; Guangdong Province Natural Science Funds [2014A030313803]; Science and technology innovation platform in Foshan city [2015AG10002]; Science and Technology Planning Project of Guangdong Province [2016A020215005]; "Guangdong TeZhi program" youth science and technology talent of project [2015TQ01R462]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Province Natural Science Funds for Distinguished Young Scholar; Guangdong Province Natural Science Funds; Science and technology innovation platform in Foshan city; Science and Technology Planning Project of Guangdong Province; "Guangdong TeZhi program" youth science and technology talent of project	This work was funded by Grants from National Natural Science Foundation of China (81402255; Wei Luo) & Guangdong Province Natural Science Funds for Distinguished Young Scholar (2016A030306050; Wei Luo) & Guangdong Province Natural Science Funds (2014A030313803; Wei Luo) & Science and technology innovation platform in Foshan city (2015AG10002; Wei Luo) & Science and Technology Planning Project of Guangdong Province (2016A020215005; Yue-jian Wang) & "Guangdong TeZhi program" youth science and technology talent of project (2015TQ01R462; Wei Luo).	Cao Su-Mei, 2011, Chin J Cancer, V30, P114; Chang KP, 2011, HEAD NECK-J SCI SPEC, V33, P886, DOI 10.1002/hed.21557; Guo R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129679; Kan R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127239; Lin JC, 1998, CANCER-AM CANCER SOC, V83, P635, DOI 10.1002/(SICI)1097-0142(19980815)83:4<635::AID-CNCR2>3.0.CO;2-J; Liu SY, 2014, ADV MECH ENG, DOI 10.1155/2014/868041; Liu X, 2012, CURR CANCER DRUG TAR, V12, P561, DOI 10.2174/156800912800673293; Liu Y, 2015, CELL MOL IMMUNOL, V12, DOI 10.1038/cmi.2014.83; Lu X, 2011, EUR J CANCER, V47, P339, DOI 10.1016/j.ejca.2010.09.025; Lu Y, 2006, PROSTATE, V66, P1311, DOI 10.1002/pros.20464; Qian BZ, 2011, NATURE, V475, P222, DOI 10.1038/nature10138; Raman D, 2007, CANCER LETT, V256, P137, DOI 10.1016/j.canlet.2007.05.013; Salazar N, 2013, CRIT REV EUKAR GENE, V23, P77, DOI 10.1615/CritRevEukaryotGeneExpr.2013006905; Savitri Eka, 2015, Glob J Health Sci, V7, P364, DOI 10.5539/gjhs.v7n3p364; Vitiello PF, 2004, IMMUNOL LETT, V91, P239, DOI 10.1016/j.imlet.2003.12.009; Yang ZH, 2012, CANCER SCI, V103, P653, DOI 10.1111/j.1349-7006.2012.02210.x; Zhu ZQ, 2013, CANCER RES, V73, P595, DOI 10.1158/0008-5472.CAN-12-1123	17	13	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0172264	10.1371/journal.pone.0172264	http://dx.doi.org/10.1371/journal.pone.0172264			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207826	Green Published, gold, Green Submitted			2022-12-27	WOS:000394424500109
J	Gonzalez, SN; Valsecchi, WM; Maugeri, D; Delfino, JM; Cazzulo, JJ				Natalia Gonzalez, Soledad; Mariela Valsecchi, Wanda; Maugeri, Dante; Maria Delfino, Jose; Jose Cazzulo, Juan			Structure, kinetic characterization and subcellular localization of the two ribulose 5-phosphate epimerase isoenzymes from Trypanosoma cruzi	PLOS ONE			English	Article							PENTOSE-PHOSPHATE PATHWAY; CYTOSOLIC D-RIBULOSE-5-PHOSPHATE 3-EPIMERASE; ISOMERASE B; ESCHERICHIA-COLI; PURIFICATION; LEISHMANIA; ENZYME; GLUCOSE-6-PHOSPHATE-DEHYDROGENASE; BRUCEI; TRANSKETOLASE	The enzyme of the pentose phosphate pathway (PPP) ribulose-5-phosphate-epimerase (RPE) is encoded by two genes present in the genome of Trypanosoma cruzi CL Brener clone: TcRPE1 and TcRPE2. Despite high sequence similarity at the amino acid residue level, the recombinant isoenzymes show a strikingly different kinetics. Whereas TcRPE2 follows a typical michaelian behavior, TcRPE1 shows a complex kinetic pattern, displaying a biphasic curve, suggesting the coexistence of -at least-two kinetically different molecular forms. Regarding the subcellular localization in epimastigotes, whereas TcRPE1 is a cytosolic enzyme, TcRPE2 is localized in glycosomes. To our knowledge, TcRPE2 is the first PPP isoenzyme that is exclusively localized in glycosomes. Over-expression of TcRPE1, but not of TcRPE2, significantly reduces the parasite doubling time in vitro, as compared with wild type epimastigotes. Both TcRPEs represent single domain proteins exhibiting the classical alpha/beta TIM-barrel fold, as expected for enzymes with this activity. With regard to the architecture of the active site, all the important amino acid residues for catalysis -with the exception of M58-are also present in both TcRPEs models. The superimposition of the binding pocket of both isoenzyme models shows that they adopt essentially identical positions in the active site with a residue specific RMSD < 2 angstrom, with the sole exception of S12, which displays a large deviation (residue specific RMSD: 11.07 angstrom). Studies on the quaternary arrangement of these isoenzymes reveal that both are present in a mixture of various oligomeric species made up of an even number of molecules, probably pointing to the dimer as their minimal functional unit. This multiplicity of oligomeric species has not been reported for any of the other RPEs studied so far and it might bear implications for the regulation of TcRPEs activity, although further investigation will be necessary to unravel the physiological significance of these structural findings.	[Natalia Gonzalez, Soledad; Maugeri, Dante; Jose Cazzulo, Juan] Univ Nacl San Martin UNSAM, CONICET, Inst Invest Biotecnol Dr Rodolfo A Ugalde, Inst Tecnol Chascomus Dr Raul Alfonsin IIB INTECH, Campus Miguelete, Buenos Aires, DF, Argentina; [Mariela Valsecchi, Wanda; Maria Delfino, Jose] Univ Buenos Aires, Inst Quim & Fisicoquim Biol, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Gonzalez, SN (corresponding author), Univ Nacl San Martin UNSAM, CONICET, Inst Invest Biotecnol Dr Rodolfo A Ugalde, Inst Tecnol Chascomus Dr Raul Alfonsin IIB INTECH, Campus Miguelete, Buenos Aires, DF, Argentina.	sgonzalez@iibintech.com.ar		Valsecchi, Wanda Mariela/0000-0002-8066-5445	National Agency for Promotion of Scientific and Technological Research; Argentinian Ministry of Science and Technology (ANPCyT, MinCyT) [PICT 2013-0969, PICT 2011-0861]	National Agency for Promotion of Scientific and Technological Research; Argentinian Ministry of Science and Technology (ANPCyT, MinCyT)	This work was supported by the National Agency for Promotion of Scientific and Technological Research, from the Argentinian Ministry of Science and Technology (ANPCyT, MinCyT), grant PICT 2013-0969 (JJC), grant PICT 2011-0861(JMD) (URL:www.agencia.mincyt.gob.ar). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akana J, 2006, BIOCHEMISTRY-US, V45, P2493, DOI 10.1021/bi052474m; Bar J, 1996, BIOSEPARATION, V6, P233; Barrett MP, 1997, PARASITOL TODAY, V13, P11, DOI 10.1016/S0169-4758(96)10075-2; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Benkert P, 2009, NUCLEIC ACIDS RES, V37, pW510, DOI 10.1093/nar/gkp322; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Blattner J, 1998, P NATL ACAD SCI USA, V95, P11596, DOI 10.1073/pnas.95.20.11596; BLATTNER J, 1992, J CELL BIOL, V119, P1129, DOI 10.1083/jcb.119.5.1129; Boratyn GM, 2013, NUCLEIC ACIDS RES, V41, pW29, DOI 10.1093/nar/gkt282; BOWIE JU, 1991, SCIENCE, V253, P164, DOI 10.1126/science.1853201; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CANNATA JJB, 1979, BIOCHEM J, V184, P409, DOI 10.1042/bj1840409; Capriles PVSZ, 2015, J MOL GRAPH MODEL, V55, P134, DOI 10.1016/j.jmgm.2014.11.002; Caruthers J, 2006, PROTEINS, V62, P338, DOI 10.1002/prot.20764; CAZZULO JJ, 1985, MOL BIOCHEM PARASIT, V16, P329, DOI 10.1016/0166-6851(85)90074-X; Chen YR, 1998, PLANT PHYSIOL, V118, P199, DOI 10.1104/pp.118.1.199; Clarke JL, 2003, MOL BIOCHEM PARASIT, V127, P1, DOI 10.1016/S0166-6851(02)00298-0; COLOVOS C, 1993, PROTEIN SCI, V2, P1511, DOI 10.1002/pro.5560020916; Comini MA, 2013, DRUG DISCOV INFEC DI, P297; Cutler P., 2008, MOL BIOMETHODS HDB, P719; CYMERYNG C, 1995, MOL BIOCHEM PARASIT, V73, P91, DOI 10.1016/0166-6851(95)00099-M; de Castro E, 2006, NUCLEIC ACIDS RES, V34, pW362, DOI 10.1093/nar/gkl124; Duffieux F, 2000, J BIOL CHEM, V275, P27559; Esteve MI, 2004, MOL BIOCHEM PARASIT, V133, P197, DOI 10.1016/j.molbiopara.2003.10.007; Faria J, 2016, SCI REP-UK, V6, DOI 10.1038/srep26937; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; Franzen O, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-531; FUNAYAMA S, 1977, EXP PARASITOL, V43, P376, DOI 10.1016/0014-4894(77)90043-1; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Gu MZ, 2013, MOL MICROBIOL, V89, P123, DOI 10.1111/mmi.12263; Guther MLS, 2014, J PROTEOME RES, V13, P2796, DOI 10.1021/pr401209w; Hanau S, 2013, BBA-PROTEINS PROTEOM, V1834, P2647, DOI 10.1016/j.bbapap.2013.09.018; Heise N, 1999, MOL BIOCHEM PARASIT, V99, P21, DOI 10.1016/S0166-6851(98)00176-5; Henderson EJ, 1970, BIOL CHEM, V245, P1416; Igoillo-Esteve M, 2007, AN ACAD BRAS CIENC, V79, P649, DOI 10.1590/S0001-37652007000400007; Igoillo-Esteve M, 2006, MOL BIOCHEM PARASIT, V149, P170, DOI 10.1016/j.molbiopara.2006.05.009; Jelakovic S, 2003, J MOL BIOL, V326, P127, DOI 10.1016/S0022-2836(02)01374-8; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; KARMALI A, 1983, BIOCHEM J, V211, P617, DOI 10.1042/bj2110617; Kaur PK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150764; Kaur PK, 2014, APPL BIOCHEM BIOTECH, V173, P1870, DOI 10.1007/s12010-014-0973-4; Kaur PK, 2012, BIOCHEM BIOPH RES CO, V421, P51, DOI 10.1016/j.bbrc.2012.03.107; Kopp J, 1999, J MOL BIOL, V287, P761, DOI 10.1006/jmbi.1999.2643; Kopriva S, 2000, J BIOL CHEM, V275, P1294, DOI 10.1074/jbc.275.2.1294; Liang WG, 2011, FASEB J, V25, P497, DOI 10.1096/fj.10-171207; Lo Conte L, 2000, NUCLEIC ACIDS RES, V28, P257, DOI 10.1093/nar/28.1.257; Loureiro I, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003430; LUPIANEZ JA, 1987, INT J BIOCHEM, V19, P1085, DOI 10.1016/0020-711X(87)90310-7; Lyngstadaas A, 1998, BBA-GEN SUBJECTS, V1381, P319, DOI 10.1016/S0304-4165(98)00046-4; Maugeri DA, 2004, FEMS MICROBIOL LETT, V234, P117, DOI 10.1016/j.femsle.2004.03.018; Maugeri DA, 2003, MOL BIOCHEM PARASIT, V130, P117, DOI 10.1016/S0166-6851(03)00173-7; Nowitzki U, 1995, PLANT MOL BIOL, V29, P1279, DOI 10.1007/BF00020468; Opperdoes FR, 2007, TRENDS PARASITOL, V23, P149, DOI 10.1016/j.pt.2007.02.004; Sambrook J, 1989, MOL CLONING LAB MANU, V2nd; Sobota JM, 2011, P NATL ACAD SCI USA, V108, P5402, DOI 10.1073/pnas.1100410108; Sodre CL, 2009, ARCH MICROBIOL, V191, P177, DOI 10.1007/s00203-008-0439-6; Stern AL, 2007, BIOCHEM J, V401, P279, DOI 10.1042/BJ20061049; Stern AL, 2011, FEBS J, V278, P793, DOI 10.1111/j.1742-4658.2010.07999.x; Stoffel SA, 2011, MOL BIOCHEM PARASIT, V179, P1, DOI 10.1016/j.molbiopara.2011.04.006; Taylor MC, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-32; Teige M, 1998, EUR J BIOCHEM, V252, P237, DOI 10.1046/j.1432-1327.1998.2520237.x; Veitch NJ, 2004, BIOCHEM J, V382, P759, DOI 10.1042/BJ20040459; Voynov V, 2012, TERAPEUTIC PROTEINS; Wallner B, 2003, PROTEIN SCI, V12, P1073, DOI 10.1110/ps.0236803; WALTER RD, 1979, TROPENMED PARASITOL, V30, P3; WEBER K, 1969, J BIOL CHEM, V244, P4406; Wise EL, 2004, ACTA CRYSTALLOGR D, V60, P1687, DOI 10.1107/S0907444904015896; WOOD T, 1979, BIOCHIM BIOPHYS ACTA, V570, P352, DOI 10.1016/0005-2744(79)90155-4; Zingales B, 2012, INFECT GENET EVOL, V12, P240, DOI 10.1016/j.meegid.2011.12.009	69	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e172405	10.1371/journal.pone.0172405	http://dx.doi.org/10.1371/journal.pone.0172405			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207833	Green Published, Green Submitted, gold			2022-12-27	WOS:000394424500131
J	Ortiz, AJ; Cortez, V; Azzouz, A; Verdu, JR				Ortiz, Antonio J.; Cortez, Vieyle; Azzouz, Abdelmonaim; Verdu, Jose R.			Isolation and determination of ivermectin in post-mortem and in vivo tissues of dung beetles using a continuous solid phase extraction method followed by LC-ESI+-MS/MS	PLOS ONE			English	Article							TANDEM MASS-SPECTROMETRY; PERFORMANCE LIQUID-CHROMATOGRAPHY; ANTI-PARASITIC AGENT; FLUORESCENCE DETECTION; MACROCYCLIC LACTONES; RESIDUE ANALYSIS; BOVINE LIVER; AVERMECTINS; ABAMECTIN; PLASMA	A new analytical method based on solvent extraction, followed by continuous solid-phase extraction (SPE) clean-up using a polymeric sorbent, was demonstrated to be applicable for the detection of ivermectin in complex biological matrices of dung beetles (hemolymph, excreta or dry tissues) using liquid chromatography combined with positive electrospray ionization tandem mass spectrometry (LC/ESI+-MS/MS). Using a signal-to-noise ratio of 3:1, the limit of detection (LOD) in the insect matrices at trace levels was 0.01 ng g-1 and the limit of quantification (LOO) was 0.1 ng g(-1). The proposed method was successfully used to quantitatively determine the levels of ivermectin in the analysis of small samples in in vivo and post mortem samples, demonstrating the usefulness for quantitative analyses that are focused on future pharmacokinetic and bioavailability studies in insects and the establishment of a new protocol to study the impact of ivermectin on non-target arthropods such as dung beetles and other insects that are related with the "dung community". Because satisfactory precision and accuracy values were obtained in both in vivo matrices, we suggest that the method can be consistently used for quantitative determinations that are focused on future pharmacokinetic and bioavailability studies in insects. Furthermore, this new analytical method was successfully applied to biological samples of dead dung beetles from the field suggesting that the method can be used to establish a new routine analysis of ivermectin residues in insect carcasses that is applied to complement typical mortality tests.	[Ortiz, Antonio J.; Azzouz, Abdelmonaim] Univ Jaen, Dept Quim Inorgan & Quim Organ, EPS Linares, Linares, Spain; [Cortez, Vieyle; Verdu, Jose R.] Univ Alicante, IUI CIBIO, Alicante, Spain	Universidad de Jaen; Universitat d'Alacant	Verdu, JR (corresponding author), Univ Alicante, IUI CIBIO, Alicante, Spain.	jr.verdu@ua.es	Azzouz, Abdelmonaim/O-2543-2019; Verdú, José/F-8269-2010; Gallardo, Vieyle Cortez/L-4692-2014	Azzouz, Abdelmonaim/0000-0001-5223-3146; Verdú, José/0000-0002-0805-8341; Gallardo, Vieyle Cortez/0000-0003-0217-3899	Secretaria de Estado de Investigacion Ministerio de Economia y Competitividad [CGL2015-68207-R]; Organism Autonomo de Parques Nacionales-Ministerio de Agricultura, Alimentacion y Medio Ambiente [OAPN 762/2012]	Secretaria de Estado de Investigacion Ministerio de Economia y Competitividad; Organism Autonomo de Parques Nacionales-Ministerio de Agricultura, Alimentacion y Medio Ambiente	Financial support was provided by Project CGL2015-68207-R of the Secretaria de Estado de Investigacion Ministerio de Economia y Competitividad, and by the Project OAPN 762/2012 of the Organism Autonomo de Parques Nacionales-Ministerio de Agricultura, Alimentacion y Medio Ambiente.	Abuin S, 2006, J CHROMATOGR A, V1114, P73, DOI 10.1016/j.chroma.2006.02.032; Aguilera-Luiz MM, 2012, FOOD CHEM, V132, P2171, DOI 10.1016/j.foodchem.2011.12.042; Asbakk K, 1999, J AGR FOOD CHEM, V47, P999, DOI 10.1021/jf980919q; Azzouz A, 2011, J AGR FOOD CHEM, V59, P5125, DOI 10.1021/jf200364w; Ballesteros E, 2004, J CHROMATOGR A, V1029, P267, DOI 10.1016/j.chroma.2003.12.009; Bassissi MF, 2004, COMP BIOCHEM PHYS C, V138, P437, DOI 10.1016/j.cca.2004.07.011; Berendsen Bjorn J.A., 2013, TRENDS ANAL CHEM, V43; CAMPBELL WC, 1983, SCIENCE, V221, P823, DOI 10.1126/science.6308762; Campbell WW, 1989, IVERMECTIN ABAMECTIN; CHABALA JC, 1980, J MED CHEM, V23, P1134, DOI 10.1021/jm00184a014; Cheng C, 2014, ANAL METHODS-UK, V6, P1581, DOI 10.1039/c3ay41943f; Croubels S, 2002, J MASS SPECTROM, V37, P840, DOI 10.1002/jms.343; Dahiya M, 2013, INDIAN J CHEM B, V52, P1313; Danaher M, 2001, ANALYST, V126, P576, DOI 10.1039/b101164m; Danaher M, 2006, J CHROMATOGR B, V844, P175, DOI 10.1016/j.jchromb.2006.07.035; Fink DW, 1989, IVERMECTIN ABAMECTIN, P173; FISHER MH, 1992, ANNU REV PHARMACOL, V32, P537, DOI 10.1146/annurev.pa.32.040192.002541; Giannetti L, 2011, ANAL CHIM ACTA, V700, P11, DOI 10.1016/j.aca.2010.12.035; Canga AG, 2009, VET J, V179, P25, DOI 10.1016/j.tvjl.2007.07.011; Howells L, 2001, ANALYST, V126, P155, DOI 10.1039/b008305o; Hu YQ, 2014, ANAL METHODS-UK, V6, P4734, DOI 10.1039/c4ay00107a; Huang JX, 2014, CHINESE CHEM LETT, V25, P635, DOI 10.1016/j.cclet.2014.01.036; Kitzman D, 2006, J PHARMACEUT BIOMED, V40, P1013, DOI 10.1016/j.jpba.2005.08.026; Krogh KA, 2008, J CHROMATOGR A, V1211, P60, DOI 10.1016/j.chroma.2008.09.081; Lehner AF, 2009, J MASS SPECTROM, V44, P111, DOI 10.1002/jms.1477; Lumaret JP, 2012, CURR PHARM BIOTECHNO, V13, P1004, DOI 10.2174/138920112800399257; Macedo F, 2015, FOOD CHEM, V179, P239, DOI 10.1016/j.foodchem.2015.01.046; Msagati TAM, 2006, TALANTA, V69, P243, DOI 10.1016/j.talanta.2005.10.002; Nilssen Arne C., 1999, Rangifer, V19, P61; PAYNE LD, 1995, J AGR FOOD CHEM, V43, P1233, DOI 10.1021/jf00053a021; Raich-Montiu J, 2008, J CHROMATOGR A, V1187, P275, DOI 10.1016/j.chroma.2008.02.063; Roncalli R. A., 1989, Ivermectin and abamectin., P173; Rubensam G, 2013, FOOD CONTROL, V29, P55, DOI 10.1016/j.foodcont.2012.05.075; Sanbonsuge A, 2011, ANAL METHODS-UK, V3, P2160, DOI 10.1039/c1ay05236e; Slootweg T, 2010, J SOIL SEDIMENT, V10, P1611, DOI 10.1007/s11368-010-0294-3; SOMMER C, 1992, B ENTOMOL RES, V82, P257, DOI 10.1017/S0007485300051804; Sutherland IH, 1989, ACT LEIDENS, V29, P161; Verdu JR, 2015, SCI REP-UK, V5, DOI 10.1038/srep13912; WALL R, 1987, NATURE, V327, P418, DOI 10.1038/327418a0; Wang H, 2009, B ENVIRON CONTAM TOX, V82, P395, DOI 10.1007/s00128-009-9638-3	40	9	9	4	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0172202	10.1371/journal.pone.0172202	http://dx.doi.org/10.1371/journal.pone.0172202			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207908	gold, Green Published, Green Submitted			2022-12-27	WOS:000394424500097
J	Shahzad, K; Nizami, AS; Sagir, M; Rehan, M; Maier, S; Khan, MZ; Ouda, OKM; Ismail, IMI; BaFail, AO				Shahzad, K.; Nizami, A. S.; Sagir, M.; Rehan, M.; Maier, S.; Khan, M. Z.; Ouda, O. K. M.; Ismail, I. M. I.; BaFail, A. O.			Biodiesel production potential from fat fraction of municipal waste in Makkah	PLOS ONE			English	Article							BIOBASED PHA PRODUCTION; ECOLOGICAL FOOTPRINT; RESIDUES	In the Kingdom of Saudi Arabia (KSA), millions of Muslims come to perform Pilgrimage every year. Around one million ton of municipal solid waste (MSW) is generated in Makkah city annually. The collected MSW is disposed of in the landfills without any treatment or energy recovery. As a result, greenhouse gas (GHG) emissions and contamination of the soil and water bodies along with leachate and odors are occurring in waste disposal vicinities. The composition of MSW shows that food waste is the largest waste stream (up to 51%) of the total generated MSW. About 13% of the food waste consists of fat content that is equivalent to about 64 thousand tons per year. This study aims to estimate the production potential of biodiesel first time in Makkah city from fat/oil fractions of MSW and highlight its economic and environmental benefits. It has been estimated that 62.53, 117.15 and 6.38 thousand tons of biodiesel, meat and bone meal (MBM) and glycerol respectively could be produced in 2014. A total electricity potential of 852 Gigawatt hour (GWh) from all three sources based on their energy contents, Higher Heating Value (HHV) of 40.17, 18.33 and 19 MJ/kg, was estimated for 2014 that will increase up to 1777 GWh in 2050. The cumulative net savings from landfill waste diversion (256 to 533 million Saudi Riyal (SAR)), carbon credits (46 to 96 million SAR), fuel savings (146 to 303 million SAR) and electricity generation (273 to 569 million SAR) have a potential to add a total net revenue of 611 to 1274 million SAR every year to the Saudi economy, from 2014 to 2050 respectively. However, further studies including real-time data about annual slaughtering activities and the amount of waste generation and its management are critical to decide optimum waste management practices based on life cycle assessment (LCA) and life cycle costing (LCC) methodologies.	[Shahzad, K.; Nizami, A. S.; Rehan, M.; Ismail, I. M. I.] King Abdulaziz Univ, CEES, Jeddah, Saudi Arabia; [Sagir, M.] Univ Gujrat, Dept Chem Engn, Gujrat, Pakistan; [Maier, S.] Graz Univ Technol, Inst Proc & Particle Engn, Graz, Austria; [Khan, M. Z.] Aligarh Muslim Univ, Dept Chem, Environm Res Lab, Aligarh, Uttar Pradesh, India; [Ouda, O. K. M.] Prince Mohamed Bin Fahd Univ, Dept Civil Engn, Al Khobar, Saudi Arabia; [BaFail, A. O.] King Abdulaziz Univ, Dept Ind Engn, Jeddah, Saudi Arabia	King Abdulaziz University; University of Gujrat; Graz University of Technology; Aligarh Muslim University; Prince Mohammad Bin Fahd University; King Abdulaziz University	Shahzad, K (corresponding author), King Abdulaziz Univ, CEES, Jeddah, Saudi Arabia.	shahzadkhu@gmail.com	Shahzad, Khurram/H-6258-2017; Ouda, Omar K M/M-9107-2019; Khan, Mohammad/AAQ-2099-2020; Rehan, Mohammad/I-5609-2012; Shahzad, Khurram/GRX-8200-2022; Ismail, Iqbal/J-2319-2016; Sagir, Muhammad/F-2600-2017; Shahzad, Khurram/X-4852-2019; Nizami, Abdul-Sattar/G-5226-2014	Shahzad, Khurram/0000-0002-6434-3198; Khan, Mohammad/0000-0003-2009-0990; Rehan, Mohammad/0000-0002-1019-8677; Nizami, Abdul-Sattar/0000-0003-3294-9256	Deanship of Scientific Research (DSR) at KAU	Deanship of Scientific Research (DSR) at KAU	Authors acknowledge the Center of Excellence in Environmental Studies (CEES), King Abdulaziz University (KAU), Jeddah, KSA and Ministry of Education, KSA for technical support. Authors are also thankful to Deanship of Scientific Research (DSR) at KAU for their support to CEES.	Abdul Aziz H., 2007, NAT SEM HAJJ BEST PR; Abu-Qudais M, 2000, ENERG CONVERS MANAGE, V41, P983, DOI 10.1016/S0196-8904(99)00155-7; Amtul S, 2014, KINGDOM 2 5M ANIMALS; da Cunha ME, 2009, FUEL PROCESS TECHNOL, V90, P570, DOI 10.1016/j.fuproc.2009.01.001; Department for Transport (DfT), 2013, BIOUK10553 DFT; EIA.U.S. Energy Information Administration, 2013, INT EN OUTL; El Hanandeh A, 2013, J CLEAN PROD, V52, P53, DOI 10.1016/j.jclepro.2013.03.009; Energy Information Administration (EIA), 2012, TOT PRIM EN PROD 201; Fan MM, 2013, APPL ENERG, V108, P333, DOI 10.1016/j.apenergy.2013.03.063; Gardy J., 2014, INT SCI J ENV SCI, V3, P233; GREET, 2010, TRANSP MOD GREET 1 8; Hoover SL, 2005, ENERGY BALANCE GRASS; Ismail I. M. I, 2016, CAN SOC CIV ENG 14 I; Kettl KH, 2012, CHEM ENGINEER TRANS, V29, P439, DOI 10.3303/CET1229074; Kettl KH, 2011, CHEM ENGINEER TRANS, V25, P983, DOI 10.3303/CET1125164; Khan Muhammad Sadiq Munfath, 2013, International Journal of Innovation and Applied Studies, V4, P101; Khan MZ, 2017, APPL ENERG, V185, P410, DOI 10.1016/j.apenergy.2016.11.005; Mekonnen T, 2014, ENV RES ENG MANAGEME; Misra RD, 2011, RENEW SUST ENERG REV, V15, P2413, DOI 10.1016/j.rser.2011.02.023; Moser BR, 2009, IN VITRO CELL DEV-PL, V45, P229, DOI 10.1007/s11627-009-9204-z; Munir S, 2016, AEROSOL AIR QUALITY; Nizami AS, 2017, APPL ENERG, V186, P189, DOI 10.1016/j.apenergy.2016.04.116; Nizami A. S., 2016, TRENDS SUSTAINABILIT, P59, DOI [10.1201/9781315370743-1, DOI 10.1201/9781315370743-1]; Nizami A-S, 2015, C 15 SCI S HAJJ UMR; Nizami AS, 2013, GREEN ENERGY TECHNOL, P79, DOI 10.1007/978-1-4471-5364-1_4; Noor ZZ, 2013, RENEW SUST ENERG REV, V20, P378, DOI 10.1016/j.rser.2012.11.050; Ouda O.K.M., 2015, J KING SAUD U ENG SC; Rathore D, 2016, BIOFUEL RES J, V3, P380, DOI 10.18331/BRJ2016.3.2.3; Rehan M, 2016, ENERG SOURCE PART A, V38, P2598, DOI 10.1080/15567036.2016.1153753; Saudi Electric Company (SEC), 2016, CURR TAR; Shahzad K, 2015, THESIS; Shahzad K, 2013, CLEAN TECHNOL ENVIR, V15, P525, DOI 10.1007/s10098-013-0608-4; Sharma YC, 2008, FUEL, V87, P2355, DOI 10.1016/j.fuel.2008.01.014; Singh A, 2013, BIOENERGY PRODUCTION, P139; Tahir MS, 2015, CHEM ENGINEER TRANS, V45, P1309, DOI 10.3303/CET1545219; Thamsiriroj T, 2010, FUEL, V89, P3579, DOI 10.1016/j.fuel.2010.06.009; Titz M, 2012, CLEAN TECHNOL ENVIR, V14, P495, DOI 10.1007/s10098-012-0464-7; United Nation Environment Programme (UNEP), 2006, IPCC GUIDELINES NATL; Uzun BB, 2012, ENERGY; Van Gerpen J, 2005, FUEL PROCESS TECHNOL, V86, P1097, DOI 10.1016/j.fuproc.2004.11.005; World Bank, 2009, GLOB STUD LIV MARK S	41	36	36	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0171297	10.1371/journal.pone.0171297	http://dx.doi.org/10.1371/journal.pone.0171297			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207856	Green Published, gold, Green Submitted			2022-12-27	WOS:000394424500022
J	Cramer, DW; Vitonis, AF				Cramer, Daniel W.; Vitonis, Allison F.			Signatures of reproductive events on blood counts and biomarkers of inflammation: Implications for chronic disease risk	PLOS ONE			English	Article							NUTRITION EXAMINATION SURVEY; ALL-CAUSE MORTALITY; BREAST-CANCER RISK; NEUTROPHIL-LYMPHOCYTE RATIO; 3RD NATIONAL-HEALTH; CARDIOVASCULAR-DISEASE; POSTMENOPAUSAL WOMEN; TOTAL HOMOCYSTEINE; 1ST BIRTH; ORAL-CONTRACEPTIVES	Whether inflammation mediates how reproductive events affect chronic-disease risk is unclear. We studied inflammatory biomarkers in the context of reproductive events using National Health and Nutrition Examination Survey (NHANES) data. From 15,986 eligible women from the 1999-2011 data cycles, we accessed information on reproductive events, blood counts, C-reactive protein (CRP), and total homocysteine (tHCY). We calculated blood-count ratios including: platelet-lymphocyte (PLR), lymphocyte-monocyte (LMR), platelet-monocyte (PMR), and neutrophil-monocyte (NMR). Using sampling weights per NHANES guidelines, means for counts, ratios, or biomarkers by reproductive events were compared using linear regression. We performed trend tests and calculated p-values with partial sum of squares F-tests. Higher PLR and lower LMR were associated with nulliparity. In postmenopausal women, lower PMR was associated with early age at first birth and higher NMR with later age at and shorter interval since last birth. Lower PNR and higher neutrophils and tHCY were associated with early natural menopause. In all women, the neutrophil count correlated positively with CRP; but, in premenopausal women, correlated inversely with tHCY. Reproductive events leave residual signatures on blood counts and inflammatory biomarkers that could underlie their links to chronic disease risk.	[Cramer, Daniel W.; Vitonis, Allison F.] Brigham & Womens Hosp, Dept Obstet & Gynecol, Obstet & Gynecol Epidemiol Ctr, 75 Francis St, Boston, MA 02115 USA; [Cramer, Daniel W.] Harvard Med Sch, Boston, MA 02115 USA; [Cramer, Daniel W.] Harvard Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health	Cramer, DW (corresponding author), Brigham & Womens Hosp, Dept Obstet & Gynecol, Obstet & Gynecol Epidemiol Ctr, 75 Francis St, Boston, MA 02115 USA.; Cramer, DW (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.; Cramer, DW (corresponding author), Harvard Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA.	dcramer@partners.org			National Institutes of Health [R35CA197605]; NATIONAL CANCER INSTITUTE [R35CA197605] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Institutes of Health (Grant number R35CA197605). The funders had no role in study design, data collection and analysis, decision to publishor preparation of the manuscript	Azab B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112361; BEAN JA, 1979, AM J EPIDEMIOL, V109, P181, DOI 10.1093/oxfordjournals.aje.a112673; BERNSTEIN L, 1985, J NATL CANCER I, V74, P741; Bhat T, 2013, EXPERT REV CARDIOVAS, V11, P55, DOI [10.1586/erc.12.159, 10.1586/ERC.12.159]; Bostom AG, 1999, ARCH INTERN MED, V159, P1077, DOI 10.1001/archinte.159.10.1077; Brown DW, 2004, ANN EPIDEMIOL, V14, P425, DOI 10.1016/j.annepidem.2003.11.002; Buyukkaya E, 2014, CLIN APPL THROMB-HEM, V20, P159, DOI 10.1177/1076029612459675; CAREL RS, 1985, PREV MED, V14, P607, DOI 10.1016/0091-7435(85)90081-7; Cauci S, 2008, OBSTET GYNECOL, V111, P857, DOI 10.1097/AOG.0b013e31816a2476; CAULEY JA, 1989, AM J EPIDEMIOL, V129, P1120, DOI 10.1093/oxfordjournals.aje.a115234; Charalampopoulos D, 2014, AM J EPIDEMIOL, V180, P29, DOI 10.1093/aje/kwu113; COLDITZ GA, 1987, AM J EPIDEMIOL, V126, P861, DOI 10.1093/oxfordjournals.aje.a114723; de Kleijn MJJ, 1999, MATURITAS, V33, P7, DOI 10.1016/S0378-5122(99)00038-9; DORGAN JF, 1995, CANCER EPIDEM BIOMAR, V4, P381; Dovizio M, 2014, BASIC CLIN PHARMACOL, V114, P118, DOI 10.1111/bcpt.12156; Elks CE, 2013, DIABETES CARE, V36, P3526, DOI 10.2337/dc13-0446; Erlinger TP, 2004, CANCER EPIDEM BIOMAR, V13, P1052; EWERTZ M, 1990, INT J CANCER, V46, P597, DOI 10.1002/ijc.2910460408; Furman MI, 2001, J AM COLL CARDIOL, V38, P1002, DOI 10.1016/S0735-1097(01)01485-1; GREEN A, 1988, BMJ-BRIT MED J, V297, P391, DOI 10.1136/bmj.297.6645.391; GRIMM RH, 1985, JAMA-J AM MED ASSOC, V254, P1932, DOI 10.1001/jama.254.14.1932; Guthrie GJK, 2013, CRIT REV ONCOL HEMAT, V88, P218, DOI 10.1016/j.critrevonc.2013.03.010; HANKINSON SE, 1995, CANCER CAUSE CONTROL, V6, P217, DOI 10.1007/BF00051793; He CY, 2010, AM J EPIDEMIOL, V171, P334, DOI 10.1093/aje/kwp372; HSIEH CC, 1990, INT J CANCER, V46, P796, DOI 10.1002/ijc.2910460508; Hu PP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108062; Jacobsen BK, 2007, AM J EPIDEMIOL, V166, P1431, DOI 10.1093/aje/kwm237; Janghorbani M, 2014, ACTA DIABETOL, V51, P519, DOI 10.1007/s00592-014-0579-x; Kluft C, 2002, VASC PHARMACOL, V39, P149, DOI 10.1016/S1537-1891(02)00304-X; Krenn-Pilko S, 2014, BRIT J CANCER, V110, P2524, DOI 10.1038/bjc.2014.163; KVALE G, 1994, INT J EPIDEMIOL, V23, P691, DOI 10.1093/ije/23.4.691; KVALE G, 1991, CANCER DETECT PREV, V15, P369; Lakshman R, 2009, J CLIN ENDOCR METAB, V94, P4953, DOI 10.1210/jc.2009-1789; Lambe M, 1996, BREAST CANCER RES TR, V38, P305, DOI 10.1007/BF01806150; LAMBE M, 1994, NEW ENGL J MED, V331, P5, DOI 10.1056/NEJM199407073310102; LAVECCHIA C, 1993, INT J CANCER, V53, P215, DOI 10.1002/ijc.2910530207; Lebrun CEI, 2005, CLIN ENDOCRINOL, V63, P50, DOI 10.1111/j.1365-2265.2005.02297.x; Leng SX, 2005, EXP GERONTOL, V40, P982, DOI 10.1016/j.exger.2005.08.006; Lu JJ, 2011, ANTIOXID REDOX SIGN, V15, P2301, DOI 10.1089/ars.2010.3792; MACMAHON B, 1970, B WORLD HEALTH ORGAN, V43, P209; Mondul AM, 2005, AM J EPIDEMIOL, V162, P1089, DOI 10.1093/aje/kwi324; Morris MS, 2000, AM J EPIDEMIOL, V152, P140, DOI 10.1093/aje/152.2.140; National Center for Health Statistics, 2010, VITAL HLTH STAT, V1, P1; Nelson JL, 1996, ARTHRITIS RHEUM, V39, P191, DOI 10.1002/art.1780390203; NESS RB, 1993, NEW ENGL J MED, V328, P1528, DOI 10.1056/NEJM199305273282104; Ni XJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111886; NYHOLM HCJ, 1993, BRIT J OBSTET GYNAEC, V100, P1115, DOI 10.1111/j.1471-0528.1993.tb15176.x; Ossewaarde ME, 2005, EPIDEMIOLOGY, V16, P556, DOI 10.1097/01.ede.0000165392.35273.d4; Parikh NI, 2010, AM HEART J, V159, DOI 10.1016/j.ahj.2009.11.017; Pfeiffer CM, 2008, CLIN CHEM, V54, P801, DOI 10.1373/clinchem.2007.100214; Pierce MB, 2005, AM J CLIN NUTR, V82, P733, DOI 10.1093/ajcn/82.4.733; Pirkle CM, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-293; Redman CWG, 2003, PLACENTA, V24, pS21, DOI 10.1053/plac.2002.0930; ROSNER B, 1983, TECHNOMETRICS, V25, P165, DOI 10.2307/1268549; SCHWARTZ J, 1991, AM J EPIDEMIOL, V134, P1402, DOI 10.1093/oxfordjournals.aje.a116045; Stephensen CB, 2000, AM J CLIN NUTR, V72, P1170; TRICHOPOULOS D, 1987, INT J CANCER, V40, P721, DOI 10.1002/ijc.2910400602; TRICHOPOULOS D, 1983, INT J CANCER, V31, P701, DOI 10.1002/ijc.2910310604; von Hundelshausen P, 2007, CIRC RES, V100, P27, DOI 10.1161/01.RES.0000252802.25497.b7; Waterhouse DF, 2008, VASC HEALTH RISK MAN, V4, P177, DOI 10.2147/vhrm.2008.04.01.177	61	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0172530	10.1371/journal.pone.0172530	http://dx.doi.org/10.1371/journal.pone.0172530			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5VB	28234958	Green Published, Green Submitted, gold			2022-12-27	WOS:000394688200087
J	Kim, JL; La Gamma, EF; Estabrook, T; Kudrick, N; Nankova, BB				Kim, Juhye Lena; La Gamma, Edmund F.; Estabrook, Todd; Kudrick, Necla; Nankova, Bistra B.			Whole genome expression profiling associates activation of unfolded protein response with impaired production and release of epinephrine after recurrent hypoglycemia	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; RAT ADRENAL-MEDULLA; TYROSINE-HYDROXYLASE; ANTECEDENT HYPOGLYCEMIA; AUTONOMIC FAILURE; MESSENGER-RNA; ER STRESS; SUBSEQUENT HYPOGLYCEMIA; MECHANISMS; NEUROENDOCRINE	Recurrent hypoglycemia can occur as a major complication of insulin replacement therapy, limiting the long-term health benefits of intense glycemic control in type 1 and advanced type 2 diabetic patients. It impairs the normal counter-regulatory hormonal and behavioral responses to glucose deprivation, a phenomenon known as hypoglycemia associated autonomic failure (HAAF). The molecular mechanisms leading to defective counter-regulation are not completely understood. We hypothesized that both neuronal (excessive cholinergic signaling between the splanchnic nerve fibers and the adrenal medulla) and humoral factors contribute to the impaired epinephrine production and release in HAAF. To gain further insight into the molecular mechanism(s) mediating the blunted epinephrine responses following recurrent hypoglycemia, we utilized a global gene expression profiling approach. We characterized the transcriptomes during recurrent (defective counter-regulation model) and acute hypoglycemia (normal counter-regulation group) in the adrenal medulla of normal Sprague-Dawley rats. Based on comparison analysis of differentially expressed genes, a set of unique genes that are activated only at specific time points after recurrent hypoglycemia were revealed. A complementary bioinformatics analysis of the functional category, pathway, and integrated network indicated activation of the unfolded protein response. Furthermore, at least three additional pathways/interaction networks altered in the adrenal medulla following recurrent hypoglycemia were identified, which may contribute to the impaired epinephrine secretion in HAAF: greatly increased neuropeptide signaling (proenkephalin, neuropeptide Y, galanin); altered ion homeostasis (Na+, K+, Ca (2+)) and downregulation of genes involved in Ca2+-dependent exocytosis of secretory vesicles. Given the pleiotropic effects of the unfolded protein response in different organs, involved in maintaining glucose homeostasis, these findings uncover broader general mechanisms that arise following recurrent hypoglycemia which may afford clinicians an opportunity to modulate the magnitude of HAAF syndrome.	[Kim, Juhye Lena; La Gamma, Edmund F.; Kudrick, Necla] Westchester Med Ctr, Maria Fareri Childrens Hosp, Reg Neonatal Ctr, Valhalla, NY USA; [La Gamma, Edmund F.; Nankova, Bistra B.] New York Med Coll, Dept Pediat, Valhalla, NY 10595 USA; [La Gamma, Edmund F.; Nankova, Bistra B.] New York Med Coll, Dept Biochem, Valhalla, NY 10595 USA; [La Gamma, Edmund F.; Nankova, Bistra B.] New York Med Coll, Dept Mol Biol, Div Newborn Med, Valhalla, NY 10595 USA; [Estabrook, Todd] New York Med Coll, Sch Med, Valhalla, NY 10595 USA	Westchester Medical Center; New York Medical College; New York Medical College; New York Medical College; New York Medical College	Nankova, BB (corresponding author), New York Med Coll, Dept Pediat, Valhalla, NY 10595 USA.; Nankova, BB (corresponding author), New York Med Coll, Dept Biochem, Valhalla, NY 10595 USA.; Nankova, BB (corresponding author), New York Med Coll, Dept Mol Biol, Div Newborn Med, Valhalla, NY 10595 USA.	Bistra_Nankova@nymc.edu	Nankova, Bistra/AEV-0617-2022	LaGamma, Edmund/0000-0001-9720-1949; Nankova, Bistra/0000-0002-3997-4369	Empire Clinical Research Investigator Program (ECRIP) of New York State, Children's and Women's Physicians of Westchester, LLP (CWPW) grant program	Empire Clinical Research Investigator Program (ECRIP) of New York State, Children's and Women's Physicians of Westchester, LLP (CWPW) grant program	This work was supported by Empire Clinical Research Investigator Program (ECRIP) of New York State (to EFL), Children's and Women's Physicians of Westchester, LLP (CWPW) grant program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreis PG, 2007, INT J MOL MED, V19, P511; [Anonymous], 1997, DIABETES, V46, P271, DOI 10.2337/diab.46.2.271; Anouar Y, 1995, NEUROENDOCRINOLOGY, V62, P611, DOI 10.1159/000127057; Aranyi T, 2007, BIOCHEM BIOPH RES CO, V359, P15, DOI 10.1016/j.bbrc.2007.05.025; Bacaj T, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002267; Bacaj T, 2013, NEURON, V80, P947, DOI 10.1016/j.neuron.2013.10.026; Balasubramanyam M, 2010, INDIAN J CLIN BIOCHE, V25, P111, DOI 10.1007/s12291-010-0022-1; Beall C, 2012, AM J PHYSIOL-REG I, V302, pR215, DOI 10.1152/ajpregu.00531.2011; Benbrook D. M., 2012, Experimental Oncology, V34, P286; Bobrovskaya L, 2010, NEUROCHEM INT, V57, P162, DOI 10.1016/j.neuint.2010.05.009; Brozzi F, 2016, UPSALA J MED SCI, V121, P133, DOI 10.3109/03009734.2015.1135217; Cao SS, 2012, CURR BIOL, V22, pR622, DOI 10.1016/j.cub.2012.07.004; Cavadas C, 2006, P NATL ACAD SCI USA, V103, P10497, DOI 10.1073/pnas.0600913103; Chan O, 2006, DIABETES, V55, P1080, DOI 10.2337/diabetes.55.04.06.db05-0958; Chapman ER, 2002, NAT REV MOL CELL BIO, V3, P498, DOI 10.1038/nrm855; Chaudhari N, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00213; Christesen HT, 2012, CLIN ENDOCRINOL, V76, P548, DOI 10.1111/j.1365-2265.2011.04250.x; Cryer PE, 2015, DIABETES, V64, P2322, DOI 10.2337/db15-0331; Cryer PE, 2013, NEW ENGL J MED, V369, P362, DOI 10.1056/NEJMra1215228; Cryer PE, 2011, AM J MED, V124, P993, DOI 10.1016/j.amjmed.2011.08.008; Cryer Philip E, 2008, Endocr Pract, V14, P750; Davis SN, 2001, J CLIN ENDOCR METAB, V86, P2043, DOI 10.1210/jc.86.5.2043; Davis SN, 2000, DIABETES, V49, P1897, DOI 10.2337/diabetes.49.11.1897; Davis Stephen N, 2014, Trans Am Clin Climatol Assoc, V125, P281; de Galan BE, 2004, J CLIN ENDOCR METAB, V89, P2057, DOI 10.1210/jc.2003-031289; Dermitzaki E, 2001, ENDOCRINOLOGY, V142, P2022, DOI 10.1210/en.142.5.2022; Dunkley PR, 2004, J NEUROCHEM, V91, P1025, DOI 10.1111/j.1471-4159.2004.02797.x; Engin F, 2014, SCI REP-UK, V4, DOI 10.1038/srep04054; Engin F, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006534; FISCHERCOLBRIE R, 1992, J NEUROCHEM, V59, P780, DOI 10.1111/j.1471-4159.1992.tb09440.x; Gaddam D, 2013, MOL BIOL CELL, V24, P14, DOI 10.1091/mbc.E12-06-0491; de la Cadena SC, 2014, APOPTOSIS, V19, P414, DOI 10.1007/s10495-013-0930-7; Gonzales JC, 2008, DIABETOLOGIA, V51, P1920, DOI 10.1007/s00125-008-1094-9; Guo L, 2006, NAT BIOTECHNOL, V24, P1162, DOI 10.1038/nbt1238; Gustavsson N, 2009, BIOSCIENCE REP, V29, P245, DOI 10.1042/BSR20090031; Halban PA, 2014, DIABETES CARE, V37, P1751, DOI 10.2337/dc14-0396; Hamelink C, 2002, P NATL ACAD SCI USA, V99, P461, DOI 10.1073/pnas.012608999; Hegde RS, 2010, CURR OPIN CELL BIOL, V22, P437, DOI 10.1016/j.ceb.2010.05.005; HELLER SR, 1991, DIABETES, V40, P223, DOI 10.2337/diabetes.40.2.223; Herlein JA, 2006, ENDOCRINOLOGY, V147, P2781, DOI 10.1210/en.2005-1247; Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270; Hollien J, 2006, SCIENCE, V313, P104, DOI 10.1126/science.1129631; Iorio V, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.53; Jackman SL, 2016, NATURE, V529, P88, DOI 10.1038/nature16507; Jessop CE, 2009, J CELL SCI, V122, P4287, DOI 10.1242/jcs.059154; KANAMATSU T, 1986, P NATL ACAD SCI USA, V83, P9245, DOI 10.1073/pnas.83.23.9245; Kudrick N, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12307; KUHN DM, 1990, J BIOL CHEM, V265, P5780; Kurimchak A, 2015, CELL CYCLE, V14, P18, DOI 10.4161/15384101.2014.985069; LaGamma EF, 2014, AM J PHYSL ENDOCRINO; Lang R, 2015, PHARMACOL REV, V67, P118, DOI 10.1124/pr.112.006536; McCrimmon RJ, 2012, J CLIN ENDOCR METAB, V97, P1, DOI 10.1210/jc.2011-1927; MCDERMOTT JC, 1989, CAN J PHYSIOL PHARM, V67, P1450, DOI 10.1139/y89-233; Meunier L, 2002, MOL BIOL CELL, V13, P4456, DOI 10.1091/mbc.E02-05-0311; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Mihailidou C, 2015, ENDOCR-RELAT CANCER, V22, P217, DOI 10.1530/ERC-15-0018; Milman S, 2012, DIABETES, V61, P1609, DOI 10.2337/db11-1622; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Orban BO, 2015, DIABETES VASC DIS RE, V12, P2, DOI 10.1177/1479164114549755; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Parab S, 2007, BRAIN RES, V1132, P42, DOI 10.1016/j.brainres.2006.11.013; Parekh B, 2009, CURR DIABETES REV, V5, P79, DOI 10.2174/157339909788166846; Podvin S, 2015, MOL CELL NEUROSCI, V68, P177, DOI 10.1016/j.mcn.2015.06.008; Raju B, 2005, DIABETES, V54, P757, DOI 10.2337/diabetes.54.3.757; Salvado L, 2015, TRENDS ENDOCRIN MET, V26, P438, DOI 10.1016/j.tem.2015.05.007; Saraf A, 2010, BIOCHEMISTRY-US, V49, P986, DOI 10.1021/bi902160t; Schonthal AH, 2013, BIOCHEM PHARMACOL, V85, P653, DOI 10.1016/j.bcp.2012.09.012; Schonn JS, 2008, P NATL ACAD SCI USA, V105, P3998, DOI 10.1073/pnas.0712373105; Schonthal AH, 2012, SCIENTIFICA, V2012, DOI 10.6064/2012/857516; Seaquist ER, 2013, J CLIN ENDOCR METAB, V98, P1845, DOI 10.1210/jc.2012-4127; Shum K, 2001, AM J PHYSIOL-ENDOC M, V281, pE455, DOI 10.1152/ajpendo.2001.281.3.E455; Sivitz WI, 2001, DIABETES, V50, P1119, DOI 10.2337/diabetes.50.5.1119; Sivitz WI, 2010, ANTIOXID REDOX SIGN, V12, P537, DOI 10.1089/ars.2009.2531; Sprague Jennifer E, 2011, Pediatr Endocrinol Rev, V9, P463; Tesfaye N, 2010, ANN NY ACAD SCI, V1212, P12, DOI 10.1111/j.1749-6632.2010.05820.x; Tsaytler P, 2011, SCIENCE, V332, P91, DOI 10.1126/science.1201396; Turcanu DS, 2012, NEUROSCI LETT, V516, P212, DOI 10.1016/j.neulet.2012.03.088; Vele S, 2011, J CLIN ENDOCR METAB, V96, P3424, DOI 10.1210/jc.2011-1723; Verberne AJM, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00038; WAKADE AR, 1988, J NEUROCHEM, V50, P1302, DOI 10.1111/j.1471-4159.1988.tb10608.x; WAKADE AR, 1988, J NEUROCHEM, V51, P820, DOI 10.1111/j.1471-4159.1988.tb01817.x; Wang F, 2012, J BIOL CHEM, V287, P10482, DOI 10.1074/jbc.M111.312223; Wang M, 2016, P NATL ACAD SCI US; Wang Q, 2013, J NEUROSCI, V33, P12705, DOI 10.1523/JNEUROSCI.3132-12.2013; Whim MD, 2006, J NEUROSCI, V26, P6637, DOI 10.1523/JNEUROSCI.5100-05.2006; Wong DL, 2007, STRESS, V10, P121, DOI 10.1080/10253890701393529; Wu J, 2006, CELL DEATH DIFFER, V13, P374, DOI 10.1038/sj.cdd.4401840; Zimmerberg J, 2006, NAT STRUCT MOL BIOL, V13, P301, DOI 10.1038/nsmb0406-301	88	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0172789	10.1371/journal.pone.0172789	http://dx.doi.org/10.1371/journal.pone.0172789			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5VB	28234964	Green Published, gold			2022-12-27	WOS:000394688200137
J	Rehman, HU; Azam, N; Yao, JT; Benso, A				Rehman, Hafeez Ur; Azam, Nouman; Yao, JingTao; Benso, Alfredo			A three-way approach for protein function classification	PLOS ONE			English	Article							THEORETIC ROUGH SETS; FUNCTION PREDICTION; GENE ONTOLOGY; DECISIONS; SEQUENCE; DATABASE; INFERENCE; REGIONS	The knowledge of protein functions plays an essential role in understanding biological cells and has a significant impact on human life in areas such as personalized medicine, better crops and improved therapeutic interventions. Due to expense and inherent difficulty of biological experiments, intelligent methods are generally relied upon for automatic assignment of functions to proteins. The technological advancements in the field of biology are improving our understanding of biological processes and are regularly resulting in new features and characteristics that better describe the role of proteins. It is inevitable to neglect and overlook these anticipated features in designing more effective classification techniques. A key issue in this context, that is not being sufficiently addressed, is how to build effective classification models and approaches for protein function prediction by incorporating and taking advantage from the ever evolving biological information. In this article, we propose a three-way decision making approach which provides provisions for seeking and incorporating future information. We considered probabilistic rough sets based models such as Game-Theoretic Rough Sets (GTRS) and Information-Theoretic Rough Sets (ITRS) for inducing three-way decisions. An architecture of protein functions classification with probabilistic rough sets based three-way decisions is proposed and explained. Experiments are carried out on Saccharomyces cerevisiae species dataset obtained from Uniprot database with the corresponding functional classes extracted from the Gene Ontology (GO) database. The results indicate that as the level of biological information increases, the number of deferred cases are reduced while maintaining similar level of accuracy.	[Rehman, Hafeez Ur; Azam, Nouman] Natl Univ Comp & Emerging Sci, Dept Comp Sci, Peshawar, Pakistan; [Yao, JingTao] Univ Regina, Dept Comp Sci, Regina, SK S4S 0A2, Canada; [Benso, Alfredo] Politecn Torino, Dept Comp & Control Engn, I-10129 Turin, Italy	University of Regina; Polytechnic University of Turin	Rehman, HU (corresponding author), Natl Univ Comp & Emerging Sci, Dept Comp Sci, Peshawar, Pakistan.	hafeez.urrehman@nu.edu.pk	Yao, JingTao/A-8483-2008; Benso, Alfredo/ABC-5311-2020; Benso, Alfredo/GRO-2198-2022; Rehman, Hafeez Ur/AAW-4327-2021	Yao, JingTao/0000-0002-7823-4136; Benso, Alfredo/0000-0003-3433-7739; Rehman, Hafeez Ur/0000-0002-3274-6347	NSERC Canada; Higher Education Commission of Pakistan	NSERC Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Higher Education Commission of Pakistan(Higher Education Commission of Pakistan)	The third author was partially supported by Discovery Grant from NSERC Canada. We are also thankful to the Higher Education Commission of Pakistan for providing student grant under the SRGP (Startup Research Grant Program) initiative. There was no additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The third author was partially supported by Discovery Grant from NSERC Canada. We are also thankful to the Higher Education Commission of Pakistan for providing student grant under the SRGP (Startup Research Grant Program) initiative. There was no additional external funding received for this study.	Alberts B, 2008, MOL BIOL CELL; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Azam N, 2014, KNOWL-BASED SYST, V72, P96, DOI 10.1016/j.knosys.2014.08.030; Azam N, 2014, INT J APPROX REASON, V55, P142, DOI 10.1016/j.ijar.2013.03.015; Baram Y, 1998, IEEE T PATTERN ANAL, V20, P769, DOI 10.1109/34.709564; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Bauer A, 2003, EUR J BIOCHEM, V270, P570, DOI 10.1046/j.1432-1033.2003.03428.x; Benso A, 2013, PROTEOME SCI, V11, DOI 10.1186/1477-5956-11-S1-S1; Benso A, 2013, PROCEEDINGS IWBBIO 2013: INTERNATIONAL WORK-CONFERENCE ON BIOINFORMATICS AND BIOMEDICAL ENGINEERING, P397; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Deng MH, 2003, J COMPUT BIOL, V10, P947, DOI 10.1089/106652703322756168; Deng X. F., 2012, LECT NOTES COMPUTER, V7413, P232, DOI DOI 10.1007/978-3-642-31900-6_46; Deng XF, 2014, FUND INFORM, V132, P291, DOI 10.3233/FI-2014-1045; Deng XF, 2014, INFORM SCIENCES, V279, P702, DOI 10.1016/j.ins.2014.04.022; DiCarlo JE, 2013, NUCLEIC ACIDS RES; Enault F, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-247; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Gaudet P, 2011, BRIEF BIOINFORM, V12, P449, DOI 10.1093/bib/bbr042; Gene Ontology Consortium, 2015, Nucleic Acids Res, V43, pD1049, DOI 10.1093/nar/gku1179; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Goudey R, 2007, J ENVIRON MANAGE, V85, P338, DOI 10.1016/j.jenvman.2006.10.012; Herbert JP, 2011, FUND INFORM, V108, P267, DOI 10.3233/FI-2011-423; Hulo N, 2006, NUCLEIC ACIDS RES, V34, pD227, DOI 10.1093/nar/gkj063; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Jiang YX, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1037-6; Kerrien S, 2012, NUCLEIC ACIDS RES, V40, pD841, DOI 10.1093/nar/gkr1088; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Laskowski RA, 2005, J MOL BIOL, V351, P614, DOI 10.1016/j.jmb.2005.05.067; Letovsky S, 2003, BIOINFORMATICS, V19, pi197, DOI 10.1093/bioinformatics/btg1026; Leyton-Brown K., 2008, ESSENTIALS GAME THEO; Liang DC, 2017, INFORM SCIENCES, V375, P183, DOI 10.1016/j.ins.2016.09.039; Liang DC, 2016, INFORM SCIENCES, V345, P46, DOI 10.1016/j.ins.2016.01.065; Liang DC, 2014, INFORM SCIENCES, V276, P186, DOI 10.1016/j.ins.2014.02.054; Liang DC, 2013, INT J APPROX REASON, V54, P1087, DOI 10.1016/j.ijar.2013.03.014; [刘盾 Liu Dun], 2012, [计算机科学, Computer Science], V39, P178; Marcotte EM, 1999, SCIENCE, V285, P751, DOI 10.1126/science.285.5428.751; Mitchell A, 2015, NUCLEIC ACIDS RES, V43, pD213, DOI 10.1093/nar/gku1243; Mitrofanova A, 2011, IEEE ACM T COMPUT BI, V8, P775, DOI 10.1109/TCBB.2010.15; Mulder NJ, 2007, NUCLEIC ACIDS RES, V35, pD224, DOI 10.1093/nar/gkl841; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Nabieva E, 2005, BIOINFORMATICS, V21, pI302, DOI 10.1093/bioinformatics/bti1054; National Library of Medicine (US) National Center for Biotechnology Information, 1982, GENBANK; Pal D, 2005, STRUCTURE, V13, P121, DOI 10.1016/j.str.2004.10.015; Panday G, 2006, COMPUTATIONAL APPROA; PAUKER SG, 1980, NEW ENGL J MED, V302, P1109, DOI 10.1056/NEJM198005153022003; PAWLAK Z, 1982, INT J COMPUT INF SCI, V11, P341, DOI 10.1007/BF01001956; Pawlak Z., 2012, ROUGH SETS THEORETIC, DOI [10.1007/978-94-011-3534-4_7, DOI 10.1007/978-94-011-3534-4]; Pazos F, 2004, P NATL ACAD SCI USA, V101, P14754, DOI 10.1073/pnas.0404569101; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; Pedrycz W, 1998, IEEE T SYST MAN CY B, V28, P103, DOI 10.1109/3477.658584; Pellegrini M, 1999, P NATL ACAD SCI USA, V96, P4285, DOI 10.1073/pnas.96.8.4285; Peters JF, 2016, KNOWL-BASED SYST, V91, P4, DOI 10.1016/j.knosys.2015.07.021; Piovesan D, 2015, NUCLEIC ACIDS RES, V43, pW134, DOI 10.1093/nar/gkv523; Politano G, 2014, J COMPUT SCI-NETH, V5, P332, DOI 10.1016/j.jocs.2013.10.005; Radivojac P, 2013, NAT METHODS, V10, P221, DOI [10.1038/NMETH.2340, 10.1038/nmeth.2340]; Rehman Hafeez Ur, 2016, BIOSTEC 2016. 9th International Joint Conference on Biomedical Engineering Systems and Technologies. Proceedings: Bioinformatics, P237; Rehman H. U., 2012, BIOINF BIOM BIBM 201, P1, DOI DOI 10.1109/BIBM.2012.6392719; Sherif M., 1961, SOCIAL JUDGMENT ASSI; TVERSKY A, 1992, PSYCHOL SCI, V3, P358, DOI 10.1111/j.1467-9280.1992.tb00047.x; Ur Rehman H, 2012, USING GNOME WIDE DAT, P497; Vazquez A, 2003, NAT BIOTECHNOL, V21, P697, DOI 10.1038/nbt825; WALD A, 1945, ANN MATH STAT, V16, P117, DOI 10.1214/aoms/1177731118; Watson JD, 2005, CURR OPIN STRUC BIOL, V15, P275, DOI 10.1016/j.sbi.2005.04.003; Yao JT, 2008, 2008 INTERNATIONAL FORUM ON KNOWLEDGE TECHNOLOGY, P291; Yao JT, 2015, IEEE T FUZZY SYST, V23, P3, DOI 10.1109/TFUZZ.2014.2360548; Yao JT, 2013, LECT NOTES ARTIF INT, V8171, P28, DOI 10.1007/978-3-642-41299-8_4; Yao Y. Y., 2015, HDB COMPUTATIONAL IN, P315; Yao YY, 2008, INT J APPROX REASON, V49, P255, DOI 10.1016/j.ijar.2007.05.019; Yao YY, 2015, LECT NOTES ARTIF INT, V9436, P62, DOI 10.1007/978-3-319-25754-9_6; Yao YY, 2011, FUND INFORM, V108, P249, DOI 10.3233/FI-2011-422; YAO YY, 1990, METHODOLOGIES FOR INTELLIGENT SYSTEMS, 5, P17; Yiyu Yao, 2012, Rough Sets and Current Trends in Computing. Proceedings 8th International Conference, RSCTC 2012, P1, DOI 10.1007/978-3-642-32115-3_1; Zhang HT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160629; Zhang Y, 2013, CAN CON EL COMP EN, P699	75	6	6	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0171702	10.1371/journal.pone.0171702	http://dx.doi.org/10.1371/journal.pone.0171702			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5VB	28234929	Green Published, gold, Green Submitted			2022-12-27	WOS:000394688200031
J	Sanchez, C; Sundermeier, B; Gray, K; Calin-Jageman, RJ				Sanchez, Clinton; Sundermeier, Brian; Gray, Kenneth; Calin-Jageman, Robert J.			Direct replication of Gervais & Norenzayan (2012): No evidence that analytic thinking decreases religious belief	PLOS ONE			English	Article							HIGHER-EDUCATION	Gervais & Norenzayan (2012) reported in Science a series of 4 experiments in which manipulations intended to foster analytic thinking decreased religious belief. We conducted a precise, large, multi-site pre-registered replication of one of these experiments. We observed little to no effect of the experimental manipulation on religious belief (d = 0.07 in the wrong direction, 95% CI[-0.12, 0.25], N = 941). The original finding does not seem to provide reliable or valid evidence that analytic thinking causes a decrease in religious belief.	[Sanchez, Clinton; Calin-Jageman, Robert J.] Dominican Univ, Dept Psychol, River Forest, IL 60305 USA; [Sanchez, Clinton] Depaul Univ, Sch Educ, Chicago, IL 60604 USA; [Sundermeier, Brian] Concordia Univ Chicago, Dept Psychol, River Forest, IL USA; [Gray, Kenneth] Coll DuPage, Dept Psychol, Glen Ellyn, IL USA	DePaul University	Calin-Jageman, RJ (corresponding author), Dominican Univ, Dept Psychol, River Forest, IL 60305 USA.	rcalinjageman@dom.edu	Calin-Jageman, Robert/K-1311-2019	Calin-Jageman, Robert/0000-0002-9837-6529				Brandt MJ, 2014, J EXP SOC PSYCHOL, V50, P217, DOI 10.1016/j.jesp.2013.10.005; Cusack M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140806; Deppe KD, 2015, JUDGM DECIS MAK, V10, P314; Francis G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114255; Gervais WM, 2015, COGNITION, V142, P312, DOI 10.1016/j.cognition.2015.05.011; Gervais WM, 2012, SCIENCE, V336, P493, DOI 10.1126/science.1215647; Klein RA, 2014, SOC PSYCHOL-GERMANY, V45, P142, DOI 10.1027/1864-9335/a000178; Mayrl D, 2011, SOC FORCES, V90, P181, DOI 10.1093/sf/90.1.181; Meyer A, 2015, J EXP PSYCHOL GEN, V144, pE16, DOI 10.1037/xge0000049; Moery E, 2016, SOC PSYCHOL PERS SCI, V7, P312, DOI 10.1177/1948550616639649; Oppenheimer DM, 2009, JUDGM DECIS MAK, V4, P326; Oppenheimer DM, 2009, J EXP SOC PSYCHOL, V45, P867, DOI 10.1016/j.jesp.2009.03.009; Pennycook G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153039; Pennycook G, 2014, INTELLIGENCE, V43, P21, DOI 10.1016/j.intell.2013.12.005; Schwadel P, 2015, J SCI STUD RELIG, V54, P402, DOI 10.1111/jssr.12187; Shenhav A, 2012, J EXP PSYCHOL GEN, V141, P423, DOI 10.1037/a0025391; Simmons J. P., 2012, DIALOGUE OFFICIAL NE, V26, P4, DOI [10.2139/ssrn.2160588, DOI 10.2139/SSRN.2160588]; Simonsohn U, 2015, PSYCHOL SCI, V26, P559, DOI 10.1177/0956797614567341; Simonsohn U, 2012, PERSPECT PSYCHOL SCI, V7, P597, DOI 10.1177/1745691612463399; Wallace BC, 2012, J STAT SOFTW, V49, P1, DOI 10.18637/jss.v049.i05; Yilmaz O, 2016, INT J PSYCHOL RELIG, V8619; Yonker JE, 2016, PSYCHOL RELIG SPIRIT, V8, P298, DOI 10.1037/rel0000095	22	47	47	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0172636	10.1371/journal.pone.0172636	http://dx.doi.org/10.1371/journal.pone.0172636			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL5VB	28234942	Green Published, gold, Green Submitted			2022-12-27	WOS:000394688200105
J	Ender, F; Wiese, AV; Schmudde, I; Sun, J; Vollbrandt, T; Konig, P; Laumonnier, Y; Kohl, J				Ender, Fanny; Wiese, Anna V.; Schmudde, Inken; Sun, Jing; Vollbrandt, Tillman; Koenig, Peter; Laumonnier, Yves; Koehl, Joerg			Differential regulation of C5a receptor 1 in innate immune cells during the allergic asthma effector phase	PLOS ONE			English	Article							DENDRITIC CELLS; T-CELLS; HUMAN EOSINOPHILS; ANAPHYLATOXIN RECEPTORS; NEUTROPHIL DYSFUNCTION; AIRWAY INFLAMMATION; LUNG INFLAMMATION; LYMPHOID-CELLS; TH2 RESPONSES; COMPLEMENT	C5a drives airway constriction and inflammation during the effector phase of allergic asthma, mainly through the activation of C5a receptor 1 (C5aR1). Yet, C5aR1 expression on myeloid and lymphoid cells during the allergic effector phase is ill-defined. Recently, we generated and characterized a floxed green fluorescent protein (GFP)-C5aR1 knock-in mouse. Here, we used this reporter strain to monitor C5aR1 expression in airway, pulmonary and lymph node cells during the effector phase of OVA-driven allergic asthma. C5aR1 reporter and wildtype mice developed a similar allergic phenotype with comparable airway resistance, mucus production, eosinophilic/neutrophilic airway inflammation and Th2/Th17 cytokine production. During the allergic effector phase, C5aR1 expression increased in lung tissue eosinophils but decreased in airway and pulmonary macrophages as well as in pulmonary CD11b(+) conventional dendritic cells (cDCs) and monocyte-derived DCs (moDCs). Surprisingly, expression in neutrophils was not affected. Of note, moDCs but not CD11b(+) cDCs from mediastinal lymph nodes (mLN) expressed less C5aR1 than DCs residing in the lung after OVA challenge. Finally, neither CD103(+) cDCs nor cells of the lymphoid lineage such as Th2 or Th17-differentiated CD4(+) T cells, B cells or type 2 innate lymphoid cells (ILC2) expressed C5aR1 under allergic conditions. Our findings demonstrate a complex regulation pattern of C5aR1 in the airways, lung tissue and mLN of mice, suggesting that the C5a/C5aR1 axis controls airway constriction and inflammation through activation of myeloid cells in all three compartments in an experimental model of allergic asthma.	[Ender, Fanny; Wiese, Anna V.; Sun, Jing; Laumonnier, Yves; Koehl, Joerg] Univ Lubeck, Inst Syst Inflammat Res, Lubeck, Germany; [Schmudde, Inken; Koenig, Peter] Univ Lubeck, Inst Anat, Lubeck, Germany; [Vollbrandt, Tillman] Univ Lubeck, Cell Anal Core, Lubeck, Germany; [Koehl, Joerg] Cincinnati Childrens Hosp Med Ctr, Div Immunobiol, Cincinnati, OH 45229 USA; [Koehl, Joerg] Univ Cincinnati, Coll Med, Cincinnati, OH 45220 USA	University of Lubeck; University of Lubeck; University of Lubeck; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati	Laumonnier, Y; Kohl, J (corresponding author), Univ Lubeck, Inst Syst Inflammat Res, Lubeck, Germany.; Kohl, J (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Immunobiol, Cincinnati, OH 45229 USA.; Kohl, J (corresponding author), Univ Cincinnati, Coll Med, Cincinnati, OH 45220 USA.	yves.laumonnier@uksh.de; joerg.koehl@uksh.de	König, Peter/AAK-2021-2020; Laumonnier, yves/F-6348-2018; Koehl, Joerg/C-8531-2011	Koehl, Joerg/0000-0003-1121-3178	Deutsche Forschungsgemeinschaft grant [K01245/1, IRTG 1911/A1, IRTG 1911/A2]	Deutsche Forschungsgemeinschaft grant(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft grant K01245/1 to J.K.; Deutsche Forschungsgemeinschaft grant IRTG 1911/A1 to Y.L., P.K.; and Deutsche Forschungsgemeinschaft grant IRTG 1911/A2 to P. K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2001, J IMMUNOL, V167, P4651, DOI 10.4049/jimmunol.167.8.4651; Alfven T, 2006, ALLERGY, V61, P414, DOI 10.1111/j.1398-9995.2005.00939.x; Arbore G, 2016, SCIENCE, V352, DOI 10.1126/science.aad1210; Baelder R, 2005, J IMMUNOL, V174, P783, DOI 10.4049/jimmunol.174.2.783; Croker DE, 2013, IMMUNOL CELL BIOL, V91, P625, DOI 10.1038/icb.2013.48; de Groot JC, 2015, ERJ OPEN RES, P1; Dunkelberger J, 2012, J IMMUNOL, V188, P4032, DOI 10.4049/jimmunol.1103141; Elsner J, 1996, EUR J IMMUNOL, V26, P1560, DOI 10.1002/eji.1830260723; Fujiu T, 2002, ANN ALLERG ASTHMA IM, V89, P90, DOI 10.1016/S1081-1206(10)61917-5; GERARD NP, 1989, J BIOL CHEM, V264, P1760; GOETZL EJ, 1976, AM J PATHOL, V85, P419; Halim TYF, 2014, IMMUNITY, V40, P425, DOI 10.1016/j.immuni.2014.01.011; HAVILAND DL, 1995, J IMMUNOL, V154, P1861; Hawlisch H, 2006, MOL IMMUNOL, V43, P13, DOI 10.1016/j.molimm.2005.06.028; Hoffmann F, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00107; Hu R, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.274; Humbles AA, 2000, NATURE, V406, P998, DOI 10.1038/35023175; Ishii M, 2007, APPL BIOCHEM BIOTECH, V137, P555, DOI 10.1007/s12010-007-9079-6; Jember AGH, 2001, J EXP MED, V193, P387, DOI 10.1084/jem.193.3.387; Karp CL, 2000, NAT IMMUNOL, V1, P221, DOI 10.1038/79759; Karsten CM, 2015, J IMMUNOL, V194, P1841, DOI 10.4049/jimmunol.1401401; Kohl J, 2006, J CLIN INVEST, V116, P783, DOI 10.1172/JCI26582; Krug N, 2001, AM J RESP CRIT CARE, V164, P1841, DOI 10.1164/ajrccm.164.10.2010096; Kwan WH, 2013, J EXP MED, V210, P257, DOI 10.1084/jem.20121525; Lajoie S, 2010, NAT IMMUNOL, V11, P928, DOI 10.1038/ni.1926; Maruo K, 1997, J ALLERGY CLIN IMMUN, V100, P253, DOI 10.1016/S0091-6749(97)70233-1; Monticelli LA, 2011, NAT IMMUNOL, V12, P1045, DOI [10.1038/ni.2131, 10.1031/ni.2131]; Nakano H, 2012, MUCOSAL IMMUNOL, V5, P53, DOI 10.1038/mi.2011.47; Nakano H, 2015, J IMMUNOL, V194, P3808, DOI 10.4049/jimmunol.1402195; Nakano Y, 2003, J ALLERGY CLIN IMMUN, V112, P525, DOI 10.1067/mai.2003.1710; Norimoto A, 2014, AM J RESP CELL MOL, V51, P201, DOI 10.1165/rcmb.2013-0522OC; Ortiz-Stern A, 2011, MUCOSAL IMMUNOL, V4, P343, DOI 10.1038/mi.2010.73; Peng Q, 2006, J IMMUNOL, V176, P3330, DOI 10.4049/jimmunol.176.6.3330; Peng Q, 2009, J IMMUNOL, V183, P6058, DOI 10.4049/jimmunol.0804186; Plantinga M, 2013, IMMUNITY, V38, P322, DOI 10.1016/j.immuni.2012.10.016; Schmudde I, 2013, MUCOSAL IMMUNOL, V6, P807, DOI 10.1038/mi.2012.119; Schmudde I, 2013, SEMIN IMMUNOL, V25, P2, DOI 10.1016/j.smim.2013.04.009; Skokowa J, 2005, J IMMUNOL, V174, P3041, DOI 10.4049/jimmunol.174.5.3041; SOLOMKIN JS, 1981, SURGERY, V90, P319; Sorkin A, 2002, NAT REV MOL CELL BIO, V3, P600, DOI 10.1038/nrm883; Soroosh P, 2013, J EXP MED, V210, P775, DOI 10.1084/jem.20121849; Strainic MG, 2008, IMMUNITY, V28, P425, DOI 10.1016/j.immuni.2008.02.001; Strainic MG, 2013, NAT IMMUNOL, V14, P162, DOI 10.1038/ni.2499; Tschernig T, 2007, EXP TOXICOL PATHOL, V58, P419, DOI 10.1016/j.etp.2007.03.004; Unnewehr H, 2013, J IMMUNOL, V190, P4215, DOI 10.4049/jimmunol.1200534; van den Berg CW, 2014, J IMMUNOL, V192, P1787, DOI 10.4049/jimmunol.1301920; van der Touw W, 2013, J IMMUNOL, V190, P5921, DOI 10.4049/jimmunol.1300847; Westphalen K, 2014, NATURE, V506, P503, DOI 10.1038/nature12902; Wezel A, 2014, J CELL MOL MED, V18, P2020, DOI 10.1111/jcmm.12357; Zhang X, 2010, J IMMUNOL, V185, P6741, DOI 10.4049/jimmunol.1000892; Zhang X, 2009, J IMMUNOL, V182, P5123, DOI 10.4049/jimmunol.0804276; Zhou Q, 2014, J IMMUNOL, V193, P496, DOI 10.4049/jimmunol.1303138	52	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2017	12	2							e0172446	10.1371/journal.pone.0172446	http://dx.doi.org/10.1371/journal.pone.0172446			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5SX	28231307	Green Published, Green Submitted, gold			2022-12-27	WOS:000394682400044
J	Jue, DW; Sang, XL; Shu, B; Liu, LQ; Wang, YC; Jia, ZW; Zou, Y; Shi, SY				Jue, Dengwei; Sang, Xuelian; Shu, Bo; Liu, Liqin; Wang, Yicheng; Jia, Zhiwei; Zou, Yu; Shi, Shengyou			Characterization and expression analysis of genes encoding ubiquitin conjugating domain-containing enzymes in Carica papaya	PLOS ONE			English	Article							FUNCTIONAL-CHARACTERIZATION; TRANSCRIPTION FACTOR; ECTOPIC EXPRESSION; RIPE MUTANT; ETHYLENE; PROTEIN; E2; GENOME; FAMILY; IDENTIFICATION	Background Ripening affects the quality and nutritional contents of fleshy fruits and is a crucial process of fruit development. Although several studies have suggested that ubiquitin-conjugating enzyme (E2s or UBC enzymes) are involved in the regulation of fruit ripening, little is known about the function of E2s in papaya (Carica papaya). Methodology/Principal findings In the present study, we searched the papaya genome and identified 34 putative UBC genes, which were clustered into 17 phylogenetic subgroups. We also analyzed the nucleotide sequences of the papaya UBC (CpUBC) genes and found that both exon-intron junctions and sequence motifs were highly conserved among the phylogenetic subgroups. Using real-time PCR analysis, we also found that all the CpUBC genes were expressed in roots, stems, leaves, male and female flowers, and mature fruit, although the expression of some of the genes was increased or decreased in one or several specific organs. We also found that the expression of 13 and two CpUBC genes were incresesd or decreased during one and two ripening stages, respectively. Expression analyses indicates possible E2s playing a more significant role in fruit ripening for further studies. Conclusions To the best of our knowledge, this is the first reported genome-wide analysis of the papaya UBC gene family, and the results will facilitate further investigation of the roles of UBC genes in fruit ripening and will aide in the functional validation of UBC genes in papaya.	[Jue, Dengwei; Sang, Xuelian; Shu, Bo; Liu, Liqin; Wang, Yicheng; Jia, Zhiwei; Shi, Shengyou] Chinese Acad Trop Agr Sci, South Subtrop Crops Res Inst, Key Lab Trop Fruit Biol, Minist Agr, Zhanjiang, Peoples R China; [Zou, Yu] Anhui Acad Agr Sci, Rice Res Inst, Hefei, Peoples R China	Chinese Academy of Tropical Agricultural Sciences; Ministry of Agriculture & Rural Affairs; Anhui Academy of Agricultural Sciences	Shi, SY (corresponding author), Chinese Acad Trop Agr Sci, South Subtrop Crops Res Inst, Key Lab Trop Fruit Biol, Minist Agr, Zhanjiang, Peoples R China.	ssy7299@163.com			Natural Science Foundation of Hainan Province [20163111]; Natural Science Foundation of China [31572087]; Natural Science Foundation of Guangdong Province of China [2014A030307031]; Basic Scientific Research Project of Non-profit Central Research Institutions [1630062015004]; Germplasm Resource Protection of Ministry of Agriculture [2016NWB053]; Germplasm Resource Protection of Ministry of Agriculture Wild Plant [1251416305010]; Science and Technology Project of Guangdong Province [2016A020208002]; Nature Science Foundation of Anhui Province [1408085MKL63]	Natural Science Foundation of Hainan Province; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province of China(National Natural Science Foundation of Guangdong Province); Basic Scientific Research Project of Non-profit Central Research Institutions; Germplasm Resource Protection of Ministry of Agriculture; Germplasm Resource Protection of Ministry of Agriculture Wild Plant; Science and Technology Project of Guangdong Province; Nature Science Foundation of Anhui Province(Natural Science Foundation of Anhui Province)	This work was supported by the Natural Science Foundation of Hainan Province (20163111), the Natural Science Foundation of China (31572087), the Natural Science Foundation of Guangdong Province of China (2014A030307031), the Basic Scientific Research Project of Non-profit Central Research Institutions (No. 1630062015004), the Germplasm Resource Protection of Ministry of Agriculture (2016NWB053), the Germplasm Resource Protection of Ministry of Agriculture Wild Plant (1251416305010), the Science and Technology Project of Guangdong Province (2016A020208002) and the Nature Science Foundation of Anhui Province (grant no. 1408085MKL63).	Bachmair A, 2001, TRENDS PLANT SCI, V6, P463, DOI 10.1016/S1360-1385(01)02080-5; Bae H, 2014, BIOCHEM BIOPH RES CO, V444, P575, DOI 10.1016/j.bbrc.2014.01.098; Barry CS, 2006, P NATL ACAD SCI USA, V103, P7923, DOI 10.1073/pnas.0602319103; Bemer M, 2012, PLANT CELL, V24, P4437, DOI 10.1105/tpc.112.103283; Callis J, 2000, CURR OPIN PLANT BIOL, V3, P381, DOI 10.1016/S1369-5266(00)00100-X; Cui F, 2012, PLANT CELL, V24, P233, DOI 10.1105/tpc.111.093062; Devitt LC, 2010, J EXP BOT, V61, P33, DOI 10.1093/jxb/erp284; Dong C, 2016, PLANT SCI, V245, P11, DOI 10.1016/j.plantsci.2016.01.003; E ZG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122621; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Evans EA, 2015, AN OVERVIEW OF GLOBA; Fabi JP, 2007, J AGR FOOD CHEM, V55, P6118, DOI 10.1021/jf070903c; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Giovannoni JJ, 2004, PLANT CELL, V16, pS170, DOI 10.1105/tpc.019158; Guo An-Yuan, 2007, Yichuan, V29, P1023, DOI 10.1360/yc-007-1023; Hackett RM, 2000, PLANT PHYSIOL, V124, P1079, DOI 10.1104/pp.124.3.1079; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Itkin M, 2009, PLANT J, V60, P1081, DOI 10.1111/j.1365-313X.2009.04064.x; Jeon EH, 2012, BIOCHEM BIOPH RES CO, V427, P309, DOI 10.1016/j.bbrc.2012.09.048; Jones D, 2001, GENOME BIOL, V1, P1; Jue DW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143488; Karlova R, 2011, PLANT CELL, V23, P923, DOI 10.1105/tpc.110.081273; Kevany BM, 2007, PLANT J, V51, P458, DOI 10.1111/j.1365-313X.2007.03170.x; Kraft E, 2005, PLANT PHYSIOL, V139, P1597, DOI 10.1104/pp.105.067983; Letunic I, 2004, NUCLEIC ACIDS RES, V32, pD142, DOI 10.1093/nar/gkh088; Li WF, 2010, PLANT J, V62, P330, DOI 10.1111/j.1365-313X.2010.04150.x; Lin YX, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-76; Lin ZF, 2009, J EXP BOT, V60, P3311, DOI 10.1093/jxb/erp204; Manning K, 2006, NAT GENET, V38, P948, DOI 10.1038/ng1841; Michelle C, 2009, J MOL EVOL, V68, P616, DOI 10.1007/s00239-009-9225-6; Ming R, 2008, NATURE, V452, P991, DOI 10.1038/nature06856; Moore S, 2002, J EXP BOT, V53, P2023, DOI 10.1093/jxb/erf057; Mukhopadhyay D, 2007, SCIENCE, V315, P201, DOI 10.1126/science.1127085; OELLER PW, 1991, SCIENCE, V254, P437, DOI 10.1126/science.1925603; Papaleo E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040786; Peng XJ, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0032997, 10.1371/journal.pone.0040120]; Proost S, 2009, PLANT CELL, V21, P3718, DOI 10.1105/tpc.109.071506; Sadanandom A, 2012, NEW PHYTOL, V196, P13, DOI 10.1111/j.1469-8137.2012.04266.x; Sato S, 2012, NATURE, V485, P635, DOI 10.1038/nature11119; Schumacher FR, 2013, J MOL BIOL, V425, P4099, DOI 10.1016/j.jmb.2013.06.039; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tang RQ, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r25; van Wijk SJL, 2010, FASEB J, V24, P981, DOI 10.1096/fj.09-136259; Vrebalov J, 2009, PLANT CELL, V21, P3041, DOI 10.1105/tpc.109.066936; Wang Y, 2015, GENE, V566, P95, DOI 10.1016/j.gene.2015.04.041; Welchman RL, 2005, NAT REV MOL CELL BIO, V6, P599, DOI 10.1038/nrm1700; Wen R, 2006, PLANT MOL BIOL, V61, P241, DOI 10.1007/s11103-006-0007-x; White PJ, 2002, J EXP BOT, V53, P1995, DOI 10.1093/jxb/erf105; WILKINSON JQ, 1995, SCIENCE, V270, P1807, DOI 10.1126/science.270.5243.1807; Winn PJ, 2004, STRUCTURE, V12, P1563, DOI 10.1016/j.str.2004.06.017; Xu L, 2009, PLANT J, V57, P279, DOI 10.1111/j.1365-313X.2008.03684.x; Yi Sheng JHH, 2012, MOL CELLULAR PROTEOM, V11, P329; Zhang M, 2009, J EXP BOT, V60, P1579, DOI 10.1093/jxb/erp026; Zhao Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028488; Zhu MK, 2014, PLANT CELL PHYSIOL, V55, P119, DOI 10.1093/pcp/pct162; Zolman BK, 2005, PLANT CELL, V17, P3422, DOI 10.1105/tpc.105.035691	56	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2017	12	2							e0171357	10.1371/journal.pone.0171357	http://dx.doi.org/10.1371/journal.pone.0171357			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5SX	28231288	Green Published, gold, Green Submitted			2022-12-27	WOS:000394682400012
J	Summers, RLS; Chen, M; Kimberley, TJ				Summers, Rebekah L. S.; Chen, Mo; Kimberley, Teresa J.			Corticospinal excitability measurements using transcranial magnetic stimulation are valid with intramuscular electromyography	PLOS ONE			English	Article							STRIATED URETHRAL SPHINCTER; MOTOR EVOKED-POTENTIALS; RESPONSES; CORTEX; EMG	Objectives Muscular targets that are deep or inaccessible to surface electromyography (sEMG) require intrinsic recording using fine-wire electromyography (fEMG). It is unknown if fEMG validly record cortically evoked muscle responses compared to sEMG. The purpose of this investigation was to establish the validity and agreement of fEMG compared to sEMG to quantify typical transcranial magnetic stimulation (TMS) measures pre and post repetitive TMS (rTMS). The hypotheses were that fEMG would demonstrate excellent validity and agreement compared with sEMG. Materials and methods In ten healthy volunteers, paired pulse and cortical silent period (CSP) TMS measures were collected before and after 1200 pulses of 1Hz rTMS to the motor cortex. Data were simultaneously recorded with sEMG and fEMG in the first dorsal interosseous. Concurrent validity (r and rho) and agreement (Tukey mean- difference) were calculated. Results fEMG quantified corticospinal excitability with good to excellent validity compared to sEMG data at both pretest (r = 0.77 - 0.97) and posttest (r = 0.83 - 0.92). Pairwise comparisons indicated no difference between sEMG and fEMG for all outcomes; however, Tukey mean- difference plots display increased variance and questionable agreement for paired pulse outcomes. CSP displayed the highest estimates of validity and agreement. Paired pulse MEP responses recorded with fEMG displayed reduced validity, agreement and less sensitivity to changes in MEP amplitude compared to sEMG. Change scores following rTMS were not significantly different between sEMG and fEMG. Conclusion fEMG electrodes are a valid means to measure CSP and paired pulse MEP responses. CSP displays the highest validity estimates, while caution is warranted when assessing paired pulse responses with fEMG. Corticospinal excitability and neuromodulatory aftereffects from rTMS may be assessed using fEMG.	[Summers, Rebekah L. S.; Kimberley, Teresa J.] Univ Minnesota, Dept Phys Med & Rehabil, Program Phys Therapy, Minneapolis, MN 55455 USA; [Summers, Rebekah L. S.; Chen, Mo; Kimberley, Teresa J.] Univ Minnesota, Dept Phys Med & Rehabil, Rehabil Sci, Minneapolis, MN 55455 USA; [Chen, Mo] Univ Minnesota, Inst Engn Med, Minneapolis, MN USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Kimberley, TJ (corresponding author), Univ Minnesota, Dept Phys Med & Rehabil, Program Phys Therapy, Minneapolis, MN 55455 USA.; Kimberley, TJ (corresponding author), Univ Minnesota, Dept Phys Med & Rehabil, Rehabil Sci, Minneapolis, MN 55455 USA.	tjk@umn.edu	Kimberley, Teresa/AAL-1893-2020	Kimberley, Teresa/0000-0001-6397-4054; Chen, Mo/0000-0002-3188-166X; Summers, Rebekah/0000-0002-1783-3362	National Center for Advancing Translational Sciences of the National Institutes of Health [UL1TR000114]	National Center for Advancing Translational Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	Research reported in this publication was supported by the National Center for Advancing Translational Sciences of the National Institutes of Health Award Number UL1TR000114. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	[Anonymous], [No title captured]; BAWA P, 1993, J PHYSIOL-LONDON, V471, P445, DOI 10.1113/jphysiol.1993.sp019909; Borich M, 2009, RESTOR NEUROL NEUROS, V27, P55, DOI 10.3233/RNN-2009-0461; Brostrom S, 2003, NEUROUROL URODYNAM, V22, P123, DOI 10.1002/nau.10030; Carroll TJ, 2011, ACTA PHYSIOL, V202, P119, DOI 10.1111/j.1748-1716.2011.02271.x; Chen M, 2015, NEUROMODULATION, V18, P678, DOI 10.1111/ner.12337; Demoule A, 2003, J APPL PHYSIOL, V94, P453, DOI 10.1152/japplphysiol.00581.2002; EARDLEY I, 1991, BRIT J UROL, V68, P81, DOI 10.1111/j.1464-410X.1991.tb15261.x; FERBERT A, 1992, J PHYSIOL-LONDON, V453, P525, DOI 10.1113/jphysiol.1992.sp019243; Giavarina D, 2015, BIOCHEM MEDICA, V25, P141, DOI 10.11613/BM.2015.015; Groppa S, 2012, CLIN NEUROPHYSIOL, V123, P858, DOI 10.1016/j.clinph.2012.01.010; Grospretre S, 2014, PHYSL REP PHYSL REPO, V2, P58; Hanajima R, 1998, J PHYSIOL-LONDON, V509, P607, DOI 10.1111/j.1469-7793.1998.607bn.x; Kimberley TJ, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00385; Kimberley TJ, 2014, ARCH PHYS MED REHABI; MILLS KR, 1991, ELECTROEN CLIN NEURO, P100; Pearce SL, 2003, J PHYSIOL-LONDON, V549, P583, DOI 10.1113/jphysiol.2002.035352; Pelliccioni G, 1997, J NEUROL SCI, V149, P69, DOI 10.1016/S0022-510X(97)05388-4; Portney LG, 2009, FDN CLIN RES APPL PR, V3rd, DOI DOI 10.1016/S0039-6257(02)00362-4; ROSSINI PM, 1995, BRAIN RES, V676, P314, DOI 10.1016/0006-8993(95)00113-5; Selvanayagam VS, 2012, J APPL PHYSIOL, V112, P259, DOI 10.1152/japplphysiol.00558.2011; Todd G, 2012, CLIN NEUROPHYSIOL, V123, P1002, DOI 10.1016/j.clinph.2011.09.019; Tsao H, 2008, J NEUROSCI METH, V171, P132, DOI 10.1016/j.jneumeth.2008.02.005; WERHAHN KJ, 1994, ELECTROEN CLIN NEURO, V93, P138, DOI 10.1016/0168-5597(94)90077-9	24	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2017	12	2							e0172152	10.1371/journal.pone.0172152	http://dx.doi.org/10.1371/journal.pone.0172152			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5SX	28231250	Green Submitted, Green Published, gold			2022-12-27	WOS:000394682400026
J	Vasilakis, DP; Whitfield, DP; Kati, V				Vasilakis, Dimitris P.; Whitfield, D. Philip; Kati, Vassiliki			A balanced solution to the cumulative threat of industrialized wind farm development on cinereous vultures (Aegypius monachus) in south-eastern Europe	PLOS ONE			English	Article							EURASIAN BLACK VULTURE; NATIONAL-PARK; CONSERVATION; MORTALITY; POPULATION; FATALITIES; BEHAVIOR; ENERGY; THRACE; RATES	Wind farm development can combat climate change but may also threaten bird populations' persistence through collision with wind turbine blades if such development is improperly planned strategically and cumulatively. Such improper planning may often occur. Numerous wind farms are planned in a region hosting the only cinereous vulture population in southeastern Europe. We combined range use modelling and a Collision Risk Model (CRM) to predict the cumulative collision mortality for cinereous vulture under all operating and proposed wind farms. Four different vulture avoidance rates were considered in the CRM. Cumulative collision mortality was expected to be eight to ten times greater in the future (proposed and operating wind farms) than currently (operating wind farms), equivalent to 44% of the current population (103 individuals) if all proposals are authorized (2744 MW). Even under the most optimistic scenario whereby authorized proposals will not collectively exceed the national target for wind harnessing in the study area (960 MW), cumulative collision mortality would still be high (17% of current population) and likely lead to population extinction. Under any wind farm proposal scenario, over 92% of expected deaths would occur in the core area of the population, further implying inadequate spatial planning and implementation of relevant European legislation with scant regard for governmental obligations to protect key species. On the basis of a sensitivity map we derive a spatially explicit solution that could meet the national target of wind harnessing with a minimum conservation cost of less than 1% population loss providing that the population mortality (5.2%) caused by the operating wind farms in the core area would be totally mitigated. Under other scenarios, the vulture population would probably be at serious risk of extinction. Our 'win-win' approach is appropriate to other potential conflicts where wind farms may cumulatively threaten wildlife populations.	[Vasilakis, Dimitris P.; Kati, Vassiliki] Univ Patras, Dept Environm & Nat Resources Management, Agrinion, Aitoloakarnania, Greece; [Vasilakis, Dimitris P.] Directorate Evros Reg Forestry Serv, Decentralized Adm Macedonia Thrace, Hellen Republ, Alexandroupolis, Evros, Greece; [Whitfield, D. Philip] Nat Res Ltd, Brathens Business Pk, Banchory, Aberdeen, Scotland	University of Patras	Vasilakis, DP; Kati, V (corresponding author), Univ Patras, Dept Environm & Nat Resources Management, Agrinion, Aitoloakarnania, Greece.; Vasilakis, DP (corresponding author), Directorate Evros Reg Forestry Serv, Decentralized Adm Macedonia Thrace, Hellen Republ, Alexandroupolis, Evros, Greece.	dvasilak@damt.gov.gr; vkati@upatras.gr	Vasilakis, Dimitris/AAC-1404-2021; Kati, Vassiliki I/AAB-9418-2020	Kati, Vassiliki I/0000-0003-3357-4556; Vasilakis, Dimitris/0000-0003-2902-9678	WWF Greece; Recreation and Development Union in Bulgaria (Life and Phare projects); Hellenic Republic; Decentralized Administration of Macedonia and Thrace; Natural Research Ltd	WWF Greece; Recreation and Development Union in Bulgaria (Life and Phare projects); Hellenic Republic; Decentralized Administration of Macedonia and Thrace; Natural Research Ltd	Fieldwork and equipment was funded primarily by WWF Greece and also by Recreation and Development Union in Bulgaria (Life and Phare projects). The work of D.P.V. is partially supported by Hellenic Republic, Decentralized Administration of Macedonia and Thrace. The funders had no involvement in any stage of the present work and views or opinions presented in this paper are solely those of the authors. Natural Research Ltd supports dissemination of results.	Band W., 2007, P259; Barros M a. S, 2015, STUDIES NEOTROPICAL, P1; BE-NATUR, 2013, TRANSN JOINT STRAT T; Bellebaum J, 2013, J NAT CONSERV, V21, P394, DOI 10.1016/j.jnc.2013.06.001; Beston JA, 2016, PRIORITIZING AVIAN S; Bougain C, 2016, IDENTIFICATION IMPOR; Brabant R, 2015, HYDROBIOLOGIA; Campioni L, 2013, OECOLOGIA, V172, P371, DOI 10.1007/s00442-012-2493-7; Carrete M, 2005, BIOL CONSERV, V126, P582, DOI 10.1016/j.biocon.2005.06.031; Carrete M, 2012, BIOL CONSERV, V145, P102, DOI 10.1016/j.biocon.2011.10.017; Carrete M, 2009, BIOL CONSERV, V142, P2954, DOI 10.1016/j.biocon.2009.07.027; Chamberlain DE, 2006, IBIS, V148, P198, DOI 10.1111/j.1474-919X.2006.00507.x; Dai KS, 2015, RENEW ENERG, V75, P911, DOI 10.1016/j.renene.2014.10.074; de la Puente Javier, 2011, P270; de Lucas M, 2008, J APPL ECOL, V45, P1695, DOI 10.1111/j.1365-2664.2008.01549.x; de Lucas M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048092; de Lucas M, 2012, BIOL CONSERV, V147, P184, DOI 10.1016/j.biocon.2011.12.029; Dimalexis A, 2010, IDENTIFICATION MAPPI; Doutau B, 2011, ANN REPORT AUGUST 20; Edenhofer O, 2011, SUMMARY POLICYMAKER; Eichhorn M, 2012, ECOL SOC, V17, DOI 10.5751/ES-04594-170201; EU, 2011, GUID WIND EN DEV ACC, P118; European Commission (EC), 1999, GUID ASS IND CUM IMP; Ferrer M, 2012, J APPL ECOL, V49, P38, DOI 10.1111/j.1365-2664.2011.02054.x; Franco José Luiz de Andrade, 2013, História, V32, P21, DOI 10.1590/S0101-90742013000200003; Georgiakakis P, 2012, ACTA CHIROPTEROL, V14, P459, DOI 10.3161/150811012X661765; Gove B., 2013, WIND FARMS BIRDS UPD; Greek Ministry of Development, 2007, 1 GREEK MIN DEV, P76; Hodzic AS, 2011, JOINT STRATEGY INTEG; Hoover SL, 2005, J WILDLIFE MANAGE, V69, P150, DOI 10.2193/0022-541X(2005)069<0150:BORHIA>2.0.CO;2; IUCN, 2013, IUCN RED LIST THREAT; Kaldellis JK, 2011, RENEW ENERG, V36, P1887, DOI 10.1016/j.renene.2011.01.002; Kati V, 2015, CONSERV BIOL, V29, P260, DOI 10.1111/cobi.12366; Korner-Nievergelt F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067997; Kret E, 2011, P C WIND EN WILDL IM, P140; Legakis A, 2009, RED BOOK THREATEN AN; Lopez-Lopez P, 2014, ECOL APPL, V24, P938, DOI 10.1890/13-2000.1; Maclean IMD, 2008, DEV GUIDELINES ORNIT; Marques AT, 2014, BIOL CONSERV, V179, P40, DOI 10.1016/j.biocon.2014.08.017; Martinez-Abrain A, 2012, J APPL ECOL, V49, P109, DOI 10.1111/j.1365-2664.2011.02080.x; Masden EA, 2010, ENVIRON IMPACT ASSES, V30, P1, DOI 10.1016/j.eiar.2009.05.002; MEECC, 2007, STRAT ENV ASS SPEC P; MEECC, 2009, NAT REN EN ACT PLAN, P109; Mojica EK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157807; ODUM WE, 1982, BIOSCIENCE, V32, P728, DOI 10.2307/1308718; Peterson Kaja, 2010, Journal of Environmental Assessment Policy and Management, V12, P185, DOI 10.1142/S1464333210003553; Reid T., 2015, J APPL ECOL, P1; Sanz-Aguilar A, 2015, BIOL CONSERV, V187, P10, DOI 10.1016/j.biocon.2015.03.029; Schaub M, 2012, BIOL CONSERV, V155, P111, DOI 10.1016/j.biocon.2012.06.021; Schindler S, 2014, J NAT HIST TAYLOR FR, P1; Schuster E, 2015, ENVIRON MANAGE, V56, P300, DOI 10.1007/s00267-015-0501-5; Skartsi T, 2008, J NAT HIST, V42, P345, DOI 10.1080/00222930701835290; Smales I, 2006, WIND FARM COLLISION, P237; Soderman T, 2009, ENVIRON IMPACT ASSES, V29, P79, DOI 10.1016/j.eiar.2008.04.001; SOULE ME, 1985, BIOSCIENCE, V35, P727, DOI 10.2307/1310054; Tabassum-Abbasi, 2014, RENEW SUST ENERG REV, V31, P270, DOI 10.1016/j.rser.2013.11.019; Vasilakis DP, 2008, J NAT HIST, V42, P355, DOI 10.1080/00222930701835308; Vasilakis DP, 2016, BIOL CONSERV, V196, P10, DOI 10.1016/j.biocon.2016.01.014; Vasilakis DP, 2016, THESIS; Wilson Janet, 2010, BUILDING FUTURE RECA, P17; Woloszyn W, 2012, ANN UMCS GEOGR GEOL, P67; WWF Greece, 2014, WIND FARMS THRAC QUA; WWF Greece, 2013, WIND FARMS THRAC UPD	63	15	16	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2017	12	2							e0172685	10.1371/journal.pone.0172685	http://dx.doi.org/10.1371/journal.pone.0172685			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5SX	28231316	Green Published, gold, Green Submitted			2022-12-27	WOS:000394682400071
J	Park, S; Kim, DH; Hwang, JH; Kim, YC; Kim, JH; Lim, CS; Kim, YS; Yang, SH; Lee, JP				Park, Sehoon; Kim, Do Hyoung; Hwang, Jin Ho; Kim, Yong-Chul; Kim, Jin Hyuk; Lim, Chun Soo; Kim, Yon Su; Yang, Seung Hee; Lee, Jung Pyo			Elevated bilirubin levels are associated with a better renal prognosis and ameliorate kidney fibrosis	PLOS ONE			English	Article							SERUM BILIRUBIN; GILBERT-SYNDROME; DISEASE; MECHANISMS; POPULATION; EVENTS	Background Bilirubin has been reported to protect against kidney injury. However, further studies highlighting the beneficial effects of bilirubin on renal fibrosis and chronic renal function decline are necessary. Methods We assessed a prospective cohort with a reference range of total bilirubin levels. The primary outcome was a 30% reduction in the estimated glomerular filtration rate (eGFR) from baseline, and the secondary outcome was a doubling of the serum creatinine levels, halving of the eGFR and the initiation of dialysis. In addition, experiments with tubular epithelial cells and C57BL/6 mice were performed to investigate the protective effects of bilirubin on kidney fibrosis. Results As a result, 1,080 patients were included in the study cohort. The study group with relative hyperbilirubinemia (total bilirubin 0.8-1.2 mg/dL) showed a better prognosis in terms of the primary outcome (adjusted hazard ratio (HR) 0.33, 95% confidence interval (CI) 0.19-0.59, P < 0.001) and the secondary outcome (adjusted HR 0.20, 95% CI 0.05 to 0.71, P = 0.01) than that of the control group. Moreover, the bilirubin-treated mice showed less fibrosis in the unilateral ureteral obstruction (UUO) model (P < 0.05). In addition, bilirubin treatment decreased fibronectin expression in tubular epithelial cells in a dose-dependent manner (P < 0.05). Conclusions Mildly elevated serum bilirubin levels were associated with better renal prognosis, and bilirubin treatment induced a beneficial effect on renal fibrosis. Therefore, bilirubin could be a potential therapeutic target to delay fibrosis-related kidney disease progression.	[Park, Sehoon; Kim, Yon Su] Seoul Natl Univ, Coll Med, Dept Biomed Sci, Seoul, South Korea; [Kim, Do Hyoung; Lim, Chun Soo; Lee, Jung Pyo] Seoul Natl Univ, Dept Internal Med, Seoul Metropolitan Govt Boramae Med Ctr, Seoul, South Korea; [Hwang, Jin Ho] Chung Ang Univ Hosp, Dept Internal Med, Seoul, South Korea; [Kim, Yong-Chul; Kim, Jin Hyuk; Lim, Chun Soo; Kim, Yon Su; Yang, Seung Hee; Lee, Jung Pyo] Seoul Natl Univ, Coll Med, Kidney Res Inst, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Chung Ang University; Chung Ang University Hospital; Seoul National University (SNU)	Lee, JP (corresponding author), Seoul Natl Univ, Dept Internal Med, Seoul Metropolitan Govt Boramae Med Ctr, Seoul, South Korea.; Yang, SH; Lee, JP (corresponding author), Seoul Natl Univ, Coll Med, Kidney Res Inst, Seoul, South Korea.	ysh5794@gmail.com; nephrolee@gmail.com	Kim, Do Hyoung/AAE-7557-2022; Kim, Yong Chul/L-8653-2019; Hwang, Jin Ho/E-7203-2015	Kim, Do Hyoung/0000-0002-8664-8830; Hwang, Jin Ho/0000-0003-0829-0922; Kim, Yong Chul/0000-0003-3215-8681	National Research Foundation of Korea (NRF) - Korean government (MSIP) [2015R1C1A1A01055717]; Korean Society of Nephrology (BAXTER)	National Research Foundation of Korea (NRF) - Korean government (MSIP); Korean Society of Nephrology (BAXTER)	JPL was funded by a grant from the National Research Foundation of Korea (NRF) funded by the Korean government (MSIP) (No. 2015R1C1A1A01055717), and by a grant from the Korean Society of Nephrology (BAXTER, 2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahanger AA, 2016, INT WOUND J, V13, P398, DOI 10.1111/iwj.12319; Akboga MK, 2015, ATHEROSCLEROSIS, V240, P110, DOI 10.1016/j.atherosclerosis.2015.02.051; Becker GJ, 2013, NEPHROL DIAL TRANSPL, V28, P2432, DOI 10.1093/ndt/gft071; Boon AC, 2015, SCI REP-UK, V5, DOI 10.1038/srep15482; Boon AC, 2014, AM J PHYSIOL-RENAL, V307, pF123, DOI 10.1152/ajprenal.00039.2014; Chin HJ, 2009, J KOREAN MED SCI, V24, pS22, DOI 10.3346/jkms.2009.24.S1.S22; Eddy AA, 1996, J AM SOC NEPHROL, V7, P2495; Eilers PHC, 1996, STAT SCI, V11, P89, DOI 10.1214/ss/1038425655; Horsfall LJ, 2013, J GASTROEN HEPATOL, V28, P1643, DOI 10.1111/jgh.12279; Inoguchi T, 2007, JAMA-J AM MED ASSOC, V298, P1398, DOI 10.1001/jama.298.12.1398-b; Kang SJ, 2014, ANN MED, V46, P138, DOI 10.3109/07853890.2014.895588; Kasap B, 2012, UROLOGY, V80, P1389, DOI [10.1038/sj.onc.1209712PMID:16799646, DOI 10.1038/SJ.ONC.1209712]; KUTNER NG, 1985, NEW ENGL J MED, V312, P1579; LeBlanc RM, 2010, AM J MED SCI, V340, P144, DOI 10.1097/MAJ.0b013e3181e52de9; Lee JP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093633; Levey AS, 2003, ANN INTERN MED, V139, P137, DOI 10.7326/0003-4819-139-2-200307150-00013; Liu YH, 2010, J AM SOC NEPHROL, V21, P212, DOI 10.1681/ASN.2008121226; Mack M, 2015, KIDNEY INT, V87, P297, DOI 10.1038/ki.2014.287; Mahabadi AA, 2014, CLIN RES CARDIOL, V103, P647, DOI 10.1007/s00392-014-0697-z; Oh SW, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-105; Pflueger A, 2005, AM J PHYSIOL-RENAL, V288, pF552, DOI 10.1152/ajprenal.00278.2004; Ram M, 2014, N-S ARCH PHARMACOL, V387, P955, DOI 10.1007/s00210-014-1011-3; Riphagen IJ, 2014, DIABETES, V63, P2845, DOI 10.2337/db13-1652; Schlondorff DO, 2008, KIDNEY INT, V74, P860, DOI 10.1038/ki.2008.351; Tanaka M, 2014, ATHEROSCLEROSIS, V234, P421, DOI 10.1016/j.atherosclerosis.2014.03.015; Vitek L, 2002, ATHEROSCLEROSIS, V160, P449, DOI 10.1016/S0021-9150(01)00601-3; Wegiel B, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00047; Wynn TA, 2012, NAT MED, V18, P1028, DOI 10.1038/nm.2807; Xu J, 2009, CELL RES, V19, P156, DOI 10.1038/cr.2009.5; Yang Y, 2006, ONCOGENE, V25, P7235, DOI 10.1038/sj.onc.1209712; Zeisberg M, 2010, J AM SOC NEPHROL, V21, P1819, DOI 10.1681/ASN.2010080793	31	16	19	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2017	12	2							e0172434	10.1371/journal.pone.0172434	http://dx.doi.org/10.1371/journal.pone.0172434			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5SK	28225832	Green Submitted, Green Published, gold			2022-12-27	WOS:000394680900041
J	Alekseeva, LA; Mironova, NL; Brenner, EV; Kurilshikov, AM; Patutina, OA; Zenkova, MA				Alekseeva, Ludmila A.; Mironova, Nadezhda L.; Brenner, Evgenyi V.; Kurilshikov, Alexander M.; Patutina, Olga A.; Zenkova, Marina A.			Alteration of the exDNA profile in blood serum of LLC-bearing mice under the decrease of tumour invasion potential by bovine pancreatic DNase I treatment	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; CELL-FREE DNA; CIRCULATING NUCLEIC-ACIDS; EXTRACELLULAR DNA; CANCER-PATIENTS; PROGNOSTIC MARKER; BINDING PROTEIN; PLASMA DNA; RECEPTOR; DEOXYRIBONUCLEASE	Taking into account recently obtained data indicating the participation of circulating extracellular DNA (exDNA) in tumorigenesis, enzymes with deoxyribonucleic activity have again been considered as potential antitumour and antimetastatic drugs. Previously, using murine Lewis lung carcinoma and hepatocellular carcinoma A1 tumour models, we have shown the antimetastatic activity of bovine DNase I, which correlates with an increase of DNase activity and a decrease of exDNA concentration in the blood serum of tumour-bearing mice. In this work, using next-generation sequencing on the ABS SOLiD (TM) 5.500 platform, we performed a search for molecular targets of DNase I by comparing the exDNA profiles of healthy animals, untreated animals with Lewis lung carcinoma (LLC) and those with LLC treated with DNase I. We found that upon DNase I treatment of LLC-bearing mice, together with inhibition of metastasis, a number of strong alterations in the patterns of exDNA were observed. The major differences in exDNA profiles between groups were: i) the level of GC-poor sequences increased during tumour development was reduced to that of healthy mice; ii) levels of sequences corresponding to tumour-associated genes Hmga2, Myc and Jun were reduced in the DNase I-treated group in comparison with non-treated mice; iii) 224 types of tandem repeat over-presented in untreated LLC-bearing mice were significantly reduced after DNase I treatment. The most important result obtained in the work is that DNase I decreased the level of B-subfamily repeats having homology to human ALU repeats, known as markers of carcinogenesis, to the level of healthy animals. Thus, the obtained data lead us to suppose that circulating exDNA plays a role in tumour dissemination, and alteration of multiple molecular targets in the bloodstream by DNase I reduces the invasive potential of tumours.	[Alekseeva, Ludmila A.; Mironova, Nadezhda L.; Brenner, Evgenyi V.; Kurilshikov, Alexander M.; Patutina, Olga A.; Zenkova, Marina A.] RAS, SB, Inst Chem Biol & Fundamental Med, Novosibirsk, Russia	Institute of Chemical Biology & Fundamental Medicine, Siberian Branch of the RAS; Russian Academy of Sciences	Zenkova, MA (corresponding author), RAS, SB, Inst Chem Biol & Fundamental Med, Novosibirsk, Russia.	marzen@niboch.nsc.ru	Zenkova, Marina A/G-5088-2013; Kurilshikov, Alexander/GWC-1519-2022; Alekseeva, Ludmila/AAF-2362-2021; Patutina, Olga/F-9159-2013	Kurilshikov, Alexander/0000-0003-2541-5627; Alekseeva, Ludmila/0000-0002-5826-5365; Zenkova, Marina/0000-0003-4044-1049; Mironova, Nadezhda/0000-0003-4375-0269	Russian Academy of Science [II.2P/VII.58-1]; Russian Foundation for Basic Research [14-04-01007];  [SS - 7623.2016.4]	Russian Academy of Science(Russian Academy of Sciences); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); 	This research was supported by the Russian Academy of Science under the programs 1.7 'Molecular and Cellular Biology' (grant # II.2P/VII.58-1), Russian Foundation for Basic Research (grant # 14-04-01007) and scientific schools SS - 7623.2016.4. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akers SN, 2014, GYNECOL ONCOL, V132, P462, DOI 10.1016/j.ygyno.2013.12.024; Alcazar-Leyva S, 2009, MED SCI MONITOR, V15, pCR51; Anker P, 1999, CANCER METAST REV, V18, P65, DOI 10.1023/A:1006260319913; Balaj L, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1180; Belancio VP, 2010, SEMIN CANCER BIOL, V20, P200, DOI 10.1016/j.semcancer.2010.06.001; BENNET RM, 1988, J IMMUNOL, V140, P2937; BENNETT RM, 1987, J EXP MED, V166, P850, DOI 10.1084/jem.166.4.850; BENNETT RM, 1985, J CLIN INVEST, V76, P2182, DOI 10.1172/JCI112226; Bergsmedh A, 2001, P NATL ACAD SCI USA, V98, P6407, DOI 10.1073/pnas.101129998; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Carreira PE, 2014, FEBS J, V281, P63, DOI 10.1111/febs.12601; Casadio V, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/270457; Chen Z, 2005, MED HYPOTHESES, V65, P956, DOI 10.1016/j.mehy.2005.04.042; Combaret V, 2002, CANCER RES, V62, P3646; Contreras-Galindo R, 2008, J VIROL, V82, P9329, DOI 10.1128/JVI.00646-08; Demers M, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2015.1134073; El-Gayar Dina, 2016, Asian Pac J Cancer Prev, V17, P939; Feng DX, 2002, PANCREAS, V25, P336, DOI 10.1097/00006676-200211000-00003; Fleischhacker M, 2007, BBA-REV CANCER, V1775, P181, DOI 10.1016/j.bbcan.2006.10.001; Fujihara J, 2012, COMP BIOCHEM PHYS B, V163, P263, DOI 10.1016/j.cbpb.2012.07.002; Gaiffe E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036766; Garcia-Olmo DC, 2010, CANCER RES, V70, P560, DOI 10.1158/0008-5472.CAN-09-3513; Gautschi O, 2004, J CLIN ONCOL, V22, P4157, DOI 10.1200/JCO.2004.11.123; Gotoh T, 2005, J CLIN ONCOL, V23, P5205, DOI 10.1200/JCO.2005.02.014; Hao TB, 2014, BRIT J CANCER, V111, P1482, DOI 10.1038/bjc.2014.470; Hawes MC, 2015, CANCER RES, V75, P4260, DOI 10.1158/0008-5472.CAN-15-1546; Healy LD, 2016, J IMMUNOL METHODS, V435, P77, DOI 10.1016/j.jim.2016.06.002; HEFENEIDER SH, 1990, J INVEST DERMATOL, V94, pS79, DOI 10.1111/1523-1747.ep12875170; Helman E, 2014, GENOME RES, V24, P1053, DOI 10.1101/gr.163659.113; Hsieh SC, 2001, RHEUMATOLOGY, V40, P851, DOI 10.1093/rheumatology/40.8.851; Iqbal S, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-1071-y; Jackson PE, 2003, CARCINOGENESIS, V24, P1657, DOI 10.1093/carcin/bgg101; Jahr S, 2001, CANCER RES, V61, P1659; Johnson PJ, 2002, CLIN CHEM, V48, P1186; Kemp JR, 2015, FRONT CHEM, V3, DOI [10.3389/fchem.2075.00068, 10.3389/fchem.2015.00068]; Kitada K, 2013, CYTOGENET GENOME RES, V139, P1, DOI 10.1159/000342885; Kostyuk S, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/782123; Lee TH, 2014, BIOCHEM BIOPH RES CO, V451, P295, DOI 10.1016/j.bbrc.2014.07.109; LI JZ, 1989, ARTHRITIS RHEUM-US, V32, P726, DOI 10.1002/anr.1780320610; Lin X, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1552-y; Lindforss U, 2005, ANTICANCER RES, V25, P657; LUNDQVIST EHA, 1991, EUR J CANCER, V27, P1313, DOI 10.1016/0277-5379(91)90103-K; Ma XT, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7604; Marchenko MM, 1999, UKR BIOKHIM ZH, V76, P131; MATIENKO NA, 1967, DOKL AKAD NAUK SSSR+, V172, P1457; MCCAFFREY PG, 1993, J BIOL CHEM, V268, P3747; Otsuka J, 2004, INT J GYNECOL CANCER, V14, P459, DOI 10.1111/j.1048-891x.2004.014305.x; Park SY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100429; Gallegos-Arreola MP, 2015, ARCH MED SCI, V11, P551, DOI 10.5114/aoms.2015.52357; Patutina O, 2011, BIOCHIMIE, V93, P689, DOI 10.1016/j.biochi.2010.12.011; Qin JB, 2014, CANCER CELL INT, V14, DOI 10.1186/1475-2867-14-23; Rawson JB, 2011, CARCINOGENESIS, V32, P741, DOI 10.1093/carcin/bgr020; Roberts SA, 2013, NAT GENET, V45, P970, DOI 10.1038/ng.2702; Rodriguez-Martin C, 2016, J HUM GENET, V7, P9; Roman Angel C, 2011, Mob Genet Elements, V1, P66; Rosner K, 2011, EXPERT REV ANTICANC, V11, P981, DOI [10.1586/ERA.11.90, 10.1586/era.11.90]; Ryan BM, 2003, GUT, V52, P101, DOI 10.1136/gut.52.1.101; SALGANIK RI, 1967, NATURE, V214, P100, DOI 10.1038/214100a0; Salvi S, 2015, DIS MARKERS, V2015, DOI 10.1155/2015/574120; SANO H, 1982, J IMMUNOL, V128, P1341; Schwarzenbach H, 2007, INT J CANCER, V120, P1465, DOI 10.1002/ijc.22470; Shi XM, 1999, J BIOL CHEM, V274, P13711, DOI 10.1074/jbc.274.19.13711; Sozzi G, 2003, J CLIN ONCOL, V21, P3902, DOI 10.1200/JCO.2003.02.006; Squire JA, 2003, GENE CHROMOSOME CANC, V38, P215, DOI 10.1002/gcc.10273; Stacey SN, 2016, HUM MOL GENET, V25, P1008, DOI 10.1093/hmg/ddv622; STROUN M, 1989, ONCOLOGY, V46, P318; SUGIHARA S, 1990, BRIT J CANCER, V62, P607, DOI 10.1038/bjc.1990.339; SUGIHARA S, 1993, BRIT J CANCER, V67, P66, DOI 10.1038/bjc.1993.10; Sunami E, 2008, ANN NY ACAD SCI, V1137, P171, DOI 10.1196/annals.1448.011; Taback B, 2004, ANN NY ACAD SCI, V1022, P17, DOI 10.1196/annals.1318.004; Taback B, 2004, ANN NY ACAD SCI, V1022, P1, DOI 10.1196/annals.1318.002; Tamkovich SN, 2006, ANN NY ACAD SCI, V1075, P191, DOI 10.1196/annals.1368.026; Wen FS, 2013, CANCER RES, V73, P4256, DOI 10.1158/0008-5472.CAN-12-3287; Widschwendter M, 2002, ONCOGENE, V21, P5462, DOI 10.1038/sj.onc.1205606; Winter N, 2008, PRENATAL DIAG, V28, P1126, DOI 10.1002/pd.2140; Xue XY, 2006, ANN NY ACAD SCI, V1075, P154, DOI 10.1196/annals.1368.021; Zhu YH, 2013, CANCER RES, V73, P2298, DOI 10.1158/0008-5472.CAN-12-2663	77	12	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2017	12	2							e0171988	10.1371/journal.pone.0171988	http://dx.doi.org/10.1371/journal.pone.0171988			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5QV	28222152	Green Published, gold, Green Submitted			2022-12-27	WOS:000394676800027
J	Hall, JE; Schaller, MD				Hall, Jessica E.; Schaller, Michael D.			Phospholipid binding to the FAK catalytic domain impacts function	PLOS ONE			English	Article							FOCAL ADHESION KINASE; PROTEIN-TYROSINE KINASE; STRUCTURAL BASIS; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; PHOSPHOTYROSINE-BINDING; PEPTIDE SUBSTRATE; CRYSTAL-STRUCTURE; PHOSPHORYLATION; ACTIVATION; CELLS	Focal adhesion kinase is an essential nonreceptor tyrosine kinase that plays an important role in development, in homeostasis and in the progression of human disease. Multiple stimuli activate FAK, which requires a change in structure from an autoinhibited to activated conformation. In the autoinhibited conformation the FERM domain associates with the catalytic domain of FAK and PI(4,5) P-2 binding to the FERM domain plays a role in the release of autoinhibition, activating the enzyme. An in silico model of FAK/PI(4,5) P2 interaction suggests that residues on the catalytic domain interact with PI(4,5) P2, in addition to the known FERM domain PI(4,5) P2 binding site. This study was undertaken to test the significance of this in silico observation. Mutations designed to disrupt the putative PI(4,5) P2 binding site were engineered into FAK. These mutants exhibited defects in phosphorylation and failed to completely rescue the phenotype associated with fak (-/-) phenotype fibroblasts demonstrating the importance of these residues in FAK function. The catalytic domain of FAK exhibited PI(4,5) P2 binding in vitro and binding activity was lost upon mutation of putative PI(4,5) P2 binding site basic residues. However, binding was not selective for PI(4,5) P2, and the catalytic domain bound to several phosphatidylinositol phosphorylation variants. The mutant exhibiting the most severe biological defect was defective for phosphatidylinositol phosphate binding, supporting the model that catalytic domain phospholipid binding is important for biochemical and biological function.	[Hall, Jessica E.; Schaller, Michael D.] West Virginia Univ, Dept Biochem, Sch Med, Morgantown, WV 26506 USA; [Schaller, Michael D.] West Virginia Univ, Mary Babb Randolph Canc Ctr, Sch Med, Morgantown, WV 26506 USA; [Hall, Jessica E.] Bucknell Univ, Dept Biol, Lewisburg, PA 17837 USA	West Virginia University; West Virginia University; Bucknell University	Schaller, MD (corresponding author), West Virginia Univ, Dept Biochem, Sch Med, Morgantown, WV 26506 USA.; Schaller, MD (corresponding author), West Virginia Univ, Mary Babb Randolph Canc Ctr, Sch Med, Morgantown, WV 26506 USA.	mschaller@hsc.wvu.edu			WVU School of Medicine; WVU Cancer Institute; NIH [P20 RR016440, P30 GM103488, P20 GM103434]	WVU School of Medicine; WVU Cancer Institute; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This project was supported by funds from the WVU School of Medicine. Imaging experiments and image analysis were performed in the West Virginia University Microscope Imaging Facility, which has been supported by the WVU Cancer Institute and NIH grants P20 RR016440, P30 GM103488 and P20 GM103434. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander NR, 2008, CURR BIOL, V18, P1295, DOI 10.1016/j.cub.2008.07.090; Bae YH, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004838; Berginski ME, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022025; Berginski Matthew E, 2013, F1000Res, V2, P68, DOI 10.12688/f1000research.2-68.v1; Brady DC, 2014, NATURE, V509, P492, DOI 10.1038/nature13180; Brami-Cherrier K, 2014, EMBO J, V33, P356, DOI 10.1002/embj.201386399; Braren R, 2006, J CELL BIOL, V172, P151, DOI 10.1083/jcb.200506184; Brown NR, 1999, NAT CELL BIOL, V1, P438, DOI 10.1038/15674; Cai XM, 2008, MOL CELL BIOL, V28, P201, DOI 10.1128/MCB.01324-07; Calalb MB, 1996, BIOCHEM BIOPH RES CO, V228, P662, DOI 10.1006/bbrc.1996.1714; CALALB MB, 1995, MOL CELL BIOL, V15, P954; Chen SY, 2006, MOL CELL BIOL, V26, P5155, DOI 10.1128/MCB.02186-05; Chen TH, 2011, ONCOGENE, V30, P153, DOI 10.1038/onc.2010.398; Chinthalapudi K, 2014, J CELL BIOL, V207, P643, DOI 10.1083/jcb.201404128; Choi CH, 2013, J CELL BIOL, V202, P849, DOI 10.1083/jcb.201302131; Clemente CFMZ, 2012, J MOL CELL CARDIOL, V52, P493, DOI 10.1016/j.yjmcc.2011.10.015; Dunty JM, 2004, MOL CELL BIOL, V24, P5353, DOI 10.1128/MCB.24.12.5353-5368.2004; Endicott JA, 2012, ANNU REV BIOCHEM, V81, P587, DOI 10.1146/annurev-biochem-052410-090317; Essayem S, 2006, ONCOGENE, V25, P1081, DOI 10.1038/sj.onc.1209130; Feng J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132833; Ferguson KM, 2000, MOL CELL, V6, P373, DOI 10.1016/S1097-2765(00)00037-X; Fruman DA, 1999, CELL, V97, P817, DOI 10.1016/S0092-8674(00)80792-8; FURUTA Y, 1995, ONCOGENE, V11, P1989; Garcia P, 1995, BIOCHEMISTRY-US, V34, P16228, DOI 10.1021/bi00049a039; Goni GM, 2014, P NATL ACAD SCI USA, V111, pE3177, DOI 10.1073/pnas.1317022111; Guan JL, 2010, IUBMB LIFE, V62, P268, DOI 10.1002/iub.303; Heerkens EHJ, 2014, J VASC RES, V51, P305, DOI 10.1159/000365479; Hubbard SR, 1997, EMBO J, V16, P5572, DOI 10.1093/emboj/16.18.5572; Iakoucheva LM, 2004, NUCLEIC ACIDS RES, V32, P1037, DOI 10.1093/nar/gkh253; ILLC D, 1995, NATURE, V377, P539; Inazawa J, 1996, HUM GENET, V98, P508, DOI 10.1007/s004390050249; Itoh T, 2001, SCIENCE, V291, P1047, DOI 10.1126/science.291.5506.1047; Klippel A, 1997, MOL CELL BIOL, V17, P338, DOI 10.1128/MCB.17.1.338; Lavelin I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073549; Lee BY, 2015, PHARMACOL THERAPEUT, V146, P132, DOI 10.1016/j.pharmthera.2014.10.001; LEV S, 1995, NATURE, V376, P737, DOI 10.1038/376737a0; Lietha D, 2007, CELL, V129, P1177, DOI 10.1016/j.cell.2007.05.041; Lim STS, 2013, MOL CELLS, V36, P1, DOI 10.1007/s10059-013-0139-1; Lowe ED, 1997, EMBO J, V16, P6646, DOI 10.1093/emboj/16.22.6646; Lu Q, 2012, MICROVASC RES, V83, P56, DOI 10.1016/j.mvr.2011.05.003; Owen JD, 1999, MOL CELL BIOL, V19, P4806; Owen KA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023123; Park MJ, 2016, MOL CELL, V62, P7, DOI 10.1016/j.molcel.2016.01.027; Pasapera AM, 2010, J CELL BIOL, V188, P877, DOI 10.1083/jcb.200906012; PEEPER DS, 1993, EMBO J, V12, P1947, DOI 10.1002/j.1460-2075.1993.tb05844.x; Peter BJ, 2003, SCIENCE; Provenzano PP, 2009, ONCOGENE, V28, P4326, DOI 10.1038/onc.2009.299; Ravichandran KS, 1997, MOL CELL BIOL, V17, P5540, DOI 10.1128/MCB.17.9.5540; Ren XD, 2000, J CELL SCI, V113, P3673; SCHALLER MD, 1994, MOL CELL BIOL, V14, P1680, DOI 10.1128/MCB.14.3.1680; Schaller MD, 2010, CANCER BIOL THER, V9, P791, DOI 10.4161/cbt.11729; Shen TL, 2005, J CELL BIOL, V169, P941, DOI 10.1083/jcb.200411155; Sugimura K, 2010, TOHOKU J EXP MED, V222, P201, DOI 10.1620/tjem.222.201; Tai YL, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/690690; Uhlik MT, 2005, J MOL BIOL, V345, P1, DOI 10.1016/j.jmb.2004.10.038; Walkiewicz KW, 2015, PROG BIOPHYS MOL BIO, V119, P60, DOI 10.1016/j.pbiomolbio.2015.06.001; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; Yu H, 1996, J BIOL CHEM, V271, P29993, DOI 10.1074/jbc.271.47.29993; Zhou J, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004593; Zhou J, 2015, BIOPHYS J, V108, P698, DOI 10.1016/j.bpj.2014.11.3454	60	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2017	12	2							e72136	10.1371/journal.pone.0172136	http://dx.doi.org/10.1371/journal.pone.0172136			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5QV	28222177	Green Published, gold, Green Submitted			2022-12-27	WOS:000394676800034
J	Hayat, T; Zahir, H; Tanveer, A; Alsaedi, A				Hayat, Tasawar; Zahir, Hina; Tanveer, Anum; Alsaedi, Ahmad			Soret and Dufour effects on MHD peristaltic transport of Jeffrey fluid in a curved channel with convective boundary conditions	PLOS ONE			English	Article							MAGNETIC-FIELD; MASS-TRANSFER; HEAT-TRANSFER; FLOW; ANNULUS; STRESS; MOTION; SLIP	The purpose of present article is to examine the peristaltic flow of Jeffrey fluid in a curved channel. An electrically conducting fluid in the presence of radial applied magnetic field is considered. Analysis of heat and mass transfer is carried out. More generalized realistic constraints namely the convective conditions are utilized. Soret and Dufour effects are retained. Problems formulation is given for long wavelength and low Reynolds number assumptions. The expressions of velocity, temperature, heat transfer coefficient, concentration and stream function are computed. Effects of emerging parameters arising in solutions are analyzed in detail. It is found that velocity is not symmetric about centreline for curvature parameter. Also maximum velocity decreases with an increase in the strength of magnetic field. Further it is noticed that Soret and Dufour numbers have opposite behavior for temperature and concentration.	[Hayat, Tasawar] Quaid I Azam Univ 45320, Dept Math, Islamabad 44000, Pakistan; [Hayat, Tasawar; Zahir, Hina; Tanveer, Anum; Alsaedi, Ahmad] King Abdulaziz Univ, Dept Elect & Comp Engn, Fac Engn, Jeddah 21589, Saudi Arabia	Quaid I Azam University; King Abdulaziz University	Tanveer, A (corresponding author), King Abdulaziz Univ, Dept Elect & Comp Engn, Fac Engn, Jeddah 21589, Saudi Arabia.	anum@math.qau.edu.pk	Alsaedi, Ahmed/A-2094-2013; Hayat, Tasawar/Y-2524-2019	Alsaedi, Ahmed/0000-0003-3452-8922; 				Abbasi FM, 2015, J MAGN MAGN MATER, V382, P104, DOI 10.1016/j.jmmm.2015.01.040; Abd Elmaboud Y, 2012, COMMUN NONLINEAR SCI, V17, P685, DOI 10.1016/j.cnsns.2011.05.039; Abd-Alla AM, 2015, J MAGN MAGN MATER, V374, P680, DOI 10.1016/j.jmmm.2014.08.091; Abd-Alla AM, 2014, J MAGN MAGN MATER, V363, P166, DOI 10.1016/j.jmmm.2014.03.023; Akbar NS, 2015, RESULTS PHYS, V5, P115, DOI 10.1016/j.rinp.2015.04.003; Akbar NS, 2015, J MAGN MAGN MATER, V381, P405, DOI 10.1016/j.jmmm.2014.12.087; Akram S, 2014, J MAGN MAGN MATER, V362, P184, DOI 10.1016/j.jmmm.2014.02.063; Ali N, 2010, EUR J MECH B-FLUID, V29, P387, DOI 10.1016/j.euromechflu.2010.04.002; Ali N, 2010, INT J HEAT MASS TRAN, V53, P3319, DOI 10.1016/j.ijheatmasstransfer.2010.02.036; Ellahi R, 2016, COMMUN THEOR PHYS, V65, P66, DOI 10.1088/0253-6102/65/1/66; Ellahi R, 2015, J MAGN MAGN MATER, V393, P284, DOI 10.1016/j.jmmm.2015.05.071; Ellahi R, 2014, J POROUS MEDIA, V17, P143, DOI 10.1615/JPorMedia.v17.i2.50; Ellahi R, 2014, INT J HEAT MASS TRAN, V71, P706, DOI 10.1016/j.ijheatmasstransfer.2013.12.038; Gad NS, 2011, APPL MATH COMPUT, V217, P4313, DOI 10.1016/j.amc.2010.08.016; Hameed M, 2015, ENG SCI TECHNOL, V18, P496, DOI 10.1016/j.jestch.2015.03.004; Hayat T, 2016, INT J HEAT MASS TRAN, V103, P1133, DOI 10.1016/j.ijheatmasstransfer.2016.07.101; Hayat T, 2014, COMPUT FLUIDS, V89, P242, DOI 10.1016/j.compfluid.2013.10.038; Hayat T, 2011, INT J HEAT MASS TRAN, V54, P5126, DOI 10.1016/j.ijheatmasstransfer.2011.07.036; Hayat T, 2011, COMMUN NONLINEAR SCI, V16, P3559, DOI 10.1016/j.cnsns.2010.12.038; Hayat T, 2011, INT J HEAT MASS TRAN, V54, P1615, DOI 10.1016/j.ijheatmasstransfer.2010.11.022; Hina S, 2015, APPL MATH COMPUT, V263, P378, DOI 10.1016/j.amc.2015.04.068; Hina S, 2012, INT J HEAT MASS TRAN, V55, P3511, DOI 10.1016/j.ijheatmasstransfer.2012.03.014; Hina S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114168; Kalantari A, 2013, ANN T NORDIC RHEOLOG; Kothandapani M, 2015, INT J HEAT MASS TRAN, V81, P234, DOI 10.1016/j.ijheatmasstransfer.2014.09.062; Mekheimer KS, 2008, PHYS LETT A, V372, P1657, DOI 10.1016/j.physleta.2007.10.028; Mustafa M, 2014, J TAIWAN INST CHEM E, V45, P308, DOI 10.1016/j.jtice.2013.07.010; Nadeem S, 2010, MATH COMPUT MODEL, V52, P107, DOI 10.1016/j.mcm.2010.02.001; Pandey SK, 2011, COMMUN NONLINEAR SCI, V16, P3591, DOI 10.1016/j.cnsns.2011.01.003; Ramesh K, 2015, J MAGN MAGN MATER, V394, P335, DOI 10.1016/j.jmmm.2015.06.052; Reddy MG, 2016, ALEX ENG J, V55, P1225, DOI 10.1016/j.aej.2016.04.009; Shehzad SA, 2015, INT J HEAT MASS TRAN, V91, P562, DOI 10.1016/j.ijheatmasstransfer.2015.07.076; Sinha A, 2015, ALEX ENG J, V54, P691, DOI 10.1016/j.aej.2015.03.030; Srinivas S, 2011, MATH COMPUT MODEL, V54, P1213, DOI 10.1016/j.mcm.2011.03.032; Vafai K, 2015, Z NATURFORSCH A, V70, P281, DOI 10.1515/zna-2014-0330; Wang YQ, 2011, APPL MATH MODEL, V35, P3737, DOI 10.1016/j.apm.2011.02.030	36	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2017	12	2							e0164854	10.1371/journal.pone.0164854	http://dx.doi.org/10.1371/journal.pone.0164854			50	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5QV	28222160	Green Published, Green Submitted, gold			2022-12-27	WOS:000394676800002
J	Song, CJ; Mitter, SK; Qi, XP; Beli, E; Rao, HV; Ding, JD; Ip, CS; Gu, HM; Akin, D; Dunn, WA; Rickman, CB; Lewin, AS; Grant, MB; Boulton, ME				Song, Chunjuan; Mitter, Sayak K.; Qi, Xiaoping; Beli, Eleni; Rao, Haripriya V.; Ding, Jindong; Ip, Colin S.; Gu, Hongmei; Akin, Debra; Dunn, William A., Jr.; Rickman, Catherine Bowes; Lewin, Alfred S.; Grant, Maria B.; Boulton, Michael E.			Oxidative stress-mediated NF kappa B phosphorylation upregulates p62/SQSTM1 and promotes retinal pigmented epithelial cell survival through increased autophagy	PLOS ONE			English	Article							TRANSCRIPTION FACTOR NRF2; GENE-EXPRESSION; ACTIVATION; PROTEASOME; PATHOGENESIS; DEGRADATION; CANCER; GROWTH; MODEL; RPE	p62 is a scaffolding adaptor implicated in the clearance of protein aggregates by autophagy. Reactive oxygen species (ROS) can either stimulate or inhibit NF kappa B-mediated gene expression influencing cellular fate. We studied the effect of hydrogen peroxide (H2O2)-mediated oxidative stress and NF kappa B signaling on p62 expression in the retinal pigment epithelium (RPE) and investigated its role in regulation of autophagy and RPE survival against oxidative damage. Cultured human RPE cell line ARPE-19 and primary human adult and fetal RPE cells were exposed to H2O2-induced oxidative stress. The human apolipoprotein E4 targeted-replacement (APOE4) mouse model of AMD was used to study expression of p62 and other autophagy proteins in the retina. p62, NF kappa B p65 (total, phosphorylated, nuclear and cytoplasmic) and ATG10 expression was assessed by mRNA and protein analyses. Cellular ROS and mitochondrial superoxide were measured by CM-H2DCFDA and Mito-SOX staining respectively. Mitochondrial viability was determined using MTT activity. qPCR-array system was used to investigate autophagic genes affected by p62. Nuclear and cytoplasmic levels of NF kappa B p65 were evaluated after cellular fractionation by Western blotting. We report that p62 is up-regulated in RPE cells under H2O2-induced oxidative stress and promotes autophagic activity. Depletion of endogenous p62 reduces autophagy by downregulation of ATG10 rendering RPE more susceptible to oxidative damage. NF kappa B p65 phosphorylation at Ser-536 was found to be critical for p62 upregulation in response to oxidative stress. Proteasome inhibition by H2O2 causes p62-NF kappa B signaling as antioxidant pre-treatment reversed p62 expression and p65 phosphorylation when RPE was challenged by H2O2 but not when by Lactacystin. p62 protein but not RNA levels are elevated in APOE4-HFC AMD mouse model, suggesting reduction of autophagic flux in disease conditions. Our findings suggest that p62 is necessary for RPE cytoprotection under oxidative stress and functions, in part, by modulating ATG10 expression. NF kappa B p65 activity may be a critical upstream initiator of p62 expression in RPE cells under oxidative stress.	[Song, Chunjuan; Rao, Haripriya V.; Akin, Debra; Dunn, William A., Jr.] Univ Florida, Dept Anat & Cell Biol, Gainesville, FL USA; [Mitter, Sayak K.; Qi, Xiaoping; Beli, Eleni; Ip, Colin S.; Gu, Hongmei; Grant, Maria B.; Boulton, Michael E.] Indiana Univ Sch Med, Dept Ophthalmol, Indianapolis, IN 46202 USA; [Ding, Jindong; Rickman, Catherine Bowes] Duke Univ, Med Ctr, Dept Ophthalmol, Durham, NC 27710 USA; [Ding, Jindong; Rickman, Catherine Bowes] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; [Lewin, Alfred S.] Univ Florida, Dept Mol Genet & Microbiol, Gainesville, FL USA; [Song, Chunjuan] Appl Genet Technol Corp, Alachua, FL USA	State University System of Florida; University of Florida; Indiana University System; Indiana University Bloomington; Duke University; Duke University; State University System of Florida; University of Florida	Boulton, ME (corresponding author), Indiana Univ Sch Med, Dept Ophthalmol, Indianapolis, IN 46202 USA.	mboulton@iupui.edu	Beli, Eleni/AAL-7433-2020; Beli, Eleni/AGR-8255-2022	Beli, Eleni/0000-0003-1889-640X; Bowes Rickman, Catherine/0000-0002-8555-9596; Ip, Colin/0000-0003-3180-3108; Lewin, Alfred/0000-0002-4192-9727	NIH [EY019688, EY021626, EY020825]; Research to Prevent Blindness, Inc.; UF Vision Core [EY021721]; Edward N. & Della L. Thome Memorial Foundation Award [EY019038, P30 EY005722]; NATIONAL EYE INSTITUTE [R01EY026161, R01EY007739, P30EY005722] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness, Inc.(Research to Prevent Blindness (RPB)); UF Vision Core; Edward N. & Della L. Thome Memorial Foundation Award; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Supported by grants from NIH - EY019688 and EY021626 to MEB, EY020825 to ASL; EY021721 UF Vision Core; EY019038, P30 EY005722 (CBR): Edward N. & Della L. Thome Memorial Foundation Award and Research to Prevent Blindness, Inc. to CBR: Unrestricted Research to Prevent Blindness, Inc. award to MEB.	Ablonczy Z, 2011, INVEST OPHTH VIS SCI, V52, P8614, DOI 10.1167/iovs.11-8021; Algvere PV, 2002, ACTA OPHTHALMOL SCAN, V80, P136, DOI 10.1034/j.1600-0420.2002.800204.x; Martin MA, 2010, MOL NUTR FOOD RES, V54, P956, DOI 10.1002/mnfr.200900159; Beatty S, 2000, SURV OPHTHALMOL, V45, P115, DOI 10.1016/S0039-6257(00)00140-5; Blasiak J, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/768026; Cai J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021164; Chen DF, 2013, NEUROSCI LETT, V538, P49, DOI 10.1016/j.neulet.2013.01.044; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; Deruy E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012712; Dunn KC, 1996, EXP EYE RES, V62, P155, DOI 10.1006/exer.1996.0020; Fernandes AF, 2008, J BIOL CHEM, V283, P20745, DOI 10.1074/jbc.M800268200; Fuertes G, 2003, INT J BIOCHEM CELL B, V35, P651, DOI 10.1016/S1357-2725(02)00382-5; Geetha T, 2012, NEUROCHEM INT, V61, P1289, DOI 10.1016/j.neuint.2012.09.005; Heo SR, 2009, NEUROSCI LETT, V450, P45, DOI 10.1016/j.neulet.2008.11.011; Hochfeld WE, 2013, ACTA PHARMACOL SIN, V34, P600, DOI 10.1038/aps.2012.189; Hu YJ, 2014, DISCOV MED, V18, P7; Jain A, 2010, J BIOL CHEM, V285, P22576, DOI 10.1074/jbc.M110.118976; Kaarniranta K, 2013, AUTOPHAGY, V9, P973, DOI 10.4161/auto.24546; Kaarniranta Kai, 2010, Front Biosci (Elite Ed), V2, P1374; Kaarniranta K, 2010, ACTA OPHTHALMOL, V88, P387, DOI 10.1111/j.1755-3768.2009.01840.x; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Komatsu M, 2010, NAT CELL BIOL, V12, P213, DOI 10.1038/ncb2021; Korolchuk VI, 2009, MOL CELL, V33, P517, DOI 10.1016/j.molcel.2009.01.021; Li Y, 2008, EXP GERONTOL, V43, P1114, DOI 10.1016/j.exger.2008.08.052; Ling JH, 2012, CANCER CELL, V21, P105, DOI 10.1016/j.ccr.2011.12.006; Liu YX, 2007, P NATL ACAD SCI USA, V104, P5205, DOI 10.1073/pnas.0700898104; Malek G, 2005, P NATL ACAD SCI USA, V102, P11900, DOI 10.1073/pnas.0503015102; Mamidipudi V, 2002, J BIOL CHEM, V277, P28010, DOI 10.1074/jbc.M109730200; Mao HY, 2014, INVEST OPHTH VIS SCI, V55, P4613, DOI 10.1167/iovs.14-14633; Martinez-Outschoorn UE, 2010, CELL CYCLE, V9, P4297, DOI 10.4161/cc.9.21.13817; Mitter SK, 2014, AUTOPHAGY, V10, P1989, DOI 10.4161/auto.36184; Mitter SK, 2012, ADV EXP MED BIOL, V723, P83, DOI 10.1007/978-1-4614-0631-0_12; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Nazarewicz RR, 2013, ANTIOXID REDOX SIGN, V19, P344, DOI 10.1089/ars.2013.5185; Nemoto T, 2003, J BIOL CHEM, V278, P39517, DOI 10.1074/jbc.M300550200; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Phillips AR, 2008, GENETICS, V178, P1339, DOI 10.1534/genetics.107.086199; Puissant A, 2012, AM J CANCER RES, V2, P397; Schimel AM, 2011, AM J PATHOL, V178, P2032, DOI 10.1016/j.ajpath.2011.01.036; Seibenhener ML, 2007, FEBS LETT, V581, P175, DOI 10.1016/j.febslet.2006.12.027; Shintani T, 2002, DEV CELL, V3, P825, DOI 10.1016/S1534-5807(02)00373-8; Stasiolek M, 2000, J BIOL CHEM, V275, P24847, DOI 10.1074/jbc.M910284199; Takada Y, 2004, J BIOL CHEM, V279, P15096, DOI 10.1074/jbc.M311192200; Unno T, 2012, P NATL ACAD SCI USA, V109, P17693, DOI 10.1073/pnas.1212786109; Viiri J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069563; Viiri J, 2010, MOL VIS, V16, P1399; Wang L, 2014, BBA-MOL CELL RES, V1843, P1248, DOI 10.1016/j.bbamcr.2014.03.016; Wang XC, 1999, INVEST OPHTH VIS SCI, V40, P477; Wooten MW, 2005, J BIOL CHEM, V280, P35625, DOI 10.1074/jbc.C500237200; Yamaguchi M, 2012, STRUCTURE, V20, P1244, DOI 10.1016/j.str.2012.04.018; Zou X, 2012, J NUTR BIOCHEM, V23, P994, DOI 10.1016/j.jnutbio.2011.05.006	51	62	67	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2017	12	2							e0171940	10.1371/journal.pone.0171940	http://dx.doi.org/10.1371/journal.pone.0171940			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5QV	28222108	Green Published, gold, Green Submitted			2022-12-27	WOS:000394676800021
J	Abram, ME; Ram, RR; Margot, NA; Barnes, TL; White, KL; Callebaut, C; Miller, MD				Abram, Michael E.; Ram, Renee R.; Margot, Nicolas A.; Barnes, Tiffany L.; White, Kirsten L.; Callebaut, Christian; Miller, Michael D.			Lack of impact of pre-existing T97A HIV-1 integrase mutation on integrase strand transfer inhibitor resistance and treatment outcome	PLOS ONE			English	Article							TREATMENT-NAIVE PATIENTS; TENOFOVIR DISOPROXIL FUMARATE; REGIMEN ELVITEGRAVIR/COBICISTAT/EMTRICITABINE/TENOFOVIR DF; PLUS EMTRICITABINE/TENOFOVIR DF; TREATMENT-EXPERIENCED PATIENTS; TWICE-DAILY RALTEGRAVIR; ANTIRETROVIRAL-NAIVE; DRUG-RESISTANCE; DOUBLE-BLIND; HIV-1-INFECTED PATIENTS	T97A is an HIV-1 integrase polymorphism associated with integrase strand transfer inhibitor (INSTI) resistance. Using pooled data from 16 clinical studies, we investigated the prevalence of T97A (pre-existing and emergent) and its impact on INSTI susceptibility and treatment response in INSTI-naive patients who enrolled on elvitegravir (EVG)- or raltegravir (RAL)-based regimens. Prior to INSTI-based therapy, primary INSTI resistance-associated mutations (RAMs) were absent and T97A pre-existed infrequently (1.4%; 47 of 3367 integrase sequences); most often among non-B (5.3%) than B (0.9%) HIV-1 subtypes. During INSTI-based therapy, few patients experienced virologic failure with emergent INSTI RAMs (3%; 122 of 3881 patients), among whom T97A emerged infrequently in the presence (n = 6) or absence (n = 8) of primary INSTI RAMs. A comparison between pre-existing and emergent T97A patient populations (i.e., in the absence of primary INSTI RAMs) showed no significant differences in EVG or RAL susceptibility in vitro. Furthermore, among all T97A-containing viruses tested, only 38-44% exhibited reduced susceptibility to EVG and/or RAL (all of low magnitude; <11-fold), while all maintained susceptibility to dolutegravir. Of the patients with pre-existing T97A, 17 had available clinical follow-up: 16 achieved virologic suppression and 1 maintained T97A and INSTI sensitivity without further resistance development. Overall, T97A is an infrequent integrase polymorphism that is enriched among nonB HIV-1 subtypes and can confer low-level reduced susceptibility to EVG and/or RAL. However, detection of T97A does not affect response to INSTI-based therapy with EVG or RAL. These results suggest a very low risk of initiating INSTI-based therapy in patients with preexisting T97A.	[Abram, Michael E.; Ram, Renee R.; Margot, Nicolas A.; Barnes, Tiffany L.; White, Kirsten L.; Callebaut, Christian; Miller, Michael D.] Gilead Sci Inc, 353 Lakeside Dr, Foster City, CA 94404 USA	Gilead Sciences	Abram, ME (corresponding author), Gilead Sci Inc, 353 Lakeside Dr, Foster City, CA 94404 USA.	Michael.Abram@gilead.com	Abram, Michael E/AEY-5248-2022	Abram, Michael E/0000-0002-6505-7281; Barnes, Tiffany/0000-0002-5995-0495				Abram M, 2016, 23 ANN C RETR OPP IN; Abram ME, 2013, ANTIMICROB AGENTS CH, V57, P2654, DOI 10.1128/AAC.02568-12; [Anonymous], 2015, C RETR OPP INF FEBR; Armenia D, 2015, J ANTIMICROB CHEMOTH, V70, P1865, DOI 10.1093/jac/dkv029; Armenia D, 2012, J INFECT DIS, V205, P557, DOI 10.1093/infdis/jir821; Arribas JR, 2008, JAIDS-J ACQ IMM DEF, V47, P74, DOI 10.1097/QAI.0b013e31815acab8; Baelen K Van, 2008, AIDS, V22, P1875, DOI [10.1097/QAD.0b013e328309efe3PMID, DOI 10.1097/QAD.0B013E328309EFE3]; Bar-Magen T, 2010, AIDS, V24, P2171, DOI 10.1097/QAD.0b013e32833cf265; Blanco JL, 2011, J INFECT DIS, V203, P1204, DOI 10.1093/infdis/jir025; Boyd SD, 2011, ANTIVIR THER, V16, P257, DOI 10.3851/IMP1749; Brenner BG, 2011, J MED VIROL, V83, P751, DOI 10.1002/jmv.22047; Brumme ZL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006687; Brun-Vezinet F, 2004, ANTIVIR THER, V9, P465; Cahn P, 2013, LANCET, V382, P700, DOI 10.1016/S0140-6736(13)61221-0; Canducci F, 2011, CLIN MICROBIOL INFEC, V17, P928, DOI 10.1111/j.1469-0691.2010.03375.x; Canducci F, 2010, J ANTIMICROB CHEMOTH, V65, P425, DOI 10.1093/jac/dkp477; Canducci F, 2009, AIDS, V23, P455, DOI 10.1097/QAD.0b013e328323da60; Cavalcanti JS, 2012, ANTIVIR RES, V95, P9, DOI 10.1016/j.antiviral.2012.04.007; Ceccherini-Silberstein F, 2010, J ANTIMICROB CHEMOTH, V65, P2305, DOI 10.1093/jac/dkq326; Ceccherini-Silberstein F, 2010, ANTIMICROB AGENTS CH, V54, P3938, DOI 10.1128/AAC.01720-09; Clumeck N, 2014, JAIDS-J ACQ IMM DEF, V65, pE121, DOI 10.1097/QAI.0000000000000089; Codoner FM, 2010, ANTIVIR RES, V88, P281, DOI 10.1016/j.antiviral.2010.09.016; Cohen C, 2011, AIDS, V25, pF7, DOI 10.1097/QAD.0b013e328345766f; Cooper DA, 2008, NEW ENGL J MED, V359, P355, DOI 10.1056/NEJMoa0708978; Delelis O, 2009, NUCLEIC ACIDS RES, V37, P1193, DOI 10.1093/nar/gkn1050; DHHS, 2016, GUIDELINES USE ANTIR; Domingo E, 2006, CURR TOP MICROBIOL, V299, P51; Doyle T, 2015, J ANTIMICROB CHEMOTH; Eron JJ, 2013, J INFECT DIS, V207, P740, DOI 10.1093/infdis/jis750; Fransen S, 2008, 48 INT C ANT AG CHEM; Fransen S, 2010, C RETR OPP INF CROI; Fransen S, 2012, J VIROL, V86, P7249, DOI 10.1128/JVI.06618-11; Fransen S, 2009, J VIROL, V83, P11440, DOI 10.1128/JVI.01168-09; Frentz D, 2012, AIDS REV, V14, P17; Gallant JE, 2004, JAMA-J AM MED ASSOC, V292, P191, DOI 10.1001/jama.292.2.191; Garrido C, 2011, ANTIVIR RES, V90, P164, DOI 10.1016/j.antiviral.2011.03.178; Garrido C, 2010, J ANTIMICROB CHEMOTH, V65, P320, DOI 10.1093/jac/dkp423; Gaur A, 2010, 17 C RETR OPP INF CR; Gilead Sciences Inc, 2016, SIRIBILD ELV COB EMT; Gilead Sciences Inc, 2014, VITEKTA ELV TABL OR; GlaxoSmithKline, 2015, TIVICAY DOL TABL OR; Gotte M, 2012, CURR OPIN VIROL, V2, P644, DOI 10.1016/j.coviro.2012.08.004; Goodman D, 2008, 17 INT HIV DRUG RES; Gunthard HF, 2016, JAMA-J AM MED ASSOC, V316, P191, DOI 10.1001/jama.2016.8900; Gutierrez C, 2013, HIV CLIN TRIALS, V14, P10, DOI [10.1310/hct1401-10, 10.1410/hct1401-10]; Hachiya A, 2015, ANTIVIR RES, V119, P84, DOI 10.1016/j.antiviral.2015.04.014; Haddad M, 2012, INT C ANT AG CHEM IC; Han YS, 2016, INFECT GENET EVOL, V46, P286, DOI 10.1016/j.meegid.2016.06.047; Hardy I, 2015, J ANTIMICROB CHEMOTH, V70, P405, DOI 10.1093/jac/dku387; Hazuda D, 2009, ANNU REV PHARMACOL, V49, P377, DOI 10.1146/annurev.pharmtox.011008.145553; Huang W, 2013, ANTIMICROB AGENTS CH, V57, P4105, DOI 10.1128/AAC.00204-13; Hurt CB, 2014, CLIN INFECT DIS, V58, P423, DOI 10.1093/cid/cit697; Hurt CB, 2011, ANTIVIR THER, V16, P137, DOI 10.3851/IMP1750; Johnson JA, 2010, J ANTIMICROB CHEMOTH, V65, P1322, DOI 10.1093/jac/dkq139; Johnson JA, 2008, PLOS MED, V5, P1112, DOI 10.1371/journal.pmed.0050158; Kityo C, 2015, EFFICACY SAFETY ELVI; Kulkarni R, 2014, HIV CLIN TRIALS, V15, P218, DOI [10.1310/hct1505-218, 10.1310/hct1504-218]; Kuritzkes DR, 2008, J INFECT DIS, V197, P867, DOI 10.1086/528802; Lataillade M, 2007, ANTIVIR THER, V12, P563; Lennox JL, 2010, JAIDS-J ACQ IMM DEF, V55, P39, DOI 10.1097/QAI.0b013e3181da1287; Lennox JL, 2009, LANCET, V374, P796, DOI 10.1016/S0140-6736(09)60918-1; Lima VD, 2009, JAIDS-J ACQ IMM DEF, V50, P529, DOI 10.1097/QAI.0b013e31819675e9; Liu J, 2011, ANTIMICROB AGENTS CH, V55, P1114, DOI 10.1128/AAC.01492-10; Liu TF, 2006, CLIN INFECT DIS, V42, P1608, DOI 10.1086/503914; Delicado TL, 2016, J ANTIMICROB CHEMOTH, V71, P362, DOI 10.1093/jac/dkv333; Low A, 2009, ANTIMICROB AGENTS CH, V53, P4275, DOI 10.1128/AAC.00397-09; Maiga AI, 2009, ANTIVIR THER, V14, P123; Malet I, 2008, ANTIMICROB AGENTS CH, V52, P1351, DOI 10.1128/AAC.01228-07; Malet I, 2011, J ANTIMICROB CHEMOTH, V66, P1481, DOI 10.1093/jac/dkr152; Malet I, 2009, J ANTIMICROB CHEMOTH, V63, P795, DOI 10.1093/jac/dkp014; Marcelin AG, 2013, INT J ANTIMICROB AG, V42, P42, DOI 10.1016/j.ijantimicag.2013.02.016; Margot NA, 2016, HIV CLIN TRIALS, V17, P78, DOI 10.1080/15284336.2016.1142731; Markowitz M, 2007, JAIDS-J ACQ IMM DEF, V46, P125, DOI 10.1097/QAI.0b013e318157131c; Marsden MD, 2011, ANTIMICROB AGENTS CH, V55, P3696, DOI 10.1128/AAC.00566-11; MCCOLL DJ, 2007, 16 INT HIV DRUG RES; Merck Sharp & Dohme Corp, 2015, ISENTRESS RALT FILM; Metzner KJ, 2009, CLIN INFECT DIS, V48, P239, DOI 10.1086/595703; Molina JM, 2012, LANCET INFECT DIS, V12, P27, DOI 10.1016/S1473-3099(11)70249-3; Monleau M, 2012, AIDS RES HUM RETROV, V28, P957, DOI 10.1089/aid.2011.0326; Myers RE, 2008, J VIROL, V82, P9228, DOI 10.1128/JVI.01535-07; Nakahara K, 2009, ANTIVIR RES, V81, P141, DOI 10.1016/j.antiviral.2008.10.007; Paredes R, 2010, J INFECT DIS, V201, P662, DOI 10.1086/650543; Park TE, 2015, EXPERT REV ANTI-INFE, V13, P1195, DOI 10.1586/14787210.2015.1075393; Pingen M, 2011, J ANTIMICROB CHEMOTH, V66, P1467, DOI 10.1093/jac/dkr157; Piralla A, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-149; Post FA, 2015, JAIDS-J ACQ IMM DEF, V68, P310, DOI 10.1097/QAI.0000000000000476; Raffi F, 2013, LANCET INFECT DIS, V13, P927, DOI 10.1016/S1473-3099(13)70257-3; Ramanathan S, 2011, CLIN PHARMACOKINET, V50, P229, DOI 10.2165/11584570-000000000-00000; Rambaut A, 2004, NAT REV GENET, V5, P52, DOI 10.1038/nrg1246; Reigadas S, 2013, J ANTIMICROB CHEMOTH, V68, P969, DOI 10.1093/jac/dks474; Reigadas S, 2011, ANTIMICROB AGENTS CH, V55, P3187, DOI 10.1128/AAC.00071-11; Reigadas S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010311; Rhee SY, 2016, J VIROL, V90, P6058, DOI 10.1128/JVI.00495-16; Rockstroh JK, 2013, JAIDS-J ACQ IMM DEF, V63, P77, DOI 10.1097/QAI.0b013e31828ace69; Rockstroh JK, 2011, AIDS, V25, P1365, DOI 10.1097/QAD.0b013e328348065a; Sax Paul E, 2014, J Acquir Immune Defic Syndr, V67, P52, DOI 10.1097/QAI.0000000000000225; Seki T, 2015, ANTIMICROB AGENTS CH, V59, P2596, DOI 10.1128/AAC.04844-14; Sichtig N, 2009, J ANTIMICROB CHEMOTH, V64, P25, DOI 10.1093/jac/dkp153; Simen BB, 2009, J INFECT DIS, V199, P693, DOI 10.1086/596736; Squires K, 2003, ANN INTERN MED, V139, P313, DOI 10.7326/0003-4819-139-5_Part_1-200309020-00006; Steigbigel RT, 2010, CLIN INFECT DIS, V50, P605, DOI 10.1086/650002; Stekler JD, 2015, ANTIVIR THER, V20, P77, DOI 10.3851/IMP2780; Tang MW, 2012, INTERVIROLOGY, V55, P98, DOI 10.1159/000331998; Theys K, 2013, FUTURE MICROBIOL, V8, P303, DOI [10.2217/FMB.13.10, 10.2217/fmb.13.10]; van Hal SJ, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-12; Van Laethem K, 2002, ANTIVIR THER, V7, P123; Varghese V, 2010, AIDS RES HUM RETROV, V26, P1323, DOI 10.1089/aid.2010.0123; Vavro C, 2013, ANTIMICROB AGENTS CH, V57, P1379, DOI 10.1128/AAC.01791-12; Vignuzzi M, 2006, NATURE, V439, P344, DOI 10.1038/nature04388; ViiV Healthcare. TRIUMEQ, 2014, TRIUMEQ AB DOL LAM T; Volpe Joseph M, 2015, J Int Assoc Provid AIDS Care, V14, P398, DOI 10.1177/2325957415596229; Wainberg MA, 2011, NEW ENGL J MED, V365, P637, DOI 10.1056/NEJMra1004180; Walmsley S, 2015, JAIDS-J ACQ IMM DEF, V70, P515, DOI 10.1097/QAI.0000000000000790; Waters JM, 2009, 18 INT HIV DRUG RES; White KL, 2015, ANTIVIR THER, V20, P317, DOI 10.3851/IMP2885; Winters MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040514; Wittkop L, 2011, LANCET INFECT DIS, V11, P363, DOI 10.1016/S1473-3099(11)70032-9; Wohl D, 2016, JAIDS-J ACQ IMM DEF, V72, P58, DOI 10.1097/QAI.0000000000000940; Wohl DA, 2014, JAIDS-J ACQ IMM DEF, V65, pE118, DOI 10.1097/QAI.0000000000000057; Young B, 2011, ANTIVIR THER, V16, P253, DOI 10.3851/IMP1748; Zolopa AR, 2010, J INFECT DIS, V201, P814, DOI 10.1086/650698	121	17	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2017	12	2							e0172206	10.1371/journal.pone.0172206	http://dx.doi.org/10.1371/journal.pone.0172206			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BI	28212411	Green Published, gold, Green Submitted			2022-12-27	WOS:000394424700023
J	McCullagh, BN; Comellas, AP; Ballas, ZK; Newell, JD; Zimmerman, B; Azar, AE				McCullagh, Brian N.; Comellas, Alejandro P.; Ballas, Zuhair K.; Newell, John D., Jr.; Zimmerman, Bridget; Azar, Antoine E.			Antibody deficiency in patients with frequent exacerbations of Chronic Obstructive Pulmonary Disease (COPD)	PLOS ONE			English	Article							PRIMARY IMMUNODEFICIENCY; COMPUTED-TOMOGRAPHY; CLINICAL-PICTURE; BRONCHIECTASIS; IMPACT	Chronic Obstructive Pulmonary Disease is the third leading cause of death in the US, and is associated with periodic exacerbations, which account for the largest proportion of health care utilization, and lead to significant morbidity, mortality, and worsening lung function. A subset of patients with COPD have frequent exacerbations, occurring 2 or more times per year. Despite many interventions to reduce COPD exacerbations, there is a significant lack of knowledge in regards to their mechanisms and predisposing factors. We describe here an important observation that defines antibody deficiency as a potential risk factor for frequent COPD exacerbations. We report a case series of patients who have frequent COPD exacerbations, and who were found to have an underlying primary antibody deficiency syndrome. We also report on the outcome of COPD exacerbations following treatment in a subset with of these patients with antibody deficiency. We identified patients with COPD who had 2 or more moderate to severe exacerbations per year; immune evaluation including serum immunoglobulin levels and pneumococcal IgG titers was performed. Patients diagnosed with an antibody deficiency syndrome were treated with either immunoglobulin replacement therapy or prophylactic antibiotics, and their COPD exacerbations were monitored over time. A total of 42 patients were identified who had 2 or more moderate to severe COPD exacerbations per year. Twenty-nine patients had an underlying antibody deficiency syndrome: common variable immunodeficiency (8), specific antibody deficiency (20), and selective IgA deficiency (1). Twenty-two patients had a follow-up for at least 1 year after treatment of their antibody deficiency, which resulted in a significant reduction of COPD exacerbations, courses of oral corticosteroid use and cumulative annual dose of oral corticosteroid use, rescue antibiotic use, and hospitalizations for COPD exacerbations. This case series identifies antibody deficiency as a potentially treatable risk factor for frequent COPD exacerbations; testing for antibody deficiency should be considered in difficult to manage frequently exacerbating COPD patients. Further prospective studies are warranted to further test this hypothesis.	[McCullagh, Brian N.; Comellas, Alejandro P.] Univ Iowa Hosp & Clin, Dept Internal Med, Div Pulm & Crit Care, Iowa City, IA 52242 USA; [Ballas, Zuhair K.] Univ Iowa Hosp & Clin, Dept Internal Med, Div Immunol, Iowa City, IA 52242 USA; [Newell, John D., Jr.] Univ Iowa, Dept Radiol, Iowa City, IA 52242 USA; [Newell, John D., Jr.] Univ Iowa, Dept Biomed Engn, Iowa City, IA 52242 USA; [Zimmerman, Bridget] Univ Iowa, Coll Publ Hlth, Dept Biostat, Iowa City, IA USA; [Azar, Antoine E.] Johns Hopkins Univ, Sch Med, Dept Internal Med, Div Allergy & Clin Immunol, Baltimore, MD 21218 USA	University of Iowa; University of Iowa; University of Iowa; University of Iowa; University of Iowa; Johns Hopkins University	Azar, AE (corresponding author), Johns Hopkins Univ, Sch Med, Dept Internal Med, Div Allergy & Clin Immunol, Baltimore, MD 21218 USA.	antoine.azar@jhmi.edu	Comellas, Alejandro/AAE-5661-2019	Ballas, Zuhair/0000-0001-5569-1230; Comellas, Alejandro/0000-0003-1521-7520; Knaack, Aaron/0000-0001-7712-1415	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK054759] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES005605] Funding Source: NIH RePORTER; NIDDK NIH HHS [P30 DK054759] Funding Source: Medline; NIEHS NIH HHS [P30 ES005605] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Aghamohammadi A, 2008, AM J OTOLARYNG, V29, P385, DOI 10.1016/j.amjoto.2007.11.007; Agusti A, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-122; Allinson James P, 2014, Evid Based Med, V19, P99, DOI 10.1136/eb-2013-101711; Azar AE, 2007, AM J MED, V120, P764, DOI 10.1016/j.amjmed.2006.12.013; Bondioni MP, 2010, J COMPUT ASSIST TOMO, V34, P395, DOI 10.1097/RCT.0b013e3181cad9da; Bonilla FA, 2005, ANN ALLERG ASTHMA IM, V94, pS1, DOI 10.1016/S1081-1206(10)61142-8; Boyle RJ, 2006, CLIN EXP IMMUNOL, V146, P486, DOI 10.1111/j.1365-2249.2006.03242.x; Carr TF, 2011, AM J RHINOL ALLERGY, V25, P241, DOI 10.2500/ajra.2011.25.3653; Costa-Carvalho BT, 2011, ALLERGOL IMMUNOPATH, V39, P128, DOI 10.1016/j.aller.2010.12.003; Cowan J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142205; Gathmann B, 2014, J ALLERGY CLIN IMMUN, V134, P116, DOI 10.1016/j.jaci.2013.12.1077; Gharagozlou M, 2006, Monaldi Arch Chest Dis, V65, P69; Gregersen S, 2009, RESP MED, V103, P873, DOI 10.1016/j.rmed.2008.12.015; Han MK, 2010, AM J RESP CRIT CARE, V182, P598, DOI 10.1164/rccm.200912-1843CC; Herath SC, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009764.pub2; Hurst JR, 2010, NEW ENGL J MED, V363, P1128, DOI 10.1056/NEJMoa0909883; Javier FC, 2000, ANN ALLERG ASTHMA IM, V84, P25, DOI 10.1016/S1081-1206(10)62736-6; Kainulainen L, 1999, J ALLERGY CLIN IMMUN, V104, P1031, DOI 10.1016/S0091-6749(99)70085-0; King PT, 2006, CLIN EXP IMMUNOL, V144, P440, DOI 10.1111/j.1365-2249.2006.03091.x; Kosacz Nicole M., 2012, Morbidity and Mortality Weekly Report, V61, P938; Lynch DA, 2015, RADIOLOGY, V277, P192, DOI 10.1148/radiol.2015141579; Orange JS, 2012, J ALLERGY CLIN IMMUN, V130, pS1, DOI 10.1016/j.jaci.2012.07.002; Pasquale MK, 2012, INT J CHRONIC OBSTR, V7, P757, DOI 10.2147/COPD.S36997; Quinti I, 2007, J CLIN IMMUNOL, V27, P308, DOI 10.1007/s10875-007-9075-1; Resnick ES, 2012, CURR OPIN ALLERGY CL, V12, P595, DOI 10.1097/ACI.0b013e32835914b9; Suissa S, 2012, THORAX, V67, P957, DOI 10.1136/thoraxjnl-2011-201518; Tabatabaie P, 2008, IRAN J ALLERGY ASTHM, V7, P69, DOI 07.02/ijaai.6977; Truong T, 2013, IMMUNOL ALLERGY CLIN, V33, P61, DOI 10.1016/j.iac.2012.10.007; van Kessel DA, 2005, EUR RESPIR J, V25, P482, DOI 10.1183/09031936.05.00073204; Vendrell M, 2005, CHEST, V127, P197, DOI 10.1378/chest.127.1.197; Vestbo J, 2013, AM J RESP CRIT CARE, V187, P347, DOI 10.1164/rccm.201204-0596PP; Wedzicha JA, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-181	32	36	37	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2017	12	2							e0172437	10.1371/journal.pone.0172437	http://dx.doi.org/10.1371/journal.pone.0172437			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BI	28212436	Green Submitted, gold, Green Published			2022-12-27	WOS:000394424700051
J	Zhang, Y; Li, Y; Liang, X; Cao, XJ; Huang, LF; Yan, J; Wei, YX; Gao, J				Zhang, Yin; Li, Yang; Liang, Xiao; Cao, Xiaojuan; Huang, Longfei; Yan, Jie; Wei, Yanxing; Gao, Jian			Hepatic transcriptome analysis and identification of differentially expressed genes response to dietary oxidized fish oil in loach Misgurnus anguillicaudatus	PLOS ONE			English	Article							ARACHIDONIC-ACID; ATLANTIC SALMON; VITAMIN-E; LIVER TRANSCRIPTOME; GROWTH-PERFORMANCE; ALPHA-TOCOPHEROL; LIPID OXIDATION; SUPPLEMENTATION; DEFENSE; PRODUCTS	RNA sequencing and short-read assembly were utilized to produce a transcriptome of livers from loaches ( Misgurnus anguillicaudatus) fed with three different diets respectively containing fresh fish oil ( FO group), medium oxidized fish oil ( MO group) and high oxidized fish oil ( HO group). A total of 60,663 unigenes were obtained in this study, with mean length 848.74 bp. 50,814, 49,584 and 49,814 unigenes were respectively obtained from FO, MO and HO groups. There were 2,343 differentially expressed genes between FO and MO, with 855 down-and 1,488 up-regulated genes in the MO group. 2,813 genes were differentially expressed between FO and HO, including 1,256 down-and 1,552 up-regulated genes in the HO group. 2,075 differentially expressed genes were found in the comparison of MO and HO, including 1,074 up-and 1,001 down-regulated genes in the MO group. Some differentially expressed genes, such as fatty acid transport protein ( fatp), fatty acid binding protein ( fabp), apolipoprotein ( apo), peroxisome proliferator activated receptor-gamma ( ppar-gamma), acetyl-CoA synthetase ( acs) and arachidonate 5-lipoxygenase ( alox5), were involved in lipid metabolism, suggesting these genes in the loach were responsive to dietary oxidized fish oil. Results of transcriptome profilings here were validated using quantitative real time PCR in fourteen randomly selected unigenes. The present study provides insights into hepatic transcriptome profile of the loach, which is a valuable resource for studies of loach genomics. More importantly, this study identifies some important genes responsible for dietary oxidized fish oil, which will benefit researches of lipid metabolism in fish.	[Zhang, Yin; Li, Yang; Liang, Xiao; Cao, Xiaojuan; Huang, Longfei; Yan, Jie; Wei, Yanxing; Gao, Jian] Huazhong Agr Univ, Key Lab Agr Anim Genet Breeding & Reprod, Key Lab Freshwater Anim Breeding, Coll Fisheries,Minist Educ,Minist Agr, Wuhan, Peoples R China; [Cao, Xiaojuan] Freshwater Aquaculture Collaborat Innovat Ctr Hub, Wuhan, Hubei, Peoples R China	Huazhong Agricultural University; Ministry of Agriculture & Rural Affairs	Gao, J (corresponding author), Huazhong Agr Univ, Key Lab Agr Anim Genet Breeding & Reprod, Key Lab Freshwater Anim Breeding, Coll Fisheries,Minist Educ,Minist Agr, Wuhan, Peoples R China.	gaojian@mail.hzau.edu.cn						[Anonymous], 1987, STANDARD METHODS ANA; Bagnat M, 2000, P NATL ACAD SCI USA, V97, P3254, DOI 10.1073/pnas.060034697; Baker RTM, 1997, AQUACULT NUTR, V3, P91, DOI 10.1046/j.1365-2095.1997.00078.x; Calder PC, 2007, BRIT J NUTR, V98, P451, DOI 10.1017/S0007114507761779; Calduch-Giner JA, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-178; Chen QL, 2016, FISH PHYSIOL BIOCHEM, V42, P979, DOI 10.1007/s10695-015-0190-2; Chen YJ, 2012, AQUACULT NUTR, V18, P321, DOI 10.1111/j.1365-2095.2011.00900.x; Cunha I, 2015, MAR BIOL, V162, P1673, DOI 10.1007/s00227-015-2706-9; Diau GY, 2005, BMC MED, V3, DOI 10.1186/1741-7015-3-11; Dong GF, 2014, AQUAC RES, V45, P1867, DOI 10.1111/are.12138; Farese RV, 2009, CELL, V139, P855, DOI 10.1016/j.cell.2009.11.005; FORDHUTCHINSON AW, 1994, ANNU REV BIOCHEM, V63, P383, DOI 10.1146/annurev.bi.63.070194.002123; Frankel E.N., 2014, LIPID OXIDATION; Gao J, 2013, AQUACULT NUTR, V19, P35, DOI 10.1111/j.1365-2095.2011.00921.x; Gao J, 2012, AQUACULTURE, V324, P97, DOI 10.1016/j.aquaculture.2011.10.031; Gregory KE, 2014, J PEDIATR-US, V164, P1486, DOI 10.1016/j.jpeds.2014.01.057; Grigorakis K, 2010, ANIM FEED SCI TECH, V158, P73, DOI 10.1016/j.anifeedsci.2010.03.012; Hamre K, 2001, FISH PHYSIOL BIOCHEM, V25, P209, DOI 10.1023/A:1022257928437; Howell B.R., 1998, BIOL FARMED FISH, P27; Innis SM, 2007, P NUTR SOC, V66, P397, DOI 10.1017/S0029665107005666; Janssens BJ, 2000, J EXP BIOL, V203, P3717; Kaneko G, 2013, GEN COMP ENDOCR, V184, P51, DOI 10.1016/j.ygcen.2013.01.003; Keller U, 2004, EUR J NUTR, V43, P353, DOI 10.1007/s00394-004-0481-3; Kitagawa T, 2011, FOLIA ZOOL, V60, P343; Kobayashi SD, 2003, EUKARYOT CELL, V2, P284, DOI 10.1128/EC.2.2.284-294.2003; KOSHIO S, 1994, J AGR FOOD CHEM, V42, P1164, DOI 10.1021/jf00041a022; KOSUTARAK P, 1995, FISHERIES SCI, V61, P696, DOI 10.2331/fishsci.61.696; Lewis-McCrea LM, 2007, AQUACULTURE, V262, P142, DOI 10.1016/j.aquaculture.2006.09.024; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Luquet S, 2004, BIOCHIMIE, V86, P833, DOI 10.1016/j.biochi.2004.09.024; McKeown CR, 2014, DEV DYNAM, V243, P800, DOI 10.1002/dvdy.24115; Morais S, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-448; Morais S, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-255; Mourente G, 2002, AQUACULTURE, V214, P343, DOI 10.1016/S0044-8486(02)00064-9; Mourente G, 2000, FISH PHYSIOL BIOCHEM, V23, P337, DOI 10.1023/A:1011128510062; NEEDLEMAN P, 1986, ANNU REV BIOCHEM, V55, P69, DOI 10.1146/annurev.biochem.55.1.69; Nuchi C, 2009, J AGR FOOD CHEM, V57, P1952, DOI 10.1021/jf803369h; Ogretmen B, 2004, NAT REV CANCER, V4, P604, DOI 10.1038/nrc1411; Panday A, 2016, ARCH IMMUNOL THER EX, V64, P463, DOI 10.1007/s00005-016-0405-y; Panserat S, 2009, AQUACULTURE, V294, P123, DOI 10.1016/j.aquaculture.2009.05.013; Rimoldi S, 2016, REV FISH BIOL FISHER, V26, P93, DOI 10.1007/s11160-015-9408-8; Rosen ED, 2000, GENE DEV, V14, P1293; SAKAI T, 1992, NIPPON SUISAN GAKK, V58, P1483, DOI 10.2331/suisan.58.1483; Sargent J, 1999, AQUACULTURE, V177, P191, DOI 10.1016/S0044-8486(99)00083-6; SCHAFFER JE, 1994, CELL, V79, P427, DOI 10.1016/0092-8674(94)90252-6; Schiavone A, 2010, CAN J ANIM SCI, V90, P197, DOI 10.4141/CJAS09095; Song JY, 2016, METAB ENG, V35, P38, DOI 10.1016/j.ymben.2015.09.006; Stahl A, 1999, MOL CELL, V4, P299, DOI 10.1016/S1097-2765(00)80332-9; Strickler SR, 2012, AM J BOT, V99, P257, DOI 10.3732/ajb.1100292; Tacchi L, 2012, BMC GENOMICS, V13, P1, DOI 10.1186/1471-2164-13-363; Toledo MS, 2005, J BIOL CHEM, V280, P16227, DOI 10.1074/jbc.M413713200; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Tsai ML, 2008, GENE, V425, P69, DOI 10.1016/j.gene.2008.08.004; Wang LG, 2015, AQUACULT NUTR, V21, P414, DOI 10.1111/anu.12171; Xiong YY, 2014, AQUACULTURE, V433, P299, DOI 10.1016/j.aquaculture.2014.06.009; Zeldin DC, 2001, J BIOL CHEM, V276, P36059, DOI 10.1074/jbc.R100030200; Zeng LG, 2012, MITOCHONDR DNA, V23, P187, DOI 10.3109/19401736.2012.668893	57	78	83	3	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2017	12	2							e0172386	10.1371/journal.pone.0172386	http://dx.doi.org/10.1371/journal.pone.0172386			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BI	28212448	Green Submitted, Green Published, gold			2022-12-27	WOS:000394424700040
J	Lin, SC; Kappes, MA; Chen, MC; Lin, CC; Wang, TT				Lin, Shih-Chao; Kappes, Matthew A.; Chen, Mei-Chun; Lin, Chi-Chen; Wang, Tony T.			Distinct susceptibility and applicability of MDCK derivatives for influenza virus research	PLOS ONE			English	Article							CELL-LINES; IN-VITRO; ASSAYS; HEMAGGLUTININ; NEURAMINIDASE; SPECIFICITY; SENSITIVITY; VIABILITY; PROVIDE; MTS	Madin-Darby Canine Kidney (MDCK) cells are widely utilized as a substrate for influenza virus isolation and propagation due to the high yields of virus. Here we compared the conventional MDCK cell line, MDCK-SIAT1 and MDCK-London for viral production, cell survival, and suitability in testing antivirals using six influenza strains including two H1N1 (pandemic and epidemic strains), three H3N2 and one influenza B strain. Overall our results suggest that MDCK-London cell line is superior for virus culturing and quantification, and hence an ideal platform to evaluate antiviral drug efficacy against multiple strains of influenza. Our data also suggests that while virus titers determined by the hemagglutination assay (HA) and neuraminidase activity (NA) are widely used to indicate viral load, there is a poor correlation between these measurements and the infectious titer obtained by plaque assay.	[Lin, Shih-Chao] Natl Chung Hsing Univ, Program Med Biotechnol, Taichung, Taiwan; [Lin, Shih-Chao; Kappes, Matthew A.; Chen, Mei-Chun; Wang, Tony T.] SRI Int, Ctr Infect Dis, Harrisonburg, VA USA; [Lin, Chi-Chen] Natl Chung Hsing Univ, Dept Biomed Sci, Taichung, Taiwan; [Lin, Chi-Chen] Asia Univ, Dept Biotechnol, Taichung, Taiwan; [Lin, Chi-Chen] China Med Univ Hosp, Dept Med Res, Taichung, Taiwan	National Chung Hsing University; SRI International; National Chung Hsing University; Asia University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan	Wang, TT (corresponding author), SRI Int, Ctr Infect Dis, Harrisonburg, VA USA.; Lin, CC (corresponding author), Natl Chung Hsing Univ, Dept Biomed Sci, Taichung, Taiwan.; Lin, CC (corresponding author), Asia Univ, Dept Biotechnol, Taichung, Taiwan.; Lin, CC (corresponding author), China Med Univ Hosp, Dept Med Res, Taichung, Taiwan.	lincc@dragon.mail.nchu.edu.tw; tony.wang@sri.com	Lin, Shih-Chao/AAG-9173-2020	Lin, Shih-Chao/0000-0003-2942-5937; Lin, Chi-Chien/0000-0002-1464-0231	National Institutes of Health [R01DK088787]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK088787] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by the National Institutes of Health grant R01DK088787.	BARLTROP JA, 1991, BIOORG MED CHEM LETT, V1, P611, DOI 10.1016/S0960-894X(01)81162-8; Fazekas De St., 1954, BRIT J EXP PATHOL, V35, P60; GIENI RS, 1995, J IMMUNOL METHODS, V187, P85, DOI 10.1016/0022-1759(95)00170-F; Govorkova EA, 1996, J VIROL, V70, P5519, DOI 10.1128/JVI.70.8.5519-5524.1996; Hirst GK, 1942, J EXP MED, V75, P49, DOI 10.1084/jem.75.1.49; Hossain MJ, 2010, J CLIN MICROBIOL, V48, P2515, DOI 10.1128/JCM.02286-09; Hussain AI, 2010, VACCINE, V28, P3848, DOI 10.1016/j.vaccine.2010.03.005; Ito T, 1997, J VIROL, V71, P3357, DOI 10.1128/JVI.71.4.3357-3362.1997; JEiUBEK J. D L., 1981, ACTA VET BRNO, V50, P8; Klimov Alexander, 2012, Methods Mol Biol, V865, P25, DOI 10.1007/978-1-61779-621-0_3; Lehmann F, 2006, CELL MOL LIFE SCI, V63, P1331, DOI 10.1007/s00018-005-5589-y; Li IWS, 2009, J CLIN VIROL, V46, P325, DOI 10.1016/j.jcv.2009.09.013; Lugovtsev VY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075014; MADIN SH, 1958, P SOC EXP BIOL MED, V98, P574, DOI 10.3181/00379727-98-24111; Matrosovich M, 2003, J VIROL, V77, P8418, DOI 10.1128/JVI.77.15.8418-8425.2003; McCloy RA, 2014, CELL CYCLE, V13, P1400, DOI 10.4161/cc.28401; Nguyen JT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009332; Oh DY, 2008, J CLIN MICROBIOL, V46, P2189, DOI 10.1128/JCM.00398-08; SCHEPETIUK SK, 1993, J VIROL METHODS, V42, P241, DOI 10.1016/0166-0934(93)90036-Q; Teferedegne B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056023; TOBITA K, 1975, MED MICROBIOL IMMUN, V162, P9, DOI 10.1007/BF02123572; VISTICA DT, 1991, CANCER RES, V51, P2515; Wagner R, 2002, REV MED VIROL, V12, P159, DOI 10.1002/rmv.352; Wang PW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010202; WILEY DC, 1987, ANNU REV BIOCHEM, V56, P365, DOI 10.1146/annurev.bi.56.070187.002053; Zhai WG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052327	26	19	19	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0172299	10.1371/journal.pone.0172299	http://dx.doi.org/10.1371/journal.pone.0172299			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207898	gold, Green Published, Green Submitted			2022-12-27	WOS:000394424500116
J	Yu, P; Xu, YF; Deng, W; Bao, LL; Huang, L; Xu, YH; Yao, YF; Qin, C				Yu, Pin; Xu, Yanfeng; Deng, Wei; Bao, Linlin; Huang, Lan; Xu, Yuhuan; Yao, Yanfeng; Qin, Chuan			Comparative pathology of rhesus macaque and common marmoset animal models with Middle East respiratory syndrome coronavirus	PLOS ONE			English	Article							DROMEDARY CAMELS; SAUDI-ARABIA; MOUSE MODEL; INFECTION; TRACT; GENERATION; OUTBREAK; OUTCOMES; DISEASE; LUNGS	Middle East respiratory syndrome (MERS), which is caused by a newly discovered coronavirus (CoV), has recently emerged. It causes severe viral pneumonia and is associated with a high fatality rate. However, the pathogenesis, comparative pathology and inflammatory cell response of rhesus macaques and common marmosets experimentally infected with MERS-CoV are unknown. We describe the histopathological, immunohistochemical, and ultrastructural findings from rhesus macaque and common marmoset animal models of MERS-CoV infection. The main histopathological findings in the lungs of rhesus macaques and common marmosets were varying degrees of pulmonary lesions, including pneumonia, pulmonary oedema, haemorrhage, degeneration and necrosis of the pneumocytes and bronchial epithelial cells, and inflammatory cell infiltration. The characteristic inflammatory cells in the lungs of rhesus macaques and common marmosets were eosinophils and neutrophils, respectively. Based on these observations, the lungs of rhesus macaques and common marmosets appeared to develop chronic and acute pneumonia, respectively. MERS-CoV antigens and viral RNA were identified in type I and II pneumocytes, alveolar macrophages and bronchial epithelial cells, and ultrastructural observations showed that viral protein was found in type II pneumocytes and inflammatory cells in both species. Correspondingly, the entry receptor DDP4 was found in type I and II pneumocytes, bronchial epithelial cells, and alveolar macrophages. The rhesus macaque and common marmoset animal models of MERS-CoV can be used as a tool to mimic the oncome of MERS-CoV infections in humans. These models can help to provide a better understanding of the pathogenic process of this virus and to develop effective medications and prophylactic treatments.	[Yu, Pin; Xu, Yanfeng; Deng, Wei; Bao, Linlin; Huang, Lan; Xu, Yuhuan; Yao, Yanfeng; Qin, Chuan] Chinese Acad Med Sci, Inst Lab Anim Sci, Beijing, Peoples R China; [Yu, Pin; Xu, Yanfeng; Deng, Wei; Bao, Linlin; Huang, Lan; Xu, Yuhuan; Yao, Yanfeng; Qin, Chuan] Peking Union Med Coll, Comparat Med Ctr, Beijing Key Lab Anim Models Emerging & Remerging, Key Lab Human Dis Comparat Med,Minist Hlth, Beijing, Peoples R China; [Yu, Pin; Xu, Yanfeng; Deng, Wei; Bao, Linlin; Huang, Lan; Xu, Yuhuan; Yao, Yanfeng; Qin, Chuan] Chinese Acad Med Sci, Inst Lab Anim Sci, 5 Panjiayuan Nanli, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Laboratory Animal Science - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Laboratory Animal Science - CAMS	Qin, C (corresponding author), Chinese Acad Med Sci, Inst Lab Anim Sci, Beijing, Peoples R China.; Qin, C (corresponding author), Peking Union Med Coll, Comparat Med Ctr, Beijing Key Lab Anim Models Emerging & Remerging, Key Lab Human Dis Comparat Med,Minist Hlth, Beijing, Peoples R China.; Qin, C (corresponding author), Chinese Acad Med Sci, Inst Lab Anim Sci, 5 Panjiayuan Nanli, Beijing, Peoples R China.	qinchuan@pumc.edu.cn	Deng, Wei/GWC-9207-2022		Sector Funds of National Health and Family Planning Commission of the People's Republic of China [201302006]	Sector Funds of National Health and Family Planning Commission of the People's Republic of China	This work was supported by the Sector Funds of National Health and Family Planning Commission of the People's Republic of China [201302006].	Agrawal AS, 2015, J VIROL, V89, P3659, DOI 10.1128/JVI.03427-14; Al-Abdallat MM, 2014, CLIN INFECT DIS, V59, P1225, DOI 10.1093/cid/ciu359; Al-Tawfiq JA, 2014, CLIN INFECT DIS, V59, P160, DOI 10.1093/cid/ciu226; Alagaili AN, 2014, MBIO, V5, DOI [10.1128/mBio.00884-14, 10.1128/mBio.01482-14]; Arabi YM, 2014, ANN INTERN MED, V160, P389, DOI 10.7326/M13-2486; Assiri A, 2013, LANCET INFECT DIS, V13, P752, DOI 10.1016/S1473-3099(13)70204-4; Baseler LJ, 2016, AM J PATHOL, V186, P630, DOI 10.1016/j.ajpath.2015.10.025; Chan RWY, 2014, LANCET RESP MED, V2, P813, DOI 10.1016/S2213-2600(14)70158-4; de Wit E, 2013, P NATL ACAD SCI USA, V110, P16598, DOI 10.1073/pnas.1310744110; Falzarano D, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004250; Falzarano D, 2013, NAT MED, V19, P1313, DOI 10.1038/nm.3362; Haagmans BL, 2015, J VIROL, V89, P6131, DOI 10.1128/JVI.00661-15; Haagmans BL, 2014, LANCET INFECT DIS, V14, P140, DOI 10.1016/S1473-3099(13)70690-X; Hocke AC, 2013, AM J RESP CRIT CARE, V188, P882, DOI 10.1164/rccm.201305-0954LE; HSU SM, 1981, J HISTOCHEM CYTOCHEM, V29, P577, DOI 10.1177/29.4.6166661; Johnson RF, 2015, VIROLOGY, V485, P422, DOI 10.1016/j.virol.2015.07.013; Meyerholz DK, 2016, AM J PATHOL, V186, P78, DOI 10.1016/j.ajpath.2015.09.014; Munster VJ, 2012, SCI REP-UK, V2, DOI 10.1038/srep00736; Ng DL, 2016, AM J PATHOL, V186, P652, DOI 10.1016/j.ajpath.2015.10.024; Nicholls JM, 2006, PLOS MED, V3, P222, DOI 10.1371/journal.pmed.0030027; Saad M, 2014, INT J INFECT DIS, V29, P301, DOI 10.1016/j.ijid.2014.09.003; The WHO MERS-CoV Research Group, 2013, PLOS CURR, V5; Yao YF, 2014, J INFECT DIS, V209, P236, DOI 10.1093/infdis/jit590; Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721; Zhao JC, 2014, P NATL ACAD SCI USA, V111, P4970, DOI 10.1073/pnas.1323279111	25	21	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0172093	10.1371/journal.pone.0172093	http://dx.doi.org/10.1371/journal.pone.0172093			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5VB	28234937	Green Published, gold, Green Submitted			2022-12-27	WOS:000394688200047
J	Bodner-Adler, B; Hanzal, E; Pablik, E; Koelbl, H; Bodner, K				Bodner-Adler, Barbara; Hanzal, Engelbert; Pablik, Eleonore; Koelbl, Heinz; Bodner, Klaus			Management of vesicovaginal fistulas (VVFs) in women following benign gynaecologic surgery: A systematic review and meta-analysis	PLOS ONE			English	Article							TRANSURETHRAL SUTURE CYSTORRHAPHY; LAPAROSCOPIC REPAIR; VESICUVAGINAL FISTULA; TRANSVAGINAL REPAIR; SURGICAL REPAIR; ROBOTIC REPAIR; ABDOMINAL APPROACH; BLADDER INJURIES; HYSTERECTOMY; EXPERIENCE	Background Vesicovaginal fistulas (VVF) are the most commonly acquired fistulas of the urinary tract, but we lack a standardized algorithm for their management. Surgery is the most commonly preferred approach to treat women with primary VVF following benign gynaecologic surgery. Objective To carry out a systematic review and meta-analysis on the effectiveness of operative techniques or conservative treatment for patients with postsurgical VVF. Our secondary objective was to define the surgical time and determine the types of study designs. Methods PubMed, Old Medline, Embase and Cochrane Central Register of Controlled Trials were used as data sources. This systematic review was modelled on the Preferred Reporting Items for Systematic Reviews and Meta-Analyses statement, including a registration number (CRD42012002097). Results We reviewed 282 full text articles to identify 124 studies for inclusion. In all, 1379/1430 (96.4%) patients were treated surgically. Overall, the transvaginal approach was performed in the majority of patients (39%), followed by a transabdominal/transvesical route (36%), a laparoscopic/robotic approach (15%) and a combined transabdominal-transvaginal approach in 3% of cases. Success rate of conservative treatment was 92.86% (95% CI: 79.54-99.89), 97.98% in surgical cases (95% CI: 96.13-99.29) and 91.63% (95% CI: 87.68-97.03) in patients with prolonged catheter drainage followed by surgery. 79/124 studies (63.7%) provided information for the length of follow-up, but showed a poor reporting standard regarding prognosis. Complications were studied only selectively. Due to the inconsistency of these data it was impossible to analyse them collectively. Conclusions Although the literature is imprecise and inconsistent, existing studies indicate that operation, mainly through a transvaginal approach, is the most commonly preferred treatment strategy in females with postsurgical VVF. Our data showed no clear odds-on favorite regarding disease management as well as surgical approach and current evidence on the surgical management of VVF does not allow any accurate estimation of success and complication rates. Standardisation of the terminology is required so that VVF can be managed with a proper surgical treatment algorithm based on characteristics of the fistula.	[Bodner-Adler, Barbara; Hanzal, Engelbert; Koelbl, Heinz; Bodner, Klaus] Med Univ Vienna, Dept Gen Gynaecol & Gynaecol Oncol, Vienna, Austria; [Pablik, Eleonore] Med Univ Vienna, Sect Med Stat, Vienna, Austria	Medical University of Vienna; Medical University of Vienna	Bodner-Adler, B (corresponding author), Med Univ Vienna, Dept Gen Gynaecol & Gynaecol Oncol, Vienna, Austria.	Barbara.Bodner-Adler@meduniwien.ac.at			Department of General Gynaecology and Gynaecologic Oncology, Medical University Vienna	Department of General Gynaecology and Gynaecologic Oncology, Medical University Vienna	This study was supported by the Department of General Gynaecology and Gynaecologic Oncology, Medical University Vienna.	Abdel-Karim AM, 2011, UROLOGY, V78, P567, DOI 10.1016/j.urology.2011.05.036; Agrawal V, 2015, UROLOGY, V86, P276, DOI 10.1016/j.urology.2015.02.074; Angioli R, 2003, CRIT REV ONCOL HEMAT, V48, P295, DOI 10.1016/S1040-8428(03)00123-9; [Anonymous], STUDY QUALITY ASSESS; Ansquer Y, 2006, ACTA OBSTET GYN SCAN, V85, P1248, DOI 10.1080/00016340600804589; Arrowsmith S, 1996, Obstet Gynecol Surv, V51, P568, DOI 10.1097/00006254-199609000-00024; AYCINENA J F, 1977, Urology, V9, P543, DOI 10.1016/0090-4295(77)90248-5; Ayed M, 2006, INT J UROL, V13, P345, DOI 10.1111/j.1442-2042.2006.01308.x; BADENOCH DF, 1987, BRIT J UROL, V59, P516, DOI 10.1111/j.1464-410X.1987.tb04866.x; Bajory Z, 2011, NEUROUROL URODYNAM, V30, P1530, DOI 10.1002/nau.21114; Baumrucker G O, 1974, Urology, V3, P333, DOI 10.1016/S0090-4295(74)80116-0; Bazi T, 2007, INT UROGYNECOL J PEL, V18, P475; BLANDY JP, 1991, J UROLOGY, V146, P761, DOI 10.1016/S0022-5347(17)37915-6; BRAMHALL TC, 1950, AM J OBSTET GYNECOL, V60, P834, DOI 10.1016/S0002-9378(16)39110-4; Brandt FT, 1998, J AM COLL SURGEONS, V186, P645, DOI 10.1016/S1072-7515(98)00129-X; CHAPRON C, 1995, J GYNECOL SURG, V11, P95, DOI 10.1089/gyn.1995.11.95; Chibber PJ, 2005, BJU INT, V96, P183, DOI 10.1111/j.1464-410X.2005.05592.x; Chien WH, 2006, GYNECOL SURG, V3, P134, DOI 10.1007/s10397-006-0176-2; Chu L, 2015, INT J CLIN EXP MED, V8, P2364; CLARK DH, 1975, SOUTHERN MED J, V68, P1410, DOI 10.1097/00007611-197511000-00021; CRUIKSHANK SH, 1987, OBSTET GYNECOL, V70, P61; Dalela D, 2006, EUROPEAN UROLOGY, V46, P551; Daley SM, 2006, J PELVIC MED SURG, V12, P229; Das Mahatpatra P, 2007, INT UROGYNECOL J, V18, P635, DOI 10.1007/s00192-006-0215-6; Dogra PN, 2011, INT UROGYNECOL J, V22, P981, DOI 10.1007/s00192-011-1389-0; Dorairajan LN, 2008, INT UROL NEPHROL, V40, P317, DOI 10.1007/s11255-007-9252-4; DORSEY JW, 1960, J UROLOGY, V83, P404, DOI 10.1016/S0022-5347(17)65727-6; Abreu LDD, 2008, J ENDOUROL, V22, P1279, DOI 10.1089/end.2008.0050; Dutto L, 2013, INT UROGYNECOL J, V24, P2029, DOI 10.1007/s00192-013-2081-3; Ezzat M, 2009, J UROLOGY, V181, P1184, DOI 10.1016/j.juro.2008.10.152; FALK HC, 1957, OBSTET GYNECOL, V9, P538; Fang G, 2015, J OBSTET GYNAECOL RE, V41, P1049, DOI 10.1111/jog.12664; Fearl C L, 1968, Trans Pac Coast Obstet Gynecol Soc, V36, P57; FLEISCHMANN J, 1988, J UROLOGY, V140, P552, DOI 10.1016/S0022-5347(17)41716-2; Flynn MK, 2004, INT UROGYNECOL J, V15, P394, DOI 10.1007/s00192-004-1188-y; FOURIE T, 1983, S AFR MED J, V63, P889; GERBER GS, 1993, J UROLOGY, V149, P229, DOI 10.1016/S0022-5347(17)36045-7; Ghoniem GM, 2014, ARAB J UROL, V12, P97, DOI 10.1016/j.aju.2013.11.006; Gozen AS, 2009, J ENDOUROL, V23, P475, DOI 10.1089/end.2008.0236; GOODWIN WE, 1980, J UROLOGY, V123, P370, DOI 10.1016/S0022-5347(17)55941-8; Grange P, 2014, UROLOGY, V84, P950, DOI 10.1016/j.urology.2014.06.020; Gupta NP, 2010, J ENDOUROL, V24, P1779, DOI 10.1089/end.2010.0049; HARROW BR, 1969, OBSTET GYNECOL, V33, P852; Hellenthal NJ, 2007, UROLOGY, V70, P797, DOI 10.1016/j.urology.2007.07.064; Hemal AK, 2008, J UROLOGY, V180, P981, DOI 10.1016/j.juro.2008.05.020; HENRIKSSON C, 1982, ACTA OBSTET GYN SCAN, V61, P143, DOI 10.3109/00016348209156545; Hessami SH, 2007, J PELVIS MED SURG, V13, P39; Hong Hye-Min, 2010, Int Neurourol J, V14, P65, DOI 10.5213/inj.2010.14.1.65; Hsieh CH, 2008, INT UROGYNECOL J, V19, P1577, DOI 10.1007/s00192-008-0611-1; IMMERGUT S, 1950, J UROLOGY, V63, P865, DOI 10.1016/S0022-5347(17)68839-6; Iselin CE, 1998, J UROLOGY, V160, P728, DOI 10.1016/S0022-5347(01)62769-1; James R, 2013, INT UROGYNECOL J, V24, P173, DOI 10.1007/s00192-011-1623-9; Javali TD, 2015, UROLOGY, V85, P544, DOI 10.1016/j.urology.2014.11.014; Javed A, 2015, J PAK MED ASSOC, V65, P954; KEETTEL WC, 1978, AM J OBSTET GYNECOL, V131, P425, DOI 10.1016/0002-9378(78)90418-0; Kochakarn W, 2007, ASIAN J SURG, V30, P267, DOI 10.1016/S1015-9584(08)60037-8; Kostakopoulos A., 1998, International Urology and Nephrology, V30, P445, DOI 10.1007/BF02550224; Krissi H, 2001, ACTA OBSTET GYN SCAN, V80, P1137, DOI 10.1034/j.1600-0412.2001.801211.x; Kristensen JK, SCAND J UROL NEPHROL, V157, P101; LANDES RR, 1979, J UROLOGY, V122, P604, DOI 10.1016/S0022-5347(17)56524-6; Lazarou G, 2006, PELVIC MED SURG, V12, P335; Ledniowska A, 2012, NEW MED, P122; Liao CY, 2012, TAIWAN J OBSTET GYNE, V51, P359, DOI 10.1016/j.tjog.2012.07.007; Llueca A, 2015, GYNECOL SURG, V12, P323, DOI 10.1007/s10397-015-0913-5; Macalpine J B, 1940, Br Med J, V2, P778; MALIN JOSEPH M., 1967, INVEST UROL, V4, P346; Mallikarjuna C, 2015, UROL INT, V95, P357, DOI 10.1159/000439355; MALMSTROM L, 1955, Urol Int, V1, P66; Martius H., 1928, ZBL GYNAK, V52, P480; McKay HA, 2004, J ENDOUROL, V18, P487, DOI 10.1089/0892779041271427; McKay HA, 1997, J UROLOGY, V158, P1513, DOI 10.1016/S0022-5347(01)64256-3; McKay HA, 2001, INT UROGYNECOL J PEL, V12, P282, DOI 10.1007/s001920170054; Melah GS, 2006, INT J GYNECOL OBSTET, V93, P252, DOI 10.1016/j.ijgo.2006.02.017; Mellano EM, 2014, CURR OPIN OBSTET GYN, V26, P415, DOI 10.1097/GCO.0000000000000095; Miklos J R, 1999, Int Urogynecol J Pelvic Floor Dysfunct, V10, P116, DOI 10.1007/s001920050029; Miklos JR, 2015, J MINIM INVAS GYN, V22, P727, DOI 10.1016/j.jmig.2015.03.001; Miklos JR, 2015, INT UROGYNECOL J, V26, P441, DOI 10.1007/s00192-014-2458-y; Milicic D, 2001, INT J GYNECOL OBSTET, V73, P35, DOI 10.1016/S0020-7292(00)00369-6; Miller E A, 2001, Curr Opin Urol, V11, P417, DOI 10.1097/00042307-200107000-00014; Modi P, 2006, UROL INT, V76, P374, DOI 10.1159/000092068; Moharram AAE, 2004, BJU INT, V93, P581, DOI 10.1111/j.1464-410X.2004.04679.x; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Moher D, 2009, BMJ-BRIT MED J, V339, DOI [10.1136/bmj.i4086, 10.1136/bmj.b2535, 10.1186/2046-4053-4-1]; Mohseni Mohammad G, 2012, Adv Biomed Res, V1, P77, DOI 10.4103/2277-9175.102984; de Toledo LGM, 2013, EINSTEIN-SAO PAULO, V11, P119, DOI 10.1590/S1679-45082013000100022; MORGAN EK, 1950, AM J SURG, V80, P383, DOI 10.1016/0002-9610(50)90441-7; MORIEL EZ, 1993, ARCH GYNECOL OBSTET, V253, P127, DOI 10.1007/BF02767329; Muto G, 2005, J UROLOGY, V174, P2239, DOI 10.1097/01.ju.0000181809.51544.20; Nabi G, 2001, J ENDOUROL, V15, P801, DOI 10.1089/089277901753205780; Nagraj HK, 2007, INT UROGYNECOL J, V18, P759, DOI 10.1007/s00192-006-0232-5; Nerli R B, 2010, Diagn Ther Endosc, V2010, P760348, DOI 10.1155/2010/760348; Nesrallah LJ, 1999, J UROLOGY, V161, P566, DOI 10.1016/S0022-5347(01)61951-7; NEZHAT CH, 1994, OBSTET GYNECOL, V83, P899; Bragayrac LAN, 2014, INT BRAZ J UROL, V40, P810, DOI 10.1590/S1677-5538.IBJU.2014.06.12; Oakley SH, 2014, FEMALE PELVIC MED RE, V20, P7, DOI 10.1097/SPV.0000000000000041; Ostad M, 1998, UROLOGY, V52, P123, DOI 10.1016/S0090-4295(98)00120-4; Ou CS, 2004, J LAPAROENDOSC ADV A, V14, P17, DOI 10.1089/109264204322862306; PEIKOFF S S, 1956, J Int Coll Surg, V26, P718; Otsuka RAP, 2008, J ENDOUROL, V22, P525, DOI 10.1089/end.2006.9846; PERSKY L, 1979, UROLOGY, V13, P273, DOI 10.1016/0090-4295(79)90419-9; PERSKY L, 1973, AM J SURG, V125, P763, DOI 10.1016/0002-9610(73)90180-3; Phipps J, 1996, GYNAECOL ENDOSC, V5, P123; Pietersma CS, 2014, BMJ CASE REPORTS; Pontes J E, 1974, Urology, V4, P109; Pshak T, 2013, UROLOGY, V82, P707, DOI 10.1016/j.urology.2013.03.076; R Core Team, 2021, R LANGUAGE ENV STAT; RADER ES, 1975, J UROLOGY, V114, P389, DOI 10.1016/S0022-5347(17)67036-8; Radopoulos DK, 2008, INT UROL NEPHROL, V40, P57, DOI 10.1007/s11255-007-9218-6; Rajamaheswari N, 2012, UROL ANNALS, V4, P154, DOI 10.4103/0974-7796.102660; RAZ S, 1993, J UROLOGY, V150, P56, DOI 10.1016/S0022-5347(17)35396-X; Razi A, 2015, ARCH GYNECOL OBSTET, V292, P121, DOI 10.1007/s00404-014-3589-6; Reynolds WS, 2008, UROLOGY, V71, P1119, DOI 10.1016/j.urology.2007.12.057; Rizvi SJ, 2010, J LAPAROENDOSC ADV S, V20, P13, DOI 10.1089/lap.2009.0176; Robles JE, 2009, UROL INT, V82, P116, DOI 10.1159/000176038; ROEN PR, 1960, ARCH SURG-CHICAGO, V80, P628; Roslan M, 2012, VIDEOSURGERY MINIINV, V7, P307, DOI 10.5114/wiitm.2011.30816; Schimpf Megan O, 2007, JSLS, V11, P378; SCHNEIDERMAN C, 1958, Can Med Assoc J, V79, P801; Sears CLG, 2007, UROLOGY, V70, P581, DOI 10.1016/j.urology.2007.05.026; Shah SJ, 2010, J ENDOUROL, V24, P1659, DOI 10.1089/end.2009.0557; Sharifiaghdas F, 2012, INT J GYNECOL OBSTET, V119, P18, DOI 10.1016/j.ijgo.2012.04.026; Sharma S, 2014, J MINIM ACCESS SURG, V10, P180, DOI 10.4103/0972-9941.141508; Shirvan MK, 2013, J UROLOGY, V189, P2125, DOI 10.1016/j.juro.2012.12.064; Simforoosh N, 2012, J LAPAROENDOSC ADV S, V22, P871, DOI 10.1089/lap.2012.0141; Sims JM., 1852, AM J MED SCI, V23, P59, DOI [10.1097/00000441-185201000-00004, DOI 10.1097/00000441-185201000-00004]; Singh RB, 2005, TROP DOCT, V35, P40, DOI 10.1258/0049475053001994; Singh Vishwajeet, 2013, Curr Urol, V7, P75, DOI 10.1159/000356253; Singh V, 2012, INT UROGYNECOL J, V23, P411, DOI 10.1007/s00192-011-1544-7; Soong Y., 1997, SMJ, V38, P475; Sotelo R, 2005, J ENDOUROL, V19, P603, DOI 10.1089/end.2005.19.603; Starkman JS, 2007, INT UROGYNECOL J, V18, P113, DOI 10.1007/s00192-006-0084-z; Sundaram BM, 2006, UROLOGY, V67, P970, DOI 10.1016/j.urology.2005.11.014; SZENDI B, 1959, Acta Med Acad Sci Hung, V14, P133; TANCER ML, 1992, SURG GYNECOL OBSTET, V175, P501; TAYLOR WN, 1948, J UROLOGY, V60, P488, DOI 10.1016/S0022-5347(17)69262-0; Tiong HY, 2007, INT UROL NEPHROL, V39, P1085, DOI 10.1007/s11255-006-9168-4; Tsivian A, 2006, J PELV MED SURG, V12, P197; Udea T, 1977, J UROLOGY, V119, P742; von Theobald P, 1998, BRIT J OBSTET GYNAEC, V105, P1216; WEIN AJ, 1980, SURG GYNECOL OBSTET, V150, P57; Wells GA, NEWCASTLE OTTOWA SCA; Wesolowski S, 1973, Br J Urol, V45, P34, DOI 10.1111/j.1464-410X.1973.tb07004.x; Wong C, 2006, J ENDOUROL, V20, P240, DOI 10.1089/end.2006.20.240; Xu ZS, 2005, INT J UROL, V12, P1037, DOI 10.1111/j.1442-2042.2005.01200.x; Zhang Q, 2013, INT UROGYNECOL J, V24, P337, DOI 10.1007/s00192-012-1850-8; Zumrutbas AE, 2014, J ENDOUROL, V28, P275, DOI 10.1089/end.2013.0435	146	46	54	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2017	12	2							e0171554	10.1371/journal.pone.0171554	http://dx.doi.org/10.1371/journal.pone.0171554			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5SK	28225769	Green Published, Green Submitted, gold			2022-12-27	WOS:000394680900018
J	Safarnejad, A; Izazola-Licea, JA				Safarnejad, Ali; Izazola-Licea, Jose-Antonio			Direct and indirect effects of enablers on HIV testing, initiation and retention in antiretroviral treatment and AIDS related mortality	PLOS ONE			English	Article							HIV/AIDS; DETERMINANTS; SPECTRUM; BARRIERS	Background An enabling environment is believed to have significant and critical effects on HIV and AIDS program implementation and desired outcomes. This paper estimates the paths, directionality, and direct and indirect associations between critical enablers with antiretroviral treatment (ART) coverage and to AIDS-related mortality. Methods Frameworks that consider the role of enablers in HIV and AIDS programs were systematically reviewed to develop a conceptual model of interaction. Measurements for constructs of the model were pooled from the latest publicly available data. A hypothetical model, including latent/unobserved factors and interaction of enablers, program activities and outcomes, was analyzed cross-sectionally with structural equation modeling. Coefficients of the model were used to estimate the indirect associations of enablers to treatment coverage and the subsequent associated impact on AIDS related mortality. Findings The model's fit was adequate (RMSEA = 0.084, 90% CI [0.062, 0.104]) and the indirect effects of enablers on outcomes were measured. Enablers having significant associations with increased ART coverage were social/financial protection, governance, anti-discrimination, gender equality, domestic AIDS spending, testing service delivery, and logistics. Interpretation Critical enablers are significantly correlated to outcomes like ART coverage and AIDS related mortality. Even while this model does not allow inference on causality, it provides directionality and magnitude of the significant associations.	[Safarnejad, Ali] UN Programme AIDS UNAIDS, Strateg Informat & Evaluat Dept, Evaluat Team, Evaluat & Econ Div, Geneva, Switzerland; [Izazola-Licea, Jose-Antonio] UN Programme AIDS UNAIDS, Programme Branch, Strateg Informat & Evaluat Dept, Evaluat & Econ Div, Geneva, Switzerland; [Safarnejad, Ali] UN Programme AIDS UNAIDS, Strateg Informat, Country Off, Hanoi, Vietnam	UNAIDS; UNAIDS	Izazola-Licea, JA (corresponding author), UN Programme AIDS UNAIDS, Programme Branch, Strateg Informat & Evaluat Dept, Evaluat & Econ Div, Geneva, Switzerland.	izazolaj@unaids.org		Izazola-Licea, Jose Antonio/0000-0002-3658-2570				Aggleton P, 2005, HIV RELATED STIGMA D; Ayala G., 2014, Journal of AIDS and Clinical Research, V5, P331; Barrett P, 2007, PERS INDIV DIFFER, V42, P815, DOI 10.1016/j.paid.2006.09.018; BENTLER PM, 1987, SOCIOL METHOD RES, V16, P78, DOI 10.1177/0049124187016001004; BENTLER PM, 1990, PSYCHOL BULL, V107, P238, DOI 10.1037/0033-2909.88.3.588; Bentler PM, 2007, PERSONALITY INDIVIDU, V42, P831; Boerma JT, 2005, J INFECT DIS, V191, pS61, DOI 10.1086/425282; Bollen KA, 1989, STRUCTURAL EQUATIONS; Cameron S, 2014, AIDS EDUC PREV, V26, P202, DOI 10.1521/aeap.2014.26.3.202; Chen FN, 2008, SOCIOL METHOD RES, V36, P462, DOI 10.1177/0049124108314720; Dhai A, 2008, THEOR MED BIOETH, V29, P293, DOI 10.1007/s11017-008-9081-1; Gardner EM, 2011, CLIN INFECT DIS, V52, P793, DOI 10.1093/cid/ciq243; Goffin RD, 2007, PERS INDIV DIFFER, V42, P831, DOI 10.1016/j.paid.2006.09.019; Gruskin S, 2014, CULTURE HLTH SEXUALI, V16, P53; Gupta GR, 2008, LANCET, V372, P764, DOI 10.1016/S0140-6736(08)60887-9; Hayduk L, 2007, PERS INDIV DIFFER, V42, P841, DOI 10.1016/j.paid.2006.10.001; Hox J.J., 1999, FAMILY SCI REV, V11, P354, DOI DOI 10.1080/10705510903008345; Joint United Nations Programme on HIV/AIDS, 2014, JOINT UN PROGR HIV A; Joint United Nations Programme on HIV/ AIDS, 2014, GAP REP; Kagee A, 2011, GLOB PUBLIC HEALTH, V6, P83, DOI 10.1080/17441691003796387; Kippax S, 2008, CURR OPIN HIV AIDS, V3, P489, DOI 10.1097/COH.0b013e32830136a0; Kline R.B., 2011, PRINCIPLES PRACTICE; Lamb MR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038443; Lleras C., 2005, ENCY SOCIAL MEASUREM, V3, P25, DOI DOI 10.1016/B0-12-369398-5/00483-7; Mahajan AP, 2008, AIDS, V22, pS67, DOI 10.1097/01.aids.0000327438.13291.62; Muthen B., 2010, MPLUS USERS GUIDE; Ntsepe Y, 2014, SAHARA J-J SOC ASP H, V11, P138, DOI 10.1080/17290376.2014.937355; Peacock D, 2009, JAIDS-J ACQ IMM DEF, V51, pS119, DOI 10.1097/QAI.0b013e3181aafd8a; Raftery AE, 1995, SOCIOL METHODOL, V25, P111, DOI 10.2307/271063; Richardson ET, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.19035; Schwartlander B, 2011, LANCET, V377, P2031, DOI 10.1016/S0140-6736(11)60702-2; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Steiger J.H., 1980, ANN M PSYCH SOC IOW; Stover J, 2008, SEX TRANSM INFECT, V84, pI24, DOI 10.1136/sti.2008.029868; Sumartojo E, 2000, AIDS, V14, pS1, DOI 10.1097/00002030-200006001-00001; Todaro M.P., 2009, EC DEV; TUCKER LR, 1973, PSYCHOMETRIKA, V38, P1, DOI 10.1007/bf02291170; UNAIDS, 2013, JOINT UN PROGR HIV A; Underwood C, 2014, JAIDS-J ACQ IMM DEF, V66, pS311, DOI 10.1097/QAI.0000000000000234; United Nations Development Programme, 2004, THAIL RESP HIV AIDS; Weir S, 2013, OPERATIONAL GUIDELIN; WHO, 2007, EV BUS STRENGTH HLTH	43	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2017	12	2							e0172569	10.1371/journal.pone.0172569	http://dx.doi.org/10.1371/journal.pone.0172569			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL5SK	28225790	Green Published, Green Submitted, gold			2022-12-27	WOS:000394680900055
J	Guo, GQ; Zhang, L; Ye, SS; Hu, YY; Li, BQ; Sun, XW; Mao, CC; Xu, JF; Chen, YP; Zhang, LF; Xue, XY				Guo, Gangqiang; Zhang, Liang; Ye, Sisi; Hu, Yingying; Li, Baoqing; Sun, Xiangwei; Mao, Chenchen; Xu, Jianfeng; Chen, Yiping; Zhang, Lifang; Xue, Xiangyang			Polymorphisms and features of cytomegalovirus UL144 and UL146 in congenitally infected neonates with hepatic involvement	PLOS ONE			English	Article							SEQUENCE VARIABILITY; ALPHA-CHEMOKINE; CLINICAL-MANIFESTATIONS; MIXED INFECTION; CMV INFECTION; STRAINS; GENES; CHILDREN; DISEASE; HYPERVARIABILITY	Human cytomegalovirus is a significant agent of hepatic involvement in neonates. In this study, we investigated the polymorphisms and features of the viral genes UL144 and UL146 as well as their significance to congenital hepatic involvement. In 79 neonates with congenital cytomegalovirus infection and hepatic involvement, full length UL144 and UL146 were successfully amplified in 73.42% and 60.76% of cases, respectively. Sequencing indicated that both genes were hypervariable. Notably, UL144 genotype B was highly associated with aspartate aminotransferase (P = 0.028) and lactate dehydrogenase (P = 0.046). Similarly, UL146 genotype G1 and G13 were significantly associated with CMV IgM (P = 0.026), CMV IgG (P = 0.034), alanine aminotransferase (P = 0.019), and aspartate aminotransferase (P = 0.032). In conclusion, dominant UL144 (genotype B) and UL146 (genotype G1 and G13) genotypes are associated with elevated levels of enzymes and CMV IgM and IgG of cytomegalovirus infection.	[Guo, Gangqiang; Ye, Sisi; Zhang, Lifang; Xue, Xiangyang] Wenzhou Med Univ, Dept Microbiol & Immunol, Inst Mol Virol & Immunol, Inst Trop Med, Wenzhou, Peoples R China; [Zhang, Liang; Sun, Xiangwei; Mao, Chenchen; Xu, Jianfeng] Wenzhou Med Univ, Dept Gen Surg, Affiliated Hosp 1, Wenzhou, Peoples R China; [Hu, Yingying] Wenzhou Med Univ, Dept Obstet & Gynecol, Affiliated Hosp 2, Wenzhou, Peoples R China; [Li, Baoqing] Wenzhou Med Univ, Dept Lab Med, Affiliated Hosp 2, Wenzhou, Peoples R China; [Li, Baoqing] Wenzhou Med Univ, Yuying Childrens Hosp, Wenzhou, Peoples R China; [Chen, Yiping] Wenzhou Med Univ, Dept Pediat Infect Dis, Affiliated Hosp 2, Wenzhou, Peoples R China; [Chen, Yiping] Wenzhou Med Univ, Yuying Childrens Hosp, Wenzhou, Peoples R China	Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University	Xue, XY (corresponding author), Wenzhou Med Univ, Dept Microbiol & Immunol, Inst Mol Virol & Immunol, Inst Trop Med, Wenzhou, Peoples R China.; Chen, YP (corresponding author), Wenzhou Med Univ, Dept Pediat Infect Dis, Affiliated Hosp 2, Wenzhou, Peoples R China.; Chen, YP (corresponding author), Wenzhou Med Univ, Yuying Childrens Hosp, Wenzhou, Peoples R China.	cccyp@163.com; wzxxy001@163.com	Chen, Yi/HIR-2608-2022; Hu, Ying/GQZ-8100-2022	Xue, Xiangyang/0000-0002-8670-2016	National Nature Science Foundation of China [81001343, 81472308, 81672707]; Zhejiang Provincial Natural Science Foundation of China [Y2100909]; Zhejiang Science and Technology Bureau [2012C33126]; Wenzhou Municipal Science and Technology Bureau [Y20160018]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); Zhejiang Science and Technology Bureau; Wenzhou Municipal Science and Technology Bureau	This work was supported by the National Nature Science Foundation of China (Grant Nos. 81001343, 81472308 and 81672707), the Zhejiang Provincial Natural Science Foundation of China (Y2100909), the Zhejiang Science and Technology Bureau (grant nos. 2012C33126), and the Wenzhou Municipal Science and Technology Bureau (grant nos. Y20160018).	Aguayo F, 2010, BIOL RES, V43, P475, DOI [10.4067/S0716-97602010000400013, /S0716-97602010000400013]; Arav-Boger R, 2002, J INFECT DIS, V186, P1057, DOI 10.1086/344238; Arav-Boger R, 2006, J INFECT DIS, V193, P788, DOI 10.1086/500508; Arav-Boger R, 2005, VIRUS GENES, V31, P65, DOI 10.1007/s11262-005-2201-3; Arav-Boger R, 2006, J INFECT DIS, V194, P464, DOI 10.1086/505427; Bale JF, 2001, J MED VIROL, V65, P90, DOI 10.1002/jmv.2006; Barbi M, 1998, EUR J EPIDEMIOL, V14, P791, DOI 10.1023/A:1007554726449; Bilavsky E, 2015, J VIRAL HEPATITIS, V22, P763, DOI 10.1111/jvh.12374; Boppana SB, 2001, NEW ENGL J MED, V344, P1366, DOI 10.1056/NEJM200105033441804; Boppana SB, 2013, CLIN INFECT DIS, V57, pS178, DOI 10.1093/cid/cit629; Bradley AJ, 2008, J MED VIROL, V80, P1615, DOI 10.1002/jmv.21241; Branas P, 2015, OPEN FORUM INFECT DI, V2, DOI 10.1093/ofid/ofv151; Cha TA, 1996, J VIROL, V70, P78, DOI 10.1128/JVI.70.1.78-83.1996; Chen HP, 2015, J GEN VIROL; Cheung TC, 2005, P NATL ACAD SCI USA, V102, P13218, DOI 10.1073/pnas.0506172102; Dolan A, 2004, J GEN VIROL, V85, P1301, DOI 10.1099/vir.0.79888-0; Dreher AM, 2014, J PEDIATR-US, V164, P855, DOI 10.1016/j.jpeds.2013.12.007; Fu XX, 2014, CHINESE SCI BULL, V59, P3120, DOI 10.1007/s11434-014-0353-z; Guo Gangqiang, 2016, Bing Du Xue Bao, V32, P610; Hassan-Walker AF, 2004, J MED VIROL, V74, P573, DOI 10.1002/jmv.20210; He R, 2006, INTERVIROLOGY, V49, P215, DOI 10.1159/000091468; He R, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-299; Heo JH, 2008, VIROLOGY, V378, P86, DOI 10.1016/j.virol.2008.05.002; Heo JH, 2015, J IMMUNOL, V195, P227, DOI 10.4049/jimmunol.1400291; Kenneson A, 2007, REV MED VIROL, V17, P253, DOI 10.1002/rmv.535; Lurain NS, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-4; Lurain NS, 1999, J VIROL, V73, P10040, DOI 10.1128/JVI.73.12.10040-10050.1999; Luttichau HR, 2010, J BIOL CHEM, V285, P9137, DOI 10.1074/jbc.M109.002774; Mao ZQ, 2007, ARCH VIROL, V152, P115, DOI 10.1007/s00705-006-0826-8; Nijman J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108018; Oka N, 2015, J MED VIROL, V87, P1441, DOI 10.1002/jmv.24239; Paradowska E, 2012, EUR J CLIN MICROBIOL, V31, P1335, DOI 10.1007/s10096-011-1447-z; Paradowska E, 2015, J MED VIROL, V87, P1737, DOI 10.1002/jmv.24222; Paradowska E, 2014, VIROLOGY, V462, P207, DOI 10.1016/j.virol.2014.06.020; Pati SK, 2013, PEDIATR INFECT DIS J, V32, P1050, DOI 10.1097/INF.0b013e31829bb0b9; Penfold MET, 1999, P NATL ACAD SCI USA, V96, P9839, DOI 10.1073/pnas.96.17.9839; Picone O, 2005, J CLIN MICROBIOL, V43, P25, DOI 10.1128/JCM.43.1.25-29.2005; Pignatelli S, 2003, J GEN VIROL, V84, P647, DOI 10.1099/vir.0.18704-0; Poole E, 2008, J VIROL, V82, P4250, DOI 10.1128/JVI.02156-07; Puchhammer-Stockl E, 2006, J CLIN VIROL, V36, P239, DOI 10.1016/j.jcv.2006.03.004; Ross SA, 2011, J INFECT DIS, V204, P1003, DOI 10.1093/infdis/jir457; Schleiss Mark R, 2003, Herpes, V10, P4; SCHRAUFSTATTER IU, 1993, J IMMUNOL, V151, P6418; Sijmons S., 2015, J VIROL; STAGNO S, 1982, NEW ENGL J MED, V306, P945, DOI 10.1056/NEJM198204223061601; Stanton R, 2005, J MED VIROL, V75, P42, DOI 10.1002/jmv.20235; Strieter RM, 2005, CYTOKINE GROWTH F R, V16, P593, DOI 10.1016/j.cytogfr.2005.04.007; Walker A, 2001, J CLIN MICROBIOL, V39, P2219, DOI 10.1128/JCM.39.6.2219-2226.2001; Waters A, 2010, J CLIN MICROBIOL, V48, P3956, DOI 10.1128/JCM.01133-10; Yamamoto AY, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2009.11.018	50	4	6	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2017	12	2							e0171959	10.1371/journal.pone.0171959	http://dx.doi.org/10.1371/journal.pone.0171959			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5QV	28222150	Green Submitted, Green Published, gold			2022-12-27	WOS:000394676800024
J	Shah, M; Jaffery, M; Adams-Huet, B; Franklin, B; Oliver, J; Mitchell, J				Shah, Meena; Jaffery, Manall; Adams-Huet, Beverley; Franklin, Brian; Oliver, Jonathan; Mitchell, Joel			Effect of meal composition on postprandial lipid concentrations and lipoprotein particle numbers: A randomized cross-over study	PLOS ONE			English	Article							ISCHEMIC-HEART-DISEASE; MONOUNSATURATED FAT; REMNANT CHOLESTEROL; CARBOHYDRATE; METABOLISM; PROTEIN; RISK; DIETS; ATHEROSCLEROSIS; MANAGEMENT	Background It is unclear how high-protein (HP) and high-monounsaturated fat (HMF) meals affect postprandial blood lipids and lipoprotein particle numbers (LPN). Purpose To compare a HP versus a HMF meal on postprandial lipid and LPN responses. Methods Twenty-four participants (age: 36.3 +/- 15.0 years; body mass index: 23.6 +/- 2.0 kg/m(2); 45.8% female) were fed a HP (31.9% energy from protein) and a HMF (35.2% fat and 20.7% monounsaturated fat) meal in a randomized cross-over trial design. Energy and carbohydrate content were the same across meals. Blood samples were drawn in the fasting state and 3 hour postprandial state, and assessed for lipids and LPN. Results Repeated measures analysis showed a significant (p< 0.05) treatment by time interaction effect for triglycerides (TG), the primary variable, total high-density lipoprotein particles (T-HDLP) and T-HDLP minus large-buoyant high-density lipoprotein 2b (T-HDLP D LBHDL2b). HP versus HMF condition led to significantly lower TG at 120 (geometric mean: 90.1 (95% confidence interval (CI): 76.4 +/- 106.3) vs. 146.5 (124.2 +/- 172.9) mg/dL) and 180 (101.4 (83.1 +/- 123.8) vs. 148.7 (121.9 +/- 181.4) mg/dL) min and higher T-HDLP at 120 (mean difference: 297.3 (95% CI: 48.6 +/- 545.9) nmol/L) and 180 (291.6 (15.8 +/- 567.5) nmol/L) min. The difference in T-HDLP by condition was due to the significantly higher small-dense HDLP (T-HDLP D LB-HDL2b) during HP versus HMF condition at 120 (mean difference: 452.6 (95% CI: 177.4 +/- 727.9) nmol/L) and 180 (496.8 (263.1 +/- 730.6) nmol/L) min. Area under the curve analysis showed that HP versus HMF condition led to significantly lower TG, non-HDLP, and very-low-density lipoprotein particles (VLDLP) responses butsignificantly less favorable responses in LB-HDL2b particles, T-HDLP D LB-HDL2b, and LBHDL2b/T-HDLP ratio. Conclusion The HP meal led to lower TG, non-HDLP, and VLDLP but less favorable LB-HDL2b, smalldense HDLP, and LB-HDL2b/T-HDLP ratio responses versus a HMF meal. Further studies are needed to confirm these findings over multiple meals.	[Shah, Meena; Jaffery, Manall; Franklin, Brian; Oliver, Jonathan; Mitchell, Joel] Texas Christian Univ, Dept Kinesiol, Ft Worth, TX 76129 USA; [Adams-Huet, Beverley] Univ Texas Southwestern Med Ctr Dallas, Dept Clin Sci, Dallas, TX 75390 USA	Texas Christian University; University of Texas System; University of Texas Southwestern Medical Center Dallas	Shah, M (corresponding author), Texas Christian Univ, Dept Kinesiol, Ft Worth, TX 76129 USA.	m.shah@tcu.edu			TCU Research and Creative Activity Funds grant	TCU Research and Creative Activity Funds grant	This work was supported by TCU Research and Creative Activity Funds grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamska E, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/147196; Ajala O, 2013, AM J CLIN NUTR, V97, P505, DOI 10.3945/ajcn.112.042457; Appel LJ, 2005, JAMA-J AM MED ASSOC, V294, P2455, DOI 10.1001/jama.294.19.2455; Arakawa M, 2011, ENDOCR J, V58, P161, DOI 10.1507/endocrj.K10E-221; Ben-Shlomo S, 2011, J HEPATOL, V54, P1214, DOI 10.1016/j.jhep.2010.09.032; BILLEAUD C, 1990, EUR J CLIN NUTR, V44, P577; BLAIR SN, 1985, AM J EPIDEMIOL, V122, P794, DOI 10.1093/oxfordjournals.aje.a114163; Coulston A, 2008, NUTR PREVENTION TREA; Damasceno NRT, 2013, ATHEROSCLEROSIS, V230, P347, DOI 10.1016/j.atherosclerosis.2013.08.014; El Khoury D, 2013, CURR OPIN LIPIDOL, V24, P207, DOI 10.1097/MOL.0b013e3283613bb7; GARG A, 1988, METABOLISM, V37, P982, DOI 10.1016/0026-0495(88)90157-6; Garg A, 1998, AM J CLIN NUTR, V67, p577S, DOI 10.1093/ajcn/67.3.577S; GARG A, 1994, JAMA-J AM MED ASSOC, V271, P1421, DOI 10.1001/jama.271.18.1421; Gill JMR, 2003, AM J CLIN NUTR, V78, P47, DOI 10.1093/ajcn/78.1.47; Hodis HN, 1999, CIRCULATION, V99, P2852, DOI 10.1161/01.CIR.99.22.2852; Hoogeveen RC, 2014, ARTERIOSCL THROM VAS, V34, P1069, DOI 10.1161/ATVBAHA.114.303284; Institute of Medicine (U.S.). Subcommittee on Interpretation and Uses of Dietary Reference Intakes. Institute of Medicine (U.S.). Standing Committee on the Scientific Evaluation of Dietary Reference Intakes. and Institute of Medicine (U.S.), 2003, DIET REF INT APPL DI, Vxv; Jacome-Sosa M, 2016, ADV NUTR, V7, P364, DOI 10.3945/an.115.010397; Jansen S, 2000, AM J CLIN NUTR, V72, P36; Luscombe-Marsh ND, 2005, AM J CLIN NUTR, V81, P762, DOI 10.1093/ajcn/81.4.762; Minicocci I, 2016, J LIPID RES, V57, P1097, DOI 10.1194/jlr.P066183; Mortensen LS, 2009, AM J CLIN NUTR, V90, P41, DOI 10.3945/ajcn.2008.27281; Nakajima K, 2011, CLIN CHIM ACTA, V412, P1306, DOI 10.1016/j.cca.2011.04.018; Norata GD, 2007, ATHEROSCLEROSIS, V193, P321, DOI 10.1016/j.atherosclerosis.2006.09.015; Oliver JM, 2015, LIPIDS HEALTH DIS, V14, DOI 10.1186/s12944-015-0021-6; PATSCH JR, 1992, ARTERIOSCLER THROMB, V12, P1336, DOI 10.1161/01.ATV.12.11.1336; Scharnagl H, 2014, CIRCULATION, V129, pE654, DOI 10.1161/CIRCULATIONAHA.113.006433; Shah M, 2016, EUR J NUTR; Tay J, 2015, AM J CLIN NUTR, V102, P780, DOI 10.3945/ajcn.115.112581; Varbo A, 2014, PHARMACOL THERAPEUT, V141, P358, DOI 10.1016/j.pharmthera.2013.11.008; Voros S, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000344; Wang L, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.114.001355; Wolfe BMJ, 1999, CLIN INVEST MED, V22, P140	33	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2017	12	2							e0172732	10.1371/journal.pone.0172732	http://dx.doi.org/10.1371/journal.pone.0172732			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5QV	28222178	Green Published, Green Submitted, gold			2022-12-27	WOS:000394676800080
J	Teixeira, LB; Pilecco, FB; Vigo, A; Drachler, MD; Leite, JCD; Knauth, DR				Teixeira, Luciana Barcellos; Pilecco, Flavia Bulegon; Vigo, Alvaro; Drachler, Maria de Lourdes; de Carvalho Leite, Jose Carlos; Knauth, Daniela Riva			Factors associated with post-diagnosis pregnancies in women living with HIV in the south of Brazil	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; POSITIVE WOMEN; REPRODUCTIVE HEALTH; MEN; TRANSMISSION; INTENTIONS; DECISIONS; CHOICES; DESIRE; CARE	Objectives To analyze the factors associated with the occurrence of pregnancies after the diagnosis of infection by HIV. Methods Cross-sectional study with women of a reproductive age living with HIV/AIDS cared for in the public services of the city of Porto Alegre, in southern Brazil. The data was analyzed from a comparison between two groups: women with and women without pregnancies after the diagnosis of HIV. Poisson regression models were used to estimate the reasons of prevalence (RP). Results The occurrence of pregnancies after the diagnosis of HIV is associated with a lower level of education (RP adjusted = 1.31; IC95%: 1.03-1.66), non-use of condoms in the first sexual intercourse (RP = 1.32; IC95%: 1.02-1.70), being 20 years old or less when diagnosed with HIV (RP = 3.48; IC95%: 2.02-6.01), and experience of violence related to the diagnosis of HIV (RP = 1.28; IC95%: 1.06-1.56). Conclusions The occurrence of pregnancies after the diagnosis of infection by HIV does not indicate the exercise of the reproductive rights of the women living with HIV/AIDS because these pregnancies occurred in contexts of great vulnerability.	[Teixeira, Luciana Barcellos] Univ Fed Rio Grande do Sul, Sch Nursing, Dept Profess Assistance & Guidance, Porto Alegre, RS, Brazil; [Teixeira, Luciana Barcellos; Drachler, Maria de Lourdes] Univ Fed Rio Grande do Sul, Grad Studies Program Publ Hlth, Porto Alegre, RS, Brazil; [Pilecco, Flavia Bulegon; Knauth, Daniela Riva] Univ Fed Rio Grande do Sul, Dept Social Med, Porto Alegre, RS, Brazil; [Pilecco, Flavia Bulegon; Vigo, Alvaro; Knauth, Daniela Riva] Univ Fed Rio Grande do Sul, Grad Studies Program Epidemiol, Porto Alegre, RS, Brazil; [Vigo, Alvaro] Univ Fed Rio Grande do Sul, Dept Stat, Porto Alegre, RS, Brazil; [de Carvalho Leite, Jose Carlos] Univ Ctr UNILASALLE, Canoas, RS, Brazil; [Pilecco, Flavia Bulegon] Univ Fed Minas Gerais, Dept Prevent & Social Med, Belo Horizonte, MG, Brazil	Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul; Centro Universitario La Salle; Universidade Federal de Minas Gerais	Teixeira, LB (corresponding author), Univ Fed Rio Grande do Sul, Sch Nursing, Dept Profess Assistance & Guidance, Porto Alegre, RS, Brazil.; Teixeira, LB (corresponding author), Univ Fed Rio Grande do Sul, Grad Studies Program Publ Hlth, Porto Alegre, RS, Brazil.	luciana.bteixeira@gmail.com	Pilecco, Flávia/E-4221-2016; Vigo, Alvaro/S-2243-2019	Pilecco, Flávia/0000-0001-8316-8797; Vigo, Alvaro/0000-0002-5797-9470	National Scientific and Technological Development Council (CNPq) [14/2009 - Universal]	National Scientific and Technological Development Council (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The project that originated data analyzed in this paper was fully funded by National Scientific and Technological Development Council (CNPq) (Process MCT/CNPq number 14/2009 - Universal). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2020, HIGH POSS COST COVID; Aska ML, 2011, WORLD J AIDS, V1, P198, DOI [10.4236/wja.2011.14029, DOI 10.4236/WJA.2011.14029]; Barbosa RM, 2003, CAD SAUDE PUBLICA, V19, P365; Barnes DB, 2009, QUAL HEALTH RES, V19, P481, DOI 10.1177/1049732309332835; Bedimo AL, 1998, SOC SCI MED, V46, P171, DOI 10.1016/S0277-9536(97)00157-3; Berquo A E, 2008, REV SAUDE PUBL S1, V42, P34; CONNOR EM, 1994, NEW ENGL J MED, V331, P1173, DOI 10.1056/NEJM199411033311801; Cooper D, 2007, SOC SCI MED, V65, P274, DOI 10.1016/j.socscimed.2007.03.019; Craft SM, 2007, AIDS BEHAV, V11, P927, DOI 10.1007/s10461-007-9219-6; Feldman R, 2003, REPROD HEALTH MATTER, V11, P162, DOI 10.1016/S0968-8080(03)02284-5; Fiore S, 2008, HUM REPROD, V23, P2140, DOI 10.1093/humrep/den232; Heard I, 2007, AIDS, V21, pS77, DOI 10.1097/01.aids.0000255089.44297.6f; KLINE A, 1995, SOC SCI MED, V40, P1539, DOI 10.1016/0277-9536(94)00280-7; KNAUTH DR, 1999, SEXUALIDADES PELO AV, V34, P121; Gogna ML, 2009, SOC SCI MED, V69, P813, DOI 10.1016/j.socscimed.2009.06.002; Li Y, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18845; Lusti-Narasimhan M, 2007, REPROD HEALTH MATTER, V15, P1, DOI 10.1016/S0968-8080(07)29033-0; Marcellin F, 2010, AIDS CARE, V22, P441, DOI 10.1080/09540120903202913; Murphy JJ, 1998, FAM PLANN PERSPECT, V30, P276, DOI 10.2307/2991503; Newell M-L, 1997, AIDS S11, P1165; Njabanou NM, 2011, J INT ASS PHYS AIDS, V12, P98; Oladapo Olufemi T, 2005, J Natl Med Assoc, V97, P1672; Paiva V, 2007, AIDS PATIENT CARE ST, V21, P268, DOI 10.1089/apc.2006.0129; Peltzer K, 2009, AIDS BEHAV, V13, P973, DOI 10.1007/s10461-008-9365-5; Phillips Deborah Y, 2014, J Assoc Nurses AIDS Care, V25, pS36, DOI 10.1016/j.jana.2012.12.006; Pilecco FB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095570; Santos NJS, 2009, CAD SAUDE PUBLICA, V25, pS321, DOI 10.1590/S0102-311X2009001400014; Sowell RL, 2002, AIDS CARE, V14, P181, DOI 10.1080/09540120220104695; Steiner RJ, 2013, AM J PUBLIC HEALTH, V103, P1357, DOI 10.2105/AJPH.2013.301265; Teixeira Ana Maria Ferreira Borges, 2006, Cad. Saúde Pública, V22, P1385, DOI 10.1590/S0102-311X2006000700004; Teixeira LB, 2013, CAD SAUDE PUBLICA, V29, P609, DOI 10.1590/S0102-311X2013000300018; UNAIDS, 2011, GLOB HIV AIDS RESP E; Wade NA, 1998, NEW ENGL J MED, V339, P1409, DOI 10.1056/NEJM199811123392001	33	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2017	12	2							e0172514	10.1371/journal.pone.0172514	http://dx.doi.org/10.1371/journal.pone.0172514			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL5QV	28222175	Green Published, Green Submitted, gold			2022-12-27	WOS:000394676800062
J	Majid, MAA; Mahboob, T; Mong, BGJ; Jaturas, N; Richard, RL; Tian-Chye, T; Phimphila, A; Mahaphonh, P; Aye, KN; Aung, WL; Chuah, J; Ziegler, AD; Yasiri, A; Sawangjaroen, N; Lim, YAL; Nissapatorn, V				Majid, Mohamad Azlan Abdul; Mahboob, Tooba; Mong, Brandon G. J.; Jaturas, Narong; Richard, Reena Leeba; Tian-Chye, Tan; Phimphila, Anusorn; Mahaphonh, Panomphanh; Aye, Kyaw Nyein; Aung, Wai Lynn; Chuah, Joon; Ziegler, Alan D.; Yasiri, Atipat; Sawangjaroen, Nongyao; Lim, Yvonne A. L.; Nissapatorn, Veeranoot			Pathogenic waterborne free-living amoebae: An update from selected Southeast Asian countries	PLOS ONE			English	Article							INCREASING IMPORTANCE; HARTMANNELLA-VERMIFORMIS; BALAMUTHIA-MANDRILLARIS; ACANTHAMOEBA SPP.; NAEGLERIA SPP.; KERATITIS; IDENTIFICATION; MENINGOENCEPHALITIS; PREVALENCE; BIOLOGY	Data on the distribution of free-living amoebae is still lacking especially in Southeast Asian region. The aquatic environment revealed a high occurrence of free-living amoebae ( FLA) due to its suitable condition and availability of food source, which subsequently causes infection to humans. A total of 94 water samples consisted of both treated and untreated from Laos ( 31), Myanmar ( 42), and Singapore ( 21) were investigated for the presence of pathogenic FLA. Each water sample was filtered and cultured onto non-nutrient agar seeded with live suspension of Escherichia coli and incubated at room temperature. Morphological identification was conducted for both trophozoites and cysts via microscopic stains ( Giemsa and immunofluorescence). The presence of Naegleria-like structures was the most frequently encountered in both treated and untreated water samples, followed by Acanthamoeba-like and Vermamoeba-like features. To identify the pathogenic isolates, species-specific primer sets were applied for molecular identification of Acanthamoeba, Naegleria, and Vermamoeba. The pathogenic species of Acanthamoeba lenticulata and A. triangularis were detected from untreated water samples, while Vermamoeba vermiformis was found in both treated and untreated water samples. Our results suggested that poor water quality as well as inadequate maintenance and treatment might be the cause of this alarming problem since chlorine disinfection is ineffective in eradicating these amoebas in treated water samples. Regular monitoring and examination of water qualities are necessary in order to control the growth, hence, further preventing the widespread of FLA infections among the public.	[Majid, Mohamad Azlan Abdul; Mahboob, Tooba; Mong, Brandon G. J.; Jaturas, Narong; Richard, Reena Leeba; Tian-Chye, Tan; Lim, Yvonne A. L.; Nissapatorn, Veeranoot] Univ Malaya, Fac Med, Dept Parasitol, Southeast Asia Water Team, Kuala Lumpur, Malaysia; [Phimphila, Anusorn; Mahaphonh, Panomphanh] Univ Hlth Sci, Dept Lab Med, Fac Med Technol, Viangchan, Laos; [Aye, Kyaw Nyein; Aung, Wai Lynn] Adv Life & Regenerating Motherland ALARM, Ecol Lab, Yangon, Myanmar; [Chuah, Joon] Natl Univ Singapore, Inst Water Policy, Singapore, Singapore; [Ziegler, Alan D.] Natl Univ Singapore, Dept Geog, Singapore, Singapore; [Yasiri, Atipat] Thammasat Univ, Chulabhorn Int Coll Med, Pathum Thani, Thailand; [Sawangjaroen, Nongyao] Prince Songkla Univ, Fac Sci, Dept Microbiol, Hat Yai, Thailand	Universiti Malaya; National University of Singapore; National University of Singapore; Chulabhorn Research Institute; Thammasat University; Prince of Songkla University	Nissapatorn, V (corresponding author), Univ Malaya, Fac Med, Dept Parasitol, Southeast Asia Water Team, Kuala Lumpur, Malaysia.	veeranoot@um.edu.my	, dr dr/AAA-5406-2022; Sawangjaroen, Nongyao/AAV-9785-2021; Richard, Reena Leeba/Q-5022-2017; LIM, YVONNE AL/B-5276-2010; ZIEGLER, ALAN/A-5463-2012; Abd Majid, Mohamad Azlan/B-9177-2017; Chuah, Joon Huang/F-9990-2010; Mahboob, Tooba/AAZ-8938-2021	LIM, YVONNE AL/0000-0003-4050-6332; ZIEGLER, ALAN/0000-0001-5305-2136; Abd Majid, Mohamad Azlan/0000-0002-8262-2764; Chuah, Joon Huang/0000-0001-9058-3497; Mahboob, Tooba/0000-0001-6476-776X	University of Malaya [UM.C/625/1/HIR/MoHE/MED/23, UM. 0000041/HIR.C3, UMRG 544/14HTM, UMRG 362/15AFR]	University of Malaya(Universiti Malaya)	University of Malaya High Impact Research Grant (UM.C/625/1/HIR/MoHE/MED/23 and UM. 0000041/HIR.C3) and University of Malaya Research Grants (UMRG 544/14HTM and UMRG 362/15AFR), received by VN and TTC.	Ab Rahim, 2010, J SAINS KESIHATAN, V8, P15; Abedkhojasteh H, 2013, IRAN J PARASITOL, V8, P481; Aitken D, 1996, OPHTHALMOLOGY, V103, P485, DOI 10.1016/S0161-6420(96)30667-2; Barete S, 2007, EMERG INFECT DIS, V13, P736, DOI 10.3201/eid1305.061347; Brieland JK, 1997, INFECT IMMUN, V65, P5330, DOI 10.1128/IAI.65.12.5330-5333.1997; Buerano Corazon C, 2014, Trop Med Health, V42, P145, DOI 10.2149/tmh.2014-15; Bunjongpuk S., 2000, THAI J PED, V39, P38; Corsaro D, 2015, PARASITOL RES, V114, P2481, DOI 10.1007/s00436-015-4445-8; De Jonckheere JF, 2004, PROTIST, V155, P89, DOI 10.1078/1434461000167; De Jonckheere JF, 2002, ACTA PROTOZOOL, V41, P309; Dyakoya I, 2005, FOLIA PARASIT, V52, P295; Eikelboom DH, 2000, PROCESS CONTROL ACTI, P29; Ettinger MR, 2003, PARASITOL RES, V89, P6, DOI 10.1007/s00436-002-0707-3; Gartstecki T, 2005, EUR J PROTISTOL, V41, P119; Ghadar-ghadr Sh, 2012, J JAHROM U MED SCI, V10, P26; Ghani MKA, 2000, INT MED J IMJ, V7, P63; Greub G, 2004, CLIN MICROBIOL REV, V17, P413, DOI 10.1128/CMR.17.2.413-433.2004; Greub G, 2003, INFECT CONT HOSP EP, V24, P784, DOI 10.1086/502137; Harrington BJ, 2008, LABMEDICINE, V39, P231, DOI 10.1309/83G3PE2H1V2NY9FK; Herriman R., 2012, VIETNAM REPORTS 2 EV; Init I, 2010, TROP BIOMED, V27, P566; Intalapaporn P, 2004, AM J TROP MED HYG, V70, P666, DOI 10.4269/ajtmh.2004.70.666; Ithoi I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024327; Izumiyama S, 2003, J EUKARYOT MICROBIOL, V50, P514, DOI 10.1111/j.1550-7408.2003.tb00614.x; Jongwutiwes S, 2000, TROP MED INT HEALTH, V5, P335, DOI 10.1046/j.1365-3156.2000.00563.x; Kamel A G M, 2004, Trop Biomed, V21, P135; Kaushal V, 2008, J Assoc Physicians India, V56, P459; Khan NA, 2006, FEMS MICROBIOL REV, V30, P564, DOI 10.1111/j.1574-6976.2006.00023.x; Kilvington S, 2004, INVEST OPHTH VIS SCI, V45, P165, DOI 10.1167/iovs.03-0559; KYLE DE, 1986, J PROTOZOOL, V33, P422, DOI 10.1111/j.1550-7408.1986.tb05634.x; Lasjerdi Z, 2011, PARASITOL RES, V109, P575, DOI 10.1007/s00436-011-2288-5; Lorenzo-Morales J, 2007, PARASITOL RES, V102, P167, DOI 10.1007/s00436-007-0754-x; MA P, 1990, REV INFECT DIS, V12, P490; Marciano-Cabral F, 2003, CLIN MICROBIOL REV, V16, P273, DOI 10.1128/CMR.16.2.273-307.2003; Marciano-Cabral F, 2000, J EUKARYOT MICROBIOL, V47, P29, DOI 10.1111/j.1550-7408.2000.tb00007.x; MARCIANOCABRAL F, 1988, MICROBIOL REV, V52, P114, DOI 10.1128/MMBR.52.1.114-133.1988; Nacapunchai D, 2001, Southeast Asian J Trop Med Public Health, V32 Suppl 2, P179; Natividad Filipinas F., 2008, Southeast Asian Journal of Tropical Medicine and Public Health, V39, P991; Phu NH, 2013, LANCET, V381, P176, DOI 10.1016/S0140-6736(12)61730-9; Onichandran S, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-244; PAGE FC, 1967, J PROTOZOOL, V14, P499, DOI 10.1111/j.1550-7408.1967.tb02036.x; Page FC, 1988, FRESHWATER BIOL ASS; Patil P.N., 2012, INT J ENV SCI, V3, P1194, DOI DOI 10.6088/IJES.2012030133028; Pelandakis M, 2002, APPL ENVIRON MICROB, V68, P2061, DOI 10.1128/AEM.68.4.2061-2065.2002; Pelandakis M, 2000, J EUKARYOT MICROBIOL, V47, P116, DOI 10.1111/j.1550-7408.2000.tb00020.x; Por Y.M., 2009, AM J OPHTHALMOL, V148, P1879; Putri DE, 2014, J CASE REP, V4, P419; Qvarnstrom Y, 2013, J EUKARYOT MICROBIOL, V60, P626, DOI 10.1111/jeu.12069; Qvarnstrom Y, 2009, J INFECT DIS, V199, P1139, DOI 10.1086/597473; Reyes-Batlle M, 2015, NOVELTY BIOMED, V3, P189, DOI [10.22037/nbm.v3i4.10386, DOI 10.22037/NBM.V3I4.10386]; Richard RL, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13070641; Schroeder JM, 2001, J CLIN MICROBIOL, V39, P1903, DOI 10.1128/JCM.39.5.1903-1911.2001; Schuster FL, 2002, CLIN MICROBIOL REV, V15, P342, DOI 10.1128/CMR.15.3.342-354.2002; Schuster FL, 2004, INT J PARASITOL, V34, P1001, DOI 10.1016/j.ijpara.2004.06.004; Siripanth Chutatip, 2005, Journal of the Medical Association of Thailand, V88, P701; Sithinamsuwan P., 2001, INT MED J THAI, V17, P350; Smirnov Alexey V., 2004, Protistology, V3, P148; Solgi R, 2012, IRAN J PARASITOL, V7, P47; Szenasi Z, 1998, J MED MICROBIOL, V47, P5, DOI 10.1099/00222615-47-1-5; Teixeira LH, 2009, BRAZ J INFECT DIS, V13, P395, DOI 10.1590/S1413-86702009000600001; Thomas V, 2008, ENVIRON MICROBIOL, V10, P2728, DOI 10.1111/j.1462-2920.2008.01693.x; Tsvetkova N, 2004, PARASITOL RES, V92, P405, DOI 10.1007/s00436-003-1052-x; Valster RM, 2011, APPL ENVIRON MICROB, V77, P7321, DOI 10.1128/AEM.05575-11; Visvesvara GS, 2007, FEMS IMMUNOL MED MIC, V50, P1, DOI 10.1111/j.1574-695X.2007.00232.x; Xuan YH, 2008, KOREAN J PARASITOL, V46, P157, DOI 10.3347/kjp.2008.46.3.157	65	31	33	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2017	12	2							e0169448	10.1371/journal.pone.0169448	http://dx.doi.org/10.1371/journal.pone.0169448			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BI	28212409	Green Published, Green Submitted, gold			2022-12-27	WOS:000394424700001
J	Vriend, J; Liu, WJ; Reiter, RJ				Vriend, Jerry; Liu, Wenjun; Reiter, Russel J.			The pineal gland: A model for adrenergic modulation of ubiquitin ligases	PLOS ONE			English	Article							ARYLALKYLAMINE-N-ACETYLTRANSFERASE; THYROXINE 5'-DEIODINASE ACTIVITY; KAPPA-B ACTIVATION; PHOTONEUROENDOCRINE TRANSDUCTION; PROTEASOMAL DEGRADATION; DEUBIQUITINATING ENZYME; II 5'-DEIODINASE; DOMAIN PROTEINS; GENE-EXPRESSION; MELATONIN	Introduction A recent study of the pineal gland of the rat found that the expression of more than 3000 genes showed significant day/night variations (The Hartley dataset). The investigators of this report made available a supplemental table in which they tabulated the expression of many genes that they did not discuss, including those coding for components of the ubiquitin proteasome system. Herein we identify the genes of the ubiquitin proteasome system whose expression were significantly influenced by environmental lighting in the Hartley dataset, those that were stimulated by DBcAMP in pineal glands in culture, and those that were stimulated by norepinephrine. Purpose Using the Ubiquitin and Ubiquitin-like Conjugation Database (UUCA) we identified ubiquitin ligases and conjugases, and deubiquitinases in the Hartley dataset for the purpose of determining whether expression of genes of the ubiquitin proteasome pathway were significantly influenced by day/night variations and if these variations were regulated by autonomic innervation of the pineal gland from the superior cervical ganglia. Methods In the Hartley experiments pineal glands groups of rats sacrificed during the day and groups sacrificed during the night were examined for gene expression. Additional groups of rats had their superior cervical ganglia removed surgically or surgically decentralized and the pineal glands likewise examined for gene expression. Results The genes with at least a 2-fold day/night significant difference in expression included genes for 5 ubiquitin conjugating enzymes, genes for 58 ubiquitin E3 ligases and genes for 6 deubiquitinases. A 35-fold day/night difference was noted in the expression of the gene Sik1, which codes for a protein containing both an ubiquitin binding domain (UBD) and an ubiquitin-associated (UBA) domain. Most of the significant differences in these genes were prevented by surgical removal, or disconnection, of the superior cervical ganglia, and most were responsive, in vitro, to treatment with a cyclic AMP analog, and norepinephrine. All previously described 24-hour rhythms in the pineal require an intact sympathetic input from the superior cervical ganglia. Conclusions The Hartley dataset thus provides evidence that the pineal gland is a highly useful model for studying adrenergically dependent mechanisms regulating variations in ubiquitin ligases, ubiquitin conjugases, and deubiquitinases, mechanisms that may be physiologically relevant not only in the pineal gland, but in all adrenergically innervated tissue.	[Vriend, Jerry] Univ Manitoba, Dept Human Anat & Cell Sci, Max Rady Coll Med, Rady Fac Hlth Sci, Winnipeg, MB, Canada; [Liu, Wenjun] Univ Manitoba, Rady Fac Hlth Sci, Dept Pathol, Max Rady Coll Med, Winnipeg, MB, Canada; [Reiter, Russel J.] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA	University of Manitoba; University of Manitoba; University of Texas System; University of Texas Health San Antonio	Vriend, J (corresponding author), Univ Manitoba, Dept Human Anat & Cell Sci, Max Rady Coll Med, Rady Fac Hlth Sci, Winnipeg, MB, Canada.	Jerry.Vriend@umanitoba.ca		Vriend, Jerry/0000-0001-6435-755X				Alonso V, 2013, MOL ENDOCRINOL, V27, P558, DOI 10.1210/me.2012-1404; Aoki K, 1998, J BIOL CHEM, V273, P26698, DOI 10.1074/jbc.273.41.26698; Aram L, 2016, DEV CELL, V37, P15, DOI 10.1016/j.devcel.2016.02.025; Drigo RAE, 2011, INT J BIOCHEM CELL B, V43, P1432, DOI 10.1016/j.biocel.2011.05.016; Bailey MJ, 2009, J BIOL CHEM, V284, P7606, DOI 10.1074/jbc.M808394200; Cao-Ehlker X, 2013, J BIOL CHEM, V288, P7580, DOI 10.1074/jbc.M112.434803; Chen CY, 2000, GENE DEV, V14, P1236; Choi HH, 2011, ONCOGENE, V30, P4791, DOI 10.1038/onc.2011.192; Conroy J, 2014, EUR J HUM GENET, V22, P505, DOI 10.1038/ejhg.2013.173; Curcio-Morelli C, 2003, J CLIN INVEST, V112, P189, DOI 10.1172/JCI200318348; De Jong MC, 2015, AM J OPHTHALMOL, V160, P1116, DOI 10.1016/j.ajo.2015.09.009; Dentice M, 2005, NAT CELL BIOL, V7, P698, DOI 10.1038/ncb1272; Dhanoa BS, 2013, HUM GENOMICS, V7, DOI 10.1186/1479-7364-7-13; Eichel K, 2016, NAT CELL BIOL, V18, P303, DOI 10.1038/ncb3307; Ernst R, 2009, MOL CELL, V36, P28, DOI 10.1016/j.molcel.2009.09.016; Espinosa EJ, 2009, CELL, V137, P938, DOI 10.1016/j.cell.2009.03.043; Fischer T, 2003, P NATL ACAD SCI USA, V100, P8270, DOI 10.1073/pnas.1432965100; Flores AN, 2014, NAT REV UROL, V11, P499, DOI 10.1038/nrurol.2014.195; Flynn M, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-235; Gastel JA, 1998, SCIENCE, V279, P1358, DOI 10.1126/science.279.5355.1358; Ge F, 2010, J PROTEOME RES, V9, P5848, DOI 10.1021/pr100616g; Gereben B, 2008, ENDOCR REV, V29, P898, DOI 10.1210/er.2008-0019; Geyer R, 2003, MOL CELL, V12, P783, DOI 10.1016/S1097-2765(03)00341-1; Gu Y, 2016, P NATL ACAD SCI USA, V113, pE51, DOI 10.1073/pnas.1517041113; GUERRERO JM, 1990, P SOC EXP BIOL MED, V194, P327; GUERRERO JM, 1988, NEUROSCI LETT, V89, P229, DOI 10.1016/0304-3940(88)90386-2; GUERRERO JM, 1988, ENDOCRINOLOGY, V122, P236, DOI 10.1210/endo-122-1-236; Gulino A, 2012, VITAM HORM, V88, P211, DOI 10.1016/B978-0-12-394622-5.00009-2; Hardeland R, 2009, BIOFACTORS, V35, P183, DOI 10.1002/biof.23; Hartley SW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137548; Hartmann-Petersen R, 2004, SEMIN CELL DEV BIOL, V15, P247, DOI 10.1016/j.semcdb.2003.12.006; Hegde AN, 2010, LEARN MEMORY, V17, P314, DOI 10.1101/lm.1504010; Ho AK, 2010, J NEUROCHEM, V112, P321, DOI 10.1111/j.1471-4159.2009.06457.x; Hochrainer K, 2005, GENOMICS, V85, P153, DOI 10.1016/j.ygeno.2004.10.006; HOWES KA, 1994, INVEST OPHTH VIS SCI, V35, P342; Hu HB, 2013, NATURE, V494, P371, DOI 10.1038/nature11831; Huang H, 2013, CELL BIOCHEM BIOPHYS, V67, P55, DOI 10.1007/s12013-013-9628-2; Huang ZP, 2010, J PINEAL RES, V48, P290, DOI 10.1111/j.1600-079X.2010.00753.x; Hurley JH, 2006, BIOCHEM J, V399, P361, DOI 10.1042/BJ20061138; Jagannath A, 2013, CELL, V154, P1100, DOI 10.1016/j.cell.2013.08.004; Jurchott K, 2003, J BIOL CHEM, V278, P27988, DOI 10.1074/jbc.M212966200; Kanyo R, 2009, ENDOCRINOLOGY, V150, P4221, DOI 10.1210/en.2009-0275; Klein D C, 1970, Adv Biochem Psychopharmacol, V3, P241; Klein DC, 2007, J BIOL CHEM, V282, P4233, DOI 10.1074/jbc.R600036200; Klein DC, 2010, MOL CELL ENDOCRINOL, V314, P170, DOI 10.1016/j.mce.2009.07.010; Klein DC, 2003, J NEUROENDOCRINOL, V15, P370, DOI 10.1046/j.1365-2826.2003.01000.x; Klein DC, 2002, BIOCHEM SOC T, V30, P365, DOI 10.1042/bst0300365; Lehmann G, 2016, BIOCHEM BIOPH RES CO, V473, P80, DOI 10.1016/j.bbrc.2016.03.055; Lignitto L, 2011, NAT CELL BIOL, V13, P412, DOI 10.1038/ncb2209; Liu YF, 2012, CURR PROTEIN PEPT SC, V13, P436, DOI 10.2174/138920312802430608; Liu ZP, 2013, CELL BIOSCI, V3, DOI 10.1186/2045-3701-3-45; Lu A, 2013, J CELL BIOL, V203, P233, DOI 10.1083/jcb.201305158; Lu HJ, 2008, MOL CELL PROTEOMICS, V7, P2073, DOI 10.1074/mcp.M800064-MCP200; Lu Z, 2007, J CELL BIOL, V177, P1077, DOI 10.1083/jcb.200610060; Ludgate M, 2011, J ENDOCRINOL, V210, P3, DOI 10.1530/JOE-11-0159; Lutz M, 2006, FEBS LETT, V580, P3921, DOI 10.1016/j.febslet.2006.06.023; Lyabin DN, 2014, WIRES RNA, V5, P95, DOI 10.1002/wrna.1200; Madden MH, 2014, CANCER CAUSE CONTROL, V25, P25, DOI 10.1007/s10552-013-0305-y; Maerki S, 2009, J CELL BIOL, V187, P791, DOI 10.1083/jcb.200906117; Martin Y, 2015, ONCOGENE, V34, P1058, DOI 10.1038/onc.2014.38; Maurice P, 2010, EMBO J, V29, P3646, DOI 10.1038/emboj.2010.236; Metzig M, 2011, INT J CANCER, V129, P607, DOI 10.1002/ijc.26124; Meyer G, 2004, NEUROPHARMACOLOGY, V47, P724, DOI 10.1016/j.neuropharm.2004.06.023; Mittal R, 2009, EMBO REP, V10, P41, DOI 10.1038/embor.2008.240; Morris MR, 2011, ONCOGENE, V30, P1390, DOI 10.1038/onc.2010.525; MURPHREE AL, 1984, SCIENCE, V223, P1028, DOI 10.1126/science.6320372; Nie J, 2002, EMBO J, V21, P93, DOI 10.1093/emboj/21.1.93; Pierce NW, 2013, CELL, V153, P206, DOI 10.1016/j.cell.2013.02.024; REITER RJ, 1992, PROG BRAIN RES, V91, P315; Reiter RJ, 2014, BRAIN STRUCT FUNCT, V219, P1873, DOI 10.1007/s00429-014-0719-7; Revel FG, 2006, ENDOCRINOLOGY, V147, P4680, DOI 10.1210/en.2006-0606; Rondou P, 2008, J BIOL CHEM, V283, P11083, DOI 10.1074/jbc.M708473200; Roy A, 2013, FEBS LETT, V587, P3567, DOI 10.1016/j.febslet.2013.09.020; RUBIO A, 1991, BIOSCIENCE REP, V11, P111, DOI 10.1007/BF01119198; Sagar GDV, 2007, MOL CELL BIOL, V27, P4774, DOI 10.1128/MCB.00283-07; Sato T, 2015, ONCOGENE, V34, P1280, DOI 10.1038/onc.2014.68; Shibata M, 2012, BIOCHEM BIOPH RES CO, V423, P104, DOI 10.1016/j.bbrc.2012.05.090; Shitani M, 2012, TUMOR BIOL, V33, P1307, DOI 10.1007/s13277-012-0378-3; Silveira WA, 2014, J APPL PHYSIOL, V117, P11, DOI 10.1152/japplphysiol.01055.2013; Skieterska K, 2016, BIOCHEM SOC T, V44, P601, DOI 10.1042/BST20150281; Smaldone G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126808; Soucy Teresa A, 2010, Genes Cancer, V1, P708, DOI 10.1177/1947601910382898; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; Soutto M, 1998, INT J BIOCHEM CELL B, V30, P235, DOI 10.1016/S1357-2725(97)00116-7; Su CH, 2011, CANCER RES, V71, P884, DOI 10.1158/0008-5472.CAN-10-2518; Su V, 2009, CELL MOL LIFE SCI, V66, P2819, DOI 10.1007/s00018-009-0048-9; Taguchi K, 2011, GENES CELLS, V16, P123, DOI 10.1111/j.1365-2443.2010.01473.x; Tian H, 2012, CANCER LETT, V325, P26, DOI 10.1016/j.canlet.2012.06.007; van Wijk SJL, 2010, FASEB J, V24, P981, DOI 10.1096/fj.09-136259; Vanecek J, 1998, PHYSIOL REV, V78, P687, DOI 10.1152/physrev.1998.78.3.687; von Gall C, 2002, CELL TISSUE RES, V309, P151, DOI 10.1007/s00441-002-0581-4; Vriend J, 2016, BBA-REV CANCER, V1865, P176, DOI 10.1016/j.bbcan.2016.02.004; Vriend J, 2015, MOL CELL ENDOCRINOL, V401, P213, DOI 10.1016/j.mce.2014.12.013; Vriend J, 2014, CELL MOL LIFE SCI, V71, P3409, DOI 10.1007/s00018-014-1659-3; Walsh MC, 2015, IMMUNOL REV, V266, P72, DOI 10.1111/imr.12302; White EA, 2012, P NATL ACAD SCI USA, V109, pE260, DOI 10.1073/pnas.1116776109; Willars GB, 2006, SEMIN CELL DEV BIOL, V17, P363, DOI 10.1016/j.semcdb.2006.03.005; Winkle CC, 2016, J NEUROSCI, V36, P4940, DOI 10.1523/JNEUROSCI.3876-15.2016; Yang W, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4818; Yang YM, 2014, J BIOL RHYTHM, V29, P243, DOI 10.1177/0748730414544741; Yang YM, 2012, BIOL OPEN, V1, P789, DOI 10.1242/bio.20121990; Yasuo S, 2007, ENDOCRINOLOGY, V148, P4385, DOI 10.1210/en.2007-0497; Yu P, 2002, GENOMICS, V79, P869, DOI 10.1006/geno.2002.6770; Zavacki AM, 2009, MOL CELL BIOL, V29, P5339, DOI 10.1128/MCB.01498-08; Zhang XF, 2013, EMBO J, V32, P996, DOI 10.1038/emboj.2013.38; Zhang XF, 2013, CELL RES, V23, P366, DOI 10.1038/cr.2013.21; Zhang Z, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.599605; Zhu X, 1998, Mol Vis, V4, P13; Zhuo XL, 2015, J CELL BIOL, V210, P727, DOI 10.1083/jcb.201502044	109	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2017	12	2							e0172441	10.1371/journal.pone.0172441	http://dx.doi.org/10.1371/journal.pone.0172441			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BI	28212404	Green Published, Green Submitted, gold			2022-12-27	WOS:000394424700052
J	AlBadri, A; Wei, J; Mehta, PK; Landes, S; Petersen, JW; Anderson, RD; Samuels, B; Azarbal, B; Handberg, EM; Li, QL; Minissian, M; Shufelt, C; Pepine, CJ; Merz, CNB				AlBadri, Ahmed; Wei, Janet; Mehta, Puja K.; Landes, Sofy; Petersen, John W.; Anderson, R. David; Samuels, Bruce; Azarbal, Babak; Handberg, Eileen M.; Li, Quanlin; Minissian, Margo; Shufelt, Chrisandra; Pepine, Carl J.; Merz, C. Noel Bairey			Acetylcholine versus cold pressor testing for evaluation of coronary endothelial function	PLOS ONE			English	Article							ISCHEMIA SYNDROME EVALUATION; SYMPATHETIC-STIMULATION; CARDIOVASCULAR EVENTS; MYOCARDIAL-PERFUSION; PROGNOSTIC VALUE; ARTERY-DISEASE; HEART-DISEASE; SYNDROME-X; DYSFUNCTION; REACTIVITY	Background Assessment of coronary endothelial function with intracoronary acetylcholine (IC-Ach) provides diagnostic and prognostic data in patients with suspected coronary microvascular dysfunction (CMD), but is often not feasible due in part to the time and expertise needed for pharmacologic mixing. Cold pressor testing (CPT) is a simple and safe stimulus useful for either invasive or non-invasive endothelial function testing and myocardial perfusion imaging but has not been specifically evaluated among symptomatic women with signs of ischemic heart disease (IHD) who have no obstructive coronary artery disease (CAD). Methods 163 women with signs and symptoms of IHD and no obstructive CAD from the NHLBI-Women's lschemia Syndrome Evaluation-Coronary Vascular Dysfunction (WISE-CVD) study underwent coronary reactivity testing with a Doppler flow wire (FloWire (R) Volcano, San Diego, CA) in the proximal left anterior descending artery. Coronary artery diameter and coronary blood flow (CBF) assessed by core lab using QCA before and after IC-Ach (18.2 mu g/ml infused over 3 minutes) and during CPT. Results Mean age was 55 12 years. Rate pressure product (RPP) in response to IC-Ach did not change (baseline to peak, P = 0.26), but increased during CPT (363 +/- 1457; P = 0.0028). CBF in response to CPT was poorly correlated to IC-Ach CBF. Change in coronary artery diameter after IC-Ach correlated with change after CPT (r= 0.59, P<0.001). The correlation coefficient was stronger in subjects with coronary dilation to IC-Ach (r = 0.628, P<0.001) versus those without dilation (r = 0.353, P = 0.002), suggesting that other factors may be important to this relationship when endothelium is abnormal. Conclusions In women with no obstructive CAD and suspected CMD, coronary diameter changes with IC-Ach and CPT are moderately-well correlated suggesting that CPT testing may be of some use, particularly among patients with normal endothelial function, however, not an alternative to IC-Ach for diagnosis of coronary endothelial dysfunction.	[AlBadri, Ahmed; Wei, Janet; Mehta, Puja K.; Landes, Sofy; Samuels, Bruce; Azarbal, Babak; Minissian, Margo; Shufelt, Chrisandra; Merz, C. Noel Bairey] Cedars Sinai Heart Inst, Los Angeles, CA USA; [Petersen, John W.; Anderson, R. David; Handberg, Eileen M.; Pepine, Carl J.] Univ Florida, Coll Med, Div Cardiovasc Med, Gainesville, FL USA; [Li, Quanlin] Cedars Sinai Med Ctr, Biostat & Bioinformat Res Ctr, Los Angeles, CA 90048 USA	Cedars Sinai Medical Center; State University System of Florida; University of Florida; Cedars Sinai Medical Center	Merz, CNB (corresponding author), Cedars Sinai Heart Inst, Los Angeles, CA USA.	Noel.BaireyMerz@cshs.org		Anderson, R. David/0000-0003-3490-3286; Petersen, John/0000-0003-0401-5421; Pepine, Carl/0000-0002-6011-681X; Shufelt, Chrisandra/0000-0001-6886-9210; Handberg, Eileen/0000-0002-7805-9577	National Heart, Lung and Blood Institutes [N01-HV-68161, N01-HV-68162, N01-HV68163, N01-HV-68164]; National Institute on Aging [U0164829, U01 HL649141, U01 HL649241, K23HL105787, T32HL69751, R01 HL090957, 1R03AG032631]; National Center for Research Resources [M01-RR00425]; National Center for Advancing Translational Sciences [UL1TR000124, UL1TR000064]; Gustavus and Louis Pfeiffer Research Foundation, Danville, NJ; Women's Guild of Cedars-Sinai Medical Center, Los Angeles, CA; Ladies Hospital Aid Society of Western Pennsylvania, Pittsburgh, PA; QMED, Inc., Laurence Harbor, NJ; Edythe L. Broad; Constance Austin Women's Heart Research Fellowships, Cedars-Sinai Medical Center, Los Angeles, California; Barbra Streisand Women's Cardiovascular Research and Education Program, Cedars-Sinai Medical Center, Los Angeles; Society for Women's Health Research (SWHR), Washington, D.C.; Linda Joy Pollin Women's Heart Health Program; Erika Glazer Women's Heart Health Project, Cedars-Sinai Medical Center, Los Angeles, California; QMED	National Heart, Lung and Blood Institutes(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Gustavus and Louis Pfeiffer Research Foundation, Danville, NJ; Women's Guild of Cedars-Sinai Medical Center, Los Angeles, CA; Ladies Hospital Aid Society of Western Pennsylvania, Pittsburgh, PA; QMED, Inc., Laurence Harbor, NJ; Edythe L. Broad; Constance Austin Women's Heart Research Fellowships, Cedars-Sinai Medical Center, Los Angeles, California; Barbra Streisand Women's Cardiovascular Research and Education Program, Cedars-Sinai Medical Center, Los Angeles; Society for Women's Health Research (SWHR), Washington, D.C.; Linda Joy Pollin Women's Heart Health Program; Erika Glazer Women's Heart Health Project, Cedars-Sinai Medical Center, Los Angeles, California; QMED	This work was supported by contracts from the National Heart, Lung and Blood Institutes nos. N01-HV-68161, N01-HV-68162, N01-HV68163, N01-HV-68164, grants U0164829, U01 HL649141, U01 HL649241, K23HL105787, T32HL69751, R01 HL090957, 1R03AG032631 from the National Institute on Aging, GCRC grant M01-RR00425 from the National Center for Research Resources, the National Center for Advancing Translational Sciences Grant UL1TR000124 and UL1TR000064, and grants from the Gustavus and Louis Pfeiffer Research Foundation, Danville, NJ, The Women's Guild of Cedars-Sinai Medical Center, Los Angeles, CA, The Ladies Hospital Aid Society of Western Pennsylvania, Pittsburgh, PA, and QMED, Inc., Laurence Harbor, NJ, the Edythe L. Broad and the Constance Austin Women's Heart Research Fellowships, Cedars-Sinai Medical Center, Los Angeles, California, the Barbra Streisand Women's Cardiovascular Research and Education Program, Cedars-Sinai Medical Center, Los Angeles, The Society for Women's Health Research (SWHR), Washington, D.C., The Linda Joy Pollin Women's Heart Health Program, and the Erika Glazer Women's Heart Health Project, Cedars-Sinai Medical Center, Los Angeles, California. Dr. Pepine received funding from QMED as donated Holter monitoring equipment for the WISE study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Suwaidi J, 2000, CIRCULATION, V101, P948, DOI 10.1161/01.CIR.101.9.948; Bottcher M, 1999, CIRCULATION, V99, P1795; Chan NN, 2001, J AM COLL CARDIOL, V38, P1814, DOI 10.1016/S0735-1097(01)01669-2; DOUCETTE JW, 1992, CIRCULATION, V85, P1899, DOI 10.1161/01.CIR.85.5.1899; GREENE MA, 1965, AM J CARDIOL, V16, P54, DOI 10.1016/0002-9149(65)90007-X; Halcox JPJ, 2002, CIRCULATION, V106, P653, DOI 10.1161/01.CIR.0000025404.78001.D8; HARRISON DG, 1993, CIRCULATION, V87, P1461, DOI 10.1161/01.CIR.87.5.1461; Hasdai D, 1997, CIRCULATION, V96, P3390; Kawano Hiroaki, 2004, Curr Drug Targets Cardiovasc Haematol Disord, V4, P23, DOI 10.2174/1568006043481301; MONTORSI P, 1991, AM J CARDIOL, V68, P1698, DOI 10.1016/0002-9149(91)90332-F; MUDGE GH, 1976, NEW ENGL J MED, V295, P1333, DOI 10.1056/NEJM197612092952401; NABEL EG, 1988, CIRCULATION, V77, P43, DOI 10.1161/01.CIR.77.1.43; NEILL WA, 1974, AM J MED, V56, P471, DOI 10.1016/0002-9343(74)90478-1; Nitenberg A, 2005, ATHEROSCLEROSIS, V183, P113, DOI 10.1016/j.atherosclerosis.2005.02.030; Pepine CJ, 2010, J AM COLL CARDIOL, V55, P2825, DOI 10.1016/j.jacc.2010.01.054; RAIZNER AE, 1980, CIRCULATION, V62, P925, DOI 10.1161/01.CIR.62.5.925; Reriani M, 2016, CORONARY ARTERY DIS, V27, P213, DOI 10.1097/MCA.0000000000000347; SAAB PG, 1993, PSYCHOPHYSIOLOGY, V30, P366, DOI 10.1111/j.1469-8986.1993.tb02058.x; Schindler TH, 2005, J AM COLL CARDIOL, V45, P1505, DOI 10.1016/j.jacc.2005.01.040; Schindler TH, 2003, ARTERIOSCL THROM VAS, V23, P495, DOI 10.1161/01.ATV.0000057571.03012.F4; Shaw LJ, 2006, CIRCULATION, V114, P894, DOI 10.1161/CIRCULATIONAHA.105.609990; VICTOR RG, 1987, HYPERTENSION, V9, P429, DOI 10.1161/01.HYP.9.5.429; VOUDOUKIS IJ, 1971, ANGIOLOGY, V22, P57, DOI 10.1177/000331977102200201; Wei J, 2012, JACC-CARDIOVASC INTE, V5, P646, DOI 10.1016/j.jcin.2012.01.023; WERNS SW, 1989, CIRCULATION, V79, P287, DOI 10.1161/01.CIR.79.2.287; ZEIHER AM, 1991, CIRCULATION, V83, P391, DOI 10.1161/01.CIR.83.2.391	26	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0172538	10.1371/journal.pone.0172538	http://dx.doi.org/10.1371/journal.pone.0172538			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207868	Green Published, Green Submitted, gold			2022-12-27	WOS:000394424500144
J	Osadchii, OE				Osadchii, Oleg E.			Effects of Na+ channel blockers on the restitution of refractory period, conduction time, and excitation wavelength in perfused guinea-pig heart	PLOS ONE			English	Article							ACTION-POTENTIAL DURATION; ANTIARRHYTHMIC DRUG-THERAPY; USE-DEPENDENT BLOCK; VENTRICULAR-FIBRILLATION; SODIUM-CHANNELS; ELECTRICAL RESTITUTION; CARDIAC-ARRHYTHMIAS; LIDOCAINE; QUINIDINE; REENTRANT	Na+ channel blockers flecainide and quinidine can increase propensity to ventricular tachyarrhythmia, whereas lidocaine and mexiletine are recognized as safe antiarrhythmics. Clinically, ventricular fibrillation is often precipitated by transient tachycardia that reduces action potential duration, suggesting that a critical shortening of the excitation wavelength (EW) may contribute to the arrhythmic substrate. This study examined whether different I-Na blockers can produce contrasting effects on the rate adaptation of the EW, which would explain the difference in their safety profile. In perfused guinea-pig hearts, effective refractory periods (ERP), conduction times, and EW values were determined over a wide range of cardiac pacing intervals. All INa blockers tested were found to flatten the slope of ERP restitution, indicating antiarrhythmic tendency. However, with flecainide and quinidine, the beneficial changes in ERP were reversed owing to the use-dependent conduction slowing, thereby leading to significantly steepened restitution of the EW. In contrast, lidocaine and mexiletine had no effect on ventricular conduction, and therefore reduced the slope of the EW restitution, as expected from their effect on ERP. These findings suggest that the slope of the EW restitution is an important electrophysiological determinant which can discriminate INa blockers with proarrhythmic and antiarrhythmic profile.	[Osadchii, Oleg E.] Univ Copenhagen, Dept Biomed Sci, Copenhagen, Denmark; [Osadchii, Oleg E.] Aalborg Univ, Dept Hlth Sci & Technol, Aalborg, Denmark	University of Copenhagen; Aalborg University	Osadchii, OE (corresponding author), Univ Copenhagen, Dept Biomed Sci, Copenhagen, Denmark.; Osadchii, OE (corresponding author), Aalborg Univ, Dept Hlth Sci & Technol, Aalborg, Denmark.	osadchiy@hst.aau.dk	Osadchii, Oleg/P-3786-2017		Department of Health Science and Technology, University of Aalborg	Department of Health Science and Technology, University of Aalborg	This work was supported by the Department of Health Science and Technology, University of Aalborg. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The author appreciates financial support from the Department of Health Science and Technology, University of Aalborg.	ANASTASIOUNANA MI, 1987, AM HEART J, V113, P1071, DOI 10.1016/0002-8703(87)90914-8; [Anonymous], 1989, NEW ENGL J MED, V321, P406; Benton RE, 2000, CLIN PHARMACOL THER, V67, P413, DOI 10.1067/mcp.2000.105761; BIGGER JT, 1970, J PHARMACOL EXP THER, V172, P239; CAMPBELL TJ, 1983, CARDIOVASC RES, V17, P251, DOI 10.1093/cvr/17.5.251; Chernyak YB, 1999, CRIT REV BIOMED ENG, V27, P359; Cherry EM, 2004, AM J PHYSIOL-HEART C, V286, pH2332, DOI 10.1152/ajpheart.00747.2003; Chudin E, 1999, BIOPHYS J, V77, P2930, DOI 10.1016/S0006-3495(99)77126-2; Clusin WT, 2003, CRIT REV CL LAB SCI, V40, P337, DOI 10.1080/713609356; COLLINSWORTH KA, 1974, CIRCULATION, V50, P1217, DOI 10.1161/01.CIR.50.6.1217; CONARD GJ, 1984, AM J CARDIOL, V53, pB41, DOI 10.1016/0002-9149(84)90501-0; COPLEN SE, 1990, CIRCULATION, V82, P1106, DOI 10.1161/01.CIR.82.4.1106; COURTNEY KR, 1981, EUR J PHARMACOL, V74, P9, DOI 10.1016/0014-2999(81)90317-4; FLAKER GC, 1992, J AM COLL CARDIOL, V20, P527, DOI 10.1016/0735-1097(92)90003-6; FOLLMER CH, 1992, CARDIOVASC RES, V26, P1121, DOI 10.1093/cvr/26.11.1121; Franz MR, 1999, CARDIOVASC RES, V41, P25, DOI 10.1016/S0008-6363(98)00268-5; Frommeyer G, 2016, NAT REV CARDIOL, V13, P36, DOI 10.1038/nrcardio.2015.110; FURUKAWA T, 1989, AM HEART J, V118, P702, DOI 10.1016/0002-8703(89)90582-6; Girouard SD, 2001, J CARDIOVASC ELECTR, V12, P697, DOI 10.1046/j.1540-8167.2001.00697.x; Girouard SD, 1996, CIRCULATION, V93, P603, DOI 10.1161/01.CIR.93.3.603; Glaaser IW, 2006, HANDB EXP PHARMACOL, V171, P99; Goldhaber JI, 2005, CIRC RES, V96, P459, DOI 10.1161/01.RES.0000156891.66893.83; GRANT AO, 1980, CIRC RES, V47, P542, DOI 10.1161/01.RES.47.4.542; Harada M, 2011, AM J PHYSIOL-HEART C, V300, pH565, DOI 10.1152/ajpheart.00209.2010; Hondeghem LM, 2010, N-S ARCH PHARMACOL, V382, P367, DOI 10.1007/s00210-010-0549-y; HONDEGHEM LM, 1988, BRIT J PHARMACOL, V93, P311, DOI 10.1111/j.1476-5381.1988.tb11436.x; Kalb SS, 2004, J CARDIOVASC ELECTR, V15, P698, DOI 10.1046/j.1540-8167.2004.03550.x; KARAGOUNIS LA, 1995, AM HEART J, V129, P343, DOI 10.1016/0002-8703(95)90017-9; KATES RE, 1978, CLIN PHARMACOL THER, V23, P30; Kim YH, 1999, CIRCULATION, V100, P666, DOI 10.1161/01.CIR.100.6.666; Kirchhof PF, 1998, CIRCULATION, V97, P2567, DOI 10.1161/01.CIR.97.25.2567; KUS T, 1990, J AM COLL CARDIOL, V16, P1229, DOI 10.1016/0735-1097(90)90558-7; Marti-Carvajal A.J., 2015, COCHRANE DB SYST REV, V8; Matthews GDK, 2013, J PHYSIOL-LONDON, V591, P4167, DOI 10.1113/jphysiol.2013.254938; MCDONALD TV, 1989, BIOPHYS J, V55, P1261, DOI 10.1016/S0006-3495(89)82921-2; MILNER PG, 1985, AM J CARDIOL, V56, P588, DOI 10.1016/0002-9149(85)91016-1; Minami T, 2004, PACE, V27, P212, DOI 10.1111/j.1540-8159.2004.00412.x; Morita N, 2011, J AM COLL CARDIOL, V57, P366, DOI 10.1016/j.jacc.2010.07.045; Osadchii O, 2007, PHARMACOL RES, V55, P287, DOI 10.1016/j.phrs.2006.12.005; Osadchii OE, 2014, SCAND CARDIOVASC J, V48, P357, DOI 10.3109/14017431.2014.976256; Osadchii OE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105599; Osadchii OE, 2014, FUND CLIN PHARMACOL, V28, P382, DOI 10.1111/fcp.12046; Osadchii OE, 2014, J CARDIOVASC PHARM, V63, P240, DOI 10.1097/FJC.0000000000000041; Osadchii OE, 2013, CAN J PHYSIOL PHARM, V91, P306, DOI 10.1139/cjpp-2012-0379; Osadchii OE, 2012, J CARDIOVASC PHARM, V60, P456, DOI 10.1097/FJC.0b013e31826b86cf; Osadchii OE, 2012, EXP PHYSIOL, V97, P807, DOI 10.1113/expphysiol.2012.065219; Osadchii OE, 2010, AM J PHYSIOL-HEART C, V298, pH210, DOI 10.1152/ajpheart.00695.2009; PANIDIS IP, 1983, J AM COLL CARDIOL, V2, P798, DOI 10.1016/S0735-1097(83)80225-3; Paul AA, 2002, BRIT J PHARMACOL, V136, P717, DOI 10.1038/sj.bjp.0704784; PENTIKAINEN PJ, 1983, EUR J CLIN PHARMACOL, V25, P773, DOI 10.1007/BF00542518; RENSMA PL, 1988, CIRC RES, V62, P395, DOI 10.1161/01.RES.62.2.395; Roden DM, 2006, HANDB EXP PHARMACOL, V171, P73; ROSEN KM, 1970, AM J CARDIOL, V25, P1, DOI 10.1016/0002-9149(70)90807-6; ROUTLEDGE PA, 1980, CLIN PHARMACOL THER, V27, P347, DOI 10.1038/clpt.1980.46; SMEETS JLRM, 1986, CIRC RES, V58, P96, DOI 10.1161/01.RES.58.1.96; Soltysinska E, 2011, PFLUG ARCH EUR J PHY, V462, P529, DOI 10.1007/s00424-011-1005-7; SUNAMI A, 1993, BRIT J PHARMACOL, V110, P183, DOI 10.1111/j.1476-5381.1993.tb13790.x; TAMARGO J, 1992, EUR HEART J, V13, P2, DOI 10.1093/eurheartj/13.suppl_F.2; VARRO A, 1986, J CARDIOVASC PHARM, V8, P178, DOI 10.1097/00005344-198601000-00026; VARRO A, 1985, J CARDIOVASC PHARM, V7, P482, DOI 10.1097/00005344-198505000-00011; Weiss JN, 2005, CIRCULATION, V112, P1232, DOI 10.1161/CIRCULATIONAHA.104.529545; Weiss JN, 1999, CIRCULATION, V99, P2819, DOI 10.1161/01.CIR.99.21.2819; WOOSLEY RL, 1984, AM HEART J, V107, P1058, DOI 10.1016/0002-8703(84)90175-3; Wyman MG, 2004, AM J CARDIOL, V94, P545, DOI 10.1016/j.amjcard.2004.05.014	64	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2017	12	2							e0172683	10.1371/journal.pone.0172683	http://dx.doi.org/10.1371/journal.pone.0172683			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5SX	28231318	Green Published, gold, Green Submitted			2022-12-27	WOS:000394682400070
J	Savini, G; Hoffer, KJ; Barboni, P; Balducci, N; Schiano-Lomoriello, D; Ducoli, P				Savini, Giacomo; Hoffer, Kenneth J.; Barboni, Piero; Balducci, Nicole; Schiano-Lomoriello, Domenico; Ducoli, Pietro			Accuracy of optical biometry combined with Placido disc corneal topography for intraocular lens power calculation	PLOS ONE			English	Article							PARTIAL-COHERENCE INTERFEROMETRY; CATARACT-SURGERY; IMMERSION ULTRASOUND; REFRACTIVE OUTCOMES; CALCULATION FORMULAS; SCHEIMPFLUG CAMERA; UNOPERATED EYES; HOFFER-Q; IOLMASTER; PREDICTION	Purpose To investigate the accuracy of a new optical biometer for intraocular lens (IOL) power calculation in eyes undergoing cataract surgery. Methods Consecutive eyes of patients undergoing cataract surgery with the same IOL model were enrolled in a prospective cohort study. Axial length (AL) and corneal power were measured with an optical biometer based on optical low-coherence interferometry and Placido-disc corneal topography. IOL power was calculated with the Hoffer Q, Holladay 1 and SRK/T formulas. For each formula the lens constant was optimized in retrospect in order to achieve a mean prediction error (PE) of zero (difference between the predicted and the postoperative refraction). Median absolute error (MedAE) and percentage of eyes with PE +/- 0.50 D were calculated. Results Seventy-four eyes of 74 cataract patients were enrolled. The MedAE was 0.25 D with all formulas. A PE within +/- 0.50 D was obtained in 89.04% of cases with the Hoffer Q and SRK/T formulas, and in 87.67% of cases with the Holladay 1 formula. Conclusions The optical biometer investigated in the present study provides accurate measurements for IOL power calculation.	[Savini, Giacomo; Schiano-Lomoriello, Domenico; Ducoli, Pietro] Fdn GB Bietti IRCCS, Rome, Italy; [Hoffer, Kenneth J.] Univ Calif Los Angeles, Stein Eye Inst, Los Angeles, CA USA; [Hoffer, Kenneth J.] St Marys Eye Ctr, Santa Monica, CA USA; [Barboni, Piero; Balducci, Nicole] Studio Oculist Azeglio, Bologna, Italy; [Barboni, Piero] Ist Sci San Raffaele, Milan, Italy	IRCCS - Fondazione "G.B. Bietti" per lo Studio e la Ricerca in Oftalmologia; University of California System; University of California Los Angeles; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Savini, G (corresponding author), Fdn GB Bietti IRCCS, Rome, Italy.	giacomo.savini@alice.it	Savini, Giacomo/J-9196-2018; Barboni, Piero/AAA-9936-2020; Hoffer, Kenneth J/P-6431-2019	Savini, Giacomo/0000-0003-0075-3582; Barboni, Piero/0000-0002-0118-4177; 	Italian Ministry of Healthand Fondazione Roma	Italian Ministry of Healthand Fondazione Roma(Fondazione Roma)	The contribution of GB Bietti Foundation IRCCS was supported by the Italian Ministry of Healthand Fondazione Roma.	Aristodemou P, 2011, J CATARACT REFR SURG, V37, P63, DOI 10.1016/j.jcrs.2010.07.032; Cooke DL, 2016, J CATARACT REFR SURG, V42, P1157, DOI 10.1016/j.jcrs.2016.06.029; Findl O, 2001, J CATARACT REFR SURG, V27, P861, DOI 10.1016/S0886-3350(00)00699-4; Gale RP, 2009, EYE, V23, P149, DOI 10.1038/sj.eye.6702954; Hoffer KJ, 2016, J CATARACT REFR SURG, V42, P62, DOI 10.1016/j.jcrs.2015.07.041; Hoffer KJ, 2015, AM J OPHTHALMOL, V160, P403, DOI 10.1016/j.ajo.2015.05.029; Hoffer KJ, 2010, J CATARACT REFR SURG, V36, P644, DOI 10.1016/j.jcrs.2009.11.007; Hoffer KJ, 2000, J CATARACT REFR SURG, V26, P1233, DOI 10.1016/S0886-3350(00)00376-X; HOFFER KJ, 1993, J CATARACT REFR SURG, V19, P700, DOI 10.1016/S0886-3350(13)80338-0; Hoffmann PC, 2013, J CATARACT REFR SURG, V39, P867, DOI 10.1016/j.jcrs.2012.12.037; HOLLADAY JT, 1988, J CATARACT REFR SURG, V14, P17, DOI 10.1016/S0886-3350(88)80059-2; Huang JH, 2015, J CATARACT REFR SURG, V41, P2233, DOI 10.1016/j.jcrs.2015.10.062; Kaswin G, 2014, J CATARACT REFR SURG, V40, P593, DOI 10.1016/j.jcrs.2013.09.015; Kaya F, 2015, J FR OPHTALMOL, V38, P717, DOI 10.1016/j.jfo.2015.03.006; Kiss B, 2002, J CATARACT REFR SURG, V28, P230, DOI 10.1016/S0886-3350(01)01274-3; Landers J, 2009, CLIN EXP OPHTHALMOL, V37, P566, DOI 10.1111/j.1442-9071.2009.02091.x; Lyle WA, 1996, J CATARACT REFR SURG, V22, P1456; Mandal P, 2014, BRIT J OPHTHALMOL, V98, P256, DOI 10.1136/bjophthalmol-2013-304002; Masket S, 1996, J CATARACT REFR SURG, V22, P1451, DOI 10.1016/S0886-3350(96)80146-5; Mattioli R, 1997, OPTOMETRY VISION SCI, V74, P881, DOI 10.1097/00006324-199711000-00021; Narvaez J, 2008, OPHTHAL SURG LAS IM, V39, P30, DOI 10.3928/15428877-20080101-08; Nejima R, 2006, OPHTHALMOLOGY, V113, P585, DOI 10.1016/j.ophtha.2005.10.064; Nemeth G, 2012, GRAEF ARCH CLIN EXP, V250, P1321, DOI 10.1007/s00417-012-2013-9; Olsen T, 2007, ACTA OPHTHALMOL SCAN, V85, P84, DOI 10.1111/j.1600-0420.2006.00774.x; Olsen T, 2011, OPHTHALMOLOGY, V118, P1710, DOI 10.1016/j.ophtha.2011.04.030; Reitblat O, 2015, CLIN EXP OPHTHALMOL, V43, P328, DOI 10.1111/ceo.12478; RETZLAFF JA, 1990, J CATARACT REFR SURG, V16, P333, DOI 10.1016/S0886-3350(13)80705-5; Savini G, 2015, J CATARACT REFR SURG, V41, P785, DOI 10.1016/j.jcrs.2014.07.035; Savini G, 2014, J CATARACT REFR SURG, V40, P1473, DOI 10.1016/j.jcrs.2013.12.018; Savini G, 2013, J CATARACT REFR SURG, V39, P598, DOI 10.1016/j.jcrs.2012.11.022; Savini G, 2012, J CATARACT REFR SURG, V38, P787, DOI 10.1016/j.jcrs.2011.11.037; Savini G, 2011, J CATARACT REFR SURG, V37, P72, DOI 10.1016/j.jcrs.2010.08.036; Srivannaboon S, 2013, GRAEF ARCH CLIN EXP, V251, P2563, DOI 10.1007/s00417-013-2439-8; TRIPOLI NK, 1995, AM J OPHTHALMOL, V120, P658, DOI 10.1016/S0002-9394(14)72213-5; Turhan SA, 2015, EYE CONTACT LENS, V41, P245, DOI 10.1097/ICL.0000000000000111	35	17	18	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2017	12	2							e0172634	10.1371/journal.pone.0172634	http://dx.doi.org/10.1371/journal.pone.0172634			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5SX	28231267	Green Published, gold, Green Submitted			2022-12-27	WOS:000394682400064
J	Schlusser, KE; Pilcher, C; Kallas, EG; Santos, BR; Deeks, SG; Facente, S; Keating, SM; Busch, MP; Murphy, G; Welte, A; Quinn, T; Eshleman, SH; Laeyendecker, O				Schlusser, Katherine E.; Pilcher, Christopher; Kallas, Esper G.; Santos, Breno R.; Deeks, Steven G.; Facente, Shelley; Keating, Sheila M.; Busch, Michael P.; Murphy, Gary; Welte, Alex; Quinn, Thomas; Eshleman, Susan H.; Laeyendecker, Oliver			Comparison of cross-sectional HIV incidence assay results from dried blood spots and plasma	PLOS ONE			English	Article							BED-ENZYME-IMMUNOASSAY; TYPE-1 SEROCONVERSION; CHALLENGES	Background Assays have been developed for cross-sectional HIV incidence estimation using plasma samples. Large scale surveillance programs are planned using dried blood spot (DBS) specimens for incidence assessment. However, limited information exists on the performance of HIV cross-sectional incidence assays using DBS. Methods The assays evaluated were: Maxim HIV-1 Limiting Antigen Avidity EIA (LAg-Avidity), Sedia HIV-1 BED-Capture EIA (BED-CEIA), and CDC modified BioRad HIV-1/2 Plus O Aviditybased Assay (CDC-BioRad Avidity) using pre-determined cutoff values. 100 matched HIV-1 positive plasma and DBS samples, with known duration of infection, from the Consortium for the Evaluation and Performance of HIV Incidence Assays repository were tested. All assays were run in duplicate. To examine the degree of variability within and between results for each sample type, both categorical and continuous results were analyzed. Associations were assessed with Bland Altman, R-2 values and Cohen's kappa coefficient (kappa). Results Intra-assay variability using the same sample type was similar for all assays (R-2 0.96 to 1.00). The R-2 values comparing DBS and plasma results for LAg-Avidity, BED-CEIA, and CDC-BioRad Avidity were 0.96, 0.94, and 0.84, respectively. The concordance and. values between DBS and plasma for all three assays were > 87% and > 0.64, respectively. The Bland-Altman analysis showed significant differences between plasma and DBS samples. For all three assays, a higher number of samples were classified as recent infections using DBS samples. Conclusions DBS and plasma sample results were highly correlated. However, when compared to plasma, each assay performed somewhat differently in DBS at the lower and higher ends of the dynamic range. DBS samples were more likely to be classified as recently infected by all three assays, which may lead to overestimation of incidence in surveys using performance criteria derived for plasma samples.	[Schlusser, Katherine E.; Quinn, Thomas; Laeyendecker, Oliver] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Pilcher, Christopher; Deeks, Steven G.; Facente, Shelley; Keating, Sheila M.; Busch, Michael P.] Univ Calif San Francisco, Sch Med, Dept Med, San Francisco, CA USA; [Kallas, Esper G.] Univ Sao Paulo, Sao Paulo, Brazil; [Kallas, Esper G.] Grp Hosp Conceicao, Porto Alegre, RS, Brazil; [Keating, Sheila M.; Busch, Michael P.] Blood Syst Res Inst, San Francisco, CA USA; [Murphy, Gary] Publ Hlth England, London, England; [Welte, Alex] Univ Stellenbosch, South African DST NRF Ctr Excellence Epidemiol Mo, Stellenbosch, South Africa; [Quinn, Thomas; Laeyendecker, Oliver] NIAID, Immunoregulat Lab, Div Intramural Res, NIH, Baltimore, MD USA; [Eshleman, Susan H.] Johns Hopkins Univ Sch Med, Dept Pathol, Baltimore, MD USA	Johns Hopkins University; University of California System; University of California San Francisco; Universidade de Sao Paulo; Vitalant; Vitalant Research Institute; Public Health England; Stellenbosch University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); NIH National Institute on Aging (NIA); Johns Hopkins University	Laeyendecker, O (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA.; Laeyendecker, O (corresponding author), NIAID, Immunoregulat Lab, Div Intramural Res, NIH, Baltimore, MD USA.	olaeyen1@jhmi.edu	Facente, Shelley/M-1147-2019	Facente, Shelley N./0000-0002-7266-352X; Laeyendecker, Oliver/0000-0002-6429-4760; Deeks, Steven/0000-0001-6371-747X; Keating, Sheila/0000-0002-8324-3694; Kallas, Esper/0000-0003-2026-6925	Division of Intramural Research, National Institute of Allergy and Infectious Diseases (NIAID), NIH; HIV Prevention Trials Network (HPTN) - NIAID, National Institutes of Child Health and Human Development (NICH/HD), National Institute on Drug Abuse, National Institute of Mental Health; Office of AIDS Research; Office of NIH, DHHS [UM1 AI1068613, R01 AI095068, R34MH096606]; Bill and Melinda Gates Foundation [OPP1017716]; NIH [P01 AI071713, R01 HD074511, P30 AI027763, R24 AI067039]; Brazilian Ministry of Health, Brazilian Program [914/BRA/3014-UNESCO]; Sao Paulo City Health Department [2004-0.168.922-7]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI068613, R01AI095068, ZIAAI000361] Funding Source: NIH RePORTER	Division of Intramural Research, National Institute of Allergy and Infectious Diseases (NIAID), NIH; HIV Prevention Trials Network (HPTN) - NIAID, National Institutes of Child Health and Human Development (NICH/HD), National Institute on Drug Abuse, National Institute of Mental Health; Office of AIDS Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of NIH, DHHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Brazilian Ministry of Health, Brazilian Program; Sao Paulo City Health Department; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported in part by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases (NIAID), NIH. Other support was provided by the HIV Prevention Trials Network (HPTN) sponsored by the NIAID, National Institutes of Child Health and Human Development (NICH/HD), National Institute on Drug Abuse, National Institute of Mental Health, and Office of AIDS Research, of the NIH, DHHS, UM1 AI1068613 (Eshleman), R01 AI095068 (Eshleman) and R34MH096606 (Pilcher). Funding for this project was also provided by the Bill and Melinda Gates Foundation (grant OPP1017716). The AM PLIAR and Options Cohorts received funding from the NIH (grants P01 AI071713 and R01 HD074511). The SCOPE study also received funding from the NIH (grants P30 AI027763 and R24 AI067039). The Sao Paulo Cohort acknowledges funding by the Brazilian Ministry of Health, Brazilian Program for STD and AIDS (grant 914/BRA/3014-UNESCO) and the Sao Paulo City Health Department (grant 2004-0.168.922-7). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barin F, 2005, J CLIN MICROBIOL, V43, P4441, DOI 10.1128/JCM.43.9.4441-4447.2005; Brookmeyer R, 2010, EPIDEMIOL REV, V32, P26, DOI 10.1093/epirev/mxq002; Busch MP, 2010, AIDS, V24, P2763, DOI 10.1097/QAD.0b013e32833f1142; Dobbs T, 2004, J CLIN MICROBIOL, V42, P2623, DOI 10.1128/JCM.42.6.2623-2628.2004; Kassanjee R, 2014, AIDS, V28, P2439, DOI 10.1097/QAD.0000000000000429; Kassanjee R, 2012, EPIDEMIOLOGY, V23, P721, DOI 10.1097/EDE.0b013e3182576c07; Laeyendecker O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068349; Lakshmi V, 2009, J MED MICROBIOL, V58, P312, DOI 10.1099/jmm.0.005249-0; Longosz AF, 2014, AIDS, V28, P1227, DOI 10.1097/QAD.0000000000000221; Mastro Timothy D, 2010, J HIV AIDS Surveill Epidemiol, V2, P1; Mei JV, 2001, J NUTR, V131, p1631S, DOI 10.1093/jn/131.5.1631S; O'Mara M, 2011, BIOANALYSIS, V3, P2335, DOI [10.4155/bio.11.220, 10.4155/BIO.11.220]; Owen M., MODIFIED BIORAD HIV; Parekh BS, 2011, AIDS RES HUM RETROV, V27, P265, DOI 10.1089/aid.2010.0159; Rottinghaus EK, 2014, 21 C RETR OPP INF BO; Wei XR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159266; Wei XR, 2010, AIDS RES HUM RETROV, V26, P61, DOI 10.1089/aid.2009.0133; Wendel SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055525; World Health Organisation (WHO), 2013, WHO MAN HIV DRUG RES	19	13	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2017	12	2							e0172283	10.1371/journal.pone.0172283	http://dx.doi.org/10.1371/journal.pone.0172283			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5SX	28231277	Green Submitted, Green Published, gold			2022-12-27	WOS:000394682400033
J	Kwak, NS; Muller, KR; Lee, SW				Kwak, No-Sang; Mueller, Klaus-Robert; Lee, Seong-Whan			A convolutional neural network for steady state visual evoked potential classification under ambulatory environment	PLOS ONE			English	Article							FREQUENCY RECOGNITION; BRAIN; INTERFACE; REHABILITATION; WALKING; SPEED; GAIT	The robust analysis of neural signals is a challenging problem. Here, we contribute a convolutional neural network (CNN) for the robust classification of a steady-state visual evoked potentials (SSVEPs) paradigm. We measure electroencephalogram (EEG)-based SSVEPs for a brain-controlled exoskeleton under ambulatory conditions in which numerous artifacts may deteriorate decoding. The proposed CNN is shown to achieve reliable performance under these challenging conditions. To validate the proposed method, we have acquired an SSVEP dataset under two conditions: 1) a static environment, in a standing position while fixated into a lower-limb exoskeleton and 2) an ambulatory environment, walking along a test course wearing the exoskeleton (here, artifacts are most challenging). The proposed CNN is compared to a standard neural network and other state-of-the-art methods for SSVEP decoding (i.e., a canonical correlation analysis (CCA)-based classifier, a multivariate synchronization index (MSI), a CCA combined with k-nearest neighbors (CCA-KNN) classifier) in an offline analysis. We found highly encouraging SSVEP decoding results for the CNN architecture, surpassing those of other methods with classification rates of 99.28% and 94.03% in the static and ambulatory conditions, respectively. A subsequent analysis inspects the representation found by the CNN at each layer and can thus contribute to a better understanding of the CNN's robust, accurate decoding abilities.	[Kwak, No-Sang; Mueller, Klaus-Robert; Lee, Seong-Whan] Korea Univ, Dept Brain & Cognit Engn, Seoul, South Korea; [Mueller, Klaus-Robert] TU Berlin, Dept Comp Sci, Berlin, Germany	Korea University; Technical University of Berlin	Lee, SW (corresponding author), Korea Univ, Dept Brain & Cognit Engn, Seoul, South Korea.	sw.lee@korea.ac.kr	Mueller, Klaus-Robert/Y-3547-2019	Mueller, Klaus-Robert/0000-0002-3861-7685	Samsung Research Funding Center of Samsung Electronics [SRFC-TC1603-02]	Samsung Research Funding Center of Samsung Electronics(Samsung)	This work was supported by Samsung Research Funding Center of Samsung Electronics under Project Number SRFC-TC1603-02. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by Samsung Research Funding Center of Samsung Electronics under Project Number SRFC-TC1603-02.	Bach S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130140; Bevilacqua V, 2014, IEEE IJCNN, P4121, DOI 10.1109/IJCNN.2014.6889955; Bishop C.M., 2006, MACH LEARN, V128; Blankertz B, 2008, IEEE SIGNAL PROC MAG, V25, P41, DOI 10.1109/MSP.2008.4408441; Blankertz B, 2011, NEUROIMAGE, V56, P814, DOI 10.1016/j.neuroimage.2010.06.048; Breitwieser C, 2012, MED BIOL ENG COMPUT, V50, P347, DOI 10.1007/s11517-012-0877-9; Carlson T, 2013, IEEE ROBOT AUTOM MAG, V20, P65, DOI 10.1109/MRA.2012.2229936; Cecotti H., 2008, 2008 19 INT C PATT R, P1, DOI DOI 10.1109/ICPR.2008.4761638; Cecotti H, 2011, PATTERN RECOGN LETT, V32, P1145, DOI 10.1016/j.patrec.2011.02.022; Cecotti H, 2011, IEEE T PATTERN ANAL, V33, P433, DOI 10.1109/TPAMI.2010.125; Chen XG, 2015, P NATL ACAD SCI USA, V112, pE6058, DOI 10.1073/pnas.1508080112; Collinger JL, 2013, LANCET, V381, P557, DOI 10.1016/S0140-6736(12)61816-9; Contreras-Vidal JL, 2014, IEEE SYS MAN CYBERN, P1489, DOI 10.1109/SMC.2014.6974126; Contreras-Vidal JL, 2013, IEEE ENG MED BIO, P1579, DOI 10.1109/EMBC.2013.6609816; Cruz-Garza JG, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00188; Dahne S, 2015, P IEEE, V103, P1507, DOI 10.1109/JPROC.2015.2425807; Do AH, 2013, J NEUROENG REHABIL, V10, DOI 10.1186/1743-0003-10-111; Donchin E, 2000, IEEE T REHABIL ENG, V8, P174, DOI 10.1109/86.847808; Dornhege G., 2007, BRAIN COMPUTER INTER; Fazli S, 2015, P IEEE, V103, P891, DOI 10.1109/JPROC.2015.2413993; Guger C, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00169; Gwin JT, 2010, J NEUROPHYSIOL, V103, P3526, DOI 10.1152/jn.00105.2010; Hecht-Nielsen R., 1992, IEEE T NEURAL NETWOR, p65e93, DOI [10.1016/B978-0-12-741252-8.50010-8, DOI 10.1016/B978-0-12-741252-8.50010-8, 10.1109/IJCNN.1989.118638, DOI 10.1109/IJCNN.1989.118638]; Hill NJ, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/2/026011; Hochberg LR, 2006, NATURE, V442, P164, DOI 10.1038/nature04970; Hwang HJ, 2012, J NEUROSCI METH, V208, P59, DOI 10.1016/j.jneumeth.2012.04.011; Kilicarslan A, 2013, IEEE ENG MED BIO, P5606, DOI 10.1109/EMBC.2013.6610821; Kim DW, 2011, J NEUROSCI METH, V197, P180, DOI 10.1016/j.jneumeth.2011.02.007; Kim JH, 2015, IEEE T NEUR SYS REH, V23, P867, DOI 10.1109/TNSRE.2014.2375879; King CE, 2013, J NEUROENG REHABIL, V10, DOI 10.1186/1743-0003-10-77; Kline JE, 2015, J NEURAL ENG, V12, DOI 10.1088/1741-2560/12/4/046022; Krepki R, 2007, MULTIMED TOOLS APPL, V33, P73, DOI 10.1007/s11042-006-0094-3; Kwak NS, 2015, J NEURAL ENG, V12, DOI 10.1088/1741-2560/12/5/056009; LaFleur K, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/4/046003; Lebedev MA, 2006, TRENDS NEUROSCI, V29, P536, DOI 10.1016/j.tins.2006.07.004; LeCun Y, 1998, LECT NOTES COMPUT SC, V1524, P9, DOI 10.1007/3-540-49430-8_2; Lemm S, 2011, NEUROIMAGE, V56, P387, DOI 10.1016/j.neuroimage.2010.11.004; Lin YP, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-119; Lin ZL, 2006, IEEE T BIO-MED ENG, V53, P2610, DOI 10.1109/TBME.2006.886577; Lopes AC, 2013, ROBOT AUTON SYST, V61, P245, DOI 10.1016/j.robot.2012.11.002; Luo A, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/2/026010; McFarland DJ, 2005, CLIN NEUROPHYSIOL, V116, P56, DOI 10.1016/j.clinph.2004.07.004; Mikolajewska E, 2012, ADV CLIN EXP MED, V21, P263; Montavon G, 2011, J MACH LEARN RES, V12, P2563; Morone G, 2015, ARCH PHYS MED REHAB, V96, pS71, DOI 10.1016/j.apmr.2014.05.026; Muller KR, 2006, IEEE SIGNAL PROC MAG, V23, P128, DOI 10.1109/MSP.2006.1708426; Muller-Putz GR, 2005, J NEURAL ENG, V2, P123, DOI 10.1088/1741-2560/2/4/008; Muller-Putz GR, 2006, IEEE T NEUR SYS REH, V14, P30, DOI 10.1109/TNSRE.2005.863842; Nilsson A, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-92; Pan J, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/3/036027; Ramos-Murguialday A, 2013, ANN NEUROL, V74, P100, DOI 10.1002/ana.23879; RUMELHART DE, 1986, NATURE, V323, P533, DOI 10.1038/323533a0; Samek Wojciech, 2014, IEEE Rev Biomed Eng, V7, P50, DOI 10.1109/RBME.2013.2290621; Suk HI, 2013, IEEE T PATTERN ANAL, V35, P286, DOI 10.1109/TPAMI.2012.69; Tangermann MW, NIPS, P1641; Tello RMG, 2014, ISSNIP BIOSIG BIOROB, P7; Tsukahara A, 2015, IEEE T NEUR SYS REH, V23, P308, DOI 10.1109/TNSRE.2014.2364618; Venkatakrishnan Anusha, 2014, Curr Phys Med Rehabil Rep, V2, P93; Won DO, 2016, J NEURAL ENG, V13, DOI 10.1088/1741-2560/13/1/016014; Yeom SK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111157; Zhang Y, 2011, P 18 INT C NEUR INF, V287, P295; Zhang YS, 2014, J NEUROSCI METH, V221, P32, DOI 10.1016/j.jneumeth.2013.07.018; Zhang Y, 2014, INT J NEURAL SYST, V24, DOI 10.1142/S0129065714500130; Zhang Y, 2012, BIOMED SIGNAL PROCES, V7, P104, DOI 10.1016/j.bspc.2011.02.002	64	149	151	9	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2017	12	2							e0172578	10.1371/journal.pone.0172578	http://dx.doi.org/10.1371/journal.pone.0172578			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5SK	28225827	Green Published, Green Submitted, gold			2022-12-27	WOS:000394680900057
J	Angelo, JR; Katsuragawa, TH; Sabroza, PC; de Carvalho, LAS; da Silva, LHP; Nobre, CA				Angelo, Jussara Rafael; Katsuragawa, Tony Hiroshi; Sabroza, Paulo Chagastelles; Sander de Carvalho, Lino Augusto; Pereira da Silva, Luiz Hildebrando; Nobre, Carlos Afonso			The role of spatial mobility in malaria transmission in the Brazilian Amazon: The case of Porto Velho municipality, Rondonia, Brazil (2010-2012)	PLOS ONE			English	Article							COLONIZATION	Background This study aims to describe the role of mobility in malaria transmission by discussing recent changes in population movements in the Brazilian Amazon and developing a flow map of disease transmission in this region. Methodology/Principal findings This study presents a descriptive analysis using an ecological approach on regional and local scales. The study location was the municipality of Porto Velho, which is the capital of Rondonia state, Brazil. Ourdataset was obtained from the official health database, the population census and an environmental database. During 2000-2007 and 2007-2010, the Porto Velho municipality had an annual population growth of 1.42% and 5.07%, respectively. This population growth can be attributed to migration, which was driven by the construction of the Madeira River hydroelectric complex. From 2010 to 2012, 63,899 malariapositive slides were reported for residents of Porto Velho municipality; 92% of the identified samples were autochthonous, and 8% were allochthonous. The flow map of patients' movements between residential areas and areas of suspected infection showed two patterns of malaria transmission: 1) commuting between residential areas and the Jirau hydropower dam reservoir, and 2) movements between urban areas and farms and resorts in rural areas. It was also observed that areas with greater occurrences of malaria were characterized by a low rate of deforestation. Conclusions The Porto Velho municipality exhibits high malaria endemicity and plays an important role in disseminating the parasite to other municipalities in the Amazon and even to non-endemic areas of the country. Migration remains an important factor for the occurrence of malaria. However, due to recent changes in human occupation of the Brazilian Amazon, characterized by intense expansion of transportation networks, commuting has also become an important factor in malaria transmission. The magnitude of this change necessitates a new model to explain malaria transmission in the Brazilian Amazon.	[Angelo, Jussara Rafael; Sabroza, Paulo Chagastelles] Fundacao Oswaldo Cruz ENSP FIOCRUZ, Dept Endemias Samuel Pessoa, Escola Nacl Saude Publ, Rio De Janeiro, RJ, Brazil; [Katsuragawa, Tony Hiroshi; Pereira da Silva, Luiz Hildebrando] Fundacao Oswaldo Cruz Rondonia Fiocruz RO, Porto Velho, Rondonia, Brazil; [Sander de Carvalho, Lino Augusto; Nobre, Carlos Afonso] INPE, Sao Paulo, Brazil; [Nobre, Carlos Afonso] Inst Nacl Pesquisas Espaciais, Ctr Ciencia Sistema Terr, Sao Paulo, Brazil	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Instituto Nacional de Pesquisas Espaciais (INPE); Instituto Nacional de Pesquisas Espaciais (INPE)	Angelo, JR (corresponding author), Fundacao Oswaldo Cruz ENSP FIOCRUZ, Dept Endemias Samuel Pessoa, Escola Nacl Saude Publ, Rio De Janeiro, RJ, Brazil.	jussara.angelo@ensp.fiocruz.br			Rede Brasileira de Pesquisas sobre Mudancas Climaticas Globais (Rede CLIMA)	Rede Brasileira de Pesquisas sobre Mudancas Climaticas Globais (Rede CLIMA)	This work was supported by the Rede Brasileira de Pesquisas sobre Mudancas Climaticas Globais (Rede CLIMA) and for the Comissao de Aperfeicoamento de Pessoal do Ensino Superior (CAPES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu C, 2010, GALICIA CLIN, V71, P15; Alves Jose, 2012, 13 JORN TRAB PRES PR; ANDERSON R M, 1991; Barbieri Alisson Flávio, 2007, Rev. bras. estud. popul., V24, P225, DOI 10.1590/S0102-30982007000200004; Becker B.K., 2009, AMAZONIA GEOPOLITICA; Becker B. K., 2001, PARCERIAS ESTRATEGIC, V6, P135; Becker Bertha K., 2005, Estud. av., V19, P71, DOI 10.1590/S0103-40142005000100005; Carvalheiro J da R, 1982, PROCESSO MIGRATORIO; Cavalcante MM de A, 2011, CONFINS, P1; Costa P, 2013, NEWSL COM BRAS BARRA; Costa SM, 2009, MOST, P211; Couto R. C. S., 1999, NOVOS CAD NAEA, V2, P205; de Castro MC, 2007, HEALTH PLACE, V13, P368, DOI 10.1016/j.healthplace.2006.03.006; de Castro MC, 2006, P NATL ACAD SCI USA, V103, P2452, DOI 10.1073/pnas.0510576103; De Castro MC, 2006, AFRICA MOVE AFRICAN, P280; Instituto Nacional de Pesquisas Espaciais, 2010, DAD TERRACLASS2010; Instituto Nacional de Pesquisas Espaciais, 2012, PROD; Instituto Nacional de Pesquisas Espaciais, 2016, TERR; Kalamaras D, SOCIAL NETWORK ANAL; Katsuragawa TH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009245; Marques A C, 1982, Rev Bras Malariol Doencas Trop, V34, P1; MARQUES A C, 1986, Memorias do Instituto Oswaldo Cruz, V81, P17, DOI 10.1590/S0074-02761986000600004; Martens P, 2000, EMERG INFECT DIS, V6, P103, DOI 10.3201/eid0602.000202; MOURA R, 2005, SAO PAULO PERSPECTIV, V19, P121, DOI DOI 10.1590/S0102-88392005000400008; Newman M., 2010, NETWORKS INTRO, DOI [10.1162/artl_r_00062, 10.1093/acprof:oso/9780199206650.001.0001, DOI 10.1093/ACPROF:OSO/9780199206650.001.0001]; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Oliveira ATR, 2011, ALGUMAS ABORDAGENS T; Pinedo-Vasquez Miguel, 2008, URBANO RURAL FAMILIA, P43; Satler D, 2009, REDES ALEM RIOS URBA; SAWYER D, 1986, Memorias do Instituto Oswaldo Cruz, V81, P31, DOI 10.1590/S0074-02761986000600005; SAWYER D, 1993, SOC SCI MED, V37, P1131, DOI 10.1016/0277-9536(93)90252-Y; Singer BH, 2001, ANN NY ACAD SCI, V954, P184; Tadei Wanderli Pedro, 1983, ACTA AMAZON, P103; Tadei WP, 1998, AM J TROP MED HYG, V59, P325, DOI 10.4269/ajtmh.1998.59.325; Valdes AC de O, 2012, MOBILIDADE ESPACIAL; Vittor AY, 2009, AM J TROP MED HYG, V81, P5	36	13	13	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2017	12	2							e0172330	10.1371/journal.pone.0172330	http://dx.doi.org/10.1371/journal.pone.0172330			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5QV	28222159	Green Published, gold, Green Submitted			2022-12-27	WOS:000394676800050
J	Borgatti, A; Winter, AL; Stuebner, K; Scott, R; Ober, CP; Anderson, KL; Feeney, DA; Vallera, DA; Koopmeiners, JS; Modiano, JF; Froelich, J				Borgatti, Antonella; Winter, Amber L.; Stuebner, Kathleen; Scott, Ruth; Ober, Christopher P.; Anderson, Kari L.; Feeney, Daniel A.; Vallera, Daniel A.; Koopmeiners, Joseph S.; Modiano, Jaime F.; Froelich, Jerry			Evaluation of 18-F-fluoro-2-deoxyglucose (FDG) positron emission tomography/computed tomography ( PET/CT) as a staging and monitoring tool for dogs with stage-2 splenic hemangiosarcoma - A pilot study	PLOS ONE			English	Article							CANINE HEMANGIOSARCOMA; F-18-FDG PET/CT; CANCER; TUMOR; DIAGNOSIS; LYMPHOMA; THERAPY; MASSES	Positron Emission Tomography-Computed Tomography (PET-CT) is routinely used for staging and monitoring of human cancer patients and is becoming increasingly available in veterinary medicine. In this study, 18-fluorodeoxyglucose ((18)FDG)-PET-CT was used in dogs with naturally occurring splenic hemangiosarcoma (HSA) to assess its utility as a staging and monitoring modality as compared to standard radiography and ultrasonography. Nine dogs with stage-2 HSA underwent (18)FDG-PET-CT following splenectomy and prior to commencement of chemotherapy. Routine staging (thoracic radiography and abdominal ultrasonography) was performed prior to (18)FDG-PET-CT in all dogs. When abnormalities not identified on routine tests were noted on (18)FDG-PET-CT, owners were given the option to repeat a PET-CT following treatment with eBAT. A PET-CT scan was repeated on Day 21 in three dogs. Abnormalities not observed on conventional staging tools, and most consistent with malignant disease based on location, appearance, and outcome, were detected in two dogs and included a right atrial mass and a hepatic nodule, respectively. These lesions were larger and had higher metabolic activity on the second scans. (18)FDG-PET-CT has potential to provide important prognostic information and influence treatment recommendations for dogs with stage-2 HSA. Additional studies will be needed to precisely define the value of this imaging tool for staging and therapy monitoring in dogs with this and other cancers.	[Borgatti, Antonella; Winter, Amber L.; Stuebner, Kathleen; Modiano, Jaime F.] Univ Minnesota, Coll Vet Med, Anim Canc Care & Res ACCR Program, St Paul, MN 55108 USA; [Borgatti, Antonella; Ober, Christopher P.; Anderson, Kari L.; Feeney, Daniel A.; Modiano, Jaime F.] Univ Minnesota, Coll Vet Med, Dept Vet Clin Sci, St Paul, MN 55108 USA; [Borgatti, Antonella; Vallera, Daniel A.; Koopmeiners, Joseph S.; Modiano, Jaime F.; Froelich, Jerry] Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN 55455 USA; [Winter, Amber L.; Stuebner, Kathleen; Scott, Ruth] Coll Vet Med, Clin Invest Ctr, St Paul, MN USA; [Vallera, Daniel A.] Univ Minnesota, Sch Med, Dept Therapeut Radiol, Minneapolis, MN 55455 USA; [Koopmeiners, Joseph S.] Univ Minnesota, Sch Publ Hlth, Div Biostat, Minneapolis, MN 55455 USA; [Froelich, Jerry] Univ Minnesota, Sch Med, Ctr Clin Imaging Res CCIR Diagnost Radiol, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Borgatti, A (corresponding author), Univ Minnesota, Coll Vet Med, Anim Canc Care & Res ACCR Program, St Paul, MN 55108 USA.; Borgatti, A (corresponding author), Univ Minnesota, Coll Vet Med, Dept Vet Clin Sci, St Paul, MN 55108 USA.; Borgatti, A (corresponding author), Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN 55455 USA.	borgatti@umn.edu	MODIANO, JAIME/K-3583-2019	MODIANO, JAIME/0000-0001-6398-7648	Office of The Director, National Institutes of Health [K01OD017242]; National Canine Cancer Foundation [AB15MN-002]; Masonic Cancer Center, University of Minnesota Sarcoma Translational Working Group; Randy Shaver Cancer Research and Community Fund; GREYIong; Angiosarcoma Awareness Foundation; Alvin S. and June Perlman Chair in Animal Oncology at the University of Minnesota; NATIONAL CANCER INSTITUTE [P30CA077598] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [K01OD017242] Funding Source: NIH RePORTER	Office of The Director, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Canine Cancer Foundation; Masonic Cancer Center, University of Minnesota Sarcoma Translational Working Group; Randy Shaver Cancer Research and Community Fund; GREYIong; Angiosarcoma Awareness Foundation; Alvin S. and June Perlman Chair in Animal Oncology at the University of Minnesota; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported in part by grant K01OD017242 (AB) from the Office of The Director, National Institutes of Health, grant AB15MN-002 from the National Canine Cancer Foundation (AB), a grant from the Masonic Cancer Center, University of Minnesota Sarcoma Translational Working Group (JFM, DAV, AB, JSK), the Randy Shaver Cancer Research and Community Fund (DAV), and a grant from GREYIong (JFM). The authors gratefully acknowledge generous support from the Angiosarcoma Awareness Foundation and donations to the Animal Cancer Care and Research Program of the University of Minnesota that helped support this project. JFM is supported in part by the Alvin S. and June Perlman Chair in Animal Oncology at the University of Minnesota. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or other supporting organizations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benz MR, 2011, J NUCL MED, V52, P1684, DOI 10.2967/jnumed.111.095257; BERG RJ, 1984, J AM ANIM HOSP ASSOC, V20, P721; Bilski M, 2012, NUCL MED REV, V15, P83, DOI [10.5603/nmr-18736, 10.5603/NMR.2012.0015]; Boellaard R, 2008, EUR J NUCL MED MOL I, V35, P2320, DOI 10.1007/s00259-008-0874-2; Bomanji JB, 2001, LANCET ONCOL, V2, P157, DOI 10.1016/S1470-2045(00)00257-6; Borgatti A, MOL CANC TH IN PRESS; Boston SE, 2011, J AM ANIM HOSP ASSOC, V47, P336, DOI 10.5326/JAAHA-MS-5603; Ceriani L, 2015, BLOOD, V126, P950, DOI 10.1182/blood-2014-12-616474; Chon E, 2012, VET COMP ONCOL, V10, P184, DOI 10.1111/j.1476-5829.2011.00265.x; Clifford CA, 2000, J VET INTERN MED, V14, P479, DOI 10.1892/0891-6640(2000)014&lt;0479:TOCHAB&gt;2.3.CO;2; Cook GJR, 2007, Q J NUCL MED MOL IM, V51, P235; Dunning D, 1998, J AM VET MED ASSOC; FRUCHTER AM, 1992, CAN VET J, V33, P171; Gardner HL, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0446-1; Gorden BH, 2014, AM J PATHOL, V184, P985, DOI 10.1016/j.ajpath.2013.12.025; Hansen AE, 2011, VET RADIOL ULTRASOUN, V52, P201, DOI 10.1111/j.1740-8261.2010.01757.x; HOLT D, 1992, J AM VET MED ASSOC, V200, P1535; Jain A, 2015, INDIAN J NUCL MED, V30, P51, DOI 10.4103/0972-3919.147541; Kim Jong-Hyuk, 2015, Vet Sci, V2, P388, DOI 10.3390/vetsci2040388; Lana S, 2007, J VET INTERN MED, V21, P764; LARSON SM, 1981, J NUCL MED, V22, P875; Lawrence J, 2010, VET COMP ONCOL, V8, P163, DOI 10.1111/j.1476-5829.2010.00218.x; LeBlanc AK, 2012, VET RADIOL ULTRASOUN, V53, P348, DOI 10.1111/j.1740-8261.2012.01925.x; Leblanc AK, 2009, VET RADIOL ULTRASOUN, V50, P215, DOI 10.1111/j.1740-8261.2009.01520.x; Quak E, 2011, EXPERT REV ANTICANC, V11, P195, DOI [10.1586/era.10.133, 10.1586/ERA.10.133]; Rahbar K, 2012, J NUCL MED, V53, P1657, DOI 10.2967/jnumed.112.110676; Schappa JT, 2013, INT J CANCER, V133, P1936, DOI 10.1002/ijc.28187; Seiler SMF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127800; Tan H, 2013, CLIN NUCL MED, V38, P1002, DOI 10.1097/RLU.0000000000000254; Thamm DH, 2013, SMALL ANIMAL CLIN ON, V5, P679; THOMAS WP, 1984, VET RADIOLOGY, V25, P65, DOI 10.1111/j.1740-8261.1984.tb01911.x; U'Ren LW, 2007, J VET INTERN MED, V21, P113, DOI 10.1892/0891-6640(2007)21[113:EOANTV]2.0.CO;2; WATERS DJ, 1988, J SMALL ANIM PRACT, V29, P805, DOI 10.1111/j.1748-5827.1988.tb01907.x; Weber WA, 1999, STRAHLENTHER ONKOL, V175, P356, DOI 10.1007/s000660050022; Weber WA, 2000, NUCL MED BIOL, V27, P683, DOI 10.1016/S0969-8051(00)00141-4	35	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2017	12	2							e0172651	10.1371/journal.pone.0172651	http://dx.doi.org/10.1371/journal.pone.0172651			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5QV	28222142	Green Submitted, Green Published, gold			2022-12-27	WOS:000394676800075
J	Chan, DL; Sjoquist, KM; Goldstein, D; Price, TJ; Martin, AJ; Bang, YJ; Kang, YK; Pavlakis, N				Chan, David L.; Sjoquist, Katrin M.; Goldstein, David; Price, Timothy J.; Martin, Andrew J.; Bang, Yung-Jue; Kang, Yoon-Koo; Pavlakis, Nick			The effect of anti-angiogenic agents on overall survival in metastatic oesophago-gastric cancer: A systematic review and meta-analysis	PLOS ONE			English	Review							ADVANCED GASTRIC-CANCER; GROWTH-FACTOR RECEPTOR; RANDOMIZED PHASE-II; DOUBLE-BLIND; 1ST-LINE THERAPY; ADENOCARCINOMA; CHEMOTHERAPY; COMBINATION; BEVACIZUMAB; TRIAL	Background Studies of anti-angiogenic agents (AAs), combined with chemotherapy (chemo) or as monotherapy in metastatic oesophago-gastric cancer (mOGC), have reported mixed outcomes. We undertook systematic review and meta-analysis to determine their overall benefits and harms. Methods Randomized controlled trials in mOGC were sought investigating the addition of AAs to standard therapy (best supportive care or chemo). The primary endpoint was overall survival (OS) with secondary endpoints progression-free survival (PFS), overall response rate (ORR) and toxicity. Estimates of treatment effect from individual trials were combined using standard techniques. Subgroup analyses were performed by line of therapy, region, age, performance status, histological type, number of metastatic sites, primary site, mechanism of action and HER2 status. Results Fifteen trials evaluating 3502 patients were included in quantitative analysis. The addition of AAs was associated with improved OS: HR 0.81 (95% CI 0.75.0.88, p<0.00001) and improved PFS: HR 0.68 (95% CI 0.63.0.74, p<0.00001). Subgroup analyses favoured greater benefit for OS in 2nd/3rd line settings (HR 0.74) compared to 1st-line settings (HR 0.91) (X-2 = 6.00, p = 0.01). OS benefit was seen across all regions D Asia (HR 0.83) and rest of world (HR 0.75) D without significant subgroup interaction. Results from 8 trials evaluating 2602 patients were pooled for toxicity > = Grade 3: with OR 1.39 (95% CI 1.17.1.65). Conclusions The addition of AAs to standard therapy in mOGC improves OS. Improved efficacy was only observed in 2nd- or 3rd-line setting and not in 1st-line setting. Consistent OS benefit was present across all geographical regions. This benefit is at the expense of increased overall toxicity.	[Chan, David L.; Pavlakis, Nick] Royal North Shore Hosp, Dept Med Oncol, Sydney, NSW, Australia; [Sjoquist, Katrin M.; Martin, Andrew J.] Univ Sydney, Natl Hlth & Med Res Council Clin Trials Ctr, Sydney, NSW, Australia; [Sjoquist, Katrin M.] St George Hosp, Dept Med Oncol, Canc Care Ctr, Sydney, NSW, Australia; [Goldstein, David] Prince Wales Hosp, Dept Med Oncol, Sydney, NSW, Australia; [Price, Timothy J.] Queen Elizabeth Hosp, Dept Med Oncol, Adelaide, SA, Australia; [Price, Timothy J.] Univ Adelaide, Adelaide, SA, Australia; [Bang, Yung-Jue] Seoul Natl Univ, Dept Internal Med, Coll Med, Seoul, South Korea; [Kang, Yoon-Koo] Univ Ulsan, Coll Med, Dept Oncol, Asan Med Ctr, Seoul, South Korea	Royal North Shore Hospital; University of Sydney; St George Hospital; University of Adelaide; Seoul National University (SNU); University of Ulsan	Pavlakis, N (corresponding author), Royal North Shore Hosp, Dept Med Oncol, Sydney, NSW, Australia.	nick.pavlakis@sydney.edu.au	Chan, David L/E-7149-2017; goldstein, david/J-6711-2012; Bang, Yung Jue/J-2759-2012; Price, Timothy/G-1404-2012	Bang, Yung Jue/0000-0001-6000-4597; Sjoquist, Katrin/0000-0001-9028-8682; Martin, Andrew/0000-0001-5804-2295; Price, Timothy/0000-0002-3922-2693; Chan, David/0000-0002-7773-3144				Bang YJ, 2010, LANCET, V376, P1302; Eatock MM, 2013, ANN ONCOL, V24, P710, DOI 10.1093/annonc/mds502; Enzinger PC, 2016, J CLIN ONCOL, V34, DOI 10.1200/jco.2016.34.4_suppl.4; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Fuchs CS, 2014, LANCET, V383, P31, DOI 10.1016/S0140-6736(13)61719-5; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Higgins J, 2011, COCHRANE HDB SYTSEMA; Jiang F, TUMOR, V29, P790; Kang Y., 2014, ANN ONCOL, V25, piv210, DOI [10.1093/annonc/mdu334.1, DOI 10.1093/ANNONC/MDU334.1, DOI 10.1093/ANN0NC/MDU334]; Katoh M, 2008, INT J ONCOL, V33, P233, DOI 10.3892/ijo_00000001; Koizumi W, 2013, BRIT J CANCER, V109, P2079, DOI 10.1038/bjc.2013.555; Li J, 2016, J CLIN ONCOL, V34, P1448, DOI 10.1200/JCO.2015.63.5995; Li J, 2013, J CLIN ONCOL, V31, P3219, DOI 10.1200/JCO.2013.48.8585; Miyamoto N, 2007, CANCER LETT, V254, P42, DOI 10.1016/j.canlet.2007.02.004; Moehler M, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2736-9; Muro K, 2015, J CLIN ONCOL, V33, DOI 10.1200/jco.2015.33.3_suppl.3; Ohtsu A, 2011, J CLIN ONCOL, V29, P3968, DOI 10.1200/JCO.2011.36.2236; Parmar MKB, 1998, STAT MED, V17, P2815, DOI 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8; Pavlakis N, 2016, J CLIN ONCOL, V34, P2728, DOI 10.1200/JCO.2015.65.1901; Qi WX, 2014, TUMOR BIOL, V35, P7675, DOI 10.1007/s13277-014-2037-3; Shen L, 2015, GASTRIC CANCER, V18, P168, DOI 10.1007/s10120-014-0351-5; Takeda M, 2007, CLIN CANCER RES, V13, P3051, DOI 10.1158/1078-0432.CCR-06-2743; Thuss-Patience PC, 2015, J CLIN ONCOL, V33, DOI 10.1200/jco.2015.33.15_suppl.4033; Van Cutsem E, 2012, J CLIN ONCOL, V30, P2119, DOI 10.1200/JCO.2011.39.9824; Wagner AD, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004064.pub3; Wilke H, 2014, LANCET ONCOL, V15, P1224, DOI 10.1016/S1470-2045(14)70420-6; Yi JH, 2012, BRIT J CANCER, V106, P1469, DOI 10.1038/bjc.2012.100; Yoon HH, 2014, J CLIN ONCOL, V32, p5s; Zhao WM, 2010, CLIN CANCER RES, V16, P5750, DOI 10.1158/1078-0432.CCR-10-0531	29	9	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2017	12	2							e0172307	10.1371/journal.pone.0172307	http://dx.doi.org/10.1371/journal.pone.0172307			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5QV	28222158	Green Submitted, Green Published, gold			2022-12-27	WOS:000394676800048
J	Jaworski, JP; Bryk, P; Brower, Z; Zheng, B; Hessell, AJ; Rosenberg, AF; Wu, TT; Sanz, I; Keefer, MC; Haigwood, NL; Kobie, JJ				Jaworski, Juan Pablo; Bryk, Peter; Brower, Zachary; Zheng, Bo; Hessell, Ann J.; Rosenberg, Alexander F.; Wu, Tong Tong; Sanz, Ignacio; Keefer, Michael C.; Haigwood, Nancy L.; Kobie, James J.			Pre-existing neutralizing antibody mitigates B cell dysregulation and enhances the Env-specific antibody response in SHIV-infected rhesus macaques	PLOS ONE			English	Article							SIMIAN IMMUNODEFICIENCY VIRUS; HIV-1/SIV CHIMERIC VIRUS; MONOCLONAL-ANTIBODIES; LAMINA PROPRIA; PERITONEAL-CAVITY; INFANT MACAQUES; LYMPHOID-TISSUE; PLASMA-CELLS; PROTECTION; VIREMIA	Our central hypothesis is that protection against HIV infection will be powerfully influenced by the magnitude and quality of the B cell response. Although sterilizing immunity, mediated by pre-formed abundant and potent antibodies is the ultimate goal for B cell-targeted HIV vaccine strategies, scenarios that fall short of this may still confer beneficial defenses against viremia and disease progression. We evaluated the impact of sub-sterilizing pre-existing neutralizing antibody on the B cell response to SHIV infection. Adult male rhesus macaques received passive transfer of a sub-sterilizing amount of polyclonal neutralizing immunoglobulin (Ig) purified from previously infected animals (SHIVIG) or control Ig prior to intra-rectal challenge with SHIVSF162P4 and extensive longitudinal sampling was performed. SHIVIG treated animals exhibited significantly reduced viral load and increased de novo Env-specific plasma antibody. Dysregulation of the B cell profile was grossly apparent soon after infection in untreated animals; exemplified by a approximate to 50% decrease in total B cells in the blood evident 2-3 weeks postinfection which was not apparent in SHIVIG treated animals. IgD+CD5+CD21+B cells phenotypically similar to marginal zone-like B cells were highly sensitive to SHIV infection, becoming significantly decreased as early as 3 days post-infection in control animals, while being maintained in SHIVIG treated animals, and were highly correlated with the induction of Env-specific plasma antibody. These results suggest that B cell dysregulation during the early stages of infection likely contributes to suboptimal Env-specific B cell and antibody responses, and strategies that limit this dysregulation may enhance the host's ability to eliminate HIV.	[Jaworski, Juan Pablo; Brower, Zachary; Hessell, Ann J.; Haigwood, Nancy L.] Oregon Hlth & Sci Univ, Oregon Natl Primate Res Ctr, Beaverton, OR USA; [Bryk, Peter] Univ Rochester, Med Ctr, Dept Microbiol & Immunol, Rochester, NY 14642 USA; [Zheng, Bo; Keefer, Michael C.; Kobie, James J.] Univ Rochester, Med Ctr, Dept Med, Div Infect Dis, Rochester, NY 14642 USA; [Rosenberg, Alexander F.] Univ Rochester, Med Ctr, Dept Med, Div Allergy Immunol & Rheumatol, Rochester, NY 14642 USA; [Wu, Tong Tong] Univ Rochester, Med Ctr, Dept Biostat & Computat Biol, Rochester, NY 14642 USA; [Sanz, Ignacio] Emory Univ, Lowance Ctr Human Immunol, Atlanta, GA 30322 USA; [Sanz, Ignacio] Emory Univ, Dept Med, Div Rheumatol, Atlanta, GA 30322 USA; [Jaworski, Juan Pablo] Natl Inst Agr Technol, Buenos Aires, DF, Argentina; [Jaworski, Juan Pablo] Natl Sci & Tech Res Council, Buenos Aires, DF, Argentina	Oregon Health & Science University; Oregon National Primate Research Center; University of Rochester; University of Rochester; University of Rochester; University of Rochester; Emory University; Emory University; Instituto Nacional de Tecnologia Agropecuaria (INTA)	Kobie, JJ (corresponding author), Univ Rochester, Med Ctr, Dept Med, Div Infect Dis, Rochester, NY 14642 USA.	james_kobie@urmc.rocheter.edu	Haigwood, Nancy Logan/AAV-7484-2020; Jaworski, Juan/ABA-4503-2020	Jaworski, Juan/0000-0002-1311-060X; Haigwood, Nancy/0000-0002-1477-9575; Hessell, Ann/0000-0001-7471-9366	NIH/NIAID/NIMH [5U19AI067854, 5R01AI117787]; University of Rochester Center for AIDS Research [P30AI078498, R37AI049660, U19AI110483, P51-OD011092]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U24AI126683, U19AI110483, P01AI125180, T32AI118689, R01AI117787, P30AI078498, UM1AI068614, R37AI049660, U19AI056390] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011092] Funding Source: NIH RePORTER	NIH/NIAID/NIMH; University of Rochester Center for AIDS Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded by the NIH/NIAID/NIMH 5U19AI067854 (HVTN/CHAVI), 5R01AI117787 to JK, University of Rochester Center for AIDS Research P30AI078498 (NIH/NIAID), R37AI049660 and U19AI110483 to IS, P51-OD011092 (NIH).	Baba TW, 2000, NAT MED, V6, P200, DOI 10.1038/72309; Barouch DH, 2013, NATURE, V503, P224, DOI 10.1038/nature12744; BEAGLEY KW, 1995, IMMUNOL CELL BIOL, V73, P425, DOI 10.1038/icb.1995.66; Brocca-Cofano E, 2011, VACCINE, V29, P3310, DOI 10.1016/j.vaccine.2011.02.066; Caskey M, 2015, NATURE, V522, P487, DOI 10.1038/nature14411; Chaoul N, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-43; Das A, 2011, CLIN IMMUNOL, V140, P223, DOI 10.1016/j.clim.2011.04.018; Das A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016524; Demberg T, 2015, VIROLOGY, V484, P323, DOI 10.1016/j.virol.2015.06.022; Fagarasan S, 2001, NATURE, V413, P639, DOI 10.1038/35098100; Gauvin J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155868; Haigwood NL, 2004, J VIROL, V78, P5983, DOI 10.1128/JVI.78.11.5983-5995.2004; Haigwood NL, 1996, IMMUNOL LETT, V51, P107, DOI 10.1016/0165-2478(96)02563-1; Harouse JM, 2001, J VIROL, V75, P1990, DOI 10.1128/JVI.75.4.1990-1995.2001; Hart M, 2007, J IMMUNOL, V178, P8212, DOI 10.4049/jimmunol.178.12.8212; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Hessell AJ, 2016, NAT MED, V22, P362, DOI 10.1038/nm.4063; Hessell AJ, 2010, J VIROL, V84, P1302, DOI 10.1128/JVI.01272-09; Hessell AJ, 2009, NAT MED, V15, P951, DOI 10.1038/nm.1974; Hessell AJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000433; Jaworski JP, 2013, J VIROL, V87, P10447, DOI 10.1128/JVI.00049-13; Kroese FGM, 1989, INT IMMUNOL, V1, P75, DOI 10.1093/intimm/1.1.75; Kuhrt D, 2010, J VIROL, V84, P2466, DOI 10.1128/JVI.01966-09; Kuwata T, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000372; Levesque MC, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000107; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; Lin M, 2013, MUCOSAL IMMUNOL; Liu JY, 2016, SCIENCE, V353, P1045, DOI 10.1126/science.aag0491; Long EM, 2002, AIDS RES HUM RETROV, V18, P567, DOI 10.1089/088922202753747914; Lynch RM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aad5752; Malherbe DC, 2011, J VIROL, V85, P5262, DOI 10.1128/JVI.02419-10; Mascola JR, 2000, NAT MED, V6, P207, DOI 10.1038/72318; Moir S, 2008, J EXP MED, V205, P1797, DOI 10.1084/jem.20072683; Montefiori DC, 2012, J INFECT DIS, V206, P431, DOI 10.1093/infdis/jis367; Morrow M, 2008, AIDS RES HUM RETROV, V24, P621, DOI 10.1089/aid.2007.0186; Neumann B, 2015, J LEUKOCYTE BIOL, V97, P19, DOI 10.1189/jlb.1HI0514-243R; Ng CT, 2010, NAT MED, V16, P1117, DOI 10.1038/nm.2233; Nishimura Y, 2003, P NATL ACAD SCI USA, V100, P15131, DOI 10.1073/pnas.2436476100; Peruchon S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005966; Richman DD, 2003, P NATL ACAD SCI USA, V100, P4144, DOI 10.1073/pnas.0630530100; Sanz I, 2008, SEMIN IMMUNOL, V20, P67, DOI 10.1016/j.smim.2007.12.006; Shibata R, 1999, NAT MED, V5, P204, DOI 10.1038/5568; Shikina T, 2004, J IMMUNOL, V172, P6259, DOI 10.4049/jimmunol.172.10.6259; Shingai M, 2013, NATURE, V503, P277, DOI 10.1038/nature12746; Tan RCH, 1999, J MED PRIMATOL, V28, P164, DOI 10.1111/j.1600-0684.1999.tb00265.x; Vossenkamper A, 2013, J EXP MED, V210, P1665, DOI 10.1084/jem.20122465; Zhang ZQ, 2007, VIROLOGY, V361, P455, DOI 10.1016/j.virol.2006.12.006	47	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2017	12	2							e0172524	10.1371/journal.pone.0172524	http://dx.doi.org/10.1371/journal.pone.0172524			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5QV	28222180	Green Published, gold			2022-12-27	WOS:000394676800064
J	Ngole-Jeme, VM; Fantke, P				Ngole-Jeme, Veronica Mpode; Fantke, Peter			Ecological and human health risks associated with abandoned gold mine tailings contaminated soil	PLOS ONE			English	Article							HEAVY-METAL CONTAMINATION; SEDIMENTS; POLLUTION; PLANTS; BIOREMEDIATION; ECOTOXICITY; TOXICITY; EXPOSURE; PROVINCE; DUST	Gold mining is a major source of metal and metalloid emissions into the environment. Studies were carried out in Krugersdorp, South Africa, to evaluate the ecological and human health risks associated with exposure to metals and metalloids in mine tailings contaminated soils. Concentrations of arsenic (As), cadmium (Cd), chromium (Cr), cobalt (Co), copper (Cu), lead (Pb), manganese (Mn), nickel (Ni), and zinc (Zn) in soil samples from the area varied with the highest contamination factors (expressed as ratio of metal or metalloid concentration in the tailings contaminated soil to that of the control site) observed for As (3.5x10(2)), Co (2.8x10(2)) and Ni (1.1x10(2)). Potential ecological risk index values for metals and metalloids determined from soil metal and metalloid concentrations and their respective risk factors were correspondingly highest for As (3.5x10(3)) and Co (1.4x10(3)), whereas Mn (0.6) presented the lowest ecological risk. Human health risk was assessed using Hazard Quotient (HQ), Chronic Hazard Index (CHI) and carcinogenic risk levels, where values of HQ > 1, CHI > 1 and carcinogenic risk values > 1x10(-4) represent elevated risks. Values for HQ indicated high exposure-related risk for As (53.7), Cr (14.8), Ni (2.2), Zn (2.64) and Mn (1.67). Children were more at risk from heavy metal and metalloid exposure than adults. Cancer-related risks associated with metal and metalloid exposure among children were also higher than in adults with cancer risk values of 3x10(-2) and 4x10(-2) for As and Ni respectively among children, and 5x10(-3) and 4x10(-3) for As and Ni respectively among adults. There is significant potential ecological and human health risk associated with metal and metalloid exposure from contaminated soils around gold mine tailings dumps. This could be a potential contributing factor to a setback in the health of residents in informal settlements dominating this mining area as the immune systems of some of these residents are already compromised by high HIV prevalence.	[Ngole-Jeme, Veronica Mpode] Univ South Africa, Dept Environm Sci, Sch Ecol & Human Sustainabil, Coll Agr & Environm Sci, Roodepoort, Gauteng Provinc, South Africa; [Fantke, Peter] Tech Univ Denmark, Dept Engn Management, Quantitat Sustainabil Assessment Div, Lyngby, Denmark	University of South Africa; Technical University of Denmark	Ngole-Jeme, VM (corresponding author), Univ South Africa, Dept Environm Sci, Sch Ecol & Human Sustainabil, Coll Agr & Environm Sci, Roodepoort, Gauteng Provinc, South Africa.	vm.ngole@gmail.com	Fantke, Peter/N-2704-2015; Jeme, Veronica/AFK-5964-2022; Fantke, Peter/GRO-6285-2022; Ngole-Jeme, Veronica/E-2932-2018; Fantke, Peter/N-3617-2019	Fantke, Peter/0000-0001-7148-6982; Jeme, Veronica/0000-0003-4470-2285; Fantke, Peter/0000-0001-7148-6982; Ngole-Jeme, Veronica/0000-0003-4470-2285; 	National Research Foundation of South Africa [82534]; Marie Curie project Quan-Tox - European Commission under the Seventh Framework Programme [631910]	National Research Foundation of South Africa(National Research Foundation - South Africa); Marie Curie project Quan-Tox - European Commission under the Seventh Framework Programme	This work is based on the research supported in part by the National Research Foundation of South Africa (Grant Number: 82534) and in part by the Marie Curie project Quan-Tox (grant agreement no. 631910) funded by the European Commission under the Seventh Framework Programme.	Abdul-Wahab SA, 2012, OPEN ENG, V2, P304, DOI 10.2478/s13531-011-0052-3; Alissa EM, 2011, J TOXICOL-US, V2011, DOI 10.1155/2011/870125; [Anonymous], 2016, CAS STUD ENV MED CSE; [Anonymous], 2013, INT J APPL SCI TECHN; Armah Frederick Ato, 2014, Int Sch Res Notices, V2014, P252148, DOI 10.1155/2014/252148; *ATSDR, 2016, TOX SUBST PORT TOX P; BRIME C, 1985, MINERAL MAG, V49, P531, DOI 10.1180/minmag.1985.049.353.06; Cairncross E, 2013, CASE STUDY EXTRACTIV; Candeias C, 2014, GEOSCIENCES, V4, P240, DOI 10.3390/geosciences4040240; Chamber of Mines, 2011, CHAMB MIN S AFR ANN; Chen SC, 2006, SCI TOTAL ENVIRON, V366, P112, DOI 10.1016/j.scitotenv.2005.08.047; Chen TB, 2005, CHEMOSPHERE, V60, P542, DOI 10.1016/j.chemosphere.2004.12.072; Chibuike G.U., 2014, APPL ENVIRON SOIL SC, DOI [10.1155/2014/752708, DOI 10.1155/2014/752708, 10.1155/ 2014/752708]; Coetzee H, 2009, 11 SAGA M EXH SWAZ 2, P461; CPCB, 2008, DISTR BROCH KANP NAG; Department of Environmental Affairs, 2014, 37603 GOV S AFR; Donkor AK, 2005, SOIL SEDIMENT CONTAM, V14, P479, DOI 10.1080/15320380500263675; Eisler R, 2004, REV ENVIRON CONTAM T, V180, P133, DOI 10.1007/0-387-21729-0_3; Emamverdian Abolghassem, 2015, ScientificWorldJournal, V2015, P756120, DOI 10.1155/2015/756120; Fayiga AO, 2004, ENVIRON POLLUT, V132, P289, DOI 10.1016/j.envpol.2004.04.020; Ferreira-Baptista L, 2005, ATMOS ENVIRON, V39, P4501, DOI 10.1016/j.atmosenv.2005.03.026; Finnegan PM, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00182; Franco-Hernandez MO, 2010, BIORESOURCE TECHNOL, V101, P3864, DOI 10.1016/j.biortech.2010.01.013; Gall JE, 2015, ENVIRON MONIT ASSESS, V187, DOI 10.1007/s10661-015-4436-3; Geosciences Cf, 2016, GUID SERV CGS AN LAB; Goddard SL, 2014, SENSORS-BASEL, V14, P21676, DOI 10.3390/s141121676; Gong QJ, 2008, J CHINA UNIV GEOSCI, V19, P230, DOI 10.1016/S1002-0705(08)60042-4; Grimalt JO, 1999, SCI TOTAL ENVIRON, V242, P3, DOI 10.1016/S0048-9697(99)00372-1; Gzik Axel, 2003, Journal of Soils and Sediments, V3, P29, DOI 10.1007/BF02989466; HAKANSON L, 1980, WATER RES, V14, P975, DOI 10.1016/0043-1354(80)90143-8; Holtz RD., 2011, INTRO GEOTECHNICAL E, V2; Hu X, 2011, ENVIRON POLLUT, V159, P1215, DOI 10.1016/j.envpol.2011.01.037; ICDD, 2002, MIN POWD DIFFR FIL D; Jaishankar Monisha, 2014, Interdiscip Toxicol, V7, P60, DOI 10.2478/intox-2014-0009; Jiao XD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127736; Kaasalainen M, 2003, ENVIRON POLLUT, V126, P225, DOI 10.1016/S0269-7491(03)00191-X; Kabata-Pendias A., 2001, TRACE METALS SOILS P, V3; Kong SF, 2012, J ENVIRON MONITOR, V14, P791, DOI 10.1039/c1em10555h; Kurt-Karakus PB, 2012, ENVIRON INT, V50, P47, DOI 10.1016/j.envint.2012.09.011; Lee JS, 2005, ENVIRON GEOCHEM HLTH, V27, P185, DOI 10.1007/s10653-005-0131-6; Lomonte C, 2008, CHEMOSPHERE, V72, P1420, DOI 10.1016/j.chemosphere.2008.05.033; Loska K, 2003, CHEMOSPHERE, V51, P723, DOI 10.1016/S0045-6535(03)00187-5; McCarthy TS, 2011, S AFR J SCI, V107, P1, DOI 10.4102/sajs.v107i5/6.712; Meunier L, 2010, ENVIRON SCI TECHNOL, V44, P2667, DOI 10.1021/es9035682; Migliorini M, 2004, ENVIRON POLLUT, V129, P331, DOI 10.1016/j.envpol.2003.09.025; Monachese M, 2012, APPL ENVIRON MICROB, V78, P6397, DOI 10.1128/AEM.01665-12; Nengovhela AC, 2006, S AFRICA WATER SA, V32, P8; Ngole VM, 2012, J SCI RES ESSAY, V7, P12; Njinga RL, 2016, J RADIAT RES APPL SC, V9, P310, DOI 10.1016/j.jrras.2016.02.003; Owsianiak M, 2015, ENVIRON POLLUT, V206, P400, DOI 10.1016/j.envpol.2015.07.025; Percival JB, 2014, GEOCHEM-EXPLOR ENV A, V14, P3, DOI 10.1144/geochem2011-071; Qu CS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046793; Rasmussen PE, 1998, ENVIRON GEOL, V33, P96, DOI 10.1007/s002540050229; Rosenbaum RK, 2008, INT J LIFE CYCLE ASS, V13, P532, DOI 10.1007/s11367-008-0038-4; Scragg A., 2006, ENV BIOTECHNOLOGY; Sethy Sunil Kumar, 2013, J Nat Sci Biol Med, V4, P272, DOI 10.4103/0976-9668.116964; Short R, 2008, GOLD S AFRICA MINING; Singh R, 2011, INDIAN J PHARM, V43, P7; Sobolev Dmitri, 2008, Int J Environ Res Public Health, V5, P450; Soliman NF, 2015, J ENVIRON HEALTH SCI, V13, DOI 10.1186/s40201-015-0223-x; Song DP, 2015, INT J ENV RES PUB HE, V12, P7100, DOI 10.3390/ijerph120707100; Sreekanth TVM, 2013, INT J ENVIRON SCI TE, V10, P1129, DOI 10.1007/s13762-013-0245-9; Steenkamp L, 2014, AJAR-AFR J AIDS RES, V13, P271, DOI 10.2989/16085906.2014.952651; Straskraba V., 1990, INT J MINE WATER, V9, P181; Tahiri M, 2002, BRIT J NUTR, V87, P47, DOI 10.1079/BJN2001476; Tariq FS, 2016, APPL ENV SOIL SCI, V2016, P12; United States Environmental Protection Agency (US-EPA), 1989, EXP FACT HDB; USEPA, 2014, REM INV FEAS STUD, P483; USEPA, 2010, RISK ASSESSMENT GUID; USEPA (United States Environmental Protection Agency), 1996, SOIL SCREEN GUID TEC; Van Reeuwijk LP, 2002, 09 ISRIC, V6; Westh TB, 2015, INT J LIFE CYCLE ASS, V20, P299, DOI 10.1007/s11367-014-0829-8; Whitehead MW, 1996, GUT, V39, P625, DOI 10.1136/gut.39.5.625; Wu QH, 2014, ECOTOX ENVIRON SAFE, V104, P143, DOI 10.1016/j.ecoenv.2014.02.017; Zheng N, 2010, SCI TOTAL ENVIRON, V408, P726, DOI 10.1016/j.scitotenv.2009.10.075; Zhou JM, 2007, PEDOSPHERE, V17, P588, DOI 10.1016/S1002-0160(07)60069-1; Zhu W, 2008, ENVIRON MONIT ASSESS, V147, P171, DOI 10.1007/s10661-007-0108-2	77	110	113	7	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2017	12	2							e0172517	10.1371/journal.pone.0172517	http://dx.doi.org/10.1371/journal.pone.0172517			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5QV	28222184	Green Published, gold, Green Submitted			2022-12-27	WOS:000394676800063
J	Ortuno-Sierra, J; Aritio-Solana, R; Inchausti, F; de Luis, EC; Molina, BL; de Albeniz, AP; Fonseca-Pedrero, E				Ortuno-Sierra, Javier; Aritio-Solana, Rebeca; Inchausti, Felix; Chocarro de Luis, Edurne; Lucas Molina, Beatriz; Perez de Albeniz, Alicia; Fonseca-Pedrero, Eduardo			Screening for depressive symptoms in adolescents at school: New validity evidences on the short form of the Reynolds Depression Scale	PLOS ONE			English	Article							MEASUREMENT INVARIANCE; FIT INDEXES; PREVALENCE; DISORDERS; EQUIVALENCE; VALIDATION; GENDER	The main purpose of the present study was to assess the depressive symptomatology and to gather new validity evidences of the Reynolds Depression Scale-Short form (RADS-SF) in a representative sample of youths. The sample consisted of 2914 adolescents with a mean age of 15.85 years (SD = 1.68). We calculated the descriptive statistics and internal consistency of the RADS-SF scores. Also, confirmatory factor analyses (CFAs) at the item level and successive multigroup CFAs to test measurement invariance, were conducted. Latent mean differences across gender and educational level groups were estimated, and finally, we studied the sources of validity evidences with other external variables. The level of internal consistency of the RADS-SF Total score by means of Ordinal alpha was .89. Results from CFAs showed that the one-dimensional model displayed appropriate goodness of-fit indices with CFI value over .95, and RMSEA value under .08. In addition, the results support the strong measurement invariance of the RADS-SF scores across gender and age. When latent means were compared, statistically significant differences were found by gender and age. Females scored 0.347 over than males in Depression latent variable, whereas older adolescents scored 0.111 higher than the younger group. In addition, the RADS-SF score was associated with the RADS scores. The results suggest that the RADS-SF could be used as an efficient screening test to assess self-reported depressive symptoms in adolescents from the general population.	[Ortuno-Sierra, Javier] Univ Loyola Andalucia, Dept Psychol, Seville, Spain; [Ortuno-Sierra, Javier; Aritio-Solana, Rebeca; Chocarro de Luis, Edurne; Perez de Albeniz, Alicia; Fonseca-Pedrero, Eduardo] Univ La Rioja, Dept Educ Sci, Logrono, Spain; [Inchausti, Felix] Navarres Hlth Syst, Pamplona, Spain; [Lucas Molina, Beatriz] Univ Valencia, Dept Psychol, Valencia, Spain	Universidad Loyola Andalucia; Universidad de La Rioja; University of Valencia	Ortuno-Sierra, J (corresponding author), Univ Loyola Andalucia, Dept Psychol, Seville, Spain.; Ortuno-Sierra, J (corresponding author), Univ La Rioja, Dept Educ Sci, Logrono, Spain.	javier.ortuno@unirioja.es	Inchausti, Felix/AAM-2189-2020; Fonseca, Eduardo/L-4848-2019; Inchausti, Felix/AAM-5892-2020; Lucas-Molina, Beatriz/K-6070-2017; Solana, Rebeca Aritio/ABH-2250-2020; Lucas-Molina, Beatriz/AAW-3175-2020	Inchausti, Felix/0000-0003-0610-8170; Lucas-Molina, Beatriz/0000-0003-4370-4799; Lucas-Molina, Beatriz/0000-0003-4370-4799; Aritio Solana, Rebeca/0000-0002-5069-2645				Angold A, 2002, J CHILD PSYCHOL PSYC, V43, P1052, DOI 10.1111/1469-7610.00232; Bae SM, 2015, NEUROPSYCH DIS TREAT, V11, P2367, DOI 10.2147/NDT.S91111; Beddington J, 2008, NATURE, V455, P1057, DOI 10.1038/4551057a; Brown T.A., 2006, CONFIRMATORY FACTOR, Vxiii; Byrne B.M., 2012, STRUCTURAL EQUATION; Byrne BM, 2008, PSICOTHEMA, V20, P872; Carle AC, 2008, EDUC PSYCHOL MEAS, V68, P281, DOI 10.1177/0013164407308471; Cheung GW, 2002, STRUCT EQU MODELING, V9, P233, DOI 10.1207/S15328007SEM0902_5; Costello EJ, 2003, ARCH GEN PSYCHIAT, V60, P837, DOI 10.1001/archpsyc.60.8.837; Crengle S, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-45; Figueras-Masip A, 2008, INT J CLIN HLTH PSYC, V8, P247; Fonseca-Pedrero E, 2011, COMPR PSYCHIAT, V52, P293, DOI 10.1016/j.comppsych.2010.07.001; Fonseca-Pedrero E, 2010, INT J TEST, V10, P133, DOI 10.1080/15305050903580822; Fonseca-Pedrero E, 2009, SCHIZOPHR RES, V111, P53, DOI 10.1016/j.schres.2009.03.006; Gore FM, 2011, LANCET, V377, P2093, DOI 10.1016/S0140-6736(11)60512-6; Heene M, 2012, STRUCT EQU MODELING, V19, P36, DOI 10.1080/10705511.2012.634710; Horwitz AG, 2011, J ADOLESCENCE, V34, P1077, DOI 10.1016/j.adolescence.2010.10.004; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Hyun MS, 2009, J ADV NURS, V65, P642, DOI 10.1111/j.1365-2648.2008.04913.x; Kays JL, 2012, J NEUROPSYCH CLIN N, V24, P118, DOI 10.1176/appi.neuropsych.12050109; Kessler RC, 2001, BIOL PSYCHIAT, V49, P1002, DOI 10.1016/S0006-3223(01)01129-5; Kessler RC, 2012, ARCH GEN PSYCHIAT, V69, P372, DOI 10.1001/archgenpsychiatry.2011.160; Kovacs M., 1992, MANUAL CHILDRENS DEP; Lorenzo-Seva U, 2006, BEHAV RES METHODS, V38, P88, DOI 10.3758/BF03192753; Lucassen MFG, 2011, AUST NZ J PSYCHIAT, V45, P376, DOI 10.3109/00048674.2011.559635; Maharajh HD, 2006, EUR CHILD ADOLES PSY, V15, P30, DOI 10.1007/s00787-006-0501-3; MEREDITH W, 1993, PSYCHOMETRIKA, V58, P525, DOI 10.1007/BF02294825; Merikangas KR, 2010, J AM ACAD CHILD PSY, V49, P980, DOI 10.1016/j.jaac.2010.05.017; Milfont TL, 2008, AUST NZ J PSYCHIAT, V42, P950, DOI 10.1080/00048670802415343; Milfont TL, 2010, INT J PSYCHOL RES, V3, P111; Muthen B.O., 2012, MPLUS USERS GUIDE, V7th; Ortuno-Sierra J, 2014, REV PSIQUIATR SALUD, V7, P121, DOI 10.1016/j.rpsm.2013.12.003; PETERSEN AC, 1993, AM PSYCHOL, V48, P155, DOI 10.1037/0003-066X.48.2.155; Reynolds W., 2002, REYNOLDS ADOLESCENT; Reynolds W.M., 1998, COMPREHENSIVE CLIN P, P419, DOI [10.1016/B0080-4270(73)00135-8, DOI 10.1016/B0080-4270(73)00135-8]; Reynolds W.M., 2008, REYNOLDS ADOLESCENT; Reynolds WM, 1998, J SCHOOL PSYCHOL, V36, P295, DOI 10.1016/S0022-4405(98)00010-7; Reynolds WM., 2002, REYNOLDS ADOLESCENT, V2nd; Riglin L, 2015, JOURNAL CHILD PSYCHO; Salmela-Aro K, 2011, ENCY ADOLESCENCE, P360; Schmeiser CB, 2006, ED MEASUREMENT, P307; Statistical Package for the Social Sciences, 2006, STAT PACKAGE SOCIAL; Szabo A, 2014, J CLIN CHILD ADOLESC, V43, P592, DOI 10.1080/15374416.2013.848770; Tisher M., 1987, CHILDRENS DEPRESSION; Walker L, 2005, AUST NZ J PSYCHIAT, V39, P136, DOI 10.1080/j.1440-1614.2005.01534.x; Yu C.-Y., 2002, THESIS; Zumbo BD, 2007, J MOD APPL STAT METH, V6, P21, DOI 10.22237/jmasm/1177992180	47	13	13	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2017	12	2							e0170950	10.1371/journal.pone.0170950	http://dx.doi.org/10.1371/journal.pone.0170950			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL5QV	28222193	Green Published, Green Submitted, gold			2022-12-27	WOS:000394676800005
J	Chan, RB; Perotte, AJ; Zhou, BW; Liong, C; Shorr, EJ; Marder, KS; Kang, UJ; Waters, CH; Levy, OA; Xu, YM; Bin Shim, H; Pe'er, I; Di Paolo, G; Alcalay, RN				Chan, Robin B.; Perotte, Adler J.; Zhou, Bowen; Liong, Christopher; Shorr, Evan J.; Marder, Karen S.; Kang, Un J.; Waters, Cheryl H.; Levy, Oren A.; Xu, Yimeng; Bin Shim, Hong; Pe'er, Itsik; Di Paolo, Gilbert; Alcalay, Roy N.			Elevated GM3 plasma concentration in idiopathic Parkinson's disease: A lipidomic analysis	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; ALPHA-SYNUCLEIN; GLUCOCEREBROSIDASE ACTIVITY; APOLIPOPROTEIN A1; ALZHEIMER-DISEASE; GAUCHER-DISEASE; MEMBRANE-LIPIDS; GBA MUTATIONS; HUMAN BRAIN; BLOOD	Parkinson's disease ( PD) is a common neurodegenerative disease whose pathological hallmark is the accumulation of intracellular a-synuclein aggregates in Lewy bodies. Lipid metabolism dysregulation may play a significant role in PD pathogenesis; however, large plasma lipidomic studies in PD are lacking. In the current study, we analyzed the lipidomic profile of plasma obtained from 150 idiopathic PD patients and 100 controls, taken from the 'Spot' study at Columbia University Medical Center in New York. Our mass spectrometry based analytical panel consisted of 520 lipid species from 39 lipid subclasses including all major classes of glycerophospholipids, sphingolipids, glycerolipids and sterols. Each lipid species was analyzed using a logistic regression model. The plasma concentrations of two lipid subclasses, triglycerides and monosialodihexosylganglioside ( GM3), were different between PD and control participants. GM3 ganglioside concentration had the most significant difference between PD and controls ( 1.531+/-0.037 pmol/mu l versus 1.337+/-0.040 pmol/mu l respectively; p-value = 5.96E-04; q-value = 0.048; when normalized to total lipid: p-value = 2.890E-05; q-value = 2.933E-03). Next, we used a collection of 20 GM3 and glucosylceramide ( GlcCer) species concentrations normalized to total lipid to perform a ROC curve analysis, and found that these lipids compare favorably with biomarkers reported in previous studies ( AUC = 0.742 for males, AUC = 0.644 for females). Our results suggest that higher plasma GM3 levels are associated with PD. GM3 lies in the same glycosphingolipid metabolic pathway as GlcCer, a substrate of the enzyme glucocerebrosidase, which has been associated with PD. These findings are consistent with previous reports implicating lower glucocerebrosidase activity with PD risk.	[Chan, Robin B.; Zhou, Bowen; Xu, Yimeng; Di Paolo, Gilbert] Columbia Univ, Dept Pathol & Cell Biol, Med Ctr, New York, NY 10027 USA; [Chan, Robin B.; Marder, Karen S.; Xu, Yimeng; Di Paolo, Gilbert; Alcalay, Roy N.] Columbia Univ, Med Ctr, Taub Inst Res Alzheimers Dis & Aging Brain, New York, NY 10027 USA; [Perotte, Adler J.; Bin Shim, Hong; Pe'er, Itsik] Columbia Univ, Med Ctr, Dept Biomed Informat, New York, NY USA; [Liong, Christopher; Shorr, Evan J.; Marder, Karen S.; Kang, Un J.; Waters, Cheryl H.; Levy, Oren A.; Alcalay, Roy N.] Columbia Univ, Med Ctr, Dept Neurol, New York, NY 10027 USA; [Di Paolo, Gilbert] Denali Therapeut, San Francisco, CA USA	Columbia University; Columbia University; Columbia University; Columbia University	Di Paolo, G (corresponding author), Columbia Univ, Dept Pathol & Cell Biol, Med Ctr, New York, NY 10027 USA.; Di Paolo, G; Alcalay, RN (corresponding author), Columbia Univ, Med Ctr, Taub Inst Res Alzheimers Dis & Aging Brain, New York, NY 10027 USA.; Alcalay, RN (corresponding author), Columbia Univ, Med Ctr, Dept Neurol, New York, NY 10027 USA.; Di Paolo, G (corresponding author), Denali Therapeut, San Francisco, CA USA.	gd2175@cumc.columbia.edu; rna2104@cumc.columbia.edu	Kang, Un/AAV-2858-2020; Levey, Allan/F-2104-2011	Kang, Un/0000-0002-5970-6839; Levey, Allan/0000-0002-3153-502X; Zhou, Bowen/0000-0003-4421-9787; Perotte, Adler/0000-0002-6695-0282	NINDS NIH HHS [K02 NS080915] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K02NS080915] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Alcalay RN, 2015, BRAIN, V138, P2648, DOI 10.1093/brain/awv179; Alcalay RN, 2014, JAMA NEUROL, V71, P752, DOI 10.1001/jamaneurol.2014.313; Auluck PK, 2010, ANNU REV CELL DEV BI, V26, P211, DOI 10.1146/annurev.cellbio.042308.113313; Begum H, 2016, SCI REP-UK, V6, DOI 10.1038/srep19139; Bjorkhem I, 2013, NEUROSCI LETT, V555, P102, DOI 10.1016/j.neulet.2013.09.003; Blanz J., 2016, J NEUROCHEM; Block RC, 2010, J CLIN LIPIDOL, V4, P17, DOI 10.1016/j.jacl.2009.11.003; Bray MS, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.R110.214643; Chan RB, 2012, J BIOL CHEM, V287, P2678, DOI 10.1074/jbc.M111.274142; Chiasserini D, 2015, MOL NEURODEGENER, V10, DOI 10.1186/s13024-015-0010-2; Clague MJ, 2016, CURR BIOL, V26, pR332, DOI 10.1016/j.cub.2016.03.001; Clark LN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125204; Di Paolo G, 2011, NAT REV NEUROSCI, V12, P284, DOI 10.1038/nrn3012; Di Pasquale E, 2010, J MOL BIOL, V397, P202, DOI 10.1016/j.jmb.2010.01.046; Gan-Or Z, 2013, NEUROLOGY, V80, P1606, DOI 10.1212/WNL.0b013e31828f180e; Gegg ME, 2015, MOVEMENT DISORD, V30, P1085, DOI 10.1002/mds.26278; Gegg ME, 2012, ANN NEUROL, V72, P455, DOI 10.1002/ana.23614; Grey M, 2015, J BIOL CHEM, V290, P2969, DOI 10.1074/jbc.M114.585703; Gulati S, 2015, CELL HOST MICROBE, V18, P371, DOI 10.1016/j.chom.2015.08.003; Hodson L, 2009, AM J PHYSIOL-ENDOC M, V296, pE64, DOI 10.1152/ajpendo.90730.2008; Iyer A, 2014, BIOPHYS J, V106, P2585, DOI 10.1016/j.bpj.2014.05.001; Jenco JM, 1998, BIOCHEMISTRY-US, V37, P4901, DOI 10.1021/bi972776r; Kim HJ, 2016, PARKINSONISM RELAT D, V23, P99, DOI 10.1016/j.parkreldis.2015.12.002; Kolter T, 2010, FEBS LETT, V584, P1700, DOI 10.1016/j.febslet.2009.10.021; Lee HJ, 2014, NAT REV NEUROL, V10, P92, DOI 10.1038/nrneurol.2013.275; Li ZG, 2015, J CLIN NEUROSCI, V22, P1268, DOI 10.1016/j.jocn.2015.02.013; Manzoni C, 2013, FASEB J, V27, P3424, DOI 10.1096/fj.12-223842; Marder K, 2003, NEUROLOGY, V61, P18, DOI 10.1212/01.WNL.0000074784.35961.C0; Mattson MP, 2004, ANN NY ACAD SCI, V1012, P37, DOI 10.1196/annals.1306.004; Meikle PJ, 2008, BLOOD CELL MOL DIS, V40, P420, DOI 10.1016/j.bcmd.2007.10.004; Mielke MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073094; Murphy KE, 2014, AUTOPHAGY, V10, P1350, DOI 10.4161/auto.29074; Murphy KE, 2014, BRAIN, V137, P834, DOI 10.1093/brain/awt367; Nalls MA, 2014, NAT GENET, V46, P989, DOI 10.1038/ng.3043; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Pan Ping-Yue, 2014, Parkinsonism Relat Disord, V20 Suppl 1, pS154, DOI 10.1016/S1353-8020(13)70037-3; Papagiannakis N, 2015, MOVEMENT DISORD, V30, P1830, DOI 10.1002/mds.26433; Pilsl A, 2012, ACTA NEUROPATHOL, V123, P173, DOI 10.1007/s00401-011-0902-3; Proia RL, 2004, NAT GENET, V36, P1147, DOI 10.1038/ng1104-1147; Qiang JK, 2013, ANN NEUROL, V74, P119, DOI 10.1002/ana.23872; Ruiperez V, 2010, PROG LIPID RES, V49, P420, DOI 10.1016/j.plipres.2010.05.004; Sakanaka K, 2014, J GENET COUNS, V23, P114, DOI 10.1007/s10897-013-9618-y; Small SA, 2015, NAT REV NEUROSCI, V16, P126, DOI 10.1038/nrn3896; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; SVENNERHOLM L, 1994, J NEUROCHEM, V63, P1802; Swanson CR, 2015, MOVEMENT DISORD, V30, P1648, DOI 10.1002/mds.26290; Vlugt KGVD, 2008, CLIN CHIM ACTA, V389, P109, DOI 10.1016/j.cca.2007.12.001; Weir JM, 2013, J LIPID RES, V54, P2898, DOI 10.1194/jlr.P035808	48	56	56	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2017	12	2							e0172348	10.1371/journal.pone.0172348	http://dx.doi.org/10.1371/journal.pone.0172348			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BI	28212433	Green Published, gold, Green Submitted			2022-12-27	WOS:000394424700036
J	Garcia-Basteiro, AL; Quinto, L; Macete, E; Bardaj, A; Gonzalez, R; Nhacolo, A; Sigauque, B; Sacoor, C; Ruperez, M; Sicuri, E; Bassat, Q; Sevene, E; Menendez, C				Garcia-Basteiro, Alberto L.; Quinto, Llorenc; Macete, Eusebio; Bardaj, Azucena; Gonzalez, Raquel; Nhacolo, Arsenio; Sigauque, Betuel; Sacoor, Charfudin; Ruperez, Maria; Sicuri, Elisa; Bassat, Quique; Sevene, Esperanca; Menendez, Clara			Infant mortality and morbidity associated with preterm and small-for-gestational-age births in Southern Mozambique: A retrospective cohort study	PLOS ONE			English	Article							MIDDLE-INCOME COUNTRIES; PREVALENCE; INDEXES; RISK	Background Preterm and small for gestational age (SGA) births have been associated with adverse outcomes during the first stages of life. We evaluated the morbidity and mortality associated with preterm and SGA births during the first year of life in a rural area of Southern Mozambique. Methods This is a retrospective cohort study using previously collected data from children born at the Manhic E a District Hospital in two different periods (2003-2005 and 2010-2012). Newborns were classified as being preterm and/or SGA or as babies not fulfilling any of the previous conditions (term non-SGA). All children were followed up for a year for morbidity and mortality outcomes. Results A total of 5574 live babies were included in the analysis. The prevalence of preterm delivery was 6.2% (345/5574); the prevalence of SGA was 14.0% (776/5542) and 2.2% (114/5542) of the children presented both conditions. During the neonatal period, preterm delivery and SGA were associated with 13 (HR: 13.0, 95% CI 4.0-42.2) and 5 times (HR: 4.5, 95% CI: 1.6-12.6) higher mortality compared to term non SGA babies. Risk of hospitalization was only increased when both conditions were present (IRR: 3.5, 95% CI: 1.5-8.1). Mortality is also increased during the entire first year, although at a lower rate. Conclusions Neonatal and infant mortality rates are remarkably high among preterm and SGA babies in southern Mozambique. These increased rates are concentrated within the neonatal period. Prompt identification of these conditions is needed to implement interventions aimed at increasing survival of these high-risk newborns.	[Garcia-Basteiro, Alberto L.; Macete, Eusebio; Bardaj, Azucena; Gonzalez, Raquel; Nhacolo, Arsenio; Sigauque, Betuel; Sacoor, Charfudin; Ruperez, Maria; Sicuri, Elisa; Bassat, Quique; Sevene, Esperanca; Menendez, Clara] Ctr Invest Saude Manhica, Manhica, Maputo Province, Mozambique; [Garcia-Basteiro, Alberto L.; Quinto, Llorenc; Bardaj, Azucena; Gonzalez, Raquel; Ruperez, Maria; Sicuri, Elisa; Bassat, Quique; Menendez, Clara] Univ Barcelona, Hosp Clin, Barcelona Ctr Int Hlth Res, ISGlobal, Barcelona, Spain; [Garcia-Basteiro, Alberto L.] Acad Med Ctr, Amsterdam Inst Global Hlth & Dev, Amsterdam, Netherlands; [Ruperez, Maria; Menendez, Clara] Consorcio Invest Biomed Red Epidemiol & Salud Pub, Barcelona, Spain; [Sicuri, Elisa] Imperial Coll London, Sch Publ Hlth, London, England	Centro de Investigacao em Saude de Manhica; ISGlobal; CRESIB; University of Barcelona; Hospital Clinic de Barcelona; University of Amsterdam; Academic Medical Center Amsterdam; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Imperial College London	Garcia-Basteiro, AL (corresponding author), Ctr Invest Saude Manhica, Manhica, Maputo Province, Mozambique.; Garcia-Basteiro, AL (corresponding author), Univ Barcelona, Hosp Clin, Barcelona Ctr Int Hlth Res, ISGlobal, Barcelona, Spain.; Garcia-Basteiro, AL (corresponding author), Acad Med Ctr, Amsterdam Inst Global Hlth & Dev, Amsterdam, Netherlands.	alberto.garcia-basteiro@manhica.net	Menéndez, Clara/Q-3446-2016; Bardají, Azucena/AAE-9145-2019; Sevene, Esperança/AAI-3532-2020; Gonzalez, Raquel/J-3604-2017; Alonso, Azucena Bardají/V-5978-2018; Bassat, Quique/P-2341-2016; Sicuri, Elisa/L-8012-2014	Menéndez, Clara/0000-0002-2641-6907; Gonzalez, Raquel/0000-0001-5487-801X; Alonso, Azucena Bardají/0000-0002-5135-0540; Bassat, Quique/0000-0003-0875-7596; Sicuri, Elisa/0000-0002-2499-2732; Quinto, Llorenc/0000-0001-9992-6951; Ruperez, Maria/0000-0001-8322-7881; Nhacolo, Arsenio/0000-0003-1055-6769	Spanish program Rio Hortega of the ISCIII [CM12/00246]; Spanish Epidemiology Society	Spanish program Rio Hortega of the ISCIII; Spanish Epidemiology Society	Salary fellowship (ALGB) from the Spanish program Rio Hortega of the ISCIII (grant number: CM12/00246) and Spanish Epidemiology Society. No further specific funding was needed for the conduct for this work.	[Anonymous], 1977, Acta Obstet Gynecol Scand, V56, P247; Ashish KC, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2232-1; BALLARD JL, 1991, J PEDIATR-US, V119, P417, DOI 10.1016/S0022-3476(05)82056-6; Bamberg Christian, 2004, Semin Fetal Neonatal Med, V9, P387; Beck S, 2010, B WORLD HEALTH ORGAN, V88, P31, DOI 10.2471/BLT.08.062554; Black RE, 2015, NESTLE NUTR WORKS SE, V81, P1, DOI 10.1159/000365790; Blencowe H, 2013, REPROD HEALTH, V10, DOI 10.1186/1742-4755-10-S1-S2; DUBOWITZ LM, 1970, J PEDIATR-US, V77, P1, DOI 10.1016/S0022-3476(70)80038-5; Feresu SA, 2002, INT J GYNECOL OBSTET, V78, P7, DOI 10.1016/S0020-7292(02)00094-2; Gladstone M, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001121; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Gonzalez R, 2012, HIV MED, V13, P581, DOI 10.1111/j.1468-1293.2012.01018.x; Gonzalez R, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001735; Gonzalez R, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001733; Harrison MS, 2016, SEMIN FETAL NEONAT M, V21, P74, DOI 10.1016/j.siny.2015.12.007; Howson C, 2012, BORN TOO SOON GLOBAL; Katz J, 2013, LANCET, V382, P417, DOI 10.1016/S0140-6736(13)60993-9; Kozuki N, 2015, J NUTR, V145, P2542, DOI 10.3945/jn.115.216374; Liu L, 2015, LANCET, V385, P430, DOI 10.1016/S0140-6736(14)61698-6; Matthews LT, 2011, BMC PEDIATR, V11, DOI 10.1186/1471-2431-11-115; Menendez C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009438; Nhacolo AQ, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-291; Onwuanaku Caroline A, 2011, BMC Res Notes, V4, P562, DOI 10.1186/1756-0500-4-562; Robillard P Y, 1992, J Perinatol, V12, P115; Rosenberg RE, 2009, J HEALTH POPUL NUTR, V27, P332; Sacoor C, 2013, INT J EPIDEMIOL, V42, P1309, DOI 10.1093/ije/dyt148; Saigal S, 2008, LANCET, V371, P261, DOI 10.1016/S0140-6736(08)60136-1; Sheridan Collette, 2005, Aust Fam Physician, V34, P717; Vyas S, 2006, HEALTH POLICY PLANN, V21, P459, DOI 10.1093/heapol/czl029; Wylie BJ, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-183	30	12	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2017	12	2							e0172533	10.1371/journal.pone.0172533	http://dx.doi.org/10.1371/journal.pone.0172533			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BI	28212393	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000394424700058
J	Juan, C; Cappe, C; Alric, B; Roby, B; Gilardeau, S; Barone, P; Girard, P				Juan, Cecile; Cappe, Celine; Alric, Baptiste; Roby, Benoit; Gilardeau, Sophie; Barone, Pascal; Girard, Pascal			The variability of multisensory processes of natural stimuli in human and non-human primates in a detection task	PLOS ONE			English	Article							AUDITORY-VISUAL INTERACTIONS; GAMMA-BAND SYNCHRONIZATION; AUDIOVISUAL INTEGRATION; OBJECT DETECTION; REACTION-TIME; MODALITY; MONKEYS; CORTEX; PHASE; CATEGORIZATION	Background Behavioral studies in both human and animals generally converge to the dogma that multisensory integration improves reaction times (RTs) in comparison to unimodal stimulation. These multisensory effects depend on diverse conditions among which the most studied were the spatial and temporal congruences. Further, most of the studies are using relatively simple stimuli while in everyday life, we are confronted to a large variety of complex stimulations constantly changing our attentional focus over time, a modality switch that can impact on stimuli detection. In the present study, we examined the potential sources of the variability in reaction times and multisensory gains with respect to the intrinsic features of a large set of natural stimuli. Methodology/Principle findings Rhesus macaque monkeys and human subjects performed a simple audio-visual stimulus detection task in which a large collection of unimodal and bimodal natural stimuli with semantic specificities was presented at different saliencies. Although we were able to reproduce the well-established redundant signal effect, we failed to reveal a systematic violation of the race model which is considered to demonstrate multisensory integration. In both monkeys and human species, our study revealed a large range of multisensory gains, with negative and positive values. While modality switch has clear effects on reaction times, one of the main causes of the variability of multisensory gains appeared to be linked to the intrinsic physical parameters of the stimuli. Conclusion/Significance Based on the variability of multisensory benefits, our results suggest that the neuronal mechanisms responsible of the redundant effect (interactions vs. integration) are highly dependent on the stimulus complexity suggesting different implications of uni- and multisensory brain regions. Further, in a simple detection task, the semantic values of individual stimuli tend to have no significant impact on task performances, an effect which is probably present in more cognitive tasks.	[Juan, Cecile; Cappe, Celine; Alric, Baptiste; Roby, Benoit; Gilardeau, Sophie; Barone, Pascal; Girard, Pascal] CNRS UMR 5549, Cerco, Toulouse, France; [Juan, Cecile; Cappe, Celine; Alric, Baptiste; Roby, Benoit; Gilardeau, Sophie; Barone, Pascal; Girard, Pascal] Univ Toulouse, Ctr Rech Cerveau & Cognit, UPS, Toulouse, France; [Girard, Pascal] INSERM, Toulouse, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm)	Girard, P (corresponding author), CNRS UMR 5549, Cerco, Toulouse, France.; Girard, P (corresponding author), Univ Toulouse, Ctr Rech Cerveau & Cognit, UPS, Toulouse, France.; Girard, P (corresponding author), INSERM, Toulouse, France.	Pascal.GIRARD@cnrs.fr	Barone, Pascal/A-4008-2009; BARONE, Pascal/AHE-2323-2022; Girard, Pascal/C-6427-2009	BARONE, Pascal/0000-0003-0125-7468; 	ANR Archicore [ANR-14-CE13-0033-02]; IBM [ANR-12-PDOC-0008]	ANR Archicore(French National Research Agency (ANR)); IBM(International Business Machines (IBM))	This work was supported by ANR Archicore (ANR-14-CE13-0033-02), IBM (ANR-12-PDOC-0008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amlot R, 2003, NEUROPSYCHOLOGIA, V41, P1, DOI 10.1016/S0028-3932(02)00139-2; Bigelow J, 2016, ANIM COGN, V19, P799, DOI 10.1007/s10071-016-0979-0; Bonnefond M, 2015, PLOS ONE, V10, P1, DOI DOI 10.1371/J0URNAL.P0NE.0128667; Bonnefond Mathilde, 2013, Commun Integr Biol, V6, pe22702, DOI 10.4161/cib.22702; Brunet NM, 2014, P NATL ACAD SCI USA, V111, P3626, DOI 10.1073/pnas.1309714111; Busch NA, 2009, J NEUROSCI, V29, P7869, DOI 10.1523/JNEUROSCI.0113-09.2009; Calvert GA, 2004, J PHYSIOL-PARIS, V98, P191, DOI 10.1016/j.jphysparis.2004.03.018; Cappe C, 2009, NEUROPSYCHOLOGIA, V47, P1045, DOI 10.1016/j.neuropsychologia.2008.11.003; Cappe C, 2010, J COGNITIVE NEUROSCI, V22, P2850, DOI 10.1162/jocn.2010.21423; Chandrasekaran C, 2013, P NATL ACAD SCI USA, V110, pE4668, DOI 10.1073/pnas.1312518110; Chandrasekaran C, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002165; Chen YC, 2013, MULTISENS RES, V26, P371, DOI 10.1163/22134808-00002420; Chi T, 2005, J ACOUST SOC AM, V118, P887, DOI 10.1121/1.1945807; Cho RY, 2002, COGN AFFECT BEHAV NE, V2, P283, DOI 10.3758/CABN.2.4.283; COHEN R, 1992, ANN NY ACAD SCI, V658, P163, DOI 10.1111/j.1749-6632.1992.tb22844.x; Collignon O, 2008, BRAIN RES, V1242, P126, DOI 10.1016/j.brainres.2008.04.023; Colonius H, 2006, PSYCHOL REV, V113, P148, DOI 10.1037/0033-295X.113.1.148; Corballis MC, 1998, BRAIN, V121, P1795, DOI 10.1093/brain/121.9.1795; Corneil BD, 2002, J NEUROPHYSIOL, V88, P438, DOI 10.1152/jn.2002.88.1.438; Cox D, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00722; Diederich A, 2003, EXP BRAIN RES, V148, P328, DOI 10.1007/s00221-002-1302-7; Dufour V, 2006, BEHAV PROCESS, V73, P107, DOI 10.1016/j.beproc.2006.04.006; Dugue L, 2011, J NEUROSCI, V31, P11889, DOI 10.1523/JNEUROSCI.1161-11.2011; Eramudugolla R, 2011, BRAIN COGNITION, V75, P60, DOI 10.1016/j.bandc.2010.09.005; Fabre-Thorpe M, 1998, CAH PSYCHOL COGN, V17, P791; Felleman DJ, 1991, DISTRIBUTED HIERARCH; Fiebelkorn IC, 2011, NEW HDB MULTISENSORY, P383; Fister JK, 2016, NEUROPSYCHOLOGIA, V88, P92, DOI 10.1016/j.neuropsychologia.2016.02.016; Fize D, 2011, P NATL ACAD SCI USA, V108, P7635, DOI 10.1073/pnas.1016213108; Forster B, 2002, EXP BRAIN RES, V143, P480, DOI 10.1007/s00221-002-1017-9; Fort A, 2002, COGNITIVE BRAIN RES, V14, P20, DOI 10.1016/S0926-6410(02)00058-7; Fort A, 2002, CEREB CORTEX, V12, P1031, DOI 10.1093/cercor/12.10.1031; Foxe JJ, 2014, EUR J NEUROSCI, V39, P1960, DOI 10.1111/ejn.12577; Foxton JM, 2010, COGNITION, V115, P71, DOI 10.1016/j.cognition.2009.11.009; FRENS MA, 1995, PERCEPT PSYCHOPHYS, V57, P802, DOI 10.3758/BF03206796; Fries P, 2005, TRENDS COGN SCI, V9, P474, DOI 10.1016/j.tics.2005.08.011; Gelskov SV, 2010, COGNITION, V114, P285, DOI 10.1016/j.cognition.2009.09.012; Giard MH, 1999, J COGNITIVE NEUROSCI, V11, P473, DOI 10.1162/089892999563544; Gleiss S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045677; Golumbic EMZ, 2013, NEURON, V77, P980, DOI 10.1016/j.neuron.2012.12.037; Gondan M, 2004, PSYCHON B REV, V11, P307, DOI 10.3758/BF03196575; Gondan M, 2007, EXP BRAIN RES, V182, P199, DOI 10.1007/s00221-007-0982-4; Greene AJ, 2001, CONSCIOUS COGN, V10, P425, DOI 10.1006/ccog.2001.0502; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; Harrington LK, 1998, EXP BRAIN RES, V122, P247, DOI 10.1007/s002210050512; Hecht D, 2009, EXP BRAIN RES, V193, P307, DOI 10.1007/s00221-008-1626-z; HERSHENSON M, 1962, J EXP PSYCHOL, V63, P289, DOI 10.1037/h0039516; HUGHES HC, 1994, J EXP PSYCHOL HUMAN, V20, P131, DOI 10.1037/0096-1523.20.1.131; Joly O, 2012, NEUROIMAGE, V62, P1376, DOI 10.1016/j.neuroimage.2012.05.070; Joly O, 2012, CEREB CORTEX, V22, P838, DOI 10.1093/cercor/bhr150; Kaas JH, 2013, AM J PRIMATOL, V75, P407, DOI 10.1002/ajp.22065; Kayser C, 2008, CEREB CORTEX, V18, P1560, DOI 10.1093/cercor/bhm187; Kirchner H, 2006, VISION RES, V46, P1762, DOI 10.1016/j.visres.2005.10.002; Lakatos P, 2007, NEURON, V53, P279, DOI 10.1016/j.neuron.2006.12.011; Lakatos P, 2009, NEURON, V64, P419, DOI 10.1016/j.neuron.2009.10.014; Lehmann S, 2005, COGNITIVE BRAIN RES, V24, P326, DOI 10.1016/j.cogbrainres.2005.02.005; Li FF, 2005, VIS COGN, V12, P893, DOI 10.1080/13506280444000571; Li FF, 2002, P NATL ACAD SCI USA, V99, P9596, DOI 10.1073/pnas.092277599; Lukas S, 2010, ACTA PSYCHOL, V134, P318, DOI 10.1016/j.actpsy.2010.03.004; Lukas S, 2010, PSYCHOL RES-PSYCH FO, V74, P255, DOI 10.1007/s00426-009-0246-y; Martinez L, 2009, BEHAV PROCESS, V82, P90, DOI 10.1016/j.beproc.2009.03.010; Mathewson KE, 2009, J NEUROSCI, V29, P2725, DOI 10.1523/JNEUROSCI.3963-08.2009; Mercier MR, 2015, J NEUROSCI, V35, P8546, DOI 10.1523/JNEUROSCI.4527-14.2015; MEREDITH MA, 1987, J NEUROSCI, V7, P3215; MEREDITH MA, 1986, BRAIN RES, V365, P350; MEREDITH MA, 1986, J NEUROPHYSIOL, V56, P640, DOI 10.1152/jn.1986.56.3.640; MILLER J, 1982, COGNITIVE PSYCHOL, V14, P247, DOI 10.1016/0010-0285(82)90010-X; Mirzaei A, 2013, VISION RES, V81, P36, DOI 10.1016/j.visres.2013.02.003; Molholm S, 2002, COGNITIVE BRAIN RES, V14, P115, DOI 10.1016/S0926-6410(02)00066-6; Monto S, 2008, J NEUROSCI, V28, P8268, DOI 10.1523/JNEUROSCI.1910-08.2008; Nidiffer AR, 2016, NEUROPSYCHOLOGIA, V88, P83, DOI 10.1016/j.neuropsychologia.2016.01.031; Otto TU, 2012, CURR BIOL, V22, P1391, DOI 10.1016/j.cub.2012.05.031; Payne C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081825; POSNER MI, 1976, PSYCHOL REV, V83, P157, DOI 10.1037/0033-295X.83.2.157; Purushothaman G, 2012, NAT NEUROSCI, V15, P905, DOI 10.1038/nn.3106; Quak M, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00197; Quinlan PT, 1999, PERCEPT PSYCHOPHYS, V61, P375, DOI 10.3758/BF03206894; RAAB DH, 1962, T NEW YORK ACAD SCI, V24, P574, DOI 10.1111/j.2164-0947.1962.tb01433.x; Rapela J, 2012, IEEE ENG MED BIO, P352, DOI 10.1109/EMBC.2012.6345941; Raposo D, 2012, J NEUROSCI, V32, P3726, DOI 10.1523/JNEUROSCI.4998-11.2012; REMINGTON RJ, 1969, J EXP PSYCHOL, V82, P250, DOI 10.1037/h0028122; Rouger J, 2007, P NATL ACAD SCI USA, V104, P7295, DOI 10.1073/pnas.0609419104; Rousselet GA, 2002, NAT NEUROSCI, V5, P629, DOI 10.1038/nn866; Saalmann YB, 2012, SCIENCE, V337, P753, DOI 10.1126/science.1223082; Sandhu R, 2013, BRAIN COGNITION, V82, P90, DOI 10.1016/j.bandc.2013.02.011; Sandhu R, 2012, ACTA PSYCHOL, V140, P111, DOI 10.1016/j.actpsy.2012.04.003; Schneider TR, 2008, EXP PSYCHOL, V55, P121, DOI 10.1027/1618-3169.55.2.121; Scott BH, 2007, J NEUROSCI, V27, P6489, DOI 10.1523/JNEUROSCI.0016-07.2007; Scott BH, 2012, P NATL ACAD SCI USA, V109, P12237, DOI 10.1073/pnas.1209685109; Senkowski D, 2011, OSCILLATORY ACTIVITY, P193, DOI 10.1163/22134808-00002420; Sliwa J, 2011, P NATL ACAD SCI USA, V108, P1735, DOI 10.1073/pnas.1008169108; Spence C, 2001, PERCEPT PSYCHOPHYS, V63, P330, DOI 10.3758/BF03194473; Sperdin HF, 2009, FRONT INTEGR NEUROSC, V3, DOI 10.3389/neuro.07.002.2009; Stanford TR, 2007, NEUROREPORT, V18, P787, DOI 10.1097/WNR.0b013e3280c1e315; Stein BE, 2009, EXP BRAIN RES, V198, P113, DOI 10.1007/s00221-009-1880-8; STEIN BE, 1993, PROG BRAIN RES, V95, P79, DOI 10.1016/S0079-6123(08)60359-3; SUMBY WH, 1954, J ACOUST SOC AM, V26, P212, DOI 10.1121/1.1907309; Van Le Q, 2013, P NATL ACAD SCI USA, V110, P19000, DOI 10.1073/pnas.1312648110; von Stein A, 2000, P NATL ACAD SCI USA, V97, P14748, DOI 10.1073/pnas.97.26.14748; Wang Y, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-79; Wichmann FA, 2010, J VISION, V10, DOI 10.1167/10.4.6; Wiggs CL, 1998, CURR OPIN NEUROBIOL, V8, P227, DOI 10.1016/S0959-4388(98)80144-X; Womelsdorf T, 2006, NATURE, V439, P733, DOI 10.1038/nature04258; WRIGHT AA, 1990, ANIM LEARN BEHAV, V18, P287, DOI 10.3758/BF03205288; Yovel G, 2013, TRENDS COGN SCI, V17, P263, DOI 10.1016/j.tics.2013.04.004	105	10	10	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2017	12	2							e0172480	10.1371/journal.pone.0172480	http://dx.doi.org/10.1371/journal.pone.0172480			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL2BI	28212416	Green Submitted, Green Published, gold			2022-12-27	WOS:000394424700056
J	Rothery, L; Scott, GW; Morrell, LJ				Rothery, Luke; Scott, Graham W.; Morrell, Lesley J.			Colour preferences of UK garden birds at supplementary seed feeders	PLOS ONE			English	Article							DIETARY CONSERVATISM; MIMULUS-AURANTIACUS; DOMESTIC CHICKS; UNITED-STATES; FLOWER COLOR; HUMMINGBIRD; CONTEXT; URBAN; FOOD; SELECTION	Supplementary feeding of garden birds generally has benefits for both bird populations and human wellbeing. Birds have excellent colour vision, and show preferences for food items of particular colours, but research into colour preferences associated with artificial feeders is limited to hummingbirds. Here, we investigated the colour preferences of common UK garden birds foraging at seed-dispensing artificial feeders containing identical food. We presented birds simultaneously with an array of eight differently coloured feeders, and recorded the number of visits made to each colour over 370 30-minute observation periods in the winter of 2014/15. In addition, we surveyed visitors to a garden centre and science festival to determine the colour preferences of likely purchasers of seed feeders. Our results suggest that silver and green feeders were visited by higher numbers of individuals of several common garden bird species, while red and yellow feeders received fewer visits. In contrast, people preferred red, yellow, blue and green feeders. We suggest that green feeders may be simultaneously marketable and attractive to foraging birds.	[Rothery, Luke; Scott, Graham W.; Morrell, Lesley J.] Univ Hull, Sch Environm Sci, Kingston Upon Hull, Yorks, England	University of Hull	Morrell, LJ (corresponding author), Univ Hull, Sch Environm Sci, Kingston Upon Hull, Yorks, England.	l.morrell@hull.ac.uk	Morrell, Lesley J/A-4311-2008	Morrell, Lesley J/0000-0003-0256-7871; Scott, Graham/0000-0003-0896-0287	Westland Horticulture; former School of Biological, Biomedical & Environmental Sciences at the University of Hull	Westland Horticulture; former School of Biological, Biomedical & Environmental Sciences at the University of Hull	Funding was provided by Westland Horticulture and the former School of Biological, Biomedical & Environmental Sciences at the University of Hull. Westland Horticulture played a role in the conceptualisation of the research question, but no role in data collection and analysis, decision to publish or preparation of the manuscript.	Bateson M, 2003, P ROY SOC B-BIOL SCI, V270, P1271, DOI 10.1098/rspb.2003.2365; Bateson M, 2002, ANIM BEHAV, V63, P587, DOI 10.1006/anbe.2001.1925; BENE FRANK, 1941, CONDOR, V43, P237, DOI 10.2307/1364506; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boogert NJ, 2006, ANIM BEHAV, V72, P1229, DOI 10.1016/j.anbehav.2006.02.021; Brigham A.J., 1999, P67; BRITTINGHAM MC, 1988, ECOLOGY, V69, P581, DOI 10.2307/1941007; COLLIAS NE, 1968, CONDOR, V70, P273, DOI 10.2307/1366705; COWIE RJ, 1988, J ANIM ECOL, V57, P611, DOI 10.2307/4928; Cuthill IC, 2006, BIRD COLOURATION MEC; Daniels GD, 2006, BIOL CONSERV, V133, P326, DOI 10.1016/j.biocon.2006.06.011; Davies NB, 2012, INTRO BEHAV ECOLOGY; Davies ZG, 2009, BIOL CONSERV, V142, P761, DOI 10.1016/j.biocon.2008.12.016; Department for Environment Food and Rural Affairs (DEFRA), 2002, WORK GRAIN NAT BIOD, P180; Duan Q, 2013, CONDOR, V115, P623, DOI 10.1525/cond.2013.120111; Endler JA, 2005, BIOL J LINN SOC, V86, P405, DOI 10.1111/j.1095-8312.2005.00540.x; Exnerova A, 2007, BEHAV ECOL, V18, P148, DOI 10.1093/beheco/arl061; Foy S, 2016, GFK POINT SALES TRAC; Fuller RA, 2008, DIVERS DISTRIB, V14, P131, DOI 10.1111/j.1472-4642.2007.00439.x; Galbraith JA, 2015, P NATL ACAD SCI USA, V112, pE2648, DOI 10.1073/pnas.1501489112; Gaston KJ, 2007, BIODIVERS CONSERV, V16, P3227, DOI 10.1007/s10531-007-9174-6; GOLDSMITH TH, 1979, J COMP PHYSIOL, V130, P209, DOI 10.1007/BF00614607; GRANT KA, 1966, AM NAT, V100, P85, DOI 10.1086/282403; GRUBB TC, 1990, ORNIS SCAND, V21, P277, DOI 10.2307/3676392; Handelman C, 2014, PLANT SPEC BIOL, V29, P65, DOI 10.1111/j.1442-1984.2012.00393.x; Harrison XA, 2014, PEERJ, V2, DOI 10.7717/peerj.616; Hartley L, 1999, NEW ZEAL J ECOL, V23, P255; Horn DJ, 2013, WILDLIFE SOC B, V37, P293, DOI 10.1002/wsb.281; Horn DJ, 2014, WILDLIFE SOC B, V38, P18, DOI 10.1002/wsb.365; Jones DN, 2008, J AVIAN BIOL, V39, P265, DOI 10.1111/j.0908-8857.2008.04271.x; Kelber A, 2003, BIOL REV, V78, P81, DOI 10.1017/S1464793102005985; Kelly DJ, 2004, ANIM BEHAV, V68, P1049, DOI 10.1016/j.anbehav.2004.07.001; Kemp DJ, 2015, AM NAT, V185, P705, DOI 10.1086/681021; Lunau K, 2011, J EXP BIOL, V214, P1607, DOI 10.1242/jeb.052688; Maller C, 2006, HEALTH PROMOT INT, V21, P45, DOI 10.1093/heapro/dai032; Marples G., 1933, British Birds, V26, P238; MARTIN TE, 1990, STUDIES AVIAN BIOL, V0013, P00353; MelendezAckerman E, 1997, ECOLOGY, V78, P2532, DOI 10.1890/0012-9658(1997)078[2532:HBAMOS]2.0.CO;2; MILLER RS, 1971, CONDOR, V73, P309, DOI 10.2307/1365757; Olsson O, 2000, P ROY SOC B-BIOL SCI, V267, P1457, DOI 10.1098/rspb.2000.1164; Peach WJ, 2014, BIRD STUDY, V61, P378, DOI 10.1080/00063657.2014.918577; Pet Food Manufacturers' Association, 2015, ANN REPORT; R Core Team, 2013, R LANG ENV STAT COMP; Richards EL, 2011, BEHAV ECOL, V22, P738, DOI 10.1093/beheco/arr047; Robinson R. A., 2006, Acta Zoologica Sinica, V52, P550; Rolshausen G, 2009, CURR BIOL, V19, P2097, DOI 10.1016/j.cub.2009.10.061; Roper TJ, 1997, APPL ANIM BEHAV SCI, V54, P207, DOI 10.1016/S0168-1591(96)01178-1; ROPER TJ, 1990, ANIM BEHAV, V39, P466, DOI 10.1016/S0003-3472(05)80410-5; Ruiz-Rodriguez M, 2013, OECOLOGIA, V173, P83, DOI 10.1007/s00442-013-2599-6; Ruxton GD, 2004, AVOIDING ATTACK EVOL; Schuck-Paim C, 2004, PLOS BIOL, V2, P2305, DOI 10.1371/journal.pbio.0020402; Schuck-Paim C, 2002, ANIM BEHAV, V64, P869, DOI 10.1006/anbe.2003.2003; Shafir S, 2002, BEHAV ECOL SOCIOBIOL, V51, P180, DOI 10.1007/s00265-001-0420-8; SIMONSON I, 1992, J MARKETING RES, V29, P281, DOI 10.2307/3172740; Stephens DW, 2008, COGN AFFECT BEHAV NE, V8, P475, DOI 10.3758/CABN.8.4.475; STILES FG, 1976, CONDOR, V78, P10, DOI 10.2307/1366912; Streisfeld MA, 2007, J EVOLUTION BIOL, V20, P122, DOI 10.1111/j.1420-9101.2006.01216.x; Thomas C., 2007, DO DIFFERENT COLOURE; Thomas RJ, 2010, BEHAV ECOL, V21, P669, DOI 10.1093/beheco/arq037; Troscianko J, 2015, METHODS ECOL EVOL, V6, P1320, DOI 10.1111/2041-210X.12439; Tryjanowski P, 2016, SCI REP-UK, V6, DOI 10.1038/srep28575; Tryjanowski P, 2015, ENVIRON SCI POLLUT R, V22, P15097, DOI 10.1007/s11356-015-4723-0; TVERSKY A, 1969, PSYCHOL REV, V76, P31, DOI 10.1037/h0026750; TVERSKY A, 1993, MANAGE SCI, V39, P1179, DOI 10.1287/mnsc.39.10.1179; VICKERY RK, 1995, GREAT BASIN NAT, V55, P177; VICKERY RK, 1992, GREAT BASIN NAT, V52, P145; Wagner H.O., 1946, Wilson Bulletin Ann Arbor, V58, P69; WHEELER TG, 1980, WILSON BULL, V92, P53; WILLSON MF, 1990, AM NAT, V136, P790, DOI 10.1086/285132; WILLSON MF, 1990, CONDOR, V92, P545, DOI 10.2307/1368671	70	4	4	8	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2017	12	2							e0172422	10.1371/journal.pone.0172422	http://dx.doi.org/10.1371/journal.pone.0172422			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BI	28212435	gold, Green Published, Green Submitted			2022-12-27	WOS:000394424700048
J	Saczynska, V; Romanik, A; Florys, K; Cecuda-Adamczewska, V; Kesik-Brodacka, M; Smietanka, K; Olszewska, M; Domanska-Blicharz, K; Minta, Z; Szewczyk, B; Plucienniczak, G; Plucienniczak, A				Saczynska, Violetta; Romanik, Agnieszka; Florys, Katarzyna; Cecuda-Adamczewska, Violetta; Kesik-Brodacka, Malgorzata; Smietanka, Krzysztof; Olszewska, Monika; Domanska-Blicharz, Katarzyna; Minta, Zenon; Szewczyk, Boguslaw; Plucienniczak, Grazyna; Plucienniczak, Andrzej			A novel hemagglutinin protein produced in bacteria protects chickens against H5N1 highly pathogenic avian influenza viruses by inducing H5 subtype-specific neutralizing antibodies	PLOS ONE			English	Article							CONSERVED EPITOPE; VACCINES PROTECT; FERRETS; HA; RECOGNITION; INFECTIONS; CHALLENGE	The highly pathogenic ( HP) H5N1 avian influenza viruses ( AIVs) cause a mortality rate of up to 100% in infected chickens and pose a permanent pandemic threat. Attempts to obtain effective vaccines against H5N1 HPAIVs have focused on hemagglutinin ( HA), an immunodominant viral antigen capable of eliciting neutralizing antibodies. The vast majority of vaccine projects have been performed using eukaryotic expression systems. In contrast, we used a bacterial expression system to produce vaccine HA protein ( bacterial HA) according to our own design. The HA protein with the sequence of the H5N1 HPAIV strain was efficiently expressed in Escherichia coli, recovered in the form of inclusion bodies and refolded by dilution between two chromatographic purification steps. Antigenicity studies showed that the resulting antigen, referred to as rH5-E. coli, preserves conformational epitopes targeted by antibodies specific for H5-subtype HAs, inhibiting hemagglutination and/ or neutralizing influenza viruses in vitro. The proper conformation of this protein and its ability to form functional oligomers were confirmed by a hemagglutination test. Consistent with the biochemical characteristics, prime-boost immunizations with adjuvanted rH5-E. coli protected 100% and 70% of specific pathogen-free, layer-type chickens against challenge with homologous and heterologous H5N1 HPAIVs, respectively. The observed protection was related to the positivity in the FluAC H5 test ( IDVet) but not to hemagglutination-inhibiting antibody titers. Due to full protection, the effective contact transmission of the homologous challenge virus did not occur. Survivors from both challenges did not or only transiently shed the viruses, as established by viral RNA detection in oropharyngeal and cloacal swabs. Our results demonstrate that vaccination with rH5-E. coli could confer control of H5N1 HPAIV infection and transmission rates in chicken flocks, accompanied by reduced virus shedding. Moreover, the role of H5 subtype-specific neutralizing antibodies in anti-influenza immunity and a novel correlate of protection are indicated.	[Saczynska, Violetta; Romanik, Agnieszka; Florys, Katarzyna; Cecuda-Adamczewska, Violetta; Kesik-Brodacka, Malgorzata; Plucienniczak, Grazyna; Plucienniczak, Andrzej] Inst Biotechnol & Antibiot, Warsaw, Poland; [Smietanka, Krzysztof; Olszewska, Monika; Domanska-Blicharz, Katarzyna; Minta, Zenon] Natl Inst Vet Res, Dept Poultry Dis, Pulawy, Poland; [Szewczyk, Boguslaw] Univ Gdansk, Dept Recombinant Vaccines, Intercollegiate Fac Biotechnol, Gdansk, Poland; [Szewczyk, Boguslaw] Med Univ Gdansk, Gdansk, Poland	Institute of Biotechnology & Antibiotics (IBA); National Veterinary Institute - National Research Institute; Fahrenheit Universities; University of Gdansk; Fahrenheit Universities; Medical University Gdansk	Saczynska, V (corresponding author), Inst Biotechnol & Antibiot, Warsaw, Poland.	saczynskav@iba.waw.pl	Sączyńska, Violetta/C-2074-2019; Romanik-Chruścielewska, Agnieszka/AAW-6799-2020; Domanska-Blicharz, Katarzyna/H-1671-2011; Kęsik-Brodacka, Małgorzata/ABG-7355-2021; Romanik, Agnieszka/B-3364-2019; Florys, Katarzyna/B-7947-2019; Cecuda-Adamczewska, Violetta/ABC-3432-2021	Sączyńska, Violetta/0000-0003-1828-6783; Domanska-Blicharz, Katarzyna/0000-0002-0642-3931; Romanik, Agnieszka/0000-0002-8537-5041; Florys, Katarzyna/0000-0001-9199-7237; Cecuda-Adamczewska, Violetta/0000-0001-6967-2970; Szewczyk, Boguslaw/0000-0003-4957-4059				Aguilar-Yanez J M, 2010, PLOS ONE, V5, DOI DOI 10.1371/JOURNAL.PONE.0011694; Biesova Z, 2009, VACCINE, V27, P6234, DOI 10.1016/j.vaccine.2009.07.107; Bosch BJ, 2010, J VIROL, V84, P10366, DOI 10.1128/JVI.01035-10; Brandenburg B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080034; Bright RA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001501; Cornelissen LAHM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010645; Corti D, 2011, SCIENCE, V333, P850, DOI 10.1126/science.1205669; Coudeville L, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-18; Crawford J, 1999, VACCINE, V17, P2265, DOI 10.1016/S0264-410X(98)00494-0; Du LY, 2013, J VIROL, V87, P2215, DOI 10.1128/JVI.02344-12; DuBois RM, 2011, J VIROL, V85, P865, DOI 10.1128/JVI.01412-10; Ekiert DC, 2009, SCIENCE, V324, P246, DOI 10.1126/science.1171491; Gromadzka B, 2008, MOL CELL PROBE, V22, P301, DOI 10.1016/j.mcp.2008.09.003; Horthongkham Navin, 2007, J Immune Based Ther Vaccines, V5, P10, DOI 10.1186/1476-8518-5-10; Hvistendahl M, 2015, SCIENCE, V348, P741, DOI 10.1126/science.348.6236.741; ICTV, 2014, INT COMM TAX VIR; Ip HS, 2015, EMERG INFECT DIS, V21, P886, DOI 10.3201/eid2105.142020; Jegerlehner A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078947; Kesik-Brodacka M, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-109; Khurana S, 2011, J VIROL, V85, P1246, DOI 10.1128/JVI.02107-10; Khurana S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011548; Khurana S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000624; Kodihalli S, 1997, J VIROL, V71, P3391, DOI 10.1128/JVI.71.5.3391-3396.1997; Kopera E, 2014, ACTA BIOCHIM POL, V61, P597; Lipatov AS, 2006, J INFECT DIS, V194, P1040, DOI 10.1086/507709; Liu G, 2012, VACCINE, V30, P6833, DOI 10.1016/j.vaccine.2012.09.013; Loeffen WLA, 2011, VACCINE, V29, P1545, DOI 10.1016/j.vaccine.2010.12.096; Mahmood K, 2008, VACCINE, V26, P5393, DOI 10.1016/j.vaccine.2008.07.084; Oh HLJ, 2010, J VIROL, V84, P8275, DOI 10.1128/JVI.02593-09; OIE, 2012, MANUAL DIAGNOSTIC TE; OKUNO Y, 1993, J VIROL, V67, P2552, DOI 10.1128/JVI.67.5.2552-2558.1993; Saczynska V, 2014, ACTA BIOCHIM POL, V61, P561; Song L, 2009, VACCINE, V27, P5875, DOI 10.1016/j.vaccine.2009.07.060; Spackman E, 2002, J CLIN MICROBIOL, V40, P3256, DOI 10.1128/JCM.40.9.3256-3260.2002; Steinhauer DA, 1999, VIROLOGY, V258, P1, DOI 10.1006/viro.1999.9716; Suarez DL, 2005, BIOLOGICALS, V33, P221, DOI 10.1016/j.biologicals.2005.08.003; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; Velkov T, 2013, MOL IMMUNOL, V56, P705, DOI 10.1016/j.molimm.2013.07.010; Verhagen JH, 2015, SCIENCE, V347, P616, DOI 10.1126/science.aaa6724; Verma S, 2012, J VIROL, V86, P12283, DOI 10.1128/JVI.01596-12; Wei CJ, 2008, J VIROL, V82, P6200, DOI 10.1128/JVI.00187-08; Weldon WC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012466; WHO, 2021, CUMULATIVE NUMBER CO; WILSON IA, 1981, NATURE, V289, P366, DOI 10.1038/289366a0; WILSON IA, 1990, ANNU REV IMMUNOL, V8, P737, DOI 10.1146/annurev.iy.08.040190.003513; Xie QM, 2009, POULTRY SCI, V88, P1608, DOI 10.3382/ps.2009-00092; Xu XY, 1999, VIROLOGY, V261, P15, DOI 10.1006/viro.1999.9820; Xuan CL, 2011, PROTEIN CELL, V2, P997, DOI 10.1007/s13238-011-1134-y	48	9	10	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2017	12	2							e0172008	10.1371/journal.pone.0172008	http://dx.doi.org/10.1371/journal.pone.0172008			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BI	28212428	Green Published, Green Submitted, gold			2022-12-27	WOS:000394424700016
J	Leelossy, A; Meszaros, R; Kovacs, A; Lagzi, I; Kovacs, T				Leelossy, Adam; Meszaros, Robert; Kovacs, Attila; Lagzi, Istvan; Kovacs, Tibor			Numerical simulations of atmospheric dispersion of iodine-131 by different models	PLOS ONE			English	Article							PARTICLE DISPERSION; IDENTIFICATION; VALIDATION; CHEMISTRY; FLEXPART	Nowadays, several dispersion models are available to simulate the transport processes of air pollutants and toxic substances including radionuclides in the atmosphere. Reliability of atmospheric transport models has been demonstrated in several recent cases from local to global scale; however, very few actual emission data are available to evaluate model results in real-life cases. In this study, the atmospheric dispersion of I-131 emitted to the atmosphere during an industrial process was simulated with different models, namely the WRF-Chem Eulerian online coupled model and the HYSPLIT and the RAPTOR Lagrangian models. Although only limited data of I-131 detections has been available, the accuracy of modeled plume direction could be evaluated in complex late autumn weather situations. For the studied cases, the general reliability of models has been demonstrated. However, serious uncertainties arise related to low level inversions, above all in case of an emission event on 4 November 2011, when an important wind shear caused a significant difference between simulated and real transport directions. Results underline the importance of prudent interpretation of dispersion model results and the identification of weather conditions with a potential to cause large model errors.	[Leelossy, Adam; Meszaros, Robert; Kovacs, Attila] Eotvos Lorand Univ, Dept Meteorol, Budapest, Hungary; [Lagzi, Istvan] Budapest Univ Technol & Econ, Inst Phys, Budapest, Hungary; [Kovacs, Tibor] Univ Pannonia, Inst Radiochem & Radioecol, Veszprem, Hungary	Eotvos Lorand University; Budapest University of Technology & Economics; University of Pannonia	Meszaros, R (corresponding author), Eotvos Lorand Univ, Dept Meteorol, Budapest, Hungary.	mrobi@nimbus.elte.hu	Leelossy, Adam/I-3183-2017; Kovacs, Tibor/H-1564-2017; Robert, Meszaros/I-5969-2017	Leelossy, Adam/0000-0001-9583-0127; Kovacs, Tibor/0000-0003-2606-0397; Robert, Meszaros/0000-0002-0550-9266	National Research, Development and Innovation Office of Hungary [K104666, K10909]	National Research, Development and Innovation Office of Hungary	Support was provided by the National Research, Development and Innovation Office of Hungary No. K104666 to IL and the National Research, Development and Innovation Office of Hungary No. K10909 to RM.	Baklanov A, 2014, ATMOS CHEM PHYS, V14, P317, DOI 10.5194/acp-14-317-2014; Draxier RR, 1998, AUST METEOROL MAG, V47, P295; Draxler R, 2015, J ENVIRON RADIOACTIV, V139, P172, DOI 10.1016/j.jenvrad.2013.09.014; Grell GA, 2005, ATMOS ENVIRON, V39, P6957, DOI 10.1016/j.atmosenv.2005.04.027; Hu XM, 2012, ATMOS ENVIRON, V46, P354, DOI 10.1016/j.atmosenv.2011.09.054; JANJIC Z.I., 2002, NCEP OFFICE NOTE, V437, P61; Jiang F, 2008, ATMOS ENVIRON, V42, P8717, DOI 10.1016/j.atmosenv.2008.08.034; Koracin D, 2011, J AIR WASTE MANAGE, V61, P660, DOI 10.3155/1047-3289.61.6.660; Leelossy A, 2014, CENT EUR J GEOSCI, V6, P257, DOI 10.2478/s13533-012-0188-6; Leelossy A, 2013, IDOJARAS, V117, P435; McGowan H, 2008, ATMOS ENVIRON, V42, P6915, DOI 10.1016/j.atmosenv.2008.05.053; Meszaros R, 2016, SCI REP-UK, V6, DOI 10.1038/srep19915; Moreira V, 2011, ATMOS POLLUT RES; Ngan F, 2015, J APPL METEOROL CLIM, V54, P1162, DOI 10.1175/JAMC-D-14-0247.1; NOAA, NCEP GDAS GFS GLOB T; NOAA, WORK GROUP 11 ATM CH; Ott A De Vismes, 2014, ICRER 2014 3 INT C R; Reuters, 2011, LOW LEV RAD PART EUR; Ryall DB, 1998, ATMOS ENVIRON, V32, P4265, DOI 10.1016/S1352-2310(98)00177-0; Stein AF, 2015, B AM METEOROL SOC, V96, P2059, DOI 10.1175/BAMS-D-14-00110.1; Stohl A, 2005, ATMOS CHEM PHYS, V5, P2461, DOI 10.5194/acp-5-2461-2005; Stohl A, 1998, ATMOS ENVIRON, V32, P4245, DOI 10.1016/S1352-2310(98)00184-8; Tie XX, 2007, ATMOS ENVIRON, V41, P1989, DOI 10.1016/j.atmosenv.2006.10.053; Tuccella P, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2011JD016302; Wang XY, 2010, ATMOS ENVIRON, V44, P660, DOI 10.1016/j.atmosenv.2009.11.011; Wotawa G., 2014, S INT SAF VIENN AUST	26	13	14	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0172312	10.1371/journal.pone.0172312	http://dx.doi.org/10.1371/journal.pone.0172312			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207853	Green Published, gold, Green Submitted			2022-12-27	WOS:000394424500119
J	Li, WF; Chiu, KH; Tien, YC; Tsai, SF; Shih, LJ; Lee, CH; Toullec, JY; Lee, CY				Li, Wenfeng; Chiu, Kuo-Hsun; Tien, Yi-Chun; Tsai, Shih-Fu; Shih, Li-Jane; Lee, Chien-Hsun; Toullec, Jean-Yves; Lee, Chi-Ying			Differential effects of silencing crustacean hyperglycemic hormone gene expression on the metabolic profiles of the muscle and hepatopancreas in the crayfish Procambarus clarkii	PLOS ONE			English	Article							MOLT-INHIBITING HORMONE; HIGH-AFFINITY BINDING; CARBOHYDRATE-METABOLISM; CARCINUS-MAENAS; SHORE CRAB; CHH; HEMOLYMPH; EYESTALK; LOBSTER; LOCALIZATION	In order to functionally characterize the metabolic roles of crustacean hyperglycemic hormone (CHH), gene expression of CHH in the crayfish (Procambarus clarkii) was knocked down by in vivo injection of CHH double-stranded RNA (dsRNA), followed by metabolomic analysis of 2 CHH target tissues (the muscle and hepatopancreas) using nuclear magnetic resonance spectroscopy. Compared to the levels in untreated and saline-injected (SAI) animals, levels of CHH transcript, but not those of molt-inhibiting hormone (a CHH-family peptide), in the eyestalk ganglia of CHH dsRNA-injected (DSI) animals were significantly decreased at 24, 48, and 72 hour post injection (hpi), with concomitant changes in levels of CHH peptide in the sinus gland (a neurohemal organ) and hemolymph. Green fluorescence protein (GFP) dsRNA failed to affect levels of CHH transcript in the eyestalk ganglia of GFP DSI animals. Number of metabolites whose levels were significantly changed by CHH dsRNA was 149 and 181 in the muscle and 24 and 12 in the hepatopancreas, at 24 and 48 hpi, respectively. Principal component analysis of these metabolites show that metabolic effects of silencing CHH gene expression were more pronounced in the muscle (with the cluster of CHH DSI group clearly being separated from that of SAI group at 24 hpi) than in the hepatopancreas. Moreover, pathway analysis of the metabolites closely related to carbohydrate and energy metabolism indicate that, for CHH DSI animals at 24 hpi, metabolic profile of the muscle was characterized by reduced synthesis of NAD(+) and adenine ribonucleotides, diminished levels of ATP, lower rate of utilization of carbohydrates through glycolysis, and a partially rescued TCA cycle, whereas that of the hepatopancreas by unaffected levels of ATP, lower rate of utilization of carbohydrates, and increased levels of ketone bodies. The combined results of metabolic changes in response to silenced CHH gene expression reveal that metabolic functions of CHH on the muscle and hepatopancreas are more diverse than previously thought and are differential between the two tissues.	[Li, Wenfeng; Tien, Yi-Chun; Tsai, Shih-Fu; Lee, Chien-Hsun; Lee, Chi-Ying] Natl Changhua Univ Educ, Dept Biol, Changhua, Taiwan; [Chiu, Kuo-Hsun] Natl Kaohsiung Marine Univ, Dept Aquaculture, Kaohsiung, Taiwan; [Shih, Li-Jane] Taoyuan Armed Forces Gen Hosp, Dept Lab Med, Taoyuan, Taiwan; [Toullec, Jean-Yves] Univ Paris 06, UPMC, Sorbonne Univ, UMR CNRS 7144,Equipe ABICE,Stn Biol Roscoff, Roscoff, France; [Toullec, Jean-Yves] CNRS, UMR 7144, Adaptat & Divers Milieu Marin, Stn Biol Roscoff, Roscoff, France	National Changhua University of Education; National Kaohsiung University of Science & Technology; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Sorbonne Universite	Lee, CY (corresponding author), Natl Changhua Univ Educ, Dept Biol, Changhua, Taiwan.	bicylee@cc.ncue.edu.tw		Lee, Chi-Ying/0000-0002-9591-1370	Ministry of Science and Technology, Taiwan [102-2311-B-018-002, 104-2311-B-018-002, 104-2811-B-018-001]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	The present study was supported financially by Ministry of Science and Technology, Taiwan (https://www.most.gov.tw/) through grants (102-2311-B-018-002 and 104-2311-B-018-002) to C-YL. WL was supported by a postdoctoral fellowship (104-2811-B-018-001) from Ministry of Science and Technology, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Canto C, 2015, CELL METAB, V22, P31, DOI 10.1016/j.cmet.2015.05.023; Chang CC, 2010, GEN COMP ENDOCR, V167, P68, DOI 10.1016/j.ygcen.2010.02.013; Chang ES, 1998, GEN COMP ENDOCR, V111, P359, DOI 10.1006/gcen.1998.7120; Chang ES, 1999, J COMP NEUROL, V414, P50; Chen HY, 2007, GEN COMP ENDOCR, V151, P72, DOI 10.1016/j.ygcen.2006.11.016; Chiarugi A, 2012, NAT REV CANCER, V12, P741, DOI 10.1038/nrc3340; Chiu KH, 2011, FISH PHYSIOL BIOCHEM, V37, P701, DOI 10.1007/s10695-011-9470-7; Christie AE, 2008, GEN COMP ENDOCR, V157, P174, DOI 10.1016/j.ygcen.2008.03.027; Christie AE, 2011, GEN COMP ENDOCR, V170, P480, DOI 10.1016/j.ygcen.2010.11.002; Chung JS, 2006, GEN COMP ENDOCR, V147, P206, DOI 10.1016/j.ygcen.2006.01.002; Cooke I.M., 1982, BIOL CRUSTACEA VOL 3, P206; DeKleijn DPV, 1995, COMP BIOCHEM PHYS B, V112, P573, DOI 10.1016/0305-0491(95)00126-3; GORGELSKALLEN JL, 1985, CELL TISSUE RES, V241, P361, DOI 10.1007/BF00217181; KALLEN JL, 1990, BIOL BULL-US, V179, P351, DOI 10.2307/1542327; Katayama H, 2002, PEPTIDES, V23, P1537, DOI 10.1016/S0196-9781(02)00094-3; Katayama H, 2009, J EXP BIOL, V212, P542, DOI 10.1242/jeb.022889; KELLER R, 1973, GEN COMP ENDOCR, V20, P572, DOI 10.1016/0016-6480(73)90089-0; Keller R., 1992, CELL MOL LIFE SCI, V48, P439, DOI DOI 10.1007/BF01928162; KUMMER G, 1993, PEPTIDES, V14, P103, DOI 10.1016/0196-9781(93)90016-A; Lee CY, 2014, J MAR SCI TECH-TAIW, V22, P75, DOI 10.6119/JMST-013-0308-1; Lehninger AL, PRINCIPLES BIOCH, P2; Lin LJ, 2013, COMP BIOCHEM PHYS A, V164, P327, DOI 10.1016/j.cbpa.2012.11.009; Liu CJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134983; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lorenzon S, 2004, J EXP BIOL, V207, P4205, DOI 10.1242/jeb.01264; Marco HG, 2000, PEPTIDES, V21, P19, DOI 10.1016/S0196-9781(99)00171-0; Montagne N, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-62; Moran LA, 1994, BIOCHEMISTRY; Mosco A, 2008, REGUL PEPTIDES, V147, P88, DOI 10.1016/j.regpep.2008.01.005; Nagai C, 2011, GEN COMP ENDOCR, V172, P293, DOI 10.1016/j.ygcen.2011.03.019; Nakatsuji T, 2000, ZOOL SCI, V17, P1129, DOI 10.2108/zsj.17.1129; PARVATHY K, 1972, MAR BIOL, V14, P58, DOI 10.1007/BF00365782; SANTOS EA, 1993, COMP BIOCHEM PHYS A, V106, P343, DOI 10.1016/0300-9629(93)90523-7; SANTOS EA, 1993, COMP BIOCHEM PHYS A, V106, P405, DOI 10.1016/0300-9629(93)90234-U; SANTOS EA, 1993, J COMP PHYSIOL B, V163, P374; SEDLMEIER D, 1981, GEN COMP ENDOCR, V45, P82, DOI 10.1016/0016-6480(81)90172-6; SEDLMEIER D, 1987, COMP BIOCHEM PHYS A, V87, P423, DOI 10.1016/0300-9629(87)90146-0; Sedlmeier D, 1981, BIOCHEM SOC T, V9, P240; Soyez D, 1997, ANN NY ACAD SCI, V814, P319, DOI 10.1111/j.1749-6632.1997.tb46174.x; Su MA, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004196; Teng Q, 2013, AQUAT TOXICOL, V130, P184, DOI 10.1016/j.aquatox.2013.01.011; WEBSTER SG, 1993, P ROY SOC B-BIOL SCI, V251, P53, DOI 10.1098/rspb.1993.0008; Webster SG, 1996, J EXP BIOL, V199, P1579; Webster SG, 2012, GEN COMP ENDOCR, V175, P217, DOI 10.1016/j.ygcen.2011.11.035; Wu HJ, 2012, ZOOL STUD, V51, P288; Wu SH, 2012, COMP BIOCHEM PHYS A, V161, P463, DOI 10.1016/j.cbpa.2012.01.007; Yeh FC, 2006, COMP BIOCHEM PHYS B, V144, P11, DOI 10.1016/j.cbpb.2006.01.007; Zou HS, 2003, J EXP ZOOL PART A, V298A, P44, DOI 10.1002/jez.a.10273	48	5	6	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0172557	10.1371/journal.pone.0172557	http://dx.doi.org/10.1371/journal.pone.0172557			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207859	Green Published, gold, Green Submitted			2022-12-27	WOS:000394424500146
J	Kurabi, A; Beasley, KA; Chang, L; McCann, J; Pak, K; Ryan, AF				Kurabi, Arwa; Beasley, Kerry A.; Chang, Lisa; McCann, James; Pak, Kwang; Ryan, Allen F.			Peptides actively transported across the tympanic membrane: Functional and structural properties	PLOS ONE			English	Article							OTITIS-MEDIA; HAIR-CELLS; CHILDREN; INFANTS; FLUID	Otitis media (OM) is the most common infectious disease of children under six, causing more antibiotic prescriptions and surgical procedures than any other pediatric condition. By screening a bacteriophage (phage) library genetically engineered to express random peptides on their surfaces, we discovered unique peptides that actively transport phage particles across the intact tympanic membrane (TM) and into the middle ear (ME). Herein our goals were to characterize the physiochemical peptide features that may underlie trans-TM phage transport; assess morphological and functional effects of phage peptides on the ME and inner ear (IE); and determine whether peptide-bearing phage transmigrate from the ME into the IE. Incubation of five peptide-bearing phage on the TM for over 4hrs resulted in demonstrably superior transport of one peptide, in level and in exponential increase over time. This suggests a preferred peptide motif for TM active transport. Functional and structural comparisons revealed unique features of this peptide: These include a central lysine residue, isoelectric point of 0.0 at physiological pH and a hydrophobic C-terminus. When the optimal peptide was applied to the TM independent of phage, similar transport was observed, indicating that integration into phage is not required. When 10 9 particles of the four different trans-TM phage were applied directly into the ME, no morphological effects were detected in the ME or IE when compared to saline or wild-type (WT) phage controls. Comparable, reversible hearing loss was observed for saline controls, WT phage and trans-TM peptide phage, suggesting a mild conductive hearing loss due to ME fluid. Perilymph titers after ME incubation established that few copies of trans-TM peptide phage crossed into the IE. The results suggest that, within the parameters tested, trans-TM peptides are safe and could be used as potential agents for noninvasive delivery of drugs, particles and gene therapy vectors to the ME.	[Kurabi, Arwa; Chang, Lisa; McCann, James; Pak, Kwang; Ryan, Allen F.] Univ Calif San Diego, Sch Med, Dept Surg, Div Otolaryngol, La Jolla, CA 92093 USA; [Beasley, Kerry A.] San Diego State Univ, Sch Speech Language & Hearing Sci, San Diego, CA 92182 USA; [Pak, Kwang; Ryan, Allen F.] San Diego Vet Adm Med Ctr, San Diego, CA USA	University of California System; University of California San Diego; California State University System; San Diego State University	Kurabi, A (corresponding author), Univ Calif San Diego, Sch Med, Dept Surg, Div Otolaryngol, La Jolla, CA 92093 USA.	akurabi@ucsd.edu			Action on Hearing Loss (London, UK); National Institutes of Health/National Institute on Deafness and other Communication Disorders [DC000129, DC006297, DC012595]; Veterans Administration Research Service [BX001295]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC000129, R01DC012595] Funding Source: NIH RePORTER	Action on Hearing Loss (London, UK); National Institutes of Health/National Institute on Deafness and other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Veterans Administration Research Service(US Department of Veterans Affairs); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	Research funding was provided by Action on Hearing Loss (London, UK) (AFR), by the National Institutes of Health/National Institute on Deafness and other Communication Disorders (AFR), through grants DC000129, DC006297, and DC012595, and by the Veterans Administration Research Service grant BX001295 (AFR).	Arguedas A, 2010, INT J PEDIATR OTORHI, V74, P1419, DOI 10.1016/j.ijporl.2010.09.022; Bordet F, 2002, PAEDIATR ANAESTH, V12, P762, DOI 10.1046/j.1460-9592.2002.00987.x; BORG E, 1987, HEARING RES, V30, P119, DOI 10.1016/0378-5955(87)90129-8; Cederholm JME, 2012, HEARING RES, V292, P71, DOI 10.1016/j.heares.2012.08.010; Cortese Riccardo, 1995, Current Opinion in Biotechnology, V6, P73, DOI 10.1016/0958-1669(95)80012-3; DALLOS P, 1978, J ACOUST SOC AM, V64, P151, DOI 10.1121/1.381980; Daly KA, 2003, ARCH OTOLARYNGOL, V129, P517, DOI 10.1001/archotol.129.5.517; Dazert S, 2007, BRAIN RES, V1178, P73, DOI 10.1016/j.brainres.2007.06.041; De Beer BA, 2004, ANN OTO RHINOL LARYN, V113, P438, DOI 10.1177/000348940411300604; Desai P, 2010, MOL MEMBR BIOL, V27, P247, DOI 10.3109/09687688.2010.522203; Ebmeyer J, 2011, BMC IMMUNOL, V12, DOI 10.1186/1471-2172-12-12; Erkman L, 1996, NATURE, V381, P603, DOI 10.1038/381603a0; Fiocchi A, 2010, INT J IMMUNOPATH PH, V23, pS56; FRIELPATTI S, 1982, PEDIATR INFECT DIS J, V1, P104, DOI 10.1097/00006454-198203000-00008; GINSBURG CM, 1980, CLIN PEDIATR, V19, P549, DOI 10.1177/000992288001900810; HENTZER E, 1969, ACTA OTO-LARYNGOL, V68, P376, DOI 10.3109/00016486909121576; Hernandez M, 2008, J INFECT DIS, V198, P1862, DOI 10.1086/593213; Housley GD, 2013, P NATL ACAD SCI USA, V110, P7494, DOI 10.1073/pnas.1222295110; Joglekar S, 2010, ACTA OTO-LARYNGOL, V130, P472, DOI 10.3109/00016480903311252; Juhn SK, 2008, CLIN EXP OTORHINOLAR, V1, P117, DOI 10.3342/ceo.2008.1.3.117; Khoo XJ, 2013, BIOMATERIALS, V34, P1281, DOI 10.1016/j.biomaterials.2012.10.025; Klausen O, 2000, ACTA OTO-LARYNGOL, P73; Klein JO, 2000, VACCINE, V19, pS2, DOI 10.1016/S0264-410X(00)00271-1; Kurabi A, 2016, SCI REP-UK, V6, DOI 10.1038/srep22663; Kurioka T, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.12.125001; Lear S, 2016, J COMPUT AID MOL DES, V30, P271, DOI 10.1007/s10822-016-9902-7; Lee BY, 2012, NAT NANOTECHNOL, V7, P351, DOI [10.1038/nnano.2012.69, 10.1038/NNANO.2012.69]; Lee WJ, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3469848; Leichtle A, 2010, J IMMUNOL, V184, P3087, DOI 10.4049/jimmunol.0901167; Levy J, 2000, AM J GASTROENTEROL, V95, pS8, DOI 10.1016/S0002-9270(99)00808-4; Li JW, 2015, AMINO ACIDS, V47, P401, DOI 10.1007/s00726-014-1874-0; Maupetit J, 2009, NUCLEIC ACIDS RES, V37, pW498, DOI 10.1093/nar/gkp323; Nicolau David P, 2007, Paediatr Drugs, V9, P119, DOI 10.2165/00148581-200709020-00005; Pichichero Michael E, 2009, Paediatr Drugs, V11, P243, DOI 10.2165/00148581-200911040-00003; Prentice P, 2015, ARCH DIS CHILDHOOD-E, V100, P197, DOI 10.1136/archdischild-2014-307676; RYAN A, 1975, NATURE, V253, P44, DOI 10.1038/253044a0; SCHMIDT SH, 1986, ACTA OTO-LARYNGOL, V101, P88, DOI 10.3109/00016488609108611; SCHMIDT SH, 1991, ORL J OTO-RHINO-LARY, V53, P32, DOI 10.1159/000276181; SILVERSTEIN H, 1966, PEDIATRICS, V38, P33; STENFORS LE, 1979, ACTA OTO-LARYNGOL, V88, P395, DOI 10.3109/00016487909137184; Weisser Caroline, 2016, J Med Case Rep, V10, P10, DOI 10.1186/s13256-016-0801-2; Wielinga EWJ, 2001, LARYNGOSCOPE, V111, P90, DOI 10.1097/00005537-200101000-00016; World Health Organization, 2004, CHRON SUPP OT MED CS; Yang R, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf4363	44	14	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0172158	10.1371/journal.pone.0172158	http://dx.doi.org/10.1371/journal.pone.0172158			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5VB	28234923	Green Published, Green Submitted, gold			2022-12-27	WOS:000394688200049
J	Lauridsen, HM; Gonzalez, AL				Lauridsen, Holly M.; Gonzalez, Anjelica L.			Biomimetic, ultrathin and elastic hydrogels regulate human neutrophil extravasation across endothelial-pericyte bilayers	PLOS ONE			English	Article							BASEMENT-MEMBRANES; MATRIX; EXPRESSION; CELLS; GROWTH	The vascular basement membrane D a thin, elastic layer of extracellular matrix separating and encasing vascular cells D provides biological and mechanical cues to endothelial cells, pericytes, and migrating leukocytes. In contrast, experimental scaffolds typically used to replicate basement membranes are stiff and bio-inert. Here, we present thin, porated polyethylene glycol hydrogels to replicate human vascular basement membranes. Like commercial transwells, our hydrogels are approximately 10 mu m thick, but like basement membranes, the hydrogels presented here are elastic (E: 50-80kPa) and contain a dense network of small pores. Moreover, the inclusion of bioactive domains introduces receptor-mediated biochemical signaling. We compare elastic hydrogels to common culture substrates (E: > 2GPa) for human endothelial cell and pericyte monolayers and bilayers to replicate postcapillary venules in vitro. Our data demonstrate that substrate elasticity facilitates differences in vascular phenotype, supporting expression of vascular markers that are increasingly replicative of venules. Endothelial cells differentially express vascular markers, like EphB4, and leukocyte adhesion molecules, such as ICAM-1, with decreased mechanical stiffness. With porated PEG hydrogels we demonstrate the ability to evaluate and observe leukocyte recruitment across endothelial cell and pericyte monolayers and bilayers, reporting that basement membrane scaffolds can significantly alter the rate of vascular migration in experimental systems. Overall, this study demonstrates the creation and utility of a new and accessible method to recapture the mechanical and biological complexity of human basement membranes in vitro.	[Lauridsen, Holly M.; Gonzalez, Anjelica L.] Yale Univ, Dept Biomed Engn, New Haven, CT 06520 USA	Yale University	Gonzalez, AL (corresponding author), Yale Univ, Dept Biomed Engn, New Haven, CT 06520 USA.	anjelica.gonzalez@yale.edu			Donna L. Dubinsky New Initiatives Grant; NIH [NIBIB 5R01EB016629, HLBI 5R01HL051014]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001863] Funding Source: NIH RePORTER	Donna L. Dubinsky New Initiatives Grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	Donna L. Dubinsky is a donor to Yale University who funded research through the Donna L. Dubinsky New Initiatives Grant that was awarded to ALG. ALG is also supported by NIH NIBIB 5R01EB016629 and NIH HLBI 5R01HL051014. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aird WC, 2007, CIRC RES, V100, P174, DOI 10.1161/01.RES.0000255690.03436.ae; Aird WC, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006429; Ayres-Sander CE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060025; Fang TH, 2004, MICROELECTRON J, V35, P595, DOI 10.1016/j.mejo.2004.02.004; Freitas RA., 1999, NANOMEDICINE; GIMBRONE MA, 1974, J CELL BIOL, V60, P673, DOI 10.1083/jcb.60.3.673; Gonzalez AL, 2004, TISSUE ENG, V10, P1775, DOI 10.1089/ten.2004.10.1775; Halfter W, 2013, CELL ADHES MIGR, V7, P64, DOI 10.4161/cam.22479; Hayenga HN, 2013, CELL MOL BIOENG, V6, P253, DOI 10.1007/s12195-013-0284-9; Hirschi KK, 1996, CARDIOVASC RES, V32, P687, DOI 10.1016/S0008-6363(96)00063-6; HOFFSTEIN ST, 1982, J CELL BIOL, V95, P234, DOI 10.1083/jcb.95.1.234; Huynh J, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002761; Jannat RA, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/19/194117; Jee AY, 2010, POLYM TEST, V29, P95, DOI 10.1016/j.polymertesting.2009.09.009; Kalluri R, 2003, NAT REV CANCER, V3, P422, DOI 10.1038/nrc1094; Last JA, 2009, J STRUCT BIOL, V167, P19, DOI 10.1016/j.jsb.2009.03.012; Lauridsen HM, 2014, TECHNOLOGY, V2, P133, DOI 10.1142/S2339547814500113; Lauridsen HM, 2014, FASEB J, V28, P1166, DOI 10.1096/fj.13-240986; Liu KK, 2001, J PHYS D APPL PHYS, V34, pL91, DOI 10.1088/0022-3727/34/15/102; Maier CL, 2010, MICROCIRCULATION, V17, P367, DOI 10.1111/j.1549-8719.2010.00038.x; Makino A, 2008, AM J PHYSIOL-CELL PH, V295, pC221, DOI 10.1152/ajpcell.00433.2007; MAKISHIMA A, 1975, J NON-CRYST SOLIDS, V17, P147, DOI 10.1016/0022-3093(75)90047-2; Mason B. N., 2012, ENG BIOMATERIALS REG, P19, DOI DOI 10.1007/978-1-4614-1080-5_2; Mazzocchi AR, 2014, CELL MOL BIOENG, V7, P369, DOI 10.1007/s12195-014-0354-7; McBride R.A., 2003, J MATER CHEM, V13, P1; SENIOR RM, 1992, J CLIN INVEST, V90, P2251, DOI 10.1172/JCI116111; Steinle JJ, 2009, EXP EYE RES, V88, P1014, DOI 10.1016/j.exer.2008.12.015; van Rijen HVM, 1998, CYTOKINE, V10, P258, DOI 10.1006/cyto.1997.0287; VLODAVSKY I, 1991, J CELL BIOCHEM, V45, P167, DOI 10.1002/jcb.240450208; Voisin MB, 2010, AM J PATHOL, V176, P482, DOI 10.2353/ajpath.2010.090510; Wang SJ, 2006, J EXP MED, V203, P1519, DOI 10.1084/jem.20051210; Winkler EA, 2011, NAT NEUROSCI, V14, P1398, DOI 10.1038/nn.2946; Wolf K, 2011, TRENDS CELL BIOL, V21, P736, DOI 10.1016/j.tcb.2011.09.006; Yang JJ, 2010, J BIOMED MATER RES A, V95A, P531, DOI 10.1002/jbm.a.32875	34	9	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e71386	10.1371/journal.pone.0171386	http://dx.doi.org/10.1371/journal.pone.0171386			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5VB	28234918	gold, Green Published, Green Submitted			2022-12-27	WOS:000394688200021
J	Munroe, ME; Pezant, N; Brown, MA; Fife, DA; Guthridge, JM; Kelly, JA; Wiley, G; Gaffney, PM; James, JA; Montgomery, CG				Munroe, Melissa E.; Pezant, Nathan; Brown, Michael A.; Fife, Dustin A.; Guthridge, Joel M.; Kelly, Jennifer A.; Wiley, Graham; Gaffney, Patrick M.; James, Judith A.; Montgomery, Courtney G.			Association of IFIH1 and pro-inflammatory mediators: Potential new clues in SLE-associated pathogenesis	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; VARIANTS; CYTOKINE; AUTOIMMUNITY; RESPONSES; HUMANS; ASSAYS; ELISA; IPS-1; RARE	Antiviral defenses are inappropriately activated in systemic lupus erythematosus (SLE) and association between SLE and the antiviral helicase gene, IFIH1, is well established. We sought to extend the previously reported association of pathogenic soluble mediators and autoantibodies with mouse Mda5 to its human ortholog, IFIH1. To better understand the role this gene plays in human lupus, we assessed association of IFIH1 variants with soluble mediators and autoantibodies in 357 European-American SLE patients, first-degree relatives, and unrelated, unaffected healthy controls. Association between each of 135 genotyped SNPs in IFIH1 and four lupus-associated plasma mediators, IL-6, TNF-alpha, IFN-beta, and IP-10, were investigated via linear regression. No significant associations were found to SNPs orthologous to those identified in exon 13 of the mouse. However, outside of this region there were significant associations between IL-6 and rs76162067 (p = 0.008), as well as IP-10 and rs79711023 (p = 0.003), located in a region of IFIH1 previously shown to directly influence MDA-5 mediated IP-10 and IL-6 secretion. SLE patients and FDRs carrying the minor allele for rs79711023 demonstrated lower levels of IP-10, while only FDRs carrying the minor allele for rs76162067 demonstrated an increased level of IL-6. This would suggest that the change in IP-10 is genotypically driven, while the change in IL-6 may be reflective of SLE transition status. These data suggest that IFIH1 may contribute to SLE pathogenesis via altered inflammatory mechanisms.	[Munroe, Melissa E.; Pezant, Nathan; Brown, Michael A.; Fife, Dustin A.; Guthridge, Joel M.; Kelly, Jennifer A.; Wiley, Graham; Gaffney, Patrick M.; James, Judith A.; Montgomery, Courtney G.] Oklahoma Med Res Fdn, Arthrit & Clin Immunol Res Program, 825 NE 13th St, Oklahoma City, OK 73104 USA; [Brown, Michael A.; Montgomery, Courtney G.] Univ Oklahoma, Hlth Sci Ctr, Dept Biostat & Epidemiol, Oklahoma City, OK 73104 USA; [James, Judith A.] Univ Oklahoma, Hlth Sci Ctr, Dept Pathol & Med, Oklahoma City, OK USA	Oklahoma Medical Research Foundation; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center	Montgomery, CG (corresponding author), Oklahoma Med Res Fdn, Arthrit & Clin Immunol Res Program, 825 NE 13th St, Oklahoma City, OK 73104 USA.; Montgomery, CG (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Biostat & Epidemiol, Oklahoma City, OK 73104 USA.	Courtney-Montgomery@omrf.org		Montgomery, Courtney/0000-0002-9606-3772; Guthridge, Joel/0000-0002-9308-237X; Gaffney, Patrick/0000-0002-1580-869X; Kelly, Jennifer/0000-0002-3203-2467; Munroe, Melissa/0000-0002-6933-9745	National Institute of Allergy, Immunology and Infectious Diseases, Office of Research on Women's Health, National Institute of General Medical Sciences; National Institute of Arthritis, Musculoskeletal and Skin Diseases [U01AI101934, R01AI024717, U19AI082714, U54GM104938, P30GM103510, P30GM110766, P30AR053483, RC1AR058554, U34AR067392, HHSN266200500026C]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI082714, U01AI101934, R01AI024717] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR053483, U34AR067392] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM104938, P30GM103510, P30GM110766] Funding Source: NIH RePORTER	National Institute of Allergy, Immunology and Infectious Diseases, Office of Research on Women's Health, National Institute of General Medical Sciences; National Institute of Arthritis, Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by the National Institute of Allergy, Immunology and Infectious Diseases, Office of Research on Women's Health, National Institute of General Medical Sciences, and the National Institute of Arthritis, Musculoskeletal and Skin Diseases under award numbers U01AI101934, R01AI024717, U19AI082714, U54GM104938, P30GM103510, P30GM110766, P30AR053483, RC1AR058554, U34AR067392, and HHSN266200500026C. This publication is the sole responsibility of the authors and does not represent the views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by the National Institute of Allergy, Immunology and Infectious Diseases, Office of Research on Women's Health, National Institute of General Medical Sciences, and the National Institute of Arthritis, Musculoskeletal and Skin Diseases under award numbers U01AI101934, R01AI024717, U19AI082714, U54GM104938, P30GM103510, P30GM110766, P30AR053483, RC1AR058554, U34AR067392, and HHSN266200500026C. This publication is the sole responsibility of the authors and does not represent the views of the National Institutes of Health.	Beaulieu LM, 2014, ARTERIOSCL THROM VAS, V34, P552, DOI 10.1161/ATVBAHA.113.302700; Bruner BF, 2012, ARTHRITIS RHEUM-US, V64, P3677, DOI 10.1002/art.34651; Champely S., 2016, BASIC FUNCTIONS POWE; Cheung CL, 2008, HUM HERED, V65, P1, DOI 10.1159/000106057; Cortes A, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3204; Dossus L, 2009, J IMMUNOL METHODS, V350, P125, DOI 10.1016/j.jim.2009.09.001; duPont NC, 2005, J REPROD IMMUNOL, V66, P175, DOI 10.1016/j.jri.2005.03.005; Ehlers CL, 2010, ADDICT BIOL, V15, P185, DOI 10.1111/j.1369-1600.2009.00195.x; Flesher DLT, 2010, EXPERT REV CLIN IMMU, V6, P461, DOI [10.1586/ECI.10.8, 10.1586/eci.10.8]; FUJINAMI RS, 1985, SCIENCE, V230, P1043, DOI 10.1126/science.2414848; Funabiki M, 2014, IMMUNITY, V40, P199, DOI 10.1016/j.immuni.2013.12.014; Guryev V, 2006, PLOS GENET, V2, P1111, DOI 10.1371/journal.pgen.0020121; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kong KO, 2009, CLIN EXP IMMUNOL, V156, P134, DOI 10.1111/j.1365-2249.2009.03880.x; Kumar H, 2006, J EXP MED, V203, P1795, DOI 10.1084/jem.20060792; Laustrup H, 2004, LUPUS, V13, P792, DOI 10.1191/0961203304lu2015oa; Lu R, 2016, DYSREGULATION INNATE; Machiela MJ, 2015, BIOINFORMATICS, V31, P3555, DOI 10.1093/bioinformatics/btv402; Molineros JE, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003222; Morris JA, 2010, BIOINFORMATICS, V26, P1786, DOI 10.1093/bioinformatics/btq280; Munroe ME, 2016, ANN RHEUM DIS; Munroe ME, 2016, ARCHRITIS R IN PRESS; Munroe ME, 2014, ARTHRITIS RHEUMATOL, V66, P1888, DOI 10.1002/art.38573; Nejentsev S, 2009, SCIENCE, V324, P387, DOI 10.1126/science.1167728; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Robinson T, 2011, J IMMUNOL, V187, P1298, DOI 10.4049/jimmunol.1100857; Shah TS, 2012, BIOINFORMATICS, V28, P1598, DOI 10.1093/bioinformatics/bts180; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; SWAAK AJG, 1989, RHEUMATOL INT, V8, P263, DOI 10.1007/BF00270982	30	9	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0171193	10.1371/journal.pone.0171193	http://dx.doi.org/10.1371/journal.pone.0171193			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5VB	28234905	Green Submitted, Green Published, gold			2022-12-27	WOS:000394688200017
J	Razaq, M; Zhang, P; Shen, HL; Salahuddin				Razaq, Muhammad; Zhang, Peng; Shen, Hai-long; Salahuddin			Influence of nitrogen and phosphorous on the growth and root morphology of Acer mono	PLOS ONE			English	Article							ARBUSCULAR MYCORRHIZAL FUNGI; BIOMASS PRODUCTION; MINERAL-NUTRITION; LOBLOLLY-PINE; BRANCH ORDERS; SEEDLINGS; FERTILIZATION; WATER; AVAILABILITY; PHOSPHATE	Nitrogen and phosphorous are critical determinants of plant growth and productivity, and both plant growth and root morphology are important parameters for evaluating the effects of supplied nutrients. Previous work has shown that the growth of Acer mono seedlings is retarded under nursery conditions; we applied different levels of N (0, 5, 10, and 15 g plant(-1)) and P (0, 4, 6 and 8 g plant(-1)) fertilizer to investigate the effects of fertilization on the growth and root morphology of four-year-old seedlings in the field. Our results indicated that both N and P application significantly affected plant height, root collar diameter, chlorophyll content, and root morphology. Among the nutrient levels, 10 g N and 8 g P were found to yield maximum growth, and the maximum values of plant height, root collar diameter, chlorophyll content, and root morphology were obtained when 10 g N and 8 g P were used together. Therefore, the present study demonstrates that optimum levels of N and P can be used to improve seedling health and growth during the nursery period.	[Razaq, Muhammad; Zhang, Peng; Shen, Hai-long; Salahuddin] Northeast Forest Univ, Sch Forestry, Harbin, Peoples R China; [Salahuddin] Agr Res Inst, Mingora, Pakistan	Northeast Forestry University - China	Zhang, P (corresponding author), Northeast Forest Univ, Sch Forestry, Harbin, Peoples R China.	zhangpeng@nefu.edu.cn			Fundamental Research Funds for the Central Universities [2572016AA40]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This study was supported by the Fundamental Research Funds for the Central Universities (2572016AA40).	ALBREGTS EE, 1991, HORTSCIENCE, V26, P135, DOI 10.21273/HORTSCI.26.2.135; Andivia E, 2011, ANN FOREST SCI, V68, P543, DOI 10.1007/s13595-011-0048-4; ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; BARRACLOUGH PB, 1989, J AGRON CROP SCI, V163, P352, DOI 10.1111/j.1439-037X.1989.tb00778.x; Bloom AJ, 2006, ANN BOT-LONDON, V97, P867, DOI 10.1093/aob/mcj605; Bojovic B., 2006, KRAGUJEV J SCI, V28, P139; Bojovic BM., 2005, ARCH BIOL SCI, V57, P283, DOI [10.2298/ABS0504283B, DOI 10.2298/ABS0504283B]; Bown HE, 2010, TREES-STRUCT FUNCT, V24, P1097, DOI 10.1007/s00468-010-0482-1; Brown KR, 2005, NEW FOREST, V29, P89, DOI 10.1007/s11056-004-5418-4; Celekli A, 2009, BIORESOURCE TECHNOL, V100, P3625, DOI 10.1016/j.biortech.2009.02.055; Chaukiyal SP, 2013, J FORESTRY RES, V24, P531, DOI 10.1007/s11676-013-0384-3; Cicek E, 2010, J ENVIRON BIOL, V31, P109; Cooke JEK, 2005, NEW PHYTOL, V167, P41, DOI 10.1111/j.1469-8137.2005.01435.x; Costa C, 2002, AGRON J, V94, P96, DOI 10.2134/agronj2002.0096; Cuesta B, 2010, FOREST ECOL MANAG, V260, P71, DOI 10.1016/j.foreco.2010.04.002; Daughtry CST, 2000, REMOTE SENS ENVIRON, V74, P229, DOI 10.1016/S0034-4257(00)00113-9; Davey CB, 1994, NATL P FOREST CONSER, P38; De Giorgio D, 2012, ITALIAN J AGRONOMY, V7, P207, DOI [10.4081/ija.2012.e29, DOI 10.4081/IJA.2012.E29]; Domenicano S, 2011, NEW FOREST, V42, P347, DOI 10.1007/s11056-011-9256-x; DREW MC, 1975, NEW PHYTOL, V75, P479, DOI 10.1111/j.1469-8137.1975.tb01409.x; Dutt S, 2013, J PLANT NUTR, V36, P15, DOI 10.1080/01904167.2012.732648; Eissenstat DM, 2015, NEW PHYTOL, V208, P114, DOI 10.1111/nph.13451; EISSENSTAT DM, 1992, J PLANT NUTR, V15, P763, DOI 10.1080/01904169209364361; Epstein E., 2004, MINERAL NUTR PLANTS; Fageria NK, 2011, ADV AGRON, V110, P251, DOI 10.1016/B978-0-12-385531-2.00004-9; Fahad S, 2015, PLANT PHYSIOL BIOCH, V96, P281, DOI 10.1016/j.plaphy.2015.08.009; Fox TR, 2000, FOREST ECOL MANAG, V138, P187, DOI 10.1016/S0378-1127(00)00396-0; GRAHAM RL, 1992, CLIMATIC CHANGE, V22, P223, DOI 10.1007/BF00143029; Gruber BD, 2013, PLANT PHYSIOL, V163, P161, DOI 10.1104/pp.113.218453; Guo DL, 2008, NEW PHYTOL, V180, P673, DOI 10.1111/j.1469-8137.2008.02573.x; Guo DL, 2004, OECOLOGIA, V140, P450, DOI 10.1007/s00442-004-1596-1; HARPER JE, 1974, CROP SCI, V14, P255, DOI 10.2135/cropsci1974.0011183X001400020026x; Hill JO, 2006, PLANT SOIL, V286, P7, DOI 10.1007/s11104-006-0014-3; Hinsinger P, 2001, PLANT SOIL, V237, P173, DOI 10.1023/A:1013351617532; Hu YC, 2005, J PLANT NUTR SOIL SC, V168, P541, DOI 10.1002/jpln.200420516; Huang BR, 2000, J AM SOC HORTIC SCI, V125, P260, DOI 10.21273/JASHS.125.2.260; Huda S. M. S., 2007, Journal of Forestry Research (Harbin), V18, P279, DOI 10.1007/s11676-007-0056-2; Jelic M, 1994, SAVREMENAPOLJOPRIVRE, V42, P27; Jin J, 2005, SOIL SCI PLANT NUTR, V51, P953, DOI 10.1111/j.1747-0765.2005.tb00133.x; Jose S, 2003, FOREST ECOL MANAG, V180, P335, DOI 10.1016/S0378-1127(02)00583-2; Juntunen ML, 2002, J ENVIRON QUAL, V31, P1868, DOI 10.2134/jeq2002.1868; KADEBA O, 1978, COMMONW FOREST REV, V57, P191; Kauter D, 2003, BIOMASS BIOENERG, V24, P411, DOI 10.1016/S0961-9534(02)00177-0; Kern CC, 2004, TREE PHYSIOL, V24, P651, DOI 10.1093/treephys/24.6.651; King JS, 1997, PLANT SOIL, V195, P107, DOI 10.1023/A:1004291430748; King N, 2006, P 13 BIENN SO SILV R, P113; Lawlor DW, 2002, J EXP BOT, V53, P773, DOI 10.1093/jexbot/53.370.773; Lelyveld L. J. van, 1990, Acta Horticulturae, P483; LI Guang-xiang, 2004, ACAD FORESTRY SCI, V33, P1005; Li H, 2012, J EXP BOT, V63, P6173, DOI 10.1093/jxb/ers271; Liang XiuLan, 2005, Acta Agronomica Sinica, V31, P667; Lima JE, 2010, PLANT CELL, V22, P3621, DOI 10.1105/tpc.110.076216; Lincoln MC, 2007, FOREST ECOL MANAG, V242, P558, DOI 10.1016/j.foreco.2007.01.069; Liu BT, 2015, NEW PHYTOL, V208, P125, DOI 10.1111/nph.13434; Liu Jin-liang, 2009, Shengtaixue Zazhi, V28, P1; Lopez-Bucio J, 2003, CURR OPIN PLANT BIOL, V6, P280, DOI 10.1016/S1369-5266(03)00035-9; Ma Z, 2001, PLANT CELL ENVIRON, V24, P459, DOI 10.1046/j.1365-3040.2001.00695.x; MASAKI T, 1992, VEGETATIO, V98, P97, DOI 10.1007/BF00045549; Mexal JG, 2002, FOREST ECOL MANAG, V168, P125, DOI 10.1016/S0378-1127(01)00735-6; Teixeira MCM, 2011, CIENC RURAL, V41, P1375, DOI 10.1590/S0103-84782011000800013; Oliet JA, 2009, EUR J FOREST RES, V128, P253, DOI 10.1007/s10342-009-0261-y; Oskarsson H, 2006, FOREST ECOL MANAG, V229, P88, DOI 10.1016/j.foreco.2006.03.018; Ostonen I, 2007, PLANT BIOSYST, V141, P426, DOI 10.1080/11263500701626069; Pandey S. T., 2006, International Journal of Agricultural Sciences, V2, P626; Pregitzer KS, 2002, ECOL MONOGR, V72, P293, DOI 10.1890/0012-9615(2002)072[0293:FRAONN]2.0.CO;2; Ryser P, 1996, FUNCT ECOL, V10, P717, DOI 10.2307/2390506; Salih N, 2005, ECOSYSTEMS, V8, P373, DOI 10.1007/s10021-003-0103-6; Samuelson L, 2001, TREE PHYSIOL, V21, P369, DOI 10.1093/treephys/21.6.369; SANGINGA N, 1989, PLANT SOIL, V118, P125, DOI 10.1007/BF02232797; Perez VS, 2007, ANN FOREST SCI, V64, P201, DOI 10.1051/forest:2006104; Shen JP, 2010, APPL SOIL ECOL, V46, P119, DOI 10.1016/j.apsoil.2010.06.015; Shubra, 2004, BIOL PLANTARUM, V48, P445, DOI 10.1023/B:BIOP.0000041101.87065.c9; Song CJ, 2010, J ARID ENVIRON, V74, P1003, DOI 10.1016/j.jaridenv.2010.02.003; SUBUDHI BPR, 1979, BIOL PLANTARUM, V21, P401, DOI 10.1007/BF02889476; Sun Y, 2010, ECOL RES, V25, P295, DOI 10.1007/s11284-009-0654-x; Sundralingam P., 1983, Malaysian Forester, V46, P86; Tang C, 2009, ENVIRON EXP BOT, V67, P228, DOI 10.1016/j.envexpbot.2009.04.004; Tian QY, 2005, PLANT SOIL, V277, P185, DOI 10.1007/s11104-005-6837-5; Tinus R. W., 1978, Tree Planters' Notes, V29, P3; Totey NG, 1992, FERTILIZER MANAGEMEN, P156; VANDENDRIESSCHE R, 1980, CAN J FOREST RES, V10, P65, DOI 10.1139/x80-011; Verma R. K., 1996, Indian Journal of Forestry, V19, P244; Wang ZQ, 2006, PLANT SOIL, V288, P155, DOI 10.1007/s11104-006-9101-8; Waraich E. A., 2015, Journal of Plant Nutrition, V38, P1929, DOI 10.1080/01904167.2015.1043377; Williamson LC, 2001, PLANT PHYSIOL, V126, P875, DOI 10.1104/pp.126.2.875; Woolfolk WTM, 2003, TREE PHYSIOL, V23, P427, DOI 10.1093/treephys/23.6.427; Xie YH, 2006, ENVIRON EXP BOT, V57, P195, DOI 10.1016/j.envexpbot.2005.06.001; Xu BC, 2012, PAK J BOT, V44, P1857; Zapata F, 2002, NUTR CYCL AGROECOSYS, V63, P43, DOI 10.1023/A:1020518830129; Zhao D, 2008, FOREST ECOL MANAG, V255, P2512, DOI 10.1016/j.foreco.2008.01.011	90	152	158	12	87	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0171321	10.1371/journal.pone.0171321	http://dx.doi.org/10.1371/journal.pone.0171321			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5VB	28234921	Green Published, Green Submitted, gold			2022-12-27	WOS:000394688200019
J	Ren, F; Chen, L; Xiong, SL; Tong, QY				Ren, Fei; Chen, Long; Xiong, Shuangli; Tong, Qunyi			Enhanced acarbose production by Streptomyces M37 using a two-stage fermentation strategy	PLOS ONE			English	Article							GLUCOSIDASE INHIBITOR ACARBOSE; FED-BATCH FERMENTATION; ACTINOPLANES SP; EXOPOLYSACCHARIDE PRODUCTION; CULTURE PROCESS; ACID; BIOSYNTHESIS; METABOLITES; GLUTAMATE; AMMONIUM	In this work, we investigated the effect of pH on Streptomyces M37 growth and its acarbose biosynthesis ability. We observed that low pH was beneficial for cell growth, whereas high pH favored acarbose synthesis. Moreover, addition of glucose and maltose to the fermentation medium after 72 h of cultivation promoted acarbose production. Based on these results, a two-stage fermentation strategy was developed to improve acarbose production. Accordingly, pH was kept at 7.0 during the first 72 h and switched to 8.0 after that. At the same time, glucose and maltose were fed to increase acarbose accumulation. With this strategy, we achieved an acarbose titer of 6210 mg/ L, representing an 85.7% increase over traditional batch fermentation without pH control. Finally, we determined that the increased acarbose production was related to the high activity of glutamate dehydrogenase and glucose 6phosphate dehydrogenase.	[Ren, Fei] Southwest Univ Sci & Technol, Sch Life Sci & Technol, Mianyang, Sichuan, Peoples R China; [Ren, Fei; Chen, Long; Tong, Qunyi] Jiangnan Univ, State Key Lab Food Sci & Technol, Wuxi, Jiangsu, Peoples R China; [Ren, Fei; Xiong, Shuangli] Engn Res Ctr Biomass Resource Utillizat & Modific, Mianyang, Sichuan, Peoples R China	Southwest University of Science & Technology - China; Jiangnan University	Ren, F (corresponding author), Southwest Univ Sci & Technol, Sch Life Sci & Technol, Mianyang, Sichuan, Peoples R China.; Ren, F; Tong, QY (corresponding author), Jiangnan Univ, State Key Lab Food Sci & Technol, Wuxi, Jiangsu, Peoples R China.; Ren, F (corresponding author), Engn Res Ctr Biomass Resource Utillizat & Modific, Mianyang, Sichuan, Peoples R China.	renfei@swust.edu.cn; tqyjn@163.com			National High Technology Research and Development program of china (863) [2007AA10Z362]; Priority Academic Program Development of Jiangsu Higher Education Institutions	National High Technology Research and Development program of china (863)(National High Technology Research and Development Program of China); Priority Academic Program Development of Jiangsu Higher Education Institutions	This work was supported by the National High Technology Research and Development program of china (863) - 2007AA10Z362, and by the Priority Academic Program Development of Jiangsu Higher Education Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; National High Technology Research and Development program of china (863)-2007AA10Z362. Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Choi BT, 2004, APPL MICROBIOL BIOT, V65, P273, DOI 10.1007/s00253-004-1639-x; DEGWERT U, 1987, J ANTIBIOT, V40, P855, DOI 10.7164/antibiotics.40.855; Fang QH, 2002, BIOTECHNOL PROGR, V18, P51, DOI 10.1021/bp010136g; GONZALEZ R, 1995, J ANTIBIOT, V48, P479, DOI 10.7164/antibiotics.48.479; Hanefeld M, 2008, CARDIOVASC DRUG THER, V22, P225, DOI 10.1007/s10557-008-6091-1; Hansen KH, 1998, WATER RES, V32, P5, DOI 10.1016/S0043-1354(97)00201-7; HUDSON RC, 1993, COMP BIOCHEM PHYS B, V106, P767, DOI 10.1016/0305-0491(93)90031-Y; INOUE S, 1983, J FERMENT TECHNOL, V61, P7; Joo JH, 2004, WORLD J MICROB BIOT, V20, P767, DOI 10.1007/s11274-004-5841-x; Lee S, 1997, J ANTIBIOT, V50, P954, DOI 10.7164/antibiotics.50.954; Lee S, 1998, J ANTIBIOT, V51, P225, DOI 10.7164/antibiotics.51.225; Li K.T., 2012, BIORESOURCE TECHNOLO; Luo HH, 2013, PROCESS BIOCHEM, V48, P195, DOI 10.1016/j.procbio.2013.01.005; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Nie Z.K., 2013, BIOPROCESS BIOSYSTEM, P1; OKAZAKI H, 1973, AGR BIOL CHEM TOKYO, V37, P2319, DOI 10.1080/00021369.1973.10861007; PARENTI F, 1979, ANNU REV MICROBIOL, V33, P389, DOI 10.1146/annurev.mi.33.100179.002133; Ren F, 2014, TROP J PHARM RES, V13, P2075, DOI 10.4314/tjpr.v13i12.19; Rockser Y, 2009, J BIOTECHNOL, V140, P114, DOI 10.1016/j.jbiotec.2008.10.016; Ruijter GJG, 1997, BBA-GEN SUBJECTS, V1334, P317, DOI 10.1016/S0304-4165(96)00110-9; Schnell O, 2007, DIABETES OBES METAB, V9, P853, DOI 10.1111/j.1463-1326.2006.00666.x; Shao M., 2015, PLOS ONE, V10; Sun LH, 2012, J MICROBIOL BIOTECHN, V22, P826, DOI 10.4014/jmb.1111.11047; Vlaev S, 2013, APPL MICROBIOL BIOT, V97, P5303, DOI 10.1007/s00253-013-4864-3; Wang YJ, 2011, WORLD J MICROB BIOT, V27, P2759, DOI 10.1007/s11274-011-0751-1; Wang YJ, 2012, BIORESOURCE TECHNOL, V103, P337, DOI 10.1016/j.biortech.2011.09.121; Wehmeier UF, 2004, APPL MICROBIOL BIOT, V63, P613, DOI 10.1007/s00253-003-1477-2; Wendler S, 2014, J BIOTECHNOL, V191, P113, DOI 10.1016/j.jbiotec.2014.08.019; Xin ZG, 2014, BIORESOURCE TECHNOL, V152, P519, DOI 10.1016/j.biortech.2013.11.063; Zhu H, 2012, BIORESOURCE TECHNOL, V116, P526, DOI 10.1016/j.biortech.2012.03.117	31	5	5	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0166985	10.1371/journal.pone.0166985	http://dx.doi.org/10.1371/journal.pone.0166985			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5VB	28234967	Green Published, Green Submitted, gold			2022-12-27	WOS:000394688200002
J	Swift-Gallant, A; Coome, LA; Monks, DA; VanderLaan, DP				Swift-Gallant, Ashlyn; Coome, Lindsay A.; Monks, D. Ashley; VanderLaan, Doug P.			Handedness is a biomarker of variation in anal sex role behavior and Recalled Childhood Gender Nonconformity among gay men	PLOS ONE			English	Article							FRATERNAL BIRTH-ORDER; EXTREME RIGHT-HANDEDNESS; ANDROGEN RECEPTOR GENE; FINGER LENGTH RATIO; FLUCTUATING ASYMMETRY; HAND PREFERENCE; CEREBRAL LATERALIZATION; PERSONALITY-TRAITS; ORIENTATION; TESTOSTERONE	Developmental theories of the biological basis of sexual orientation suggest that sexually differentiated psychological and behavioural traits should be linked with sexual orientation. Subgroups of gay men delineated by anal sex roles differ according to at least one such trait: gender expression. The present study assessed the hypothesis that handedness, a biologically determined sexually differentiated trait, corresponds to differences in subgroups of gay men based on anal sex role. Furthermore, it assessed whether handedness mediates the association between gender nonconformity and male sexual orientation. Straight and gay men (N=333) completed the Edinburgh Inventory of Handedness and the Recalled Childhood Gender Nonconformity Scale. Gay men also completed measures of anal sex role preference. As in previous studies, gay men showed greater non-right-handedness and gender nonconformity than straight men. Also, among gay men, bottoms/versatiles ( i.e., gay men who take a receptive anal sex role, or who take on both a receptive and insertive anal sex role) were more gender-nonconforming than tops ( i.e., gay men who take an insertive anal sex role). In support of the hypothesis, bottoms/versatiles were more non-righthanded than tops and handedness mediated the male sexual orientation and anal sex role differences in Recalled Childhood Gender Nonconformity. Together, these findings suggest that developmental processes linked to handedness underpin variation among men in sexual orientation and gender nonconformity as well as variation among subgroups of gay men that are delineated by anal sex roles.	[Swift-Gallant, Ashlyn; Coome, Lindsay A.; Monks, D. Ashley; VanderLaan, Doug P.] Univ Toronto, Dept Psychol, Toronto, ON, Canada; [Swift-Gallant, Ashlyn; Coome, Lindsay A.; Monks, D. Ashley; VanderLaan, Doug P.] Univ Toronto, Dept Psychol, Mississauga, ON, Canada; [VanderLaan, Doug P.] CAMH, Child Youth & Family Div, Underserved Populat Res Program, Toronto, ON, Canada	University of Toronto; University of Toronto; University Toronto Mississauga; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada	VanderLaan, DP (corresponding author), Univ Toronto, Dept Psychol, Toronto, ON, Canada.; VanderLaan, DP (corresponding author), Univ Toronto, Dept Psychol, Mississauga, ON, Canada.; VanderLaan, DP (corresponding author), CAMH, Child Youth & Family Div, Underserved Populat Res Program, Toronto, ON, Canada.	doug.vanderlaan@utoronto.ca		Swift-Gallant, Ashlyn/0000-0001-7224-2672	National Sciences and Engineering Research Council of Canada (NSERC); NSERC Discovery Grants [RGPIN-2016-06302, RGPIN-2016-06446]	National Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC Discovery Grants(Natural Sciences and Engineering Research Council of Canada (NSERC))	The research reported in this article was supported by a doctoral Canadian graduate scholarship National Sciences and Engineering Research Council of Canada (NSERC; http://www.nserc-crsng.gc.ca) grant to ASG, and NSERC Discovery Grants to DAM (RGPIN-2016-06302) and DPV (RGPIN-2016-06446). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank all our volunteers who assisted in participant recruitment at the Toronto Pride Festival (Mary Loka, Lindsay Melhuish, Phil Nguyen, Lauren Oakley, Martha Pokarowski Firyal Ramzan, Anna Takagi and Robert Wither). The research reported in this article was supported by a doctoral Canada Graduate Scholarship from the National Sciences and Engineering Research Council of Canada (NSERC) and an Ontario Graduate Scholarship to ASG, was well as by NSERC Discovery Grants to DAM and DPV.	Arning L, 2015, SCI REP-UK, V5, DOI 10.1038/srep08325; Auyeung B, 2009, PSYCHOL SCI, V20, P144, DOI 10.1111/j.1467-9280.2009.02279.x; Bailey J. M, 2003, MAN WHO WOULD BE QUE; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Berenbaum SA, 2003, J CLIN ENDOCR METAB, V88, P1102, DOI 10.1210/jc.2002-020782; Blanchard R, 2006, HORM BEHAV, V49, P405, DOI 10.1016/j.yhbeh.2005.09.002; Blanchard R, 2008, LATERALITY, V13, P51, DOI 10.1080/13576500701710432; Blanchard R, 2007, ARCH SEX BEHAV, V36, P163, DOI 10.1007/s10508-006-9159-7; Blanchard R, 2015, ARCH SEX BEHAV, V44, P1503, DOI 10.1007/s10508-015-0555-8; Bogaert AF, 1999, ARCH SEX BEHAV, V28, P213, DOI 10.1023/A:1018780108597; Bogaert AF, 2003, BEHAV NEUROSCI, V117, P381, DOI 10.1037/0735-7044.117.2.381; Bogaert AF, 2002, BIOL PSYCHOL, V59, P135, DOI 10.1016/S0301-0511(01)00131-4; Bogaert AF, 2007, BEHAV NEUROSCI, V121, P845, DOI 10.1037/0735-7044.121.5.845; Bogaert AF, 2007, NEUROPSYCHOLOGY, V21, P141, DOI 10.1037/0894-4105.21.1.141; Breedlove SM, 2010, ENDOCRINOLOGY, V151, P4116, DOI 10.1210/en.2010-0041; CASEY MB, 1990, NEUROPSYCHOLOGIA, V28, P749; Dangerfield II DT, 2016, ARCH SEX BEHAV, P1; ELLIS L, 1987, PSYCHOL BULL, V101, P233, DOI 10.1037/0033-2909.101.2.233; Ellis L, 2016, LATERALITY ASYMMETRI, P1; GALABURDA AM, 1987, NEUROPSYCHOLOGIA, V25, P853, DOI 10.1016/0028-3932(87)90091-1; GESCHWIND N, 1985, ARCH NEUROL-CHICAGO, V42, P428, DOI 10.1001/archneur.1985.04060050026008; GESCHWIND N, 1982, P NATL ACAD SCI-BIOL, V79, P5097, DOI 10.1073/pnas.79.16.5097; GOOREN L, 1990, PSYCHONEUROENDOCRINO, V15, P3, DOI 10.1016/0306-4530(90)90041-7; Green R, 2001, ARCH SEX BEHAV, V30, P565, DOI 10.1023/A:1011908532367; Grimbos T, 2010, BEHAV NEUROSCI, V124, P278, DOI 10.1037/a0018764; Gutwinski S, 2011, DTSCH ARZTEBL INT, V108, P849, DOI 10.3238/arztebl.2011.0849; Hall PA, 2008, ARCH SEX BEHAV, V37, P158, DOI 10.1007/s10508-007-9282-0; Hampson E, 2015, LATERALITY ASYMMETRI, P1; Hampson E, 2012, NEUROPSYCHOLOGIA, V50, P2018, DOI 10.1016/j.neuropsychologia.2012.04.027; HELLEDAY J, 1994, NEUROPSYCHOLOGIA, V32, P875, DOI 10.1016/0028-3932(94)90024-8; Hines M, 2002, CHILD DEV, V73, P1678, DOI 10.1111/1467-8624.00498; Hojat M, 2004, ADV HEALTH SCI EDUC, V9, P241, DOI 10.1023/B:AHSE.0000038173.00909.f6; Kelso WM, 2000, NEUROPSYCHOLOGY, V14, P370, DOI 10.1037//0894-4105.14.3.370; Kishida M, 2015, ARCH SEX BEHAV, V44, P1493, DOI 10.1007/s10508-014-0474-0; Kraemer B, 2009, ARCH SEX BEHAV, V38, P359, DOI 10.1007/s10508-007-9262-4; Lalumiere ML, 2000, PSYCHOL BULL, V126, P575, DOI 10.1037//0033-2909.126.4.575; LEVAY S, 1991, SCIENCE, V253, P1034, DOI 10.1126/science.1887219; Lippa RA, 2003, ARCH SEX BEHAV, V32, P103, DOI 10.1023/A:1022444223812; Lippa RA, 2005, ANN REV SEX RES, V16, P119; Lust JM, 2011, NEUROPSYCHOLOGY, V25, P581, DOI 10.1037/a0023293; MACKE JP, 1993, AM J HUM GENET, V53, P844; Mathews GA, 2004, PSYCHONEUROENDOCRINO, V29, P810, DOI 10.1016/S0306-4530(03)00145-8; Mazur T, 2005, ARCH SEX BEHAV, V34, P411, DOI 10.1007/s10508-005-4341-x; Medland SE, 2005, BEHAV GENET, V35, P735, DOI 10.1007/s10519-005-6187-3; Miller SS, 2008, ARCH SEX BEHAV, V37, P150, DOI 10.1007/s10508-007-9256-2; Moskowitz DA, 2011, ARCH SEX BEHAV, V40, P835, DOI 10.1007/s10508-011-9754-0; Mustanski BS, 2002, ARCH SEX BEHAV, V31, P113, DOI 10.1023/A:1014039403752; NASS R, 1987, NEUROLOGY, V37, P711, DOI 10.1212/WNL.37.4.711; Ngun TC, 2011, FRONT NEUROENDOCRIN, V32, P227, DOI 10.1016/j.yfrne.2010.10.001; Nicholls MER, 1996, J CLIN EXP NEUROPSYC, V18, P905, DOI 10.1080/01688639608408312; Orlebeke J. F., 1992, NEUROPSYCHOLOGY, V6, P351; Papadatou-Pastou M, 2008, PSYCHOL BULL, V134, P677, DOI 10.1037/a0012814; Rahman Q, 2005, BIOL LETT-UK, V1, P393, DOI 10.1098/rsbl.2005.0342; Rahman Q, 2005, PSYCHONEUROENDOCRINO, V30, P382, DOI 10.1016/j.psyneuen.2004.10.006; Sanders AR, 2015, PSYCHOL MED, P45; Savin-Williams RC, 2013, DEV REV, V33, P58, DOI 10.1016/j.dr.2013.01.001; Sun T, 2006, NAT REV NEUROSCI, V7, P655, DOI 10.1038/nrn1930; Tut TG, 1997, J CLIN ENDOCR METAB, V82, P3777, DOI 10.1210/jc.82.11.3777; Vuoksimaa E, 2010, PSYCHONEUROENDOCRINO, V35, P1462, DOI 10.1016/j.psyneuen.2010.04.013; Watson DB, 1992, JAMA-J AM MED ASSOC, P267; Wisniewski AB, 2005, ARCH SEX BEHAV, V34, P167, DOI 10.1007/s10508-005-1794-x; Yeo R.A., 1994, DEV INSTABILITY ITS, P283; YEO RA, 1993, PSYCHOBIOLOGY, V21, P161; Zheng LJ, 2015, ARCH SEX BEHAV, V44, P1431, DOI 10.1007/s10508-014-0475-z; Zheng LJ, 2012, ARCH SEX BEHAV, V41, P683, DOI 10.1007/s10508-011-9819-0; Zucker KJ, 2006, SEX ROLES, V54, P469, DOI 10.1007/s11199-006-9019-x; Zucker KJ, 2001, J CHILD PSYCHOL PSYC, V42, P767, DOI 10.1111/1469-7610.00773	67	17	17	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0170241	10.1371/journal.pone.0170241	http://dx.doi.org/10.1371/journal.pone.0170241			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL5VB	28234947	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000394688200006
J	Wagemans, BAJM; van Zwam, WH; Nelemans, PJ; van Oostenbrugge, RJ; Postma, AA				Wagemans, Bart A. J. M.; van Zwam, Wim H.; Nelemans, Patricia J.; van Oostenbrugge, Robert J.; Postma, Alida A.			4D-CTA improves diagnostic certainty and accuracy in the detection of proximal intracranial anterior circulation occlusion in acute ischemic stroke	PLOS ONE			English	Article							4D CT ANGIOGRAPHY; PERFUSION	Introduction In acute ischemic stroke, imaging of the cranio-cervical vessels is essential for intra-arterial treatment selection. Fast, reliable and easy accessible imaging is necessary 24 hours a day, 7 days a week. Radiologists in training and non-expert readers often perform initial reviewing. In this pilot study, the potential benefit of adding 4Dimensional-CT Angiography (4D-CTA) to the patient selection protocol for intra-arterial therapy is investigated. Materials and methods Twenty-five datasets of prospectively recruited patients, eligible for intra-arterial treatment, were enrolled. Four radiologists-in-training consecutively reviewed CTA, CT-Perfusion and 4D-CTA (post-processed from CTP datasets) and scored: occlusion-presence and diagnostic certainty (scale 1-10). Time-to-diagnosis was registered. Results Arterial occlusion was present in 8 patients. Accuracy improved from 88-92% after CTA and CTP assessment to 96-100% after 4D-CTA assessment (P-values >0,05). Mean diagnostic certainty improved from 7,2-8,6 to 8,8-9,3 (P-values all < 0,05). Mean time to diagnosis increased from 3, 5, 5 and 4 minutes after CTA to 9, 14, 12, and 10 minutes after 4D-CTA. Conclusion 4D-CTA as an additive to regular CTA and CT-Perfusion in patients with acute ischemic stroke eligible for intra-arterial treatment shows a tendency to increase diagnostic accuracy and improves diagnostic certainty, when reviewed by radiologist in training, while only mildly prolonging time to diagnosis.	[Wagemans, Bart A. J. M.; van Zwam, Wim H.; Postma, Alida A.] Maastricht Univ, Med Ctr, Dept Radiol, Maastricht, Netherlands; [Nelemans, Patricia J.] Maastricht Univ, Med Ctr, Dept Clin Epidemiol, Maastricht, Netherlands; [van Oostenbrugge, Robert J.] Maastricht Univ, Med Ctr, Dept Neurol, Maastricht, Netherlands	Maastricht University; Maastricht University; Maastricht University	Wagemans, BAJM (corresponding author), Maastricht Univ, Med Ctr, Dept Radiol, Maastricht, Netherlands.	bart.wagemans@mumc.nl	Jacobi-Postma, linda (Alida) A/ABG-1756-2021	Jacobi-Postma, linda (Alida) A/0000-0002-1116-054X				Berkhemer OA, 2015, NEW ENGL J MED, V372, P11, DOI 10.1056/NEJMoa1411587; Campbell BCV, 2015, NEW ENGL J MED, V372, P1009, DOI 10.1056/NEJMoa1414792; Dehkharghani S, 2015, AJNR AM J NEURORADIO; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Feigin VL, 2014, LANCET, V383, P245, DOI 10.1016/S0140-6736(13)61953-4; Frolich AMJ, 2014, EUR RADIOL, V24, P390, DOI 10.1007/s00330-013-3024-6; Frolich AMJ, 2013, AM J NEURORADIOL, V34, P1908, DOI 10.3174/ajnr.A3533; Goyal M, 2015, NEW ENGL J MED, V372, P1019, DOI 10.1056/NEJMoa1414905; Hopyan J, 2010, RADIOLOGY, V255, P142, DOI 10.1148/radiol.09091021; Kaschka IN, 2014, CLIN NEURORADIOL; Kortman HG, 2014, AJNR AM J NEURORADIO; Lozano R, 2013, LANCET, V381, P628; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Ng FC, 2016, J NEUROIMAGING, V26, P588, DOI 10.1111/jon.12375; Power S, 2015, EUR J RADIOL, V84, P1333, DOI 10.1016/j.ejrad.2015.04.012; Sabarudin A, 2014, QUANT IMAGING MED SU, V4, P282, DOI 10.3978/j.issn.2223-4292.2014.07.10; Saver JL, 2014, INT J STROKE, V9, P658, DOI 10.1111/j.1747-4949.2012.00856.x; Vachha BA, 2015, RADIOL CLIN N AM, V53, P801, DOI 10.1016/j.rcl.2015.02.012; Wardlaw JM, 2004, STROKE, V35, P2477, DOI 10.1161/01.STR.0000143453.78005.44	19	10	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0172356	10.1371/journal.pone.0172356	http://dx.doi.org/10.1371/journal.pone.0172356			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5VB	28234928	gold, Green Submitted, Green Published			2022-12-27	WOS:000394688200073
J	Wunsch, T; Alexander, N; Kroll, J; Stoggl, T; Schwameder, H				Wunsch, Tobias; Alexander, Nathalie; Kroell, Josef; Stoeggl, Thomas; Schwameder, Hermann			Effects of a leaf spring structured midsole on joint mechanics and lower limb muscle forces in running	PLOS ONE			English	Article							LOWER-EXTREMITY; NORMAL WALKING; ENERGY; POWER; EMG; STIFFNESS; ECONOMY	To enhance running performance in heel-toe running, a leaf spring structured midsole shoe (LEAF) has recently been introduced. The purpose of this study was to investigate the effect of a LEAF compared to a standard foam midsole shoe (FOAM) on joint mechanics and lower limb muscle forces in overground running. Nine male long-distance heel strike runners ran on an indoor track at 3.0 +/- 0.2 m/s with LEAF and FOAM shoes. Running kinematics and kinetics were recorded during the stance phase. Absorbed and generated energy (negative and positive work) of the hip, knee and ankle joint as well as muscle forces of selected lower limb muscles were determined using a musculoskeletal model. A significant reduction in energy absorption at the hip joint as well as energy generation at the ankle joint was found for LEAF compared to FOAM. The mean lower limb muscle forces of the m. soleus, m. gastrocnemius lateralis and m. gastrocnemius medialis were significantly reduced for LEAF compared to FOAM. Furthermore, m. biceps femoris showed a trend of reduction in running with LEAF. The remaining lower limb muscles analyzed (m. gluteus maximus, m. rectus femoris, m. vastus medialis, m. vastus lateralis, m. tibialis anterior) did not reveal significant differences between the shoe conditions. The findings of this study indicate that LEAF positively influenced the energy balance in running by reducing lower limb muscle forces compared to FOAM. In this way, LEAF could contribute to an overall increased running performance in heel-toe running.	[Wunsch, Tobias; Alexander, Nathalie; Kroell, Josef; Stoeggl, Thomas; Schwameder, Hermann] Salzburg Univ, Dept Sport Sci & Kinesiol, Salzburg, Austria	Salzburg University	Wunsch, T (corresponding author), Salzburg Univ, Dept Sport Sci & Kinesiol, Salzburg, Austria.	tobias.wunsch@sbg.ac.at	; Stoggl, Thomas/A-4537-2014	Schwameder, Hermann/0000-0002-0380-8801; Alexander, Nathalie/0000-0002-2864-2246; Stoggl, Thomas/0000-0002-6685-1540	Open Access Publication Fund of the University of Salzburg; adidas AG, Herzogenaurach, Germany	Open Access Publication Fund of the University of Salzburg; adidas AG, Herzogenaurach, Germany	This study was supported by adidas FUTURE Team, adidas AG, Herzogenaurach, Germany (www.adidas-group.com). adidas had no involvement in the collection, analysis, or interpretation of any data. None of the authors of this article has any conflict of interest. The results of the current study do not constitute endorsement of the product by the authors or the journal. Furthermore, we acknowledge financial support bythe Open Access Publication Fund of the University of Salzburg.	Alexander N, 2016, J APPL BIOMECH, V32, P150, DOI 10.1123/jab.2015-0021; Andersen MS, 2010, COMPUT METHOD BIOMEC, V13, P171, DOI 10.1080/10255840903067080; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Correa TA, 2010, J BIOMECH, V43, P1618, DOI 10.1016/j.jbiomech.2010.02.008; Damsgaard M, 2006, SIMUL MODEL PRACT TH, V14, P1100, DOI 10.1016/j.simpat.2006.09.001; DeMers MS, 2014, J ORTHOP RES, V32, P769, DOI 10.1002/jor.22601; Derrick TR, 1998, MED SCI SPORT EXER, V30, P128, DOI 10.1097/00005768-199801000-00018; Frederick EC, 1986, J SPORT SCI, V4, P169, DOI 10.1080/02640418608732116; Hamill J, 2014, EUR J SPORT SCI, V14, P130, DOI 10.1080/17461391.2012.728249; Hamner SR, 2010, J BIOMECH, V43, P2709, DOI 10.1016/j.jbiomech.2010.06.025; Hansen Ernst Albin, 2009, Journal of Physiological Anthropology, V28, P261, DOI 10.2114/jpa2.28.261; Horsman MDK, 2007, CLIN BIOMECH, V22, P239, DOI 10.1016/j.clinbiomech.2006.10.003; Kersting UG, 2010, 13TH INTERNATIONAL S; Knoepfli-Lenzin C, 2014, J SPORT SCI; Kyrolainen H, 2001, MED SCI SPORT EXER, V33, P1330; Miller RH, 2009, COMPUT METHOD BIOMEC, V12, P217, DOI [10.1080/10255840802430579, 10.1080/10255840903093490]; Nigg B. M, 2010, BIOMECHANIC SPORT SH; Nigg BM, 2003, J BIOMECH, V36, P569, DOI 10.1016/S0021-9290(02)00428-1; NIGG BM, 1992, MED SCI SPORT EXER, V24, P595; O'Connor KM, 2006, J ELECTROMYOGR KINES, V16, P522, DOI 10.1016/j.jelekin.2005.09.003; Rasmussen J, 2001, J BIOMECH, V34, P409, DOI 10.1016/S0021-9290(00)00191-3; Roberts TJ, 2005, J EXP BIOL, V208, P1963, DOI 10.1242/jeb.01555; Roy JPR, 2006, MED SCI SPORT EXER, V38, P562, DOI 10.1249/01.mss.0000193562.22001.e8; Ryschon TW, 1997, J APPL PHYSIOL, V83, P867, DOI 10.1152/jappl.1997.83.3.867; Sasaki K, 2006, J BIOMECH, V39, P2005, DOI 10.1016/j.jbiomech.2005.06.019; SHORTEN MR, 1993, J BIOMECH, V26, P41, DOI 10.1016/0021-9290(93)90078-S; Sinclair J., 2016, FOOT ANKLE ONLINE J, V9, P37, DOI [https://doi.org/10.3827/faoj.2016.0902.0008, DOI 10.3827/FAOJ.2016.0902.0008]; Stefanyshyn DJ, 1998, J SPORT SCI, V16, P177; Valente G, 2013, J BIOMECH, V46, P2186, DOI 10.1016/j.jbiomech.2013.06.030; Wakeling JM, 2001, EUR J APPL PHYSIOL, V86, P40, DOI 10.1007/s004210100508; WINTER DA, 1983, J BIOMECH, V16, P91, DOI 10.1016/0021-9290(83)90050-7; Worobets J., 2013, FOOTWEAR SCI, V5, pS75, DOI DOI 10.1080/19424280.2013.799566; Wunsch T, 2014, INT CALG RUNN S CALG, P154; Wunsch T, 2016, EUROPEAN J SPORT SCI, P1; Wunsch T, 2015, FOOTWEAR SCI; Wunsch T, 2015, FOOTW BIOM S 2015 LI	36	7	7	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0172287	10.1371/journal.pone.0172287	http://dx.doi.org/10.1371/journal.pone.0172287			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5VB	28234946	Green Published, Green Submitted, gold			2022-12-27	WOS:000394688200063
J	Asghar, MZ; Khan, A; Ahmad, S; Qasim, M; Khan, IA				Asghar, Muhammad Zubair; Khan, Aurangzeb; Ahmad, Shakeel; Qasim, Maria; Khan, Imran Ali			Lexicon-enhanced sentiment analysis framework using rule-based classification scheme	PLOS ONE			English	Article								With the rapid increase in social networks and blogs, the social media services are increasingly being used by online communities to share their views and experiences about a particular product, policy and event. Due to economic importance of these reviews, there is growing trend of writing user reviews to promote a product. Nowadays, users prefer online blogs and review sites to purchase products. Therefore, user reviews are considered as an important source of information in Sentiment Analysis (SA) applications for decision making. In this work, we exploit the wealth of user reviews, available through the online forums, to analyze the semantic orientation of words by categorizing them into +ive and -ive classes to identify and classify emoticons, modifiers, general-purpose and domain-specific words expressed in the public's feedback about the products. However, the un-supervised learning approach employed in previous studies is becoming less efficient due to data sparseness, low accuracy due to non-consideration of emoticons, modifiers, and presence of domain specific words, as they may result in inaccurate classification of users' reviews. Lexicon-enhanced sentiment analysis based on Rule-based classification scheme is an alternative approach for improving sentiment classification of users' reviews in online communities. In addition to the sentiment terms used in general purpose sentiment analysis, we integrate emoticons, modifiers and domain specific terms to analyze the reviews posted in online communities. To test the effectiveness of the proposed method, we considered users reviews in three domains. The results obtained from different experiments demonstrate that the proposed method overcomes limitations of previous methods and the performance of the sentiment analysis is improved after considering emoticons, modifiers, negations, and domain specific terms when compared to baseline methods.	[Asghar, Muhammad Zubair; Qasim, Maria] Gomal Univ, ICIT, Dera Ismail Khan, Pakistan; [Khan, Aurangzeb] Univ Sci & Technol, Dept Comp Sci, Bannu, Pakistan; [Ahmad, Shakeel] King Abdul Aziz Univ KAU Saudi Arabia, FCITR, Jeddah, Saudi Arabia; [Khan, Imran Ali] COMSATS Inst Informat Technol, Abbottabad, Pakistan	Gomal University; University of Science & Technology Bannu; King Abdulaziz University; COMSATS University Islamabad (CUI)	Asghar, MZ (corresponding author), Gomal Univ, ICIT, Dera Ismail Khan, Pakistan.	zubair@gu.edu.pk	ahmad, shakeel/F-5194-2015; Asghar, Muhammad Zubair/M-6411-2015; Khan, Imran Ali/GVT-0232-2022; Khan, imran/GQQ-2176-2022	ahmad, shakeel/0000-0003-4653-3323; Asghar, Muhammad Zubair/0000-0003-3320-2074; Khan, Imran Ali/0000-0002-8774-2896; 				Aminu M, 2016, CONTEXTUAL SENTIMENT; Asghar MS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0114840; Asghar MZ, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-2809-x; Asghar MZ, 2015, THESIS; Baccianella S, 2015, SENTIWORDNET 3 0 ENH, V10, P2200; Bird S., 2009, NATURAL LANGUAGE PRO; Bo Pang, 2008, Foundations and Trends in Information Retrieval, V2, P1, DOI 10.1561/1500000001; Boratto L., 2016, S KNOWLEDGE BASED SY; Cambria E, 2016, IEEE INTELL SYST, V31, P102, DOI 10.1109/MIS.2016.31; Choi Y, 2009, P 2009 C EMPIRICAL M, V2, P590; Ferrara E., 2015, PEERJ COMPUT SCI, V1, P1; Gu B, 2015, PROCEEDINGS OF THE TWENTY-FOURTH INTERNATIONAL JOINT CONFERENCE ON ARTIFICIAL INTELLIGENCE (IJCAI), P3532; Gu B, 2015, IEEE T NEUR NET LEAR, V26, P1403, DOI 10.1109/TNNLS.2014.2342533; Ikeda D., 2008, IJCNLP, P296; Kalaivani P., 2013, INDIAN J COMPUTER SC, V4, P285; Kennedy A., 2006, COMPUT INTELL, V22, P2006; Khan A, 2011, TRENDS APPL SCI RES, V6, P1141, DOI [10.3923/tasr.2011.1141.1157, DOI 10.3923/TASR.2011.1141.1157, DOI 10.3923/tasr.2011.1141.1157]; Khan FH, 2014, DECIS SUPPORT SYST, V57, P245, DOI 10.1016/j.dss.2013.09.004; Kundi F.M., 2014, LIFE SCI J, V11, P66; Kundi Fazal Masud, 2014, J BASIC APPL SCI RES, V4, P238; Li S., 2010, P 23 INT C COMPUTATI, P635; Liu CL, 2012, IEEE T SYST MAN CY C, V42, P397, DOI 10.1109/TSMCC.2011.2136334; Pensa RG, 2016, IEEE COMPUT INTELL M, V11, P11, DOI 10.1109/MCI.2016.2572518; Poria S., 2015, P 2015 C EMP METH NA, P2539; Severyn A, 2015, SIGIR 2015: PROCEEDINGS OF THE 38TH INTERNATIONAL ACM SIGIR CONFERENCE ON RESEARCH AND DEVELOPMENT IN INFORMATION RETRIEVAL, P959, DOI 10.1145/2766462.2767830; Taboada M, 2011, COMPUT LINGUIST, V37, P267, DOI 10.1162/COLI_a_00049; Wang YY, 2016, J BIOTECHNOL, V239, P61, DOI 10.1016/j.jbiotec.2016.09.015; Zhao J., 2016, SENTIMENT ANAL MININ; Zou Q, 2016, BMC SYST BIOL, V10, DOI 10.1186/s12918-016-0353-5	29	63	65	4	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2017	12	2							e0171649	10.1371/journal.pone.0171649	http://dx.doi.org/10.1371/journal.pone.0171649			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5SX	28231286	Green Published, gold, Green Submitted			2022-12-27	WOS:000394682400014
J	Cook, ECL; Nelson, JK; Sorrentino, V; Koenis, D; Moeton, M; Scheij, S; Ottenhoff, R; Bleijlevens, B; Loregger, A; Zelcer, N				Cook, Emma C. L.; Nelson, Jessica K.; Sorrentino, Vincenzo; Koenis, Duco; Moeton, Martina; Scheij, Saskia; Ottenhoff, Roelof; Bleijlevens, Boris; Loregger, Anke; Zelcer, Noam			Identification of the ER-resident E3 ubiquitin ligase RNF145 as a novel LXR-regulated gene	PLOS ONE			English	Article							LIVER-X-RECEPTOR; STEROL-SENSING DOMAIN; HMG COA REDUCTASE; ELEMENT-BINDING PROTEIN-1C; LIPID-METABOLISM; TRANSCRIPTION FACTORS; CHOLESTEROL EFFLUX; HUMAN MACROPHAGES; DEGRADATION; ALPHA	Cellular cholesterol metabolism is subject to tight regulation to maintain adequate levels of this central lipid molecule. Herein, the sterol-responsive Liver X Receptors (LXRs) play an important role owing to their ability to reduce cellular cholesterol load. In this context, identifying the full set of LXR-regulated genes will contribute to our understanding of their role in cholesterol metabolism. Using global transcriptional analysis we report here the identification of RNF145 as an LXR-regulated target gene. We demonstrate that RNF145 is regulated by LXRs in both human and mouse primary cells and cell lines, and in vivo in mice. Regulation of RNF145 by LXR depends on a functional LXR-element in its proximal promotor. Consistent with LXR-dependent regulation of Rnf145 we show that regulation is lost in macrophages and fibroblasts from Lxr alpha beta((-/-)) mice, and also in vivo in livers of Lxr alpha((-/-)) mice treated with the LXR synthetic ligand T0901317. RNF145 is closely related to RNF139/TRC8, an E3 ligase implicated in control of SREBP processing. However, silencing of RNF145 in HepG2 or HeLa cells does not impair SREBP1/2 processing and sterol-responsive gene expression in these cells. Similar to TRC8, we demonstrate that RNF145 is localized to the ER and that it possesses intrinsic E3 ubiquitin ligase activity. In summary, we report the identification of RNF145 as an ER-resident E3 ubiquitin ligase that is transcriptionally controlled by LXR.	[Cook, Emma C. L.; Nelson, Jessica K.; Sorrentino, Vincenzo; Koenis, Duco; Moeton, Martina; Scheij, Saskia; Ottenhoff, Roelof; Bleijlevens, Boris; Loregger, Anke; Zelcer, Noam] Univ Amsterdam, Acad Med Ctr, Dept Med Biochem, Meibergdreef 9, Amsterdam, Netherlands; [Sorrentino, Vincenzo] Ecole Polytech Fed Lausanne, Lab Integrat & Syst Physiol, Lausanne, Switzerland	University of Amsterdam; Academic Medical Center Amsterdam; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Zelcer, N (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Med Biochem, Meibergdreef 9, Amsterdam, Netherlands.	n.zelcer@amc.uva.nl	Cook, Emma/AAA-2707-2020; Sorrentino, Vincenzo/R-4403-2018	Cook, Emma/0000-0002-1415-4049; Sorrentino, Vincenzo/0000-0002-7212-370X; Koenis, Duco Steven/0000-0002-7213-0950; Zelcer, Noam/0000-0001-6935-7532	Dutch Heart Foundation [2016T015, 2013T111]; ERC from the European Research Council [617376]	Dutch Heart Foundation(Netherlands Heart Foundation); ERC from the European Research Council	AL is supported by a Dekker Junior Postdoc grant from the Dutch Heart Foundation (2016T015). NZ is an Established Investigator of the Dutch Heart Foundation (2013T111) and is supported by an ERC Consolidator grant (617376) from the European Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank members of the Zelcer group, Jan Aten and Irith Koster for their comments and suggestions, Albert van Wijk for assistance with isolation of primary rat hepatocytes and Cindy van Roomen for her help with the animal experiments. AL is supported by a Dekker Junior Postdoc grant from the Dutch Heart Foundation (2016T015). NZ is an Established Investigator of the Dutch Heart Foundation (2013T111) and is supported by an ERC Consolidator grant (617376) from the European Research Council.	Blackinton JG, 2016, NUCLEIC ACIDS RES, V44, P426, DOI 10.1093/nar/gkv1066; Boergesen M, 2012, MOL CELL BIOL, V32, P852, DOI 10.1128/MCB.06175-11; Chawla A, 2001, MOL CELL, V7, P161, DOI 10.1016/S1097-2765(01)00164-2; Demerath EW, 2015, HUM MOL GENET, V24, P4464, DOI 10.1093/hmg/ddv161; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Dobson L, 2015, NUCLEIC ACIDS RES, V43, pW408, DOI 10.1093/nar/gkv451; Galhardo M, 2014, GENOM DATA, V2, P230, DOI 10.1016/j.gdata.2014.07.002; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; Graham DB, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8838; Hegarty BD, 2005, P NATL ACAD SCI USA, V102, P791, DOI 10.1073/pnas.0405067102; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hijmans BS, 2015, FASEB J, V29, P1153, DOI 10.1096/fj.14-254656; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; Hsieh J, 2016, NATURE, V535, P303, DOI 10.1038/nature18628; Irisawa M, 2009, J BIOL CHEM, V284, P28995, DOI 10.1074/jbc.M109.041376; Isai YC, 2012, MOL BIOL CELL, V23, P4484, DOI [10.1091/mbc.E12-08-0631, DOI 10.1091/MBC.E12-08-0631]; Janowski BA, 1996, NATURE, V383, P728, DOI 10.1038/383728a0; Jo Y, 2011, P NATL ACAD SCI USA, V108, P20503, DOI 10.1073/pnas.1112831108; Kennedy MA, 2001, J BIOL CHEM, V276, P39438, DOI 10.1074/jbc.M105863200; Kikkert M, 2004, J BIOL CHEM, V279, P3525, DOI 10.1074/jbc.M307453200; Kim KH, 2009, MOL ENDOCRINOL, V23, P466, DOI 10.1210/me.2008-0295; Kuwabara PE, 2002, TRENDS GENET, V18, P193, DOI 10.1016/S0168-9525(02)02640-9; Lee JH, 2014, HEPATOLOGY, V60, P844, DOI 10.1002/hep.27011; Lee JP, 2010, MOL CANCER RES, V8, P93, DOI 10.1158/1541-7786.MCR-08-0491; Li PP, 2013, CELL, V155, P200, DOI 10.1016/j.cell.2013.08.054; Loregger A, 2016, MOL CELL BIOL, V36, P285, DOI 10.1128/MCB.00890-15; Maxfield FR, 2010, CURR OPIN CELL BIOL, V22, P422, DOI 10.1016/j.ceb.2010.05.004; Millard EE, 2005, J BIOL CHEM, V280, P28581, DOI 10.1074/jbc.M414024200; Motazacker MM, 2012, EUR HEART J, V33, P1360, DOI 10.1093/eurheartj/ehs010; Nelson JK, 2017, ATVBAHA, V116; Neutzner A, 2011, J BIOL CHEM, V286, P8633, DOI 10.1074/jbc.M110.197459; Pearson W R, 2000, Methods Mol Biol, V132, P185; Pehkonen P, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-50; Pizarro A, 2013, NUCLEIC ACIDS RES, V41, pD1009, DOI 10.1093/nar/gks1161; Radhakrishnan A, 2008, CELL METAB, V8, P512, DOI 10.1016/j.cmet.2008.10.008; Repa JJ, 2000, GENE DEV, V14, P2819, DOI 10.1101/gad.844900; Sallam T, 2016, NATURE, V534, P124, DOI 10.1038/nature17674; Schwartz AL, 2009, ANNU REV PHARMACOL, V49, P73, DOI 10.1146/annurev.pharmtox.051208.165340; SEGLEN PO, 1979, J TOXICOL ENV HEALTH, V5, P551, DOI 10.1080/15287397909529766; Sever N, 2003, MOL CELL, V11, P25, DOI 10.1016/S1097-2765(02)00822-5; Sharpe LJ, 2014, TRENDS BIOCHEM SCI, V39, P527, DOI 10.1016/j.tibs.2014.08.008; Song BL, 2005, MOL CELL, V19, P829, DOI 10.1016/j.molcel.2005.08.009; Sorrentino V, 2012, CURR OPIN LIPIDOL, V23, P213, DOI 10.1097/MOL.0b013e3283532947; Spann NJ, 2012, CELL, V151, P138, DOI 10.1016/j.cell.2012.06.054; Sundqvist A, 2005, CELL METAB, V1, P379, DOI 10.1016/j.cmet.2005.04.010; Venkateswaran A, 2000, P NATL ACAD SCI USA, V97, P12097, DOI 10.1073/pnas.200367697; Wagner BL, 2003, MOL CELL BIOL, V23, P5780, DOI 10.1128/MCB.23.16.5780-5789.2003; Wong J, 2004, ARTERIOSCL THROM VAS, V24, P2365, DOI 10.1161/01.ATV.0000148707.93054.7d; Yabe D, 2002, P NATL ACAD SCI USA, V99, P16672, DOI 10.1073/pnas.262669399; Yang CD, 2006, J BIOL CHEM, V281, P27816, DOI 10.1074/jbc.M603781200; Zelcer N, 2006, J CLIN INVEST, V116, P607, DOI 10.1172/JCI27883; Zelcer N, 2007, P NATL ACAD SCI USA, V104, P10601, DOI 10.1073/pnas.0701096104; Zelcer N, 2014, MOL CELL BIOL, V34, P1262, DOI 10.1128/MCB.01140-13; Zelcer N, 2009, SCIENCE, V325, P100, DOI 10.1126/science.1168974	55	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2017	12	2							e0172721	10.1371/journal.pone.0172721	http://dx.doi.org/10.1371/journal.pone.0172721			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5SX	28231341	gold, Green Published			2022-12-27	WOS:000394682400077
J	Davy, BM; Winett, RA; Savla, J; Marinik, EL; Baugh, ME; Flack, KD; Halliday, TM; Kelleher, SA; Winett, SG; Williams, DM; Boshra, S				Davy, Brenda M.; Winett, Richard A.; Savla, Jyoti; Marinik, Elaina L.; Baugh, Mary Elizabeth; Flack, Kyle D.; Halliday, Tanya M.; Kelleher, Sarah A.; Winett, Sheila G.; Williams, David M.; Boshra, Soheir			Resist diabetes: A randomized clinical trial for resistance training maintenance in adults with prediabetes	PLOS ONE			English	Article							ACTIVITY PROMOTION PROGRAMS; PREVENTION PROGRAM; SELF-REGULATION; INCREASED RISK; COMBINED DIET; OLDER-ADULTS; COMMUNITY; GLUCOSE; INTERVENTION; PARTICIPATION	Objective To determine whether a social cognitive theory (SCT)-based intervention improves resistance training (RT) maintenance and strength, and reduces prediabetes prevalence. Research design and methods Sedentary, overweight/obese (BMI: 25-39.9 kg/m(2)) adults aged 50-69 (N = 170) with prediabetes participated in the 15-month trial. Participants completed a supervised 3-month RT (2x/wk) phase and were randomly assigned (N = 159) to one of two 6-month maintenance conditions: SCT or standard care. Participants continued RT at a self-selected facility. The final 6-month period involved no contact. Assessments occurred at baseline and months 3, 9, and 15. The SCT faded-contact intervention consisted of nine tailored transition (i.e., supervised training to training alone) and nine follow-up sessions. Standard care involved six generic follow-up sessions. Primary outcomes were prevalence of normoglycemia and muscular strength. Results The retention rate was 76%. Four serious adverse events were reported. After 3 months of RT, 34% of participants were no longer prediabetic. This prevalence of normoglycemia was maintained through month 15 (30%), with no group difference. There was an 18% increase in the odds of being normoglycemic for each% increase in fat-free mass. Increases in muscular strength were evident at month 3 and maintained through month 15 (P<0.001), which represented improvements of 21% and 14% for chest and leg press, respectively. Results did not demonstrate a greater reduction in prediabetes prevalence in the SCT condition. Conclusions Resistance training is an effective, maintainable strategy for reducing prediabetes prevalence and increasing muscular strength. Future research which promotes RT initiation and maintenance in clinical and community settings is warranted.	[Davy, Brenda M.; Marinik, Elaina L.; Baugh, Mary Elizabeth; Flack, Kyle D.; Halliday, Tanya M.] Virginia Tech, Dept Human Nutr Foods & Exercise, Blacksburg, VA 24061 USA; [Winett, Richard A.] Virginia Tech, Dept Psychol, Blacksburg, VA USA; [Savla, Jyoti] Virginia Tech, Dept Human Dev, Blacksburg, VA USA; [Kelleher, Sarah A.] Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Durham, NC USA; [Winett, Sheila G.] PCR Inc, Blacksburg, VA USA; [Williams, David M.] Brown Univ, Sch Publ Hlth, Dept Behav & Social Sci, Providence, RI 02912 USA; [Boshra, Soheir] Carilion Clin, Roanoke, VA USA	Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; Duke University; Brown University	Davy, BM (corresponding author), Virginia Tech, Dept Human Nutr Foods & Exercise, Blacksburg, VA 24061 USA.	bdavy@vt.edu	Savla, Jyoti/N-6085-2019; Williams, David M/F-8559-2011; Savla, Jyoti/J-7125-2015	Savla, Jyoti/0000-0001-7142-3770; Williams, David M/0000-0003-2335-8673; Savla, Jyoti/0000-0001-7142-3770; Halliday, Tanya/0000-0001-6178-0686; Flack, Kyle/0000-0001-7622-4770; Baugh, Mary Elizabeth/0000-0002-3469-7040	National Institutes of Health [RAW: R01DK082383]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors received funding from the National Institutes of Health (BMD, RAW: R01DK082383).	Ackermann RT, 2015, ANN INTERN MED, V163, P475, DOI 10.7326/M15-1563; Ackermann RT, 2008, AM J PREV MED, V35, P357, DOI 10.1016/j.amepre.2008.06.035; Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS14, DOI 10.2337/dc14-S014; American College of Sport Medicine, 2005, ACSMS GUIDELINES EXE; Amundson HA, 2009, DIABETES EDUCATOR, V35, P209, DOI 10.1177/0145721709333269; Balk EM, 2015, ANN INTERN MED, V163, P437, DOI 10.7326/M15-0452; Bray GA, 1999, DIABETES CARE, V22, P623; Centers for Disease Control and Prevention, 2014, NAT DIAB REP EST DAT; Diabetes Prevention Program Research Group, 2012, DIABETES CARE, V35, P723, DOI DOI 10.2337/DC11-1468; Dunstan DW, 2006, DIABETES CARE, V29, P2586, DOI 10.2337/dc06-1310; Eikenberg JD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148009; Estabrooks PA, 2008, PATIENT EDUC COUNS, V72, P34, DOI 10.1016/j.pec.2008.01.007; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Halliday TM, 2014, EAT BEHAV, V15, P379, DOI 10.1016/j.eatbeh.2014.04.004; Herman WH, 2016, DIABETES CARE, V39, pS3, DOI 10.2337/dc16-S002; Herman WH, 2013, AM J MANAG CARE, V19, P194; Johannsen NM, 2016, SPORTS MED; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; KOHL HW, 1988, AM J EPIDEMIOL, V127, P1228, DOI 10.1093/oxfordjournals.aje.a114915; Kraschnewski JL, 2016, PREV MED, V87, P121, DOI 10.1016/j.ypmed.2016.02.038; Li R, 2015, ANN INTERN MED, V163, P452, DOI 10.7326/M15-0469; Liu CJ, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002759.pub2; Loustalot F, 2013, RES Q EXERCISE SPORT, V84, P30, DOI 10.1080/02701367.2013.762289; Marinik EL, 2014, CONTEMP CLIN TRIALS, V37, P19, DOI 10.1016/j.cct.2013.11.006; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Nathan DM, 2007, DIABETES CARE, V30, P753, DOI 10.2337/dc07-9920; Payne WR, 2008, DIABETES CARE, V31, P2244, DOI 10.2337/dc08-0152; Perreault L, 2012, LANCET, V379, P2243, DOI 10.1016/S0140-6736(12)60525-X; Peterson MD, 2016, SPORTS MED, V46, P619, DOI 10.1007/s40279-015-0463-z; Pickering Thomas G, 2005, J Clin Hypertens (Greenwich), V7, P102, DOI 10.1111/j.1524-6175.2005.04377.x; Pruessner JC, 2003, PSYCHONEUROENDOCRINO, V28, P916, DOI 10.1016/S0306-4530(02)00108-7; SHIMOKATA H, 1991, DIABETES, V40, P44, DOI 10.2337/diabetes.40.1.44; Short KR, 2001, INT J SPORT NUTR EXE, V11, pS119, DOI 10.1123/ijsnem.11.s1.s119; Tabak AG, 2012, LANCET, V379, P2279, DOI 10.1016/S0140-6736(12)60283-9; Teychenne M, 2015, INT J BEHAV NUTR PHY, V12, DOI 10.1186/s12966-015-0266-5; Umpierre D, 2011, JAMA-J AM MED ASSOC, V305, P1790, DOI 10.1001/jama.2011.576; Williams DM, 2015, J AGING PHYS ACTIV, V23, P279, DOI 10.1123/japa.2013-0184; Winett RA, 2015, TRANSL BEHAV MED, V5, P149, DOI 10.1007/s13142-015-0304-5; Winett RA, 2014, TRANSL BEHAV MED, V4, P333, DOI 10.1007/s13142-014-0263-2	42	14	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2017	12	2							e0172610	10.1371/journal.pone.0172610	http://dx.doi.org/10.1371/journal.pone.0172610			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL5SX	28231265	gold, Green Published			2022-12-27	WOS:000394682400060
J	Hurd, TR; Gleeson, JP; Melnik, S				Hurd, Thomas R.; Gleeson, James P.; Melnik, Sergey			A framework for analyzing contagion in assortative banking networks	PLOS ONE			English	Article							TOPOLOGY; MODEL	We introduce a probabilistic framework that represents stylized banking networks with the aim of predicting the size of contagion events. Most previous work on random financial networks assumes independent connections between banks, whereas our framework explicitly allows for (dis) assortative edge probabilities (i.e., a tendency for small banks to link to large banks). We analyze default cascades triggered by shocking the network and find that the cascade can be understood as an explicit iterated mapping on a set of edge probabilities that converges to a fixed point. We derive a cascade condition, analogous to the basic reproduction number R-0 in epidemic modelling, that characterizes whether or not a single initially defaulted bank can trigger a cascade that extends to a finite fraction of the infinite network. This cascade condition is an easily computed measure of the systemic risk inherent in a given banking network topology. We use percolation theory for random networks to derive a formula for the frequency of global cascades. These analytical results are shown to provide limited quantitative agreement with Monte Carlo simulation studies of finite-sized networks. We show that edge-assortativity, the propensity of nodes to connect to similar nodes, can have a strong effect on the level of systemic risk as measured by the cascade condition. However, the effect of assortativity on systemic risk is subtle, and we propose a simple graph theoretic quantity, which we call the graph-assortativity coefficient, that can be used to assess systemic risk.	[Hurd, Thomas R.] McMaster Univ, Dept Math, Hamilton, ON, Canada; [Gleeson, James P.; Melnik, Sergey] Univ Limerick, Dept Math & Stat, MACSI, Limerick, Ireland	McMaster University; University of Limerick	Hurd, TR (corresponding author), McMaster Univ, Dept Math, Hamilton, ON, Canada.	hurdt@mcmaster.ca			Natural Sciences and Engineering Research Council of Canada; Global Risk Institute for Financial Services of Canada; Science Foundation Ireland [11/PI/1026]; Irish Research Council	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Global Risk Institute for Financial Services of Canada; Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Irish Research Council(Irish Research Council for Science, Engineering and Technology)	This work was funded in part by Natural Sciences and Engineering Research Council of Canada (www.nserc-crsng.gc.ca) and the Global Risk Institute for Financial Services of Canada (http://globalriskinstitute.org/) (T.R.H.), Science Foundation Ireland (http://www.sfi.ie/) (11/PI/1026, J.P.G., S.M.), and the Irish Research Council (www.research.ie) (New Foundations grant, S.M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was funded in part by Natural Sciences and Engineering Research Council of Canada and the Global Risk Institute for Financial Services of Canada (T.R.H.), Science Foundation Ireland (11/PI/1026, J.P.G., S.M.), and the Irish Research Council (New Foundations grant, S.M.).	Amini H, 2016, MATH FINANC, V26, P329, DOI 10.1111/mafi.12051; Bardoscia M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163825; Bech ML, 2010, PHYSICA A, V389, P5223, DOI 10.1016/j.physa.2010.05.058; Bollobas B., 2001, CAMBRIDGE STUDIES AD, V2nd, P34; Cont R, 2013, HANDBOOK ON SYSTEMIC RISK, P327; Craig B, 2014, J FINANC INTERMED, V23, P322, DOI 10.1016/j.jfi.2014.02.003; Deprez P, 2015, CONSTRUCTION DIRECTE; Faqeeh A, 2015, PHYS REV E, V91, DOI 10.1103/PhysRevE.91.052807; Fricke D, 2015, COMPUT ECON, V45, P359, DOI 10.1007/s10614-014-9427-x; Gai P, 2010, P ROY SOC A-MATH PHY, V466, P2401, DOI 10.1098/rspa.2009.0410; Gleeson JP, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.026106; Gleeson JP, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.046117; Gleeson JP, 2012, ADV NETWORK ANAL ITS, V18, DOI 10.1007/978-3-642-30904-5_2; Hurd T.R., 2016, SPRINGER BRIEFS QUAN, DOI [10.1007/978-3-319-33930-6, DOI 10.1007/978-3-319-33930-6]; Hurd TR, 2016, RECENT PROGR MODERN; Huser AC, 2015, TOO INTERCONNECTED F; Janson S, 2009, COMB PROBAB COMPUT, V18, P205, DOI 10.1017/S0963548308009644; May RM, 2010, J R SOC INTERFACE, V7, P823, DOI 10.1098/rsif.2009.0359; Melnik S, 2013, CHAOS, V23, DOI 10.1063/1.4790836; Melnik S, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.036112; Newman M, 2010, NETWORKS INTRO, DOI 10.1093/acprof:oso/9780199206650.001.0001; Nier E, 2007, J ECON DYN CONTROL, V31, P2033, DOI 10.1016/j.jedc.2007.01.014; Soramaki K, 2007, PHYSICA A, V379, P317, DOI 10.1016/j.physa.2006.11.093; Upper C, 2011, J FINANC STABIL, V7, P111, DOI 10.1016/j.jfs.2010.12.001; Watts DJ, 2002, P NATL ACAD SCI USA, V99, P5766, DOI 10.1073/pnas.082090499	26	6	7	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2017	12	2							e0170579	10.1371/journal.pone.0170579	http://dx.doi.org/10.1371/journal.pone.0170579			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5SX	28231324	Green Published, gold, Green Submitted			2022-12-27	WOS:000394682400003
J	Palma-Vera, SE; Schoen, J; Chen, S				Palma-Vera, Sergio E.; Schoen, Jennifer; Chen, Shuai			Periovulatory follicular fluid levels of estradiol trigger inflammatory and DNA damage responses in oviduct epithelial cells	PLOS ONE			English	Article							FALLOPIAN-TUBE EPITHELIUM; OVARIAN CARCINOGENESIS; ESTROUS-CYCLE; EXPRESSION; MODEL; PIG; PROGESTERONE; CARCINOMA; EXPOSURE; QUALITY	Objective Ovarian steroid hormones (mainly E2 and P4) regulate oviduct physiology. Serum-E2 acts on the oviduct epithelium from the basolateral cell compartment. Upon ovulation, the apical compartment of the oviduct epithelium is temporarily exposed to follicular fluid, which contains much higher levels of E2 than serum. The aim of this study was to evaluate the effects of human periovulatory follicular fluid levels of E2 on oviduct epithelial cells using two porcine in vitro models. Methods A cell line derived from the porcine oviductal epithelium (CCLV-RIE270) was characterized (lineage markers, proliferation characteristics and transformation status). Primary porcine oviduct epithelial cells (POEC) were cultured in air-liquid interface and differentiation was assessed histologically. Both cultures were exposed to E2 (10 ng/ml and 200 ng/ml). Proliferation of CCLV-RIE270 and POEC was determined by real-time impedance monitoring and immunohistochemical detection of Ki67. Furthermore, marker gene expression for DNA damage response (DDR) and inflammation was quantified. Results CCLV-RIE270 was not transformed and exhibited properties of secretory oviduct epithelial cells. Periovulatory follicular fluid levels of E2 (200 ng/ml) upregulated the expression of inflammatory genes in CCLV-RIE270 but not in POEC (except for IL8). Expression of DDR genes was elevated in both models. A significant increase in cell proliferation could not be detected in response to E2. Conclusions CCLV-RIE270 and POEC are complementary models to evaluate the consequences of oviduct exposure to follicular fluid components. Single administration of periovulatory follicular	[Palma-Vera, Sergio E.; Schoen, Jennifer; Chen, Shuai] Leibniz Inst Farm Anim Biol FBN, Inst Reprod Biol, Dummerstorf, Germany; [Palma-Vera, Sergio E.] Free Univ Berlin, Dept Vet Med, Inst Vet Biochem, Berlin, Germany; [Chen, Shuai] Hebei Univ, Coll Life Sci, Baoding, Peoples R China	Forschungsinstitut fur Nutztierbiologie (FBN); Free University of Berlin; Hebei University	Chen, S (corresponding author), Leibniz Inst Farm Anim Biol FBN, Inst Reprod Biol, Dummerstorf, Germany.; Chen, S (corresponding author), Hebei Univ, Coll Life Sci, Baoding, Peoples R China.	chen@fbn-dummerstorf.de	Chen, Shuai/AFF-9254-2022	Chen, Shuai/0000-0003-0139-5545	Dahlem Research School (FU Berlin), Germany; Nature Science Funds from Hebei Ministry of Education , China [QN2014124]	Dahlem Research School (FU Berlin), Germany; Nature Science Funds from Hebei Ministry of Education , China	SEPV was supported by Dahlem Research School (FU Berlin), Germany. SC was supported by the Nature Science Funds from Hebei Ministry of Education (QN2014124), China.	Abe H, 2007, REPROD DOMEST ANIM, V42, P292, DOI 10.1111/j.1439-0531.2006.00781.x; ABE H, 1993, ANAT REC, V235, P399, DOI 10.1002/ar.1092350309; Aguilar JJ, 2012, J EQUINE VET SCI, V32, P99, DOI 10.1016/j.jevs.2011.08.001; Bahar-Shany K, 2014, GYNECOL ONCOL, V132, P322, DOI 10.1016/j.ygyno.2013.12.015; Bendixen E, 2010, BRIEF FUNCT GENOMICS, V9, P208, DOI 10.1093/bfgp/elq004; Cavalieri E, 2014, MOL ASPECTS MED, V36, P1, DOI 10.1016/j.mam.2013.08.002; Chelikani P, 2004, CELL MOL LIFE SCI, V61, P192, DOI 10.1007/s00018-003-3206-5; Chen S., 2015, BIOMED RES INT, V2015, P12, DOI DOI 10.1016/J.APPLTHERMALENG.2015.12.110; Chen S, 2015, HISTOCHEM CELL BIOL, V144, P509, DOI 10.1007/s00418-015-1351-1; Chen S, 2013, THERIOGENOLOGY, V80, P862, DOI 10.1016/j.theriogenology.2013.07.011; Chen S, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.108829; de los Santos MJ, 2013, HUM REPROD, V28, P224, DOI 10.1093/humrep/des349; Eddie SL, 2015, GYNECOL ONCOL, V136, P348, DOI 10.1016/j.ygyno.2014.12.015; Flisikowska T, 2013, TRANSGENIC RES, V22, P673, DOI 10.1007/s11248-013-9720-9; Hussain SP, 2007, INT J CANCER, V121, P2373, DOI 10.1002/ijc.23173; Hwang BJ, 1999, P NATL ACAD SCI USA, V96, P424, DOI 10.1073/pnas.96.2.424; King SM, 2011, ENDOCR-RELAT CANCER, V18, P627, DOI 10.1530/ERC-11-0107; Lau A, 2014, EXP BIOL MED, V239, P24, DOI 10.1177/1535370213508216; Levanon K, 2010, ONCOGENE, V29, P1103, DOI 10.1038/onc.2009.402; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Menezo Y, 1997, EUR J OBSTET GYN R B, V73, P99, DOI 10.1016/S0301-2115(97)02729-2; Meng XB, 1999, SCI CHINA SER C, V42, P427, DOI 10.1007/BF02882063; Miessen K, 2011, THERIOGENOLOGY, V76, P900, DOI 10.1016/j.theriogenology.2011.04.021; Nik NN, 2014, ANNU REV PATHOL-MECH, V9, P27, DOI 10.1146/annurev-pathol-020712-163949; Perkins JR, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-296; Steinhauer N, 2004, REPROD DOMEST ANIM, V39, P110, DOI 10.1111/j.1439-0531.2004.00490.x; Straub RH, 2007, ENDOCR REV, V28, P521, DOI 10.1210/er.2007-0001; Wen XS, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-117; Wunder DM, 2005, J ASSIST REPROD GEN, V22, P257, DOI 10.1007/s10815-005-5149-2; Yager JD, 2015, STEROIDS, V99, P56, DOI 10.1016/j.steroids.2014.08.006	30	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2017	12	2							e0172192	10.1371/journal.pone.0172192	http://dx.doi.org/10.1371/journal.pone.0172192			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5SX	28231273	Green Published, gold, Green Submitted			2022-12-27	WOS:000394682400030
J	Talevich, JR; Read, SJ; Walsh, DA; Iyer, R; Chopra, G				Talevich, Jennifer R.; Read, Stephen J.; Walsh, David A.; Iyer, Ravi; Chopra, Gurveen			Toward a comprehensive taxonomy of human motives	PLOS ONE			English	Article							PERSONALITY STRUCTURE; GOAL SYSTEMS; HUMAN-VALUES; MOTIVATION; DOMAIN; SELF; PREDICTION; MODEL; NEEDS; LIFE	A major success in personality has been the development of a consensual structure of traits. However, much less progress has been made on the structure of an equally important aspect of human psychology: motives. We present an empirically and theoretically structured hierarchical taxonomy of 161 motives gleaned from a literature review from McDougall to the present and based on the cluster analysis of similarity judgments among these 161 motives, a broader sampling of motives than previous work. At the broadest level were: Meaning, Communion, and Agency. These divided into nine clusters: Morality & Virtue, Religion & Spirituality, Self-Actualization, Avoidance, Social Relating, Family, Health, Mastery & Competence, and Financial & Occupational Success. Each divided into more concrete clusters to form 5 levels. We discuss contributions to research on motives, especially recent work on goal systems, and the aiding of communication and systematization of research. Finally, we compare the taxonomy to other motive organizations.	[Talevich, Jennifer R.; Read, Stephen J.; Walsh, David A.; Chopra, Gurveen] Univ Southern Calif, Dept Psychol, Los Angeles, CA 90007 USA; [Iyer, Ravi] Ranker, Los Angeles, CA USA	University of Southern California	Read, SJ (corresponding author), Univ Southern Calif, Dept Psychol, Los Angeles, CA 90007 USA.	read@usc.edu			Navy Personnel Research, Studies, and Technology Department [W911NF-07-D-001]	Navy Personnel Research, Studies, and Technology Department	This research was funded by Contract No. W911NF-07-D-001 "Measuring Teamwork Skills and Predicting Reactions to Policies Using Computer Agents" to SJR from the Navy Personnel Research, Studies, and Technology Department. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldenderfer MS., 1984, CLUSTER ANAL; Allport G. W., 1937, PERSONALITY PSYCHOL; [Anonymous], 1989, GOAL CONCEPTS PERSON, DOI DOI 10.4324/9781315717517; [Anonymous], 2008, HDB MOTIVATION SCI; [Anonymous], 1998, SELF REGULATION BEHA, DOI DOI 10.1017/CBO9781139174794; Ashton MC, 2007, PERS SOC PSYCHOL REV, V11, P150, DOI 10.1177/1088868306294907; Atkinson J.W., 1964, INTRO MOTIVATION, DOI DOI 10.1007/s00431-012-1719-3; Atkinson J.W., 1970, DYNAMICS ACTION; Austin JT, 1996, PSYCHOL BULL, V120, P338, DOI 10.1037/0033-2909.120.3.338; Bakan D ., 1966, DUALITY HUMAN EXISTE; Bernard LC, 2014, MOTIV EMOTION, V38, P47, DOI 10.1007/s11031-013-9360-7; Block J, 2010, PSYCHOL INQ, V21, P2, DOI 10.1080/10478401003596626; BRAITHWAITE VA, 1985, J PERS SOC PSYCHOL, V49, P250, DOI 10.1037/0022-3514.49.1.250; Brougham RR, 2005, INT J AGING HUM DEV, V61, P141, DOI 10.2190/5TEF-E52V-8JR4-U3Q4; Brougham RR, 2007, INT J AGING HUM DEV, V65, P203, DOI 10.2190/AG.65.3.b; Brownstein AL, 2009, DECOMPOSING TRAITS G; Bugental DB, 2000, PSYCHOL BULL, V126, P187, DOI 10.1037/0033-2909.126.2.187; Cantor N., 1987, PERSONALITY SOCIAL I; Cattell R.B., 1957, PERSONALITY MOTIVATI; Chulef AS, 2001, MOTIV EMOTION, V25, P191, DOI 10.1023/A:1012225223418; Clark L.A., 2008, HDB PERSONALITY THEO, P265; Deci EL, 2000, PSYCHOL INQ, V11, P227, DOI 10.1207/S15327965PLI1104_01; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Digman JM, 1997, J PERS SOC PSYCHOL, V73, P1246, DOI 10.1037/0022-3514.73.6.1246; EMMONS RA, 1986, J PERS SOC PSYCHOL, V51, P1058, DOI 10.1037/0022-3514.51.5.1058; Emmons RA, 1998, SOC INDIC RES, V45, P391, DOI 10.1023/A:1006926720976; Fiske ST., 2004, SOCIAL BEINGS CORE M; Ford D.H., 1987, HUMANS SELF CONSTRUC; Ford ME, 1987, HUMANS SELF CONSTRUC; Goldberg L.R., 1981, REV PERSONAL SOC PSY, V2, P141, DOI DOI 10.1037/0022-3514.59.6.1216; Gray JA, 2000, NEUROPSYCHOLOGY ANXI; Grouzet FME, 2005, J PERS SOC PSYCHOL, V89, P800, DOI 10.1037/0022-3514.89.5.800; HOFSTEE WKB, 1992, J PERS SOC PSYCHOL, V63, P146, DOI 10.1037/0022-3514.63.1.146; John O. P., 1990, HDB PERSONALITY THEO, P66; John O. P., 2008, HDB PERSONALITY THEO, V3, P114; Kenrick DT, 2010, PERSPECT PSYCHOL SCI, V5, P292, DOI 10.1177/1745691610369469; Kruglanski AW, 2002, ADV EXP SOC PSYCHOL, V34, P331, DOI 10.1016/S0065-2601(02)80008-9; Larsen JT, 2001, J PERS SOC PSYCHOL, V81, P684, DOI 10.1037//0022-3514.81.4.684; Lee K, 2004, MULTIVAR BEHAV RES, V39, P329, DOI 10.1207/s15327906mbr3902_8; Lewin K., 1935, DYNAMIC THEORY PERS; Lewin K., 1936, PRINCIPLES TOPOLOGIC, DOI [https://doi.org/10.1037/10019-000, DOI 10.1037/10019-000]; LITTLE BR, 1983, ENVIRON BEHAV, V15, P273, DOI 10.1177/0013916583153002; MARKUS HR, 1991, PSYCHOL REV, V98, P224, DOI 10.1037/0033-295X.98.2.224; Maslow A. H., 1954, MOTIVATION PERSONALI; Maslow AH, 1943, PSYCHOL REV, V50, P370, DOI 10.1037/h0054346; McClelland D.C., 1987, HUMAN MOTIVATION; McDougall W., 1933, ENERGIES MEN; Miller L. C., 1987, SELF DISCLOSURE THEO; MISCHEL W, 1995, PSYCHOL REV, V102, P246, DOI 10.1037/0033-295X.102.2.246; Murray H.A., 1938, EXPLOR PERS; PETERSON CHRISTOPHER, 2004, CHARACTER STRENGTHS; Pickering AD., 1997, HDB PERS THEORY RES, P277; Plato, 1925, PLATO 12 VOLUMES, V1-12; Rackham H, 1934, NICOMACHEAN ETHICS, VI; Read SJ, 1989, GOAL CONCEPTS PERSON; Reiss S, 1998, PSYCHOL ASSESSMENT, V10, P97, DOI 10.1037/1040-3590.10.2.97; Reiss S, 2004, REV GEN PSYCHOL, V8, P179, DOI 10.1037/1089-2680.8.3.179; Reisz Z, 2013, PERS INDIV DIFFER, V55, P699, DOI 10.1016/j.paid.2013.05.023; Rokeach M, 1980, Nebr Symp Motiv, V27, P261; Rokeach M., 1973, NATURE HUMAN VALUES; Schank RC., 1977, SCRIPTS PLANS GOALS; SCHWARTZ SH, 1992, ADV EXP SOC PSYCHOL, V25, P1, DOI 10.1016/s0065-2601(08)60281-6; SCHWARTZ SH, 1987, J PERS SOC PSYCHOL, V53, P550, DOI 10.1037/0022-3514.53.3.550; Schwartz SH, 2012, J PERS SOC PSYCHOL, V103, P663, DOI 10.1037/a0029393; Seligman M.E.P., 2011, FLOURISH VISIONARY N; SPENCE JT, 1979, J PERS SOC PSYCHOL, V37, P1673, DOI 10.1037/0022-3514.37.10.1673; Talevich J. R., 2013, J MENTAL HLTH LAW PO, V2, P244; Talevich JR, 2014, BASIC APPL SOC PSYCH, V36, P35, DOI 10.1080/01973533.2013.856784; Talevich JR, 2012, NEURAL NETWORK MODEL; Triandis H. C., 1995, INDIVIDUALISM COLLEC, DOI 10.4324/9780429499845; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; WICKER FW, 1984, J PERS, V52, P285, DOI 10.1111/j.1467-6494.1984.tb00883.x; WIGGINS JS, 1979, J PERS SOC PSYCHOL, V37, P395, DOI 10.1037/0022-3514.37.3.395; WISHART D, 2006, CLUSTANGRAPHICS PRIM	74	20	20	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2017	12	2							e0172279	10.1371/journal.pone.0172279	http://dx.doi.org/10.1371/journal.pone.0172279			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL5SX	28231252	gold, Green Published, Green Submitted			2022-12-27	WOS:000394682400032
J	Wang, JN; Zhang, DD; Huang, RZ; Li, XS; Huang, WX				Wang, Junna; Zhang, Dandan; Huang, Rongzhong; Li, Xingsheng; Huang, Wenxiang			Gamma-glutamyltransferase and risk of cardiovascular mortality: A dose-response meta-analysis of prospective cohort studies	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; OXIDATIVE STRESS; REGRESSION-MODELS; BLOOD-PRESSURE; FLOW RESERVE; ALL-CAUSE; TRANSPEPTIDASE; ALCOHOL; CONSUMPTION; MEN	Background Serum gamma-glutamyltransferase (GGT) elevation likely contributes to cardiovascular (CV) mortality, however it has remained unknown whether a dose-response relationship exists between serum GGT and CV mortality. Methods We searched the PubMed, EMBASE, and Cochrane library databases for prospective cohort studies published up to October 2, 2016. Summary hazard ratios (HRs) with their corresponding 95% confidence intervals (CIs) were calculated using a fixed effects model. Findings Nine prospective studies, including 527,589 participants and more than 7,011 cases, were included in this meta-analysis. For the moderate, high, and highest levels of GGT, the pooled HRs of CV mortality were 1.11 (95% CI = 1.04-1.19), 1.29 (95% CI = 1.21-1.38) and 1.59 (95% CI = 1.47-1.72), respectively (all p < 0.05 as compared to the lowest levels of GGT). Additionally, the HR per incremental increase of GGT by 10 U/L was 1.10 (95% CI = 1.08-1.11). Evidence of a positive relationship with nonlinear trend for GGT elevation with CV mortality in females was found (P = 0.04 for nonlinearity). However, a linear model was better fit to illustrate the GGT-CV mortality among males (P = 0.304 for nonlinearity). Conclusions These findings indicate that serum GGT activity within the reference interval is positively associated with increased risk of CV mortality in a dose-response manner.	[Wang, Junna; Huang, Wenxiang] Chongqing Med Univ, Dept Infect Dis, Affiliated Hosp 1, Chongqing, Peoples R China; [Zhang, Dandan; Li, Xingsheng] Chongqing Med Univ, Dept Gerontol, Affiliated Hosp 2, Chongqing, Peoples R China; [Huang, Rongzhong] Chongqing Med Univ, Dept Rehabil Med, Affiliated Hosp 2, Chongqing, Peoples R China	Chongqing Medical University; Chongqing Medical University; Chongqing Medical University	Huang, WX (corresponding author), Chongqing Med Univ, Dept Infect Dis, Affiliated Hosp 1, Chongqing, Peoples R China.; Li, XS (corresponding author), Chongqing Med Univ, Dept Gerontol, Affiliated Hosp 2, Chongqing, Peoples R China.	lxs2858@163.com; hwx8623@163.com			Chongqing Science Foundation, China [KJ130332]; young elite talents project in the second Affiliated Hospital of Chongqing Medical University [2014]; Health Bureau, Chongqing, China [20102153]	Chongqing Science Foundation, China; young elite talents project in the second Affiliated Hospital of Chongqing Medical University; Health Bureau, Chongqing, China	This project was supported by the Chongqing Science Foundation, China (No: KJ130332), The young elite talents project (No: 2014) in the second Affiliated Hospital of Chongqing Medical University and the research projects of Health Bureau, Chongqing, China (No:20102153). The funders play a role in decision to publish, or preparation of the manuscript.	Ali SS, 2016, NUTR METAB, V13, P1; Angeli V, 2009, ARCH BIOCHEM BIOPHYS, V481, P191, DOI 10.1016/j.abb.2008.10.027; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Belcastro E, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0687-6; Bradley RD, 2014, ATHEROSCLEROSIS, V233, P387, DOI 10.1016/j.atherosclerosis.2014.01.010; Breitling LP, 2011, J HEPATOL, V55, P594, DOI 10.1016/j.jhep.2010.12.029; Bulusu S, 2016, ANN CLIN BIOCHEM, V53, P312, DOI 10.1177/0004563215597010; Chen JT, 2016, AGING CLIN EXP RES, V28, P619, DOI 10.1007/s40520-015-0460-y; Ciftci O, 2013, CORONARY ARTERY DIS, V24, P201, DOI 10.1097/MCA.0b013e32835e5c86; Daeppen JB, 1998, ALCOHOL CLIN EXP RES, V22, P941, DOI 10.1111/j.1530-0277.1998.tb03893.x; Danielsson J, 2013, INT J MOL SCI, V14, P11929, DOI 10.3390/ijms140611929; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Ding M, 2014, CIRCULATION, V129, P643, DOI 10.1161/CIRCULATIONAHA.113.005925; Du GL, 2013, PREV MED, V57, P31, DOI 10.1016/j.ypmed.2013.03.011; Dugani S, 2016, CURR CARDIOL REP, V18, DOI 10.1007/s11886-015-0679-4; DURRLEMAN S, 1989, STAT MED, V8, P551, DOI 10.1002/sim.4780080504; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Emdin M, 2005, CIRCULATION, V112, P2078, DOI 10.1161/CIRCULATIONAHA.105.571919; Emdin M, 2002, STROKE, V33, P1163, DOI 10.1161/01.STR.0000012344.35312.13; Erdogan D, 2005, BLOOD PRESSURE, V14, P345, DOI 10.1080/08037050500356550; Ezzati M, 2015, NAT REV CARDIOL, V12, P508, DOI 10.1038/nrcardio.2015.82; Fraser A, 2007, ARTERIOSCL THROM VAS, V27, P2729, DOI 10.1161/ATVBAHA.107.152298; Galderisi M, 2002, AM J CARDIOL, V90, P860, DOI 10.1016/S0002-9149(02)02708-X; GJERDE H, 1987, BRIT J ADDICT, V82, P1027; Haring R, 2009, HEPATOLOGY, V50, P1403, DOI 10.1002/hep.23135; HARRELL FE, 1988, J NATL CANCER I, V80, P1198, DOI 10.1093/jnci/80.15.1198; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hozawa A, 2007, ATHEROSCLEROSIS, V194, P498, DOI 10.1016/j.atherosclerosis.2006.08.058; Kengne AP, 2012, J HEPATOL, V57, P1083, DOI 10.1016/j.jhep.2012.06.034; Kim DJ, 2005, DIABETIC MED, V22, P1134, DOI 10.1111/j.1464-5491.2005.01581.x; KIRCHER T, 1985, NEW ENGL J MED, V313, P1263, DOI 10.1056/NEJM198511143132005; Klatsky AL, 2015, J INTERN MED, V278, P238, DOI 10.1111/joim.12390; Koehler EM, 2014, LIVER INT, V34, P296, DOI 10.1111/liv.12311; Kontis V, 2014, LANCET, V384, P427, DOI 10.1016/S0140-6736(14)60616-4; Kunutsor SK, 2015, J HYPERTENS, V33, P2373, DOI 10.1097/HJH.0000000000000763; Kunutsor SK, 2014, ANN EPIDEMIOL, V24, P809, DOI 10.1016/j.annepidem.2014.09.001; Lee DS, 2007, ARTERIOSCL THROM VAS, V27, P127, DOI 10.1161/01.ATV.0000251993.20372.40; Lee DH, 2008, ARTERIOSCL THROM VAS, V28, pE26, DOI 10.1161/ATVBAHA.107.159376; Lee DH, 2006, EUR HEART J, V27, P2170, DOI 10.1093/eurheartj/ehl086; Lee DH, 2009, EUR J CARDIOV PREV R, V16, P16, DOI 10.1097/HJR.0b013e32830aba5c; Li YY, 2016, J ATHEROSCLER THROMB, V23, P792, DOI 10.5551/jat.32698; Long Y, 2014, FREE RADICAL RES, V48, P716, DOI 10.3109/10715762.2014.902055; Loomba R, 2013, J CLIN EXP HEPATOL, V3, P4, DOI 10.1016/j.jceh.2012.10.004; MACMAHON S, 1990, LANCET, V335, P765, DOI 10.1016/0140-6736(90)90878-9; Mahady SE, 2016, J CLIN GASTROENTEROL; Meisinger C, 2006, ATHEROSCLEROSIS, V189, P297, DOI 10.1016/j.atherosclerosis.2006.01.010; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; NILSSEN O, 1994, AM J EPIDEMIOL, V139, P787, DOI 10.1093/oxfordjournals.aje.a117075; Orsini N, 2006, STATA J, V6, P40, DOI 10.1177/1536867X0600600103; Paolicchi A, 2004, CIRCULATION, V109, P1440, DOI 10.1161/01.CIR.0000120558.41356.E6; Peters JL, 2008, J CLIN EPIDEMIOL, V61, P991, DOI 10.1016/j.jclinepi.2007.11.010; Petitti DB., 1999, METAANALYSIS DECISIO; ROLLASON JG, 1972, CLIN CHIM ACTA, V39, P75, DOI 10.1016/0009-8981(72)90301-4; Rong Y, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.e8539; Ruhl CE, 2009, GASTROENTEROLOGY, V136, P477, DOI 10.1053/j.gastro.2008.10.052; RUMBERGER JA, 1995, CIRCULATION, V92, P2157, DOI 10.1161/01.CIR.92.8.2157; Ruttmann E, 2005, CIRCULATION, V112, P2130, DOI 10.1161/CIRCULATIONAHA.105.552547; Saijo Y, 2008, NUTR METAB CARDIOVAS, V18, P211, DOI 10.1016/j.numecd.2006.10.002; Silva ERDE, 2000, CIRCULATION, V102, P2347, DOI 10.1161/01.CIR.102.19.2347; Sinn DH, 2016, GASTROENTEROLOGY, V150; Sung KC, 2015, CLIN CHEM, V61, P1173, DOI 10.1373/clinchem.2015.240424; Turgut O, 2011, J ATHEROSCLER THROMB, V18, P177, DOI 10.5551/jat.6189; Ucar H, 2015, SCAND J CLIN LAB INV, V75, P7, DOI 10.3109/00365513.2014.954141; van Houwelingen HC, 2002, STAT MED, V21, P589, DOI 10.1002/sim.1040; VANBARNEVELD T, 1989, EUR J CLIN NUTR, V43, P809; Wallin A, 2011, BRIT J CANCER, V104, P1196, DOI 10.1038/bjc.2011.49; Wannamethee SG, 2008, ATHEROSCLEROSIS, V201, P168, DOI 10.1016/j.atherosclerosis.2008.01.019; Wells G, 2000, NEWCASTLE OTTAWA SCA; Whitfield JB, 2001, CRIT REV CL LAB SCI, V38, P263, DOI 10.1080/20014091084227; Wickham S, 2011, ANAL BIOCHEM, V414, P208, DOI 10.1016/j.ab.2011.03.026	70	17	17	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2017	12	2							e0172631	10.1371/journal.pone.0172631	http://dx.doi.org/10.1371/journal.pone.0172631			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5SX	28231268	Green Published, gold, Green Submitted			2022-12-27	WOS:000394682400063
J	Wierzbicka, M; Niemczyk, K; Bruzgielewicz, A; Durko, M; Klatka, J; Kopec, T; Osuch-Wojcikiewicz, E; Pietruszewska, W; Szymanski, M; Szyfter, W				Wierzbicka, Malgorzata; Niemczyk, Kazimierz; Bruzgielewicz, Antoni; Durko, Marcin; Klatka, Janusz; Kopec, Tomasz; Osuch-Wojcikiewicz, Ewa; Pietruszewska, Wioletta; Szymanski, Marcin; Szyfter, Witold			Multicenter experiences in temporal bone cancer surgery based on 89 cases	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; MIDDLE-EAR CANCER; POSTOPERATIVE RADIOTHERAPY; MALIGNANT-TUMORS; RADICAL SURGERY; STAGING SYSTEM; RESECTION; MANAGEMENT; OUTCOMES; RADIATION	Objective To present outcomes of extensive surgery: lateral, subtotal, total petrosectomies in patients with temporal bone invasion resulting from specific primary cancers. Study design Retrospective case review. Setting Four tertiary referral centers. Material 89 patients with cancer of the temporal bone treated between January 2006 and December 2010. Intervention Multidisciplinary team approach including surgical resection, reconstruction, and postoperative radiotherapy. Main outcome measure Disease-specific survival, overall survival. Results In 27.0% of the patients, relapse was reported, with an average of 6.3 months after surgery; 31 patients (34.8%) died during the follow-up. The average mortality was 22.1 months. Fiftyfour patients (58.7%) stayed alive during the time of observation. The average survival time was 42.0 months. The median time of survival with relapse was 12 months (range: 1-51 months). The three-year disease-free rate was 38.0% and the overall survival rate was 58.7%. Conclusions Petrosectomy is an effective treatment for malignant temporal bone invasion. The probability of a good outcome was statistically decreased with a high T grade, positive margins, and salvage surgery. Younger age is connected with better prognosis. One of the major tasks remains to improve detection and to shorten the time to diagnosis, keeping in mind that symptoms are insidious and in younger people, the time before diagnosis was longer.	[Wierzbicka, Malgorzata; Kopec, Tomasz; Szyfter, Witold] Med Univ, ENT Dept, Poznan, Poland; [Niemczyk, Kazimierz; Bruzgielewicz, Antoni; Osuch-Wojcikiewicz, Ewa] Med Univ, ENT Dept, Warsaw, Poland; [Durko, Marcin; Pietruszewska, Wioletta] Med Univ, ENT Dept, Lodz, Poland; [Klatka, Janusz; Szymanski, Marcin] Med Univ, ENT Dept, Lublin, Poland	Medical University of Lublin	Wierzbicka, M (corresponding author), Med Univ, ENT Dept, Poznan, Poland.	otosk2@ump.edu.pl	Szymanski, Marcin/B-1480-2013; Pietruszewska, Wioletta Anna/S-9632-2016; Szymański, Marcin/S-7521-2019	Pietruszewska, Wioletta Anna/0000-0001-5109-3911; Szymański, Marcin/0000-0003-2777-1254; Wierzbicka, Malgorzata/0000-0003-0006-6352; Klatka, Janusz/0000-0002-3805-4640; Bruzgielewicz, Antoni/0000-0002-9228-6346; Durko, Marcin/0000-0003-2793-3524; Osuch-Wojcikiewicz, Ewa/0000-0002-2798-1035; Szyfter, Witold/0000-0001-7870-1964				ARRIAGA M, 1990, ANN OTO RHINOL LARYN, V99, P714, DOI 10.1177/000348949009900909; Badakh DK, 2014, J CANCER RES THER, V10, P342, DOI 10.4103/0973-1482.136624; Bibas AG, 2008, J LARYNGOL OTOL, V122, P1156, DOI 10.1017/S0022215107001338; Chi FL, 2011, OTOL NEUROTOL, V32, P665, DOI 10.1097/MAO.0b013e318210b90f; Fujiwara M, 2014, LARYNGOSCOPE; Gidley PW, 2013, NEUROSURG CLIN N AM, V24, P97, DOI 10.1016/j.nec.2012.08.009; Gillespie MB, 2001, ARCH OTOLARYNGOL, V127, P803; GRAHAM MD, 1984, LARYNGOSCOPE, V94, P528, DOI 10.1288/00005537-198404000-00019; Gurgel RK, 2009, LARYNGOSCOPE, V119, P1913, DOI 10.1002/lary.20202; Hanasono MM, 2012, LARYNGOSCOPE, V122, P2663, DOI 10.1002/lary.23528; Hirsch BE, 2002, ARCH OTOLARYNGOL, V128, P93; Jia XH, 2014, EUR ARCH OTO-RHINO-L, V271, P2675, DOI 10.1007/s00405-013-2728-1; Kay S, 2013, OTOL NEUROTOL, V34, P1748, DOI 10.1097/MAO.0b013e3182a1ac1c; Koto M, 2016, HEAD NECK-J SCI SPEC, V38, P512, DOI 10.1002/hed.23905; Kreppel M, 2013, ORAL ONCOL, V49, P903, DOI 10.1016/j.oraloncology.2013.06.009; Kunst H, 2008, OTOL NEUROTOL, V29, P549, DOI 10.1097/MAO.0b013e31816c7c71; Leong SC, 2013, LARYNGOSCOPE, V123, P2442, DOI 10.1002/lary.24063; LEWIS JS, 1975, ARCH OTOLARYNGOL, V101, P23; Lustig LR, 1997, AM J OTOL, V18, P230; Martinez-Devesa P, 2008, SKULL BASE-INTERD AP, V18, P1, DOI 10.1055/s-2007-992766; Masterson L, 2014, OTOL NEUROTOL, V35, P501, DOI 10.1097/MAO.0000000000000265; Moffat DA, 2005, LARYNGOSCOPE, V115, P341, DOI 10.1097/01.mlg.0000154744.71184.c7; Moffat DA, 1997, OTOLARYNG HEAD NECK, V116, P617, DOI 10.1016/S0194-5998(97)70237-7; Moffat David A, 2003, Curr Opin Otolaryngol Head Neck Surg, V11, P107, DOI 10.1097/00020840-200304000-00008; Moncrieff MD, 2007, J PLAST RECONSTR AES, V60, P607, DOI 10.1016/j.bjps.2006.11.005; Moody SA, 2000, AM J OTOL, V21, P582; Moore MG, 2007, OTOLARYNG HEAD NECK, V137, P893, DOI 10.1016/j.otohns.2007.09.010; Nakagawa T, 2006, OTOL NEUROTOL, V27, P242, DOI 10.1097/01.mao.0000190463.88873.3d; Okada T, 2008, J NEUROSURG, V108, P97, DOI 10.3171/JNS/2008/108/01/0097; PRASAD S, 1994, OTOLARYNG HEAD NECK, V110, P270, DOI 10.1016/S0194-5998(94)70769-3; Shen WD, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-554; Simo R, 2011, HEAD NECK CANC MULTI, P362; Yin M, 2006, AURIS NASUS LARYNX, V33, P251, DOI 10.1016/j.anl.2005.11.012; Zhang T, 2013, LARYNGOSCOPE, V123, P244, DOI 10.1002/lary.23637	34	11	14	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2017	12	2							e0169399	10.1371/journal.pone.0169399	http://dx.doi.org/10.1371/journal.pone.0169399			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5SK	28225795	gold, Green Submitted, Green Published			2022-12-27	WOS:000394680900002
J	Ramirez, JD; Florez, C; Olivera, M; Bernal, MC; Giraldo, JC				David Ramirez, Juan; Florez, Carolina; Olivera, Mario; Consuelo Bernal, Maria; Cesar Giraldo, Julio			Blastocystis subtyping and its association with intestinal parasites in children from different geographical regions of Colombia	PLOS ONE			English	Article							GIARDIA-INTESTINALIS; ZOO ANIMALS; PCR; HOMINIS; IDENTIFICATION	Blastocystis is a common enteric protist colonizing probably more than 1 billion people with a large variety of non-human hosts. Remarkable genetic diversity has been observed, leading to the subdivision of the genus into multiple subtypes (ST), some of which are exclusively found in non-human hosts. The aim of this study was to determine the distribution of Blastocystis STs/18S alleles in symptomatic (abdominal pain, anal pruritus, diarrhea, headache, nauseas and/or vomit) and asymptomatic children from nine geographical regions of Colombia. A total of 2026 fecal samples were collected as part of a national survey to estimate the frequency of intestinal parasites in children. A set of 256 samples that were Blastocystis positive was finally selected. The samples were submitted to DNA extraction, Real Time PCR and sequencing using Blastocystis-specific primers targeting the small subunit rRNA gene for ST identification. DNA of Ascaris lumbricoides (16.4%), Trichuris trichiura (8.2%), hookworms (Necator americanus/Ancylostoma duodenale) (7.3%), Giardia duodenalis (23.1%), Entamoeba complex (82%), Entamoeba coli (55%), Hymenolepis nana (0.8%), Endolimax nana (33.2%) and Neobalantidium coli (2.7%) was detected in the Blastocystispositive samples. We detected ST1 (21.4%), ST2 (19.5%), ST3 (55.5%), ST4 (0.8%), ST6 (2%) and ST7 (0.8%); alleles 1, 2, 4, 81, 82 and 83 for ST1; alleles 9, 11, 12, 15, 67, 71 and 73 for ST2; alleles 34, 36, 38, 45, 49, 55, 134 and 128 for ST3; allele 42 for ST4; allele 122 for ST6, and allele 142 for ST7. Further studies implementing high-resolution molecular markers are necessary to understand the dynamics of Blastocystis transmission and the role of this Stramenopila in health and disease.	[David Ramirez, Juan] Univ Rosario, Fac Ciencias Nat & Matemat, Programa Biol, Grp Invest Microbiol UR GIMUR, Bogota, Colombia; [Florez, Carolina; Olivera, Mario] Inst Nacl Salud, Grp Parasitol, Bogota, Colombia; [Consuelo Bernal, Maria; Cesar Giraldo, Julio] Univ Incca Colombia, Programa Profes Biol, Grp Invest Parasitol & Microbiol Trop GIPAMT, Bogota, Colombia	Universidad del Rosario; Instituto Nacional de Salud (Colombia)	Ramirez, JD (corresponding author), Univ Rosario, Fac Ciencias Nat & Matemat, Programa Biol, Grp Invest Microbiol UR GIMUR, Bogota, Colombia.	juand.ramirez@urosario.edu.co	Ramirez, Juan David/F-3524-2016; Olivera, Mario/T-5486-2018	Ramirez, Juan David/0000-0002-1344-9312; Bernal Lizarazu, Maria Consuelo/0000-0002-9049-1629; Olivera, Mario/0000-0002-6885-6353				Alfellani MA, 2013, ACTA TROP, V126, P11, DOI 10.1016/j.actatropica.2012.12.011; Asher AJ, 2012, PARASITOL RES, V110, P853, DOI 10.1007/s00436-011-2565-3; Bertrand I, 2005, J CLIN MICROBIOL, V43, P5940, DOI 10.1128/JCM.43.12.5940-5944.2005; Boadi S, 2014, J CLIN PATHOL, V67, P811, DOI 10.1136/jclinpath-2014-202224; Cabrine-Santos M, 2015, REV INST MED TROP SP, V57, P211, DOI 10.1590/S0036-46652015000300005; Casero R., 2015, ACTA TROP, V126, P12; Clark CG, 2013, ADV PARASIT, V82, P1, DOI 10.1016/B978-0-12-407706-5.00001-0; Ramirez JD, 2016, INFECT GENET EVOL, V41, P32, DOI 10.1016/j.meegid.2016.03.017; Ramirez JD, 2014, INFECT GENET EVOL, V22, P223, DOI 10.1016/j.meegid.2013.07.020; Dogruman-Al F, 2009, MEM I OSWALDO CRUZ, V104, P724, DOI 10.1590/S0074-02762009000500011; Duffy T, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000419; Forsell J, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1637-8; Fouad Shawky A, 2011, Arab J Gastroenterol, V12, P194, DOI 10.1016/j.ajg.2011.11.005; Haque R, 2005, J INFECT DIS, V192, P2171, DOI 10.1086/498169; Kaneda Y, 2001, AM J TROP MED HYG, V65, P393, DOI 10.4269/ajtmh.2001.65.393; Lee LI, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-130; Londono-Franco AL, 2014, BIOMEDICA, V34, P218, DOI [10.7705/biomedica.v34i2.2124, 10.1590/S0120-41572014000200008]; Malheiros AF, 2011, AM J TROP MED HYG, V85, P1050, DOI 10.4269/ajtmh.2011.11-0481; Mejia R, 2013, AM J TROP MED HYG, V88, P1041, DOI 10.4269/ajtmh.12-0726; Menounos PG, 2008, MOL CELL PROBE, V22, P24, DOI 10.1016/j.mcp.2007.06.007; Montresor A., 2002, HELMINTH CONTROL SCH; Moosavi A, 2012, PARASITOL RES, V111, P2311, DOI 10.1007/s00436-012-3085-5; Nagel R, 2012, INTERN MED J, V42, P1187, DOI 10.1111/j.1445-5994.2011.02626.x; Parkar U, 2007, PARASITOLOGY, V134, P359, DOI 10.1017/S0031182006001582; Parkar U, 2010, VET PARASITOL, V169, P8, DOI 10.1016/j.vetpar.2009.12.032; Poirier P, 2011, J CLIN MICROBIOL, V49, P975, DOI 10.1128/JCM.01392-10; Roberts T, 2013, EUR J CLIN MICROBIOL, V32, P335, DOI 10.1007/s10096-012-1746-z; Scicluna SM, 2006, PROTIST, V157, P77, DOI 10.1016/j.protis.2005.12.001; Souppart L, 2010, PARASITOL RES, V106, P505, DOI 10.1007/s00436-009-1693-5; Stensvold CR, 2007, TRENDS PARASITOL, V23, P93, DOI 10.1016/j.pt.2007.01.004; Stensvold CR, 2012, INFECT GENET EVOL, V12, P263, DOI 10.1016/j.meegid.2011.11.002; Stensvold CR, 2009, INT J PARASITOL, V39, P473, DOI 10.1016/j.ijpara.2008.07.006; Stensvold CR, 2013, J CLIN MICROBIOL, V51, P190, DOI 10.1128/JCM.02541-12; Stensvold CR, 2011, AM J TROP MED HYG, V84, P883, DOI 10.4269/ajtmh.2011.11-0005; Stensvold R, 2006, J PARASITOL, V92, P1081, DOI 10.1645/GE-840R.1; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Dominguez-Marquez MV, 2009, PARASITOL RES, V105, P949, DOI 10.1007/s00436-009-1485-y; Yoshikawa H, 2004, TRENDS PARASITOL, V20, P251, DOI 10.1016/j.pt.2004.03.010; Yoshikawa H, 2000, J CLIN MICROBIOL, V38, P1324, DOI 10.1128/JCM.38.4.1324-1330.2000	39	54	57	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2017	12	2							e0172586	10.1371/journal.pone.0172586	http://dx.doi.org/10.1371/journal.pone.0172586			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5QV	28222192	Green Published, gold			2022-12-27	WOS:000394676800070
J	Hoffmann, S; Schmidt, C; Walter, S; Bender, JK; Gerlach, RG				Hoffmann, Stefanie; Schmidt, Christiane; Walter, Steffi; Bender, Jennifer K.; Gerlach, Roman G.			Scarless deletion of up to seven methyl-accepting chemotaxis genes with an optimized method highlights key function of CheM in Salmonella Typhimurium	PLOS ONE			English	Article							ESCHERICHIA-COLI; CHEMORECEPTORS; IDENTIFICATION; PATHOGENICITY; CONSTRUCTION; MUTAGENESIS; EXPRESSION; VECTORS; MANIPULATION; REPLACEMENT	Site-directed scarless mutagenesis is an essential tool of modern pathogenesis research. We describe an optimized two-step protocol for genome editing in Salmonella enterica serovar Typhimurium to enable multiple sequential mutagenesis steps in a single strain. The system is based on the. Red recombinase-catalyzed integration of a selectable antibiotics resistance marker followed by replacement of this cassette. Markerless mutants are selected by expressing the meganuclease I-SceI which induces double-strand breaks in bacteria still harboring the resistance locus. Our new dual-functional plasmid pWRG730 allows for heat-inducible expression of the. Red recombinase and tet-inducible production of I-SceI. Methyl-accepting chemotaxis proteins (MCP) are transmembrane chemoreceptors for a vast set of environmental signals including amino acids, sugars, ions and oxygen. Based on the sensory input of MCPs, chemotaxis is a key component for Salmonella virulence. To determine the contribution of individual MCPs we sequentially deleted seven MCP genes. The individual mutations were validated by PCR and genetic integrity of the final seven MCP mutant WRG279 was confirmed by whole genome sequencing. The successive MCP mutants were functionally tested in a HeLa cell infection model which revealed increased invasion rates for non-chemotactic mutants and strains lacking the MCP CheM (Tar). The phenotype of WRG279 was reversed with plasmid-based expression of CheM. The complemented WRG279 mutant showed also partially restored chemotaxis in swarming assays on semi-solid agar. Our optimized scarless deletion protocol enables efficient and precise manipulation of the Salmonella genome. As demonstrated with whole genome sequencing, multiple subsequent mutagenesis steps can be realized without the introduction of unwanted mutations. The sequential deletion of seven MCP genes revealed a significant role of CheM for the interaction of S. Typhimurium with host cells which might give new insights into mechanisms of Salmonella host cell sensing.	[Hoffmann, Stefanie; Schmidt, Christiane; Walter, Steffi; Gerlach, Roman G.] Robert Koch Inst, Project Grp 5, Wernigerode, Germany; [Bender, Jennifer K.] Robert Koch Inst, Div Nosocomial Pathogens & Antibiot Resistances, Dept Infect Dis, Wernigerode, Germany	Robert Koch Institute; Robert Koch Institute	Gerlach, RG (corresponding author), Robert Koch Inst, Project Grp 5, Wernigerode, Germany.	GerlachR@rki.de			Deutsche Forschungsgemeinschaft [GE 2533/2-2]; Robert Koch Insitute	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Robert Koch Insitute	This project was funded in part by the 'Deutsche Forschungsgemeinschaft' (www.dfg.de) grant GE 2533/2-2 and an intramural research grant of the Robert Koch Insitute (www.rki.de) to RGG.	ADLER J, 1966, SCIENCE, V153, P708, DOI 10.1126/science.153.3737.708; Bender Jennifer K, 2013, PLoS One, V8, pe73287, DOI 10.1371/journal.pone.0073287; Bibikov SI, 2004, J BACTERIOL, V186, P3730, DOI 10.1128/JB.186.12.3730-3737.2004; Blank K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015763; BLAT Y, 1995, J BACTERIOL, V177, P1683, DOI 10.1128/jb.177.7.1683-1691.1995; Carter Z, 2010, YEAST, V27, P765, DOI 10.1002/yea.1774; Costantino N, 2003, P NATL ACAD SCI USA, V100, P15748, DOI 10.1073/pnas.2434959100; Cox MM, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-59; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Datta S, 2006, GENE, V379, P109, DOI 10.1016/j.gene.2006.04.018; Dowd SE, 2008, FOODBORNE PATHOG DIS, V5, P205, DOI 10.1089/fpd.2007.0062; Edwards JC, 2006, MOL MICROBIOL, V62, P823, DOI 10.1111/j.1365-2958.2006.05411.x; Ellis HM, 2001, P NATL ACAD SCI USA, V98, P6742, DOI 10.1073/pnas.121164898; Erhardt M, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004800; Frye J, 2006, J BACTERIOL, V188, P2233, DOI 10.1128/JB.188.6.2233-2243.2006; Gerlach RG, 2008, CELL MICROBIOL, V10, P2364, DOI 10.1111/j.1462-5822.2008.01218.x; Gerlach RG, 2007, CELL MICROBIOL, V9, P1834, DOI 10.1111/j.1462-5822.2007.00919.x; Gerlach RG, 2009, APPL ENVIRON MICROB, V75, P1575, DOI 10.1128/AEM.02509-08; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Hazelbauer GL, 2008, TRENDS BIOCHEM SCI, V33, P9, DOI 10.1016/j.tibs.2007.09.014; JONES BD, 1992, INFECT IMMUN, V60, P2475, DOI 10.1128/IAI.60.6.2475-2480.1992; Kalinin Y, 2010, J BACTERIOL, V192, P1796, DOI 10.1128/JB.01507-09; Karlinsey JE, 2007, METHOD ENZYMOL, V421, P199, DOI 10.1016/S0076-6879(06)21016-4; Katashkina JI, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-34; KHORAMIANFALSAFI T, 1990, MICROB PATHOGENESIS, V9, P47, DOI 10.1016/0882-4010(90)90039-S; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Kolodziej AF, 1996, BIOCHEMISTRY-US, V35, P14782, DOI 10.1021/bi961481v; KONDOH H, 1979, P NATL ACAD SCI USA, V76, P260, DOI 10.1073/pnas.76.1.260; Lazova MD, 2012, MOL MICROBIOL, V84, P697, DOI 10.1111/j.1365-2958.2012.08051.x; Lee DJ, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-252; Lee Song-Choon, 2009, V530, P15, DOI 10.1007/978-1-59745-471-1_2; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Liang RB, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-209; Luo ML, 2016, BIOTECHNOL BIOENG, V113, P930, DOI 10.1002/bit.25851; Marzel A, 2016, CLIN INFECT DIS, V62, P879, DOI 10.1093/cid/civ1221; McDonough E, 2014, MOL MICROBIOL, V92, P302, DOI 10.1111/mmi.12557; Misselwitz B, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002810; MONTEILHET C, 1990, NUCLEIC ACIDS RES, V18, P1407, DOI 10.1093/nar/18.6.1407; Murphy KC, 2003, BMC MOL BIOL, V4, DOI 10.1186/1471-2199-4-11; Octavia S, 2015, J CLIN MICROBIOL, V53, P3507, DOI 10.1128/JCM.01733-15; Pines G, 2015, ACS SYNTH BIOL, V4, P1176, DOI 10.1021/acssynbio.5b00009; Posfai G, 1999, NUCLEIC ACIDS RES, V27, P4409, DOI 10.1093/nar/27.22.4409; Pyne ME, 2015, APPL ENVIRON MICROB, V81, P5103, DOI 10.1128/AEM.01248-15; R Core Team, 2021, R LANGUAGE ENV STAT; Ranallo RT, 2006, FEMS IMMUNOL MED MIC, V47, P462, DOI 10.1111/j.1574-695X.2006.00118.x; Reisch CR, 2015, SCI REP-UK, V5, DOI 10.1038/srep15096; Rivera-Chavez F, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003267; Rivero-Muller A, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm250; Ronda C, 2016, SCI REP-UK, V6, DOI 10.1038/srep19452; Sawitzke JA, 2007, METHOD ENZYMOL, V421, P171, DOI 10.1016/S0076-6879(06)21015-2; Stecher B, 2004, INFECT IMMUN, V72, P4138, DOI 10.1128/IAI.72.7.4138-4150.2004; Steglich M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139811; Sun W, 2008, APPL ENVIRON MICROB, V74, P4241, DOI 10.1128/AEM.00940-08; Thomason Lynn, 2007, Curr Protoc Mol Biol, VChapter 1, DOI 10.1002/0471142727.mb0117s79; Tischer BK, 2006, BIOTECHNIQUES, V40, P191, DOI 10.2144/000112096; Trulzsch K, 2004, INFECT IMMUN, V72, P5227, DOI 10.1128/IAI.72.9.5227-5234.2004; Wadhams GH, 2004, NAT REV MOL CELL BIO, V5, P1024, DOI 10.1038/nrm1524; Wang HL, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gkt1339; Wang HH, 2009, NATURE, V460, P894, DOI 10.1038/nature08187; WANG RF, 1991, GENE, V100, P195, DOI 10.1016/0378-1119(91)90366-J; Wickham H., 2016, GGPLOT2 ELEGANT GRAP, DOI 10.1007/978-3-319-24277-4; Wille T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123646; YAMAMOTO K, 1993, P NATL ACAD SCI USA, V90, P217, DOI 10.1073/pnas.90.1.217; Yu BJ, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn359; Zhang Y, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-42	67	22	22	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2017	12	2							e0172630	10.1371/journal.pone.0172630	http://dx.doi.org/10.1371/journal.pone.0172630			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BI	28212413	gold, Green Published			2022-12-27	WOS:000394424700063
J	Yang, QX; Xu, J; Cao, BG; Li, XQ				Yang, Qingxia; Xu, Jun; Cao, Binggang; Li, Xiuqing			A simplified fractional order impedance model and parameter identification method for lithium-ion batteries	PLOS ONE			English	Article							CHARGE ESTIMATION; STATE; OPTIMIZATION; SOC	Identification of internal parameters of lithium-ion batteries is a useful tool to evaluate battery performance, and requires an effective model and algorithm. Based on the least square genetic algorithm, a simplified fractional order impedance model for lithium-ion batteries and the corresponding parameter identification method were developed. The simplified model was derived from the analysis of the electrochemical impedance spectroscopy data and the transient response of lithium-ion batteries with different states of charge. In order to identify the parameters of the model, an equivalent tracking system was established, and the method of least square genetic algorithm was applied using the time-domain test data. Experiments and computer simulations were carried out to verify the effectiveness and accuracy of the proposed model and parameter identification method. Compared with a second-order resistance-capacitance (2-RC) model and recursive least squares method, small tracing voltage fluctuations were observed. The maximum battery voltage tracing error for the proposed model and parameter identification method is within 0.5%; this demonstrates the good performance of the model and the efficiency of the least square genetic algorithm to estimate the internal parameters of lithium-ion batteries.	[Yang, Qingxia; Xu, Jun; Cao, Binggang] Xi An Jiao Tong Univ, Sch Mech Engn, State Key Lab Mfg Syst Engn, Xian, Shaanxi, Peoples R China; [Li, Xiuqing] Henan Univ Sci & Technol, Engn Res Ctr Tribol & Mat Protect, Minist Educ, Luoyang, Henan, Peoples R China	Xi'an Jiaotong University; Henan University of Science & Technology	Xu, J (corresponding author), Xi An Jiao Tong Univ, Sch Mech Engn, State Key Lab Mfg Syst Engn, Xian, Shaanxi, Peoples R China.; Li, XQ (corresponding author), Henan Univ Sci & Technol, Engn Res Ctr Tribol & Mat Protect, Minist Educ, Luoyang, Henan, Peoples R China.	xujun018@gmail.com; hkdlxq@yeah.net	li, xq/AAL-6475-2020; Xu, Jun/J-5945-2013	Xu, Jun/0000-0001-7255-9952; Li, Xiuqing/0000-0003-0034-2468	National Natural Science Foundation of China [51405374]; Postdoctoral Science Foundation of China [2014M560763]; Postdoctoral Science Special Foundation of China [2016T90904]; Scientific Research Staring Foundation for Doctor of Henan University of Science and Technology [13480001]; Key Scientific Research Project of High School in Henan Province [17A430015]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Postdoctoral Science Foundation of China(China Postdoctoral Science Foundation); Postdoctoral Science Special Foundation of China(China Postdoctoral Science Foundation); Scientific Research Staring Foundation for Doctor of Henan University of Science and Technology; Key Scientific Research Project of High School in Henan Province	This work has been funded by the National Natural Science Foundation of China (grant no. 51405374), http://www.nsfc.gov.cn; the Postdoctoral Science Foundation of China (grant no. 2014M560763), http://jj.chinapostdoctor.org.cn; the Postdoctoral Science Special Foundation of China (grant no. 2016T90904), http://jj.chinapostdoctor.org.cn; the Scientific Research Staring Foundation for Doctor of Henan University of Science and Technology (grant no. 13480001), http://www.haust.edu.cn; and the Key Scientific Research Project of High School in Henan Province (grant no. 17A430015), http://cas.rcloud.edu.cn.	Andre D, 2013, J POWER SOURCES, V224, P20, DOI 10.1016/j.jpowsour.2012.10.001; Bizeray AM, 2015, J POWER SOURCES, V296, P400, DOI 10.1016/j.jpowsour.2015.07.019; Buller S, 2005, IEEE T IND APPL, V41, P742, DOI 10.1109/TIA.2005.847280; Chen ZY, 2016, APPL ENERG, V184, P365, DOI 10.1016/j.apenergy.2016.10.026; Chen Z, 2013, J POWER SOURCES, V240, P184, DOI 10.1016/j.jpowsour.2013.03.158; Cheng XM, 2016, ENERGIES, V9, DOI 10.3390/en9070539; Concepcion A. M., 2010, FRACTIONAL ORDER SYS; DOYLE M, 1993, J ELECTROCHEM SOC, V140, P1526, DOI 10.1149/1.2221597; Farmann A, 2015, J POWER SOURCES, V299, P176, DOI 10.1016/j.jpowsour.2015.08.087; Feng X, 2015, ELECTR POW SYST RES, V129, P150, DOI 10.1016/j.epsr.2015.08.011; Forman JC, 2012, J POWER SOURCES, V210, P263, DOI 10.1016/j.jpowsour.2012.03.009; Gallo D, 2013, ENERGIES, V6, P4572, DOI 10.3390/en6094572; He ZC, 2016, ENERGIES, V9, DOI 10.3390/en9060444; Hu XS, 2011, J ZHEJIANG UNIV-SC A, V12, P818, DOI 10.1631/jzus.A1100141; Kim T, 2015, J POWER SOURCES, V295, P16, DOI 10.1016/j.jpowsour.2015.03.184; Leith DJ, 2000, INT J CONTROL, V73, P1001, DOI 10.1080/002071700411304; Liu BH, 2016, APPL ENERG, V183, P278, DOI 10.1016/j.apenergy.2016.08.101; Long B, 2013, ENERGIES, V6, P5200, DOI 10.3390/en6105200; Mesbahi T, 2016, ELECTR POW SYST RES, V131, P195, DOI 10.1016/j.epsr.2015.10.018; Sabatier J, 2015, SIGNAL PROCESS, V107, P290, DOI 10.1016/j.sigpro.2014.06.008; Schmidt AP, 2010, J POWER SOURCES, V195, P5071, DOI 10.1016/j.jpowsour.2010.02.029; Schmidt JP, 2013, J POWER SOURCES, V221, P70, DOI 10.1016/j.jpowsour.2012.07.100; Wang BJ, 2015, J POWER SOURCES, V293, P151, DOI 10.1016/j.jpowsour.2015.05.059; Xu JG, 2015, J ELECTROCHEM SOC, V162, pA2026, DOI 10.1149/2.0291510jes; Xu JS, 2016, SCI REP-UK, V6, DOI [10.1038/srep21829, 10.1038/srep27524]; Xu J, 2016, APPL ENERG, V172, P180, DOI 10.1016/j.apenergy.2016.03.108; Xu J, 2013, J POWER SOURCES, V233, P277, DOI 10.1016/j.jpowsour.2013.01.094; Zahid T, 2016, ENERGIES, V9, DOI 10.3390/en9090720; Zhou DM, 2016, ENERGIES, V9, DOI 10.3390/en9030123; Zou ZY, 2014, ENERGIES, V7, P5065, DOI 10.3390/en7085065	30	25	25	6	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2017	12	2							e0172424	10.1371/journal.pone.0172424	http://dx.doi.org/10.1371/journal.pone.0172424			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BI	28212405	Green Published, gold, Green Submitted			2022-12-27	WOS:000394424700049
J	Burke, JL; Carroll, AL				Burke, Jordan Lewis; Carroll, Allan L.			Breeding matters: Natal experience influences population state-dependent host acceptance by an eruptive insect herbivore	PLOS ONE			English	Article							MOUNTAIN PINE-BEETLE; DENDROCTONUS-PONDEROSAE COLEOPTERA; KILLING BARK BEETLES; LODGEPOLE PINE; BEHAVIORAL SYNDROMES; RANGE EXPANSION; IPS-PINI; MONOTERPENE COMPOSITION; BRITISH-COLUMBIA; CLIMATE-CHANGE	Eruptive forest insects are highly influential agents of change in forest ecosystems, and their effects have increased with recent climate change. State-dependent life histories contribute significantly to the population dynamics of eruptive forest insect herbivores; however, the proximate mechanisms by which these species shift between states is poorly understood. Laboratory bioassays were conducted using the mountain pine beetle (Dendroctonus ponderosae) to determine the effect of maternal host selection on offspring host preferences, as they apply to population state-dependent behaviors. Female mountain pine beetles exhibited state-dependent preference for artificial host material amended with monoterpenes in the absence of other cues, such that individuals reared in high-density epidemic-state simulations rejected low monoterpene conditions, while low-density endemic-state beetles accepted low monoterpene conditions. State-specific behavior in offspring was dependent on rearing conditions, as a function of maternal host selection, and these effects were observed within one generation. Density-dependent host selection behaviors exhibited by female mountain pine beetle offspring is reinforced by context-dependent maternal effects arising from parental host selection, and in situ exposure to conspecifics. These results demonstrate potential proximate mechanisms that control population dynamics in eruptive forest insects, and will allow for more accurate predictions of continued impact and spread of these species.	[Burke, Jordan Lewis; Carroll, Allan L.] Univ British Columbia, Dept Forest & Conservat Sci, Fac Forestry, Vancouver, BC, Canada	University of British Columbia	Burke, JL (corresponding author), Univ British Columbia, Dept Forest & Conservat Sci, Fac Forestry, Vancouver, BC, Canada.	jordan.lewis.burke@gmail.com			Natural Sciences and Engineering Research Council of Canada (NSERC) Strategic Network TRIA-Net Turning Risk Into Action for the Mountain Pine Beetle Epidemic; NSERC Discovery Grant	Natural Sciences and Engineering Research Council of Canada (NSERC) Strategic Network TRIA-Net Turning Risk Into Action for the Mountain Pine Beetle Epidemic; NSERC Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC))	Funding for this research was provided by The Natural Sciences and Engineering Research Council of Canada (NSERC) Strategic Network TRIA-Net Turning Risk Into Action for the Mountain Pine Beetle Epidemic (tria-net.srv.ualberta.ca/) and a NSERC Discovery Grant (http://www.nserc-crsng.gc.ca/Professors-Professeurs/grants-subs/DGIGP-PSIGP_eng.asp) to AC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams AS, 2009, CAN J FOREST RES, V39, P1133, DOI 10.1139/X09-034; Amman G.D., 1983, INT145 USDA FOR SERV; AMMAN GD, 1972, J ECON ENTOMOL, V65, P138, DOI 10.1093/jee/65.1.138; Amman GD, 1976, INT209 USDA FOR SERV; BERRYMAN AA, 1978, RES POPUL ECOL, V19, P181, DOI 10.1007/BF02518826; Boone CK, 2013, J CHEM ECOL, V39, P1003, DOI 10.1007/s10886-013-0313-0; Boone CK, 2011, CAN J FOREST RES, V41, P1174, DOI [10.1139/X11-041, 10.1139/x11-041]; BORDEN JH, 1987, CAN J FOREST RES, V17, P118, DOI 10.1139/x87-023; Borden JH, 2008, J ECON ENTOMOL, V101, P1266, DOI 10.1603/0022-0493(2008)101[1266:SBOMFA]2.0.CO;2; Burke JL, 2016, FOREST ECOL MANAG, V359, P59, DOI 10.1016/j.foreco.2015.09.044; CARO TM, 1986, ANIM BEHAV, V34, P1483, DOI 10.1016/S0003-3472(86)80219-6; CARROLL AL, 2004, CHALLENGES SOLUTIONS, P221; CHITTY DENNIS, 1960, CANADIAN JOUR ZOOL, V38, P99, DOI 10.1139/z60-011; Chubaty AM, 2009, ECOL MODEL, V220, P1241, DOI 10.1016/j.ecolmodel.2009.01.039; Clark EL, 2014, PEERJ, V2, DOI 10.7717/peerj.240; Clark EL, 2010, CAN ENTOMOL, V142, P557, DOI 10.4039/n10-022; Cooke Barry J., 2007, P487; Czesak ME, 2003, EVOLUTION, V57, P1121; Dowdy S., 2004, STAT RES, V3rd; Elkin CM, 2005, FUNCT ECOL, V19, P102, DOI 10.1111/j.0269-8463.2005.00935.x; Emlen DJ, 1997, BEHAV ECOL SOCIOBIOL, V41, P335, DOI 10.1007/s002650050393; Erbilgin N, 2014, NEW PHYTOL, V201, P940, DOI 10.1111/nph.12573; Eveleigh ES, 2007, P NATL ACAD SCI USA, V104, P16976, DOI 10.1073/pnas.0704301104; FURNISS MM, 1969, J ECON ENTOMOL, V62, P518, DOI 10.1093/jee/62.2.518; GINZBURG LR, 1994, J ANIM ECOL, V63, P79, DOI 10.2307/5585; GLIWICZ ZM, 1992, OECOLOGIA, V91, P463, DOI 10.1007/BF00650317; Graf M, 2012, CAN ENTOMOL, V144, P467, DOI 10.4039/tce.2012.38; Gross MR, 1996, TRENDS ECOL EVOL, V11, P92, DOI 10.1016/0169-5347(96)81050-0; GUO PZ, 1991, P NATL ACAD SCI USA, V88, P10905, DOI 10.1073/pnas.88.23.10905; Hagen SB, 2007, ECOGRAPHY, V30, P299, DOI [10.1111/j.2007.0906-7590.04981.x, 10.1111/j.0906-7590.2007.04981.x]; Hall DE, 2013, PLANT PHYSIOL, V161, P600, DOI 10.1104/pp.112.208546; HOUSTON AI, 1992, EVOL ECOL, V6, P243, DOI 10.1007/BF02214164; HYNUM BG, 1980, CAN ENTOMOL, V112, P185, DOI 10.4039/Ent112185-2; Inchausti P, 2009, PHILOS T R SOC B, V364, P1117, DOI 10.1098/rstb.2008.0292; Jepsen JU, 2008, J ANIM ECOL, V78, P182; Jonsson AM, 2009, GLOBAL CHANGE BIOL, V15, P486, DOI 10.1111/j.1365-2486.2008.01742.x; Keeling CI, 2006, NEW PHYTOL, V170, P657, DOI 10.1111/j.1469-8137.2006.01716.x; Tran JK, 2007, ECOL APPL, V17, P882, DOI 10.1890/06-0512; Klepzig KD, 1996, J CHEM ECOL, V22, P1367, DOI 10.1007/BF02027719; Klutsch JG, 2016, OECOLOGIA, V182, P1, DOI 10.1007/s00442-016-3559-8; Kolb TE, 2016, FOREST ECOL MANAG, V380, P321, DOI 10.1016/j.foreco.2016.04.051; Lardies MA, 2004, OECOLOGIA, V138, P387, DOI 10.1007/s00442-003-1447-5; Luttbeg B, 2010, PHILOS T R SOC B, V365, P3977, DOI 10.1098/rstb.2010.0207; McGhehey JH, 1971, NORX9 NO FOR RES CTR; McNamara JM, 1996, NATURE, V380, P215, DOI 10.1038/380215a0; MICHAEL RR, 1972, J INSECT PHYSIOL, V18, P2189, DOI 10.1016/0022-1910(72)90248-X; Netherer S, 2010, FOREST ECOL MANAG, V259, P831, DOI 10.1016/j.foreco.2009.07.034; PITMAN GB, 1971, J ECON ENTOMOL, V64, P426, DOI 10.1093/jee/64.2.426; Plaistow SJ, 2009, PHILOS T R SOC B, V364, P1049, DOI 10.1098/rstb.2008.0251; Powell JA, 2014, ECOL MODEL, V273, P173, DOI 10.1016/j.ecolmodel.2013.10.034; Pureswaran DS, 2005, AGR FOREST ENTOMOL, V7, P219, DOI 10.1111/j.1461-9555.2005.00264.x; Pureswaran DS, 2003, ENVIRON ENTOMOL, V32, P963, DOI 10.1603/0046-225X-32.5.963; Raffa KF, 2008, BIOSCIENCE, V58, P501, DOI 10.1641/B580607; Raffa KF, 2015, CABI CLIM CHANGE SER, V7, P173, DOI 10.1079/9781780643786.0173; Raffa KF, 2013, P NATL ACAD SCI USA, V110, P2193, DOI 10.1073/pnas.1216666110; RAFFA KF, 1982, CAN ENTOMOL, V114, P97, DOI 10.4039/Ent11497-2; RAFFA KF, 1982, ENVIRON ENTOMOL, V11, P486, DOI 10.1093/ee/11.2.486; Rasanen K, 2005, OECOLOGIA, V142, P546, DOI 10.1007/s00442-004-1762-5; Reid ML, 2011, ARTHROPOD-PLANT INTE, V5, P331, DOI 10.1007/s11829-011-9137-4; Robert LE, 2012, CAN J FOREST RES, V42, P463, DOI [10.1139/x2012-005, 10.1139/X2012-005]; Robinson A., 2015, THESIS; Rosenberger DW, 2016, ENTOMOL EXP APPL, V160, P195, DOI 10.1111/eea.12463; Royama T., 1992, ANAL POPULATION ECOL; Safranyik L., 2006, The mountain pine beetle: a synthesis of biology, management and impacts on lodgepole pine; Safranyik L, 2010, CAN ENTOMOL, V142, P415, DOI 10.4039/n08-CPA01; SAFRANYIK L, 1992, J APPL ENTOMOL, V113, P441, DOI 10.1111/j.1439-0418.1992.tb00687.x; Safranyik L., 1975, MANAGEMENT LODGEPOLE, P406; SHRIMPTON DM, 1968, CAN J BOTANY, V46, P757, DOI 10.1139/b68-104; Sih A, 2004, Q REV BIOL, V79, P241, DOI 10.1086/422893; Sih A, 2004, TRENDS ECOL EVOL, V19, P372, DOI 10.1016/j.tree.2004.04.009; Six DL, 2003, CAN J FOREST RES, V33, P1331, DOI [10.1139/x03-047, 10.1139/X03-047]; Smith GD, 2011, AGR FOREST ENTOMOL, V13, P37, DOI 10.1111/j.1461-9563.2010.00499.x; Taft S, 2015, J CHEM ECOL, V41, P540, DOI 10.1007/s10886-015-0590-x; Taft S, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00342; THOMSON AJ, 1984, CAN J FOREST RES, V14, P255, DOI 10.1139/x84-049; Turchin P., 2003, MONOGRAPHS POPULATIO, P472; Wallin KF, 2000, ENVIRON ENTOMOL, V29, P442, DOI 10.1603/0046-225X-29.3.442; Wallin KF, 2004, ECOL MONOGR, V74, P101, DOI 10.1890/02-4004; Wallin KF, 2002, ENVIRON ENTOMOL, V31, P1276, DOI 10.1603/0046-225X-31.6.1276; Wallin KF, 2002, ENTOMOL EXP APPL, V103, P205, DOI 10.1023/A:1021103320908; Wallin KF, 1999, J CHEM ECOL, V25, P861, DOI 10.1023/A:1020853019309; WHITE TCR, 1976, OECOLOGIA, V22, P119, DOI 10.1007/BF00344712; Wolf JB, 2009, PHILOS T R SOC B, V364, P1107, DOI 10.1098/rstb.2008.0238; Wood S. L., 1982, GREAT BASIN NATURALI	84	5	5	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0172448	10.1371/journal.pone.0172448	http://dx.doi.org/10.1371/journal.pone.0172448			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207862	Green Submitted, gold, Green Published			2022-12-27	WOS:000394424500139
J	Cai, TT; Zhu, HL; Xu, J; Wu, SJ; Li, XG; He, SL				Cai, Tingting; Zhu, Huilin; Xu, Jie; Wu, Shijing; Li, Xinge; He, Sailing			Human cortical neural correlates of visual fatigue during binocular depth perception: An fNIRS study	PLOS ONE			English	Article							NEAR-INFRARED SPECTROSCOPY; PROCESSING REGIONS; HUMAN BRAIN; DISPARITY; STEREOPSIS; RESPONSES; CORTEX; STIMULI; FMRI	Functional near-infrared spectroscopy (fNIRS) was adopted to investigate the cortical neural correlates of visual fatigue during binocular depth perception for different disparities (from 0.1 degrees to 1.5 degrees). By using a slow event-related paradigm, the oxyhaemoglobin (HbO) responses to fused binocular stimuli presented by the random-dot stereogram (RDS) were recorded over the whole visual dorsal area. To extract from an HbO curve the characteristics that are correlated with subjective experiences of stereopsis and visual fatigue, we proposed a novel method to fit the time-course HbO curve with various response functions which could reflect various processes of binocular depth perception. Our results indicate that the parietal-occipital cortices are spatially correlated with binocular depth perception and that the process of depth perception includes two steps, associated with generating and sustaining stereovision. Visual fatigue is caused mainly by generating stereovision, while the amplitude of the haemodynamic response corresponding to sustaining stereovision is correlated with stereopsis. Combining statistical parameter analysis and the fitted time-course analysis, fNIRS could be a promising method to study visual fatigue and possibly other multi-process neural bases.	[Cai, Tingting; Zhu, Huilin; Xu, Jie; Wu, Shijing; Li, Xinge; He, Sailing] South China Normal Univ, South China Acad Adv Optoelect, Ctr Opt & Electromagent Res, Guangzhou, Guangdong, Peoples R China; [Wu, Shijing] South China Normal Univ, Sch Informat & Optoelect Sci & Engn, Guangzhou, Guangdong, Peoples R China; [Li, Xinge] South China Normal Univ, Guangzhou, Guangdong, Peoples R China; [He, Sailing] Royal Inst Technol, Dept Electromagnet Engn, Stockholm, Sweden	South China Normal University; South China Normal University; South China Normal University; Royal Institute of Technology	He, SL (corresponding author), South China Normal Univ, South China Acad Adv Optoelect, Ctr Opt & Electromagent Res, Guangzhou, Guangdong, Peoples R China.; He, SL (corresponding author), Royal Inst Technol, Dept Electromagnet Engn, Stockholm, Sweden.	sailing@jorcep.org	He, Sailing/C-2438-2009	He, Sailing/0000-0002-3401-1125	National Natural Science Foundation of China [11621101]; Guangdong Innovative Research Team Program [201001D0104799318]; Natural Science Foundation of Guangdong province [2014A030310502]; Chinese Postdoctoral Science Foundation [2015M580725, 2016T90791]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Innovative Research Team Program; Natural Science Foundation of Guangdong province(National Natural Science Foundation of Guangdong Province); Chinese Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by the National Natural Science Foundation of China (NO. 11621101, http://www.nsfc.gov.cn/, SH); Guangdong Innovative Research Team Program (NO. 201001D0104799318, http://cxtd.gdstc.gov.cn/, SH); Natural Science Foundation of Guangdong province (NO. 2014A030310502, http://www.gdstc.gov.cn/, HZ); Chinese Postdoctoral Science Foundation (NO. 2015M580725 & NO. 2016T90791, http://chinapostdoctor.org.cn/WebSite/program/Default.aspx, HZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen PM, 2003, OPTOMETRY VISION SCI, V80, P245, DOI 10.1097/00006324-200303000-00014; Backus BT, 2001, J NEUROPHYSIOL, V86, P2054, DOI 10.1152/jn.2001.86.4.2054; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Chul J, 2009, NEUROIMAGE, V44, P428, DOI 10.1016/j.neuroimage.2008.08.036; Cumming BG, 1999, J NEUROSCI, V19, P5602; Cumming BG, 2001, ANNU REV NEUROSCI, V24, P203, DOI 10.1146/annurev.neuro.24.1.203; Ding XP, 2013, NEUROPSYCHOLOGIA, V51, P704, DOI 10.1016/j.neuropsychologia.2012.12.018; Durand JB, 2009, NEUROIMAGE, V46, P1114, DOI 10.1016/j.neuroimage.2009.03.023; Ehlis AC, 2005, BIOL PSYCHOL, V69, P315, DOI 10.1016/j.biopsycho.2004.09.003; Emoto M, 2005, J DISP TECHNOL, V1, P328, DOI 10.1109/JDT.2005.858938; Georgieva S, 2009, J NEUROSCI, V29, P727, DOI 10.1523/JNEUROSCI.4753-08.2009; Hagura H, 2006, ELECT IMAGING, V2006; Homae F, 2007, NEUROSCI RES, V59, P29, DOI 10.1016/j.neures.2007.05.005; Huppert TJ, 2006, NEUROIMAGE, V29, P368, DOI 10.1016/j.neuroimage.2005.08.065; Iwami T, 2002, NEUROSCI LETT, V327, P29, DOI 10.1016/S0304-3940(02)00353-1; Jang K E, 2009, J BIOMEDICAL OPTICS, V14, P659; JOBSIS FF, 1977, SCIENCE, V198, P1264, DOI 10.1126/science.929199; Kim D, 2014, INT J IMAG SYST TECH, V24, P94, DOI 10.1002/ima.22083; Koessler L, 2009, NEUROIMAGE, V46, P64, DOI 10.1016/j.neuroimage.2009.02.006; KUMAR T, 1992, VISION RES, V32, P1667, DOI 10.1016/0042-6989(92)90159-G; Lambooij M, 2009, J IMAGING SCI TECHN, V53, DOI 10.2352/J.ImagingSci.Technol.2009.53.3.030201; Li H- CO, 2008, 3DTV C TRUE VIS CAPT; Lloyd-Fox S, 2010, NEUROSCI BIOBEHAV R, V34, P269, DOI 10.1016/j.neubiorev.2009.07.008; Mapp AP, 2003, PERCEPT PSYCHOPHYS, V65, P310, DOI 10.3758/BF03194802; Neri P, 2004, J NEUROPHYSIOL, V92, P1880, DOI 10.1152/jn.01042.2003; Nishida Y, 2001, NEUROREPORT, V12, P2259, DOI 10.1097/00001756-200107200-00043; Orban GA, 2011, ANNU REV NEUROSCI, V34, P361, DOI 10.1146/annurev-neuro-061010-113819; Parker AJ, 2007, NAT REV NEUROSCI, V8, P379, DOI 10.1038/nrn2131; Petit L, 1999, J NEUROPHYSIOL, V82, P463, DOI 10.1152/jn.1999.82.1.463; Preston TJ, 2008, J NEUROSCI, V28, P11315, DOI 10.1523/JNEUROSCI.2728-08.2008; Rosen BR, 2010, NEURON, V39, P555; Roth HL, 2002, BRAIN, V125, P2023, DOI 10.1093/brain/awf210; Sai LY, 2014, BRAIN TOPOGR, V27, P652, DOI 10.1007/s10548-014-0352-z; Seraglia B, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00176; Singh AK, 2005, NEUROIMAGE, V27, P842, DOI 10.1016/j.neuroimage.2005.05.019; Speranza F, 2006, PROC SPIE, V6055, DOI 10.1117/12.640865; Suryakumar R, 2007, VISION RES, V47, P260, DOI 10.1016/j.visres.2006.10.003; Tak S, 2011, NEUROIMAGE, V55, P176, DOI 10.1016/j.neuroimage.2010.11.046; Tanabe S, 2005, J NEUROPHYSIOL, V94, P2683, DOI 10.1152/jn.00319.2005; Tsukuda S, 1988, CASE REPORT MANIFEST, V16, P69; Ward LM, 2016, BRAIN TOPOGR, P1; Wijeakumar S, 2012, INVEST OPHTH VIS SCI, V53, P5881, DOI 10.1167/iovs.12-10399; Zhu H, PROGR EL RES S 2016	43	9	9	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0172426	10.1371/journal.pone.0172426	http://dx.doi.org/10.1371/journal.pone.0172426			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207899	gold, Green Published, Green Submitted			2022-12-27	WOS:000394424500134
J	Karnes, JH; Shaffer, CM; Bastarache, L; Gaudieri, S; Glazer, AM; Steiner, HE; Mosley, JD; Mallal, S; Denny, JC; Phillips, EJ; Roden, DM				Karnes, Jason H.; Shaffer, Christian M.; Bastarache, Lisa; Gaudieri, Silvana; Glazer, Andrew M.; Steiner, Heidi E.; Mosley, Jonathan D.; Mallal, Simon; Denny, Joshua C.; Phillips, Elizabeth J.; Roden, Dan M.			Comparison of HLA allelic imputation programs	PLOS ONE			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; RESOLUTION SNP DATA; POPULATION; ASSOCIATIONS; HLA-B-ASTERISK-5701; HYPERSENSITIVITY; HLA-DRB1; GENOTYPE; RISK	Imputation of human leukocyte antigen (HLA) alleles from SNP-level data is attractive due to importance of HLA alleles in human disease, widespread availability of genome-wide association study (GWAS) data, and expertise required for HLA sequencing. However, comprehensive evaluations of HLA imputations programs are limited. We compared HLA imputation results of HIBAG, SNP2HLA, and HLA* IMP: 02 to sequenced HLA alleles in 3,265 samples from BioVU, a de-identified electronic health record database coupled to a DNA biorepository. We performed four-digit HLA sequencing for HLA-A, -B, -C, -DRB1, -DPB1, and -DQB1 using long-read 454 FLX sequencing. All samples were genotyped using both the Illumina HumanExome BeadChip platform and a GWAS platform. Call rates and concordance rates were compared by platform, frequency of allele, and race/ethnicity. Overall concordance rates were similar between programs in European Americans (EA) (0.975 [SNP2HLA]; 0.939 [HLA* IMP: 02]; 0.976 [HIBAG]). SNP2HLA provided a significant advantage in terms of call rate and the number of alleles imputed. Concordance rates were lower overall for African Americans (AAs). These observations were consistent when accuracy was compared across HLA loci. All imputation programs performed similarly for low frequency HLA alleles. Higher concordance rates were observed when HLA alleles were imputed from GWAS platforms versus the HumanExome BeadChip, suggesting that high genomic coverage is preferred as input for HLA allelic imputation. These findings provide guidance on the best use of HLA imputation methods and elucidate their limitations.	[Karnes, Jason H.; Steiner, Heidi E.] Univ Arizona, Coll Pharm, Dept Pharm Practice & Sci, Tucson, AZ 85721 USA; [Shaffer, Christian M.; Glazer, Andrew M.; Mosley, Jonathan D.; Denny, Joshua C.; Phillips, Elizabeth J.; Roden, Dan M.] Vanderbilt Univ, Med Ctr, Dept Med, Div Clin Pharmacol, Nashville, TN USA; [Bastarache, Lisa; Denny, Joshua C.; Roden, Dan M.] Vanderbilt Univ, Sch Med, Dept Biomed Informat, Nashville, TN 37212 USA; [Gaudieri, Silvana; Mallal, Simon; Phillips, Elizabeth J.] Vanderbilt Univ, Med Ctr, Dept Med, Div Infect Dis, Nashville, TN USA; [Gaudieri, Silvana] Univ Western Australia, Sch Anat Physiol & Human Biol, Nedlands, WA, Australia; [Gaudieri, Silvana; Mallal, Simon; Phillips, Elizabeth J.] Murdoch Univ, Inst Immunol & Infect Dis, Murdoch, WA, Australia; [Mallal, Simon] Vanderbilt Univ, Sch Med, Dept Pathol Microbiol & Immunol, Nashville, TN 37212 USA; [Roden, Dan M.] Vanderbilt Univ, Sch Med, Dept Pharmacol, Nashville, TN 37212 USA	University of Arizona; Vanderbilt University; Vanderbilt University; Vanderbilt University; University of Western Australia; Murdoch University; Vanderbilt University; Vanderbilt University	Roden, DM (corresponding author), Vanderbilt Univ, Med Ctr, Dept Med, Div Clin Pharmacol, Nashville, TN USA.; Roden, DM (corresponding author), Vanderbilt Univ, Sch Med, Dept Biomed Informat, Nashville, TN 37212 USA.; Roden, DM (corresponding author), Vanderbilt Univ, Sch Med, Dept Pharmacol, Nashville, TN 37212 USA.	dan.roden@vanderbilt.edu	Roden, Dan/ABD-5412-2021; Mallal, Simon Alexander/HDM-9561-2022; Denny, Josh/AAL-3359-2021	Mallal, Simon Alexander/0000-0002-7036-1309; Denny, Josh/0000-0002-3049-7332; , Silvana/0000-0001-6873-0198; Glazer, Andrew/0000-0002-3938-4713; Mosley, Jonathan/0000-0001-6421-2887	Vanderbilt CTSA grant from NCATS/NIH [ULTR000445]; HumanExome BeadChip; NIH [RC2GM092618, U01HG004603, U19HL065962]; NCATS/NIH [UL1TR000445]; VUMC Clinical Pharmacology Training grant [T32 GM07569]; American Heart Association [16SDG29090005, 15POST22660017]; ACCP Research Institute Futures Grants Award from the American College of Clinical Pharmacy;  [5U01GM092691-04];  [1R01AR062886-01]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM115305, T32GM007569] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM010685] Funding Source: NIH RePORTER	Vanderbilt CTSA grant from NCATS/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); HumanExome BeadChip; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCATS/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); VUMC Clinical Pharmacology Training grant; American Heart Association(American Heart Association); ACCP Research Institute Futures Grants Award from the American College of Clinical Pharmacy; ; ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	The dataset used in the analyses described were obtained from Vanderbilt University Medical Centers BioVU which is supported by institutional funding and by the Vanderbilt CTSA grant ULTR000445 from NCATS/NIH. HumanExome BeadChip genotyping was supported institutionally. Genome-wide genotyping was funded by NIH grants RC2GM092618 from NIGMS/OD, U01HG004603 from NHGRI/NIGMS, and U19HL065962 from NHGRI/NIGMS. BioVU is supported by institutional funding and by the Vanderbilt CTSA grant UL1TR000445 from NCATS/NIH. JHK has been supported by the VUMC Clinical Pharmacology Training grant (T32 GM07569), the American Heart Association (16SDG29090005 and 15POST22660017), and an ACCP Research Institute Futures Grants Award from the American College of Clinical Pharmacy. SR is supported by 5U01GM092691-04 and 1R01AR062886-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The dataset used in the analyses described were obtained from Vanderbilt University Medical Centers BioVU which is supported by institutional funding and by the Vanderbilt CTSA grant ULTR000445 from NCATS/NIH. HumanExome BeadChip genotyping was supported institutionally. Genome-wide genotyping was funded by NIH grants RC2GM092618 from NIGMS/OD, U01HG004603 from NHGRI/NIGMS, and U19HL065962 from NHGRI/NIGMS. BioVU is supported by institutional funding and by the Vanderbilt CTSA grant UL1TR000445 from NCATS/NIH.; JHK has been supported by the VUMC Clinical Pharmacology Training grant (T32 GM07569), the American Heart Association (16SDG29090005 and 15POST22660017), and an ACCP Research Institute Futures Grants Award from the American College of Clinical Pharmacy. SR is supported by 5U01GM092691-04 and 1R01AR062886-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bowton E, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008604; Cortes A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8146; Cruz-Tapias P, 2012, AUTOIMMUN REV, V11, P281, DOI 10.1016/j.autrev.2011.10.002; Daly AK, 2009, NAT GENET, V41, P816, DOI 10.1038/ng.379; Dilthey AT, 2011, BIOINFORMATICS, V27, P968, DOI 10.1093/bioinformatics/btr061; Guo Y, 2014, NAT PROTOC, V9, P2643, DOI 10.1038/nprot.2014.174; Hung SL, 2005, P NATL ACAD SCI USA, V102, P4134, DOI 10.1073/pnas.0409500102; Invernizzi P, 2012, GENES IMMUN, V13, P461, DOI 10.1038/gene.2012.17; Jia XM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064683; Karnes JH, 2014, THROMB HAEMOSTASIS, P113; Khor SS, 2015, PHARMACOGENOMICS J, V15, P530, DOI 10.1038/tpj.2015.4; Khor SS, 2015, PHARMACOGENOMICS J; Leslie S, 2008, AM J HUM GENET, V82, P48, DOI 10.1016/j.ajhg.2007.09.001; Levin AM, 2014, BMC GENET, V15, DOI 10.1186/1471-2156-15-72; Mallal S, 2002, LANCET, V359, P727, DOI 10.1016/S0140-6736(02)07873-X; Mallal S, 2008, NEW ENGL J MED, V358, P568, DOI 10.1056/NEJMoa0706135; Milicic A, 2002, J RHEUMATOL, V29, P1821; Nunes K, 2016, HUM IMMUNOL, V77, P307, DOI 10.1016/j.humimm.2015.11.004; Okada Y, 2015, NAT GENET, V47, P798, DOI 10.1038/ng.3310; Parkes M, 2013, NAT REV GENET, V14, P661, DOI 10.1038/nrg3502; Petersdorf EW, 2013, BLOOD, V122, P1863, DOI 10.1182/blood-2013-05-355982; Pillai NE, 2014, HUM MOL GENET, V23, P4443, DOI 10.1093/hmg/ddu149; Pritchard JK, 2000, GENETICS, V155, P945; Raychaudhuri S, 2012, NAT GENET, V44, P291, DOI 10.1038/ng.1076; Roden DM, 2008, CLIN PHARMACOL THER, V84, P362, DOI 10.1038/clpt.2008.89; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Vlachopoulou E, 2014, TISSUE ANTIGENS, V83, P350, DOI 10.1111/tan.12343; Yoshida K, 2011, ARTHRITIS RHEUM-US, V63, P3058, DOI 10.1002/art.30501; Zheng X, 2014, PHARMACOGENOMICS J, V14, P192, DOI 10.1038/tpj.2013.18; Zuvich RL, 2011, GENET EPIDEMIOL, V35, P887, DOI 10.1002/gepi.20639	30	42	42	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0172444	10.1371/journal.pone.0172444	http://dx.doi.org/10.1371/journal.pone.0172444			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207879	Green Published, Green Submitted, gold			2022-12-27	WOS:000394424500137
J	Morandi, E; Tanasescu, R; Tarlinton, RE; Constantinescu, CS; Zhang, WY; Tench, C; Gran, B				Morandi, Elena; Tanasescu, Radu; Tarlinton, Rachael E.; Constantinescu, Cris S.; Zhang, Weiya; Tench, Christopher; Gran, Bruno			The association between human endogenous retroviruses and multiple sclerosis: A systematic review and meta-analysis	PLOS ONE			English	Article							REAL-TIME PCR; BRAIN-LESIONS; COPY NUMBER; W ENV; EXPRESSION; CELLS; RNA; HRES-1; MSRV; INSERTIONS	Background The interaction between genetic and environmental factors is crucial to multiple sclerosis (MS) pathogenesis. Human Endogenous Retroviruses (HERVs) are endogenous viral elements of the human genome whose expression is associated with MS. Objective To perform a systematic review and meta-analysis and to assess qualitative and quantitative evidence on the expression of HERV families in MS patients. Methods Medline, Embase and the Cochrane Library were searched for published studies on the association of HERVs and MS. Meta-analysis was performed on the HERV-W family. Odds Ratio (OR) and 95% confidence interval (CI) were calculated for association. Results 43 reports were extracted (25 related to HERV-W, 13 to HERV-H, 9 to HERV-K, 5 to HRES-1 and 1 to HER-15 family). The analysis showed an association between expression of all HERV families and MS. For HERV-W, adequate data was available for meta-analysis. Results from meta-analyses of HERV-W were OR = 22.66 (95% CI 6.32 to 81.20) from 4 studies investigating MSRV/HERV-W(MS-associated retrovirus) envelope mRNA in peripheral blood mononuclear cells, OR = 44.11 (95% CI 12.95 to 150.30) from 6 studies of MSRV/HERV-W polymerase mRNA in serum/plasma and OR = 6.00 (95% CI 3.35 to 10.74) from 4 studies of MSRV/HERV-W polymerase mRNA in CSF. Conclusions This systematic review and meta-analysis shows an association between expression of HERVs, and in particular the HERV-W family, and MS.	[Morandi, Elena; Tanasescu, Radu; Constantinescu, Cris S.; Tench, Christopher; Gran, Bruno] Univ Nottingham, Div Clin Neurosci, Sch Med, Nottingham, England; [Tanasescu, Radu] Univ Med & Pharm Carol Davila, Colentina Hosp, Div Clin Neurosci, Dept Neurol, Bucharest, Romania; [Tarlinton, Rachael E.] Univ Nottingham, Sch Vet Med & Sci, Nottingham, England; [Constantinescu, Cris S.; Gran, Bruno] Nottingham Univ Hosp NHS Trust, Dept Neurol, Nottingham, England; [Zhang, Weiya] Univ Nottingham, Sch Med, Div Rheumatol Orthopaed & Dermatol, Nottingham, England	University of Nottingham; Carol Davila University of Medicine & Pharmacy; University of Nottingham; Nottingham University Hospital NHS Trust; University of Nottingham	Gran, B (corresponding author), Univ Nottingham, Div Clin Neurosci, Sch Med, Nottingham, England.; Gran, B (corresponding author), Nottingham Univ Hosp NHS Trust, Dept Neurol, Nottingham, England.	bruno.gran@nuh.nhs.uk	Tanasescu, Radu/B-2453-2008; Morandi, Elena/AAF-8466-2021	Tanasescu, Radu/0000-0003-2282-1793; Gran, Bruno/0000-0001-6384-2342; Morandi, Elena/0000-0002-8222-1514; Zhang, Weiya/0000-0003-1142-1460				Alvarez-Lafuente R, 2008, MULT SCLER J, V14, P595, DOI 10.1177/1352458507086425; Antony JM, 2004, NAT NEUROSCI, V7, P1088, DOI 10.1038/nn1319; Antony JM, 2007, AIDS RES HUM RETROV, V23, P1251, DOI 10.1089/aid.2006.0274; Antony JM, 2006, AIDS RES HUM RETROV, V22, P1253, DOI 10.1089/aid.2006.22.1253; Arru Giannina, 2007, Int J Biomed Sci, V3, P292; Ascherio A, 2007, ANN NEUROL, V61, P288, DOI 10.1002/ana.21117; Bar-Or A, 2016, LANCET NEUROL, V15, P9, DOI 10.1016/S1474-4422(15)00342-7; Brudek T, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-104; Christensen T, 2000, ACTA NEUROL SCAND, V101, P229, DOI 10.1034/j.1600-0404.2000.101004229.x; Christensen T, 2005, REV MED VIROL, V15, P179, DOI 10.1002/rmv.465; Christensen T, 2003, MULT SCLER J, V9, P6, DOI 10.1191/1352458503ms867oa; de la Hera B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090182; de la Hera B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062090; de Villiers JNP, 2006, METAB BRAIN DIS, V21, P163, DOI 10.1007/s11011-006-9016-3; do Olival GS, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00172; Dolei A, 2002, NEUROLOGY, V58, P471, DOI 10.1212/WNL.58.3.471; Duperray A, 2015, INT IMMUNOL, V27, P545, DOI 10.1093/intimm/dxv025; Garcia-Montojo M, 2014, RETROVIROLOGY, V11, DOI 10.1186/1742-4690-11-2; Garcia-Montojo M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053623; Garson JA, 1998, LANCET, V351, P33, DOI 10.1016/S0140-6736(98)24001-3; Garson JA, 2009, AIDS RES HUM RETROV, V25, P377, DOI 10.1089/aid.2008.0270; Gifford R, 2003, VIRUS GENES, V26, P291, DOI 10.1023/A:1024455415443; Grandi N, 2016, RETROVIROLOGY, V13, DOI 10.1186/s12977-016-0301-x; Hansen B, 2011, PLOS ONE; Johnston JB, 2001, ANN NEUROL, V50, P434, DOI 10.1002/ana.1131; Kremer D, 2013, ANN NEUROL, V74, P721, DOI 10.1002/ana.23970; Laska MJ, 2012, J VIROL, V86, P3713, DOI 10.1128/JVI.06723-11; Laufer G, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-37; Mameli G, 2007, J GEN VIROL, V88, P264, DOI 10.1099/vir.0.81890-0; Mameli G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044991; Mameli G, 2009, J VIROL METHODS, V161, P98, DOI 10.1016/j.jviromet.2009.05.024; Martinelli-Boneschi F, 2012, MULT SCLER J, V18, P1384, DOI 10.1177/1352458512439118; Menard A, 1997, FEBS LETT, V413, P477, DOI 10.1016/S0014-5793(97)00889-2; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Moyes DL, 2008, AIDS RES HUM RETROV, V24, P363, DOI 10.1089/aid.2007.0196; Moyes DL, 2005, GENOMICS, V86, P337, DOI 10.1016/j.ygeno.2005.06.004; Nexo BA, 2016, IMMUNOL RES, V64, P55, DOI 10.1007/s12026-015-8671-z; Nexo BA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016652; Nissen KK, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-188; Nowak J, 2003, J NEUROVIROL, V9, P112, DOI 10.1080/13550280390173355; Perron H, 1997, P NATL ACAD SCI USA, V94, P7583, DOI 10.1073/pnas.94.14.7583; Perron H, 2005, J NEUROVIROL, V11, P23, DOI 10.1080/13550280590901741; Perron H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080128; Perron H, 2012, MULT SCLER J, V18, P1721, DOI 10.1177/1352458512441381; Perron H, 2009, J NEUROL SCI, V286, P65, DOI 10.1016/j.jns.2009.04.034; Pugliatti M, 2001, ACTA NEUROL SCAND, V103, P20, DOI 10.1034/j.1600-0404.2001.00207.x; Rasmussen H B, 1996, Mult Scler, V2, P133; Rasmussen HB, 2000, DIS MARKERS, V16, P101, DOI 10.1155/2000/590914; Rasmussen HB, 1998, DIS MARKERS, V13, P251, DOI 10.1155/1998/952586; Rasmussen HB, 1997, ACTA NEUROL SCAND, V95, P38, DOI 10.1111/j.1600-0404.1997.tb08148.x; Rasmussen HB, 1999, AUTOIMMUNITY, V29, P141, DOI 10.3109/08916939908995384; Rolland A, 2006, J IMMUNOL, V176, P7636, DOI 10.4049/jimmunol.176.12.7636; Schmitt K, 2013, J VIROL, V87, P13837, DOI 10.1128/JVI.02388-13; Serra C, 2001, NEUROL SCI, V22, P171, DOI 10.1007/s100720170019; Sotgiu S, 2002, EUR J NEUROL, V9, P329, DOI 10.1046/j.1468-1331.2002.00412.x; Tai AK, 2008, MULT SCLER J, V14, P1175, DOI 10.1177/1352458508094641; van Horssen J, 2016, MULT SCLER RELAT DIS, V8, P11, DOI 10.1016/j.msard.2016.04.006; Wells GA, 2012, NEWCASTLE OTTAWA SCA, DOI [10.2307/632432, DOI 10.2307/632432]; Wildschutte JH, 2016, P NATL ACAD SCI USA, V113, pE2326, DOI 10.1073/pnas.1602336113; Zawada M, 2003, POL J PHARMACOL, V55, P869	60	62	65	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0172415	10.1371/journal.pone.0172415	http://dx.doi.org/10.1371/journal.pone.0172415			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207850	Green Published, gold			2022-12-27	WOS:000394424500132
J	Saur, T; Morin, E; Habouzit, F; Bernet, N; Escudie, R				Saur, Thibaut; Morin, Emilie; Habouzit, Frederic; Bernet, Nicolas; Escudie, Renaud			Impact of wall shear stress on initial bacterial adhesion in rotating annular reactor	PLOS ONE			English	Article							TURBULENT-FLOW REGIMES; BIOFILM FORMATION; QUANTITATIVE METHOD; MICROBIAL ADHESION; SURFACE-PROPERTIES; CANDIDA-KRUSEI; CO-ADHESION; CELL; CHAMBER; MICROORGANISMS	The objective of this study was to investigate the bacterial adhesion under different wall shear stresses in turbulent flow and using a diverse bacterial consortium. A better understanding of the mechanisms governing microbial adhesion can be useful in diverse domains such as industrial processes, medical fields or environmental biotechnologies. The impact of wall shear stress - four values ranging from 0.09 to 7.3 Pa on polypropylene (PP) and polyvinyl chloride (PVC) - was carried out in rotating annular reactors to evaluate the adhesion in terms of morphological and microbiological structures. A diverse inoculum consisting of activated sludge was used. Epifluorescence microscopy was used to quantitatively and qualitatively characterize the adhesion. Attached bacterial communities were assessed by molecular fingerprinting profiles (CE-SSCP). It has been demonstrated that wall shear stress had a strong impact on both quantitative and qualitative aspects of the bacterial adhesion. ANOVA tests also demonstrated the significant impact of wall shear stress on all three tested morphological parameters (surface coverage, number of objects and size of objects) (p-values < 2.10(-16)). High wall shear stresses increased the quantity of attached bacteria but also altered their spatial distribution on the substratum surface. As the shear increased, aggregates or clusters appeared and their size grew when increasing the shears. Concerning the microbiological composition, the adhered bacterial communities changed gradually with the applied shear.	[Saur, Thibaut; Morin, Emilie; Habouzit, Frederic; Bernet, Nicolas; Escudie, Renaud] INRA, LBE, Narbonne, France	INRAE	Escudie, R (corresponding author), INRA, LBE, Narbonne, France.	renaud.escudie@supagro.inra.fr	BERNET, Nicolas/B-7333-2011	BERNET, Nicolas/0000-0003-2710-3547; Escudie, Renaud/0000-0003-0736-0327	University of Montpellier II	University of Montpellier II	The authors are thankful to the University of Montpellier II and the LBE for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERECK CD, 1986, J FLUID MECH, V164, P155, DOI 10.1017/S0022112086002513; Andrews CS, 2001, BIOMATERIALS, V22, P3225, DOI 10.1016/S0142-9612(01)00160-0; [Anonymous], 2010, R LANG ENV STAT COMP; [Anonymous], 1986, ENCY FLUID MECH; Bakker DP, 2003, APPL ENVIRON MICROB, V69, P6280, DOI 10.1128/AEM.69.10.6280-6287.2003; BOS R, 1994, J MICROBIOL METH, V20, P289, DOI 10.1016/0167-7012(94)90053-1; BOS R, 1995, J MICROBIOL METH, V23, P169, DOI 10.1016/0167-7012(95)00013-B; Busscher HJ, 2006, CLIN MICROBIOL REV, V19, P127, DOI 10.1128/CMR.19.1.127-141.2006; Characklis W. G., 1990, BIOFILMS; FENSTERMACHER PR, 1979, J FLUID MECH, V94, P103, DOI 10.1017/S0022112079000963; Florjanic M, 2011, INT J PHARMACEUT, V405, P16, DOI 10.1016/j.ijpharm.2010.11.038; Habimana O, 2014, J MEMBRANE SCI, V454, P82, DOI 10.1016/j.memsci.2013.11.043; Habouzit F, 2011, BIORESOURCE TECHNOL, V102, P4054, DOI 10.1016/j.biortech.2010.12.023; Brugnoni LI, 2012, J FOOD ENG, V111, P546, DOI 10.1016/j.jfoodeng.2012.03.023; Brugnoni LI, 2011, J FOOD ENG, V102, P266, DOI 10.1016/j.jfoodeng.2010.08.029; Kolenbrander PE, 2010, NAT REV MICROBIOL, V8, P471, DOI 10.1038/nrmicro2381; Lecuyer S, 2011, BIOPHYS J, V100, P341, DOI 10.1016/j.bpj.2010.11.078; Lelievre C, 2002, CHEM ENG SCI, V57, P1287, DOI 10.1016/S0009-2509(02)00019-2; Liu Y, 2002, WATER RES, V36, P1653, DOI 10.1016/S0043-1354(01)00379-7; Meylheuc T, 2006, COLLOID SURFACE B, V52, P128, DOI 10.1016/j.colsurfb.2006.04.016; Michelland RJ, 2009, MOL ECOL RESOUR, V9, P1359, DOI 10.1111/j.1755-0998.2009.02609.x; Milferstedt K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080692; Moreira JMR, 2014, COLLOID SURFACE B, V123, P1, DOI 10.1016/j.colsurfb.2014.08.016; Nicolella C, 2000, J BIOTECHNOL, V80, P1, DOI 10.1016/S0168-1656(00)00229-7; Ochoa JC, 2007, CHEM ENG SCI, V62, P3672, DOI 10.1016/j.ces.2007.03.023; Oksanen J., 2016, R PACKAG; Park A, 2011, BIOCHIP J, V5, P236, DOI 10.1007/s13206-011-5307-9; Perni S, 2006, FOOD CONTROL, V17, P875, DOI 10.1016/j.foodcont.2005.06.002; Racina A, 2006, EXP FLUIDS, V41, P513, DOI 10.1007/s00348-006-0178-x; Rasband W., 2006, IMAGEJ; Rochex A, 2008, WATER RES, V42, P4915, DOI 10.1016/j.watres.2008.09.015; Taylor GI, 1923, PHILOS T R SOC LOND, V223, P289, DOI 10.1098/rsta.1923.0008; Teodosio JS, 2011, BIOFOULING, V27, P1, DOI 10.1080/08927014.2010.535206; Thomas WE, 2002, CELL, V109, P913, DOI 10.1016/S0092-8674(02)00796-1; VANOSS CJ, 1995, COLLOID SURFACE B, V5, P91, DOI 10.1016/0927-7765(95)01217-7; Wang H, 2011, COLLOID SURFACE B, V87, P415, DOI 10.1016/j.colsurfb.2011.05.053; Wery N, 2008, APPL ENVIRON MICROB, V74, P3030, DOI 10.1128/AEM.02760-07; Young KD, 2006, MICROBIOL MOL BIOL R, V70, P660, DOI 10.1128/MMBR.00001-06	38	40	40	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0172113	10.1371/journal.pone.0172113	http://dx.doi.org/10.1371/journal.pone.0172113			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207869	gold, Green Published, Green Submitted			2022-12-27	WOS:000394424500086
J	Stahl, BC; Wakunuma, K; Rainey, S; Hansen, C				Stahl, Bernd Carsten; Wakunuma, Kutoma; Rainey, Stephen; Hansen, Christian			Improving brain computer interface research through user involvement - The transformative potential of integrating civil society organisations in research projects	PLOS ONE			English	Article							SCIENCE; INNOVATION; COMMUNICATION; PERSPECTIVES; NEUROSCIENCE; PRIVACY; MODEL; FIELD; NGOS; BCI	Research on Brain Computer Interfaces (BCI) often aims to provide solutions for vulnerable populations, such as individuals with diseases, conditions or disabilities that keep them from using traditional interfaces. Such research thereby contributes to the public good. This contribution to the public good corresponds to a broader drive of research and funding policy that focuses on promoting beneficial societal impact. One way of achieving this is to engage with the public. In practical terms this can be done by integrating civil society organisations (CSOs) in research. The open question at the heart of this paper is whether and how such CSO integration can transform the research and contribute to the public good. To answer this question the paper describes five detailed qualitative case studies of research projects including CSOs. The paper finds that transformative impact of CSO integration is possible but by no means assured. It provides recommendations on how transformative impact can be promoted.	[Stahl, Bernd Carsten; Wakunuma, Kutoma; Rainey, Stephen; Hansen, Christian] De Montfort Univ, Sch Comp Sci & Informat, Ctr Comp & Social Responsibil, Leicester, Leics, England	De Montfort University	Stahl, BC (corresponding author), De Montfort Univ, Sch Comp Sci & Informat, Ctr Comp & Social Responsibil, Leicester, Leics, England.	bstahl@dmu.ac.uk	Stahl, Bernd Carsten/AAK-4828-2021	Stahl, Bernd Carsten/0000-0002-4058-4456; Rainey, Stephen/0000-0002-5540-6046; Wakunuma, Kutoma/0000-0002-8236-3221	European Community's Seventh Framework Programme (FP7) [288928]	European Community's Seventh Framework Programme (FP7)	The research leading to these results has received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement no 288928.	Allison B, 2010, IEEE T NEUR SYS REH, V18, P107, DOI 10.1109/TNSRE.2009.2039495; [Anonymous], 2005, EUR J DEV RES; [Anonymous], GUID CSO PART RES CO; ARGYRIS C, 1989, AM BEHAV SCI, V32, P612, DOI 10.1177/0002764289032005008; Arnold M., 2003, Information and Organization, V13, P231, DOI 10.1016/S1471-7727(03)00013-7; Arstila V, 2011, TRAMES-J HUMANIT SOC, V15, P204, DOI 10.3176/tr.2011.2.08; Attiah MA, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00086; BBSRC / EPSRC, 2010, SYNTH BIOL DIAL REP; Bernauer T, 2013, GLOBAL ENVIRON CHANG, V23, P439, DOI 10.1016/j.gloenvcha.2013.01.001; Bonaci T, 2014, 2014 IEEE INTERNATIONAL SYMPOSIUM ON ETHICS IN SCIENCE, TECHNOLOGY AND ENGINEERING; Braun M, 2015, PLOS ONE, V10; Burt RS, 2005, BROKERAGE CLOSURE IN; Bush, 1945, SCI THE ENDLESS FRON, DOI DOI 10.1016/j.techsoc.2019.03.007; Butler T, 1998, J INFORM TECHNOL, V13, P285, DOI 10.1057/jit.1998.7; Cada K, 2013, J CLEAN PROD, V49, P25, DOI 10.1016/j.jclepro.2012.07.039; Cahill C, 2007, DES STUD, V28, P325, DOI 10.1016/j.destud.2007.02.006; Charmaz K, 2007, SAGE HDB GROUNDED TH, DOI DOI 10.4135/9781848607941; Cooke B, 2001, PARTICIPATION NEW TY; Diep L, 2013, EDUC SCI, V3, P30, DOI 10.3390/educsci3010030; Doyle C, 2008, SOC SCI MED, V66, P1928, DOI 10.1016/j.socscimed.2007.12.029; Dudo A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148867; European Commission, HOR 2020 SCI SOC PRO; European Commission, 2012, MON POL RES ACT SCI; European Science Foundation, 2013, SCI SOC CAR OUR FUT; EvoLuTioN M., 2014, OPEN BCI DIY NEUROSC; Farah MJ, 2005, NEUROETHICS PRACTICA, P9; Ferretti MP, 2009, SCI PUBL POLICY, V36, P287, DOI 10.3152/030234209X436527; Fisher CE, 2010, HARVARD REV PSYCHIAT, V18, P230, DOI 10.3109/10673229.2010.496623; Frediani A. A., 2012, CAPABILITY APPROACH, P203, DOI [DOI 10.1007/978-94-007-3879-9_12, 10.1007/978-94-007-3879-9_12]; Gall E, 2011, STACS HDB CSOS; GARUD R, 1994, ORGAN SCI, V5, P344, DOI 10.1287/orsc.5.3.344; GIBBONS M., 1994, NEW PRODUCTION KNOWL; Godin B, 2006, SCI TECHNOL HUM VAL, V31, P639, DOI 10.1177/0162243906291865; Godin Benoit, 2009, MAKING SCI TECHNOLOG; Gomez-Jauregui J, 2004, REPROD HEALTH MATTER, V12, P42, DOI 10.1016/S0968-8080(04)24146-5; Ienca M, 2016, ETHICS INF TECHNOL, V18, P117, DOI 10.1007/s10676-016-9398-9; Iuculano T, 2013, J NEUROSCI, V33, P4482, DOI 10.1523/JNEUROSCI.4927-12.2013; Jasanoff S, 2011, SCI ENG ETHICS, V17, P621, DOI 10.1007/s11948-011-9302-2; Johnson M. A., 2012, P 8 S US PRIV SEC SO, P1, DOI DOI 10.1145/2335356.2335369; Joss S., 2002, PARTICIPATORY TECHNO; Joss S., 1999, SCI PUBL POLICY, V26, P290, DOI [DOI 10.3152/147154399781782338, 10.3152/147154399781782338]; Klein E, 2015, INFORM CONSENT IMPLA; Klein HK, 1999, MIS QUART, V23, P67, DOI 10.2307/249410; KLINE SJ, 1985, RES MANAGE, V28, P36, DOI 10.1080/00345334.1985.11756910; KYNG M, 1991, COMMUN ACM, V34, P64, DOI 10.1145/125319.125323; Lebedev MA, 2006, TRENDS NEUROSCI, P29; Lister S., 2003, DEV POLICY REV, V21, P93, DOI DOI 10.1111/1467-7679.00200; Martin A, 1997, AGR SYST, V55, P195, DOI 10.1016/S0308-521X(97)00007-3; Menuz V, 2013, SCI ENG ETHICS, V19, P161, DOI 10.1007/s11948-011-9294-y; Mercer C, 2013, GEOFORUM, V45, P108, DOI 10.1016/j.geoforum.2012.10.008; Mindtecstore, NEUR NEC EUR; Myers M.D, 2002, QUALITATIVE RES INFO; Myers M. D., 2004, SOCIAL THEORY PHILOS, P103; Nijboer F., 2015, ANN PHYS REHABIL MED, P1; Nijboer F, 2013, NEUROETHICS-NETH, V6, P541, DOI 10.1007/s12152-011-9132-6; Nissenbaum H, 2004, WASH LAW REV, V79, P119; Nowotny H, 2003, MINERVA, V41, P179, DOI 10.1023/A:1025505528250; Nugroho Y, 2011, RES POLICY, V40, P761, DOI 10.1016/j.respol.2011.03.002; O'Connell G, 2011, EMBO REP, V12, P630, DOI 10.1038/embor.2011.115; Oishi Meeko Mitsuko K., 2010, DESIGN USE ASSISTIVE; Phillimore J, 1999, TECHNOVATION, V19, P673, DOI 10.1016/S0166-4972(99)00062-0; Pomey MP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122499; Potestio ML, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143088; Racine E, 2010, SOC SCI MED, V71, P725, DOI 10.1016/j.socscimed.2010.05.017; Randolph A. B., 2012, 2012 45th Hawaii International Conference on System Sciences (HICSS), P572, DOI 10.1109/HICSS.2012.451; Randolph AB, 2011, INT J HUM-COMPUT INT, V27, P24, DOI 10.1080/10447318.2011.535750; Revel M, 2014, MAIN FINDINGS REPORT; Revel M, 2012, FP7 SURVEY REPORT CO; Rodriguez H, 2013, RES POLICY, V42, P1126, DOI 10.1016/j.respol.2013.02.006; Rowe G, 2005, SCI TECHNOL HUM VAL, V30, P251, DOI 10.1177/0162243904271724; Safire W, 2005, ARE YOUR THOUGHTS YO; SALAMON LM, 1994, FOREIGN AFF, V73, P109, DOI 10.2307/20046747; Shen FX, 2013, HARVARD J LAW PUBL P, V36, P653; Smart protein, 2021, EUROPEAN UNIONS HORI; Stahl BC, 2014, EUR J INFORM SYST, V23, P1, DOI 10.1057/ejis.2012.58; Stahl BC, 2013, SCI PUBL POLICY, V40, P708, DOI 10.1093/scipol/sct067; Stelfox HT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140141; Strauss A., 1996, GROUNDED THEORY GRUN; Subhashini R, 2015, PROCEDIA COMPUT SCI, V48, P530, DOI 10.1016/j.procs.2015.04.131; The Engage2020 Consortium, 2014, PUBL ENG METH TOOLS; Todt O, 2004, SAFETY SCI, V42, P143, DOI 10.1016/S0925-7535(03)00022-5; Trimper John B, 2014, Front Neuroeng, V7, P4, DOI 10.3389/fneng.2014.00004; Tsipouri L, 2012, SCI PUBL POLICY, V39, P732, DOI 10.1093/scipol/scs091; van Erp JBF, 2012, COMPUTER, V45, P26, DOI 10.1109/MC.2012.107; van Oudheusden M, 2014, J RESPONSIBLE INNOV, V1, P67, DOI 10.1080/23299460.2014.882097; Varey RJ, 2002, J INF TECHNOL, V17, P229, DOI 10.1080/0268396022000017725; Vaughan TM, 2006, IEEE T NEUR SYS REH, V14, P229, DOI 10.1109/TNSRE.2006.875577; Venthur B., 2010, 2010 IEEE International Conference on Systems, Man and Cybernetics (SMC 2010), P417, DOI 10.1109/ICSMC.2010.5641772; Vlek RJ, 2012, J NEUROL PHYS THER, V36, P94, DOI 10.1097/NPT.0b013e31825064cc; Wahlstrom K, 2013, AICE 2013, P1; WALSHAM G, 1995, EUR J INFORM SYST, V4, P74, DOI 10.1057/ejis.1995.9; Wardlaw JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025829; Wehling P, 2012, POIESIS PRAX INT J T, P1; Wolpaw JR, 2002, CLIN NEUROPHYSIOL, V113, P767, DOI 10.1016/S1388-2457(02)00057-3; Wynne B, 2008, PUBLIC UNDERST SCI, V17, P21, DOI 10.1177/0963662507085162; Zander TO, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00053	97	2	2	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0171818	10.1371/journal.pone.0171818	http://dx.doi.org/10.1371/journal.pone.0171818			38	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL2BG	28207882	Green Published, Green Submitted, gold			2022-12-27	WOS:000394424500055
J	Cao, XL; Wang, SB; Zhong, BL; Zhang, L; Ungvari, GS; Ng, CH; Li, L; Chiu, HFK; Lok, GKI; Lu, JP; Jia, FJ; Xiang, YT				Cao, Xiao-Lan; Wang, Shi-Bin; Zhong, Bao-Liang; Zhang, Ling; Ungvari, Gabor S.; Ng, Chee H.; Li, Lu; Chiu, Helen F. K.; Lok, Grace K. I.; Lu, Jian-Ping; Jia, Fu-Jun; Xiang, Yu-Tao			The prevalence of insomnia in the general population in China: A meta-analysis	PLOS ONE			English	Article							SLEEP LOSS; SCHIZOPHRENIA; EPIDEMIOLOGY; PERFORMANCE; DEPRESSION; SYMPTOMS; EXERCISE; TRIALS; BIAS; CARE	This is the first meta-analysis of the pooled prevalence of insomnia in the general population of China. A systematic literature search was conducted via the following databases: PubMed, PsycINFO, EMBASE and Chinese databases (China National Knowledge Interne (CNKI), WanFang Data and SinoMed). Statistical analyses were performed using the Comprehensive Meta-Analysis program. A total of 17 studies with 115,988 participants met the inclusion criteria for the analysis. The pooled prevalence of insomnia in China was 15.0% (95% Confidence interval [CI]: 12.1%-18.5%). No significant difference was found in the prevalence between genders or across time period. The pooled prevalence of insomnia in population with a mean age of 43.7 years and older (11.6%; 95% CI: 7.5%-17.6%) was significantly lower than in those with a mean age younger than 43.7 years (20.4%; 95% CI: 14.2%-28.2%). The prevalence of insomnia was significantly affected by the type of assessment tools (Q = 14.1, P = 0.001). The general population prevalence of insomnia in China is lower than those reported in Western countries but similar to those in Asian countries. Younger Chinese adults appear to suffer from more insomnia than older adults.	[Cao, Xiao-Lan; Lu, Jian-Ping] Shenzhen Kangning Hosp, Shenzhen Key Lab Psychol Healthcare, Shenzhen, Peoples R China; [Cao, Xiao-Lan; Lu, Jian-Ping] Shenzhen Kangning Hosp, Shenzhen Inst Mental Hlth, Shenzhen, Peoples R China; [Cao, Xiao-Lan; Lu, Jian-Ping] Shenzhen Mental Hlth Ctr, Shenzhen, Peoples R China; [Cao, Xiao-Lan] Shenzhen Univ, Fac Mental Hlth, Shenzhen, Guangdong, Peoples R China; [Wang, Shi-Bin; Li, Lu; Lok, Grace K. I.; Xiang, Yu-Tao] Univ Macau, Fac Hlth Sci, Unit Psychiat, Macau, Macao, Peoples R China; [Zhong, Bao-Liang] Huazhong Univ Sci & Technol, Tongji Med Coll, Affiliated Mental Hlth Ctr, Wuhan, Peoples R China; [Zhang, Ling] Natl Clin Res Ctr Mental Disorders, Beijing, Peoples R China; [Zhang, Ling] Capital Med Univ, Beijing Anding Hosp, Beijing Inst Brain Disorders, Ctr Depress, Beijing, Peoples R China; [Zhang, Ling] Capital Med Univ, Beijing Anding Hosp, Mood Disorders Ctr, Beijing, Peoples R China; [Ungvari, Gabor S.] Univ Notre Dame Australia, Marian Ctr, Perth, WA, Australia; [Ungvari, Gabor S.] Univ Western Australia, Sch Psychiat & Clin Neurosci, Perth, WA, Australia; [Ng, Chee H.] Univ Melbourne, Dept Psychiat, Melbourne, Vic, Australia; [Chiu, Helen F. K.] Chinese Univ Hong Kong, Dept Psychiat, Hong Kong, Hong Kong, Peoples R China; [Lok, Grace K. I.] Kiang Wu Nursing Coll Macau, Macau, Macao, Peoples R China; [Jia, Fu-Jun] Guangdong Gen Hosp, Guangdong Mental Hlth Ctr, Guangzhou, Guangdong, Peoples R China; [Jia, Fu-Jun] Guangdong Acad Med Sci, Guangzhou, Guangdong, Peoples R China	Shenzhen University; University of Macau; Huazhong University of Science & Technology; Capital Medical University; Capital Medical University; University of Notre Dame Australia; University of Western Australia; University of Melbourne; Chinese University of Hong Kong; Kiang Wu Nursing College of Macau; Guangdong Academy of Medical Sciences & Guangdong General Hospital; Guangdong Academy of Medical Sciences & Guangdong General Hospital	Xiang, YT (corresponding author), Univ Macau, Fac Hlth Sci, Unit Psychiat, Macau, Macao, Peoples R China.; Jia, FJ (corresponding author), Guangdong Gen Hosp, Guangdong Mental Hlth Ctr, Guangzhou, Guangdong, Peoples R China.; Jia, FJ (corresponding author), Guangdong Acad Med Sci, Guangzhou, Guangdong, Peoples R China.	jiafujun@126.com; xyutly@gmail.com	Zhong, Baoliang/AEN-1897-2022; Cao, Xiao-Lan/X-4670-2019	Zhong, Baoliang/0000-0002-7229-1519; Ng, Chee/0000-0002-3811-2732	Shenzhen Science and Technology Innovation Committee [JCYJ 20140415092628039, JCYJ 20160429185235132, JCYJ 20160429185854999]	Shenzhen Science and Technology Innovation Committee	The study was supported by the Shenzhen Science and Technology Innovation Committee (JCYJ 20140415092628039; JCYJ 20160429185235132; JCYJ 20160429185854999), http://www.szsti.gov.cn/.; The study was supported by the Shenzhen Science and technology Innovation Committee (JCYJ 20140415092628039; JCYJ 20160429185235132; JCYJ 20160429185854999).	Barendregt JJ, 2013, J EPIDEMIOL COMMUN H, V67, P974, DOI 10.1136/jech-2013-203104; Benca RM, 2001, J CLIN PSYCHIAT, V62, P33; Calem M, 2012, SLEEP, V35, P377, DOI 10.5665/sleep.1700; Chen YL, 2004, STRAIT J PREV MED, V10, P4; Dai FX, 2011, J SHANDONG MED COLL, V33, P266; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Ford ES, 2014, SLEEP, V37, P1283, DOI 10.5665/sleep.3914; Fullagar HHK, 2015, SPORTS MED, V45, P161, DOI 10.1007/s40279-014-0260-0; GREENLAND S, 1989, INT J EPIDEMIOL, V18, P269, DOI 10.1093/ije/18.1.269; [谷岩 Gu Yan], 2015, [中国心理卫生杂志, Chinese Mental Health Journal], V29, P199; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Kronholm E, 2016, J SLEEP RES, V25, P454, DOI 10.1111/jsr.12398; Krystal Andrew D, 2003, Clin Cornerstone, V5, P41; Leger D, 2005, CURR MED RES OPIN, V21, P1785, DOI 10.1185/030079905X65637; Li SX, 2005, PERFORMANCE ASSESSME; Li Y, 2016, DRUG ALCOHOL DEPEN, V162, P146, DOI 10.1016/j.drugalcdep.2016.02.040; Long J, 2014, ACTA PSYCHIAT SCAND, V130, P244, DOI 10.1111/acps.12296; Lu YW, 2003, MED J CHINESE PEOLE, V15, P584; Nowicki Z, 2016, PSYCHIATR POL, V50, P165, DOI 10.12740/PP/58771; Ohayon MM, 2002, SLEEP MED REV, V6, P97, DOI 10.1053/smrv.2002.0186; Ohayon MM, 2003, J PSYCHIAT RES, V37, P9, DOI 10.1016/S0022-3956(02)00052-3; Paulson JF, 2010, JAMA-J AM MED ASSOC, V303, P1961, DOI 10.1001/jama.2010.605; Roth Thomas, 2007, J Clin Sleep Med, V3, pS7; Sanderson S, 2007, INT J EPIDEMIOL, V36, P666, DOI 10.1093/ije/dym018; Scott JPR, 2006, PHYSIOL BEHAV, V87, P396, DOI 10.1016/j.physbeh.2005.11.009; Sivertsen B, 2009, J PSYCHOSOM RES, V67, P109, DOI 10.1016/j.jpsychores.2009.05.001; Staner L, 2010, SLEEP MED REV, V14, P35, DOI 10.1016/j.smrv.2009.09.003; Sterne JAC, 2001, BMJ-BRIT MED J, V323, P101, DOI 10.1136/bmj.323.7304.101; Su KQ, 2008, CHIN MENT HLTH J, V22, P318; Su KQ, 2008, CHIN MENT HLTH J, V22, P302; Sun FY, 2011, SHANXI CHINESE MED, V32, P298; Voelker R, 2004, JAMA-J AM MED ASSOC, V291, P2177, DOI 10.1001/jama.291.18.2177; Wen C, 2010, CHINESE J HLTH ED, V26, P844; Wen C, 2010, CHINESE J HLTH ED, V26, P832; Winsper C, 2013, ACTA PSYCHIAT SCAND, V128, P413, DOI 10.1111/acps.12113; Xiang YT, 2008, SLEEP, V31, P1655, DOI 10.1093/sleep/31.12.1655; Xie ZL, 2010, J CHINESE MED, V25, P131; Xu JC, 2011, SURVEY SLEEP DISORDE; Ye LF, 2014, CHIN J CLIN ELECT ED, V8, P3469; You LN, 2014, CHIN J CLIN ELECT ED, V8, P2051; Zhan YQ, 2014, HEART ASIA, V6, P88, DOI 10.1136/heartasia-2013-010440; Zhang JX, 2008, CHINESE J PSYCHIAT, V41, P161; Zhang JX, 2008, CHINESE J PSYCHIAT, V41, P182; Zhang RZ, 2015, CHIN J NERV DIS, V141, P150; Zheng W, 2016, ACTA PSYCHIAT SCAND, V134, P385, DOI 10.1111/acps.12631; Zhong BL, 2013, SOC PSYCH PSYCH EPID, V48, P1569, DOI 10.1007/s00127-013-0672-4; 刘春生, 2011, [中国中医基础医学杂志, Chinese Journal of Basic Medicine in Traditional Chinese Medicine], V17, P1028	47	165	192	10	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0170772	10.1371/journal.pone.0170772	http://dx.doi.org/10.1371/journal.pone.0170772			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5VB	28234940	Green Submitted, Green Published, gold			2022-12-27	WOS:000394688200013
J	Feldmann, C; Zayat, R; Goetzenich, A; Aljalloud, A; Woelke, E; Maas, J; Tewarie, L; Schmitz-Rode, T; Autschbach, R; Steinseifer, U; Moza, A				Feldmann, Christina; Zayat, Rashad; Goetzenich, Andreas; Aljalloud, Ali; Woelke, Eva; Maas, Judith; Tewarie, Lachmandath; Schmitz-Rode, Thomas; Autschbach, Ruediger; Steinseifer, Ulrich; Moza, Ajay			Perioperative onset of acquired von Willebrand syndrome: Comparison between HVAD, HeartMate II and on-pump coronary bypass surgery	PLOS ONE			English	Article							VENTRICULAR ASSIST DEVICE; CONTINUOUS-FLOW; AORTIC-STENOSIS; ADVERSE EVENTS; DISEASE; TRANSPLANTATION; RISTOCETIN; THERAPY; BRIDGE; CENTRIFUGAL	Objectives Acquired von Willebrand syndrome (AvWS) is associated with postoperative bleeding complications in patients with continuous flow left ventricular assist devices (CF-LVADs). The aim of this study is to analyze the perioperative vWF profile comparing an axial pump (HMII) to a centrifugal pump (HVAD) regarding the correlation between perioperative occurrence of AvWS, early-and late-postoperative bleeding events. Methods From July 2013 until March 2015 blood samples of 33 patients (12 HMII/8 HVAD/13 controls) were prospectively collected at 12 different time points and analyzed for the vWF antigen (vWF: Ag), its activity (vWF: Ac) and the vWF: Ac/vWF: Ag-ratio (vWF: ratio). The follow up period for postoperative bleeding events was from July 2013 until July 2016. Results Postoperatively, there was no difference in the vWF-profile between HVAD and HMII groups. However, a subgroup of patients already had significantly lower vWF: ratios preoperatively. Postoperatively, both CF-LVAD groups presented significantly lower vWF: ratios compared to the control group. Bleeding events per patient-year did not differ between the two groups (HMII vs. HVAD: 0.67 vs. 0.85, p = 0.685). We detected a correlation between vWF: ratio < 0.7at LVAD-start (r = -0.583, p = 0.006) or at the end of surgery (r = -0.461, p = 0.035) and the occurrence of pericardial tamponade. In the control group, the drop in both vWF: Ag and vWF: Ac recovered immediately postoperatively above preoperative values. Conclusion A subgroup of patients with end-stage heart failure already suffers AvWS preoperatively. In both CF-LVAD groups, AvWS begins immediately after surgery. Intraoperative vWF: ratios < 0.7 correlate with higher incidences of pericardial tamponade and re-operation. The presumably dilutive effect of the heart lung machine on vWF vanishes immediately at the end of surgery, possibly as part of an acute-phase response.	[Feldmann, Christina; Woelke, Eva; Maas, Judith; Schmitz-Rode, Thomas; Steinseifer, Ulrich] Rhein Westfal TH Aachen, Inst Appl Med Engn, Helmholtz Inst, Dept Cardiovasc Engn, Aachen, Germany; [Zayat, Rashad; Goetzenich, Andreas; Aljalloud, Ali; Tewarie, Lachmandath; Autschbach, Ruediger; Moza, Ajay] Univ Hosp RWTH Aachen, Dept Thorac & Cardiovasc Surg, Aachen, Germany; [Feldmann, Christina] Hannover Med Sch, Dept Cardiac Thorac Transplantat & Vasc Surg, Hannover, Germany	Helmholtz Association; RWTH Aachen University; RWTH Aachen University; RWTH Aachen University Hospital; Hannover Medical School	Zayat, R (corresponding author), Univ Hosp RWTH Aachen, Dept Thorac & Cardiovasc Surg, Aachen, Germany.	rzayat@ukaachen.de	Zayat, Rashad/K-1543-2019; Zayat, Rashad/U-5505-2019	Schmitz-Rode, Thomas/0000-0002-1181-2165; Zayat, Rashad/0000-0003-2243-8743	German Heart Foundation (Deutsche Herzstiftung) [F/27/15]; German Heart Foundation	German Heart Foundation (Deutsche Herzstiftung); German Heart Foundation	This study was supported by the German Heart Foundation (Deutsche Herzstiftung, Grant ID: F/27/15). AG and CF received the grant from the German Heart Foundation.	Aaronson KD, 2012, CIRCULATION, V125, P3191, DOI 10.1161/CIRCULATIONAHA.111.058412; Baldauf C, 2009, J THROMB HAEMOST, V7, P2096, DOI 10.1111/j.1538-7836.2009.03640.x; Chin BSP, 2003, BLOOD COAGUL FIBRIN, V14, P515, DOI 10.1097/00001721-200309000-00001; Crow S, 2010, ANN THORAC SURG, V90, P1263, DOI 10.1016/j.athoracsur.2010.04.099; Egger C, 2013, ARTIF ORGANS, V37, P833, DOI 10.1111/aor.12116; Federici AB, 2004, BLOOD, V103, P2032, DOI 10.1182/blood-2003-06-2072; Federici AB, 2013, SEMIN THROMB HEMOST, V39, P191, DOI 10.1055/s-0033-1334867; Geisen U, 2008, EUR J CARDIO-THORAC, V33, P679, DOI 10.1016/j.ejcts.2007.12.047; Geisen U, 2014, THROMB RES, V134, P246, DOI 10.1016/j.thromres.2014.04.033; Genovese EA, 2009, ANN THORAC SURG, V88, P1162, DOI 10.1016/j.athoracsur.2009.06.028; Gill JC, 2003, HAEMOPHILIA, V9, P688, DOI 10.1046/j.1351-8216.2003.00816.x; Goda M, 2013, J HEART LUNG TRANSPL, V32, P539, DOI 10.1016/j.healun.2013.02.006; Graf L, 2014, INT J LAB HEMATOL, V36, P341, DOI 10.1111/ijlh.12218; Harvey L, 2014, ANN CARDIOTHORAC SUR, V3, P475, DOI 10.3978/j.issn.2225-319X.2014.08.19; Heilmann C, 2011, EUR J CARDIO-THORAC, V40, P1328, DOI 10.1016/j.ejcts.2011.03.021; HEYDE EC, 1958, NEW ENGL J MED, V259, P196; John R, 2008, ANN THORAC SURG, V86, P1227, DOI 10.1016/j.athoracsur.2008.06.030; Klovaite J, 2009, J AM COLL CARDIOL, V53, P2162, DOI 10.1016/j.jacc.2009.02.048; Lahpor J, 2010, EUR J CARDIO-THORAC, V37, P357, DOI 10.1016/j.ejcts.2009.05.043; Lawrie AS, 2013, HAEMOPHILIA, V19, P338, DOI 10.1111/hae.12064; Lippi G, 2007, CLIN CHIM ACTA, V381, P167, DOI 10.1016/j.cca.2007.03.007; Malehsa D, 2009, EUR J CARDIO-THORAC, V35, P1091, DOI 10.1016/j.ejcts.2009.01.042; MANNUCCI PM, 1977, LANCET, V1, P869; McIlvennan CK, 2014, CIRC-CARDIOVASC QUAL, V7, P13, DOI 10.1161/CIRCOUTCOMES.113.000762; Meyer AL, 2014, JACC-HEART FAIL, V2, P141, DOI 10.1016/j.jchf.2013.10.008; Michiels JJ, 2006, CLIN APPL THROMB-HEM, V12, P397, DOI 10.1177/1076029606293422; Michiels JJ, 2004, BLOOD COAGUL FIBRIN, V15, P323, DOI 10.1097/00001721-200406000-00006; POTTINGER BE, 1989, THROMB RES, V53, P387, DOI 10.1016/0049-3848(89)90317-4; Siedlecki CA, 1996, BLOOD, V88, P2939, DOI 10.1182/blood.V88.8.2939.bloodjournal8882939; Slaughter MS, 2013, J HEART LUNG TRANSPL, V32, P675, DOI 10.1016/j.healun.2013.04.004; Slaughter MS, 2010, J CARDIOVASC TRANSL, V3, P618, DOI 10.1007/s12265-010-9222-6; Slaughter MS, 2009, NEW ENGL J MED, V361, P2241, DOI 10.1056/NEJMoa0909938; Starling RC, 2011, J AM COLL CARDIOL, V57, P1890, DOI 10.1016/j.jacc.2010.10.062; Stulak JM, 2016, J THORAC CARDIOV SUR, V151, P177, DOI 10.1016/j.jtcvs.2015.09.100; Tiede A, 2008, J THROMB HAEMOST, V6, P569, DOI 10.1111/j.1538-7836.2008.02909.x; Tiede A, 2012, THROMB RES, V130, pS2, DOI 10.1016/S0049-3848(13)70003-3; Uriel N, 2010, J AM COLL CARDIOL, V56, P1207, DOI 10.1016/j.jacc.2010.05.016; Vincentelli A, 2003, NEW ENGL J MED, V349, P343, DOI 10.1056/NEJMoa022831; Whincup RH, 2002, EUR HEART J, V23, P1764, DOI 10.1053/euhj.2001.3237	39	8	8	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0171029	10.1371/journal.pone.0171029	http://dx.doi.org/10.1371/journal.pone.0171029			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5VB	28234916	Green Published, Green Submitted, gold			2022-12-27	WOS:000394688200016
J	Hunt, WG; Wiens, JD; Law, PR; Fuller, MR; Hunt, TL; Driscoll, DE; Jackman, RE				Hunt, W. Grainger; Wiens, J. David; Law, Peter R.; Fuller, Mark R.; Hunt, Teresa L.; Driscoll, Daniel E.; Jackman, Ronald E.			Quantifying the demographic cost of human-related mortality to a raptor population	PLOS ONE			English	Article							DENSITY-DEPENDENT FECUNDITY; SPANISH IMPERIAL EAGLE; HABITAT HETEROGENEITY; INCREASING POPULATION; SIZE; SURVIVAL; PERFORMANCE; BEHAVIOR; QUALITY; BIRDS	Raptors are exposed to a wide variety of human-related mortality agents, and yet population- level effects are rarely quantified. Doing so requires modeling vital rates in the context of species life-history, behavior, and population dynamics theory. In this paper, we explore the details of such an analysis by focusing on the demography of a resident, tree-nesting population of golden eagles (Aquila chrysaetos) in the vicinity of an extensive (142 km 2) windfarm in California. During 1994-2000, we tracked the fates of > 250 radio-marked individuals of four life-stages and conducted five annual surveys of territory occupancy and reproduction. Collisions with wind turbines accounted for 41% of 88 uncensored fatalities, most of which were subadults and nonbreeding adults (floaters). A consistent overall male preponderance in the population meant that females were the limiting sex in this territorial, monogamous species. Estimates of potential population growth rate and associated variance indicated a stable breeding population, but one for which any further decrease in vital rates would require immigrant floaters to fill territory vacancies. Occupancy surveys 5 and 13 years later (2005 and 2013) showed that the nesting population remained intact, and no upward trend was apparent in the proportion of subadult eagles as pair members, a condition that would have suggested a deficit of adult replacements. However, the number of golden eagle pairs required to support windfarm mortality was large. We estimated that the entire annual reproductive output of 216-255 breeding pairs would have been necessary to support published estimates of 55-65 turbine blade-strike fatalities per year. Although the vital rates forming the basis for these calculations may have changed since the data were collected, our approach should be useful for gaining a clearer understanding of how anthropogenic mortality affects the health of raptor populations, particularly those species with delayed maturity and naturally low reproductive rates.	[Hunt, W. Grainger] Peregrine Fund, Boise, ID 83709 USA; [Hunt, W. Grainger; Hunt, Teresa L.; Driscoll, Daniel E.; Jackman, Ronald E.] Univ Calif Santa Cruz, Long Marine Lab, Predatory Bird Res Grp, Santa Cruz, CA 95064 USA; [Wiens, J. David] US Geol Survey, Forest & Rangeland Ecosyst Sci Ctr, Corvallis, OR USA; [Law, Peter R.] Nelson Mandela Metropolitan Univ, Ctr African Conservat Ecol, Port Elizabeth, South Africa; [Fuller, Mark R.] US Geol Survey, Forest & Rangeland Ecosyst Sci Ctr, Boise, ID USA; [Hunt, Teresa L.; Jackman, Ronald E.] Garcia & Associates, San Anselmo, CA USA; [Driscoll, Daniel E.] Amer Eagle Res Inst, Apache Junction, AZ USA	University of California System; University of California Santa Cruz; United States Department of the Interior; United States Geological Survey; Nelson Mandela University; United States Department of the Interior; United States Geological Survey	Hunt, WG (corresponding author), Peregrine Fund, Boise, ID 83709 USA.; Hunt, WG (corresponding author), Univ Calif Santa Cruz, Long Marine Lab, Predatory Bird Res Grp, Santa Cruz, CA 95064 USA.	grainger@peregrinefund.org		Law, Peter/0000-0003-3382-0286; Wiens, J. David/0000-0002-2020-038X	National Renewable Energy Laboratory [AT-5-15174-01, XAT-6-16459-01, DE-AC36-98-GO10337]; California Energy Commission [CEC-500-97-4033, CEC -500-2006-056]; Kenetech Windpower, Inc.	National Renewable Energy Laboratory(United States Department of Energy (DOE)); California Energy Commission; Kenetech Windpower, Inc.	The National Renewable Energy Laboratory (http://www.nrel.gov/docs/fy16osti/65688.pdf) Contracts to the University of California, Santa Cruz: AT-5-15174-01, XAT-6-16459-01, and DE-AC36-98-GO10337. The California Energy Commission (http://www.energy.ca.gov/) Contracts to the University of California, Santa Cruz: CEC-500-97-4033 and CEC -500-2006-056. Kenetech Windpower, Inc. (now defunct) funded project startup for several months in 1994. East Bay Regional Park District (http://www.ebparks.org/) funded occasional golden eagle nesting surveys by TLH after 2006. The United States Geological Survey (http://fresc.usgs.gov/) provided stipends (via The Peregrine Fund, Boise Idaho (http://www.peregrnefund.org) to WGH and PRL for data analysis and write-up during 2014-2015. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Garcia and Associates provided support in the form of salaries for authors [TLH, REJ], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.	[Anonymous], 2002, BIRDS N AM; [Anonymous], 2002, P50002043F CAL EN CO; APLIC, 2012, RED AV COLL POW LIN; Barraquand F, 2014, J ANIM ECOL, V83, P375, DOI 10.1111/1365-2656.12140; Bell DA, 2010, SCIENCE, V330, P913, DOI 10.1126/science.330.6006.913-a; BROWN JL, 1969, WILSON BULL, V81, P293; BUNCK CM, 1995, J WILDLIFE MANAGE, V59, P790, DOI 10.2307/3801958; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Carrete M, 2006, OIKOS, V112, P680, DOI 10.1111/j.0030-1299.2006.14528.x; Casado E, 2008, IBIS, V150, P788, DOI 10.1111/j.1474-919X.2008.00862.x; Caswell, 2000, MATRIX POPULATION MO; Craig GR, 2004, J WILDLIFE MANAGE, V68, P1032, DOI 10.2193/0022-541X(2004)068[1032:SRAROP]2.0.CO;2; DHONDT AA, 1992, J ANIM ECOL, V61, P643, DOI 10.2307/5619; Elliott JE, 2011, EMERG TOP ECOTOXICOL, V3, P213, DOI 10.1007/978-0-387-89432-4_7; Fasce P, 2011, IBIS, V153, P581, DOI 10.1111/j.1474-919X.2011.01125.x; Fernandez-Bellon D, 2016, ECOLOGY, V97, P406, DOI 10.1890/15-0357.1; Ferrer M, 2003, BIOL CONSERV, V114, P463, DOI 10.1016/S0006-3207(03)00085-5; Ferrer M, 1996, ECOLOGY, V77, P69, DOI 10.2307/2265655; Ferrer M, 2015, IBIS, V157, P849, DOI 10.1111/ibi.12289; Ferrer M, 2014, J APPL ECOL, V51, P1255, DOI 10.1111/1365-2664.12308; Gaillard JM, 2010, PHILOS T R SOC B, V365, P2255, DOI 10.1098/rstb.2010.0085; Guil F, 2015, GLOB ECOL CONSERV, V3, P379, DOI 10.1016/j.gecco.2015.01.005; Hager SB, 2009, J RAPTOR RES, V43, P210, DOI 10.3356/JRR-08-63.1; Haig SM, 2014, CONDOR, V116, P408, DOI 10.1650/CONDOR-14-36.1; Haller Heinrich, 1996, Ornithologische Beobachter Beiheft, V9, P1; Hunt W. G., 1999, SR50026092 NAT REN E; Hunt W.G., 2006, CEC5002006056; Hunt WG, 2015, IBIS, V157, P888, DOI 10.1111/ibi.12283; Hunt WG, 1998, OIKOS, V82, P191, DOI 10.2307/3546929; Hunt WG, 2000, ECOLOGY, V81, P1162, DOI 10.2307/177189; ICF International, 2015, 0090408 ICF INT; Kokko H, 1998, AM NAT, V152, P354, DOI 10.1086/286174; Lehman RN, 2007, BIOL CONSERV, V136, P159, DOI 10.1016/j.biocon.2006.09.015; Lopez-Sepulcre A, 2005, AM NAT, V166, P317, DOI 10.1086/432560; Loss SR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101565; Loss SR, 2013, BIOL CONSERV, V168, P201, DOI 10.1016/j.biocon.2013.10.007; Lutmerding JA, 2012, J RAPTOR RES, V46, P17, DOI 10.3356/JRR-11-LUTM.1; Madry MM, 2015, ENVIRON RES LETT, V10, DOI 10.1088/1748-9326/10/3/034003; Marques AT, 2014, BIOL CONSERV, V179, P40, DOI 10.1016/j.biocon.2014.08.017; Moffat C. B., 1903, Irish Naturalist, Vxii, P152; NEWTON I, 1991, IBIS, V133, P76, DOI 10.1111/j.1474-919X.1991.tb07671.x; Newton I., 1998, POPULATION LIMITATIO; Orloff S, 1992, CEC3001992001; Pokras Mark A., 2009, P7; POLLOCK KH, 1989, J WILDLIFE MANAGE, V53, P7, DOI 10.2307/3801296; Powell LA, 2007, CONDOR, V109, P949, DOI 10.1650/0010-5422(2007)109[949:AVODPU]2.0.CO;2; PULLIAM HR, 1988, AM NAT, V132, P652, DOI 10.1086/284880; PULLIAM HR, 1991, AM NAT, V137, pS50, DOI 10.1086/285139; Rattner BA, 2014, ENVIRON SCI TECHNOL, V48, P8433, DOI 10.1021/es501740n; Rodenhouse NL, 1997, ECOLOGY, V78, P2025, DOI 10.2307/2265942; Rutz C, 2006, P ROY SOC B-BIOL SCI, V273, P2069, DOI 10.1098/rspb.2006.3507; Sergio F, 2003, J ANIM ECOL, V72, P857, DOI 10.1046/j.1365-2656.2003.00758.x; Sergio F, 2007, BEHAV ECOL, V18, P811, DOI 10.1093/beheco/arm052; Sillett TS, 2004, ECOLOGY, V85, P2467, DOI 10.1890/03-0272; Smallwood KS, 2008, J WILDLIFE MANAGE, V72, P215, DOI 10.2193/2007-032; Smallwood KS, 2009, J WILDLIFE MANAGE, V73, P1062, DOI 10.2193/2008-464; Steenhof K., 1987, National Wildlife Federation Scientific and Technical Series, P157; Steifetten O, 2006, BIOL CONSERV, V132, P88, DOI 10.1016/j.biocon.2006.03.016; Tsai K, 1999, J WILDLIFE MANAGE, V63, P1369, DOI 10.2307/3802856; U. S. Fish and Wildlife Service/, 2016, BALD GOLDEN EAGLES P; Virani MZ, 2011, BIOL CONSERV, V144, P746, DOI 10.1016/j.biocon.2010.10.024; Warkentin IG, 2016, IBIS, V158, P656, DOI 10.1111/ibi.12369; Watson J., 2010, GOLDEN EAGLE, V2; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; Wiens JD, 2015, 20151039 US GEOL SUR; Williams AP, 2015, GEOPHYS RES LETT, V42, P6819, DOI 10.1002/2015GL064924; Zabala J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090254	67	23	24	3	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0172232	10.1371/journal.pone.0172232	http://dx.doi.org/10.1371/journal.pone.0172232			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5VB	28234926	Green Published, Green Submitted, gold			2022-12-27	WOS:000394688200056
J	Perez-Sanchez, A; Borras-Linares, I; Barrajon-Catalan, E; Arraez-Roman, D; Gonzalez-Alvarez, I; Ibanez, E; Segura-Carretero, A; Bermejo, M; Micol, V				Perez-Sanchez, Almudena; Borras-Linares, Isabel; Barrajon-Catalan, Enrique; Arraez-Roman, David; Gonzalez-Alvarez, Isabel; Ibanez, Elena; Segura-Carretero, Antonio; Bermejo, Marival; Micol, Vicente			Evaluation of the intestinal permeability of rosemary (Rosmarinus officinalis L.) extract polyphenols and terpenoids in Caco-2 cell monolayers	PLOS ONE			English	Article							PHOSPHOLIPID MODEL MEMBRANES; DRUG-DELIVERY SYSTEMS; CANCER-CELLS; ANTIOXIDANT PROPERTIES; BIOAVAILABILITY; TRANSPORT; CLASSIFICATION; ABSORPTION; FLAVONOIDS; CARNOSOL	Rosemary (Rosmarinus officinalis) is grown throughout the world and is widely used as a medicinal herb and to season and preserve food. Rosemary polyphenols and terpenoids have attracted great interest due to their potential health benefits. However, complete information regarding their absorption and bioavailability in Caco-2 cell model is scarce. The permeation properties of the bioactive compounds (flavonoids, diterpenes, triterpenes and phenylpropanoids) of a rosemary extract (RE), obtained by supercritical fluid extraction, was studied in Caco-2 cell monolayer model, both in a free form or liposomed. Compounds were identified and quantitated by liquid chromatography coupled to quadrupole time-of-flight with electrospray ionization mass spectrometry analysis (HPLC-ESI-QTOF-MS), and the apparent permeability values (P-app) were determined, for the first time in the extract, for 24 compounds in both directions across cell monolayer. For some compounds, such as triterpenoids and some flavonoids, P-app values found were reported for the first time in Caco-2 cells. Our results indicate that most compounds are scarcely absorbed, and passive diffusion is suggested to be the primary mechanism of absorption. The use of liposomes to vehiculize the extract resulted in reduced permeability for most compounds. Finally, the biopharmaceutical classification (BCS) of all the compounds was achieved according to their permeability and solubility data for bioequivalence purposes. BCS study reveal that most of the RE compounds could be classified as classes III and IV (low permeability); therefore, RE itself should also be classified into this category.	[Perez-Sanchez, Almudena; Barrajon-Catalan, Enrique; Micol, Vicente] Miguel Hernandez Univ, Inst Mol & Cell Biol, Avda Univ S-N, Elche, Spain; [Borras-Linares, Isabel; Arraez-Roman, David; Segura-Carretero, Antonio] Univ Granada, Fac Sci, Dept Analyt Chem, Avda Fuentenueva S-N, Granada, Spain; [Borras-Linares, Isabel; Arraez-Roman, David; Segura-Carretero, Antonio] Res & Dev Funct Food Ctr CIDAF, Hlth Sci Technol Pk,Avda Conocimiento 37, Armilla, Spain; [Barrajon-Catalan, Enrique; Gonzalez-Alvarez, Isabel; Bermejo, Marival] Univ Miguel Hernandez, Dept Engn, Pharmacokinet & Pharmaceut Technol Area, Alicante, Spain; [Barrajon-Catalan, Enrique] INVTROTECNIA SL, Santiago Grisolia 2, Madrid, Spain; [Ibanez, Elena] CSIC UAM, Inst Food Sci Res CIAL, Lab Food, Nicolas Cabrera 9,Campus Cantoblanco, Madrid, Spain; [Micol, Vicente] Inst Salud Carlos III, CIBER, CIBERobn, Fisiopatol Obesidad & Nutr, Madrid, Spain	Universidad Miguel Hernandez de Elche; University of Granada; Universidad Miguel Hernandez de Elche; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UAM - Instituto de Investigacion en Ciencias de la Alimentacion (CIAL); CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III	Micol, V (corresponding author), Miguel Hernandez Univ, Inst Mol & Cell Biol, Avda Univ S-N, Elche, Spain.; Micol, V (corresponding author), Inst Salud Carlos III, CIBER, CIBERobn, Fisiopatol Obesidad & Nutr, Madrid, Spain.	vmicol@umh.es	Gonzalez-Alvarez, Isabel/AAD-5896-2019; Carretero, Antonio Segura/B-6867-2014; Bermejo, Marival/A-4163-2009; Barrajón-Catalán, Enrique/C-2884-2013; Borrás, Isabel/K-9154-2014; Arraez-Roman, David/M-8256-2014; GONZALEZ-ALVAREZ, ISABEL/N-3614-2013; Micol, Vicente/K-6841-2014; Ibanez, Elena/AAJ-2177-2020	Gonzalez-Alvarez, Isabel/0000-0002-1685-142X; Carretero, Antonio Segura/0000-0002-5564-5338; Bermejo, Marival/0000-0001-5022-0544; Barrajón-Catalán, Enrique/0000-0001-8113-0795; Borrás, Isabel/0000-0002-5227-9002; Arraez-Roman, David/0000-0003-1267-6676; GONZALEZ-ALVAREZ, ISABEL/0000-0002-1685-142X; Ibanez, Elena/0000-0003-2127-8303; Micol, Vicente/0000-0001-8089-0696	Spanish Ministry of Science and Innovation [AGL2011-29857-C03-02, AGL2011-29857-C03-03, AGL2015-67995-C3-1-R, AGL2015-67995-C3-2-R, AP2007-03246]; Spanish Ministry of Economy and Competitiveness (MINECO) [PTQ-13-06429, PTQ-14-07243]; Andalusian Regional Government Council of Innovation and Science [P11-CTS-7625]; Generalitat Valenciana [PROMETEO/2016/006, ACOMP/2013/093, ACIF/2013/064]; CIBER [CB12/03/30038]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Spanish Ministry of Economy and Competitiveness (MINECO)(Spanish Government); Andalusian Regional Government Council of Innovation and Science; Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); CIBER	This work was supported by projects AGL2011-29857-C03-02, AGL2011-29857-C03-03, AGL2015-67995-C3-1-R, and AGL2015-67995-C3-2-R, and FPU grant (AP2007-03246) from Spanish Ministry of Science and Innovation; Torres Quevedo grants PTQ-13-06429 and PTQ-14-07243 from the Spanish Ministry of Economy and Competitiveness (MINECO); grant P11-CTS-7625 from Andalusian Regional Government Council of Innovation and Science; PROMETEO/2016/006, ACOMP/2013/093 and ACIF/2013/064 from Generalitat Valenciana; CIBER (CB12/03/30038, Fisiopatologia de la Obesidad y la Nutricion, CIBERobn, Instituto de Salud Carlos III). The authors are also thankful to ChemAxon for providing a free academic license of Marvin for structure handling and other toolkits. The funder Invitrotecnia S. L. provided support in the form of salaries for author EBC.; This work was supported by projects AGL2011-29857-C03-02, AGL2011-29857-C03-03, AGL2015-67995-C3-1-R, and AGL2015-67995-C3-2-R, and FPU grant (AP2007-03246) from Spanish Ministry of Science and Innovation; Torres Quevedo grants PTQ-13-06429 and PTQ-14-07243 from the Spanish Ministry of Economy and Competitiveness (MINECO); grant P11-CTS-7625 from Andalusian Regional Government Council of Innovation and Science; PROMETEO/2016/006, ACOMP/2013/093 and ACIF/2013/064 from Generalitat Valenciana; CIBER (CB12/03/30038, Fisiopatologia de la Obesidad y la Nutricion, CIBERobn, Instituto de Salud Carlos III). The authors are also thankful to ChemAxon for providing a free academic license of Marvin for structure handling and other toolkits.	Altinier G, 2007, J AGR FOOD CHEM, V55, P1718, DOI 10.1021/jf062610+; Alves DS, 2004, BIOCHEM PHARMACOL, V68, P549, DOI 10.1016/j.bcp.2004.04.012; Ambrosini MV, 1997, PHYSIOL BEHAV, V62, P773, DOI 10.1016/S0031-9384(97)00196-0; AMIDON GL, 1995, PHARMACEUT RES, V12, P413, DOI 10.1023/A:1016212804288; Anabousi S, 2006, EUR J PHARM SCI, V29, P367, DOI 10.1016/j.ejps.2006.07.004; Anilkumar APP, 2008, ACTA NEUROPSYCHIATR, V20, P129, DOI 10.1111/j.1601-5215.2008.00280.x; Arranz E, 2015, J FUNCT FOODS, V13, P384, DOI 10.1016/j.jff.2015.01.015; ARTURSSON P, 1991, BIOCHEM BIOPH RES CO, V175, P880, DOI 10.1016/0006-291X(91)91647-U; Artursson P, 2001, ADV DRUG DELIVER REV, V46, P27, DOI 10.1016/S0169-409X(00)00128-9; ARTURSSON P, 1990, J PHARM SCI-US, V79, P476, DOI 10.1002/jps.2600790604; Bakirel T, 2008, J ETHNOPHARMACOL, V116, P64, DOI 10.1016/j.jep.2007.10.039; Barrajon-Catalan E., 2016, CURCUMIN CLIN USES H, P99; Barrajon-Catalan E, 2010, CANCER LETT, V290, P192, DOI 10.1016/j.canlet.2009.09.010; Benet LZ, 2013, J PHARM SCI-US, V102, P34, DOI 10.1002/jps.23359; Borras-Linares I, 2015, INT J MOL SCI, V16, P18396, DOI 10.3390/ijms160818396; Borras-Linares I, 2015, FOOD CHEM TOXICOL, V80, P215, DOI 10.1016/j.fct.2015.03.013; Bozin B, 2007, J AGR FOOD CHEM, V55, P7879, DOI 10.1021/jf0715323; Catania A, 2013, BREAST CANCER RES TR, V141, P55, DOI 10.1007/s10549-013-2667-y; Caturla N, 2003, FREE RADICAL BIO MED, V34, P648, DOI 10.1016/S0891-5849(02)01366-7; Cristina SR, 2010, J AGR FOOD CHEM, V58, P1144, DOI [10.1021/jf9028087q, DOI 10.1021/JF9028087Q]; D'Antuono I, 2015, FOOD FUNCT, V6, P1268, DOI [10.1039/c5fo00137d, 10.1039/C5FO00137D]; Del Campo J, 2000, J FOOD PROTECT, V63, P1359, DOI 10.4315/0362-028X-63.10.1359; Doolaege EHA, 2011, PLANT FOOD HUM NUTR, V66, P196, DOI 10.1007/s11130-011-0233-5; Dorrie J, 2001, CANCER LETT, V170, P33, DOI 10.1016/S0304-3835(01)00549-3; Fale PL, 2013, FOOD FUNCT, V4, P426, DOI 10.1039/c2fo30318c; Funes L, 2010, CHEM PHYS LIPIDS, V163, P190, DOI 10.1016/j.chemphyslip.2009.11.004; Herrero M, 2010, J CHROMATOGR A, V1217, P2512, DOI 10.1016/j.chroma.2009.11.032; Huang SC, 2005, BIOCHEM PHARMACOL, V69, P221, DOI 10.1016/j.bcp.2004.09.019; Kasim NA, 2004, MOL PHARMACEUT, V1, P85, DOI 10.1021/mp034006h; Kaur H, 2014, J PHARMACEUTICS, V2014, DOI 10.1155/2014/180845; Lian T, 2001, J PHARM SCI-US, V90, P667, DOI 10.1002/jps.1023; Lin HX, 2007, INT J PHARMACEUT, V330, P23, DOI 10.1016/j.ijpharm.2006.08.043; Lo AH, 2002, CARCINOGENESIS, V23, P983, DOI 10.1093/carcin/23.6.983; Mukkavilli R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108386; Perez-Fons L, 2006, ARCH BIOCHEM BIOPHYS, V453, P224, DOI 10.1016/j.abb.2006.07.004; Perez-Fons L, 2010, J AGR FOOD CHEM, V58, P161, DOI 10.1021/jf9026487; Qiang ZY, 2011, J ETHNOPHARMACOL, V137, P1107, DOI 10.1016/j.jep.2011.07.037; Vaquero MR, 2013, MOL NUTR FOOD RES, V57, P1834, DOI 10.1002/mnfr.201300052; Seiquer I, 2015, FOOD CHEM, V188, P496, DOI 10.1016/j.foodchem.2015.05.006; Serra H, 2008, BIOORGAN MED CHEM, V16, P4009, DOI 10.1016/j.bmc.2008.01.028; Sharma A, 1997, INT J PHARM, V154, P123, DOI 10.1016/S0378-5173(97)00135-X; Sotelo-Felix JI, 2002, J ETHNOPHARMACOL, V81, P145, DOI 10.1016/S0378-8741(02)00090-9; Takagi T, 2006, MOL PHARMACEUT, V3, P631, DOI 10.1021/mp0600182; Tarko Tomasz, 2013, Rocz Panstw Zakl Hig, V64, P79; Tian XJ, 2009, INT J PHARMACEUT, V367, P58, DOI 10.1016/j.ijpharm.2008.09.023; Tsai TH, 2013, J MED FOOD, V16, P324, DOI 10.1089/jmf.2012.2577; Valdes A, 2014, ANAL CHEM, V86, P9807, DOI 10.1021/ac502401j; Valdes A, 2013, GENES NUTR, V8, P43, DOI 10.1007/s12263-012-0311-9; van Breemen Richard B, 2005, Expert Opin Drug Metab Toxicol, V1, P175, DOI 10.1517/17425255.1.2.175; Wang Y, 2011, BIOPHARM DRUG DISPOS, V32, P16, DOI 10.1002/bdd.735; Yang YY, 2014, TOXICOL IN VITRO, V28, P388, DOI 10.1016/j.tiv.2013.12.002; Yue-Chun L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039394	52	29	32	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0172063	10.1371/journal.pone.0172063	http://dx.doi.org/10.1371/journal.pone.0172063			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5VB	28234919	Green Published, Green Submitted, gold			2022-12-27	WOS:000394688200044
J	Buzatto, GP; Tamashiro, E; Proenca-Modena, JL; Saturno, TH; Prates, MC; Gagliardi, TB; Carenzi, LR; Massuda, ET; Hyppolito, MA; Valera, FCP; Arruda, E; Anselmo-Lima, WT				Buzatto, G. P.; Tamashiro, E.; Proenca-Modena, J. L.; Saturno, T. H.; Prates, M. C.; Gagliardi, T. B.; Carenzi, L. R.; Massuda, E. T.; Hyppolito, M. A.; Valera, F. C. P.; Arruda, E.; Anselmo-Lima, W. T.			The pathogens profile in children with otitis media with effusion and adenoid hypertrophy	PLOS ONE			English	Article							CLINICAL-PRACTICE GUIDELINE; MIDDLE-EAR MUCOSA; MORAXELLA-CATARRHALIS; RESPIRATORY VIRUSES; BACTERIAL PATHOGENS; CHRONIC TONSILLITIS; CORONAVIRUS; INFECTIONS; MANAGEMENT; EPITHELIUM	Objectives To evaluate the presence of viruses and bacteria in middle ear and adenoids of patients with and without otitis media with effusion (OME). Methods Adenoid samples and middle ear washes (MEW) were obtained from children with OME associated with adenoid hypertrophy undergoing adenoidectomy and tympanostomy, and compared to those obtained from patients undergoing cochlear implant surgery, as a control group. Specific DNA or RNA of 9 respiratory viruses (rhinovirus, influenza virus, picornavirus, syncytial respiratory virus, metapneumovirus, coronavirus, enterovirus, adenovirus and bocavirus) and 5 bacteria (S. pneumoniae, H. influenzae, M. catarrhalis, P. aeruginosa and S. aureus) were extracted and quantified by real-time PCR. Results 37 OME and 14 cochlear implant children were included in the study. At the adenoid, virus and bacteria were similarly detected in both OME and control patients. At the middle ear washes, however, a higher prevalence of bacteria was observed in patients with OME (p = 0.01). S. pneumoniae (p = 0.01) and M. catarrhalis (p = 0.022) were the bacteria responsible for this difference. Although total virus detection was not statistically different from controls at the middle ear washes (p = 0.065), adenovirus was detected in higher proportions in adenoid samples of OME patients than controls (p = 0.019). Conclusions Despite both OME and control patients presented similar rates of viruses and bacteria at the adenoid, children with OME presented higher prevalence of S. pneumonia, M. catarrhalis in middle ear and adenovirus in adenoids when compared to controls. These findings could suggest that these pathogens could contribute to the fluid persistence in the middle ear.	[Buzatto, G. P.; Tamashiro, E.; Carenzi, L. R.; Massuda, E. T.; Hyppolito, M. A.; Valera, F. C. P.; Anselmo-Lima, W. T.] Univ Sao Paulo, Dept Ophthalmol Otorhinolaryngol & Head & Neck Su, Ribeirao Preto Sch Med, Ribeirao Preto, SP, Brazil; [Proenca-Modena, J. L.] Univ Estadual Campinas, Dept Genet Evolut & Bioagents, Inst Biol, UNICAMP, Campinas, SP, Brazil; [Saturno, T. H.; Prates, M. C.; Gagliardi, T. B.; Arruda, E.] Univ Sao Paulo, Dept Mol & Cell Biol, Ribeirao Preto Sch Med, Ribeirao Preto, SP, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Estadual de Campinas; Universidade de Sao Paulo	Anselmo-Lima, WT (corresponding author), Univ Sao Paulo, Dept Ophthalmol Otorhinolaryngol & Head & Neck Su, Ribeirao Preto Sch Med, Ribeirao Preto, SP, Brazil.	wtalima@fmrp.usp.br	Proenca-Modena, Jose Luiz/C-8231-2014; Tamashiro, Edwin/C-5062-2012; Massuda, Eduardo T/K-5248-2014; Hyppolito, Miguel A/H-5299-2012; Valera, Fabiana Cardoso Pereira/D-3787-2012; Gagliardi, Talita/V-1342-2019	Proenca-Modena, Jose Luiz/0000-0002-4996-3153; Tamashiro, Edwin/0000-0002-3153-6292; Massuda, Eduardo T/0000-0003-3441-5709; Hyppolito, Miguel A/0000-0001-9688-782X; Valera, Fabiana Cardoso Pereira/0000-0002-6605-5317; Gagliardi, Talita/0000-0003-4953-7135	FAPESP-Fundac Eaode Amparo a Pesquisado Estadode Sao Paulo	FAPESP-Fundac Eaode Amparo a Pesquisado Estadode Sao Paulo	This work was supported by the FAPESP-Fundac Eaode Amparo a Pesquisado Estadode Sao Paulo. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKERLUND A, 1993, ACTA OTO-LARYNGOL, V113, P642, DOI 10.3109/00016489309135878; ALHO OP, 1995, ARCH OTOLARYNGOL, V121, P432; Anderson BD, 2012, J CLIN VIROL, V54, P265, DOI 10.1016/j.jcv.2012.03.006; Avadhanula V, 2006, J VIROL, V80, P1629, DOI 10.1128/JVI.80.4.1629-1636.2006; Bhargava R, 2014, J LARYNGOL OTOL, V128, P1060, DOI 10.1017/S0022215114002503; CARRIE S, 1992, ACTA OTO-LARYNGOL, V112, P504, DOI 10.3109/00016489209137432; Cengel S, 2006, INT J PEDIATR OTORHI, V70, P639, DOI 10.1016/j.ijporl.2005.08.013; CHOMCZYNSKI P, 1993, BIOTECHNIQUES, V15, P532; Emaneini M, 2013, INT J PEDIATR OTORHI, V77, P1841, DOI 10.1016/j.ijporl.2013.08.024; Fliegauf M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059925; Hall-Stoodley L, 2006, JAMA-J AM MED ASSOC, V296, P202, DOI 10.1001/jama.296.2.202; Huang HD, 2013, RENAL FAILURE, V35, P1334, DOI 10.3109/0886022X.2013.829403; Jartti T, 2014, ALLERGY, V69, P658, DOI 10.1111/all.12396; Jourdain S, 2011, CLIN MICROBIOL INFEC, V17, P907, DOI 10.1111/j.1469-0691.2010.03410.x; Koopman L, 2008, ARCH OTOLARYNGOL, V134, P128, DOI 10.1001/archoto.2007.3; Liu CM, 2011, ARCH OTOLARYNGOL, V137, P664, DOI 10.1001/archoto.2011.116; Marchisio P, 2003, PEDIATR INFECT DIS J, V22, P262, DOI 10.1097/00006454-200303000-00012; Marseglia GL, 2008, OTOLARYNG HEAD NECK, V138, P572, DOI 10.1016/j.otohns.2008.01.020; Ministerio da Saude, DEP VIG DOENC TRANSM; Monasta L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036226; Moyse E, 2000, ARCH OTOLARYNGOL, V126, P1105, DOI 10.1001/archotol.126.9.1105; Murphy TF, 2009, CLIN INFECT DIS, V49, P124, DOI 10.1086/599375; Nistico L, 2011, J CLIN MICROBIOL, V49, P1411, DOI 10.1128/JCM.00756-10; Parikh SR, 2006, OTOLARYNG HEAD NECK, V135, P684, DOI 10.1016/j.otohns.2006.05.003; Pitkaranta A, 1998, J PEDIATR-US, V133, P390, DOI 10.1016/S0022-3476(98)70276-8; POST JC, 1995, JAMA-J AM MED ASSOC, V273, P1598, DOI 10.1001/jama.273.20.1598; Proenca-Modena JL, 2014, INT J PEDIATR OTORHI, V78, P1655, DOI 10.1016/j.ijporl.2014.07.015; Proenca-Modena JL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042136; Robb PJ, 2007, PEDIAT ENT, P413; Robinson CM, 2014, ANNU REV VIROL, V1, P55, DOI 10.1146/annurev-virology-031413-085550; Rosenfeld RM, 2016, OTOLARYNG HEAD NECK, V154, pS1, DOI 10.1177/0194599815623467; Rosenfeld RM, 2004, OTOLARYNG HEAD NECK, V130, pS95, DOI 10.1016/j.otohns.2004.02.002; Rosenfeld RM, 2003, LARYNGOSCOPE, V113, P1645, DOI 10.1097/00005537-200310000-00004; Rovers MM, 2004, LANCET, V363, P465, DOI 10.1016/S0140-6736(04)15495-0; Saafan ME, 2013, EUR ARCH OTO-RHINO-L, V270, P2417, DOI 10.1007/s00405-012-2259-1; SADE J, 1970, ACTA OTO-LARYNGOL, V70, P351, DOI 10.3109/00016487009181896; Saylam G, 2010, ARCH OTOLARYNGOL, V136, P550, DOI 10.1001/archoto.2010.70; Siegel SJ, 2014, CELL HOST MICROBE, V16, P55, DOI 10.1016/j.chom.2014.06.005; Vareille M, 2011, CLIN MICROBIOL REV, V24, P210, DOI 10.1128/CMR.00014-10; Verduin CM, 2002, CLIN MICROBIOL REV, V15, P125, DOI 10.1128/CMR.15.1.125-144.2002; Wang DY, 1997, CLIN OTOLARYNGOL, V22, P172, DOI 10.1046/j.1365-2273.1997.00002.x; Wang MC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101175; Wood GM, 1996, CLIN INFECT DIS, V22, P632, DOI 10.1093/clinids/22.4.632; Wright ED, 1998, INT J PEDIATR OTORHI, V45, P207, DOI 10.1016/S0165-5876(98)00113-X; Zuniga EI, 2015, ANNU REV VIROL, V2, P573, DOI 10.1146/annurev-virology-100114-055226	45	45	53	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2017	12	2							e0171049	10.1371/journal.pone.0171049	http://dx.doi.org/10.1371/journal.pone.0171049			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5SX	28231295	Green Published, gold, Green Submitted			2022-12-27	WOS:000394682400007
J	Palermo, E; Laut, J; Nov, O; Cappa, P; Porfiri, M				Palermo, Eduardo; Laut, Jeffrey; Nov, Oded; Cappa, Paolo; Porfiri, Maurizio			A natural user interface to integrate citizen science and physical exercise	PLOS ONE			English	Article							ROBOT-ASSISTED THERAPY; STROKE REHABILITATION; ECOLOGICAL RESEARCH; KINECT APPLICATIONS; MOTOR RECOVERY; ARM; SYSTEM; MOTION; SENSOR; TOOL	Citizen science enables volunteers to contribute to scientific projects, where massive data collection and analysis are often required. Volunteers participate in citizen science activities online from their homes or in the field and are motivated by both intrinsic and extrinsic factors. Here, we investigated the possibility of integrating citizen science tasks within physical exercises envisaged as part of a potential rehabilitation therapy session. The citizen science activity entailed environmental mapping of a polluted body of water using a miniature instrumented boat, which was remotely controlled by the participants through their physical gesture tracked by a low-cost markerless motion capture system. Our findings demonstrate that the natural user interface offers an engaging and effective means for performing environmental monitoring tasks. At the same time, the citizen science activity increases the commitment of the participants, leading to a better motion performance, quantified through an array of objective indices. The study constitutes a first and necessary step toward rehabilitative treatments of the upper limb through citizen science and low-cost markerless optical systems.	[Palermo, Eduardo; Laut, Jeffrey; Cappa, Paolo; Porfiri, Maurizio] NYU, Tandon Sch Engn, Dept Mech & Aerosp Engn, Brooklyn, NY 11201 USA; [Palermo, Eduardo; Cappa, Paolo] Sapienza Univ Rome, Dept Mech & Aerosp Engn, Rome, Italy; [Nov, Oded] NYU, Tandon Sch Engn, Dept Technol Management & Innovat, Brooklyn, NY USA	New York University; New York University Tandon School of Engineering; Sapienza University Rome; New York University; New York University Tandon School of Engineering	Porfiri, M (corresponding author), NYU, Tandon Sch Engn, Dept Mech & Aerosp Engn, Brooklyn, NY 11201 USA.	mporfiri@nyu.edu	Coish, Elizabeth/AAU-1245-2020; Palermo, Eduardo/AAX-8426-2021	Palermo, Eduardo/0000-0002-3213-8261; Porfiri, Maurizio/0000-0002-1480-3539	National Science Foundation [BCS-1 124795, CBET-1604355]; Directorate For Engineering [1604355] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This research was supported by the National Science Foundation under Grant #s BCS-1 124795 and CBET-1604355, www.nsf.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acai M, 2010, GAIT POSTURE, V32, P641, DOI 10.1016/j.gaitpost.2010.09.008; Allen I.E., 2007, QUAL PROG, V40, P64, DOI DOI 10.1111/J.1365-2929.2004.02012.X; ARMSTRONG RL, 1987, PERCEPT MOTOR SKILL, V64, P359, DOI 10.2466/pms.1987.64.2.359; Attygalle S, 2008, 2008 VIRTUAL REHABILITATION, P168, DOI 10.1109/ICVR.2008.4625155; Awad M., 2014, P IEEE SEGAH, P1; Bach-y-Rita Paul, 2002, Top Stroke Rehabil, V8, P1; Bamberg SJM, 2008, IEEE T INF TECHNOL B, V12, P413, DOI 10.1109/TITB.2007.899493; Becker M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081638; Bouzit M, 2002, IEEE-ASME T MECH, V7, P256, DOI 10.1109/TMECH.2002.1011262; Bowser A, 2014, P COMP PUBL 17 ACM C, P137, DOI DOI 10.1145/2556420.2556502; BURTON S, 1991, PUBLIC OPIN QUART, V55, P50, DOI 10.1086/269241; BUTEFISCH C, 1995, J NEUROL SCI, V130, P59, DOI 10.1016/0022-510X(95)00003-K; Cappa F, 2016, J ENVIRON MANAGE, V182, P374, DOI 10.1016/j.jenvman.2016.07.092; Cappa P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083945; Casella G, 2002, STAT INFERENCE, V2; Celik O, 2010, IEEE T NEUR SYS REH, V18, P433, DOI 10.1109/TNSRE.2010.2047600; Chang CM, 2012, PATIENT PREFER ADHER, V6, P821, DOI 10.2147/PPA.S37190; Charles Jeanne, 2005, Neural Plasticity, V12, P245, DOI 10.1155/NP.2005.245; Connolly TM, 2012, COMPUT EDUC, V59, P661, DOI 10.1016/j.compedu.2012.03.004; Conrad CC, 2011, ENVIRON MONIT ASSESS, V176, P273, DOI 10.1007/s10661-010-1582-5; Cooper CB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106508; Coote S, 2008, CLIN REHABIL, V22, P395, DOI 10.1177/0269215507085060; Crowley D. N., 2012, P IEEE INT GAM INN C, P1, DOI DOI 10.1109/IGIC.2012.6329849; Da Gama A., 2012, 2012 IEEE Symposium on 3D User Interfaces (3DUI), P145, DOI 10.1109/3DUI.2012.6184203; Diaz I, 2011, J ROBOT, V2011, DOI 10.1155/2011/759764; Dickinson JL, 2012, FRONT ECOL ENVIRON, V10, P291, DOI 10.1890/110236; Dickinson JL, 2010, ANNU REV ECOL EVOL S, V41, P149, DOI 10.1146/annurev-ecolsys-102209-144636; Dipietro L, 2009, CORTEX, V45, P318, DOI 10.1016/j.cortex.2008.02.008; Dong SF, 2006, IEEE T NEUR SYS REH, V14, P55, DOI 10.1109/TNSRE.2005.863839; Duncan PW, 2002, STROKE, V33, P167, DOI 10.1161/hs0102.101014; Fern'ndez-Baena A., 2012, 2012 4th International Conference on Intelligent Networking and Collaborative Systems (INCoS 2012), P656, DOI 10.1109/iNCoS.2012.66; Flores E., 2008, P 2008 INT C ADV COM, P381, DOI [10.1145/1501750.1501839, DOI 10.1145/1501750.1501839]; Fortson L, 2011, ARXIV11045512; Foster-Smith J, 2003, BIOL CONSERV, V113, P199, DOI 10.1016/S0006-3207(02)00373-7; Gerling K., 2012, P 2012 ACM ANN C HUM, P1873, DOI [10.1145/2207676.2208324, DOI 10.1145/2207676.2208324]; Gladstone DJ, 2002, NEUROREHAB NEURAL RE, V16, P232, DOI 10.1177/154596802401105171; Gonzalez A, 2014, SENSORS-BASEL, V14, P16955, DOI 10.3390/s140916955; Gouveia C, 2004, J ENVIRON MANAGE, V71, P135, DOI 10.1016/j.jenvman.2004.01.009; Gregersen A., 2011, MEDIEKULTUR J MEDIA, V51, P94, DOI [DOI 10.7146/MEDIEKULTUR.V27I51.4084, 10.7146/mediekultur.v27i51.4084]; Gupta A, 2006, IEEE-ASME T MECH, V11, P280, DOI 10.1109/TMECH.2006.875558; Haklay M, 2013, CROWDSOURCING GEOGRA, P105, DOI [10.1007/978-94-007-4587-2_7, DOI 10.1007/978-94-007-4587-2_7]; Han JG, 2013, IEEE T CYBERNETICS, V43, P1318, DOI 10.1109/TCYB.2013.2265378; HIGHLAND TR, 1992, SPINE, V17, pS77, DOI 10.1097/00007632-199206001-00003; Holden MK, 2007, IEEE T NEUR SYS REH, V15, P36, DOI 10.1109/TNSRE.2007.891388; Johansson BB, 2011, ACTA NEUROL SCAND, V123, P147, DOI 10.1111/j.1600-0404.2010.01417.x; Johnson MJ, 2006, J NEUROENG REHABIL, V3, DOI 10.1186/1743-0003-3-29; Kitsunezaki N, 2013, IEEE INT SYM MED MEA, P294, DOI 10.1109/MeMeA.2013.6549755; Kwakkel G, 2008, NEUROREHAB NEURAL RE, V22, P111, DOI 10.1177/1545968307305457; Lange B, 2011, IEEE ENG MED BIO, P1831, DOI 10.1109/IEMBS.2011.6090521; Langhorne P, 2011, LANCET, V377, P1693, DOI 10.1016/S0140-6736(11)60325-5; Laut J, J ASS INFORM SCI TEC; Laut J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117013; Laut J, 2014, IEEE-ASME T MECH, V19, P1541, DOI 10.1109/TMECH.2013.2287705; Laut J, 2014, IEEE CONTR SYST MAG, V34, P60, DOI 10.1109/MCS.2013.2287386; Liao WW, 2012, CLIN REHABIL, V26, P111, DOI 10.1177/0269215511416383; Lintott CJ, 2008, MON NOT R ASTRON SOC, V389, P1179, DOI 10.1111/j.1365-2966.2008.13689.x; Liu T, 2010, SENSORS-BASEL, V10, P10240, DOI 10.3390/s101110240; Liu T, 2009, IEEE SENS J, V9, P1103, DOI 10.1109/JSEN.2009.2026509; Lloyd-Jones D, 2010, CIRCULATION, V121, pE46, DOI 10.1161/CIRCULATIONAHA.109.192667; Lukowicz P, 2006, LECT NOTES COMPUT SC, V3968, P101; Malfait N, 2004, J NEUROSCI, V24, P8084, DOI 10.1523/JNEUROSCI.1742-04.2004; Masia L, 2011, J NEUROENG REHABIL, V8, DOI 10.1186/1743-0003-8-28; MASSEY FJ, 1951, J AM STAT ASSOC, V46, P68, DOI 10.2307/2280095; Microsoft, KIN SDK; Mitra S, 2007, IEEE T SYST MAN CY C, V37, P311, DOI 10.1109/TSMCC.2007.893280; Morrow K, 2006, 2006 INTERNATIONAL WORKSHOP ON VIRTUAL REHABILITATION, P6, DOI 10.1109/IWVR.2006.1707518; Nov O., 2010, PROC 19 INT C WORLD, P741, DOI [10.1145/1772690.1772766, DOI 10.1145/1772690.1772766]; Nov O, 2011, P 2011 ICONFERENCE, P68, DOI [DOI 10.1145/1940761.1940771, 10.1145/1940761.1940771]; Nov O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090375; NYU, BROOKL ATL; O'Luanaigh P, 2005, GAME DESIGN COMPLETE; Obdrzalek S, 2012, IEEE ENG MED BIO, P1188, DOI 10.1109/EMBC.2012.6346149; Pacilli A, 2014, APPL BIONICS BIOMECH, V11, P91, DOI [10.1155/2014/251931, 10.3233/ABB-140095]; Parker J. R., 2008, LOADING, V2, P2; Patane F, 2011, IEEE T NEUR SYS REH, V19, P157, DOI 10.1109/TNSRE.2010.2089535; Patritti BL, 2010, PM&R, V2, P71, DOI 10.1016/j.pmrj.2009.10.012; Patton JL, 2004, IEEE T BIO-MED ENG, V51, P636, DOI 10.1109/TBME.2003.821035; Pearsall H, 2013, URBAN STUD, V50, P2293, DOI 10.1177/0042098013478236; Pett M.A., 1997, NONPARAMETRIC STAT H; Phamduy P, 2015, IEEE T MULTIMEDIA, V17, P2328, DOI 10.1109/TMM.2015.2480226; Rastgaar M, 2014, TR AUGM HUM PERF, V2, P157, DOI 10.1007/978-94-017-8932-5__6; Rohrer B, 2002, J NEUROSCI, V22, P8297; Rossi S, 2014, P IEEE RAS-EMBS INT, P504, DOI 10.1109/BIOROB.2014.6913827; Saini S., 2012, 2012 Proceedings of International Conference on Computer & Information Science (ICCIS 2012), P55, DOI 10.1109/ICCISci.2012.6297212; Saposnik G, 2010, STROKE, V41, P1477, DOI 10.1161/STROKEAHA.110.584979; Scott D, 2009, GEOFORUM, V40, P373, DOI 10.1016/j.geoforum.2008.12.002; Silvertown J, 2009, TRENDS ECOL EVOL, V24, P467, DOI 10.1016/j.tree.2009.03.017; Stewart KC, 2006, J NEUROL SCI, V244, P89, DOI 10.1016/j.jns.2006.01.005; Swinnen SP, 2002, NAT REV NEUROSCI, V3, P350, DOI 10.1038/nrn807; Takahashi CD, 2001, J NEUROPHYSIOL, V86, P1047, DOI 10.1152/jn.2001.86.2.1047; Tao WJ, 2012, SENSORS-BASEL, V12, P2255, DOI 10.3390/s120202255; Taub E, 2013, STROKE, V44, P1383, DOI 10.1161/STROKEAHA.111.000559; Taub E, 2011, J CHILD NEUROL, V26, P1163, DOI 10.1177/0883073811408423; Volpe BT, 2001, CURR OPIN NEUROL, V14, P745, DOI 10.1097/00019052-200112000-00011; Webster D, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-108; Wu G, 2005, J BIOMECH, V38, P981, DOI 10.1016/j.jbiomech.2004.05.042; Zhang WL, 2016, J DYN SYST-T ASME, V138, DOI 10.1115/1.4033949	97	14	14	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2017	12	2							e0172587	10.1371/journal.pone.0172587	http://dx.doi.org/10.1371/journal.pone.0172587			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL5SX	28231261	Green Published, gold			2022-12-27	WOS:000394682400057
J	Tromp, I; Kiefte-de Jong, J; Raat, H; Jaddoe, V; Franco, O; Hofman, A; de Jongste, J; Moll, H				Tromp, Ilse; Kiefte-de Jong, Jessica; Raat, Hein; Jaddoe, Vincent; Franco, Oscar; Hofman, Albert; de Jongste, Johan; Moll, Henriette			Breastfeeding and the risk of respiratory tract infections after infancy: The Generation R Study	PLOS ONE			English	Article							HOSPITALIZATION; CHILDHOOD; DURATION; DISEASES; CHILDREN; ILLNESS	Background The protection of breastfeeding against respiratory tract infections in the first year of life has often been suggested. Few studies examined the effect of breastfeeding on respiratory tract infections after infancy. Objective To examine the association between breastfeeding with lower respiratory tract infections (LRTI) and upper respiratory tract infections (URTI) after infancy up to 4 years of age (n = 5322). Methods This study was embedded in The Generation R study, a Dutch population-based prospective cohort study from fetal life until young adulthood. Information on breastfeeding duration (never; <3 months; 3-6 months;>= 6 months) and dose (never; partially until 4 months; predominantly until 4 months) were collected by questionnaire at 2, 6, and 12 months of age. Information on doctor attendance for LRTI and URTI were obtained by questionnaire at 2, 3, and 4 years of age. Results Breastfeeding for 6 months or longer was significantly associated with a reduced risk of LRTI up to 4 years of age (aOR: 0.71; 95% CI: 0.51-0.98). Similar ORs for LRTI were found with breastfeeding for less than 3 months and 3-6 months. Although in the same direction, weaker ORs were found for URTI and breastfeeding duration. The same trend was found for partial and predominant breastfeeding until 4 months and LRTI and URTI. Conclusion Breastfeeding duration for 6 months or longer is associated with a reduced risk of LRTI in pre-school children. These findings are compatible with the hypothesis that the protective effect of breastfeeding for respiratory tract infections persist after infancy therefore supporting current recommendations for breastfeeding for at least 6 months.	[Tromp, Ilse; Jaddoe, Vincent] Erasmus MC, Univ Med Ctr, Generat R Study Grp, Rotterdam, Netherlands; [Tromp, Ilse; Kiefte-de Jong, Jessica; Jaddoe, Vincent; de Jongste, Johan; Moll, Henriette] Erasmus MC, Univ Med Ctr, Sophia Childrens Hosp, Dept Pediat, Rotterdam, Netherlands; [Kiefte-de Jong, Jessica; Jaddoe, Vincent; Franco, Oscar; Hofman, Albert] Erasmus MC, Univ Med Ctr, Dept Epidemiol, Rotterdam, Netherlands; [Kiefte-de Jong, Jessica] Leiden Univ Coll, Dept Global Publ Hlth, The Hague, Netherlands; [Raat, Hein] Erasmus MC, Univ Med Ctr, Dept Publ Hlth, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus MC - Sophia Children's Hospital; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Kiefte-de Jong, J (corresponding author), Erasmus MC, Univ Med Ctr, Sophia Childrens Hosp, Dept Pediat, Rotterdam, Netherlands.; Kiefte-de Jong, J (corresponding author), Erasmus MC, Univ Med Ctr, Dept Epidemiol, Rotterdam, Netherlands.; Kiefte-de Jong, J (corresponding author), Leiden Univ Coll, Dept Global Publ Hlth, The Hague, Netherlands.	j.c.kiefte-dejong@erasmusmc.nl	Kiefte-de Jong, Jessica/GLV-3216-2022; Franco, Óscar H/ABE-2305-2020	Kiefte-de Jong, Jessica/0000-0002-8136-0918; Franco, Óscar H/0000-0002-4606-4929	Erasmus Medical Center; Erasmus University Rotterdam; Netherlands Organization for Health Research and Development (Zon Mw); Europe Container terminals B.V	Erasmus Medical Center; Erasmus University Rotterdam; Netherlands Organization for Health Research and Development (Zon Mw)(Netherlands Organization for Health Research and Development); Europe Container terminals B.V	This phase of the Generation R Study was supported by the Erasmus Medical Center, the Erasmus University Rotterdam, the Netherlands Organization for Health Research and Development (Zon Mw) and Europe Container terminals B.V. The funders had no role in the design of the study, the data collection and analyses, the interpretation of data, or the preparation of, review of, and decision to submit the manuscript.	Agostoni C, 2009, J PEDIATR GASTR NUTR, V49, P112, DOI 10.1097/MPG.0b013e31819f1e05; [Anonymous], 1991, IND ASS BREAST FEED, V91, P14; Chantry CJ, 2006, PEDIATRICS, V117, P425, DOI 10.1542/peds.2004-2283; Craig JC, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1594; Duijts L, 2010, PEDIATRICS, V126, pE18, DOI 10.1542/peds.2008-3256; Duijts L, 2009, MATERN CHILD NUTR, V5, P199, DOI 10.1111/j.1740-8709.2008.00176.x; Fisk CM, 2011, MATERN CHILD NUTR, V7, P61, DOI 10.1111/j.1740-8709.2010.00241.x; Gabriele C, 2012, EUR J EPIDEMIOL, V27, P453, DOI 10.1007/s10654-012-9675-9; Hanson LA, 1998, ANN ALLERG ASTHMA IM, V81, P523, DOI 10.1016/S1081-1206(10)62704-4; Hanson LA, 2003, ANN NY ACAD SCI, V987, P199, DOI 10.1111/j.1749-6632.2003.tb06049.x; Hanson LA, 2000, ACTA PAEDIATR, V89, P252, DOI 10.1080/080352500750028339; Hanson LA, 2007, P NUTR SOC, V66, P384, DOI 10.1017/S0029665107005654; Hasegawa K, 2015, PEDIATR INFECT DIS J, V34, P681, DOI 10.1097/INF.0000000000000704; Hatakka K, 2010, SCAND J INFECT DIS, V42, P704, DOI 10.3109/00365548.2010.483476; Hetzner NMP, 2009, MATERN CHILD HLTH J, V13, P795, DOI 10.1007/s10995-008-0401-x; Hornell A, 2013, FOOD NUTR RES, V57, DOI 10.3402/fnr.v57i0.20823; Jaddoe VWV, 2012, EUR J EPIDEMIOL, V27, P739, DOI 10.1007/s10654-012-9735-1; Jansen MAE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126019; Kramer MS, 2001, JAMA-J AM MED ASSOC, V285, P413, DOI 10.1001/jama.285.4.413; Ladomenou F, 2010, ARCH DIS CHILD, V95, P1004, DOI 10.1136/adc.2009.169912; Lanting CI, 2005, ACTA PAEDIATR, V94, P935, DOI 10.1080/08035250510036723; Li RW, 2014, PEDIATRICS, V134, pS13, DOI 10.1542/peds.2014-0646D; MICKEY RM, 1989, AM J EPIDEMIOL, V129, P125, DOI 10.1093/oxfordjournals.aje.a115101; Prietsch SOM, 2008, CAD SAUDE PUBLICA, V24, P1429, DOI 10.1590/S0102-311X2008000600023; PUKANDER J, 1985, ACTA OTO-LARYNGOL, V100, P260, DOI 10.3109/00016488509104788; Quigley MA, 2007, PEDIATRICS, V119, pE837, DOI 10.1542/peds.2006-2256; Rebhan B, 2009, ACTA PAEDIATR, V98, P974, DOI 10.1111/j.1651-2227.2009.01281.x; SASSEN ML, 1994, AM J OTOLARYNG, V15, P351, DOI 10.1016/0196-0709(94)90134-1; Schack-Nielsen L, 2006, CURR OPIN CLIN NUTR, V9, P289, DOI 10.1097/01.mco.0000222114.84159.79; Statistics Netherlands, 2012, WELF NETH INC WELF S; Statistics Netherlands, 2004, DUTCH STAND CLASS ED; Sterne JAC, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2393; Swertz O, 2004, MIGRANTS NETHERLANDS; Tarrant M, 2010, EPIDEMIOLOGY, V21, P847, DOI 10.1097/EDE.0b013e3181f55803; Twisk JWR, 2004, EUR J EPIDEMIOL, V19, P769, DOI 10.1023/B:EJEP.0000036572.00663.f2; Walker CLF, 2013, LANCET, V381, P1405, DOI 10.1016/S0140-6736(13)60222-6; World Health Organization, 2001, OPT DUR EXCL BREASTF; Yamakawa M, 2015, MATERN CHILD HLTH J, V19, P1956, DOI 10.1007/s10995-015-1703-4	38	61	63	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2017	12	2							e0172763	10.1371/journal.pone.0172763	http://dx.doi.org/10.1371/journal.pone.0172763			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5SX	28231310	Green Published, gold			2022-12-27	WOS:000394682400079
J	Biswas, S; Subramanian, A; ELMojtaba, IM; Chattopadhyay, J; Sarkar, RR				Biswas, Santanu; Subramanian, Abhishek; ELMojtaba, Ibrahim M.; Chattopadhyay, Joydev; Sarkar, Ram Rup			Optimal combinations of control strategies and cost-effective analysis for visceral leishmaniasis disease transmission	PLOS ONE			English	Article							PHLEBOTOMUS-ARGENTIPES; MODEL; DYNAMICS; BIHAR; NETS; BIOLOGY; VECTOR; IMPACT; CANINE; STATE	Visceral leishmaniasis (VL) is a deadly neglected tropical disease that poses a serious problem in various countries all over the world. Implementation of various intervention strategies fail in controlling the spread of this disease due to issues of parasite drug resistance and resistance of sandfly vectors to insecticide sprays. Due to this, policy makers need to develop novel strategies or resort to a combination of multiple intervention strategies to control the spread of the disease. To address this issue, we propose an extensive SIR-type model for anthroponotic visceral leishmaniasis transmission with seasonal fluctuations modeled in the form of periodic sandfly biting rate. Fitting the model for real data reported in South Sudan, we estimate the model parameters and compare the model predictions with known VL cases. Using optimal control theory, we study the effects of popular control strategies namely, drug-based treatment of symptomatic and PKDL-infected individuals, insecticide treated bednets and spray of insecticides on the dynamics of infected human and vector populations. We propose that the strategies remain ineffective in curbing the disease individually, as opposed to the use of optimal combinations of the mentioned strategies. Testing the model for different optimal combinations while considering periodic seasonal fluctuations, we find that the optimal combination of treatment of individuals and insecticide sprays perform well in controlling the disease for the time period of intervention introduced. Performing a cost-effective analysis we identify that the same strategy also proves to be efficacious and cost-effective. Finally, we suggest that our model would be helpful for policy makers to predict the best intervention strategies for specific time periods and their appropriate implementation for elimination of visceral leishmaniasis.	[Biswas, Santanu] Adamas Univ, Dept Math, Kolkata, India; [Subramanian, Abhishek; Sarkar, Ram Rup] CSIR, Natl Chem Lab, Chem Engn & Proc Dev, Dr Homi Bhabha Rd, Pune 411008, Maharashtra, India; [Subramanian, Abhishek; Sarkar, Ram Rup] Acad Sci & Innovat Res AcSIR, CSIR NCL Campus, Pune 411008, Maharashtra, India; [ELMojtaba, Ibrahim M.] Sultan Qaboos Univ, Coll Sci, Dept Math & Stat, POB 36, Muscat, Oman; [Chattopadhyay, Joydev] Indian Stat Inst, Agr & Ecol Res Unit, 203 BT Rd, Kolkata 700108, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Chemical Laboratory (NCL); Academy of Scientific & Innovative Research (AcSIR); Sultan Qaboos University; Indian Statistical Institute; Indian Statistical Institute Kolkata	Sarkar, RR (corresponding author), CSIR, Natl Chem Lab, Chem Engn & Proc Dev, Dr Homi Bhabha Rd, Pune 411008, Maharashtra, India.; Sarkar, RR (corresponding author), Acad Sci & Innovat Res AcSIR, CSIR NCL Campus, Pune 411008, Maharashtra, India.	rr.sarkar@ncl.res.in	Subramanian, Abhishek/AAN-1302-2020; Elmojtaba, Ibrahim/AAH-4270-2020	Subramanian, Abhishek/0000-0002-4601-5991; SARKAR, RAM RUP/0000-0001-7115-163X; ELmojtaba, Ibrahim/0000-0001-6018-4671	Council of Scientific and Industrial Research (CSIR), India [BSC0114]; DBT-BINC	Council of Scientific and Industrial Research (CSIR), India(Council of Scientific & Industrial Research (CSIR) - India); DBT-BINC	This work was supported by grant from 12th FYP project HOPE (BSC0114) of Council of Scientific and Industrial Research (CSIR), India to RRS. AS acknowledges the Senior Research Fellowship from DBT-BINC.	Abubakar A, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002720; Agyingi EO, 2011, J BIOL SYST, V19, P237, DOI 10.1142/S0218339011003841; Ashford DA, 1998, AM J TROP MED HYG, V59, P53, DOI 10.4269/ajtmh.1998.59.53; Ashford RW, 2000, INT J PARASITOL, V30, P1269, DOI 10.1016/S0020-7519(00)00136-3; Biswas S., 2016, NONLINEAR DYNAMICS; Brahmachari U N, 1922, Ind Med Gaz, V57, P125; Buratti M, 1998, J COMB DES, V6, P337, DOI 10.1002/(SICI)1520-6610(1998)6:5<337::AID-JCD3>3.3.CO;2-O; Chakravarty J, 2010, J GLOB INFECT DIS, V2, P167, DOI 10.4103/0974-777X.62887; Chappuis F, 2007, NAT REV MICROBIOL, V5, P873, DOI 10.1038/nrmicro1748; Chaves LF, 2004, ACTA TROP, V92, P245, DOI 10.1016/j.actatropica.2004.08.004; Chowdhury R, 2011, AM J TROP MED HYG, V84, P662, DOI 10.4269/ajtmh.2011.10-0682; Coleman M, 2015, P NATL ACAD SCI USA, V112, P8573, DOI 10.1073/pnas.1507782112; Croft SL, 2006, CLIN MICROBIOL REV, V19, P111, DOI 10.1128/CMR.19.1.111-126.2006; Das P, 2007, J BIOL SYST, V15, P139, DOI 10.1142/S0218339007002155; Dietze R, 1997, CLIN INFECT DIS, V25, P1240, DOI 10.1086/516096; Dinesh DS, 2008, TROP MED INT HEALTH, V13, P953, DOI 10.1111/j.1365-3156.2008.02096.x; Dinesh DS, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000859; Dye C, 1996, AM J TROP MED HYG, V55, P125, DOI 10.4269/ajtmh.1996.55.125; DYE C, 1992, PARASITOLOGY, V104, pS7, DOI 10.1017/S0031182000075211; DYE C, 1988, T ROY SOC TROP MED H, V82, P843, DOI 10.1016/0035-9203(88)90013-2; ELmojtaba IM, 2013, MATH METHOD APPL SCI, V36, P216, DOI 10.1002/mma.2589; ELmojtaba IM, 2010, APPL MATH COMPUT, V217, P2567, DOI 10.1016/j.amc.2010.07.069; Gavgani ASM, 2002, LANCET, V360, P374, DOI 10.1016/S0140-6736(02)09609-5; Geweke J., 1991, ACCURACY SAMPLING BA, P148; Gradoni L, 2015, VET PARASITOL, V208, P94, DOI 10.1016/j.vetpar.2015.01.003; Haario H, 2001, BERNOULLI, V7, P223, DOI 10.2307/3318737; Haario H, 2006, STAT COMPUT, V16, P339, DOI 10.1007/s11222-006-9438-0; Heffernan JM, 2005, J R SOC INTERFACE, V2, P281, DOI 10.1098/rsif.2005.0042; Lee BY, 2012, AM J TROP MED HYG, V86, P417, DOI 10.4269/ajtmh.2012.10-0415; Lenhart S., 2007, OPTIMAL CONTROL APPL; LEWIS DJ, 1974, ANNU REV ENTOMOL, V19, P363, DOI 10.1146/annurev.en.19.010174.002051; Marino S, 2008, J THEOR BIOL, V254, P178, DOI 10.1016/j.jtbi.2008.04.011; Mondal D, 2013, EMERG INFECT DIS, V19, P1131, DOI 10.3201/eid1907.120932; Mubayi A, 2010, J THEOR BIOL, V262, P177, DOI 10.1016/j.jtbi.2009.09.012; Okosun KO, 2013, BIOSYSTEMS, V111, P83, DOI 10.1016/j.biosystems.2012.09.008; Reithinger Richard, 2002, Trends in Parasitology, V18, P289, DOI 10.1016/S1471-4922(02)02296-1; Rock KS, 2015, TRENDS PARASITOL, V31, P251, DOI 10.1016/j.pt.2015.03.007; Sardar T, 2016, MATH METHOD APPL SCI, V39, P4181, DOI 10.1002/mma.3855; Sardar T, 2016, VIRULENCE, V7, P187, DOI 10.1080/21505594.2015.1096470; Sardar T, 2015, MATH BIOSCI, V263, P18, DOI 10.1016/j.mbs.2015.01.009; Sardar T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081231; Stauch Anette, 2012, PLoS Negl Trop Dis, V6, pe1973, DOI 10.1371/journal.pntd.0001973; Stauch A, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002810; Stauch A, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001405; Stockdale L, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002278; Subramanian A, 2015, MATHEMATICS, V3, P913, DOI 10.3390/math3030913; W. H. O, 2015, SUMM VISC LEISHM VL; World Health Organization, 2014, LEISHM FACT SHEET; Zamir M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160513	49	15	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2017	12	2							e0172465	10.1371/journal.pone.0172465	http://dx.doi.org/10.1371/journal.pone.0172465			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5QV	28222162	Green Published, Green Submitted, gold			2022-12-27	WOS:000394676800057
J	Ghielmetti, G; Scherrer, S; Friedel, U; Frei, D; Suter, D; Perler, L; Wittenbrink, MM				Ghielmetti, Giovanni; Scherrer, Simone; Friedel, Ute; Frei, Daniel; Suter, Dominique; Perler, Lukas; Wittenbrink, Max M.			Epidemiological tracing of bovine tuberculosis in Switzerland, multilocus variable number of tandem repeat analysis of Mycobacterium bovis and Mycobacterium caprae	PLOS ONE			English	Article							COMPLEX BACTERIA; STRAINS; LOCI; MICROEVOLUTION; IDENTIFICATION; SURVEILLANCE; WILDLIFE; PROPOSAL; EUROPE; GENOME	Background After 15 years of absence, in 2013 bovine tuberculosis (bTB), caused by Mycobacterium (M.) bovis and M. caprae, reemerged in the Swiss dairy cattle population. In order to identify the sources of infection as well as the spread of the agents, molecular-epidemiologic tracing by MIRU-VNTR analysis in combination with spoligotyping was performed. A total of 17 M. bovis and 7M. caprae isolates were cultured from tuberculous bovine lymph nodes and analyzed with a set of 49 genetic markers by using automated capillary electrophoresis. Results The outbreak in the western part of Switzerland was caused by M. bovis spoligotype SB0120. With the exception of four single-locus variations observed in MIRU 20, the MIRU-VNTR profiles of the 17 M. bovis isolates were identical, indicating a single source of infection. M. bovis detected in one archival bovine specimen from the outbreak region showed an identical MIRU-VNTR profile, suggesting persistence of the agent in a dairy herd for nearly fifteen years. The outbreak in the eastern part of Switzerland was caused by M. caprae spoligotype SB0418. All Swiss M. caprae isolates showed the Lechtal-type MIRU-VNTR profile, described as endemic in wild ruminants and in dairy cattle in Austrian bordering regions. This suggests the agent was most likely introduced by Swiss dairy cattle summering on Austrian pastures. Conclusions The present study is the first MIRU-VNTR analysis of Swiss bTB mycobacterial isolates. The genotyping assay was found to be highly discriminating and suitable for the epidemiological tracing of further outbreaks. These findings will contribute to the development of an international MIRU-VNTR database aiming to improve bTB surveillance.	[Ghielmetti, Giovanni; Scherrer, Simone; Friedel, Ute; Frei, Daniel; Wittenbrink, Max M.] Univ Zurich, Inst Vet Bacteriol, Vetsuisse Fac, CH-8006 Zurich, Switzerland; [Suter, Dominique; Perler, Lukas] Fed Food Safety & Vet Off, Bern, Switzerland	University of Zurich	Ghielmetti, G (corresponding author), Univ Zurich, Inst Vet Bacteriol, Vetsuisse Fac, CH-8006 Zurich, Switzerland.	giovanni.ghielmetti@vetbakt.uzh.ch	Ghielmetti, Giovanni/GVS-0748-2022; Scherrer, Simone/F-3663-2019	Scherrer, Simone/0000-0001-9548-8798; Ghielmetti, Giovanni/0000-0002-3936-9687	Swiss Federal Food Safety and Veterinary Office [710000136]	Swiss Federal Food Safety and Veterinary Office	This work was funded by the Swiss Federal Food Safety and Veterinary Office; contract number 710000136 to GG UF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajoj SAM, 2010, J CLIN MICROBIOL, V48, P3813, DOI 10.1128/JCM.00556-10; Allix C, 2006, J CLIN MICROBIOL, V44, P1951, DOI 10.1128/JCM.01775-05; Allix-Beguec C, 2014, J CLIN MICROBIOL, V52, P164, DOI 10.1128/JCM.02519-13; Aranaz A, 2003, INT J SYST EVOL MICR, V53, P1785, DOI 10.1099/ijs.0.02532-0; Boniotti MB, 2009, J CLIN MICROBIOL, V47, P636, DOI 10.1128/JCM.01192-08; Ciliberti A, 2015, PREV VET MED, V118, P271, DOI 10.1016/j.prevetmed.2014.11.021; De Kantor IN, 1998, LAB SERVICES TUBERCU, P38; Erler W, 2004, J CLIN MICROBIOL, V42, P2234, DOI 10.1128/JCM.42.5.2234-2238.2004; Fine Amanda E, 2011, Vet Med Int, V2011, P765430, DOI 10.4061/2011/765430; Firdessa R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052851; Fluckiger G, 1960, EIDGENOOSSISCHES VET, P5; Fritschi E, 1960, EIDGENOOSSISCHES VET, P12; Gormley E, 2014, RES VET SCI; Haddad N, 2001, J CLIN MICROBIOL, V39, P3623, DOI 10.1128/JCM.39.10.3623-3632.2001; Hauer A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117103; Hilty M, 2005, VET MICROBIOL, V109, P217, DOI 10.1016/j.vetmic.2005.05.017; Hur M, 2011, INT J TUBERC LUNG D, V15, P795, DOI 10.5588/ijtld.10.0367; Le Fleche P, 2002, BMC MICROBIOL, V2, DOI 10.1186/1471-2180-2-37; McMurray CL, 2010, J MICROBIOL METH, V80, P109, DOI 10.1016/j.mimet.2009.10.016; Meylan M, 2013, SCHWEIZ ARCH TIERH, V155, P573, DOI 10.1024/0036-7281/a000514; Navarro Y, 2016, VET MICROBIOL, V183, P97, DOI 10.1016/j.vetmic.2015.11.032; Rodriguez-Campos S, 2014, RES VET SCI; Romero B, 2008, VET MICROBIOL, V132, P87, DOI 10.1016/j.vetmic.2008.04.032; Roring S, 2004, VET MICROBIOL, V101, P65, DOI 10.1016/j.vetmic.2004.02.013; Roring S, 2002, J CLIN MICROBIOL, V40, P2126, DOI 10.1128/JCM.40.6.2126-2133.2002; Ruettger A, 2012, J CLIN MICROBIOL, V50, P2492, DOI 10.1128/JCM.00442-12; Schiller I, 2011, VET MICROBIOL, V151, P153, DOI 10.1016/j.vetmic.2011.02.039; Schoepf K, 2012, ISRN VET SCI, DOI DOI 10.5402/2012/245138; Skuce RA, 2002, MICROBIOL-SGM, V148, P519, DOI 10.1099/00221287-148-2-519; Smith NH, 2012, INFECT GENET EVOL, V12, P873, DOI 10.1016/j.meegid.2011.08.002; Smittipat N, 2000, TUBERCLE LUNG DIS, V80, P69, DOI 10.1054/tuld.2000.0236; Suppiger F, 1999, SCHWEIZ ARCH TIERH, V141, P11; Supply P, 2000, MOL MICROBIOL, V36, P762, DOI 10.1046/j.1365-2958.2000.01905.x; Supply P, 2001, J CLIN MICROBIOL, V39, P3563, DOI 10.1128/JCM.39.10.3563-3571.2001; Supply P, 2006, J CLIN MICROBIOL, V44, P4498, DOI 10.1128/JCM.01392-06; Tschopp A, 1985, THESIS; van Deutekom H, 2005, J CLIN MICROBIOL, V43, P4473, DOI 10.1128/JCM.43.9.4473-4479.2005; Xiao M, 2012, J CLIN MICROBIOL, V50, P2755, DOI 10.1128/JCM.00777-12	38	22	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2017	12	2							e0172474	10.1371/journal.pone.0172474	http://dx.doi.org/10.1371/journal.pone.0172474			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5QV	28222182	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000394676800059
J	Marin, D; Marin, N; del Corral, H; Lopez, L; Ramirez-Agudelo, ME; Rojas, CA; Arbelaez, MP; Garcia, LF; Rojas, M				Marin, Diana; Marin, Nancy; del Corral, Helena; Lopez, Lucelly; Elena Ramirez-Agudelo, Maria; Rojas, Carlos A.; Arbelaez, Maria P.; Garcia, Luis F.; Rojas, Mauricio			PPD-induced monocyte mitochondrial damage is associated with a protective effect to develop tuberculosis in BCG vaccinated individuals: A cohort study	PLOS ONE			English	Article							BACILLUS-CALMETTE-GUERIN; MYCOBACTERIUM-TUBERCULOSIS; MACROPHAGE APOPTOSIS; LATENT TUBERCULOSIS; CELL-DEATH; ACTIVE TUBERCULOSIS; INFECTION; NECROSIS; INDUCTION; DISEASE	Introduction The mechanisms of mononuclear phagocyte death have been associated with the permissiveness and resistance to mycobacterial replication, but it remains unknown whether or not they help predict the risk of developing TB. Objective To describe the factors associated with the induction of monocyte mitochondrial and membrane damage in response to PPD as well as determine if this type of damage might predict the susceptibility of developing active tuberculosis in a cohort of household contacts (HHCs) from Medellin, Colombia from 2005 to 2008. Methods The prospective cohort study contains 2060 HHCs patients with pulmonary tuberculosis who were meticulously followed for two years. A survey of the socio-demographic, clinical, epidemiological factors and blood samples were collected. Mononuclear cell cultures were stimulated with or without PPD and the type of monocyte death was determined by the flow of cytometry, an indicator was also used for its analysis. Logistic regression was adjusted by the Generalized Estimations Equations and the survival was estimated with the Kaplan-Meier and Cox regression. Confidence intervals were used for estimating the association. Results 1,859 out of 2,060 blood samples of the HHCs patients analyzed showed monocyte death. In response to PPD, 83.4% underwent mitochondrial damage while 50.9% had membrane damage. The membrane damage in response to PPD was higher in children under 4 years (OR: 1.57; (95% CI: 1.1 to 2.4) and the HHCs who slept regularly in the same household has an index case of (OR: 1.54; 95% CI: 1.0 to 2.3). After adjustment by age, comorbidities, nutritional status, proximity to index case and overcrowding, the risk of developing active TB among BCG vaccinated HHCs individuals with induction of mitochondrial damage was HR = 0.19 (95% CI: 0.1 to 0.5). Conclusions The induction of monocytes mitochondrial damage by PPD stimulation correlates with protection of TB disease development in BCG-vaccinated HHCs. This represents a potential tool to predict susceptibility of developing active disease in this population.	[Marin, Diana; del Corral, Helena; Lopez, Lucelly; Rojas, Carlos A.; Arbelaez, Maria P.] Univ Antioquia, Fac Nacl Salud Publ, Grp Epidemiol, Medellin, Colombia; [Marin, Diana; Marin, Nancy; del Corral, Helena; Lopez, Lucelly; Elena Ramirez-Agudelo, Maria; Rojas, Carlos A.; Arbelaez, Maria P.; Garcia, Luis F.; Rojas, Mauricio] CCITB, Medellin, Colombia; [Marin, Nancy; Elena Ramirez-Agudelo, Maria; Garcia, Luis F.; Rojas, Mauricio] Univ Antioquia, Fac Med, Grp Inmunol Celular & Inmunogenet, Medellin, Colombia; [Rojas, Mauricio] Univ Antioquia, Sede Invest Univ, Unidad Citometria Flujo, Medellin, Colombia; [Marin, Diana; Lopez, Lucelly] Univ Pontificia Bolivariana, Fac Med, Medellin, Colombia; [Marin, Nancy; del Corral, Helena] Univ Antioquia, Escuela Microbiol, Medellin, Colombia	Universidad de Antioquia; Universidad de Antioquia; Universidad de Antioquia; Universidad Pontificia Bolivariana; Universidad de Antioquia	Marin, D (corresponding author), Univ Antioquia, Fac Nacl Salud Publ, Grp Epidemiol, Medellin, Colombia.; Marin, D; Rojas, M (corresponding author), CCITB, Medellin, Colombia.; Rojas, M (corresponding author), Univ Antioquia, Fac Med, Grp Inmunol Celular & Inmunogenet, Medellin, Colombia.; Rojas, M (corresponding author), Univ Antioquia, Sede Invest Univ, Unidad Citometria Flujo, Medellin, Colombia.; Marin, D (corresponding author), Univ Pontificia Bolivariana, Fac Med, Medellin, Colombia.	dianamarcela.marin@upb.edu.co; mauricio.rojas@udea.edu.co	Rojas Cruz, Carlos Alberto/GZM-2307-2022; Rojas Lopez, Mauricio/P-4924-2018	Rojas Cruz, Carlos Alberto/0000-0003-0915-6653; Rojas Lopez, Mauricio/0000-0002-7791-9328; Marin Agudelo, Nancy Dora/0000-0002-2626-3349; Marin Pineda, Diana/0000-0002-4715-8388; Lopez Lopez, Lucelly/0000-0002-1534-520X	Colciencias (Colombian Administrative Department of Science, Technology and Innovation), Bogota Universidad de Antioquia [11150416335, 34261817270]	Colciencias (Colombian Administrative Department of Science, Technology and Innovation), Bogota Universidad de Antioquia	Funding for this research was gratefully received from Colciencias (Colombian Administrative Department of Science, Technology and Innovation, http://www.colciencias.gov.co/), Bogota Universidad de Antioquia (Grants: 11150416335 and 34261817270). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Funding for this research was received from Colciencias (http://www.coiciencias.gov.coi), Bogota, (Grants: 11150416335 and 34261817270). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilo JI, 2013, CELL MICROBIOL, V15, P1994, DOI 10.1111/cmi.12169; Ai JW, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.10; Andersen P, 2007, TRENDS MOL MED, V13, P175, DOI 10.1016/j.molmed.2007.03.004; [Anonymous], 2013, MEDELLIN SECRETARIA; Barry CE, 2009, NAT REV MICROBIOL, V7, P845, DOI 10.1038/nrmicro2236; Briken V, 2008, FUTURE MICROBIOL, V3, P415, DOI 10.2217/17460913.3.4.415; Campbell GR, 2013, AIDS, V27, P1397, DOI 10.1097/QAD.0b013e32836010dd; Campbell GR, 2012, AUTOPHAGY, V8, P1523, DOI 10.4161/auto.21154; Campbell GR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002689; Danelishvili L, 2003, CELL MICROBIOL, V5, P649, DOI 10.1046/j.1462-5822.2003.00312.x; Danelishvili L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010474; del Corral H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008257; Dietrich J, 2009, APMIS, V117, P440, DOI 10.1111/j.1600-0463.2009.02458.x; Elliott TOJP, 2015, J INFECT DIS, V212, P1469, DOI 10.1093/infdis/jiv238; Fratazzi C, 1999, J LEUKOCYTE BIOL, V66, P763, DOI 10.1002/jlb.66.5.763; Gerber A, 2000, DERMATOLOGY, V201, P111, DOI 10.1159/000018472; Gil DP, 2004, J INFECT DIS, V189, P2120, DOI 10.1086/386369; Harris J, 2010, CLIN EXP IMMUNOL, V161, P1, DOI 10.1111/j.1365-2249.2010.04146.x; He H, 2015, EUR J CLIN MICROBIOL, V34, P1103, DOI 10.1007/s10096-015-2335-8; Kaufmann SHE, 2006, NAT REV IMMUNOL, V6, P699, DOI 10.1038/nri1920; Keane J, 1997, INFECT IMMUN, V65, P298, DOI 10.1128/IAI.65.1.298-304.1997; Keane J, 2002, TUBERCULOSIS, V82, P55, DOI 10.1054/tube.2002.0322; Klingler K, 1997, INFECT IMMUN, V65, P5272, DOI 10.1128/IAI.65.12.5272-5278.1997; Kornfeld H, 1999, CELL DEATH DIFFER, V6, P71, DOI 10.1038/sj.cdd.4400454; Kremer L, 1997, EUR J IMMUNOL, V27, P2450, DOI 10.1002/eji.1830270945; Kumar V, 2013, ROBBINS BASIC PATHOL, Vxii; Lee J, 2009, YONSEI MED J, V50, P1, DOI 10.3349/ymj.2009.50.1.1; McCormick AL, 2008, CURR TOP MICROBIOL, V325, P281; MOLLOY A, 1994, J EXP MED, V180, P1499, DOI 10.1084/jem.180.4.1499; Moraco AH, 2014, SEMIN IMMUNOL, V26, P497, DOI 10.1016/j.smim.2014.10.001; Nigou J, 2002, MICROBES INFECT, V4, P945, DOI 10.1016/S1286-4579(02)01621-0; Pai M, 2015, LUNG INDIA, V32, P205, DOI 10.4103/0970-2113.156210; Pan H, 2005, NATURE, V434, P767, DOI 10.1038/nature03419; Placido R, 1997, J PATHOL, V181, P31, DOI 10.1002/(SICI)1096-9896(199701)181:1<31::AID-PATH722>3.0.CO;2-G; Rangaka MX, 2012, LANCET INFECT DIS, V12, P45, DOI 10.1016/S1473-3099(11)70210-9; Repasy T, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003190; Rojas M, 2000, J INFECT DIS, V182, P240, DOI 10.1086/315676; Rojas M, 1999, J IMMUNOL, V162, P6122; Roulston A, 1999, ANNU REV MICROBIOL, V53, P577, DOI 10.1146/annurev.micro.53.1.577; Sanchez MD, 2006, MICROBES INFECT, V8, P2492, DOI 10.1016/j.micinf.2006.06.005; Schaible UE, 2003, NAT MED, V9, P1039, DOI 10.1038/nm906; Schaible UE, 2007, PLOS MED, V4, P806, DOI 10.1371/journal.pmed.0040115; Social SSdSyP, COB VAC VAC GRUP ED; Wallis RS, 2010, LANCET, V375, P1920, DOI 10.1016/S0140-6736(10)60359-5; WHO, 2009, GLOB TUB CONTR 2009; Williams EP, 2015, CURR OBES REP, V4, P363, DOI 10.1007/s13679-015-0169-4; Yuen CM, 2015, LANCET, V386, P2334, DOI 10.1016/S0140-6736(15)00322-0; Zychlinsky Arturo, 1993, Trends in Microbiology, V1, P114, DOI 10.1016/0966-842X(93)90118-B	48	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2017	12	2							e0171930	10.1371/journal.pone.0171930	http://dx.doi.org/10.1371/journal.pone.0171930			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5QV	28222109	Green Published, gold, Green Submitted			2022-12-27	WOS:000394676800020
J	Takara, K; Maruo, N; Oka, K; Kaji, C; Hatakeyama, Y; Sawa, N; Kato, Y; Yamashita, J; Kojima, H; Sawa, Y				Takara, Kenyo; Maruo, Naoki; Oka, Kyoko; Kaji, Chiaki; Hatakeyama, Yuji; Sawa, Naruhiko; Kato, Yukinari; Yamashita, Junro; Kojima, Hiroshi; Sawa, Yoshihiko			Morphological study of tooth development in podoplanin-deficient mice	PLOS ONE			English	Article							MUCIN-TYPE GLYCOPROTEIN; GERM-CELL TUMORS; PLATELET-AGGREGATION; EPITHELIAL-CELLS; IMMUNOHISTOCHEMICAL EXAMINATION; MARKER PODOPLANIN; EXPRESSING CELLS; MEMBRANE-PROTEIN; DENDRITIC CELLS; I CELLS	Podoplanin is a mucin-type highly O-glycosylated glycoprotein identified in several somatyic cells: podocytes, alveolar epithelial cells, lymphatic endothelial cells, lymph node stromal fibroblastic reticular cells, osteocytes, odontoblasts, mesothelial cells, glia cells, and others. It has been reported that podoplanin-RhoA interaction induces cytoskeleton relaxation and cell process stretching in fibroblastic cells and osteocytes, and that podoplanin plays a critical role in type I alveolar cell differentiation. It appears that podoplanin plays a number of different roles in contributing to cell functioning and growth by signaling. However, little is known about the functions of podoplanin in the somatic cells of the adult organism because an absence of podoplanin is lethal at birth by the respiratory failure. In this report, we investigated the tooth germ development in podoplanin-knockout mice, and the dentin formation in podoplanin-conditional knockout mice having neural crest-derived cells with deficiency in podoplanin by the Wnt1 promoter and enhancer-driven Cre recombinase: Wnt1-Cre; Pdpn(Delta/Delta) mice. In the Wnt1-Cre; Pdpn(Delta/Delta)mice, the tooth and alveolar bone showed no morphological abnormalities and grow normally, indicating that podoplanin is not critical in the development of the tooth and bone.	[Takara, Kenyo; Oka, Kyoko; Kaji, Chiaki; Kojima, Hiroshi] Fukuoka Dent Coll, Dept Oral Growth & Dev, Fukuoka, Japan; [Maruo, Naoki] Fukuoka Dent Coll, Dept Odontol, Fukuoka, Japan; [Hatakeyama, Yuji; Sawa, Yoshihiko] Fukuoka Dent Coll, Dept Morphol Biol, Fukuoka, Japan; [Sawa, Naruhiko; Yamashita, Junro] Fukuoka Dent Coll, Dept Oral & Maxillofacial Surg, Fukuoka, Japan; [Kato, Yukinari] Tohoku Univ, Dept Reg Innovat, Grad Sch Med, Sendai, Miyagi, Japan	Fukuoka Dental College (FDC); Fukuoka Dental College (FDC); Fukuoka Dental College (FDC); Fukuoka Dental College (FDC); Tohoku University	Sawa, Y (corresponding author), Fukuoka Dent Coll, Dept Morphol Biol, Fukuoka, Japan.	ysawa@college.fdcnet.ac.jp	Yamashita, Junro/D-4787-2019	Yamashita, Junro/0000-0002-5486-1362; Kato, Yukinari/0000-0001-5385-8201	NIH/NIDCR grant [R01DE023538]; Japan Society for the Promotion of Science [15H05060]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE023538] Funding Source: NIH RePORTER	NIH/NIDCR grant; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by NIH/NIDCR grant R01DE023538 (Yamashita, J.) and Grant-in-Aid for Scientific Research (B) 15H05060 (principal investigator: Sawa, Y.) from Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by NIH/NIDCR grant R01DE023538 (Yamashita, J.) and Grant-in-Aid for Scientific Research (B) 15H05060 (principal investigator: Sawa, Y.) from Japan Society for the Promotion of Science.	Acton SE, 2014, NATURE, V514, P498, DOI 10.1038/nature13814; Amano I, 2011, ACTA HISTOCHEM CYTOC, V44, P267, DOI 10.1267/ahc.11037; BreitenederGeleff S, 1997, AM J PATHOL, V151, P1141; Chai Y, 2000, DEVELOPMENT, V127, P1671; Chu AY, 2005, MODERN PATHOL, V18, P105, DOI 10.1038/modpathol.3800259; Chung IH, 2009, STEM CELLS, V27, P866, DOI 10.1002/stem.2; Coleman JLJ, 2015, FRONT ENDOCRINOL, V6, DOI 10.3389/fendo.2015.00105; DOBBS LG, 1988, BIOCHIM BIOPHYS ACTA, V970, P146, DOI 10.1016/0167-4889(88)90173-5; FARR A, 1992, J HISTOCHEM CYTOCHEM, V40, P651, DOI 10.1177/40.5.1374092; Gonzalez RF, 1998, BBA-PROTEIN STRUCT M, V1429, P208, DOI 10.1016/S0167-4838(98)00231-3; Hata M, 2008, ARCH ORAL BIOL, V53, P835, DOI 10.1016/j.archoralbio.2008.02.006; Hata M, 2010, ACTA HISTOCHEM CYTOC, V43, P77, DOI 10.1267/ahc.10011; Imaizumi Y, 2010, ACTA HISTOCHEM CYTOC, V43, P115, DOI 10.1267/ahc.10023; Ishizawa K, 2009, CLIN NEUROPATHOL, V28, P373, DOI 10.2379/NPX09169; Jokinen CH, 2008, AM J CLIN PATHOL, V129, P886, DOI 10.1309/M7D5KTVYYE51XYQA; Kaji C, 2012, J ANAT, V220, P435, DOI 10.1111/j.1469-7580.2012.01484.x; Kaneko M, 2004, J BIOL CHEM, V279, P38838, DOI 10.1074/jbc.M407210200; Kato Y, 2003, J BIOL CHEM, V278, P51599, DOI 10.1074/jbc.M309935200; Kato Y, 2008, CANCER SCI, V99, P54, DOI 10.1111/j.1349-7006.2007.00634.x; Kawamoto T, 2003, ARCH HISTOL CYTOL, V66, P123, DOI 10.1679/aohc.66.123; Kimura N, 2005, PATHOL INT, V55, P83, DOI 10.1111/j.1440-1827.2005.01791.x; Makinena T, 2007, CELL MOL LIFE SCI, V64, P1915, DOI 10.1007/s00018-007-7040-z; Marsee DK, 2009, APPL IMMUNOHISTO M M, V17, P102, DOI 10.1097/PAI.0b013e318183a8e2; Martin-Villar E, 2006, J CELL SCI, V119, P4541, DOI 10.1242/jcs.03218; Mishima K, 2006, ACTA NEUROPATHOL, V111, P483, DOI 10.1007/s00401-006-0063-y; Noda Y, 2010, ACTA HISTOCHEM CYTOC, V43, P61, DOI 10.1267/ahc.10008; NOSE K, 1990, CELL GROWTH DIFFER, V1, P511; Oka K, 2007, DEV BIOL, V303, P391, DOI 10.1016/j.ydbio.2006.11.025; Ramirez MI, 2003, DEV BIOL, V256, P61, DOI 10.1016/S0012-1606(02)00098-2; RISHI AK, 1995, DEV BIOL, V167, P294, DOI 10.1006/dbio.1995.1024; Sawa Y, 2008, ACTA HISTOCHEM CYTOC, V41, P121, DOI 10.1267/ahc.08019; Schacht V, 2005, AM J PATHOL, V166, P913, DOI 10.1016/S0002-9440(10)62311-5; Schacht V, 2003, EMBO J, V22, P3546, DOI 10.1093/emboj/cdg342; Scholl FG, 1999, J CELL SCI, V112, P4601; Schulze E, 1999, HISTOCHEM CELL BIOL, V111, P61, DOI 10.1007/s004180050334; Schwab W, 1999, ACTA HISTOCHEM, V101, P431, DOI 10.1016/S0065-1281(99)80043-9; Shibahara J, 2006, VIRCHOWS ARCH, V448, P493, DOI 10.1007/s00428-005-0133-x; Sonne SB, 2006, VIRCHOWS ARCH, V449, P200, DOI 10.1007/s00428-006-0223-4; Tomooka M, 2013, ACTA HISTOCHEM CYTOC, V46, P171, DOI 10.1267/ahc.13035; Uhrin P, 2010, BLOOD, V115, P3997, DOI 10.1182/blood-2009-04-216069; Wetterwald A, 1996, BONE, V18, P125, DOI 10.1016/8756-3282(95)00457-2; Williams MC, 1996, AM J RESP CELL MOL, V14, P577, DOI 10.1165/ajrcmb.14.6.8652186; Yamazaki H, 2007, STEM CELLS, V25, P78, DOI 10.1634/stemcells.2006-0360; Yu HB, 2007, AM J CLIN PATHOL, V128, P776, DOI 10.1309/7P8U659JBJCV6EEU; Zhang KQ, 2006, MOL CELL BIOL, V26, P4539, DOI 10.1128/MCB.02120-05; Zimmer G, 1999, BIOCHEM J, V341, P277, DOI 10.1042/0264-6021:3410277	46	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2017	12	2							e0171912	10.1371/journal.pone.0171912	http://dx.doi.org/10.1371/journal.pone.0171912			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5QV	28222099	gold, Green Published, Green Submitted			2022-12-27	WOS:000394676800019
J	Schoonees, A; Rohwer, A; Young, T				Schoonees, Anel; Rohwer, Anke; Young, Taryn			Evaluating evidence-based health care teaching and learning in the undergraduate human nutrition; occupational therapy; physiotherapy; and speech, language and hearing therapy programs at a sub-Saharan African academic institution	PLOS ONE			English	Article							EVIDENCE-BASED MEDICINE; STUDENTS; PERCEPTIONS; INFORMATION; KNOWLEDGE; ATTITUDES; EDUCATION	Background It is important that all undergraduate healthcare students are equipped with evidence-based health care (EBHC) knowledge and skills to encourage evidence-informed decision-making after graduation. We assessed EBHC teaching and learning in undergraduate human nutrition (HN); occupational therapy (OT); physiotherapy (PT); and speech, language and hearing therapy (SPLH) programs at a sub-Saharan African university. Methods We used methodological triangulation to obtain a comprehensive understanding of EBHC teaching and learning: (1) through a document review of module guides, we identified learning outcomes related to pre-specified EBHC competencies; we conducted (2) focus group discussions and interviews of lecturers to obtain their perspectives on EBHC and on EBHC teaching and learning; and we (3) invited final year students (2013) and 2012 graduates to complete an online survey on EBHC attitudes, self-perceived EBHC competence, and their experience of EBHC teaching and learning. Results We reviewed all module outlines (n = 89) from HN, PT and SLHT. The OT curriculum was being revised at that time and could not be included. Six lecturers each from HN and OT, and five lecturers each from PT and SLHT participated in the focus groups. Thirty percent (53/176) of invited students responded to the survey. EBHC competencies were addressed to varying degrees in the four programs, although EBHC teaching and learning mostly occurred implicitly. Learning outcomes referring to EBHC focused on enabling competencies (e.g., critical thinking, biostatistics, epidemiology) and were concentrated in theoretical modules. Key competencies (e.g., asking questions, searching databases, critical appraisal) were rarely addressed explicitly. Students felt that EBHC learning should be integrated throughout the four year study period to allow for repetition, consolidation and application of knowledge and skills. Lecturers highlighted several challenges to teaching and practising EBHC, including lack of evidence relevant to the African context and lack of time within curricula.	[Schoonees, Anel; Rohwer, Anke; Young, Taryn] Univ Stellenbosch, Ctr Evidence Based Hlth Care, Fac Med & Hlth Sci, Cape Town, South Africa	Stellenbosch University	Schoonees, A (corresponding author), Univ Stellenbosch, Ctr Evidence Based Hlth Care, Fac Med & Hlth Sci, Cape Town, South Africa.	anelschoonees@sun.ac.za		Young, Taryn/0000-0003-2406-081X; Schoonees, Anel/0000-0001-8989-6891	Stellenbosch University's Faculty of Medicine and Health Sciences strategic fund	Stellenbosch University's Faculty of Medicine and Health Sciences strategic fund	The authors declare no conflict of interest. The funder, Stellenbosch University's Faculty of Medicine and Health Sciences strategic fund, had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akobeng AK, 2005, ARCH DIS CHILD, V90, P837, DOI 10.1136/adc.2005.071761; [Anonymous], READ PAPER BASICS EV; Asokan G V, 2012, J Evid Based Med, V5, P226, DOI 10.1111/jebm.12000; Baum KD, 2003, MED ED ONLINE, V8, P4; Bennett S, 2011, J EVAL CLIN PRACT, V17, P635, DOI 10.1111/j.1365-2753.2010.01602.x; Birbeck GL, 2013, BMC MED, V11, DOI [10.1186/1741-7015-11-223, 10.1186/1741-7015-11-226]; Bloom B.S., 1956, TAXONOMY ED OBJECTIV; Boruff JT, 2011, HEALTH INFO LIBR J, V28, P264, DOI [10.1111/J.1471-1842.2011.00953.x, 10.1111/j.1471-1842.2011.00953.x]; Bozzolan M, 2014, PHYSIOTHER THEOR PR, V30, P557, DOI 10.3109/09593985.2014.910285; Byham-Gray LD, 2005, J AM DIET ASSOC, V105, P1574, DOI 10.1016/j.jada.2005.07.007; Cameron Karen Ann V, 2005, Occup Ther Int, V12, P123, DOI 10.1002/oti.1; Chiu YW, 2012, ASIA PAC J CLIN NUTR, V21, P630; Dawes Martin, 2005, BMC Med Educ, V5, P1; Dizon JMR, 2014, BMC MED EDUC, V14, DOI 10.1186/1472-6920-14-147; Eraut M, 2000, BRIT J EDUC PSYCHOL, V70, P113, DOI 10.1348/000709900158001; Forland F, 2013, EVIDENCE BASED MED, V18; Frenk J, 2010, LANCET, V376, P1923, DOI 10.1016/S0140-6736(10)61854-5; Glasziou P, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1253; Gray M, 2012, AUST OCCUP THER J, V59, P445, DOI 10.1111/j.1440-1630.2012.01029.x; Greenhalgh T, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3725; Harden RM, 2001, MED TEACH, V23, P123, DOI 10.1080/01421590120036547; Kelly MP, 2015, BMC MED ETHICS, V16, DOI 10.1186/s12910-015-0063-3; Kendrick T, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1499; Khan Khalid S, 2006, BMC Med Educ, V6, P59, DOI 10.1186/1472-6920-6-59; Levels of Evidence Working Group Oxford Centre for Evidence-Based Medicine, 2015, OXFORD 2011 LEVELS E; Long K, 2011, INTERNET J ALLIED HE, V9; Maggio LA, 2013, ACAD MED, V88, P1022, DOI 10.1097/ACM.0b013e3182951959; Niemivirta M, 1999, INT J EDUC RES, V31, P499; Rindflesch A, 2013, WORK, V44, P265, DOI 10.3233/WOR-121503; Rohwer A, 2015, AFR J HLTH PROF ED, V7, P98; Rohwer A, 2014, BMC MED EDUC, V14, DOI 10.1186/1472-6920-14-236; Rohwer A, 2013, BMC MED EDUC, V13, DOI 10.1186/1472-6920-13-77; Sackett DL, 1996, BRIT MED J, V312, P71, DOI 10.1136/bmj.312.7023.71; Salbach NM, 2011, J EVAL CLIN PRACT, V17, P794, DOI 10.1111/j.1365-2753.2010.01478.x; Salls J, 2009, OCCUP THER HEALTH CA, V23, P134, DOI 10.1080/07380570902773305; Smith R, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g371; Spek B, 2013, INT J LANG COMM DIS, V48, P444, DOI 10.1111/1460-6984.12020; Straus SE, 2000, CAN MED ASSOC J, V163, P837; Thomas DE, 2003, J HUM NUTR DIET, V16, P315, DOI 10.1046/j.1365-277X.2003.00462.x; Young T, 2015, S AFR FAM PRACT, V57, P354, DOI 10.1080/20786190.2015.1090689; Young T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086706	41	11	13	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0172199	10.1371/journal.pone.0172199	http://dx.doi.org/10.1371/journal.pone.0172199			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207842	Green Published, gold, Green Submitted			2022-12-27	WOS:000394424500096
J	Zhai, CP; Hanaor, D; Gan, YX				Zhai, Chongpu; Hanaor, Dorian; Gan, Yixiang			Universality of the emergent scaling in finite random binary percolation networks	PLOS ONE			English	Article							DIELECTRIC-PROPERTIES; AC CONDUCTIVITY; RANDOM PACKINGS; BEHAVIOR	In this paper we apply lattice models of finite binary percolation networks to examine the effects of network configuration on macroscopic network responses. We consider both square and rectangular lattice structures in which bonds between nodes are randomly assigned to be either resistors or capacitors. Results show that for given network geometries, the overall normalised frequency-dependent electrical conductivities for different capacitor proportions are found to converge at a characteristic frequency. Networks with sufficiently large size tend to share the same convergence point uninfluenced by the boundary and electrode conditions, can be then regarded as homogeneous media. For these networks, the span of the emergent scaling region is found to be primarily determined by the smaller network dimension (width or length). This study identifies the applicability of power-law scaling in random two phase systems of different topological configurations. This understanding has implications in the design and testing of disordered systems in diverse applications.	[Zhai, Chongpu; Hanaor, Dorian; Gan, Yixiang] Univ Sydney, Sch Civil Engn, Sydney, NSW, Australia; [Hanaor, Dorian] Tech Univ Berlin, Inst Mat Sci & Technol, Berlin, Germany	University of Sydney; Technical University of Berlin	Gan, YX (corresponding author), Univ Sydney, Sch Civil Engn, Sydney, NSW, Australia.	yixang.gan@sydney.edu.au	Zhai, Chongpu/AAM-9601-2020; Hanaor, Dorian A. H./G-7012-2012; ZHAI, Chongpu/AAK-8999-2021; Gan, Yixiang/B-1551-2008; ZHAI, Chongpu/AAE-6809-2020	Hanaor, Dorian A. H./0000-0003-4455-7006; ZHAI, Chongpu/0000-0002-2849-7894; Gan, Yixiang/0000-0002-9621-0277; 	Australian Research Council [DE130101639]	Australian Research Council(Australian Research Council)	Financial support for this research is from the Australian Research Council through grants DE130101639 is greatly appreciated. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almond DP, 2013, PHYSICA A, V392, P1004, DOI 10.1016/j.physa.2012.10.035; Almond DP, 2011, SPRINGER PROC MATH, V3, P3, DOI 10.1007/978-3-642-16876-5_1; Almond DP, 2006, J PHYS D APPL PHYS, V39, P1295, DOI 10.1088/0022-3727/39/7/S03; Almond DP, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.157601; Almond DP, 1999, J PHYS-CONDENS MAT, V11, P9081, DOI 10.1088/0953-8984/11/46/310; Bakkali H, 2016, SCI REP-UK, V6, DOI 10.1038/srep29676; Bertei A, 2012, POWDER TECHNOL, V231, P44, DOI 10.1016/j.powtec.2012.07.041; Bertei A, 2011, POWDER TECHNOL, V213, P100, DOI 10.1016/j.powtec.2011.07.011; Bouamrane R, 2003, J PHYS-CONDENS MAT, V15, P4089, DOI 10.1088/0953-8984/15/24/302; CLERC JP, 1990, ADV PHYS, V39, P191, DOI 10.1080/00018739000101501; Creyssels M, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.075135; Deschamps R, 2000, TIME DOMAIN REFLECTO; Dyre JC, 2009, REP PROG PHYS, V72, DOI 10.1088/0034-4885/72/4/046501; FRANK DJ, 1988, PHYS REV B, V37, P302, DOI 10.1103/PhysRevB.37.302; Galvao RKH, 2013, IEEE T CIRCUITS-I, V60, P624, DOI 10.1109/TCSI.2012.2209733; Jonckheere T, 1998, J PHYS A-MATH GEN, V31, P3687, DOI 10.1088/0305-4470/31/16/002; JONSCHER AK, 1977, NATURE, V267, P673, DOI 10.1038/267673a0; Li W, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2405382; McCullen NJ, 2009, J PHYS D APPL PHYS, V42, DOI 10.1088/0022-3727/42/6/064001; MILTON GW, 1980, APPL PHYS LETT, V37, P300, DOI 10.1063/1.91895; Moreira AA, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.255701; Murphy KD, 2006, PHILOS MAG, V86, P3325, DOI 10.1080/14786430500197934; Nawroj AI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082260; Papathanassiou AN, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2779255; Picu RC, 2011, SOFT MATTER, V7, P6768, DOI 10.1039/c1sm05022b; Pollock HM, 2001, J PHYS D APPL PHYS, V34, pR23, DOI 10.1088/0022-3727/34/9/201; Sabatier J, 2006, SIGNAL PROCESS, V86, P2645, DOI 10.1016/j.sigpro.2006.02.030; Sakellis I, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3466904; Tighe BP, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.168303; Unuma T, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4833400; Volker B, 2012, J POWER SOURCES, V215, P199, DOI 10.1016/j.jpowsour.2012.05.014; Zhai CP, 2016, EXTREME MECH LETT, V9, P422, DOI 10.1016/j.eml.2016.03.021	32	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0172298	10.1371/journal.pone.0172298	http://dx.doi.org/10.1371/journal.pone.0172298			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207872	Green Submitted, Green Published, gold			2022-12-27	WOS:000394424500115
J	Lee, J; Yoon, K; Ryu, S; Chang, Y; Kim, HR				Lee, Jieun; Yoon, Kijung; Ryu, Seungho; Chang, Yoosoo; Kim, Hyoung-Ryoul			High-normal levels of hs-CRP predict the development of non-alcoholic fatty liver in healthy men	PLOS ONE			English	Article							C-REACTIVE PROTEIN; CORONARY-HEART-DISEASE; METABOLIC SYNDROME; INSULIN-RESISTANCE; CARDIOVASCULAR RISK; HEPATIC STEATOSIS; INFLAMMATION; PREVALENCE; MARKER; AMINOTRANSFERASE	We performed a follow-up study to address whether high sensitivity C-reactive protein (hsCRP) levels within the normal range can predict the development of non-alcoholic fatty liver disease (NAFLD) in healthy male subjects. Among15347 male workers between 30 and 59 years old who received annual health check-ups in 2002, a NAFLD-free cohort of 4,138 was followed through December 2009. Alcohol consumption was assessed with a questionnaire. At each visit, abdominal ultrasonography was performed to identify fatty liver disease. The COX proportional hazard model was used to evaluate the relationship between hs-CRP and incident NAFLD. During the follow-up period, 28.8% (1191 of 4138) of participants developed NAFLD. The hazard ratios of NAFLD were increased by hs-CRP categories within the normal range in the non-adjusted model and age-adjusted model. After adjusting for age, exercise, smoking, BMI, systolic BP, triglyceride, and fasting glucose, these incidences were only increased between the lowest and the highest hs-CRP categories. The risk for NAFLD increased as the hs-CRP level increased (p< 0.001). As the hs-CRP level increased within the healthy cohort, the risk of developing NAFLD increased. This trend remained true even if the hs-CRP level remained within the normal range. hs-CRP can be used as a predictor of NAFLD, as well as other obesity-associated diseases. Therefore, individuals with higher hs-CRP levels (even within the normal range) may require appropriate follow-up and management to prevent NAFLD development.	[Lee, Jieun] Ajou Univ, Sch Med, Ajou Univ Hosp, Hlth Promot Ctr, Suwon, South Korea; [Yoon, Kijung; Chang, Yoosoo] Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Hlth Screening Ctr, Seoul, South Korea; [Ryu, Seungho] Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Dept Occupat Med, Seoul, South Korea; [Kim, Hyoung-Ryoul] Catholic Univ Korea, Dept Occupat & Environm Med, Coll Med, Seoul, South Korea	Ajou University; Ajou University Hospital; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Catholic University of Korea	Kim, HR (corresponding author), Catholic Univ Korea, Dept Occupat & Environm Med, Coll Med, Seoul, South Korea.	cyclor@catholic.ac.kr		Chang, Yoosoo/0000-0002-6945-9050				Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80; Bozic MA, 2013, NUTR CLIN PRACT, V28, P448, DOI 10.1177/0884533613489153; Browning JD, 2004, J CLIN INVEST, V114, P147, DOI 10.1172/JCI200422422; Chang Y, 2009, GUT, V58, P1419, DOI 10.1136/gut.2008.161885; Chang Y, 2007, CLIN CHEM, V53, P686, DOI 10.1373/clinchem.2006.081257; Chiang CH, 2010, CLIN BIOCHEM, V43, P1399, DOI 10.1016/j.clinbiochem.2010.09.003; Choi DH, 2013, WORLD J GASTROENTERO, V19, P6453, DOI 10.3748/wjg.v19.i38.6453; Clark JM, 2003, AM J GASTROENTEROL, V98, P960, DOI [10.1016/S0002-9270(03)00265-X, 10.1111/j.1572-0241.2003.07486.x]; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; FEINGOLD KR, 1992, DIABETES, V41, P97, DOI 10.2337/diab.41.2.S97; Festa A, 2000, CIRCULATION, V102, P42, DOI 10.1161/01.CIR.102.1.42; Genc H, 2013, ANN HEPATOL, V12, P380, DOI 10.1016/S1665-2681(19)31338-9; Hamaguchi M, 2005, ANN INTERN MED, V143, P722, DOI 10.7326/0003-4819-143-10-200511150-00009; Haverkate F, 1997, LANCET, V349, P462, DOI 10.1016/S0140-6736(96)07591-5; Kawada T, 2012, ANN HUM BIOL, V39, P108, DOI 10.3109/03014460.2011.652170; Kim JH, 2014, KOREAN J INTERN MED, V29, P31, DOI 10.3904/kjim.2014.29.1.31; Koenig W, 1999, CIRCULATION, V99, P237, DOI 10.1161/01.CIR.99.2.237; Kojima S, 2003, J GASTROENTEROL, V38, P954, DOI 10.1007/s00535-003-1178-8; Kuller LH, 1996, AM J EPIDEMIOL, V144, P537, DOI 10.1093/oxfordjournals.aje.a008963; Kumar R, 2012, INDIAN J MED RES, V136, P229; Kuppan G, 2012, DIABETES TECHNOL THE, V14, P152, DOI 10.1089/dia.2011.0213; Lambert M, 2004, CLIN CHEM, V50, P1762, DOI 10.1373/clinchem.2004.036418; Lazo M, 2008, SEMIN LIVER DIS, V28, P339, DOI 10.1055/s-0028-1091978; Lee JY, 2007, J HEPATOL, V47, P239, DOI 10.1016/j.jhep.2007.02.007; Libby P, 2010, CIRC J, V74, P213, DOI 10.1253/circj.CJ-09-0706; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Mendall MA, 1996, BRIT MED J, V312, P1061; Mittal S, 2013, J CLIN GASTROENTEROL, V47, pS2, DOI 10.1097/MCG.0b013e3182872f29; Musso G, 2012, HEPATOLOGY, V56, DOI 10.1002/hep.25677; Musso G, 2011, ANN MED, V43, P617, DOI 10.3109/07853890.2010.518623; Ndumele CE, 2011, ARTERIOSCL THROM VAS, V31, P1927, DOI 10.1161/ATVBAHA.111.228262; Nigam P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0049286; Ridker PM, 2003, CIRCULATION, V107, P391, DOI 10.1161/01.CIR.0000055014.62083.05; Rodriguez-Hernandez H, 2013, INT J ENDOCRINOL, V2013, DOI 10.1155/2013/678159; Ryu S, 2007, CLIN CHEM, V53, P71, DOI 10.1373/clinchem.2006.078980; Tarantino G, 2013, WORLD J GASTROENTERO, V19, P6735, DOI 10.3748/wjg.v19.i40.6735; Wen CP, 2009, PUBLIC HEALTH NUTR, V12, P497, DOI 10.1017/S1368980008002802; Wong VWS, 2013, J GASTROEN HEPATOL, V28, P18, DOI 10.1111/jgh.12011; Wong VWS, 2011, GUT, V60, P829, DOI 10.1136/gut.2011.237974; Yatsuzuka S, 2014, ANN CLIN BIOCHEM, V51, P68, DOI 10.1177/0004563213487892	41	39	41	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0172666	10.1371/journal.pone.0172666	http://dx.doi.org/10.1371/journal.pone.0172666			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5VB	28234943	Green Published, gold, Green Submitted			2022-12-27	WOS:000394688200107
J	Ramachandran, RK; Sorensen, MD; Aaberg-Jessen, C; Hermansen, SK; Kristensen, BW				Ramachandran, Rahimsan K.; Sorensen, Mia D.; Aaberg-Jessen, Charlotte; Hermansen, Simon K.; Kristensen, Bjarne W.			Expression and prognostic impact of matrix metalloproteinase-2 (MMP-2) in astrocytomas	PLOS ONE			English	Article							STEM-CELL MARKERS; IMMUNOREACTIVE PROTEIN; MESENCHYMAL DIFFERENTIATION; GRADE GLIOMAS; GROWTH-FACTOR; GELATINASE-A; GLIOBLASTOMA; TISSUE; MUTATION; RADIOTHERAPY	Astrocytomas are the most frequent primary brain tumors in adults, and despite aggressive treatment patients often experience recurrence. Survival decreases with increasing tumor grade, and especially patients with grade IV glioblastoma have poor prognosis due to the aggressive character of this tumor. Matrix metalloproteinase-2 (MMP-2) is an extracellular matrix degrading enzyme which has been shown to play important roles in different cancers. The aim of this study was to investigate the expression and prognostic potential of MMP-2 in astrocytomas. Tissue samples from 89 patients diagnosed with diffuse astrocytoma, anaplastic astrocytoma and glioblastoma were stained immunohistochemically using a monoclonal MMP-2 antibody. The MMP-2 intensity in cytoplasm/membrane was quantified by a trained software-based classifier using systematic random sampling in 10% of the tumor area. We found MMP-2 expression in tumor cells and blood vessels. Measurements of MMP-2 intensity increased with tumor grade, and MMP-2 expression was found to be significantly higher in glioblastomas compared to normal brain tissue (p<0.001), diffuse astrocytomas (p<0.001) and anaplastic astrocytomas (p<0.05). MMP-2 expression was associated with shorter overall survival in patients with grade II-IV astrocytic tumors (HR 1.60; 95% CI 1.03-2.48; p = 0.036). In glioblastoma, high MMP-2 was associated with poorer prognosis in patients who survived longer than 8.5 months independent of age and gender (HR 2.27; 95% CI 1.07-4.81; p = 0.033). We found a positive correlation between MMP-2 and tissue inhibitor of metalloproteinases-1 (TIMP-1), and combined MMP-2 and TIMP-1 had stronger prognostic value than MMP-2 alone also when adjusting for age and gender (HR 2.78; 95% CI 1.30-5.92; p = 0.008). These findings were validated in bioinformatics databases. In conclusion, this study indicates that MMP-2 is associated with aggressiveness in astrocytomas and may hold an unfavorable prognostic value in patients with glioblastoma.	[Ramachandran, Rahimsan K.; Sorensen, Mia D.; Aaberg-Jessen, Charlotte; Hermansen, Simon K.; Kristensen, Bjarne W.] Odense Univ Hosp, Dept Pathol, Odense, Denmark; [Ramachandran, Rahimsan K.; Sorensen, Mia D.; Aaberg-Jessen, Charlotte; Hermansen, Simon K.; Kristensen, Bjarne W.] Univ Southern Denmark, Dept Clin Res, Odense, Denmark	University of Southern Denmark; Odense University Hospital; University of Southern Denmark	Sorensen, MD (corresponding author), Odense Univ Hosp, Dept Pathol, Odense, Denmark.; Sorensen, MD (corresponding author), Univ Southern Denmark, Dept Clin Res, Odense, Denmark.	mia.soerensen@rsyd.dk	Kristensen, Bjarne Winther/AAX-5491-2020; Kristensen, Bjarne Winther/A-6690-2012	Kristensen, Bjarne Winther/0000-0002-6352-0826; Kristensen, Bjarne Winther/0000-0002-6352-0826; Sorensen, Mia Dahl/0000-0002-0105-2940; Hermansen, Simon Kjaer/0000-0002-6420-8199; Poulsen, Charlotte Aaberg/0000-0003-1407-7976	Odense University Hospital Research Funds	Odense University Hospital Research Funds	This work wa ssupported by Odense University Hospital Research Funds.The funder hadno role in study design, datac ollection and analysis, decision to publish, or preparation of the manuscript.	Aaberg-Jessen C, 2009, J NEURO-ONCOL, V95, P117, DOI 10.1007/s11060-009-9910-8; Abounader R, 2005, NEURO-ONCOLOGY, V7, P436, DOI 10.1215/S1152851705000050; Baker AH, 2002, J CELL SCI, V115, P3719, DOI 10.1242/jcs.00063; Batchelor TT, 2010, J CLIN ONCOL, V28, P2817, DOI 10.1200/JCO.2009.26.3988; Bhat KPL, 2013, CANCER CELL, V24, P331, DOI 10.1016/j.ccr.2013.08.001; Bleeker FE, 2010, ACTA NEUROPATHOL, V119, P487, DOI 10.1007/s00401-010-0645-6; Ceccarelli M, 2016, CELL, V164, P550, DOI 10.1016/j.cell.2015.12.028; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Christensen K, 2008, J NEURO-ONCOL, V90, P157, DOI 10.1007/s11060-008-9648-8; Cohen-Inbar O, 2016, CAN J NEUROL SCI, V43, P494, DOI 10.1017/cjn.2016.34; Coniglio SJ, 2012, MOL MED, V18, P519, DOI 10.2119/molmed.2011.00217; Crocker M, 2011, NEURO-ONCOLOGY, V13, P99, DOI 10.1093/neuonc/noq170; da Silva R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119781; Dahlrot Rikke H, 2014, CNS Oncol, V3, P287, DOI 10.2217/cns.14.30; Dahlrot RH, 2013, J NEURO-ONCOL, V115, P453, DOI 10.1007/s11060-013-1246-8; Dahlrot RH, 2013, J NEURO-ONCOL, V114, P309, DOI 10.1007/s11060-013-1186-3; Dahlrot RH, 2013, INT J CLIN EXP PATHO, V6, P31; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Gavrielides MA, 2011, ARCH PATHOL LAB MED, V135, P233, DOI 10.1043/1543-2165-135.2.233; Gu J, 2009, EUR J PEDIATR, V168, P705, DOI 10.1007/s00431-008-0828-5; Habberstad AH, 2012, CLIN NEUROPATHOL, V31, P361, DOI 10.5414/NP300439; Handsley MM, 2005, INT J CANCER, V115, P849, DOI 10.1002/ijc.20945; Hermansen SK, 2013, J NEURO-ONCOL, V111, P71, DOI 10.1007/s11060-012-0992-3; Hua Y, 2015, J MOL NEUROSCIENCE M; Jaalinoja J, 2000, J NEURO-ONCOL, V46, P81, DOI 10.1023/A:1006421112839; Jensen SS, 2013, INT J CLIN EXP PATHO, V6, P1294; Jensen SS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159746; Jensen SS, 2013, NEUROSURGERY, V73, P868, DOI 10.1227/NEU.0000000000000118; Kanayama H, 1998, CANCER, V82, P1359, DOI 10.1002/(SICI)1097-0142(19980401)82:7<1359::AID-CNCR20>3.0.CO;2-4; Karsy M, 2012, FOLIA NEUROPATHOL, V50, P301, DOI 10.5114/fn.2012.32361; Kessler J, 2015, RADIOTHER ONCOL, V116, P381, DOI 10.1016/j.radonc.2015.08.007; Kolenda J, 2011, J NEURO-ONCOL, V103, P43, DOI 10.1007/s11060-010-0357-8; Kunishio Katsuzo, 2003, Brain Tumor Pathol, V20, P39, DOI 10.1007/BF02483445; Lathia JD, 2014, CELL REP, V6, P117, DOI 10.1016/j.celrep.2013.11.043; Laurinaviciene A, 2011, DIAGN PATHOL, V6, DOI 10.1186/1746-1596-6-87; Leinonen T, 2008, HISTOL HISTOPATHOL, V23, P693, DOI 10.14670/HH-23.693; LIOTTA LA, 1980, NATURE, V284, P67, DOI 10.1038/284067a0; Louis DN, 2016, WHO CLASSIFICATION T, DOI [10.1016/S1470-2045(12)70265-6, DOI 10.1016/S1470-2045(12)70265-6]; Malmstrom A, 2012, LANCET ONCOL, V13, P916, DOI 10.1016/S1470-2045(12)70265-6; Munthe S, 2016, J NEURO-ONCOL, V130, P53, DOI 10.1007/s11060-016-2221-y; Music D, 2016, J NEUROONCOLOGY; Nagaishi M, 2012, BRAIN PATHOL, V22, P670, DOI 10.1111/j.1750-3639.2012.00571.x; Nakada M, 1999, AM J PATHOL, V154, P417, DOI 10.1016/S0002-9440(10)65288-1; Nomura H, 1996, INT J CANCER, V69, P9, DOI 10.1002/(SICI)1097-0215(19960220)69:1<9::AID-IJC3>3.0.CO;2-8; Nuttall RK, 2003, MOL CANCER RES, V1, P333; Paldor I, 2016, J CLIN NEUROSCI, V34, P117, DOI 10.1016/j.jocn.2016.05.016; Pennacchietti S, 2003, CANCER CELL, V3, P347, DOI 10.1016/S1535-6108(03)00085-0; Petterson SA, 2015, J NEURO-ONCOL, V122, P517, DOI 10.1007/s11060-015-1723-3; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Piao YJ, 2012, NEURO-ONCOLOGY, V14, P1379, DOI 10.1093/neuonc/nos158; Preusser M, 2011, ANN NEUROL, V70, P9, DOI 10.1002/ana.22425; Reifenberger G, 2012, INT J CANCER, V131, P1342, DOI 10.1002/ijc.27385; Rempe RG, 2016, J CEREBRAL BLOOD FLO; Rutledge WC, 2013, CLIN CANCER RES, V19, P4951, DOI 10.1158/1078-0432.CCR-13-0551; Shi SR, 2008, AM J CLIN PATHOL, V129, P358, DOI 10.1309/7CXUYXT23E5AL8KQ; SHIMA I, 1992, CANCER, V70, P2747, DOI 10.1002/1097-0142(19921215)70:12<2747::AID-CNCR2820701204>3.0.CO;2-5; SILVERMAN JF, 1989, ACTA CYTOL, V33, P576; Still K, 2000, PROSTATE, V42, P18; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Tabouret E, 2014, NEURO-ONCOLOGY, V16, P392, DOI 10.1093/neuonc/not226; Talvensaari-Mattila A, 1998, CANCER-AM CANCER SOC, V83, P1153, DOI 10.1002/(SICI)1097-0142(19980915)83:6<1153::AID-CNCR14>3.0.CO;2-4; Thorns V, 2003, ANTICANCER RES, V23, P3937; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Wang JB, 2014, ONCOL LETT, V7, P651, DOI 10.3892/ol.2014.1806; Wang Maode, 2003, Brain Tumor Pathol, V20, P65, DOI 10.1007/BF02483449; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Westerlund A, 1999, GYNECOL ONCOL, V75, P91, DOI 10.1006/gyno.1999.5533; Wick W, 2012, LANCET ONCOL, V13, P707, DOI 10.1016/S1470-2045(12)70164-X; Wirsching Hans-Georg, 2016, Handb Clin Neurol, V134, P381, DOI 10.1016/B978-0-12-802997-8.00023-2; Xia L, 2015, ONCOTARGET, V6, P17354, DOI 10.18632/oncotarget.4008; Yano H, 2001, Brain Tumor Pathol, V18, P7, DOI 10.1007/BF02478919; Yong VW, 2001, NAT REV NEUROSCI, V2, P502, DOI 10.1038/35081571	72	43	45	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0172234	10.1371/journal.pone.0172234	http://dx.doi.org/10.1371/journal.pone.0172234			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5VB	28234925	Green Published, gold, Green Submitted			2022-12-27	WOS:000394688200057
J	Siddiqui, M; Ahmad, MS; Atia-tul-Wahab; Yousuf, S; Fatima, N; Shaikh, NN; Atta-ur-Rahman; Choudhary, MI				Siddiqui, Mahwish; Ahmad, Malik Shoaib; Atia-tul-Wahab; Yousuf, Sammer; Fatima, Narjis; Shaikh, Nimra Naveed; Atta-ur-Rahman; Choudhary, M. Iqbal			Biotransformation of a potent anabolic steroid, mibolerone, with Cunninghamella blakesleeana, C. echinulata, and Macrophomina phaseolina, and biological activity evaluation of its metabolites	PLOS ONE			English	Article							CISPLATIN-INDUCED CYTOTOXICITY; MICROBIAL TRANSFORMATION; CERVICAL-CANCER; COLON-CANCER; ANDROGEN; CELLS; HYDROXYLATION; BIOCATALYSTS; PRODUCTS; SURVIVAL	Seven metabolites were obtained from the microbial transformation of anabolic-androgenic steroid mibolerone (1) with Cunninghamella blakesleeana, C. echinulata, and Macrophomina phaseolina. Their structures were determined as 10 beta, 17 alpha-dihydroxy-7 alpha, 17 alpha-dimethylestr-4-en-3one (2), 6 beta, 17 alpha-dihydroxy-7 alpha, 17 alpha-dimethylestr-4-en-3-one (3), 6 beta, 10 beta, 17 beta-trihydroxy-7 alpha, 17 alpha dimethylestr- 4-en-3-one (4), 11 beta, 17 beta-dihydroxy-(20-hydroxymethyl)-7 alpha, 17 alpha-dimethylestr-4-en3- one (5), 1 alpha, 17 beta-dihydroxy-7 alpha, 17 alpha-dimethylestr-4-en-3-one (6), 1 alpha, 11 beta, 17 beta-trihydroxy-7 alpha, 17 alpha dimethylestr- 4-en-3-one (7), and 11 beta, 17 beta-dihydroxy-7 alpha, 17 alpha-dimethylestr-4-en-3-one (8), on the basis of spectroscopic studies. All metabolites, except 8, were identified as new compounds. This study indicates that C. blakesleeana, and C. echinulata are able to catalyze hydroxylation at allylic positions, whileM. phaseolina can catalyze hydroxylation of CH2 and CH3 groups of substrate 1. Mibolerone (1) was found to be a moderate inhibitor of beta-glucuronidase enzyme (IC50 = 42.98 +/- 1.24 mu M) during random biological screening, while its metabolites 2 - 4, and 8 were found to be inactive. Mibolerone (1) was also found to be significantly active against Leishmania major promastigotes (IC50 = 29.64 +/- 0.88 mu M). Its transformed products 3 (IC50 = 79.09 +/- 0.06 mu M), and 8 (IC50 = 70.09 +/- 0.05 mu M) showed a weak leishmanicidal activity, while 2 and 4 were found to be inactive. In addition, substrate 1 (IC50 = 35.7 +/- 4.46 mu M), and its metabolite 8 (IC50 = 34.16 +/- 5.3 mu M) exhibited potent cytotoxicity against HeLa cancer cell line (human cervical carcinoma). Metabolite 2 (IC50 = 46.5 +/- 5.4 mu M) also showed a significant cytotoxicity, while 3 (IC50 = 107.8 +/- 4.0 mu M) and 4 (IC50 = 152.5 +/- 2.15 mu M) showed weak cytotoxicity against HeLa cancer cell line. Compound 1 (IC50 = 46.3 +/- 11.7 mu M), and its transformed products 2 (IC50 = 43.3 +/- 7.7 mu M), 3 (IC50 = 65.6 +/- 2.5 mu M), and 4 (IC50 = 89.4 +/- 2.7 mu M) were also found to be moderately toxic to 3T3 cell line (mouse fibroblast). Interestingly, metabolite 8 showed no cytotoxicity against 3T3 cell line. Compounds 1 - 4, and 8 were also evaluated for inhibition of tyrosinase, carbonic anhydrase, and a-glucosidase enzymes, and all were found to be inactive.	[Siddiqui, Mahwish; Ahmad, Malik Shoaib; Yousuf, Sammer; Shaikh, Nimra Naveed; Atta-ur-Rahman; Choudhary, M. Iqbal] Univ Karachi, HEJ Res Inst Chem, Int Ctr Chem & Biol Sci, Karachi, Pakistan; [Atia-tul-Wahab; Fatima, Narjis; Choudhary, M. Iqbal] Univ Karachi, Dr Panjwani Ctr Mol Med & Drug Res, Int Ctr Chem & Biol Sci, Karachi, Pakistan; [Choudhary, M. Iqbal] King Abdulaziz Univ, Dept Biochem, Fac Sci, Jeddah, Saudi Arabia	University of Karachi; University of Karachi; King Abdulaziz University	Choudhary, MI (corresponding author), Univ Karachi, HEJ Res Inst Chem, Int Ctr Chem & Biol Sci, Karachi, Pakistan.; Choudhary, MI (corresponding author), Univ Karachi, Dr Panjwani Ctr Mol Med & Drug Res, Int Ctr Chem & Biol Sci, Karachi, Pakistan.; Choudhary, MI (corresponding author), King Abdulaziz Univ, Dept Biochem, Fac Sci, Jeddah, Saudi Arabia.	iqbal.choudhary@iccs.edu	Rahman, Atta-ur/M-3329-2013; Choudhary, M. Iqbal iqbal/C-8633-2012; Wahab, Atia tul/C-5839-2018	Choudhary, M. Iqbal iqbal/0000-0001-5356-3585; Wahab, Atia tul/0000-0002-2730-5547; FATIMA RIZWAN, NARJIS/0000-0001-8757-1583; Shaikh, Nimra Naveed/0000-0002-6956-3253; Ahmad, Malik Shoaib/0000-0003-1739-8302	OPCW; OPCW (Organization for the Prohibition of Chemical Weapons)	OPCW; OPCW (Organization for the Prohibition of Chemical Weapons)	OPCW financially support the whole project, through are search project entitled, "Structural and biological studies on new anabolic steroids obtained by Biotransformation".; The authors acknowledge the financial support of OPCW (Organization for the Prohibition of Chemical Weapons) through a research project entitled, "Structural and biological studies on new anabolic steroids obtained by biotransformation".	ADLERCREUTZ H, 1976, J CLIN ENDOCR METAB, V43, P497, DOI 10.1210/jcem-43-3-497; Ahmad MS, 2014, STEROIDS, V82, P53, DOI 10.1016/j.steroids.2014.01.001; Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; Babcock JC, 1967, US, Patent No. [3341557 A, 3341557]; Baydoun E, 2014, STEROIDS, V88, P95, DOI 10.1016/j.steroids.2014.06.020; Bernhardt R, 2006, J BIOTECHNOL, V124, P128, DOI 10.1016/j.jbiotec.2006.01.026; Borges KB, 2009, TETRAHEDRON-ASYMMETR, V20, P385, DOI 10.1016/j.tetasy.2009.02.009; Choudhary MI, 2011, STEROIDS, V76, P1288, DOI 10.1016/j.steroids.2011.06.007; Choudhary MI, 2010, STEROIDS, V75, P956, DOI 10.1016/j.steroids.2010.05.017; Choudhary MI, 2005, CHEM BIODIVERS, V2, P516, DOI 10.1002/cbdv.200590033; Choudhary MI, 2007, STEROIDS, V72, P923, DOI 10.1016/j.steroids.2007.08.002; Choudhary MI, 2006, CHEM PHARM BULL, V54, P927, DOI 10.1248/cpb.54.927; Cops EJ, 2008, J STEROID BIOCHEM, V110, P236, DOI 10.1016/j.jsbmb.2007.10.014; Cresnar B, 2011, BBA-PROTEINS PROTEOM, V1814, P29, DOI 10.1016/j.bbapap.2010.06.020; Edmondson R, 2002, BRIT J CANCER, V86, P879, DOI 10.1038/sj.bjc.6600154; Hafiza WAWN, 2014, ONCOTARGETS THER, V7, P1375, DOI 10.2147/OTT.S62928; Holland HL, 2000, CURR OPIN BIOTECH, V11, P547, DOI 10.1016/S0958-1669(00)00142-7; Jones WJ, 2007, ENVIRON SCI TECHNOL, V41, P8301, DOI 10.1021/es071409s; Kim DH, 2001, ARCH PHARM RES, V24, P564, DOI 10.1007/BF02975166; Kuhn JG, 1998, ONCOLOGY-NY, V12, P39; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Pariente R, 2016, J PINEAL RES, V60, P55, DOI 10.1111/jpi.12288; REDDY BS, 1973, J NATL CANCER I, V50, P1437, DOI 10.1093/jnci/50.6.1437; Rizza P, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3619; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Siewers V, 2004, APPL ENVIRON MICROB, V70, P3868, DOI 10.1128/AEM.70.7.3868-3876.2004; Smith C, 2015, STEROIDS, V102, P39, DOI 10.1016/j.steroids.2015.06.008; Spek AL, 2009, ACTA CRYSTALLOGR D, V65, P148, DOI 10.1107/S090744490804362X; Wang F, 2013, FEBS LETT, V587, P488, DOI 10.1016/j.febslet.2013.01.016; Yang Q, 2007, J CENT SOUTH UNIV T, V14, P524, DOI 10.1007/s11771-007-0102-4; Zhu QC, 2013, TUMOR BIOL, V34, P1285, DOI 10.1007/s13277-013-0684-4	31	18	18	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e71476	10.1371/journal.pone.0171476	http://dx.doi.org/10.1371/journal.pone.0171476			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5VB	28234904	Green Submitted, Green Published, gold			2022-12-27	WOS:000394688200023
J	Duy, DL; Suda, Y; Irie, K				Duy, Duong Long; Suda, Yasuyuki; Irie, Kenji			Cytoplasmic deadenylase Ccr4 is required for translational repression of LRG1 mRNA in the stationary phase	PLOS ONE			English	Article							POLY(A) TAIL LENGTH; WALL INTEGRITY PATHWAY; SACCHAROMYCES-CEREVISIAE; PUF PROTEIN; YEAST; EXPRESSION; COMPLEX; TRANSCRIPTION; CONTRIBUTES; PHOSPHORYLATION	Ccr4 is a major cytoplasmic deadenylase involved in mRNA poly(A) tail shortening in Saccharomyces cerevisiae. We have previously shown that Ccr4 negatively regulates expression of LRG1 mRNA encoding a GTPase-activating protein for the small GTPase Rho1, a component of cell wall integrity pathway, and deletion of LRG1 suppresses the temperature-sensitive growth defect of the ccr4. mutant. We have also shown that the slow growth of the ccr4. mutant is suppressed by deletion of another gene, PBP1, encoding a poly(A)-binding protein (Pab1)-binding protein 1; however, the underlying mechanism still remains unknown. In this study, we investigated how ccr4 Delta and pbp1 Delta mutations influence on the length of poly(A) tail and LRG1 mRNA and protein levels during long-term cultivation. In the log-phase ccr4 Delta mutant cells, LRG1 poly(A) tail was longer and LRG1 mRNA level was higher than those in the log-phase wild-type (WT) cells. Unexpectedly, Lrg1 protein level in the ccr4 Delta mutant cells was comparable with that in WT. In the stationary-phase ccr4 Delta mutant cells, LRG1 poly(A) tail length was still longer and LRG1 mRNA level was still higher than those in WT cells. In contrast to the log phase, Lrg1 protein level in the stationaryphase ccr4 Delta mutant cells was maintained much higher than that in the stationary-phase WT cells. Consistently, active translating ribosomes still remained abundant in the stationary-phase ccr4 Delta mutant cells, whereas they were strongly decreased in the stationary-phase WT cells. Loss of PBP1 reduced the LRG1 poly(A) tail length as well as LRG1 mRNA and protein levels in the stationary-phase ccr4. mutant cells. Our results suggest that Ccr4 regulates not only LRG1 mRNA level through poly(A) shortening but also the translation of LRG1 mRNA, and that Pbp1 is involved in the Ccr4-mediated regulation of mRNA stability and translation.	[Duy, Duong Long; Suda, Yasuyuki; Irie, Kenji] Univ Tsukuba, Grad Sch Comprehens Human Sci, Dept Mol Cell Biol, Tsukuba, Ibaraki, Japan; [Duy, Duong Long; Suda, Yasuyuki; Irie, Kenji] Univ Tsukuba, Fac Med, Tsukuba, Ibaraki, Japan; [Suda, Yasuyuki] RIKEN, Live Cell Super Resolut Imaging Res Team, Ctr Adv Photon, Wako, Saitama, Japan	University of Tsukuba; University of Tsukuba; RIKEN	Irie, K (corresponding author), Univ Tsukuba, Grad Sch Comprehens Human Sci, Dept Mol Cell Biol, Tsukuba, Ibaraki, Japan.; Irie, K (corresponding author), Univ Tsukuba, Fac Med, Tsukuba, Ibaraki, Japan.	kirie@md.tsukuba.ac.jp	Suda, Yasuyuki/D-3870-2017; Suda, Yasuyuki/AAH-5065-2020	Suda, Yasuyuki/0000-0001-8725-8001; Suda, Yasuyuki/0000-0001-8725-8001; Duong, Long Duy/0000-0001-6016-9682	Ministry of Education, Culture, Sports, Science and Technology of Japan [24570192, 15K06944]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grants-in Aid for Scientific Research (grant numbers 24570192 and 15K06944) to Kenji Irie from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the members of Molecular Cell Biology Laboratory for valuable discussions. This research was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to K.I., grant number 24570192 and 15K06944).	Ameres SL, 2013, NAT REV MOL CELL BIO, V14, P475, DOI 10.1038/nrm3611; Beilharz TH, 2007, RNA, V13, P982, DOI 10.1261/rna.569407; Belle A, 2006, P NATL ACAD SCI USA, V103, P13004, DOI 10.1073/pnas.0605420103; Bentley DL, 2014, NAT REV GENET, V15, P163, DOI 10.1038/nrg3662; Bessa D, 2012, YEAST, V29, P419, DOI 10.1002/yea.2919; Brown CE, 1998, MOL CELL BIOL, V18, P6548, DOI 10.1128/MCB.18.11.6548; Castelnuovo M, 2013, NAT STRUCT MOL BIOL, V20, P851, DOI 10.1038/nsmb.2598; Chen JJ, 2002, EMBO J, V21, P1414, DOI 10.1093/emboj/21.6.1414; Collart MA, 2016, WIRES RNA, V7, P438, DOI 10.1002/wrna.1332; Coller J, 2005, CELL, V122, P875, DOI 10.1016/j.cell.2005.07.012; Cooke A, 2010, J BIOL CHEM, V285, P28506, DOI 10.1074/jbc.M110.150763; DeMille D, 2015, MOL BIOL CELL, V26, P569, DOI 10.1091/mbc.E14-06-1088; Dever TE, 2016, GENETICS, V203, P65, DOI 10.1534/genetics.115.186221; Elden AC, 2010, NATURE, V466, P1069, DOI 10.1038/nature09320; Galdieri L, 2010, OMICS, V14, P629, DOI 10.1089/omi.2010.0069; Gerber AP, 2004, PLOS BIOL, V2, P342, DOI 10.1371/journal.pbio.0020079; Goldstrohm AC, 2007, J BIOL CHEM, V282, P109, DOI 10.1074/jbc.M609413200; Goldstrohm AC, 2006, NAT STRUCT MOL BIOL, V13, P533, DOI 10.1038/nsmb1100; Gray JV, 2004, MICROBIOL MOL BIOL R, V68, P187, DOI 10.1128/MMBR.68.2.187-206.2004; Huch S, 2014, WIRES RNA, V5, P747, DOI 10.1002/wrna.1244; Ito W, 2011, EUKARYOT CELL, V10, P1340, DOI 10.1128/EC.05181-11; Kaiser C., 1994, METHODS IN YEAST GEN; Kimura Y, 2013, EUKARYOT CELL, V12, P864, DOI 10.1128/EC.00370-12; Kushnirov VV, 2000, YEAST, V16, P857, DOI 10.1002/1097-0061(20000630)16:9<857::AID-YEA561>3.0.CO;2-B; Lenssen E, 2005, MOL CELL BIOL, V25, P488, DOI 10.1128/MCB.25.1.488-498.2005; Lenssen E, 2002, MOL MICROBIOL, V43, P1023, DOI 10.1046/j.1365-2958.2002.02799.x; Li X, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00250-16; Li X, 2007, J PROTEOME RES, V6, P1190, DOI 10.1021/pr060559j; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Mangus DA, 2004, MOL CELL BIOL, V24, P5521, DOI 10.1128/MCB.24.12.5521-5533.2004; Mangus DA, 1998, MOL CELL BIOL, V18, P7383, DOI 10.1128/MCB.18.12.7383; Manukyan A, 2008, GENETICS, V179, P345, DOI 10.1534/genetics.108.086744; Parker R, 2012, GENETICS, V191, P671, DOI 10.1534/genetics.111.137265; Preissler S, 2015, EMBO J, V34, P1905, DOI 10.15252/embj.201490194; Sakumoto NM, 1999, YEAST, V15, P1669, DOI 10.1002/(SICI)1097-0061(199911)15:15<1669::AID-YEA480>3.0.CO;2-6; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Stewart MS, 2007, EUKARYOT CELL, V6, P262, DOI 10.1128/EC.00188-06; Subtelny AO, 2014, NATURE, V508, P66, DOI 10.1038/nature13007; Swisher KD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010006; Tadauchi T, 2004, MOL CELL BIOL, V24, P3670, DOI 10.1128/MCB.24.9.3670-3681.2004; Traven A, 2009, GENETICS, V182, P955, DOI 10.1534/genetics.109.104414; Wells SE, 1998, MOL CELL, V2, P135, DOI 10.1016/S1097-2765(00)80122-7; Wilinski D, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9213; Woolstencroft RN, 2006, J CELL SCI, V119, P5178, DOI 10.1242/jcs.03221; Yokoshi M, 2014, MOL CELL, V55, P186, DOI 10.1016/j.molcel.2014.05.022	45	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2017	12	2							e0172476	10.1371/journal.pone.0172476	http://dx.doi.org/10.1371/journal.pone.0172476			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5SX	28231297	gold, Green Submitted, Green Published			2022-12-27	WOS:000394682400047
J	Jiao, DM; Yan, L; Wang, LS; Hu, HZ; Tang, XL; Chen, J; Wang, J; Li, Y; Chen, QY				Jiao, De-min; Yan, Li; Wang, Li-shan; Hu, Hui-zhen; Tang, Xia-li; Chen, Jun; Wang, Jian; Li, You; Chen, Qing-yong			RETRACTED: Exploration of inhibitory mechanisms of curcumin in lung cancer metastasis using a miRNA-transcription factor-target gene network (Retracted article. See vol. 12, 2017)	PLOS ONE			English	Article; Retracted Publication							SQUAMOUS-CELL CARCINOMA; POOR-PROGNOSIS; UP-REGULATION; IN-VIVO; INVASION; PROLIFERATION; MIGRATION; MIR-34A; OVEREXPRESSION; APOPTOSIS	The present study was aimed to unravel the inhibitory mechanisms of curcumin for lung cancer metastasis via constructing a miRNA-transcription factor (TF)-target gene network. Differentially expressed miRNAs between human high-metastatic non-small cell lung cancer 95D cells treated with and without curcumin were identified using a TaqMan human miRNA array followed by real-time PCR, out of which, the top 6 miRNAs (miR-302b-3p, miR-3355p, miR-338-3p, miR-34c-5p, miR-29c-3p and miR-34a-35p) with more verified target genes and TFs than other miRNAs as confirmed by a literature review were selected for further analysis. The miRecords database was utilized to predict the target genes of these 6 miRNAs, TFs of which were identified based on the TRANSFAC database. The findings of the above procedure were used to construct a miRNA-TF-target gene network, among which miR-34a-5p, miR-34c-5p and miR-302b-3p seemed to regulate CCND1, WNT1 and MYC to be involved in Wnt signaling pathway through the LEF1 transcription factor. Therefore, we suggest miR-34a-5p/miR-34c-5p/miR-302b-3p - LEF1 - CCND1/WNT1/MYC axis may be a crucial mechanism in inhibition of lung cancer metastasis by curcumin.	[Jiao, De-min; Hu, Hui-zhen; Tang, Xia-li; Chen, Jun; Wang, Jian; Li, You; Chen, Qing-yong] 117th Hosp PLA, Dept Resp Dis, Hangzhou, Zhejiang, Peoples R China; [Yan, Li] 117th Hosp PLA, Dept Oncol, Hangzhou, Zhejiang, Peoples R China; [Wang, Li-shan] Shanghai Jiao Tong Univ, Minist Educ, BioX Inst, Key Lab Genet Dev & Neuropsychiat Disorders, Shanghai, Peoples R China	Shanghai Jiao Tong University	Chen, QY (corresponding author), 117th Hosp PLA, Dept Resp Dis, Hangzhou, Zhejiang, Peoples R China.	cqyong117@163.com			Zhejiang Traditional Chinese Medicine Administration Bureau [2011ZA093]; Public Welfare Project of Science and Technology Department of Zhejiang Province [2014C33277, 2013C33209, 2017C33062]; Natural Science Foundation of Zhejiang Province of China [LY17H160001]; Science and Technology Plan Project of Hangzhou City [20130633629, 20140633640, 20160533674]	Zhejiang Traditional Chinese Medicine Administration Bureau; Public Welfare Project of Science and Technology Department of Zhejiang Province; Natural Science Foundation of Zhejiang Province of China(Natural Science Foundation of Zhejiang Province); Science and Technology Plan Project of Hangzhou City	This work was supported by Zhejiang Traditional Chinese Medicine Administration Bureau [Project: NO. 2011ZA093], Public Welfare Project of Science and Technology Department of Zhejiang Province (2014C33277, 2013C33209, 2017C33062), Natural Science Foundation of Zhejiang Province of China (LY17H160001) and Science and Technology Plan Project of Hangzhou City (20130633629, 20140633640 and 20160533674). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basak SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073195; Catuogno S, 2013, ONCOGENE, V32, P341, DOI 10.1038/onc.2012.51; Chen K, 2007, NAT REV GENET, V8, P93, DOI 10.1038/nrg1990; Chen PH, 2014, J NEUROCHEM, V131, P731, DOI 10.1111/jnc.12820; Da W, 2015, TUMOR BIOL, V36, P5215, DOI 10.1007/s13277-015-3178-8; Dragoj M, 2015, TUMOR BIOL, V36, P8773, DOI 10.1007/s13277-015-3620-y; Fan ZG, 2015, ONCOL REP, V34, P691, DOI 10.3892/or.2015.4044; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Geng DZ, 2015, INT J GYNECOL CANCER, V25, P707, DOI 10.1097/IGC.0000000000000399; Guo JL, 2013, MOL CELL BIOCHEM, V382, P103, DOI 10.1007/s11010-013-1723-6; Ji C, 2008, CANCER CHEMOTH PHARM, V62, P857, DOI 10.1007/s00280-007-0674-6; Jia LF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108435; Jin H, 2015, ONCOL REP, V34, P2782, DOI 10.3892/or.2015.4258; Killian PH, 2012, CARCINOGENESIS, V33, P2507, DOI 10.1093/carcin/bgs312; Lei B, 2015, AM J CANCER RES, V5, P3123; Li JY, 2016, CELL PHYSIOL BIOCHEM, V38, P1715, DOI 10.1159/000443111; Liang JQ, 2015, MOL CANCER RES, V13, P681, DOI 10.1158/1541-7786.MCR-14-0503; Liao HH, 2015, INT J CLIN EXP MED, V8, P8948; Lu Y, VITRO CELLULAR DEV B; Mahran RI, 2017, AAPS J, V19, P54, DOI 10.1208/s12248-016-0003-2; Murakami T, 2001, BIOCHEM BIOPH RES CO, V288, P8, DOI 10.1006/bbrc.2001.5719; Nakashima T, 2008, ONCOL REP, V19, P203; Nguyen DX, 2009, CELL, V138, P51, DOI 10.1016/j.cell.2009.04.030; Nie JH, 2015, ONCOL REP, V34, P311, DOI 10.3892/or.2015.3962; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Toden S, 2015, CANCER PREV RES, V8, P431, DOI 10.1158/1940-6207.CAPR-14-0354; Wang LM, 2016, TUMOR BIOL, V37, P847, DOI 10.1007/s13277-015-3330-5; Wang P, 2013, MAT SCI ENG C-MATER, V33, P4802, DOI 10.1016/j.msec.2013.07.047; Watson AL, 2013, CANCER DISCOV, V3, P674, DOI 10.1158/2159-8290.CD-13-0081; Wingender E, 2008, BRIEF BIOINFORM, V9, P326, DOI 10.1093/bib/bbn016; Wu KL, 2015, LUNG CANCER, V88, P187, DOI 10.1016/j.lungcan.2015.02.012; Xiao FF, 2009, NUCLEIC ACIDS RES, V37, pD105, DOI 10.1093/nar/gkn851; Xu M, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0972-x; Ye MX, 2015, CANCER LETT, V357, P196, DOI 10.1016/j.canlet.2014.11.028; Zhang EB, 2016, TUMOR BIOL, V37, P4007, DOI 10.1007/s13277-015-4185-5; Zhang MX, 2014, J EXP CLIN CANC RES, V33, DOI 10.1186/1756-9966-33-10; Zhang Y, 2013, J MATER CHEM B, V1, P132, DOI 10.1039/c2tb00071g; Zhao HE, 2013, ONCOL REP, V29, P1027, DOI 10.3892/or.2013.2234	40	16	16	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2017	12	2							e0172470	10.1371/journal.pone.0172470	http://dx.doi.org/10.1371/journal.pone.0172470			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5SX	28231299	Green Published, gold, Green Submitted			2022-12-27	WOS:000394682400046
J	Machida, RJ; Lin, YY				Machida, Ryuji J.; Lin, Ya-Ying			Occurrence of mitochondrial CO1 pseudogenes in Neocalanus plumchrus (Crustacea: Copepoda): Hybridization indicated by recombined nuclear mitochondrial pseudogenes	PLOS ONE			English	Article							SUB-ARCTIC PACIFIC; REGIONAL-VARIATIONS; OYASHIO REGION; LIFE-CYCLE; ENZYMATIC AMPLIFICATION; CRISTATUS CRUSTACEA; EUCALANUS-BUNGII; DOMESTIC CAT; GENOME SIZE; DNA	A portion of the mitochondrial cytochrome c oxidase I gene was sequenced using both genomic DNA and complement DNA from three planktonic copepod Neocalanus species (N. cristatus, N. plumchrus, and N. flemingeri). Small but critical sequence differences in CO1 were observed between gDNA and cDNA from N. plumchrus. Furthermore, careful observation revealed the presence of recombination between sequences in gDNA from N. plumchrus. Moreover, a chimera of the N. cristatus and N. plumchrus sequences was obtained from N. plumchrus gDNA. The observed phenomena can be best explained by the preferential amplification of the nuclear mitochondrial pseudogenes from gDNA of N. plumchrus. Two conclusions can be drawn from the observations. First, nuclear mitochondrial pseudogenes are pervasive in N. plumchrus. Second, a mating between a female N. cristatus and a male N. plumchrus produced viable offspring, which further backcrossed to a N. plumchrus individual. These observations not only demonstrate intriguing mating behavior in these species, but also emphasize the importance of careful interpretation of species marker sequences amplified from gDNA.	[Machida, Ryuji J.; Lin, Ya-Ying] Acad Sinica, Biodivers Res Ctr, Taipei, Taiwan	Academia Sinica - Taiwan	Machida, RJ (corresponding author), Acad Sinica, Biodivers Res Ctr, Taipei, Taiwan.	ryujimachida@gmail.com			Academia Sinica; Ministry of Science and Technology, Taiwan [102-2611-M-001-002-MY3, 105-2621-B-001-003]	Academia Sinica(Academia Sinica - Taiwan); Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	This work was funded by Academia Sinica and the Ministry of Science and Technology, Taiwan (102-2611-M-001-002-MY3, 105-2621-B-001-003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams KL, 2000, NATURE, V408, P354, DOI 10.1038/35042567; Baeza JA, 2013, ZOOL J LINN SOC-LOND, V168, P699, DOI 10.1111/zoj.12044; Antunes A, 2007, J HERED, V98, P414, DOI 10.1093/jhered/esm062; Bensasson D, 2000, MOL BIOL EVOL, V17, P406, DOI 10.1093/oxfordjournals.molbev.a026320; Bensasson D, 2001, TRENDS ECOL EVOL, V16, P314, DOI 10.1016/S0169-5347(01)02151-6; Bensasson D, 2001, MOL BIOL EVOL, V18, P246, DOI 10.1093/oxfordjournals.molbev.a003798; Berg OG, 2000, MOL BIOL EVOL, V17, P951, DOI 10.1093/oxfordjournals.molbev.a026376; Buhay JE, 2009, J CRUSTACEAN BIOL, V29, P96, DOI 10.1651/08-3020.1; Collura RV, 1996, CURR BIOL, V6, P1337, DOI 10.1016/S0960-9822(02)70720-3; GRAUR D, 1989, J MOL EVOL, V28, P279, DOI 10.1007/BF02103423; Hazkani-Covo E, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000834; Hlaing T, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-11; Kamimura N, 1989, J MOL BIOL, V16, P111; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kebschull JM, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv717; Kim JH, 2006, GENE, V366, P292, DOI 10.1016/j.gene.2005.08.023; Kim SJ, 2013, MOL ECOL RESOUR, V13, P781, DOI 10.1111/1755-0998.12119; Kobari T, 2001, J PLANKTON RES, V23, P287, DOI 10.1093/plankt/23.3.287; Kobari T, 2001, MAR ECOL PROG SER, V209, P243, DOI 10.3354/meps209243; Kobari T, 1999, MAR BIOL, V134, P683, DOI 10.1007/s002270050584; LOPEZ JV, 1994, J MOL EVOL, V39, P174; Machida RJ, 2006, MAR BIOL, V148, P1071, DOI 10.1007/s00227-005-0140-0; Machida RJ, 2004, GENE, V332, P71, DOI 10.1016/j.gene.2004.01.019; MILLER CB, 1984, PROG OCEANOGR, V13, P201, DOI 10.1016/0079-6611(84)90009-0; Nielsen KK, 2001, MOL PHYLOGENET EVOL, V18, P362, DOI 10.1006/mpev.2000.0885; PAABO S, 1990, J BIOL CHEM, V265, P4718; Parent GJ, 2012, LIMNOL OCEANOGR, V57, P1057, DOI 10.4319/lo.2012.57.4.1057; Petrov DA, 2001, TRENDS GENET, V17, P23, DOI 10.1016/S0168-9525(00)02157-0; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SchneiderBroussard R, 1997, MOL BIOL EVOL, V14, P156, DOI 10.1093/oxfordjournals.molbev.a025748; Simone D, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-517; Song H, 2008, P NATL ACAD SCI USA, V105, P13486, DOI 10.1073/pnas.0803076105; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Sunnucks P, 1996, MOL BIOL EVOL, V13, P510, DOI 10.1093/oxfordjournals.molbev.a025612; Taanman JW, 1999, BBA-BIOENERGETICS, V1410, P103, DOI 10.1016/S0005-2728(98)00161-3; Tsuda A, 1999, MAR BIOL, V135, P533, DOI 10.1007/s002270050654; Williams ST, 2001, MOL BIOL EVOL, V18, P1484, DOI 10.1093/oxfordjournals.molbev.a003934; Wyngaard GA, 2000, HYDROBIOLOGIA, V417, P43, DOI 10.1023/A:1003855322358; ZISCHLER H, 1995, NATURE, V378, P489, DOI 10.1038/378489a0	39	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2017	12	2							e0172710	10.1371/journal.pone.0172710	http://dx.doi.org/10.1371/journal.pone.0172710			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5SX	28231343	Green Published, gold, Green Submitted			2022-12-27	WOS:000394682400075
J	Zhang, WX; Fan, JJ; Tan, QQ; Zhao, MM; Zhou, T; Cao, FL				Zhang, Wangxiang; Fan, Junjun; Tan, Qianqian; Zhao, Mingming; Zhou, Ting; Cao, Fuliang			The effects of exogenous hormones on rooting process and the activities of key enzymes of Malus hupehensis stem cuttings	PLOS ONE			English	Article							SUPEROXIDE-DISMUTASE; ANTIOXIDANT ENZYMES; BIOCHEMICAL-CHANGES; PEROXIDASE-ACTIVITY; ADVENTITIOUS ROOTS; ABSCISIC-ACID; IN-VITRO; AUXIN; STRESS; LIGNIN	Malus hupehensis is an excellent Malus rootstock species, known for its strong adverse-resistance and apomixes. In the present study, stem cuttings of M. hupehensis were treated with three types of exogenous hormones, including indole acetic acid (IAA), naphthalene acetic acid (NAA), or green growth regulator (GGR). The effects and mechanisms of exogenous hormone treatment and antioxidant enzyme activity on adventitious root formation were investigated. The results showed that the apparent morphology of the adventitious root had four stages, including root pre-emergence stage (S-0), early stage of root formation (S-1), massive root formation stage (S-2), and later stage of root formation (S-3). The suitable concentrations of the three exogenous hormones, IAA, NAA and GGR, were 100 mg.L-1, 300 mg.L-1, and 300 mg.L-1, respectively. They shortened the rooting time by 25-47.4% and increased the rooting percentages of cuttings by 0.9-1.3 times, compared with that in the control. The dispersion in S0 stage was 3.6 times of that in the S1 stage after exogenous hormone application. The earlier the third critical point (P-3) appeared, the shorter the rooting time and the greater the rooting percentage of the cuttings. During rhizogenesis, the activities of three antioxidant enzymes (POD, SOD, and PPO) showed an A-shaped trend. However, peak values of enzyme activity appeared at different points, which were 9 d before the P-3, P-3, and the fourth critical point (P-4), respectively. Exogenous hormone treatment reduced the time to reach the peak value by 18 days, although the peak values of the enzymatic activities did not significantly changed. Our results suggested that exogenous hormone treatment mainly acted during the root pre-emergence stage, accelerated the synthesis of antioxidant enzymes, reduced the rooting time, and consequently promoted root formation. The three kinds of antioxidant enzymes acted on different stages of rooting.	[Zhang, Wangxiang; Fan, Junjun; Zhao, Mingming; Zhou, Ting; Cao, Fuliang] Nanjing Forestry Univ, Coll Forestry, Nanjing, Jiangsu, Peoples R China; [Zhang, Wangxiang; Fan, Junjun; Zhao, Mingming; Zhou, Ting; Cao, Fuliang] Coinnovat Ctr Sustainable Forestry Southern China, Nanjing, Jiangsu, Peoples R China; [Zhang, Wangxiang] Yangzhou Crabapple Hort Co Ltd, Yangzhou, Jiangsu, Peoples R China; [Tan, Qianqian] Suzhou Forestry Stn, Suzhou, Peoples R China	Nanjing Forestry University	Zhang, WX (corresponding author), Nanjing Forestry Univ, Coll Forestry, Nanjing, Jiangsu, Peoples R China.; Zhang, WX (corresponding author), Coinnovat Ctr Sustainable Forestry Southern China, Nanjing, Jiangsu, Peoples R China.; Zhang, WX (corresponding author), Yangzhou Crabapple Hort Co Ltd, Yangzhou, Jiangsu, Peoples R China.	malus2011@163.com			National Key Technology Research and Development Program of the Ministry of Science and Technology of China [2015BAD0760104]; Jiangsu Province Science and Technology Support Program [6E2016388]; Jiangsu Province Agricultural Science and Technology Innovation Fund Project [CX(14)2029]	National Key Technology Research and Development Program of the Ministry of Science and Technology of China(National Key Technology R&D Program); Jiangsu Province Science and Technology Support Program; Jiangsu Province Agricultural Science and Technology Innovation Fund Project	The National Key Technology Research and Development Program of the Ministry of Science and Technology of China (2015BAD0760104), the Jiangsu Province Science and Technology Support Program (6E2016388) and the Jiangsu Province Agricultural Science and Technology Innovation Fund Project (CX(14)2029) funded this work. Yangzhou Crabapple Horticulture Company Limited provided support in the form of salaries for author WZ, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author (WZ) is articulated in the 'author contributions' section.	Almeselmani M, 2006, PLANT SCI, V171, P382, DOI 10.1016/j.plantsci.2006.04.009; Agullo-Anton MA, 2011, J PLANT GROWTH REGUL, V30, P100, DOI 10.1007/s00344-010-9174-8; Agullo-Anton MA, 2014, PHYSIOL PLANTARUM, V150, P446, DOI 10.1111/ppl.12114; BALAKRISHNAMURTHY G, 1988, CURR SCI INDIA, V57, P960; BOWLER C, 1992, ANNU REV PLANT PHYS, V43, P83, DOI 10.1146/annurev.pp.43.060192.000503; De Klerk GJ, 1999, IN VITRO CELL DEV-PL, V35, P189, DOI 10.1007/s11627-999-0076-z; Gaia G, 2009, ANN PLANT REV, V37, P127; GIANNOPOLITIS CN, 1977, PLANT PHYSIOL, V59, P309, DOI 10.1104/pp.59.2.309; Graves William R., 2002, Journal of Environmental Horticulture, V20, P57; Guan L, 2015, CRIT REV PLANT SCI, V34, P506, DOI 10.1080/07352689.2015.1090831; Jackson PAP, 2001, PLANT PHYSIOL, V127, P1065, DOI 10.1104/pp.010192; Keeley K, 2004, AM J ENOL VITICULT, V55, P265; Kevers C, 1997, J APPL BOT-ANGEW BOT, V71, P71; Kose C, 2011, J SCI FOOD AGR, V91, P738, DOI 10.1002/jsfa.4244; LEWIS NG, 1990, ANNU REV PLANT PHYS, V41, P455, DOI 10.1146/annurev.pp.41.060190.002323; Man WU, 2010, SHANDONG AGR SCI, P24; Mayer AM, 2006, PHYTOCHEMISTRY, V67, P2318, DOI 10.1016/j.phytochem.2006.08.006; Metaxas DJ, 2004, PLANT GROWTH REGUL, V44, P257, DOI 10.1007/s10725-004-5931-7; MONCOUSIN C, 1983, BIOCHEM PHYSIOL PFL, V178, P263, DOI 10.1016/S0015-3796(83)80040-7; Nag S, 2001, J PLANT GROWTH REGUL, V20, P182, DOI 10.1007/s003440010016; Naija S, 2008, CR BIOL, V331, P518, DOI 10.1016/j.crvi.2008.04.002; Negishi N, 2014, NEW FOREST, V45, P577, DOI 10.1007/s11056-014-9420-1; Papadakis AK, 2002, PLANT PHYSIOL BIOCH, V40, P549, DOI 10.1016/S0981-9428(02)01423-7; Passardi F, 2005, PLANT CELL REP, V24, P255, DOI 10.1007/s00299-005-0972-6; Rout GR, 1996, PLANT GROWTH REGUL, V19, P35, DOI 10.1007/BF00024400; Rout GR, 2006, PLANT GROWTH REGUL, V48, P111, DOI 10.1007/s10725-005-5665-1; SATO Y, 1993, PLANTA, V189, P584, DOI 10.1007/BF00198223; SCHMIDT H, 1977, Z PFLANZENZUCHT, V78, P3; Steffens B, 2006, PLANTA, V223, P604, DOI 10.1007/s00425-005-0111-1; Syros T, 2004, J PLANT PHYSIOL, V161, P69, DOI 10.1078/0176-1617-00938; Tartoura KAH, 2001, ACTA PHYSIOL PLANT, V23, P149, DOI 10.1007/s11738-001-0002-4; Tian M, 2003, PLANT SCI, V165, P701, DOI 10.1016/S0168-9452(03)00224-3; Tonon G, 2001, TREE PHYSIOL, V21, P655, DOI 10.1093/treephys/21.10.655; Ueda Y, 2013, PLANT PHYSIOL BIOCH, V70, P396, DOI 10.1016/j.plaphy.2013.06.009; Wei YW, 2012, HORTICULTURE SEED, P37; Yan YH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090700; Yilmaz Hayrullah, 2003, Turkish Journal of Botany, V27, P495; Yv DJ, 1974, FLORA REIPUBLICAE PO, V36; Zhang WX, J PLANT GROWTH REGUL; Zhao YunLong, 2013, Scientia Silvae Sinicae, V49, P45; Zhou Z. Q., 1999, GENET RESOUR CROP EV, V46, P599	41	20	25	4	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2017	12	2							e0172320	10.1371/journal.pone.0172320	http://dx.doi.org/10.1371/journal.pone.0172320			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5SX	28231330	gold, Green Published, Green Submitted			2022-12-27	WOS:000394682400035
J	Cho, YE; Im, EJ; Moon, PG; Mezey, E; Song, BJ; Baek, MC				Cho, Young-Eun; Im, Eun-Ju; Moon, Pyong-Gon; Mezey, Esteban; Song, Byoung-Joon; Baek, Moon-Chang			Increased liver-specific proteins in circulating extracellular vesicles as potential biomarkers for drug- and alcohol-induced liver injury	PLOS ONE			English	Article							ACETAMINOPHEN HEPATOTOXICITY; MESSENGER-RNAS; EXOSOMES; IDENTIFICATION; MOUSE; MICRORNAS; MODEL; RAT; AMINOTRANSFERASE; MECHANISMS	Drug- and alcohol-induced liver injury are a leading cause of liver failure and transplantation. Emerging evidence suggests that extracellular vesicles (EVs) are a source of biomarkers because they contain unique proteins reflecting the identity and tissue-specific origin of the EV proteins. This study aimed to determine whether potentially hepatotoxic agents, such as acetaminophen (APAP) and binge alcohol, can increase the amounts of circulating EVs and evaluate liver-specific EV proteins as potential biomarkers for liver injury. The circulating EVs, isolated from plasma of APAP-exposed, ethanol-fed mice, or alcoholic hepatitis patients versus normal control counterparts, were characterized by proteomics and biochemical methods. Liver specific EV proteins were analyzed by immunoblots and ELISA. The amounts of total and liver-specific proteins in circulating EVs from APAP-treated mice significantly increased in a dose-and time-dependent manner. Proteomic analysis of EVs from APAP-exposed mice revealed that the amounts of liver-specific and/or hepatotoxic proteins were increased compared to those of controls. Additionally, the increased protein amounts in EVs following APAP exposure returned to basal levels when mice were treated with N-acetylcysteine or glutathione. Similar results of increased amounts and liver-specific proteins in circulating EVs were also observed in mice exposed to hepatotoxic doses of thioacetamide or D-galactosamine but not by non-hepatotoxic penicillin or myotoxic bupivacaine. Additionally, binge ethanol exposure significantly elevated liver-specific proteins in circulating EVs from mice and alcoholics with alcoholic hepatitis, compared to control counterparts. These results indicate that circulating EVs in drug-and alcohol-mediated hepatic injury contain liver-specific proteins that could serve as specific biomarkers for hepatotoxicity.	[Cho, Young-Eun; Im, Eun-Ju; Moon, Pyong-Gon; Baek, Moon-Chang] Kyungpook Natl Univ, Cell & Matrix Res Inst, Sch Med, Dept Mol Med, Daegu, South Korea; [Cho, Young-Eun; Song, Byoung-Joon] NIAAA, Sect Mol Pharmacol & Toxicol, Lab Membrane Biochem & Biophys, NIH, Bethesda, MD USA; [Mezey, Esteban] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA	Kyungpook National University; National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); Johns Hopkins University	Baek, MC (corresponding author), Kyungpook Natl Univ, Cell & Matrix Res Inst, Sch Med, Dept Mol Med, Daegu, South Korea.	mcbaek@knu.ac.kr		Mezey, Esteban/0000-0001-8217-4466	National Research Foundation of Korea (NRF) - Korea government [2014R1A5A2009242]; Intramural Fund of the National Institute on Alcoholism and Alcohol Abuse, NIH, U.S.A; Korean Research Institute of Bioscience and Biotechnology; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK089502] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000036] Funding Source: NIH RePORTER	National Research Foundation of Korea (NRF) - Korea government(National Research Foundation of Korea); Intramural Fund of the National Institute on Alcoholism and Alcohol Abuse, NIH, U.S.A; Korean Research Institute of Bioscience and Biotechnology; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by a National Research Foundation of Korea (NRF) grant funded by the Korea government (2014R1A5A2009242) and by the Intramural Fund of the National Institute on Alcoholism and Alcohol Abuse, NIH, U.S.A. In addition, this research was partially supported by the Korean Biomedical Scientist Fellowship Program Award (to YEC) by the Korean Research Institute of Bioscience and Biotechnology.	Abdelmegeed MA, 2016, FREE RADICAL BIO MED, V91, P188, DOI 10.1016/j.freeradbiomed.2015.12.016; Abdelmegeed MA, 2013, FREE RADICAL BIO MED, V65, P1238, DOI 10.1016/j.freeradbiomed.2013.09.009; Abdelmegeed MA, 2012, J HEPATOL, V57, P860, DOI 10.1016/j.jhep.2012.05.019; Abdelmegeed MA, 2011, J NUTR, V141, P603, DOI 10.3945/jn.110.135210; Antoine DJ, 2013, HEPATOLOGY, V58, P777, DOI 10.1002/hep.26294; Antoine DJ, 2012, J HEPATOL, V56, P1070, DOI 10.1016/j.jhep.2011.12.019; Bala S, 2012, HEPATOLOGY, V56, P1946, DOI 10.1002/hep.25873; Baldwin S, 2016, NANOMEDICINE NANOTEC; Bell LN, 2012, ALIMENT PHARM THER, V35, P600, DOI 10.1111/j.1365-2036.2011.04982.x; Bertola A, 2013, NAT PROTOC, V8, P627, DOI 10.1038/nprot.2013.032; Caradec J, 2014, CLIN BIOCHEM, V47, P1286, DOI 10.1016/j.clinbiochem.2014.06.011; Cho YE, 2014, ELECTROPHORESIS, V35, P911, DOI 10.1002/elps.201300137; Cho YE, 2013, PROTEOMICS, V13, P1257, DOI 10.1002/pmic.201200368; Cho YE, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.010884; Chun LJ, 2009, J CLIN GASTROENTEROL, V43, P342, DOI 10.1097/MCG.0b013e31818a3854; Conde-Vancells J, 2010, PROTEOM CLIN APPL, V4, P416, DOI 10.1002/prca.200900103; Conde-Vancells J, 2008, J PROTEOME RES, V7, P5157, DOI 10.1021/pr8004887; Corrado C, 2013, INT J MOL SCI, V14, P5338, DOI 10.3390/ijms14035338; Cui YX, 2010, PHARMACOGENOMICS, V11, P573, DOI 10.2217/PGS.10.37; Dragovic RA, 2011, NANOMED-NANOTECHNOL, V7, P780, DOI 10.1016/j.nano.2011.04.003; Fujita Y, 2016, CANCER SCI, V107, P385, DOI 10.1111/cas.12896; Gholson CF, 1997, AM J GASTROENTEROL, V92, P1788; Hirsova P, 2016, HEPATOLOGY, V64, P2219, DOI 10.1002/hep.28814; Kalra H, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17020170; Kwon HJ, 2014, HEPATOLOGY, V60, P146, DOI 10.1002/hep.27036; Lee JE, 2016, J PROTEOMICS, V131, P17, DOI 10.1016/j.jprot.2015.10.005; Lee WM, 2003, NEW ENGL J MED, V349, P474, DOI 10.1056/NEJMra021844; Lemoinne S, 2014, NAT REV GASTRO HEPAT, V11, DOI 10.1038/nrgastro.2014.7; Leung TM, 2012, HEPATOLOGY, V55, P1596, DOI 10.1002/hep.25543; Lewis PJS, 2011, HEPATOLOGY, V54, P1767, DOI 10.1002/hep.24538; Lieber CS, 2004, AM J CLIN NUTR, V79, P502; Masyuk AI, 2013, J HEPATOL, V59, P621, DOI 10.1016/j.jhep.2013.03.028; McGill MR, 2014, HEPATOLOGY, V60, P1336, DOI 10.1002/hep.27265; Merrick B. Alex, 2009, V99, P367; Mofrad P, 2003, HEPATOLOGY, V37, P1286, DOI 10.1053/jhep.2003.50229; Moon PG, 2016, CLIN CANCER RES, V22, P1757, DOI 10.1158/1078-0432.CCR-15-0654; Nathwani RA, 2005, HEPATOLOGY, V41, P380, DOI 10.1002/hep.20548; Navarro VJ, 2006, NEW ENGL J MED, V354, P731, DOI 10.1056/NEJMra052270; Patel SJ, 2012, NAT BIOTECHNOL, V30, P179, DOI 10.1038/nbt.2089; Peinado H, 2012, NAT MED, V18, P883, DOI 10.1038/nm.2753; Platt R, 2008, PHARMACOEPIDEM DR S, V17, P1175, DOI 10.1002/pds.1668; Ramaiah SK, 2007, FOOD CHEM TOXICOL, V45, P1551, DOI 10.1016/j.fct.2007.06.007; Rodriguez-Suarez E, 2014, J PROTEOMICS, V103, P227, DOI 10.1016/j.jprot.2014.04.008; Royo F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068693; Saito C, 2010, HEPATOLOGY, V51, P246, DOI 10.1002/hep.23267; Singal AK, 2014, CLIN GASTROENTEROL H, V12, P555, DOI 10.1016/j.cgh.2013.06.013; Stine JG, 2011, EXPERT OPIN DRUG MET, V7, P875, DOI 10.1517/17425255.2011.577415; Tonomura Y, 2012, TOXICOLOGY, V302, P179, DOI 10.1016/j.tox.2012.07.012; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Van Summeren A, 2013, OMICS, V17, P71, DOI 10.1089/omi.2012.0079; Wang K, 2009, P NATL ACAD SCI USA, V106, P4402, DOI 10.1073/pnas.0813371106; Weerasinghe SVW, 2014, AM J PHYSIOL-GASTR L, V307, pG355, DOI 10.1152/ajpgi.00303.2013; Wetmore BA, 2010, HEPATOLOGY, V51, P2127, DOI 10.1002/hep.23574; Yang X, 2014, TOXICOL LETT, V225, P401, DOI 10.1016/j.toxlet.2014.01.013; Yang X, 2012, TOXICOL SCI, V125, P335, DOI 10.1093/toxsci/kfr321	55	45	46	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2017	12	2							e0172463	10.1371/journal.pone.0172463	http://dx.doi.org/10.1371/journal.pone.0172463			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5SK	28225807	Green Submitted, Green Published, gold			2022-12-27	WOS:000394680900044
J	Choi, YS; Park, YB; Ha, CW; Kim, JA; Heo, JC; Han, WJ; Oh, SY; Choi, SJ				Choi, Yoo Shin; Park, Yong-Beom; Ha, Chul-Won; Kim, Jin A.; Heo, Jin-Chul; Han, Woo-Jung; Oh, Soo-Young; Choi, Suk-Joo			Different characteristics of mesenchymal stem cells isolated from different layers of full term placenta	PLOS ONE			English	Article							AMNIOTIC EPITHELIAL-CELLS; STROMAL CELLS; BONE-MARROW; PROGENITOR CELLS; CHORIONIC VILLI; FETAL; TISSUE; MEMBRANE; ORIGIN; CORD	Background The placenta is a very attractive source of mesenchymal stem cells (MSCs) for regenerative medicine due to readily availability, non-invasive acquisition, and avoidance of ethical issues. Isolating MSCs from parts of placenta tissue has obtained growing interest because they are assumed to exhibit different proliferation and differentiation potentials due to complex structures and functions of the placenta. The objective of this study was to isolate MSCs from different parts of the placenta and compare their characteristics. Methods Placenta was divided into amniotic epithelium (AE), amniotic membrane (AM), chorionic membrane (CM), chorionic villi (CV), chorionic trophoblast without villi (CT-V), decidua (DC), and whole placenta (Pla). Cells isolated from each layer were subjected to analyses for their morphology, proliferation ability, surface markers, and multi-lineage differentiation potential. MSCs were isolated from all placental layers and their characteristics were compared. Findings Surface antigen phenotype, morphology, and differentiation characteristics of cells from all layers indicated that they exhibited properties of MSCs. MSCs from different placental layers had different proliferation rates and differentiation potentials. MSCs from CM, CT-V, CV, and DC had better population doubling time and multi-lineage differentiation potentials compared to those from other layers. Conclusions Our results indicate that MSCs with different characteristics can be isolated from all layers of term placenta. These finding suggest that it is necessary to appropriately select MSCs from different placental layers for successful and consistent outcomes in clinical applications.	[Choi, Yoo Shin] Chung Ang Univ, Coll Med, Chung Ang Univ Hosp, Dept Surg, Seoul, South Korea; [Park, Yong-Beom] Chung Ang Univ, Chung Ang Univ Hosp, Dept Orthoped Surg, Coll Med, Seoul, South Korea; [Ha, Chul-Won; Kim, Jin A.; Heo, Jin-Chul; Han, Woo-Jung] Sungkyunkwan Univ, Sch Med, Dept Orthoped Surg, Samsung Med Ctr, Seoul, South Korea; [Ha, Chul-Won; Kim, Jin A.; Heo, Jin-Chul; Han, Woo-Jung] Samsung Med Ctr, Stem Cell & Regenerat Med Inst, Seoul, South Korea; [Ha, Chul-Won] Sungkyunkwan Univ, Dept Hlth Sci & Technol, SAIHST, Seoul, South Korea; [Oh, Soo-Young; Choi, Suk-Joo] Sungkyunkwan Univ, Sch Med, Dept Obstet & Gynecol, Samsung Med Ctr, Seoul, South Korea	Chung Ang University; Chung Ang University Hospital; Chung Ang University; Chung Ang University Hospital; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Sungkyunkwan University (SKKU); Samsung Medical Center	Ha, CW (corresponding author), Sungkyunkwan Univ, Sch Med, Dept Orthoped Surg, Samsung Med Ctr, Seoul, South Korea.; Ha, CW (corresponding author), Samsung Med Ctr, Stem Cell & Regenerat Med Inst, Seoul, South Korea.; Ha, CW (corresponding author), Sungkyunkwan Univ, Dept Hlth Sci & Technol, SAIHST, Seoul, South Korea.	chulwon.ha@gmail.com	Ha, C/GZL-9046-2022	Park, Yong-Beom/0000-0002-3741-2311	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HI14C3484]	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea	This research was supported by a grant (HI14C3484) of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) funded by the Ministry of Health & Welfare, Republic of Korea. The funding sources had no involvement in the study design, collection, data analysis, data interpretation, writing of the manuscript, or the decision to submit the manuscript for publication.	Bacenkova D, 2011, CYTOTHERAPY, V13, P1047, DOI 10.3109/14653249.2011.592522; Baek GO, 2006, J KOREAN ORTHOPAEDIC, V9, P188; Barlow S, 2008, STEM CELLS DEV, V17, P1095, DOI 10.1089/scd.2007.0154; Battula VL, 2008, DIFFERENTIATION, V76, P326, DOI 10.1111/j.1432-0436.2007.00225.x; Bilic G, 2008, CELL TRANSPLANT, V17, P955, DOI 10.3727/096368908786576507; Brooke G, 2008, STEM CELLS DEV, V17, P929, DOI 10.1089/scd.2007.0156; El-Ansary M, 2012, STEM CELL REV REP, V8, P972, DOI 10.1007/s12015-011-9322-y; Fariha MMN, 2011, CYTOTHERAPY, V13, P582, DOI 10.3109/14653249.2010.549121; Han Zhi-Bo, 2013, Zhongguo Shi Yan Xue Ye Xue Za Zhi, V21, P754, DOI 10.7534/j.issn.1009-2137.2013.03.042; Hass R, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-12; Ilancheran S, 2009, PLACENTA, V30, P2, DOI 10.1016/j.placenta.2008.09.009; in't Anker PS, 2004, STEM CELLS, V22, P1338, DOI 10.1634/stemcells.2004-0058; Indumathi S, 2013, TISSUE CELL, V45, P434, DOI 10.1016/j.tice.2013.07.007; Jones GN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043395; Koo BK, 2012, J KOREAN MED SCI, V27, P857, DOI 10.3346/jkms.2012.27.8.857; Kulterer B, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-70; Macias MI, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.06.045; Mathews S, 2015, SCI REP-UK, V5, DOI 10.1038/srep10054; Miki T, 2005, STEM CELLS, V23, P1549, DOI 10.1634/stemcells.2004-0357; Miki Toshio, 2010, Curr Protoc Stem Cell Biol, VChapter 1, DOI [10.1002/9780470151808.sc01e03s3, 10.1002/9780470151808.sc01e03s12]; Moore RM, 2003, PLACENTA, V24, P173, DOI 10.1053/plac.2002.0886; Nazarov I, 2012, STEM CELL TRANSL MED, V1, P359, DOI 10.5966/sctm.2011-0021; Ochsenbein-Kolble N, 2003, J PERINAT MED, V31, P287, DOI 10.1515/JPM.2003.040; Parant O, 2009, LAB INVEST, V89, P915, DOI 10.1038/labinvest.2009.55; Parolini O, 2008, STEM CELLS, V26, P300, DOI 10.1634/stemcells.2007-0594; Pedram MS, 2010, SPINAL CORD, V48, P457, DOI 10.1038/sc.2009.153; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Portmann-Lanz CB, 2006, AM J OBSTET GYNECOL, V194, P664, DOI 10.1016/j.ajog.2006.01.101; Rosada C, 2003, CALCIFIED TISSUE INT, V72, P135, DOI 10.1007/s00223-002-2002-9; Sabapathy V, 2012, STEM CELLS INT, V2012, DOI 10.1155/2012/174328; Semenov OV, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2009.10.869; Shaer A, 2014, PAK J MED SCI, V30, P1022, DOI 10.12669/pjms.305.4537; Stadler G, 2008, CYTOTHERAPY, V10, P743, DOI 10.1080/14653240802345804; Strom SC, 2006, STEM CELL REV; Tamagawa Tomoharu, 2004, Hum Cell, V17, P125; Wegmeyer H, 2013, STEM CELLS DEV, V22, P2606, DOI 10.1089/scd.2013.0016; Wolbank S, 2007, TISSUE ENG, V13, P1173, DOI 10.1089/ten.2006.0313; Yamahara K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088319; Zhang XH, 2006, BIOCHEM BIOPH RES CO, V340, P944, DOI 10.1016/j.bbrc.2005.12.091; Zhu YZ, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt436	40	27	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2017	12	2							e0172642	10.1371/journal.pone.0172642	http://dx.doi.org/10.1371/journal.pone.0172642			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5SK	28225815	Green Published, gold, Green Submitted			2022-12-27	WOS:000394680900059
J	Nater, A; Martin, AR; Sahgal, A; Choi, D; Fehlings, MG				Nater, Anick; Martin, Allan R.; Sahgal, Arjun; Choi, David; Fehlings, Michael G.			Symptomatic spinal metastasis: A systematic literature review of the preoperative prognostic factors for survival, neurological, functional and quality of life in surgically treated patients and methodological recommendations for prognostic studies	PLOS ONE			English	Article							CORD COMPRESSION; SCORING SYSTEMS; CLINICAL-PREDICTION; SURGERY; MANAGEMENT; CANCER; EXPECTANCY; PHYSICIANS; ACCURATE	Purpose While several clinical prediction rules (CPRs) of survival exist for patients with symptomatic spinal metastasis (SSM), these have variable prognostic ability and there is no recognized CPR for health related quality of life (HRQoL). We undertook a critical appraisal of the literature to identify key preoperative prognostic factors of clinical outcomes in patients with SSM who were treated surgically. The results of this study could be used to modify existing or develop new CPRs. Methods Seven electronic databases were searched (1990-2015), without language restriction, to identify studies that performed multivariate analysis of preoperative predictors of survival, neurological, functional and HRQoL outcomes in surgical patients with SSM. Individual studies were assessed for class of evidence. The strength of the overall body of evidence was evaluated using GRADE for each predictor. Results Among 4,818 unique citations, 17 were included; all were in English, rated Class III and focused on survival, revealing a total of 46 predictors. The strength of the overall body of evidence was very low for 39 and low for 7 predictors. Due to considerable heterogeneity in patient samples and prognostic factors investigated as well as several methodological issues, our results had a moderately high risk of bias and were difficult to interpret. Conclusions The quality of evidence for predictors of survival was, at best, low. We failed to identify studies that evaluated preoperative prognostic factors for neurological, functional, or HRQoL outcomes in surgical patients with SSM. We formulated methodological recommendations for prognostic studies to promote acquiring high-quality evidence to better estimate predictor effect sizes to improve patient education, surgical decision-making and development of CPRs.	[Nater, Anick; Martin, Allan R.; Fehlings, Michael G.] Univ Toronto, Div Neurosurg, Dept Surg, Toronto, ON, Canada; [Sahgal, Arjun] Sunnybrook Odette Canc Ctr, Dept Radiat Oncol, Toronto, ON, Canada; [Choi, David] UCL, Dept Neurosurg, Natl Hosp Neurol & Neurosurg, London, England; [Choi, David] UCL, Inst Neurol, London, England; [Fehlings, Michael G.] Univ Hlth Network, Toronto Western Hosp, Dept Neurosurg, Toronto, ON, Canada	University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; University of London; University College London; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Fehlings, MG (corresponding author), Univ Toronto, Div Neurosurg, Dept Surg, Toronto, ON, Canada.; Fehlings, MG (corresponding author), Univ Hlth Network, Toronto Western Hosp, Dept Neurosurg, Toronto, ON, Canada.	michael.fehlings@uhn.ca		Fehlings, Michael/0000-0002-5722-6364; Choi, David/0000-0002-3320-6609	Gerry and Tootsie Halbert Chair in Neural Repair and Regeneration; DeZwirek Family Foundation	Gerry and Tootsie Halbert Chair in Neural Repair and Regeneration; DeZwirek Family Foundation	Dr. Fehlings is supported by the Gerry and Tootsie Halbert Chair in Neural Repair and Regeneration and the; The authors thank Samantha Smith for collection of full text articles, Marina Eglesias and Melanie Anderson, information specialists at the University Health Network Health Sciences Libraries, for their invaluable help designing and performing our thorough literature search, and Dr. Pierre Cote for his insightful comments on an earlier version of this manuscript. No funding was received in direct support of this research but Dr. Fehlings is supported by the Gerry and Tootsie Halbert Chair in Neural Repair and Regeneration and the DeZwirek Family Foundation.DeZwirek Family Foundation.	Aizenberg MR, 2012, J NEUROSURG-SPINE, V16, P86, DOI 10.3171/2011.9.SPINE11422; Altman DG, 2001, BMJ-BRIT MED J, V323, P224, DOI 10.1136/bmj.323.7306.224; Arrigo RT, 2011, NEUROSURGERY, V68, P674, DOI 10.1227/NEU.0b013e318207780c; Balshem H, 2011, J CLIN EPIDEMIOL, V64, P401, DOI 10.1016/j.jclinepi.2010.07.015; Bartels RHMA, 2007, CANCER-AM CANCER SOC, V110, P2042, DOI 10.1002/cncr.23002; Bartels RHMA, 2016, NEURO-ONCOLOGY, V18, P114, DOI 10.1093/neuonc/nov149; Bollen L, 2013, EUR SPINE J, V22, P1408, DOI 10.1007/s00586-013-2726-4; Bollen L, 2016, SPINE, V41, pE155, DOI 10.1097/BRS.0000000000001192; Bradburn MJ, 2003, BRIT J CANCER, V89, P431, DOI 10.1038/sj.bjc.6601119; Cahill KS, 2011, NEUROSURGERY, V68, P705, DOI 10.1227/NEU.0b013e31820773b2; Chaichana KL, 2008, NEUROSURGERY, V62, P683, DOI 10.1227/01.neu.0000317317.33365.15; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chen HJ, 2010, SPINE, V35, pE1339, DOI 10.1097/BRS.0b013e3181e574f5; Chen YJ, 2015, J ORTHOP SURG RES, V10, DOI 10.1186/s13018-015-0291-8; Choi D, 2015, NEUROSURGERY, V77, P698, DOI 10.1227/NEU.0000000000000907; Chow E, 2001, CLIN ONCOL-UK, V13, P209, DOI 10.1007/s001740170078; Clark TG, 2003, BRIT J CANCER, V89, P232, DOI 10.1038/sj.bjc.6601118; Clement-Duchene C, 2010, ONCOLOGIST, V15, P782, DOI 10.1634/theoncologist.2009-0149; Cole JS, 2008, LANCET NEUROL, V7, P459, DOI 10.1016/S1474-4422(08)70089-9; Crnalic S, 2012, SPINE, V37, P2168, DOI 10.1097/BRS.0b013e31826011bc; Dettori JR, 2013, METHODOLOGY CHECKLIS; Falicov A, 2006, SPINE, V31, P2849, DOI 10.1097/01.brs.0000245838.37817.40; Fehlings MG, 2016, J CLIN ONCOL, V34, P268, DOI 10.1200/JCO.2015.61.9338; Finkelstein JA, 2003, J BONE JOINT SURG BR, V85B, P1045, DOI 10.1302/0301-620X.85B7.14201; Fujibayashi S, 2010, SPINE J, V10, P42, DOI 10.1016/j.spinee.2009.06.016; Hayden JA, 2006, ANN INTERN MED, V144, P427, DOI 10.7326/0003-4819-144-6-200603210-00010; Holmebakk T, 2011, EJSO-EUR J SURG ONC, V37, P571, DOI 10.1016/j.ejso.2011.02.009; Hosono N, 2005, CLIN ORTHOP RELAT R, P196, DOI 10.1097/01.blo.0000160003.70673.2a; Ibrahim A, 2008, J NEUROSURG-SPINE, V8, P271, DOI 10.3171/SPI/2008/8/3/271; Jansson KA, 2006, EUR SPINE J, V15, P196, DOI 10.1007/s00586-004-0870-6; Jayasekera J, 2014, PHARMACOECONOMICS, V32, P173, DOI 10.1007/s40273-013-0121-y; Kim CH, 2011, SPINE J, V11, P1015, DOI 10.1016/j.spinee.2011.09.007; L'Esperance S, 2012, CURR ONCOL, V19, pE478, DOI 10.3747/co.19.1128; Lei M, 2015, EUR SPINE J; Lei MX, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1852-2; Leithner A, 2008, EUR SPINE J, V17, P1488, DOI 10.1007/s00586-008-0763-1; Liang TZ, 2013, CLIN ORTHOP RELAT R, V471, P628, DOI 10.1007/s11999-012-2699-3; LORENZ EN, 1969, J ATMOS SCI, V26, P636, DOI 10.1175/1520-0469(1969)26<636:APARBN>2.0.CO;2; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Mollahoseini R, 2011, J RES MED SCI, V16, P1183; Moon KY, 2011, J KOREAN NEUROSURG S, V50, P216, DOI 10.3340/jkns.2011.50.3.216; Moons KGM, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b375; National Collaborating Centre for Cancer (UK), 2008, MET SPIN CORD COMPR; Nemelc RM, 2014, EUR SPINE J, V23, P2272, DOI 10.1007/s00586-014-3268-0; North RB, 2005, J NEUROSURG-SPINE, V2, P564, DOI 10.3171/spi.2005.2.5.0564; Park JH, 2011, J KOREAN NEUROSURG S, V50, P434, DOI 10.3340/jkns.2011.50.5.434; Patchell RA, 2005, LANCET, V366, P643, DOI 10.1016/S0140-6736(05)66954-1; Pointillart V, 2011, J CANCER RES CLIN, V137, P849, DOI 10.1007/s00432-010-0946-0; Prasad D, 2005, LANCET ONCOL, V6, P15, DOI 10.1016/S1470-2045(04)01709-7; Quan GMY, 2011, EUR SPINE J, V20, P1970, DOI 10.1007/s00586-011-1867-6; Randolph AG, 1998, CRIT CARE MED, V26, P1603, DOI 10.1097/00003246-199809000-00036; Sauerbrei W, 2005, ADV OTO-RHINO-LARYNG, V62, P184; Sciubba DM, 2010, J NEUROSURG-SPINE, V13, P94, DOI 10.3171/2010.3.SPINE09202; Skelly AC, 2013, SPINE, V38, pS9, DOI 10.1097/BRS.0b013e3182a7ebbf; Steyerberg EW, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001381; Tomita K, 2001, SPINE, V26, P298, DOI 10.1097/00007632-200102010-00016; Vigano A, 1999, CANCER, V86, P170, DOI 10.1002/(SICI)1097-0142(19990701)86:1<170::AID-CNCR23>3.0.CO;2-S; Wai EK, 2003, SPINE, V28, P508, DOI 10.1097/00007632-200303010-00018; Wibmer C, 2011, SPINE, V36, P1977, DOI 10.1097/BRS.0b013e3182011f84; Williams BJ, 2009, J NEUROSURG-SPINE, V10, P414, DOI 10.3171/2009.1.SPINE08509	60	18	22	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2017	12	2							e0171507	10.1371/journal.pone.0171507	http://dx.doi.org/10.1371/journal.pone.0171507			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5SK	28225772	gold, Green Published, Green Submitted			2022-12-27	WOS:000394680900014
J	Bizhang, M; Schmidt, I; Chun, YHP; Arnold, WH; Zimmer, S				Bizhang, Mozhgan; Schmidt, Ilka; Chun, Yong-Hee Patricia; Arnold, Wolfgang H.; Zimmer, Stefan			Toothbrush abrasivity in a long-term simulation on human dentin depends on brushing mode and bristle arrangement	PLOS ONE			English	Article							ELECTRIC TOOTHBRUSHES; CERVICAL LESIONS; PLAQUE REMOVAL; IN-VITRO; SONIC TOOTHBRUSHES; ERODED DENTIN; ENAMEL; FORCE; TOOTHPASTE; POWER	Objective The aim of this study was to evaluate the susceptibility of dentin to brushing abrasion using four different toothbrushes (rotating-oscillating, sonic and two types of manual toothbrushes) with the same brushing forces. Methods Dentin samples (n = 72) were selected from 72 impacted third molars. Half of the surface of dentin samples was covered with an adhesive tape, creating a protected and a freely exposed area in the same specimen. Brushing was performed with either a: sonic (Sonicare PowerUp, Philips GmbH, Hamburg, Germany), b: oscillating-rotating (Oral B Vitality Precisions Clean, Procter & Gamble, Schwalbach am Taunus, Germany) or two different manual toothbrushes c: flat trim brush head toothbrush (Dr. Best: Original, Glaxo-Smith-Kline, Buhl, Germany) and d: rippled-shaped brush head toothbrush (Blend-a-Dent, Complete V-Interdental, Blend-a-med, Schwalbach, Germany) in a custom made automatic brushing machine. The brushing force was set to 2 N and a whitening toothpaste (RDA = 150) was used. The simulation period was performed over a calculated period to mimic a brushing behavior of two times a day brushing for eight years and six months. Dentin loss was quantitatively determined by profilometry and statistically analyzed by Wilcoxon and Mann-Whitney-U Test (p < 0.05). Results The mean (standard deviation) surface loss was 21.03 (+/- 1.26) mu m for the sonic toothbrush, 15.71 (+/- 0.85) mu m for the oscillating-rotating toothbrush, 6.13 (+/- 1.24) mu m for the manual toothbrush with flat trim brush head and 2.50 (+/- 0.43) mu m for the manual toothbrush with rippled-shaped brush head. Differences between all groups were statistically significant at p<0.05. Conclusion Using the same brushing force and a highly abrasive toothpaste, manual toothbrushes are significantly less abrasive compared to power toothbrushes for an 8.5-year simulation.	[Bizhang, Mozhgan; Schmidt, Ilka; Zimmer, Stefan] Univ Witten Herdecke, Fac Hlth, Sch Dent, Dept Operat & Prevent Dent, Witten, Germany; [Chun, Yong-Hee Patricia] Univ Texas Hlth Sci Ctr San Antonio, Dept Periodont, Dept Cellular Syst & Anat, San Antonio, TX 78229 USA; [Arnold, Wolfgang H.] Univ Witten Herdecke, Dept Biol & Mat Sci Dent, Witten, Germany	Witten Herdecke University; University of Texas System; University of Texas Health San Antonio; Witten Herdecke University	Bizhang, M (corresponding author), Univ Witten Herdecke, Fac Hlth, Sch Dent, Dept Operat & Prevent Dent, Witten, Germany.	mozhgan.bizhang@uni-wh.de		Bizhang, Mozhgan/0000-0001-6623-8466				ABSI EG, 1992, J ORAL REHABIL, V19, P101, DOI 10.1111/j.1365-2842.1992.tb01086.x; Addy M, 2008, PERIODONTOL 2000, V48, P54, DOI 10.1111/j.1600-0757.2008.00253.x; Bizhang M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153250; Boyd RL, 1997, J CLIN DENT, V8, P72; BREITENMOSER J, 1979, J PERIODONTOL, V50, P211; British Standards Institution, 1981, SPECIFICATION FOR TO, V5136, P1; Cho LR, 2002, J ORAL REHABIL, V29, P816, DOI 10.1046/j.1365-2842.2002.00877.x; Choi S, 2012, J MICROSC-OXFORD, V247, P176, DOI 10.1111/j.1365-2818.2012.03630.x; Creeth Jonathan E, 2009, J Dent Hyg, V83, P111; da Cas Natalia Ventura, 2013, Gen Dent, V61, pe8; Dyer D, 2000, J CLIN PERIODONTOL, V27, P99, DOI 10.1034/j.1600-051x.2000.027002099.x; EFRAIMSEN H E, 1990, Clinical Preventive Dentistry, V12, P13; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; FRALEIGH CM, 1967, J DENT RES, V46, P209, DOI 10.1177/00220345670460011201; Ganss C, 2009, CLIN ORAL INVEST, V13, P203, DOI 10.1007/s00784-008-0230-8; Hellyer PH, 2011, BRIT DENT J, V211, P109, DOI 10.1038/sj.bdj.2011.618; Hooper S, 2003, J CLIN PERIODONTOL, V30, P802, DOI 10.1034/j.1600-051X.2003.00367.x; Janusz Karen, 2008, J Contemp Dent Pract, V9, P1; Knezevic Alena, 2010, J Calif Dent Assoc, V38, P109; Kuroe T, 2001, QUINTESSENCE INT, V32, P111; Lee WC, 1996, J PROSTHET DENT, V75, P487, DOI 10.1016/S0022-3913(96)90451-5; Litonjua LA, 2004, AM J DENT, V17, P237; Litonjua Luis A, 2005, Compend Contin Educ Dent, V26, P767; MANLY RS, 1966, J DENT RES, V45, P1822, DOI 10.1177/00220345660450064601; McCracken GI, 2003, J CLIN PERIODONTOL, V30, P409, DOI 10.1034/j.1600-051X.2003.20008.x; MIERAU HD, 1984, DEUT ZAHNAERZTL Z, V39, P634; Moore C, 2005, J CLIN PERIODONTOL, V32, P1242, DOI 10.1111/j.1600-051X.2005.00857.x; RADENTZ WH, 1976, J PERIODONTOL, V47, P148, DOI 10.1902/jop.1976.47.3.148; Sancakli HS, 2015, AUST DENT J, V60, P38, DOI 10.1111/adj.12271; Sanz M, 2015, J CLIN PERIODONTOL, V42, pS214, DOI 10.1111/jcpe.12367; Schemehorn BR, 1996, AM J DENT, V9, pS19; Sharma S, 2012, J ORAL SCI, V54, P183, DOI 10.2334/josnusd.54.183; Shay Kenneth, 2004, J Contemp Dent Pract, V5, P101; Sorensen JA, 2002, AM J DENT, V15, DOI [10.1016/j.jdent.2009.03.005, DOI 10.1016/J.DENT.2009.03.005]; Teixeira Erica C N, 2005, J Esthet Restor Dent, V17, P172, DOI 10.1111/j.1708-8240.2005.tb00109.x; Turssi CP, 2005, AM J DENT, V18, P251; Van der Weijden FA, 2015, J CLIN PERIODONTOL; VanderWeijden FA, 1996, AM J DENT, V9, pS31; VANDERWEIJDEN GA, 1995, J CLIN PERIODONTOL, V22, P648; Voronets J, 2008, CARIES RES, V42, P286, DOI 10.1159/000148160; Walters Patricia A, 2007, J Contemp Dent Pract, V8, P1; Wiegand A, 2006, J PERIODONTAL RES, V41, P221, DOI 10.1111/j.1600-0765.2005.00850.x; Wiegand A, 2006, CARIES RES, V40, P60, DOI 10.1159/000088908; Wiegand A, 2014, CARIES RES, V48, P154, DOI 10.1159/000353143; Wiegand A, 2008, AM J DENT, V21, P113; Wiegand A, 2013, CLIN ORAL INVEST, V17, P815, DOI 10.1007/s00784-012-0788-z; Wiegand A, 2009, J DENT, V37, P480, DOI 10.1016/j.jdent.2009.03.005; Wood I, 2008, J DENT, V36, P759, DOI 10.1016/j.jdent.2008.06.004; Yaacob M, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002281.pub3	49	22	23	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2017	12	2							e0172060	10.1371/journal.pone.0172060	http://dx.doi.org/10.1371/journal.pone.0172060			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5QV	28222156	Green Published, gold, Green Submitted			2022-12-27	WOS:000394676800030
J	Dumas-Mallet, E; Smith, A; Boraud, T; Gonon, F				Dumas-Mallet, Estelle; Smith, Andy; Boraud, Thomas; Gonon, Francois			Poor replication validity of biomedical association studies reported by newspapers	PLOS ONE			English	Article							EFFECT SIZES; MEDIA; COVERAGE; TRIALS; REPRODUCIBILITY; DEPRESSION; EVOLUTION; ARTICLES; BENEFITS; RISK	Objective To investigate the replication validity of biomedical association studies covered by newspapers. Methods We used a database of 4723 primary studies included in 306 meta-analysis articles. These studies associated a risk factor with a disease in three biomedical domains, psychiatry, neurology and four somatic diseases. They were classified into a lifestyle category (e.g. smoking) and a non-lifestyle category (e.g. genetic risk). Using the database Dow Jones Factiva, we investigated the newspaper coverage of each study. Their replication validity was assessed using a comparison with their corresponding meta-analyses. Results Among the 5029 articles of our database, 156 primary studies (of which 63 were lifestyle studies) and 5 meta-analysis articles were reported in 1561 newspaper articles. The percentage of covered studies and the number of newspaper articles per study strongly increased with the impact factor of the journal that published each scientific study. Newspapers almost equally covered initial (5/39 12.8%) and subsequent (58/600 9.7%) lifestyle studies. In contrast, initial non-lifestyle studies were covered more often (48/366 13.1%) than subsequent ones (45/3718 1.2%). Newspapers never covered initial studies reporting null findings and rarely reported subsequent null observations. Only 48.7% of the 156 studies reported by newspapers were confirmed by the corresponding meta-analyses. Initial non-lifestyle studies were less often confirmed (16/48) than subsequent ones (29/45) and than lifestyle studies (31/63). Psychiatric studies covered by newspapers were less often confirmed (10/38) than the neurological (26/41) or somatic (40/77) ones. This is correlated to an even larger coverage of initial studies in psychiatry. Whereas 234 newspaper articles covered the 35 initial studies that were later disconfirmed, only four press articles covered a subsequent null finding and mentioned the refutation of an initial claim. Conclusion Journalists preferentially cover initial findings although they are often contradicted by meta-analyses and rarely inform the public when they are disconfirmed.	[Dumas-Mallet, Estelle; Smith, Andy] Univ Bordeaux, Ctr Emile Durkheim, CNRS, UMR5116, Pessac, France; [Dumas-Mallet, Estelle; Boraud, Thomas; Gonon, Francois] Univ Bordeaux, CNRS, UMR5293, Inst Neurodegenerat Dis, Bordeaux, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Humanities & Social Sciences (INSHS); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux	Dumas-Mallet, E (corresponding author), Univ Bordeaux, Ctr Emile Durkheim, CNRS, UMR5116, Pessac, France.; Dumas-Mallet, E (corresponding author), Univ Bordeaux, CNRS, UMR5293, Inst Neurodegenerat Dis, Bordeaux, France.	estelle.mallet@u-bordeaux.fr		DUMAS-MALLET, Estelle/0000-0002-6011-8428				Aarts AA, 2015, SCIENCE, V349, DOI 10.1126/science.aac4716; Bacchetti P, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001628; Baker M, 2016, NATURE, V533, P452, DOI 10.1038/533452a; Bartlett C, 2002, BRIT MED J, V325, P81, DOI 10.1136/bmj.325.7355.81; Begley CG, 2015, CIRC RES, V116, P116, DOI 10.1161/CIRCRESAHA.114.303819; Bourdaa M, 2015, PUBLIC UNDERST SCI, V24, P200, DOI 10.1177/0963662513484842; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; Dougherty DD, 1999, LANCET, V354, P2132, DOI 10.1016/S0140-6736(99)04030-1; Dumas-Mallet E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158064; Freedman LP, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002165; Gan HK, 2012, J NATL CANCER I, V104, P590, DOI 10.1093/jnci/djs141; Gonon F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044275; Gonon F, 2011, AM J MED GENET B, V156B, P989, DOI 10.1002/ajmg.b.31236; Heres S, 2006, AM J PSYCHIAT, V163, P185, DOI 10.1176/appi.ajp.163.2.185; Holtzman NA, 2005, COMMUNITY GENET, V8, P133, DOI 10.1159/000086756; Horwitz AV, 2005, J GERONTOL B-PSYCHOL, V60, P48; Ioannidis JPA, 2011, JAMA-J AM MED ASSOC, V305, P2200, DOI 10.1001/jama.2011.713; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Ioannidis JPA, 2001, NAT GENET, V29, P306, DOI 10.1038/ng749; Ioannidis JPA, 2001, P NATL ACAD SCI USA, V98, P831, DOI 10.1073/pnas.021529998; Jensen JD, 2013, BMC MED INFORM DECIS, V13, DOI 10.1186/1472-6947-13-S3-S4; Jensen JD, 2012, PUBLIC UNDERST SCI, V21, P689, DOI 10.1177/0963662510387759; Kitzinger J, 1997, EUR J COMMUN, V12, P319, DOI 10.1177/0267323197012003002; Larsson Anna, 2003, Health Expect, V6, P323, DOI 10.1046/j.1369-7625.2003.00228.x; Moynihan R, 2000, NEW ENGL J MED, V342, P1645, DOI 10.1056/NEJM200006013422206; Munafo MR, 2009, MOL PSYCHIATR, V14, P119, DOI 10.1038/mp.2008.77; Pereira TV, 2012, JAMA-J AM MED ASSOC, V308, P1676, DOI 10.1001/jama.2012.13444; Prinz F, 2011, NAT REV DRUG DISCOV, V10, P712, DOI 10.1038/nrd3439-c1; Risch N, 2009, JAMA-J AM MED ASSOC, V301, P2462, DOI 10.1001/jama.2009.878; Sarewitz D, 2012, NATURE, V485, P149, DOI 10.1038/485149a; Stryker JE, 2002, PREV MED, V35, P519, DOI 10.1006/pmed.2002.1102; Tajika A, 2015, BRIT J PSYCHIAT, V207, P357, DOI 10.1192/bjp.bp.113.143701; Trikalinos TA, 2004, J CLIN EPIDEMIOL, V57, P1124, DOI 10.1016/j.jclinepi.2004.02.018; Trikalinos TA, 2004, EUR J HUM GENET, V12, P762, DOI 10.1038/sj.ejhg.5201227; Turner Erick H, 2008, N Engl J Med, V358, P252, DOI 10.1056/NEJMsa065779; Volkow ND, 2009, JAMA-J AM MED ASSOC, V302, P1084, DOI 10.1001/jama.2009.1308; Watts S, 2014, NATURE, V508, P151, DOI 10.1038/508151a; Yavchitz A, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001308	38	39	39	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2017	12	2							e0172650	10.1371/journal.pone.0172650	http://dx.doi.org/10.1371/journal.pone.0172650			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5QV	28222122	Green Published, Green Submitted, gold			2022-12-27	WOS:000394676800074
J	Dumitrescu, L; Ritchie, MD; Denny, JC; El Rouby, NM; McDonough, CW; Bradford, Y; Ramirez, AH; Bielinski, SJ; Basford, MA; Chai, HS; Peissig, P; Carrell, D; Pathak, J; Rasmussen, LV; Wang, XM; Pacheco, JA; Kho, AN; Hayes, MG; Matsumoto, M; Smith, ME; Li, RL; Cooper-DeHoff, RM; Kullo, IJ; Chute, CG; Chisholm, RL; Jarvik, GP; Larson, EB; Carey, D; McCarty, CA; Williams, MS; Roden, DM; Bottinger, E; Johnson, JA; de Andrade, M; Crawford, DC				Dumitrescu, Logan; Ritchie, Marylyn D.; Denny, Joshua C.; El Rouby, Nihal M.; McDonough, Caitrin W.; Bradford, Yuki; Ramirez, Andrea H.; Bielinski, Suzette J.; Basford, Melissa A.; Chai, High Seng; Peissig, Peggy; Carrell, David; Pathak, Jyotishman; Rasmussen, Luke V.; Wang, Xiaoming; Pacheco, Jennifer A.; Kho, Abel N.; Hayes, M. Geoffrey; Matsumoto, Martha; Smith, Maureen E.; Li, Rongling; Cooper-DeHoff, Rhonda M.; Kullo, Iftikhar J.; Chute, Christopher G.; Chisholm, Rex L.; Jarvik, Gail P.; Larson, Eric B.; Carey, David; McCarty, Catherine A.; Williams, Marc S.; Roden, Dan M.; Bottinger, Erwin; Johnson, Julie A.; de Andrade, Mariza; Crawford, Dana C.			Genome-wide study of resistant hypertension identified from electronic health records	PLOS ONE			English	Article							GENETIC EPIDEMIOLOGY RESEARCH; CORONARY-ARTERY-DISEASE; BLOOD-PRESSURE RESPONSE; MEDICAL-RECORDS; EMERGE NETWORK; CONTROL RATES; QUALITY-CONTROL; PULSE PRESSURE; MEAN ARTERIAL; ADULT HEALTH	Resistant hypertension is defined as high blood pressure that remains above treatment goals in spite of the concurrent use of three antihypertensive agents from different classes. Despite the important health consequences of resistant hypertension, few studies of resistant hypertension have been conducted. To perform a genome-wide association study for resistant hypertension, we defined and identified cases of resistant hypertension and hypertensives with treated, controlled hypertension among > 47,500 adults residing in the US linked to electronic health records (EHRs) and genotyped as part of the electronic MEdical Records & GEnomics (eMERGE) Network. Electronic selection logic using billing codes, laboratory values, text queries, and medication records was used to identify resistant hypertension cases and controls at each site, and a total of 3,006 cases of resistant hypertension and 876 controlled hypertensives were identified among eMERGE Phase I and II sites. After imputation and quality control, a total of 2,530,150 SNPs were tested for an association among 2,830 multi-ethnic cases of resistant hypertension and 876 controlled hypertensives. No test of association was genome-wide significant in the full dataset or in the dataset limited to European American cases (n = 1,719) and controls (n = 708). The most significant finding was CLNK rs13144136 at p = 1.00x10(-6) (odds ratio = 0.68; 95% CI = 0.58-0.80) in the full dataset with similar results in the European American only dataset. We also examined whether SNPs known to influence blood pressure or hypertension also influenced resistant hypertension. None was significant after correction for multiple testing. These data highlight both the difficulties and the potential utility of EHR-linked genomic data to study clinically-relevant traits such as resistant hypertension.	[Dumitrescu, Logan] Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37212 USA; [Ritchie, Marylyn D.; Bradford, Yuki] Geisinger Hlth Syst, Biomed & Translat Informat, Danville, PA USA; [Denny, Joshua C.; Wang, Xiaoming] Vanderbilt Univ, Dept Biomed Informat, 221 Kirkland Hall, Nashville, TN 37235 USA; [Denny, Joshua C.; Ramirez, Andrea H.; Roden, Dan M.] Vanderbilt Univ, Dept Med, Nashville, TN USA; [El Rouby, Nihal M.; McDonough, Caitrin W.; Cooper-DeHoff, Rhonda M.; Johnson, Julie A.] Univ Florida, Coll Pharm, Dept Pharmacotherapy & Translat Res, Gainesville, FL USA; [El Rouby, Nihal M.; McDonough, Caitrin W.; Cooper-DeHoff, Rhonda M.; Johnson, Julie A.] Univ Florida, Coll Pharm, Ctr Pharmacogen, Gainesville, FL USA; [Bielinski, Suzette J.] Mayo Clin, Div Epidemiol, Rochester, MN USA; [Basford, Melissa A.] Vanderbilt Univ, Res Off, 221 Kirkland Hall, Nashville, TN 37235 USA; [Chai, High Seng; Pathak, Jyotishman; Matsumoto, Martha; de Andrade, Mariza] Mayo Clin, Div Biomed Stat & Informat, Dept Hlth Sci Res, Rochester, MN USA; [Peissig, Peggy] Marshfield Clin Res Fdn, Biomed Informat Res Ctr, Marshfield, WI USA; [Carrell, David; Larson, Eric B.] Grp Hlth Res Inst, Seattle, WA USA; [Rasmussen, Luke V.] Northwestern Univ, Dept Prevent Med, Div Hlth & Biomed Informat, Chicago, IL 60611 USA; [Pacheco, Jennifer A.; Smith, Maureen E.; Chisholm, Rex L.] Northwestern Univ, Ctr Genet Med, Chicago, IL 60611 USA; [Kho, Abel N.; Hayes, M. Geoffrey] Northwestern Univ, Dept Med, Feinberg Sch Med, Chicago, IL 60611 USA; [Li, Rongling] NHGRI, Div Genom Med, Bethesda, MD 20892 USA; [Cooper-DeHoff, Rhonda M.; Crawford, Dana C.] Case Western Reserve Univ, Inst Computat Biol, Epidemiol & Biostat, Cleveland, OH 44106 USA; [Kullo, Iftikhar J.] Mayo Clin, Dept Cardiovasc Dis, Rochester, MN USA; [Chute, Christopher G.] Johns Hopkins Univ, Div Gen Internal Med, Baltimore, MD USA; [Jarvik, Gail P.] Univ Washington, Med Ctr, Dept Med, Seattle, WA 98195 USA; [Carey, David] Geisinger Hlth Syst, Weis Ctr Res, Danville, PA USA; [McCarty, Catherine A.] Essentia Inst Rural Hlth, Duluth, MN USA; [Williams, Marc S.] Geisinger Hlth Syst, Genom Med Inst, Danville, PA USA; [Roden, Dan M.] Vanderbilt Univ, Dept Pharmacol, Nashville, TN USA; [Bottinger, Erwin] Mt Sinai, Charles R Bronfman Inst Personalized Med, New York, NY USA; [Johnson, Julie A.] Univ Florida, Coll Med, Div Cardiovasc Med, Gainesville, FL USA	Vanderbilt University; Geisinger Health System; Vanderbilt University; Vanderbilt University; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Mayo Clinic; Vanderbilt University; Mayo Clinic; Northwestern University; Northwestern University; Northwestern University; Feinberg School of Medicine; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Case Western Reserve University; Mayo Clinic; Johns Hopkins University; University of Washington; University of Washington Seattle; Geisinger Health System; Geisinger Health System; Vanderbilt University; Icahn School of Medicine at Mount Sinai; State University System of Florida; University of Florida	Crawford, DC (corresponding author), Case Western Reserve Univ, Inst Computat Biol, Epidemiol & Biostat, Cleveland, OH 44106 USA.	dana.crawford@case.edu	Chute, Christopher/AAT-8540-2021; Crawford, Dana/O-5578-2019; Denny, Josh/AAL-3359-2021; Roden, Dan/ABD-5412-2021; Bielinski, Suzette/A-2238-2009; Chisholm, Rex/B-3418-2009	Crawford, Dana/0000-0002-6437-6248; Denny, Josh/0000-0002-3049-7332; Hayes, M Geoffrey/0000-0002-4617-3981; Rasmussen, Luke/0000-0002-4497-8049; McDonough, Caitrin/0000-0001-6393-7288; Bielinski, Suzette/0000-0002-2905-5430; Chisholm, Rex/0000-0002-5638-3990; Pacheco, Jennifer/0000-0001-8021-5818; McCarty, Catherine/0000-0003-1089-0142	NHGRI; NIGMS [U01HG04599, U01HG006379, U01HG004610, U01HG006375, U01HG004608, U01HG004609, U01HG006388, U01HG04603, U01HG006378, U01HG006385, U01HG006382, U01HG006380, U01HG006830, U01HG006828]; Vanderbilt CTSA grant from NCATS/NIH [UL1 TR000445]; Mayo Clinic Biobank - Mayo Clinic Center for Individualized Medicine; NIH [R01 HL074730, U01 GM074492, U01 NS038529, R01 NS073346];  [KL2 TR001429]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR001429, UL1TR001422] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG006388, U01HG008672, U01HG008673, U01HG008701, U01HG008657] Funding Source: NIH RePORTER	NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Vanderbilt CTSA grant from NCATS/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Mayo Clinic Biobank - Mayo Clinic Center for Individualized Medicine; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	The eMERGE Network is funded by NHGRI, with additional funding from NIGMS through the following grants: U01HG04599 and U01HG006379 to Mayo Clinic; U01HG004610 and U01HG006375 to Group Health Cooperative and University of Washington, Seattle; U01HG004608 to Marshfield Clinic; U01HG006389 to Essentia Institute of Rural Health; U01HG004609 and U01HG006388 to Northwestern University; U01HG04603 and U01HG006378 to Vanderbilt University; U01HG006385 to the Coordinating Center; U01HG006382 to Geisinger Clinic; U01HG006380 to Mount Sinai School of Medicine; U01HG006830 to The Children's Hospital of Philadelphia; and U01HG006828 to Cincinnati Children's Hospital and Boston Children's Hospital. A portion of the dataset(s) used for the analyses described were obtained from Vanderbilt University Medical Centers BioVU, supported by institutional funding and by the Vanderbilt CTSA grant UL1 TR000445 from NCATS/NIH, and the Mayo Clinic Biobank supported by the Mayo Clinic Center for Individualized Medicine. INVEST-GENES was funded by NIH grants R01 HL074730 and U01 GM074492. SPS3 and SPS3-GENES were funded by NIH grants U01 NS038529, U01 GM074492, and R01 NS073346. CWM was also supported by KL2 TR001429. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	1000 Genomes Project Consortium, 2015, Nature, V526, P68, DOI 10.1038/nature15393; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; [Anonymous], 2013, NAT GENET, DOI DOI 10.1038/NG.2797; Bakris G, 2014, J AM SOC HYPERTENS, V8, P127, DOI 10.1016/j.jash.2013.07.009; Banda Y, 2015, GENETICS, V200, P1285, DOI 10.1534/genetics.115.178616; Basson J, 2014, AM J HYPERTENS, V27, P431, DOI [10.1093/ajh/hpu149, 10.1093/ajh/hpt283]; Binder A, 2007, CURR OPIN CARDIOL, V22, P176, DOI 10.1097/HCO.0b013e3280d357f9; Blech I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018743; Calhoun DA, 2008, HYPERTENSION, V51, P1403, DOI 10.1161/HYPERTENSIONAHA.108.189141; Caro JJ, 1999, CAN MED ASSOC J, V160, P41; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Collins FS, 2015, NEW ENGL J MED, V372, P793, DOI 10.1056/NEJMp1500523; Crawford DC, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00184; Cruz-Gonzalez I, 2009, J HUM HYPERTENS, V23, P556, DOI 10.1038/jhh.2009.19; Cruz-Gonzalez I, 2009, BMC CARDIOVASC DISOR, V9, P1; Cutler JA, 2008, HYPERTENSION, V52, P818, DOI 10.1161/HYPERTENSIONAHA.108.113357; Daly AK, 2012, ANNU REV PHARMACOL, V52, P21, DOI 10.1146/annurev-pharmtox-010611-134743; Delaneau O, 2013, NAT METHODS, V10, P5, DOI 10.1038/nmeth.2307; Denny JC, 2011, AM J HUM GENET, V89, P529, DOI 10.1016/j.ajhg.2011.09.008; Dumitrescu L, 2010, GENET MED, V12, P648, DOI 10.1097/GIM.0b013e3181efe2df; Ehret GB, 2011, NATURE, P478; El Rouby N, 2015, CURR HYPERTENS REP, V17, DOI 10.1007/s11906-015-0583-8; Fields LE, 2004, HYPERTENSION, V44, P398, DOI 10.1161/01.HYP.0000142248.54761.56; Fontana V, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.001398; Franceschini N, 2013, AM J HUM GENET, V93, P545, DOI 10.1016/j.ajhg.2013.07.010; Franceschini N, 2011, AM J HYPERTENS, V24, P392, DOI 10.1038/ajh.2010.218; Friedman O, 2010, AM J MED, V123, P173, DOI 10.1016/j.amjmed.2009.08.008; Gaziano JM, 2016, J CLIN EPIDEMIOLOGY; Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80; Gong Y, 2015, J HYPERTENS, V33, P2278, DOI 10.1097/HJH.0000000000000714; Gottesman O, 2013, GENET MED, V15, P761, DOI 10.1038/gim.2013.72; Grady BJ, 2010, BIOCOMPUT-PAC SYM, P315; Group PMIPW, 2015, PREC MED IN COH PROG; Guo FJ, 2012, J AM COLL CARDIOL, V60, P599, DOI 10.1016/j.jacc.2012.04.026; Hall JB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099161; Han D, 2014, BMC GENOMICS, V15, DOI [10.1186/1471-2164-15-95, 10.1186/1471-2164-15-477]; Hannila-Handelberg T, 2005, BMC MED GENET, V6, DOI 10.1186/1471-2350-6-4; He J, 2013, CIRC-CARDIOVASC GENE, V6, P598, DOI 10.1161/CIRCGENETICS.113.000307; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Ho H, 2005, HYPERTENSION, V45, P294, DOI 10.1161/01.HYP.0000151361.31736.96; Hong Kyung-Won, 2013, Genomics & Informatics, V11, P129, DOI 10.5808/GI.2013.11.3.129; Howie B, 2012, NAT GENET, V44, P955, DOI 10.1038/ng.2354; Jachymova M, 2001, BIOCHEM BIOPH RES CO, V284, P426, DOI 10.1006/bbrc.2001.5007; Johnson JA, 2012, ANN MED, V44, pS17, DOI 10.3109/07853890.2011.653399; Kato N, 2011, NAT GENET, V43, P530, DOI 10.1038/ng.834; Keating BJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003583; Kelly TN, 2013, HYPERTENSION, V62, P853, DOI 10.1161/HYPERTENSIONAHA.113.01148; Kho AN, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001807; Kim SJ, 2012, CIRC J, V76, P907, DOI 10.1253/circj.CJ-11-0713; Kirby JC, 2016, J AM MED INFORM ASS; Kraja AT, 2011, DIABETES, V60, P1329, DOI 10.2337/db10-1011; Kvale MN, 2015, GENETICS, V200, P1051, DOI 10.1534/genetics.115.178905; Lenfant C, 2002, ARCH INTERN MED, V162, P131, DOI 10.1001/archinte.162.2.131; Lettre G, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001300; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Levy D, 2009, NAT GENET, V41, P677, DOI 10.1038/ng.384; Lu XF, 2015, HUM MOL GENET, V24, P865, DOI 10.1093/hmg/ddu478; Lupton SJ, 2011, TWIN RES HUM GENET, V14, P295, DOI 10.1375/twin.14.4.295; Mahajan A, 2014, NAT GENET, V46, P234, DOI 10.1038/ng.2897; Mazzaglia G, 2005, J HYPERTENS, V23, P2093, DOI 10.1097/01.hjh.0000186832.41125.8a; McCarty CA, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-13; Melka MG, 2012, J CLIN ENDOCR METAB, V97, pE145, DOI 10.1210/jc.2011-1801; Myat A, 2012, BMJ-BRIT MED J, P345; Newton KM, 2013, J AM MED INFORM ASSN, V20, pE147, DOI 10.1136/amiajnl-2012-000896; Newton-Cheh C, 2009, NAT GENET, P41; Ong KL, 2007, HYPERTENSION, V49, P69, DOI 10.1161/01.HYP.0000252676.46043.18; Padmanabhan S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001177; Payne K A, 2000, Curr Hypertens Rep, V2, P515, DOI 10.1007/s11906-996-0035-6; Pepine CJ, 2003, JAMA-J AM MED ASSOC, V290, P2805, DOI 10.1001/jama.290.21.2805; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pritchard JK, 2000, GENETICS, V155, P945; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Pulley J, 2010, CTS-CLIN TRANSL SCI, V3, P42, DOI 10.1111/j.1752-8062.2010.00175.x; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Roden DM, 2008, CLIN PHARMACOL THER, V84, P362, DOI 10.1038/clpt.2008.89; Roden DM, 2012, CLIN PHARMACOL THER, V91, P1083, DOI 10.1038/clpt.2012.42; Rolnick SJ, 2013, CLIN MED RES, V11, P54, DOI 10.3121/cmr.2013.1113; Salfati E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133031; Salvi E, 2017, HYPERTENSION, V69, P51, DOI 10.1161/HYPERTENSIONAHA.116.08267; Sarafidis PA, 2008, J AM COLL CARDIOL, V52, P1749, DOI 10.1016/j.jacc.2008.08.036; Sarafidis PA, 2013, NAT REV NEPHROL, V9, P51, DOI 10.1038/nrneph.2012.260; Simino J, 2014, AM J HUM GENET, V95, P24, DOI 10.1016/j.ajhg.2014.05.010; Skol AD, 2006, NAT GENET, V38, P209, DOI 10.1038/ng1706; Slavin TP, 2011, HUM GENET, V130, P725, DOI 10.1007/s00439-011-1009-6; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; The SPSSG, LANCET, V382, P507; Turner Stephen, 2011, Curr Protoc Hum Genet, VChapter 1, DOI 10.1002/0471142905.hg0119s68; Verma SS, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00370; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Wain LV, 2011, NAT GENET, V43, P1005, DOI 10.1038/ng.922; Welter Danielle, 2014, Nucleic Acids Res, V42, pD1001, DOI 10.1093/nar/gkt1229; White WB, 2014, J AM SOC HYPERTENS, V8, P743, DOI 10.1016/j.jash.2014.06.005; Zuvich RL, 2011, GENET EPIDEMIOL, V35, P887, DOI 10.1002/gepi.20639	93	24	24	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2017	12	2							e0171745	10.1371/journal.pone.0171745	http://dx.doi.org/10.1371/journal.pone.0171745			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5QV	28222112	gold, Green Published, Green Submitted			2022-12-27	WOS:000394676800017
J	Girona, MM; Rossi, S; Lussier, JM; Walsh, D; Morin, H				Girona, Miguel Montoro; Rossi, Sergio; Lussier, Jean-Martin; Walsh, Denis; Morin, Hubert			Understanding tree growth responses after partial cuttings: A new approach	PLOS ONE			English	Article							HEIGHT-DIAMETER MODEL; BLACK SPRUCE STANDS; MARIANA MILL. BSP; BOREAL FOREST; PICEA-MARIANA; INDIVIDUAL-TREE; JACK PINE; FIR FORESTS; COMPETITION; MORTALITY	Forest ecosystem management heads towards the use of partial cuttings. However, the wide variation in growth response of residual trees remains unexplained, preventing a suitable prediction of forest productivity. The aim of the study was to assess individual growth and identify the driving factors involved in the responses of residual trees. Six study blocks in even-aged black spruce [Picea mariana (Mill.) B.S.P.] stands of the eastern Canadian boreal forest were submitted to experimental shelterwood and seed-tree treatments. Individual-tree models were applied to 1039 trees to analyze their patterns of radial growth during the 10 years after partial cutting by using the nonlinear Schnute function on tree-ring series. The trees exhibited different growth patterns. A sigmoid growth was detected in 32% of trees, mainly in control plots of older stands. Forty-seven percent of trees located in the interior of residual strips showed an S-shape, which was influenced by stand mortality, harvested intensity and dominant height. Individuals showing an exponential pattern produced the greatest radial growth after cutting and were edge trees of younger stands with higher dominant height. A steady growth decline was observed in 4% of trees, represented by the individuals suppressed and insensitive to the treatment. The analyses demonstrated that individual nonlinear models are able to assess the variability in growth within the stand and the factors involved in the occurrence of the different growth patterns, thus improving understanding of the tree responses to partial cutting. This new approach can sustain forest management strategies by defining the best conditions to optimize the growth yield of residual trees.	[Girona, Miguel Montoro; Rossi, Sergio; Walsh, Denis; Morin, Hubert] Univ Quebec Chicoutimi, Dept Sci Fondamentales, Chicoutimi, PQ, Canada; [Rossi, Sergio] Chinese Acad Sci, South China Bot Garden, Prov Key Lab Appl Bot, Key Lab Vegetat Restorat Management Degraded Ecos, Guangzhou, Guangdong, Peoples R China; [Lussier, Jean-Martin] Nat Resources Canada, Canadian Forest Serv, Canadian Wood Fibre Ctr, Quebec City, PQ, Canada	University of Quebec; University of Quebec Chicoutimi; Chinese Academy of Sciences; South China Botanical Garden, CAS; Natural Resources Canada; Canadian Forest Service	Girona, MM (corresponding author), Univ Quebec Chicoutimi, Dept Sci Fondamentales, Chicoutimi, PQ, Canada.	miguel.montoro1@uqac.ca	Girona, Miguel Montoro/AAH-1642-2020	Girona, Miguel Montoro/0000-0002-6916-3639; Lussier, Jean-Martin/0000-0003-1474-6674	Fonds de Recherche du Quebec - Nature et Technologies (FQRNT); Programme de mise en valeur des ressources forestieres (MFFPQ); Canadian Wood Fibre Centre of the Canadian Forest Service (Natural Resources Canada); Forest Complexity Modelling program of Center for Forest Research	Fonds de Recherche du Quebec - Nature et Technologies (FQRNT); Programme de mise en valeur des ressources forestieres (MFFPQ); Canadian Wood Fibre Centre of the Canadian Forest Service (Natural Resources Canada)(Natural Resources CanadaCanadian Forest Service); Forest Complexity Modelling program of Center for Forest Research	This project was supported by the Fonds de Recherche du Quebec - Nature et Technologies (FQRNT), the Programme de mise en valeur des ressources forestieres (MFFPQ), the Canadian Wood Fibre Centre of the Canadian Forest Service (Natural Resources Canada), and the Forest Complexity Modelling program of Center for Forest Research.	Adame P, 2008, FOREST ECOL MANAG, V256, P88, DOI 10.1016/j.foreco.2008.04.006; Alteyrac J, 2005, WOOD FIBER SCI, V37, P83; Bauhus J., 2013, MANAGING FORESTS COM, P187; Belien E, 2014, TREES-STRUCT FUNCT, V28, P1257, DOI 10.1007/s00468-014-1011-4; Bladon KD, 2008, FOREST CHRON, V84, P70, DOI 10.5558/tfc84070-1; BREDENKAMP BV, 1988, FOREST SCI, V34, P790; Bright RM, 2012, ENVIRON IMPACT ASSES, V37, P2, DOI 10.1016/j.eiar.2012.01.002; Burns RM., 1990, SILVICS N AM; Linares JC, 2010, J ECOL, V98, P592, DOI 10.1111/j.1365-2745.2010.01645.x; Castedo-Dorado F, 2006, FOREST ECOL MANAG, V229, P202, DOI 10.1016/j.foreco.2006.04.028; Cavazos T, 2002, J CLIMATE, V15, P2477, DOI 10.1175/1520-0442(2002)015<2477:IVAWWM>2.0.CO;2; Crecente-Campo F, 2010, FOREST ECOL MANAG, V259, P943, DOI 10.1016/j.foreco.2009.11.036; De Grandpre L, 2009, ECOSYSTEM MANAGEMENT; Eerikainen K, 2003, FOREST ECOL MANAG, V175, P355, DOI 10.1016/S0378-1127(02)00138-X; Fernandez-de-Una L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122255; Fraver S, 2014, J VEG SCI, V25, P374, DOI 10.1111/jvs.12096; Fuller AK, 2004, FOREST ECOL MANAG, V191, P373, DOI 10.1016/j.foreco.2004.01.014; Gauthier S., 2009, ECOSYSTEM MANAGEMENT; Genet A, 2013, FOREST ECOL MANAG, V305, P158, DOI 10.1016/j.foreco.2013.05.046; Girona MM, 2016, FORESTS, V7, DOI 10.3390/f7100240; Giroud G, 2016, FOREST ECOL MANAG, V378, P131, DOI 10.1016/j.foreco.2016.07.031; Graham MH, 2003, ECOLOGY, V84, P2809, DOI 10.1890/02-3114; GROOT A, 1994, CAN J FOREST RES, V24, P225, DOI 10.1139/x94-033; GUAY R, 1992, FOREST CHRON, V68, P138, DOI 10.5558/tfc68138-1; Harper KA, 2015, J ECOL, V103, P550, DOI 10.1111/1365-2745.12398; HUANG SM, 1992, CAN J FOREST RES, V22, P1297, DOI 10.1139/x92-172; Jamarillo- Correa JP, 2004, MOL ECOL, V13, P2735, DOI [10.1111/j.1365-294X.2004.02258.x, DOI 10.1111/J.1365-294X.2004.02258.X]; Krause C, 1995, FOREST CHRON, V71, P747, DOI 10.5558/tfc71747-6; Krause C, 2011, SCAND J FOREST RES, V26, P477, DOI 10.1080/02827581.2011.579995; Lei Y.C., 2004, NONLINEAR ANAL-MODEL, V9, P65, DOI [DOI 10.15388/NA.2004.9.1.15171, 10.15388/na.2004.9.1.15171]; Lemay A., 2016, GROWTH WOOD QUALITY; Lessard E, 2014, FOREST ECOL MANAG, V313, P307, DOI 10.1016/j.foreco.2013.10.030; Liu C, 2007, FOREST ECOL MANAG, V250, P148, DOI 10.1016/j.foreco.2007.05.010; Liu Zhao-gang, 2003, Journal of Forestry Research (Harbin), V14, P19, DOI 10.1007/BF02856757; Lussier JM, 2002, CAN J FOREST RES, V32, P539, DOI [10.1139/x01-201, 10.1139/X01-201]; Mailly D, 2003, CAN J FOREST RES, V33, P435, DOI 10.1139/X02-122; MCCOMB WC, 1993, J FOREST, V91, P31; Messier C, 2016, CURR FOR REP, V2, P150, DOI 10.1007/s40725-016-0036-x; MILLER GW, 1993, NE673 USDA FOR SERV; Ni FB, 2002, INT J CLIMATOL, V22, P1645, DOI 10.1002/joc.804; Orwig DA, 1997, TREES-STRUCT FUNCT, V11, P474, DOI 10.1007/s004680050110; Paine CET, 2012, METHODS ECOL EVOL, V3, P245, DOI 10.1111/j.2041-210X.2011.00155.x; Pamerleau-Couture E, 2015, FORESTRY, V88, P471, DOI 10.1093/forestry/cpv017; Peng Changhui, 2001, Northern Journal of Applied Forestry, V18, P87; Piepho HP, 2006, HORTSCIENCE, V41, P446, DOI 10.21273/HORTSCI.41.2.446; Pretzsch H, 2009, FOREST DYNAMICS, GROWTH AND YIELD: FROM MEASUREMENT TO MODEL, P1, DOI 10.1007/978-3-540-88307-4_1; Rijal B, 2012, FORESTRY, V85, P379, DOI 10.1093/forestry/cps036; Rinntech, 2003, TSAP WIN TIM SER AN; Riopel M, 2010, CAN J FOREST RES, V40, P1458, DOI 10.1139/X10-059; Robitaille A., 1998, PAYSAGES REGIONAUX Q; Rossi S, 2011, GLOBAL CHANGE BIOL, V17, P614, DOI 10.1111/j.1365-2486.2010.02191.x; Rossi S, 2009, FOREST ECOL MANAG, V258, P2153, DOI 10.1016/j.foreco.2009.08.023; Rotzer T, 2010, FORESTRY; Ruel JC, 2000, FOREST ECOL MANAG, V135, P169, DOI 10.1016/S0378-1127(00)00308-X; Saucier J.-P., 1998, AUBELLE S, P1; SCHNUTE J, 1981, CAN J FISH AQUAT SCI, V38, P1128, DOI 10.1139/f81-153; Sharma M, 2004, SCAND J FOREST RES, V19, P442, DOI 10.1080/02827580410030163; Sharma M, 2007, FOREST ECOL MANAG, V249, P187, DOI 10.1016/j.foreco.2007.05.006; Smith D.M., 1997, PRACTICE SILVICULTUR; Subedi N, 2013, GLOBAL CHANGE BIOL, V19, P505, DOI 10.1111/gcb.12033; Tabachnick B. G., 2013, USING MULTIVARIATE S; Thorpe HC, 2008, ECOL APPL, V18, P1652, DOI 10.1890/07-1697.1; Thorpe HC, 2007, CAN J FOREST RES, V37, P1563, DOI 10.1139/X07-148; Thorpe HC, 2007, FOREST CHRON, V83, P319, DOI 10.5558/tfc83319-3; Thurig E, 2005, FOREST ECOL MANAG, V204, P51, DOI [10.1016/j.foreco.2004.07.070, 10.1016/j.forceo.2004.07.070]; Vaganov E. A., 2006, GROWTH DYNAMICS CONI; Vincent M, 2009, FORESTRY, V82, P557, DOI 10.1093/forestry/cpp025; Wang YF, 2015, ENVIRON EARTH SCI, V74, P6471, DOI 10.1007/s12665-015-4168-2; Zhang LJ, 2004, FOREST CHRON, V80, P366, DOI 10.5558/tfc80366-3; Zhang LJ, 1997, ANN BOT-LONDON, V79, P251, DOI 10.1006/anbo.1996.0334; Zhang S, 2008, PUBLICATIONS, VSP-526E, P653; Zhang Shaoang, 1997, Southern Journal of Applied Forestry, V21, P199	72	50	50	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2017	12	2							e0172653	10.1371/journal.pone.0172653	http://dx.doi.org/10.1371/journal.pone.0172653			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5QV	28222200	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000394676800076
J	Kato, Y; Nakakura, S; Asaoka, R; Matsuya, K; Fujio, Y; Kiuchi, Y				Kato, Yoshitake; Nakakura, Shunsuke; Asaoka, Ryo; Matsuya, Kanae; Fujio, Yuki; Kiuchi, Yoshiaki		Ocular Biomech Study Grp	Cataract surgery causes biomechanical alterations to the eye detectable by Corvis ST tonometry	PLOS ONE			English	Article							INTRAOCULAR-LENS IMPLANTATION; OPEN-ANGLE GLAUCOMA; CORNEAL DISPLACEMENT; DEFORMATION RESPONSE; OCULAR BIOMECHANICS; PHACOEMULSIFICATION; PRESSURE; NONCONTACT; HYSTERESIS; PARAMETERS	Purpose Modern cataract surgery is generally considered to bring about modest and sustained intraocular pressure (IOP) reduction. However, the pathophysiological mechanism for this remains unclear. Moreover, a change in ocular biomechanical properties after surgery can affect the measurement of IOP. The aim of the study is to investigate ocular biomechanics, before and following cataract surgery, using Corvis ST tonometry (CST). Patients and methods Fifty-nine eyes of 59 patients with cataract were analyzed. IOP with Goldmann applanation tonometry (IOP-G), axial length, corneal curvature and CST parameters were measured before cataract surgery and, up to 3 months, following surgery. Since CST parameters are closely related to IOP-G, linear modeling was carried out to investigate whether there was a change in CST measurements following cataract surgery, adjusted for a change in IOP-G. Results IOP-G significantly decreased after surgery (mean +/- standard deviation: 11.8 +/- 3.1 mmHg) compared to pre-surgery (15.2 +/- 4.3 mmHg, P<0.001). Peak distance (the distance between the two surrounding peaks of the cornea at the highest concavity), maximum deformation amplitude (the movement of the corneal apex from the start of deformation to the highest concavity) and A1/A2 velocity (the corneal velocity during inward or outward movement) significantly increased after cataract surgery (P<0.05) while radius (the central curvature radius at the highest concavity) was significantly smaller following cataract surgery (P<0.05). Linear modeling supported many of these findings, suggesting that peak distance, maximum deformation amplitude and A2 velocity were increased, whereas A2 deformation amplitude and highest concavity time were decreased (after adjustment for IOP change), following cataract surgery. Conclusion Corneal biomechanical properties, as measured with CST, were observed to change significantly following cataract surgery.	[Kato, Yoshitake; Nakakura, Shunsuke; Matsuya, Kanae; Fujio, Yuki] Saneikai Tsukazaki Hosp, Dept Ophthalmol, Himeji, Hyogo, Japan; [Asaoka, Ryo] Univ Tokyo, Dept Ophthalmol, Tokyo, Japan; [Kiuchi, Yoshiaki] Hiroshima Univ, Dept Ophthalmol & Visual Sci, Hiroshima, Japan	University of Tokyo; Hiroshima University	Nakakura, S (corresponding author), Saneikai Tsukazaki Hosp, Dept Ophthalmol, Himeji, Hyogo, Japan.	shunsukenakakura@yahoo.co.jp						Asaoka R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140385; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Cetinkaya S, 2015, INDIAN J OPHTHALMOL, V63, P743, DOI 10.4103/0301-4738.171020; Glass DH, 2008, INVEST OPHTH VIS SCI, V49, P3919, DOI 10.1167/iovs.07-1321; Hassan Z, 2014, CONTACT LENS ANTERIO, V37, P337, DOI 10.1016/j.clae.2014.05.001; Hong JX, 2013, INVEST OPHTH VIS SCI, V54, P659, DOI 10.1167/iovs.12-10984; Hsu CH, 2015, INVEST OPHTH VIS SCI, V56, P7807, DOI 10.1167/iovs.15-17926; Ishii K, 2013, CLIN EXP OPHTHALMOL, V41, P6, DOI 10.1111/j.1442-9071.2012.02830.x; Kamiya K, 2010, CORNEA, V29, P1256, DOI 10.1097/ICO.0b013e3181d9284b; Kawai M, 2012, INVEST OPHTH VIS SCI, V53, P7951, DOI 10.1167/iovs.12-10231; Khairallah M, 2015, INVEST OPHTH VIS SCI, V56, P6762, DOI 10.1167/iovs.15-17201; Kiuchi Y, 2012, JPN J OPHTHALMOL, V56, P273, DOI 10.1007/s10384-012-0131-x; Kreutzer TC, 2010, J CATARACT REFR SURG, V36, P53, DOI 10.1016/j.jcrs.2009.07.035; Kucumen RB, 2008, J CATARACT REFR SURG, V34, P2096, DOI 10.1016/j.jcrs.2008.08.017; Leccisotti A, 2016, J CATARACT REFR SURG, V42, P127, DOI 10.1016/j.jcrs.2015.07.047; Lee R, 2016, J GLAUCOMA, V25, pE603, DOI 10.1097/IJG.0000000000000284; Maeda N, 2014, JPN J OPHTHALMOL, V58, P483, DOI 10.1007/s10384-014-0344-2; Metzler KM, 2014, J CATARACT REFR SURG, V40, P888, DOI 10.1016/j.jcrs.2014.02.032; Miguel Almeida Raquel, 2015, J EMMTROPIA, V4, P185; Nakakura S, 2013, INVEST OPHTH VIS SCI, V54, P2474, DOI 10.1167/iovs.12-11424; Nemeth G, 2013, J REFRACT SURG, V29, P558, DOI 10.3928/1081597X-20130719-06; Perez-Rico C, 2015, ACTA OPHTHALMOL, V93, pe193, DOI 10.1111/aos.12530; Rimayanti U, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096066; Roberts CJ, 2014, J CATARACT REFR SURG, V40, P862, DOI 10.1016/j.jcrs.2014.04.019; Schwenn O, 2001, J CATARACT REFR SURG, V27, P421, DOI 10.1016/S0886-3350(00)00577-0; Siriwardena D, 2000, BRIT J OPHTHALMOL, V84, P1056, DOI 10.1136/bjo.84.9.1056; Slabaugh MA, 2014, AM J OPHTHALMOL, V157, P26, DOI 10.1016/j.ajo.2013.08.023; Steinberg J, 2015, CORNEA, V34, P1404, DOI 10.1097/ICO.0000000000000598; Tian L, 2015, ACTA OPHTHALMOL; Tibshirani RJ, 2012, ANN STAT, V40, P1198, DOI 10.1214/12-AOS1003; Tong JT, 1998, J CATARACT REFR SURG, V24, P256, DOI 10.1016/S0886-3350(98)80208-3; Wallentin N, 1998, INVEST OPHTH VIS SCI, V39, P1410; Wang W, 2015, INVEST OPHTH VIS SCI, V56, P5557, DOI 10.1167/iovs.15-16926; Wu Y, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/7840284; Zong Y, 2016, J GLAUCOMA	35	10	10	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2017	12	2							e0171941	10.1371/journal.pone.0171941	http://dx.doi.org/10.1371/journal.pone.0171941			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5QV	28222145	Green Published, Green Submitted, gold			2022-12-27	WOS:000394676800022
J	Peres, S; Jolicoeur, M; Moulin, C; Dague, P; Schuster, S				Peres, Sabine; Jolicoeur, Mario; Moulin, Cecile; Dague, Philippe; Schuster, Stefan			How important is thermodynamics for identifying elementary flux modes?	PLOS ONE			English	Article							GENOME-SCALE MODELS; COMPUTATION; NETWORKS; BALANCE; METABOLISM	We present a method for computing thermodynamically feasible elementary flux modes (tEFMs) using equilibrium constants without need of internal metabolite concentrations. The method is compared with the method based on a binary distinction between reversible and irreversible reactions. When all reactions are reversible, adding the constraints based on equilibrium constants reduces the number of elementary flux modes (EFMs) by a factor of two. Declaring in advance some reactions as irreversible, based on reliable biochemical expertise, can in general reduce the number of EFMs by a greater factor. But, even in this case, computing tEFMs can rule out some EFMs which are biochemically irrelevant. We applied our method to two published models described with binary distinction: the monosaccharide metabolism and the central carbon metabolism of Chinese hamster ovary cells. The results show that the binary distinction is in good agreement with biochemical observations. Moreover, the suppression of the EFMs that are not consistent with the equilibrium constants appears to be biologically relevant.	[Peres, Sabine; Moulin, Cecile; Dague, Philippe] Univ Paris Saclay, Univ Paris Sud, CNRS, LRI, F-91405 Orsay, France; [Peres, Sabine; Dague, Philippe] Univ Paris Saclay, INRA, MaIAGE, F-78350 Jouy En Josas, France; [Jolicoeur, Mario] Ecole Polytech Montreal, Res Lab Appl Metab Engn, Dept Chem Engn, POB 6079,Ctr Ville Stn, Montreal, PQ, Canada; [Schuster, Stefan] Friedrich Schiller Univ Jena, Dept Bioinformat, D-07743 Jena, Germany	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Universite de Montreal; Polytechnique Montreal; Friedrich Schiller University of Jena	Peres, S (corresponding author), Univ Paris Saclay, Univ Paris Sud, CNRS, LRI, F-91405 Orsay, France.; Peres, S (corresponding author), Univ Paris Saclay, INRA, MaIAGE, F-78350 Jouy En Josas, France.; Schuster, S (corresponding author), Friedrich Schiller Univ Jena, Dept Bioinformat, D-07743 Jena, Germany.	speres@lri.fr; stefan.schuster@uni-jena.de		Moulin, Cecile/0000-0002-7709-9761; Peres, Sabine/0000-0002-4467-9989				Acuna V, 2010, BIOSYSTEMS, V99, P210, DOI 10.1016/j.biosystems.2009.11.004; Acuna V, 2009, BIOSYSTEMS, V95, P51, DOI 10.1016/j.biosystems.2008.06.015; Ataman M, 2015, CURR OPIN BIOTECH, V36, P176, DOI 10.1016/j.copbio.2015.08.021; Atkins P., 2014, PHYS CHEM, V10th; Beard DA, 2004, J THEOR BIOL, V228, P327, DOI 10.1016/j.jtbi.2004.01.008; Beard DA, 2002, BIOPHYS J, V83, P79, DOI 10.1016/S0006-3495(02)75150-3; CLARKE BL, 1981, J CHEM PHYS, V75, P4970, DOI 10.1063/1.441885; Durot M, 2009, FEMS MICROBIOL REV, V33, P164, DOI 10.1111/j.1574-6976.2008.00146.x; Farkas J, 1902, J REINE ANGEW MATH, V124, P1; Flamholz A, 2012, NUCLEIC ACIDS RES, V40, pD770, DOI 10.1093/nar/gkr874; Forsythe RG, 1997, COMPUT APPL BIOSCI, V13, P537; Fukuda K., 1996, Combinatorics and Computer Science. 8th Franco-Japanese and 4th Franco-Chinese Conference. Selected Papers, P91; Funahashi A, 2008, P IEEE, V96, P1254, DOI 10.1109/JPROC.2008.925458; Gerstl MP, 2015, BIOINFORMATICS, V31, P2232, DOI 10.1093/bioinformatics/btv111; Gerstl MP, 2015, SCI REP-UK, V5, DOI 10.1038/srep08930; Gerstl MP, 2016, FEBS J; Ghorbaniaghdam A, 2013, BIOPROC BIOSYST ENG, V36, P469, DOI 10.1007/s00449-012-0804-3; Gudmundsson S, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-489; Henry CS, 2007, BIOPHYS J, V92, P1792, DOI 10.1529/biophysj.106.093138; Hoppe A, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-23; Hoppe A, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-28; Jankowski MD, 2008, BIOPHYS J, V95, P1487, DOI 10.1529/biophysj.107.124784; Jevremovic D, 2011, PARALLEL COMPUT, V37, P261, DOI 10.1016/j.parco.2011.04.002; Jol SJ, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002415; Klamt S, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-2; Kummel A, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-512; Kummel A, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100074; Michal M, 1994, BIOCH PATHWAYS ATLAS; Motzkin T.S., 1953, CONTRIBUTIONS THEORY, V2; Muller AC, 2014, J MATH BIOL, V69, P1151, DOI 10.1007/s00285-013-0731-1; Noor E, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003483; Noor E, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003098; Noor E, 2012, BIOINFORMATICS, V28, P2037, DOI 10.1093/bioinformatics/bts317; O'Brien EJ, 2015, CELL, V161, P971, DOI 10.1016/j.cell.2015.05.019; Prausse eMTE, 2015, BIOTECHNOL BIOENG; REDER C, 1988, J THEOR BIOL, V135, P175, DOI 10.1016/S0022-5193(88)80073-0; Robitaille J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136815; Rother K, 2010, BIOPHYS J, V98, P2478, DOI 10.1016/j.bpj.2010.02.052; Schuster S, 2000, NAT BIOTECHNOL, V18, P326, DOI 10.1038/73786; SCHUSTER S, 1991, J MATH BIOL, V29, P425, DOI 10.1007/BF00160470; SCHUSTER STEFAN, 1994, J BIOL SYST, V2, P165, DOI [DOI 10.1142/S0218339094000131, 10.1142/S0218339094000131]; Schwender J, 2004, NATURE, V432, P779, DOI 10.1038/nature03145; Sheikholeslami Z, 2013, J BIOTECHNOL, V164, P469, DOI 10.1016/j.jbiotec.2013.01.025; Terzer M, 2008, BIOINFORMATICS, V24, P2229, DOI 10.1093/bioinformatics/btn401; VARMA A, 1994, BIO-TECHNOL, V12, P994, DOI 10.1038/nbt1094-994; Vijayasankaran N, 2005, APPL MICROBIOL BIOT, V68, P737, DOI 10.1007/s00253-005-1920-7; von Kamp A, 2006, BIOINFORMATICS, V22, P1930, DOI 10.1093/bioinformatics/btl267	48	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2017	12	2							e0171440	10.1371/journal.pone.0171440	http://dx.doi.org/10.1371/journal.pone.0171440			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5QV	28222104	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000394676800010
J	Qin, L; Liu, X; Liu, SY; Liu, Y; Yang, YX; Yang, H; Chen, YM; Chen, LF				Qin, Lu; Liu, Xi; Liu, Shiyong; Liu, Yi; Yang, Yixuan; Yang, Hui; Chen, Yangmei; Chen, Lifen			Differentially expressed proteins underlying childhood cortical dysplasia with epilepsy identified by iTRAQ proteomic profiling	PLOS ONE			English	Article							ACID-BINDING PROTEINS; NEURITE OUTGROWTH; OXIDATIVE STRESS; BRAIN; GROWTH; PROSAPOSIN; TISSUE; PHOSPHORYLATION; DEFICIENCY; PLASTICITY	Cortical dysplasia accounts for at least 14% of epilepsy cases, and is mostly seen in children. However, the understanding of molecular mechanisms and pathogenesis underlying cortical dysplasia is limited. The aim of this cross-sectional study is to identify potential key molecules in the mechanisms of cortical dysplasia by screening the proteins expressed in brain tissues of childhood cortical dysplasia patients with epilepsy using isobaric tags for relative and absolute quantitation-based tandem mass spectrometry compared to controls, and several differentially expressed proteins that are not reported to be associated with cortical dysplasia previously were selected for validation using real-time polymerase chain reaction, immunoblotting and immunohistochemistry. 153 out of 3340 proteins were identified differentially expressed between childhood cortical dysplasia patients and controls. And FSCN1, CRMP1, NDRG1, DPYSL5, MAP4, and FABP3 were selected for validation and identified to be increased in childhood cortical dysplasia patients, while PRDX6 and PSAP were identified decreased. This is the first report on differentially expressed proteins in childhood cortical dysplasia. We identified differential expression of FSCN1, CRMP1, NDRG1, DPYSL5, MAP4, FABP3, PRDX6 and PSAP in childhood cortical dysplasia patients, these proteins are involved in various processes and have various function. These results may provide new directions or targets for the research of childhood cortical dysplasia, and may be helpful in revealing molecular mechanisms and pathogenesis and/or pathophysiology of childhood cortical dysplasia if further investigated.	[Qin, Lu; Liu, Xi; Liu, Yi; Chen, Yangmei; Chen, Lifen] Chongqing Med Univ, Dept Neurol, Affiliated Hosp 2, Chongqing, Peoples R China; [Liu, Shiyong; Yang, Hui] Third Mil Med Univ, Dept Neurosurg, Xinqiao Hosp, Chongqing, Peoples R China; [Yang, Yixuan] Chongqing Med Univ, Dept Infect Dis, Affiliated Hosp 2, Chongqing, Peoples R China	Chongqing Medical University; Army Medical University; Chongqing Medical University	Chen, LF (corresponding author), Chongqing Med Univ, Dept Neurol, Affiliated Hosp 2, Chongqing, Peoples R China.	lifen_chen@163.com	yang, yx/GZM-0464-2022	Liu, Xi/0000-0003-3142-7843	National Natural Science Foundation of China [81571259]; Chongqing Municipal Public Health Bureau, Chongqing People's Municipal Government [2015ZDXM011]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chongqing Municipal Public Health Bureau, Chongqing People's Municipal Government	This study is supported by National Natural Science Foundation of China (grant number: 81571259, website of funder: http://www.nsfc.gov.cn/, receiver: YC), and Chongqing Municipal Public Health Bureau, Chongqing People's Municipal Government (grant number: 2015ZDXM011, website of funder: http/www. cgwsjsw.gov.cn/, receiver: LC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bast T, 2006, ACTA NEUROL SCAND, V113, P72, DOI 10.1111/j.1600-0404.2005.00555.x; Blumcke I, 2011, EPILEPSIA, V52, P158, DOI 10.1111/j.1528-1167.2010.02777.x; Brot S, 2010, J NEUROSCI, V30, P10639, DOI 10.1523/JNEUROSCI.0059-10.2010; Carter AR, 2002, J NEUROSCI, V22, P1316, DOI 10.1523/JNEUROSCI.22-04-01316.2002; Chen YH, 2007, MOL CELL PROTEOMICS, V6, P2072, DOI 10.1074/mcp.M700395-MCP200; Chong PK, 2010, J PROTEOMICS, V73, P1632, DOI 10.1016/j.jprot.2010.04.005; Cohan CS, 2001, CELL MOTIL CYTOSKEL, V48, P109, DOI 10.1002/1097-0169(200102)48:2<109::AID-CM1002>3.0.CO;2-G; Crino, 2000, Curr Treat Options Neurol, V2, P543, DOI 10.1007/s11940-000-0032-z; Echaniz-Laguna A, 2007, NEUROMUSCULAR DISORD, V17, P163, DOI 10.1016/j.nmd.2006.10.002; Elleder M, 2005, NEUROPEDIATRICS, V36, P171, DOI 10.1055/s-2005-865608; Gan CS, 2007, J PROTEOME RES, V6, P821, DOI 10.1021/pr060474i; GAO WQ, 1995, J NEUROSCI, V15, P2656; Giorgianni F, 2014, INT J MOL SCI, V15, P9285, DOI 10.3390/ijms15069285; Goemaere J, 2012, J COMP NEUROL, V520, P258, DOI 10.1002/cne.22689; GOSHIMA Y, 1995, NATURE, V376, P509, DOI 10.1038/376509a0; Hasan MR, 2006, FEBS LETT, V580, P3505, DOI 10.1016/j.febslet.2006.05.028; Hayashi M, 2009, NEUROPATHOLOGY, V29, P1, DOI 10.1111/j.1440-1789.2008.00888.x; Higurashi M, 2012, DEV NEUROBIOL, V72, P1528, DOI 10.1002/dneu.22017; Ho J, 2009, J PROTEOME RES, V8, P583, DOI 10.1021/pr8007368; Inagaki N, 2001, NAT NEUROSCI, V4, P781, DOI 10.1038/90476; Kraft R, 2006, J NEUROSCI, V26, P8734, DOI 10.1523/JNEUROSCI.2106-06.2006; Lee Sang Kun, 2013, J Epilepsy Res, V3, P43, DOI 10.14581/jer.13009; Lim S, 2009, J PROTEOME RES, V8, P4062, DOI 10.1021/pr900430n; Liu JS, 2011, CURR NEUROL NEUROSCI, V11, P171, DOI 10.1007/s11910-010-0176-5; Liu JY, 2016, ANN NEUROL; Liu RZ, 2010, INT J DEV BIOL, V54, P1229, DOI 10.1387/ijdb.092976rl; Luo J, 2012, NEUROCHEM RES, V37, P1381, DOI 10.1007/s11064-012-0712-6; Matsushima K, 2005, CELL STRUCT FUNCT, V29, P111, DOI 10.1247/csf.29.111; Megiorni F, 2005, NEUROSCI LETT, V381, P169, DOI 10.1016/j.neulet.2005.02.027; Melotte V, 2010, FASEB J, V24, P4153, DOI 10.1096/fj.09-151464; Meriaux C, 2014, HIPPOCAMPUS, V24, P628, DOI 10.1002/hipo.22246; Moreda-Pineiro A, 2014, ANAL CHIM ACTA, V836, P1, DOI 10.1016/j.aca.2014.04.053; Motta M, 2016, CLIN GENET, V90, P220, DOI 10.1111/cge.12753; Nabeka H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110534; Okuda T, 2008, J HISTOCHEM CYTOCHEM, V56, P175, DOI 10.1369/jhc.7A7323.2007; Pelsers MMAL, 2004, CLIN CHEM, V50, P1568, DOI 10.1373/clinchem.2003.030361; Pierce A, 2008, MOL CELL PROTEOMICS, V7, P853, DOI 10.1074/mcp.M700251-MCP200; Reynolds JM, 2007, J IMMUNOL, V179, P313, DOI 10.4049/jimmunol.179.1.313; Schleicher TR, 2014, MOL CELL PROTEOMICS, V13, P2673, DOI 10.1074/mcp.M113.037259; Scholl T, 2016, BRAIN PATHOL; Schwartz PM, 1997, NEURON, V19, P269, DOI 10.1016/S0896-6273(00)80938-1; See ALP, 2014, CURR CANCER DRUG TAR, V14, P294, DOI 10.2174/1568009614666140305222328; Shaker T, 2016, SEMIN PEDIATR NEUROL, V23, P108, DOI 10.1016/j.spen.2016.06.007; Shepherd C, 2013, EPILEPSIA, V54, P898, DOI 10.1111/epi.12143; Shim SY, 2012, FREE RADICAL RES, V46, P231, DOI 10.3109/10715762.2011.649749; Singh SP, 2016, AM J PHYSIOL-CELL PH, V310, pC1, DOI 10.1152/ajpcell.00229.2015; Sisodiya SM, 2004, LANCET NEUROL, V3, P29, DOI 10.1016/S1474-4422(03)00620-3; Steinacker P, 2004, NEUROSCI LETT, V370, P36, DOI 10.1016/j.neulet.2004.07.061; Takaya R, 2016, GENES CELLS, V21, P994; Tokuraku K, 2007, J BIOCHEM, V141, P585, DOI 10.1093/jb/mvm063; Tong SW, 2012, J CELL BIOCHEM, V113, P1671, DOI 10.1002/jcb.24036; Aguiar CCT, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/795259; Uchida Y, 2005, GENES CELLS, V10, P165, DOI 10.1111/j.1365-2443.2005.00827.x; Veyrac A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023721; Wakisaka Y, 2003, J HISTOCHEM CYTOCHEM, V51, P1515, DOI 10.1177/002215540305101111; Wu Q, 2014, ADV EXP MED BIOL, V800, P25, DOI [10.1007/978-94-007-7687-6, 10.1007/978-94-007-7687-6_2]; Xiao F, 2009, BRAIN RES, V1255, P180, DOI 10.1016/j.brainres.2008.12.008; Xue B, 2011, NEUROSCI RES, V71, P22, DOI 10.1016/j.neures.2011.06.001; Yamashita N, 2011, J NEUROSCI, V31, P1773, DOI 10.1523/JNEUROSCI.5337-10.2011; Yamashita N, 2006, J NEUROSCI, V26, P13357, DOI 10.1523/JNEUROSCI.4276-06.2006; Yoshimura T, 2005, CELL, V120, P137, DOI 10.1016/j.cell.2004.11.012; Zhang HM, 2013, J PROTEOME RES, V12, P2967, DOI 10.1021/pr400247f; Zhang XD, 2014, AM J TRANSL RES, V6, P267	63	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2017	12	2							e0172214	10.1371/journal.pone.0172214	http://dx.doi.org/10.1371/journal.pone.0172214			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5QV	28222113	Green Published, gold, Green Submitted			2022-12-27	WOS:000394676800042
J	De Nicola, L; Provenzano, M; Chiodini, P; Borrelli, S; Russo, L; Bellasi, A; Santoro, D; Conte, G; Minutolo, R				De Nicola, Luca; Provenzano, Michele; Chiodini, Paolo; Borrelli, Silvio; Russo, Luigi; Bellasi, Antonio; Santoro, Domenico; Conte, Giuseppe; Minutolo, Roberto			Epidemiology of low-proteinuric chronic kidney disease in renal clinics	PLOS ONE			English	Article							CARDIOVASCULAR MORTALITY; CUMULATIVE INCIDENCE; DIABETES-MELLITUS; PHOSPHATE BINDERS; SERUM PHOSPHORUS; RISK PROFILE; CKD PATIENTS; STAGE; AGE; PROGRESSION	CKD patients with low-grade proteinuria (LP) are common in nephrology clinics. However, prevalence, characteristics, and the competing risks of ESRD and death as the specific determinants, are still unknown. We analyzed epidemiological features of LP status in a prospective cohort of 2,340 patients with CKD stage III-V referred from >= 6 months in 40 nephrology clinics in Italy. LP status was defined as proteinuria < 0.5 g/24h according to current KDIGO guidelines. Patients with higher proteinuria constituted the control group (CON). LP patients were 54.5% of the whole cohort. As compared to CON, LP were older (70.0 +/- 12.1 vs 65.4+/- 14.1 y), and less likely to be male (55.8 vs 62.0%) and diabetic (27.6 vs 34.1%), and had hypertension as the most common cause of CKD (39.8%). They had higher eGFR (34.8+/- 13.5 vs 26.8+/- 13.2 mL/min/1.73m(2)) and hemoglobin (12.7+/-1.7 vs 12.3+/-1.7 g/dL), while systolic blood pressure (137+/-18 vs 140+/-18 mmHg) and serum phosphorus (3.7 +/- 0.8 vs 3.9+/-0.8 mg/dL) were lower [ P< 0.001 for all comparisons]. Over a median follow-up of 48 months, an inverse relative risk of ESRD and death was observed in LP (death>>-ESRD; P = 0.002) versus CON (ESRD>>death; P<0.0001). Modifiable risk factors were also different in LP, with smoking, lower hemoglobin, and proteinuria being associated with higher mortality risk while lower BMI and higher phosphorus predicting ESRD at multivariable Cox analyses [ P<0.05 for all]. Therefore, in nephrology clinics, LP patients are the majority and show distinctive basal features. More important, they are more exposed to death than ESRD and do present specific modifiable determinants of either outcome; indeed, in LP, while smoking plays a role for mortality, lower BMI and higher phosphorus levels-even if in the normal range-are predictors of ESRD. These data support the need to further study the low proteinuric CKD population to guide management.	[De Nicola, Luca; Provenzano, Michele; Borrelli, Silvio; Conte, Giuseppe; Minutolo, Roberto] Univ Naples 2, Nephrol Unit, Naples, Italy; [Chiodini, Paolo] Univ Naples 2, Med Stat Unit, Naples, Italy; [Russo, Luigi] Univ Naples Federico II, Nephrol Unit, Naples, Italy; [Bellasi, Antonio] St Anna Hosp Como, Nephrol Unit, Como, Italy; [Santoro, Domenico] Univ Messina, Nephrol Unit, Messina, Italy	Universita della Campania Vanvitelli; Universita della Campania Vanvitelli; University of Naples Federico II; Ospedale Sant'Anna di Como; University of Messina	De Nicola, L (corresponding author), Univ Naples 2, Nephrol Unit, Naples, Italy.	luca.denicola@unina2.it	bellasi, antonio/M-3744-2013; santoro, domenico/P-7902-2014; Borrelli, Silvio/AAH-8549-2019; Provenzano, Michele/AAG-6214-2019; Chiodini, Paolo/E-7290-2014; De Nicola, Luca/AAB-7682-2019	bellasi, antonio/0000-0001-7830-1645; santoro, domenico/0000-0002-4279-6559; Borrelli, Silvio/0000-0002-4414-4597; Chiodini, Paolo/0000-0003-0139-2264; Provenzano, Michele/0000-0002-2168-702X; Minutolo, Roberto/0000-0001-5686-2089				Alves TP, 2010, J AM SOC NEPHROL, V21, P1361, DOI 10.1681/ASN.2009060654; Bellasi A, 2016, NEPHROL DIAL TRANSPL, V31, P184, DOI 10.1093/ndt/gfv405; Bello AK, 2015, AM J KIDNEY DIS, V65, P15, DOI 10.1053/j.ajkd.2014.07.033; Betriu A, 2014, NEPHROL DIAL TRANSPL, V29, P1415, DOI 10.1093/ndt/gfu038; Burton P, 1998, STAT MED, V17, P1261, DOI 10.1002/(SICI)1097-0258(19980615)17:11<1261::AID-SIM846>3.0.CO;2-Z; Chan MR, 2007, AM J MED, V120, P1063, DOI 10.1016/j.amjmed.2007.04.024; Conte G, 2014, NEPHROL DIAL TRANSPL, V29, P770, DOI 10.1093/ndt/gft324; Da JJ, 2015, AM J KIDNEY DIS, V66, P258, DOI 10.1053/j.ajkd.2015.01.009; De Nicola L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127071; De Nicola L, 2015, NEPHROL DIAL TRANSPL, V30, P806, DOI 10.1093/ndt/gfu383; De Nicola L, 2012, KIDNEY INT, V82, P482, DOI 10.1038/ki.2012.174; De Nicola L, 2011, CLIN J AM SOC NEPHRO, V6, P2421, DOI 10.2215/CJN.01180211; de Seigneux S, 2015, J AM SOC NEPHROL, V26, P1608, DOI 10.1681/ASN.2014010104; Delanaye Pierre, 2016, Clin Biochem Rev, V37, P17; Di Iorio BR, 2013, NEPHROL DIAL TRANSPL, V28, P632, DOI 10.1093/ndt/gfs477; Dwyer J., 1993, NUTR KIDNEY, V2nd ed., P61; Glassock RJ, 2014, NEPHROL DIAL TRANSPL, V29, P774, DOI 10.1093/ndt/gft306; Gorriz JL, 2015, CLIN J AM SOC NEPHRO, V10, P654, DOI 10.2215/CJN.07450714; GRAY RJ, 1988, ANN STAT, V16, P1141, DOI 10.1214/aos/1176350951; Hallan SI, 2012, JAMA-J AM MED ASSOC, V308, P2349, DOI 10.1001/jama.2012.16817; Haynes R, 2014, AM J KIDNEY DIS, V64, P40, DOI 10.1053/j.ajkd.2013.12.013; Hoefield RA, 2010, AM J KIDNEY DIS, V56, P1072, DOI 10.1053/j.ajkd.2010.06.010; Hsu CY, 2005, ARCH INTERN MED, V165, P923, DOI 10.1001/archinte.165.8.923; Hsu CY, 2006, ANN INTERN MED, V144, P21, DOI 10.7326/0003-4819-144-1-200601030-00006; Jones C, 2006, NEPHROL DIAL TRANSPL, V21, P2133, DOI 10.1093/ndt/gfl198; Kalantar-Zadeh K, 2007, CURR OPIN CLIN NUTR, V10, P433, DOI 10.1097/MCO.0b013e3281a30594; Kestenbaum B, 2016, NEPHROL DIAL TRANSPL, V31, P189, DOI 10.1093/ndt/gfv406; Khan Saeed R, 2004, Clin Exp Nephrol, V8, P75; Kochar SC, 2002, LIFETIME DATA ANAL, V8, P277, DOI 10.1023/A:1015806021930; Kramer H, 2016, AM J KIDNEY DIS, V67, P62, DOI 10.1053/j.ajkd.2015.05.023; Kuro-o M, 2013, NAT REV NEPHROL, V9, P650, DOI 10.1038/nrneph.2013.111; Latouche A, 2013, J CLIN EPIDEMIOL, V66, P648, DOI 10.1016/j.jclinepi.2012.09.017; Levey AS, 2011, KIDNEY INT, V80, P17, DOI 10.1038/ki.2010.483; Levin A, 2012, KIDNEY INT S, V2013, P1, DOI DOI 10.1038/kisup.2012.73; Levin A, 2008, AM J KIDNEY DIS, V52, P661, DOI 10.1053/j.ajkd.2008.06.023; Lu JL, 2015, LANCET DIABETES ENDO, V3, P704, DOI 10.1016/S2213-8587(15)00128-X; Mehrotra R, 2013, KIDNEY INT, V84, P989, DOI 10.1038/ki.2013.145; Menon V, 2008, KIDNEY INT, V73, P1310, DOI 10.1038/ki.2008.67; Minutolo R, 2014, CLIN J AM SOC NEPHRO, V9, P1586, DOI 10.2215/CJN.10481013; Minutolo R, 2013, NEPHROL DIAL TRANSPL, V28, P3035, DOI 10.1093/ndt/gft338; Mottl AK, 2013, J DIABETES COMPLICAT, V27, P123, DOI 10.1016/j.jdiacomp.2012.09.010; Nakamura K, 2015, KIDNEY INT, V88, P1144, DOI 10.1038/ki.2015.212; Noordzij M, 2013, NEPHROL DIAL TRANSPL, V28, P2670, DOI 10.1093/ndt/gft355; Obi Y, 2010, CLIN J AM SOC NEPHRO, V5, P1558, DOI 10.2215/CJN.08061109; Packham DK, 2012, AM J KIDNEY DIS, V59, P75, DOI 10.1053/j.ajkd.2011.09.017; Porrini E, 2015, LANCET DIABETES ENDO, V3, P382, DOI 10.1016/S2213-8587(15)00094-7; Rein P, 2015, ATHEROSCLEROSIS, V240, P21, DOI 10.1016/j.atherosclerosis.2015.02.037; Skali H, 2011, AM HEART J, V162, P548, DOI 10.1016/j.ahj.2011.06.006; Smart NA, 2011, AM J MED, V124, P1073, DOI 10.1016/j.amjmed.2011.04.026; Sud M, 2014, AM J KIDNEY DIS, V63, P928, DOI 10.1053/j.ajkd.2013.12.008; Titze S, 2015, NEPHROL DIAL TRANSPL, V30, P441, DOI 10.1093/ndt/gfu294; Tseng CL, 2008, ARCH INTERN MED, V168, P55, DOI 10.1001/archinternmed.2007.9; Zhang LX, 2012, LANCET, V379, P815, DOI 10.1016/S0140-6736(12)60033-6; Zoccali C, 2011, J AM SOC NEPHROL, V22, P1923, DOI 10.1681/ASN.2011020175	54	26	28	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2017	12	2							e0172241	10.1371/journal.pone.0172241	http://dx.doi.org/10.1371/journal.pone.0172241			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BI	28212407	Green Published, gold, Green Submitted			2022-12-27	WOS:000394424700024
J	Ikeda, T; Uchida, K; Yamauchi, Y; Nagase, T; Oba, K; Yamada, Y				Ikeda, Takamitsu; Uchida, Kanji; Yamauchi, Yasuhiro; Nagase, Takahide; Oba, Koji; Yamada, Yoshitsugu			Relationship between pre-anesthetic and intra-anesthetic airway resistance in patients undergoing general anesthesia: A prospective observational study	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; MAXIMUM EXPIRATORY FLOW; MECHANICALLY VENTILATED PATIENTS; RESPIRATORY RESISTANCE; TRACHEAL INTUBATION; FORCED OSCILLATION; VOLUME CURVES; SEVOFLURANE; ISOFLURANE; SPIROMETRY	Surgery patients in Japan undergo routine spirometry testing prior to general anesthesia. The use of a flow sensor during general anesthesia has recently become common. However, it is not certain whether the information derived from flow-volume curves is being adequately used for mechanical ventilation management during general anesthesia. So far, there have been no attempts to calculate airway resistance using flow-volume curves. Therefore, we performed a prospective, observational study to investigate the relationship between pre-anesthetic and intra-anesthetic airway resistance in patients scheduled for surgery under general anesthesia. We calculated pre-anesthetic and intra-anesthetic airway resistance in each patient, based on the slopes of flow-volume curves obtained prior to and during general anesthesia. We also calculated endotracheal tube resistance to correct the intra-anesthetic airway resistance values calculated. A total of 526 patients were included in the study, and 98 patients had a forced expiratory volume in the first second/forced vital capacity ratio of <70%. Pre-anesthetic airway resistance was significantly higher in patients with airflow obstruction than in those without airflow obstruction (p < 0.001), whereas no significant difference in intra-anesthetic airway resistance was found between patients with and without airflow obstruction during mechanical ventilation (p = 0.48). Pre-anesthetic and intra-anesthetic airway resistance values were closer to each other in patients without airflow obstruction, with a mean difference <1.0 cmH(2)O L-1 s(-1), than in those with airflow obstruction, although these respiratory parameters were significantly different (p < 0.001). Intra-anesthetic airway resistance was not related to the FEV1/FVC ratio, regardless of the degree to which the FEV1/FVC ratio reflected pre-anesthetic airway resistance. As compared with patients with airflow obstruction, the mean difference between pre-anesthetic and intra-anesthetic airway resistance was small in patients without airflow obstruction.	[Ikeda, Takamitsu; Uchida, Kanji; Yamada, Yoshitsugu] Univ Tokyo, Grad Sch Med, Dept Anesthesiol, Tokyo, Japan; [Yamauchi, Yasuhiro; Nagase, Takahide] Univ Tokyo, Grad Sch Med, Dept Resp Med, Tokyo, Japan; [Oba, Koji] Univ Tokyo, Sch Publ Hlth, Grad Sch Med, Dept Biostat, Tokyo, Japan	University of Tokyo; University of Tokyo; University of Tokyo	Ikeda, T (corresponding author), Univ Tokyo, Grad Sch Med, Dept Anesthesiol, Tokyo, Japan.	voice_575@live.jp	OBA, Koji/I-3980-2019	OBA, Koji/0000-0001-5468-8988; Ikeda, Takamitsu/0000-0002-1245-2958				Aerts JGJV, 1999, ACTA ANAESTH SCAND, V43, P322, DOI 10.1034/j.1399-6576.1999.430313.x; Arora V, 1996, LUNG INDIA, V14, P169; Barash P., 2009, CLIN ANESTHESIA; Crapo Robert O, 2003, Respir Care, V48, P764; Criee CP, 2011, RESP MED, V105, P959, DOI 10.1016/j.rmed.2011.02.006; Dikmen Y, 2003, ANAESTHESIA, V58, P745, DOI 10.1046/j.1365-2044.2003.03285.x; FRASER R G, 1961, J Can Assoc Radiol, V12, P102; Global Initiative for Chronic Obstructive Lung Disease, GLOBAL STRATEGY DIAG; Goldman MD, 2001, PULM PHARMACOL THER, V14, P341, DOI 10.1006/pupt.2001.0310; Herzog H, 1969, RESP RES, P205; HOGG JC, 1968, NEW ENGL J MED, V278, P1355, DOI 10.1056/NEJM196806202782501; HYATT RE, 1958, J APPL PHYSIOL, V13, P331, DOI 10.1152/jappl.1958.13.3.331; Kondili E, 2004, INTENS CARE MED, V30, P1311, DOI 10.1007/s00134-004-2255-z; LOFASO F, 1992, AM REV RESPIR DIS, V146, P974, DOI 10.1164/ajrccm/146.4.974; Loring SH, 1998, PHYSL BASIS VENTILAT, P177; MacIntyre NR, 2009, RESP CARE, V54, P1050; MACKLEM PT, 1967, J APPL PHYSIOL, V22, P395, DOI 10.1152/jappl.1967.22.3.395; Mahut B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005270; MEAD J, 1967, J APPL PHYSIOL, V22, P95, DOI 10.1152/jappl.1967.22.1.95; MEAD J, 1978, J APPL PHYSIOL, V44, P156, DOI 10.1152/jappl.1978.44.2.156; MEAD J, 1970, NEW ENGL J MED, V282, P1318, DOI 10.1056/NEJM197006042822311; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; MOON RE, 2005, MILLERS ANESTHESIA, P1437; Moran I, 2011, INTENS CARE MED, V37, P1773, DOI 10.1007/s00134-011-2351-9; Murgu SD, 2007, EGYPT J BRONCHOL, V1, P87; Murgu SD, 2005, J BRONCHOL INTERN PU, V12, P239, DOI 10.1097/01.laboratory.0000185588.63895.5f; Nyktari V, 2011, BRIT J ANAESTH, V107, P454, DOI 10.1093/bja/aer155; Ochi G, 1993, J Anesth, V7, P120, DOI 10.1007/s0054030070120; Oostveen E, 2003, EUR RESPIR J, V22, P1026, DOI 10.1183/09031936.03.00089403; Rooke GA, 1997, ANESTHESIOLOGY, V86, P1294, DOI 10.1097/00000542-199706000-00010; VANBRABANDT H, 1983, J APPL PHYSIOL, V55, P1733, DOI 10.1152/jappl.1983.55.6.1733; Walter B, 2012, MED PHYSL; West J.B., RESP PHYSL ESSENTIAL; WILT TJ, 2005, EVID REP TECHNOL ASS, V121, P1; Wu RSC, 1996, BRIT J ANAESTH, V77, P735, DOI 10.1093/bja/77.6.735; ZIN WA, 1982, J APPL PHYSIOL, V52, P1266, DOI 10.1152/jappl.1982.52.5.1266; ZIN WA, 1986, J APPL PHYSIOL, V61, P1647, DOI 10.1152/jappl.1986.61.5.1647	37	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2017	12	2							e0172421	10.1371/journal.pone.0172421	http://dx.doi.org/10.1371/journal.pone.0172421			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BI	28212451	Green Submitted, gold, Green Published			2022-12-27	WOS:000394424700047
J	Mahault, B; Saxena, A; Nisoli, C				Mahault, Benoit; Saxena, Avadh; Nisoli, Cristiano			Emergent inequality and self-organized social classes in a network of power and frustration	PLOS ONE			English	Article							ARTIFICIAL SPIN ICE; STATISTICAL-MECHANICS; WEALTH; ENTROPY; INCOME	We propose a simple agent-based model on a network to conceptualize the allocation of limited wealth among more abundant expectations at the interplay of power, frustration, and initiative. Concepts imported from the statistical physics of frustrated systems in and out of equilibrium allow us to compare subjective measures of frustration and satisfaction to collective measures of fairness in wealth distribution, such as the Lorenz curve and the Gini index. We find that a completely libertarian, law-of-the-jungle setting, where every agent can acquire wealth from or lose wealth to anybody else invariably leads to a complete polarization of the distribution of wealth vs. opportunity. This picture is however dramatically ameliorated when hard constraints are imposed over agents in the form of a limiting network of transactions. There, an out of equilibrium dynamics of the networks, based on a competition between power and frustration in the decision-making of agents, leads to network coevolution. The ratio of power and frustration controls different dynamical regimes separated by kinetic transitions and characterized by drastically different values of equality. It also leads, for proper values of social initiative, to the emergence of three self-organized social classes, lower, middle, and upper class. Their dynamics, which appears mostly controlled by the middle class, drives a cyclical regime of dramatic social changes.	[Mahault, Benoit] CEA Saclay, CNRS UMR 3680, Serv Phys Etat Condense, F-91191 Gif Sur Yvette, France; [Mahault, Benoit; Saxena, Avadh; Nisoli, Cristiano] Los Alamos Natl Lab, Div Theoret, Los Alamos, NM 87545 USA; [Mahault, Benoit; Saxena, Avadh; Nisoli, Cristiano] Los Alamos Natl Lab, Ctr Nonlinear Studies, Los Alamos, NM 87545 USA; [Nisoli, Cristiano] Los Alamos Natl Lab, Inst Mat Sci, Los Alamos, NM 87545 USA	CEA; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Universite Paris Saclay; United States Department of Energy (DOE); Los Alamos National Laboratory; United States Department of Energy (DOE); Los Alamos National Laboratory; United States Department of Energy (DOE); Los Alamos National Laboratory	Nisoli, C (corresponding author), Los Alamos Natl Lab, Div Theoret, Los Alamos, NM 87545 USA.; Nisoli, C (corresponding author), Los Alamos Natl Lab, Ctr Nonlinear Studies, Los Alamos, NM 87545 USA.; Nisoli, C (corresponding author), Los Alamos Natl Lab, Inst Mat Sci, Los Alamos, NM 87545 USA.	cristiano.nisoli@gmail.com	Nisoli, Cristiano/O-5134-2019	Nisoli, Cristiano/0000-0003-0053-1023; Mahault, Benoit/0000-0001-9915-0233				Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Amaral LAN, 2000, P NATL ACAD SCI USA, V97, P11149, DOI 10.1073/pnas.200327197; Andrews Edmund L., 2008, NY TIMES; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Barba A, 2009, CAMB J ECON, V33, P113, DOI 10.1093/cje/ben030; Barrat A., 2008, DYNAMICAL PROCESSES, DOI [10.1017/CBO9780511791383, DOI 10.1017/CBO9780511791383]; Benabou R., 1996, NBER MACROECON ANNU, V11, P11, DOI [10.1086/654291, DOI 10.1086/654291]; Bettencourt LMA, 2007, P NATL ACAD SCI USA, V104, P7301, DOI 10.1073/pnas.0610172104; Bettencourt LMA, 2013, SCIENCE, V340, P1438, DOI 10.1126/science.1235823; Bonica A, 2013, J ECON PERSPECT, V27, P103, DOI 10.1257/jep.27.3.103; Cohen R., 2010, COMPLEX NETWORKS STR; Davies JB, 2011, ECON J, V121, P223, DOI 10.1111/j.1468-0297.2010.02391.x; Deininger K, 1996, WORLD BANK ECON REV, V10, P565, DOI 10.1093/wber/10.3.565; Demirguc-Kunt A., 2009, FINANCE INEQUALITY T; DiPrete TA, 2006, ANNU REV SOCIOL, V32, P271, DOI 10.1146/annurev.soc.32.061604.123127; Dorogovtsev SN, 2008, REV MOD PHYS, V80, P1275, DOI 10.1103/RevModPhys.80.1275; Dragulescu A, 2000, EUR PHYS J B, V17, P723, DOI 10.1007/s100510070114; Erdos P., 1961, ACTA MATH HUNGARICA, V12, P261, DOI 10.1007/BF02066689; Fotouhi B, 2013, EUR PHYS J B, V86, DOI 10.1140/epjb/e2013-40920-6; Gao JX, 2012, NAT PHYS, V8, P40, DOI 10.1038/nphys2180; Gilbert I, 2016, PHYS TODAY, V69, P54, DOI 10.1063/PT.3.3237; Gilbert I, 2014, NAT PHYS, V10, P671, DOI [10.1038/NPHYS3037, 10.1038/nphys3037]; Gilens M., 2012, AFFLUENCE INFLUENCE; Gilens M, 2014, PERSPECT POLIT, V12, P564, DOI 10.1017/S1537592714001595; Gini C., 1912, REPRINTED MEMORIE ME, V1; Gross T, 2008, J R SOC INTERFACE, V5, P259, DOI 10.1098/rsif.2007.1229; Jones CI, 2015, J ECON PERSPECT, V29, P29, DOI 10.1257/jep.29.1.29; Krugman P., 2013, NY TIMES, P15; Kuznets S, 1955, AM ECON REV, V45, P1; Libal A, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.228302; Liljeros F, 2003, MICROBES INFECT, V5, P189, DOI 10.1016/S1286-4579(02)00058-8; Lorenz MO, 1905, J AM STAT ASSOC, V9, P209; Marx K., 1885, KAPITAL KRITIK POLIT, V24; Marx K., 1867, KAPITAL KAPITAL KRIT; Marx Karl, 1894, KAPITAL KRITIK POLIT; MERTON RK, 1968, SCIENCE, V159, P56, DOI 10.1126/science.159.3810.56; Mishel L, 2012, STATE WORKING AM; Nisoli C, 2014, NEW J PHYS, V16, DOI 10.1088/1367-2630/16/11/113049; Nisoli C, 2013, REV MOD PHYS, V85, P1473, DOI 10.1103/RevModPhys.85.1473; Palley TI, 2007, FINANCIALIZAITON WHA, P201, DOI [10.1080/02673030601132797, DOI 10.1080/02673030601132797]; Pareto V., 1897, J POLIT ECON, V5, P485, DOI [DOI 10.1086/250454, 10.1086/250454]; Pareto V., 1896, PARETOCOURSE EC POLI; Pauling L, 1935, J AM CHEM SOC, V57, P2680, DOI 10.1021/ja01315a102; PERSKY J, 1992, J ECON PERSPECT, V6, P181, DOI 10.1257/jep.6.2.181; Piketty T, 2014, SCIENCE, V344, P838, DOI 10.1126/science.1251936; Piketty Thomas, 2014, Q J ECON, V129, P1255; Powell WW, 1996, ADMIN SCI QUART, V41, P116, DOI 10.2307/2393988; Ramirez AP, 1999, NATURE, V399, P333, DOI 10.1038/20619; Saez E, 2014, WEALTH INEQALITY US; Sherman M, 2009, SHOT HIST FINANCIAL, P7; Spilerman S, 2000, ANNU REV SOCIOL, V26, P497, DOI 10.1146/annurev.soc.26.1.497; Stephens M, 2007, HOUSING STUD, V22, P201, DOI 10.1080/02673030601132797; Wang RF, 2006, NATURE, V439, P303, DOI 10.1038/nature04447; White A., 2007, PSYCHTALK, V56, P17; Wolff EN, 2013, J ECON ISSUES, V47, P333, DOI 10.2753/JEI0021-3624470205; Yakovenko VM, 2009, REV MOD PHYS, V81, P1703, DOI 10.1103/RevModPhys.81.1703; Zhang S, 2013, NATURE, V500, P553, DOI 10.1038/nature12399	57	4	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2017	12	2							e0171832	10.1371/journal.pone.0171832	http://dx.doi.org/10.1371/journal.pone.0171832			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL2BI	28212440	Green Published, Green Submitted, gold			2022-12-27	WOS:000394424700012
J	Malachowicz, M; Wenne, R; Burzynski, A				Malachowicz, Magdalena; Wenne, Roman; Burzynski, Artur			De novo assembly of the sea trout (Salmo trutta m. trutta) skin transcriptome to identify putative genes involved in the immune response and epidermal mucus secretion	PLOS ONE			English	Article							ATLANTIC SALMON; RAINBOW-TROUT; MUCIN BIOSYNTHESIS; FISH; EXPRESSION; SALAR; INFECTION; RECEPTOR; DIFFERENTIATION; IDENTIFICATION	In fish, the skin is a multifunctional organ and the first barrier against pathogens. Salmonids differ in their susceptibility to microorganisms due to varied skin morphology and gene expression patterns. The brown trout is a salmonid species with important commercial and ecological value in Europe. However, there is a lack of knowledge regarding the genes involved in the immune response and mucus secretion in the skin of this fish. Thus, we characterized the skin transcriptome of anadromous brown trout using next-generation sequencing ( NGS). A total of 1,348,306 filtered reads were obtained and assembled into 75,970 contigs. Of these contigs 48.57% were identified using BLAST tool searches against four public databases. KEGG pathway and Gene Ontology analyses revealed that 13.40% and 34.57% of the annotated transcripts, respectively, represent a variety of biological processes and functions. Among the identified KEGG Orthology categories, the best represented were signal transduction ( 23.28%) and immune system ( 8.82%), with a variety of genes involved in immune pathways, implying the differentiation of immune responses in the trout skin. We also identified and transcriptionally characterized 8 types of mucin proteins the main structural components of the mucosal layer. Moreover, 140 genes involved in mucin synthesis were identified, and 1,119 potential simple sequence repeats ( SSRs) were detected in 3,134 transcripts.	[Malachowicz, Magdalena; Wenne, Roman; Burzynski, Artur] Inst Oceanol PAS, Sopot, Poland	Polish Academy of Sciences; Institute of Oceanology of the Polish Academy of Sciences	Malachowicz, M (corresponding author), Inst Oceanol PAS, Sopot, Poland.	mwarzecha@iopan.gda.pl	Burzynski, Artur/J-7048-2012; Malachowicz, Magdalena/M-9469-2017; Malachowicz, Magdalena/K-1436-2019; Wenne, Roman/S-8294-2017	Burzynski, Artur/0000-0002-0185-197X; Malachowicz, Magdalena/0000-0002-3088-9619; Malachowicz, Magdalena/0000-0002-3088-9619; Wenne, Roman/0000-0001-6994-1181				Alexander John B., 1992, Annual Review of Fish Diseases, V2, P249, DOI 10.1016/0959-8030(92)90066-7; Anderson D. P., 1989, Viruses of lower vertebrates., P469; Ao JQ, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005118; Aranishi F, 1997, FISH PHYSIOL BIOCHEM, V16, P471, DOI 10.1023/A:1007736804243; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bahar AA, 2013, PHARMACEUTICALS-BASE, V6, P1543, DOI 10.3390/ph6121543; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Bergsson G, 2005, FEBS J, V272, P4960, DOI 10.1111/j.1742-4658.2005.04906.x; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Charles A, 2001, IMMUNOBIOL IMMUNE SY, V5th; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Dekker J, 2002, TRENDS BIOCHEM SCI, V27, P126, DOI 10.1016/S0968-0004(01)02052-7; Desseyn JL, 2000, MOL BIOL EVOL, V17, P1175, DOI 10.1093/oxfordjournals.molbev.a026400; Du LM, 2013, J HERED, V104, P154, DOI 10.1093/jhered/ess082; Du YS, 2015, FISH SHELLFISH IMMUN, V44, P307, DOI 10.1016/j.fsi.2015.02.029; Elliott Diane G., 2000, P95, DOI 10.1016/B978-012529650-2/50008-1; Elliott J.M., 1994, QUANTITATIVE ECOLOGY; ELLIS AE, 1988, MICROB PATHOGENESIS, V4, P299, DOI 10.1016/0882-4010(88)90090-3; Ellis AE, 2001, DEV COMP IMMUNOL, V25, P827, DOI 10.1016/S0145-305X(01)00038-6; Esteban Angeles M, 2012, ISRN IMMUNOL, V2012, P853470, DOI [10.5402/2012/853470, DOI 10.5402/2012/853470]; Fast MD, 2002, COMP BIOCHEM PHYS A, V132, P645, DOI 10.1016/S1095-6433(02)00109-5; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; FREEDMAN SJ, 1991, COMP BIOCHEM PHYS B, V98, P549, DOI 10.1016/0305-0491(91)90252-9; Gasque P, 2004, MOL IMMUNOL, V41, P1089, DOI 10.1016/j.molimm.2004.06.011; Gonzalez SF, 2007, DEV COMP IMMUNOL, V31, P576, DOI 10.1016/j.dci.2006.08.010; HAGEN FK, 1993, J BIOL CHEM, V268, P18960; Hashimoto M, 2007, GLYCOBIOLOGY, V17, P994, DOI 10.1093/glycob/cwm068; Hikima JI, 2011, DEV COMP IMMUNOL, V35, P924, DOI 10.1016/j.dci.2010.10.011; HJELMELAND K, 1983, J FISH BIOL, V23, P13, DOI 10.1111/j.1095-8649.1983.tb02878.x; Hollingsworth MA, 2004, NAT REV CANCER, V4, P45, DOI 10.1038/nrc1251; Hoorens PR, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-140; Hordvik I, 2015, BIOMOLECULES, V5, P166, DOI 10.3390/biom5010166; ICES, 2015, 2015ACOM08 ICES CM; Janda JM, 2010, CLIN MICROBIOL REV, V23, P35, DOI 10.1128/CMR.00039-09; Jevtov I, 2014, SCI REP-UK, V4, DOI 10.1038/srep06653; Jonsson B, 2009, J FISH BIOL, V75, P2381, DOI 10.1111/j.1095-8649.2009.02380.x; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Karsi A, 2002, GENE, V285, P157, DOI 10.1016/S0378-1119(02)00414-6; Klemetsen A, 2003, ECOL FRESHW FISH, V12, P1, DOI 10.1034/j.1600-0633.2003.00010.x; Krasnov A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-130; Kumar S., 2016, MOL BIOL EVOLUTION, V33, DOI [DOI 10.1093/M0LBEV/MSW054, https://doi.org/10.1093/molbev/msw054, 10.1093/molbev/msw054]; Lang T, 2004, GLYCOBIOLOGY, V14, P521, DOI 10.1093/glycob/cwh066; LaPatra S. E., 1989, Journal of Aquatic Animal Health, V1, P277, DOI 10.1577/1548-8667(1989)001&lt;0277:IHNVII&gt;2.3.CO;2; Letunic I, 2015, NUCLEIC ACIDS RES, V43, pD257, DOI 10.1093/nar/gku949; Li DJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-192; Lien S, 2016, NATURE, V533, P200, DOI 10.1038/nature17164; Lin KBL, 2008, IMMUNITY, V28, P75, DOI 10.1016/j.immuni.2007.11.019; Linden SK, 2008, MUCOSAL IMMUNOL, V1, P183, DOI 10.1038/mi.2008.5; Long Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056998; Magnadottir B, 2006, FISH SHELLFISH IMMUN, V20, P137, DOI 10.1016/j.fsi.2004.09.006; Malachowicz M, 2015, MAR GENOM, V23, P37, DOI 10.1016/j.margen.2015.04.005; Marel Maria van der, 2012, Fish Shellfish Immunol, V32, P494, DOI 10.1016/j.fsi.2011.12.008; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Marshall WS, 2010, COMP BIOCHEM PHYS A, V155, P275, DOI 10.1016/j.cbpa.2009.11.016; Meng Z, 2012, J IMMUNOL, V189, P4024, DOI 10.4049/jimmunol.1201244; Micallef G, 2012, MAR BIOTECHNOL, V14, P559, DOI 10.1007/s10126-012-9447-2; Moller S, 2001, BIOINFORMATICS, V17, P646, DOI 10.1093/bioinformatics/17.7.646; Moniaux N, 2001, FRONT BIOSCI-LANDMRK, V6, pD1192, DOI 10.2741/Moniaux; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Mu YN, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-506; Nawrocki EP, 2015, NUCLEIC ACIDS RES, V43, pD130, DOI 10.1093/nar/gku1063; Neuhaus H, 2007, DIS AQUAT ORGAN, V77, P17, DOI 10.3354/dao01836; Noga EJ, 2009, COMP BIOCHEM PHYS B, V152, P299, DOI 10.1016/j.cbpb.2008.12.018; Padra JT, 2014, INFECT IMMUN, V82, P5235, DOI 10.1128/IAI.01931-14; Pan CY, 2007, DNA CELL BIOL, V26, P403, DOI 10.1089/dna.2006.0564; Peatman E, 2015, TISSUE BARRIERS, V3, DOI 10.1080/21688370.2015.1068907; Perez-Sanchez J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065457; Perez-Vilar J, 1998, J BIOL CHEM, V273, P14442, DOI 10.1074/jbc.273.23.14442; Pluta K, 2012, PHYSIOL GENOMICS, V44, P1165, DOI 10.1152/physiolgenomics.00088.2012; Pocwierz-Kotus A, 2014, ANIM GENET, V45, P96, DOI 10.1111/age.12095; Salinas I, 2011, DEV COMP IMMUNOL, V35, P1346, DOI 10.1016/j.dci.2011.11.009; Saurabh S, 2008, AQUAC RES, V39, P223, DOI 10.1111/j.1365-2109.2007.01883.x; Schnoes AM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000605; Soares-Silva M, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00183; SPECIAN RD, 1991, AM J PHYSIOL, V260, pC183, DOI 10.1152/ajpcell.1991.260.2.C183; STROUS GJ, 1992, CRIT REV BIOCHEM MOL, V27, P57, DOI 10.3109/10409239209082559; Subramanian S, 2009, MAR BIOTECHNOL, V11, P748, DOI 10.1007/s10126-009-9189-y; Tacchi L, 2015, AQUACULTURE, V435, P120, DOI 10.1016/j.aquaculture.2014.09.027; Tsutsui S, 2011, J BIOCHEM, V150, P501, DOI 10.1093/jb/mvr085; Varshney RK, 2005, TRENDS BIOTECHNOL, V23, P48, DOI 10.1016/j.tibtech.2004.11.005; Was A, 2003, MAR BIOTECHNOL, V5, P234, DOI 10.1007/s10126-002-0068-z; Was A, 2002, AQUACULTURE, V204, P493, DOI 10.1016/S0044-8486(01)00835-3; Webster TMU, 2013, ENVIRON SCI TECHNOL, V47, P8869, DOI 10.1021/es401380p; Webster TMU, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1254-5; Xie SB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094496; Xu Y, 1998, J BIOL CHEM, V273, P21783, DOI 10.1074/jbc.273.34.21783; Yan HY, 2009, J FISH BIOL, V75, P845, DOI 10.1111/j.1095-8649.2009.02326.x; Zalapa JE, 2012, AM J BOT, V99, P193, DOI 10.3732/ajb.1100394; Zhulidov PA, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh031	91	22	22	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2017	12	2							e0172282	10.1371/journal.pone.0172282	http://dx.doi.org/10.1371/journal.pone.0172282			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BI	28212382	Green Published, gold			2022-12-27	WOS:000394424700027
J	Cao, Z; Wang, ZJ; Shang, ZL; Zhao, JC				Cao, Zhen; Wang, Zhenjie; Shang, Zhonglin; Zhao, Jiancheng			Classification and identification of Rhodobryum roseum Limpr. and its adulterants based on fourier-transform infrared spectroscopy (FTIR) and chemometrics	PLOS ONE			English	Article							PHYLOGENETIC-RELATIONSHIPS; WAVELET TRANSFORM; MOSSES; AUTHENTICATION; MICROORGANISMS; CHLOROPLAST; SPECTRA; AREAS; CWT	Fourier-transform infrared spectroscopy (FTIR) with the attenuated total reflectance technique was used to identify Rhodobryum roseum from its four adulterants. The FTIR spectra of six samples in the range from 4000 cm(-1) to 600 cm(-1) were obtained. The second-derivative transformation test was used to identify the small and nearby absorption peaks. A cluster analysis was performed to classify the spectra in a dendrogram based on the spectral similarity. Principal component analysis (PCA) was used to classify the species of six moss samples. A cluster analysis with PCA was used to identify different genera. However, some species of the same genus exhibited highly similar chemical components and FTIR spectra. Fourier self-deconvolution and discrete wavelet transform (DWT) were used to enhance the differences among the species with similar chemical components and FTIR spectra. Three scales were selected as the feature-extracting space in the DWT domain. The results show that FTIR spectroscopy with chemometrics is suitable for identifying Rhodobryum roseum and its adulterants.	[Cao, Zhen; Shang, Zhonglin; Zhao, Jiancheng] Hebei Normal Univ, Coll Life Sci, Shijiazhuang, Peoples R China; [Cao, Zhen; Wang, Zhenjie] Hebei Coll Ind & Technol, Shijiazhuang, Peoples R China	Hebei Normal University	Zhao, JC (corresponding author), Hebei Normal Univ, Coll Life Sci, Shijiazhuang, Peoples R China.	zhaojiancheng@mail.hebtu.edu.cn			Natural Science Foundation of China [31370237]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Natural Science Foundation of China 31370237 (JZ), https://isisn.nsfc.gov.cn/egrantindex/funcindex/prjsearch-list#.	Addison PS, 1997, INSIGHT, V39, P493; Asakawa Y, 2013, PHYTOCHEMISTRY, V91, P52, DOI 10.1016/j.phytochem.2012.04.012; Chan KLA, 2008, APPL SPECTROSC, V62, P1095, DOI 10.1366/000370208786049042; Cheng CG, 2008, ACTA CHIM SINICA, V66, P793; Cheng CG, 2010, VIB SPECTROSC, V54, P50, DOI 10.1016/j.vibspec.2010.06.004; Cox CJ, 1999, PLANT SYST EVOL, V215, P119, DOI 10.1007/BF00984651; Cox CJ, 2004, SYST BOT, V29, P234, DOI 10.1600/036364404774195458; Cox CJ, 2003, J BRYOL, V25, P31, DOI 10.1179/037366803125002635; Crandall-Stotler B, 2007, FLORA N AM N MEXICO, P3; Crosby M. R., 1999, CHECKLIST MOSSES; DAUBECHIES I, 1990, IEEE T INFORM THEORY, V36, P961, DOI 10.1109/18.57199; De Luca M, 2011, FOOD CHEM, V124, P1113, DOI 10.1016/j.foodchem.2010.07.010; DEFERNEZ M, 1995, J AGR FOOD CHEM, V43, P109, DOI 10.1021/jf00049a021; DONG A, 1990, BIOCHEMISTRY-US, V29, P3303, DOI 10.1021/bi00465a022; Foan L, 2014, ENVIRON POLLUT, V184, P113, DOI 10.1016/j.envpol.2013.08.006; Forina M, 2008, CHEMOMETR INTELL LAB, V93, P132, DOI 10.1016/j.chemolab.2008.05.003; Giese AT, 1955, APPL SPECTROSC, V9, P78, DOI 10.1366/000370255774634089; Hu T, 2011, SPECTROSC-BIOMED APP, V25, P271, DOI 10.1155/2011/908150; KEMSLEY EK, 1994, FOOD CONTROL, V5, P241, DOI 10.1016/0956-7135(94)90023-X; Kohler A, 2007, ANAL BIOANAL CHEM, V389, P1143, DOI 10.1007/s00216-007-1414-9; Lu HF, 2004, ACTA BOT SIN, V46, P401; Marchant BP, 2003, BIOSYST ENG, V85, P261, DOI 10.1016/S1537-5110(03)00063-1; Mark H, 2003, SPECTROSCOPY, V18, P25; Montes J, 2011, NOVA HEDWIGIA, V93, P47; Movasaghi Z, 2008, APPL SPECTROSC REV, V43, P134, DOI 10.1080/05704920701829043; Naumann A, 2010, FIELD CROP RES, V119, P78, DOI 10.1016/j.fcr.2010.06.017; Naumann A, 2009, ANALYST, V134, P1215, DOI 10.1039/b821286d; NAUMANN D, 1988, J MOL STRUCT, V174, P165, DOI 10.1016/0022-2860(88)80152-2; Naumann D, 1991, J GEN MICROBIOL, V137, P69, DOI [10.1099/00221287-137-1-69, DOI 10.1099/00221287-137-1-69]; Poulli KI, 2005, ANAL CHIM ACTA, V542, P151, DOI 10.1016/j.aca.2005.03.061; Qiao F, 2003, DRUG STANOAROS CHINA, V6, P3; Salzer R, 2000, FRESEN J ANAL CHEM, V366, P712, DOI 10.1007/s002160051565; Sockalingum GD, 1998, CELL MOL BIOL, V44, P261; Subasi A, 2012, COMPUT BIOL MED, V42, P806, DOI 10.1016/j.compbiomed.2012.06.004; SUSI H, 1983, BIOCHEM BIOPH RES CO, V115, P391, DOI 10.1016/0006-291X(83)91016-1; Wang X, 2010, SPECTROCHIM ACTA A, V91, P165; Wenning M, 2013, APPL MICROBIOL BIOT, V97, P7111, DOI 10.1007/s00253-013-5087-3; WHITBECK MR, 1981, APPL SPECTROSC, V35, P93, DOI 10.1366/0003702814731851; Xu H-C, 2008, J SHAANXI NORMAL U, V36, P88; Yang JW, 2005, LECT NOTES COMPUT SC, V3522, P427; Zhang CJ, 2008, SPECTROSC-INT J, V22, P371, DOI 10.1155/2008/729607	41	25	25	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0172359	10.1371/journal.pone.0172359	http://dx.doi.org/10.1371/journal.pone.0172359			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207900	Green Published, gold, Green Submitted			2022-12-27	WOS:000394424500124
J	Picazo, J; Ruiz-Contreras, J; Casado-Flores, J; Negreira, S; Baquero, F; Hernandez-Sampelayo, T; Otheo, E; Mendez, C				Picazo, Juan; Ruiz-Contreras, Jesus; Casado-Flores, Juan; Negreira, Sagrario; Baquero, Fernando; Hernandez-Sampelayo, Teresa; Otheo, Enrique; Mendez, Cristina		Heracles Study Grp	Effect of the different 13-valent pneumococcal conjugate vaccination uptakes on the invasive pneumococcal disease in children: Analysis of a hospital-based and population-based surveillance study in Madrid, Spain, 2007-2015	PLOS ONE			English	Article							ACUTE OTITIS-MEDIA; REAL-TIME PCR; STREPTOCOCCUS-PNEUMONIAE; NASOPHARYNGEAL CARRIAGE; SEROTYPES; COLONIZATION; VACCINES; TRENDS; PCV13; SCHEDULE	In the Community of Madrid, the 13-valent pneumococcal conjugate vaccine (PCV13) replaced the 7-valent (PCV7) in the fully government-funded Regional Immunization Program (RIP) in May, 2010, but was later excluded in May, 2012, and included again in January, 2015. These unique changes allowed us to assess the impact of the different pneumococcal vaccination policies on PCV13 uptake in infants and on the incidence rate (IR) of invasive pneumococcal disease (IPD) in children <15 years old. In this prospective, active, surveillance study, we estimated PCV13 uptakes, IR and incidence rate ratios (IRR) for total IPD and for IPD caused by PCV13- and non-PCV13 serotypes in children <15 years, stratified by age, in four periods with different vaccination policies: fully government-funded PCV7 vaccination, fully government-funded PCV13, mixed public/ private funding and only private funding. Vaccine uptakes reached 95% in periods with public-funded pneumococcal vaccination, but fell to 67% in the private funding period. Overall, IR of IPD decreased by 68% (p<0.001) in 2014-15, due to 93% reduction in the IR of PCV13-type IPD (p<0.001) without significant changes in non-PCV13-type IPD. A fully government-funded PCV13 vaccination program lead to high vaccine uptake and dramatic reductions in both overall and PCV13-type IPD IR. When this program was switched to private PCV13 vaccination, there was a fall in vaccine coverage and stagnation in the decline of PCV13-type IPD with data suggesting a weakening of herd immunity.	[Picazo, Juan] Univ Complutense, Sch Med, Dept Med, Madrid, Spain; [Ruiz-Contreras, Jesus; Negreira, Sagrario] Hosp Univ 12 Octubre, Dept Pediat, Madrid, Spain; [Ruiz-Contreras, Jesus; Negreira, Sagrario; Hernandez-Sampelayo, Teresa] Univ Complutense, Sch Med, Dept Pediat, Madrid, Spain; [Casado-Flores, Juan] Hosp Univ Infantil Nino Jesus, Pediat ICU, Madrid, Spain; [Casado-Flores, Juan; Baquero, Fernando] Univ Autonoma Madrid, Sch Med, Dept Pediat, Madrid, Spain; [Baquero, Fernando] Hosp Univ La Paz, Dept Pediat, Madrid, Spain; [Hernandez-Sampelayo, Teresa] Hosp Gen Univ Gregorio Maranon, Dept Pediat, Madrid, Spain; [Hernandez-Sampelayo, Teresa] CIBERES, CIBER Resp Dis, Madrid, Spain; [Otheo, Enrique] Hosp Univ Ramoon y Cajal, Dept Pediat, Madrid, Spain; [Mendez, Cristina] Pfizer SLU, Dept Med, Madrid, Spain	Complutense University of Madrid; Hospital Universitario 12 de Octubre; Complutense University of Madrid; Autonomous University of Madrid; Hospital Universitario La Paz; General University Gregorio Maranon Hospital; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Pfizer	Picazo, J (corresponding author), Univ Complutense, Sch Med, Dept Med, Madrid, Spain.	jpicazo@picazo.net	Matos, teresa ths Hernández-Sampelayo/M-7200-2018	Matos, teresa ths Hernández-Sampelayo/0000-0002-3296-6331; RUIZ-CONTRERAS, JESUS/0000-0002-2788-7524	Pfizer S.L.U., Madrid, Spain	Pfizer S.L.U., Madrid, Spain	This work was supported in part by an unrestricted grant from Pfizer S.L.U., Madrid, Spain. The funder played an indirect role through the participation of a co-author in study design, coordination of study centers, critical revision and final approval of the manuscript, and the agreement to be accountable for all aspects of the work.	Aguiar SI, 2014, EUROSURVEILLANCE, V19, P18, DOI 10.2807/1560-7917.ES2014.19.12.20750; Bogaert D, 2004, LANCET INFECT DIS, V4, P144, DOI 10.1016/S1473-3099(04)00938-7; Sanz JC, 2010, J CLIN MICROBIOL, V48, P593, DOI 10.1128/JCM.01651-09; Carvalho MDS, 2007, J CLIN MICROBIOL, V45, P2460, DOI 10.1128/JCM.02498-06; Centers for Disease Control and Prevention (CDC), 2005, MMWR Morb Mortal Wkly Rep, V54, P893; Centres for Disease Control and Prevention, 2014, ACT BACT COR SURV RE; Cohen R, 2015, VACCINE, V33, P5118, DOI 10.1016/j.vaccine.2015.08.010; Cohen R, 2012, PEDIATR INFECT DIS J, V31, P297, DOI 10.1097/INF.0b013e318247ef84; Corless CE, 2001, J CLIN MICROBIOL, V39, P1553, DOI 10.1128/JCM.39.4.1553-1558.2001; Dagan R, 2015, J INFECT DIS, V211, P1144, DOI 10.1093/infdis/jiu576; Desai AP, 2015, PEDIATR INFECT DIS J, V34, P1168, DOI 10.1097/INF.0000000000000849; Fenoll A, 2015, VACCINE, V33, P5691, DOI 10.1016/j.vaccine.2015.08.009; Gervaix A, 2014, CLIN THER, V36, P802, DOI 10.1016/j.clinthera.2014.03.001; Gladstone RA, 2015, VACCINE, V33, P2015, DOI 10.1016/j.vaccine.2015.03.012; Gounder PP, 2014, J INFECT DIS, V209, P1251, DOI 10.1093/infdis/jit642; Griffin MR, 2013, NEW ENGL J MED, V369, P155, DOI 10.1056/NEJMoa1209165; Horacio AN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073704; Kalekar PS, TIME SERIES FORECAST; Kaplan SL, 2013, PEDIATR INFECT DIS J, V32, P203, DOI 10.1097/INF.0b013e318275614b; Link-Gelles R, 2013, VACCINE, V31, P2572, DOI 10.1016/j.vaccine.2013.03.049; Loughlin AM, 2014, PEDIATR INFECT DIS J, V33, P504, DOI 10.1097/INF.0000000000000279; Moore MR, 2015, LANCET INFECT DIS, V15, P301, DOI 10.1016/S1473-3099(14)71081-3; Picazo J, 2011, VACCINE, V29, P1770, DOI 10.1016/j.vaccine.2010.12.114; Picazo J, 2011, CLIN VACCINE IMMUNOL, V18, P89, DOI 10.1128/CVI.00317-10; Picazo J, 2013, CLIN VACCINE IMMUNOL, V20, P1524, DOI 10.1128/CVI.00239-13; Picazo J, 2013, PEDIATR INFECT DIS J, V32, P656, DOI 10.1097/INF.0b013e31827e8594; Picazo J, 2011, PEDIATR INFECT DIS J, V30, P471, DOI 10.1097/INF.0b013e31820a418a; Shea KM, 2011, VACCINE, V29, P8042, DOI 10.1016/j.vaccine.2011.08.057; van der Linden M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131494; van Hoek AJ, 2014, VACCINE, V32, P4349, DOI 10.1016/j.vaccine.2014.03.017; von Gottberg A, 2014, NEW ENGL J MED, V371, P1889, DOI 10.1056/NEJMoa1401914; Waight PA, 2015, LANCET INFECT DIS, V15, P535, DOI 10.1016/S1473-3099(15)70044-7; [No title captured]	33	20	24	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0172222	10.1371/journal.pone.0172222	http://dx.doi.org/10.1371/journal.pone.0172222			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207888	Green Published, Green Submitted, gold			2022-12-27	WOS:000394424500102
J	Godoy, A; Tabacof, P; Von Zuben, FJ				Godoy, Alan; Tabacof, Pedro; Von Zuben, Fernando J.			The role of the interaction network in the emergence of diversity of behavior	PLOS ONE			English	Article							CELLULAR-AUTOMATA; EVOLUTION; DYNAMICS; ROBUST; COMPUTATION; TOPOLOGY	How can systems in which individuals' inner workings are very similar to each other, as neural networks or ant colonies, produce so many qualitatively different behaviors, giving rise to roles and specialization? In this work, we bring new perspectives to this question by focusing on the underlying network that defines how individuals in these systems interact. We applied a genetic algorithm to optimize rules and connections of cellular automata in order to solve the density classification task, a classical problem used to study emergent behaviors in decentralized computational systems. The networks used were all generated by the introduction of shortcuts in an originally regular topology, following the small-world model. Even though all cells follow the exact same rules, we observed the existence of different classes of cells' behaviors in the best cellular automata found D most cells were responsible for memory and others for integration of information. Through the analysis of structural measures and patterns of connections (motifs) in successful cellular automata, we observed that the distribution of shortcuts between distant regions and the speed in which a cell can gather information from different parts of the system seem to be the main factors for the specialization we observed, demonstrating how heterogeneity in a network can create heterogeneity of behavior.	[Godoy, Alan; Von Zuben, Fernando J.] Univ Estadual Campinas, Sch Elect & Comp Engn, Lab Bioinformat & Bioinspired Comp, Campinas, SP, Brazil; [Godoy, Alan] CPqD Fdn, Campinas, SP, Brazil; [Tabacof, Pedro] Univ Estadual Campinas, Sch Elect & Comp Engn, RECOD Lab, Campinas, SP, Brazil	Universidade Estadual de Campinas; Universidade Estadual de Campinas	Godoy, A (corresponding author), Univ Estadual Campinas, Sch Elect & Comp Engn, Lab Bioinformat & Bioinspired Comp, Campinas, SP, Brazil.; Godoy, A (corresponding author), CPqD Fdn, Campinas, SP, Brazil.	godoy@dca.fee.unicamp.br	Von Zuben, Fernando J./K-5979-2017	Von Zuben, Fernando J./0000-0002-4128-5415	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [142118/2010-9]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (http://cnpq.br/) provided a doctorate fellowship to Alan Godoy (142118/2010-9). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGNATI LF, 1995, NEUROSCIENCE, V69, P711, DOI 10.1016/0306-4522(95)00308-6; Agnati LF, 2010, BRAIN RES REV, V64, P137, DOI 10.1016/j.brainresrev.2010.03.003; Aldana M, 2003, P NATL ACAD SCI USA, V100, P8710, DOI 10.1073/pnas.1536783100; Andre D., 1996, Genetic Programming. Proceedings of the First Annual Conference 1996, P3; Andreica A, 2012, STUDIA U BABES BOLYA, V57; [Anonymous], 2009, COMPLEX ADAPTIVE SYS; [Anonymous], 1978, PROBL PEREDACHI INFO; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Baronchelli A, 2013, TRENDS COGN SCI, V17, P348, DOI 10.1016/j.tics.2013.04.010; Cancho RFI, 2003, LECT NOTES PHYS, V625, P114; Chen DB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077455; Cook M., 2004, COMPLEX SYST, V15, P1; Crutchfield James P., 2003, P361; CRUTCHFIELD JP, 1993, PHYSICA D, V69, P279, DOI 10.1016/0167-2789(93)90092-F; Darabos C, 2007, ADV COMPLEX SYST, V10, P85, DOI 10.1142/S0219525907001124; Darabos C, 2006, LECT NOTES COMPUT SC, V4173, P512; Darabos C, 2011, INTELL ARTIF, V5, P37, DOI 10.3233/IA-2011-0003; Das R, 1994, LECT NOTES COMPUT SC, V866, P344; Fowler JH, 2011, P NATL ACAD SCI USA, V108, P1993, DOI 10.1073/pnas.1011687108; Franks NR, 2002, PHILOS T R SOC B, V357, P1567, DOI 10.1098/rstb.2002.1066; GASTWIRT.JL, 1972, REV ECON STAT, V54, P306, DOI 10.2307/1937992; Godoy A, 2013, P 15 ANN C COMP GEN, P1415; Goldberg D., 1989, GENETIC ALGORITHMS I; Heylighen F, 2004, P COLL INT 4; Hordijk W, 1996, EMBEDDED PARTICLE CO; Hutchins E, 1991, ORGAN SCI, V2, P14, DOI 10.1287/orsc.2.1.14; Juille H., 1998, Genetic Programming 1998. Proceedings of the Third Annual Conference, P519; Katare S, 2006, COMPLEXITY, V11, P26, DOI 10.1002/cplx.20119; KAUFFMAN S, 1969, NATURE, V224, P177, DOI 10.1038/224177a0; Kennedy J, 1998, J CONFLICT RESOLUT, V42, P56, DOI 10.1177/0022002798042001003; LAND M, 1995, PHYS REV LETT, V74, P5148, DOI 10.1103/PhysRevLett.74.5148; Langville AN, 2005, SIAM REV, V47, P135, DOI 10.1137/S0036144503424786; LEVINE JM, 1993, ANNU REV PSYCHOL, V44, P585, DOI 10.1146/annurev.psych.44.1.585; Lizier JT, 2007, LECT NOTES ARTIF INT, V4648, P895; Lizier JT, 2014, EMERGENCE COMPLEX CO, V9, P115, DOI 10.1007/978-3-642-53734-9_5; Lizier JT, 2013, IEEE SYMP ART LIFE, P43, DOI 10.1109/ALIFE.2013.6602430; Lizier JT, 2011, ARTIF LIFE, V17, P293, DOI 10.1162/artl_a_00040; Macedo HB, 2013, IEEE SYS MAN CYBERN, P1566, DOI 10.1109/SMC.2013.270; Marques-Pita M., 2011, 2011 IEEE SSCI Symposium on Artificial Life (ALIFE), P233, DOI 10.1109/ALIFE.2011.5954670; Marr C, 2005, PHYSICA A, V354, P641, DOI 10.1016/j.physa.2005.02.019; Mathias N, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.021117; Merkle D, 2008, APPL INTELL; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; MITCHELL M, 1994, PHYSICA D, V75, P361, DOI 10.1016/0167-2789(94)90293-3; Mitchell M., 1993, Complex Systems, V7, P89; Mitchell M., 2009, COMPLEXITY GUIDED TO; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Newman MEJ, 2001, PHYS REV E, V64, DOI [10.1103/PhysRevE.64.016131, 10.1103/PhysRevE.64.016132]; Oikonomou P, 2006, NAT PHYS, V2, P532, DOI 10.1038/nphys359; Oliveira GMB, 2009, ELECTRON NOTES THEOR, V252, P121, DOI 10.1016/j.entcs.2009.09.018; Orwell G., 1945, ANIMAL FARM FAIRY ST; Oshima H, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.036114; Packard N. H., 1988, DYN PATTERNS COMPLEX, V212, P293; Page L, 1999, PAGERANK CITATION RA, DOI DOI 10.1109/IISWC.2012.6402911; Page SE, 2007, DIFFERENCE POWER DIV; Pratt SC, 2008, BEHAV ECOL SOCIOBIOL, V62, P1369, DOI 10.1007/s00265-008-0565-9; Preston SD, 2002, BEHAV BRAIN SCI, V25, P1, DOI 10.1017/S0140525X02000018; Qian JF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017013; Quiroga RQ, 2005, NATURE, V435, P1102, DOI 10.1038/nature03687; Romano ALT, 2009, STUD COMPUT INTELL, V204, P85; Seung S., 2012, CONNECTOME BRAINS WI; Sipper M, 1997, PHYSICA D, V99, P428, DOI 10.1016/S0167-2789(96)00172-8; Tassier T, 2001, IEEE T EVOLUT COMPUT, V5, P482, DOI 10.1109/4235.956712; Tomassini M, 2004, LECT NOTES COMPUT SC, V3242, P672; Tomassini M, 2005, COMPLEX SYST, V15, P261; Turing AM, 1937, P LOND MATH SOC, V42, P230, DOI 10.1112/plms/s2-42.1.230; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Watts Duncan J., 2003, SMALL WORLDS DYNAMIC; Wentian Li, 1990, Complex Systems, V4, P281; Wernicke S, 2006, IEEE ACM T COMPUT BI, V3, P347, DOI 10.1109/TCBB.2006.51; WOLFRAM S, 1983, REV MOD PHYS, V55, P601, DOI 10.1103/RevModPhys.55.601; Wolfram S., 2002, NEW KIND SCI; Wolz D, 2008, J CELL AUTOM, V3, P289	73	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0172073	10.1371/journal.pone.0172073	http://dx.doi.org/10.1371/journal.pone.0172073			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL5VB	28234962	gold, Green Submitted, Green Published			2022-12-27	WOS:000394688200045
J	Hu, BF; Chen, SC; Hu, J; Xia, F; Xu, JF; Li, Y; Shi, Z				Hu, Bifeng; Chen, Songchao; Hu, Jie; Xia, Fang; Xu, Junfeng; Li, Yan; Shi, Zhou			Application of portable XRF and VNIR sensors for rapid assessment of soil heavy metal pollution	PLOS ONE			English	Article							ORGANIC-MATTER; REFLECTANCE SPECTROSCOPY; SPECTRAL LIBRARY; URBAN SOILS; PREDICTION; CONTAMINATION; FEASIBILITY; REGRESSION; ANALYZER; ELEMENTS	Rapid heavy metal soil surveys at large scale with high sampling density could not be conducted with traditional laboratory physical and chemical analyses because of the high cost, low efficiency and heavy workload involved. This study explored a rapid approach to assess heavy metals contamination in 301 farmland soils from Fuyang in Zhejiang Province, in the southern Yangtze River Delta, China, using portable proximal soil sensors. Portable X-ray fluorescence spectroscopy (PXRF) was used to determine soil heavy metals total concentrations while soil pH was predicted by portable visible-near infrared spectroscopy (PVNIR). Zn, Cu and Pb were successfully predicted by PXRF (R-2 > 0.90 and RPD > 2.50) while As and Ni were predicted with less accuracy (R-2 <0.75 and RPD <1.40). The pH values were well predicted by PVNIR. Classification of heavy metals contamination grades in farmland soils was conducted based on previous results; the Kappa coefficient was 0.87, which showed that the combination of PXRF and PVNIR was an effective and rapid method to determine the degree of pollution with soil heavy metals. This study provides a new approach to assess soil heavy metals pollution; this method will facilitate large-scale surveys of soil heavy metal pollution.	[Hu, Bifeng; Hu, Jie; Xia, Fang; Shi, Zhou] Zhejiang Univ, Inst Agr Remote Sensing & Informat Technol Applic, Hangzhou, Zhejiang, Peoples R China; [Chen, Songchao] INRA, Ardon, InfoSol Unit, Orleans, France; [Chen, Songchao] AGROCAMPUS OUEST, INRA, UMR SAS, Rennes, France; [Xu, Junfeng] Hangzhou Normal Univ, Coll Sci, Hangzhou, Zhejiang, Peoples R China; [Li, Yan] Zhejiang Univ, Sch Publ Affairs, Inst Land Sci & Property Management, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; INRAE; INRAE; Institut Agro; Agrocampus Ouest; Hangzhou Normal University; Zhejiang University	Li, Y (corresponding author), Zhejiang Univ, Sch Publ Affairs, Inst Land Sci & Property Management, Hangzhou, Zhejiang, Peoples R China.	liyan522@zju.edu.cn	shi, Zhou/A-2283-2015; Hu, Bifeng/G-2190-2018; Chen, Songchao/S-7982-2019; shi, Zhou/M-7845-2019	shi, Zhou/0000-0003-3914-5402; Chen, Songchao/0000-0003-1245-0482; shi, Zhou/0000-0003-3914-5402; Hu, Jie/0000-0003-0831-3792; Hu, Bifeng/0000-0001-9353-0307	Key Research and Development Project of Zhejiang Province [2015C02G1320007]; Fundamental Research Funds for the Central Universities	Key Research and Development Project of Zhejiang Province; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was founded by Key Research and Development Project of Zhejiang Province (2015C02G1320007) and Fundamental Research Funds for the Central Universities. The authors thankfully acknowledge Professors Jie Peng and Shuo Li for their suggestions for this paper. Thanks to Zongzheng Liang and Yuanyuan Yang for their assistance in soil samples analysis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam N, 2015, ENVIRON MONIT ASSESS, V187, DOI 10.1007/s10661-015-4855-1; Carr R, 2008, ENVIRON GEOCHEM HLTH, V30, P45, DOI 10.1007/s10653-007-9106-0; Chang CW, 2001, SOIL SCI SOC AM J, V65, P480, DOI 10.2136/sssaj2001.652480x; Chen SC, 2016, SPECTROSC SPECT ANAL, V36, P1712, DOI 10.3964/j.issn.1000-0593(2016)06-1712-05; China National Environmental Protection Agency, 1995, GB156181995 CHIN NAT; China National Environmental Protection Agency, 2004, HJT1662004 CHIN NAT; Horta A, 2015, GEODERMA, V241, P180, DOI 10.1016/j.geoderma.2014.11.024; Hou XD, 2004, APPL SPECTROSC REV, V39, P1, DOI 10.1081/ASR-120028867; Huang QT, 2009, SPECTROSC SPECT ANAL, V29, P1434, DOI 10.3964/j.issn.1000-0593(2009)05-1434-05; Ji WJ, 2012, SPECTROSC SPECT ANAL, V32, P2393, DOI 10.3964/j.issn.1000-0593(2012)09-2393-06; Kilbride C, 2006, ENVIRON POLLUT, V143, P16, DOI 10.1016/j.envpol.2005.11.013; Kodom K, 2012, SOIL SEDIMENT CONTAM, V21, P1006, DOI 10.1080/15320383.2012.712073; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Li S, 2008, ENVIRON SCI TECHNOL, P03; Li S, 2015, REMOTE SENS-BASEL, V7, P7029, DOI 10.3390/rs70607029; Liu R, 2016, ENVIRON POLLUT, V210, P174, DOI 10.1016/j.envpol.2015.11.044; Lu AX, 2010, SPECTROSC SPECT ANAL, V30, P2848, DOI 10.3964/j.issn.1000-0593(2010)10-2848-05; Luo XS, 2012, SCI TOTAL ENVIRON, V421, P17, DOI 10.1016/j.scitotenv.2011.04.020; Markey AM, 2008, J ENVIRON HEALTH, V70, P24; NSPCIR Ministry of Environmental Protection Ministry of Land and Resources, 2014, NAT SOIL POLL COND I; ORLIC I, 1986, J RADIOAN NUCL CH AR, V102, P203, DOI 10.1007/BF02037961; Puga AP, 2015, ENVIRON SCI POLLUT R, V22, P17606, DOI 10.1007/s11356-015-4977-6; Saby NPA, 2009, SCI TOTAL ENVIRON, V407, P5644, DOI 10.1016/j.scitotenv.2009.07.002; Shi Z, 2015, EUR J SOIL SCI, V66, P679, DOI 10.1111/ejss.12272; Shi Z, 2014, SCI CHINA EARTH SCI, V57, P1671, DOI 10.1007/s11430-013-4808-x; Thermo Fisher Scientific, 2012, US GUID ABR XL2 AN V; Wang DD, 2015, GEODERMA, V243, P157, DOI 10.1016/j.geoderma.2014.12.011; Wei BG, 2010, MICROCHEM J, V94, P99, DOI 10.1016/j.microc.2009.09.014; Weindorf DC, 2012, ENVIRON MONIT ASSESS, V184, P217, DOI 10.1007/s10661-011-1961-6; Wu YZ, 2005, APPL GEOCHEM, V20, P1051, DOI 10.1016/j.apgeochem.2005.01.009; Wu YZ, 2005, ENVIRON SCI TECHNOL, V39, P873, DOI 10.1021/es0492642; Xia F, 2015, J INFRARED MILLIM W, V34, P593; Yang ZP, 2011, J GEOCHEM EXPLOR, V108, P27, DOI 10.1016/j.gexplo.2010.09.006; Zhang XY, 2009, ENVIRON MONIT ASSESS, V154, P439, DOI 10.1007/s10661-008-0410-7; Zhang XY, 2008, ENVIRON POLLUT, V156, P1260, DOI 10.1016/j.envpol.2008.03.009	35	86	94	10	92	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0172438	10.1371/journal.pone.0172438	http://dx.doi.org/10.1371/journal.pone.0172438			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5VB	28234944	gold, Green Submitted, Green Published			2022-12-27	WOS:000394688200078
J	Milewska-Hendel, A; Baczewska, AH; Sala, K; Dmuchowski, W; Bragoszewska, P; Gozdowski, D; Jozwiak, A; Chojnacki, T; Swiezewska, E; Kurczynska, E				Milewska-Hendel, Anna; Baczewska, Aneta H.; Sala, Katarzyna; Dmuchowski, Wojciech; Bragoszewska, Paulina; Gozdowski, Dariusz; Jozwiak, Adam; Chojnacki, Tadeusz; Swiezewska, Ewa; Kurczynska, Ewa			Quantitative and qualitative characteristics of cell wall components and prenyl lipids in the leaves of Tilia x euchlora trees growing under salt stress	PLOS ONE			English	Article							CLASSICAL ARABINOGALACTAN PROTEIN; PLASMA-MEMBRANE; POLYISOPRENOID ALCOHOLS; SOMATIC EMBRYOGENESIS; NICOTIANA-ALATA; POLLEN TUBES; GENE FAMILY; GROWTH; L.; EXPRESSION	The study was focused on assessing the presence of arabinogalactan proteins (AGPs) and pectins within the cell walls as well as prenyl lipids, sodium and chlorine content in leaves of Tilia x euchlora trees. The leaves that were analyzed were collected from trees with and without signs of damage that were all growing in the same salt stress conditions. The reason for undertaking these investigations was the observations over many years that indicated that there are trees that present a healthy appearance and trees that have visible symptoms of decay in the same habitat. Leaf samples were collected from trees growing in the median strip between roadways that have been intensively salted during the winter season for many years. The sodium content was determined using atomic spectrophotometry, chloride using potentiometric titration and poly-isoprenoids using HPLC/ UV. AGPs and pectins were determined using immunohistochemistry methods. The immunohistochemical analysis showed that rhamnogalacturonans I (RG-I) and homogalacturonans were differentially distributed in leaves from healthy trees in contrast to leaves from injured trees. In the case of AGPs, the most visible difference was the presence of the JIM16 epitope. Chemical analyses of sodium and chloride showed that in the leaves from injured trees, the level of these ions was higher than in the leaves from healthy trees. Based on chromatographic analysis, four polyisoprenoid alcohols were identified in the leaves of T. x euchlora. The levels of these lipids were higher in the leaves from healthy trees. The results suggest that the differences that were detected in the apoplast and symplasm may be part of the defensive strategy of T. x euchlora trees to salt stress, which rely on changes in the chemical composition of the cell wall with respect to the pectic and AGP epitopes and an increased synthesis of prenyl lipids.	[Milewska-Hendel, Anna; Sala, Katarzyna; Kurczynska, Ewa] Univ Silesia, Fac Biol & Environm Protect, Dept Cell Biol, Katowice, Poland; [Baczewska, Aneta H.; Dmuchowski, Wojciech] Polish Acad Sci, Bot Garden, Ctr Conservat Biol Divers, Warsaw, Poland; [Dmuchowski, Wojciech; Gozdowski, Dariusz] Warsaw Univ Life Sci SGGW, Warsaw, Poland; [Bragoszewska, Paulina] Natl Res Inst, Inst Environm Protect, Warsaw, Poland; [Jozwiak, Adam; Chojnacki, Tadeusz; Swiezewska, Ewa] Polish Acad Sci, Inst Biochem & Biophys, Warsaw, Poland	University of Silesia in Katowice; Polish Academy of Sciences; Warsaw University of Life Sciences; Institute of Environmental Protection - National Research Institute; Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences	Milewska-Hendel, A (corresponding author), Univ Silesia, Fac Biol & Environm Protect, Dept Cell Biol, Katowice, Poland.	anna.milewska@us.edu.pl	; Jozwiak, Adam/E-7717-2011	Milewska-Hendel, Anna/0000-0002-9066-477X; Jozwiak, Adam/0000-0002-7666-7747; Sala, Katarzyna/0000-0002-5978-3623; Gozdowski, Dariusz/0000-0002-7365-7607; Swiezewska, Ewa/0000-0002-3439-8948; Kurczynska, Ewa/0000-0003-0772-8961	Ministry of Science and Higher Education of Poland; National Science Centre of Poland [UMO-2012/07/B/NZ3/02437]	Ministry of Science and Higher Education of Poland(Ministry of Science and Higher Education, Poland); National Science Centre of Poland(National Science Centre, Poland)	This research was supported financially by: 1) the Ministry of Science and Higher Education of Poland as part of the statutory activities of the Department of Cell Biology, University of Silesia and 2) the National Science Centre of Poland [UMO-2012/07/B/NZ3/02437] (ES). There was no additional external funding received for this study.	Al-Abdoulhadi I. A., 2012, African Journal of Agricultural Research, V7, P3314; Alaoui-Sosse B, 1998, TREES-STRUCT FUNCT, V12, P424; Allen S.E., 1974, CHEM ANAL ECOLOGICAL; Baczewska A.H., 2011, OCHR SROD ZASOB NATU, V48, P84; Baczewska AH, 2014, DENDROBIOLOGY, V72, P177, DOI 10.12657/denbio.072.015; Bajda A, 2005, ACTA BIOCHIM POL, V52, P233; Bajda A, 2009, PHYSIOL PLANTARUM, V135, P351, DOI 10.1111/j.1399-3054.2009.01204.x; Baldwin L, 2014, PHYTOCHEMISTRY, V104, P37, DOI 10.1016/j.phytochem.2014.04.011; BASILE DV, 1987, BRYOLOGIST, V90, P401, DOI 10.2307/3243105; Bergamini E, 2003, BIOGERONTOLOGY, V4, P337, DOI 10.1023/B:BGEN.0000006637.48753.07; Boughanmi N, 2010, PROTOPLASMA, V242, P69, DOI 10.1007/s00709-010-0125-9; Cekstere Gunta, 2008, Urban Forestry & Urban Greening, V7, P207, DOI 10.1016/j.ufug.2008.02.004; CLARKE AE, 1979, PHYTOCHEMISTRY, V18, P521, DOI 10.1016/S0031-9422(00)84255-7; Cosgrove DJ, 1997, PLANT CELL, V9, P1031, DOI 10.1105/tpc.9.7.1031; Czerniawska-Kusza I, 2004, ENVIRON TOXICOL, V19, P296, DOI 10.1002/tox.20037; Dajic Z, 2006, PHYSIOLOGY AND MOLECULAR BIOLOGY OF STRESS TOLERANCE IN PLANTS, P41, DOI 10.1007/1-4020-4225-6_3; Dmuchowski W, 2014, J ELEMENTOL, V19, P65, DOI 10.5601/jelem.2014.19.1.588; Dmuchowski Wojciech, 2011, Ecological Questions, V15, P97, DOI 10.2478/v10090-011-0041-4; Dmuchowski W, 2013, FRESEN ENVIRON BULL, V22, P987; Dmuchowski W, 2011, POL J ENVIRON STUD, V20, P489; Ellis M, 2010, PLANT PHYSIOL, V153, P403, DOI 10.1104/pp.110.156000; Fay L, 2012, WATER AIR SOIL POLL, V223, P2751, DOI 10.1007/s11270-011-1064-6; Fernandes JC, 2013, PLANT SCI, V205, P111, DOI 10.1016/j.plantsci.2013.01.013; Franklin JA, 2004, PHYSIOL PLANTARUM, V120, P482, DOI 10.1111/j.0031-9317.2004.00246.x; Fricke W, 2006, J EXP BOT, V57, P1079, DOI 10.1093/jxb/erj095; Fricke W, 2004, PLANTA, V219, P515, DOI 10.1007/s00425-004-1263-0; Gao MG, 1999, PLANT J, V19, P321, DOI 10.1046/j.1365-313X.1999.00544.x; Gozdzicka-Jozefiak A, 2010, REAKCJE KOMOREK ROSL, VII; Green SM, 2008, ENVIRON POLLUT, V152, P20, DOI 10.1016/j.envpol.2007.06.005; Gutkowska M, 2004, BIOCHEM BIOPH RES CO, V322, P998, DOI 10.1016/j.bbrc.2004.08.025; Heidarvand L, 2010, ACTA PHYSIOL PLANT, V32, P419, DOI 10.1007/s11738-009-0451-8; Hjertman M, 1997, FEBS LETT, V195, P755; IRAKI NM, 1989, PLANT PHYSIOL, V91, P54, DOI 10.1104/pp.91.1.54; Janz D, 2012, NEW PHYTOL, V194, P129, DOI 10.1111/j.1469-8137.2011.03975.x; Johnsen HR, 2015, NEW PHYTOL, V207, P805, DOI 10.1111/nph.13378; Jones L, 2003, P NATL ACAD SCI USA, V100, P11783, DOI 10.1073/pnas.1832434100; Jozwiak A, 2013, BBA-MOL CELL BIOL L, V1831, P438, DOI 10.1016/j.bbalip.2012.11.006; Kayama M, 2003, ENVIRON POLLUT, V124, P127, DOI 10.1016/S0269-7491(02)00415-3; KOMALAVILAS P, 1991, J BIOL CHEM, V266, P15956; Kozlowski T.T, 1997, TREE PHYSIOL, V17, P490, DOI DOI 10.1093/TREEPHYS/17.7.490; Kreuzwieser J, 2014, PLANT CELL ENVIRON, V37, P2245, DOI 10.1111/pce.12310; LACROIX R. L., 1970, Communications in Soil Science and Plant Analysis, V1, P1, DOI 10.1080/00103627009366233; Lamport DTA, 2006, NEW PHYTOL, V169, P479, DOI 10.1111/j.1469-8137.2005.01591.x; Lax S, 2009, ENVIRON GEOL, V58, P1041, DOI 10.1007/s00254-008-1584-6; Le Gall Hyacinthe, 2015, Plants-Basel, V4, P112, DOI 10.3390/plants4010112; Li CH, 2014, PLANT CELL, V26, P2538, DOI 10.1105/tpc.114.125187; Li SX, 1996, PLANT MOL BIOL, V32, P641, DOI 10.1007/BF00020205; Li YY, 2009, ENVIRON EXP BOT, V66, P341, DOI 10.1016/j.envexpbot.2009.02.001; LI YQ, 1992, PLANTA, V188, P532, DOI 10.1007/BF00197045; Liesebach H, 2008, DENDROBIOLOGY, V59, P13; Lima RB, 2013, CARBOHYD POLYM, V93, P135, DOI 10.1016/j.carbpol.2012.05.015; Lind JL, 1996, SEX PLANT REPROD, V9, P75, DOI 10.1007/BF02153054; Loreto F, 2001, PLANT PHYSIOL, V127, P1781, DOI 10.1104/pp.010497; Ma HL, 2010, J EXP BOT, V61, P2647, DOI 10.1093/jxb/erq104; McCartney L, 2000, PLANT J, V22, P105, DOI 10.1046/j.1365-313x.2000.00719.x; Munck IA, 2010, FOREST ECOL MANAG, V260, P1218, DOI 10.1016/j.foreco.2010.07.015; Munns R, 2002, PLANT CELL ENVIRON, V25, P239, DOI 10.1046/j.0016-8025.2001.00808.x; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; Munns R, 2015, NEW PHYTOL, V208, P668, DOI 10.1111/nph.13519; Muszynska A, 2014, ACTA PHYSIOL PLANT, V36, P1155, DOI 10.1007/s11738-014-1490-3; Nothnagel EA, 1997, INT REV CYTOL, V174, P195, DOI 10.1016/S0074-7696(08)62118-X; Oleksyn J, 2007, POL J ECOL, V55, P245; Ouyang B, 2007, J EXP BOT, V58, P507, DOI 10.1093/jxb/erl258; Palin R, 2012, BIOSYSTEMS, V109, P397, DOI 10.1016/j.biosystems.2012.04.006; Park MH, 2003, PLANT PHYSIOL, V131, P1450, DOI 10.1104/pp.015628; Pauleit S, 1988, GARTEN LANDSCHRAFT, V7, P38; PENNELL RI, 1989, J CELL BIOL, V108, P1967, DOI 10.1083/jcb.108.5.1967; Penuelas J, 2005, TRENDS PLANT SCI, V10, P166, DOI 10.1016/j.tplants.2005.02.005; Perkin Elmer, 1990, AN METH AT ABS SPECT; Potocka I, 2012, PLANT CELL REP, V31, P2031, DOI 10.1007/s00299-012-1314-0; Putoczki TL, 2007, PLANTA, V226, P1131, DOI 10.1007/s00425-007-0559-2; Sala K, 2013, BIOL PLANTARUM, V57, P410, DOI 10.1007/s10535-013-0304-6; SAMSON MR, 1984, PHYTOCHEMISTRY, V23, P493, DOI 10.1016/S0031-9422(00)80365-9; Sasidharan R, 2011, CRIT REV PLANT SCI, V30, P548, DOI 10.1080/07352689.2011.615706; Schmohl N, 2000, PLANT CELL ENVIRON, V23, P735, DOI 10.1046/j.1365-3040.2000.00591.x; SCHOPFER P, 1991, PLANTA, V183, P139, DOI 10.1007/BF00197578; Schultz CJ, 2000, PLANT CELL, V12, P1751, DOI 10.1105/tpc.12.9.1751; SEHMER L, 1995, J PLANT PHYSIOL, V147, P144, DOI 10.1016/S0176-1617(11)81427-6; SERPE MD, 1994, PLANTA, V193, P542, DOI 10.1007/BF02411560; SHORTLE W C, 1970, Plant Disease Reporter, V54, P360; Siedlecka JKN, 2016, LIPIDS, V51, P229, DOI 10.1007/s11745-015-4104-y; Skorupinska-Tudek K, 2003, LIPIDS, V38, P981, DOI 10.1007/s11745-003-1152-3; Skorupinska-Tudek K, 2008, CHEM REC, V8, P33, DOI 10.1002/tcr.20137; Sperry JS, 2008, PLANT CELL ENVIRON, V31, P632, DOI 10.1111/j.1365-3040.2007.01765.x; Surmacz L, 2011, BIOCHEM BIOPH RES CO, V407, P627, DOI 10.1016/j.bbrc.2011.03.059; Svetek J, 1999, J BIOL CHEM, V274, P14724, DOI 10.1074/jbc.274.21.14724; Talboys PJ, 2011, NEW PHYTOL, V190, P618, DOI 10.1111/j.1469-8137.2010.03625.x; Teichmann T, 2008, TREE PHYSIOL, V28, P1305, DOI 10.1093/treephys/28.9.1305; Ulvskov P, 2005, PLANTA, V220, P609, DOI 10.1007/s00425-004-1373-8; van Hengel AJ, 2003, PLANT J, V36, P256, DOI 10.1046/j.1365-313X.2003.01874.x; van Hengel AJ, 2002, PHYSIOL PLANTARUM, V114, P637, DOI 10.1034/j.1399-3054.2002.1140418.x; Verhertbruggen Y., 2006, PLANT CELL MONOGR, V6, P139, DOI DOI 10.1007/7089_; Willats WGT, 1999, ANAL BIOCHEM, V268, P143, DOI 10.1006/abio.1998.3039; Yan Y., 2015, COMPUTATIONAL INTELL, V2015, P1, DOI DOI 10.1016/J.ATMOSENV.2015.01.039; Youl JJ, 1998, P NATL ACAD SCI USA, V95, P7921, DOI 10.1073/pnas.95.14.7921; Zagorchev L., 2008, General and Applied Plant Physiology, V34, P159	96	20	20	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0172682	10.1371/journal.pone.0172682	http://dx.doi.org/10.1371/journal.pone.0172682			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5VB	28234963	Green Published, gold			2022-12-27	WOS:000394688200114
J	Ipsaro, JJ; Shen, C; Arai, E; Xu, Y; Kinney, JB; Joshua-Tor, L; Vakoc, CR; Shi, JW				Ipsaro, Jonathan J.; Shen, Chen; Arai, Eri; Xu, Yali; Kinney, Justin B.; Joshua-Tor, Leemor; Vakoc, Christopher R.; Shi, Junwei			Rapid generation of drug-resistance alleles at endogenous loci using CRISPR-Cas9 indel mutagenesis	PLOS ONE			English	Article							INHIBITION; EFFICIENT; DNA; LEUKEMIA; DOT1L; BRAF	Genetic alterations conferring resistance to the effects of chemical inhibitors are valuable tools for validating on-target effects in cells. Unfortunately, for many therapeutic targets such alleles are not available. To address this issue, we evaluated whether CRISPR-Cas9mediated insertion/deletion (indel) mutagenesis can produce drug-resistance alleles at endogenous loci. This method takes advantage of the heterogeneous in-frame alleles produced following Cas9-mediated DNA cleavage, which we show can generate rare alleles that confer resistance to the growth-arrest caused by chemical inhibitors. We used this approach to identify novel resistance alleles of two lysine methyltransferases, DOT1L and EZH2, which are each essential for the growth of MLL-fusion leukemia cells. We biochemically characterized the DOT1L mutation, showing that it is significantly more active than the wild-type enzyme. These findings validate the on-target anti-leukemia activities of existing DOT1L and EZH2 inhibitors and reveal a simple method for deriving drug-resistance alleles for novel targets, which may have utility during early stages of drug development.	[Ipsaro, Jonathan J.; Shen, Chen; Xu, Yali; Kinney, Justin B.; Joshua-Tor, Leemor; Vakoc, Christopher R.] Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA; [Arai, Eri; Shi, Junwei] Univ Penn, Perelman Sch Med, Abramson Family Canc Res Inst, Dept Canc Biol, Philadelphia, PA 19104 USA; [Xu, Yali] SUNY Stony Brook, Mol & Cellular Biol Program, Stony Brook, NY 11794 USA; [Joshua-Tor, Leemor] Cold Spring Harbor Lab, Howard Hughes Med Inst, WM Keck Struct Biol Lab, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory; University of Pennsylvania; Pennsylvania Medicine; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Cold Spring Harbor Laboratory; Howard Hughes Medical Institute	Vakoc, CR (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.; Shi, JW (corresponding author), Univ Penn, Perelman Sch Med, Abramson Family Canc Res Inst, Dept Canc Biol, Philadelphia, PA 19104 USA.	vakoc@cshl.edu; jushi@upenn.edu		Joshua-Tor, Leemor/0000-0001-8185-8049	Leukemia and Lymphoma Society; Burroughs-Wellcome Fund; Pershing Square Sohn Cancer Research Alliance; Starr Cancer Consortium; NIH/NCI [R01 CA174793]; Stand Up To Cancer Philip A. Sharp Awards; old Spring Harbor Laboratory Sponsored Research; Simons Center for Quantitative Biology at Cold Spring Harbor Laboratory; Cold Spring Harbor Laboratory Women in Science Award; NATIONAL CANCER INSTITUTE [P30CA045508, R01CA174793] Funding Source: NIH RePORTER	Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Burroughs-Wellcome Fund(Burroughs Wellcome Fund); Pershing Square Sohn Cancer Research Alliance(Pershing Square Sohn Cancer Research Alliance); Starr Cancer Consortium; NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Stand Up To Cancer Philip A. Sharp Awards; old Spring Harbor Laboratory Sponsored Research; Simons Center for Quantitative Biology at Cold Spring Harbor Laboratory; Cold Spring Harbor Laboratory Women in Science Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Leukemia and Lymphoma Society, the Burroughs-Wellcome Fund, the Pershing Square Sohn Cancer Research Alliance, the Starr Cancer Consortium, and the NIH/NCI grant R01 CA174793 (to CRV); the Stand Up To Cancer Philip A. Sharp Awards, and the Cold Spring Harbor Laboratory Sponsored Research (to JS); the Simons Center for Quantitative Biology at Cold Spring Harbor Laboratory (to JBK); and by the Cold Spring Harbor Laboratory Women in Science Award (to LJ). LJ is an investigator of the Howard Hughes Medical Institute.	Nguyen AT, 2011, GENE DEV, V25, P1345, DOI 10.1101/gad.2057811; Azam M, 2003, CELL, V112, P831, DOI 10.1016/S0092-8674(03)00190-9; Bernt KM, 2011, CANCER CELL, V20, P66, DOI 10.1016/j.ccr.2011.06.010; BOTSTEIN D, 1985, SCIENCE, V229, P1193, DOI 10.1126/science.2994214; Chen SH, 2016, CANCER DISCOV, V6, P300, DOI 10.1158/2159-8290.CD-15-0896; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Daigle SR, 2013, BLOOD, V122, P1017, DOI 10.1182/blood-2013-04-497644; Daigle SR, 2011, CANCER CELL, V20, P53, DOI 10.1016/j.ccr.2011.06.009; Donovan KF, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170445; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Foster SA, 2016, CANCER CELL, V29, P477, DOI 10.1016/j.ccell.2016.02.010; Hess GT, 2016, NAT METHODS, V13, P1036, DOI [10.1038/NMETH.4038, 10.1038/nmeth.4038]; Hohmann AF, 2016, NAT CHEM BIOL; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Jasin M, 2016, DNA REPAIR AMST; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Knutson SK, 2013, P NATL ACAD SCI USA, V110, P7922, DOI 10.1073/pnas.1303800110; Komor AC, 2016, NATURE, V533, P420, DOI 10.1038/nature17946; Ma YQ, 2016, NAT METHODS, V13, P1029, DOI [10.1038/NMETH.4027, 10.1038/nmeth.4027]; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Moreno-Mateos MA, 2015, NAT METHODS, V12, P982, DOI [10.1038/NMETH.3543, 10.1038/nmeth.3543]; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Munoz DM, 2016, CANC DISCOV; Neff T, 2012, P NATL ACAD SCI USA, V109, P5028, DOI 10.1073/pnas.1202258109; Nishida K, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8729; Poulikakos PI, 2011, NATURE, V480, P387, DOI 10.1038/nature10662; Shi J, 2013, ONCOGENE, V32, P930, DOI 10.1038/onc.2012.110; Shi JW, 2015, NAT BIOTECHNOL, V33, P661, DOI 10.1038/nbt.3235; van Overbeek M, 2016, MOL CELL, V63, P633, DOI 10.1016/j.molcel.2016.06.037; Xu BW, 2015, BLOOD, V125, P346, DOI 10.1182/blood-2014-06-581082; Zuber J, 2011, NAT BIOTECHNOL, V29, P79, DOI 10.1038/nbt.1720	32	22	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2017	12	2							e0172177	10.1371/journal.pone.0172177	http://dx.doi.org/10.1371/journal.pone.0172177			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5SX	28231254	Green Submitted, gold, Green Accepted, Green Published			2022-12-27	WOS:000394682400029
J	Attout, L; Noel, MP; Nassogne, MC; Rousselle, L				Attout, Lucie; Noel, Marie-Pascale; Nassogne, Marie-Cecile; Rousselle, Laurence			The role of short-term memory and visuospatial skills in numerical magnitude processing: Evidence from Turner syndrome	PLOS ONE			English	Article							WORKING-MEMORY; LEARNING-DISABILITY; FRAGILE-X; NUMEROSITY; CHILDREN; GIRLS; NUMBER; MATHEMATICS; DURATION; ABILITY	Most studies on magnitude representation have focused on the visual modality with no possibility of disentangling the influence of visuo-spatial skills and short-term memory (STM) abilities on quantification processes. This study examines this issue in patients with Turner syndrome (TS), a genetic condition characterized by a specific cognitive profile frequently associating poor mathematical achievement, low spatial skills and reduced STM abilities. In order to identify the influence of visuo-spatial and STM processing on numerical magnitude abilities, twenty female participants with TS and twenty control female participants matched for verbal IQ and education level were administered a series of magnitude comparison tasks. The tasks differed on the nature of the magnitude to be processed (continuous, discrete and symbolic magnitude), on visuo-spatial processing requirement (no/high) and on STM demands (low in simultaneous presentation vs. high in sequential presentation). Our results showed a lower acuity when participants with TS compared the numerical magnitudes of stimuli presented sequentially (low visuo-spatial processing and high STM load: Dot sequence and Sound sequence) while no difference was observed in the numerical comparison of sets presented simultaneously. In addition, the group difference in sequential tasks disappeared when controlling for STM abilities. Finally, both groups demonstrated similar performance when comparing continuous or symbolic magnitude stimuli and they exhibited comparable subitizing abilities. These results highlight the importance of STM abilities in extracting numerosity through a sequential presentation and underline the importance of considering the impact of format presentation on magnitude judgments.	[Attout, Lucie; Noel, Marie-Pascale] Catholic Univ Louvain, Psychol Sci Res Inst, Louvain La Neuve, Belgium; [Attout, Lucie; Rousselle, Laurence] Univ Liege, Res Unit Enfances, Liege, Belgium; [Nassogne, Marie-Cecile] St Luc Univ Hosp, Dept Pediat Neurol, Brussels, Belgium	Universite Catholique Louvain; University of Liege; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc	Attout, L (corresponding author), Catholic Univ Louvain, Psychol Sci Res Inst, Louvain La Neuve, Belgium.; Attout, L (corresponding author), Univ Liege, Res Unit Enfances, Liege, Belgium.	lucie.attout@ulg.ac.be	Noel, Marie-Pascale/H-7145-2019	Noel, Marie-Pascale/0000-0001-7497-7402; Attout, Lucie/0000-0002-4494-9379; Nassogne, Marie-Cecile/0000-0001-6936-1611	F.R.S.-FNRS (Fund for Scientific Research, FNRS, Belgium); Support Fund Marguerite-Marie Delacroix	F.R.S.-FNRS (Fund for Scientific Research, FNRS, Belgium)(Fonds de la Recherche Scientifique - FNRS); Support Fund Marguerite-Marie Delacroix	This work was supported by grants from the F.R.S.-FNRS (Fund for Scientific Research, FNRS, Belgium) and from the Support Fund Marguerite-Marie Delacroix. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansari D, 2010, LEARN INDIVID DIFFER, V20, P123, DOI 10.1016/j.lindif.2009.06.001; Attout L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092049; Bachot J., 2005, PSYCHOL SCI, V47, P172, DOI DOI 10.1016/0010-0277(92)90049-N; Baddeley A.D., 1974, MOTIV ADV RES THEORY, V8, P47, DOI [DOI 10.1016/S0079-7421(08)60452-1, 10.1016/S0079-7421(08)60452-1]; Baddeley A. D, 1986, WORKING MEMORY; Barth H, 2005, P NATL ACAD SCI USA, V102, P14116, DOI 10.1073/pnas.0505512102; Benoit L, 2004, COGNITIVE DEV, V19, P291, DOI 10.1016/j.cogdev.2004.03.005; Bray S, 2011, CEREB CORTEX, V21, P2471, DOI 10.1093/cercor/bhr017; Breukelaar JWC, 1998, J EXP PSYCHOL ANIM B, V24, P84, DOI 10.1037/0097-7403.24.1.84; Bruandet M, 2004, NEUROPSYCHOLOGIA, V42, P288, DOI 10.1016/j.neuropsychologia.2003.08.007; Buchanan L, 1998, DEV NEUROPSYCHOL, V14, P341, DOI 10.1080/87565649809540715; Buchanan L, 1998, BRAIN COGNITION, V37, P72; Cavdaroglu S, 2015, NEUROIMAGE, V116, P135, DOI 10.1016/j.neuroimage.2015.04.019; Cornoldi C, 2001, BRAIN COGNITION, V46, P90, DOI 10.1016/S0278-2626(01)80041-5; Cornoldi C., 2003, VISUO SPATIAL WORKIN; Davenport M., 2007, NEUROGENETIC DEV DIS; De Smedt B, 2013, TRENDS NEUROSCI EDUC, V2, P48, DOI 10.1016/j.tine.2013.06.001; De Smedt B, 2009, J EXP CHILD PSYCHOL, V103, P186, DOI 10.1016/j.jecp.2009.01.004; DEHAENE S, 1993, J COGNITIVE NEUROSCI, V5, P390, DOI 10.1162/jocn.1993.5.4.390; Dehaene S., 1995, MATH COGNITION, V1, P83, DOI DOI 10.1155/2014/461647; Dormal V, 2006, ACTA PSYCHOL, V121, P109, DOI 10.1016/j.actpsy.2005.06.003; Dormal V, 2007, EXP PSYCHOL, V54, P289, DOI 10.1027/1618-3169.54.4.289; Dormal V, 2013, PSYCHOL RES-PSYCH FO, V77, P116, DOI 10.1007/s00426-012-0414-3; Dormal V, 2012, HUM BRAIN MAPP, V33, P1490, DOI 10.1002/hbm.21300; Dormal V, 2010, NEUROIMAGE, V52, P1677, DOI 10.1016/j.neuroimage.2010.04.254; Dormal V, 2009, HUM BRAIN MAPP, V30, P2466, DOI 10.1002/hbm.20677; DOWNEY J, 1991, J LEARN DISABIL, V24, P32, DOI 10.1177/002221949102400107; Fias W., 2005, HDB MATH COGNITION, P43; Gebuis T, 2009, COGN PROCESS, V10, P133, DOI 10.1007/s10339-008-0219-x; Gelman R., 1978, CHILDS UNDERSTANDING; Haberecht MF, 2001, HUM BRAIN MAPP, V14, P96, DOI 10.1002/hbm.1044; Halberda J, 2008, DEV PSYCHOL, V44, P1457, DOI 10.1037/a0012682; Hart SJ, 2006, BRAIN, V129, P1125, DOI 10.1093/brain/awl046; Herrera A, 2008, ACTA PSYCHOL, V128, P225, DOI 10.1016/j.actpsy.2008.01.002; Hong D, 2009, DEV DISABIL RES REV, V15, P270, DOI 10.1002/ddrr.79; Kesler SR, 2006, CEREB CORTEX, V16, P849, DOI 10.1093/cercor/bhj028; Knops A, 2006, NEUROIMAGE, V29, P1, DOI 10.1016/j.neuroimage.2005.07.009; LAHOOD BJ, 1985, J ADOLESCENT HEALTH, V6, P358, DOI 10.1016/S0197-0070(85)80003-6; Mazzocco MMM, 2010, LEARN INDIVID DIFFER, V20, P70, DOI 10.1016/j.lindif.2009.10.011; Mazzocco MMM, 2009, DEV DISABIL RES REV, V15, P35, DOI 10.1002/ddrr.50; Mazzocco MMM, 2006, CHILD NEUROPSYCHOL, V12, P87, DOI 10.1080/09297040500266951; Mazzocco MMM, 2001, J LEARN DISABIL-US, V34, P520, DOI 10.1177/002221940103400605; Mazzocco MMM, 1998, PEDIATRICS, V102, P492; MECK WH, 1983, J EXP PSYCHOL ANIM B, V9, P320, DOI 10.1037/0097-7403.9.3.320; Molko N, 2004, CEREB CORTEX, V14, P840, DOI 10.1093/cercor/bhh042; Murphy MM, 2006, BRAIN COGNITION, V61, P195, DOI 10.1016/j.bandc.2005.12.014; Nieder A, 2006, SCIENCE, V313, P1431, DOI 10.1126/science.1130308; NIELSEN J, 1991, HUM GENET, V87, P81, DOI 10.1007/BF01213097; Noel MP, 2004, CAH PSYCHOL COGN, V22, P3; PENNINGTON BF, 1985, CORTEX, V21, P391, DOI 10.1016/S0010-9452(85)80004-6; Piazza M, 2011, COGNITION, V121, P147, DOI 10.1016/j.cognition.2011.05.007; Pica P, 2004, SCIENCE, V306, P499, DOI 10.1126/science.1102085; Raghubar KP, 2010, LEARN INDIVID DIFFER, V20, P110, DOI 10.1016/j.lindif.2009.10.005; Robinson A, 1989, BIRTH DEFECTS ORIG A, V26, P59; Rousselle L, 2004, J EXP CHILD PSYCHOL, V87, P57, DOI 10.1016/j.jecp.2003.10.005; Rousselle L, 2008, DEV PSYCHOL, V44, P544, DOI 10.1037/0012-1649.44.2.544; Rousselle L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072621; ROVET J, 1994, J CLIN EXP NEUROPSYC, V16, P820, DOI 10.1080/01688639408402696; ROVET JF, 1993, J LEARN DISABIL, V26, P333, DOI 10.1177/002221949302600506; SILBERT A, 1977, BEHAV GENET, V7, P11; Simon TJ, 2008, NEUROPSYCHOLOGIA, V46, P82, DOI 10.1016/j.neuropsychologia.2007.08.016; Tamm L, 2003, BIOL PSYCHIAT, V53, P107, DOI 10.1016/S0006-3223(02)01488-9; Temple CM, 1998, DEV NEUROPSYCHOL, V14, P47, DOI 10.1080/87565649809540700; TEMPLE CM, 1995, CORTEX, V31, P109, DOI 10.1016/S0010-9452(13)80109-8; Temple CM, 2002, Q J EXP PSYCHOL-A, V55, P733, DOI 10.1080/02724980143000550; Temple CM, 1996, DEV NEUROPSYCHOL, V12, P343, DOI 10.1080/87565649609540657; Tokita M, 2012, PSYCHON B REV, V19, P285, DOI 10.3758/s13423-011-0206-6; van Dijck JP, 2011, COGNITION, V119, P114, DOI 10.1016/j.cognition.2010.12.013; Walsh V, 2003, TRENDS COGN SCI, V7, P483, DOI 10.1016/j.tics.2003.09.002; Xu YD, 2006, NATURE, V440, P91, DOI 10.1038/nature04262; Zorzi M, 2006, NEUROPSYCHOLOGIA, V44, P1061, DOI 10.1016/j.neuropsychologia.2005.10.025	71	7	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2017	12	2							e0171454	10.1371/journal.pone.0171454	http://dx.doi.org/10.1371/journal.pone.0171454			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL5QV	28222116	gold, Green Published, Green Submitted			2022-12-27	WOS:000394676800011
J	Govindaraj, S; Shanmuganathan, A; Rajan, R				Govindaraj, Sakthivel; Shanmuganathan, Annadurai; Rajan, Ravindran			Maternal psychological stress-induced developmental disability, neonatal mortality and stillbirth in the offspring of Wistar albino rats	PLOS ONE			English	Article							BODY-WEIGHT; PRENATAL STRESS; BIRTH-DEFECTS; FOOD-INTAKE; PREGNANCY; FETAL; GLUCOCORTICOIDS; EXPOSURE; MUSCLE; GROWTH	Background Stress is an inevitable part of life, and maternal stress during the gestational period has dramatic effects in the early programming of the physiology and behavior of offspring. The developmental period is crucial for the well-being of the offspring. Prenatal stress influences the developmental outcomes of the fetus, in part because the developing brain is particularly vulnerable to stress. The etiology of birth defects of the offspring is reported to be 30-40% genetic and 7-10% multifactorial, with the remaining 50% still unknown and also there is no clear cause for neonatal mortality and still-birth. Objective The present study explores the association of maternal psychological stress on mother and the offspring's incidence of birth defects, stillbirth, and neonatal mortality. Study design Pregnant animals were restrained to induce psychological stress (3 times per day, 45 minutes per session). Except control group, other animals were exposed to restraint stress during the gestational period: early gestational stress (EGS, stress exposure during 1st day to 10th days of gestational period), late gestational stress (LGS, stress exposure during 11th day to till parturition), and full term gestational stress (FGS, stress exposure to the whole gestational period). The effects of maternal stress on the mother and their offspring were analyzed. Results Expectant female rats exposed to stress by physical restraint showed decreased body weight gain, food intake, and fecal pellet levels. Specifically, the offspring of female rats subjected to late gestational and full term gestational restraint stress showed more deleterious effects, such as physical impairment (LGS 24.44%, FGS 10%), neonatal mortality (EGS 2.56%, LGS 24.44%, FGS 17.5%), stillbirths (FGS 27.5%), low birth weight (EGS 5.42g, LGS 4.40g, FGS 4.12g), preterm births (EGS 539 Hrs, LGS 514 Hrs, FGS 520.6 Hrs), and delayed eyelid opening (EGS 15.16 Days, LGS 17 Days, FGS 17.67 Days). Conclusion The results of this study reveal that maternal stress may be associated with the offspring's abnormal structural phenotyping, preterm birth, stillbirth and neonatal mortality.	[Govindaraj, Sakthivel; Shanmuganathan, Annadurai; Rajan, Ravindran] Univ Madras, Dr ALM Post Grad Inst Basic Med Sci, Dept Physiol, Taramani Campus, Madras, Tamil Nadu, India	University of Madras	Rajan, R (corresponding author), Univ Madras, Dr ALM Post Grad Inst Basic Med Sci, Dept Physiol, Taramani Campus, Madras, Tamil Nadu, India.	ravindran.unom@gmail.com						Amugongo SK, 2014, AGING DIS, V5, P1, DOI 10.14336/AD.2014.05001; BARKER DJP, 1990, BRIT MED J, V301, P1111, DOI 10.1136/bmj.301.6761.1111; BARLOW SM, 1978, TERATOLOGY, V18, P211, DOI 10.1002/tera.1420180206; Butchart A, 2003, B WORLD HEALTH ORGAN, V81, P17; Cabrera RJ, 1999, BRAZ J MED BIOL RES, V32, P1229, DOI 10.1590/S0100-879X1999001000009; Carmichael SL, 2007, EPIDEMIOLOGY, V18, P356, DOI 10.1097/01.ede.0000259986.85239.87; Challis JRG, 2001, MOL CELL ENDOCRINOL, V185, P135, DOI 10.1016/S0303-7207(01)00624-4; Charil A, 2010, BRAIN RES REV, V65, P56, DOI 10.1016/j.brainresrev.2010.06.002; Chen WQ, 2010, EXP BIOL MED, V235, P577, DOI 10.1258/ebm.2010.009329; Christiaens I, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0353-0; Christianson A, 2006, GLOBAL REPORT BIRTH, P10; Cleasby ME, 2003, ENDOCRINOLOGY, V144, P999, DOI 10.1210/en.2002-220559; D'mello AP, 2006, PSYCHONEUROENDOCRINO, V31, P395, DOI 10.1016/j.psyneuen.2005.10.003; Delaere F, 2010, DIABETES METAB, V36, P257, DOI 10.1016/j.diabet.2010.05.001; DELANY AM, 1994, J CELL BIOCHEM, V56, P295, DOI 10.1002/jcb.240560304; DEVOS P, 1995, J BIOL CHEM, V270, P15958, DOI 10.1074/jbc.270.27.15958; Gupta N, 2014, INDIAN PEDIATR, V51, P693, DOI 10.1007/s13312-014-0483-z; Heszele MFC, 2004, ENDOCRINOLOGY, V145, P4803, DOI 10.1210/en.2004-1037; Hobel CJ, 2008, CLIN OBSTET GYNECOL, V51, P333, DOI 10.1097/GRF.0b013e31816f2709; Hoeijmakers L, 2015, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00103; Liu XY, 2011, EXP THER MED, V2, P977, DOI 10.3892/etm.2011.292; MacDorman M. F., 2013, NATL VITAL STAT REPO, V64, P24; Madhyastha S., 2012, RES J PHARM BIOL CHE, V3, P1387; Manoj PDS, 2015, IEEE T COMPUT, V64, P3022, DOI 10.1109/TC.2015.2389827; Mastorakos G, 2003, ANN NY ACAD SCI, V997, P136, DOI 10.1196/annals.1290.016; McEwen BS, 2015, NAT NEUROSCI, V18, P1353, DOI 10.1038/nn.4086; Mowery TM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10416; Mulligan CJ, 2012, EPIGENETICS-US, V7, P853, DOI 10.4161/epi.21180; Park-Wyllie L, 2000, TERATOLOGY, V62, P385, DOI 10.1002/1096-9926(200012)62:6<385::AID-TERA5>3.0.CO;2-Z; Quetzal AC, 2014, PSYCHOL SCI, V24, P1309; Sandman CA, 2006, PEPTIDES, V27, P1457, DOI 10.1016/j.peptides.2005.10.002; Seckl JR, 2004, EUR J ENDOCRINOL, V151, pU49, DOI 10.1530/eje.0.151u049; Tiao G, 1996, J CLIN INVEST, V97, P339, DOI 10.1172/JCI118421; Tschanz SA, 2002, EUR J PEDIATR, V161, P26, DOI 10.1007/s00431-001-0852-1; Tyrka AR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030148; Vegiopoulos A, 2007, MOL CELL ENDOCRINOL, V275, P43, DOI 10.1016/j.mce.2007.05.015; Ward ID, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-S1-S9; WARD RM, 1994, CLIN PERINATOL, V21, P523, DOI 10.1016/S0095-5108(18)30330-0; Zakrzewska KE, 1999, DIABETES, V48, P365, DOI 10.2337/diabetes.48.2.365	39	15	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2017	12	2							e0171089	10.1371/journal.pone.0171089	http://dx.doi.org/10.1371/journal.pone.0171089			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5QV	28222133	Green Submitted, gold, Green Published			2022-12-27	WOS:000394676800007
J	Kotreka, UK; Davis, VL; Adeyeye, MC				Kotreka, Udaya K.; Davis, Vicki L.; Adeyeye, Moji C.			Development of topical ophthalmic In Situ gel-forming estradiol delivery system intended for the prevention of age-related cataracts	PLOS ONE			English	Article							LENS EPITHELIAL-CELLS; OCULAR DRUG-DELIVERY; BLUE MOUNTAINS EYE; ESTROGEN-RECEPTOR; PHYSIOLOGICAL CONDITIONS; 17-BETA-ESTRADIOL; HYDROGELS; TIMOLOL; VITRO; BETA	The goal of this study was to develop and characterize an ion-activated in situ gel-forming estradiol (E-2) solution eye drops intended for the prevention of age-related cataracts. Accordingly, in situ gelling eye drops were made using gellan gum as an ion-activated gel-forming polymer, polysorbate-80 as drug solubilizing agent, mannitol as tonicity agent, and combination of potassium sorbate and edetate disodium dihydrate (EDTA) as preservatives. The formulations were tested for the following characteristics: pH, clarity, osmolality, antimicrobial efficacy, rheological behavior, and in vitro drug release. Stability of the formulation was also monitored for 6 months at multiple storage conditions per ICH Q1A (R2) guidelines. The solution eye drops resulted in an in-situ phase change to gel-state when mixed with simulated tear fluid (STF). The gel structure formation was confirmed by viscoelastic measurements. Drug release from the gel followed non-fickian mechanism with 80% of drug released in 8 hr. The formulations were found to be clear, isotonic with suitable pH and viscoelastic behavior and stable at accelerated and long-term storage conditions for 6 months. In vitro results suggest that the developed formulation is suitable for further investigation in animal models to elucidate the ability of estrogen to prevent and delay cataracts.	[Kotreka, Udaya K.; Davis, Vicki L.; Adeyeye, Moji C.] Duquesne Univ, Grad Sch Pharmaceut Sci, Pittsburgh, PA 15219 USA; [Kotreka, Udaya K.] Vanda Pharmaceut Inc, Washington, DC USA; [Adeyeye, Moji C.] Roosevelt Univ, Coll Pharm, Schaumburg, IL 60173 USA	Duquesne University	Adeyeye, MC (corresponding author), Duquesne Univ, Grad Sch Pharmaceut Sci, Pittsburgh, PA 15219 USA.; Adeyeye, MC (corresponding author), Roosevelt Univ, Coll Pharm, Schaumburg, IL 60173 USA.	madeyeye@roosevelt.edu			CURE Grant, Pennsylvania Department of Health	CURE Grant, Pennsylvania Department of Health	This work was supported by the CURE Grant, Pennsylvania Department of Health. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeyeye CM, 2002, AAPS PHARMSCITECH, V3, pE8, DOI [10.1208/pt030208, DOI 10.1208/PT030208]; Adeyeye MC, 2011, US Patent Publication, Patent No. [0082128 A1, 0082128]; Al-Ghananeem A, 2002, AAPS PHARMSCITECH, V3, P40; [Anonymous], 1996, GUID IND Q2 R1 ICH H; [Anonymous], 1996, Santee Pharmaceutical Co, Ltd, Patent No. [US5559157, 5559157]; Bachmann GA, 1998, AM J OBSTET GYNECOL, V178, pS257, DOI 10.1016/S0002-9378(98)70558-7; Balasubramaniam Jagdish, 2003, Acta Pharmaceutica (Zagreb), V53, P251; Bigsby RM, 1999, P NATL ACAD SCI USA, V96, P9328, DOI 10.1073/pnas.96.16.9328; Cammarata PR, 2004, EXP EYE RES, V78, P861, DOI 10.1016/j.exer.2003.09.027; Carlfors J, 1998, EUR J PHARM SCI, V6, P113, DOI 10.1016/S0928-0987(97)00074-2; Centers for Disease Control and Prevention, 2011, STAT VIS AG PUBL HLT; Centers for Disease Control and Prevention, 1983, CAT MAJ BLIND DIS; Colitz CMH, 2009, MOL VIS, V15, P2259; Congdon N, 2004, ARCH OPHTHALMOL-CHIC, V122, P487; Cumming RG, 1997, AM J EPIDEMIOL, V145, P242; Davies NM, 2000, CLIN EXP PHARMACOL P, V27, P558, DOI 10.1046/j.1440-1681.2000.03288.x; Davis VL, 2002, P NATL ACAD SCI USA, V99, P9427, DOI 10.1073/pnas.132247999; delCastillo JMB, 1997, OPHTHALMOLOGY, V104, P970; Dikstein S, 1992, US Patent, Patent No. 5106615; Ellwein LB, 2002, ARCH OPHTHALMOL-CHIC, V120, P804; *FDA, 1995, GUID IND IMM REL SOL; Flanner H.H., 1996, PHARM TECHNOL, V20, P64; Food and Drug Administration, 2003, GUID IND Q1AR2 STAB; Gongdon N, 2001, INVEST OPHTH VIS SCI, V42, P2478; Hagerstrom H, 2000, EUR J PHARM SCI, V9, P301, DOI 10.1016/S0928-0987(99)00070-6; Hales AM, 1997, J EXP MED, V185, P273, DOI 10.1084/jem.185.2.273; Hariharan S, 2006, PHARM RES-DORDR, V23, P184, DOI 10.1007/s11095-005-8418-y; Kalam MA, 2008, J DISPER SCI TECHNOL, V29, P89, DOI 10.1080/01932690701688482; Kanthan GL, 2008, OPHTHALMOLOGY, V115, P808, DOI 10.1016/j.ophtha.2007.07.008; Kirker MR, 2013, EXP EYE RES, V112, P1, DOI 10.1016/j.exer.2013.04.002; Kitano M, 1998, INT J PHARM, V174, P19, DOI 10.1016/S0378-5173(98)00234-8; Klein BEK, 2008, OPHTHALMOLOGY, V115, P477, DOI 10.1016/j.ophtha.2007.11.024; Klein BEK, 2000, AM J OPHTHALMOL, V130, P322, DOI 10.1016/S0002-9394(00)00474-8; KORSMEYER RW, 1983, INT J PHARM, V15, P25, DOI 10.1016/0378-5173(83)90064-9; Kotreka UK, 2011, THESIS; Lai KR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078647; Le Bourlais C, 1998, PROG RETIN EYE RES, V17, P33, DOI 10.1016/S1350-9462(97)00002-5; Lindblad BE, 2010, OPHTHALMOLOGY, V117, P424, DOI 10.1016/j.ophtha.2009.07.046; LIVINGSTON PM, 1994, DEV OPHTHALMOL, V26, P1; LOFTSSON T, 1989, ACTA PHARM NORDICA, V1, P185; Lokind KB, 1996, INT J PHARM, V127, P155, DOI 10.1016/0378-5173(95)04118-4; Martens-Lobenhoffer J, 2002, CLIN PHARMACOKINET, V41, P197, DOI 10.2165/00003088-200241030-00004; MESEGUER G, 1994, J DRUG TARGET, V2, P269, DOI 10.3109/10611869409015908; Morishima K, 2007, US Patent, Patent No. [0248697A1, 0248697]; Munaut C, 2001, BRIT J OPHTHALMOL, V85, P877, DOI 10.1136/bjo.85.7.877; Mundada AS, 2009, CRIT REV THER DRUG, V26, P85, DOI 10.1615/CritRevTherDrugCarrierSyst.v26.i1.30; Nagarwal RC, 2009, AAPS PHARMSCITECH, V10, P977, DOI 10.1208/s12249-009-9285-3; Nanjawade BK, 2007, J CONTROL RELEASE, V122, P119, DOI 10.1016/j.jconrel.2007.07.009; Ogueta SB, 1999, INVEST OPHTH VIS SCI, V40, P1906; Oliveira Regina de Souza Carvalho de Salles, 2005, Clinics, V60, P455, DOI 10.1590/S1807-59322005000600005; Paulsson M, 1999, EUR J PHARM SCI, V9, P99, DOI 10.1016/S0928-0987(99)00051-2; Qian Y, 2010, DRUG DEV IND PHARM, V36, P1340, DOI 10.3109/03639041003801893; ROZIER A, 1989, INT J PHARM, V57, P163, DOI 10.1016/0378-5173(89)90305-0; RUCKER C W, 1965, Invest Ophthalmol, V4, P377; Rupenthal ID, 2011, INT J PHARMACEUT, V411, P69, DOI 10.1016/j.ijpharm.2011.03.042; Schenker HI, 2000, AM J OPHTHALMOL, V130, P145, DOI 10.1016/S0002-9394(00)00458-X; Shedden A, 2001, CLIN THER, V23, P440, DOI 10.1016/S0149-2918(01)80048-5; Singh BN, 2004, PHARM DEV TECHNOL, V9, P399, DOI 10.1081/PDT-200035793; Sultana Y, 2006, DRUG DELIV, V13, P215, DOI 10.1080/10717540500309164; Sunil T, 2012, J PHARM BIOALLIED SC, V4, pS6, DOI 10.4103/0975-7406.94117; Tsuji M, 2004, US Patent, Patent No. [0034042 A1, 0034042]; Variankaval NE, 2002, J MATER SCI-MATER M, V13, P271, DOI 10.1023/A:1014058817352; World Health Organization, 2012, GLOBAL DATA VISUAL I; World Health Organization, 2013, UN EYE HLTH GLOB ACT; Worzala K, 2001, ARCH INTERN MED, V161, P1448, DOI 10.1001/archinte.161.11.1448; Zhang XH, 2003, J CATARACT REFR SURG, V29, P71, DOI 10.1016/S0886-3350(02)01436-0; ZIGNANI M, 1995, ADV DRUG DELIVER REV, V16, P51, DOI 10.1016/0169-409X(95)00015-Y	67	37	38	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2017	12	2							e0172306	10.1371/journal.pone.0172306	http://dx.doi.org/10.1371/journal.pone.0172306			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5QV	28222100	Green Submitted, Green Published, gold			2022-12-27	WOS:000394676800047
J	Rudqvist, N; Spetz, J; Schuler, E; Parris, TZ; Langen, B; Helou, K; Forssell-Aronsson, E				Rudqvist, Nils; Spetz, Johan; Schuler, Emil; Parris, Toshima Z.; Langen, Britta; Helou, Khalil; Forssell-Aronsson, Eva			Transcriptional response to I-131 exposure of rat thyroid gland	PLOS ONE			English	Article							GENE-EXPRESSION; PROCEDURE GUIDELINES; MOUSE-TISSUES; DOSE-RATE; AT-211; CANCER; METAIODOBENZYLGUANIDINE; RADIOIODINE; RADIATION; THERAPY	Humans are exposed to (131) I in medical diagnostics and treatment but also from nuclear accidents, and better knowledge of the molecular response in thyroid is needed. The aim of the study was to examine the transcriptional response in thyroid tissue 24 h after (131) I administration in rats. The exposure levels were chosen to simulate both the clinical situation and the case of nuclear fallout. Thirty-six male rats were i.v. injected with 0-4700 kBq (131) I, and killed at 24 h after injection (Dthyroid = 0.0058-3.0 Gy). Total RNA was extracted from individual thyroid tissue samples and mRNA levels were determined using oligonucleotide microarray technique. Differentially expressed transcripts were determined using Nexus Expression 3.0. Hierarchical clustering was performed in the R statistical computing environment. Pathway analysis was performed using the Ingenuity Pathway Analysis tool and the Gene Ontology database. T4 and TSH plasma concentrations were measured using ELISA. Totally, 429 differentially regulated transcripts were identified. Downregulation of thyroid hormone biosynthesis associated genes (e.g. thyroglobulin, thyroid peroxidase, the sodium-iodine symporter) was identified in some groups, and an impact on thyroid function was supported by the pathway analysis. Recurring downregulation of Dbp and Slc47a2 was found. Dbp exhibited a pattern with monotonous reduction of downregulation with absorbed dose at 0.0058-0.22 Gy. T4 plasma levels were increased and decreased in rats whose thyroids were exposed to 0.057 and 0.22 Gy, respectively. Different amounts of injected (131) I gave distinct transcriptional responses in the rat thyroid. Transcriptional response related to thyroid function and changes in T4 plasma levels were found already at very low absorbed doses to thyroid.	[Rudqvist, Nils; Spetz, Johan; Schuler, Emil; Langen, Britta; Forssell-Aronsson, Eva] Univ Gothenburg, Sahlgrenska Acad, Sahlgrenska Canc Ctr, Dept Radiat Phys,Inst Clin Sci, Gothenburg, Sweden; [Parris, Toshima Z.; Helou, Khalil] Univ Gothenburg, Sahlgrenska Acad, Sahlgrenska Canc Ctr, Dept Oncol,Inst Clin Sci, Gothenburg, Sweden	University of Gothenburg; University of Gothenburg	Forssell-Aronsson, E (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Sahlgrenska Canc Ctr, Dept Radiat Phys,Inst Clin Sci, Gothenburg, Sweden.	eva.forssell_aronsson@radfys.gu.se	Parris, Toshima/Q-5427-2018; Spetz, Johan/P-1662-2017	Parris, Toshima/0000-0003-0834-5540; Spetz, Johan/0000-0002-5216-9786; Forssell-Aronsson, Eva/0000-0002-7558-4368; Rudqvist, Nils/0000-0002-9720-3124	European Commission [TARCC HEALTH-F2-2007-201962]; Swedish Research Council [21073]; Swedish Cancer Society [3427]; BioCARE - a National Strategic Research Program at the University of Gothenburg; Swedish Radiation Safety Authority; King Gustav V Jubilee Clinic Cancer Research Foundation; Sahlgrenska University Hospital Research Funds; Wilhelm and Martina Lundgren foundation; Assar Gabrielsson Cancer Research Foundation	European Commission(European CommissionEuropean Commission Joint Research Centre); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); BioCARE - a National Strategic Research Program at the University of Gothenburg; Swedish Radiation Safety Authority; King Gustav V Jubilee Clinic Cancer Research Foundation; Sahlgrenska University Hospital Research Funds; Wilhelm and Martina Lundgren foundation; Assar Gabrielsson Cancer Research Foundation	This study was supported by grants from the European Commission FP7 Collaborative Project TARCC HEALTH-F2-2007-201962, the Swedish Research Council (grant no. 21073), the Swedish Cancer Society (grant no. 3427), BioCARE - a National Strategic Research Program at the University of Gothenburg, the Swedish Radiation Safety Authority, the King Gustav V Jubilee Clinic Cancer Research Foundation, the Sahlgrenska University Hospital Research Funds, the Wilhelm and Martina Lundgren foundation and the Assar Gabrielsson Cancer Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abend M, 2013, BRIT J CANCER, V109, P2286, DOI 10.1038/bjc.2013.574; Abend M, 2013, BR J CANC; Abend M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039103; Akahane Keiichi, 2012, Environmentalist, V32, P136, DOI 10.1007/s10669-011-9381-2; Amundson SA, 1999, RADIAT RES, V152, P225, DOI 10.2307/3580321; [Anonymous], [No title captured]; Bombardieri E, 2010, EUR J NUCL MED MOL I, V37, P2436, DOI 10.1007/s00259-010-1545-7; Bonnema SJ, 2012, ENDOCR REV, V33, P920, DOI 10.1210/er.2012-1030; Brans B, 2002, MED PEDIATR ONCOL, V38, P41, DOI 10.1002/mpo.1261; Cardis E, 2005, JNCI-J NATL CANCER I, V97, P724, DOI 10.1093/jnci/dji129; Carrasquillo JA, 2013, 1311MIBG THER NUCL O, P691; CHAPMAN EM, 1946, JAMA-J AM MED ASSOC, V131, P86, DOI 10.1001/jama.1946.02870190010003; Forssell-Aronsson E, 2011, REP MED IMAGING, V4, P19; Giammarile F, 2008, EUR J NUCL MED MOL I, V35, P1039, DOI 10.1007/s00259-008-0715-3; HERTZ S, 1946, JAMA-J AM MED ASSOC, V131, P81, DOI 10.1001/jama.1946.02870190005002; JEEVANRAM RK, 1986, NUCL MED BIOL, V13, P277, DOI 10.1016/0883-2897(86)90108-X; LANCE GN, 1967, COMPUT J, V10, P271, DOI 10.1093/comjnl/10.3.271; Langen B, 2015, EJNMMI RES, V5, P1, DOI 10.1186/s13550-014-0078-7; Langen B, 2013, J NUCL MED, V54, P990, DOI 10.2967/jnumed.112.114462; Lorenz S, 2010, BBA-MOL CELL RES, V1803, P352, DOI 10.1016/j.bbamcr.2010.01.007; MANGNER TJ, 1986, J NUCL MED, V27, P37; Norden MM, 2007, CANCER RES, V67, P7512, DOI 10.1158/0008-5472.CAN-07-0823; RON E, 1995, RADIAT RES, V141, P259, DOI 10.2307/3579003; Rudqvist N, 2014, NUCL MED BIOL; Rudqvist N., 2015, THESIS; Rudqvist N, 2015, EJNMMI RES, V5, DOI 10.1186/s13550-015-0137-8; Rudqvist N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131686; Rudqvist N, 2015, NUCL MED BIOL, V42, P263, DOI 10.1016/j.nucmedbio.2014.11.006; Rudqvist N, 2012, EJNMMI RES, V2, DOI 10.1186/2191-219X-2-32; Schipper ML, 2007, EUR J NUCL MED MOL I, V34, P638, DOI 10.1007/s00259-006-0254-8; Schuler E., 2014, THESIS; Schuler E, 2014, NUCL MED BIOL, V41, P825, DOI 10.1016/j.nucmedbio.2014.07.010; Schuler E, 2014, NUCL MED BIOL, V41, P238, DOI 10.1016/j.nucmedbio.2013.12.001; Schuler E, 2011, EJNMMI RES, V1, DOI 10.1186/2191-219X-1-29; Selmansberger M, 2014, ONCOGENE; Selmansberger M, 2015, CARCINOGENESIS; Spetz J, 2013, CANCER BIOTHER RADIO, V28, P657, DOI 10.1089/cbr.2013.1483; UN Sci. Comm. Eff. At. Radiat, 2000, REP GEN ASS SCI ANN, VII, P451; Wafelman AR, 1996, NUKLEARMED, V35, P122; WHO (World Health Organization), 1993, BIOM RISK ASS CONC P	40	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2017	12	2							e0171797	10.1371/journal.pone.0171797	http://dx.doi.org/10.1371/journal.pone.0171797			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5QV	28222107	Green Published, Green Submitted, gold			2022-12-27	WOS:000394676800018
J	Shabangu, FW; Yemane, D; Stafford, KM; Ensor, P; Findlay, KP				Shabangu, Fannie W.; Yemane, Dawit; Stafford, Kathleen M.; Ensor, Paul; Findlay, Ken P.			Modelling the effects of environmental conditions on the acoustic occurrence and behaviour of Antarctic blue whales	PLOS ONE			English	Article							BALAENOPTERA-MUSCULUS; SOUTHERN-HEMISPHERE; OCEAN; TEMPERATURE; WIND; CALIFORNIA; FREQUENCY; SOUNDS; CALLS; KRILL	Harvested to perilously low numbers by commercial whaling during the past century, the large scale response of Antarctic blue whales Balaenoptera musculus intermedia to environmental variability is poorly understood. This study uses acoustic data collected from 586 sonobuoys deployed in the austral summers of 1997 through 2009, south of 38 degrees S, coupled with visual observations of blue whales during the IWC SOWER line-transect surveys. The characteristic Z-call and D-call of Antarctic blue whales were detected using an automated detection template and visual verification method. Using a random forest model, we showed the environmental preferences pattern, spatial occurrence and acoustic behaviour of Antarctic blue whales. Distance to the southern boundary of the Antarctic Circumpolar Current (SBACC), latitude and distance from the nearest Antarctic shores were the main geographic predictors of blue whale call occurrence. Satellite-derived sea surface height, sea surface temperature, and productivity (chlorophyll-a) were the most important environmental predictors of blue whale call occurrence. Call rates of D-calls were strongly predicted by the location of the SBACC, latitude and visually detected number of whales in an area while call rates of Z-call were predicted by the SBACC, latitude and longitude. Satellite-derived sea surface height, wind stress, wind direction, water depth, sea surface temperatures, chlorophyll-a and wind speed were important environmental predictors of blue whale call rates in the Southern Ocean. Blue whale call occurrence and call rates varied significantly in response to inter-annual and long term variability of those environmental predictors. Our results identify the response of Antarctic blue whales to inter-annual variability in environmental conditions and highlighted potential suitable habitats for this population. Such emerging knowledge about the acoustic behaviour, environmental and habitat preferences of Antarctic blue whales is important in improving the management and conservation of this highly depleted species.	[Shabangu, Fannie W.; Yemane, Dawit] Dept Agr Forestry & Fisheries, Fisheries Management, Cape Town, South Africa; [Shabangu, Fannie W.; Findlay, Ken P.] Univ Pretoria, Mammal Res Inst, Whale Unit, Wynberg, South Africa; [Stafford, Kathleen M.] Univ Washington, Appl Phys Lab, Seattle, WA 98105 USA; [Ensor, Paul] Australian Marine Mammal Ctr, Australian Antarctic Div, Hobart, Tas, Australia; [Findlay, Ken P.] Cape Peninsula Univ Technol, Ctr Sustainable Oceans Econ, Cape Town, South Africa	University of Pretoria; University of Washington; University of Washington Seattle; Australian Antarctic Division; Cape Peninsula University of Technology	Shabangu, FW (corresponding author), Dept Agr Forestry & Fisheries, Fisheries Management, Cape Town, South Africa.; Shabangu, FW (corresponding author), Univ Pretoria, Mammal Res Inst, Whale Unit, Wynberg, South Africa.	fannie.shabangu@yahoo.com	Findlay, Ken P/A-5766-2019	Findlay, Ken P/0000-0001-7154-8805; Shabangu, Fannie W./0000-0002-3668-3566; Stafford, Kathleen/0000-0003-0039-5025	International Whaling Commission; National Research Institute of Far Seas Fisheries via Southern Ocean Whale and Ecosystem Research program of the International Whaling Commission; South African National Antarctic Programme; National Research Foundation	International Whaling Commission; National Research Institute of Far Seas Fisheries via Southern Ocean Whale and Ecosystem Research program of the International Whaling Commission; South African National Antarctic Programme; National Research Foundation	This work was supported by the International Whaling Commission and National Research Institute of Far Seas Fisheries via Southern Ocean Whale and Ecosystem Research program of the International Whaling Commission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are greatly indebted to the International Whaling Commission for granting permission to use the IWC SOWER passive acoustic data together with the cruise reports, acoustic data records and visual survey data. We thank the captains, crew and researchers aboard the IWC SOWER survey vessels, the Shonan Maru and the Shonan Maru No 2 for the collection of these data. South African National Antarctic Programme and National Research Foundation funded the South African Blue Whale Project. Marcel du Plessis and Hazel Little of the Department of Oceanography, University of Cape Town, are thanked for the fruitful discussions regarding the best satellite products to use to obtain chlorophyll-a data for the cloudy Southern Ocean. Cathy Boucher, Department of Agriculture, Fisheries and Forestry, is acknowledged for collating some of our figures. GlobColour data (http://globcolour.info) used in this study has been developed, validated, and distributed by ACRI-ST, France. We are grateful to two anonymous reviewers for their constructive comments that improved the structure of this paper.	Amante C., 2009, PSYCHOLOGIST, DOI [10.7289/V5C8276M, DOI 10.7289/V5C8276M]; Atkinson A, 2004, NATURE, V432, P100, DOI 10.1038/nature02996; Attard CRM, 2012, MOL ECOL, V21, P5715, DOI 10.1111/mec.12025; Au W.W.L., 2008, PRINCIPLES MARINE BI; Ballance LT, 2009, ENCYCLOPEDIA OF MARINE MAMMALS, 2ND EDITION, P196; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Behrenfeld MJ, 2006, NATURE, V444, P752, DOI 10.1038/nature05317; Best P, 2007, WHALES DOLPHINS SO A; Bivand R, 2015, PACKAGE RGDAL; Branch TA, 2007, MAMMAL REV, V37, P116, DOI 10.1111/j.1365-2907.2007.00106.x; Branch TA, 2004, MAR MAMMAL SCI, V20, P726, DOI 10.1111/j.1748-7692.2004.tb01190.x; Breiman L, 2014, RANDOMFOREST BREIMAN; Chamberlain S., 2016, R PACKAGE VERSION 0; Chereskin TK, 2011, ENCY OCEAN SCI, P222; Constable AJ, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2001JC001270; Donlon C, 2007, B AM METEOROL SOC, V88, P1197, DOI 10.1175/BAMS-88-8-1197; Ducet N, 2000, J GEOPHYS RES-OCEANS, V105, P19477, DOI 10.1029/2000JC900063; Elith J, 2008, J ANIM ECOL, V77, P802, DOI 10.1111/j.1365-2656.2008.01390.x; Elliott NV, 2007, WHALES HOT WATER IMP; Etnoyer P, 2006, DEEP-SEA RES PT II, V53, P340, DOI 10.1016/j.dsr2.2006.01.010; Fetterer F., 2016, **DATA OBJECT**; Figueroa HK, 2006, XBAT EXTENSIBLE BIOA; FOX J, 1992, J AM STAT ASSOC, V87, P178, DOI 10.2307/2290467; Fox J., 2018, R COMPANION APPL REG, VThird; Gavrilov AN, 2012, J ACOUST SOC AM, V131, P4476, DOI 10.1121/1.4707425; Griffis R, 2013, NCA REGION INPUT REP, P119, DOI 10.5822/978-1-61091-480-2_5; Hair J.F., 2010, MULTIVARIATE DATA AN, V7th ed; Hastie T., 2009, ELEMENTS STAT LEARNI, V2nd ed.; James G, 2013, SPRINGER TEXTS STAT, V103, P1, DOI 10.1007/978-1-4614-7138-7_1; Kahru M, 2010, REMOTE SENS LETT, V1, P119, DOI 10.1080/01431160903547940; Kasamatsu F, 2000, POLAR BIOL, V23, P466, DOI 10.1007/s003009900107; Kuhn M., 2013, APPL PREDICTIVE MODE, DOI 10.1007/978-1-4614-6849-3; Langlais C, 2010, MERCATOR Q NEWSLETT, V36, P50; Leathwick JR, 2006, MAR ECOL PROG SER, V321, P267, DOI 10.3354/meps321267; Mackintosh NA, 1929, DISCOVERY REP, VI, P259; Maritorena S, 2010, REMOTE SENS ENVIRON, V114, P1791, DOI 10.1016/j.rse.2010.04.002; Matsuoka K, 2003, ANTARCTIC BIOLOGY IN A GLOBAL CONTEXT, PROCEEDINGS, P26; Matsuoka Koji, 2003, Journal of Cetacean Research and Management, V5, P173; Matthews J. N., 2001, Journal of Cetacean Research and Management, V3, P271; Matworks Inc, 2014, MATLAB R2014A VERSIO; Mellinger DK, 2000, J ACOUST SOC AM, V107, P3518, DOI 10.1121/1.429434; Mendelssohn R., 2015, R PACKAGE VERSION 3; Miller BS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107740; Miller BS, 2013, CONSIDERATION UNPUB; Moore SE, 2009, ENCYCLOPEDIA OF MARINE MAMMALS, 2ND EDITION, P238; National Climatic Data Center, 2007, GHRSST LEV 4 AVHRR O, DOI 10.5067/GHAAO-4BC01; Nicol S, 2008, MAR FRESHWATER RES, V59, P361, DOI 10.1071/MF07161; NOWLIN WD, 1986, REV GEOPHYS, V24, P469, DOI 10.1029/RG024i003p00469; O'Brien RM, 2007, QUAL QUANT, V41, P673, DOI 10.1007/s11135-006-9018-6; Oleson EM, 2007, MAR ECOL PROG SER, V330, P269, DOI 10.3354/meps330269; ORSI AH, 1995, DEEP-SEA RES PT I, V42, P641, DOI 10.1016/0967-0637(95)00021-W; Pierce D., 2014, R PACKAGE VERSION 1; R Core Team, 2015, LANG ENV STAT COMP 3; Rahmstorf S., 2009, ENCY COMPLEXITY SYST, P1; Rankin Shannon, 2005, Journal of Cetacean Research and Management, V7, P13; Rice D. W., 1998, SOC MARINE MAMMALOGY, V4; RIFFENBURGH B, 2007, ENCY ANTARCTIC; Rintoul SR, 2011, ENCY OCEAN SCI, P178; Samaran F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071561; Samaran F, 2010, APPL ACOUST, V71, P1099, DOI 10.1016/j.apacoust.2010.05.014; Shabangu FW, 2014, FISH RES, V151, P47, DOI 10.1016/j.fishres.2013.12.008; Sirovic A, 2004, DEEP-SEA RES PT II, V51, P2327, DOI 10.1016/j.dsr2.2004.08.005; Sirovic A, 2007, J ACOUST SOC AM, V122, P1208, DOI 10.1121/1.2749452; Sirovic A, 2016, BIOACOUSTICS, V25, P145, DOI 10.1080/09524622.2015.1124248; Sirovic A, 2011, DEEP-SEA RES PT II, V58, P1719, DOI 10.1016/j.dsr2.2010.08.019; Sokolov S, 2009, J GEOPHYS RES-OCEANS, V114, DOI 10.1029/2008JC005108; Stafford KM, 2004, DEEP-SEA RES PT I, V51, P1337, DOI 10.1016/j.dsr.2004.05.007; Swart S, 2014, J MARINE SYSTEMS; Thomalla SJ, 2015, ICES J MARINE SCI; Thomas PO, 2016, MAR MAMMAL SCI, V32, P682, DOI 10.1111/mms.12281; Thompson PO, 1996, MAR MAMMAL SCI, V12, P288, DOI 10.1111/j.1748-7692.1996.tb00578.x; Tynan CT, 1998, NATURE, V392, P708, DOI 10.1038/33675; Urick R.J, 1983, PRINCIPLES UNDERWATE; Weber L.H., 1985, P284; White WB, 1996, NATURE, V380, P699, DOI 10.1038/380699a0; Whitehouse MJ, 2009, MAR ECOL PROG SER, V393, P69, DOI 10.3354/meps08288; Wickham H, 2015, STRINGR SIMPLE CONSI; Wright MN, 2016, J STAT SOFT IN PRESS; Yuan XJ, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2003JD004179; Zhang H., 2006, J HIGHWAY TRANSPORTA, V2, P29	80	18	19	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2017	12	2							e0172705	10.1371/journal.pone.0172705	http://dx.doi.org/10.1371/journal.pone.0172705			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5QV	28222124	Green Published, gold, Green Submitted			2022-12-27	WOS:000394676800078
J	Viscardi, DZ; Arrigo, JD; Correia, CDC; Kassuya, CAL; Cardoso, CAL; Maldonade, IR; Argandona, EJS				Viscardi, Danieli Zuntini; Arrigo, Jucicleia da Silva; Chaves Correia, Camila de Azevedo; Leite Kassuya, Candida Aparecida; Lima Cardoso, Claudia Andrea; Maldonade, Iriani Rodrigues; Sanjinez Argandona, Eliana Janet			Seed and peel essential oils obtained from Campomanesia adamantium fruit inhibit inflammatory and pain parameters in rodents	PLOS ONE			English	Article							CHEMICAL-COMPOSITION; ANTIINFLAMMATORY PROPERTIES; ANTIMICROBIAL ACTIVITY; FORMALIN TEST; GC-MS; ANTIOXIDANT; ANTICANCER; EXTRACT	Campomanesia adamantium (Myrtaceae) is popularly known as "gabiroba" and has been used in folk medicine as antirheumatic, antidiarrheal, hypocholesterolemic and anti-inflammatory. This study evaluated the anti-inflammatory and antinociceptive activities and toxicology of essential oils from peel (EOP) and seed (EOS) of C. adamantium fruits in animal models. Different groups were treated with doses of 100 and 300 mg/kg and the inflammatory parameters were evaluated in carrageenan induced paw oedema and leukocyte migration in pleurisy model, while antinociceptive activity was evaluated using formalin method in rodents. The major constituent of EOP and EOS was limonene with 13.07% and 20.89%, respectively. No clinical signs of toxicity have been observed in animals. It was observed a significant decreased (P<0.01) in leukocyte migration at the dose of 300 mg/kg of EOP and EOS, with maximal inhibition of 89 +/- 3% for EOP and 80 +/- 6% for EOS. Paw oedema was inhibited at all times, and maximal inhibition was at the dose of 100 mg/kg at 2 h after carrageenan injection with 72 +/- 2% for EOP and 74 +/- 2% for EOS. EOS and EOP also reduced the first and second phases of formalin-induced nociception test. In the first formalin-phase, maximal inhibitions were at 48 +/- 5% for EOP and 66 +/- 4% for EOS (300 mg/kg). At the inflammatory phase induced by formalin, maximal inhibitions were 72 +/- 2% for EOP and 80 +/- 2% for EOS at the dose of 100 mg/kg. Seed and peel essential oils from C. adamantium fruit inhibited leukocyte migration, inflammatory and neurogenic pain and oedema suggesting their use as nutraceutical or pharmacological agent.	[Viscardi, Danieli Zuntini; Arrigo, Jucicleia da Silva; Chaves Correia, Camila de Azevedo] Fed Univ Grande Dourados, Coll Exact & Technol Sci, Dourados, MS, Brazil; [Leite Kassuya, Candida Aparecida] Fed Univ Grande Dourados, Coll Hlth Sci, Dourados, MS, Brazil; [Lima Cardoso, Claudia Andrea] Univ Estadual Mato Grosso do Sul, Course Chem, Dourados, MS, Brazil; [Maldonade, Iriani Rodrigues] Brazilian Agr Res Agcy Embrapa, Brasilia, DF, Brazil; [Sanjinez Argandona, Eliana Janet] Fed Univ Grande Dourados, Coll Food Engn, Dourados, MS, Brazil	Universidade Federal da Grande Dourados; Universidade Federal da Grande Dourados; Universidade Estadual de Mato Grosso do Sul; Universidade Federal da Grande Dourados	Viscardi, DZ (corresponding author), Fed Univ Grande Dourados, Coll Exact & Technol Sci, Dourados, MS, Brazil.	danieliviscardi@ufgd.edu.br	Kassuya, Candida A. L./G-8329-2011; Maldonade, Iriani/AAT-7399-2021; Cardoso, Claudia Andrea Lima/AAK-5578-2020; Maldonade, Iriani/A-5953-2013	Maldonade, Iriani/0000-0003-2283-1270; Cardoso, Claudia Andrea Lima/0000-0002-4907-0056; Maldonade, Iriani/0000-0003-2283-1270; Kassuya, Candida/0000-0002-8998-9219	Fundacao de Amparo a Pesquisa do Estado do Mato Grosso do Sul (FUNDECT) through the project FUNDECT/CAPES [45/2014]; Fundacao de Amparo a Pesquisa do Estado do Mato Grosso do Sul (FUNDECT) through the project PAPOS REDE PRO-CENTRO-OESTE FASE II [23/200.622/2014]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)	Fundacao de Amparo a Pesquisa do Estado do Mato Grosso do Sul (FUNDECT) through the project FUNDECT/CAPES; Fundacao de Amparo a Pesquisa do Estado do Mato Grosso do Sul (FUNDECT) through the project PAPOS REDE PRO-CENTRO-OESTE FASE II; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The authors also wish to thank the Fundacao de Amparo a Pesquisa do Estado do Mato Grosso do Sul (FUNDECT) for financial support, through the projects FUNDECT/CAPES no 45/2014 - PAPOS REDE PRO-CENTRO-OESTE FASE II - No 23/200.622/2014 and the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors kindly acknowledge the Study Group on Agro-Industrial Products and Processes of Cerrado (GEPPAC) for technical support. The authors also wish to thank the Fundacao de Amparo a Pesquisa do Estado do Mato Grosso do Sul (FUNDECT) for financial support, through the projects FUNDECT/CAPES no 45/2014 PAPOS REDE PRO-CENTROOESTE-FASE II -No 23/200.622/2014 and the Conselho Nacional de Desenvolvimento Cientifico e TecnolOgico (CNPq).	Adams RP, 2007, IDENTIFICATION ESSEN, P53; Afoulous S, 2013, FOOD CHEM TOXICOL, V56, P352, DOI 10.1016/j.fct.2013.02.008; AOAC, 1990, OFFICIAL METHODS ANA, V2, P4; Breda CA, 2012, FOOD CHEM, V135, P2960, DOI 10.1016/j.foodchem.2012.07.029; Cabrini DA, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1093/ecam/neq026; Chi GF, 2013, INFLAMMATION, V36, P501, DOI 10.1007/s10753-012-9571-1; Coutinho ID, 2009, BRAZ J PHARM SCI, V45, P767, DOI 10.1590/S1984-82502009000400022; d'Alessio PA, 2013, LIFE SCI, V92, P1151, DOI 10.1016/j.lfs.2013.04.013; de Lima VT, 2014, PHYTOMEDICINE, V21, P1298, DOI 10.1016/j.phymed.2014.07.004; de Oliveira AM, 2012, INT J MOL SCI, V13, P1598, DOI 10.3390/ijms13021598; Decosterd I, 2012, PAIN, V2, P149; Esteves I, 2005, J ETHNOPHARMACOL, V101, P191, DOI 10.1016/j.jep.2005.04.020; Fernandes TD, 2015, TOXICOL REP, V2, P184, DOI 10.101611.toxrep.2014.11.018; Ferreira LC, 2013, J ETHNOPHARMACOL, V145, P100, DOI 10.1016/j.jep.2012.10.037; Formagio ASN, 2011, LAT AM J PHARM, V30, P1555; HUNSKAAR S, 1985, J NEUROSCI METH, V14, P69, DOI 10.1016/0165-0270(85)90116-5; Kim MJ, 2014, NAT PROD COMMUN, V9, P727; Kassuya CAL, 2009, J ETHNOPHARMACOL, V124, P369, DOI 10.1016/j.jep.2009.06.003; Cardoso CAL, 2010, J MED FOOD, V13, P1273, DOI 10.1089/jmf.2009.0047; Lima NGPB, 2013, PHARMACOL BIOCHEM BE, V103, P450, DOI 10.1016/j.pbb.2012.09.005; Lorenzi H., 2000, ARVORES BRASILEIRAS; Leite JFM, 2012, MOLECULES, V17, P3277, DOI 10.3390/molecules17033277; Organization for Economic Co-operation and Development, 2008, GUID 425 AC OR TOX U; Piccinelli AC, 2015, NUTR NEUROSCI, V18, P217, DOI 10.1179/1476830514Y.0000000119; Violante IMP, 2012, BRAZ J MICROBIOL, V43, P1302, DOI 10.1590/S1517-83822012000400009; Ramos D. D., 2007, REV BRAS BIOCIENCIAS, V5, P774; Pascoal ACRF, 2014, MOLECULES, V19, P1843, DOI 10.3390/molecules19021843; Sahranavard S, 2014, IRAN J PHARM RES, V13, P119; SHIBATA M, 1989, PAIN, V38, P347, DOI 10.1016/0304-3959(89)90222-4; Souza JC, 2014, NUTRITIONAL NEUROSCI, DOI 10.1179; TJOLSEN A, 1992, PAIN, V51, P5, DOI 10.1016/0304-3959(92)90003-T; VANDENDOOL H, 1963, J CHROMATOGR, V11, P463, DOI 10.1016/S0021-9673(01)80947-X; VELO GP, 1973, J PATHOL, V111, P149, DOI 10.1002/path.1711110302	33	16	16	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2017	12	2							e0157107	10.1371/journal.pone.0157107	http://dx.doi.org/10.1371/journal.pone.0157107			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5QV	28222179	gold, Green Submitted, Green Published			2022-12-27	WOS:000394676800001
J	Zhang, JJ; Peng, K; Zhang, J; Meng, XW; Ji, FH				Zhang, Jing-jing; Peng, Ke; Zhang, Juan; Meng, Xiao-wen; Ji, Fu-hai			Dexmedetomidine preconditioning may attenuate myocardial ischemia/reperfusion injury by down-regulating the HMGB1-TLR4-MyD88-NF-kappa B signaling pathway	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; MOBILITY GROUP BOX-1; NF-KAPPA-B; CHOLINERGIC ANTIINFLAMMATORY PATHWAY; ENDOTOXIN-INDUCED SHOCK; INFLAMMATORY RESPONSES; SARCOPLASMIC-RETICULUM; MICE; ACTIVATION; PROTEIN	Aims To investigate whether dexmedetomidine (DEX) preconditioning could alleviate the inflammation caused by myocardial ischemia/reperfusion (I/R) injury by reducing HMGB1-TLR4MyD88-NF-kappa B signaling. Methods Seventy rats were randomly assigned into five groups: sham group, myocardial I/R group (I/R), DEX+I/R group (DEX), DEX+yohimbine+I/R group (DEX/YOH), and yohimbine+I/R group (YOH). Animals were subjected to 30 min of ischemia induced by occluding the left anterior descending artery followed by 120 min of reperfusion. Myocardial infarct size and histological scores were evaluated. The levels of IL-6 and TNF-alpha in serum and myocardium were quantified by enzyme-linked immunosorbent assay, and expression of HMGB1, TLR4, MyD88, I kappa B and NF-kappa B in the myocardial I/R area were determined with Western blot and immunocytochemistry. Results Myocardial infarct sizes, histological scores, levels of circulating and myocardial IL-6 and TNF-alpha, the expression of HMGB1, TLR4, MyD88 and NF-kappa B, and the degradation of I kappa B were significantly increased in the I/R group compared with the sham group (P<0.01). DEX preconditioning significantly reduced the myocardial infarct size and histological scores (P<0.01 vs. I/R group). Similarly, the serum and myocardial levels of IL-6 and TNF-alpha, the expression of HMGB1, TLR4, MyD88 and NF-kappa B, and the degradation of I kappa B were significantly reduced in the DEX group (P<0.01 vs. I/R group). These effects were partly reversed by yohimbine, a selective alpha(2)-adrenergic receptor antagonist, while yohimbine alone had no significant effect on any of the above indicators. Conclusion DEX preconditioning reduces myocardial I/R injury in part by attenuating inflammation, which may be attributed to the downregulation of the HMGB1-TLR4-MyD88-NF-kappa B signaling pathway mediated by the alpha 2-adrenergic receptor activation.	[Zhang, Jing-jing; Peng, Ke; Zhang, Juan; Meng, Xiao-wen; Ji, Fu-hai] Soochow Univ, Affiliated Hosp 1, Dept Anesthesiol, Suzhou, Peoples R China	Soochow University - China	Ji, FH (corresponding author), Soochow Univ, Affiliated Hosp 1, Dept Anesthesiol, Suzhou, Peoples R China.	jifuhai198901@163.com			National Natural Science Foundation of China (NSFC) [81471835, 81471889]; Key Provincial Talents of Jiangsu Province [RC201107]; Science and Technology Development Projects of Soochow [SYSD2013076]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Key Provincial Talents of Jiangsu Province; Science and Technology Development Projects of Soochow	This work was funded by the National Natural Science Foundation of China (NSFC) (81471835, 81471889), Key Provincial Talents of Jiangsu Province (RC201107), Science and Technology Development Projects of Soochow (SYSD2013076). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham E, 2000, J IMMUNOL, V165, P2950, DOI 10.4049/jimmunol.165.6.2950; Albus U., 2012, GUIDE CARE USE LAB A, DOI DOI 10.1258/LA.2012.150312; Andrassy M, 2008, CIRCULATION, V117, P3216, DOI 10.1161/CIRCULATIONAHA.108.769331; Biccard BM, 2008, ANAESTHESIA, V63, P4, DOI 10.1111/j.1365-2044.2007.05306.x; Cho HI, 2013, J NAT PROD, V76, P1717, DOI 10.1021/np4004323; Fan HY, 2012, EVID-BASED COMPL ALT, V2012, P1, DOI 10.1155/2012/508938; Frantz S, 1999, J CLIN INVEST, V104, P271, DOI 10.1172/JCI6709; Friesen RH, 2013, ANESTH ANALG, V117, P953, DOI 10.1213/ANE.0b013e3182a15aa6; Giallauria F, 2010, ATHEROSCLEROSIS, V208, P280, DOI 10.1016/j.atherosclerosis.2009.07.025; Gilsbach R, 2012, BRIT J PHARMACOL, V165, P90, DOI 10.1111/j.1476-5381.2011.01533.x; Gordon S, 2012, CIRC RES, V110, P1546, DOI 10.1161/RES.0b013e31825ec26d; Gu J, 2011, ACTA ANAESTH SCAND, V55, P1272, DOI 10.1111/j.1399-6576.2011.02526.x; Gu JT, 2011, CRIT CARE, V15, DOI 10.1186/cc10283; Hua F, 2015, J CEREBR BLOOD F MET, V35, P536, DOI 10.1038/jcbfm.2014.240; Huang Y, 2014, INT J MOL SCI, V15, P4049, DOI 10.3390/ijms15034049; Ibacache M, 2012, BBA-MOL BASIS DIS, V1822, P537, DOI 10.1016/j.bbadis.2011.12.013; Ji FH, 2013, CIRCULATION, V127, P1576, DOI 10.1161/CIRCULATIONAHA.112.000936; Jiang LL, 2014, MOL MED REP, V9, P419, DOI 10.3892/mmr.2013.1867; Kawada T, 2013, ACTA PHYSIOL, V209, P55, DOI 10.1111/apha.12123; Kempf T, 2012, J MOL MED, V90, P361, DOI 10.1007/s00109-011-0847-y; Kim HM, 2007, CELL, V130, P906, DOI 10.1016/j.cell.2007.08.002; Klune JR, 2008, MOL MED, V14, P476, DOI 10.2119/2008-00034.Klune; Kumar S, 2009, BIOCHEM BIOPH RES CO, V387, P77, DOI 10.1016/j.bbrc.2009.06.115; Leary S., 2013, AVMA GUIDELINES FOR; LEE JC, 1985, AM J PATHOL, V121, P316; Michael LH, 1995, AM J PHYSIOL-HEART C, V269, pH2147, DOI 10.1152/ajpheart.1995.269.6.H2147; Niu XY, 2013, CNS NEUROSCI THER, V19, P897, DOI 10.1111/cns.12172; Obayah GM, 2010, EUR J ANAESTH, V27, P280, DOI 10.1097/EJA.0b013e3283347c15; Oda Y, 2012, RESUSCITATION, V83, P1006, DOI 10.1016/j.resuscitation.2012.01.030; Okada H, 2007, RESUSCITATION, V74, P538, DOI 10.1016/j.resuscitation.2007.01.032; Ostadal B, 2009, PHARMACOL REP, V61, P3, DOI 10.1016/S1734-1140(09)70002-7; Oyama J, 2004, CIRCULATION, V109, P784, DOI 10.1161/01.CIR.0000112575.66565.84; Park JS, 2004, J BIOL CHEM, V279, P7370, DOI 10.1074/jbc.M306793200; Pavlov VA, 2006, BIOCHEM SOC T, V34, P1037, DOI 10.1042/BST0341037; Steffens S, 2009, THROMB HAEMOSTASIS, V102, P240, DOI 10.1160/TH08-12-0837; Tan F, 2015, BIOMED REP, V3, P365, DOI 10.3892/br.2015.427; Taniguchi T, 2004, CRIT CARE MED, V32, P1322, DOI 10.1097/01.CCM.0000128579.84228.2A; Taniguchi T, 2008, J ANESTH, V22, P221, DOI 10.1007/s00540-008-0611-9; Tsai CT, 2015, CARDIOVASC RES, V105, P318, DOI 10.1093/cvr/cvv008; Vilahur G, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00496; Volz HC, 2012, CLIN RES CARDIOL, V101, P427, DOI 10.1007/s00392-011-0409-x; Wang J, 2015, WORLD J GASTROENTERO, V21, P8314, DOI 10.3748/wjg.v21.i27.8314; Wijeysundera DN, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004126.pub2; Willigers HM, 2003, ANESTH ANALG, V96, P657, DOI 10.1213/01.ANE.0000048708.75957.FF; Xiang H, 2014, INFLAMMATION, V37, P1763, DOI 10.1007/s10753-014-9906-1; Ye WB, 2016, INT IMMUNOPHARMACOL, V39, P149, DOI 10.1016/j.intimp.2016.07.018; Yoshitomi O, 2012, SHOCK, V38, P92, DOI 10.1097/SHK.0b013e318254d3fb; Yu M, 2006, SHOCK, V26, P174, DOI 10.1097/01.shk.0000225404.51320.82; Zhang J, 2015, SCI REP-UK, V5, DOI 10.1038/srep15503	49	53	61	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2017	12	2							e0172006	10.1371/journal.pone.0172006	http://dx.doi.org/10.1371/journal.pone.0172006			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5QV	28222157	Green Published, Green Submitted, gold			2022-12-27	WOS:000394676800028
J	Axton, RA; Haideri, SS; Lopez-Yrigoyen, M; Taylor, HA; Forrester, LM				Axton, Richard A.; Haideri, Sharmin S.; Lopez-Yrigoyen, Martha; Taylor, Helen A.; Forrester, Lesley M.			SplitAx: A novel method to assess the function of engineered nucleases	PLOS ONE			English	Article							GENOME; ACTIVATION	Engineered nucleases have been used to generate knockout or reporter cell lines and a range of animal models for human disease. These new technologies also hold great promise for therapeutic genome editing. Current methods to evaluate the activity of these nucleases are time consuming, require extensive optimization and are hampered by readouts with low signals and high background. We have developed a simple and easy to perform method ( SplitAx) that largely addresses these issues and provides a readout of nuclease activity. The assay involves splitting the N-terminal ( amino acid 1-158) coding region of GFP and an out-of-frame of C-terminal region with a nuclease binding site sequence. Following exposure to the test nuclease, cutting and repair by error prone non-homologous end joining ( NHEJ) restores the reading frame resulting in the production of a full length fluorescent GFP protein. Fluorescence can also be restored by complementation between the N-terminal and C-terminal coding sequences in trans. We demonstrate successful use of the SplitAx assay to assess the function of zinc finger nucleases, CRISPR hCAS9 and TALENS. We also test the activity of multiple gRNAs in CRISPR/hCas9/D10A systems. The zinc finger nucleases and guide RNAs that showed functional activity in the SplitAx assay were then used successfully to target the endogenous AAVS1, SOX6 and Cfms loci. This simple method can be applied to other unrelated proteins such as ZsGreen1 and provides a test system that does not require complex optimization.	[Axton, Richard A.; Haideri, Sharmin S.; Lopez-Yrigoyen, Martha; Taylor, Helen A.; Forrester, Lesley M.] Univ Edinburgh, Edinburgh bioQuarter, MRC, Ctr Regenerat Med, SCRM Bldg,5 Little France Dr, Edinburgh, Midlothian, Scotland	University of Edinburgh	Forrester, LM (corresponding author), Univ Edinburgh, Edinburgh bioQuarter, MRC, Ctr Regenerat Med, SCRM Bldg,5 Little France Dr, Edinburgh, Midlothian, Scotland.	L.Forrester@ed.ac.uk		Lopez-Yrigoyen, Martha/0000-0002-5115-3942	MRC [MR/L012766/1] Funding Source: UKRI; Medical Research Council [MR/L012766/1] Funding Source: Medline; Wellcome Trust [102610] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Alwin S, 2005, MOL THER, V12, P610, DOI 10.1016/j.ymthe.2005.06.094; Chang CJ, 2012, BLOOD, V120, P3906, DOI 10.1182/blood-2012-03-420703; Cradick TJ, 2014, METHODS MOL BIOL, V1114, P339, DOI 10.1007/978-1-62703-761-7_22; Crone D. E., 2013, GFP BASED BIOSENSORS; DeKelver RC, 2010, GENOME RES, V20, P1133, DOI 10.1101/gr.106773.110; Epinat JC, 2003, NUCLEIC ACIDS RES, V31, P2952, DOI 10.1093/nar/gkg375; Gaj T, 2012, NAT METHODS, V9, P805, DOI [10.1038/nmeth.2030, 10.1038/NMETH.2030]; Gao XF, 2013, STEM CELL REP, V1, P183, DOI 10.1016/j.stemcr.2013.06.002; Ghosh I, 2000, J AM CHEM SOC, V122, P5658, DOI 10.1021/ja994421w; Hockemeyer D, 2011, NAT BIOTECHNOL, V29, P731, DOI 10.1038/nbt.1927; Huang YM, 2009, BIOCHEMISTRY-US, V48, P929, DOI 10.1021/bi802027g; Kim Y, 2013, NAT BIOTECHNOL, V31, P251, DOI 10.1038/nbt.2517; Kozak M, 2002, GENE, V299, P1, DOI 10.1016/S0378-1119(02)01056-9; Li Y, 2012, SCI REP-UK, V2, DOI 10.1038/srep00897; Lohmann F, 2008, DEVELOPMENT, V135, P2071, DOI 10.1242/dev.018200; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mashiko D, 2013, SCI REP-UK, V3, DOI 10.1038/srep03355; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Olenych S.G., 2007, CURR PROTOC CELL BIO, DOI [10.1002/0471143030.cb2105-36, DOI 10.1002/0471143030.CB2105-36]; Perez-Pinera P, 2013, NAT METHODS, V10, P973, DOI [10.1038/NMETH.2600, 10.1038/nmeth.2600]; Qiu P, 2004, BIOTECHNIQUES, V36, P702, DOI 10.2144/04364PF01; Sander JD, 2011, NAT BIOTECHNOL, V29, P697, DOI 10.1038/nbt.1934; Sanjana NE, 2012, NAT PROTOC, V7, P171, DOI 10.1038/nprot.2011.431; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Yang LH, 2013, NUCLEIC ACIDS RES, V41, P9049, DOI 10.1093/nar/gkt555	27	1	1	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2017	12	2							e0171698	10.1371/journal.pone.0171698	http://dx.doi.org/10.1371/journal.pone.0171698			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BI	28212417	gold, Green Published, Green Submitted			2022-12-27	WOS:000394424700011
J	Brown, MA; Howatson, G; Quin, E; Redding, E; Stevenson, EJ				Brown, Meghan A.; Howatson, Glyn; Quin, Edel; Redding, Emma; Stevenson, Emma J.			Energy intake and energy expenditure of pre-professional female contemporary dancers	PLOS ONE			English	Article							DIETARY DATA-COLLECTION; FREE-LIVING CONDITIONS; BALLET DANCERS; PHYSICAL-ACTIVITY; BODY-COMPOSITION; ACTIVITY MONITOR; SOCCER PLAYERS; RECOVERY; EXERCISE; SPORTS	Many athletes in aesthetic and weight dependent sports are at risk of energy imbalance. However little is known about the exercise and eating behaviours of highly trained dance populations. This investigation sought to determine the energy intake and energy expenditure of pre-professional female contemporary dancers. Twenty-five female contemporary dance students completed the study. Over a 7-day period, including five week days ( with scheduled dance training at a conservatoire) and two weekend days ( with no scheduled dance training at the conservatoire), energy intake ( self-reported weighed food diary and 24 h dietary recall) and expenditure ( tri-axial accelerometry) were recorded. Mean daily energy intake and expenditure were different over the 7-day period ( P = 0.014) equating to an energy deficit of -356 +/- 668 kcal.day(-1) ( or -1.5 +/- 2.8 MJ.day(-1)). Energy expenditure was not different when comparing week and weekend days ( P = 0.297). However daily energy intake ( P = 0.002), energy availability ( P = 0.003), and energy balance ( P = 0.004) were lower during the week compared to the weekend, where energy balance became positive. The percentage contribution of macronutrients to total energy intake also differed; with higher fat ( P = 0.022) and alcohol ( P = 0.020), and lower carbohydrate ( P = 0.001) and a trend for lower protein ( P = 0.051) at the weekend. Energy balance and appropriate macronutrient intake are essential for maintaining the demands of training, performance and recovery. Whilst aesthetics are important, female contemporary dancers may be at risk of the numerous health and performance impairments associated with negative energy balance, particularly during periods of scheduled training.	[Brown, Meghan A.; Howatson, Glyn] Northumbria Univ, Fac Hlth & Life Sci, Newcastle Upon Tyne NE1 8ST, Tyne & Wear, England; [Brown, Meghan A.] Univ Gloucestershire, Sch Sport & Exercise, Gloucester GL2 9HW, England; [Howatson, Glyn] North West Univ, Sch Biol Sci, Water Res Grp, Potchefstroom, South Africa; [Quin, Edel; Redding, Emma] Trinity Laban Conservatoire Mus & Dance, Fac Dance, London SE8 3DZ, England; [Stevenson, Emma J.] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England	Northumbria University; University of Gloucestershire; North West University - South Africa; Newcastle University - UK	Howatson, G (corresponding author), Northumbria Univ, Fac Hlth & Life Sci, Newcastle Upon Tyne NE1 8ST, Tyne & Wear, England.; Howatson, G (corresponding author), North West Univ, Sch Biol Sci, Water Res Grp, Potchefstroom, South Africa.	glyn.howatson@northumbria.ac.uk	Howatson, Glyn/AAE-9508-2021	Howatson, Glyn/0000-0001-8494-2043; Brown, Meghan/0000-0003-3260-977X				Ainsworth BE, 2011, MED SCI SPORT EXER, V43, P1575, DOI 10.1249/MSS.0b013e31821ece12; Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; Angle S, 2009, INT J BEHAV NUTR PHY, V6, DOI 10.1186/1479-5868-6-41; Ashley J, 2007, OBESITY ETIOLOGY ASS, P99; Barnes MJ, 2014, SPORTS MED, V44, P909, DOI 10.1007/s40279-014-0192-8; Barnes MJ, 2010, J SCI MED SPORT, V13, P189, DOI 10.1016/j.jsams.2008.12.627; Beck KL, 2015, INT J SPORT NUTR EXE, V25, P335, DOI 10.1123/ijsnem.2014-0089; Beck S, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00568; Beelen M, 2010, INT J SPORT NUTR EXE, V20, P515, DOI 10.1123/ijsnem.20.6.515; Bingham S. A., 1987, Nutrition Abstracts and Reviews. Series A-Human and Experimental, V57, P705; Briggs M, 2015, NUTRIENTS, V7, P5400; Briggs MA, 2015, NUTRIENTS, V7, P5948, DOI 10.3390/nu7075262; Brown MA, 2015, J SPORTS MED PHYS FI, DOI [10.1080/0264041031000140554, DOI 10.1080/0264041031000140554]; Burke LM, 2006, J SPORT SCI, V24, P675, DOI 10.1080/02640410500482602; Burke LM, 2003, J APPL PHYSIOL, V95, P983, DOI 10.1152/japplphysiol.00115.2003; Calabrese L H, 1983, Phys Sportsmed, V11, P86, DOI 10.1080/00913847.1983.11708458; Catellier DJ, 2005, MED SCI SPORT EXER, V37, pS555, DOI 10.1249/01.mss.0000185651.59486.4e; Cho Kang Ok, 2014, J Exerc Nutrition Biochem, V18, P169, DOI 10.5717/jenb.2014.18.2.169; CLAESSENS ALM, 1987, J SPORT MED PHYS FIT, V27, P310; DAHLSTROM M, 1990, CLIN PHYSIOL, V10, P11, DOI 10.1111/j.1475-097X.1990.tb00080.x; Davidsen L, 2007, INT J OBESITY, V31, P1777, DOI 10.1038/sj.ijo.0803699; Deakin V., 2000, CLIN SPORTS NUTR, P30; Doyle-Lucas Ashley F, 2010, J Dance Med Sci, V14, P146; DURNIN JVGA, 1974, BRIT J NUTR, V32, P77, DOI 10.1079/BJN19740060; HAMILTON LH, 1988, MED SCI SPORT EXER, V20, P560; Harris JA, 1918, P NATL ACAD SCI USA, V4, P370, DOI 10.1073/pnas.4.12.370; Hassapidou MN, 2001, J HUM NUTR DIET, V14, P391, DOI 10.1046/j.1365-277X.2001.00307.x; HERGENROEDER AC, 1993, MED SCI SPORT EXER, V25, P145, DOI 10.1249/00005768-199301000-00020; Hill RJ, 1999, EUR J CLIN NUTR, V53, P752, DOI 10.1038/sj.ejcn.1600836; Hirsch NM., 2003, J DANCE MED SCI, V7, P73; Hoch AZ, 2011, CLIN J SPORT MED, V21, P119, DOI 10.1097/JSM.0b013e3182042a9a; Jarrett H, 2015, J PHYS ACT HEALTH, V12, P382, DOI 10.1123/jpah.2013-0070; Karlsson J, 2000, INT J OBESITY, V24, P1715, DOI 10.1038/sj.ijo.0801442; Kaufman BA, 2002, J CLIN ENDOCR METAB, V87, P2777, DOI 10.1210/jc.87.6.2777; Kostrzewa-Tarnowska Aleksandra, 2003, Polish Journal of Food and Nutrition Sciences, V12, P71; Kozey S, 2010, J PHYS ACT HEALTH, V7, P508, DOI 10.1123/jpah.7.4.508; Laws H., 2005, FIT DANCE 2 REPORT 2; LICHTENBELT WDV, 1995, BRIT J NUTR, V74, P439, DOI 10.1079/BJN19950150; Loucks AB, 2004, J SPORT SCI, V22, P1, DOI 10.1080/0264041031000140518; Macfarlane DJ, 2006, J APPL PHYSIOL, V101, P1328, DOI 10.1152/japplphysiol.00336.2006; Magkos F, 2003, CURR OPIN CLIN NUTR, V6, P539, DOI 10.1097/00075197-200309000-00007; Mcminn D, 2013, INT J EXERC SCI, V6, P217; Ottevaere C, 2011, J SPORT SCI, V29, P103, DOI 10.1080/02640414.2010.521169; Pacy P, 1996, DANCE RES J SOC DANC, V14, P93; Parr EB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088384; Pasiakos Cao JJ, 2013, FASEB J OFFICIAL PUB, V27, P3837; Pasiakos Margolis LM, 2015, FASEB J OFFICIAL PUB, V29, P1136; Redding E., 2004, J DANCE MED SCI, V8, P69; Robbeson JG, 2015, INT J SPORT NUTR EXE, V25, P344, DOI 10.1123/ijsnem.2013-0161; Rumbold PLS, 2011, APPETITE, V57, P443, DOI 10.1016/j.appet.2011.06.013; Russell M, 2011, J STRENGTH COND RES, V25, P1816, DOI 10.1519/JSC.0b013e3181e7fbdd; SANDRI SC, 1993, INT J SPORT NUTR, V3, P334, DOI 10.1123/ijsn.3.3.334; Sasaki JE, 2011, J SCI MED SPORT, V14, P411, DOI 10.1016/j.jsams.2011.04.003; Silva MR, 2014, ENCY SYSTEMS CONTROL, P1; Sirard JR, 2000, MED SCI SPORT EXER, V32, P695, DOI 10.1097/00005768-200003000-00022; Siri W., 1961, TECHNIQUES MEASURING, P223; Sousa M, 2013, MED PROBL PERFORM AR, V28, P119; Stewart A, 2011, INT SOC ADV KINANTHR; Sundgot-Borgen J, 2011, J SPORT SCI, V29, pS101, DOI 10.1080/02640414.2011.565783; Tipton KD, 2004, J SPORT SCI, V22, P65, DOI 10.1080/0264041031000140554; Twitchett Emily, 2010, J Dance Med Sci, V14, P127; Warren MP, 2002, J CLIN ENDOCR METAB, V87, P3162, DOI 10.1210/jc.87.7.3162; Wyon MA, 2011, INT J SPORTS MED, V32, P851, DOI 10.1055/s-0031-1279718	63	24	24	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2017	12	2							e0171998	10.1371/journal.pone.0171998	http://dx.doi.org/10.1371/journal.pone.0171998			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BI	28212449	Green Published, Green Accepted, gold			2022-12-27	WOS:000394424700015
J	Dekens, MPS; Foulkes, NS; Tessmar-Raible, K				Dekens, Marcus P. S.; Foulkes, Nicholas S.; Tessmar-Raible, Kristin			Instrument design and protocol for the study of light controlled processes in aquatic organisms, and its application to examine the effect of infrared light on zebrafish	PLOS ONE			English	Article							LOCOMOTOR-ACTIVITY; DIEL VARIATIONS; CLOCK GENE; ENTRAINMENT; PHOTOPERIOD; EXPRESSION; THYROXINE; DIVERSITY; CORTISOL; RHYTHMS	The acquisition of reliable data strongly depends on experimental design. When studying the effects of light on processes such as behaviour and physiology it is crucial to maintain all environmental conditions constant apart from the one under study. Furthermore, the precise values of the environmental factors applied during the experiment should be known. Although seemingly obvious, these conditions are often not met when the effects of light are being studied. Here, we document and discuss the wavelengths and light intensities of natural and artificial light sources. We present standardised experimental protocols together with building plans of a custom made instrument designed to accurately control light and temperature for experiments using fresh water or marine species. Infrared light is commonly used for recording behaviour and in electrophysiological experiments although the properties of fish photoreceptors potentially allow detection into the far red. As an example of our experimental procedure we have applied our protocol and instrument to specifically test the impact of infrared light ( 840 nm) on the zebrafish circadian clock, which controls many aspects of behaviour, physiology and metabolism. We demonstrate that infrared light does not influence the zebrafish circadian clock. Our results help to provide a solid framework for the future study of light dependent processes in aquatic organisms.	[Dekens, Marcus P. S.; Tessmar-Raible, Kristin] Univ Vienna, Vienna Bioctr, Max Perutz Labs, Vienna, Austria; [Foulkes, Nicholas S.] Karlsruhe Inst Technol, Eggenstein, Germany; [Foulkes, Nicholas S.] Heidelberg Univ, Ctr Organismal Studies, Heidelberg, Germany; [Tessmar-Raible, Kristin] Univ Vienna, Res Platform Rhythms Life, Vienna, Austria	Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); Helmholtz Association; Karlsruhe Institute of Technology; Ruprecht Karls University Heidelberg; University of Vienna	Dekens, MPS; Tessmar-Raible, K (corresponding author), Univ Vienna, Vienna Bioctr, Max Perutz Labs, Vienna, Austria.; Foulkes, NS (corresponding author), Karlsruhe Inst Technol, Eggenstein, Germany.; Foulkes, NS (corresponding author), Heidelberg Univ, Ctr Organismal Studies, Heidelberg, Germany.; Tessmar-Raible, K (corresponding author), Univ Vienna, Res Platform Rhythms Life, Vienna, Austria.	marcus.dekens@gmail.com; nicholas.foulkes@kit.edu; kristin.tessmar@mfpl.ac.at	Tessmar-Raible, Kristin/F-9642-2011	Tessmar-Raible, Kristin/0000-0002-8038-1741; Dekens, Marcus P.S./0000-0003-1689-3491	Austrian Science Fund FWF [P 28970] Funding Source: Medline; European Research Council [337011] Funding Source: Medline	Austrian Science Fund FWF(Austrian Science Fund (FWF)); European Research Council(European Research Council (ERC)European Commission)		[Anonymous], 1908, BIOMETRIKA, V6, P1; Bridges CDB, 1972, HDB SENSORY PHYSIOLO, P417, DOI DOI 10.1007/978-3-642-65066-6_11; BROCKERHOFF SE, 1995, P NATL ACAD SCI USA, V92, P10545, DOI 10.1073/pnas.92.23.10545; Cahill GM, 1998, NEUROREPORT, V9, P3445, DOI 10.1097/00001756-199810260-00020; Carr AJF, 2005, NAT CELL BIOL, V7, P319, DOI 10.1038/ncb1232; Cavallari N, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001142; Cermakian N, 2002, CURR BIOL, V12, P844, DOI 10.1016/S0960-9822(02)00835-7; Cuesta IH, 2014, CHRONOBIOL INT, V31, P468, DOI 10.3109/07420528.2013.856316; Davies WIL, 2015, GENOME RES, V25, P1666, DOI 10.1101/gr.189886.115; Davies WL, 2010, PHOTOCH PHOTOBIO SCI, V9, P1444, DOI 10.1039/c0pp00203h; DAVIS RE, 1965, ANIM BEHAV, V13, P154, DOI 10.1016/0003-3472(65)90086-2; Dekens MPS, 2008, EMBO J, V27, P2757, DOI 10.1038/emboj.2008.183; Dekens MPS, 2003, CURR BIOL, V13, P2051, DOI 10.1016/j.cub.2003.10.022; Enright JM, 2015, CURR BIOL, V25, P3048, DOI 10.1016/j.cub.2015.10.018; Feillet CA, 2006, CURR BIOL, V16, P2016, DOI 10.1016/j.cub.2006.08.053; Fischer RM, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001585; Gavriouchkina D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012542; Kazimi N, 1999, DEV BRAIN RES, V117, P47, DOI 10.1016/S0165-3806(99)00096-6; Koyanagi M, 2014, BBA-BIOENERGETICS, V1837, P710, DOI 10.1016/j.bbabio.2013.09.003; Lahiri K, 2005, PLOS BIOL, V3, P2005, DOI 10.1371/journal.pbio.0030351; Livne ZB, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006445; Lopez-Olmeda JF, 2010, CHRONOBIOL INT, V27, P1380, DOI 10.3109/07420528.2010.501926; Lythgoe J.N., 1988, P57; Mracek P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067858; MULLINS MC, 1994, CURR BIOL, V4, P189, DOI 10.1016/S0960-9822(00)00048-8; NOESKE TA, 1983, J FISH BIOL, V23, P705, DOI 10.1111/j.1095-8649.1983.tb02947.x; Osborne NS, 1939, J RES NAT BUR STAND, V23, P197, DOI 10.6028/jres.023.008; Peirson SN, 2009, PHILOS T R SOC B, V364, P2849, DOI 10.1098/rstb.2009.0050; Perez-Escudero A, 2014, NAT METHODS, V11, P743, DOI [10.1038/NMETH.2994, 10.1038/nmeth.2994]; Rensing L, 2002, CHRONOBIOL INT, V19, P807, DOI 10.1081/CBI-120014569; SMITH RC, 1981, APPL OPTICS, V20, P177, DOI 10.1364/AO.20.000177; SPIELER RE, 1984, T AM FISH SOC, V113, P528, DOI 10.1577/1548-8659(1984)113&lt;528:EOPAFS&gt;2.0.CO;2; SPIELER RE, 1992, NATO ADV SCI INST SE, V236, P137; Storch KF, 2009, P NATL ACAD SCI USA, V106, P6808, DOI 10.1073/pnas.0902063106; Tamai TK, 2004, CURR BIOL, V14, pR104, DOI 10.1016/j.cub.2004.01.014; Tarttelin EE, 2012, J EXP BIOL, V215, P2898, DOI 10.1242/jeb.071084; Villamizar N, 2014, ZEBRAFISH, V11, P173, DOI 10.1089/zeb.2013.0926; WEBER DN, 1987, EXPERIENTIA, V43, P621, DOI 10.1007/BF02126355; Weger BD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017080; Westerfield M., 1995, ZEBRAFISH BOOK GUIDE; Whitmore D, 2000, NATURE, V404, P87, DOI 10.1038/35003589; Zantke J, 2013, CELL REP, V5, P99, DOI 10.1016/j.celrep.2013.08.031; Ziv L, 2006, P NATL ACAD SCI USA, V103, P4146, DOI 10.1073/pnas.0600571103	43	8	8	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2017	12	2							e0172038	10.1371/journal.pone.0172038	http://dx.doi.org/10.1371/journal.pone.0172038			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BI	28212399	Green Published, Green Submitted, gold			2022-12-27	WOS:000394424700017
J	Bai, B; Ban, B; Liu, ZJ; Zhang, MM; Tan, BK; Chen, J				Bai, Bo; Ban, Bo; Liu, Zunjing; Zhang, Man Man; Tan, Bee Kang; Chen, Jing			Circulating C1q complement/TNF-related protein (CTRP) 1, CTRP9, CTRP12 and CTRP13 concentrations in Type 2 diabetes mellitus: In vivo regulation by glucose	PLOS ONE			English	Article							ADIPOKINE ADIPOLIN/CTRP12; INSULIN SENSITIVITY; METFORMIN INCREASES; ADIPOSE-TISSUE; EX-VIVO; OBESITY; ASSOCIATION; ADIPONECTIN; CHOLESTEROL; WOMEN	Objectives The C1q complement/TNF-related protein (CTRP) superfamily, which includes the adipokine adiponectin, has been shown in animal models to have positive metabolic and cardiovascular effects. We sought to investigate circulating CTRP1, CTRP9, CTRP12 and CTRP13 concentrations in persons with type 2 diabetes mellitus (T2DM), with age and BMI matched controls, and to examine the effects of a 2 hour 75g oral glucose tolerance test (OGTT) on serum CTRP1, CTRP9, CTRP12 and CTRP13 levels in persons with T2DM. Design Cross-sectional study [newly diagnosed T2DM (n = 124) and control (n = 139) participants]. Serum CTRP1, CTRP9, CTRP12 and CTRP13 were measured by ELISA. Results Systolic and diastolic blood pressure, total cholesterol (TCH), Low-density lipoprotein (LDL)-cholesterol, triglycerides, TCH/High-density lipoprotein (HDL) ratio, triglycerides/HDL ratio, glucose, insulin, homeostatic model assessment-insulin resistance (HOMA-IR), C-reactive protein and endothelial lipase were significantly higher, whereas leptin and adiponectin were significantly lower in T2DM participants. Serum CTRP1 were significantly higher and CTRP12 significantly lower in T2DM participants. Age, diastolic blood pressure, glucose and CTRP12 were predictive of serum CTRP1; leptin was predictive of serum CTRP9; glucose and CTRP1 were predictive of serum CTRP12; endothelial lipase was predictive of serum CTRP13. Finally, serum CTRP1 were significantly higher and CTRP12 significantly lower in T2DM participants after a 2 hour 75g OGTT. Conclusions Our data supports CTRP1 and CTRP12 as potential novel biomarkers for the prediction and early diagnosis of T2DM. Furthermore, pharmacological agents that target CTRP1 and CTRP12 could represent a new strategy in the treatment of T2DM.	[Bai, Bo; Chen, Jing] Jining Med Univ, Inst Neurobiol, Jinin, Peoples R China; [Ban, Bo; Zhang, Man Man] Jining Med Univ, Dept Endocrine & Metab Dis, Jining Med Coll, Affiliated Hosp, Jining, Peoples R China; [Liu, Zunjing] China Japan Friendship Hosp, Dept Neurol, Beijing, Peoples R China; [Tan, Bee Kang; Chen, Jing] Univ Warwick, Warwick Med Sch, Coventry, W Midlands, England; [Tan, Bee Kang] Heart England NHS Fdn Trust, Dept Obstet & Gynaecol, Birmingham Heartlands & Solihull Hosp, Birmingham, W Midlands, England	Jining Medical University; Jining Medical University; China-Japan Friendship Hospital; University of Warwick; Heart of England NHS Foundation Trust	Chen, J (corresponding author), Jining Med Univ, Inst Neurobiol, Jinin, Peoples R China.; Tan, BK; Chen, J (corresponding author), Univ Warwick, Warwick Med Sch, Coventry, W Midlands, England.; Tan, BK (corresponding author), Heart England NHS Fdn Trust, Dept Obstet & Gynaecol, Birmingham Heartlands & Solihull Hosp, Birmingham, W Midlands, England.	B.K.Tan@warwick.ac.uk; Jing.Chen@warwick.ac.uk			National Nature Science Foundation of China [31271243, 81070961]; Natural Science Foundation of Shandong province [ZR2009CZ006, ZR2011CM027]; China-Japan Friendship Hospital Youth Science and Technology Excellence [2014-QNYC-A-04]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shandong province(Natural Science Foundation of Shandong Province); China-Japan Friendship Hospital Youth Science and Technology Excellence	This work was supported by grants from National Nature Science Foundation of China (31271243 and 81070961), http://www.nsfc.gov.cn/publish/portal1/BBai; the Natural Science Foundation of Shandong province (ZR2009CZ006 and ZR2011CM027), http://www.sdnsf.gov.cn/portal/BBan and the China-Japan Friendship Hospital Youth Science and Technology Excellence Project No. 2014-QNYC-A-04. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adya R, 2012, J VASC RES, V49, P534, DOI 10.1159/000338279; Ban B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112931; Borch-Johnsen K, 2001, EXP CLIN ENDOCR DIAB, V109, pS86, DOI 10.1055/s-2001-18572; Clement K, 1997, INT J OBESITY, V21, P556, DOI 10.1038/sj.ijo.0800440; da Luz PL, 2008, CLINICS, V63, P427, DOI 10.1590/S1807-59322008000400003; Enomoto T, 2011, J BIOL CHEM, V286, P34552, DOI 10.1074/jbc.M111.277319; Hallschmid M, 2009, DIABETES, V58, P637, DOI 10.2337/db08-1176; Han S, 2016, INT J ENDOCRINOL, V2016, DOI 10.1155/2016/5479627; Huang J, 2010, TRANSL RES, V156, P1, DOI 10.1016/j.trsl.2010.05.003; Hwang YC, 2014, INT J OBESITY, V38, P1207, DOI 10.1038/ijo.2013.242; Jeon JH, 2008, FASEB J, V22, P1502, DOI 10.1096/fj.07-9412com; Jung CH, 2014, J CLIN ENDOCR METAB, V99, pE2477, DOI 10.1210/jc.2014-2524; Lewington S, 2007, LANCET, V370, P1829, DOI 10.1016/S0140-6736(07)61778-4; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Ouchi N, 1999, CIRCULATION, V100, P2473, DOI 10.1161/01.CIR.100.25.2473; Pan XB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094478; Peterson JM, 2013, AM J PHYSIOL-REG I, V305, pR522, DOI 10.1152/ajpregu.00110.2013; Peterson JM, 2012, J BIOL CHEM, V287, P1576, DOI 10.1074/jbc.M111.278333; Rodriguez S, 2016, AM J PHYSIOL-ENDOC M, V311, pE678, DOI 10.1152/ajpendo.00087.2016; Shehzad A, 2012, HORM-INT J ENDOCRINO, V11, P8, DOI 10.1007/BF03401534; Tan BK, 2006, DIABETOLOGIA, V49, P2723, DOI 10.1007/s00125-006-0419-9; Tan BK, 2014, CLIN ENDOCRINOL, V81, P841, DOI 10.1111/cen.12438; Tan BK, 2014, J ENDOCRINOL, V221, P111, DOI 10.1530/JOE-13-0537; Tan BK, 2013, J CLIN ENDOCR METAB, V98, pE1891, DOI 10.1210/jc.2013-2227; Tan BK, 2013, J ENDOCRINOL, V219, P101, DOI 10.1530/JOE-13-0277; Tan BK, 2011, DIABETES, V60, P2758, DOI 10.2337/db11-0672; Tan BK, 2009, DIABETES CARE, V32, P129, DOI 10.2337/dc08-1236; Wei ZK, 2014, AM J PHYSIOL-ENDOC M, V306, pE779, DOI 10.1152/ajpendo.00593.2013; Wei ZK, 2012, J BIOL CHEM, V287, P10301, DOI 10.1074/jbc.M111.303651; Wei ZK, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.201087; Wolf RM, 2016, J CLIN ENDOCR METAB, V101, P2211, DOI 10.1210/jc.2016-1027; Wong GW, 2009, FASEB J, V23, P241, DOI 10.1096/fj.08-114991; Xin YP, 2014, ENDOCR J, V61, P841, DOI 10.1507/endocrj.EJ14-0016	33	46	52	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0172271	10.1371/journal.pone.0172271	http://dx.doi.org/10.1371/journal.pone.0172271			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207876	Green Published, gold, Green Submitted			2022-12-27	WOS:000394424500111
J	Bradley, D; Conklin, E; Papastamatiou, YP; McCauley, DJ; Pollock, K; Kendall, BE; Gaines, SD; Caselle, JE				Bradley, Darcy; Conklin, Eric; Papastamatiou, Yannis P.; McCauley, Douglas J.; Pollock, Kydd; Kendall, Bruce E.; Gaines, Steven D.; Caselle, Jennifer E.			Growth and life history variability of the grey reef shark (Carcharhinus amblyrhynchos) across its range	PLOS ONE			English	Article							GULF-OF-MEXICO; REPRODUCTIVE-BIOLOGY; GALEOCERDO-CUVIER; LAMNA-NASUS; TIGER SHARK; BASE-LINES; POPULATION-STRUCTURE; AGE VALIDATION; SPHYRNA-TIBURO; BARRIER-REEF	For broadly distributed, often overexploited species such as elasmobranchs (sharks and rays), conservation management would benefit from understanding how life history traits change in response to local environmental and ecological factors. However, fishing obfuscates this objective by causing complex and often mixed effects on the life histories of target species. Disentangling the many drivers of life history variability requires knowledge of elasmobranch populations in the absence of fishing, which is rarely available. Here, we describe the growth, maximum size, sex ratios, size at maturity, and offer a direct estimate of survival of an unfished population of grey reef sharks (Carcharhinus amblyrhynchos) using data from an eight year tag-recapture study. We then synthesized published information on the life history of C. amblyrhynchos from across its geographic range, and for the first time, we attempted to disentangle the contribution of fishing from geographic variation in an elasmobranch species. For Palmyra's unfished C. amblyrhynchos population, the von Bertalanffy growth function (VBGF) growth coefficient k was 0.05 and asymptotic length L-infinity was 163.3 cm total length (TL). Maximum size was 175.5 cm TL from a female shark, length at maturity was estimated at 116.7-123.2 cm TL for male sharks, maximum lifespan estimated from VBGF parameters was 18.1 years for both sexes combined, and annual survival was 0.74 year(-1). Consistent with findings from studies on other elasmobranch species, we found significant intraspecific variability in reported life history traits of C. amblyrhynchos. However, contrary to what others have reported, we did not find consistent patterns in life history variability as a function of biogeography or fishing. Ultimately, the substantial, but not yet predictable variability in life history traits observed for C. amblyrhynchos across its geographic range suggests that regional management may be necessary to set sustainable harvest targets and to recover this and other shark species globally.	[Bradley, Darcy; Kendall, Bruce E.; Gaines, Steven D.] Univ Calif Santa Barbara, Bren Sch Environm Sci & Management, Santa Barbara, CA 93106 USA; [Conklin, Eric; Pollock, Kydd] Nature Conservancy, Honolulu, HI USA; [Papastamatiou, Yannis P.] Florida Int Univ, Dept Biol Sci, North Miami, FL USA; [McCauley, Douglas J.] Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA; [McCauley, Douglas J.; Caselle, Jennifer E.] Univ Calif Santa Barbara, Inst Marine Sci, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara; Nature Conservancy; State University System of Florida; Florida International University; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara	Bradley, D (corresponding author), Univ Calif Santa Barbara, Bren Sch Environm Sci & Management, Santa Barbara, CA 93106 USA.	darcybradley@ucsb.edu	Gaines, Steven/Y-3234-2019; Kendall, Bruce/C-1871-2008	Kendall, Bruce/0000-0003-1782-8106; Bradley, Darcy/0000-0003-2581-8768	Koaniani Foundation; Georgia Welles and Deke Welles; Marisla Foundation grant; NSF [DGE-114408]; Dr. Daniel Vapnek Fellowship (UCSB Bren School); AAUS Kathy Johnston English Scholarship	Koaniani Foundation; Georgia Welles and Deke Welles; Marisla Foundation grant; NSF(National Science Foundation (NSF)); Dr. Daniel Vapnek Fellowship (UCSB Bren School); AAUS Kathy Johnston English Scholarship	Funding was provided by the Koaniani Foundation (TNC), Georgia Welles and Deke Welles (TNC), and a Marisla Foundation grant (JEC). DB was supported by a NSF Graduate Research Fellowship (DGE-114408), a Dr. Daniel Vapnek Fellowship (UCSB Bren School), and an AAUS Kathy Johnston English Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike H., 1973, 2 INT S INF THEOR, P267, DOI DOI 10.1007/978-1-4612-1694-0_15; Almany GR, 2004, OECOLOGIA, V141, P105, DOI 10.1007/s00442-004-1617-0; Barnett A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036574; Baum JK, 2004, ECOL LETT, V7, P135, DOI 10.1111/j.1461-0248.2003.00564.x; Beverton R.J.H., 1959, CIBA FDN C AGEING, V5, P142, DOI DOI 10.1002/9780470715253.CH10; Bradley D, SCI REPORTS IN PRESS; Cailliet GM, 2015, J FISH BIOL, V87, P1271, DOI 10.1111/jfb.12829; Cailliet G. M., 1990, NOAA TECH REP NMFS, V90, P167; Cailliet GM, 2006, ENVIRON BIOL FISH, V77, P211, DOI 10.1007/s10641-006-9105-5; Campana SE, 2001, J FISH BIOL, V59, P197, DOI [10.1111/j.1095-8649.2001.tb00127.x, 10.1006/jfbi.2001.1668]; Campana SE, 2009, SHARKS OPEN OCEAN BI; Carlson JK, 2003, MAR FRESHWATER RES, V54, P227, DOI 10.1071/MF02153; Carlson JK, 1997, ENVIRON BIOL FISH, V50, P331, DOI 10.1023/A:1007342203214; Carlson JK, 2006, ENVIRON BIOL FISH, V77, P279, DOI 10.1007/s10641-006-9129-x; Cassoff RM, 2007, CAN J FISH AQUAT SCI, V64, P19, DOI 10.1139/F06-167; Chin A, 2013, J FISH BIOL, V82, P1192, DOI 10.1111/jfb.12057; CLARK EUGENIE, 1965, BULL MAR SCI, V15, P13; Compagno L. J. V., 1984, FAO Fisheries Synopsis, P251; Costello C, 2012, SCIENCE, V338, P517, DOI 10.1126/science.1223389; Davidson LNK, 2015, FISH FISH; DAWSON E. YALE, 1959, PACIFIC NAT, V1, P1; DeCrosta MA, 1984, P 2 S RES INV NW HAW, V2, P75; Driggers WB, 2004, ENVIRON BIOL FISH, V71, P171, DOI 10.1007/s10641-004-0105-z; Dulvy NK, 2014, ELIFE, V3, DOI 10.7554/eLife.00590; Dureuil M, 2015, J FISH BIOL, V87, P1389, DOI 10.1111/jfb.12830; Ebert D.A., 2013, FAO SPECIES CAT FISH, V7, P1; Economakis AE, 1998, ENVIRON BIOL FISH, V51, P129, DOI 10.1023/A:1007416813214; Ellis JR, 2008, ICES J MAR SCI, V65, P979, DOI 10.1093/icesjms/fsn080; Espinoza M, 2014, MAR BIOL; Eveson JP, 2007, CAN J FISH AQUAT SCI, V64, P602, DOI 10.1139/F07-036; FABENS AJ, 1965, GROWTH, V29, P265; Farrell ED, 2010, J FISH BIOL, V77, P1505, DOI 10.1111/j.1095-8649.2010.02771.x; Francis MP, 2007, MAR FRESHWATER RES, V58, P10, DOI 10.1071/MF06069; FRANCIS RICC, 1988, CAN J FISH AQUAT SCI, V45, P936, DOI 10.1139/f88-115; FRANCIS RICC, 1988, NEW ZEAL J MAR FRESH, V22, P43, DOI 10.1080/00288330.1988.9516276; Friedlander AM, 2002, MAR ECOL PROG SER, V230, P253, DOI 10.3354/meps230253; Frisk MG, 2001, CAN J FISH AQUAT SCI, V58, P969, DOI 10.1139/cjfas-58-5-969; Garrick JAF, 1982, NOAA TECH REP; GULLAND J. A., 1959, JOUR CONSEIL PERM INTERNATL EXPLOR MER, V25, P47; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Heupel MR, 2014, MAR ECOL PROG SER, V496, P47, DOI 10.3354/meps10529; Heupel MR, 2009, FISH RES, V95, P350, DOI 10.1016/j.fishres.2008.10.005; Heupel MR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009650; Hisano M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025028; HOENIG JM, 1983, FISH B-NOAA, V81, P898; Hoenig JM, 1990, ELASMOBRANCHS LIVING; Holmes BJ, 2015, J FISH BIOL, V87, P422, DOI 10.1111/jfb.12732; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; JAMES IR, 1991, BIOMETRICS, V47, P1519, DOI 10.2307/2532403; Jiao Y, 2005, FISH RES, V72, P173, DOI 10.1016/j.fishres.2004.11.003; KIMURA DK, 1993, FISH B-NOAA, V91, P271; Kneebone J, 2008, MAR BIOL, V154, P423, DOI 10.1007/s00227-008-0934-y; Knip DM, 2012, J FISH BIOL, V80, P767, DOI 10.1111/j.1095-8649.2012.03223.x; Kumoru L., 2003, 176 M STAND COMM TUN; Kuparinen A, 2007, TRENDS ECOL EVOL, V22, P652, DOI 10.1016/j.tree.2007.08.011; Lombardi-Carlson LA, 2003, MAR FRESHWATER RES, V54, P875, DOI 10.1071/MF03023; Lowe CG, 1996, ENVIRON BIOL FISH, V47, P203, DOI 10.1007/BF00005044; MALLER RA, 1988, AUST J MAR FRESH RES, V39, P459; McCauley DJ, 2012, ECOL APPL, V22, P385, DOI 10.1890/11-1059.1; McCook LJ, 2010, P NATL ACAD SCI USA, V107, P18278, DOI 10.1073/pnas.0909335107; McGarvey R, 1999, MAR FRESHWATER RES, V50, P333, DOI 10.1071/MF97172; MCKIBBEN JN, 1986, B MAR SCI, V38, P89; Meyer CG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084799; Mourier J, 2013, J FISH BIOL, V82, P979, DOI 10.1111/jfb.12039; Myers RA, 2003, NATURE, V423, P280, DOI 10.1038/nature01610; Nadon MO, 2012, CONSERV BIOL, V26, P493, DOI 10.1111/j.1523-1739.2012.01835.x; Natanson LJ, 2002, FISH B-NOAA, V100, P266; Neer JA, 2005, ENVIRON BIOL FISH, V73, P321, DOI 10.1007/s10641-005-2136-5; Nelson GA, 2014, **DATA OBJECT**; Papastamatiou YP, 2009, J FISH BIOL, V75, P647, DOI 10.1111/j.1095-8649.2009.02329.x; Pardo SA, 2013, METHODS ECOL EVOL, V4, P353, DOI 10.1111/2041-210x.12020; PAULY D, 1980, J CONSEIL, V39, P175; Plummer M, 2014, RJAGS BAYESIAN GRAPH; R Core Team, 2021, R LANGUAGE ENV STAT; Radtke RL, 1984, P 2 S RES INV NWHI, V2, P121; Richards SA, 2005, ECOLOGY, V86, P2805, DOI 10.1890/05-0074; Rizzari JR, 2014, MAR BIOL, V161, P2847, DOI 10.1007/s00227-014-2550-3; Robbins W.D, 2006, THESIS JAMES COOK U; Robbins WD, 2006, CURR BIOL, V16, P2314, DOI 10.1016/j.cub.2006.09.044; Robinson L, 2013, AFR J MAR SCI, V35, P9, DOI 10.2989/1814232X.2013.769906; Royle J. A., 2008, HIERARCHICAL MODELIN; SAINSBURY KJ, 1980, CAN J FISH AQUAT SCI, V37, P241, DOI 10.1139/f80-031; Sandin SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001548; Simpfendorfer CA, 2008, J FISH BIOL, V72, P711, DOI 10.1111/j.1095-8649.2007.01764.x; Simpfendorfer CA, 2000, FISH B-NOAA, V98, P811; Skomal GB, 2003, FISH B-NOAA, V101, P627; Skomal G, 2007, MAR TECHNOL SOC J, V41, P44, DOI 10.4031/002533207787441999; Smart JJ, 2015, AFR J MAR SCI, V37, P177, DOI 10.2989/1814232X.2015.1025428; Smart JJ, 2016, FISH FISHERIES; Smart JJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153116; Sminkey TR, 1995, COPEIA, P871; Smith SE, 1998, MAR FRESHWATER RES, V49, P663, DOI 10.1071/MF97135; Speed CW, 2011, MAR ECOL PROG SER, V429, P261, DOI 10.3354/meps09080; STEVENS JD, 1984, PROC R SOC SER B-BIO, V222, P79, DOI 10.1098/rspb.1984.0050; STEVENS JD, 1991, AUST J MAR FRESH RES, V42, P151; Stevens JD, 2000, ICES J MAR SCI, V57, P476, DOI 10.1006/jmsc.2000.0724; Stevenson C, 2007, CORAL REEFS, V26, P47, DOI 10.1007/s00338-006-0158-x; Tester A.L., 1969, COOPERATIVE SHARK RE; Vianna GMS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060331; von BERTALANFFY LUDWIG, 1938, HUMAN BIOL, V10, P181; Walker TI, 2007, MAR FRESHWATER RES, V58, P67, DOI 10.1071/MF06074; Walker TI, 1998, FISH RES, V39, P139, DOI 10.1016/S0165-7836(98)00180-5; Wass RC, 1971, THESIS; Wearmouth VJ, 2008, ADV MAR BIOL, V54, P107, DOI 10.1016/S0065-2881(08)00002-3; Wetherbee BM, 1997, MAR ECOL PROG SER, V151, P181, DOI 10.3354/meps151181; Wetherbee BM, 1996, ENVIRON BIOL FISH, V45, P299, DOI 10.1007/BF00003099; WOOD CC, 1979, J FISH RES BOARD CAN, V36, P647, DOI 10.1139/f79-094	107	27	28	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0172370	10.1371/journal.pone.0172370	http://dx.doi.org/10.1371/journal.pone.0172370			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207874	Green Submitted, Green Published, gold			2022-12-27	WOS:000394424500128
J	Guthrie, JL; Fisman, D; Gardy, JL				Guthrie, Jennifer L.; Fisman, David; Gardy, Jennifer L.			Self-rated health and reasons for nonvaccination against seasonal influenza in Canadian adults with asthma	PLOS ONE			English	Article							PNEUMOCOCCAL VACCINATION; ELDERLY OUTPATIENTS; MEDICAL-RECORDS; DISEASE; SURVEILLANCE; CHILDREN; FLU; US	Introduction While seasonal influenza vaccination is recommended for individuals with asthma, uptake in this population is low. We examined how self-rated health impacts reasons for not being immunized against influenza in Canadian adults with asthma, focusing on those who have never been immunized. Methods We pooled four cycles of the Canadian Community Health Survey (cycles 3.1(2005), 2007/ 08, 2009/10 and 2011/12), grouping individuals by whether their reasons for not having been vaccinated were perceptual or technical. We used a multivariable logistic regression model, adjusted for confounders, to quantify the relationship between self-rated health and their reported reasons for not vaccinating. Results Among the 9,836 respondents, 84.4% cited perceptual barriers as a reason for not being vaccinated. After adjusting for socio-demographic characteristics and province of residence, we determined that reporting perceptual barriers was associated with self-rated health status, with the adjusted odds ratios ranging from 1.42 (95% CI: 0.97, 2.09) to 2.64 (95% CI: 1.74, 3.99) for fair and excellent health versus poor health, respectively. Each increase in self-rated health category was associated with greater odds of citing a perceptual rather than technical barrier as a reason for non-vaccination. Discussion Self-reported health influences people's perception of the need for influenza vaccination. Viewing the results through the lens of the precaution adoption process model suggests that personalizing communication around both the risk of influenza and the effectiveness of the vaccine may improve uptake amongst adults with asthma.	[Guthrie, Jennifer L.; Gardy, Jennifer L.] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC, Canada; [Fisman, David] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada	University of British Columbia; University of Toronto	Guthrie, JL (corresponding author), Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC, Canada.	jennifer.guthrie@alumni.ubc.ca	Guthrie, Jennifer/ABE-2378-2021	Guthrie, Jennifer/0000-0001-8565-203X; Gardy, Jennifer/0000-0001-7255-7631				Centers for Disease Control and Prevention, 2015, FLU PEOPL ASTHM SEAS; Chen Y, 2007, VACCINE, V25, P7436, DOI 10.1016/j.vaccine.2007.08.003; Chi RC, 2006, J AM GERIATR SOC, V54, P217, DOI 10.1111/j.1532-5415.2005.00577.x; Dube E, 2014, AM J INFECT CONTROL, V42, pE55, DOI 10.1016/j.ajic.2014.01.006; Government of Canada PHA of C, 2015, PUBL FUND INFL VACC; Government of Canada SC, 2015, CAN COMM HLTH SURV A; Government of Canada SC, 2013, ACC REG MED DOCT; Government of Canada SC, 2015, ASTHM AG GROUP SEX N; HARLOW SD, 1989, AM J EPIDEMIOL, V129, P233, DOI 10.1093/oxfordjournals.aje.a115129; Kam K, 2013, PAED CHILD HEALT-CAN, V18, pE55, DOI 10.1093/pch/18.9.e55; LINET MS, 1989, J CLIN EPIDEMIOL, V42, P1207, DOI 10.1016/0895-4356(89)90119-4; Locksley RM, 2014, IMMUNOL CELL BIOL, V92, P389, DOI 10.1038/icb.2014.24; Lu PJ, 2009, AM J PREV MED, V37, P109, DOI 10.1016/j.amepre.2009.03.021; Mac Donald R, 1999, AM J PREV MED, V16, P173, DOI 10.1016/S0749-3797(98)00159-7; Manor O, 2001, INT J EPIDEMIOL, V30, P600, DOI 10.1093/ije/30.3.600; Mirabelli MC, 2014, J ASTHMA, V51, P956, DOI 10.3109/02770903.2014.930480; Nowak GJ, 2015, VACCINE, V33, P2741, DOI 10.1016/j.vaccine.2015.04.064; O'Halloran AC, 2016, AM J PREV MED, V50, pE15, DOI 10.1016/j.amepre.2015.06.008; Robinson C A, 1993, Qual Health Res, V3, P6, DOI 10.1177/104973239300300102; Santos-Sancho JM, 2013, INFECTION, V41, P465, DOI 10.1007/s15010-013-0414-2; Schanzer DL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080481; Schrag SJ, 2006, PEDIATR INFECT DIS J, V25, P395, DOI 10.1097/01.inf.0000214988.81379.71; Statistics Canada, TRENDS INFL VACC CAN; Thomas Steven, 2009, Health Rep, V20, P53; TOREN K, 1993, CHEST, V104, P600, DOI 10.1378/chest.104.2.600; Toren K, 2006, J CLIN EPIDEMIOL, V59, P90, DOI 10.1016/j.jclinepi.2005.03.019; Villacorta Reginald, 2015, Prev Med Rep, V2, P355, DOI 10.1016/j.pmedr.2015.04.017; Vozoris NT, 2009, RESP MED, V103, P50, DOI 10.1016/j.rmed.2008.08.004; Webster RG, 2014, TXB INFLUENZA; Weinstein N.D., 2008, HLTH BEHAV HLTH ED T, V4th; WEINSTEIN ND, 1988, HEALTH PSYCHOL, V7, P355, DOI 10.1037/0278-6133.7.4.355; Wu S, 2003, J HEALTH ECON, V22, P675, DOI 10.1016/S0167-6296(03)00042-0; Zimmerman RK, 2003, VACCINE, V21, P1486, DOI 10.1016/S0264-410X(02)00700-4	33	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0172117	10.1371/journal.pone.0172117	http://dx.doi.org/10.1371/journal.pone.0172117			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL2BG	28207823	gold, Green Published, Green Submitted			2022-12-27	WOS:000394424500087
J	Kicken, CH; Roest, M; Henskens, YMC; de Laat, B; Huskens, D				Kicken, Cecile H.; Roest, Mark; Henskens, Yvonne M. C.; de laat, Bas; Huskens, Dana			Application of an optimized flow cytometry-based quantification of Platelet Activation (PACT): Monitoring platelet activation in platelet concentrates	PLOS ONE			English	Article							LIGHT TRANSMISSION; STORAGE; TRANSFUSION; BLOOD; AGGREGATION; SURVIVAL	Background Previous studies have shown that flow cytometry is a reliable test to quantify platelet function in stored platelet concentrates (PC). It is thought that flow cytometry is laborious and hence expensive. We have optimized the flow cytometry-based quantification of agonist induced platelet activation (PACT) to a labor, time and more cost-efficient test. Currently the quality of PCs is only monitored by visual inspection, because available assays are unreliable or too laborious for use in a clinical transfusion laboratory. Therefore, the PACT was applied to monitor PC activation during storage. Study design and methods The optimized PACT was used to monitor 5 PCs during 10 days of storage. In brief, optimized PACT uses a ready-to-use reaction mix, which is stable at -20 degrees C. When needed, a test strip is thawed and platelet activation is initiated by mixing PC with PACT. PACT was based on the following agonists: adenosine diphosphate (ADP), collagen-related peptide (CRP) and thrombin receptor -activating peptide (TRAP-6). Platelet activation was measured as P-selectin expression. Light transmission aggregometry (LTA) was performed as a reference. Results Both PACT and LTA showed platelet function decline during 10-day storage after stimulation with ADP and collagen/CRP; furthermore, PACT showed decreasing TRAP-induced activation. Major differences between the two tests are that PACT is able to measure the status of platelets in the absence of agonists, and it can differentiate between the number of activated platelets and the amount of activation, whereas LTA only measures aggregation in response to an agonist. Also, PACT is more time-efficient compared to LTA and allows high-throughput analysis. Conclusion PACT is an optimized platelet function test that can be used to monitor the activation of PCs. PACT has the same accuracy as LTA with regard to monitoring PCs, but it is superior to both LTA and conventional flow cytometry based tests with regard to labor-, time- and cost efficiency.	[Kicken, Cecile H.] Maastricht Univ, Med Ctr, Dept Anesthesiol & Pain Therapy, Maastricht, Netherlands; [Kicken, Cecile H.; Roest, Mark; de laat, Bas; Huskens, Dana] Synapse Res Inst, Maastricht, Netherlands; [Roest, Mark; de laat, Bas; Huskens, Dana] Maastricht Univ, Dept Biochem, Cardiovasc Res Inst, Maastricht, Netherlands; [Henskens, Yvonne M. C.] Maastricht Univ, Med Ctr, Cent Diagnost Lab, Maastricht, Netherlands	Maastricht University; Maastricht University; Maastricht University	Kicken, CH (corresponding author), Maastricht Univ, Med Ctr, Dept Anesthesiol & Pain Therapy, Maastricht, Netherlands.; Kicken, CH (corresponding author), Synapse Res Inst, Maastricht, Netherlands.	c.kicken@thrombin.com	Henskens, Yvonne/AAD-8596-2020	Kicken, Cecile/0000-0002-8010-8091	Synapse Research Institute	Synapse Research Institute	The authors did not receive specific funding for this work, therefore it was funded with departmental funds from Synapse Research Institute.	Bertolini F, 1996, TRANSFUSION, V36, P128, DOI 10.1046/j.1537-2995.1996.36296181924.x; BORN GVR, 1963, J PHYSIOL-LONDON, V168, P178, DOI 10.1113/jphysiol.1963.sp007185; Cattaneo M, 2013, J THROMB HAEMOST; Dumont LJ, 2002, TRANSFUSION, V42, P847, DOI 10.1046/j.1537-2995.2002.00147.x; Femia EA, 2013, J THROMB HAEMOST, V11, P2193, DOI 10.1111/jth.12432; Holme PA, 1997, ARTERIOSCL THROM VAS, V17, P646, DOI 10.1161/01.ATV.17.4.646; Holme S, 1997, TRANSFUSION, V37, P12, DOI 10.1046/j.1537-2995.1997.37197176945.x; HOLME S, 1978, J LAB CLIN MED, V92, P53; Kaufman RM, 2015, ANN INTERN MED, V162, P205, DOI 10.7326/M14-1589; Kicken C, 2015, THROMB RES, V135, P679, DOI 10.1016/j.thromres.2015.01.004; Kozek-Langenecker SA, 2013, EUR J ANAESTH, V30, P270, DOI 10.1097/EJA.0b013e32835f4d5b; Lance MD, 2012, VOX SANG, V103, P79, DOI 10.1111/j.1423-0410.2011.01580.x; Michelson AD, 2006, PATHOPHYSIOL HAEMO T, V35, P67, DOI 10.1159/000093547; Middelburg RA, 2013, TRANSFUSION, V53, P1780, DOI 10.1111/trf.12001; Paniccia R, 2015, VASC HEALTH RISK MAN, V11, P133, DOI 10.2147/VHRM.S44469; Panzer S, 2011, VOX SANG, V101, P1, DOI 10.1111/j.1423-0410.2011.01467.x; Rinder HM, 2003, TRANSFUSION, V43, P2, DOI 10.1046/j.1537-2995.2003.00261.x; Roest M, 2013, TRANSFUS MED HEMOTH, V40, P117, DOI 10.1159/000350688; Sodergren AL, 2016, VOX SANG, V110, P116, DOI 10.1111/vox.12324; Tynngard N, 2015, PLATELETS, V26, P177, DOI 10.3109/09537104.2014.891728; van Bladel ER, 2014, BLOOD, V123, P1556, DOI 10.1182/blood-2013-08-519686	21	11	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0172265	10.1371/journal.pone.0172265	http://dx.doi.org/10.1371/journal.pone.0172265			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207883	Green Published, Green Submitted, gold			2022-12-27	WOS:000394424500110
J	Kim, SY; Kim, MS; Park, B; Kim, JH; Choi, HG				Kim, So Young; Kim, Min-Su; Park, Bumjung; Kim, Jin-Hwan; Choi, Hyo Geun			Allergic rhinitis, atopic dermatitis, and asthma are associated with differences in school performance among Korean adolescents	PLOS ONE			English	Article							QUALITY-OF-LIFE; LATER ACHIEVEMENT; CHILDREN; SLEEP; DEPRESSION; READINESS; BURDEN; HEALTH; IMPACT; REPLICATION	Several studies have reported negative relations between allergic diseases and school performance but have not simultaneously considered various allergic diseases, including allergic rhinitis, asthma, and atopic dermatitis, and only examined a limited number of participants. The present study investigated the associations of allergic rhinitis, asthma, and atopic dermatitis with school performance in a large, representative Korean adolescent population. A total of 299,695 7th through 12th grade students participated in the Korea Youth Risk Behaviour Web-based Survey (KYRBWS) from 2009 to 2013. The subjects' history of allergic rhinitis, asthma, and atopic dermatitis and number of school absences due to these diseases in the previous 12 months were examined and compared. School performance was classified into 5 levels. The relations between allergic disorders and school performance were analyzed using multiple logistic regressions with complex sampling and adjusted for the subjects' durations of sleep, days of physical activity, body mass indexes (BMIs), regions of residence, economic levels, parents' education levels, stress levels, smoking status, and alcohol use. A subgroup analysis of the economic groups was performed. Allergic rhinitis was positively correlated with better school performance in a dose-dependent manner (adjusted odds ratios, AOR, [95% confidence interval, CI] = 1.50 [1.43-1.56 > 1.33 [1.28-1.38] > 1.17 [1.13-1.22] > 1.09 [1.05-1.14] for grades A > B > C > D; P < 0.001). Asthma was negatively correlated with better school performance (AOR [95% CI] = 0.74 [0.66-0.83], 0.87 [0.79-0.96], 0.83 [0.75-0.91], 0.93 [0.85-1.02] for performance A, B, C, and D, respectively; P < 0.001). Atopic dermatitis was not significantly correlated with school performance. The subgroup analysis of the students' economic levels revealed associations between allergic diseases and school performance. Compared to other allergic disorders, the asthma group had more school absences due to their symptoms (P < 0.001). School performance was positively correlated with allergic rhinitis and negatively correlated with asthma in Korean adolescents, even after adjusting for other variables. The asthma group had an increased number of school absence days, which presumably contributes to these students' poor school performance.	[Kim, So Young] CHA Univ, CHA Bundang Med Ctr, Dept Otorhinolaryngol Head & Neck Surg, Seongnam, South Korea; [Kim, Min-Su] Korea Univ, Ansan Hosp, Dept Otorhinolaryngol Head & Neck Surg, Ansan, South Korea; [Park, Bumjung; Choi, Hyo Geun] Hallym Univ, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Anyang, South Korea; [Kim, Jin-Hwan] Hallym Univ, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Seoul, South Korea	Pochon Cha University; Korea University; Korea University Medicine (KU Medicine); Hallym University; Hallym University	Choi, HG (corresponding author), Hallym Univ, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Anyang, South Korea.	pupen@naver.com	Choi, Hyo Geun/K-4461-2019	Choi, Hyo Geun/0000-0003-1655-9549	National Research Foundation (NRF) of Korea [NRF-2015-R1D1A1A01060860]; Hallym University Sacred Heart Hospital [HURF-2016-38]	National Research Foundation (NRF) of Korea(National Research Foundation of Korea); Hallym University Sacred Heart Hospital	This work was supported in part by a research grant (NRF-2015-R1D1A1A01060860) from the National Research Foundation (NRF) of Korea and a Research Grant funded by Hallym University Sacred Heart Hospital (HURF-2016-38).	Adamia N, 2015, Georgian Med News, P38; Akinbami LJ, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-2354; [Anonymous], 2009, RELIABILITY VALIDITY; Bae Jisuk, 2010, J Prev Med Public Health, V43, P403, DOI 10.3961/jpmph.2010.43.5.403; Bae Jisuk, 2010, J Prev Med Public Health, V43, P396, DOI 10.3961/jpmph.2010.43.5.396; Bahreinian S, 2011, CHEST, V140, P1138, DOI 10.1378/chest.11-0219; Bousquet J, 2008, ALLERGY, V63, P8, DOI 10.1111/j.1398-9995.2007.01620.x; Brockmann PE, 2015, SLEEP MED, V16, P1077, DOI 10.1016/j.sleep.2015.03.021; Camfferman D, 2013, INT J PSYCHOPHYSIOL, V89, P265, DOI 10.1016/j.ijpsycho.2013.01.006; Centers for Disease Control and Prevention, BMI CHILDR TEENS 201; Chen H, 2008, VALUE HEALTH, V11, P231, DOI 10.1111/j.1524-4733.2007.00229.x; Cisternas MG, 2003, J ALLERGY CLIN IMMUN, V111, P1212, DOI 10.1067/mai.2003.1449; Dean BB, 2009, J ASTHMA, V46, P861, DOI 10.3109/02770900903184237; Ferro MA, 2016, J ASTHMA, V53, P282, DOI 10.3109/02770903.2015.1104694; Gelis N, 2007, Hippokratia, V11, P138; Gustafsson D, 2000, ALLERGY, V55, P240, DOI 10.1034/j.1398-9995.2000.00391.x; Hunter SJ, 2016, AM J RESP CRIT CARE, V194, P739, DOI 10.1164/rccm.201510-2099OC; Jauregui I, 2009, J INVEST ALLERG CLIN, V19, P32; Kim SY, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003096; Kohlboeck G, 2013, PEDIAT ALLERG IMM-UK, V24, P230, DOI 10.1111/pai.12056; Kronholm E, 2015, J SLEEP RES, V24, P3, DOI 10.1111/jsr.12258; Lee Mee-Ri, 2012, J Prev Med Public Health, V45, P374, DOI 10.3961/jpmph.2012.45.6.374; Long A, 2002, Evid Rep Technol Assess (Summ), P1; Mansfield LE, 2004, ANN ALLERG ASTHMA IM, V92, P240, DOI 10.1016/S1081-1206(10)61554-2; Meltzer EO, 2016, IMMUNOL ALLERGY CLIN, V36, P235, DOI 10.1016/j.iac.2015.12.002; Mir E, 2012, ASIA PAC ALLERGY, V2, P93, DOI 10.5415/apallergy.2012.2.2.93; Montoro J, 2009, J INVEST ALLERG CLIN, V19, P40; Mortz CG, 2015, ALLERGY, V70, P836, DOI 10.1111/all.12619; Myong JP, 2012, ASIAN NURS RES, V6, P102, DOI 10.1016/j.anr.2012.08.001; Nathan RA, 2007, ALLERGY ASTHMA PROC, V28, P3, DOI 10.2500/aap.2007.28.2934; Ozdoganoglu T, 2012, THER ADV RESPIR DIS, V6, P11, DOI 10.1177/1753465811431975; Pagani LS, 2014, HEALTH EDUC BEHAV, V41, P25, DOI 10.1177/1090198113478818; Pagani LS, 2010, DEV PSYCHOL, V46, P984, DOI 10.1037/a0018881; Romano E, 2010, DEV PSYCHOL, V46, P995, DOI 10.1037/a0018880; Sanchez Jorge, 2016, Rev Alerg Mex, V63, P32; Schoeppe S., 2014, J PEDIAT RIO J, V14, P91, DOI DOI 10.1016/JJPED.2014.05.002; Seok H, 2016, TOHOKU J EXP MED, V238, P25, DOI 10.1620/tjem.238.25; Sole Dirceu, 2006, J Pediatr (Rio J), V82, P341, DOI [10.1590/S0021-75572006000600006, 10.2223/JPED.1521]; Sundbom F, 2016, J ASTHMA, V53, P398, DOI 10.3109/02770903.2015.1126846; The Global Asthma Network, INT STUD ASTH ALL CH; Tokunaga T, 2015, AM J RHINOL ALLERGY, V29, P94, DOI 10.2500/ajra.2015.29.4135; Vamanshankar H, 2013, J LARYNGOL OTOL, V127, P378, DOI 10.1017/S0022215113000170; Zhang Y, 2014, ALLERGY ASTHMA IMMUN, V6, P105, DOI 10.4168/aair.2014.6.2.105	43	70	72	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0171394	10.1371/journal.pone.0171394	http://dx.doi.org/10.1371/journal.pone.0171394			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL2BG	28207843	gold, Green Submitted, Green Published			2022-12-27	WOS:000394424500027
J	Tian, H; Yuan, XL; Duan, JF; Li, WH; Zhai, BN; Gao, YJ				Tian, Hui; Yuan, Xiaolei; Duan, Jianfeng; Li, Wenhu; Zhai, Bingnian; Gao, Yajun			Influence of nutrient signals and carbon allocation on the expression of phosphate and nitrogen transporter genes in winter wheat ( Triticum aestivum L.) roots colonized by arbuscular mycorrhizal fungi	PLOS ONE			English	Article							MEDICAGO-TRUNCATULA ROOTS; GROWTH; MAIZE; NITRATE; HYPHAE; PCR	Arbuscular mycorrhizal (AM) colonization of plant roots causes the down-regulation of expression of phosphate (Pi) or nitrogen (N) transporter genes involved in direct nutrient uptake pathways. The mechanism of this effect remains unknown. In the present study, we sought to determine whether the expression of Pi or N transporter genes in roots of winter wheat colonized by AM fungus responded to (1) Pi or N nutrient signals transferred from the AM extra-radical hyphae, or (2) carbon allocation changes in the AM association. A threecompartment culture system, comprising a root compartment (RC), a root and AM hyphae compartment (RHC), and an AM hyphae compartment (HC), was used to test whether the expression of Pi or N transporter genes responded to nutrients (Pi, NH4+ and NO3-) added only to the HC. Different AM inoculation density treatments (roots were inoculated with 0, 20, 50 and 200 g AM inoculum) and light regime treatments (6 hours light and 18 hours light) were established to test the effects of carbon allocation on the expression of Pi or N transporter genes in wheat roots. The expression of two Pi transporter genes (TaPT4 and TaPHT1.2), five nitrate transporter genes (TaNRT1.1, TaNRT1.2, TaNRT2.1, TaNRT2.2, and TaNRT2.3), and an ammonium transporter gene (TaAMT1.2) was quantified using realtime polymerase chain reaction. The expression of TaPT4, TaNRT2.2, and TaAMT1.2 was down-regulated by AM colonization only when roots of host plants received Pi or N nutrient signals. However, the expression of TaPHT1.2, TaNRT2.1, and TaNRT2.3 was down-regulated by AM colonization, regardless of whether there was nutrient transfer from AM hyphae. The expression of TaNRT1.2 was also down-regulated by AM colonization even when there was no nutrient transfer from AM hyphae. The present study showed that an increase in carbon consumption by the AM fungi did not necessarily result in greater down-regulation of expression of Pi or N transporter genes.	[Tian, Hui; Yuan, Xiaolei; Duan, Jianfeng; Li, Wenhu; Zhai, Bingnian; Gao, Yajun] Northwest A&F Univ, Key Lab Plant Nutr & Agrienvironm Northwest China, Minist Agr, Coll Nat Resources & Environm, Yangling, Shaanxi, Peoples R China	Ministry of Agriculture & Rural Affairs; Northwest A&F University - China	Zhai, BN (corresponding author), Northwest A&F Univ, Key Lab Plant Nutr & Agrienvironm Northwest China, Minist Agr, Coll Nat Resources & Environm, Yangling, Shaanxi, Peoples R China.	zhaibingnian@nwsuaf.edu.cn			National Key Technology RD Program [2015BAD23B04]; Special Fund for Agro-scientific Research in the Public Interest [201503124]; Fundamental Research Funds for the Central Universities [2452015048]	National Key Technology RD Program(National Key Technology R&D Program); Special Fund for Agro-scientific Research in the Public Interest; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	The work was funded by the National Key Technology R&D Program (2015BAD23B04), Special Fund for Agro-scientific Research in the Public Interest (201503124) and the Fundamental Research Funds for the Central Universities (2452015048).	Avio L, 2006, NEW PHYTOL, V172, P347, DOI 10.1111/j.1469-8137.2006.01839.x; Bago B, 2000, PLANT PHYSIOL, V124, P949, DOI 10.1104/pp.124.3.949; Bao SJ, 2011, BOTANY, V89, P647, DOI [10.1139/B11-053, 10.1139/b11-053]; Bellefeuille SD, 2016, HARMFUL ALGAE, V55, P272, DOI 10.1016/j.hal.2016.03.021; Burleigh SH, 2002, PLANT SOIL, V244, P247, DOI 10.1023/A:1020227232140; Burleigh SH, 2001, PLANT SCI, V160, P899, DOI 10.1016/S0168-9452(00)00460-X; Calderon FJ, 2012, SOIL SCI SOC AM J, V76, P1614, DOI 10.2136/sssaj2011.0440; Daniels B. A., 1982, Methods and principles of mycorrhizal research., P29; Drissner D, 2007, SCIENCE, V318, P265, DOI 10.1126/science.1146487; Duan JF, 2015, PLANT PHYSIOL BIOCH, V96, P199, DOI 10.1016/j.plaphy.2015.08.006; Feddermann N, 2010, FUNGAL ECOL, V3, P1, DOI 10.1016/j.funeco.2009.07.003; Gobbato E, 2015, CURR OPIN PLANT BIOL, V26, P1, DOI 10.1016/j.pbi.2015.05.006; Grace EJ, 2009, NEW PHYTOL, V181, P938, DOI 10.1111/j.1469-8137.2008.02720.x; Harrison MJ, 2010, ARBUSCULAR MYCORRHIZAS: PHYSIOLOGY AND FUNCTION, P117, DOI 10.1007/978-90-481-9489-6_6; Hodge A, 2010, FUNGAL ECOL, V3, P267, DOI 10.1016/j.funeco.2010.02.002; Hohnjec N, 2005, PLANT PHYSIOL, V137, P1283, DOI 10.1104/pp.104.056572; Horneck DA, 1998, HANDBOOK OF REFERENCE METHODS FOR PLANT ANALYSIS, P75; JAKOBSEN I, 1992, NEW PHYTOL, V120, P371, DOI 10.1111/j.1469-8137.1992.tb01077.x; Javot H, 2007, PLANT CELL ENVIRON, V30, P310, DOI 10.1111/j.1365-3040.2006.01617.x; Konvalinkova T, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00782; [李宝珍 LI Bao-Zhen], 2009, [植物生理学通讯, Plant Physiology Communications], V45, P80; Li JR, 2012, PLANT BIOTECHNOL REP, V6, P183, DOI 10.1007/s11816-011-0213-0; [刘芳朋 Liu Fangpeng], 2012, [河北农业大学学报, Journal of Agricultural University of Hebei], V35, P1; Liu H, 1998, MOL PLANT MICROBE IN, V11, P14, DOI 10.1094/MPMI.1998.11.1.14; Liu JQ, 2005, PLANT J, V41, P257, DOI 10.1111/j.1365-313X.2004.02289.x; Martin AB, 2000, PLANT SCI, V154, P143, DOI 10.1016/S0168-9452(99)00251-4; MCGONIGLE TP, 1990, NEW PHYTOL, V116, P629, DOI 10.1111/j.1469-8137.1990.tb00548.x; Nagy R, 2006, PLANT BIOLOGY, V8, P186, DOI 10.1055/s-2005-873052; PHILLIPS JM, 1970, T BRIT MYCOL SOC, V55, P158, DOI 10.1016/S0007-1536(70)80110-3; Ruffel S, 2014, J EXP BOT, V65, P5509, DOI 10.1093/jxb/eru321; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schmitz AM, 2014, J INTEGR PLANT BIOL, V56, P250, DOI 10.1111/jipb.12155; Smith S.E., 2008, MYCORRHIZAL SYMBIOSI, V3rd ed; Smith SE, 2003, PLANT PHYSIOL, V133, P16, DOI 10.1104/pp.103.024380; Stonor RN, 2014, MYCORRHIZA, V24, P465, DOI 10.1007/s00572-014-0556-9; Tanaka Y, 2005, PLANT CELL ENVIRON, V28, P1247, DOI 10.1111/j.1365-3040.2005.01360.x; Tian H, 2013, MYCORRHIZA, V23, P507, DOI 10.1007/s00572-013-0491-1; Tisserant E, 2012, NEW PHYTOL, V193, P755, DOI 10.1111/j.1469-8137.2011.03948.x; van Aarle IM, 2002, MYCOL RES, V106, P1224, DOI 10.1017/S0953756202006470; [王萍 WANG Ping], 2006, [植物营养与肥料学报, Plant nutrition and fertitizer science], V12, P584; Wang YY, 2012, TRENDS PLANT SCI, V17, P458, DOI 10.1016/j.tplants.2012.04.006; Zhang L., 2011, THESIS	42	18	23	3	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0172154	10.1371/journal.pone.0172154	http://dx.doi.org/10.1371/journal.pone.0172154			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207830	Green Published, Green Submitted, gold			2022-12-27	WOS:000394424500090
J	Dewhurst, HM; Torres, MP				Dewhurst, Henry M.; Torres, Matthew P.			Systematic analysis of non-structural protein features for the prediction of PTM function potential by artificial neural networks	PLOS ONE			English	Article							REGULATORY ELEMENTS; STRUCTURAL-ANALYSIS; WEB SERVER; RESOURCE	Post-translational modifications (PTMs) provide an extensible framework for regulation of protein behavior beyond the diversity represented within the genome alone. While the rate of identification of PTMs has rapidly increased in recent years, our knowledge of PTM functionality encompasses less than 5% of this data. We previously developed SAPH-ire (Structural Analysis of PTM Hotspots) for the prioritization of eukaryotic PTMs based on function potential of discrete modified alignment positions (MAPs) in a set of 8 protein families. A proteome-wide expansion of the dataset to all families of PTM-bearing, eukaryotic proteins with a representational crystal structure and the application of artificial neural network (ANN) models demonstrated the broader applicability of this approach. Although structural features of proteins have been repeatedly demonstrated to be predictive of PTM functionality, the availability of adequately resolved 3D structures in the Protein Data Bank (PDB) limits the scope of these methods. In order to bridge this gap and capture the larger set of PTM-bearing proteins without an available, homologous structure, we explored all available MAP features as ANN inputs to identify predictive models that do not rely on 3D protein structural data. This systematic, algorithmic approach explores 8 available input features in exhaustive combinations (247 models; size 2-8). To control for potential bias in random sampling for holdback in training sets, we iterated each model across 100 randomized, sample training and testing sets D yielding 24,700 individual ANNs. The size of the analyzed dataset and iterative generation of ANNs represents the largest and most thorough investigation of predictive models for PTM functionality to date. Comparison of input layer combinations allows us to quantify ANN performance with a high degree of confidence and subsequently select a top-ranked, robust fit model which highlights 3,687 MAPs, including 10,933 PTMs with a high probability of biological impact but without a currently known functional role.	[Dewhurst, Henry M.; Torres, Matthew P.] Georgia Inst Technol, Sch Biol Sci, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology	Torres, MP (corresponding author), Georgia Inst Technol, Sch Biol Sci, Atlanta, GA 30332 USA.	mtorres35@gatech.edu		Torres, Matthew/0000-0001-7296-4536	Georgia Institute of Technology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R00GM094533, R01GM117400] Funding Source: NIH RePORTER	Georgia Institute of Technology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Support was provided by the Georgia Institute of Technology startup funding to MT [http://biosci.gatech.edu]. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Almeida JS, 2002, CURR OPIN BIOTECH, V13, P72, DOI 10.1016/S0958-1669(02)00288-4; Ba ANN, 2010, MOL BIOL EVOL, V27, P2027, DOI 10.1093/molbev/msq090; Bairoch A, 2005, NUCLEIC ACIDS RES, V33, pD154, DOI 10.1093/nar/gki070; Beltrao P, 2012, CELL, V150, P413, DOI 10.1016/j.cell.2012.05.036; Calaway R, 2015, DOPARALLEL; Craveur P., 2014, DATABASE, V2014, P1, DOI DOI 10.1093/DATA-BASE/BAU041; Dewhurst HM, 2015, MOL CELL PROTEOMICS, V14, P2285, DOI 10.1074/mcp.M115.051177; Dewhurst HM, 2015, MOL CELL PROTEOMICS; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Duan GY, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004049; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Fritsch S, 2016, NEURALNET; Hornbeck PV, 2015, NUCLEIC ACIDS RES, V43, pD512, DOI 10.1093/nar/gku1267; Huang KY, 2016, NUCLEIC ACIDS RES, V44, pD435, DOI 10.1093/nar/gkv1240; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Johnson JR, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004362; Landry CR, 2009, TRENDS GENET, V25, P193, DOI 10.1016/j.tig.2009.03.003; Lienhard GE, 2008, TRENDS BIOCHEM SCI, V33, P351, DOI 10.1016/j.tibs.2008.05.004; Liu B, 2015, NUCLEIC ACIDS RES, V43, pW65, DOI 10.1093/nar/gkv458; Lu CT, 2013, NUCLEIC ACIDS RES, V41, pD295, DOI 10.1093/nar/gks1229; Meistrell ML, 1989, P ANN S COMP APPL ME; Ooms J, 2016, RMYSQL; Pejaver V, 2014, PROTEIN SCI, V23, P1077, DOI 10.1002/pro.2494; Sing T, 2015, ROCR; Torres MP, 2016, MOL CELL PROTEOMICS, V15, P3513, DOI 10.1074/mcp.M116.062331; Trask A, 2015, PR MACH LEARN RES, V37, P2266; Vandermarliere E, 2013, PROTEOMICS, V13, P1028, DOI 10.1002/pmic.201200232; Xiao QY, 2016, SCI REP-UK, V6, DOI 10.1038/srep24735; Xin FX, 2012, BIOINFORMATICS, V28, P2905, DOI 10.1093/bioinformatics/bts541	29	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2017	12	2							e0172572	10.1371/journal.pone.0172572	http://dx.doi.org/10.1371/journal.pone.0172572			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5SK	28225828	Green Submitted, Green Published, gold			2022-12-27	WOS:000394680900056
J	Zhou, J; Yang, Y; Zhang, D; Zhou, L; Tao, L; Lu, LM				Zhou, Jian; Yang, Yue; Zhang, Duo; Zhou, Liang; Tao, Lei; Lu, Li-Ming			Genetic polymorphisms and plasma levels of BCL11A contribute to the development of laryngeal squamous cell carcinoma	PLOS ONE			English	Article							NEGATIVE BREAST-CANCER; EXPRESSION; SURVIVAL; RELAPSE; STEM	Objective We investigated the association between B-cell lymphoma/leukaemia 11A (BCL11A) rs11886868 and rs4671393 polymorphism, plasma BCL11A concentration, and the hazard of developing laryngeal squamous cell carcinoma (LSCC). Participants and method In this research, 330 LSCC patients, 310 healthy controls, and 155 vocal leukoplakia patients were genotyped for the BCL11A (rs11886868 C/T and rs4671393 A/G) genotypes by pyrosequencing; the BCL11A concentration was measured using ELISA. Results LSCC Patients had a notably higher occurrence of CT at rs11886868 (OR = 2.64, P = 0.025) than the control group; they also had higher GG at rs4671393 (OR = 2.53, P = 0.018). Advanced (III and IV) stage LSCC patients had a notably greater frequency of CT at rs11886868 than those with initial (I and II) stage LSCC (OR = 2.71, P = 0.044 vs. OR = 2.58, P = 0.051). Additionally, there was a 1.59 fold increase in susceptibility for initial stage LSCC related to the G allele (AG/GG) at rs4671393 (P = 0.005); while for patients of advanced stage LSCC the OR was 1.73 (P = 0.002). Moreover, the OR of lymph node metastasis patients at rs4671393 G alleles was 2.41 (P < 0.01); it was 1.38 (P = 0.035) in patients without lymph metastasis. Patients with high incidences of the rs4671393 variation genotype had high plasma BCL11A levels. Conclusions BCL11A rs11886868 and rs4671393 genotype variations and correspondingly high BCL11A plasma levels are related to LSCC, besides, differences in plasma levels and genotype distribution may be related to lymph node metastasis status and the stage of LSCC.	[Zhou, Jian; Yang, Yue; Zhang, Duo; Zhou, Liang; Tao, Lei] Fudan Univ, Dept Otolaryngol, Eye Ear Nose & Throat Hosp, Shanghai, Peoples R China; [Tao, Lei] Shanghai Key Clin Disciplines Otorhinolaryngol, Shanghai, Peoples R China; [Lu, Li-Ming] Shanghai Jiao Tong Univ, Sch Med, Shanghai Inst Immunol, Shanghai, Peoples R China	Fudan University; Chinese Academy of Sciences; Shanghai Jiao Tong University	Tao, L (corresponding author), Fudan Univ, Dept Otolaryngol, Eye Ear Nose & Throat Hosp, Shanghai, Peoples R China.; Tao, L (corresponding author), Shanghai Key Clin Disciplines Otorhinolaryngol, Shanghai, Peoples R China.; Lu, LM (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Inst Immunol, Shanghai, Peoples R China.	doctortaolei@163.com; lulunew2003@163.com			Shanghai Science and Technology Development Funds Training Program of the Excellent Young Talents of the Shanghai Municipal Health System [090A1401000, 100A1405900, XYQ2011055, XYQ2011015]; Shanghai Municipal Science and Technology Foundation [11JC1410802, 14411961900]; National Natural Science Foundation of China [81671579, 31370904, 30972691]; Shanghai Pujiang Program [15PJD021]; Program for scientific and technological innovation from the Science and Technology Commission of Shanghai Municipality [15401900500]; Shuguang Planning of Shanghai Municipal Education Commission [16SG14]	Shanghai Science and Technology Development Funds Training Program of the Excellent Young Talents of the Shanghai Municipal Health System; Shanghai Municipal Science and Technology Foundation; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Pujiang Program(Shanghai Pujiang Program); Program for scientific and technological innovation from the Science and Technology Commission of Shanghai Municipality; Shuguang Planning of Shanghai Municipal Education Commission	Funded by Shanghai Science and Technology Development Funds 090A1401000, 100A1405900 Training Program of the Excellent Young Talents of the Shanghai Municipal Health System XYQ2011055, XYQ2011015, Shanghai Municipal Science and Technology Foundation 11JC1410802, 14411961900, National Natural Science Foundation of China 81671579, 31370904, 30972691, Shanghai Pujiang Program 15PJD021 Program for scientific and technological innovation from the Science and Technology Commission of Shanghai Municipality 15401900500, and Shuguang Planning of Shanghai Municipal Education Commission 16SG14.	Alhamarneh O, 2011, HEAD NECK-J SCI SPEC, V33, P415, DOI 10.1002/hed.21464; Chen ZY, 2009, BLOOD CELL MOL DIS, V42, P144, DOI 10.1016/j.bcmd.2008.12.003; Desmedt C, 2007, CLIN CANCER RES, V13, P3207, DOI 10.1158/1078-0432.CCR-06-2765; Hatzis C, 2011, JAMA-J AM MED ASSOC, V305, P1873, DOI 10.1001/jama.2011.593; Insinga A, 2013, P NATL ACAD SCI USA, V110, P3931, DOI 10.1073/pnas.1213394110; Jiang BY, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-61; Khaled WT, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6987; Kuo TY, 2007, J NEUROSCI RES, V85, P1628, DOI 10.1002/jnr.21300; Ma XJ, 2004, CANCER CELL, V5, P607, DOI 10.1016/j.ccr.2004.05.015; Marioni G, 2006, CANCER TREAT REV, V32, P504, DOI 10.1016/j.ctrv.2006.07.002; Moyer Jeffrey S, 2004, Curr Opin Otolaryngol Head Neck Surg, V12, P82, DOI 10.1097/00020840-200404000-00005; Nakamura T, 2000, MOL CELL BIOL, V20, P3178, DOI 10.1128/MCB.20.9.3178-3186.2000; Ng SYM, 2009, IMMUNITY, V30, P493, DOI 10.1016/j.immuni.2009.01.014; Osei-Sarfo K, 2013, CARCINOGENESIS, V34, P2673, DOI 10.1093/carcin/bgt223; Sankaran VG, 2008, SCIENCE, V322, P1839, DOI 10.1126/science.1165409; Satterwhite E, 2001, BLOOD, V98, P3413, DOI 10.1182/blood.V98.12.3413; Schmidt M, 2008, CANCER RES, V68, P5405, DOI 10.1158/0008-5472.CAN-07-5206; Weniger MA, 2006, LEUKEMIA, V20, P1880, DOI 10.1038/sj.leu.2404324; Zhang N, 2015, J THORAC DIS, V7, P1630, DOI 10.3978/j.issn.2072-1439.2015.09.39	19	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2017	12	2							e0171116	10.1371/journal.pone.0171116	http://dx.doi.org/10.1371/journal.pone.0171116			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5SK	28225775	Green Submitted, Green Published, gold			2022-12-27	WOS:000394680900008
J	Huang, DZ; Wu, ZH				Huang, Daizheng; Wu, Zhihui			Forecasting outpatient visits using empirical mode decomposition coupled with back-propagation artificial neural networks optimized by particle swarm optimization	PLOS ONE			English	Article							PREDICTION; PSO; SPECTRUM; POWER	Accurately predicting the trend of outpatient visits by mathematical modeling can help policy makers manage hospitals effectively, reasonably organize schedules for human resources and finances, and appropriately distribute hospital material resources. In this study, a hybrid method based on empirical mode decomposition and back-propagation artificial neural networks optimized by particle swarm optimization is developed to forecast outpatient visits on the basis of monthly numbers. The data outpatient visits are retrieved from January 2005 to December 2013 and first obtained as the original time series. Second, the original time series is decomposed into a finite and often small number of intrinsic mode functions by the empirical mode decomposition technique. Third, a three-layer back-propagation artificial neural network is constructed to forecast each intrinsic mode functions. To improve network performance and avoid falling into a local minimum, particle swarm optimization is employed to optimize the weights and thresholds of back-propagation artificial neural networks. Finally, the super-position of forecasting results of the intrinsic mode functions is regarded as the ultimate forecasting value. Simulation indicates that the proposed method attains a better performance index than the other four methods.	[Huang, Daizheng; Wu, Zhihui] Guangxi Med Univ, Sch Preclin Med, Dept Biomed Engn, Nanning, Guangxi Provinc, Peoples R China	Guangxi Medical University	Huang, DZ (corresponding author), Guangxi Med Univ, Sch Preclin Med, Dept Biomed Engn, Nanning, Guangxi Provinc, Peoples R China.	daizheng-huang@qq.com			Basic Ability Promotion for Young Teachers of the Guangxi Education Department [KY2016YB093]	Basic Ability Promotion for Young Teachers of the Guangxi Education Department	This work was supported by the project of Basic Ability Promotion for Young Teachers of the Guangxi Education Department (KY2016YB093).	Abadan S., 2014, APPL MATH SCI, V8, P3133, DOI 10.12988/ams.2014.43189; Alavi AH, 2011, COMPUT STRUCT, V89, P2176, DOI 10.1016/j.compstruc.2011.08.019; Cheng CH, 2008, EXPERT SYST APPL, V34, P2568, DOI 10.1016/j.eswa.2007.04.007; Eberhart R., 1995, P 6 INT S MICR MACH, P39; Montain ME, 2015, COMPUT CHEM ENG, V82, P13, DOI 10.1016/j.compchemeng.2015.05.026; Fakhar MS, 2015, INT J ELEC POWER, V73, P983, DOI 10.1016/j.ijepes.2015.06.030; Fu K, 2014, BIOMED SIGNAL PROCES, V13, P15, DOI 10.1016/j.bspc.2014.03.007; Gan RJ, 2016, PEERJ, V4, DOI 10.7717/peerj.2684; Gan RJ, 2015, COMPUT MATH METHOD M, V2015, DOI 10.1155/2015/328273; Gevrey M, 2003, ECOL MODEL, V160, P249, DOI 10.1016/S0304-3800(02)00257-0; Grossi E, 2007, EUR J GASTROEN HEPAT, V19, P1046, DOI 10.1097/MEG.0b013e3282f198a0; Hadavandi E, 2011, EXPERT SYST APPL, V38, P9392, DOI 10.1016/j.eswa.2011.01.132; Hoel T., 2018, DATA SCI HELPS NORWA; Huang DZ, 2015, J ELECTR ENG TECHNOL, V10, P41, DOI 10.5370/JEET.2015.10.1.041; Huang NE, 1998, P ROY SOC A-MATH PHY, V454, P903, DOI 10.1098/rspa.1998.0193; Illias HA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129363; Jiang SY, 2008, J MATER PROCESS TECH, V196, P190, DOI 10.1016/j.jmatprotec.2007.05.034; KARUNANITHI N, 1994, J COMPUT CIVIL ENG, V8, P201, DOI 10.1061/(ASCE)0887-3801(1994)8:2(201); Kisi O, 2014, WATER RESOUR MANAG, V28, P4045, DOI 10.1007/s11269-014-0726-8; Leo M, 2014, OPT ENG, V53, DOI 10.1117/1.OE.53.11.112314; Momeni E, 2015, MEASUREMENT, V60, P50, DOI 10.1016/j.measurement.2014.09.075; Neshat N, 2015, J CLEAN PROD, V105, P206, DOI 10.1016/j.jclepro.2014.10.083; Pi EX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082413; Ratnaweera A, 2004, IEEE T EVOLUT COMPUT, V8, P240, DOI [10.1109/TEVC.2004.826071, 10.1109/tevc.2004.826071]; Ren P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132116; Sadati N, 2009, APPL SOFT COMPUT, V9, P652, DOI 10.1016/j.asoc.2008.09.005; Samanta B, 2004, MECH SYST SIGNAL PR, V18, P625, DOI 10.1016/S0888-3270(03)00020-7; Shakya P, 2014, J SOUND VIB, V333, P5614, DOI 10.1016/j.jsv.2014.04.058; Shi YH, 1998, IEEE C EVOL COMPUTAT, P69, DOI 10.1109/ICEC.1998.699146; Sudheer C, 2014, NEURAL COMPUT APPL, V24, P1381, DOI 10.1007/s00521-013-1341-y; Teodoro D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061180; Tsai YL, 2015, APPL OPTICS, V54, pE41, DOI 10.1364/AO.54.000E41; Wang SX, 2016, RENEW ENERG, V94, P629, DOI 10.1016/j.renene.2016.03.103; Wang WC, 2013, J HYDROINFORM, V15, P1377, DOI 10.2166/hydro.2013.134; Wang YN, 2015, IEEE T POWER ELECTR, V30, P7038, DOI 10.1109/TPEL.2014.2383443; Wang YM, 2015, KNOWL-BASED SYST, V88, P12, DOI 10.1016/j.knosys.2015.08.013; Warner B, 1996, AM STAT, V50, P284, DOI 10.2307/2684922; Yu JB, 2008, NEUROCOMPUTING, V71, P1054, DOI 10.1016/j.neucom.2007.10.013; Yu Y, 2015, J INTEL MAT SYST STR, V26, P1789, DOI 10.1177/1045389X15577649; Zabalza JM, 2014, IEEE GEOSCI REMOTE S, V11, P1886, DOI 10.1109/LGRS.2014.2312754; Zhang GQ, 1998, INT J FORECASTING, V14, P35, DOI 10.1016/S0169-2070(97)00044-7; Zhang PP, 2015, BIOCHEM ENG J, V103, P138, DOI 10.1016/j.bej.2015.07.004; Zhang XY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063116	43	12	13	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2017	12	2							e0172539	10.1371/journal.pone.0172539	http://dx.doi.org/10.1371/journal.pone.0172539			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5QV	28222194	Green Published, gold, Green Submitted			2022-12-27	WOS:000394676800065
J	Shimomoto, T; Collins, LB; Yi, XW; Holley, DW; Zhang, ZF; Tian, X; Uchida, K; Wang, CG; Horkko, S; Willis, MS; Gold, A; Bultman, SJ; Nakamura, J				Shimomoto, Takasumi; Collins, Leonard B.; Yi, Xianwen; Holley, Darcy W.; Zhang, Zhenfa; Tian, Xu; Uchida, Koji; Wang, Chunguang; Horkko, Sohvi; Willis, Monte S.; Gold, Avram; Bultman, Scott J.; Nakamura, Jun			A purified MAA-based ELISA is a useful tool for determining anti-MAA antibody titer with high sensitivity	PLOS ONE			English	Article							MALONDIALDEHYDE-ACETALDEHYDE ADDUCTS; LOW-DENSITY LIPOPROTEINS; PROTEIN ADDUCTS; LIPID-PEROXIDATION; APOPTOTIC CELLS; OXIDIZED LDL; LIVER; MICE; ATHEROSCLEROSIS; IMMUNIZATION	Atherosclerosis is widely accepted to be a chronic inflammatory disease, and the immunological response to the accumulation of LDL is believed to play a critical role in the development of this disease. 1,4-Dihydropyridine-type MAA-adducted LDL has been implicated in atherosclerosis. Here, we have demonstrated that pure MAA-modified residues can be chemically conjugated to large proteins without by-product contamination. Using this pure antigen, we established a purified MAA-ELISA, with which a marked increase in anti-MAA antibody titer was determined at a very early stage of atherosclerosis in 3-month ApoE (-/-)mice fed with a normal diet. Our methods of N-epsilon-MAA-L-lysine purification and purified antigen- based ELISA will be easily applicable for biomarker-based detection of early stage atherosclerosis in patients, as well as for the development of an adduct-specific Liquid Chromatography/ Mass Spectrometry-based quantification of physiological and pathological levels of MAA.	[Shimomoto, Takasumi; Collins, Leonard B.; Zhang, Zhenfa; Tian, Xu; Gold, Avram; Nakamura, Jun] Univ N Carolina, Dept Environm Sci & Engn, Chapel Hill, NC 27514 USA; [Yi, Xianwen] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC USA; [Holley, Darcy W.; Bultman, Scott J.] Univ N Carolina, Dept Genet, Chapel Hill, NC USA; [Uchida, Koji] Nagoya Univ, Sch Bioagr Sci, Nagoya, Aichi, Japan; [Wang, Chunguang; Horkko, Sohvi] Univ Oulu, Res Unit Biomed, Med Microbiol & Immunol, Fac Med, Oulu, Finland; [Wang, Chunguang; Horkko, Sohvi] Univ Hosp, Med Res Ctr, Oulu, Finland; [Wang, Chunguang; Horkko, Sohvi] Univ Hosp, Nordlab Oulu, Oulu, Finland; [Wang, Chunguang; Horkko, Sohvi] Univ Oulu, Oulu, Finland; [Willis, Monte S.] Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC USA; [Willis, Monte S.] Univ N Carolina, McAllister Heart Inst, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Nagoya University; University of Oulu; University of Oulu; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Nakamura, J (corresponding author), Univ N Carolina, Dept Environm Sci & Engn, Chapel Hill, NC 27514 USA.	junnakamura77777@gmail.com	Willis, Monte S/J-9994-2015; Wang, Chunguang/AAE-7054-2020; Wang, Chunguang/AAE-6997-2020	Willis, Monte S/0000-0002-0769-5816; Wang, Chunguang/0000-0001-5569-321X; , Xianwen/0000-0001-9320-2020; Uchida, Koji/0000-0003-3894-5299; Nakamura, Jun/0000-0002-1756-7199; Collins, Leonard/0000-0002-7734-9708	NIH [P42-ES05948, P30-ES10126]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES005948, P30ES010126] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by NIH grants P42-ES05948 and P30-ES10126. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DEJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115163; Antoniak DT, 2015, FREE RADICAL BIO MED, V89, P409, DOI 10.1016/j.freeradbiomed.2015.09.003; Domingues RM, 2013, J PROTEOMICS, V92, P110, DOI 10.1016/j.jprot.2013.06.004; DONOHUE TM, 1983, ARCH BIOCHEM BIOPHYS, V220, P239, DOI 10.1016/0003-9861(83)90406-X; Duryee MJ, 2004, ALCOHOL CLIN EXP RES, V28, P1931, DOI 10.1097/01.ALC.0000148115.90045.C5; Gonen A, 2014, J LIPID RES, V55, P2137, DOI 10.1194/jlr.M053256; HABERLAND ME, 1982, P NATL ACAD SCI-BIOL, V79, P1712, DOI 10.1073/pnas.79.6.1712; Hill GE, 1998, ATHEROSCLEROSIS, V141, P107, DOI 10.1016/S0021-9150(98)00153-1; Holvoet P, 1998, ATHEROSCLEROSIS, V137, pS33, DOI 10.1016/S0021-9150(97)00305-5; Ishii T, 2006, CHEM RES TOXICOL, V19, P122, DOI 10.1021/tx050231p; Kato R, 2009, ARTERIOSCL THROM VAS, V29, P33, DOI 10.1161/ATVBAHA.108.164723; Kearley ML, 1999, CHEM RES TOXICOL, V12, P100, DOI 10.1021/tx980132u; Kharbanda KK, 2002, BIOCHEM PHARMACOL, V63, P553, DOI 10.1016/S0006-2952(01)00883-8; KIKUGAWA K, 1988, ANAL BIOCHEM, V174, P512, DOI 10.1016/0003-2697(88)90051-6; KIKUGAWA K, 1984, ARCH BIOCHEM BIOPHYS, V229, P7, DOI 10.1016/0003-9861(84)90124-3; McCaskill ML, 2011, ALCOHOL CLIN EXP RES, V35, P1106, DOI 10.1111/j.1530-0277.2011.01443.x; OHYA T, 1993, BIOL PHARM BULL, V16, P137; PALINSKI W, 1994, ARTERIOSCLER THROMB, V14, P605, DOI 10.1161/01.ATV.14.4.605; PALINSKI W, 1995, P NATL ACAD SCI USA, V92, P821, DOI 10.1073/pnas.92.3.821; Robertson AKL, 2004, SCAND J IMMUNOL, V59, P285, DOI 10.1111/j.0300-9475.2004.01403.x; Rolla R, 2000, HEPATOLOGY, V31, P878, DOI 10.1053/he.2000.5373; Silva GP, 2013, BRAZ J MED BIOL RES, V46, P148, DOI 10.1590/1414-431X20122556; Slatter DA, 1998, FEBS LETT, V421, P180, DOI 10.1016/S0014-5793(97)01554-8; Thiele GM, 2005, BIOCHEM PHARMACOL, V70, P1593, DOI 10.1016/j.bcp.2005.08.014; Thiele GM, 1998, ALCOHOL CLIN EXP RES, V22, P1731, DOI 10.1111/j.1530-0277.1998.tb03973.x; Tsimikas S, 2011, J AM COLL CARDIOL, V58, P1715, DOI 10.1016/j.jacc.2011.07.017; Tuma DJ, 1996, HEPATOLOGY, V23, P872, DOI 10.1002/hep.510230431; Uchida K, 1997, ARCH BIOCHEM BIOPHYS, V346, P45, DOI 10.1006/abbi.1997.0266; Uchida K, 2006, FREE RADICAL RES, V40, P1335, DOI 10.1080/10715760600902302; Veneskoski M, 2011, FREE RADICAL BIO MED, V51, P834, DOI 10.1016/j.freeradbiomed.2011.05.029; Wang CG, 2013, INT IMMUNOL, V25, P575, DOI 10.1093/intimm/dxt022; Willis MS, 2002, INT IMMUNOPHARMACOL, V2, P519, DOI 10.1016/S1567-5769(01)00195-3; XIANG ZQ, 1995, VIROLOGY, V209, P569, DOI 10.1006/viro.1995.1289; Xu DS, 1997, CHEM RES TOXICOL, V10, P978, DOI 10.1021/tx970069t; Yamada S, 2001, J LIPID RES, V42, P1187	35	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2017	12	2							e72172	10.1371/journal.pone.0172172	http://dx.doi.org/10.1371/journal.pone.0172172			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5QV	28222187	Green Submitted, Green Published, gold			2022-12-27	WOS:000394676800038
J	Estrada, F; Tol, RSJ; Botzen, WJW				Estrada, Francisco; Tol, Richard S. J.; Botzen, Wouter J. W.			Global economic impacts of climate variability and change during the 20th century	PLOS ONE			English	Article							DAMAGE COSTS; UNCERTAINTY; ADAPTATION; TEMPERATURES; OSCILLATION; WEATHER; MODELS; CMIP5	Estimates of the global economic impacts of observed climate change during the 20th century obtained by applying five impact functions of different integrated assessment models ( IAMs) are separated into their main natural and anthropogenic components. The estimates of the costs that can be attributed to natural variability factors and to the anthropogenic intervention with the climate system in general tend to show that: 1) during the first half of the century, the amplitude of the impacts associated with natural variability is considerably larger than that produced by anthropogenic factors and the effects of natural variability fluctuated between being negative and positive. These non-monotonic impacts are mostly determined by the low-frequency variability and the persistence of the climate system; 2) IAMs do not agree on the sign ( nor on the magnitude) of the impacts of anthropogenic forcing but indicate that they steadily grew over the first part of the century, rapidly accelerated since the mid 1970's, and decelerated during the first decade of the 21st century. This deceleration is accentuated by the existence of interaction effects between natural variability and natural and anthropogenic forcing. The economic impacts of anthropogenic forcing range in the tenths of percentage of the world GDP by the end of the 20th century; 3) the impacts of natural forcing are about one order of magnitude lower than those associated with anthropogenic forcing and are dominated by the solar forcing; 4) the interaction effects between natural and anthropogenic factors can importantly modulate how impacts actually occur, at least for moderate increases in external forcing. Human activities became dominant drivers of the estimated economic impacts at the end of the 20th century, producing larger impacts than those of low-frequency natural variability. Some of the uses and limitations of IAMs are discussed.	[Estrada, Francisco] Univ Nacl Autonoma Mexico, Ctr Ciencias Atmosfera, Mexico City, DF, Mexico; [Estrada, Francisco; Tol, Richard S. J.; Botzen, Wouter J. W.] Vrije Univ Amsterdam, Inst Environm Studies, Amsterdam, Netherlands; [Tol, Richard S. J.] Univ Sussex, Dept Econ, Falmer, England; [Tol, Richard S. J.] Vrije Univ Amsterdam, Dept Spatial Econ, Amsterdam, Netherlands; [Tol, Richard S. J.] Tinbergen Inst, Amsterdam, Netherlands; [Tol, Richard S. J.] CESifo, Munich, Germany; [Botzen, Wouter J. W.] Univ Utrecht, Utrecht Univ Sch Econ USE, Utrecht, Netherlands	Universidad Nacional Autonoma de Mexico; Vrije Universiteit Amsterdam; University of Sussex; Vrije Universiteit Amsterdam; Tinbergen Institute; Ifo Institut; Utrecht University	Estrada, F (corresponding author), Univ Nacl Autonoma Mexico, Ctr Ciencias Atmosfera, Mexico City, DF, Mexico.; Estrada, F (corresponding author), Vrije Univ Amsterdam, Inst Environm Studies, Amsterdam, Netherlands.	feporrua@atmosfera.unam.mx	Tol, Richard S. J./D-5245-2011; Botzen, Wouter/L-3123-2013	Tol, Richard S. J./0000-0002-8012-3988; Botzen, Wouter/0000-0002-8563-4963; Estrada Porrua, Francisco/0000-0002-1403-2180				Ackerman F, 2009, CLIMATIC CHANGE, V95, P297, DOI 10.1007/s10584-009-9570-x; Anthoff D, 2014, ANN OPER RES, V220, P223, DOI 10.1007/s10479-013-1343-2; Brohan P, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006548; Costinot A, 2016, J POLIT ECON, V124, P205, DOI 10.1086/684719; de Bruin KC, 2009, CLIMATIC CHANGE, V95, P63, DOI 10.1007/s10584-008-9535-5; Dell M, 2014, J ECON LIT, V52, P740, DOI 10.1257/jel.52.3.740; Deschenes O, 2011, AM ECON J-APPL ECON, V3, P152, DOI 10.1257/app.3.4.152; Enfield DB, 2001, GEOPHYS RES LETT, V28, P2077, DOI 10.1029/2000GL012745; Estrada F, 2015, CLIM CHANG ECON, V6, DOI 10.1142/S2010007815500153; Estrada F, 2015, ENVIRON MODELL SOFTW, V69, P155, DOI 10.1016/j.envsoft.2015.03.010; Estrada F, 2014, BOL SOC MAT MEX, V20, P107, DOI 10.1007/s40590-014-0009-7; Estrada F, 2013, NAT GEOSCI, V6, P1050, DOI 10.1038/NGEO1999; Estrada F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060017; Estrada F, 2010, CLIMATIC CHANGE, V101, P407, DOI 10.1007/s10584-010-9928-0; Gay-Garcia C, 2009, CLIMATIC CHANGE, V94, P333, DOI 10.1007/s10584-008-9524-8; Hansen J, 2011, ATMOS CHEM PHYS, V11, P13421, DOI 10.5194/acp-11-13421-2011; HASSELMANN K, 1993, J CLIMATE, V6, P1957, DOI 10.1175/1520-0442(1993)006<1957:OFFTDO>2.0.CO;2; Hope C, 2006, INTEGRATED ASSESSMEN; Huber M, 2012, NAT GEOSCI, V5, P31, DOI [10.1038/ngeo1327, 10.1038/NGEO1327]; HURRELL JW, 1995, SCIENCE, V269, P676, DOI 10.1126/science.269.5224.676; Kahn ME, 2016, REV ENV ECON POLICY, V10, P166, DOI 10.1093/reep/rev023; Kaufmann RK, 1997, NATURE, V388, P39, DOI 10.1038/40332; Kaufmann RK, 2011, P NATL ACAD SCI USA, V108, P11790, DOI 10.1073/pnas.1102467108; Kirtman B., 2013, IPCC 2013 CLIMATE CH, P953; Knutti R, 2010, J CLIMATE, V23, P2739, DOI 10.1175/2009JCLI3361.1; Kumar A, 2009, MON WEATHER REV, V137, P2622, DOI 10.1175/2009MWR2814.1; Kurukulasuriya P, 2006, WORLD BANK ECON REV, V20, P367, DOI 10.1093/wber/lhl004; Miller RL, 2014, J ADV MODEL EARTH SY, V6, P441, DOI 10.1002/2013MS000266; Nordhaus W., 2013, DICE 2013R INTRO USE, P1; Nordhaus W. D., 2008, QUESTION BALANCE WEI; Nordhaus W.D., 2003, WARMING WORLD EC MOD; Nordhaus WD, 2011, SSRN ELECT J; Notz D, 2015, PHILOS T R SOC A, V373, DOI 10.1098/rsta.2014.0164; Oreskes N, 1994, SCIENCE, P263; Parson EA, 1997, ANNU REV ENERG ENV, V22, P589, DOI 10.1146/annurev.energy.22.1.589; Pindyck RS, 2013, J ECON LIT, V51, P860, DOI 10.1257/jel.51.3.860; Schlenker W, 2009, P NATL ACAD SCI USA, V106, P15594, DOI 10.1073/pnas.0906865106; Schneider SH., 1997, ENVIRON MODEL ASSESS, V2, P229, DOI [10.1023/A:1019090117643, DOI 10.1023/A:1019090117643]; Schwartz SE, 2012, SURV GEOPHYS, V33, P745, DOI 10.1007/s10712-012-9180-4; Stainforth DA, 2007, PHILOS T R SOC A, V365, P2145, DOI 10.1098/rsta.2007.2074; Stern N, 2008, AM ECON REV, V98, P1, DOI 10.1257/aer.98.2.1; Stern N, 2013, J ECON LIT, V51, P838, DOI 10.1257/jel.51.3.838; Swanson KL, 2009, P NATL ACAD SCI USA, V106, P16120, DOI 10.1073/pnas.0908699106; Taylor KE, 2012, B AM METEOROL SOC, V93, P485, DOI 10.1175/BAMS-D-11-00094.1; Tol R.S.J., 1998, ENVIRON MODEL ASSESS, V3, P63, DOI DOI 10.1023/A:1019050503531; Tol RSJ, 2014, J ECON PERSPECT, V28, P221, DOI 10.1257/jep.28.2.221; Tol RSJ, 2013, CLIMATIC CHANGE, V117, P795, DOI 10.1007/s10584-012-0613-3; Tol RSJ, 2009, J ECON PERSPECT, V23, P29, DOI 10.1257/jep.23.2.29; TOL RSJ, 1993, THEOR APPL CLIMATOL, V48, P63, DOI 10.1007/BF00864914; Tol RSJ, 1998, CLIMATIC CHANGE, V38, P87, DOI 10.1023/A:1005390515242; Tol RSJ, 2002, ENVIRON RESOUR ECON, V21, P135, DOI 10.1023/A:1014539414591; Tol RSJ, 2002, ENVIRON RESOUR ECON, V21, P47, DOI 10.1023/A:1014500930521; TRENBERTH KE, 1984, MON WEATHER REV, V112, P326, DOI 10.1175/1520-0493(1984)112<0326:SVNITS>2.0.CO;2; van den Bergh JCJM, 2014, NAT CLIM CHANGE, V4, P253, DOI 10.1038/NCLIMATE2135; Weigel AP, 2010, J CLIMATE, V23, P4175, DOI 10.1175/2010JCLI3594.1; Weitzman ML, 2009, REV ECON STAT, V91, P1, DOI 10.1162/rest.91.1.1; Wolter K., 1998, WEATHER, V53, P315, DOI DOI 10.1002/J.1477-8696.1998.TB06408.X; Wu ZW, 2011, CLIM DYNAM, V37, P1661, DOI 10.1007/s00382-010-0938-4	58	11	11	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2017	12	2							e0172201	10.1371/journal.pone.0172201	http://dx.doi.org/10.1371/journal.pone.0172201			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL2BI	28212384	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000394424700022
J	Chiva-Blanch, G; Laake, K; Myhre, P; Bratseth, V; Arnesen, H; Solheim, S; Badimon, L; Seljeflot, I				Chiva-Blanch, Gemma; Laake, Kristian; Myhre, Peder; Bratseth, Vibeke; Arnesen, Harald; Solheim, Svein; Badimon, Lina; Seljeflot, Ingebjorg			Platelet-, monocyte-derived and tissue factor-carrying circulating microparticles are related to acute myocardial infarction severity	PLOS ONE			English	Article							HIGH CARDIOVASCULAR RISK; ATHEROSCLEROTIC PLAQUES; INDUCE PROCOAGULANT; BLOOD; ACTIVATION; CORONARY; PHOSPHATIDYLSERINE; INTERVENTION; PROGNOSIS; OUTCOMES	Objective Circulating microparticles (cMPs) are phospholipid-rich vesicles released from cells when activated or injured, and contribute to the formation of intracoronary thrombi. Tissue factor (TF, CD142) is the main trigger of fibrin formation and TF-carrying cMPs are considered one of the most procoagulant cMPs. Similar types of atherosclerotic lesions may lead to different types of AMI, although the mechanisms behind are unresolved. Therefore, we aimed to investigate the phenotype of cMPs found in plasma of ACS patients and its relation to AMI severity and thrombotic burden. Methods In a cross-sectional study, two hundred patients aged 75 +/- 4 years were included in the study 2-8 weeks after suffering an AMI. Annexin V positive (AV(+))-cMPs derived from blood and vascular cells were measured by flow cytometry. Plasma procoagulant activity (TF-PCA) was measured through a chromogenic assay. Results STEMI patients (n = 75) showed higher levels of platelet-derived cMPs [CD61(+)/AV(+), CD31(+)/ AV(+), CD42b(+)/AV(+) and CD31(+)/ CD42b(+)/AV(+), P = 0.048, 0.038, 0.009 and 0.006, respectively], compared to NSTEMI patients (n = 125). Patients who suffered a heart failure during AMI (n = 17) had increased levels of platelet (CD61(+))- and monocyte (CD14(+))- derived cMPs carrying TF (CD142(+)) (P<0.0001 and 0.004, respectively). Additionally, NYHA class III (n = 23) patients showed higher levels of CD142(+)/AV +, CD14(+)/AV(+) and CD14(+)/CD142 +/AV(+) cMPs than those in class I/ II (P = 0.001, 0.015 and 0.014, respectively). The levels of these cMPs positively correlated with TF-PCA (r >= 0.166, P <= 0.027, all). Conclusions Platelets and monocytes remain activated in AMI patients treated as per guidelines and release cMPs that discriminate AMI severity. Therefore, TF-MPs, and platelet- and monocyte-MPs may reflect thrombotic burden in AMI patients.	[Chiva-Blanch, Gemma; Laake, Kristian; Myhre, Peder; Bratseth, Vibeke; Arnesen, Harald; Solheim, Svein; Seljeflot, Ingebjorg] Oslo Univ Hosp Ulleval, Dept Cardiol, Ctr Clin Heart Res, Oslo, Norway; [Chiva-Blanch, Gemma; Laake, Kristian; Myhre, Peder; Arnesen, Harald; Seljeflot, Ingebjorg] Univ Oslo, Fac Med, Oslo, Norway; [Chiva-Blanch, Gemma; Badimon, Lina] CSIC ICCC, Cardiovasc Res Ctr, Barcelona, Spain; [Chiva-Blanch, Gemma; Badimon, Lina] Biomed Res Inst St Pau, IIB St Pau, Barcelona, Spain	University of Oslo; University of Oslo; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Institut Catala de Ciencies Cardiovasculars (ICCC)	Chiva-Blanch, G (corresponding author), Oslo Univ Hosp Ulleval, Dept Cardiol, Ctr Clin Heart Res, Oslo, Norway.; Chiva-Blanch, G (corresponding author), Univ Oslo, Fac Med, Oslo, Norway.; Chiva-Blanch, G (corresponding author), CSIC ICCC, Cardiovasc Res Ctr, Barcelona, Spain.; Chiva-Blanch, G (corresponding author), Biomed Res Inst St Pau, IIB St Pau, Barcelona, Spain.	GChiva@santpau.cat	Chiva-Blanch, Gemma/O-8072-2018; BADIMON, LINA/S-2950-2019; Badimon, Lina/O-4711-2014	Chiva-Blanch, Gemma/0000-0001-6093-0160; Badimon, Lina/0000-0002-9162-2459	Institute de Salud Carlos III (ISCIII), Spain [CD13/00023]; Stein Erik Hagens Foundation of Clinical Heart Research, Oslo, Norway	Institute de Salud Carlos III (ISCIII), Spain; Stein Erik Hagens Foundation of Clinical Heart Research, Oslo, Norway	GC-B is a Sara Borrell Postdoctoral Fellow (CD13/00023) from Institute de Salud Carlos III (ISCIII), Spain. This work was supported by Stein Erik Hagens Foundation of Clinical Heart Research, Oslo, Norway.	Aharon A, 2008, THROMB HAEMOSTASIS, V100, P878, DOI 10.1160/TH07-11-0691; Bogdanov VY, 2009, J THROMB HAEMOST, V7, P894, DOI 10.1111/j.1538-7836.2009.03315.x; Chiva-Blanch G, 2017, INT J CARDIOL, V227, P876, DOI 10.1016/j.ijcard.2016.11.302; Chiva-Blanch G, 2016, INT J CARDIOL, V208, P147, DOI 10.1016/j.ijcard.2016.01.211; Chiva-Blanch G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148176; Chung SY, 2016, INT J CARDIOL, V223, P412, DOI 10.1016/j.ijcard.2016.08.068; Hartopo AB, 2016, ARCH MED SCI, V12, P529, DOI 10.5114/aoms.2016.59926; Huisse MG, 2009, THROMB HAEMOSTASIS, V101, P734, DOI 10.1160/TH08-06-0407; Jung C, 2012, ATHEROSCLEROSIS, V221, P226, DOI 10.1016/j.atherosclerosis.2011.12.025; Kopp CW, 2011, PLATELETS, V22, P530, DOI 10.3109/09537104.2011.573599; Laake K, 2014, BMC GERIATR, V14, DOI 10.1186/1471-2318-14-74; Langer F, 2014, THROMB HAEMOSTASIS, V111, P590, DOI 10.1160/TH13-09-0802; Leroyer AS, 2007, J AM COLL CARDIOL, V49, P772, DOI 10.1016/j.jacc.2006.10.053; Nieuwland R, 2000, BLOOD, V95, P930, DOI 10.1182/blood.V95.3.930.003k46_930_935; Nomura S, 2008, THROMB RES, V123, P8, DOI 10.1016/j.thromres.2008.06.006; O'Gara PT, 2013, CIRCULATION, V127, P529, DOI 10.1161/CIR.0b013e3182742c84; Porto I, 2012, EUR HEART J, V33, P2928, DOI 10.1093/eurheartj/ehs065; SATTA N, 1994, J IMMUNOL, V153, P3245; Sinning JM, 2011, EUR HEART J, V32, P2034, DOI 10.1093/eurheartj/ehq478; Stepien E, 2012, ARCH MED RES, V43, P31, DOI 10.1016/j.arcmed.2012.01.006; Steppich B, 2005, THROMB HAEMOSTASIS, V93, P35, DOI 10.1160/TH04-06-0393; Steppich BA, 2009, THROMB J, V7, DOI 10.1186/1477-9560-7-11; Suades R, 2016, INT J CARDIOL, V202, P378, DOI 10.1016/j.ijcard.2015.09.011; Suades R, 2015, J THROMB HAEMOST, V13, P1776, DOI 10.1111/jth.13065; Suades R, 2015, THROMB HAEMOSTASIS, V114, P1310, DOI 10.1160/TH15-04-0325; Suades R, 2015, SEMIN THROMB HEMOST, V41, P590, DOI 10.1055/s-0035-1556591; Suades R, 2012, THROMB HAEMOSTASIS, V108, P1208, DOI 10.1160/TH12-07-0486; TRIP MD, 1990, NEW ENGL J MED, V322, P1549, DOI 10.1056/NEJM199005313222201; Van der Zee PM, 2006, CLIN CHEM, V52, P657, DOI 10.1373/clinchem.2005.057414; Wang LX, 2016, INT J CARDIOL, V223, P121, DOI 10.1016/j.ijcard.2016.07.260	30	66	66	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0172558	10.1371/journal.pone.0172558	http://dx.doi.org/10.1371/journal.pone.0172558			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207887	Green Published, gold, Green Submitted			2022-12-27	WOS:000394424500147
J	Feinberg, M; Tullett, AM; Mensch, Z; Hart, W; Gottlieb, S				Feinberg, Matthew; Tullett, Alexa M.; Mensch, Zachary; Hart, William; Gottlieb, Sara			The political reference point: How geography shapes political identity	PLOS ONE			English	Article							IDEOLOGY; POLARIZATION; PERSONALITY; ELECTORATE; PSYCHOLOGY; LIBERALS; SELF	It is commonly assumed that how individuals identify on the political spectrum whether liberal, conservative, or moderate has a universal meaning when it comes to policy stances and voting behavior. But, does political identity mean the same thing from place to place? Using data collected from across the U. S. we find that even when people share the same political identity, those in bluer locations are more likely to support left-leaning policies and vote for Democratic candidates than those in "redder" locations. Because the meaning of political identity is inconsistent across locations, individuals who share the same political identity sometimes espouse opposing policy stances. Meanwhile, those with opposing identities sometimes endorse identical policy stances. Such findings suggest that researchers, campaigners, and pollsters must use caution when extrapolating policy preferences and voting behavior from political identity, and that animosity toward the other end of the political spectrum is sometimes misplaced.	[Feinberg, Matthew] Univ Toronto, Rotman Sch Management, Toronto, ON, Canada; [Tullett, Alexa M.; Mensch, Zachary; Hart, William] Univ Alabama, Dept Psychol, Box 870348, Tuscaloosa, AL 35487 USA; [Gottlieb, Sara] Univ Calif Berkeley, Dept Psychol, 3210 Tolman Hall, Berkeley, CA 94720 USA	University of Toronto; University of Alabama System; University of Alabama Tuscaloosa; University of California System; University of California Berkeley	Feinberg, M (corresponding author), Univ Toronto, Rotman Sch Management, Toronto, ON, Canada.	matthew.feinberg@rotman.utoronto.ca						Asch S. E., 1951, GROUPS LEADERSHIP ME, P177; Baldassarri D, 2008, AM J SOCIOL, V114, P408, DOI 10.1086/590649; BANAJI MR, 1994, ANNU REV PSYCHOL, V45, P297, DOI 10.1146/annurev.psych.45.1.297; Carney DR, 2008, POLIT PSYCHOL, V29, P807, DOI 10.1111/j.1467-9221.2008.00668.x; Cohen GL, 2003, J PERS SOC PSYCHOL, V85, P808, DOI 10.1037/0022-3514.85.5.808; CONOVER PJ, 1981, AM J POLIT SCI, V25, P617, DOI 10.2307/2110756; Converse P., 1964, IDEOLOGY DISCONTENT, P206; Ellis C, 2009, ELECT STUD, V28, P388, DOI 10.1016/j.electstud.2009.05.010; Feldman S., 2013, OXFORD HDB POLITICAL, P477; Festinger L, 1954, HUM RELAT, V7, P117, DOI 10.1177/001872675400700202; Fiorina MP, 2008, ANNU REV POLIT SCI, V11, P563, DOI 10.1146/annurev.polisci.11.053106.153836; Graham J, 2009, J PERS SOC PSYCHOL, V96, P1029, DOI 10.1037/a0015141; Haidt J, 2012, NEW YORK TIMES  0917; Hatemi PK, 2012, TRENDS GENET, V28, P525, DOI 10.1016/j.tig.2012.07.004; Huddy L, 2001, POLIT PSYCHOL, V22, P127, DOI 10.1111/0162-895X.00230; Iyengar S, 2015, AM J POLIT SCI, V59, P690, DOI 10.1111/ajps.12152; Iyengar S, 2012, PUBLIC OPIN QUART, V76, P405, DOI 10.1093/poq/nfs038; Jost JT, 2008, PERSPECT PSYCHOL SCI, V3, P126, DOI 10.1111/j.1745-6916.2008.00070.x; Jost JT, 2003, PSYCHOL BULL, V129, P339, DOI 10.1037/0033-2909.129.3.339; Kinder D., 1998, HDB SOCIAL PSYCHOL P, VVolume 2, P778; Lakoff George, 2008, POLITICAL MIND WHY Y; Mannheim K., 1936, IDEOLOGY UTOPIA, DOI 10.4324/9781315002828; McGuire WJ., 1988, ADV EXPT SOCIAL PSYC, Vvol. 21, P97, DOI DOI 10.1016/S0065-2601(08)60225-7; Morgan GS, 2014, BEHAV BRAIN SCI, V37, P321, DOI 10.1017/S0140525X13002665; Oxley DR, 2008, SCIENCE, V321, P1667, DOI 10.1126/science.1157627; Page BenjaminI., 1992, RATIONAL PUBLIC 50 Y; Robinson JP, 1998, PUBLIC OPIN QUART, V52, P134; Settle JE, 2010, J POLIT, V72, P1189, DOI 10.1017/S0022381610000617; Sherif M., 1936, PSYCHOL SOCIAL NORMS; Skitka LJ, 2005, J PERS SOC PSYCHOL, V88, P895, DOI 10.1037/0022-3514.88.6.895; Sniderman PM., 2004, STUDIES PUBLIC OPINI, P337; Stimson James A., 2004, TIDES CONSENT PUBLIC; Tajfel H, 1979, SOCIAL PSYCHOL INTER, V33, P74, DOI DOI 10.1146/ANNUREV.PS.33.020182.000245; Tetlock PE, 2000, J PERS SOC PSYCHOL, V78, P853, DOI 10.1037/0022-3514.78.5.853; Treier S, 2009, PUBLIC OPIN QUART, V73, P679, DOI 10.1093/poq/nfp067; Zaller JohnR., 1992, NATURE ORIGINS MASS	37	12	12	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0171497	10.1371/journal.pone.0171497	http://dx.doi.org/10.1371/journal.pone.0171497			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL2BG	28207906	gold, Green Published, Green Submitted			2022-12-27	WOS:000394424500032
J	Feng, XD; Pi, LY; Sriram, S; Schultz, GS; Gibson, DJ				Feng, Xiaodi; Pi, Liya; Sriram, Sriniwas; Schultz, Gregory S.; Gibson, Daniel J.			Connective tissue growth factor is not necessary for haze formation in excimer laser wounded mouse corneas	PLOS ONE			English	Article							MYOFIBROBLAST DIFFERENTIATION; PHOTOREFRACTIVE KERATECTOMY; FIBROBLAST PROLIFERATION; FACTOR EXPRESSION; RABBIT CORNEAS; MESSENGER-RNA; FACTOR GENE; TEAR FLUID; PDGF-BB; CELLS	We sought to determine if connective tissue growth factor (CTGF) is necessary for the formation of corneal haze after corneal injury. Mice with post-natal, tamoxifen-induced, knockout of CTGF were subjected to excimer laser phototherapeutic keratectomy (PTK) and the corneas were allowed to heal. The extent of scaring was observed in non-induced mice, heterozygotes, and full homozygous knockout mice and quantified by macrophotography. The eyes from these mice were collected after euthanization for re-genotyping to control for possible Cre-mosaicism. Primary corneal fibroblasts from CTGF knockout corneas were established in a gel plug assay. The plug was removed, simulating an injury, and the rate of hole closure and the capacity for these cells to form light reflecting cells in response to CTGF and platelet-derived growth factor B (PDGF-B) were tested and compared to wild-type cells. We found that independent of genotype, each group of mice was still capable of forming light reflecting haze in the cornea after laser ablation (p = 0.40). Results from the gel plug closure rate in primary cell cultures of knockout cells were not statistically different from serum starved wild-type cells, independent of treatment. Compared to the serum starved wild-type cells, stimulation with PDGF-BB significantly increased the KO cell culture's light reflection (p = 0.03). Most interestingly, both reflective cultures were positive for alpha-SMA, but the cellular morphology and levels of alpha-SMA were distinct and not in proportion to the light reflection seen. This new work demonstrates that corneas without CTGF can still form sub-epithelial haze, and that the light reflecting phenotype can be reproduced in culture. These data support the possibilities of growth factor redundancy and that multiple pro-haze pathways exist.	[Feng, Xiaodi; Schultz, Gregory S.; Gibson, Daniel J.] Univ Florida, Inst Wound Res, Gainesville, FL 32611 USA; [Pi, Liya] Univ Florida, Dept Pediat, Gainesville, FL USA; [Sriram, Sriniwas] Univ Florida, Dept Biomed Engn, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Gibson, DJ (corresponding author), Univ Florida, Inst Wound Res, Gainesville, FL 32611 USA.	gibsondj@ufl.edu		Gibson, Daniel/0000-0003-0379-0100	National Eye Institute R01 Regulation of Stromal Wound Healing [R01-EY05587]; National Eye Institute Vision Core [EY021721]; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [R01EY005587, P30EY021721] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [K01AA024174] Funding Source: NIH RePORTER	National Eye Institute R01 Regulation of Stromal Wound Healing; National Eye Institute Vision Core(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by National Eye Institute R01 Regulation of Stromal Wound Healing (R01-EY05587), https://nei.nih.gov; National Eye Institute Vision Core (EY021721), https://nei.nih.gov; and Research to Prevent Blindness (Institutional), http://rpbusa.org. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; R01 Regulation of Stromal Wound Healing (R01-EY05587), NEI Vision Core (EY021721), and supported in part by an unrestricted grant from Research to Prevent Blindness.	Blalock TD, 2003, INVEST OPHTH VIS SCI, V44, P1879, DOI 10.1167/iovs.02-0860; Blalock TD, 2004, EXP EYE RES, V78, P1127, DOI 10.1016/j.exer.2004.01.012; Blalock TD, 2012, INVEST OPHTH VIS SCI, V53, P3387, DOI 10.1167/iovs.12-9425; BRADHAM DM, 1991, J CELL BIOL, V114, P1285, DOI 10.1083/jcb.114.6.1285; Dammeier J, 1998, INT J BIOCHEM CELL B, V30, P909, DOI 10.1016/S1357-2725(98)00046-6; Duncan MR, 1999, FASEB J, V13, P1774, DOI 10.1096/fasebj.13.13.1774; Folger PA, 2001, INVEST OPHTH VIS SCI, V42, P2534; Frazier K, 1996, J INVEST DERMATOL, V107, P404, DOI 10.1111/1523-1747.ep12363389; Gibson DJ, 2014, INVEST OPHTH VIS SCI, V55, P2062, DOI 10.1167/iovs.13-12735; Gibson DJ, 2013, INVEST OPHTH VIS SCI, V54, P4776, DOI 10.1167/iovs.13-11976; Grotendorst Gary R., 1997, Cytokine and Growth Factor Reviews, V8, P171, DOI 10.1016/S1359-6101(97)00010-5; Grotendorst GR, 2005, FASEB J, V19, P729, DOI 10.1096/fj.04-3217com; GROTENDORST GR, 1991, J CELL PHYSIOL, V149, P235, DOI 10.1002/jcp.1041490209; Grotendorst GR, 1996, CELL GROWTH DIFFER, V7, P469; Grotendorst GR, 2004, FASEB J, V18, P469, DOI 10.1096/fj.03-0699com; Heldin CH, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-97; IGARASHI A, 1993, MOL BIOL CELL, V4, P637, DOI 10.1091/mbc.4.6.637; Igarashi Atsuyuki, 1992, Journal of Dermatology (Tokyo), V19, P642; Kamiyama K, 1998, CORNEA, V17, P315, DOI 10.1097/00003226-199805000-00013; Karamichos D, 2010, INVEST OPHTH VIS SCI, V51, P1382, DOI 10.1167/iovs.09-3860; Kaur H, 2009, EXP EYE RES, V88, P960, DOI 10.1016/j.exer.2008.12.006; Kim A, 2010, INVEST OPHTH VIS SCI, V51, P864, DOI 10.1167/iovs.09-4200; Kim WJ, 1999, INVEST OPHTH VIS SCI, V40, P1364; Moller-Pedersen T, 2004, EXP EYE RES, V78, P553, DOI 10.1016/S0014-4835(03)00208-2; Pi LY, 2012, FASEB J, V26, P3365, DOI 10.1096/fj.11-200154; Radhakrishnan SS, 2012, INVEST OPHTH VIS SCI, V53, P8076, DOI 10.1167/iovs.12-10790; Robinson PM, 2012, METHODS MOL BIOL, V820, P117, DOI 10.1007/978-1-61779-439-1_8; Sriram S, 2014, EXP EYE RES, V125, P173, DOI 10.1016/j.exer.2014.06.014; Sriram S, 2013, INVEST OPHTH VIS SCI, V54, P8214, DOI 10.1167/iovs.13-12758; Tuominen ISJ, 2001, EXP EYE RES, V72, P631, DOI 10.1006/exer.2001.0999; Vesaluoma M, 1997, CURR EYE RES, V16, P825, DOI 10.1076/ceyr.16.8.825.8984	31	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0172304	10.1371/journal.pone.0172304	http://dx.doi.org/10.1371/journal.pone.0172304			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207886	Green Published, Green Submitted, gold			2022-12-27	WOS:000394424500118
J	Wilson, DR; Mattlage, AE; Seier, NM; Todd, JD; Price, BG; Kwapiszeski, SJ; Vardey, R; Billinger, SA				Wilson, David R.; Mattlage, Anna E.; Seier, Nicole M.; Todd, Jonathan D.; Price, Brian G.; Kwapiszeski, Sarah J.; Vardey, Rakesh; Billinger, Sandra A.			Recumbent Stepper Submaximal Test response is reliable in adults with and without stroke	PLOS ONE			English	Article							PEAK OXYGEN-UPTAKE; EXERCISE TEST; OLDER-ADULTS; CARDIORESPIRATORY FITNESS; AEROBIC EXERCISE; ASSOCIATION; STATEMENT; VALIDITY; PEOPLE	Purpose The purpose of the present study was to determine the reliability of the exercise response (predicted peak VO2) using the total body recumbent stepper (TBRS) submaximal exercise test in: 1) healthy adults 20-70 years of age and 2) adults participating in inpatient stroke rehabilitation. We hypothesized that the predicted peak VO2 (Visit 1) would have an excellent relationship (r > 0.80) to predicted peak VO2 (Visit 2). We also wanted to test whether the exercise response at Visit 1 and Visit 2 would be significantly different. Methods Healthy adults were recruited from the Kansas City metro area. Stroke participants were recruited during their inpatient rehabilitation stay. Eligible participants completed 2 TBRS submaximal exercise tests between 24 hours and 5 days at similar times of day. Results A total of 70 participants completed the study. Healthy adults (n = 50) were 36 M, 38.1 +/- 10.1 years and stroke participants (n = 20) were 15 M, 62.5 +/- 11.8 years of age. The exercise response was reliable for healthy adults (r = 0.980, p<0.01) and stroke participants (r = 0.987, p<0.01) between Visit 1 and Visit 2. Repeated Measures ANOVA showed a significant difference in predicted values between the two visits for healthy adults (47.2 +/- 8.4 vs 47.7 +/- 8.5 mL.kg(-1).min(-1); p = 0.04) but not for stroke participants (25.0 +/- 9.9 vs 25.3 +/- 11.4 mL.kg(-1).min(-1); p = 0.65). Conclusion These results suggest that the exercise response is reliable using the TBRS submaximal exercise test in this cohort of healthy adults and stroke participants.	[Wilson, David R.; Mattlage, Anna E.; Seier, Nicole M.; Todd, Jonathan D.; Price, Brian G.; Kwapiszeski, Sarah J.; Billinger, Sandra A.] Univ Kansas, Med Ctr, Dept Phys Therapy & Rehabil Sci, Kansas City, KS 66103 USA; [Vardey, Rakesh] Univ Kansas, Med Ctr, Dept Phys Med & Rehabil, Kansas City, KS 66103 USA	University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center	Billinger, SA (corresponding author), Univ Kansas, Med Ctr, Dept Phys Therapy & Rehabil Sci, Kansas City, KS 66103 USA.	sbillinger@kumc.edu			Eunice Kennedy Shriver National Institute of Child Health and Human Development [K01HD067318, T32HD057850]; American Heart Association [14PRE20040026]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD057850] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); American Heart Association(American Heart Association); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	SAB was supported in part by K01HD067318 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (www.nichd.nih.gov). AEM and SJK were supported in part by T32HD057850 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development and AEM also in part by Award Number 14PRE20040026 from the American Heart Association (www.heart.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACSM, 2014, ACSMS GUIDELINES EXE; Biasin L, 2014, INTEGRATING AEROBIC; Billinger SA, 2008, PHYS THER, V88, P1188, DOI 10.2522/ptj.20080072; Billinger SA, 2014, STROKE, V45, P2532, DOI 10.1161/STR.0000000000000022; Billinger SA, 2012, MED SCI SPORT EXER, V44, P1539, DOI 10.1249/MSS.0b013e31824f5be4; Billinger SA, 2008, J STRENGTH COND RES, V22, P1556, DOI 10.1519/JSC.0b013e3181739dd7; Dalleck LC, 2011, PERCEPT MOTOR SKILL, V112, P183, DOI 10.2466/06.15.27.PMS.112.1.183-192; Dorn J, 1999, CIRCULATION, V100, P1764, DOI 10.1161/01.CIR.100.17.1764; Doyle L, 2013, J NEUROL PHYS THER, V37, P20, DOI 10.1097/NPT.0b013e318282975c; Golding L., 2000, YS WAY PHYS FITNESS; Hanson LC, 2015, PHYSIOTHERAPY; Harper LD, 2016, J STRENGTH CONDITION; Herda AA, 2014, PHYS THER, V94, P722, DOI 10.2522/ptj.20130307; Kaminsky LA, 2013, CIRCULATION, V127, P652, DOI 10.1161/CIR.0b013e31827ee100; Looney Marilyn A, 2003, J Appl Meas, V4, P43; Mattlage Anna E, 2013, Cardiopulm Phys Ther J, V24, P14; Mendelsohn ME, 2008, PHYS THER, V88, P747, DOI 10.2522/ptj.20070161; Myers J, 2002, NEW ENGL J MED, V346, P793, DOI 10.1056/NEJMoa011858; Noonan V, 2000, PHYS THER, V80, P782, DOI 10.1093/ptj/80.8.782; Portney, 2019, FDN CLIN RES APPL PR; Prout EC, 2015, ARCH PHYS MED REHAB, V96, P823, DOI 10.1016/j.apmr.2014.12.005; Rimmer J, 2002, ACSMS RESOURCES CLIN; Vancampfort D, 2016, PSYCHIAT DANUB, V28, P39	23	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0172294	10.1371/journal.pone.0172294	http://dx.doi.org/10.1371/journal.pone.0172294			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207854	gold, Green Published, Green Submitted			2022-12-27	WOS:000394424500113
J	Vallejo-Cardona, AA; Martinez-Palou, R; Chavez-Gomez, B; Garcia-Caloca, G; Guerra-Camacho, J; Ceron-Camacho, R; Reyes-Avila, J; Karamath, JR; Aburto, J				Adriana Vallejo-Cardona, Alba; Martinez-Palou, Rafael; Chavez-Gomez, Benjamin; Garcia-Caloca, Graciela; Guerra-Camacho, Jairo; Ceron-Camacho, Ricardo; Reyes-Avila, Jesus; Robert Karamath, James; Aburto, Jorge			Demulsification of crude oil-in-water emulsions by means of fungal spores	PLOS ONE			English	Article							DEMULSIFYING EFFICIENCY; SEQUENCE ALIGNMENT; DE-EMULSIFICATION; ENHANCEMENT; INTERFACE; BREAKING; BACTERIA	The present feature describes for the first time the application of spores from Aspergillus sp. IMPMS7 to break out crude oil-in-water emulsions (O/W). The fungal spores were isolated from marine sediments polluted with petroleum hydrocarbons. The spores exhibited the ability to destabilize different O/W emulsions prepared with medium, heavy or extra-heavy Mexican crude oils with specific gravities between 10.1 and 21.2 degrees API. The isolated fungal spores showed a high hydrophobic power of 89.3 +/- 1.9% and with 2 g of spores per liter of emulsion, the half-life for emulsion destabilization was roughly 3.5 and 0.7 h for extra-heavy and medium crude oil, respectively. Then, the kinetics of water separation and the breaking of the O/W emulsion prepared with heavy oil through a spectrofluorometric technique were studied. A decrease in the fluorescence ratio at 339 and 326 nm (I339/I326) was observed in emulsions treated with spores, which is similar to previously reported results using chemical demulsifiers.	[Adriana Vallejo-Cardona, Alba] CONACYT Ctr Invest & Asistencia Tecnol & Diseno E, Ave Normalistas 800, Guadalajara, Jalisco, Mexico; [Martinez-Palou, Rafael; Chavez-Gomez, Benjamin; Garcia-Caloca, Graciela; Guerra-Camacho, Jairo; Ceron-Camacho, Ricardo; Reyes-Avila, Jesus; Robert Karamath, James; Aburto, Jorge] Inst Mexicano Petr, Direcc Invest Transformac Hidrocarburos, Gerencia Transformac Biomasa, Eje Cent Lazaro Cardenas Norte 152, Mexico City, DF, Mexico	Instituto Mexicano del Petroleo	Aburto, J (corresponding author), Inst Mexicano Petr, Direcc Invest Transformac Hidrocarburos, Gerencia Transformac Biomasa, Eje Cent Lazaro Cardenas Norte 152, Mexico City, DF, Mexico.	jaburto@imp.mx	Aburto, Jorge/B-4600-2009; Aburto, Jorge/AAR-7902-2021; Cerón-Camacho, Ricardo/I-4167-2017; Cerón-Camacho, Ricardo/P-1868-2019; Cardona, Alba Adriana Vallejo/G-8039-2019; Martinez-Palou, Rafael/O-1737-2019	Aburto, Jorge/0000-0002-8282-6046; Cerón-Camacho, Ricardo/0000-0003-2757-4963; Cerón-Camacho, Ricardo/0000-0003-2757-4963; Cardona, Alba Adriana Vallejo/0000-0002-4568-3787; Martinez-Palou, Rafael/0000-0003-3598-7207	Instituto Mexicano del Petroleo [D.60016]; IMP [D.60016 (D.01225)]	Instituto Mexicano del Petroleo; IMP	The authors thank Instituto Mexicano del Petroleo for the financial support provided through the project D.60016.; The Authors thank financial support from IMP through project D.60016 (D.01225).	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; American Public Health Association, 2012, INDIAN J ENV SCI, V22nd ed.; Bai N, ENV SCI POLLUT RES; Coutinho JOPA, 2013, BIORESOURCE TECHNOL, V128, P646, DOI 10.1016/j.biortech.2012.09.137; Dalmazzone C, 2009, OIL GAS SCI TECHNOL, V64, P543, DOI 10.2516/ogst:2008041; Das M, 2001, BIORESOURCE TECHNOL, V79, P15, DOI 10.1016/S0960-8524(01)00039-6; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Henderson SB, 1999, MAR POLLUT BULL, V38, P1141, DOI 10.1016/S0025-326X(99)00144-7; HILLIS DM, 1993, SYST BIOL, V42, P182, DOI 10.2307/2992540; Hou N, 2014, ENVIRON SCI POLLUT R, V21, P10386, DOI 10.1007/s11356-014-2931-7; Huang XF, 2009, BIORESOURCE TECHNOL, V100, P1358, DOI 10.1016/j.biortech.2008.08.004; Imhof A, 1999, J PHYS CHEM B, V103, P1408, DOI 10.1021/jp983241q; JANIYANI KL, 1994, WORLD J MICROB BIOT, V10, P452, DOI 10.1007/BF00144471; Larone DH, 2012, MED IMPORTANT FUNGI; Li X, 2012, PROCESS BIOCHEM, V47, P626, DOI 10.1016/j.procbio.2012.01.004; Martinez-Palou R, 2011, J PETROL SCI ENG, V75, P274; Martinez-Palou R, 2015, IONIC LIQUIDS - CURRENT STATE OF THE ART, P305, DOI 10.5772/59094; Martinez-Palou R, 2015, CHEM ENG PROCESS, V98, P112, DOI 10.1016/j.cep.2015.09.014; Martinez-Palou R, 2013, FUEL, V113, P407, DOI 10.1016/j.fuel.2013.05.094; Mohebali G, 2012, COLLOID SURFACE B, V98, P120, DOI 10.1016/j.colsurfb.2012.04.037; Mullins OC, 2008, SPE J, V13, P48, DOI 10.2118/95801-PA; Murillo-Hernandez JA, 2009, ENERG FUEL, V23, P4584, DOI 10.1021/ef9004175; Nadarajah N, 2002, WORLD J MICROB BIOT, V18, P435, DOI 10.1023/A:1015517308905; Park SH, 2000, BIOTECHNOL LETT, V22, P1389, DOI 10.1023/A:1005660901558; ROSENBERG M, 1980, FEMS MICROBIOL LETT, V9, P29, DOI 10.1111/j.1574-6968.1980.tb05599.x; Soca-Chafre G, 2011, FUNGAL BIOL-UK, V115, P143, DOI 10.1016/j.funbio.2010.11.004; Steffens J, 2011, J FLUORESC, V21, P859, DOI 10.1007/s10895-009-0586-4; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Torres E, 2005, ARCH BIOCHEM BIOPHYS, V437, P224, DOI 10.1016/j.abb.2005.03.006	29	9	9	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0170985	10.1371/journal.pone.0170985	http://dx.doi.org/10.1371/journal.pone.0170985			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5VB	28234917	Green Published, gold, Green Submitted			2022-12-27	WOS:000394688200015
J	Kimaro, GD; Mfinanga, S; Simms, V; Kivuyo, S; Bottomley, C; Hawkins, N; Harrison, TS; Jaffar, S; Guinness, L				Kimaro, Godfather Dickson; Mfinanga, Sayoki; Simms, Victoria; Kivuyo, Sokoine; Bottomley, Christian; Hawkins, Neil; Harrison, Thomas S.; Jaffar, Shabbar; Guinness, Lorna		REMSTART Trial Team	The costs of providing antiretroviral therapy services to HIV-infected individuals presenting with advanced HIV disease at public health centres in Dar es Salaam, Tanzania: Findings from a randomised trial evaluating different health care strategies	PLOS ONE			English	Article							SOUTH-AFRICA; MORTALITY; DELIVERY; PROGRAM; DURBAN	Background Understanding the costs associated with health care delivery strategies is essential for planning. There are few data on health service resources used by patients and their associated costs within antiretroviral (ART) programmes in Africa. Material and methods The study was nested within a large trial, which evaluated screening for cryptococcal meningitis and tuberculosis and a short initial period of home-based adherence support for patients initiating ART with advanced HIV disease in Tanzania and Zambia. The economic evaluation was done in Tanzania alone. We estimated costs of providing routine ART services from the health service provider's perspective using a micro-costing approach. Incremental costs for the different novel components of service delivery were also estimated. All costs were converted into US dollars (US$) and based on 2012 prices. Results Of 870 individuals enrolled in Tanzania, 434 were enrolled in the intervention arm and 436 in the standard care/control arm. Overall, the median (IQR) age and CD4 cell count at enrolment were 38 [31, 44] years and 52 [20, 89] cells/mm3, respectively. The mean per patient costs over the first three months and over a one year period of follow up following ART initiation in the standard care arm were US$ 107 (95%CI 101-112) and US$ 265 (95%CI 254-275) respectively. ART drugs, clinic visits and hospital admission constituted 50%, 19%, and 19% of the total cost per patient year, while diagnostic tests and non-ART drugs (co-tri-moxazole) accounted for 10% and 2% of total per patient year costs. The incremental costs of the intervention to the health service over the first three months was US$ 59 (p<0.001; 95%CI 52-67) and over a one year period was US$ 67(p<0.001; 95%CI 50-83). This is equivalent to an increase of 55% (95%CI 51%-59%) in the mean cost of care over the first three months, and 25% (95%CI 20%-30%) increase over one year of follow up.	[Kimaro, Godfather Dickson; Mfinanga, Sayoki; Kivuyo, Sokoine] Natl Inst Med Res, Muhimbili Med Res Ctr, Dar Es Salaam, Tanzania; [Kimaro, Godfather Dickson; Simms, Victoria; Bottomley, Christian] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London, England; [Hawkins, Neil; Guinness, Lorna] London Sch Hyg & Trop Med, Dept Global Hlth & Dev, London, England; [Harrison, Thomas S.] St Georges Univ London, Inst Infect & Immun, London, England; [Jaffar, Shabbar] Univ Liverpool Liverpool Sch Trop Med, Dept Int Publ Hlth, Liverpool, Merseyside, England	National Institute of Medical Research; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; St Georges University London; Liverpool School of Tropical Medicine	Kimaro, GD (corresponding author), Natl Inst Med Res, Muhimbili Med Res Ctr, Dar Es Salaam, Tanzania.; Kimaro, GD (corresponding author), London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London, England.	fatherdk@yahoo.com	Simms, Victoria/AAU-4134-2021; Guinness, Lorna/AAN-3875-2020; Simms, Victoria/C-3278-2009	Simms, Victoria/0000-0002-4897-458X; Harrison, Thomas/0000-0003-3619-4348; Guinness, Lorna/0000-0002-1013-4200; Bottomley, Christian/0000-0002-5241-8412; Kivuyo, Sokoine Lesikari/0000-0003-2257-5254; Hawkins, Neil/0000-0003-3199-221X; Jaffar, Shabbar/0000-0002-9615-1588	European and Developing Countries Clinical Trials Partnership [IP.2009.33011.003]; HIV Research Trust Scholarship [HIVRT15-008]; Medical Research Council [MR/K012126/1] Funding Source: researchfish	European and Developing Countries Clinical Trials Partnership; HIV Research Trust Scholarship; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was nested within the REMSTART trial which was funded by the European and Developing Countries Clinical Trials Partnership (IP.2009.33011.003). GDK received a scholarship from HIV Research Trust Scholarship (HIVRT15-008) for his course on economic evaluation and attachment with experienced researchers at London School of Hygiene and Tropical Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliyu HB, 2012, JAIDS-J ACQ IMM DEF, V61, P221, DOI 10.1097/QAI.0b013e3182683b04; Amuron B, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-290; Bank of Tanzania, 2012, EXCH RAT; Bank of Tanzania, 2012, THE TREAS BOND; Bassett IV, 2010, AIDS, V24, pS37, DOI 10.1097/01.aids.0000366081.91192.1c; Beck EJ, 2010, CURR OPIN HIV AIDS, V5, P215, DOI 10.1097/COH.0b013e32833860e9; Bratt JH, 2011, TROP MED INT HEALTH, V16, P110, DOI 10.1111/j.1365-3156.2010.02640.x; Cianci F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100107; Frick KD, 2009, MED CARE, V47, pS76, DOI 10.1097/MLR.0b013e31819bc064; Frontieres MS, 2013, UNTANGLING WEB ANTIR; Galarraga O, 2011, PHARMACOECONOMICS, V29, P579, DOI 10.2165/11586120-000000000-00000; Gray A., 2011, APPL METHODS COST EF; Ingle SM, 2010, AIDS, V24, P2717, DOI 10.1097/QAD.0b013e32833fb71f; Ingle SM, 2010, SAMJ S AFR MED J, V100, P675, DOI 10.7196/SAMJ.3952; Institute for Quality and Efficiency in Health Care, 2009, WORK PAP COST EST; Jaffar S, 2009, LANCET, V374, P2080, DOI 10.1016/S0140-6736(09)61674-3; James C, 2013, COSTS DELIVERING HLT; Kirkwood Betty R, 2003, ESSENTIAL MED STAT; Kranzer K, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.2.17383; Larson BA, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18026; Lawn SD, 2005, AIDS, V19, P2141, DOI 10.1097/01.aids.0000194802.89540.e1; Long L, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001055; Losina E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009538; Loubiere S, 2008, ANTIVIR THER, V13, P241; Marseille E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051993; Menzies NA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048726; Mfinanga S, 2015, LANCET, V6736, P1; National Bureau of Statistics, 2013, UN REP TANZ POP DIST; National Bureau of Statistics, 2013, HIV AIDS MAL IND SUR; Rosen S, 2008, TROP MED INT HEALTH, V13, P1005, DOI 10.1111/j.1365-3156.2008.02114.x; Scott CA, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-296; Siapka M, 2014, B WORLD HEALTH ORGAN, V92, P499, DOI 10.2471/BLT.13.127639; The United Republic of Tanzania, 2012, REPORT LAW MARRIAGE; UNAIDS, 2011, WORKB COLL COST INF; UNAIDS, 2016, GLOB REP GLOB AIDS E; Vassall A, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001120; World Bank, GDP DEFL; World Health Organisation, 2013, WHO CONS GUID US ANT	38	17	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0171917	10.1371/journal.pone.0171917	http://dx.doi.org/10.1371/journal.pone.0171917			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5VB	28234969	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000394688200038
J	Zamri, EN; Moy, FM; Hoe, VCW				Zamri, E. N.; Moy, F. M.; Hoe, V. C. W.			Association of psychological distress and work psychosocial factors with self-reported musculoskeletal pain among secondary school teachers in Malaysia	PLOS ONE			English	Article							LOW-BACK-PAIN; ANXIETY STRESS SCALES; RISK-FACTORS; NECK PAIN; PSYCHOMETRIC PROPERTIES; CONSTRUCT-VALIDITY; PREVALENCE; HEALTH; VERSION; RELIABILITY	Background Musculoskeletal pain is common among teachers. Work-related psychosocial factors are found to be associated with the development of musculoskeletal pain, however psychological distress may also play an important role. Objectives To assess the prevalence of self-reported low back pain (LBP), and neck and/or shoulder pain (NSP) among secondary school teachers; and to evaluate the association of LBP and NSP with psychological distress and work-related psychosocial factors. Methods This was a cross-sectional study conducted among teachers in the state of Penang, Malaysia. The participants were recruited via a two stage sampling method. Information on demographic, psychological distress, work-related psychosocial factors, and musculoskeletal pain (LBP and NSP) in the past 12 months was collected using a self-administered questionnaire. Poisson regression was used to estimate the prevalence ratio (PR) for the associations between psychological distress and work-related psychosocial factors with LBP and NSP. Results The prevalence of self-reported LBP and NSP among 1482 teachers in the past 12 months was 48.0% (95% Confidence Interval (CI) 45.2%, 50.9%) and 60.1% (95% CI 57.4%, 62.9%) respectively. From the multivariate analysis, self-reported LBP was associated with teachers who reported severe to extremely severe depression (PR: 1.71, 95% CI 1.25, 2.32), severe to extremely severe anxiety (1.46, 95% CI 1.22, 1.75), high psychological job demand (1.29, 95% CI 1.06, 1.57), low skill discretion (1.28, 95% CI 1.13, 1.47) and poorer mental health (0.98, 95% CI 0.97, 0.99). Self-reported NSP was associated with mild to moderate anxiety (1.18, 95% CI 1.06, 1.33), severe to extremely severe anxiety (1.25, 95% CI 1.09, 1.43), low supervisory support (1.13, 95% CI 1.03, 1.25) and poorer mental health (0.98, 95% CI 0.97, 0.99). Conclusions Self-reported LBP and NSP were common among secondary school teachers. Interventions targeting psychological distress and work-related psychosocial characteristics may reduce musculoskeletal pain among school teachers.	[Zamri, E. N.; Moy, F. M.] Univ Malaya, Fac Med, Dept Social & Prevent Med, Julius Ctr, Kuala Lumpur, Malaysia; [Zamri, E. N.] Adv Med & Dent Inst, Cluster Lifestyle Sci, George Town, Malaysia; [Hoe, V. C. W.] Univ Malaya, Fac Med, Dept Social & Prevent Med, Ctr Occupat & Environm Hlth UM, Kuala Lumpur, Malaysia	Universiti Malaya; Universiti Malaya	Moy, FM (corresponding author), Univ Malaya, Fac Med, Dept Social & Prevent Med, Julius Ctr, Kuala Lumpur, Malaysia.	moyfm@ummc.edu.my	Zamri, Eva/AAU-1976-2021; Hoe, VICTOR CW/B-5190-2010; zamri, eva/AAE-1250-2019; Moy, Foong Ming/B-7899-2010	Hoe, VICTOR CW/0000-0002-8073-157X; Moy, Foong Ming/0000-0002-0306-4419; ZAMRI, EVA NABIHA/0000-0002-7774-6949	Ministry of Education, High Impact Research [H-20001-00-E2000069]; University Malaya Research Program [RP001B-13HTM]; Ministry of Higher Education's Academic Training Scheme, Malaysia	Ministry of Education, High Impact Research; University Malaya Research Program; Ministry of Higher Education's Academic Training Scheme, Malaysia	Ministry of Education, High Impact Research grant (H-20001-00-E2000069). ENZ was supported by the Ministry of Higher Education's Academic Training Scheme, Malaysia. The funders had no role in study design, data collection and analysis, decision to publish,or preparation of the manuscript.; We are grateful to all the school administrators and teachers for their cooperation and participation in this study. This study was supported by the Ministry of Education, High Impact Research grant (H-20001-00-E2000069) and the University Malaya Research Program grant (RP001B-13HTM). The approval from the Ministry of Education is acknowledged. ENZ was supported by the Ministry of Higher Education's Academic Training Scheme, Malaysia.	[Anonymous], 2005, GUIDELINES DATA PROC; [Anonymous], 2000, WHO TECHN REP SER; Antony MM, 1998, PSYCHOL ASSESSMENT, V10, P176, DOI 10.1037/1040-3590.10.2.176; Atlas A., 2007, PHILIPP J ALLIED HLT, V2, P34, DOI [10.36413/pjahs.0201.004, DOI 10.36413/PJAHS.0201.004]; Barros Aluisio J D, 2003, BMC Med Res Methodol, V3, P21, DOI 10.1186/1471-2288-3-21; BONGERS PM, 1993, SCAND J WORK ENV HEA, V19, P297, DOI 10.5271/sjweh.1470; Brown TA, 1997, BEHAV RES THER, V35, P79, DOI 10.1016/S0005-7967(96)00068-X; Bugajska J, 2013, RHEUMATOL INT, V33, P2975, DOI 10.1007/s00296-013-2843-8; Cardoso J.P., 2009, REV BRAS EPIDEMIOL, V12, P604, DOI [10.1590/S1415-790X2009000400010, DOI 10.1590/S1415-790X2009000400010]; Carlisle KN, 2014, SAF HEALTH WORK, V5, P203, DOI 10.1016/j.shaw.2014.07.005; Chiu TW, 2006, PUBLIC HEALTH, V120, P563, DOI 10.1016/j.puhe.2006.01.007; Chiu TTW, 2007, J OCCUP REHABIL, V17, P19, DOI 10.1007/s10926-006-9046-z; Coggon D, 2013, PAIN, V154, P856, DOI 10.1016/j.pain.2013.02.008; Crawford JO, 2007, OCCUP MED-OXFORD, V57, P300, DOI 10.1093/occmed/kqm036; Darwish MA, 2013, PAIN RES TREAT, V2013, DOI 10.1155/2013/878570; Erick PN, 2014, BMC MUSCULOSKEL DIS, V15, DOI 10.1186/1471-2474-15-359; Erick PN, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-260; Feyer AM, 2000, OCCUP ENVIRON MED, V57, P116, DOI 10.1136/oem.57.2.116; Hadi Azlihanis Abdul, 2006, Southeast Asian Journal of Tropical Medicine and Public Health, V37, P1254; Henry JD, 2005, BRIT J CLIN PSYCHOL, V44, P227, DOI 10.1348/014466505X29657; Hoogendoorn WE, 2001, SCAND J WORK ENV HEA, V27, P258, DOI 10.5271/sjweh.613; Jin K, 2004, J SAFETY RES, V35, P23, DOI 10.1016/j.jsr.2003.11.002; Karasek R., 1985, JOB CONTENT QUESTION; Korkmaz NC, 2011, SCI RES ESSAYS, V6, P649; Lavoie-Tremblay M, 2010, HEALTH CARE MANAG, V29, P293, DOI 10.1097/HCM.0b013e3181fa022e; LEINO P, 1993, PAIN, V53, P89, DOI 10.1016/0304-3959(93)90060-3; Linton SJ, 2000, SPINE, V25, P1148, DOI 10.1097/00007632-200005010-00017; Macfarlane GJ, 2009, ANN RHEUM DIS, V68, P885, DOI 10.1136/ard.2008.090829; Mohd Anuar NF, 2016, IRAN J PUBLIC HEALTH, V45, P85; Moore SC, 2016, JAMA INTERN MED, V176, P816, DOI 10.1001/jamainternmed.2016.1548; Moy FM, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-611; Musa R, 2007, ASEAN J PSYCHIATR, V8, P82; Nahit ES, 2003, ANN RHEUM DIS, V62, P755, DOI 10.1136/ard.62.8.755; Ng F, 2007, ACTA NEUROPSYCHIATR, V19, P304, DOI 10.1111/j.1601-5215.2007.00217.x; Noor N.M., 2014, MJPHM, V14, P56; Nurul Izzah A. S., 2010, American Journal of Applied Sciences, V7, P634; Palmer KT, 2008, PAIN, V136, P30, DOI 10.1016/j.pain.2007.06.011; Papathanasiou George, 2009, Hellenic J Cardiol, V50, P283; Pihl E, 2002, J SPORT MED PHYS FIT, V42, P466; Rajan B, 2016, INT J PHYS ED SPORTS, V3, P35; Rodriguez-Romero B, 2015, CLIN RHEUMATOL, V34, P1131, DOI 10.1007/s10067-014-2550-1; Rottermund J, 2015, MED PR, V66, P771, DOI 10.13075/mp.5893.00121; Schaufeli W.B., 2014, BRIDGING OCCUPATIONA, P43; Tsuboi H, 2002, IND HEALTH, V40, P266, DOI 10.2486/indhealth.40.266; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Yue PY, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-789	46	27	29	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0172195	10.1371/journal.pone.0172195	http://dx.doi.org/10.1371/journal.pone.0172195			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL5VB	28234933	Green Published, gold, Green Submitted			2022-12-27	WOS:000394688200050
J	Zhang, YN; Wang, YJ; Zuo, QS; Li, D; Zhang, WH; Wang, F; Ji, YQ; Jin, J; Lu, ZY; Wang, M; Zhang, C; Li, BC				Zhang, Yani; Wang, Yingjie; Zuo, Qisheng; Li, Dong; Zhang, Wenhui; Wang, Fei; Ji, Yanqin; Jin, Jing; Lu, Zhenyu; Wang, Man; Zhang, Chen; Li, Bichun			CRISPR/Cas9 mediated chicken Stra8 gene knockout and inhibition of male germ cell differentiation	PLOS ONE			English	Article							RETINOIC ACID; GENOME; SYSTEM	An efficient genome editing approach had been established to construct the stable transgenic cell lines in the domestic chicken (Gallus gallus domesticus) at present. Our objectives were to investigate gene function in the differentiation process of chicken embryonic stem cells (ESCs) into spermatogonial stem cells(SSCs). Three guides RNA (gRNAs) were designed to knockout the Stra8 gene, and knockout efficiency was evaluated in domestic chicken cells using cleavage activity of in vitro transcription of gRNA, Luciferase-SSA assay, T7 endonuclease I assay(T7E1) and TA clone sequence. In addition, the Cas9/gRNA plasmid was transfected into ESCs to confirm the function of Stra8. SSA assay results showed that luciferase activity of the vector expressing gRNA-1 and gRNA-2 was higher than that of gRNA-3. TA clone sequencing showed that the knockdown efficiency was 25% (10/40) in DF-1 cells, the knockdown efficiency was 23% (9/40) in chicken ESCs. T7E1 assay indicated that there were cleavage activity for three individuals, and the knockdown efficiency was 12% (3/25). Cell morphology, qRT-PCR, immunostaining and FCS indicated that Cas9/gRNA not only resulted in the knockout of Stra8 gene, but also suggested that the generation of SSCs was blocked by the Stra8 gene knockdown in vitro. Taken together, our results indicate that the CRISPR/Cas9 system could mediate stable Stra8 gene knockdown in domestic chicken's cells and inhibit ECSs differentiation into SSCs.	[Zhang, Yani; Wang, Yingjie; Zuo, Qisheng; Li, Dong; Zhang, Wenhui; Wang, Fei; Ji, Yanqin; Jin, Jing; Lu, Zhenyu; Wang, Man; Zhang, Chen; Li, Bichun] Yangzhou Univ, Coll Anim Sci & Technol, Yangzhou, Jiangsu, Peoples R China; [Zhang, Yani; Wang, Yingjie; Zuo, Qisheng; Li, Dong; Zhang, Wenhui; Wang, Fei; Ji, Yanqin; Jin, Jing; Lu, Zhenyu; Wang, Man; Zhang, Chen; Li, Bichun] Key Lab Anim Genet Breeding Reprod & Mol Design J, Yangzhou, Jiangsu, Peoples R China	Yangzhou University	Li, BC (corresponding author), Yangzhou Univ, Coll Anim Sci & Technol, Yangzhou, Jiangsu, Peoples R China.; Li, BC (corresponding author), Key Lab Anim Genet Breeding Reprod & Mol Design J, Yangzhou, Jiangsu, Peoples R China.	yubcli@yzu.edu.cn			National Natural Science Foundation of China [31301959]; Natural Science Foundation of Jiangsu Province [BK20161331]; science and technology projects fund of Yangzhou City [YZ2015105]; Priority Academic Program Development of Jiangsu Higher Education Institutions	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); science and technology projects fund of Yangzhou City; Priority Academic Program Development of Jiangsu Higher Education Institutions	This work was supported by the National Natural Science Foundation of China (31301959), Natural Science Foundation of Jiangsu Province (BK20161331), science and technology projects fund of Yangzhou City (YZ2015105), Priority Academic Program Development of Jiangsu Higher Education Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the Poultry Institute of the Chinese Academy of Agricultural Sciences Experimental Poultry Farm for providing experimental materials. This work was supported by the National Natural Science Foundation of China (31301959), Natural Science Foundation of Jiangsu Province (BK20161331), science and technology projects fund of Yangzhou City (YZ2015105), Priority Academic Program Development of Jiangsu Higher Education Institutions.	Bai YC, 2016, G3-GENES GENOM GENET, V6, P917, DOI 10.1534/g3.116.027706; Cong L, 2015, METHODS MOL BIOL, V1239, P197, DOI 10.1007/978-1-4939-1862-1_10; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Dai JianMing, 2007, Chinese Journal of Animal Science, V43, P15; [张振韬 Zhang Zhentao], 2014, [畜牧兽医学报, Acta Veterinaria et Zootechnica Sinica], V45, P38; Huang XiaoMei, 2014, Acta Veterinaria et Zootechnica Sinica, V45, P1253; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Jin K., 2014, CHINA POULTRY, V36, P8; Jinek M, 2014, SCIENCE, V343, P1215, DOI 10.1126/science.1247997; Mark M, 2008, J CELL SCI, V121, P3233, DOI 10.1242/jcs.035071; OuladAbdelghani M, 1996, J CELL BIOL, V135, P469, DOI 10.1083/jcb.135.2.469; Pain B, 1996, DEVELOPMENT, V122, P2339; Sommer D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4045; Sternberg SH, 2014, NATURE, V507, P62, DOI 10.1038/nature13011; Tedesco M, 2009, J BIOL CHEM, V284, P35781, DOI 10.1074/jbc.M109.056481; Veron N, 2015, DEV BIOL, V407, P68, DOI 10.1016/j.ydbio.2015.08.007; Xiao An, 2011, Yichuan, V33, P665, DOI 10.3724/SP.J.1005.2011.00665; Zhang ZT, 2015, J BIOL CHEM, V290, P13605, DOI 10.1074/jbc.M114.601401	18	18	21	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0172207	10.1371/journal.pone.0172207	http://dx.doi.org/10.1371/journal.pone.0172207			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5VB	28234938	Green Submitted, Green Published, gold			2022-12-27	WOS:000394688200051
J	Attuquayefio, T; Stevenson, RJ; Oaten, MJ; Francis, HM				Attuquayefio, Tuki; Stevenson, Richard J.; Oaten, Megan J.; Francis, Heather M.			A four-day Western-style dietary intervention causes reductions in hippocampal-dependent learning and memory and interoceptive sensitivity	PLOS ONE			English	Article							SATURATED-FAT DIET; MILD COGNITIVE IMPAIRMENT; REFINED SUGAR DIET; HIGH-ENERGY DIET; NEUROTROPHIC FACTOR; PREFRONTAL CORTEX; OXIDATIVE STRESS; SYNAPTIC PLASTICITY; GLUCOSE REGULATION; INDUCED OBESITY	In animals, a Western style diet-high in saturated fat and added sugar-causes impairments in hippocampal-dependent learning and memory (HDLM) and perception of internal bodily state (interoception). In humans, while there is correlational support for a link between Western- style diet, HDLM, and interoception, there is as yet no causal data. Here, healthy individuals were randomly assigned to consume either a breakfast high in saturated fat and added sugar (Experimental condition) or a healthier breakfast (Control condition), over four consecutive days. Tests of HDLM, interoception and biological measures were administered before and after breakfast on the days one and four, and participants completed food diaries before and during the study. At the end of the study, the Experimental condition showed significant reductions in HDLM and reduced interoceptive sensitivity to hunger and fullness, relative to the Control condition. The Experimental condition also showed a markedly different blood glucose and triglyceride responses to their breakfast, relative to Controls, with larger changes in blood glucose across breakfast being associated with greater reductions in HDLM. The Experimental condition compensated for their energy-dense breakfast by reducing carbohydrate intake, while saturated fat intake remained consistently higher than Controls. This is the first experimental study in humans to demonstrate that a Western-style diet impacts HDLM following a relatively short exposure-just as in animals. The link between diet-induced HDLM changes and blood glucose suggests one pathway by which diet impacts HDLM in humans.	[Attuquayefio, Tuki; Stevenson, Richard J.; Francis, Heather M.] Macquarie Univ, Dept Psychol, Sydney, NSW, Australia; [Oaten, Megan J.] Griffiths Univ, Sch Appl Psychol, Gold Coast, Qld, Australia	Macquarie University; Griffith University	Stevenson, RJ (corresponding author), Macquarie Univ, Dept Psychol, Sydney, NSW, Australia.	dick.stevenson@mq.edu.au	Attuquayefio, Tuki/I-3983-2019	Attuquayefio, Tuki/0000-0003-0328-1066; Francis, Heather/0000-0002-7223-7782; Oaten, Megan/0000-0001-8855-219X; Stevenson, Richard/0000-0002-2461-5777	Australian Research Council [DP150100105]; Department of Psychology, Macquarie University	Australian Research Council(Australian Research Council); Department of Psychology, Macquarie University	The Australian Research Council (http://www.arc.gov.au/) grant DP150100105 (to RJS & MO) was used to purchase equipment and materials.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank the Australian Research Council [DP150100105] and the Department of Psychology, Macquarie University for providing funding for this project.	[Anonymous], 2014, AUSTR FOOD SUPPL NUT; [Anonymous], 2008, NAT DIET NUTR SURV; [Anonymous], 2014, SR27 USDA DEP AGR NU; Attuquayefio TN, 2016, J EXP PSYCHOL ANIM L; Attuquayefio T, 2015, APPETITE, V95, P554, DOI 10.1016/j.appet.2015.08.023; Baker KD, 2016, NEUROBIOL LEARN MEM, V136, P127, DOI 10.1016/j.nlm.2016.10.002; Bayer-Carter JL, 2011, ARCH NEUROL-CHICAGO, V68, P743, DOI 10.1001/archneurol.2011.125; Baym CL, 2014, AM J CLIN NUTR, V99, P1026, DOI 10.3945/ajcn.113.079624; Beilharz JE, 2016, BEHAV BRAIN RES, V306, P1, DOI 10.1016/j.bbr.2016.03.018; Beilharz JE, 2014, BRAIN BEHAV IMMUN, V37, P134, DOI 10.1016/j.bbi.2013.11.016; Boitard C, 2014, BRAIN BEHAV IMMUN, V40, P9, DOI 10.1016/j.bbi.2014.03.005; Bonner-Jackson A, 2015, ALZHEIMERS RES THER, V7, DOI 10.1186/s13195-015-0147-9; Braam LAJLM, 1998, AM J EPIDEMIOL, V147, P1081, DOI 10.1093/oxfordjournals.aje.a009402; Brandt J., 1991, CLIN NEUROPSYCHOL, V5, P125, DOI [10.1080/13854049108403297, DOI 10.1080/13854049108403297]; Brannigan M, 2015, PHYSIOL BEHAV, V139, P423, DOI 10.1016/j.physbeh.2014.11.050; Burrows T, 2016, J HUM NUTR DIET, V10, P1; Cai DS, 2013, TRENDS ENDOCRIN MET, V24, P40, DOI 10.1016/j.tem.2012.11.003; Clifton PG, 1998, BEHAV NEUROSCI, V112, P502, DOI 10.1037/0735-7044.112.3.502; Crawford JR, 2001, PSYCHOL MED, V31, P451, DOI 10.1017/S0033291701003634; Darling JN, 2013, OBESITY, V21, P910, DOI 10.1002/oby.20167; Davidson TL, 2010, BEHAV NEUROSCI, V124, P97, DOI 10.1037/a0018402; Davidson TL, 2009, HIPPOCAMPUS, V19, P235, DOI 10.1002/hipo.20499; Davidson TL, 2005, PHYSIOL BEHAV, V86, P731, DOI 10.1016/j.physbeh.2005.09.004; Edwards LM, 2011, FASEB J, V25, P1088, DOI 10.1096/fj.10-171983; FARQUHAR JW, 1966, J CLIN INVEST, V45, P1648, DOI 10.1172/JCI105472; Francis H, 2013, J HUM NUTR DIET, V26, P234, DOI 10.1111/jhn.12008; Francis H, 2013, APPETITE, V63, P119, DOI 10.1016/j.appet.2012.12.018; Francis HM, 2013, PROTEOMICS, V13, P3076, DOI 10.1002/pmic.201300124; Francis HM, 2011, BEHAV NEUROSCI, V125, P943, DOI 10.1037/a0025998; Furlong TM, 2014, J NEUROSCI, V34, P5012, DOI 10.1523/JNEUROSCI.3707-13.2014; Gardener SL, 2015, MOL PSYCHIATR, V20, P860, DOI 10.1038/mp.2014.79; Gibson E Leigh, 2013, Front Hum Neurosci, V7, P838, DOI 10.3389/fnhum.2013.00838; Gold SM, 2007, DIABETOLOGIA, V50, P711, DOI 10.1007/s00125-007-0602-7; Goldbart AD, 2006, BRAIN RES, V1090, P190, DOI 10.1016/j.brainres.2006.03.046; Granholm AC, 2008, J ALZHEIMERS DIS, V14, P133; Granic A, 2016, J NUTRI NUTRI DIS, V146, P365; Greenwood CE, 1996, BEHAV NEUROSCI, V110, P451, DOI 10.1037/0735-7044.110.3.451; GREENWOOD CE, 1990, BEHAV NEURAL BIOL, V53, P74, DOI 10.1016/0163-1047(90)90831-P; Greenwood CE, 2001, NEUROBIOL LEARN MEM, V75, P179, DOI 10.1006/nlme.2000.3964; Greenwood CE, 2003, DIABETES CARE, V26, P1961, DOI 10.2337/diacare.26.7.1961; Hanson AJ, 2015, J ALZHEIMERS DIS, V48, P205, DOI 10.3233/JAD-150273; Hargrave SL, 2016, CURR OPIN BEHAV SCI, V9, P40, DOI 10.1016/j.cobeha.2015.12.001; HEBBEN N, 1985, BEHAV NEUROSCI, V99, P1031, DOI 10.1037/0735-7044.99.6.1031; Hoane MR, 2011, BEHAV BRAIN RES, V223, P119, DOI 10.1016/j.bbr.2011.04.028; Holloway CJ, 2011, AM J CLIN NUTR, V93, P748, DOI 10.3945/ajcn.110.002758; Hoyland A, 2008, NEUROSCI BIOBEHAV R, V32, P72, DOI 10.1016/j.neubiorev.2007.05.006; Hsu TM, 2015, HIPPOCAMPUS, V25, P227, DOI 10.1002/hipo.22368; Jurdak N, 2008, NUTR NEUROSCI, V11, P48, DOI 10.1179/147683008X301333; Jurdak N, 2009, PHYSIOL BEHAV, V96, P1, DOI 10.1016/j.physbeh.2008.07.023; KALMIJN S, 1995, DIABETOLOGIA, V38, P1096, DOI 10.1007/BF00402181; Kanoski SE, 2007, BEHAV BRAIN RES, V182, P57, DOI 10.1016/j.bbr.2007.05.004; Kanoski SE, 2010, J ALZHEIMERS DIS, V21, P207, DOI 10.3233/JAD-2010-091414; Kanoski SE, 2010, J EXP PSYCHOL-ANIM B, V36, P313, DOI 10.1037/a0017228; Kanoski SE, 2005, PHYSIOL BEHAV, V103, P59; Kaplan RJ, 2000, AM J CLIN NUTR, V72, P825; Karlsson J, 2000, INT J OBESITY, V24, P1715, DOI 10.1038/sj.ijo.0801442; Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074; Koopman KE, 2014, HEPATOLOGY, V60, P545, DOI 10.1002/hep.27149; Kramer JH, 2004, J INT NEUROPSYCH SOC, V10, P639, DOI 10.1017/S1355617704104050; Lee J, 2015, NUTRITION, V31, P647, DOI 10.1016/j.nut.2014.10.008; Macdiarmid J, 1998, NUTR RES REV, V11, P231, DOI 10.1079/NRR19980017; Maki PM, 2009, NEUROLOGY, V72, P1661, DOI 10.1212/WNL.0b013e3181a55f65; Marin I, 2013, LEARN MEMORY, V20, P601, DOI 10.1101/lm.028357.112; Martinez-Lapiscina EH, 2013, J NEUROL NEUROSUR PS, V84, P1318, DOI 10.1136/jnnp-2012-304792; McMillan L, 2011, APPETITE, V56, P143, DOI 10.1016/j.appet.2010.11.149; Messier C, 2007, BEHAV BRAIN RES, V178, P139, DOI 10.1016/j.bbr.2006.12.011; Molteni R, 2002, NEUROSCIENCE, V112, P803, DOI 10.1016/S0306-4522(02)00123-9; Morrison CD, 2010, J NEUROCHEM, V114, P1581, DOI 10.1111/j.1471-4159.2010.06865.x; Nelson H., 1991, NATL ADULT READING T; Nilsson A, 2013, NUTR METAB, V10, DOI 10.1186/1743-7075-10-49; Papathanasiou G, 2010, EUR J CARDIOV PREV R, V17, P380, DOI 10.1097/HJR.0b013e328333ede6; Parent MB, 2014, AM J PHYSIOL-REG I, V306, pR701, DOI 10.1152/ajpregu.00496.2013; Pistell PJ, 2010, J NEUROIMMUNOL, V219, P25, DOI 10.1016/j.jneuroim.2009.11.010; Rozin P, 1998, PSYCHOL SCI, V9, P392, DOI 10.1111/1467-9280.00073; Sample CH, 2015, APPETITE, V93, P13, DOI 10.1016/j.appet.2015.05.018; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; SASS KJ, 1992, J CLIN EXP NEUROPSYC, V14, P662, DOI 10.1080/01688639208402854; Schnabel R, 2012, CLIN NEUROPSYCHOL, V26, P102, DOI 10.1080/13854046.2011.640642; SCHOELLER DA, 1995, METABOLISM, V44, P18, DOI 10.1016/0026-0495(95)90204-X; Schulze MB, 2005, AM J CLIN NUTR, V82, P675, DOI 10.1093/ajcn/82.3.675; SIMPSON PM, 1991, INT J GERIATR PSYCH, V6, P95, DOI 10.1002/gps.930060208; Sorensen LB, 2005, AM J CLIN NUTR, V82, P421, DOI 10.1093/ajcn/82.2.421; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; Stewart R, 1999, DIABETIC MED, V16, P93, DOI 10.1046/j.1464-5491.1999.00027.x; Stranahan AM, 2008, HIPPOCAMPUS, V18, P1085, DOI 10.1002/hipo.20470; Sullivan K, 2005, ARCH CLIN NEUROPSYCH, V20, P745, DOI 10.1016/j.acn.2005.04.006; Tooze JA, 2004, AM J CLIN NUTR, V79, P795; Tran DMD, 2015, PSYCHOL SCI, V26, P1947, DOI 10.1177/0956797615608240; Travis SG, 2014, NEUROPSYCHOLOGIA, V53, P233, DOI 10.1016/j.neuropsychologia.2013.11.016; Vanhanen M, 1998, DIABETES CARE, V21, P398, DOI 10.2337/diacare.21.3.398; Warner-Schmidt JL, 2006, HIPPOCAMPUS, V16, P239, DOI 10.1002/hipo.20156; Wechsler D., 1997, WECHSLER ADULT INTEL; Wechsler D, 2009, WECHSLER ADULT INTEL; White CL, 2009, NEUROBIOL DIS, V35, P3, DOI 10.1016/j.nbd.2009.04.002; Wu A, 2003, NEUROSCIENCE, V119, P365, DOI 10.1016/S0306-4522(03)00154-4; Wu AG, 2004, EUR J NEUROSCI, V19, P1699, DOI 10.1111/j.1460-9568.2004.03246.x; Yirmiya R, 2011, BRAIN BEHAV IMMUN, V25, P181, DOI 10.1016/j.bbi.2010.10.015	97	61	61	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2017	12	2							e0172645	10.1371/journal.pone.0172645	http://dx.doi.org/10.1371/journal.pone.0172645			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL5SX	28231304	Green Submitted, Green Published, gold			2022-12-27	WOS:000394682400065
J	Serive, B; Nicolau, E; Berard, JB; Kaas, R; Pasquet, V; Picot, L; Cadoret, JP				Serive, Benoit; Nicolau, Elodie; Berard, Jean-Baptiste; Kaas, Raymond; Pasquet, Virginie; Picot, Laurent; Cadoret, Jean-Paul			Community analysis of pigment patterns from 37 microalgae strains reveals new carotenoids and porphyrins characteristic of distinct strains and taxonomic groups	PLOS ONE			English	Article							PERFORMANCE LIQUID-CHROMATOGRAPHY; PHOTOSYNTHETIC PIGMENTS; CHLOROPHYLL-A; HPLC METHOD; MARINE-PHYTOPLANKTON; CHEMICAL-COMPOSITION; GROWTH-RATE; LIGHT; METABOLITES; PHASE	Phytoplankton, with an estimated 30 000 to 1 000 000 species clustered in 12 phyla, presents a high taxonomic and ecophysiological diversity, reflected by the complex distribution of pigments among the different algal classes. High performance liquid chromatography is the gold standard method for qualitative and quantitative analysis of phytoplankton pigments in seawater and culture samples, but only a few pigments can be used as robust chemotaxonomic markers. A major challenge is thus to identify new ones, characteristic of a strain, species, class or taxon that cannot be currently identified on the basis of its pigment signature. Using an optimized extraction process coupled to a HPLC de-replication strategy, we examined the pigment composition of 37 microalgae strains, representative of the broad taxonomic diversity of marine and freshwater species ( excluding cyanobacteria). For each species, the major pigments already described were unambiguously identified. We also observed the presence of several minor unidentified pigments in each chromatogram. The global analysis of pigment compositions revealed a total of 124 pigments, including 98 pigments or derivatives unidentified using the standards. Absorption spectra indicated that 35 corresponded to chlorophyll/ porphyrin derivatives, 57 to carotenoids and six to derivatives having both spectral signatures. Sixty-one of these unidentified or new carotenoids and porphyrin derivatives were characteristic of particular strains or species, indicating their possible use as highly specific chemotaxonomic markers capable of identifying one strain out of the 37 selected. We developed a graphical analysis using Gephi software to give a clear representation of pigment communities among the various phytoplankton strains, and to reveal strain-characteristic and shared pigments. This made it possible to reconstruct the taxonomic evolution of microalgae classes, on the basis of the conservation, loss, and/ or appearance of pigments.	[Serive, Benoit; Nicolau, Elodie; Berard, Jean-Baptiste; Kaas, Raymond; Cadoret, Jean-Paul] IFREMER, Lab Physiol & Biotechnol Algues, Nantes, France; [Pasquet, Virginie; Picot, Laurent] Univ la Rochelle, UMRi CNRS LIENSs 7266, La Rochelle, France	Ifremer; La Rochelle Universite	Serive, B; Nicolau, E (corresponding author), IFREMER, Lab Physiol & Biotechnol Algues, Nantes, France.	benoit.serive@live.fr; elodie.nicolau@ifremer.fr	NICOLAU, Elodie/ADO-7121-2022; bérard, jean-baptiste/AAX-6898-2021	Nicolau, Elodie/0000-0003-0849-4503; Berard, Jean-Baptiste/0000-0001-7350-8006; Cadoret, Jean-Paul/0000-0001-7542-5474	Region Pays de la Loire [2008-09351]; French National Agency for Research [ANR-08EB10-0016]	Region Pays de la Loire(Region Pays de la Loire); French National Agency for Research(French National Research Agency (ANR))	This research was supported by a doctoral fellowship grant from Region Pays de la Loire for BS's PhD (No 2008-09351), and by French National Agency for Research (ANR-08EB10-0016) for PHOTOMER project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abby SS, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00505; AITZETMULLER K, 1969, PHYTOCHEMISTRY, V8, P1761, DOI 10.1016/S0031-9422(00)85966-X; Archibald JM, 2002, TRENDS GENET, V18, P577, DOI 10.1016/S0168-9525(02)02777-4; Bastian M., 2009, GEPHI OPEN SOURCE SO, DOI DOI 10.13140/2.1.1341.1520; Baudelet PH, 2013, MAR DRUGS, V11, P4390, DOI 10.3390/md11114390; Bernal FA, 2012, J CHIL CHEM SOC, V57, P1256, DOI 10.4067/S0717-97072012000300013; Bode HB, 2002, CHEMBIOCHEM, V3, P619, DOI 10.1002/1439-7633(20020703)3:7<619::AID-CBIC619>3.0.CO;2-9; Boroczky K, 2006, CHEM BIODIVERS, V3, P622, DOI 10.1002/cbdv.200690065; BRODY M, 1959, J GEN PHYSIOL, V43, P251, DOI 10.1085/jgp.43.2.251; Camp D, 2012, J NAT PROD, V75, P72, DOI 10.1021/np200687v; Carbonera D, 2014, CURR PROTEIN PEPT SC, V15, P332, DOI 10.2174/1389203715666140327111139; Chauton MS, 2003, MAR ECOL PROG SER, V256, P57, DOI 10.3354/meps256057; Claustre H, 2004, MAR CHEM, V85, P41, DOI 10.1016/j.marchem.2003.09.002; Delwiche CF, 1999, AM NAT, V154, pS164, DOI 10.1086/303291; Donkor VA, 1997, ACTA PROTOZOOL, V36, P49; Donkor VA, 1996, AQUAT MICROB ECOL, V11, P143, DOI 10.3354/ame011143; Dubinsky Z, 2009, AQUAT MICROB ECOL, V56, P163, DOI 10.3354/ame01345; Durnford DG, 2006, EUKARYOT CELL, V5, P2079, DOI 10.1128/EC.00222-06; Egeland ES, 2000, J CHEM SOC PERK T 1, P1223, DOI 10.1039/a910345g; Estevez MS, 2001, J PHOTOCH PHOTOBIO B, V62, P19, DOI 10.1016/S1011-1344(01)00157-9; EVERITT DA, 1990, DEEP-SEA RES, V37, P975, DOI 10.1016/0198-0149(90)90106-6; Figueroa FL, 2010, MAR POLLUT BULL, V60, P1768, DOI 10.1016/j.marpolbul.2010.06.009; Figueroa FL, 2003, J PHOTOCH PHOTOBIO B, V72, P35, DOI 10.1016/j.jphotobiol.2003.09.002; Gantt E, 1990, BIOL RED ALGAE, P203; Gao Y, 2009, PHOTOCHEM PHOTOBIOL, V85, P774, DOI 10.1111/j.1751-1097.2008.00493.x; Graziani G, 2013, FOOD FUNCT, V4, P144, DOI 10.1039/c2fo30198a; Hansen ME, 2005, ANAL CHEM, V77, P6805, DOI 10.1021/ac040191e; Henriksen P, 2002, J PLANKTON RES, V24, P835, DOI 10.1093/plankt/24.9.835; Higgins H.W., 2011, PHYTOPLANKTON PIGMEN, P257, DOI [10.1017/CBO9780511732263, DOI 10.1017/CBO9780511732263, DOI 10.1017/CBO9780511732263.010]; HOLDEN M, 1963, PHOTOCHEM PHOTOBIOL, V2, P175, DOI 10.1111/j.1751-1097.1963.tb08213.x; Huang JJH, 2011, FOOD CHEM, V129, P783, DOI 10.1016/j.foodchem.2011.05.021; Ivanisevic J, 2011, METABOLOMICS, V7, P289, DOI 10.1007/s11306-010-0239-2; Jeffrey S. W., 1996, PHYTOPLANKTON PIGMEN; Jeffrey S.W., 2011, PHYTOPLANKTON PIGMEN, P3, DOI [10.1017/cbo9780511732263, DOI 10.1017/CBO9780511732263.004]; JEFFREY SW, 1987, MAR ECOL PROG SER, V35, P293, DOI 10.3354/meps035293; Juin C, 2015, MAR DRUGS, V13, P2541, DOI 10.3390/md13042541; KLEIN B, 1988, J EXP MAR BIOL ECOL, V115, P237, DOI 10.1016/0022-0981(88)90157-8; Knight V, 2003, APPL MICROBIOL BIOT, V62, P446, DOI 10.1007/s00253-003-1381-9; Kuczynska P, 2015, MAR DRUGS, V13, P5847, DOI 10.3390/md13095847; Kuwahara SS, 2011, OPT LASER ENG, V49, P434, DOI 10.1016/j.optlaseng.2010.11.015; Lang I, 2011, BMC PLANT BIOL, V11, P124, DOI DOI 10.1186/1471-2229-11-124; LATASA M, 1994, J PLANKTON RES, V16, P83, DOI 10.1093/plankt/16.1.83; Legrand C, 2003, PHYCOLOGIA, V42, P406, DOI 10.2216/i0031-8884-42-4-406.1; LEWITUS AJ, 1990, MAR ECOL PROG SER, V61, P171, DOI 10.3354/meps061171; Lohr M, 1999, P NATL ACAD SCI USA, V96, P8784, DOI 10.1073/pnas.96.15.8784; Lohr M, 2001, PLANTA, V212, P382, DOI 10.1007/s004250000403; Louda JW, 2000, ORG GEOCHEM, V31, P1561; MacIntyre HL, 2002, J PHYCOL, V38, P17, DOI 10.1046/j.1529-8817.2002.00094.x; MacIntyre HL, 2000, TRENDS PLANT SCI, V5, P12, DOI 10.1016/S1360-1385(99)01504-6; Mangoni O, 2011, MAR DRUGS, V9, P242, DOI 10.3390/md9020242; MANTOURA RFC, 1983, ANAL CHIM ACTA, V151, P297, DOI 10.1016/S0003-2670(00)80092-6; Mouget JL, 2005, J APPL PHYCOL, V17, P437, DOI 10.1007/s10811-005-0561-7; Mouget JL, 2004, J PHOTOCH PHOTOBIO B, V75, P1, DOI 10.1016/j.jphotobiol.2004.04.002; Mulders KJM, 2013, J APPL PHYCOL, V25, P1421, DOI 10.1007/s10811-012-9954-6; MURRAY AP, 1986, MAR CHEM, V19, P211, DOI 10.1016/0304-4203(86)90024-1; Nishitani G, 2012, APPL ENVIRON MICROB, V78, P813, DOI 10.1128/AEM.06544-11; Pickering MD, 2011, GEOCHIM COSMOCHIM AC, V75, P533, DOI 10.1016/j.gca.2010.10.020; Pietra F, 1997, NAT PROD REP, V14, P453, DOI 10.1039/np9971400453; Polivka T, 2010, CAROTENOIDS: PHYSICAL, CHEMICAL, AND BIOLOGICAL FUNCTIONS AND PROPERTIES, P137; Reuss N, 2005, MAR CHEM, V95, P283, DOI 10.1016/j.marchem.2004.10.002; Rial P, 2013, J PLANKTON RES, V35, P433, DOI 10.1093/plankt/fbs099; Rodriguez-Rojo S, 2012, J FOOD ENG, V109, P98, DOI 10.1016/j.jfoodeng.2011.09.029; Rontani JF, 2003, ORG GEOCHEM, V34, P1, DOI 10.1016/S0146-6380(02)00185-7; Roy S., 2011, PHYTOPLANKTON PIGMEN; SAKSHAUG E, 1986, J PLANKTON RES, V8, P619, DOI 10.1093/plankt/8.4.619; Salvadori E, 2012, PHYS CHEM CHEM PHYS, V14, P12238, DOI 10.1039/c2cp40877e; Scheer H, 2003, ADV PHOTOSYNTHESIS R, V13; Schmidt B, 2008, ANAL CHEM, V80, P1978, DOI 10.1021/ac702064p; Serive B, 2012, BIORESOURCE TECHNOL, V124, P311, DOI 10.1016/j.biortech.2012.07.105; Sestak Z., 2004, CAROTENOIDS, V42, DOI 10.1023/b:phot.0000040641.40049.19,2; Skovgaard A, 1998, AQUAT MICROB ECOL, V15, P293, DOI 10.3354/ame015293; STAUBER JL, 1988, J PHYCOL, V24, P158; Steinbrenner J, 2003, PLANT MOL BIOL, V52, P343, DOI 10.1023/A:1023948929665; Stonik V, 2015, MAR DRUGS, V13, P3672, DOI 10.3390/md13063672; Szymczak-Zyla M, 2011, MAR CHEM, V125, P39, DOI 10.1016/j.marchem.2011.02.002; Takaichi S, 2011, MAR DRUGS, V9, P1101, DOI 10.3390/md9061101; Tamm M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122526; Thompson PA, 2007, DEEP-SEA RES PT II, V54, P1003, DOI 10.1016/j.dsr2.2006.12.009; Thrane JE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137645; Tukaj Z, 2003, PLANT PHYSIOL BIOCH, V41, P337, DOI 10.1016/S0981-9428(03)00028-7; Van Heukelem L, 2001, J CHROMATOGR A, V910, P31, DOI 10.1016/S0378-4347(00)00603-4; Van Heukelem L, 1995, OCEANOGRAPHIC LIT RE, V5, P376; VANHEUKELEM L, 1992, J PHYCOL, V28, P867; WILHELM C, 1991, J APPL PHYCOL, V3, P305, DOI 10.1007/BF00026092; Wolf D, 2007, CHIMIA, V61, P339, DOI 10.2533/chimia.2007.339; Wright SW, 2010, DEEP-SEA RES PT II, V57, P758, DOI 10.1016/j.dsr2.2009.06.015; Wright SW, 2006, HANDB ENVIRON CHEM, V2, P71, DOI 10.1007/698_2_003; WRIGHT SW, 1991, MAR ECOL PROG SER, V77, P183, DOI 10.3354/meps077183; Zapata M, 2004, MAR ECOL PROG SER, V270, P83, DOI 10.3354/meps270083; Zapata M, 2000, MAR ECOL PROG SER, V195, P29, DOI 10.3354/meps195029; Zapata M, 2012, MAR ECOL PROG SER, V465, P33, DOI 10.3354/meps09879	91	30	29	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2017	12	2							e0171872	10.1371/journal.pone.0171872	http://dx.doi.org/10.1371/journal.pone.0171872			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5SX	28231253	Green Submitted, Green Published, gold			2022-12-27	WOS:000394682400023
J	Di Cicco, E; Ferguson, HW; Schulze, AD; Kaukinen, KH; Li, S; Vanderstichel, R; Wessel, O; Rimstad, E; Gardner, IA; Hammell, KL; Miller, KM				Di Cicco, Emiliano; Ferguson, Hugh W.; Schulze, Angela D.; Kaukinen, Karia H.; Li, Shaorong; Vanderstichel, Raphael; Wessel, Oystein; Rimstad, Espen; Gardner, Ian A.; Hammell, K. Larry; Miller, Kristina M.			Heart and skeletal muscle inflammation (HSMI) disease diagnosed on a British Columbia salmon farm through a longitudinal farm study	PLOS ONE			English	Article							PISCINE ORTHOREOVIRUS PRV; ATLANTIC SALMON; PANCREAS DISEASE; REOVIRUS PRV; SALAR; CARDIOMYOPATHY; WILD	Heart and skeletal muscle inflammation (HSMI) is an emerging disease of marine-farmed Atlantic Salmon (Salmo salar), first recognized in 1999 in Norway, and later also reported in Scotland and Chile. We undertook a longitudinal study involving health evaluation over an entire marine production cycle on one salmon farm in British Columbia (Canada). In previous production cycles at this farm site and others in the vicinity, cardiac lesions not linked to a specific infectious agent or disease were identified. Histologic assessments of both live and moribund fish samples collected at the farm during the longitudinal study documented at the population level the development, peak, and recovery phases of HSMI. The fish underwent histopathological evaluation of all tissues, Twort's Gram staining, immunohistochemistry, and molecular quantification in heart tissue of 44 agents known or suspected to cause disease in salmon. Our analysis showed evidence of HSMI histopathological lesions over an 11-month timespan, with the prevalence of lesions peaking at 80-100% in sampled fish, despite mild clinical signs with no associated elevation in mortalities reported at the farm level. Diffuse mononuclear inflammation and myodegeneration, consistent with HSMI, was the predominant histologic observation in affected heart and skeletal muscle. Infective agent monitoring identified three agents at high prevalence in salmon heart tissue, including Piscine orthoreovirus (PRV), and parasites Paranucleospora theridion and Kudoa thyrsites. However, PRV alone was statistically correlated with the occurrence and severity of histopathological lesions in the heart. Immunohistochemical staining further localized PRV throughout HSMI development, with the virus found mainly within red blood cells in early cases, moving into the cardiomyocytes within or, more often, on the periphery of the inflammatory reaction during the peak disease, and reducing to low or undetectable levels later in the production cycle. This study represents the first longitudinal assessment of HSMI in a salmon farm in British Columbia, providing new insights on the pathogenesis of the disease.	[Di Cicco, Emiliano; Schulze, Angela D.; Kaukinen, Karia H.; Li, Shaorong; Miller, Kristina M.] Fisheries & Oceans Canada, Pacific Biol Stn, Nanaimo, BC, Canada; [Di Cicco, Emiliano] Pacific Salmon Fdn, Vancouver, BC, Canada; [Ferguson, Hugh W.] St Georges Univ, St Georges, St George, Grenada; [Vanderstichel, Raphael; Gardner, Ian A.; Hammell, K. Larry] Univ Prince Edward Isl, Ctr Vet Epidemiol Res, Dept Hlth Management, Atlantic Vet Coll, Charlottetown, PE, Canada; [Wessel, Oystein; Rimstad, Espen] Norwegian Univ Life Sci, Dept Food Safety & Infect Biol, Oslo, Norway	Fisheries & Oceans Canada; University of Prince Edward Island; Norwegian University of Life Sciences	Di Cicco, E; Miller, KM (corresponding author), Fisheries & Oceans Canada, Pacific Biol Stn, Nanaimo, BC, Canada.; Di Cicco, E (corresponding author), Pacific Salmon Fdn, Vancouver, BC, Canada.	emiliano.dicicco@dfo-mpo.gc.ca; Kristi.Saunders@dfo-mpo.gc.ca	Vanderstichel, Raphael/ABE-7078-2020	Hammell, Keith Larry/0000-0002-1473-8730; Vanderstichel, Raphael/0000-0002-8847-6876	Pacific Salmon Foundation "Salish Sea Marine Survival" project; Genome British Columbia; Department of Fisheries and Oceans (DFO), Canada	Pacific Salmon Foundation "Salish Sea Marine Survival" project; Genome British Columbia; Department of Fisheries and Oceans (DFO), Canada	This project was part of the Strategic Salmon Health Initiative, co-funded by the Pacific Salmon Foundation Salish Sea Marine Survival project, Genome British Columbia, and the Department of Fisheries and Oceans (DFO), Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Borno G, 2014, FISKEHELSERAPPORTEN, V2014, P16; Braden L., 2016, HSMI STILL NOT BC; Cohen BI, 2012, UNCERTAIN FUTURE FRA, V1, P36; DFO, 2015, DFO CAN SCI ADVIS SE; FERGUSON HW, 1990, DIS AQUAT ORGAN, V8, P225, DOI 10.3354/dao008225; Ferguson HW, 2005, J FISH DIS, V28, P119, DOI 10.1111/j.1365-2761.2004.00602.x; Finstad OW, 2014, THESIS, P28; Finstad OW, 2014, VET RES, V45, DOI 10.1186/1297-9716-45-35; Finstad OW, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-27; Garseth AH, 2013, J FISH DIS, V36, P483, DOI 10.1111/j.1365-2761.2012.01450.x; Garseth AH, 2014, THESIS, P99; Garseth AH, 2012, HEART SKELETAL MUSCL; Garseth AH, 2013, PREV VET MED, V112, P138, DOI 10.1016/j.prevetmed.2013.06.007; Garver KA, 2015, J FISH DIS, P1; Garver KA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146229; Godoy MG, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0554-y; GOLLER T, 1986, VIRCHOWS ARCH B, V50, P373, DOI 10.1007/BF02889915; Hauge H., 2016, Veterinary Research, V47; Johansen LH, 2016, MOL IMMUNOL, V73, P138, DOI 10.1016/j.molimm.2016.04.007; Johansen LH, 2015, FISH SHELLFISH IMMUN, V46, P612, DOI 10.1016/j.fsi.2015.07.023; Kindermann I, 2012, J AM COLL CARDIOL, V59, P779, DOI 10.1016/j.jacc.2011.09.074; Kongtorp RT, 2009, J FISH DIS, V32, P253, DOI 10.1111/j.1365-2761.2008.00983.x; Kongtorp RT, 2006, J FISH DIS, V29, P233, DOI 10.1111/j.1365-2761.2006.00710.x; Kongtorp RT, 2004, DIS AQUAT ORGAN, V59, P217, DOI 10.3354/dao059217; Kongtorp RT, 2004, J FISH DIS, V27, P351, DOI 10.1111/j.1365-2761.2004.00549.x; LANDIS JR, 1977, BIOMETRICS, V33, P363, DOI 10.2307/2529786; Lovoll M, 2012, DIS AQUAT ORGAN, V99, P7, DOI 10.3354/dao02451; Lovoll M, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-309; Marine Harvest ASA, 2015, ANN REP US SEC EXCH, P20; Marty GD, 2015, J FISH DIS, V38, P713, DOI 10.1111/jfd.12285; Mikalsen AB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107132; Mikalsen AB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037269; MILLER KM, 2016, 2016038 DFO CAN SCI; Miller KM, 2014, EVOL APPL, V7, P812, DOI 10.1111/eva.12164; MUNRO ALS, 1984, HELGOLANDER MEERESUN, V37, P571; Olsen AB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131638; Palacios G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011487; Sandoval A., 2011, ADL DIAGNOSTIC CHILE, V7, P1; Sherry B, 1998, CURR TOP MICROBIOL, V233, P51; Siah A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141475; Watanabe K, 2006, DIS AQUAT ORGAN, V70, P183, DOI 10.3354/dao070183; Wiik-Nielsen J, 2016, J FISH DIS, P1	44	54	55	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2017	12	2							e0171471	10.1371/journal.pone.0171471	http://dx.doi.org/10.1371/journal.pone.0171471			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5SK	28225783	Green Accepted, Green Published, gold			2022-12-27	WOS:000394680900013
J	Narita, M; Shimura, E; Nagasawa, A; Aiuchi, T; Suda, Y; Hamada, Y; Ikegami, D; Iwasawa, C; Arakawa, K; Igarashi, K; Kuzumaki, N; Yoshioka, Y; Ochiya, T; Takeshima, H; Ushijima, T; Narita, M				Narita, Michiko; Shimura, Eri; Nagasawa, Atsumi; Aiuchi, Toshiki; Suda, Yukari; Hamada, Yusuke; Ikegami, Daigo; Iwasawa, Chizuru; Arakawa, Kazuhiko; Igarashi, Katsuhide; Kuzumaki, Naoko; Yoshioka, Yusuke; Ochiya, Takahiro; Takeshima, Hideyuki; Ushijima, Toshikazu; Narita, Minoru			Chronic treatment of non-small-cell lung cancer cells with gefitinib leads to an epigenetic loss of epithelial properties associated with reductions in microRNA-155 and-200c	PLOS ONE			English	Article							MESENCHYMAL TRANSITION; TUMOR PROGRESSION; RESISTANCE; EGFR; EXPRESSION; CARCINOMA; MUTATION; NUCLEUS	Background The EGFR tyrosine kinase inhibitor gefitinib is used in therapy for non-small-cell lung cancer (NSCLC). However, its application is limited by resistance-accelerated disease progression, which is accompanied by the epithelial-to-mesenchymal transition (EMT). In the present study, we performed multiple expression analyses of microRNAs (miRNAs) and quantified the expression of several related EMT players in gefitinib-resistant NSCLC cells. Methods and results To establish gefitinib-resistant NSCLC cells, gefitinib-sensitive HCC827 cells, which exhibit an in-frame deletion [E746-A750] in EGFR exon 19, were exposed to gefitinib for at least 1.5 months. Next, to profile "gefitinib-resistant HCC827 (HCC827GR)" cells, which have a secondary T790M mutation in EGFR exon 20, a miRNA array analysis was performed in HCC827 and HCC827GR cells. The greatest differences were seen in the levels of miR-155 and miR-200c, which essentially disappeared in HCC827GR cells. In addition to these reductions, the levels of smad2 and zeb1, which are both key players in EMT and targets for miR-155 and miR-200c, respectively, were dramatically increased in HCC827GR cells. In HCC827GR cells, the expression of epithelial-cadherin (E-cadherin) was greatly reduced with repressive histone modifications, whereas vimentin, which is expressed in mesenchymal cells, was dramatically increased with active histone modifications. In another gefitinib-resistant NSCLC cell line (H1975 cells), similar to the findings in HCC827GR cells, both miR-155 and miR-200c were absent, and the EMT was induced along with epigenetic modifications. Interestingly, the inhibition of both miR-155 and miR-200c in HCC827 cells without gefitinib induced significant increases in smad2 and zeb1 along with a dramatic decrease in E-cadherin and a slight increase in vimentin. Furthermore, although the inhibition of these miRNAs in HCC827 cells decreased gefitinib sensitivity, this dual-inhibition in HCC827 cells without gefitinib did not produce a secondary T790M mutation in EGFR exon 20. Conclusion and implications These results suggest that chronic treatment of NSCLC cells with gefitinib changes the expression of miRNAs, including dramatic reductions in miR-155 and miR-200c along with an EGFR mutation. Furthermore, this depletion of miR-155 and miR-200c may be associated with the EMT along with histone modifications, and may contribute to the decrease in the sensitivity to gefitinib independent of a secondary EGFR mutation.	[Narita, Michiko; Shimura, Eri; Nagasawa, Atsumi; Aiuchi, Toshiki; Suda, Yukari; Hamada, Yusuke; Ikegami, Daigo; Iwasawa, Chizuru; Arakawa, Kazuhiko; Kuzumaki, Naoko; Ochiya, Takahiro; Narita, Minoru] Hoshi Univ, Sch Pharm & Pharmaceut Sci, Dept Pharmacol, Shinagawa Ku, Tokyo, Japan; [Igarashi, Katsuhide; Ushijima, Toshikazu; Narita, Minoru] Hoshi Univ, Sch Pharm & Pharmaceut Sci, Life Sci Tokyo Adv Res Ctr L StaR, Shinagawa Ku, Tokyo, Japan; [Yoshioka, Yusuke; Ochiya, Takahiro] Natl Canc Ctr, Div Mol & Cellular Med, Chuo Ku, Tokyo, Japan; [Takeshima, Hideyuki; Ushijima, Toshikazu] Natl Canc Ctr, Div Epigen, Chuo Ku, Tokyo, Japan	Hoshi University; Hoshi University; National Cancer Center - Japan; National Cancer Center - Japan	Narita, M (corresponding author), Hoshi Univ, Sch Pharm & Pharmaceut Sci, Dept Pharmacol, Shinagawa Ku, Tokyo, Japan.; Narita, M (corresponding author), Hoshi Univ, Sch Pharm & Pharmaceut Sci, Life Sci Tokyo Adv Res Ctr L StaR, Shinagawa Ku, Tokyo, Japan.	narita@hoshi.ac.jp	Hamada, Yusuke/HHN-8877-2022; Ushijima, Toshikazu/AAP-5742-2021; Ochiya, Takahiro/AAH-7585-2019	Ushijima, Toshikazu/0000-0003-3405-7817; Takeshima, Hideyuki/0000-0002-8552-2427	MEXT-Supported Program for the Strategic Research Foundation at Private Universities [S1411019]	MEXT-Supported Program for the Strategic Research Foundation at Private Universities(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the MEXT-Supported Program for the Strategic Research Foundation at Private Universities 2014-2018, S1411019 (Minoru Narita) [http://www.mext.go.jp/english/].; We thank Dr. Aya Maekawa (Laboratory of Molecular Genetics, The Institute of Medical Science, The University of Tokyo) for helping our sequence analysis. This study was supported by the MEXT-Supported Program for the Strategic Research Foundation at Private Universities (2014-2018, S1411019).	Bell DW, 2005, NAT GENET, V37, P1315, DOI 10.1038/ng1671; Chiu CF, 2016, P NATL ACAD SCI USA, V113, pE2526, DOI 10.1073/pnas.1522612113; Ciardiello F, 2001, CLIN CANCER RES, V7, P2958; Esteller Manel, 2011, Genes Cancer, V2, P604, DOI 10.1177/1947601911423096; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Francis H, 2010, INTERN MED J, V40, P611, DOI 10.1111/j.1445-5994.2009.02141.x; Gailhouste L, 2013, HISTOL HISTOPATHOL, V28, P437, DOI 10.14670/HH-28.437; Guz M, 2014, DIS MARKERS, V2014, DOI 10.1155/2014/218169; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Imai S, 2011, J NEUROSCI, V31, P15294, DOI 10.1523/JNEUROSCI.0921-11.2011; Jackman D, 2010, J CLIN ONCOL, V28, P357, DOI 10.1200/JCO.2009.24.7049; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Kuzumaki N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044368; Li JY, 2014, ONCOTARGET, V5, P7902, DOI 10.18632/oncotarget.2302; Li T, 2013, WORLD J GASTROENTERO, V19, P5615, DOI 10.3748/wjg.v19.i34.5615; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Nijkamp MM, 2011, RADIOTHER ONCOL, V99, P344, DOI 10.1016/j.radonc.2011.05.066; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Shah NR, 2014, WORLD J CLIN ONCOL, V5, P48, DOI 10.5306/wjco.v5.i2.48; Takeshima H, 2009, GENOME RES, V19, P1974, DOI 10.1101/gr.093310.109; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Xiao Dakai, 2010, J Thorac Dis, V2, P154, DOI 10.3978/j.issn.2072-1439.2010.02.03.7; Xiong MX, 2012, AM J PHYSIOL-RENAL, V302, pF369, DOI 10.1152/ajprenal.00268.2011; Xu J, 2009, CELL RES, V19, P156, DOI 10.1038/cr.2009.5; Yang Jie, 2013, Zhonghua Nan Ke Xue, V19, P831	26	20	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2017	12	2							e0172115	10.1371/journal.pone.0172115	http://dx.doi.org/10.1371/journal.pone.0172115			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5SK	28225782	gold, Green Published, Green Submitted			2022-12-27	WOS:000394680900029
J	Spuler, M				Spueler, Martin			A high-speed brain-computer interface (BCI) using dry EEG electrodes	PLOS ONE			English	Article							PERFORMANCE; CLASSIFICATION; POTENTIALS	Recently, brain-computer interfaces (BCIs) based on visual evoked potentials (VEPs) have been shown to achieve remarkable communication speeds. As they use electroencephalography (EEG) as non-invasive method for recording neural signals, the application of gel-based EEG is time-consuming and cumbersome. In order to achieve a more user-friendly system, this work explores the usability of dry EEG electrodes with a VEP-based BCI. While the results show a high variability between subjects, they also show that communication speeds of more than 100 bit/min are possible using dry EEG electrodes. To reduce performance variability and deal with the lower signal-to-noise ratio of the dry EEG electrodes, an averaging method and a dynamic stopping method were introduced to the BCI system. Those changes were shown to improve performance significantly, leading to an average classification accuracy of 76% with an average communication speed of 46 bit/min, which is equivalent to a writing speed of 8.8 error-free letters per minute. Although the BCI system works substantially better with gel-based EEG, dry EEG electrodes are more user-friendly and still allow high-speed BCI communication.	[Spueler, Martin] Eberhard Karls Univ Tubingen, Dept Comp Engn, Tubingen, Germany	Eberhard Karls University of Tubingen	Spuler, M (corresponding author), Eberhard Karls Univ Tubingen, Dept Comp Engn, Tubingen, Germany.	spueler@informatik.uni-tuebingen.de			German Research Council (DFG) [SP 1533/2-1]; Open Access Publishing Fund of the University of Tubingen	German Research Council (DFG)(German Research Foundation (DFG)); Open Access Publishing Fund of the University of Tubingen	This work was supported by the German Research Council (DFG; SP 1533/2-1) and the Open Access Publishing Fund of the University of Tubingen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baek HJ, 2013, BIOMED ENG LETT, V3, P158, DOI 10.1007/s13534-013-0099-6; Cecotti H, 2011, J PHYSIOL-PARIS, V105, P106, DOI 10.1016/j.jphysparis.2011.08.003; Chen XG, 2015, P NATL ACAD SCI USA, V112, pE6058, DOI 10.1073/pnas.1508080112; Chi YM, 2012, IEEE T NEUR SYS REH, V20, P228, DOI 10.1109/TNSRE.2011.2174652; Dal Seno B, 2010, IEEE T NEUR SYS REH, V18, P20, DOI 10.1109/TNSRE.2009.2032642; Duvinage M, 2013, BIOMED ENG ONLINE, V12, DOI 10.1186/1475-925X-12-56; FARWELL LA, 1988, ELECTROEN CLIN NEURO, V70, P510, DOI 10.1016/0013-4694(88)90149-6; Grozea C, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/2/025008; Grummett TS, 2015, PHYSIOL MEAS, V36, P1469, DOI 10.1088/0967-3334/36/7/1469; Guger C., 2011, P 5 INT BRAIN COMP I, P316; Kubler A, 2004, J PSYCHOPHYSIOL, V18, P121, DOI 10.1027/0269-8803.18.23.121; Nakanishi M, 2015, IEEE ENG MED BIO, P1057, DOI 10.1109/EMBC.2015.7318547; Pasion R, 2016, J NEUROSCI METH, V267, P126, DOI 10.1016/j.jneumeth.2016.04.009; Pfurtscheller G, 2001, P IEEE, V89, P1123, DOI 10.1109/5.939829; Popescu F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000637; Saab J., 2011, P 5 INT BRAIN COMP I, P312; Schreuder M, 2011, IEEE ENG MED BIO, P4580, DOI 10.1109/IEMBS.2011.6091134; Schreuder M, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00112; Sellers EW, 2009, LECT NOTES COMPUT SC, V5611, P623, DOI 10.1007/978-3-642-02577-8_68; Spuler M, 2015, IEEE ENG MED BIO, P1087, DOI 10.1109/EMBC.2015.7318554; Spuler M, 2014, IEEE T NEUR SYS REH, V22, P1097, DOI 10.1109/TNSRE.2013.2290870; Spuler M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051077; Spuler M, 2012, CLIN NEUROPHYSIOL, V123, P1328, DOI 10.1016/j.clinph.2011.11.082; Spuler M, 2012, P 20 EUR S ART NEUR, P103, DOI [10.13140/2.1.2186.7526, DOI 10.13140/2.1.2186.7526]; Vidaurre C, 2010, BRAIN TOPOGR, V23, P194, DOI 10.1007/s10548-009-0121-6; Wang F, 2016, J NEURAL ENG, V13, DOI 10.1088/1741-2560/13/4/046021; Wolpaw J R, 1998, IEEE Trans Rehabil Eng, V6, P326, DOI 10.1109/86.712231; Wolpaw JR, 2002, CLIN NEUROPHYSIOL, V113, P767, DOI 10.1016/S1388-2457(02)00057-3; Yuan P, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/2/026014; Yue Liu, 2012, 2012 IEEE International Conference on Virtual Environments Human-Computer Interfaces and Measurement Systems (VECIMS), P34; Zander TO, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00053	31	51	54	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2017	12	2							e0172400	10.1371/journal.pone.0172400	http://dx.doi.org/10.1371/journal.pone.0172400			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5SK	28225794	Green Published, gold, Green Submitted			2022-12-27	WOS:000394680900039
J	Liu, F; Pawan, KC; Zhang, G; Zhe, J				Liu, Fan; Pawan, K. C.; Zhang, Ge; Zhe, Jiang			In situ single cell detection via microfluidic magnetic bead assay	PLOS ONE			English	Article							CIRCULATING TUMOR-CELLS; MESENCHYMAL STEM-CELLS; METASTATIC BREAST-CANCER; PERIPHERAL-BLOOD; IMPEDANCE CYTOMETRY; DRUG RESPONSES; BONE-MARROW; SEPARATION; PARTICLES; CHIP	We present a single cell detection device based on magnetic bead assay and micro Coulter counters. This device consists of two successive micro Coulter counters, coupled with a high gradient magnetic field generated by an external magnet. The device can identify single cells in terms of the transit time difference of the cell through the two micro Coulter counters. Target cells are conjugated with magnetic beads via specific antibody and antigen binding. A target cell traveling through the two Coulter counters interacts with the magnetic field, and have a longer transit time at the 1st counter than that at the 2nd counter. In comparison, a non-target cell has no interaction with the magnetic field, and hence has nearly the same transit times through the two counters. Each cell passing through the two counters generates two consecutive voltage pulses one after the other; the pulse widths and magnitudes indicating the cell's transit times through the counters and the cell's size respectively. Thus, by measuring the pulse widths (transit times) of each cell through the two counters, each single target cell can be differentiated from non-target cells even if they have similar sizes. We experimentally proved that the target human umbilical vein endothelial cells (HUVECs) and non-target rat adipose-derived stem cells (rASCs) have significant different transit time distribution, from which we can determine the recognition regions for both cell groups quantitatively. We further demonstrated that within a mixed cell population of rASCs and HUVECs, HUVECs can be detected in situ and the measured HUVECs ratios agree well with the preset ratios. With the simple device structure and easy sample preparation, this method is expected to enable single cell detection in a continuous flow and can be applied to facilitate general cell detection applications such as stem cell identification and enumeration.	[Liu, Fan; Zhe, Jiang] Univ Akron, Dept Mech Engn, Akron, OH 44325 USA; [Pawan, K. C.; Zhang, Ge] Univ Akron, Dept Biomed Engn, Akron, OH 44325 USA	University System of Ohio; University of Akron; University System of Ohio; University of Akron	Zhe, J (corresponding author), Univ Akron, Dept Mech Engn, Akron, OH 44325 USA.; Zhang, G (corresponding author), Univ Akron, Dept Biomed Engn, Akron, OH 44325 USA.	ge10@uakron.edu; jzhe@uakron.edu		Liu, Fan/0000-0001-8827-2278	National Science Foundation [DBI-IDBR-1353720, ECCS-1625544]	National Science Foundation(National Science Foundation (NSF))	This work supported by National Science Foundation: DBI-IDBR-1353720, JZ, https://www.nsf.gov/awardsearch/showAward?AWD_ID=1353720; and National Science Foundation: ECCS-1625544, JZ, https://nsf.gov/awardsearch/showAward?AWD_ID=1625544&HistoricalAwards=false. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abonnenc M, 2009, ANAL BIOANAL CHEM, V395, P747, DOI 10.1007/s00216-009-3006-3; Adams JD, 2008, P NATL ACAD SCI USA, V105, P18165, DOI 10.1073/pnas.0809795105; Alunni-Fabbroni M, 2010, METHODS, V50, P289, DOI 10.1016/j.ymeth.2010.01.027; Arya SK, 2012, LAB CHIP, V12, P2362, DOI 10.1039/c2lc21174b; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Baksh D, 2004, J CELL MOL MED, V8, P301, DOI 10.1111/j.1582-4934.2004.tb00320.x; Bendall SC, 2011, SCIENCE, V332, P687, DOI 10.1126/science.1198704; BERGE LI, 1990, MEAS SCI TECHNOL, V1, P471, DOI 10.1088/0957-0233/1/6/001; Blasius AL, 2006, J IMMUNOL, V177, P3260, DOI 10.4049/jimmunol.177.5.3260; Buggenthin F, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-297; Carbonaro A, 2008, LAB CHIP, V8, P1478, DOI 10.1039/b801929k; Chen P, 2014, LAB CHIP MULTISCALE, P446; Cho SH, 2010, LAB CHIP, V10, P1567, DOI 10.1039/c000136h; Corcione A, 2004, P NATL ACAD SCI USA, V101, P11064, DOI 10.1073/pnas.0402455101; Cristofanilli M, 2005, J CLIN ONCOL, V23, P1420, DOI 10.1200/JCO.2005.08.140; Cristofanilli M, 2004, NEW ENGL J MED, V351, P781, DOI 10.1056/NEJMoa040766; De Coppi P, 2007, NAT BIOTECHNOL, V25, P100, DOI 10.1038/nbt1274; Deans RJ, 2000, EXP HEMATOL, V28, P875, DOI 10.1016/S0301-472X(00)00482-3; DEBLOIS RW, 1970, REV SCI INSTRUM, V41, P909, DOI 10.1063/1.1684724; DEWYNTER EA, 1995, STEM CELLS, V13, P524, DOI 10.1002/stem.5530130510; Dodd SJ, 1999, BIOPHYS J, V76, P103, DOI 10.1016/S0006-3495(99)77182-1; Edgar R, 2006, P NATL ACAD SCI USA, V103, P4841, DOI 10.1073/pnas.0601211103; Etzrodt M, 2014, CELL STEM CELL, V15, P546, DOI 10.1016/j.stem.2014.10.015; Fonnum G, 2005, J MAGN MAGN MATER, V293, P41, DOI 10.1016/j.jmmm.2005.01.041; Gassner AL, 2009, LAB CHIP, V9, P2356, DOI 10.1039/b901865d; Gawad S, 2001, LAB CHIP, V1, P76, DOI 10.1039/b103933b; Gijs MAM, 2010, CHEM REV, V110, P1518, DOI 10.1021/cr9001929; GOMM JJ, 1995, ANAL BIOCHEM, V226, P91, DOI 10.1006/abio.1995.1196; Gough AH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102678; Han Y, 2016, LAB CHIP, V16, P773, DOI 10.1039/c5lc01207d; Hejazian M, 2015, LAB CHIP, V15, P959, DOI 10.1039/c4lc01422g; Holmes D, 2010, ANAL CHEM, V82, P1455, DOI 10.1021/ac902568p; Holmes D, 2009, LAB CHIP, V9, P2881, DOI 10.1039/b910053a; Inglis DW, 2004, APPL PHYS LETT, V85, P5093, DOI 10.1063/1.1823015; Jacobson A, 2000, BIOCHEM J, V348, P29, DOI 10.1042/0264-6021:3480029; Jagtiani AV, 2011, J MICROMECH MICROENG, V21, DOI 10.1088/0960-1317/21/4/045036; KATO K, 1993, CYTOMETRY, V14, P384, DOI 10.1002/cyto.990140407; KELLY BS, 1979, IMMUNOLOGY, V37, P45; Kim S, 2013, ANAL CHEM, V85, P2779, DOI 10.1021/ac303284u; Kozissnik B, 2013, MRS BULL, V38, P927, DOI 10.1557/mrs.2013.257; Kuhara M, 2004, ANAL CHEM, V76, P6207, DOI 10.1021/ac0493727; Lara O, 2004, EXP HEMATOL, V32, P891, DOI 10.1016/j.exphem.2004.07.007; Lawson DA, 2015, NATURE, V526, P131, DOI 10.1038/nature15260; Liu C, 2007, CHINA COMMUN, V4, P8; Liu F, 2016, MICROFLUID NANOFLUID, V20, DOI 10.1007/s10404-015-1672-3; Liu F, 2016, ANAL CHEM, V88, P711, DOI 10.1021/acs.analchem.5b02716; Loo LH, 2007, NAT METHODS, V4, P445, DOI 10.1038/NMETH1032; McCloskey KE, 2003, ANAL CHEM, V75, P6868, DOI 10.1021/ac034315j; MILTENYI S, 1990, CYTOMETRY, V11, P231, DOI 10.1002/cyto.990110203; Moore LR, 2001, J MAGN MAGN MATER, V225, P277, DOI 10.1016/S0304-8853(00)01251-8; Narsinh KH, 2011, J CLIN INVEST, V121, P1217, DOI 10.1172/JCI44635; Nebe-von-Caron G, 2000, J MICROBIOL METH, V42, P97, DOI 10.1016/S0167-7012(00)00181-0; Pamme N, 2004, ANAL CHEM, V76, P7250, DOI 10.1021/ac049183o; Pamme N, 2006, LAB CHIP, V6, P974, DOI 10.1039/b604542a; Plouffe BD, 2012, ANAL CHEM, V84, P1336, DOI 10.1021/ac2022844; Qin ZP, 2011, MEAS SCI TECHNOL, V22, DOI 10.1088/0957-0233/22/4/045804; Reagan MR, 2011, STEM CELLS, V29, P920, DOI 10.1002/stem.645; Reiter RE, 1998, P NATL ACAD SCI USA, V95, P1735, DOI 10.1073/pnas.95.4.1735; Riethdorf S, 2007, CLIN CANCER RES, V13, P920, DOI 10.1158/1078-0432.CCR-06-1695; Robert D, 2011, LAB CHIP, V11, P1902, DOI 10.1039/c0lc00656d; Safarik I, 1999, J CHROMATOGR B, V722, P33, DOI 10.1016/S0378-4347(98)00338-7; Sivagnanam V, 2010, LANGMUIR, V26, P6091, DOI 10.1021/la9045572; Sun T, 2010, MICROFLUID NANOFLUID, V8, P423, DOI 10.1007/s10404-010-0580-9; Talasaz AH, 2009, P NATL ACAD SCI USA, V106, P3970, DOI 10.1073/pnas.0813188106; Valero A, 2010, LAB CHIP, V10, P2216, DOI 10.1039/c003982a; Van der Auwera I, 2010, BRIT J CANCER, V102, P276, DOI 10.1038/sj.bjc.6605472; van Reenen A, 2014, LAB CHIP, V14, P1966, DOI 10.1039/c3lc51454d; Wu YJ, 2007, STEM CELLS, V25, P2648, DOI 10.1634/stemcells.2007-0226; Xia N, 2006, BIOMED MICRODEVICES, V8, P299, DOI 10.1007/s10544-006-0033-0; Yuan HL, 2010, NANOSCALE RES LETT, V5, P1817, DOI 10.1007/s11671-010-9718-7; Zborowski M, 1999, J MAGN MAGN MATER, V194, P224, DOI 10.1016/S0304-8853(98)00581-2; Zhao XJ, 2004, P NATL ACAD SCI USA, V101, P15027, DOI 10.1073/pnas.0404806101; Zola H, 2006, MOL MED, V12, P312, DOI 10.2119/2006-00081.Zola	73	13	13	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2017	12	2							e0172697	10.1371/journal.pone.0172697	http://dx.doi.org/10.1371/journal.pone.0172697			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5QV	28222140	Green Published, Green Submitted, gold			2022-12-27	WOS:000394676800077
J	Santos, JA; Piccinelli, AC; Formagio, MD; Oliveira, CS; dos Santos, EP; Stefanello, MEA; Lanza, U; Oliveira, RJ; Sugizaki, MM; Kassuya, CAL				Santos, Joyce Alencar; Piccinelli, Ana Claudia; Formagio, Maira Dante; Oliveira, Cristhian Santos; dos Santos, Elide Pereira; Alves Stefanello, Maria Elida; Lanza Junior, Ubirajara; Oliveira, Rodrigo Juliano; Sugizaki, Mario Mateus; Kassuya, Caandida Aparecida Leite			Antidepressive and antinociceptive effects of ethanolic extract and fruticuline A from Salvia lachnostachys Benth leaves on rodents	PLOS ONE			English	Article							NEUROPATHIC PAIN; MICE; MODEL	Objectives This study investigated the antidepressant and antinociceptive effects of ethanolic extract (SLEE) and pure fruticuline A obtained from Salvia lachnostachys leaves on rats and mice. Methods In this study, SLEE (100 mg/kg, p. o. route) was evaluated for its effects on spared nerve injury (SNI) in rats. The animals were submitted to mechanical sensitivity, forced swim (FST) and cold sensitivity tests 10 and 15 days after surgery. SLEE (100 mg/kg, p. o.) and fruticuline A (3 mg/kg, p. o.) were also evaluated with respect to nociceptive behavior induced by formalin. In addition, clonidine-induced depressive-like behavior was also analyzed. Results The oral administration of SLEE for up to 15 days and the subcutaneous injection of 10 mg/ kg of ketamine (positive control) significantly inhibited SNI-induced mechanical hyperalgesia and decreased immobility in the FST. On the 15th day of oral treatment, SLEE prevented the SNI-induced increase in cold sensitivity. In the formalin test, SLEE and fruticuline A significantly reduced the frequency of paw licking during the first and second phases and decreased the formation of edema. In locomotor analysis (open field test without clonidine treatment), SLEE and fruticuline A did not alter the response. SLEE and fruticuline A significantly attenuated clonidine-induced suppression of spontaneous locomotor activity (squares invaded and licking) and emotionality (grooming and freezing) compared with controls, similar to the naive group. Conclusion SLEE exhibits antihyperalgesic, antidepressant, and antinociceptive effects, and fruticuline A appears to be at least partly responsible for the effects of SLEE. Together, these results demonstrate the antidepressive effects of SLEE and fruticuline A and indicate that both derivatives obtained from S. lachnostachys act against spontaneous neuropathic pain.	[Santos, Joyce Alencar] Fed Univ Grande Dourados, Coll Exact Sci & Technol, Dourados, MS, Brazil; [Piccinelli, Ana Claudia; Formagio, Maira Dante; Lanza Junior, Ubirajara; Kassuya, Caandida Aparecida Leite] Fed Univ Grande Dourados, Coll Hlth Sci, Dourados, MS, Brazil; [Oliveira, Cristhian Santos; Alves Stefanello, Maria Elida] Univ Fed Parana, Dept Chem, Curitiba, PR, Brazil; [dos Santos, Elide Pereira] Univ Fed Parana, Dept Bot, Curitiba, PR, Brazil; [Oliveira, Rodrigo Juliano] Univ Fed Mato Grosso do Sul, Coll Hlth Sci, Campo Grande, MS, Brazil; [Sugizaki, Mario Mateus] Univ Fed Mato Grosso, Coll Hlth Sci, Sinop, MT, Brazil	Universidade Federal da Grande Dourados; Universidade Federal da Grande Dourados; Universidade Federal do Parana; Universidade Federal do Parana; Universidade Federal de Mato Grosso do Sul; Universidade Federal de Mato Grosso	Santos, JA (corresponding author), Fed Univ Grande Dourados, Coll Exact Sci & Technol, Dourados, MS, Brazil.	joycealencarr@hotmail.com	Oliveira, Cristhian/AAU-9118-2020; Kassuya, Candida A. L./G-8329-2011; Oliveira, Rodrigo Juliano/M-3151-2018; Radai, Joyce Alencar Santos/AAF-2906-2019; LANZA, Ubirajara Lanza Jr ULJ/D-3691-2017; Oliveira, Rodrigo Juliano/AGQ-6655-2022; Oliveira, Rodrigo/D-9982-2013; sugizaki, mario/AAM-9904-2020; Santos, Elide/C-5841-2013	Oliveira, Rodrigo Juliano/0000-0003-3514-3346; LANZA, Ubirajara Lanza Jr ULJ/0000-0001-5461-3177; Oliveira, Rodrigo Juliano/0000-0003-3514-3346; Santos, Elide/0000-0002-8600-3039; Kassuya, Candida/0000-0002-8998-9219; Oliveira, Cristhian/0000-0001-5620-393X; Dante Formagio, Maira/0000-0003-0616-3305	Fundacao de Amparo a Pesquisa do Estado do Mato Grosso do Sul (FUNDECT) [45/2014, 23/200.622/2014]	Fundacao de Amparo a Pesquisa do Estado do Mato Grosso do Sul (FUNDECT)	The authors thank the Fundacao de Amparo a Pesquisa do Estado do Mato Grosso do Sul (FUNDECT) for financial support, through the projects FUNDECT/CAPES no 45/2014 - PAPOS REDE PRO-CENTRO-OESTE EASE II - No 23/200.622/2014 and the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Rodrigues MRA, 2012, J ETHNOPHARMACOL, V139, P519, DOI 10.1016/j.jep.2011.11.042; Barauna SC, 2006, PHARMACOL BIOCHEM BE, V85, P160, DOI 10.1016/j.pbb.2006.07.030; Baron R, 2010, LANCET NEUROL, V9, P807, DOI 10.1016/S1474-4422(10)70143-5; Bisio A, 2008, J AGR FOOD CHEM, V56, P10468, DOI 10.1021/jf802200x; Bongiorno P, 2010, NAT MED J, V2, P3; Bourquin AF, 2006, PAIN, V122, P14, DOI 10.1016/j.pain.2005.10.036; Boyce-Rustay JM, 2010, METHODS MOL BIOL, V617, P41, DOI 10.1007/978-1-60327-323-7_4; Braida D, 2009, BRIT J PHARMACOL, V157, P844, DOI 10.1111/j.1476-5381.2009.00230.x; de Almeida AAC, 2014, PHARMACOL BIOCHEM BE, V118, P69, DOI 10.1016/j.pbb.2014.01.006; Chang CY, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/159015; Colla ARS, 2014, PHARMACOL BIOCHEM BE, V124, P108, DOI 10.1016/j.pbb.2014.05.015; Decosterd I, 2000, PAIN, V87, P149, DOI 10.1016/S0304-3959(00)00276-1; Erbano M, 2012, MICROSC RES TECHNIQ, V75, P1737, DOI 10.1002/jemt.22125; Gonzalez-Cortazar M, 2013, MOLECULES, V18, P13260, DOI 10.3390/molecules181113260; HUNSKAAR S, 1987, PAIN, V30, P103, DOI 10.1016/0304-3959(87)90088-1; Ito S, 2001, NEUROSCI RES, V41, P299, DOI 10.1016/S0168-0102(01)00289-9; Jung HJ, 2009, J ETHNOPHARMACOL, V126, P355, DOI 10.1016/j.jep.2009.08.031; Kassuya CAL, 2009, J ETHNOPHARMACOL, V124, P369, DOI 10.1016/j.jep.2009.06.003; Maletic V, 2009, FRONT BIOSCI-LANDMRK, V14, P5291, DOI 10.2741/3598; Marcus DJ, 2015, MOL PAIN, V11, DOI 10.1186/s12990-015-0031-4; Oliveira CS, 2016, PHYTOCHEM LETT, V17, P140, DOI 10.1016/j.phytol.2016.07.005; Piccinelli AC, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/835914; PORSOLT RD, 1977, ARCH INT PHARMACOD T, V229, P327; Reuben SS, 1998, ANESTHESIOLOGY, V89, P527, DOI 10.1097/00000542-199808000-00034; Sagheddu C, 2015, NEUROPHARMACOLOGY, V97, P383, DOI 10.1016/j.neuropharm.2015.06.003; Snedecor SJ, 2013, J PAIN RES, V6, P539, DOI 10.2147/JPR.S45966; Walker JB, 2007, ANN BOT-LONDON, V100, P375, DOI 10.1093/aob/mcl176; Wang J, 2011, ANESTHESIOLOGY, V115, P812, DOI 10.1097/ALN.0b013e31822f16ae; Xu B, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-15; Yang LM, 2014, BRAIN RES BULL, V100, P22, DOI 10.1016/j.brainresbull.2013.10.007; Zaki H. F., 2013, African Journal of Pharmacy and Pharmacology, V7, P2960	31	13	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2017	12	2							e72151	10.1371/journal.pone.0172151	http://dx.doi.org/10.1371/journal.pone.0172151			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5QV	28222143	gold, Green Submitted, Green Published			2022-12-27	WOS:000394676800035
J	Gu, J; Cavanagh, K; Baer, R; Strauss, C				Gu, Jenny; Cavanagh, Kate; Baer, Ruth; Strauss, Clara			An empirical examination of the factor structure of compassion	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; LOVING-KINDNESS MEDITATION; MINDFULNESS; LOVE; CARE; FIT	Compassion has long been regarded as a core part of our humanity by contemplative traditions, and in recent years, it has received growing research interest. Following a recent review of existing conceptualisations, compassion has been defined as consisting of the following five elements: 1) recognising suffering, 2) understanding the universality of suffering in human experience, 3) feeling moved by the person suffering and emotionally connecting with their distress, 4) tolerating uncomfortable feelings aroused (e.g., fear, distress) so that we remain open to and accepting of the person suffering, and 5) acting or being motivated to act to alleviate suffering. As a prerequisite to developing a high quality compassion measure and furthering research in this field, the current study empirically investigated the factor structure of the five-element definition using a combination of existing and newly generated self-report items. This study consisted of three stages: a systematic consultation with experts to review items from existing self-report measures of compassion and generate additional items (Stage 1), exploratory factor analysis of items gathered from Stage 1 to identify the underlying structure of compassion (Stage 2), and confirmatory factor analysis to validate the identified factor structure (Stage 3). Findings showed preliminary empirical support for a five-factor structure of compassion consistent with the five-element definition. However, findings indicated that the 'tolerating' factor may be problematic and not a core aspect of compassion. This possibility requires further empirical testing. Limitations with items from included measures lead us to recommend against using these items collectively to assess compassion. Instead, we call for the development of a new self-report measure of compassion, using the five-element definition to guide item generation. We recommend including newly generated 'tolerating' items in the initial item pool, to determine whether or not factor-level issues are resolved once item-level issues are addressed.	[Gu, Jenny; Cavanagh, Kate; Strauss, Clara] Univ Sussex, Sch Psychol, Falmer, E Sussex, England; [Baer, Ruth] Univ Kentucky, Dept Psychol, Lexington, KY 40506 USA; [Baer, Ruth] Univ Oxford, Warneford Hosp, Dept Psychiat, Oxford, England; [Strauss, Clara] Sussex Partnership NHS Fdn Trust, Hove, England	University of Sussex; University of Kentucky; University of Oxford	Strauss, C (corresponding author), Univ Sussex, Sch Psychol, Falmer, E Sussex, England.; Strauss, C (corresponding author), Sussex Partnership NHS Fdn Trust, Hove, England.	c.y.strauss@sussex.ac.uk		Cavanagh, Kate/0000-0002-9863-1462; Gu, Jenny/0000-0003-3660-4204; Strauss, Clara/0000-0002-0303-763X	Economic and Social Research Council; Sussex Partnership NHS Foundation Trust [ES/J500173/1]; Economic and Social Research Council [1362793] Funding Source: researchfish	Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Sussex Partnership NHS Foundation Trust; Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This research was funded by the Economic and Social Research Council and Sussex Partnership NHS Foundation Trust in a joint Doctoral Training Scholarship provided to the first author (grant no. ES/J500173/1).	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Baer RA, 2006, ASSESSMENT, V13, P27, DOI 10.1177/1073191105283504; BENTLER PM, 1980, PSYCHOL BULL, V88, P588, DOI 10.1037/0033-2909.107.2.238; BENTLER PM, 1990, PSYCHOL BULL, V107, P238, DOI 10.1037/0033-2909.88.3.588; Bohlmeijer E., 2011, ASSESSMENT; Browne M.W., 1992, SOCIOL METHOD RES, V21, P230, DOI 10.1177/0049124192021002005; Burnell L., 2013, INT J CARING SCI, V6, P180, DOI DOI 10.1177/1078345817716436; Crocker J, 2008, J PERS SOC PSYCHOL, V95, P555, DOI 10.1037/0022-3514.95.3.555; Dalai Lama, 2002, VISIONS COMPASSION W, P213; Darwin C., 1871, P423; Davidson R.J., 2015, WORLD HAPPINESS REPO, P88; Davis M. H., 1980, JSAS CATALOG SELECTE, V10, P1, DOI DOI 10.1037/0022-3514.44.1.113; de Waal Frans, 2009, THE AGE OF EMPATHY; Department of Health, 2013, HDB NHS CONST; Desbordes G, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00292; Feldman C, 2011, CONTEMP BUDDHISM, V12, P143, DOI 10.1080/14639947.2011.564831; Field A., 2013, DISCOVERING STAT USI; Fredrickson BL, 2008, J PERS SOC PSYCHOL, V95, P1045, DOI 10.1037/a0013262; Gilbert P., 2005, COMPASSION CONCEPTUA, P263, DOI [DOI 10.4324/9780203003459, 10.4324/9780203003459]; Gilbert P., 2009, COMPASSIONATE MIND N; Gilbert P., 2010, COMPASSIONATE MIND; Gilbert P., 2005, COMPASSION CONCEPTUA, P9, DOI DOI 10.4324/9780203003459; Goetz JL, 2010, PSYCHOL BULL, V136, P351, DOI 10.1037/a0018807; Goleman Daniel, 2003, DESTRUCTIVE EMOTIONS; Hacker T., 2008, THESIS U GLASGOW; Henry JD, 2005, BRIT J CLIN PSYCHOL, V44, P227, DOI 10.1348/014466505X29657; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Hutcherson CA, 2008, EMOTION, V8, P720, DOI 10.1037/a0013237; Hwang JY, 2008, PASTOR PSYCHOL, V56, P421, DOI 10.1007/s11089-008-0117-2; IBM Corp Released, 2021, IBM SPSS STAT WINDOW; Institute of Medicine, 2001, CROSSING QUALITY CHA, DOI DOI 10.17226/10027; Jazaieri H, 2013, J HAPPINESS STUD, V14, P1113, DOI 10.1007/s10902-012-9373-z; Jazaieri H, 2014, MOTIV EMOTION, V38, P23, DOI 10.1007/s11031-013-9368-z; Jinpa GT, 2010, COMPASSION CUL UNPUB; John O.P., 1999, HDB PERSONALITY THEO, VVolume 2, P102; Joinson C, 1992, Nursing, V22, P118; KABATZINN J, 1982, GEN HOSP PSYCHIAT, V4, P33, DOI 10.1016/0163-8343(82)90026-3; Keltner D., 2009, BORN BE GOOD SCI MEA; Klimecki OM, 2013, SOCIAL COGNITIVE AFF; Kline R.B., 2011, PRINCIPLES PRACTICE; Lown BA, 2015, PATIENT EDUC COUNS, V98, P1005, DOI 10.1016/j.pec.2015.03.019; Lown BA, 2011, HEALTH AFFAIR, V30, P1772, DOI 10.1377/hlthaff.2011.0539; MacCallum RC, 1999, PSYCHOL METHODS, V4, P84, DOI 10.1037/1082-989x.4.1.84; Martins D, 2013, J HEALTH CARE POOR U, V24, P1235, DOI 10.1353/hpu.2013.0148; Mascaro JS, 2013, SOC COGN AFFECT NEUR, V8, P48, DOI 10.1093/scan/nss095; Mongrain M, 2011, J HAPPINESS STUD, V12, P963, DOI 10.1007/s10902-010-9239-1; Moses J., 2002, ONENESS GREAT PRINCI; Neff KD, 2013, SELF IDENTITY; Neff KD, 2003, SELF IDENTITY, V2, P223, DOI 10.1080/15298860390209035; Neff KD, 2013, J CLIN PSYCHOL, V69, P28, DOI 10.1002/jclp.21923; Osborne J., 2005, PRACTICAL ASSESSMENT, V10, P1, DOI [10.7275/jyj1-4868, DOI 10.7275/JYJ1-4868, 10.4135/9781412995627.d8, DOI 10.4135/9781412995627.D8]; Pommier E. A, 2010, THESIS; Raes F, 2011, CLIN PSYCHOL PSYCHOT, V18, P250, DOI 10.1002/cpp.702; Schermelleh-Engel K, 2003, METHODS PSYCHOL RES, V8, P23, DOI DOI 10.1002/0470010940; Segal Z. V., 2002, MINDFULNESS BASED CO; Segal Z.V., 2013, MINDFULNESS BASED CO, V2nd ed.; Shapiro SL, 1998, J BEHAV MED, V21, P581, DOI 10.1023/A:1018700829825; Sprecher S, 2005, J SOC PERS RELAT, V22, P629, DOI 10.1177/0265407505056439; STEIGER JH, 1990, MULTIVAR BEHAV RES, V25, P173, DOI 10.1207/s15327906mbr2502_4; Stewart-Brown S, 2009, HEALTH QUAL LIFE OUT, V7, DOI 10.1186/1477-7525-7-15; Strauss C, 2016, CLIN PSYCHOL REV, V47, P15, DOI 10.1016/j.cpr.2016.05.004; Strohminger N, 2014, COGNITION, V131, P159, DOI 10.1016/j.cognition.2013.12.005; van den Brink E., 2015, MINDFULNESS BASED CO; VELICER WF, 1990, MULTIVAR BEHAV RES, V25, P1, DOI 10.1207/s15327906mbr2501_1; Wallace BA, 2001, J CONSCIOUSNESS STUD, V8, P209	65	33	35	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2017	12	2							e0172471	10.1371/journal.pone.0172471	http://dx.doi.org/10.1371/journal.pone.0172471			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL2BI	28212391	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000394424700054
J	Krawczenko, A; Bielawska-Pohl, A; Wojtowicz, K; Jura, R; Paprocka, M; Wojdat, E; Kozlowska, U; Klimczak, A; Grillon, C; Kieda, C; Dus, D				Krawczenko, Agnieszka; Bielawska-Pohl, Aleksandra; Wojtowicz, Karolina; Jura, Roksana; Paprocka, Maria; Wojdat, Elzbieta; Kozlowska, Urszula; Klimczak, Aleksandra; Grillon, Catherine; Kieda, Claudine; Dus, Danuta			Expression and activity of multidrug resistance proteins in mature endothelial cells and their precursors: A challenging correlation	PLOS ONE			English	Article							CANCER STEM-CELLS; P-GLYCOPROTEIN; DRUG-RESISTANCE; ABC TRANSPORTERS; GENE-EXPRESSION; BREAST-CANCER; SUBSTRATE; MECHANISMS; PHENOTYPE; MOLECULES	Active cellular transporters of harmful agents D multidrug resistance ( mdr) proteins D are present in tumor, stem and endothelial cells, among others. While mdr proteins are broadly studied in tumor cells, their role in non-tumor cells and the significance of their action not connected with removal of harmful xenobiotics is less extensively documented. Proper assessment of mdr proteins expression is difficult. Mdr mRNA presence is most often evaluated but that does not necessarily correlate with the protein level. The protein expression itself is difficult to determine; usually cells with mdr overexpression are studied, not cells under physiological conditions, in which a low expression level of mdr protein is often insufficient for detection in vitro. Various methods are used to identify mdr mRNA and protein expression, together with functional tests demonstrating their biological drug transporting activities. Data comparing different methods of investigating expression of mdr mRNAs and their corresponding proteins are still scarce. In this article we present the results of a study concerning mdr mRNA and protein expression. Our goal was to search for the best method to investigate the expression level and functional activity of five selected mdr proteins D MDR1, BCRP, MRP1, MRP4 and MRP5 D in established in vitro cell lines of human endothelial cells ( ECs) and their progenitors. Endothelial cells demonstrated mdr presence at the mRNA level, which was not always confirmed at the protein level or in functional tests. Therefore, several different assays had to be applied for evaluation of mdr proteins expression and functions in endothelial cells. Among them functional tests seemed to be the most conclusive, although not very specific.	[Krawczenko, Agnieszka; Bielawska-Pohl, Aleksandra; Paprocka, Maria; Wojdat, Elzbieta; Kozlowska, Urszula; Klimczak, Aleksandra; Dus, Danuta] Polish Acad Sci, Hirszfeld Inst Immunol & Expt Therapy, Wroclaw, Poland; [Wojtowicz, Karolina] Poznan Univ Med Sci, Dept Histol & Embryol, Poznan, Poland; [Jura, Roksana] Wroclaw Res Ctr EIT, Wroclaw, Poland; [Grillon, Catherine; Kieda, Claudine] CNRS UPR 4301, Ctr Biophys Mol, Cellular Microenvironm & Pharmacol Targets, Orleans, France	Polish Academy of Sciences; Hirszfeld Institute of Immunology & Experimental Therapy of the Polish Academy of Sciences; Poznan University of Medical Sciences; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC)	Krawczenko, A (corresponding author), Polish Acad Sci, Hirszfeld Inst Immunol & Expt Therapy, Wroclaw, Poland.	krawczen@iitd.pan.wroc.pl	Grillon, Catherine/I-4974-2016; Klimczak, Aleksandra/AAF-6136-2020; Kieda, Claudine/U-1361-2019	Grillon, Catherine/0000-0001-5019-7831; Bielawska-Pohl, Aleksandra/0000-0002-2757-5571; Kozlowska, Urszula/0000-0003-0213-0215; Krawczenko, Agnieszka/0000-0003-4545-8843; Dus, Danuta/0000-0003-2429-7315; Paprocka, Maria/0000-0001-6673-9631; Elzbieta, Wojdat/0000-0001-5315-1468; Klimczak, Aleksandra/0000-0001-6590-4420; Wojtowicz, Karolina/0000-0003-1704-6542				Baker M, 2015, NATURE, V527, P545, DOI 10.1038/527545a; Beck WT, 1996, CANCER RES, V56, P3010; Begley DJ, 2003, PROG DRUG RES, V61, P39; Bidlingmaier S, 2008, J MOL MED, V86, P1025, DOI 10.1007/s00109-008-0357-8; Breier A, 2013, ANTI-CANCER AGENT ME, V13, P159, DOI 10.2174/187152013804487380; Bunting KD, 2002, STEM CELLS, V20, P11, DOI 10.1002/stem.200011; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Dean M, 2009, J MAMMARY GLAND BIOL, V14, P3, DOI 10.1007/s10911-009-9109-9; Eilers M, 2008, EXP BIOL MED, V233, P1149, DOI 10.3181/0802-RM-59; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Glavinas Hristos, 2004, Current Drug Delivery, V1, P27, DOI 10.2174/1567201043480036; GOSLAND M, 1993, CANCER RES, V53, P5382; GRANDI M, 1986, BRIT J CANCER, V54, P515, DOI 10.1038/bjc.1986.206; Hegewisch-Becker S, 1998, ANN ONCOL, V9, P85, DOI 10.1023/A:1008255725515; HOLLO Z, 1994, BBA-BIOMEMBRANES, V1191, P384, DOI 10.1016/0005-2736(94)90190-2; Homolya L, 1996, BRIT J CANCER, V73, P849, DOI 10.1038/bjc.1996.151; Huang LM, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-49; Iqbal M, 2016, J NEUROENDOCRINOL, V28, DOI 10.1111/jne.12360; Jouan E, 2016, PHARMACEUTICS, V8, DOI 10.3390/pharmaceutics8020012; Kappelmayer J, 2012, J INT FEDERATION CLI, V27, P12; Kemper K, 2010, CANCER RES, V70, P719, DOI 10.1158/0008-5472.CAN-09-1820; Kieda C, 2002, ENDOTHELIUM-J ENDOTH, V9, P247, DOI 10.1080/10623320214736; Kondratov RV, 2001, P NATL ACAD SCI USA, V98, P14078, DOI 10.1073/pnas.241314798; Koshkin V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041368; Kosztyu P, 2015, EUR J HAEMATOL, V95, P150, DOI 10.1111/ejh.12470; Lebedeva IV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022429; LEHNE G, 1995, CYTOMETRY, V20, P228, DOI 10.1002/cyto.990200306; Nakanishi T, 2012, CHIN J CANCER, V31, P73, DOI 10.5732/cjc.011.10320; Olson DP, 2001, CYTOMETRY, V46, P105, DOI 10.1002/cyto.1072; Paprocka M, 2011, CYTOM PART A, V79A, P594, DOI 10.1002/cyto.a.21092; Podolak-Dawidziak M, 2005, ADV CLIN EXP MED, V14, P1151; Pozniak B, 2015, IN VIVO, V29, P149; Russel FGM, 2010, ENZYME AND TRANSPORT; Scherrmann Jean-Michel, 2005, Expert Opin Drug Metab Toxicol, V1, P233, DOI 10.1517/17425255.1.2.233; Shah MA, 2001, CLIN CANCER RES, V7, P2168; Sharom FJ, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00041; Stevens T, 2000, AM J PHYSIOL-LUNG C, V279, pL419, DOI 10.1152/ajplung.2000.279.3.L419; Szyda A, 2006, ACTA BIOCHIM POL, V53, P815, DOI 10.18388/abp.2006_3311; VANDERHEYDEN S, 1995, CRIT REV CL LAB SCI, V32, P221, DOI 10.3109/10408369509084685; Vasconcelos FC, 2011, CYTOM PART B-CLIN CY, V80B, P158, DOI 10.1002/cyto.b.20580; Vilas-Boas V, 2011, CYTOM PART A, V79A, P912, DOI 10.1002/cyto.a.21135; Warren MS, 2009, PHARMACOL RES, V59, P404, DOI 10.1016/j.phrs.2009.02.007; Wartenberg M, 2002, BBA-MOL CELL RES, V1589, P49, DOI 10.1016/S0167-4889(01)00185-9; Webb M, 1996, BRIT J HAEMATOL, V93, P650, DOI 10.1046/j.1365-2141.1996.d01-1680.x; Yuan SY., 2010, REGULATION ENDOTHELI; Zhou S, 2001, NAT MED, V7, P1028, DOI 10.1038/nm0901-1028	46	10	10	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2017	12	2							e0172371	10.1371/journal.pone.0172371	http://dx.doi.org/10.1371/journal.pone.0172371			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BI	28212450	Green Submitted, Green Published, gold			2022-12-27	WOS:000394424700039
J	Dasgupta, M; Kishore, N				Dasgupta, Moumita; Kishore, Nand			Selective inhibition of aggregation/fibrillation of bovine serum albumin by osmolytes: Mechanistic and energetics insights	PLOS ONE			English	Article							INCREASED THERMAL-STABILITY; PROTEIN AGGREGATION; ELECTROSTATIC INTERACTIONS; BETA-AGGREGATION; LIGHT-SCATTERING; FIBRIL FORMATION; AMYLOID FIBRILS; GLYCINE BETAINE; THIOFLAVIN T; LOW PH	Bovine serum albumin (BSA) is an important transport protein of the blood and its aggregation/fibrillation would adversely affect its transport ability leading to metabolic disorder. Therefore, understanding the mechanism of fibrillation/aggregation of BSA and design of suitable inhibitor molecules for stabilizing its native conformation, are of utmost importance. The qualitative and quantitative aspects of the effect of osmolytes (proline, hydroxyproline, glycine betaine, sarcosine and sorbitol) on heat induced aggregation/fibrillation of BSA at physiological pH (pH 7.4) have been studied employing a combination of fluorescence spectroscopy, Rayleigh scattering, isothermal titration calorimetry (ITC), dynamic light scattering (DLS) and transmission electron microscopy (TEM). Formation of fibrils by BSA under the given conditions was confirmed from increase in fluorescence emission intensities of Thioflavin T over a time period of 600 minutes and TEM images. Absence of change in fluorescence emission intensities of 8-Anilinonaphthalene-1-sulfonic acid (ANS) in presence of native and aggregated BSA signify the absence of any amorphous aggregates. ITC results have provided important insights on the energetics of interaction of these osmolytes with different stages of the fibrillar aggregates of BSA, thereby suggesting the possible modes/ mechanism of inhibition of BSA fibrillation by these osmolytes. The heats of interaction of the osmolytes with different stages of fibrillation of BSA do not follow a trend, suggesting that the interactions of stages of BSA aggregates are osmolyte specific. Among the osmolytes used here, we found glycine betaine to be supporting and promoting the aggregation process while hydroxyproline to be maximally efficient in suppressing the fibrillation process of BSA, followed by sorbitol, sarcosine and proline in the following order of their decreasing potency: Hydroxyproline> Sorbitol> Sarcosine> Proline> Glycine betaine.	[Dasgupta, Moumita; Kishore, Nand] Indian Inst Technol, Dept Chem, Bombay, Maharashtra, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Bombay	Kishore, N (corresponding author), Indian Inst Technol, Dept Chem, Bombay, Maharashtra, India.	nandk@chem.iitb.ac.in			Indian Institute of Technology, Bombay	Indian Institute of Technology, Bombay	Support was provided by the Indian Institute of Technology, Bombay.	ARAKAWA T, 1982, BIOCHEMISTRY-US, V21, P6536, DOI 10.1021/bi00268a033; ARAKAWA T, 1982, BIOCHEMISTRY-US, V21, P6545, DOI 10.1021/bi00268a034; Arosio P, 2013, PHARM RES-DORDR, V30, P641, DOI 10.1007/s11095-012-0885-3; BACK JF, 1979, BIOCHEMISTRY-US, V18, P5191, DOI 10.1021/bi00590a025; Bhattacharya M, 2011, J PHYS CHEM B, V115, P4195, DOI 10.1021/jp111528c; Borzova VA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153495; Botelho HM, 2012, J BIOL CHEM, V287, P42233, DOI 10.1074/jbc.M112.396416; Bouma B, 2003, J BIOL CHEM, V278, P41810, DOI 10.1074/jbc.M303925200; CANETE M, 1987, CELL MOL BIOL, V33, P191; Chiti F, 2002, NAT STRUCT BIOL, V9, P137, DOI 10.1038/nsb752; Choudhary S, 2015, SCI REP-UK, V5, DOI 10.1038/srep17599; Choudhary S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104600; DANIEL E, 1966, BIOCHEMISTRY-US, V5, P1893, DOI 10.1021/bi00870a016; Esbjorner EK, 2014, CHEM BIOL, V21, P732, DOI 10.1016/j.chembiol.2014.03.014; GEKKO K, 1990, J BIOCHEM-TOKYO, V107, P572, DOI 10.1093/oxfordjournals.jbchem.a123088; Guo F, 2009, J PHYS CHEM B, V113, P16632, DOI 10.1021/jp9072284; Holm NK, 2007, BBA-PROTEINS PROTEOM, V1774, P1128, DOI 10.1016/j.bbapap.2007.06.008; Hurshman AR, 2004, BIOCHEMISTRY-US, V43, P7365, DOI 10.1021/bi049621l; Juarez J, 2009, BIOPHYS J, V96, P2353, DOI 10.1016/j.bpj.2008.12.3901; Kachooei E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041344; Kar K, 2007, BIOPOLYMERS, V87, P339, DOI 10.1002/bip.20834; Khan JM, 2014, PHYS CHEM CHEM PHYS, V16, P5150, DOI 10.1039/c3cp54941k; Khan SH, 2010, IUBMB LIFE, V62, P891, DOI 10.1002/iub.406; Khurana R, 2005, J STRUCT BIOL, V151, P229, DOI 10.1016/j.jsb.2005.06.006; Kirchoff W.H., EXAM PROGRAM; Krebs MRH, 2007, BIOPHYS J, V92, P1336, DOI 10.1529/biophysj.106.094342; Kumar N, 2013, BIOPHYS CHEM, V171, P9, DOI 10.1016/j.bpc.2012.11.004; Kumar R, 2009, ARCH BIOCHEM BIOPHYS, V491, P1, DOI 10.1016/j.abb.2009.09.007; Kumar S, 2009, BIOCHEMISTRY-US, V48, P6441, DOI 10.1021/bi900682w; Kurganov B. I., 2015, BIOCH ANAL BIOCH, V4, pe 155, DOI [10.4172/2161-1009.1000e155, DOI 10.4172/2161-1009.1000E155]; Kurganov BI, 2002, BIOCHEMISTRY-MOSCOW+, V67, P409, DOI 10.1023/A:1015277805345; Kurganov BI, 2016, INT J BIOL MACROMOL; Kuznetsova IM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030724; Lee J, 2011, NAT CHEM BIOL, V7, P602, DOI [10.1038/nchembio.624, 10.1038/NCHEMBIO.624]; Li Rui, 2016, Biotechnol Rep (Amst), V9, P46, DOI 10.1016/j.btre.2016.01.002; LIN MY, 1989, NATURE, V339, P360, DOI 10.1038/339360a0; Macchi F, 2012, INT J MOL SCI, V13, P3801, DOI 10.3390/ijms13033801; Militello V, 2004, BIOPHYS CHEM, V107, P175, DOI 10.1016/j.bpc.2003.09.004; Militello V, 2003, BIOPHYS CHEM, V105, P133, DOI 10.1016/S0301-4622(03)00153-4; Mishra R, 2005, J BIOL CHEM, V280, P15553, DOI 10.1074/jbc.M410947200; Mitraki A, 2010, ADV PROTEIN CHEM STR, V79, P89, DOI 10.1016/S1876-1623(10)79003-9; Nandi P.K., 1976, J PHYS CHEM, V80, P249, DOI [DOI 10.1021/J100544A008, 10.1021/j100544a008]; Natalello A, 2009, PROTEINS, V75, P509, DOI 10.1002/prot.22266; PAPAGEORGIOU GC, 1995, PHOTOSYNTH RES, V44, P243, DOI 10.1007/BF00048597; POKLAR N, 1993, BIOPHYS CHEM, V47, P143, DOI 10.1016/0301-4622(93)85032-D; Saha S, 2014, J PHYS CHEM B, V118, P9155, DOI 10.1021/jp502435f; SANTORO MM, 1992, BIOCHEMISTRY-US, V31, P5278, DOI 10.1021/bi00138a006; Sen P, 2009, SPECTROCHIM ACTA A, V74, P94, DOI 10.1016/j.saa.2009.05.010; Shammas SL, 2011, BIOPHYS J, V100, P2783, DOI 10.1016/j.bpj.2011.04.039; Singh LR, 2009, BBA-PROTEINS PROTEOM, V1794, P929, DOI 10.1016/j.bbapap.2009.02.005; Sober H.A., 1973, SELECTED DATA MOL BI, pC; STRYER LUBERT, 1965, J MOL BIOL, V13, P482; Trnkova L., 2010, NATURAL SCI, V2, P563, DOI DOI 10.4236/ns.2010.26071; Valstar A, 2000, LANGMUIR, V16, P922, DOI 10.1021/la990423i; VASSAR PS, 1959, ARCH PATHOL, V68, P487; Vetri V, 2011, ARCH BIOCHEM BIOPHYS, V508, P13, DOI 10.1016/j.abb.2011.01.024; Wang W, 2010, INT J PHARMACEUT, V390, P89, DOI 10.1016/j.ijpharm.2010.02.025; Yang DS, 1999, J BIOL CHEM, V274, P32970, DOI 10.1074/jbc.274.46.32970; Yohannes G, 2010, ANAL CHIM ACTA, V675, P191, DOI 10.1016/j.aca.2010.07.016; Yoshiike Y, 2003, J BIOL CHEM, V278, P23648, DOI 10.1074/jbc.M212785200; Yoshimoto N, 2003, BIOMACROMOLECULES, V4, P1530, DOI 10.1021/bm015662a; Zheng J, 2007, BIOPHYS J, V93, P3046, DOI 10.1529/biophysj.107.110700	62	37	38	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0172208	10.1371/journal.pone.0172208	http://dx.doi.org/10.1371/journal.pone.0172208			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207877	Green Published, gold, Green Submitted			2022-12-27	WOS:000394424500098
J	Hee, JS; Cresswell, P				Hee, Jia Shee; Cresswell, Peter			Viperin interaction with mitochondrial antiviral signaling protein (MAVS) limits viperin-mediated inhibition of the interferon response in macrophages	PLOS ONE			English	Article							C VIRUS-REPLICATION; WEST NILE VIRUS; NF-KAPPA-B; RIG-I; ENDOPLASMIC-RETICULUM; INDUCIBLE PROTEIN; INFLUENZA-VIRUS; MEMBRANES; ACID; IDENTIFICATION	Viperin is an antiviral protein that is upregulated by interferons and by ligands for a variety of innate immune receptors. It possesses diverse capabilities and functions in an array of viral infections. Studies have shown that it appears to be particularly important in defence against RNA viruses, such as West Nile, Dengue, and Chikungunya viruses, although the specific mechanisms involved are not well understood at the molecular level. Here we identify the mitochondrial antiviral signalling protein MAVS as a novel viperin interaction partner, most likely in mitochondria associated membranes, and characterize a more central, overarching role of viperin as a negative regulator of the interferon response, an ability that can be regulated by the viperin-MAVS interaction. This suggests a novel mechanism of viperin action in immune defence against RNA viruses by which it may prevent pathology from excessive immune responses.	[Hee, Jia Shee; Cresswell, Peter] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA	Yale University	Cresswell, P (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA.	peter.cresswell@yale.edu			NIH [R21-AI119837]; Agency of Science, Technology and Research, Singapore; Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [P30CA016359] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001863] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Agency of Science, Technology and Research, Singapore(Agency for Science Technology & Research (A*STAR)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by the Howard Hughes Medical Institute and NIH grant R21-AI119837 awarded to PC. JSH was supported by a scholarship from the Agency of Science, Technology and Research, Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bamming D, 2009, J BIOL CHEM, V284, P9700, DOI 10.1074/jbc.M807365200; Banerjee S, 2014, MBIO, V5, DOI 10.1128/mBio.00856-14; Barral PM, 2009, PHARMACOL THERAPEUT, V124, P219, DOI 10.1016/j.pharmthera.2009.06.012; Brubaker SW, 2014, CELL, V156, P800, DOI 10.1016/j.cell.2014.01.021; Castanier C, 2010, EMBO REP, V11, P133, DOI 10.1038/embor.2009.258; Chin KC, 2001, P NATL ACAD SCI USA, V98, P15125, DOI 10.1073/pnas.011593298; Dixit E, 2010, CELL, V141, P668, DOI 10.1016/j.cell.2010.04.018; Gitlin L, 2006, P NATL ACAD SCI USA, V103, P8459, DOI 10.1073/pnas.0603082103; Hayashi T, 2009, TRENDS CELL BIOL, V19, P81, DOI 10.1016/j.tcb.2008.12.002; Helbig KJ, 2014, J MOL BIOL, V426, P1210, DOI 10.1016/j.jmb.2013.10.019; Helbig KJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002178; Helbig KJ, 2011, HEPATOLOGY, V54, P1506, DOI 10.1002/hep.24542; Hinson ER, 2009, P NATL ACAD SCI USA, V106, P20452, DOI 10.1073/pnas.0911679106; Hinson ER, 2009, J BIOL CHEM, V284, P4705, DOI 10.1074/jbc.M807261200; Horner SM, 2011, P NATL ACAD SCI USA, V108, P14590, DOI 10.1073/pnas.1110133108; Jiang D, 2010, J VIROL, V84, P8332, DOI 10.1128/JVI.02199-09; Jiang X, 2011, IMMUNITY, V34, P285, DOI 10.1016/j.immuni.2011.03.012; Kagan JC, 2012, TRENDS IMMUNOL, V33, P442, DOI 10.1016/j.it.2012.06.005; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091; Komuro A, 2006, J VIROL, V80, P12332, DOI 10.1128/JVI.01325-06; Koshiba T, 2013, BBA-MOL CELL RES, V1833, P225, DOI 10.1016/j.bbamcr.2012.03.005; Magalhaes AC, 2016, SCI REP-UK, V6, DOI 10.1038/srep26028; Qiu LQ, 2009, BLOOD, V113, P3520, DOI 10.1182/blood-2008-07-171942; Rayamajhi M, 2014, CELL, V156, P629, DOI 10.1016/j.cell.2014.01.045; Rivieccio MA, 2006, J IMMUNOL, V177, P4735, DOI 10.4049/jimmunol.177.7.4735; Rothenfusser S, 2005, J IMMUNOL, V175, P5260, DOI 10.4049/jimmunol.175.8.5260; Saito T, 2007, P NATL ACAD SCI USA, V104, P582, DOI 10.1073/pnas.0606699104; Saitoh T, 2011, IMMUNITY, V34, P352, DOI 10.1016/j.immuni.2011.03.010; Schneider WM, 2014, ANNU REV IMMUNOL, V32, P513, DOI 10.1146/annurev-immunol-032713-120231; Seo JY, 2011, CELL HOST MICROBE, V10, P534, DOI 10.1016/j.chom.2011.11.004; Seo JY, 2011, SCIENCE, V332, P1093, DOI 10.1126/science.1202007; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Suthar MS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000757; Szretter KJ, 2011, J VIROL, V85, P11557, DOI 10.1128/JVI.05519-11; Tang HB, 2016, SCI REP-UK, V6, DOI 10.1038/srep30529; Teng TS, 2012, J CLIN INVEST, V122, P4447, DOI 10.1172/JCI63120; Vance JE, 2014, BBA-MOL CELL BIOL L, V1841, P595, DOI 10.1016/j.bbalip.2013.11.014; Venkataraman T, 2007, J IMMUNOL, V178, P6444, DOI 10.4049/jimmunol.178.10.6444; Vitour D, 2009, J BIOL CHEM, V284, P21797, DOI 10.1074/jbc.M109.018275; Waheed AA, 2007, CELL HOST MICROBE, V2, P71, DOI 10.1016/j.chom.2007.07.005; Wang PH, 2013, CELL REP, V3, P1057, DOI 10.1016/j.celrep.2013.02.027; Wang SS, 2012, J GEN VIROL, V93, P83, DOI 10.1099/vir.0.033860-0; Wang XY, 2007, CELL HOST MICROBE, V2, P96, DOI 10.1016/j.chom.2007.06.009; Wieckowski MR, 2009, NAT PROTOC, V4, P1582, DOI 10.1038/nprot.2009.151	45	22	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0172236	10.1371/journal.pone.0172236	http://dx.doi.org/10.1371/journal.pone.0172236			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207838	Green Published, gold, Green Submitted			2022-12-27	WOS:000394424500105
J	Bloss, S; Klemann, C; Rother, AK; Mehmecke, S; Schumacher, U; Mucke, U; Mucke, M; Stieber, C; Klawonn, F; Kortum, X; Lechner, W; Grigull, L				Bloess, Susanne; Klemann, Christian; Rother, Ann-Katrin; Mehmecke, Sandra; Schumacher, Ulrike; Muecke, Urs; Muecke, Martin; Stieber, Christiane; Klawonn, Frank; Kortum, Xiaowei; Lechner, Werner; Grigull, Lorenz			Diagnostic needs for rare diseases and shared prediagnostic phenomena: Results of a German-wide expert Delphi survey	PLOS ONE			English	Article							PRIMARY CILIARY DYSKINESIA	Background Worldwide approximately 7,000 rare diseases have been identified. Accordingly, 4 million individuals live with a rare disease in Germany. The mean time to diagnosis is about 6 years and patients receive several incorrect diagnoses during this time. A multiplicity of factors renders diagnosing a rare disease extremely difficult. Detection of shared phenomena among individuals with different rare diseases could assist the diagnostic process. In order to explore the demand for diagnostic support and to obtain the commonalities among patients, a nationwide Delphi survey of centers for rare diseases and patient groups was conducted. Methods A two-step Delphi survey was conducted using web-based technologies in all centers for rare diseases in Germany. Moreover, the leading patient support group, the German foundation for rare diseases (ACHSE), was contacted to involve patients as experts in their disease. In the survey the experts were invited to name rare diseases with special need for diagnostic improvement. Secondly, communal experiences of affected individuals were collected. Results 166 of 474 contacted experts (35%) participated in the first round of the Delphi process and 95 of 166 (57%) participated in the second round. Metabolic (n = 74) and autoimmune diseases (n = 39) were ranked the highest for need for diagnostic support. For three diseases (i.e. scleroderma, Pompe's disease, and pulmonary arterial hypertension), a crucial need for diagnostic support was explicitly stated. A typical experience of individuals with a rare disease was stigmatization of having psychological or psychosomatic problems. In addition, most experts endured an 'odyssey' of seeing many different medical specialists before a correct diagnosis (n = 38) was confirmed. Conclusion There is need for improving the diagnostic process in individuals with rare diseases. Shared experiences in individuals with a rare disease were observed, which could possibly be utilized for diagnostic support in the future.	[Bloess, Susanne; Rother, Ann-Katrin; Mehmecke, Sandra; Muecke, Urs; Grigull, Lorenz] Hannover Med Sch, Dept Pediat Hematol & Oncol, Hannover, Germany; [Klemann, Christian] Univ Freiburg, Univ Med Ctr Freiburg, CCI, Freiburg, Germany; [Klemann, Christian] Univ Freiburg, Univ Med Ctr Freiburg, Ctr Pediat & Adolescent Med, Freiburg, Germany; [Mehmecke, Sandra] Hannover Med Sch, Dept Neurol, Hannover, Germany; [Schumacher, Ulrike] DRK Clementinenkrankenhaus, Hannover, Germany; [Muecke, Martin; Stieber, Christiane] Univ Hosp Bonn, Ctr Rare Dis Bonn ZSEB, Bonn, Germany; [Klawonn, Frank; Kortum, Xiaowei] Ostfalia Univ Appl Sci, Wolfenbuettel, Germany; [Klawonn, Frank] Helmholtz Ctr Infect Res, Braunschweig, Germany; [Lechner, Werner] Improved Med Diagnost IMD GmbH, Hannover, Germany	Hannover Medical School; University of Freiburg; University of Freiburg; Hannover Medical School; University of Bonn; Helmholtz Association; Helmholtz-Center for Infection Research	Grigull, L (corresponding author), Hannover Med Sch, Dept Pediat Hematol & Oncol, Hannover, Germany.	Grigull.lorenz@mh-hannover.de	Mücke, Martin Dr./G-3807-2015; Klawonn, Frank/HFH-5887-2022; Klemann, Christian/AAQ-9301-2020	Mücke, Martin Dr./0000-0002-9275-9035; Klawonn, Frank/0000-0001-9613-182X; Klemann, Christian/0000-0002-5639-8690	Robert Bosch foundation, Stuttgart, Germany	Robert Bosch foundation, Stuttgart, Germany	The Robert Bosch foundation, Stuttgart, Germany provided funding for this study. However, this funding did not play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript and only provided financial support in the form of authors' salaries and research materials. The funder provided support in the form of salaries for authors [XK, WL, SB, SM, AR], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank all experts and patients and patient groups for participating in the study. Mwe-Mwe Chao critically revised the manuscript. The Robert Bosch Foundation (Stuttgart, Germany) funded this work.	Ahrens-Nicklas RC, 2015, J ADOLESC HLTH; Ayme S, 2007, BUNDESGESUNDHEITSBLA, V50, P1477, DOI 10.1007/s00103-007-0381-9; Ayme S, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/1750-1172-9-30; Berody S, 2015, JOINT BONE SPINE; Bhattacharya K, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/s13023-014-0192-7; Bolger F, 2011, TECHNOL FORECAST SOC, V78, P1500, DOI 10.1016/j.techfore.2011.07.007; Bouwman MG, 2010, ARCH DIS CHILD; Bush A, 1998, EUR RESPIR J, V12, P982, DOI 10.1183/09031936.98.12040982; Coren ME, 2002, ACTA PAEDIATR, V91, P667, DOI 10.1080/080352502760069089; Cunningham-Rundles C, 1999, CLIN IMMUNOL, V92, P34, DOI 10.1006/clim.1999.4725; Gagnier JJ, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-106; Grahame R, 2009, CURR PAIN HEADACHE R, V13, P427, DOI 10.1007/s11916-009-0070-5; Guffon N, 2015, ORPHANET J RARE DIS, V10, DOI 10.1186/s13023-015-0259-0; Hallal C, 2012, PEDIATR SURG INT, V28, P1211, DOI 10.1007/s00383-012-3214-3; Hughes D, 2008, PAED CHILD HEALT-CAN, V13, P672, DOI 10.1093/pch/13.8.672; Keeney S, 2001, INT J NURS STUD, V38, P195, DOI 10.1016/S0020-7489(00)00044-4; Kishnani PS, 2013, AM J MED GENET A, V161, P2431, DOI 10.1002/ajmg.a.36110; Knight I, 2015, AM J MED GENET C, V169, P123, DOI 10.1002/ajmg.c.31428; Kuckartz U., 2009, EINFUHRUNG COMPUTERG; Lehman H, 2015, CURR MED RES OPIN, V31, P697, DOI 10.1185/03007995.2014.1001063; Limb L, 2010, EXPERIENCES RARE DIS; Linertova R, 2012, HEALTH POLICY, V108, P19, DOI 10.1016/j.healthpol.2012.08.001; Linstone H. A., 1975, DELPHI METHOD TECHNI; Mayer K, 2013, EUR J HUM GENET, V21, DOI 10.1038/ejhg.2012.162; Pierucci P, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-33; Prencipe N, 2015, CLIN ENDOCRINOL OXF; Rother AK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135180; Sedel F, 2007, J INHERIT METAB DIS, V30, P631, DOI 10.1007/s10545-007-0661-4; Seymour B, 2005, J CLIN PATHOL, V58, P546, DOI 10.1136/jcp.2004.016204; Vazquez-Costa M, 2013, REV CLIN ESP, V213, P158, DOI 10.1016/j.rce.2012.05.012; Wang RT, 2014, PLOS CURR, V6, P1, DOI [DOI 10.1371/CURRENTS.MD.E1E8F2BE7C94, DOI 10.1371/CURRENTS.MD.E1E8F2BE7C949F9FFE81EC6FCA1CCE6A]; Weathers AL, 2009, SEMIN NEUROL; Wong SH, 2015, EUR J HUM GENET	33	43	44	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0172532	10.1371/journal.pone.0172532	http://dx.doi.org/10.1371/journal.pone.0172532			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5VB	28234950	Green Published, gold, Green Submitted			2022-12-27	WOS:000394688200088
J	Orobaton, N; Abdulazeez, J; Abegunde, D; Shoretire, K; Maishanu, A; Ikoro, N; Fapohunda, B; Balami, W; Beal, K; Ganiyu, A; Gwamzhi, R; Austin, A				Orobaton, Nosakhare; Abdulazeez, Jumare; Abegunde, Dele; Shoretire, Kamil; Maishanu, Abubakar; Ikoro, Nnenna; Fapohunda, Bolaji; Balami, Wapada; Beal, Katherine; Ganiyu, Akeem; Gwamzhi, Ringpon; Austin, Anne			Implementing at-scale, community-based distribution of misoprostol tablets to mothers in the third stage of labor for the prevention of postpartum haemorrhage in Sokoto State, Nigeria: Early results and lessons learned	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; ORAL MISOPROSTOL; LEVEL	Background Postpartum haemorrhage (PPH) is a leading cause of maternal death in Sokoto State, Nigeria, where 95% of women give birth outside of a health facility. Although pilot schemes have demonstrated the value of community-based distribution of misoprostol for the prevention of PPH, none have provided practical insight on taking such programs to scale. Methods A community-based system for the distribution of misoprostol tablets (in 600ug) and chlorhexidine digluconate gel 7.1% to mother-newborn dyads was introduced by state government officials and community leaders throughout Sokoto State in April 2013, with the potential to reach an estimated 190,467 annual births. A simple outcome form that collected distribution and consumption data was used to assess the percentage of mothers that received misoprostol at labor through December 2014. Mothers' conditions were tracked through 6 weeks postpartum. Verbal autopsies were conducted on associated maternal deaths. Results Misoprostol distribution was successfully introduced and reached mothers in labor in all 244 wards in Sokoto State. Community data collection systems were successfully operational in all 244 wards with reliable capacity to record maternal deaths. 70,982 women or 22% of expected births received misoprostol from April 2013 to December 2014. Between April and December 2013, 33 women (< 1%) reported that heavy bleeding persisted after misoprostol use and were promptly referred. There were a total of 11 deaths in the 2013 cohort which were confirmed as maternal deaths by verbal autopsies. Between January and December of 2014, a total 434 women (1.25%) that ingested misoprostol reported associated side effects. Conclusion It is feasible and safe to utilize government guidelines on results-based primary health care to successfully introduce community distribution of life saving misoprostol at scale to reduce PPH and improve maternal outcomes. Lessons from Sokoto State's at-scale program implementation, to assure every mother's right to uterotonics, can inform scale-up elsewhere in Nigeria.	[Orobaton, Nosakhare; Abdulazeez, Jumare; Abegunde, Dele; Shoretire, Kamil; Maishanu, Abubakar; Ikoro, Nnenna; Fapohunda, Bolaji; Beal, Katherine; Ganiyu, Akeem; Gwamzhi, Ringpon; Austin, Anne] JSI Res & Training Inst Inc, Boston, MA 02210 USA; [Orobaton, Nosakhare; Abdulazeez, Jumare; Abegunde, Dele; Shoretire, Kamil; Maishanu, Abubakar; Fapohunda, Bolaji; Ganiyu, Akeem; Gwamzhi, Ringpon; Austin, Anne] USAID Targeted States High Impact Project TSHIP, Sokoto, Nigeria; [Balami, Wapada] Fed Minist Hlth, Dept Family Hlth, Abuja, Nigeria		Austin, A (corresponding author), JSI Res & Training Inst Inc, Boston, MA 02210 USA.; Austin, A (corresponding author), USAID Targeted States High Impact Project TSHIP, Sokoto, Nigeria.	anne_austin@jsi.com			United States Agency for International Development (USAID) Mission for Nigeria under the Targeted States High Impact Project (TSHIP) [620-A-00-09-00014-00]; JSI Research & Training Institute, Inc	United States Agency for International Development (USAID) Mission for Nigeria under the Targeted States High Impact Project (TSHIP)(United States Agency for International Development (USAID)); JSI Research & Training Institute, Inc	This manuscript was funded by the United States Agency for International Development (USAID) Mission for Nigeria under the Targeted States High Impact Project (TSHIP), Cooperative Agreement No. 620-A-00-09-00014-00 and JSI Research & Training Institute, Inc.	Abegunde D, 2015, INT J GYNECOL OBSTET, V128, P251, DOI 10.1016/j.ijgo.2014.09.029; [Anonymous], 2010, WHO MODEL LIST ESSEN; [Anonymous], 2010, ESS MED LIST; [Anonymous], 2012, WHO RECCOMENDATIONS; Austin A, 2015, INT J WOMENS HEALTH, V7, P345, DOI 10.2147/IJWH.S79573; Cannon M, 2016, GLOB PUBLIC HEALTH, P1; Chen Cecilia, 2004, Afr Health Sci, V4, P205; Derman RJ, 2006, LANCET, V368, P1248, DOI 10.1016/S0140-6736(06)69522-6; Diadhiou M, 2011, INT J GYNECOL OBSTET, V115, P251, DOI 10.1016/j.ijgo.2011.08.002; Diop A, 2016, LANCET GLOB HEALTH, V4, pE37, DOI 10.1016/S2214-109X(15)00219-3; Ejembi C, 2014, AFR J REPROD HEALTH, V18, P166; Fapohunda B, 2014, INT J WOMENS HEALTH, V6, P171, DOI 10.2147/IJWH.S54628; Fapohunda BM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069569; Jadesimi A, 2006, J FAM PLAN REPROD H, V32, P213, DOI 10.1783/147118906778586660; Jegede AS, 2007, PLOS MED, V4, P417, DOI 10.1371/journal.pmed.0040073; JSI Research & Training Institute I, 2013, TARGETED STATES HIGH; Musa AO, 2015, INT J GYNAECOL OBSTE; National Population Commission [Nigeria] and ICF Macro, 2009, AB NIG AB NIG ROCKV; National Population Commission (NPC) [Nigeria] and ICF International, 2013, AB NIG ROCKV; National Primary Health Care Development Agency, 2007, WARD MIN HLTH CAR PA; Orobaton N, 2016, GLOB HEALTH-SCI PRAC, V4, P99, DOI 10.9745/GHSP-D-15-00261; Orobaton N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134040; Prata N, 2009, HEALTH POLICY, V89, P131, DOI 10.1016/j.healthpol.2008.05.007; Raghavan S, 2012, INT J GYNECOL OBSTET, V119, pS35, DOI 10.1016/j.ijgo.2012.03.013; Say L, 2014, LANCET GLOB HEALTH, V2, pE323, DOI 10.1016/S2214-109X(14)70227-X; Simmons R, 2007, SCALING UP HEALTH SERVICE DELIVERY: FROM PILOT INNOVATIONS TO POLICIES AND PROGRAMMES, P1; Spicer N, 2014, SOC SCI MED, V121, P30, DOI 10.1016/j.socscimed.2014.09.046; The Selection and Use of Essential Medicines, 2013, WHO TECHN REP SER; United Nations Fund for Population Activities - UNFPA, 2009, UNFPA SUPP TRAD REL; Weeks AD, 2013, ARCH DIS CHILD-FETAL, V98, pA55; WHO (World Health Organization), 2015, TRENDS MATERNAL MORT; Winikoff B, 2010, LANCET, V375, P210, DOI 10.1016/S0140-6736(09)61924-3; World Health Organisation, 2013, WORLD HLTH ORG	33	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0170739	10.1371/journal.pone.0170739	http://dx.doi.org/10.1371/journal.pone.0170739			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5VB	28234894	Green Published, Green Submitted, gold			2022-12-27	WOS:000394688200010
J	Xu, XL; Liu, XM; Long, JH; Hu, ZQ; Zheng, QN; Zhang, CL; Li, L; Wang, Y; Jia, Y; Qiu, W; Zhou, J; Yao, WJ; Zeng, Z				Xu, Xiaoli; Liu, Xianmei; Long, Jinhua; Hu, Zuquan; Zheng, Qinni; Zhang, Chunlin; Li, Long; Wang, Yun; Jia, Yi; Qiu, Wei; Zhou, Jing; Yao, Weijuan; Zeng, Zhu			Interleukin-10 reorganizes the cytoskeleton of mature dendritic cells leading to their impaired biophysical properties and motilities	PLOS ONE			English	Article							ENDOTHELIAL-CELLS; CANCER; MIGRATION; ADHESION; EXPRESSION; MATURATION; FASCIN; DIFFERENTIATION; PHOSPHATASES; FIBROBLASTS	Interlukin-10 (IL-10) is an immunomodulatory cytokine which predominantly induces immune-tolerance. It has been also identified as a major cytokine in the tumor microenvironment that markedly mediates tumor immune escape. Previous studies on the roles of IL-10 in tumor immunosuppression mainly focus on its biochemical effects. But the effects of IL-10 on the biophysical characteristics of immune cells are ill-defined. Dendritic cells (DCs) are the most potent antigen-presenting cells and play a key role in the anti-tumor immune response. IL-10 can affect the immune regulatory functions of DCs in various ways. In this study, we aim to explore the effects of IL-10 on the biophysical functions of mature DCs (mDCs). mDCs were treated with different concentrations of IL-10 and their biophysical characteristics were identified. The results showed that the biophysical properties of mDCs, including electrophoresis mobility, osmotic fragility and deformability, as well as their motilities, were impaired by IL-10. Meanwhile, the cytoskeleton (F-actin) of mDCs was reorganized by IL-10. IL-10 caused the alternations in the expressions of fasin1 and profilin1 as well as the phosphorylation of cofilin1 in a concentration-dependent fashion. Moreover, Fourier transformed infrared resonance data showed that IL-10 made the status of gene transcription and metabolic turnover of mDCs more active. These results demonstrate a new aspect of IL-10's actions on the immune system and represent one of the mechanisms for immune escape of tumors. It may provide a valuable clue to optimize and improve the efficiency of DC-based immunotherapy against cancer.	[Xu, Xiaoli; Liu, Xianmei; Hu, Zuquan; Zheng, Qinni; Wang, Yun; Jia, Yi; Qiu, Wei; Zhou, Jing; Zeng, Zhu] Guizhou Med Univ, Key Lab Biol & Med Engn, Guiyang, Peoples R China; [Xu, Xiaoli; Liu, Xianmei; Hu, Zuquan; Zhang, Chunlin; Wang, Yun; Jia, Yi; Qiu, Wei; Zhou, Jing; Zeng, Zhu] Guizhou Med Univ, Engn Ctr Med Biotechnol Applicat, Guiyang, Peoples R China; [Xu, Xiaoli; Liu, Xianmei; Hu, Zuquan; Wang, Yun; Jia, Yi; Qiu, Wei; Zhou, Jing; Zeng, Zhu] Guizhou Med Univ, Sch Biol & Engn, Guiyang, Peoples R China; [Xu, Xiaoli; Liu, Xianmei; Yao, Weijuan] Peking Univ, Hlth Sci Ctr, Sch Basic Med Sci, Hemorheol Ctr, Beijing, Peoples R China; [Long, Jinhua] Guizhou Med Univ, Affiliated Canc Hosp, Dept Head & Neck, Guiyang, Peoples R China; [Li, Long] Guizhou Med Univ, Affiliated Hosp 3, Dept Nephropathy & Rheumatism, Duyun, Peoples R China	Guizhou Medical University; Guizhou Medical University; Guizhou Medical University; Peking University; Guizhou Medical University; Guizhou Medical University	Zeng, Z (corresponding author), Guizhou Med Univ, Key Lab Biol & Med Engn, Guiyang, Peoples R China.; Zeng, Z (corresponding author), Guizhou Med Univ, Engn Ctr Med Biotechnol Applicat, Guiyang, Peoples R China.; Zeng, Z (corresponding author), Guizhou Med Univ, Sch Biol & Engn, Guiyang, Peoples R China.; Yao, WJ (corresponding author), Peking Univ, Hlth Sci Ctr, Sch Basic Med Sci, Hemorheol Ctr, Beijing, Peoples R China.	weijuanyao@bjmu.edu.cn; zengzhu100@sina.com	Jia, Yi/GVW-1870-2022; Zeng, Zhu/R-1576-2019	Jia, Yi/0000-0002-4563-917X; 	National Natural Science Foundation of China [31260227, 11162003, 31570938, 31660258, 21561006]; Collaborative Innovation Program of Guizhou Province [2015-04]; China Postdoctoral Science Foundation [2015M582747XB]; Science and Technology Innovative Talent Team of Guizhou Province [2015-4021]; Key Project of the Ministry of Education of China [210196]; Science and Technology Foundation of Guizhou Province [LH-20147092]; Technology Foundation for Selected Overseas Chinese of Guizhou Province [2013-8]; University Outstanding Science and Technology Innovation Scholars of Guizhou Province [KY-2014-244]; Bureau of Science and Technology of Guiyang [20141001-37]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Collaborative Innovation Program of Guizhou Province; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Science and Technology Innovative Talent Team of Guizhou Province; Key Project of the Ministry of Education of China(Ministry of Education, China); Science and Technology Foundation of Guizhou Province; Technology Foundation for Selected Overseas Chinese of Guizhou Province; University Outstanding Science and Technology Innovation Scholars of Guizhou Province; Bureau of Science and Technology of Guiyang	This research was funded by grants from National Natural Science Foundation of China (Nos. 31260227 and 11162003 to ZZ, No. 31570938 to WY, No. 31660258 to ZH, No. 21561006 to YJ), 2011 Collaborative Innovation Program of Guizhou Province (No. 2015-04 to ZZ), China Postdoctoral Science Foundation (No. 2015M582747XB to ZH), Science and Technology Innovative Talent Team of Guizhou Province (No. 2015-4021 to ZZ), Key Project of the Ministry of Education of China (No. 210196 to ZZ), Science and Technology Foundation of Guizhou Province (No. LH-20147092 to ZH), Technology Foundation for Selected Overseas Chinese of Guizhou Province (No. 2013-8 to ZZ), Supporting Project of University Outstanding Science and Technology Innovation Scholars of Guizhou Province (No. KY-2014-244 to ZH), and Bureau of Science and Technology of Guiyang (No. 20141001-37 to ZH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was funded by grants from National Natural Science Foundation of China (Nos. 31260227 and 11162003 to ZZ, No. 31570938 to WY, No. 31660258 to ZH, No. 21561006 to YJ), 2011 Collaborative Innovation Program of Guizhou Province (No. 2015-04 to ZZ), China Postdoctoral Science Foundation (No. 2015M582747XB to ZH), Science and Technology Innovative Talent Team of Guizhou Province (No. 2015-4021 to ZZ), Key Project of the Ministry of Education of China (No. 210196 to ZZ), Science and Technology Foundation of Guizhou Province (No. LH-2014-7092 to ZH), Technology Foundation for Selected Overseas Chinese of Guizhou Province (No. 2013-8 to ZZ), Supporting Project of University Outstanding Science and Technology Innovation Scholars of Guizhou Province (No. KY-2014-244 to ZH), and Bureau of Science and Technology of Guiyang (No. 20141001-37 to ZH).	Bae YH, 2010, P NATL ACAD SCI USA, V107, P21547, DOI 10.1073/pnas.1002309107; Bellomo C, 2016, BR J CANC; Boer EF, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004946; Commeren DL, 2003, IMMUNOLOGY, V110, P188, DOI 10.1046/j.1365-2567.2003.01730.x; Coosemans A, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2015.1111505; Dawe HR, 2003, CURR BIOL, V13, P252, DOI 10.1016/S0960-9822(03)00040-X; de Araujo CC, 2016, SCAND J MED SCI SPOR; de Vries IJM, 2003, CANCER RES, V63, P12; Denning TL, 2007, NAT IMMUNOL, V8, P1086, DOI 10.1038/ni1511; Ding ZJ, 2009, EXP CELL RES, V315, P2963, DOI 10.1016/j.yexcr.2009.07.004; Dong R, 2014, BIOMED ENG ONLINE, V13, DOI 10.1186/1475-925X-13-2; Fallqvist B, 2016, J MECH BEHAV BIOMED, V59, P168, DOI 10.1016/j.jmbbm.2015.11.039; Galluzzi L, 2012, ONCOIMMUNOLOGY, V1, P1111, DOI 10.4161/onci.21494; Groux H, 2004, SEMIN IMMUNOL, V16, P99, DOI 10.1016/j.smim.2003.12.004; Gu L, 2005, CELL BIOCHEM BIOPHYS, V43, P355, DOI 10.1385/CBB:43:3:355; Gunawan M, 2015, NAT IMMUNOL, V16, P505, DOI 10.1038/ni.3125; Hecht I, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002044; Itakura E, 2011, MODERN PATHOL, V24, P801, DOI 10.1038/modpathol.2011.5; Jiang YH, 2005, CLIN HEMORHEOL MICRO, V32, P261; Kalinski P, 2013, EXPERT REV VACCINES, V12, P285, DOI [10.1586/erv.13.22, 10.1586/ERV.13.22]; Khare P, 2016, MOL CARCINOG; Kovacs E, 2010, LEUKEMIA RES, V34, P912, DOI 10.1016/j.leukres.2009.08.012; Lippitz BE, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2015.1093722; Lippitz BE, 2013, LANCET ONCOL, V14, pE218, DOI 10.1016/S1470-2045(12)70582-X; Maldonado-Lopez R, 1999, J EXP MED, V189, P587, DOI 10.1084/jem.189.3.587; Malinova D, 2016, J LEUKOCYTE BIOL, V99, P699, DOI 10.1189/jlb.2A0215-050RR; Mannino MH, 2015, CANCER LETT, V367, P103, DOI 10.1016/j.canlet.2015.07.009; Mizuno K, 2013, CELL SIGNAL, V25, P457, DOI 10.1016/j.cellsig.2012.11.001; Mobini M, 2016, IRAN J BASIC MED SCI, V19, P119; Mocellin S, 2005, J LEUKOCYTE BIOL, V78, P1043, DOI 10.1189/jlb.0705358; Nguyen VA, 2002, EUR J IMMUNOL, V32, P3638, DOI 10.1002/1521-4141(200212)32:12<3638::AID-IMMU3638>3.0.CO;2-C; Niwa R, 2002, CELL, V108, P233, DOI 10.1016/S0092-8674(01)00638-9; Ohta Y, 2003, GENES CELLS, V8, P811, DOI 10.1046/j.1365-2443.2003.00678.x; Othman Mohamed S, 2013, ISRN Hepatol, V2013, P412317, DOI 10.1155/2013/412317; Parker KH, 2015, ADV CANCER RES, V128, P95, DOI 10.1016/bs.acr.2015.04.002; Rabinovich GA, 2007, ANNU REV IMMUNOL, V25, P267, DOI 10.1146/annurev.immunol.25.022106.141609; Ramesh J, 2001, J BIOCHEM BIOPH METH, V50, P33, DOI 10.1016/S0165-022X(01)00172-5; Romeo GR, 2008, J BIOL CHEM, V283, P9595, DOI 10.1074/jbc.M710092200; Ross R, 1998, J IMMUNOL, V160, P3776; Rust MB, 2012, CELL ADHES MIGR, V6, P13, DOI 10.4161/cam.19845; Sabat R, 2010, CYTOKINE GROWTH F R, V21, P331, DOI 10.1016/j.cytogfr.2010.09.002; Salman A, 2003, J BIOCHEM BIOPH METH, V55, P141, DOI 10.1016/S0165-022X(02)00182-3; Sato T, 2011, IMMUNOL RES, V51, P170, DOI 10.1007/s12026-011-8262-6; Shen M, 2016, ONCOTARGET; Shutt DC, 2000, CELL MOTIL CYTOSKEL, V46, P200, DOI 10.1002/1097-0169(200007)46:3<200::AID-CM5>3.0.CO;2-M; Steinman RM, 2007, NATURE, V449, P419, DOI 10.1038/nature06175; Tan C., 2016, THESIS; Tang M, 2016, CELL MOL LIFE SCI; Tojkander S, 2012, J CELL SCI, V125, P1855, DOI 10.1242/jcs.098087; van Helden SFG, 2006, J IMMUNOL, V177, P1567, DOI 10.4049/jimmunol.177.3.1567; Wagner A, 2016, PLOS ONE, V11; Wang XW, 2010, CLIN HEMORHEOL MICRO, V46, P265, DOI 10.3233/CH-2010-1334; Winder SJ, 2005, J CELL SCI, V118, P651, DOI 10.1242/jcs.01670; Wu C, 2016, IMMUNOLOGY; Wu L, 2016, TUMOUR BIOL; Xu N, 2016, HEILONGJIANG MED PHA, V38, P101; Xu XF, 2010, J BIOMECH, V43, P2339, DOI 10.1016/j.jbiomech.2010.04.028; Xue HW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154815; Yamakita Y, 2011, J IMMUNOL, V186, P2850, DOI 10.4049/jimmunol.1001667; Yamakita Y, 2009, CELL MOTIL CYTOSKEL, V66, P524, DOI 10.1002/cm.20356; Yamashiro S, 2012, CRIT REV IMMUNOL, V32, P11, DOI 10.1615/CritRevImmunol.v32.i1.20; Yao J, 2014, ONCOL LETT, V7, P902, DOI 10.3892/ol.2014.1804; Yao WJ, 2003, CELL MOTIL CYTOSKEL, V56, P1, DOI 10.1002/cm.10129; Yi DH, 2013, SCAND J IMMUNOL, V78, P167, DOI 10.1111/sji.12060; Zeng Z, 2006, CELL BIOCHEM BIOPHYS, V45, P19, DOI 10.1385/CBB:45:1:19; Zeng Z, 2007, CELL MOTIL CYTOSKEL, V64, P186, DOI 10.1002/cm.20175; Zeng Z, 2009, CELL BIOCHEM BIOPHYS, V55, P33, DOI 10.1007/s12013-009-9055-6; Zeng Zhu, 2015, DENDRITIC CELLS BIOP; Zheng QN, 2014, CLIN HEMORHEOL MICRO, V56, P25, DOI 10.3233/CH-121653	69	12	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0172523	10.1371/journal.pone.0172523	http://dx.doi.org/10.1371/journal.pone.0172523			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5VB	28234961	Green Submitted, Green Published, gold			2022-12-27	WOS:000394688200086
J	Hayat, T; Aziz, A; Muhammad, T; Alsaedi, A				Hayat, Tasawar; Aziz, Arsalan; Muhammad, Taseer; Alsaedi, Ahmed			A revised model for Jeffrey nanofluid subject to convective condition and heat generation/absorption	PLOS ONE			English	Article							BOUNDARY-LAYER-FLOW; NONLINEARLY STRETCHING SHEET; HOMOTOPY ANALYSIS METHOD; MAGNETOHYDRODYNAMIC 3-DIMENSIONAL FLOW; NON-NEWTONIAN NANOFLUID; MAGNETIC-FIELD; NATURAL-CONVECTION; MIXED CONVECTION; VERTICAL PLATE; MASS-TRANSFER	Here magnetohydrodynamic (MHD) boundary layer flow of Jeffrey nanofluid by a nonlinear stretching surface is addressed. Heat generation/absorption and convective surface condition effects are considered. Novel features of Brownian motion and thermophoresis are present. A non-uniform applied magnetic field is employed. Boundary layer and small magnetic Reynolds number assumptions are employed in the formulation. A newly developed condition with zero nanoparticles mass flux is imposed. The resulting nonlinear systems are solved. Convergence domains are explicitly identified. Graphs are analyzed for the outcome of sundry variables. Further local Nusselt number is computed and discussed. It is observed that the effects of Hartman number on the temperature and concentration distributions are qualitatively similar. Both temperature and concentration distributions are enhanced for larger Hartman number.	[Hayat, Tasawar; Aziz, Arsalan; Muhammad, Taseer] Quaid I Azam Univ, Dept Math, Islamabad, Pakistan; [Hayat, Tasawar; Alsaedi, Ahmed] King Abdulaziz Univ, Dept Math, Nonlinear Anal & Appl Math NAAM Res Grp, Fac Sci, Jeddah, Saudi Arabia	Quaid I Azam University; King Abdulaziz University	Muhammad, T (corresponding author), Quaid I Azam Univ, Dept Math, Islamabad, Pakistan.	taseer_qau@yahoo.com	Hayat, Tasawar/Y-2524-2019; Alsaedi, Ahmed/A-2094-2013; Muhammad, Taseer/F-9103-2018	Alsaedi, Ahmed/0000-0003-3452-8922; Muhammad, Taseer/0000-0002-0838-2731; Aziz, Arsalan/0000-0002-1985-7392				Abbasbandy S, 2014, INT J NUMER METHOD H, V24, P390, DOI 10.1108/HFF-05-2012-0096; Alsaedi A, 2012, Z NATURFORSCH A, V67, P517, DOI 10.5560/ZNA.2012-0054; [Anonymous], 1995, ENHANCING THERMAL CO; Buongiorno J, 2006, J HEAT TRANS-T ASME, V128, P240, DOI 10.1115/1.2150834; Chamkha A, 2015, INT J NUMER METHOD H, V25, P422, DOI 10.1108/HFF-02-2014-0027; Cortell R, 2008, PHYS LETT A, V372, P631, DOI 10.1016/j.physleta.2007.08.005; Cortell R, 2007, APPL MATH COMPUT, V184, P864, DOI 10.1016/j.amc.2006.06.077; Dehghan M, 2010, NUMER METH PART D E, V26, P448, DOI 10.1002/num.20460; Ellahi R, 2015, INT J HEAT MASS TRAN, V81, P449, DOI 10.1016/j.ijheatmasstransfer.2014.10.041; Ellahi R, 2013, APPL MATH MODEL, V37, P1451, DOI 10.1016/j.apm.2012.04.004; Ellahi R, 2015, IEEE T NANOTECHNOL, V14, P726, DOI 10.1109/TNANO.2015.2435899; Gao ZK, 2016, CHEM ENG J, V291, P74, DOI 10.1016/j.cej.2016.01.039; Gao ZK, 2015, SCI REP-UK, V5, DOI 10.1038/srep08222; Gao ZK, 2015, EXP THERM FLUID SCI, V60, P157, DOI 10.1016/j.expthermflusci.2014.09.008; Gao ZK, 2016, IEEE T INSTRUM MEAS, V65, P1690, DOI 10.1109/TIM.2016.2540862; Gireesha BJ, 2015, J NANOFLUIDS, V4, P474, DOI 10.1166/jon.2015.1177; GUPTA PS, 1977, CAN J CHEM ENG, V55, P744, DOI 10.1002/cjce.5450550619; Hayat T, 2016, ADV POWDER TECHNOL, V27, P504, DOI 10.1016/j.apt.2016.02.002; Hayat T, 2016, INT J NUMER METHOD H, V26, P214, DOI 10.1108/HFF-02-2015-0053; Hayat T, 2015, J MAGN MAGN MATER, V385, P222, DOI 10.1016/j.jmmm.2015.02.046; Hayat T, 2009, NONLINEAR ANAL-REAL, V10, P966, DOI 10.1016/j.nonrwa.2007.11.020; Hayat T, 2017, COMPUT METHOD APPL M, V315, P467, DOI 10.1016/j.cma.2016.11.002; Hayat T, 2016, APPL SCI-BASEL, V6, DOI 10.3390/app6110346; Hayat T, 2017, INT J THERM SCI, V111, P274, DOI 10.1016/j.ijthermalsci.2016.08.009; Hayat T, 2016, J MOL LIQ, V221, P1121, DOI 10.1016/j.molliq.2016.06.083; Hayat T, 2016, INT J HEAT MASS TRAN, V100, P566, DOI 10.1016/j.ijheatmasstransfer.2016.04.113; Hayat T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155185; Hayat T, 2016, J MAGN MAGN MATER, V408, P99, DOI 10.1016/j.jmmm.2016.02.017; Hayat T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148662; Hayat T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145332; Hayat T, 2015, Z NATURFORSCH A, V70, P225, DOI 10.1515/zna-2014-0331; Hsiao KL, 2016, APPL THERM ENG, V98, P850, DOI 10.1016/j.applthermaleng.2015.12.138; Ibrahim W, 2013, COMPUT FLUIDS, V86, P433, DOI 10.1016/j.compfluid.2013.07.029; Khan WA, 2010, INT J HEAT MASS TRAN, V53, P2477, DOI 10.1016/j.ijheatmasstransfer.2010.01.032; Kothandapani M, 2008, INT J NONLIN MECH, V43, P915, DOI 10.1016/j.ijnonlinmec.2008.06.009; Kuznetsov AV, 2014, INT J THERM SCI, V77, P126, DOI 10.1016/j.ijthermalsci.2013.10.007; Liao S, 2004, APPL MATH COMPUT, V147, P499, DOI [10.1016/S0096-3003(02)00790-7, 10.1016/50096-3003(02)00790-7]; Lin YH, 2015, INT J HEAT MASS TRAN, V84, P903, DOI 10.1016/j.ijheatmasstransfer.2015.01.099; Mabood F, 2015, J MAGN MAGN MATER, V374, P569, DOI 10.1016/j.jmmm.2014.09.013; Makinde OD, 2011, INT J THERM SCI, V50, P1326, DOI 10.1016/j.ijthermalsci.2011.02.019; Malvandi A, 2016, APPL THERM ENG, V100, P979, DOI 10.1016/j.applthermaleng.2016.02.061; Malvandi A, 2015, J MAGN MAGN MATER, V382, P296, DOI 10.1016/j.jmmm.2015.01.060; Malvandi A., 2013, J THERMODYN, V2013, DOI DOI 10.1155/2013/764827; Mukhopadhyay S, 2013, ALEX ENG J, V52, P563, DOI 10.1016/j.aej.2013.07.004; Mustafa M, 2015, INT J NONLIN MECH, V71, P22, DOI 10.1016/j.ijnonlinmec.2015.01.005; Rahman SU, 2016, J MOL LIQ, V218, P484, DOI 10.1016/j.molliq.2016.02.080; Rana P, 2012, COMMUN NONLINEAR SCI, V17, P212, DOI 10.1016/j.cnsns.2011.05.009; Sheikholeslami M, 2015, INT J HEAT MASS TRAN, V89, P799, DOI 10.1016/j.ijheatmasstransfer.2015.05.110; Sheikholeslami M, 2014, J MOL LIQ, V190, P112, DOI 10.1016/j.molliq.2013.11.002; Sheikholeslami M, 2014, J MAGN MAGN MATER, V349, P188, DOI 10.1016/j.jmmm.2013.08.040; Sheikholeslami M, 2015, APPL SCI-BASEL, V5, P294, DOI 10.3390/app5030294; Sheikholeslami M, 2015, IEEE T NANOTECHNOL, V14, P561, DOI 10.1109/TNANO.2015.2416318; Sheikholeslami M, 2015, J MAGN MAGN MATER, V374, P36, DOI 10.1016/j.jmmm.2014.08.021; Sui JZ, 2015, INT J HEAT MASS TRAN, V85, P1023, DOI 10.1016/j.ijheatmasstransfer.2015.02.014; Turkyilmazoglu M, 2013, INT J HEAT MASS TRAN, V59, P167, DOI 10.1016/j.ijheatmasstransfer.2012.12.009; Turkyilmazoglu M, 2013, INT J HEAT MASS TRAN, V57, P82, DOI 10.1016/j.ijheatmasstransfer.2012.10.006; Turkyilmazoglu M, 2016, FILOMAT, V30, P1633, DOI 10.2298/FIL1606633T; Vajravelu K, 2001, APPL MATH COMPUT, V124, P281, DOI 10.1016/S0096-3003(00)00062-X; Zeeshan A, 2014, J COMPUT THEOR NANOS, V11, P646, DOI 10.1166/jctn.2014.3408; Zhang CL, 2015, APPL MATH MODEL, V39, P165, DOI 10.1016/j.apm.2014.05.023	60	35	35	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2017	12	2							e0172518	10.1371/journal.pone.0172518	http://dx.doi.org/10.1371/journal.pone.0172518			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5SX	28231298	Green Published, gold, Green Submitted			2022-12-27	WOS:000394682400052
J	Jin, HS; Park, SY; Kim, K; Lee, YJ; Nam, GW; Kang, NJ; Lee, DW				Jin, Hyeon-Su; Park, Seon Yeong; Kim, Kyungmin; Lee, Yong-Jik; Nam, Gae-Won; Kang, Nam Joo; Lee, Dong-Woo			Development of a keratinase activity assay using recombinant chicken feather keratin substrates	PLOS ONE			English	Article							MOLECULAR CHARACTERIZATION; GENOMIC ORGANIZATION; BETA-KERATINS; PROTEASE; DEGRADATION; BACTERIUM; PURIFICATION; SEQUENCE; MICROORGANISMS; DECOMPOSITION	Poultry feathers consist mainly of the protein keratin, which is rich in beta-pleated sheets and consequently resistant to proteolysis. Although many keratinases have been identified, the reasons for their substrate specificity towards beta-keratin remain unclear due to difficulties in preparing a soluble feather keratin substrate for use in activity assays. In the present study, we overexpressed Gallus gallus chromosomes 2 and 27 beta-keratin-encoding genes in Escherichia coli, purified denatured recombinant proteins by Ni2+ affinity chromatography, and refolded by stepwise dialysis to yield soluble keratins. To assess the keratinolytic activity, we compared the proteolytic activity of crude extracts from the feather-degrading bacterium Fervidobacterium islandicum AW-1 with proteinase K, trypsin, and papain using purified recombinant keratin and casein as substrates. All tested proteases showed strong proteolytic activities for casein, whereas only F. islandicum AW-1 crude extracts and proteinase K exhibited pronounced keratinolytic activity for the recombinant keratin. Moreover, LC-MS/MS analysis of keratin hydrolysates allowed us to predict the P1 sites of keratinolytic enzymes in the F. islandicum AW-1 extracts, thereby qualifying and quantifying the extent of keratinolysis. The soluble keratin-based assay has clear therapeutic and industrial potential for the development of a high-throughput screening system for proteases hydrolyzing disease-related protein aggregates, as well as mechanically resilient keratin-based polymers.	[Jin, Hyeon-Su; Park, Seon Yeong; Kim, Kyungmin; Lee, Yong-Jik; Lee, Dong-Woo] Kyungpook Natl Univ, Sch Appl Biosci, Daegu, South Korea; [Nam, Gae-Won] Seowon Univ, Dept Cosmet Sci Technol, Chongju, South Korea; [Kang, Nam Joo] Kyungpook Natl Univ, Sch Food Sci & Biotechnol, Daegu, South Korea	Kyungpook National University; Seowon University; Kyungpook National University	Lee, DW (corresponding author), Kyungpook Natl Univ, Sch Appl Biosci, Daegu, South Korea.; Kang, NJ (corresponding author), Kyungpook Natl Univ, Sch Food Sci & Biotechnol, Daegu, South Korea.	njkang@knu.ac.kr; leehicam@knu.ac.kr			national coordinating centre for global cosmetics R&D (NCR) - Ministry of Health and Welfare [HN14C0097]; National Research Foundation of Korea (NRF) [2014R1A2A2A01006765]; Korean government (MSIP); Strategic Initiative for Microbiomes in Agriculture and Food [916006-2]; Ministry of Agriculture, Food and Rural Affairs	national coordinating centre for global cosmetics R&D (NCR) - Ministry of Health and Welfare; National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korean government (MSIP); Strategic Initiative for Microbiomes in Agriculture and Food; Ministry of Agriculture, Food and Rural Affairs	This work was supported by the national coordinating centre for global cosmetics R&D (NCR) grant HN14C0097 to N.J. Kang, funded by the Ministry of Health and Welfare, by the National Research Foundation of Korea (NRF) grant 2014R1A2A2A01006765 to D.W. Lee, funded by the Korean government (MSIP), and by the Strategic Initiative for Microbiomes in Agriculture and Food grant 916006-2 to D.W. Lee, funded by the Ministry of Agriculture, Food and Rural Affairs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews GL, 2011, ANAL CHEM, V83, P5442, DOI 10.1021/ac200812d; Ben Elhoul M, 2016, INT J BIOL MACROMOL, V92, P299, DOI 10.1016/j.ijbiomac.2016.07.009; BOCKLE B, 1995, APPL ENVIRON MICROB, V61, P3705; Bouacem K, 2016, INT J BIOL MACROMOL, V86, P321, DOI 10.1016/j.ijbiomac.2016.01.074; EBELING W, 1974, EUR J BIOCHEM, V47, P91, DOI 10.1111/j.1432-1033.1974.tb03671.x; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; ELMAYERG.HH, 1971, CAN J MICROBIOL, V17, P1067, DOI 10.1139/m71-169; Friedrich AB, 1996, APPL ENVIRON MICROB, V62, P2875, DOI 10.1128/AEM.62.8.2875-2882.1996; Greenwold MJ, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-148; Gupta R, 2006, APPL MICROBIOL BIOT, V70, P21, DOI 10.1007/s00253-005-0239-8; Habbeche A, 2014, J BIOSCI BIOENG, V117, P413, DOI 10.1016/j.jbiosc.2013.09.006; Henry J, 2012, FRONT BIOSCI-LANDMRK, V17, P1517, DOI 10.2741/4001; Herzog B, 2016, SYST APPL MICROBIOL, V39, P49, DOI 10.1016/j.syapm.2015.10.004; Jin EQ, 2011, J AGR FOOD CHEM, V59, P1729, DOI 10.1021/jf1039519; Keil B, 1987, Protein Seq Data Anal, V1, P13; Kim JM, 2001, PROCESS BIOCHEM, V37, P287, DOI 10.1016/S0032-9592(01)00206-0; Kluskens LD, 2002, EXTREMOPHILES, V6, P185, DOI 10.1007/s007920100239; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; KUNITZ M, 1947, J GEN PHYSIOL, V30, P291, DOI 10.1085/jgp.30.4.291; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lange L, 2016, APPL MICROBIOL BIOT, V100, P2083, DOI 10.1007/s00253-015-7262-1; Lateef A, 2015, BIOTECHNOL BIOTEC EQ, V29, P54, DOI 10.1080/13102818.2014.986360; LATSHAW JD, 1994, ANIM FEED SCI TECH, V47, P179, DOI 10.1016/0377-8401(94)90122-8; Lee YJ, 2015, STAND GENOMIC SCI, V10, DOI 10.1186/s40793-015-0063-4; Lee YS, 2015, EVID-BASED COMPL ALT, V2015, DOI 10.1155/2015/520578; Letourneau F, 1998, LETT APPL MICROBIOL, V26, P77; LIN XA, 1995, APPL ENVIRON MICROB, V61, P1469, DOI 10.1128/AEM.61.4.1469-1474.1995; LIN XA, 1992, APPL ENVIRON MICROB, V58, P3271, DOI 10.1128/AEM.58.10.3271-3275.1992; Lowe CB, 2015, MOL BIOL EVOL, V32, P23, DOI 10.1093/molbev/msu309; Macedo AJ, 2005, APPL ENVIRON MICROB, V71, P594, DOI 10.1128/AEM.71.1.594-596.2005; Matsui T, 2009, APPL MICROBIOL BIOT, V82, P941, DOI 10.1007/s00253-009-1880-4; Montes-Zarazua E, 2015, ADV MATER SCI ENG, V2015, DOI 10.1155/2015/907567; Nam GW, 2002, ARCH MICROBIOL, V178, P538, DOI 10.1007/s00203-002-0489-0; Ng CS, 2014, GENOME BIOL EVOL, V6, P2258, DOI 10.1093/gbe/evu181; Onifade AA, 1998, BIORESOURCE TECHNOL, V66, P1, DOI 10.1016/S0960-8524(98)00033-9; Rawlings ND, 2016, NUCLEIC ACIDS RES, V44, pD343, DOI 10.1093/nar/gkv1118; Riessen S, 2001, EXTREMOPHILES, V5, P399, DOI 10.1007/s007920100209; Riffel A, 2003, ARCH MICROBIOL, V179, P258, DOI 10.1007/s00203-003-0525-8; ROSEN H, 1957, ARCH BIOCHEM BIOPHYS, V67, P10, DOI 10.1016/0003-9861(57)90241-2; Sanghvi G, 2016, INT J BIOL MACROMOL, V87, P256, DOI 10.1016/j.ijbiomac.2016.02.067; Santos RMDB, 1996, CURR MICROBIOL, V33, P364, DOI 10.1007/s002849900129; Shilov IV, 2007, MOL CELL PROTEOMICS, V6, P1638, DOI 10.1074/mcp.T600050-MCP200; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Strasser B, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0360-y; Suzuki Y, 2006, J BIOSCI BIOENG, V102, P73, DOI 10.1263/jbb.102.73; Thys RCS, 2004, LETT APPL MICROBIOL, V39, P181, DOI 10.1111/j.1472-765X.2004.01558.x; Tork SE, 2013, INT J BIOL MACROMOL, V55, P169, DOI 10.1016/j.ijbiomac.2013.01.002; Villa ALV, 2013, BMC BIOTECHNOL, V13, DOI 10.1186/1472-6750-13-15; Verma A, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01189; Wang B, 2016, PROG MATER SCI, V76, P229, DOI 10.1016/j.pmatsci.2015.06.001; Wang LY, 2015, APPL MICROBIOL BIOT, V99, P3949, DOI 10.1007/s00253-014-6207-4; Williams CM, 1999, POULTRY SCI, V78, P956, DOI 10.1093/ps/78.7.956; WILLIAMS CM, 1990, APPL ENVIRON MICROB, V56, P1509, DOI 10.1128/AEM.56.6.1509-1515.1990; WILLIAMS CM, 1989, J APPL BACTERIOL, V67, P25, DOI 10.1111/j.1365-2672.1989.tb04951.x; Wu P, 2015, P NATL ACAD SCI USA, V112, pE6770, DOI 10.1073/pnas.1520566112; Yamamura S, 2002, J BIOSCI BIOENG, V93, P595, DOI 10.1263/jbb.93.595; Yoshioka M, 2007, J APPL MICROBIOL, V102, P509, DOI 10.1111/j.165-2672.2006.03080.x; YU RJ, 1968, J BACTERIOL, V96, P1435, DOI 10.1128/JB.96.4.1435-1436.1968	58	30	32	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2017	12	2							e0172712	10.1371/journal.pone.0172712	http://dx.doi.org/10.1371/journal.pone.0172712			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5SX	28231319	Green Published, gold, Green Submitted			2022-12-27	WOS:000394682400076
J	Munoz, S; Guerrero, FD; Kellogg, A; Heekin, AM; Leung, MY				Munoz, Sergio; Guerrero, Felix D.; Kellogg, Anastasia; Heekin, Andrew M.; Leung, Ming-Ying			Bioinformatic prediction of G protein-coupled receptor encoding sequences from the transcriptome of the foreleg, including the Haller's organ, of the cattle tick, Rhipicephalus australis	PLOS ONE			English	Article							BOOPHILUS-MICROPLUS ACARI; SYNGANGLION TRANSCRIPTOME; FAMILIES; EXPRESSION; CLONING; GENES; MODEL; CLASSIFICATION; IDENTIFICATION; NEUROPEPTIDES	The cattle tick of Australia, Rhipicephalus australis, is a vector for microbial parasites that cause serious bovine diseases. The Haller's organ, located in the tick's forelegs, is crucial for host detection and mating. To facilitate the development of new technologies for better control of this agricultural pest, we aimed to sequence and annotate the transcriptome of the R. australis forelegs and associated tissues, including the Haller's organ. As G protein-coupled receptors (GPCRs) are an important family of eukaryotic proteins studied as pharmaceutical targets in humans, we prioritized the identification and classification of the GPCRs expressed in the foreleg tissues. The two forelegs from adult R. australis were excised, RNA extracted, and pyrosequenced with 454 technology. Reads were assembled into unigenes and annotated by sequence similarity. Python scripts were written to find open reading frames (ORFs) from each unigene. These ORFs were analyzed by different GPCR prediction approaches based on sequence alignments, support vector machines, hidden Markov models, and principal component analysis. GPCRs consistently predicted by multiple methods were further studied by phylogenetic analysis and 3D homology modeling. From 4,782 assembled unigenes, 40,907 possible ORFs were predicted. Using Blastp, Pfam, GPCRpred, TMHMM, and PCA-GPCR, a basic set of 46 GPCR candidates were compiled and a phylogenetic tree was constructed. With further screening of tertiary structures predicted by RaptorX, 6 likely GPCRs emerged and the strongest candidate was classified by PCA-GPCR to be a GABA(B) receptor.	[Munoz, Sergio; Kellogg, Anastasia; Leung, Ming-Ying] Univ Texas El Paso, Bioinformat Program, El Paso, TX 79968 USA; [Guerrero, Felix D.; Heekin, Andrew M.] USDA ARS, Knipling Bushland US Livestock Insects Res Lab, Kerrville, TX USA	University of Texas System; University of Texas El Paso; United States Department of Agriculture (USDA)	Leung, MY (corresponding author), Univ Texas El Paso, Bioinformat Program, El Paso, TX 79968 USA.	mleung@utep.edu		Leung, Ming-Ying/0000-0003-2035-1214	USDA-ARS Knipling Bushland US Livestock Insects Research Laboratory CRIS project [6205-32000-031-00]; USDA-NIFA-HSI [2012-38422-19910]; NIH [2G12MD007592]; OECD Co-operative Research Programme: Biological Resource Management for Sustainable Agricultural Systems; National Institute of Minority Health and Health Disparities [2G12MD007592]; OECD Co-operative Research Programme; National Institute on Minority Health and Health Disparities [G12MD007592] Funding Source: NIH RePORTER	USDA-ARS Knipling Bushland US Livestock Insects Research Laboratory CRIS project; USDA-NIFA-HSI; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OECD Co-operative Research Programme: Biological Resource Management for Sustainable Agricultural Systems(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); National Institute of Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); OECD Co-operative Research Programme; National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	SM, AK, and MYL acknowledge funding support from USDA-NIFA-HSI grant 2012-38422-19910 (https://nifa.usda.gov/) and National Institute of Minority Health and Health Disparities (www.nimhd.nih.gov) Grant 2G12MD007592. FDG and AMH acknowledge funding support from USDA-ARS Knipling Bushland US Livestock Insects Research Laboratory (https://www.ars.usda.gov/plains-area/kerrville-tx/knipling-bushland-us-livestock-insects-research-laboratory/) CRIS project 6205-32000-031-00. FDG acknowledges the receipt of a fellowship from the OECD Co-operative Research Programme (http://www.oecd.org/tad/crp/about-the-co-operative-research-programme-crp.htm): Biological Resource Management for Sustainable Agricultural Systems in 2009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This article reports the results of research only. Mention of trade names or commercial products in this publication is solely for the purpose of providing specific information and does not imply recommendation of endorsement by the U.S. Department of Agriculture. The authors wish to thank Dr. Louise Jackson (Biosecurity Queensland, QDAFF) and Mr. Jason Tidwell (USDA-ARS CFTRL, Edinburg, TX) for help with obtaining tick materials; as well as Mr. Jon Mohl for technical support for the computational analysis. FDG and AMH acknowledge funding support from USDA-ARS Knipling Bushland US Livestock Insects Research Laboratory CRIS project 6205-32000-031-00. SM, AK, and MYL acknowledge funding support from USDA-NIFA-HSI grant 2012-38422-19910 and NIH Grant 2G12MD007592. FDG acknowledges the receipt of a fellowship from the OECD Co-operative Research Programme: Biological Resource Management for Sustainable Agricultural Systems in 2009. USDA is an equal opportunity provider and employer.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bairoch A, 2005, NUCLEIC ACIDS RES, V33, pD154, DOI 10.1093/nar/gki070; Bateman A, 2000, NUCLEIC ACIDS RES, V28, P263, DOI 10.1093/nar/28.1.263; Bhasin M, 2004, NUCLEIC ACIDS RES, V32, pW383, DOI 10.1093/nar/gkh416; Bissinger BW, 2011, INSECT MOL BIOL, V20, P465, DOI 10.1111/j.1365-2583.2011.01086.x; Bock R, 2004, PARASITOLOGY, V129, pS247, DOI 10.1017/S0031182004005190; Campos TDL, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-242; Chen A, 2004, INSECT MOL BIOL, V13, P45, DOI 10.1111/j.1365-2583.2004.00457.x; Chevreux B, 2004, GENOME RES, V14, P1147, DOI 10.1101/gr.1917404; Christie AE, 2011, GEN COMP ENDOCR, V170, P144, DOI 10.1016/j.ygcen.2010.09.018; DEBRUYNE M, 1994, J INSECT PHYSIOL, V40, P143, DOI 10.1016/0022-1910(94)90086-8; FOELIX RF, 1972, Z ZELLFORSCH MIK ANA, V124, P275, DOI 10.1007/BF00355031; George JE, 2004, PARASITOLOGY, V129, pS353, DOI 10.1017/S0031182003004682; Gibson AK, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-135; Gookin TE, 2013, METHODS MOL BIOL, V1043, P1, DOI 10.1007/978-1-62703-532-3_1; Gross AD, 2015, INSECT BIOCHEM MOLEC, V63, P47, DOI 10.1016/j.ibmb.2015.04.008; Guerrero FD, 2016, TICKS TICK-BORNE DIS, V7, P670, DOI 10.1016/j.ttbdis.2016.02.014; Gulia-Nuss M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10507; Hill CA, 2002, SCIENCE, V298, P176, DOI 10.1126/science.1076196; Holmes SP, 2000, INSECT MOL BIOL, V9, P457, DOI 10.1046/j.1365-2583.2000.00208.x; Isberg V, 2016, NUCLEIC ACIDS RES, V44, pD356, DOI 10.1093/nar/gkv1178; Kallberg M, 2012, NAT PROTOC, V7, P1511, DOI 10.1038/nprot.2012.085; King N, 2003, SCIENCE, V301, P361, DOI 10.1126/science.1083853; KOLAKOWSKI LF, 1994, RECEPTOR CHANNEL, V2, P1; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leonovich SA, 2004, EXP APPL ACAROL, V32, P89, DOI 10.1023/B:APPA.0000018200.24760.78; Liebmann C, 2004, CURR PHARM DESIGN, V10, P1937, DOI 10.2174/1381612043384367; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Meruelo AD, 2012, PROTEIN SCI, V21, P1746, DOI 10.1002/pro.2157; Mirzadegan T, 2003, BIOCHEMISTRY-US, V42, P2759, DOI 10.1021/bi027224+; Muller CE, 2012, PHARMACOL THERAPEUT, V135, P292, DOI 10.1016/j.pharmthera.2012.06.002; Nordstrom KJV, 2011, MOL BIOL EVOL, V28, P2471, DOI 10.1093/molbev/msr061; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Peng ZL, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-420; Schioth HB, 2005, GEN COMP ENDOCR, V142, P94, DOI 10.1016/j.ygcen.2004.12.018; Simo Ladislav, 2014, P309; Soares SF, 2012, ACTA TROP, V124, P192, DOI 10.1016/j.actatropica.2012.08.007; STEWART NP, 1982, J PARASITOL, V68, P691, DOI 10.2307/3280930; Suzek BE, 2007, BIOINFORMATICS, V23, P1282, DOI 10.1093/bioinformatics/btm098; Vaidehi N, 2002, P NATL ACAD SCI USA, V99, P12622, DOI 10.1073/pnas.122357199; Veenstra JA, 2016, GEN COMP ENDOCR, V229, P41, DOI [10.1016/j.ygcen.2015.11.019, 10.1016/j.ygcen.2015.07.014]; Veenstra JA, 2012, INSECT BIOCHEM MOLEC, V42, P277, DOI 10.1016/j.ibmb.2011.12.009; Vieira FG, 2011, GENOME BIOL EVOL, V3, P476, DOI 10.1093/gbe/evr033; Wistrand M, 2006, PROTEIN SCI, V15, P509, DOI 10.1110/ps.051745906; Zamanian M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-596	46	8	8	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2017	12	2							e0172326	10.1371/journal.pone.0172326	http://dx.doi.org/10.1371/journal.pone.0172326			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5SX	28231302	Green Submitted, Green Published, gold			2022-12-27	WOS:000394682400036
J	Tomasek, BJ; Williams, MM; Davis, AS				Tomasek, Bradley J.; Williams, Martin M., II; Davis, Adam S.			Changes in field workability and drought risk from projected climate change drive spatially variable risks in Illinois cropping systems	PLOS ONE			English	Article							CONTERMINOUS UNITED-STATES; AGRICULTURAL PRODUCTIVITY; SOIL WORKABILITY; INTEGRATED ASSESSMENT; CHANGE IMPACTS; LAND-USE; PART II; WATER; PRECIPITATION; CONSEQUENCES	As weather patterns become more volatile and extreme, risks introduced by weather variability will become more critical to agricultural production. The availability of days suitable for field work is driven by soil temperature and moisture, both of which may be altered by climate change. We projected changes in Illinois season length, spring field workability, and summer drought risk under three different emissions scenarios (B1, A1B, and A2) down to the crop district scale. Across all scenarios, thermal time units increased in parallel with a longer frost-free season. An increase in late March and Early April field workability was consistent across scenarios, but a decline in overall April through May workable days was observed for many cases. In addition, summer drought metrics were projected to increase for most scenarios. These results highlight how the spatial and temporal variability in climate change may present unique challenges to mitigation and adaptation efforts.	[Tomasek, Bradley J.] Univ Illinois, Dept Crop Sci, Urbana, IL 61801 USA; [Williams, Martin M., II; Davis, Adam S.] USDA ARS, Global Change & Photosynthesis Res Unit, Urbana, IL USA	University of Illinois System; University of Illinois Urbana-Champaign; United States Department of Agriculture (USDA)	Tomasek, BJ (corresponding author), Univ Illinois, Dept Crop Sci, Urbana, IL 61801 USA.	bradley.tomasek@duke.edu		Williams, Martin/0000-0002-6302-7724; Davis, Adam/0000-0002-7196-1197	United States Department of Agriculture-Agricultural Research Services [3611-22000-018]	United States Department of Agriculture-Agricultural Research Services	This work was supported by the United States Department of Agriculture-Agricultural Research Services Project 3611-22000-018. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, R LANG ENV STAT COMP; [Anonymous], 2002, STOCHASTIC WEATHER G; APLAND J, 1993, J PROD AGRIC, V6, P437, DOI 10.2134/jpa1993.0437; Aurbacher J, 2013, AGR SYST, V119, P44, DOI 10.1016/j.agsy.2013.04.005; Beguer A o a S, 2013, SPEI CALCULATION STA; Betts AK, 1996, J GEOPHYS RES-ATMOS, V101, P7209, DOI 10.1029/95JD02135; Bruce WB, 2002, J EXP BOT, V53, P13, DOI 10.1093/jexbot/53.366.13; Caubel J, 2015, AGR FOREST METEOROL, V207, P94, DOI 10.1016/j.agrformet.2015.02.005; Cherkauer KA, 2010, J GREAT LAKES RES, V36, P33, DOI 10.1016/j.jglr.2009.11.012; Chien HC, 2013, J HYDROL, V491, P73, DOI 10.1016/j.jhydrol.2013.03.026; Choi Y-S, 2016, INT J CLIMATOL; Collins WD, 2006, J CLIMATE, V19, P2122, DOI 10.1175/JCLI3761.1; Cooper G, 1997, J AGR ENG RES, V68, P253, DOI 10.1006/jaer.1997.0204; de Toro A, 2004, AGR SYST, V79, P109, DOI 10.1016/S0308-521X(03)00073-8; Dirmeyer PA, 2009, J HYDROMETEOROL, V10, P278, DOI 10.1175/2008JHM1016.1; Earl R, 1997, SOIL TILL RES, V40, P155, DOI 10.1016/S0167-1987(96)01072-0; Ewert F, 2015, ENVIRON MODELL SOFTW, V72, P287, DOI 10.1016/j.envsoft.2014.12.003; Fischer G, 2005, PHILOS T R SOC B, V360, P2067, DOI 10.1098/rstb.2005.1744; Foley JA, 2011, NATURE, V478, P337, DOI 10.1038/nature10452; Gornall J, 2010, PHILOS T R SOC B, V365, P2973, DOI 10.1098/rstb.2010.0158; Grundstein A, 2009, CLIMATIC CHANGE, V93, P103, DOI 10.1007/s10584-008-9480-3; Guo ZC, 2012, J CLIMATE, V25, P4744, DOI 10.1175/JCLI-D-11-00651.1; Harding KJ, 2016, GEOPHYS RES LETT, V43, P10773, DOI 10.1002/2016GL069981; Harding KJ, 2012, J HYDROMETEOROL, V13, P1687, DOI 10.1175/JHM-D-11-099.1; Hayhoe K, 2010, J GREAT LAKES RES, V36, P7, DOI 10.1016/j.jglr.2010.03.012; Howden SM, 2007, P NATL ACAD SCI USA, V104, P19691, DOI 10.1073/pnas.0701890104; Izaurralde RC, 2003, AGR FOREST METEOROL, V117, P97, DOI 10.1016/S0168-1923(03)00024-8; Keller T, 2012, SOIL RES, V50, P7, DOI 10.1071/SR11174; Lobell DB, 2014, SCIENCE, V344, P516, DOI 10.1126/science.1251423; Lobell DB, 2013, NAT CLIM CHANGE, V3, P497, DOI [10.1038/nclimate1832, 10.1038/NCLIMATE1832]; Mishra V, 2010, J HYDROMETEOROL, V11, P46, DOI 10.1175/2009JHM1156.1; Mueller L, 2003, SOIL TILL RES, V72, P9, DOI 10.1016/S0167-1987(03)00046-1; Nakicenovic N., 2000, SPECIAL REPORT EMISS; National Agricultural Statistics Service, 2012, ILL PROGR COND REP; National Climatic Data Center, 2012, DAIL SUMM; National Cooperative Soil Survey, 2012, NAT COOP SOIL CHAR D; Naz BS, 2016, GLOBAL PLANET CHANGE, V143, P100, DOI 10.1016/j.gloplacha.2016.06.003; Olesen JE, 2002, EUR J AGRON, V16, P239, DOI 10.1016/S1161-0301(02)00004-7; Pachauri R.K., 2008, CLIMATE CHANGE 2007; Rotz CA, 2005, APPL ENG AGRIC, V21, P563; ROUNSEVELL MDA, 1993, SOIL USE MANAGE, V9, P15, DOI 10.1111/j.1475-2743.1993.tb00921.x; Rounsevell MDA, 2003, AGR ECOSYST ENVIRON, V95, P465, DOI 10.1016/S0167-8809(02)00217-7; Schmidhuber J, 2007, P NATL ACAD SCI USA, V104, P19703, DOI 10.1073/pnas.0701976104; Semenov MA, 1997, CLIMATIC CHANGE, V35, P397, DOI 10.1023/A:1005342632279; Semenov MA, 2010, CLIM RES, V41, P1, DOI 10.3354/cr00836; Sheffield J, 2008, CLIM DYNAM, V31, P79, DOI 10.1007/s00382-007-0340-z; Smit B., 2002, Mitigation and Adaptation Strategies for Global Change, V7, P85, DOI 10.1023/A:1015862228270; Smithers J, 2001, APPL GEOGR, V21, P175, DOI 10.1016/S0143-6228(01)00004-2; Southworth J, 2000, AGR ECOSYST ENVIRON, V82, P139, DOI 10.1016/S0167-8809(00)00223-1; Spokas K, 2009, WEED SCI, V57, P216, DOI 10.1614/WS-08-142.1; Thornthwaite CW, 1948, GEOGR REV, V38, P55, DOI 10.2307/210739; Tomasek BJ, 2015, AGRON J, V107, P627, DOI 10.2134/agronj14.0393; Trnka M, 2011, GLOB CHANGE BIOL; Urban DW, 2015, CLIMATIC CHANGE, V130, P247, DOI 10.1007/s10584-015-1362-x; Van Der Schrier G., 2011, J GEOPHYS RES, V116; Vicente-Serrano SM, 2013, P NATL ACAD SCI USA, V110, P52, DOI 10.1073/pnas.1207068110; Vicente-Serrano SM, 2010, J CLIMATE, V23, P1696, DOI 10.1175/2009JCLI2909.1; Winkler JA, 2002, J GREAT LAKES RES, V28, P608, DOI 10.1016/S0380-1330(02)70609-6; Wuebbles D. J., 2004, Mitigation and Adaptation Strategies for Global Change, V9, P335, DOI 10.1023/B:MITI.0000038843.73424.de; Wuebbles DJ, 2010, J GREAT LAKES RES, V36, P1, DOI 10.1016/j.jglr.2009.09.009	60	23	23	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2017	12	2							e0172301	10.1371/journal.pone.0172301	http://dx.doi.org/10.1371/journal.pone.0172301			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5SX	28231329	Green Published, gold, Green Submitted			2022-12-27	WOS:000394682400034
J	Falcon-Lezama, JA; Santos-Luna, R; Roman-Perez, S; Martinez-Vega, RA; Herrera-Valdez, MA; Kuri-Morales, AF; Adams, B; Kuri-Morales, PA; Lopez-Cervantes, M; Ramos-Castaneda, J				Abelardo Falcon-Lezama, Jorge; Santos-Luna, Rene; Roman-Perez, Susana; Arali Martinez-Vega, Ruth; Arieli Herrera-Valdez, Marco; Fernando Kuri-Morales, Angel; Adams, Ben; Antonio Kuri-Morales, Pablo; Lopez-Cervantes, Malaquias; Ramos-Castaneda, Jose			Analysis of spatial mobility in subjects from a Dengue endemic urban locality in Morelos State, Mexico	PLOS ONE			English	Article							GLOBAL POSITIONING SYSTEM; GPS DATA-LOGGERS; HUMAN MOVEMENT; POPULATION-MOVEMENT; TRANSMISSION; PATTERNS; CONTACT; IQUITOS; TRAVEL	Introduction Mathematical models and field data suggest that human mobility is an important driver for Dengue virus transmission. Nonetheless little is known on this matter due the lack of instruments for precise mobility quantification and study design difficulties. Materials and methods We carried out a cohort-nested, case-control study with 126 individuals (42 cases, 42 intradomestic controls and 42 population controls) with the goal of describing human mobility patterns of recently Dengue virus-infected subjects, and comparing them with those of noninfected subjects living in an urban endemic locality. Mobility was quantified using a GPSdata logger registering way points at 60-second intervals for a minimum of 15 natural days. Results Although absolute displacement was highly biased towards the intradomestic and peridomestic areas, occasional displacements exceeding a 100-Km radius from the center of the studied locality were recorded for all three study groups and individual displacements were recorded traveling across six states from central Mexico. Additionally, cases had a larger number of visits out of the municipality's administrative limits when compared to intradomestic controls (cases: 10.4 versus intradomestic controls: 2.9, p = 0.0282). We were able to identify extradomestic places within and out of the locality that were independently visited by apparently non-related infected subjects, consistent with houses, working and leisure places. Conclusions Results of this study show that human mobility in a small urban setting exceeded that considered by local health authority's administrative limits, and was different between recently infected and non-infected subjects living in the same household. These observations provide important insights about the role that human mobility may have in Dengue virus transmission and persistence across endemic geographic areas that need to be taken into account when planning preventive and control measures. Finally, these results are a valuable reference when setting the parameters for future mathematical modeling studies.	[Abelardo Falcon-Lezama, Jorge; Ramos-Castaneda, Jose] Inst Nacl Salud Publ, Ctr Invest Enfermedades Infecciosas, Cuernavaca, Morelos, Mexico; [Santos-Luna, Rene; Roman-Perez, Susana] Inst Nacl Salud Publ, Subdirecc Geog Med, Cuernavaca, Morelos, Mexico; [Arali Martinez-Vega, Ruth] OLFIS, Bucaramanga, Santander, Colombia; [Arali Martinez-Vega, Ruth] Univ Santander, Campus Univ, Bucaramanga, Santander, Colombia; [Arieli Herrera-Valdez, Marco] Univ Nacl Autonoma Mexico, Inst Matemat, Mexico City, DF, Mexico; [Fernando Kuri-Morales, Angel] Inst Tecnol Autonomo Mexico, Dept Comp, Mexico City, DF, Mexico; [Adams, Ben] Univ Bath, Dept Math Sci, Bath, Avon, England; [Antonio Kuri-Morales, Pablo] Subsecretaria Prevenc & Promoc Salud, Mexico City, DF, Mexico; [Lopez-Cervantes, Malaquias] Univ Nacl Autonoma Mexico, Fac Med, Unidad Proyectos Especiales Invest Sociomed, Mexico City, DF, Mexico; [Ramos-Castaneda, Jose] Univ Texas Med Branch, Ctr Trop Dis, Galveston, TX 77555 USA; [Abelardo Falcon-Lezama, Jorge] Fdn Carlos Slim, Mexico City, DF, Mexico; [Arieli Herrera-Valdez, Marco] Univ Nacl Autonoma Mexico, Fac Ciencias, Dept Matemat, Mexico City, DF, Mexico	Instituto Nacional de Salud Publica; Instituto Nacional de Salud Publica; Universidad Industrial de Santander; Universidad Nacional Autonoma de Mexico; Instituto Tecnologico Autonomo de Mexico; University of Bath; Universidad Nacional Autonoma de Mexico; University of Texas System; University of Texas Medical Branch Galveston; Universidad Nacional Autonoma de Mexico	Ramos-Castaneda, J (corresponding author), Inst Nacl Salud Publ, Ctr Invest Enfermedades Infecciosas, Cuernavaca, Morelos, Mexico.; Ramos-Castaneda, J (corresponding author), Univ Texas Med Branch, Ctr Trop Dis, Galveston, TX 77555 USA.	jramos@insp.mx	Martínez-Vega, Ruth/AAD-3601-2019; Herrera-Valdez, Marco Arieli/J-5782-2019; Ramos-Castañeda, jose/V-6678-2019; Falcon-Lezama, Jorge Abelardo/GPS-5230-2022	Martínez-Vega, Ruth/0000-0002-6477-334X; Herrera-Valdez, Marco Arieli/0000-0001-8224-9077; Falcon-Lezama, Jorge Abelardo/0000-0001-9081-4064; RAMOS-CASTANEDA, JOSE/0000-0003-3682-1938	Consejo Nacional de Ciencia y Tecnologia, Mexico; Fondo Sectorial de Investigacion en Salud y Seguridad Social [0161157]; Servicios de Salud de Morelos; Div Of Biological Infrastructure [1300426] Funding Source: National Science Foundation	Consejo Nacional de Ciencia y Tecnologia, Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Fondo Sectorial de Investigacion en Salud y Seguridad Social; Servicios de Salud de Morelos; Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by Consejo Nacional de Ciencia y Tecnologia, Mexico, Fondo Sectorial de Investigacion en Salud y Seguridad Social, 0161157.; Authors wish to thank to Servicios de Salud de Morelos for its support to this project.	Adams B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006763; Al-Tawfiq JA, 2014, TRAVEL MED INFECT DI, V12, P422, DOI 10.1016/j.tmaid.2014.06.007; Alirol E, 2011, LANCET INFECT DIS, V11, P131, DOI 10.1016/S1473-3099(10)70223-1; Martinez-Vega RA, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004296; Belderok SM, 2013, EMERG INFECT DIS, V19, P925, DOI 10.3201/eid1906.111864; Brockmann D, 2006, NATURE, V439, P462, DOI 10.1038/nature04292; Cooper SM, 2010, J WILDLIFE DIS, V46, P152, DOI 10.7589/0090-3558-46.1.152; Duong V, 2015, P NATL ACAD SCI USA, V112, P14688, DOI 10.1073/pnas.1508114112; Hernandez-Avila JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070231; Falcon-Lezama JA, 2016, B MATH BIOL, V78, P2011, DOI 10.1007/s11538-016-0209-6; Gonzalez MC, 2008, NATURE, V453, P779, DOI 10.1038/nature06958; Herrera-Valdez MA, 2011, MATH BIOSCI ENG, V8, P21, DOI 10.3934/mbe.2011.8.21; Kuri-Morales A, 2009, ENG APPL ARTIF INTEL, V22, P57, DOI 10.1016/j.engappai.2008.04.003; Paz-Soldan VA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002888; Paz-Soldan VA, 2010, AM J TROP MED HYG, V82, P723, DOI 10.4269/ajtmh.2010.09-0496; Porter KR, 2005, AM J TROP MED HYG, V72, P60, DOI 10.4269/ajtmh.2005.72.60; Rigau-Perez JG, 1998, LANCET, V352, P971, DOI 10.1016/S0140-6736(97)12483-7; Sarfraz MS, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-853; Seto EYW, 2007, GEOSPATIAL HEALTH, V1, P233, DOI 10.4081/gh.2007.271; Shepard DS, 2016, LANCET INFECT DIS, V16, P935, DOI 10.1016/S1473-3099(16)00146-8; Sifuna P, 2014, INT J EPIDEMIOL, V43, P1097, DOI 10.1093/ije/dyu139; Smith DL, 2014, T ROY SOC TROP MED H, V108, P185, DOI 10.1093/trstmh/tru026; Stoddard ST, 2013, P NATL ACAD SCI USA, V110, P994, DOI 10.1073/pnas.1213349110; Vazquez-Prokopec GM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058802; Vazquez-Prokopec GM, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-68; Wen TH, 2012, ANN ASSOC AM GEOGR, V102, P1026, DOI 10.1080/00045608.2012.671130; WORLD HEALTH ORGANIZATION, 2009, DENGUE: GUIDELINES FOR DIAGNOSIS, TREATMENT, PREVENTION AND CONTROL, P3	27	7	7	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2017	12	2							e0172313	10.1371/journal.pone.0172313	http://dx.doi.org/10.1371/journal.pone.0172313			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5SK	28225820	gold, Green Published, Green Submitted			2022-12-27	WOS:000394680900034
J	Henry, MJ; Herrmann, B; Grahn, JA				Henry, Molly J.; Herrmann, Bjorn; Grahn, Jessica A.			What can we learn about beat perception by comparing brain signals and stimulus envelopes?	PLOS ONE			English	Article							FALSE DISCOVERY RATE; NEURONAL ENTRAINMENT; NEURAL OSCILLATIONS; AUDITORY-CORTEX; RHYTHM; SYNCHRONIZATION; METER; SPEECH; MUSIC; COMPLEXITY	Entrainment of neural oscillations on multiple time scales is important for the perception of speech. Musical rhythms, and in particular the perception of a regular beat in musical rhythms, is also likely to rely on entrainment of neural oscillations. One recently proposed approach to studying beat perception in the context of neural entrainment and resonance (the "frequency-tagging" approach) has received an enthusiastic response from the scientific community. A specific version of the approach involves comparing frequency-domain representations of acoustic rhythm stimuli to the frequency-domain representations of neural responses to those rhythms (measured by electroencephalography, EEG). The relative amplitudes at specific EEG frequencies are compared to the relative amplitudes at the same stimulus frequencies, and enhancements at beat-related frequencies in the EEG signal are interpreted as reflecting an internal representation of the beat. Here, we show that frequency-domain representations of rhythms are sensitive to the acoustic features of the tones making up the rhythms (tone duration, onset/offset ramp duration); in fact, relative amplitudes at beat-related frequencies can be completely reversed by manipulating tone acoustics. Crucially, we show that changes to these acoustic tone features, and in turn changes to the frequency-domain representations of rhythms, do not affect beat perception. Instead, beat perception depends on the pattern of onsets (i.e., whether a rhythm has a simple or complex metrical structure). Moreover, we show that beat perception can differ for rhythms that have numerically identical frequency-domain representations. Thus, frequency-domain representations of rhythms are dissociable from beat perception. For this reason, we suggest caution in interpreting direct comparisons of rhythms and brain signals in the frequency domain. Instead, we suggest that combining EEG measurements of neural signals with creative behavioral paradigms is of more benefit to our understanding of beat perception.	[Henry, Molly J.; Herrmann, Bjorn; Grahn, Jessica A.] Univ Western Ontario, Dept Psychol, Brain & Mind Inst, London, ON, Canada	Western University (University of Western Ontario)	Henry, MJ (corresponding author), Univ Western Ontario, Dept Psychol, Brain & Mind Inst, London, ON, Canada.	mhenry55@uwo.ca	Grahn, Jessica/A-1371-2010; Herrmann, Björn/H-8000-2019	Grahn, Jessica/0000-0001-7270-2114; Herrmann, Björn/0000-0001-6362-3043	Natural Sciences and Engineering Research Council Discovery grant [RGPIN/402557]; James S. McDonnell Foundation; Brain and Mind Institute at the University of Western Ontario; NSERC Discovery Grant	Natural Sciences and Engineering Research Council Discovery grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); James S. McDonnell Foundation; Brain and Mind Institute at the University of Western Ontario; NSERC Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC))	The study was funded by a Natural Sciences and Engineering Research Council Discovery grant (RGPIN/402557; http://www.nserc-crsng.gc.ca/), a James S. McDonnell Foundation grant to JAG, and the Brain and Mind Institute at the University of Western Ontario (postdoctoral fellowship awards to MJH and BH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to Morgane Ellahe Lashkari-Moghaddam, Cassie Masschelein, and Sean Gilmore for assistance with data collection and to Daniel Cameron and Avital Sternin for helpful comments on an earlier version of this manuscript. This work was supported by a James S. McDonnell Foundation Scholar Award, an NSERC Discovery Grant to JAG, and the Brain and Mind Institute at the University of Western Ontario (postdoctoral fellowship awards to MJH and BH).	[Anonymous], INT C MUS PERC COGN; Benjamini Y, 2001, ANN STAT, V29, P1165; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bishop GH, 1933, AM J PHYSIOL, V103, P213, DOI 10.1152/ajplegacy.1932.103.1.213; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Chemin B, 2014, PSYCHOL SCI, V25, P2147, DOI 10.1177/0956797614551161; Chen JL, 2008, J COGNITIVE NEUROSCI, V20, P226, DOI 10.1162/jocn.2008.20018; Cummins F, 2012, FRONT PSYCHOL, P3; Ding N, 2013, J NEUROSCI, V33, P5728, DOI 10.1523/JNEUROSCI.5297-12.2013; Ding N, 2012, J NEUROPHYSIOL, V107, P78, DOI 10.1152/jn.00297.2011; Etchell AC, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00467; Farrugia N, 2012, INT C MUS PERC COGN; Fitch WT, 2007, MUSIC PERCEPT, V25, P43, DOI 10.1525/mp.2007.25.1.43; Fitch WT, 2006, COGNITION, V100, P173, DOI 10.1016/j.cognition.2005.11.009; Fujii S, 2013, FRONT HUM NEUROSCI, P7; Fujioka T, 2012, J NEUROSCI, V32, P1791, DOI 10.1523/JNEUROSCI.4107-11.2012; Ghitza O, 2011, FRONT PSYCHOL, P2; Gibbings AWC, 2014, THESIS; Giraud AL, 2012, NAT NEUROSCI, V15, P511, DOI 10.1038/nn.3063; Grahn JA, 2007, J COGNITIVE NEUROSCI, V19, P893, DOI 10.1162/jocn.2007.19.5.893; Grahn JA, 2011, NEUROIMAGE, V54, P1231, DOI 10.1016/j.neuroimage.2010.09.033; Grahn JA, 2009, NEUROIMAGE, V47, P1894, DOI 10.1016/j.neuroimage.2009.04.039; Grahn JA, 2009, CORTEX, V45, P54, DOI 10.1016/j.cortex.2008.01.005; Hagmann CE, 2010, BEHAV PROCESS, V85, P99, DOI 10.1016/j.beproc.2010.06.015; Henry MJ, 2012, P NATL ACAD SCI USA, V109, P20095, DOI 10.1073/pnas.1213390109; Herrmann B, 2013, J NEUROSCI, V33, P15799, DOI 10.1523/JNEUROSCI.1434-13.2013; Honing H, 2014, ADV EXP MED BIOL, V829, P305, DOI 10.1007/978-1-4939-1782-2_16; Honing H, 2012, ANN NY ACAD SCI, V1252, P85, DOI 10.1111/j.1749-6632.2011.06402.x; Kayser C, 2015, J NEUROSCI, V35, P7750, DOI 10.1523/JNEUROSCI.0268-15.2015; Kayser C, 2009, NEURON, V61, P597, DOI 10.1016/j.neuron.2009.01.008; Keller PE, 2015, FRONT HUM NEUR 12 IN; Kleiner M, 2007, PERCEPTION, V36, P14; Ladinig O, 2009, MUSIC PERCEPT, V26, P377, DOI 10.1525/MP.2009.26.4.377; Lakatos P, 2008, SCIENCE, V320, P110, DOI 10.1126/science.1154735; Lakatos P, 2013, NEURON, V77, P750, DOI 10.1016/j.neuron.2012.11.034; Large EW, 2009, ANN NY ACAD SCI, V1169, P46, DOI 10.1111/j.1749-6632.2009.04550.x; Large EW, 2008, PSYCHOLOGY OF TIME, P189, DOI 10.1016/B978-0-08046-977-5.00006-5; Large EW, 2002, COGNITIVE SCI, V26, P1, DOI 10.1207/s15516709cog2601_1; Larillot O, 2007, P 10 INT C DIG AUD E; Lewis PA, 2004, NEUROPSYCHOLOGIA, V42, P1301, DOI 10.1016/j.neuropsychologia.2004.03.001; Manning F, 2013, PSYCHON B REV, V20, P1133, DOI 10.3758/s13423-013-0439-7; McDermott J, 2007, COGNITION, V104, P654, DOI 10.1016/j.cognition.2006.07.011; Meltzer B, 2015, FRONT HUM NEUROSCI, P9; Merchant H, 2015, PHILOS T R SOC B, V370, P91, DOI 10.1098/rstb.2014.0093; Mesgarani N, 2009, J NEUROPHYSIOL, V102, P3329, DOI 10.1152/jn.91128.2008; Motz BA, 2013, BRAIN COGNITION, V81, P329, DOI 10.1016/j.bandc.2013.01.005; Mullensiefan D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089642; Nespoli G, 2014, J CANADIAN ACOUSTICA, V42, P74; Nozaradan S, 2016, BRAIN STRUCT FUNCT; Nozaradan S, 2014, PHILISOPHICAL T RO B, V369, P1; Nozaradan S, 2013, NEUR M PLANN; Nozaradan S, 2014, 30 INT C CLIN NEUR I; Nozaradan S, 2015, CEREB CORTEX, V25, P736, DOI 10.1093/cercor/bht261; Nozaradan S, 2012, J NEUROSCI, V32, P17572, DOI 10.1523/JNEUROSCI.3203-12.2012; Nozaradan S, 2011, J NEUROSCI, V31, P10234, DOI 10.1523/JNEUROSCI.0411-11.2011; PARNCUTT R, 1994, MUSIC PERCEPT, V11, P409; Pasley BN, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001251; Patel AD, 2005, EXP BRAIN RES, V163, P226, DOI 10.1007/s00221-004-2159-8; Patel AD, 2009, CURR BIOL, V19, P827, DOI 10.1016/j.cub.2009.03.038; Peelle JE, 2013, CEREB CORTEX; Peelle JE, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00320; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; POVEL DJ, 1985, MUSIC PERCEPT, V2, P411; Rajendran V, 2014, 9 FED EUR NEUR SOC F; Rajendran V, 2014, 5 INT C AUD CORT 201; Rosenthal R, 2003, PSYCHOL METHODS, V8, P492, DOI 10.1037/1082-989X.8.4.492; Schlichting N, 2015, MEI COGSCI C 2015 LJ; Smith SW, 1997, SCI ENG GUIDE DIGITA, P185; Snyder JS, 2005, COGNITIVE BRAIN RES, V24, P117, DOI 10.1016/j.cogbrainres.2004.12.014; Su YH, 2012, PSYCHOL RES-PSYCH FO, V76, P373, DOI 10.1007/s00426-011-0346-3; Thut G, 2011, FRONT PSYCHOL, P2; Wieland EA, 2015, BRAIN LANG, V144, P26, DOI 10.1016/j.bandl.2015.03.008; Winkler I, 2009, P NATL ACAD SCI USA, V106, P2468, DOI 10.1073/pnas.0809035106	74	17	17	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2017	12	2							e0172454	10.1371/journal.pone.0172454	http://dx.doi.org/10.1371/journal.pone.0172454			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL5SK	28225796	Green Published, gold, Green Submitted			2022-12-27	WOS:000394680900043
J	Xu, WJ; Liu, JH; Ma, DL; Yuan, G; Lu, Y; Yang, Y				Xu, Weijie; Liu, Juanhong; Ma, Delin; Yuan, Gang; Lu, Yan; Yang, Yan			Capsaicin reduces Alzheimer-associated tau changes in the hippocampus of type 2 diabetes rats	PLOS ONE			English	Article							INSULIN-RESISTANCE; PROTEIN-TAU; NEUROFIBRILLARY TANGLES; DISEASE; RECEPTOR; HYPERPHOSPHORYLATION; SECRETION; CHANNEL; OBESITY; DIET	Type 2 diabetes (T2D) is a high-risk factor for Alzheimer's disease (AD) due to impaired insulin signaling pathway in brain. Capsaicin is a specific transient receptor potential vanilloid 1 (TRPV1) agonist which was proved to ameliorate insulin resistance. In this study, we investigated whether dietary capsaicin could reduce the risk of AD in T2D. T2D rats were fed with capsaicin-containing high fat (HF) diet for 10 consecutive days (T2D+CAP). Pair-fed T2D rats (T2D+PF) fed with the HF-diet of average dose of T2D+CAP group were included to control for the effects of reduced food intake and body weight. Capsaicin-containing standard chow was also introduced to non-diabetic rats (NC+CAP). Blood glucose and insulin were monitored. The phosphorylation level of tau at individual sites, the activities of phosphatidylinositol 3 kinase/protein kinase B (PI3K/AKT) and glycogen synthase kinase-3 beta (GSK-3 beta) were analyzed by Western blots. The results revealed that the levels of phosphorylated tau protein at sites Ser199, Ser202 and Ser396 in hippocampus of T2D+CAP group were decreased significantly, but these phospho-sites in T2D+PF group didn't show such improvements compared with T2D group. There were almost no changes in non-diabetic rats on capsaicin diet (NC+CAP) compared with the non-diabetic rats with normal chow (NC). Increased activity of PI3K/AKT and decreased activity of GSK-3 beta were detected in hippocampus of T2D+CAP group compared with T2D group, and these changes did not show in T2D+PF group either. These results demonstrated that dietary capsaicin appears to prevent the hyperphosphorylation of AD-associated tau protein by increasing the activity of PI3K/AKT and inhibiting GSK-3 beta in hippocampus of T2D rats, which supported that dietary capsaicin might have a potential use for the prevention of AD in T2D.	[Xu, Weijie; Liu, Juanhong; Ma, Delin; Yuan, Gang; Yang, Yan] Huazhong Univ Sci & Technol, Tongji Hosp, Dept Endocrinol, Tongji Med Coll, Wuhan, Peoples R China; [Lu, Yan] Fudan Univ, Zhongshan Hosp, Dept Endocrinol & Metab, Shanghai, Peoples R China	Huazhong University of Science & Technology; Fudan University	Yang, Y (corresponding author), Huazhong Univ Sci & Technol, Tongji Hosp, Dept Endocrinol, Tongji Med Coll, Wuhan, Peoples R China.; Lu, Y (corresponding author), Fudan Univ, Zhongshan Hosp, Dept Endocrinol & Metab, Shanghai, Peoples R China.	lu.yan2@zs-hospital.sh.cn; yangyan6910@163.com			Research Funding for Young Doctors of Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology [2201101901]; Natural Science Foundation of China (NSFC) [81370941, 81500636, 81670754]; China International Medical Foundation (CIMF)Novo Nordisk China Diabetes Young Scientific Talent Research Funding; Overseas Returnee Research Funding of Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology	Research Funding for Young Doctors of Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology; Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); China International Medical Foundation (CIMF)Novo Nordisk China Diabetes Young Scientific Talent Research Funding; Overseas Returnee Research Funding of Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology	The work was supported by the Research Funding for Young Doctors of Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology (2201101901 to WX), the Natural Science Foundation of China (NSFC) (81370941 to GY, 81500636 to DM and 81670754 to YY), China International Medical Foundation (CIMF)Novo Nordisk China Diabetes Young Scientific Talent Research Funding (2014 to YY), Overseas Returnee Research Funding of Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology (2016 to YY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiba Y, 2004, BIOCHEM BIOPH RES CO, V321, P219, DOI 10.1016/j.bbrc.2004.06.149; ARRIAGADA PV, 1992, NEUROLOGY, V42, P631, DOI 10.1212/WNL.42.3.631; Bloomgarden ZT, 2016, J DIABETES, V8, P4, DOI 10.1111/1753-0407.12345; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Chatterjee S, 2016, DIABETES CARE, V39, P300, DOI 10.2337/dc15-1588; Chen J, 2015, CARDIOVASC DIABETOL, V14, DOI 10.1186/s12933-015-0183-6; Chen YX, 2014, NEUROSCI BULL, V30, P282, DOI 10.1007/s12264-013-1408-x; Clegg ME, 2013, EUR J NUTR, V52, P1579, DOI 10.1007/s00394-012-0463-9; de la Monte SM, 2012, CURR ALZHEIMER RES, V9, P35; Derbenev AV, 2016, SEMIN IMMUNOPATHOL, V38, P397, DOI 10.1007/s00281-015-0529-x; Gao C, 2012, REV NEUROSCIENCE, V23, P1, DOI [10.1515/RNS.2011.061, 10.1515/rns.2011.061]; GomezIsla T, 1997, ANN NEUROL, V41, P17, DOI 10.1002/ana.410410106; Gong CX, 2010, DRUG AGING, V27, P351, DOI 10.2165/11536110-000000000-00000; GOVINDARAJAN VS, 1991, CRIT REV FOOD SCI, V29, P435, DOI 10.1080/10408399109527536; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; GRUNDKEIQBAL I, 1986, J BIOL CHEM, V261, P6084; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Henry MS, 2013, INT J GERIATR PSYCH, V28, P331, DOI 10.1002/gps.3829; Herrmann N, 2011, DRUGS, V71, P2031, DOI 10.2165/11595870-000000000-00000; Herrup K, 2015, NAT NEUROSCI, V18, P794, DOI 10.1038/nn.4017; Hwang E, 2016, PIGM CELL MELANOMA R, V29, P81, DOI 10.1111/pcmr.12430; Jiang X, 2013, J ALZHEIMERS DIS, V35, P91, DOI 10.3233/JAD-121837; Kang JH, 2010, OBESITY, V18, P780, DOI 10.1038/oby.2009.301; Kauer JA, 2009, TRENDS NEUROSCI, V32, P215, DOI 10.1016/j.tins.2008.12.006; Lee E, 2015, FASEB J, V29, P3182, DOI 10.1096/fj.14-268300; Li T, 2006, BIOCHEMISTRY-US, V45, P3125, DOI 10.1021/bi051634r; Liu Y, 2011, J PATHOL, V225, P54, DOI 10.1002/path.2912; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Mezey E, 2000, P NATL ACAD SCI USA, V97, P3655, DOI 10.1073/pnas.060496197; Moloney AM, 2010, NEUROBIOL AGING, V31, P224, DOI 10.1016/j.neurobiolaging.2008.04.002; Nilius B, 2014, PHARMACOL REV, V66, P676, DOI 10.1124/pr.113.008268; Norton S, 2014, LANCET NEUROL, V13, P788, DOI 10.1016/S1474-4422(14)70136-X; O'Neill J, 2012, PHARMACOL REV, V64, P939, DOI 10.1124/pr.112.006163; Popkie AP, 2010, J BIOL CHEM, V285, P41337, DOI 10.1074/jbc.M110.170704; Schuh Artur F, 2011, ISRN Neurol, V2011, P306905, DOI 10.5402/2011/306905; Skovso S, 2014, J DIABETES INVEST, V5, P349, DOI 10.1111/jdi.12235; Speakman JR, 2011, MOL ASPECTS MED, V32, P159, DOI 10.1016/j.mam.2011.07.001; Tremblay A, 2015, INT J OBES LOND; Wang PJ, 2012, DIABETES, V61, P2155, DOI 10.2337/db11-1503; Wang Y, 2014, BIOCHEM J, V458, P491, DOI 10.1042/BJ20131176; Westerterp-Plantenga MS, 2005, INT J OBESITY, V29, P682, DOI 10.1038/sj.ijo.0802862; Xu WJ, 2015, J INVEST MED, V63, P267, DOI 10.1097/JIM.0000000000000129; Yang HJ, 2015, NUTR METAB, V12, DOI 10.1186/s12986-015-0005-6; Yang Y, 2006, PROG BIOCHEM BIOPHYS, V33, P458; Yang Y, 2013, J ALZHEIMERS DIS, V33, P329, DOI 10.3233/JAD-2012-121294; Zhang YL, 2016, CURR OPIN CHEM ENG, V12, P1, DOI 10.1016/j.coche.2016.01.004	46	44	44	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2017	12	2							e0172477	10.1371/journal.pone.0172477	http://dx.doi.org/10.1371/journal.pone.0172477			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5SK	28225806	Green Submitted, Green Published, gold			2022-12-27	WOS:000394680900045
J	Arnold, T; Brinkley-Rubinstein, L; Chan, PA; Perez-Brumer, A; Bologna, ES; Beauchamps, L; Johnson, K; Mena, L; Nunn, A				Arnold, Trisha; Brinkley-Rubinstein, Lauren; Chan, Philip A.; Perez-Brumer, Amaya; Bologna, Estefany S.; Beauchamps, Laura; Johnson, Kendra; Mena, Leandro; Nunn, Amy			Social, structural, behavioral and clinical factors influencing retention in Pre-Exposure Prophylaxis (PrEP) care in Mississippi	PLOS ONE			English	Article							PREVENT HIV-INFECTION; NEW-YORK-CITY; TRANSGENDER WOMEN; CASE-MANAGEMENT; YOUNG MEN; SEX; HEALTH; BARRIERS; BLACK; ACCEPTABILITY	Pre-exposure prophylaxis (PrEP) is a biomedical intervention that can reduce rates of HIV transmission when taken once daily by HIV-negative individuals. Little is understood about PrEP uptake and retention in care among the populations most heavily impacted by the HIV epidemic, particularly among young men who have sex with men (YMSM) in the Deep South. Therefore, this study explored the structural, social, behavioral, and clinical factors that affect PrEP use and retention in care among YMSM in Jackson, Mississippi. Thirty MSM who were prescribed PrEP at an outpatient primary care clinic were interviewed and included 23 men who had been retained in PrEP care and seven who had not been retained. The mean age of participants was 26.6 years. Most (23) participants were African American. Major factors affecting PrEP use and retention in PrEP care included 1) structural factors such as cost and access to financial assistance for medications and clinical services; 2) social factors such as stigma and relationship status; 3) behavioral factors including sexual risk behaviors; and 4) clinical factors such as perceived and actual side effects. Many participants also discussed the positive spillover effects of PrEP use and reported that PrEP had a positive impact on their health. Four of the seven individuals who had not been retained re-enrolled in PrEP care after completing their interviews, suggesting that case management and ongoing outreach can enhance retention in PrEP care. Interventions to enhance retention in PrEP care among MSM in the Deep South will be most effective if they address the complex structural, social, clinical, and behavioral factors that influence PrEP uptake and retention in PrEP care.	[Arnold, Trisha; Bologna, Estefany S.; Beauchamps, Laura; Mena, Leandro] Univ Mississippi, Med Ctr, Dept Med, Jackson, MS 39216 USA; [Arnold, Trisha; Bologna, Estefany S.] Jackson State Univ, Jackson, MS 39217 USA; [Brinkley-Rubinstein, Lauren] Univ N Carolina, Dept Social Med, Chapel Hill, NC USA; [Brinkley-Rubinstein, Lauren] Univ N Carolina, Ctr Hlth Equity Res, Chapel Hill, NC USA; [Chan, Philip A.; Nunn, Amy] Brown Univ, Warren Alpert Med Sch, Providence, RI 02912 USA; [Chan, Philip A.; Nunn, Amy] Miriam Hosp, Providence, RI 02906 USA; [Perez-Brumer, Amaya] Columbia Univ, Dept Sociomed Sci, New York, NY USA; [Johnson, Kendra] Mississippi Dept Hlth, Jackson, MS USA; [Nunn, Amy] Brown Univ, Sch Publ Hlth, Providence, RI 02912 USA	University of Mississippi; University of Mississippi Medical Center; Jackson State University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Brown University; Lifespan Health Rhode Island; Miriam Hospital; Columbia University; Brown University	Arnold, T (corresponding author), Univ Mississippi, Med Ctr, Dept Med, Jackson, MS 39216 USA.; Arnold, T (corresponding author), Jackson State Univ, Jackson, MS 39217 USA.	tarnold@umc.edu	Perez-Brumer, Amaya/AAF-6336-2021	Chan, Philip/0000-0003-0964-5895; Perez-Brumer, Amaya/0000-0003-2441-4358	Gilead Sciences [K23AI096923, K01AA020228]; Lifespan/Tufts/Brown Center for AIDS Research - National Institute of Allergy And Infectious Diseases [P30AI042853]; Brown Initiative in HIV and AIDS Clinical Research for Minority Communities [R25MH083620]; UCLA HIV/AIDS, Substance Abuse and Trauma Training Program (HA-STTP) [R25DA035692]; HIV and Other Infectious Consequences of Substance Abuse [T32DA013911]; Lifespan/Brown Criminal Justice Research Program on HIV and Substance Use [R23DA037190, R25-DA037190-02]; NATIONAL INSTITUTE OF MENTAL HEALTH [R34MH109371, R25MH083620] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA013911] Funding Source: NIH RePORTER	Gilead Sciences(Gilead Sciences); Lifespan/Tufts/Brown Center for AIDS Research - National Institute of Allergy And Infectious Diseases; Brown Initiative in HIV and AIDS Clinical Research for Minority Communities; UCLA HIV/AIDS, Substance Abuse and Trauma Training Program (HA-STTP); HIV and Other Infectious Consequences of Substance Abuse; Lifespan/Brown Criminal Justice Research Program on HIV and Substance Use; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	PH received funding from Gilead Sciences, K23AI096923, http://www.rdatlas.com/portal/portal.cfm?page=grants&applicationid=8525338. AN received funding from Gilead Sciences, K01AA020228, http://www.rdatlas.com/portal/portal.cfm?page=grants&applicationid=8499170. PH received funding from Lifespan/Tufts/Brown Center for AIDS Research funded by the National Institute of Allergy And Infectious Diseases, P30AI042853, http://www.rdatlas.com/portal/portal.cfm?page=grants&applicationid=8685871. AN received funding from Lifespan/Tufts/Brown Center for AIDS Research funded by the National Institute of Allergy And Infectious Diseases, P30AI042853, http://www.rdatlas.com/portal/portal.cfm?page=grants&applicationid=8685871. LB's efforts are supported by The Brown Initiative in HIV and AIDS Clinical Research for Minority Communities, R25MH083620, http://www.rdatlas.com/portal/portal.cfm?page=grants&applicationid=8296333. LB efforts are supported by UCLA HIV/AIDS, Substance Abuse and Trauma Training Program (HA-STTP), R25DA035692, http://www.ha-sttp.com/pdf/HA-STTP_Recruitment_Flyer_2015.pdf. LB efforts are supported by HIV and Other Infectious Consequences of Substance Abuse, T32DA013911, http://www.rdatlas.com/portal/portal.cfm?page=grants&applicationid=8871700. LB efforts are supported by Lifespan/Brown Criminal Justice Research Program on HIV and Substance Use, R23DA037190, http://grantome.com/grant/NIH/R25-DA037190-02. TA efforts are supported by The Brown Initiative in HIV and AIDS Clinical Research for Minority Communities, R25MH083620, http://www.rdatlas.com/portal/portal.cfm?page=grants&applicationid=8296333. EB efforts are supported by The Brown Initiative in HIV and AIDS Clinical Research for Minority Communities, R25MH083620, http://www.rdatlas.com/portal/portal.cfm?page=grants&applicationid=8296333. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson PL, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004006; Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Bauermeister JA, 2014, CURR HIV RES, V11, P520, DOI 10.2174/1570162X12666140129100411; Bush S, 2016, ASM ICAAC RACIAL CHA; Centers for Disease Control and Prevention, 2015, EPIDEMIOLOGY OF HIV; Centers for Disease Control and Prevention, 2013, DIAGNOSES OF HIV INF; Centers for Disease Control and Prevention, 2015, HIV SURVEILLANCE MEN; Chan PA, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20903; Christopoulos KA, 2011, CLIN INFECT DIS, V52, pS214, DOI 10.1093/cid/ciq045; Cohen SE, 2015, JAIDS-J ACQ IMM DEF, V68, P439, DOI 10.1097/QAI.0000000000000479; Cunningham CO, 2007, AIDS PATIENT CARE ST, V21, P177, DOI 10.1089/apc.2006.103; Cunningham WE, 2008, J NATL MED ASSOC, V100, P840, DOI 10.1016/S0027-9684(15)31379-1; Gengiah TN, 2014, INT J CLIN PHARM-NET, V36, P70, DOI 10.1007/s11096-013-9861-1; Gilmore HJ, 2013, AIDS PATIENT CARE ST, V27, P560, DOI 10.1089/apc.2013.0116; Golub SA, 2013, AIDS PATIENT CARE ST, V27, P248, DOI 10.1089/apc.2012.0419; Grant R, 2014, LANCET INFECT DIS, P1; Grant RM, 2014, LANCET INFECT DIS, V14, P820, DOI 10.1016/S1473-3099(14)70847-3; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Grohskopf LA, 2013, JAIDS-J ACQ IMM DEF, V64, P79, DOI 10.1097/QAI.0b013e31828ece33; Haire BG, 2015, HIV AIDS-RES PALLIAT, V7, P241, DOI 10.2147/HIV.S72419; Herron PD, 2016, LGBT HEALTH, V3, P103, DOI 10.1089/lgbt.2014.0114; Juliet Corbin AS, 2008, BASICS OF QUALITATIV; Katz MH, 2001, ANN INTERN MED, V135, P557, DOI 10.7326/0003-4819-135-8_Part_1-200110160-00006; Krakower DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033119; Liu AY, 2016, JAMA INTERN MED, V176, P75, DOI 10.1001/jamainternmed.2015.4683; Marcus JL, 2016, CURR HIV-AIDS REP, V13, P116, DOI 10.1007/s11904-016-0308-x; Marmot M, 2008, LANCET, V372, P1661, DOI 10.1016/S0140-6736(08)61690-6; Mayer KH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087298; McCallister S, 2016, ASM HIV 1 SEROCONVER; Millett GA, 2012, LANCET, V380, P341, DOI 10.1016/S0140-6736(12)60899-X; Mississippi State Department of Health, 2006, REPORT NO 1545 861X; Molina JM, 2015, NEW ENGL J MED, V373, P2237, DOI 10.1056/NEJMoa1506273; Mutchler MG, 2015, AIDS PATIENT CARE ST, V29, P490, DOI 10.1089/apc.2015.0002; Oldenburg C, 2015, STATE LEVEL STRUCTUR; Parker S, 2015, AIDS PATIENT CARE ST, V29, P639, DOI 10.1089/apc.2015.0186; Perez-Figueroa RE, 2015, AIDS EDUC PREV, V27, P112, DOI 10.1521/aeap.2015.27.2.112; Philbin MM, 2016, AIDS PATIENT CARE ST, V30, P282, DOI 10.1089/apc.2016.0037; Prejean J, 2013, J COMMUN HEALTH, V38, P414, DOI 10.1007/s10900-012-9633-1; Prejean J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017502; Rosenberg Eli Samuel, 2016, JMIR Public Health Surveill, V2, pe22, DOI 10.2196/publichealth.5684; Rucinski KB, 2013, AIDS BEHAV, V17, P2180, DOI 10.1007/s10461-013-0443-y; Thigpen MC, 2012, NEW ENGL J MED, V367, P423, DOI 10.1056/NEJMoa1110711; Thomas DR, 2006, AM J EVAL, V27, P237, DOI 10.1177/1098214005283748; US Public Health Service Center for Disease Control and Prevention, PREEXPOSURE PROPHYLA; Van Damme L, 2012, NEW ENGL J MED, V367, P411, DOI 10.1056/NEJMoa1202614	45	119	119	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2017	12	2							e0172354	10.1371/journal.pone.0172354	http://dx.doi.org/10.1371/journal.pone.0172354			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL5QV	28222118	Green Published, Green Submitted, gold			2022-12-27	WOS:000394676800053
J	Garcia-Garcia, M; Via, M; Zarnowiec, K; SanMiguel, I; Escera, C; Clemente, IC				Garcia-Garcia, Manuel; Via, Marc; Zarnowiec, Katarzyna; SanMiguel, Iria; Escera, Carles; Clemente, Immaculada C.			COMT and DRD2/ANKK-1 gene-gene interaction account for resetting of gamma neural oscillations to auditory stimulus-driven attention	PLOS ONE			English	Article							CATECHOL-O-METHYLTRANSFERASE; DOPAMINE-RECEPTOR GENE; WORKING-MEMORY; PARKINSONS-DISEASE; DRD2 POLYMORPHISMS; PREFRONTAL CORTEX; INVOLUNTARY ATTENTION; COGNITIVE FUNCTION; HUMAN STRIATUM; BAND ACTIVITY	Attention capture by potentially relevant environmental stimuli is critical for human survival, yet it varies considerably among individuals. A large series of studies has suggested that attention capture may depend on the cognitive balance between maintenance and manipulation of mental representations and the flexible switch between goal-directed representations and potentially relevant stimuli outside the focus of attention; a balance that seems modulated by a prefrontostriatal dopamine pathway. Here, we examined inter-individual differences in the cognitive control of attention through studying the effects of two single nucleotide polymorphisms regulating dopamine at the prefrontal cortex and the striatum (i.e., COMTMet108/158Val and ANKK1/DRD2TaqIA) on stimulus-driven attention capture. Healthy adult participants (N = 40) were assigned to different groups according to the combination of the polymorphisms COMTMet108/158Val and ANKK1/DRD2TaqIA, and were instructed to perform on a well-established distraction protocol. Performance in individuals with a balance between prefrontal dopamine display and striatal receptor density was slowed down by the occurrence of unexpected distracting events, while those with a rather unbalanced dopamine activity were able maintain task performance with no time delay, yet at the expense of a slightly lower accuracy. This advantage, associated to their distinct genetic profiles, was paralleled by an electrophysiological mechanism of phase-resetting of gamma neural oscillation to the novel, distracting events. Taken together, the current results suggest that the epistatic interaction between COMTVal108/158Met and ANKK1/DRD2 TaqIa genetic polymorphisms lies at the basis of stimulus-driven attention capture.	[Garcia-Garcia, Manuel; Via, Marc; Zarnowiec, Katarzyna; SanMiguel, Iria; Escera, Carles; Clemente, Immaculada C.] Univ Barcelona, Inst Neurosci, Barcelona, Spain; [Garcia-Garcia, Manuel; Via, Marc; Zarnowiec, Katarzyna; SanMiguel, Iria; Escera, Carles; Clemente, Immaculada C.] Univ Barcelona, Dept Clin Psychol & Psychobiol, Brainlab Cognit Neurosci Res Grp, Barcelona, Spain; [Via, Marc; SanMiguel, Iria; Escera, Carles; Clemente, Immaculada C.] IR SJD, Barcelona, Spain	University of Barcelona; University of Barcelona	Escera, C (corresponding author), Univ Barcelona, Inst Neurosci, Barcelona, Spain.; Escera, C (corresponding author), Univ Barcelona, Dept Clin Psychol & Psychobiol, Brainlab Cognit Neurosci Res Grp, Barcelona, Spain.; Escera, C (corresponding author), IR SJD, Barcelona, Spain.	cescera@ub.edu	Escera, Carles/A-8658-2010; SanMiguel, Iria/C-2909-2013; Clemente, I Concepcion/H-5399-2013; Via, Marc/L-6511-2014	Escera, Carles/0000-0001-8203-2951; SanMiguel, Iria/0000-0002-7462-8621; Clemente, I Concepcion/0000-0003-0728-0925; Via, Marc/0000-0002-9966-9921	Spanish Ministry of Economy and Knowledge [PSI 2015-63664-P]; Catalan Government [SGR2014-177]; ICREA Academia Distinguished Professorship	Spanish Ministry of Economy and Knowledge(Spanish Government); Catalan Government; ICREA Academia Distinguished Professorship(ICREA)	This work was supported by grants from the Spanish Ministry of Economy and Knowledge (PSI 2015-63664-P), the Catalan Government (SGR2014-177), and the ICREA Academia Distinguished Professorship awarded to CE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altamura M, 2016, NEUROSCI LETT, V610, P86, DOI 10.1016/j.neulet.2015.10.018; Arnsten AFT, 1998, TRENDS COGN SCI, V2, P436, DOI 10.1016/S1364-6613(98)01240-6; Belouchrani A, 1997, IEEE T SIGNAL PROCES, V45, P434, DOI 10.1109/78.554307; Berryhill ME, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055862; Bilder RM, 2004, NEUROPSYCHOPHARMACOL, V29, P1943, DOI 10.1038/sj.npp.1300542; Birkas E, 2006, BRAIN RES, V1103, P150, DOI 10.1016/j.brainres.2006.03.021; Busch NA, 2006, NEUROIMAGE, V33, P1169, DOI 10.1016/j.neuroimage.2006.07.034; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; CAMPS M, 1989, NEUROSCIENCE, V28, P275, DOI 10.1016/0306-4522(89)90179-6; Cools R, 2001, CEREB CORTEX, V11, P1136, DOI 10.1093/cercor/11.12.1136; Cools R, 2004, J NEUROSCI, V24, P1129, DOI 10.1523/JNEUROSCI.4312-03.2004; Cools R, 2003, NEUROPSYCHOLOGIA, V41, P1431, DOI 10.1016/S0028-3932(03)00117-9; Cools R, 2008, NEUROSCIENTIST, V14, P381, DOI 10.1177/1073858408317009; Cools R, 2011, BIOL PSYCHIAT, V69, pE113, DOI 10.1016/j.biopsych.2011.03.028; Debener S, 2003, NEUROREPORT, V14, P683, DOI 10.1097/00001756-200304150-00005; do Vale S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104869; Dominguez-Borras J, 2009, CEREB CORTEX, V19, P1521, DOI 10.1093/cercor/bhn188; Durstewitz D, 2000, J NEUROPHYSIOL, V83, P1733, DOI 10.1152/jn.2000.83.3.1733; Escera C, 2003, EUR J NEUROSCI, V18, P2408, DOI 10.1046/j.1460-9568.2003.02937.x; Escera C, 1998, J COGNITIVE NEUROSCI, V10, P590, DOI 10.1162/089892998562997; Escera C, 2001, EUR J NEUROSCI, V14, P877, DOI 10.1046/j.0953-816x.2001.01707.x; Escera C, 2007, J PSYCHOPHYSIOL, V21, P251, DOI 10.1027/0269-8803.21.34.251; Frank MJ, 2005, J COGNITIVE NEUROSCI, V17, P51, DOI 10.1162/0898929052880093; Fries P, 2001, SCIENCE, V291, P1560, DOI 10.1126/science.1055465; Garcia-Garcia M, 2011, NEUROIMAGE, V56, P1641, DOI 10.1016/j.neuroimage.2011.02.053; Garcia-Garcia M, 2010, NEUROIMAGE, V49, P1038, DOI 10.1016/j.neuroimage.2009.07.059; Getzmann S, 2013, NEUROIMAGE, V64, P290, DOI 10.1016/j.neuroimage.2012.08.079; Good P, 2005, PERMUTATION PARAMETR; Herrmann CS, 2004, TRENDS COGN SCI, V8, P347, DOI 10.1016/j.tics.2004.06.006; Jonsson EG, 1999, MOL PSYCHIATR, V4, P290, DOI 10.1038/sj.mp.4000532; Kaplan F, 2007, FRONT NEUROSCI-SWITZ, V1, P225, DOI 10.3389/neuro.01.1.1.017.2007; Klimesch W, 2007, BRAIN RES REV, V53, P63, DOI 10.1016/j.brainresrev.2006.06.003; Komek K, 2012, EUR J NEUROSCI, V36, P2146, DOI 10.1111/j.1460-9568.2012.08071.x; Lachman HM, 1996, PHARMACOGENETICS, V6, P243, DOI 10.1097/00008571-199606000-00007; Lehikoinen P, 1998, MOL PSYCHIATR, V3, P256; Lewis DA, 2001, J COMP NEUROL, V432, P119, DOI 10.1002/cne.1092; Lewis SJG, 2003, J NEUROSCI, V23, P6351, DOI 10.1523/jneurosci.23-15-06351.2003; Mannisto PT, 1999, PHARMACOL REV, V51, P593; Neville MJ, 2004, HUM MUTAT, V23, P540, DOI 10.1002/humu.20039; Reuter M, 2006, INT J NEUROPSYCHOPH, V9, P155, DOI 10.1017/S1461145705005419; Reuter M, 2005, BEHAV BRAIN RES, V164, P93, DOI 10.1016/j.bbr.2005.06.002; Ritchie T, 2003, NEUROCHEM RES, V28, P73, DOI 10.1023/A:1021648128758; SanMiguel I, 2008, J COGNITIVE NEUROSCI, V20, P1131, DOI 10.1162/jocn.2008.20078; SAWAGUCHI T, 1994, J NEUROPHYSIOL, V71, P515, DOI 10.1152/jn.1994.71.2.515; Spielberger C. D., 1973, MANUAL STATE TRAIT I; Stelzel C, 2009, EUR J NEUROSCI, V29, P1056, DOI 10.1111/j.1460-9568.2009.06647.x; Tallon-Baudry C, 1999, TRENDS COGN SCI, V3, P151, DOI 10.1016/S1364-6613(99)01299-1; TallonBaudry C, 1997, J NEUROSCI, V17, P722; Thompson J, 1997, PHARMACOGENETICS, V7, P479, DOI 10.1097/00008571-199712000-00006; Tian T, 2013, J NEUROSCI, V33, P17519, DOI 10.1523/JNEUROSCI.2163-13.2013; TIITINEN H, 1993, NATURE, V364, P59, DOI 10.1038/364059a0; Williams GV, 2006, NEUROSCIENCE, V139, P263, DOI 10.1016/j.neuroscience.2005.09.028; Winterer G, 2004, AM J PSYCHIAT, V161, P490, DOI 10.1176/appi.ajp.161.3.490; Womelsdorf T, 2006, NATURE, V439, P733, DOI 10.1038/nature04258; Yordanova J, 1997, INT J NEUROSCI, V92, P241, DOI 10.3109/00207459708986404; Yordanova J, 2000, NEUROREPORT, V11, P2325, DOI 10.1097/00001756-200007140-00051; Yordanova J, 2001, CLIN NEUROPHYSIOL, V112, P1096, DOI 10.1016/S1388-2457(01)00524-7; Zhao FS, 2015, SCI REP-UK, V5, DOI 10.1038/srep17996	58	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2017	12	2							e0172362	10.1371/journal.pone.0172362	http://dx.doi.org/10.1371/journal.pone.0172362			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5QV	28222164	Green Published, Green Submitted, gold			2022-12-27	WOS:000394676800054
J	Bekru, ET; Cherie, A; Anjulo, AA				Bekru, Eyasu Tamru; Cherie, Amsale; Anjulo, Antehun Alemayehu			Job satisfaction and determinant factors among midwives working at health facilities in Addis Ababa city, Ethiopia	PLOS ONE			English	Article							NURSES	Background Midwives are the primary source of care and support for mothers and newborns at the most vulnerable time in their lives. The Ethiopian National Reproductive Health Strategy targeted reduction of Maternal Mortality rate to 267/100,000 live births in the years 2006-2015. Midwives play a crucial role in the care of pregnant women, from the first antenatal visit right through to the delivery and the postpartum period. Methodology Institution based cross-sectional study was carried out from March 2015 to April 2015 in Addis Ababa city, Ethiopia to assess job satisfaction and its determinants among midwives working at government health facilities. A total of 234 midwives were involved from 84 health centers and 8 governmental hospitals proportional to the size of health centers and hospitals using simple random sampling method. A total of 175 and 59 midwives were taken from health centers and government hospitals respectively. Different variables like Socio demographic, Job related domain and Organizational domain were collected using pre structured questionnaire after getting written consent. Data entry and analysis were done using SPSS 21.00. Binary logistic regression was used to determine factors affecting job satisfaction. P-values less than 0.05 were considered statistically significant. Result From 234 eligible respondents 221 midwives participated in this study which makes a response rate of 94.44%. The overall mean job satisfaction was 52.9%. Independent predictors of job satisfaction includes Sex [AOR = 4.07 (95% CI: 1.36-12.37)], working unit [AOR = 0.04 (95% CI:(0.001-0.45)], Educational status [AOR = 5.74(95% CI: 1.48-40.47)], Marital status [AOR = 3.48 [1.01-11.97)], supervision [AOR = 4.33 (95% CI: 1.53-20.22)], standard of care[AOR 4.80, (3.38-50.10)] and work load [AOR 8.94, (95% CI 2.37-22.65)]. Midwives were least satisfied from salary, extrinsic reward and professional opportunity subscales while they were most satisfied from coworker relation and the standard of care they provided to clients. Conclusion Half of study subjects were satisfied with their job. Governmental and Nongovernmental organizations should consider the factors that contribute to job dissatisfaction in order to improve service provision.	[Bekru, Eyasu Tamru] Wolaita Sodo Univ, Dept Nursing, Coll Hlth Sci & Med, Wolaita Sodo, Ethiopia; [Cherie, Amsale] Univ Addis Ababa, Sch Publ Hlth, Addis Ababa, Ethiopia; [Anjulo, Antehun Alemayehu] Wolaita Sodo Univ, Sch Med, Coll Hlth Sci & Med, Wolaita Sodo, Ethiopia	Addis Ababa University	Anjulo, AA (corresponding author), Wolaita Sodo Univ, Sch Med, Coll Hlth Sci & Med, Wolaita Sodo, Ethiopia.	Antehunalemayehu@gmail.com						Ahmed SM, 2013, INT J PHARM SCI RES, V4, P2351, DOI 10.13040/IJPSR.0975-8232.4(6).2351-58; Al-Enezi N, 2009, APPL NURS RES, V22, P94, DOI 10.1016/j.apnr.2007.05.005; Asegid A, 2014, NURS RES PRACT, V2014, DOI 10.1155/2014/909768; Bahalkani Habib Akhtar, 2011, J Ayub Med Coll Abbottabad, V23, P130; Beatrice J., 2010, J NURSMANAG, V18, P93847; Bergstrom A, MEASURING JOB SATISF; Bhatti N, 2012, IMPACT AUTOCRATIC DE; Castillo J. X., 2004, J AGR ED, V45, P65, DOI DOI 10.5032/jae.2004.03065; Celik M1, 2011, POLISH J MANAG STUD, V4; Contributors Osh, JOB SAT THEOR DEF; Coward R T, 1992, J Rural Health, V8, P255, DOI 10.1111/j.1748-0361.1992.tb00366.x; Danish RQ., 2010, INT J BUSINESS MANAG, V5, P159, DOI [10.5539/ijbm.v5n2p159, DOI 10.5539/IJBM.V5N2P159]; Dignani L., 2013, J US CHINA PUBLIC AD, V10, P379; EDHS, 2011, ETH DEM HLTH SURV 20; El-Jardali F, 2009, BMC NURS, V8, DOI 10.1186/1472-6955-8-3; Ethiopia Ministry of Health, 2006, NAT REPR HLTH STRAT, P1; Federal Democratic Republic of Ethiopia Ministry of Health, HLTH SECT DEV PROGR; Kekana H P P, 2007, Curationis, V30, P24; Kumar R, 2013, HUM RESOUR HEALTH, V11, DOI 10.1186/1478-4491-11-2; Liljestrand J, 2004, J PUBLIC HEALTH POL, V25, P299, DOI 10.1057/palgrave.jphp.3190030; Lu H, 2005, INT J NURS STUD, V42, P211, DOI 10.1016/j.ijnurstu.2004.09.003; Medhin G/ G, GREENER J MED SCI, V4; Ministry of Health UNFP, 2012, STAT ETH MIDW 2012; Murrells T, 2008, BMC NURS, V7, DOI 10.1186/1472-6955-7-7; Naicker S, 2009, ETHNICITY DIS; Olatunji S.O., 2014, INT MULTIDISCIPLINAR, V8, P126, DOI [10.4314/afrrev.v8i1.10, DOI 10.4314/AFRREV.V8I1.10]; Rao MTK, Q PUBL J APPL MANAG, V1; Sachs JD, 2004, B WORLD HEALTH ORGAN, V82, P947; Shah Makhdoom A, 2004, Aust J Adv Nurs, V21, P10; Tang W. M., 2012, INT J NURS SCI, V2, P29, DOI [DOI 10.5923/J.NURSING.20120204.01, 10.5923/j.nursing.20120204.01]; Tourangeau AE, 2006, NURS RES, V55, P128, DOI 10.1097/00006199-200603000-00008; WHO UNFPH, 2014, MIDW INT C UN PATHW; Williams Lippincott., 2014, AJN, V114, P18, DOI [10.1097/01.NAJ.0000453741.11196.d4, DOI 10.1097/01.NAJ.0000453741.11196.D4]; Yami A, 2011, ETHIOP J HEALTH SCI, V21, P19; Zizzo K., 2009, THESIS	35	21	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2017	12	2							e0172397	10.1371/journal.pone.0172397	http://dx.doi.org/10.1371/journal.pone.0172397			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL2BI	28212425	gold, Green Published, Green Submitted			2022-12-27	WOS:000394424700043
J	Ikeda, S; Yamashita, H; Kondo, S; Inoue, K; Morishima, S; Koike, K				Ikeda, Shota; Yamashita, Hiroshi; Kondo, Shi-nobu; Inoue, Ken; Morishima, Shin-ya; Koike, Kazuhiko			Zooxanthellal genetic varieties in giant clams are partially determined by species-intrinsic and growth-related characteristics	PLOS ONE			English	Article							CORAL-ALGAL SYMBIOSES; SYMBIODINIUM-MICROADRIATICUM; TRIDACNA-GIGAS; EARLY ONTOGENY; CLADE-D; DIVERSITY; ECOLOGY; REEF; SPECIFICITY; IDENTITY	Giant clams ( tridacnine shellfishes) are large bivalves that inhabit tropical and subtropical waters and harbor the symbiotic microalgae zooxanthellae, which consist of diverse phylotypes ( clades). Each clade exhibits unique physiological characteristics, and the cladal composition may influence the host's survival and its ability to tolerate environmental changes. Using quantitative PCR ( qPCR) assays, we investigated the zooxanthellal genetic clades in Tridacna crocea ( n = 93) and Tridacna squamosa ( n = 93). These two clam species were artificially bred and maintained for an extended time period under an equivalent environment in an outdoor pond. Results showed that T. crocea had a simpler cladal composition and with an apparent dominance of clade A, whereas multiple clades were present in T. squamosa. The zooxanthellae clade A is known to occur in other zooxanthellae-bearing animals that inhabit shallow waters, which is consistent to the shallow water habitat preference of T. crocea. Interestingly, in larger individuals of T. squamosa, the main zooxanthellal clade was C rather than A. The mechanism underlying the dominance of clade C in the larger T. squamosa has not yet been clarified. However, the additional photosynthates supplied by clade C may be preferable for growing clams, as is observed in corals. The cladal composition of giant clams has previously been reported to be primarily controlled by environmental factors. However, our experiments subjected different clam species to the same environmental conditions, and our results suggested that species-intrinsic and/ or growth-related processes may also influence the cladal composition.	[Ikeda, Shota; Morishima, Shin-ya; Koike, Kazuhiko] Hiroshima Univ, Grad Sch Biosphere Sci, Higashihiroshima, Hiroshima, Japan; [Yamashita, Hiroshi] Japan Fisheries Res & Educ Agcy, Seikai Natl Fisheries Res Inst, Res Ctr Subtrop Fisheries, Ishigaki, Okinawa, Japan; [Kondo, Shi-nobu; Inoue, Ken] Okinawa Prefectural Fisheries Res & Extens Ctr, Itoman, Okinawa, Japan	Hiroshima University; Japan Fisheries Research & Education Agency (FRA)	Koike, K (corresponding author), Hiroshima Univ, Grad Sch Biosphere Sci, Higashihiroshima, Hiroshima, Japan.	kazkoike@hiroshima-u.ac.jp	Koike, Kazuhiko/A-3392-2019	Yamashita, Hiroshi/0000-0002-3909-5073; Kazuhiko, Koike/0000-0001-5380-5839	Grants-in-Aid for Scientific Research [26660164] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Abrego D, 2009, MOL ECOL, V18, P3532, DOI 10.1111/j.1365-294X.2009.04276.x; Baillie BK, 2000, J PHYCOL, V36, P1153, DOI 10.1046/j.1529-8817.2000.00010.x; Baker AC, 2001, NATURE, V411, P765, DOI 10.1038/35081151; Baker AC, 2003, ANNU REV ECOL EVOL S, V34, P661, DOI 10.1146/annurev.ecolsys.34.011802.132417; BECKVAR N, 1981, AQUACULTURE, V24, P21, DOI 10.1016/0044-8486(81)90040-5; Belda-Baillie CA, 1999, J EXP MAR BIOL ECOL, V241, P207, DOI 10.1016/S0022-0981(99)00079-9; BUDDEMEIER RW, 1993, BIOSCIENCE, V43, P320, DOI 10.2307/1312064; Cantin NE, 2009, CORAL REEFS, V28, P405, DOI 10.1007/s00338-009-0478-8; Carlos AA, 2000, MAR ECOL PROG SER, V195, P93, DOI 10.3354/meps195093; Correa AMS, 2009, MAR BIOL, V156, P2403, DOI 10.1007/s00227-009-1263-5; DeBoer TS, 2012, MAR ECOL PROG SER, V444, P117, DOI 10.3354/meps09413; Fabricius KE, 2004, MOL ECOL, V13, P2445, DOI 10.1111/j.1365-294X.2004.02230.x; FITT WK, 1986, AQUACULTURE, V55, P5, DOI 10.1016/0044-8486(86)90051-7; Franklin EC, 2012, MOL ECOL RESOUR, V12, P369, DOI 10.1111/j.1755-0998.2011.03081.x; Glynn PW, 2001, B MAR SCI, V69, P79; Gomez-Cabrera del C. M, 2008, CORAL REEFS, V27, P219; Hirose E, 2006, MAR BIOL, V148, P551, DOI 10.1007/s00227-005-0119-x; Ishikura M, 2004, MAR BIOTECHNOL, V6, P378, DOI 10.1007/s10126-004-1800-7; Jones AM, 2008, P ROY SOC B-BIOL SCI, V275, P1359, DOI 10.1098/rspb.2008.0069; Jones A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010437; KLUMPP DW, 1994, MAR ECOL PROG SER, V107, P147, DOI 10.3354/meps107147; LaJeunesse TC, 2008, LIMNOL OCEANOGR, V53, P719, DOI 10.4319/lo.2008.53.2.0719; Lee SY, 2015, EUR J PHYCOL, V50, P155, DOI 10.1080/09670262.2015.1018336; Maruyama T, 1997, MAR BIOL, V127, P473, DOI 10.1007/s002270050035; Mieog JC, 2007, CORAL REEFS, V26, P449, DOI 10.1007/s00338-007-0244-8; Neo ML, 2015, BIOL CONSERV, V181, P111, DOI 10.1016/j.biocon.2014.11.004; NORTON JH, 1992, BIOL BULL, V183, P503, DOI 10.2307/1542028; Pochon X, 2010, MOL PHYLOGENET EVOL, V56, P492, DOI 10.1016/j.ympev.2010.03.040; Rowan R, 2004, NATURE, V430, P742, DOI 10.1038/430742a; Rowan R, 1997, NATURE, V388, P265, DOI 10.1038/40843; Rowan R, 1998, J PHYCOL, V34, P407, DOI 10.1046/j.1529-8817.1998.340407.x; Sampayo EM, 2008, P NATL ACAD SCI USA, V105, P10444, DOI 10.1073/pnas.0708049105; Sison MP, 2003, THESIS; STREAMER M, 1988, SYMBIOSIS, V6, P237; Suwa R, 2008, MAR ECOL PROG SER, V361, P129, DOI 10.3354/meps07372; TAYLOR DL, 1969, J PHYCOL, V5, P336, DOI 10.1111/j.1529-8817.1969.tb02623.x; Tchernov D, 2004, P NATL ACAD SCI USA, V101, P13531, DOI 10.1073/pnas.0402907101; Team R Core, 2014, R LANG ENV STAT COMP; Thornhill DJ, 2006, MAR BIOL, V148, P711, DOI 10.1007/s00227-005-0114-2; TRENCH RK, 1981, BIOL BULL-US, V161, P180, DOI 10.2307/1541117; Winters G, 2009, MAR ECOL PROG SER, V384, P107, DOI 10.3354/meps08036; Yamashita H, 2013, CORAL REEFS, V32, P355, DOI 10.1007/s00338-012-0980-2; Yamashita H, 2013, PHYCOL RES, V61, P68, DOI 10.1111/pre.12004; Yamashita H, 2011, MAR BIOL, V158, P87, DOI 10.1007/s00227-010-1544-z	44	33	34	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2017	12	2							e0172285	10.1371/journal.pone.0172285	http://dx.doi.org/10.1371/journal.pone.0172285			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BI	28212387	gold, Green Submitted, Green Published			2022-12-27	WOS:000394424700028
J	McLean, S; Salmon, PM; Gorman, AD; Read, GJM; Solomon, C				McLean, Scott; Salmon, Paul M.; Gorman, Adam D.; Read, Gemma J. M.; Solomon, Colin			What's in a game? A systems approach to enhancing performance analysis in football	PLOS ONE			English	Article							COGNITIVE WORK ANALYSIS; SOCIOTECHNICAL SYSTEMS; QUANTITATIVE-ANALYSIS; ECOLOGICAL DYNAMICS; ROAD TRANSPORT; SOCCER; VARIABILITY; FATIGUE; SUCCESS; SCIENCE	Purpose Performance analysis (PA) in football is considered to be an integral component of understanding the requirements for optimal performance. Despite vast amounts of research in this area key gaps remain, including what comprises PA in football, and methods to minimise research-practitioner gaps. The aim of this study was to develop a model of the football match system in order to better describe and understand the components of football performance. Such a model could inform the design of new PA methods. Method Eight elite level football Subject Method Experts (SME's) participated in two workshops to develop a systems model of the football match system. The model was developed using a first-of-its-kind application of Cognitive Work Analysis (CWA) in football. CWA has been used in many other non-sporting domains to analyse and understand complex systems. Result Using CWA, a model of the football match 'system' was developed. The model enabled identification of several PA measures not currently utilised, including communication between team members, adaptability of teams, playing at the appropriate tempo, as well as attacking and defending related measures. Conclusion The results indicate that football is characteristic of a complex sociotechnical system, and revealed potential new and unique PA measures regarded as important by SME's, yet not currently measured. Importantly, these results have identified a gap between the current PA research and the information that is meaningful to football coaches and practitioners.	[McLean, Scott; Gorman, Adam D.; Solomon, Colin] Univ Sunshine Coast, Sch Hlth & Sport Sci, Sippy Downs, Qld, Australia; [McLean, Scott; Salmon, Paul M.; Read, Gemma J. M.] Univ Sunshine Coast, Ctr Human Factors & Sociotech Syst, Sippy Downs, Qld, Australia	University of the Sunshine Coast; University of the Sunshine Coast	McLean, S (corresponding author), Univ Sunshine Coast, Sch Hlth & Sport Sci, Sippy Downs, Qld, Australia.; McLean, S (corresponding author), Univ Sunshine Coast, Ctr Human Factors & Sociotech Syst, Sippy Downs, Qld, Australia.	scott.mclean@research.usc.edu.au	McLean, Scott/AAA-3891-2020; Gorman, Adam/K-2415-2016	McLean, Scott/0000-0002-7269-5847; Gorman, Adam/0000-0003-2847-7268; Read, Gemma/0000-0003-3360-812X; Salmon, Paul/0000-0001-7403-0286	Australian Research Council Future Fellowship [FT140100681]	Australian Research Council Future Fellowship(Australian Research Council)	Thank you to the SME's for your participation in the study. Professor Paul Salmon's contribution to this article was funded through his Australian Research Council Future Fellowship (FT140100681).	Bartletti R, 2007, SPORT BIOMECH, V6, P224, DOI 10.1080/14763140701322994; Bishop D, 2008, SPORTS MED, V38, P253, DOI 10.2165/00007256-200838030-00005; Buchheit M, 2010, INT J SPORTS MED, V31, P709, DOI 10.1055/s-0030-1261897; Bush MD, 2015, INT J SPORTS PHYSL P; Carling C, 2014, J SPORT SCI, V32, P2, DOI 10.1080/02640414.2013.807352; Collet C, 2013, J SPORT SCI, V31, P123, DOI 10.1080/02640414.2012.727455; Cornelissen M, 2014, APPL ERGON, V45, P1484, DOI 10.1016/j.apergo.2014.04.010; Couceiro MS, 2016, SPORTS MED, V46, P1781, DOI 10.1007/s40279-016-0549-2; Davids K, 2003, SPORTS MED, V33, P245, DOI 10.2165/00007256-200333040-00001; Davids K, 2008, DYNAMICS SKILL ACQUI; Drust B, 2013, J SPORT SCI, V31, P1377, DOI 10.1080/02640414.2013.828544; Gomez MA, 2012, EUR J SPORT SCI, V12, P393, DOI 10.1080/17461391.2011.566373; James N, 2004, J SPORT SCI, V22, P507, DOI DOI 10.1080/02640410410001675423; Jenkins DP, 2008, ERGONOMICS, V51, P798, DOI 10.1080/00140130801915246; Jenkins DP, 2008, THEOR ISS ERGON SCI, V9, P273, DOI 10.1080/14639220701561833; Jenkins DP, 2011, THEOR ISS ERGON SCI, V12, P1, DOI 10.1080/14639220903353401; Lausic D, 2009, RES Q EXERCISE SPORT, V80, P281, DOI 10.1080/02701367.2009.10599563; Liu HY, 2016, J SPORT SCI, V34, P509, DOI 10.1080/02640414.2015.1117121; Mackenzie R, 2013, J SPORT SCI, V31, P639, DOI 10.1080/02640414.2012.746720; McLean S, 2016, SPORTS, V4, DOI 10.3390/sports4030039; Morris G, 2016, J SPORTS SCI, P1; Moura FA, 2012, SPORT BIOMECH, V11, P85, DOI 10.1080/14763141.2011.637123; Oberstone J, 2009, J QUANT ANAL SPORTS, V5, DOI 10.2202/1559-0410.1183; Paul DJ, 2015, IJSPP, V10; Rampinini E, 2009, J SCI MED SPORT, V12, P227, DOI 10.1016/j.jsams.2007.10.002; Read GJM, 2016, APPL ERGON, V53, P209, DOI 10.1016/j.apergo.2015.10.004; Read GJM, 2015, ERGONOMICS, V58, P822, DOI 10.1080/00140139.2014.980335; Redwood-Brown A., 2008, INT J PERF ANAL SPOR, V8, P172, DOI [DOI 10.1080/24748668.2008.11868458, https://doi.org/10.1080/24748668.2008.11868458]; REEP C, 1968, J R STAT SOC SER A-G, V131, P581, DOI 10.2307/2343726; Reilly T, 2003, J SPORT SCI, V21, P693, DOI 10.1080/0264041031000102105; Reilly T, 2008, SPORTS MED, V38, P357, DOI 10.2165/00007256-200838050-00001; Salas E, 2005, SMALL GR RES, V36, P555, DOI 10.1177/1046496405277134; Salmon P, 2015, ERGONOMICS IN PRESS; Salmon P., 2009, HUMAN FACTORS METHOD; Salmon PM, 2016, ACCIDENT ANAL PREV, V96, P140, DOI 10.1016/j.aap.2016.05.025; Salmon PM, 2016, APPL ERGON, V53, P312, DOI 10.1016/j.apergo.2015.06.021; Salmon PM, 2012, SAFETY SCI, V50, P1829, DOI 10.1016/j.ssci.2012.04.011; Sarmento H, 2014, J SPORT SCI, V32, P1831, DOI 10.1080/02640414.2014.898852; Stanton N.A., 2013, HUMAN FACTORS METHOD; Stanton NA, 2014, APPL ERGON, V45, P110, DOI 10.1016/j.apergo.2013.04.022; Suzuki K., 2004, INT J SPORT HLTH SCI, V2, P34, DOI DOI 10.5432/IJSHS.2.34; Tenga A., 2009, INT J PERF ANAL SPOR, V9, P8, DOI [DOI 10.1080/24748668.2009, 10.1080/24748668.2009.11868461, DOI 10.1080/24748668.2009.11868461]; Travassos B, 2013, INT J PERF ANAL SPOR, V13, P83, DOI 10.1080/24748668.2013.11868633; van Duijn MAJ., 2006, METHODOLOGY-EUR, V2, P2, DOI [DOI 10.1027/1614-2241.2.1.2, 10.1027/1614-2241.2.1.2]; Vicente K., 1999, COGNITIVE WORK ANAL; Vilar L, 2012, SPORTS MED, V42, P1, DOI 10.2165/11596520-000000000-00000; Vogelbein M, 2014, J SPORT SCI, V32, P1076, DOI 10.1080/02640414.2013.879671; Wallace JL, 2014, J SCI MED SPORT, V17, P223, DOI 10.1016/j.jsams.2013.03.016; Wesson J, 2002, SCI SOCCER; Weston M, 2011, INT J SPORT PHYSIOL, V6, P174, DOI 10.1123/ijspp.6.2.174	50	44	44	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2017	12	2							e0172565	10.1371/journal.pone.0172565	http://dx.doi.org/10.1371/journal.pone.0172565			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL2BI	28212392	Green Published, Green Submitted, gold			2022-12-27	WOS:000394424700059
J	Timilsina, RR; Kotani, K; Kamijo, Y				Timilsina, Raja Rajendra; Kotani, Koji; Kamijo, Yoshio			Sustainability of common pool resources	PLOS ONE			English	Article							PUBLIC-GOODS GAME; COOPERATION; TRAGEDY; PERSPECTIVE; EVOLUTION; FIELD; TIME	Sustainability has become a key issue in managing natural resources together with growing concerns for capitalism, environmental and resource problems. We hypothesize that the ongoing modernization of competitive societies, which we refer to as "capitalism," affects human nature for utilizing common pool resources, thus compromising sustainability. To test this hypothesis, we design and implement a set of dynamic common pool resource games and experiments in the following two types of Nepalese areas: ( i) rural ( non-capitalistic) and ( ii) urban ( capitalistic) areas. We find that a proportion of prosocial individuals in urban areas is lower than that in rural areas, and urban residents deplete resources more quickly than rural residents. The composition of proself and prosocial individuals in a group and the degree of capitalism are crucial in that an increase in prosocial members in a group and the rural dummy positively affect resource sustainability by 65% and 63%, respectively. Overall, this paper shows that when societies move toward more capitalistic environments, the sustainability of common pool resources tends to decrease with the changes in individual preferences, social norms, customs and views to others through human interactions. This result implies that individuals may be losing their coordination abilities for social dilemmas of resource sustainability in capitalistic societies.	[Timilsina, Raja Rajendra; Kotani, Koji; Kamijo, Yoshio] Kochi Univ Technol, Sch Econ & Management, Kochi, Kochi, Japan; [Kotani, Koji; Kamijo, Yoshio] Kochi Univ Technol, Res Ctr Future Design, Kochi, Kochi, Japan; [Kotani, Koji] Rikkyo Univ, Coll Business, Toshima Ku, Tokyo, Japan; [Kotani, Koji] Kyushu Univ, Urban Inst, Nishi Ku, Fukuoka, Japan	Kochi University Technology; Kochi University Technology; Rikkyo University; Kyushu University	Kotani, K (corresponding author), Kochi Univ Technol, Sch Econ & Management, Kochi, Kochi, Japan.; Kotani, K (corresponding author), Kochi Univ Technol, Res Ctr Future Design, Kochi, Kochi, Japan.; Kotani, K (corresponding author), Rikkyo Univ, Coll Business, Toshima Ku, Tokyo, Japan.; Kotani, K (corresponding author), Kyushu Univ, Urban Inst, Nishi Ku, Fukuoka, Japan.	kojikotani757@gmail.com	Kotani, Koji/X-7947-2019; Kotani, Koji/C-6896-2011; Timilsina, Raja/AAJ-8063-2020	Kotani, Koji/0000-0003-0667-1895; Kotani, Koji/0000-0003-0667-1895; Timilsina, Raja/0000-0001-9916-4934; Kamijo, Yoshio/0000-0002-2184-9594	Japan Society for the Promotion of Science [16H03621]; Kochi University of Technology;  [16K13362]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Kochi University of Technology; 	This work was supported by Japan Society for the Promotion of Science as the Grant-in-Aid for Scientific Research B (16H03621), Grant-in-Aid for Challenging Exploratory Research (16K13362) of KK and personal research fund of YK from Kochi University of Technology.	Botelho A, 2014, EXP ECON, V17, P649, DOI 10.1007/s10683-013-9388-2; Brosig-Koch J, 2011, J PUBLIC ECON, V95, P1373, DOI 10.1016/j.jpubeco.2011.06.002; Bru L., 2003, Experimental Economics, V6, P91, DOI 10.1023/A:1024209010570; Cardenas JC, 2011, ENVIRON RESOUR ECON, V48, P451, DOI 10.1007/s10640-010-9452-8; Cardenas JC, 2004, AGR SYST, V82, P307, DOI 10.1016/j.agsy.2004.07.008; Chen MH, 2016, PHYS LETT A, V380, P40, DOI 10.1016/j.physleta.2015.09.047; Chen MH, 2015, APPL MATH COMPUT, V251, P192, DOI 10.1016/j.amc.2014.11.052; Croson R, 2009, J ECON LIT, V47, P448, DOI 10.1257/jel.47.2.448; Dawkins R, 2006, SELFISH GENE; Fehr E, 2011, J PUBLIC ECON, V95, P1144, DOI 10.1016/j.jpubeco.2011.05.013; Fischer ME, 2004, J ENVIRON ECON MANAG, V48, P811, DOI 10.1016/j.jeem.2003.12.002; Fruteau C, 2013, CURR BIOL, V23, P665, DOI 10.1016/j.cub.2013.02.039; Gordon HS, 1954, J POLIT ECON, V62, P124, DOI 10.1086/257497; HARDIN G, 1968, SCIENCE, V162, P1243, DOI 10.1126/science.162.3859.1243; Henrich J, 2003, EVOL ANTHROPOL, V12, P123, DOI 10.1002/evan.10110; Henrich J, 2005, BEHAV BRAIN SCI, V28, P795, DOI 10.1017/S0140525X05000142; Henrich J, 2015, BEHAV BRAIN SCI, V7, P595, DOI [10.1126/science.1182238, DOI 10.1126/SCIENCE.1182238]; Herr A, 1997, GAME ECON BEHAV, V19, P77, DOI 10.1006/game.1997.0541; Janssen MA, 2011, EXP ECON, V14, P547, DOI 10.1007/s10683-011-9281-9; Keser C, 1999, INT J GAME THEORY, V28, P241, DOI 10.1007/s001820050108; Kimbrough EO, 2015, J ENVIRON ECON MANAG, V72, P38, DOI 10.1016/j.jeem.2015.04.004; Leibbrandt A, 2013, P NATL ACAD SCI USA, V110, P9305, DOI 10.1073/pnas.1300431110; Mason CF, 1997, J ENVIRON ECON MANAG, V34, P148, DOI 10.1006/jeem.1997.1006; Murphy RO, 2011, JUDGM DECIS MAK, V6, P771; North D. C., 1990, I I CHANGE EC PERFOR; Ockenfels A, 1999, J PUBLIC ECON, V71, P275, DOI 10.1016/S0047-2727(98)00072-3; Ostrom E., 1990, GOVERNING COMMONS EV; Ostrom E, 2009, SCIENCE, V325, P419, DOI 10.1126/science.1172133; Perc M, 2010, BIOSYSTEMS, V99, P109, DOI 10.1016/j.biosystems.2009.10.003; Piketty T., 2014, CAPITAL 21 CENTURY; Richarson P, 2008, NOT GENES ALONE CULT; Schumpeter J. A., 1943, CAPITALISM SOCIALISM, DOI DOI 10.1007/s11135-015-0230-0; Shahrier S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165067; Velez MA, 2009, J ECON BEHAV ORGAN, V70, P485, DOI 10.1016/j.jebo.2008.02.008; Wakano JY, 2009, P NATL ACAD SCI USA, V106, P7910, DOI 10.1073/pnas.0812644106; WALKER JM, 1992, ECON J, V102, P1149, DOI 10.2307/2234382; Wang Z, 2015, EUR PHYS J B, V88, DOI 10.1140/epjb/e2015-60270-7; Wang Z, 2013, SCI REP-UK, V3, DOI 10.1038/srep01183; Wilson DS, 2009, EVOL HUM BEHAV, V30, P190, DOI 10.1016/j.evolhumbehav.2008.12.002; Wooldridge J.M., 2008, INTRO ECONOMETRICS; Xia CY, 2012, ADV COMPLEX SYST, V15, DOI 10.1142/S0219525912500567; Zhu CJ, 2014, PHYSICA A, V406, P145, DOI 10.1016/j.physa.2014.03.035	42	24	24	3	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2017	12	2							e0170981	10.1371/journal.pone.0170981	http://dx.doi.org/10.1371/journal.pone.0170981			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL2BI	28212426	Green Submitted, Green Published, gold			2022-12-27	WOS:000394424700004
J	Lea, T; Kolstee, J; Lambert, S; Ness, R; Hannan, S; Holt, M				Lea, Toby; Kolstee, Johann; Lambert, Sarah; Ness, Ross; Hannan, Siobhan; Holt, Martin			Methamphetamine treatment outcomes among gay men attending a LGBTI-specific treatment service in Sydney, Australia	PLOS ONE			English	Article							SUBSTANCE-ABUSE TREATMENT; COGNITIVE-BEHAVIORAL INTERVENTIONS; AMPHETAMINE-TYPE STIMULANTS; SEXUAL RISK BEHAVIORS; DEPENDENCE SCALE SDS; BISEXUAL MEN; DRUG-USE; CRYSTAL METHAMPHETAMINE; TREATMENT PROGRAM; HIV-INFECTION	Gay and bisexual men (GBM) report higher rates of methamphetamine use compared to heterosexual men, and thus have a heightened risk of developing problems from their use. We examined treatment outcomes among GBM clients receiving outpatient counseling at a lesbian, gay, bisexual, transgender and intersex (LGBTI)-specific, harm reduction treatment service in Sydney, Australia. GBM receiving treatment for methamphetamine use from ACON's Substance Support Service between 2012-15 (n = 101) were interviewed at treatment commencement, and after 4 sessions (n = 60; follow-up 1) and 8 sessions (n = 32; follow-up 2). At each interview, clients completed measures of methamphetamine use and dependence, other substance use, injecting risk practices, psychological distress and quality of life. The median age of participants was 41 years and 56.4% identified as HIV-positive. Participants attended a median of 5 sessions and attended treatment for a median of 112 days. There was a significant reduction in the median days of methamphetamine use in the previous 4 weeks between baseline (4 days), follow-up 1 (2 days) and follow-up 2 (2 days; p =.001). There was a significant reduction in the proportion of participants reporting methamphetamine dependence between baseline (92.1%), follow-up 1 (78.3%) and follow-up 2 (71.9%, p<.001). There were also significant reductions in psychological distress (p<.001), and significant improvements in quality of life (p<.001). Clients showed reductions in methamphetamine use and improved psychosocial functioning over time, demonstrating the potential effectiveness of a LGBTI-specific treatment service.	[Lea, Toby; Holt, Martin] UNSW Australia, Ctr Social Res Hlth, Sydney, NSW, Australia; [Kolstee, Johann; Lambert, Sarah; Ness, Ross; Hannan, Siobhan] ACON, Sydney, NSW, Australia	University of New South Wales Sydney	Lea, T (corresponding author), UNSW Australia, Ctr Social Res Hlth, Sydney, NSW, Australia.	toby.lea@unsw.edu.au	Holt, Martin/X-6482-2019	Holt, Martin/0000-0002-2586-8274; Lea, Toby/0000-0001-5942-0550	Australian Government Department of Health; NSW Ministry of Health	Australian Government Department of Health(Australian GovernmentDepartment of Health & Ageing); NSW Ministry of Health	The Centre for Social Research in Health receives funding from the Australian Government Department of Health. ACON receives funding from the NSW Ministry of Health, and the Substance Support Service is funded by the Australian Government Department of Health. The funding bodies had no involvement in the conduct of this study or the preparation of this manuscript. The authors received no specific funding for this work.	[Anonymous], [No title captured]; Australian Institute of Health and Welfare, 2014, DRUG STAT SER, V28; Australian Institute of Health and Welfare, 2015, DRUG TREATM SER, V25; Baker A, 2005, ADDICTION, V100, P367, DOI 10.1111/j.1360-0443.2005.01002.x; Baker A, 2001, ADDICTION, V96, P1279, DOI 10.1046/j.1360-0443.2001.96912797.x; Bariola, 2015, CLOSER LOOK PRIVATE; Bourne A, 2015, SEX TRANSM INFECT, V91, P564, DOI 10.1136/sextrans-2015-052052; Brecht ML, 2005, J SUBST ABUSE TREAT, V29, P295, DOI 10.1016/j.jsat.2005.08.012; Brensilver M, 2013, DRUG ALCOHOL REV, V32, P449, DOI 10.1111/dar.12048; Center for Substance Abuse Treatment, 2012, PROV INTR SUBST AB T; Cochran BN, 2006, J SUBST ABUSE TREAT, V30, P135, DOI 10.1016/j.jsat.2005.11.009; Cochran BN, 2007, SUBST USE MISUSE, V42, P161, DOI 10.1080/10826080601094207; Courtney KE, 2014, DRUG ALCOHOL DEPEN, V143, P11, DOI 10.1016/j.drugalcdep.2014.08.003; Findlay J., 2015, GAY NEWS NETWOR 0817; Flentje A, 2015, J CONSULT CLIN PSYCH, V83, P325, DOI 10.1037/a0038724; GOSSOP M, 1995, ADDICTION, V90, P607, DOI 10.1111/j.1360-0443.1995.tb02199.x; Green AI, 2006, CULT HEALTH SEX, V8, P317, DOI 10.1080/13691050600783320; Halkitis PN., 2014, CURR ADDICT REP, V1, P206, DOI [10.1007/s40429-014-0023-x, DOI 10.1007/S40429-014-0023-X]; Hayes S.C., 2011, ACCEPTANCE COMMITMEN; Hillhouse MP, 2007, ADDICTION, V102, P84, DOI 10.1111/j.1360-0443.2007.01768.x; Hopwood M, 2015, INT J DRUG POLICY, V26, P210, DOI 10.1016/j.drugpo.2014.10.013; Hurley M, 2009, CULT HEALTH SEX, V11, P597, DOI 10.1080/13691050902721853; Jaffe A, 2007, EXP CLIN PSYCHOPHARM, V15, P301, DOI 10.1037/1064-1297.15.3.301; Jenner L, 2008, TREATMENT APPROACHES; Kenny P, 2011, SUBST ABUSE TREAT PR, V6, DOI 10.1186/1747-597X-6-3; Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074; Lea T, 2016, INT J DRUG POLICY, V29, P66, DOI 10.1016/j.drugpo.2016.01.003; Lee NK, 2008, DRUG ALCOHOL REV, V27, P309, DOI 10.1080/09595230801919494; Lombardi E., 2007, J LGBT HLTH RES, V3, P37, DOI DOI 10.1300/J463V03N02_; Matheson A., 2010, DRUG USE DEPENDENCE; Matthews CR, 2006, J MENT HLTH COUNS, V28, P111, DOI DOI 10.17744/mehc.28.2.9m35re2aj9l28j47; McCann E, 2014, INT J MENT HEALTH NU, V23, P118, DOI 10.1111/inm.12018; McKetin R, 2006, DRUG ALCOHOL DEPEN, V85, P198, DOI 10.1016/j.drugalcdep.2006.04.007; McKetin R, 2013, DRUG ALCOHOL REV, V32, P80, DOI 10.1111/j.1465-3362.2012.00471.x; Vu NTT, 2015, J INT AIDS SOC, V18, DOI 10.7448/IAS.18.1.19273; Peck JA, 2005, J URBAN HEALTH, V82, pI100, DOI 10.1093/jurban/jti029; Pennay AE, 2009, DRUG ALCOHOL REV, V28, P636, DOI 10.1111/j.1465-3362.2009.00074.x; Prestage G, 2007, DRUG ALCOHOL DEPEN, V91, P260, DOI 10.1016/j.drugalcdep.2007.06.009; Prestage G, 2009, SEX HEALTH, V6, P310, DOI 10.1071/SH09014; Rawstorne P, 2007, ARCH SEX BEHAV, V36, P646, DOI 10.1007/s10508-007-9206-z; Reback Cathy, 1997, SOCIAL CONSTRUCTION; Reback CJ, 2014, ADDICT BEHAV, V39, P1286, DOI 10.1016/j.addbeh.2011.11.029; Reback CJ, 2003, AIDS CARE, V15, P775, DOI 10.1080/09540120310001618621; Ritter A., 2012, DRUG POLICY MODELLIN, V23; Roxburgh A., 2015, DRUG RELATED HOSP ST; Roxburgh A, 2016, INT J DRUG POLICY, V28, P76, DOI 10.1016/j.drugpo.2015.11.005; Schmidt S, 2006, EUR J PUBLIC HEALTH, V16, P420, DOI 10.1093/eurpub/cki155; Scott N, 2015, ADDICTION, V110, P120, DOI 10.1111/add.12740; Scott S., 2015, ABC NEWS; Senreich E, 2009, J GAY LESBIAN MENT H, V13, P145, DOI 10.1080/19359700902870072; Senreich E, 2010, SUBST USE MISUSE, V45, P1077, DOI 10.3109/10826080903483855; Shoptaw S, 2005, DRUG ALCOHOL DEPEN, V78, P125, DOI 10.1016/j.drugalcdep.2004.10.004; Slade T, 2011, AUST NZ J PSYCHIAT, V45, P308, DOI 10.3109/00048674.2010.543653; SLAVIN S, 2004, CONTEMP DRUG PROBL, V31, P425; Topp L, 1997, ADDICTION, V92, P839, DOI 10.1046/j.1360-0443.1997.9278397.x; Vosburgh HW, 2012, AIDS BEHAV, V16, P1394, DOI 10.1007/s10461-011-0131-8; Yaphe S, 2012, SEX TRANSM INFECT, V88, P558, DOI 10.1136/sextrans-2012-050566	57	24	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0172560	10.1371/journal.pone.0172560	http://dx.doi.org/10.1371/journal.pone.0172560			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL2BG	28207902	Green Published, gold, Green Submitted			2022-12-27	WOS:000394424500148
J	Peng, YF; Yang, H; Ye, Q; Zhou, HM; Zheng, MH; Shi, YH				Peng, Yuanfei; Yang, Hua; Ye, Qing; Zhou, Houming; Zheng, Minhua; Shi, Yinghong			Inhibition of peritoneal dissemination of colon cancer by hyperthermic CO2 insufflation: A novel approach to prevent intraperitoneal tumor spread	PLOS ONE			English	Article							COLORECTAL-CANCER; GASTRIC-CANCER; CYTOREDUCTIVE SURGERY; RAT MODEL; CARCINOMATOSIS; PNEUMOPERITONEUM; CHEMOTHERAPY; LAPAROSCOPY; CELLS; FEASIBILITY	Background The increasing use of laparoscopic surgery for advanced gastrointestinal cancer raises concerns about intra-peritoneal tumor spread. Prevention of peritoneal dissemination is extremely important but a preventive modality is lacking. The aim of this study was to examine a novel approach (hyperthermic CO2 insufflation, HT-CO2) for preventing peritoneal dissemination during laparoscopic surgery. Methods A peritoneal dissemination model was established in Balb/c nu/nu mice by intraperitoneal injection of human colon cancer cells (SW1116, 1x10(6)). The mice (n = 48) were subsequently randomized into two groups and subjected to hyperthermic CO2 (43 degrees C, > 95% humidity, HT-CO2 group) or standard normothermic CO2 (21 degrees C, < 1% relative humidity, NTCO2 group) insufflation for 3 hours. The mice were sacrificed 28 days later. The peritoneal dissemination was quantitatively analyzed by counting and weighing the peritoneal nodules. The port sites and ascites volume were measured. The peritoneal damage of HT-CO2 was histologically examined with light microscopy and scanning electron microscopy. Intraabdominal adhesions were evaluated 4 weeks later. Results The number of peritoneal nodules in the HT-CO2 group was significantly less than that in the NT-CO2 group (10.21 +/- 3.72 vs. 67.12 +/- 5.49, P< 0.01). The mean weight of metastatic tumors in the HT-CO2 group was significantly lower than that in the NT-CO2 group (0.31 +/- 0.10g vs. 2.16 +/- 0.31g, P< 0.01). Massive ascites were found in the NT-CO2 group while significantly less ascites developed in HT-CO2-treated mice (8.26 +/- 0.31ml vs. 1.27 +/- 0.28ml, P< 0.01). No port-site metastases were detected in the HT-CO2 group while the incidence of the NT-CO2 group was 12.5% (3/24). HT-CO2 subjection resulted in slight peritoneal damage; the peritoneum returned to normal within five days. No adhesions formed after HT-CO2 treatment. Conclusions HT-CO2 can suppress peritoneal dissemination of colon cancer cells and only causes slight and transient peritoneal damage. HT-CO2 may serve as a promising adjuvant treatment for preventing peritoneal dissemination in laparoscopic resection of advanced colorectal cancer.	[Peng, Yuanfei; Yang, Hua; Shi, Yinghong] Fudan Univ, Zhongshan Hosp, Liver Canc Inst, Dept Liver Surg, Shanghai, Peoples R China; [Peng, Yuanfei; Yang, Hua; Shi, Yinghong] Minist Educ, Key Lab Carcinogenesis & Canc Invas, Shanghai, Peoples R China; [Ye, Qing] Fujian Med Univ, Dept Gastrointestinal Tumor Surg, Fujian Prov Tumor Hosp, Fujian, Peoples R China; [Zhou, Houming; Zheng, Minhua] Shanghai Jiao Tong Univ, Dept Gen Surg, Shanghai Minimally Invas Surg Ctr, Inst Digest Surg,Ruijin Hosp,Sch Med, Shanghai, Peoples R China	Fudan University; Fujian Medical University; Shanghai Jiao Tong University	Shi, YH (corresponding author), Fudan Univ, Zhongshan Hosp, Liver Canc Inst, Dept Liver Surg, Shanghai, Peoples R China.; Shi, YH (corresponding author), Minist Educ, Key Lab Carcinogenesis & Canc Invas, Shanghai, Peoples R China.	peng.yuanfei@zs-hospital.sh.cn			National Natural Science Foundation of China [81572296]; Young Backbone talents Training Foundation of the Fujian healthcare system [2013-ZQN-JC-9]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Young Backbone talents Training Foundation of the Fujian healthcare system	This work was supported by the grants from National Natural Science Foundation of China (No. 81572296), the Young Backbone talents Training Foundation of the Fujian healthcare system (No.2013-ZQN-JC-9). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyoshi T, 2016, WORLD J GASTROENTERO, V22, P718, DOI 10.3748/wjg.v22.i2.718; Aoyagi T, 2014, WORLD J GASTROENTERO, V20, P12493, DOI 10.3748/wjg.v20.i35.12493; ASAO T, 1994, CANCER LETT, V78, P57, DOI 10.1016/0304-3835(94)90031-0; Baratti D, 2014, DIS COLON RECTUM, V57, P858, DOI 10.1097/DCR.0000000000000149; Barchi LC, 2016, ABCD-ARQ BRAS CIR DI, V29, P117, DOI 10.1590/0102-6720201600020013; Gupta A, 2002, ANZ J SURG, V72, P254, DOI 10.1046/j.1445-2197.2002.02385.x; Hildebrandt B, 2002, CRIT REV ONCOL HEMAT, V43, P33, DOI 10.1016/S1040-8428(01)00179-2; Hirabayashi Y, 2002, SURG ENDOSC, V16, P864, DOI 10.1007/s00464-001-9121-7; Jung DH, 2015, SURG ENDOSCOPY; Kim IY, 2015, ONCOTARGETS THER, V8, P3441, DOI 10.2147/OTT.S93420; Kudo M, 2004, INT J HYPERTHER, V20, P441, DOI 10.1080/02656730310001637352; Lee SW, 1998, SURG ENDOSC-ULTRAS, V12, P828, DOI 10.1007/s004649900723; Loggie BW, 2015, ONCOLOGY-NY, V29, P515; Marz L, 2015, GASTROENTEROL REP, V3, P298, DOI 10.1093/gastro/gov044; Mutter D, 1999, SURG ENDOSC, V13, P365, DOI 10.1007/s004649900991; Peng YF, 2008, ONCOL REP, V19, P73; Peng YF, 2009, J SURG RES, V151, P40, DOI 10.1016/j.jss.2008.03.039; Pestieau SR, 2000, DIS COLON RECTUM, V43, P1341, DOI 10.1007/BF02236627; Roviello F, 2013, EJSO-EUR J SURG ONC, V39, P1309, DOI 10.1016/j.ejso.2013.10.010; Sloothaak DAM, 2014, EJSO-EUR J SURG ONC, V40, P1453, DOI 10.1016/j.ejso.2014.06.012; Sloothaak DAM, 2014, BRIT J CANCER, V111, P1112, DOI 10.1038/bjc.2014.369; Sugarbaker PH, 2005, CANCER INVEST, V23, P155, DOI 10.1081/CNV-200050478; Takeuchi H, 2004, SURG ENDOSC, V18, P1795, DOI 10.1007/s00464-003-9322-3; Volz J, 1999, CANCER, V86, P770, DOI 10.1002/(SICI)1097-0142(19990901)86:5<770::AID-CNCR11>3.0.CO;2-3; Zayyan KS, 2003, SURG ENDOSC, V17, P273, DOI 10.1007/s00464-002-8824-8; Zhou HM, 2012, ASIAN PAC J CANCER P, V13, P117, DOI 10.7314/APJCP.2012.13.1.117	26	5	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0172097	10.1371/journal.pone.0172097	http://dx.doi.org/10.1371/journal.pone.0172097			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207849	Green Published, gold, Green Submitted			2022-12-27	WOS:000394424500083
J	Donovan, VM; Brown, GS; Mallory, FF				Donovan, Victoria M.; Brown, Glen S.; Mallory, Frank F.			The impacts of forest management strategies for woodland caribou vary across biogeographic gradients	PLOS ONE			English	Article							RANGIFER-TARANDUS-CARIBOU; HOME-RANGE SIZE; BOREAL FOREST; HABITAT SELECTION; SITE FIDELITY; SPACE USE; CONSERVATION; FRAGMENTATION; DISTURBANCES; BIODIVERSITY	Loss or alteration of forest ecosystems due to anthropogenic activities has prompted the need for mitigation measures aimed at protecting habitat for forest-dependent wildlife. Understanding how wildlife respond to such management efforts is essential for achieving conservation targets. Boreal caribou are a species of conservation concern due to the impacts of human induced habitat alteration; however the effects of habitat management activities are poorly understood. We assessed the relationship between large scale patterns in forest harvesting and caribou spatial behaviours over a 20-year period, spanning a change in forest management intended to protect caribou habitat. Caribou range size, fidelity, and proximity to forest harvests were assessed in relation to change in harvest patterns through time and across two landscapes that varied widely in natural disturbance and community dynamics. We observed up to 89% declines in total area harvested within our study areas, with declining harvest size and aggregation. These landscape outcomes were coincident with caribou exhibiting greater fidelity and spacing farther away from disturbances at smaller scales, hypothesized to be beneficial for acquiring food and avoiding predators. Contrary to our expectation that the large scale maintenance of habitat patches would permit caribou to space away from disturbance, their proximity to harvest blocks at the population range scale did not decrease through time, suggesting that movement toward landscape recovery for caribou in previously harvested regions will likely stretch over multiple decades. Caribou spatial behaviours varied across the two landscapes independently of forest management. Our study underlines the importance of understanding both changes in industry demands, as well as natural landscape variation in habitat when managing wildlife.	[Donovan, Victoria M.; Brown, Glen S.; Mallory, Frank F.] Laurentian Univ, Dept Biol, Sudbury, ON, Canada; [Brown, Glen S.] Trent Univ, Minist Nat Resources & Forestry, Wildlife Res & Monitoring Sect, DNA Bldg,2140 East Bank Dr, Peterborough, ON, Canada; [Donovan, Victoria M.] Univ Nebraska, Dept Agron & Hort, 140 Keim Hall, Lincoln, NE 68588 USA	Laurentian University; Ministry of Natural Resources & Forestry; Trent University; University of Nebraska System; University of Nebraska Lincoln	Donovan, VM (corresponding author), Laurentian Univ, Dept Biol, Sudbury, ON, Canada.; Donovan, VM (corresponding author), Univ Nebraska, Dept Agron & Hort, 140 Keim Hall, Lincoln, NE 68588 USA.	victoria.donovan@huskers.unl.edu		Donovan, Victoria/0000-0002-2906-5268	Species at Risk Stewardship Fund; Laurentian University	Species at Risk Stewardship Fund; Laurentian University	This work was supported by the Species at Risk Stewardship Fund, https://www.ontario.ca/page/grants-protecting-species-risk; and Laurentian University, https://laurentian.ca/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the Ontario Ministry of Natural Resources and Forestry and the Ministere de l'Energie et des Resources Naturelles, Quebec for providing the data for this project, and the Species at Risk Research Fund for Ontario and Laurentian University for their financial support.	Ancrenaz M, 2004, INT J PRIMATOL, V25, P983, DOI 10.1023/B:IJOP.0000043347.84757.9a; Armstrong Ted, 1998, Rangifer, V18, P221; Baldwin DJ., 2000, ECOLOGY MANAGED TERR, P12; Barton K., 2014, MUMIN MULTIMODEL INF; Battin J, 2004, CONSERV BIOL, V18, P1482, DOI 10.1111/j.1523-1739.2004.00417.x; Beauchesne D, 2014, BIOL CONSERV, V172, P190, DOI 10.1016/j.biocon.2014.03.002; Belleau A, 2011, ECOSCIENCE, V18, P329, DOI 10.2980/18-4-3393; Benson JF, 2013, METHODS ECOL EVOL, V4, P244, DOI 10.1111/2041-210x.12006; Bergeron Y, 2004, ECOLOGY, V85, P1916, DOI 10.1890/02-0716; Boissonneau AN., 1966, CAN J EARTH SCI, V3, P559, DOI DOI 10.1139/E66-040; Brown Glen S., 2003, Rangifer, P227; Calenge C, 2006, ECOL MODEL, V197, P516, DOI 10.1016/j.ecolmodel.2006.03.017; Canada Environment, 2011, REC STAT WOODL CAR B; Cobb TP, 2007, CAN J FOREST RES, V37, P1310, DOI 10.1139/X06-310; Courbin N, 2009, LANDSCAPE ECOL, V24, P1375, DOI 10.1007/s10980-009-9389-x; Courtois R, 2007, ECOSCIENCE, V14, P491, DOI 10.2980/1195-6860(2007)14[491:EOFDOD]2.0.CO;2; Couture L, GREAT US RECESSION C, V28, P1; Dalerum F, 2007, CAN J ZOOL, V85, P26, DOI 10.1139/Z06-186; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Faille G, 2010, BIOL CONSERV, V143, P2840, DOI 10.1016/j.biocon.2010.08.001; Ferguson SH, 2004, J ZOOL, V262, P125, DOI 10.1017/S0952836903004552; Ferguson SH, 1999, ECOL LETT, V2, P311, DOI 10.1046/j.1461-0248.1999.00090.x; Festa-Bianchet M, 2011, CAN J ZOOL, V89, P419, DOI [10.1139/z11-025, 10.1139/Z11-025]; Gray MA, 2007, CONSERV BIOL, V21, P133, DOI 10.1111/j.1523-1739.2006.00557.x; Hazell Megan E., 2011, Rangifer, V31, P63; Hins C, 2009, FOREST ECOL MANAG, V257, P636, DOI 10.1016/j.foreco.2008.09.049; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; JEGLUM JK, 1995, CAN J BOT, V73, P629, DOI 10.1139/b95-067; Kernohan Brian J., 2001, P125, DOI 10.1016/B978-012497781-5/50006-2; Kie JG, 1999, J MAMMAL, V80, P1114, DOI 10.2307/1383163; Kurek Przemyslaw, 2011, Acta Zoologica Lituanica, V21, P17, DOI 10.2478/v10043-011-0004-4; Latham ADM, 2011, J WILDLIFE MANAGE, V75, P204, DOI 10.1002/jwmg.28; Lawton JH, 1998, NATURE, V391, P72, DOI 10.1038/34166; Lesmerises F, 2012, FOREST ECOL MANAG, V276, P125, DOI 10.1016/j.foreco.2012.03.025; Lesmerises R, 2013, ECOL EVOL, V3, P2880, DOI 10.1002/ece3.695; Li C, 1997, ECOLOGICAL RES SUSTA, P369; Mahoney S. P., 2001, Rangifer, V21, P35; Mallory F.F., 1998, RANGIFER SPECIAL ISS, V10, P49, DOI DOI 10.7557/2.18.5.1541; McGarigal K., 2012, TECH REP; Metsaranta JM, 2007, NORTHEAST NAT, V14, P571, DOI 10.1656/1092-6194(2007)14[571:EAHSOA]2.0.CO;2; Nagubadi RV, 2013, FOREST SCI, V59, P517, DOI 10.5849/forsci.12-013; Newsome TM, 2013, ECOGRAPHY, V36, P914, DOI 10.1111/j.1600-0587.2013.00056.x; OMNR, 2012, STAT ONT FOR; OMNR, 2009, ONT WOODL CAR CONS P; *OMNR, 1988, TIMB MAN GUID PROV M; [OMNR] Ontario Ministry of Natural Resources, 2001, FOR MAN GUID NAT DIS; Ontario Ministry of Natural Resources and Forestry (OMNRF), 2014, INT ASS WOODL CAR TH, P74; Ontario Ministry of Natural Resources and Forestry (OMNRF), 2014, INT RANG ASS WOODL C, px + 71; Ontario Ministry of Natural Resources and Forestry (OMNRF), 2014, INT RANG ASS WOODL T; Pellerin M, 2008, WILDLIFE BIOL, V14, P101, DOI 10.2981/0909-6396(2008)14[101:RDCCHS]2.0.CO;2; Pinheiro J, R PACKAGE VERSION; Popp Jesse N., 2011, Rangifer, V31, P87; Potvin F, 2005, CAN J FOREST RES, V35, P151, DOI 10.1139/X04-151; Proceviat S., 2003, THESIS; Racey G, 1999, FOREST MANA IN PRESS; SAUNDERS DA, 1991, CONSERV BIOL, V5, P18, DOI 10.1111/j.1523-1739.1991.tb00384.x; Schaefer JA, 2000, LANDSCAPE ECOL, V15, P731, DOI 10.1023/A:1008160408257; Schaefer JA, 2003, CONSERV BIOL, V17, P1435, DOI 10.1046/j.1523-1739.2003.02288.x; Seaman DE, 1999, J WILDLIFE MANAGE, V63, P739, DOI 10.2307/3802664; Seip DR, 1991, RANGIFER, V7, P46, DOI DOI 10.7557/2.11.4.993; SIMS RA, 1995, ANN SCI FOREST, V52, P573, DOI 10.1051/forest:19950605; Smith KG, 2000, CAN J ZOOL, V78, P1433, DOI 10.1139/cjz-78-8-1433; Vors LS, 2007, J WILDLIFE MANAGE, V71, P1249, DOI 10.2193/2006-263; Watson JEM, 2005, J BIOGEOGR, V32, P1353, DOI 10.1111/j.1365-2699.2005.01256.x; Watson PR, 1997, THESIS; Wittmer HU, 2007, J ANIM ECOL, V76, P568, DOI 10.1111/j.1365-2656.2007.01220.x; Wittmer HU, 2006, CAN J ZOOL, V84, P537, DOI 10.1139/Z06-026; Wiwchar David M. A., 2012, Rangifer, V32, P309; ZOLADESKI CA, 1990, AM MIDL NAT, V124, P289, DOI 10.2307/2426178	69	9	9	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0170759	10.1371/journal.pone.0170759	http://dx.doi.org/10.1371/journal.pone.0170759			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5VB	28234901	Green Submitted, Green Published, gold			2022-12-27	WOS:000394688200011
J	Honore, C; Atallah, V; Mir, O; Orbach, D; Ferron, G; LePechoux, C; Delhorme, JB; Philippe-Chomette, P; Sarnacki, S; Msika, S; Terrier, P; Glehen, O; Martelli, H; Minard-Colin, V; Bertucci, F; Blay, JY; Bonvalot, S; Elias, D; LeCesne, A; Sargos, P				Honore, C.; Atallah, V.; Mir, O.; Orbach, D.; Ferron, G.; LePechoux, C.; Delhorme, J. B.; Philippe-Chomette, P.; Sarnacki, S.; Msika, S.; Terrier, P.; Glehen, O.; Martelli, H.; Minard-Colin, V.; Bertucci, F.; Blay, J. Y.; Bonvalot, S.; Elias, D.; LeCesne, A.; Sargos, P.		French Network Rare Peritoneal; French Pediat Canc Soc SFCE; French Reference Network Sarcoma; French Sarcoma Clinical Network	Abdominal desmoplastic small round cell tumor without extraperitoneal metastases: Is there a benefit for HIPEC after macroscopically complete cytoreductive surgery?	PLOS ONE			English	Article							HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY; PERITONEAL CARCINOMATOSIS; MULTIMODAL TREATMENT; RADIATION-THERAPY; TRABECTEDIN; CHILDREN; SURVIVAL; FUSION; TRIAL	Background Desmoplastic Small Round Cell Tumor (DSRCT) is a rare disease affecting predominantly children and young adults and for which the benefit of hyperthermic intraperitoneal chemotherapy (HIPEC) after complete cytoreductive surgery (CCRS) remains unknown. Methods To identify patients with DSRCT without extraperitoneal metastases (EPM) who underwent CCRS between 1991 and 2015, a retrospective nation- wide survey was conducted by crossing the prospective and retrospective databases of the French Network for Rare Peritoneal Malignancies, French Reference Network in Sarcoma Pathology, French Sarcoma Clinical Network and French Pediatric Cancer Society. Results A mong the 107 patients with DSRCT, 48 had no EPM and underwent CCRS. The median peritoneal cancer index (PCI) was 9 (range: 2 - 27). Among these 48 patients, 38 (79%) had pre-and/ or postoperative chemotherapy and 23 (48%) postoperative whole abdominopelvic radiotherapy (WAP-RT). Intraperitoneal chemotherapy was administered to 11 patients (23%): two received early postoperative intraperitoneal chemotherapy (EPIC) and nine HIPEC. After a median follow-up of 30 months, the median overall survival (OS) of the entire cohort was 42 months. The 2-y and 5-y OS were 72% and 19%. The 2-y and 5-y diseasefree survival (DFS) were 30% and 12%. WAP-RT was the only variable associated with longer peritoneal recurrence-free survival and DFS after CCRS. The influence of HIPEC/ EPIC on OS and DFS was not statistically conclusive. Conclusion The benefit of HIPEC is still unknown and should be evaluated in a prospective trial. The value of postoperative WAP-RT seems to be confirmed.	[Honore, C.; Elias, D.] Gustave Roussy Canc Campus, Dept Surg Oncol, Villejuif, France; [Atallah, V.; Sargos, P.] Bergonie Inst, Dept Radiotherapy, Bordeaux, France; [Mir, O.; LeCesne, A.] Gustave Roussy Canc Campus, Dept Med Oncol, Villejuif, France; [Orbach, D.] Inst Curie, Dept Pediat Adolescent & Young Adult Oncol, Paris, France; [Ferron, G.] Claudius Regaud Inst, Dept Surg Oncol, Toulouse, France; [LePechoux, C.] Gustave Roussy Canc Campus, Dept Radiotherapy, Villejuif, France; [Delhorme, J. B.] Strasbourg Univ, Hautepierre Hosp, Dept Gen & Digest Surg, Strasbourg, France; [Philippe-Chomette, P.] Robert Debre Hosp, Dept Pediat Surg, Paris, France; [Sarnacki, S.] Paris Descartes Univ, Necker Enfants Malad Hosp, Dept Pediat Surg, Paris, France; [Msika, S.] Paris Diderot Univ, Louis Mourier Hosp, Digest Surg, Colombes, France; [Terrier, P.] Gustave Roussy Canc Campus, Dept Pathol, Villejuif, France; [Glehen, O.] Lyon Civil Hosp, Dept Surg Oncol, South Lyon Univ Hosp Ctr, Lyon, France; [Martelli, H.] Univ Paris 11, Kremlin Bicetre Hosp, Dept Pediat Surg, Le Kremlin Bicetre, France; [Minard-Colin, V.] Gustave Roussy Canc Campus, Dept Pediat Oncol, Villejuif, France; [Bertucci, F.] Aix Marseille Univ, Paoli Calmettes Inst, Dept Med Oncol, Marseille, France; [Blay, J. Y.] Ctr Leon Berard, Dept Med Oncol, Lyon, France; [Bonvalot, S.] Inst Curie, Dept Surg, Paris, France	UNICANCER; Gustave Roussy; UNICANCER; Institut Bergonie; UNICANCER; Gustave Roussy; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UNICANCER; Institut Claudius Regaud; UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Louis-Mourier - APHP; UDICE-French Research Universities; Universite Paris Cite; UNICANCER; Gustave Roussy; CHU Lyon; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC); UNICANCER; Centre Leon Berard; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie	Honore, C (corresponding author), Gustave Roussy Canc Campus, Dept Surg Oncol, Villejuif, France.	Charles.HONORE@gustaveroussy.fr	Sarnacki, Sabine/I-2692-2017; Mir, Olivier/GNP-7828-2022; Blay, Jean-Yves/N-3966-2016	Sarnacki, Sabine/0000-0003-4304-5578; Mir, Olivier/0000-0002-6761-4002; Blay, Jean-Yves/0000-0001-7190-120X; Glehen, Olivier/0000-0002-2802-4974				Baratti D, 2010, ANN SURG ONCOL, V17, P3220, DOI 10.1245/s10434-010-1178-x; Bender JLG, 2013, J CLIN ONCOL, V31, P3034, DOI 10.1200/JCO.2012.47.0914; Bertuzzi A, 2002, J CLIN ONCOL, V20, P2181, DOI 10.1200/JCO.2002.08.033; Bonvalot S, 2005, EJSO, V31, P917, DOI 10.1016/j.ejso.2005.04.010; Brunetti AE, 2014, ANTICANCER RES, V34, P3683; Casey DL, 2014, PEDIATR BLOOD CANCER, V61, P1565, DOI 10.1002/pbc.25088; Chalasani Pavani, 2009, Clin Adv Hematol Oncol, V7, P473; Chan AS, 1999, PEDIATR DEVEL PATHOL, V2, P188, DOI 10.1007/s100249900108; Chuk MK, 2012, PEDIATR BLOOD CANCER, V59, P865, DOI 10.1002/pbc.24201; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Dufresne Armelle, 2012, Sarcoma, V2012, P714986, DOI 10.1155/2012/714986; Fan HS, 2015, INT J SURG CASE REP, V7, P85, DOI 10.1016/j.ijscr.2014.09.022; Ferrari A, 2007, PEDIATR BLOOD CANCER, V49, P864, DOI 10.1002/pbc.20682; Frezza AM, 2014, CLIN SARCOMA RES, V4, DOI 10.1186/2045-3329-4-3; GERALD WL, 1991, AM J SURG PATHOL, V15, P499, DOI 10.1097/00000478-199106000-00001; Glehen O, 2010, CANCER-AM CANCER SOC, V116, P5608, DOI 10.1002/cncr.25356; Hassan I, 2005, CANCER-AM CANCER SOC, V104, P1264, DOI 10.1002/cncr.21282; Hayes-Jordan A, 2012, PEDIATR BLOOD CANCER, V59, P395, DOI 10.1002/pbc.24160; Hayes-Jordan A, 2014, ANN SURG ONCOL, V21, P220, DOI 10.1245/s10434-013-3269-y; Hayes-Jordan A, 2010, J PEDIATR SURG, V45, P1000, DOI 10.1016/j.jpedsurg.2010.02.034; Honore C, 2016, J VISC SURG, V153, P101, DOI 10.1016/j.jviscsurg.2015.11.010; Honore C, 2015, ANN SURG ONCOL, V22, P1073, DOI 10.1245/s10434-014-4123-6; Italiano A, 2013, TARGET ONCOL, V8, P211, DOI 10.1007/s11523-012-0251-8; Jacquet P, 1996, Cancer Treat Res, V82, P359; Kretschmar CS, 1996, J PEDIAT HEMATOL ONC, V18, P293, DOI 10.1097/00043426-199608000-00012; Kushner BH, 1996, J CLIN ONCOL, V14, P1526, DOI 10.1200/JCO.1996.14.5.1526; LADANYI M, 1994, CANCER RES, V54, P2837; Lal DR, 2005, J PEDIATR SURG, V40, P251, DOI 10.1016/j.jpedsurg.2004.09.046; Lettieri CK, 2014, J CANCER EPIDEMIOL, V2014, DOI 10.1155/2014/680126; Lopez-Gonzalez A, 2011, MED ONCOL, V28, pS644, DOI 10.1007/s12032-010-9687-9; Mora J, 2015, FUTURE ONCOL, V11, P1071, DOI 10.2217/fon.15.32; Msika S, 2010, J PEDIATR SURG, V45, P1617, DOI 10.1016/j.jpedsurg.2010.03.002; Osborne E, 2015, RADIOTHER ONCOL, V30; Philippe-Chomette P, 2012, PEDIATR BLOOD CANCER, V58, P891, DOI 10.1002/pbc.23403; Pinnix CC, 2012, INT J RADIAT ONCOL, V83, P317, DOI 10.1016/j.ijrobp.2011.06.1985; RODRIGUEZ E, 1993, CANCER GENET CYTOGEN, V69, P17, DOI 10.1016/0165-4608(93)90105-U; Sommariva A, 2013, ANTICANCER RES, V33, P3989; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Thijs AMJ, 2010, PEDIATR BLOOD CANCER, V55, P1431, DOI 10.1002/pbc.22755; Turaga KK, 2014, ANN SURG ONCOL, V21, P1426, DOI 10.1245/s10434-014-3496-x	40	32	35	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e71639	10.1371/journal.pone.0171639	http://dx.doi.org/10.1371/journal.pone.0171639			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5VB	28234908	Green Published, gold, Green Submitted			2022-12-27	WOS:000394688200028
J	Tagai, K; Shimakura, H; Isobe, H; Nittono, H				Tagai, Keiko; Shimakura, Hitomi; Isobe, Hiroko; Nittono, Hiroshi			The light-makeup advantage in facial processing: Evidence from event-related potentials	PLOS ONE			English	Article							N170 COMPONENT; ERP EVIDENCE; FACE; ATTRACTIVENESS; PERCEPTION; COSMETICS; BEAUTY; EASE; AGE	The effects of makeup on attractiveness have been evaluated using mainly subjective measures. In this study, event-related brain potentials (ERPs) were recorded from a total of 45 Japanese women (n = 23 and n = 22 for Experiment 1 and 2, respectively) to examine the neural processing of faces with no makeup, light makeup, and heavy makeup. To have the participants look at each face carefully, an identity judgement task was used: they were asked to judge whether the two faces presented in succession were of the same person or not. The ERP waveforms in response to the first faces were analyzed. In two experiments with different stimulus probabilities, the amplitudes of N170 and vertex positive potential (VPP) were smaller for faces with light makeup than for faces with heavy makeup or no makeup. The P1 amplitude did not differ between facial types. In a subsequent rating phase, faces with light makeup were rated as more attractive than faces with heavy makeup and no makeup. The results suggest that the processing fluency of faces with light makeup is one of the reasons why light makeup is preferred to heavy makeup and no makeup in daily life.	[Tagai, Keiko; Shimakura, Hitomi; Isobe, Hiroko] Shiseido Global Innovat Ctr, Yokohama, Kanagawa, Japan; [Nittono, Hiroshi] Osaka Univ, Grad Sch Human Sci, Suita, Osaka, Japan	Shiseido Company, Limited; Osaka University	Tagai, K (corresponding author), Shiseido Global Innovat Ctr, Yokohama, Kanagawa, Japan.	keiko.tagai@to.shiseido.co.jp	Nittono, Hiroshi/C-4043-2009	Nittono, Hiroshi/0000-0001-5671-609X; Shimakura, Hitomi/0000-0003-3385-4435	SHISEIDO CO., LTD	SHISEIDO CO., LTD	This study was funded by SHISEIDO CO., LTD. KT HS HI are employees of SHISEIDO CO., LTD. HN was a technical advisor of SHISEIDO CO., LTD and received remuneration therefrom for his services. The funder provided support in the form of salaries for authors (KT, HS, HI) as well as research funds, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Blackman C., 2012, 100 YEARS OF FASHION; CASH TF, 1989, J SOC PSYCHOL, V129, P349, DOI 10.1080/00224545.1989.9712051; Chen CJ, 2013, INT CONF BIOMETR; Craik J., 1993, FACE FASHION CULTURA; Eimer M, 2000, NEUROREPORT, V11, P2319, DOI 10.1097/00001756-200007140-00050; Etcoff N., 1999, SURVIVAL PRETTIEST S; Etcoff NL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025656; Hahn AC, 2016, SOC NEUROSCI-UK, V11, P207, DOI 10.1080/17470919.2015.1059361; Halit H, 2000, NEUROREPORT, V11, P1871, DOI 10.1097/00001756-200006260-00014; Herrmann MJ, 2005, J NEURAL TRANSM, V112, P1073, DOI 10.1007/s00702-004-0250-8; Jones AL, 2014, Q J EXP PSYCHOL, V67, P2060, DOI 10.1080/17470218.2014.908932; Komes J, 2015, FRONT PSYCHOL, V6, DOI [10.3389/fpsyg.2015.01420, 10.3389/fpsyg.7015.01420]; LANGLOIS JH, 1990, PSYCHOL SCI, V1, P115, DOI 10.1111/j.1467-9280.1990.tb00079.x; Luo WB, 2010, NEUROIMAGE, V49, P1857, DOI 10.1016/j.neuroimage.2009.09.018; Minami T, 2011, NEUROSCIENCE, V176, P265, DOI 10.1016/j.neuroscience.2010.12.026; Mulhern R., 2003, International Journal of Cosmetic Science, V25, P199, DOI 10.1046/j.1467-2494.2003.00188.x; Nakajima K, 2012, NEUROPSYCHOLOGIA, V50, P2499, DOI 10.1016/j.neuropsychologia.2012.06.022; Nash R, 2006, J APPL SOC PSYCHOL, V36, P493, DOI 10.1111/j.0021-9029.2006.00016.x; Rossion B, 2011, VISION RES, V51, P1297, DOI 10.1016/j.visres.2011.04.003; Schacht A, 2008, COGN AFFECT BEHAV NE, V8, P132, DOI 10.3758/CABN.8.2.132; Schulz C, 2012, NEUROPSYCHOLOGIA, V50, P2426, DOI 10.1016/j.neuropsychologia.2012.06.013; SHAFFER JP, 1986, J AM STAT ASSOC, V81, P826, DOI 10.2307/2289016; Stephen ID, 2010, PERCEPTION, V39, P1104, DOI 10.1068/p6730; Stephen ID, 2009, INT J PRIMATOL, V30, P845, DOI 10.1007/s10764-009-9380-z; Suzuki S., 2015, MAKEUP REFLECTS TIME; Tagai K, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00226; Trujillo L, 2014, COGN AFFECT BEHAV NE, V14, P1061, DOI 10.3758/s13415-013-0230-2; Ueda S, 2010, PERCEPTION, V39, P260, DOI 10.1068/p6634; VASEY MW, 1987, PSYCHOPHYSIOLOGY, V24, P479, DOI 10.1111/j.1469-8986.1987.tb00324.x; Wiese H, 2008, NEUROPSYCHOLOGIA, V46, P2973, DOI 10.1016/j.neuropsychologia.2008.06.007; Wiese H, 2014, NEUROPSYCHOLOGIA, V56, P26, DOI 10.1016/j.neuropsychologia.2013.12.023; Winkielman P, 2001, J PERS SOC PSYCHOL, V81, P989, DOI 10.1037//0022-3514.81.6.989; Winkielman P, 2006, PSYCHOL SCI, V17, P799, DOI 10.1111/j.1467-9280.2006.01785.x; Zheng X, 2012, NEUROPSYCHOLOGIA, V50, P1451, DOI 10.1016/j.neuropsychologia.2012.02.030	34	8	8	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0172489	10.1371/journal.pone.0172489	http://dx.doi.org/10.1371/journal.pone.0172489			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL5VB	28234959	Green Published, Green Submitted, gold			2022-12-27	WOS:000394688200085
J	Zhao, J; Bai, Y; Jin, L; Weng, YF; Wang, YJ; Wu, H; Li, X; Huang, Y; Wang, SY				Zhao, Jing; Bai, Yun; Jin, Lei; Weng, Yingfeng; Wang, Yujie; Wu, Hui; Li, Xia; Huang, Ying; Wang, Shengyue			A functional variant in the 3 '-UTR of VEGF predicts the 90-day outcome of ischemic stroke in Chinese patients	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; FACTOR GENE POLYMORPHISMS; BLOOD-BRAIN-BARRIER; CEREBRAL INFARCTION; ATRIAL-FIBRILLATION; INCREASED RISK; BINDING-SITE; EXPRESSION; SUSCEPTIBILITY; ANGIOGENESIS	Vascular endothelial growth factor (VEGF) plays critical roles in angiogenesis and vasculogenesis, which are associated with post-stroke functional recovery. However, the effects of the VEGFA polymorphisms on the outcome of ischemic stroke (IS) have been rarely reported. We therefore investigated the associations of + 936C/T variant (rs3025039) with the susceptibilities and the 90-day outcomes from 494 IS patients and 337 healthy controls in Chinese population through the establishment of logistic multivariate regression model. Stroke severity at admission and outcome of 90 days were respectively assessed according to the National Institutes of Health Stroke Scale and the modified Rankin Scale. The analysis showed that there were no significant associations of the rs3025039 genotypes with the susceptibility (P = 0.229) and the severity (P = 0.734). However, when we divided the 308 IS patients into two groups according to the different outcomes, we found that the rs3025039 TC+ TT genotype significantly increased the risk of poor recovery [adjusted odds ratio (OR), 1.99; 95% confidence interval (CI), 1.18-3.37]. Interestingly, we observed another 3'UTR variant, + 1451C/T (rs3025040), exhibited strong linkage disequilibrium (r(2) = 1.0) with + 936C/T and was located in a predicted microRNA-binding site. The rs3025040 T allele significantly decreased the luciferase activities in four cell lines, which indicated a potential disruption of the miRNA-mRNA interaction that would result in lower VEGF expression levels. Our data suggested that the + 936C/T variants significantly increased the risk of poorer stroke outcome by affecting the bindings of miR-199a and miR-199b to VEGF mRNA at the rs30250340 polymorphic site.	[Zhao, Jing; Weng, Yingfeng; Wu, Hui] Minhang Dist Cent Hosp, Dept Neurol, Shanghai, Peoples R China; [Bai, Yun; Jin, Lei; Wang, Yujie; Li, Xia; Wang, Shengyue] Chinese Natl Human Genome Ctr Shanghai, Shanghai MOST Key Lab Hlth & Dis Genom, Shanghai, Peoples R China; [Jin, Lei] Fudan Univ, Sch Life Sci, Shanghai, Peoples R China; [Huang, Ying] Luoxin Biotechnol Co Shanghai, Shanghai, Peoples R China	Fudan University	Bai, Y; Wang, SY (corresponding author), Chinese Natl Human Genome Ctr Shanghai, Shanghai MOST Key Lab Hlth & Dis Genom, Shanghai, Peoples R China.	baiyun@chgc.sh.cn; wangsy@chgc.sh.cn			National Natural Science Foundation of China [30901240, 81572232, 81271868]; Shanghai Natural Science Foundation [13ZR1429500, 13ZR1436600]; Shanghai Municipal Commission for Science and Technology [15DZ2291400]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Natural Science Foundation(Natural Science Foundation of Shanghai); Shanghai Municipal Commission for Science and Technology	This work was supported by the National Natural Science Foundation of China (30901240, 81572232, 81271868), Shanghai Natural Science Foundation (13ZR1429500, 13ZR1436600), Shanghai Municipal Commission for Science and Technology (15DZ2291400).	Abumiya T, 1999, J CEREBR BLOOD F MET, V19, P1038, DOI 10.1097/00004647-199909000-00012; ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Al-Habboubi HH, 2011, EUR CYTOKINE NETW, V22, P154, DOI 10.1684/ecn.2011.0289; Aro E, 2012, J BIOL CHEM, V287, P37134, DOI 10.1074/jbc.M112.352872; Atzeni F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062330; Bellenguez C, 2012, NAT GENET, V44, P328, DOI 10.1038/ng.1081; Bhattacharya A, 2014, NUCLEIC ACIDS RES, V42, pD86, DOI 10.1093/nar/gkt1028; Chen HK, 2015, GENE, V558, P181, DOI 10.1016/j.gene.2015.01.023; Chen J, 2006, NEUROSCIENCE, V141, P737, DOI 10.1016/j.neuroscience.2006.04.042; Chen T, 2015, STEM CELLS, V33, P1405, DOI 10.1002/stem.1930; Fan X, 2009, BRAIN RES REV, V62, P99, DOI 10.1016/j.brainresrev.2009.09.006; Feigin VL, 2014, LANCET, V383, P245, DOI 10.1016/S0140-6736(13)61953-4; Fu Y, 2011, EUR NEUROL, V66, P47, DOI 10.1159/000329276; Goda N, 2015, BMC MED GENET, V16, DOI 10.1186/s12881-015-0219-5; Goldstein LB, 2001, STROKE, V32, P280, DOI 10.1161/01.STR.32.1.280; Gong J, 2015, DATABASE-OXFORD, DOI 10.1093/database/bav029; Gretarsdottir S, 2008, ANN NEUROL, V64, P402, DOI 10.1002/ana.21480; Gu S, 2012, INT J MOL SCI, V13, P8449, DOI 10.3390/ijms13078449; Gudbjartsson DF, 2009, NAT GENET, V41, P876, DOI 10.1038/ng.417; Hassan A, 2000, BRAIN, V123, P1784, DOI 10.1093/brain/123.9.1784; HATANO S, 1976, B WORLD HEALTH ORGAN, V54, P533; Holliday EG, 2012, NAT GENET, V44, P1147, DOI 10.1038/ng.2397; Ikram MA, 2009, NEW ENGL J MED, V360, P1718, DOI 10.1056/NEJMoa0900094; Ikuhashi Y, 2007, ACTA OBSTET GYN SCAN, V86, P1352, DOI 10.1080/00016340701644991; Jiang Guohui, 2016, Int J Neurosci, V126, P326, DOI 10.3109/00207454.2014.994209; Kim JG, 2008, CLIN CANCER RES, V14, P62, DOI 10.1158/1078-0432.CCR-07-1537; Kim OJ, 2011, STROKE, V42, P2393, DOI 10.1161/STROKEAHA.110.607739; Kim VN, 2006, TRENDS GENET, V22, P165, DOI 10.1016/j.tig.2006.01.003; Kovacs Z, 1996, STROKE, V27, P1865, DOI 10.1161/01.STR.27.10.1865; Krippl P, 2003, INT J CANCER, V106, P468, DOI 10.1002/ijc.11238; LEUNG DW, 1989, SCIENCE, V246, P1306, DOI 10.1126/science.2479986; Liu CX, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-661; Liu LP, 2011, STROKE, V42, P3651, DOI 10.1161/STROKEAHA.111.635755; Maeda M, 2003, BBA-GEN SUBJECTS, V1623, P41, DOI 10.1016/S0304-4165(03)00161-2; Meyer BC, 2002, STROKE, V33, P1261, DOI 10.1161/01.STR.0000015625.87603.A7; Miller CL, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004263; Quinn TJ, 2007, STROKE, V38, pE144, DOI 10.1161/STROKEAHA.107.490110; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Reitmeir R, 2012, ACTA NEUROPATHOL, V123, P273, DOI 10.1007/s00401-011-0914-z; Renner W, 2000, J VASC RES, V37, P443, DOI 10.1159/000054076; Soliman S, 2014, J PHARMACOL EXP THER, V349, P444, DOI 10.1124/jpet.113.212613; Song GG, 2014, HUM IMMUNOL, V75, P541, DOI 10.1016/j.humimm.2014.02.022; Sun YJ, 2003, J CLIN INVEST, V111, P1843, DOI 10.1172/JCI200317977; Tu JW, 2014, MED SCI MONITOR, V20, P2520, DOI 10.12659/MSM.891394; Wang CX, 2011, J GASTROEN HEPATOL, V26, P1630, DOI 10.1111/j.1440-1746.2011.06758.x; Waters RJ, 2005, CURR OPIN CRIT CARE, V11, P105, DOI 10.1097/01.ccx.0000155354.78617.91; Wu T, 2016, BRAIN BEHAV, V6, DOI 10.1002/brb3.482; Yang SB, 2015, FEBS LETT, V589, P2087, DOI 10.1016/j.febslet.2015.06.029; Yang YQ, 2014, GENET MOL RES, V13, P5011, DOI 10.4238/2014.July.4.16; Yuan M, 2013, ATHEROSCLEROSIS, V226, P447, DOI 10.1016/j.atherosclerosis.2012.11.026; Zhang ZG, 2000, J CLIN INVEST, V106, P829, DOI 10.1172/JCI9369; Zhang ZG, 2002, J CEREBR BLOOD F MET, V22, P379, DOI 10.1097/00004647-200204000-00002; Zhao J, 2013, BRAIN RES, V1537, P312, DOI 10.1016/j.brainres.2013.08.061	53	7	9	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0172709	10.1371/journal.pone.0172709	http://dx.doi.org/10.1371/journal.pone.0172709			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5VB	28234972	Green Submitted, gold, Green Published			2022-12-27	WOS:000394688200120
J	Tsvetkova, M; Garcia-Gavilanes, R; Floridi, L; Yasseri, T				Tsvetkova, Milena; Garcia-Gavilanes, Ruth; Floridi, Luciano; Yasseri, Taha			Even good bots fight: The case of Wikipedia	PLOS ONE			English	Article								In recent years, there has been a huge increase in the number of bots online, varying from Web crawlers for search engines, to chatbots for online customer service, spambots on social media, and content-editing bots in online collaboration communities. The online world has turned into an ecosystem of bots. However, our knowledge of how these automated agents are interacting with each other is rather poor. Bots are predictable automatons that do not have the capacity for emotions, meaning-making, creativity, and sociality and it is hence natural to expect interactions between bots to be relatively predictable and uneventful. In this article, we analyze the interactions between bots that edit articles on Wikipedia. We track the extent to which bots undid each other's edits over the period 2001-2010, model how pairs of bots interact over time, and identify different types of interaction trajectories. We find that, although Wikipedia bots are intended to support the encyclopedia, they often undo each other's edits and these sterile "fights" may sometimes continue for years. Unlike humans on Wikipedia, bots' interactions tend to occur over longer periods of time and to be more reciprocated. Yet, just like humans, bots in different cultural environments may behave differently. Our research suggests that even relatively "dumb" bots may give rise to complex interactions, and this carries important implications for Artificial Intelligence research. Understanding what affects bot-bot interactions is crucial for managing social media well, providing adequate cyber-security, and designing well functioning autonomous vehicles.	[Tsvetkova, Milena; Garcia-Gavilanes, Ruth; Floridi, Luciano; Yasseri, Taha] Univ Oxford, Oxford Internet Inst, Oxford, England; [Floridi, Luciano; Yasseri, Taha] Alan Turing Inst, London, England	University of Oxford	Yasseri, T (corresponding author), Univ Oxford, Oxford Internet Inst, Oxford, England.; Yasseri, T (corresponding author), Alan Turing Inst, London, England.	taha.yasseri@oii.ox.ac.uk	Yasseri, Taha/AAK-9213-2021; Tsvetkova, Milena/AAE-9386-2021; Floridi, Luciano/G-7699-2014	Yasseri, Taha/0000-0002-1800-6094; Tsvetkova, Milena/0000-0002-3552-108X; Floridi, Luciano/0000-0002-5444-2280	European Union [645043]; Alan Turing Institute [TU/B/000045] Funding Source: researchfish	European Union(European Commission); Alan Turing Institute	This work has received funding from the European Union's Horizon 2020 research and innovation program under grant agreement No. 645043: HUMANE.	Abokhodair N, 2015, PROCEEDINGS OF THE 2015 ACM INTERNATIONAL CONFERENCE ON COMPUTER-SUPPORTED COOPERATIVE WORK AND SOCIAL COMPUTING (CSCW'15), P839, DOI 10.1145/2675133.2675208; [Anonymous], 1997, BOTS ORIGIN NEW SPEC; [Anonymous], 2008, USENIX SECURITY S; Berners-Lee T, 1991, SHORT SUMMARY WORLD; Brandes U., 2009, P 18 INT C WORLD WID, P731, DOI DOI 10.1145/1526709.1526808; Brown John Seely, 2000, SOCIAL LIFE INFORM; Cashmore Pete, 2009, MASHABLE; Ferrara E, 2016, COMMUN ACM, V59, P96, DOI 10.1145/2818717; Floridi L, 2004, MIND MACH, V14, P349, DOI 10.1023/B:MIND.0000035461.63578.9d; Franklin S., 1996, P 3 INT WORKSH AG TH, P21, DOI DOI 10.1007/BFB0013570; Geiger RS, 2013, P 9 INT S OP COLL WI, P1, DOI DOI 10.1145/2491055.249106100010; Halfaker A, 2012, COMPUTER, V45, P79, DOI 10.1109/MC.2012.82; Holiday R, 2014, OBSERVER; Kittur A, 2007, CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, VOLS 1 AND 2, P453; Kivela M, 2014, J COMPLEX NETW, V2, P203, DOI 10.1093/comnet/cnu016; Koster M, 1993, GUIDELINES ROBOT WRI; Marciel M, 2016, PROCEEDINGS OF THE 25TH INTERNATIONAL CONFERENCE ON WORLD WIDE WEB (WWW'16), P357, DOI 10.1145/2872427.28829801; Murphy D, 2015, PC MAGAZINE; Newitz Annalee., 2015, GIZMODO; Niederer S, 2010, NEW MEDIA SOC, V12, P1368, DOI 10.1177/1461444810365297; Russell S, 2009, ARTIFICIAL INTELLIGE; Steiner T, 2014, P INT S OP COLL OPEN, P1; Sumi R., 2011, Proceedings of the 2011 IEEE Third International Conference on Privacy, Security, Risk and Trust and IEEE Third International Conference on Social Computing (PASSAT/SocialCom 2011), P724, DOI 10.1109/PASSAT/SocialCom.2011.47; Sysomos.com, 2009, IN DEPTH LOOK MOST A; Varvello M, 2010, NOSSDAV 2010: PROCEEDINGS OF THE 20TH INTERNATIONAL WORKSHOP ON NETWORK AND OPERATING SYSTEMS SUPPORT FOR DIGITAL AUDIO AND VIDEO, P9; Yasseri T., 2014, GLOBAL WIKIPEDIA INT; Yasseri T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038869; Zeifman I., 2015, 2015 BOT TRAFFIC REP	28	41	43	3	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2017	12	2							e0171774	10.1371/journal.pone.0171774	http://dx.doi.org/10.1371/journal.pone.0171774			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5SX	28231323	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000394682400018
J	Ying, SH; Li, D; Xiao, B; Peng, YX; Du, SY; Xu, MF				Ying, Shihui; Li, Dan; Xiao, Bin; Peng, Yaxin; Du, Shaoyi; Xu, Meifeng			Nonlinear image registration with bidirectional metric and reciprocal regularization	PLOS ONE			English	Article							SYMMETRIC DIFFEOMORPHIC REGISTRATION; ALGORITHM; MAPPINGS; HAMMER	Nonlinear registration is an important technique to align two different images and widely applied in medical image analysis. In this paper, we develop a novel nonlinear registration framework based on the diffeomorphic demons, where a reciprocal regularizer is introduced to assume that the deformation between two images is an exact diffeomorphism. In detail, first, we adopt a bidirectional metric to improve the symmetry of the energy functional, whose variables are two reciprocal deformations. Secondly, we slack these two deformations into two independent variables and introduce a reciprocal regularizer to assure the deformations being the exact diffeomorphism. Then, we utilize an alternating iterative strategy to decouple the model into two minimizing subproblems, where a new closed form for the approximate velocity of deformation is calculated. Finally, we compare our proposed algorithm on two data sets of real brain MR images with two relative and conventional methods. The results validate that our proposed method improves accuracy and robustness of registration, as well as the gained bidirectional deformations are actually reciprocal.	[Ying, Shihui; Li, Dan; Peng, Yaxin] Shanghai Univ, Dept Math, Shanghai 200444, Peoples R China; [Xiao, Bin] Shanghai Jiao Tong Univ, MedX Res Inst, Sch Biomed Engn, Shanghai 200240, Peoples R China; [Du, Shaoyi] Xi An Jiao Tong Univ, Inst Artificial Intelligence & Robot, Xian 710049, Peoples R China; [Xu, Meifeng] Xi An Jiao Tong Univ, Affiliated Hosp 2, Xian 710004, Peoples R China	Shanghai University; Shanghai Jiao Tong University; Xi'an Jiaotong University; Xi'an Jiaotong University	Xu, MF (corresponding author), Xi An Jiao Tong Univ, Affiliated Hosp 2, Xian 710004, Peoples R China.	xumf96@163.com	shen, ying/HHS-5635-2022		National Natural Science Foundation of China [11471208, 61573274]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The research is supported by the National Natural Science Foundation of China (11471208, 61573274).	Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Ashburner J, 2011, NEUROIMAGE, V55, P954, DOI 10.1016/j.neuroimage.2010.12.049; Avants BB, 2008, MED IMAGE ANAL, V12, P26, DOI 10.1016/j.media.2007.06.004; Beg MF, 2005, INT J COMPUT VISION, V61, P139, DOI 10.1023/B:VISI.0000043755.93987.aa; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Cachier P, 2003, COMPUT VIS IMAGE UND, V89, P272, DOI 10.1016/S1077-3142(03)00002-X; Cao Y, 2005, IEEE T MED IMAGING, V24, P1216, DOI 10.1109/TMI.2005.853923; Chui HL, 2003, COMPUT VIS IMAGE UND, V89, P114, DOI 10.1016/S1077-3142(03)00009-2; Dupuis P, 1998, Q APPL MATH, V56, P587, DOI 10.1090/qam/1632326; Gerber S, 2010, MED IMAGE ANAL, V14, P643, DOI 10.1016/j.media.2010.05.008; Hernandez M, 2008, 2 MICCAI WORKSH MATH, P24; Holm DD, 2009, Q APPL MATH, V67, P661, DOI 10.1090/S0033-569X-09-01134-2; Kimmel R, 1998, P NATL ACAD SCI USA, V95, P8431, DOI 10.1073/pnas.95.15.8431; Klein A, 2009, NEUROIMAGE, V46, P786, DOI 10.1016/j.neuroimage.2008.12.037; Ni D, 2017, PATTERN RECOGN, V63, P551, DOI 10.1016/j.patcog.2016.09.033; Qiu A, 2007, NEUROIMAGE, V37, P821, DOI 10.1016/j.neuroimage.2007.05.007; Rohde GK, 2003, IEEE T MED IMAGING, V22, P1470, DOI 10.1109/TMI.2003.819299; Shen DG, 2002, IEEE T MED IMAGING, V21, P1421, DOI 10.1109/TMI.2002.803111; Smolentsev N., 2007, J MATH SCI, V146, P6213, DOI DOI 10.1007/S10958-007-0471-0; Sommer S, 2013, SIAM J IMAGING SCI, V6, P341, DOI 10.1137/110859002; Sorzano COS, 2005, IEEE T BIO-MED ENG, V52, P652, DOI 10.1109/TBME.2005.844030; Sotiras A, 2013, IEEE T MED IMAGING, V32, P1153, DOI 10.1109/TMI.2013.2265603; Toga AW, 2001, IMAGE VISION COMPUT, V19, P3, DOI 10.1016/S0262-8856(00)00055-X; Trouve A, 2005, FOUND COMPUT MATH, V5, P173, DOI 10.1007/s10208-004-0128-z; Trouve A, 1995, PREPRINT; Vercauteren T, 2008, LECT NOTES COMPUT SC, V5241, P754, DOI 10.1007/978-3-540-85988-8_90; Vercauteren T, 2009, NEUROIMAGE, V45, pS61, DOI 10.1016/j.neuroimage.2008.10.040; Wang Y, 2016, IEEE T MED IMAGING, V35, P589, DOI 10.1109/TMI.2015.2485299; Wu GR, 2014, HUM BRAIN MAPP, V35, P1044, DOI 10.1002/hbm.22233; Wu GR, 2010, NEUROIMAGE, V49, P2225, DOI 10.1016/j.neuroimage.2009.10.065; Ye XJ, 2009, LECT NOTES COMPUT SC, V5875, P855; Younes L, 2010, SHAPES DIFFEOMORPHIS	33	6	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2017	12	2							e0172432	10.1371/journal.pone.0172432	http://dx.doi.org/10.1371/journal.pone.0172432			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5SX	28231342	Green Published, gold, Green Submitted			2022-12-27	WOS:000394682400043
J	Deyab, G; Hokstad, I; Whist, JE; Smastuen, MC; Agewall, S; Lyberg, T; Bottazzi, B; Meroni, PL; Leone, R; Hjeltnes, G; Hollan, I				Deyab, Gia; Hokstad, Ingrid; Whist, Jon Elling; Smastuen, Milada Cvancarova; Agewall, Stefan; Lyberg, Torstein; Bottazzi, Barbara; Meroni, Pier Luigi; Leone, Roberto; Hjeltnes, Gunnbjorg; Hollan, Ivana			Anti-rheumatic treatment is not associated with reduction of pentraxin 3 in rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis	PLOS ONE			English	Article							DISEASE-ACTIVITY; VASCULAR INFLAMMATION; ENDOTHELIAL FUNCTION; PTX3; MARKER; METHOTREXATE; EXPRESSION; PROGRESSION; THERAPY; INSULIN	Background Pentraxin 3 is proposed to be a marker of inflammation and cardiovascular risk, but its role in inflammatory rheumatic diseases (IRDs) is still uncertain. Therefore, we wanted to examine if anti-rheumatic treatment reduced serum PTX3 (s-PTX3) levels in IRDs, and if s-PTX3 levels were related to other markers of inflammation and to endothelial function (EF). Methods We examined s-PTX3, EF and established inflammatory biomarkers in 114 IRD patients from the PSARA study before and after 6 weeks and 6 months of treatment with methotrexate (MTX) or anti-tumor necrosis factor alpha (anti-TNF) therapy with or without MTX comedication. Results s-PTX3 levels in all IRD diagnoses were above the upper limit of the reference range. In contrast to established inflammatory markers, in particular CRP and ESR, s-PTX3 levels did not change significantly after 6 weeks and 6 months of anti-rheumatic therapy. There was no difference in change in s-PTX3 levels from baseline to 6 weeks and 6 months between MTX monotherapy and anti-TNF regimens. CRP, ESR and EF were not related to changes in sPTX3 neither in crude nor adjusted analyses. Conclusion IRD patients have increased s-PTX3 levels, which, in contrast to other inflammatory markers, do not seem to improve within 6 months of therapy with MTX and/or anti-TNF. Thus, sPTX3 might reflect a persisting immune process, even a causal factor of inflammation, not inhibited by the standard anti-rheumatic treatment. Furthermore, even though s-PTX3 is thought to be a strong predictor of cardiovascular prognosis, it was not related to EF.	[Deyab, Gia; Whist, Jon Elling] Innlandet Hosp Trust, Dept Med Biochem, Lillehammer, Norway; [Hokstad, Ingrid; Hollan, Ivana] Lillehammer Hosp Rheumat Dis, Lillehammer, Norway; [Whist, Jon Elling; Hollan, Ivana] Innlandet Hosp Trust, Dept Res, Brumunddal, Norway; [Smastuen, Milada Cvancarova] Oslo & Akershus Univ Coll, Inst Hlth Care, Hlth Sci PhD Programme, Oslo, Norway; [Agewall, Stefan] Oslo Univ Hosp, Oslo, Norway; [Agewall, Stefan] Univ Oslo, Inst Clin Sci, Oslo, Norway; [Lyberg, Torstein] Oslo Univ Hosp, Dept Med Biochem, Oslo, Norway; [Bottazzi, Barbara; Leone, Roberto] Humanitas Res Hosp, Milan, Italy; [Meroni, Pier Luigi] Univ Milan, Dept Clin Sci & Community Hlth, Milan, Italy; [Meroni, Pier Luigi] IRCCS Ist Auxol Italiano, Milan, Italy; [Meroni, Pier Luigi] ASST G Pini, Milan, Italy; [Hjeltnes, Gunnbjorg] Innlandet Hosp Trust, Dept Med, Lillehammer, Norway; [Hollan, Ivana] Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA; [Hollan, Ivana] Harvard Med Sch, Boston, MA USA	Innlandet Hospital Trust; Innlandet Hospital Trust; Oslo Metropolitan University (OsloMet); University of Oslo; University of Oslo; University of Oslo; University of Milan; IRCCS Istituto Auxologico Italiano; Innlandet Hospital Trust; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Deyab, G (corresponding author), Innlandet Hosp Trust, Dept Med Biochem, Lillehammer, Norway.	gyyadeyab@gmail.com	bottazzi, barbara/ABH-9274-2020; meroni, pier luigi/K-8473-2016; Leone, Roberto/HGE-8714-2022; Agewall, Stefan/ABE-6327-2020	bottazzi, barbara/0000-0002-1930-9257; meroni, pier luigi/0000-0002-3394-1451; Leone, Roberto/0000-0003-4978-7847; 	Department of Research, Innlandet Hospital Trust, Norway [150323]	Department of Research, Innlandet Hospital Trust, Norway	Analysis and G. Deyab's work is funded by Department of Research, Innlandet Hospital Trust, Norway (150323), URL: http://www.sykehuset-innlandet.no/fag/forskning/forskningsavdelingen. The funders had no role in study design, data collection, decision to publish, or preparation of the manuscript, but they funded the analysis.	ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Atzeni F, 2010, AUTOIMMUN REV, V9, P845, DOI 10.1016/j.autrev.2010.08.001; Bevelacqua V, 2006, INT J MOL MED, V18, P415; Bjorklund TC, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-223; Bonetti PO, 2003, J AM COLL CARDIOL, V41, P1761, DOI 10.1016/S0735-1097(03)00329-2; Bottazzi B, 2010, ANNU REV IMMUNOL, V28, P157, DOI 10.1146/annurev-immunol-030409-101305; Breland UM, 2010, RHEUMATOLOGY, V49, P1118, DOI 10.1093/rheumatology/keq005; Dagna L, 2011, ANN INTERN MED, V155, P425, DOI 10.7326/0003-4819-155-7-201110040-00005; Deniz T, 2014, ACTA REUMATOL PORT, V39, P137; Fazzini F, 2001, ARTHRITIS RHEUM, V44, P2841, DOI 10.1002/1529-0131(200112)44:12<2841::AID-ART472>3.0.CO;2-6; Feldmann M, 2002, NAT REV IMMUNOL, V2, P364, DOI 10.1038/nri802; Foo SS, 2015, TRENDS MICROBIOLOGY; Helseth R, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/608414; Hjeltnes G, 2011, SCAND J RHEUMATOL, V40, P422, DOI 10.3109/03009742.2011.585350; Hollan I, 2010, ARTHRIT CARE RES, V62, P378, DOI 10.1002/acr.20094; Huang XL, 2016, ARCH MED RES, V47, P223, DOI 10.1016/j.arcmed.2016.05.006; Jaillon S, 2007, J EXP MED, V204, P793, DOI 10.1084/jem.20061301; Klouche M, 2004, ATHEROSCLEROSIS, V175, P221, DOI 10.1016/j.atherosclerosis.2004.03.020; Knoflach M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031474; Kunes ZH P, 2012, MEDIAT INFLAMM, V2012, P10; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Luchetti MM, 2000, CLIN EXP IMMUNOL, V119, P196, DOI 10.1046/j.1365-2249.2000.01110.x; Mease PJ, 2012, NAT REV RHEUMATOL, V8, P251, DOI 10.1038/nrrheum.2012.56; MOLL J M H, 1973, Seminars in Arthritis and Rheumatism, V3, P55, DOI 10.1016/0049-0172(73)90035-8; Norata GD, 2009, CIRCULATION, V120, P699, DOI 10.1161/CIRCULATIONAHA.108.806547; Nurmohamed MT, 2015, NAT REV RHEUMATOL, V11, P693, DOI 10.1038/nrrheum.2015.112; Okan G, 2015, J CLIN LAB ANAL; Onkelinx S, 2012, VASC MED, V17, P79, DOI 10.1177/1358863X12436708; Padeh S, 2013, IMMUNOL RES, V56, P444, DOI 10.1007/s12026-013-8417-8; Pavy S, 2006, JOINT BONE SPINE, V73, P388, DOI 10.1016/j.jbspin.2006.01.007; Ramonda R, 2014, JOINT BONE SPINE, V81, P421, DOI 10.1016/j.jbspin.2014.02.005; Ramonda R, 2013, EXP BIOL MED, V238, P1431, DOI 10.1177/1535370213506435; Ridker PM, 2003, CIRCULATION, V107, P363, DOI 10.1161/01.CIR.0000053730.47739.3C; Rolph MS, 2002, ARTERIOSCL THROM VAS, V22, pE10, DOI 10.1161/01.ATV.0000015595.95497.2F; Rothman KJ, 2014, J GEN INTERN MED, V29, P1060, DOI 10.1007/s11606-013-2755-z; Salio M, 2008, CIRCULATION, V117, P1055, DOI 10.1161/CIRCULATIONAHA.107.749234; Silva LCR, 2010, IMMUNOTHERAPY-UK, V2, P817, DOI [10.2217/imt.10.67, 10.2217/IMT.10.67]; Suzuki S, 2008, AM HEART J, V155, P75, DOI 10.1016/j.ahj.2007.08.013; Tekeoglu I, 2016, CYTOKINE, V83, P171, DOI 10.1016/j.cyto.2016.04.009; Tombetti E, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/s13075-014-0479-z; Turesson C, 2008, VASC HEALTH RISK MAN, V4, P605, DOI 10.2147/VHRM.S2453; Uysal S, 2014, EUR REV MED PHARMACO, V18, P3453; van der Heijde D, 2011, ANN RHEUM DIS, V70, P905, DOI 10.1136/ard.2011.151563; VANDERLINDEN S, 1984, ARTHRITIS RHEUM, V27, P361; Ward MM, 2016, ARTHRITIS RHEUMATOL, V68, P282, DOI 10.1002/art.39298; Wessels JAM, 2008, RHEUMATOLOGY, V47, P249, DOI 10.1093/rheumatology/kem279; Yamasaki K, 2009, CLIN CHEM LAB MED, V47, P471, DOI 10.1515/CCLM.2009.110	47	20	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2017	12	2							e0169830	10.1371/journal.pone.0169830	http://dx.doi.org/10.1371/journal.pone.0169830			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5SK	28225768	Green Submitted, Green Published, gold			2022-12-27	WOS:000394680900004
J	Ruiz-Extremera, A; Pavon-Castillero, EJ; Florido, M; de Rueda, PM; Munoz-Gamez, JA; Casado, J; Carazo, A; Quiles, R; Jimenez-Ruiz, SM; Gila, A; Luna, JD; Leon, J; Salmeron, J				Ruiz-Extremera, A.; Pavon-Castillero, E. J.; Florido, M.; Munoz de Rueda, P.; Munoz-Gamez, J. A.; Casado, J.; Carazo, A.; Quiles, R.; Jimenez-Ruiz, S. M.; Gila, A.; Luna, J. D.; Leon, J.; Salmeron, J.			Influence of HLA class I, HLA class II and KIRs on vertical transmission and chronicity of hepatitis C virus in children	PLOS ONE			English	Article							PREGNANT-WOMEN; GENETIC-FACTORS; INFECTION; RISK; COMBINATION; CLEARANCE; RIBAVIRIN; RECEPTOR; DISEASE; IL28B	Background & aim There is evidence that maternal viral load of HCV during delivery influences the risk for Mother-to-child transmission (MTCT), but this does not explain all cases. We study the role of the immunogenetic profile (HLA, KIRs and KIR-ligand binding) of mothers and children in HCV-MTCT and in chronicity in the children. Methodology 79 HCV-RNA (+) mothers and their 98 children were included. 24 children were infected, becoming chronic in 8 cases and clearing in 16. HLA-class-I and II and KIRs were determined by Luminex. Results MTCT study: The presence of HLA-C1-ligand in mothers and/or their children reduces the risk of transmission (mothers: Pc = 0.011, children: P = 0.033), whereas the presence of HLA-C2C2-ligand in mothers increases it (Pc = 0.011). In children KIR2DL3-HLA-C1 is a protector factor (Pc = 0.011). Chronicity in children study: Maternal DQA1*01 allele (Pc = 0.027), KIR2DS1 (Pc = 0.011) or KIR3DS1 (Pc = 0.011) favours chronicity in the child. The presence of the DQB1*03 allele (Pc = 0.027) and KIR2DS3 (P = 0.056) in the child and homozygosity for KIR3DL1/3DL1 (Pc = 0.011) and for the HLA-Bw4/Bw4 ligand (P = 0.027) is associated with viral clearance, whereas the presence of HLA-Bw6 ligand (P = 0.027), the binding of KIR3DS1-HLA-Bw4 (P = 0.037) and heterozygosity for KIR3DL1/3DS1 (Pc = 0.011) favour viral chronicity. Mother/child allele matching: In the joint HLA analysis, matching was greater between mothers and children with chronic infection vs those who had cleared the virus (67%+/- 4.1 vs 57%+/- 1.2, P = 0.003). Conclusions The HLA-C1 ligand in the mother is related to MTCT, while several genetic factors of the mother or child are involved in the chronification or clearance of infection in the child. Matching allelic data is considered to be an indicator of HCV chronicity in the child and can be used as a potential prognostic test. This implies that NK cells may play a previously undocumented role in protecting against MTCT and that both NK cell immunity and adaptive T-cell responses may influence viral clearance in infected children.	[Ruiz-Extremera, A.] San Cecilio Univ Hosp, Paediat Unit, Granada, Spain; [Ruiz-Extremera, A.] Virgen de las Nieves Univ Hosp, Granada, Spain; [Ruiz-Extremera, A.] Univ Granada, Dept Paediat, Granada, Spain; [Ruiz-Extremera, A.; Munoz de Rueda, P.; Quiles, R.; Gila, A.; Leon, J.; Salmeron, J.] Inst Salud Carlos III, CIBER Liver & Digest Dis CIBERehd, Madrid, Spain; [Ruiz-Extremera, A.; Pavon-Castillero, E. J.; Munoz de Rueda, P.; Munoz-Gamez, J. A.; Casado, J.; Carazo, A.; Quiles, R.; Gila, A.; Luna, J. D.; Leon, J.; Salmeron, J.] Inst Invest Biosanitaria Granada, Granada, Spain; [Pavon-Castillero, E. J.; Florido, M.; Munoz de Rueda, P.; Munoz-Gamez, J. A.; Casado, J.; Carazo, A.; Quiles, R.; Jimenez-Ruiz, S. M.; Gila, A.; Leon, J.; Salmeron, J.] San Cecilio Univ Hosp, Res Unit, Clin Management Unit Digest Dis, Granada, Spain; [Jimenez-Ruiz, S. M.; Salmeron, J.] Univ Granada, Dept Med, Granada, Spain; [Luna, J. D.] Univ Granada, Biostat Dept, Granada, Spain	Hospital Universitario San Cecilio; Hospital Universitario Virgen de las Nieves; University of Granada; CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; CIBEREHD; Instituto de Salud Carlos III; Instituto de Investigacion Biosanitaria IBS Granada; Hospital Universitario San Cecilio; University of Granada; University of Granada	Pavon-Castillero, EJ (corresponding author), Inst Invest Biosanitaria Granada, Granada, Spain.; Pavon-Castillero, EJ (corresponding author), San Cecilio Univ Hosp, Res Unit, Clin Management Unit Digest Dis, Granada, Spain.	estherjpavon@yahoo.es	de dios luna del castillo, juan/N-9183-2016; casado, Jorge/GVT-9383-2022	Ruiz-Extremera, Angeles o Angela/0000-0001-7978-1708; Quiles, Rosa/0000-0001-6089-6193	Institute de Salud Carlos III (FIS; FEDER) [PI08/0704, PI13/0192]; Consejeria de Salud de la Junta de Andalucia [PI-387-2005, PI-0635-2010, PI-0161-2012]; Giber de Enfermedades Hepaticas y Digestivas (Ciberehd) [CB06/04/0044]; FEDER	Institute de Salud Carlos III (FIS; FEDER); Consejeria de Salud de la Junta de Andalucia(Junta de Andalucia); Giber de Enfermedades Hepaticas y Digestivas (Ciberehd); FEDER(European Commission)	This work was partially supported by: Institute de Salud Carlos III (FIS; FEDER): PI08/0704; PI13/0192; Consejeria de Salud de la Junta de Andalucia: PI-387-2005; PI-0635-2010; PI-0161-2012; Giber de Enfermedades Hepaticas y Digestivas (Ciberehd) (CB06/04/0044); and FEDER. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arshad M, 2011, J VIRAL HEPATITIS, V18, P229, DOI 10.1111/j.1365-2893.2010.01413.x; Azzari C, 2008, J MED VIROL, V80, P65, DOI 10.1002/jmv.21023; Babor F, 2014, BLOOD, V124, P2248, DOI 10.1182/blood-2014-05-572065; Bevilacqua E, 2009, VIROLOGY, V390, P64, DOI 10.1016/j.virol.2009.05.007; Caggiari L, 2011, INT J BIOL MARKER, V26, P221, DOI 10.5301/JBM.2011.8903; Cangussu LOF, 2011, SCAND J IMMUNOL, V74, P282, DOI 10.1111/j.1365-3083.2011.02568.x; Carneiro VL, 2010, LIVER INT, V30, P567, DOI 10.1111/j.1478-3231.2010.02212.x; Ceci O, 2001, J PEDIATR GASTR NUTR, V33, P570, DOI 10.1097/00005176-200111000-00011; De Re V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117420; De Re V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084940; Dring MM, 2011, P NATL ACAD SCI USA, V108, P5736, DOI 10.1073/pnas.1016358108; Duggal P, 2013, ANN INTERN MED, V158, P235, DOI 10.7326/0003-4819-158-4-201302190-00003; Harris RA, 2008, HEPATOLOGY, V48, P70, DOI 10.1002/hep.22287; Hiroishi K, 1997, HEPATOLOGY, V25, P705, DOI 10.1002/hep.510250336; Khakoo SI, 2004, SCIENCE, V305, P872, DOI 10.1126/science.1097670; Lanier LL, 2008, NAT IMMUNOL, V9, P495, DOI 10.1038/ni1581; Martinetti M, 2006, INT J IMMUNOPATH PH, V19, P369, DOI 10.1177/039463200601900213; Middleton D, 2003, TISSUE ANTIGENS, V61, P403, DOI 10.1034/j.1399-0039.2003.00062.x; de Rueda PM, 2011, AM J GASTROENTEROL, V106, P1246, DOI 10.1038/ajg.2011.82; Munoz-Almagro C, 2002, MED CLIN-BARCELONA, V118, P452, DOI 10.1016/S0025-7753(02)72417-2; Paximadis M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016541; Rivero-Juarez A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061992; Ruiz-Extremera A, 2000, PEDIATR INFECT DIS J, V19, P511, DOI 10.1097/00006454-200006000-00004; Ruiz-Extremera A, 2005, AM J OBSTET GYNECOL, V193, P2010, DOI 10.1016/j.ajog.2005.04.045; Ruiz-Extremera A, 2011, HEPATOLOGY, V53, P1830, DOI 10.1002/hep.24298; Schwimmer JB, 2000, SEMIN LIVER DIS, V20, P37, DOI 10.1055/s-2000-9257; Song RJ, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003867; Uhrberg M, 2005, EUR J IMMUNOL, V35, P10, DOI 10.1002/eji.200425743; Umemura T, 2014, HUM IMMUNOL, V75, P822, DOI 10.1016/j.humimm.2014.06.003; Zahran KM, 2010, INT J GYNECOL OBSTET, V111, P171, DOI 10.1016/j.ijgo.2010.06.013	30	7	9	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2017	12	2							e0172527	10.1371/journal.pone.0172527	http://dx.doi.org/10.1371/journal.pone.0172527			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5SK	28225833	gold, Green Published, Green Submitted			2022-12-27	WOS:000394680900050
J	Lin, HC; Xirasagar, S; Chung, SD; Huang, CC; Tsai, MC; Chen, CH				Lin, Herng-Ching; Xirasagar, Sudha; Chung, Shiu-Dong; Huang, Chung-Chien; Tsai, Ming-Chieh; Chen, Chao-Hung			Fewer acute respiratory infection episodes among patients receiving treatment for gastroesophageal reflux disease	PLOS ONE			English	Article							CARE RESOURCE UTILIZATION; PROTON PUMP INHIBITORS; EXTRAOESOPHAGEAL MANIFESTATIONS; CLINICAL SPECTRUM; CHRONIC COUGH; LANSOPRAZOLE; EPIDEMIOLOGY; POPULATION; RANITIDINE; OMEPRAZOLE	Patients with gastroesophageal reflux disease (GERD) present with comorbid complications with implications for healthcare utilization. To date, little is known about the effects of GERD treatment with a proton-pump inhibitor (PPI) on patients' subsequent healthcare utilization for acute respiratory infections (ARIs). This population-based study compared ARI episodes captured through outpatient visits, one year before and one year after GERD patients received PPI treatment. We used retrospective data from the Longitudinal Health Insurance Database 2005 in Taiwan, comparing 21,486 patients diagnosed with GERD from 2010 to 2012 with 21,486 age-sex matched comparison patients without GERD. Annual ARI episodes represented by ambulatory care visits for ARI (visits during a 7-day period bundled into one episode), were compared between the patient groups during the 1-year period before and after the index date (date of GERD diagnosis for study patients, first ambulatory visit in the same year for their matched comparison counterpart). Multiple regression analysis using a difference-in-difference approach was performed to estimate the adjusted association between GERD treatment and the subsequent annual ARI rate. We found that the mean annual ARI episode rate among GERD patients reduced by 11.4%, from 4.39 before PPI treatment, to 3.89 following treatment (mean change = -0.5 visit, 95% confidence interval (CI) = (-0.64, -0.36)). In Poisson regression analysis, GERD treatment showed an independent association with the annual ARI rate, showing a negative estimate (with p<0.001). The study suggests that GERD treatment with PPIs may help reduce healthcare visits for ARIs, highlighting the importance of treatment-seeking by GERD patients and compliance with treatment.	[Lin, Herng-Ching; Huang, Chung-Chien] Taipei Med Univ, Sch Hlth Care Adm, Taipei, Taiwan; [Lin, Herng-Ching; Chen, Chao-Hung] Taipei Med Univ, Coll Med, Res Ctr Sleep Med, Taipei, Taiwan; [Xirasagar, Sudha] Univ South Carolina, Dept Hlth Serv Policy & Management, Arnold Sch Publ Hlth, Columbia, SC USA; [Chung, Shiu-Dong] Far Eastern Mem Hosp, Dept Surg, Taipei, Taiwan; [Tsai, Ming-Chieh] Cathay Gen Hosp, Div Gastroenterol, Dept Internal Med, Hsinchu Branch, Hsinchu, Taiwan; [Chen, Chao-Hung] Natl Yang Ming Univ, Dept & Inst Physiol, Taipei, Taiwan; [Chen, Chao-Hung] Mackay Jr Coll Med Nursing & Management, Dept Cosmet Applicat & Management, Taipei, Taiwan; [Chen, Chao-Hung] MacKay Mem Hosp, Dept Thorac Surg, Taipei, Taiwan	Taipei Medical University; Taipei Medical University; University of South Carolina System; University of South Carolina Columbia; Far Eastern Memorial Hospital; Cathay General Hospital; National Yang Ming Chiao Tung University; Mackay Junior College of Medicine, Nursing & Management; Mackay Memorial Hospital	Chen, CH (corresponding author), Taipei Med Univ, Coll Med, Res Ctr Sleep Med, Taipei, Taiwan.; Chen, CH (corresponding author), Natl Yang Ming Univ, Dept & Inst Physiol, Taipei, Taiwan.; Chen, CH (corresponding author), Mackay Jr Coll Med Nursing & Management, Dept Cosmet Applicat & Management, Taipei, Taiwan.; Chen, CH (corresponding author), MacKay Mem Hosp, Dept Thorac Surg, Taipei, Taiwan.	s448@eip.mkc.edu.tw	Huang, CC/AAX-5872-2021; Xirasagar, Sudha/AAA-2350-2022	Huang, CC/0000-0003-0818-7175; 				D'Urzo A, 2002, CAN FAM PHYSICIAN, V48, P1311; Dal-Paz K, 2012, DIS ESOPHAGUS, V25, P107, DOI 10.1111/j.1442-2050.2011.01227.x; Dent J, 2005, GUT, V54, P710, DOI 10.1136/gut.2004.051821; El-Serag HB, 2007, CLIN GASTROENTEROL H, V5, P17, DOI 10.1016/j.cgh.2006.09.016; El-Serag HB, 2014, GUT, V63, P871, DOI 10.1136/gutjnl-2012-304269; El-Serag HB, 2005, AM J GASTROENTEROL, V100, P1243, DOI 10.1111/j.1572-0241.2005.41703.x; El-Serag HB, 2001, AM J GASTROENTEROL, V96, P979; Gerson LB, 2012, DIS ESOPHAGUS, V25, P694, DOI 10.1111/j.1442-2050.2011.01313.x; Gibson PG, 2003, COCHRANE DATABASE SY, pCD001496, DOI DOI 10.1002/14651858.CD001496; Gosselin A, 2009, VALUE HEALTH, V12, P34, DOI 10.1111/j.1524-4733.2008.00399.x; Gunaratnam NT, 2006, ALIMENT PHARM THERAP, V23, P1473, DOI 10.1111/j.1365-2036.2006.02911.x; Gurski Richard Ricachenevski, 2006, J. bras. pneumol., V32, P150, DOI 10.1590/S1806-37132006000200011; HAVELUND T, 1988, BRIT MED J, V296, P89, DOI 10.1136/bmj.296.6615.89; Irwin RS, 1998, CHEST, V114, p133S, DOI 10.1378/chest.114.2_Supplement.133S; Irwin RS, 2000, AM J GASTROENTEROL, V95, pS9, DOI 10.1016/S0002-9270(00)01073-X; Katz PO, 2010, J GASTROINTEST SURG, V14, P62, DOI 10.1007/s11605-009-1015-3; Lewis JV, 2009, SOUTH MED J, V102, P995, DOI 10.1097/SMJ.0b013e3181b666e5; Littner MR, 2005, CHEST, V128, P1128, DOI 10.1378/chest.128.3.1128; Locke GR, 1997, GASTROENTEROLOGY, V112, P1448, DOI 10.1016/S0016-5085(97)70025-8; Maher Maha M, 2010, Saudi J Gastroenterol, V16, P84, DOI 10.4103/1319-3767.61233; Noordzij JP, 2001, LARYNGOSCOPE, V111, P2147, DOI 10.1097/00005537-200112000-00013; Nwokediuko Sylvester Chuks, 2012, ISRN Gastroenterol, V2012, P391631, DOI 10.5402/2012/391631; Pisegna JM, 2016, J VOICE IN PRESS; Poelmans J, 2005, GUT, V54, P1492, DOI 10.1136/gut.2004.053025; Poh CH, 2010, GASTROINTEST ENDOSC, V71, P28, DOI 10.1016/j.gie.2009.08.024; Richter JE, 2005, ALIMENT PHARM THER, V22, P70, DOI 10.1111/j.1365-2036.2005.02613.x; ROBINSON M, 1995, ALIMENT PHARM THERAP, V9, P25; Stanghellini V, 1999, SCAND J GASTROENTERO, V34, P29; Vakil N, 2006, AM J GASTROENTEROL, V101, P1900, DOI 10.1111/j.1572-0241.2006.00630.x; Wahlqvist P, 2006, ALIMENT PHARM THERAP, V24, P259, DOI 10.1111/j.1365-2036.2006.02996.x; Watanabe Y, 2003, SCAND J GASTROENTERO, V38, P807, DOI 10.1080/00365520310004506; Wong WM, 2003, ALIMENT PHARM THER, V18, P595, DOI 10.1046/j.1365-2036.2003.01737.x; Yoshida N, 2000, ALIMENT PHARM THERAP, V14, P74, DOI 10.1046/j.1365-2036.2000.014s1074.x; Yuksel ES, 2012, SWISS MED WKLY, V142, DOI 10.4414/smw.2012.13544	35	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2017	12	2							e0172436	10.1371/journal.pone.0172436	http://dx.doi.org/10.1371/journal.pone.0172436			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5QV	28222168	Green Submitted, Green Published, gold			2022-12-27	WOS:000394676800056
J	Liu, Y; Buck, JR; Ikonomidou, VN				Liu, Yang; Buck, John R.; Ikonomidou, Vasiliki N.			Generalized min-max bound-based MRI pulse sequence design framework for wide-range T1 relaxometry: A case study on the tissue specific imaging sequence	PLOS ONE			English	Article							MULTIPLE-SCLEROSIS; MAGNETIZATION-TRANSFER; RELAXATION-TIMES; BRAIN; T-1; ACQUISITION; SIGNAL; NOISE; CONTRAST; DISEASE	This paper proposes a new design strategy for optimizing MRI pulse sequences for T-1 relaxometry. The design strategy optimizes the pulse sequence parameters to minimize the maximum variance of unbiased T-1 estimates over a range of T-1 values using the Crame A r-Rao bound. In contrast to prior sequences optimized for a single nominal T-1 value, the optimized sequence using our bound-based strategy achieves improved precision and accuracy for a broad range of T-1 estimates within a clinically feasible scan time. The optimization combines the downhill simplex method with a simulated annealing process. To show the effectiveness of the proposed strategy, we optimize the tissue specific imaging (TSI) sequence. Preliminary Monte Carlo simulations demonstrate that the optimized TSI sequence yields improved precision and accuracy over the popular driven-equilibrium single- pulse observation of T-1 (DESPOT1) approach for normal brain tissues (estimated T-1 700-2000 ms at 3.0T). The relative mean estimation error (MSE) for T-1 estimation is less than 1.7% using the optimized TSI sequence, as opposed to less than 7.0% using DESPOT1 for normal brain tissues. The optimized TSI sequence achieves good stability by keeping the MSE under 7.0% over larger T-1 values corresponding to different lesion tissues and the cerebrospinal fluid (up to 5000 ms). The T-1 estimation accuracy using the new pulse sequence also shows improvement, which is more pronounced in low SNR scenarios.	[Liu, Yang; Buck, John R.] Univ Massachusetts Dartmouth, Dept Elect & Comp Engn, Dartmouth, MA 02747 USA; [Ikonomidou, Vasiliki N.] George Mason Univ, Dept Bioengn, Fairfax, VA 22030 USA	University of Massachusetts System; University Massachusetts Dartmouth; George Mason University	Liu, Y (corresponding author), Univ Massachusetts Dartmouth, Dept Elect & Comp Engn, Dartmouth, MA 02747 USA.	yang.liu@umassd.edu	Liu, Yang/AAH-8479-2019	Liu, Yang/0000-0001-9322-7543				Akcakaya M, 2015, MAGN RESON MED, V73, P1741, DOI 10.1002/mrm.25285; Alexander DC, 2008, MAGN RESON MED, V60, P439, DOI 10.1002/mrm.21646; Bagnato F, 2006, AM J NEURORADIOL, V27, P2161; Bagnato F, 2011, MULT SCLER J, V17, P1424, DOI 10.1177/1352458511414601; BERNSTEIN MA, 1989, MED PHYS, V16, P813, DOI 10.1118/1.596304; BYDDER GM, 1985, J COMPUT ASSIST TOMO, V9, P659, DOI 10.1097/00004728-198507010-00002; Cercignani M, 2006, MAGN RESON MED, V56, P803, DOI 10.1002/mrm.21003; Chang LC, 2008, MAGN RESON MED, V60, P496, DOI 10.1002/mrm.21669; CRAWLEY AP, 1988, MAGN RESON MED, V7, P23, DOI 10.1002/mrm.1910070104; Deoni SCL, 2003, MAGNET RESON MED, V49, P515, DOI 10.1002/mrm.10407; Deoni SCL, 2006, MAGN RESON IMAGING, V24, P1241, DOI 10.1016/j.mri.2006.03.015; Deoni Sean C L, 2010, Top Magn Reson Imaging, V21, P101, DOI 10.1097/RMR.0b013e31821e56d8; EDELSTEIN WA, 1983, J COMPUT ASSIST TOMO, V7, P391, DOI 10.1097/00004728-198306000-00001; Fera F, 2004, J MAGN RESON IMAGING, V19, P19, DOI 10.1002/jmri.10440; Funai A, 2010, I S BIOMED IMAGING, P712, DOI 10.1109/ISBI.2010.5490075; Giovanni BF, 2010, NAT REV NEUROL, V6, P67, DOI [10.1038/nrneurol.2009.215, DOI 10.1038/NRNEUROL.2009.215]; GUDBJARTSSON H, 1995, MAGNET RESON MED, V34, P910, DOI 10.1002/mrm.1910340618; HENKELMAN RM, 1985, MED PHYS, V12, P232, DOI 10.1118/1.595711; Ikonomidou VN, 2005, MAGN RESON MED, V54, P373, DOI 10.1002/mrm.20561; Kay S. M., 1993, FUNDAMENTALS OF STAT, V1; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; Koohi A, 2011, P INT SOC MAGN RES M, P4369; Lankford CL, 2013, MAGN RESON MED, V69, P127, DOI 10.1002/mrm.24241; LARSSON HBW, 1989, MAGNET RESON MED, V11, P337, DOI 10.1002/mrm.1910110308; Li K, 2010, MAGN RESON MED, V64, P491, DOI 10.1002/mrm.22440; Liu Y, 2013, P BIOM ENG SOC BMES; Look D. C., 1970, Review of Scientific Instruments, V41, P250, DOI 10.1063/1.1684482; Manfredonia F, 2007, ARCH NEUROL-CHICAGO, V64, P411, DOI 10.1001/archneur.64.3.411; MCDONALD GG, 1973, J MAGN RESON, V9, P358, DOI 10.1016/0022-2364(73)90177-7; McRobbie D. W., 2006, MRI PICTURE PROTON; Neema M, 2007, J NEUROIMAGING, V17, p16S, DOI 10.1111/j.1552-6569.2007.00131.x; NELDER JA, 1965, COMPUT J, V7, P308, DOI 10.1093/comjnl/7.4.308; Press W. H., 1992, NUMERICAL RECIPES FO, V77; Riva M, 2009, AM J NEURORADIOL, V30, P1394, DOI 10.3174/ajnr.A1573; SCHARF LL, 1993, SIGNAL PROCESS, V31, P301, DOI 10.1016/0165-1684(93)90088-R; Stanisz GJ, 2005, MAGNET RESON MED, V54, P507, DOI 10.1002/mrm.20605; Steenwijk MD, 2016, MULT SCLER J, V22, P1279, DOI 10.1177/1352458515615953; Teixeira R, 2014, P INT SOC MAGN RES M, P3200; Vrenken H, 2006, RADIOLOGY, V240, P811, DOI 10.1148/radiol.2403050569; Vymazal J, 1999, RADIOLOGY, V211, P489, DOI 10.1148/radiology.211.2.r99ma53489; Wansapura JP, 1999, JMRI-J MAGN RESON IM, V9, P531, DOI 10.1002/(SICI)1522-2586(199904)9:4<531::AID-JMRI4>3.0.CO;2-L; Zhao B, 2014, IEEE T MED IMAGING, V33, P1832, DOI 10.1109/TMI.2014.2322815	42	14	15	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2017	12	2							e0172573	10.1371/journal.pone.0172573	http://dx.doi.org/10.1371/journal.pone.0172573			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5QV	28222197	Green Published, Green Submitted, gold			2022-12-27	WOS:000394676800069
J	Ni, JB; Bai, SL; Gao, L; Qian, MJ; Zhong, LB; Teng, YW				Ni, Junbei; Bai, Songling; Gao, Ling; Qian, Minjie; Zhong, Linbing; Teng, Yuanwen			Identification, classification, and transcription profiles of the B-type response regulator family in pear	PLOS ONE			English	Article							ANTHOCYANIN BIOSYNTHESIS; SIGNAL-TRANSDUCTION; SEED DEVELOPMENT; CELL-DIVISION; GENE FAMILY; CYTOKININ; ROLES; EVOLUTION; DORMANCY; CULTURES	Type-B response regulators (B-RRs) are transcription factors that function in the final step of two-component signaling systems. In model plants, B-RRs have been shown to play important roles in cytokinin signal transduction. However, the functions of B-RRs in pear have not been well studied. In this report, we conducted a genome-wide analysis and identified 11 putative genes encoding B-PpRR proteins based on the published genome sequence of Pyrus bretschneideri. A phylogenetic tree of the B-PpRR family was constructed, and the motif distribution, chromosome localization, and gene structure of B-PpRR family genes were determined. Gene transcript profiles, which were determined from transcriptome data, indicated that B-PpRR genes potentially function during pear fruit development, bud dormancy, and light/hormone-induced anthocyanin accumulation. Treatment of the fruitlets of 'Cuiguan' pear (Pyrus pyrifolia), which never accumulates anthocyanin, with the cytokinin N-(2-chloro-4-pyridyl)-N ' phenylurea (CPPU) clearly induced anthocyanin accumulation. Anthocyanins accumulated in the skin of fruitlets by 16 days after CPPU treatment, along with the significant activation of most anthocyanin biosynthetic genes. Analyses of B-PpRR transcript levels suggested that B-PpRR genes mediated this accumulation of anthocyanins. These findings enrich our understanding of the function of B-PpRR genes in the physiological processes of pear.	[Ni, Junbei; Bai, Songling; Gao, Ling; Qian, Minjie; Teng, Yuanwen] Zhejiang Univ, Dept Hort, Hangzhou, Zhejiang, Peoples R China; [Ni, Junbei; Bai, Songling; Gao, Ling; Qian, Minjie; Teng, Yuanwen] Minist Agr China, Key Lab Hort Plant Growth Dev & Qual Improvement, Hangzhou, Zhejiang, Peoples R China; [Ni, Junbei; Bai, Songling; Gao, Ling; Qian, Minjie; Teng, Yuanwen] Zhejiang Prov Key Lab Integrat Biol Hort Plants, Hangzhou, Zhejiang, Peoples R China; [Zhong, Linbing] Tonglu Extens Ctr Agr & Forestal Technol, Tonglu, Zhejiang, Peoples R China	Zhejiang University; Ministry of Agriculture & Rural Affairs	Teng, YW (corresponding author), Zhejiang Univ, Dept Hort, Hangzhou, Zhejiang, Peoples R China.; Teng, YW (corresponding author), Minist Agr China, Key Lab Hort Plant Growth Dev & Qual Improvement, Hangzhou, Zhejiang, Peoples R China.; Teng, YW (corresponding author), Zhejiang Prov Key Lab Integrat Biol Hort Plants, Hangzhou, Zhejiang, Peoples R China.	ywteng@zju.edu.cn	Ni, Junbei/GXN-0224-2022; Bai, Songling/X-9850-2019; Teng, Yuanwen/A-3515-2015	Bai, Songling/0000-0002-8103-3095; Teng, Yuanwen/0000-0001-8656-9035	National Natural Science Foundation of China [31471852, 31272141, 31501736]; Earmarked Fund for Modern Agro-industry Technology Research Systems [CARS-29]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Earmarked Fund for Modern Agro-industry Technology Research Systems	This work was supported by the National Natural Science Foundation of China (Grant Nos. 31471852, 31272141) (YT), the Earmarked Fund for Modern Agro-industry Technology Research Systems (CARS-29) (YT), and the National Natural Science Foundation of China (Grant No. 31501736) (SB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the National Natural Science Foundation of China (Grant Nos. 31471852, 31272141) (YT), the Earmarked Fund for Modern Agro-industry Technology Research Systems (CARS-29) (YT), and the National Natural Science Foundation of China (Grant No. 31501736) (SB).	Argyros RD, 2008, PLANT CELL, V20, P2102, DOI 10.1105/tpc.108.059584; Bai SL, 2014, PLANTA, V240, P1051, DOI 10.1007/s00425-014-2129-8; Bai SL, 2013, PLANT CELL PHYSIOL, V54, P1132, DOI 10.1093/pcp/pct067; Bailey TL, 1998, BIOINFORMATICS, V14, P48, DOI 10.1093/bioinformatics/14.1.48; Bhattacharya Amita, 2006, Indian Journal of Plant Physiology, V11, P287; CROSBY KE, 1981, PLANT PHYSIOL, V68, P985, DOI 10.1104/pp.68.5.985; D'Agostino IB, 2000, PLANT PHYSIOL, V124, P1706, DOI 10.1104/pp.124.4.1706; Das PK, 2012, MOL CELLS, V34, P93, DOI 10.1007/s10059-012-0114-2; DEIKMAN J, 1995, PLANT PHYSIOL, V108, P47, DOI 10.1104/pp.108.1.47; Dello Ioio R, 2008, SCIENCE, V322, P1380, DOI 10.1126/science.1164147; Deluc L, 2006, PLANT PHYSIOL, V140, P499, DOI 10.1104/pp.105.067231; Deng WK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111988; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; GILLASPY G, 1993, PLANT CELL, V5, P1439, DOI 10.1105/tpc.5.10.1439; Hu B, 2015, BIOINFORMATICS, V31, P1296, DOI 10.1093/bioinformatics/btu817; Hwang I, 2001, NATURE, V413, P383, DOI 10.1038/35096500; Ishida K, 2008, PLANT CELL PHYSIOL, V49, P47, DOI 10.1093/pcp/pcm165; Jaakola L, 2013, TRENDS PLANT SCI, V18, P477, DOI 10.1016/j.tplants.2013.06.003; Ji XH, 2015, PLANT CELL TISS ORG, V120, P325, DOI 10.1007/s11240-014-0609-y; Jin JP, 2014, NUCLEIC ACIDS RES, V42, pD1182, DOI 10.1093/nar/gkt1016; Kakimoto T, 2003, ANNU REV PLANT BIOL, V54, P605, DOI 10.1146/annurev.arplant.54.031902.134802; Kobayashi S, 2002, PLANTA, V215, P924, DOI 10.1007/s00425-002-0830-5; Koornneef M, 2002, CURR OPIN PLANT BIOL, V5, P33, DOI 10.1016/S1369-5266(01)00219-9; Liu GQ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-700; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mason MG, 2004, PLANT PHYSIOL, V135, P927, DOI 10.1104/pp.103.038109; Matsuo S, 2012, J EXP BOT, V63, P5569, DOI 10.1093/jxb/ers207; Mistry J, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt263; Mizuno T, 1997, DNA Res, V4, P161, DOI 10.1093/dnares/4.2.161; Mok DWS, 2001, ANNU REV PLANT PHYS, V52, P89, DOI 10.1146/annurev.arplant.52.1.89; MORI T, 1994, J SCI FOOD AGR, V65, P271, DOI 10.1002/jsfa.2740650303; Moubayidin L, 2010, CURR BIOL, V20, P1138, DOI 10.1016/j.cub.2010.05.035; Muller B, 2007, SCIENCE, V318, P68, DOI 10.1126/science.1145461; Ramirez-Carvajal GA, 2008, NEW PHYTOL, V177, P77, DOI 10.1111/j.1469-8137.2007.02240.x; Riou-Khamlichi C, 1999, SCIENCE, V283, P1541, DOI 10.1126/science.283.5407.1541; ROUSSELIN P, 1992, THEOR APPL GENET, V85, P213, DOI 10.1007/BF00222862; Schaller GE, 2007, PLANT PHYSIOL, V143, P555, DOI 10.1104/pp.106.093666; Suttle JC, 1998, PHYSIOL PLANTARUM, V103, P59, DOI 10.1034/j.1399-3054.1998.1030108.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Vandenbussche F, 2007, PLANT J, V49, P428, DOI 10.1111/j.1365-313X.2006.02973.x; Wu J, 2013, GENOME RES, V23, P396, DOI 10.1101/gr.144311.112; Zhang CX, 2006, ANN BOT-LONDON, V98, P537, DOI 10.1093/aob/mcl144; Zhang D, 2012, SCI HORTIC, V134, P53	44	16	17	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0171523	10.1371/journal.pone.0171523	http://dx.doi.org/10.1371/journal.pone.0171523			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207822	Green Submitted, Green Published, gold			2022-12-27	WOS:000394424500033
J	Smits, M; Keizer, E; Giesen, P; Deilkas, ECT; Hofoss, D; Bondevik, GT				Smits, Marleen; Keizer, Ellen; Giesen, Paul; Deilkas, Ellen Catharina Tveter; Hofoss, Dag; Bondevik, Gunnar Tschudi			The psychometric properties of the 'safety attitudes questionnaire' in out-of-hours primary care services in the Netherlands	PLOS ONE			English	Article							PATIENT SAFETY; AMBULATORY VERSION; HEALTH-CARE; CULTURE; CLIMATE; HOSPITALS; COUNTRIES	Background The Safety Attitudes Questionnaire (SAQ) is one of the most widely used instruments to assess safety culture among healthcare providers. The ambulatory version of the SAQ (SAQ-AV) can be used in the primary care setting. Our study objective was to examine the underlying factors and psychometric properties of the Dutch translation of the SAQ-AV in out-of-hours primary care services. Design Cross-sectional observational study using a web-survey. Setting Sixteen out-of-hours general practitioner cooperatives and two call centers in the Netherlands. Participants Primary healthcare providers in out-of-hours services. Main outcome measures Item-descriptive statistics, factor loadings, Cronbach's alpha scores, corrected item-total correlations, scale correlations. Results The questionnaire was answered by 853 (43.2%) healthcare professionals. In the factor analyses, 784 respondents were included; mainly general practitioners (N = 470) and triage nurses (N = 189). Items were included in the analyses based on question type and results from previous studies. Five factors were drawn with reliability scores between. 49 and .86 and a good construct validity. The five factors covered 27 of the 62 questionnaire items, with three to five items per factor. Conclusions The Dutch translation of the SAQ-AV, with five factors, seems to be a reliable tool for measuring patient safety culture and guide quality improvement interventions in out-of-hours primary care services. The Dutch factor structure differed from the original SAQ-AV and other translated versions. In future studies, the questionnaire should be validated further by examining if there is a relationship between the responses on the SAQ-AV, patient experiences, and the occurrence of adverse events.	[Smits, Marleen; Keizer, Ellen; Giesen, Paul] Radboud Univ Nijmegen, Radboud Sci Ctr Qual Healthcare IQ Healthcare, Radboud Inst Hlth Sci, Med Ctr, Nijmegen, Netherlands; [Deilkas, Ellen Catharina Tveter] Akershus Univ Hosp, Hlth Serv Res Unit, Lorenskog, Norway; [Deilkas, Ellen Catharina Tveter] Norwegian Directorate Hlth, Oslo, Norway; [Hofoss, Dag] Univ Oslo, Inst Hlth & Soc, Oslo, Norway; [Bondevik, Gunnar Tschudi] Univ Bergen, Dept Global Publ Hlth & Primary Care, Bergen, Norway; [Bondevik, Gunnar Tschudi] Natl Ctr Emergency Primary Hlth Care, Uni Res Hlth, Bergen, Norway	Radboud University Nijmegen; University of Oslo; University of Oslo; University of Bergen	Smits, M (corresponding author), Radboud Univ Nijmegen, Radboud Sci Ctr Qual Healthcare IQ Healthcare, Radboud Inst Hlth Sci, Med Ctr, Nijmegen, Netherlands.	marleen.smits@radboudumc.nl	Keizer, E/I-1902-2015; Giesen, P.H.J./L-4325-2015; Deilkås, Ellen T/E-5356-2015; Smits, Marleen/I-4555-2015; Bondevik, Gunnar Tschudi/AAS-1565-2020	Keizer, E/0000-0001-8244-741X; Smits, Marleen/0000-0001-9073-5382; 				Beaton DE, 2000, SPINE, V25, P3186, DOI 10.1097/00007632-200012150-00014; Bondevik GT, 2014, SCAND J PRIM HEALTH, V32, P132, DOI 10.3109/02813432.2014.962791; Bondevik GT, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-139; Colla JB, 2005, QUAL SAF HEALTH CARE, V14, P364, DOI 10.1136/qshc.2005.014217; de Vries EN, 2008, QUAL SAF HEALTH CARE, V17, P216, DOI 10.1136/qshc.2007.023622; Deilkas E, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-85; Deilkas ET, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-191; Deilkas ET, 2010, THESIS; DiCuccio MH, 2015, J PATIENT SAF, V11, P135, DOI 10.1097/PTS.0000000000000058; DZIUBAN CD, 1974, PSYCHOL BULL, V81, P358, DOI 10.1037/h0036316; Field A., 2013, DISCOVERING STAT USI; Flin R, 2006, QUAL SAF HEALTH CARE, V15, P109, DOI 10.1136/qshc.2005.014761; Gallego B, 2012, INT J QUAL HEALTH C, V24, P311, DOI 10.1093/intqhc/mzs028; Giesen P, 2007, QUAL SAF HEALTH CARE, V16, P181, DOI 10.1136/qshc.2006.018846; Giesen P, 2011, ANN INTERN MED, V155, P108, DOI 10.7326/0003-4819-155-2-201107190-00006; Huibers L, 2014, EUR J GEN PRACT, V20, P229, DOI 10.3109/13814788.2013.846320; Klemenc-Ketis Z, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-016-1972-7; Modak I, 2007, J GEN INTERN MED, V22, P1, DOI 10.1007/s11606-007-0114-7; Nunnally J., 1978, PSYCHOMETRIC THEORY; Pronovost PJ, 2006, HEALTH SERV RES, V41, P1599, DOI 10.1111/j.1475-6773.2006.00567.x; Sexton JB, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-44; Singer SJ, 2003, QUAL SAF HEALTH CARE, V12, P112, DOI 10.1136/qhc.12.2.112; Smits M, 2009, QUAL SAF HEALTH CARE, V18, P292, DOI 10.1136/qshc.2007.025965; Smits M, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-335; Sorra JS, 2004, AHRQ PUBLICATION, V04-0041; Thomas EJ, 2005, BMC HEALTH SERV RES, V5, DOI 10.1186/1472-6963-5-28; Wagner C, 2013, INT J QUAL HEALTH C, V25, P213, DOI 10.1093/intqhc/mzt024; Weingart Saul N, 2004, Jt Comm J Qual Saf, V30, P125; Zeller RA, 1980, MEASUREMENT SOCIAL S, P56	30	16	17	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0172390	10.1371/journal.pone.0172390	http://dx.doi.org/10.1371/journal.pone.0172390			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL2BG	28207909	gold, Green Published			2022-12-27	WOS:000394424500129
J	Stahel, P; Kim, JJ; Xiao, CT; Cant, JP				Stahel, Priska; Kim, Julie J.; Xiao, Changting; Cant, John P.			Of the milk sugars, galactose, but not prebiotic galacto-oligosaccharide, improves insulin sensitivity in male Sprague-Dawley rats	PLOS ONE			English	Article							HEPATIC GLYCOGEN-SYNTHESIS; RESISTANCE SYNDROME; GLUCOSE-METABOLISM; DAIRY CONSUMPTION; HEALTHY-SUBJECTS; GUT MICROFLORA; WHEY-PROTEIN; FRUCTOSE; ADULTS; RISK	Background Consumption of dairy products reduces risk of type 2 diabetes. Milk proteins and fats exhibit anti-diabetic properties but milk sugars have been studied little in this context. Galactose from milk lactose is readily converted to glycogen in the liver but its effects on insulin sensitivity have not been assessed. Prebiotic oligosaccharides from milk alter gut microbiota and can thereby influence host metabolism. Our objective was to assess the effect on insulin sensitivity of dietary galactose compared to glucose and fructose, and fermentable galactooligosaccharides compared to non-fermentable methylcellulose. Methods Diets containing 15% of dry matter from glucose, fructose, galactose, galacto-oligosaccharides, or methylcellulose were fed to 36 rats per diet for 9 weeks. Hyperinsulinemic-euglycemic clamps with [3-H-3]glucose infusion and a steady-state 2-[1-C-14]deoxyglucose bolus injection were used to assess insulin sensitivity and glucose uptake indices. Tissue was collected in fed, fasted and fasted, insulin-stimulated states. Results Galactose increased glucose infusion rate during the clamp by 53% and decreased endogenous glucose production by 57% compared to glucose and fructose. Fed-state hepatic glycogen content was greater with galactose compared to glucose and fructose, consistent with a potentiation of the insulin effect on glycogen synthase by dephosphorylation. Galactose decreased the fecal Firmicutes:Bacteroidetes ratio while galacto-oligosaccharides increased abundance of fecal Bifidobacterium spp. 481-fold compared to methylcellulose, and also increased abundance of Lactobacillus spp. and Bacteroidetes. Galacto-oligosaccharides did not affect glucose infusion rate or endogenous glucose production during basal or clamp periods compared to methylcellulose. Conclusions Galactose at 15% of daily intake improved hepatic insulin sensitivity in rats compared to glucose and fructose. Galactose caused an increase in fed-state hepatic glycogen content and a favourable shift in gut microbial populations. Intake of galacto-oligosaccharides improved the gut microbial profile but did not improve insulin sensitivity.	[Stahel, Priska; Kim, Julie J.; Cant, John P.] Univ Guelph, Dept Anim Biosci, Guelph, ON, Canada; [Xiao, Changting] Univ Toronto, Dept Physiol & Med, Toronto, ON, Canada	University of Guelph; University of Toronto	Cant, JP (corresponding author), Univ Guelph, Dept Anim Biosci, Guelph, ON, Canada.	jcant@uoguelph.ca	Cant, John/ABF-5323-2021	Cant, John/0000-0003-2021-1764; Xiao, Changting/0000-0002-4432-5689	Dairy Farmers of Ontario; Canadian Dairy Commission; OMAFRA HQP Program	Dairy Farmers of Ontario; Canadian Dairy Commission; OMAFRA HQP Program	This study was funded in part by Dairy Farmers of Ontario, which is a non-profit marketing group owned and operated by dairy farmers. The funding body was not involved in study design, data collection and analysis, decision to publish, or preparation of the manuscript. JPC received this funding [https://www.milk.org/corporate/main.asp]. PS was supported by scholarships from the Canadian Dairy Commission and OMAFRA HQP Program.	Aldredge DL, 2013, GLYCOBIOLOGY, V23, P664, DOI 10.1093/glycob/cwt007; AOAC International, 1996, OFFICIAL METHODS ANA, V16th; Barosa C, 2012, METABOLISM, V61, P250, DOI 10.1016/j.metabol.2011.06.022; Basciano Heather, 2005, Nutr Metab (Lond), V2, P5, DOI 10.1186/1743-7075-2-5; Bhatia S, 2015, MOL NUTR FOOD RES, V59, P566, DOI 10.1002/mnfr.201400639; Bowen J, 2005, INT J OBESITY, V29, P957, DOI 10.1038/sj.ijo.0802895; Bray GA, 2004, AM J CLIN NUTR, V79, P537; Cani PD, 2007, DIABETOLOGIA, V50, P2374, DOI 10.1007/s00125-007-0791-0; Cani PD, 2006, DIABETES, V55, P1484, DOI 10.2337/db05-1360; Cani PD, 2005, J ENDOCRINOL, V185, P457, DOI 10.1677/joe.1.06100; Marin-Manzano MC, 2013, J AGR FOOD CHEM, V61, P7560, DOI 10.1021/jf402218z; Choi HK, 2005, ARCH INTERN MED, V165, P997, DOI 10.1001/archinte.165.9.997; Corfield AP, 2000, GUT, V47, P589, DOI 10.1136/gut.47.4.589; De Angel RE, 2009, IN VIVO, V23, P527; Delmee E, 2006, LIFE SCI, V79, P1007, DOI 10.1016/j.lfs.2006.05.013; Elliott SS, 2002, AM J CLIN NUTR, V76, P911, DOI 10.1093/ajcn/76.5.911; ERCAN N, 1994, ARCH BIOCHEM BIOPHYS, V315, P35, DOI 10.1006/abbi.1994.1467; Geurts L, 2014, BENEF MICROBES, V5, P3, DOI 10.3920/BM2012.0065; Hernandez-Hernandez O, 2012, J NUTR, V142, P1232, DOI 10.3945/jn.111.155762; Jakubowicz D, 2014, DIABETOLOGIA, V57, P1807, DOI 10.1007/s00125-014-3305-x; Josse AR, 2011, J NUTR, V141, P1626, DOI 10.3945/jn.111.141028; Kasuga M, 2006, J CLIN INVEST, V116, P1756, DOI 10.1172/JCI29189; KLIEGMAN RM, 1988, PEDIATR RES, V24, P302, DOI 10.1203/00006450-198809000-00005; Knol J, 2005, J PEDIATR GASTR NUTR, V40, P36, DOI 10.1097/00005176-200501000-00007; Kowluru RA, 2001, DIABETES, V50, P1938, DOI 10.2337/diabetes.50.8.1938; Leforestier G, 2009, EUR J NUTR, V48, P457, DOI 10.1007/s00394-009-0036-8; Liu SM, 2006, DIABETES CARE, V29, P1579, DOI 10.2337/dc06-0256; Liu WJ, 2011, AM J PATHOL, V178, P1489, DOI 10.1016/j.ajpath.2010.12.052; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mennen LI, 2000, NUTR RES, V20, P335, DOI 10.1016/S0271-5317(00)00127-5; Mozaffarian D, 2010, ANN INTERN MED, V153, P790, DOI 10.7326/0003-4819-153-12-201012210-00005; NIEWOEHNER CB, 1992, AM J PHYSIOL, V263, pE42, DOI 10.1152/ajpendo.1992.263.1.E42; Nilsson M, 2007, AM J CLIN NUTR, V85, P996, DOI 10.1093/ajcn/85.4.996; Otsyula M, 2003, INT J TOXICOL, V22, P423, DOI 10.1080/10915810390251410; Pantophlet AJ, 2016, J DAIRY SCI, V99, P3072, DOI 10.3168/jds.2015-10277; Parnell JA, 2012, J NUTR, V107, P1; Paturi G, 2012, J FUNCT FOODS, V4, P520, DOI 10.1016/j.jff.2012.02.013; Pereira MA, 2002, JAMA-J AM MED ASSOC, V287, P2081, DOI 10.1001/jama.287.16.2081; Ramana BV, 2006, ACTA DIABETOL, V43, P135, DOI 10.1007/s00592-006-0229-z; THORBURN AW, 1989, AM J CLIN NUTR, V49, P1155, DOI 10.1093/ajcn/49.6.1155; Tuohy KM, 2005, CURR PHARM DESIGN, V11, P75, DOI 10.2174/1381612053382331; White PJ, 2016, MOL METAB, V5, P538, DOI 10.1016/j.molmet.2016.04.006; Xiao CT, 2005, J DAIRY SCI, V88, P2794, DOI 10.3168/jds.S0022-0302(05)72959-3; ZAVARONI I, 1980, METABOLISM, V29, P970, DOI 10.1016/0026-0495(80)90041-4; Zemel MB, 2004, OBES RES, V12, P582, DOI 10.1038/oby.2004.67	45	12	13	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0172260	10.1371/journal.pone.0172260	http://dx.doi.org/10.1371/journal.pone.0172260			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207812	Green Submitted, Green Published, gold			2022-12-27	WOS:000394424500108
J	Reimann, H; Fettrow, TD; Thompson, ED; Agada, P; McFadyen, BJ; Jeka, JJ				Reimann, Hendrik; Fettrow, Tyler D.; Thompson, Elizabeth D.; Agada, Peter; McFadyen, Bradford J.; Jeka, John J.			Complementary mechanisms for upright balance during walking	PLOS ONE			English	Article							GALVANIC VESTIBULAR STIMULATION; FALSE DISCOVERY RATE; CENTER-OF-MASS; LATERAL BALANCE; GAIT; STABILIZATION; POSTURE; PERTURBATIONS; RESPONSES; REFLEXES	Lateral balance is a critical factor in keeping the human body upright during walking. Two important mechanisms for balance control are the stepping strategy, in which the foot placement is changed in the direction of a sensed fall to modulate how the gravitational force acts on the body, and the lateral ankle strategy, in which the body mass is actively accelerated by an ankle torque. Currently, there is minimal evidence about how these two strategies complement one another to achieve upright balance during locomotion. We use Galvanic vestibular stimulation (GVS) to induce the sensation of a fall at heel-off during gait initiation. We found that young healthy adults respond to the illusory fall using both the lateral ankle strategy and the stepping strategy. The stance foot center of pressure (CoP) is shifted in the direction of the perceived fall by approximate to 2.5 mm, starting approximate to 247 ms after stimulus onset. The foot placement of the following step is shifted by approximate to 15 mm in the same direction. The temporal delay between these two mechanisms suggests that they independently contribute to upright balance during locomotion, potentially in a serially coordinated manner. Modeling results indicate that without the lateral ankle strategy, a much larger step width is required to maintain upright balance, suggesting that the small but early CoP shift induced by the lateral ankle strategy is critical for upright stability during locomotion. The relative importance of each mechanism and how neurological disorders may affect their implementation remain an open question.	[Reimann, Hendrik; Fettrow, Tyler D.; Thompson, Elizabeth D.; Agada, Peter; Jeka, John J.] Temple Univ, Dept Kinesiol, Philadelphia, PA 19122 USA; [Thompson, Elizabeth D.] Temple Univ, Dept Phys Therapy, Philadelphia, PA 19122 USA; [McFadyen, Bradford J.] Univ Laval, Ctr Interdisciplinary Res Rehabil & Social Integr, Quebec City, PQ, Canada; [McFadyen, Bradford J.] Univ Laval, Dept Rehabil, Quebec City, PQ, Canada	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Laval University; Laval University	Reimann, H (corresponding author), Temple Univ, Dept Kinesiol, Philadelphia, PA 19122 USA.	hendrikreimann@temple.edu	Reimann, Hendrik/ABA-8096-2021; Fettrow, Tyler/AAW-2562-2021	Fettrow, Tyler/0000-0003-3325-6726; McFadyen, Bradford/0000-0003-1992-4927; Reimann, Hendrik/0000-0002-3418-9345; Agada, Peter/0000-0001-9339-0738	German Research Foundation [RE3780/1-1]	German Research Foundation(German Research Foundation (DFG))	Hendrik Reimann received a Research Fellowship from the German Research Foundation (RE3780/1-1).	Benjamini Y, 2001, ANN STAT, V29, P1165; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bent LR, 2005, EXERC SPORT SCI REV, V33, P107, DOI 10.1097/00003677-200507000-00002; Bent LR, 2004, J NEUROPHYSIOL, V92, P1269, DOI 10.1152/jn.01260.2003; Bent LR, 2004, EXP BRAIN RES, V157, P407, DOI 10.1007/s00221-004-1854-9; Bent LR, 2000, NEUROSCI LETT, V279, P157, DOI 10.1016/S0304-3940(99)00989-1; Blouin JS, 2011, J APPL PHYSIOL, V111, P1484, DOI 10.1152/japplphysiol.00621.2011; Donelan JM, 2004, J BIOMECH, V37, P827, DOI 10.1016/j.jbiomech.2003.06.002; ELBLE RJ, 1991, J NEUROL, V238, P1, DOI 10.1007/BF00319700; FITZPATRICK R, 1994, J PHYSIOL-LONDON, V478, P173, DOI 10.1113/jphysiol.1994.sp020240; Fitzpatrick RC, 1999, J PHYSIOL-LONDON, V517, P931, DOI 10.1111/j.1469-7793.1999.0931s.x; FORSSBERG H, 1975, BRAIN RES, V85, P103, DOI 10.1016/0006-8993(75)91013-6; GEORGOPOULOS AP, 1989, SCIENCE, V245, P1209, DOI 10.1126/science.2675307; Hof AL, 2013, EXP BRAIN RES, V230, P301, DOI 10.1007/s00221-013-3655-5; Hof AL, 2010, J EXP BIOL, V213, P2655, DOI 10.1242/jeb.042572; Hof AL, 2005, J BIOMECH, V38, P1, DOI 10.1016/j.jbiomech.2004.03.025; Hof AL, 2008, HUM MOVEMENT SCI, V27, P112, DOI 10.1016/j.humov.2007.08.003; Hof AL, 2007, GAIT POSTURE, V25, P250, DOI 10.1016/j.gaitpost.2006.04.013; Horak F, 1996, HDB PHYSIOL 12, V12, P255; HORAK FB, 1986, J NEUROPHYSIOL, V55, P1369, DOI 10.1152/jn.1986.55.6.1369; Hsu WL, 2007, J NEUROPHYSIOL, V97, P3024, DOI 10.1152/jn.01142.2006; Kajita S, 2003, IEEE INT CONF ROBOT, P1620, DOI 10.1109/ROBOT.2003.1241826; Kuo AD, 1999, INT J ROBOT RES, V18, P917, DOI 10.1177/02783649922066655; Kuo AD, 2007, HUM MOVEMENT SCI, V26, P617, DOI 10.1016/j.humov.2007.04.003; Logan D, 2014, J NEUROPHYSIOL, V112, P165, DOI 10.1152/jn.01062.2012; Salzman B, 2010, AM FAM PHYSICIAN, V82, P61; Scholz JP, 2007, EXP BRAIN RES, V180, P163, DOI 10.1007/s00221-006-0848-1; TOWNSEND MA, 1985, J BIOMECH, V18, P21, DOI 10.1016/0021-9290(85)90042-9; van der Kooij H, 1999, BIOL CYBERN, V80, P299, DOI 10.1007/s004220050527; Verrel J, 2010, EXP BRAIN RES, V207, P13, DOI 10.1007/s00221-010-2424-y; Wang Y, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/281912; Winter D.A., 1995, GAIT POSTURE, V3, P193, DOI 10.1016/0966-6362(96)82849-9; WINTER DA, 1987, IEEE ENG MED BIOL, V6, P8, DOI 10.1109/MEMB.1987.5006430; Winter DA, 1990, BIOMECHANICAL WALKIN; ZAJAC FE, 1989, EXERCISE SPORT SCI R, V17, P187; Zehr EP, 1999, PROG NEUROBIOL, V58, P185, DOI 10.1016/S0301-0082(98)00081-1	36	33	34	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0172215	10.1371/journal.pone.0172215	http://dx.doi.org/10.1371/journal.pone.0172215			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5VB	28234936	Green Submitted, Green Published, gold			2022-12-27	WOS:000394688200052
J	Sam, K; Ctvrtecka, R; Miller, SE; Rosati, ME; Molem, K; Damas, K; Gewa, B; Novotny, V				Sam, Katerina; Ctvrtecka, Richard; Miller, Scott E.; Rosati, Margaret E.; Molem, Kenneth; Damas, Kipiro; Gewa, Bradley; Novotny, Vojtech			Low host specificity and abundance of frugivorous lepidoptera in the lowland rain forests of Papua New Guinea	PLOS ONE			English	Article							INSECT SEED PREDATORS; SHOREA DIPTEROCARPACEAE; SPECIES-DIVERSITY; DNA BARCODES; FRUIT; COMMUNITIES; EVENTS; PLANTS	We studied a community of frugivorous Lepidoptera in the lowland rainforest of Papua New Guinea. Rearing revealed 122 species represented by 1,720 individuals from 326 woody plant species. Only fruits from 52% ( 171) of the plant species sampled were attacked. On average, Lepidoptera were reared from 1 in 89 fruits and a kilogram of fruit was attacked by 1.01 individuals. Host specificity of Lepidoptera was notably low: 69% ( 33) of species attacked plants from > 1 family, 8% ( 4) fed on single family, 6% ( 3) on single genus and 17% ( 8) were monophagous. The average kilogram of fruits was infested by 0.81 individual from generalist species ( defined here as feeding on > 1 plant genus) and 0.07 individual from specialist species ( feeding on a single host or congeneric hosts). Lepidoptera preferred smaller fruits with both smaller mesocarp and seeds. Large- seeded fruits with thin mesocarp tended to host specialist species whereas those with thick, fleshy mesocarp were often infested with both specialist and generalist species. The very low incidence of seed damage suggests that predispersal seed predation by Lepidoptera does not play a major role in regulating plant populations via density- dependent mortality processes outlined by the Janzen-Connell hypothesis.	[Sam, Katerina; Ctvrtecka, Richard; Novotny, Vojtech] Univ South Bohemia, Fac Sci, Ceske Budejovice, Czech Republic; [Sam, Katerina; Novotny, Vojtech] Biol Ctr CAS, Inst Entomol, Ceske Budejovice, Czech Republic; [Miller, Scott E.; Rosati, Margaret E.] Smithsonian Inst, Natl Museum Nat Hist, Washington, DC 20560 USA; [Molem, Kenneth; Damas, Kipiro; Gewa, Bradley] New Guinea Binatang Res Ctr, Madang, Papua N Guinea; [Damas, Kipiro] Univ Papua New Guinea, Waigani, Natl Capital Di, Papua N Guinea; [Damas, Kipiro] Papua New Guinea Forest Res Inst, Lae, Morobe Province, Papua N Guinea	University of South Bohemia Ceske Budejovice; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; Smithsonian Institution; Smithsonian National Museum of Natural History; University of Papua New Guinea	Sam, K (corresponding author), Univ South Bohemia, Fac Sci, Ceske Budejovice, Czech Republic.; Sam, K (corresponding author), Biol Ctr CAS, Inst Entomol, Ceske Budejovice, Czech Republic.	katerina.sam.cz@gmail.com	Novotny, Vojtech/G-9434-2014; Ctvrtecka, Richard/P-7060-2017; Sam, Katerina/I-2209-2014	Novotny, Vojtech/0000-0001-7918-8023; Ctvrtecka, Richard/0000-0002-0599-6850; Sam, Katerina/0000-0002-3436-0579; Miller, Scott/0000-0002-4138-1378	Darwin Initiative for the survival of species [22-002]; Czech Science Foundation [GA13-09979S]; U.S. National Science Foundation [DEB 0841885]; Biodiversity Institute of Ontario/iBOL	Darwin Initiative for the survival of species; Czech Science Foundation(Grant Agency of the Czech Republic); U.S. National Science Foundation(National Science Foundation (NSF)); Biodiversity Institute of Ontario/iBOL	This work was supported by the Darwin Initiative for the survival of species 22-002, (http://www.darwininitiative.org.uk/); Czech Science Foundation grant GA13-09979S, (https://gacr.cz/en/); U.S. National Science Foundation grant DEB 0841885, (http://www.nsf.gov/); and the Biodiversity Institute of Ontario/iBOL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the staff at the New Guinea Binatang Research Center for field assistance, supported by the Darwin Initiative for the survival of species (22-002). David Adamski, Don Davis, Marianne Horak, Klaus Sattler, M. Alma Solis, John Tennent, Kevin Tuck, John Brown, Jeremy Holloway, and Jadranka Rota have assisted with identifications of the moths. Karolyn Darrow, Lauren Helgen, and many taxonomists have assisted in building the broader DNA barcode library used for Lepidoptera identifications. The Natural History Museum, London, has provided access to historical collections. Field work was supported by the Czech Science Foundation grant GA13-09979S and U.S. National Science Foundation grant DEB 0841885. DNA sequencing was provided by Paul Hebert at the Biodiversity Institute of Ontario as a part of the iBOL project. The Kenya project was organized by Robert Copeland and Robert Wharton at the International Centre of Insect Physiology and Ecology, in cooperation with the Kenya Wildlife Service and National Museums of Kenya.	Adamski D, 2006, P ENTOMOL SOC WASH, V108, P341; Adamski D, 2010, REV AFRICAN BLASTOBA; Anderson-Teixeira KJ, 2015, GLOBAL CHANGE BIOL, V21, P528, DOI 10.1111/gcb.12712; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Brown JW, 2014, AFR ENTOMOL, V22, P343, DOI 10.4001/003.022.0225; Brown J. W., 2008, FOOD PLANT DATABASE; Brown John W., 2006, American Entomologist, V52, P182; Butterill PT, 2015, ECOL ENTOMOL, V40, P409, DOI 10.1111/een.12198; Christensen C, 1972, MICROFLORA SEED DETE, P59; Clarke J.F.G., 1986, Smithsonian Contributions to Zoology, P1; Cock M. J. W., 2013, Journal of Research on the Lepidoptera, V46, P1; CONNELL J H, 1971, P298; Copeland Robert S., 2009, Journal of East African Natural History, V98, P11; Craft KJ, 2010, P NATL ACAD SCI USA, V107, P5041, DOI 10.1073/pnas.0913084107; Ctvrtecka R, 2016, AUSTRAL ECOL, V41, P228, DOI 10.1111/aec.12326; Ctvrtecka R, 2014, J TROP ECOL, V30, P521, DOI 10.1017/S0266467414000406; DREW RAI, 1987, AUST J ZOOL, V35, P283, DOI 10.1071/ZO9870283; EVANS D E, 1970, Journal of the Entomological Society of Southern Africa, V33, P349; Gilligan TM, 2011, ZOOTAXA, V3, P1; Gorham, 1991, AGR HDB, P319; GORHAM J.R, 1991, AGR HDB, V1, P1; Hebert PDN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068535; HERRERA CM, 1982, AM NAT, V120, P218, DOI 10.1086/283984; Hoddle MS, 2008, J ECON ENTOMOL, V101, P1310, DOI 10.1603/0022-0493(2008)101[1310:LAAPAH]2.0.CO;2; Holloway J.D., 2001, FAUNA MALESIANA HDB, V3; Horak M., 2006, OLETHREUTINE MOTHS A; Hosaka T, 2011, J TROP ECOL, V27, P651, DOI 10.1017/S0266467411000393; Hosaka T, 2009, J TROP ECOL, V25, P625, DOI 10.1017/S0266467409990265; JANZEN DH, 1970, AM NAT, V104, P501, DOI 10.1086/282687; JANZEN DH, 1980, J ECOL, V68, P929, DOI 10.2307/2259466; JANZEN DH, 1981, BIOTROPICA, V13, P271, DOI 10.2307/2387805; Kolb A, 2007, PERSPECT PLANT ECOL, V9, P79, DOI 10.1016/j.ppees.2007.09.001; Laidlaw M, 2007, AUSTRAL ECOL, V32, P10, DOI 10.1111/j.1442-9993.2007.01739.x; MANZUR MI, 1984, OIKOS, V43, P265, DOI 10.2307/3544142; Marler TE, 2010, AM J BOT, V97, P841, DOI 10.3732/ajb.0900251; MATTSON WJ, 1980, ANNU REV ECOL SYST, V11, P119, DOI 10.1146/annurev.es.11.110180.001003; McAlpine J.R., 1983, CLIMATE PAPUA NEW GU; McQuate GT, 2000, J ECON ENTOMOL, V93, P846, DOI 10.1603/0022-0493-93.3.846; Miller SE, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0339; Miller SE, 2014, P ENTOMOL SOC WASH, V116, P137, DOI 10.4289/0013-8797.116.1.137; Mirocha C J, 1974, Annu Rev Phytopathol, V12, P303, DOI 10.1146/annurev.py.12.090174.001511; Muli Benjamin Kimwele, 2009, International Journal of Biodiversity Science & Management, V5, P35, DOI 10.1080/17451590902771300; Nakagawa M, 2003, B ENTOMOL RES, V93, P455, DOI 10.1079/BER2003257; Neunzig H. H., 2003, PYRALOIDEA PYRALIDAE; Novotny V, 2005, P ROY SOC B-BIOL SCI, V272, P1083, DOI 10.1098/rspb.2004.3023; Novotny V, 2002, NATURE, V416, P841, DOI 10.1038/416841a; Novotny V, 2012, AM NAT, V179, P351, DOI 10.1086/664082; Novotny V, 2010, J ANIM ECOL, V79, P1193, DOI 10.1111/j.1365-2656.2010.01728.x; NYE I. W. B., 1961, EAST AFRICAN AFRIC AND FOREST JOUR, V27, P55; Paijmans K, 1976, NEW GUINEA VEGETATIO; Parsons M., 1999, BUTTERFLIES PAPUA NE, DOI DOI 10.7717/peerj.2653; PELLMYR O, 1994, NATURE, V372, P257, DOI 10.1038/372257a0; Powell Jerry A., 1999, Handbuch der Zoologie (Berlin), V4, P403; Ramirez N, 2010, PERSPECT PLANT ECOL, V12, P193, DOI 10.1016/j.ppees.2010.04.001; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Ratnasingham S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066213; Razowski J, 2012, ZOOTAXA, P1; Robinson G.S., 1993, TINEID GENERA AUSTR; Robinson Gaden S., 1994, P1; Robinson GS, 2009, BIOL DISTRIBUTION DI; Schindel D, 2011, ZOOKEYS, P152; Schindel David E., 2010, P109, DOI 10.1201/EBK1420095012-c10; SHORT HL, 1976, J WILDLIFE MANAGE, V40, P283, DOI 10.2307/3800427; Steffan-Dewenter I, 2001, P ROY SOC B-BIOL SCI, V268, P1685, DOI 10.1098/rspb.2001.1737; Terborgh J, 2012, AM NAT, V179, P303, DOI 10.1086/664183; Vincent JB, 2015, AUSTRAL ECOL, V40, P151, DOI 10.1111/aec.12187; Whalley PES, 1964, ACTA ZOOLOGICA CRACO, P561; Whitfeld TJS, 2012, ECOGRAPHY, V35, P821, DOI 10.1111/j.1600-0587.2011.07181.x; Wilson AJ, 2012, ARTHROPOD-PLANT INTE, V6, P635, DOI 10.1007/s11829-012-9205-4; Wilson John James, 2012, Methods Mol Biol, V858, P17, DOI 10.1007/978-1-61779-591-6_3	70	15	15	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2017	12	2							e0171843	10.1371/journal.pone.0171843	http://dx.doi.org/10.1371/journal.pone.0171843			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5SX	28231249	Green Published, gold			2022-12-27	WOS:000394682400022
J	Gu, JW; Skals, RK; Torp-Pedersen, C; Lundbye-Christensen, S; Jakobsen, CJ; Baech, J; Petersen, MS; Andreasen, JJ				Gu, Jiwei; Skals, Regitze Kuhr; Torp-Pedersen, Christian; Lundbye-Christensen, Soren; Jakobsen, Carl-Johan; Baech, John; Petersen, Mikkel Steen; Andreasen, Jan Jesper			Storage time of intraoperative transfused allogeneic red blood cells is not associated with new-onset postoperative atrial fibrillation in cardiac surgery	PLOS ONE			English	Article							LONG-TERM MORTALITY; BYPASS SURGERY; DURATION; METAANALYSIS; MANAGEMENT; MECHANISMS; OUTCOMES; RISK	Background Allogeneic red blood cell (RBC) transfusion has been associated with new-onset postoperative atrial fibrillation (POAF) following cardiac surgery. Prolonged storage time of RBC may increase the risk. The primary aim of the study was to evaluate whether the storage time of RBC is associated with development of POAF. Materials and methods Pre-,per-and postoperative data were retrieved from the Western Denmark Heart Registry and local blood banks regarding patients who underwent coronary artery bypass surgery, valve surgery or combined procedures in Aalborg or Aarhus University Hospital during 2010-2014. Multiple logistic regression was used to determine the risk of POAF according to transfusion of RBC on the day of surgery. Furthermore, we determined trend in storage time of RBC according to risk of POAF using restricted cubic splines. Patients with a history of preoperative atrial fibrillation, patients who received transfusions preoperative and patients who died at the day of surgery were among excluded patients. Results A total of 2,978 patients with a mean age of 66.4 years were included and 609 patients (21%) received RBC transfusion on the day of surgery. POAF developed in 752 patients (25%) and transfused patients were at an increased risk compared with non-transfused patients (adjusted Odds Ratios for patients receiving RBC: 1.37; 95% CI: 1.11-1.69,P-value = 0.004). However, RBC transfusion was not necessarily the cause of POAF and may only be a marker for development of POAF. There was no significant association between storage time of RBC and POAF. Conclusions In contrast to intraoperative allogeneic RBC transfusion in general, increased storage time of RBC is not associated with development of POAF in cardiac surgery.	[Gu, Jiwei] Ningxia Med Univ, Gen Hosp, Ctr Heart, Dept Cardiovasc Surg, Ningxia, Peoples R China; [Gu, Jiwei; Andreasen, Jan Jesper] Aalborg Univ, Dept Clin Med, Aalborg, Denmark; [Gu, Jiwei; Lundbye-Christensen, Soren; Andreasen, Jan Jesper] Aalborg Univ Hosp, Atrial Fibrillat Study Grp, Aalborg, Denmark; [Skals, Regitze Kuhr; Torp-Pedersen, Christian] Aalborg Univ Hosp, Unit Epidemiol & Biostat, Aalborg, Denmark; [Lundbye-Christensen, Soren] Aalborg Univ Hosp, Unit Clin Biostat, Aalborg, Denmark; [Jakobsen, Carl-Johan] Aarhus Univ Hosp, Dept Anaesthesiol, Aarhus, Denmark; [Baech, John] Aalborg Univ Hosp, Dept Clin Immunol, Aalborg, Denmark; [Petersen, Mikkel Steen] Aarhus Univ Hosp, Dept Clin Immunol, Aarhus, Denmark; [Gu, Jiwei; Andreasen, Jan Jesper] Aalborg Univ Hosp, Dept Cardiothorac Surg, Aalborg, Denmark	Ningxia Medical University; Aalborg University; Aalborg University; Aalborg University Hospital; Aalborg University; Aalborg University Hospital; Aalborg University; Aalborg University Hospital; Aarhus University; Aalborg University; Aalborg University Hospital; Aarhus University; Aalborg University; Aalborg University Hospital	Andreasen, JJ (corresponding author), Aalborg Univ, Dept Clin Med, Aalborg, Denmark.; Andreasen, JJ (corresponding author), Aalborg Univ Hosp, Atrial Fibrillat Study Grp, Aalborg, Denmark.; Andreasen, JJ (corresponding author), Aalborg Univ Hosp, Dept Cardiothorac Surg, Aalborg, Denmark.	jja@rn.dk		Lundbye-Christensen, Soren/0000-0002-9420-2783; Andreasen, Jan Jesper/0000-0002-2382-3734	Danish Council for Strategic Research [0603-00283B]; Region Nordjyllands Sundhedsvidenskabelige Forskningsfond	Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF)); Region Nordjyllands Sundhedsvidenskabelige Forskningsfond	This work was supported Danish Council for Strategic Research: 0603-00283B (URL: ufm.dk). There is no grant number Associated with the grant from Region Nordjyllands Sundhedsvidenskabelige Forskningsfond (URL: http://www.rn.dk/Sundhed/Til-sundhedsfaglige-og-samarbejdspartnere/Forskning/Forskningsfinansiering/Sundhedsvidenskabelige-Forskningsfond). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alameddine AK, 2014, J CARDIAC SURG, V29, P593, DOI 10.1111/jocs.12383; Almac E, 2007, BEST PRACT RES-CLIN, V21, P195, DOI 10.1016/j.bpa.2007.01.004; Anselmi A, 2009, ANN THORAC SURG, V88, P326, DOI 10.1016/j.athoracsur.2009.01.031; Aranki SF, 1996, CIRCULATION, V94, P390, DOI 10.1161/01.CIR.94.3.390; Dunning J, 2008, EUR J CARDIO-THORAC, V34, P73, DOI 10.1016/j.ejcts.2008.02.024; Dunning J, 2006, EUR J CARDIO-THORAC, V30, P852, DOI 10.1016/j.ejcts.2006.09.003; El-Chami MF, 2010, J AM COLL CARDIOL, V55, P1370, DOI 10.1016/j.jacc.2009.10.058; Ferraris VA, 2013, AM J SURG, V205, P457, DOI 10.1016/j.amjsurg.2012.07.042; Horwich P, 2013, J CARDIAC SURG, V28, P8, DOI 10.1111/jocs.12033; Jensen PN, 2012, PHARMACOEPIDEM DR S, V21, P141, DOI 10.1002/pds.2317; Kaw R, 2011, J THORAC CARDIOV SUR, V141, P1305, DOI 10.1016/j.jtcvs.2010.10.040; Kinnunen EM, 2015, J SURG RES, V197, P58, DOI 10.1016/j.jss.2015.03.025; Kirchhof P., 2016, EUR HEART J; Koch CG, 2006, ANN THORAC SURG, V81, P1650, DOI 10.1016/j.athoracsur.2005.12.037; Koch CG, 2006, ANN THORAC SURG, V82, P1747, DOI 10.1016/j.athoracsur.2006.05.045; Lau DH, 2016, EUR HEART J, V37, P1573, DOI 10.1093/eurheartj/ehv375; Lelubre C, 2013, CRIT CARE, V17, DOI 10.1186/cc12600; Mariscalco G, 2013, KARDIOL POL, V71, P1115, DOI 10.5603/KP.2013.0291; Munkholm SB, 2015, DAN MED J, V62; Ng MSY, 2015, INTENS CARE MED, V41, P2087, DOI 10.1007/s00134-015-4078-5; Peretto G, 2014, CARDIOL RES PRACT, V2014, DOI 10.1155/2014/615987; Perrier S, 2016, ANN THORAC SURG; Phan K, 2015, EUR J CARDIO-THORAC, V48, P817, DOI 10.1093/ejcts/ezu551; Schmidt Morten, 2010, Clin Epidemiol, V2, P137; Sood N, 2009, J CARDIOTHOR VASC AN, V23, P22, DOI 10.1053/j.jvca.2008.06.009; Steiner ME, 2015, NEW ENGL J MED, V372, P1419, DOI 10.1056/NEJMoa1414219; Villareal RP, 2004, J AM COLL CARDIOL, V43, P742, DOI 10.1016/j.jacc.2003.11.023; Vlahou A, 2016, THORAC CARDIOVASC SU; Yadava M, 2014, CARDIOL CLIN, V32, P627, DOI 10.1016/j.ccl.2014.07.002; Zakkar M, 2015, PHARMACOL THERAPEUT, V154, P13, DOI 10.1016/j.pharmthera.2015.06.009	30	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2017	12	2							e72726	10.1371/journal.pone.0172726	http://dx.doi.org/10.1371/journal.pone.0172726			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5SK	28225837	gold, Green Submitted, Green Published			2022-12-27	WOS:000394680900066
J	Hwang, S; Greenlee, JJ; Nicholson, EM				Hwang, Soyoun; Greenlee, Justin J.; Nicholson, Eric M.			Use of bovine recombinant prion protein and real-time quaking-induced conversion to detect cattle transmissible mink encephalopathy prions and discriminate classical and atypical L- and H-Type bovine spongiform encephalopathy	PLOS ONE			English	Article							CHRONIC WASTING DISEASE; CYCLIC AMPLIFICATION; CEREBROSPINAL-FLUID; SCRAPIE; IDENTIFICATION; GERMANY; VARIANT; FRANCE; BSE	Prions are amyloid-forming proteins that cause transmissible spongiform encephalopathies through a process involving conversion from the normal cellular prion protein to the pathogenic misfolded conformation (PrPSc). This conversion has been used for in vitro assays including serial protein misfolding amplification and real-time quaking induced conversion (RT-QuIC). RT-QuIC can be used for the detection of prions in a variety of biological tissues from humans and animals. Extensive work has been done to demonstrate that RT-QuIC is a rapid, specific, and highly sensitive prion detection assay. RT-QuIC uses recombinant prion protein to detect minute amounts of PrP Sc. RT-QuIC has been successfully used to detect PrP Sc from different prion diseases with a variety of substrates including hamster, human, sheep, bank vole, bovine and chimeric forms of prion protein. However, recombinant bovine prion protein has not been used to detect transmissible mink encephalopathy (TME) or to differentiate types of bovine spongiform encephalopathy (BSE) in samples from cattle. We evaluated whether PrP Sc from TME and BSE infected cattle can be detected with RT-QuIC using recombinant bovine prion proteins, and optimized the reaction conditions to specifically detect cattle TME and to discriminate between classical and atypical BSE by conversion efficiency. We also found that substrate composed of the disease associated E211K mutant protein can be effective for the detection of TME in cattle and that wild type prion protein appears to be a practical substrate to discriminate between the different types of BSEs.	[Hwang, Soyoun; Greenlee, Justin J.; Nicholson, Eric M.] ARS, Virus & Pr Res Unit, Natl Anim Dis Ctr, USDA, Ames, IA 50011 USA	United States Department of Agriculture (USDA)	Nicholson, EM (corresponding author), ARS, Virus & Pr Res Unit, Natl Anim Dis Ctr, USDA, Ames, IA 50011 USA.	Eric.Nicholson@ars.usda.gov	West Greenlee, Mary Heather/B-5342-2016; Greenlee, Justin/Y-5732-2019	West Greenlee, Mary Heather/0000-0002-6622-0044; Greenlee, Justin/0000-0003-2202-3054	United States Department of Agriculture, Agriculture Research Service	United States Department of Agriculture, Agriculture Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This research was funded in its entirety by congressionally appropriated funds to the United States Department of Agriculture, Agriculture Research Service. The funder of the work did not influence study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Atarashi R, 2011, PRION, V5, P150, DOI 10.4161/pri.5.3.16893; Atarashi R, 2011, NAT MED, V17, P175, DOI 10.1038/nm.2294; Baron T, 2007, EMERG INFECT DIS, V13, P1887, DOI 10.3201/eid1312.070635; Beringue V, 2006, PLOS PATHOG, V2, P956, DOI 10.1371/journal.ppat.0020112; Biacabe AG, 2004, EMBO REP, V5, P110, DOI 10.1038/sj.embor.7400054; Biacabe AG, 2008, EMERG INFECT DIS, V14, P298, DOI 10.3201/eid1402.071141; Buschmann A, 2006, VET MICROBIOL, V117, P103, DOI 10.1016/j.vetmic.2006.06.016; Buschmann A, 2004, J VIROL METHODS, V117, P27, DOI 10.1016/j.jviromet.2003.11.017; Casalone C, 2004, P NATL ACAD SCI USA, V101, P3065, DOI 10.1073/pnas.0305777101; Caughey B, 2001, ADV VIRUS RES, V56, P277, DOI 10.1016/S0065-3527(01)56031-5; Cheng KD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084812; Collinge J, 2001, ANNU REV NEUROSCI, V24, P519, DOI 10.1146/annurev.neuro.24.1.519; Comoy EE, 2013, PATHOGENS, V2, P520, DOI 10.3390/pathogens2030520; Corsaro A, 2011, INT J BIOCHEM CELL B, V43, DOI [10.1099/vir.0.033365-0, DOI 10.1099/VIR.0.033365-0]; CUTLIP RC, 1994, J INFECT DIS, V169, P814, DOI 10.1093/infdis/169.4.814; Dassanayake RP, 2016, J GEN VIROL, V97, P803, DOI 10.1099/jgv.0.000367; Davenport KA, 2016, J VIROL, V90, P10752, DOI 10.1128/JVI.01121-16; Elder AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080203; Greenlee JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038678; Greenlee MHW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119431; Haley NJ, 2014, J CLIN MICROBIOL, V52, P3237, DOI 10.1128/JCM.01258-14; Hamir AN, 2007, VET PATHOL, V44, P487, DOI 10.1354/vp.44-4-487; Hamir AN, 2006, VET PATHOL, V43, P118, DOI 10.1354/vp.43-2-118; Heaton MP, 2008, BMC VET RES, V4, DOI 10.1186/1746-6148-4-25; John TR, 2013, PRION, V7, P253, DOI 10.4161/pri.24430; MARSH RF, 1991, J GEN VIROL, V72, P589, DOI 10.1099/0022-1317-72-3-589; MARSH RF, 1969, J INFECT DIS, V120, P713, DOI 10.1093/infdis/120.6.713; Masujin K, 2016, J CLIN MICROBIOL, V54, P676, DOI 10.1128/JCM.02731-15; McGuire LI, 2012, ANN NEUROL, V72, P278, DOI 10.1002/ana.23589; Nicholson EM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002912; Orru CD, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8050140; Orru CD, 2015, PLOS PATHOG, V11, DOI [10.1371/journal.ppat.1004983, 10.1371/journal.ppat.1005117]; Orru CD, 2015, MBIO, V6, DOI 10.1128/mBio.02451-14; Orru CD, 2015, J CLIN MICROBIOL, V53, P1115, DOI 10.1128/JCM.02906-14; Orru CD, 2014, NEW ENGL J MED, V371, P519, DOI 10.1056/NEJMoa1315200; Orru CD, 2012, PRION, V6, P147, DOI 10.4161/pri.19430; Peden AH, 2012, J GEN VIROL, V93, P438, DOI 10.1099/vir.0.033365-0; Peretz D, 1997, J MOL BIOL, V273, P614, DOI 10.1006/jmbi.1997.1328; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Richt JA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000156; Saa Paula, 2004, V299, P53; Soto C, 2005, FEBS LETT, V579, P638, DOI 10.1016/j.febslet.2004.12.035; Soto C, 2002, TRENDS NEUROSCI, V25, P390, DOI 10.1016/S0166-2236(02)02195-1; Van Everbroeck B, 1999, J HISTOCHEM CYTOCHEM, V47, P1465; Vrentas CE, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-167; Vrentas CE, 2012, PROTEIN EXPRES PURIF, V82, P380, DOI 10.1016/j.pep.2012.02.008; Weissmann C, 1996, FEBS LETT, V389, P3, DOI 10.1016/0014-5793(96)00610-2; Wilham JM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001217; Zhang YB, 2000, J BIOL CHEM, V275, P33650, DOI 10.1074/jbc.C000483200	49	16	16	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2017	12	2							e0172391	10.1371/journal.pone.0172391	http://dx.doi.org/10.1371/journal.pone.0172391			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5SK	28225797	Green Published, Green Submitted, gold			2022-12-27	WOS:000394680900038
J	Lin, E; Tsai, SJ; Kuo, PH; Liu, YL; Yang, AC; Kao, CF; Yang, CH				Lin, Eugene; Tsai, Shih-Jen; Kuo, Po-Hsiu; Liu, Yu-Li; Yang, Albert C.; Kao, Chung-Feng; Yang, Cheng-Hung			The ADAMTS9 gene is associated with cognitive aging in the elderly in a Taiwanese population	PLOS ONE			English	Article							GCKR RS780094 POLYMORPHISM; ALZHEIMERS-DISEASE; INSULIN-RESISTANCE; METABOLIC PHENOTYPES; PRO12ALA POLYMORPHISM; OBESITY; RISK; VARIANT; EXPRESSION; LOCI	Evidence indicates that the pathophysiologic mechanisms associated with insulin resistance may contribute to cognitive aging and Alzheimer's diseases. In this study, we hypothesize that single nucleotide polymorphisms (SNPs) within insulin resistance-associated genes, such as the ADAM metallopeptidase with thrombospondin type 1 motif 9 (ADAMTS9), glucokinase regulator (GCKR), and peroxisome proliferator activated receptor gamma (PPARG) genes, may be linked with cognitive aging independently and/or through complex interactions in an older Taiwanese population. A total of 547 Taiwanese subjects aged over 60 years from the Taiwan Biobank were analyzed. Mini-Mental State Examinations (MMSE) were administered to all subjects, and MMSE scores were used to measure cognitive functions. Our data showed that four SNPs (rs73832338, rs9985304, rs4317088, and rs9831846) in the ADAMTS9 gene were significantly associated with cognitive aging among the subjects (P = 1.5 x 10(-6) similar to 0.0002). This association remained significant after performing Bonferroni correction. Additionally, we found that interactions between the ADAMTS9 rs9985304 and ADAMTS9 rs76346246 SNPs influenced cognitive aging (P < 0.001). However, variants in the GCKR and PPARG genes had no association with cognitive aging in our study. Our study indicates that the ADAMTS9 gene may contribute to susceptibility to cognitive aging independently as well as through SNP-SNP interactions.	[Lin, Eugene] China Med Univ, Inst Biomed Sci, Taichung, Taiwan; [Lin, Eugene] Vita Genom Inc, Taipei, Taiwan; [Lin, Eugene] TickleFish Syst Corp, Seattle, WA 98115 USA; [Tsai, Shih-Jen; Yang, Albert C.; Yang, Cheng-Hung] Taipei Vet Gen Hosp, Dept Psychiat, Taipei, Taiwan; [Tsai, Shih-Jen; Yang, Albert C.; Yang, Cheng-Hung] Natl Yang Ming Univ, Div Psychiat, Taipei, Taiwan; [Kuo, Po-Hsiu] Natl Taiwan Univ, Inst Epidemiol & Prevent Med, Dept Publ Hlth, Taipei, Taiwan; [Liu, Yu-Li] Natl Hlth Res Inst, Ctr Neuropsychiat Res, Zhunan Township, Miaoli County, Taiwan; [Kao, Chung-Feng] Natl Chung Hsing Univ, Dept Agron, Coll Agr & Nat Resources, Taichung, Taiwan	China Medical University Taiwan; Vita Genomics Incorporated; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Taiwan University; National Health Research Institutes - Taiwan; National Chung Hsing University	Lin, E (corresponding author), China Med Univ, Inst Biomed Sci, Taichung, Taiwan.; Lin, E (corresponding author), Vita Genom Inc, Taipei, Taiwan.; Lin, E (corresponding author), TickleFish Syst Corp, Seattle, WA 98115 USA.; Yang, CH (corresponding author), Taipei Vet Gen Hosp, Dept Psychiat, Taipei, Taiwan.; Yang, CH (corresponding author), Natl Yang Ming Univ, Div Psychiat, Taipei, Taiwan.	eugene.lin@vitagenomics.com; chyang@vghtpe.gov.tw	Tsai, Shih-Jen/AAK-7944-2020	Tsai, Shih-Jen/0000-0002-9987-022X; Kuo, Po-Hsiu/0000-0003-0365-3587	Ministry of Economic Affairs in Taiwan [S099000280249-154]; Taipei Veterans General Hospital, Taiwan [VGHUST103-G1-4-1, V105C-008, V105E17-002-MY2-1]; National Health Research Institutes, Taiwan [NP-105-SP-04]; Ministry of Science and Technology, Taiwan [MST 102-2314-B-002-117-MY3]	Ministry of Economic Affairs in Taiwan(Ministry of Economic Affairs, Taiwan); Taipei Veterans General Hospital, Taiwan(Taipei Veterans General Hospital); National Health Research Institutes, Taiwan(National Health Research Institutes - Taiwan); Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by the Ministry of Economic Affairs in Taiwan (http://www.moea.gov.tw/; SBIR Grant S099000280249-154; EL), by Taipei Veterans General Hospital, Taiwan (www.vghtpe.gov.tw/; Grants VGHUST103-G1-4-1, V105C-008, and V105E17-002-MY2-1; SJT), by the National Health Research Institutes, Taiwan (Grant NP-105-SP-04; YLL), and by the Ministry of Science and Technology, Taiwan (https://www.most.gov.tw/; Grant MST 102-2314-B-002-117-MY3; PHK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The commercial affiliation, Vita Genomics, Inc., provided support in the form of salary for author EL, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the author contributions section.	Bhatt SP, 2012, DIABETES TECHNOL THE, V14, P828, DOI 10.1089/dia.2011.0277; Black MH, 2015, J CLIN ENDOCR METAB, V100, P1187, DOI 10.1210/jc.2014-3246; Boesgaard TW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007236; CHEN C, 2016, HUM MOL GENET; Craft S, 2007, CURR ALZHEIMER RES, V4, P147, DOI 10.2174/156720507780362137; Deeb SS, 1998, NAT GENET, V20, P284, DOI 10.1038/3099; Demircan K, 2013, NEUROSCI LETT, V544, P25, DOI 10.1016/j.neulet.2013.02.064; Fan CT, 2008, PHARMACOGENOMICS, V9, P235, DOI 10.2217/14622416.9.2.235; Fritsche LG, 2013, NAT GENET, V45, P433, DOI 10.1038/ng.2578; Gao L, 2016, J ALZHEIMERS DIS, V50, P13, DOI 10.3233/JAD-150580; Hao K, 2015, MOL ASPECTS MED, V43-44, P66, DOI 10.1016/j.mam.2015.06.006; Hsiao TJ, DIABETES M IN PRRESS; Hsiao TJ, 2016, BIOCHEM GENET, V54, P830, DOI 10.1007/s10528-016-9760-y; Hsiao TJ, 2016, J GENET, V95, P595, DOI 10.1007/s12041-016-0671-9; Hsiao TJ, 2016, MOL CELL ENDOCRINOL, V433, P20, DOI 10.1016/j.mce.2016.05.020; Hsiao TJ, 2015, ENDOCRINE, V48, P786, DOI 10.1007/s12020-014-0407-7; Hsiao TJ, 2014, J INVEST MED, V62, P310, DOI 10.2310/JIM.0000000000000030; Hsiao TJ, 2014, GENE, V533, P32, DOI 10.1016/j.gene.2013.10.016; Hsiao TJ, 2013, GENES NUTR, V8, P137, DOI 10.1007/s12263-012-0304-8; Koster B, 2005, DIABETIC MED, V22, P1677, DOI 10.1111/j.1464-5491.2005.01700.x; Lane HY, 2012, MOL DIAGN THER, V16, P15, DOI 10.2165/11597270-000000000-00000; Lemarchant S, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-133; Lin E, 2016, DEMENT GERIATR COGN; Lin E, 2016, SCI REP-UK, V6, DOI 10.1038/srep36830; Liou YJ, 2012, PHARMACOGENOMICS J, V12, P54, DOI 10.1038/tpj.2010.74; Lou XY, 2007, AM J HUM GENET, V80, P1125, DOI 10.1086/518312; Neumann KF, 2008, CURR ALZHEIMER RES, V5, P438, DOI 10.2174/156720508785908919; Onuma H, 2010, J HUM GENET, V55, P600, DOI 10.1038/jhg.2010.75; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Reid MJ, 2009, NEUROSCI LETT, V452, P252, DOI 10.1016/j.neulet.2009.01.058; Roncero I, 2004, J NEUROCHEM, V88, P1203, DOI 10.1046/j.1471-4159.2003.02269.x; Roncero I, 2009, J NEUROENDOCRINOL, V21, P973, DOI 10.1111/j.1365-2826.2009.01919.x; Sanchez JLG, 2002, EUR J ENDOCRINOL, V147, P495, DOI 10.1530/eje.0.1470495; Sheehan B, 2012, THER ADV NEUROL DISO, V5, P349, DOI 10.1177/1756285612455733; Sparso T, 2008, DIABETOLOGIA, V51, P70, DOI 10.1007/s00125-007-0865-z; Trombetta M, 2013, ACTA DIABETOL, V50, P401, DOI 10.1007/s00592-012-0443-9; Vagelatos NT, 2013, EPIDEMIOL REV, V35, P152, DOI 10.1093/epirev/mxs012; VidalPuig AJ, 1997, J CLIN INVEST, V99, P2416, DOI 10.1172/JCI119424; Wang KC, 2012, NEUROEPIDEMIOLOGY, V38, P237, DOI 10.1159/000337428; Watson GS, 2006, J NEUROL SCI, V245, P21, DOI 10.1016/j.jns.2005.08.017; Watson GS, 2005, AM J GERIAT PSYCHIAT, V13, P950, DOI 10.1176/appi.ajgp.13.11.950; Watson GS, 2003, CNS DRUGS, V17, P27, DOI 10.2165/00023210-200317010-00003; West NA, 2010, NEUROBIOL AGING, V31, P741, DOI 10.1016/j.neurobiolaging.2008.06.005; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120	44	19	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2017	12	2							e0172440	10.1371/journal.pone.0172440	http://dx.doi.org/10.1371/journal.pone.0172440			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5SK	28225792	Green Published, gold, Green Submitted			2022-12-27	WOS:000394680900042
J	Rempel, RS; Hornseth, ML				Rempel, Robert S.; Hornseth, Megan L.			Binational climate change vulnerability assessment of migratory birds in the Great Lakes Basins: Tools and impediments	PLOS ONE			English	Article							HABITAT MODELS; CONSERVATION	Climate change is a global concern, requiring international strategies to reduce emissions, however, climate change vulnerability assessments are often local in scope with assessment areas restricted to jurisdictional boundaries. In our study we explored tools and impediments to understanding and responding to the effects of climate change on vulnerability of migratory birds from a binational perspective. We apply and assess the utility of a Climate Change Vulnerability Index on 3 focal species using distribution or niche modeling frameworks. We use the distributional forecasts to explore possible changes to jurisdictional conservation responsibilities resulting from shifting distributions for: eastern meadowlark (Sturnella magna), wood thrush (Hylocichla mustelina), and hooded warbler (Setophaga citrina). We found the Climate Change Vulnerability Index to be a well-organized approach to integrating numerous lines of evidence concerning effects of climate change, and provided transparency to the final assessment of vulnerability. Under this framework, we identified that eastern meadowlark and wood thrush are highly vulnerable to climate change, but hooded warbler is less vulnerable. Our study revealed impediments to assessing and modeling vulnerability to climate change from a binational perspective, including gaps in data or modeling for climate exposure parameters. We recommend increased cross-border collaboration to enhance the availability and resources needed to improve vulnerability assessments and development of conservation strategies. We did not find evidence to suggest major shifts in jurisdictional responsibility for the 3 focal species, but results do indicate increasing responsibility for these birds in the Canadian Provinces. These Provinces should consider conservation planning to help ensure a future supply of necessary habitat for these species.	[Rempel, Robert S.; Hornseth, Megan L.] Ontario Minist Nat Resources & Forestry, Ctr Northern Forest Ecosyst Res, Thunder Bay, ON, Canada; [Hornseth, Megan L.] Borealis Ecol, Orangeville, ON, Canada	Ministry of Natural Resources & Forestry	Rempel, RS (corresponding author), Ontario Minist Nat Resources & Forestry, Ctr Northern Forest Ecosyst Res, Thunder Bay, ON, Canada.	rob.rempel@ontario.ca	Rempel, Robert/C-2186-2013	Rempel, Robert/0000-0003-0369-8080; Hornseth, Megan/0000-0002-9596-0316	Ministry of Natural Resources and Forestry under the Canada-Ontario Agreement Respecting the Great Lakes Basin Ecosystem (COA) Climate Change/Biodiversity panel	Ministry of Natural Resources and Forestry under the Canada-Ontario Agreement Respecting the Great Lakes Basin Ecosystem (COA) Climate Change/Biodiversity panel	This study received funding through the Ministry of Natural Resources and Forestry under the Canada-Ontario Agreement Respecting the Great Lakes Basin Ecosystem (COA) Climate Change/Biodiversity panel.; We thank Adam Hogg of Ontario's Ministry of Natural Resources and Forestry (MNRF) for GIS preparation, Jenny Gleeson (MNRF) for project support, Rachel Gagnon for a review of the manuscript, and Jenny Rodgers (MNRF) for final editing. This study received funding through the Ministry of Natural Resources and Forestry under the Canada-Ontario Agreement Respecting the Great Lakes Basin Ecosystem (COA) Climate Change/Biodiversity panel.	Akcakaya H. R., 2005, APPL BIOMATHEMATICS; [Anonymous], 2007, CLIM CHANG ATL 147 B; [Anonymous], 2014, RES AN 1966 2012; Berger J, 2014, CONSERV BIOL, V28, P4, DOI 10.1111/cobi.12235; Berteaux D, 2014, CHANGEMENTS CLIMATIQ; Berteaux Dominique, 2010, Diversity, V2, P1181, DOI 10.3390/d2111181; Brown CJ, 2014, DIVERS DISTRIB, V20, P538, DOI 10.1111/ddi.12159; Butt N, 2016, BIOL CONSERV, V199, P10, DOI 10.1016/j.biocon.2016.04.020; Cadman MD, 2007, ATLAS BREEDING BIRDS; Chiver I., 2011, BIRDS N AM ONLINE; ClimateWizard, 2015, CLOM WIZ 2015; COSEWIC, 2011, COSEWIC ASS STAT REP; COSEWIC (Committee on the Status of Endangered Wildlife in Canada), 2012, COSEWIC ASS STAT REP; Dunn EH, 1999, CONSERV BIOL, V13, P1404, DOI 10.1046/j.1523-1739.1999.98400.x; Dybas CL, 2014, BIOSCIENCE, V64, P1067, DOI 10.1093/biosci/biu183; Evans M, 2011, BIRDS N AM ONLINE; Fussel HM, 2006, CLIMATIC CHANGE, V75, P301, DOI 10.1007/s10584-006-0329-3; Gaston KJ, 2003, STRUCTURE DYNAMICS G; Girvetz EH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008320; Hamon W.R., 1961, J HYDRAULICS DIVISIO, V87, P107, DOI DOI 10.1061/JYCEAJ.0000599; Henson B.L., 2005, GREAT LAKES CONSERVA; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Iverson LR, 2008, FOREST ECOL MANAG, V254, P390, DOI 10.1016/j.foreco.2007.07.023; Iverson LR, 2011, ECOSYSTEMS, V14, P1005, DOI 10.1007/s10021-011-9456-4; James R. D., 1987, BREEDING BIRDS ONTAR; Lankford AJ, 2014, WILDLIFE SOC B, V38, P386, DOI 10.1002/wsb.399; Matthews SN, 2011, ECOGRAPHY, V34, P933, DOI 10.1111/j.1600-0587.2011.06803.x; Matthews SN, 2011, FOREST ECOL MANAG, V262, P1460, DOI 10.1016/j.foreco.2011.06.047; McKenney D, 2013, FOREST CHRON, V89, P659, DOI 10.5558/tfc2013-118; Melles SJ, 2011, GLOBAL CHANGE BIOL, V17, P17, DOI 10.1111/j.1365-2486.2010.02214.x; NatureServ, 2015, CLIM CHANG VULN IND; NatureServe, 2015, CLIM CHANG VULN IND; Naujokaitis-Lewis IR, 2013, DIVERS DISTRIB, V19, P541, DOI 10.1111/ddi.12063; Roth RR, 1996, WOOD THRUSH HYLOCICH; Rowland EL, 2011, ENVIRON MANAGE, V47, P322, DOI 10.1007/s00267-010-9608-x; Small-Lorenz SL, 2013, NAT CLIM CHANGE, V3, P91, DOI 10.1038/nclimate1810; Stralberg D, 2015, ECOL APPL, V25, P52, DOI 10.1890/13-2289.1; Stralberg D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006825; Tischendorf L., 2003, HOODED WARBLER POPUL; Williams JW, 2007, FRONT ECOL ENVIRON, V5, P475, DOI 10.1890/070037; Williams SE, 2008, PLOS BIOL, V6, P2621, DOI 10.1371/journal.pbio.0060325; Young B.E., 2012, RAPID ASSESSMENT PLA; Young B.E., 2015, GUIDELINES USING NAT; Young BE, 2015, WILDLIFE SOC B, V39, P174, DOI 10.1002/wsb.478	44	1	1	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2017	12	2							e72668	10.1371/journal.pone.0172668	http://dx.doi.org/10.1371/journal.pone.0172668			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5SK	28225817	Green Published, Green Submitted, gold			2022-12-27	WOS:000394680900062
J	Karamintziou, SD; Custodio, AL; Piallat, B; Polosan, M; Chabardes, S; Stathis, PG; Tagaris, GA; Sakas, DE; Polychronaki, GE; Tsirogiannis, GL; David, O; Nikita, KS				Karamintziou, Sofia D.; Custodio, Ana Luisa; Piallat, Brigitte; Polosan, Mircea; Chabardes, Stephan; Stathis, Pantelis G.; Tagaris, George A.; Sakas, Damianos E.; Polychronaki, Georgia E.; Tsirogiannis, George L.; David, Olivier; Nikita, Konstantina S.			Algorithmic design of a noise-resistant and efficient closed-loop deep brain stimulation system: A computational approach	PLOS ONE			English	Article							HIGH-FREQUENCY STIMULATION; HUMAN SUBTHALAMIC NUCLEUS; PARKINSONS-DISEASE; NEURONAL OSCILLATIONS; GLOBUS-PALLIDUS; BASAL GANGLIA; NEUROMODULATION; PARAMETERS; SEVERITY; DEVICE	Advances in the field of closed-loop neuromodulation call for analysis and modeling approaches capable of confronting challenges related to the complex neuronal response to stimulation and the presence of strong internal and measurement noise in neural recordings. Here we elaborate on the algorithmic aspects of a noise-resistant closed-loop subthalamic nucleus deep brain stimulation system for advanced Parkinson's disease and treatment-refractory obsessive-compulsive disorder, ensuring remarkable performance in terms of both efficiency and selectivity of stimulation, as well as in terms of computational speed. First, we propose an efficient method drawn from dynamical systems theory, for the reliable assessment of significant nonlinear coupling between beta and high-frequency subthalamic neuronal activity, as a biomarker for feedback control. Further, we present a model-based strategy through which optimal parameters of stimulation for minimum energy desynchronizing control of neuronal activity are being identified. The strategy integrates stochastic modeling and derivative-free optimization of neural dynamics based on quadratic modeling. On the basis of numerical simulations, we demonstrate the potential of the presented modeling approach to identify, at a relatively low computational cost, stimulation settings potentially associated with a significantly higher degree of efficiency and selectivity compared with stimulation settings determined post-operatively. Our data reinforce the hypothesis that model-based control strategies are crucial for the design of novel stimulation protocols at the backstage of clinical applications.	[Karamintziou, Sofia D.; Polychronaki, Georgia E.; Tsirogiannis, George L.; Nikita, Konstantina S.] Natl Tech Univ Athens, Sch Elect & Comp Engn, Athens, Greece; [Karamintziou, Sofia D.] Univ Calif Riverside, Dept Mech Engn, Riverside, CA 92521 USA; [Custodio, Ana Luisa] FCT UNL CMA, Dept Math, Caparica, Portugal; [Piallat, Brigitte; Chabardes, Stephan; David, Olivier] Univ Grenoble Alpes, Grenoble Inst Neurosci, GIN, Grenoble, France; [Piallat, Brigitte; Chabardes, Stephan; David, Olivier] INSERM, U1216, Grenoble, France; [Polosan, Mircea] Univ Hosp Grenoble, Dept Psychiat, Grenoble, France; [Chabardes, Stephan] Univ Hosp Grenoble, Dept Neurosurg, Grenoble, France; [Stathis, Pantelis G.] Mediterraneo Hosp, Dept Neurol, Athens, Greece; [Tagaris, George A.] G Gennimatas Gen Hosp Athens, Dept Neurol, Athens, Greece; [Sakas, Damianos E.] Univ Athens, Sch Med, Evangelismos Gen Hosp, Dept Neurosurg, Athens, Greece	National Technical University of Athens; University of California System; University of California Riverside; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Athens Medical School; Evangelismos Hospital; National & Kapodistrian University of Athens	Karamintziou, SD; Nikita, KS (corresponding author), Natl Tech Univ Athens, Sch Elect & Comp Engn, Athens, Greece.; Karamintziou, SD (corresponding author), Univ Calif Riverside, Dept Mech Engn, Riverside, CA 92521 USA.	skaram@biosim.ntua.gr; knikita@ece.ntua.gr	Ferrat, Frederique/E-9929-2011; Custodio, Ana Luisa/A-1657-2012; David, Olivier/A-6068-2009; David, Olivier/S-9463-2019	Ferrat, Frederique/0000-0003-3629-1965; Custodio, Ana Luisa/0000-0003-0890-7398; David, Olivier/0000-0003-0776-0216; David, Olivier/0000-0003-0776-0216; Nikita, Konstantina/0000-0001-8255-4354	Faculdade de Ciencias e Tecnologia (FCT) [UID/MAT/00297/2013]; Agence Nationale pour la Recherche [ANR-14-CE13-0030-01 PHYSIOBS]	Faculdade de Ciencias e Tecnologia (FCT); Agence Nationale pour la Recherche(French National Research Agency (ANR))	Support for A. L. Custodio was provided by Faculdade de Ciencias e Tecnologia (FCT) under the project UID/MAT/00297/2013 (Centro de Matematica e Aplicacoes). Support for B. Piallat, M. Polosan, S. Chabardes and O. David was provided by Agence Nationale pour la Recherche, grant ANR-14-CE13-0030-01 PHYSIOBS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abouzeid A, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.011911; Adamchic I, 2014, MOVEMENT DISORD, V29, P1679, DOI 10.1002/mds.25923; Afshar P, 2013, FRONT NEURAL CIRCUIT, V6, DOI 10.3389/fncir.2012.00117; Audet C, 2003, SIAM J OPTIMIZ, V13, P889, DOI 10.1137/S1052623400378742; Bahramisharif A, 2015, BIOL PSYCHIAT; Bastin J, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.73; Bikson M, 2015, PROG BRAIN RES, V222, P1, DOI 10.1016/bs.pbr.2015.08.005; Bronstein JM, 2015, NEUROMODULATION, V18, P85, DOI 10.1111/ner.12227; Canavier CC, 2015, CURR OPIN NEUROBIOL, V31, P206, DOI 10.1016/j.conb.2014.12.003; Carron R, 2013, FRONT SYST NEUROSCI, V7, DOI 10.3389/fnsys.2013.00112; Connolly AT, 2015, J NEUROPHYSIOL, V114, P209, DOI 10.1152/jn.00840.2014; Connolly AT, 2015, J NEUROSCI, V35, P6231, DOI 10.1523/JNEUROSCI.4137-14.2015; Connolly AT, 2015, P 7 INT IEEE EMBS C; Custodio AL, 2008, IMA J NUMER ANAL, V28, P770, DOI 10.1093/imanum/drn045; Custodio AL, 2007, SIAM J OPTIMIZ, V18, P537, DOI 10.1137/050646706; Custodio AL, 2010, COMPUT OPTIM APPL, V46, P265, DOI 10.1007/s10589-009-9283-0; Davis C., 1954, AM J MATH, V76, P733, DOI [10.2307/2372648, DOI 10.2307/2372648]; de Hemptinne C, 2013, P NATL ACAD SCI USA, V110, P4780, DOI 10.1073/pnas.1214546110; Deuschl G, 2006, NEW ENGL J MED, V355, P896, DOI 10.1056/NEJMoa060281; Ermentrout GB, 2011, J COMPUT NEUROSCI, V31, P185, DOI 10.1007/s10827-010-0305-9; Feng XJ, 2007, J COMPUT NEUROSCI, V23, P265, DOI 10.1007/s10827-007-0031-0; Feng X, 2007, J NEURAL ENG, V4, pL14, DOI 10.1088/1741-2560/4/2/L03; Foutz TJ, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/6/066008; Galan RF, 2009, SPR SER COMPUT NEURO, V2, P65, DOI 10.1007/978-0-387-93797-7_4; Gottwald GA, 2005, PHYSICA D, V212, P100, DOI 10.1016/j.physd.2005.09.011; Gottwald GA, 2009, SIAM J APPL DYN SYST, V8, P129, DOI 10.1137/080718851; Grahn PJ, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00169; Grill WM, 2015, PROG BRAIN RES, V222, P147, DOI 10.1016/bs.pbr.2015.07.031; Grill WM, 2004, NEUROREPORT, V15, P1137, DOI 10.1097/00001756-200405190-00011; Grosenick L, 2015, NEURON, V86, P106, DOI 10.1016/j.neuron.2015.03.034; Hauptmann C, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/5/056008; Hurtado JM, 2004, J NEUROPHYSIOL, V91, P1883, DOI 10.1152/jn.00853.2003; Iolov A, 2014, J NEURAL ENG, V11, DOI 10.1088/1741-2560/11/4/046004; Karamintziou S D, 2015, P 7 INT IEEE EMBS C; Karamintziou SD, 2016, J NEURAL ENG, V13, DOI 10.1088/1741-2560/13/1/016013; Karamintziou SD, 2014, J NEURAL ENG, V11, DOI 10.1088/1741-2560/11/5/056019; Kiss IZ, 2007, SCIENCE, V316, P1886, DOI 10.1126/science.1140858; Koss AM, 2005, ANN NEUROL, V58, P168, DOI 10.1002/ana.20525; Kumar R, 1999, NEUROLOGY, V53, P871, DOI 10.1212/WNL.53.4.871; Kuncel AM, 2004, CLIN NEUROPHYSIOL, V115, P2431, DOI 10.1016/j.clinph.2004.05.031; Lai HY, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/3/036001; Lee HM, 2015, IEEE J SOLID-ST CIRC, V50, P360, DOI 10.1109/JSSC.2014.2355814; Lipsman N, 2013, LANCET, V381, P1361, DOI 10.1016/S0140-6736(12)62188-6; Little S, 2015, PROG BRAIN RES, V222, P163, DOI 10.1016/bs.pbr.2015.09.002; Little S, 2012, ANN NY ACAD SCI, V1265, P9, DOI 10.1111/j.1749-6632.2012.06650.x; Liu JB, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/4/045002; Lopez-Azcarate J, 2010, J NEUROSCI, V30, P6667, DOI 10.1523/JNEUROSCI.5459-09.2010; Lourens MAJ, 2015, J NEURAL ENG, V12, DOI 10.1088/1741-2560/12/2/026005; Mauroy A, 2014, SIAM J APPL DYN SYST, V13, P306, DOI 10.1137/130931151; Mayberg HS, 2005, NEURON, V45, P651, DOI 10.1016/j.neuron.2005.02.014; McConnell GC, 2012, J NEUROSCI, V32, P15657, DOI 10.1523/JNEUROSCI.2824-12.2012; Metman LV, 2015, MOVEMENT DISORD, V30, P1461, DOI 10.1002/mds.26338; Moran A, 2008, BRAIN, V131, P3395, DOI 10.1093/brain/awn270; Muller UJ, 2009, PHARMACOPSYCHIATRY, V42, P288, DOI 10.1055/s-0029-1233489; Nabi A, 2013, J COMPUT NEUROSCI, V34, P259, DOI 10.1007/s10827-012-0419-3; Nakao H., 2015, CONTEMP PHYS, P1, DOI DOI 10.1080/00107514.2015.1094987; NGUYEN TAD, 2014, BIOSCI BIOTECHNOL RE, V11, P11; Nuttin B, 1999, LANCET, V354, P1526, DOI 10.1016/S0140-6736(99)02376-4; Okun MS, 2012, LANCET NEUROL, V11, P140, DOI 10.1016/S1474-4422(11)70308-8; Piallat B, 2011, ANN NEUROL, V69, P793, DOI 10.1002/ana.22222; Reich MM, 2015, ANN CLIN TRANSL NEUR, V2, P427, DOI 10.1002/acn3.168; Rise M. T., 1998, Patent No. [US 5,716,377, 5716377]; ROSE RM, 1989, PROC R SOC SER B-BIO, V237, P267, DOI 10.1098/rspb.1989.0049; Rosenblum M, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.064101; Rosin B, 2011, NEURON, V72, P370, DOI 10.1016/j.neuron.2011.08.023; Rossberg AG, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.016216; Ryapolova-Webb E, 2014, J NEURAL ENG, V11, DOI 10.1088/1741-2560/11/1/016009; Sanders TH, 2013, J NEUROPHYSIOL, V110, P720, DOI 10.1152/jn.00672.2012; Santaniello S, 2015, P NATL ACAD SCI USA, V112, pE586, DOI 10.1073/pnas.1406549111; Sharott A, 2014, J NEUROSCI, V34, P6273, DOI 10.1523/JNEUROSCI.1803-13.2014; Sherwood WE, 2010, SIAM J APPL DYN SYST, V9, P659, DOI 10.1137/090773519; Stanslaski S, 2012, IEEE T NEUR SYS REH, V20, P410, DOI 10.1109/TNSRE.2012.2183617; Steigerwald F, 2008, J NEUROPHYSIOL, V100, P2515, DOI 10.1152/jn.90574.2008; Sun JF, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.046213; Syta A, 2015, MECCANICA, V50, P1961, DOI 10.1007/s11012-015-0140-1; Tass PA, 2003, NEUROPSYCHOPHARMACOL, V28, pS27, DOI 10.1038/sj.npp.1300144; Tort ABL, 2010, J NEUROPHYSIOL, V104, P1195, DOI 10.1152/jn.00106.2010; Tsang EW, 2012, NEUROLOGY, V78, P1930, DOI 10.1212/WNL.0b013e318259e183; Tukhlina N, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.011918; Vandewalle V, 1999, LANCET, V353, P724, DOI 10.1016/S0140-6736(98)05964-9; Volkmann J, 2006, MOVEMENT DISORD, V21, pS284, DOI 10.1002/mds.20961; Voloh B, DETAILED CHARACTERIZ; Voytek B, 2015, BIOL PSYCHIAT, V77, P1089, DOI 10.1016/j.biopsych.2015.04.016; Ward Matthew P, 2010, Front Neuroeng, V3, P7, DOI 10.3389/fneng.2010.00007; Welter ML, 2011, TRANSL PSYCHIAT, V1, DOI 10.1038/tp.2011.5; Widge AS, 2016, BIOL PSYCHIAT, V79, pE9, DOI 10.1016/j.biopsych.2015.06.005; Widge AS, 2014, J NEURAL ENG, V11, DOI 10.1088/1741-2560/11/2/024001; Williams A, 2010, LANCET NEUROL, V9, P581, DOI 10.1016/S1474-4422(10)70093-4; Williams ZM, 2015, NAT NEUROSCI, V18, P618, DOI 10.1038/nn.4007; Wilson D, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004673; Wilson D, 2014, J COMPUT NEUROSCI, V37, P243, DOI 10.1007/s10827-014-0499-3; Wong S, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/2/026006; Yang AI, 2014, J NEUROSCI, V34, P12816, DOI 10.1523/JNEUROSCI.1895-14.2014; Zhang K, 2010, J NEUROSURG, V112, P1271, DOI 10.3171/2009.10.JNS09371	94	5	5	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2017	12	2							e0171458	10.1371/journal.pone.0171458	http://dx.doi.org/10.1371/journal.pone.0171458			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5QV	28222198	Green Published, Green Submitted, gold			2022-12-27	WOS:000394676800012
J	Ramsey, D; Scoto, M; Mayhew, A; Main, M; Mazzone, ES; Montes, J; de Sanctis, R; Young, SD; Salazar, R; Glanzman, AM; Pasternak, A; Quigley, J; Mirek, E; Duong, T; Gee, R; Civitello, M; Tennekoon, G; Pane, M; Pera, MC; Bushby, K; Day, J; Darras, BT; De Vivo, D; Finkel, R; Mercuri, E; Muntoni, F				Ramsey, Danielle; Scoto, Mariacristina; Mayhew, Anna; Main, Marion; Mazzone, Elena S.; Montes, Jacqueline; de Sanctis, Roberto; Young, Sally Dunaway; Salazar, Rachel; Glanzman, Allan M.; Pasternak, Amy; Quigley, Janet; Mirek, Elizabeth; Duong, Tina; Gee, Richard; Civitello, Matthew; Tennekoon, Gihan; Pane, Marika; Pera, Maria Carmela; Bushby, Kate; Day, John; Darras, Basil T.; De Vivo, Darryl; Finkel, Richard; Mercuri, Eugenio; Muntoni, Francesco			Revised Hammersmith Scale for spinal muscular atrophy: A SMA specific clinical outcome assessment tool	PLOS ONE			English	Article							FUNCTIONAL MOTOR SCALE; ITEM RESPONSE THEORY; NATURAL-HISTORY; ISIS-SMNRX; CHILDREN; INSTRUMENTS	Recent translational research developments in Spinal Muscular Atrophy (SMA), outcome measure design and demands from regulatory authorities require that clinical outcome assessments are 'fit for purpose'. An international collaboration (SMA REACH UK, Italian SMA Network and PNCRN USA) undertook an iterative process to address discontinuity in the recorded performance of the Hammersmith Functional Motor Scale Expanded and developed a revised functional scale using Rasch analysis, traditional psychometric techniques and the application of clinical sensibility via expert panels. Specifically, we intended to develop a psychometrically and clinically robust functional clinician rated outcome measure to assess physical abilities in weak SMA type 2 through to strong ambulant SMA type 3 patients. The final scale, the Revised Hammersmith Scale (RHS) for SMA, consisting of 36 items and two timed tests, was piloted in 138 patients with type 2 and 3 SMA in an observational cross-sectional multi-centre study across the three national networks. Rasch analysis demonstrated very good fit of all 36 items to the construct of motor performance, good reliability with a high Person Separation Index PSI 0.98, logical and hierarchical scoring in 27/36 items and excellent targeting with minimal ceiling. The RHS differentiated between clinically different groups: SMA type, World Health Organisation (WHO) categories, ambulatory status, and SMA type combined with ambulatory status (all p < 0.001). Construct and concurrent validity was also confirmed with a strong significant positive correlation with the WHO motor milestones r(s) = 0.860, p < 0.001. We conclude that the RHS is a psychometrically sound and versatile clinical outcome assessment to test the broad range of physical abilities of patients with type 2 and 3 SMA. Further longitudinal testing of the scale with regards change in scores over 6 and 12 months are required prior to its adoption in clinical trials.	[Ramsey, Danielle; Scoto, Mariacristina; Main, Marion; Mercuri, Eugenio; Muntoni, Francesco] UCL Great Ormond St Inst Child Hlth, Dubowitz Neuromuscular Ctr, London, England; [Mayhew, Anna; Bushby, Kate] Newcastle Univ, John Walton Muscular Dystrophy Res Ctr, Inst Med Genet, Newcastle, NSW, Australia; [Mazzone, Elena S.; de Sanctis, Roberto; Pane, Marika; Pera, Maria Carmela; Mercuri, Eugenio] Univ Cattolica Sacro Cuore, Dept Child Neurol, Rome, Italy; [Montes, Jacqueline; Young, Sally Dunaway; Salazar, Rachel; De Vivo, Darryl] Columbia Univ, Dept Neurol, Med Ctr, New York, NY USA; [Glanzman, Allan M.] Childrens Hosp Philadelphia, Dept Phys Therapy, Philadelphia, PA 19104 USA; [Pasternak, Amy; Quigley, Janet; Mirek, Elizabeth; Darras, Basil T.] Boston Childrens Hosp, Dept Neurol, Boston, MA USA; [Pasternak, Amy; Quigley, Janet; Mirek, Elizabeth; Darras, Basil T.] Boston Childrens Hosp, Dept Phys Therapy, Boston, MA USA; [Pasternak, Amy; Quigley, Janet; Mirek, Elizabeth; Darras, Basil T.] Boston Childrens Hosp, Dept Occupat Therapy Serv, Boston, MA USA; [Duong, Tina; Day, John] Stanford Univ, Dept Neurol, Palo Alto, CA 94304 USA; [Gee, Richard] Stanford Univ, Lucille Packard Childrens Hosp, Palo Alto, CA 94304 USA; [Civitello, Matthew; Finkel, Richard] Univ Cent Florida, Coll Med, Nemours Childrens Hosp, Orlando, FL 32816 USA; [Tennekoon, Gihan] Univ Penn, Childrens Hosp Philadelphia, Dept Neurol, Philadelphia, PA 19104 USA; [Tennekoon, Gihan] Univ Penn, Pearlman Sch Med, Philadelphia, PA 19104 USA	University of London; University College London; University of Newcastle; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Columbia University; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Stanford University; Lucile Packard Children's Hospital (LPCH); Stanford University; State University System of Florida; University of Central Florida; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania	Muntoni, F (corresponding author), UCL Great Ormond St Inst Child Hlth, Dubowitz Neuromuscular Ctr, London, England.	f.muntoni@ucl.ac.uk	Mazzone, Elena/AAF-4444-2020; Mercuri, Eugenio/G-1351-2015; Pera, Maria Carmela/J-6068-2018	Dunaway Young, Sally/0000-0001-9322-0608; Darras, Basil/0000-0002-1536-8145; Duong, Tina/0000-0003-3177-4722; Day, John/0000-0002-0086-9529; Ramsey, Danielle/0000-0003-1275-2640; Pane, Marika/0000-0002-4851-6124; Mercuri, Eugenio/0000-0002-9851-5365; Pera, Maria Carmela/0000-0001-6777-1721	SMA Trust [13/LO/1748, 513395]; Muscular Dystrophy UK Centre [07DN02, 37787]; MRC Translational Research Centre [MR/K501074/1]; National Institute for Health Research Biomedical Research Centre at Great Ormond Street Hospital for Children NHS Foundation Trust and University College London [515048]; SMA Foundation, New York, NY; Telethon/Famiglie SMA [ReteSMA GSP 13002]; National Institute for Health Research [NF-SI-0515-10022] Funding Source: researchfish	SMA Trust; Muscular Dystrophy UK Centre(Muscular Dystrophy Association); MRC Translational Research Centre(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research Biomedical Research Centre at Great Ormond Street Hospital for Children NHS Foundation Trust and University College London; SMA Foundation, New York, NY; Telethon/Famiglie SMA(Fondazione Telethon); National Institute for Health Research(National Institute for Health Research (NIHR))	The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. This study was supported, in the UK, by The SMA Trust financial support to FM for the SMA REACH UK project and the positions of MS, DR, AM and FM, and included support for hosting the international workshops. Grant number 13/LO/1748; 513395; http://www.hra.nhs.uk/news/research-summaries/uk-national-platform-for-spinal-muscular-atrophy-sma/; http://www.smatrust.org/research-project/improving-standards-care-translational-research-sma/. The financial support of the Muscular Dystrophy UK Centre grant (07DN02; 37787 http://www.musculardystrophyuk.org/grants/clinical-trial-coordinators/); of the MRC Translational Research Centre to UCL and Newcastle (MR/K501074/1), and of the National Institute for Health Research Biomedical Research Centre (515048) at Great Ormond Street Hospital for Children NHS Foundation Trust and University College London is also gratefully acknowledged (http://www.gosh.nhs.uk/research-and-innovation/nihr-great-ormond-street-brc/about-brc). The SMA Foundation, New York, NY is also gratefully acknowledged for supporting the PNCR network in USA. https://www.urmc.rochester.edu/neurology/sma.aspx http://www.smafoundation.org/research/clinical/#Natural_History_Study. Telethon/Famiglie SMA are also gratefully acknowledged for supporting the Italian SMA Network (ReteSMA GSP 13002). http://www.famigliesma.org/index.php?option=com_content&view=article&id=430&Itemid=684.	[Anonymous], 2001, ICF INT CLASFUNCT; [Anonymous], 1997, RUMM 2030 COMP PROGR; Arnold WD, 2015, MUSCLE NERVE, V51, P157, DOI 10.1002/mus.24497; Cano SJ, 2014, MUSCLE NERVE, V49, P422, DOI 10.1002/mus.23937; Castro D, 2014, CURR TREAT OPTION NE, V16, DOI 10.1007/s11940-014-0316-3; Chang CH, 2005, EVAL HEALTH PROF, V28, P264, DOI 10.1177/0163278705278275; Chiriboga CA, 2016, NEUROLOGY, V86, P890, DOI 10.1212/WNL.0000000000002445; Darras BT, 2015, NEUROMUSCULAR DISORD, VSecond, P117; de Vet HW, 2011, MEASUREMENT MED PRAC; DUBOWITZ V, 1995, NEUROMUSCULAR DISORD, V5, P3, DOI 10.1016/0960-8966(94)00075-K; Dubowitz V, 1999, Eur J Paediatr Neurol, V3, P49; Farrar MA, 2013, J PEDIATR-US, V162, P155, DOI 10.1016/j.jpeds.2012.05.067; FDA, 2009, GUID IND PAT REP OUT; Feldkotter M, 2002, AM J HUM GENET, V70, P358, DOI 10.1086/338627; Finkel RS, 2014, NEUROMUSCULAR DISORD, V24, P920, DOI 10.1016/j.nmd.2014.06.416; Glanzman AM, 2010, NEUROMUSCULAR DISORD, V20, P155, DOI 10.1016/j.nmd.2009.11.014; Glanzman AM, 2011, J CHILD NEUROL, V26, P1499, DOI 10.1177/0883073811420294; Goemans NM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161955; Hays RD, 2000, MED CARE, V38, P28; Hobart JC, 2007, LANCET NEUROL, V6, P1094, DOI 10.1016/S1474-4422(07)70290-9; IBM Corp, 1989, IBM SPSS STAT VERS 2; Kaufmann P, 2012, NEUROLOGY, V79, P1889, DOI 10.1212/WNL.0b013e318271f7e4; Krosschell K, 2004, MODIFIED HAMMERSMITH; Krosschell KJ, 2006, NEUROMUSCULAR DISORD, V16, P417, DOI 10.1016/j.nmd.2006.03.015; Krosschell KJ, 2011, MUSCLE NERVE, V44, P246, DOI 10.1002/mus.22040; Main M, 2003, EUR J PAEDIATR NEURO, V7, P155, DOI 10.1016/S1090-3798(03)00060-6; Mazzone E, 2014, NEUROMUSCULAR DISORD, V24, P347, DOI 10.1016/j.nmd.2014.01.003; Mazzone E, 2015, MUSCLE NERVE; Mazzone ES, 2009, NEUROMUSCULAR DISORD, V19, P458, DOI 10.1016/j.nmd.2009.06.368; Mcdonald CM, 2013, MUSCLE NERVE, V48, P343, DOI 10.1002/mus.23902; Mensch SM, 2015, RES DEV DISABIL, V47, P185, DOI 10.1016/j.ridd.2015.09.002; Mercuri E, 2008, Neuromuscul Disord, V18, P894, DOI 10.1016/j.nmd.2008.07.003; Mercuri E, 2016, NEUROMUSCULAR DISORD, V26; Mercuri E, 2012, LANCET NEUROL, V11, P443, DOI 10.1016/S1474-4422(12)70061-3; Mokkink LB, 2010, QUAL LIFE RES, V19, P539, DOI 10.1007/s11136-010-9606-8; MUNSAT TL, 1992, NEUROMUSCULAR DISORD, V2, P423, DOI 10.1016/S0960-8966(06)80015-5; Munsat TL., 1991, NEUROMUSCUL DISORD, V1, P81, DOI [10.1016/0960-8966(91)90052-t, DOI 10.1016/0960-8966(91)90052-T]; O'Hagen JM, 2007, NEUROMUSCULAR DISORD, V17, P693, DOI 10.1016/j.nmd.2007.05.009; Pane M, 2008, NEUROMUSCULAR DISORD, V18, P536, DOI 10.1016/j.nmd.2008.05.004; Piepers S, 2008, J NEUROL, V255, P1400, DOI 10.1007/s00415-008-0929-0; Reeve BB, 2007, QUAL LIFE RES, V16, P175, DOI 10.1007/s11136-007-9190-8; Scott E, 2012, PHYSIOTHER RES INT, V17, DOI 10.1002/pri.520; Walton MK, 2015, VALUE HEALTH, V18, P741, DOI 10.1016/j.jval.2015.08.006; Wang CH, 2007, J CHILD NEUROL, V22, P1027, DOI 10.1177/0883073807305788; Wijnhoven Trudy M, 2004, Food Nutr Bull, V25, pS37	46	43	46	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2017	12	2							e0172346	10.1371/journal.pone.0172346	http://dx.doi.org/10.1371/journal.pone.0172346			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL5QV	28222119	Green Published, Green Submitted, gold			2022-12-27	WOS:000394676800052
J	Louis, J; Pedrotti, ML; Gazeau, F; Guieu, C				Louis, Justine; Pedrotti, Maria Luiza; Gazeau, Frederic; Guieu, Cecile			Experimental evidence of formation of Transparent Exopolymer Particles (TEP) and POC export provoked by dust addition under current and high pCO(2) conditions	PLOS ONE			English	Article							NORTHWESTERN MEDITERRANEAN SEA; DISSOLVED ORGANIC-MATTER; SAHARAN DUST; ATMOSPHERIC DEPOSITION; CARBON FLUXES; MINERAL DUST; TIME-SERIES; AGGREGATION; DYNAMICS; CO2	The evolution of organic carbon export to the deep ocean, under anthropogenic forcing such as ocean warming and acidification, needs to be investigated in order to evaluate potential positive or negative feedbacks on atmospheric CO2 concentrations, and therefore on climate. As such, modifications of aggregation processes driven by transparent exopolymer particles ( TEP) formation have the potential to affect carbon export. The objectives of this study were to experimentally assess the dynamics of organic matter, after the simulation of a Saharan dust deposition event, through the measurement over one week of TEP abundance and size, and to evaluate the effects of ocean acidification on TEP formation and carbon export following a dust deposition event. Three experiments were performed in the laboratory using 300 L tanks filled with filtered seawater collected in the Mediterranean Sea, during two 'no bloom' periods ( spring at the start of the stratification period and autumn at the end of this stratification period) and during the winter bloom period. For each experiment, one of the two tanks was acidified to reach pH conditions slightly below values projected for 2100 (similar to 7.6-7.8). In both tanks, a dust deposition event of 10 g m(-2) was simulated at the surface. Our results suggest that Saharan dust deposition triggered the abiotic formation of TEP, leading to the formation of organic-mineral aggregates. The amount of particulate organic carbon ( POC) exported was proportional to the flux of lithogenic particles to the sediment traps. Depending on the season, the POC flux following artificial dust deposition ranged between 38 and 90 mg m(-2) over six experimental days. Such variability is likely linked to the seasonal differences in the quality and quantity of TEP-precursors initially present in seawater. Finally, these export fluxes were not significantly different at the completion of the three experiments between the two pH conditions.	[Louis, Justine; Pedrotti, Maria Luiza; Gazeau, Frederic; Guieu, Cecile] UPMC Univ Paris 06, Sorbonne Univ, INSU CNRS, Lab Oceanog Villefranche, Villefranche Sur Mer, France; [Louis, Justine] Univ Rennes 1, IUT St Brieuc, Dept Genie Biol, St Brieuc, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Sorbonne Universite; Universite de Rennes	Louis, J (corresponding author), UPMC Univ Paris 06, Sorbonne Univ, INSU CNRS, Lab Oceanog Villefranche, Villefranche Sur Mer, France.; Louis, J (corresponding author), Univ Rennes 1, IUT St Brieuc, Dept Genie Biol, St Brieuc, France.	justine.louis35@gmail.com	Gazeau, Frédéric/G-3050-2011; Guieu, Cecile/AAU-6883-2021	Gazeau, Frédéric/0000-0001-8807-4597; Guieu, Cecile/0000-0001-6373-8326; Louis, Justine/0000-0002-8589-5768				ALLDREDGE AL, 1993, DEEP-SEA RES PT I, V40, P1131, DOI 10.1016/0967-0637(93)90129-Q; Armstrong RA, 2001, DEEP-SEA RES PT II, V49, P219, DOI 10.1016/S0967-0645(01)00101-1; Avril B, 2002, DEEP-SEA RES PT II, V49, P2163, DOI 10.1016/S0967-0645(02)00033-4; Beauvais S, 2003, MAR ECOL PROG SER, V262, P97, DOI 10.3354/meps262097; BENNER R, 1992, SCIENCE, V255, P1561, DOI 10.1126/science.255.5051.1561; BERGAMETTI G, 1989, J GEOPHYS RES-ATMOS, V94, P14855, DOI 10.1029/JD094iD12p14855; BERGAMETTI G, 1989, NATO ADV SCI I C-MAT, V282, P227; Bhaskar PV, 2005, CURR SCI INDIA, V88, P45; Bonnet S, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2005JC003213; Bressac M, 2014, BIOGEOSCIENCES, V11, P1007, DOI 10.5194/bg-11-1007-2014; Bressac M, 2013, GLOBAL BIOGEOCHEM CY, V27, P859, DOI 10.1002/gbc.20076; Chin WC, 1998, NATURE, V391, P568, DOI 10.1038/35345; D'Ortenzio F, 2009, BIOGEOSCIENCES, V6, P139, DOI 10.5194/bg-6-139-2009; Desboeufs K, 2014, BIOGEOSCIENCES, V11, P5581, DOI 10.5194/bg-11-5581-2014; Dickson A.G., 2007, GUIDE BEST PRACTICES, V3; Dunne JP, 2007, GLOBAL BIOGEOCHEM CY, P21, DOI DOI 10.1029/2006GB002907.GB4006; Engel A, 2004, NATURE, V428, P929, DOI 10.1038/nature02453; Gasol JM, 2000, SCI MAR, V64, P197, DOI 10.3989/scimar.2000.64n2197; Guerzoni S, 1999, PROG OCEANOGR, V44, P147, DOI 10.1016/S0079-6611(99)00024-5; Guieu C, 2014, BIOGEOSCIENCES, V11, P425, DOI 10.5194/bg-11-425-2014; Guieu C, 2010, BIOGEOSCIENCES, V7, P2765, DOI 10.5194/bg-7-2765-2010; Guieu C, 2015, ENCY MAR GEOSCI, V611, P94; Journel B, 1998, THESIS; KEPKAY PE, 1994, MAR ECOL PROG SER, V109, P293, DOI 10.3354/meps109293; Kovac N, 2002, MAR CHEM, V78, P205, DOI 10.1016/S0304-4203(02)00033-6; Lavigne H, 2016, SEACARB SEAWATER CAR; Lee C, 2009, DEEP-SEA RES PT II, V56, P1420, DOI 10.1016/j.dsr2.2008.11.029; Liu Q, 2000, INT J MINER PROCESS, V60, P229, DOI 10.1016/S0301-7516(00)00018-1; LOGAN BE, 1995, DEEP-SEA RES PT II, V42, P203, DOI 10.1016/0967-0645(95)00012-F; LOYEPILOT MD, 1986, NATURE, V321, P427, DOI 10.1038/321427a0; LoyePilot MD, 1996, ENVIR SCI TECH LIB, V11, P191; Mari X, 2001, LIMNOL OCEANOGR, V46, P1831, DOI 10.4319/lo.2001.46.7.1831; Marty JC, 2002, DEEP-SEA RES PT II, V49, P1965, DOI 10.1016/S0967-0645(02)00022-X; MCCAVE IN, 1984, DEEP-SEA RES, V31, P329, DOI 10.1016/0198-0149(84)90088-8; Miquel JC, 2011, PROG OCEANOGR, V91, P461, DOI 10.1016/j.pocean.2011.07.018; Moulin C, 1997, J GEOPHYS RES-ATMOS, V102, P16947, DOI 10.1029/96JD02620; OBERNOSTERER I, 1995, MAR ECOL PROG SER, V116, P247, DOI 10.3354/meps116247; Pachauri R.K., 2015, IPCC 2014 CLIMATE CH, P151; Passow U, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2005GB002579; Passow U, 2002, PROG OCEANOGR, V55, P287, DOI 10.1016/S0079-6611(02)00138-6; Passow U, 2004, GEOCHEM GEOPHY GEOSY, V5, DOI 10.1029/2003GC000670; PASSOW U, 1994, MAR ECOL PROG SER, V113, P185, DOI 10.3354/meps113185; Passow U, 2000, MAR ECOL PROG SER, V192, P1, DOI 10.3354/meps192001; Passow U, 2014, LIMNOL OCEANOGR, V59, P532, DOI 10.4319/lo.2014.59.2.0532; Passow U, 2012, MAR ECOL PROG SER, V470, P249, DOI 10.3354/meps09985; Passow U, 2012, MAR CHEM, V128, P72, DOI 10.1016/j.marchem.2011.10.004; Pedrotti ML, 2010, MAR ECOL PROG SER, V419, P57, DOI 10.3354/meps08840; Pedrotti ML, 2012, J PLANKTON RES, V34, P388, DOI 10.1093/plankt/fbs012; Rochelle-Newall EJ, 2010, J PLANKTON RES, V32, P1433, DOI 10.1093/plankt/fbq060; Salter I, 2010, LIMNOL OCEANOGR, V55, P2207, DOI 10.4319/lo.2010.55.5.2207; Sinking G., 2009, BIOGEOSCIENCES, V6, P85; Ternon E, 2010, BIOGEOSCIENCES, V7, P809, DOI 10.5194/bg-7-809-2010; Touratier F, 2011, DEEP-SEA RES PT I, V58, P1, DOI 10.1016/j.dsr.2010.10.002; Verdugo P, 2004, MAR CHEM, V92, P67, DOI 10.1016/j.marchem.2004.06.017; Vincent J, 2016, ATMOS CHEM PHYS, V16, P8749, DOI 10.5194/acp-16-8749-2016	55	12	12	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2017	12	2							e0171980	10.1371/journal.pone.0171980	http://dx.doi.org/10.1371/journal.pone.0171980			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BI	28212418	Green Published, Green Submitted, gold			2022-12-27	WOS:000394424700014
J	Li, T; Li, W; Yang, YH; Zhang, WS				Li, Tao; Li, Wu; Yang, Yehui; Zhang, Wensheng			Classification of brain disease in magnetic resonance images using two-stage local feature fusion	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; PRODROMAL ALZHEIMERS-DISEASE; CORTICAL THICKNESS; MRI; DIAGNOSIS; PATTERN; SCALE; PROGRESSION; BIOMARKER; ATROPHY	Background Many classification methods have been proposed based on magnetic resonance images. Most methods rely on measures such as volume, the cerebral cortical thickness and grey matter density. These measures are susceptible to the performance of registration and limited in representation of anatomical structure. This paper proposes a two-stage local feature fusion method, in which deformable registration is not desired and anatomical information is represented from moderate scale. Methods Keypoints are firstly extracted from scale-space to represent anatomical structure. Then, two kinds of local features are calculated around the keypoints, one for correspondence and the other for representation. Scores are assigned for keypoints to quantify their effect in classification. The sum of scores for all effective keypoints is used to determine which group the test subject belongs to. Results We apply this method to magnetic resonance images of Alzheimer's disease and Parkinson's disease. The advantage of local feature in correspondence and representation contributes to the final classification. With the help of local feature (Scale Invariant Feature Transform, SIFT) in correspondence, the performance becomes better. Local feature (Histogram of Oriented Gradient, HOG) extracted from 16x16 cell block obtains better results compared with 4x4 and 8x8 cell block. Discussion This paper presents a method which combines the effect of SIFT descriptor in correspondence and the representation ability of HOG descriptor in anatomical structure. This method has the potential in distinguishing patients with brain disease from controls.	[Li, Tao; Li, Wu; Yang, Yehui; Zhang, Wensheng] Chinese Acad Sci, Inst Automat, Beijing, Peoples R China; [Li, Tao; Li, Wu; Yang, Yehui; Zhang, Wensheng] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Automation, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Li, W; Zhang, WS (corresponding author), Chinese Acad Sci, Inst Automat, Beijing, Peoples R China.; Li, W; Zhang, WS (corresponding author), Univ Chinese Acad Sci, Beijing, Peoples R China.	wu.li@ia.ac.cn; wensheng.zhang@ia.ac.cn	Lang, Ming/HIK-0758-2022; yang, yang/HGT-7999-2022; Yang, Ye/GZM-4812-2022; Li, Wu/AHA-4320-2022		National Natural Science Foundation of China [61432008, 81171314, 61532006, 61305018]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This paper is supported by the National Natural Science Foundation of China grant 61432008, 81171314,61532006, 61305018 (http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulkadir A, 2011, NEUROIMAGE, V58, P785, DOI 10.1016/j.neuroimage.2011.06.029; Ahmed OB, 2015, MULTIMED TOOLS APPL, V74, P1249, DOI DOI 10.1007/s11042-014-2123-y; Arimura H, 2006, INT J COMPUT ASS RAD, V1, P19; Bay H, 2006, LECT NOTES COMPUT SC, V3951, P404, DOI 10.1007/11744023_32; Behera NKS, 2015, SMART INNOV SYST TEC, V33, DOI 10.1007/978-81-322-2202-6_27; BRUN A, 1981, HISTOPATHOLOGY, V5, P549, DOI 10.1111/j.1365-2559.1981.tb01818.x; Burns A, 2009, BMJ-BRIT MED J, V338, pb157; Chan D, 2001, ANN NEUROL, V49, P433, DOI 10.1002/ana.92.abs; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chawla NV, 2002, J ARTIF INTELL RES, V16, P321, DOI 10.1613/jair.953; Chen Y, 2014, J NEUROSCI METH, V221, P22, DOI 10.1016/j.jneumeth.2013.09.001; Costafreda SG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006353; Cui Y, 2012, NEUROIMAGE, V59, P1209, DOI 10.1016/j.neuroimage.2011.08.013; Daliri MR, 2012, J MED SYST, V36, P995, DOI 10.1007/s10916-011-9738-6; Davatzikos C, 2008, NEUROBIOL AGING, V29, P514, DOI 10.1016/j.neurobiolaging.2006.11.010; de Jong LW, 2008, BRAIN, V131, P3277, DOI 10.1093/brain/awn278; Oliveira PPD, 2010, J ALZHEIMERS DIS, V19, P1263, DOI 10.3233/JAD-2010-1322; Desikan RS, 2009, BRAIN, V132, P2048, DOI 10.1093/brain/awp123; Donoho DL, 2010, P IEEE, V98, P913, DOI 10.1109/JPROC.2010.2045630; Duchesne S, 2008, IEEE T MED IMAGING, V27, P509, DOI 10.1109/TMI.2007.908685; Duncan GW, 2013, MOVEMENT DISORD, V28, P425, DOI 10.1002/mds.25352; Ecker C, 2010, NEUROIMAGE, V49, P44, DOI 10.1016/j.neuroimage.2009.08.024; ESCOUFIER Y, 1973, BIOMETRICS, V29, P751, DOI 10.2307/2529140; Fan Y, 2008, NEUROIMAGE, V41, P277, DOI 10.1016/j.neuroimage.2008.02.043; Farhan S, 2014, COMPUT MATH METHOD M, V2014, DOI 10.1155/2014/862307; Gerardin E, 2009, NEUROIMAGE, V47, P1476, DOI 10.1016/j.neuroimage.2009.05.036; Gong QY, 2011, NEUROIMAGE, V55, P1497, DOI 10.1016/j.neuroimage.2010.11.079; Hinrichs C, 2011, NEUROIMAGE, V55, P574, DOI 10.1016/j.neuroimage.2010.10.081; Jung WB, 2015, PSYCHIAT INVEST, V12, P92, DOI 10.4306/pi.2015.12.1.92; Kloppel S, 2008, BRAIN, V131, P681, DOI 10.1093/brain/awm319; Lao ZQ, 2004, NEUROIMAGE, V21, P46, DOI 10.1016/j.neuroimage.2003.09.027; Lerch JP, 2008, NEUROBIOL AGING, V29, P23, DOI 10.1016/j.neurobiolaging.2006.09.013; Liu F, 2013, LECT NOTES COMPUT SC, V8150, P311, DOI 10.1007/978-3-642-40763-5_39; Liu F, 2014, NEUROIMAGE, V84, P466, DOI 10.1016/j.neuroimage.2013.09.015; Liu L, 2016, INF SCI, V358, P358; Lowe DG, 2004, INT J COMPUT VISION, V60, P91, DOI 10.1023/B:VISI.0000029664.99615.94; Magnin B, 2009, NEURORADIOLOGY, V51, P73, DOI 10.1007/s00234-008-0463-x; Maintz J B, 1998, Med Image Anal, V2, P1, DOI 10.1016/S1361-8415(01)80026-8; Marcus DS, 2007, J COGNITIVE NEUROSCI, V19, P1498, DOI 10.1162/jocn.2007.19.9.1498; Mikolajczyk K, 2002, LECT NOTES COMPUT SC, V2350, P128, DOI 10.1007/3-540-47969-4_9; Mizotin M, 2012, IEEE IMAGE PROC, P1241, DOI 10.1109/ICIP.2012.6467091; Moradi M, 2006, MED IMAGING PROCESSI; Mwangi B, 2012, BRAIN, V135, P1508, DOI 10.1093/brain/aws084; Nouretdinov I, 2011, NEUROIMAGE, V56, P809, DOI 10.1016/j.neuroimage.2010.05.023; Ojala T, 2002, IEEE T PATTERN ANAL, V24, P971, DOI 10.1109/TPAMI.2002.1017623; Pedrosa DJ, 2012, EXP NEUROL, V237, P435, DOI 10.1016/j.expneurol.2012.07.002; Petzinger GM, 2013, LANCET NEUROL, V12, P716, DOI 10.1016/S1474-4422(13)70123-6; Querbes O, 2009, BRAIN, V132, P2036, DOI 10.1093/brain/awp105; Rueda Andrea, 2012, Progress in Pattern Recognition, Image Analysis, ComputerVision, and Applications. Proceedings 17th Iberoamerican Congress, CIARP 2012, P559, DOI 10.1007/978-3-642-33275-3_69; Scovanner P., 2007, P 15 ACM INT C MULT, P357, DOI DOI 10.1145/1291233.1291311; Sherman S.M., 2001, EXPLORING THALAMUS, V1st Edn; Simoes R, 2014, NEURORADIOLOGY, V56, P709, DOI 10.1007/s00234-014-1385-4; Smith EE, 2009, COGNITIVE PSYCHOL MI; Sotiras A, 2013, IEEE T MED IMAGING, V32, P1153, DOI 10.1109/TMI.2013.2265603; STUSS DT, 1992, J CONSULT CLIN PSYCH, V60, P349, DOI 10.1037/0022-006X.60.3.349; Sun DQ, 2009, BIOL PSYCHIAT, V66, P1055, DOI 10.1016/j.biopsych.2009.07.019; Sveinbjornsdottir S, 2016, J NEUROCHEM, V139, P318, DOI 10.1111/jnc.13691; Thung KH, 2016, BRAIN STRUCT FUNCT, V221, P3979, DOI 10.1007/s00429-015-1140-6; Toews M, 2010, NEUROIMAGE, V49, P2318, DOI 10.1016/j.neuroimage.2009.10.032; Vedaldi A, 2010, P 18 ACM INT C MULT, P1469, DOI DOI 10.1145/1873951.1874249; Vemuri P, 2008, NEUROIMAGE, V39, P1186, DOI 10.1016/j.neuroimage.2007.09.073; Vijayalaxmi, 2015, MUTAT RES-REV MUTAT, V764, P51, DOI 10.1016/j.mrrev.2015.02.002; Wang HK, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0029452, 10.1371/journal.pone.0041330, 10.1371/journal.pone.0038619]; West MJ, 2004, NEUROBIOL AGING, V25, P1205, DOI 10.1016/j.neurobiolaging.2003.12.005; Yuan L, 2015, NEUROCOMPUTING, V170, P213, DOI 10.1016/j.neucom.2014.05.095; Zeng LL, 2017, CLIM DYNAM, V48, P1911, DOI 10.1007/s00382-016-3182-8; Zhang DQ, 2012, NEUROIMAGE, V59, P895, DOI 10.1016/j.neuroimage.2011.09.069; Zhang H, 2011, NEUROIMAGE, V54, P2885, DOI 10.1016/j.neuroimage.2010.10.051; Zhang Y, 2007, NEUROLOGY, V68, P13, DOI 10.1212/01.wnl.0000250326.77323.01; Zhou L, 2013, NEUROCOMPUTING, V122, P284, DOI 10.1016/j.neucom.2013.06.023; Zhu XF, 2016, IEEE T BIO-MED ENG, V63, P607, DOI 10.1109/TBME.2015.2466616; Zhu XF, 2014, NEUROIMAGE, V100, P91, DOI 10.1016/j.neuroimage.2014.05.078; 2011, PROG NEUROBIOL, V95, P629, DOI DOI 10.1016/J.PNEUROBIO.2011.09.005	73	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0171749	10.1371/journal.pone.0171749	http://dx.doi.org/10.1371/journal.pone.0171749			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207873	Green Submitted, Green Published, gold			2022-12-27	WOS:000394424500051
J	Blute, ML; Damaschke, N; Wagner, J; Yang, B; Gleave, M; Fazli, L; Shi, FF; Abel, EJ; Downs, TM; Huang, W; Jarrard, DF				Blute, Michael L., Jr.; Damaschke, Nathan; Wagner, Jennifer; Yang, Bing; Gleave, Martin; Fazli, Ladan; Shi, Fangfang; Abel, E. Jason; Downs, Tracy M.; Huang, Wei; Jarrard, David F.			Persistence of senescent prostate cancer cells following prolonged neoadjuvant androgen deprivation therapy	PLOS ONE			English	Article							CELLULAR SENESCENCE; IN-VIVO; PROGRESSION; CASTRATION; CARCINOMA; PROLIFERATION; EXPRESSION; APOPTOSIS; ANTIGEN; TUMORS	Purpose Androgen deprivation therapy (ADT) commonly leads to incomplete cell death and the fate of persistent cells involves, in part, a senescent phenotype. Senescence is terminal growth arrest in response to cell stress that is characterized by increased lysosomal-beta-galactosidase (GLB1) the origin of senescence associated-beta-gal activity (SA-beta-gal). In the current study senescence is examined in vivo after ADT use in a neoadjuvant trial. Methods and materials Tissue microarrays were generated from prostate cancer specimens (n = 126) from a multicenter neoadjuvant ADT trial. Arrays were subjected to multiplexed immunofluorescent staining for GLB1, Ki67, cleaved caspase 3 (CC3) and E-cadherin. Automated quantitative imaging was performed using Vectra T and expression correlated with clinicopathologic features. Results Tissue was analyzed from 59 patients treated with neoadjuvant ADT and 67 receiving no therapy preoperatively. Median follow-up was 85.3 mo and median ADT treatment was 5 mo. In PC treated with neoadjuvant ADT, GLB1 expression increased in intermediate Gleason score (GS 6-7; p = 0.001), but not high grade (GS 8-10) cancer. Significantly higher levels of GLB1 were seen in tissues undergoing neoadjuvant ADT longer than 5 months compared to untreated tissues (p = 0.002). In contrast, apoptosis significantly increased earlier (1-4 mo) after ADT treatment (p < 0.5). Conclusions Increased GLB1 after neoadjuvant ADT occurs primarily among more clinically favorable intermediate grade cancers and enrichment of the phenotype occurs in a temporally prolonged fashion. Senescence may explain the persistence of PCa cells after ADT. Given concerns for the detrimental longer term presence of senescent cells, targeting these cells for removal may improve outcomes.	[Blute, Michael L., Jr.; Damaschke, Nathan; Wagner, Jennifer; Yang, Bing; Shi, Fangfang; Abel, E. Jason; Downs, Tracy M.; Jarrard, David F.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Urol, Highland Ave, Madison, WI 53706 USA; [Gleave, Martin; Fazli, Ladan] Univ British Columbia, Vancouver Prostate Ctr, Vancouver, BC, Canada; [Abel, E. Jason; Downs, Tracy M.; Huang, Wei; Jarrard, David F.] Univ Wisconsin, Carbone Comprehens Canc Ctr, Madison, WI 53706 USA; [Huang, Wei] Univ Wisconsin, Dept Pathol, Sch Med & Publ Hlth, Highland Ave, Madison, WI 53706 USA; [Jarrard, David F.] Univ Wisconsin, Environm & Mol Toxicol, Univ Ave Madison, Madison, WI 53706 USA; [Jarrard, David F.] Wisconsin Inst Med Res, Madison, WI 53705 USA	University of Wisconsin System; University of Wisconsin Madison; University of British Columbia; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Jarrard, DF (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Urol, Highland Ave, Madison, WI 53706 USA.; Jarrard, DF (corresponding author), Univ Wisconsin, Carbone Comprehens Canc Ctr, Madison, WI 53706 USA.; Jarrard, DF (corresponding author), Univ Wisconsin, Environm & Mol Toxicol, Univ Ave Madison, Madison, WI 53706 USA.; Jarrard, DF (corresponding author), Wisconsin Inst Med Res, Madison, WI 53705 USA.	jarrard@urology.wisc.edu		Gleave, Martin/0000-0003-4235-0167	Department of Defense Prostate Cancer Research Program; Prostate Cancer Foundation; Gen6 Foundation;  [T32CA009614];  [T32CA009135]; NATIONAL CANCER INSTITUTE [T32CA009135] Funding Source: NIH RePORTER	Department of Defense Prostate Cancer Research Program(United States Department of Defense); Prostate Cancer Foundation; Gen6 Foundation; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by: Department of Defense Prostate Cancer Research Program; Prostate Cancer Foundation; Training grants to MLB (T32CA009614) and ND (Cancer Biology T32CA009135); and the Gen6 Foundation.	Agus DB, 1999, J NATL CANCER I, V91, P1869, DOI 10.1093/jnci/91.21.1869; Benaim EA, 2002, EUR UROL, V42, P12, DOI 10.1016/S0302-2838(02)00238-5; Benaim EA, 2002, UROLOGY, V59, P73, DOI 10.1016/S0090-4295(01)01440-6; Bringold F, 2000, EXP GERONTOL, V35, P317, DOI 10.1016/S0531-5565(00)00083-8; Chi KN, 2005, J NATL CANCER I, V97, P1287, DOI 10.1093/jnci/dji252; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Dorr JR, 2013, NATURE, V501, P421, DOI 10.1038/nature12437; Ewald JA, 2013, PROSTATE, V73, P337, DOI 10.1002/pros.22571; Ewald JA, 2010, JNCI-J NATL CANCER I, V102, P1536, DOI 10.1093/jnci/djq364; Gewirtz DA, 2013, AUTOPHAGY, V9, P808, DOI 10.4161/auto.23922; Glass TR, 2003, J UROLOGY, V169, P164, DOI 10.1016/S0022-5347(05)64059-1; Grivas PD, 2013, CRIT REV ONCOL HEMAT, V85, P82, DOI 10.1016/j.critrevonc.2012.05.003; Halvorsen Ole Johan, 2008, APMIS Suppl, P5; Haugstetter AM, 2010, BRIT J CANCER, V103, P505, DOI 10.1038/sj.bjc.6605784; Hussain M, 2013, NEW ENGL J MED, V368, P1314, DOI 10.1056/NEJMoa1212299; KELLY WK, 1993, J CLIN ONCOL, V11, P607, DOI 10.1200/JCO.1993.11.4.607; Kucway R, 2002, J UROLOGY, V167, P2443, DOI 10.1016/S0022-5347(05)65001-X; Lee BY, 2006, AGING CELL, V5, P187, DOI 10.1111/j.1474-9726.2006.00199.x; Majumder PK, 2008, CANCER CELL, V14, P146, DOI 10.1016/j.ccr.2008.06.002; Montironi R, 1998, J CLIN PATHOL, V51, P5, DOI 10.1136/jcp.51.1.5; NEWLING DWW, 1993, EUR UROL, V24, P87; NEWLING DWW, 1993, CANCER, V72, P3793, DOI 10.1002/1097-0142(19931215)72:12+<3793::AID-CNCR2820721706>3.0.CO;2-U; Pernicova Z, 2011, NEOPLASIA, V13, P526, DOI 10.1593/neo.11182; Sciarra A, 2012, UROL ONCOL-SEMIN ORI, V30, P614, DOI 10.1016/j.urolonc.2010.09.006; Smitherman AB, 2003, PROSTATE, V57, P24, DOI 10.1002/pros.10271; Sweeney C., 2014, CHAARTED STUDY ABSTR; Tangen Catherine M, 2003, Clin Prostate Cancer, V2, P41, DOI 10.3816/CGC.2003.n.011; Vaillancourt L, 1996, AM J SURG PATHOL, V20, P86, DOI 10.1097/00000478-199601000-00010; Wagner J., 2015, INDOLENT PROSTATE CA; Wang Q, 2013, JNCI-J NATL CANCER I, V105, P1463, DOI 10.1093/jnci/djt241; Warren M, 2009, APPL IMMUNOHISTO M M, V17, P23, DOI 10.1097/PAI.0b013e31817c3334; WESTIN P, 1995, AM J PATHOL, V146, P1368; Xie N, 2015, INT J CANCER, V136, pE27, DOI 10.1002/ijc.29147	33	18	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0172048	10.1371/journal.pone.0172048	http://dx.doi.org/10.1371/journal.pone.0172048			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5VB	28234906	gold, Green Published, Green Submitted			2022-12-27	WOS:000394688200043
J	Curry, A; Khatri, I; Kos, O; Zhu, F; Gorczynski, R				Curry, Anna; Khatri, Ismat; Kos, Olha; Zhu, Fang; Gorczynski, Reginald			Importance of CD200 expression by tumor or host cells to regulation of immunotherapy in a mouse breast cancer model	PLOS ONE			English	Article							METASTATIC GROWTH; DIABETIC-PATIENTS; METFORMIN; MICE; INVASIVENESS; INFLAMMATION; RESPONSES; DRUG	Cell-surface CD200 expression by mouse EMT6 breast tumor cells increased primary tumor growth and metastasis to the draining lymph nodes (DLN) in normal (WT) BALB/c female recipients, while lack of CD200R1 expression in a CD200R1 (-/-) host negated this effect. Silencing CD200 expression in EMT6 (siCD200) tumor cells also reduced their ability to grow and metastasize in WT animals. The cellular mechanisms responsible for these effects have not been studied in detail. We report characterization of tumor infiltrating (TILs) and draining lymph node (DLN) cells in WT and CD200 (-/-)BALB/c mice, receiving WT tumor cells, or EMT6 lacking CD200 expression (EMT6 (siCD200) cells). Our data show an important correlation with augmented CD8 (+) cytotoxic T cells and resistance to tumor growth in mice lacking exposure (on either host cells or tumor) to the immunoregulatory molecule CD200. Confirmation of the importance of such CD8 (+) cells came from monitoring tumor growth and characterization of the TILs and DLN cells in WT mice challenged with EMT6 and EMT6 (siCD200) tumors and treated with CD8 and CD4 depleting antibodies. Finally, we have assessed the mechanisms (s) whereby addition of metformin as an augmenting chemotherapeutic agent in CD200 (-/-)animals given EMT6 tumors and treated with a previously established immunotherapy regime can increase host resistance. Our data support the hypothesis that increased autophagy in the presence of metformin increases CD8 (+) responses and tumor resistance, an effect attenuated by the autophagy inhibitor verteporfin.	[Curry, Anna; Khatri, Ismat; Kos, Olha; Zhu, Fang; Gorczynski, Reginald] Univ Hlth Network, Dept Surg, Transplant Res Div, Toronto, ON, Canada; [Gorczynski, Reginald] Univ Toronto, Dept Immunol, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto	Gorczynski, R (corresponding author), Univ Hlth Network, Dept Surg, Transplant Res Div, Toronto, ON, Canada.; Gorczynski, R (corresponding author), Univ Toronto, Dept Immunol, Toronto, ON, Canada.	reg.gorczynski@utoronto.ca	Gorczynski, Reginald/AAA-1435-2019		CIHR [777532247]; Canadian Institutes of Health Research (CIHR)	CIHR(Canadian Institutes of Health Research (CIHR)); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This work was supported by a CIHR grant to Reginald Gorczynski (Grant Number 777532247).; This work was supported by a grant to RMG from the Canadian Institutes of Health Research (CIHR).	Perez-Yepez EA, 2014, CANCER LETT, V354, P164, DOI 10.1016/j.canlet.2014.08.015; Anisimov VN, 2005, EXP GERONTOL, V40, P685, DOI 10.1016/j.exger.2005.07.007; Apte RN, 2006, CANCER METAST REV, V25, P387, DOI 10.1007/s10555-006-9004-4; Ben Sahra I, 2008, ONCOGENE, V27, P3576, DOI 10.1038/sj.onc.1211024; Bunt SK, 2007, CANCER RES, V67, P10019, DOI 10.1158/0008-5472.CAN-07-2354; Donohue E, 2011, J BIOL CHEM, V286, P7290, DOI 10.1074/jbc.M110.139915; Dowling RJO, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-33; Eikawa S, 2015, P NATL ACAD SCI USA, V112, P1809, DOI 10.1073/pnas.1417636112; Erin N, 2015, ONCOGENE, V34, P3860, DOI 10.1038/onc.2014.317; Evans JMM, 2005, BMJ-BRIT MED J, V330, P1304, DOI 10.1136/bmj.38415.708634.F7; Gorczynski RM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113597; Gorczynski RM, 2013, BREAST CANCER RES TR, V142, P271, DOI 10.1007/s10549-013-2735-3; Gorczynski RM, 2011, BREAST CANCER RES TR, V130, P49, DOI 10.1007/s10549-010-1259-3; Gutschalk CM, 2013, CANCER MED-US, V2, P117, DOI 10.1002/cam4.20; Hirsch HA, 2009, CANCER RES, V69, P7507, DOI 10.1158/0008-5472.CAN-09-2994; Hoek RM, 2000, SCIENCE, V290, P1768, DOI 10.1126/science.290.5497.1768; Jiralerspong S, 2009, J CLIN ONCOL, V27, P3297, DOI 10.1200/JCO.2009.19.6410; Kasznicki J, 2014, ANN TRANSL MED, V2, DOI 10.3978/j.issn.2305-5839.2014.06.01; Krelin Y, 2007, CANCER RES, V67, P1062, DOI 10.1158/0008-5472.CAN-06-2956; Landman GWD, 2010, DIABETES CARE, V33, P322, DOI 10.2337/dc09-1380; Liu BL, 2009, CELL CYCLE, V8, P2031, DOI 10.4161/cc.8.13.8814; Orecchioni S, 2015, INT J CANCER, V136, pE534, DOI 10.1002/ijc.29193; Parmiani G, 2007, ANN ONCOL, V18, P226, DOI 10.1093/annonc/mdl158; Podnos A, 2012, BREAST CANCER RES TR, V136, P117, DOI 10.1007/s10549-012-2258-3; Snelgrove RJ, 2008, NAT IMMUNOL, V9, P1074, DOI 10.1038/ni.1637; Su SC, 2014, CANCER CELL, V25, P605, DOI 10.1016/j.ccr.2014.03.021; Vazquez-Martin A, 2011, BREAST CANCER RES TR, V126, P355, DOI 10.1007/s10549-010-0924-x; Xu XJ, 2014, NAT IMMUNOL, V15, P1152, DOI 10.1038/ni.3025	28	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e71586	10.1371/journal.pone.0171586	http://dx.doi.org/10.1371/journal.pone.0171586			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5VB	28234914	Green Published, gold, Green Submitted			2022-12-27	WOS:000394688200026
J	Rowinska, Z; Koeppel, TA; Sanati, M; Schelzig, H; Jankowski, J; Weber, C; Zernecke, A; Liehn, EA				Rowinska, Zuzanna; Koeppel, Thomas A.; Sanati, Maryam; Schelzig, Hubert; Jankowski, Joachim; Weber, Christian; Zernecke, Alma; Liehn, Elisa A.			Role of the CX3C chemokine receptor CX3CR1 in the pathogenesis of atherosclerosis after aortic transplantation	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; ALLOGRAFT-REJECTION; LESION FORMATION; GROWTH-FACTOR; MOUSE MODELS; FRACTALKINE; CX(3)CR1; MICE; ARTERIOSCLEROSIS; ATHEROGENESIS	Background The CX3C chemokine receptor CX3CR1 is expressed on monocytes as well as tissue resident cells, such as smooth muscle cells ( SMCs). Its role in atherosclerotic tissue remodeling of the aorta after transplantation has not been investigated. Methods We here have orthotopically transplanted infrarenal Cx3cr1(-/-) Apoe(-/-) and Cx3cr1(+/+) Apoe(-/-)aortic segments into Apoe(-/-) mice, as well as Apoe(-/-) aortic segments into Cx3cr1(-/-) Apoe(-/-)mice. The intimal plaque size and cellular plaque composition of the transplanted aortic segment were analyzed after four weeks of atherogenic diet. Results Transplantation of Cx3cr(-/-) Apoe(-/-) aortic segments into Apoe(-/-) mice resulted in reduced atherosclerotic plaque formation compared to plaque size in Apoe(-/-) or Cx3cr1(-/-) Apoe(-/-) mice after transplantation of Apoe(-/-) aortas. This reduction in lesion formation was associated with reduced numbers of lesional SMCs but not macrophages within the transplanted Cx3cr(-/-) Apoe(-/-) aortic segment. No differences in frequencies of proliferating and apoptotic cells could be observed. Conclusion These results indicate that CX3CR1 on resident vessel wall cells plays a key role in atherosclerotic plaque formation in transplanted aortic grafts. Targeting of vascular CX3CL1/ CX3CR1 may therefore be explored as a therapeutic option in vascular transplantation procedures.	[Rowinska, Zuzanna] Ruhr Univ Bochum, St Josef Hosp, Dept Vasc Surg, Bochum, Germany; [Rowinska, Zuzanna] Ruhr Univ Bochum, St Josef Hosp, Interdisciplinary Vein Ctr, Bochum, Germany; [Rowinska, Zuzanna; Sanati, Maryam; Jankowski, Joachim; Liehn, Elisa A.] Rhein Westfal TH Aachen, Univ Hosp, Inst Mol Cardiovasc Res, Aachen, Germany; [Koeppel, Thomas A.] Hosp Asklepios St Georg Hamburg, Div Vasc Surg, Hamburg, Germany; [Schelzig, Hubert] Dusseldorf Univ Hosp, Dept Vasc & Endovasc Surg, Dusseldorf, Germany; [Jankowski, Joachim] Maastricht Univ, Sch Cardiovasc Dis CARIM, Maastricht, Netherlands; [Weber, Christian] Ludwig Maximilian Univ Munich, Inst Prevent & Epidemiol Cardiovasc Dis, Munich, Germany; [Zernecke, Alma] Univ Hosp Wurzburg, Inst Expt Biomed, Wurzburg, Germany; [Liehn, Elisa A.] Univ Med & Pharm, Human Genet Lab, Craiova, Romania	Ruhr University Bochum; Ruhr University Bochum; RWTH Aachen University; RWTH Aachen University Hospital; Asklepios Klinik St. Georg; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital; Maastricht University; University of Munich; University of Wurzburg; University of Medicine & Pharmacy of Craiova	Rowinska, Z (corresponding author), Ruhr Univ Bochum, St Josef Hosp, Dept Vasc Surg, Bochum, Germany.; Rowinska, Z (corresponding author), Ruhr Univ Bochum, St Josef Hosp, Interdisciplinary Vein Ctr, Bochum, Germany.; Rowinska, Z (corresponding author), Rhein Westfal TH Aachen, Univ Hosp, Inst Mol Cardiovasc Res, Aachen, Germany.	z.rowinska@klinikum-bochum.de	Weber, Christian/AAW-2153-2020; Liehn, Elisa Anamaria/D-9623-2011	Weber, Christian/0000-0003-4610-8714; Liehn, Elisa Anamaria/0000-0002-1253-3272	Interdisciplinary Centre for Clinical Research IZKF Aachen; faculty of Medicine at RWTH Aachen University	Interdisciplinary Centre for Clinical Research IZKF Aachen; faculty of Medicine at RWTH Aachen University	This study was supported by the Interdisciplinary Centre for Clinical Research IZKF Aachen (junior research group to E.L.) with in the faculty of Medicine at RWTH Aachen University.	Apostolakis S, 2013, ACTA PHARMACOL SIN, V34, P1251, DOI 10.1038/aps.2013.92; Back M, 2015, J INTERN MED, V278, P462, DOI 10.1111/joim.12367; Bazan JF, 1997, NATURE, V385, P640, DOI 10.1038/385640a0; Butoi ED, 2011, BBA-MOL CELL RES, V1813, P2026, DOI 10.1016/j.bbamcr.2011.08.009; Cao G, 2006, TRANSPL P, V38, P1998, DOI 10.1016/j.transproceed.2006.06.081; Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723; Combadiere C, 2003, CIRCULATION, V107, P1009, DOI 10.1161/01.CIR.0000057548.68243.42; Combadiere C, 2008, CIRCULATION, V117, P1649, DOI 10.1161/CIRCULATIONAHA.107.745091; Dambrin C, 1999, J HEART LUNG TRANSPL, V18, P946, DOI 10.1016/S1053-2498(99)00051-0; Daugherty A, 2002, AM J MED SCI, V323, P3, DOI 10.1097/00000441-200201000-00002; Fong AM, 1998, J EXP MED, V188, P1413, DOI 10.1084/jem.188.8.1413; Greaves DR, 2001, ARTERIOSCL THROM VAS, V21, P923, DOI 10.1161/01.ATV.21.6.923; Hoffmann U, 2010, TRANSPL IMMUNOL, V23, P204, DOI 10.1016/j.trim.2010.06.006; Hu HZ, 2004, AM J TRANSPLANT, V4, P432, DOI 10.1111/j.1600-6143.2004.00354.x; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Landsman L, 2009, BLOOD, V113, P963, DOI 10.1182/blood-2008-07-170787; Lenzen MJ, 2005, EUR HEART J, V26, P1169, DOI 10.1093/eurheartj/ehi238; Lesnik P, 2003, J CLIN INVEST, V111, P333, DOI 10.1172/JCI200315555; Liehn Elisa A, 2015, Discoveries (Craiova), V3, pe42, DOI 10.15190/d.2015.34; Liu H, 2010, CARDIOVASC DRUG THER, V24, P17, DOI 10.1007/s10557-009-6210-7; Liu P, 2008, ARTERIOSCL THROM VAS, V28, P243, DOI 10.1161/ATVBAHA.107.158675; Lucas AD, 2003, CIRCULATION, V108, P2498, DOI 10.1161/01.CIR.0000097119.57756.EF; Ludwig A, 2002, J IMMUNOL, V168, P604, DOI 10.4049/jimmunol.168.2.604; Postea O, 2012, ARTERIOSCL THROM VAS, V32, P1186, DOI 10.1161/ATVBAHA.111.243485; Poupel L, 2013, ARTERIOSCL THROM VAS, V33, P2297, DOI 10.1161/ATVBAHA.112.300930; Robinson LA, 2000, J IMMUNOL, V165, P6067, DOI 10.4049/jimmunol.165.11.6067; Rowinska Z, 2012, EUR J RADIOL, V81, P244, DOI 10.1016/j.ejrad.2010.12.083; Ruth JH, 2001, ARTHRITIS RHEUM, V44, P1568, DOI 10.1002/1529-0131(200107)44:7<1568::AID-ART280>3.0.CO;2-1; Saederup N, 2008, CIRCULATION, V117, P1642, DOI 10.1161/CIRCULATIONAHA.107.743872; Swier VJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138539; Virmani R, 2000, ARTERIOSCL THROM VAS, V20, P1262, DOI 10.1161/01.ATV.20.5.1262; White GE, 2010, CARDIOVASC RES, V85, P825, DOI 10.1093/cvr/cvp341; Xu QB, 2004, AM J PATHOL, V165, P1, DOI 10.1016/S0002-9440(10)63270-1; Zernecke A, 2008, ARTERIOSCL THROM VAS, V28, P1897, DOI 10.1161/ATVBAHA.107.161174	34	6	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0170644	10.1371/journal.pone.0170644	http://dx.doi.org/10.1371/journal.pone.0170644			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5VB	28234900	Green Published, Green Submitted, gold			2022-12-27	WOS:000394688200009
J	Yamada, Y; Takanashi, M; Sudo, K; Ueda, S; Ohno, S; Kuroda, M				Yamada, Yuko; Takanashi, Masakatsu; Sudo, Katsuko; Ueda, Shinobu; Ohno, Shinichiro; Kuroda, Masahiko			Novel form of miR-29b suppresses bleomycin-induced pulmonary fibrosis	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR-3; MICRORNA THERAPEUTICS; COLLAGEN EXPRESSION; RENAL FIBROSIS; PIRFENIDONE; ANGIOGENESIS; ACTIVATION; REGULATOR; CARCINOMA; MIGRATION	MicroRNA 29b (miR-29b) replacement therapy is effective for suppressing fibrosis in a mouse model. However, to develop clinical applications for miRNA mimics, the side effects of nucleic acid drugs have to be addressed. In this study, we focused on miRNA mimics in order to develop therapies for idiopathic pulmonary fibrosis. We developed a single-stranded RNA, termed "miR-29b Psh-match," that has a unique structure to avoid problems associated with the therapeutic uses of miRNAs. A comparison of miR-29b Psh-match and double-stranded one, termed "miR-29b mimic" indicated that the single-stranded form was significantly effective towards fibrosis according to both in vivo and in vitro experiments. This novel form of miR-29b may become the foundation for developing an effective therapeutic drug for pulmonary fibrosis.	[Yamada, Yuko; Takanashi, Masakatsu; Ueda, Shinobu; Ohno, Shinichiro; Kuroda, Masahiko] Tokyo Med Univ, Dept Mol Pathol, Shinjuku Ku, Tokyo, Japan; [Sudo, Katsuko] Tokyo Med Univ, Anim Res Ctr, Shinjuku Ku, Tokyo, Japan	Tokyo Medical University; Tokyo Medical University	Kuroda, M (corresponding author), Tokyo Med Univ, Dept Mol Pathol, Shinjuku Ku, Tokyo, Japan.	Kuroda@tokyo-med.ac.jp	慎一郎, 大野/AAI-7736-2021	Ohno, Shin-ichiro/0000-0003-1064-4750	Japan Society for the Promotion of Science (JSPS) [26296088, 16K09376, 15K15100]; Ministry of Education, Culture, Sports, Science and Technology of Japan	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This research was supported in part by Grants-in-Aid for scientific research (B: 26296088) and (C: 16K09376) and a Grant-in-Aid for Exploratory Research (15K15100) from Japan Society for the Promotion of Science (JSPS) and supported in part by Strategic Research Foundation Grant-aided Project for Private Universities from the Ministry of Education, Culture, Sports, Science and Technology of Japan.; We thank Akio Ishikawa for his technical assistance. This research was supported in part by Grants-in-Aid for scientific research (B: 26296088) and (C: 16K09376) and a Grant-in-Aid for Exploratory Research (15K15100) from Japan Society for the Promotion of Science (JSPS) and supported in part by Strategic Research Foundation Grant-aided Project for Private Universities from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Abe N, 2007, J AM CHEM SOC, V129, P15108, DOI 10.1021/ja0754453; Agostini M, 2014, ONCOTARGET, V5, P872, DOI 10.18632/oncotarget.1825; ASHCROFT T, 1988, J CLIN PATHOL, V41, P467, DOI 10.1136/jcp.41.4.467; Bando M, 2016, RESPIR INVESTIG, V54, P298, DOI 10.1016/j.resinv.2016.03.007; Cushing L, 2011, AM J RESP CELL MOL, V45, P287, DOI 10.1165/rcmb.2010-0323OC; D'Alessandro-Gabazza CN, 2012, AM J RESP CELL MOL, V46, P397, DOI 10.1165/rcmb.2011-0158OC; du Bois RM, 2010, NAT REV DRUG DISCOV, V9, P129, DOI 10.1038/nrd2958; Hamasaki T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042655; Huebner RH, 2008, BIOTECHNIQUES, V44, P507, DOI 10.2144/000112729; Inui M, 2010, NAT REV MOL CELL BIO, V11, P252, DOI 10.1038/nrm2868; King TE, 2014, NEW ENGL J MED, V370, P2083, DOI 10.1056/NEJMoa1402582; King TE, 2011, LANCET, V378, P1949, DOI 10.1016/S0140-6736(11)60052-4; Lin XC, 2009, INVEST OPHTH VIS SCI, V50, P3763, DOI 10.1167/iovs.08-2815; Maurer B, 2010, ARTHRITIS RHEUM-US, V62, P1733, DOI 10.1002/art.27443; Montgomery RL, 2014, EMBO MOL MED, V6, P1347, DOI 10.15252/emmm.201303604; Nishikawa R, 2015, FEBS LETT, V589, P2136, DOI 10.1016/j.febslet.2015.06.005; Noble PW, 2011, LANCET, V377, P1760, DOI 10.1016/S0140-6736(11)60405-4; Qin W, 2011, J AM SOC NEPHROL, V22, P1462, DOI 10.1681/ASN.2010121308; Richeldi L, 2014, NEW ENGL J MED, V370, P2071, DOI 10.1056/NEJMoa1402584; Roberts AB, 2003, ANN NY ACAD SCI, V995, P1, DOI 10.1111/j.1749-6632.2003.tb03205.x; Roderburg C, 2011, HEPATOLOGY, V53, P209, DOI 10.1002/hep.23922; Rogliani P, 2016, PULMONARY PHARM THER; Sekiya Y, 2011, BIOCHEM BIOPH RES CO, V412, P74, DOI 10.1016/j.bbrc.2011.07.041; Takanashi M, 2015, MOL THER-NUCL ACIDS, V4, DOI 10.1038/mtna.2015.34; Taketani Y, 2016, MOL THER-NUCL ACIDS, V5, DOI 10.1038/mtna.2016.1; Tatematsu M, 2014, BIOCHEM J, V458, P195, DOI 10.1042/BJ20131492; van Rooij E, 2008, P NATL ACAD SCI USA, V105, P13027, DOI 10.1073/pnas.0805038105; van Rooij E, 2012, NAT REV DRUG DISCOV, V11, P860, DOI 10.1038/nrd3864; van Rooij E, 2012, CIRC RES, V110, P496, DOI 10.1161/CIRCRESAHA.111.247916; Varkouhi AK, 2011, J CONTROL RELEASE, V151, P220, DOI 10.1016/j.jconrel.2010.11.004; Wang B, 2012, J AM SOC NEPHROL, V23, P252, DOI 10.1681/ASN.2011010055; Xiao J, 2012, MOL THER, V20, P1251, DOI 10.1038/mt.2012.36; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054; Zhang HY, 2016, CANCER LETT, V375, P331, DOI 10.1016/j.canlet.2016.03.026; Zhang YQ, 2012, J BIOL CHEM, V287, P14851, DOI 10.1074/jbc.M111.314922	35	8	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0171957	10.1371/journal.pone.0171957	http://dx.doi.org/10.1371/journal.pone.0171957			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5VB	28234907	gold, Green Published, Green Submitted			2022-12-27	WOS:000394688200041
J	Fernald, KDS; Pennings, HPG; van den Bosch, JF; Commandeur, HR; Claassen, E				Fernald, K. D. S.; Pennings, H. P. G.; van den Bosch, J. F.; Commandeur, H. R.; Claassen, E.			The moderating role of absorptive capacity and the differential effects of acquisitions and alliances on Big Pharma firms' innovation performance	PLOS ONE			English	Article							RESEARCH-AND-DEVELOPMENT; PHARMACEUTICAL-INDUSTRY; EXTERNAL KNOWLEDGE; REAL OPTIONS; PRODUCT DEVELOPMENT; BIOTECHNOLOGY; EXPLOITATION; EXPLORATION; DRUG; TECHNOLOGY	In the context of increased pharmaceutical innovation deficits and Big Pharma blockbusters' patent expirations, this paper examines the moderating role of firms' absorptive capacity in external innovation activities of Big Pharma firms. The study indicates a rising interest of Big Pharma in acquisitions of and alliances with biotechnology companies. Unfortunately, this increased interest is not reflected in the number of new drugs generated by Big Pharma. We find that acquisitions of biotech companies have negatively affected Big Pharma firms' innovation performance on average but these acquisitions might have a positive effect at higher levels of acquiring firms' absorptive capacity. Moreover, also acquisitions of pharma companies and alliances with biotech companies only have a positive effect on innovation performance at sufficiently high levels of absorptive capacity. The moderating role of absorptive capacity implicates that a tight integration of internal R&D efforts and (unrelated) external knowledge is crucial for harnessing complementarity effects.	[Fernald, K. D. S.; Pennings, H. P. G.; Commandeur, H. R.] Erasmus Univ, Erasmus Sch Econ, Appl Econ Dept, Rotterdam, Netherlands; [Fernald, K. D. S.; van den Bosch, J. F.; Claassen, E.] Vrije Univ Amsterdam, Fac Earth & Life Sci, Biol & Soc Res Dept, Athena Inst, Amsterdam, Netherlands	Erasmus University Rotterdam; Vrije Universiteit Amsterdam	Fernald, KDS (corresponding author), Erasmus Univ, Erasmus Sch Econ, Appl Econ Dept, Rotterdam, Netherlands.; Fernald, KDS (corresponding author), Vrije Univ Amsterdam, Fac Earth & Life Sci, Biol & Soc Res Dept, Athena Inst, Amsterdam, Netherlands.	kenneth.fernald@gmail.com		Pennings, Enrico/0000-0003-1403-9857				Ahuja G, 2001, STRATEGIC MANAGE J, V22, P197, DOI 10.1002/smj.157; Al-Laham A, 2010, SCAND J MANAG, V26, P25, DOI 10.1016/j.scaman.2009.11.005; Amir-Aslani A, 2006, TECHNOVATION, V26, P573, DOI 10.1016/j.technovation.2005.06.001; Andriopoulos C, 2009, ORGAN SCI, V20, P696, DOI 10.1287/orsc.1080.0406; Arora A, 2009, MANAGE SCI, V55, P1638, DOI 10.1287/mnsc.1090.1055; Ashburn TT, 2004, NAT REV DRUG DISCOV, V3, P673, DOI 10.1038/nrd1468; BARNEY J, 1991, J MANAGE, V17, P99, DOI 10.1177/014920639101700108; Belderbos R, 2004, INT J IND ORGAN, V22, P1237, DOI 10.1016/j.ijindorg.2004.08.001; Berchicci L, 2013, RES POLICY, V42, P117, DOI 10.1016/j.respol.2012.04.017; Cardinal LB, 2001, ORGAN SCI, V12, P19, DOI 10.1287/orsc.12.1.19.10119; Cassiman B, 2006, MANAGE SCI, V52, P68, DOI 10.1287/mnsc.1050.0470; Cassiman B, 2005, RES POLICY, V34, P195, DOI 10.1016/j.respol.2005.01.002; Catozzella A, 2014, IND INNOV, V21, P179, DOI 10.1080/13662716.2014.910890; Ceccagnoli M, INTERNAL R D VERSUS; Cefis E, 2010, ECON INNOV NEW TECH, V19, P27, DOI 10.1080/10438590903016385; Chesbrough H., 2003, OPEN INNOVATION NEW; Chiaroni D., 2005, IND CLUSTERS BIOTECH; Chiaroni D, 2008, J BUSINESS CHEM, V5, P6; Claassen E., 2013, TECHN INVESTMENT, V4, P35488, DOI [10.4236/ti.2013.43020, DOI 10.4236/TI.2013.43020]; Cloodt M, 2006, RES POLICY, V35, P642, DOI 10.1016/j.respol.2006.02.007; Cohen FJ, 2005, NAT REV DRUG DISCOV, V4, P78, DOI 10.1038/nrd1610; COHEN WM, 1990, ADMIN SCI QUART, V35, P128, DOI 10.2307/2393553; Danzon PM, 2007, MANAG DECIS ECON, V28, P307, DOI 10.1002/mde.1343; Danzon PM, 2005, J HEALTH ECON, V24, P317, DOI 10.1016/j.jhealeco.2004.09.006; Das TK, 2000, J MANAGE, V26, P31, DOI 10.1016/S0149-2063(99)00037-9; Das TK, 2000, ORGAN SCI, V11, P77, DOI 10.1287/orsc.11.1.77.12570; de Man AP, 2005, TECHNOVATION, V25, P1377, DOI 10.1016/j.technovation.2004.07.021; de Rond M, 2004, ORGAN SCI, V15, P56, DOI 10.1287/orsc.1030.0037; Deeds DL, 1996, J BUS VENTURING, V11, P41, DOI 10.1016/0883-9026(95)00087-9; Denicolai S, 2014, R&D MANAGE, V44, P248, DOI 10.1111/radm.12065; DeRuiter J, 2012, US PHARM, V37, P46; Dhankhar A, 2012, ESCAPING SWORD DAMOC; DiMasi JA, 2003, J HEALTH ECON, V22, P151, DOI 10.1016/S0167-6296(02)00126-1; DiMasi JA, 2000, DRUG INF J, V34, P1169, DOI 10.1177/009286150003400425; Drakeman DL, 2014, NAT BIOTECHNOL, V32, P621, DOI 10.1038/nbt.2947; Drews J, 1998, DRUG DISCOV TODAY, V3, P491, DOI 10.1016/S1359-6446(98)01252-5; Drews Jurgen, 1996, DRUG INF J, V30, P97; Duysters G, 2003, R&D MANAGE, V33, P49, DOI 10.1111/1467-9310.00281; Dyer JH, 1998, ACAD MANAGE REV, V23, P660, DOI 10.2307/259056; EvaluatePharma, 2014, PHARM BIOT SAL AN CO; Fernald K, 2015, J PROD INNOVAT MANAG, V32, P971, DOI 10.1111/jpim.12218; Fetterhoff TJ, 2006, RES TECHNOL MANAGE, V49, P14, DOI 10.1080/08956308.2006.11657373; Flatten TC, 2011, EUR MANAG J, V29, P98, DOI 10.1016/j.emj.2010.11.002; Frantz S, 2006, NAT REV DRUG DISCOV, V5, P977, DOI 10.1038/nrd2206; Gassmann O., 2005, CREATIVITY INNOVATIO, V14, P233, DOI DOI 10.1111/J.1467-8691.2005.00344.X; Gilsing V, 2006, RES POLICY, V35, P1, DOI 10.1016/j.respol.2005.06.007; Gottinger HW, 2008, BUS HIST, V50, P583, DOI 10.1080/00076790802246020; Grabowski HG, 2006, HEALTH AFFAIR, V25, P452, DOI 10.1377/hlthaff.25.2.452; GRAVES SB, 1993, STRATEGIC MANAGE J, V14, P593, DOI 10.1002/smj.4250140803; Grill P, 2011, RESOURCE BASED THEOR; Grimpe C, 2007, J PROD INNOVAT MANAG, V24, P614, DOI 10.1111/j.1540-5885.2007.00275.x; Hagedoorn J, 2002, TECHNOL ANAL STRATEG, V14, P67, DOI 10.1080/09537320220125892; Hagedoorn J, 2012, RES POLICY, V41, P1072, DOI 10.1016/j.respol.2012.02.012; *Haspeslagh P.C., 1991, MANAGING ACQUISITION; HITT MA, 1991, ACAD MANAGE J, V34, P693, DOI 10.2307/256412; Hoang H, 2010, STRATEGIC MANAGE J, V31, P734, DOI 10.1002/smj.834; Hopkins MM, 2007, RES POLICY, V36, P566, DOI 10.1016/j.respol.2007.02.013; Inoue H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121973; Jeon J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131642; KATZ R, 1982, R&D MANAGE, V12, P7, DOI 10.1111/j.1467-9310.1982.tb00478.x; Keil T, 2008, STRATEG MANAGE J, V29, P895, DOI 10.1002/smj.672; Kessel M, 2011, NAT BIOTECHNOL, V29, P27, DOI 10.1038/nbt.1748; KOGUT B, 1994, MANAGE SCI, V40, P123, DOI 10.1287/mnsc.40.1.123; Laursen K, 2012, IND CORP CHANGE, V21, P1181, DOI 10.1093/icc/dts025; Lavie D, 2010, ACAD MANAG ANN, V4, P109, DOI 10.1080/19416521003691287; Leiblein MJ, 2003, J MANAGE, V29, P937, DOI 10.1016/S0149-2063(03)00085-0; Lin CH, 2012, TECHNOVATION, V32, P282, DOI 10.1016/j.technovation.2012.01.004; March JG, 1991, ORGAN SCI, V2, P71, DOI 10.1287/orsc.2.1.71; Martinez B, 2007, WALL STREET J, V1, P12; Meeus MTH, 2001, ORGAN STUD, V22, P145, DOI 10.1177/017084060102200106; Mittra J, 2007, TECHNOL ANAL STRATEG, V19, P279, DOI 10.1080/09537320701281540; Miyazaki H, 2009, APPL ECON LETT, V16, P199, DOI 10.1080/13504850601018163; Munos B, 2009, NAT REV DRUG DISCOV, V8, P959, DOI 10.1038/nrd2961; Nightingale P, 2004, TRENDS BIOTECHNOL, V22, P564, DOI 10.1016/j.tibtech.2004.09.010; Oltra M. J., 2003, CREATIVITY INNOVATIO, V12, P137, DOI DOI 10.1111/1467-8691.00277; PISANO GP, 1991, RES POLICY, V20, P237, DOI 10.1016/0048-7333(91)90054-T; Pronker ES, 2011, VACCINE, V29, P5846, DOI 10.1016/j.vaccine.2011.06.051; Reuer JJ, 2005, J MANAGE, V31, P403, DOI 10.1177/0149206304272184; Riccobono F, 2014, TECHNOL ANAL STRATEG, P1; Roijakkers N, 2006, RES POLICY, V35, P431, DOI 10.1016/j.respol.2006.01.006; Rothaermel FT, 2007, ORGAN SCI, V18, P898, DOI 10.1287/orsc.1070.0291; Rothaermel FT, 2004, STRATEGIC MANAGE J, V25, P201, DOI 10.1002/smj.376; Rydzewski RM, 2010, REAL WORLD DRUG DISC; Saenz-Royo C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126076; Sampson RC, 2007, ACAD MANAGE J, V50, P364, DOI 10.5465/AMJ.2007.24634443; Schmid EF, 2005, DRUG DISCOV TODAY, V10, P1031, DOI 10.1016/S1359-6446(05)03524-5; Schweizer L, 2005, ACAD MANAGE J, V48, P1051, DOI 10.2307/20159729; Stock G.N., 2001, J HIGH TECHNOLOGY MA, V12, P77, DOI DOI 10.1016/S1047-8310(00)00040-7; Tait J, 2004, CHEM IND-LONDON, P24; Tsai KH, 2008, J BUS VENTURING, V23, P91, DOI 10.1016/j.jbusvent.2005.07.002; Tsai WP, 2001, ACAD MANAGE J, V44, P996, DOI 10.2307/3069443; VANDEVEN AH, 1995, ACAD MANAGE REV, V20, P510, DOI 10.2307/258786; Warner AG, 2006, J MANAGE, V32, P279, DOI 10.1177/0149206305280108; Willyard C, 2009, NAT MED, V15, P466, DOI 10.1038/nm0509-466b; Zahra SA, 2008, J BUS VENTURING, V23, P195, DOI 10.1016/j.jbusvent.2007.01.001	95	13	16	4	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2017	12	2							e0172488	10.1371/journal.pone.0172488	http://dx.doi.org/10.1371/journal.pone.0172488			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL5SX	28231332	Green Published, gold, Green Submitted			2022-12-27	WOS:000394682400048
J	Skielboe, AK; Bandholm, TQ; Hakmann, S; Mourier, M; Kallemose, T; Dixen, U				Skielboe, Ane Katrine; Bandholm, Thomas Quaade; Hakmann, Stine; Mourier, Malene; Kallemose, Thomas; Dixen, Ulrik			Cardiovascular exercise and burden of arrhythmia in patients with atrial fibrillation A randomized controlled trial	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; RISK; REDUCTION; PREVALENCE; DURATION; ADULTS; LIFE; ECG	Background Physical activity at moderate-high intensity is recommended to prevent lifestyle diseases. Patients with atrial fibrillation are at risk of a sedentary lifestyle due to fear of exercise-induced episodes of atrial fibrillation. The burden of arrhythmia can be reduced by physical exercise. The effect of exercise intensity on burden of atrial fibrillation needs to be studied further. Methods and results In a 12-week randomized controlled trial, 76 patients with paroxysmal/persistent atrial fibrillation were allocated to perform exercise at either low intensity or high intensity (50% and 80% of maximal perceived exertion, respectively). Primary outcome was burden of AF measured by daily electrocardiography-reporting during 12 weeks. Secondarily, change in maximal oxygen uptake (peak VO2) and 1-year hospitalization was compared between low and high intensity exercise. Sixty-three patients completed the follow-up. In the intention-to-treat analysis, we found no statistical difference in burden of atrial fibrillation between low and high intensity exercise (incidence rate ratio 0.742, 95% CI 0.29-1.91, P = 0.538). No serious adverse events were reported and there was no difference in hospitalization between the two exercise groups. Both exercise groups improved significantly in peak VO2 (low intensity: 3.62 mL O-2/kg/min, SD 3.77; high intensity: 2.87 mL O-2/kg/min, SD 4.98), with no statistical difference between-groups (mean difference: 0.76 mL O-2/kg/min, 95% CI -3.22-1.7). Conclusions High intensity physical exercise was not superior to low intensity physical exercise in reducing burden of atrial fibrillation. HI exercise was well tolerated; no evidence of an increased risk was found for HI compared to LI exercise. Larger studies are required to further prove our findings.	[Skielboe, Ane Katrine; Hakmann, Stine; Dixen, Ulrik] Copenhagen Univ Hosp Amager & Hvidovre, Dept Cardiol, Hvidovre, Denmark; [Bandholm, Thomas Quaade; Kallemose, Thomas] Copenhagen Univ Hosp Amager & Hvidovre, Clin Res Ctr, Hvidovre, Denmark; [Bandholm, Thomas Quaade; Mourier, Malene] Copenhagen Univ Hosp Amager & Hvidovre, Dept Phys Therapy, Phys Med & Rehabil Res Copenhagen PMR C, Hvidovre, Denmark; [Bandholm, Thomas Quaade] Copenhagen Univ Hosp Amager & Hvidovre, Dept Orthoped Surg, Hvidovre, Denmark		Skielboe, AK (corresponding author), Copenhagen Univ Hosp Amager & Hvidovre, Dept Cardiol, Hvidovre, Denmark.	a.k.skielboe@gmail.com	Bandholm, Thomas/AAZ-8632-2020	Bandholm, Thomas/0000-0001-6884-1971; Skielboe, Ane Katrine/0000-0001-9523-3760	Danish Heart Foundation [13-04-R95-A4645-22748, 14-R97-A5061]; Knud & Dagny Gad Foundation [42680/Ivo]; Hvidovre Hospital's Research Foundation; Eva & Henry Fraenkel's Foundation; Health Foundation; Thorkild Steenbeck's Grant; Master Joiner Sophus Jacobsen & wife Astrid Jacobsens Foundation; Den Midtjyske Bladfond; Toyota Foundation; Arvid Nilsson's Foundation; C. C. Klestrup & wife Henriette Klestrups Memorial Grant	Danish Heart Foundation; Knud & Dagny Gad Foundation; Hvidovre Hospital's Research Foundation; Eva & Henry Fraenkel's Foundation; Health Foundation; Thorkild Steenbeck's Grant; Master Joiner Sophus Jacobsen & wife Astrid Jacobsens Foundation; Den Midtjyske Bladfond; Toyota Foundation; Arvid Nilsson's Foundation; C. C. Klestrup & wife Henriette Klestrups Memorial Grant	Several private and public foundations have kindly offered grant support: The Danish Heart Foundation (AKS), Grant number 13-04-R95-A4645-22748 & 14-R97-A5061, https://www.njerteforeningen.dk/?gclid=CP2WoauGwMwCFSLicgodtVgMUA; Knud & Dagny Gad Foundation, Grant number 42680/Ivo, http://gadandresenfonden.DK; Hvidovre Hospital's Research Foundation (AKS), Grant number n.a., http://www.hospital.dk/forskning/Sider/Forskning.aspx; Eva & Henry Fraenkel's Foundation (UD), Grant number n.a., http://www.fraenkelsmindefond.org/;, The Health Foundation (UD), Grant number n.a., http://www.helsefonden.dk/; Thorkild Steenbeck's Grant (UD), Grant number n.a., no website; Master Joiner Sophus Jacobsen & wife Astrid Jacobsens Foundation (UD), Grant number n.a., no website; Den Midtjyske Bladfond (UD), Grant number n.a., no website; Toyota Foundation (UD), Grant number n. a., no website. Arvid Nilsson's Foundation (UD), Grant number n.a., http://arvidnilssonsfond.dk/; C. C. Klestrup & wife Henriette Klestrups Memorial Grant (UD), Grant number n.a., no website. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abed HS, 2013, JAMA-J AM MED ASSOC, V310, P2050, DOI 10.1001/jama.2013.280521; Andersen K, 2013, ECOSYSTEMS, P1; [Anonymous], 2009, NUTR REV, V67, P114, DOI 10.1111/j.1753-4887.2008.00136.x; ATWOOD JE, 1988, J AM COLL CARDIOL, V11, P508, DOI 10.1016/0735-1097(88)91524-0; Balady GJ, 2010, CIRCULATION, V122, P191, DOI 10.1161/CIR.0b013e3181e52e69; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; Boriani G, 2011, STROKE, V42, P1768, DOI 10.1161/STROKEAHA.110.609297; Botto GL, 2009, J CARDIOVASC ELECTR, V20, P241, DOI 10.1111/j.1540-8167.2008.01320.x; Bubien RS, 1996, CIRCULATION, V94, P1585, DOI 10.1161/01.CIR.94.7.1585; Capucci A, 2005, J AM COLL CARDIOL, V46, P1913, DOI 10.1016/j.jacc.2005.07.044; COUMEL P, 1994, EUR HEART J, V15, P9, DOI 10.1093/eurheartj/15.suppl_A.9; Dieberg G, 2015, J APPL PHYSIOL, V119, P726, DOI 10.1152/japplphysiol.00904.2014; Doliwa PS, 2009, SCAND CARDIOVASC J, V43, P163, DOI 10.1080/14017430802593435; DUNBAR CC, 1992, MED SCI SPORT EXER, V24, P94; Edvardsen E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085276; Giacomantonio NB, 2013, CAN J CARDIOL, V29, P483, DOI 10.1016/j.cjca.2012.07.003; Glotzer TV, 2009, CIRC-ARRHYTHMIA ELEC, V2, P474, DOI 10.1161/CIRCEP.109.849638; Hegbom Finn, 2006, J Cardiopulm Rehabil, V26, P24, DOI 10.1097/00008483-200601000-00005; Hendrikx T, 2014, BMC CARDIOVASC DISOR, V14, DOI 10.1186/1471-2261-14-41; Hoffmann TC, 2014, BMJ-BRIT MED J, V348, DOI [10.1136/bmj.g1687, 10.1055/s-0041-111066]; Ingemansson MP, 1998, HEART, V80, P71, DOI 10.1136/hrt.80.1.71; Johnson JS, 1998, CHEST, V113, P816, DOI 10.1378/chest.113.3.816; Kwok CS, 2014, INT J CARDIOL, V177, P467, DOI 10.1016/j.ijcard.2014.09.104; Lowres N, 2012, EUR J PREV CARDIOL, V19, P1091, DOI 10.1177/1741826711422505; Malmo V, 2016, CIRCULATION; Members AF, 2012, EUROPACE, V14, P1385, DOI [10.1093/europace/eus305, DOI 10.1093/EUROPACE/EUS305]; Moher David, 2012, Int J Surg, V10, P28, DOI 10.1016/j.ijsu.2011.10.001; Mozaffarian D, 2008, CIRCULATION, V118, P800, DOI 10.1161/CIRCULATIONAHA.108.785626; Myrstad M, 2014, AM J CARDIOL, V114, P1229, DOI 10.1016/j.amjcard.2014.07.047; Olshansky B, 2014, PHYSICIAN SPORTSMED, V42, P45, DOI 10.3810/psm.2014.02.2047; Osbak PS, 2011, AM HEART J, V162, P1080, DOI 10.1016/j.ahj.2011.09.013; Pathak RK, 2015, J AM COLL CARDIOL, V66, P985, DOI 10.1016/j.jacc.2015.06.488; Pathak RK, 2014, J AM COLL CARDIOL, V64, P2222, DOI 10.1016/j.jacc.2014.09.028; Plisiene J, 2008, CLIN RES CARDIOL, V97, P820, DOI 10.1007/s00392-008-0692-3; Reed JL, 2013, CAN J CARDIOL, V29, P1721, DOI 10.1016/j.cjca.2013.09.020; Stefansdottir H, 2011, EUROPACE, V13, P1110, DOI 10.1093/europace/eur132; Turakhia MP, 2015, CIRC-ARRHYTHMIA ELEC, V8, P1040, DOI 10.1161/CIRCEP.114.003057; Wanahita N, 2008, AM HEART J, V155, P310, DOI 10.1016/j.ahj.2007.10.004; Wang TJ, 2004, JAMA-J AM MED ASSOC, V292, P2471, DOI 10.1001/jama.292.20.2471; Wilhelm M, 2014, EUR J PREV CARDIOL, V21, P1040, DOI 10.1177/2047487313476414; World Health Organization, 2021, CONSOLIDATED GUIDELI	41	20	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2017	12	2							e0170060	10.1371/journal.pone.0170060	http://dx.doi.org/10.1371/journal.pone.0170060			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5SX	28231325	Green Submitted, Green Published, gold			2022-12-27	WOS:000394682400002
J	Ao, WY; Clifford, A; Corpuz, M; Jenison, R				Ao, Wanyuan; Clifford, Adrianne; Corpuz, Maylene; Jenison, Robert			A novel approach to eliminate detection of contaminating Staphylococcal species introduced during clinical testing	PLOS ONE			English	Article							COAGULASE-NEGATIVE STAPHYLOCOCCI; REAL-TIME-PCR; BLOOD CULTURE; MOLECULAR METHODS; BACTERIAL; INTERVENTION; MISMATCHES; SAMPLES; AUREUS; REDUCE	We describe here a strategy that can distinguish between Staphylococcus species truly present in a clinical sample from contaminating Staphylococcus species introduced during the testing process. Contaminating Staphylococcus species are present at low levels in PCR reagents and colonize lab personnel. To eliminate detection of contaminants, we describe an approach that utilizes addition of sufficient quantities of either non-target Staphylococcal cells (Staphylococcus succinus or Staphylococcus muscae) or synthetic oligonucleotide templates to helicase dependent isothermal amplification reactions to consume Staphylococcus-specific tuf and mecA gene primers such that contaminating Staphylococcus amplification is suppressed to below assay limits of detection. The suppressor template DNA is designed with perfect homology to the primers used in the assay but an internal sequence that is unrelated to the Staphylococcal species targeted for detection. Input amount of the suppressor is determined by a mathematical model described herein and is demonstrated to completely suppress contaminating levels of Staphylococcus while not negatively impacting the appropriate clinical assay limit of detection. We have applied this approach to improve the specificity of detection of Staphylococcus species present in positive blood cultures using a chip-based array that produces results visible to the unaided eye.	[Ao, Wanyuan; Clifford, Adrianne; Corpuz, Maylene; Jenison, Robert] Great Basin Corp, Salt Lake City, UT 84111 USA		Jenison, R (corresponding author), Great Basin Corp, Salt Lake City, UT 84111 USA.	rjenison@gbscience.com						Al-Hamad A, 2016, J INFECT PUBLIC HEAL, V9, P66, DOI 10.1016/j.jiph.2015.06.007; Ao W, 2016, US Patent, Patent No. 9434999; Becker K, 2006, J CLIN MICROBIOL, V44, P229, DOI 10.1128/JCM.44.1.229-231.2006; Corless CE, 2000, J CLIN MICROBIOL, V38, P1747, DOI 10.1128/JCM.38.5.1747-1752.2000; Dobosy JR, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-80; Ge Y, 2011, CHINESE MED J-PEKING, V124, P4002, DOI 10.3760/cma.j.issn.0366-6999.2011.23.029; Grice EA, 2009, SCIENCE, V324, P1190, DOI 10.1126/science.1171700; Hicke B, 2012, J CLIN MICROBIOL, V50, P2681, DOI 10.1128/JCM.00621-12; Humphrey B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132954; Jacobs MR, 2013, TRANSFUSION, V53, P2690, DOI 10.1111/trf.12150; Klaschik S, 2002, MOL BIOTECHNOL, V22, P231, DOI 10.1385/MB:22:3:231; Kolman Sara, 2010, BMC Res Notes, V3, P110, DOI 10.1186/1756-0500-3-110; Leber A, 2010, 50 ANN INT C ANT AG; Lefever S, 2013, CLIN CHEM, V59, P1470, DOI 10.1373/clinchem.2013.203653; Lehmann LE, 2008, MED MICROBIOL IMMUN, V197, P313, DOI 10.1007/s00430-007-0063-0; Lucignano B, 2011, J CLIN MICROBIOL, V49, P2252, DOI 10.1128/JCM.02460-10; Marlowe EM, 2003, J CLIN MICROBIOL, V41, P1266, DOI 10.1128/JCM.41.3.1266-1269.2003; Pasko C, 2012, J CLIN MICROBIOL, V50, P810, DOI 10.1128/JCM.05534-11; Peacock SJ, 2001, TRENDS MICROBIOL, V9, P605, DOI 10.1016/S0966-842X(01)02254-5; Ramirez P, 2015, AM J INFECT CONTROL, V43, P844, DOI 10.1016/j.ajic.2015.04.183; Rea L, 2012, IVD TECHNOLOGY, V18, P17; Schutz E, 1999, BIOTECHNIQUES, V27, P1218, DOI 10.2144/99276bc04; SHEINESS D, 1992, J CLIN MICROBIOL, V30, P642, DOI 10.1128/JCM.30.3.642-648.1992; Sollid JUE, 2014, INFECT GENET EVOL, V21, P531, DOI 10.1016/j.meegid.2013.03.020; Souvenir D, 1998, J CLIN MICROBIOL, V36, P1923, DOI 10.1128/JCM.36.7.1923-1926.1998; Van Hal SJ, 2008, SCAND J INFECT DIS, V40, P551, DOI 10.1080/00365540701877304; Weddle G, 2011, PEDIATR EMERG CARE, V27, P179, DOI 10.1097/PEC.0b013e31820d652b	27	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2017	12	2							e0171915	10.1371/journal.pone.0171915	http://dx.doi.org/10.1371/journal.pone.0171915			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5SK	28225823	Green Published, Green Submitted, gold			2022-12-27	WOS:000394680900024
J	Hernandez, BY; Zhu, XM; Goodman, MT; Gatewood, R; Mendiola, P; Quinata, K; Paulino, YC				Hernandez, Brenda Y.; Zhu, Xuemei; Goodman, Marc T.; Gatewood, Robert; Mendiola, Paul; Quinata, Katrina; Paulino, Yvette C.			Betel nut chewing, oral premalignant lesions, and the oral microbiome	PLOS ONE			English	Article							STREPTOCOCCUS-ANGINOSUS INFECTION; SQUAMOUS-CELL CARCINOMA; ARECA NUT; HUMAN-PAPILLOMAVIRUS; BACTERIA PRESENT; HEAD; PERIODONTITIS; CANCER; EPIDEMIOLOGY; ASSOCIATION	Oral cancers are attributed to a number of causal agents including tobacco, alcohol, human papillomavirus (HPV), and areca (betel) nut. Although betel nut chewing has been established as an independent cause of oral cancer, the mechanisms of carcinogenesis are poorly understood. An investigation was undertaken to evaluate the influence of betel nut chewing on the oral microbiome and oral premalignant lesions. Study participants were recruited from a dental clinic in Guam. Structured interviews and oral examinations were performed. Oral swabbing and saliva samples were evaluated by 454 pyrosequencing of the V3-V5 region of the 16S rRNA bacterial gene and genotyped for HPV. One hundred twenty-two adults were enrolled including 64 current betel nut chewers, 37 former chewers, and 21 with no history of betel nut use. Oral premalignant lesions, including leukoplakia and submucous fibrosis, were observed in 10 chewers. Within-sample bacterial diversity was significantly lower in long-term (>= 10 years) chewers vs. never chewers and in current chewers with oral lesions vs. individuals without lesions. Between-sample bacterial diversity based on Unifrac distances significantly differed by chewing status and oral lesion status. Current chewers had significantly elevated levels of Streptococcus infantis and higher and lower levels of distinct taxa of the Actinomyces and Streptococcus genera. Long-term chewers had reduced levels of Parascardovia and Streptococcus. Chewers with oral lesions had significantly elevated levels of Oribacterium, Actinomyces, and Streptococcus, including Streptococcus anginosus. In multivariate analyses, controlling for smoking, oral HPV, S. anginosus, and S. infantis levels, current betel nut chewing remained the only predictor of oral premalignant lesions. Our study provides evidence that betel nut chewing alters the oral bacterial microbiome including that of chewers who develop oral premalignant lesions. Nonetheless, whether microbial changes are involved in betel nut-induced oral carcinogenesis is only speculative. Further research is needed to discern the clinical significance of an altered oral microbiome and the mechanisms of oral cancer development in betel nut chewers.	[Hernandez, Brenda Y.; Zhu, Xuemei] Univ Hawaii, Ctr Canc, Honolulu, HI 96822 USA; [Goodman, Marc T.] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA; [Gatewood, Robert; Mendiola, Paul; Quinata, Katrina; Paulino, Yvette C.] Univ Guam, Canc Res Ctr, Mangilao, GU USA	Cancer Research Center of Hawaii; University of Hawaii System; Cedars Sinai Medical Center; University of Guam	Hernandez, BY (corresponding author), Univ Hawaii, Ctr Canc, Honolulu, HI 96822 USA.	brenda@cc.hawaii.edu		Goodman, Marc/0000-0002-4839-3021	National Cancer Institute [U54CA143727, U54CA143728]; NATIONAL CANCER INSTITUTE [P30CA071789, U54CA143727, U54CA143728] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by funding from grants U54CA143727 and U54CA143728 from the National Cancer Institute.	Aagaard K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036466; Aas JA, 2005, J CLIN MICROBIOL, V43, P5721, DOI 10.1128/JCM.43.11.5721-5732.2005; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Bebek G, 2012, HUM MOL GENET, V21, P1557, DOI 10.1093/hmg/ddr593; Bik EM, 2010, ISME J, V4, P962, DOI 10.1038/ismej.2010.30; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Casarin RCV, 2013, J PERIODONTAL RES, V48, P30, DOI 10.1111/j.1600-0765.2012.01498.x; Chang JS, 2013, ORAL ONCOL, V49, P1010, DOI 10.1016/j.oraloncology.2013.07.004; Chang LY, 2009, J PERIODONTAL RES, V44, P175, DOI 10.1111/j.1600-0765.2008.01104.x; Chang WC, 2006, INT J OBESITY, V30, P359, DOI 10.1038/sj.ijo.0803053; CHAO A, 1984, SCAND J STAT, V11, P265; Chapman MG, 1999, MAR ECOL PROG SER, V180, P257, DOI 10.3354/meps180257; Charlson ES, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015216; Chatrchaiwiwatana Supaporn, 2006, Journal of the Medical Association of Thailand, V89, P1004; Ciantar M, 2005, J PERIODONTOL, V76, P194, DOI 10.1902/jop.2005.76.2.194; Dahlen G, 2010, ANAEROBE, V16, P331, DOI 10.1016/j.anaerobe.2010.04.003; DAVE BJ, 1991, MUTAGENESIS, V6, P159, DOI 10.1093/mutage/6.2.159; Dayama A, 2011, ASIAN PAC J CANCER P, V12, P1333; De Miranda CM, 1986, INT DENT J, V46, P350; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Faith DP, 2006, PHYLOGENETIC DIVERSI; GOOD IJ, 1956, BIOMETRIKA, V43, P45; Gupta PC, 2004, ANN ACAD MED SINGAP, V33, P31; Gupta PC, 2002, ADDICT BIOL, V7, P77, DOI 10.1080/13556210020091437; Haddock Robert L, 2006, Asian Pac J Cancer Prev, V7, P411; Hernandez BY, 2006, J CLIN MICROBIOL, V44, P513, DOI 10.1128/JCM.44.2.513-517.2006; Hezel M, 2013, ORAL DIS; Hooper SJ, 2007, J MED MICROBIOL, V56, P1651, DOI 10.1099/jmm.0.46918-0; Hooper SJ, 2006, J CLIN MICROBIOL, V44, P1719, DOI 10.1128/JCM.44.5.1719-1725.2006; Human Microbiome Project Consortium, 2012, Nature, V486, P207, DOI 10.1038/nature11234; Humans IWGotEoCRt, 2012, REV HUM CARC E; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kreimer AR, 2005, CANCER EPIDEM BIOMAR, V14, P467, DOI 10.1158/1055-9965.EPI-04-0551; Kuczynski Justin, 2012, Curr Protoc Microbiol, VChapter 1, DOI [10.1002/0471250953.bi1007s36, 10.1002/9780471729259.mc01e05s27]; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lozupone CA, 2007, APPL ENVIRON MICROB, V73, P1576, DOI 10.1128/AEM.01996-06; Mager DL, 2005, J TRANSL MED, V3, DOI 10.1186/1479-5876-3-27; Mielke P. W., 2001, PERMUTATION METHODS; Morita E, 2003, CANCER SCI, V94, P492, DOI 10.1111/j.1349-7006.2003.tb01471.x; Moritani K, 2015, ORAL DIS, V21, P748, DOI 10.1111/odi.12341; Mortazavi Hamed, 2014, J Dent Res Dent Clin Dent Prospects, V8, P6, DOI 10.5681/joddd.2014.002; Moutasim KA, 2011, J PATHOL, V223, P366, DOI 10.1002/path.2786; Nagy KN, 1998, ORAL ONCOL, V34, P304, DOI 10.1016/S1368-8375(98)80012-2; Papke RL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140907; Parmar Girish, 2008, J Oral Sci, V50, P57, DOI 10.2334/josnusd.50.57; Paulino YC, 2014, BMC ORAL HEALTH, V14, DOI 10.1186/1472-6831-14-151; Paulino Yvette C, 2011, Hawaii J Public Health, V3, P19; Pushalkar S, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-144; Saraiya M, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv086; Sasaki M, 2005, ORAL DIS, V11, P151, DOI 10.1111/j.1601-0825.2005.01051.x; Sasaki M, 2001, J MED MICROBIOL, V50, P952, DOI 10.1099/0022-1317-50-11-952; Schmidt BL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098741; Segata N, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r42; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI DOI 10.1002/J.1538-7305.1948.TB01338.X; Strickland SS, 1997, ANN HUM BIOL, V24, P453, DOI 10.1080/03014469700005212; Tateda M, 2000, INT J MOL MED, V6, P699; Tezal M, 2009, CANCER EPIDEM BIOMAR, V18, P2406, DOI 10.1158/1055-9965.EPI-09-0334; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wu J, 2016, ISME J, V10, P2435, DOI 10.1038/ismej.2016.37	63	62	66	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2017	12	2							e0172196	10.1371/journal.pone.0172196	http://dx.doi.org/10.1371/journal.pone.0172196			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5SK	28225785	gold, Green Submitted, Green Published			2022-12-27	WOS:000394680900031
J	Li, J; Zhou, WX; Francisco, P; Wong, R; Zhang, DK; Smith, SM				Li, Jing; Zhou, Wenxu; Francisco, Perigio; Wong, Russell; Zhang, Dongke; Smith, Steven M.			Inhibition of Arabidopsis chloroplast beta-amylase BAM3 by maltotriose suggests a mechanism for the control of transitory leaf starch mobilisation	PLOS ONE			English	Article							ADP-GLUCOSE PYROPHOSPHORYLASE; POSTTRANSLATIONAL REDOX-MODIFICATION; ENZYME; DEGRADATION; BREAKDOWN; LEAVES; CALCIUM; LIGHT; PHOSPHOGLUCAN; METABOLISM	Starch breakdown in leaves at night is tightly matched to the duration of the dark period, but the mechanism by which this regulation is achieved is unknown. In Arabidopsis chloroplasts, beta-amylase BAM3 hydrolyses transitory starch, producing maltose and residual maltotriose. The aim of the current research was to investigate the regulatory and kinetic properties of BAM3. The BAM3 protein was expressed in Escherichia coli and first assayed using a model substrate. Enzyme activity was stimulated by treatment with dithiothreitol and was increased 40% by 2-10 mu M Ca2+ but did not require Mg2+. In order to investigate substrate specificity and possible regulatory effects of glucans, we developed a GC-MS method to assay reaction products. BAM3 readily hydrolysed maltohexaose with a K-m of 1.7 mM and K-cat of 4300 s(-1) but activity was 3.4-fold lower with maltopentaose and was negligible with maltotetraose. With maltohexaose or amylopectin as substrates and using [UL-C-13(12)]maltose in an isotopic dilution method, we discovered that BAM3 activity is inhibited by maltotriose at physiological (mM) concentrations, but not by maltose. In contrast, the extracellular beta-amylase of barley is only weakly inhibited by maltotriose. Our results may explain the impaired starch breakdown in maltotriose-accumulating mutants such as dpe1 which lacks the chloroplast disproportionating enzyme (DPE1) metabolising maltotriose to glucose. We hypothesise that the rate of starch breakdown in leaves can be regulated by inhibition of BAM3 by maltotriose, the concentration of which is determined by DPE, which is in turn influenced by the stromal concentration of glucose. Since the plastid glucose transporter pGlcT catalyses facilitated diffusion between stroma and cytosol, changes in consumption of glucose in the cytosol are expected to lead to concomitant changes in plastid glucose and maltotriose, and hence compensatory changes in BAM3 activity.	[Li, Jing; Francisco, Perigio; Wong, Russell] Univ Western Australia, Sch Plant Biol, Nedlands, WA, Australia; [Zhou, Wenxu; Zhang, Dongke] Univ Western Australia, Ctr Energy, Fac Engn Comp & Math, Nedlands, WA, Australia; [Smith, Steven M.] Univ Tasmania, Sch Biol Sci, Hobart, Tas, Australia	University of Western Australia; University of Western Australia; University of Tasmania	Smith, SM (corresponding author), Univ Tasmania, Sch Biol Sci, Hobart, Tas, Australia.	Steven.Smith@utas.edu.au	Zhou, Wenxu/T-6917-2019; Smith, Steven/G-7183-2015	Zhang, Dongke/0000-0003-0715-7986; Smith, Steven/0000-0001-5661-9994	Australian Research Council [DP0666434, FF0457721, CE0561495, LP100200135, LP100200137]	Australian Research Council(Australian Research Council)	This work was funded by the Australian Research Council; Grants DP0666434, FF0457721, CE0561495, LP100200135 and LP100200137, http://www.arc.gov.au/.; We acknowledge the Australian Research Council for financial support.	Baunsgaard L, 2005, PLANT J, V41, P595, DOI 10.1111/j.1365-313X.2004.02322.x; CHAPMAN GW, 1972, BIOCHIM BIOPHYS ACTA, V276, P491, DOI 10.1016/0005-2744(72)91010-8; Chia T, 2004, PLANT J, V37, P853, DOI 10.1111/j.1365-313X.2003.02012.x; Cho MH, 2011, NEW PHYTOL, V190, P101, DOI 10.1111/j.1469-8137.2010.03580.x; Critchley JH, 2001, PLANT J, V26, P89, DOI 10.1046/j.1365-313x.2001.01012.x; Dahot MU, 2004, J ENZYM INHIB MED CH, V19, P157, DOI 10.1080/14756360310001650255; Delatte T, 2006, J BIOL CHEM, V281, P12050, DOI 10.1074/jbc.M513661200; Edner C, 2007, PLANT PHYSIOL, V145, P17, DOI 10.1104/pp.107.104224; Fettke J, 2006, PLANT J, V46, P668, DOI 10.1111/j.1365-313X.2006.02732.x; Fulton DC, 2008, PLANT CELL, V20, P1040, DOI 10.1105/tpc.107.056507; Gibon Y, 2004, PLANT J, V39, P847, DOI 10.1111/j.1365-313X.2004.02173.x; Hendriks JHM, 2003, PLANT PHYSIOL, V133, P838, DOI 10.1104/pp.103.024513; Ishijima S, 2003, ARCH BIOCHEM BIOPHYS, V412, P126, DOI 10.1016/S0003-9861(03)00038-9; KAKEFUDA G, 1989, PLANT PHYSIOL, V91, P136, DOI 10.1104/pp.91.1.136; Kotting O, 2009, PLANT CELL, V21, P334, DOI 10.1105/tpc.108.064360; Kotting O, 2005, PLANT PHYSIOL, V137, P242, DOI 10.1104/pp.104.055954; KREIMER G, 1988, PLANT PHYSIOL, V86, P423, DOI 10.1104/pp.86.2.423; Lao NT, 1999, PLANT J, V20, P519, DOI 10.1046/j.1365-313X.1999.00625.x; Li J, 2009, ARCH BIOCHEM BIOPHYS, V489, P92, DOI 10.1016/j.abb.2009.07.024; Love J, 2004, PLANT CELL, V16, P956, DOI 10.1105/tpc.020214; Ma Y, 2000, J CEREAL SCI, V31, P335, DOI 10.1006/jcrs.2000.0303; Mikkelsen R, 2005, P NATL ACAD SCI USA, V102, P1785, DOI 10.1073/pnas.0406674102; Monroe JD, 2014, PLANT PHYSIOL, V166, P1748, DOI 10.1104/pp.114.246421; Niittyla T, 2004, SCIENCE, V303, P87, DOI 10.1126/science.1091811; Ritte G, 2004, PLANT PHYSIOL, V135, P2068, DOI 10.1104/pp.104.041301; Ritte G, 2000, PLANT J, V21, P387, DOI 10.1046/j.1365-313x.2000.00683.x; Rolland F, 2006, ANNU REV PLANT BIOL, V57, P675, DOI 10.1146/annurev.arplant.57.032905.105441; Sai JQ, 2002, PLANT CELL, V14, P1279, DOI 10.1105/tpc.000653; Santelia D, 2015, CURR OPIN PLANT BIOL, V25, P1, DOI 10.1016/j.pbi.2015.04.003; Santelia D, 2011, PLANT CELL, V23, P4096, DOI 10.1105/tpc.111.092155; SCIALDONE A, 2013, ELIFE, V2, P64689, DOI DOI 10.1104/PP.114.246421; Servaites JC, 2002, J EXP BOT, V53, P1581, DOI 10.1093/jxb/erf009; Seung D, 2013, J BIOL CHEM, V288, P33620, DOI 10.1074/jbc.M113.514794; Smith AM, 2005, ANNU REV PLANT BIOL, V56, P73, DOI 10.1146/annurev.arplant.56.032604.144257; Sparla F, 2006, PLANT PHYSIOL, V141, P840, DOI 10.1104/pp.106.079186; Stettler M, 2009, MOL PLANT, V2, P1233, DOI 10.1093/mp/ssp093; STITT M, 1978, BIOCHIM BIOPHYS ACTA, V544, P200, DOI 10.1016/0304-4165(78)90223-4; Stitt M, 2012, CURR OPIN PLANT BIOL, V15, P282, DOI 10.1016/j.pbi.2012.03.016; Sulpice R, 2014, MOL PLANT, V7, P137, DOI 10.1093/mp/sst127; SUN ZT, 1991, ARCH BIOCHEM BIOPHYS, V284, P298, DOI 10.1016/0003-9861(91)90299-X; Takaha T, 1996, J BIOL CHEM, V271, P2902, DOI 10.1074/jbc.271.6.2902; Tiessen A, 2002, PLANT CELL, V14, P2191, DOI 10.1105/tpc.003640; Valerio C, 2011, J EXP BOT, V62, P545, DOI 10.1093/jxb/erq288; Weber A, 2000, PLANT CELL, V12, P787, DOI 10.1105/tpc.12.5.787; Weber APM, 2011, ANNU REV PLANT BIOL, V62, P53, DOI 10.1146/annurev-arplant-042110-103903	45	12	12	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2017	12	2							e0172504	10.1371/journal.pone.0172504	http://dx.doi.org/10.1371/journal.pone.0172504			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5SK	28225829	gold, Green Published, Green Accepted			2022-12-27	WOS:000394680900047
J	Zhao, Y; Tang, XX; Zhao, XW; Wang, Y				Zhao, Yan; Tang, Xuexi; Zhao, Xiaowei; Wang, You			Effect of various nitrogen conditions on population growth, temporary cysts and cellular biochemical compositions of Karenia mikimotoi	PLOS ONE			English	Article							HARMFUL ALGAL BLOOMS; RED TIDE; HETEROCAPSA-CIRCULARISQUAMA; PHAEODACTYLUM-TRICORNUTUM; PHOTOSYNTHETIC APPARATUS; DINOFLAGELLATE BLOOMS; MARINE-PHYTOPLANKTON; NUTRIENT; EUTROPHICATION; BAY	The harmful algal bloom (HAB)-forming dinoflagellate Karenia mikimotoi was exposed to different nitrogen (N) conditions, in order to study the population growth, temporary cyst production and cellular biochemical compositions in laboratory. The results indicated the population growth of K. mikimotoi was inhibited by different levels of N starvation but showed similar fast recovery after the resupplement of N, and temporary cysts were induced in the period of N starvation. K. mikimotoi grew well in inorganic (NO3-, NO2- and NH4+) and organic (urea) nitrogen sources, but the growth parameters (K, T-p, r) showed differences when simulated by Logistic model regressions. When the cellular organic compounds were measured simultaneously, K. mikimotoi cultured in urea produced more short-chained fatty acids while K. mikimotoi cultured in NH4+ produced more non-fatty acids compounds, indicating the potential change of toxins production cultured by various N sources. We concluded that K. mikimotoi could adapt to fluctuating N environments typical of coastal environments including total N concentration (deficiency or recovery) and relative compositions (different N sources).	[Zhao, Yan; Tang, Xuexi; Zhao, Xiaowei; Wang, You] Ocean Univ China, Dept Marine Ecol, Qingdao, Peoples R China	Ocean University of China	Wang, Y (corresponding author), Ocean Univ China, Dept Marine Ecol, Qingdao, Peoples R China.	wangyou@ouc.edu.cn			National Science Foundation of China [U 1406403]	National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Science Foundation of China, grant number: U 1406403, (http://wm.nsfc.gov.cn/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DM, 2002, ESTUARIES, V25, P704, DOI 10.1007/BF02804901; ANDERSON DM, 1985, J EXP MAR BIOL ECOL, V86, P1, DOI 10.1016/0022-0981(85)90039-5; ANTIA NJ, 1991, PHYCOLOGIA, V30, P1, DOI 10.2216/i0031-8884-30-1-1.1; Arrigo KR, 2005, NATURE, V437, P349, DOI 10.1038/nature04159; Arzul G., 1995, P395; Chen Y, 2011, CHIN J OCEANOL LIMN, V29, P860, DOI 10.1007/s00343-011-0514-8; Eker-Develi E, 2006, AQUAT SCI, V68, P28, DOI 10.1007/s00027-005-0810-5; Fan C, 2003, MAR BIOL, V142, P949, DOI 10.1007/s00227-003-1017-8; Fistarol GO, 2004, ENVIRON MICROBIOL, V6, P791, DOI 10.1111/j.1462-2920.2004.00609.x; FURNAS MJ, 1983, J PLANKTON RES, V5, P657, DOI 10.1093/plankt/5.5.657; Garces E, 2002, J PLANKTON RES, V24, P681, DOI 10.1093/plankt/24.7.681; Garces E, 1998, J PHYCOL, V34, P880, DOI 10.1046/j.1529-8817.1998.340880.x; GEIDER RJ, 1993, J PHYCOL, V29, P755, DOI 10.1111/j.0022-3646.1993.00755.x; Gentien P, 2007, PHILOS T R SOC B, V362, P1937, DOI 10.1098/rstb.2007.2079; Glibert PM, 2011, CHIN J OCEANOL LIMN, V29, P724, DOI 10.1007/s00343-011-0502-z; GLIBERT PM, 1991, LIMNOL OCEANOGR, V36, P895, DOI 10.4319/lo.1991.36.5.0895; Glibert PM, 2006, BIOGEOCHEMISTRY, V77, P441, DOI 10.1007/s10533-005-3070-5; GREENE RM, 1992, PLANT PHYSIOL, V100, P565, DOI 10.1104/pp.100.2.565; Guillard R.R.L., 1975, CULTURE MARINE INVER, P29, DOI [10.1007/978-1-4615-8714-9_3, DOI 10.1007/978-1-4615-8714-9_3]; HALLEGRAEFF GM, 1993, PHYCOLOGIA, V32, P79, DOI 10.2216/i0031-8884-32-2-79.1; Heisler J, 2008, HARMFUL ALGAE, V8, P3, DOI 10.1016/j.hal.2008.08.006; Howarth RW, 2006, LIMNOL OCEANOGR, V51, P364, DOI 10.4319/lo.2006.51.1_part_2.0364; Lee J, 2015, HARMFUL ALGAE, V47, P126, DOI 10.1016/j.hal.2015.06.002; Lei QY, 2011, HARMFUL ALGAE, V12, P39, DOI 10.1016/j.hal.2011.08.010; Leong SCY, 2004, TOXICON, V43, P407, DOI 10.1016/j.toxicon.2004.01.015; LEVASSEUR M, 1993, J PHYCOL, V29, P587, DOI 10.1111/j.0022-3646.1993.00587.x; Li J, 2010, HARMFUL ALGAE, V9, P531, DOI 10.1016/j.hal.2010.03.007; Li J, 2009, MAR ECOL PROG SER, V383, P11, DOI 10.3354/meps07975; Lin SJ, 2015, SCIENCE, V350, P691, DOI 10.1126/science.aad0408; Long H., 2005, J FUJIAN FISH, V4, P22, DOI [10.3969/j.issn.1006-5601.2005.04.006, DOI 10.3969/J.ISSN.1006-5601.2005.04.006]; Ma Long, 2010, Marine Environmental Science, V29, P794; Marasovic I, 1989, ENCYSTMENT EXCYSTMEN; MCCARTHY JJ, 1977, LIMNOL OCEANOGR, V22, P996, DOI 10.4319/lo.1977.22.6.0996; Miller C. B., 2003, BIOL OCEANOGRAPHY; Nagasaki K, 2000, NIPPON SUISAN GAKK, V66, P666; Nezan E, 2014, HARMFUL ALGAE, V40, P75, DOI 10.1016/j.hal.2014.10.006; Olli K, 2004, MAR BIOL, V145, P1, DOI 10.1007/s00227-004-1295-9; Olli K, 2002, J PHYCOL, V38, P145, DOI 10.1046/j.1529-8817.2002.01113.x; Parrish CC, 1998, PHYTOCHEMISTRY, V47, P783, DOI 10.1016/S0031-9422(97)00661-4; Parsons T.R., 1984, MANUAL BIOL CHEM MET; Pfiester L.A., 1987, Botanical Monographs (Oxford), V21, P611; SCIANDRA A, 1994, MAR ECOL PROG SER, V105, P301, DOI 10.3354/meps105301; Sellem F, 2000, WATER RES, V34, P550, DOI 10.1016/S0043-1354(99)00181-5; Shinizu Y, 1993, PARIS HARMFUL MARINE, P351; TAKAYAMA H, 1984, Bulletin of Plankton Society of Japan, V31, P7; Tang YZ, 2012, HARMFUL ALGAE, V20, P71, DOI 10.1016/j.hal.2012.08.001; Thessen AE, 2009, HARMFUL ALGAE, V8, P792, DOI 10.1016/j.hal.2009.01.003; Uchida T, 1999, J EXP MAR BIOL ECOL, V241, P285, DOI 10.1016/S0022-0981(99)00088-X; Wang Y, 2008, HARMFUL ALGAE, V7, P65, DOI 10.1016/j.hal.2007.05.005; Yang ZB, 2004, HARMFUL ALGAE, V3, P149, DOI 10.1016/j.hal.2003.10.001; Young EB, 2003, J PHYCOL, V39, P897, DOI 10.1046/j.1529-8817.2003.03042.x; Zhao Y, 2015, J PHYCOL, V51, P872, DOI 10.1111/jpy.12327; Zhao Y, 2015, J PHYCOL, V51, P726, DOI 10.1111/jpy.12314; Zhou Ming-Jiang, 2001, Chinese Bulletin of Life Sciences, V13, P54	54	15	18	3	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2017	12	2							e0171996	10.1371/journal.pone.0171996	http://dx.doi.org/10.1371/journal.pone.0171996			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5SK	28225802	Green Published, gold, Green Submitted			2022-12-27	WOS:000394680900026
J	Wu, PY; Cheng, CY; Liu, CE; Lee, YC; Yang, CJ; Tsai, MS; Cheng, SH; Lin, SP; Lin, DY; Wang, NC; Lee, YC; Sun, HY; Tang, HJ; Hung, CC				Wu, Pei-Ying; Cheng, Chien-Yu; Liu, Chun-Eng; Lee, Yi-Chien; Yang, Chia-Jui; Tsai, Mao-Song; Cheng, Shu-Hsing; Lin, Shih-Ping; Lin, De-Yu; Wang, Ning-Chi; Lee, Yi-Chieh; Sun, Hsin-Yun; Tang, Hung-Jen; Hung, Chien-Ching			Multicenter study of skin rashes and hepatotoxicity in antiretroviral-naive HIV-positive patients receiving non-nucleoside reverse-transcriptase inhibitor plus nucleoside reverse-transcriptase inhibitors in Taiwan	PLOS ONE			English	Article							TRANSMITTED DRUG-RESISTANCE; INFECTED PATIENTS; RISK-FACTORS; HIV-1-INFECTED PATIENTS; ADVERSE EVENTS; NEVIRAPINE USE; HEPATITIS-C; PROTEASE INHIBITORS; CLINICAL-TRIALS; VIRUS-INFECTION	Objectives Two nucleos(t) ide reverse-transcriptase inhibitors (NRTIs) plus 1 non-NRTI (nNRTI) remain the preferred or alternative combination antiretroviral therapy (cART) for antiretroviral-naive HIV-positive patients in Taiwan. The three most commonly used nNRTIs are nevirapine (NVP), efavirenz (EFV) and rilpivirine (RPV). This study aimed to determine the incidences of hepatotoxicity and skin rashes within 4 weeks of initiation of cART containing 1 nNRTI plus 2 NRTIs. Methods Between June, 2012 and November, 2015, all antiretroviral-naive HIV-positive adult patients initiating nNRTI-containing cART at 8 designated hospitals for HIV care were included in this retrospective observational study. According to the national HIV treatment guidelines, patients were assessed at baseline, 2 and 4 weeks of cART initiation, and subsequently every 8 to 12 weeks. Plasma HIV RNA load, CD4 cell count and aminotransferases were determined. The toxicity grading scale of the Division of AIDS (DAIDS) 2014 was used for reporting clinical and laboratory adverse events. Results During the 3.5-year study period, 2,341 patients initiated nNRTI-containing cART: NVP in 629 patients, EFV 1,363 patients, and RPV 349 patients. Rash of any grade occurred in 14.1% (n = 331) of the patients. In multiple logistic regression analysis, baseline CD4 cell counts (per 100-cell/mu l increase, adjusted odds ratio [AOR], 1.125; 95% confidence interval [95% CI], 1.031-1.228) and use of NVP (AOR, 2.443; 95% CI, 1.816-3.286) (compared with efavirenz) were independently associated with the development of skin rashes. Among the 1,455 patients (62.2%) with aminotransferase data both at baseline and week 4, 72 (4.9%) developed grade 2 or greater hepatotoxicity. In multiple logistic regression analysis, presence of antibody for hepatitis C virus (HCV) (AOR, 2.865; 95% CI, 1.439-5.704) or hepatitis B surface antigen (AOR, 2.397; 95% CI, 1.150-4.997), and development of skin rashes (AOR, 2.811; 95% CI, 1.051-7.521) were independently associated with the development of hepatotoxicity. Conclusions The baseline CD4 cell counts and use of NVP were associated with increased risk of skin rashes, while hepatotoxicity was independently associated with HCV or hepatitis B virus coinfection, and development of skin rashes in antiretroviral-naive HIV-positive Taiwanese patients within 4 weeks of initiation of nNRTI-containing regimens.	[Wu, Pei-Ying] Natl Taiwan Univ Hosp, Ctr Infect Control, Taipei, Taiwan; [Cheng, Chien-Yu; Cheng, Shu-Hsing] Taoyuan Gen Hosp, Dept Internal Med, Minist Hlth & Welf, Taoyuan, Taiwan; [Cheng, Chien-Yu] Natl Yang Ming Univ, Sch Publ Hlth, Taipei, Taiwan; [Liu, Chun-Eng] Changhua Christian Hosp, Dept Internal Med, Changhua, Taiwan; [Lee, Yi-Chien] Ditmanson Med Fdn Chia Yi Christian Hosp, Dept Internal Med, Chiayi, Taiwan; [Yang, Chia-Jui] Natl Yang Ming Univ, Sch Med, Taipei, Taiwan; [Yang, Chia-Jui; Tsai, Mao-Song] Far Eastern Mem Hosp, Dept Internal Med, New Taipei, Taiwan; [Cheng, Shu-Hsing] Taipei Med Univ, Sch Publ Hlth, Coll Publ Hlth & Nutr, Taipei, Taiwan; [Lin, Shih-Ping] Taichung Vet Gen Hosp, Dept Internal Med, Taichung, Taiwan; [Lin, De-Yu; Wang, Ning-Chi] Triserv Gen Hosp, Dept Internal Med, Taipei, Taiwan; [Lin, De-Yu; Wang, Ning-Chi] Natl Def Med Coll, Taipei, Taiwan; [Lee, Yi-Chieh] Lotung Poh Ai Hosp, Med Lo Hsu Fdn, Dept Internal Med, Ilan, Taiwan; [Sun, Hsin-Yun; Hung, Chien-Ching] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei, Taiwan; [Sun, Hsin-Yun; Hung, Chien-Ching] Natl Taiwan Univ, Coll Med, Taipei, Taiwan; [Tang, Hung-Jen] Chi Mei Med Ctr, Dept Internal Med, Tainan, Taiwan; [Tang, Hung-Jen] Chia Nan Univ Pharm & Sci, Dept Hlth & Nutr, Tainan, Taiwan; [Hung, Chien-Ching] Natl Taiwan Univ, Dept Parasitol, Coll Med, Taipei, Taiwan	National Taiwan University; National Taiwan University Hospital; National Yang Ming Chiao Tung University; Changhua Christian Hospital; National Yang Ming Chiao Tung University; Far Eastern Memorial Hospital; Taipei Medical University; Taichung Veterans General Hospital; Tri-Service General Hospital; National Defense Medical Center; National Taiwan University; National Taiwan University Hospital; National Taiwan University; Chi Mei Hospital; Chia Nan University of Pharmacy & Science; National Taiwan University	Sun, HY (corresponding author), Natl Taiwan Univ Hosp, Dept Internal Med, Taipei, Taiwan.; Sun, HY (corresponding author), Natl Taiwan Univ, Coll Med, Taipei, Taiwan.; Tang, HJ (corresponding author), Chi Mei Med Ctr, Dept Internal Med, Tainan, Taiwan.; Tang, HJ (corresponding author), Chia Nan Univ Pharm & Sci, Dept Hlth & Nutr, Tainan, Taiwan.	hysun@ntu.edu.tw; 8409d1@gmail.com	cheng, chien-yu/M-1108-2019; Lin, Deyu/AAC-7486-2019; Wang, Ning-Chi/GLT-7544-2022	cheng, chien-yu/0000-0002-1886-0370; Lin, Deyu/0000-0003-1400-4769; SUN, HSIN-YUN/0000-0003-0074-7721	Centers for Disease Control, Taiwan [MOHW104-CDC-C-114-000301]	Centers for Disease Control, Taiwan	This study was supported by grants from the Centers for Disease Control, Taiwan (MOHW104-CDC-C-114-000301 to C.H.).	[Anonymous], 2014, DIV AIDS DAIDS LABL; [Anonymous], 2015, GUIDELINES USE ANTIR; Bendavid E, 2011, AIDS, V25, P211, DOI 10.1097/QAD.0b013e328340fdf8; Chantarangsu S, 2009, PHARMACOGENET GENOM, V19, P139, DOI 10.1097/FPC.0b013e32831d0faf; Chu KM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009183; Cohen CJ, 2013, AIDS, V27, P939, DOI 10.1097/QAD.0b013e32835cee6e; DHHS, 2015, GUIDELINES USE ANTIR; Dieterich DT, 2004, CLIN INFECT DIS, V38, pS80, DOI 10.1086/381450; Ena J, 2003, INT J STD AIDS, V14, P776, DOI 10.1258/09564620360719840; Ford N, 2013, AIDS, V27, P1135, DOI 10.1097/QAD.0b013e32835e0752; Gazzard B, 2010, AIDS REV, V12, P67; John M, 1998, AIDS, V12, P2289, DOI 10.1097/00002030-199817000-00010; Kovari H, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw009; Lai CC, 2016, J ANTIMICROB CHEMOTH, V71, P226, DOI 10.1093/jac/dkv284; Lai CC, 2012, J ANTIMICROB CHEMOTH, V67, P1254, DOI 10.1093/jac/dkr601; Law WP, 2003, AIDS, V17, P2191, DOI 10.1097/00002030-200310170-00007; Lee KY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088497; Lee YS, 2015, EVID-BASED COMPL ALT, V2015, DOI 10.1155/2015/520578; Likanonsakul Sirirat, 2009, AIDS Res Ther, V6, P22, DOI 10.1186/1742-6405-6-22; Lin PH, 2013, EMERG MICROBES INFEC, V2, DOI 10.1038/emi.2013.83; Luetkemeyer AF, 2013, CLIN INFECT DIS, V57, P586, DOI 10.1093/cid/cit246; Manfredi R, 2004, JAIDS-J ACQ IMM DEF, V35, P492, DOI 10.1097/00126334-200404150-00007; Manosuthi W, 2006, HIV MED, V7, P378, DOI 10.1111/j.1468-1293.2006.00396.x; Martin-Carbonero L, 2003, HIV CLIN TRIALS, V4, P115; Martinez E, 2001, AIDS, V15, P1261, DOI 10.1097/00002030-200107060-00007; Martinez E, 2003, NEW ENGL J MED, V349, P1036, DOI 10.1056/NEJMoa021589; Mckoy JM, 2009, DRUG SAFETY, V32, P147, DOI 10.2165/00002018-200932020-00007; Molina JM, 2014, HIV MED, V15, P57, DOI 10.1111/hiv.12071; Moodley D, 2003, J INFECT DIS, V187, P725, DOI 10.1086/367898; Nelson M, 2012, J ANTIMICROB CHEMOTH, V67, P2020, DOI 10.1093/jac/dks130; Nunez M, 2001, J ACQ IMMUN DEF SYND, V27, P426, DOI 10.1097/00126334-200108150-00002; Peters PJ, 2010, HIV MED, V11, P650, DOI 10.1111/j.1468-1293.2010.00873.x; Ragni MV, 1999, J INFECT DIS, V180, P2027, DOI 10.1086/315143; Rivero A, 2007, J ANTIMICROB CHEMOTH, V59, P342, DOI 10.1093/jac/dkl524; Sanne I, 2005, J INFECT DIS, V191, P825, DOI 10.1086/428093; Sarfo FS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094854; Shubber Z, 2013, AIDS, V27, P1403, DOI 10.1097/QAD.0b013e32835f1db0; Stern JO, 2003, JAIDS-J ACQ IMM DEF, V34, pS21, DOI 10.1097/00126334-200309011-00005; Sulkowski MS, 2002, HEPATOLOGY, V35, P182, DOI 10.1053/jhep.2002.30319; Sun HY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090194; Sun HY, 2009, AM J GASTROENTEROL, V104, P877, DOI 10.1038/ajg.2008.159; The Clinical Effectiveness Group of the British Association for Sexual Health and HIV (BASHH) and the British HIV Association (BHIVA), 2012, UK NAT GUID SAF SEX; Tseng YT, 2014, INT J INFECT DIS, V29, P12, DOI 10.1016/j.ijid.2014.08.012; van Leth F, 2004, LANCET, V363, P1253, DOI 10.1016/S0140-6736(04)15997-7; Wit FWNM, 2002, J INFECT DIS, V186, P23, DOI 10.1086/341084; World Health Organization, 2015, CONS GUID US ANT DRU; Yang JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106141	47	18	18	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2017	12	2							e0171596	10.1371/journal.pone.0171596	http://dx.doi.org/10.1371/journal.pone.0171596			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5QV	28222098	Green Submitted, gold, Green Published			2022-12-27	WOS:000394676800015
J	Kua, KP; Lee, SWH				Kua, Kok Pim; Lee, Shaun Wen Huey			Complementary and alternative medicine for the treatment of bronchiolitis in infants: A systematic review	PLOS ONE			English	Review							CHILDREN; HOSPITALIZATIONS; EFFICACY; SULFATE; SAFETY	Background Bronchiolitis is a common cause of hospitalization among infants. The limited effectiveness of conventional medication has prompted the use of complementary and alternative medicine ( CAM) as alternative or adjunctive therapy for the management of bronchiolitis. Aims To determine the effectiveness and safety of CAM for the treatment of bronchiolitis in infants aged less than 2 years. Methods A systematic electronic search was performed in Medline, Embase, CINAHL, AMED, and Cochrane Central Register of Controlled Trials ( CENTRAL) from their respective inception to June 30, 2016 for studies evaluating CAM as an intervention to treat bronchiolitis in infants ( 1 month to 2 years of age). The CAM could be any form of treatment defined by the National Center for Complementary and Integrative Health ( NCCIH) and was utilized either as a single agent or adjunctive therapy. The predefined primary outcome was length of hospital stay. Secondary outcomes were time to resolution of bronchiolitis symptoms, adverse events, and all other clinical outcomes reported by the included studies. Results The review identified 11 studies ( 8 randomized controlled trials and 3 cohort studies) examining four herbal preparations and four supplements used either as adjunctive or alternative therapy for bronchiolitis in 904 infants. Most studies were of moderate quality. Among six studies reporting on length of stay, a significant benefit was found for Chinese herbal medicine compared to ribavirin in one cohort study ( n = 66) and vitamin D compared to placebo in one randomized controlled trial ( n = 89). Studies of Chinese herbal medicine ( 4 studies, n = 365), vitamin D ( 1 study, n = 89), N-acetylcysteine ( 1 study, n = 100), and magnesium ( 2 studies, n = 176) showed some benefits with respect to clinical severity scores, oxygen saturation, and other symptoms, although data were sparse for any single intervention and the outcomes assessed and reported varied across studies. Only five studies reported on adverse events; no serious adverse events were reported. Conclusions Among 11 studies examining the effect of CAM on inpatients with bronchiolitis, six reported on the review's primary outcome of length of hospital stay. In general, findings did not show a significant benefit associated with the primary outcome. Preliminary evidence indicated that Chinese herbal medicine mixtures, vitamin D, N-acetylcysteine, and magnesium might be useful in managing the symptoms of bronchiolitis. However, the evidence was not sufficient or rigorous enough to formulate recommendations for the use of any CAM. Among studies that reported adverse events, no serious harms were noted.	[Kua, Kok Pim; Lee, Shaun Wen Huey] Monash Univ, Sch Pharm, Bandar Sunway, Selangor, Malaysia; [Kua, Kok Pim] Minist Hlth, Dept Pharm, Petaling Dist Hlth Off, Kelana Jaya, Selangor, Malaysia	Monash University; Monash University Sunway; Kementerian Kesihatan Malaysia	Lee, SWH (corresponding author), Monash Univ, Sch Pharm, Bandar Sunway, Selangor, Malaysia.	shaun.lee@monash.edu	Lee, Shaun/E-9934-2014	Lee, Shaun/0000-0001-7361-6576; Kua, Kok Pim/0000-0001-7910-4301				[Anonymous], 2008, Zhongguo Zhong Xi Yi Jie He Za Zhi, V28, P162; [Anonymous], COMPL ALT INT HLTH W; Arvind J, 2013, AUSTRALAS MED J, V6, P550; Bansal A, 2011, INDIAN J PEDIATR, V78, P33, DOI 10.1007/s12098-010-0244-5; Dahiru Tukur, 2008, Ann Ib Postgrad Med, V6, P21; Dawson-Caswell M, 2011, AM FAM PHYSICIAN, V83, P141; Dubben HH, 2005, BRIT MED J, V331, P433, DOI 10.1136/bmj.38478.497164.F7; Feng X, 2006, J TRADITIONAL CHINES, V26, P266; Fernandes RM, 2015, PEDIATRICS, V135, pE1399, DOI 10.1542/peds.2014-3557; Florin TA, 2016, LANCET; Fraser WD, 2013, CALCIFIED TISSUE INT, V92, P118, DOI 10.1007/s00223-012-9693-3; Goldman P, 2001, ANN INTERN MED, V135, P594, DOI 10.7326/0003-4819-135-8_Part_1-200110160-00010; Hasegawa K, 2013, PEDIATRICS, V132, P28, DOI 10.1542/peds.2012-3877; Heydarian F, 2011, IRAN J PEDIATR, V21, P231; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Jiang LH, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004560.pub4; Kemper KJ, 2001, ARCH DIS CHILD, V84, P6, DOI 10.1136/adc.84.1.6; Kose M, 2014, EUR J PEDIATR, V173, P1157, DOI 10.1007/s00431-014-2309-3; Krzywinski M, 2013, NAT METHODS, V10, P1041, DOI 10.1038/nmeth.2698; Langley JM, 2003, J INFECT DIS, V188, P1764, DOI 10.1086/379740; Lieberthal AS, 2006, PEDIATRICS, V118, P1774, DOI 10.1542/peds.2006-2223; Meissner HC, 2016, NEW ENGL J MED, V374, P62, DOI 10.1056/NEJMra1413456; MILNER AD, 1989, THORAX, V44, P1, DOI 10.1136/thx.44.1.1; Modaresi MR, 2015, INDIAN J PEDIAT; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; National Institute for Health and Care Excellence, BRONCH CHILDR DIAGN; Naz F, 2014, JCPSP-J COLL PHYSICI, V24, P408, DOI 06.2014/JCPSP.408411; Pocock SJ, 2016, NEW ENGL J MED, V375, P861, DOI 10.1056/NEJMra1510064; Ralston SL, 2014, PEDIATRICS, V134, pE1474, DOI 10.1542/peds.2014-2742; Ricci V, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2305; Saad K, 2015, PEDIAT ALLER IMM PUL, V28, P102, DOI 10.1089/ped.2015.0492; Shang X, 2015, CLIN RESP J; Shay DK, 1999, JAMA-J AM MED ASSOC, V282, P1440, DOI 10.1001/jama.282.15.1440; Shekelle PG, 2003, JAMA-J AM MED ASSOC, V289, P1537, DOI 10.1001/jama.289.12.1537; Smyth RL, 2006, LANCET, V368, P312, DOI 10.1016/S0140-6736(06)69077-6; Turner LA, 2011, BMC COMPLEM ALTERN M, V11, DOI 10.1186/1472-6882-11-67; U.S. Food and Drug Administration, PED EXCL 695 STUD AG; Vickers A, 1998, CONTROL CLIN TRIALS, V19, P159, DOI 10.1016/S0197-2456(97)00150-5; Viswanathan M, 2003, AHRQ PUBLICATION; WANG EEL, 1992, AM REV RESPIR DIS, V145, P106, DOI 10.1164/ajrccm/145.1.106; Wang WS, 1997, SHANXI J TRADITIONAL, V13, P20; Wasserstein RL, 2016, AM STAT, V70, P129, DOI 10.1080/00031305.2016.1154108; Welliver J R, 1993, Pediatr Rev, V14, P134, DOI 10.1542/pir.14-4-134; Wells GA., 2015, NEWCASTLE OTTAWA SCA	44	11	13	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2017	12	2							e0172289	10.1371/journal.pone.0172289	http://dx.doi.org/10.1371/journal.pone.0172289			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BI	28212381	gold, Green Submitted, Green Published			2022-12-27	WOS:000394424700029
J	Li, GL; Qian, H				Li, Gen-Liang; Qian, Hui			Transcriptome using Illumina sequencing reveals the traits of spermatogenesis and developing testes in Eriocheir sinensis	PLOS ONE			English	Article							CHINESE MITTEN CRAB; SPERMATOGONIAL STEM-CELLS; RNA-SEQ; SACCHAROMYCES-CEREVISIAE; EXPRESSION ANALYSIS; BUDDING YEAST; CYCLE; GENE; DYNAMICS; MEIOSIS	Chinese mitten crab (Eriocheir sinensis) has the spermatozoa with typical aflagellate, decondensed chromatin, cup-shaped nuclei, and radial arms. However, the mechanism of spermatogenesis during which the specific spermatozoa are generated in this species is yet unclear. Here, the transcriptome of developing testis in E. sinensis was analyzed using the ways of RNA-seq and bioinformatics analysis to identify candidate genes potentially involved in development of testis and spermatogenesis. The Illumina HiSeq2500 sequencing of three replicons of samples produced a total of 145.19 M clean reads representing with a total of 21.34 Gb bases and 45.48% GC content. 56.30% clean reads were mapped to the draft genome of E. sinensis. The assembly of the transcriptome yielded contigs of 5691802 sequences and unigenes of 406527 sequences. Total 24246 and 40793 transcripts were annotated using Swissprot and Nr database, respectively. There were 48213 (70.31%) and 7858 (46.25%) transcripts with identity of more than 99 matching to mature testis unigenes in the databases of Nr and EST, respectively. The analytic results of KOG, GO and KEGG showed wide potential molecular functions of transcripts in the developing testes. KEGG analysis of unigenes yielded total 9422 predicted genes. Those predicted genes were involved in total 216 KEGG pathways related to the physiological activities of developing testis. 1975 predicted genes were involved in cellular and subcellular structural alteration of male germ cells. There were important roles of some pathways in the processes of morphological and structural biogenesis pertaining to testis development and spermatogenesis. Other 583 unigenes encoding the genetic and epigenetic factors also be found, which might contribute to the decondensation and stability of decondensed nuclei in the spermatozoa. These predicted events provide a view of the potential molecular mechanisms of development of testis and spermatogenesis in E. sinensis.	[Li, Gen-Liang; Qian, Hui] Youjiang Med Univ Nationalities, Baise, Guangxi, Peoples R China	Youjiang Medical University for Nationalities	Li, GL (corresponding author), Youjiang Med Univ Nationalities, Baise, Guangxi, Peoples R China.	ligenliang@163.com	li, genliang/AAV-8643-2020	Li, Genliang/0000-0001-6037-0458	National Natural Science Foundation of China [31260635]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (No. 31260635). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGARWAL ML, 1995, P NATL ACAD SCI USA, V92, P8493, DOI 10.1073/pnas.92.18.8493; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; BROWN VI, 1991, DNA CELL BIOL, V10, P399, DOI 10.1089/dna.1991.10.399; Brumell JH, 2004, CURR OPIN MICROBIOL, V7, P78, DOI 10.1016/j.mib.2003.12.005; Cherubini G, 2006, CELL CYCLE, V5, P2244, DOI 10.4161/cc.5.19.3263; Cooke PS, 2015, ASIAN J ANDROL, V17, P355, DOI 10.4103/1008-682X.148072; Dai W, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-9; Davidson G, 2010, TRENDS CELL BIOL, V20, P453, DOI 10.1016/j.tcb.2010.05.002; Demidova AR, 2009, J BIOL CHEM, V284, P4132, DOI 10.1074/jbc.M808118200; DIRICK L, 1995, EMBO J, V14, P4803, DOI 10.1002/j.1460-2075.1995.tb00162.x; DU N, 1988, Acta Zoologica Sinica, V34, P329; Du Nanshan, 1987, Oceanologia et Limnologia Sinica, V18, P119; Du NS, 1987, OCEANOL LIMNOL SINIC, V18, P216; Dupont J, 2014, MOL CELL ENDOCRINOL, V382, P527, DOI 10.1016/j.mce.2013.09.028; Eom KS, 2016, J MICROBIOL BIOTECHN, V26, P2019, DOI 10.4014/jmb.1609.09021; Gutierrez-Escribano P, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7871; He L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053915; He L, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0033735, 10.1371/journal.pone.0045607]; Hou CC, 2013, MOL BIOL REP, V40, P1043, DOI 10.1007/s11033-012-2145-3; Kassir Y, 2003, INT REV CYTOL, V224, P111, DOI 10.1016/S0074-7696(05)24004-4; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Kimura H, 2015, SCHIZOPHRENIA BULL, V41, P744, DOI 10.1093/schbul/sbu147; Komeya M, 2015, ASIAN J ANDROL, V17, P771, DOI 10.4103/1008-682X.154995; KRON SJ, 1995, CURR OPIN CELL BIOL, V7, P845, DOI 10.1016/0955-0674(95)80069-7; Kumar A., 2012, INT J APPL ENG RES, V7, P9, DOI DOI 10.1371/J0URNAL.P0NE.0043761; Lee GE, 2010, J BIOL CHEM, V285, P37630, DOI 10.1074/jbc.M110.148536; Li G, 2017, MITOCHONDRIAL DNA A; Li GL, 2017, CYTOTECHNOLOGY, V69, P75, DOI 10.1007/s10616-016-0038-3; Li Q., 2016, CELL MOL NEUROBIOL, V3, P3; Li Q, 2015, GENE, V562, P117, DOI 10.1016/j.gene.2015.02.060; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Lu Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097645; Mahajan S, 2015, J BIOL CHEM, V290, P18304, DOI 10.1074/jbc.M115.638064; Mao H, 2012, MOL BIOL REP, V39, P7031, DOI 10.1007/s11033-012-1534-y; Mazzolini L, 2016, CELL CYCLE, V15, P2742, DOI 10.1080/15384101.2016.1220455; Mendenhall MD, 1998, MICROBIOL MOL BIOL R, V62, P1191, DOI 10.1128/MMBR.62.4.1191-1243.1998; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nagano MC, 2013, CURR TOP DEV BIOL, V102, P61, DOI 10.1016/B978-0-12-416024-8.00003-9; Nusse O, 2011, THESCIENTIFICWORLDJO, V11, P2364, DOI 10.1100/2011/741046; Oelschlaegel T, 2005, CELL, V120, P773, DOI 10.1016/j.cell.2005.01.032; Ohno H, 2006, J BIOCHEM, V139, P943, DOI 10.1093/jb/mvj120; Pesin JA, 2008, ANNU REV CELL DEV BI, V24, P475, DOI 10.1146/annurev.cellbio.041408.115949; Sato M, 2011, SCIENCE, V334, P1141, DOI 10.1126/science.1210333; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Song LS, 2016, GIGASCIENCE, V5, DOI 10.1186/s13742-016-0112-y; Stegmeier F, 2004, ANNU REV GENET, V38, P203, DOI 10.1146/annurev.genet.38.072902.093051; Stuart LM, 2005, IMMUNITY, V22, P539, DOI 10.1016/j.immuni.2005.05.002; Sun X, 2012, GENE, V508, P78, DOI 10.1016/j.gene.2012.07.035; Sun XA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012738; Tang EI, 2016, SEMIN CELL DEV BIOL; Tjelle TE, 2000, BIOESSAYS, V22, P255, DOI 10.1002/(SICI)1521-1878(200003)22:3<255::AID-BIES7>3.0.CO;2-R; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Visone V, 2014, INT J MOL SCI, V15, P17162, DOI 10.3390/ijms150917162; VONFIGURA K, 1986, ANNU REV BIOCHEM, V55, P167, DOI 10.1146/annurev.biochem.55.1.167; Wang Q, 2000, J E CHINA NORMAL U N, V3, P98; Wang YL, 2014, GENE, V536, P9, DOI 10.1016/j.gene.2013.11.099; Wong C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033635; Wu H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070078; Wu J, 2008, CELL SIGNAL, V20, P1052, DOI 10.1016/j.cellsig.2008.01.011; Wu JL, 2016, GENE, V575, P276, DOI 10.1016/j.gene.2015.09.005; Zhang EF, 2010, DEV GENES EVOL, V220, P151, DOI 10.1007/s00427-010-0336-2; Zhang W, 2011, GENET MOL BIOL, V34, P136, DOI 10.1590/S1415-47572010005000099; Zhang ZH, 2016, SCI REP-UK, V6, DOI 10.1038/srep25089	65	15	15	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2017	12	2							e0172478	10.1371/journal.pone.0172478	http://dx.doi.org/10.1371/journal.pone.0172478			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BI	28212420	Green Published, gold, Green Submitted			2022-12-27	WOS:000394424700055
J	Cagno, V; Sgorbini, B; Sanna, C; Cagliero, C; Ballero, M; Civra, A; Donalisio, M; Bicchi, C; Lembo, D; Rubiolo, P				Cagno, Valeria; Sgorbini, Barbara; Sanna, Cinzia; Cagliero, Cecilia; Ballero, Mauro; Civra, Andrea; Donalisio, Manuela; Bicchi, Carlo; Lembo, David; Rubiolo, Patrizia			In vitro anti-herpes simplex virus-2 activity of Salvia desoleana Atzei & V. Picci essential oil	PLOS ONE			English	Article							CHEMICAL-COMPOSITION; ACQUISITION; HERPESVIRUSES; INFECTIVITY; INHIBITION; EXTRACT	Salvia desoleana Atzei & V. Picci is an indigenous species in Sardinia island used in folk medicine to treat menstrual, digestive and central nervous system diseases. Nowadays, it is widely cultivated for the pleasant smell of its essential oil (EO), whose antimicrobial and antifungal activities have already been screened. This study evaluated the in vitro anti-Herpes Simplex Virus-2 (HSV-2) activity of S. desoleana EO, fractions and main components: linalyl acetate, alpha terpinyl acetate, and germacrene D. Phytochemical composition of S. desoleana EO was studied by GC-FID/MS analysis and the active fraction(s) and/or compounds in S. desoleana EO were identified with a bioassay-guided fractionation procedure through in vitro assays on cell viability and HSV-2 and RSV inhibition. S. desoleana EO inhibits both acyclovir sensitive and acyclovir resistant HSV-2 strains with EC50 values of 23.72 mu g/ml for the former and 28.57 mu g/ml for the latter. Moreover, a significant suppression of HSV-2 replication was observed with an EC50 value of 33.01 mu g/ml (95% CI: 26.26 to 41.49) when the EO was added post-infection. Among the fractions resulting from flash column chromatography on silica gel, the one containing 54% of germacrene D showed a similar spectrum of activity of S. desoleana EO with a stronger suppression in post-infection stage. These results indicated that S. desoleana EO can be of interest to develop new and alternative anti-HSV-2 products active also against acyclovir-resistant HSV-2 strains.	[Cagno, Valeria; Civra, Andrea; Donalisio, Manuela; Lembo, David] Univ Turin, Dept Clin & Biol Sci, Mol Virol Lab, Turin, Italy; [Sgorbini, Barbara; Cagliero, Cecilia; Bicchi, Carlo; Rubiolo, Patrizia] Univ Turin, Dipartimento Sci & Tecnol Farmaco, Turin, Italy; [Sanna, Cinzia; Ballero, Mauro] Univ Cagliari, Dipartimento Sci Vita & Ambiente, Cagliari, Italy	University of Turin; University of Turin; University of Cagliari	Lembo, D (corresponding author), Univ Turin, Dept Clin & Biol Sci, Mol Virol Lab, Turin, Italy.; Rubiolo, P (corresponding author), Univ Turin, Dipartimento Sci & Tecnol Farmaco, Turin, Italy.	david.lembo@unito.it; patrizia.rubiolo@unito.it	Cagno, Valeria/AAE-7612-2020; Sgorbini, Barbara/AAL-6368-2020	Sgorbini, Barbara/0000-0001-6848-1304; Cagno, Valeria/0000-0002-5597-334X; RUBIOLO, Patrizia/0000-0002-6819-2614	Turin University, Turin (Italy) [Ex60%2015]	Turin University, Turin (Italy)	BS, CC, CB, PR are indebted with the project Studio di metaboliti secondari biologicamente attivi da matrici di origine vegetale financially supported by Ricerca Locale (Ex60%2015) of Turin University, Turin (Italy). DL was supported by a donation from Mrs. Silvana Legnani.	Adams RP, 2007, IDENTIFICATION EO CO; Astani A, 2014, IRAN J MICROBIOL, V6, P149; Astani A, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1093/ecam/nep187; Astani A, 2010, PHYTOTHER RES, V24, P673, DOI 10.1002/ptr.2955; ATZEI A D, 1982, Webbia, V36, P71; Atzei A.D., 2003, PIANTE NELLA TRADIZI; Bankova V, 2014, PHYTOMEDICINE, V21, P1432, DOI 10.1016/j.phymed.2014.04.026; Bicchi C, 2008, FLAVOUR FRAG J, V23, P382, DOI 10.1002/ffj.1905; Brady RC, 2004, ANTIVIR RES, V61, P73, DOI 10.1016/j.antiviral.2003.09.006; Brown ZA, 1997, NEW ENGL J MED, V337, P509, DOI 10.1056/NEJM199708213370801; Chiang LC, 2005, CLIN EXP PHARMACOL P, V32, P811, DOI 10.1111/j.1440-1681.2005.04270.x; Civitelli L, 2014, PHYTOMEDICINE, V21, P857, DOI 10.1016/j.phymed.2014.01.013; Civra A, 2014, SCI REP-UK, V4, DOI 10.1038/srep07487; Corey L, 2004, JAIDS-J ACQ IMM DEF, V35, P435, DOI 10.1097/00126334-200404150-00001; Donalisio M, 2016, BIOMATERIALS, V85, P40, DOI 10.1016/j.biomaterials.2016.01.055; Donalisio M, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-266; Freeman EE, 2006, AIDS, V20, P73, DOI 10.1097/01.aids.0000198081.09337.a7; Gupta R, 2007, LANCET, V370, P2127, DOI 10.1016/S0140-6736(07)61908-4; KIMBERLIN DW, 1995, ANTIVIR RES, V26, P369, DOI 10.1016/0166-3542(95)00027-J; Koch C, 2008, J PHARM PHARMACOL, V60, P1545, DOI 10.1211/jpp/60.11.0017; Loizzo MR, 2008, PHYTOMEDICINE, V15, P79, DOI 10.1016/j.phymed.2007.03.013; Martinez JP, 2015, NAT PROD REP, V32, P29, DOI 10.1039/c4np00085d; Peana AT, 1999, PLANTA MED, V65, P752, DOI 10.1055/s-2006-960857; Rapposelli E, 2015, GENET RESOUR CROP EV, V62, P959, DOI 10.1007/s10722-015-0263-1; Schnitzler P, 2008, PHYTOMEDICINE, V15, P734, DOI 10.1016/j.phymed.2008.04.018; Sokovic MD, 2009, FLAVOUR FRAG J, V24, P83, DOI 10.1002/ffj.1920; Whitley RJ, 2001, LANCET, V357, P1513, DOI 10.1016/S0140-6736(00)04638-9	27	19	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0172322	10.1371/journal.pone.0172322	http://dx.doi.org/10.1371/journal.pone.0172322			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207861	Green Published, gold, Green Submitted			2022-12-27	WOS:000394424500122
J	Gotte, M; Seidel, CC; Kesting, SV; Rosenbaum, D; Boos, J				Goette, Miriam; Seidel, Corinna Caroline; Kesting, Sabine Verena; Rosenbaum, Dieter; Boos, Joachim			Objectively measured versus self-reported physical activity in children and adolescents with cancer	PLOS ONE			English	Article							MOTOR-PERFORMANCE; PEDIATRIC CANCER; FITNESS; LEUKEMIA; BENEFITS; MONITOR; HEALTH; SCHOOL; YOUTH	Objective Existing research recognizes low levels of physical activity in pediatric patients with cancer, but much uncertainty exists about their capability to self-reflect physical activity levels. The objective of this study was to compare results of subjective self-reports and objective accelerometers regarding levels of daily walking as well as moderate-to-vigorous physical activities. Methods Results of the objective assessment tool StepWatchTM Activity Monitor and self-reporting with a standardized questionnaire were compared in 28 children and adolescents during cancer treatment. Results The patients were 13.8 +/- 2.8 years of age and 3.4 +/- 2.0 months after cancer diagnosis. The Bland-Altman plots indicated a fairly symmetrical under- and over-estimation for daily minutes of walking with the limits of agreement ranging from -100.8 to 87.3 min (d = -6.7 min). Mean difference for moderate-to-vigorous physical activity was almost zero but limits of agreement are ranging from-126.8 to 126.9 min. The comparison for the days with at least 60 min of moderate-to-vigorous physical activity showed a marked difference with 3.0 2.6 self-reported days versus only 0.1 +/- 0.4 measured days. Conclusions These findings suggest that physical activity in pediatric cancer patients should preferably be assessed with objective methods. Greater efforts are needed to implement supervised exercise interventions during treatment incorporating methods to improve self-reflection of physical activity.	[Goette, Miriam; Kesting, Sabine Verena; Boos, Joachim] Univ Childrens Hosp Munster, Dept Pediat Hematol & Oncol, Munster, Germany; [Seidel, Corinna Caroline; Rosenbaum, Dieter] Univ Hosp Munster, Inst Expt Musculoskeletal Med, Movement Anal Lab, Munster, Germany	University of Munster; University of Munster	Gotte, M (corresponding author), Univ Childrens Hosp Munster, Dept Pediat Hematol & Oncol, Munster, Germany.	miriam.goette@ukmuenster.de	Rosenbaum, Dieter/U-6089-2019	Gotte, Miriam/0000-0003-0841-8738	Cora-Lobscheid Stiftung; Kinderkrebshilfe Munster e.V.	Cora-Lobscheid Stiftung; Kinderkrebshilfe Munster e.V.	This work was funded by the Cora-Lobscheid Stiftung https://www.deutsches-stiftungszentrum.de/stiftungen/cora-lobscheid-stiftung and the Kinderkrebshilfe Munster e.V. http://www.kinderkrebshilfe-muenster.de/.	Aznar S, 2006, APPL PHYSIOL NUTR ME, V31, P407, DOI 10.1139/H06-014; Beulertz J, 2013, PEDIATR HEMAT ONCOL, V30, P336, DOI 10.3109/08880018.2013.776155; Bos K, 2009, MOTORIK MODUL PHYS F; Braam KI, 2016, SUPPORT CARE CANCER, V24, P2259, DOI 10.1007/s00520-015-2993-1; Darcy L, 2016, J PEDIATR ONCOL NURS, V33, P173, DOI 10.1177/1043454215610489; Eime RM, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-98; Finnegan L, 2007, ONCOL NURS FORUM, V34, P201, DOI 10.1188/07.ONF.E60-E69; Fraser BJ, 2016, MED SCI SPORT EXER, V48, P1715, DOI 10.1249/MSS.0000000000000955; Gotte M, 2015, EUR J PEDIATR, V174, P791, DOI 10.1007/s00431-014-2460-x; Gotte M, 2014, PEDIATR BLOOD CANCER, V61, P1023, DOI 10.1002/pbc.24898; Janssen I, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-40; Juan AFS, 2008, INT J SPORTS MED, V29, P163, DOI 10.1055/s-2007-964908; Kesting SV, 2016, PEDIATR BLOOD CANCER, V63, P737, DOI 10.1002/pbc.25852; Kesting SV, 2015, J PEDIAT HEMATOL ONC, V37, P509, DOI 10.1097/MPH.0000000000000396; LeBlanc AGW, 2010, PEDIATR EXERC SCI, V22, P523, DOI 10.1123/pes.22.4.523; Manios Y, 2013, J SPORT MED PHYS FIT, V53, P502; McDonald CM, 2005, ARCH PHYS MED REHAB, V86, P793, DOI 10.1016/j.apmr.2004.10.011; Muller C, 2014, INT J SPORTS MED, V35, P696, DOI 10.1055/s-0033-1358475; Orsey AD, 2013, PEDIATR BLOOD CANCER, V60, P1908, DOI 10.1002/pbc.24641; Ozdoba R, 2004, PEDIATR EXERC SCI, V16, P158, DOI 10.1123/pes.16.2.158; Pinto AJ, 2016, CLIN RHEUMATOL, V35, P1507, DOI 10.1007/s10067-016-3234-9; Rueegg CS, 2013, PEDIATR BLOOD CANCER, V60, P1714, DOI 10.1002/pbc.24595; Sandroff BM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093511; Shephard RJ, 2003, BRIT J SPORT MED, V37, P197, DOI 10.1136/bjsm.37.3.197; Storti KL, 2008, MED SCI SPORT EXER, V40, P59, DOI 10.1249/mss.0b013e318158b504; Tan SY, 2013, LEUKEMIA RES, V37, P14, DOI 10.1016/j.leukres.2012.09.005; Timmons BW, 2007, APPL PHYSIOL NUTR ME, V32, pS122, DOI 10.1139/H07-112; Tudor-Locke C, 2008, MED SCI SPORT EXER, V40, pS537, DOI 10.1249/MSS.0b013e31817c7133; Vanhees L, 2005, EUR J CARDIOV PREV R, V12, P102, DOI 10.1097/00149831-200504000-00004; Welk GJ, 2000, RES Q EXERCISE SPORT, V71, pS59, DOI 10.1080/02701367.2000.11082788; Winter C, 2009, PEDIATR BLOOD CANCER, V53, P438, DOI 10.1002/pbc.22055; Winter CC, 2013, SUPPORT CARE CANCER, V21, P1629, DOI 10.1007/s00520-012-1707-1; Woll A, 2011, EUR J PEDIATR, V170, P1129, DOI 10.1007/s00431-010-1391-4	33	15	15	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0172216	10.1371/journal.pone.0172216	http://dx.doi.org/10.1371/journal.pone.0172216			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207820	gold, Green Published, Green Submitted			2022-12-27	WOS:000394424500100
J	Puglisi, I; De Patrizio, A; Schena, L; Jung, T; Evoli, M; Pane, A; Hoa, NV; Tri, MV; Wright, S; Ramstedt, M; Olsson, C; Faedda, R; di San Lio, GM; Cacciola, SO				Puglisi, Ivana; De Patrizio, Alessandro; Schena, Leonardo; Jung, Thomas; Evoli, Maria; Pane, Antonella; Nguyen Van Hoa; Mai Van Tri; Wright, Sandra; Ramstedt, Mauritz; Olsson, Christer; Faedda, Roberto; di San Lio, Gaetano Magnano; Cacciola, Santa Olga			Two previously unknown Phytophthora species associated with brown rot of Pomelo (Citrus grandis) fruits in Vietnam	PLOS ONE			English	Article							ROOT-ROT; SP NOV.; MOLECULAR PHYLOGENY; LEAF-BLIGHT; 1ST REPORT; IDENTIFICATION; COLOCASIAE; TREES; DNA; MITOCHONDRIAL	Two distinct Phytophthora taxa were found to be associated with brown rot of pomelo (Citrus grandis), a new disease of this ancestral Citrus species, in the Vinh Long province, Mekong River Delta area, southern Vietnam. On the basis of morphological characters and using the ITS1-5.8S-ITS2 region of the rDNA and the cytochrome oxidase subunit 1 (COI) as barcode genes, one of the two taxa was provisionally named as Phytophthora sp. prodigiosa, being closely related to but distinct from P. insolita, a species in Phytophthora Clade 9, while the other one, was closely related to but distinct from the Clade 2 species P. meadii and was informally designated as Phytophthora sp. mekongensis. Isolates of P. sp. prodigiosa and P. sp. mekongensis were also obtained from necrotic fibrous roots of Volkamer lemon (C. volkameriana) rootstocks grafted with 'King' mandarin (Citrus nobilis) and from trees of pomelo, respectively, in other provinces of the Mekong River Delta, indicating a widespread occurrence of both Phytophthora species in this citrus-growing area. Koch's postulates were fulfilled via pathogenicity tests on fruits of various Citrus species, including pomelo, grapefruit (Citrus x paradisi), sweet orange (Citrus x sinensis) and bergamot (Citrus x bergamia) as well as on the rootstock of 2-year-old trees of pomelo and sweet orange on 'Carrizo' citrange (C. sinensis 'Washington Navel' x Poncirus trifoliata). This is the first report of a Phytophthora species from Clade 2 other than P. citricola and P. citrophthora as causal agent of fruit brown rot of Citrus worldwide and the first report of P. insolita complex in Vietnam. Results indicate that likely Vietnam is still an unexplored reservoir of Phytophthora diversity.	[Puglisi, Ivana; De Patrizio, Alessandro; Evoli, Maria; Pane, Antonella; Faedda, Roberto; Cacciola, Santa Olga] Univ Catania, Dept Agr Food & Environm, Catania, Italy; [Puglisi, Ivana; Schena, Leonardo; di San Lio, Gaetano Magnano] Univ Mediterranea Reggio Calabria, Dipartimento Agr, Reggio Di Calabria, Italy; [Jung, Thomas] Mendel Univ Brno, Phytophthora Res Ctr, Zemedelska 1, Brno 61300, Czech Republic; [Jung, Thomas] Phytophthora Res & Consultancy, Rain 9, Nussdorf, Germany; [Nguyen Van Hoa; Mai Van Tri] Southern Hort Res Inst, My Tho, Tien Giang, Vietnam; [Wright, Sandra] Univ Gavle, Dept Elect Math & Nat Sci, Gavle, Sweden; [Ramstedt, Mauritz] Swedish Agr Univ SLU, Dept Forest Mycol & Plant Pathol, Uppsala, Sweden; [Olsson, Christer] Gothenburg Univ, Dept Biol & Environm Sci, Gothenburg, Sweden	University of Catania; Universita Mediterranea di Reggio Calabria; Mendel University in Brno; University of Gavle; Swedish University of Agricultural Sciences; University of Gothenburg	Cacciola, SO (corresponding author), Univ Catania, Dept Agr Food & Environm, Catania, Italy.	olgacacciola@unict.it	Jung, Thomas/F-1665-2013; di San Lio, Gaetano Magnano/E-9778-2016; Wright, Sandra A. I./AAG-6424-2019; , Santa Olga Cacciola/H-7416-2019; Schena, Leonardo/A-7492-2018	Jung, Thomas/0000-0003-2034-0718; di San Lio, Gaetano Magnano/0000-0002-4835-4874; Wright, Sandra A. I./0000-0002-8895-5631; Schena, Leonardo/0000-0002-9737-2593	STINT (The Swedish Foundation for International Cooperation in Research and Higher Education); SAMAGRUMI (Sensori Ambientali per il Miglioramento della Qualita delle Produzioni Agrumicole) [PO. FESR 2007-2013]; Italian Ministry of Education, University and Research (MIUR) [RBFR10PZ4N]	STINT (The Swedish Foundation for International Cooperation in Research and Higher Education); SAMAGRUMI (Sensori Ambientali per il Miglioramento della Qualita delle Produzioni Agrumicole); Italian Ministry of Education, University and Research (MIUR)(Ministry of Education, Universities and Research (MIUR))	This research was funded by an initiation grant of STINT (The Swedish Foundation for International Cooperation in Research and Higher Education), SAMAGRUMI (Sensori Ambientali per il Miglioramento della Qualita delle Produzioni Agrumicole) - PO. FESR 2007-2013-Sicily, and a grant MIUR-FIRB 2010 (RBFR10PZ4N) from the Italian Ministry of Education, University and Research (MIUR) Metagenomic strategies to assess genetic diversity in soil-borne Phytophthora species.; This research was funded by an initiation grant of STINT (The Swedish Foundation for International Cooperation in Research and Higher Education), SAMAGRUMI (Sensori Ambientali per it Miglioramento della Qualita delle Produzioni Agrumicole) PO. FESR 2007-2013-Sicily, and a grant MIUR-FIRB 2010 (RBFR1OPZ4N) from the Italian Ministry of Education, University and Research (MIUR) "Metagenomic strategies to assess genetic diversity in soil-borne Phytophthora species." The authors wish to thank Mrs. Ann Davies for the English revision of the manuscript.	Abad ZG, 2014, MYCOLOGIA, V106, P431, DOI 10.3852/12-119; Agosteo GE, 2014, BERGAMOT DISEASES CI, P37; ANN PJ, 1980, MYCOLOGIA, V72, P1180, DOI 10.2307/3759572; Bandyopadhyay R, 2011, PLANT DIS, V95, P618, DOI 10.1094/PDIS-12-10-0890; Barrett H. C., 1976, Systematic Botany, V1, P105, DOI 10.2307/2418763; Bawage S, 2013, J MYCOLOGY; Biasi A, 2016, GENETIC ANAL PHYTOPH; Blair JE, 2008, FUNGAL GENET BIOL, V45, P266, DOI 10.1016/j.fgb.2007.10.010; Brasier CM, 2003, MYCOL RES, V107, P477, DOI 10.1017/S0953756203007548; Cacciola SO, 2011, PLANT DIS, V95, P769, DOI 10.1094/PDIS-11-10-0823; Cacciola Santa Olga, 2008, V3, P61, DOI 10.1007/978-1-4020-8571-0_4; Catala S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119311; CHEE KH, 1969, T BRIT MYCOL SOC, V52, P425, DOI 10.1016/S0007-1536(69)80126-9; Cooke DEL, 2000, FUNGAL GENET BIOL, V30, P17, DOI 10.1006/fgbi.2000.1202; Das AK, 2012, AUSTRALAS PLANT DIS, V7, P131, DOI 10.1007/s13314-012-0066-6; De Patrizio A, 2013, J PLANT PATHOL, V95, p[S4, S41]; Erwin DC, PHYTOPHTHORA DIS WOR; Evoli M, 2016, THESIS; Ferguson L, 1990, USITC PUBL, P18; Gallegly ME, 2008, PHYTOPHTHORA IDENTIF, P158; Graham JH, 2000, COMPENDIUM CITRUS DI, P12; Grunwald NJ, 2011, PLANT DIS, V95, P337, DOI 10.1094/PDIS-08-10-0609; Hall BG, 2013, MOL BIOL EVOL, V30, P1229, DOI 10.1093/molbev/mst012; Jung T, 2016, FOREST PATHOL, V46, P134, DOI 10.1111/efp.12239; Jung T, 2011, PERSOONIA, V26, P13, DOI 10.3767/003158511X557577; Jung T, 1996, PHYTON-ANN REI BOT A, V36, P95; KO WH, 1979, MYCOLOGIA, V71, P434, DOI 10.2307/3759163; Kroon LPNM, 2012, PHYTOPATHOLOGY, V102, P348, DOI 10.1094/PHYTO-01-11-0025; Tri MV, 2015, PHYTOPATHOL MEDITERR, V54, P275; Mammella MA, 2013, PHYTOPATHOLOGY, V103, P610, DOI 10.1094/PHYTO-10-12-0263-R; Mammella MA, 2011, FUNGAL BIOL-UK, V115, P432, DOI 10.1016/j.funbio.2011.02.018; Man in 't Veld W. A., 2015, MYCOLOGIA, V107, P54, DOI DOI 10.3852/12-371; Martin FN, 2003, MYCOLOGIA, V95, P269, DOI 10.2307/3762038; Martin FN, 2012, PLANT DIS, V96, P1080, DOI 10.1094/PDIS-12-11-1036-FE; MASAGO H, 1977, PHYTOPATHOLOGY, V67, P425, DOI 10.1094/Phyto-67-425; Miyasaka SC, 2013, CABI PLANT PROT SER, P104, DOI 10.1079/9781780640938.0104; Nath VS, 2014, FEMS MICROBIOL LETT, V352, P174, DOI 10.1111/1574-6968.12395; Nechwatal J, 2013, PLANT PATHOL, V62, P355, DOI 10.1111/j.1365-3059.2012.02638.x; Omane E, 2012, PLANT DIS, V96, P292, DOI 10.1094/PDIS-09-11-0789; OUDEMANS P, 1991, MYCOL RES, V95, P1025, DOI 10.1016/S0953-7562(09)80543-1; Pane A, 2008, PLANT DIS, V92, P313, DOI 10.1094/PDIS-92-2-0313B; Pane A., 2001, Plant Disease, V85, P97, DOI 10.1094/PDIS.2001.85.1.97A; Pane A, 2009, PLANT DIS, V93, P844, DOI 10.1094/PDIS-93-8-0844C; Park J, 2008, PLANT DIS, V92, P966, DOI 10.1094/PDIS-92-6-0966; Paull RE, 2012, CROP PRODUCTION SCI, V2, P381; Prigigallo MI, 2015, PLANT PATHOL, V64, P1308, DOI 10.1111/ppa.12362; Prigigallo MI, 2015, PHYTOPATHOLOGY; Robideau GP, 2011, MOL ECOL RESOUR, V11, P1002, DOI 10.1111/j.1755-0998.2011.03041.x; Scanu B, 2016, PLANT PATHOL, V65, P26, DOI 10.1111/ppa.12399; Scibetta S, 2012, J MICROBIOL METH, V88, P356, DOI 10.1016/j.mimet.2011.12.012; Stamps DJ, 1985, IMI DESCRIPTIONS FUN, V84, P834; STAMPS DJ, 1990, MYCOL PAP, V162, P1; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thanh DVT, 2004, DIVERSITY MANAGEMENT, P238; Timmer LW, 1999, CITRUS HLTH MANAGEME, P197; Vavilov N.I, 1951, ORIGIN VARIATION IMM; Vettraino AM, 2012, LETT APPL MICROBIOL, V55, P390, DOI 10.1111/j.1472-765x.2012.03310.x; Yang X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103450; Yang X, 2013, MYCOTAXON, V126, P167, DOI 10.5248/126.167	61	27	28	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0172085	10.1371/journal.pone.0172085	http://dx.doi.org/10.1371/journal.pone.0172085			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28208159	Green Published, gold, Green Submitted			2022-12-27	WOS:000394424500080
J	Tsumura, Y; Tsushima, Y; Tamura, A; Hasebe, M; Kanou, M; Kato, H; Kobayashi, T				Tsumura, Yoshinori; Tsushima, Yu; Tamura, Azusa; Hasebe, Makiko; Kanou, Masanobu; Kato, Hirotsugu; Kobayashi, Tsunefumi			TMG-123, a novel glucokinase activator, exerts durable effects on hyperglycemia without increasing triglyceride in diabetic animal models	PLOS ONE			English	Article							TRANSGENIC MICE; TYPE-2; LIVER; HOMEOSTASIS; EXPRESSION; MANAGEMENT; METFORMIN; MK-0941; AZD1656; CELLS	Glucokinase (GK) plays a critical role for maintaining glucose homeostasis with regulating glucose uptake in liver and insulin secretion in pancreas. GK activators have been reported to decrease blood glucose levels in patients with type 2 diabetes mellitus. However, clinical development of GK activators has failed due to the loss of glucose-lowering effects and increased plasma triglyceride levels after chronic treatment. Here, we generated a novel GK activator, TMG-123, examined its in vitro and in vivo pharmacological characteristics, and evaluated its risks of aforementioned clinical issues. TMG-123 selectively activated GK enzyme activity without increasing Vmax. TMG-123 improved glucose tolerance without increasing plasma insulin levels in both insulin-deficient (Goto-Kakizaki rats) and insulin resistant (db/db mice) models. The beneficial effect on glucose tolerance was greater than results observed with clinically available antidiabetic drugs such as metformin and glibenclamide in Zucker Diabetic Fatty rats. TMG-123 also improved glucose tolerance in combination with metformin. After 4 weeks of administration, TMG-123 reduced the Hemoglobin A1c levels without affecting liver and plasma triglyceride levels in Goto-Kakizaki rats and Diet Induced Obesity mice. Moreover, TMG-123 sustained its effect on Hemoglobin Al c levels even after 24 weeks of administration without affecting triglycerides. Taken together, these data indicate that TMG-123 exerts glucose-lowering effects in both insulin-deficient and -resistant diabetes, and sustains reduced Hemoglobin Al c levels without affecting hepatic and plasma triglycerides even after chronic treatment. Therefore, TMG-123 is expected to be an antidiabetic drug that overcomes the concerns previously reported with other GK activators.	[Tsumura, Yoshinori; Tsushima, Yu; Tamura, Azusa; Hasebe, Makiko; Kanou, Masanobu; Kato, Hirotsugu; Kobayashi, Tsunefumi] Teijin Pharma Ltd, Pharmaceut Dev Res Labs, Hino, Tokyo, Japan; [Kanou, Masanobu; Kato, Hirotsugu] Teijin Pharma Ltd, Pharmaceut Discovery Res Labs, Hino, Tokyo, Japan	Teijin Pharma Limited; Teijin Pharma Limited	Tsushima, Y (corresponding author), Teijin Pharma Ltd, Pharmaceut Dev Res Labs, Hino, Tokyo, Japan.	y.tsushima@teijin.co.jp		Tsumura, Yoshinori/0000-0002-7223-6018	Teijin Pharma Limited	Teijin Pharma Limited(Teijin Pharma Limited)	This study was supported by Teijin Pharma Limited. Teijin Pharma Limited provided support in the form of salaries for all authors [Y. Tsumura, Y. Tsushima, AT, MH, MK, HK, and TK], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS81, DOI 10.2337/dc14-S081; Amin NB, 2015, DIABETES OBES METAB, V17, P751, DOI 10.1111/dom.12474; De Ceuninck F, 2013, BRIT J PHARMACOL, V168, P339, DOI 10.1111/j.1476-5381.2012.02184.x; Eiki J, 2011, MOL PHARMACOL, V80, P1156, DOI 10.1124/mol.111.074401; Erion DM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097139; Ferre T, 1996, FASEB J, V10, P1213, DOI 10.1096/fasebj.10.10.8751724; Ferre T, 2003, DIABETOLOGIA, V46, P1662, DOI 10.1007/s00125-003-1244-z; Grewala AS, 2014, MINI-REV MED CHEM, V14, P585, DOI 10.2174/1389557514666140722082713; Grimsby J, 2003, SCIENCE, V301, P370, DOI 10.1126/science.1084073; Hariharan N, 1997, DIABETES, V46, P11, DOI 10.2337/diabetes.46.1.11; Hundal RS, 2000, DIABETES, V49, P2063, DOI 10.2337/diabetes.49.12.2063; Inzucchi SE, 2016, OBSTET GYNECOL, V127, P780, DOI 10.1097/AOG.0000000000001332; Inzucchi SE, 2015, DIABETES CARE, V38, P140, DOI 10.2337/dc14-2441; Kazierad D, 2013, DIABETES S1, V62, pA1; Kiyosue A, 2013, DIABETES OBES METAB, V15, P923, DOI 10.1111/dom.12100; LIANG Y, 1991, J BIOL CHEM, V266, P6999; MACKINNON AM, 1987, J LIPID RES, V28, P847; Massa ML, 2011, IUBMB LIFE, V63, P1, DOI 10.1002/iub.411; Matschinsky FM, 2006, DIABETES, V55, P1; MATSCHINSKY FM, 1990, DIABETES, V39, P647, DOI 10.2337/diabetes.39.6.647; Matschinsky FM, 2009, NAT REV DRUG DISCOV, V8, P399, DOI 10.1038/nrd2850; Meininger GE, 2011, DIABETES CARE, V34, P2560, DOI 10.2337/dc11-1200; Mittermayer F, 2015, CURR DIABETES REV, V11, P17, DOI 10.2174/1573399810666141224121927; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; Pfefferkorn JA, 2012, J MED CHEM, V55, P1318, DOI 10.1021/jm2014887; Roma LP, 2015, AM J PHYSIOL-ENDOC M, V309, pE632, DOI 10.1152/ajpendo.00154.2015; Shiota M, 2001, DIABETES, V50, P622, DOI 10.2337/diabetes.50.3.622; Tornovsky-Babeay S, 2014, CELL METAB, V19, P109, DOI 10.1016/j.cmet.2013.11.007; Tourrel C, 2002, DIABETES, V51, P1443, DOI 10.2337/diabetes.51.5.1443; Wilding JPH, 2013, DIABETES OBES METAB, V15, P750, DOI 10.1111/dom.12088; WILSON JE, 1995, REV PHYSIOL BIOCH P, V126, P65, DOI 10.1007/BFb0049776; Winzell MS, 2011, EUR J PHARMACOL, V663, P80, DOI 10.1016/j.ejphar.2011.05.009; Woo SL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091111	33	16	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0172252	10.1371/journal.pone.0172252	http://dx.doi.org/10.1371/journal.pone.0172252			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207836	Green Published, Green Submitted, gold			2022-12-27	WOS:000394424500106
J	Ye, T; Wang, Y; Guo, ZX; Li, YJ				Ye, Tao; Wang, Yao; Guo, Zhixing; Li, Yijia			Factor contribution to fire occurrence, size, and burn probability in a subtropical coniferous forest in East China	PLOS ONE			English	Article							SPATIAL-PATTERNS; WILDFIRE; CLASSIFICATION; REGRESSION; MODELS; REGIME; SIMULATION; CALIFORNIA; SEVERITY; PROVINCE	The contribution of factors including fuel type, fire-weather conditions, topography and human activity to fire regime attributes (e.g. fire occurrence, size distribution and severity) has been intensively discussed. The relative importance of those factors in explaining the burn probability (BP), which is critical in terms of fire risk management, has been insufficiently addressed. Focusing on a subtropical coniferous forest with strong human disturbance in East China, our main objective was to evaluate and compare the relative importance of fuel composition, topography, and human activity for fire occurrence, size and BP. Local BP distribution was derived with stochastic fire simulation approach using detailed historical fire data (1990-2010) and forest-resource survey results, based on which our factor contribution analysis was carried out. Our results indicated that fuel composition had the greatest relative importance in explaining fire occurrence and size, but human activity explained most of the variance in BP. This implies that the influence of human activity is amplified through the process of overlapping repeated ignition and spreading events. This result emphasizes the status of strong human disturbance in local fire processes. It further confirms the need for a holistic perspective on factor contribution to fire likelihood, rather than focusing on individual fire regime attributes, for the purpose of fire risk management.	[Ye, Tao; Wang, Yao; Li, Yijia] Beijing Normal Univ, Acad Disaster Reduct & Emergency Management, Minist Civil Affairs, Beijing, Peoples R China; [Ye, Tao; Wang, Yao; Li, Yijia] Beijing Normal Univ, Minist Educ, Beijing, Peoples R China; [Ye, Tao; Wang, Yao; Li, Yijia] Beijing Normal Univ, Fac Geog Sci, Beijing, Peoples R China; [Ye, Tao; Wang, Yao; Li, Yijia] Beijing Normal Univ, Catastrophe Res Ctr, Beijing, Peoples R China; [Guo, Zhixing] State Ocean Adm Peoples Republ China, Natl Marine Hazard Mitigat Serv, Beijing, Peoples R China	Beijing Normal University; Beijing Normal University; Beijing Normal University; Beijing Normal University	Wang, Y (corresponding author), Beijing Normal Univ, Acad Disaster Reduct & Emergency Management, Minist Civil Affairs, Beijing, Peoples R China.; Wang, Y (corresponding author), Beijing Normal Univ, Minist Educ, Beijing, Peoples R China.; Wang, Y (corresponding author), Beijing Normal Univ, Fac Geog Sci, Beijing, Peoples R China.; Wang, Y (corresponding author), Beijing Normal Univ, Catastrophe Res Ctr, Beijing, Peoples R China.	wangyao@mail.bnu.edu.cn		Ye, Tao/0000-0002-5037-8410	National Key Research and Development Program of China [2016YFA0602404]	National Key Research and Development Program of China	This reseach was funded by National Key Research and Development Program of China under grant No. 2016YFA0602404. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ager AA, 2013, RISK ANAL, V33, P1000, DOI 10.1111/j.1539-6924.2012.01911.x; Almeida RM, 2011, J PHYS C SER, P285; Arpaci A, 2014, APPL GEOGR, V53, P258, DOI 10.1016/j.apgeog.2014.05.015; Barros AMG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084760; Biswas S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124346; Bowman DMJS, 2011, J BIOGEOGR, V38, P2223, DOI 10.1111/j.1365-2699.2011.02595.x; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Calkin DE, 2014, P NATL ACAD SCI USA, V111, P746, DOI 10.1073/pnas.1315088111; Canada Forestry Canada Fire Danger Group, 1992, Information Report ST-X, Forestry Canada; Casella G, 2004, GEN ACCEPT REJECT SA, V45, P342; Chang Y, 2016, NAT HAZARDS, V81, P981, DOI 10.1007/s11069-015-2116-9; Chuvieco E, 2009, INT J WILDLAND FIRE, V18, P430, DOI 10.1071/WF08020; Cutler DR, 2007, ECOLOGY, V88, P2783, DOI 10.1890/07-0539.1; De Angelis A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116875; DeWilde L, 2006, ECOSYSTEMS, V9, P1342, DOI 10.1007/s10021-006-0095-0; Finney MA, 2011, STOCH ENV RES RISK A, V25, P973, DOI 10.1007/s00477-011-0462-z; Genuer R, 2010, PATTERN RECOGN LETT, V31, P2225, DOI 10.1016/j.patrec.2010.03.014; Gill AM, 2008, INT J WILDLAND FIRE, V17, P688, DOI 10.1071/WF07145; Gromping U, 2006, J STAT SOFTW, V17, DOI 10.18637/jss.v017.i01; Haas JR, 2015, RISK ANAL, V35, P226, DOI 10.1111/risa.12270; Haas JR, 2013, LANDSCAPE URBAN PLAN, V119, P44, DOI 10.1016/j.landurbplan.2013.06.011; Hastie T., 2009, ELEMENTS STAT LEARNI, V2nd ed.; Iudin DI, 2015, COMMUN NONLINEAR SCI, V21, P190, DOI 10.1016/j.cnsns.2014.10.019; Joel LS, 2012, CELLULAR AUTOMATA DI; Johnson JW, 2004, ORGAN RES METHODS, V7, P238, DOI 10.1177/1094428104266510; Kellogg LKB, 2008, LANDSCAPE ECOL, V23, P227, DOI 10.1007/s10980-007-9188-1; Krebs P, 2010, THEOR BIOSCI, V129, P53, DOI 10.1007/s12064-010-0082-z; Lindeman RH, 1979, INTRO BIVARIATE MULT; Liu XP, 2012, NAT HAZARDS, V64, P381, DOI 10.1007/s11069-012-0244-z; Liu ZJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127690; Liu ZH, 2012, GLOBAL CHANGE BIOL, V18, P2041, DOI 10.1111/j.1365-2486.2012.02649.x; Liu ZY, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0066666, 10.1371/journal.pone.0055618]; Lozano FJ, 2008, REMOTE SENS ENVIRON, V112, P708, DOI 10.1016/j.rse.2007.06.006; Mao X., 1993, J APPL METEOROL, V4, P100; Metropolis N., 1987, LOS ALAMOS SCI, V15, P125, DOI DOI 10.1128/JCM.05092-11; NOBLE IR, 1980, AUST J ECOL, V5, P201, DOI 10.1111/j.1442-9993.1980.tb01243.x; Oliveira S, 2012, FOREST ECOL MANAG, V275, P117, DOI 10.1016/j.foreco.2012.03.003; Pan JH, 2016, NAT HAZARDS, V81, P1879, DOI 10.1007/s11069-016-2160-0; Parisien M-A, 2005, FORESTRY; Parisien MA, 2013, NAT HAZARDS, V66, P439, DOI 10.1007/s11069-012-0495-8; Parks SA, 2011, INT J WILDLAND FIRE, V20, P815, DOI 10.1071/WF10051; Pastor E, 2003, PROG ENERG COMBUST, V29, P139, DOI 10.1016/S0360-1285(03)00017-0; Pereira AC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102380; Pierce AD, 2012, FOREST ECOL MANAG, V279, P77, DOI 10.1016/j.foreco.2012.05.010; Prasad AM, 2006, ECOSYSTEMS, V9, P181, DOI 10.1007/s10021-005-0054-1; Pyne S, 1996, INTRO WILDLAND FIRE, P1; Rollins MG, 2002, LANDSCAPE ECOL, V17, P539, DOI 10.1023/A:1021584519109; Rothermel R. C., 1972, USDA Forests Service Research Paper, Intermountain Forest and Range Experiment Station; Salis M, 2014, NAT HAZARDS, V71, P1389, DOI 10.1007/s11069-013-0951-0; Schoennagel T, 2004, BIOSCIENCE, V54, P661, DOI 10.1641/0006-3568(2004)054[0661:TIOFFA]2.0.CO;2; State Forestry Administration of PR China, 2014, CHIN FOR RES 2009 20; State Forestry Administration of PR China, CHIN FOR STAT YB; Syphard AD, 2007, ECOL APPL, V17, P1388, DOI 10.1890/06-1128.1; Thompson MP, 2011, STOCH ENV RES RISK A, V25, P761, DOI 10.1007/s00477-011-0461-0; Viedma O, 2009, INT J WILDLAND FIRE, V18, P575, DOI 10.1071/WF08030; Wang LT, 2013, NAT HAZARDS, V65, P819, DOI 10.1007/s11069-012-0391-2; Wang Z, 1992, J NAT DISASTERS, V3, P39, DOI DOI 10.13577/J.JND.1992.0306; Wer B, 2004, NAT RESOUR MODEL, V17, P359; Westerling AL, 2006, SCIENCE, V313, P940, DOI 10.1126/science.1128834; Wotton BM, 2009, ENVIRON ECOL STAT, V16, P107, DOI 10.1007/s10651-007-0084-2	60	23	24	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0172110	10.1371/journal.pone.0172110	http://dx.doi.org/10.1371/journal.pone.0172110			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL2BG	28207837	Green Submitted, gold, Green Published			2022-12-27	WOS:000394424500085
J	Zange, JC; Schopen, K; Albracht, K; Gerlach, DA; Frings-Meuthen, P; Maffiuletti, NA; Bloch, W; Rittweger, J				Zange, Jochen; Schopen, Kathrin; Albracht, Kirsten; Gerlach, Darius A.; Frings-Meuthen, Petra; Maffiuletti, Nicola A.; Bloch, Wilhelm; Rittweger, Joern			Using the Hephaistos orthotic device to study countermeasure effectiveness of neuromuscular electrical stimulation and dietary lupin protein supplementation, a randomised controlled trial	PLOS ONE			English	Article							MUSCLE DISUSE ATROPHY; WHEY-PROTEIN; BONE LOSS; BED REST; METABOLIC-ACIDOSIS; BODY-COMPOSITION; SPACE-FLIGHT; RAT MUSCLE; EXERCISE; VOLUME	Purpose The present study investigated whether neuromuscular electrical stimulation for 20 min twice a day with an electrode placed over the soleus muscle and nutritional supplementation with 19 g of protein rich lupin seeds can reduce the loss in volume and strength of the human calf musculature during long term unloading by wearing an orthotic unloading device. Methods Thirteen healthy male subjects (age of 26.4 +/- 3.7 years) wore a Hephaistos orthosis one leg for 60 days during all habitual activities. The leg side was randomly chosen for every subject. Six subjects only wore the orthosis as control group, and 7 subjects additionally received the countermeasure consisting of neuromuscular electrical stimulation of the soleus and lateral gastrocnemius muscles and lupin protein supplementation. Twenty-eight days before and on the penultimate day of the intervention cross-sectional images of the calf muscles were taken by magnetic resonance imaging (controls n = 5), and maximum voluntary torque (controls n = 6) of foot plantar flexion was estimated under isometric (extended knee, 90 degrees knee flexion) and isokinetic conditions (extended knee), respectively. Results After 58 days of wearing the orthosis the percentage loss of volume in the entire triceps surae muscle of the control subjects (-11.9 +/- 4.4%, mean +/- standard deviation) was reduced by the countermeasure (-3.5 +/- 7.2%, p = 0.032). Wearing the orthosis generally reduced plantar flexion torques values, however, only when testing isometric contraction at 90 degrees knee ankle the countermeasure effected a significantly lower percentage decrease of torque (-9.7 +/- 7.2%, mean + SD) in comparison with controls (-22.3 +/- 11.2%, p = 0.032). Conclusion Unloading of calf musculature by an orthotic device resulted in the expected loss of muscle volume and maximum of plantar flexion torque. Neuromuscular electrical muscle stimulation and lupin protein supplementation could significantly reduce the process of atrophy.	[Zange, Jochen; Schopen, Kathrin; Gerlach, Darius A.; Frings-Meuthen, Petra; Rittweger, Joern] German Aerosp Ctr DLR, Inst Aerosp Med, Div Space Physiol, Cologne, Germany; [Schopen, Kathrin; Bloch, Wilhelm] German Sport Univ Cologne, Dept Mol & Cellular Sport Med, Cologne, Germany; [Albracht, Kirsten] German Sport Univ Cologne, Inst Biomech & Orthopaed, Cologne, Germany; [Maffiuletti, Nicola A.] Schulthess Clin, Human Performance Lab, Zurich, Switzerland; [Rittweger, Joern] Univ Cologne, Dept Paediat & Adolescent Med, Cologne, Germany	Helmholtz Association; German Aerospace Centre (DLR); German Sport University Cologne; German Sport University Cologne; Schulthess Clinic; University of Cologne	Rittweger, J (corresponding author), German Aerosp Ctr DLR, Inst Aerosp Med, Div Space Physiol, Cologne, Germany.; Rittweger, J (corresponding author), Univ Cologne, Dept Paediat & Adolescent Med, Cologne, Germany.	jochen.zange@dlr.de	Rittweger, Jörn/A-4308-2009; Maffiuletti, Nicola A./AAF-3861-2019; Gerlach, Darius/GON-7187-2022	Rittweger, Jörn/0000-0002-2223-8963; Maffiuletti, Nicola A./0000-0001-5670-286X; Gerlach, Darius/0000-0001-7044-6065; Zange, Jochen/0000-0003-1822-0952; Albracht, Kirsten/0000-0002-4271-2511	DLR [2475101]; Helmholtz Space Life Sciences Research School (SpaceLife); Helmholtz Association [VH-KO-300]; German Aerospace Center (DLR); I.A.C.E.R. S.r.l., Venezia, Italy; University of Verona, Italy	DLR(Helmholtz AssociationGerman Aerospace Centre (DLR)); Helmholtz Space Life Sciences Research School (SpaceLife); Helmholtz Association(Helmholtz Association); German Aerospace Center (DLR)(Helmholtz AssociationGerman Aerospace Centre (DLR)); I.A.C.E.R. S.r.l., Venezia, Italy; University of Verona, Italy	This study was funded by the internal cost object 2475101 of DLR. Kathrin Schopen received a Helmholtz Space Life Sciences Research School (SpaceLife) PhD scholarship. SpaceLife was funded in equal parts by the Helmholtz Association (grant no.: VH-KO-300) and the German Aerospace Center (DLR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r The authors would like to acknowledge the support by Chiara Fassina and Massimo Marcon from I.A.C.E.R. S.r.l., Venezia, Italy who provided the T-ONE MEDI PRO device for this study. We further acknowledge the support by Paolo Bruseghini from the University of Verona, Italy, who supported this study in scope of an internship, the support by all subjects taking part in this study, as well as the support by the staff of the Space Physiology group at DLR. This study was funded by the internal cost object 2475101 of DLR. Kathrin Schopen received a Helmholtz Space Life Sciences Research School (SpaceLife) PhD scholarship. SpaceLife was funded in equal parts by the Helmholtz Association (grant no.: VH-KO-300) and the German Aerospace Center (DLR).	Belavy DL, 2009, EUR J APPL PHYSIOL, V107, P489, DOI 10.1007/s00421-009-1136-0; Bertoglio JC, 2011, FITOTERAPIA, V82, P933, DOI 10.1016/j.fitote.2011.05.007; Bickel CS, 2011, EUR J APPL PHYSIOL, V111, P2399, DOI 10.1007/s00421-011-2128-4; Boone CH, 2015, APPL PHYSIOL NUTR ME, V40, P797, DOI 10.1139/apnm-2015-0027; Buehring B, 2011, J APPL PHYSIOL, V111, P87, DOI 10.1152/japplphysiol.01294.2010; CRESSWELL AG, 1995, EXP BRAIN RES, V105, P283; Dirks ML, 2014, ACTA PHYSIOL, V210, P628, DOI 10.1111/apha.12200; Dupont AC, 2003, IEEE T NEUR SYS REH, V11, P218, DOI 10.1109/TNSRE.2003.817674; Duranti M, 2008, TRENDS FOOD SCI TECH, V19, P624, DOI 10.1016/j.tifs.2008.07.002; Frings-Meuthen P, 2008, J BONE MINER RES, V23, P517, DOI [10.1359/jbmr.071118, 10.1359/JBMR.071118]; GIBSON JNA, 1988, LANCET, V2, P767; GORDON T, 1994, PHYS THER, V74, P50, DOI 10.1093/ptj/74.1.50; GOULD N, 1983, CLIN ORTHOP RELAT R, P190; Guo BS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030348; Hamada T, 2004, J APPL PHYSIOL, V96, P911, DOI 10.1152/japplphysiol.00664.2003; Hargens AR, 2013, EUR J APPL PHYSIOL, V113, P2183, DOI 10.1007/s00421-012-2523-5; HENRIKSSON J, 1982, AM J PHYSIOL, V242, pC272, DOI 10.1152/ajpcell.1982.242.5.C272; HERBISON GJ, 1973, ARCH PHYS MED REHAB, V54, P156; Houston M E, 1983, Can J Appl Sport Sci, V8, P49; Hulmi JJ, 2015, J INT SOC SPORT NUTR, V12, DOI 10.1186/s12970-015-0109-4; Kemmler W, 2016, OSTEOPOROSIS INT, V27, P3261, DOI 10.1007/s00198-016-3662-z; KOSMAN AJ, 1946, AM J PHYSIOL, V145, P447, DOI 10.1152/ajplegacy.1946.145.4.447; Koukourikos Konstantinos, 2014, Acta Inform Med, V22, P406, DOI 10.5455/aim.2014.22.406-410; LeBlanc A, 2000, J APPL PHYSIOL, V89, P2158, DOI 10.1152/jappl.2000.89.6.2158; LeBlanc A, 2013, OSTEOPOROSIS INT, V24, P2105, DOI 10.1007/s00198-012-2243-z; Maffiuletti NA, 2003, EUR J APPL PHYSIOL, V90, P601, DOI 10.1007/s00421-003-0914-3; Maffiuletti NA, 2002, J APPL PHYSIOL, V92, P1383, DOI 10.1152/japplphysiol.00884.2001; MAY RC, 1987, AM J PHYSIOL, V252, pE712, DOI 10.1152/ajpendo.1987.252.6.E712; MITCH WE, 1994, J CLIN INVEST, V93, P2127, DOI 10.1172/JCI117208; Paoli A, 2016, TRANSITION NUTR, V8; Rittweger J, 2014, Below-knee orthosis, Patent No. [PCT/EP2012/067730, 2012067730]; Rittweger J, 2010, BONE, V46, P137, DOI 10.1016/j.bone.2009.08.051; Shackelford LC, 2004, J APPL PHYSIOL, V97, P119, DOI 10.1152/japplphysiol.00741.2003; Stein TP, 2013, EUR J APPL PHYSIOL, V113, P2171, DOI 10.1007/s00421-012-2548-9; Stein TP, 2011, CRIT REV FOOD SCI, V51, P828, DOI 10.1080/10408398.2010.482679; Tanaka M, 2014, ACTA HISTOCHEM, V116, P1192, DOI 10.1016/j.acthis.2014.06.009; Tesch P A, 1991, Physiologist, V34, pS104; Tieland M, 2012, J AM MED DIR ASSOC, V13, P713, DOI 10.1016/j.jamda.2012.05.020; Traon APL, 2007, EUR J APPL PHYSIOL, V101, P143, DOI 10.1007/s00421-007-0474-z; Vaz MA, 2013, J ORTHOP RES, V31, P511, DOI 10.1002/jor.22264; Weber T, 2013, J MUSCULOSKEL NEURON, V13, P487; Weber T, 2014, CLIN PHYSIOL FUNCT I, V34, P229; Weber-Carstens S, 2013, AM J RESP CRIT CARE, V187, P387, DOI 10.1164/rccm.201209-1649OC; Weinheimer EM, 2012, J NUTR, V142, P1532, DOI 10.3945/jn.111.153619; Weisgarber KD, 2015, J NUTR HEALTH AGING, V19, P511, DOI 10.1007/s12603-015-0454-7; Williams N, 2014, PHYSIOTHER THEOR PR, V30, P6, DOI 10.3109/09593985.2013.811567; Zange J, 1997, INT J SPORTS MED, V18, pS308, DOI 10.1055/s-2007-972738; Zange J, 2009, EUR J APPL PHYSIOL, V105, P271, DOI 10.1007/s00421-008-0899-z	48	4	4	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0171562	10.1371/journal.pone.0171562	http://dx.doi.org/10.1371/journal.pone.0171562			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207840	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000394424500037
